Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AAAS ENSG00000094914 "Aladin WD repeat nucleoporin" Q9NRG9 12 53307456-53324864 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040086 Approved Approved "Nuclear membrane,Centrosome,Cytosol" NA NA "Nuclear membrane" "Centrosome, Cytosol" "HPA040086: AB_10805602" "unprognostic (1.53e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (1.51e-3)" "unprognostic (1.70e-1)" "unprognostic (4.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.57e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (2.53e-1)" "unprognostic (7.44e-2)" 15.0 35.1 13.4 22.0 16.6 19.9 16.5 19.2 18.4 17.6 16.4 22.6 20.9 15.4 19.3 26.1 18.2 25.3 19.4 20.7 13.2 11.8 20.4 26.0 13.4 23.4 19.3 10.1 19.7 27.3 33.1 27.3 23.6 15.8 17.3 19.3 21.5 22.8 18.5 19.7 22.2 17.5 21.2 16.4 22.0 19.1 26.6 19.5 39.1 19.5 24.6 24.4 17.2 16.9 15.3 17.2 8.2 14.7 10.0 16.7 10.1 10.3 31.5 24.6 15.1 11.7 14.2 15.8 11.8 12.8 29.8 17.2 21.4 22.0 24.8 20.4 15.0 16.9 15.1 42.9 31.5 17.6 15.7 27.7 20.2 13.9 21.5 11.9 17.8 15.3 13.6 15.9 19.7 19.2 16.2 23.4 21.3 26.7 28.8 14.4 33.5 28.0 18.5 16.9 12.2 22.0 27.5 16.4 27.8 21.1 8.5 13.2 16.9 8.7 19.7 9.1 16.4 25.3 15.6 10.6 14.2 21.5 11.3 12.5 12.9 16.3 22.6 11.4 15.5 16.3 1.2 12.1 8.2 13.7 14.0 16.5 15.2 12.3 12.6 13.7 15.3 16.7 16.2 1.1 10.0 14.7 17.2 12.6 10.1 13.4 16.6 19.2 18.4 13.2 11.8 19.3 10.1 15.8 19.5 11.9 5.6 10.4 16.1 6.5 11.3 5.9 15.3 6.7 7.9 14.0 15.7 53.6 11.6 17.4 11.4 9.1 9.8 23.3 16.1 43.4 12.2 8.6 8.1 11.5 25.1 1.6 8.1 10.4 9.1 18.3 16.4 10.8 10.1 10.8 11.5 17.4 9.4 13.5 12.0 15.4 14.7 19.4 11.3 26.5 45.3 6.5 30.6 10.2 16.2 8.0 AAGAB "FLJ11506, p34" ENSG00000103591 "Alpha and gamma adaptin binding protein" Q6PD74 15 67201033-67255195 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039371, HPA040174" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA039371: AB_10805476, HPA040174: AB_10805605" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (8.25e-2)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (2.84e-2)" "unprognostic (4.52e-2)" "unprognostic (9.10e-2)" "unprognostic (5.28e-2)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.88e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (1.53e-1)" 19.3 23.6 17.0 15.6 22.5 15.6 20.3 13.3 29.8 16.7 23.6 14.7 24.1 13.3 18.1 24.7 22.3 14.6 16.1 14.8 15.9 22.5 29.5 22.2 15.2 15.4 17.7 20.2 14.4 18.0 29.9 39.1 16.0 31.5 16.9 29.7 14.9 19.3 19.0 33.4 14.3 21.9 18.4 13.8 18.2 20.1 23.8 13.4 25.9 28.8 18.1 21.4 19.8 14.1 16.1 23.9 28.4 24.7 27.7 26.8 20.1 18.3 33.3 24.0 24.6 23.9 19.5 12.0 19.3 28.6 23.5 27.0 24.6 20.0 17.7 19.8 20.3 29.5 37.1 49.9 22.6 24.6 24.6 23.6 16.8 25.0 10.0 25.9 28.5 19.7 19.0 31.2 17.4 37.5 15.7 18.5 23.5 34.7 25.1 22.8 22.4 17.3 12.2 20.6 23.0 12.1 19.5 30.8 21.4 21.5 43.4 34.4 22.0 23.2 16.7 27.3 22.0 27.3 21.8 19.3 21.4 25.9 19.0 26.9 13.1 43.9 26.5 20.3 26.7 21.3 28.4 18.9 18.5 23.5 24.6 26.8 16.1 20.8 22.1 23.9 12.5 17.7 19.4 10.1 27.7 24.7 17.7 25.1 20.1 17.0 22.5 13.3 29.8 15.9 22.5 17.7 20.2 31.5 13.4 3.0 4.8 13.8 14.3 10.6 12.5 11.2 5.1 18.7 17.0 26.2 25.5 14.1 14.9 23.4 7.6 12.0 20.0 0.0 27.3 12.2 10.3 19.0 10.4 11.9 14.4 17.5 15.1 6.2 12.4 6.4 7.2 9.5 6.8 25.2 14.3 13.7 19.6 17.8 10.6 17.0 17.7 12.9 11.3 35.2 37.3 12.0 13.8 15.0 13.5 21.1 AAK1 "DKFZp686K16132, KIAA1048" ENSG00000115977 "AP2 associated kinase 1" Q2M2I8 2 69457997-69674349 "Enzymes, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 109.7" "Cell type enhanced" "Detected in all" 9 "Cone photoreceptor cells: 732.4;Rod photoreceptor cells: 621.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017931, HPA020289" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA No "Vesicles, Plasma membrane" Cytosol "HPA017931: AB_1844406, HPA020289: AB_1844407" "unprognostic (2.11e-3)" "unprognostic (3.18e-2)" "unprognostic (3.67e-1)" "unprognostic (1.01e-3)" "unprognostic (5.06e-2)" "unprognostic (4.04e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-1)" "unprognostic (3.52e-1)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.24e-1)" "unprognostic (7.65e-2)" "unprognostic (4.18e-2)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.76e-3)" "unprognostic (1.18e-1)" 5.1 5.9 11.0 5.7 11.9 7.8 6.9 25.2 26.5 4.8 4.2 3.9 6.3 3.8 4.7 7.1 3.8 4.9 4.3 7.9 14.4 12.8 7.2 3.1 7.5 6.8 9.4 11.6 3.3 6.7 109.7 10.3 6.9 10.2 5.0 4.6 4.7 3.6 12.3 6.8 3.7 3.7 5.4 9.3 5.5 5.4 4.1 6.9 4.7 16.0 2.1 5.3 4.9 5.8 1.0 0.8 4.1 3.9 2.8 5.6 1.3 16.8 10.1 9.3 9.0 8.9 9.9 29.9 13.7 10.9 8.3 7.4 10.2 6.7 0.6 3.4 17.9 11.4 7.9 7.1 7.1 17.0 12.5 3.0 9.1 6.1 6.9 8.1 6.4 21.7 8.5 6.3 15.6 20.3 6.8 17.6 8.6 1.9 9.5 14.4 2.8 5.9 3.4 4.4 3.1 5.6 3.9 10.0 1.4 6.6 35.3 3.1 4.9 7.9 6.1 7.1 6.4 3.6 9.1 17.5 18.7 12.5 13.4 13.5 9.3 2.4 1.0 15.6 10.9 12.7 2.5 1.4 0.6 4.5 0.6 4.2 0.4 4.0 3.0 0.8 1.0 5.6 4.5 4.1 2.8 3.9 0.7 3.1 1.3 11.0 11.9 25.2 26.5 14.4 12.8 9.4 11.6 10.2 6.9 32.8 38.8 3.0 17.4 14.2 235.7 71.2 99.3 10.7 23.9 136.1 732.4 65.1 36.5 37.7 19.2 43.8 67.4 23.3 57.5 45.9 24.0 51.4 20.7 30.1 51.9 289.2 69.3 93.9 98.0 23.3 35.4 45.1 10.1 50.5 26.9 42.5 48.8 26.4 43.9 53.7 621.3 19.4 29.2 45.9 51.3 8.7 178.4 135.1 14.6 50.6 AAMDC "C11orf67, CK067, FLJ21035, PTD015" ENSG00000087884 "Adipogenesis associated Mth938 domain containing" Q9H7C9 11 77821109-77918432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 155.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 73.6" "Low region specificity" "Detected in all" "HPA037918, HPA037919" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037918: AB_2675737, HPA037919: AB_2675738" "unprognostic (3.10e-2)" "unprognostic (9.04e-3)" "unprognostic (6.02e-2)" "unprognostic (4.67e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-1)" "unprognostic (7.08e-2)" "unprognostic (1.90e-1)" "unprognostic (2.08e-1)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "unprognostic (3.84e-2)" 18.8 42.2 7.5 7.5 11.4 5.2 16.2 10.9 8.6 13.8 15.8 9.5 16.9 10.1 18.0 9.5 12.4 13.4 11.8 35.0 7.5 6.4 12.8 15.5 11.8 3.5 13.0 6.8 14.3 18.1 6.9 11.1 7.9 9.9 12.6 8.3 10.0 16.7 14.5 155.8 13.0 13.6 21.0 15.3 7.4 14.2 14.4 13.1 6.5 14.1 15.7 5.0 14.4 17.0 8.1 13.2 43.3 11.9 13.7 18.0 6.4 7.8 6.4 10.0 7.1 29.3 20.4 2.7 13.0 8.9 11.8 14.8 73.6 11.9 5.3 12.7 21.8 11.7 4.4 15.0 8.7 14.1 12.2 12.1 5.1 11.1 13.5 14.4 2.8 4.6 27.1 6.0 12.4 6.6 11.0 35.0 7.1 5.8 8.6 24.9 9.2 6.0 11.4 4.7 22.0 11.0 5.8 17.2 5.1 15.6 4.7 3.5 13.4 16.5 7.2 9.2 15.6 11.1 5.7 36.4 12.5 6.8 23.6 4.3 9.3 14.5 9.7 4.8 4.7 6.9 43.3 11.9 12.3 6.1 6.6 7.8 7.0 11.9 10.0 12.7 8.1 10.4 7.8 6.9 13.7 6.4 13.2 18.0 6.4 7.5 11.4 10.9 8.6 7.5 6.4 13.0 6.8 9.9 13.1 77.4 23.1 12.7 70.3 57.1 10.1 103.7 63.7 44.2 25.0 75.0 3.9 21.7 122.7 56.1 47.2 50.1 92.1 0.0 64.0 37.5 60.8 57.8 40.4 94.8 39.9 11.1 21.8 93.9 31.4 27.5 63.3 28.7 79.2 82.0 49.3 57.0 62.2 98.2 60.5 133.6 12.6 45.3 59.7 89.5 53.2 88.1 13.2 17.5 57.2 63.6 AAMP ENSG00000127837 "Angio associated migratory cell protein" Q13685 2 218264123-218270257 "Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017717, HPA031868" Approved Supported Microtubules,Cytosol NA NA Microtubules Cytosol "CAB017717: , HPA031868: AB_2674078" "unprognostic (1.57e-1)" "unprognostic (6.12e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.39e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (8.94e-2)" "unprognostic (7.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (4.22e-2)" "unprognostic (5.51e-2)" "unprognostic (1.23e-3)" "unprognostic (5.26e-2)" "unprognostic (1.92e-1)" "unprognostic (9.09e-2)" 36.3 40.4 41.2 35.5 49.1 15.9 36.7 40.8 48.5 36.5 48.5 30.8 48.3 38.7 38.2 34.1 50.0 40.1 50.2 39.7 37.3 35.7 38.2 49.8 28.8 29.0 39.0 51.4 53.1 59.2 44.0 37.9 40.4 40.8 39.3 37.2 28.7 43.9 41.4 47.8 42.6 39.0 42.8 32.8 32.2 51.4 50.9 36.5 27.8 46.6 33.6 32.1 39.9 34.6 30.2 50.9 15.7 53.2 27.2 31.6 41.8 32.5 27.4 19.5 26.7 30.3 21.1 37.3 22.7 36.1 43.9 32.7 58.6 25.6 16.2 33.5 29.0 42.8 24.7 39.5 34.5 34.8 26.6 50.0 37.1 28.1 66.4 42.0 34.7 24.5 26.5 40.4 46.0 40.3 26.5 25.5 32.0 50.1 21.5 28.8 47.9 30.4 58.9 32.4 46.9 19.2 22.6 25.8 29.0 27.0 41.8 25.4 24.1 15.2 34.1 33.2 32.8 27.0 27.1 21.9 32.5 21.5 21.1 27.2 27.8 49.8 27.6 30.6 22.7 21.1 15.7 44.2 14.9 28.8 53.2 29.3 27.3 25.4 26.1 50.9 30.2 31.6 28.8 7.0 27.2 50.2 29.7 27.2 41.8 41.2 49.1 40.8 48.5 37.3 35.7 39.0 51.4 40.8 36.5 38.7 32.8 54.2 73.5 80.4 43.9 30.0 48.4 32.1 34.2 40.1 11.8 138.1 87.9 70.2 2.4 44.1 68.2 0.0 83.0 108.9 77.1 66.5 33.5 40.9 79.6 60.4 72.5 38.6 32.3 5.9 77.1 54.7 59.1 73.9 72.0 67.5 73.1 66.6 70.4 67.0 30.1 64.7 66.5 69.1 46.6 85.1 169.5 35.5 82.0 104.3 AANAT SNAT ENSG00000129673 "Aralkylamine N-acetyltransferase" Q16613 17 76453351-76470117 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Melatonin biosynthesis" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 27.7;testis: 8.2" "Cell type enriched" "Detected in some" 9 "Bipolar cells: 269.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.6;Daudi: 3.8;SCLC-21H: 5.7;U-266/70: 4.6;U-266/84: 4.8;U-698: 6.8" "Not detected" "Not detected" HPA054321 Supported Cytosol "Intracellular and membrane" NA NA Cytosol "HPA054321: AB_2682449" "unprognostic (7.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-1)" "unprognostic (1.83e-2)" "unprognostic (2.03e-2)" "unprognostic (1.05e-2)" "unprognostic (3.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.61e-1)" "unprognostic (9.30e-2)" "unprognostic (4.19e-1)" "unprognostic (2.81e-7)" "unprognostic (1.04e-1)" "unprognostic (6.00e-2)" "unprognostic (4.47e-2)" "unprognostic (1.34e-2)" 0.3 0.2 1.2 3.8 0.8 2.7 0.3 1.3 1.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.8 0.4 1.8 0.3 1.2 1.5 0.3 0.3 0.3 3.3 1.7 0.7 0.4 0.3 0.0 0.9 0.3 1.9 0.3 0.0 27.7 0.3 0.3 1.8 3.3 0.7 0.3 1.2 2.2 0.2 8.2 0.3 0.3 0.8 0.3 0.3 0.9 0.3 1.3 1.3 2.2 0.1 1.8 0.2 0.0 0.9 4.6 0.7 0.5 0.0 0.1 0.5 0.0 0.4 0.3 0.1 0.1 3.3 3.8 0.5 0.0 0.7 1.2 0.0 0.0 0.3 0.0 1.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.4 0.0 2.0 0.4 0.6 0.1 0.1 1.2 1.5 0.4 0.2 0.2 2.0 0.0 0.1 5.7 0.4 0.1 0.2 1.6 0.6 2.8 0.7 0.0 0.0 1.8 0.2 0.1 4.6 4.8 6.8 1.2 0.4 0.8 2.0 0.1 2.2 0.2 0.0 0.0 0.6 0.1 0.0 0.0 1.3 0.0 0.2 0.6 1.8 0.0 1.3 0.1 0.0 1.2 0.8 1.3 0.9 1.2 1.5 1.7 0.7 1.9 0.3 0.0 0.0 0.0 0.0 0.0 269.2 0.3 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 1.2 0.0 0.0 12.3 0.3 0.0 0.0 0.0 0.0 6.6 0.2 0.0 0.0 0.3 29.7 0.0 0.0 1.7 1.0 0.0 0.1 0.0 0.0 0.0 AAR2 "bA234K24.2, C20orf4" ENSG00000131043 "AAR2 splicing factor homolog" Q9Y312 20 36236459-36270918 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034220, HPA048645" Uncertain Approved Cytosol NA NA Cytosol "CAB034220: AB_1564205, HPA048645: AB_2680475" "unprognostic (1.73e-1)" "unprognostic (1.30e-1)" "unprognostic (3.92e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.54e-3)" "prognostic unfavorable (1.83e-6)" "unprognostic (5.09e-2)" "unprognostic (6.84e-2)" "unprognostic (6.38e-2)" "unprognostic (3.79e-1)" "unprognostic (3.31e-1)" "unprognostic (4.61e-3)" "unprognostic (4.58e-2)" "unprognostic (5.85e-2)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" 18.8 22.3 9.8 11.6 14.0 18.4 20.0 11.3 19.0 17.0 21.9 21.3 12.9 12.3 27.3 21.3 16.1 19.7 16.5 16.2 9.9 9.2 16.2 22.2 15.5 23.1 13.2 12.5 19.5 21.0 19.5 9.5 20.6 13.6 22.8 14.3 20.3 22.7 18.7 19.3 21.9 17.8 23.2 13.0 16.8 20.4 38.5 10.8 28.8 17.8 17.1 15.6 23.1 19.4 20.6 27.5 28.4 30.1 31.7 30.9 28.7 11.8 14.3 13.4 15.3 23.0 15.4 11.0 11.6 15.5 27.7 21.7 32.2 16.2 8.3 16.5 16.9 21.4 17.1 21.9 22.4 17.6 7.4 13.0 26.0 9.6 19.4 17.3 17.7 13.2 18.8 31.8 19.8 15.0 13.8 16.8 16.5 16.1 16.4 14.9 14.5 24.4 21.5 11.5 18.0 23.6 13.7 22.4 18.8 15.5 9.3 15.5 16.7 17.4 46.3 14.7 13.0 26.7 19.0 11.9 26.0 16.6 15.3 14.5 14.6 18.4 16.3 18.5 11.8 13.6 28.4 25.5 22.9 25.8 27.3 25.8 19.0 24.3 24.7 27.5 20.6 30.9 26.2 5.2 31.7 30.1 22.4 27.5 28.7 9.8 14.0 11.3 19.0 9.9 9.2 13.2 12.5 13.6 10.8 6.0 12.2 11.0 8.4 5.0 4.7 5.1 10.2 12.0 4.5 8.7 7.9 17.7 10.0 16.4 2.3 11.2 6.4 0.0 18.1 13.6 9.3 8.9 16.1 10.4 13.0 14.3 10.9 10.4 16.2 3.1 10.3 8.4 10.1 10.8 10.6 5.7 14.2 5.8 14.2 6.8 2.8 6.5 9.8 14.4 14.4 6.6 15.6 7.7 9.8 7.4 AARS "AlaRS, CMT2N" ENSG00000090861 "Alanyl-tRNA synthetase" P49588 16 70252295-70289543 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease mutation, Epilepsy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034261, HPA040870" Supported Supported Cytosol NA NA 700000 Cytosol "CAB034261: AB_1562673, HPA040870: AB_10794995" "unprognostic (1.98e-2)" "unprognostic (6.87e-2)" "unprognostic (8.02e-2)" "unprognostic (5.72e-2)" "unprognostic (3.58e-1)" "unprognostic (2.50e-2)" "unprognostic (7.99e-2)" "unprognostic (2.36e-1)" "unprognostic (1.99e-1)" "unprognostic (1.76e-1)" "unprognostic (8.33e-2)" "unprognostic (2.92e-1)" "unprognostic (3.42e-2)" "unprognostic (3.75e-2)" "unprognostic (2.05e-3)" "unprognostic (8.22e-2)" "unprognostic (3.83e-3)" 22.8 25.3 28.0 19.6 34.8 5.9 22.6 36.4 54.0 22.3 18.4 30.6 21.4 16.8 22.0 33.9 14.5 20.4 14.1 20.9 29.5 31.7 25.5 36.4 19.5 17.9 40.3 40.5 18.7 45.4 61.2 23.1 21.0 37.5 23.2 17.5 17.3 30.1 30.0 25.2 14.1 14.4 28.4 33.2 16.7 21.1 12.2 32.7 10.3 42.1 10.6 20.9 17.7 26.9 13.4 11.6 3.9 13.3 21.3 13.4 11.6 23.3 39.3 10.8 40.3 25.4 23.1 26.2 18.5 25.7 23.4 29.6 32.2 31.5 26.5 24.9 18.6 17.9 27.3 31.3 25.2 32.9 12.0 11.3 26.1 16.7 28.5 67.3 15.6 15.7 27.3 38.1 44.9 100.6 18.6 23.1 41.9 33.2 35.0 17.4 52.8 16.8 18.3 20.4 30.1 22.7 32.1 6.9 57.9 15.9 12.0 13.5 11.6 51.4 12.1 45.5 16.1 37.9 34.5 15.3 17.3 16.8 17.1 15.4 49.4 32.4 48.9 29.5 24.5 33.8 3.9 8.6 3.9 12.6 12.7 12.8 13.4 10.9 12.1 11.6 11.4 13.1 13.4 1.3 21.3 13.3 7.9 8.4 11.6 28.0 34.8 36.4 54.0 29.5 31.7 40.3 40.5 37.5 32.7 8.9 17.3 8.2 15.7 7.3 35.7 22.2 17.8 14.7 11.4 8.7 17.7 53.2 29.9 24.7 8.6 14.3 9.8 46.7 25.3 24.1 12.2 18.2 20.7 43.2 23.5 52.4 22.4 19.0 9.4 5.2 29.1 9.8 11.8 34.3 13.3 35.9 23.6 8.6 38.2 27.4 38.4 0.0 13.9 17.5 29.0 7.4 43.5 10.5 12.1 13.3 AARSD1 MGC2744 ENSG00000266967 "Alanyl-tRNA synthetase domain containing 1" Q9BTE6 17 42950526-42964498 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021408, HPA022869, HPA023714" Supported Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (2.85e-3)" "unprognostic (9.78e-2)" "unprognostic (1.67e-1)" "unprognostic (8.53e-2)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (7.41e-2)" "unprognostic (1.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.67e-6)" "unprognostic (2.20e-1)" "unprognostic (2.51e-1)" "unprognostic (3.73e-2)" "unprognostic (4.69e-3)" 11.2 13.5 16.2 9.9 20.5 9.1 13.7 20.5 25.2 13.2 10.5 11.9 14.3 8.3 15.6 14.8 12.6 13.9 12.7 21.7 14.8 15.7 13.6 16.0 8.0 10.2 14.1 21.7 18.2 29.6 16.7 12.4 9.5 19.2 12.5 11.7 13.1 16.6 13.0 41.1 10.1 8.1 15.6 11.1 9.7 11.3 58.4 9.5 8.8 14.4 20.6 14.4 10.0 10.0 17.2 18.4 2.3 15.1 14.5 16.3 9.2 14.3 19.8 15.4 15.3 18.7 18.0 11.7 15.7 13.2 18.3 12.2 17.2 12.1 39.0 0.7 16.3 11.2 12.3 21.2 23.6 21.0 13.0 16.7 15.3 21.4 9.1 24.7 30.3 8.6 16.3 12.8 12.6 32.1 12.6 14.7 17.7 27.9 8.3 17.3 8.2 30.0 21.4 10.6 19.9 9.9 19.7 31.5 40.0 18.0 13.6 19.9 12.4 7.5 7.8 19.9 17.4 21.1 25.2 13.8 18.8 17.0 9.6 21.7 13.1 16.6 24.1 12.5 18.7 20.1 2.3 10.6 0.8 12.3 15.1 16.2 15.4 12.9 14.6 17.1 17.2 16.3 15.7 0.3 14.5 12.6 18.4 12.2 9.2 16.2 20.5 20.5 25.2 14.8 15.7 14.1 21.7 19.2 9.5 11.9 8.0 23.8 7.0 7.3 22.2 0.6 5.1 12.0 14.8 14.0 31.4 7.6 3.3 6.7 55.5 6.7 5.4 0.0 5.2 7.8 8.8 6.4 4.7 3.4 4.6 14.3 11.5 5.5 3.8 15.9 12.0 5.2 3.3 5.4 4.9 6.0 3.4 5.8 10.3 4.1 16.1 0.0 9.5 39.6 21.5 4.0 2.3 11.5 9.3 6.3 ABCA12 "DKFZP434G232, ICR2B, LI2" ENSG00000144452 "ATP binding cassette subfamily A member 12" Q86UK0 2 214931542-215138428 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 23.1;tongue: 29.3" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 11.4;Suprabasal keratinocytes: 33.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 28.7;SK-BR-3: 13.4;T-47d: 7.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebral cortex: 1.6;hippocampal formation: 1.8" HPA078239 Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoli, Cytosol" "HPA078239: AB_2732373" "unprognostic (6.12e-2)" "unprognostic (4.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.49e-1)" "unprognostic (2.13e-1)" "unprognostic (2.09e-4)" "unprognostic (6.52e-3)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (2.50e-2)" "unprognostic (7.69e-2)" "unprognostic (5.92e-2)" "unprognostic (2.64e-2)" "unprognostic (2.36e-1)" "unprognostic (5.08e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.9 0.1 0.1 6.2 0.3 0.0 1.4 0.0 0.0 4.4 8.4 0.1 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 6.1 4.9 0.0 0.1 0.4 0.0 0.3 0.0 0.1 23.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.0 29.3 6.1 0.1 3.7 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.7 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 2.0 0.0 13.4 0.0 0.1 7.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 11.4 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.1 0.3 0.4 0.0 0.0 0.3 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.7 0.0 0.0 0.0 0.2 0.5 0.2 33.8 2.9 0.0 0.0 2.2 ABCA13 "FLJ33876, FLJ33951" ENSG00000179869 "ATP binding cassette subfamily A member 13" 7 48171458-48647496 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 64.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.7;LHCN-M2: 3.7;U-2 OS: 10.4;U-266/84: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063601 Approved Vesicles,Centrosome,Cytosol NA NA Vesicles "Centrosome, Cytosol" "HPA063601: AB_2685057" "unprognostic (8.97e-2)" "unprognostic (5.82e-2)" "unprognostic (3.18e-1)" "unprognostic (6.48e-2)" "unprognostic (2.65e-2)" "unprognostic (5.59e-2)" "unprognostic (5.19e-2)" "unprognostic (2.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.86e-3)" "unprognostic (6.03e-3)" "unprognostic (3.26e-1)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (3.62e-2)" 0.3 0.2 0.1 0.3 1.0 35.4 0.7 0.0 1.1 1.2 0.3 0.4 0.0 0.3 0.3 1.1 10.3 1.8 0.5 3.5 1.8 0.2 1.1 0.7 15.7 0.2 0.1 0.0 0.4 1.2 0.1 8.7 1.2 0.4 0.2 0.4 0.0 1.7 0.4 0.8 1.3 0.3 0.2 0.9 1.3 0.2 4.2 0.0 4.6 7.1 5.4 14.4 0.5 0.3 0.6 0.6 3.2 0.7 1.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.3 1.0 0.0 0.3 0.0 0.0 0.0 2.2 0.0 1.9 0.6 1.2 2.1 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 1.0 0.8 0.0 0.3 0.0 0.1 3.7 0.0 0.0 0.1 0.1 0.0 2.1 0.3 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.0 0.6 10.4 0.4 1.5 3.1 4.2 0.0 1.3 0.4 0.4 3.2 0.7 0.6 0.3 0.4 0.3 0.4 0.2 0.2 0.1 0.6 0.4 0.4 1.6 1.0 0.3 0.6 0.1 0.2 0.1 1.0 0.0 1.1 1.8 0.2 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.0 0.0 64.3 9.1 1.8 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.2 0.0 0.0 0.0 0.3 0.1 ABCA3 "ABC-C, ABC3, EST111653, LBM180" ENSG00000167972 "ATP binding cassette subfamily A member 3" Q99758 16 2275881-2340746 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;lung: 75.8" "Cell type enriched" "Detected in many" 6 "Alveolar cells type 2: 382.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007884 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007884: AB_1078077" "unprognostic (2.64e-1)" "unprognostic (2.19e-2)" "unprognostic (6.09e-3)" "unprognostic (2.61e-3)" "unprognostic (2.20e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-2)" "unprognostic (1.86e-1)" "unprognostic (6.58e-3)" "unprognostic (3.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (3.32e-2)" "unprognostic (7.85e-2)" "unprognostic (2.91e-1)" "unprognostic (1.30e-1)" 6.3 6.2 12.9 3.4 15.3 1.6 7.0 21.9 30.8 3.0 3.8 13.1 1.8 2.7 3.2 4.2 3.6 4.9 3.3 5.6 14.6 13.8 3.9 1.5 75.8 3.9 11.4 13.1 3.2 9.6 14.8 6.0 4.7 18.3 5.3 2.1 4.9 8.5 5.0 5.0 4.2 2.5 5.0 11.3 3.7 3.0 7.2 6.1 5.6 16.2 0.5 6.4 3.0 1.3 0.2 0.5 0.0 0.6 2.0 1.5 0.4 0.3 9.7 1.8 15.1 0.4 0.0 0.1 2.6 0.6 1.0 1.1 1.3 1.5 0.1 3.8 1.2 0.9 0.2 8.7 0.1 0.3 15.2 5.8 1.0 1.1 0.2 1.3 0.1 1.6 0.1 0.2 0.1 0.5 6.2 14.7 0.1 10.4 0.0 0.0 12.9 0.0 1.0 2.0 2.3 4.7 2.4 0.3 1.7 8.7 0.3 21.2 15.3 1.8 10.7 0.2 0.8 34.9 0.9 4.2 0.1 0.5 4.1 4.3 2.8 1.2 0.0 2.1 5.2 0.1 0.0 0.1 0.0 1.5 0.1 0.8 0.2 0.6 1.4 0.5 0.1 0.6 1.5 0.0 2.0 0.6 0.0 0.3 0.4 12.9 15.3 21.9 30.8 14.6 13.8 11.4 13.1 18.3 6.1 65.5 382.0 0.0 0.4 0.6 16.5 5.1 2.5 4.0 17.0 17.4 11.8 0.0 0.0 4.6 7.7 4.2 0.2 0.0 3.3 0.0 1.4 1.9 27.8 0.9 0.9 17.5 5.2 2.5 2.7 2.7 1.7 1.6 1.7 2.8 0.7 6.9 2.4 0.0 3.2 1.5 9.5 6.5 3.1 1.9 14.0 1.4 0.0 2.5 0.6 0.1 ABCA4 "ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1" ENSG00000198691 "ATP binding cassette subfamily A member 4" P78363 1 93992835-94121132 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" Translocase "Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 142.7" "Group enriched" "Detected in some" 14 "Cone photoreceptor cells: 424.1;Rod photoreceptor cells: 455.0" "Cancer enhanced" "Detected in many" "lung cancer: 3.1" "Region enriched" "Detected in some" 13 "pons and medulla: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2;SuSa: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064420, HPA078826" Enhanced Approved Cytosol NA NA Cytosol "HPA064420: , HPA078826: " "unprognostic (1.25e-1)" "unprognostic (3.93e-1)" "unprognostic (3.29e-2)" "unprognostic (7.17e-4)" "unprognostic (1.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.45e-4)" "unprognostic (3.77e-2)" "unprognostic (5.25e-1)" "unprognostic (3.70e-1)" "unprognostic (5.18e-2)" "unprognostic (1.17e-9)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.72e-4)" 0.7 0.0 0.3 0.2 0.4 0.0 1.1 0.2 0.9 0.7 0.2 3.2 0.2 3.7 0.2 12.9 0.2 0.6 0.2 0.2 2.0 0.2 6.7 1.2 0.4 0.3 0.3 0.2 0.3 0.2 0.0 0.2 0.8 25.5 0.3 0.0 142.7 0.2 2.1 0.2 3.5 4.2 0.2 0.2 0.2 0.1 2.1 0.2 0.2 0.7 0.2 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 5.0 0.2 0.3 0.0 0.2 0.1 0.0 0.0 11.2 0.5 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.7 3.5 1.2 0.6 0.0 0.0 0.5 0.0 0.5 0.0 0.2 1.0 0.0 0.0 0.2 0.0 1.4 0.5 0.0 2.0 0.0 0.0 0.2 0.3 0.3 0.5 0.5 0.0 0.0 1.0 4.2 0.2 5.1 0.4 0.0 0.2 0.3 2.2 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.9 2.0 0.2 0.3 0.2 25.5 0.2 0.0 0.6 0.0 0.2 0.1 14.3 0.8 0.0 2.7 0.0 7.0 424.1 0.1 0.0 0.0 8.5 0.8 0.0 0.0 0.0 1.1 0.2 1.5 0.0 0.0 0.1 9.5 0.0 0.6 0.0 15.5 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.4 0.0 455.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.5 ABCA8 KIAA0822 ENSG00000141338 "ATP binding cassette subfamily A member 8" O94911 17 68867292-68955392 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Leydig cells: 465.4;Muller glia cells: 138.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 16.6;ASC TERT1: 37.0;HSkMC: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044914 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044914: AB_10964859" "unprognostic (2.58e-2)" "unprognostic (2.76e-2)" "unprognostic (1.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.04e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (5.22e-2)" "unprognostic (6.68e-2)" "unprognostic (8.76e-2)" "unprognostic (1.42e-3)" "unprognostic (3.52e-3)" "unprognostic (1.88e-1)" "unprognostic (3.29e-1)" "unprognostic (6.14e-3)" 29.1 25.2 10.0 3.4 27.2 0.5 15.1 3.2 15.4 7.3 12.8 29.9 3.9 5.4 10.2 13.0 12.4 17.6 14.3 30.0 12.5 5.5 8.1 26.6 15.2 1.3 37.8 9.2 44.7 5.1 4.5 14.8 7.6 22.2 10.3 14.3 16.4 9.8 7.9 8.9 4.9 9.9 7.1 28.2 9.9 11.5 15.8 42.7 0.0 13.0 14.2 2.8 13.6 20.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 16.6 37.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.1 0.0 0.0 27.9 0.0 0.4 0.0 0.2 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.0 27.2 3.2 15.4 12.5 5.5 37.8 9.2 22.2 42.7 47.6 0.6 0.0 1.3 5.4 1.4 12.5 0.0 0.0 7.9 0.0 2.0 0.1 0.0 0.0 4.2 4.2 0.0 0.0 0.0 0.1 35.3 0.3 1.1 35.8 0.9 4.8 0.0 7.4 1.9 4.3 465.4 1.8 1.7 0.0 0.0 138.5 0.0 0.0 66.1 0.0 2.1 38.8 6.2 1.1 1.2 4.1 0.2 0.0 0.0 0.2 ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168922938-169031322 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 47.4" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 38.7;Alveolar cells type 2: 58.1;Club cells: 35.2;granulocytes: 22.1;Hepatocytes: 17.9" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.0;NB-4: 1.7;PC-3: 1.0;THP-1: 2.6;TIME: 1.8;U-2197: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 38.7 58.1 0.0 0.0 0.0 0.0 0.3 0.0 16.0 35.2 0.0 0.0 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.1 17.9 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 ABCB6 "EST45597, MTABC3, umat" ENSG00000115657 "ATP binding cassette subfamily B member 6 (Langereis blood group)" Q9NP58 2 219209766-219219017 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dyskeratosis congenita, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 4.0;Club cells: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046723, HPA058011" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol" NA NA 22000 "Golgi apparatus" "Nucleoplasm, Plasma membrane, Mitochondria, Cytosol" "HPA046723: AB_10960288, HPA058011: AB_2683578" "unprognostic (8.04e-2)" "unprognostic (3.22e-2)" "unprognostic (4.53e-3)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (9.45e-7)" "unprognostic (2.26e-1)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" "unprognostic (1.18e-4)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.51e-1)" "unprognostic (9.55e-2)" "unprognostic (7.75e-2)" "unprognostic (2.30e-1)" 10.1 8.4 8.2 3.9 13.5 10.2 9.2 7.6 9.1 6.9 7.6 5.4 8.3 8.1 7.1 10.1 9.0 8.4 8.5 9.5 5.6 8.2 6.9 16.2 7.2 4.9 9.8 7.6 13.1 7.1 8.0 6.0 3.7 9.2 9.2 4.2 6.0 5.6 11.3 24.0 5.5 8.0 9.5 9.2 3.2 6.8 19.5 7.7 0.8 9.9 11.3 4.7 14.8 6.0 2.8 5.6 1.3 1.1 1.2 3.2 2.4 0.1 9.9 2.0 12.5 14.0 5.0 12.3 3.7 3.4 4.1 4.1 15.2 2.1 0.1 19.1 3.6 2.2 21.4 0.2 1.5 1.3 6.3 2.2 15.5 10.9 27.9 16.9 0.0 5.2 7.3 1.8 2.7 0.0 6.1 7.1 2.1 13.1 1.9 2.7 5.1 1.0 0.1 3.1 23.0 4.1 5.2 6.3 0.6 2.2 0.2 7.4 7.9 7.7 18.3 8.1 8.0 5.5 0.3 3.2 5.5 0.2 7.4 4.3 5.0 4.0 0.0 6.2 0.1 7.3 1.3 1.1 0.0 1.7 0.9 0.5 2.8 1.3 0.7 0.9 2.3 3.2 2.1 0.0 1.2 0.8 5.6 1.1 2.4 8.2 13.5 7.6 9.1 5.6 8.2 9.8 7.6 9.2 7.7 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 4.0 2.3 0.0 0.0 0.2 0.0 0.6 1.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.7 0.0 0.2 0.9 0.2 0.3 0.2 0.0 0.0 0.0 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;pancreas: 25.5;pituitary gland: 26.6" "Group enriched" "Detected in some" 8 "Bipolar cells: 39.2;Intestinal endocrine cells: 21.0" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 4.7;AN3-CA: 3.8;SCLC-21H: 6.7" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" No NA Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: AB_2677947" "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 1.3 6.7 4.4 0.8 6.1 0.9 4.0 28.0 12.3 3.0 1.3 2.6 7.7 1.9 3.1 3.7 0.8 1.2 0.9 2.9 5.1 4.8 1.0 0.8 2.9 0.8 3.6 7.2 0.9 25.5 1.0 26.6 1.6 8.5 2.8 1.3 0.7 0.9 8.5 2.3 1.1 1.5 1.3 4.0 0.9 3.5 1.1 2.3 0.0 6.2 0.0 0.8 0.7 0.8 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 4.7 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 4.4 6.1 28.0 12.3 5.1 4.8 3.6 7.2 8.5 2.3 0.0 0.0 0.0 0.0 0.0 39.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 21.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 0.0 1.2 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.0 0.1 ABCC9 "CMD1O, SUR2" ENSG00000069431 "ATP binding cassette subfamily C member 9" O60706 12 21797401-21942529 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Atrial fibrillation, Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 47.6;Hepatocytes: 84.7;Sertoli cells: 129.4;Smooth muscle cells: 47.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 17.6;BJ hTERT+: 10.1;CACO-2: 16.0;HSkMC: 21.0;U-138 MG: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007279 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007279: AB_1844435" "unprognostic (4.82e-2)" "unprognostic (3.62e-2)" "unprognostic (5.51e-4)" "unprognostic (1.09e-1)" "unprognostic (1.09e-1)" "unprognostic (8.30e-2)" "unprognostic (3.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.47e-2)" "unprognostic (8.72e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-1)" "prognostic unfavorable (1.85e-5)" "unprognostic (2.66e-2)" "unprognostic (1.21e-2)" "unprognostic (3.10e-3)" "unprognostic (8.22e-5)" 21.6 4.7 5.5 2.6 5.4 1.2 25.8 1.5 8.6 12.4 6.8 4.8 5.1 3.0 15.3 6.3 9.1 9.5 9.6 26.2 5.7 2.6 5.6 31.1 6.2 2.7 2.9 4.2 11.8 5.8 1.7 2.7 2.8 5.5 7.0 1.6 10.8 4.8 8.4 33.2 3.3 4.1 17.1 4.9 3.5 9.1 3.4 4.2 0.1 6.3 14.5 1.2 9.5 8.4 1.6 0.9 1.8 0.8 0.5 0.9 0.0 0.6 0.1 7.5 0.2 17.6 8.0 0.2 4.1 10.1 4.5 2.3 16.0 0.7 0.3 0.8 0.4 0.5 0.2 0.0 0.0 4.7 0.2 0.1 0.3 0.5 0.2 0.0 0.3 0.4 21.0 0.0 4.5 1.7 0.3 0.0 0.3 0.2 0.9 0.2 0.9 0.2 0.2 1.0 0.8 0.4 0.3 0.2 0.2 0.0 0.8 0.3 1.2 0.2 0.4 0.1 1.2 0.8 0.2 0.2 17.5 1.3 1.5 5.3 0.8 0.8 0.3 4.3 0.2 0.3 0.9 0.5 0.4 0.9 0.4 0.6 0.7 0.7 0.7 0.2 1.6 0.6 0.8 1.8 0.5 0.8 0.9 0.4 0.0 5.5 5.4 1.5 8.6 5.7 2.6 2.9 4.2 5.5 4.2 32.8 47.6 0.0 1.0 3.1 0.4 27.8 0.0 36.1 39.8 0.0 0.0 0.2 0.0 0.0 0.2 4.9 0.0 0.0 0.2 0.1 10.6 0.4 22.1 84.7 0.1 1.6 0.0 11.1 3.3 0.0 0.3 2.1 10.1 0.0 0.0 13.1 0.1 0.0 0.4 0.0 1.1 129.4 47.2 0.5 0.7 1.9 0.2 0.0 0.0 1.4 ABCE1 "OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I" ENSG00000164163 "ATP binding cassette subfamily E member 1" P61221 4 145097932-145129179 "Predicted intracellular proteins" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012476, HPA036846" Approved Enhanced Cytosol No No Cytosol "CAB012476: , HPA036846: AB_2675346" "unprognostic (2.22e-3)" "unprognostic (8.11e-3)" "prognostic favorable (8.69e-4)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (5.51e-3)" "prognostic unfavorable (6.29e-4)" "unprognostic (5.68e-3)" "unprognostic (6.77e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (1.56e-2)" "unprognostic (1.38e-3)" "unprognostic (2.85e-1)" "unprognostic (2.40e-1)" "unprognostic (2.08e-2)" "unprognostic (2.21e-1)" 27.5 19.4 17.5 23.3 23.7 17.5 25.3 21.0 23.2 20.8 16.5 17.7 14.7 14.4 19.5 15.8 28.5 19.4 16.4 19.5 19.5 18.0 23.1 40.1 17.3 27.3 22.1 15.5 28.2 34.2 23.0 31.7 21.2 26.0 18.4 21.1 11.0 19.0 15.1 33.1 19.9 14.1 20.7 22.1 29.0 16.7 21.2 20.7 36.5 20.1 29.7 29.5 26.0 19.0 9.9 13.2 1.0 8.8 10.4 18.2 9.9 26.7 14.0 21.7 15.0 18.9 27.4 21.2 29.3 21.1 35.7 25.3 21.1 25.4 43.9 9.5 26.1 18.8 18.0 32.3 38.2 48.4 24.4 19.0 24.7 10.5 18.6 24.9 56.9 20.0 20.2 26.7 37.8 53.4 18.4 38.3 33.5 49.6 32.9 38.1 16.1 54.5 19.0 17.9 41.4 32.5 29.0 26.1 31.3 26.8 17.8 27.1 13.3 17.8 30.3 20.9 17.2 18.1 22.3 25.2 35.4 21.8 24.6 35.3 29.5 47.0 47.0 21.7 49.7 39.1 1.0 6.7 0.7 9.2 8.8 18.2 9.9 11.1 11.1 13.2 9.2 15.6 12.9 0.6 10.4 8.1 7.4 12.4 9.9 17.5 23.7 21.0 23.2 19.5 18.0 22.1 15.5 26.0 20.7 23.8 16.0 38.8 65.1 53.1 33.8 21.0 15.3 32.1 52.4 24.4 19.6 32.6 33.2 31.5 22.0 37.2 6.4 23.3 24.2 35.3 34.5 51.8 31.3 28.0 37.4 39.7 19.7 22.1 22.2 9.3 43.4 34.8 18.6 27.9 22.3 17.5 33.7 3.5 32.5 29.3 34.2 32.3 31.6 76.0 70.9 51.9 22.2 27.7 30.4 68.4 ABCF1 "ABC50, EST123147" ENSG00000204574 "ATP binding cassette subfamily F member 1" Q8NE71 6 30571376-30597179 "Plasma proteins, Predicted intracellular proteins" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017578 Approved Enhanced Cytosol NA NA Cytosol "HPA017578: AB_1844438" "unprognostic (5.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.49e-1)" "unprognostic (1.41e-3)" "unprognostic (4.31e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (5.50e-2)" "unprognostic (3.45e-2)" "unprognostic (1.70e-2)" "unprognostic (2.35e-1)" "unprognostic (2.77e-1)" "unprognostic (3.50e-2)" "unprognostic (1.65e-1)" "unprognostic (3.65e-1)" "unprognostic (1.68e-3)" "unprognostic (7.16e-2)" 16.1 12.5 12.1 11.8 13.9 31.9 12.4 12.1 15.7 11.4 13.7 9.8 9.5 7.1 17.0 9.6 14.6 10.9 10.6 13.1 12.0 7.3 15.5 18.3 13.5 9.4 10.6 10.5 12.5 14.0 23.1 16.6 21.6 13.7 12.4 13.6 9.2 14.1 15.3 70.6 21.3 17.6 15.2 12.7 13.9 19.6 22.0 13.2 14.7 13.8 14.9 13.0 14.2 13.5 10.1 9.3 4.1 7.9 11.9 14.3 6.5 12.1 5.4 7.1 9.7 8.0 5.2 3.2 10.3 5.3 7.1 9.9 18.0 3.0 10.2 11.2 6.4 9.8 8.8 10.5 6.0 13.9 7.2 9.1 12.4 7.6 5.6 2.5 12.6 4.1 4.7 6.2 11.1 2.8 1.9 2.3 2.9 22.6 3.7 7.9 2.7 6.6 2.8 4.9 4.2 3.3 20.8 7.0 10.7 5.5 11.0 6.5 13.4 5.6 15.6 3.1 3.5 3.9 3.4 7.1 13.9 4.2 3.3 5.6 13.6 22.0 17.7 1.5 14.7 10.1 4.1 7.9 3.4 14.3 6.7 12.2 10.1 10.4 12.8 7.1 9.1 9.5 9.7 3.7 11.9 7.3 9.3 5.9 6.5 12.1 13.9 12.1 15.7 12.0 7.3 10.6 10.5 13.7 13.2 47.6 84.6 56.7 79.8 76.5 41.7 75.9 38.2 49.5 78.5 55.8 62.8 83.9 51.4 84.1 80.0 46.5 74.6 46.7 75.7 116.4 50.0 62.6 85.4 115.0 44.1 52.4 48.7 34.4 39.0 122.9 35.9 46.8 33.7 67.7 40.5 42.0 84.8 38.6 48.8 58.5 108.2 71.1 55.1 135.4 94.1 74.2 138.9 55.4 45.7 74.3 ABCF2 "ABC28, EST133090, HUSSY-18, M-ABC1" ENSG00000033050 "ATP binding cassette subfamily F member 2" Q9UG63 7 151212490-151227230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 228 "Cardiomyocytes: 20.9;Cytotrophoblasts: 24.9;Extravillous trophoblasts: 22.8;Hofbauer cells: 18.5;Syncytiotrophoblasts: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020091, CAB020682, HPA021815, HPA030388" Approved Enhanced Cytosol NA NA Cytosol "CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558" "unprognostic (6.80e-2)" "unprognostic (4.23e-1)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.52e-6)" "unprognostic (1.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.73e-1)" "unprognostic (6.31e-2)" "unprognostic (5.58e-2)" "unprognostic (9.93e-2)" "unprognostic (1.16e-2)" "unprognostic (1.95e-1)" "unprognostic (6.07e-2)" "unprognostic (7.84e-3)" 18.3 15.4 14.9 15.9 18.8 9.7 12.6 19.0 29.6 10.9 14.2 16.3 12.9 9.5 14.9 17.7 16.1 13.7 13.6 22.2 14.5 17.4 14.2 10.6 12.4 16.1 16.4 23.3 13.6 17.7 25.1 14.9 15.2 17.1 13.9 17.7 13.7 12.5 16.8 46.6 17.4 10.7 21.7 12.7 15.5 13.9 20.7 16.7 15.8 14.8 16.5 22.4 14.5 11.2 13.0 14.2 6.8 15.0 15.7 22.4 14.5 17.9 29.2 10.2 36.4 20.9 17.5 13.9 21.8 18.8 28.4 24.2 24.8 12.6 29.5 18.9 24.4 23.9 14.2 32.1 26.7 27.7 14.7 26.7 12.3 14.5 15.0 24.6 29.0 19.6 23.1 22.6 31.6 18.6 12.3 23.9 17.7 35.1 12.4 25.3 45.6 32.2 34.6 24.7 21.9 31.7 20.7 16.4 27.2 19.5 13.1 17.8 17.3 20.8 21.9 14.6 11.3 9.3 15.0 21.4 18.2 7.3 21.7 32.9 24.1 25.7 21.8 25.1 29.2 34.3 6.8 12.1 4.0 15.9 14.3 22.4 12.7 16.2 15.9 14.2 13.0 15.3 15.8 1.7 15.7 15.0 10.2 16.9 14.5 14.9 18.8 19.0 29.6 14.5 17.4 16.4 23.3 17.1 16.7 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 ABCF2 "ABC28, EST133090, HUSSY-18, M-ABC1" ENSG00000285292 "ATP binding cassette subfamily F member 2" Q9UG63 7 151207837-151227166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 41.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA020091, HPA021815, HPA030388" Approved Uncertain Cytosol NA NA Cytosol "HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558" 7.9 4.3 4.4 6.5 6.4 2.4 6.1 4.2 10.8 5.5 5.4 5.4 4.0 3.6 5.7 3.3 6.1 5.8 4.3 4.5 4.1 6.2 5.2 5.8 6.1 5.0 8.3 4.0 6.0 10.8 2.7 4.1 5.7 4.1 5.2 4.4 2.9 5.8 20.3 5.6 3.1 6.0 3.1 5.9 3.3 7.2 5.6 5.2 4.9 5.5 6.8 4.8 3.3 8.5 11.3 8.7 9.8 10.0 24.2 13.4 12.7 11.8 9.0 18.8 10.4 12.2 5.0 18.2 10.0 8.7 11.4 9.3 10.3 19.5 13.8 16.7 18.9 10.0 14.3 14.3 18.4 7.8 4.2 12.1 9.5 5.6 18.9 24.3 4.7 11.5 9.9 20.7 17.8 8.5 15.0 9.6 26.5 8.9 15.5 9.7 26.4 0.9 8.2 16.5 9.5 8.7 10.1 20.3 4.0 10.3 3.5 9.7 20.2 10.9 8.0 8.1 5.9 10.3 14.1 8.4 2.4 12.9 20.6 12.4 13.1 22.8 16.0 19.5 7.7 8.7 9.8 2.3 10.3 7.1 24.2 8.5 14.4 12.6 11.3 8.4 12.7 12.0 0.7 10.0 5.5 6.8 12.7 13.4 0.0 0.3 9.0 17.6 24.2 17.5 0.0 7.6 0.0 0.0 0.0 7.9 0.0 0.0 0.0 37.1 11.3 15.3 0.0 0.0 0.0 1.0 10.7 10.3 11.4 0.0 9.5 6.4 10.4 10.5 41.5 9.8 4.6 18.6 0.0 8.0 12.9 0.0 20.1 13.8 0.0 11.9 12.9 17.6 22.3 8.4 22.0 0.0 14.9 12.2 13.9 ABCF3 EST201864 ENSG00000161204 "ATP binding cassette subfamily F member 3" Q9NUQ8 3 184186023-184194012 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036332 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA036332: AB_10603571" "unprognostic (1.70e-2)" "unprognostic (1.16e-1)" "unprognostic (3.10e-2)" "unprognostic (3.81e-2)" "unprognostic (4.11e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.16e-5)" "unprognostic (5.18e-2)" "unprognostic (5.97e-2)" "unprognostic (2.67e-1)" "unprognostic (1.01e-1)" "unprognostic (5.52e-2)" "unprognostic (1.85e-2)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.94e-2)" "unprognostic (6.53e-2)" 13.0 47.0 18.9 10.6 19.7 12.4 12.7 23.0 27.2 15.3 12.1 15.4 33.8 13.1 13.5 11.1 16.1 15.0 10.8 22.9 15.4 16.8 16.5 22.3 12.1 12.7 15.4 15.1 17.8 19.7 41.6 17.9 16.0 19.8 13.3 11.8 15.5 21.4 30.1 33.8 15.2 12.8 10.8 12.3 14.9 13.3 12.6 18.6 8.8 15.4 14.4 14.2 12.5 13.8 16.1 16.4 13.9 19.4 14.5 25.4 21.5 21.9 13.6 7.8 15.0 22.8 12.8 15.4 16.0 17.9 21.7 17.1 23.2 8.8 13.3 32.4 17.1 25.5 21.1 12.1 16.8 11.3 16.9 11.6 11.4 11.9 13.6 19.2 12.8 11.7 18.8 15.5 15.3 15.3 12.8 15.5 11.7 10.5 16.1 15.3 26.5 12.5 8.2 11.8 22.8 18.9 12.6 13.0 22.3 11.9 13.3 13.5 7.8 16.5 31.8 14.7 8.9 43.0 11.3 15.1 11.7 12.7 18.2 23.6 18.2 17.5 17.1 18.1 12.8 14.3 5.3 18.6 13.9 22.7 19.4 23.5 16.0 20.1 18.7 16.4 16.1 25.4 20.5 9.3 14.5 19.1 10.1 17.2 21.5 18.9 19.7 23.0 27.2 15.4 16.8 15.4 15.1 19.8 18.6 8.9 1.3 14.9 9.2 12.9 15.7 10.5 12.7 4.0 4.5 14.0 13.7 32.3 24.9 18.7 6.1 9.2 19.0 0.0 19.5 21.8 10.8 7.8 9.2 18.1 18.8 19.1 10.9 14.1 10.3 7.6 11.5 8.1 15.1 28.9 12.7 13.7 17.3 10.2 11.0 23.7 20.6 6.5 7.3 10.7 14.7 8.9 36.6 15.4 13.1 11.5 ABHD13 "bA153I24.2, BEM46L1, C13orf6, FLJ14906" ENSG00000139826 "Abhydrolase domain containing 13" Q7L211 13 108218379-108234255 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032143, HPA032144" Approved Approved Cytosol NA NA Cytosol "HPA032143: AB_2674178, HPA032144: AB_10602304" "unprognostic (2.69e-1)" "unprognostic (2.81e-1)" "unprognostic (1.36e-2)" "unprognostic (2.91e-2)" "unprognostic (8.36e-2)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (2.63e-1)" "unprognostic (8.75e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (6.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.73e-2)" "unprognostic (1.61e-1)" "unprognostic (1.14e-1)" "unprognostic (5.62e-2)" 13.6 12.5 13.8 14.3 14.2 26.7 14.9 17.0 15.5 13.6 17.0 6.8 14.5 13.8 16.3 21.0 15.2 13.5 13.8 12.9 11.7 10.4 12.5 20.1 15.4 14.8 10.1 10.4 13.2 12.4 9.6 14.1 16.5 11.1 13.0 15.0 10.5 14.7 18.1 12.9 12.7 16.7 13.7 10.1 20.0 13.9 8.9 8.2 26.4 15.4 11.3 14.5 13.3 18.6 8.5 8.9 19.2 10.4 11.8 11.8 10.1 9.0 3.8 10.2 5.6 8.0 9.5 4.9 9.0 9.1 7.9 9.5 5.8 8.7 7.7 9.5 7.0 7.8 8.3 7.5 10.4 12.7 10.3 6.6 9.4 5.4 5.7 8.0 19.4 11.6 9.7 10.0 6.2 8.1 7.5 9.3 10.7 5.0 4.4 8.1 3.8 9.4 8.2 4.8 13.5 4.5 8.1 7.3 4.5 11.2 8.2 7.7 9.6 4.8 8.0 9.7 9.4 7.4 18.1 9.7 5.7 5.9 6.6 6.0 8.5 6.7 8.4 13.4 12.2 10.2 8.7 10.4 19.2 8.0 9.5 11.8 8.5 10.9 9.5 8.9 8.1 10.5 8.7 11.3 11.8 8.4 6.7 10.2 10.1 13.8 14.2 17.0 15.5 11.7 10.4 10.1 10.4 11.1 8.2 20.8 11.0 23.1 17.8 39.4 12.5 6.1 22.9 8.1 9.1 10.4 0.0 18.2 8.3 16.4 13.8 17.2 11.8 0.0 18.5 12.2 20.3 17.8 13.9 24.5 17.6 17.5 29.3 19.0 17.3 14.3 14.4 18.7 25.3 17.2 11.7 11.8 16.0 11.5 16.3 10.0 11.6 19.4 18.8 12.8 10.9 44.7 17.8 24.5 10.0 19.0 ABHD14B "CIB, MGC15429" ENSG00000114779 "Abhydrolase domain containing 14B" Q96IU4 3 51968510-51983409 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036444, HPA036642" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA 2600000 Nucleoli "Nucleoplasm, Cytosol" "HPA036444: AB_10672221, HPA036642: AB_10672225" "unprognostic (8.97e-2)" "prognostic favorable (6.92e-5)" "unprognostic (1.84e-1)" "prognostic favorable (5.42e-5)" "unprognostic (1.07e-1)" "unprognostic (2.21e-2)" "unprognostic (2.06e-3)" "unprognostic (1.35e-3)" "unprognostic (3.95e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.93e-5)" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (9.70e-2)" "unprognostic (3.70e-2)" 40.0 34.2 6.2 19.8 7.5 11.4 25.2 10.7 7.0 21.9 33.6 8.6 32.1 30.3 19.6 21.7 27.7 22.0 32.9 12.2 6.2 5.8 42.6 78.4 21.5 35.1 7.8 7.3 29.5 45.0 14.2 15.2 11.4 6.7 30.9 20.2 29.1 39.4 35.0 11.7 16.0 58.7 22.6 8.9 23.3 18.7 11.2 6.2 26.0 35.3 15.2 32.5 24.6 16.9 24.9 15.5 12.5 9.4 9.9 27.2 14.0 10.3 8.8 0.7 10.4 28.8 25.7 2.7 4.1 4.8 7.6 8.9 6.5 20.5 11.6 3.3 14.3 3.5 5.2 6.4 5.9 5.8 15.8 6.9 18.3 7.7 25.5 15.5 10.2 18.9 33.2 20.4 7.7 10.5 11.7 9.2 17.7 10.6 18.6 14.7 10.1 4.5 7.8 1.0 11.3 22.6 11.6 1.4 52.4 13.8 4.2 4.4 4.7 10.4 19.4 33.0 1.6 27.9 7.0 8.7 4.0 19.1 9.1 2.4 23.7 11.1 4.8 8.8 32.8 7.0 12.5 9.4 4.2 18.3 7.6 27.2 24.9 23.0 22.4 15.5 18.7 23.4 21.3 0.8 9.9 4.8 11.3 16.3 14.0 6.2 7.5 10.7 7.0 6.2 5.8 7.8 7.3 6.7 6.2 6.0 25.8 75.9 43.7 26.9 12.4 3.2 56.0 24.1 9.1 66.3 13.7 13.4 124.3 28.2 1.4 33.6 100.6 0.0 40.7 15.9 35.2 36.3 50.7 104.1 49.3 7.9 72.9 30.7 50.2 0.5 60.1 36.2 52.3 32.5 83.5 7.7 25.4 66.2 43.9 216.2 37.1 38.8 41.0 0.5 3.4 26.6 9.8 59.8 107.0 52.8 ABHD15 ENSG00000168792 "Abhydrolase domain containing 15" Q6UXT9 17 29560547-29567137 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA014470 Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" "HPA014470: AB_1852993" "unprognostic (1.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.38e-1)" "unprognostic (8.60e-3)" "unprognostic (1.91e-1)" "unprognostic (1.62e-1)" "unprognostic (4.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.85e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-3)" "unprognostic (3.00e-2)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (3.46e-1)" "unprognostic (5.45e-2)" 22.6 3.5 4.9 6.0 3.2 5.4 21.6 2.9 4.1 3.8 8.8 4.2 4.4 8.5 4.2 3.1 4.1 4.3 7.8 6.6 2.1 1.9 8.4 21.2 5.6 12.7 2.7 3.9 2.8 10.9 8.8 8.5 3.2 4.3 4.0 5.0 3.6 4.5 4.6 2.1 3.4 12.7 5.5 3.3 9.1 6.3 1.4 4.6 1.6 5.2 2.7 6.0 5.6 9.1 2.0 17.0 11.1 0.4 7.2 5.0 0.7 3.8 15.0 1.9 5.3 20.6 9.0 7.9 5.3 5.9 5.3 4.9 3.4 2.0 5.7 3.9 5.7 9.4 10.6 6.6 2.3 2.9 17.7 5.0 2.3 7.4 4.3 6.3 5.9 10.7 6.7 6.2 5.1 0.9 3.9 3.8 3.4 3.0 5.5 2.8 5.2 5.6 6.9 0.4 13.0 4.5 13.1 7.3 13.2 9.5 5.9 1.3 2.2 8.0 3.6 2.0 2.1 9.1 13.7 4.7 3.1 3.9 7.7 4.6 9.3 6.2 3.0 6.1 3.7 6.5 11.1 0.4 1.8 1.9 0.2 5.0 1.0 1.0 1.7 1.0 2.0 0.3 1.0 0.5 7.2 0.2 17.0 0.9 0.7 4.9 3.2 2.9 4.1 2.1 1.9 2.7 3.9 4.3 4.6 3.0 5.5 5.6 1.1 1.1 0.0 2.0 5.1 5.3 4.5 7.0 0.0 0.9 0.0 2.8 0.2 1.4 8.3 0.0 6.6 1.0 3.8 1.2 2.3 25.3 6.6 1.6 6.9 3.7 6.7 0.2 4.4 8.2 5.0 3.6 6.3 0.9 4.8 0.0 4.2 5.4 0.7 0.0 2.0 0.5 0.4 2.0 0.2 14.4 6.3 1.1 ABHD2 LABH2 ENSG00000140526 "Abhydrolase domain containing 2" P08910 15 89087459-89202360 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 303.3;Hepatocytes: 272.0;Late spermatids: 360.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 29.0;neutrophil: 22.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.0" "Cell line enriched" "Detected in all" 4 "HEL: 85.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005999 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA005999: AB_1078080" "unprognostic (6.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.00e-2)" "unprognostic (2.16e-1)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (3.34e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-3)" "unprognostic (1.80e-1)" "prognostic favorable (2.18e-7)" "unprognostic (4.17e-1)" "unprognostic (3.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" 13.2 24.8 14.8 9.5 19.3 15.6 11.7 25.2 23.4 10.7 16.1 12.0 6.5 23.4 18.2 34.7 9.0 12.1 32.2 24.5 12.2 11.3 11.8 76.4 22.2 11.2 11.1 14.8 13.1 28.3 11.2 18.1 5.6 19.8 22.9 9.6 22.6 11.8 10.0 19.3 7.5 18.5 11.4 8.3 14.2 35.8 42.9 7.6 7.7 8.6 8.1 12.1 13.5 10.4 1.1 3.0 29.0 7.0 4.7 3.5 2.5 8.1 15.8 3.9 4.2 7.7 10.4 2.1 5.5 16.5 5.3 5.0 3.9 14.2 2.3 6.4 6.9 14.6 10.9 8.6 6.7 7.5 12.2 3.8 85.1 3.7 3.0 3.9 5.8 20.0 5.3 4.8 18.8 12.1 8.7 6.4 5.3 7.5 7.3 14.5 3.4 3.6 1.4 1.7 19.2 4.7 5.2 8.2 17.7 7.1 12.9 6.7 10.1 10.5 4.9 8.8 3.7 5.5 4.6 9.8 18.6 6.3 6.7 13.8 6.0 11.9 2.8 15.2 5.4 14.4 3.1 5.6 29.0 1.6 4.8 0.9 1.1 1.5 1.5 3.0 1.1 1.4 1.5 22.7 4.7 7.0 2.4 3.5 2.5 14.8 19.3 25.2 23.4 12.2 11.3 11.1 14.8 19.8 7.6 89.3 113.5 3.0 42.1 16.6 23.6 42.1 163.1 95.0 100.1 40.1 17.7 3.6 1.7 43.2 303.3 25.9 52.7 23.3 74.0 6.2 25.7 185.3 57.9 272.0 39.6 19.1 46.9 22.7 53.9 360.0 30.5 37.9 55.6 12.6 45.6 51.3 79.4 31.3 56.3 11.3 14.4 77.6 50.5 77.4 9.8 15.3 2.2 22.5 31.7 70.1 ABHD5 "CGI-58, NCIE2" ENSG00000011198 "Abhydrolase domain containing 5" Q8WTS1 3 43690108-43734371 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Cataract, Deafness, Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 70.3" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 171.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0" "Group enriched" "Detected in many" 5 "granulocytes: 26.1;monocytes: 7.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020685, HPA035851, HPA035852" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073" "unprognostic (2.58e-1)" "unprognostic (2.73e-1)" "prognostic favorable (8.89e-4)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (6.13e-2)" "unprognostic (2.40e-2)" "unprognostic (5.33e-2)" "unprognostic (3.50e-3)" "unprognostic (2.56e-2)" "unprognostic (4.13e-3)" "prognostic favorable (9.17e-5)" "unprognostic (2.48e-1)" "unprognostic (8.87e-2)" "unprognostic (4.18e-2)" "unprognostic (4.18e-2)" 26.5 10.5 5.2 7.4 12.2 32.2 70.3 8.5 10.3 7.6 10.2 10.5 5.9 7.4 4.6 4.0 22.7 3.7 10.4 9.8 7.4 4.5 10.1 18.4 14.1 8.7 18.5 4.6 4.2 12.8 9.1 8.6 20.2 14.9 5.8 6.7 4.4 21.1 7.4 10.4 24.8 15.1 8.1 19.0 7.0 8.9 8.1 12.5 3.3 13.2 9.9 6.7 11.2 16.0 1.7 3.6 26.1 7.6 0.9 2.4 2.5 8.5 3.0 3.6 3.8 15.2 5.8 7.5 34.9 13.9 9.6 7.2 4.7 3.0 7.1 4.8 10.9 8.5 2.8 5.7 8.5 9.8 25.8 5.5 18.2 11.6 3.2 7.6 4.1 5.9 6.4 29.5 16.1 13.8 8.4 16.0 4.8 10.8 5.4 21.3 4.6 2.9 2.9 9.7 6.8 9.8 1.3 10.4 4.1 12.4 17.0 4.4 6.0 15.3 8.3 3.6 4.0 8.9 3.5 8.8 8.5 6.7 15.7 15.1 4.9 13.6 3.4 9.0 7.5 6.6 26.1 7.6 4.4 1.2 3.7 1.0 1.7 0.9 1.4 3.6 1.2 0.8 1.3 21.0 0.9 2.7 0.9 2.4 2.5 5.2 12.2 8.5 10.3 7.4 4.5 18.5 4.6 14.9 12.5 23.8 43.8 8.5 23.5 35.4 11.3 9.7 15.3 17.4 25.0 26.2 25.5 13.3 28.2 49.4 13.5 16.9 64.4 23.3 53.5 21.2 16.2 21.6 16.1 11.3 16.6 3.2 34.9 14.7 26.6 12.9 4.9 30.4 6.8 16.2 17.1 12.4 61.4 24.6 5.3 31.4 14.7 0.0 26.8 35.6 43.9 35.8 171.7 15.8 18.2 41.1 ABI2 "ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2" ENSG00000138443 "Abl interactor 2" Q9NYB9 2 203328219-203447723 "Predicted intracellular proteins" "Host-virus interaction, Neurogenesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070567 Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA070567: AB_2686281" "unprognostic (5.26e-3)" "unprognostic (5.26e-3)" "unprognostic (1.86e-1)" "unprognostic (4.11e-3)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (1.81e-3)" "unprognostic (7.05e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-3)" "unprognostic (6.19e-3)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.24e-2)" "unprognostic (2.94e-1)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" 8.6 11.6 28.8 7.7 41.8 2.8 12.8 24.4 50.7 17.2 11.5 18.7 8.4 5.1 23.3 16.1 10.5 19.4 11.4 25.1 26.0 24.0 17.8 6.3 13.4 6.4 19.1 30.2 24.3 6.5 18.6 21.5 15.9 17.6 16.4 9.5 11.7 7.1 20.3 5.9 6.4 6.9 21.2 18.8 10.2 6.9 22.2 16.8 11.6 22.2 3.2 7.3 10.2 8.4 1.7 13.8 0.4 3.7 3.9 5.3 3.4 7.2 11.2 40.2 25.3 9.5 16.4 8.8 12.6 11.2 11.0 12.7 10.3 13.7 0.0 8.7 14.8 15.3 8.0 18.2 13.3 21.9 3.6 10.4 18.2 12.0 8.0 14.6 7.8 8.3 11.6 6.4 20.0 15.6 31.8 20.3 20.9 12.8 16.3 19.3 13.1 19.5 7.4 20.8 6.8 25.0 12.9 20.3 1.3 11.3 7.5 16.1 21.2 2.4 7.4 14.0 31.7 9.7 9.1 15.1 20.2 17.1 10.8 13.7 11.5 10.5 10.0 21.8 3.2 12.8 0.2 1.5 0.0 3.8 1.7 4.1 1.7 4.3 4.4 4.3 1.7 5.3 4.5 0.4 3.9 3.7 13.8 4.6 3.4 28.8 41.8 24.4 45.2 26.0 24.0 19.1 30.2 17.6 16.8 50.6 24.5 13.0 49.7 26.8 105.5 50.4 25.5 83.0 35.2 50.6 153.2 18.7 28.2 19.2 102.1 33.4 9.5 0.0 11.6 14.1 50.4 34.8 15.1 9.8 14.0 96.9 47.3 57.7 11.1 62.2 43.1 22.6 47.2 22.6 8.6 78.1 13.9 17.5 59.4 28.0 93.6 25.8 56.7 71.0 49.9 22.8 16.5 17.5 18.0 32.3 ABLIM1 "abLIM, LIMAB1, limatin" ENSG00000099204 "Actin binding LIM protein 1" O14639 10 114431113-114685003 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 294.8;Cardiomyocytes: 567.5;Peritubular cells: 388.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 84.9" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 43.9" "Group enriched" "Detected in many" 11 "B-cells: 14.8;NK-cells: 17.1;T-cells: 43.9" "Cell line enhanced" "Detected in many" "hTCEpi: 42.8;OE19: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038951, HPA038952" Approved Supported Cytosol NA NA Cytosol "HPA038951: AB_10673017, HPA038952: AB_10670915" "unprognostic (2.25e-2)" "unprognostic (3.96e-2)" "unprognostic (2.91e-1)" "unprognostic (1.26e-1)" "unprognostic (5.89e-3)" "unprognostic (1.07e-2)" "unprognostic (3.19e-2)" "unprognostic (5.07e-2)" "unprognostic (4.39e-2)" "unprognostic (1.05e-1)" "unprognostic (3.20e-2)" "unprognostic (3.23e-1)" "prognostic favorable (2.72e-5)" "unprognostic (2.77e-2)" "unprognostic (1.92e-1)" "unprognostic (3.22e-1)" "unprognostic (5.87e-2)" 66.7 23.6 11.2 16.8 14.1 3.0 21.2 84.9 14.1 18.7 14.7 6.8 10.7 9.6 16.9 9.8 73.5 13.7 14.1 55.9 10.0 9.2 14.1 7.3 15.7 13.8 10.1 5.6 64.4 7.4 12.8 22.7 8.3 12.8 14.0 15.3 26.6 53.8 18.6 18.6 25.3 16.0 15.4 9.9 8.4 31.3 17.2 3.1 38.3 75.8 44.3 70.4 20.3 28.0 14.8 0.1 2.3 0.0 17.1 43.9 12.7 11.6 8.5 31.0 7.0 0.3 0.1 0.3 2.4 0.8 0.6 1.4 11.7 18.8 15.5 33.4 2.7 4.1 25.6 10.2 16.5 0.7 5.2 9.0 0.1 24.8 32.1 0.1 6.0 0.1 0.4 42.8 4.1 13.6 12.9 12.2 5.4 0.0 23.9 0.1 4.3 1.2 2.7 11.8 39.9 9.9 0.5 6.5 20.0 9.9 26.4 10.8 13.4 10.0 15.3 5.6 14.6 7.8 0.0 8.3 0.0 11.2 0.2 4.5 0.1 0.0 35.9 0.5 13.5 0.2 2.3 0.0 0.2 8.8 0.0 17.0 12.4 16.5 9.9 0.1 14.8 43.9 27.8 0.7 17.1 0.0 0.1 8.9 12.7 11.2 14.1 84.9 11.1 10.0 9.2 10.1 5.6 12.8 3.1 294.8 29.0 14.3 27.1 77.0 38.7 567.5 48.4 101.7 104.6 50.6 17.7 0.8 29.9 34.2 88.3 105.0 50.6 0.0 48.7 0.8 28.6 31.2 1.1 36.6 0.6 55.6 16.1 37.4 1.0 104.4 210.9 5.9 20.3 1.8 87.8 58.6 40.5 31.7 388.2 31.6 105.4 0.0 16.5 3.6 3.9 165.6 0.6 20.3 46.1 115.5 ABR MDB ENSG00000159842 "Active BCR-related" Q12979 17 1003518-1229021 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.6" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "basophil: 8.9" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.9" "Cell line enhanced" "Detected in some" "Daudi: 18.8;hTERT-RPE1: 20.2;LHCN-M2: 12.6;RPMI-8226: 10.8;TIME: 20.9;U-251 MG: 21.0;U-698: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053618, HPA054824" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA053618: AB_2682208, HPA054824: AB_2682616" "unprognostic (1.69e-1)" "prognostic favorable (4.03e-4)" "unprognostic (1.58e-1)" "unprognostic (1.94e-3)" "unprognostic (1.12e-1)" "unprognostic (2.20e-2)" "unprognostic (4.99e-2)" "unprognostic (7.53e-2)" "unprognostic (1.91e-1)" "unprognostic (9.61e-2)" "unprognostic (7.20e-3)" "unprognostic (4.43e-3)" "prognostic favorable (2.21e-4)" "unprognostic (2.27e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-1)" "unprognostic (1.74e-2)" 12.9 5.8 31.8 18.0 28.7 6.0 5.8 7.0 43.6 6.6 19.9 12.0 2.3 9.4 7.9 4.0 11.0 6.1 6.7 26.6 24.0 16.9 6.8 4.0 9.3 6.9 14.1 27.0 3.9 5.0 8.3 6.0 7.2 11.3 4.6 21.6 19.4 23.7 3.4 2.9 5.9 11.9 25.1 8.1 8.1 13.6 3.8 11.3 2.9 7.0 2.3 18.0 7.2 7.4 0.3 0.7 8.9 0.8 0.0 0.8 0.0 0.5 0.6 0.2 0.0 0.9 0.1 0.5 0.1 0.1 0.0 0.0 0.4 0.0 18.8 0.3 0.1 0.8 0.0 2.0 0.0 0.4 5.8 10.2 0.0 0.2 0.0 0.4 2.3 6.7 0.2 0.0 0.1 6.7 20.2 0.0 0.0 0.0 0.0 12.6 0.7 0.0 2.5 0.1 0.4 0.1 0.1 0.0 10.8 0.1 0.2 0.2 0.3 0.0 0.0 1.0 0.0 5.9 2.9 20.9 0.1 0.2 2.1 21.0 0.0 0.2 15.4 1.0 4.1 0.4 8.9 0.3 1.0 0.2 0.8 0.4 0.1 0.3 0.0 0.7 0.3 0.0 0.3 0.9 0.0 0.4 0.0 0.8 0.0 31.8 28.7 7.0 43.6 24.0 16.9 14.1 27.0 11.3 11.3 29.8 21.1 7.8 15.2 15.1 60.3 21.8 25.5 10.7 17.0 1.8 2.0 1.9 0.0 15.6 33.8 21.5 39.3 0.0 5.5 2.5 13.4 17.6 18.5 0.8 27.7 11.1 14.5 18.4 24.0 112.5 12.7 28.3 18.6 18.0 35.9 29.4 29.8 25.9 8.9 5.8 18.0 38.8 21.7 1.9 7.5 14.8 1.8 13.8 49.9 22.6 ABRACL "C6orf115, Costars, HSPC280, PRO2013" ENSG00000146386 "ABRA C-terminal like" Q9P1F3 6 139028682-139043302 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.9" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 308.6;Proximal tubular cells: 337.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 77.9;U-937: 75.7" "Low region specificity" "Detected in all" HPA030217 Enhanced Approved Nucleoplasm,Cytosol NA NA 7400000 Nucleoplasm Cytosol "HPA030217: AB_10602335" "unprognostic (1.10e-2)" "unprognostic (1.63e-1)" "unprognostic (9.30e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.72e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.21e-1)" "unprognostic (8.17e-2)" "unprognostic (2.16e-1)" "unprognostic (3.07e-3)" "unprognostic (5.90e-3)" "unprognostic (3.63e-2)" "unprognostic (3.29e-2)" "prognostic favorable (1.65e-6)" 12.2 4.2 12.0 25.5 10.1 23.1 22.1 1.8 19.0 6.5 28.4 2.4 10.6 22.6 10.3 43.8 23.5 6.0 10.9 7.9 15.1 7.1 29.0 26.8 14.0 39.0 5.5 10.3 5.1 9.5 10.3 9.3 12.9 4.8 8.2 26.9 4.3 19.9 9.7 2.3 12.8 35.5 7.1 5.1 45.6 13.7 20.1 5.0 60.2 13.2 19.2 26.0 23.0 9.0 17.1 37.2 30.5 82.9 24.6 48.8 51.8 11.2 6.0 15.5 14.4 6.2 9.7 17.0 9.0 6.4 6.8 14.0 13.4 13.2 0.0 16.4 8.8 29.4 17.1 13.6 19.4 7.9 29.9 25.1 43.9 3.4 4.6 9.0 73.2 20.2 8.7 16.4 9.1 7.5 12.3 35.5 31.0 5.5 15.4 19.4 23.6 45.6 77.9 18.5 17.6 11.8 29.5 9.5 3.5 18.2 33.4 34.7 3.8 6.1 17.2 28.0 22.9 6.8 55.0 26.4 4.3 3.7 9.0 15.9 8.4 23.8 3.0 5.5 75.7 12.8 30.5 31.7 18.9 29.8 55.8 46.1 15.3 48.8 38.1 33.8 17.1 47.7 44.3 8.6 24.6 82.9 37.2 43.5 51.8 12.0 10.1 1.8 19.0 15.1 7.1 5.5 10.3 4.8 5.0 17.9 26.9 128.7 58.7 124.0 0.2 2.8 30.6 20.1 22.7 41.8 0.0 69.4 51.4 124.4 2.6 35.9 215.0 0.0 127.3 176.9 29.2 47.3 79.5 178.9 308.6 0.0 41.3 49.1 193.8 9.4 4.4 118.3 82.7 71.3 101.8 34.9 147.3 167.5 12.0 337.1 1.3 32.3 17.4 1.4 2.1 78.7 40.6 137.1 116.5 103.7 ABRAXAS2 "ABRO1, Em:AC068896.4, FAM175B, KIAA0157" ENSG00000165660 "Abraxas 2, BRISC complex subunit" Q15018 10 124801785-124836670 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 23.8;Ciliated cells: 22.7;Collecting duct cells: 22.7;monocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037591, HPA037592, HPA074089" Approved Supported Cytosol Yes No Cytosol "HPA037591: AB_10671877, HPA037592: AB_2675566, HPA074089: AB_2686659" "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (6.81e-2)" "unprognostic (3.72e-2)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.09e-2)" "unprognostic (1.58e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" 18.4 17.3 16.1 13.1 16.5 14.3 17.0 16.3 20.5 15.6 14.8 10.6 8.1 13.7 16.0 13.3 17.9 13.9 11.2 13.2 15.1 14.5 18.6 19.9 12.5 15.4 13.1 14.4 15.1 11.8 17.5 13.9 17.7 15.9 13.5 14.5 8.5 14.9 13.5 32.2 19.1 20.8 14.4 16.1 20.3 13.2 11.1 12.1 23.9 20.5 16.0 17.4 16.2 16.2 12.2 13.9 18.5 15.2 7.8 12.2 7.7 14.2 9.8 10.6 14.4 13.7 13.6 9.1 14.7 23.3 17.7 16.4 7.8 13.8 16.0 12.6 15.9 9.6 16.1 16.5 13.8 18.7 13.9 11.4 12.1 8.1 9.7 17.5 20.8 12.8 14.8 16.9 17.4 31.5 19.2 13.3 14.3 12.6 11.1 14.3 9.3 15.9 18.6 9.0 12.9 9.1 12.9 11.1 9.7 13.0 7.2 7.3 13.4 11.7 11.4 15.9 11.1 9.3 14.4 11.4 9.5 7.6 11.1 17.5 11.6 10.7 15.5 12.5 10.3 6.7 18.5 11.4 10.4 8.9 15.2 12.2 12.1 10.3 12.1 13.9 12.2 11.2 12.1 4.6 7.8 12.0 9.4 11.9 7.7 16.1 16.5 16.3 20.5 15.1 14.5 13.1 14.4 15.9 12.1 23.8 11.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 11.4 22.7 0.0 14.6 14.9 11.6 0.0 0.0 0.0 0.0 11.0 10.8 0.0 0.0 11.6 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 36.1 0.0 0.0 7.8 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 ABTB1 "BPOZ, Btb3, BTBD21, EF1ABP" ENSG00000114626 "Ankyrin repeat and BTB domain containing 1" Q969K4 3 127672935-127680920 "Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 107.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 107.3" "Lineage enriched" "Detected in all" 12 "granulocytes: 107.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035022, HPA035023" Uncertain Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035022: AB_10669998, HPA035023: AB_10602104" "unprognostic (6.76e-2)" "unprognostic (9.18e-3)" "unprognostic (2.11e-2)" "unprognostic (6.34e-2)" "unprognostic (6.51e-2)" "unprognostic (2.00e-3)" "unprognostic (4.43e-2)" "unprognostic (2.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.48e-3)" "unprognostic (4.55e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.88e-1)" "unprognostic (1.81e-2)" "unprognostic (3.98e-2)" "unprognostic (7.92e-3)" 20.4 13.7 11.7 17.7 20.1 42.3 14.2 43.4 27.2 15.4 14.3 13.8 12.9 12.3 15.6 10.9 9.6 13.1 17.6 20.4 10.9 8.2 11.4 8.3 15.5 22.1 9.7 15.8 15.8 11.2 7.8 15.3 12.0 11.4 13.5 4.9 12.4 15.2 14.5 25.1 11.6 13.0 13.3 7.5 41.4 11.7 5.9 12.5 17.8 10.2 9.1 10.4 14.6 17.4 2.9 3.8 107.3 8.6 3.2 5.8 5.1 3.1 7.6 0.7 1.5 7.2 6.9 5.8 5.0 8.7 3.5 4.8 0.2 6.7 1.4 9.0 3.8 4.3 1.4 0.0 3.8 0.8 14.7 2.1 2.3 13.5 1.8 5.8 0.3 7.1 8.6 4.1 3.5 0.9 11.3 3.6 5.9 0.1 10.3 3.7 5.0 3.5 9.9 0.6 3.6 8.4 2.2 4.2 9.8 5.2 2.0 7.0 4.7 3.6 4.4 18.2 1.9 1.1 2.6 6.6 3.6 3.1 6.5 1.6 8.4 2.7 0.4 8.5 2.9 5.7 4.5 8.6 20.5 2.4 6.2 2.3 2.5 2.6 2.3 3.8 2.9 2.2 1.9 107.3 3.2 5.4 2.4 5.8 5.1 11.7 20.1 43.4 27.2 10.9 8.2 9.7 15.8 11.4 12.5 17.9 18.3 15.2 14.1 10.4 9.9 6.2 10.2 4.0 2.3 7.0 17.7 6.5 13.3 12.2 0.4 13.5 12.4 0.0 15.1 20.9 14.5 11.3 14.9 8.5 19.9 3.2 23.0 23.4 52.6 1.9 31.4 20.7 10.1 45.9 16.6 16.2 19.1 23.0 21.2 17.0 30.1 64.7 31.9 0.7 6.8 8.2 13.3 46.5 11.2 8.4 AC004922.1 ENSG00000284292 7 99325879-99394653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 25 "Club cells: 4.5;Exocrine glandular cells: 1.3;granulocytes: 1.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004334 Uncertain Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "HPA004334: AB_1078215" 6.0 5.2 4.2 9.4 6.2 6.9 7.8 3.2 9.1 5.3 6.6 4.6 5.6 13.8 5.8 3.8 5.3 5.0 4.5 4.9 7.1 4.1 6.3 4.6 8.1 3.2 6.0 3.9 6.4 3.0 4.1 5.2 6.2 5.0 3.1 4.9 3.3 5.4 4.6 2.4 9.6 4.2 3.0 6.5 7.0 3.9 3.2 2.9 6.0 6.4 4.4 4.6 4.1 7.9 13.0 18.1 16.3 5.1 11.9 18.0 4.2 4.0 0.4 1.0 0.6 2.8 5.1 3.3 1.8 3.0 3.2 7.2 5.9 4.4 10.9 3.5 3.8 2.8 1.2 3.8 0.6 2.2 7.5 2.5 2.9 1.9 0.9 2.7 3.1 2.7 1.1 3.1 1.2 0.7 4.4 2.3 3.9 4.0 2.1 7.9 4.9 1.2 2.6 1.7 11.9 2.1 1.1 1.5 0.6 2.0 1.1 1.0 2.8 4.6 8.4 0.7 2.2 1.7 2.9 4.9 2.6 7.2 4.3 0.0 2.3 4.7 3.0 4.2 5.7 9.2 15.5 18.1 7.1 16.3 5.1 7.3 7.0 6.9 13.0 7.9 6.1 6.1 13.9 5.1 15.0 8.9 11.9 18.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005324.3 ENSG00000251537 17 15571491-15651653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 23.3;tongue: 21.1;vagina: 17.9" "Group enriched" "Detected in some" 11 "Club cells: 1.2;Pancreatic endocrine cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.6;HeLa: 3.1;OE19: 2.2" "HPA023623, HPA066431" Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (3.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (2.48e-1)" "unprognostic (1.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.87e-3)" "unprognostic (1.93e-1)" "unprognostic (2.98e-2)" "unprognostic (4.39e-2)" "unprognostic (4.81e-3)" "unprognostic (6.35e-3)" "unprognostic (1.80e-11)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (5.30e-2)" "unprognostic (3.09e-1)" 7.5 2.8 0.9 1.5 1.0 1.0 7.7 0.9 1.0 5.3 2.2 1.3 0.0 2.1 0.7 1.5 23.3 0.8 4.0 2.6 0.8 0.9 0.9 1.0 2.1 1.6 3.7 0.0 0.7 1.0 0.8 0.7 12.4 2.7 1.4 0.9 0.2 2.4 1.1 2.9 4.4 1.6 2.1 1.5 1.0 2.8 1.8 1.0 1.6 1.8 21.1 17.5 3.2 17.9 0.6 0.6 0.0 0.1 0.0 0.5 0.0 0.6 3.5 0.1 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.1 3.1 0.1 0.1 1.0 0.0 6.6 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.4 1.0 0.0 0.0 0.6 0.4 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.3 0.9 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.9 1.0 0.8 0.9 3.7 0.0 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008397.2 ENSG00000285188 "CAMP-specific 3',5'-cyclic phosphodiesterase 4C " Q08493 19 18207961-18255419 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 22.4;intestine: 15.6;pancreas: 14.2" "Group enriched" "Detected in some" 8 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;U-2197: 1.6;U-87 MG: 4.8" "HPA048975, HPA054218" Uncertain Approved "Midbody ring,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Midbody ring" "HPA048975: AB_2680581, HPA054218: " 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.2 1.9 15.6 0.0 0.0 1.3 1.1 3.6 4.0 1.0 22.4 0.6 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.8 0.0 0.0 1.7 0.0 2.1 1.1 3.7 0.0 8.0 0.6 0.0 0.4 7.1 0.2 0.0 0.0 0.4 0.8 4.1 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 3.7 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.4 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.9 0.0 0.0 0.3 0.4 0.0 0.8 0.0 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.7 0.1 0.2 0.0 0.0 0.2 1.6 0.0 0.3 0.2 0.1 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008403.1 ENSG00000268465 19 48465837-48472431 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.7;intestine: 3.6;testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;LHCN-M2: 3.6;NB-4: 3.8;U-698: 5.0" HPA060662 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA060662: AB_2732652" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.5 0.1 3.6 0.0 2.7 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.3 0.1 1.6 0.0 0.2 0.1 0.5 4.7 0.1 0.0 0.0 0.0 1.0 0.5 0.7 0.4 0.0 1.0 0.0 0.0 0.0 0.0 2.9 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.6 2.3 1.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 1.9 0.3 0.0 3.6 0.0 0.0 3.8 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.9 0.9 5.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.2 1.0 0.3 0.4 0.3 0.0 0.6 0.1 0.0 0.0 0.4 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008687.1 ENSG00000267335 19 49022953-49036895 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "pancreas: 8.2;pituitary gland: 19.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 7.4;U-251 MG: 10.6" HPA038925 Uncertain Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA038925: AB_2676272" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 19.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.9 0.2 0.1 0.2 0.0 1.9 0.0 0.0 0.1 0.3 0.1 1.2 0.0 0.3 0.0 0.3 1.1 0.0 0.0 0.6 0.2 0.9 0.0 0.9 0.1 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.0 0.2 0.5 0.2 0.0 0.0 0.1 0.2 1.2 0.2 0.0 0.0 0.0 0.7 0.2 0.1 0.4 0.1 0.5 0.0 0.2 0.4 0.0 2.7 2.3 0.7 10.6 0.5 2.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC008695.1 ENSG00000273217 5 131425891-131796983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.1" "Lineage enriched" "Detected in many" 5 "T-cells: 11.1" "Cell line enhanced" "Detected in some" "A549: 7.0;HeLa: 1.3;HL-60: 1.4;HMC-1: 2.8;U-937: 1.7" "HPA037982, HPA037983" Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA037982: AB_10670535, HPA037983: AB_2675769" 4.0 2.5 3.6 2.4 4.3 3.8 2.9 3.4 4.1 2.7 2.7 3.8 2.1 2.4 3.5 2.4 2.5 2.5 2.4 2.6 2.5 2.5 2.5 2.5 2.6 3.5 5.8 2.6 4.0 2.5 2.4 6.1 4.5 3.5 2.5 2.4 1.4 2.5 2.4 4.2 2.5 2.5 3.0 3.3 2.5 2.5 4.2 5.2 2.4 2.5 1.1 2.4 3.0 4.0 2.0 0.3 2.3 0.9 2.4 11.1 2.8 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.0 1.7 0.0 0.6 0.9 2.3 3.3 0.4 5.7 1.4 3.6 3.8 0.3 2.0 11.1 5.0 0.6 2.4 0.9 0.0 2.8 2.8 3.6 4.3 3.4 4.1 2.5 2.5 5.8 2.6 3.5 5.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008878.3 ENSG00000268861 19 7382834-7472477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 7.7;bone marrow: 7.1;lymphoid tissue: 8.6" "Cell type enhanced" "Detected in single" 40 "Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 18.3;HL-60: 8.3;MOLT-4: 11.7;REH: 9.6;THP-1: 13.8;U-698: 10.9;U-937: 8.6" "HPA042689, HPA071867" Supported Uncertain Cytosol NA NA Cytosol "HPA042689: AB_10794385, HPA071867: AB_2686466" "unprognostic (1.46e-1)" "unprognostic (2.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.20e-2)" "unprognostic (3.92e-2)" "unprognostic (2.45e-4)" 0.0 1.2 4.3 7.1 0.0 0.0 0.0 0.5 0.0 0.9 0.1 1.5 0.0 2.1 0.0 0.2 0.0 1.0 8.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 2.3 4.9 0.0 0.0 0.7 4.8 2.4 7.4 1.4 7.7 3.3 0.1 4.2 1.4 0.0 0.2 0.5 0.0 1.3 0.3 0.0 0.0 1.1 0.0 0.3 0.0 0.0 18.3 0.0 4.5 0.0 0.0 2.5 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.4 8.3 7.3 2.8 0.1 0.1 2.2 0.0 1.0 4.7 0.0 0.0 3.7 0.0 11.7 3.0 0.0 0.9 0.0 9.6 0.1 3.7 0.2 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 13.8 0.0 0.1 0.3 0.2 0.0 0.1 0.0 10.9 0.3 8.6 0.0 0.9 1.7 7.7 2.7 1.9 1.5 7.4 3.6 1.8 1.1 6.7 4.2 1.4 4.3 0.1 3.3 1.4 1.7 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011005.1 ENSG00000230626 7 129126518-129130793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 7.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.7;MCF7: 2.3;RT4: 1.9" HPA051993 Uncertain Approved Cytosol NA NA Cytosol "HPA051993: AB_2681685" "unprognostic (2.03e-1)" "unprognostic (7.97e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-3)" "unprognostic (1.58e-1)" "unprognostic (2.67e-3)" "unprognostic (1.35e-2)" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (3.11e-2)" "unprognostic (3.61e-1)" "unprognostic (2.60e-2)" "unprognostic (3.01e-1)" "unprognostic (1.06e-1)" "unprognostic (4.36e-5)" "unprognostic (3.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.6 0.4 0.9 0.3 0.7 0.6 0.1 0.2 0.6 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.7 1.7 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.5 0.0 2.3 0.4 0.1 0.2 0.1 0.5 0.2 0.0 0.0 0.0 1.9 0.3 0.1 0.0 0.0 0.8 0.1 0.0 0.7 0.0 0.2 0.0 0.9 0.3 0.2 0.1 0.3 0.4 0.0 0.0 0.5 0.3 0.9 0.3 0.3 0.5 0.4 0.3 0.6 0.4 0.6 0.4 0.4 0.8 0.7 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012476.1 ENSG00000285396 15 40695129-40732158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 19.5;testis: 16.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039310 Approved Approved "Nucleoli rim,Cytosol" NA NA "Nucleoli rim" Cytosol "HPA039310: AB_2676434" 0.4 0.8 0.0 4.2 0.0 0.9 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.1 0.8 2.1 0.2 1.4 0.9 0.0 0.2 0.3 0.8 0.9 0.0 0.0 0.3 0.5 0.9 0.0 3.9 0.0 0.1 0.0 0.0 0.3 0.0 1.8 0.9 1.2 0.0 0.2 3.0 1.6 16.7 0.0 19.5 0.1 2.1 6.1 0.0 0.0 1.3 1.0 2.3 0.4 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.5 1.2 0.2 1.0 0.2 1.1 0.3 0.4 1.3 0.2 0.3 2.3 1.2 0.1 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC023509.3 ENSG00000267281 12 53506688-53625979 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 3.0;Club cells: 3.4;Collecting duct cells: 1.8;granulocytes: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.5" HPA003384 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (1.14e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (8.37e-4)" "unprognostic (6.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.08e-5)" "unprognostic (1.91e-2)" "unprognostic (2.26e-7)" "unprognostic (9.21e-2)" "unprognostic (2.50e-1)" "unprognostic (3.72e-1)" "unprognostic (9.77e-3)" 4.5 2.4 3.9 2.0 6.0 4.5 4.6 14.9 5.2 3.3 2.7 7.8 2.1 1.4 4.5 1.8 3.2 3.6 3.8 3.7 4.4 2.8 2.4 3.8 7.0 3.6 6.8 2.3 5.1 3.5 1.4 3.6 2.9 5.1 3.3 3.5 3.1 3.0 4.3 4.5 3.4 2.4 5.7 4.7 2.9 3.1 4.7 6.6 1.9 2.4 1.7 4.1 5.9 2.5 0.7 1.4 2.9 2.2 0.2 2.5 0.5 0.6 4.5 0.0 0.5 1.8 2.3 0.0 0.0 1.5 1.6 0.3 0.5 0.7 1.7 0.4 0.0 0.0 1.4 0.3 1.2 1.3 1.8 0.9 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.5 0.9 0.0 0.0 2.0 1.9 0.0 1.8 0.0 0.0 0.0 0.2 0.8 0.2 0.7 0.3 0.0 0.5 0.0 0.2 0.0 1.4 0.0 0.0 0.3 1.3 2.3 1.8 0.0 0.6 0.6 0.0 0.3 0.0 0.6 1.5 0.8 0.9 0.0 2.9 1.7 0.5 2.5 2.2 0.5 0.2 0.2 0.4 0.9 0.7 0.0 0.4 2.4 0.2 0.0 1.4 0.3 0.5 3.9 6.0 14.9 5.2 4.4 2.8 6.8 2.3 5.1 6.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.8 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC104662.2 ENSG00000281028 4 25160663-25277306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004099 Uncertain Uncertain Cytosol NA NA Cytosol "HPA004099: AB_1855353" "unprognostic (3.59e-2)" 1.7 2.3 6.7 5.5 11.1 6.7 3.7 9.7 9.3 2.0 4.1 4.3 5.0 7.8 1.7 2.5 5.4 3.5 1.6 1.5 7.3 2.8 10.1 4.0 4.4 10.0 2.4 1.5 1.8 2.9 14.9 2.8 7.1 1.1 5.4 2.1 4.5 2.5 1.8 0.0 6.0 2.6 11.3 2.5 3.6 9.2 10.6 6.1 5.3 1.6 5.3 3.1 4.8 2.1 2.0 7.5 1.9 1.4 4.3 0.9 5.3 3.7 4.4 2.4 3.2 6.1 4.1 8.9 9.1 11.4 12.2 4.0 7.5 13.5 2.1 11.4 10.7 2.9 9.3 3.8 6.9 5.8 2.6 6.3 9.1 3.8 0.6 12.4 3.6 3.1 0.7 4.5 4.6 2.2 3.9 6.0 4.2 15.7 3.5 6.1 10.8 0.9 3.6 6.7 2.4 6.3 12.0 5.9 2.7 9.8 5.0 1.0 3.6 1.3 2.6 4.4 2.9 1.7 7.4 6.3 1.8 2.9 5.2 10.6 12.0 19.1 5.4 6.5 4.6 7.5 1.9 6.2 2.4 1.8 1.6 2.1 2.4 2.3 1.4 1.9 1.8 2.1 3.2 1.4 1.3 2.0 4.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC245033.1 ENSG00000260836 15 82536788-82573194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 11.3" "Group enriched" "Detected in some" 240 "Alveolar cells type 1: 29.8;Alveolar cells type 2: 42.6;Ciliated cells: 20.1;Club cells: 15.9;granulocytes: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 19.0" HPA055060 Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoli, Cytosol" "HPA055060: AB_2682686" "unprognostic (2.91e-2)" 1.5 0.9 5.3 0.9 7.1 0.9 1.3 6.1 11.3 0.9 1.0 1.4 0.0 0.9 0.9 0.9 1.5 0.9 0.9 1.3 3.9 1.6 0.9 1.0 1.1 0.9 3.2 6.1 0.9 1.0 0.9 2.0 1.0 7.3 1.1 1.1 1.9 0.9 0.9 2.0 0.9 1.4 0.9 2.4 1.1 0.9 1.4 1.7 0.0 1.0 0.0 1.0 1.7 0.8 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.7 0.7 19.0 0.3 0.0 0.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.1 6.1 11.3 3.9 1.6 3.2 6.1 7.3 1.7 29.8 42.6 0.0 0.0 0.0 0.0 0.0 0.0 20.1 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACACA "ACAC, ACC, ACC1" ENSG00000278540 "Acetyl-CoA carboxylase alpha" Q13085 17 37084988-37406818 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Allosteric enzyme, Ligase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013715, HPA036650, HPA063018" Approved Supported "Nucleoli fibrillar center,Actin filaments,Cytosol" NA NA Cytosol "Nucleoli fibrillar center, Actin filaments" "CAB013715: , HPA036650: AB_2675228, HPA063018: AB_2684922" "unprognostic (1.96e-2)" "unprognostic (1.07e-2)" "unprognostic (3.04e-2)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.24e-5)" "unprognostic (8.81e-2)" "unprognostic (6.56e-2)" "unprognostic (2.38e-3)" "unprognostic (3.38e-1)" "unprognostic (2.24e-1)" "unprognostic (6.72e-2)" "unprognostic (1.18e-1)" "unprognostic (4.89e-1)" "unprognostic (4.49e-2)" "unprognostic (2.03e-2)" 10.7 4.8 5.6 2.5 7.7 3.0 18.5 6.0 11.5 5.3 4.2 6.9 12.7 3.8 4.5 11.7 9.2 3.8 3.6 2.3 4.9 3.0 5.8 7.3 3.5 6.3 4.6 4.3 2.3 13.6 7.9 2.6 6.1 12.2 5.1 4.8 4.6 14.4 11.3 5.4 2.5 7.8 4.2 2.3 3.9 5.5 5.7 2.0 4.2 4.5 5.0 4.3 4.6 4.4 3.2 1.3 4.1 2.0 3.9 2.0 14.9 3.1 18.2 19.1 25.4 25.1 6.3 6.6 9.4 6.9 12.6 12.1 2.6 2.0 5.4 10.7 18.3 15.4 3.3 22.6 10.9 5.9 9.9 11.9 7.9 12.3 4.0 6.4 2.4 20.2 13.2 18.4 13.7 8.7 12.2 10.7 28.3 1.4 1.0 12.6 6.8 9.8 13.8 9.4 9.9 10.5 11.4 2.7 16.4 16.9 20.6 8.1 11.9 5.6 5.3 16.5 11.2 7.4 10.8 5.9 9.4 8.2 1.6 4.0 4.7 18.6 5.4 5.4 8.1 1.1 2.8 0.3 2.3 4.1 2.1 2.7 2.5 2.7 3.2 4.4 3.9 2.7 1.3 2.0 2.7 2.4 3.2 2.0 29.8 40.1 3.7 15.6 10.3 15.4 6.5 2.5 8.1 12.5 10.4 25.5 14.2 8.3 5.9 46.0 7.5 4.8 23.3 7.2 5.4 7.5 20.3 6.9 8.1 5.0 22.3 8.6 4.3 2.1 39.8 9.2 4.2 10.1 3.6 7.2 19.9 6.5 5.8 14.9 5.0 10.7 6.5 4.8 7.9 17.9 13.9 13.6 4.3 8.7 18.2 ACAT2 ENSG00000120437 "Acetyl-CoA acetyltransferase 2" Q9BWD1 6 159760328-159779055 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 20.4;liver: 31.0" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 168.5;Exocrine glandular cells: 155.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 48.1" "Low region specificity" "Detected in all" "CAB021106, HPA025736, HPA025765, HPA025811" Enhanced Approved Nucleoplasm,Cytosol NA NA 16000000 Cytosol Nucleoplasm "CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488" "unprognostic (3.31e-1)" "unprognostic (2.44e-2)" "prognostic favorable (1.12e-4)" "prognostic unfavorable (7.25e-4)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" "unprognostic (9.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-1)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (8.56e-2)" "unprognostic (2.54e-2)" 1.6 2.6 2.7 1.5 1.7 1.6 2.2 2.2 6.3 2.1 4.3 3.2 1.4 4.8 5.7 1.0 0.7 0.7 2.9 3.6 3.0 31.0 1.8 2.5 2.9 2.1 0.7 1.3 1.2 0.9 4.2 3.9 2.3 0.5 0.1 2.4 1.6 1.4 5.1 1.1 1.7 6.6 0.9 4.2 1.1 2.6 13.3 9.5 12.3 8.4 10.0 20.4 12.2 6.7 6.3 42.7 16.3 6.1 11.3 1.4 5.9 7.1 14.1 24.4 24.5 8.6 5.6 3.0 4.7 48.1 6.5 17.7 46.2 16.7 3.3 18.1 13.1 10.2 40.6 6.1 7.6 3.5 6.1 3.4 23.3 10.0 2.1 6.9 16.0 14.1 9.6 8.5 11.9 13.0 12.1 14.3 6.7 4.6 8.1 9.6 17.4 32.9 8.7 11.4 6.5 6.9 4.5 2.4 2.0 8.5 15.1 4.3 5.2 4.5 7.3 15.2 4.6 8.4 13.8 1.5 14.9 7.8 6.1 7.1 12.3 13.9 8.4 13.7 13.3 15.9 13.8 9.5 13.3 16.0 12.3 3.2 10.0 5.6 8.7 20.4 12.2 11.9 35.5 24.6 29.0 23.2 14.0 1.2 40.8 20.1 21.6 19.2 2.0 44.4 59.7 47.3 168.5 10.9 23.5 0.0 155.7 84.2 22.6 31.4 12.7 55.7 46.8 12.7 16.4 12.9 10.5 110.0 12.7 23.1 28.7 92.8 21.4 21.8 47.0 17.5 18.0 33.8 19.6 0.0 34.0 14.7 48.7 18.3 29.4 26.6 23.3 27.6 ACBD6 MGC2404 ENSG00000230124 "Acyl-CoA binding domain containing 6" Q9BR61 1 180269653-180502954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 143.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028179, HPA028457" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028179: AB_10601788, HPA028457: " "unprognostic (3.12e-1)" "unprognostic (4.38e-2)" "unprognostic (1.66e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (1.75e-2)" "unprognostic (2.03e-2)" "unprognostic (2.73e-2)" "unprognostic (7.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (4.02e-7)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.51e-1)" 6.5 7.5 7.3 9.7 7.7 9.1 7.1 17.4 8.1 8.0 5.2 6.5 9.6 5.8 8.6 7.6 5.4 6.0 7.1 8.9 6.6 6.8 5.5 6.8 11.2 6.1 7.9 10.5 9.7 6.8 10.5 11.3 5.8 6.8 5.0 6.5 7.2 7.6 9.5 6.3 5.2 7.8 4.0 6.8 6.1 18.2 7.3 8.1 8.1 7.7 7.1 7.6 6.9 11.5 14.5 2.7 13.3 16.4 10.9 7.7 21.2 15.8 13.6 10.0 9.5 16.6 28.5 9.8 19.7 17.1 15.5 22.3 15.6 18.8 20.3 9.6 8.4 15.3 10.0 18.1 10.9 14.2 19.5 14.8 14.3 12.7 24.5 25.3 13.4 15.0 25.9 10.6 16.7 15.0 19.0 15.3 23.2 15.3 13.7 19.3 21.6 23.9 15.0 14.5 7.5 21.8 11.3 35.9 14.5 11.1 21.4 27.4 13.1 22.0 13.1 14.2 23.1 18.9 15.3 12.8 15.4 15.6 21.1 32.4 16.7 42.7 14.0 15.6 15.1 1.9 8.4 2.7 9.3 13.3 10.7 11.5 8.0 7.9 14.5 8.8 10.0 10.9 0.6 16.4 10.0 11.8 7.4 7.7 29.8 24.1 29.2 23.8 18.9 50.3 40.9 17.8 34.8 39.8 15.7 37.3 143.2 34.9 32.0 69.5 28.1 4.2 0.0 36.3 31.1 30.4 19.4 18.6 11.6 38.5 49.3 18.7 20.9 11.1 43.0 47.5 25.5 35.4 34.3 18.7 36.3 29.4 14.0 47.7 38.9 5.8 58.2 26.4 104.2 59.8 19.6 70.6 22.5 24.7 15.2 ACBD7 "bA455B2.2, FLJ38219" ENSG00000176244 "Acyl-CoA binding domain containing 7" Q8N6N7 10 15077523-15088776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 35.3" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 2.7;Cone photoreceptor cells: 2.0;Early spermatids: 4.1;Intestinal endocrine cells: 1.7;Late spermatids: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 24.2;MOLT-4: 20.4;U-266/84: 15.3;U-698: 17.6" "Region enriched" "Detected in many" 5 "olfactory region: 21.6" "Low region specificity" "Detected in all" "HPA043326, HPA062478" Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043326: AB_2678429, HPA062478: AB_2684777" "unprognostic (2.15e-1)" "unprognostic (8.94e-2)" "unprognostic (7.79e-3)" "unprognostic (6.53e-3)" "unprognostic (7.30e-2)" "unprognostic (6.89e-3)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.32e-1)" "unprognostic (6.34e-2)" "unprognostic (3.59e-3)" "unprognostic (3.06e-1)" "unprognostic (2.18e-4)" "unprognostic (9.72e-2)" "unprognostic (2.95e-1)" "unprognostic (2.14e-1)" "unprognostic (6.90e-2)" 1.1 1.1 25.0 1.5 27.1 3.9 8.3 12.9 35.3 1.1 1.4 9.3 0.0 2.5 1.4 2.7 1.7 4.4 1.7 1.2 25.3 9.8 1.4 1.7 1.4 2.1 15.0 16.2 1.7 1.5 1.5 0.7 1.3 14.0 1.5 1.6 0.0 4.7 1.4 2.0 3.0 1.9 1.3 6.6 1.6 1.8 5.9 11.7 2.9 4.2 0.0 1.7 1.4 0.5 1.7 1.5 3.8 0.6 2.1 1.1 0.2 2.5 0.6 9.8 4.7 0.6 0.4 1.2 0.7 0.6 1.8 3.0 2.8 3.0 2.3 3.4 2.3 2.5 0.6 5.8 1.8 2.6 5.1 8.0 2.4 0.7 1.5 0.1 0.4 1.0 0.1 0.1 0.6 0.1 2.6 2.4 24.2 1.9 2.8 1.9 7.8 20.4 2.2 4.9 0.6 1.7 11.0 3.5 5.3 1.2 1.0 8.1 4.9 2.5 5.6 1.1 3.9 8.0 0.6 0.7 0.4 5.4 1.0 2.1 7.7 15.3 17.6 1.6 0.4 0.7 3.8 0.6 0.8 1.1 0.6 0.9 1.3 0.6 0.6 0.3 1.7 1.1 1.1 3.7 2.1 0.5 1.5 0.5 0.2 25.0 27.1 12.9 21.8 25.3 9.8 15.0 16.2 14.0 11.7 0.0 1.1 0.0 0.1 0.1 0.1 0.0 0.0 2.7 0.0 0.0 2.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.0 0.1 ACCSL ENSG00000205126 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like" Q4AC99 11 44047981-44059977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.6;testis: 2.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 22 "melanoma: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 4.1;U-266/70: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA065042 Approved Cytosol NA NA Cytosol "HPA065042: " "unprognostic (2.37e-2)" "unprognostic (2.91e-1)" "unprognostic (9.76e-5)" "unprognostic (7.42e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACIN1 "ACINUS, fSAP152, KIAA0670" ENSG00000100813 "Apoptotic chromatin condensation inducer 1" Q9UKV3 14 23058564-23095614 "Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000657 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000657: AB_1078091" "unprognostic (2.54e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.89e-3)" "prognostic unfavorable (4.88e-5)" "unprognostic (1.49e-3)" "unprognostic (9.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.00e-2)" "unprognostic (6.64e-3)" "unprognostic (1.35e-3)" "unprognostic (4.34e-2)" "unprognostic (2.78e-2)" "unprognostic (2.28e-2)" "unprognostic (7.33e-2)" 32.4 44.4 34.6 46.6 36.2 57.6 32.5 45.7 41.8 36.6 30.1 39.1 35.2 28.5 52.9 32.2 39.3 34.6 33.3 29.7 33.1 28.3 34.9 35.5 28.8 41.1 34.4 27.7 43.9 34.5 51.1 48.3 37.0 33.7 35.4 34.6 31.5 33.0 38.3 43.8 38.1 35.1 40.1 35.0 52.9 34.0 34.5 40.6 44.2 38.5 27.1 45.9 30.5 47.8 6.9 6.8 13.4 4.9 9.7 5.5 2.7 23.7 24.5 38.7 31.3 24.2 19.5 38.9 26.5 18.7 32.1 26.2 32.4 27.9 44.1 15.7 21.9 21.1 26.2 53.4 30.3 33.0 31.0 23.7 38.8 25.9 44.6 13.9 42.0 34.5 22.8 18.7 32.8 27.7 26.3 28.0 32.9 35.7 17.7 24.1 29.7 47.6 41.5 43.5 26.4 23.4 43.2 30.1 23.5 26.6 42.0 25.8 19.0 35.2 23.0 20.9 29.4 18.9 34.0 28.6 22.0 22.0 20.8 24.4 18.8 21.1 45.7 19.5 31.9 23.8 4.1 4.9 5.6 5.5 4.5 4.4 4.4 3.7 4.2 4.1 6.9 5.1 4.6 13.4 9.7 3.7 6.8 3.8 2.7 34.6 36.2 45.7 41.8 33.1 28.3 34.4 27.7 33.7 40.6 65.5 108.5 33.5 28.5 33.2 38.0 57.7 30.6 109.7 78.5 33.2 25.5 48.1 14.9 45.8 27.6 44.3 40.8 46.7 42.7 55.4 35.5 30.5 120.8 24.7 40.9 14.3 55.9 32.5 26.9 5.0 42.6 35.7 25.3 52.3 37.3 25.9 52.1 42.1 36.0 14.1 42.2 6.5 39.6 35.1 34.6 40.7 57.9 36.3 40.7 34.1 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "placenta: 96.2;salivary gland: 74.8" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 26.5;Extravillous trophoblasts: 87.8;Syncytiotrophoblasts: 61.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 7.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 7.3;NK-cells: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 32.2;HEL: 10.3;SK-BR-3: 17.2;U-937: 6.5" "Group enriched" "Detected in many" 9 "amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6" "Not detected" "Not detected" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: AB_2686610" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 10.4 0.9 0.4 0.7 0.5 0.4 5.3 0.2 0.4 2.9 1.8 0.1 0.6 0.7 2.0 5.2 2.5 2.4 1.2 1.0 0.5 0.4 1.1 14.5 1.5 1.0 0.5 0.2 0.9 0.7 0.3 0.6 96.2 0.2 1.1 2.0 0.3 74.8 0.4 2.1 2.5 1.0 3.2 0.7 1.1 0.9 1.5 0.1 0.4 3.8 2.3 2.0 3.2 4.1 0.8 0.4 7.3 0.6 2.2 0.4 0.3 0.1 0.0 0.1 0.2 1.5 0.1 32.2 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 10.3 0.2 1.8 0.0 0.1 1.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 1.3 0.2 0.2 0.2 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.4 4.5 0.1 0.1 0.8 17.2 0.0 1.9 1.7 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 6.5 0.1 0.7 0.2 7.3 0.4 0.5 0.1 0.2 0.1 0.2 0.4 0.8 0.3 0.3 1.0 2.2 0.6 0.3 0.1 0.3 0.4 0.5 0.2 0.4 0.5 0.4 0.5 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.6 2.5 1.4 0.0 0.0 2.0 26.5 1.7 0.0 1.9 1.4 2.0 0.0 0.0 87.8 1.8 0.4 2.3 5.8 4.6 1.6 1.7 3.7 0.3 1.1 0.3 0.2 0.0 0.0 0.1 2.5 0.6 0.0 1.1 0.3 0.9 0.0 0.0 4.5 3.3 0.0 61.6 0.5 0.4 0.1 ACLY "ACL, ATPCL, CLATP" ENSG00000131473 "ATP citrate lyase" P53396 17 41866908-41930542 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007783, HPA022434, HPA022953, HPA022959, HPA028758" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 2100000 "Plasma membrane, Cytosol" Nucleoplasm "CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575" "unprognostic (2.21e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.41e-1)" "unprognostic (1.21e-2)" "unprognostic (2.83e-1)" "unprognostic (8.94e-3)" "prognostic unfavorable (3.66e-4)" "unprognostic (3.38e-3)" "unprognostic (4.11e-2)" "unprognostic (5.94e-3)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.88e-3)" "unprognostic (1.66e-1)" "unprognostic (9.36e-2)" "unprognostic (3.90e-2)" "unprognostic (4.67e-3)" 38.3 24.0 16.7 26.2 22.9 19.1 35.7 21.5 29.1 22.9 22.2 25.1 18.0 30.7 27.0 24.9 23.2 23.7 28.2 18.4 18.3 33.7 37.8 22.2 23.3 27.4 23.1 17.9 19.0 30.6 27.1 19.5 26.7 49.0 41.3 23.2 15.6 25.4 19.6 10.9 19.6 29.6 27.2 26.2 24.5 24.6 20.7 21.4 32.0 21.3 18.2 24.6 20.3 21.3 16.1 23.9 25.2 26.3 16.0 23.9 21.4 23.4 80.1 37.8 32.6 58.5 54.9 34.8 33.1 36.2 41.7 52.4 40.6 27.1 38.2 21.3 46.4 39.2 37.4 48.7 56.7 34.9 34.4 46.6 21.8 46.1 42.2 27.2 35.3 28.6 43.6 17.1 73.2 14.8 27.4 43.9 29.6 26.9 30.5 34.5 23.9 58.1 19.8 24.6 15.8 14.5 38.1 45.7 49.0 42.7 41.9 71.2 39.1 23.6 73.9 25.3 34.1 44.1 33.8 47.2 32.6 26.8 32.7 54.3 17.9 22.7 36.3 55.0 27.4 26.4 18.9 20.7 25.2 23.8 22.1 22.5 16.1 19.0 21.3 23.9 13.8 14.6 16.1 10.7 16.0 26.3 13.9 23.9 21.4 16.7 22.9 21.5 27.7 18.3 33.7 23.1 17.9 49.0 21.4 26.8 22.1 18.5 8.0 22.1 9.0 9.6 40.8 18.7 15.9 22.7 3.9 19.9 10.0 29.9 66.2 28.7 23.4 0.0 29.7 39.3 29.9 33.0 14.0 24.6 27.1 17.5 63.4 40.5 40.5 11.4 57.2 21.6 30.4 31.5 46.6 7.0 34.4 17.3 48.1 71.1 6.5 12.9 16.5 21.4 33.8 28.9 18.5 21.3 19.8 12.0 ACO1 "IREB1, IREBP, IRP1" ENSG00000122729 "Aconitase 1" P21399 9 32384603-32454769 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Lyase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.9" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 174.5;Proximal tubular cells: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019371, HPA024157" Enhanced Supported Mitochondria,Cytosol NA NA 8000000 "Mitochondria, Cytosol" "HPA019371: AB_1844519, HPA024157: AB_1844520" "unprognostic (2.11e-1)" "unprognostic (5.61e-2)" "unprognostic (8.38e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-1)" "unprognostic (3.12e-2)" "unprognostic (4.25e-3)" "unprognostic (2.61e-2)" "unprognostic (1.37e-1)" "unprognostic (1.19e-1)" "unprognostic (2.55e-1)" "unprognostic (3.08e-1)" "prognostic favorable (5.73e-5)" "unprognostic (2.54e-1)" "unprognostic (6.58e-2)" "unprognostic (1.65e-1)" "unprognostic (3.23e-2)" 41.4 27.2 9.6 7.1 9.4 1.5 30.1 8.9 8.1 9.3 19.7 6.2 6.4 21.9 12.8 14.6 12.8 7.2 8.9 15.1 6.5 7.6 40.5 80.9 9.2 9.4 6.1 6.2 14.1 27.9 8.9 8.7 11.3 7.7 10.7 9.8 11.7 11.7 9.5 11.2 5.5 28.4 14.5 6.0 6.4 13.5 11.4 5.9 6.0 18.4 7.2 5.1 13.9 11.7 4.7 7.1 21.4 8.8 4.7 7.4 6.2 9.5 8.7 6.8 10.7 53.1 28.8 3.1 18.1 44.5 8.3 6.6 9.2 3.0 1.9 5.8 18.9 22.8 1.3 13.5 17.3 16.8 6.0 3.6 14.0 9.5 10.0 26.7 1.3 5.6 25.0 5.3 21.4 15.1 25.7 21.5 7.4 5.0 4.1 23.7 2.5 7.4 6.7 7.1 6.0 9.4 5.8 10.1 1.9 31.7 8.8 0.9 2.8 18.8 0.7 1.9 7.6 4.4 3.4 23.2 30.4 10.3 10.1 4.7 2.1 3.9 3.8 21.2 4.7 2.6 21.4 8.7 2.4 7.4 8.8 6.4 4.7 5.2 5.7 7.1 4.2 6.8 7.0 1.0 4.7 7.2 3.4 2.8 6.2 9.6 9.4 8.9 8.1 6.5 7.6 6.1 6.2 7.7 5.9 3.0 25.5 7.5 6.9 3.9 18.8 39.8 45.9 8.1 9.1 22.7 21.6 39.8 16.6 14.3 6.3 18.2 29.7 0.0 35.8 17.8 21.6 11.2 2.3 174.5 13.3 31.8 4.7 14.1 12.7 5.1 21.9 7.2 6.8 2.8 32.4 30.7 23.2 21.0 21.9 160.8 13.9 19.4 22.3 6.1 16.2 4.6 44.7 8.7 26.9 7.1 ACOT11 "BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1" ENSG00000162390 "Acyl-CoA thioesterase 11" Q8WXI4 1 54542257-54639192 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 80.9;Late spermatids: 73.7;Muller glia cells: 81.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.3" "Cell line enhanced" "Detected in many" "HaCaT: 12.6;OE19: 17.6;RT4: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041047 Enhanced Supported Cytosol NA NA Cytosol "HPA041047: AB_2677273" "unprognostic (9.73e-2)" "unprognostic (1.28e-1)" "prognostic favorable (9.37e-4)" "unprognostic (3.61e-4)" "unprognostic (5.42e-2)" "unprognostic (1.94e-1)" "unprognostic (2.20e-3)" "unprognostic (5.12e-4)" "unprognostic (1.05e-1)" "unprognostic (2.84e-2)" "unprognostic (9.60e-2)" "unprognostic (1.02e-1)" "prognostic favorable (3.07e-8)" "unprognostic (5.89e-2)" "unprognostic (1.08e-1)" "unprognostic (3.83e-2)" "unprognostic (8.49e-3)" 1.3 4.1 5.7 1.9 7.3 3.0 1.2 3.7 8.6 3.7 10.9 9.6 10.0 28.2 3.6 5.2 14.8 2.7 4.0 22.2 5.9 2.6 15.1 1.2 1.7 1.5 3.1 9.5 4.6 3.0 9.4 18.8 1.4 11.1 3.9 9.5 22.0 9.4 4.5 6.8 2.6 22.5 14.6 6.2 1.3 9.0 6.6 3.9 0.0 10.1 5.7 2.7 9.1 5.5 1.3 1.3 8.3 1.3 0.9 0.9 0.6 4.3 2.8 1.4 0.9 0.6 1.3 2.2 2.5 0.2 0.9 0.6 4.2 11.1 1.0 4.2 2.1 2.7 12.6 0.6 2.2 0.5 2.6 1.0 10.3 4.0 1.8 0.2 1.2 1.7 1.4 2.5 0.4 1.1 1.2 2.3 0.8 0.6 1.5 2.9 1.4 0.5 1.7 2.3 17.6 0.6 0.9 7.5 1.0 1.0 26.2 2.9 2.9 1.2 0.9 0.5 4.9 1.1 3.3 2.4 2.0 1.7 1.3 1.0 1.7 0.8 1.1 0.9 7.7 0.9 2.0 1.3 8.3 0.8 0.7 0.7 0.7 0.7 0.5 1.3 1.3 0.9 0.9 2.8 0.9 0.9 0.9 0.6 0.6 5.7 7.3 3.7 8.6 5.9 2.6 3.1 9.5 11.1 3.9 0.0 8.5 2.7 14.4 4.2 46.5 21.5 12.7 12.0 10.3 24.4 0.0 1.8 10.0 4.7 13.0 1.8 80.9 0.0 2.2 5.4 3.5 4.9 15.0 0.0 7.6 14.3 45.7 1.8 5.6 73.7 12.7 9.1 8.5 2.8 31.3 81.2 3.9 34.5 16.6 31.2 4.0 0.0 3.8 0.5 0.2 2.5 2.1 0.0 34.5 20.9 ACOT12 "Cach, STARD15, THEAL" ENSG00000172497 "Acyl-CoA thioesterase 12" Q8WYK0 5 81330005-81394179 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 49.6" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 37.1" "Cancer enriched" "Detected in single" 76 "liver cancer: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;CACO-2: 2.5;Karpas-707: 1.8;SK-MEL-30: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA037723, HPA037724" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037723: AB_10672606, HPA037724: AB_2675631" "unprognostic (6.06e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.30e-4)" "unprognostic (7.68e-2)" "unprognostic (8.22e-2)" "unprognostic (5.68e-3)" "unprognostic (2.46e-1)" "unprognostic (6.86e-2)" "unprognostic (1.46e-2)" "unprognostic (3.07e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.2 49.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.5 0.1 0.0 0.1 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.4 0.0 0.0 0.6 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ACOT7 "ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126" ENSG00000097021 "Acyl-CoA thioesterase 7" O00154 1 6264269-6394391 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.0" "Cell type enhanced" "Detected in many" 8 "granulocytes: 137.0;Late spermatids: 118.5;Proximal tubular cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 20.5;plasmacytoid DC: 19.4" "Group enriched" "Detected in many" 4 "dendritic cells: 19.4;NK-cells: 20.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025735, HPA025762" Enhanced Supported Nucleoplasm,Cytosol No No 29000 Cytosol Nucleoplasm "HPA025735: AB_1844523, HPA025762: AB_1844524" "unprognostic (3.94e-2)" "unprognostic (1.74e-1)" "unprognostic (7.09e-2)" "unprognostic (4.33e-2)" "unprognostic (4.10e-2)" "unprognostic (5.06e-2)" "prognostic unfavorable (2.31e-5)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.35e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.55e-6)" "unprognostic (2.68e-2)" "unprognostic (1.45e-1)" "unprognostic (9.06e-2)" "unprognostic (3.72e-2)" 4.7 13.3 25.8 10.8 29.8 7.7 3.9 23.9 50.0 4.4 18.3 11.3 0.5 33.2 5.1 3.8 14.3 4.4 5.3 6.3 27.8 43.9 29.4 9.1 8.6 12.3 36.0 20.7 5.3 4.0 1.9 18.5 7.4 49.9 5.6 13.5 6.6 4.1 4.9 1.5 9.4 33.2 14.3 14.2 8.9 6.2 13.1 6.9 9.0 2.3 6.5 11.6 9.1 6.6 1.0 19.4 0.4 0.6 20.5 4.4 2.8 23.7 20.7 20.4 22.0 4.7 7.8 7.7 20.5 10.6 30.4 18.2 71.4 7.7 29.1 15.1 16.6 23.5 23.5 32.9 54.7 11.4 25.5 28.7 15.3 16.4 25.3 19.3 17.9 12.7 6.9 10.5 25.1 29.8 8.1 17.0 36.5 12.4 6.3 16.0 27.7 37.3 19.0 10.2 23.9 48.0 44.6 23.5 19.7 17.1 9.1 11.2 31.7 18.4 28.3 65.2 10.5 10.1 8.4 27.5 27.7 16.2 27.4 32.3 5.3 21.6 40.9 17.5 31.3 16.8 0.0 0.1 0.1 4.1 0.6 1.0 1.0 3.4 3.6 2.9 0.4 1.2 2.3 0.4 20.5 0.5 19.4 4.4 2.8 25.8 29.8 23.9 50.0 27.8 43.9 36.0 20.7 49.9 6.9 6.0 25.5 13.7 13.3 28.2 33.6 8.1 12.7 1.4 7.9 8.7 9.8 15.1 13.3 19.1 73.6 15.6 70.9 0.0 6.2 23.1 14.2 7.0 137.0 13.4 26.8 44.5 4.6 5.5 4.0 118.5 3.4 16.9 37.1 25.2 88.8 10.6 16.5 29.1 6.7 214.2 15.6 0.0 6.2 38.2 26.7 25.7 14.4 21.4 48.7 19.5 ACOT9 "ACATE2, CGI-16, MT-ACT48" ENSG00000123130 "Acyl-CoA thioesterase 9" Q9Y305 X 23702253-23766475 "Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 296.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035533 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA035533: AB_10696506" "unprognostic (5.69e-2)" "unprognostic (6.34e-2)" "unprognostic (1.59e-1)" "unprognostic (2.09e-1)" "unprognostic (1.53e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (1.12e-1)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (9.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.15e-3)" "unprognostic (6.53e-2)" "unprognostic (1.68e-1)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" 19.1 15.9 6.3 14.1 7.7 10.5 29.2 6.5 13.6 15.4 16.3 5.4 17.6 11.5 21.2 16.1 12.0 14.5 15.5 35.7 5.7 7.7 12.8 15.5 23.6 36.0 7.3 8.6 13.4 16.6 9.1 7.8 13.3 12.7 12.8 12.7 13.9 16.3 23.0 28.8 10.4 12.5 35.7 13.8 15.8 15.0 7.1 4.5 3.8 15.1 11.4 9.7 15.9 14.4 5.5 16.4 11.1 26.5 6.0 10.0 8.4 26.1 17.9 7.8 17.1 12.8 14.7 3.9 20.8 18.0 20.6 20.0 15.8 23.7 1.3 13.3 23.1 27.8 16.0 9.8 26.4 28.7 6.1 14.9 8.9 18.7 11.4 17.3 3.4 11.3 12.9 18.1 24.1 27.5 13.5 30.1 0.2 5.6 9.0 22.2 9.1 4.8 8.4 11.3 10.3 21.8 5.1 29.7 11.1 24.4 9.7 1.5 7.5 22.6 9.5 13.3 30.2 10.7 4.6 27.9 17.2 11.4 24.9 11.3 2.2 5.1 0.1 12.7 3.4 14.5 9.1 16.1 11.1 5.6 22.2 7.6 5.5 7.0 6.3 16.4 4.6 2.3 5.3 8.4 6.0 26.5 2.8 10.0 8.4 6.3 7.7 6.5 13.6 5.7 7.7 7.3 8.6 12.7 4.5 44.7 33.0 11.4 38.4 17.9 4.3 37.2 15.3 28.1 35.2 15.7 23.6 3.6 5.0 60.6 0.7 35.1 10.5 0.0 45.6 9.3 28.3 31.5 35.9 11.3 39.9 4.8 2.4 35.6 33.3 0.0 16.7 63.3 32.1 296.6 8.7 10.0 62.9 11.8 24.1 25.0 9.3 25.8 20.3 1.8 9.6 9.4 2.5 22.3 9.4 32.8 ACOX2 "BRCACOX, BRCOX, THCCox" ENSG00000168306 "Acyl-CoA oxidase 2" Q99424 3 58505136-58537319 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 70.5" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 75.4;Proximal tubular cells: 33.8" "Cancer enhanced" "Detected in many" "liver cancer: 25.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 12.5;ASC TERT1: 20.7;fHDF/TERT166: 6.7;Hep G2: 8.0;HSkMC: 13.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA038280, HPA064845" Enhanced Approved Vesicles,Cytosol No No 190000 Vesicles Cytosol "HPA038280: AB_10672623, HPA064845: AB_2685368" "unprognostic (6.62e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-1)" "unprognostic (2.51e-2)" "unprognostic (8.34e-2)" "unprognostic (1.48e-2)" "unprognostic (8.67e-3)" "unprognostic (6.45e-2)" "unprognostic (1.00e-1)" "unprognostic (1.85e-1)" "unprognostic (1.70e-3)" "unprognostic (1.26e-2)" "unprognostic (1.68e-3)" "unprognostic (4.00e-3)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (5.63e-3)" 4.0 5.3 1.9 3.8 2.5 0.1 3.4 1.6 2.1 4.4 10.2 2.7 9.5 10.0 9.0 6.2 3.8 4.4 4.8 8.8 2.4 1.4 17.1 70.5 2.8 0.7 2.0 1.7 5.1 2.9 3.8 3.0 1.4 4.0 7.2 3.4 11.4 3.0 5.9 4.2 1.7 13.7 10.6 2.5 0.9 2.6 4.0 2.0 1.0 7.7 2.7 1.6 5.4 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.5 20.7 3.6 2.3 0.2 0.0 0.3 0.6 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 1.8 0.0 0.0 13.5 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.5 1.6 2.1 2.4 1.4 2.0 1.7 4.0 2.0 3.0 4.3 0.5 7.2 0.6 0.2 14.4 0.0 0.0 1.2 3.5 0.0 0.6 13.3 0.3 0.1 1.1 5.4 0.0 1.7 0.2 5.0 0.8 1.1 75.4 5.3 1.6 2.9 4.3 2.2 1.4 10.0 0.8 0.0 0.0 4.7 10.0 0.5 0.0 8.1 33.8 0.8 6.5 3.4 0.2 0.5 0.3 0.7 0.0 3.6 0.8 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732573-111118222 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 29.7;lung: 20.8;placenta: 23.8" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 27.4" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A-431: 9.1;RPMI-8226: 16.5;RT4: 21.3;U-266/70: 14.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035392, HPA035393" Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035392: AB_2674604, HPA035393: AB_2674605" "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favorable (6.48e-4)" 0.3 0.3 0.2 0.5 0.4 1.6 0.3 0.2 0.4 0.4 0.4 0.2 2.3 0.0 0.3 29.7 0.2 0.5 0.4 0.3 0.2 0.2 0.6 0.2 20.8 0.6 0.2 0.2 0.2 0.4 4.9 0.7 23.8 0.4 4.1 0.1 0.2 0.5 0.2 0.3 0.4 0.3 2.6 0.2 1.3 0.4 4.6 0.2 0.6 1.5 0.2 0.9 8.5 5.2 1.0 0.6 4.1 1.1 0.7 0.6 0.3 9.1 0.0 0.2 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.6 0.2 0.2 0.1 0.2 1.0 0.0 0.0 0.0 0.2 3.2 0.2 0.4 0.2 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.3 0.0 0.4 1.4 1.4 0.1 3.3 0.7 0.4 3.1 0.1 0.4 0.1 0.2 16.5 0.0 21.3 2.0 0.4 0.1 0.4 0.1 0.7 0.2 1.0 0.3 0.2 0.4 0.2 0.1 14.4 3.7 0.5 0.1 0.2 0.2 2.2 1.1 0.5 0.4 0.7 0.2 1.0 0.4 0.6 0.2 0.8 0.5 0.4 4.1 0.7 0.4 0.6 0.4 0.3 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.0 27.4 0.0 0.2 0.2 0.6 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.1 0.0 1.2 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.3 0.9 2.2 0.3 0.0 0.0 0.0 0.7 ACP1 "HAAP, LMW-PTP, LMWPTP" ENSG00000143727 "Acid phosphatase 1" P24666 2 264140-278283 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 913.9;Late spermatids: 1666.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016754 Approved Approved Nucleoplasm,Cytosol NA NA 3700000 Nucleoplasm Cytosol "HPA016754: AB_1844505" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (6.25e-3)" "unprognostic (1.06e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (6.67e-6)" "unprognostic (2.45e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (9.72e-3)" "unprognostic (4.89e-2)" "unprognostic (2.71e-2)" "unprognostic (7.10e-2)" "unprognostic (2.88e-2)" "unprognostic (3.39e-2)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" 22.3 59.7 38.0 20.8 40.3 38.0 33.0 27.9 43.7 23.1 29.7 27.4 24.4 31.1 25.2 36.2 24.8 29.5 26.9 27.4 34.6 33.7 42.1 54.8 24.7 29.4 31.5 34.6 33.7 53.0 28.4 43.9 39.7 39.7 27.0 32.8 28.5 46.0 23.8 35.4 21.6 34.5 24.2 28.6 28.1 34.2 38.3 21.2 33.0 32.5 32.8 29.8 22.7 20.3 33.9 20.3 17.3 23.0 35.3 41.0 33.1 17.8 26.6 41.5 22.8 18.8 18.8 33.7 21.7 23.1 21.7 19.2 36.5 18.0 11.2 16.9 20.3 28.5 17.5 40.3 23.6 19.6 27.3 41.0 32.8 24.1 79.8 26.1 37.2 18.9 19.2 21.5 20.3 25.2 23.0 24.6 42.0 33.1 21.9 25.6 24.2 40.0 36.0 50.1 47.2 30.0 26.6 42.1 25.6 33.9 25.5 45.3 44.8 13.5 32.0 43.4 28.3 18.9 19.9 20.3 23.9 15.9 19.7 32.7 29.8 59.1 34.9 28.3 32.2 28.1 17.3 19.8 17.1 30.1 22.7 39.7 33.9 34.3 34.4 17.7 31.1 41.0 39.7 3.5 35.3 23.0 20.3 35.6 33.1 38.0 40.3 27.9 43.7 34.6 33.7 31.5 34.6 39.7 21.2 41.7 88.5 101.3 80.3 70.3 51.3 74.2 109.5 129.8 67.1 64.6 7.9 179.7 228.8 194.3 913.9 64.7 84.9 163.5 146.5 234.8 71.9 111.0 68.2 112.0 123.7 27.0 79.2 50.3 57.7 1666.6 87.5 74.7 77.6 116.4 107.9 64.8 155.5 108.7 86.7 241.7 43.6 90.5 79.3 111.8 121.7 79.7 157.0 93.8 114.3 108.3 ACP5 "HPAP, TRAP" ENSG00000102575 "Acid phosphatase 5, tartrate resistant" P13686 19 11574660-11579008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 117.9;lung: 151.9" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 439.8;Ito cells: 434.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 51.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 14.6;BJ hTERT+: 9.8;K-562: 10.3;RPMI-8226: 13.9;SK-MEL-30: 41.4;U-138 MG: 38.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002584, HPA057655, HPA059463" Enhanced Uncertain Cytosol "Intracellular and membrane" NA NA 3700000 Cytosol "CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028" "unprognostic (4.27e-2)" "unprognostic (2.05e-2)" "unprognostic (2.93e-1)" "unprognostic (8.60e-3)" "unprognostic (2.96e-1)" "unprognostic (1.95e-2)" "unprognostic (5.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.13e-2)" "unprognostic (3.80e-1)" "unprognostic (3.66e-3)" "unprognostic (9.09e-2)" "unprognostic (1.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 117.9 2.8 0.9 21.1 1.1 1.4 7.7 0.7 1.0 11.9 10.2 1.2 2.1 7.7 7.7 6.5 12.1 3.5 9.1 6.8 0.9 0.4 28.0 16.3 151.9 30.8 1.0 1.0 13.2 8.7 0.2 1.6 9.2 1.2 6.4 8.7 19.1 8.6 2.8 3.0 10.4 15.6 3.3 1.9 20.7 15.0 3.5 0.7 9.2 2.2 8.2 18.4 11.4 10.1 51.4 13.9 16.8 9.4 2.6 16.0 8.1 3.3 0.4 0.0 0.0 0.2 0.0 14.6 0.4 9.8 0.0 0.0 0.0 0.1 0.5 0.6 2.9 2.4 0.1 0.0 1.5 0.0 3.7 0.3 0.1 0.0 1.8 0.6 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.7 0.3 0.5 0.3 0.1 0.3 0.1 0.7 13.9 0.0 0.1 0.2 0.3 0.0 0.0 41.4 0.4 0.0 0.1 0.3 38.9 0.4 0.7 0.1 0.2 1.8 0.2 8.0 0.0 1.2 0.0 9.4 16.8 4.1 9.1 2.1 51.4 6.4 4.7 1.7 23.5 8.3 4.7 2.6 2.6 8.7 13.9 16.0 8.1 0.9 1.1 0.7 1.0 0.9 0.4 1.0 1.0 1.2 0.7 8.9 8.5 68.7 8.2 9.2 6.0 1.1 22.9 2.7 2.3 7.0 17.7 29.7 8.3 1.6 0.1 2.9 5.9 0.0 9.9 23.7 12.1 16.2 65.4 6.4 439.8 1.6 2.9 434.6 101.6 0.0 1.7 100.7 13.5 131.7 4.5 43.7 4.7 21.0 11.3 91.3 31.7 0.0 3.2 0.0 0.1 9.7 21.9 25.4 8.3 4.3 ACSBG2 "BGR, DKFZp434K1635, PRTD-NY3" ENSG00000130377 "Acyl-CoA synthetase bubblegum family member 2" Q5FVE4 19 6135247-6193094 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis" "Developmental protein, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 71.3" "Group enriched" "Detected in some" 68 "Early spermatids: 443.1;Late spermatids: 1482.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;HEL: 3.4;Karpas-707: 2.6;MCF7: 1.0" "Not detected" "Not detected" "HPA043421, HPA051013" Enhanced Supported Cytosol NA NA Cytosol "HPA043421: AB_10794182, HPA051013: AB_2681311" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-1)" "unprognostic (3.27e-2)" "unprognostic (4.33e-2)" "unprognostic (1.92e-4)" "unprognostic (1.96e-2)" "unprognostic (4.17e-2)" "unprognostic (2.07e-1)" "unprognostic (2.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.13e-2)" "unprognostic (3.91e-3)" "unprognostic (2.20e-1)" "unprognostic (9.23e-2)" "unprognostic (8.78e-2)" "unprognostic (4.70e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.0 0.6 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 2.6 0.0 1.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.5 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 443.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1482.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.0 0.0 6.5 0.0 14.2 5.7 0.0 1.1 0.0 0.0 0.0 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 60.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 70.1;Proximal tubular cells: 99.5;Syncytiotrophoblasts: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Uncertain Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "HPA024693: AB_2671654" "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favorable (2.41e-4)" 13.2 37.6 4.8 7.7 4.4 1.1 16.3 2.0 4.0 8.4 19.1 4.0 30.3 9.2 3.5 15.4 6.7 4.3 7.2 12.9 5.6 2.0 60.0 15.0 9.0 3.7 3.7 2.8 9.4 3.4 2.6 1.7 14.1 3.9 12.4 7.4 7.6 10.1 33.3 28.4 9.7 22.4 4.5 3.5 4.5 8.0 4.5 3.6 3.5 30.6 6.6 5.9 13.0 7.6 7.8 13.8 11.9 6.2 1.2 4.3 2.1 9.6 3.1 2.6 6.2 27.5 5.0 15.3 2.3 3.4 5.0 9.9 12.3 18.5 6.0 5.1 2.8 4.6 5.8 1.8 11.4 6.0 7.5 4.4 10.3 1.5 21.8 4.6 1.3 9.6 22.2 17.5 6.4 0.8 18.0 6.8 7.9 1.2 3.4 5.4 11.6 3.1 4.1 0.4 18.2 4.6 7.8 1.9 15.2 1.6 37.7 8.5 4.6 4.5 6.9 4.7 5.5 6.0 8.8 5.1 9.2 2.9 1.3 0.7 6.1 1.2 3.1 3.8 6.5 0.5 0.0 2.5 11.9 1.8 6.2 1.6 7.8 1.3 1.8 13.8 1.9 0.6 0.8 0.4 1.2 5.4 5.2 4.3 2.1 4.8 4.4 2.0 4.0 5.6 2.0 3.7 2.8 3.9 3.6 26.8 22.4 2.4 22.9 5.4 0.0 17.3 10.2 12.0 17.0 3.5 0.0 70.1 10.0 10.9 0.2 5.2 47.0 0.0 3.9 9.5 5.9 3.5 21.9 34.1 19.9 0.0 9.8 4.3 8.8 1.3 24.7 11.5 3.3 15.4 19.9 6.6 4.5 35.1 13.4 99.5 0.2 0.0 3.9 0.0 2.7 6.0 67.7 5.7 18.3 10.6 ACSL1 "ACS1, FACL1, FACL2, LACS, LACS1, LACS2" ENSG00000151726 "Acyl-CoA synthetase long chain family member 1" P33121 4 184755595-184826818 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.0;liver: 190.9" "Group enriched" "Detected in many" 4 "Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 80.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 80.2" "Cell line enhanced" "Detected in many" "ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011316, HPA011964" Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA011316: AB_1844536, HPA011964: AB_1844537" "unprognostic (1.10e-2)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (1.82e-3)" "unprognostic (2.75e-2)" "unprognostic (1.79e-1)" "unprognostic (5.89e-2)" "unprognostic (9.83e-2)" "unprognostic (3.15e-1)" "prognostic favorable (1.25e-5)" "unprognostic (2.77e-1)" "unprognostic (4.38e-2)" "unprognostic (6.25e-3)" "unprognostic (3.13e-2)" 105.0 6.7 4.2 14.1 13.5 46.0 54.4 3.2 9.6 7.2 12.2 16.4 5.5 4.9 5.7 12.7 8.8 6.4 5.7 24.3 6.4 4.1 32.8 190.9 20.7 18.9 24.0 3.8 4.2 7.3 5.9 8.7 4.4 11.6 14.2 2.6 9.1 17.9 4.8 89.1 20.4 4.5 6.4 18.2 16.9 6.5 6.4 15.9 2.1 8.3 10.1 5.8 7.6 11.0 0.5 2.2 80.2 8.9 0.7 0.7 2.9 6.1 1.9 1.2 3.1 151.2 36.7 1.0 3.4 1.7 2.0 1.4 0.4 1.7 2.5 0.3 4.0 4.9 3.8 5.4 2.2 1.7 12.4 1.9 1.8 1.7 5.0 24.3 4.9 4.6 80.3 18.6 1.7 8.7 3.6 2.6 0.4 0.8 7.8 9.8 3.2 0.3 6.8 0.2 4.1 2.7 0.9 1.0 3.2 47.8 17.5 4.6 4.3 3.1 9.4 10.5 0.5 3.4 5.0 2.8 1.8 2.1 4.3 1.0 3.0 1.5 1.1 5.8 6.9 2.8 2.3 8.9 2.8 0.5 5.2 0.5 0.5 0.4 0.2 2.2 0.5 0.4 0.3 80.2 0.7 3.6 0.4 0.7 2.9 4.2 13.5 3.2 9.6 6.4 4.1 24.0 3.8 11.6 15.9 23.8 107.2 14.5 16.5 18.7 5.8 89.7 28.1 13.4 21.6 29.6 17.7 8.6 79.6 3.9 359.4 5.6 2.6 0.0 11.0 1.9 9.1 56.1 23.1 1018.8 39.4 3.2 0.0 19.0 136.2 335.5 17.8 64.1 30.4 24.4 4.2 3.3 9.0 0.9 15.6 75.0 10.3 12.9 12.0 8.1 16.7 35.9 2.9 10.0 1.7 21.4 ACSS2 "ACAS2, AceCS, ACS, ACSA, dJ1161H23.1" ENSG00000131069 "Acyl-CoA synthetase short chain family member 2" Q9NR19 20 34872146-34927962 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.4" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 98.3;Mucus-secreting cells: 80.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6" "Cell line enhanced" "Detected in many" "RPMI-8226: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004141 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA004141: AB_1078094" "unprognostic (1.97e-2)" "unprognostic (1.33e-1)" "unprognostic (1.70e-1)" "unprognostic (2.25e-2)" "unprognostic (1.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (3.92e-2)" "unprognostic (1.66e-1)" "unprognostic (1.42e-2)" "prognostic favorable (2.04e-4)" "unprognostic (2.72e-1)" "unprognostic (2.32e-1)" "unprognostic (3.08e-1)" "unprognostic (2.54e-1)" 30.3 12.6 2.8 9.2 7.0 1.9 12.4 5.6 7.0 6.8 21.0 10.6 8.3 21.4 6.6 7.0 8.1 4.5 7.7 24.8 2.9 2.5 11.2 15.7 11.7 3.2 6.8 3.2 5.1 3.2 4.7 2.5 4.6 5.5 3.4 10.4 3.5 9.8 6.8 63.4 6.8 24.1 3.0 6.1 2.7 13.4 3.1 7.1 1.1 3.9 7.3 3.0 6.5 6.1 0.7 12.6 17.0 11.6 0.3 3.0 4.7 11.9 1.6 1.2 1.6 8.5 9.0 12.4 7.1 5.5 2.0 3.5 4.3 6.6 0.0 8.1 3.1 7.7 9.0 2.9 17.9 1.5 0.1 2.8 16.6 0.8 2.0 6.2 1.6 9.1 6.1 3.9 2.9 2.8 2.9 3.1 1.2 10.5 1.3 2.7 1.4 0.5 7.3 0.8 3.6 20.3 4.4 7.8 26.2 6.8 1.2 1.1 5.4 8.7 6.4 6.9 3.4 3.1 3.6 11.7 2.4 3.3 4.3 2.3 11.3 8.2 3.8 6.7 2.6 1.9 17.0 11.6 3.0 0.6 7.2 0.5 0.4 1.6 0.7 12.6 0.7 3.0 1.5 6.5 0.3 3.4 2.1 1.1 4.7 2.8 7.0 5.6 7.0 2.9 2.5 6.8 3.2 5.5 7.1 11.9 40.9 3.0 8.5 6.9 6.0 70.4 25.5 5.3 13.6 10.4 5.9 13.6 10.0 16.5 7.2 13.2 98.3 23.3 29.5 8.5 8.9 8.8 9.2 44.8 14.7 7.9 7.5 10.4 17.2 6.0 10.6 13.8 13.5 19.8 80.6 8.8 18.1 60.0 4.2 51.2 3.4 12.9 9.9 11.6 7.3 9.5 17.5 5.0 60.0 8.9 ACTL6A "Actl6, Arp4, BAF53A, INO80K" ENSG00000136518 "Actin like 6A" O96019 3 179562880-179588408 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 197.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012188, HPA018671, HPA063149" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: " "unprognostic (2.13e-1)" "unprognostic (5.33e-2)" "unprognostic (1.54e-2)" "unprognostic (2.24e-3)" "unprognostic (7.79e-3)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.89e-5)" "unprognostic (3.36e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-2)" "prognostic unfavorable (5.44e-5)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (4.21e-2)" "unprognostic (1.96e-1)" "unprognostic (4.21e-3)" "unprognostic (5.20e-2)" 18.8 17.9 9.9 23.4 16.8 8.7 21.3 8.7 9.6 16.8 21.3 15.3 15.6 14.5 24.8 16.4 23.2 16.3 14.9 24.2 8.7 7.4 19.6 18.6 14.6 17.4 16.7 5.4 24.8 20.9 13.7 23.4 20.1 13.7 17.7 23.5 10.4 19.0 17.4 12.8 19.4 19.8 16.1 14.8 19.3 16.7 47.5 17.0 46.1 21.9 20.4 23.8 18.7 22.7 17.5 19.8 8.0 16.1 14.5 22.4 13.8 46.2 14.0 34.9 18.4 13.4 14.7 27.4 18.7 14.6 34.9 29.6 31.6 22.8 36.2 33.6 17.5 40.6 21.4 30.5 23.0 43.5 35.8 25.4 29.6 15.5 23.9 15.3 36.7 18.6 10.2 23.6 22.5 19.0 11.0 19.8 21.9 23.0 20.7 25.1 31.6 32.1 22.7 31.0 42.0 31.4 30.2 29.2 66.9 27.6 18.7 28.7 20.5 28.8 28.8 28.8 18.2 56.2 30.3 14.9 24.9 21.5 25.5 56.3 13.5 20.1 55.5 13.8 39.1 27.4 3.3 11.3 8.0 15.1 14.3 20.0 17.5 17.5 17.4 19.8 13.7 19.2 19.4 1.5 14.5 16.1 11.2 22.4 13.8 9.9 16.8 8.7 9.6 8.7 7.4 16.7 5.4 13.7 17.0 20.8 23.9 24.3 37.3 41.9 4.8 6.0 28.1 30.8 23.9 26.2 7.9 42.0 29.9 42.1 15.5 20.7 13.0 0.0 39.2 57.0 28.9 28.3 13.9 14.0 30.6 0.0 29.2 12.3 18.6 11.4 30.0 16.7 28.7 33.3 24.6 16.3 32.2 17.5 28.3 17.9 12.3 25.8 23.6 197.2 97.8 40.1 25.6 19.2 36.2 35.1 ACTL8 CT57 ENSG00000117148 "Actin like 8" Q9H568 1 17755313-17827063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 42 "testis: 23.6" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 42.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-266/84: 72.4" HPA027176 Approved Cytosol NA NA Cytosol "HPA027176: AB_1844553" "unprognostic (1.79e-3)" "unprognostic (3.18e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (6.18e-2)" "prognostic unfavorable (7.02e-4)" "unprognostic (1.63e-3)" "unprognostic (2.33e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (3.69e-1)" "unprognostic (4.89e-1)" "unprognostic (1.43e-1)" "unprognostic (5.49e-2)" "unprognostic (4.68e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.2 0.0 0.7 0.0 0.0 2.9 1.8 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 72.4 0.0 1.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 42.7 0.0 0.0 0.0 0.6 0.0 ACTN4 FSGS1 ENSG00000130402 "Actinin alpha 4" O43707 19 38647649-38731583 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 92.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001873, HPA006035" Supported Approved "Nuclear bodies,Actin filaments,Cytosol" NA NA 230000000 "Nuclear bodies, Actin filaments" Cytosol "HPA001873: AB_1078096, HPA006035: AB_1078095" "unprognostic (1.03e-1)" "unprognostic (6.34e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-2)" "unprognostic (2.37e-1)" "unprognostic (3.34e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (1.70e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (5.65e-4)" "unprognostic (2.99e-1)" "prognostic favorable (5.25e-5)" "unprognostic (6.59e-2)" "unprognostic (1.91e-1)" "unprognostic (6.75e-3)" "unprognostic (6.52e-2)" 38.3 39.2 19.2 30.1 24.4 28.1 34.1 16.6 26.6 45.2 47.9 31.8 23.4 51.0 70.1 22.2 61.4 37.9 41.5 25.0 19.6 16.2 48.4 34.1 39.5 17.7 27.8 18.7 33.6 34.1 17.8 21.0 65.9 21.8 33.7 22.4 29.2 41.4 35.4 16.0 40.4 69.4 54.0 32.9 40.8 34.3 13.4 24.6 11.6 29.2 30.5 42.9 40.3 41.1 2.6 8.5 12.9 5.7 17.5 9.7 5.6 45.0 92.0 13.5 6.4 7.8 9.5 26.8 20.5 27.7 30.5 24.6 33.0 35.0 10.0 49.3 45.8 20.1 21.6 8.2 32.4 9.1 24.6 8.5 14.1 42.4 28.5 17.2 10.3 17.6 15.7 10.8 26.6 17.9 27.9 18.8 3.2 16.4 10.8 23.3 23.5 3.3 6.9 9.5 32.0 21.8 10.1 12.6 5.2 33.0 47.2 10.1 5.9 37.1 29.7 13.5 11.0 12.2 12.4 32.0 34.9 17.0 16.7 68.1 4.8 10.9 8.3 30.9 11.0 62.4 4.5 5.1 10.9 9.7 5.7 7.8 2.4 4.5 9.7 4.6 2.6 0.8 3.3 12.9 17.5 4.6 8.5 7.1 5.6 19.2 24.4 16.6 26.6 19.6 16.2 27.8 18.7 21.8 24.6 166.7 126.4 42.4 207.1 208.5 22.7 6.4 155.4 60.2 92.1 144.8 13.7 98.7 16.6 365.0 2.2 134.9 407.6 46.7 359.3 199.5 77.2 206.6 71.6 102.0 64.3 22.3 155.5 128.3 61.9 2.3 38.3 59.0 43.9 214.6 286.1 119.2 403.9 205.1 67.1 64.3 30.5 187.5 173.6 27.6 11.9 177.2 140.5 81.2 173.4 281.0 ACTR2 ARP2 ENSG00000138071 "ARP2 actin related protein 2 homolog" P61160 2 65227753-65271253 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005083, HPA015050" Approved Approved Cytosol NA NA 76000000 Cytosol "CAB005083: AB_2221848, HPA015050: AB_1844556" "unprognostic (2.23e-1)" "unprognostic (1.15e-3)" "unprognostic (3.89e-2)" "unprognostic (2.52e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.50e-4)" "unprognostic (3.88e-2)" "unprognostic (3.16e-2)" "unprognostic (7.06e-2)" "unprognostic (1.16e-2)" "unprognostic (8.59e-2)" "unprognostic (2.36e-3)" "unprognostic (3.18e-2)" "unprognostic (4.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.03e-2)" 31.7 22.3 40.0 58.1 46.1 41.0 24.9 38.5 53.8 24.9 39.3 19.2 16.1 29.1 23.9 18.9 39.5 17.8 26.0 28.9 39.5 35.6 25.8 30.3 32.0 63.1 36.8 39.4 20.9 19.3 19.8 19.6 31.2 30.2 21.1 40.2 16.0 26.7 19.3 28.8 21.2 33.1 29.7 42.6 56.6 29.6 13.7 28.1 59.6 20.9 19.4 69.2 31.9 25.2 21.2 44.9 54.9 53.2 21.3 25.2 59.3 36.4 30.7 29.3 31.4 31.2 42.5 30.6 51.7 39.7 39.9 27.8 34.4 29.9 80.9 26.5 56.3 25.0 27.5 25.2 35.8 65.3 46.6 21.1 89.4 21.8 32.3 35.6 83.8 104.5 36.7 28.1 44.4 42.9 32.2 48.9 28.4 37.9 29.5 66.0 27.0 43.7 43.8 24.4 33.3 22.2 47.5 38.0 33.7 45.6 47.6 15.0 24.6 33.5 38.2 35.4 27.7 23.6 56.2 65.3 44.0 26.9 28.8 56.3 22.7 20.9 115.0 37.8 82.0 49.7 54.3 38.9 45.3 23.6 51.5 25.2 21.2 21.2 22.1 44.9 18.0 16.7 23.3 54.9 21.3 53.2 16.8 23.5 59.3 40.0 46.1 38.5 53.8 39.5 35.6 36.8 39.4 30.2 28.1 80.4 111.6 136.8 71.7 66.3 77.0 65.9 48.4 108.4 77.3 92.5 62.8 71.7 43.1 90.0 29.2 109.9 187.6 0.0 111.8 119.6 73.2 98.2 183.9 89.4 243.0 98.5 106.4 111.1 406.7 68.0 60.4 280.8 84.4 189.4 124.2 80.7 125.1 196.0 70.0 71.7 76.6 122.9 96.6 23.6 47.2 79.3 104.0 175.7 110.8 175.4 ACTR6 "ARP6, FLJ13433" ENSG00000075089 "ARP6 actin related protein 6 homolog" Q9GZN1 12 100199122-100241865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038587, HPA038588" Uncertain Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA038587: AB_10670781, HPA038588: AB_10672719" "unprognostic (1.24e-2)" "unprognostic (8.43e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (1.24e-2)" "prognostic unfavorable (7.70e-9)" "unprognostic (4.11e-2)" "unprognostic (1.09e-1)" "unprognostic (1.05e-1)" "unprognostic (6.98e-2)" "unprognostic (3.99e-1)" "unprognostic (5.32e-2)" "unprognostic (4.30e-2)" "unprognostic (3.22e-1)" "unprognostic (6.67e-3)" "unprognostic (3.40e-2)" 7.6 8.0 12.6 6.6 13.8 5.6 20.5 14.8 20.2 10.3 9.9 10.2 6.9 7.5 8.6 7.2 10.4 9.6 5.9 8.1 15.2 15.7 12.3 12.5 8.2 11.6 13.8 15.4 9.9 5.9 15.8 14.0 11.6 21.2 11.0 10.6 6.7 7.7 12.2 8.3 6.8 9.2 8.3 12.8 9.6 7.3 13.9 14.6 13.4 9.6 5.8 11.9 11.6 8.6 6.1 6.1 4.6 5.8 7.9 10.9 6.6 18.0 7.1 9.0 11.0 9.0 11.1 18.5 5.1 8.9 8.5 5.8 5.1 5.3 9.5 7.1 8.0 8.0 5.9 13.2 8.3 15.5 9.0 11.9 5.8 7.2 5.4 9.8 8.9 6.0 6.6 10.1 7.2 9.3 13.0 11.5 13.9 10.1 3.8 11.8 3.9 11.9 10.0 8.8 7.0 8.9 7.3 8.8 11.1 11.5 10.4 7.9 13.8 9.3 19.8 9.1 9.6 12.9 8.5 5.8 5.2 3.8 6.9 5.4 6.4 16.2 12.2 3.6 5.9 7.5 3.8 2.8 4.6 8.0 5.8 9.9 6.0 8.8 7.5 4.1 6.1 10.9 10.0 2.1 7.9 4.5 6.1 7.7 6.6 12.6 13.8 14.8 20.2 15.2 15.7 13.8 15.4 21.2 14.6 14.9 15.3 10.1 32.9 20.4 31.8 31.3 5.1 32.1 14.8 22.7 17.7 49.3 39.7 17.9 95.8 19.5 8.9 23.3 10.5 57.0 22.6 20.7 32.3 13.7 20.8 31.8 12.0 14.7 19.9 23.7 18.7 18.5 30.4 19.8 9.8 24.1 12.4 10.7 21.2 53.1 29.9 32.3 25.4 36.4 22.6 17.2 80.3 33.8 11.3 26.9 ACVR1 "ACVR1A, ACVRLK2, ALK2, SKR1" ENSG00000115170 "Activin A receptor type 1" Q04771 2 157736444-157875862 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007505, HPA046514" Approved Uncertain Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA007505: AB_1844752, HPA046514: AB_2732526" "unprognostic (6.99e-2)" "unprognostic (3.32e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.73e-1)" "unprognostic (6.09e-2)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (3.99e-1)" "unprognostic (3.20e-1)" "unprognostic (2.65e-2)" "unprognostic (4.29e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.17e-4)" 18.9 9.2 18.0 10.0 12.7 1.6 38.7 15.3 12.2 25.2 14.4 7.4 8.4 8.9 24.8 26.8 11.0 16.6 20.5 18.8 18.7 8.6 21.7 18.9 22.5 15.1 10.4 7.9 18.5 12.3 11.3 17.0 14.2 12.3 16.8 10.5 14.3 18.1 13.6 15.6 12.8 11.5 29.2 12.3 9.2 11.8 8.8 10.9 7.5 34.0 14.6 6.9 16.1 32.5 1.4 2.4 3.8 2.6 1.9 10.0 1.6 2.1 4.3 5.0 6.5 25.4 26.5 7.0 15.4 25.6 12.4 13.2 3.4 4.8 0.0 7.1 16.6 12.0 6.0 3.6 8.3 13.3 14.7 3.1 8.7 2.5 4.9 20.1 0.6 10.4 33.2 15.8 25.3 32.3 16.2 13.4 2.4 3.2 2.4 15.5 3.8 0.1 0.2 7.5 3.0 7.8 1.4 6.7 1.8 16.0 8.1 4.4 5.5 5.9 3.4 21.1 8.2 1.8 2.3 19.3 18.8 6.2 9.2 5.8 1.6 1.2 0.1 19.3 0.5 20.2 3.8 2.6 0.2 1.1 1.7 1.2 1.4 7.8 2.5 1.8 0.8 3.1 1.5 0.8 1.9 2.3 2.4 10.0 1.6 18.0 12.7 15.3 12.2 18.7 8.6 10.4 7.9 12.3 10.9 8.9 7.0 0.8 6.8 8.8 7.5 9.2 12.7 6.7 9.1 7.0 0.0 7.0 5.0 8.4 0.5 13.5 3.1 0.0 15.5 4.4 11.6 8.9 4.7 12.1 6.5 3.2 4.1 17.2 11.6 1.1 18.7 7.7 3.3 3.6 5.2 6.1 14.7 3.5 14.9 15.3 1.5 12.9 15.5 0.5 2.5 6.6 8.8 1.0 3.5 7.6 ACVR1B "ActRIB, ACVRLK4, ALK4, SKR2" ENSG00000135503 "Activin A receptor type 1B" P36896 12 51951667-51997078 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026126, HPA063761" Approved Approved Cytosol NA NA Cytosol "CAB026126: , HPA063761: AB_2685115" "unprognostic (8.66e-2)" "unprognostic (5.72e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.21e-3)" "unprognostic (1.00e-1)" "unprognostic (7.68e-2)" "unprognostic (5.29e-2)" "unprognostic (2.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.52e-2)" "unprognostic (9.02e-2)" "unprognostic (6.60e-2)" "unprognostic (8.96e-2)" "unprognostic (4.79e-2)" 11.1 7.4 12.0 6.4 14.6 7.9 14.3 14.2 24.4 8.6 16.7 5.1 28.0 19.2 6.7 13.1 14.4 10.9 11.1 7.6 11.2 10.5 24.6 21.0 10.3 7.1 8.1 14.7 7.1 35.1 24.9 10.9 7.5 7.3 10.0 17.1 8.7 21.7 34.3 11.7 30.6 19.8 8.2 5.8 6.7 17.2 10.6 4.8 3.9 9.9 5.8 8.4 10.1 12.1 0.5 1.3 6.8 4.0 0.1 1.6 0.6 6.4 14.1 11.0 6.0 12.6 9.9 6.2 7.3 8.3 7.8 5.9 28.4 10.0 2.8 10.2 7.9 8.6 11.4 10.4 8.8 8.1 4.1 12.3 6.9 3.5 8.8 14.4 11.2 26.0 19.3 11.5 8.8 11.1 8.3 10.9 10.3 7.4 8.8 6.9 13.1 10.6 9.7 10.6 13.6 4.9 5.7 8.5 3.6 21.9 9.8 14.0 11.6 7.8 11.2 5.1 8.1 12.4 7.3 6.9 5.4 8.2 6.0 3.5 5.4 3.7 3.9 5.8 5.4 6.9 4.5 2.2 6.8 0.7 3.3 1.0 0.1 0.6 0.7 1.3 0.5 1.6 0.9 1.9 0.1 4.0 0.7 1.0 0.6 12.0 14.6 14.2 24.4 11.2 10.5 8.1 14.7 7.3 4.8 3.0 12.0 3.4 9.2 16.6 41.6 5.4 22.9 13.4 14.8 24.4 27.5 0.5 3.3 12.7 2.3 9.8 23.9 0.0 12.5 0.6 5.7 12.2 10.5 19.5 3.7 35.0 23.6 14.7 16.7 6.3 9.2 7.7 6.8 2.8 32.6 10.6 12.7 24.6 8.9 16.5 23.8 6.5 15.9 3.9 16.5 22.1 0.5 2.5 22.6 11.2 ACVR2A "ACTRII, ACVR2" ENSG00000121989 "Activin A receptor type 2A" P27037 2 147844517-147930826 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 21.0;RH-30: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046997 Approved Approved Cytosol NA NA Cytosol "HPA046997: AB_10970077" "unprognostic (4.55e-2)" "unprognostic (2.26e-2)" "unprognostic (2.09e-1)" "unprognostic (7.34e-3)" "unprognostic (2.75e-1)" "unprognostic (1.17e-1)" "unprognostic (4.41e-3)" "unprognostic (8.73e-3)" "unprognostic (1.30e-2)" "unprognostic (3.61e-1)" "unprognostic (1.34e-2)" "unprognostic (1.52e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.95e-1)" "unprognostic (3.99e-2)" 12.0 6.0 13.6 8.2 9.9 3.8 10.7 14.5 14.2 10.2 14.1 4.7 9.7 10.4 9.3 9.9 13.6 7.6 17.7 5.6 10.0 9.0 9.0 10.3 7.5 4.7 5.9 10.6 7.6 9.8 8.6 15.9 10.6 7.3 12.2 9.1 7.6 12.2 12.0 19.6 29.5 17.8 13.8 5.4 6.5 9.3 11.0 6.4 1.5 9.5 6.9 6.8 13.5 11.8 0.7 3.0 0.5 3.6 7.7 4.6 1.4 1.3 1.6 10.0 3.7 5.9 3.8 4.1 3.1 3.7 5.3 9.3 4.3 6.0 0.0 2.8 4.9 1.9 4.7 9.1 4.5 6.8 1.0 5.5 0.6 2.8 7.4 21.0 0.6 0.7 6.3 5.7 3.4 6.8 4.1 4.0 1.2 1.4 2.6 3.6 3.5 0.3 0.5 11.3 4.0 2.6 0.1 17.5 0.9 4.2 8.5 9.9 5.6 2.6 3.1 3.8 4.5 1.9 1.0 3.1 4.9 5.8 4.6 2.1 0.7 0.2 1.8 3.0 0.3 3.9 0.4 3.0 0.5 1.2 3.6 0.5 0.3 4.6 2.1 2.3 0.7 3.0 0.7 0.1 7.7 3.1 3.0 0.4 1.4 13.6 9.9 14.5 14.2 10.0 9.0 5.9 10.6 7.3 6.4 6.0 6.5 0.5 6.7 26.4 15.8 7.8 10.2 8.1 11.4 7.0 13.7 3.9 1.7 5.0 4.1 9.8 13.2 0.0 5.6 2.1 13.5 6.7 0.0 8.6 4.7 11.1 8.6 12.9 9.4 0.8 9.2 7.6 10.1 8.2 13.8 3.7 6.3 8.6 10.6 5.0 8.5 32.3 14.4 13.8 12.8 26.1 4.5 5.1 8.5 7.1 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453851-38493142 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 16.4;NTERA-2: 20.3;SuSa: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007398, CAB025115, HPA040384" Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" No No Cytosol "Nucleoplasm, Nuclear bodies" "CAB025115: , HPA007398: AB_2667822, HPA040384: AB_2732484" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 2.8 7.4 5.5 4.6 7.9 1.1 5.5 13.2 7.5 5.2 3.4 7.2 4.5 2.8 4.7 5.1 2.5 5.6 3.3 3.9 5.9 5.4 5.3 5.4 6.9 2.2 5.9 5.4 8.3 6.1 11.3 5.1 16.0 6.5 3.9 3.6 5.0 4.6 4.2 15.9 2.4 2.8 4.6 4.7 3.1 4.0 9.1 9.1 12.8 4.8 1.7 2.2 4.2 10.3 0.3 0.3 0.5 0.2 0.5 1.6 0.3 0.8 1.4 16.4 1.4 0.6 0.4 8.8 0.3 0.5 0.3 0.7 2.3 1.1 0.1 1.2 0.3 0.5 1.0 6.3 1.0 0.9 2.4 4.1 4.2 2.5 3.5 0.8 2.9 1.6 0.7 0.9 0.5 1.8 1.0 1.1 6.2 6.9 1.4 0.3 1.3 5.1 1.9 20.3 0.8 0.7 1.7 5.5 1.0 1.0 1.9 3.8 6.7 0.4 2.5 2.2 12.2 1.3 3.9 0.9 0.5 2.7 0.4 1.4 3.9 5.4 0.9 0.6 2.5 1.1 0.5 0.1 0.1 0.4 0.2 0.6 0.2 1.0 0.5 0.0 0.3 1.6 1.5 0.3 0.5 0.2 0.3 0.7 0.3 5.5 7.9 13.2 7.0 5.9 5.4 5.9 5.4 6.5 9.1 6.0 6.7 0.5 3.6 3.5 20.7 11.6 5.1 6.7 4.5 0.0 21.6 6.7 0.0 3.2 9.1 6.1 2.9 0.0 3.3 5.8 3.1 3.2 1.1 7.5 2.2 20.6 6.9 4.9 2.1 12.6 10.9 3.2 6.8 0.0 3.2 9.6 3.8 2.5 7.4 2.8 25.5 0.0 5.6 8.1 19.0 3.4 5.1 2.5 4.7 3.3 ACYP1 ENSG00000119640 "Acylphosphatase 1" P07311 14 75053221-75069483 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034944 Approved Approved Nucleoplasm,Cytosol NA NA 92000 Cytosol Nucleoplasm "HPA034944: AB_10669898" "prognostic favorable (1.17e-4)" "unprognostic (3.83e-3)" "unprognostic (1.92e-1)" "unprognostic (5.90e-2)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (6.14e-7)" "unprognostic (5.48e-2)" "unprognostic (4.40e-1)" "unprognostic (1.64e-2)" "unprognostic (1.37e-3)" "unprognostic (3.56e-2)" "unprognostic (4.74e-2)" "unprognostic (6.69e-3)" "unprognostic (9.39e-2)" "unprognostic (1.07e-1)" "unprognostic (5.32e-3)" 8.7 27.4 23.0 13.9 20.4 12.7 16.2 24.0 25.2 10.6 14.9 14.8 14.3 11.3 10.2 26.9 11.6 21.4 7.1 10.8 19.9 30.2 12.2 5.2 10.9 17.6 28.7 19.3 9.1 7.0 8.9 38.2 10.4 24.4 10.0 19.8 9.4 9.7 12.9 22.3 24.4 11.3 11.4 27.5 10.9 14.0 16.7 22.9 8.3 20.2 10.3 19.0 7.5 12.0 10.6 7.6 12.3 6.6 10.0 17.8 5.1 24.8 13.7 19.8 12.1 8.0 9.4 11.0 14.3 5.6 14.6 20.8 13.8 28.1 27.5 8.8 5.9 8.7 22.4 13.0 6.3 23.9 39.9 16.0 17.8 36.1 9.7 4.8 11.2 18.7 5.2 9.1 20.1 10.4 9.4 19.1 26.1 14.0 33.2 19.1 17.0 25.1 20.9 6.0 21.8 13.8 20.2 26.1 12.8 20.5 13.2 36.3 14.7 9.8 6.7 22.2 9.8 14.8 11.1 9.0 10.0 18.5 20.1 15.3 7.9 16.0 28.8 15.3 13.2 10.7 3.9 2.2 12.3 8.6 4.3 9.7 10.0 14.5 9.9 3.8 10.6 12.2 11.3 0.9 10.0 6.6 7.6 17.8 5.1 23.0 20.4 24.0 25.2 19.9 30.2 28.7 19.3 24.4 22.9 6.0 7.8 18.2 36.9 25.4 31.8 17.9 35.7 80.3 19.4 62.8 11.8 19.4 33.2 16.7 18.7 25.1 15.8 70.0 16.2 27.5 20.2 16.2 11.5 4.3 19.1 41.3 28.9 6.7 3.8 7.0 15.5 11.7 37.1 10.0 22.3 16.1 18.0 20.1 15.6 17.3 29.9 25.8 25.8 90.7 15.8 21.0 11.4 22.3 32.3 31.1 ADA ENSG00000196839 "Adenosine deaminase" P00813 20 44619522-44652233 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Nucleotide metabolism" Hydrolase "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 90.2;Leydig cells: 39.1;monocytes: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 64.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "JURKAT: 61.5;MOLT-4: 198.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001399, CAB004307, HPA023884" Enhanced Supported "Plasma membrane,Cytosol" No No 650000 "Plasma membrane" Cytosol "CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573" "unprognostic (4.30e-2)" "unprognostic (6.89e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.23e-7)" "unprognostic (9.33e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (6.77e-5)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (2.94e-14)" "unprognostic (2.29e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-1)" 8.1 3.2 2.5 5.4 6.5 5.3 5.1 0.9 5.0 2.8 7.4 5.0 1.8 142.2 1.7 3.4 4.6 2.4 3.0 9.2 2.7 0.8 1.3 2.1 2.8 8.9 3.6 2.3 1.2 2.4 0.8 0.3 1.8 3.9 1.8 1.5 0.7 2.6 1.3 2.0 2.8 5.0 2.1 1.3 9.5 19.7 1.6 6.1 99.0 2.8 2.1 7.6 3.6 2.6 1.3 41.6 0.5 64.0 16.9 10.3 9.6 1.4 4.0 2.0 1.4 3.9 5.5 3.3 1.4 0.8 1.4 1.0 1.8 1.5 4.0 1.7 1.9 2.7 0.2 1.4 5.9 0.8 0.3 1.8 0.8 0.7 1.4 1.6 0.6 2.2 26.2 2.5 0.5 0.9 1.3 5.4 61.5 2.0 3.3 0.6 3.4 198.0 2.9 0.5 1.8 1.4 10.7 2.8 9.9 0.2 0.0 0.0 0.9 2.1 0.4 2.5 2.7 0.4 1.9 1.7 1.0 2.0 2.2 0.2 4.3 2.7 8.3 0.3 3.3 0.9 0.0 1.8 0.2 8.7 30.7 5.7 1.3 7.3 10.3 6.8 1.0 5.7 8.1 0.5 16.9 64.0 41.6 5.3 9.6 2.5 6.5 0.9 5.0 2.7 0.8 3.6 2.3 3.9 6.1 0.0 3.4 12.7 3.0 11.4 0.0 1.9 0.0 2.7 0.0 1.8 0.0 2.3 0.0 3.7 0.1 16.2 0.5 0.0 17.9 90.2 16.7 0.9 0.0 2.9 27.6 0.0 0.0 6.7 13.4 1.5 39.1 14.4 8.5 49.5 1.4 2.9 8.2 0.0 2.5 2.1 0.0 12.9 16.1 0.4 1.3 12.2 3.1 30.5 3.3 2.4 ADAM17 "CD156B, cSVP, TACE" ENSG00000151694 "ADAM metallopeptidase domain 17" P78536 2 9488486-9555792 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010738, HPA051575" Approved Supported Cytosol "Intracellular and membrane" NA NA 27000 Cytosol "HPA010738: AB_1078100, HPA051575: AB_2681539" "unprognostic (2.28e-1)" "unprognostic (1.29e-3)" "unprognostic (1.28e-1)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "unprognostic (5.15e-2)" "unprognostic (2.12e-3)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (3.69e-1)" "unprognostic (3.53e-3)" "unprognostic (3.13e-1)" "unprognostic (3.82e-3)" "unprognostic (8.63e-2)" "unprognostic (2.61e-1)" "unprognostic (4.48e-2)" "prognostic unfavorable (4.23e-5)" 18.6 11.0 13.6 15.4 13.8 21.9 14.7 20.4 15.5 14.0 11.7 13.8 8.3 8.7 14.2 15.8 18.7 10.7 17.4 13.4 11.2 12.4 12.4 7.8 24.7 15.0 11.6 11.7 18.1 9.6 10.9 11.9 29.0 11.2 8.2 9.4 10.6 12.5 9.8 12.3 16.7 11.1 13.9 14.3 21.4 8.9 17.4 12.3 14.7 12.5 13.9 20.3 12.3 14.4 7.0 7.7 16.0 10.2 6.0 7.9 6.0 7.7 12.7 13.4 13.9 26.4 19.7 24.1 8.1 13.8 9.3 13.9 11.2 18.6 22.0 11.7 10.1 27.3 14.1 9.8 17.2 12.8 8.8 9.8 11.2 9.6 9.9 37.3 11.0 12.6 22.0 17.3 14.9 29.0 20.8 23.4 8.4 15.3 8.5 10.0 7.3 8.2 11.0 11.0 10.8 5.1 9.6 13.1 10.4 12.4 12.8 7.9 19.7 9.0 11.0 19.2 15.1 5.7 14.2 18.7 16.6 8.7 11.6 15.4 11.1 9.9 19.2 13.8 7.1 19.7 16.0 9.8 7.6 6.1 10.2 7.9 7.0 5.0 5.1 7.7 5.1 4.5 4.6 11.8 6.0 9.5 4.3 5.7 6.0 13.6 13.8 20.4 13.1 11.2 12.4 11.6 11.7 11.2 12.3 44.7 76.6 33.0 41.9 115.4 24.9 2.8 12.7 25.4 40.9 29.6 51.1 25.3 5.0 20.9 64.8 44.9 15.5 23.3 16.8 39.0 58.0 41.4 29.0 11.0 32.9 9.5 18.9 42.4 70.5 10.4 17.5 74.4 38.8 26.2 13.4 12.3 18.2 17.3 15.2 7.5 38.2 38.8 26.7 25.4 37.8 135.3 46.8 26.2 12.5 92.9 ADAMTS15 ENSG00000166106 "ADAM metallopeptidase with thrombospondin type 1 motif 15" Q8TE58 11 130448974-130476641 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.4" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 9.6;Fibroblasts: 8.2;Leydig cells: 4.6;Melanocytes: 3.3;Smooth muscle cells: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 36.6;ASC TERT1: 22.1;EFO-21: 18.4;hTERT-RPE1: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA042867 Uncertain Approved Cytosol "Secreted to extracellular matrix" NA NA Cytosol "HPA042867: AB_10794535" "unprognostic (7.64e-2)" "unprognostic (1.49e-3)" "unprognostic (7.15e-2)" "unprognostic (1.34e-3)" "unprognostic (1.07e-3)" "unprognostic (7.07e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (6.18e-2)" "unprognostic (4.37e-2)" "unprognostic (2.56e-1)" "unprognostic (7.40e-2)" "unprognostic (1.29e-2)" "unprognostic (5.95e-3)" "unprognostic (6.68e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.63e-5)" 47.4 1.1 0.2 1.7 0.3 0.1 14.5 0.1 0.8 3.4 3.8 0.8 3.0 0.6 3.7 9.8 3.8 9.3 9.1 12.6 0.4 0.3 9.1 0.4 6.6 5.6 0.8 0.2 7.0 1.6 0.9 1.0 16.4 1.3 3.7 2.1 10.9 1.0 1.3 1.6 4.1 3.1 6.9 1.4 1.9 4.9 2.4 0.6 0.7 9.8 2.5 0.8 8.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.4 36.6 22.1 0.0 1.3 2.6 0.5 0.1 0.2 0.6 0.0 18.4 0.1 1.3 3.4 0.3 0.3 0.1 0.0 0.8 0.0 1.6 0.0 0.3 0.0 0.0 7.2 0.0 0.3 0.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.0 2.8 0.0 2.0 0.0 0.0 0.0 0.3 0.0 5.9 0.0 0.0 2.7 1.9 0.0 0.0 0.3 4.3 3.5 1.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.7 0.4 0.3 0.8 0.2 1.3 0.6 0.0 0.0 0.0 0.1 0.5 0.0 9.6 0.0 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.5 8.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.3 0.0 0.5 0.0 0.7 0.0 0.7 0.8 0.0 0.0 3.3 0.1 0.3 0.3 0.7 0.0 2.1 0.0 ADAMTSL4 "DKFZP434K1772, TSRC1" ENSG00000143382 "ADAMTS like 4" Q6UY14 1 150549369-150560937 "Disease related genes, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 157.1" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 113.3;Extravillous trophoblasts: 39.4;Syncytiotrophoblasts: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;monocytes: 3.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 30.2;BEWO: 63.6;HSkMC: 14.2;K-562: 20.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA006279 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 47000000 "Plasma membrane, Cytosol" "HPA006279: AB_1078102" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (8.09e-4)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (7.52e-2)" "unprognostic (3.56e-2)" "unprognostic (1.68e-2)" "unprognostic (1.28e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.44e-2)" "unprognostic (7.40e-3)" 14.4 2.4 0.8 8.9 1.4 2.2 13.2 0.7 1.1 11.0 8.2 1.5 3.9 2.2 9.7 8.1 19.7 11.1 6.6 10.7 1.0 0.2 3.4 14.9 13.3 2.3 1.4 0.4 14.5 1.8 0.2 1.3 157.1 3.4 9.4 2.4 19.1 5.7 2.3 21.1 5.4 6.0 17.4 2.2 3.9 8.9 3.3 1.1 0.8 3.8 15.5 4.8 19.1 15.9 0.0 0.5 2.3 3.5 0.0 0.1 0.6 6.7 0.1 0.1 1.2 6.2 30.2 63.6 6.5 5.7 3.9 2.2 0.5 2.6 0.0 1.3 4.4 0.0 3.4 0.2 0.9 1.6 0.5 0.1 1.9 0.7 2.7 5.0 0.0 0.9 14.2 0.2 0.9 2.2 3.3 0.0 0.0 20.3 0.2 0.6 0.1 0.0 0.3 1.1 0.1 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.2 2.0 5.0 0.0 3.3 1.4 3.5 1.2 0.2 1.8 2.7 0.1 0.6 0.1 1.4 0.2 1.2 0.1 0.0 1.6 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 3.5 0.0 0.0 0.6 0.8 1.4 0.7 1.1 1.0 0.2 1.4 0.4 3.4 1.1 0.0 1.0 0.8 2.1 2.2 1.0 2.0 7.6 1.4 0.0 0.0 0.0 113.3 0.0 1.1 0.4 3.5 0.0 0.0 0.5 39.4 15.5 1.3 2.3 9.2 28.7 0.0 0.0 1.3 22.6 0.0 27.9 16.5 3.3 25.2 0.0 2.4 7.4 0.0 3.2 0.0 2.4 0.0 1.4 0.0 0.9 2.5 83.2 0.0 0.1 1.7 ADAP1 "CENTA1, GCS1L" ENSG00000105963 "ArfGAP with dual PH domains 1" O75689 7 897901-955407 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8;intestine: 30.8" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 56.4;Mucus-secreting cells: 30.1;Paneth cells: 34.3;Undifferentiated cells: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 31.2;CAPAN-2: 22.5;HMC-1: 21.6;OE19: 57.2;THP-1: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007033, HPA012049" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007033: AB_1846529, HPA012049: AB_1846527" "unprognostic (2.45e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (4.41e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (9.13e-4)" "unprognostic (3.06e-1)" "unprognostic (9.10e-3)" "unprognostic (1.70e-2)" "unprognostic (1.38e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-1)" "prognostic favorable (4.13e-5)" "unprognostic (5.88e-2)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-2)" 3.0 2.1 32.9 8.9 25.9 8.1 1.2 13.8 41.8 3.6 30.8 30.3 1.7 16.7 2.6 1.3 4.5 4.2 6.2 3.9 36.1 17.7 6.5 1.6 5.8 3.3 28.0 20.1 0.7 5.4 3.7 1.3 3.0 19.3 1.9 20.6 0.9 3.0 3.1 0.8 2.0 22.8 7.7 36.1 7.4 16.3 1.1 19.3 0.0 4.8 0.4 2.3 5.1 1.0 1.3 5.5 3.4 11.7 1.6 6.8 3.7 31.2 1.1 0.0 1.1 0.4 0.0 0.3 1.0 0.0 0.3 0.1 12.4 22.5 0.0 3.1 0.1 0.0 14.3 1.7 2.4 0.1 0.1 1.3 0.0 1.9 7.0 0.5 0.2 21.6 0.5 6.7 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 10.0 0.0 8.4 1.0 57.2 0.0 4.2 0.0 0.1 1.7 7.6 0.9 0.3 0.9 0.4 0.1 0.1 8.1 36.7 0.1 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 6.5 1.1 1.1 7.6 3.4 6.8 8.1 3.3 1.3 2.0 6.1 5.5 1.1 0.6 3.1 3.4 1.6 11.7 0.4 0.9 3.7 32.9 25.9 13.8 33.4 36.1 17.7 28.0 20.1 19.3 19.3 0.0 13.0 3.2 2.5 0.9 4.2 7.7 7.6 8.1 2.3 7.0 0.0 0.1 8.3 3.7 0.0 0.5 56.4 0.0 4.0 0.4 1.4 2.0 6.9 0.4 11.1 0.0 15.5 0.0 21.6 0.0 0.0 13.7 10.1 0.0 30.1 1.2 12.4 34.3 0.0 5.9 0.6 0.0 1.0 0.3 0.9 1.1 0.6 4.4 26.9 3.3 ADARB1 "ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1" ENSG00000197381 "Adenosine deaminase, RNA specific B1" P78563 21 45073853-45226560 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 59.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 52.9;Horizontal cells: 65.2;Muller glia cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 27.9;HHSteC: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029645 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029645: AB_10602106" "unprognostic (2.69e-1)" "unprognostic (7.65e-2)" "prognostic unfavorable (8.16e-5)" "unprognostic (1.82e-2)" "unprognostic (1.07e-2)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (6.97e-2)" "unprognostic (3.82e-2)" "unprognostic (1.23e-2)" "unprognostic (1.28e-1)" "unprognostic (3.44e-1)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.57e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-2)" "unprognostic (2.38e-2)" 12.2 5.3 7.1 10.4 8.4 4.5 8.9 33.1 11.6 11.7 17.2 2.5 5.6 2.9 13.4 6.6 14.0 8.8 11.1 6.7 7.3 8.1 4.6 4.0 19.9 11.8 7.4 8.1 5.3 4.7 19.0 3.7 12.0 13.6 14.7 5.0 11.0 4.6 8.7 11.8 10.8 5.9 59.9 3.5 10.5 11.7 3.8 4.0 3.9 3.8 4.5 8.4 34.6 20.3 6.1 2.1 4.8 0.6 0.5 2.6 0.5 3.1 0.4 2.5 2.9 3.1 2.1 3.4 2.1 3.5 6.9 4.4 5.0 0.5 1.0 5.8 10.5 3.8 0.3 3.7 8.9 7.6 0.7 3.3 6.9 27.9 3.3 32.3 4.7 3.4 11.6 3.9 2.4 7.2 2.6 7.2 9.6 1.6 0.4 20.0 2.3 3.1 4.5 4.0 1.6 4.8 0.9 2.4 3.2 1.5 1.0 14.7 3.9 17.1 0.7 5.4 4.3 1.6 3.8 7.6 2.3 2.8 9.2 8.0 3.1 1.4 0.8 2.0 11.1 12.1 1.3 0.2 4.8 1.1 0.6 1.8 2.4 2.6 1.6 0.0 6.1 1.8 1.4 0.2 0.5 0.3 2.1 1.6 0.5 7.1 8.4 33.1 11.6 7.3 8.1 7.4 8.1 13.6 4.0 0.0 0.6 3.2 2.5 9.8 52.9 17.1 0.0 0.0 2.3 0.0 11.8 0.4 0.0 1.3 2.0 13.5 0.4 0.0 0.4 0.9 11.0 4.9 8.1 5.9 6.1 65.2 0.0 14.7 3.4 1.9 3.4 2.9 5.0 7.2 0.7 34.4 1.0 0.0 5.3 2.2 15.5 0.0 18.6 4.1 11.5 6.4 0.8 6.9 1.2 2.0 ADAT2 "DEADC1, dJ20N2.1, TAD2" ENSG00000189007 "Adenosine deaminase, tRNA specific 2" Q7Z6V5 6 143422832-143450673 "Enzymes, Predicted intracellular proteins" "tRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035479 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA035479: AB_10611672" "unprognostic (2.24e-1)" "unprognostic (3.07e-3)" "unprognostic (1.55e-1)" "unprognostic (8.20e-2)" "unprognostic (3.05e-2)" "unprognostic (8.58e-2)" "unprognostic (1.07e-3)" "unprognostic (3.31e-2)" "unprognostic (1.34e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-2)" "unprognostic (9.28e-5)" "unprognostic (4.88e-2)" "unprognostic (6.96e-2)" "unprognostic (7.29e-2)" "unprognostic (4.08e-2)" 7.3 9.5 6.6 15.1 9.4 17.1 8.6 7.7 8.8 6.6 9.5 4.9 4.7 9.9 8.3 5.3 12.0 7.9 7.6 4.2 5.2 3.8 7.5 13.2 11.3 17.6 4.9 8.0 7.5 13.3 7.1 9.6 4.0 7.3 8.6 13.3 6.0 10.1 6.2 13.3 17.1 10.0 6.5 6.7 13.1 10.8 4.1 5.3 8.6 10.8 10.1 13.5 6.6 8.7 2.8 3.2 0.4 1.4 1.9 6.6 2.3 2.9 2.5 3.1 10.6 2.6 8.5 4.7 4.2 1.9 2.9 4.1 6.7 7.5 10.5 4.6 2.8 3.3 8.6 5.8 5.9 5.7 5.5 13.0 14.8 10.5 13.5 3.3 20.8 7.4 2.9 8.7 5.7 9.1 2.5 6.2 9.7 16.1 9.1 4.4 4.2 8.0 11.7 4.0 4.0 4.8 9.8 9.2 8.5 4.5 3.3 6.9 4.7 3.5 9.5 2.8 1.7 4.0 7.6 4.8 4.3 3.6 8.8 8.0 9.4 6.6 7.9 4.0 17.5 4.9 0.0 0.9 0.0 3.2 1.4 4.7 2.8 3.0 2.9 3.2 2.0 3.4 5.1 0.4 1.9 0.2 3.0 6.6 2.3 6.6 9.4 7.7 8.8 5.2 3.8 4.9 8.0 7.3 5.3 6.0 11.7 0.8 3.4 6.0 3.6 2.7 0.0 2.7 4.5 1.8 0.0 2.0 3.3 3.4 1.0 4.7 1.8 23.3 3.4 2.1 4.4 2.9 7.0 4.0 4.1 1.6 4.1 4.3 5.1 1.1 6.4 2.8 5.0 0.0 5.6 2.0 4.8 0.0 3.2 0.7 3.1 0.0 4.9 1.8 5.4 8.2 0.7 6.9 7.8 3.8 ADCK2 MGC20727 ENSG00000133597 "AarF domain containing kinase 2" Q7Z695 7 140673153-140696261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036036 Approved Uncertain Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA036036: AB_10672078" "unprognostic (2.76e-1)" "unprognostic (1.79e-1)" "unprognostic (5.72e-2)" "unprognostic (5.30e-2)" "unprognostic (4.03e-3)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" "unprognostic (7.48e-2)" "unprognostic (2.61e-1)" "unprognostic (7.10e-3)" "unprognostic (6.81e-3)" "unprognostic (9.36e-3)" "prognostic favorable (9.75e-5)" "unprognostic (1.89e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (2.13e-1)" 12.3 10.6 15.3 11.3 16.6 8.8 13.4 15.4 27.0 12.3 15.1 26.3 13.2 8.8 10.3 11.4 18.0 20.0 10.3 10.2 16.6 18.2 12.3 12.5 12.8 15.6 19.5 13.1 14.5 22.8 21.4 12.7 19.9 18.2 14.4 13.2 10.7 16.8 14.0 12.5 25.8 13.0 10.9 24.0 13.6 13.0 7.6 13.3 20.6 25.1 9.9 16.2 13.4 18.9 8.2 12.0 3.2 5.0 5.1 7.3 2.2 16.0 11.6 2.7 12.7 10.0 11.4 16.5 8.3 10.2 8.7 5.8 10.5 11.4 21.6 12.6 5.8 20.4 13.3 13.9 9.5 2.6 15.9 14.2 4.5 4.5 5.1 13.9 3.0 11.3 9.5 29.1 5.0 6.9 9.0 7.5 15.4 7.9 10.6 3.1 20.0 22.5 7.5 4.0 12.8 12.6 17.8 0.1 10.4 4.7 16.1 10.8 7.6 11.4 16.7 11.4 5.5 14.8 6.1 7.9 10.9 3.8 18.1 16.0 7.4 11.2 15.8 16.1 12.1 12.9 0.0 3.7 3.2 5.4 5.0 4.9 8.2 4.8 5.3 5.7 4.2 7.3 4.7 0.1 5.1 3.0 12.0 6.0 2.2 15.3 16.6 15.4 27.0 16.6 18.2 19.5 13.1 18.2 13.3 8.9 5.1 8.2 18.5 11.0 11.4 5.8 5.1 2.7 1.2 8.7 0.0 25.4 5.0 5.3 16.9 9.0 8.5 0.0 6.4 18.4 7.1 15.5 11.5 8.6 27.9 11.1 16.1 6.7 7.9 12.5 3.1 11.8 3.3 7.2 13.8 11.6 5.9 14.4 12.7 4.8 4.8 0.0 6.9 5.9 3.1 12.2 28.3 7.7 11.3 16.1 ADCK5 FLJ35454 ENSG00000173137 "AarF domain containing kinase 5" Q3MIX3 8 144373101-144393242 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025692, HPA028679" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA025692: AB_10599486, HPA028679: AB_10600226" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (8.96e-2)" "unprognostic (1.68e-2)" "unprognostic (1.00e-1)" "unprognostic (2.31e-3)" "unprognostic (6.45e-2)" "unprognostic (2.70e-1)" "unprognostic (4.25e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (1.33e-3)" "unprognostic (1.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-1)" "unprognostic (2.90e-2)" 4.1 10.0 4.8 8.9 4.5 4.5 4.3 11.5 9.1 4.6 18.3 2.8 7.6 19.1 5.8 4.2 7.2 4.2 6.3 3.8 3.9 4.1 4.8 6.9 3.7 5.0 3.4 8.4 5.5 5.6 4.7 4.1 3.7 4.5 4.7 4.0 4.6 7.4 4.7 5.6 8.3 17.0 2.7 2.4 6.7 5.6 7.7 3.8 6.8 4.1 4.9 6.1 5.1 5.0 4.7 6.3 2.5 5.4 1.8 4.1 2.8 3.9 4.9 1.1 3.4 0.9 0.8 5.7 3.3 1.9 2.7 0.9 5.3 4.2 1.7 2.4 0.7 0.9 5.2 0.2 3.6 0.2 4.4 1.6 4.5 3.6 5.9 2.7 1.0 3.5 1.4 2.1 0.9 0.8 1.5 1.8 3.1 2.9 3.1 1.5 10.3 3.2 4.4 0.7 3.4 3.7 4.3 1.7 3.1 1.8 3.7 0.7 1.8 4.9 3.9 2.8 0.9 3.4 3.0 1.3 1.4 5.2 3.5 2.2 1.4 0.4 1.6 3.2 3.9 2.0 1.8 4.2 2.5 2.3 5.4 3.0 1.8 2.8 1.8 6.3 4.7 2.9 1.5 0.7 1.8 5.0 4.0 4.1 2.8 4.8 4.5 11.5 9.1 3.9 4.1 3.4 8.4 4.5 3.8 3.0 1.7 2.2 3.4 3.7 9.2 2.0 7.6 6.7 1.2 5.2 15.7 3.5 3.3 7.7 6.5 4.1 43.3 0.0 6.3 9.4 3.9 2.3 9.2 6.7 7.0 3.2 8.1 3.7 3.8 8.6 5.5 5.2 3.3 11.8 26.0 5.8 9.0 14.0 6.7 5.1 15.2 12.9 3.3 13.4 10.4 4.4 2.1 5.7 20.0 2.2 ADCY7 "AC7, KIAA0037" ENSG00000121281 "Adenylate cyclase 7" P51828 16 50246137-50318135 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 34.7;granulocytes: 48.6;Hofbauer cells: 30.2;Kupffer cells: 61.4;Macrophages: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 23.3;HMC-1: 65.3;RPMI-8226: 32.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041218, HPA048241" Uncertain Approved Cytosol NA NA Cytosol "HPA041218: AB_2677365, HPA048241: AB_2680326" "unprognostic (1.98e-1)" "prognostic unfavorable (5.31e-4)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (3.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.90e-2)" "unprognostic (7.75e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.18e-1)" "unprognostic (5.59e-3)" "unprognostic (7.34e-2)" "unprognostic (2.15e-3)" "unprognostic (2.18e-1)" "unprognostic (9.52e-4)" 6.3 4.3 7.0 17.4 9.7 14.9 3.9 1.2 5.2 3.7 5.0 9.8 0.8 2.8 3.7 4.8 13.2 5.3 6.9 7.3 5.3 4.2 3.3 3.6 16.4 16.5 8.8 4.4 17.1 3.7 1.0 3.4 9.7 8.6 3.5 5.9 6.2 6.5 1.6 1.8 7.9 10.4 5.0 12.3 26.9 4.9 2.1 9.2 21.8 3.7 3.1 26.0 6.6 6.1 3.6 12.5 6.5 16.7 8.4 7.0 5.0 4.0 5.5 0.2 0.8 0.6 7.1 0.5 2.8 1.3 2.2 2.0 5.2 8.4 1.6 7.6 11.4 0.1 14.7 5.8 2.4 2.7 15.4 2.0 23.3 4.2 1.5 6.5 4.4 65.3 3.8 2.4 1.6 2.6 1.2 0.6 5.3 8.5 3.2 3.1 2.3 1.7 10.4 1.0 1.9 7.9 1.6 2.1 32.4 1.5 0.4 1.0 2.7 1.5 0.6 1.3 1.4 0.1 13.0 5.2 0.3 7.6 0.8 0.8 0.3 0.1 3.5 2.4 9.5 1.0 6.5 7.8 2.9 7.0 11.7 5.1 3.2 2.8 5.0 12.5 3.6 2.6 3.7 4.4 8.4 16.7 6.5 3.9 5.0 7.0 9.7 1.2 5.2 5.3 4.2 8.8 4.4 8.6 9.2 17.9 34.7 6.9 0.3 3.3 1.0 0.6 0.0 0.0 12.5 0.0 5.9 9.3 0.0 1.6 1.3 1.0 1.7 0.0 0.2 0.9 11.4 0.3 48.6 0.2 30.2 0.0 0.0 1.8 61.4 0.5 0.6 41.8 5.0 3.6 0.5 0.9 3.1 7.0 1.1 0.0 0.4 6.5 1.4 0.0 0.7 3.4 3.3 18.5 2.1 1.0 ADCY9 AC9 ENSG00000162104 "Adenylate cyclase 9" O60503 16 3953387-4116185 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 36.4" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041328, HPA044225" Approved Approved Cytosol NA NA Cytosol "HPA041328: AB_2677414, HPA044225: AB_2678863" "unprognostic (1.78e-1)" "unprognostic (5.54e-2)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (6.62e-2)" "unprognostic (1.30e-2)" "unprognostic (2.52e-1)" "unprognostic (3.61e-2)" "unprognostic (6.93e-2)" "unprognostic (4.76e-3)" "unprognostic (5.40e-2)" "unprognostic (1.37e-1)" "prognostic favorable (5.24e-8)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (1.55e-2)" 5.2 4.8 7.1 3.2 10.9 0.9 5.4 8.5 9.6 7.0 6.4 4.1 4.4 6.5 6.5 4.4 6.8 7.7 6.5 13.3 6.2 3.0 8.0 9.6 11.1 2.5 3.0 6.2 9.4 12.5 12.3 5.8 7.8 7.7 3.6 5.5 9.0 10.1 5.0 36.4 4.4 10.9 6.3 2.2 3.2 5.5 4.4 3.4 0.7 21.8 7.7 3.0 7.9 4.8 0.1 1.0 3.2 1.5 1.0 1.9 0.9 4.9 7.6 2.3 4.3 8.3 10.2 3.5 8.8 9.2 4.9 4.0 6.3 4.4 0.0 13.5 24.0 3.0 4.8 9.1 5.4 3.4 6.1 8.8 0.2 17.4 12.1 9.1 0.6 4.0 10.8 8.5 5.7 3.0 4.1 3.3 1.6 2.7 0.0 5.0 9.1 0.0 2.6 4.2 2.1 4.1 7.8 11.1 0.2 1.8 1.3 5.3 2.3 6.8 8.1 5.9 2.7 20.5 8.9 3.0 9.8 2.7 9.5 3.8 1.9 1.1 1.0 2.1 2.7 3.8 3.2 1.5 1.0 1.9 1.5 1.7 0.0 0.6 0.6 0.1 0.1 0.1 1.1 0.3 1.0 0.0 1.0 0.0 0.9 7.1 10.9 8.5 9.6 6.2 3.0 3.0 6.2 7.7 3.4 11.9 10.9 0.5 1.0 5.7 9.3 15.1 28.1 6.7 7.9 12.2 11.8 1.4 0.0 3.8 0.6 5.2 13.6 0.0 4.6 1.7 6.9 0.6 0.0 17.4 1.4 1.6 1.2 8.0 5.9 1.5 7.8 2.6 6.8 1.0 8.4 7.5 2.8 0.0 7.1 4.7 12.8 0.0 13.8 1.1 5.2 3.3 0.8 4.3 5.2 0.9 ADD2 ADDB ENSG00000075340 "Adducin 2" P35612 2 70607618-70768225 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "bone marrow: 53.6;brain: 35.0" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 28.5;Erythroid cells: 70.0;Horizontal cells: 131.9" "Cancer enhanced" "Detected in many" "testis cancer: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 4.7;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 20 "B-cells: 4.7;monocytes: 4.4;T-cells: 1.9" "Cell line enhanced" "Detected in many" "HAP1: 14.3;JURKAT: 13.9;K-562: 18.7;NTERA-2: 36.9;RPMI-8226: 17.6;SCLC-21H: 18.4;U-251 MG: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009796, HPA034509, HPA034510" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 66000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202" "unprognostic (3.58e-2)" "unprognostic (2.68e-4)" "unprognostic (3.83e-2)" "unprognostic (3.01e-4)" "unprognostic (1.94e-1)" "unprognostic (2.25e-3)" "unprognostic (1.35e-1)" "unprognostic (3.26e-1)" "unprognostic (3.49e-1)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (8.93e-2)" "unprognostic (4.47e-7)" "unprognostic (2.81e-4)" "unprognostic (1.77e-1)" "unprognostic (1.71e-3)" "unprognostic (1.31e-3)" 1.9 2.6 14.0 2.6 17.9 53.6 1.5 29.7 35.0 1.3 1.3 1.2 0.0 1.0 1.3 1.2 2.3 1.4 1.2 1.5 14.1 10.7 0.9 0.9 1.8 3.1 6.0 19.7 1.0 2.1 1.3 2.8 1.6 14.0 1.3 1.2 1.7 1.1 1.1 1.6 1.2 1.2 1.9 6.0 1.9 1.1 2.9 2.7 0.0 2.3 0.0 2.9 1.5 0.5 4.7 0.1 0.1 4.4 0.0 1.9 0.6 7.1 8.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.1 5.3 0.0 14.3 0.0 0.0 0.0 8.4 0.7 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.4 0.0 13.9 18.7 0.0 0.0 0.0 0.1 0.6 36.9 0.0 0.2 0.0 0.2 17.6 2.4 0.0 18.4 8.3 9.1 0.0 0.0 4.2 0.0 4.4 0.3 0.0 0.4 0.0 19.4 6.0 7.0 0.0 0.3 2.9 3.3 0.1 0.1 0.0 0.0 2.4 0.1 4.7 0.0 0.0 0.1 4.0 1.9 1.0 0.1 0.0 4.4 0.0 0.0 0.6 14.0 17.9 29.7 35.0 14.1 10.7 6.0 19.7 14.0 2.7 0.0 0.3 3.4 0.1 0.1 19.8 2.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 28.5 2.9 0.0 70.0 0.9 0.2 1.0 0.7 0.0 0.0 0.2 131.9 0.0 1.3 0.3 24.0 0.9 0.0 1.7 1.0 0.0 0.5 0.5 0.0 0.7 0.0 9.4 0.0 0.0 0.7 3.2 0.1 0.2 0.0 0.0 0.6 ADGRE2 "CD312, EMR2" ENSG00000127507 "Adhesion G protein-coupled receptor E2" Q9UHX3 19 14732393-14778541 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Cell adhesion, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.7;lymphoid tissue: 38.9" "Cell type enhanced" "Detected in many" 15 "granulocytes: 44.2;Kupffer cells: 60.1;Macrophages: 39.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7" "Group enriched" "Detected in many" 8 "granulocytes: 24.2;monocytes: 28.7" "Cell line enhanced" "Detected in some" "HEL: 10.3;HMC-1: 16.6;NB-4: 10.1;RPMI-8226: 7.3;U-937: 13.2" HPA055200 Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA055200: " "unprognostic (2.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (9.10e-2)" "unprognostic (3.58e-2)" "unprognostic (2.77e-2)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.32e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.35e-6)" "unprognostic (1.46e-1)" "unprognostic (2.45e-3)" "unprognostic (2.50e-1)" "unprognostic (1.01e-1)" 6.3 3.1 1.7 22.9 1.9 7.2 4.4 1.0 1.3 14.9 8.1 2.5 0.9 2.4 12.0 1.0 1.9 2.3 3.3 7.3 2.0 1.8 3.4 4.3 15.6 37.4 2.2 0.0 5.3 3.5 0.7 1.6 10.9 2.4 3.8 2.5 3.2 2.4 3.9 3.5 3.0 3.0 2.0 3.1 38.9 2.0 2.2 1.4 2.8 3.4 5.2 2.8 7.5 2.1 0.1 3.1 24.2 28.7 1.2 0.0 1.8 0.2 1.0 0.1 0.2 0.1 0.3 1.1 0.8 1.1 0.0 0.0 0.2 0.2 0.2 0.1 0.7 2.1 1.7 0.3 0.1 0.0 0.2 0.2 10.3 3.3 0.2 0.5 3.8 16.6 0.8 1.5 3.7 0.6 0.1 0.1 0.9 2.4 0.4 1.2 0.5 1.3 10.1 0.4 0.7 0.2 0.1 1.4 7.3 0.0 0.3 0.1 0.2 2.1 1.8 0.4 0.2 0.3 4.8 0.3 0.3 0.3 0.2 0.1 0.2 0.1 0.2 1.0 13.2 0.6 19.6 4.4 24.2 0.0 15.7 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 19.1 1.2 28.7 0.6 0.0 1.8 1.7 1.9 1.0 1.3 2.0 1.8 2.2 0.0 2.4 1.4 3.0 10.6 5.4 4.4 0.0 0.7 0.6 0.0 4.0 4.5 0.0 0.0 0.1 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.3 0.3 1.7 44.2 0.4 13.5 0.0 1.2 1.3 60.1 2.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.2 0.3 0.0 0.3 0.7 0.0 3.0 ADGRE5 "CD97, TM7LN1" ENSG00000123146 "Adhesion G protein-coupled receptor E5" P48960 19 14380501-14408725 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 102.4;Kupffer cells: 83.8;T-cells: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA013707 Enhanced Approved Cytosol "Secreted to blood" NA Yes 10000000 930000 Cytosol "HPA013707: AB_1846345" "unprognostic (3.16e-1)" "unprognostic (1.80e-1)" "unprognostic (5.10e-2)" "unprognostic (2.30e-1)" "unprognostic (2.85e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.51e-2)" "unprognostic (6.06e-3)" "unprognostic (3.14e-2)" "unprognostic (1.08e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.87e-6)" "unprognostic (2.08e-2)" "unprognostic (4.14e-2)" "unprognostic (2.44e-2)" "unprognostic (6.41e-2)" 17.7 8.9 2.5 23.0 4.0 55.3 14.3 1.1 5.2 21.7 15.9 12.9 0.5 12.9 56.9 18.5 11.6 19.1 27.1 16.4 3.0 2.4 10.7 15.5 30.3 41.1 6.3 3.2 10.7 16.2 2.4 3.3 18.2 5.9 11.3 9.0 6.9 17.0 3.6 12.5 6.0 22.2 36.2 4.2 56.9 15.0 6.9 4.9 24.3 8.6 3.7 22.5 34.7 12.4 3.9 13.3 95.3 43.2 22.8 25.8 23.3 30.8 21.9 0.2 21.0 9.3 15.3 3.3 21.4 34.5 15.4 16.9 6.2 31.3 3.5 21.7 27.5 22.0 7.3 5.7 10.4 6.9 19.2 6.4 6.9 32.5 2.7 11.5 14.9 32.3 6.7 0.3 15.7 5.4 5.0 1.5 6.1 9.0 27.7 16.8 6.9 0.9 20.0 0.6 24.5 27.3 2.0 9.2 16.1 5.2 2.7 0.2 0.7 12.2 17.5 15.2 0.5 4.5 13.8 3.7 5.2 8.7 21.7 35.2 0.0 0.1 0.2 18.7 26.7 19.5 42.0 18.6 95.3 25.8 36.7 17.3 3.9 13.1 17.8 13.3 2.6 9.4 12.8 82.7 22.8 43.2 6.4 9.0 23.3 2.5 4.0 1.1 5.2 3.0 2.4 6.3 3.2 5.9 4.9 32.8 102.4 15.9 7.4 0.0 0.2 3.1 12.7 50.9 31.8 0.0 0.0 2.7 0.0 15.1 0.0 4.5 10.2 23.3 19.1 36.8 4.8 9.8 70.9 1.5 47.0 0.0 4.7 26.4 83.8 1.0 6.1 50.6 0.0 2.8 34.7 2.3 17.9 21.0 4.6 0.7 1.2 25.8 17.2 0.5 5.7 0.0 6.6 152.3 31.8 14.1 ADGRG2 "EDDM6, GPR64, HE6, TM7LN2" ENSG00000173698 "Adhesion G protein-coupled receptor G2" Q8IZP9 X 18989309-19122637 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 202.4" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 5.1;Ciliated cells: 4.0;Glandular cells: 3.0;Horizontal cells: 3.2;Muller glia cells: 4.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.3;BEWO: 7.9;HeLa: 6.5;NTERA-2: 6.8;SH-SY5Y: 7.1;U-2197: 15.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001478, HPA050029" Enhanced Approved "Plasma membrane,Cytosol" NA NA 7900000 "Plasma membrane, Cytosol" "HPA001478: AB_1078923, HPA050029: AB_2680996" "unprognostic (3.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.40e-1)" "unprognostic (2.55e-2)" "unprognostic (1.58e-1)" "unprognostic (4.43e-3)" "unprognostic (2.63e-4)" "unprognostic (2.66e-1)" "unprognostic (1.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-7)" "unprognostic (6.37e-2)" "unprognostic (3.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" 4.4 0.3 0.4 0.9 0.2 0.2 2.8 0.1 0.2 0.8 1.0 0.1 6.6 0.2 0.5 202.4 0.9 6.9 1.4 1.8 0.6 0.6 0.7 0.9 1.7 3.1 0.2 0.2 0.9 0.9 24.8 1.9 0.6 0.3 3.2 0.2 1.6 9.6 0.8 0.6 0.3 1.4 0.6 0.2 1.2 3.5 4.7 0.2 2.7 1.8 0.6 1.9 1.1 1.5 0.1 0.2 0.9 0.6 0.0 0.2 0.0 0.2 6.3 0.0 0.0 0.1 1.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.5 0.0 6.5 0.3 0.9 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 2.3 6.8 0.0 2.1 0.0 0.1 4.5 0.0 1.3 2.4 7.1 1.6 0.1 0.0 1.2 0.1 0.1 0.1 0.2 0.4 15.7 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.9 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.7 0.0 0.6 0.1 0.0 0.0 0.4 0.2 0.1 0.2 0.6 0.6 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.8 5.1 4.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 3.0 0.0 0.4 0.0 3.2 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 1.8 0.0 1.4 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 ADH1A ADH1 ENSG00000187758 "Alcohol dehydrogenase 1A (class I), alpha polypeptide" P07327 4 99276367-99291028 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 322 "liver: 250.3" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 212.0" "Cancer enriched" "Detected in some" 251 "liver cancer: 165.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 11.2" "CAB009562, HPA047814, HPA060902" Enhanced Approved "Plasma membrane,Cytosol" NA NA 12000000 "Plasma membrane, Cytosol" "CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.89e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.40e-1)" "prognostic favorable (2.38e-4)" "unprognostic (2.78e-3)" "unprognostic (4.25e-1)" "unprognostic (4.79e-3)" "unprognostic (6.21e-2)" "unprognostic (9.36e-2)" "unprognostic (3.25e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 250.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 11.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 212.0 0.0 0.0 0.0 7.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 ADH1B ADH2 ENSG00000196616 "Alcohol dehydrogenase 1B (class I), beta polypeptide" P00325 4 99304964-99352760 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 253.5;liver: 466.3" "Cell type enriched" "Detected in many" 38 "Hepatocytes: 3603.2" "Cancer enriched" "Detected in many" 31 "liver cancer: 223.1" "Group enriched" "Detected in some" 5 "midbrain: 2.3;pons and medulla: 1.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "ASC diff: 394.3" "HPA047814, HPA060902" Supported Approved "Plasma membrane,Cytosol" NA NA 16000000 "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.13e-2)" "unprognostic (9.80e-3)" "unprognostic (6.59e-2)" "unprognostic (5.56e-2)" "unprognostic (9.49e-2)" "unprognostic (5.53e-2)" "unprognostic (1.54e-3)" "unprognostic (1.04e-2)" "unprognostic (6.51e-2)" "unprognostic (2.73e-2)" "unprognostic (7.47e-3)" "unprognostic (7.79e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (4.60e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-2)" 253.5 12.3 0.2 21.8 0.0 0.4 78.7 0.2 0.4 18.3 60.0 0.4 5.7 3.5 12.8 14.4 33.5 22.3 31.9 24.2 0.3 0.0 9.2 466.3 43.8 17.5 2.3 0.1 18.0 8.7 0.8 5.3 0.9 1.6 30.7 10.1 2.3 11.2 3.9 20.5 11.9 25.4 30.8 2.4 5.9 10.9 18.0 0.2 0.2 16.1 9.7 2.0 42.3 76.0 0.6 0.2 1.2 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 394.3 57.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.2 0.1 0.1 0.2 0.4 0.1 0.0 0.6 0.3 0.4 1.2 0.8 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.0 2.3 0.1 1.6 0.2 0.0 4.3 14.0 0.4 19.8 0.0 8.9 66.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.4 9.2 0.0 46.7 0.0 0.0 81.0 0.3 1.1 3603.2 0.1 0.0 0.0 93.9 77.5 0.0 51.2 1.0 27.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 43.7 0.0 0.0 11.4 0.1 12.5 0.0 0.1 ADH1C ADH3 ENSG00000248144 "Alcohol dehydrogenase 1C (class I), gamma polypeptide" P00326 4 99336492-99353027 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 47.1;liver: 149.4;stomach 1: 43.1" "Cell type enhanced" "Detected in many" 15 "Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3" "Cancer enriched" "Detected in many" 7 "liver cancer: 238.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC TERT1: 5.2;HSkMC: 15.4" "HPA047814, HPA060902" Supported Supported "Plasma membrane,Cytosol" NA NA 9700000 "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (3.98e-2)" "unprognostic (9.88e-3)" "unprognostic (7.04e-2)" "unprognostic (1.90e-1)" "unprognostic (5.14e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.55e-4)" "prognostic favorable (2.99e-4)" "unprognostic (8.25e-2)" "unprognostic (8.89e-3)" "unprognostic (7.95e-2)" "unprognostic (2.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.21e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (9.37e-2)" 4.7 0.0 0.0 18.5 0.0 0.0 1.1 0.0 0.0 1.1 37.9 0.0 1.1 43.4 0.3 1.2 1.7 0.0 12.0 2.0 0.0 8.3 149.4 1.1 0.0 0.2 0.0 1.1 11.4 0.0 0.0 0.0 0.0 2.5 13.6 0.0 1.1 0.8 6.0 0.0 47.1 0.9 0.5 0.0 43.1 1.6 0.0 0.0 0.5 2.0 0.2 1.3 0.7 0.2 0.2 0.3 0.1 0.1 0.3 0.1 0.0 2.3 0.0 0.1 1.8 5.2 1.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.1 0.5 1.4 0.3 15.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 1.0 0.4 0.0 0.1 0.1 0.9 2.2 0.9 0.0 0.4 1.6 0.7 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.3 0.2 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.1 3.0 5.3 1.5 3.6 0.0 0.0 0.8 50.9 80.3 45.5 27.9 0.0 0.0 0.0 141.2 2.4 0.0 51.2 23.3 606.8 0.0 0.0 1.2 0.0 378.8 0.0 0.0 20.7 12.9 12.9 0.6 9.8 0.0 0.0 3.6 36.7 0.0 99.5 63.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 355.3 2.0 ADH4 ADH-2 ENSG00000198099 "Alcohol dehydrogenase 4 (class II), pi polypeptide" P08319 4 99123657-99157792 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 345.2" "Cell type enriched" "Detected in some" 34 "Hepatocytes: 802.6" "Cancer enriched" "Detected in some" 60 "liver cancer: 230.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "Hep G2: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA020525 Enhanced Uncertain Nucleoplasm,Cytosol NA NA 5300000 "Nucleoplasm, Cytosol" "HPA020525: AB_1844609" "unprognostic (2.75e-1)" "unprognostic (1.69e-2)" "unprognostic (1.85e-2)" "unprognostic (5.54e-3)" "unprognostic (2.14e-2)" "unprognostic (1.33e-2)" "prognostic favorable (7.08e-6)" "unprognostic (1.49e-1)" "unprognostic (1.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.88e-1)" "unprognostic (2.34e-2)" "unprognostic (7.16e-3)" "unprognostic (2.20e-1)" "unprognostic (5.89e-3)" 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 3.6 0.0 0.1 11.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.2 345.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.1 4.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.1 0.1 0.5 1.2 0.7 2.8 0.5 0.4 0.9 0.1 0.3 0.3 0.2 0.3 0.5 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.2 0.5 0.3 0.0 0.2 0.3 0.0 0.2 0.4 0.3 0.1 0.6 0.8 22.4 0.1 1.8 0.5 0.3 0.0 0.2 0.2 0.2 0.1 0.2 0.4 1.0 0.1 0.3 0.3 0.6 0.4 0.0 0.2 0.2 1.8 0.5 0.2 0.4 0.2 0.3 2.0 0.3 0.0 0.3 0.5 0.0 0.4 0.5 0.2 0.5 0.1 0.6 0.4 0.7 0.1 0.7 0.1 2.8 0.4 0.5 0.9 0.5 0.8 0.4 0.5 0.5 0.1 1.2 0.8 0.8 1.0 0.4 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 15.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 21.9 0.0 0.0 23.3 0.5 0.0 0.0 0.0 0.0 802.6 0.0 0.0 0.0 13.5 20.9 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 ADH7 ADH-4 ENSG00000196344 "Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide" P40394 4 99412261-99435737 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7" "Group enriched" "Detected in some" 15 "Ciliated cells: 8.1;Club cells: 10.3" "Group enriched" "Detected in some" 17 "cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC TERT1: 4.0;HaCaT: 4.5" "Not detected" "Not detected" HPA039695 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039695: AB_10795681" "unprognostic (1.02e-2)" "unprognostic (8.64e-2)" "unprognostic (4.86e-2)" "unprognostic (5.66e-3)" "unprognostic (4.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.1 0.0 68.7 30.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 8.1 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 ADIRF "AFRO, APM2, C10orf116" ENSG00000148671 "Adipogenesis regulatory factor" Q15847 10 86968192-86983934 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 1712.2;Smooth muscle cells: 2588.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.9;naive CD8 T-cell: 2.8" "Lineage enriched" "Detected in single" 11 "T-cells: 3.9" "Cell line enhanced" "Detected in many" "A-431: 25.7;HaCaT: 66.5;PC-3: 36.3;RT4: 46.2" "Low region specificity" "Detected in many" HPA026810 Approved Supported Nucleoplasm,Cytosol NA NA 580000 "Nucleoplasm, Cytosol" "HPA026810: AB_2672003" 123.4 9.5 15.7 21.4 6.1 1.5 109.7 1.6 8.4 44.3 65.3 6.8 21.6 66.2 25.3 34.6 24.3 34.7 29.9 24.8 17.3 6.1 20.3 10.3 32.5 5.4 10.5 9.3 54.7 12.6 7.2 11.7 8.7 7.2 38.6 7.0 23.6 41.5 38.8 30.5 23.7 69.5 19.8 9.6 10.0 12.2 12.5 9.9 1.2 29.7 38.6 8.3 39.5 41.6 0.0 0.3 0.0 0.3 0.0 3.9 0.6 25.7 0.3 0.0 0.0 2.1 12.7 1.8 9.0 9.7 0.0 0.0 0.9 3.3 0.0 0.3 11.0 0.6 66.5 0.0 2.1 0.1 0.9 0.0 0.0 2.7 0.2 1.2 0.0 0.4 0.3 4.1 0.0 5.9 0.9 3.6 0.3 0.1 3.6 0.3 3.2 0.1 0.7 0.1 0.5 36.3 0.1 0.0 0.3 0.4 46.2 1.6 0.1 3.0 13.8 0.1 0.0 17.0 0.3 9.8 0.3 2.1 1.7 0.0 0.5 0.4 0.0 0.7 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.3 0.0 3.9 2.8 0.0 0.0 0.0 0.0 0.2 0.6 15.7 6.1 1.6 7.9 17.3 6.1 10.5 9.3 7.2 9.9 1712.2 356.0 16.7 133.5 469.5 4.8 0.0 50.9 125.8 883.8 177.9 2.0 235.3 1145.6 5.7 8.2 494.5 1530.9 23.3 240.4 10.7 324.4 500.6 48.4 93.5 24.0 0.0 28.8 792.4 7.8 23.6 1212.4 52.8 578.6 174.1 95.1 265.3 201.2 1122.8 441.6 716.9 13.2 1448.7 2588.8 2.5 4.4 383.4 139.5 13.1 194.6 684.0 ADK AK ENSG00000156110 "Adenosine kinase" P55263 10 74151185-74709303 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Purine salvage" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 71.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032876, HPA038391, HPA038409, HPA075222" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 320000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: " "unprognostic (1.55e-3)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.62e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.93e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.64e-1)" "unprognostic (2.88e-1)" "unprognostic (1.55e-1)" "unprognostic (8.15e-3)" "unprognostic (2.51e-1)" "unprognostic (1.89e-3)" "unprognostic (2.03e-1)" "unprognostic (2.88e-2)" "unprognostic (4.97e-3)" "unprognostic (2.95e-2)" 13.8 10.7 11.8 13.6 25.4 12.1 14.5 11.2 11.8 9.5 9.3 9.0 9.6 8.8 6.6 10.6 29.4 8.9 6.3 15.7 9.8 11.1 19.0 71.9 15.1 17.9 12.3 9.3 5.2 12.6 15.1 23.5 43.2 11.6 8.7 10.8 8.5 13.1 11.4 18.1 20.8 6.4 8.3 13.2 11.3 7.4 11.9 10.3 13.4 20.8 24.1 21.9 12.6 14.7 49.3 23.0 5.4 21.6 6.5 15.7 9.8 38.1 8.6 9.1 12.2 9.2 14.2 21.0 33.2 26.3 25.7 28.9 24.1 39.8 20.0 8.3 13.3 12.1 34.9 10.7 35.3 41.2 13.4 12.3 12.7 14.1 25.9 10.5 20.3 5.2 13.0 23.3 18.7 46.6 19.0 22.3 9.3 10.1 6.5 19.3 21.3 23.9 27.5 2.6 17.8 60.9 23.1 15.8 17.2 28.1 21.0 7.2 8.5 14.6 56.7 11.0 8.5 37.7 15.4 19.1 8.5 15.7 22.7 27.3 9.4 10.6 22.6 16.1 29.3 5.2 1.3 10.1 1.4 4.5 18.0 10.0 29.7 9.5 8.2 23.0 49.3 7.9 6.5 5.4 6.5 21.6 16.7 15.7 9.8 11.8 25.4 11.2 11.8 9.8 11.1 12.3 9.3 11.6 10.3 77.4 57.2 37.1 62.9 83.7 14.5 53.3 35.7 34.8 76.2 29.6 53.0 120.6 77.9 60.0 55.9 14.7 5.9 0.0 58.9 113.1 27.2 33.9 19.8 112.8 36.3 11.1 10.4 14.7 21.4 22.9 15.5 40.6 45.5 31.5 11.5 10.0 45.7 14.0 11.3 48.3 27.9 6.5 32.8 13.3 12.2 84.8 89.7 20.3 19.9 57.0 ADNP2 "KIAA0863, ZNF508" ENSG00000101544 "ADNP homeobox 2" Q6IQ32 18 80109031-80147523 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007126 Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA007126: AB_1080729" "unprognostic (4.93e-2)" "unprognostic (1.45e-1)" "unprognostic (1.05e-2)" "unprognostic (2.25e-1)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.42e-2)" "unprognostic (2.31e-1)" "unprognostic (1.24e-1)" "unprognostic (6.05e-2)" "unprognostic (3.40e-2)" "unprognostic (8.35e-2)" "prognostic favorable (6.39e-5)" "unprognostic (8.64e-2)" "unprognostic (3.59e-1)" "prognostic unfavorable (9.90e-4)" "unprognostic (5.19e-2)" 11.3 8.8 9.1 7.6 10.4 40.5 10.9 8.4 12.5 7.7 8.6 14.4 7.1 10.8 10.2 13.5 12.5 10.0 11.1 10.2 9.8 7.0 8.4 11.3 10.3 11.6 8.0 10.4 12.7 10.4 12.7 12.4 11.4 10.4 9.2 8.2 12.6 9.1 8.9 4.0 16.5 9.7 13.1 10.1 8.7 11.2 24.4 6.7 14.3 10.1 8.1 10.4 11.3 10.8 2.4 2.3 1.7 3.0 1.4 4.4 1.5 11.2 8.8 18.4 13.5 4.2 6.0 13.9 8.2 9.3 9.7 12.3 8.2 5.7 0.1 3.2 6.5 12.2 10.3 17.9 10.5 10.6 10.2 8.9 15.8 6.8 9.0 7.7 23.1 17.7 6.1 9.9 9.9 13.6 6.5 9.8 18.2 15.2 16.8 5.7 7.9 21.2 4.7 12.5 5.0 10.3 8.0 20.6 8.0 5.8 15.1 12.6 16.1 9.3 9.1 6.4 9.4 8.9 17.6 6.5 11.6 29.1 4.8 8.9 6.0 11.0 23.4 7.8 9.7 7.8 0.0 1.1 0.7 3.4 1.7 2.4 2.4 4.4 2.9 0.6 1.1 2.4 4.1 1.7 1.4 3.0 2.3 2.1 1.5 9.1 10.4 8.4 12.5 9.8 7.0 8.0 10.4 10.4 6.7 17.9 18.1 2.9 21.0 35.0 19.0 14.9 10.2 5.3 11.4 3.5 25.5 8.0 0.0 6.8 6.7 11.3 10.7 0.0 9.5 6.7 11.4 19.3 11.5 16.3 8.2 23.8 21.4 16.0 9.7 7.2 6.9 11.0 13.5 1.8 14.4 8.6 9.0 13.9 11.0 5.7 29.2 0.0 14.5 38.4 36.9 37.8 8.1 8.6 12.1 26.2 ADORA2B ENSG00000170425 "Adenosine A2b receptor" P29275 17 15944917-15975746 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 65.4;Suprabasal keratinocytes: 56.2;Urothelial cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.8;myeloid DC: 8.4" "Group enriched" "Detected in many" 86 "dendritic cells: 8.4;granulocytes: 12.8;monocytes: 4.5" "Cell line enhanced" "Detected in many" "GAMG: 50.2;HMC-1: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073747 Uncertain Cytosol NA NA Cytosol "HPA073747: " "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (4.68e-1)" "unprognostic (7.88e-3)" "unprognostic (2.64e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "unprognostic (1.38e-1)" "unprognostic (1.66e-9)" "unprognostic (2.07e-1)" "unprognostic (3.49e-1)" "unprognostic (1.50e-2)" "unprognostic (2.84e-1)" 1.5 1.5 7.6 4.5 9.1 1.6 1.8 7.3 8.7 2.9 15.3 2.4 0.0 0.8 1.7 1.5 11.1 2.2 3.8 1.2 6.6 3.0 0.6 0.7 4.1 1.0 1.9 5.4 0.6 2.8 0.4 1.9 9.0 5.2 1.7 12.8 10.5 1.9 0.7 0.7 10.4 1.6 2.8 3.9 0.7 2.6 0.7 2.6 0.1 0.6 4.4 4.5 6.8 5.6 0.0 8.4 12.8 4.5 0.0 0.0 1.5 10.0 5.5 0.1 0.2 1.8 3.5 0.2 1.9 8.7 5.7 7.1 2.6 10.5 1.3 2.4 1.7 50.2 15.8 2.4 14.5 7.6 2.8 5.5 9.7 1.8 3.8 7.1 0.0 50.7 2.0 6.2 8.1 18.9 9.8 2.8 1.5 0.4 0.0 5.6 2.6 0.6 1.9 0.6 21.6 7.8 0.0 0.1 0.0 5.8 2.7 0.2 0.3 4.3 1.0 2.6 4.3 0.0 1.5 2.4 2.0 5.4 5.6 9.0 0.8 0.0 0.0 8.1 0.0 2.8 12.8 4.0 2.6 0.0 4.5 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.4 0.0 2.3 0.1 0.0 1.5 7.6 9.1 7.3 8.7 6.6 3.0 1.9 5.4 5.2 2.6 3.0 3.4 0.0 12.7 65.4 0.0 1.2 2.5 8.1 7.9 0.0 0.0 10.1 0.0 6.2 0.3 0.6 4.9 0.0 0.8 2.8 6.1 11.9 0.0 0.0 4.6 0.0 2.4 0.0 2.7 0.0 0.0 5.1 6.8 0.0 1.4 7.4 0.8 4.8 0.0 0.0 0.5 0.0 1.9 0.5 1.2 56.2 5.1 0.0 3.7 26.7 ADRA1A "ADRA1C, ADRA1L1" ENSG00000120907 "Adrenoceptor alpha 1A" P35348 8 26748150-26867273 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.1" "Group enriched" "Detected in some" 15 "Early spermatids: 50.8;Hepatocytes: 14.0;Late spermatids: 20.6" "Cancer enhanced" "Detected in some" "liver cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 1.3;HAP1: 1.7;JURKAT: 2.0;NTERA-2: 2.3;U-2 OS: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029678, HPA029679, HPA076693" Approved Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: " "unprognostic (1.27e-1)" "unprognostic (1.68e-2)" "unprognostic (1.99e-1)" "unprognostic (3.57e-1)" "unprognostic (5.04e-4)" "unprognostic (1.97e-1)" "unprognostic (9.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.58e-2)" "unprognostic (7.47e-2)" "unprognostic (1.71e-2)" "unprognostic (6.06e-3)" "unprognostic (7.41e-2)" "unprognostic (1.52e-2)" "unprognostic (1.30e-1)" 14.5 0.7 7.1 1.1 3.9 0.3 3.4 6.2 4.9 0.9 1.5 5.9 4.9 1.0 1.8 2.0 0.9 0.6 0.5 10.1 11.6 2.0 0.8 45.1 3.9 1.4 4.7 4.7 1.0 0.5 0.3 0.6 0.3 3.8 10.2 0.7 0.6 4.6 11.2 0.6 0.9 1.3 2.4 1.9 7.0 1.2 0.5 4.2 0.0 0.6 0.1 0.6 0.6 0.7 0.3 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 7.1 3.9 6.2 4.9 11.6 2.0 4.7 4.7 3.8 4.2 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 1.3 0.0 20.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ADRA2B "ADRA2L1, ADRA2RL1, ADRARL1" ENSG00000274286 "Adrenoceptor alpha 2B" P18089 2 96112875-96116245 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.1;EFO-21: 3.3;HAP1: 1.8;NTERA-2: 1.8;SuSa: 3.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA066029, HPA074948" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA066029: AB_2685599, HPA074948: " "unprognostic (6.16e-2)" "unprognostic (1.31e-2)" "unprognostic (1.76e-2)" "unprognostic (4.93e-4)" "unprognostic (1.84e-2)" "unprognostic (5.24e-2)" "unprognostic (6.80e-5)" "unprognostic (4.85e-2)" "unprognostic (1.69e-1)" "unprognostic (3.16e-2)" "unprognostic (8.34e-2)" "unprognostic (2.54e-1)" "unprognostic (2.21e-1)" "unprognostic (4.43e-2)" "unprognostic (3.39e-1)" "unprognostic (1.36e-1)" "unprognostic (6.55e-2)" 4.9 2.2 0.3 0.4 2.2 1.2 8.1 0.1 0.7 4.5 4.0 1.9 0.2 0.5 1.3 7.5 4.3 0.8 3.2 6.1 0.5 2.9 7.5 0.3 0.2 4.4 0.0 5.0 2.3 1.0 0.0 1.3 3.3 3.3 0.4 0.9 1.8 2.9 8.0 0.3 1.2 2.1 0.6 4.8 0.7 2.6 1.9 0.0 2.1 1.8 0.0 3.8 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.3 0.2 1.8 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.7 0.0 0.1 1.8 0.1 0.3 0.0 0.0 0.4 0.0 0.3 1.4 0.0 0.0 1.2 0.0 3.1 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 2.0 0.0 1.4 1.2 1.8 0.0 0.4 0.0 0.2 0.0 0.7 0.0 0.0 0.5 0.1 0.4 0.9 0.0 0.0 0.3 0.0 2.4 3.1 0.3 0.0 1.7 0.9 1.7 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 32.3 8.0 0.0 0.2 1.3 0.3 0.0 0.0 0.3 ADRB2 "ADRB2R, ADRBR, B2AR, BAR" ENSG00000169252 "Adrenoceptor beta 2" P07550 5 148825245-148828687 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.6" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 104.2;Basal keratinocytes: 344.2;granulocytes: 116.5;Suprabasal keratinocytes: 214.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 24.5;hTERT-HME1: 25.4;PC-3: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003431, HPA075322" Uncertain Uncertain Cytosol NA NA Cytosol "HPA003431: AB_1845333, HPA075322: " "unprognostic (2.28e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (9.35e-3)" "unprognostic (5.54e-2)" "unprognostic (2.34e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-2)" "unprognostic (2.23e-1)" "prognostic favorable (3.15e-9)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" 11.7 0.2 0.7 0.9 0.4 4.6 13.8 0.0 0.3 6.1 0.9 0.3 0.9 0.2 6.4 1.4 1.1 2.8 0.7 0.3 0.2 6.0 8.5 1.1 0.9 0.0 0.0 0.5 0.0 4.0 3.8 0.7 3.3 0.1 4.4 15.9 1.3 1.2 1.0 3.7 2.9 0.0 0.5 2.0 2.3 5.4 4.8 6.1 14.0 10.8 7.3 34.6 9.6 7.6 0.0 0.0 0.0 0.3 0.0 0.0 1.5 4.4 2.0 2.3 0.0 3.3 0.0 2.1 0.4 7.4 6.8 0.0 9.2 2.3 0.0 0.2 0.0 1.6 0.0 0.2 0.0 3.8 0.0 24.5 0.6 25.4 1.7 0.9 0.0 0.0 2.9 5.3 0.0 0.0 4.2 0.1 0.0 10.5 2.2 1.4 4.3 1.1 1.9 0.0 0.0 1.8 0.2 0.6 0.9 0.0 2.3 4.1 0.0 1.8 2.5 1.1 0.7 0.0 0.1 0.0 5.0 0.8 3.5 4.7 14.0 34.6 7.8 25.7 4.8 8.2 20.9 5.3 3.0 1.4 12.9 7.6 7.3 10.8 6.1 0.4 9.6 104.2 33.5 11.1 31.2 344.2 0.2 12.4 0.0 8.1 33.0 0.0 0.0 0.3 0.0 1.4 0.2 17.5 0.0 0.0 0.2 0.2 6.1 16.2 116.5 11.9 14.7 0.0 2.9 6.7 12.7 0.4 0.0 16.5 28.7 1.0 1.4 3.5 5.3 0.0 0.0 0.0 4.8 0.0 3.6 0.0 0.0 214.5 0.5 35.5 0.8 48.5 ADRM1 "ARM1, GP110, Rpn13" ENSG00000130706 "Adhesion regulating molecule 1" Q16186 20 62302093-62308862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Late spermatids: 1352.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 113.5" "Low region specificity" "Detected in all" HPA042266 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042266: AB_10794044" "unprognostic (5.49e-2)" "unprognostic (5.14e-3)" "unprognostic (7.34e-2)" "unprognostic (6.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-3)" "unprognostic (2.14e-2)" "unprognostic (3.56e-2)" "unprognostic (2.13e-3)" "unprognostic (8.98e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (4.15e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.47e-2)" 22.9 22.9 14.8 23.4 16.8 30.5 17.0 24.1 29.3 14.7 16.9 18.8 12.4 24.0 19.9 15.3 23.9 14.0 20.4 24.6 14.6 15.1 21.7 54.5 15.7 22.1 15.5 13.4 17.2 34.9 9.5 13.4 27.6 21.4 14.8 7.9 14.8 21.0 18.3 86.6 26.4 19.5 17.3 15.4 23.5 20.1 30.0 10.1 23.8 16.4 29.1 29.4 17.3 14.6 79.2 67.2 69.4 78.0 51.7 77.6 70.9 33.9 38.1 10.7 22.8 10.2 7.5 29.1 22.5 15.3 42.2 16.9 113.5 36.0 18.3 41.1 12.8 24.1 38.4 13.4 33.0 13.0 21.3 27.5 44.4 27.6 59.8 17.3 22.9 42.4 9.5 20.3 27.5 11.0 7.0 16.3 18.2 32.4 20.0 9.7 45.7 28.7 44.9 36.2 16.5 56.9 23.1 18.8 29.0 11.3 25.6 19.2 23.9 24.2 38.5 27.0 7.6 26.8 25.3 23.9 42.2 44.7 41.1 45.0 42.7 33.6 24.4 44.4 23.1 30.5 48.3 66.3 69.4 66.0 78.0 58.9 79.2 59.8 62.7 67.2 75.5 45.1 51.4 62.2 51.7 65.0 62.7 77.6 70.9 14.8 16.8 24.1 29.3 14.6 15.1 15.5 13.4 21.4 10.1 32.8 25.1 83.4 87.4 131.7 31.3 16.5 53.5 32.1 30.7 62.8 17.7 212.4 97.8 167.4 291.0 91.6 138.0 46.7 184.0 146.0 94.9 83.7 41.5 89.8 134.3 31.8 55.5 94.5 71.8 1352.6 67.0 102.8 92.8 165.1 52.2 58.4 189.2 105.2 81.7 101.6 22.8 64.7 95.7 129.4 168.8 129.5 353.8 81.2 63.5 120.7 ADSL ENSG00000239900 "Adenylosuccinate lyase" P30566 22 40346500-40390463 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Purine biosynthesis" Lyase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000525, CAB019285" Enhanced Enhanced Cytosol NA NA 180000 Cytosol "CAB019285: , HPA000525: AB_1078106" "unprognostic (2.80e-1)" "unprognostic (2.12e-1)" "prognostic favorable (2.38e-4)" "unprognostic (2.64e-1)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" "prognostic unfavorable (5.81e-8)" "unprognostic (1.35e-1)" "unprognostic (1.25e-1)" "unprognostic (3.99e-1)" "unprognostic (6.28e-2)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (8.43e-2)" "unprognostic (2.70e-1)" "unprognostic (4.06e-1)" "unprognostic (1.44e-2)" 9.3 11.6 5.0 13.7 8.5 11.2 9.0 6.8 10.1 7.9 9.5 7.3 4.4 6.0 10.8 9.4 9.7 9.0 6.9 14.6 4.5 4.7 12.0 17.3 6.8 17.6 4.9 4.9 10.5 21.8 5.4 9.1 9.5 5.1 7.1 9.7 9.2 14.7 6.4 79.0 6.2 9.4 10.7 4.9 14.5 9.6 10.9 4.4 18.8 8.4 23.6 15.5 9.5 7.4 15.3 28.8 11.0 22.7 19.8 34.0 24.6 21.4 25.3 21.8 31.1 14.7 20.8 25.3 19.6 19.4 42.6 32.5 41.8 12.6 62.4 16.7 22.7 19.4 16.2 48.6 31.6 43.8 16.6 45.7 28.3 28.6 38.5 30.9 92.1 23.8 22.3 17.9 37.4 39.7 21.1 31.4 28.2 33.4 27.4 31.8 24.0 28.4 32.9 35.5 25.9 27.0 43.3 45.8 44.3 27.4 17.0 14.1 13.9 23.4 13.0 37.2 20.0 17.9 29.1 20.8 22.8 42.2 20.1 37.5 26.0 45.4 47.8 19.0 34.2 22.2 11.0 19.3 7.8 16.2 22.7 22.8 15.3 34.0 21.7 28.8 14.9 27.0 20.8 1.9 19.8 20.2 14.9 34.0 24.6 5.0 8.5 6.8 10.1 4.5 4.7 4.9 4.9 5.1 4.4 11.9 9.6 11.9 15.4 16.1 15.9 25.7 20.4 5.3 7.9 3.5 35.3 78.9 6.6 48.2 34.1 17.1 14.2 0.0 38.1 60.7 23.3 13.9 36.8 21.3 54.2 6.4 13.3 33.2 40.2 16.1 23.0 24.7 11.8 41.5 20.7 43.1 33.8 7.0 13.4 13.5 17.0 25.8 17.6 39.7 73.9 13.2 27.7 27.4 37.6 9.3 ADSS ENSG00000035687 "Adenylosuccinate synthase" P30520 1 244408494-244452134 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024400 Supported Supported "Plasma membrane,Cytosol" NA NA 620000 Cytosol "Plasma membrane" "HPA024400: AB_1844623" "unprognostic (4.24e-3)" "unprognostic (2.63e-1)" "unprognostic (3.95e-2)" "unprognostic (8.68e-2)" "unprognostic (6.91e-2)" "unprognostic (2.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.10e-1)" "unprognostic (1.35e-1)" "unprognostic (7.62e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-1)" "unprognostic (1.18e-2)" 19.4 17.8 23.2 23.8 31.2 29.2 26.3 18.3 26.3 20.9 20.9 35.9 27.1 21.1 18.9 23.3 27.7 18.3 15.8 9.8 24.9 23.4 25.1 19.3 19.2 21.2 42.5 16.6 20.9 21.2 26.6 17.7 21.0 34.9 19.8 22.7 13.1 25.0 21.7 11.0 26.5 23.2 22.9 29.3 24.9 24.7 48.9 36.7 26.7 26.3 17.9 24.8 26.5 21.8 10.9 13.6 24.6 21.3 15.5 16.0 11.9 25.7 14.2 12.4 10.9 14.6 20.9 22.9 26.0 21.9 18.7 14.2 18.7 24.9 23.0 17.3 20.0 8.0 19.5 13.5 17.0 21.0 17.0 24.0 15.3 14.2 14.1 17.5 36.2 19.8 14.3 20.6 17.4 17.6 21.8 66.6 12.7 26.5 17.1 18.5 6.1 23.2 24.3 33.0 24.6 15.7 21.5 11.8 24.8 31.0 16.0 16.9 14.8 22.1 20.6 26.0 13.8 14.3 19.3 29.1 17.3 9.5 20.0 27.0 20.8 27.2 17.4 14.3 42.5 25.5 24.6 15.8 13.0 15.0 20.5 16.0 10.9 13.7 12.8 13.6 8.6 11.8 13.3 11.9 15.5 21.3 5.5 14.7 11.9 23.2 31.2 18.3 26.3 24.9 23.4 42.5 16.6 34.9 36.7 44.7 30.5 40.0 44.7 90.9 12.4 5.8 35.7 127.2 85.3 57.6 5.9 47.0 74.6 41.2 102.9 33.7 30.0 0.0 44.0 83.0 35.8 40.9 28.9 29.6 33.8 9.5 17.3 37.4 38.1 103.8 17.5 51.2 40.5 37.9 29.4 34.0 38.5 21.0 15.9 57.5 7.2 12.9 34.0 104.8 68.7 86.1 45.2 60.6 38.1 62.8 AEBP1 ACLP ENSG00000106624 "AE binding protein 1" Q8IUX7 7 44104361-44114562 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Calmodulin-binding, DNA-binding, Repressor" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 177.1" "Cell type enhanced" "Detected in many" 19 "Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 10.5" "Cell line enhanced" "Detected in many" "ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009966, HPA047724, HPA063595, HPA064970" Supported Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 2300000 Vesicles "Nucleoplasm, Cytosol" "CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394" "unprognostic (1.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.66e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.13e-1)" "unprognostic (7.00e-2)" "unprognostic (8.79e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "unprognostic (1.26e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (9.31e-9)" "unprognostic (2.88e-3)" "unprognostic (9.58e-2)" "unprognostic (1.17e-2)" "unprognostic (6.28e-3)" 46.5 19.0 8.9 23.9 9.5 3.1 90.9 1.7 5.4 78.1 20.5 17.9 15.8 5.8 73.7 39.4 20.7 43.7 47.9 35.4 12.7 6.4 19.6 6.3 35.5 13.0 12.5 10.8 84.8 8.8 2.7 10.9 26.7 17.2 46.1 7.9 33.3 11.9 70.2 11.4 19.7 16.9 42.6 43.7 16.6 17.6 30.6 9.6 48.0 19.6 12.3 7.5 58.2 177.1 2.3 10.5 0.0 0.0 0.2 1.4 0.4 0.1 0.0 10.8 0.0 34.9 12.4 0.2 45.9 30.3 5.2 1.1 0.0 0.0 1.2 5.1 49.3 0.0 0.0 0.5 0.8 2.2 0.1 0.0 3.1 0.0 0.0 9.8 0.0 0.0 18.8 0.0 17.7 0.0 0.2 2.3 34.8 1.9 0.0 0.0 0.0 19.9 3.7 4.6 0.0 0.0 16.5 0.4 0.3 1.2 0.0 1.1 6.1 0.0 0.0 20.1 10.6 0.1 3.3 8.0 0.0 21.3 0.1 0.0 0.2 0.2 24.2 0.1 0.0 28.2 0.0 0.0 0.0 0.4 0.0 0.3 2.1 0.4 0.0 0.0 2.3 1.4 0.8 0.0 0.2 0.0 10.5 0.0 0.4 8.9 9.5 1.7 5.4 12.7 6.4 12.5 10.8 17.2 9.6 0.0 4.5 6.7 5.4 30.7 0.2 15.5 0.0 4.0 2.3 7.0 0.0 1.7 0.0 0.8 2.0 14.4 0.0 0.0 0.0 2.6 159.0 2.4 2.3 0.0 3.1 0.0 0.0 38.6 1.9 9.5 140.4 3.8 81.0 1.0 0.0 0.1 0.7 0.0 478.4 0.6 0.6 38.8 174.1 2.4 4.5 24.0 2.9 0.7 0.0 2.0 AFAP1 "AFAP, AFAP-110" ENSG00000196526 "Actin filament associated protein 1" Q8N556 4 7758714-7939926 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 151.9;Extravillous trophoblasts: 100.0;Late spermatids: 257.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.0" "Group enriched" "Detected in many" 5 "granulocytes: 6.0;T-cells: 2.9" "Cell line enhanced" "Detected in many" "TIME: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015642, CAB024712" Enhanced Supported "Actin filaments,Focal adhesion sites,Cytosol" NA NA "Actin filaments, Cytosol" "Focal adhesion sites" "CAB024712: , HPA015642: AB_1844632" "unprognostic (1.12e-1)" "unprognostic (2.78e-2)" "unprognostic (3.97e-1)" "unprognostic (7.29e-2)" "unprognostic (2.02e-1)" "unprognostic (1.93e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (2.84e-4)" "unprognostic (2.00e-1)" "unprognostic (3.39e-2)" "unprognostic (3.40e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (8.18e-4)" "unprognostic (1.40e-2)" "unprognostic (1.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.44e-2)" 14.0 3.9 9.5 11.6 10.2 1.0 15.8 10.3 12.2 11.0 17.8 4.4 6.5 6.7 18.7 6.6 13.1 9.0 14.7 11.0 7.1 5.8 5.2 1.8 8.7 5.3 4.7 6.9 12.1 6.6 31.9 13.0 14.4 5.6 10.3 11.7 12.4 9.6 12.7 5.7 5.8 8.8 32.1 8.3 4.6 8.4 21.7 3.2 3.3 8.6 5.6 6.1 16.2 13.1 0.0 0.0 6.0 0.9 0.0 2.9 1.5 10.1 7.6 5.4 4.3 5.3 9.6 7.2 15.2 22.6 14.7 13.6 2.4 2.4 0.0 5.1 24.7 24.4 4.9 2.8 6.1 9.7 0.2 1.9 0.0 11.0 1.4 14.8 0.0 0.1 5.9 4.6 18.3 12.0 24.4 17.6 1.5 0.2 2.2 7.6 3.3 0.1 0.0 2.3 4.3 14.7 0.0 4.0 0.5 1.6 1.3 10.7 17.9 5.2 3.6 4.1 7.5 1.3 0.1 41.6 18.0 4.0 23.3 7.4 0.0 0.0 0.0 6.4 0.0 20.5 0.0 0.9 6.0 1.1 0.2 1.4 0.0 1.6 1.5 0.0 0.0 2.9 1.3 2.3 0.0 0.1 0.0 1.3 1.5 9.5 10.2 10.3 10.8 7.1 5.8 4.7 6.9 5.6 3.2 6.0 1.3 0.0 7.2 2.6 1.0 4.9 17.8 5.3 9.1 10.4 3.9 4.5 0.0 16.4 151.9 13.7 8.0 0.0 6.7 100.0 15.5 12.1 0.0 0.0 6.9 0.0 13.9 16.5 0.3 257.9 10.3 0.0 1.7 1.0 19.4 9.1 19.5 5.8 11.7 2.6 0.4 6.5 10.3 11.4 8.8 3.8 7.3 3.2 12.4 8.9 AFAP1L2 "Em:AC005383.4, FLJ14564, KIAA1914, XB130" ENSG00000169129 "Actin filament associated protein 1 like 2" Q8N4X5 10 114294824-114404756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 47.9" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 38.4;Sertoli cells: 19.4;Smooth muscle cells: 17.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 39.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 4.0;T-cells: 4.0" "Cell line enhanced" "Detected in some" "A-431: 26.4;CAPAN-2: 28.5;EFO-21: 21.2;HaCaT: 36.3;RPMI-8226: 18.6;RPTEC TERT1: 22.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "cerebellum: 169.5;olfactory region: 48.1" HPA037843 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA037843: AB_10669990" "unprognostic (2.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-1)" "unprognostic (5.06e-3)" "unprognostic (4.14e-2)" "unprognostic (9.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.55e-5)" "unprognostic (1.11e-1)" "unprognostic (3.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.86e-1)" 4.5 1.7 9.0 5.9 6.3 0.3 7.1 24.7 8.8 12.9 7.1 5.3 30.5 2.4 22.3 9.7 5.9 13.8 3.6 2.9 7.8 7.1 9.1 1.2 3.2 2.4 8.0 6.7 9.3 8.2 35.1 1.8 10.6 5.5 7.9 3.2 8.1 4.2 28.4 1.8 5.7 4.0 11.1 5.7 39.9 4.1 1.5 6.5 3.4 47.9 7.5 4.3 3.7 14.0 4.0 0.3 0.4 0.0 0.8 4.0 1.4 26.4 3.9 3.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 28.5 0.0 21.2 0.2 0.4 36.3 0.1 9.9 0.0 0.5 0.0 0.0 0.2 0.0 1.1 0.0 1.0 0.0 10.8 3.0 2.7 0.1 0.1 1.0 0.0 0.0 0.0 1.1 0.6 0.0 0.2 0.7 0.2 0.3 0.3 18.6 22.4 0.2 0.1 0.1 0.8 0.6 1.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.6 3.8 2.7 2.8 0.0 4.0 0.9 2.2 0.4 0.8 0.0 0.3 4.0 1.4 9.0 6.3 24.7 8.5 7.8 7.1 8.0 6.7 5.5 6.5 0.0 0.0 0.5 8.2 11.0 0.8 1.2 0.0 0.0 2.3 38.4 0.0 0.6 0.0 0.6 1.0 9.5 2.5 0.0 12.8 0.9 5.8 3.2 0.0 0.0 0.4 1.6 0.0 4.9 0.0 2.1 2.8 0.0 5.0 1.0 1.3 2.8 14.6 1.7 1.8 0.3 0.5 19.4 17.6 0.0 0.8 5.9 0.2 3.2 1.7 3.0 AFF3 "LAF4, MLLT2-like" ENSG00000144218 "AF4/FMR2 family member 3" P51826 2 99545419-100142739 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 79.7;Horizontal cells: 44.5" "Cancer enhanced" "Detected in many" "breast cancer: 11.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 16.2;naive B-cell: 27.5;plasmacytoid DC: 12.8" "Group enriched" "Detected in many" 16 "B-cells: 27.5;dendritic cells: 12.8" "Cell line enhanced" "Detected in many" "Daudi: 23.7;U-698: 35.1" "Low region specificity" "Detected in all" "HPA044512, HPA053379" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044512: AB_10795984, HPA053379: AB_2682133" "unprognostic (1.05e-2)" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.88e-3)" "unprognostic (1.02e-1)" "unprognostic (4.98e-5)" "unprognostic (1.11e-3)" "unprognostic (3.04e-2)" "unprognostic (8.75e-2)" "unprognostic (3.07e-1)" "unprognostic (1.95e-3)" "unprognostic (7.57e-2)" "prognostic unfavorable (5.64e-4)" "unprognostic (6.40e-3)" "unprognostic (6.79e-2)" "unprognostic (3.69e-2)" "unprognostic (7.87e-3)" 3.2 2.4 6.0 40.2 6.1 10.3 16.6 20.5 9.9 4.2 4.2 1.8 0.8 1.2 8.9 1.7 4.1 4.1 2.3 4.9 6.3 6.2 1.8 2.4 7.6 23.3 5.4 6.8 7.5 1.1 0.3 5.2 6.9 4.4 18.9 2.3 5.5 6.6 3.3 1.0 1.0 5.9 8.6 6.6 43.6 4.8 6.0 2.5 34.7 1.7 0.7 42.0 7.4 2.7 27.5 12.8 0.2 0.2 0.9 1.2 0.4 0.1 0.0 10.0 3.5 0.0 0.4 0.0 1.4 0.3 3.0 1.0 0.0 0.0 23.7 0.1 1.5 7.6 0.1 0.2 0.0 1.8 6.0 2.9 0.0 0.1 0.0 0.2 0.1 6.8 0.6 0.0 6.2 0.1 7.7 0.0 1.3 0.1 0.0 0.0 0.1 1.9 0.3 1.3 0.0 1.6 3.2 0.0 0.1 0.0 0.0 9.9 3.5 0.1 0.1 6.4 1.3 11.9 10.9 3.9 9.5 2.6 0.3 1.5 0.2 0.0 35.1 8.8 0.8 0.8 0.2 0.2 0.0 0.0 0.2 0.2 16.2 0.1 0.0 2.9 27.5 1.2 0.0 0.1 0.9 0.2 12.8 0.0 0.4 6.0 6.1 20.5 9.9 6.3 6.2 5.4 6.8 4.4 2.5 6.0 29.7 79.7 0.4 1.5 15.0 9.6 0.0 0.0 6.8 0.0 11.8 0.2 0.0 0.0 25.7 1.2 0.0 0.0 0.0 0.1 4.7 14.7 0.0 0.8 1.4 44.5 22.0 0.6 7.0 28.0 10.0 12.9 13.5 0.0 0.3 8.9 0.0 0.0 19.8 0.8 1.4 0.0 6.9 5.1 7.0 1.1 0.1 2.2 0.0 0.1 AFG1L "AFG1, LACE1" ENSG00000135537 "AFG1 like ATPase" Q8WV93 6 108294894-108526796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 10.7;Club cells: 9.1;Distal tubular cells: 8.3;Proximal tubular cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030154, HPA030155, HPA030659" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415" "unprognostic (9.76e-5)" "unprognostic (1.72e-1)" "unprognostic (1.68e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-1)" "unprognostic (7.04e-2)" "unprognostic (2.57e-1)" "unprognostic (5.53e-2)" "unprognostic (2.35e-3)" "unprognostic (1.48e-1)" "unprognostic (2.73e-2)" "unprognostic (9.61e-2)" "unprognostic (8.40e-8)" "unprognostic (2.03e-2)" "unprognostic (2.03e-1)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 4.9 7.3 7.6 6.5 6.6 4.3 5.7 6.2 7.3 4.1 5.7 7.3 6.9 8.9 3.7 4.9 5.5 5.1 4.8 9.4 6.3 4.9 11.0 7.6 9.1 4.8 7.3 7.4 4.1 5.2 11.6 6.9 4.7 6.1 3.9 7.0 5.5 4.7 5.4 9.0 4.2 6.3 4.0 5.6 4.4 6.0 25.4 6.5 5.6 6.6 4.1 4.5 4.8 4.3 5.7 3.0 5.1 7.2 4.2 4.4 1.7 3.5 1.9 4.7 8.2 4.8 7.1 4.6 3.9 5.9 6.6 6.5 7.4 4.4 6.3 5.3 6.1 7.8 2.0 5.9 5.9 7.4 3.6 3.5 7.5 2.4 8.6 4.8 6.6 3.7 6.6 4.9 4.9 8.0 4.2 3.5 4.8 7.5 3.0 6.1 3.3 1.2 6.2 3.0 6.0 3.7 4.4 6.3 3.6 8.2 3.9 5.1 4.5 3.3 4.7 8.7 6.5 3.8 13.0 4.3 4.0 1.0 3.5 4.5 2.1 3.2 4.9 5.0 7.9 6.1 0.0 3.1 5.1 2.0 2.2 2.6 4.8 3.2 3.8 2.7 5.7 4.4 2.9 0.8 4.2 7.2 3.0 4.1 1.7 7.6 6.6 6.2 7.3 6.3 4.9 7.3 7.4 6.1 6.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 10.7 9.1 3.5 0.0 5.1 8.3 2.7 0.0 0.0 0.0 0.0 3.3 4.1 0.0 0.0 2.3 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.9 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 AFP "FETA, HPAFP" ENSG00000081051 "Alpha fetoprotein" P02771 4 73431138-73456174 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "heart muscle: 4.3;liver: 9.6;lung: 2.9" "Group enriched" "Detected in some" 10 "Hepatocytes: 99.9;Proximal tubular cells: 38.7" "Group enriched" "Detected in some" 14 "liver cancer: 208.8;testis cancer: 49.4" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 190 "Hep G2: 219.7" "Region enhanced" "Detected in single" "cerebellum: 0.8" "Not detected" "Not detected" "HPA010607, HPA023600, CAB024283, CAB025339" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 3010000 930000 "Golgi apparatus" Cytosol "CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769" "unprognostic (4.69e-1)" "unprognostic (1.87e-1)" "unprognostic (3.34e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-3)" "unprognostic (2.95e-2)" "unprognostic (3.35e-1)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-6)" "unprognostic (1.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.14e-1)" 0.0 0.4 0.1 0.0 1.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.3 0.3 0.0 0.0 9.6 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 219.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 6.6 0.0 0.0 0.0 0.3 0.0 2.4 0.7 0.3 0.0 0.0 99.9 2.1 0.0 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 AFTPH "FLJ20080, FLJ23793, MGC33965, Nbla10388" ENSG00000119844 Aftiphilin Q6ULP2 2 64524305-64593005 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034990, HPA034991" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA Cytosol "Golgi apparatus, Vesicles" "HPA034990: AB_2674398, HPA034991: AB_10603577" "unprognostic (7.30e-2)" "unprognostic (4.72e-2)" "unprognostic (9.16e-2)" "unprognostic (8.54e-2)" "unprognostic (3.24e-1)" "unprognostic (4.25e-2)" "unprognostic (2.54e-2)" "unprognostic (1.75e-2)" "unprognostic (1.52e-1)" "unprognostic (8.44e-2)" "unprognostic (3.42e-2)" "unprognostic (4.65e-2)" "prognostic favorable (2.37e-5)" "prognostic favorable (8.44e-4)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "prognostic favorable (1.83e-4)" 12.4 14.8 18.0 25.8 20.0 11.4 20.8 29.8 22.9 14.9 20.1 9.5 16.7 14.1 12.9 28.6 20.7 14.7 16.9 13.5 15.6 14.5 34.8 20.3 18.7 20.7 12.8 21.4 13.1 19.4 26.8 22.6 9.8 16.3 22.3 21.5 9.8 18.5 17.4 12.2 21.8 19.0 14.7 12.2 17.1 20.0 15.1 16.7 20.0 16.0 9.9 24.7 16.5 20.9 16.4 11.8 21.4 10.2 4.9 9.0 4.2 14.0 9.3 6.9 8.3 9.0 7.7 11.5 8.1 12.1 13.3 10.1 10.7 10.7 20.9 8.0 9.9 15.5 11.4 12.0 11.2 17.4 20.2 6.6 9.9 5.9 12.5 9.5 18.9 17.1 3.8 24.0 8.6 19.8 9.9 10.4 10.6 7.4 19.0 8.2 8.0 10.2 23.2 6.4 26.6 7.0 8.4 11.2 13.5 24.1 15.1 12.9 6.5 8.5 19.6 16.6 9.3 11.8 14.6 8.9 10.0 11.5 8.4 8.9 21.5 12.7 32.2 7.5 21.6 11.0 21.4 6.9 11.6 5.8 6.7 6.9 16.4 7.3 7.0 9.0 14.8 7.0 5.6 12.1 4.9 10.2 11.8 9.0 4.2 18.0 20.0 29.8 22.9 15.6 14.5 12.8 21.4 16.3 16.7 23.8 34.9 38.0 28.0 109.0 24.1 12.2 38.2 36.1 36.4 19.2 19.6 11.7 31.5 20.6 25.3 24.5 36.1 46.7 22.5 9.6 19.7 47.3 45.1 31.0 18.9 35.0 44.7 18.4 49.2 43.0 14.7 40.2 21.9 36.1 37.7 38.6 23.4 40.3 19.4 57.5 29.8 25.8 17.6 30.9 18.8 107.9 22.8 26.7 37.0 44.4 AGAP2 CENTG1 ENSG00000135439 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 2" Q99490 12 57723761-57742157 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.9;lymphoid tissue: 18.8" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 7.5;Horizontal cells: 7.9;Sertoli cells: 32.3;T-cells: 12.1" "Cancer enriched" "Detected in many" 12 "glioma: 20.6" "Group enriched" "Detected in many" 4 "amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 18.0;Karpas-707: 17.5;RH-30: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023474, HPA075831" Enhanced Supported "Nucleoplasm,Midbody ring,Cytosol" NA NA "Nucleoplasm, Cytosol" "Midbody ring" "HPA023474: AB_1855378, HPA075831: " "unprognostic (1.87e-1)" "unprognostic (2.46e-3)" "unprognostic (9.26e-2)" "unprognostic (5.56e-4)" "unprognostic (3.95e-1)" "unprognostic (1.14e-2)" "unprognostic (5.00e-2)" "unprognostic (2.36e-2)" "unprognostic (3.39e-1)" "unprognostic (2.80e-1)" "unprognostic (1.93e-3)" "unprognostic (4.18e-1)" "unprognostic (4.81e-9)" "unprognostic (3.30e-1)" "unprognostic (2.72e-2)" "unprognostic (3.07e-1)" "unprognostic (5.75e-2)" 3.8 1.8 34.3 11.8 40.2 8.1 0.7 48.2 55.9 0.6 2.1 1.2 0.0 2.0 1.5 0.9 1.6 0.8 2.8 4.3 37.6 8.9 1.2 0.8 2.2 13.5 6.3 3.1 1.2 2.4 1.7 1.2 1.7 2.5 1.0 1.2 0.7 4.5 0.9 8.3 2.1 2.2 0.8 2.1 10.0 2.1 0.9 0.7 18.8 0.9 1.5 16.6 2.9 0.6 1.9 1.4 6.3 1.2 2.3 6.3 1.7 3.0 4.5 8.7 2.5 0.0 0.0 5.0 2.1 0.4 0.0 0.2 0.5 2.9 7.9 0.6 0.0 1.6 1.9 0.0 0.0 0.0 8.6 1.3 8.7 0.7 1.4 0.0 8.9 18.0 0.0 0.0 0.0 0.0 3.7 0.0 9.3 0.0 17.5 0.0 5.3 15.7 5.7 1.4 0.9 4.6 6.5 43.8 5.7 0.0 2.6 2.5 9.1 1.1 1.6 1.8 0.0 1.1 6.3 4.8 2.4 4.1 4.6 1.5 7.4 4.4 3.9 4.4 5.9 4.1 6.0 0.8 1.0 4.8 1.2 5.1 1.9 4.8 5.1 1.4 1.6 2.0 3.0 6.3 2.3 0.7 1.2 6.3 1.7 34.3 40.2 48.2 35.4 37.6 8.9 6.3 3.1 2.5 0.7 3.0 0.6 4.1 0.2 0.0 7.5 2.2 2.5 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.4 0.2 2.3 0.0 1.4 7.9 0.0 0.6 0.6 0.7 0.0 1.6 0.0 3.6 0.3 0.1 0.1 0.0 0.7 0.0 1.9 32.3 1.2 0.7 0.4 0.4 0.0 12.1 0.1 0.0 AGBL3 "CCP3, MGC32955" ENSG00000146856 "ATP/GTP binding protein like 3" Q8NEM8 7 134986508-135147963 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 40.4;Spermatocytes: 19.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020397, HPA024150" Uncertain Approved Cytosol NA No Cytosol "HPA020397: AB_2242453, HPA024150: AB_1844639" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (4.72e-2)" "unprognostic (2.18e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-3)" "unprognostic (3.32e-3)" "unprognostic (4.18e-2)" "unprognostic (7.15e-4)" "unprognostic (5.00e-3)" "unprognostic (6.10e-4)" "unprognostic (3.16e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (2.18e-2)" "unprognostic (2.14e-1)" "unprognostic (8.13e-2)" "unprognostic (1.11e-3)" 3.2 2.7 4.2 4.1 8.4 3.8 4.6 8.7 4.5 4.3 2.4 4.4 4.5 1.6 5.5 15.4 2.2 3.6 3.1 2.4 5.0 3.4 5.3 2.6 3.6 4.0 2.7 4.5 6.8 4.5 0.6 9.2 1.9 3.3 3.8 3.0 3.1 4.9 4.3 4.2 4.7 3.7 3.3 2.9 6.5 4.4 18.7 3.7 2.7 5.4 0.8 2.8 3.3 2.5 2.2 1.7 0.5 0.2 2.2 5.0 1.7 2.6 1.4 3.6 0.8 1.0 1.4 2.2 0.7 0.0 0.5 0.8 4.7 3.0 4.3 1.3 0.0 1.4 2.8 1.3 0.5 0.0 3.4 8.8 3.6 5.3 4.6 0.0 1.6 0.0 0.2 0.0 2.1 0.0 0.0 1.6 4.7 2.6 2.5 0.6 2.5 0.9 1.5 3.1 0.4 0.3 2.5 0.2 1.2 2.6 0.5 2.1 2.4 0.5 0.0 0.3 0.1 1.9 3.5 0.0 0.4 0.9 0.5 1.6 5.3 1.6 1.9 1.8 4.3 4.4 0.0 0.2 0.4 2.4 0.0 1.8 2.1 1.2 2.5 0.5 2.2 2.0 5.0 0.5 2.2 0.1 1.7 1.7 1.7 4.2 8.4 8.7 4.5 5.0 3.4 2.7 4.5 3.3 3.7 3.0 1.1 1.3 1.0 1.1 4.9 1.6 5.1 5.3 2.3 8.7 2.0 0.2 6.6 3.1 40.4 3.8 0.3 0.0 2.5 0.3 1.4 1.5 1.1 1.6 0.4 3.2 2.9 5.5 1.6 8.5 3.1 0.3 5.0 11.8 0.3 2.7 1.6 0.0 2.1 5.1 2.9 0.0 2.3 19.5 3.6 0.3 0.1 1.0 0.0 0.8 AGBL5 "CCP5, FLJ21839" ENSG00000084693 "ATP/GTP binding protein like 5" Q8NDL9 2 27042364-27070622 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 91.6" "Group enriched" "Detected in many" 7 "Early spermatids: 249.1;Late spermatids: 264.5;Spermatocytes: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030981 Uncertain Supported "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cytokinetic bridge" "Microtubules, Cytosol" "HPA030981: AB_10611673" "unprognostic (1.29e-2)" "unprognostic (8.70e-2)" "unprognostic (2.26e-1)" "unprognostic (3.13e-3)" "unprognostic (1.95e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.86e-1)" "unprognostic (4.34e-1)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (3.41e-2)" "unprognostic (5.56e-2)" "unprognostic (2.05e-1)" "unprognostic (1.69e-2)" "unprognostic (4.50e-2)" 3.8 8.1 3.9 3.5 4.8 3.8 4.2 3.1 6.6 5.0 6.8 6.6 11.7 2.8 5.4 9.3 6.3 7.2 6.6 4.1 3.4 3.9 8.2 3.0 3.6 3.2 3.5 3.4 5.9 5.9 11.2 6.2 6.3 5.4 6.8 3.8 7.7 8.2 5.9 2.6 6.8 3.9 8.6 3.4 4.6 5.4 91.6 3.5 8.4 9.9 4.9 4.4 7.8 3.5 5.7 5.4 7.1 2.3 11.2 6.3 4.6 23.0 15.0 24.5 16.3 5.2 10.5 27.4 4.7 10.3 13.7 14.2 12.9 17.7 12.8 14.9 8.1 19.3 10.6 19.6 21.4 15.2 10.7 29.0 18.7 18.7 27.8 10.6 9.0 6.3 11.0 16.2 12.0 9.9 21.0 14.3 18.7 16.0 10.4 13.2 9.1 26.2 13.6 17.3 16.8 10.3 27.1 27.7 20.0 14.1 5.9 16.4 23.5 9.3 7.3 15.2 25.1 11.0 7.0 6.8 12.8 17.6 6.1 10.1 20.8 10.9 26.2 14.2 10.4 11.4 7.1 2.3 5.7 4.5 1.3 3.4 5.7 5.7 6.3 5.4 3.0 5.1 2.8 1.4 11.2 0.9 3.0 3.6 4.6 3.9 4.8 3.1 6.6 3.4 3.9 3.5 3.4 5.4 3.5 0.0 8.5 1.9 5.9 3.0 4.9 5.0 12.7 1.4 5.7 8.7 0.0 12.8 16.6 7.0 249.1 3.6 4.6 0.0 5.2 6.0 4.1 6.6 1.1 3.4 4.4 0.0 2.4 6.2 2.7 264.5 9.8 5.3 6.8 6.4 8.7 4.4 4.8 7.0 10.6 18.1 8.7 0.0 5.8 150.8 30.0 2.4 7.0 4.1 8.4 6.8 AGL ENSG00000162688 "Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" P35573 1 99850084-99924023 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycogen biosynthesis" "Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 23.1;skeletal muscle: 85.6;tongue: 34.4" "Cell type enhanced" "Detected in all" 6 "Muller glia cells: 151.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028498, HPA054340" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 16000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA028498: AB_10600975, HPA054340: AB_2682455" "unprognostic (2.90e-1)" "unprognostic (5.34e-2)" "unprognostic (3.99e-3)" "unprognostic (2.18e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "unprognostic (1.12e-1)" "unprognostic (1.92e-2)" "unprognostic (9.37e-3)" "unprognostic (1.11e-1)" "unprognostic (8.10e-3)" "unprognostic (7.61e-2)" "prognostic favorable (1.73e-10)" "unprognostic (6.38e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" "unprognostic (7.13e-2)" 5.0 4.5 2.5 4.7 3.6 2.0 4.2 5.4 6.1 3.4 4.5 2.1 5.4 3.3 4.8 4.2 9.1 4.1 2.6 8.2 2.2 2.3 5.8 23.1 4.2 5.3 2.4 4.2 3.8 3.6 8.7 4.7 4.8 2.9 5.5 4.2 3.9 5.1 8.7 85.6 3.7 4.0 5.4 2.8 4.8 4.4 2.9 1.2 7.1 4.3 34.4 3.4 6.7 3.6 3.0 2.3 3.5 1.6 6.1 4.3 2.1 12.1 3.6 4.3 7.0 7.1 6.8 14.5 3.8 5.7 3.4 6.0 13.5 4.1 15.9 7.4 6.5 3.0 6.9 25.1 7.5 6.4 8.4 7.9 9.2 12.4 7.5 4.7 8.2 5.6 8.2 4.9 4.7 3.9 4.8 5.3 5.6 15.2 1.1 3.5 3.8 9.6 2.6 6.8 5.4 4.6 0.0 1.4 0.8 10.3 16.4 10.7 7.4 11.1 10.7 6.0 8.4 7.7 5.5 5.4 4.1 5.9 5.5 3.7 4.5 3.6 18.4 7.2 2.2 2.1 0.1 1.3 3.5 4.3 1.6 4.1 3.0 3.2 2.9 2.3 2.9 3.2 3.2 1.5 6.1 0.9 2.1 3.3 2.1 2.5 3.6 5.4 6.1 2.2 2.3 2.4 4.2 2.9 1.2 20.8 23.2 15.3 15.5 9.4 36.9 94.9 20.4 29.4 29.6 15.7 51.1 77.6 19.9 11.9 1.1 10.8 15.8 23.3 11.2 17.2 13.6 9.9 10.4 84.7 15.8 49.3 16.1 16.0 16.2 1.1 9.5 9.2 15.1 10.8 18.2 151.6 14.2 10.5 20.1 16.3 47.8 6.5 14.2 8.1 11.7 8.2 24.4 15.0 17.4 16.6 AGO1 "EIF2C1, hAGO1" ENSG00000092847 "Argonaute 1, RISC catalytic component" Q9UL18 1 35869808-35930528 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Repressor, Ribonucleoprotein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067849 Supported "Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Cytosol "HPA067849: " "unprognostic (2.35e-1)" "unprognostic (3.14e-2)" "unprognostic (1.27e-2)" "unprognostic (8.66e-3)" "unprognostic (1.20e-1)" "unprognostic (3.71e-2)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.61e-2)" "unprognostic (6.08e-2)" "unprognostic (1.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.60e-4)" "unprognostic (7.52e-2)" "unprognostic (1.74e-1)" "unprognostic (7.57e-2)" "unprognostic (5.77e-3)" 12.3 15.9 16.6 14.4 19.0 11.3 11.2 23.3 21.3 15.7 12.1 22.2 19.0 13.2 14.3 9.3 11.7 13.8 11.3 14.0 15.7 13.8 11.7 8.6 11.8 14.3 14.5 20.0 17.2 12.6 21.6 13.5 9.8 16.3 15.4 12.8 13.0 11.7 22.3 14.8 16.3 13.8 15.7 13.7 15.7 12.2 10.7 16.4 13.1 12.2 8.3 14.4 12.4 11.5 2.3 2.5 3.7 7.1 2.1 3.1 4.9 8.2 5.4 13.2 11.6 8.2 5.0 13.6 4.5 6.8 8.0 7.4 9.9 5.4 9.0 5.6 8.9 5.5 4.0 18.9 7.1 9.4 8.9 5.9 19.6 8.8 7.6 3.2 11.6 7.9 4.2 2.5 13.3 6.9 4.6 11.3 8.4 13.2 5.6 5.7 4.5 12.1 5.0 28.3 9.9 4.5 9.0 9.9 3.9 2.6 10.8 16.2 6.7 14.5 5.7 4.8 14.7 4.8 3.9 7.8 5.9 12.9 8.0 8.2 5.6 4.5 4.6 6.4 6.5 7.6 2.7 5.6 2.6 3.1 7.1 3.0 2.3 2.6 2.9 2.4 2.3 2.8 2.9 3.7 2.1 5.6 2.5 2.4 4.9 16.6 19.0 23.3 21.3 15.7 13.8 14.5 20.0 16.3 16.4 3.0 9.4 14.9 5.9 12.4 32.3 11.5 12.7 8.1 9.1 14.0 37.3 4.4 1.7 9.9 4.5 11.7 12.6 0.0 11.4 4.2 7.4 8.4 16.1 11.3 12.2 33.4 24.9 9.8 20.4 5.5 13.8 12.5 5.0 7.2 16.1 12.5 9.8 10.5 19.4 9.2 31.5 12.9 10.4 9.2 15.6 12.7 1.9 8.6 15.2 6.0 AGO2 "CASC7, EIF2C2, hAGO2, LINC00980, Q10" ENSG00000123908 "Argonaute 2, RISC catalytic component" Q9UKV8 8 140520156-140635619 "Enzymes, Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019309, HPA067849" Approved Supported "Cytosol,Cytoplasmic bodies" NA NA 35000000 "Cytoplasmic bodies" Cytosol "CAB019309: , HPA067849: " "unprognostic (2.75e-2)" "unprognostic (1.79e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.46e-1)" "unprognostic (2.15e-1)" "unprognostic (1.49e-3)" "unprognostic (8.86e-2)" "unprognostic (2.21e-1)" "unprognostic (8.50e-2)" "unprognostic (3.47e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.82e-5)" "unprognostic (1.32e-1)" "unprognostic (2.77e-1)" "unprognostic (1.32e-1)" "unprognostic (3.02e-1)" 11.2 6.6 7.7 9.9 13.1 16.2 25.0 9.9 11.4 7.5 9.2 12.1 12.8 5.3 10.2 10.4 10.6 8.6 8.8 12.4 8.8 5.3 6.9 7.4 13.2 12.5 13.4 5.0 11.8 8.4 13.2 8.8 9.9 10.7 7.5 6.9 5.6 8.1 12.6 37.1 14.1 7.5 15.0 11.7 6.9 10.0 5.9 12.7 11.1 8.6 8.2 8.9 10.4 18.4 2.5 2.1 6.4 2.6 2.4 3.0 1.5 12.8 10.6 10.9 12.4 7.1 8.4 9.2 8.1 5.9 3.6 4.5 11.7 3.9 14.7 10.2 7.8 3.9 8.7 18.4 8.7 8.1 8.3 9.6 17.2 18.2 7.4 6.5 7.1 5.9 5.7 7.9 10.0 10.5 5.0 8.4 9.3 18.0 9.3 11.8 19.4 12.2 5.6 8.0 8.8 18.5 12.6 9.2 6.6 4.6 13.3 12.8 9.3 12.6 4.3 9.0 11.7 11.1 10.3 11.7 6.3 17.6 9.9 12.9 8.2 2.7 10.4 4.7 12.9 9.3 1.8 2.6 0.7 2.7 2.3 3.0 1.3 2.6 2.3 2.1 2.5 2.7 2.7 6.4 2.4 2.3 1.5 2.1 1.5 7.7 13.1 9.9 11.4 8.8 5.3 13.4 5.0 10.7 12.7 20.8 21.4 18.4 57.8 19.5 24.7 19.4 10.2 24.1 36.4 14.0 41.2 36.5 6.6 23.4 15.7 24.8 9.7 70.0 15.6 17.2 23.7 85.4 16.2 12.4 13.3 39.7 23.3 25.8 23.8 10.0 34.5 19.0 5.0 22.6 22.7 30.6 29.0 17.5 43.5 7.4 29.6 32.3 13.1 3.2 1.4 20.8 66.1 25.4 19.6 78.7 AGO3 "EIF2C3, FLJ12765, hAGO3" ENSG00000126070 "Argonaute 3, RISC catalytic component" Q9H9G7 1 35930718-36072500 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048342, HPA067849, HPA075436" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "Nucleoplasm, Cytosol" "HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750" "unprognostic (4.10e-2)" "unprognostic (7.10e-2)" "unprognostic (4.94e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (1.89e-2)" "unprognostic (2.12e-2)" "unprognostic (4.39e-4)" "unprognostic (5.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-1)" "unprognostic (4.97e-2)" "unprognostic (2.96e-2)" "unprognostic (9.28e-3)" "unprognostic (1.61e-1)" "unprognostic (4.45e-2)" "unprognostic (9.06e-2)" "unprognostic (1.81e-1)" 9.8 8.1 8.8 16.2 11.7 20.6 9.6 12.8 9.6 9.4 7.4 13.8 10.4 4.6 9.5 10.9 7.8 7.4 8.8 9.5 8.0 7.4 8.2 11.3 9.6 9.3 11.5 6.1 10.8 9.7 13.3 28.0 11.0 9.1 9.8 7.1 8.7 7.7 14.1 8.3 12.5 7.3 12.0 10.9 8.3 8.0 21.4 13.5 14.4 9.7 4.7 10.1 8.4 13.9 6.5 5.1 14.0 6.0 6.0 5.5 2.3 6.6 4.6 5.9 4.6 8.3 5.0 7.1 5.5 5.8 8.5 9.1 5.0 7.5 7.4 6.8 5.6 9.8 5.6 6.3 4.0 11.4 10.2 3.9 9.0 8.0 3.8 4.4 8.7 7.6 2.4 3.6 12.2 7.7 3.4 7.2 7.8 9.7 10.8 7.4 2.5 6.3 4.7 10.2 3.5 8.1 7.7 7.9 7.3 2.7 6.5 7.2 4.5 9.8 2.5 3.4 9.4 3.7 3.6 5.6 5.9 15.1 5.2 5.9 6.0 10.3 10.3 3.0 5.6 5.7 8.5 4.7 13.2 5.5 4.2 3.5 6.2 3.6 3.9 5.1 6.5 5.0 5.0 14.0 6.0 6.0 4.5 3.4 2.3 8.8 11.7 12.8 9.6 8.0 7.4 11.5 6.1 9.1 13.5 80.4 42.9 19.0 30.7 34.5 67.6 16.7 7.6 12.0 26.1 24.4 106.0 9.2 0.0 13.1 43.3 29.9 12.7 0.0 10.6 11.0 30.1 30.9 56.4 20.3 14.3 39.7 44.9 31.3 28.4 54.4 35.1 34.5 21.9 14.4 14.3 46.3 13.7 7.0 38.9 6.7 82.2 19.4 33.0 33.1 19.8 29.4 10.8 27.7 16.3 25.0 AGO4 "EIF2C4, FLJ20033, hAGO4, KIAA1567" ENSG00000134698 "Argonaute 4, RISC catalytic component" Q9HCK5 1 35808172-35857890 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 21.6" "Low region specificity" "Detected in all" "CAB012179, HPA067849" Approved Supported "Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Cytosol "CAB012179: , HPA067849: " "unprognostic (2.67e-2)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (5.01e-2)" "unprognostic (1.76e-1)" "prognostic favorable (5.70e-5)" "unprognostic (3.92e-3)" "unprognostic (3.99e-3)" "unprognostic (2.32e-2)" "unprognostic (9.28e-2)" "unprognostic (3.16e-1)" "unprognostic (2.45e-3)" "unprognostic (4.91e-3)" "unprognostic (4.96e-2)" "unprognostic (2.58e-1)" "unprognostic (3.96e-1)" "unprognostic (1.58e-2)" 10.8 6.3 8.4 11.5 9.5 24.2 10.2 16.2 12.7 11.1 11.8 16.4 9.9 6.5 16.2 11.1 10.0 9.2 10.8 14.7 8.8 7.9 6.5 9.0 14.4 18.1 9.6 11.1 9.7 11.2 13.0 7.8 12.1 7.9 12.6 9.0 12.4 10.8 9.0 16.0 26.8 10.6 13.6 7.6 18.7 11.8 16.1 12.0 9.6 7.4 9.1 9.1 13.2 13.6 0.8 2.9 10.7 3.7 0.8 2.1 1.1 5.2 1.3 10.2 5.8 5.4 6.2 5.2 4.0 4.0 4.2 4.8 0.7 8.0 8.4 5.5 5.8 4.3 2.1 4.4 3.2 4.0 9.2 4.0 4.2 3.5 2.4 5.1 4.8 6.6 3.9 6.9 2.3 3.5 8.0 7.1 10.2 3.2 3.4 5.5 0.8 7.7 5.4 3.3 3.3 2.4 7.8 9.2 1.0 4.1 6.6 4.5 6.6 3.6 3.3 11.2 9.2 2.7 21.6 8.4 3.2 1.6 3.2 3.0 4.9 1.6 1.3 3.9 6.2 2.8 1.8 3.7 4.1 1.4 2.1 2.1 0.8 1.1 1.6 2.9 0.7 0.5 0.7 10.7 0.8 1.9 0.6 0.3 1.1 8.4 9.5 16.2 12.7 8.8 7.9 9.6 11.1 7.9 12.0 17.9 20.0 7.3 3.9 8.8 25.1 19.3 20.4 8.1 10.3 10.4 21.6 3.5 1.7 5.4 1.7 8.7 6.7 0.0 4.9 4.0 5.4 7.4 2.3 9.7 11.6 6.4 12.1 19.6 49.2 1.0 4.6 18.3 3.3 5.4 9.7 6.7 10.6 9.1 5.3 1.2 33.7 19.4 4.2 6.6 1.6 11.2 3.4 9.6 6.0 3.8 AGRN AGRIN ENSG00000188157 Agrin O00468 1 1020123-1056118 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Developmental protein" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 79.0;Collecting duct cells: 148.3;Ductal cells: 85.5;Pancreatic endocrine cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 46.4;EFO-21: 54.1;HaCaT: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040090 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 15000000 Cytosol "Plasma membrane" "HPA040090: AB_10805603" "unprognostic (8.04e-2)" "unprognostic (8.25e-3)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.82e-3)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (9.49e-3)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (8.49e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-1)" "unprognostic (1.31e-2)" 10.2 2.8 13.0 5.3 12.4 2.9 8.3 2.3 24.0 11.3 8.5 20.5 8.9 9.8 8.2 14.5 8.8 11.4 37.2 8.1 10.9 8.3 36.0 9.3 18.1 2.3 9.3 7.0 7.6 25.2 5.7 5.0 11.0 12.7 8.7 2.5 13.6 26.5 10.8 4.7 18.6 11.2 3.9 7.7 7.2 14.1 7.5 8.1 6.4 27.0 9.5 7.6 13.7 6.2 0.0 0.1 0.0 0.5 0.0 1.1 0.1 27.0 16.8 3.3 10.9 0.5 0.7 29.4 13.7 4.4 9.2 5.6 14.1 46.4 0.5 54.1 2.1 4.5 47.1 1.1 16.9 1.1 1.0 6.4 0.0 22.0 14.8 3.9 0.3 5.5 2.4 7.3 2.9 6.4 12.8 1.6 0.4 5.6 0.1 0.7 22.2 0.2 3.8 7.0 8.7 12.3 4.3 6.4 4.0 16.1 12.1 0.8 6.5 27.8 30.1 26.5 3.3 26.5 2.1 23.9 11.3 40.0 1.5 11.0 0.3 0.2 1.0 7.1 2.5 3.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 13.0 12.4 2.3 22.0 10.9 8.3 9.3 7.0 12.7 8.1 23.8 9.1 2.4 7.5 13.4 0.8 2.2 79.0 5.3 14.8 148.3 7.9 1.1 1.7 85.5 0.1 17.9 18.6 0.0 14.5 4.6 5.6 15.4 2.3 8.9 3.9 4.8 6.4 13.5 2.1 0.8 5.2 3.1 23.6 27.1 10.4 10.0 62.9 14.0 2.5 11.3 5.4 6.5 8.5 0.5 9.6 5.3 1.0 1.0 18.4 13.7 AHCY SAHH ENSG00000101444 Adenosylhomocysteinase P23526 20 34280268-34311802 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "One-carbon metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 192.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041225, HPA044675" Approved Supported Cytosol NA NA 3900000 Cytosol "HPA041225: AB_2677371, HPA044675: AB_2679041" "unprognostic (3.35e-1)" "unprognostic (2.17e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-2)" "unprognostic (7.74e-2)" "unprognostic (3.15e-2)" "unprognostic (7.34e-3)" "unprognostic (1.10e-1)" "unprognostic (8.88e-2)" "unprognostic (2.61e-1)" "unprognostic (4.21e-2)" "unprognostic (1.24e-1)" "unprognostic (5.27e-2)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.88e-1)" "unprognostic (2.93e-3)" 15.3 18.6 11.7 15.4 15.0 17.0 24.3 6.3 16.4 25.1 30.0 14.7 18.4 24.6 20.2 23.9 43.4 26.6 22.4 26.0 12.0 12.8 52.2 99.8 19.1 18.1 16.0 10.6 39.1 72.0 15.7 15.0 44.5 13.2 26.9 20.2 14.4 32.4 18.3 48.2 14.8 20.4 18.8 15.7 17.9 22.2 33.3 13.4 25.0 52.8 31.0 29.2 18.2 20.5 9.1 24.1 2.3 26.0 4.6 7.4 11.4 37.4 49.1 20.8 36.7 24.3 26.2 23.9 15.4 22.1 34.3 27.3 132.5 32.4 58.3 27.5 19.7 22.2 43.0 48.9 86.4 22.1 7.7 29.7 70.3 24.4 85.2 26.2 32.8 23.1 54.2 39.4 21.3 34.3 18.4 23.4 21.7 34.2 14.8 18.2 39.6 42.8 31.0 26.7 48.0 47.9 32.2 53.0 41.0 30.7 26.6 36.1 24.0 30.7 36.5 51.0 17.2 54.8 30.6 14.8 29.9 31.9 15.1 29.0 22.1 32.3 35.1 22.0 20.3 15.9 2.3 13.7 0.4 4.1 26.0 6.7 9.1 6.0 5.3 21.1 7.8 6.6 7.4 1.1 4.6 16.5 24.1 6.7 11.4 11.7 15.0 6.3 16.4 12.0 12.8 16.0 10.6 13.2 13.4 38.7 21.0 33.5 72.2 32.5 11.9 44.7 25.5 17.4 29.6 26.2 0.0 93.3 49.7 60.3 58.3 23.6 33.8 0.0 70.9 130.4 41.1 68.4 20.7 56.7 103.0 11.1 20.2 16.5 33.2 135.4 39.4 28.0 25.3 26.2 64.7 41.2 59.2 24.6 38.2 192.2 10.2 12.9 38.1 20.7 47.5 34.5 76.9 18.5 111.0 66.8 AHCYL1 "IRBIT, PPP1R78, XPVKONA" ENSG00000168710 "Adenosylhomocysteinase like 1" O43865 1 109984686-110023741 "Predicted intracellular proteins" "One-carbon metabolism" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042589 Approved Supported Cytosol NA NA Cytosol "HPA042589: AB_10793885" "unprognostic (8.72e-2)" "unprognostic (2.34e-1)" "prognostic favorable (7.00e-4)" "unprognostic (1.83e-3)" "unprognostic (5.01e-2)" "unprognostic (1.81e-1)" "unprognostic (2.72e-2)" "unprognostic (3.09e-2)" "unprognostic (1.32e-1)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.68e-1)" "unprognostic (2.38e-2)" "unprognostic (3.79e-2)" "unprognostic (2.89e-1)" "unprognostic (8.87e-2)" "unprognostic (4.84e-3)" 24.0 25.7 61.7 11.7 71.2 4.8 19.7 33.2 61.4 26.7 26.3 47.7 17.7 46.5 21.0 36.0 18.3 28.0 24.7 13.9 51.6 57.2 38.6 25.4 16.5 10.5 72.3 49.9 17.6 27.1 53.0 16.3 20.6 55.7 17.3 19.7 9.7 17.9 25.8 27.1 14.2 22.9 21.8 48.8 12.1 19.6 10.2 47.5 6.8 28.6 8.6 13.4 16.7 15.3 8.0 6.2 8.7 9.3 3.9 8.2 3.7 22.7 19.4 18.3 18.9 44.3 26.1 30.2 18.1 20.5 17.2 17.0 15.0 13.2 9.7 15.5 26.7 13.1 14.7 16.2 20.7 22.8 81.2 14.0 16.0 25.2 15.8 46.0 13.7 11.3 26.6 13.1 21.4 31.4 42.0 21.6 16.5 11.5 19.7 17.7 18.1 11.4 6.8 21.6 32.2 15.0 12.4 38.1 10.7 37.6 23.1 17.9 11.6 28.1 33.7 37.7 29.2 18.0 13.8 18.6 16.6 16.3 19.5 16.0 16.3 6.7 8.3 34.1 15.1 33.8 5.0 8.8 7.7 4.3 9.3 4.4 6.8 4.4 5.7 6.2 8.0 4.6 4.4 8.7 3.9 6.3 5.7 8.2 3.7 61.7 71.2 33.2 51.5 51.6 57.2 72.3 49.9 55.7 47.5 32.8 64.0 27.3 82.1 79.2 59.7 41.9 107.0 33.5 34.2 111.7 210.1 72.2 106.1 110.2 22.2 52.0 80.5 23.3 97.7 41.1 77.1 89.9 31.1 135.4 38.2 60.4 82.1 64.4 67.4 22.3 86.6 50.2 59.1 34.3 66.6 96.8 88.6 38.6 76.7 118.7 100.2 45.3 90.1 25.8 13.5 94.7 83.9 28.0 71.2 97.0 AHCYL2 KIAA0828 ENSG00000158467 "Adenosylhomocysteinase like 2" Q96HN2 7 129225023-129430211 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 72.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 75.8;Enterocytes: 114.1;Muller glia cells: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 8 "HDLM-2: 73.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053128 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA053128: AB_2682050" "unprognostic (1.57e-1)" "unprognostic (2.91e-1)" "unprognostic (8.52e-3)" "unprognostic (1.71e-3)" "unprognostic (7.44e-3)" "prognostic favorable (4.17e-4)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (3.35e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-1)" "unprognostic (6.79e-3)" "prognostic favorable (1.08e-7)" "unprognostic (4.70e-3)" "unprognostic (2.46e-1)" "unprognostic (7.21e-2)" "unprognostic (2.62e-1)" 4.3 6.6 12.8 5.9 20.3 1.5 4.3 7.2 16.9 7.1 61.8 13.3 5.1 23.1 6.1 3.3 5.7 4.4 22.7 3.4 16.5 9.6 11.9 3.4 26.1 4.2 10.7 14.9 5.7 5.8 9.1 12.8 5.1 19.8 5.0 72.4 24.3 15.0 3.3 20.7 9.8 15.0 5.3 11.4 2.9 16.5 8.1 9.6 4.6 24.1 4.0 4.0 5.4 4.7 0.9 1.3 2.0 2.5 3.3 5.0 0.5 2.7 4.3 8.3 4.9 2.2 3.3 1.7 2.1 3.0 2.4 2.2 2.5 1.8 1.6 2.2 2.3 5.2 1.9 4.1 3.4 2.7 73.5 5.1 3.9 4.8 2.0 1.3 2.8 5.0 3.0 4.4 1.9 3.0 4.1 4.8 3.2 1.7 9.3 3.1 2.5 4.2 3.7 4.1 2.7 3.0 2.8 2.2 4.4 4.9 3.6 3.8 2.4 4.9 2.1 2.9 7.2 2.0 2.1 2.7 2.1 1.2 5.5 2.2 3.9 4.4 2.2 5.4 3.1 3.2 0.1 1.2 2.0 0.9 2.5 1.2 0.9 1.5 0.7 1.3 0.5 1.3 0.5 0.4 3.3 1.2 0.4 5.0 0.5 12.8 20.3 7.2 16.9 16.5 9.6 10.7 14.9 19.8 9.6 56.6 75.8 3.4 4.5 13.9 9.4 4.5 17.8 5.3 19.4 5.2 5.9 8.4 10.0 3.6 61.0 3.9 114.1 0.0 4.9 2.2 3.1 6.2 5.7 4.9 3.9 4.8 8.7 4.3 8.3 20.3 3.7 5.1 23.6 7.2 29.7 87.7 4.5 30.8 6.3 15.7 5.0 6.5 1.2 4.6 2.4 8.5 12.7 3.2 32.7 13.9 AHNAK MGC5395 ENSG00000124942 "AHNAK nucleoprotein" Q09666 11 62433542-62556235 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 86.5;fHDF/TERT166: 80.4;TIME: 84.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019010, HPA019070, HPA026643" Uncertain Enhanced "Plasma membrane,Cytosol" NA NA 950000 "Plasma membrane, Cytosol" "HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426" "unprognostic (1.39e-1)" "unprognostic (7.84e-2)" "unprognostic (3.46e-1)" "unprognostic (3.19e-1)" "unprognostic (1.96e-2)" "unprognostic (5.99e-2)" "unprognostic (2.53e-1)" "unprognostic (1.63e-2)" "unprognostic (4.84e-2)" "unprognostic (1.98e-3)" "prognostic unfavorable (2.42e-4)" "unprognostic (4.30e-1)" "unprognostic (4.49e-3)" "unprognostic (5.42e-2)" "unprognostic (1.18e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (3.47e-6)" 85.2 8.2 15.3 35.3 9.3 10.0 91.1 9.3 10.8 69.7 66.3 16.8 36.4 13.0 52.2 47.4 96.9 39.4 59.2 55.8 20.9 6.0 18.4 16.0 54.9 16.6 16.2 13.4 40.2 8.9 8.0 5.3 39.8 15.9 42.6 26.8 29.6 35.5 36.8 64.8 88.4 38.2 101.5 16.1 16.9 38.3 16.9 16.2 5.8 18.4 72.9 44.0 54.3 86.1 8.2 28.9 15.3 30.1 11.1 16.7 12.2 26.5 15.7 1.4 6.5 64.4 86.5 10.4 24.1 29.6 15.4 8.6 13.5 9.5 0.0 9.2 80.4 11.9 35.4 6.0 29.7 19.7 21.5 1.0 3.2 23.3 4.0 12.3 4.4 21.2 31.2 34.9 30.2 27.7 19.7 31.7 0.4 3.0 20.5 31.2 10.3 0.0 8.6 0.4 8.5 23.8 0.0 6.6 15.9 34.2 17.4 0.0 1.3 24.3 10.3 10.3 31.1 19.7 4.1 84.1 27.5 17.9 34.1 10.6 3.6 0.7 0.0 20.9 1.4 8.9 15.3 30.1 0.1 16.7 17.5 11.0 8.2 10.7 13.1 28.9 5.2 1.4 7.6 0.4 11.1 14.0 7.9 7.9 12.2 15.3 9.3 9.3 10.8 20.9 6.0 16.2 13.4 15.9 16.2 408.0 109.1 70.5 114.1 425.8 1.3 166.6 206.4 97.7 178.6 183.2 0.0 83.1 11.6 83.1 9.2 245.0 291.2 0.0 57.2 123.8 177.9 136.3 226.0 73.3 79.4 1.6 45.8 165.7 304.6 18.1 418.0 252.7 301.9 91.0 140.5 27.9 164.5 142.7 438.1 5.4 1.0 174.6 271.5 1.7 7.6 533.5 85.5 86.3 79.4 166.3 AHNAK2 C14orf78 ENSG00000185567 "AHNAK nucleoprotein 2" Q8IVF2 14 104937244-104978357 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 131.1" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 101.5;Horizontal cells: 57.2;Suprabasal keratinocytes: 143.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "ASC diff: 28.6;ASC TERT1: 32.5;HBEC3-KT: 28.6;hTCEpi: 72.0;hTERT-HME1: 30.7;TIME: 32.3" "HPA000878, HPA002940, HPA004145, HPA020111" Enhanced Enhanced "Plasma membrane,Cytosol" No No Cytosol "Plasma membrane" "HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371" "unprognostic (3.56e-1)" "unprognostic (6.04e-2)" "unprognostic (6.19e-3)" "unprognostic (1.31e-3)" "unprognostic (9.55e-4)" "unprognostic (1.76e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (2.79e-5)" "unprognostic (3.43e-1)" "unprognostic (3.06e-3)" "prognostic unfavorable (4.05e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.23e-5)" 6.9 1.8 2.9 2.0 5.6 1.0 8.5 3.0 13.7 17.2 23.0 2.9 5.7 1.7 16.3 2.9 25.8 7.1 3.2 1.5 2.4 3.1 1.1 10.8 2.3 1.0 2.7 11.6 1.8 1.2 1.2 0.7 1.8 23.3 5.7 5.1 10.1 6.0 14.6 1.6 131.1 4.8 19.9 4.8 1.1 7.1 3.2 0.8 0.0 1.2 14.4 3.0 10.0 19.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 20.0 0.0 1.4 28.6 32.5 0.0 2.4 5.1 0.9 0.4 0.0 8.9 0.0 3.4 18.8 20.0 14.5 0.0 28.6 0.4 0.0 0.1 0.0 13.3 0.1 2.6 0.0 0.9 4.1 72.0 2.8 30.7 12.3 12.5 0.0 0.0 0.0 14.4 1.6 0.0 0.0 0.0 2.1 9.9 0.0 1.3 0.0 19.6 0.0 0.1 0.1 10.6 0.0 0.5 0.6 1.3 0.0 32.3 6.9 4.3 7.9 2.2 0.0 0.0 0.0 21.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 5.6 3.0 13.7 2.4 3.1 2.7 11.6 23.3 0.8 11.9 1.4 0.0 4.0 101.5 4.7 1.0 0.0 25.4 18.2 1.8 2.0 0.0 0.0 10.2 20.6 16.7 0.0 0.0 7.7 0.2 11.4 1.9 16.2 0.5 1.0 57.2 0.0 1.8 0.3 1.6 0.6 0.7 30.4 0.0 0.0 3.0 41.0 0.0 0.4 0.3 10.5 0.0 7.2 0.4 3.8 143.9 0.1 0.7 0.0 4.9 AHR bHLHe76 ENSG00000106546 "Aryl hydrocarbon receptor" P35869 7 16916359-17346152 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Cancer-related genes, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 69.6" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 140.0;granulocytes: 130.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 28.0;hTERT-HME1: 29.2;RT4: 24.0" "CAB005072, HPA029722, HPA029723" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025" "unprognostic (1.29e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-2)" "unprognostic (7.28e-2)" "unprognostic (1.22e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-1)" "unprognostic (4.32e-2)" "unprognostic (9.98e-2)" "unprognostic (1.24e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (2.00e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-2)" "unprognostic (9.45e-2)" 23.1 12.2 2.5 13.2 3.5 19.8 19.1 1.6 3.5 14.6 14.0 5.7 8.7 8.5 11.9 10.1 14.2 11.2 22.2 14.8 3.2 2.2 7.3 23.9 26.4 20.0 6.5 2.5 21.3 6.8 4.5 3.8 69.6 3.7 21.4 8.9 10.9 11.1 8.5 5.2 16.6 13.7 12.1 4.8 15.6 13.3 6.8 4.0 7.1 12.4 7.9 12.3 26.7 26.6 1.1 9.3 5.6 7.6 3.1 2.9 2.0 3.0 2.5 1.0 0.0 7.7 5.3 0.4 6.3 9.1 2.9 4.3 3.0 6.8 0.0 1.9 9.2 11.6 8.4 0.6 5.7 7.7 0.1 1.4 1.8 3.2 2.7 14.3 3.0 4.5 7.2 28.0 11.1 29.2 13.3 9.7 0.0 0.2 0.0 13.2 1.5 0.0 4.8 0.8 23.0 4.0 0.0 0.0 0.1 9.3 24.0 0.9 0.0 4.7 5.1 4.6 7.7 3.6 1.0 1.6 1.2 0.0 15.9 0.0 1.3 0.0 0.0 20.4 11.7 20.0 0.7 7.6 5.6 0.7 3.6 1.1 0.8 2.6 1.4 9.3 1.1 1.5 1.1 0.8 3.1 1.3 2.2 2.9 2.0 2.5 3.5 1.6 3.5 3.2 2.2 6.5 2.5 3.7 4.0 140.0 72.8 9.4 40.0 66.9 34.6 12.9 43.3 42.8 75.1 7.0 7.9 3.1 0.0 15.8 4.8 55.4 13.6 0.0 13.4 1.2 31.0 42.7 130.4 40.0 24.3 41.3 5.2 44.2 75.1 2.4 3.4 73.2 67.4 36.9 10.6 0.5 24.6 16.9 2.5 5.6 5.7 6.5 41.1 2.4 2.3 78.0 18.0 7.5 12.6 90.1 AHRR "AHH, AHHR, bHLHe77, KIAA1234" ENSG00000063438 "Aryl-hydrocarbon receptor repressor" A9YTQ3 5 304176-438291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 44.3" "Group enriched" "Detected in some" 8 "Early spermatids: 233.3;Late spermatids: 118.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 23.8;HMC-1: 35.8;NB-4: 43.1;WM-115: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA021483 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021483: AB_1855110" "unprognostic (2.06e-4)" "unprognostic (3.48e-2)" "unprognostic (8.71e-3)" "unprognostic (2.23e-1)" "unprognostic (1.09e-1)" "unprognostic (9.33e-4)" "unprognostic (4.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.02e-5)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.65e-6)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.55e-2)" 0.8 0.4 1.0 4.6 0.8 0.2 2.4 0.4 1.4 2.4 1.2 0.7 1.4 0.7 1.6 0.9 1.4 0.5 4.4 0.3 1.2 1.0 0.6 0.4 6.2 0.4 0.3 0.0 2.1 1.0 0.1 1.3 2.1 0.9 0.6 1.2 2.7 0.9 0.3 0.6 5.8 1.7 0.9 0.3 4.7 0.7 44.3 0.3 0.1 0.9 1.8 4.2 2.0 3.6 0.9 2.3 1.0 0.5 0.0 1.0 0.3 0.1 4.0 0.6 0.5 2.2 4.6 4.7 8.5 11.5 4.8 9.5 0.1 3.2 0.3 4.4 15.4 1.3 0.2 0.7 0.2 2.1 0.6 1.7 4.0 23.8 0.1 1.6 1.2 35.8 0.9 0.3 3.3 0.4 6.4 1.7 1.0 0.6 0.3 5.1 0.3 0.3 43.1 0.1 1.0 4.0 0.6 0.2 0.4 0.1 0.0 5.6 0.2 11.3 2.1 5.8 0.1 0.2 14.7 2.1 8.9 1.1 10.0 0.3 1.3 2.1 0.3 3.8 0.3 25.2 0.0 0.5 1.0 0.3 0.0 0.1 0.2 0.6 0.3 0.0 0.9 0.1 0.1 0.5 0.0 0.1 2.3 1.0 0.3 1.0 0.8 0.4 1.4 1.2 1.0 0.3 0.0 0.9 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 233.3 1.0 0.0 0.0 0.2 4.3 3.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 118.4 3.1 2.2 18.6 10.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 6.5 1.4 21.3 7.0 1.3 0.7 0.0 0.0 0.1 AHSA1 "Aha1, C14orf3, hAha1, p38" ENSG00000100591 "Activator of HSP90 ATPase activity 1" O95433 14 77457870-77469474 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 177.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000903, CAB006244" Supported Supported Cytosol NA NA 28000 Cytosol "CAB006244: AB_425858, HPA000903: AB_1078112" "unprognostic (3.91e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (3.48e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (5.04e-6)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.88e-1)" "unprognostic (2.63e-2)" "unprognostic (2.16e-2)" "unprognostic (1.33e-1)" "unprognostic (3.06e-2)" "unprognostic (1.44e-2)" "unprognostic (3.01e-1)" 23.7 39.3 37.8 26.9 44.4 20.7 58.9 33.1 52.1 25.7 27.9 22.6 28.9 21.0 31.7 34.9 27.2 56.4 18.6 47.8 38.2 38.2 31.5 28.4 21.9 29.4 61.8 29.7 30.3 25.4 32.0 37.0 34.9 50.1 32.0 34.9 11.5 24.7 35.3 48.5 20.8 20.7 40.0 42.5 21.5 22.8 40.5 54.3 26.0 37.6 24.5 40.3 24.8 177.1 44.3 36.6 34.5 45.1 42.3 42.3 26.9 33.8 66.9 18.3 23.9 28.4 20.5 32.2 25.2 20.0 39.6 29.7 50.1 29.3 63.0 19.8 24.6 45.9 38.7 66.0 32.3 44.2 25.0 39.3 29.7 33.3 60.4 20.9 18.7 42.9 18.1 43.2 26.6 13.0 23.7 37.4 41.0 36.7 20.3 24.7 93.0 46.0 35.7 31.8 57.6 70.4 37.1 21.7 31.4 31.2 35.2 28.2 31.1 23.4 52.3 21.6 29.8 31.9 25.9 19.4 21.5 30.5 24.1 35.8 20.5 41.2 48.4 31.2 37.6 23.6 32.6 28.2 34.5 37.8 39.0 42.3 44.3 34.8 38.7 36.6 34.3 40.0 40.1 20.2 42.3 45.1 34.1 40.0 26.9 37.8 44.4 33.1 52.1 38.2 38.2 61.8 29.7 50.1 54.3 32.8 22.9 72.8 138.0 138.5 35.7 79.2 35.7 115.1 37.5 26.2 80.5 132.6 63.0 69.8 30.4 41.4 51.9 0.0 42.8 89.9 69.9 112.4 76.0 37.3 81.2 17.5 75.1 23.4 22.5 25.2 62.7 50.6 86.0 82.0 41.3 42.4 57.3 50.1 62.6 59.7 52.4 97.0 101.1 80.9 45.1 122.5 114.3 44.9 57.2 106.3 AIDA "C1orf80, FLJ12806" ENSG00000186063 "Axin interactor, dorsalization associated" Q96BJ3 1 222668013-222713210 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027935 Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA027935: AB_10602226" "unprognostic (2.33e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (2.63e-2)" "unprognostic (7.28e-2)" "unprognostic (2.58e-2)" "unprognostic (2.26e-2)" "unprognostic (2.73e-1)" "unprognostic (4.43e-2)" "unprognostic (2.09e-3)" "unprognostic (2.08e-1)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.28e-1)" "unprognostic (2.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" 37.7 20.7 22.6 20.2 28.1 9.8 33.7 19.8 20.4 28.7 32.6 13.3 20.1 13.7 22.3 32.7 31.5 17.9 22.7 43.2 21.6 23.8 27.9 27.6 30.5 25.0 25.2 17.0 25.4 21.0 16.4 22.5 26.0 25.7 29.6 20.5 13.7 16.1 24.9 20.2 14.9 19.5 33.3 27.5 24.9 19.7 23.1 22.5 21.1 30.5 13.5 27.9 42.0 39.7 14.2 6.7 4.4 4.4 3.3 9.1 3.8 18.2 14.1 16.8 18.0 47.8 45.2 18.4 34.3 36.8 24.6 22.7 16.0 15.7 9.8 17.4 40.5 19.0 11.3 20.7 22.7 30.1 14.6 7.6 12.4 17.0 15.3 25.2 15.2 7.3 27.4 20.4 29.2 28.4 26.6 29.9 12.6 18.7 13.9 46.1 6.8 9.9 9.4 41.9 20.8 30.3 10.8 47.4 14.2 28.4 12.4 11.1 18.6 22.9 13.6 20.8 27.1 11.1 9.5 23.7 33.2 16.4 32.1 40.3 10.4 19.5 8.8 30.8 9.6 32.5 4.4 2.6 2.6 5.7 4.0 4.9 13.7 7.3 6.2 2.4 14.2 7.6 5.8 1.5 3.3 4.4 6.7 9.1 3.8 22.6 28.1 19.8 20.4 21.6 23.8 25.2 17.0 25.7 22.5 20.8 37.5 39.7 31.9 28.8 17.4 7.5 15.3 38.8 20.5 31.4 31.4 17.3 24.9 34.0 14.2 47.6 16.2 23.3 32.8 46.9 47.4 44.9 3.5 31.0 28.3 22.3 34.7 44.8 32.3 16.7 55.8 29.7 35.4 74.9 21.2 22.9 42.9 21.0 47.7 42.5 13.4 32.3 50.5 35.9 15.1 26.5 7.6 24.0 19.0 25.1 AIF1 "AIF-1, Em:AF129756.17, IBA1, IRT-1" ENSG00000204472 "Allograft inflammatory factor 1" P55008 6 31615184-31617021 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 119.2;lymphoid tissue: 99.3" "Group enriched" "Detected in many" 19 "Hofbauer cells: 1482.8;Kupffer cells: 1886.5;Macrophages: 1383.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 23 "classical monocyte: 67.4;intermediate monocyte: 104.8;myeloid DC: 35.9;neutrophil: 51.7;non-classical monocyte: 119.2" "Group enriched" "Detected in many" 33 "dendritic cells: 35.9;granulocytes: 51.7;monocytes: 119.2" "Cell line enhanced" "Detected in some" "HEL: 25.8;HMC-1: 37.2;JURKAT: 15.1;NB-4: 59.1;THP-1: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049234, HPA062949" Enhanced Uncertain Cytosol NA NA Cytosol "HPA049234: AB_2680685, HPA062949: AB_2732694" "unprognostic (3.20e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-2)" "unprognostic (2.33e-2)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (6.98e-2)" "unprognostic (4.83e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.29e-1)" "unprognostic (1.02e-2)" "unprognostic (9.59e-2)" "unprognostic (4.89e-2)" 13.5 9.5 13.0 27.7 23.8 39.8 7.8 1.8 10.0 5.2 8.0 17.0 0.1 6.1 3.2 8.3 3.6 5.6 9.8 5.8 10.2 10.2 15.4 12.6 19.9 40.5 16.9 3.1 4.9 3.4 2.0 4.9 17.0 12.8 6.1 9.7 4.6 5.7 4.3 3.5 2.9 10.8 11.1 28.5 99.3 4.8 2.6 16.2 71.7 3.6 1.7 9.8 11.2 3.5 0.7 35.9 51.7 119.2 0.3 2.1 59.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 1.7 37.2 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.1 0.0 0.0 0.0 0.2 59.1 0.1 0.0 0.0 9.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.3 0.0 0.5 67.4 3.2 0.2 104.8 0.2 0.7 0.3 0.3 35.9 0.1 2.1 1.7 51.7 0.3 119.2 3.3 0.1 59.6 13.0 23.8 1.8 10.0 10.2 10.2 16.9 3.1 12.8 16.2 23.8 84.5 70.4 0.6 28.8 0.0 5.5 25.5 18.7 35.2 40.1 0.0 9.9 0.0 0.0 1.1 13.5 0.4 0.0 0.4 10.9 24.2 0.3 64.9 8.9 1482.8 0.0 1.2 43.0 1886.5 1.5 6.9 1383.0 37.1 40.5 0.0 0.0 0.1 5.8 0.7 3.1 0.0 51.8 17.6 0.3 1.5 24.7 19.0 27.4 0.4 0.0 AIFM2 "AMID, FLJ14497, PRG3" ENSG00000042286 "Apoptosis inducing factor, mitochondria associated 2" Q9BRQ8 10 70098223-70132934 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 41.9" "Cell type enhanced" "Detected in many" 5 "monocytes: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 57.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028961, HPA042309, HPA075576" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: " "unprognostic (6.62e-2)" "unprognostic (2.73e-1)" "unprognostic (4.29e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.26e-3)" "unprognostic (2.57e-2)" "unprognostic (7.95e-3)" "unprognostic (2.80e-1)" "unprognostic (5.31e-2)" "unprognostic (8.90e-2)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.49e-1)" "unprognostic (4.59e-3)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (2.92e-4)" 32.9 7.8 3.1 6.6 5.9 1.3 41.9 5.0 3.7 3.5 9.0 2.1 22.1 7.6 4.5 9.6 9.1 4.0 7.6 19.7 2.8 4.1 10.2 18.2 8.1 4.0 2.9 2.4 7.5 3.6 3.9 3.1 5.2 3.5 6.4 5.9 9.2 5.8 15.2 9.1 2.8 9.9 7.8 3.7 5.9 6.5 3.1 2.1 1.0 10.8 6.4 7.3 11.8 15.7 3.4 0.7 1.5 1.0 7.8 3.5 1.2 8.8 15.4 0.4 4.0 9.3 3.5 0.1 3.5 8.8 7.3 8.3 11.9 17.2 1.3 9.1 4.9 9.7 9.6 4.3 1.2 2.0 17.2 0.7 0.0 9.1 57.7 20.0 0.1 2.2 4.7 2.9 11.7 2.5 4.6 3.2 0.6 6.7 7.6 3.7 11.2 0.4 0.4 1.6 7.1 5.0 0.2 1.4 4.2 3.9 6.5 1.3 0.3 6.5 5.7 10.0 0.6 0.2 2.4 4.0 0.1 9.0 5.4 10.3 5.7 10.6 2.4 4.9 0.3 4.8 1.5 0.9 1.0 3.5 0.8 3.1 3.4 1.2 3.0 0.7 2.9 1.7 2.7 1.0 7.8 1.0 0.5 2.4 1.2 3.1 5.9 5.0 3.7 2.8 4.1 2.9 2.4 3.5 2.1 6.0 13.1 2.2 11.6 2.1 5.5 11.7 10.2 9.4 10.3 17.4 0.0 12.6 3.3 35.2 19.5 2.3 32.9 0.0 19.3 2.5 6.3 12.0 11.5 20.2 10.5 1.6 11.5 2.5 1.8 33.7 4.9 3.5 8.5 59.5 6.0 4.5 31.0 17.5 4.2 11.5 1.7 19.4 13.0 3.2 3.2 1.3 15.6 5.1 9.0 14.8 AIM2 PYHIN4 ENSG00000163568 "Absent in melanoma 2" O14862 1 159062484-159147096 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 44.7;lymphoid tissue: 43.8" "Group enriched" "Detected in some" 6 "B-cells: 18.9;Early spermatids: 19.7;Late spermatids: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "memory B-cell: 44.7;naive B-cell: 14.3" "Lineage enriched" "Detected in many" 9 "B-cells: 44.7" "Cell line enhanced" "Detected in some" "Daudi: 31.8;HDLM-2: 44.3;Karpas-707: 17.6;U-266/70: 14.8;U-266/84: 11.1;U-87 MG: 13.7" "Low region specificity" "Detected in all" "HPA031365, HPA040309" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA031365: AB_10601332, HPA040309: AB_2676925" "unprognostic (6.05e-2)" "unprognostic (7.68e-2)" "unprognostic (4.24e-3)" "unprognostic (2.08e-2)" "unprognostic (6.94e-2)" "unprognostic (3.44e-1)" "unprognostic (3.20e-1)" "unprognostic (1.35e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-3)" "unprognostic (7.10e-3)" "unprognostic (1.13e-1)" "unprognostic (1.23e-12)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-3)" 0.7 0.3 1.3 28.2 0.9 0.4 0.6 0.5 0.6 0.4 1.9 0.1 0.0 0.7 0.2 0.2 4.1 0.5 1.1 0.5 1.2 0.6 0.9 0.8 2.0 24.1 0.5 0.2 0.6 0.3 0.0 8.8 0.4 0.5 0.7 1.0 0.5 1.9 0.0 0.2 0.3 12.8 0.2 2.6 43.8 1.3 1.4 1.4 1.4 0.7 0.6 25.9 4.0 0.5 44.7 1.2 4.7 2.4 0.0 3.3 1.4 5.3 0.0 0.3 0.0 0.0 4.4 0.0 0.0 0.5 0.4 0.3 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 44.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 2.9 0.0 2.8 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.1 14.8 11.1 0.3 13.7 1.2 2.3 4.2 2.4 0.0 0.6 2.1 1.7 44.7 1.6 1.1 1.2 14.3 0.1 0.4 4.7 0.0 2.2 0.0 3.3 1.4 1.3 0.9 0.5 0.6 1.2 0.6 0.5 0.2 0.5 1.4 0.0 0.0 18.9 0.1 0.0 0.7 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.9 24.1 0.3 1.0 3.3 1.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.1 0.0 0.4 AIMP1 "EMAP-2, EMAPII, p43, SCYE1" ENSG00000164022 "Aminoacyl tRNA synthetase complex interacting multifunctional protein 1" Q12904 4 106315544-106349226 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis" "Cytokine, RNA-binding, tRNA-binding" Leukodystrophy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017618, HPA018476" Supported Enhanced Cytosol "Secreted to blood" NA NA 6500000 Cytosol "CAB017618: AB_2285445, HPA018476: AB_1848137" "unprognostic (1.17e-3)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.36e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.29e-3)" "unprognostic (8.10e-2)" "unprognostic (4.85e-2)" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "unprognostic (1.23e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (7.13e-2)" "unprognostic (1.73e-1)" "unprognostic (2.27e-2)" 30.7 26.6 20.2 25.7 24.5 42.2 30.3 22.5 22.9 29.9 33.7 17.0 33.6 27.7 29.3 28.4 35.0 25.6 23.7 23.6 21.2 18.4 40.4 35.3 23.4 24.6 29.8 21.8 35.9 27.2 24.1 44.0 27.3 26.5 29.8 28.4 14.1 25.6 32.1 67.8 22.6 39.1 32.8 30.1 26.9 25.2 15.9 29.4 31.3 35.9 40.6 25.8 41.2 25.9 28.2 35.9 24.6 32.7 23.7 33.4 16.6 22.9 14.7 15.5 21.9 18.6 27.9 26.0 30.7 23.6 24.0 28.8 25.3 33.9 40.7 23.2 25.5 18.9 23.0 23.6 29.1 34.4 22.6 14.8 24.0 19.0 40.2 35.7 47.5 27.8 21.5 33.6 25.5 41.4 17.9 20.8 22.4 41.0 22.0 26.5 16.6 32.0 22.6 17.6 31.7 14.7 26.3 31.4 36.6 29.7 20.0 24.9 18.5 19.6 54.2 27.6 22.8 25.9 33.4 17.7 31.7 29.0 23.5 35.7 25.0 35.0 41.6 26.4 37.2 34.0 22.4 26.9 24.6 21.8 29.0 26.0 27.7 27.3 21.8 27.6 28.2 28.5 25.9 3.7 23.7 32.7 35.9 33.4 16.6 20.2 24.5 22.5 22.9 21.2 18.4 29.8 21.8 26.5 29.4 65.5 48.1 80.4 112.4 44.6 44.9 91.2 84.1 77.6 91.0 62.8 33.4 105.8 132.6 104.1 59.3 50.6 74.9 23.3 110.5 122.1 61.9 108.3 78.4 110.0 97.3 23.8 70.9 63.3 84.2 9.9 91.7 82.1 30.4 91.0 106.7 52.5 101.3 87.7 80.2 119.0 35.9 58.2 70.0 117.4 69.1 43.8 126.2 64.5 109.4 153.1 AIMP2 "JTV-1, JTV1, p38, PRO0992" ENSG00000106305 "Aminoacyl tRNA synthetase complex interacting multifunctional protein 2" Q13155 7 6009245-6023834 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Protein biosynthesis" "Developmental protein" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.1" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019098, HPA020057" Supported Approved Cytosol NA NA 8200 Cytosol "HPA019098: AB_1852040, HPA020057: AB_1852042" "unprognostic (1.24e-3)" "unprognostic (1.66e-2)" "unprognostic (7.30e-2)" "unprognostic (2.77e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (9.29e-2)" "unprognostic (3.41e-2)" "unprognostic (8.75e-2)" "unprognostic (1.11e-1)" "unprognostic (5.13e-2)" "unprognostic (3.96e-1)" "prognostic favorable (1.38e-5)" "unprognostic (7.44e-2)" "unprognostic (8.97e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (3.09e-4)" 10.2 11.2 6.3 6.9 7.3 5.3 11.2 5.3 11.0 5.6 14.9 10.2 7.1 22.8 8.9 10.8 11.2 7.7 8.7 17.7 6.5 5.8 18.6 30.7 6.8 15.1 6.8 8.2 7.5 9.6 12.3 4.5 9.0 7.6 6.1 12.2 6.6 13.6 9.0 66.1 10.3 21.0 9.8 7.2 9.4 7.5 20.4 5.1 9.3 12.9 28.4 9.1 8.2 6.6 19.0 37.3 13.8 30.0 17.8 17.7 16.1 26.1 29.7 10.1 14.4 10.7 11.7 34.4 14.9 10.0 24.4 18.2 32.4 17.4 32.2 14.0 15.2 27.9 29.2 34.1 22.3 15.2 10.4 25.8 17.8 17.5 24.2 33.1 25.0 16.1 18.0 33.0 22.0 36.1 4.1 18.2 13.6 24.9 10.7 17.8 41.5 10.8 45.5 41.0 13.0 21.6 24.3 22.4 27.2 35.7 12.2 20.2 19.1 15.0 30.3 20.3 13.4 28.3 20.4 15.2 14.0 34.9 23.2 32.4 13.7 20.7 27.8 11.7 35.8 22.6 13.8 25.0 7.6 17.7 30.0 15.0 19.0 12.2 14.0 37.3 13.3 12.2 12.8 2.5 17.8 22.1 23.9 13.0 16.1 6.3 7.3 5.3 11.0 6.5 5.8 6.8 8.2 7.6 5.1 8.9 9.3 13.7 15.6 9.6 9.6 1.7 28.1 25.4 17.0 12.2 5.9 42.3 59.7 47.3 99.1 15.8 18.7 0.0 49.8 47.9 11.5 12.2 11.6 30.6 44.3 6.4 6.4 13.5 19.2 61.8 18.4 16.6 18.6 50.5 15.4 16.4 34.2 10.5 17.0 54.2 9.1 12.9 15.1 55.6 21.1 10.2 33.1 10.2 35.9 16.5 AIP "ARA9, FKBP16, XAP2" ENSG00000110711 "Aryl hydrocarbon receptor interacting protein" O00170 11 67483041-67491103 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cushing syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033674, HPA050217, CAB069477" Approved Supported Cytosol NA NA Cytosol "CAB033674: AB_2224981, CAB069477: AB_10002466, HPA050217: AB_2681055" "unprognostic (2.59e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (8.15e-2)" "unprognostic (9.54e-2)" "unprognostic (4.02e-2)" "unprognostic (2.17e-2)" "unprognostic (1.14e-1)" "unprognostic (6.19e-3)" "unprognostic (2.18e-1)" "unprognostic (9.75e-2)" "unprognostic (1.16e-1)" "unprognostic (5.28e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (9.45e-2)" 23.1 30.5 30.7 31.1 32.6 25.1 29.0 30.3 34.2 27.8 38.5 26.6 24.2 23.7 30.6 24.2 30.8 25.0 28.6 34.7 28.0 25.4 28.0 20.7 24.7 55.2 34.2 24.6 45.5 23.0 18.2 22.0 23.6 27.1 36.2 14.6 21.4 25.0 28.1 26.5 15.9 25.0 29.8 30.2 37.9 22.9 18.2 30.4 34.6 38.0 16.6 33.5 33.1 60.6 56.5 49.8 36.9 38.0 37.6 80.0 41.7 20.6 24.0 13.8 13.2 17.8 17.9 10.5 13.0 16.4 22.5 16.5 37.5 20.6 36.8 31.9 14.4 17.2 16.8 15.6 13.6 8.7 53.8 16.8 22.3 26.2 22.3 18.4 22.3 39.2 21.3 12.9 20.0 13.0 21.9 11.5 36.6 12.7 22.2 14.6 39.6 47.4 55.0 13.0 31.5 30.8 21.1 21.0 32.5 15.7 12.3 21.9 21.9 16.9 12.1 51.4 5.6 16.2 22.6 18.8 19.9 19.4 29.1 11.9 18.2 24.9 28.8 27.2 17.4 15.3 36.9 28.9 31.0 49.5 33.4 53.5 56.5 58.5 57.9 43.1 48.7 53.2 50.8 19.0 37.6 38.0 49.8 80.0 41.7 30.7 32.6 30.3 34.2 28.0 25.4 34.2 24.6 27.1 30.4 29.8 24.6 50.9 30.2 27.0 32.4 19.3 15.3 13.4 14.8 47.1 3.9 48.9 69.6 40.7 21.2 47.5 49.9 0.0 36.9 47.7 44.7 36.1 75.1 22.2 59.5 35.0 30.6 40.5 53.1 12.2 49.2 58.2 54.0 72.1 26.8 34.6 40.6 49.1 33.2 67.7 25.0 38.8 53.6 25.0 29.0 18.4 49.8 95.0 21.7 35.7 AIPL1 LCA4 ENSG00000129221 "Aryl hydrocarbon receptor interacting protein like 1" Q9NZN9 17 6393693-6435199 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "retina: 123.7" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 388.8;Rod photoreceptor cells: 1307.2" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.1;OE19: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA026578 Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026578: AB_2671905" "unprognostic (2.42e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "unprognostic (1.68e-3)" "unprognostic (3.24e-1)" "unprognostic (1.13e-3)" "unprognostic (3.76e-1)" "unprognostic (5.35e-2)" 0.1 0.1 1.4 0.4 0.3 2.9 0.1 0.5 0.8 0.2 0.1 0.1 0.1 0.0 0.1 0.3 1.1 0.0 0.3 0.1 0.6 0.5 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.0 0.8 0.1 0.1 0.1 0.0 123.7 2.3 0.1 0.1 2.4 0.1 0.1 0.1 1.0 0.2 3.3 0.1 0.2 0.4 0.1 0.2 0.1 0.1 1.0 1.1 2.2 0.7 1.1 0.6 0.0 0.1 1.5 0.5 0.1 0.1 0.0 0.4 0.0 0.3 0.1 0.5 0.1 0.1 0.3 0.1 0.0 0.1 4.1 0.1 0.2 0.2 0.2 0.3 0.4 1.7 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.4 0.2 0.1 0.8 7.6 1.3 0.1 0.0 0.0 0.1 1.0 0.2 0.2 0.9 0.3 0.0 0.3 0.2 0.0 0.0 0.3 0.2 0.4 0.3 0.3 0.1 0.1 0.6 0.5 0.2 0.9 0.7 0.6 0.6 0.3 0.3 0.6 0.3 0.1 0.3 1.0 0.3 0.4 2.2 1.1 0.5 1.1 0.4 0.0 1.4 0.3 0.5 0.5 0.6 0.5 0.5 0.1 0.1 0.1 3.0 0.6 0.0 1.0 0.7 109.4 0.6 0.0 0.0 2.3 0.0 388.8 0.1 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 62.0 0.0 2.5 0.0 1.0 0.0 0.3 1.7 0.0 0.0 135.1 0.1 0.0 0.4 0.0 1307.2 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 2.0 AJM1 "ajm-1, C9orf172" ENSG00000232434 "Apical junction component 1 homolog" C9J069 9 136844415-136848801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;testis: 15.0" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 5.2;Ductal cells: 1.4;granulocytes: 1.1;Pancreatic endocrine cells: 1.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 22.7" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 11 "dendritic cells: 3.9;monocytes: 1.6;T-cells: 1.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021200 Uncertain Approved "Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" "HPA021200: AB_10601695" "unprognostic (3.30e-3)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (9.54e-2)" "unprognostic (2.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.27e-2)" "unprognostic (8.00e-2)" "unprognostic (6.29e-2)" "unprognostic (4.33e-1)" "unprognostic (2.72e-3)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (2.71e-3)" "unprognostic (2.94e-1)" "unprognostic (6.07e-3)" "unprognostic (7.27e-2)" 1.1 1.9 4.6 1.3 6.3 1.4 1.1 22.7 7.9 1.1 4.0 1.1 1.1 3.3 1.2 1.1 1.1 0.3 1.1 1.2 4.4 3.1 1.1 1.1 1.1 1.1 2.1 1.1 1.1 7.6 1.1 5.2 1.1 1.1 2.6 1.1 1.1 2.0 2.2 3.9 1.5 4.3 1.1 1.3 3.6 2.3 15.0 1.1 1.1 1.1 1.1 1.1 2.6 1.1 0.2 3.9 0.1 1.6 0.2 1.9 0.8 3.7 3.0 0.4 1.1 0.5 0.4 4.9 3.0 0.5 0.4 0.2 1.0 2.0 2.3 2.6 0.8 1.0 4.2 0.4 1.1 0.0 5.8 2.2 0.6 5.6 0.9 1.7 1.3 4.2 0.9 1.5 0.5 0.3 2.5 0.2 1.1 3.5 1.5 0.7 4.1 0.4 4.5 1.2 3.1 3.9 2.8 0.9 7.3 0.9 0.7 7.4 2.6 1.9 7.6 4.0 0.6 6.0 2.8 3.1 5.0 3.5 1.7 1.8 6.6 4.5 0.8 8.8 4.6 1.2 0.0 1.6 0.1 1.9 1.0 0.4 0.2 0.5 0.9 1.5 0.0 0.2 0.9 0.1 0.2 1.5 3.9 0.1 0.8 4.6 6.3 22.7 6.8 4.4 3.1 2.1 1.1 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AK1 ENSG00000106992 "Adenylate kinase 1" P00568 9 127866480-127877743 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 84.5;skeletal muscle: 279.0" "Cell type enhanced" "Detected in all" 11 "Late spermatids: 823.7;Peritubular cells: 363.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006456, CAB009893" Enhanced Supported Cytosol NA NA 32000000 Cytosol "CAB009893: AB_2225151, HPA006456: AB_1078116" "unprognostic (6.07e-3)" "unprognostic (1.44e-2)" "unprognostic (2.36e-2)" "unprognostic (1.03e-1)" "unprognostic (3.44e-1)" "unprognostic (3.09e-1)" "unprognostic (1.52e-2)" "unprognostic (3.12e-2)" "unprognostic (2.19e-1)" "unprognostic (5.74e-2)" "unprognostic (6.65e-3)" "unprognostic (2.07e-1)" "unprognostic (1.81e-2)" "prognostic favorable (7.31e-4)" "unprognostic (2.62e-1)" "unprognostic (8.40e-3)" "unprognostic (6.99e-3)" 7.7 9.2 19.6 3.7 18.8 6.5 3.9 9.8 17.3 10.5 8.6 18.1 12.2 5.2 3.4 17.3 9.0 84.5 12.0 60.4 17.6 18.5 6.3 10.7 18.7 2.2 16.4 15.3 12.3 4.6 5.6 7.1 2.9 17.5 5.2 10.8 7.0 13.4 15.7 279.0 3.4 2.6 6.3 11.5 5.6 5.8 9.8 11.1 0.0 10.5 61.5 4.0 4.4 4.4 1.2 3.4 2.8 0.4 1.4 1.5 1.2 15.0 6.5 8.3 11.4 20.3 41.3 7.6 10.5 10.6 18.7 11.4 4.8 9.6 0.4 11.5 21.6 12.4 21.7 0.0 11.7 7.5 2.4 7.2 2.2 18.7 8.4 11.4 0.0 0.2 31.4 22.8 13.9 10.1 10.3 25.0 0.2 8.9 0.6 21.2 14.4 0.0 0.3 3.0 37.8 20.2 0.4 8.4 3.3 12.5 1.1 13.6 8.4 27.7 16.0 8.0 4.5 12.8 9.0 20.6 13.1 5.3 46.1 10.0 1.0 0.1 0.0 16.4 0.0 9.1 0.9 0.4 0.4 1.5 0.3 1.1 0.3 0.6 1.1 0.1 1.2 0.3 1.1 2.8 1.4 0.4 3.4 0.3 1.2 19.6 18.8 9.8 17.3 17.6 18.5 16.4 15.3 17.5 11.1 38.7 148.9 3.7 16.6 23.5 48.5 42.8 30.6 46.8 19.4 7.0 15.7 6.3 14.9 97.5 229.8 49.4 94.1 93.5 54.8 37.4 51.2 15.5 1.1 69.2 46.3 46.1 102.2 47.9 3.2 823.7 209.7 11.0 79.2 2.8 66.4 290.8 46.6 58.8 363.1 6.3 55.1 25.8 50.9 14.4 15.6 24.8 11.3 7.5 73.1 20.9 AK5 ENSG00000154027 "Adenylate kinase 5" Q9Y6K8 1 77282051-77559969 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.5" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 137.0;Extravillous trophoblasts: 30.0;Spermatogonia: 72.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 10.9;naive CD4 T-cell: 14.2" "Group enriched" "Detected in many" 15 "dendritic cells: 10.9;T-cells: 14.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 30.3;BJ: 20.7;fHDF/TERT166: 23.6;LHCN-M2: 59.3;U-2 OS: 18.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019128, HPA057255" Enhanced Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA019128: AB_1844682, HPA057255: AB_2683383" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (1.13e-1)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (6.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.91e-2)" "prognostic favorable (3.88e-4)" "unprognostic (3.56e-3)" "unprognostic (6.17e-4)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (6.76e-2)" 1.8 2.1 43.8 1.9 35.7 3.7 14.1 1.3 95.5 2.0 1.8 20.4 0.0 1.8 1.6 1.5 1.8 1.8 1.7 1.5 35.8 11.8 2.0 1.2 1.4 2.5 13.0 41.1 1.5 2.1 2.4 1.4 1.8 11.4 2.7 1.8 0.0 3.1 2.7 1.3 2.4 1.7 1.7 14.2 2.4 2.9 7.3 13.9 0.0 1.7 0.0 2.1 1.5 0.4 0.8 10.9 0.7 0.7 0.1 14.2 1.9 0.0 1.1 0.9 0.0 11.2 30.3 0.4 20.7 4.4 3.4 1.4 0.1 0.5 0.1 0.1 23.6 1.3 0.1 0.0 0.0 1.7 0.7 0.2 0.1 0.1 0.0 0.5 0.1 0.0 3.7 0.1 0.6 1.3 12.0 9.7 0.1 0.2 0.2 59.3 0.2 0.0 0.1 1.2 5.5 7.5 0.5 2.2 0.3 9.2 0.3 4.6 1.1 0.0 0.0 1.3 0.1 0.1 0.1 2.4 8.2 18.6 0.4 0.6 4.8 4.3 0.0 1.6 1.0 3.0 0.7 0.7 0.0 3.4 0.1 0.5 0.8 3.2 1.6 10.9 0.8 14.2 7.8 0.5 0.1 0.2 1.2 1.4 1.9 43.8 35.7 1.3 47.1 35.8 11.8 13.0 41.1 11.4 13.9 0.0 0.0 0.0 0.5 0.2 0.5 1.2 0.0 0.0 0.0 1.8 0.0 0.9 6.6 0.2 137.0 1.1 0.0 0.0 0.6 30.0 1.2 2.2 0.0 0.0 2.2 12.7 11.5 0.6 0.0 16.1 1.1 0.4 3.3 0.0 0.0 0.0 0.1 0.0 0.7 4.5 0.2 0.0 3.1 6.5 72.5 0.3 2.4 1.5 0.0 0.1 AK6 CINAP ENSG00000085231 "Adenylate kinase 6" Q9Y3D8 5 69350984-69370013 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 216.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005361, HPA070217" Supported Supported "Nuclear speckles,Centrosome,Cytosol" No No "Nuclear speckles" "Centrosome, Cytosol" "CAB005361: AB_2302969, HPA070217: " "unprognostic (5.47e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (8.58e-2)" "unprognostic (8.73e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.79e-1)" "unprognostic (3.41e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (2.25e-2)" "unprognostic (1.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (2.22e-1)" "unprognostic (2.55e-2)" 27.6 27.7 25.1 16.9 25.4 14.8 23.3 21.5 23.6 17.6 22.7 11.3 16.4 18.3 18.3 30.4 26.7 15.4 15.1 17.9 23.2 22.2 30.2 42.3 17.0 18.7 20.9 16.2 18.8 17.2 15.8 26.3 21.5 23.3 18.2 20.6 12.3 14.5 14.6 41.4 11.9 24.0 16.7 19.6 21.8 17.0 46.1 17.5 25.2 24.3 24.2 18.8 19.7 13.7 22.2 22.0 14.3 15.9 16.6 21.2 10.0 17.1 9.6 12.6 16.8 20.6 13.7 23.6 25.9 9.7 12.8 15.9 26.7 14.9 36.9 24.6 11.7 30.5 5.8 19.7 12.4 19.5 15.1 9.4 18.1 20.4 20.4 16.9 21.5 7.9 8.0 16.4 12.7 18.2 12.2 8.2 21.2 16.9 12.2 16.4 20.0 19.8 14.6 10.4 8.6 6.4 23.3 15.6 20.4 20.0 14.0 6.5 6.4 13.4 10.8 18.6 10.7 11.5 24.3 10.8 9.6 15.4 17.8 21.4 14.7 30.5 32.7 12.4 31.7 12.4 13.7 13.0 14.3 15.5 15.9 16.1 22.2 18.4 19.3 18.0 18.1 20.1 21.2 2.1 16.6 14.2 22.0 18.1 10.0 25.1 25.4 21.5 23.6 23.2 22.2 20.9 16.2 23.3 17.5 20.8 35.4 37.1 87.7 0.0 18.7 49.5 17.8 33.5 30.7 22.7 9.8 72.3 157.5 66.4 145.7 28.1 24.8 0.0 67.7 77.3 45.1 82.1 19.8 41.0 62.2 19.1 9.4 27.6 25.3 216.1 31.1 35.2 0.0 50.5 24.5 36.8 52.7 29.1 30.1 110.2 20.0 51.8 65.6 42.4 42.4 0.0 55.4 25.9 41.3 76.3 AKAP10 "D-AKAP2, MGC9414, PRKA10" ENSG00000108599 "A-kinase anchoring protein 10" O43572 17 19904302-19978343 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028901 Approved Supported "Plasma membrane,Cytosol" Yes No "Plasma membrane, Cytosol" "HPA028901: AB_10602227" "unprognostic (2.17e-2)" "unprognostic (3.48e-2)" "unprognostic (5.33e-1)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-3)" "unprognostic (3.88e-1)" "unprognostic (7.69e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (3.21e-2)" "unprognostic (3.21e-2)" "unprognostic (2.49e-2)" "unprognostic (7.15e-2)" "unprognostic (2.16e-2)" "unprognostic (5.20e-2)" 20.5 24.2 22.5 19.4 25.5 16.1 21.2 22.8 27.9 21.2 19.4 17.4 13.4 16.1 22.3 15.9 18.5 19.2 18.4 14.4 20.1 17.9 22.7 14.9 18.5 24.3 22.4 23.2 24.3 16.2 28.0 20.3 20.3 19.2 19.5 20.3 16.1 17.8 21.3 13.7 17.5 18.5 22.9 19.0 28.6 20.2 22.9 24.2 25.9 26.0 9.1 20.5 22.2 22.7 7.3 6.1 24.4 10.3 5.1 7.9 3.0 8.7 10.5 7.0 4.9 9.3 11.8 13.0 10.2 11.0 11.4 13.7 11.4 5.3 7.5 6.9 8.1 9.9 9.3 9.0 8.5 15.6 6.2 7.7 6.4 10.3 5.5 8.8 4.6 10.6 9.9 10.7 10.4 12.9 12.8 9.1 9.2 4.1 3.8 11.8 6.3 8.6 6.9 4.6 12.2 3.6 5.7 23.0 3.9 9.5 5.6 2.4 7.2 11.7 5.5 9.7 45.2 13.4 5.2 8.0 8.8 7.3 7.5 9.4 4.7 5.0 9.2 11.7 5.6 8.5 3.6 7.3 8.8 6.7 10.3 6.1 6.0 6.5 7.2 6.1 7.3 7.9 7.0 24.4 5.1 9.3 4.6 4.9 3.0 22.5 25.5 22.8 27.9 20.1 17.9 22.4 23.2 19.2 24.2 3.0 10.5 23.8 8.2 6.3 24.2 7.7 10.2 18.7 13.6 5.2 15.7 11.8 1.7 8.1 10.1 10.0 11.8 0.0 6.2 9.3 8.2 12.9 9.3 11.1 14.2 31.8 6.9 16.0 28.9 8.5 14.1 22.0 5.0 21.6 10.6 10.9 7.0 14.8 13.1 4.5 23.0 19.4 9.9 15.1 25.3 6.8 11.7 17.3 10.3 9.8 AKAP11 "AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11" ENSG00000023516 "A-kinase anchoring protein 11" Q9UKA4 13 42272153-42323267 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039089 Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoli, Plasma membrane, Cytosol" "HPA039089: AB_10674279" "unprognostic (6.43e-2)" "prognostic unfavorable (9.26e-4)" "unprognostic (4.91e-1)" "unprognostic (6.89e-2)" "unprognostic (1.92e-1)" "unprognostic (7.34e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (7.91e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (7.49e-3)" "unprognostic (7.44e-2)" "unprognostic (1.49e-1)" "unprognostic (6.02e-2)" "unprognostic (1.10e-1)" 11.2 13.6 21.7 10.0 42.3 3.0 11.0 19.9 30.7 17.1 9.1 9.0 5.9 6.9 13.0 15.2 10.2 10.2 9.7 10.4 18.3 17.9 12.9 9.9 10.2 13.4 16.4 22.8 14.6 6.4 11.6 14.5 7.2 20.3 11.1 10.1 6.7 7.6 12.4 5.7 9.1 8.1 13.4 21.4 11.7 9.5 18.1 16.0 5.6 13.3 4.6 12.6 10.4 9.4 3.0 1.6 4.2 1.4 4.8 2.7 0.7 9.4 9.7 11.9 7.0 15.6 19.2 5.2 12.8 10.7 7.8 7.3 10.6 7.9 19.5 5.0 14.3 8.2 11.3 10.3 10.7 14.9 20.7 4.8 5.5 6.7 5.2 12.3 13.6 13.5 14.0 11.1 15.8 13.9 11.4 11.3 9.8 18.0 7.9 15.6 7.1 7.9 4.4 7.0 13.9 4.5 6.6 8.4 9.4 7.7 7.0 5.1 7.4 9.8 6.5 4.5 5.7 5.6 7.4 15.7 13.2 6.9 19.8 9.6 3.0 3.8 10.1 16.8 7.0 9.2 4.2 0.9 1.2 1.7 1.1 2.1 2.7 2.4 1.6 1.0 3.0 2.1 2.1 0.3 4.8 1.4 1.6 2.7 0.7 21.7 42.3 19.9 24.6 18.3 17.9 16.4 22.8 20.3 16.0 23.8 23.3 15.9 13.0 10.9 54.0 42.5 15.3 30.8 40.9 27.9 35.3 3.6 1.7 10.1 7.6 19.9 8.4 23.3 8.1 3.1 16.4 11.4 33.5 19.7 10.7 39.7 20.2 27.6 23.5 9.4 20.1 21.2 8.5 11.8 14.2 66.5 10.8 15.8 31.5 17.7 36.7 19.4 17.9 31.7 33.9 14.8 2.1 15.9 11.2 11.3 AKAP12 "AKAP250, SSeCKS" ENSG00000131016 "A-kinase anchoring protein 12" Q02952 6 151239999-151358557 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ito cells: 255.3;Muller glia cells: 521.2;Spermatocytes: 222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 184 "basophil: 20.4" "Lineage enriched" "Detected in single" 184 "granulocytes: 20.4" "Cell line enhanced" "Detected in many" "GAMG: 37.5;REH: 42.9;TIME: 42.7;U-251 MG: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006344, CAB026379, HPA056230" Enhanced Enhanced "Plasma membrane,Cytosol" No No 6400000 "Plasma membrane, Cytosol" "CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073" "unprognostic (6.66e-2)" "unprognostic (1.51e-1)" "unprognostic (9.90e-3)" "prognostic unfavorable (7.08e-4)" "unprognostic (2.61e-2)" "unprognostic (8.88e-2)" "unprognostic (5.05e-2)" "prognostic unfavorable (6.34e-5)" "unprognostic (1.34e-1)" "unprognostic (8.26e-3)" "unprognostic (2.59e-1)" "unprognostic (4.72e-2)" "unprognostic (4.51e-3)" "unprognostic (1.10e-3)" "unprognostic (3.51e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-2)" 52.5 11.2 11.5 11.0 18.1 2.0 38.5 31.3 21.2 11.5 23.4 1.9 5.9 6.1 20.5 13.6 12.8 15.6 32.3 22.8 9.8 17.4 14.9 20.6 18.2 6.9 11.4 9.9 49.0 7.6 2.0 11.1 24.1 28.7 13.5 9.4 26.6 3.3 14.7 11.3 4.1 10.6 27.9 14.1 8.1 12.4 62.0 6.6 0.3 11.4 6.6 2.8 34.5 24.7 0.0 0.0 20.4 0.0 0.0 0.1 0.0 1.7 8.5 12.3 0.0 23.3 35.0 4.3 10.0 5.4 4.5 4.5 0.2 32.4 0.0 4.0 7.5 37.5 0.2 23.4 7.4 4.0 11.1 8.6 0.1 9.5 7.9 2.6 0.0 2.2 24.7 0.0 19.0 1.0 5.9 29.3 0.1 2.1 0.2 16.2 0.1 0.0 0.0 7.7 0.0 10.1 42.9 0.5 0.0 26.0 1.4 8.8 5.1 3.2 0.1 5.6 18.2 0.6 0.1 42.7 0.6 8.0 25.5 45.7 0.0 0.0 0.0 14.8 0.0 8.5 20.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.1 31.3 19.1 9.8 17.4 11.4 9.9 28.7 6.6 11.9 21.0 12.7 21.4 17.4 9.5 7.8 7.6 8.1 23.9 48.8 2.0 1.6 1.7 120.3 57.8 105.1 0.0 0.0 5.7 5.5 80.8 45.7 64.5 3.9 20.4 0.0 1.7 255.3 23.1 93.7 36.8 11.7 55.6 1.0 0.0 521.2 193.7 0.0 104.0 64.3 24.1 97.0 171.6 222.6 34.3 9.9 8.4 7.2 0.0 129.4 AKAP13 "AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB" ENSG00000170776 "A-kinase anchoring protein 13" Q12802 15 85380571-85749358 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 334.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 57.9" "Low region specificity" "Detected in all" HPA019773 Approved Supported Cytosol NA NA Cytosol "HPA019773: AB_1844686" "unprognostic (4.61e-2)" "unprognostic (1.16e-1)" "unprognostic (3.96e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (5.33e-2)" "unprognostic (7.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (3.99e-2)" "unprognostic (3.92e-1)" "unprognostic (6.69e-2)" "unprognostic (4.88e-2)" "unprognostic (4.80e-2)" "unprognostic (1.46e-1)" "unprognostic (3.81e-3)" 35.9 11.1 7.2 32.5 9.3 23.7 17.1 1.9 7.8 24.6 13.6 8.4 23.0 7.8 57.8 24.5 16.1 16.3 22.1 40.5 8.8 6.1 10.9 14.0 54.9 40.1 9.0 5.5 20.0 26.4 8.0 40.5 22.5 12.4 16.7 10.4 17.2 17.8 26.5 35.8 17.0 21.0 37.4 13.7 42.9 17.8 15.0 7.1 36.0 26.0 18.7 38.6 24.6 18.2 19.3 27.1 61.4 19.4 27.7 35.4 11.0 4.7 10.5 7.6 2.8 11.5 12.8 4.2 3.9 8.3 3.4 3.3 4.0 3.9 21.9 5.5 6.6 8.6 9.8 8.3 3.5 3.2 16.0 4.2 28.7 7.1 3.0 6.3 5.8 57.9 9.3 9.3 4.2 14.3 3.8 9.0 7.8 1.8 10.4 5.1 2.2 8.3 4.4 4.8 7.8 4.3 5.9 7.6 8.0 5.4 9.7 4.8 8.7 10.4 2.9 5.4 8.4 2.1 4.9 10.3 4.1 2.9 2.5 3.8 16.5 10.4 17.5 2.4 19.1 3.2 61.4 17.8 46.3 35.4 14.9 19.7 19.3 23.7 26.2 10.3 19.2 20.1 22.1 29.0 27.7 19.4 27.1 18.8 11.0 7.2 9.3 1.9 7.8 8.8 6.1 9.0 5.5 12.4 7.1 116.1 334.6 137.1 78.6 67.2 14.1 192.2 61.1 66.9 83.0 38.4 39.3 28.1 5.0 64.0 191.2 85.8 74.3 0.0 61.0 23.2 98.8 69.1 266.3 40.4 69.7 12.7 61.0 62.6 122.3 118.3 71.9 149.2 94.5 132.6 46.2 47.4 80.6 56.3 59.8 8.3 17.2 84.1 70.0 22.6 29.6 69.1 19.6 196.1 44.7 144.5 AKAP17A "721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y" ENSG00000197976 "A-kinase anchoring protein 17A" Q02040 X 1591593-1602514 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043247, HPA051020" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA043247: AB_10964776, HPA051020: AB_2681314" "unprognostic (4.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.40e-4)" "unprognostic (5.38e-2)" "unprognostic (1.59e-2)" "unprognostic (9.73e-3)" "unprognostic (6.25e-2)" "unprognostic (2.09e-1)" "unprognostic (7.91e-3)" "prognostic favorable (2.42e-4)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.52e-7)" "unprognostic (1.86e-2)" "unprognostic (2.71e-1)" "unprognostic (4.03e-2)" "prognostic favorable (1.11e-5)" 7.4 10.3 28.1 14.5 42.3 18.0 24.5 27.5 25.2 32.8 7.2 2.5 2.5 14.2 40.9 9.7 9.2 9.1 7.4 12.5 27.1 3.4 20.3 16.4 12.2 15.4 37.6 27.1 38.0 15.6 5.2 31.0 42.7 33.7 12.6 4.3 2.5 17.0 7.8 6.9 12.3 11.6 3.2 27.8 21.4 14.2 7.0 37.2 2.5 16.1 2.5 8.9 6.8 47.6 1.8 1.8 7.0 1.0 1.3 1.6 0.4 9.6 12.5 10.0 11.3 4.9 6.3 24.5 10.5 4.3 8.5 7.2 13.8 9.0 14.6 6.8 5.2 12.0 8.5 6.0 5.2 5.1 12.0 20.8 18.2 12.0 12.8 10.6 7.0 30.6 5.6 9.8 6.3 7.0 10.1 5.8 7.4 11.3 9.3 4.9 6.4 15.5 30.5 14.9 2.2 10.8 11.8 11.9 12.2 5.7 6.8 11.2 16.4 8.2 13.4 12.7 8.6 8.7 12.9 11.2 13.3 6.1 11.4 9.1 40.2 6.7 20.3 5.4 11.5 3.5 7.0 1.0 1.9 0.8 0.5 0.9 1.8 1.0 1.6 0.6 1.2 0.8 0.8 4.1 1.3 0.8 1.8 0.5 0.4 28.1 42.3 27.5 25.2 27.1 3.4 37.6 27.1 33.7 37.2 23.8 25.9 29.8 31.3 39.4 23.2 9.9 7.6 10.7 21.6 12.2 9.8 20.9 11.6 17.7 40.2 26.1 21.4 0.0 13.4 24.6 26.6 35.0 25.3 19.5 20.2 15.9 21.7 29.4 20.6 11.0 35.9 36.0 38.8 27.9 23.5 23.7 19.9 24.6 29.7 5.7 13.9 0.0 25.5 16.3 30.3 41.3 60.8 37.0 20.0 42.9 AKNAD1 "C1orf62, MGC26989" ENSG00000162641 "AKNA domain containing 1" Q5T1N1 1 108815898-108858228 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 57 "testis: 12.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 58.5" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.5;HBEC3-KT: 1.3;hTCEpi: 4.0;hTERT-HME1: 2.2;LHCN-M2: 1.2" "HPA030270, HPA030271, HPA030272" Uncertain Approved "Microtubules,Cytokinetic bridge,Cytosol" NA NA Cytosol "Microtubules, Cytokinetic bridge" "HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342" "unprognostic (4.93e-2)" "unprognostic (1.72e-1)" "unprognostic (5.52e-2)" "unprognostic (2.00e-3)" "unprognostic (7.22e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-5)" "unprognostic (8.15e-2)" "unprognostic (5.95e-2)" "unprognostic (2.83e-2)" "unprognostic (1.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.00e-8)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "unprognostic (5.75e-2)" "unprognostic (8.22e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.9 0.6 0.0 0.9 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 3.5 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 2.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 58.5 1.0 0.0 0.0 0.2 0.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.6 2.3 0.0 1.7 0.0 0.3 0.6 0.3 0.0 1.1 0.0 0.0 0.0 0.7 0.5 0.7 0.1 0.6 0.0 0.4 0.0 AKR1A1 "ALR, DD3" ENSG00000117448 "Aldo-keto reductase family 1 member A1" P14550 1 45550543-45570049 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Proximal tubular cells: 1001.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006246, HPA017919, HPA019649, HPA027734" Approved Supported Nucleoplasm,Cytosol NA NA 8100000 Cytosol Nucleoplasm "CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976" "unprognostic (1.73e-1)" "prognostic favorable (2.66e-6)" "unprognostic (4.03e-1)" "prognostic favorable (2.92e-4)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (6.54e-3)" "unprognostic (1.31e-3)" "unprognostic (2.52e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (8.43e-2)" "unprognostic (4.51e-2)" "unprognostic (1.56e-2)" "unprognostic (2.46e-1)" "unprognostic (2.89e-2)" "unprognostic (4.57e-2)" 20.0 20.4 12.0 27.9 13.9 9.7 31.8 11.5 23.6 21.7 39.6 18.7 20.0 43.6 18.5 31.7 39.0 21.8 31.7 18.5 11.2 12.0 79.6 80.4 26.0 33.8 15.0 13.9 18.3 44.2 11.3 27.5 20.2 13.1 19.4 28.9 16.7 59.8 24.1 13.4 18.2 69.7 19.4 16.3 25.6 27.7 10.5 13.1 24.8 24.6 31.3 33.2 17.4 18.6 23.3 46.8 26.8 56.3 13.8 18.7 38.4 16.4 23.8 21.8 16.8 47.4 34.4 15.4 19.5 45.7 17.1 34.5 9.9 12.7 40.6 15.7 22.3 17.9 21.1 22.9 28.5 16.1 16.3 20.6 23.5 20.2 43.3 39.6 30.3 26.4 38.0 25.8 21.6 40.2 32.3 39.4 29.6 12.0 32.5 20.0 11.9 32.4 13.2 23.7 53.3 16.3 37.4 26.1 47.1 48.6 22.5 26.0 15.0 16.9 67.5 24.7 31.3 18.9 17.4 24.0 7.9 17.6 27.4 11.6 22.4 29.9 19.1 15.5 39.5 6.7 26.8 56.3 10.5 16.3 51.8 17.8 23.3 15.3 16.0 46.8 22.7 13.1 13.5 2.6 13.8 38.1 40.8 18.7 38.4 12.0 13.9 11.5 23.6 11.2 12.0 15.0 13.9 13.1 13.1 44.7 49.4 132.5 80.9 43.7 20.8 32.3 96.8 60.2 53.4 75.0 35.3 93.6 154.2 163.4 4.1 51.7 130.2 0.0 136.9 121.2 79.9 92.3 108.6 269.4 347.1 15.9 113.6 74.9 110.8 5.9 63.3 159.5 77.6 161.5 133.1 26.5 118.5 151.9 52.6 1001.5 34.9 6.5 49.5 3.2 27.2 41.0 56.8 53.3 166.2 98.2 AKR1B1 "ALDR1, AR" ENSG00000085662 "Aldo-keto reductase family 1 member B" P15121 7 134442350-134459284 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adrenal gland: 302.2;seminal vesicle: 109.3" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026425, CAB027391, CAB047353, HPA052751" Enhanced Supported Nucleoplasm,Cytosol No No 1700000 Cytosol Nucleoplasm "CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935" "unprognostic (2.76e-2)" "unprognostic (2.84e-2)" "unprognostic (2.02e-2)" "unprognostic (1.37e-2)" "unprognostic (6.81e-2)" "unprognostic (2.26e-1)" "unprognostic (4.18e-2)" "unprognostic (5.09e-2)" "unprognostic (2.51e-3)" "unprognostic (2.47e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "prognostic unfavorable (2.44e-5)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.00e-4)" 5.9 302.2 7.5 4.7 13.7 2.5 9.5 6.9 10.9 4.4 3.9 8.2 50.4 2.7 4.6 6.1 4.2 4.6 5.2 24.2 7.3 8.4 17.7 2.5 6.9 10.0 9.5 9.0 8.2 7.2 9.4 8.0 24.8 11.9 5.5 4.1 5.8 4.4 109.3 37.6 2.8 4.8 5.6 7.9 6.7 5.0 5.2 5.9 7.3 6.0 10.3 7.6 7.1 3.7 31.4 34.8 22.5 26.0 26.3 42.7 47.2 13.5 122.4 13.8 19.5 59.5 16.2 36.8 13.1 224.5 19.3 25.0 5.6 12.4 0.0 6.1 21.9 85.2 5.7 15.0 13.1 15.4 4.8 13.7 6.9 18.4 16.6 85.3 0.0 0.0 15.1 9.8 27.6 7.3 18.9 27.2 13.6 0.0 4.6 21.3 0.2 20.3 9.3 22.9 0.9 0.1 21.2 8.8 10.2 106.2 66.2 10.3 22.9 91.9 0.1 9.6 9.4 0.0 10.3 21.4 19.1 8.9 1.7 14.2 12.6 13.9 34.2 101.0 0.0 11.4 22.5 26.0 1.2 37.9 17.0 34.0 31.4 32.4 36.7 34.8 28.5 42.7 41.1 2.1 26.3 8.9 4.9 22.0 47.2 7.5 13.7 6.9 10.9 7.3 8.4 9.5 9.0 11.9 5.9 11.9 23.7 50.6 46.4 18.3 34.0 127.0 30.6 24.1 23.9 615.9 7.9 969.9 139.3 102.5 3.0 53.2 0.7 0.0 35.6 1080.2 76.5 15.6 52.0 1.3 331.4 68.3 29.7 89.6 135.4 11.5 73.4 69.6 28.7 93.8 13.6 46.3 62.2 5.8 72.9 43.7 20.2 58.2 30.9 20.7 70.9 10.2 1691.2 45.4 5.0 37.4 AKR1B10 "AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI" ENSG00000198074 "Aldo-keto reductase family 1 member B10" O60218 7 134527592-134541408 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 41.5;intestine: 99.7;stomach 1: 68.6" "Group enriched" "Detected in many" 5 "Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4" "Cancer enhanced" "Detected in many" "liver cancer: 353.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 99 "A549: 217.4;Hep G2: 60.3;OE19: 227.4" "HPA020280, CAB070163, HPA073633" Enhanced Supported "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 68000000 Cytosol "Plasma membrane" "CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (1.29e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.91e-4)" "unprognostic (6.03e-2)" "unprognostic (4.67e-2)" "unprognostic (2.57e-1)" "unprognostic (2.16e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (4.80e-9)" "unprognostic (2.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" 0.6 0.8 0.6 2.2 0.6 0.0 0.6 0.6 0.6 13.1 11.5 0.6 0.6 99.7 0.6 0.9 41.5 0.0 28.9 0.6 0.6 0.0 4.0 6.3 2.0 0.6 0.6 0.6 0.6 0.6 0.0 2.5 0.6 0.6 2.0 7.3 1.3 6.1 0.6 0.6 1.0 54.1 7.1 0.6 0.6 68.6 0.8 0.6 0.9 0.7 28.6 3.6 16.3 22.9 0.4 0.1 1.8 0.2 0.4 0.2 0.1 0.0 217.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 60.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 227.4 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.2 1.8 0.4 0.1 0.1 0.1 0.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 0.0 0.0 0.5 1.9 2.5 0.0 0.4 275.2 5.3 1.2 0.0 0.0 0.2 0.0 21.5 0.3 0.0 221.4 23.3 23.1 0.1 0.1 0.3 0.0 31.6 0.0 0.0 3.4 3.7 1.6 0.4 3.1 0.0 0.0 1.0 11.7 0.0 89.4 24.6 1.8 1.4 0.0 0.0 0.9 0.0 0.0 9.2 0.2 0.0 41.3 5.2 AKR1B15 ENSG00000227471 "Aldo-keto reductase family 1 member B15" C9JRZ8 7 134549136-134579875 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 61.7;placenta: 31.8" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 2.3;Late spermatids: 2.7;Syncytiotrophoblasts: 8.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "A549: 15.5;HDLM-2: 12.3;Hep G2: 10.8;SK-BR-3: 5.2;U-87 MG: 6.6" "HPA020280, HPA073633" Uncertain Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (2.35e-1)" "unprognostic (3.85e-2)" "unprognostic (9.74e-3)" "unprognostic (2.74e-2)" "unprognostic (2.08e-1)" "prognostic favorable (8.36e-4)" "prognostic unfavorable (1.80e-5)" "unprognostic (5.04e-2)" "unprognostic (2.39e-1)" "unprognostic (2.75e-1)" "unprognostic (2.14e-3)" "unprognostic (1.24e-1)" "unprognostic (1.22e-7)" "unprognostic (6.88e-2)" "unprognostic (4.29e-1)" "unprognostic (2.99e-3)" "prognostic unfavorable (1.90e-5)" 2.7 0.1 0.1 0.1 0.1 0.0 61.7 0.1 0.2 1.6 0.6 0.2 0.1 5.6 0.1 1.5 3.8 0.0 2.2 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 31.8 0.2 0.8 0.2 0.5 2.9 0.1 11.6 1.9 1.7 0.8 0.4 0.1 5.0 0.6 0.1 0.3 0.4 16.1 1.8 1.5 3.0 0.1 0.0 1.8 0.1 0.4 0.0 0.3 0.0 15.5 0.2 0.0 0.6 0.5 1.0 0.0 0.4 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.0 0.1 0.0 12.3 0.1 0.1 0.2 10.8 0.0 0.2 0.5 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 3.2 0.3 0.0 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.6 5.2 0.0 0.1 0.1 0.3 0.0 0.1 0.7 0.4 0.0 0.2 0.2 0.2 6.6 0.2 0.2 1.8 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.1 AKR1C1 "DD1, DDH, DDH1, HAKRC, MBAB" ENSG00000187134 "Aldo-keto reductase family 1 member C1" Q04828 10 4963253-4983283 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 145.9;tongue: 74.5" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8" "Cancer enhanced" "Detected in many" "liver cancer: 64.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 8 "ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5" "CAB047303, HPA068265" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "CAB047303: , HPA068265: AB_2685966" "unprognostic (1.54e-2)" "prognostic favorable (3.05e-4)" "unprognostic (4.04e-2)" "unprognostic (8.38e-2)" "unprognostic (3.18e-2)" "unprognostic (7.05e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (8.38e-2)" "unprognostic (4.65e-1)" "unprognostic (1.82e-2)" "prognostic favorable (8.03e-9)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (6.30e-2)" 52.0 3.8 2.1 3.4 4.1 1.4 36.0 2.6 2.7 2.2 3.2 2.6 1.2 6.2 1.4 4.0 19.2 1.7 16.1 22.1 2.6 2.6 32.0 145.9 11.2 2.5 5.4 1.4 3.8 4.9 0.6 4.1 0.7 6.6 5.1 3.2 3.8 13.1 3.4 17.1 4.7 4.6 4.8 6.8 0.9 21.9 5.2 3.2 0.0 11.5 74.5 5.0 17.4 10.8 0.0 0.9 4.2 0.1 0.3 1.7 0.8 0.0 25.5 0.1 25.7 185.8 22.4 0.0 0.8 5.7 0.3 0.2 0.4 0.0 0.0 0.3 5.7 4.4 0.2 0.0 1.3 0.1 0.0 0.0 0.7 4.1 315.1 1.8 0.1 0.0 11.4 1.6 2.6 1.6 0.0 0.6 0.1 5.4 0.0 4.4 0.1 0.0 0.0 0.0 134.5 0.0 0.0 0.0 0.2 1.4 4.8 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.4 5.0 2.2 0.1 5.9 0.2 0.1 0.0 0.0 7.9 0.7 0.0 4.2 0.1 1.1 1.7 0.0 0.1 0.0 0.7 0.4 0.2 0.0 0.3 1.5 0.9 0.3 0.0 0.9 0.4 0.8 2.1 4.1 2.6 2.7 2.6 2.6 5.4 1.4 6.6 3.2 62.5 27.2 1.5 11.8 18.8 2.5 2.4 239.5 96.4 128.5 59.3 0.0 0.0 11.6 33.9 14.9 17.8 9.3 70.0 290.3 0.0 13.4 11.4 4.6 511.8 0.3 0.0 1.7 26.4 14.5 8.0 140.4 3.8 101.3 8.2 1.7 47.9 184.6 0.9 138.6 40.8 4.3 0.0 14.4 1.7 0.7 17.9 0.1 0.9 2.6 140.8 AKR1C2 "BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD" ENSG00000151632 "Aldo-keto reductase family 1 member C2" P52895 10 4987400-5018031 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 71.9;liver: 122.7;tongue: 111.8" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 135.0;Hepatocytes: 341.7;Pancreatic endocrine cells: 140.7" "Group enriched" "Detected in many" 6 "cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "Group enriched" "Detected in some" 4 "A549: 130.6;ASC diff: 162.1;Hep G2: 243.7;OE19: 168.2;RT4: 74.6" "CAB047304, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB047304: , HPA068265: AB_2685966" "unprognostic (6.77e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (2.86e-2)" "unprognostic (8.65e-2)" "unprognostic (5.03e-2)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.25e-3)" "unprognostic (8.58e-2)" "unprognostic (1.09e-2)" "unprognostic (8.60e-3)" "unprognostic (1.46e-2)" "unprognostic (8.30e-2)" 60.4 4.0 1.8 2.0 3.3 0.0 71.9 2.5 2.1 1.3 2.9 1.0 1.2 5.5 1.0 3.0 17.4 1.5 19.4 9.3 1.7 2.3 4.8 122.7 5.9 1.1 4.7 0.9 1.9 2.4 0.0 1.8 0.1 4.2 8.1 2.4 2.0 12.0 2.4 19.8 4.2 2.4 4.4 3.9 0.6 26.2 2.3 2.6 0.1 4.2 111.8 5.5 25.3 11.9 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 130.6 0.1 13.8 162.1 5.6 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.0 0.7 0.9 0.6 3.6 0.0 0.6 0.0 0.0 0.0 0.0 36.8 243.7 0.3 0.0 0.0 14.5 8.2 0.6 0.6 0.0 0.0 0.0 5.0 0.0 1.3 0.2 0.0 0.0 0.0 168.2 0.0 0.0 0.0 2.1 1.2 74.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.1 4.8 0.0 0.0 0.0 0.0 1.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.8 3.3 2.5 2.1 1.7 2.3 4.7 0.9 4.2 2.6 11.9 3.2 0.0 3.2 10.5 1.8 3.7 135.0 18.7 19.4 0.0 0.0 0.0 0.0 12.3 18.3 8.7 9.3 0.0 93.5 0.1 15.0 4.5 0.0 341.7 0.1 3.2 1.7 12.3 13.7 5.6 73.4 1.1 8.5 1.0 2.8 33.8 140.7 7.0 73.9 2.6 2.6 0.0 7.6 0.3 0.3 11.8 0.0 1.3 7.4 79.1 AKR1C3 "DDX, HAKRB, HSD17B5, KIAA0119, PGFS" ENSG00000196139 "Aldo-keto reductase family 1 member C3" P42330 10 5035354-5107686 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.1;intestine: 52.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 261.7;Exocrine glandular cells: 644.1;Pancreatic endocrine cells: 362.8;Proximal tubular cells: 434.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 50.1;gdT-cell: 26.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 115.0;ASC diff: 66.2;Hep G2: 48.3;OE19: 226.4;RT4: 45.4" "CAB010874, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 11000000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB010874: AB_476751, HPA068265: AB_2685966" "unprognostic (4.20e-3)" "unprognostic (2.70e-2)" "unprognostic (8.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.41e-1)" "unprognostic (6.74e-2)" "unprognostic (5.08e-2)" "unprognostic (1.31e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (4.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.79e-3)" "unprognostic (4.24e-3)" 16.6 6.6 3.2 3.2 3.9 3.5 12.8 3.2 3.9 3.2 17.3 3.2 3.2 52.3 3.2 3.2 6.0 4.5 32.2 4.8 4.4 1.0 20.1 34.4 5.5 3.2 3.2 3.2 3.2 4.2 1.8 3.2 3.2 4.2 3.2 11.4 3.2 4.4 3.2 13.0 2.6 31.1 4.2 3.2 3.2 28.6 3.2 3.2 3.2 3.2 3.2 3.2 12.3 3.2 0.1 9.6 50.1 0.7 4.6 26.7 9.7 0.0 115.0 0.0 33.6 66.2 23.8 0.0 0.0 1.6 0.0 0.1 3.4 1.9 0.0 6.2 1.5 3.4 0.9 0.1 2.3 0.0 0.2 0.0 0.2 35.6 48.3 0.3 0.0 0.0 13.2 4.7 1.5 0.0 1.9 2.2 0.2 0.7 0.0 3.0 0.2 0.7 0.1 0.0 226.4 0.3 0.2 0.7 3.4 11.3 45.4 0.0 0.2 16.5 0.0 0.0 0.0 0.0 0.0 16.0 0.3 0.3 6.9 0.2 0.0 0.0 0.0 3.8 4.5 0.3 50.1 0.7 1.1 26.7 0.2 1.7 0.0 5.0 4.8 0.5 0.1 3.2 2.4 1.9 4.6 0.3 9.6 4.9 9.7 3.2 3.9 3.2 3.9 4.4 1.0 3.2 3.2 4.2 3.2 41.7 4.0 1.5 1.1 10.6 1.7 3.6 0.0 88.3 61.4 34.9 0.0 0.1 36.5 85.3 2.9 61.2 261.7 0.0 644.1 0.0 13.8 0.7 5.7 0.0 1.6 1.6 18.4 0.0 0.0 2.1 72.5 19.0 20.3 5.4 31.0 121.7 362.8 121.1 100.4 434.1 3.6 25.8 8.0 0.3 0.7 9.4 0.0 0.0 103.0 27.3 AKR1C4 "3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581" ENSG00000198610 "Aldo-keto reductase family 1 member C4" P17516 10 5195462-5218949 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 127.0" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 437.4" "Cancer enriched" "Detected in some" 86 "liver cancer: 108.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.2;gdT-cell: 1.1" "Group enriched" "Detected in many" 6 "granulocytes: 1.2;T-cells: 1.1" "Group enriched" "Detected in some" 4 "HDLM-2: 11.6;OE19: 5.1" "HPA044720, HPA068265" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 1800000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA044720: AB_2679058, HPA068265: AB_2685966" "unprognostic (2.21e-1)" "unprognostic (3.04e-1)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (5.99e-2)" "unprognostic (9.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-1)" "unprognostic (7.34e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 127.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 1.1 0.1 0.0 1.5 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.5 0.3 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 5.1 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 45.9 2.7 1.2 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 23.3 0.6 0.0 0.0 0.0 0.0 437.4 0.0 0.0 0.0 14.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 AKR1D1 SRD5B1 ENSG00000122787 "Aldo-keto reductase family 1 member D1" P51857 7 138002324-138117986 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 103.2" "Group enriched" "Detected in some" 41 "Early spermatids: 50.2;Hepatocytes: 96.2;Late spermatids: 85.4" "Cancer enriched" "Detected in single" 77 "liver cancer: 20.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 20 "Hep G2: 16.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA057002 Enhanced Approved Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA057002: AB_2683308" "unprognostic (2.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "prognostic favorable (9.91e-5)" "unprognostic (6.11e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (6.87e-2)" "unprognostic (2.94e-1)" "unprognostic (9.68e-3)" "unprognostic (2.90e-1)" "unprognostic (5.80e-2)" "unprognostic (3.11e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 2.7 0.5 0.7 0.7 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.8 0.3 0.2 0.1 0.0 0.6 0.3 0.0 0.0 0.2 0.3 0.1 0.4 0.3 16.9 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.2 0.1 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.4 0.3 0.2 0.1 0.3 0.2 0.3 0.3 0.2 0.2 0.3 0.3 2.7 0.5 0.6 0.4 0.4 0.3 0.6 0.4 0.4 0.3 1.1 0.5 0.7 1.8 0.7 0.5 0.5 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 50.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 96.2 0.4 0.0 0.0 1.3 1.9 85.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.1 AKR7A2 AFAR ENSG00000053371 "Aldo-keto reductase family 7 member A2" O43488 1 19303965-19312146 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Proximal tubular cells: 516.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032587, CAB032841, HPA064638" Enhanced Supported Cytosol NA NA 2700000 Cytosol "CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307" "unprognostic (1.06e-1)" "unprognostic (3.48e-2)" "unprognostic (7.23e-2)" "unprognostic (5.76e-2)" "unprognostic (9.92e-2)" "unprognostic (1.09e-1)" "unprognostic (1.14e-2)" "unprognostic (3.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (5.11e-2)" "unprognostic (7.11e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.72e-2)" "unprognostic (8.53e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.59e-4)" 21.2 39.0 25.2 14.0 26.9 15.2 22.0 19.8 26.2 32.9 38.5 28.1 28.7 56.0 20.2 23.0 25.7 35.1 31.9 31.2 22.0 19.4 49.3 32.4 14.4 21.9 24.9 26.2 31.6 60.8 14.8 19.0 17.2 23.6 19.9 19.5 25.8 21.4 24.9 33.8 18.8 43.1 20.8 20.0 16.3 22.3 21.6 21.4 24.7 22.9 20.2 18.3 16.7 21.6 23.0 40.1 13.7 29.0 22.2 27.1 23.5 24.1 15.3 16.8 15.5 26.6 25.9 11.2 18.1 22.2 25.4 22.9 19.4 20.5 17.5 19.4 24.3 14.3 19.3 18.7 27.2 12.1 13.9 29.7 11.0 14.8 31.0 20.7 12.1 8.9 25.8 21.5 19.5 12.0 24.1 21.5 23.1 16.0 16.5 26.0 24.1 23.5 11.8 4.8 34.0 19.3 24.8 21.0 30.9 24.7 10.7 31.6 11.8 19.7 17.9 30.4 10.0 35.5 42.3 16.8 15.9 16.9 17.1 13.5 20.1 12.6 21.4 34.4 27.9 22.4 0.1 29.0 13.7 23.0 23.7 26.8 23.0 20.7 20.3 40.1 21.4 23.9 20.6 3.4 22.2 17.8 35.0 27.1 23.5 25.2 26.9 19.8 26.2 22.0 19.4 24.9 26.2 23.6 21.4 14.9 21.1 39.8 56.3 21.6 32.8 23.2 94.3 28.1 11.4 73.3 5.9 113.3 215.5 57.4 69.6 30.0 128.4 23.3 32.2 83.3 55.7 48.3 10.3 81.5 89.0 20.6 95.6 38.1 55.4 39.4 71.7 32.8 50.6 63.1 87.2 111.7 40.7 123.6 63.6 516.4 22.5 45.3 39.1 63.0 23.2 29.7 85.8 48.1 129.1 48.9 AKR7A3 ENSG00000162482 "Aldo-keto reductase family 7 member A3" O95154 1 19282558-19289250 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 48.5;liver: 27.4;pancreas: 59.0;stomach 1: 35.5" "Cell type enhanced" "Detected in many" 19 "Cholangiocytes: 178.3;Enterocytes: 187.5;Proximal tubular cells: 542.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Group enriched" "Detected in some" 4 "OE19: 11.3;SK-BR-3: 18.4" HPA064638 Approved Cytosol NA NA 1000000 Cytosol "HPA064638: AB_2685307" "unprognostic (7.78e-2)" "unprognostic (5.07e-2)" "unprognostic (6.08e-2)" "unprognostic (1.61e-1)" "unprognostic (1.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (7.70e-3)" "unprognostic (2.72e-1)" "unprognostic (2.50e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.80e-7)" "unprognostic (4.53e-2)" "unprognostic (5.58e-2)" "unprognostic (2.85e-1)" "unprognostic (2.35e-1)" 0.7 0.4 0.7 0.7 0.7 0.0 0.7 0.7 0.9 0.7 5.1 0.7 0.7 48.5 0.7 1.3 0.7 0.0 6.9 0.7 0.7 0.2 13.4 27.4 0.7 0.7 0.7 0.7 1.0 59.0 0.0 0.7 0.7 0.7 0.7 3.0 0.7 0.7 0.7 0.7 0.2 27.0 0.7 0.7 0.7 35.5 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.3 1.9 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.6 0.4 0.4 0.2 1.8 0.1 0.1 0.2 0.1 0.4 1.4 0.2 0.3 0.3 0.0 0.6 0.0 0.0 0.0 0.2 0.6 0.2 0.6 0.8 0.1 0.1 0.3 0.3 0.2 0.3 0.0 0.2 0.0 0.3 0.2 0.3 0.1 0.5 0.4 1.4 0.3 11.3 0.6 0.7 0.1 1.4 0.0 0.3 0.9 1.4 0.3 18.4 0.4 0.1 3.3 0.4 0.3 0.3 0.2 1.0 0.3 1.3 0.3 0.3 0.5 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.7 0.7 0.7 0.9 0.7 0.2 0.7 0.7 0.7 0.7 0.0 0.0 3.5 0.6 0.7 0.4 0.8 178.3 4.0 0.0 27.9 0.0 0.4 101.2 3.8 2.7 0.2 187.5 0.0 28.4 0.2 0.0 1.1 4.6 92.4 0.3 0.0 20.0 5.5 1.9 3.1 0.3 0.3 0.0 0.0 51.4 3.5 17.3 81.8 0.4 542.3 1.1 0.0 0.4 1.1 0.9 0.5 0.5 0.0 99.7 0.3 AKT1S1 "Lobe, MGC2865, PRAS40" ENSG00000204673 "AKT1 substrate 1" Q96B36 19 49869033-49878459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 108.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021903, HPA043590, HPA064427" Uncertain Supported Cytosol NA NA Cytosol "CAB021903: , HPA043590: AB_2678569, HPA064427: AB_2685261" "unprognostic (2.11e-1)" "unprognostic (1.38e-1)" "unprognostic (2.64e-1)" "unprognostic (2.21e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.41e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-1)" "prognostic favorable (6.60e-4)" "unprognostic (5.48e-2)" "prognostic unfavorable (7.34e-6)" "unprognostic (3.20e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (3.65e-1)" 22.2 22.9 16.2 11.9 18.1 10.7 13.8 12.9 19.9 16.9 15.3 21.3 20.1 18.8 17.1 13.5 21.1 14.7 14.6 20.1 15.1 12.6 15.0 43.0 11.7 7.2 17.4 11.3 15.5 17.3 19.1 14.7 25.7 18.3 15.1 13.0 14.8 17.2 19.2 72.7 21.2 16.3 15.8 13.7 10.5 16.2 13.5 21.4 7.4 17.8 20.5 10.5 15.4 29.5 1.9 3.5 5.0 4.3 2.0 3.0 1.3 23.4 28.5 8.3 19.2 17.8 19.1 14.8 21.1 23.9 20.0 17.4 15.3 15.7 4.7 10.9 23.9 15.1 16.2 14.4 24.0 11.8 10.5 40.0 5.6 16.4 14.5 15.9 4.9 9.3 23.5 22.3 21.7 24.7 15.0 18.5 5.7 18.6 6.2 18.0 16.5 4.6 12.2 21.8 28.7 41.5 5.6 11.7 14.2 19.9 16.7 19.5 22.7 18.1 32.3 12.9 10.2 16.9 9.7 17.7 41.5 21.6 11.9 20.7 9.1 22.3 5.0 24.0 9.1 19.7 0.4 3.1 2.4 2.1 4.0 1.4 1.2 1.6 2.3 2.3 1.9 1.4 2.3 5.0 2.0 4.3 3.5 3.0 1.3 16.2 18.1 12.9 19.9 15.1 12.6 17.4 11.3 18.3 21.4 0.0 3.5 10.4 23.0 13.1 11.4 5.0 30.6 0.0 2.3 10.4 2.0 54.1 38.1 28.9 22.9 16.1 47.2 46.7 35.0 41.2 27.7 36.6 4.6 32.6 27.1 9.5 28.8 11.6 19.4 9.0 22.2 18.2 11.8 32.5 33.0 28.6 28.4 31.6 26.9 40.7 10.7 25.8 30.1 11.6 13.4 17.6 108.7 9.6 31.9 23.8 AKT2 ENSG00000105221 "AKT serine/threonine kinase 2" P31751 19 40230317-40285536 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 109.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004204, HPA064521" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "CAB004204: AB_626659, HPA064521: AB_2685278" "unprognostic (6.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.85e-1)" "unprognostic (6.40e-3)" "unprognostic (9.59e-2)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (2.49e-2)" "unprognostic (3.02e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (1.30e-2)" "unprognostic (1.89e-1)" "unprognostic (3.28e-1)" "unprognostic (6.16e-2)" "unprognostic (2.00e-1)" 31.1 20.3 15.4 17.6 15.2 21.3 18.2 46.3 18.2 23.3 18.2 23.4 21.2 12.3 22.8 28.0 22.1 22.7 14.0 23.1 15.4 10.0 23.0 62.5 14.6 17.8 17.9 13.3 27.8 24.5 21.1 24.0 17.5 14.7 19.7 12.3 26.8 18.5 24.3 48.5 18.3 17.1 20.0 16.8 18.7 15.5 21.3 15.7 26.6 52.6 29.5 23.6 19.6 19.9 6.3 8.8 7.7 4.4 3.2 4.9 2.4 22.8 56.3 21.5 22.1 26.8 32.8 11.9 15.3 22.6 31.7 28.3 24.8 21.3 23.3 13.6 33.6 13.3 10.0 23.8 31.8 20.4 22.3 27.1 15.3 35.7 15.5 16.8 17.5 18.4 30.2 19.1 21.5 20.4 25.1 6.9 25.7 19.6 24.5 17.6 19.0 27.8 8.5 11.6 25.4 15.1 18.5 11.7 16.8 24.7 37.4 29.6 18.1 15.7 26.8 12.7 23.0 21.2 22.6 6.8 19.4 19.2 17.3 23.9 22.8 19.5 19.1 18.9 20.8 15.8 7.6 4.4 3.6 4.5 2.0 4.5 3.9 3.6 3.0 3.0 6.3 3.5 4.9 7.7 3.2 2.6 8.8 2.7 2.4 15.4 15.2 46.3 18.2 15.4 10.0 17.9 13.3 14.7 15.7 14.9 12.8 36.4 20.9 21.2 67.1 26.8 28.1 12.0 10.3 57.6 39.3 25.4 18.3 18.1 2.9 17.0 18.8 0.0 26.0 20.6 22.1 24.5 13.9 74.6 19.3 57.2 18.5 12.9 19.7 7.4 39.7 13.5 21.9 19.8 19.0 52.5 20.4 19.2 25.1 18.3 109.8 19.4 23.3 11.6 16.2 24.0 32.4 17.1 20.1 24.4 AKT3 "PKBG, PRKBG, RAC-gamma" ENSG00000117020 "AKT serine/threonine kinase 3" Q9Y243 1 243488233-243851079 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013090, HPA026441" Approved Supported Cytosol NA NA Cytosol "CAB013090: AB_2533692, HPA026441: AB_1844711" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (2.40e-2)" "unprognostic (8.45e-2)" "unprognostic (1.89e-1)" "unprognostic (1.75e-1)" "unprognostic (1.96e-1)" "unprognostic (3.77e-1)" "unprognostic (2.32e-1)" "unprognostic (2.28e-1)" "unprognostic (5.47e-3)" "unprognostic (1.37e-1)" "unprognostic (6.71e-2)" "unprognostic (3.64e-3)" "unprognostic (1.29e-1)" "unprognostic (8.14e-2)" "prognostic unfavorable (9.27e-4)" 15.4 17.0 16.0 7.8 15.2 2.2 11.0 39.9 33.4 16.9 16.1 12.4 17.4 4.1 19.7 12.3 10.0 11.8 12.1 9.8 15.5 13.6 12.8 4.0 11.3 7.9 14.2 15.8 29.8 4.4 15.1 14.6 17.0 18.4 19.4 6.6 8.9 4.1 23.9 4.8 4.7 8.1 20.4 12.1 9.9 8.7 10.4 14.8 2.9 17.7 5.0 6.2 17.2 18.6 1.9 0.8 1.2 0.9 3.8 3.6 0.6 23.6 2.4 15.0 0.0 11.1 12.7 8.0 13.3 12.3 8.7 7.7 0.1 9.7 0.0 0.0 17.0 7.5 0.3 8.3 5.3 11.5 6.0 6.5 0.3 0.0 0.0 5.8 0.1 2.6 6.6 0.0 10.8 9.8 18.9 17.7 3.9 0.0 0.1 3.9 0.0 5.1 1.1 6.4 0.0 3.7 2.7 9.1 0.1 2.9 0.9 19.3 25.4 0.1 0.0 24.0 9.1 0.0 8.1 13.9 15.5 11.9 0.1 11.1 1.3 0.4 2.8 11.3 1.3 12.9 1.2 0.9 0.5 2.3 0.3 3.6 1.0 2.2 2.5 0.8 1.9 1.9 1.7 0.2 3.8 0.7 0.6 0.7 0.6 16.0 15.2 39.9 22.9 15.5 13.6 14.2 15.8 18.4 14.8 3.0 2.1 8.6 11.6 2.2 41.5 5.5 5.1 0.0 4.5 26.2 31.4 9.5 0.0 10.4 71.8 31.5 0.0 0.0 1.5 6.5 7.3 18.3 4.7 0.2 2.7 39.7 0.0 44.8 8.8 51.9 25.3 9.5 6.8 10.0 0.0 20.1 1.0 0.0 33.2 4.4 33.7 19.4 22.9 12.2 11.5 1.5 10.4 13.8 0.0 7.2 AL121900.2 ENSG00000284776 20 18567453-18744216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Ciliated cells: 5.3" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBF TERT88: 22.9" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA040981: AB_10673268" 4.0 5.7 4.0 4.4 5.8 5.8 6.0 4.5 14.1 3.6 6.2 2.0 6.0 5.2 7.4 5.9 4.5 5.4 5.4 7.8 4.4 15.4 6.3 4.7 6.9 4.5 5.4 7.7 16.1 8.3 5.3 4.4 7.6 4.6 6.4 3.1 8.8 8.2 12.2 1.1 5.5 5.9 4.3 5.8 0.9 6.8 5.4 3.6 5.1 9.9 6.8 5.7 6.4 4.9 6.9 2.9 4.8 3.9 5.9 1.7 3.7 1.8 7.9 3.9 2.6 9.1 0.5 2.4 6.5 6.2 0.7 0.9 5.6 0.5 1.9 7.8 3.5 3.5 4.9 15.1 22.9 0.9 0.3 5.1 2.0 2.0 3.1 10.0 6.0 0.0 14.4 4.5 7.4 3.6 8.0 1.5 0.9 7.9 5.3 2.8 1.7 0.8 2.1 3.2 0.0 0.3 4.1 5.5 4.9 4.7 7.8 2.0 0.2 6.4 3.1 6.6 5.0 6.5 0.0 8.5 0.4 7.1 5.3 1.7 8.5 1.5 5.1 1.6 5.6 2.9 3.2 2.7 4.8 4.8 5.9 4.9 5.4 3.6 6.9 2.9 1.7 3.4 1.9 3.9 2.8 1.2 4.5 1.7 8.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL136454.1 ENSG00000231767 1 192716132-192716653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 13.4;Club cells: 30.7;Distal tubular cells: 36.5;granulocytes: 33.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 7.5;SK-MEL-30: 6.6;THP-1: 7.8" "HPA041344, HPA049132, HPA054087" Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373" "unprognostic (2.56e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-2)" "unprognostic (8.64e-2)" "unprognostic (3.78e-1)" "unprognostic (5.09e-2)" "unprognostic (7.80e-3)" "prognostic favorable (5.72e-4)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.48e-4)" "unprognostic (3.07e-2)" "unprognostic (6.43e-2)" "unprognostic (5.80e-2)" "unprognostic (7.99e-2)" "unprognostic (2.58e-2)" "unprognostic (2.10e-2)" "unprognostic (3.62e-2)" 1.7 0.9 0.3 2.3 0.6 1.9 2.6 0.9 0.9 1.3 0.7 0.0 3.9 2.8 1.8 2.5 0.8 0.7 1.8 0.8 0.5 1.2 0.4 1.3 3.3 1.7 0.2 2.6 7.3 0.0 0.0 0.6 0.8 1.5 0.0 0.4 5.9 4.2 3.4 0.1 1.6 0.6 0.7 3.0 1.2 0.4 1.0 0.2 0.6 2.5 0.8 3.0 2.3 6.1 2.6 1.3 1.9 4.5 7.4 6.4 1.7 0.7 0.5 1.1 0.5 0.0 4.4 0.2 1.0 0.0 0.6 0.0 1.3 0.4 4.4 0.0 0.3 1.8 0.3 0.5 0.0 1.4 0.9 0.8 0.9 3.3 0.4 1.2 2.3 0.5 0.8 0.3 0.0 0.1 0.3 0.4 0.2 1.3 0.0 0.9 1.5 7.5 1.9 0.2 0.4 1.7 0.5 1.0 0.6 2.2 1.4 2.7 0.3 2.7 6.6 0.2 1.7 7.8 0.9 1.1 2.1 1.4 4.0 2.6 1.8 1.5 1.4 1.2 0.2 1.3 1.4 0.7 3.2 1.9 4.6 6.1 5.7 3.5 2.6 5.8 7.4 7.0 0.4 4.5 1.4 2.4 3.6 6.4 8.9 8.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 30.7 1.8 0.0 0.0 36.5 1.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.8 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL139011.2 ENSG00000258465 1 160217464-160285130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 14 "Alveolar cells type 2: 1.6;Club cells: 3.4;granulocytes: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0" "HPA027218, HPA027381, HPA044837" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496" "unprognostic (4.71e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (8.04e-4)" "unprognostic (4.70e-2)" "unprognostic (1.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.87e-3)" "unprognostic (2.92e-1)" "unprognostic (5.29e-1)" "unprognostic (1.06e-1)" "unprognostic (5.18e-3)" 8.6 4.0 3.7 3.0 10.2 2.0 4.4 15.4 11.4 4.8 4.7 8.6 2.5 3.5 6.3 4.2 5.3 6.4 4.6 16.7 3.8 3.9 6.2 10.8 4.1 3.2 3.6 5.9 7.6 4.0 6.7 4.1 5.0 9.1 5.5 3.5 6.1 5.5 3.0 14.6 4.0 4.2 7.8 4.1 3.7 4.3 4.8 4.1 2.5 7.9 3.8 3.4 5.8 4.7 5.8 8.9 6.7 6.5 8.0 5.0 8.0 0.1 2.1 0.3 0.5 6.7 1.9 0.6 0.9 5.9 3.3 0.8 0.0 0.8 0.2 6.6 1.0 5.2 0.8 1.1 0.2 0.0 6.0 0.0 0.3 0.7 0.2 3.4 0.0 0.3 3.2 0.2 3.0 3.4 3.5 0.5 0.8 1.0 4.7 0.5 0.3 1.1 0.0 0.3 0.6 0.6 0.5 0.0 0.3 0.3 0.8 0.6 0.8 0.2 1.4 0.0 1.0 2.8 5.6 0.0 0.8 0.8 0.0 0.2 0.8 3.4 0.5 0.4 0.3 0.3 6.4 6.3 6.2 3.6 6.5 5.0 5.8 4.4 4.7 8.9 3.9 2.5 3.2 6.7 8.0 6.3 2.5 4.9 8.0 3.7 10.2 15.4 11.4 3.8 3.9 3.6 5.9 9.1 4.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AL139300.1 ENSG00000256500 14 103562962-103685924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.2" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 1.4;granulocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044617, HPA052450" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (1.56e-1)" 10.2 7.5 16.6 7.8 20.3 2.8 15.5 21.9 25.1 5.9 4.8 3.2 5.1 2.0 5.5 4.6 5.8 3.9 4.2 20.0 17.2 17.2 5.3 5.6 4.2 7.7 17.3 6.2 5.0 15.8 9.9 5.8 4.2 5.2 5.0 2.9 2.7 7.7 6.3 37.2 2.0 4.2 8.5 22.6 2.9 2.8 18.5 4.0 2.2 7.8 9.2 5.4 6.6 6.9 4.2 4.9 4.2 5.1 2.3 4.4 1.3 6.3 12.0 13.2 1.2 7.3 9.0 5.8 18.5 14.3 20.9 13.2 7.3 9.7 16.2 12.1 13.4 14.1 6.3 8.8 10.6 13.3 5.4 1.0 6.2 6.3 6.8 9.7 8.5 3.7 7.0 2.9 10.0 11.4 11.8 11.9 10.7 8.3 4.2 15.0 12.1 13.3 3.1 9.1 14.3 15.1 5.9 10.4 8.7 10.7 7.4 17.3 10.6 11.0 4.6 10.3 5.5 10.2 4.9 8.4 9.2 7.3 14.7 8.7 5.4 6.3 18.5 15.5 3.5 8.3 0.7 3.2 4.2 2.8 4.3 2.9 1.9 3.4 4.1 1.9 4.2 4.4 1.9 2.8 2.3 5.1 4.9 4.2 1.3 16.6 20.3 21.9 25.1 17.2 17.2 17.3 6.2 5.2 4.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALDH1A1 "ALDH1, PUMB1, RALDH1" ENSG00000165092 "Aldehyde dehydrogenase 1 family member A1" P00352 9 72900662-73080442 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 207.2" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 583.5;Hepatocytes: 620.8;Leydig cells: 376.3" "Cancer enhanced" "Detected in all" "liver cancer: 399.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 34.2" "Lineage enriched" "Detected in many" 30 "monocytes: 34.2" "Cell line enhanced" "Detected in some" "A549: 294.7;Hep G2: 90.7;RPTEC TERT1: 52.5" "Region enriched" "Detected in all" 6 "midbrain: 171.1" "HPA002123, CAB020690" Enhanced Approved Enhanced Cytosol NA NA 62000000 Cytosol "CAB020690: , HPA002123: AB_1844722" "unprognostic (8.46e-3)" "prognostic favorable (7.77e-5)" "unprognostic (5.59e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-2)" "unprognostic (8.71e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (4.53e-2)" "unprognostic (6.83e-2)" "unprognostic (4.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.24e-3)" "unprognostic (2.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-3)" 20.0 26.9 8.8 12.3 21.4 3.9 10.8 44.8 11.7 33.6 53.6 14.5 65.3 77.1 25.5 87.1 14.5 27.8 38.3 8.9 12.5 5.9 86.7 207.2 31.4 9.4 56.4 3.6 35.8 69.7 0.7 57.5 7.9 14.0 20.0 13.1 30.2 31.8 40.3 12.1 2.7 76.5 17.1 29.1 16.3 75.5 43.0 14.9 2.0 45.8 21.0 16.8 14.1 16.0 0.3 0.5 1.1 34.2 0.0 0.1 10.5 0.0 294.7 0.0 0.0 1.7 0.0 0.1 10.2 0.0 0.0 0.0 9.9 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 90.7 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.5 0.0 1.1 0.0 11.3 0.5 0.0 0.1 0.0 0.5 0.0 0.0 3.3 0.1 52.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 34.2 0.5 0.0 5.8 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 1.1 0.0 0.4 0.3 0.0 10.5 8.8 21.4 44.8 11.7 12.5 5.9 56.4 3.6 14.0 14.9 89.3 82.8 17.6 12.3 2.4 0.0 2.8 211.5 583.5 271.8 109.9 0.0 1.1 330.0 52.4 8.7 10.5 29.0 23.3 296.8 1.1 30.2 1.8 152.7 620.8 115.7 0.0 52.7 105.0 82.2 16.5 376.3 13.6 6.8 5.4 141.2 0.0 193.4 16.9 194.8 295.4 0.3 25.8 9.2 3.6 3.8 2.8 2.1 20.0 42.1 18.3 ALDH1A3 "ALDH6, RALDH3" ENSG00000184254 "Aldehyde dehydrogenase 1 family member A3" P47895 15 100877714-100916626 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1" "Group enriched" "Detected in many" 7 "melanoma: 16.8;prostate cancer: 80.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA046271, HPA064749" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046271: AB_10965992, HPA064749: AB_2685344" "unprognostic (6.87e-2)" "unprognostic (2.23e-1)" "unprognostic (6.20e-3)" "unprognostic (1.21e-3)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (6.28e-2)" "unprognostic (5.46e-2)" "unprognostic (9.62e-2)" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (2.56e-1)" "unprognostic (1.25e-2)" "unprognostic (2.61e-2)" "unprognostic (2.12e-1)" "unprognostic (7.34e-2)" "unprognostic (6.07e-3)" 30.3 5.7 2.3 14.9 1.6 0.0 11.1 4.1 2.6 14.2 11.5 1.6 10.5 5.2 5.9 37.9 10.5 11.5 15.0 6.1 2.1 2.0 3.7 1.7 4.2 5.5 2.6 1.7 9.0 7.4 3.2 13.2 5.1 3.9 51.9 3.2 49.9 41.5 19.2 6.1 1.7 15.6 14.2 6.4 1.5 5.3 15.9 0.7 0.6 0.9 15.2 18.9 18.0 9.8 0.3 1.5 2.1 0.2 0.0 0.0 0.1 42.6 5.7 0.0 0.0 9.4 4.2 0.1 0.3 0.3 0.2 0.1 0.1 34.1 0.3 0.5 11.5 6.8 53.0 1.0 131.3 0.8 0.0 0.2 0.2 2.3 0.0 3.2 0.1 0.2 3.0 3.6 2.9 0.5 43.5 0.4 0.0 0.0 0.3 0.2 0.4 0.0 0.2 1.1 1.1 34.7 0.0 0.5 0.2 0.0 35.8 0.0 3.0 13.2 11.7 4.0 0.4 1.1 0.3 6.7 0.0 0.1 75.5 1.6 0.0 0.4 0.2 60.0 0.0 62.0 1.0 0.2 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.1 2.3 1.6 4.1 2.6 2.1 2.0 2.6 1.7 3.9 0.7 14.9 7.5 0.0 119.5 0.6 0.0 1.2 0.0 38.8 62.6 97.7 0.0 7.4 3.3 68.6 0.8 5.6 0.2 0.0 1.2 0.3 4.7 329.1 5.7 0.0 1.0 0.0 3.4 1.3 0.0 2.5 180.1 1.3 0.0 1.0 1.5 0.0 18.3 0.0 127.3 0.5 0.0 12.9 0.9 0.5 0.7 1.4 4.1 0.0 0.2 421.1 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392664-38398661 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 113.9" "Group enriched" "Detected in many" 5 "Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 55.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021037, HPA077080" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA 210000 Mitochondria "Nucleoplasm, Vesicles, Cytosol" "HPA021037: AB_1844724, HPA077080: " "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.89e-2)" 7.4 4.9 2.1 16.8 2.1 0.6 5.4 1.1 5.4 5.8 25.4 1.7 6.1 7.0 27.3 10.7 21.6 16.7 30.8 11.6 3.1 2.0 18.0 55.2 3.5 5.9 2.4 2.0 12.2 14.6 1.4 1.4 1.6 3.0 22.7 11.5 5.2 5.9 18.2 19.4 3.0 11.2 113.9 2.7 2.8 15.8 7.8 1.7 1.6 6.3 7.0 2.0 54.5 8.3 5.9 9.4 1.2 10.5 7.5 10.2 5.1 21.5 20.1 6.2 9.9 8.8 10.5 5.0 10.3 5.2 8.7 9.0 13.4 4.2 13.6 6.2 14.5 13.2 3.0 20.4 21.9 8.7 15.2 8.8 6.7 14.8 39.8 6.4 10.7 7.6 12.5 4.8 7.1 6.2 17.9 8.3 3.3 19.4 13.4 13.2 8.2 0.0 4.3 18.4 55.5 9.0 4.4 37.6 10.4 7.8 9.7 13.6 6.3 7.9 5.2 6.0 6.8 4.9 8.4 5.6 10.1 16.7 8.4 12.9 2.0 3.9 5.4 5.2 11.0 6.8 0.2 4.2 0.2 7.3 9.1 10.2 5.9 7.0 6.6 9.4 3.1 5.8 6.8 1.2 7.5 10.5 1.3 4.8 5.1 2.1 2.1 1.1 5.4 3.1 2.0 2.4 2.0 3.0 1.7 8.9 1.7 3.6 3.8 0.9 1.3 5.6 117.2 0.0 3.4 15.7 2.0 1.3 14.9 60.1 0.5 3.8 7.0 0.0 5.9 40.0 6.2 2.9 9.2 113.4 6.5 0.0 15.0 9.8 3.8 1.3 6.1 4.0 0.0 7.2 16.9 1.3 14.2 3.5 6.3 118.8 0.3 0.0 9.5 0.3 0.6 0.9 1.5 2.9 68.9 2.6 ALDH1L1 "10-fTHF, FTHFD" ENSG00000144908 "Aldehyde dehydrogenase 1 family member L1" O75891 3 126103562-126197994 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 48.1;liver: 148.7" "Group enriched" "Detected in many" 6 "Hepatocytes: 554.3;Proximal tubular cells: 175.8" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.9;Hep G2: 23.9;Karpas-707: 24.7;RPMI-8226: 12.9;RT4: 66.0;U-266/70: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036900, HPA050139" Enhanced Supported Supported Cytosol No No 640000 Cytosol "HPA036900: AB_10672273, HPA050139: AB_2681031" "unprognostic (5.93e-2)" "unprognostic (1.22e-1)" "unprognostic (9.12e-2)" "unprognostic (2.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.12e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (4.73e-2)" "unprognostic (3.05e-3)" "unprognostic (8.40e-2)" "prognostic favorable (2.42e-8)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (7.03e-3)" "unprognostic (7.93e-2)" 28.9 12.1 13.7 1.8 17.1 1.2 6.0 8.6 10.9 7.8 4.9 5.7 2.3 1.1 1.9 2.2 3.6 3.4 1.9 8.1 8.9 5.3 48.1 148.7 1.3 1.2 9.2 10.1 11.3 10.2 1.4 0.9 1.1 10.8 3.3 3.3 5.1 34.1 4.1 30.7 1.5 1.3 2.4 7.7 1.1 1.9 4.9 6.2 0.0 1.7 6.2 2.8 11.0 3.1 0.1 0.8 0.8 0.2 0.2 0.4 0.0 0.4 0.0 0.0 0.0 10.9 0.0 0.1 0.1 0.4 0.1 0.2 0.0 0.9 0.7 3.2 0.0 0.6 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 23.9 3.2 3.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 24.7 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 12.9 0.3 66.0 0.1 0.1 0.3 3.2 0.0 0.2 0.0 0.0 0.1 0.4 1.9 0.0 0.0 13.6 4.2 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.4 0.2 0.2 0.2 0.0 0.8 0.1 0.0 13.7 17.1 8.6 10.9 8.9 5.3 9.2 10.1 10.8 6.2 0.0 5.9 4.5 44.7 0.1 0.2 14.9 22.9 10.7 64.8 12.2 0.0 0.0 61.3 2.2 18.0 2.7 2.3 0.0 4.8 0.1 0.8 8.1 25.6 554.3 0.1 0.0 1.2 12.3 15.3 25.4 24.5 2.6 3.3 0.0 9.1 35.7 1.9 0.0 21.2 175.8 1.0 6.5 1.0 1.1 1.2 0.0 0.1 7.0 2.2 48.0 ALDH3A1 ALDH3 ENSG00000108602 "Aldehyde dehydrogenase 3 family member A1" P30838 17 19737984-19748943 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6" "Cell type enhanced" "Detected in many" 15 "Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 1.8" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 22 "A549: 261.5;OE19: 326.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB045957, HPA051150, HPA063783" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122" "unprognostic (3.11e-5)" "unprognostic (1.20e-2)" "unprognostic (1.08e-1)" "unprognostic (7.04e-3)" "unprognostic (4.36e-3)" "prognostic favorable (7.55e-5)" "unprognostic (3.12e-1)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.69e-3)" "unprognostic (5.54e-2)" "unprognostic (1.72e-1)" "unprognostic (3.84e-2)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (7.23e-2)" 0.7 0.1 0.2 0.8 0.4 0.0 0.5 0.2 0.3 1.3 0.9 0.8 0.3 1.3 0.2 0.4 88.2 1.2 3.8 0.2 0.4 0.0 0.4 0.4 26.0 0.2 0.2 0.3 0.6 0.2 0.0 0.3 0.2 1.8 0.5 0.6 0.5 26.7 0.3 0.4 16.2 0.6 0.3 0.3 0.3 49.9 0.3 0.2 0.2 0.2 106.6 70.3 1.6 3.9 1.1 0.3 0.0 0.0 2.4 0.7 0.1 0.0 261.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 13.1 0.0 0.1 0.0 0.1 1.5 0.0 0.6 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 326.9 1.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.4 0.0 0.2 0.3 1.8 0.2 3.0 5.6 0.0 23.3 39.2 0.0 0.4 2.5 100.4 55.7 0.0 0.0 0.0 0.0 0.8 1.3 0.4 3.3 0.0 0.4 0.0 0.6 2.6 2.3 0.0 0.2 0.0 1.7 0.6 0.8 1.9 0.9 1.1 0.0 0.0 4.2 1.9 5.8 5.9 1.8 4.4 0.1 0.0 0.3 0.7 7.3 28.0 0.0 0.0 7.5 32.1 ALDH7A1 "ATQ1, EPD, PDE" ENSG00000164904 "Aldehyde dehydrogenase 7 family member A1" P49419 5 126531200-126595418 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 64.4" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023296, HPA053675" Enhanced Supported Mitochondria,Cytosol Yes No 140000 Mitochondria Cytosol "HPA023296: AB_1844738, HPA053675: " "unprognostic (1.37e-1)" "unprognostic (9.67e-2)" "unprognostic (2.07e-2)" "unprognostic (2.20e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.58e-3)" "unprognostic (9.49e-3)" "unprognostic (7.61e-2)" "unprognostic (7.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.33e-1)" "prognostic favorable (3.08e-4)" "unprognostic (1.51e-1)" "unprognostic (3.70e-1)" "unprognostic (3.10e-3)" "unprognostic (4.93e-2)" 9.0 14.2 46.0 3.4 39.1 0.8 18.8 11.0 22.5 14.0 11.5 23.1 7.2 9.5 10.5 7.5 13.5 11.9 7.8 10.8 35.0 17.3 46.5 64.4 6.4 3.1 28.7 18.5 27.6 10.8 17.7 5.9 17.7 16.9 17.6 11.2 13.7 15.0 12.2 4.5 11.9 8.1 9.8 20.2 2.8 9.0 4.9 28.4 4.0 19.4 10.1 7.4 7.2 7.1 1.3 9.7 0.7 0.3 0.1 1.8 0.6 15.0 10.0 28.3 46.8 23.5 14.0 36.1 18.1 22.4 21.1 27.2 28.0 14.5 0.0 18.5 14.1 8.8 11.3 8.8 61.1 19.4 0.0 10.6 2.9 14.9 23.8 11.5 0.0 0.0 17.1 14.4 16.4 11.8 15.6 16.8 0.0 0.0 0.0 18.5 9.9 0.6 0.0 19.1 11.1 8.5 9.0 32.1 0.0 20.0 11.5 9.6 11.5 0.0 10.0 10.5 22.7 18.0 0.6 20.4 6.1 18.9 7.0 12.4 0.0 0.0 0.0 3.3 0.0 9.8 0.7 0.3 0.1 0.2 0.0 0.3 1.3 0.3 0.2 2.7 1.1 1.8 1.0 0.3 0.1 0.0 9.7 0.1 0.6 46.0 39.1 11.0 22.5 35.0 17.3 28.7 18.5 16.9 28.4 14.9 24.0 11.8 48.6 23.0 22.4 35.5 25.5 20.1 33.0 40.1 21.6 364.8 64.6 31.9 24.9 14.7 17.8 0.0 12.1 88.6 30.8 28.6 6.9 69.5 42.5 23.8 20.8 20.9 9.4 29.5 23.6 7.4 52.3 12.6 22.1 96.8 15.1 8.6 35.0 241.4 12.2 19.4 17.3 1.0 3.1 14.1 185.9 2.5 43.7 34.8 ALDH9A1 "ALDH4, ALDH7, ALDH9, E3" ENSG00000143149 "Aldehyde dehydrogenase 9 family member A1" P49189 1 165662216-165698863 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Muller glia cells: 289.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006077, HPA010873" Approved Approved Cytosol "Intracellular and membrane" NA NA 1100000 Cytosol "HPA006077: , HPA010873: AB_1078126" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (4.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.21e-2)" "unprognostic (1.25e-1)" "unprognostic (4.14e-2)" "unprognostic (4.87e-2)" "unprognostic (2.30e-1)" "unprognostic (1.83e-1)" "prognostic favorable (4.56e-4)" "unprognostic (5.51e-2)" "unprognostic (9.05e-2)" "unprognostic (1.67e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-1)" "unprognostic (2.15e-1)" 39.1 52.7 30.8 17.4 25.4 7.7 39.6 16.2 26.6 20.3 18.0 22.7 17.1 19.5 15.5 35.5 47.0 18.8 22.2 22.2 24.8 21.1 50.5 73.5 20.7 20.4 23.7 18.4 20.6 17.8 31.2 19.2 14.1 22.8 24.6 18.7 27.2 52.2 23.2 29.9 22.6 23.9 19.2 21.9 18.8 14.7 37.3 21.5 12.4 45.1 24.2 27.9 18.5 19.1 29.6 20.2 29.4 24.5 23.1 39.0 24.4 17.0 16.7 15.6 14.0 49.9 44.0 13.1 22.6 32.1 22.8 19.8 10.3 12.8 0.0 21.7 20.2 11.2 13.5 12.6 22.1 27.0 7.9 16.0 10.9 12.0 11.2 25.7 17.0 11.6 28.2 11.2 24.1 20.2 31.6 19.7 14.5 17.2 15.4 35.4 10.2 11.3 17.6 22.7 44.9 20.5 9.7 19.8 22.8 29.6 16.2 18.6 12.8 16.1 18.2 20.7 22.1 34.6 25.9 19.4 13.8 13.5 16.7 11.4 14.4 18.7 17.0 15.5 16.3 13.2 26.8 20.3 28.1 28.3 21.5 30.1 29.6 27.7 30.6 20.2 26.0 28.1 32.0 29.4 23.1 24.5 12.6 39.0 24.4 30.8 25.4 16.2 26.6 24.8 21.1 23.7 18.4 22.8 21.5 14.9 37.5 27.9 34.1 29.0 24.6 38.9 48.4 69.6 30.7 48.8 21.6 42.9 82.9 36.4 32.5 37.9 44.4 23.3 32.5 64.2 46.7 49.5 36.9 114.6 53.7 12.7 53.6 52.8 58.2 28.9 88.3 37.5 54.0 19.8 52.5 289.8 28.8 31.6 108.5 141.7 26.8 25.8 36.0 33.8 46.2 45.4 31.9 38.9 58.1 23.5 ALDOA ENSG00000149925 "Aldolase, fructose-bisphosphate A" P04075 16 30064164-30070457 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 1296.2" "Group enriched" "Detected in some" 13284 "Cardiomyocytes: 1628.0;Cytotrophoblasts: 1088.2;Extravillous trophoblasts: 1710.3;Hofbauer cells: 1077.0;Syncytiotrophoblasts: 1138.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA004177, CAB006252" Enhanced Approved Cytosol NA NA 1200000000 Cytosol "CAB006252: AB_437007, HPA004177: AB_1078128" "unprognostic (2.63e-2)" "unprognostic (3.22e-2)" "unprognostic (6.80e-2)" "unprognostic (1.33e-1)" "unprognostic (6.74e-3)" "unprognostic (4.28e-3)" "prognostic unfavorable (5.79e-5)" "prognostic unfavorable (7.32e-5)" "unprognostic (1.68e-1)" "unprognostic (1.81e-1)" "unprognostic (2.30e-2)" "unprognostic (1.57e-1)" "unprognostic (1.81e-1)" "unprognostic (1.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.19e-3)" "unprognostic (4.48e-2)" 27.9 30.9 34.7 24.2 42.3 36.0 25.3 31.2 59.7 21.0 32.8 16.3 25.9 29.4 21.9 33.9 73.5 22.1 24.4 109.3 31.6 33.4 28.2 11.1 17.9 34.0 35.0 49.6 23.4 19.4 51.0 25.2 19.9 38.0 23.6 23.5 24.6 37.9 36.9 1296.2 28.4 21.5 30.1 22.7 17.4 24.4 9.2 18.9 18.5 26.6 189.8 29.0 36.8 27.7 61.1 142.9 165.7 166.3 50.5 93.2 217.0 138.8 104.7 31.5 101.2 48.3 55.1 100.7 84.1 87.6 85.8 107.3 74.0 107.1 94.7 137.9 84.8 47.1 106.1 63.2 183.3 63.0 41.6 83.1 77.5 84.0 163.3 75.5 112.6 83.2 75.5 64.7 96.3 64.7 141.5 63.1 44.7 66.6 62.5 90.9 198.0 68.4 93.0 78.4 54.0 88.3 102.2 50.6 211.6 106.8 79.1 63.1 44.4 52.4 221.3 78.4 41.1 94.1 76.4 75.0 126.7 50.6 69.1 90.9 123.6 84.3 86.6 235.7 109.4 100.0 106.7 164.0 130.3 70.2 156.8 79.1 61.1 76.8 72.5 142.9 55.5 73.8 70.3 165.7 50.5 166.3 53.8 93.2 217.0 34.7 42.3 31.2 59.7 31.6 33.4 35.0 49.6 38.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 1628.0 0.0 0.0 0.0 0.0 0.0 1088.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1710.3 0.0 0.0 0.0 0.0 1077.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1138.4 0.0 0.0 0.0 ALDOA ENSG00000285043 "Aldolase, fructose-bisphosphate A" P04075 16 30053090-30070420 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Glycolysis Lyase "Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 1558.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA004177 Uncertain Approved Cytosol NA NA 1200000000 Cytosol "HPA004177: AB_1078128" 1.8 0.9 2.7 1.1 5.0 2.1 7.2 0.7 7.7 4.9 1.5 2.0 2.4 0.0 2.5 3.9 0.9 3.6 1.6 5.3 2.3 1.3 0.0 2.3 2.0 0.8 4.4 2.2 0.8 0.8 3.0 1.4 4.0 2.4 0.5 2.8 1.6 7.5 10.6 0.6 0.1 1.9 0.4 1.7 1.3 11.6 0.8 1.2 4.7 0.2 2.7 1.2 1.0 7.0 6.6 0.9 6.2 4.2 8.5 12.5 3.8 8.9 1.9 6.2 1.5 5.2 1.5 4.1 7.0 5.5 21.8 3.6 5.1 24.7 6.0 6.8 1.8 6.4 14.1 11.1 3.8 4.4 8.0 6.0 8.3 6.0 11.6 10.6 2.3 5.1 0.5 10.8 12.4 4.5 7.8 4.0 1.2 7.2 13.5 3.9 5.0 8.1 2.1 1.7 5.6 7.7 4.0 22.7 15.3 0.7 6.2 5.1 1.0 1.7 1.5 0.6 5.2 4.0 1.7 8.1 2.5 3.7 5.4 7.4 5.5 8.1 7.7 11.5 3.5 0.1 6.2 0.1 5.3 2.6 7.4 7.0 7.0 5.7 6.6 6.2 8.5 6.6 0.9 4.2 2.3 5.6 5.4 12.5 11.9 25.9 269.9 530.0 703.6 362.0 0.0 315.9 36.1 40.9 40.1 111.9 0.0 94.5 100.6 190.1 242.7 1558.3 46.7 66.6 0.0 38.0 448.8 200.0 94.7 0.0 692.8 311.1 289.1 683.7 930.6 352.7 289.5 877.3 70.3 597.6 553.3 106.3 971.1 380.8 45.3 219.0 478.6 664.3 23.8 81.3 598.3 0.0 258.9 731.1 912.8 ALDOC ENSG00000109107 "Aldolase, fructose-bisphosphate C" P09972 17 28573115-28577264 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 166.7;heart muscle: 56.9" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 100.1;Horizontal cells: 259.0;Rod photoreceptor cells: 259.1" "Cancer enriched" "Detected in all" 6 "glioma: 128.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 63.4;U-266/70: 43.8;U-87 MG: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003282, CAB020828, HPA067442" Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" Yes No 280000000 "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB020828: , HPA003282: AB_1078130, HPA067442: " "unprognostic (2.90e-1)" "unprognostic (4.45e-3)" "unprognostic (5.69e-3)" "unprognostic (1.43e-1)" "unprognostic (3.56e-1)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (6.03e-3)" "unprognostic (3.90e-1)" "unprognostic (3.24e-2)" "prognostic unfavorable (1.29e-7)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-1)" 26.0 9.4 86.7 4.8 78.9 7.5 9.8 100.1 166.7 3.8 5.3 17.4 0.3 7.0 4.4 4.6 7.1 3.9 4.4 56.9 64.6 54.3 3.3 26.2 4.6 6.5 69.9 51.4 12.8 1.6 4.7 2.3 2.1 98.1 6.0 5.6 16.5 4.2 6.1 1.7 12.5 15.0 4.6 34.4 6.7 8.7 4.6 23.4 0.0 2.1 0.5 10.0 3.4 3.5 12.2 4.6 8.8 4.1 13.7 20.5 8.8 7.5 0.5 3.5 14.7 7.4 7.6 0.7 3.9 8.8 3.0 18.5 4.4 0.7 3.5 4.6 3.4 0.8 9.9 2.4 24.1 5.6 3.1 2.3 6.8 2.8 7.5 6.9 2.5 8.0 7.0 3.4 0.3 6.0 0.4 1.3 7.3 4.6 19.1 2.6 3.6 2.9 8.3 5.5 1.6 3.9 2.4 0.4 63.4 0.4 1.0 9.4 16.7 2.2 18.1 0.1 5.8 9.8 5.6 0.9 0.3 1.4 0.5 0.6 43.8 12.5 2.6 28.6 7.1 0.5 0.1 3.5 1.4 11.4 4.1 16.2 12.2 15.6 9.2 4.6 11.5 20.5 15.1 8.8 13.7 2.3 2.2 19.5 8.8 86.7 78.9 100.1 78.5 64.6 54.3 69.9 51.4 98.1 23.4 0.0 12.0 9.3 17.7 6.6 72.2 19.0 5.1 0.0 7.9 7.0 100.1 1.2 3.3 14.2 0.8 8.4 22.7 0.0 8.9 3.9 7.1 4.4 12.7 50.8 4.4 259.0 20.7 16.5 4.7 0.8 8.6 3.7 23.6 58.7 8.7 81.4 11.6 14.0 9.6 1.6 259.1 12.9 17.6 0.4 3.2 9.5 1.3 17.0 3.3 8.0 ALG13 "CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W" ENSG00000101901 "ALG13, UDP-N-acetylglucosaminyltransferase subunit" Q9NP73 X 111665811-111760649 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase" "Congenital disorder of glycosylation, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002853, HPA005498" Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA002853: AB_1078131, HPA005498: " "unprognostic (4.13e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-2)" "unprognostic (1.51e-1)" "unprognostic (6.97e-2)" "unprognostic (6.14e-2)" "unprognostic (2.74e-1)" "unprognostic (6.55e-3)" "unprognostic (2.26e-2)" "unprognostic (3.39e-3)" "unprognostic (1.73e-2)" "unprognostic (4.62e-3)" "prognostic unfavorable (1.10e-6)" "unprognostic (1.19e-1)" "unprognostic (1.29e-2)" "unprognostic (9.70e-2)" "unprognostic (2.45e-2)" 20.6 23.0 18.4 23.2 23.2 19.3 24.8 20.9 25.5 21.1 23.3 21.6 22.0 18.0 26.3 28.5 18.3 22.5 22.2 16.8 16.6 16.2 23.5 31.1 19.7 28.4 22.4 16.1 24.2 18.8 13.0 41.7 18.7 19.5 26.7 26.5 16.3 19.5 25.6 11.2 25.2 25.7 23.5 21.6 31.4 20.1 19.0 20.3 23.6 24.5 14.6 25.8 18.3 20.9 10.2 14.4 21.7 12.5 3.4 11.1 7.1 10.9 12.4 11.1 7.0 7.2 10.4 6.3 8.9 9.2 11.5 14.3 12.4 11.5 9.5 17.1 12.3 23.8 6.3 13.2 6.3 12.1 6.8 8.8 5.2 14.0 14.1 10.7 9.5 21.0 12.3 11.8 9.2 20.0 12.0 12.5 10.9 11.6 27.4 11.4 27.8 8.0 8.6 10.2 32.8 17.0 6.2 7.1 13.2 18.3 16.9 6.7 9.8 12.7 7.7 7.7 11.6 6.9 9.2 8.4 9.9 4.9 12.8 17.0 13.2 21.9 15.3 10.6 12.6 7.5 21.7 12.4 12.2 7.8 12.5 7.6 8.4 8.9 7.6 14.4 10.2 11.1 9.1 2.5 3.4 9.4 7.5 10.7 7.1 18.4 23.2 20.9 25.5 16.6 16.2 22.4 16.1 19.5 20.3 14.9 31.5 32.3 54.9 31.3 12.7 15.1 20.4 34.8 25.0 17.4 9.8 22.8 38.1 27.8 14.0 38.3 32.8 0.0 45.1 32.1 22.1 46.9 109.4 26.7 37.3 11.1 25.4 23.4 36.4 6.8 19.8 44.5 27.0 35.1 42.8 12.8 44.6 41.2 15.2 44.0 14.8 25.8 39.0 9.9 16.3 30.9 40.7 34.5 28.5 55.9 ALG2 "CDG1I, CDGIi, FLJ14511, hALPG2, NET38" ENSG00000119523 "ALG2, alpha-1,3/1,6-mannosyltransferase" Q9H553 9 99216426-99221956 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041512, HPA041601" Approved Enhanced "Actin filaments,Cytosol" No No "Actin filaments, Cytosol" "HPA041512: AB_10794380, HPA041601: AB_10794302" "unprognostic (8.86e-3)" "unprognostic (4.39e-1)" "unprognostic (2.37e-1)" "prognostic favorable (8.44e-5)" "unprognostic (9.21e-3)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.06e-2)" "unprognostic (5.94e-2)" "unprognostic (3.31e-1)" "unprognostic (3.66e-1)" "unprognostic (2.99e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.28e-7)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-2)" "unprognostic (4.81e-1)" 12.5 28.0 9.2 9.4 9.7 10.5 16.4 13.1 12.5 18.8 12.9 11.6 31.1 11.0 15.2 39.2 12.3 15.8 13.9 12.1 8.3 9.5 24.8 45.5 16.0 12.8 10.8 6.5 18.4 43.4 14.7 22.4 22.5 12.0 16.7 14.9 14.7 24.1 32.6 13.3 8.7 15.5 12.6 11.3 15.9 15.0 12.6 9.7 14.8 26.0 9.9 15.8 12.9 11.8 16.8 41.0 18.2 18.5 17.5 26.4 17.8 8.1 11.0 8.1 11.6 30.1 19.6 16.7 16.7 26.6 17.1 14.9 13.1 11.8 8.8 7.8 19.2 23.2 32.3 13.7 17.9 17.2 13.3 6.3 5.2 8.7 19.4 36.2 9.1 9.9 21.4 23.4 14.5 26.4 16.5 19.1 5.7 9.1 19.9 15.8 17.1 4.6 10.9 10.5 26.9 15.5 5.3 16.5 13.7 22.9 10.4 8.7 7.1 12.3 22.7 21.5 12.9 9.2 7.8 13.5 11.7 11.6 14.9 10.4 18.7 10.1 3.8 22.0 7.3 5.7 18.2 18.5 11.2 18.6 14.6 26.4 16.8 17.7 18.4 23.0 13.3 15.4 15.0 5.0 17.5 12.9 41.0 18.8 17.8 9.2 9.7 13.1 12.5 8.3 9.5 10.8 6.5 12.0 9.7 11.9 22.2 18.6 17.3 20.7 11.4 6.0 20.4 14.7 14.8 22.7 2.0 44.0 18.3 32.0 22.1 17.7 16.9 0.0 30.7 28.2 25.8 31.0 7.0 52.1 25.7 9.5 12.0 24.5 25.6 16.5 24.7 22.6 20.3 93.8 19.7 13.4 30.1 14.0 23.7 31.7 7.0 6.5 18.9 20.2 23.7 20.7 74.6 15.9 16.8 28.9 ALG5 bA421P11.2 ENSG00000120697 "ALG5, dolichyl-phosphate beta-glucosyltransferase" Q9Y673 13 36949775-37000261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007989 Approved Approved Cytosol No No Cytosol "HPA007989: AB_1078132" "unprognostic (1.87e-1)" "unprognostic (1.73e-2)" "unprognostic (6.07e-2)" "unprognostic (1.05e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.57e-2)" "unprognostic (5.82e-2)" "unprognostic (5.21e-2)" "unprognostic (7.46e-2)" "unprognostic (3.51e-2)" "unprognostic (3.30e-1)" "prognostic favorable (1.40e-5)" "unprognostic (7.44e-2)" "unprognostic (1.66e-1)" "unprognostic (7.14e-3)" "unprognostic (1.86e-1)" 14.7 18.2 11.8 14.0 14.2 11.3 19.9 10.9 13.7 16.7 16.5 10.3 34.2 13.0 13.5 34.8 11.7 12.4 12.9 13.1 10.0 10.5 18.1 36.7 19.1 28.0 16.1 12.8 11.8 60.4 11.8 11.6 17.0 12.1 12.9 20.8 7.3 30.2 37.0 9.0 11.0 12.6 10.9 15.1 12.9 17.6 7.2 14.2 15.4 25.5 12.1 12.4 12.4 11.1 19.1 45.5 17.7 24.8 22.1 25.2 26.9 9.6 13.0 12.0 12.3 33.1 22.2 8.8 26.8 28.5 22.7 18.6 25.4 33.7 13.9 11.1 16.2 19.3 23.9 14.8 20.4 21.2 14.8 29.0 31.9 10.8 15.9 32.4 27.0 16.7 23.3 30.1 18.1 24.3 14.9 17.3 15.6 14.6 17.3 20.5 17.3 18.2 21.6 12.3 60.8 10.6 22.2 14.8 34.0 24.1 18.3 9.6 18.7 11.3 21.0 15.5 9.5 12.7 26.9 13.2 12.7 7.2 14.0 17.0 14.8 11.4 18.2 19.6 17.2 21.0 17.7 24.1 10.0 24.4 24.8 24.6 19.1 23.0 24.4 23.6 17.0 21.2 23.2 2.7 22.1 20.2 45.5 25.2 26.9 11.8 14.2 10.9 13.7 10.0 10.5 16.1 12.8 12.1 14.2 47.6 44.6 33.5 34.8 30.8 16.4 9.7 81.5 22.7 31.8 50.6 9.8 71.9 19.9 78.2 27.2 40.9 34.9 0.0 121.6 63.8 57.3 47.1 28.8 63.8 63.1 11.1 34.7 32.5 37.8 17.9 37.2 44.2 75.9 39.7 51.8 33.6 80.6 45.6 36.0 43.5 23.5 45.3 44.3 47.0 21.3 26.5 68.0 41.5 66.2 37.2 ALKBH5 "FLJ20308, OFOXD1" ENSG00000091542 "AlkB homolog 5, RNA demethylase" Q6P6C2 17 18183078-18209954 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 130.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007196 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA007196: AB_1850461" "unprognostic (1.07e-1)" "unprognostic (1.51e-1)" "unprognostic (2.23e-2)" "unprognostic (1.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.94e-2)" "prognostic favorable (3.75e-4)" "unprognostic (6.54e-2)" "unprognostic (3.99e-2)" "unprognostic (2.88e-2)" "unprognostic (3.22e-2)" "unprognostic (4.68e-3)" "prognostic unfavorable (5.69e-4)" 18.0 19.5 17.1 14.6 21.9 19.1 26.2 23.4 25.3 18.2 21.8 20.1 18.8 15.1 22.1 12.1 17.3 30.5 18.7 45.8 16.5 18.9 16.0 24.2 14.7 16.9 19.0 16.9 20.9 25.0 22.7 20.2 14.8 15.4 19.4 8.9 19.9 23.7 21.1 130.4 12.7 16.9 20.4 15.3 18.8 16.2 29.7 17.6 26.8 23.5 19.5 13.7 26.8 44.8 11.5 8.9 17.6 10.6 7.6 17.0 5.7 33.1 32.0 13.0 23.4 19.1 13.3 11.3 16.0 19.8 26.3 24.5 36.1 8.8 21.0 23.7 17.6 13.9 21.9 19.6 16.9 13.6 23.9 26.7 15.4 18.2 20.1 17.8 11.1 20.7 12.7 11.5 19.7 11.7 16.7 15.2 16.4 16.7 9.6 14.6 24.6 23.9 12.4 11.0 13.9 16.4 21.7 25.7 36.8 7.7 11.4 13.4 17.7 20.0 13.9 18.2 42.7 14.0 9.6 15.4 25.4 17.7 37.2 31.3 11.2 8.5 12.7 46.1 18.2 16.6 4.3 7.2 17.6 15.1 7.4 14.0 7.9 13.6 17.0 8.9 11.5 10.9 11.0 4.6 7.6 10.6 6.6 7.9 5.7 17.1 21.9 23.4 25.3 16.5 18.9 19.0 16.9 15.4 17.6 32.8 25.7 39.8 24.5 57.5 79.0 78.7 25.5 28.1 18.2 26.2 37.3 28.1 71.3 24.0 48.1 37.6 35.4 46.7 27.3 36.7 47.3 36.0 41.4 52.9 29.7 112.8 58.5 27.6 39.9 29.1 38.0 25.6 47.2 17.2 41.8 72.5 28.5 42.4 48.8 81.8 52.8 19.4 44.3 106.7 98.2 48.9 26.3 48.4 31.6 21.6 ALMS1 KIAA0328 ENSG00000116127 "ALMS1, centrosome and basal body associated protein" 2 73385758-73610793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 55.4;Late spermatids: 63.9;Rod photoreceptor cells: 38.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RH-30: 24.2" "Low region specificity" "Detected in all" "HPA035276, HPA043200" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Centrosome, Cytosol" Nucleoplasm "HPA035276: , HPA043200: AB_10796689" "unprognostic (2.86e-1)" "unprognostic (9.67e-2)" "unprognostic (2.58e-2)" "unprognostic (4.50e-3)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (2.91e-3)" "unprognostic (7.73e-2)" "unprognostic (1.02e-1)" "unprognostic (8.58e-2)" "unprognostic (4.78e-2)" "unprognostic (1.84e-1)" "unprognostic (3.43e-2)" "unprognostic (1.63e-1)" "unprognostic (7.85e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 3.4 1.7 3.0 6.5 5.5 6.3 3.9 5.5 4.5 6.0 4.0 5.4 4.3 2.0 7.4 3.9 2.2 7.9 4.3 1.6 3.4 3.5 2.1 2.7 2.5 2.0 5.0 11.0 4.0 6.1 6.6 3.2 3.6 3.6 3.3 4.7 2.3 5.8 2.3 1.8 2.4 4.2 3.2 2.1 2.8 23.2 3.4 6.7 5.1 1.9 3.2 2.9 4.1 0.8 1.3 1.3 0.4 0.5 1.2 0.0 8.5 3.4 6.3 4.6 2.5 4.1 3.9 2.9 3.2 4.8 3.6 3.7 1.2 8.1 1.8 4.9 6.4 3.8 10.6 3.3 7.3 4.8 2.9 5.3 3.7 3.0 2.1 7.4 2.6 3.1 2.0 6.7 3.3 2.3 4.3 7.5 6.0 4.3 4.0 2.5 7.0 3.4 8.1 2.4 3.1 7.8 24.2 3.4 1.2 3.1 5.1 6.1 6.7 1.1 2.7 5.1 1.4 1.8 2.7 6.8 7.1 5.4 7.0 5.0 2.5 8.6 2.6 4.2 3.0 0.0 0.1 1.3 1.2 0.2 0.3 0.2 0.6 0.1 0.1 0.8 0.4 0.6 0.0 0.5 0.4 1.3 0.1 0.0 6.0 9.3 0.0 2.6 2.2 23.1 5.8 2.5 21.4 12.5 10.4 23.6 2.6 0.0 3.9 55.4 8.6 3.8 0.0 3.0 2.2 4.8 3.9 4.7 2.1 2.8 20.6 7.0 0.6 3.0 63.9 7.5 3.1 3.3 2.8 5.6 5.7 2.9 0.0 8.5 1.1 38.5 6.5 3.9 25.2 24.4 2.9 1.6 2.5 4.6 1.8 ALOX12 12S-LOX ENSG00000108839 "Arachidonate 12-lipoxygenase, 12S type" P18054 17 6996065-7010736 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Hydrolase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 1.8;Suprabasal keratinocytes: 1.0;Urothelial cells: 1.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "A-431: 17.5;HEL: 28.0" "Region enriched" "Detected in single" 5 "olfactory region: 5.4" "HPA010691, CAB019287, HPA064819" Enhanced Supported "Nuclear speckles,Vesicles,Cytosol" NA NA 5800000 Cytosol "Nuclear speckles, Vesicles" "CAB019287: , HPA010691: AB_1844756, HPA064819: " "unprognostic (3.61e-3)" "unprognostic (6.93e-2)" "unprognostic (7.17e-5)" "unprognostic (9.43e-2)" "unprognostic (6.06e-2)" "unprognostic (2.25e-3)" "unprognostic (2.45e-1)" "unprognostic (3.16e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-2)" "unprognostic (3.96e-5)" "unprognostic (4.01e-3)" "unprognostic (2.25e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (5.90e-2)" "unprognostic (3.47e-2)" 0.3 0.6 0.3 1.5 0.4 2.0 0.3 0.3 1.0 28.6 0.4 0.3 0.3 0.7 3.4 0.5 28.4 0.4 1.6 0.8 0.3 0.1 0.3 0.3 0.5 1.9 0.5 0.3 0.4 0.8 0.0 0.3 0.7 0.4 0.3 0.0 0.4 8.1 0.3 0.5 12.8 0.8 0.3 0.3 1.5 0.3 0.6 0.3 0.3 0.8 22.7 9.5 1.2 42.7 1.1 1.3 4.8 0.9 0.7 0.8 14.3 17.5 2.9 1.3 1.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 2.6 0.6 0.9 0.6 0.0 1.0 2.2 0.0 0.1 0.0 1.9 2.3 28.0 3.9 1.9 0.1 0.2 4.6 0.0 0.0 0.0 0.0 1.7 0.0 1.9 1.8 1.0 0.0 0.2 0.3 0.6 0.9 0.1 0.6 1.0 0.6 0.4 0.0 2.2 0.1 0.6 0.5 0.6 0.2 1.8 1.0 0.7 3.2 1.5 0.9 1.5 0.7 0.5 0.2 0.5 0.9 2.1 0.7 1.8 0.9 1.7 0.7 0.5 0.5 1.1 0.5 0.8 0.7 0.7 0.2 0.4 4.8 0.7 0.4 1.3 0.3 14.3 0.3 0.4 0.3 0.6 0.3 0.1 0.5 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 1.7 ALOX12B 12R-LOX ENSG00000179477 "Arachidonate 12-lipoxygenase, 12R type" O75342 17 8072636-8087703 "Disease related genes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 38.9;tongue: 55.3" "Cell type enhanced" "Detected in some" 11 "Horizontal cells: 1.6;Rod photoreceptor cells: 1.1;Suprabasal keratinocytes: 1.6" "Group enriched" "Detected in many" 9 "cervical cancer: 2.6;head and neck cancer: 11.2;melanoma: 4.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "basophil: 7.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.0" "Cell line enhanced" "Detected in some" "HEK 293: 3.2;hTCEpi: 3.6;JURKAT: 6.7;OE19: 3.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA024002 Supported Supported Cytosol NA NA Cytosol "HPA024002: AB_1844757" "unprognostic (1.27e-2)" "unprognostic (1.59e-2)" "unprognostic (4.28e-3)" "unprognostic (1.38e-2)" "unprognostic (3.94e-3)" "unprognostic (1.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-1)" "unprognostic (4.40e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.02e-1)" "unprognostic (8.01e-2)" "unprognostic (3.46e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 1.1 0.1 0.3 7.7 0.1 0.1 0.1 0.1 0.5 0.1 3.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.6 38.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 55.3 11.4 0.1 6.2 0.9 0.2 7.0 0.0 0.2 1.1 0.2 1.2 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 1.0 0.5 0.2 0.2 0.0 0.0 3.2 0.0 0.9 0.2 0.0 0.5 0.0 0.0 3.6 0.2 0.6 0.1 0.0 6.7 0.0 0.0 0.0 0.1 0.3 0.0 0.6 3.8 0.3 2.3 0.0 0.9 0.4 0.0 1.0 1.4 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 2.3 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.5 0.0 0.7 0.9 0.3 0.5 0.0 0.3 1.1 1.0 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.9 0.4 1.6 0.0 0.0 0.0 0.0 ALOX15B 15-LOX-2 ENSG00000179593 "Arachidonate 15-lipoxygenase, type B" O15296 17 8039017-8049134 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9" "Cell type enhanced" "Detected in many" 26 "Alveolar cells type 2: 58.0;Kupffer cells: 33.3;monocytes: 149.7" "Cancer enhanced" "Detected in all" "prostate cancer: 91.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 6.1;myeloid DC: 6.8" "Group enriched" "Detected in many" 9 "dendritic cells: 6.8;monocytes: 6.1" "Cell line enhanced" "Detected in some" "HHSteC: 6.1;HSkMC: 13.0;hTCEpi: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA010562 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA010562: AB_2668305" "unprognostic (1.76e-2)" "unprognostic (6.47e-2)" "unprognostic (2.56e-1)" "unprognostic (2.28e-3)" "unprognostic (1.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.59e-1)" "unprognostic (1.59e-2)" "unprognostic (9.37e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.49e-2)" 8.9 0.6 0.4 0.7 0.6 0.3 57.4 0.1 0.4 7.6 4.6 0.1 0.0 0.2 0.3 0.7 30.6 0.8 0.5 0.2 1.3 0.0 2.9 0.7 44.0 7.1 1.8 0.3 0.8 0.8 0.2 0.9 0.7 1.3 35.9 0.3 0.1 3.6 0.2 0.3 15.4 1.9 0.2 4.1 3.1 1.6 1.0 2.0 0.5 0.8 6.6 4.1 1.1 12.9 0.0 6.8 0.2 6.1 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 13.0 26.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.7 0.0 0.2 0.0 1.7 0.4 0.6 0.1 0.4 1.3 0.0 1.8 0.3 1.3 2.0 0.0 58.0 0.0 0.5 2.7 0.0 0.3 2.5 2.7 2.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.1 16.8 1.1 0.0 4.1 0.0 0.0 1.3 33.3 0.0 0.0 1.9 5.0 149.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 1.0 0.7 0.0 0.0 1.8 ALOXE3 "E-LOX, eLOX3" ENSG00000179148 "Arachidonate lipoxygenase 3" Q9BYJ1 17 8095900-8119047 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 30.2" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 1.6;Glandular cells: 2.0;Pancreatic endocrine cells: 3.6;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.9" "Group enriched" "Detected in many" 8 "basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1" "Group enriched" "Detected in some" 5 "gdT-cell: 1.0;naive CD4 T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enhanced" "Detected in some" "A-431: 6.6;HBEC3-KT: 10.8;hTCEpi: 8.0;hTERT-HME1: 15.1;T-47d: 4.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA023120, HPA078597" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023120: AB_10959300, HPA078597: AB_2732385" "unprognostic (2.40e-1)" "unprognostic (3.01e-2)" "unprognostic (1.87e-3)" "unprognostic (2.09e-4)" "unprognostic (1.07e-2)" "unprognostic (4.06e-2)" "unprognostic (3.56e-4)" "unprognostic (3.60e-1)" "unprognostic (4.65e-2)" "unprognostic (3.82e-2)" "unprognostic (3.72e-1)" "unprognostic (3.66e-5)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" 0.1 0.0 0.1 0.1 1.1 0.0 1.6 1.4 2.3 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 30.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 1.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 2.7 0.2 6.6 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.4 0.1 0.5 0.2 0.2 0.1 3.2 0.5 0.9 10.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.0 0.2 15.1 0.0 0.0 1.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.7 0.0 0.0 4.8 0.0 0.1 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 1.4 2.3 0.1 0.1 0.1 0.1 1.1 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.9 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.5 1.6 0.9 0.0 0.0 0.7 ALPK2 HAK ENSG00000198796 "Alpha kinase 2" Q86TB3 18 58481247-58628957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 79.2;Cone photoreceptor cells: 45.2;monocytes: 31.5" "Cancer enriched" "Detected in some" 6 "renal cancer: 7.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 26.6;BJ hTERT+: 16.2;fHDF/TERT166: 24.0;U-138 MG: 13.5" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected" "Not detected" "HPA027377, HPA027976, HPA028084, HPA029801" Uncertain Approved Cytosol NA NA Cytosol "HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006" "unprognostic (7.35e-2)" "unprognostic (4.91e-2)" "unprognostic (1.64e-1)" "unprognostic (4.60e-3)" "unprognostic (2.64e-1)" "unprognostic (8.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.20e-5)" "unprognostic (5.27e-3)" "unprognostic (2.50e-1)" "unprognostic (4.73e-2)" "unprognostic (3.20e-2)" 0.8 0.0 0.1 2.8 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.8 0.0 0.4 35.3 0.1 0.0 5.2 2.8 0.1 3.3 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.2 0.4 0.1 35.3 0.3 0.6 0.1 0.1 0.2 1.2 0.6 0.1 5.5 0.3 12.4 7.9 0.5 0.1 0.0 0.5 0.0 1.8 0.0 0.3 0.0 0.0 7.0 0.5 0.0 0.2 1.8 0.1 26.6 16.2 11.2 9.7 1.7 0.0 0.0 2.8 24.0 1.5 0.0 0.0 0.0 11.5 5.8 0.0 0.0 2.2 0.9 1.5 0.0 0.0 1.6 0.0 3.4 0.1 0.3 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.0 0.0 13.5 6.0 1.8 4.5 10.9 9.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 79.2 0.0 0.0 0.0 0.0 45.2 0.0 1.7 0.4 14.2 0.0 0.0 0.0 0.6 0.0 0.7 0.1 0.0 2.4 0.5 1.6 0.0 0.6 0.0 15.3 0.3 0.9 0.0 31.5 0.0 2.9 0.3 0.2 0.0 9.8 0.5 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.0 0.0 ALPL "HOPS, TNSALP" ENSG00000162551 "Alkaline phosphatase, liver/bone/kidney" P05186 1 21509372-21578412 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Biomineralization Hydrolase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 73.3;liver: 52.7;lung: 45.1" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 88.5;Hepatocytes: 25.3;Ito cells: 25.8;Proximal tubular cells: 44.8;Rod photoreceptor cells: 28.1" "Cancer enhanced" "Detected in all" "testis cancer: 199.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 91 "neutrophil: 73.3" "Lineage enriched" "Detected in single" 127 "granulocytes: 73.3" "Cell line enhanced" "Detected in some" "HSkMC: 53.1;hTEC/SVTERT24-B: 41.5;LHCN-M2: 30.2;SCLC-21H: 26.4;SuSa: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007105, HPA008765, CAB020829" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 7300000 Cytosol "CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138" "unprognostic (3.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.05e-3)" "unprognostic (6.50e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (7.08e-4)" "unprognostic (1.17e-2)" "unprognostic (2.48e-3)" "unprognostic (1.74e-1)" "unprognostic (7.28e-2)" "unprognostic (1.73e-2)" "unprognostic (2.27e-1)" "unprognostic (9.70e-3)" "unprognostic (2.58e-1)" 15.9 22.7 4.5 17.6 6.0 2.6 10.6 2.2 7.8 2.2 2.1 4.1 0.7 1.9 3.7 1.1 2.0 5.7 2.8 10.9 5.7 4.2 29.7 52.7 45.1 28.1 5.3 4.8 1.2 4.3 2.4 4.1 2.2 7.7 2.6 1.3 18.3 3.1 6.6 0.9 1.8 2.7 2.5 3.8 19.6 1.8 2.9 2.7 0.5 3.7 1.7 3.9 7.1 8.4 0.5 0.0 73.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 2.0 3.3 0.1 0.7 0.2 0.4 0.2 0.0 0.7 2.3 0.0 0.0 0.0 9.1 0.0 0.1 0.0 0.6 0.0 1.1 1.1 0.5 0.0 0.2 53.1 0.0 41.5 0.1 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 12.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 26.4 0.3 0.0 0.0 0.1 14.8 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 73.3 0.0 0.0 0.0 0.0 0.0 4.5 6.0 2.2 7.8 5.7 4.2 5.3 4.8 7.7 2.7 3.0 88.5 0.5 0.5 0.1 2.6 2.0 0.0 1.4 10.3 0.0 0.0 0.0 6.6 0.0 1.2 7.1 0.0 23.3 0.0 0.3 0.3 1.5 7.0 25.3 0.1 1.6 0.0 25.8 1.0 4.4 0.3 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 44.8 28.1 0.0 1.0 0.3 13.6 0.4 1.3 0.0 0.0 0.3 ALS2 ALS2CR6 ENSG00000003393 "ALS2, alsin Rho guanine nucleotide exchange factor" Q96Q42 2 201700554-201781189 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.8" "Cell type enhanced" "Detected in many" 6 "granulocytes: 45.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 66.8" "Group enriched" "Detected in many" 6 "basophil: 19.0;eosinophil: 5.5" "Lineage enriched" "Detected in all" 10 "granulocytes: 19.0" "Cell line enhanced" "Detected in many" "HMC-1: 53.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 158.8" HPA046588 Enhanced Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA046588: AB_2679709" "unprognostic (3.43e-2)" "unprognostic (2.11e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-3)" "unprognostic (2.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.04e-3)" "unprognostic (9.17e-2)" "unprognostic (4.16e-2)" "unprognostic (1.52e-1)" "unprognostic (2.99e-1)" "unprognostic (2.83e-2)" "unprognostic (1.09e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (2.10e-1)" "unprognostic (1.84e-1)" 6.9 5.3 8.2 4.2 14.7 7.8 8.1 66.8 15.6 5.9 5.6 10.1 5.5 7.4 10.3 10.7 4.7 6.7 6.4 19.9 8.3 7.3 10.4 18.3 7.9 4.1 6.8 11.0 6.8 5.6 8.8 16.8 7.2 13.6 6.6 6.0 8.5 5.2 5.5 12.2 6.9 8.4 7.4 8.3 5.3 6.7 6.1 9.0 3.5 7.5 5.9 4.5 5.5 5.3 1.2 1.0 19.0 1.2 1.7 1.8 0.7 5.1 3.6 8.8 8.2 6.0 6.5 6.6 9.2 12.4 12.2 14.2 8.4 5.1 0.6 4.0 9.6 8.3 5.3 5.0 9.3 15.5 1.7 5.1 12.2 3.5 4.8 7.4 9.6 53.0 5.6 5.2 10.2 8.8 9.5 12.3 4.9 5.8 3.7 9.2 4.1 3.4 12.7 7.3 3.2 5.5 2.8 4.9 1.8 7.7 7.1 4.1 5.4 5.3 5.8 8.2 22.1 3.7 4.0 7.3 10.8 5.2 3.7 4.6 4.1 5.6 2.1 7.9 1.9 6.8 19.0 0.7 5.5 1.7 1.2 1.8 1.2 1.2 1.2 1.0 1.2 1.3 1.5 0.6 1.7 0.8 0.5 1.8 0.7 8.2 14.7 66.8 15.6 8.3 7.3 6.8 11.0 13.6 9.0 11.9 18.4 1.9 3.3 4.7 14.7 26.3 7.6 13.4 3.4 8.7 27.5 4.6 0.0 5.6 13.0 7.7 5.2 0.0 2.8 2.4 5.9 3.8 45.1 17.1 4.9 7.9 4.6 15.4 3.5 5.3 7.2 5.3 0.0 1.0 6.7 6.8 5.9 3.7 7.8 4.8 14.7 0.0 4.1 6.5 2.8 5.3 5.6 4.3 3.8 3.3 ALS2CR12 ENSG00000155749 "Amyotrophic lateral sclerosis 2 chromosome region 12" Q96Q35 2 201288271-201357398 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.3;epididymis: 14.4;testis: 29.9" "Group enriched" "Detected in some" 6 "Ciliated cells: 99.0;Early spermatids: 82.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 14.3" "Cell type enhanced" "Detected in many" "neutrophil: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.0;U-2197: 9.6" "Low region specificity" "Detected in many" HPA035793 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035793: AB_10602429" "unprognostic (1.45e-1)" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.40e-3)" "unprognostic (1.40e-5)" "unprognostic (1.37e-1)" "unprognostic (3.62e-2)" "unprognostic (1.14e-1)" "unprognostic (6.23e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-2)" "unprognostic (2.23e-1)" "unprognostic (8.25e-2)" 0.8 0.9 1.5 0.7 3.6 4.3 0.5 0.7 1.1 0.9 0.6 7.6 0.4 0.3 0.7 14.4 1.1 9.9 0.9 4.7 2.1 2.6 1.3 0.7 3.7 1.4 1.0 1.3 5.3 0.7 1.2 1.3 0.9 14.3 0.4 0.9 0.5 0.7 0.7 1.4 1.1 0.9 0.9 0.9 0.8 0.5 29.9 1.3 0.4 1.7 0.4 0.5 0.6 0.4 1.8 0.5 7.3 1.1 2.8 1.5 0.4 0.3 0.4 2.1 1.5 5.7 2.2 0.1 1.5 0.5 1.3 0.9 0.0 0.5 0.7 1.2 2.2 1.0 2.0 0.8 0.2 0.6 1.2 0.2 0.3 2.5 0.7 1.1 2.1 1.9 1.1 0.6 1.3 0.3 1.7 0.2 2.5 1.0 2.9 1.3 0.0 1.1 1.8 0.6 0.8 1.2 0.5 1.0 1.3 0.8 0.5 0.5 1.3 1.6 0.0 7.0 2.2 1.5 2.5 1.6 2.9 1.7 9.6 1.0 1.6 3.1 1.0 2.8 1.0 1.3 5.4 1.1 1.0 1.5 0.5 0.7 0.6 1.0 0.9 0.5 1.8 1.2 1.4 7.3 2.8 0.6 0.4 0.6 0.4 1.5 3.6 0.7 1.0 2.1 2.6 1.0 1.3 14.3 1.3 0.0 0.3 0.0 0.0 0.5 5.4 5.7 0.0 99.0 9.1 0.0 9.8 0.0 3.3 0.0 82.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.3 1.6 0.0 0.0 0.0 16.0 0.6 0.0 0.0 1.0 0.0 0.8 0.1 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.1 AMBP "EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI" ENSG00000106927 "Alpha-1-microglobulin/bikunin precursor" P02760 9 114060127-114078472 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "liver: 592.2" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 9824.4" "Cancer enriched" "Detected in many" 115 "liver cancer: 2620.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 154 "Hep G2: 168.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001497, CAB069436, HPA075585" Approved Approved "Golgi apparatus,Vesicles,Cytosol" "Secreted to blood" NA NA 71000000000 Vesicles "Golgi apparatus, Cytosol" "CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: " "unprognostic (6.92e-2)" "unprognostic (3.61e-1)" "unprognostic (4.95e-3)" "prognostic favorable (1.20e-4)" "unprognostic (9.79e-2)" "unprognostic (2.90e-1)" "unprognostic (1.04e-3)" "unprognostic (7.59e-2)" "unprognostic (2.83e-2)" "unprognostic (2.04e-1)" "unprognostic (2.14e-1)" "unprognostic (7.84e-2)" "unprognostic (4.36e-2)" "unprognostic (2.89e-3)" "unprognostic (4.66e-2)" "unprognostic (2.97e-3)" "unprognostic (9.45e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.8 0.1 0.0 0.0 1.7 592.2 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 168.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.0 0.8 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 42.0 0.6 1.3 0.0 0.0 2035.7 0.0 1.2 1.8 0.0 0.0 3.3 105.1 19.2 0.0 0.4 256.9 25.3 0.3 0.1 0.4 0.0 9824.4 0.7 0.0 2.4 175.6 182.3 40.5 0.6 0.0 0.0 6.4 0.9 0.0 22.8 1.1 0.0 9.9 0.0 0.0 0.0 0.2 0.1 0.4 1.1 3.8 1.0 0.3 AMDHD1 MGC35366 ENSG00000139344 "Amidohydrolase domain containing 1" Q96NU7 12 95943293-95968716 "Enzymes, Predicted intracellular proteins" "Histidine metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 99.0" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 125.2" "Cancer enriched" "Detected in many" 14 "liver cancer: 23.4" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 19.5;HMC-1: 21.5;Karpas-707: 26.6;SiHa: 17.8;SK-BR-3: 20.0;U-266/70: 21.5;U-266/84: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039720, HPA040149" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" No NA 410000 Cytosol "Nucleoplasm, Plasma membrane" "HPA039720: AB_10672967, HPA040149: " "unprognostic (4.81e-2)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.09e-2)" "unprognostic (1.80e-2)" "unprognostic (2.88e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.06e-1)" "unprognostic (7.01e-2)" "unprognostic (3.35e-3)" "unprognostic (1.17e-1)" "unprognostic (4.63e-3)" "unprognostic (3.98e-2)" "unprognostic (1.70e-1)" "unprognostic (4.08e-3)" "unprognostic (2.61e-1)" 1.1 5.7 0.5 2.4 0.8 2.0 0.9 0.5 1.3 0.7 0.7 0.6 0.4 1.9 0.9 0.5 0.8 0.5 0.7 1.1 0.6 0.5 4.4 99.0 1.3 1.4 0.5 0.4 0.7 1.1 0.0 1.2 0.6 1.0 0.7 0.0 0.8 1.3 0.7 11.3 2.2 1.9 0.6 0.6 2.9 1.9 6.2 0.5 0.7 0.6 0.7 0.7 0.8 0.9 1.5 1.2 3.7 3.8 5.7 1.6 1.4 19.5 4.3 0.3 2.8 0.1 0.0 4.4 0.6 0.2 0.3 0.6 1.9 2.5 1.7 1.9 0.0 1.1 3.7 0.1 0.0 0.1 6.8 0.7 1.9 3.0 3.8 0.0 2.5 21.5 0.0 0.1 0.3 0.0 0.1 0.1 1.7 1.3 26.6 0.0 3.0 1.6 4.8 2.0 0.7 1.0 3.5 0.1 2.2 0.0 1.8 2.2 3.2 17.8 20.0 2.3 0.0 2.1 3.6 0.0 2.8 9.7 3.5 2.4 21.5 25.2 2.7 1.9 5.2 3.1 0.3 1.6 3.7 1.2 1.4 1.1 1.5 0.6 1.6 1.2 1.0 1.0 1.1 1.2 5.7 3.8 0.6 0.3 1.4 0.5 0.8 0.5 0.6 0.6 0.5 0.5 0.4 1.0 0.5 0.0 0.3 2.2 0.2 0.3 0.0 0.4 0.0 0.0 1.2 3.5 0.0 0.5 3.3 0.1 0.6 0.3 0.0 0.0 1.0 0.1 0.3 0.0 0.0 125.2 4.1 1.6 1.7 11.1 3.7 0.0 0.3 1.1 3.3 0.0 0.0 1.9 0.3 0.0 0.0 23.2 0.0 0.0 0.0 1.2 1.9 0.3 0.2 2.9 0.0 0.1 AMDHD2 CGI-14 ENSG00000162066 "Amidohydrolase domain containing 2" Q9Y303 16 2520357-2531422 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 104.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA041184, HPA041321" Enhanced Approved Nucleoli,Cytosol No No 69000 "Nucleoli, Cytosol" "HPA041184: AB_10803998, HPA041321: AB_10795588" "unprognostic (1.20e-1)" "prognostic favorable (5.19e-4)" "unprognostic (7.86e-3)" "unprognostic (2.39e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-2)" "unprognostic (8.68e-2)" "unprognostic (1.30e-1)" "unprognostic (8.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" 12.8 16.9 8.6 11.4 10.1 12.7 10.9 7.3 16.0 9.4 8.8 11.1 11.3 19.5 10.4 11.9 8.4 9.0 14.6 11.8 7.1 4.8 15.3 10.5 20.0 15.8 9.8 11.3 8.1 10.1 6.5 7.5 10.7 8.9 8.6 2.4 10.9 16.1 9.6 10.2 15.0 19.1 7.2 8.3 22.2 11.5 25.7 7.9 7.3 9.9 11.0 8.9 9.3 8.0 9.8 17.1 16.6 15.8 4.9 8.1 4.8 6.5 8.8 1.9 4.0 2.1 1.7 14.3 5.9 2.5 4.7 5.9 6.3 11.6 3.0 4.2 1.1 10.1 6.0 1.1 1.6 0.1 3.8 5.3 4.3 7.9 8.2 8.0 3.1 14.1 4.0 1.7 3.4 0.5 1.2 2.9 8.5 9.8 7.2 1.9 15.6 5.1 8.6 4.1 0.5 6.8 19.7 3.0 11.0 1.3 3.6 7.3 7.2 3.8 9.2 15.5 0.3 9.5 0.8 4.0 5.3 8.1 10.5 3.0 15.2 9.7 5.9 5.9 5.9 6.6 9.9 6.1 16.5 7.4 15.8 5.5 9.8 5.9 5.3 2.3 7.4 5.0 4.2 16.6 4.9 15.2 17.1 8.1 4.8 8.6 10.1 7.3 16.0 7.1 4.8 9.8 11.3 8.9 7.9 3.0 12.3 13.1 4.6 7.9 9.0 2.0 7.6 5.3 2.3 5.2 5.9 14.1 5.0 24.6 45.6 7.1 18.1 0.0 14.7 23.4 8.0 6.0 6.9 10.4 104.3 22.3 12.1 18.4 33.6 16.0 9.8 15.9 18.6 34.3 9.0 10.8 16.8 14.4 6.0 38.1 12.0 0.0 4.4 7.7 17.2 7.9 23.3 15.3 7.0 3.8 AMER3 "FAM123C, FLJ38377" ENSG00000178171 "APC membrane recruitment protein 3" Q8N944 2 130755435-130768134 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.1" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 6.2;Horizontal cells: 3.2;Intestinal endocrine cells: 14.6;Rod photoreceptor cells: 5.0" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 30.1" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045593, HPA054230" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA045593: AB_10965021, HPA054230: AB_2682423" "unprognostic (6.68e-2)" "unprognostic (3.73e-1)" "unprognostic (2.17e-2)" "unprognostic (1.83e-1)" "unprognostic (2.71e-1)" "unprognostic (5.33e-3)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (6.46e-3)" 0.5 2.4 4.8 0.7 6.0 0.8 0.5 30.1 13.9 0.5 0.8 0.0 0.0 2.0 0.6 0.5 0.5 0.5 0.5 0.5 2.7 4.3 0.5 0.5 0.5 0.6 1.8 5.6 0.6 3.3 0.4 3.4 0.5 3.0 0.6 0.8 0.7 0.5 0.5 0.5 0.7 1.2 0.5 0.8 0.6 2.5 1.6 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.3 0.3 1.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.1 0.2 1.5 0.2 0.1 0.3 0.1 0.0 4.8 6.0 30.1 10.3 2.7 4.3 1.8 5.6 3.0 0.7 0.0 0.0 0.0 0.0 0.0 6.2 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 14.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.1;ovary: 38.2;testis: 15.2" "Group enriched" "Detected in some" 4 "granulocytes: 25.4;Ito cells: 12.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "HEL: 28.3;K-562: 15.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "hippocampal formation: 14.3" "HPA060228, HPA069636" Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA060228: AB_2684227, HPA069636: AB_2686163" "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 27.1 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.6 0.4 0.2 0.4 0.8 0.2 0.0 0.2 1.1 0.3 0.2 0.2 0.2 38.2 8.8 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.2 0.2 2.5 0.0 0.4 0.5 0.2 3.7 0.3 15.2 0.2 0.2 0.2 0.5 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 28.3 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 2.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 25.4 0.0 0.1 0.0 0.0 12.3 2.2 1.3 4.6 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.9 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 AMIGO2 "ALI1, DEGA" ENSG00000139211 "Adhesion molecule with Ig like domain 2" Q86SJ2 12 47075707-47079951 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.4" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 58.0;Ito cells: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.9;fHDF/TERT166: 39.3;hTERT-RPE1: 69.7;LHCN-M2: 39.3;RT4: 53.8;U-2 OS: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054004, HPA059601" Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" NA Yes 160000 "Golgi apparatus, Plasma membrane" Cytosol "HPA054004: AB_2682339, HPA059601: AB_2684078" "unprognostic (2.63e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" "unprognostic (3.91e-2)" "unprognostic (3.86e-1)" "unprognostic (1.07e-2)" "unprognostic (3.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (2.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-2)" "unprognostic (2.95e-1)" "unprognostic (7.47e-2)" "unprognostic (2.29e-3)" 5.6 11.9 5.4 4.0 8.8 1.4 14.5 1.6 6.5 18.3 20.3 3.5 1.9 1.6 19.7 12.4 3.1 21.2 12.4 3.4 2.7 7.5 4.3 2.9 11.9 6.7 2.9 5.1 43.4 2.3 2.0 9.5 7.6 16.2 12.8 5.6 6.7 3.1 7.1 1.5 2.3 7.1 21.0 3.0 9.8 3.5 13.1 3.6 1.6 2.5 4.1 4.5 16.6 15.1 2.8 7.4 0.1 0.2 6.6 14.2 4.3 9.0 22.5 1.4 0.0 0.5 0.0 3.7 3.1 8.5 1.0 0.8 0.0 40.9 0.0 10.3 39.3 25.8 13.6 0.0 25.1 1.2 1.7 0.1 0.0 2.2 0.0 0.8 0.2 0.3 0.2 4.4 26.9 13.3 69.7 3.2 0.2 1.7 0.0 39.3 0.4 0.7 0.0 0.9 4.5 5.7 0.0 10.1 0.0 11.6 53.8 4.1 0.0 16.2 1.9 0.1 0.8 2.4 0.2 0.8 0.5 32.6 0.3 25.1 0.3 0.0 0.0 2.1 0.7 0.6 0.0 0.1 0.0 4.0 0.2 5.4 2.8 6.2 6.2 0.6 1.3 14.2 11.1 0.1 6.6 0.0 7.4 3.6 4.3 5.4 8.8 1.6 6.5 2.7 7.5 2.9 5.1 16.2 3.6 8.9 1.9 5.9 10.4 2.2 21.1 0.8 0.0 2.7 6.8 1.8 0.0 0.7 1.7 4.3 1.2 4.5 0.0 0.0 17.0 23.1 6.7 5.2 6.9 0.8 4.4 0.0 58.0 30.7 3.8 0.9 2.3 2.3 1.7 8.2 2.5 14.9 26.7 0.8 0.7 0.0 4.1 0.0 25.5 0.3 0.7 0.4 7.1 4.4 0.2 13.4 AMMECR1L MGC4268 ENSG00000144233 "AMMECR1 like" Q6DCA0 2 127861630-127885922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 45.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000590, HPA057234" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000590: AB_2666037, HPA057234: AB_2683376" "unprognostic (1.34e-1)" "unprognostic (1.29e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.92e-1)" "unprognostic (9.10e-2)" "unprognostic (2.66e-2)" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-1)" "unprognostic (1.12e-2)" "unprognostic (8.91e-2)" 7.8 6.4 5.2 5.2 5.2 5.0 7.1 5.7 5.2 7.6 5.5 5.2 5.2 4.6 8.7 5.2 6.4 6.9 5.9 5.2 5.2 3.3 5.2 7.7 5.6 5.2 5.2 5.2 7.6 8.8 7.6 5.2 7.3 5.2 6.4 5.7 45.9 5.9 5.2 5.2 7.2 5.8 7.5 5.2 6.8 6.1 7.9 5.2 5.2 6.1 5.2 5.4 5.8 7.3 4.2 5.4 9.0 3.7 3.5 6.1 3.2 12.3 8.3 17.1 14.0 16.2 13.2 16.2 14.6 13.3 16.1 14.6 18.4 9.3 12.1 9.8 14.4 7.6 12.3 16.5 12.2 17.8 14.2 12.1 15.2 12.3 10.4 19.4 15.1 15.7 14.6 26.7 19.8 26.7 15.5 16.9 12.4 13.9 12.1 13.0 8.7 14.0 14.6 13.5 9.5 15.3 14.8 13.7 6.8 12.8 10.8 11.3 12.8 12.1 18.9 29.4 14.6 8.8 10.5 16.7 20.0 18.7 9.3 11.0 10.2 15.0 12.4 9.6 9.7 13.2 1.6 3.2 9.0 4.7 3.7 6.1 3.6 4.5 4.1 4.8 4.2 4.1 3.8 4.3 3.5 3.7 5.4 4.2 3.2 5.2 5.2 5.7 5.2 5.2 3.3 5.2 5.2 5.2 5.2 17.9 7.2 8.2 7.4 16.0 5.1 11.2 7.6 18.7 11.4 3.5 5.9 4.4 0.0 5.2 10.1 6.7 6.3 0.0 4.9 5.8 11.0 10.9 6.9 14.3 3.9 1.6 5.2 8.0 6.6 12.4 6.4 6.1 5.0 1.8 11.6 4.3 7.3 7.0 7.8 4.1 5.5 0.0 8.0 6.3 10.4 13.8 6.4 2.5 9.1 12.5 AMOTL1 JEAP ENSG00000166025 "Angiomotin like 1" Q8IY63 11 94706431-94876753 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 78.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3;NK-cell: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 36.6;WM-115: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001196 Approved Approved "Cell Junctions,Cytosol" NA NA 11000 Cytosol "Cell Junctions" "HPA001196: AB_1078147" "unprognostic (2.21e-1)" "unprognostic (5.25e-2)" "unprognostic (4.23e-2)" "unprognostic (5.43e-2)" "unprognostic (7.58e-2)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (2.40e-1)" "unprognostic (2.09e-1)" "unprognostic (7.97e-2)" "unprognostic (1.85e-1)" "unprognostic (5.95e-2)" "prognostic favorable (5.03e-6)" "unprognostic (7.47e-3)" "unprognostic (1.39e-1)" "unprognostic (1.68e-2)" "unprognostic (1.29e-2)" 14.4 5.7 3.3 6.9 4.0 0.6 9.2 3.7 4.8 12.8 15.4 2.7 9.1 2.2 16.4 11.4 19.3 7.5 10.9 10.1 3.1 3.9 4.4 4.8 10.0 2.5 3.2 2.5 7.3 10.8 13.5 13.9 25.4 3.5 18.7 4.0 11.3 8.9 13.6 78.2 11.7 4.8 32.8 2.6 6.2 8.1 7.1 1.8 12.9 8.6 21.9 10.1 24.4 9.5 2.3 1.0 0.0 0.7 2.3 0.1 0.5 18.3 5.2 14.0 0.0 15.1 13.2 6.7 10.2 17.8 4.7 5.5 9.6 0.5 0.8 5.0 13.8 3.8 23.9 6.6 36.6 4.9 1.4 5.1 9.9 5.4 0.0 3.5 2.1 0.0 7.8 22.7 16.0 26.8 12.1 9.7 3.9 24.9 0.9 11.0 5.3 6.7 1.3 2.1 0.0 3.5 0.0 25.5 1.5 6.6 7.7 10.7 12.9 0.6 14.1 3.6 9.9 0.7 3.1 8.9 12.9 9.5 0.2 7.0 0.5 0.0 5.2 3.6 0.0 35.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.6 2.3 0.0 0.0 0.0 2.3 0.2 1.0 0.0 0.5 3.3 4.0 3.7 3.0 3.1 3.9 3.2 2.5 3.5 1.8 32.8 28.3 0.9 15.3 31.5 1.9 39.3 7.6 5.3 13.6 7.0 3.9 25.5 0.0 14.1 104.0 28.1 0.0 0.0 14.6 12.7 38.7 10.8 2.3 15.3 4.3 14.3 0.0 28.8 4.3 25.4 7.5 4.7 10.1 1.8 0.0 15.0 12.1 0.0 11.7 2.9 1.1 12.9 26.7 17.0 12.7 23.5 23.3 1.5 0.0 6.4 AMPD2 SPG63 ENSG00000116337 "Adenosine monophosphate deaminase 2" Q01433 1 109616104-109632051 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 64.4" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 58.9;Horizontal cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 8.8;granulocytes: 29.7;monocytes: 24.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027137, HPA045760, HPA050590" Approved Enhanced Cytosol NA NA 380000 Cytosol "HPA027137: AB_2672129, HPA045760: AB_2679443, HPA050590: AB_2681184" "unprognostic (2.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.50e-1)" "unprognostic (1.43e-3)" "unprognostic (9.01e-2)" "unprognostic (5.25e-2)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (4.02e-1)" "unprognostic (1.23e-1)" "unprognostic (8.10e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.78e-10)" "unprognostic (9.16e-2)" "unprognostic (2.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" 8.1 22.7 20.2 21.7 41.3 64.4 4.9 16.3 26.8 9.5 10.1 9.5 6.3 17.1 9.0 6.0 5.9 11.8 13.2 5.2 21.7 19.4 7.8 13.0 8.2 10.7 14.2 14.2 16.3 9.4 13.0 37.1 10.8 18.3 9.7 5.7 15.7 9.1 12.2 2.1 10.0 11.6 9.1 8.5 15.9 8.3 5.3 12.2 10.3 6.4 3.0 7.5 8.2 8.1 2.8 8.8 29.7 24.5 3.0 4.3 5.4 10.9 12.7 18.7 15.8 16.3 16.3 7.1 15.6 31.9 16.0 15.8 9.7 4.7 5.4 12.0 29.2 10.5 8.6 9.8 14.5 9.9 8.7 13.2 28.5 16.7 10.8 15.3 12.1 30.7 18.3 7.7 21.1 16.4 28.9 13.8 11.9 8.8 14.7 11.4 16.9 17.9 29.0 12.1 10.2 13.6 12.7 7.2 8.4 14.7 6.7 14.5 15.3 10.6 13.0 12.6 7.0 7.3 11.3 13.1 19.8 23.0 24.1 16.0 29.5 14.3 7.8 29.5 18.8 20.6 0.5 9.2 11.2 3.4 19.6 4.3 2.8 3.3 3.4 8.8 1.7 3.8 2.8 29.7 3.0 24.5 1.4 2.6 5.4 20.2 41.3 16.3 26.8 21.7 19.4 14.2 14.2 18.3 12.2 3.0 8.5 8.3 4.7 7.9 35.7 2.5 17.8 4.0 5.7 0.0 58.9 4.0 6.6 9.7 2.9 6.2 3.9 0.0 9.6 7.4 11.8 4.5 3.5 17.8 10.5 49.3 16.8 6.2 37.8 1.3 12.0 28.6 5.0 1.0 8.6 9.1 8.3 0.0 20.1 3.9 5.8 12.9 11.7 4.5 2.6 7.0 2.2 10.1 9.7 3.4 AMPH ENSG00000078053 Amphiphysin P49418 7 38383704-38631567 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 57.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 53.7;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 54.5" "Cancer enhanced" "Detected in many" "glioma: 3.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 31.2;ASC TERT1: 18.5;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 14.4;GAMG: 21.3;HBF TERT88: 11.1;U-138 MG: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008559, HPA019828, HPA019829" Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802" "unprognostic (1.76e-2)" "unprognostic (1.59e-1)" "unprognostic (5.94e-2)" "unprognostic (7.36e-2)" "unprognostic (3.24e-3)" "unprognostic (2.92e-1)" "unprognostic (4.90e-2)" "unprognostic (2.55e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "prognostic favorable (9.96e-4)" "unprognostic (5.06e-2)" "unprognostic (5.81e-5)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 3.8 2.4 17.4 2.5 17.7 1.0 2.8 29.7 57.2 7.7 2.2 1.8 0.0 1.4 5.1 4.7 4.5 5.7 4.2 6.5 13.5 16.0 3.7 1.4 1.6 1.3 10.4 20.4 1.7 2.9 1.2 12.6 1.0 26.5 2.4 2.5 4.8 1.5 4.2 2.9 1.3 1.9 5.0 4.9 1.9 2.0 3.5 1.5 0.0 1.2 0.2 1.1 2.9 1.7 0.2 1.6 0.0 0.8 0.7 2.9 0.2 0.0 0.0 7.9 0.0 31.2 18.5 0.0 1.1 0.0 12.1 14.4 0.0 0.0 0.0 0.0 2.2 21.3 0.0 0.0 0.0 11.1 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 10.8 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.2 0.0 0.1 0.0 0.1 4.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 11.8 8.4 4.1 4.5 0.0 0.1 0.0 8.0 0.1 10.6 0.0 0.8 0.0 2.9 0.2 1.7 0.0 1.0 1.5 0.2 0.2 0.4 2.0 0.0 0.7 0.2 1.6 0.2 0.2 17.4 17.7 29.7 32.9 13.5 16.0 10.4 20.4 26.5 1.5 0.0 0.0 0.5 0.1 0.2 53.7 6.3 0.0 0.0 0.0 0.0 82.5 0.0 1.7 0.1 7.7 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.6 0.0 5.5 14.2 10.2 2.6 0.0 0.0 0.0 0.0 4.7 0.1 0.0 4.6 0.0 54.5 6.5 3.0 0.4 3.0 0.3 0.0 0.0 0.0 0.0 AMZ2 ENSG00000196704 "Archaelysin family metallopeptidase 2" Q86W34 17 68247574-68257164 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 585.3;Late spermatids: 1307.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023299, HPA052406" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA023299: AB_2226909, HPA052406: AB_2681818" "unprognostic (3.04e-1)" "unprognostic (3.68e-2)" "unprognostic (3.93e-2)" "unprognostic (3.27e-3)" "unprognostic (3.32e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.43e-1)" "unprognostic (3.92e-2)" "unprognostic (2.83e-3)" "unprognostic (3.59e-3)" "unprognostic (3.37e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.37e-1)" "unprognostic (2.95e-1)" "unprognostic (3.28e-1)" "unprognostic (7.62e-2)" 22.3 21.3 29.3 13.7 43.3 14.2 20.8 29.2 35.8 19.8 19.8 20.3 19.6 11.9 19.0 25.3 22.3 24.6 17.7 33.6 26.8 23.7 26.8 16.6 14.1 22.4 26.0 27.0 23.4 20.4 29.4 25.4 18.9 28.3 21.1 15.0 19.0 17.9 25.1 39.9 15.5 13.5 19.3 27.8 16.6 15.7 77.2 20.5 15.5 28.4 20.6 22.4 20.2 14.9 20.9 17.2 31.4 21.1 34.8 31.2 19.7 23.4 26.1 22.1 18.7 17.0 29.6 34.8 17.0 23.0 29.6 24.9 10.7 15.1 35.1 19.2 26.3 27.9 11.6 18.0 50.1 38.9 12.4 17.0 12.9 11.6 20.8 32.2 11.7 22.3 25.2 56.3 27.5 51.3 29.3 29.9 30.2 13.2 22.5 37.4 17.4 26.4 10.9 10.4 12.5 24.4 10.1 60.2 26.3 17.8 12.4 22.3 17.5 15.8 32.6 31.7 47.6 25.7 8.1 15.5 39.9 19.0 14.3 18.4 31.6 29.0 60.6 28.1 16.7 20.1 31.4 14.4 19.6 22.1 16.6 28.6 17.4 27.3 29.0 17.2 20.9 24.4 26.3 25.2 34.8 21.1 15.7 31.2 19.7 29.3 43.3 29.2 35.8 26.8 23.7 26.0 27.0 28.3 20.5 11.9 14.1 28.3 32.0 16.6 13.3 73.2 22.9 57.6 21.6 22.7 7.9 54.0 92.9 25.1 585.3 25.4 8.9 0.0 22.9 56.9 31.5 18.0 32.4 13.7 37.1 17.5 20.3 22.7 19.9 1307.8 33.4 36.7 54.0 56.9 16.8 56.2 24.4 12.9 30.8 48.5 11.6 19.4 27.2 187.0 54.0 19.7 28.6 51.1 15.8 15.9 ANAPC13 "APC13, DKFZP566D193, SWM1" ENSG00000129055 "Anaphase promoting complex subunit 13" Q9BS18 3 134477706-134486716 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 393.0;Proximal tubular cells: 267.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046114 Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA046114: AB_10961429" "unprognostic (2.84e-2)" "prognostic favorable (1.66e-4)" "unprognostic (2.98e-1)" "unprognostic (7.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.67e-4)" "unprognostic (3.57e-1)" "unprognostic (2.90e-1)" "unprognostic (2.28e-3)" "unprognostic (6.44e-2)" "unprognostic (4.36e-1)" "prognostic favorable (2.66e-7)" "unprognostic (3.10e-1)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (1.16e-1)" 35.5 29.5 29.0 10.8 24.0 9.7 26.2 14.6 26.7 21.3 20.0 14.8 19.6 13.2 18.7 46.5 24.5 19.2 19.3 37.5 25.3 36.3 47.1 54.4 22.1 17.3 33.3 13.3 30.1 36.0 29.6 34.3 34.8 29.2 29.1 18.3 23.4 30.5 22.6 36.8 14.4 25.4 20.7 23.2 19.2 20.1 20.4 12.4 14.1 44.3 22.2 13.4 27.3 16.9 25.5 26.9 69.4 30.5 18.7 30.0 22.8 21.1 13.3 21.0 17.9 35.8 47.6 16.2 27.6 25.5 20.2 19.1 16.6 12.6 14.4 60.0 40.4 24.4 12.5 19.6 19.7 29.2 7.2 9.1 14.7 10.8 27.7 25.8 24.0 10.5 31.6 21.6 20.3 38.1 22.7 31.3 14.1 19.5 12.3 63.7 27.2 12.2 23.6 14.3 36.7 13.0 9.8 16.5 26.2 39.4 13.2 8.6 14.1 24.5 9.0 24.0 23.5 22.5 23.6 21.8 28.2 11.4 39.5 12.1 13.6 14.7 29.8 17.3 13.3 24.0 28.9 28.3 24.2 16.4 30.5 21.3 25.5 24.6 21.4 26.9 18.6 30.0 25.2 69.4 18.7 29.6 20.5 20.5 22.8 29.0 24.0 14.6 26.7 25.3 36.3 33.3 13.3 29.2 12.4 32.8 43.1 47.7 44.5 37.4 40.5 107.7 56.0 49.5 20.5 80.3 11.8 81.7 393.0 47.8 34.9 60.7 30.8 0.0 47.0 87.8 59.7 60.7 17.4 58.7 70.2 19.1 39.2 50.3 63.1 66.9 46.9 40.0 92.8 13.6 36.6 50.4 36.3 39.1 41.4 267.1 26.5 19.4 61.3 39.2 65.8 44.3 58.8 34.5 32.7 45.2 ANAPC16 "APC16, bA570G20.3, C10orf104, CENP-27, FLJ33728" ENSG00000166295 "Anaphase promoting complex subunit 16" Q96DE5 10 72216000-72235860 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037815 Approved Supported Cytosol NA NA Cytosol "HPA037815: AB_10672288" "unprognostic (2.87e-1)" "unprognostic (4.35e-3)" "unprognostic (2.01e-2)" "unprognostic (7.12e-3)" "unprognostic (2.16e-1)" "unprognostic (6.20e-3)" "unprognostic (1.51e-2)" "unprognostic (2.00e-1)" "unprognostic (1.82e-1)" "unprognostic (3.10e-2)" "unprognostic (1.90e-2)" "unprognostic (2.11e-1)" "unprognostic (2.75e-3)" "unprognostic (7.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-3)" 16.9 26.7 13.9 15.6 15.9 10.8 18.7 21.6 15.8 18.3 21.2 9.4 25.8 13.1 19.1 19.9 22.7 19.9 17.0 35.6 14.8 9.5 24.9 22.7 15.8 21.6 18.7 9.8 23.4 49.0 17.9 27.3 12.4 13.6 23.9 15.3 17.5 41.4 26.2 46.3 14.2 19.6 26.4 14.4 23.2 23.6 11.9 18.0 25.5 32.3 20.5 20.9 22.4 32.2 32.1 23.5 18.4 11.9 16.5 26.2 15.5 11.3 5.7 5.8 6.9 15.7 7.5 4.5 4.1 7.9 5.5 5.2 6.9 15.0 11.5 6.7 5.5 6.6 9.2 5.0 9.8 5.5 13.3 8.5 5.8 5.3 6.8 19.0 9.8 7.3 9.8 44.2 4.8 16.6 12.2 6.6 16.3 8.5 13.9 6.3 7.1 8.1 9.7 4.5 8.2 3.3 4.8 5.2 11.2 14.1 5.0 8.6 7.8 6.9 18.6 13.7 7.7 5.9 10.2 8.8 2.9 6.9 4.7 6.1 14.1 11.8 11.9 8.2 18.8 3.4 16.2 11.3 18.4 16.7 11.4 18.2 27.7 18.7 16.4 9.0 32.1 26.2 20.9 10.5 16.5 11.9 23.5 16.3 15.5 13.9 15.9 21.6 15.8 14.8 9.5 18.7 9.8 13.6 18.0 145.9 175.2 315.0 204.1 99.3 78.1 380.0 252.3 196.7 161.5 211.1 35.3 168.3 580.3 194.9 57.7 177.7 157.0 93.5 256.5 162.3 141.2 194.7 195.4 368.3 197.3 31.8 155.4 152.2 273.2 38.0 216.3 147.2 183.9 367.9 211.1 118.1 181.5 190.4 235.1 374.6 112.6 226.4 253.6 129.9 117.2 123.2 124.8 276.7 182.8 189.1 ANAPC7 APC7 ENSG00000196510 "Anaphase promoting complex subunit 7" Q9UJX3 12 110372900-110403730 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009567 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009567: AB_2227137" "unprognostic (2.49e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.36e-2)" "unprognostic (2.02e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (3.20e-1)" "unprognostic (7.08e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.36e-10)" "unprognostic (1.45e-1)" "unprognostic (9.92e-2)" "unprognostic (3.08e-2)" "unprognostic (1.58e-2)" 15.6 20.3 17.8 14.7 25.1 12.2 19.9 24.8 25.1 20.6 16.2 16.8 12.2 11.9 21.4 19.8 34.2 20.9 15.6 18.8 19.1 18.5 21.4 16.8 16.6 20.8 16.2 22.1 18.1 16.7 26.6 14.9 9.6 17.6 21.8 18.9 16.4 19.7 21.3 29.7 16.0 13.3 24.0 17.1 16.8 14.9 36.3 16.3 25.8 23.2 24.5 22.2 19.2 22.5 14.9 17.7 17.6 15.1 20.1 22.4 12.5 18.7 25.9 18.9 16.1 19.9 10.1 10.8 13.2 12.0 24.4 17.0 26.4 12.1 30.0 13.4 17.7 14.1 19.1 28.2 18.1 24.9 16.0 22.7 26.5 19.2 21.8 14.5 23.7 12.6 11.0 13.0 21.1 14.1 17.4 23.6 21.6 41.6 6.2 19.1 20.1 35.8 17.7 16.5 18.4 22.6 27.7 18.8 35.7 16.5 24.1 24.7 14.2 20.6 16.3 21.6 17.5 34.4 21.5 14.8 14.6 13.7 12.9 15.5 10.9 22.1 40.5 16.3 20.3 16.8 14.3 10.5 17.6 17.2 15.1 20.2 13.3 18.5 16.5 17.7 14.9 15.5 16.5 8.3 20.1 13.1 9.7 22.4 12.5 17.8 25.1 24.8 25.1 19.1 18.5 16.2 22.1 17.6 16.3 14.9 13.6 11.2 18.2 9.0 18.1 15.9 12.7 14.7 25.0 12.2 19.6 10.3 10.0 15.4 5.7 13.5 7.4 0.0 13.1 8.1 9.4 15.1 15.1 13.5 19.4 20.6 10.4 11.6 15.9 8.5 17.0 10.3 16.9 9.0 10.2 16.7 13.1 7.0 20.5 11.9 22.2 12.9 11.2 79.8 34.1 11.7 6.1 15.2 14.5 15.5 ANKEF1 "ANKRD5, dJ839B4.6, FLJ21669" ENSG00000132623 "Ankyrin repeat and EF-hand domain containing 1" Q9NU02 20 9986126-10058303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.0;testis: 22.7" "Group enriched" "Detected in many" 13 "Early spermatids: 319.3;Late spermatids: 291.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 17.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA041151 Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Nucleoli fibrillar center, Plasma membrane, Cytosol" "HPA041151: AB_10796569" "unprognostic (4.72e-2)" "unprognostic (9.86e-2)" "unprognostic (2.31e-2)" "unprognostic (2.09e-1)" "unprognostic (5.38e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (3.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.28e-1)" "unprognostic (6.73e-2)" "prognostic favorable (4.44e-4)" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.58e-4)" "unprognostic (3.11e-1)" 5.6 2.9 1.4 2.3 2.4 0.5 3.7 5.7 2.0 2.7 3.1 0.8 11.3 2.9 1.9 4.2 4.7 4.9 4.0 3.2 2.3 2.5 5.7 6.7 2.3 1.3 1.5 1.1 3.6 25.0 5.3 13.6 1.7 4.1 3.4 3.0 3.0 4.2 13.0 1.7 2.9 3.6 1.0 1.2 1.8 5.1 22.7 1.0 3.2 8.6 2.5 3.9 2.1 2.6 2.5 1.6 0.7 0.1 1.5 5.4 1.3 10.0 10.3 1.4 2.5 2.1 1.2 5.9 1.9 0.1 1.8 0.9 5.9 9.1 0.0 3.1 0.4 10.8 8.7 1.8 12.0 2.2 0.0 1.6 1.3 2.0 5.5 1.4 1.1 0.2 3.7 8.6 1.5 1.7 4.2 1.5 3.9 3.8 8.9 0.4 3.1 1.6 0.0 4.3 12.0 2.4 0.0 0.0 6.8 4.4 6.5 7.7 3.9 4.6 10.2 0.0 3.6 8.9 0.9 1.1 1.3 1.4 0.1 1.9 9.2 17.8 1.5 2.6 0.3 1.7 0.0 0.0 0.0 2.8 0.1 5.4 2.5 3.3 2.6 0.2 2.3 4.1 3.0 0.7 1.5 0.0 1.6 3.8 1.3 1.4 2.4 5.7 2.0 2.3 2.5 1.5 1.1 4.1 1.0 3.0 4.1 0.0 2.1 0.2 1.2 1.5 0.0 24.1 2.3 7.0 0.0 1.9 1.7 4.0 319.3 0.7 2.2 0.0 5.4 1.5 0.2 1.6 1.1 7.8 1.1 3.2 5.1 0.0 0.3 291.0 3.1 1.4 0.0 0.0 4.6 1.0 5.4 4.5 3.9 2.1 4.8 0.0 0.1 5.0 2.4 0.3 1.3 1.3 3.4 1.3 ANKH "ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1" ENSG00000154122 "ANKH inorganic pyrophosphate transport regulator" Q9HCJ1 5 14704800-14871785 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Phosphate transport, Transport" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 119.8;Hofbauer cells: 162.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068104 Approved Cytosol NA NA Cytosol "HPA068104: AB_2685954" "unprognostic (1.15e-1)" "unprognostic (3.35e-1)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (6.58e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.83e-2)" "unprognostic (2.11e-1)" "unprognostic (2.38e-2)" "unprognostic (2.99e-1)" "unprognostic (1.54e-3)" "unprognostic (1.76e-3)" "unprognostic (1.71e-1)" "unprognostic (8.66e-2)" "unprognostic (6.46e-2)" 8.5 9.7 15.2 8.0 17.0 5.9 9.2 29.1 25.9 4.4 10.9 19.5 3.4 14.4 6.5 4.7 6.8 7.2 8.4 27.0 15.9 14.9 7.4 18.1 6.3 9.6 19.7 17.1 14.9 13.1 19.6 19.2 7.3 15.4 29.5 10.3 16.1 11.7 8.6 31.0 17.4 14.9 7.6 22.6 6.3 6.5 2.0 15.3 9.3 9.5 12.7 11.8 6.4 6.3 2.5 0.6 0.7 1.4 0.6 7.0 0.7 3.8 2.9 3.8 0.6 7.9 18.8 1.8 3.8 7.6 1.5 1.5 2.3 5.0 9.1 8.9 5.1 3.5 2.5 2.5 4.1 1.7 3.6 6.3 0.2 27.6 6.2 2.6 2.2 0.7 5.9 7.3 4.5 5.2 5.2 3.0 6.8 1.9 19.7 4.8 5.2 3.7 7.1 1.5 5.1 3.3 5.3 1.8 8.2 0.0 1.3 9.3 2.5 18.3 3.0 4.0 3.6 0.1 0.8 3.0 3.9 4.0 6.4 6.8 5.2 4.8 7.1 13.5 8.2 16.1 0.7 0.4 0.1 2.4 0.7 4.0 2.5 5.0 3.9 0.6 2.1 5.7 2.6 0.5 0.6 1.4 0.6 7.0 0.7 15.2 17.0 29.1 25.9 15.9 14.9 19.7 17.1 15.4 15.3 23.8 15.5 11.5 72.4 22.3 53.3 63.0 2.5 9.4 14.8 7.0 119.8 58.3 5.0 1.7 1.1 23.5 47.0 93.5 10.3 3.1 22.5 50.7 17.3 31.4 162.5 19.1 40.1 9.8 59.0 1.4 4.6 30.3 10.1 0.0 31.7 18.8 6.8 28.1 29.7 9.8 47.3 0.0 13.9 2.6 5.9 9.4 35.1 19.1 30.4 13.2 ANKIB1 "DKFZP434A0225, KIAA1386" ENSG00000001629 "Ankyrin repeat and IBR domain containing 1" Q9P2G1 7 92246234-92401384 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019358, HPA021780" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019358: AB_1844831, HPA021780: AB_2670819" "unprognostic (1.77e-1)" "unprognostic (5.96e-3)" "unprognostic (1.23e-1)" "unprognostic (4.97e-3)" "unprognostic (2.75e-1)" "unprognostic (7.67e-2)" "unprognostic (4.88e-3)" "unprognostic (2.14e-1)" "unprognostic (4.24e-2)" "unprognostic (1.87e-2)" "unprognostic (1.52e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-3)" "unprognostic (4.05e-2)" "unprognostic (3.00e-1)" "unprognostic (3.00e-2)" "unprognostic (3.20e-1)" 11.9 11.8 21.4 9.2 29.2 5.8 12.3 15.0 25.5 13.6 12.1 34.9 16.0 10.7 12.6 16.4 11.8 10.0 14.7 9.7 22.7 20.0 25.3 10.1 10.6 11.5 31.1 18.4 13.1 12.7 28.5 10.9 12.2 23.4 10.2 12.6 8.4 12.7 18.4 8.6 14.0 11.3 13.4 23.8 11.4 10.9 19.4 35.0 11.5 17.1 4.5 11.1 13.1 13.3 4.8 4.5 3.1 2.0 3.2 4.9 1.1 16.8 10.3 9.1 13.8 16.9 18.0 9.7 13.2 15.1 12.8 16.8 7.5 26.1 9.7 11.6 19.5 33.1 8.1 8.4 13.8 19.6 16.4 6.9 6.1 11.9 6.0 11.5 8.7 13.6 12.2 11.7 15.1 20.0 18.0 14.5 8.8 7.8 21.0 15.1 13.6 18.5 8.2 9.9 11.8 11.6 7.0 11.2 10.4 13.6 14.6 12.7 14.9 18.9 21.3 11.1 18.9 8.8 5.0 12.9 24.8 20.1 28.0 13.4 13.2 23.5 12.2 14.4 10.6 28.3 2.8 1.3 3.1 2.7 2.0 2.2 3.9 2.6 3.8 1.1 4.8 2.2 2.8 0.8 3.2 1.6 4.5 4.9 1.1 21.4 29.2 15.0 25.5 22.7 20.0 31.1 18.4 23.4 35.0 23.8 25.4 15.9 15.3 16.6 20.1 32.3 17.8 14.7 23.9 26.2 17.7 11.3 1.7 18.0 40.4 15.7 15.3 0.0 16.6 22.9 19.1 16.9 26.5 12.9 11.8 28.6 40.3 28.3 21.1 45.0 30.8 16.4 16.9 6.4 23.5 26.9 26.0 7.0 38.2 30.1 15.7 19.4 18.1 58.5 57.5 19.8 11.7 17.5 19.2 21.8 ANKLE1 "ANKRD41, FLJ39369, LEMD6" ENSG00000160117 "Ankyrin repeat and LEM domain containing 1" Q8NAG6 19 17281645-17287646 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9" "Group enriched" "Detected in some" 7 "Erythroid cells: 23.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.3" "Group enriched" "Detected in many" 4 "B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3" "Cell line enhanced" "Detected in many" "Daudi: 30.8;HEL: 12.6;HL-60: 13.5;NB-4: 17.4;U-937: 24.2" "Low region specificity" "Detected in all" "HPA026789, HPA073498" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026789: AB_10611675, HPA073498: AB_2686612" "unprognostic (5.66e-2)" "unprognostic (2.21e-1)" "unprognostic (6.90e-2)" "prognostic unfavorable (4.86e-5)" "unprognostic (2.73e-1)" "unprognostic (1.72e-3)" "unprognostic (2.19e-2)" "unprognostic (2.09e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (7.89e-4)" "unprognostic (5.86e-2)" "unprognostic (0.00e+0)" "unprognostic (2.03e-1)" "unprognostic (1.61e-1)" "unprognostic (2.00e-3)" "unprognostic (4.30e-2)" 0.6 0.5 1.0 12.9 3.1 22.6 0.6 8.3 1.4 0.7 0.7 0.6 0.2 0.3 0.9 1.3 0.5 0.8 0.5 0.2 1.0 1.2 0.5 0.5 1.3 3.7 1.6 0.7 1.7 0.2 0.6 0.9 1.1 1.4 1.0 0.5 0.4 0.7 0.6 0.9 1.4 1.2 0.9 1.2 5.7 0.3 1.0 0.5 8.9 0.6 0.2 5.3 1.0 0.7 3.0 2.2 0.7 4.3 0.0 0.4 0.8 0.1 0.3 1.5 0.8 0.0 0.3 1.5 0.5 0.1 0.3 0.2 7.0 0.4 30.8 0.3 0.1 0.0 0.6 11.9 0.1 0.3 9.3 1.6 12.6 4.9 0.0 0.1 13.5 5.2 0.1 0.4 1.2 0.0 0.3 0.2 2.6 1.6 3.6 0.1 0.2 9.3 17.4 3.8 0.1 1.1 7.5 0.0 3.1 0.1 0.1 0.4 2.7 3.0 0.2 0.2 0.3 0.0 8.9 0.6 0.1 0.5 0.6 0.3 0.3 0.3 10.9 0.1 24.2 0.6 0.0 1.8 0.7 0.0 4.3 0.0 3.0 0.0 0.4 2.2 1.7 0.1 0.0 0.0 0.0 3.1 1.1 0.0 0.8 1.0 3.1 8.3 1.4 1.0 1.2 1.6 0.7 1.4 0.5 0.0 0.3 0.8 0.8 0.7 2.0 0.8 0.0 1.4 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.2 0.0 23.3 0.2 0.4 0.4 0.3 1.1 0.0 0.7 0.0 0.0 0.0 0.8 0.0 1.7 1.2 0.0 1.0 0.7 0.2 0.4 0.0 1.4 0.0 1.5 6.5 0.4 0.5 0.9 0.4 0.3 0.0 0.0 0.1 ANKMY1 "FLJ20499, ZMYND13" ENSG00000144504 "Ankyrin repeat and MYND domain containing 1" Q9P2S6 2 240479422-240569209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.0" "Group enriched" "Detected in many" 5 "Early spermatids: 147.5;Late spermatids: 162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA026620, HPA048869" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026620: AB_1844834, HPA048869: " "unprognostic (2.89e-3)" "unprognostic (1.03e-1)" "unprognostic (3.83e-2)" "unprognostic (3.22e-3)" "unprognostic (3.46e-1)" "unprognostic (3.97e-5)" "unprognostic (8.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.40e-3)" "unprognostic (1.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.36e-2)" "unprognostic (2.59e-5)" "unprognostic (2.01e-1)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.20e-4)" 4.5 4.3 5.2 9.0 7.9 9.8 5.8 6.4 7.3 7.2 5.7 10.3 10.8 5.8 6.6 9.0 5.3 21.8 9.2 3.6 6.1 4.3 5.1 5.1 6.3 7.2 8.7 4.8 7.3 8.0 6.6 5.4 6.4 6.4 5.8 5.1 5.1 6.9 13.6 5.0 7.2 6.2 5.8 6.3 7.3 8.4 45.0 6.7 6.0 6.0 3.4 10.7 5.8 6.0 7.4 4.2 6.9 3.4 2.0 7.5 3.4 5.3 11.7 2.5 4.7 2.3 3.3 10.6 2.5 3.9 2.1 2.9 3.7 11.0 5.3 0.5 2.8 3.2 5.8 4.9 6.0 2.5 9.8 4.0 10.5 5.7 9.8 1.9 5.8 10.1 5.3 14.7 2.0 14.1 6.5 2.2 8.5 9.7 6.8 3.6 5.1 5.3 9.6 2.1 9.2 7.0 15.2 7.7 8.4 3.3 11.5 6.0 4.4 2.1 5.6 7.8 3.2 4.8 9.0 2.7 8.0 2.7 3.1 4.4 15.8 3.9 5.1 4.5 8.9 6.1 0.1 3.3 6.9 7.5 2.6 4.3 4.7 4.8 4.7 4.2 7.4 7.1 5.1 1.3 2.0 3.4 2.8 1.5 3.4 5.2 7.9 6.4 7.3 6.1 4.3 8.7 4.8 6.4 6.7 0.0 7.2 2.7 1.6 0.8 3.4 1.8 2.5 30.8 10.3 3.5 3.9 2.8 1.7 2.2 147.5 2.8 4.3 0.0 3.7 1.6 1.5 2.0 5.7 5.5 2.5 3.2 4.1 3.1 7.0 162.8 3.7 4.0 0.0 4.6 4.6 1.9 2.5 0.0 2.8 2.6 3.5 0.0 1.3 14.7 8.8 1.9 2.4 4.4 4.9 1.4 ANKMY2 "DKFZP564O043, ZMYND20" ENSG00000106524 "Ankyrin repeat and MYND domain containing 2" Q8IV38 7 16599776-16645817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067100 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA067100: AB_2685777" "unprognostic (3.07e-1)" "unprognostic (4.20e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (1.99e-3)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.11e-2)" "unprognostic (3.00e-2)" "prognostic favorable (1.05e-7)" "unprognostic (5.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.55e-1)" "unprognostic (3.85e-2)" 9.6 10.3 14.5 6.6 30.1 10.0 11.8 14.6 28.7 12.4 13.6 9.0 13.3 12.2 10.8 10.4 9.4 13.1 11.1 30.2 18.5 12.7 13.3 8.9 9.4 6.7 12.7 21.2 21.5 9.6 13.2 14.9 7.3 20.4 11.3 14.1 11.8 11.4 16.3 17.3 8.5 13.5 14.4 11.9 8.8 19.1 8.0 7.8 8.9 17.7 7.5 7.1 14.6 11.6 6.7 4.9 18.5 8.9 10.6 10.2 5.2 10.5 9.0 12.3 12.2 11.7 12.3 6.6 12.9 15.8 10.0 15.4 15.0 16.2 2.1 15.1 13.5 20.9 11.1 8.3 4.9 15.0 4.7 5.7 19.1 10.8 6.7 7.6 14.2 7.4 10.6 2.6 10.0 10.1 13.9 9.0 13.0 19.6 3.5 14.1 2.8 6.0 9.9 8.2 32.7 10.7 9.9 11.1 5.1 15.5 9.2 7.8 4.7 8.7 6.4 5.2 12.0 7.6 12.8 5.5 7.7 6.9 17.2 8.8 12.9 9.4 3.3 11.9 11.7 12.3 18.5 3.2 14.3 10.0 4.3 9.6 6.7 8.2 10.2 4.9 6.7 6.9 8.2 2.7 10.6 8.9 4.7 8.3 5.2 14.5 30.1 14.6 28.7 18.5 12.7 12.7 21.2 20.4 7.8 3.0 10.8 3.7 9.1 4.1 13.2 33.4 12.7 40.2 19.4 10.4 5.9 11.7 18.3 5.8 18.4 5.8 14.9 0.0 8.0 9.4 11.8 5.1 5.8 5.0 8.0 7.9 18.5 3.7 4.8 26.3 11.8 5.0 13.5 7.2 14.1 16.0 4.9 10.5 12.7 9.7 18.2 25.8 14.6 3.7 4.1 3.6 14.2 6.2 15.0 5.4 ANKRD10 FLJ20093 ENSG00000088448 "Ankyrin repeat domain 10" Q9NXR5 13 110878540-110915069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034211, HPA038878, HPA038879" Uncertain Approved Microtubules,Cytosol NA NA Microtubules Cytosol "CAB034211: AB_2058024, HPA038878: AB_2676252, HPA038879: AB_2676253" "unprognostic (3.29e-2)" "unprognostic (2.38e-1)" "unprognostic (9.26e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-3)" "unprognostic (2.49e-1)" "unprognostic (4.97e-3)" "unprognostic (9.60e-2)" "unprognostic (1.16e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (1.25e-6)" "unprognostic (1.95e-1)" "unprognostic (2.68e-1)" "unprognostic (8.32e-2)" "prognostic favorable (6.41e-6)" 35.1 23.1 19.1 36.8 21.5 44.3 49.7 26.2 19.3 34.9 31.9 33.1 30.6 25.4 44.2 55.6 20.1 28.8 31.7 25.3 18.0 18.3 32.5 27.9 30.8 33.3 28.5 13.9 37.3 34.1 18.8 36.2 41.9 21.9 38.1 30.5 37.4 27.3 29.4 79.3 28.4 30.5 33.1 27.3 48.9 25.9 18.2 23.4 35.4 30.4 27.8 33.4 33.1 45.1 30.8 21.2 20.5 16.6 18.6 24.5 15.8 12.4 10.5 24.2 20.2 18.6 18.1 10.8 8.5 17.9 8.5 10.6 10.9 24.6 17.3 18.7 6.4 13.9 29.0 10.4 8.0 11.6 41.3 15.5 20.6 23.5 22.5 7.4 29.6 18.0 17.1 12.2 6.0 8.9 18.0 11.5 17.4 9.0 11.9 23.0 3.7 17.0 33.1 13.4 27.7 6.5 26.4 8.9 17.1 23.4 13.9 19.4 14.5 6.4 11.4 13.4 19.0 8.2 37.9 9.9 10.1 8.4 4.9 8.6 14.9 15.8 10.0 19.0 14.6 15.8 20.5 16.6 13.7 21.0 13.1 17.7 28.0 19.8 17.0 21.2 30.8 21.4 22.9 10.3 18.6 13.1 19.8 24.5 15.8 19.1 21.5 26.2 19.3 18.0 18.3 28.5 13.9 21.9 23.4 14.9 53.7 35.3 31.3 83.8 31.7 31.1 43.3 44.2 54.6 36.6 51.1 34.9 16.6 42.2 5.8 78.9 36.0 0.0 43.4 36.8 86.9 44.8 29.0 39.9 42.8 30.2 40.3 47.9 43.7 3.7 36.2 54.3 69.2 50.5 51.0 27.7 35.6 37.4 48.4 35.6 49.5 51.8 92.6 24.4 19.8 68.0 32.5 44.7 52.3 36.6 ANKRD11 "LZ16, T13" ENSG00000167522 "Ankyrin repeat domain 11" Q6UB99 16 89267619-89490561 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019288, HPA041593, HPA049470" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780" "unprognostic (7.31e-2)" "unprognostic (6.35e-2)" "unprognostic (1.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.39e-4)" "unprognostic (1.81e-1)" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (7.67e-4)" "unprognostic (1.56e-3)" "unprognostic (1.79e-1)" "unprognostic (7.93e-2)" "unprognostic (5.78e-3)" "unprognostic (2.16e-1)" 24.2 23.3 22.8 25.6 23.1 48.7 41.4 32.3 31.7 22.0 24.1 22.9 22.0 22.4 26.9 18.9 25.0 23.4 23.4 22.2 24.6 20.0 17.8 15.1 32.3 33.8 20.8 21.0 32.6 27.9 33.7 31.5 18.8 19.3 20.5 14.9 23.3 21.4 25.8 27.0 35.8 24.1 26.7 20.3 26.1 22.6 21.3 22.1 26.1 21.6 19.3 19.6 23.4 34.4 4.2 7.2 11.7 5.9 9.8 4.5 1.8 21.9 27.5 27.7 21.2 17.1 17.7 26.8 25.1 16.9 15.2 10.8 32.0 23.6 20.4 17.4 18.2 17.1 22.3 18.9 23.1 17.2 10.1 22.6 16.1 19.1 25.6 25.9 11.8 18.3 19.6 23.5 19.9 25.8 22.1 18.2 34.3 34.5 16.3 19.0 20.8 19.5 29.8 24.3 11.4 25.4 40.4 32.0 17.0 15.8 18.5 16.3 20.0 36.2 7.6 26.0 14.7 17.8 18.6 33.6 32.1 30.0 17.7 27.5 29.8 10.4 25.4 25.8 19.6 17.3 7.5 3.9 3.7 3.8 4.0 4.3 3.1 4.3 4.5 2.1 4.2 3.8 3.5 11.7 9.8 5.9 7.2 4.2 1.8 22.8 23.1 32.3 31.7 24.6 20.0 20.8 21.0 19.3 22.1 122.1 96.0 57.0 118.7 103.5 174.0 224.2 89.2 33.5 56.9 68.0 149.2 36.4 26.6 65.7 85.7 83.9 67.5 46.7 62.6 29.3 87.3 94.1 53.2 57.8 42.6 147.8 102.5 75.5 58.0 27.9 96.1 74.6 45.5 95.6 51.2 90.0 94.9 50.7 99.7 28.0 102.5 38.8 89.3 78.8 102.6 106.9 32.4 71.0 51.7 144.5 ANKRD12 "FLJ20053, GAC-1, KIAA0874" ENSG00000101745 "Ankyrin repeat domain 12" Q6UB98 18 9136228-9285985 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040705 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040705: AB_10673301" "unprognostic (2.20e-1)" "unprognostic (1.14e-1)" "unprognostic (3.59e-1)" "unprognostic (1.37e-1)" "unprognostic (1.46e-1)" "unprognostic (3.41e-3)" "unprognostic (7.25e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" "unprognostic (2.39e-2)" "unprognostic (4.62e-1)" "unprognostic (1.56e-1)" "unprognostic (3.03e-1)" "unprognostic (1.03e-2)" 17.0 10.9 22.2 23.1 26.1 19.6 15.4 48.1 25.4 17.8 18.8 10.1 18.2 13.7 14.6 15.4 16.1 12.1 16.1 12.3 19.9 13.5 14.7 16.5 14.6 22.1 20.2 18.3 16.3 16.7 15.5 16.4 19.2 17.4 15.9 13.6 9.5 15.7 20.6 25.8 21.8 18.1 17.2 21.3 20.3 15.3 29.3 23.8 11.4 18.2 13.0 19.5 24.2 22.6 18.7 19.2 51.2 10.7 8.8 19.0 5.2 4.2 2.9 4.0 2.6 6.4 6.6 3.2 6.6 6.2 2.4 3.3 2.6 3.3 5.9 3.9 4.5 7.3 3.9 2.9 2.6 6.5 6.2 3.6 2.7 2.1 3.8 4.7 6.3 8.7 3.4 5.8 3.4 5.5 5.4 4.0 3.5 6.1 46.8 5.8 2.4 4.2 4.3 1.5 10.5 3.0 3.8 5.6 21.5 3.1 6.8 9.3 3.4 6.5 3.2 4.7 3.7 4.0 5.3 8.6 17.7 8.2 14.1 6.1 13.7 21.1 11.0 8.7 3.4 6.6 27.4 8.7 25.5 14.5 7.7 16.1 18.7 18.7 13.9 5.9 17.3 19.0 14.8 51.2 8.8 10.7 19.2 13.0 5.2 22.2 26.1 48.1 25.4 19.9 13.5 20.2 18.3 17.4 23.8 259.1 252.1 212.5 167.3 96.2 295.2 122.2 76.5 112.4 180.9 64.6 492.8 36.1 16.6 83.3 150.6 136.7 122.5 70.0 72.2 31.7 114.1 175.8 178.3 57.2 58.3 270.1 88.9 119.7 80.5 178.4 124.8 126.0 86.0 167.7 80.4 131.0 84.0 75.9 133.0 29.3 294.9 109.9 138.1 215.6 153.7 83.9 65.3 191.8 63.5 140.5 ANKRD18A "FLJ35740, KIAA2015" ENSG00000180071 "Ankyrin repeat domain 18A" Q8IVF6 9 38571358-38620660 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "bone marrow: 24.4;brain: 11.1;testis: 19.1" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Muller glia cells: 13.3;Rod photoreceptor cells: 33.7;Spermatocytes: 25.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 16.6" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (1.26e-1)" "unprognostic (2.37e-1)" "unprognostic (4.34e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-2)" "unprognostic (1.94e-5)" "unprognostic (2.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.58e-2)" "unprognostic (7.03e-2)" "unprognostic (2.14e-1)" 0.5 0.7 1.4 0.8 9.1 24.4 1.1 0.4 4.1 1.0 2.1 8.5 2.4 0.9 0.7 1.1 1.4 1.2 2.7 1.1 3.0 2.2 1.5 1.2 1.5 0.8 4.8 2.3 0.4 4.1 2.5 3.2 0.7 8.7 1.6 1.5 0.4 0.9 3.9 0.4 2.4 1.5 0.7 11.1 0.5 2.0 19.1 6.9 0.0 3.8 0.0 0.5 0.7 0.8 0.4 0.0 1.1 0.0 0.1 1.7 0.1 4.5 3.5 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.9 0.0 0.0 0.9 3.4 3.2 0.0 0.0 4.8 0.0 4.8 2.8 0.0 16.6 0.4 0.0 2.3 0.0 3.1 1.7 0.0 7.0 1.6 0.3 0.3 4.3 0.1 0.8 3.6 5.8 2.0 0.0 6.3 6.3 2.1 1.9 1.5 3.0 2.3 0.5 0.1 7.4 2.5 7.9 4.3 0.0 1.3 0.1 0.0 0.3 0.5 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.5 0.0 0.7 0.0 1.3 0.8 0.0 0.4 0.7 1.7 0.5 0.1 0.0 0.0 1.0 0.1 1.4 9.1 0.4 4.1 3.0 2.2 4.8 2.3 8.7 6.9 0.0 1.0 0.0 1.8 0.6 3.9 6.5 0.0 17.4 5.7 1.8 2.0 0.0 1.7 4.4 4.9 0.0 0.7 0.0 2.0 0.1 0.0 2.0 0.0 0.5 0.1 0.0 4.1 0.0 0.0 1.3 0.6 0.0 0.0 0.0 3.6 13.3 3.7 2.9 0.4 0.1 33.7 0.0 0.1 25.6 2.0 1.5 0.0 0.0 2.3 0.7 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9;testis: 26.9" "Group enriched" "Detected in many" 6 "Ciliated cells: 16.0;Early spermatids: 23.8;Muller glia cells: 23.4;Spermatocytes: 37.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 20.8" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Approved "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 1.5 0.9 4.3 0.1 0.4 0.2 1.3 12.9 3.9 0.3 0.2 0.2 0.1 0.0 0.5 1.0 2.1 1.0 0.9 0.3 2.1 1.3 0.1 0.4 0.7 0.1 1.0 1.4 0.1 0.1 0.1 1.6 1.3 2.6 2.0 0.3 0.2 0.2 0.1 1.4 5.5 0.2 0.1 1.0 0.9 0.0 26.9 0.1 0.1 0.9 1.6 0.7 1.2 1.1 0.5 0.8 0.1 0.2 0.0 0.8 0.1 7.5 8.5 0.7 0.2 0.3 1.4 0.7 1.6 1.7 2.1 2.3 1.6 0.2 0.2 0.4 0.2 2.3 1.7 4.6 1.6 2.9 0.1 4.6 8.2 9.9 3.1 0.0 2.7 0.6 1.1 4.5 2.9 7.6 0.9 3.9 0.0 4.5 2.1 2.6 1.3 0.2 20.8 7.3 0.3 3.7 0.0 10.5 1.5 1.2 1.8 0.2 7.3 3.5 0.4 0.6 6.8 6.0 10.1 3.9 1.7 7.6 3.5 3.0 1.2 0.8 0.1 0.8 0.1 1.2 0.0 0.1 0.1 0.3 0.1 0.7 0.4 0.2 0.6 0.0 0.5 0.4 0.8 0.1 0.0 0.2 0.8 0.1 0.1 4.3 0.4 12.9 3.9 2.1 1.3 1.0 1.4 2.6 0.1 0.0 0.0 0.0 4.4 1.8 2.6 2.4 2.5 16.0 3.4 1.8 0.0 0.0 0.0 0.6 23.8 0.0 0.3 0.0 0.4 0.2 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.6 0.6 0.1 0.0 0.0 1.6 23.4 0.3 1.4 0.7 0.0 4.3 0.0 0.0 37.6 1.7 2.9 0.0 0.0 1.0 3.5 ANKRD23 "DARP, FLJ32449, MARP3" ENSG00000163126 "Ankyrin repeat domain 23" Q86SG2 2 96824526-96857934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 184.5" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "Karpas-707: 29.7" "Not detected" "Not detected" HPA036201 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA036201: AB_10673347" "unprognostic (2.48e-1)" "unprognostic (7.83e-4)" "unprognostic (4.93e-4)" "unprognostic (1.21e-2)" "unprognostic (4.28e-1)" "unprognostic (3.28e-1)" "unprognostic (3.27e-2)" "unprognostic (6.66e-2)" "unprognostic (2.46e-2)" "unprognostic (3.59e-2)" "unprognostic (1.81e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-6)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (2.70e-4)" 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 2.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.7 0.0 0.1 2.2 0.1 184.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 12.2 0.9 0.1 0.1 0.4 0.2 0.5 0.0 0.9 1.2 0.4 0.3 0.5 0.3 0.6 0.0 0.2 0.8 0.2 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.8 0.7 0.4 0.4 0.1 0.1 0.6 1.4 0.2 0.3 0.4 0.0 0.1 0.1 1.1 0.6 29.7 0.2 0.7 0.3 0.6 0.3 0.1 0.2 1.0 0.0 3.7 0.1 0.7 1.1 0.1 0.2 0.5 0.0 0.1 0.8 0.0 0.2 0.3 0.5 0.5 0.0 1.3 0.5 0.2 0.3 0.8 0.3 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.9 0.0 0.2 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.6 0.7 2.1 2.5 0.0 10.7 2.3 0.0 2.0 0.3 0.0 0.3 3.0 0.6 0.4 0.0 0.9 0.1 0.9 0.4 1.1 1.0 0.2 1.6 0.0 2.5 0.8 1.5 1.4 0.0 0.0 0.0 1.1 1.8 0.1 0.0 2.8 0.0 3.6 0.0 1.9 1.0 0.4 1.1 0.2 0.0 0.6 0.1 ANKRD24 KIAA1981 ENSG00000089847 "Ankyrin repeat domain 24" Q8TF21 19 4183354-4224814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 9 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "Karpas-707: 5.6;U-266/70: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041534, HPA048498" Uncertain Uncertain Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA041534: AB_2677537, HPA048498: AB_2680420" "unprognostic (3.70e-2)" "unprognostic (3.96e-3)" "unprognostic (5.23e-9)" "unprognostic (7.03e-2)" "unprognostic (5.01e-2)" "unprognostic (2.31e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.53e-1)" "unprognostic (3.52e-2)" "unprognostic (3.41e-2)" "unprognostic (1.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.27e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-4)" 1.4 2.1 6.0 0.8 8.5 1.1 1.2 1.4 22.1 1.0 1.1 0.8 0.1 1.9 1.0 2.1 0.5 1.4 1.3 0.6 5.1 4.4 1.8 5.5 1.1 1.0 4.1 9.4 1.4 3.3 2.4 3.8 1.9 2.3 4.3 0.9 1.0 1.7 1.7 2.5 1.1 1.5 0.7 2.3 1.5 1.6 7.3 1.8 0.1 1.9 0.1 0.6 0.6 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 3.2 0.3 3.4 0.2 0.1 0.0 0.0 0.1 0.1 0.1 2.0 0.4 0.2 0.2 0.1 0.5 0.0 2.4 0.3 0.1 0.1 0.1 1.8 0.1 0.3 1.8 0.1 0.3 0.8 0.5 0.1 2.0 0.1 5.6 0.0 0.7 0.0 0.1 2.5 0.7 0.7 0.4 0.0 0.4 0.0 0.2 0.9 0.2 0.1 0.1 0.3 0.6 0.7 0.4 0.0 0.1 1.2 0.9 0.0 18.9 1.6 0.1 0.8 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 8.5 1.4 22.1 5.1 4.4 4.1 9.4 2.3 1.8 0.0 3.4 0.0 0.2 0.0 0.8 0.8 2.5 0.0 2.3 0.0 3.9 0.2 0.0 0.1 0.5 0.0 0.3 0.0 0.0 17.7 0.0 0.2 0.0 1.0 0.3 0.0 3.5 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.7 1.1 0.0 0.9 0.0 0.2 0.0 ANKRD27 "DKFZp434L0718, FLJ00040, VARP" ENSG00000105186 "Ankyrin repeat domain 27" Q96NW4 19 32597007-32676597 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 53.0" "Low region specificity" "Detected in all" HPA042769 Approved Approved Cytosol NA NA Cytosol "HPA042769: AB_10796584" "unprognostic (2.16e-3)" "unprognostic (6.04e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (1.63e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.21e-5)" "unprognostic (9.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.90e-2)" "unprognostic (6.22e-3)" "unprognostic (3.74e-2)" "unprognostic (2.14e-1)" "unprognostic (4.94e-2)" "unprognostic (4.07e-1)" "unprognostic (2.26e-2)" 13.1 10.5 14.3 12.2 16.3 12.1 13.3 18.6 19.3 12.7 20.7 14.4 9.4 10.2 15.0 12.6 19.8 11.0 10.5 12.3 12.6 12.5 13.4 6.2 13.7 13.5 15.3 12.0 12.5 9.7 12.8 11.5 18.6 17.6 17.4 16.5 14.5 13.2 19.6 26.0 16.5 14.1 16.2 15.3 12.0 14.9 22.6 14.3 24.6 18.9 10.7 17.2 23.9 17.5 5.5 8.8 20.0 11.0 19.6 13.2 8.6 12.2 14.1 4.6 8.2 9.6 7.4 11.3 7.1 7.2 7.8 10.3 11.1 7.5 13.4 6.6 8.9 8.2 7.6 11.7 8.7 13.0 18.1 5.9 53.0 5.3 9.1 12.0 20.3 19.2 5.4 11.6 8.4 13.7 5.4 7.8 10.0 14.1 30.4 5.9 12.0 7.8 17.6 2.4 15.5 5.5 11.7 6.2 4.9 6.2 11.9 8.5 3.5 6.9 11.8 8.3 6.4 4.9 9.9 7.2 8.5 9.1 7.8 10.8 7.9 4.7 9.2 8.5 20.0 5.4 20.0 7.7 19.3 10.4 11.0 13.2 5.5 10.7 11.5 8.8 5.5 8.5 8.9 6.5 19.6 8.6 4.3 9.1 8.6 14.3 16.3 18.6 19.3 12.6 12.5 15.3 12.0 17.6 14.3 14.9 10.3 5.4 4.8 13.9 8.4 7.9 10.2 4.0 4.5 8.7 19.6 11.5 0.0 2.8 3.5 5.9 7.8 0.0 5.1 9.2 7.0 7.8 11.5 3.6 7.2 11.1 8.7 4.3 10.8 10.8 10.0 7.4 15.1 2.8 9.5 4.1 5.8 9.0 8.9 5.4 13.4 0.0 11.3 3.8 16.2 13.6 12.7 8.7 7.7 7.3 ANKRD34A ANKRD34 ENSG00000272031 "Ankyrin repeat domain 34A" Q69YU3 1 145959442-145964582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 18.1" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 8.1;Cardiomyocytes: 2.9;Muller glia cells: 1.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.5;T-cells: 3.5" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029642, HPA029643" Uncertain Enhanced Cytosol NA NA Cytosol "HPA029642: AB_10599277, HPA029643: AB_10601878" "unprognostic (1.98e-1)" "unprognostic (5.66e-2)" "unprognostic (1.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-2)" "unprognostic (4.36e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-1)" "unprognostic (3.19e-1)" "unprognostic (2.15e-2)" "unprognostic (6.68e-3)" "unprognostic (9.66e-8)" "unprognostic (6.36e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (9.23e-2)" 0.8 1.3 6.4 2.0 10.5 0.3 0.6 7.8 18.1 0.9 0.7 1.2 0.0 1.6 1.5 1.2 0.9 0.7 1.1 1.7 4.2 0.5 0.2 0.7 1.4 0.4 6.7 1.6 0.5 2.0 1.2 0.5 5.7 1.7 0.4 1.3 0.8 2.2 2.3 0.8 1.6 1.6 0.0 1.4 1.1 0.5 1.0 0.0 0.6 0.0 1.5 0.9 0.0 1.5 0.4 0.6 0.3 0.3 3.5 1.0 1.4 0.8 0.7 2.5 3.6 2.8 0.3 2.7 5.2 0.6 1.7 0.2 0.8 2.8 0.3 3.5 1.4 0.6 1.1 0.8 0.4 5.9 1.7 0.2 2.1 0.0 0.5 0.3 2.3 2.5 0.3 2.3 2.6 3.7 0.9 2.3 1.3 6.4 4.0 2.5 1.1 0.8 0.3 0.2 3.1 0.3 0.7 12.6 1.1 0.1 3.5 2.5 0.5 0.1 1.6 0.3 3.6 0.4 0.8 6.3 4.3 5.3 1.4 4.5 8.6 0.4 6.2 2.2 0.5 0.0 0.1 0.6 3.5 0.3 2.6 1.5 1.7 1.9 0.4 1.4 2.3 3.4 0.3 0.3 0.0 0.1 1.7 1.0 0.0 0.0 0.0 0.4 0.2 8.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.5 0.3 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.1 0.0 1.4 0.3 1.4 0.0 0.7 0.4 0.4 0.1 0.1 0.0 0.0 0.1 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 31.0" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 2.0;Collecting duct cells: 3.5;Intestinal endocrine cells: 1.7;Kupffer cells: 3.2" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enriched" "Detected in many" 6 "basal ganglia: 31.0" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.2" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.1 0.3 0.9 1.5 31.0 5.7 0.3 0.0 0.9 0.5 0.1 0.4 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.0 4.1 2.8 0.1 0.2 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 0.4 1.0 0.1 1.0 5.1 0.0 0.1 0.0 4.6 0.1 0.0 0.0 0.0 7.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 46.9 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.9 31.0 0.0 0.9 1.0 4.1 1.2 0.2 0.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.7 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ANKRD36 UNQ2430 ENSG00000135976 "Ankyrin repeat domain 36" A6QL64 2 97113496-97264521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 71.9;Spermatocytes: 72.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 13.9" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (4.24e-3)" "unprognostic (7.59e-2)" "unprognostic (6.15e-3)" "unprognostic (9.86e-2)" "unprognostic (9.83e-3)" "unprognostic (5.25e-3)" "unprognostic (5.65e-2)" "unprognostic (1.49e-2)" "unprognostic (4.37e-2)" "unprognostic (1.94e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-2)" "unprognostic (9.14e-7)" "unprognostic (1.67e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.75e-1)" 5.1 3.3 8.8 6.0 14.5 22.0 6.8 20.5 10.2 5.6 4.6 4.8 2.2 3.0 8.5 7.7 2.4 6.0 3.8 3.9 7.6 3.3 3.2 1.8 5.0 5.0 4.0 11.3 8.9 5.1 5.3 9.2 2.3 6.8 4.8 5.2 4.7 4.3 3.1 2.2 5.9 4.3 4.7 3.7 5.9 5.1 13.3 8.2 5.6 5.4 2.1 3.7 4.0 4.9 9.9 11.7 9.3 3.3 4.9 9.2 1.7 6.2 1.5 5.1 3.2 1.1 2.6 2.4 2.4 1.7 1.9 1.9 1.6 3.2 8.0 1.6 2.3 1.5 3.1 1.9 2.1 1.6 3.8 2.8 6.0 6.8 2.9 0.5 4.4 2.6 1.7 1.4 1.4 2.4 3.0 3.4 11.2 4.1 13.9 0.8 1.1 5.5 5.8 1.2 0.5 2.9 5.3 2.1 2.2 1.4 3.0 3.6 2.6 2.5 1.5 0.8 2.9 1.6 2.5 5.2 5.4 5.3 6.2 2.8 8.2 3.5 6.5 3.1 6.4 1.8 9.3 2.6 3.5 9.2 1.2 9.1 9.9 8.4 7.3 1.2 9.9 8.6 9.2 3.9 4.9 3.3 11.7 7.0 1.7 8.8 14.5 20.5 10.2 7.6 3.3 4.0 11.3 6.8 8.2 41.7 27.2 12.9 8.0 14.0 47.0 19.1 0.0 44.2 27.3 7.0 70.7 0.9 0.0 5.7 53.0 19.6 2.0 0.0 15.9 4.8 14.4 5.5 25.5 0.8 4.5 20.6 13.2 9.8 4.6 5.3 24.2 17.3 37.1 4.6 6.8 13.0 9.3 3.4 17.0 1.4 71.9 0.0 23.1 72.1 11.9 8.2 0.3 25.4 8.5 12.9 ANKRD36B "FLJ21281, KIAA1641" ENSG00000196912 "Ankyrin repeat domain 36B" Q8N2N9 2 97492663-97589965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.4" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 49.5" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "unprognostic (2.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-1)" "unprognostic (8.72e-3)" "unprognostic (5.03e-2)" "unprognostic (7.17e-3)" "unprognostic (4.20e-2)" "unprognostic (4.00e-2)" "unprognostic (2.13e-6)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (7.71e-3)" "unprognostic (6.98e-2)" 1.0 1.5 2.0 2.8 7.0 16.4 3.3 6.8 6.7 1.4 1.7 1.6 0.2 1.3 3.8 2.0 0.5 2.0 2.1 0.8 3.1 1.1 0.4 2.2 2.3 4.3 6.2 3.8 1.7 1.8 3.3 0.7 3.9 1.8 2.7 1.0 2.6 3.0 0.7 3.6 2.1 1.9 1.9 1.7 1.7 7.5 4.0 4.2 1.3 2.8 2.1 1.2 0.8 3.5 2.6 3.4 0.7 2.6 3.0 0.3 3.6 2.3 2.7 2.3 1.6 3.6 1.7 2.6 1.7 1.7 1.9 2.2 4.5 5.2 1.4 2.1 1.6 1.7 1.7 1.2 1.8 1.5 4.2 4.1 4.7 1.6 1.2 3.2 2.4 2.4 2.1 2.1 3.5 4.0 2.2 10.7 5.5 4.4 2.0 0.9 4.0 5.8 1.3 0.8 2.7 5.0 1.3 1.8 1.8 2.3 3.0 4.3 1.9 1.6 1.4 3.6 2.6 3.0 3.3 3.0 3.5 3.5 3.4 6.1 7.7 4.8 1.8 4.3 1.5 3.4 0.7 0.9 2.2 0.3 2.0 2.2 2.6 1.8 0.3 3.5 3.0 2.3 0.5 2.6 0.2 2.6 1.3 0.3 11.9 16.7 6.2 6.2 0.0 34.4 12.2 2.5 30.8 31.8 8.7 19.6 1.3 0.0 6.9 39.2 6.8 2.6 0.0 11.9 3.0 2.6 4.5 22.0 0.6 2.9 15.9 13.8 3.1 2.7 3.6 11.8 3.9 0.0 10.0 9.0 9.5 8.7 4.0 7.1 0.5 35.1 6.5 1.4 49.5 6.8 0.0 0.1 13.8 5.8 10.4 ANKRD36C DKFZp667P0924 ENSG00000174501 "Ankyrin repeat domain 36C" Q5JPF3 2 95836919-95991831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.6" "Cell type enhanced" "Detected in many" 9 "Exocrine glandular cells: 514.5;Pancreatic endocrine cells: 319.5;Urothelial cells: 431.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 25.5" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (6.32e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-1)" "unprognostic (3.79e-3)" "unprognostic (1.29e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.44e-2)" "unprognostic (5.29e-3)" "unprognostic (5.35e-6)" "unprognostic (9.99e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" 2.2 1.0 4.2 1.8 4.1 13.2 5.3 8.0 5.8 3.1 3.1 0.5 2.8 0.7 3.2 1.9 1.8 2.6 4.0 1.5 3.3 1.8 1.2 0.8 2.0 2.7 1.6 1.7 5.6 3.1 1.2 3.9 0.9 3.1 1.6 2.1 2.1 9.2 1.5 0.9 2.9 2.6 1.5 1.9 2.4 4.5 10.1 1.1 2.8 1.6 2.4 4.0 2.5 2.2 11.1 19.6 18.1 2.0 7.2 12.5 0.7 6.6 1.3 2.8 1.9 1.8 4.9 1.0 1.6 1.1 2.1 2.7 1.5 1.5 6.6 2.1 1.1 2.1 1.5 2.5 1.2 2.7 3.8 3.3 2.7 3.2 1.9 0.4 7.8 2.0 1.4 1.0 1.6 0.8 2.1 3.5 9.6 2.6 8.4 2.3 0.9 6.0 2.9 0.6 0.3 25.5 3.2 2.1 2.7 1.0 1.3 2.5 2.2 1.0 1.7 1.1 1.1 0.8 1.9 3.9 2.6 2.9 2.0 1.9 3.2 2.6 7.2 0.7 5.4 1.0 18.1 2.0 1.5 12.5 0.3 8.1 9.2 10.0 8.1 1.4 11.1 8.7 8.5 0.1 7.2 0.5 19.6 8.3 0.7 4.2 4.1 8.0 5.8 3.3 1.8 1.6 1.7 3.1 1.1 35.7 24.0 8.3 28.7 9.5 80.2 21.4 5.1 61.6 79.6 8.7 74.6 0.2 0.0 187.2 85.1 14.3 7.4 23.3 514.5 0.7 15.0 147.9 31.4 1.3 6.9 31.8 20.2 8.0 6.7 8.4 30.2 13.0 13.5 40.5 53.0 17.5 319.5 7.4 34.3 0.3 74.8 19.4 17.0 86.7 12.4 6.5 0.2 28.8 13.0 431.0 ANKRD37 Lrp2bp ENSG00000186352 "Ankyrin repeat domain 37" Q7Z713 4 185396021-185400628 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 135.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036626, HPA058127" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA036626: AB_10671963, HPA058127: AB_2683614" "unprognostic (9.08e-2)" "unprognostic (2.85e-3)" "unprognostic (3.89e-2)" "unprognostic (2.36e-3)" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (7.51e-2)" "unprognostic (9.12e-2)" "unprognostic (1.74e-1)" "unprognostic (1.09e-1)" "unprognostic (7.36e-2)" "unprognostic (9.69e-3)" "unprognostic (2.81e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (6.45e-3)" "unprognostic (1.08e-1)" 7.7 8.9 11.0 3.9 15.2 3.3 10.9 9.9 20.9 17.2 7.5 6.0 5.4 4.8 4.9 4.1 35.8 8.0 4.8 13.6 12.0 9.6 6.4 14.2 12.4 3.0 12.3 5.8 14.8 13.5 1.7 11.7 10.7 16.8 24.1 7.0 8.4 35.4 21.9 22.1 7.3 4.9 5.0 16.1 4.6 5.2 8.7 14.2 1.5 14.2 18.6 12.2 14.3 22.8 7.7 4.2 10.2 3.9 3.2 8.1 3.0 6.2 0.9 0.7 3.6 4.9 3.1 3.4 2.9 2.2 2.1 4.7 1.5 1.8 3.0 1.2 5.3 4.4 2.4 3.4 3.7 2.7 8.5 0.9 2.0 3.2 4.5 2.1 1.9 4.7 0.6 4.0 2.0 2.8 15.7 2.7 2.0 3.1 5.1 5.9 1.6 1.6 7.5 1.0 0.6 5.0 0.5 1.0 8.2 2.6 0.5 5.0 8.9 2.0 2.0 8.6 2.7 1.8 1.2 3.5 4.6 3.7 2.6 3.3 9.6 2.8 1.3 13.1 1.4 5.3 0.4 3.8 10.2 5.5 3.5 4.7 7.6 4.3 8.1 2.6 7.7 3.3 4.7 2.0 3.2 3.9 4.2 5.1 3.0 11.0 15.2 9.9 20.9 12.0 9.6 12.3 5.8 16.8 14.2 20.8 23.7 16.6 23.8 52.8 24.8 1.2 0.0 101.7 22.7 8.7 27.5 15.7 21.6 17.9 3.7 11.7 61.7 23.3 20.0 36.6 28.6 40.4 63.2 20.4 13.8 9.5 115.1 10.4 6.7 2.0 8.6 24.5 135.0 28.9 93.8 89.4 40.5 35.1 11.0 15.7 103.2 6.5 35.0 13.3 15.1 42.0 70.6 11.7 31.3 16.2 ANKRD40 MGC15396 ENSG00000154945 "Ankyrin repeat domain 40" Q6AI12 17 50693190-50707924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021668, HPA021759, HPA074884" Uncertain Approved "Nucleoli fibrillar center,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoli fibrillar center, Cytosol" "HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: " "unprognostic (2.73e-1)" "unprognostic (1.82e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (4.99e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (7.02e-4)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (3.84e-2)" "unprognostic (1.53e-1)" "unprognostic (4.77e-2)" "unprognostic (1.00e-2)" "unprognostic (9.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" 25.1 13.0 39.1 9.3 44.1 4.4 20.2 13.7 27.0 12.3 11.3 42.9 7.8 7.4 14.6 9.2 11.9 9.2 10.4 14.8 42.1 29.0 11.5 11.2 14.1 9.6 58.5 15.1 13.8 10.9 19.0 4.9 14.4 26.1 12.2 10.7 7.6 8.8 16.7 59.2 7.8 7.7 17.9 67.2 12.2 9.1 6.4 34.1 4.7 10.9 8.6 8.9 10.6 16.4 9.5 13.3 6.6 10.8 9.6 13.8 3.8 18.9 18.3 16.6 16.6 23.9 19.9 14.5 17.1 18.8 20.1 19.0 38.6 9.7 20.1 24.0 21.9 21.6 10.8 23.6 13.9 32.8 18.5 15.2 27.5 11.9 18.9 13.1 19.1 11.7 17.0 14.3 19.5 24.5 14.7 15.7 16.7 15.5 20.3 16.5 14.8 23.8 6.9 18.3 15.4 17.3 16.3 30.0 14.3 15.7 16.4 8.8 24.6 9.5 13.1 18.3 30.1 15.1 12.8 19.1 27.3 21.6 14.1 21.8 21.5 19.6 18.3 15.0 7.4 22.2 6.6 7.1 2.8 10.9 10.3 12.4 9.5 12.2 12.3 6.6 9.4 11.5 13.8 1.8 9.6 10.8 13.3 8.5 3.8 39.1 44.1 13.7 27.0 42.1 29.0 58.5 15.1 26.1 34.1 14.9 10.7 16.2 21.0 40.1 14.2 28.6 7.6 4.0 3.4 17.4 3.9 14.2 23.2 16.2 1.7 28.1 8.0 0.0 15.0 17.0 18.3 19.2 9.2 16.6 16.6 33.4 5.8 29.4 22.2 0.9 31.7 20.2 25.3 9.0 12.3 15.3 16.3 10.5 35.3 17.4 9.8 45.3 26.1 19.3 23.9 29.1 8.9 19.2 12.8 21.1 ANKRD42 "FLJ37874, PPP1R79, SARP" ENSG00000137494 "Ankyrin repeat domain 42" Q8N9B4 11 83193739-83260694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 73.6;Early spermatids: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039917 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039917: AB_10672894" "unprognostic (6.59e-2)" "unprognostic (9.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.31e-3)" "unprognostic (9.12e-2)" "unprognostic (3.78e-1)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.09e-2)" "unprognostic (3.10e-3)" "unprognostic (1.79e-1)" "unprognostic (4.25e-1)" "unprognostic (1.90e-1)" 5.6 14.5 13.9 5.4 22.1 8.3 7.1 4.8 15.1 8.2 5.4 3.0 11.6 5.8 6.9 22.2 5.6 17.2 8.7 5.4 18.1 13.4 12.3 5.2 7.4 4.5 8.2 12.4 9.9 8.6 16.8 17.9 4.5 13.1 8.4 4.8 6.5 6.7 10.3 6.1 6.2 5.3 6.7 8.7 4.8 6.4 41.8 5.3 1.0 13.0 1.5 4.5 6.8 16.1 7.1 4.8 7.9 11.1 5.8 4.3 2.1 3.9 6.9 3.3 6.8 10.7 11.2 3.0 8.1 6.3 4.8 3.0 4.2 4.8 1.7 10.5 7.2 9.7 8.5 3.5 5.5 4.0 2.2 2.8 2.8 9.4 2.7 7.4 7.8 6.6 6.6 6.6 12.1 6.5 9.4 4.9 2.8 8.1 1.6 6.9 5.8 1.1 8.6 2.8 6.1 4.4 1.9 5.0 2.0 16.0 4.7 2.7 3.5 10.5 6.6 2.1 4.6 9.9 4.4 7.1 7.5 5.2 27.2 3.7 2.1 4.7 3.3 5.9 4.9 3.1 7.9 3.6 4.3 4.1 4.1 2.8 7.1 3.7 4.3 4.8 5.2 1.9 3.0 3.0 5.8 11.1 2.0 1.4 2.1 13.9 22.1 4.8 15.1 18.1 13.4 8.2 12.4 13.1 5.3 8.9 13.6 3.2 17.5 10.0 3.0 6.7 7.6 73.6 7.9 7.0 37.3 2.7 8.3 6.6 123.0 7.1 3.6 0.0 5.8 2.7 8.7 10.0 12.8 3.8 4.4 1.6 2.9 9.2 8.2 53.0 8.1 9.0 6.8 6.4 3.2 6.7 5.4 3.6 9.9 11.4 21.3 12.9 8.7 38.6 18.1 13.4 4.6 7.0 3.1 11.2 ANKRD45 "CT117, FLJ45235" ENSG00000183831 "Ankyrin repeat domain 45" Q5TZF3 1 173609561-173669862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8" "Group enriched" "Detected in some" 5 "Ciliated cells: 33.5;Cone photoreceptor cells: 35.3;Early spermatids: 19.6;Late spermatids: 9.9;Spermatocytes: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.0;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.5;GAMG: 4.1;HBF TERT88: 4.3;SH-SY5Y: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031655, HPA031656, HPA031657" Enhanced Approved "Plasma membrane,Centrosome,Cytosol" NA NA Cytosol "Plasma membrane, Centrosome" "HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196" "unprognostic (1.93e-1)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-1)" "unprognostic (3.57e-2)" "unprognostic (2.69e-3)" "unprognostic (4.15e-2)" "unprognostic (6.93e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (4.49e-2)" "unprognostic (8.80e-3)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (1.61e-1)" 0.5 1.3 5.9 0.4 14.6 0.5 0.6 1.1 7.0 2.8 0.7 9.0 1.3 0.4 3.3 2.5 0.5 24.8 1.0 0.9 7.7 4.7 2.7 0.5 2.8 0.4 2.4 5.3 2.4 1.0 16.8 7.9 0.4 9.2 1.9 0.5 1.8 0.4 1.2 0.4 0.4 0.5 2.4 2.7 1.3 0.5 20.8 4.2 0.0 1.3 0.0 0.4 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 12.0 0.0 0.0 1.0 2.1 0.1 4.2 3.8 6.5 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 4.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 2.3 0.0 0.4 0.1 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.3 0.4 0.0 1.6 10.8 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.9 0.0 2.2 0.1 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.9 14.6 1.1 7.0 7.7 4.7 2.4 5.3 9.2 4.2 0.0 1.7 0.0 0.2 0.2 0.5 0.7 0.0 33.5 1.2 5.2 35.3 0.2 1.7 0.6 19.6 1.5 0.0 0.0 0.4 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 9.9 1.7 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.4 0.5 1.8 0.0 0.3 28.6 4.9 0.0 0.1 0.0 0.0 0.1 ANKRD46 ENSG00000186106 "Ankyrin repeat domain 46" Q86W74 8 100509752-100559784 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013758 Approved Approved Cytosol NA NA Cytosol "HPA013758: AB_10962626" "unprognostic (3.71e-3)" "unprognostic (9.01e-2)" "unprognostic (2.03e-1)" "unprognostic (2.22e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (2.63e-1)" "unprognostic (8.84e-2)" "unprognostic (4.79e-2)" "unprognostic (3.56e-1)" "unprognostic (2.98e-2)" "unprognostic (1.51e-1)" "unprognostic (8.08e-3)" "unprognostic (5.29e-2)" "unprognostic (1.82e-1)" "unprognostic (1.81e-2)" "unprognostic (6.29e-3)" 13.0 29.7 25.8 6.0 23.4 1.6 11.1 25.2 34.2 12.2 6.9 13.9 7.6 7.6 9.7 12.8 9.6 8.9 5.9 14.5 24.0 25.9 23.8 29.5 8.0 6.8 21.7 25.2 17.6 13.6 10.7 10.8 15.2 24.5 10.6 7.1 7.7 11.7 10.7 40.3 8.3 8.1 9.5 20.6 7.9 8.4 6.1 14.6 9.4 14.7 6.1 7.9 8.2 7.6 11.3 7.9 10.4 6.0 12.7 15.8 8.7 5.5 7.0 10.6 5.9 8.1 4.8 11.7 7.3 3.3 5.6 4.8 10.1 3.4 17.6 13.8 2.5 1.8 4.3 10.7 5.4 6.0 6.2 9.4 21.9 3.5 7.9 4.8 5.1 2.8 3.4 10.0 3.6 6.0 6.1 6.9 12.3 11.5 5.7 5.3 6.3 23.8 9.5 7.7 14.4 5.2 18.5 3.5 11.7 8.2 6.0 11.6 11.8 3.1 5.8 4.6 13.2 8.6 8.9 5.1 2.6 2.9 3.8 2.8 13.5 12.8 14.5 2.8 16.8 4.1 10.4 6.0 6.1 12.5 3.2 15.2 11.3 12.0 10.9 7.9 9.5 15.8 13.5 1.5 12.7 5.1 7.4 11.2 8.7 25.8 23.4 25.2 34.2 24.0 25.9 21.7 25.2 24.5 14.6 6.0 3.8 12.0 9.0 9.6 28.0 13.7 7.6 4.0 1.2 21.0 17.7 27.0 24.9 7.2 0.8 11.4 8.4 0.0 5.3 11.8 12.0 9.1 4.6 30.4 9.8 63.5 7.0 17.2 7.2 1.1 19.5 3.4 10.1 8.2 8.1 46.0 3.3 8.4 24.8 39.6 28.0 25.8 11.8 8.1 15.1 12.4 19.6 10.0 8.6 7.9 ANKRD50 KIAA1223 ENSG00000151458 "Ankyrin repeat domain 50" Q9ULJ7 4 124664052-124712732 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.4;monocytes: 3.8" "Cell line enhanced" "Detected in many" "hTERT-HME1: 22.2;HUVEC TERT2: 22.1;TIME: 55.6" "Low region specificity" "Detected in all" HPA044008 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044008: AB_10961996" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (6.85e-3)" "unprognostic (5.90e-1)" "unprognostic (9.77e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (7.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (3.28e-4)" "unprognostic (1.67e-1)" "unprognostic (8.25e-2)" "unprognostic (5.55e-3)" "unprognostic (4.82e-2)" "unprognostic (8.23e-2)" "unprognostic (8.16e-3)" 10.1 4.8 6.6 8.2 6.8 4.7 7.6 4.0 8.3 17.1 10.0 4.3 8.7 3.7 17.5 7.4 11.4 5.9 10.2 7.3 6.2 6.5 9.8 6.9 13.4 5.4 5.5 6.5 9.0 5.2 12.5 3.9 17.1 6.2 19.1 6.9 6.7 7.7 7.9 3.2 12.9 7.9 14.2 4.8 7.1 8.2 16.8 4.8 15.4 9.2 5.8 4.4 16.5 10.9 0.1 2.4 0.5 3.8 0.4 0.1 0.4 2.3 4.3 12.3 5.7 9.8 6.3 1.2 6.0 5.1 3.1 2.0 1.9 3.0 0.0 1.9 8.5 2.8 2.1 8.1 4.6 5.5 0.0 1.7 1.9 5.6 1.8 7.0 3.2 2.5 6.3 6.3 4.9 22.2 5.9 22.1 2.2 3.5 4.2 5.9 5.3 4.0 1.1 2.5 3.4 6.4 3.3 3.8 0.5 3.9 9.6 3.5 4.4 4.1 2.6 4.8 5.3 2.8 2.7 55.6 6.7 5.2 3.2 5.1 3.1 0.0 0.8 3.0 1.4 7.6 0.0 1.5 0.5 0.0 3.8 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.1 0.0 0.4 2.3 0.9 0.0 0.4 6.6 6.8 4.0 8.3 6.2 6.5 5.5 6.5 6.2 4.8 29.8 18.2 0.5 15.0 35.8 2.8 8.4 15.3 8.1 6.8 5.2 0.0 1.9 0.0 8.8 35.0 14.5 3.8 0.0 17.2 23.7 15.5 12.9 4.7 6.8 4.8 20.6 8.1 31.9 10.0 45.7 6.4 8.7 10.1 2.8 3.1 2.9 13.7 2.9 11.3 3.3 1.0 0.0 18.6 16.8 9.7 26.8 3.4 0.0 4.5 15.8 ANKRD55 FLJ11795 ENSG00000164512 "Ankyrin repeat domain 55" Q3KP44 5 56099678-56233359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7" "Group enriched" "Detected in some" 7 "Early spermatids: 143.8;Ito cells: 52.8" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3" "Group enriched" "Detected in many" 67 "granulocytes: 13.1;T-cells: 14.3" "Group enriched" "Detected in some" 6 "HEL: 24.5;HMC-1: 12.7;NB-4: 16.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051049, HPA061649" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA051049: AB_2681326, HPA061649: " "unprognostic (1.00e-4)" "unprognostic (1.58e-4)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (7.78e-4)" "unprognostic (1.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.33e-1)" "unprognostic (1.40e-1)" "unprognostic (7.19e-6)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (1.01e-1)" 0.9 0.5 3.3 1.3 20.0 1.4 0.5 0.5 6.7 0.3 0.5 1.5 0.0 0.5 0.3 0.2 0.6 0.6 0.8 0.4 4.3 7.8 1.1 5.7 0.6 6.1 2.3 3.5 0.5 0.3 0.2 0.5 1.4 9.9 0.3 0.7 0.7 2.1 0.3 0.3 0.9 2.4 0.5 4.1 3.0 0.7 16.7 1.8 0.0 0.4 0.0 3.8 1.0 0.3 0.0 0.0 13.1 0.2 0.0 14.3 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 24.5 0.1 0.9 0.0 1.1 12.7 0.0 0.0 0.0 0.0 0.0 3.0 0.0 2.0 0.8 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.3 0.0 1.6 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.4 0.3 12.6 0.2 13.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 14.3 0.5 1.2 0.0 0.0 0.0 0.6 2.1 3.3 20.0 0.5 6.7 4.3 7.8 2.3 3.5 9.9 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 143.8 1.0 0.0 0.0 0.2 0.3 0.6 0.0 2.3 0.5 0.6 0.0 0.0 52.8 4.1 14.1 0.6 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.7 0.2 0.0 0.0 0.0 3.2 0.5 0.0 1.0 2.2 0.0 0.1 ANKS1A "ANKS1, KIAA0229" ENSG00000064999 "Ankyrin repeat and sterile alpha motif domain containing 1A" Q92625 6 34889265-35091413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 74.5;Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SCLC-21H: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036768, HPA036769" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036768: AB_10670923, HPA036769: AB_10672473" "unprognostic (3.75e-2)" "unprognostic (2.67e-1)" "unprognostic (2.59e-2)" "unprognostic (7.79e-3)" "unprognostic (5.73e-2)" "prognostic favorable (7.48e-4)" "unprognostic (1.18e-3)" "unprognostic (3.51e-3)" "unprognostic (1.62e-1)" "unprognostic (2.18e-1)" "unprognostic (1.42e-1)" "unprognostic (1.38e-2)" "prognostic favorable (8.05e-5)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.23e-2)" "unprognostic (7.80e-2)" 13.6 15.6 11.8 10.5 20.7 5.0 11.5 19.2 19.9 8.8 20.3 11.6 33.9 9.8 10.2 11.0 15.4 19.8 9.9 14.8 11.7 8.0 10.3 11.6 14.5 8.0 15.0 8.8 14.6 11.0 13.9 12.8 27.3 12.8 9.3 8.7 19.7 8.5 30.4 14.8 11.6 10.9 13.9 10.6 18.6 12.3 23.6 13.9 9.5 11.3 4.2 9.1 22.7 9.9 1.3 3.4 2.4 4.3 0.5 1.5 1.1 8.1 3.6 8.4 8.1 3.8 3.5 12.9 3.4 3.8 3.8 5.0 10.1 4.9 5.4 5.4 3.3 7.3 8.3 9.7 9.1 4.2 4.3 11.4 3.9 4.7 7.6 2.3 6.2 3.9 4.3 8.4 4.9 6.2 4.4 9.1 6.0 6.7 2.5 3.6 5.4 3.7 7.0 6.1 10.5 4.4 4.8 4.4 5.8 8.3 15.7 32.8 8.2 4.9 8.0 25.0 11.0 6.1 7.2 7.9 4.1 5.2 4.2 4.9 3.8 5.8 2.6 3.2 9.4 11.4 0.0 2.0 1.2 0.9 2.9 1.2 1.3 0.8 1.5 1.5 0.5 1.0 0.8 2.4 0.5 4.3 3.4 1.0 1.1 11.8 20.7 19.2 19.9 11.7 8.0 15.0 8.8 12.8 13.9 74.5 10.7 4.6 6.7 10.8 27.5 21.2 12.7 29.4 9.1 12.2 60.9 7.4 0.0 6.6 11.3 34.4 11.8 0.0 5.1 6.3 8.5 9.5 2.3 4.9 9.8 7.9 12.7 50.3 26.9 8.1 11.8 10.1 5.0 4.6 11.3 21.8 8.6 5.8 28.3 5.6 44.8 19.4 8.9 5.8 4.9 17.9 10.4 2.5 7.7 11.5 ANKS1B "AIDA-1, ANKS2, cajalin-2, EB-1" ENSG00000185046 "Ankyrin repeat and sterile alpha motif domain containing 1B" Q7Z6G8 12 98726457-99984654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 66.2;skeletal muscle: 28.2" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 136.4;Horizontal cells: 28.6;Late spermatids: 63.3" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 12.1;ASC TERT1: 7.1;SCLC-21H: 13.2" "HPA044628, HPA078230" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA044628: , HPA078230: " "unprognostic (5.50e-2)" "unprognostic (3.26e-2)" "unprognostic (1.01e-2)" "unprognostic (6.87e-3)" "unprognostic (1.18e-1)" "unprognostic (1.14e-4)" "unprognostic (7.94e-2)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (3.03e-2)" "unprognostic (4.97e-4)" "unprognostic (2.81e-1)" "unprognostic (1.14e-3)" "unprognostic (1.64e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.75e-3)" 2.3 4.5 21.4 1.7 41.2 1.2 3.7 21.0 66.2 3.3 2.3 27.5 0.0 1.5 3.3 2.4 3.9 4.4 2.2 2.2 28.3 17.3 5.4 1.8 2.0 1.6 20.3 24.8 9.7 2.1 1.9 4.4 2.7 16.0 4.1 2.1 0.1 3.8 3.7 28.2 1.9 1.6 3.3 25.8 2.0 1.8 7.6 23.0 0.0 6.3 0.0 1.3 2.1 0.8 2.1 2.4 5.3 3.1 3.1 8.3 1.3 0.3 2.5 12.1 2.9 4.9 7.1 0.7 0.0 1.2 0.9 0.9 0.3 0.9 1.0 0.5 1.8 3.7 0.5 0.1 0.1 0.3 1.5 0.8 0.1 0.8 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.9 0.2 0.7 0.5 0.5 3.5 0.1 2.2 0.9 0.0 0.3 0.1 0.0 13.2 1.4 1.1 3.9 1.5 1.0 4.5 0.1 0.1 1.1 1.1 0.7 0.7 0.1 0.7 0.6 1.1 0.3 1.1 5.3 1.4 2.1 1.7 2.1 2.5 1.9 2.9 1.6 1.3 2.1 2.4 2.3 3.9 3.1 3.1 2.4 8.3 1.3 21.4 41.2 21.0 27.9 28.3 17.3 20.3 24.8 16.0 23.0 3.0 3.8 0.0 1.1 1.0 13.7 2.5 0.0 5.3 2.3 8.7 17.7 0.3 0.0 0.1 136.4 0.7 0.0 0.0 0.0 0.2 3.2 0.4 1.1 0.2 0.5 28.6 0.0 0.6 0.0 63.3 1.1 0.8 5.0 0.0 0.0 1.7 0.0 0.0 5.6 2.6 2.8 6.5 1.4 4.7 4.5 1.3 0.7 1.0 0.0 0.6 ANKS3 "FLJ32345, FLJ32767, KIAA1977" ENSG00000168096 "Ankyrin repeat and sterile alpha motif domain containing 3" Q6ZW76 16 4696510-4734378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 98.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041409, HPA041482" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041409: AB_10794375, HPA041482: AB_10795594" "unprognostic (3.02e-1)" "unprognostic (2.19e-1)" "unprognostic (3.06e-2)" "unprognostic (2.55e-2)" "unprognostic (5.44e-2)" "unprognostic (1.31e-3)" "unprognostic (1.05e-2)" "unprognostic (8.65e-2)" "unprognostic (3.75e-1)" "unprognostic (4.42e-2)" "unprognostic (7.36e-3)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (2.19e-1)" "unprognostic (2.66e-1)" "unprognostic (9.96e-2)" "unprognostic (1.57e-3)" 6.9 10.1 7.4 6.4 12.0 4.2 8.9 14.5 11.1 8.1 9.3 8.2 5.0 6.2 8.7 6.7 8.2 9.3 6.8 5.6 8.3 8.5 10.5 5.0 5.8 8.6 10.0 10.9 15.7 16.5 6.8 14.2 5.6 9.7 9.1 3.2 10.9 14.4 10.2 7.7 8.3 4.8 11.7 7.0 5.2 6.1 8.0 7.5 3.2 9.4 3.4 4.7 7.6 7.5 3.3 5.3 0.0 1.6 1.3 3.8 1.1 1.9 23.2 3.0 6.6 5.9 4.9 7.0 8.7 7.1 8.1 7.3 12.0 4.9 4.4 11.0 5.8 3.2 3.9 6.5 4.7 3.6 5.7 12.5 4.0 10.8 2.9 6.4 2.1 3.6 3.0 5.1 7.8 7.5 4.9 1.5 2.9 9.4 1.4 4.8 7.1 4.2 7.9 8.1 2.9 4.5 6.8 7.5 7.9 6.2 2.4 9.8 9.5 4.5 6.6 3.7 1.8 6.6 2.8 2.7 6.0 8.1 11.1 4.4 6.9 12.3 6.6 3.2 2.3 6.8 0.0 1.1 0.0 2.4 1.6 2.9 3.3 2.7 1.7 1.9 3.3 3.8 2.5 0.0 1.3 1.4 5.3 1.7 1.1 7.4 12.0 14.5 11.1 8.3 8.5 10.0 10.9 9.7 7.5 6.0 14.7 4.7 12.4 6.8 42.9 3.2 10.2 12.0 9.1 21.0 104.1 9.6 16.6 15.3 5.5 7.5 7.8 0.0 7.4 7.2 11.0 10.5 0.0 5.7 6.9 47.7 8.6 8.6 2.1 4.2 25.0 6.0 10.1 15.4 10.4 12.4 9.9 14.8 26.5 11.3 98.5 6.5 13.5 24.1 25.8 8.4 5.6 13.1 10.7 6.2 ANKS4B "FLJ38819, HARP" ENSG00000175311 "Ankyrin repeat and sterile alpha motif domain containing 4B" Q8N8V4 16 21233665-21253845 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 64.5;kidney: 16.2;liver: 15.0" "Group enriched" "Detected in some" 14 "Enterocytes: 78.6;Hepatocytes: 24.1;Intestinal endocrine cells: 24.1;Mucus-secreting cells: 34.5;Paneth cells: 31.7;Proximal tubular cells: 28.1;Undifferentiated cells: 21.9" "Group enriched" "Detected in many" 8 "colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;HDLM-2: 5.4;Hep G2: 12.8;OE19: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043523, HPA061125" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043523: AB_10966687, HPA061125: " "unprognostic (1.35e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-2)" "unprognostic (3.32e-2)" "unprognostic (8.42e-3)" "unprognostic (8.61e-2)" "unprognostic (2.36e-1)" "unprognostic (9.48e-2)" "unprognostic (2.04e-1)" "unprognostic (4.08e-1)" "unprognostic (1.08e-1)" "unprognostic (9.75e-4)" "unprognostic (5.15e-3)" "unprognostic (1.88e-1)" "unprognostic (4.77e-2)" "unprognostic (4.34e-3)" 0.1 0.1 0.1 4.3 0.2 0.0 0.1 0.9 0.1 0.1 26.9 0.0 0.0 9.3 0.1 1.5 0.1 0.1 9.2 0.1 0.1 0.1 16.2 15.0 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 7.6 0.0 0.1 0.0 0.5 0.1 64.5 0.1 0.1 0.1 1.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.6 2.0 0.4 1.1 0.4 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.1 0.0 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 3.3 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.5 0.4 0.4 0.3 0.3 0.2 0.5 0.3 0.2 0.1 0.8 0.4 0.4 2.0 1.1 0.2 0.6 0.3 0.1 0.1 0.2 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.2 0.6 2.5 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.7 0.1 78.6 0.0 1.5 0.0 0.0 0.3 1.1 24.1 0.0 0.0 24.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 34.5 1.2 1.2 31.7 0.0 28.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.5 21.9 0.3 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favorable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.0 3.7 5.8 4.3 9.9 1.8 4.8 31.2 9.5 7.3 6.5 9.4 2.6 5.9 6.0 7.4 7.5 7.8 7.7 2.9 6.9 6.1 7.7 1.8 7.2 3.4 10.1 4.4 9.6 18.1 10.0 2.8 2.8 11.4 3.6 7.3 4.2 3.1 3.5 3.3 4.4 5.4 8.9 6.1 2.5 7.7 6.1 9.2 1.8 13.4 2.4 4.5 5.4 6.4 0.9 0.0 0.0 0.1 0.0 2.1 0.2 5.2 7.9 7.3 12.8 6.1 5.0 4.9 3.8 6.6 4.3 5.2 4.3 3.8 9.7 2.9 5.4 6.2 15.6 5.3 6.4 2.3 13.5 5.5 2.3 4.7 1.8 6.0 1.2 1.6 6.1 8.1 5.9 6.0 5.3 4.9 9.0 16.3 2.3 3.3 8.7 0.5 2.5 11.5 23.5 8.6 6.5 18.1 0.7 7.7 3.3 4.7 5.4 1.6 9.4 4.3 6.2 0.0 2.7 4.9 4.5 4.9 12.2 3.7 4.5 7.6 1.6 6.3 4.4 6.4 0.0 0.1 0.0 1.3 0.0 0.7 0.9 0.7 2.1 0.0 0.6 1.8 0.9 0.0 0.0 0.0 0.0 1.1 0.2 5.8 9.9 31.2 9.5 6.9 6.1 10.1 4.4 11.4 9.2 6.0 8.0 2.4 0.7 1.5 6.1 4.4 12.7 5.3 4.5 12.2 7.9 2.3 3.3 3.6 2.9 3.1 4.2 0.0 7.7 2.5 3.4 3.4 1.1 1.5 1.6 0.0 4.7 1.8 1.5 4.9 2.6 1.1 0.0 1.0 6.8 1.4 7.0 3.5 4.2 5.0 0.6 0.0 2.3 4.2 4.9 1.0 0.9 2.1 7.6 2.4 ANKZF1 "FLJ10415, ZNF744" ENSG00000163516 "Ankyrin repeat and zinc finger domain containing 1" Q9H8Y5 2 219229757-219236669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035208 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA035208: AB_10602229" "unprognostic (5.23e-2)" "unprognostic (2.23e-1)" "unprognostic (1.12e-3)" "unprognostic (8.27e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (3.87e-2)" "unprognostic (9.68e-3)" "unprognostic (7.82e-3)" "unprognostic (1.24e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.49e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.88e-3)" 10.1 11.1 14.8 19.0 19.8 13.7 12.9 38.4 25.9 13.8 15.4 17.5 21.7 17.5 14.3 14.7 17.1 21.1 11.7 13.8 12.7 9.6 15.2 15.8 13.2 23.2 19.6 13.5 19.6 19.0 12.3 22.7 11.3 16.4 16.6 10.4 13.6 18.2 22.7 18.9 21.7 19.5 9.5 18.5 21.0 15.1 8.7 18.8 18.7 14.0 8.8 19.8 16.8 16.2 11.7 8.3 10.7 10.6 20.6 17.8 11.0 19.5 3.9 5.2 7.6 7.2 5.9 20.5 6.5 6.5 9.0 11.4 9.5 8.3 4.1 11.6 2.7 9.9 14.4 6.9 11.0 6.6 8.6 7.1 9.1 11.6 8.8 7.1 5.6 9.0 6.0 21.9 6.7 10.6 14.8 6.1 10.8 15.3 9.5 4.5 8.6 8.7 14.7 8.5 8.0 7.1 8.9 6.2 13.2 4.9 5.0 6.7 6.2 6.6 15.6 12.5 13.5 4.0 13.7 6.5 7.4 5.7 5.9 8.1 20.9 11.8 7.4 12.6 8.5 3.2 8.4 7.7 8.8 14.6 7.5 15.4 11.0 14.7 14.4 7.8 11.7 17.8 16.3 10.7 20.6 10.6 8.3 14.0 11.0 14.8 19.8 38.4 25.9 12.7 9.6 19.6 13.5 16.4 18.8 14.9 15.0 12.3 13.1 8.2 34.6 8.1 10.2 54.9 22.7 12.2 29.5 8.7 11.6 17.4 3.8 7.9 16.3 23.3 10.9 18.1 7.4 12.2 21.8 10.9 6.6 30.2 9.2 6.2 10.0 3.1 22.2 9.3 10.1 12.6 19.3 22.3 13.7 17.5 15.6 9.6 53.8 6.5 6.4 9.6 15.9 8.7 9.7 31.9 16.6 9.2 ANO6 "DKFZp313M0720, TMEM16F" ENSG00000177119 "Anoctamin 6" Q4KMQ2 12 45215987-45440404 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Lipid transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038958 Approved Approved "Plasma membrane,Cytosol" NA NA 1500000 "Plasma membrane, Cytosol" "HPA038958: AB_10672835" "prognostic unfavorable (7.56e-5)" "prognostic unfavorable (3.82e-4)" "unprognostic (2.16e-1)" "unprognostic (1.75e-2)" "unprognostic (1.29e-1)" "unprognostic (9.82e-3)" "unprognostic (7.43e-2)" "unprognostic (3.01e-3)" "unprognostic (7.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.41e-3)" "unprognostic (3.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-3)" "unprognostic (1.26e-1)" "unprognostic (4.20e-2)" "unprognostic (1.28e-1)" 40.7 15.3 6.4 17.3 7.0 3.8 42.8 2.5 7.3 22.2 29.7 6.1 34.8 16.5 33.2 16.0 21.2 18.5 20.2 20.7 6.7 5.4 21.6 25.4 25.6 11.7 7.6 4.2 27.4 12.7 20.1 7.1 23.3 8.8 21.6 6.9 14.2 16.8 39.3 40.3 10.0 41.3 42.8 14.6 12.5 13.5 10.4 5.8 21.6 11.2 14.7 9.6 37.6 38.1 2.1 7.1 4.4 9.3 3.1 4.0 5.0 13.6 15.7 8.8 12.0 40.6 21.1 33.7 19.2 24.2 13.3 12.3 23.6 20.7 7.1 18.0 30.0 11.8 18.1 8.0 10.6 15.5 10.4 5.7 8.2 6.4 19.9 12.9 12.7 6.6 17.6 10.6 11.1 16.4 31.7 17.4 14.9 6.2 11.5 14.1 3.6 13.5 4.1 9.8 0.0 5.9 7.8 11.5 7.8 12.2 21.7 4.0 13.7 20.1 12.5 9.2 23.9 14.7 20.1 23.8 14.2 9.1 14.3 9.7 6.1 7.0 8.6 12.8 40.8 11.3 4.4 7.7 1.9 3.3 9.3 3.4 2.1 3.2 2.8 7.1 1.7 2.9 2.0 0.9 3.1 8.6 3.6 4.0 5.0 6.4 7.0 2.5 7.3 6.7 5.4 7.6 4.2 8.8 5.8 56.6 10.2 3.7 20.1 27.1 0.4 20.3 30.6 6.7 13.6 17.4 0.0 29.4 3.3 35.0 1.0 34.4 4.9 0.0 32.0 21.1 32.3 17.2 12.7 81.6 17.8 0.0 8.1 54.0 49.8 1.3 47.5 21.3 16.9 8.2 11.4 9.8 55.0 10.2 38.2 18.0 0.2 38.8 31.6 2.4 4.2 19.3 20.6 6.4 10.7 25.1 ANP32A "C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32" ENSG00000140350 "Acidic nuclear phosphoprotein 32 family member A" P39687 15 68778535-68820897 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005231, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 740000 "Nucleoplasm, Centrosome" Cytosol "CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (3.03e-1)" "unprognostic (6.96e-2)" "unprognostic (2.29e-2)" "unprognostic (1.04e-2)" "unprognostic (4.44e-2)" "unprognostic (4.00e-2)" "unprognostic (3.74e-2)" "unprognostic (1.20e-1)" "unprognostic (7.83e-2)" "unprognostic (4.16e-2)" "unprognostic (3.24e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" 25.8 20.4 32.7 32.0 40.1 46.0 28.2 50.7 33.7 24.5 30.7 40.5 16.0 27.0 26.8 21.7 28.8 30.0 23.4 47.8 32.3 23.6 30.0 29.6 27.2 55.0 33.9 30.0 26.7 25.6 24.2 18.3 38.6 26.6 30.4 35.4 27.2 23.6 27.8 41.7 18.9 28.9 30.5 42.7 40.1 29.8 9.4 36.7 75.0 29.0 18.5 52.4 35.7 27.6 12.7 19.8 27.7 19.9 18.1 12.3 9.6 26.4 32.5 42.8 36.9 15.0 13.2 28.4 14.0 18.7 27.4 23.2 26.8 49.9 85.9 26.2 15.7 16.2 38.9 98.9 28.6 33.0 38.7 33.7 65.0 27.5 33.5 9.3 51.1 35.2 10.5 20.2 15.0 30.0 18.0 39.8 41.7 47.2 33.6 23.5 18.5 51.3 42.0 37.9 26.2 16.5 72.0 39.7 51.0 24.1 41.9 56.8 35.2 21.3 24.0 39.3 44.7 31.9 67.1 17.8 28.5 45.3 19.6 37.3 20.4 56.6 99.5 18.9 86.1 26.0 8.1 17.6 27.7 11.9 19.9 10.0 12.7 9.8 12.3 19.8 12.7 12.1 10.6 18.1 18.1 16.8 17.6 11.2 9.6 32.7 40.1 50.7 33.7 32.3 23.6 33.9 30.0 26.6 36.7 101.3 93.6 54.3 58.8 57.6 85.2 68.1 48.4 129.8 100.1 66.3 33.4 225.4 91.2 95.6 3.6 76.3 57.2 70.0 83.9 137.0 53.5 48.8 89.1 75.9 163.6 62.0 75.3 58.3 145.4 4.0 32.2 112.8 74.2 132.6 83.9 86.2 70.3 56.1 28.0 115.7 65.9 25.8 68.0 7.7 13.8 30.6 194.4 102.2 82.6 46.3 ANP32B "APRIL, PHAPI2, SSP29" ENSG00000136938 "Acidic nuclear phosphoprotein 32 family member B" Q92688 9 97983361-98015943 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063133, HPA067561, HPA069657" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 290000 Nucleoplasm "Centrosome, Cytosol" "HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: " "unprognostic (2.82e-1)" "unprognostic (2.05e-2)" "unprognostic (4.57e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-1)" "unprognostic (5.52e-2)" "prognostic unfavorable (1.98e-7)" "unprognostic (6.76e-3)" "unprognostic (5.70e-2)" "unprognostic (7.16e-2)" "unprognostic (3.50e-1)" "unprognostic (6.39e-2)" "unprognostic (9.22e-3)" "unprognostic (5.20e-2)" "unprognostic (2.36e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-2)" 43.0 24.6 37.9 46.5 55.5 105.7 37.7 15.6 30.1 43.2 38.9 81.0 24.6 32.7 46.3 38.4 40.4 28.4 39.2 27.0 41.8 32.0 26.0 35.9 35.0 70.4 55.7 21.7 51.1 46.0 29.3 20.7 37.5 41.8 38.9 42.3 26.2 32.5 29.7 29.4 38.6 34.9 45.3 88.3 38.6 36.7 19.0 47.6 85.9 37.0 31.9 81.8 64.5 58.6 34.8 32.6 36.8 44.6 22.7 51.3 25.1 71.5 38.7 43.2 36.0 24.3 43.0 39.4 37.2 33.0 40.0 33.7 48.5 35.2 87.8 22.3 24.9 30.5 47.4 58.1 42.0 45.9 56.9 32.8 76.0 33.2 52.3 31.3 130.1 44.3 32.5 30.7 32.1 66.3 32.6 34.7 78.8 146.1 62.2 30.8 95.5 98.2 115.7 16.8 70.3 38.5 58.7 67.3 41.7 26.1 30.0 34.9 30.5 43.6 42.7 38.1 22.2 24.1 48.7 42.0 26.1 42.3 32.8 39.0 56.5 63.8 53.0 24.2 52.3 48.6 23.1 27.2 36.8 22.7 30.9 31.3 34.8 42.7 31.9 32.6 29.6 51.3 38.7 11.3 22.7 44.6 31.8 50.8 25.1 37.9 55.5 15.6 30.1 41.8 32.0 55.7 21.7 41.8 47.6 80.4 91.7 174.3 178.4 160.5 57.6 74.9 101.9 53.5 93.3 71.5 23.6 273.1 82.9 105.6 102.1 109.0 128.4 327.1 148.0 437.2 99.8 129.7 116.6 84.4 250.6 112.8 144.0 112.3 244.5 70.6 135.4 174.1 121.4 164.1 222.6 53.5 126.7 126.7 136.5 75.6 33.5 148.8 133.5 138.6 318.8 134.8 278.6 173.4 278.8 183.9 ANP32D PP32R2 ENSG00000139223 "Acidic nuclear phosphoprotein 32 family member D" O95626 12 48472665-48473624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.3;REH: 1.2" "HPA063133, HPA067561" Uncertain Enhanced Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (2.20e-1)" "unprognostic (3.75e-1)" "unprognostic (3.18e-1)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (1.72e-3)" "unprognostic (2.30e-2)" "unprognostic (3.62e-3)" "unprognostic (2.76e-2)" "unprognostic (3.48e-1)" 0.1 0.9 0.3 0.0 0.2 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.6 0.8 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.7 0.0 0.2 1.1 0.1 0.0 0.2 0.5 0.3 0.2 0.4 0.3 0.2 0.0 0.1 0.2 0.2 0.5 0.2 0.9 0.8 0.0 0.4 0.1 0.1 0.1 0.6 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.4 0.4 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ANP32E "LANP-L, LANPL, MGC5350" ENSG00000143401 "Acidic nuclear phosphoprotein 32 family member E" Q9BTT0 1 150218417-150236156 "Predicted intracellular proteins" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021114, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 18000 "Nucleoplasm, Centrosome" Cytosol "CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (8.95e-2)" "unprognostic (1.69e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (3.91e-2)" "unprognostic (7.73e-3)" "unprognostic (2.47e-1)" "prognostic unfavorable (3.82e-8)" "unprognostic (1.76e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (3.52e-1)" 11.5 18.3 31.2 21.0 30.9 38.4 10.6 50.3 20.6 14.3 11.3 18.3 13.5 12.9 16.5 21.0 12.8 12.8 11.9 19.8 22.9 25.9 18.6 16.8 13.3 38.4 26.5 19.5 19.1 6.9 20.1 14.7 12.3 21.2 14.2 10.9 20.1 9.2 20.9 25.5 12.5 14.5 25.2 32.7 20.3 9.9 6.0 17.8 52.2 18.1 13.6 34.7 20.6 12.1 24.5 8.2 20.7 10.5 14.6 27.0 15.7 34.3 22.2 46.4 23.0 3.6 5.4 17.7 18.5 10.5 17.9 17.2 16.4 24.4 62.6 16.5 10.6 10.6 12.0 26.1 11.5 25.7 71.6 15.8 43.3 27.6 23.6 3.4 87.0 22.0 4.4 1.8 16.7 15.4 8.8 13.2 30.5 41.4 37.1 16.3 35.6 35.5 22.7 46.8 11.2 10.2 37.8 25.8 32.9 12.7 13.8 15.2 26.2 38.6 6.2 10.8 21.5 16.8 44.5 13.6 9.2 25.9 9.4 36.9 47.9 48.1 61.3 10.4 62.8 16.7 20.7 10.5 16.3 18.0 7.3 27.0 24.5 24.2 19.7 8.2 17.0 17.4 21.6 7.2 14.6 8.8 5.7 25.7 15.7 31.2 30.9 50.3 20.6 22.9 25.9 26.5 19.5 21.2 17.8 11.9 78.4 61.4 38.4 86.4 117.9 90.4 22.9 60.2 30.7 69.8 31.4 37.5 72.9 27.5 1.1 45.4 12.3 140.2 23.2 113.7 65.8 16.5 60.2 48.9 46.0 60.4 13.8 39.9 41.9 1.4 28.1 57.2 64.1 62.3 11.5 131.8 20.8 17.5 31.5 44.8 110.8 25.8 85.5 9.3 21.8 86.1 34.0 89.3 28.0 19.3 ANXA1 "ANX1, LPC1" ENSG00000135046 "Annexin A1" P04083 9 73151757-73170393 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Phospholipase A2 inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 432.6;tongue: 235.4" "Cell type enhanced" "Detected in many" 10 "granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011271, HPA011272, CAB013023, CAB035987, CAB058693" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA Yes 77000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884" "unprognostic (2.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.08e-2)" "prognostic favorable (5.71e-5)" "unprognostic (1.53e-2)" "unprognostic (4.28e-2)" "unprognostic (1.82e-2)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-3)" "unprognostic (1.47e-1)" "unprognostic (9.82e-3)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "prognostic favorable (4.57e-5)" "prognostic unfavorable (6.19e-6)" 52.7 3.5 2.7 11.5 3.3 81.4 45.9 0.9 2.5 61.5 8.5 3.6 5.5 2.4 6.9 11.2 432.6 11.9 14.9 8.9 3.2 2.5 9.1 2.1 37.3 7.6 4.3 1.9 11.7 2.4 0.5 6.3 149.5 13.5 12.9 4.4 6.4 93.0 7.2 7.9 11.6 6.4 12.3 6.5 5.9 5.9 5.6 3.1 3.9 21.7 235.4 153.3 18.0 83.1 0.7 98.9 146.2 79.1 27.3 52.5 102.8 66.2 104.7 4.7 4.9 66.8 63.6 0.3 114.8 71.8 47.5 32.2 3.0 59.9 0.1 38.0 100.1 105.0 81.6 10.1 69.5 37.7 37.5 0.7 5.1 31.1 0.1 53.3 11.0 2.5 36.6 57.6 48.0 94.4 44.0 67.3 6.0 21.0 2.8 58.5 0.2 19.5 6.0 5.9 26.5 42.6 0.0 26.7 0.2 106.8 14.0 0.0 0.0 39.5 1.0 26.5 65.5 0.2 1.7 83.1 55.7 35.1 76.5 58.9 0.4 0.1 0.2 128.7 10.3 83.8 146.2 79.1 141.1 52.2 21.5 52.5 0.7 47.0 45.9 98.9 0.2 13.7 25.4 8.6 27.3 19.3 3.5 8.3 102.8 2.7 3.3 0.9 2.5 3.2 2.5 4.3 1.9 13.5 3.1 541.9 512.9 7.3 2232.0 752.1 0.0 11.9 17.8 1060.0 889.5 59.3 0.0 1215.0 0.0 156.6 6.3 398.1 0.8 0.0 20.0 1352.9 735.1 1709.3 2387.0 2.5 570.9 0.0 5.1 113.5 449.6 2.3 206.0 1058.5 291.8 475.3 1.8 0.2 431.7 0.0 8.9 3.1 0.0 64.7 275.6 0.7 2.9 522.6 5914.0 282.4 0.5 4139.3 ANXA11 ANX11 ENSG00000122359 "Annexin A11" P50995 10 80150889-80205572 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004851, HPA027545" Supported Supported Nucleoplasm,Cytosol NA NA 530000 Nucleoplasm Cytosol "CAB004851: AB_626682, HPA027545: AB_1844851" "unprognostic (1.85e-2)" "unprognostic (2.85e-2)" "unprognostic (5.35e-3)" "unprognostic (5.06e-2)" "unprognostic (8.18e-3)" "unprognostic (1.99e-1)" "unprognostic (4.01e-3)" "unprognostic (6.28e-2)" "unprognostic (2.32e-2)" "unprognostic (4.88e-2)" "unprognostic (3.46e-2)" "unprognostic (2.56e-2)" "prognostic favorable (6.69e-8)" "unprognostic (2.69e-3)" "unprognostic (1.84e-1)" "unprognostic (6.79e-2)" "unprognostic (2.02e-1)" 44.1 7.3 19.4 27.8 23.8 37.0 61.1 22.8 24.4 26.4 34.4 8.6 18.4 28.6 20.2 36.4 49.5 23.9 47.5 57.1 17.2 8.3 39.1 21.9 35.1 38.1 10.8 14.2 27.3 24.0 26.2 9.7 35.0 7.5 28.9 27.6 16.7 20.2 27.8 39.5 18.6 44.1 28.1 11.2 22.9 29.3 15.1 6.6 45.7 18.9 39.2 31.8 34.9 39.6 12.7 14.4 77.9 12.1 11.6 21.9 13.0 35.1 30.8 1.8 9.2 39.5 39.0 19.7 26.3 67.8 16.4 17.0 27.9 55.0 2.3 19.1 39.3 1.3 46.1 7.9 22.0 10.0 59.8 14.0 14.4 18.3 21.6 23.2 15.8 35.8 41.2 13.3 9.1 7.0 32.5 23.3 19.0 14.1 26.7 12.9 20.9 19.2 34.9 3.3 35.4 65.5 14.7 2.7 53.3 27.7 32.7 0.8 6.4 11.3 45.5 25.7 16.1 13.5 19.4 28.0 11.5 17.3 26.3 13.8 16.3 22.2 15.2 12.0 26.4 7.6 22.6 12.1 77.9 14.5 9.6 15.3 12.7 18.3 20.3 9.1 10.9 17.3 14.9 43.8 11.6 10.7 14.4 21.9 13.0 19.4 23.8 22.8 24.4 17.2 8.3 10.8 14.2 7.5 6.6 89.3 65.4 74.2 217.3 45.4 1.2 269.2 201.2 96.4 109.2 209.3 0.0 234.0 281.8 337.9 2.4 74.8 352.8 0.0 309.2 260.9 113.9 251.0 115.3 34.3 206.7 3.2 74.5 82.9 136.2 4.7 86.0 136.1 86.0 249.7 151.8 36.1 317.7 312.1 87.0 110.5 2.3 90.5 126.4 2.8 34.1 36.8 155.2 122.2 162.8 514.6 ANXA2 "ANX2, ANX2L4, CAL1H, LIP2, LPC2D" ENSG00000182718 "Annexin A2" P07355 15 60347134-60402883 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Host-virus interaction" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004311, HPA046964, HPA061798" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 16000000 "Plasma membrane" Cytosol "CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671" "unprognostic (1.61e-1)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "prognostic favorable (6.88e-5)" "unprognostic (4.06e-3)" "unprognostic (5.42e-3)" "prognostic unfavorable (2.54e-5)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.94e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (8.47e-6)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (7.74e-2)" "unprognostic (2.55e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (6.59e-5)" 91.7 29.8 4.9 23.5 7.1 6.6 50.1 4.5 5.6 65.1 39.1 8.6 38.2 26.4 38.3 40.3 158.8 26.2 54.9 29.9 4.7 5.5 36.7 28.5 62.0 46.6 10.8 5.7 23.3 94.3 29.7 12.8 84.1 25.7 29.5 35.2 31.7 74.7 27.9 22.7 77.3 71.9 37.1 15.1 32.6 25.6 18.7 7.1 14.6 31.0 122.7 81.4 34.0 87.4 35.5 209.6 183.3 138.0 15.2 83.9 150.8 144.7 161.6 8.5 3.8 116.8 187.4 37.1 173.0 111.6 109.9 96.5 76.6 69.9 0.3 142.5 223.8 82.7 154.9 38.0 324.9 120.6 30.8 4.0 2.9 77.8 29.7 70.4 0.1 2.1 91.5 88.7 78.1 168.4 132.2 204.9 2.1 11.5 16.9 234.8 16.8 0.6 8.5 18.5 123.9 125.9 1.7 46.9 8.1 194.9 88.2 11.2 6.3 68.4 15.6 67.9 92.0 33.4 6.0 233.6 93.8 127.8 314.4 169.8 6.3 20.7 2.8 88.3 1.6 186.5 183.3 138.0 17.7 33.4 122.6 36.5 35.5 38.5 38.5 209.6 16.9 4.5 18.1 3.9 15.2 129.1 32.0 83.9 150.8 4.9 7.1 4.5 5.6 4.7 5.5 10.8 5.7 25.7 7.1 1989.1 372.8 135.8 2699.6 2231.6 2.1 19.9 922.3 1675.6 1452.5 532.1 0.0 1604.6 11.6 3597.2 77.7 904.5 724.0 23.3 2130.9 2200.2 1229.1 3363.5 101.8 70.0 1517.4 0.0 99.2 465.3 432.0 90.7 714.0 1131.8 1344.5 1757.5 521.7 18.0 3399.7 582.2 600.4 22.4 6.8 181.1 774.1 7.0 17.7 2032.4 961.8 162.4 580.5 3656.9 ANXA2R "AXIIR, C5orf39" ENSG00000177721 "Annexin A2 receptor" Q3ZCQ2 5 43039081-43043170 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.9;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" 13 "B-cells: 27.5;Ito cells: 22.1;Kupffer cells: 18.7;T-cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 10.1;JURKAT: 12.3;MOLT-4: 10.8;REH: 11.3;U-937: 41.9" HPA051482 Uncertain Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA051482: AB_2681500" "unprognostic (3.38e-2)" "unprognostic (2.00e-3)" "unprognostic (1.21e-2)" "unprognostic (1.92e-2)" "unprognostic (1.40e-2)" "unprognostic (3.92e-3)" "unprognostic (5.65e-3)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (8.14e-2)" "unprognostic (2.13e-2)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.36e-8)" "unprognostic (2.68e-1)" "unprognostic (2.77e-1)" "unprognostic (2.68e-1)" "unprognostic (1.68e-1)" 5.5 1.6 1.3 8.8 4.1 13.1 8.6 1.0 1.5 5.7 4.1 2.0 1.8 2.5 3.6 3.9 4.6 3.7 2.9 2.2 1.7 1.3 2.4 1.4 7.2 19.0 2.6 0.5 2.0 1.1 0.7 1.8 2.6 1.4 5.7 2.2 2.1 2.9 1.9 4.4 2.2 7.5 3.2 1.9 14.9 2.4 2.3 2.0 25.1 3.1 1.8 13.4 5.2 5.6 8.9 1.4 1.5 2.1 6.5 28.9 7.7 0.7 0.7 0.6 0.4 1.1 3.0 0.2 0.2 0.1 0.1 0.3 1.4 0.9 2.8 2.5 0.5 0.8 0.3 1.8 0.2 0.1 4.6 1.4 0.9 1.9 0.6 1.5 1.0 0.4 10.1 0.1 0.8 0.1 0.0 5.6 12.3 0.6 3.6 0.7 1.0 10.8 1.5 0.0 0.6 5.5 11.3 1.4 1.6 0.3 0.4 2.2 0.0 1.0 0.2 0.2 0.1 0.3 1.9 3.5 0.2 0.0 0.3 0.9 1.6 2.3 1.1 1.3 41.9 0.5 1.5 1.1 0.5 16.0 0.7 18.6 8.7 16.6 17.5 1.0 8.9 28.9 21.2 0.9 6.5 2.1 1.4 17.7 7.7 1.3 4.1 1.0 1.5 1.7 1.3 2.6 0.5 1.4 2.0 0.0 16.4 27.5 1.6 3.3 0.0 1.2 2.5 2.7 2.3 0.0 0.0 0.4 0.0 0.2 3.0 15.4 0.2 0.0 0.0 0.9 4.1 1.2 14.0 0.8 7.6 0.0 1.7 22.1 18.7 1.3 1.4 6.9 6.8 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 2.8 0.7 0.8 1.9 0.3 60.4 0.5 0.9 ANXA4 ANX4 ENSG00000196975 "Annexin A4" P09525 2 69644425-69827100 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 212.1;pancreas: 160.1" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 1936.3;Ductal cells: 852.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 68.0;Hep G2: 71.0;RPTEC TERT1: 99.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB005076, HPA007393, CAB017560" Enhanced Approved Cytosol NA NA 580000 Cytosol "CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168" "prognostic unfavorable (8.55e-4)" "unprognostic (3.37e-2)" "unprognostic (4.82e-2)" "unprognostic (9.03e-2)" "unprognostic (1.62e-3)" "unprognostic (1.66e-1)" "unprognostic (3.57e-1)" "unprognostic (3.21e-1)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (7.23e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.79e-1)" "unprognostic (8.85e-2)" "unprognostic (3.60e-2)" "unprognostic (3.97e-2)" 18.7 5.9 4.2 12.2 4.3 4.1 9.7 1.3 3.0 16.9 32.7 5.3 12.9 43.2 22.8 11.5 16.1 11.9 212.1 6.8 4.3 3.1 36.2 30.9 19.2 5.9 5.1 2.4 12.3 160.1 5.8 3.3 50.9 11.8 18.1 14.9 10.3 11.7 11.4 6.9 12.9 85.7 12.3 6.5 7.2 16.9 5.6 3.6 4.0 24.7 12.9 8.3 11.0 13.2 17.6 21.3 27.6 23.7 3.6 10.3 8.9 10.8 39.4 0.5 4.9 30.3 26.2 1.8 10.5 15.9 4.3 6.1 5.9 19.5 3.5 68.0 17.1 12.9 16.8 3.8 16.9 4.5 10.0 3.2 5.4 3.6 71.0 21.5 1.8 7.0 15.5 16.7 5.8 14.2 10.2 11.1 1.7 0.3 3.2 11.8 9.8 2.8 3.4 0.9 44.1 5.4 2.9 1.1 4.3 99.5 15.7 0.8 3.7 11.6 16.1 15.8 6.0 5.3 24.5 16.0 8.0 3.9 10.6 5.8 1.3 1.4 0.1 12.4 9.3 5.4 27.6 14.8 11.9 10.3 17.4 7.8 17.6 5.3 7.7 21.3 15.9 0.9 5.8 2.0 3.6 23.7 6.4 5.9 8.9 4.2 4.3 1.3 3.0 4.3 3.1 5.1 2.4 11.8 3.6 190.6 117.9 20.5 84.8 65.9 7.2 9.8 1936.3 278.4 133.1 80.3 5.9 74.2 187.3 852.8 12.6 41.2 479.2 0.0 308.4 326.2 105.4 51.9 108.6 59.2 193.0 7.9 17.9 27.0 44.2 6.5 59.8 61.9 87.7 107.4 167.5 40.5 315.1 293.7 86.7 253.0 56.9 6.5 52.0 11.5 3.6 69.5 367.6 32.5 132.9 90.2 ANXA6 ANX6 ENSG00000197043 "Annexin A6" P08133 5 151100712-151157882 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "monocytes: 703.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 106.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002462, CAB005077, HPA009650, HPA009977" Enhanced Approved Cytosol NA NA 970000 Cytosol "CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: " "unprognostic (1.74e-1)" "unprognostic (5.85e-2)" "unprognostic (1.03e-1)" "unprognostic (5.81e-2)" "unprognostic (2.44e-1)" "unprognostic (9.41e-2)" "unprognostic (1.17e-1)" "unprognostic (1.75e-1)" "unprognostic (9.63e-2)" "unprognostic (1.60e-2)" "unprognostic (1.08e-3)" "unprognostic (2.49e-2)" "prognostic unfavorable (1.31e-5)" "unprognostic (6.29e-2)" "unprognostic (1.74e-1)" "unprognostic (1.28e-3)" "unprognostic (1.38e-3)" 78.3 38.2 22.2 44.7 38.3 28.6 109.1 22.0 70.0 37.4 50.2 13.3 34.1 12.5 52.2 34.2 27.0 39.5 39.0 53.0 28.7 37.8 22.1 54.7 33.7 66.7 38.6 30.0 54.9 27.6 8.2 41.4 47.4 62.5 39.3 24.0 36.7 19.7 60.7 85.4 16.6 30.7 82.8 16.8 41.4 31.3 16.8 7.2 44.6 25.5 34.7 50.1 53.0 51.4 36.4 22.4 15.0 15.3 47.0 58.1 50.1 0.3 3.8 24.6 36.3 106.1 48.5 6.7 49.5 58.7 37.2 51.8 13.0 1.9 3.3 17.4 63.0 30.6 0.0 19.0 23.3 37.8 13.3 6.8 1.9 7.8 24.4 35.7 12.0 12.0 60.1 0.1 31.6 5.1 55.8 47.3 23.1 2.6 46.1 87.7 11.8 22.1 18.5 6.9 0.1 11.0 14.5 76.0 3.6 5.5 0.0 1.5 6.4 5.1 35.1 21.3 40.2 60.1 22.7 41.5 35.0 10.6 2.5 12.9 25.8 35.1 0.5 19.0 56.2 5.6 13.8 15.3 15.0 58.1 10.3 38.6 35.0 43.4 52.6 22.4 36.4 30.4 36.9 3.3 47.0 4.6 5.5 34.8 50.1 22.2 38.3 22.0 70.0 28.7 37.8 38.6 30.0 62.5 7.2 14.9 22.4 101.1 11.4 9.7 15.2 49.2 7.6 6.7 0.0 22.7 5.9 54.7 21.6 5.4 35.0 27.8 0.3 23.3 15.2 28.6 64.5 7.2 54.5 119.4 69.2 14.3 20.5 73.6 41.2 35.0 114.2 32.6 52.3 703.3 0.6 42.9 18.1 0.3 198.7 35.6 109.8 226.4 105.6 2.7 1.0 7.0 148.2 109.7 1.9 1.1 ANXA7 ANX7 ENSG00000138279 "Annexin A7" P20073 10 73375101-73414076 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 438.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 124.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004312, HPA064290" Approved Approved Nucleoplasm,Cytosol NA NA 540000 Nucleoplasm Cytosol "CAB004312: AB_626681, HPA064290: AB_2685233" "unprognostic (1.48e-1)" "unprognostic (4.70e-2)" "unprognostic (1.90e-1)" "unprognostic (2.23e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (2.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.67e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (6.93e-2)" "unprognostic (3.06e-2)" 27.4 27.1 28.0 18.5 28.7 24.1 29.3 23.5 33.1 25.2 21.1 25.0 15.5 13.0 25.1 28.2 24.7 19.7 20.7 36.6 27.2 26.8 39.4 40.8 21.5 33.0 26.0 28.8 26.2 24.2 103.3 28.1 23.3 24.9 24.1 25.4 22.8 26.0 25.3 75.4 21.5 17.3 32.3 25.4 21.3 18.0 11.7 15.5 17.1 30.2 28.2 26.7 27.6 20.5 35.3 36.4 53.0 34.9 33.0 44.4 42.5 24.7 17.9 7.0 17.1 27.5 27.1 15.3 16.6 43.7 21.7 18.4 26.2 29.4 9.9 16.9 31.2 14.3 20.8 13.0 19.6 21.6 24.4 9.7 14.0 9.0 23.2 24.3 19.9 6.4 16.8 19.1 27.1 48.7 19.1 19.2 10.8 18.1 28.2 27.6 19.8 11.2 12.8 7.8 14.8 124.5 9.3 20.0 18.0 37.6 15.2 5.6 7.8 18.6 43.1 15.6 10.3 26.9 10.6 17.9 8.9 16.1 26.8 21.3 18.3 25.9 14.0 21.0 25.8 6.8 53.0 34.9 45.1 22.2 26.2 30.1 35.3 34.4 27.7 36.4 24.0 31.5 27.7 35.4 33.0 25.6 15.6 44.4 42.5 28.0 28.7 23.5 33.1 27.2 26.8 26.0 28.8 24.9 15.5 62.5 47.8 60.3 122.2 76.5 30.6 118.6 63.7 88.3 48.9 89.0 13.7 182.8 164.2 134.1 6.4 80.4 61.4 23.3 132.0 94.9 102.4 102.2 105.2 113.2 105.4 9.5 184.2 56.4 82.6 3.6 126.8 86.9 81.0 438.2 73.6 57.2 111.8 42.1 164.1 200.8 21.6 25.8 92.7 20.5 33.6 80.8 148.3 76.1 67.3 127.8 ANXA9 ANX31 ENSG00000143412 "Annexin A9" O76027 1 150982017-150995634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 62.0;seminal vesicle: 78.1" "Cell type enhanced" "Detected in many" 15 "Cholangiocytes: 45.9;Hepatocytes: 14.9;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.5;Hep G2: 14.6;MCF7: 19.5;OE19: 17.0;T-47d: 48.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028404, HPA028698" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA028404: AB_10599190, HPA028698: AB_10600227" "unprognostic (4.06e-1)" "unprognostic (1.55e-2)" "unprognostic (3.15e-3)" "unprognostic (2.08e-3)" "unprognostic (2.93e-2)" "unprognostic (4.49e-2)" "unprognostic (1.84e-2)" "unprognostic (3.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "unprognostic (2.97e-1)" "prognostic favorable (8.74e-6)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (8.99e-2)" "unprognostic (1.72e-2)" 2.4 1.1 1.2 0.9 1.2 0.3 2.6 1.3 2.5 2.3 0.9 0.6 62.0 1.4 6.0 11.6 10.7 2.3 12.5 1.9 1.4 1.0 12.1 15.8 1.2 0.5 1.8 0.8 1.8 32.0 9.9 1.2 0.7 1.3 4.1 0.0 1.2 2.5 78.1 0.9 18.9 1.2 0.9 3.2 1.0 1.3 3.6 0.6 1.3 10.4 9.1 21.1 4.5 4.4 0.5 3.8 2.5 3.1 0.1 0.8 0.8 4.0 0.9 1.4 1.4 0.0 0.0 4.1 0.3 0.2 0.0 0.0 12.1 14.5 0.1 0.8 0.0 0.4 2.4 0.0 0.2 0.0 1.2 1.4 2.0 1.4 14.6 0.0 0.7 0.9 0.0 0.1 0.0 0.0 3.2 0.0 0.6 0.9 4.4 0.0 19.5 0.1 1.0 0.3 17.0 0.2 0.9 0.2 4.8 0.0 5.7 2.2 1.2 0.9 10.0 0.5 0.8 48.4 1.2 1.5 0.3 0.4 0.2 0.2 1.3 4.1 6.3 2.1 1.3 1.1 0.0 3.1 1.8 0.1 1.8 0.8 0.5 0.3 0.5 3.8 0.1 0.8 0.2 2.5 0.1 0.4 0.0 0.0 0.8 1.2 1.2 1.3 0.9 1.4 1.0 1.8 0.8 1.3 0.6 0.0 0.6 0.0 0.3 0.1 0.0 0.3 45.9 1.4 0.0 12.2 0.0 1.7 3.3 10.1 0.7 0.0 0.0 0.0 6.8 0.2 0.6 0.1 1.1 14.9 1.8 0.0 0.0 0.0 0.8 0.0 1.4 0.0 1.7 0.0 0.0 0.0 3.1 0.0 1.1 33.2 0.0 0.0 0.1 6.1 0.1 0.0 1.3 0.0 0.4 4.9 AOC3 "HPAO, VAP-1, VAP1" ENSG00000131471 "Amine oxidase, copper containing 3" Q16853 17 42851184-42858130 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enriched" "Detected in some" 18 "ASC diff: 85.5" "Low region specificity" "Detected in many" "HPA000980, CAB025797" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted - unknown location" NA NA 240000000 Cytosol "Golgi apparatus" "CAB025797: , HPA000980: AB_1078170" "unprognostic (2.20e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (2.97e-2)" "unprognostic (1.17e-1)" "unprognostic (2.64e-1)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (4.00e-2)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.79e-5)" "unprognostic (5.61e-2)" "unprognostic (1.67e-1)" "unprognostic (8.39e-2)" "prognostic unfavorable (6.98e-4)" 97.0 11.5 0.4 18.7 1.0 0.0 67.7 0.5 1.3 26.9 44.3 1.0 16.3 3.6 44.7 34.8 36.1 18.5 50.9 12.1 0.4 0.4 5.8 8.3 48.0 7.9 0.5 1.2 23.8 2.4 2.2 1.3 10.8 2.0 36.5 9.4 32.1 8.0 24.7 7.7 5.5 15.0 79.2 0.6 7.5 17.7 16.2 0.3 1.0 6.6 11.6 2.6 75.9 20.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 85.5 0.1 1.3 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.3 1.5 0.1 0.1 4.7 0.2 0.0 0.2 0.9 0.2 0.1 0.2 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.7 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.1 1.2 1.4 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.5 1.3 0.4 0.4 0.5 1.2 2.0 0.3 3.0 8.9 0.8 0.0 2.6 0.0 3.2 0.0 1.4 3.4 0.0 0.0 0.1 0.0 0.1 3.8 4.7 0.0 0.0 0.2 0.1 2.6 0.2 1.1 0.0 1.1 0.0 0.0 22.7 3.0 2.1 3.1 0.5 3.3 0.0 0.0 0.4 0.1 0.0 70.4 0.7 0.5 116.4 56.5 0.9 0.7 1.6 0.2 0.0 0.0 0.3 AP000646.1 ENSG00000285509 11 121024125-121113108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 2.0;parathyroid gland: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.0" "HPA038593, HPA038594" Uncertain Uncertain Cytosol NA NA Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" 0.0 0.0 0.2 0.0 0.0 0.8 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.5 0.6 0.8 0.2 0.5 0.0 0.8 2.0 2.5 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.3 0.8 1.7 0.4 0.3 0.4 0.2 1.9 2.4 2.3 0.3 1.1 1.2 0.6 0.7 0.8 1.0 0.0 0.8 0.5 2.5 0.1 0.4 4.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 1.1 1.0 0.0 1.0 0.6 1.6 0.0 0.0 0.2 0.1 0.3 0.0 1.4 0.2 2.5 0.7 0.2 0.7 2.2 3.0 0.8 0.1 0.0 2.5 1.4 0.2 0.0 2.0 0.2 0.5 0.9 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP001273.2 ENSG00000284057 11 93741664-93812378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 8.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 6.5" "HPA040511, HPA046619" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA040511: AB_10795369, HPA046619: " 2.4 3.0 1.8 4.2 3.4 0.6 2.7 2.8 2.4 3.6 6.1 3.5 3.6 8.2 2.6 3.0 2.9 2.5 3.3 4.0 2.0 16.9 17.6 3.6 1.7 3.9 1.9 4.8 5.4 5.3 5.9 2.8 3.2 4.5 2.7 4.2 3.8 2.8 4.2 3.7 11.1 2.9 4.5 1.9 3.7 2.6 3.6 4.2 5.7 2.0 1.8 3.0 1.0 2.7 2.9 4.4 2.9 3.0 3.8 2.0 0.2 0.0 4.5 0.8 3.3 0.0 0.6 0.0 1.4 0.9 1.9 1.5 1.1 0.3 4.0 2.4 0.0 1.7 5.0 0.7 0.0 1.3 0.0 0.0 1.5 0.0 0.8 0.0 0.9 0.0 0.7 0.0 0.5 3.4 0.0 2.6 0.9 0.5 5.2 0.0 2.1 3.5 1.9 6.5 0.0 1.0 2.6 1.7 4.8 0.0 0.3 0.4 0.0 1.3 3.5 3.8 2.0 0.9 2.2 0.0 0.8 0.7 1.8 0.9 0.9 3.7 0.3 1.1 1.6 2.9 2.9 4.4 3.2 2.1 3.0 2.7 2.6 2.6 2.9 1.0 2.9 3.6 4.4 3.0 2.3 1.5 3.8 2.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP1B1 "ADTB1, AP105A, BAM22, CLAPB2" ENSG00000100280 "Adaptor related protein complex 1 beta 1 subunit" Q10567 22 29327680-29423179 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hofbauer cells: 116.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065226, HPA068520" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 1000000 "Golgi apparatus" "Vesicles, Cytosol" "HPA065226: AB_2685438, HPA068520: AB_2685998" "unprognostic (1.78e-1)" "prognostic favorable (4.81e-4)" "unprognostic (2.40e-1)" "unprognostic (2.21e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.55e-5)" "unprognostic (4.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-3)" "unprognostic (1.60e-1)" "prognostic favorable (7.24e-6)" "unprognostic (1.85e-2)" "unprognostic (3.78e-2)" "unprognostic (2.94e-2)" "unprognostic (3.76e-2)" 22.2 25.8 28.0 32.3 35.2 29.9 17.2 37.3 43.1 17.2 23.9 26.5 23.9 32.1 14.8 18.4 46.4 17.7 22.0 16.6 24.4 30.4 24.2 25.8 21.2 37.2 29.4 24.1 12.7 28.4 48.2 31.1 32.3 31.9 27.3 21.8 24.1 29.5 31.2 31.3 34.0 28.7 19.3 22.4 33.0 24.9 23.4 16.7 25.2 21.6 25.5 37.4 25.6 21.0 12.2 16.9 3.1 17.3 4.0 5.8 11.6 26.4 15.1 15.7 16.7 12.0 8.8 19.6 18.6 20.8 22.9 22.0 23.1 10.9 14.6 12.4 21.1 10.8 23.8 22.5 31.4 14.6 18.8 32.8 24.2 19.6 13.1 13.4 34.5 33.6 12.7 11.7 21.9 17.7 10.6 31.8 5.5 16.5 17.9 15.2 28.9 14.6 11.4 12.2 39.2 17.2 27.9 17.3 38.9 16.2 60.2 24.9 17.6 23.1 27.1 11.6 11.2 22.0 15.8 27.4 26.5 16.4 15.1 19.4 19.5 10.1 26.8 18.8 15.1 15.4 0.0 15.5 3.1 5.8 17.3 5.8 10.1 3.9 4.9 16.9 12.2 3.2 3.2 1.7 4.0 17.3 5.2 5.2 11.6 28.0 35.2 37.3 43.1 24.4 30.4 29.4 24.1 31.9 16.7 11.9 16.0 31.4 7.7 6.4 25.7 14.5 28.1 9.4 11.4 21.0 37.3 42.2 19.9 40.6 6.3 16.7 63.6 23.3 35.1 25.4 7.8 16.3 4.7 29.2 116.9 42.9 20.7 41.7 83.2 10.4 10.9 34.0 11.8 26.2 22.1 26.2 48.1 26.4 11.7 18.8 37.8 6.5 6.9 22.1 13.6 8.0 57.1 15.2 26.2 15.2 AP1G1 "ADTG, CLAPG1" ENSG00000166747 "Adaptor related protein complex 1 gamma 1 subunit" O43747 16 71729000-71809201 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 197.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009049, HPA041224" Approved Enhanced Vesicles,Cytosol NA NA 150000 Vesicles Cytosol "CAB009049: AB_2058329, HPA041224: AB_2677370" "unprognostic (4.84e-2)" "unprognostic (5.07e-2)" "unprognostic (2.65e-2)" "unprognostic (2.91e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (8.90e-2)" "unprognostic (9.16e-2)" "unprognostic (2.72e-1)" "unprognostic (2.22e-2)" "unprognostic (4.30e-2)" "prognostic favorable (2.96e-8)" "unprognostic (1.27e-1)" "unprognostic (2.04e-1)" "unprognostic (5.68e-2)" "unprognostic (1.75e-1)" 23.2 29.8 20.4 19.2 26.3 59.1 22.4 31.8 29.2 19.7 20.4 29.2 19.8 19.2 19.6 23.9 30.1 17.9 18.7 14.5 18.5 17.4 32.8 29.5 23.8 20.0 24.2 20.1 18.3 25.6 53.5 27.4 25.1 27.9 20.8 23.4 20.8 28.2 20.2 30.0 27.7 24.4 16.0 20.3 24.3 24.8 26.5 26.7 30.0 23.1 21.8 28.3 18.1 20.1 7.5 8.5 17.6 8.8 7.6 9.0 4.2 16.5 24.3 18.7 19.0 20.0 19.1 16.2 17.2 16.5 23.1 22.3 23.4 18.4 20.6 16.6 23.4 16.8 21.2 25.2 18.9 31.1 8.3 13.0 13.4 12.7 17.7 11.8 16.1 44.7 15.9 13.5 30.8 19.1 14.6 19.5 14.1 17.8 8.7 22.6 29.5 14.9 13.6 17.0 13.1 10.6 24.0 15.0 22.0 21.6 19.0 17.2 10.3 21.3 13.5 9.5 20.1 23.5 12.8 23.0 19.9 15.5 10.6 12.6 13.8 17.9 42.6 16.0 13.1 16.9 5.8 7.9 10.9 8.3 8.8 8.3 6.3 7.3 9.0 8.5 7.5 5.9 7.2 17.6 7.6 6.8 6.0 7.3 4.2 20.4 26.3 31.8 29.2 18.5 17.4 24.2 20.1 27.9 26.7 29.8 33.2 26.0 27.0 25.5 25.6 10.9 48.4 20.1 19.4 34.9 68.7 10.8 16.6 16.6 197.4 21.8 29.4 0.0 18.7 11.5 18.8 36.6 20.7 51.9 14.6 28.6 22.4 25.2 31.0 105.9 16.4 23.4 21.9 10.8 21.7 16.7 25.1 24.1 18.7 36.0 62.0 19.4 22.8 25.0 34.2 33.8 20.5 22.3 17.8 42.6 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 beta 2 subunit" Q13367 15 82659281-82709914 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 17.0;Cone photoreceptor cells: 25.5;Horizontal cells: 12.7;Intestinal endocrine cells: 13.4;Rod photoreceptor cells: 56.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 11.8;SCLC-21H: 19.3;SH-SY5Y: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 1.5 5.4 17.0 2.0 15.5 2.4 1.6 32.3 35.8 1.6 1.6 2.7 0.0 1.8 2.0 2.2 1.6 1.4 1.4 1.1 12.1 11.0 1.3 1.2 1.3 1.6 5.7 18.6 1.8 2.7 8.3 12.3 1.4 16.0 1.7 1.5 3.5 1.7 2.0 1.1 1.8 1.5 1.8 3.7 1.3 2.1 2.6 2.7 0.0 1.7 0.0 1.9 1.8 0.6 1.0 0.5 3.2 1.0 1.1 0.9 0.2 0.2 0.2 5.2 2.0 0.5 0.1 4.6 0.3 0.0 0.6 0.1 0.5 0.5 0.5 3.5 0.1 1.1 0.7 0.5 0.0 0.1 1.6 0.5 0.3 0.5 0.2 0.3 0.4 1.2 0.5 0.6 0.1 0.2 0.3 0.1 1.9 0.6 0.5 0.1 0.8 0.3 0.4 6.0 0.1 0.2 0.3 0.1 0.1 0.0 11.8 19.3 14.9 2.9 0.8 1.3 0.6 0.2 1.0 0.3 0.4 0.8 0.3 1.0 1.0 5.7 0.5 1.4 0.3 0.9 0.7 1.0 0.5 0.6 0.4 0.3 0.6 0.5 0.3 0.1 1.0 0.9 0.5 3.2 1.1 0.6 0.5 0.3 0.2 17.0 15.5 32.3 25.6 12.1 11.0 5.7 18.6 16.0 2.7 0.0 0.6 0.0 1.9 0.3 17.0 0.8 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.3 0.1 0.4 0.8 0.0 0.0 0.1 12.7 13.4 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.5 56.5 0.0 0.4 8.1 3.0 0.1 0.0 0.0 0.0 0.8 AP3D1 ADTD ENSG00000065000 "Adaptor related protein complex 3 delta 1 subunit" O14617 19 2100988-2164468 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074408 Approved Cytosol No No 10000 Cytosol "HPA074408: AB_2686686" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (1.12e-1)" "unprognostic (2.24e-3)" "unprognostic (1.37e-1)" "unprognostic (6.35e-2)" "prognostic unfavorable (9.23e-4)" "unprognostic (4.24e-2)" "unprognostic (8.05e-2)" "unprognostic (5.70e-2)" "unprognostic (6.68e-3)" "unprognostic (9.37e-2)" "prognostic favorable (2.61e-6)" "unprognostic (8.11e-3)" "unprognostic (1.22e-1)" "unprognostic (6.25e-2)" "unprognostic (1.73e-2)" 22.4 30.3 27.6 26.0 31.5 18.6 27.1 38.1 41.5 24.8 23.1 22.3 30.1 27.1 27.9 23.9 28.1 26.3 22.6 32.6 25.6 23.6 28.6 45.5 23.5 29.7 19.7 29.8 24.4 55.3 32.1 39.8 26.8 25.1 23.1 18.0 25.9 35.1 28.6 42.6 21.2 26.2 25.7 16.5 25.0 25.9 33.2 21.2 23.6 34.6 19.3 22.5 27.8 23.5 4.1 11.0 5.1 5.0 7.8 8.4 2.9 32.2 33.6 20.3 30.6 26.0 22.1 24.7 26.3 25.9 28.1 25.6 38.1 17.9 17.7 15.2 38.9 34.4 22.1 29.2 31.8 18.6 25.5 27.7 22.8 21.9 29.8 45.3 24.6 30.5 27.1 21.4 29.1 42.8 23.8 27.2 12.8 23.4 61.8 24.6 23.6 23.8 13.4 30.2 22.3 21.7 25.6 22.1 23.5 21.1 46.6 28.8 24.0 23.7 25.1 44.3 19.6 24.3 28.8 35.1 26.8 11.4 36.2 30.4 52.4 50.5 22.6 36.6 16.4 26.6 0.3 4.9 3.9 5.3 5.0 8.4 3.5 5.2 6.3 5.6 4.1 4.3 5.3 5.1 7.8 4.1 11.0 3.0 2.9 27.6 31.5 38.1 41.5 25.6 23.6 19.7 29.8 25.1 21.2 56.6 63.9 17.1 33.7 18.0 63.0 60.7 45.9 22.7 37.5 38.4 33.4 44.8 18.3 48.1 58.7 32.2 59.6 0.0 63.4 58.0 31.5 49.3 16.2 46.1 57.4 46.1 45.9 31.9 25.9 49.2 35.1 37.6 37.1 16.2 41.5 59.4 61.9 44.6 35.7 30.6 41.1 19.4 28.1 72.4 116.5 20.5 65.2 27.7 43.7 53.9 AP5S1 "C20orf29, FLJ11168" ENSG00000125843 "Adaptor related protein complex 5 sigma 1 subunit" Q9NUS5 20 3820524-3828837 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034200, HPA043533, HPA048244" Uncertain Enhanced Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328" "unprognostic (1.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (2.74e-2)" "unprognostic (1.34e-1)" "unprognostic (2.05e-2)" "unprognostic (5.49e-2)" "unprognostic (7.76e-2)" "unprognostic (1.33e-1)" "unprognostic (8.91e-2)" "unprognostic (5.15e-3)" "unprognostic (8.17e-2)" "prognostic favorable (5.53e-5)" "unprognostic (2.92e-1)" "unprognostic (1.62e-1)" "unprognostic (6.09e-3)" "unprognostic (5.08e-2)" 9.4 14.9 10.1 8.6 13.4 10.7 6.8 7.9 15.3 6.7 10.6 12.0 13.9 10.4 7.1 11.8 8.5 8.2 10.6 13.2 10.2 9.3 12.4 18.9 7.9 19.3 8.9 10.7 8.1 16.9 12.1 9.4 13.0 7.1 8.2 7.5 13.4 13.8 7.0 27.2 7.3 9.9 6.7 8.2 10.2 9.9 19.9 6.3 11.2 13.2 11.2 8.3 7.0 5.8 7.8 10.8 4.7 12.9 6.5 11.9 6.6 11.0 21.2 3.0 2.0 4.1 5.3 3.6 6.7 5.5 6.7 5.3 17.9 11.9 6.4 7.3 7.1 12.7 9.9 2.5 10.9 2.3 3.5 7.0 10.6 6.2 15.4 7.0 7.3 6.5 9.0 6.2 8.3 6.6 4.5 7.8 7.8 7.5 12.6 8.8 18.1 16.9 6.4 2.6 8.0 17.3 7.2 5.0 6.6 7.5 9.0 9.1 3.6 6.7 20.5 11.1 2.1 10.1 3.7 10.6 14.1 6.7 7.2 12.7 6.8 7.5 3.5 4.9 6.6 12.0 1.7 8.3 4.7 11.9 12.9 9.2 6.1 10.1 9.9 10.8 7.8 9.4 8.7 2.1 6.5 7.0 8.7 10.3 6.6 10.1 13.4 7.9 15.3 10.2 9.3 8.9 10.7 7.1 6.3 0.0 8.8 3.7 4.0 1.4 14.4 10.1 10.2 5.3 4.5 3.5 9.8 17.2 10.0 8.7 2.6 6.7 8.5 0.0 11.0 12.0 4.2 4.0 13.9 7.4 13.6 23.8 12.1 6.7 5.1 2.5 5.5 6.2 5.0 13.6 5.9 12.3 9.1 7.4 3.9 6.2 19.6 12.9 3.9 14.9 8.5 0.9 15.4 4.9 5.2 2.7 APAF1 "APAF-1, CED4" ENSG00000120868 "Apoptotic peptidase activating factor 1" O14727 12 98645141-98735433 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031373, CAB069399" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB069399: AB_1611908, HPA031373: AB_10602230" "unprognostic (1.32e-1)" "unprognostic (5.12e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.21e-1)" "unprognostic (3.94e-1)" "unprognostic (8.21e-3)" "unprognostic (2.03e-3)" "unprognostic (1.35e-1)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (5.63e-2)" "unprognostic (6.04e-2)" "unprognostic (9.93e-3)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.07e-2)" 10.5 4.7 10.3 11.0 11.0 36.1 8.8 13.4 11.5 10.8 11.6 8.2 5.5 7.0 10.6 7.5 6.2 6.3 11.6 5.8 10.2 8.6 5.8 6.8 11.8 11.2 8.8 6.7 10.8 7.4 5.7 6.2 10.1 8.2 9.1 12.9 8.5 8.2 6.4 6.0 7.5 14.9 7.2 10.9 15.9 8.6 6.1 9.3 15.7 7.0 3.9 14.2 9.5 9.0 2.8 6.3 33.0 8.7 1.1 1.9 1.5 4.4 6.6 20.4 7.8 7.0 12.4 5.6 11.2 8.3 8.5 8.6 4.3 3.2 6.7 3.2 9.3 3.2 7.3 14.2 8.1 10.7 4.7 5.7 12.2 6.3 5.3 2.4 11.8 15.7 5.1 2.5 8.6 4.5 9.4 14.5 4.7 5.6 3.4 12.4 1.3 6.3 12.4 5.6 5.0 3.9 7.9 16.3 2.1 5.0 7.9 3.0 5.1 8.7 3.7 3.2 13.1 6.4 17.8 11.2 5.8 4.5 6.5 3.6 2.3 4.4 7.4 2.2 16.7 7.6 6.2 8.7 7.2 1.9 3.6 1.5 2.4 1.4 1.1 6.3 2.8 1.4 0.9 33.0 1.1 3.6 4.6 0.9 1.5 10.3 11.0 13.4 11.5 10.2 8.6 8.8 6.7 8.2 9.3 11.9 8.0 5.9 4.8 3.4 6.4 1.4 2.5 5.3 4.5 7.0 13.7 3.3 0.0 7.6 0.6 9.2 14.4 0.0 7.0 6.6 8.2 7.3 5.8 5.5 10.5 4.8 11.5 14.1 39.2 0.8 5.5 26.0 10.1 6.4 16.4 2.5 14.3 19.2 4.9 1.5 10.2 0.0 5.2 3.9 11.1 2.9 1.6 9.6 11.5 9.0 APBB1IP "INAG1, RIAM" ENSG00000077420 "Amyloid beta precursor protein binding family B member 1 interacting protein" Q7Z5R6 10 26438203-26567803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.2;lymphoid tissue: 100.5" "Cell type enhanced" "Detected in many" 12 "B-cells: 48.4;Hofbauer cells: 56.0;Kupffer cells: 108.6;Macrophages: 52.4;T-cells: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 54.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 25.7;MOLT-4: 22.0;REH: 49.7;U-698: 52.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017009, HPA063903" Enhanced Enhanced "Plasma membrane,Cytosol" No NA "Plasma membrane, Cytosol" "HPA017009: AB_2669505, HPA063903: AB_2685147" "unprognostic (1.31e-2)" "unprognostic (3.26e-2)" "unprognostic (2.79e-3)" "prognostic favorable (7.48e-4)" "unprognostic (3.06e-1)" "unprognostic (1.07e-2)" "unprognostic (3.83e-2)" "unprognostic (3.05e-1)" "unprognostic (1.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.72e-2)" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (7.77e-3)" "unprognostic (2.68e-2)" "unprognostic (6.00e-2)" "unprognostic (2.38e-2)" 18.3 3.9 7.9 27.7 14.2 25.8 10.1 1.2 7.3 2.6 3.9 16.6 0.0 4.5 2.0 1.5 2.9 4.9 7.5 4.8 7.3 4.9 4.8 25.4 11.1 28.2 14.5 3.2 1.5 3.0 1.3 2.7 5.5 11.1 2.5 4.5 1.6 4.0 1.6 1.5 2.8 12.0 4.7 21.9 41.5 5.4 1.3 12.1 100.5 3.0 0.7 26.2 8.0 3.9 11.0 14.8 54.2 10.3 5.3 9.5 3.5 0.0 0.4 0.0 0.0 3.4 5.7 3.0 9.6 1.8 5.5 5.3 0.0 0.0 25.7 0.1 6.4 5.9 0.0 0.0 0.0 7.6 0.0 0.0 18.6 0.0 0.0 0.0 3.5 0.0 8.2 0.0 0.2 0.0 0.6 0.0 10.6 0.0 16.4 0.0 0.0 22.0 4.9 0.0 2.0 0.0 49.7 0.0 18.2 1.5 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 12.1 0.0 0.0 0.1 1.8 0.0 4.5 0.0 52.9 4.5 18.2 0.0 19.0 7.1 16.1 9.5 6.9 7.7 9.5 8.1 7.9 4.4 11.0 9.3 9.0 54.2 5.3 10.3 14.8 7.6 3.5 7.9 14.2 1.2 7.3 7.3 4.9 14.5 3.2 11.1 12.1 0.0 25.9 48.4 0.0 1.0 0.0 0.9 5.1 6.7 4.5 3.5 0.0 2.0 0.0 4.1 0.3 1.7 0.0 0.0 0.0 14.9 4.1 0.1 22.0 21.5 56.0 0.0 0.0 8.6 108.6 0.0 0.0 52.4 3.3 8.2 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.0 1.0 0.0 0.9 0.1 1.1 69.3 0.0 0.0 APBB3 FE65L2 ENSG00000113108 "Amyloid beta precursor protein binding family B member 3" O95704 5 140558268-140564781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.6" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005571, HPA076196" Approved Approved "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA005571: AB_1844912, HPA076196: " "unprognostic (7.63e-2)" "unprognostic (4.58e-2)" "unprognostic (1.13e-2)" "unprognostic (1.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-3)" "unprognostic (1.44e-1)" "unprognostic (5.06e-2)" "unprognostic (7.22e-2)" "unprognostic (1.98e-1)" "prognostic favorable (6.79e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.06e-6)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.38e-2)" "unprognostic (4.67e-2)" 4.2 5.6 7.5 4.3 9.2 3.3 3.4 26.6 23.8 4.5 4.3 8.2 5.7 2.0 4.7 6.3 4.2 6.0 7.8 8.2 9.7 13.1 3.3 3.4 3.2 2.6 7.9 7.3 4.3 3.5 8.2 11.0 5.7 10.9 5.9 3.6 8.7 8.8 7.4 2.5 3.4 2.8 4.1 4.2 4.7 4.4 11.8 5.5 2.0 6.7 3.3 3.4 3.8 2.3 1.4 1.8 7.7 3.6 0.7 1.4 1.1 0.6 0.7 0.5 2.9 0.0 1.2 5.8 1.4 1.7 2.1 3.9 1.9 1.7 2.4 3.3 2.5 1.3 1.1 0.0 2.2 0.6 2.3 1.2 0.9 5.2 0.1 3.5 0.8 1.0 7.6 0.9 1.8 1.4 0.5 1.5 5.6 0.4 6.6 2.2 1.4 0.3 1.8 1.2 0.7 3.6 0.4 0.7 1.4 1.8 1.5 9.0 4.5 3.8 1.3 5.1 0.3 4.0 3.9 1.1 0.4 1.0 0.0 0.2 2.5 1.9 0.3 0.9 0.6 0.8 7.7 1.4 0.0 1.4 3.6 0.9 0.5 1.0 1.3 1.0 1.4 0.6 1.3 3.3 0.7 0.6 1.8 1.0 1.1 7.5 9.2 26.6 17.4 9.7 13.1 7.9 7.3 10.9 5.5 3.0 9.4 3.4 2.8 2.5 22.6 1.9 12.7 1.4 6.8 5.2 0.0 9.5 5.0 3.3 48.3 5.8 5.0 0.0 1.4 10.2 4.1 2.9 10.4 14.3 11.9 17.5 5.2 7.4 29.1 31.3 5.2 10.2 6.8 4.6 3.6 12.4 2.3 3.2 4.6 3.1 15.7 0.0 3.1 8.4 6.0 2.5 9.8 4.4 2.8 2.4 APC2 APCL ENSG00000115266 "APC2, WNT signaling pathway regulator" O95996 19 1446302-1473244 "Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 59.4" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 41.9;Horizontal cells: 42.9;Muller glia cells: 26.1;Rod photoreceptor cells: 10.3" "Cancer enriched" "Detected in some" 27 "glioma: 17.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 6.5;SCLC-21H: 7.8;SH-SY5Y: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078002 Supported "Cytokinetic bridge,Midbody,Cytosol" Yes No "Cytokinetic bridge, Midbody" Cytosol "HPA078002: AB_2686874" "unprognostic (1.78e-3)" "unprognostic (1.65e-1)" "unprognostic (2.88e-5)" "unprognostic (3.64e-2)" "unprognostic (3.59e-1)" "unprognostic (1.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-2)" "unprognostic (3.45e-2)" "unprognostic (9.49e-3)" "unprognostic (7.39e-2)" "unprognostic (3.70e-2)" "unprognostic (4.99e-2)" "unprognostic (1.98e-3)" 1.5 4.7 17.3 1.4 16.4 1.5 1.3 21.7 59.4 1.4 1.6 20.7 0.0 2.1 1.4 1.4 1.4 1.5 1.6 1.4 16.8 13.9 1.3 1.3 1.4 1.4 15.0 14.0 1.3 2.0 1.3 3.0 1.4 17.1 1.4 1.4 0.8 1.7 1.4 1.6 1.4 1.8 1.5 13.9 1.4 1.4 1.8 14.5 0.0 1.5 0.0 1.3 1.6 0.0 1.1 0.2 0.4 0.0 0.0 0.1 0.1 0.2 0.5 6.5 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.1 0.0 0.7 0.0 0.0 7.8 26.5 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.5 0.5 0.2 0.2 1.9 0.4 0.3 0.7 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 17.3 16.4 21.7 21.3 16.8 13.9 15.0 14.0 17.1 14.5 0.0 0.0 0.0 0.1 0.0 41.9 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 42.9 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.7 0.0 10.3 0.0 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.1 APEH "D3F15S2, D3S48E, DNF15S2" ENSG00000164062 "Acylaminoacyl-peptide hydrolase" P13798 3 49674002-49683963 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029700, HPA029701, HPA029702, HPA029703" Enhanced Enhanced Cytosol No No 1600000 Cytosol "HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348" "unprognostic (4.93e-2)" "unprognostic (5.42e-2)" "unprognostic (6.04e-3)" "unprognostic (2.71e-1)" "unprognostic (9.32e-2)" "unprognostic (8.20e-2)" "unprognostic (3.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.89e-2)" "unprognostic (8.03e-2)" "unprognostic (3.21e-1)" "unprognostic (4.30e-2)" "prognostic favorable (3.32e-10)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.34e-2)" "unprognostic (7.67e-2)" 12.3 31.4 14.3 16.9 18.4 17.3 13.5 14.2 28.2 13.4 23.5 14.4 25.3 24.2 14.1 19.0 23.8 17.2 19.1 23.1 14.2 14.2 33.6 36.9 15.0 23.9 13.9 20.0 13.9 22.7 33.5 26.6 18.6 16.3 16.1 26.6 19.5 19.8 19.8 55.1 16.9 21.7 14.1 9.8 19.2 21.9 22.3 11.7 22.6 26.6 26.6 20.7 19.9 13.7 20.5 26.2 30.4 27.9 21.8 29.5 28.1 25.8 21.1 23.2 30.0 20.3 13.6 30.7 16.9 21.7 23.8 25.5 34.0 28.1 33.1 19.0 19.2 21.7 24.0 25.9 39.2 18.1 15.7 10.7 35.7 35.3 27.8 20.1 38.2 55.6 15.4 29.6 13.6 28.3 23.8 21.5 23.3 22.1 16.5 23.6 23.9 26.9 19.4 13.7 37.3 19.3 10.2 19.9 43.0 47.1 61.4 11.1 19.3 19.1 46.4 21.0 17.9 30.6 20.4 9.7 14.7 25.8 23.0 22.8 18.9 13.5 19.7 25.4 27.1 21.2 30.2 25.5 30.4 28.5 27.9 22.5 20.5 23.5 26.7 26.2 17.4 24.9 24.2 8.0 21.8 26.7 21.0 29.5 28.1 14.3 18.4 14.2 28.2 14.2 14.2 13.9 20.0 16.3 11.7 38.7 22.3 16.0 19.8 7.7 7.8 42.0 33.1 9.4 20.5 26.2 11.8 72.6 36.5 39.0 4.6 8.3 73.8 23.3 30.4 54.6 12.8 15.2 23.1 65.2 45.5 7.9 25.4 14.1 36.8 8.1 14.1 18.1 20.3 22.6 44.7 21.8 35.8 28.8 12.7 64.9 9.9 12.9 14.2 30.5 28.4 8.2 51.9 25.3 51.1 21.0 APIP "APIP2, CGI-29, Mmrp19" ENSG00000149089 "APAF1 interacting protein" Q96GX9 11 34853094-34916499 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 159.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021188, HPA024131" Approved Approved Nucleoplasm,Cytosol NA NA 77000 Nucleoplasm Cytosol "HPA021188: AB_10610977, HPA024131: AB_10602171" "unprognostic (2.80e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-2)" "unprognostic (3.68e-3)" "unprognostic (4.22e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.74e-2)" "unprognostic (3.84e-2)" "unprognostic (9.16e-2)" "unprognostic (2.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-1)" "unprognostic (3.23e-1)" "unprognostic (5.48e-2)" "unprognostic (7.44e-2)" "unprognostic (1.58e-2)" 23.2 29.8 12.0 13.7 18.7 9.6 15.8 7.6 12.6 12.7 13.8 17.9 16.8 10.5 15.3 10.8 12.2 13.9 12.1 15.4 14.5 11.7 24.8 21.8 16.2 14.4 21.5 11.7 13.2 19.7 13.4 10.3 12.5 21.1 14.1 12.6 10.4 18.5 20.4 48.7 6.8 13.9 16.0 27.8 13.9 19.1 9.7 21.1 23.9 19.0 12.9 11.5 19.0 16.1 14.2 25.6 14.9 19.8 17.5 15.8 10.6 8.6 9.3 11.0 2.6 9.0 9.0 4.9 12.8 12.3 12.6 14.4 5.5 7.6 26.6 7.8 4.7 13.0 10.4 20.1 8.6 16.3 16.3 19.1 13.7 9.9 13.9 13.9 38.0 10.5 8.8 6.4 8.0 13.2 5.6 10.3 15.5 32.2 16.4 8.7 8.3 18.1 17.5 8.8 11.8 22.0 11.7 32.3 9.1 13.0 12.5 9.3 4.5 16.1 12.9 15.7 5.5 13.5 11.8 8.6 9.5 9.6 24.3 3.1 16.1 12.0 30.0 11.8 8.1 12.1 4.7 16.9 14.9 11.0 17.5 13.6 14.2 13.4 11.9 25.6 13.4 13.8 11.7 4.1 17.5 19.8 16.5 15.8 10.6 12.0 18.7 7.6 12.6 14.5 11.7 21.5 11.7 21.1 21.1 32.8 26.7 21.4 29.7 22.1 22.7 19.8 40.8 48.2 28.4 17.4 3.9 31.1 159.2 23.6 5.4 20.4 30.7 23.3 28.4 20.1 20.0 35.6 19.7 21.2 67.0 17.5 34.1 22.1 46.7 7.4 22.2 39.5 20.3 66.7 30.2 16.6 21.6 24.6 23.3 70.8 21.9 38.8 25.8 22.8 24.0 23.1 22.1 24.1 38.3 41.1 APOA1 ENSG00000118137 "Apolipoprotein A1" P02647 11 116835751-116837950 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 573.5" "Cell type enriched" "Detected in many" 33 "Hepatocytes: 19896.2" "Cancer enriched" "Detected in many" 48 "liver cancer: 4515.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 4 "dendritic cells: 3.6;T-cells: 2.4" "Cell line enriched" "Detected in some" 18 "Hep G2: 253.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB016778, HPA046715" Supported Approved Vesicles,Cytosol "Secreted to blood" NA NA 1450000000000 220000000000 Vesicles Cytosol "CAB016778: , HPA046715: AB_2679768" "unprognostic (1.88e-3)" "unprognostic (4.53e-2)" "unprognostic (7.46e-2)" "unprognostic (4.00e-3)" "unprognostic (3.70e-2)" "unprognostic (1.41e-1)" "prognostic favorable (5.05e-4)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (9.60e-3)" "unprognostic (1.59e-3)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.67e-8)" "unprognostic (3.46e-3)" "unprognostic (1.15e-1)" "unprognostic (6.24e-2)" "unprognostic (9.54e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 24.6 0.2 0.2 55.6 0.2 0.3 0.2 0.1 0.3 1.3 0.2 0.0 0.2 573.5 0.2 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.0 127.9 0.2 0.2 0.4 0.3 11.8 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.5 3.6 0.0 0.7 0.7 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 14.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 253.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 1.3 1.6 0.0 0.2 0.4 1.7 0.7 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.0 2.4 0.7 0.3 0.0 0.2 1.8 0.8 0.5 0.8 1.7 0.0 0.7 0.0 3.6 2.1 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 3.5 174.9 0.2 0.1 0.6 24.6 596.2 0.0 2.3 0.0 0.0 0.4 0.0 0.1 30.6 1.9 0.9 256.9 1.0 1.1 1.5 0.1 2.3 19896.2 3.1 0.0 1.7 472.6 569.9 110.5 20.8 0.6 0.0 0.0 0.5 0.1 0.2 0.3 4.6 2.2 0.6 6.5 0.7 10.3 9.1 0.5 3.5 2.9 0.3 0.3 APOB ENSG00000084674 "Apolipoprotein B" P04114 2 21001429-21044073 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Atherosclerosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 145 "intestine: 224.8;liver: 442.2" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 2874.2" "Cancer enriched" "Detected in some" 99 "liver cancer: 295.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "Hep G2: 155.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016070, HPA049793" Supported Supported Vesicles,Cytosol "Secreted to blood" NA NA 1490000000000 89000000000 "Vesicles, Cytosol" "CAB016070: AB_626690, HPA049793: AB_2680885" "unprognostic (1.63e-2)" "unprognostic (2.71e-2)" "unprognostic (1.75e-1)" "unprognostic (1.06e-1)" "unprognostic (1.04e-2)" "unprognostic (7.31e-2)" "unprognostic (1.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.43e-2)" "unprognostic (8.89e-3)" "unprognostic (3.01e-1)" "unprognostic (4.59e-3)" "unprognostic (3.60e-3)" "unprognostic (2.89e-2)" "unprognostic (2.38e-1)" "unprognostic (2.99e-1)" "unprognostic (6.23e-2)" 0.3 0.1 0.1 0.0 0.1 0.0 2.3 0.1 0.1 0.1 68.9 0.0 0.0 24.9 0.1 0.0 0.1 0.1 0.0 1.2 0.1 0.1 0.1 442.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 224.8 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.3 0.9 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 155.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.4 0.2 0.1 0.9 0.3 0.0 0.3 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 14.6 293.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.0 2874.2 0.1 0.0 0.0 51.5 53.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 APOBEC3F "ARP8, BK150C2.4.MRNA, KA6" ENSG00000128394 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3F" Q8IUX4 22 39040604-39053910 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.7" HPA073637 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA073637: " "unprognostic (1.38e-3)" "unprognostic (1.28e-3)" "unprognostic (4.63e-2)" "unprognostic (1.63e-2)" "unprognostic (6.16e-2)" "unprognostic (3.51e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" "unprognostic (6.03e-2)" "unprognostic (1.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.88e-1)" "unprognostic (2.06e-3)" "unprognostic (9.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.49e-1)" "prognostic favorable (8.28e-4)" 6.9 9.0 1.9 7.9 2.3 2.5 3.1 0.7 2.0 9.6 5.4 3.9 14.5 3.1 8.2 5.6 5.6 8.1 3.1 6.7 2.4 1.7 5.9 4.5 5.4 13.1 1.8 1.2 14.1 5.5 3.9 4.9 1.7 2.6 6.4 2.4 6.6 6.4 16.3 3.2 1.6 5.0 3.9 3.6 14.3 4.3 11.9 1.9 7.3 4.2 2.5 15.9 5.4 4.5 23.2 4.3 5.9 9.1 9.3 6.9 4.7 4.4 3.5 1.4 5.5 4.1 6.1 2.0 3.4 6.3 8.1 12.9 3.0 8.0 10.6 3.6 7.1 6.7 5.6 1.3 5.3 3.2 10.0 4.4 14.3 0.0 1.5 8.1 1.5 6.0 8.0 2.3 4.1 1.4 4.4 7.4 2.8 1.0 17.7 4.0 3.2 3.2 1.9 0.6 0.0 0.5 5.3 0.5 2.3 6.7 5.9 0.7 1.1 4.1 1.1 2.2 3.3 4.2 1.2 1.9 1.7 4.7 0.2 1.5 3.1 1.6 0.5 4.9 1.4 2.6 1.4 3.3 5.9 6.1 6.6 6.9 16.4 4.0 6.2 4.3 23.2 2.5 3.9 1.5 9.3 9.1 3.7 5.4 4.7 1.9 2.3 0.7 2.0 2.4 1.7 1.8 1.2 2.6 1.9 0.0 0.3 5.2 4.0 0.8 0.0 4.4 10.2 2.7 0.0 0.0 0.0 1.4 1.7 7.1 2.1 1.5 0.5 0.0 3.5 1.2 2.2 3.4 2.3 0.9 5.0 0.0 1.2 4.3 2.1 3.3 4.6 1.9 5.0 6.4 2.1 2.0 4.6 2.8 6.0 2.8 0.3 0.0 1.9 0.3 0.2 0.6 1.4 5.3 1.5 6.2 APOBEC3G "bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019" ENSG00000239713 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3G" Q9HC16 22 39077005-39087743 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.4" "Cell type enhanced" "Detected in many" 10 "B-cells: 66.5;monocytes: 92.8;T-cells: 124.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 14.8;Daudi: 20.0;HDLM-2: 16.7;Karpas-707: 23.0" "HPA001812, HPA073637" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001812: AB_1078175, HPA073637: " "prognostic favorable (4.78e-4)" "prognostic favorable (4.70e-4)" "unprognostic (8.18e-3)" "prognostic favorable (6.03e-5)" "unprognostic (2.37e-1)" "unprognostic (3.43e-1)" "unprognostic (7.77e-2)" "unprognostic (2.33e-1)" "unprognostic (4.23e-1)" "unprognostic (4.13e-3)" "unprognostic (9.13e-3)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.66e-13)" "unprognostic (3.41e-2)" "unprognostic (5.83e-2)" "unprognostic (2.91e-2)" "prognostic favorable (6.30e-4)" 6.0 6.1 1.9 8.0 2.2 4.8 3.8 1.4 1.8 6.4 4.2 2.8 8.0 1.7 6.1 4.3 3.7 8.8 7.2 4.6 2.4 1.7 4.1 4.1 5.1 16.0 2.5 1.3 12.4 0.9 2.0 3.4 3.4 2.5 5.0 3.3 4.8 3.8 28.0 3.3 1.2 5.6 3.6 3.1 18.9 3.5 15.6 1.4 6.5 3.8 2.6 15.2 7.4 6.0 16.1 8.6 5.9 17.5 35.5 64.4 39.1 1.9 0.0 0.0 0.0 2.5 4.9 0.1 0.4 8.2 9.6 14.8 0.7 11.9 20.0 0.2 3.4 6.1 0.0 0.1 0.6 2.8 16.7 0.0 10.3 0.0 0.1 11.1 3.4 4.9 7.4 0.2 5.2 1.1 0.0 1.3 0.6 0.9 23.0 1.4 0.0 3.8 3.4 0.3 0.0 0.7 7.7 0.0 12.7 0.0 8.8 0.0 0.0 0.2 0.0 1.1 0.9 0.0 6.5 0.0 1.5 0.1 0.0 0.0 0.0 1.9 0.2 1.7 3.1 2.5 4.0 6.8 4.5 64.4 15.1 37.7 16.1 20.2 49.8 8.6 11.6 6.9 30.3 5.9 35.5 17.5 5.5 15.8 39.1 1.9 2.2 1.4 1.8 2.4 1.7 2.5 1.3 2.5 1.4 3.0 12.8 66.5 12.9 1.5 0.2 2.2 2.5 8.1 12.5 0.0 2.0 2.9 5.0 8.7 39.3 8.7 0.0 23.3 2.1 1.2 7.7 7.9 11.6 0.8 27.1 0.0 5.8 10.4 18.7 11.7 17.5 15.2 6.8 92.8 1.7 7.8 2.3 1.5 8.5 1.0 1.0 19.4 8.0 0.7 1.1 1.1 0.8 124.6 1.1 18.5 APOBEC3H ARP10 ENSG00000100298 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3H" Q6NTF7 22 39097224-39104067 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.7;ductus deferens: 14.1" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 6.2;monocytes: 18.0;T-cells: 23.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 15.7;MAIT T-cell: 6.6;memory CD4 T-cell: 8.6;memory CD8 T-cell: 13.2;naive CD8 T-cell: 6.4;NK-cell: 11.8;T-reg: 7.5" "Group enriched" "Detected in many" 14 "NK-cells: 11.8;T-cells: 15.7" "Cell line enhanced" "Detected in some" "Daudi: 4.4;HDLM-2: 4.3;Karpas-707: 11.3;U-266/70: 7.5" "HPA021492, HPA058565" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021492: AB_10964888, HPA058565: " "unprognostic (7.09e-3)" "prognostic favorable (1.20e-4)" "unprognostic (1.05e-1)" "unprognostic (6.81e-4)" "unprognostic (3.40e-1)" "unprognostic (1.54e-3)" "unprognostic (2.30e-2)" "unprognostic (1.36e-2)" "unprognostic (2.17e-1)" "unprognostic (3.83e-2)" "unprognostic (5.07e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.73e-12)" "unprognostic (1.05e-1)" "unprognostic (1.03e-1)" "unprognostic (6.55e-3)" "prognostic favorable (8.43e-7)" 1.7 2.2 0.7 6.2 1.2 4.9 1.0 0.8 0.9 1.5 2.3 0.9 14.1 0.4 1.7 6.4 1.5 1.9 2.7 5.9 0.7 0.7 2.3 1.3 4.2 5.3 2.0 1.0 0.9 3.8 0.8 2.0 1.3 1.2 1.6 5.6 1.1 3.3 3.6 2.7 0.5 2.7 1.6 2.1 7.5 2.0 4.0 0.3 3.7 1.8 1.2 5.5 3.1 1.5 1.0 0.1 0.0 1.0 11.8 15.7 2.9 0.0 0.7 0.1 0.0 0.0 0.4 3.2 0.0 0.2 0.3 0.1 0.0 0.4 4.4 1.7 0.4 0.0 0.2 0.0 0.9 0.0 4.3 0.5 1.0 0.2 0.1 0.4 0.0 3.3 2.9 2.5 0.3 0.4 0.3 0.0 0.2 0.0 11.3 1.3 1.3 2.0 0.4 0.0 0.1 0.0 2.4 0.0 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 1.7 0.1 0.7 0.0 0.0 0.2 0.0 0.0 7.5 1.0 0.2 0.3 1.9 0.1 0.0 0.2 0.0 15.7 0.3 6.6 1.0 8.6 13.2 0.1 0.3 0.5 6.4 0.0 11.8 1.0 0.0 7.5 2.9 0.7 1.2 0.8 0.9 0.7 0.7 2.0 1.0 1.2 0.3 0.0 6.2 0.8 0.5 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.5 0.0 3.8 0.0 0.0 0.6 0.6 0.0 0.0 0.8 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 23.2 0.0 0.6 APOL6 "APOL-VI, APOLVI" ENSG00000221963 "Apolipoprotein L6" Q9BWW8 22 35648395-35668409 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB028574, HPA029165, HPA029167" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832" "unprognostic (7.25e-3)" "unprognostic (2.67e-2)" "unprognostic (1.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.76e-1)" "unprognostic (1.55e-1)" "unprognostic (2.32e-2)" "unprognostic (8.29e-2)" "unprognostic (3.76e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-3)" "unprognostic (1.46e-1)" "unprognostic (6.65e-3)" "unprognostic (2.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.71e-2)" "prognostic favorable (6.61e-4)" 40.6 9.2 4.8 18.8 5.5 10.1 32.3 1.9 4.2 7.4 17.9 4.1 5.0 14.0 8.8 9.5 9.8 5.9 12.5 9.3 4.0 4.3 15.4 36.9 15.8 17.0 4.6 2.2 17.0 4.7 3.7 5.1 8.9 5.9 11.7 8.9 6.4 10.1 5.6 7.4 3.6 36.6 6.4 7.6 19.5 10.1 2.5 4.5 12.7 24.8 7.7 13.4 8.5 14.1 1.2 2.8 9.2 9.0 5.9 9.1 4.2 7.2 2.3 0.2 0.9 18.1 9.1 10.2 3.1 8.2 10.2 12.9 1.1 8.2 10.0 1.5 8.0 7.5 9.4 0.0 5.0 2.7 18.9 0.1 4.2 1.5 2.3 14.3 5.8 7.4 11.6 3.4 3.5 2.0 2.3 2.1 4.6 0.4 18.3 1.9 0.7 8.1 1.8 0.3 0.5 3.1 3.4 4.0 4.8 4.5 16.6 0.2 0.1 4.9 4.2 5.6 0.7 0.7 6.8 2.2 2.5 1.5 1.7 1.6 9.7 7.7 1.0 4.8 9.3 3.6 6.4 5.6 2.9 9.1 8.9 7.7 1.2 6.1 7.2 2.8 1.0 6.0 6.7 9.2 5.9 9.0 0.3 6.3 4.2 4.8 5.5 1.9 4.2 4.0 4.3 4.6 2.2 5.9 4.5 65.5 29.3 17.5 9.9 7.1 0.1 6.6 38.2 40.2 40.9 12.2 0.0 6.7 8.3 30.0 10.4 23.9 70.1 0.0 36.3 26.7 19.5 29.2 36.8 105.8 31.4 0.0 45.4 41.7 43.9 4.6 24.2 30.8 8.5 23.4 48.8 3.1 38.3 42.1 17.7 23.8 0.0 0.0 13.4 0.2 0.2 4.5 2.1 51.7 25.8 43.1 APOO "FAM121B, MGC4825, Mic23, MIC26, My025" ENSG00000184831 "Apolipoprotein O" Q9BUR5 X 23833353-23907934 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 152.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003187 Supported Approved Mitochondria,Cytosol "Secreted to blood" NA NA Mitochondria Cytosol "HPA003187: AB_1079375" "unprognostic (2.53e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.86e-2)" "unprognostic (6.38e-3)" "unprognostic (3.45e-1)" "unprognostic (2.42e-1)" "unprognostic (6.18e-2)" "unprognostic (2.95e-1)" "unprognostic (6.45e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.22e-1)" "prognostic favorable (2.56e-6)" "unprognostic (2.53e-2)" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (5.88e-3)" 5.6 13.1 25.5 5.4 21.2 4.4 9.0 18.5 30.9 9.1 10.9 8.5 5.5 9.2 7.2 13.5 7.2 13.6 6.1 38.4 26.0 23.8 29.5 12.2 5.5 6.6 24.9 17.5 7.1 9.0 20.1 15.8 7.1 21.5 9.3 12.5 11.7 14.6 10.4 26.0 4.3 7.6 7.8 18.1 5.4 10.3 10.5 6.8 7.7 13.3 10.4 7.2 6.3 5.8 9.8 14.2 8.5 13.3 7.8 15.0 6.6 14.7 13.5 22.7 15.8 3.8 8.7 3.6 7.4 9.1 15.8 16.7 8.0 7.1 12.8 9.3 6.8 20.6 12.2 28.6 14.8 17.6 13.5 20.3 6.5 13.4 12.6 9.0 16.3 7.3 9.7 8.8 17.4 13.0 8.5 11.0 16.1 9.1 14.5 14.6 13.9 16.4 17.6 20.7 19.4 21.9 12.7 11.3 30.7 30.9 7.6 15.4 11.2 16.1 15.4 15.8 23.3 26.6 7.3 2.7 10.2 6.2 36.5 11.2 11.3 19.8 11.6 16.5 8.1 14.9 8.5 4.2 1.5 11.5 13.3 15.0 9.8 12.7 11.3 12.0 8.3 10.3 10.1 2.5 7.8 12.6 14.2 11.5 6.6 25.5 21.2 18.5 30.9 26.0 23.8 24.9 17.5 21.5 6.8 14.9 7.8 15.6 14.2 12.5 19.3 55.7 25.5 87.0 9.1 22.7 13.7 16.6 152.5 24.6 16.8 8.7 14.4 0.0 14.1 7.3 12.6 14.5 3.5 11.9 20.3 19.1 6.9 9.8 10.1 11.7 10.6 11.2 27.0 55.9 17.6 40.5 12.0 18.4 14.9 67.7 23.7 6.5 6.2 14.0 50.7 6.0 10.4 10.0 20.9 15.4 APRT ENSG00000198931 "Adenine phosphoribosyltransferase" P07741 16 88809339-88811944 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026681 Approved Approved Nucleoplasm,Cytosol NA NA 1200000 "Nucleoplasm, Cytosol" "HPA026681: AB_1844964" "unprognostic (5.87e-2)" "unprognostic (5.10e-2)" "unprognostic (1.98e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.71e-1)" "unprognostic (1.82e-1)" "unprognostic (6.78e-2)" "unprognostic (8.74e-2)" "unprognostic (9.58e-3)" "unprognostic (1.14e-1)" "unprognostic (2.51e-1)" "unprognostic (4.75e-2)" "unprognostic (1.48e-2)" 22.9 37.1 10.9 33.6 13.2 32.9 31.6 10.1 15.3 22.7 31.1 10.7 33.6 27.1 19.9 28.3 50.7 21.0 30.4 22.5 9.1 8.2 27.7 60.4 30.6 94.2 14.8 10.7 17.9 58.2 19.4 15.6 19.3 11.0 25.1 15.1 13.9 48.2 37.4 26.2 49.8 24.3 18.4 12.1 30.4 27.5 16.0 12.2 37.9 29.5 49.7 35.8 18.5 32.8 65.4 92.1 24.2 70.2 58.2 83.7 104.7 25.6 37.7 7.4 33.3 9.1 18.1 39.4 19.4 17.3 22.9 8.9 38.8 31.2 23.9 38.1 11.0 10.9 27.5 12.1 31.9 4.6 16.8 72.1 20.3 17.8 40.5 28.8 13.9 16.7 19.3 34.6 18.3 23.2 10.6 28.6 40.7 42.7 17.9 11.6 94.5 39.2 41.1 28.5 26.7 49.4 42.3 11.5 56.5 25.3 17.5 36.8 22.6 37.0 21.7 20.9 7.2 71.5 27.7 18.5 20.7 18.1 16.7 19.1 35.2 29.5 65.7 30.5 37.0 18.3 8.5 70.2 24.2 63.0 57.7 83.7 63.2 81.9 67.5 71.6 65.4 75.9 64.3 4.3 58.2 37.1 92.1 66.1 104.7 10.9 13.2 10.1 15.3 9.1 8.2 14.8 10.7 11.0 12.2 107.2 125.0 285.8 232.8 283.3 20.2 39.3 252.3 87.0 112.6 87.2 5.9 238.4 344.8 378.2 9.5 147.6 262.7 70.0 383.2 347.1 184.5 203.2 130.3 282.7 315.2 14.3 202.5 130.8 259.2 24.9 222.1 260.5 281.7 449.1 262.5 57.6 343.1 185.9 127.3 427.1 16.1 38.8 137.7 8.1 99.7 432.5 144.4 269.7 340.7 292.1 AR "AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1" ENSG00000169083 "Androgen receptor" P10275 X 67544032-67730619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 49.0" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 189.5;Leydig cells: 72.2;Peritubular cells: 81.3;Sertoli cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in single" 16 "dendritic cells: 5.4" "Cell line enhanced" "Detected in some" "AF22: 11.3;BJ hTERT+: 9.8;HAP1: 14.4;LHCN-M2: 12.6;RH-30: 20.9;T-47d: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000001, HPA004733, CAB065764" Enhanced Supported Cytosol NA NA Cytosol "CAB000001: AB_2060174, CAB065764: AB_10620739, HPA004733: " "unprognostic (1.34e-1)" "unprognostic (8.10e-3)" "unprognostic (2.49e-2)" "unprognostic (5.95e-2)" "unprognostic (1.04e-2)" "unprognostic (3.35e-2)" "prognostic favorable (8.77e-4)" "unprognostic (4.99e-2)" "unprognostic (1.72e-1)" "unprognostic (7.79e-2)" "unprognostic (2.30e-1)" "unprognostic (2.29e-1)" "prognostic favorable (1.03e-8)" "unprognostic (8.23e-3)" "unprognostic (8.90e-2)" "unprognostic (4.23e-2)" "unprognostic (7.97e-2)" 10.1 1.2 0.9 1.6 0.9 0.1 10.7 0.4 1.6 34.4 1.9 2.4 25.4 0.2 20.5 20.5 2.2 17.5 4.3 5.7 0.9 1.5 6.3 49.0 1.5 0.2 1.2 0.7 14.4 1.0 0.1 2.3 0.3 1.9 28.0 0.5 3.8 1.6 36.1 8.1 3.9 1.1 7.6 1.9 0.9 1.6 9.3 1.2 5.4 3.1 2.0 1.2 6.3 13.1 0.0 5.4 0.3 0.0 0.1 0.0 0.1 0.0 4.7 11.3 0.0 0.0 0.1 0.0 6.0 9.8 0.4 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 14.4 0.0 0.1 0.0 1.9 0.0 1.1 0.0 0.7 0.0 0.0 4.6 0.0 1.7 0.0 0.0 3.5 0.1 4.1 1.9 12.6 1.2 0.0 0.0 4.5 0.0 0.0 0.0 20.9 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 3.2 8.8 5.3 0.2 0.2 2.0 0.1 3.0 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 5.4 0.0 0.1 0.9 0.9 0.4 1.6 0.9 1.5 1.2 0.7 1.9 1.2 0.0 5.3 0.0 18.1 8.7 0.6 31.3 12.7 6.7 19.4 3.5 0.0 1.9 1.7 7.5 0.9 4.9 0.0 0.0 0.0 0.1 9.4 31.9 1.1 189.5 0.7 0.0 0.0 14.7 1.6 1.6 72.2 2.1 10.1 2.8 0.0 0.2 1.0 0.0 81.3 22.3 0.3 64.7 12.3 0.5 1.0 14.1 0.8 0.0 0.0 15.9 ARAP1 CENTD2 ENSG00000186635 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1" Q96P48 11 72685069-72793599 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020703, HPA070383" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA 39000 "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "CAB020703: , HPA070383: AB_2686262" "unprognostic (3.60e-2)" "unprognostic (7.68e-2)" "unprognostic (6.19e-2)" "unprognostic (5.98e-2)" "unprognostic (5.76e-2)" "unprognostic (1.64e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (4.01e-2)" "unprognostic (4.07e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-5)" "unprognostic (1.84e-1)" "unprognostic (1.05e-3)" "unprognostic (6.93e-2)" "unprognostic (2.57e-2)" "prognostic favorable (6.41e-4)" "unprognostic (7.56e-3)" 19.2 29.6 28.8 32.9 29.1 51.1 17.9 34.0 37.5 19.6 16.8 26.6 20.0 17.4 23.7 20.0 21.1 30.3 26.1 20.3 27.7 14.4 20.9 16.6 35.5 27.8 27.5 17.8 28.8 18.9 14.3 31.0 20.9 23.0 21.3 11.2 18.1 19.9 19.0 12.9 27.5 23.6 17.1 25.6 53.8 16.2 23.5 32.3 18.8 24.7 14.0 18.6 28.4 19.6 3.3 7.4 24.0 22.5 6.1 4.4 6.4 7.2 15.5 5.9 7.2 25.3 17.2 8.9 10.0 18.1 11.4 11.4 21.1 19.4 16.2 20.2 16.8 15.5 24.6 9.0 23.9 4.9 19.0 10.6 13.7 14.6 29.1 17.5 9.3 38.5 18.3 25.5 18.7 9.0 14.3 12.1 11.9 11.4 6.5 5.3 15.0 14.1 32.4 3.7 13.1 10.0 13.8 9.0 7.9 10.7 23.2 6.2 12.5 7.3 10.9 32.3 7.9 9.5 21.2 14.3 16.2 11.3 16.4 6.1 10.5 5.1 8.5 8.6 13.9 8.6 7.5 11.0 13.3 4.4 18.7 2.6 3.3 2.9 3.3 7.4 2.6 2.3 2.7 24.0 6.1 22.5 2.5 3.1 6.4 28.8 29.1 34.0 37.5 27.7 14.4 27.5 17.8 23.0 32.3 26.8 28.8 11.5 8.0 6.5 4.1 2.0 5.1 8.1 3.4 15.7 31.4 7.0 8.3 13.1 49.1 4.4 11.6 0.0 6.4 7.7 16.7 4.7 10.4 10.2 37.8 0.0 22.3 12.9 43.1 4.4 19.2 39.0 8.5 10.8 13.9 8.6 10.7 7.0 14.2 4.7 2.9 0.0 6.1 0.3 2.5 4.6 4.1 6.7 12.1 6.7 ARCN1 COPD ENSG00000095139 "Archain 1" P48444 11 118572390-118603033 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037573, HPA044874" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 340000 Vesicles "Golgi apparatus, Cytosol" "HPA037573: AB_10696938, HPA044874: AB_2679126" "unprognostic (1.46e-2)" "unprognostic (4.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.20e-1)" "unprognostic (9.99e-2)" "unprognostic (2.30e-2)" "prognostic unfavorable (2.97e-5)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-3)" "unprognostic (9.39e-2)" "unprognostic (3.56e-2)" "unprognostic (7.99e-2)" "unprognostic (9.20e-2)" "unprognostic (4.14e-3)" "unprognostic (5.56e-3)" 46.9 37.4 26.7 30.3 32.9 15.0 35.7 34.4 38.8 48.8 36.7 37.3 39.9 36.0 39.8 61.6 38.6 32.6 38.0 39.5 28.7 30.6 39.1 61.4 34.0 27.3 30.4 24.7 45.1 65.2 49.7 64.7 46.0 38.3 42.4 39.6 29.3 62.0 46.9 25.8 31.9 47.1 41.9 34.3 34.9 38.1 37.9 29.7 39.0 44.1 29.3 39.2 46.9 42.1 22.7 29.1 46.2 33.0 34.1 39.5 26.7 24.7 20.7 36.3 26.5 44.7 47.8 19.6 62.3 55.4 28.2 33.8 65.2 32.8 26.0 53.5 69.5 40.9 33.4 40.5 36.6 39.4 35.8 18.9 55.9 15.0 35.5 50.8 34.3 32.7 41.6 30.5 46.6 43.5 39.7 42.7 25.8 28.7 36.6 53.1 39.7 30.8 30.5 22.8 51.4 27.7 26.9 35.3 39.6 34.2 26.8 24.9 25.0 34.7 33.8 17.6 35.1 43.0 30.7 39.0 35.7 17.6 33.7 28.8 21.5 19.0 37.9 21.0 32.2 42.3 46.2 26.4 26.3 30.5 33.0 39.5 22.7 30.2 29.3 29.1 20.7 29.1 26.6 23.1 34.1 32.1 24.4 28.3 26.7 26.7 32.9 34.4 38.8 28.7 30.6 30.4 24.7 38.3 29.7 32.8 42.8 17.5 25.2 28.0 19.4 40.3 30.6 48.2 45.5 29.6 3.9 13.9 8.3 32.0 9.5 32.1 50.4 0.0 32.8 30.7 36.6 44.9 38.1 51.8 26.5 17.5 38.6 35.6 36.5 5.6 44.5 24.8 21.9 45.1 66.8 15.7 39.0 28.1 38.9 27.0 11.7 19.4 38.9 40.0 50.4 30.4 25.3 24.9 34.6 42.9 ARF1 ENSG00000143761 "ADP ribosylation factor 1" P84077 1 228082660-228099212 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB007742 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB007742: AB_562043" "unprognostic (9.54e-2)" "unprognostic (1.35e-2)" "unprognostic (2.30e-2)" "unprognostic (2.50e-3)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (4.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.73e-1)" "unprognostic (8.95e-3)" "unprognostic (6.74e-2)" "unprognostic (2.96e-2)" "unprognostic (5.85e-2)" "unprognostic (2.69e-2)" "unprognostic (1.56e-1)" "unprognostic (8.57e-2)" "unprognostic (1.94e-1)" 72.0 70.1 64.8 51.0 82.5 111.1 59.3 50.0 116.9 76.0 76.7 53.5 63.6 73.6 71.1 63.3 81.1 66.8 58.5 101.1 70.3 65.9 81.7 135.9 77.4 55.6 52.7 56.5 73.5 109.2 64.9 79.7 129.6 61.4 70.1 55.7 67.8 106.7 68.6 96.5 57.5 91.6 54.7 45.9 81.5 66.0 73.0 33.8 75.6 102.9 60.5 76.5 72.6 57.6 37.4 73.3 111.7 70.0 41.5 64.7 110.7 64.1 44.4 36.5 36.2 42.2 53.4 60.7 56.9 61.0 63.3 55.6 52.5 61.8 32.7 61.2 60.6 29.5 41.6 44.7 55.7 31.8 48.1 71.3 31.8 31.3 52.2 81.7 45.9 47.5 51.0 68.0 58.3 61.5 54.0 62.4 37.4 60.9 75.1 60.9 46.2 46.6 68.0 46.8 90.7 90.9 37.8 32.3 101.9 44.7 33.3 51.6 45.6 36.7 111.5 63.4 13.2 76.6 93.4 55.8 46.6 37.0 67.7 85.3 71.0 39.6 44.9 64.1 39.2 93.9 104.5 70.0 77.2 53.1 66.5 64.7 37.4 45.7 49.1 54.5 34.9 36.2 39.4 111.7 41.5 63.0 73.3 51.8 110.7 64.8 82.5 50.0 116.9 70.3 65.9 52.7 56.5 61.4 33.8 160.8 159.4 184.0 242.8 233.2 114.0 114.2 104.4 214.2 168.4 109.9 43.2 328.6 195.6 344.6 194.6 176.5 349.6 46.7 355.5 480.3 217.0 287.7 192.9 110.7 362.5 149.4 220.8 138.7 177.0 322.5 212.3 230.8 285.1 408.4 315.0 144.2 328.8 293.4 213.6 122.7 61.1 226.4 208.9 174.2 166.0 249.9 565.9 208.8 250.8 292.8 ARF6 ENSG00000165527 "ADP ribosylation factor 6" P62330 14 49893092-49897054 "Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Suprabasal keratinocytes: 588.6;Urothelial cells: 680.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002778, CAB079914" Approved Supported Cytosol NA NA 130000 Cytosol "CAB002778: , CAB079914: AB_2539861" "unprognostic (1.21e-1)" "unprognostic (2.75e-3)" "unprognostic (1.80e-1)" "unprognostic (7.02e-2)" "unprognostic (2.85e-1)" "unprognostic (1.83e-1)" "unprognostic (4.12e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (3.10e-5)" "unprognostic (1.61e-1)" "unprognostic (1.67e-1)" "unprognostic (8.37e-3)" "unprognostic (1.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.49e-2)" 19.7 14.3 8.1 22.3 11.0 31.8 18.7 10.8 11.2 23.1 27.2 9.6 17.4 20.6 17.5 17.8 73.2 16.0 20.4 12.8 7.9 7.7 21.4 23.0 19.3 27.0 10.3 11.0 17.3 15.9 8.2 10.3 29.1 9.8 21.6 23.6 13.7 25.0 13.6 20.6 42.7 43.7 16.7 10.7 28.9 20.6 17.3 8.9 33.7 18.8 34.4 44.0 22.2 35.2 22.9 15.7 17.6 21.5 18.5 26.4 13.9 41.4 17.4 11.8 13.6 16.2 21.7 24.1 26.1 19.0 18.6 19.3 12.6 29.1 27.1 13.5 21.7 14.3 30.7 13.2 20.9 22.2 53.2 10.6 13.9 9.4 11.2 18.3 25.4 18.7 16.8 25.1 15.0 29.1 22.4 20.5 17.6 13.3 54.1 25.7 29.7 22.4 22.4 12.8 22.5 25.2 17.5 15.4 15.8 48.1 33.8 17.4 11.5 20.7 31.3 25.3 15.0 23.7 20.7 27.0 34.8 17.8 20.4 19.5 29.1 29.9 20.5 12.4 15.1 24.6 17.6 14.3 13.3 24.4 21.5 26.4 22.9 24.1 24.7 15.7 17.5 16.8 21.3 9.8 18.5 19.3 10.4 23.2 13.9 8.1 11.0 10.8 11.2 7.9 7.7 10.3 11.0 9.8 8.9 47.6 25.1 175.3 466.8 532.8 22.5 16.1 104.4 18.7 33.0 96.0 2.0 137.2 134.3 117.8 2.7 72.9 203.3 93.5 70.0 160.9 87.6 430.3 78.5 116.3 146.8 31.8 95.3 90.9 177.7 5.6 31.1 185.3 288.5 199.2 149.8 40.2 95.1 160.9 30.8 117.8 17.6 45.3 154.6 55.6 45.6 588.6 169.7 182.7 111.6 680.4 ARFGAP3 ARFGAP1 ENSG00000242247 "ADP ribosylation factor GTPase activating protein 3" Q9NP61 22 42796502-42858106 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000638 Approved Supported "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA000638: AB_1078188" "unprognostic (3.29e-2)" "unprognostic (6.08e-2)" "unprognostic (3.22e-1)" "prognostic favorable (8.97e-6)" "unprognostic (5.83e-2)" "unprognostic (8.85e-3)" "unprognostic (5.00e-3)" "unprognostic (1.00e-1)" "unprognostic (2.05e-1)" "unprognostic (1.31e-1)" "unprognostic (9.06e-3)" "unprognostic (1.67e-1)" "unprognostic (1.87e-1)" "unprognostic (2.52e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (2.65e-4)" "unprognostic (1.73e-1)" 19.0 48.7 12.5 14.5 13.4 18.4 18.8 15.9 12.8 26.6 15.0 14.2 26.5 16.1 18.4 24.8 13.0 13.4 16.6 14.6 12.3 11.0 28.9 42.1 18.6 12.3 17.5 9.9 17.9 53.9 16.3 41.7 21.8 13.4 30.2 13.9 13.6 49.1 31.2 17.6 12.1 36.4 15.2 13.9 16.5 21.4 23.4 15.2 15.4 37.9 9.0 16.2 21.5 23.7 12.8 27.7 32.4 23.9 23.4 31.5 13.9 18.4 6.0 13.3 7.8 18.4 31.0 5.5 35.7 24.0 16.2 19.6 7.2 10.4 9.4 8.0 31.8 13.4 4.6 5.8 10.2 17.6 5.7 7.9 11.0 8.3 11.2 25.6 9.9 17.2 13.6 18.3 13.5 24.3 23.0 16.4 8.6 4.9 42.2 28.0 4.8 15.0 5.2 2.1 9.9 7.3 9.7 30.1 11.6 25.5 8.5 4.7 3.0 17.3 6.9 13.9 10.3 7.2 7.4 21.2 19.1 14.0 16.7 9.5 30.7 14.7 10.4 13.7 10.5 14.8 32.4 17.0 18.0 24.3 21.9 31.5 12.6 16.1 21.2 16.6 12.8 10.6 14.7 26.5 23.4 23.9 27.7 13.8 13.9 12.5 13.4 15.9 12.8 12.3 11.0 17.5 9.9 13.4 15.2 35.7 51.5 39.5 70.2 23.7 41.2 21.3 35.7 84.3 64.8 54.1 17.7 15.4 56.3 52.2 11.9 35.0 39.2 0.0 56.1 22.1 47.4 159.4 64.6 31.1 27.0 31.8 47.1 25.8 15.4 9.0 44.5 51.2 65.8 21.6 37.7 37.8 72.0 14.0 42.8 48.2 30.4 38.8 58.0 142.3 58.1 23.3 50.1 45.0 18.9 72.5 ARFGEF1 "ARFGEP1, BIG1, DKFZP434L057, p200" ENSG00000066777 "ADP ribosylation factor guanine nucleotide exchange factor 1" Q9Y6D6 8 67173511-67343677 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023399, HPA023822" Supported Supported Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA023399: AB_1844981, HPA023822: AB_1844982" "prognostic unfavorable (8.76e-4)" "unprognostic (1.62e-1)" "unprognostic (4.60e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (4.52e-1)" "unprognostic (5.38e-2)" "unprognostic (4.67e-2)" "unprognostic (2.13e-3)" "unprognostic (1.31e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (1.62e-1)" "unprognostic (1.61e-2)" 17.0 17.1 14.5 24.3 15.6 24.9 14.0 20.4 16.3 17.7 24.7 9.5 24.7 16.8 15.4 20.3 23.8 13.1 16.0 12.0 11.3 11.7 23.9 15.3 18.6 22.7 11.4 9.5 15.1 21.4 38.6 21.8 17.4 16.7 15.8 17.7 13.2 20.7 29.4 20.9 18.4 26.9 13.8 12.0 20.1 19.5 27.1 12.6 36.7 22.9 15.7 16.8 22.9 17.7 2.1 3.7 8.4 3.7 3.7 6.1 1.3 15.8 10.3 10.1 3.7 11.7 16.0 11.9 11.2 12.5 11.4 11.6 6.3 15.5 12.0 4.9 14.0 13.9 11.4 12.1 15.7 14.0 15.4 8.5 20.2 6.3 6.8 10.1 10.3 20.2 9.8 11.3 10.2 17.5 11.8 16.2 12.7 12.4 13.1 13.1 3.5 24.2 4.9 22.1 17.4 9.5 11.9 7.2 2.4 18.9 29.5 4.0 7.8 7.2 17.5 9.8 16.1 30.2 9.2 19.7 7.9 10.5 10.3 8.3 11.5 12.5 9.0 12.4 10.6 7.3 8.0 2.6 6.6 4.8 3.7 6.1 2.1 3.2 3.9 2.6 2.1 5.3 4.5 8.4 3.7 1.5 3.7 5.9 1.3 14.5 15.6 20.4 16.3 11.3 11.7 11.4 9.5 16.7 12.6 41.7 17.2 18.8 23.7 21.1 35.4 28.2 20.4 30.8 26.1 36.6 131.6 16.1 10.0 24.5 19.5 24.8 32.5 0.0 22.1 13.2 15.8 30.7 15.0 17.8 14.2 41.3 28.3 22.1 29.5 23.4 37.2 23.8 16.9 27.9 29.9 21.4 31.5 23.0 28.3 21.0 94.9 6.5 17.5 49.4 48.5 25.7 20.8 23.0 22.7 61.6 ARFGEF2 BIG2 ENSG00000124198 "ADP ribosylation factor guanine nucleotide exchange factor 2" Q9Y6D5 20 48921890-49036693 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 95.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026078, CAB026382" Supported Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "CAB026382: , HPA026078: AB_1844983" "unprognostic (1.50e-2)" "unprognostic (9.56e-3)" "unprognostic (4.14e-2)" "unprognostic (4.94e-3)" "unprognostic (5.30e-2)" "unprognostic (6.94e-2)" "unprognostic (1.57e-2)" "unprognostic (2.99e-1)" "unprognostic (8.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.12e-2)" "unprognostic (1.11e-1)" "prognostic favorable (6.15e-7)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (2.85e-1)" "unprognostic (3.90e-2)" 12.9 29.8 9.4 16.6 15.9 15.6 18.7 14.2 21.8 12.7 15.6 12.5 19.2 15.8 13.8 12.4 15.2 10.4 12.8 19.2 11.1 11.0 17.1 20.1 11.5 14.3 11.5 12.6 12.2 21.6 95.3 17.1 15.4 16.1 12.6 17.6 13.4 15.1 24.7 16.2 15.5 16.5 11.6 11.9 14.0 17.4 23.2 8.5 15.5 23.6 11.6 16.0 16.1 11.6 2.5 2.4 7.3 1.7 1.8 2.8 1.0 9.5 11.0 5.1 3.3 9.6 8.8 12.9 8.0 10.8 21.3 10.5 20.0 11.2 13.6 12.2 11.5 19.4 11.5 10.1 12.7 18.5 5.0 3.7 10.1 11.2 18.4 12.4 12.3 11.7 9.0 14.0 14.2 14.9 7.7 14.9 6.6 7.7 13.7 11.3 4.3 7.7 6.8 5.0 11.0 10.1 8.1 13.3 16.6 11.1 13.8 4.6 5.5 23.3 38.4 15.3 6.4 15.4 12.8 18.6 20.6 9.4 10.4 7.4 20.9 18.8 10.1 13.4 6.7 6.9 7.3 1.7 0.7 1.6 1.1 2.8 1.6 1.9 1.8 2.4 2.5 2.7 2.4 0.5 1.8 1.1 2.4 0.5 1.0 9.4 15.9 14.2 21.8 11.1 11.0 11.5 12.6 16.1 8.5 17.9 21.3 13.7 11.9 10.1 14.5 33.1 20.4 12.0 21.6 10.4 13.7 8.6 1.7 8.5 12.6 17.5 21.6 23.3 11.5 7.7 10.3 18.9 15.0 23.1 9.7 11.1 12.0 24.5 14.8 18.7 9.5 11.2 10.1 12.6 22.6 6.2 13.3 20.1 10.6 10.5 15.7 6.5 8.0 25.6 19.6 13.6 25.1 6.4 18.4 12.4 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568164 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 91.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: AB_2683236" "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favorable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favorable (7.34e-5)" 43.5 31.8 59.1 46.5 63.6 67.5 46.1 82.1 72.8 37.9 41.7 44.9 33.5 35.2 62.2 50.9 38.1 50.2 55.0 40.4 55.7 20.6 30.5 24.4 65.3 75.7 62.5 44.5 65.2 34.1 24.0 61.1 48.3 44.0 38.9 48.6 35.5 46.8 48.2 34.1 53.0 54.3 43.3 51.8 50.4 42.8 25.9 67.2 40.2 45.5 22.0 61.0 44.0 44.9 23.7 23.2 34.7 18.0 16.5 18.6 10.9 26.6 14.8 67.4 15.1 10.7 18.6 15.0 29.7 9.0 10.0 15.2 30.2 38.8 32.4 10.2 11.6 11.7 30.2 14.2 12.2 18.8 42.1 15.1 37.2 91.5 15.5 9.5 60.0 24.8 16.6 16.1 9.1 12.3 25.0 12.7 22.5 13.4 25.2 12.8 9.4 23.7 31.9 17.8 19.6 5.6 40.9 16.9 15.4 11.2 31.1 17.6 25.3 14.0 22.5 6.7 27.9 17.7 31.1 23.0 13.4 13.4 14.9 16.6 28.3 23.3 38.8 27.7 38.5 15.3 34.7 18.0 16.7 18.6 14.6 17.2 20.7 13.8 11.6 14.4 23.7 15.8 13.8 30.3 16.5 13.4 23.2 15.5 10.9 59.1 63.6 82.1 72.8 55.7 20.6 62.5 44.5 44.0 67.2 131.0 200.7 147.3 175.2 232.4 221.8 78.3 101.9 224.9 215.0 108.2 127.6 118.5 84.6 100.9 28.5 282.9 157.6 93.5 97.9 120.4 173.1 219.9 158.9 69.6 87.5 287.6 180.1 188.4 85.6 18.1 236.2 133.0 121.4 162.3 134.2 304.1 112.4 133.3 204.7 39.4 283.1 213.4 189.5 194.6 112.8 229.2 154.9 147.4 126.3 268.6 ARHGAP10 "FLJ20896, FLJ41791, GRAF2" ENSG00000071205 "Rho GTPase activating protein 10" A1A4S6 4 147732063-148072780 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 127.4;monocytes: 96.4;Peritubular cells: 113.8;Rod photoreceptor cells: 129.8;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 9 "cerebellum: 154.3" HPA039589 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039589: " "unprognostic (8.57e-3)" "unprognostic (1.34e-1)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (2.79e-1)" "unprognostic (3.41e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-2)" "prognostic favorable (8.15e-5)" "prognostic unfavorable (6.26e-4)" "unprognostic (1.54e-1)" "unprognostic (1.02e-3)" "unprognostic (1.09e-2)" 31.2 7.9 2.3 11.3 3.2 2.0 27.8 1.8 3.7 20.1 23.9 1.9 13.2 3.4 15.4 17.6 25.2 17.6 20.3 20.0 2.8 1.6 9.6 4.8 11.8 8.3 3.8 1.9 19.9 7.8 20.8 4.7 7.5 9.9 19.8 6.0 16.0 6.7 17.0 37.5 12.3 8.9 58.0 5.2 9.7 15.9 11.2 2.5 8.7 9.9 12.4 7.9 28.7 24.9 0.0 2.6 14.0 1.5 4.1 9.7 2.1 9.8 4.0 2.2 4.5 16.7 22.8 22.7 13.7 11.4 8.8 6.9 10.3 5.7 0.0 2.3 11.6 7.4 4.9 7.9 11.2 10.7 5.4 5.3 3.3 3.1 0.3 25.8 3.3 4.0 11.8 8.8 11.0 9.4 11.2 10.6 2.9 0.5 18.7 15.7 12.0 2.0 0.0 2.0 6.6 2.0 3.8 6.2 11.5 6.1 9.1 5.3 2.5 3.6 14.4 3.8 9.8 1.8 0.3 10.6 8.3 6.4 5.0 6.5 7.0 0.8 0.0 12.7 0.4 7.3 0.0 1.5 14.0 5.2 0.0 9.7 0.0 3.9 5.7 2.6 0.0 1.1 5.7 0.2 4.1 0.0 0.0 4.6 2.1 2.3 3.2 1.8 3.7 2.8 1.6 3.8 1.9 9.9 2.5 3.0 2.6 0.0 6.9 12.8 3.8 58.3 5.1 0.0 2.3 1.8 41.2 24.2 0.0 4.2 7.8 9.0 0.0 0.0 13.5 41.5 17.5 3.3 1.1 11.3 20.5 3.2 0.0 6.2 3.9 6.2 127.4 12.8 5.0 96.4 0.0 7.7 14.2 0.0 113.8 11.7 129.8 142.3 59.0 3.9 16.1 8.9 10.6 12.5 1.1 2.4 ARHGAP11A KIAA0013 ENSG00000198826 "Rho GTPase activating protein 11A" Q6P4F7 15 32615144-32639949 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.4;lymphoid tissue: 35.0" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 20.0;Spermatocytes: 24.4;Spermatogonia: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040830, HPA066481" Enhanced Approved Nucleoli,Cytosol No Yes Cytosol Nucleoli "HPA040830: AB_10805830, HPA066481: " "unprognostic (5.00e-2)" "unprognostic (5.57e-2)" "unprognostic (6.10e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.05e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (4.87e-2)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (3.43e-2)" "unprognostic (1.07e-12)" "unprognostic (7.37e-2)" "unprognostic (5.23e-1)" "unprognostic (1.54e-2)" "unprognostic (9.64e-2)" 1.9 1.5 2.0 17.2 2.9 16.4 3.3 1.1 3.9 1.6 5.4 1.6 0.5 4.3 2.3 0.5 7.5 0.5 4.1 1.4 2.2 1.9 0.8 1.2 2.0 9.4 4.4 0.8 0.8 3.1 0.9 1.0 4.7 2.0 1.2 6.7 0.8 2.0 0.5 1.7 3.2 9.6 3.3 8.9 5.0 2.6 6.4 1.9 35.0 1.0 5.3 10.3 2.6 2.7 0.9 1.7 2.6 1.8 0.5 3.8 1.1 23.5 25.4 20.3 13.4 1.4 3.8 12.2 23.9 13.8 22.8 17.6 17.5 12.0 13.7 7.6 14.0 26.1 17.5 14.3 12.5 30.8 26.9 8.3 43.4 22.9 8.9 0.5 32.3 17.4 1.2 1.5 18.3 14.5 4.3 16.8 27.0 30.0 32.6 26.4 9.6 16.9 10.8 12.7 19.7 14.9 20.1 45.5 10.7 8.1 12.5 19.6 13.5 25.1 13.0 5.4 11.0 18.5 31.0 12.9 30.8 22.8 12.9 25.4 11.9 18.8 37.8 13.2 38.4 26.9 0.1 1.1 2.6 2.3 1.8 0.9 0.9 3.8 3.3 1.7 0.7 1.5 2.0 0.0 0.5 0.3 0.6 2.8 1.1 2.0 2.9 1.1 3.9 2.2 1.9 4.4 0.8 2.0 1.9 0.0 2.9 1.5 0.9 4.2 0.0 0.8 5.1 1.4 2.3 1.8 0.0 2.5 0.0 0.8 2.9 1.1 0.5 0.0 0.7 20.0 1.1 1.0 0.0 1.0 8.0 0.0 0.0 2.5 4.1 3.4 0.6 3.2 0.0 3.6 3.7 0.0 0.5 1.1 0.4 0.2 0.9 6.5 0.9 24.4 18.6 1.9 2.6 3.2 5.1 1.4 ARHGAP17 "FLJ10308, FLJ13219, NADRIN, RICH1, WBP15" ENSG00000140750 "Rho GTPase activating protein 17" Q68EM7 16 24919385-25015666 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041703 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041703: AB_10794304" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (8.11e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.42e-2)" "unprognostic (3.49e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (3.02e-2)" "unprognostic (6.62e-2)" "unprognostic (8.81e-3)" "unprognostic (4.99e-2)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.76e-4)" 25.0 23.2 12.3 22.5 21.7 10.1 20.6 12.2 15.8 15.1 15.8 22.9 6.8 14.3 21.4 12.4 19.1 16.8 15.4 18.9 13.4 5.4 15.0 12.6 17.8 28.7 28.0 8.7 15.1 14.0 17.0 20.5 62.6 16.3 13.7 16.0 19.3 16.4 10.9 22.0 19.2 25.5 15.1 19.6 40.8 16.5 18.6 24.8 16.9 17.1 12.4 29.6 13.4 16.8 25.7 24.6 8.0 17.2 5.7 7.2 6.8 20.5 11.8 15.8 16.7 16.3 17.2 17.8 14.6 13.9 15.5 15.0 18.3 8.2 9.6 9.7 25.6 14.5 5.8 15.7 9.2 16.3 14.9 21.7 8.5 28.0 30.0 18.6 11.1 7.9 21.9 5.5 16.5 11.9 10.9 25.5 8.4 10.4 0.0 16.9 14.4 10.3 13.9 19.0 5.6 10.8 48.5 13.4 3.7 18.7 4.5 11.0 11.5 14.4 14.7 5.5 13.3 8.1 28.1 34.9 11.6 9.4 25.8 11.0 9.9 12.3 5.6 14.1 16.4 10.1 3.5 9.0 8.0 6.3 17.2 5.7 25.7 5.6 6.4 13.9 24.0 6.4 6.2 4.7 5.7 14.0 24.6 7.2 6.8 12.3 21.7 12.2 15.8 13.4 5.4 28.0 8.7 16.3 24.8 8.9 11.2 6.4 5.7 12.9 5.5 22.7 12.7 6.7 7.9 5.2 9.8 9.2 3.3 11.9 4.5 28.4 31.3 0.0 13.8 16.2 9.9 8.7 6.9 5.8 23.1 9.5 20.2 28.3 25.4 7.3 12.4 15.9 15.1 6.4 22.2 6.1 15.0 28.3 11.0 3.8 7.2 25.8 24.7 4.4 14.9 21.0 13.2 13.6 15.3 11.3 ARHGAP18 "bA307O14.2, MacGAP" ENSG00000146376 "Rho GTPase activating protein 18" Q8N392 6 129576132-129710225 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 362.7;granulocytes: 240.9;Syncytiotrophoblasts: 177.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 92.9;LHCN-M2: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031595 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA 840000 "Plasma membrane, Cytosol" "Nuclear speckles" "HPA031595: AB_10959905" "unprognostic (6.39e-2)" "unprognostic (1.60e-1)" "unprognostic (5.45e-2)" "unprognostic (5.49e-2)" "unprognostic (3.05e-1)" "unprognostic (3.17e-1)" "unprognostic (9.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.98e-2)" "unprognostic (3.12e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (4.08e-1)" "unprognostic (2.29e-3)" "unprognostic (2.22e-1)" "unprognostic (3.05e-2)" "unprognostic (5.52e-2)" "unprognostic (1.08e-1)" 23.8 32.2 4.1 14.1 4.0 1.7 19.7 2.5 2.4 9.6 19.5 2.9 12.0 13.3 7.8 25.8 5.8 15.7 11.8 16.9 4.4 6.8 33.2 4.5 38.8 15.5 4.1 1.4 8.0 38.2 10.6 22.0 16.7 12.2 9.6 8.2 10.4 16.7 24.2 12.1 5.4 40.6 6.5 9.0 15.8 15.1 10.9 3.8 5.1 12.7 12.1 6.4 10.3 5.8 2.9 11.8 13.0 5.9 2.5 5.8 6.0 1.9 4.3 0.4 0.6 4.2 6.0 3.5 14.6 11.2 6.5 4.3 2.2 3.2 1.6 7.2 9.8 2.0 2.5 3.1 4.8 12.1 1.5 1.3 10.4 3.4 12.8 6.0 1.5 92.9 3.8 0.7 11.7 10.5 13.6 18.4 0.0 5.5 4.0 26.1 0.5 0.0 1.5 0.4 3.6 1.0 0.0 2.0 3.0 19.8 1.1 0.0 0.0 1.2 2.0 7.2 2.2 2.2 1.8 14.0 6.8 0.9 0.5 11.7 1.8 1.3 1.0 2.3 2.8 9.4 8.9 5.2 13.0 5.3 5.9 3.3 2.9 2.8 5.8 4.8 1.7 0.5 2.9 4.0 2.5 3.1 11.8 2.7 6.0 4.1 4.0 2.5 2.4 4.4 6.8 4.1 1.4 12.2 3.8 53.6 36.1 12.9 16.2 11.6 0.0 3.1 15.3 362.7 50.0 36.6 2.0 73.2 127.6 38.7 17.9 35.4 23.6 0.0 105.3 16.5 19.2 20.3 240.9 4.4 101.2 0.0 12.6 11.6 45.7 13.8 3.4 131.1 6.8 18.0 19.9 14.3 82.5 24.6 1.1 20.3 0.6 25.8 11.9 3.4 1.2 11.3 177.5 25.4 28.3 15.9 ARHGAP22 RhoGAP2 ENSG00000128805 "Rho GTPase activating protein 22" Q7Z5H3 10 48446034-48656265 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 32.3" "Group enriched" "Detected in many" 5 "Early spermatids: 51.6;Late spermatids: 92.5;monocytes: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6" "Group enriched" "Detected in many" 29 "B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 28.1;LHCN-M2: 25.4;TIME: 26.9;U-87 MG: 33.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020696, HPA040391, HPA064439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266" "unprognostic (1.87e-1)" "unprognostic (3.98e-2)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.07e-1)" "unprognostic (6.74e-3)" "unprognostic (4.81e-3)" "unprognostic (2.78e-1)" "unprognostic (1.66e-1)" "unprognostic (3.03e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.16e-8)" "unprognostic (7.40e-2)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (3.66e-2)" 2.6 3.1 10.2 6.7 12.5 3.0 2.0 7.3 12.2 1.8 2.7 32.3 1.0 1.7 2.1 1.9 1.6 2.2 4.4 3.3 12.5 9.6 1.2 0.8 2.9 6.0 18.3 6.6 7.7 1.5 2.7 1.8 2.2 24.6 3.2 2.8 1.6 3.4 3.2 3.9 3.4 2.5 3.4 27.3 6.2 2.3 4.6 18.4 2.0 6.0 0.4 5.4 3.1 1.9 2.6 2.9 0.0 3.2 0.0 0.0 0.9 2.4 0.5 0.1 0.0 2.1 8.6 1.7 13.1 6.0 1.2 1.7 2.7 0.3 0.0 0.5 5.1 0.9 4.8 0.1 4.4 2.1 0.2 4.5 6.9 0.0 0.0 1.1 0.7 0.8 2.0 4.5 15.0 1.2 28.1 8.2 0.0 6.5 1.2 25.4 0.1 0.1 0.0 2.8 0.0 0.2 0.0 0.0 3.1 2.5 0.2 0.4 2.6 0.6 0.0 0.2 0.2 0.1 0.1 26.9 12.3 0.1 1.6 9.1 0.0 0.0 0.0 33.5 0.1 1.9 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 10.2 12.5 7.3 9.2 12.5 9.6 18.3 6.6 24.6 18.4 0.0 1.7 1.3 4.2 3.1 1.0 2.4 0.0 6.7 4.5 0.0 2.0 9.2 0.0 2.5 51.6 1.4 0.0 0.0 3.9 0.2 2.6 1.0 0.0 0.0 10.4 0.0 0.0 2.5 9.5 92.5 2.6 11.0 1.7 23.4 0.0 1.5 2.0 0.0 5.6 0.0 1.4 0.0 0.5 1.4 4.2 0.5 0.8 0.0 0.0 0.5 ARHGAP23 KIAA1501 ENSG00000275832 "Rho GTPase activating protein 23" Q9P227 17 38419280-38512392 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 56.6;Ito cells: 51.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 77.1;RT4: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019818, HPA047291" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA019818: AB_1844993, HPA047291: AB_2680012" "unprognostic (3.35e-1)" "unprognostic (5.11e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (6.87e-5)" "unprognostic (9.53e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (1.99e-1)" "unprognostic (5.56e-2)" "unprognostic (1.50e-3)" "prognostic unfavorable (3.24e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.38e-5)" "unprognostic (8.36e-2)" "unprognostic (5.83e-2)" "unprognostic (4.57e-2)" "unprognostic (2.25e-1)" 4.3 2.7 11.7 3.5 32.1 4.2 1.7 3.6 20.1 4.4 1.4 52.4 0.0 1.0 5.1 1.5 13.3 4.0 3.6 7.8 12.6 1.6 0.5 5.7 1.3 42.3 12.6 6.1 0.8 1.5 0.0 9.5 20.2 3.7 0.9 0.9 0.7 6.6 2.1 16.3 1.1 5.5 16.3 10.5 0.5 5.2 39.0 1.4 0.9 0.5 5.0 11.6 2.3 0.0 0.8 0.0 0.1 0.0 0.1 0.1 8.2 4.4 4.0 1.3 2.5 8.5 5.0 11.3 12.8 10.0 5.8 14.7 14.5 0.1 9.4 26.3 5.0 77.1 0.4 16.0 7.1 0.9 0.8 0.0 14.1 0.1 12.8 0.8 0.0 4.9 3.1 7.2 4.6 8.2 10.2 1.5 0.1 2.2 5.6 0.0 2.4 1.5 2.4 0.3 1.7 4.3 8.7 2.7 4.2 30.0 0.9 2.3 6.8 0.0 0.1 5.9 1.7 1.9 14.8 16.9 5.9 3.4 3.0 1.7 1.7 0.4 4.2 2.0 14.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 11.9 1.0 0.0 14.3 8.9 56.6 16.3 2.5 1.4 15.9 3.5 0.0 20.8 0.0 2.6 6.7 24.5 0.0 23.3 1.2 2.1 14.3 5.3 0.0 0.2 4.2 25.4 0.0 51.5 3.7 15.8 8.3 0.9 1.7 0.0 0.2 7.5 4.4 0.0 6.7 0.0 3.3 0.0 7.2 17.6 1.9 22.6 13.8 0.0 0.0 35.6 ARHGAP24 "DKFZP564B1162, FilGAP, FLJ33877" ENSG00000138639 "Rho GTPase activating protein 24" Q8N264 4 85475114-86002670 "Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 62.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 105.7;Distal tubular cells: 192.3;Proximal tubular cells: 165.1;Syncytiotrophoblasts: 194.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5" "Group enriched" "Detected in many" 4 "B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 36.4;ASC TERT1: 22.1;HHSteC: 21.3;HUVEC TERT2: 39.2;RPTEC TERT1: 22.0;TIME: 27.6;U-138 MG: 19.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014288 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014288: AB_1844994" "unprognostic (2.19e-1)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.95e-2)" "unprognostic (2.81e-1)" "unprognostic (9.22e-2)" "unprognostic (5.75e-3)" "unprognostic (4.28e-3)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (5.91e-2)" "unprognostic (6.45e-2)" "prognostic favorable (1.67e-11)" "unprognostic (1.75e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (8.75e-4)" 21.3 1.9 5.3 16.4 7.9 10.7 17.6 1.8 9.4 5.8 6.2 8.4 2.4 4.8 9.2 7.3 7.7 3.9 7.1 16.8 6.3 7.3 62.5 6.0 9.9 23.8 11.0 3.3 4.1 21.5 6.9 8.2 13.9 9.0 6.7 4.3 8.7 9.0 5.8 7.6 6.2 8.7 13.2 19.8 33.6 15.9 2.8 6.7 2.1 17.8 6.5 24.2 13.0 5.2 23.1 6.5 2.8 8.0 0.0 0.0 1.4 0.9 1.9 1.4 0.0 36.4 22.1 1.5 6.9 9.2 1.7 2.7 0.0 0.0 0.9 2.4 15.4 2.1 0.0 0.0 2.9 3.6 0.0 0.3 1.1 0.2 0.0 21.3 0.1 0.0 16.1 0.3 3.3 1.5 7.8 39.2 0.0 2.0 0.1 14.9 0.0 0.0 0.0 0.1 0.4 3.6 0.1 7.3 3.6 22.0 0.0 0.7 0.7 0.7 1.1 2.4 1.6 0.1 0.0 27.6 19.7 0.4 1.4 0.1 0.1 0.0 1.2 3.3 0.7 6.4 0.0 8.0 0.0 0.0 1.5 0.0 23.1 0.0 0.0 1.9 18.4 0.0 0.0 2.8 0.0 1.1 6.5 0.0 1.4 5.3 7.9 1.8 9.4 6.3 7.3 11.0 3.3 9.0 6.7 53.6 24.5 105.7 2.4 7.2 3.7 22.1 43.3 25.4 10.3 43.6 5.9 36.9 192.3 7.0 17.7 4.9 0.0 0.0 10.3 22.3 17.9 2.2 1.1 6.6 10.1 104.9 2.4 5.5 24.7 6.8 15.5 12.9 18.6 0.0 2.5 40.3 7.3 2.9 11.7 165.1 6.2 6.5 14.0 5.2 4.1 5.5 194.7 0.9 3.0 1.7 ARHGAP26 "GRAF, KIAA0621, OPHN1L, OPHN1L1" ENSG00000145819 "Rho GTPase activating protein 26" Q9UNA1 5 142770377-143229011 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "neutrophil: 19.6;NK-cell: 5.8" "Group enriched" "Detected in many" 4 "granulocytes: 19.6;NK-cells: 5.8" "Cell line enhanced" "Detected in many" "Karpas-707: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035106, HPA035107" Enhanced Approved Cytosol NA NA Cytosol "HPA035106: AB_2674465, HPA035107: AB_10669855" "prognostic favorable (2.05e-4)" "prognostic favorable (1.36e-4)" "prognostic favorable (6.95e-4)" "prognostic favorable (5.93e-6)" "unprognostic (1.19e-1)" "unprognostic (1.93e-2)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.22e-1)" "unprognostic (9.43e-3)" "unprognostic (7.19e-3)" "unprognostic (8.65e-2)" "unprognostic (3.21e-3)" "unprognostic (5.67e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-2)" "prognostic favorable (2.88e-6)" 13.3 5.7 18.4 18.6 22.7 33.9 13.0 29.2 23.9 15.9 14.2 7.5 9.9 13.2 9.4 10.9 7.6 18.5 16.4 17.0 12.8 10.5 8.0 7.7 20.0 8.8 12.9 15.4 4.8 5.5 4.8 15.1 22.4 11.9 8.5 14.8 8.8 14.6 11.2 14.0 8.5 12.6 11.1 12.6 18.9 17.0 16.1 12.2 10.3 10.0 5.4 13.6 9.4 10.6 0.3 2.0 19.6 2.8 5.8 3.0 1.0 6.9 14.0 3.9 3.6 5.8 6.4 6.0 0.8 1.2 3.4 5.9 19.1 15.8 1.0 6.9 2.2 10.3 3.3 1.9 6.6 4.2 14.3 2.2 0.0 1.8 12.1 3.7 10.2 1.4 2.3 11.6 6.2 14.3 2.7 5.0 4.8 0.2 39.7 1.0 1.1 5.8 4.2 1.8 10.3 3.6 2.2 5.8 16.6 9.9 10.7 1.5 2.4 1.8 1.9 3.2 3.1 1.0 3.1 9.6 1.8 2.6 0.2 3.6 1.8 5.7 0.2 4.8 9.7 2.5 2.9 2.8 1.6 3.0 1.7 1.3 0.2 0.6 1.8 2.0 0.3 0.2 0.8 19.6 5.8 1.0 0.5 0.2 1.0 18.4 22.7 29.2 23.9 12.8 10.5 12.9 15.4 11.9 12.2 14.9 22.7 2.9 13.9 6.2 9.5 33.7 25.5 12.0 12.5 0.0 7.9 1.1 0.0 15.6 62.7 31.7 30.5 0.0 18.9 0.7 11.6 26.2 25.5 4.3 21.6 71.5 3.5 30.1 49.8 105.1 6.1 31.8 10.1 6.4 26.2 6.3 16.0 21.5 13.4 4.4 54.5 45.3 12.7 1.9 11.3 4.8 1.6 22.7 21.7 31.9 ARHGAP27 "CAMGAP1, FLJ43547, SH3D20, SH3P20" ENSG00000159314 "Rho GTPase activating protein 27" Q6ZUM4 17 45393902-45434421 "Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 38.8" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 60.1;Paneth cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 12.4;HMC-1: 11.6;OE19: 14.6;RT4: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023919, HPA053053" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023919: AB_2059402, HPA053053: AB_2682027" "unprognostic (9.80e-2)" "unprognostic (1.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.89e-3)" "unprognostic (4.66e-1)" "unprognostic (2.69e-2)" "unprognostic (7.69e-2)" "unprognostic (6.89e-2)" "unprognostic (2.26e-1)" "unprognostic (2.33e-1)" "unprognostic (1.49e-2)" "unprognostic (1.96e-3)" "unprognostic (5.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "prognostic favorable (3.21e-4)" 6.0 3.1 4.9 21.9 8.7 15.0 5.5 5.2 6.3 9.3 23.1 6.4 2.7 14.9 3.2 7.8 35.0 4.5 17.4 7.0 7.5 3.2 11.0 2.4 10.5 24.1 8.2 2.4 2.4 3.5 4.3 4.0 9.7 7.5 6.1 13.0 3.8 13.6 9.1 2.6 11.6 38.8 3.8 10.2 28.6 8.8 2.9 8.0 29.4 6.3 5.8 34.1 8.0 15.0 4.1 7.8 10.4 11.2 1.9 3.1 3.5 4.3 4.3 0.1 1.3 0.6 0.3 12.4 0.0 0.2 0.3 0.1 3.8 8.7 4.0 8.5 0.3 1.9 2.8 0.5 0.8 0.2 8.0 2.7 0.2 1.6 2.4 0.1 0.0 11.6 0.6 3.5 0.0 1.3 0.4 2.6 4.3 1.0 7.2 0.3 3.0 3.7 1.3 0.2 14.6 3.6 3.1 0.2 1.3 2.8 18.8 0.6 0.4 0.5 3.7 0.2 1.5 2.9 7.3 4.1 0.0 1.1 0.0 0.4 9.0 5.8 0.8 0.2 1.1 0.0 1.0 4.7 4.2 2.8 9.3 1.8 4.1 1.7 3.1 4.5 3.4 1.4 1.4 10.4 1.9 11.2 7.8 2.3 3.5 4.9 8.7 5.2 6.3 7.5 3.2 8.2 2.4 7.5 8.0 6.0 19.1 20.6 15.4 9.2 2.6 9.8 17.8 2.7 7.9 17.4 3.9 6.4 3.3 4.9 0.8 20.2 60.1 0.0 3.0 8.9 2.5 21.5 4.6 1.5 13.3 1.6 18.4 16.5 38.7 0.9 0.3 16.4 6.8 1.0 29.2 1.2 11.8 59.6 0.0 5.0 1.4 0.0 3.1 2.3 1.9 7.5 11.8 14.9 32.0 47.8 ARHGAP29 PARG1 ENSG00000137962 "Rho GTPase activating protein 29" Q52LW3 1 94148988-94275068 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 271.0;Glandular cells: 419.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 38 "monocytes: 3.7" "Cell line enhanced" "Detected in many" "A-431: 48.5;hTERT-HME1: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026534 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Nucleoplasm, Centrosome" "Plasma membrane, Cytosol" "HPA026534: AB_1844998" "unprognostic (2.49e-1)" "unprognostic (1.52e-3)" "unprognostic (3.16e-2)" "prognostic unfavorable (6.26e-5)" "unprognostic (8.53e-2)" "unprognostic (2.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (4.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.81e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (4.61e-3)" 28.1 3.2 7.2 6.8 10.6 0.3 24.4 34.9 11.5 11.9 7.4 2.3 9.0 2.8 10.3 8.1 6.9 8.2 9.1 15.9 7.8 5.2 27.7 21.1 23.0 8.2 6.7 3.6 11.5 6.5 12.8 7.4 22.9 10.0 12.2 4.7 11.7 20.7 10.4 10.3 13.5 5.4 8.0 6.4 26.0 8.8 7.7 7.0 2.2 22.7 8.9 3.8 10.6 14.8 0.0 0.0 0.0 3.7 0.0 0.0 0.3 48.5 2.0 3.0 0.0 10.6 25.2 10.8 16.3 26.5 13.8 20.2 5.8 2.4 0.0 36.7 32.6 15.8 10.4 0.1 11.1 28.5 0.0 1.6 0.2 2.8 2.6 1.0 0.0 0.0 4.9 2.0 10.5 43.7 16.3 37.2 0.0 0.0 0.0 13.7 1.6 0.9 0.0 3.9 0.2 33.4 0.6 2.5 0.0 29.1 4.3 0.0 0.6 10.0 7.8 0.7 12.2 2.3 0.1 33.3 8.4 11.5 12.9 12.5 0.0 0.0 0.0 1.6 0.0 0.4 0.0 1.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 7.2 10.6 34.9 11.5 7.8 5.2 6.7 3.6 10.0 7.0 47.6 17.3 2.9 135.8 20.8 9.7 19.9 25.5 9.4 33.0 123.9 17.7 21.9 46.4 71.3 49.8 271.0 0.0 0.0 14.7 90.4 34.4 419.1 3.5 51.3 2.6 87.4 0.0 176.8 18.6 16.2 22.7 5.6 25.3 0.0 0.9 95.2 37.1 0.0 20.5 47.5 80.7 187.5 197.8 66.2 123.5 15.1 11.8 4.3 0.4 45.2 ARHGAP33 "FLJ39019, SNX26, TCGAP" ENSG00000004777 "Rho GTPase activating protein 33" O14559 19 35774532-35788822 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 23.6;Cone photoreceptor cells: 23.6;Horizontal cells: 19.1;Rod photoreceptor cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 33.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030117, HPA030118" Supported Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA030117: AB_10599306, HPA030118: AB_10601238" "unprognostic (1.44e-3)" "unprognostic (3.40e-2)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (2.66e-1)" "unprognostic (2.82e-3)" "unprognostic (3.61e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" "unprognostic (2.97e-3)" "unprognostic (2.40e-2)" "prognostic unfavorable (3.09e-8)" "unprognostic (5.70e-2)" "unprognostic (2.66e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-2)" 4.8 7.6 17.2 6.6 21.9 27.8 4.0 18.1 27.1 6.0 3.8 22.0 2.8 6.8 8.4 2.9 3.6 6.1 4.9 4.5 14.9 11.7 3.8 2.0 4.7 8.7 18.4 13.8 11.8 7.3 6.2 13.2 3.3 12.7 5.8 2.9 6.8 8.9 6.2 4.7 12.9 6.0 4.0 15.4 7.8 7.2 18.2 17.9 12.2 6.8 2.3 4.2 3.1 5.3 0.1 0.0 0.7 0.0 0.0 0.4 0.0 4.9 3.1 8.9 6.7 0.3 0.9 0.7 4.0 0.5 1.5 1.1 1.3 3.7 2.9 1.5 1.1 1.3 1.3 1.1 1.1 0.6 9.0 2.0 4.2 4.1 1.2 0.4 1.5 33.6 1.3 0.2 1.2 0.4 1.3 0.9 11.6 2.0 12.7 1.3 3.8 10.2 4.1 2.0 1.8 1.4 14.0 1.4 1.4 0.7 0.8 8.9 5.5 1.8 3.3 0.6 1.2 4.7 4.1 1.7 6.4 6.3 3.3 4.7 11.3 2.1 2.9 2.3 4.9 4.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 17.2 21.9 18.1 27.1 14.9 11.7 18.4 13.8 12.7 17.9 0.0 0.6 0.0 0.8 1.4 23.6 1.7 5.1 4.0 4.5 1.8 23.6 0.3 0.0 0.4 8.0 0.8 0.3 0.0 0.6 1.0 1.4 0.6 4.7 0.8 1.0 19.1 3.4 0.0 0.3 6.3 3.7 0.0 0.0 0.0 1.7 10.1 0.6 0.0 2.8 0.0 29.9 0.0 2.3 11.6 5.6 1.5 0.3 4.8 2.5 0.3 ARHGAP39 "CrGAP, KIAA1688, Vilse" ENSG00000147799 "Rho GTPase activating protein 39" Q9C0H5 8 144529179-144605816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.8" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 20.1;Cone photoreceptor cells: 19.6;Rod photoreceptor cells: 23.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044491 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Nucleoplasm, Microtubules, Cytokinetic bridge" "HPA044491: AB_10794775" "unprognostic (3.42e-2)" "unprognostic (2.65e-2)" "unprognostic (9.85e-2)" "unprognostic (4.17e-1)" "unprognostic (1.53e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-7)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (2.02e-1)" "unprognostic (6.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (9.97e-2)" 1.1 1.9 3.6 1.0 3.5 0.0 1.2 6.2 7.0 2.0 2.0 2.4 1.7 1.2 1.4 7.0 0.9 0.4 5.3 4.4 1.8 0.2 1.5 0.3 3.3 0.9 2.9 2.0 4.0 0.9 2.1 0.9 3.5 2.3 0.6 2.6 2.4 0.6 7.2 0.9 1.2 12.8 2.8 0.1 0.5 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 7.6 7.6 3.6 5.6 0.7 0.6 7.0 2.0 0.6 2.5 1.6 4.9 4.5 0.8 5.2 0.8 2.6 6.5 1.8 1.9 0.5 0.0 6.8 0.1 5.0 3.1 1.2 0.0 0.8 0.5 3.1 3.2 1.3 1.3 0.8 0.3 7.0 0.0 1.0 12.4 4.2 0.0 3.8 3.1 10.9 3.9 2.9 2.9 2.0 3.9 10.5 7.4 5.8 2.0 3.4 1.4 8.6 1.1 1.9 1.9 0.1 6.3 4.1 0.0 0.1 0.3 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.9 0.0 0.5 3.3 7.1 1.6 0.0 20.1 3.4 3.5 19.6 0.4 0.0 2.2 2.1 0.7 3.9 0.0 2.1 0.7 1.3 1.1 0.0 1.3 0.4 3.2 0.0 1.3 0.0 2.5 2.0 0.0 5.0 0.0 3.6 3.5 1.1 8.6 7.8 1.4 23.7 6.5 1.5 8.1 7.7 2.6 0.5 0.0 4.3 0.6 ARHGAP40 "C20orf95, dJ1100H13.4" ENSG00000124143 "Rho GTPase activating protein 40" Q5TG30 20 38601934-38651035 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 18.6;epididymis: 38.0;skin 1: 26.7" "Cell type enhanced" "Detected in some" 12 "Collecting duct cells: 3.5;Early spermatids: 3.2;Late spermatids: 2.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.7;HBEC3-KT: 12.2;RPTEC TERT1: 10.8;SK-BR-3: 11.6;T-47d: 14.0" "Not detected" "Not detected" "HPA042636, HPA042840" Uncertain Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" No NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA042636: AB_10962149, HPA042840: AB_10963929" "unprognostic (9.89e-3)" "unprognostic (2.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-3)" "unprognostic (1.69e-1)" "unprognostic (3.09e-2)" "unprognostic (4.35e-2)" "unprognostic (5.63e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (2.89e-4)" "unprognostic (2.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.54e-1)" 0.3 0.0 0.3 0.3 0.3 0.0 18.6 0.3 0.5 1.6 0.3 0.4 5.2 0.8 0.6 38.0 15.8 0.0 0.9 0.3 0.3 0.1 4.1 0.3 1.8 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 3.0 0.0 0.3 1.9 5.1 0.3 26.7 0.3 0.7 0.3 0.3 2.6 1.2 0.6 0.3 0.3 5.2 6.6 3.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.1 0.1 0.8 0.0 3.4 0.0 0.0 0.0 0.0 12.2 0.2 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 11.6 0.0 1.5 14.0 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.3 0.3 0.6 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 3.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.2 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" "A6NI28, Q9H2Q1" 11 100687653-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 38.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Early spermatids: 72.6;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.1;RH-30: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: AB_2684308" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 11.1 4.9 6.8 8.9 5.8 0.9 10.4 3.0 7.0 9.8 8.3 4.1 2.3 9.9 11.4 7.7 4.3 5.6 9.5 6.5 8.8 3.8 11.9 12.7 13.7 5.1 6.3 5.3 4.8 2.6 9.1 6.0 38.0 5.9 4.8 8.4 25.5 5.1 3.8 9.0 7.2 12.1 5.8 8.7 8.2 11.7 4.1 6.7 12.7 10.9 7.4 3.8 5.5 7.9 1.5 2.5 0.0 0.0 0.7 0.4 0.3 0.5 3.6 4.6 0.1 2.6 3.5 3.2 0.6 0.9 1.1 2.1 4.4 23.1 0.7 6.5 1.7 4.1 7.8 2.3 1.7 1.1 0.0 2.0 11.2 9.1 1.5 4.6 0.1 0.0 3.3 2.2 4.3 0.7 2.6 1.7 2.8 0.4 0.0 3.5 0.6 1.2 0.0 5.6 6.4 5.7 3.4 16.0 0.4 5.4 15.0 2.5 1.6 7.7 0.3 6.1 10.0 0.8 1.4 3.0 3.0 3.7 3.6 1.7 3.3 0.0 4.5 3.5 2.7 13.1 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.3 6.8 5.8 3.0 7.0 8.8 3.8 6.3 5.3 5.9 6.7 44.7 4.0 5.1 4.8 2.2 2.6 4.2 10.2 16.0 21.6 3.5 23.6 0.6 1.7 4.1 72.6 2.9 10.0 23.3 3.3 1.8 4.5 10.0 0.0 5.9 1.3 1.6 1.7 9.2 0.3 27.0 1.1 2.2 10.1 0.0 2.8 31.8 6.5 5.7 2.5 15.8 60.0 38.8 12.3 1.9 1.6 3.0 5.4 0.0 2.4 17.3 ARHGAP5 "GFI2, p190-B, p190BRhoGAP, RhoGAP5" ENSG00000100852 "Rho GTPase activating protein 5" Q13017 14 32076114-32159728 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 267.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046993, HPA056507" Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA046993: AB_2679895, HPA056507: AB_2683158" "unprognostic (1.79e-1)" "unprognostic (2.03e-1)" "unprognostic (2.66e-3)" "unprognostic (6.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (1.55e-2)" "unprognostic (6.23e-2)" "unprognostic (2.88e-1)" "unprognostic (2.18e-1)" "unprognostic (1.28e-2)" "unprognostic (6.63e-2)" "prognostic favorable (3.97e-8)" "unprognostic (9.79e-2)" "unprognostic (2.21e-1)" "unprognostic (2.13e-1)" "unprognostic (1.00e-2)" 11.3 13.1 29.8 8.4 26.1 4.0 13.0 39.1 29.2 14.2 14.6 11.5 7.9 16.0 13.2 11.9 31.5 11.1 15.3 28.0 29.5 19.6 20.8 14.5 12.8 5.9 26.8 23.4 23.3 13.5 21.8 27.6 16.9 24.2 14.7 12.3 9.2 26.0 14.5 11.5 14.0 17.3 13.4 26.6 18.7 13.3 20.4 30.6 8.8 32.5 7.7 8.0 15.6 25.8 7.3 9.0 1.5 1.8 6.8 7.4 2.3 19.0 15.5 15.5 22.7 20.4 14.3 8.9 11.9 14.7 7.2 10.9 19.7 18.7 5.6 10.6 15.0 12.2 20.3 14.7 12.8 14.2 5.6 8.6 8.5 9.6 28.8 13.9 5.1 5.1 15.9 26.0 6.8 25.5 17.9 8.8 10.7 7.5 16.8 11.7 10.0 11.2 0.2 7.7 21.2 18.7 12.2 19.0 1.1 15.9 50.9 24.0 9.4 31.9 17.2 24.1 18.0 17.8 0.3 14.2 13.4 20.3 11.1 8.7 6.4 12.5 0.8 6.8 5.5 36.6 1.5 1.8 0.0 4.0 0.8 4.8 7.3 7.0 3.7 6.1 7.1 7.4 4.3 0.6 6.8 1.3 9.0 5.7 2.3 29.8 26.1 39.1 29.2 29.5 19.6 26.8 23.4 24.2 30.6 178.6 60.0 8.7 112.0 83.7 78.5 267.9 53.5 62.9 76.2 55.8 108.0 20.8 46.4 45.5 30.6 29.2 76.6 46.7 40.4 10.4 47.7 94.2 4.7 45.6 15.8 62.0 59.4 36.8 15.2 47.7 96.7 33.3 64.1 19.8 49.4 93.1 55.1 77.2 94.4 48.0 87.6 58.2 56.6 94.1 58.3 61.5 11.2 20.3 44.5 133.8 ARHGAP6 rhoGAPX-1 ENSG00000047648 "Rho GTPase activating protein 6" O43182 X 11137543-11665701 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 57.3;seminal vesicle: 58.8" "Cell type enhanced" "Detected in many" 10 "Glandular cells: 77.5;granulocytes: 39.3;Sertoli cells: 45.3;Smooth muscle cells: 47.5" "Cancer enhanced" "Detected in many" "prostate cancer: 12.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 15.1;ASC TERT1: 19.6;HEL: 19.3;HMC-1: 13.6;HSkMC: 19.3;K-562: 14.0;RT4: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001798, HPA036779, HPA064390" Enhanced Supported Cytosol "Intracellular and membrane" NA NA 920000 Cytosol "HPA001798: , HPA036779: AB_10672229, HPA064390: AB_2685253" "unprognostic (2.36e-1)" "unprognostic (1.68e-2)" "unprognostic (3.49e-2)" "unprognostic (7.31e-2)" "unprognostic (6.34e-2)" "unprognostic (1.69e-2)" "unprognostic (4.70e-2)" "unprognostic (2.79e-1)" "unprognostic (1.70e-1)" "unprognostic (7.46e-4)" "unprognostic (1.53e-1)" "unprognostic (1.59e-1)" "prognostic favorable (1.55e-8)" "unprognostic (1.60e-2)" "unprognostic (5.96e-2)" "unprognostic (1.28e-2)" "unprognostic (7.99e-4)" 9.4 1.2 16.7 2.6 10.0 0.7 6.3 0.6 2.9 9.5 11.7 4.1 57.3 2.0 10.2 9.0 4.1 7.6 5.4 3.6 5.6 4.3 6.0 1.1 8.7 1.2 2.3 3.6 15.1 1.9 1.1 6.6 6.2 2.7 24.8 3.7 3.2 2.5 58.8 8.0 2.3 4.2 12.1 3.1 5.0 4.1 2.2 3.3 0.0 25.9 3.1 1.4 14.3 8.0 1.3 0.2 1.0 0.9 0.0 0.1 2.7 0.0 0.0 1.3 0.0 15.1 19.6 0.3 0.1 0.3 0.8 0.5 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.5 0.0 0.7 0.0 0.2 19.3 0.0 0.0 5.5 0.0 13.6 19.3 0.0 1.4 0.0 1.7 0.3 0.0 14.0 6.5 0.8 0.0 0.0 0.0 0.3 0.1 0.2 0.0 6.4 8.1 4.6 11.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.8 0.3 3.9 0.1 0.3 0.0 0.0 0.1 0.0 2.1 1.0 0.3 0.5 0.0 0.9 0.0 1.3 0.0 0.1 0.2 0.4 0.0 0.0 1.0 0.0 0.7 0.2 0.0 2.7 16.7 10.0 0.6 2.9 5.6 4.3 2.3 3.6 2.7 3.3 0.0 1.7 0.5 15.5 1.8 1.0 2.5 0.0 9.4 4.5 31.4 0.0 0.3 21.6 0.0 0.1 5.5 0.0 0.0 0.9 0.7 8.2 77.5 39.3 0.0 3.8 0.0 1.2 9.8 3.2 0.4 15.0 12.3 5.0 3.6 0.2 5.7 0.5 0.0 9.6 6.1 0.3 45.3 47.5 0.2 0.4 1.5 0.0 0.0 0.0 16.6 ARHGDIA "GDIA1, RHOGDI" ENSG00000141522 "Rho GDP dissociation inhibitor alpha" P52565 17 81867721-81871406 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010005, HPA021407" Approved Supported Cytosol NA NA 49000000 Cytosol "CAB010005: AB_2227516, HPA021407: AB_1856267" "unprognostic (1.08e-1)" "unprognostic (2.29e-2)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" "unprognostic (5.00e-2)" "unprognostic (8.39e-3)" "unprognostic (1.39e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (5.32e-2)" "unprognostic (4.67e-2)" "unprognostic (2.67e-2)" "unprognostic (6.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-1)" "unprognostic (3.29e-1)" "unprognostic (6.88e-3)" 67.9 52.5 43.8 71.8 59.5 91.1 57.2 20.4 65.7 41.2 55.4 44.6 29.7 85.9 50.0 34.1 55.0 40.9 46.2 36.7 41.5 44.6 50.9 64.9 56.0 68.2 39.9 43.4 49.7 65.9 30.6 42.9 52.8 39.0 44.1 27.2 39.9 52.7 43.2 36.7 41.0 88.8 35.7 41.7 57.1 68.4 26.3 35.4 67.1 41.2 41.4 49.9 42.2 44.8 17.0 24.0 35.0 41.0 18.4 29.9 22.8 65.1 64.3 20.9 33.5 19.4 24.4 23.9 56.0 36.1 42.1 31.4 31.5 24.8 34.5 24.0 42.3 36.8 35.9 23.1 42.2 17.8 26.8 59.2 36.4 38.4 41.0 39.5 57.3 53.5 30.8 19.6 30.5 26.6 21.5 64.0 29.5 30.0 48.6 33.8 39.2 83.2 58.4 24.9 21.8 56.9 38.1 26.8 27.5 27.6 40.3 27.9 82.0 29.4 75.9 52.5 16.0 35.6 47.2 70.5 84.1 71.9 77.6 95.1 42.8 22.3 35.6 73.0 34.6 57.0 15.7 20.5 35.0 29.9 31.3 28.5 17.0 25.0 28.5 21.2 13.2 16.8 19.7 13.3 18.4 41.0 24.0 23.9 22.8 43.8 59.5 20.4 65.7 41.5 44.6 39.9 43.4 39.0 35.4 35.7 65.2 154.6 166.1 113.0 16.9 3.4 50.9 29.4 47.8 75.0 9.8 118.2 114.4 225.7 4.6 94.6 257.9 0.0 230.6 215.0 113.6 128.9 116.5 75.0 216.3 49.3 129.2 117.2 156.8 12.5 80.3 143.8 183.9 315.6 139.3 79.0 299.1 224.5 69.6 115.6 10.8 116.4 103.8 37.1 37.5 101.5 185.6 157.4 104.4 180.7 ARHGDIB "GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2" ENSG00000111348 "Rho GDP dissociation inhibitor beta" P52566 12 14942017-14961728 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "blood: 333.1;bone marrow: 150.7;lymphoid tissue: 221.4" "Cell type enhanced" "Detected in many" 7 "granulocytes: 669.1;Hofbauer cells: 807.6;Kupffer cells: 661.4;Macrophages: 633.0;T-cells: 892.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 102.5;HL-60: 119.9;HMC-1: 135.8;JURKAT: 91.1;MOLT-4: 141.9;REH: 119.4;U-698: 109.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018584, HPA051235" Enhanced Supported Cytosol NA NA 120000000 Cytosol "CAB018584: AB_647972, HPA051235: AB_2681398" "unprognostic (2.29e-3)" "unprognostic (8.10e-2)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (9.16e-2)" "unprognostic (1.90e-2)" "unprognostic (2.44e-1)" "unprognostic (1.47e-2)" "unprognostic (3.46e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (4.42e-3)" "unprognostic (4.97e-2)" "prognostic favorable (3.42e-4)" 40.3 13.4 9.0 66.1 18.4 150.7 27.9 1.8 8.9 14.6 14.5 13.9 3.6 8.5 14.7 13.2 16.9 18.2 18.3 20.5 8.3 7.8 24.5 20.0 41.3 93.9 17.0 3.9 11.7 7.1 3.9 8.1 35.6 11.4 18.0 16.1 20.4 22.4 7.6 13.3 14.7 38.3 15.7 17.9 157.8 11.1 11.2 15.8 221.4 22.7 12.4 108.1 31.2 13.5 114.0 95.5 267.1 151.9 96.3 231.1 333.1 9.4 0.3 0.3 21.0 1.4 1.1 0.1 0.3 0.1 0.1 0.1 1.2 10.4 76.0 4.9 1.7 0.1 10.4 0.0 16.8 1.1 0.1 0.0 102.5 0.2 0.0 0.3 119.9 135.8 0.1 2.1 0.0 1.5 0.3 59.0 91.1 0.5 29.2 1.8 0.0 141.9 86.3 0.4 0.2 0.1 119.4 1.3 34.0 3.3 52.6 0.1 0.0 0.1 13.6 0.1 0.9 0.7 87.3 74.7 0.3 0.7 0.1 2.2 4.8 0.7 109.8 0.3 84.1 0.1 206.0 109.9 267.1 125.6 130.8 123.3 114.0 144.4 140.7 95.5 103.2 141.1 146.5 237.7 96.3 151.9 41.4 231.1 333.1 9.0 18.4 1.8 8.9 8.3 7.8 17.0 3.9 11.4 15.8 56.6 190.4 437.8 45.8 60.7 0.3 8.1 15.3 38.8 80.8 55.8 0.0 51.5 14.9 20.5 1.2 156.9 3.8 23.3 303.9 465.0 49.8 3.3 669.1 4.7 807.6 0.0 1.2 329.0 661.4 2.0 49.5 633.0 86.0 32.5 2.2 1.9 43.8 20.4 55.2 6.1 1.0 239.3 61.4 0.7 1.5 49.1 56.9 892.2 5.7 85.5 ARHGDIG RHOGDI-3 ENSG00000242173 "Rho GDP dissociation inhibitor gamma" Q99819 16 268727-283010 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 60.4;intestine: 31.7;pancreas: 45.3" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 3.3;Exocrine glandular cells: 9.9;Pancreatic endocrine cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.2;HEK 293: 18.8;MCF7: 24.2;SCLC-21H: 8.5;SH-SY5Y: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078260 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA078260: AB_2732375" "unprognostic (1.11e-2)" "unprognostic (5.69e-2)" "unprognostic (7.98e-2)" "unprognostic (2.66e-2)" "unprognostic (9.04e-2)" "unprognostic (2.13e-2)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.44e-2)" "unprognostic (3.18e-1)" "unprognostic (2.94e-1)" "unprognostic (5.86e-6)" "unprognostic (2.81e-2)" "unprognostic (4.34e-1)" "unprognostic (2.15e-1)" "unprognostic (6.32e-2)" 3.7 3.1 37.3 1.8 15.6 1.0 1.1 43.3 60.4 1.0 1.8 3.7 0.0 31.7 1.1 2.3 1.1 1.0 0.9 3.6 29.0 27.4 1.0 0.9 1.0 1.0 21.2 21.4 1.0 45.3 0.9 1.7 2.4 12.7 1.1 1.2 0.6 1.3 1.3 2.0 0.9 12.0 1.3 8.6 1.0 9.3 2.0 2.0 0.0 0.9 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 2.0 0.0 0.6 0.1 0.3 0.0 0.3 0.0 0.3 0.1 0.0 0.7 0.4 0.0 0.1 5.2 0.0 0.0 0.0 18.8 0.0 0.3 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.2 0.0 1.2 0.2 0.0 24.2 0.0 0.3 2.6 1.3 0.0 0.0 0.0 0.4 0.0 0.0 8.5 10.5 0.1 0.1 0.0 0.3 1.8 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 37.3 15.6 43.3 43.8 29.0 27.4 21.2 21.4 12.7 2.0 0.0 0.0 0.0 0.0 0.3 3.3 0.8 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.4 0.0 1.3 0.0 9.9 0.2 0.4 0.0 0.0 0.0 0.4 0.0 1.2 1.3 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.9 6.4 0.3 0.0 0.0 2.7 0.0 0.2 0.2 2.5 0.0 0.3 0.0 0.9 0.0 ARHGEF1 "LBCL2, P115-RHOGEF, SUB1.5" ENSG00000076928 "Rho guanine nucleotide exchange factor 1" Q92888 19 41883161-41930150 "Plasma proteins, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 61.0" "Cell type enhanced" "Detected in many" 8 "T-cells: 145.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009502, HPA012924, HPA060784" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363" "prognostic favorable (5.92e-4)" "unprognostic (2.09e-1)" "unprognostic (8.29e-3)" "unprognostic (8.10e-3)" "unprognostic (7.63e-2)" "unprognostic (7.59e-3)" "unprognostic (4.99e-2)" "unprognostic (7.28e-2)" "unprognostic (5.88e-2)" "unprognostic (1.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.29e-3)" "prognostic unfavorable (3.36e-8)" "unprognostic (3.54e-1)" "unprognostic (1.95e-1)" "unprognostic (8.00e-2)" "unprognostic (4.65e-2)" 15.5 8.4 10.7 40.1 16.5 50.0 13.8 8.7 13.8 11.7 14.1 23.3 9.7 13.7 12.7 9.6 12.2 13.0 14.1 9.3 10.6 6.2 12.4 10.4 23.7 57.8 18.1 8.5 12.5 10.8 7.0 11.8 9.6 11.8 11.4 5.8 12.1 13.1 9.2 5.2 12.9 29.3 9.0 12.2 61.0 17.0 3.7 15.6 43.6 13.4 8.6 40.8 12.4 11.7 11.1 10.8 13.7 26.9 15.4 26.3 14.3 20.0 24.4 5.6 7.0 8.0 8.4 6.6 10.6 16.3 13.5 11.9 7.4 17.3 26.9 19.6 9.7 7.1 11.8 7.2 16.4 4.3 25.2 8.3 21.7 10.5 9.7 11.7 23.1 35.9 10.2 10.9 13.0 8.5 7.2 12.8 24.0 8.5 16.6 7.7 13.8 16.2 18.0 6.4 16.0 19.0 24.5 10.5 15.9 8.3 11.1 3.7 15.7 14.8 6.6 12.1 3.0 7.8 39.6 17.3 17.9 12.1 9.5 16.4 22.6 14.3 23.2 14.6 36.9 28.3 5.1 9.4 13.7 25.1 19.8 20.3 10.8 19.1 26.3 10.8 11.1 20.0 20.4 13.7 15.4 26.9 5.8 19.4 14.3 10.7 16.5 8.7 13.8 10.6 6.2 18.1 8.5 11.8 15.6 6.0 19.5 51.4 11.9 12.9 17.4 2.8 7.6 1.4 2.3 7.0 25.5 11.4 3.3 21.3 1.1 20.3 9.5 0.0 21.5 19.5 14.6 12.3 31.1 9.5 33.0 11.1 20.8 18.4 49.7 0.0 17.8 29.5 18.6 25.2 27.7 10.8 38.4 20.1 15.6 5.8 20.1 25.8 9.8 4.8 8.6 12.9 8.5 145.4 26.3 10.1 ARHGEF10L "FLJ10521, KIAA1626" ENSG00000074964 "Rho guanine nucleotide exchange factor 10 like" Q9HCE6 1 17539835-17697874 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 50.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 40 "classical monocyte: 13.1;intermediate monocyte: 13.0;myeloid DC: 9.7;non-classical monocyte: 3.3" "Group enriched" "Detected in many" 46 "dendritic cells: 9.7;monocytes: 13.1" "Cell line enhanced" "Detected in many" "Hep G2: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026426, HPA026440, HPA028115" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles, Cytosol" "HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285" "unprognostic (4.34e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-2)" "unprognostic (2.59e-1)" "unprognostic (1.03e-1)" "prognostic favorable (8.13e-5)" "unprognostic (3.61e-2)" "unprognostic (7.90e-2)" "unprognostic (2.10e-2)" "unprognostic (1.75e-3)" "unprognostic (1.94e-3)" "unprognostic (5.83e-2)" "prognostic favorable (5.65e-4)" "unprognostic (4.11e-2)" "unprognostic (1.66e-1)" "unprognostic (8.17e-2)" "unprognostic (5.21e-3)" 9.5 6.1 6.2 6.1 6.2 0.7 7.8 31.7 7.5 8.5 13.4 7.1 9.9 9.0 7.7 11.2 14.4 6.4 11.7 16.0 5.7 6.1 16.4 50.7 7.8 2.2 6.3 3.8 5.3 30.2 8.1 2.7 3.3 9.1 6.6 7.4 9.6 13.2 12.3 33.4 13.4 9.7 10.5 5.9 5.4 6.5 3.9 5.9 0.4 10.4 7.4 2.9 9.6 11.9 0.0 9.7 0.2 13.1 0.0 0.0 4.5 5.3 6.1 7.8 2.7 13.3 4.5 5.2 3.6 7.2 4.4 3.7 6.3 16.1 0.0 6.9 6.8 6.1 4.1 1.1 1.9 0.9 0.1 2.0 0.0 6.2 17.7 3.0 0.0 0.0 6.0 3.8 2.7 0.7 8.8 0.8 0.0 0.0 0.1 12.1 5.0 0.0 0.1 3.4 8.1 0.0 0.0 3.1 1.9 9.3 11.1 11.4 8.4 2.8 2.0 8.3 2.3 7.6 6.4 0.0 3.8 4.6 4.5 1.5 0.0 1.6 0.0 5.9 0.1 2.0 0.0 13.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.0 4.5 6.2 6.2 31.7 7.5 5.7 6.1 6.3 3.8 9.1 5.9 3.0 6.1 0.5 4.6 5.0 12.7 31.1 20.4 1.4 9.1 29.6 2.0 0.4 8.3 12.1 8.9 2.7 18.6 0.0 17.5 0.4 6.2 5.5 0.0 35.4 22.2 9.5 36.2 3.1 5.1 6.9 4.6 15.0 3.3 2.8 41.8 12.8 12.3 21.0 6.3 15.5 5.3 12.9 11.4 2.1 1.5 7.5 0.8 0.0 41.6 8.8 ARHGEF12 "KIAA0382, LARG" ENSG00000196914 "Rho guanine nucleotide exchange factor 12" Q9NZN5 11 120336914-120489936 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.2;NK-cells: 1.5;T-cells: 1.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018911, CAB025581" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB025581: , HPA018911: AB_1845003" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (6.91e-3)" "unprognostic (1.28e-1)" "unprognostic (7.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.56e-1)" "unprognostic (5.55e-2)" "unprognostic (4.79e-2)" "unprognostic (7.77e-2)" "unprognostic (4.34e-3)" "unprognostic (4.78e-2)" "prognostic favorable (5.43e-6)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" 17.6 19.2 27.6 8.3 32.5 5.9 19.6 40.4 41.5 21.7 16.4 12.4 15.7 14.9 17.5 15.9 17.8 18.6 17.3 23.4 21.8 17.7 41.2 38.8 24.1 6.5 15.8 26.3 16.3 16.9 55.8 17.2 25.4 21.1 16.8 17.8 20.7 16.7 20.0 24.1 29.0 14.8 18.6 10.8 12.4 19.0 6.7 13.0 3.0 31.3 15.0 10.9 19.4 22.9 0.3 0.3 2.2 0.1 1.5 1.0 0.4 13.2 11.1 14.9 14.3 20.2 20.2 6.2 15.6 17.7 9.5 12.1 13.0 9.7 1.1 19.2 27.8 16.8 9.9 19.1 19.7 18.6 10.9 9.4 21.5 12.0 9.9 18.1 0.0 16.0 19.3 14.3 20.8 23.2 21.0 28.7 11.7 18.1 44.1 23.9 9.2 0.0 0.0 4.1 17.1 9.6 4.7 17.1 4.2 23.3 23.0 11.0 13.6 21.8 18.3 5.7 9.3 15.6 1.7 28.4 21.1 9.0 13.7 11.3 13.0 5.2 7.3 8.7 2.8 15.9 2.2 0.0 0.0 1.0 0.1 0.2 0.3 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.5 0.1 0.3 0.7 0.4 27.6 32.5 40.4 41.5 21.8 17.7 15.8 26.3 21.1 13.0 68.5 79.7 12.3 48.8 80.4 124.2 79.1 58.6 52.2 67.1 92.5 174.7 13.7 29.9 34.0 5.0 74.1 47.9 23.3 43.8 8.3 45.2 80.8 10.5 105.8 6.1 85.8 36.4 81.0 27.2 11.5 27.6 17.4 49.0 10.8 44.1 42.4 44.6 49.0 31.5 60.7 84.8 25.8 70.9 13.5 11.9 74.4 24.0 17.5 34.8 95.3 ARHGEF17 "KIAA0337, p164-RhoGEF, TEM4" ENSG00000110237 "Rho guanine nucleotide exchange factor 17" Q96PE2 11 73308289-73369388 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Sertoli cells: 84.1;Smooth muscle cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "myeloid DC: 1.0;plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007991 Uncertain Approved Cytosol NA NA Cytosol "HPA007991: AB_1845005" "unprognostic (2.36e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (8.27e-5)" "unprognostic (6.96e-2)" "unprognostic (1.57e-1)" "unprognostic (1.39e-1)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (1.69e-1)" "unprognostic (1.46e-3)" "unprognostic (1.15e-2)" "unprognostic (2.39e-1)" "unprognostic (1.47e-1)" "unprognostic (7.54e-3)" "unprognostic (7.12e-3)" "unprognostic (6.85e-3)" "unprognostic (3.42e-3)" 16.7 10.0 18.1 7.0 43.0 2.5 11.1 31.8 35.1 17.1 16.7 9.5 3.5 4.3 20.4 12.6 8.3 14.3 13.9 21.0 13.7 11.4 12.9 2.6 14.8 4.1 8.5 23.1 15.5 5.6 24.7 7.8 18.5 19.6 13.6 4.5 11.4 6.9 23.3 7.3 4.7 7.5 17.9 6.9 7.6 10.5 4.8 13.5 0.8 18.1 3.3 2.2 11.7 10.1 0.0 1.5 0.2 0.2 0.0 0.2 0.0 4.7 5.6 12.2 14.2 9.6 8.2 7.5 13.3 19.4 13.5 8.5 15.3 4.1 0.0 9.5 24.7 6.1 7.5 4.0 5.3 5.5 8.4 1.2 0.0 9.1 5.7 11.1 0.3 0.2 14.1 6.2 7.9 4.7 8.6 10.0 0.6 0.4 0.1 7.3 6.6 0.1 8.3 1.6 3.1 1.2 2.0 14.1 0.3 8.3 3.3 7.9 6.1 11.3 13.3 15.5 11.7 22.6 3.9 6.4 6.5 13.6 2.7 4.2 0.8 0.1 0.0 2.2 0.9 9.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 18.1 43.0 31.8 35.1 13.7 11.4 8.5 23.1 19.6 13.5 14.9 12.3 0.0 1.9 3.1 7.1 21.0 7.6 4.0 9.1 7.0 0.0 6.1 0.0 5.6 1.0 6.3 0.0 0.0 0.6 3.9 12.2 2.5 0.0 0.4 1.9 22.3 1.2 12.3 0.0 1.1 10.0 2.3 1.7 1.8 0.3 10.4 1.6 0.0 19.1 3.1 1.3 84.1 53.6 1.8 9.4 2.4 5.1 0.0 0.8 1.4 ARHGEF18 "KIAA0521, MGC15913, P114-RhoGEF" ENSG00000104880 "Rho/Rac guanine nucleotide exchange factor 18" Q6ZSZ5 19 7395113-7472477 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Basal keratinocytes: 2.6;Cone photoreceptor cells: 3.9;Intestinal endocrine cells: 1.7;Melanocytes: 1.7;Smooth muscle cells: 1.7;Suprabasal keratinocytes: 3.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042689, HPA071867" Approved Enhanced Cytosol NA NA Cytosol "HPA042689: AB_10794385, HPA071867: AB_2686466" "unprognostic (2.55e-1)" "unprognostic (1.31e-2)" "unprognostic (1.57e-1)" "unprognostic (6.01e-2)" "unprognostic (1.65e-2)" "prognostic favorable (4.21e-4)" "unprognostic (1.13e-1)" "unprognostic (1.52e-3)" "unprognostic (3.56e-1)" "unprognostic (2.36e-1)" "unprognostic (1.40e-1)" "unprognostic (8.26e-2)" "prognostic favorable (3.11e-5)" "unprognostic (1.08e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (3.79e-3)" 8.7 13.3 12.3 16.7 15.0 18.3 7.1 13.2 22.2 9.9 19.3 19.9 10.4 19.0 16.1 7.4 15.6 10.6 12.7 5.4 10.9 8.8 15.8 10.9 12.2 20.6 14.6 12.9 9.3 23.0 16.2 13.3 11.5 11.8 11.3 8.1 12.5 13.1 12.2 7.7 11.8 27.8 8.7 10.4 31.2 17.4 10.6 14.0 4.6 10.7 8.5 13.0 12.6 12.9 8.9 3.3 8.6 4.2 1.7 5.9 3.5 22.0 12.6 6.4 9.4 5.3 5.7 21.1 10.1 7.6 13.6 14.1 17.2 10.8 22.0 20.9 6.5 10.1 16.3 6.3 19.3 3.6 28.7 11.3 10.7 9.1 10.2 14.6 11.9 13.1 6.7 14.0 13.4 8.7 6.6 6.4 8.8 9.6 9.7 11.0 7.8 12.8 13.8 10.5 10.6 20.8 17.2 11.1 7.7 5.6 22.7 6.3 9.7 11.1 10.4 12.6 5.0 11.6 11.6 15.2 11.6 12.9 17.5 12.3 23.8 17.6 13.5 10.7 10.0 9.9 8.6 1.9 8.3 4.1 3.4 5.9 4.2 5.5 5.9 2.1 8.9 5.0 5.1 4.2 1.7 4.2 3.3 4.0 3.5 12.3 15.0 13.2 22.2 10.9 8.8 14.6 12.9 11.8 14.0 0.0 0.6 0.0 0.0 2.6 0.0 0.2 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.6 1.7 1.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 1.7 0.0 0.0 3.3 0.0 0.0 0.0 0.3 ARHGEF26 "DKFZP434D146, SGEF" ENSG00000114790 "Rho guanine nucleotide exchange factor 26" Q96DR7 3 154121003-154257827 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 1: 315.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 10.0;U-251 MG: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017722, HPA049195" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017722: AB_1856800, HPA049195: AB_2680671" "unprognostic (1.41e-1)" "unprognostic (1.43e-3)" "unprognostic (3.55e-1)" "unprognostic (7.99e-3)" "unprognostic (2.82e-1)" "unprognostic (9.42e-3)" "prognostic favorable (9.74e-4)" "unprognostic (7.06e-2)" "unprognostic (1.16e-1)" "unprognostic (6.01e-5)" "unprognostic (1.44e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-1)" "unprognostic (5.53e-3)" "unprognostic (3.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.24e-3)" 11.2 4.0 9.1 5.8 8.7 1.0 9.8 5.6 17.8 9.2 20.0 6.5 3.3 10.3 5.9 3.1 12.0 8.3 17.6 4.1 8.7 4.6 3.1 22.0 18.6 1.0 5.4 6.3 5.3 27.1 13.9 2.9 4.7 12.2 5.3 3.7 4.4 4.1 5.5 1.5 7.0 11.5 12.7 9.7 1.6 12.3 7.4 5.5 0.0 4.1 2.5 2.0 7.4 11.4 0.0 0.3 0.0 0.5 0.0 0.1 0.0 5.3 3.1 6.1 4.2 2.7 0.4 0.1 0.3 0.0 1.6 1.8 2.5 0.4 2.5 0.4 0.1 2.8 6.3 3.1 1.5 2.8 0.0 8.1 0.0 2.3 0.8 2.5 0.8 0.1 0.9 0.1 1.9 0.3 0.9 0.1 2.6 0.0 0.0 1.0 6.2 1.1 0.1 3.9 1.2 2.7 0.0 10.0 0.0 0.5 3.5 2.3 0.7 0.7 8.8 1.3 3.3 5.4 0.4 0.0 0.9 4.0 0.0 18.1 2.6 0.4 0.0 1.6 0.0 6.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.1 8.7 5.6 10.1 8.7 4.6 5.4 6.3 12.2 5.5 315.6 29.8 0.9 7.9 17.3 9.4 1.2 20.4 21.4 17.0 3.5 3.9 1.4 0.0 1.9 9.1 3.0 2.6 0.0 2.2 1.0 8.1 6.7 4.7 44.5 0.6 4.8 0.0 8.6 2.8 1.7 9.8 0.9 3.3 1.8 4.5 70.3 1.7 2.9 17.7 0.0 50.2 0.0 4.2 2.9 32.4 20.7 5.1 5.7 1.7 5.3 ARHGEF28 "p190RhoGEF, RGNEF, RIP2" ENSG00000214944 "Rho guanine nucleotide exchange factor 28" Q8N1W1 5 73626158-73941993 "Predicted intracellular proteins" Differentiation "Guanine-nucleotide releasing factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.0" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 46.8;Muller glia cells: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 38.4;LHCN-M2: 35.3;TIME: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037602 Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Microtubules, Cytosol" "Plasma membrane" "HPA037602: AB_10672282" "unprognostic (1.97e-1)" "prognostic favorable (5.31e-4)" "unprognostic (7.66e-2)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (3.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (5.37e-1)" "unprognostic (3.63e-1)" "unprognostic (2.62e-1)" "unprognostic (3.04e-1)" "prognostic favorable (1.91e-6)" "unprognostic (1.07e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-2)" "prognostic favorable (8.98e-4)" 3.4 17.7 3.0 2.7 1.4 0.0 7.7 2.3 2.3 9.7 6.7 1.1 8.6 2.3 11.9 9.7 7.1 7.5 12.0 1.5 1.4 1.9 43.0 5.5 5.5 0.3 1.7 3.2 14.5 19.2 0.2 7.0 1.1 2.5 5.1 2.8 4.3 20.0 9.5 0.9 11.1 3.9 2.7 3.3 2.0 14.8 2.0 1.0 4.1 10.5 6.0 6.0 3.4 6.2 0.0 0.0 0.0 0.0 0.6 1.2 0.1 11.1 7.9 0.0 1.0 1.0 1.4 0.0 4.1 8.2 5.2 5.2 2.3 4.8 0.0 8.8 1.4 11.9 3.8 0.5 6.6 7.9 0.1 1.1 0.2 1.2 10.1 8.3 0.0 0.0 1.3 2.7 8.1 38.4 9.8 17.0 0.2 0.0 0.0 35.3 1.0 0.0 0.0 0.1 2.9 3.2 0.0 2.1 1.3 14.2 6.8 0.7 1.5 2.0 0.3 0.2 0.0 1.7 0.0 22.6 2.6 3.5 0.2 3.8 0.4 0.0 0.0 3.9 0.5 1.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.1 3.0 1.4 2.3 2.3 1.4 1.9 1.7 3.2 2.5 1.0 26.8 13.1 0.0 12.3 22.9 0.7 1.8 28.1 46.8 12.5 29.6 0.0 0.1 13.3 12.3 2.9 8.5 3.0 0.0 9.6 0.2 1.3 9.3 1.1 6.7 0.3 12.7 10.9 1.8 0.3 1.7 9.5 1.3 1.7 1.0 9.6 36.2 17.9 5.7 5.3 18.3 1.0 6.5 3.8 0.7 0.4 22.3 0.1 0.0 6.9 14.9 ARHGEF3 "DKFZP434F2429, GEF3, STA3, XPLN" ENSG00000163947 "Rho guanine nucleotide exchange factor 3" Q9NR81 3 56727418-57079329 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "T-cells: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 35.6;RPMI-8226: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034715, HPA064945" Uncertain Approved Cytosol NA NA Cytosol "HPA034715: AB_10600780, HPA064945: AB_2685389" "unprognostic (1.84e-2)" "unprognostic (2.22e-2)" "unprognostic (1.62e-2)" "prognostic favorable (2.17e-4)" "unprognostic (8.25e-2)" "prognostic favorable (2.61e-4)" "unprognostic (9.42e-2)" "unprognostic (3.83e-2)" "unprognostic (9.67e-2)" "unprognostic (7.44e-2)" "unprognostic (6.90e-2)" "unprognostic (4.99e-2)" "prognostic favorable (1.96e-7)" "unprognostic (8.24e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-2)" 14.5 33.0 8.3 14.2 22.8 6.4 13.5 24.0 31.1 12.8 12.9 8.8 8.2 4.8 29.6 14.4 16.2 17.8 16.6 9.3 19.0 12.0 19.5 3.9 18.1 19.5 9.3 18.4 20.6 36.9 29.8 30.4 15.5 18.3 11.6 10.5 19.9 18.6 12.3 7.7 10.8 9.1 26.1 9.7 14.9 11.3 10.2 5.8 33.4 10.9 10.2 20.4 13.9 11.2 8.4 4.4 4.9 9.3 11.9 32.7 20.8 9.6 3.4 0.5 3.2 1.1 0.9 6.9 1.0 0.9 1.1 1.4 1.6 9.2 5.0 1.0 1.9 10.7 5.0 3.0 12.7 1.2 7.3 1.4 4.1 2.2 35.6 2.8 0.0 4.6 4.2 8.4 0.9 1.4 10.0 10.5 5.4 1.1 11.3 2.4 1.4 13.7 0.5 0.9 7.8 5.3 0.0 3.8 37.0 8.3 5.3 0.6 1.6 6.2 4.6 2.7 3.7 1.2 4.3 4.8 0.5 2.6 2.2 1.6 14.5 5.6 18.4 9.1 5.0 4.4 4.9 7.1 1.1 32.7 8.0 24.5 8.4 25.2 28.5 4.4 5.6 20.7 25.2 2.7 11.9 9.3 1.9 20.7 20.8 8.3 22.8 24.0 31.1 19.0 12.0 9.3 18.4 18.3 5.8 14.9 21.9 10.7 8.2 9.8 9.6 8.7 0.0 8.1 6.8 22.7 3.9 9.4 10.0 8.6 15.7 23.0 1.1 0.0 8.7 6.3 12.2 14.3 12.8 0.0 7.2 0.0 9.2 12.3 28.4 10.9 16.4 15.8 10.1 5.4 0.7 8.9 7.8 0.0 22.6 6.9 1.1 0.0 4.2 1.7 2.7 13.0 10.0 44.8 2.6 10.7 ARHGEF33 ENSG00000214694 "Rho guanine nucleotide exchange factor 33" A8MVX0 2 38889841-38975449 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 42.5" "Group enriched" "Detected in some" 5 "Early spermatids: 25.0;Late spermatids: 21.2;Spermatocytes: 30.7;Spermatogonia: 34.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 42.5" "Cell type enriched" "Detected in single" 8 "eosinophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Group enriched" "Detected in some" 4 "BEWO: 9.0;HeLa: 4.0;SiHa: 11.2" "Region enriched" "Detected in single" 32 "cerebellum: 314.4" "Region enriched" "Detected in all" 11 "cerebellum: 47.0" "HPA034661, HPA041051" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034661: AB_10669679, HPA041051: AB_2677274" "unprognostic (8.38e-2)" "unprognostic (7.05e-4)" "unprognostic (1.95e-1)" "unprognostic (4.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-1)" "unprognostic (3.66e-1)" "unprognostic (3.37e-1)" "unprognostic (5.82e-2)" "unprognostic (2.05e-3)" "unprognostic (4.99e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.56e-1)" "unprognostic (2.42e-1)" "unprognostic (1.99e-1)" 0.3 4.0 3.7 1.0 8.6 0.0 1.7 42.5 3.4 2.3 0.7 0.6 0.7 0.1 2.8 5.1 0.7 2.2 1.4 0.8 3.3 3.6 1.4 0.2 1.2 0.5 2.0 2.9 6.8 0.2 2.2 3.5 0.8 3.2 1.7 0.6 0.8 0.4 1.2 0.4 1.3 0.6 1.0 1.5 0.5 0.9 10.1 2.4 0.2 1.4 0.2 0.4 1.2 0.6 0.2 0.1 6.7 0.8 0.0 0.2 0.1 0.3 0.0 0.4 0.2 0.2 0.2 9.0 0.8 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.9 1.0 0.3 4.0 0.3 0.7 0.4 0.3 0.8 1.0 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.4 0.5 0.3 11.2 0.4 0.0 1.1 0.0 0.3 0.6 0.2 1.5 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.1 0.0 0.6 6.7 0.0 0.8 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 3.7 8.6 42.5 3.4 3.3 3.6 2.0 2.9 3.2 2.4 0.0 1.0 0.0 0.1 0.0 2.5 0.4 0.0 5.3 1.2 0.0 0.0 0.8 0.0 0.1 25.0 0.3 0.0 0.0 0.0 1.3 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 21.2 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.2 0.2 3.1 0.0 0.7 30.7 34.3 0.1 0.5 0.0 0.0 0.2 ARHGEF37 FLJ41603 ENSG00000183111 "Rho guanine nucleotide exchange factor 37" A1IGU5 5 149551947-149634968 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 66.1;seminal vesicle: 73.8" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 9.0;neutrophil: 4.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "EFO-21: 10.1;HaCaT: 18.5;hTCEpi: 24.5" "Region enhanced" "Detected in some" "cerebellum: 9.5" "Low region specificity" "Detected in all" "HPA043885, HPA053487" Uncertain Approved Cytosol NA NA Cytosol "HPA043885: AB_2678715, HPA053487: AB_2682167" "unprognostic (3.51e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-1)" "unprognostic (3.92e-1)" "unprognostic (1.17e-1)" "unprognostic (6.87e-2)" "unprognostic (1.54e-3)" "unprognostic (1.54e-1)" "unprognostic (2.64e-1)" "unprognostic (6.93e-2)" "unprognostic (2.13e-3)" "unprognostic (1.16e-2)" "prognostic favorable (6.85e-4)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.50e-2)" "unprognostic (2.10e-1)" 2.5 2.7 10.8 1.9 13.2 3.0 16.8 6.7 7.1 4.0 10.2 17.5 66.1 4.5 4.4 9.5 7.6 7.4 4.6 6.4 12.8 9.5 4.6 1.4 4.3 1.0 19.1 5.8 2.2 7.0 29.6 5.3 3.6 12.3 16.0 5.2 12.0 23.2 73.8 11.9 29.3 4.8 7.0 31.7 1.0 11.7 4.8 15.1 0.7 2.1 4.8 3.4 6.4 5.4 0.7 1.1 9.0 1.2 0.2 0.8 0.0 3.0 1.2 0.8 3.6 0.2 0.4 2.1 0.4 0.6 0.6 0.6 0.0 4.0 0.4 10.1 0.4 1.1 18.5 0.3 1.8 1.2 0.8 0.9 0.3 1.9 0.2 0.7 0.0 0.5 0.5 24.5 1.9 2.4 2.0 3.0 1.3 0.4 0.7 0.0 0.4 0.5 0.6 0.2 7.5 2.2 0.3 0.4 0.0 4.1 1.5 1.5 3.6 2.2 0.2 0.3 0.4 5.5 0.1 2.4 0.2 0.7 0.0 0.5 0.5 1.0 0.3 0.7 0.1 2.6 9.0 0.9 0.5 0.4 1.2 0.5 0.2 0.3 0.3 0.3 0.7 0.8 0.6 4.9 0.2 0.5 1.1 0.2 0.0 10.8 13.2 6.7 7.1 12.8 9.5 19.1 5.8 12.3 15.1 0.0 5.0 3.7 8.4 6.1 4.1 14.8 15.3 6.7 6.8 8.7 3.9 4.9 0.0 3.2 4.2 6.0 12.6 0.0 4.5 1.2 2.1 9.6 6.9 2.6 2.8 4.8 10.9 6.7 2.8 1.0 1.7 3.7 3.3 4.6 6.1 40.8 4.1 8.0 9.9 1.3 7.3 6.5 4.1 13.2 5.5 8.4 3.8 4.4 7.5 4.5 ARHGEF40 "FLJ10357, solo" ENSG00000165801 "Rho guanine nucleotide exchange factor 40" Q8TER5 14 21070270-21090240 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 58.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 2.8;neutrophil: 9.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.2" "Cell line enhanced" "Detected in many" "AF22: 17.4;ASC TERT1: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030745, HPA030746, HPA030757" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203" "unprognostic (6.30e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-1)" "unprognostic (5.91e-2)" "unprognostic (2.55e-1)" "unprognostic (8.16e-3)" "unprognostic (1.27e-2)" "unprognostic (9.84e-3)" "unprognostic (1.33e-1)" "unprognostic (8.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.53e-1)" "unprognostic (6.01e-3)" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (2.33e-1)" "unprognostic (8.95e-2)" 15.7 32.9 9.3 7.4 9.2 1.7 12.4 16.5 8.2 16.2 8.2 11.4 30.9 3.5 13.6 12.6 5.9 9.3 20.2 7.8 10.2 4.6 7.2 16.9 9.3 4.2 12.6 4.5 15.7 16.6 17.7 6.6 6.3 9.1 9.8 6.3 10.3 20.1 30.0 6.5 4.9 5.2 11.2 10.5 19.5 6.4 4.7 10.8 1.3 11.0 4.9 2.5 8.6 9.6 0.0 1.0 9.2 1.3 0.1 0.0 0.5 1.6 1.5 17.4 3.1 14.8 22.3 0.6 5.8 15.7 6.8 5.3 0.7 4.1 0.0 0.9 11.5 6.9 2.5 1.5 2.0 2.6 3.2 0.6 2.3 1.7 4.7 2.0 1.5 8.6 9.0 1.4 5.9 1.8 13.4 0.0 0.0 0.7 0.7 5.5 0.2 0.0 4.8 3.9 0.3 0.3 0.5 11.5 0.7 4.4 2.1 0.4 6.0 3.2 0.3 4.7 3.6 1.5 5.1 2.8 14.1 9.2 6.2 2.7 1.4 0.0 0.0 4.8 2.1 3.8 0.0 1.3 2.8 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 9.2 0.1 0.0 0.0 0.0 0.5 9.3 9.2 16.5 8.2 10.2 4.6 12.6 4.5 9.1 10.8 6.0 5.3 0.9 6.7 4.2 8.1 10.6 58.6 0.0 2.3 14.0 0.0 0.9 16.6 18.1 0.8 9.0 1.7 0.0 8.9 0.7 16.6 2.0 36.9 26.9 12.7 4.8 7.5 6.7 26.9 2.0 22.5 16.1 21.9 3.6 8.7 33.2 12.1 0.0 22.6 6.0 6.8 25.8 24.2 2.6 2.5 3.9 1.0 1.9 20.0 4.9 ARHGEF5 "GEF5, P60, TIM, TIM1" ENSG00000050327 "Rho guanine nucleotide exchange factor 5" Q12774 7 144355288-144380632 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 44.1;Paneth cells: 42.1;Urothelial cells: 36.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "B-cells: 3.1;granulocytes: 1.1;T-cells: 4.2" "Cell line enhanced" "Detected in many" "A-431: 20.7;CAPAN-2: 14.1;hTCEpi: 15.6;WM-115: 15.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA020980, HPA029504, HPA044188, HPA045619, HPA045699" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423" "unprognostic (1.45e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-2)" "unprognostic (1.94e-1)" "unprognostic (9.45e-2)" "unprognostic (2.69e-2)" "unprognostic (9.95e-3)" "unprognostic (9.21e-2)" "unprognostic (1.05e-2)" "unprognostic (2.27e-1)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "prognostic favorable (3.28e-7)" "unprognostic (4.67e-2)" "unprognostic (4.86e-1)" "unprognostic (2.36e-1)" "unprognostic (7.76e-2)" 2.3 1.0 1.2 5.2 1.8 0.9 7.6 1.2 1.2 4.6 7.7 1.2 7.4 8.5 3.4 7.8 16.6 2.5 8.4 1.3 1.2 0.4 9.0 6.7 4.8 3.2 1.2 1.2 3.0 8.8 7.7 4.3 14.3 2.6 6.6 4.6 4.0 17.7 9.4 1.2 21.1 16.7 2.2 1.7 2.4 6.5 1.4 1.2 1.5 11.6 10.0 4.5 3.4 6.9 3.1 0.2 1.1 0.1 0.0 4.2 0.4 20.7 2.0 0.0 0.0 0.0 0.0 7.1 2.2 1.5 1.0 1.3 7.0 14.1 0.0 6.8 0.9 1.7 9.7 0.8 9.6 1.0 0.0 2.9 0.0 3.2 1.1 2.3 0.0 0.0 3.6 15.6 0.7 7.2 3.2 0.2 0.0 0.0 0.0 0.9 8.6 0.0 0.0 4.5 9.3 3.8 0.8 0.0 0.2 11.5 7.1 0.0 0.0 8.8 8.6 3.7 2.6 5.3 1.3 0.2 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 15.3 0.0 0.0 0.0 0.8 0.1 1.3 1.8 2.7 2.1 0.1 3.1 2.7 0.7 1.1 0.0 0.0 0.2 4.2 0.4 1.2 1.8 1.2 1.2 1.2 0.4 1.2 1.2 2.6 1.2 6.0 15.0 0.8 31.5 16.5 0.0 1.1 7.6 18.7 12.5 21.0 3.9 9.2 5.0 12.2 1.3 0.8 44.1 0.0 14.5 11.9 2.3 16.5 0.0 5.9 1.5 0.0 9.2 1.3 0.0 0.4 1.4 0.0 5.0 0.0 15.4 3.4 19.5 42.1 1.4 3.4 2.4 0.0 1.6 0.4 0.9 14.6 11.9 0.5 15.6 36.6 ARHGEF6 "alpha-PIX, alphaPIX, Cool-2, Cool2, KIAA0006, MRX46" ENSG00000129675 "Rac/Cdc42 guanine nucleotide exchange factor 6" Q15052 X 136665547-136782088 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 54.5;granulocytes: 188.3;Kupffer cells: 44.7" "Cancer enhanced" "Detected in all" "glioma: 24.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 22.0;HL-60: 27.4;HMC-1: 104.4;JURKAT: 28.7;U-937: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003578 Approved Approved Cytosol NA NA Cytosol "HPA003578: AB_1078203" "unprognostic (9.64e-2)" "unprognostic (3.47e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-2)" "unprognostic (7.28e-2)" "unprognostic (2.06e-3)" "unprognostic (9.08e-2)" "unprognostic (7.87e-3)" "unprognostic (4.21e-1)" "unprognostic (2.56e-1)" "unprognostic (1.15e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-3)" "unprognostic (5.29e-2)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (1.28e-3)" 22.0 10.4 16.9 15.3 15.4 14.8 13.9 6.4 14.6 6.4 8.3 12.8 3.7 4.0 8.4 6.1 4.4 4.5 9.5 27.0 21.7 13.6 5.0 4.5 13.8 20.6 20.7 10.2 9.5 2.7 8.8 4.8 24.4 15.1 6.4 6.3 8.4 6.2 5.1 37.5 4.3 9.6 9.3 14.6 20.2 6.4 3.2 14.6 2.6 4.1 8.6 20.5 8.8 7.9 3.1 8.8 31.5 8.8 5.5 9.9 6.2 0.2 0.0 1.0 0.0 2.3 5.8 0.0 0.3 1.8 0.3 1.6 0.0 0.0 1.0 0.4 1.5 1.6 0.1 1.2 0.0 0.3 5.1 0.4 22.0 0.0 0.0 0.8 27.4 104.4 6.3 0.0 1.1 0.0 2.0 0.6 28.7 0.1 4.3 3.9 0.0 12.8 16.8 0.9 0.0 0.4 4.9 7.4 0.0 0.3 5.5 0.0 1.3 0.0 0.2 0.8 0.5 0.6 11.4 0.1 1.5 0.2 1.8 1.4 0.7 0.0 10.5 7.0 29.3 2.0 20.2 7.2 31.5 6.8 8.8 8.0 3.1 7.6 5.5 8.8 2.6 7.0 6.1 4.2 5.5 6.8 2.8 9.9 6.2 16.9 15.4 6.4 14.0 21.7 13.6 20.7 10.2 15.1 14.6 6.0 12.8 13.2 0.8 1.0 0.5 54.5 0.0 1.4 3.4 1.8 0.0 0.2 1.7 0.4 11.0 8.4 0.0 0.0 1.6 0.2 5.3 0.4 188.3 1.3 13.2 12.7 0.0 12.3 44.7 20.0 13.8 26.2 3.3 11.8 0.1 2.8 1.0 0.0 13.8 0.3 0.3 12.9 10.8 0.5 0.6 1.5 0.3 22.3 0.0 0.6 ARHGEF9 "KIAA0424, PEM-2" ENSG00000131089 "Cdc42 guanine nucleotide exchange factor 9" O43307 X 63634967-63809274 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.6" "Group enriched" "Detected in many" 6 "Bipolar cells: 169.8;Cone photoreceptor cells: 219.9;Horizontal cells: 77.9;Rod photoreceptor cells: 311.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035419, HPA055291" Approved Supported Cytosol NA NA Cytosol "HPA035419: AB_10669859, HPA055291: AB_2682774" "unprognostic (3.19e-1)" "unprognostic (6.15e-2)" "unprognostic (4.02e-2)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.66e-1)" "unprognostic (1.98e-3)" "unprognostic (1.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.08e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.02e-5)" "unprognostic (4.56e-2)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (8.98e-2)" 5.7 9.6 22.6 4.5 42.6 3.2 6.9 19.5 38.2 6.0 8.2 7.1 1.2 10.9 6.2 4.2 7.7 5.4 6.0 22.0 24.6 22.4 6.8 4.1 4.3 4.6 12.5 28.3 10.4 4.8 11.8 8.3 4.4 17.4 8.2 8.7 9.9 4.5 7.0 3.9 7.0 8.1 8.4 8.5 4.9 6.9 2.2 9.9 2.1 6.1 0.8 5.4 7.3 3.2 5.4 3.7 1.8 3.6 11.5 8.5 2.8 4.6 7.1 11.2 7.2 5.1 7.0 0.9 8.5 7.1 7.8 6.8 0.5 5.0 9.8 6.2 5.2 8.3 0.1 5.0 10.4 7.7 13.4 5.1 8.2 3.1 0.4 2.6 4.2 3.6 8.4 4.6 3.9 12.8 7.9 5.2 10.3 1.2 16.1 7.6 6.6 8.4 2.4 7.7 4.8 8.3 12.9 23.0 9.7 4.9 4.2 0.2 3.2 3.9 7.6 4.3 5.2 5.5 4.9 2.6 5.2 5.3 24.5 3.5 5.5 4.2 7.6 6.3 7.5 3.7 1.0 2.8 1.8 8.5 3.6 5.6 3.5 4.6 4.9 3.7 5.4 5.6 5.2 1.6 11.5 2.4 2.9 4.1 2.8 22.6 42.6 19.5 37.2 24.6 22.4 12.5 28.3 17.4 9.9 8.9 10.7 17.4 5.4 5.0 169.8 34.3 2.5 9.4 7.9 10.4 219.9 4.1 11.6 5.5 1.7 8.7 16.0 0.0 7.8 1.2 6.2 4.4 13.9 7.5 8.6 77.9 20.1 11.6 3.2 4.2 14.4 5.6 13.5 1.8 13.8 28.4 6.4 14.0 14.5 16.5 311.4 0.0 18.4 1.4 3.2 5.3 3.7 20.3 19.1 4.8 ARID3A "BRIGHT, DRIL1" ENSG00000116017 "AT-rich interaction domain 3A" Q99856 19 925781-975934 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 38.3" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 156.8;Extravillous trophoblasts: 418.2;Syncytiotrophoblasts: 433.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 64.0;CACO-2: 21.6;K-562: 27.8;THP-1: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004793, HPA076330" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004793: AB_1847870, HPA076330: AB_2732309" "unprognostic (1.34e-1)" "unprognostic (2.62e-3)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (1.31e-3)" "unprognostic (5.67e-2)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (5.22e-2)" "unprognostic (2.54e-1)" "prognostic favorable (1.95e-5)" "unprognostic (4.00e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (3.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.30e-1)" "unprognostic (8.95e-2)" 4.0 2.3 1.7 6.2 2.3 11.5 4.4 4.8 3.8 3.6 5.0 1.6 3.3 4.2 2.9 2.9 4.1 2.7 3.2 2.1 2.2 1.5 4.4 2.6 6.1 7.8 2.8 2.0 1.6 5.5 3.4 4.1 38.3 2.1 2.3 1.8 2.6 2.8 5.6 2.0 3.3 5.0 2.6 2.4 8.3 3.4 17.8 2.5 6.6 2.1 2.1 4.6 4.0 6.9 1.5 9.2 6.4 2.9 1.9 0.5 0.8 1.1 1.5 5.3 1.3 2.2 1.7 64.0 5.0 3.2 2.7 1.8 21.6 0.1 0.4 1.2 1.7 0.6 0.4 2.1 1.1 1.2 6.6 1.5 2.1 1.9 19.4 0.9 7.4 5.5 2.4 1.7 1.7 0.4 0.4 0.9 1.7 27.8 6.2 0.7 1.7 2.8 8.4 5.1 0.8 0.3 6.5 1.6 4.1 0.3 1.1 2.5 4.9 1.6 1.3 0.9 12.3 2.3 19.9 1.5 1.8 2.4 2.5 0.5 14.6 13.0 3.8 1.1 4.3 1.2 0.8 2.4 1.6 0.5 2.1 0.5 1.5 0.3 0.4 1.5 0.9 0.5 0.2 6.4 1.9 2.9 9.2 0.3 0.8 1.7 2.3 4.8 3.8 2.2 1.5 2.8 2.0 2.1 2.5 6.0 3.2 27.9 7.8 13.2 8.8 6.5 0.0 0.0 1.2 14.0 7.9 156.8 8.3 4.8 29.9 7.8 3.2 23.3 2.8 418.2 16.2 7.5 3.5 6.7 78.2 6.4 45.1 9.8 34.1 2.0 6.6 32.5 15.1 35.1 11.2 2.3 9.8 0.0 6.0 4.5 3.3 0.0 12.8 0.6 8.5 13.4 433.4 10.9 4.3 1.8 ARID4A "RBBP1, RBP-1, RBP1" ENSG00000032219 "AT-rich interaction domain 4A" P29374 14 58298385-58373887 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048899 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA048899: " "unprognostic (1.57e-1)" "unprognostic (9.39e-2)" "unprognostic (5.17e-2)" "unprognostic (2.69e-1)" "unprognostic (3.70e-2)" "prognostic favorable (1.91e-4)" "unprognostic (2.71e-1)" "prognostic favorable (7.82e-4)" "unprognostic (2.08e-2)" "unprognostic (6.92e-2)" "unprognostic (3.27e-1)" "unprognostic (3.72e-2)" "unprognostic (9.32e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (4.11e-2)" "unprognostic (3.52e-2)" 15.1 8.5 17.3 15.1 22.2 34.5 13.4 45.9 27.0 12.8 12.0 7.9 12.7 10.2 11.6 9.7 10.1 10.7 10.7 10.0 13.3 11.5 11.3 21.7 12.0 15.8 9.6 18.7 15.3 11.4 17.2 22.9 11.3 17.3 10.8 10.6 6.4 10.8 13.5 10.6 13.2 12.3 12.5 11.0 15.3 10.2 7.9 15.0 15.0 12.6 4.5 12.8 13.8 11.9 15.1 7.5 42.7 14.1 10.7 11.1 3.6 6.7 5.7 16.0 7.9 7.9 9.6 8.1 8.1 6.9 5.5 8.7 6.7 10.7 16.3 8.6 6.8 5.3 7.8 7.0 3.9 8.1 11.4 4.5 7.4 6.4 6.4 4.8 15.5 10.7 7.2 4.3 5.3 5.5 8.8 8.7 9.5 8.3 13.5 5.8 9.1 11.2 14.0 3.1 6.6 6.9 11.6 13.8 4.8 5.9 12.0 13.8 11.9 13.7 6.9 9.6 8.2 11.8 14.3 12.3 9.4 7.4 7.5 3.7 4.4 3.3 15.0 5.6 9.9 4.7 19.3 7.6 21.7 8.5 7.8 9.5 11.6 10.3 8.8 5.6 15.1 11.1 10.8 42.7 10.7 14.1 7.5 7.2 3.6 17.3 22.2 45.9 27.0 13.3 11.5 9.6 18.7 17.3 15.0 77.4 85.3 20.4 20.9 34.1 91.9 45.6 15.3 8.1 40.9 26.2 49.1 16.0 16.6 19.0 13.5 41.6 29.5 23.3 19.0 18.3 27.2 20.2 63.6 37.6 29.9 106.5 21.9 33.2 40.4 5.3 33.6 50.9 25.3 68.5 30.9 64.2 20.9 36.8 33.9 11.9 63.2 19.4 25.5 37.6 24.7 29.2 17.0 54.9 29.8 15.5 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027205, HPA027333" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027205: , HPA027333: AB_1845013" "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 15.3 13.8 14.9 19.0 22.5 34.1 15.9 32.8 17.6 19.7 13.4 19.2 18.2 9.1 18.7 18.1 12.0 15.0 15.2 10.6 15.2 14.5 13.1 14.0 15.5 22.3 26.9 13.9 21.8 16.8 23.8 25.7 14.7 20.3 17.9 10.7 12.0 16.7 17.0 12.3 12.3 14.2 14.6 19.8 19.8 14.7 19.5 23.4 33.7 20.2 8.2 18.9 18.2 18.6 17.1 11.7 35.9 11.8 16.6 17.0 6.0 12.2 9.2 16.2 12.5 11.9 12.5 13.3 14.0 12.3 9.7 9.5 9.5 13.1 14.4 16.3 10.5 6.9 10.9 13.1 5.9 14.1 18.5 14.2 11.6 11.1 7.9 9.1 12.4 17.1 8.4 8.0 11.9 10.2 12.7 13.1 9.2 15.0 20.7 9.1 5.5 18.5 11.3 14.8 8.8 6.1 6.9 11.5 12.0 10.6 10.3 13.2 18.3 17.8 14.8 13.8 4.9 15.6 20.1 18.0 12.0 9.1 14.6 13.6 20.2 16.0 14.4 8.2 9.1 16.0 24.6 7.1 19.5 16.1 7.6 14.7 15.6 17.0 13.7 6.8 17.1 16.9 14.4 35.9 16.6 11.8 11.7 13.6 6.0 14.9 22.5 32.8 17.6 15.2 14.5 26.9 13.9 20.3 23.4 95.3 99.9 54.7 68.9 110.4 111.2 62.2 35.7 91.0 101.2 29.6 113.9 55.7 16.6 62.0 329.6 108.9 41.9 46.7 41.8 58.1 114.7 81.5 105.3 23.1 39.4 106.5 86.4 65.7 52.4 349.2 93.7 99.4 79.2 108.2 45.8 77.7 57.3 49.9 72.9 15.0 150.5 45.3 129.6 212.6 167.8 93.1 131.0 129.6 39.6 111.5 ARID5B "FLJ21150, MRF2" ENSG00000150347 "AT-rich interaction domain 5B" Q14865 10 61901300-62096944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.6" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 860.1;Smooth muscle cells: 627.3;Syncytiotrophoblasts: 769.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015037 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Cytosol" "HPA015037: AB_1845015" "unprognostic (3.31e-1)" "unprognostic (1.99e-2)" "unprognostic (2.94e-2)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (5.60e-2)" "unprognostic (1.50e-2)" "unprognostic (4.90e-2)" "unprognostic (3.90e-1)" "unprognostic (6.03e-2)" "unprognostic (1.97e-1)" "unprognostic (5.75e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (2.58e-1)" "unprognostic (1.94e-1)" "unprognostic (3.93e-2)" 43.3 5.6 7.8 13.8 9.9 4.2 22.6 3.3 11.5 27.5 14.0 9.5 4.4 6.8 29.4 10.4 14.0 15.6 27.2 16.0 5.9 5.1 14.6 5.7 14.6 14.4 11.8 6.5 18.6 4.3 14.7 11.4 22.4 9.4 16.6 8.2 6.9 14.5 7.3 88.6 15.0 12.1 29.4 10.4 12.7 9.4 7.7 10.5 8.6 7.5 11.7 18.0 22.5 17.1 21.2 1.0 4.3 3.6 5.7 14.7 2.6 0.8 0.3 2.3 5.9 5.2 14.0 0.4 16.9 45.7 12.1 9.5 20.5 0.9 1.4 4.1 16.2 1.7 5.6 8.1 2.5 14.6 5.3 2.4 0.8 4.1 5.1 9.7 0.2 10.1 17.6 1.3 7.1 8.1 10.4 1.4 2.9 0.7 2.3 3.9 2.9 5.5 0.4 0.4 3.9 5.4 6.7 3.9 0.4 7.9 9.2 1.3 1.7 7.5 4.1 4.9 5.5 3.5 0.2 1.3 6.7 9.1 10.1 4.2 0.1 0.0 4.4 5.8 0.3 2.1 4.3 0.6 0.4 7.3 1.4 0.9 19.0 10.5 6.3 1.0 21.2 6.9 4.5 1.2 5.7 3.6 0.5 14.7 2.6 7.8 9.9 3.3 11.5 5.9 5.1 11.8 6.5 9.4 10.5 122.1 57.7 77.2 286.1 860.1 43.7 59.7 12.7 50.9 120.6 48.8 0.0 138.5 84.6 43.9 23.9 62.4 4.7 23.3 12.8 104.6 292.5 224.3 23.2 5.1 46.6 69.9 34.9 106.8 33.2 10.0 140.4 39.6 131.6 60.5 13.2 19.3 30.6 20.9 57.0 145.5 2.8 129.4 627.3 5.7 0.5 417.5 769.7 77.6 30.2 122.9 ARL13A ARL13 ENSG00000174225 "ADP ribosylation factor like GTPase 13A" Q5H913 X 100969708-100990829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 16.6" "Group enriched" "Detected in some" 23 "Early spermatids: 58.2;Late spermatids: 44.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.7" "HPA037377, HPA037378" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA037377: AB_2675442, HPA037378: AB_10670932" "unprognostic (4.40e-2)" "unprognostic (1.05e-1)" "unprognostic (1.02e-1)" "unprognostic (1.08e-2)" "unprognostic (1.93e-1)" "unprognostic (9.06e-3)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.51e-2)" "unprognostic (4.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (9.37e-4)" "unprognostic (2.14e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.6 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 1.2 0.4 0.1 0.1 0.2 0.3 16.6 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.8 0.2 0.0 0.4 0.1 0.5 0.0 1.1 1.9 0.1 0.6 0.0 0.0 0.5 0.3 0.1 0.0 0.0 6.7 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 1.2 1.1 0.7 0.0 1.7 0.1 0.0 0.0 0.0 0.4 0.4 0.3 0.9 0.3 0.0 0.1 0.7 0.0 0.2 0.0 0.4 1.6 0.0 0.1 0.7 0.0 0.4 0.0 0.1 1.2 0.3 0.1 0.0 0.3 2.0 0.6 0.3 0.0 0.0 0.3 0.2 0.2 1.3 0.3 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 1.5 0.0 0.0 0.0 0.0 0.0 ARL14EP "ARF7EP, C11orf46, FLJ38968" ENSG00000152219 "ADP ribosylation factor like GTPase 14 effector protein" Q8N8R7 11 30323051-30338227 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039634, HPA048127" Approved Supported "Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol" NA NA "Vesicles, Focal adhesion sites, Cytosol" Nucleoplasm "HPA039634: AB_2676606, HPA048127: AB_2680277" "prognostic favorable (2.50e-5)" "unprognostic (8.93e-2)" "unprognostic (6.19e-3)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (5.26e-4)" "unprognostic (2.50e-2)" "unprognostic (6.50e-3)" "unprognostic (5.76e-2)" "unprognostic (8.86e-2)" "unprognostic (1.04e-1)" "unprognostic (8.57e-3)" "unprognostic (1.60e-1)" "unprognostic (3.47e-1)" "unprognostic (4.50e-2)" "prognostic favorable (7.49e-4)" 13.9 21.5 24.5 12.9 29.1 6.3 18.7 22.7 23.4 17.0 14.5 8.0 22.4 8.7 18.1 22.7 11.1 15.8 12.4 20.5 17.7 15.5 16.5 17.6 10.3 23.5 15.5 20.5 20.1 15.0 33.4 28.6 10.6 15.1 19.0 10.3 9.0 17.0 19.9 28.0 11.6 12.5 18.3 16.0 18.2 14.4 14.5 15.0 11.6 23.3 13.9 19.1 16.1 15.1 17.6 12.7 5.5 9.6 24.4 28.7 11.2 5.8 8.5 9.5 8.3 15.6 17.0 4.8 11.5 14.5 10.4 11.6 4.7 2.2 23.8 7.9 8.2 11.6 9.9 13.8 9.7 14.8 18.9 17.1 7.2 6.7 8.2 24.6 12.8 8.3 17.6 19.6 4.9 18.7 15.2 11.4 9.9 11.3 13.0 18.1 5.6 11.6 10.6 11.0 13.1 11.9 10.2 23.2 9.7 13.9 8.1 10.9 11.6 8.9 12.0 14.1 8.9 12.7 7.3 10.0 12.0 6.4 23.5 10.9 20.4 11.6 15.5 11.4 8.0 11.4 5.5 9.6 3.0 12.1 9.4 28.7 17.6 14.8 13.4 12.7 14.0 13.7 13.1 1.7 24.4 7.0 9.1 9.5 11.2 24.5 29.1 22.7 23.4 17.7 15.5 15.5 20.5 15.1 15.0 26.8 28.1 30.5 38.1 11.0 32.2 57.0 17.8 34.8 20.5 24.4 13.7 14.7 64.6 23.3 99.1 24.8 6.3 0.0 19.6 10.7 22.3 27.7 26.6 24.2 22.8 30.2 13.9 12.9 24.3 44.0 25.3 30.9 25.3 43.3 10.0 34.4 19.0 9.7 23.7 27.2 28.6 12.9 24.1 60.6 33.2 9.7 9.3 28.9 10.4 24.4 ARL2 ARFL2 ENSG00000213465 "ADP ribosylation factor like GTPase 2" P36404 11 65014113-65022184 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 847.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044610 Supported Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol" NA NA Nucleoplasm "Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol" "HPA044610: AB_10964207" "unprognostic (9.23e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (1.61e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-3)" "unprognostic (2.34e-1)" "unprognostic (9.85e-3)" "unprognostic (6.43e-2)" "unprognostic (6.87e-3)" "prognostic favorable (7.70e-4)" "unprognostic (2.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (1.24e-2)" 39.6 32.0 37.3 17.7 78.7 19.8 26.8 16.1 46.5 21.2 23.5 34.7 13.4 23.9 26.8 20.2 23.7 35.2 22.4 52.6 34.8 32.7 33.8 6.6 23.1 14.8 36.1 38.2 27.2 29.9 22.5 15.4 25.5 32.7 25.3 15.5 30.3 26.9 33.1 78.3 19.6 23.4 28.2 44.9 16.7 18.9 31.4 28.7 7.9 26.3 23.6 12.9 24.7 22.8 43.7 37.8 18.7 21.8 21.0 40.7 34.7 36.1 57.7 17.9 26.4 48.6 36.9 16.3 17.8 41.3 25.6 25.3 16.3 25.0 14.0 34.1 25.1 39.0 23.3 18.8 31.4 12.2 14.6 29.5 14.1 26.0 24.6 37.2 17.1 12.8 29.0 26.3 21.3 47.8 37.4 34.0 16.9 33.2 26.1 17.2 42.8 14.1 38.5 28.0 17.2 47.1 7.5 19.6 33.6 27.5 15.8 33.3 18.8 15.3 15.9 50.2 17.6 16.6 21.0 25.6 48.3 16.3 38.3 18.4 9.0 12.6 8.6 22.8 24.7 39.2 10.2 21.8 18.7 34.8 21.2 37.6 43.7 32.2 33.6 27.6 37.3 36.8 40.7 2.8 21.0 12.4 37.8 20.6 34.7 37.3 78.7 16.1 46.5 34.8 32.7 36.1 38.2 32.7 28.7 20.8 35.8 37.0 78.1 72.4 72.3 89.8 50.9 32.1 52.4 78.5 27.5 165.9 227.1 118.2 362.1 147.4 126.8 46.7 66.9 164.2 116.5 55.8 93.5 17.1 87.0 65.2 80.0 119.1 47.3 847.8 66.4 70.8 168.7 138.9 56.4 119.5 81.6 95.1 66.8 340.4 40.2 64.7 111.8 98.4 65.3 72.4 89.7 39.2 87.9 60.9 ARL4A ARL4 ENSG00000122644 "ADP ribosylation factor like GTPase 4A" P40617 7 12686856-12690934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Group enriched" "Detected in all" 6 "Early spermatids: 1213.7;Late spermatids: 2876.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 61.8;K-562: 73.5" "Low region specificity" "Detected in all" HPA064513 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA064513: AB_2685276" "unprognostic (8.29e-2)" "unprognostic (1.34e-1)" "unprognostic (3.94e-1)" "unprognostic (4.97e-2)" "unprognostic (3.88e-2)" "unprognostic (7.43e-2)" "unprognostic (1.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-2)" "unprognostic (7.27e-3)" "unprognostic (1.74e-1)" "unprognostic (9.29e-2)" "unprognostic (9.42e-3)" "unprognostic (9.49e-3)" 22.6 3.6 12.3 6.7 6.7 30.8 21.5 3.0 15.8 16.9 19.4 3.2 7.4 11.3 13.6 9.9 23.5 11.0 7.5 7.0 6.0 4.6 5.2 6.6 8.6 9.5 10.3 11.0 5.2 3.5 1.8 5.6 19.2 8.5 12.0 13.7 4.0 39.0 6.8 4.2 34.9 44.6 12.8 6.5 9.5 10.3 71.2 6.7 3.7 8.8 9.2 6.5 10.5 25.0 22.8 7.4 3.3 15.4 6.5 17.6 7.3 10.1 10.9 29.0 61.8 4.7 7.8 0.0 4.1 3.8 6.8 4.1 9.6 7.7 0.0 1.8 5.8 17.5 2.9 6.4 5.3 6.9 2.2 4.8 2.1 14.2 8.9 9.7 8.9 3.8 3.5 21.1 4.0 17.9 4.3 16.3 4.1 73.5 10.0 6.9 4.4 0.4 12.6 10.5 29.7 12.5 0.0 10.1 4.7 9.0 4.9 5.3 5.0 6.9 7.3 1.4 7.8 3.6 7.3 5.6 2.7 9.7 10.3 16.7 4.6 6.0 2.3 7.1 3.7 10.9 3.3 7.8 0.3 6.3 13.0 17.6 21.4 15.0 9.7 7.4 22.8 7.4 6.1 1.1 6.5 15.4 6.6 8.9 7.3 12.3 6.7 3.0 15.8 6.0 4.6 10.3 11.0 8.5 6.7 20.8 20.7 36.3 179.9 301.7 21.4 12.9 40.8 100.4 60.3 19.2 80.5 129.5 23.2 34.7 1213.7 160.4 353.7 23.3 25.7 18.5 63.5 47.1 78.5 18.7 55.4 3.2 60.0 103.2 124.4 2876.1 63.9 134.7 114.7 54.1 63.0 9.4 39.9 112.2 25.1 13.0 114.7 12.9 42.2 236.6 53.4 205.1 371.3 38.3 56.5 52.6 ARL4C "ARL7, LAK" ENSG00000188042 "ADP ribosylation factor like GTPase 4C" P56559 2 234493041-234497053 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 168.9;Kupffer cells: 128.2;T-cells: 193.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 38.6;RPTEC TERT1: 72.9;U-2197: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028927 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA028927: AB_10602387" "unprognostic (1.93e-1)" "unprognostic (1.14e-1)" "unprognostic (3.20e-3)" "prognostic unfavorable (2.90e-7)" "unprognostic (8.01e-3)" "unprognostic (3.35e-2)" "unprognostic (9.26e-2)" "unprognostic (2.68e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-2)" "unprognostic (3.17e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.69e-8)" "unprognostic (8.57e-2)" "unprognostic (4.64e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (6.99e-5)" 9.3 6.8 11.1 17.7 9.6 30.3 12.8 19.2 21.2 6.4 6.2 4.9 3.1 3.9 3.6 9.4 13.9 7.6 19.2 3.6 9.1 16.5 8.5 7.9 9.9 28.9 9.4 11.8 2.6 3.6 0.8 5.4 16.8 23.9 6.7 7.4 5.9 14.2 3.6 1.7 15.1 8.1 3.6 5.3 28.0 7.9 1.9 1.8 44.7 2.5 4.4 20.1 14.0 10.8 5.9 17.8 18.7 0.5 18.2 29.7 8.7 7.2 22.5 2.9 0.3 2.6 0.8 7.5 0.7 3.4 0.9 1.6 10.4 14.3 0.0 1.9 1.9 27.4 5.5 2.9 15.6 1.0 6.7 1.0 0.0 0.1 0.1 2.7 0.0 0.6 1.6 10.4 8.8 5.4 38.6 1.5 19.2 0.0 24.2 4.1 1.0 21.0 0.0 3.0 5.4 5.1 0.0 13.0 4.1 72.9 8.1 10.6 1.9 0.2 1.7 1.1 4.8 0.2 0.4 3.3 14.6 5.6 39.9 14.0 12.1 4.4 0.3 25.1 0.0 7.6 18.7 0.4 8.4 29.7 0.5 29.2 5.9 20.7 23.5 3.2 5.7 18.7 20.9 0.7 18.2 0.2 17.8 25.8 8.7 11.1 9.6 19.2 21.2 9.1 16.5 9.4 11.8 23.9 1.8 68.5 22.3 38.9 97.5 110.8 168.9 8.1 50.9 6.7 44.3 14.0 7.9 25.6 0.0 15.7 7.5 16.9 0.2 0.0 4.9 3.3 28.8 51.3 25.6 3.0 29.0 101.7 1.7 9.8 128.2 4.2 0.3 83.9 40.5 43.3 0.0 30.9 11.5 0.0 0.0 1.0 10.8 0.0 16.0 0.4 0.8 37.5 12.2 193.9 0.4 46.5 ARL6IP6 MGC33864 ENSG00000177917 "ADP ribosylation factor like GTPase 6 interacting protein 6" Q8N6S5 2 152717893-152761253 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.7" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 127.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.7;eosinophil: 45.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 50.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014743 Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA014743: AB_1845030" "unprognostic (4.41e-1)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "unprognostic (9.86e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (5.43e-2)" "unprognostic (2.07e-2)" "unprognostic (2.00e-3)" "unprognostic (4.95e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.14e-1)" "unprognostic (2.67e-1)" "unprognostic (4.57e-1)" "unprognostic (7.39e-2)" 6.1 5.1 8.4 4.2 10.1 14.5 9.4 6.6 11.4 4.7 5.7 10.1 7.9 6.5 5.6 2.5 7.8 5.1 5.6 3.2 11.4 4.9 3.3 2.3 7.2 7.2 15.9 7.4 6.9 3.3 2.6 8.3 10.2 12.9 4.6 4.1 3.4 4.9 4.8 9.7 8.2 6.1 4.7 12.4 8.7 6.0 7.3 13.5 2.5 4.1 4.6 5.4 6.3 18.9 5.7 7.4 50.7 3.5 2.6 5.6 3.6 8.3 5.1 12.5 3.5 3.1 3.8 19.4 10.2 4.1 8.6 10.8 13.5 12.2 14.7 10.3 4.3 4.1 9.6 6.6 4.5 8.9 23.0 14.0 12.0 5.1 12.0 4.2 9.9 11.3 2.8 5.3 9.3 7.5 3.3 6.4 11.0 13.3 9.5 6.6 6.0 10.2 10.7 12.1 2.6 11.6 11.8 12.4 11.8 3.6 6.2 11.0 11.8 9.3 0.9 8.1 4.5 4.2 7.5 8.8 13.7 9.3 9.5 8.9 9.1 9.1 11.9 6.6 8.5 11.2 50.7 2.8 45.4 4.1 3.0 4.2 5.7 4.2 4.1 3.2 4.9 4.3 3.7 7.5 2.6 3.5 7.4 5.6 3.6 8.4 10.1 6.6 11.4 11.4 4.9 15.9 7.4 12.9 13.5 14.9 10.6 31.2 40.7 94.6 5.6 3.9 20.4 17.4 15.9 10.4 3.9 127.9 14.9 23.8 9.4 27.2 12.3 0.0 16.4 114.2 39.0 25.6 26.5 4.7 35.6 7.9 13.3 21.5 27.9 14.2 18.1 34.9 43.9 56.9 21.6 17.2 18.4 17.5 15.9 7.7 14.7 32.3 26.0 21.3 24.3 93.2 90.6 45.0 22.6 48.9 ARMC5 FLJ13063 ENSG00000140691 "Armadillo repeat containing 5" Q96C12 16 31458080-31467166 "Disease related genes, Predicted intracellular proteins" "Cushing syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041524, HPA063706" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA041524: AB_10796676, HPA063706: AB_2685098" "unprognostic (1.37e-1)" "unprognostic (1.68e-3)" "unprognostic (8.22e-3)" "unprognostic (9.96e-2)" "unprognostic (2.59e-1)" "unprognostic (2.94e-3)" "unprognostic (4.09e-2)" "unprognostic (6.14e-3)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favorable (1.97e-6)" "unprognostic (4.70e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 8.3 8.1 6.6 8.1 11.6 35.3 8.4 13.1 13.6 5.3 5.7 7.8 5.5 9.7 9.1 6.0 8.4 7.1 4.9 6.6 8.4 7.5 6.7 16.1 8.4 7.3 8.9 5.4 8.6 9.3 9.2 9.4 7.3 9.1 7.2 2.9 6.5 10.4 5.8 14.2 13.2 8.3 4.5 5.9 8.6 8.0 6.0 8.9 6.8 9.9 6.8 5.3 5.1 16.8 4.0 10.0 2.8 3.1 9.8 4.9 3.2 2.9 4.7 2.1 3.0 1.3 1.0 5.3 3.9 1.7 2.3 1.9 4.4 3.1 2.9 8.2 2.2 2.3 4.5 2.4 3.5 0.4 4.1 6.0 1.3 7.1 10.1 2.5 8.8 8.9 2.4 4.0 2.3 0.6 2.6 3.5 4.9 6.5 7.1 1.6 7.4 3.3 35.4 3.3 1.3 3.0 5.9 3.0 10.8 1.7 3.5 6.7 5.9 3.6 4.9 2.7 1.3 3.2 10.5 6.5 5.0 3.7 2.0 3.2 6.5 5.6 1.8 3.3 7.4 3.5 2.8 3.1 0.9 4.9 1.6 4.1 4.0 3.8 3.8 4.1 3.5 3.4 3.8 1.8 9.8 1.7 10.0 4.6 3.2 6.6 11.6 13.1 13.6 8.4 7.5 8.9 5.4 9.1 8.9 6.0 14.7 4.5 7.9 5.8 3.9 5.6 10.2 1.4 7.9 0.0 5.9 6.2 3.3 4.7 1.0 8.5 10.3 0.0 4.0 4.6 5.8 5.6 9.2 23.6 5.3 12.7 7.5 6.2 4.8 0.0 4.0 3.0 1.7 2.8 5.2 6.8 3.3 3.6 5.3 3.7 5.2 0.0 6.4 3.9 6.1 5.5 9.6 5.0 3.8 4.8 ARMC6 MGC19595 ENSG00000105676 "Armadillo repeat containing 6" Q6NXE6 19 19033575-19060311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 54.4" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041420, HPA041681" Supported Enhanced Cytosol NA NA Cytosol "HPA041420: AB_2677469, HPA041681: AB_10793928" "unprognostic (2.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (2.11e-2)" "unprognostic (1.65e-2)" "unprognostic (3.55e-2)" "unprognostic (2.43e-1)" "unprognostic (8.98e-2)" "unprognostic (2.36e-1)" "unprognostic (7.04e-3)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (6.37e-2)" "unprognostic (1.70e-1)" "unprognostic (3.73e-2)" "unprognostic (1.40e-1)" 9.8 10.1 10.3 9.6 11.3 12.9 10.6 13.0 20.1 8.5 10.2 10.2 5.7 8.9 9.5 10.0 10.9 9.2 9.5 11.4 10.7 12.0 10.4 54.4 8.0 12.6 10.1 11.4 10.1 6.7 9.2 11.2 10.3 12.6 10.9 8.2 11.0 12.2 8.1 14.8 9.4 7.9 8.4 8.7 11.1 8.3 17.1 7.2 21.4 16.1 12.3 10.7 8.4 7.5 10.3 19.8 6.3 13.9 20.7 16.4 11.8 21.5 14.7 10.8 13.3 5.2 9.0 14.0 14.0 8.2 23.0 17.1 20.6 19.6 32.9 22.8 11.7 8.4 11.0 25.8 16.6 12.7 6.9 36.3 16.5 13.9 16.5 11.6 29.6 19.3 11.3 15.9 15.6 11.0 5.1 14.5 19.6 28.8 12.7 12.5 26.4 31.1 23.8 25.2 24.6 30.4 25.9 9.8 23.5 11.2 14.6 25.0 10.8 11.2 14.4 11.4 7.7 12.3 18.5 9.4 11.8 10.3 16.7 28.6 9.8 17.3 31.6 9.8 40.0 15.3 6.3 13.3 3.5 16.4 13.9 12.3 10.2 9.2 14.2 19.8 10.3 12.0 13.5 2.8 20.7 10.8 12.7 15.9 11.8 10.3 11.3 13.0 20.1 10.7 12.0 10.1 11.4 12.6 7.2 0.0 5.1 8.2 6.4 6.0 13.4 5.3 10.2 2.7 6.8 12.2 11.8 18.4 6.6 16.1 19.0 6.7 8.4 0.0 9.1 16.5 6.6 9.4 1.1 51.6 18.2 4.8 14.5 8.6 16.1 32.0 9.5 8.6 5.0 18.0 9.8 15.6 9.2 12.7 7.8 10.2 16.2 12.9 5.0 15.6 30.0 8.8 10.9 7.9 14.7 4.2 ARMC7 FLJ22160 ENSG00000125449 "Armadillo repeat containing 7" Q9H6L4 17 75109952-75130265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024229, HPA053076" Uncertain Supported Cytosol NA NA Cytosol "HPA024229: AB_2059152, HPA053076: AB_2682036" "unprognostic (1.35e-1)" "prognostic favorable (2.98e-4)" "unprognostic (7.73e-2)" "unprognostic (5.84e-2)" "unprognostic (4.15e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.84e-2)" "unprognostic (3.68e-1)" "unprognostic (4.28e-2)" "unprognostic (3.40e-2)" "unprognostic (4.86e-2)" "prognostic favorable (1.27e-4)" "unprognostic (1.93e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.98e-2)" 7.5 7.5 11.1 14.1 9.8 6.1 12.0 26.6 13.8 7.8 13.5 7.6 8.8 15.3 7.9 8.1 11.2 8.4 10.1 9.8 10.5 7.9 31.6 13.3 15.8 19.5 7.8 7.4 6.3 8.9 11.2 7.9 9.2 9.5 11.9 11.3 8.9 11.4 12.3 7.2 12.6 13.7 8.5 6.9 15.0 15.5 9.8 8.4 14.8 14.9 5.9 13.4 9.6 11.1 11.9 10.5 22.1 11.3 11.6 16.6 9.1 9.9 19.8 6.0 5.6 5.0 2.9 6.5 5.6 6.0 10.7 9.6 16.2 9.6 5.8 7.3 5.0 5.9 8.1 9.6 4.0 5.2 5.8 15.7 11.1 8.8 10.0 10.6 8.4 10.8 3.8 7.5 6.7 4.0 5.2 9.7 9.6 10.1 11.7 3.5 13.8 16.1 9.4 2.9 21.3 15.0 9.4 12.1 10.8 23.6 17.6 5.5 8.3 10.3 10.4 11.8 10.7 12.1 8.3 7.5 10.9 10.2 4.5 8.5 9.9 3.6 8.4 4.8 6.2 7.8 20.5 11.3 22.1 15.8 8.0 13.7 11.9 11.4 13.2 10.5 9.5 8.8 13.2 15.4 11.6 6.1 9.0 16.6 9.1 11.1 9.8 26.6 13.8 10.5 7.9 7.8 7.4 9.5 8.4 11.9 9.1 9.8 2.2 4.0 5.2 2.4 5.1 8.1 4.5 21.0 0.0 12.2 29.9 7.4 5.2 4.3 18.0 0.0 8.4 7.5 3.9 4.9 10.4 4.0 13.3 0.0 5.8 11.6 5.6 8.5 4.9 9.6 11.8 15.4 8.3 3.1 8.7 28.1 3.5 10.9 3.0 19.4 4.6 4.1 6.0 4.0 4.1 11.5 6.6 3.3 ARMC8 "DKFZP434A043, GID5, HSPC056, VID28" ENSG00000114098 "Armadillo repeat containing 8" Q8IUR7 3 138187248-138298389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036996, HPA044869" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA036996: AB_10672786, HPA044869: AB_2679123" "unprognostic (2.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (3.51e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (7.48e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (3.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.06e-2)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" 19.4 13.5 16.9 14.3 21.9 43.5 14.5 52.6 26.4 17.1 14.4 16.8 9.4 9.9 15.2 10.8 18.0 13.7 13.0 14.4 16.9 20.9 16.6 13.8 13.9 16.3 17.6 16.1 14.3 11.9 20.5 26.1 16.3 26.3 14.5 15.9 12.5 11.9 15.8 34.6 11.8 13.1 20.6 18.7 16.7 14.2 14.7 19.1 21.3 18.2 12.1 18.4 16.9 12.9 25.6 25.4 40.1 23.8 25.3 26.5 19.3 20.4 10.0 13.2 10.7 16.7 14.8 17.8 15.9 15.4 21.8 21.4 15.7 10.9 19.4 16.4 13.6 25.6 10.8 17.0 15.5 27.0 13.0 12.0 34.5 6.6 10.6 21.2 26.7 38.7 22.0 9.9 14.0 20.2 11.9 17.0 17.0 12.8 11.0 27.0 18.0 18.7 12.6 18.3 15.5 8.8 14.7 21.3 15.4 14.3 19.1 15.4 11.2 22.8 7.9 13.2 18.0 15.7 14.1 18.4 11.7 9.5 15.4 11.6 21.2 16.2 29.7 10.5 12.8 11.5 32.3 22.1 40.1 22.8 23.8 26.0 25.6 21.0 24.0 25.4 22.0 24.6 24.4 15.6 25.3 23.5 11.2 26.5 19.3 16.9 21.9 52.6 26.4 16.9 20.9 17.6 16.1 26.3 19.1 26.8 13.1 26.2 26.3 27.5 36.5 20.9 20.4 10.7 29.6 12.2 31.4 25.9 10.0 17.4 5.7 22.2 15.9 70.0 12.8 23.2 20.3 19.7 33.6 21.2 20.1 41.3 22.5 23.4 25.0 5.8 28.1 27.7 18.6 15.4 15.1 24.5 11.5 20.4 20.8 23.7 42.0 12.9 28.9 44.1 30.6 24.8 28.5 26.1 16.1 24.0 ARMCX1 "ALEX1, GASP7" ENSG00000126947 "Armadillo repeat containing, X-linked 1" Q9P291 X 101550531-101554700 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 26.9;ASC TERT1: 24.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;LHCN-M2: 24.4;RH-30: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000268, HPA005685, CAB020695" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "CAB020695: , HPA000268: , HPA005685: AB_10600781" "unprognostic (2.31e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-1)" "unprognostic (2.18e-3)" "unprognostic (2.13e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.32e-5)" "unprognostic (1.02e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-3)" "unprognostic (8.77e-2)" "unprognostic (2.12e-2)" "unprognostic (1.09e-2)" 17.5 29.8 13.6 7.4 16.5 2.7 18.9 13.4 21.5 24.4 18.7 9.6 15.9 6.2 27.3 19.0 12.3 16.3 14.8 26.6 13.3 18.4 12.1 3.8 11.6 4.4 13.7 14.6 42.6 10.2 20.1 18.0 12.5 16.4 25.8 7.0 13.0 12.0 21.1 22.7 8.1 7.6 26.3 9.1 11.4 10.0 8.1 10.5 3.5 14.0 11.6 3.3 26.8 29.7 0.2 9.9 0.5 4.3 2.1 3.7 2.1 0.7 0.2 5.6 0.0 26.9 24.2 0.0 8.7 17.2 11.0 27.8 0.0 0.1 0.0 7.5 13.4 12.1 0.7 0.0 1.2 6.2 0.0 0.0 5.0 1.7 0.0 14.2 0.0 0.0 20.2 1.7 8.3 0.0 9.1 6.6 0.0 0.1 0.1 24.4 0.3 0.0 0.0 8.0 0.0 0.0 0.0 30.8 0.0 7.5 0.0 5.5 4.6 0.0 0.1 15.0 1.6 0.9 3.7 8.7 6.7 3.5 19.4 0.1 0.0 0.1 0.0 6.5 0.0 4.1 0.0 4.3 0.5 0.0 3.9 0.7 0.0 0.6 0.3 9.9 0.2 1.5 3.7 0.1 2.1 1.1 5.1 0.9 2.1 13.6 16.5 13.4 19.9 13.3 18.4 13.7 14.6 16.4 10.5 23.8 6.1 0.0 23.8 29.5 26.3 54.8 7.6 5.3 5.7 22.7 5.9 1.4 11.6 14.6 0.3 23.2 0.5 0.0 6.0 2.1 52.1 21.0 24.2 0.4 23.6 20.6 5.2 17.8 9.4 0.9 43.7 11.0 55.6 6.4 1.0 31.1 7.5 0.0 41.8 11.4 13.3 45.3 48.4 1.7 0.7 19.1 2.2 1.0 0.6 7.4 ARMCX3 "ALEX3, GASP6" ENSG00000102401 "Armadillo repeat containing, X-linked 3" Q9UH62 X 101622797-101627843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000325, HPA000967, HPA001530" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349" "unprognostic (1.67e-1)" "unprognostic (2.14e-1)" "unprognostic (5.23e-2)" "unprognostic (8.69e-3)" "unprognostic (1.73e-2)" "unprognostic (1.47e-2)" "unprognostic (9.72e-3)" "unprognostic (2.19e-2)" "unprognostic (4.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.38e-3)" "unprognostic (2.12e-2)" "prognostic favorable (1.55e-5)" "unprognostic (3.29e-2)" "unprognostic (3.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.55e-2)" 21.0 39.2 26.6 14.8 32.9 8.5 20.5 20.5 36.9 30.6 18.8 21.0 37.1 13.3 26.9 67.8 12.7 17.1 22.0 31.7 28.0 26.6 24.0 17.8 19.1 12.7 27.8 29.6 26.7 38.2 62.0 37.9 28.5 35.4 29.1 14.8 13.6 34.8 31.6 25.5 7.9 13.8 24.6 25.7 24.1 19.0 9.2 22.8 8.2 31.9 17.1 13.7 21.4 21.3 11.6 18.8 25.2 11.8 10.2 14.8 9.4 8.8 6.0 16.4 9.1 37.8 42.2 3.7 19.5 18.8 8.6 24.9 7.1 8.2 3.4 11.2 22.7 17.5 1.7 12.3 7.1 10.5 6.7 7.8 6.3 20.4 10.2 30.0 6.1 15.0 23.3 9.6 10.3 11.1 21.6 16.2 3.8 4.8 30.2 23.3 3.9 5.0 0.2 8.3 16.2 1.3 6.4 21.4 3.0 12.0 3.7 7.6 6.5 9.4 0.6 20.2 23.8 7.1 6.3 22.7 11.4 7.4 25.7 3.8 24.5 6.6 0.0 17.3 4.9 9.6 25.2 11.2 9.5 10.9 11.3 14.8 11.6 10.8 9.5 11.3 7.9 12.2 8.5 4.1 10.2 11.8 18.8 6.6 9.4 26.6 32.9 20.5 36.9 28.0 26.6 27.8 29.6 35.4 22.8 41.7 29.7 51.4 69.7 33.7 60.9 87.7 56.0 14.7 34.2 71.5 55.0 47.1 31.5 41.8 0.5 61.9 17.9 46.7 26.6 17.4 93.4 96.0 76.3 43.1 44.4 58.8 78.9 51.5 46.4 1.1 59.8 60.8 92.8 22.6 46.0 98.2 30.2 24.6 68.2 33.5 12.2 32.3 93.7 1.9 0.4 18.7 96.1 34.6 28.6 71.5 ARMCX5 "FLJ12969, GASP5" ENSG00000125962 "Armadillo repeat containing, X-linked 5" Q6P1M9 X 102599168-102604159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000996 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Cytosol" "Plasma membrane" "HPA000996: AB_1078212" "unprognostic (7.71e-2)" "unprognostic (2.43e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (1.54e-1)" "unprognostic (5.05e-2)" "unprognostic (4.07e-2)" "prognostic favorable (6.58e-5)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (2.83e-1)" "unprognostic (3.28e-3)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (2.83e-1)" "unprognostic (5.24e-2)" 8.6 13.2 11.4 7.0 17.3 6.4 13.8 24.3 19.8 11.2 9.5 8.7 13.1 7.9 13.3 12.5 10.1 11.9 7.5 7.8 11.1 6.3 10.0 15.5 8.3 6.9 8.1 12.9 16.5 25.3 14.5 26.4 6.1 12.8 16.6 11.9 9.2 13.4 11.0 6.1 9.9 10.4 10.8 7.0 10.2 11.7 6.1 8.4 9.5 15.3 7.0 9.6 10.4 9.8 9.7 9.3 2.5 9.8 7.1 15.9 8.5 8.1 7.3 17.4 9.2 7.8 8.8 9.8 8.0 6.2 9.4 16.7 8.7 10.1 0.0 9.8 8.0 10.7 7.1 15.5 7.6 10.7 0.0 6.2 8.2 9.3 7.2 10.1 14.9 9.6 10.9 9.9 8.1 9.8 7.6 9.5 0.0 7.9 0.0 12.4 7.2 10.5 1.8 7.8 14.0 14.0 10.4 42.6 0.0 7.0 11.3 8.3 7.4 14.3 7.5 11.4 5.2 5.1 7.2 9.6 7.0 6.2 7.9 5.7 0.0 5.8 0.0 5.5 15.2 17.9 0.0 9.5 2.5 12.0 9.8 11.5 9.7 11.3 9.4 9.3 6.0 15.9 12.3 0.8 7.1 6.0 8.1 7.7 8.5 11.4 17.3 24.3 19.8 11.1 6.3 8.1 12.9 12.8 8.4 6.0 5.8 4.7 10.7 4.9 16.0 3.5 5.1 17.4 9.1 8.7 19.6 4.9 18.3 7.9 0.2 7.2 7.4 0.0 8.5 3.0 5.2 9.0 1.1 8.3 5.4 1.6 9.2 6.2 7.3 0.0 7.8 6.7 8.5 1.8 11.4 6.2 7.8 2.9 5.6 9.1 19.3 0.0 6.2 1.7 6.1 5.0 3.1 6.2 8.6 9.4 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing, X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: AB_2678277, HPA048125: AB_2680275" "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 15.1 17.2 11.7 12.1 12.1 7.6 12.7 10.9 12.1 18.7 12.0 15.4 22.6 6.7 17.3 25.9 17.3 14.1 12.4 15.6 11.3 12.6 14.1 12.2 11.2 12.1 13.1 10.3 21.3 27.2 23.4 21.0 16.3 13.1 17.7 9.0 11.8 39.2 23.5 6.5 11.3 10.4 17.1 16.7 22.6 10.6 9.0 11.4 17.9 17.3 9.7 19.3 18.8 13.7 12.8 14.1 10.0 7.0 8.1 8.7 6.4 6.6 7.9 12.4 7.0 25.4 15.1 2.4 14.1 13.7 12.6 24.7 4.8 6.5 7.1 14.4 13.2 13.2 7.0 12.0 5.7 9.9 6.1 7.3 6.7 11.0 6.3 11.7 6.5 8.4 9.4 5.8 7.7 4.0 17.6 12.8 3.7 5.5 9.2 18.9 16.4 9.5 0.0 8.9 8.7 1.6 9.8 16.6 2.6 9.1 0.9 6.8 6.4 8.2 0.0 10.5 9.9 5.8 3.1 9.9 15.4 6.9 21.4 3.2 11.4 6.1 0.0 4.6 1.7 5.0 10.0 3.8 6.3 6.5 7.0 8.7 12.8 7.0 7.3 8.1 9.1 8.4 7.8 0.5 8.1 5.0 14.1 3.9 6.4 11.7 12.1 10.9 12.1 11.3 12.6 13.1 10.3 13.1 11.4 8.9 7.8 28.4 14.8 11.8 4.8 8.1 12.7 1.4 6.8 29.6 15.7 31.9 19.9 36.6 0.4 25.1 3.1 0.0 24.2 14.6 30.1 15.7 13.9 13.4 60.4 9.5 15.7 23.4 19.6 1.3 17.3 28.6 35.4 30.7 15.5 28.2 25.6 14.0 18.7 17.2 4.1 25.8 15.6 2.6 2.2 14.1 28.8 33.1 13.8 15.9 ARMT1 "C6orf211, FLJ12910" ENSG00000146476 "Acidic residue methyltransferase 1" Q9H993 6 151452258-151470101 "Predicted intracellular proteins" "DNA damage" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003004, HPA005819" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 3200000 "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA003004: AB_1078358, HPA005819: AB_1845741" "unprognostic (5.16e-3)" "prognostic unfavorable (7.09e-4)" "prognostic favorable (4.14e-4)" "unprognostic (6.39e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (1.37e-2)" "unprognostic (9.47e-2)" "unprognostic (2.33e-2)" "unprognostic (2.16e-1)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.16e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-2)" "unprognostic (4.12e-1)" "unprognostic (1.22e-1)" 15.5 15.8 10.7 11.5 16.2 3.9 20.5 17.5 18.2 13.7 12.8 7.5 9.9 14.7 13.0 13.4 11.5 10.6 9.0 13.4 11.4 13.0 34.7 33.2 15.4 15.0 10.9 8.6 15.3 7.7 7.7 13.8 26.7 18.6 11.6 14.2 9.2 8.8 10.6 14.9 7.0 16.2 11.8 10.6 16.2 10.9 10.8 9.4 13.2 26.5 11.9 14.0 14.1 10.6 9.6 12.3 26.9 18.6 10.8 13.2 10.8 8.2 6.3 13.3 11.9 10.9 17.2 21.5 15.5 13.5 13.0 17.3 16.4 6.8 12.3 10.4 10.9 11.9 8.4 39.3 11.6 22.0 13.6 12.3 8.9 7.5 19.0 13.6 16.6 11.2 13.8 8.2 17.4 10.3 10.8 18.4 9.3 12.7 15.9 16.2 34.3 10.4 16.0 22.7 8.1 5.3 13.8 11.5 9.7 39.8 10.5 5.5 3.6 12.9 12.2 7.9 24.9 34.6 13.1 15.2 6.4 8.9 23.5 12.3 7.4 9.3 14.7 11.3 20.6 7.4 22.8 14.7 26.9 7.8 18.6 10.3 9.6 10.2 8.3 12.3 7.1 9.5 8.7 12.2 10.8 16.6 4.6 13.2 10.8 10.7 16.2 17.5 18.2 11.4 13.0 10.9 8.6 18.6 9.4 23.8 36.8 8.9 7.0 0.0 8.9 16.5 7.6 20.1 11.4 22.7 7.9 26.6 38.1 17.4 0.9 7.7 12.9 23.3 15.6 32.5 8.4 5.6 3.5 43.3 30.5 7.9 4.7 17.2 35.4 2.3 17.8 24.7 0.0 31.5 10.6 14.5 16.3 7.0 13.8 56.4 19.8 0.0 13.7 18.9 17.0 0.0 30.1 12.8 13.8 8.4 ARPC1A "Arc40, SOP2Hs, SOP2L" ENSG00000241685 "Actin related protein 2/3 complex subunit 1A" Q92747 7 99325910-99366262 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA004334 Approved Approved "Cell Junctions,Cytosol" NA NA 2400000 "Cell Junctions" Cytosol "HPA004334: AB_1078215" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (6.22e-3)" "unprognostic (1.93e-2)" "unprognostic (8.38e-3)" "unprognostic (1.95e-2)" "prognostic unfavorable (4.70e-4)" "unprognostic (2.52e-2)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.89e-2)" "unprognostic (7.88e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (7.07e-2)" "unprognostic (1.83e-1)" 36.6 39.8 40.2 25.2 41.0 18.7 49.1 32.3 55.9 40.0 43.6 32.3 37.9 50.1 30.4 45.9 58.3 43.3 32.1 65.3 45.9 43.5 30.6 41.2 29.6 32.2 38.6 39.7 47.2 41.9 30.9 31.4 31.8 40.6 28.2 44.2 33.9 31.7 36.7 20.9 46.1 55.0 31.9 27.9 26.8 53.1 28.6 25.1 23.7 44.4 41.8 31.6 31.5 33.9 11.1 16.1 33.2 29.1 10.9 12.6 9.9 45.5 24.8 28.2 12.9 26.3 44.9 24.0 32.8 38.5 33.4 33.4 27.8 52.6 16.0 48.5 39.7 49.5 19.4 37.0 47.5 40.5 7.9 31.1 8.5 18.5 22.4 29.0 10.0 11.2 41.7 26.6 43.1 46.0 39.7 54.7 13.2 21.3 18.5 51.3 66.6 16.8 13.4 26.5 51.0 56.2 9.9 19.5 19.5 24.8 27.7 29.2 24.9 32.1 46.1 43.6 49.9 23.0 14.8 42.4 42.9 38.4 75.5 52.2 7.2 13.3 22.7 37.0 22.6 56.2 33.2 18.9 31.9 9.8 28.6 7.6 11.0 9.3 12.6 16.1 11.1 12.1 9.1 23.8 10.9 29.1 11.7 12.1 9.9 40.2 41.0 32.3 55.9 45.9 43.5 38.6 39.7 40.6 25.1 47.6 40.3 44.7 107.8 36.9 36.8 41.2 86.6 64.3 34.2 55.8 17.7 167.1 114.4 166.9 15.6 83.7 206.9 116.8 242.7 281.6 45.8 130.5 12.7 70.0 73.9 31.8 71.2 92.1 68.9 20.6 61.9 41.2 75.9 60.5 155.3 53.9 324.8 150.8 63.3 116.3 29.0 181.1 159.3 117.8 120.8 41.9 108.5 26.7 144.4 216.4 ARPC1B "ARC41, p40-ARC, p41-ARC" ENSG00000130429 "Actin related protein 2/3 complex subunit 1B" O15143 7 99374249-99394814 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 213.6" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 816.2;Hofbauer cells: 990.8;Kupffer cells: 840.4;monocytes: 924.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 112.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004832 Enhanced Supported Vesicles,Cytosol NA NA 53000000 "Vesicles, Cytosol" "HPA004832: AB_1845044" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (2.84e-3)" "unprognostic (2.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (2.57e-4)" "unprognostic (4.37e-2)" "unprognostic (7.76e-2)" "unprognostic (1.02e-2)" "unprognostic (1.56e-1)" "unprognostic (4.86e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (1.18e-1)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (7.27e-2)" 31.8 17.8 8.7 50.7 14.4 56.4 35.4 1.9 7.7 17.9 30.7 8.4 18.1 32.6 17.4 21.8 16.0 18.3 23.4 24.4 5.7 7.0 27.9 34.8 40.0 92.8 10.7 3.7 11.6 13.0 3.8 13.1 36.2 9.4 15.6 10.5 20.6 18.3 15.1 10.6 10.0 42.3 12.1 10.2 81.8 16.3 10.8 9.3 31.0 23.0 13.7 37.2 19.0 21.1 53.5 133.7 127.2 154.4 38.9 83.4 213.6 16.0 29.2 2.2 6.4 8.5 30.7 22.4 22.3 22.5 9.0 8.0 19.0 62.6 27.9 41.8 24.3 19.7 12.1 2.8 19.7 3.7 22.7 10.5 20.3 8.5 13.1 24.5 20.3 69.1 17.1 10.2 12.7 12.6 18.1 23.7 14.9 22.5 67.3 13.1 74.1 22.4 44.5 8.0 19.0 63.6 18.1 2.0 68.3 18.6 7.9 1.8 5.9 15.2 67.1 112.2 7.6 15.8 41.4 34.6 25.7 21.3 45.3 28.1 12.5 24.9 34.1 25.6 53.0 46.0 53.7 153.2 121.6 53.8 154.4 50.2 53.5 62.8 59.6 133.7 42.8 37.0 49.3 127.2 38.9 142.0 77.9 83.4 213.6 8.7 14.4 1.9 7.7 5.7 7.0 10.7 3.7 9.4 9.3 38.7 80.0 287.6 95.5 53.8 9.2 5.6 119.8 56.2 54.6 123.9 7.9 492.8 21.6 353.0 2.6 242.9 360.5 0.0 368.7 816.2 113.0 95.0 189.2 37.0 990.8 1.6 108.2 201.3 840.4 4.0 34.5 558.1 170.4 924.3 71.7 20.6 324.8 290.8 17.0 73.6 15.8 90.5 96.8 2.1 14.7 32.4 253.6 319.0 152.9 154.0 ARPC5 "ARC16, dJ127C7.3, p16-Arc" ENSG00000162704 "Actin related protein 2/3 complex subunit 5" O15511 1 183620846-183635757 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 154.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022013, HPA031972" Approved Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA 15000000 "Vesicles, Plasma membrane, Cell Junctions, Cytosol" "HPA022013: AB_1845045, HPA031972: " "unprognostic (3.82e-1)" "unprognostic (8.78e-2)" "unprognostic (1.43e-1)" "unprognostic (2.36e-2)" "unprognostic (1.74e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (5.90e-3)" "unprognostic (3.84e-2)" "unprognostic (3.17e-3)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.21e-10)" "unprognostic (3.03e-2)" "unprognostic (4.66e-2)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" 46.6 25.1 24.9 57.5 24.3 25.2 28.9 13.8 24.8 26.6 42.3 26.5 18.6 40.8 39.0 26.7 44.5 29.3 24.6 36.8 28.2 22.3 28.8 29.7 52.3 58.3 28.4 18.7 27.3 21.5 12.4 18.2 84.8 20.0 23.2 29.2 17.0 25.4 16.5 16.4 25.2 47.3 32.8 46.0 79.9 35.6 21.7 23.5 61.2 27.5 22.7 52.8 30.6 30.8 27.4 68.9 154.0 96.6 30.7 40.7 124.3 51.8 28.8 24.8 17.0 20.5 29.3 59.3 71.3 55.0 31.1 25.4 26.0 36.8 47.7 81.2 41.0 20.1 36.1 17.4 24.3 16.5 68.7 15.6 28.8 39.2 22.4 33.4 41.8 56.3 35.4 25.9 37.6 29.9 35.7 36.4 33.8 21.9 39.6 40.2 21.3 39.0 11.3 23.6 40.3 11.1 36.3 22.0 46.0 17.4 26.9 10.8 28.9 74.3 32.1 27.6 27.1 32.2 37.4 81.1 45.4 23.6 50.8 68.6 47.2 52.1 32.7 35.8 30.2 34.9 79.3 80.0 124.1 34.8 89.8 27.7 27.4 34.2 35.5 68.9 24.4 37.1 37.6 154.0 30.7 96.6 32.5 40.7 124.3 24.9 24.3 13.8 21.1 28.2 22.3 28.4 18.7 20.0 23.5 348.4 174.9 170.6 139.1 221.2 29.2 25.0 142.7 81.7 120.6 78.5 13.7 419.1 140.9 316.3 26.2 168.2 202.4 0.0 245.8 625.6 206.8 137.2 247.7 72.7 547.8 36.5 193.8 182.3 533.2 18.6 116.5 649.2 241.3 607.8 124.2 50.0 287.4 192.9 172.5 110.5 24.5 239.3 277.9 83.0 95.6 214.0 166.8 309.6 117.5 206.4 ARPP21 "ARPP-21, R3HDM3, TARPP" ENSG00000172995 "CAMP regulated phosphoprotein 21" Q9UBL0 3 35638945-35794496 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.8;Cardiomyocytes: 3.4;Early spermatids: 1.6;Late spermatids: 2.2" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Region enriched" "Detected in all" 5 "basal ganglia: 146.9" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 12.1" "Lineage enriched" "Detected in single" 30 "dendritic cells: 12.1" "Cell line enhanced" "Detected in some" "JURKAT: 46.2;MOLT-4: 27.1;REH: 15.0;RH-30: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017303 Enhanced Supported Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA017303: AB_1845049" "unprognostic (1.72e-4)" "unprognostic (2.35e-1)" "unprognostic (1.10e-2)" "unprognostic (6.61e-2)" "unprognostic (6.30e-3)" "unprognostic (8.90e-2)" "unprognostic (2.42e-3)" "unprognostic (1.27e-1)" "unprognostic (7.42e-4)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "unprognostic (1.52e-1)" 1.2 1.3 12.3 1.5 146.9 4.6 1.1 27.8 67.9 1.1 1.4 0.3 0.0 1.3 1.1 1.1 3.2 1.1 1.1 1.1 6.8 2.8 2.0 2.9 1.2 1.2 3.9 11.5 1.1 1.1 1.1 1.9 1.1 6.7 2.0 1.5 0.0 1.1 1.3 43.6 1.1 1.4 1.1 0.8 1.2 1.1 1.1 14.8 41.2 1.5 3.5 1.5 1.1 0.1 0.1 12.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.2 0.0 46.2 0.0 0.1 1.1 0.0 27.1 0.0 0.0 0.0 1.1 15.0 8.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 12.3 146.9 27.8 14.7 6.8 2.8 3.9 11.5 6.7 14.8 0.0 0.0 0.0 0.0 0.0 2.8 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ARRB2 "ARR2, BARR2, DKFZp686L0365" ENSG00000141480 "Arrestin beta 2" P32121 17 4710489-4721499 "Predicted intracellular proteins" "Protein transport, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 102.8;lymphoid tissue: 66.6" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 226.1;Kupffer cells: 213.1;Macrophages: 203.0;monocytes: 348.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 42.4;HMC-1: 71.5;NB-4: 43.0;U-937: 61.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075177 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA075177: " "unprognostic (1.12e-1)" "prognostic favorable (2.93e-5)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" "unprognostic (7.43e-2)" "unprognostic (3.37e-2)" "unprognostic (2.62e-3)" "unprognostic (3.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.58e-1)" "unprognostic (1.66e-3)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.32e-2)" "unprognostic (8.61e-2)" "unprognostic (4.92e-2)" "unprognostic (1.49e-1)" "unprognostic (1.88e-1)" 21.6 15.6 23.7 47.8 18.3 102.8 10.0 28.1 26.3 8.7 16.1 20.4 1.9 23.0 7.4 7.8 7.1 10.8 14.8 10.2 27.3 20.9 10.5 15.6 35.0 31.3 20.1 19.6 8.7 8.3 6.6 10.2 16.0 19.7 7.4 13.2 10.7 8.7 6.2 5.5 5.8 21.0 13.7 21.7 66.6 12.5 5.0 18.3 23.5 6.4 3.2 17.0 15.7 7.1 2.2 18.0 52.9 32.8 5.9 11.4 16.0 3.7 19.9 7.8 7.5 1.5 2.2 4.1 2.9 4.0 8.7 10.9 6.8 3.1 10.4 2.7 2.2 4.2 6.3 12.9 4.1 9.0 24.8 18.8 42.4 10.1 12.0 2.3 18.8 71.5 2.0 5.3 10.7 4.3 5.7 6.6 19.7 2.8 10.5 1.9 6.6 18.8 43.0 4.2 10.0 4.1 22.2 6.9 11.6 3.0 2.0 8.1 11.2 6.6 11.5 5.1 3.4 5.5 8.9 5.7 3.3 6.6 5.6 11.1 4.4 5.9 5.9 8.7 61.3 4.8 22.6 30.4 52.5 11.0 31.5 7.8 2.2 7.1 11.4 18.0 1.9 6.8 9.0 52.9 5.9 32.8 4.4 6.0 16.0 23.7 18.3 28.1 26.3 27.3 20.9 20.1 19.6 19.7 18.3 20.8 44.9 18.5 7.0 10.2 17.4 8.1 10.2 8.1 18.2 3.5 2.0 4.8 13.3 8.8 0.4 9.2 10.3 0.0 6.2 9.4 8.1 3.9 91.4 12.1 226.1 20.6 8.1 19.6 213.1 1.8 4.6 203.0 10.1 348.1 14.3 4.7 7.6 17.3 4.6 12.9 7.5 19.4 5.4 0.5 11.8 7.3 5.0 76.9 11.9 10.5 ARSA ENSG00000100299 "Arylsulfatase A" P15289 22 50622754-50628173 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 87.0;Late spermatids: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005554, CAB025183" Enhanced Uncertain "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 4500000 "Golgi apparatus" Cytosol "CAB025183: , HPA005554: AB_1078220" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (4.07e-2)" "prognostic favorable (2.96e-5)" "unprognostic (4.66e-2)" "unprognostic (4.40e-1)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.61e-2)" "unprognostic (2.16e-1)" "unprognostic (4.47e-2)" "unprognostic (2.76e-1)" "unprognostic (9.90e-2)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" "unprognostic (7.73e-3)" 19.0 15.2 14.0 15.2 15.7 16.6 15.2 11.9 17.9 12.0 20.3 21.4 26.4 30.2 13.3 21.4 15.6 18.5 23.3 18.8 13.4 8.8 17.5 24.1 15.7 16.8 19.1 10.3 9.3 45.4 13.1 20.4 18.5 17.3 15.8 8.8 14.0 36.8 21.9 6.3 11.1 23.4 8.7 13.2 25.6 23.6 27.2 17.9 10.6 18.7 7.5 16.5 14.8 13.3 5.6 15.7 30.1 19.8 3.9 8.9 7.7 4.1 5.8 2.8 5.4 20.9 11.4 7.0 6.7 8.2 2.9 5.0 1.6 6.4 2.8 4.1 11.0 5.4 6.4 0.6 6.2 0.4 1.2 4.4 1.6 6.5 5.8 14.5 2.4 17.1 13.5 12.1 4.8 3.1 9.9 6.6 5.8 1.7 39.3 5.9 4.7 2.2 2.8 0.8 4.3 5.8 2.0 0.2 12.9 4.9 6.4 1.3 4.3 9.5 8.5 4.8 2.6 3.8 3.0 11.6 2.1 8.0 7.5 1.9 9.3 0.8 2.1 6.1 2.2 6.9 4.3 13.7 17.1 8.9 16.0 7.9 5.6 6.5 7.3 11.2 5.6 3.9 5.3 30.1 3.9 19.8 15.7 8.5 7.7 14.0 15.7 11.9 17.9 13.4 8.8 19.1 10.3 17.3 17.9 6.0 11.7 17.5 11.1 4.1 4.9 6.5 30.6 13.4 4.5 12.2 3.9 10.2 1.7 28.6 51.1 7.9 87.0 23.3 18.7 18.1 13.0 12.6 5.8 27.6 33.4 6.4 35.3 9.2 28.5 100.4 10.0 17.4 16.9 37.9 23.2 9.3 25.7 35.9 5.6 20.6 6.2 0.0 4.7 43.1 3.1 4.8 11.1 10.5 19.0 14.9 ARSF ENSG00000062096 "Arylsulfatase F" P54793 X 3041471-3112726 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;kidney: 11.5;skin 1: 8.3" "Cell type enhanced" "Detected in some" 31 "Distal tubular cells: 1.7;Proximal tubular cells: 4.6" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.0;U-266/70: 1.1" HPA000549 Uncertain Cytosol "Secreted in other tissues" NA NA Cytosol "HPA000549: AB_1845055" "unprognostic (2.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.87e-1)" "unprognostic (5.41e-3)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (9.72e-2)" "unprognostic (4.70e-1)" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (3.59e-1)" "unprognostic (1.23e-1)" "unprognostic (9.76e-2)" "unprognostic (1.48e-1)" 0.0 4.6 2.7 0.0 5.3 0.0 0.1 0.0 1.9 0.4 0.0 0.0 0.0 2.5 3.1 0.0 0.0 0.0 1.3 0.5 11.5 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.6 1.5 0.3 0.2 1.9 0.3 0.8 0.3 0.0 0.2 0.4 0.5 0.7 0.0 0.2 2.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.1 0.5 0.1 0.1 1.1 0.1 0.1 0.8 0.4 0.3 1.9 0.3 0.4 0.2 0.3 0.3 0.1 0.3 0.2 0.0 0.3 0.3 0.3 1.2 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 ASAP1 "CENTB4, DDEF1, KIAA1249, PAP, ZG14P" ENSG00000153317 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 1" Q9ULH1 8 130052104-130443660 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 156.9;Late spermatids: 319.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in many" 5 "dendritic cells: 4.1;granulocytes: 13.0;monocytes: 6.6" "Cell line enhanced" "Detected in all" "TIME: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011136, CAB037292, HPA048565" Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA 25000 "Plasma membrane, Centrosome, Cytosol" "CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445" "unprognostic (1.20e-2)" "unprognostic (1.15e-2)" "unprognostic (7.68e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.77e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (5.63e-8)" "prognostic unfavorable (3.56e-5)" "unprognostic (3.34e-1)" "unprognostic (5.27e-2)" "unprognostic (8.56e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.50e-7)" "unprognostic (3.79e-2)" "unprognostic (1.19e-1)" "unprognostic (7.38e-2)" "unprognostic (1.22e-3)" 34.1 17.2 10.5 9.5 12.5 29.7 19.8 6.4 21.8 19.3 8.9 9.1 6.6 4.4 15.6 18.9 10.5 11.8 14.5 17.5 10.0 11.0 7.9 7.6 26.2 12.9 11.3 8.0 15.2 6.8 21.7 8.2 27.3 15.2 9.9 7.2 13.9 6.2 13.9 13.0 12.1 8.4 16.6 11.9 26.1 8.0 21.7 9.7 5.6 12.3 10.6 14.5 12.9 21.2 1.5 4.1 13.0 6.6 0.7 1.6 1.1 15.5 11.7 17.1 9.6 14.9 22.1 13.7 16.7 29.1 20.4 21.8 5.9 5.9 3.6 11.9 24.2 13.6 3.9 8.7 14.6 28.6 5.6 5.3 6.2 6.9 7.6 38.2 2.7 1.9 20.7 4.8 10.8 18.0 22.1 21.4 2.1 3.2 14.4 17.8 4.6 3.5 2.7 4.3 7.7 10.6 5.0 3.0 2.4 5.2 8.4 4.9 15.9 12.3 7.5 8.8 15.0 6.3 6.1 62.6 16.4 7.9 6.4 24.5 13.2 3.0 2.5 12.1 3.9 18.2 0.0 2.4 1.6 0.7 2.4 0.4 1.5 1.2 1.0 4.1 1.3 1.6 1.0 13.0 0.7 6.6 0.4 0.8 1.1 10.5 12.5 6.4 14.6 10.0 11.0 11.3 8.0 15.2 9.7 3.0 7.5 14.3 18.6 42.4 18.5 31.3 12.7 2.7 13.6 3.5 15.7 35.8 3.3 9.1 156.9 106.7 3.5 23.3 7.5 32.0 42.0 21.7 9.2 7.4 54.2 58.8 12.6 90.9 55.3 319.2 36.2 54.3 42.2 55.9 3.9 9.5 9.1 3.5 51.6 3.4 7.2 77.6 58.7 29.0 94.8 39.3 39.0 12.9 3.5 17.4 ASAP2 "CENTB3, DDEF2, KIAA0400, PAP, SHAG1" ENSG00000151693 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 2" O43150 2 9206765-9405683 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "basophil: 6.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018615 Approved Supported Cytosol NA NA 66000 Cytosol "CAB018615: AB_2242947" "unprognostic (1.19e-1)" "unprognostic (2.66e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (3.06e-2)" "unprognostic (1.08e-3)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (8.33e-2)" "unprognostic (1.58e-3)" "unprognostic (3.14e-1)" "unprognostic (3.16e-1)" "unprognostic (2.64e-2)" "unprognostic (3.24e-2)" 13.7 3.4 7.3 8.2 14.5 0.9 11.7 16.3 13.9 13.8 15.3 8.1 6.8 12.1 19.3 10.5 8.1 10.1 16.5 10.5 8.1 5.6 21.7 3.7 9.0 2.6 10.7 7.3 7.9 7.0 12.4 44.1 9.2 10.8 6.6 14.4 10.7 7.1 8.9 3.3 12.3 13.5 12.6 8.7 1.6 21.6 38.5 7.8 0.1 17.5 6.1 3.3 8.5 11.4 0.0 0.9 6.2 0.0 0.0 0.0 0.3 11.7 6.8 12.6 7.4 9.3 13.0 2.1 11.8 9.6 8.7 8.8 4.7 17.6 0.0 10.5 13.3 19.3 11.3 6.9 20.8 10.9 8.4 2.9 2.7 5.2 9.0 22.7 0.0 0.8 4.8 8.6 10.5 34.4 26.6 18.0 2.2 1.2 1.2 33.9 7.3 3.3 0.7 6.0 17.3 8.1 6.5 18.8 2.2 17.2 9.1 5.6 21.5 9.9 6.6 11.0 7.1 4.5 1.9 28.0 14.8 0.7 11.4 10.8 0.0 0.0 0.0 10.8 0.0 18.8 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 7.3 14.5 16.3 11.6 8.1 5.6 10.7 7.3 10.8 7.8 17.9 8.8 0.0 15.4 33.1 28.4 1.2 7.6 6.7 7.9 33.2 0.0 0.8 43.1 14.8 51.2 28.1 27.6 0.0 12.3 0.3 8.0 16.4 1.1 3.6 9.9 6.4 8.7 38.1 4.9 36.9 2.6 5.8 32.1 11.8 37.5 19.5 38.5 35.1 3.5 23.5 4.6 25.8 24.2 49.4 7.0 28.1 0.3 0.0 18.8 38.4 ASB2 ASB-2 ENSG00000100628 "Ankyrin repeat and SOCS box containing 2" Q96Q27 14 93934153-93976791 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 96.9" "Cell type enhanced" "Detected in some" 17 "Cardiomyocytes: 40.8;Early spermatids: 26.4;Late spermatids: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 8 "eosinophil: 23.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.1" "Cell line enhanced" "Detected in some" "Karpas-707: 8.8;RPMI-8226: 8.0;U-266/70: 24.0;U-266/84: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001546 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA001546: AB_1078224" "unprognostic (5.65e-4)" "unprognostic (8.19e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.62e-6)" "unprognostic (4.11e-2)" "unprognostic (1.61e-1)" "unprognostic (5.29e-2)" "unprognostic (1.05e-3)" "unprognostic (4.25e-2)" "unprognostic (1.48e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (2.49e-7)" "unprognostic (2.51e-3)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.27e-1)" 3.1 0.5 0.2 7.9 0.8 0.4 0.5 0.2 1.7 7.4 14.0 0.0 4.6 2.2 11.9 5.7 7.2 6.5 7.7 17.2 0.2 0.2 0.3 0.3 0.8 2.3 0.3 0.6 2.3 0.3 0.3 0.2 0.3 0.5 8.5 1.5 1.5 1.6 5.8 96.9 0.5 4.4 24.4 0.3 1.5 5.0 0.3 0.0 0.0 0.7 25.7 4.7 14.3 4.5 0.9 2.6 23.1 3.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 24.0 5.3 0.8 0.2 2.5 0.5 0.0 0.0 23.1 0.8 1.0 0.1 0.9 0.8 1.7 2.6 0.2 0.1 0.2 0.0 0.0 3.0 0.1 1.1 0.5 0.2 0.8 0.2 1.7 0.2 0.2 0.3 0.6 0.5 0.0 0.0 0.0 1.4 0.0 0.3 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 26.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 20.6 0.3 1.0 1.7 9.0 0.0 0.9 0.3 0.0 0.4 0.0 1.1 0.0 3.1 0.9 5.9 0.1 2.4 6.9 0.0 0.1 ASCC1 "ASC1p50, CGI-18, Em:AC022392.3" ENSG00000138303 "Activating signal cointegrator 1 complex subunit 1" Q8N9N2 10 72096032-72217134 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038038, HPA057567" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038038: AB_10674544, HPA057567: " "unprognostic (1.96e-1)" "unprognostic (2.79e-2)" "unprognostic (5.36e-2)" "unprognostic (1.03e-2)" "unprognostic (2.92e-3)" "unprognostic (2.34e-2)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.22e-2)" "unprognostic (8.30e-3)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.66e-1)" "unprognostic (6.64e-2)" 17.2 23.3 23.2 13.3 25.9 10.9 20.9 27.4 23.8 21.2 12.4 25.7 19.6 9.5 16.9 21.3 16.4 17.2 16.0 26.4 24.7 21.6 18.6 24.3 12.7 19.8 35.2 14.9 21.9 24.8 19.3 22.0 14.5 28.2 15.4 12.9 13.1 11.9 19.5 25.7 14.8 12.5 18.0 35.4 16.9 13.7 20.9 34.5 20.8 17.8 9.4 20.9 18.0 15.7 24.9 22.9 25.4 14.9 19.7 24.2 14.6 13.4 17.7 13.5 25.5 18.7 19.6 10.3 8.2 17.6 14.0 17.3 19.2 48.6 18.2 16.9 11.9 10.2 17.5 10.8 16.5 15.2 12.8 9.6 11.4 14.6 17.7 16.9 12.5 12.1 18.4 36.2 15.0 21.1 19.4 17.1 20.1 15.8 22.7 14.9 12.8 16.4 17.3 7.1 9.8 4.3 9.3 10.9 13.3 24.1 9.1 12.8 9.2 11.4 29.4 22.2 12.0 10.1 8.5 16.2 7.1 13.5 5.6 8.6 14.1 18.2 22.0 11.4 28.6 5.5 16.5 14.9 25.4 14.5 14.7 14.4 24.3 17.2 15.2 15.1 24.9 24.2 21.9 9.4 19.7 11.5 22.9 21.6 14.6 23.2 25.9 27.4 23.8 24.7 21.6 35.2 14.9 28.2 34.5 8.9 4.3 18.4 13.0 5.6 11.5 19.7 5.1 5.3 7.9 12.2 13.7 14.9 19.9 17.7 22.1 10.8 4.5 23.3 17.8 16.4 12.8 6.0 12.7 17.7 15.8 23.8 3.5 7.4 28.5 10.0 19.0 7.9 18.6 27.9 4.9 17.7 13.3 4.5 19.4 9.2 13.9 12.9 17.9 28.9 20.6 6.0 12.7 16.6 4.7 8.2 ASCC2 "ASC1p100, DKFZp586O0223, FLJ21588" ENSG00000100325 "Activating signal cointegrator 1 complex subunit 2" Q9H1I8 22 29788608-29838304 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 128.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001439, HPA052879" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" Nucleoplasm "HPA001439: AB_1078229, HPA052879: AB_2732577" "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (8.58e-2)" "unprognostic (3.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.45e-3)" "unprognostic (3.01e-3)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (5.39e-2)" "unprognostic (1.56e-2)" "unprognostic (1.24e-1)" "unprognostic (3.97e-3)" "unprognostic (5.19e-2)" "unprognostic (7.53e-2)" "unprognostic (3.81e-1)" "unprognostic (2.05e-3)" 19.5 24.2 13.1 22.1 15.1 32.3 23.1 13.4 14.0 16.8 16.9 17.9 22.5 16.5 17.1 17.7 31.1 14.6 19.0 17.7 10.8 8.2 15.8 35.3 19.2 20.2 15.4 9.1 16.2 18.4 17.5 20.6 23.2 12.5 20.1 17.8 17.6 22.2 30.9 50.0 21.7 22.3 14.2 12.9 22.7 25.8 41.0 13.0 28.9 21.9 25.0 26.6 19.1 21.2 11.3 21.1 28.5 27.6 17.3 18.8 10.9 19.7 11.5 12.5 16.9 18.8 16.7 18.0 20.6 15.9 21.4 21.5 13.4 10.7 19.7 14.9 19.8 13.6 24.0 16.0 23.4 18.1 25.2 28.0 16.9 14.6 16.0 23.6 30.3 51.5 17.9 21.3 24.3 22.4 12.6 18.7 13.3 17.4 19.2 19.3 24.4 18.5 16.0 9.1 27.9 15.7 22.4 15.4 20.6 13.1 32.7 19.4 17.1 19.1 21.1 15.3 13.4 15.0 15.9 18.4 30.0 5.1 18.1 20.3 23.0 17.5 23.4 17.5 17.0 21.6 18.2 16.7 28.5 18.8 27.6 16.8 11.3 14.2 15.8 21.1 8.9 14.7 14.8 5.1 17.3 22.5 12.0 16.4 10.9 13.1 15.1 13.4 14.0 10.8 8.2 15.4 9.1 12.5 13.0 17.9 14.3 24.0 18.4 26.7 9.0 16.5 25.5 18.7 18.2 38.4 3.9 37.6 10.0 24.0 92.7 20.5 38.5 23.3 21.6 52.8 23.3 15.9 34.6 23.2 27.5 4.8 14.9 17.8 24.8 128.4 28.7 33.0 27.0 22.6 17.2 11.8 22.4 24.6 23.3 15.2 13.6 19.4 16.0 39.1 19.2 34.4 37.1 35.9 20.3 30.8 ASCC3 "ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH" ENSG00000112249 "Activating signal cointegrator 1 complex subunit 3" Q8N3C0 6 100508194-100881372 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031608, HPA031609, HPA031610" Enhanced Supported "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526" "unprognostic (6.79e-2)" "unprognostic (1.46e-2)" "unprognostic (2.96e-3)" "unprognostic (1.12e-1)" "unprognostic (9.70e-3)" "unprognostic (4.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.14e-2)" "unprognostic (4.02e-1)" "unprognostic (3.34e-1)" "unprognostic (5.08e-3)" "unprognostic (1.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-1)" "unprognostic (1.55e-2)" 15.9 15.4 10.9 15.5 14.5 13.6 13.4 16.1 11.7 16.7 13.2 7.7 10.1 11.4 16.4 12.9 18.4 11.3 11.1 14.9 9.7 8.4 10.4 28.3 12.6 13.1 13.1 7.6 13.8 15.1 25.0 38.6 26.1 10.4 16.4 17.1 6.4 15.4 14.0 13.6 15.3 16.1 12.2 15.5 17.7 11.5 11.7 12.4 25.0 10.6 11.6 15.2 16.0 17.9 8.5 9.4 5.9 6.4 6.0 7.8 1.8 7.1 8.9 13.4 8.2 15.0 19.2 20.8 31.2 20.1 10.8 12.5 18.1 5.7 21.9 6.1 20.9 8.6 16.0 11.5 27.7 17.5 13.8 9.8 16.6 16.6 11.8 13.8 17.5 12.8 17.4 14.2 15.7 20.0 10.2 19.8 9.1 19.5 10.0 29.7 6.9 8.7 5.3 7.0 13.7 6.8 10.5 10.2 8.1 10.6 20.2 8.8 6.6 12.9 11.8 5.4 24.9 6.5 10.0 27.1 12.0 9.1 10.4 13.1 4.3 4.0 19.5 8.7 13.2 12.5 5.9 3.9 2.4 6.7 6.4 7.8 5.8 5.6 6.0 4.1 8.5 6.5 6.2 0.3 6.0 5.2 9.4 4.3 1.8 10.9 14.5 16.1 11.7 9.7 8.4 13.1 7.6 10.4 12.4 29.8 19.8 36.0 39.8 22.7 25.2 28.6 20.4 33.5 39.8 3.5 21.6 20.4 10.0 20.1 6.1 18.0 14.6 23.3 21.5 57.6 23.6 58.3 20.9 28.8 15.8 27.0 13.3 8.6 19.6 1.5 21.3 20.7 5.0 15.4 16.4 16.4 22.7 11.0 16.3 9.7 30.3 6.5 26.4 47.4 20.0 24.0 31.8 23.5 17.1 49.7 ASCL1 "ASH1, bHLHa46, HASH1" ENSG00000139352 "Achaete-scute family bHLH transcription factor 1" P50553 12 102957686-102960516 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3;liver: 23.0;pituitary gland: 29.4" "Cell type enriched" "Detected in some" 7 "Intestinal endocrine cells: 34.9" "Group enriched" "Detected in many" 6 "glioma: 21.4;lung cancer: 11.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "SCLC-21H: 33.4;SH-SY5Y: 18.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029217, HPA076307" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA029217: AB_10669595, HPA076307: " "unprognostic (7.92e-2)" "unprognostic (4.37e-3)" "unprognostic (4.55e-2)" "unprognostic (5.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.22e-2)" "unprognostic (1.56e-1)" "unprognostic (2.09e-1)" "unprognostic (4.84e-2)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (7.10e-6)" "unprognostic (3.40e-1)" "unprognostic (2.17e-1)" "unprognostic (3.76e-1)" "unprognostic (5.52e-2)" 0.9 2.8 11.1 0.7 6.9 0.7 0.7 3.3 19.3 1.3 0.9 6.6 0.0 0.9 1.0 0.8 0.7 2.2 0.8 0.7 8.5 5.8 0.8 23.0 1.7 1.4 7.6 4.7 1.6 0.9 0.7 29.4 0.8 13.9 1.1 1.0 0.0 0.7 0.8 0.8 0.7 0.8 0.9 18.7 0.7 3.2 0.9 7.3 6.0 1.0 0.0 0.8 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.4 18.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 6.9 3.3 10.7 8.5 5.8 7.6 4.7 13.9 7.3 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.1 4.8 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 ASIC3 "ACCN3, DRASIC, TNaC1" ENSG00000213199 "Acid sensing ion channel subunit 3" Q9UHC3 7 151048292-151052756 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 11.8;Early spermatids: 11.6;Late spermatids: 43.6" "Cancer enhanced" "Detected in many" "testis cancer: 7.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 17.2;U-266/84: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049155, HPA054805" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA049155: AB_2680657, HPA054805: AB_2732588" "unprognostic (8.71e-3)" "unprognostic (1.09e-1)" "unprognostic (1.92e-4)" "unprognostic (2.73e-1)" "unprognostic (7.06e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.42e-1)" "unprognostic (4.45e-2)" "unprognostic (8.64e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-12)" "unprognostic (1.49e-2)" "unprognostic (7.38e-2)" "unprognostic (1.65e-2)" "unprognostic (5.31e-3)" 2.6 2.4 6.8 0.9 27.1 1.5 1.3 20.1 15.4 3.6 2.3 0.9 0.5 2.9 4.9 3.5 0.6 2.4 1.9 2.4 6.5 5.3 1.5 1.3 2.7 1.9 4.2 9.9 3.0 1.4 1.4 7.1 1.8 6.2 1.9 1.8 0.7 1.7 1.4 9.0 3.5 2.7 2.4 6.0 2.1 2.8 10.2 2.2 0.5 1.1 0.5 1.9 0.9 1.2 0.0 0.0 0.0 0.8 0.0 0.7 0.0 1.3 3.6 1.7 2.4 3.3 0.0 7.4 0.4 0.0 0.3 0.4 0.7 1.6 0.9 0.4 0.2 1.6 2.3 0.9 0.0 0.7 7.8 4.2 1.6 2.7 0.0 0.0 0.1 3.9 0.5 0.5 0.2 0.0 2.6 0.1 0.9 3.8 6.4 0.5 6.0 0.3 0.4 1.7 0.1 2.8 2.9 1.6 0.5 0.3 1.3 2.2 8.6 0.6 0.4 4.1 4.6 1.7 0.4 0.1 1.5 2.2 4.0 1.0 17.2 9.1 0.1 2.1 5.7 1.4 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.8 27.1 20.1 15.4 6.5 5.3 4.2 9.9 6.2 2.2 0.0 0.3 0.0 0.0 0.6 8.6 1.6 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.2 11.6 0.3 0.3 0.0 0.3 0.1 0.5 0.2 9.2 0.6 0.6 6.4 0.0 0.0 0.6 43.6 1.4 0.3 0.0 1.0 0.0 1.9 0.3 0.0 1.8 0.3 5.0 0.0 0.0 9.2 5.1 0.6 0.6 0.0 0.2 0.1 ASL ENSG00000126522 "Argininosuccinate lyase" P04424 7 66075798-66093558 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 99.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 226.8;Hepatocytes: 477.5;Paneth cells: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003696, HPA016646" Enhanced Approved Cytosol NA NA 10000000 Cytosol "CAB003696: AB_425316, HPA016646: AB_1845096" "unprognostic (2.95e-2)" "prognostic unfavorable (4.05e-6)" "unprognostic (4.83e-1)" "unprognostic (4.18e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (2.07e-1)" "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (7.25e-2)" "unprognostic (4.95e-2)" "unprognostic (2.07e-2)" "unprognostic (3.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-1)" "unprognostic (8.40e-3)" 5.6 4.8 4.0 8.0 4.3 7.3 5.9 7.2 7.4 5.5 17.2 3.7 7.8 20.8 5.0 7.1 7.7 4.9 19.5 4.3 3.7 4.3 16.0 99.5 8.1 4.5 4.4 6.2 5.9 10.4 3.3 5.8 3.3 7.2 5.4 12.4 5.8 7.1 5.7 2.4 4.1 16.6 3.4 3.2 8.6 12.6 2.1 3.5 1.2 7.1 7.9 5.9 5.2 5.9 8.6 19.3 20.7 18.4 30.4 9.2 10.7 18.2 7.5 4.1 14.8 9.5 7.3 9.0 12.8 11.2 18.3 16.7 16.9 22.6 5.6 20.5 16.8 13.3 5.0 2.6 21.7 5.3 4.6 3.4 7.4 7.3 26.1 17.7 8.4 21.7 13.7 7.9 12.8 20.5 4.6 18.0 4.0 13.1 10.7 10.1 13.0 1.7 11.6 6.2 22.8 9.7 4.5 4.3 19.3 13.3 11.0 7.1 9.7 11.7 40.8 4.4 4.4 17.8 7.6 20.4 23.2 12.0 9.2 16.5 11.7 6.1 7.3 21.9 16.0 18.7 12.1 18.1 20.7 7.7 18.4 6.5 8.6 5.2 6.1 19.3 5.6 3.7 4.0 4.0 30.4 13.8 1.2 9.2 10.7 4.0 4.3 7.2 7.4 3.7 4.3 4.4 6.2 7.2 3.5 17.9 52.0 20.8 16.7 4.8 12.5 7.1 132.5 38.8 15.9 29.6 21.6 19.3 44.7 51.9 3.5 25.6 226.8 0.0 192.3 35.3 14.5 13.1 44.9 477.5 40.4 14.3 51.9 35.6 39.6 4.9 8.6 16.1 8.5 61.3 87.3 6.5 99.6 217.5 7.8 174.9 12.2 12.9 13.9 3.0 5.8 3.8 18.7 27.5 126.5 20.6 ASMTL ENSG00000169093 "Acetylserotonin O-methyltransferase like" O95671 X 1403139-1453762 "Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 87.4;monocytes: 172.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 52.7" "Low region specificity" "Detected in all" "HPA003630, HPA021865" Supported Enhanced Cytosol NA NA Cytosol "HPA003630: AB_1078230, HPA021865: AB_1845099" "unprognostic (3.89e-2)" "unprognostic (1.14e-3)" "unprognostic (2.28e-1)" "unprognostic (1.87e-2)" "unprognostic (7.99e-2)" "unprognostic (9.05e-2)" "unprognostic (8.17e-2)" "unprognostic (5.23e-2)" "unprognostic (8.40e-2)" "unprognostic (1.24e-1)" "unprognostic (1.91e-3)" "unprognostic (7.24e-2)" "unprognostic (3.26e-3)" "unprognostic (9.70e-2)" "unprognostic (8.38e-2)" "unprognostic (2.91e-1)" "unprognostic (2.20e-1)" 10.4 11.7 28.5 8.9 42.3 9.1 33.6 24.5 38.9 46.4 10.6 3.3 3.3 6.9 52.0 9.2 8.6 11.4 8.2 50.0 29.4 11.4 35.2 15.3 7.0 11.8 25.5 55.3 47.6 13.2 9.9 31.4 27.5 36.7 12.5 4.6 3.3 16.2 16.0 10.0 11.0 8.9 7.5 31.9 11.5 9.0 4.6 25.0 3.3 12.8 3.3 7.2 9.1 31.5 19.8 23.3 34.5 16.4 27.8 16.9 12.3 5.3 9.4 11.2 8.5 6.7 10.5 15.6 6.4 8.4 7.3 9.4 8.5 6.5 9.5 3.6 8.4 7.9 2.0 2.9 3.1 4.6 14.0 9.4 8.1 6.2 10.1 15.4 3.8 52.7 13.9 5.3 5.6 5.4 8.2 8.6 7.4 4.1 7.7 5.8 20.1 16.4 15.1 13.5 5.0 5.8 13.4 10.6 23.0 5.1 2.9 0.4 5.3 8.6 11.1 7.9 8.0 2.5 5.2 11.2 6.1 6.7 11.5 2.3 9.9 3.0 24.1 7.8 5.6 1.8 20.1 14.2 34.5 16.9 16.4 14.8 13.8 15.3 15.6 12.1 19.8 13.5 10.6 20.4 27.8 11.5 23.3 16.5 12.3 28.5 42.3 24.5 38.9 29.4 11.4 25.5 55.3 36.7 25.0 11.9 6.5 18.6 21.6 16.4 16.6 16.5 2.5 10.7 6.8 14.0 3.9 28.3 23.2 11.7 0.8 17.9 15.9 0.0 14.8 22.3 23.9 19.4 54.2 24.6 17.5 87.4 13.8 14.1 11.0 1.5 24.2 15.1 11.8 172.3 16.9 15.3 11.0 17.3 40.7 25.8 9.4 32.3 24.5 2.3 7.9 13.7 55.5 20.2 17.0 16.6 ASNS ENSG00000070669 "Asparagine synthetase (glutamine-hydrolyzing)" P08243 7 97852118-97872542 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Asparagine biosynthesis" Ligase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 68.0" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 197.3;Erythroid cells: 93.5;Late spermatids: 147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 8.6;T-cells: 13.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004924, HPA029318, HPA064737" Approved Enhanced Cytosol No No Cytosol "HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341" "unprognostic (3.93e-2)" "unprognostic (2.51e-1)" "unprognostic (6.70e-2)" "prognostic unfavorable (4.24e-4)" "unprognostic (3.64e-1)" "prognostic unfavorable (8.79e-5)" "prognostic unfavorable (9.42e-6)" "unprognostic (2.28e-2)" "unprognostic (9.08e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" "unprognostic (2.53e-3)" "prognostic unfavorable (6.21e-7)" "unprognostic (5.33e-1)" "unprognostic (2.15e-1)" "unprognostic (6.21e-2)" "unprognostic (1.33e-1)" 6.5 7.5 15.9 10.9 21.4 7.6 9.9 31.7 32.3 5.7 10.1 9.4 5.6 6.5 10.0 19.9 10.2 6.9 6.8 9.2 24.5 20.4 6.5 5.9 9.6 16.0 16.3 13.4 19.2 68.0 16.7 16.7 3.2 35.9 9.2 12.7 4.4 49.9 9.3 3.5 13.6 7.8 11.3 20.6 11.0 20.8 16.9 9.2 3.6 16.7 8.2 15.0 9.6 6.6 8.6 1.4 1.5 1.2 2.2 13.2 3.2 19.0 7.3 7.4 60.1 5.9 8.3 18.1 14.1 9.0 6.7 20.2 9.4 7.6 15.0 7.1 28.7 14.0 8.7 19.1 22.3 16.1 18.7 14.1 4.8 3.7 7.0 54.3 30.6 13.5 16.3 75.0 8.8 54.5 3.6 5.5 14.1 26.8 53.3 10.6 40.3 0.9 8.1 10.1 45.6 20.0 2.3 1.4 39.3 4.3 3.7 32.3 24.3 3.6 19.6 76.0 9.9 8.3 21.5 1.4 3.3 22.1 8.8 6.6 63.1 31.5 57.1 41.8 13.9 32.1 1.5 0.3 0.5 3.8 1.2 4.9 8.6 7.4 3.4 1.4 6.2 10.2 5.5 1.5 2.2 0.8 0.1 13.2 3.2 15.9 21.4 31.7 32.3 24.5 20.4 16.3 13.4 35.9 9.2 8.9 4.5 3.7 18.8 11.0 20.1 5.9 12.7 1.4 3.4 8.7 23.6 2.0 6.6 34.4 197.3 3.1 1.7 93.5 52.9 7.7 6.6 17.6 8.1 1.6 1.0 23.8 23.4 2.5 0.6 147.0 8.9 1.8 8.5 11.8 12.9 8.5 38.4 11.9 8.9 3.1 25.4 6.5 12.3 2.3 7.0 9.5 4.7 13.3 7.9 15.2 ASNSD1 "FLJ20752, NBLA00058, NS3TP1" ENSG00000138381 "Asparagine synthetase domain containing 1" "L0R819, Q9NWL6" 2 189661385-189670831 "Predicted intracellular proteins" "Amino-acid biosynthesis, Asparagine biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036132, HPA036133, HPA075042" Uncertain Approved Cytosol NA NA Cytosol "HPA036132: AB_2674960, HPA036133: AB_10696650, HPA075042: AB_2686731" "unprognostic (1.32e-1)" "unprognostic (1.70e-1)" "unprognostic (4.88e-2)" "unprognostic (2.15e-3)" "prognostic favorable (4.54e-4)" "unprognostic (8.42e-2)" "prognostic unfavorable (8.66e-4)" "unprognostic (5.68e-2)" "unprognostic (1.35e-2)" "unprognostic (1.41e-3)" "unprognostic (2.09e-1)" "unprognostic (6.32e-3)" "unprognostic (8.98e-3)" "unprognostic (8.11e-2)" "unprognostic (2.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" 23.1 22.4 25.5 15.9 24.7 25.5 29.1 41.0 29.4 22.7 19.5 14.1 18.1 18.0 23.6 17.3 18.2 20.6 18.2 23.9 22.9 26.0 25.0 31.9 16.9 22.3 24.2 22.6 33.2 22.4 20.8 36.8 26.8 29.1 19.6 16.5 13.2 18.2 18.6 52.4 14.0 15.4 23.9 27.8 22.0 18.1 14.0 21.8 20.1 25.0 19.8 20.8 22.4 23.6 15.9 11.0 41.9 11.2 21.5 24.5 15.2 13.4 10.5 22.2 18.6 24.2 23.6 19.5 29.3 27.6 31.7 31.6 26.2 9.6 26.8 17.8 25.1 15.0 11.2 23.9 20.3 37.3 28.2 26.7 24.9 20.1 26.3 26.9 24.5 14.0 24.1 15.1 27.8 24.5 20.2 28.4 18.5 23.1 20.2 29.4 17.7 29.0 26.2 33.2 20.8 41.3 16.5 20.0 25.5 17.8 19.1 25.4 16.1 21.2 15.7 24.9 29.3 22.6 22.7 22.1 25.7 20.0 21.7 28.8 29.7 40.0 47.0 21.8 14.6 22.8 24.6 11.2 41.9 17.7 9.4 21.5 15.8 19.5 19.0 11.0 15.9 23.3 20.8 20.4 21.5 10.3 10.1 24.5 15.2 25.5 24.7 41.0 29.4 22.9 26.0 24.2 22.6 29.1 21.8 50.6 27.5 45.5 20.4 26.7 19.3 37.6 20.4 36.1 39.8 15.7 11.8 58.7 69.6 30.2 4.1 29.1 17.7 0.0 39.1 34.4 35.2 20.0 18.5 48.0 29.2 14.3 34.5 29.4 26.6 4.6 37.7 28.0 16.9 27.1 23.3 29.4 31.7 8.6 31.8 45.3 23.4 45.3 32.3 27.7 32.4 24.8 100.2 41.5 24.7 17.5 ASPA "ACY2, ASP" ENSG00000108381 Aspartoacylase P45381 17 3472374-3503419 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.3;kidney: 33.2" "Group enriched" "Detected in many" 4 "Collecting duct cells: 24.4;Leydig cells: 46.1;Melanocytes: 43.9;Peritubular cells: 45.3;Proximal tubular cells: 65.3" "Cancer enhanced" "Detected in some" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 8.3;ASC TERT1: 6.5;CACO-2: 5.5;HSkMC: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022142, HPA022145" Enhanced Approved Cytosol NA NA Cytosol "HPA022142: AB_1845102, HPA022145: AB_1845103" "unprognostic (4.42e-2)" "unprognostic (4.79e-2)" "unprognostic (2.02e-2)" "unprognostic (2.79e-3)" "unprognostic (4.36e-2)" "unprognostic (5.01e-1)" "unprognostic (1.08e-3)" "unprognostic (3.57e-1)" "unprognostic (4.17e-1)" "unprognostic (3.43e-1)" "unprognostic (5.27e-2)" "unprognostic (6.27e-2)" "unprognostic (1.25e-1)" "unprognostic (7.07e-4)" "unprognostic (2.77e-1)" "unprognostic (4.68e-1)" "unprognostic (1.49e-1)" 10.9 4.1 14.5 1.8 37.6 1.7 3.3 3.0 19.4 6.2 3.6 35.2 3.1 9.7 4.1 5.5 4.5 5.0 3.3 2.2 21.9 11.0 33.2 12.6 3.2 1.3 50.2 11.3 2.9 1.0 0.9 0.9 3.1 18.9 4.0 4.6 2.6 1.9 4.8 9.3 4.6 13.3 2.9 22.4 4.6 3.9 5.6 51.3 0.0 1.8 1.1 0.8 4.5 3.5 1.7 1.2 3.6 0.7 1.6 1.3 0.2 0.4 0.2 0.9 0.7 8.3 6.5 0.5 0.4 0.3 0.3 0.3 5.5 0.3 1.1 0.3 1.0 0.5 0.5 0.5 0.3 0.4 2.9 0.3 0.5 0.9 0.4 0.9 0.7 0.8 11.7 0.6 0.7 0.2 0.4 0.1 0.7 0.6 2.0 0.4 0.4 0.4 1.0 0.8 0.4 0.5 0.4 0.5 0.9 0.4 1.7 0.7 0.5 1.6 0.6 1.3 0.8 0.6 0.3 0.6 1.0 0.7 0.7 0.4 1.2 0.6 0.7 0.4 0.6 0.8 3.4 0.7 0.8 1.2 0.6 1.0 1.1 1.0 0.9 0.5 1.7 1.2 1.3 3.6 1.6 0.7 1.2 0.5 0.2 14.5 37.6 3.0 19.4 21.9 11.0 50.2 11.3 18.9 51.3 8.9 1.0 0.0 1.2 4.6 0.4 0.8 5.1 0.0 1.2 24.4 0.0 0.0 6.6 0.0 2.8 0.5 1.0 0.0 0.2 0.1 7.4 0.3 0.0 10.2 0.2 7.9 2.4 4.9 1.5 0.5 46.1 0.8 43.9 0.0 0.1 3.4 0.0 0.0 45.3 65.3 0.5 0.0 4.2 4.8 0.6 1.5 0.1 0.0 1.2 1.7 ASPDH ENSG00000204653 "Aspartate dehydrogenase domain containing" A6ND91 19 50511600-50514690 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.9;kidney: 24.7;liver: 59.8" "Group enriched" "Detected in some" 8 "Hepatocytes: 137.5;Proximal tubular cells: 442.0" "Cancer enriched" "Detected in some" 13 "liver cancer: 24.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 13.6;MOLT-4: 15.9;SH-SY5Y: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042631, HPA042654" Approved Approved Nucleoplasm,Cytosol Yes NA 51000 Nucleoplasm Cytosol "HPA042631: AB_10794530, HPA042654: AB_10794383" "unprognostic (5.79e-2)" "unprognostic (9.47e-2)" "unprognostic (8.97e-3)" "unprognostic (6.13e-3)" "unprognostic (5.13e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-3)" "unprognostic (3.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.09e-2)" "unprognostic (2.87e-3)" "unprognostic (6.70e-3)" "unprognostic (9.65e-3)" "unprognostic (3.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.31e-4)" "unprognostic (1.99e-3)" 1.3 3.2 11.7 1.6 16.2 1.3 0.9 7.4 26.9 0.9 1.0 8.9 0.0 6.9 1.1 0.9 1.2 0.9 2.3 1.2 12.9 8.3 24.7 59.8 1.1 1.6 9.2 9.8 0.9 1.5 0.9 7.7 0.9 4.1 1.2 0.9 1.0 2.3 0.9 1.1 1.8 2.9 0.9 5.1 1.4 1.1 1.1 6.6 1.3 1.7 0.0 0.9 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 13.6 0.0 0.6 3.8 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 1.6 0.0 1.6 15.9 0.1 0.0 0.5 0.3 0.3 0.3 1.1 0.0 0.2 1.8 9.5 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 3.7 0.7 2.0 0.2 2.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.7 16.2 7.4 26.9 12.9 8.3 9.2 9.8 4.1 6.6 0.0 0.0 0.9 0.0 0.0 22.8 0.3 2.5 0.0 0.0 8.7 3.9 0.0 38.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 6.8 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 442.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASPM "ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5" ENSG00000066279 "Abnormal spindle microtubule assembly" Q8IZT6 1 197084128-197146694 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Calmodulin-binding "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 62.8" "Cell type enhanced" "Detected in many" 16 "Erythroid cells: 70.0;Spermatocytes: 32.6;Spermatogonia: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "plasmacytoid DC: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;T-cells: 2.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB017816 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "CAB017816: " "unprognostic (3.24e-1)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.67e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (2.41e-4)" "unprognostic (4.67e-3)" "unprognostic (9.29e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.03e-1)" "unprognostic (0.00e+0)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "unprognostic (4.94e-2)" "unprognostic (3.66e-2)" 0.7 0.7 0.2 12.4 0.4 13.8 1.5 0.2 0.4 1.2 2.8 0.2 0.2 2.8 0.3 1.5 8.7 0.2 0.4 0.6 0.2 0.2 0.5 1.3 1.9 7.0 0.3 0.2 0.5 0.3 0.0 0.2 1.8 0.5 0.4 2.8 0.3 1.5 0.2 0.5 4.6 3.1 0.8 0.5 4.3 1.7 6.3 0.2 62.8 0.3 5.0 6.9 1.2 2.3 0.0 1.5 0.0 0.0 0.3 2.4 0.0 20.1 11.3 18.3 11.2 1.1 2.5 6.9 16.1 11.3 16.0 12.7 7.8 15.7 20.5 5.7 12.6 7.0 20.3 15.7 6.4 20.0 18.5 11.9 14.4 26.5 7.5 0.2 21.5 10.3 0.2 0.6 12.8 9.0 4.1 16.8 16.6 18.0 24.4 16.4 7.9 17.2 10.0 8.3 16.2 3.1 13.2 25.2 15.1 5.8 5.5 9.6 13.7 22.9 11.8 5.1 11.8 13.2 8.9 12.8 9.9 9.7 17.0 29.2 7.0 9.5 11.9 7.8 5.9 20.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 2.4 0.0 0.2 0.4 0.2 0.4 0.2 0.2 0.3 0.2 0.5 0.2 0.0 0.6 3.7 0.6 5.5 0.0 1.0 0.0 0.0 1.2 1.8 0.0 6.4 0.0 0.3 2.9 0.3 0.3 70.0 0.0 13.2 1.3 0.7 1.1 1.0 9.3 0.0 0.0 1.8 4.0 3.3 0.6 3.1 0.0 1.0 1.5 0.5 0.4 0.0 1.4 0.0 0.3 0.0 0.0 32.6 30.2 3.0 3.1 4.9 4.9 1.7 ASPN "FLJ20129, PLAP-1, SLRR1C" ENSG00000106819 Asporin Q9BXN1 9 92456205-92482506 "Disease related genes, Plasma proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 62.1" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 59.6;Fibroblasts: 60.7;Ito cells: 22.7;Sertoli cells: 38.8;Smooth muscle cells: 29.5;Suprabasal keratinocytes: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.7;BJ hTERT+: 5.0;HHSteC: 21.0;HSkMC: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007894, HPA008435, HPA024230" Approved Uncertain Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 33000 Nucleoplasm Cytosol "HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (8.13e-3)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (1.01e-2)" "unprognostic (9.50e-3)" "unprognostic (1.17e-1)" "unprognostic (2.74e-3)" "unprognostic (6.38e-2)" "unprognostic (3.70e-2)" "unprognostic (4.70e-2)" "prognostic unfavorable (1.64e-7)" "unprognostic (1.42e-3)" "unprognostic (3.04e-2)" "unprognostic (6.27e-3)" "unprognostic (2.48e-2)" 13.4 2.2 0.5 5.2 1.7 0.0 4.8 0.4 0.7 40.2 14.6 0.6 8.1 2.8 62.1 26.7 15.3 9.9 26.4 31.6 0.6 0.6 3.5 21.9 10.3 0.7 0.9 1.4 7.8 4.7 0.8 1.9 3.7 1.0 12.2 3.6 1.6 2.0 3.6 10.8 3.7 19.7 37.1 0.8 0.8 8.8 6.7 0.4 1.5 7.1 27.7 2.2 24.2 3.8 0.4 0.2 1.9 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.3 14.7 0.0 2.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 4.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.2 0.1 0.7 0.2 0.0 0.0 0.5 1.7 0.4 0.7 0.6 0.6 0.9 1.4 1.0 0.4 0.0 1.4 0.0 0.0 59.6 0.5 3.6 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 0.3 5.8 0.0 0.0 0.0 0.0 60.7 0.0 1.1 0.4 0.2 0.0 0.0 22.7 0.0 0.2 5.5 0.5 13.5 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.6 38.8 29.5 0.0 0.0 23.6 0.0 0.0 0.0 0.0 ASPRV1 "FLJ25084, SASPase, Taps" ENSG00000244617 "Aspartic peptidase retroviral like 1" Q53RT3 2 69960089-69962265 "Plasma proteins, Predicted membrane proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 75.3" "Cell type enhanced" "Detected in some" 18 "Spermatogonia: 3.0;Suprabasal keratinocytes: 9.4" "Group enriched" "Detected in many" 8 "head and neck cancer: 23.1;melanoma: 35.1" "Cell type enriched" "Detected in some" 6 "neutrophil: 11.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "REH: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034809, HPA034810" Enhanced Approved Cytosol NA NA 83000 Cytosol "HPA034809: AB_2674343, HPA034810: AB_10601456" "unprognostic (4.75e-4)" "unprognostic (1.90e-3)" "unprognostic (2.34e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (1.17e-2)" "unprognostic (1.93e-3)" "unprognostic (1.51e-1)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (4.19e-3)" "unprognostic (1.27e-1)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (1.74e-1)" "unprognostic (4.84e-2)" "unprognostic (2.43e-2)" 0.2 0.2 0.5 0.1 0.6 0.0 5.5 0.8 0.4 0.3 0.0 0.3 0.3 0.6 0.0 0.4 0.1 0.1 0.6 0.7 0.2 0.0 0.1 0.1 0.7 0.9 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.2 1.0 75.3 0.2 0.2 1.0 0.4 0.1 0.4 0.0 0.1 0.0 0.6 0.1 1.2 11.2 0.1 0.3 0.9 0.5 0.1 0.7 1.8 3.5 2.3 0.9 0.5 0.4 0.7 0.5 0.3 1.2 0.1 1.3 0.3 0.3 0.4 0.5 1.6 0.2 0.4 2.4 4.7 2.8 0.4 1.2 0.9 2.3 2.0 1.1 0.7 0.4 0.8 0.7 0.4 3.1 1.0 3.6 0.4 0.5 2.0 5.2 1.8 0.4 0.4 8.9 1.0 0.5 0.1 0.1 2.0 0.5 0.2 1.4 1.4 0.4 0.1 1.0 0.3 0.1 1.8 0.1 0.3 3.9 2.4 2.7 0.2 1.6 2.0 0.0 0.1 1.9 0.7 0.1 0.7 0.0 0.3 0.6 0.1 0.1 0.2 0.6 11.2 0.3 0.1 1.2 0.9 0.5 0.0 0.0 0.0 0.1 0.3 1.1 1.2 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.1 0.3 0.4 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.2 0.9 0.0 0.0 0.0 0.6 0.7 0.2 0.0 0.7 0.7 1.4 0.0 0.0 1.1 3.0 9.4 0.3 0.0 0.0 0.1 ASS1 "ASS, CTLN1" ENSG00000130707 "Argininosuccinate synthase 1" P00966 9 130444929-130501274 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 121.5;liver: 309.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 457.5;Hepatocytes: 809.9;Proximal tubular cells: 889.6;Urothelial cells: 385.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 87.4;HaCaT: 82.8;hTCEpi: 80.5;RPMI-8226: 134.1;THP-1: 100.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA020896, HPA020934" Enhanced Approved Nucleoplasm,Cytosol No No 4500000 Cytosol Nucleoplasm "HPA020896: AB_1845117, HPA020934: AB_1845118" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (8.14e-9)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "unprognostic (3.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.02e-2)" "unprognostic (4.24e-2)" "unprognostic (2.92e-3)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (3.14e-1)" "unprognostic (4.72e-3)" 20.6 15.4 4.6 7.1 4.1 0.0 15.7 2.3 5.4 8.3 18.5 3.5 33.9 11.9 12.0 12.6 9.4 16.6 14.0 11.4 3.8 5.7 121.5 309.9 8.0 2.2 3.2 4.3 11.4 7.9 0.5 4.6 8.7 4.5 12.1 16.8 10.7 26.3 40.6 7.4 12.5 26.8 5.9 3.4 2.7 5.2 8.7 2.2 0.8 17.5 7.0 4.5 17.7 8.6 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.7 1.1 1.3 2.2 8.9 22.7 4.3 14.0 87.4 2.8 8.5 5.0 3.3 0.0 9.5 28.9 0.8 82.8 5.8 0.5 1.9 2.0 2.6 0.0 1.8 12.8 31.0 1.7 0.1 15.0 80.5 4.5 8.1 0.0 0.1 37.6 0.4 52.2 2.8 58.1 0.6 24.5 1.8 60.2 2.6 0.1 1.5 134.1 7.6 5.8 33.8 0.5 50.0 52.7 3.9 5.4 36.2 100.4 0.0 1.1 7.0 0.2 1.2 8.7 8.3 2.9 22.0 13.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 4.6 4.1 2.3 5.4 3.8 5.7 3.2 4.3 4.5 2.2 23.8 25.8 33.7 45.3 62.6 0.0 5.0 94.3 20.1 50.0 45.4 0.0 159.6 112.7 79.7 0.8 23.2 457.5 0.0 98.3 5.0 15.7 85.0 5.7 809.9 12.7 0.0 11.5 35.0 18.0 2.7 28.7 2.6 3.3 2.8 129.1 4.8 73.5 143.8 117.4 889.6 0.3 0.0 10.8 1.1 2.0 15.3 120.5 12.5 77.1 385.2 ASTN2 KIAA0634 ENSG00000148219 "Astrotactin 2" O75129 9 116425225-117415070 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Early spermatids: 119.3;Late spermatids: 157.4" "Cancer enhanced" "Detected in all" "prostate cancer: 15.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027035 Uncertain Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA027035: AB_1845122" "unprognostic (3.25e-2)" "unprognostic (2.70e-2)" "unprognostic (7.41e-3)" "unprognostic (5.42e-3)" "unprognostic (1.89e-1)" "unprognostic (2.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.80e-1)" "unprognostic (3.40e-2)" "unprognostic (2.93e-1)" "prognostic favorable (6.66e-16)" "unprognostic (3.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" 4.1 11.9 13.0 3.3 14.9 4.4 5.3 17.2 25.5 5.6 4.6 20.0 5.5 4.6 3.8 5.3 3.2 9.6 3.4 18.6 13.5 16.3 5.5 5.2 3.0 3.0 15.4 19.4 4.0 7.4 5.6 10.7 2.6 16.1 29.2 4.2 6.7 6.1 13.6 7.7 3.5 5.2 3.6 11.3 3.1 4.1 16.7 16.9 1.9 2.4 0.9 2.4 3.6 3.0 2.3 1.3 2.5 0.7 7.8 10.3 1.3 2.5 7.8 3.1 4.7 5.2 4.8 10.4 3.8 1.5 1.7 1.9 5.4 3.0 5.8 4.5 2.5 6.3 0.9 7.6 0.4 2.1 3.1 2.0 2.2 3.7 11.1 2.0 1.4 4.2 6.5 0.7 5.2 0.4 3.7 1.2 6.9 2.7 4.3 5.2 2.6 2.7 1.1 9.1 6.9 4.7 3.3 18.4 1.7 5.3 8.3 4.3 24.9 4.6 1.5 3.2 10.5 10.4 0.9 2.4 4.0 6.5 3.9 3.3 6.3 3.6 5.5 7.1 1.4 16.9 2.5 0.6 0.6 3.9 0.4 4.8 2.0 4.2 3.2 0.3 2.3 4.0 3.3 2.4 7.8 0.7 1.3 10.3 1.3 13.0 14.9 17.2 23.2 13.5 16.3 15.4 19.4 16.1 16.9 6.0 6.2 0.0 3.6 1.1 2.1 19.3 2.5 17.4 7.9 1.8 9.8 0.4 3.3 0.7 119.3 0.7 0.7 0.0 1.0 0.3 3.6 12.1 5.8 1.8 2.5 9.5 12.1 0.6 0.0 157.4 2.6 0.3 0.0 0.0 0.9 3.3 0.7 2.6 5.3 5.7 4.7 0.0 3.8 5.1 13.0 0.5 0.2 2.5 1.7 2.0 ASZ1 "ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3" ENSG00000154438 "Ankyrin repeat, SAM and basic leucine zipper domain containing 1" Q8WWH4 7 117363222-117428123 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 15.7" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 87.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "Daudi: 4.0;U-266/70: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA020558 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020558: AB_1845123" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 87.1 20.1 0.0 0.0 0.0 0.0 0.1 ATAD5 "C17orf41, ELG1, FLJ12735, FRAG1" ENSG00000176208 "ATPase family, AAA domain containing 5" Q96QE3 17 30831970-30895869 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.0;lymphoid tissue: 29.9" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 32.2;Spermatogonia: 35.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA066823 Approved "Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol" "Intracellular and membrane" Yes No Nucleoplasm "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA066823: " "unprognostic (3.12e-1)" "unprognostic (7.36e-2)" "unprognostic (1.12e-2)" "unprognostic (1.36e-3)" "unprognostic (3.33e-1)" "unprognostic (1.05e-2)" "unprognostic (1.28e-4)" "unprognostic (1.77e-1)" "unprognostic (1.79e-3)" "unprognostic (7.24e-2)" "unprognostic (2.78e-1)" "unprognostic (3.19e-3)" "unprognostic (6.30e-10)" "unprognostic (3.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (1.38e-1)" 2.0 1.2 1.1 8.1 3.8 19.0 2.4 9.6 3.2 2.7 3.3 1.2 0.7 2.8 2.1 2.5 4.0 2.0 1.7 1.4 1.8 1.3 1.9 1.4 2.3 6.4 1.9 2.7 3.0 1.7 1.3 3.1 5.3 2.3 1.8 3.1 0.6 2.1 1.2 1.3 4.5 3.4 1.5 1.5 6.3 2.2 4.0 2.6 29.9 1.8 2.7 5.3 1.8 2.7 2.3 2.1 3.1 1.3 3.0 1.6 0.3 4.8 4.0 9.6 9.1 0.2 1.0 3.8 4.2 2.2 4.7 6.8 4.4 3.4 12.9 4.1 2.0 3.2 8.8 6.2 3.2 8.6 2.9 5.4 7.8 5.2 3.0 0.1 15.2 6.4 0.4 0.4 7.0 2.4 0.9 2.4 12.7 12.1 10.9 3.1 2.8 16.9 7.5 5.6 3.5 1.9 11.6 18.2 6.2 1.2 5.1 5.6 5.0 4.8 2.7 2.5 5.5 5.2 6.8 1.9 5.9 7.9 8.3 7.6 3.6 3.8 16.3 2.6 7.2 5.7 1.2 1.0 1.4 1.6 1.3 0.9 1.2 0.9 1.2 0.7 2.3 1.1 1.2 3.1 3.0 0.6 2.1 1.4 0.3 1.1 3.8 9.6 3.2 1.8 1.3 1.9 2.7 2.3 2.6 3.0 2.6 13.3 3.2 4.1 18.5 2.7 0.0 4.0 3.4 3.5 0.0 13.2 0.0 2.7 12.9 2.9 2.2 0.0 2.5 20.4 3.9 1.6 3.5 0.5 7.3 11.1 0.0 2.5 3.2 4.6 3.4 7.2 6.8 10.8 4.5 3.9 2.9 2.9 2.1 0.3 19.9 0.0 6.2 32.2 35.1 4.0 6.6 5.3 9.3 1.4 ATAT1 "C6orf134, Em:AB023049.7, FLJ13158, MEC17" ENSG00000137343 "Alpha tubulin acetyltransferase 1" Q5SQI0 6 30626842-30646823 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 67.3;Late spermatids: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 10.9;AN3-CA: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046816, HPA050999" Approved Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Golgi apparatus, Cytosol" "HPA046816: AB_2679822, HPA050999: AB_2681303" "unprognostic (3.98e-1)" "unprognostic (3.18e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-2)" "unprognostic (8.86e-2)" "unprognostic (8.18e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.49e-2)" "unprognostic (5.39e-2)" "unprognostic (2.37e-2)" "unprognostic (1.29e-3)" "unprognostic (1.25e-2)" "prognostic unfavorable (7.78e-5)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.35e-4)" 4.8 3.8 16.8 5.4 16.8 4.4 4.1 12.5 20.7 5.5 4.9 16.3 3.0 4.6 10.2 21.0 3.2 8.3 5.4 3.9 15.7 15.9 4.4 3.8 3.9 4.8 14.0 12.2 10.1 4.4 4.4 10.6 4.3 13.0 9.8 5.3 4.1 5.4 4.0 4.5 6.9 6.1 4.9 13.5 4.3 7.9 7.0 12.8 3.3 4.3 1.7 5.6 4.0 3.8 1.7 2.6 2.6 1.7 0.7 2.1 0.8 2.0 1.1 10.9 8.1 1.5 1.1 0.4 0.3 0.1 0.4 0.8 2.9 2.1 0.3 1.7 1.7 3.4 2.4 4.0 1.4 0.1 1.5 4.7 0.1 0.4 2.7 0.7 0.2 1.3 2.2 0.9 0.7 0.0 1.3 0.9 5.6 1.6 0.2 2.0 1.8 1.6 0.7 0.7 3.3 0.2 0.9 0.3 0.6 2.0 3.0 0.6 4.3 0.7 1.0 0.7 0.3 4.4 0.5 0.8 3.1 2.2 0.1 0.8 1.6 2.1 1.0 2.5 4.8 3.2 2.6 1.7 1.3 0.8 1.5 1.0 1.7 1.0 0.8 1.6 1.2 2.1 1.6 0.3 0.7 1.1 2.6 0.9 0.8 16.8 16.8 12.5 20.7 15.7 15.9 14.0 12.2 13.0 12.8 0.0 1.0 0.0 12.1 4.9 9.3 1.3 5.1 5.3 1.2 14.0 9.8 9.9 6.6 9.5 67.3 4.9 7.3 0.0 3.9 5.7 6.2 9.0 1.1 1.6 5.3 1.6 17.2 3.7 1.8 33.6 3.7 3.7 0.0 12.6 9.3 11.5 7.5 10.5 8.1 3.7 9.6 6.5 4.2 9.9 9.3 4.6 7.4 5.0 10.2 12.3 ATF4 "CREB-2, TAXREB67, TXREB" ENSG00000128272 "Activating transcription factor 4" P18848 22 39519695-39522685 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011596 Approved Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "CAB011596: AB_725569" "unprognostic (2.51e-2)" "unprognostic (7.36e-2)" "unprognostic (1.79e-1)" "unprognostic (1.09e-1)" "unprognostic (4.45e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (4.07e-4)" "unprognostic (4.43e-2)" "unprognostic (1.97e-1)" "unprognostic (5.16e-2)" "unprognostic (1.50e-1)" "unprognostic (4.41e-1)" "prognostic unfavorable (9.77e-5)" "unprognostic (7.06e-2)" "unprognostic (9.78e-2)" "unprognostic (6.40e-2)" "unprognostic (1.95e-1)" 66.7 46.6 35.0 35.8 42.1 137.9 134.9 38.1 44.1 46.9 99.1 27.3 66.6 40.2 52.1 45.1 69.9 39.8 47.0 44.1 35.7 30.6 41.5 90.1 53.0 37.1 69.3 21.8 53.6 125.3 24.7 40.2 56.8 49.7 70.0 41.2 39.6 241.8 72.7 127.2 42.6 44.3 119.7 64.3 43.2 70.1 23.8 50.4 21.6 62.5 66.7 49.3 118.9 104.7 29.2 32.6 24.1 26.4 19.3 23.0 19.9 38.8 23.8 41.6 53.4 46.5 46.2 68.9 47.0 74.4 38.0 48.6 52.2 29.9 75.0 10.3 35.1 31.1 30.8 67.2 55.7 46.4 46.1 48.6 51.4 24.3 52.9 103.1 96.3 48.7 78.0 121.5 67.9 99.9 66.3 36.6 84.3 54.3 80.8 28.8 24.5 57.4 70.2 36.3 81.1 30.9 59.7 27.5 77.2 49.7 33.2 62.7 26.1 21.1 56.8 137.4 38.5 34.9 119.5 28.7 22.9 66.5 25.0 31.9 88.1 104.5 87.2 25.3 49.2 51.2 24.1 26.4 17.5 16.2 22.5 20.8 29.2 21.7 20.7 32.6 21.1 23.0 20.8 13.2 19.3 23.6 20.2 22.8 19.9 35.0 42.1 38.1 44.1 35.7 30.6 69.3 21.8 49.7 50.4 157.8 172.8 188.6 330.4 394.4 108.5 145.0 117.2 83.0 146.7 41.8 88.4 123.5 56.3 170.1 15.6 186.5 266.9 93.5 655.8 206.2 207.6 323.9 217.1 158.0 101.8 65.2 255.8 129.5 155.4 14.0 171.5 207.5 226.0 296.6 194.4 68.5 384.2 163.2 194.5 61.4 234.9 329.8 310.0 70.1 62.6 293.5 182.6 142.2 164.7 347.0 ATF5 ENSG00000169136 "Activating transcription factor 5" Q9Y2D1 19 49928702-49933935 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 24 "liver: 470.7" "Cell type enhanced" "Detected in all" 19 "Hepatocytes: 1071.5;monocytes: 428.4" "Cancer enriched" "Detected in all" 7 "liver cancer: 200.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 11.9;intermediate monocyte: 11.7;myeloid DC: 7.5;plasmacytoid DC: 18.7" "Group enriched" "Detected in all" 7 "dendritic cells: 18.7;monocytes: 11.9" "Cell line enhanced" "Detected in all" "HDLM-2: 45.9;Karpas-707: 79.8;THP-1: 66.5;U-266/84: 101.3;U-698: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030187 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030187: AB_10601666" "unprognostic (2.09e-2)" "prognostic favorable (1.14e-4)" "unprognostic (9.38e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.52e-1)" "unprognostic (6.70e-2)" "unprognostic (3.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.83e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (3.39e-7)" "unprognostic (3.06e-2)" "unprognostic (8.06e-2)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" 4.6 6.6 2.1 5.0 2.7 2.9 7.0 1.3 2.2 2.4 2.9 2.4 3.9 4.6 2.3 4.0 3.4 2.6 3.1 4.2 2.1 2.1 3.0 470.7 2.8 5.0 2.2 1.4 2.6 3.8 1.4 1.9 4.4 2.1 2.8 1.6 2.6 3.1 2.5 4.3 2.1 4.2 2.5 2.6 3.3 2.8 5.3 1.9 3.8 20.0 3.3 5.5 5.6 7.1 1.1 18.7 2.2 11.9 1.5 1.3 2.5 10.0 7.0 2.7 1.8 2.8 2.4 2.7 7.4 6.2 7.6 4.6 5.3 5.5 9.0 3.7 4.2 5.2 3.6 3.4 3.0 3.6 45.9 3.4 6.1 2.2 4.0 1.9 23.7 17.5 17.0 4.8 5.5 1.3 1.9 3.2 20.1 5.5 79.8 3.7 9.4 3.4 5.2 1.3 2.7 9.5 28.5 2.9 3.6 8.6 13.6 4.3 3.1 17.0 7.3 5.1 1.0 6.0 66.5 5.5 14.8 9.4 1.7 7.5 2.1 101.3 47.6 11.6 9.5 5.5 0.3 11.9 0.7 0.7 11.7 1.3 1.1 0.9 0.9 7.5 0.7 0.7 0.9 2.2 1.5 3.0 18.7 0.9 2.5 2.1 2.7 1.3 2.2 2.1 2.1 2.2 1.4 2.1 1.9 11.9 11.0 53.7 10.0 20.0 3.2 6.9 48.4 9.4 5.7 15.7 5.9 27.8 11.6 11.4 203.6 16.7 30.2 46.7 25.7 13.8 18.6 21.5 5.8 1071.5 79.6 87.4 20.6 44.2 56.2 107.0 12.4 56.5 38.8 428.4 16.5 9.5 17.3 14.4 15.6 28.4 7.2 12.9 15.1 6.2 5.7 21.0 29.7 10.2 18.3 15.5 ATF7 ATFA ENSG00000170653 "Activating transcription factor 7" P17544 12 53507856-53626410 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003384 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (2.20e-2)" "unprognostic (3.10e-2)" "unprognostic (2.48e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (4.73e-2)" "unprognostic (1.54e-2)" "unprognostic (9.16e-3)" "unprognostic (3.59e-3)" "unprognostic (8.03e-2)" "unprognostic (1.76e-3)" "unprognostic (2.59e-1)" "unprognostic (3.28e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (2.51e-1)" "unprognostic (3.37e-1)" "unprognostic (1.17e-1)" 22.6 12.2 18.3 14.6 25.3 11.4 21.5 56.1 22.9 17.8 17.7 31.6 12.1 10.5 21.5 13.0 19.7 14.6 15.6 18.8 20.1 9.5 15.1 12.3 18.0 10.3 28.2 12.9 23.5 15.6 15.3 17.3 15.4 22.2 17.1 18.6 15.6 21.9 13.4 23.1 20.9 12.2 24.5 22.3 11.4 16.1 12.4 27.5 11.4 15.2 10.8 13.1 18.1 18.4 11.5 11.4 14.2 19.5 15.5 11.5 9.3 10.0 19.5 10.4 11.4 19.9 25.5 6.9 12.1 12.6 13.5 9.0 14.0 15.7 15.8 16.1 14.9 5.5 12.6 8.1 13.4 12.4 15.2 10.3 13.6 22.5 14.9 13.4 17.4 10.2 19.9 17.6 16.8 19.1 22.5 26.4 8.6 15.5 14.6 20.1 18.6 10.4 12.2 10.3 11.4 10.6 13.9 12.5 15.2 20.3 13.0 8.7 9.3 18.5 13.7 19.2 10.6 18.3 10.8 19.4 16.1 11.4 12.8 10.9 7.2 8.6 10.1 13.2 16.5 14.7 12.9 14.8 14.2 8.6 19.5 8.7 10.8 11.5 8.4 11.4 11.5 8.5 9.9 9.3 15.5 14.3 7.8 10.8 9.3 18.3 25.3 56.1 22.9 20.1 9.5 28.2 12.9 22.2 27.5 11.9 15.9 15.9 19.8 19.7 8.2 13.6 25.5 13.4 10.3 14.0 23.6 19.3 31.5 26.8 29.2 25.1 15.8 0.0 27.5 19.6 17.7 30.9 28.8 12.5 22.3 9.5 17.9 27.6 21.9 26.4 25.0 17.3 23.6 16.2 19.1 22.1 21.8 14.0 23.0 37.9 9.6 25.8 23.7 8.1 16.3 25.2 23.3 17.9 19.9 24.1 ATG13 KIAA0652 ENSG00000175224 "Autophagy related 13" O75143 11 46617527-46674818 "Cancer-related genes, Predicted intracellular proteins, Transporters" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039350 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA039350: AB_10673142" "unprognostic (3.66e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (5.36e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (7.57e-2)" "unprognostic (2.44e-2)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" "unprognostic (7.68e-2)" "unprognostic (3.47e-1)" 13.8 15.8 20.2 11.9 27.3 25.8 12.5 32.8 37.0 13.2 12.6 39.5 9.2 14.3 12.9 16.8 14.9 16.6 14.5 17.8 19.5 16.3 14.3 21.1 11.5 13.6 31.8 18.2 15.6 19.7 24.4 23.1 13.5 27.2 12.8 12.0 21.3 17.0 13.5 20.9 16.3 12.4 12.3 15.7 16.2 16.5 60.6 34.9 14.8 18.6 8.8 15.8 12.5 13.0 15.8 20.0 38.9 24.0 17.0 24.7 20.3 13.8 25.5 19.6 11.5 27.3 32.1 19.8 16.2 28.7 20.0 25.7 17.3 13.9 13.0 11.5 24.4 26.0 17.0 18.8 21.9 20.3 24.6 35.9 14.0 17.8 30.4 30.7 18.6 24.3 38.6 26.2 13.8 30.5 28.6 19.7 30.4 24.4 29.8 17.9 20.8 18.5 27.6 24.5 25.5 22.1 17.7 25.4 22.8 13.4 15.3 18.7 18.8 22.4 18.0 23.9 19.7 25.7 38.5 19.4 24.7 15.1 22.7 17.6 27.2 30.1 16.5 30.6 16.9 18.1 21.2 20.7 26.9 21.3 24.0 17.2 15.8 19.2 16.8 20.0 12.7 16.6 18.3 38.9 17.0 18.7 14.9 24.7 20.3 20.2 27.3 32.8 37.0 19.5 16.3 31.8 18.2 27.2 34.9 14.9 15.2 10.4 10.0 8.2 22.0 12.4 5.1 2.7 10.3 12.2 37.3 8.7 6.6 16.3 35.8 11.7 19.0 46.7 28.1 18.9 8.4 17.1 8.1 19.4 13.5 31.8 17.2 12.9 15.2 36.4 10.6 13.5 11.8 22.6 19.5 15.2 26.0 12.2 10.6 11.2 29.7 12.9 13.7 31.1 10.4 10.0 22.1 10.9 10.4 14.3 ATG16L1 "APG16L, ATG16A, ATG16L, FLJ10035, WDR30" ENSG00000085978 "Autophagy related 16 like 1" Q676U5 2 233210051-233295674 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012577, HPA063900" Supported Approved Cytosol NA NA Cytosol "HPA012577: AB_1845155, HPA063900: AB_2685146" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (3.57e-2)" "unprognostic (2.22e-3)" "unprognostic (1.89e-1)" "unprognostic (4.49e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.51e-1)" "unprognostic (1.80e-1)" "unprognostic (1.85e-2)" "unprognostic (6.66e-3)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.93e-2)" "unprognostic (1.41e-1)" "unprognostic (2.41e-1)" "unprognostic (2.08e-1)" 7.7 8.1 7.8 15.7 16.4 28.2 11.9 25.3 22.7 9.8 12.0 13.5 7.4 11.4 12.3 14.8 11.8 8.4 9.7 11.3 9.6 9.0 10.0 15.0 8.0 11.4 10.9 9.4 9.7 12.8 11.6 6.6 8.6 12.3 13.2 13.8 9.4 11.8 10.7 19.4 16.9 11.5 10.7 9.7 12.1 13.0 16.7 9.2 13.8 12.3 10.2 14.3 11.7 12.5 3.3 2.1 4.4 6.2 6.0 7.3 3.1 10.8 11.5 4.1 6.9 10.7 7.8 13.1 9.9 7.9 8.9 8.4 8.4 7.8 2.8 3.6 8.2 11.6 5.5 9.1 4.8 7.9 5.4 7.8 6.5 7.4 13.3 8.1 5.4 8.3 4.2 8.5 10.4 8.5 5.6 8.6 3.9 6.7 2.8 7.8 8.9 5.6 10.7 17.5 10.6 12.8 4.0 9.5 2.3 7.9 7.1 8.4 5.8 6.8 8.4 5.1 6.9 5.0 5.8 10.1 5.6 4.6 8.9 8.3 6.3 3.3 5.2 9.2 5.5 8.9 0.0 2.5 4.4 7.3 2.0 6.0 3.3 5.0 6.4 2.1 3.2 5.6 5.5 1.7 6.0 6.2 1.1 5.6 3.1 7.8 16.4 25.3 22.7 9.6 9.0 10.9 9.4 12.3 9.2 6.0 8.0 7.4 4.2 8.0 5.7 3.6 2.5 14.7 11.4 5.2 3.9 4.3 5.0 6.1 0.7 5.6 8.1 0.0 6.0 5.1 4.7 5.6 9.2 8.3 4.8 1.6 8.6 7.4 5.7 1.3 3.7 3.9 10.1 6.4 4.6 7.2 12.1 7.0 3.5 4.5 15.7 6.5 6.5 9.7 15.6 11.5 3.1 13.8 7.3 4.5 ATG3 "APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96" ENSG00000144848 "Autophagy related 3" Q9NT62 3 112532509-112562046 "Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 501.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037260, HPA040471" Enhanced Supported "Plasma membrane,Cytosol" NA NA 26000 "Plasma membrane, Cytosol" "CAB037260: AB_1078236, HPA040471: AB_2677000" "unprognostic (2.77e-2)" "prognostic favorable (6.82e-4)" "unprognostic (4.90e-3)" "unprognostic (1.30e-1)" "unprognostic (2.63e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.35e-6)" "unprognostic (6.79e-2)" "unprognostic (6.67e-2)" "unprognostic (6.99e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.52e-3)" "unprognostic (4.66e-2)" "unprognostic (6.02e-2)" "unprognostic (3.48e-2)" "unprognostic (5.25e-2)" 24.2 27.7 30.8 30.3 34.2 51.6 23.1 19.5 26.8 20.0 24.3 29.9 16.6 24.5 18.0 17.0 23.6 15.7 17.4 20.9 31.4 27.1 32.2 36.2 23.2 31.0 38.9 17.9 21.1 29.0 24.5 27.7 24.5 33.3 18.5 26.9 13.1 20.3 22.3 18.7 19.6 27.9 19.6 53.3 40.1 23.5 51.7 34.8 33.8 28.2 23.4 28.6 21.6 19.7 12.3 34.5 35.6 61.9 9.7 15.0 24.0 31.2 17.1 16.1 16.4 21.2 17.6 18.1 27.7 20.2 27.4 25.1 23.9 18.7 39.4 21.1 23.8 33.6 22.8 26.3 24.0 38.5 6.7 12.7 24.8 17.0 15.3 33.1 43.3 21.1 16.2 18.4 26.8 41.4 18.0 25.4 25.1 21.2 33.9 28.9 27.4 25.5 20.4 17.6 41.1 34.1 22.4 14.4 33.2 22.7 17.1 27.8 10.9 23.0 22.0 32.3 15.9 24.8 32.5 20.5 29.3 23.9 12.3 24.2 22.1 21.1 61.0 26.8 40.4 21.5 10.8 34.3 23.9 8.6 51.6 10.7 12.3 10.6 10.6 34.5 11.5 10.4 10.2 35.6 9.7 61.9 7.4 15.0 24.0 30.8 34.2 19.5 26.8 31.4 27.1 38.9 17.9 33.3 34.8 44.7 36.6 54.6 35.3 65.8 20.1 77.1 38.2 29.4 29.6 24.4 11.8 64.1 99.5 58.2 501.6 54.0 48.5 93.5 75.2 69.9 44.7 31.1 38.2 35.8 111.6 17.5 30.0 36.2 92.5 97.9 39.4 118.7 65.8 143.3 50.3 40.1 56.9 45.6 40.7 62.4 18.1 58.2 69.0 227.9 110.0 61.7 102.3 47.9 67.3 39.9 ATG4B "Apg4B, AUTL1, DKFZp586D1822, KIAA0943" ENSG00000168397 "Autophagy related 4B cysteine peptidase" Q9Y4P1 2 241637213-241673857 "Enzymes, Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037195, HPA069803" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB037195: AB_1078237, HPA069803: AB_2686200" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "unprognostic (2.67e-3)" "unprognostic (1.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.61e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (3.02e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.60e-1)" "unprognostic (6.63e-2)" "unprognostic (1.66e-1)" "prognostic favorable (9.64e-4)" 10.9 16.5 19.6 16.6 21.3 31.3 15.1 34.8 25.7 13.5 18.7 21.7 23.2 14.6 33.5 24.0 26.7 17.7 18.8 19.5 20.5 21.5 17.2 15.5 15.8 19.4 29.2 19.7 17.3 19.2 18.7 27.4 15.4 20.3 20.5 18.9 20.8 22.8 14.2 17.2 26.6 21.1 18.9 23.1 18.7 15.5 28.0 21.4 21.2 18.2 7.3 21.9 15.3 14.4 16.5 20.3 18.9 18.6 11.4 19.6 16.8 8.7 13.6 19.5 15.0 19.5 14.2 19.3 12.8 14.0 16.6 13.8 14.9 15.5 6.7 5.8 23.0 13.4 12.9 18.5 24.4 16.1 14.3 18.8 19.8 22.0 32.2 25.4 11.4 11.1 14.1 17.0 18.6 18.0 17.7 17.1 26.1 16.8 10.3 18.8 21.4 20.4 20.1 22.7 15.7 14.5 35.2 17.9 10.1 13.0 28.3 19.5 13.5 10.9 14.5 15.3 16.6 16.0 16.8 18.6 15.8 10.8 10.5 13.8 11.6 12.1 25.7 19.2 14.2 14.8 4.6 18.6 18.9 18.7 15.5 15.5 15.7 15.2 16.5 20.3 16.5 19.6 14.7 14.8 11.4 16.2 16.3 19.3 16.8 19.6 21.3 34.8 25.7 20.5 21.5 29.2 19.7 20.3 21.4 29.8 35.6 22.7 23.7 21.6 21.6 14.1 33.1 10.7 13.6 26.2 31.4 31.0 16.6 32.4 12.9 23.6 57.6 23.3 34.9 23.5 23.5 30.3 18.5 24.9 29.3 39.7 34.4 24.5 27.8 19.8 20.4 31.5 27.0 64.1 34.3 30.2 33.1 28.1 23.3 18.2 25.2 19.4 23.4 44.0 53.5 22.2 45.1 33.0 27.0 27.5 ATG4C "APG4C, AUTL1, AUTL3, FLJ14867" ENSG00000125703 "Autophagy related 4C cysteine peptidase" Q96DT6 1 62784135-62865513 "Enzymes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007049 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007049: AB_1845159" "unprognostic (1.28e-1)" "unprognostic (2.69e-1)" "prognostic favorable (9.83e-4)" "unprognostic (7.43e-2)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (3.76e-2)" "unprognostic (8.36e-2)" "unprognostic (1.83e-2)" "unprognostic (1.30e-1)" "unprognostic (3.77e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-2)" "unprognostic (1.81e-1)" "unprognostic (4.17e-2)" "unprognostic (3.26e-2)" "unprognostic (1.19e-1)" 8.8 9.8 19.4 11.3 32.8 6.0 9.2 16.7 23.4 10.6 9.5 29.8 7.2 7.7 9.6 7.2 8.6 8.0 10.4 7.2 23.7 15.5 13.5 12.6 9.2 13.7 42.6 16.5 10.3 11.2 15.5 11.3 15.0 22.4 8.0 10.6 4.9 10.8 8.0 6.4 6.3 7.8 11.2 26.5 13.3 8.6 8.9 40.4 11.0 12.0 3.7 12.4 13.4 6.8 20.6 19.4 16.0 10.9 7.0 9.4 6.7 7.6 6.1 9.5 8.3 12.5 13.5 9.5 11.5 7.8 11.1 12.5 4.5 6.1 16.3 8.9 5.8 13.0 5.9 11.3 8.7 16.1 12.2 10.4 18.3 6.5 5.8 8.9 14.8 12.3 11.1 6.2 11.8 5.6 10.8 13.3 18.0 15.5 13.3 9.3 3.6 14.9 5.7 13.9 11.0 10.1 17.9 22.8 11.5 8.0 5.6 12.9 6.5 7.6 14.4 14.8 17.2 7.0 7.0 5.2 8.9 8.7 15.0 12.6 11.6 15.6 13.3 10.2 14.7 10.7 16.0 10.9 8.5 4.8 8.8 6.6 20.6 6.6 5.6 19.4 19.1 9.4 7.7 1.6 7.0 5.0 11.6 5.7 6.7 19.4 32.8 16.7 23.4 23.7 15.5 42.6 16.5 22.4 40.4 6.0 8.8 28.4 6.2 4.4 5.1 8.1 10.2 1.4 9.1 7.0 2.0 33.2 16.6 6.4 1.3 11.6 3.6 0.0 7.3 24.5 8.4 4.1 11.5 8.9 31.5 4.8 5.8 13.5 18.6 1.4 8.1 20.5 8.5 30.7 4.4 9.7 4.5 4.5 9.2 19.9 5.1 6.5 7.6 30.5 13.3 3.4 24.3 9.6 6.6 2.7 ATG7 "APG7L, DKFZp434N0735, GSA7" ENSG00000197548 "Autophagy related 7" O95352 3 11272309-11557665 "Predicted intracellular proteins, Transporters" "Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 78.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3" "Group enriched" "Detected in all" 5 "dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007639, CAB018771" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 13000 Cytosol "Nucleoplasm, Plasma membrane" "CAB018771: AB_2062165, HPA007639: AB_1845162" "unprognostic (3.97e-2)" "unprognostic (2.83e-2)" "prognostic favorable (9.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.79e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.80e-3)" "unprognostic (2.30e-2)" "unprognostic (2.67e-1)" "prognostic favorable (9.55e-4)" "unprognostic (1.61e-1)" "unprognostic (3.65e-2)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" 27.0 18.6 14.8 21.1 21.9 37.5 16.6 14.1 29.2 16.4 15.2 26.2 13.4 11.6 28.9 15.9 18.9 17.4 15.1 12.3 14.0 13.1 13.1 11.8 18.4 18.8 14.8 17.1 15.5 13.1 18.7 23.0 18.7 21.6 12.9 17.8 19.3 16.6 11.6 15.8 22.2 16.9 18.3 16.6 19.7 13.1 19.7 13.9 17.7 12.7 12.2 21.6 16.5 15.2 4.0 23.8 31.3 39.7 5.9 4.8 14.2 18.4 14.6 6.5 3.4 11.5 15.2 32.4 17.4 22.7 17.4 20.3 6.2 16.8 8.5 10.6 15.4 18.1 5.7 7.2 24.4 30.0 7.5 9.1 6.1 14.1 7.4 15.2 17.6 20.3 15.6 11.3 33.7 21.2 18.0 24.0 5.4 9.0 7.0 24.1 12.0 5.0 8.2 5.1 8.5 18.9 6.3 7.8 7.5 13.1 13.3 5.8 5.7 12.4 10.5 6.7 8.4 11.4 17.2 16.3 14.3 10.4 9.4 24.3 4.5 11.7 14.3 23.2 16.6 19.3 13.1 39.7 24.5 4.8 22.9 3.7 4.0 4.0 4.5 23.8 3.7 3.5 4.2 31.3 5.9 16.3 4.2 3.4 14.2 14.8 21.9 14.1 29.2 14.0 13.1 14.8 17.1 21.6 13.9 0.0 9.8 6.1 6.1 9.8 11.1 3.9 0.0 12.0 5.7 7.0 17.7 13.7 6.6 10.0 41.0 10.5 6.9 23.3 11.3 14.0 8.9 5.5 14.9 7.8 50.1 19.1 10.9 20.9 20.3 78.6 9.5 19.9 3.3 9.0 7.0 9.3 12.7 7.0 9.2 5.4 12.5 6.5 5.1 19.5 11.5 6.8 16.0 10.0 7.3 7.3 ATIC "AICARFT, IMPCHASE, PURH" ENSG00000138363 "5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase" P31939 2 215311817-215349773 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Hydrolase, Multifunctional enzyme, Transferase" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 144.4;Extravillous trophoblasts: 132.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013462, HPA021012" Supported Approved "Plasma membrane,Cytosol" NA NA 3400000 Cytosol "Plasma membrane" "CAB013462: , HPA021012: AB_1845169" "unprognostic (1.41e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (8.46e-2)" "unprognostic (2.90e-1)" "unprognostic (3.81e-2)" "prognostic unfavorable (1.99e-7)" "unprognostic (1.86e-2)" "unprognostic (5.07e-2)" "unprognostic (1.83e-1)" "unprognostic (6.31e-3)" "unprognostic (9.21e-2)" "prognostic unfavorable (8.77e-4)" "unprognostic (1.00e-1)" "unprognostic (1.30e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-3)" 19.4 27.4 21.1 23.0 28.4 16.9 24.8 12.1 32.3 20.6 26.7 29.1 18.1 23.4 27.9 15.6 19.1 21.9 19.1 18.2 20.3 21.1 23.1 35.6 17.3 36.1 29.7 19.9 23.4 32.9 25.1 21.1 31.1 24.4 21.9 35.9 19.5 14.4 29.4 35.5 17.0 20.6 26.7 21.7 29.0 20.4 15.0 28.0 46.3 16.1 13.5 35.3 27.6 18.0 21.7 13.4 2.9 8.9 19.6 22.8 10.0 20.5 31.1 17.4 29.5 23.4 23.7 8.7 21.0 18.3 24.0 27.6 60.0 32.2 29.9 26.0 21.9 33.8 21.6 38.2 31.7 34.5 22.3 36.9 36.4 26.7 53.7 30.3 45.6 18.7 20.0 24.3 32.1 38.8 16.6 16.0 29.0 47.0 25.0 33.0 30.3 39.7 22.2 66.8 32.9 17.5 36.9 25.0 26.8 25.5 33.2 27.3 18.9 16.9 20.8 23.7 40.4 34.1 16.2 14.1 20.4 21.1 26.3 13.2 31.6 41.2 62.1 17.7 25.4 29.4 2.9 6.0 0.1 13.2 8.9 22.8 21.7 18.6 20.0 13.4 13.2 18.9 17.5 0.7 19.6 7.4 11.7 17.7 10.0 21.1 28.4 12.1 32.3 20.3 21.1 29.7 19.9 24.4 28.0 11.9 17.1 19.3 23.5 13.4 9.6 18.5 25.5 26.8 19.4 22.7 3.9 144.4 23.2 32.2 0.8 6.3 13.5 0.0 42.8 132.7 23.3 16.1 24.3 18.7 46.4 9.5 18.5 4.3 15.0 0.0 22.2 18.7 28.7 32.5 29.9 20.6 30.0 21.0 32.2 44.0 12.8 25.8 19.8 3.2 40.3 7.4 79.8 21.5 52.7 17.4 ATOH1 "bHLHa14, HATH1, MATH-1, Math1" ENSG00000172238 "Atonal bHLH transcription factor 1" Q92858 4 93828753-93830964 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "intestine: 29.5" "Cell type enriched" "Detected in some" 36 "Mucus-secreting cells: 198.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HL-60: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA049400 Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA049400: " "prognostic favorable (3.26e-5)" "unprognostic (5.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.70e-1)" 0.0 0.0 0.1 6.4 0.1 0.0 0.1 0.1 0.1 0.1 22.5 0.0 0.0 8.8 0.1 0.0 0.1 0.1 2.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 15.0 0.0 0.1 0.0 0.0 0.1 29.5 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.2 0.5 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 ATP11B "ATPIF, ATPIR, KIAA0956" ENSG00000058063 "ATPase phospholipid transporting 11B (putative)" Q9Y2G3 3 182793500-182921635 "Enzymes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036237, HPA036238" Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA036237: AB_10673123, HPA036238: AB_10670792" "unprognostic (4.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (6.73e-2)" "unprognostic (2.03e-3)" "unprognostic (7.28e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.02e-1)" "unprognostic (1.71e-1)" "unprognostic (1.62e-1)" "unprognostic (3.22e-1)" "unprognostic (8.66e-2)" "unprognostic (1.35e-1)" 16.8 7.9 7.7 19.7 9.8 35.4 17.0 18.4 9.4 20.5 21.6 8.9 14.3 13.6 15.0 11.7 37.3 11.8 12.7 21.1 6.9 5.9 13.7 14.3 19.4 20.3 10.3 5.7 15.2 14.6 21.0 26.0 8.0 8.3 16.8 16.9 9.8 19.7 13.8 13.1 21.8 22.8 16.5 11.3 23.4 27.6 22.8 8.9 49.0 10.8 20.4 21.9 22.7 25.5 3.6 4.2 7.5 1.8 3.0 3.4 1.3 22.7 3.3 7.2 10.0 15.3 16.8 6.6 10.5 14.5 8.2 9.6 8.1 11.8 10.6 18.0 15.1 17.1 13.8 8.5 10.8 14.3 23.4 6.8 25.4 4.4 1.7 8.9 20.0 16.3 11.3 12.3 9.2 13.3 12.1 12.8 16.9 9.0 32.9 13.2 7.7 16.6 6.4 5.1 12.9 6.4 6.9 21.0 12.7 9.9 19.1 4.3 7.7 29.3 3.7 12.8 6.8 4.1 14.9 12.6 12.5 13.5 10.7 18.2 45.0 40.2 19.8 8.6 8.6 7.3 7.5 1.7 7.2 3.1 1.8 3.0 3.6 2.7 3.1 1.9 2.4 2.3 3.4 6.8 3.0 1.7 4.2 2.0 1.3 7.7 9.8 18.4 9.4 6.9 5.9 10.3 5.7 8.3 8.9 14.9 10.4 9.7 20.0 30.5 11.4 15.9 17.8 6.7 11.4 19.2 13.7 9.6 0.0 10.9 27.7 14.5 26.1 46.7 14.4 3.2 14.9 34.3 10.5 13.6 9.2 36.5 6.4 14.1 17.8 19.9 17.8 17.7 13.5 5.4 27.5 8.1 20.8 27.1 19.8 6.2 28.3 19.4 16.5 15.4 10.7 39.0 8.0 24.9 20.4 44.2 ATP12A "#945, 2, ATP1AL1, HK" ENSG00000075673 "ATPase H+/K+ transporting non-gastric alpha2 subunit" P54707 13 24680411-24712493 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 12.3;lymphoid tissue: 38.4" "Group enriched" "Detected in some" 7 "Ciliated cells: 5.3;Club cells: 18.2" "Cancer enhanced" "Detected in many" "testis cancer: 12.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Cell type enriched" "Detected in single" 5 "T-reg: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enriched" "Detected in some" 8 "SuSa: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039526 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039526: AB_10673534" "unprognostic (8.33e-3)" "unprognostic (3.58e-2)" "unprognostic (2.93e-1)" "unprognostic (5.21e-3)" "unprognostic (2.58e-1)" "unprognostic (1.21e-2)" "unprognostic (8.03e-3)" "unprognostic (2.64e-1)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.67e-1)" "unprognostic (6.80e-2)" "unprognostic (8.22e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.2 1.3 0.4 0.1 0.0 0.0 0.0 0.2 0.2 12.3 0.1 0.0 0.1 0.3 0.2 8.8 0.1 6.1 0.0 0.1 0.0 0.1 1.0 0.0 0.2 5.8 0.4 0.3 2.2 0.0 0.4 0.0 0.1 9.8 0.1 0.0 0.1 0.1 0.1 1.0 0.0 1.2 0.2 2.9 38.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.2 1.3 0.3 0.2 0.1 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 5.3 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.2 ATP13A3 AFURS1 ENSG00000133657 "ATPase 13A3" Q9H7F0 3 194402672-194498364 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029471 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Nucleoli "Plasma membrane, Cytosol" "HPA029471: AB_10600784" "unprognostic (5.07e-2)" "unprognostic (3.53e-2)" "unprognostic (2.94e-1)" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (9.87e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.34e-2)" "unprognostic (3.77e-1)" 27.1 14.4 9.0 20.8 12.7 17.5 22.8 15.3 13.8 12.1 13.4 10.8 17.2 11.4 16.2 13.2 12.4 11.3 17.1 37.8 9.6 8.1 29.7 56.9 22.1 11.6 10.1 8.3 13.2 11.4 37.6 10.6 28.9 10.6 11.8 12.6 12.9 16.7 15.9 11.8 7.7 15.0 12.1 9.0 17.1 16.3 8.8 8.4 18.9 37.1 12.0 12.7 17.8 16.1 1.9 2.4 2.3 2.3 2.2 4.7 1.0 49.1 5.6 10.0 9.5 11.4 17.8 24.4 16.9 18.4 18.4 33.5 30.8 12.0 19.4 50.3 24.3 61.0 16.7 9.6 16.8 42.8 64.7 8.3 10.7 7.4 6.5 19.8 34.8 28.1 8.1 7.5 38.2 24.9 30.2 9.5 12.0 12.3 39.3 22.3 8.4 14.0 6.9 9.5 16.1 9.7 12.8 21.6 11.6 15.6 15.7 15.4 8.1 17.9 18.6 12.5 8.8 35.7 24.4 12.4 22.5 18.7 44.6 31.5 25.9 46.7 34.5 44.6 20.7 15.5 1.8 1.7 2.3 1.8 2.3 2.2 1.9 1.7 2.8 2.4 1.1 2.5 2.5 0.3 2.2 0.9 1.6 4.7 1.0 9.0 12.7 15.3 13.8 9.6 8.1 10.1 8.3 10.6 8.4 47.6 35.1 27.9 35.7 73.3 24.1 34.6 96.8 24.1 37.5 47.1 19.6 25.7 3.3 56.7 1.9 46.6 20.8 0.0 60.7 16.3 46.0 62.6 8.1 112.9 37.1 14.3 29.4 49.1 35.1 1.1 9.5 48.5 59.1 8.2 21.5 10.3 76.7 20.4 12.4 39.8 13.3 12.9 36.0 14.0 7.0 62.2 54.0 20.1 19.9 58.3 ATP23 "KUB3, XRCC6BP1" ENSG00000166896 "ATP23 metallopeptidase and ATP synthase assembly factor homolog" Q9Y6H3 12 57941541-57957269 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.5" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 11.7;Distal tubular cells: 14.9;Extravillous trophoblasts: 11.6;granulocytes: 10.5;Hofbauer cells: 9.7;Proximal tubular cells: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 15.2;RH-30: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035804, HPA043204" Uncertain Enhanced "Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA "Vesicles, Plasma membrane" "Cell Junctions, Cytosol" "HPA035804: AB_10601026, HPA043204: AB_2678361" "unprognostic (2.56e-1)" "unprognostic (1.31e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (5.28e-2)" "unprognostic (5.41e-3)" "unprognostic (1.03e-2)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (4.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-1)" 6.7 4.9 4.3 5.2 5.3 11.3 4.8 6.1 4.8 5.6 8.2 1.3 2.5 3.9 3.2 4.2 7.3 3.1 2.4 6.4 4.2 3.6 5.4 6.2 2.7 6.8 2.7 3.8 4.2 5.8 3.2 3.0 3.5 2.9 5.1 8.2 2.3 3.4 3.3 11.7 5.6 4.3 6.5 3.4 3.7 3.8 39.5 2.0 20.8 4.7 5.9 4.7 6.3 6.2 3.0 4.5 12.0 4.5 2.6 5.6 3.0 2.0 1.5 1.9 2.2 2.8 2.7 1.0 1.9 2.0 2.2 2.1 1.2 2.5 6.9 2.5 1.5 2.2 1.9 1.8 2.0 3.8 3.5 1.8 4.5 1.3 2.0 1.2 9.1 3.1 1.4 1.5 1.3 0.6 2.2 1.5 5.0 4.7 5.0 1.8 3.1 4.9 15.2 1.7 3.4 3.7 3.2 49.9 2.9 1.8 2.6 1.2 1.8 3.1 2.9 1.6 0.9 5.0 8.6 0.8 1.7 2.9 2.2 1.9 4.1 2.1 3.6 1.8 9.8 2.7 7.6 4.5 12.0 3.5 2.4 2.6 3.0 4.0 3.3 4.5 3.0 4.3 4.0 1.9 2.6 4.2 2.1 5.6 3.0 4.3 5.3 6.1 4.8 4.2 3.6 2.7 3.8 2.9 2.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.4 3.5 0.0 11.7 14.9 5.1 0.0 0.0 0.0 0.0 9.4 11.6 0.0 0.0 10.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.8 0.0 0.0 4.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 ATP6AP1L ENSG00000205464 "ATPase H+ transporting accessory protein 1 like" Q52LC2 5 82279462-82386977 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 27.5;Early spermatids: 20.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 8 "dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2" "Cell line enriched" "Detected in some" 5 "MOLT-4: 15.7" HPA053771 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA053771: AB_2682257" "unprognostic (1.64e-1)" "unprognostic (8.15e-2)" "unprognostic (5.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (5.09e-1)" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-3)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" 1.6 1.0 2.6 0.2 2.4 0.6 0.7 2.5 2.1 1.8 1.2 0.1 1.5 0.1 1.4 2.4 1.7 2.0 2.7 1.8 0.8 1.4 1.5 0.7 2.5 4.4 2.4 0.1 2.0 0.7 1.4 0.6 2.6 2.5 3.3 5.1 0.2 0.6 2.7 0.8 1.8 3.8 1.5 0.4 0.9 0.5 0.1 1.3 0.0 0.1 1.5 1.2 0.0 0.1 0.0 0.1 1.0 0.6 0.3 0.0 0.1 0.3 0.4 0.9 0.1 0.0 0.0 0.0 0.9 1.3 0.0 0.3 2.9 0.0 1.3 0.6 0.5 0.2 0.3 2.3 0.2 0.0 2.1 1.1 0.0 2.6 0.2 0.5 0.2 0.7 1.2 0.0 0.2 15.7 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.2 0.1 0.7 1.2 0.0 1.5 0.0 1.3 0.0 0.0 0.0 1.6 0.5 2.3 1.9 12.1 2.4 0.0 14.7 1.2 5.2 27.5 6.1 1.7 2.6 20.6 1.8 1.3 0.0 2.9 2.7 3.8 1.2 2.3 1.6 1.2 1.6 1.2 4.9 1.5 16.6 4.4 1.3 0.0 1.0 1.8 10.6 2.6 0.0 2.8 1.1 14.2 0.0 1.4 14.0 5.5 1.3 2.9 1.9 1.1 1.3 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2;parathyroid gland: 65.6" "Cell type enhanced" "Detected in all" 8 "Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" NA NA 21000 "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favorable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (6.90e-4)" 9.4 15.6 19.3 9.3 46.1 9.9 9.1 55.8 66.2 8.0 11.6 25.8 5.1 17.9 11.4 11.1 9.6 9.7 12.2 9.9 23.8 32.8 20.3 11.3 12.7 6.6 23.6 24.8 11.4 9.3 65.6 23.6 11.2 43.3 9.9 11.3 19.7 8.2 10.7 28.9 14.7 12.4 11.7 23.7 11.1 8.8 9.8 13.1 5.2 16.3 6.7 7.8 6.7 6.9 6.3 9.1 14.2 10.5 0.1 2.8 4.2 6.6 13.8 8.5 15.2 14.2 12.4 4.9 4.7 8.8 10.1 13.3 8.8 15.0 1.2 8.7 9.7 13.9 14.5 13.0 8.0 11.8 10.3 13.6 10.7 10.4 6.9 8.8 4.6 19.6 9.1 11.6 16.2 6.9 12.6 7.1 5.0 38.9 42.3 15.0 5.7 1.8 4.1 5.4 8.8 0.1 0.1 8.8 18.6 11.7 5.3 23.4 12.4 7.3 6.7 14.0 11.5 16.3 7.0 4.2 8.6 0.3 12.6 5.6 17.2 23.4 2.5 11.5 0.1 10.0 12.1 10.5 8.0 0.8 3.4 1.2 3.5 0.6 0.1 9.1 6.3 1.0 0.8 14.2 0.1 2.4 4.7 2.8 4.2 19.3 46.1 55.8 65.9 23.8 32.8 23.6 24.8 43.3 13.1 17.9 46.6 27.3 45.1 17.5 158.7 19.5 30.6 6.7 14.8 14.0 276.9 26.4 10.0 14.7 2.4 19.2 44.6 46.7 15.8 13.4 33.9 38.7 23.1 33.6 46.0 90.6 81.5 19.6 33.1 3.1 16.1 25.8 38.8 3.6 23.1 51.9 17.6 38.6 22.3 28.4 349.7 6.5 48.9 38.7 18.5 17.7 83.5 4.4 19.5 10.7 ATP6V0A2 "a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1" ENSG00000185344 "ATPase H+ transporting V0 subunit a2" Q9Y487 12 123712318-123761755 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044279 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA044279: AB_10961274" "unprognostic (2.60e-1)" "unprognostic (8.79e-3)" "unprognostic (3.60e-2)" "unprognostic (1.50e-1)" "unprognostic (2.70e-1)" "unprognostic (2.29e-2)" "unprognostic (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (3.77e-2)" "unprognostic (1.75e-1)" "unprognostic (8.85e-3)" "unprognostic (1.63e-1)" "unprognostic (1.26e-1)" "unprognostic (7.48e-2)" "unprognostic (1.12e-1)" "unprognostic (3.47e-1)" "unprognostic (1.58e-1)" 13.5 9.4 7.2 13.0 9.9 15.5 11.5 16.2 9.8 8.9 13.1 13.0 9.0 16.0 13.4 8.8 9.1 10.4 10.4 13.6 8.0 7.9 8.9 13.7 13.1 16.6 12.8 6.9 9.7 18.1 8.1 10.4 10.2 9.1 9.8 12.0 9.8 24.5 10.0 13.0 20.5 15.8 12.3 9.4 13.1 15.9 15.9 10.8 24.0 10.3 8.6 17.5 11.0 10.3 2.3 3.4 13.1 1.5 2.1 2.7 0.9 3.3 8.4 8.8 11.8 5.2 5.0 5.4 4.0 4.7 5.2 5.7 6.2 2.7 12.8 2.8 5.4 5.5 7.1 11.4 4.2 3.9 8.7 6.4 18.4 6.7 3.6 8.2 11.7 37.8 4.5 3.7 6.1 6.6 5.2 4.5 10.1 11.1 2.3 5.7 9.2 11.0 14.3 9.2 5.0 5.6 10.6 7.6 4.1 5.0 8.3 5.3 9.0 6.8 4.7 6.0 4.7 4.9 8.5 6.5 6.6 2.5 8.1 6.7 7.6 8.4 11.9 5.5 7.1 5.6 6.4 0.9 13.1 2.1 0.9 1.5 1.3 2.1 1.8 1.1 2.3 1.9 2.7 2.4 2.1 1.5 3.4 1.4 0.9 7.2 9.9 16.2 9.8 8.0 7.9 12.8 6.9 9.1 10.8 6.0 14.1 16.0 6.8 9.0 18.1 7.9 17.8 8.1 9.1 8.7 11.8 4.7 0.0 7.4 7.9 8.9 10.5 0.0 9.5 4.6 8.0 12.1 71.8 9.5 7.4 11.1 12.7 14.1 10.8 3.1 8.1 11.7 1.7 10.0 10.1 12.2 6.7 8.0 8.9 3.7 27.6 6.5 8.9 19.5 11.5 12.4 5.7 13.1 9.9 10.6 ATP6V0A4 "a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2" ENSG00000105929 "ATPase H+ transporting V0 subunit a4" Q9HBG4 7 138706294-138799560 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 40.6;salivary gland: 55.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 15.7;Cytotrophoblasts: 11.7;Distal tubular cells: 26.6;Melanocytes: 6.8" "Cancer enriched" "Detected in many" 8 "renal cancer: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 35.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA018029, HPA064555" Enhanced Uncertain Cytosol NA NA Cytosol "HPA018029: AB_1845190, HPA064555: AB_2685284" "unprognostic (1.99e-2)" "unprognostic (8.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.10e-2)" "unprognostic (1.43e-1)" "unprognostic (6.53e-2)" "unprognostic (4.63e-2)" "unprognostic (4.28e-1)" "unprognostic (1.35e-1)" "unprognostic (9.79e-3)" "unprognostic (1.73e-1)" "prognostic favorable (1.32e-6)" "unprognostic (4.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-2)" 0.1 0.0 0.5 0.0 0.3 0.0 2.2 0.1 0.4 1.7 0.0 0.3 3.1 0.0 0.3 0.5 2.7 0.0 0.0 0.0 0.4 0.3 40.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.2 1.0 0.2 0.5 0.0 0.3 55.4 1.2 0.0 6.5 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 1.8 7.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 3.1 1.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 3.0 0.1 0.0 0.0 0.0 35.9 1.2 2.0 0.1 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.1 0.4 0.4 0.3 0.3 0.0 0.2 0.1 0.0 0.6 0.0 0.8 0.0 0.0 0.3 0.0 1.4 1.2 15.7 2.0 11.7 26.6 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.3 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 4.2 0.0 0.0 1.1 ATP6V0B "ATP6F, HATPL, VMA16" ENSG00000117410 "ATPase H+ transporting V0 subunit b" Q99437 1 43974487-43978295 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 173.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 173.6" "Group enriched" "Detected in all" 4 "dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044281 Approved Cytosol NA NA Cytosol "HPA044281: " "unprognostic (1.38e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (5.69e-2)" "unprognostic (5.31e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (7.23e-2)" "prognostic favorable (3.24e-4)" "unprognostic (6.13e-2)" "prognostic favorable (3.62e-6)" "unprognostic (5.55e-2)" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (8.87e-4)" 20.4 35.7 35.4 21.8 35.3 84.2 28.5 29.1 56.4 23.3 28.3 32.2 26.7 19.2 13.9 35.6 21.9 20.0 22.0 24.8 41.2 44.7 47.6 56.3 25.8 28.5 43.6 31.5 12.9 87.0 32.5 36.3 35.0 33.9 27.0 32.0 32.4 34.8 22.2 27.9 20.1 20.2 19.1 34.8 33.2 25.2 15.3 24.8 16.3 38.7 19.5 24.7 23.2 16.5 23.7 58.0 173.6 78.0 8.8 14.2 87.6 23.7 23.2 19.3 24.2 29.7 15.7 23.6 21.4 31.8 41.6 36.0 24.9 26.0 22.1 19.8 22.6 49.4 19.7 45.0 32.2 19.6 20.7 46.9 27.6 40.1 35.8 47.1 42.9 53.7 19.3 42.5 45.8 40.6 26.7 20.0 31.0 27.5 48.5 34.0 25.1 17.7 71.5 31.8 34.5 49.6 25.1 18.5 60.2 43.3 29.3 45.5 22.5 14.4 57.1 53.6 22.8 23.4 77.2 10.1 21.5 18.3 38.7 51.4 39.3 57.7 24.5 29.2 61.2 33.5 31.9 78.0 64.2 13.2 48.1 13.0 23.7 14.2 12.7 48.1 19.1 10.8 10.9 173.6 8.8 44.0 58.0 13.7 87.6 35.4 35.3 29.1 56.4 41.2 44.7 43.6 31.5 33.9 24.8 74.5 137.9 144.5 130.3 298.3 238.3 92.4 122.3 100.4 66.0 268.7 96.2 165.0 170.8 307.8 2.7 147.4 174.0 23.3 286.0 191.3 151.0 308.8 203.1 213.0 743.7 122.3 214.8 101.3 356.6 8.6 73.1 420.3 266.6 357.1 190.7 203.9 311.9 371.7 61.5 175.0 164.2 77.6 135.2 133.6 224.9 313.3 415.2 116.5 165.6 262.4 ATP6V0C "ATP6C, ATP6L, ATPL, VATL, Vma3" ENSG00000185883 "ATPase H+ transporting V0 subunit c" P27449 16 2513870-2520218 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 11 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 58.3;Ciliated cells: 45.5;Club cells: 33.0;granulocytes: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065100 Approved Cytosol NA NA Cytosol "HPA065100: AB_2685421" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (5.96e-2)" "unprognostic (7.67e-2)" "unprognostic (2.31e-1)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" "prognostic favorable (1.07e-6)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (2.85e-1)" "unprognostic (5.04e-2)" 56.5 68.2 61.2 53.6 83.5 87.2 24.1 76.0 156.7 27.7 42.9 39.2 25.2 55.2 28.0 21.9 48.7 25.6 23.0 32.5 64.3 70.1 78.0 37.3 40.5 37.1 55.4 74.2 27.2 42.7 41.9 52.3 35.1 70.4 35.7 19.5 40.1 54.3 30.3 108.8 38.7 52.8 18.3 41.9 48.3 59.0 30.4 29.4 25.1 25.7 34.7 29.2 20.8 29.6 15.9 28.2 50.6 42.5 13.0 16.1 18.2 29.7 31.9 17.3 24.6 21.9 10.9 41.3 44.1 13.9 18.5 17.8 29.7 38.6 15.0 40.6 21.1 31.7 36.2 18.4 26.2 9.3 38.3 54.8 17.2 25.7 36.3 31.1 27.2 53.0 19.7 19.6 23.4 12.3 18.8 13.2 16.9 40.6 28.8 16.0 58.0 27.4 71.1 33.5 19.6 39.2 44.0 15.0 47.1 32.5 17.7 56.4 45.8 37.1 43.1 35.3 16.1 41.5 34.8 31.5 29.8 35.5 44.8 31.5 53.7 65.5 27.5 26.2 20.1 30.1 22.1 32.6 50.6 14.8 36.3 15.1 15.9 13.4 16.1 20.4 15.4 15.6 13.5 43.7 13.0 42.5 28.2 13.2 18.2 61.2 83.5 76.0 123.3 64.3 70.1 55.4 74.2 70.4 29.4 23.8 58.3 0.5 0.1 0.9 0.5 0.0 0.0 45.5 33.0 1.8 0.0 0.5 0.0 0.5 0.0 0.1 3.2 0.0 0.2 0.7 0.5 0.0 16.3 0.5 0.9 0.0 0.0 1.8 1.8 0.0 0.6 0.7 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.5 0.7 0.0 0.1 0.4 1.0 0.9 1.0 0.7 0.9 0.1 ATP6V1A "ATP6A1, ATP6V1A1, VA68, Vma1, VPP2" ENSG00000114573 "ATPase H+ transporting V1 subunit A" P38606 3 113747019-113812056 "Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Translocase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 467.9;Late spermatids: 569.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.6" "Group enriched" "Detected in all" 6 "dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006910, HPA035084" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA 2700000 "Vesicles, Cytosol" Nucleoplasm "CAB006910: , HPA035084: AB_2674454" "unprognostic (1.32e-1)" "unprognostic (8.68e-2)" "unprognostic (5.87e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.00e-1)" "unprognostic (3.43e-2)" "unprognostic (2.90e-2)" "unprognostic (1.42e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-2)" "unprognostic (5.19e-3)" "prognostic favorable (3.82e-12)" "unprognostic (8.82e-2)" "unprognostic (2.46e-3)" "unprognostic (2.43e-1)" "unprognostic (1.52e-2)" 12.8 19.8 24.1 10.4 33.2 7.4 12.7 34.8 52.8 14.0 11.1 10.3 5.6 9.3 7.5 8.2 13.2 10.0 10.8 4.7 26.2 38.2 47.9 18.2 12.3 11.4 25.4 25.0 6.2 10.5 39.3 13.5 12.3 52.0 11.2 11.8 14.7 18.0 8.4 4.5 12.6 7.9 8.2 13.6 13.7 10.9 8.9 8.3 9.6 21.0 5.7 13.6 10.2 8.2 3.8 16.4 33.6 15.4 3.8 3.4 6.0 25.4 11.6 14.6 12.7 30.9 13.8 15.6 13.8 21.1 14.5 20.1 21.8 20.5 20.9 32.9 20.1 16.1 16.6 33.0 18.2 19.1 9.5 9.1 18.5 18.0 16.8 25.5 13.6 21.7 18.6 12.6 18.8 13.2 22.6 23.6 10.6 21.1 15.8 21.5 16.7 9.9 6.1 18.3 17.8 14.6 8.6 10.6 23.7 39.8 24.3 28.3 10.4 24.2 16.5 18.1 21.0 25.0 11.0 21.7 13.6 10.1 9.3 8.2 16.6 17.8 19.3 26.6 17.2 15.0 9.2 15.4 5.2 2.8 11.7 2.6 3.8 2.6 2.7 16.4 2.9 2.5 2.9 33.6 3.8 9.5 4.6 3.4 6.0 24.1 33.2 34.8 52.8 26.2 38.2 25.4 25.0 52.0 8.3 26.8 28.3 28.9 13.2 27.0 92.7 7.9 33.1 14.7 19.4 94.2 39.3 18.1 69.6 25.2 467.9 26.0 24.0 0.0 23.9 18.8 17.8 28.2 10.4 64.4 67.8 95.3 53.6 36.2 95.4 569.6 16.7 67.0 43.9 49.5 25.8 42.1 22.3 24.6 21.5 62.8 37.3 6.5 14.6 25.3 14.3 41.9 36.7 17.1 21.3 21.1 ATP6V1C1 "ATP6C, ATP6D, VATC, Vma5" ENSG00000155097 "ATPase H+ transporting V1 subunit C1" P21283 8 103021063-103073051 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023943, HPA057297" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023943: AB_1845197, HPA057297: AB_2683402" "unprognostic (5.73e-3)" "unprognostic (3.30e-1)" "unprognostic (1.09e-2)" "unprognostic (1.93e-2)" "unprognostic (1.52e-2)" "unprognostic (3.35e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (3.29e-2)" "unprognostic (3.87e-1)" "unprognostic (5.62e-2)" "unprognostic (1.19e-1)" "unprognostic (5.59e-2)" "unprognostic (3.98e-2)" "unprognostic (1.23e-1)" "unprognostic (3.85e-1)" "unprognostic (3.88e-1)" "unprognostic (2.83e-1)" 17.1 23.1 25.1 16.8 36.7 6.5 15.7 26.2 58.8 13.6 11.1 11.4 7.6 12.1 14.1 10.9 10.6 12.2 13.7 19.0 28.5 28.0 35.0 18.1 12.9 15.9 23.2 33.3 14.4 12.9 21.3 29.2 20.2 45.1 13.2 13.7 11.5 10.4 12.2 11.7 8.5 12.8 14.5 15.0 14.3 12.1 13.0 12.5 10.7 26.9 8.4 15.6 15.5 10.7 10.6 16.3 27.9 24.3 10.0 12.5 10.8 29.1 17.5 9.3 6.9 24.4 15.8 11.5 21.9 21.8 24.6 29.1 12.9 29.6 18.8 25.1 17.4 39.3 11.8 18.3 17.0 35.2 12.3 14.1 18.3 13.3 15.3 26.0 9.8 22.1 15.1 22.2 33.0 15.9 14.8 18.5 12.2 23.3 15.4 27.3 13.2 18.3 7.2 8.1 26.5 17.0 10.6 16.4 14.2 27.5 21.0 11.9 10.2 12.3 11.7 38.3 17.3 24.5 11.6 22.0 14.3 14.5 31.7 15.3 20.2 7.3 17.9 27.7 20.4 13.8 8.4 17.4 20.6 9.1 24.3 10.2 10.6 7.7 8.9 16.3 10.2 9.0 9.7 27.9 10.0 22.1 8.8 12.5 10.8 25.1 36.7 26.2 58.8 28.5 28.0 23.2 33.3 45.1 12.5 29.8 23.7 18.1 27.2 31.0 29.7 39.1 12.7 41.5 18.2 29.6 15.7 32.6 54.7 34.3 128.0 23.1 13.6 23.3 27.3 30.1 23.0 29.4 23.1 15.3 87.3 35.0 15.0 18.4 45.4 117.5 22.5 45.4 18.6 26.2 12.6 31.4 26.9 14.4 17.3 112.2 20.4 19.4 32.5 10.5 20.2 28.7 62.6 17.5 13.4 25.0 ATP6V1H "CGI-11, SFD, SFDalpha, SFDbeta, VMA13" ENSG00000047249 "ATPase H+ transporting V1 subunit H" Q9UI12 8 53715557-53843558 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009532, HPA023421" Approved Supported "Plasma membrane,Actin filaments,Cytosol" NA NA 48000 "Actin filaments, Cytosol" "Plasma membrane" "CAB009532: AB_667834, HPA023421: AB_1845202" "unprognostic (1.67e-3)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (2.16e-2)" "unprognostic (2.38e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (2.01e-1)" "unprognostic (1.95e-1)" "unprognostic (6.39e-3)" "unprognostic (1.56e-1)" "unprognostic (5.30e-2)" "prognostic favorable (1.46e-7)" "unprognostic (1.06e-1)" "unprognostic (3.37e-2)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" 14.1 25.1 42.2 9.7 41.5 14.0 15.8 22.5 46.2 14.6 12.1 12.0 10.5 8.3 13.7 19.3 18.1 13.1 11.6 17.2 39.0 25.5 36.6 11.3 13.8 11.1 21.4 30.0 15.0 11.7 27.0 20.0 14.0 30.0 19.6 12.0 12.7 16.4 18.2 17.3 14.4 8.3 14.6 14.7 10.2 13.3 10.8 11.3 15.3 30.0 11.5 12.3 15.3 11.0 12.0 16.3 30.6 17.0 18.8 17.7 9.3 19.2 13.5 12.3 13.3 21.9 14.0 10.5 21.4 19.2 24.6 24.8 12.5 22.3 12.2 20.1 17.2 33.6 30.2 20.3 26.5 21.7 19.1 16.5 13.4 14.1 15.2 31.8 8.6 15.0 20.9 32.9 16.8 26.3 23.1 16.4 14.0 16.9 6.0 31.2 13.4 13.5 13.6 12.1 15.8 8.0 11.7 5.0 7.7 34.8 25.8 9.9 16.4 12.3 22.1 33.3 14.4 28.1 7.3 19.1 10.9 10.0 26.0 11.6 12.8 12.8 14.2 26.3 11.7 11.8 19.0 11.5 30.6 11.5 13.0 13.1 12.0 14.2 13.7 16.3 10.8 13.8 14.3 13.8 18.8 17.0 13.4 17.7 9.3 42.2 41.5 22.5 46.2 39.0 25.5 21.4 30.0 30.0 11.3 35.7 20.6 45.5 34.9 26.3 65.4 25.0 28.1 28.1 37.5 55.8 106.0 58.8 89.5 44.6 6.6 20.4 29.0 0.0 27.2 36.4 26.2 27.6 15.1 20.3 58.3 58.8 33.9 30.7 34.6 6.2 40.0 49.3 28.7 37.9 16.0 52.6 36.9 27.5 45.3 44.2 68.3 19.4 20.3 15.0 47.2 27.5 83.6 39.2 19.6 31.1 ATP8B1 "ATPIC, BRIC, FIC1, PFIC, PFIC1" ENSG00000081923 "ATPase phospholipid transporting 8B1" O43520 18 57646426-57803101 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Lipid transport, Transport" Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 198.4;Mucus-secreting cells: 179.9;Undifferentiated cells: 138.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.5;HBF TERT88: 24.7;RT4: 58.5" "Low region specificity" "Detected in many" "HPA018673, HPA018674" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA018673: AB_1845207, HPA018674: AB_1845208" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "prognostic favorable (2.60e-4)" "unprognostic (8.81e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (9.62e-3)" "unprognostic (1.97e-1)" "unprognostic (3.30e-3)" "unprognostic (4.55e-3)" "prognostic favorable (6.35e-4)" "unprognostic (1.88e-1)" "unprognostic (2.22e-1)" "unprognostic (3.25e-1)" "unprognostic (8.60e-3)" 3.8 2.3 0.0 1.8 0.0 0.0 3.4 0.0 0.3 4.5 21.3 8.9 2.4 0.8 6.7 2.6 4.8 1.8 0.2 0.0 2.1 3.0 3.6 0.0 0.1 0.7 10.7 2.7 1.1 1.3 6.0 19.3 5.8 2.8 0.4 3.6 11.1 2.0 0.2 1.2 13.3 0.0 5.7 0.2 12.8 5.4 6.0 2.0 4.7 2.1 0.7 1.3 0.3 10.2 3.5 0.1 0.1 3.6 6.6 5.0 19.9 19.4 21.0 13.1 2.6 8.9 0.7 6.0 27.5 8.3 15.2 0.1 4.2 24.7 0.2 0.4 0.1 0.9 0.9 1.1 0.2 0.1 1.0 3.8 6.3 11.1 15.5 11.0 0.2 0.1 0.4 12.1 4.9 0.2 0.2 0.2 11.0 1.0 0.1 0.1 0.2 2.9 58.5 0.4 0.3 0.4 12.3 0.1 0.5 3.8 0.6 12.6 17.1 0.6 2.7 4.6 0.2 0.1 0.2 0.4 0.2 0.9 0.8 2.1 0.5 1.3 0.9 1.0 2.7 1.0 0.7 0.5 6.0 0.9 1.0 4.7 0.7 1.2 2.0 0.4 0.3 17.9 18.2 4.5 44.8 6.9 0.7 4.0 33.1 40.2 48.9 38.4 0.0 17.1 0.0 20.8 2.0 26.8 198.4 0.0 45.9 1.9 5.1 74.4 4.6 16.8 2.3 6.4 65.7 30.1 3.8 0.0 0.3 1.3 6.8 1.0 179.9 0.2 33.7 74.8 0.0 0.1 1.1 12.9 17.6 0.3 1.2 14.3 9.2 1.5 138.5 100.6 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2" "Group enriched" "Detected in many" 4 "Early spermatids: 23.4;granulocytes: 19.6;Hofbauer cells: 12.9;Kupffer cells: 29.9;Late spermatids: 19.9;Macrophages: 17.3;T-cells: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 6.9;NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 19.1;NB-4: 7.3;THP-1: 12.3;U-937: 38.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 2.3 1.2 1.6 1.5 2.1 28.1 1.0 0.6 0.9 26.0 1.5 1.7 1.6 0.4 18.2 3.5 0.6 9.5 3.1 0.8 2.5 0.9 1.0 1.2 3.2 0.7 2.7 0.1 3.9 0.4 0.2 1.1 2.9 2.1 0.7 1.2 0.8 0.9 0.6 0.4 0.5 1.1 2.7 3.1 2.3 0.6 0.9 4.6 0.8 0.5 0.8 2.1 1.3 1.5 0.0 2.2 6.9 1.7 10.6 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 5.2 0.0 3.0 0.6 0.0 0.0 5.3 19.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 38.5 0.0 6.9 1.7 2.4 0.5 0.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 10.6 0.3 0.0 0.0 0.8 1.6 2.1 0.6 0.9 2.5 0.9 2.7 0.1 2.1 4.6 0.0 3.4 1.3 0.1 1.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 23.4 0.5 0.4 0.0 0.0 1.6 3.3 0.5 19.6 2.8 12.9 0.0 0.0 1.8 29.9 19.9 1.7 17.3 1.7 1.0 0.3 0.5 0.0 0.0 0.7 0.8 0.0 0.0 4.3 0.4 0.6 0.3 2.4 8.6 0.0 0.1 ATPAF2 "ATP12, Atp12p, LP3663, MGC29736" ENSG00000171953 "ATP synthase mitochondrial F1 complex assembly factor 2" Q8N5M1 17 17977409-18039209 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023329, HPA059422" Supported Enhanced Cytosol No No Cytosol "HPA023329: AB_1845209, HPA059422: AB_2684011" "unprognostic (3.16e-2)" "unprognostic (1.98e-2)" "unprognostic (4.40e-2)" "prognostic favorable (4.95e-4)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (2.70e-3)" "unprognostic (1.67e-2)" "prognostic favorable (6.00e-5)" "unprognostic (1.32e-1)" "unprognostic (2.53e-1)" "unprognostic (5.15e-1)" "unprognostic (2.62e-2)" 9.8 23.1 14.2 11.0 12.5 18.0 11.4 18.1 20.9 10.3 14.3 17.1 12.7 11.5 9.9 12.1 16.1 11.1 8.9 25.3 12.4 12.6 19.1 21.6 9.8 12.5 12.7 11.6 9.8 14.5 20.0 14.2 11.5 13.0 11.3 14.1 15.4 19.5 10.7 28.3 16.4 13.8 11.2 10.9 13.6 12.9 17.3 12.5 12.9 14.2 13.5 19.1 13.0 10.4 13.0 24.2 6.9 20.6 3.9 6.0 9.7 5.7 10.7 7.1 6.7 7.1 7.7 7.1 5.1 7.4 10.9 9.3 14.1 8.8 11.5 11.4 8.7 6.0 8.9 6.7 10.8 9.6 9.2 5.3 2.5 6.9 8.1 12.0 3.6 8.0 9.1 7.8 9.8 5.5 7.7 12.4 9.6 4.0 4.0 5.9 11.6 8.4 5.5 4.7 21.4 6.1 8.7 12.4 13.2 8.7 5.1 4.6 6.2 6.7 3.5 6.2 50.3 11.2 7.3 5.2 2.7 5.8 10.2 4.8 2.8 3.5 4.2 5.0 5.3 14.2 3.5 20.6 6.9 4.8 14.0 5.3 13.0 3.7 4.6 24.2 9.4 5.7 4.4 1.4 3.9 10.1 20.5 6.0 9.7 14.2 12.5 18.1 20.9 12.4 12.6 12.7 11.6 13.0 12.5 6.0 8.5 16.9 12.6 13.6 9.0 25.4 17.8 21.4 6.8 12.2 31.4 27.6 56.3 18.3 40.0 10.9 11.3 0.0 10.6 25.5 10.8 12.5 12.7 18.3 40.8 9.5 13.9 8.0 20.6 31.1 6.1 17.9 16.9 28.9 15.7 9.6 13.2 21.0 6.3 41.3 16.8 0.0 12.2 15.2 11.9 16.6 24.0 10.9 19.4 8.2 ATRN "DPPT-L, MGCA" ENSG00000088812 Attractin O75882 20 3471040-3651122 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008853 Approved Approved Cytosol "Secreted to blood" NA NA 39000000000 Cytosol "HPA008853: AB_1078248" "unprognostic (6.42e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (2.52e-1)" "unprognostic (5.27e-2)" "unprognostic (1.65e-1)" "unprognostic (3.99e-2)" "unprognostic (4.28e-1)" "unprognostic (3.40e-2)" "unprognostic (4.61e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.19e-6)" "unprognostic (3.71e-2)" "unprognostic (9.49e-2)" "unprognostic (2.77e-1)" "unprognostic (3.91e-2)" 12.1 22.8 14.9 7.4 20.7 5.7 13.0 18.4 29.3 13.5 22.8 18.3 7.4 39.9 12.2 12.2 9.3 9.2 12.4 14.8 13.6 14.7 18.4 45.2 10.6 7.1 12.8 18.9 11.5 17.7 40.3 13.4 16.5 16.1 10.1 9.5 12.2 14.0 10.7 11.7 13.6 31.1 11.3 15.2 9.7 17.1 16.2 12.3 5.4 24.1 7.5 7.1 12.0 9.8 3.6 5.7 5.7 6.5 3.0 4.8 1.9 17.9 16.9 10.1 8.4 17.9 29.3 12.9 12.0 17.1 12.7 10.8 7.2 12.3 0.0 8.1 16.8 15.6 25.2 6.8 26.2 17.0 2.0 5.8 5.6 4.7 15.6 10.8 11.9 3.8 15.6 21.3 13.4 13.0 15.9 16.4 3.9 8.8 8.8 12.3 5.1 4.8 4.5 6.7 5.9 10.2 4.0 23.4 13.4 11.6 12.8 6.0 9.3 12.0 22.4 16.4 10.3 12.0 11.4 20.1 13.5 8.0 14.2 11.8 6.2 8.7 0.0 8.3 8.0 13.5 5.7 6.5 3.6 4.8 5.6 2.3 2.8 2.7 3.0 5.7 3.6 4.4 3.7 0.0 3.0 5.7 5.3 3.4 1.9 14.9 20.7 18.4 29.3 13.6 14.7 12.8 18.9 16.1 12.3 14.9 7.2 7.3 3.8 5.7 22.1 10.4 22.9 6.7 5.7 10.4 35.3 6.4 1.7 6.4 6.3 8.4 6.1 0.0 12.5 7.2 9.3 6.1 6.9 39.5 9.6 35.0 9.2 20.9 13.9 2.5 11.5 6.3 6.8 6.4 10.2 12.7 10.7 15.3 7.4 7.9 18.2 32.3 5.2 16.7 21.7 6.4 4.2 5.0 10.5 3.1 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: AB_2686306" "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 8.1 9.1 17.7 11.9 25.1 5.5 9.1 33.7 29.5 14.8 13.5 12.9 10.3 8.2 20.5 9.8 11.1 11.0 12.1 11.8 18.0 11.0 9.1 10.1 14.8 11.6 21.1 17.7 10.7 10.3 18.4 11.6 10.3 16.4 14.2 8.5 9.8 8.4 14.0 26.3 12.0 8.3 19.1 16.1 11.4 10.3 8.1 25.6 4.6 11.8 12.5 7.4 11.7 11.3 0.4 0.8 4.4 1.7 0.1 2.5 0.8 3.4 2.0 0.7 0.0 3.5 4.8 4.6 3.7 8.7 2.3 2.7 2.1 2.2 0.1 5.0 7.1 3.0 3.2 0.2 2.3 3.3 1.9 3.6 0.5 3.2 6.7 5.7 3.2 5.6 3.7 4.5 4.8 4.1 8.9 4.6 0.7 0.0 4.1 1.9 1.7 0.2 3.6 0.7 1.1 3.3 0.2 4.6 3.0 3.1 5.8 0.2 2.0 3.4 4.3 7.0 7.0 2.8 5.5 7.0 3.2 4.9 3.7 3.3 24.3 13.9 0.1 2.0 3.3 7.8 0.7 1.7 0.4 2.5 1.3 1.9 0.4 1.7 2.4 0.8 0.1 0.2 1.5 4.4 0.1 0.7 0.4 1.3 0.8 17.7 25.1 33.7 29.5 18.0 11.0 21.1 17.7 16.4 25.6 44.7 20.4 14.9 54.4 81.3 39.6 30.2 25.5 22.7 26.1 10.4 94.2 0.3 6.6 15.9 3.6 15.7 12.5 0.0 7.4 3.0 26.7 57.3 38.1 25.3 20.8 36.5 1.2 20.3 33.9 1.8 9.8 33.2 30.4 28.9 12.3 24.2 22.2 13.5 26.5 7.7 108.3 51.8 35.3 0.9 1.3 42.7 0.3 44.9 6.8 52.7 ATXN10 "E46L, FLJ37990, SCA10" ENSG00000130638 "Ataxin 10" Q9UBB4 22 45671798-45845307 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049531 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA049531: AB_2680806" "unprognostic (5.73e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.76e-2)" "unprognostic (3.01e-2)" "unprognostic (7.50e-2)" "unprognostic (1.19e-3)" "unprognostic (3.18e-1)" "unprognostic (2.15e-2)" "unprognostic (5.07e-2)" "unprognostic (8.38e-2)" "unprognostic (3.51e-1)" "unprognostic (1.23e-2)" "unprognostic (1.18e-1)" "unprognostic (6.22e-2)" "unprognostic (7.48e-2)" "unprognostic (6.98e-2)" 18.1 33.3 40.2 20.6 40.5 20.9 38.5 31.7 75.3 28.5 20.6 20.9 22.0 13.8 28.8 23.9 27.5 33.6 23.3 42.3 44.5 42.4 32.0 37.0 30.5 38.8 35.6 41.2 35.4 33.5 39.7 32.6 28.1 38.1 28.3 21.8 18.0 22.6 30.1 47.5 18.3 13.6 29.7 38.3 18.3 18.5 31.5 22.3 34.0 37.2 21.8 28.7 26.8 21.8 23.3 52.2 28.1 40.4 25.2 31.0 33.3 41.3 21.4 41.6 25.1 19.1 28.8 22.4 47.3 50.5 33.8 37.2 10.7 27.8 42.7 19.6 47.3 17.4 24.7 30.0 31.5 36.6 7.8 31.0 20.0 41.3 20.5 27.6 53.4 15.0 29.6 22.0 17.6 27.7 41.4 24.7 19.8 14.6 23.7 51.2 17.6 29.0 24.0 27.5 23.4 16.6 42.0 16.0 34.6 43.1 39.6 23.1 36.2 29.4 17.7 32.0 32.9 26.7 28.6 22.5 34.3 12.8 12.2 15.5 23.4 14.1 34.4 21.3 22.5 36.3 19.0 31.7 28.1 23.4 37.6 31.0 23.3 23.3 28.3 52.2 22.6 25.7 24.8 1.5 25.2 40.4 18.5 21.9 33.3 40.2 40.5 31.7 75.3 44.5 42.4 35.6 41.2 38.1 22.3 32.8 25.7 30.5 107.7 44.9 67.9 77.5 68.8 58.9 42.1 55.8 19.6 90.0 58.0 72.1 42.5 42.6 15.9 46.7 60.7 89.4 55.5 67.5 38.2 48.6 63.4 66.7 57.9 33.2 52.7 30.9 53.2 45.5 23.6 62.3 32.0 70.5 50.1 24.6 71.1 51.6 43.1 45.3 38.1 108.0 105.2 36.3 43.7 34.8 46.1 79.0 ATXN2 "ATX2, SCA2, TNRC13" ENSG00000204842 "Ataxin 2" Q99700 12 111443485-111599676 "Disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018295, HPA020339, HPA021146" Enhanced Enhanced Cytosol NA NA Cytosol "HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132" "unprognostic (3.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (1.55e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (2.34e-1)" "unprognostic (2.77e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (4.58e-1)" "unprognostic (5.28e-2)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (3.40e-2)" 21.3 23.4 25.1 24.3 26.5 15.5 34.5 32.4 32.8 21.2 20.7 32.6 20.5 17.6 24.0 20.3 17.6 26.5 20.8 25.9 24.6 26.7 19.0 20.8 30.2 15.2 29.5 25.9 30.2 16.8 33.4 23.3 25.2 26.4 22.0 17.6 21.0 16.2 24.0 28.0 15.1 15.4 26.7 28.8 16.5 16.8 30.8 30.2 18.4 23.8 14.2 13.1 22.7 24.5 9.9 8.0 11.1 10.8 10.7 10.6 4.8 18.9 22.8 20.5 21.9 21.1 18.0 17.3 25.0 14.7 17.9 15.3 13.5 14.3 15.2 8.9 25.9 14.1 15.5 27.9 10.9 22.2 13.8 24.2 23.3 12.5 22.8 28.5 15.4 12.8 17.9 12.1 22.3 24.6 28.3 16.3 12.9 29.0 9.2 21.2 14.7 12.7 13.8 20.3 10.8 14.9 12.2 12.5 12.1 17.0 24.0 18.9 16.6 25.8 29.0 13.2 16.8 17.6 9.1 25.5 21.7 13.7 19.8 14.1 15.7 21.4 15.8 12.3 12.8 14.6 10.3 6.8 11.1 8.2 6.8 10.6 9.9 9.2 9.3 8.0 6.1 8.5 7.1 7.8 10.7 10.8 4.8 4.1 4.8 25.1 26.5 32.4 32.8 24.6 26.7 29.5 25.9 26.4 30.2 74.5 67.7 20.4 26.9 31.4 99.3 31.9 25.5 52.2 48.9 34.9 127.6 26.0 3.3 21.8 8.2 36.2 18.2 0.0 22.0 22.0 34.9 31.4 23.1 32.7 21.1 62.0 39.7 69.3 34.5 6.6 60.7 30.7 30.4 14.4 27.9 39.3 26.1 17.5 44.6 12.4 87.1 32.3 34.9 72.8 69.6 30.7 39.2 21.5 30.3 38.4 ATXN2L "A2D, A2lp" ENSG00000168488 "Ataxin 2 like" Q8WWM7 16 28823035-28837237 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041506, HPA043391, HPA071955" Approved Enhanced Cytosol NA NA Cytosol "HPA041506: AB_2677521, HPA043391: AB_2678459, HPA071955: AB_2686478" "unprognostic (1.64e-2)" "unprognostic (1.72e-1)" "unprognostic (7.33e-3)" "unprognostic (1.03e-2)" "unprognostic (3.11e-1)" "unprognostic (6.63e-2)" "prognostic unfavorable (9.85e-4)" "unprognostic (5.59e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (2.83e-2)" "prognostic unfavorable (7.99e-7)" "unprognostic (1.79e-1)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (2.98e-1)" 24.7 31.1 32.5 38.7 30.4 56.8 44.9 57.9 42.5 27.4 24.6 28.0 22.8 35.1 28.4 22.9 29.5 26.2 25.8 24.8 31.1 22.2 30.9 32.9 37.1 46.2 33.8 36.1 31.7 34.8 39.9 44.8 31.2 28.9 29.2 22.8 22.5 30.9 34.2 27.9 31.7 31.9 27.8 33.6 44.0 30.2 77.2 33.1 45.2 31.4 19.5 36.8 25.5 38.8 6.8 9.5 4.2 3.7 3.0 4.0 1.4 17.8 23.0 23.9 26.9 14.8 15.3 28.1 18.1 17.6 19.9 22.3 29.0 21.4 41.7 23.3 12.8 31.3 26.1 22.4 18.2 22.2 32.5 19.9 27.7 27.3 29.5 26.7 31.2 39.2 19.5 21.9 28.2 40.6 17.7 17.5 41.6 36.2 52.9 16.3 25.5 37.9 52.9 24.2 10.9 16.1 50.1 16.6 28.9 11.9 18.6 25.0 19.9 10.5 20.1 21.8 15.8 21.9 33.0 20.8 24.8 20.6 15.9 24.8 75.7 52.6 37.4 18.7 30.0 28.5 0.7 3.7 2.2 2.9 3.3 3.0 6.8 3.5 3.5 2.7 5.7 3.3 4.0 4.2 3.0 2.6 9.5 2.8 1.4 32.5 30.4 57.9 42.5 31.1 22.2 33.8 36.1 28.9 33.1 26.8 32.3 17.5 21.3 32.4 29.7 1.6 28.1 12.0 17.0 19.2 43.2 19.8 1.7 15.3 49.2 24.3 18.2 0.0 17.3 19.6 20.3 21.6 24.4 13.4 21.5 25.4 23.6 28.3 22.5 13.8 19.8 25.3 8.5 20.8 21.3 9.2 25.3 17.5 18.7 3.3 45.8 12.9 15.3 69.2 27.9 27.1 28.7 21.8 21.3 21.7 ATXN7 "ADCAII, OPCA3, SCA7" ENSG00000163635 "Ataxin 7" O15265 3 63898399-64003453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.4" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA034989 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034989: AB_10602596" "unprognostic (1.51e-2)" "unprognostic (2.44e-1)" "unprognostic (5.98e-2)" "unprognostic (2.18e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.22e-4)" "unprognostic (9.65e-2)" "unprognostic (2.76e-2)" "unprognostic (2.46e-1)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "unprognostic (9.77e-3)" "unprognostic (2.56e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (3.45e-2)" 8.8 6.4 4.9 14.5 7.4 19.7 8.9 10.2 6.5 9.5 10.7 4.9 6.7 8.0 10.9 9.2 9.2 7.5 11.4 7.5 5.0 4.3 6.3 8.2 10.2 19.9 6.1 3.1 12.4 21.7 15.3 10.9 15.1 6.0 8.2 8.1 15.1 12.2 7.8 9.6 10.6 12.5 9.2 5.7 11.1 7.2 14.6 6.7 55.4 8.8 8.5 24.2 8.4 10.2 0.9 0.5 11.1 0.5 2.6 5.9 1.1 6.0 4.9 5.0 4.1 5.8 6.6 6.6 3.5 6.5 7.5 6.1 6.9 5.9 5.8 2.1 6.8 8.1 4.0 6.4 6.6 8.0 15.2 2.6 10.1 5.8 2.1 2.9 4.2 12.2 6.3 3.6 11.1 12.4 5.6 5.6 9.6 3.8 17.7 4.6 14.4 8.9 3.5 3.4 4.1 2.2 3.8 4.6 7.0 3.7 7.2 2.0 3.7 7.8 5.2 7.1 4.2 3.6 6.1 7.7 6.5 8.9 9.5 8.1 8.0 8.1 6.4 7.7 7.1 6.2 11.1 0.3 0.9 3.2 0.5 2.6 0.0 5.9 3.4 0.1 0.9 5.7 3.7 1.2 2.6 0.1 0.5 4.7 1.1 4.9 7.4 10.2 6.5 5.0 4.3 6.1 3.1 6.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 ATXN7 "ADCAII, OPCA3, SCA7" ENSG00000285258 "Ataxin 7" O15265 3 63864557-64003462 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 8.9" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 72.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA034989 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034989: AB_10602596" 0.4 0.0 1.5 2.8 1.3 0.0 2.0 0.7 0.0 2.0 2.0 0.0 0.9 0.8 0.0 1.0 0.9 0.9 2.1 0.5 1.0 3.0 1.9 0.9 0.9 0.5 0.6 0.3 3.1 0.8 0.3 1.5 1.0 0.0 0.8 1.8 0.1 4.9 3.6 8.9 1.9 2.5 4.3 0.7 2.4 0.1 3.5 3.3 3.3 6.1 3.3 3.0 2.5 4.1 5.6 1.5 3.2 6.9 1.1 2.1 4.8 2.8 3.4 2.3 4.9 6.6 2.6 6.3 4.3 2.5 4.6 4.6 5.8 1.9 6.9 5.2 6.8 4.2 2.9 3.9 2.3 9.8 2.9 13.2 3.0 4.0 2.2 1.6 0.8 5.8 2.9 2.5 2.6 3.4 1.1 1.7 6.0 4.9 3.9 2.9 1.4 6.7 4.0 6.1 3.3 3.6 4.7 5.4 4.8 4.3 2.4 4.8 3.6 5.7 1.9 2.7 2.5 1.2 2.9 4.9 2.9 2.4 1.6 4.3 3.5 2.5 8.9 2.5 1.4 3.6 4.3 0.7 8.9 7.8 5.7 20.9 38.7 67.5 0.0 33.1 8.1 5.7 5.2 96.2 0.0 0.0 2.5 11.6 15.5 24.4 0.0 3.7 0.0 4.1 20.9 14.9 17.4 0.0 23.8 25.3 33.7 34.3 6.2 11.8 10.2 11.8 8.2 19.4 28.6 2.0 27.1 12.4 0.3 72.4 0.0 19.6 12.5 15.3 40.4 0.0 40.6 18.2 34.4 ATXN7L1 "ATXN7L4, KIAA1218, MGC33190" ENSG00000146776 "Ataxin 7 like 1" Q9ULK2 7 105605067-105876604 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 68.4;Late spermatids: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021448 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021448: AB_1845213" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (4.36e-2)" "unprognostic (1.01e-2)" "unprognostic (2.84e-1)" "unprognostic (8.20e-3)" "unprognostic (3.69e-1)" "unprognostic (2.51e-2)" "unprognostic (8.71e-2)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (8.65e-2)" "unprognostic (2.22e-1)" "unprognostic (3.79e-1)" "unprognostic (5.75e-2)" "unprognostic (1.07e-1)" "unprognostic (2.01e-1)" 10.8 10.7 10.3 12.1 16.6 7.7 10.6 24.7 13.4 13.3 11.7 9.7 12.3 7.9 9.2 9.1 9.6 11.7 8.4 6.4 8.5 6.2 14.1 12.3 7.8 15.6 7.1 7.3 13.3 7.2 11.2 17.8 10.8 6.9 10.1 11.6 8.3 11.4 12.1 5.2 12.2 10.9 9.7 6.9 10.4 9.8 20.8 9.9 12.4 11.8 4.6 17.9 11.3 11.7 3.9 3.1 4.3 4.8 4.2 14.5 3.4 2.9 3.9 8.4 3.9 5.2 6.1 2.6 5.2 5.2 4.7 4.4 3.8 5.6 1.2 4.1 5.4 4.1 2.7 4.7 5.3 3.4 16.1 3.1 3.9 2.9 3.6 3.1 6.3 13.0 4.2 4.4 3.1 3.1 3.4 4.2 2.8 4.6 2.6 3.8 6.9 3.4 3.5 15.5 8.0 3.9 3.4 2.8 0.8 3.5 2.9 5.2 3.5 3.7 7.3 7.3 8.6 3.8 6.4 10.5 7.3 3.4 6.0 2.0 0.6 0.0 0.1 4.6 9.8 7.3 2.3 4.2 4.3 2.9 4.8 2.1 3.9 7.5 6.4 3.1 3.6 8.2 4.7 1.4 4.2 2.8 2.1 14.5 3.4 10.3 16.6 24.7 13.4 8.5 6.2 7.1 7.3 6.9 9.9 0.0 4.6 3.6 4.7 4.5 8.2 2.4 2.5 16.0 2.3 5.2 2.0 5.6 5.0 3.3 68.4 3.6 10.8 0.0 2.3 3.1 4.9 5.1 4.7 13.4 6.5 7.9 5.2 6.7 10.3 39.7 6.1 6.3 8.5 7.2 8.2 2.0 3.7 10.5 4.2 29.8 0.6 6.5 4.2 7.9 1.7 3.4 4.5 8.7 8.1 3.3 ATXN7L2 "FLJ00381, MGC46534" ENSG00000162650 "Ataxin 7 like 2" Q5T6C5 1 109483479-109492804 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029827, HPA054952" Uncertain Approved "Nucleoli rim,Vesicles,Cytosol" NA NA "Nucleoli rim" "Vesicles, Cytosol" "HPA029827: AB_10602390, HPA054952: AB_2682647" "unprognostic (4.53e-2)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (3.90e-2)" "unprognostic (4.61e-5)" "unprognostic (2.40e-4)" "unprognostic (1.75e-1)" "unprognostic (3.53e-2)" "unprognostic (8.07e-2)" "unprognostic (2.77e-4)" "unprognostic (2.85e-2)" "prognostic unfavorable (1.19e-8)" "unprognostic (3.70e-2)" "unprognostic (1.08e-1)" "unprognostic (8.27e-2)" "unprognostic (3.94e-3)" 4.2 5.2 7.5 4.0 9.2 10.2 2.6 15.2 10.9 2.8 2.8 5.1 1.2 2.7 4.4 1.8 2.8 3.3 3.8 2.0 6.5 3.3 3.4 3.0 3.4 3.8 5.7 7.0 7.3 2.4 1.6 9.9 2.5 4.7 2.2 1.4 5.7 1.8 3.2 13.3 3.5 3.1 2.0 3.1 5.4 2.9 8.8 4.8 2.7 4.2 1.0 2.6 3.2 2.4 2.4 1.3 2.4 2.4 2.7 5.6 2.2 2.2 1.7 1.2 4.6 1.6 2.9 3.2 1.6 2.1 3.4 2.3 3.6 1.5 5.8 2.6 2.0 0.9 2.5 2.4 2.2 0.4 5.3 3.4 3.2 3.6 1.6 1.0 4.8 7.6 3.1 1.2 3.5 0.0 1.4 0.8 6.3 5.4 3.3 0.6 7.0 8.4 6.3 7.0 2.3 2.5 6.0 2.9 4.1 1.2 2.3 10.7 4.3 1.7 5.7 2.6 0.3 1.0 5.0 0.3 2.4 7.1 2.2 6.4 2.2 1.4 5.5 2.8 4.0 6.0 0.0 1.9 2.4 5.4 2.4 5.0 2.3 4.3 5.6 1.3 2.4 4.0 3.8 1.9 2.7 1.6 1.0 3.8 2.2 7.5 9.2 15.2 10.9 6.5 3.3 5.7 7.0 4.7 4.8 0.0 0.3 0.8 1.4 0.6 3.2 1.6 2.5 0.0 2.3 1.8 2.0 1.2 0.0 1.2 1.8 0.9 0.6 0.0 1.6 1.2 1.5 0.4 4.6 1.0 0.5 3.2 1.7 1.8 1.2 0.0 1.1 0.8 0.0 0.0 1.0 1.6 1.4 0.9 1.4 0.6 1.6 0.0 1.0 3.8 3.8 0.6 2.6 2.5 0.9 0.6 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 32.3;testis: 41.1" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved Nucleoplasm,Centrosome,Cytosol Yes Yes "Nucleoplasm, Centrosome, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 3.7 2.3 1.5 12.7 1.3 8.3 3.0 1.3 1.8 1.4 6.7 1.3 0.8 7.3 1.8 1.2 7.7 1.1 3.7 4.1 1.1 1.1 2.4 5.1 2.9 12.3 1.6 0.9 8.3 1.4 0.3 0.7 6.1 1.5 1.0 8.3 1.5 2.7 0.5 6.9 2.1 7.2 2.7 1.3 7.4 4.3 41.1 1.1 32.3 1.2 5.9 13.3 2.4 2.4 3.9 5.2 6.0 8.7 2.0 6.6 2.6 33.0 24.4 16.3 11.5 0.9 2.1 20.7 27.1 12.7 65.7 27.7 68.2 23.2 10.8 18.7 11.1 34.1 26.7 29.0 18.2 70.0 9.8 11.1 19.3 25.0 42.5 0.5 25.8 27.2 1.0 1.9 22.7 20.4 5.2 15.3 17.7 21.9 8.6 27.9 33.7 15.4 20.0 14.9 27.1 25.1 11.7 31.5 12.0 10.5 8.7 14.1 7.6 37.9 43.6 18.2 15.6 25.8 16.1 8.8 28.6 28.3 15.8 38.2 12.1 14.0 18.8 15.4 15.0 23.6 0.2 5.3 6.0 1.9 8.7 2.9 3.9 3.3 1.9 5.2 1.4 1.5 1.5 3.7 2.0 4.8 1.2 6.6 2.6 1.5 1.3 1.3 1.8 1.1 1.1 1.6 0.9 1.5 1.1 0.0 3.2 4.5 1.1 1.0 1.0 3.4 2.5 1.4 2.3 3.5 2.0 9.8 1.7 3.9 16.9 1.6 5.3 70.0 4.2 59.5 3.8 0.7 55.2 2.4 14.8 1.6 5.8 3.1 2.4 9.5 1.4 5.5 0.0 18.0 5.7 3.5 3.6 3.5 0.4 1.9 2.5 6.5 2.1 16.2 31.6 1.0 6.9 4.9 9.8 1.4 AUTS2 "FBRSL2, KIAA0442" ENSG00000158321 "AUTS2, activator of transcription and developmental regulator" Q8WXX7 7 69598296-70793495 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Autism, Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.6;naive B-cell: 11.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 28.1;REH: 27.4;SCLC-21H: 38.5;SH-SY5Y: 20.9;T-47d: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000390 Approved Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA000390: AB_1845218" "unprognostic (8.73e-3)" "unprognostic (2.24e-1)" "unprognostic (4.62e-2)" "unprognostic (8.78e-2)" "unprognostic (2.44e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.07e-3)" "unprognostic (3.33e-2)" "unprognostic (3.52e-2)" "unprognostic (8.46e-2)" "unprognostic (3.29e-3)" "unprognostic (1.76e-2)" "unprognostic (2.47e-1)" "unprognostic (3.04e-1)" "unprognostic (7.33e-2)" 10.3 7.3 29.3 11.6 30.3 9.3 20.3 14.3 19.1 10.5 14.0 17.3 4.1 8.9 10.5 12.4 13.7 8.0 16.6 5.6 22.2 12.9 14.6 19.7 14.7 6.1 14.8 12.3 17.2 6.0 9.9 17.4 5.7 18.9 14.6 13.1 9.9 52.1 8.3 14.9 23.3 18.8 13.6 10.2 8.2 11.3 10.0 20.6 10.5 6.7 7.9 8.9 13.0 10.8 11.6 3.2 0.8 0.2 1.5 2.2 0.7 0.1 2.5 28.1 1.5 1.8 1.1 0.3 1.7 0.0 0.1 0.1 9.5 0.1 4.1 0.6 1.7 0.1 9.1 3.4 3.8 0.8 18.6 7.5 2.0 2.6 0.1 0.8 0.0 0.1 2.9 5.2 4.2 1.0 1.0 0.0 4.5 0.1 2.2 2.4 1.6 0.4 0.8 20.0 6.2 0.0 27.4 13.7 11.6 0.0 4.1 38.5 20.9 1.8 3.1 0.0 12.7 26.3 0.0 0.0 0.1 9.4 3.0 17.2 0.0 0.0 14.2 0.0 0.0 0.0 0.8 0.2 0.2 1.6 0.1 2.2 8.6 1.1 1.5 0.7 11.6 0.2 0.9 0.5 1.5 0.1 3.2 0.2 0.7 29.3 30.3 14.3 19.1 22.2 12.9 14.8 12.3 18.9 20.6 17.9 31.0 10.7 17.8 25.3 35.0 19.0 10.2 12.0 19.4 8.7 15.7 1.0 5.0 9.8 26.8 8.3 16.3 0.0 1.1 0.1 11.3 21.3 0.0 24.5 0.7 60.4 27.7 16.0 3.1 14.8 14.7 4.3 16.9 1.0 20.8 14.3 2.6 14.0 13.8 9.8 22.5 25.8 7.4 11.3 15.4 14.1 1.1 19.2 22.7 20.3 AXIN2 "DKFZp781B0869, MGC126582" ENSG00000168646 "Axin 2" Q9Y2T1 17 65528563-65561647 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 87.1" "Cancer enhanced" "Detected in all" "colorectal cancer: 33.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 11.8;CACO-2: 22.1;Hep G2: 32.9;OE19: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012283, CAB017783" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB012283: AB_2290204, CAB017783: " "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.48e-1)" "unprognostic (9.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (4.57e-2)" "unprognostic (8.84e-3)" "prognostic favorable (6.58e-4)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (3.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.74e-1)" "unprognostic (1.25e-1)" 7.4 10.1 9.0 7.0 8.9 0.9 5.2 8.2 13.1 16.5 12.2 8.7 10.5 7.2 29.0 7.7 6.5 18.6 6.9 7.3 7.9 5.7 3.5 2.5 15.2 3.4 5.3 10.3 14.7 3.9 3.2 5.8 18.2 10.6 14.8 15.2 7.8 4.6 9.8 12.4 14.9 7.5 18.0 4.8 6.9 14.6 6.8 9.0 27.6 11.3 3.6 3.8 11.8 8.7 4.1 0.0 4.4 0.0 1.9 5.1 0.8 0.0 5.9 11.8 0.2 4.3 1.8 5.2 0.1 0.5 0.4 0.7 22.1 2.1 0.4 0.7 3.4 0.4 0.1 2.4 0.0 0.8 1.0 1.3 0.0 1.0 32.9 0.4 0.0 0.0 1.0 0.9 0.9 0.2 0.7 1.0 2.2 0.0 0.5 0.6 0.1 5.7 0.0 2.3 36.5 0.2 4.1 0.6 0.0 1.1 0.1 3.7 2.4 0.2 0.1 2.0 9.1 0.4 0.1 2.6 2.3 4.3 3.3 0.7 0.0 1.2 1.5 1.1 0.2 1.1 4.4 0.0 0.0 0.3 0.0 0.8 1.0 2.3 0.4 0.0 4.1 5.1 0.8 0.0 1.9 0.0 0.0 0.0 0.8 9.0 8.9 8.2 13.1 7.9 5.7 5.3 10.3 10.6 9.0 0.0 7.0 0.0 1.2 10.0 3.8 8.1 2.5 1.4 10.3 0.0 3.9 14.3 0.0 1.0 27.8 3.8 2.8 0.0 0.7 87.1 17.5 4.1 0.0 1.9 3.3 1.6 5.2 1.3 0.0 11.2 6.1 0.3 16.9 1.8 18.7 3.5 0.7 3.5 10.3 0.6 1.9 12.9 5.9 5.4 12.6 4.8 11.9 0.0 16.8 1.1 AZIN2 "ADC, KIAA1945, ODC-p, ODC1L, ODCp" ENSG00000142920 "Antizyme inhibitor 2" Q96A70 1 33081104-33120530 "Predicted intracellular proteins" "Polyamine biosynthesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1;testis: 22.9" "Group enriched" "Detected in many" 23 "Early spermatids: 190.6;Late spermatids: 686.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 17.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 17.9" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 14.3;SK-MEL-30: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028527 Approved Cytosol NA NA Cytosol "HPA028527: AB_10602077" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.16e-3)" "unprognostic (7.50e-2)" "unprognostic (8.28e-2)" "unprognostic (4.56e-2)" "unprognostic (1.15e-4)" "unprognostic (9.19e-3)" "unprognostic (3.89e-2)" "unprognostic (1.54e-2)" "unprognostic (1.06e-3)" "unprognostic (2.16e-1)" "unprognostic (3.18e-1)" "unprognostic (6.91e-2)" "unprognostic (2.91e-1)" "unprognostic (9.45e-2)" "unprognostic (2.41e-1)" 1.5 5.3 7.8 3.1 11.9 0.2 3.6 5.8 14.6 5.1 4.4 23.1 0.5 1.4 3.8 3.4 1.7 7.0 4.1 5.7 10.1 7.8 3.5 0.9 2.5 1.9 10.2 12.2 9.9 3.0 4.4 2.9 1.4 13.6 3.9 3.0 3.4 3.5 3.6 0.9 1.8 1.3 3.4 18.1 1.9 1.8 22.9 10.1 0.7 4.3 0.0 3.0 2.3 1.9 0.2 17.9 3.5 0.0 0.0 1.6 0.7 0.5 0.6 2.0 1.2 1.0 4.5 0.6 0.7 3.1 3.2 2.6 0.3 2.6 0.0 0.9 0.5 1.7 1.4 1.4 0.6 0.9 0.0 0.0 0.1 0.1 0.5 4.9 0.0 0.2 4.4 2.8 2.6 1.0 14.3 0.4 0.7 0.1 0.2 2.3 0.0 0.2 0.9 1.0 0.3 0.4 1.4 1.9 0.1 2.2 0.1 0.4 2.1 0.5 0.0 18.4 1.9 0.8 0.3 0.1 0.7 1.4 2.2 0.4 1.1 0.0 0.0 4.9 0.0 0.8 3.5 0.0 0.0 1.3 0.0 1.4 0.2 1.4 1.4 0.0 0.0 1.6 1.6 0.0 0.0 0.0 17.9 0.0 0.7 7.8 11.9 5.8 12.8 10.1 7.8 10.2 12.2 13.6 10.1 0.0 4.8 2.0 2.4 0.0 7.1 0.8 0.0 4.0 1.2 1.8 17.7 0.4 0.0 1.3 190.6 1.1 4.2 0.0 1.2 0.4 1.2 1.5 0.0 0.0 1.1 6.4 1.2 1.8 0.3 686.4 5.8 0.4 0.0 2.8 1.2 9.9 1.2 4.8 7.1 2.6 7.6 6.5 0.9 18.8 5.9 0.0 0.2 1.5 2.5 0.8 B2M ENSG00000166710 Beta-2-microglobulin P61769 15 44711477-44718877 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Immunity "Amyloidosis, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "monocytes: 43079.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 178.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002572, HPA006361" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1790000000 3200000000 "Golgi apparatus, Plasma membrane" Cytosol "CAB002572: AB_563434, HPA006361: AB_1078278" "unprognostic (9.45e-2)" "unprognostic (5.63e-2)" "unprognostic (3.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.18e-1)" "unprognostic (4.82e-2)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (2.44e-3)" "unprognostic (2.02e-2)" "unprognostic (4.77e-2)" "unprognostic (2.39e-1)" "unprognostic (5.25e-2)" "unprognostic (1.97e-2)" "unprognostic (2.17e-2)" 127.2 50.9 24.2 109.2 29.8 131.1 85.2 11.8 23.1 70.5 111.4 29.1 43.3 79.1 72.7 74.7 80.5 36.8 112.8 73.6 26.0 23.1 109.7 140.3 191.2 172.1 42.2 18.8 54.8 42.7 7.8 40.5 91.9 33.1 78.7 128.9 53.5 121.5 40.9 45.7 94.1 178.5 55.1 56.7 272.8 52.5 30.0 29.5 108.0 97.7 71.5 131.6 135.9 73.5 138.9 74.9 341.3 132.8 128.8 215.8 323.7 33.7 14.9 1.4 8.4 55.5 74.8 52.9 22.3 45.6 36.4 61.8 19.4 78.7 16.1 31.6 21.7 34.6 29.7 5.6 9.9 17.5 112.5 13.2 61.2 90.6 22.5 42.2 34.2 36.7 37.8 9.3 11.1 12.0 49.2 24.8 9.3 15.5 2.2 40.2 18.0 14.0 90.3 2.5 9.7 31.9 17.1 36.6 101.9 31.7 139.7 5.9 2.1 23.3 18.9 26.3 8.0 6.3 178.1 49.3 71.4 7.9 94.1 43.6 41.7 95.3 29.9 69.6 113.1 34.1 221.2 90.4 210.9 126.8 132.8 125.9 138.9 171.7 141.1 58.9 109.4 137.0 167.5 341.3 128.8 106.5 74.9 215.8 323.7 24.2 29.8 11.8 23.1 26.0 23.1 42.2 18.8 33.1 29.5 3147.5 4324.0 5959.3 2738.0 6967.5 30.8 1001.8 3658.6 2584.4 1819.9 1992.5 25.5 1178.5 880.3 10047.2 36.4 7847.2 5137.6 1074.6 7941.0 3388.9 4495.5 5043.9 2851.5 3441.9 11377.9 4.8 2180.6 6477.0 10376.7 71.4 2794.5 10340.1 6397.4 43079.4 4753.5 280.0 9393.5 5334.1 1587.5 2212.2 49.3 3951.7 5055.6 55.6 68.2 7534.8 673.0 11479.7 3001.5 5867.1 B3GNT7 beta3GnT7 ENSG00000156966 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7" Q8NFL0 2 231395543-231401164 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.7;intestine: 41.2" "Cell type enhanced" "Detected in many" 12 "Intestinal endocrine cells: 99.1;Mucus-secreting cells: 119.1;Undifferentiated cells: 275.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 19.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.0;HEL: 11.8;THP-1: 10.5;WM-115: 18.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA013881, HPA035625, HPA035626" Enhanced Approved "Golgi apparatus,Mitotic spindle,Cytosol" "Intracellular and membrane" NA NA 2100000 "Golgi apparatus" "Mitotic spindle, Cytosol" "HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-3)" "unprognostic (1.46e-2)" "unprognostic (1.28e-2)" "unprognostic (2.69e-1)" "unprognostic (1.36e-1)" "unprognostic (2.31e-2)" "unprognostic (6.18e-2)" "unprognostic (5.82e-2)" "unprognostic (2.17e-2)" "unprognostic (7.77e-2)" "unprognostic (4.27e-3)" "unprognostic (6.96e-2)" "unprognostic (1.18e-1)" "prognostic favorable (6.00e-4)" "unprognostic (3.57e-1)" 3.0 10.3 5.3 2.3 4.9 5.5 1.9 0.9 3.2 1.2 28.0 3.8 0.8 12.2 1.6 3.5 1.9 3.6 93.7 26.8 4.2 4.4 1.4 1.3 17.7 1.8 4.0 2.0 13.0 18.9 6.7 8.9 10.7 3.2 1.6 35.5 2.0 4.0 2.3 0.4 2.4 41.2 1.1 1.9 6.7 17.1 1.6 2.2 1.2 4.2 1.7 3.9 1.2 0.6 7.1 4.2 0.4 0.3 19.9 2.0 0.5 0.5 2.1 0.2 0.4 0.1 0.2 0.8 0.2 0.8 0.1 0.1 1.0 15.0 1.7 4.6 0.2 0.1 3.9 0.2 0.0 0.1 0.2 0.4 11.8 0.3 0.7 0.1 0.1 0.6 0.1 1.1 0.1 0.2 0.8 0.2 0.3 0.3 0.3 0.1 0.6 0.1 0.5 4.9 5.8 2.6 0.2 0.0 0.2 0.5 1.3 0.4 0.6 0.2 1.3 0.5 5.7 0.5 10.5 0.2 0.3 0.3 0.2 0.1 1.8 0.6 0.5 0.3 0.1 18.2 0.3 0.0 0.4 2.0 0.3 0.4 7.1 0.0 0.2 4.2 5.1 0.1 0.5 0.1 19.9 0.3 2.1 0.1 0.5 5.3 4.9 0.9 3.2 4.2 4.4 4.0 2.0 3.2 2.2 38.7 24.6 2.2 1.2 2.1 0.2 0.8 84.1 75.0 33.0 1.8 2.0 0.4 0.0 13.5 0.3 0.7 75.7 0.0 73.7 52.0 2.2 11.2 9.2 0.0 9.0 0.0 99.1 3.7 7.0 0.9 1.4 13.6 3.3 4.6 119.1 0.5 58.2 46.0 7.8 0.1 1.6 0.0 1.4 0.7 1.3 2.4 1.7 6.9 275.6 13.2 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369796-382116 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1;ovary: 18.6" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 17.5;Cardiomyocytes: 11.2;Horizontal cells: 31.8;Muller glia cells: 40.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.2;NTERA-2: 18.0;SCLC-21H: 22.4;SH-SY5Y: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043276, HPA053126" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA No "Nucleoplasm, Cytosol" Vesicles "HPA043276: , HPA053126: AB_2682049" "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 1.6 2.5 20.6 2.8 16.7 1.2 3.5 26.5 35.1 5.9 2.0 8.6 0.8 2.4 8.6 2.4 1.8 8.7 2.1 1.4 17.6 16.8 1.2 1.1 1.3 1.6 11.5 14.9 18.6 1.8 6.3 6.1 1.1 13.0 3.8 1.6 2.3 4.0 3.7 1.1 3.8 2.9 3.1 8.3 1.5 1.5 1.8 11.0 0.0 1.1 0.0 1.7 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 20.2 11.5 0.0 0.0 4.7 3.6 0.9 1.6 0.5 2.0 0.0 0.0 2.7 0.4 3.2 0.7 2.7 4.8 0.5 0.0 6.8 0.0 6.4 6.2 0.2 0.0 4.9 0.4 2.9 0.1 2.2 7.3 0.2 1.0 6.1 0.0 0.0 5.9 0.2 0.0 18.0 0.3 7.9 0.0 0.0 2.6 0.2 0.0 22.4 27.3 1.3 1.0 0.2 2.2 7.9 0.0 4.9 1.1 6.4 1.9 0.2 0.0 0.9 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 16.7 26.5 21.2 17.6 16.8 11.5 14.9 13.0 11.0 0.0 0.0 0.0 1.3 0.7 17.5 11.2 0.0 0.0 0.0 1.8 3.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 31.8 1.7 0.0 0.0 0.0 2.8 0.0 3.3 0.0 0.0 40.9 0.3 0.0 1.1 0.0 8.1 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.0 0.4 B4GALT3 beta4Gal-T3 ENSG00000158850 "Beta-1,4-galactosyltransferase 3" O60512 1 161171310-161177968 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 95.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 74.9" "Low region specificity" "Detected in all" HPA010793 Approved Supported "Golgi apparatus,Cytosol" NA NA 74000 "Golgi apparatus" Cytosol "HPA010793: AB_1078256" "unprognostic (5.67e-3)" "unprognostic (7.68e-3)" "unprognostic (1.20e-2)" "unprognostic (8.15e-3)" "unprognostic (3.91e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.87e-5)" "unprognostic (3.11e-2)" "unprognostic (3.13e-1)" "unprognostic (4.64e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (7.12e-7)" "unprognostic (1.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" 20.7 18.7 16.5 17.2 22.1 17.3 33.4 20.1 23.2 15.0 19.0 12.4 22.2 18.4 13.6 21.0 20.4 17.2 17.5 17.2 13.4 14.7 22.5 21.7 20.8 21.6 16.4 13.4 25.4 37.5 15.8 29.1 41.0 16.6 18.5 19.3 14.8 33.0 27.8 19.5 20.2 15.1 11.7 14.1 26.6 21.5 28.4 16.4 14.8 28.2 10.7 21.4 20.6 22.9 16.7 22.6 7.1 12.6 15.1 25.5 11.9 9.9 6.6 9.8 12.9 14.6 7.5 15.7 5.7 10.2 11.8 10.9 13.0 20.4 9.2 16.3 6.4 11.3 10.2 10.3 6.3 7.0 9.6 12.6 5.3 4.4 10.4 10.5 10.3 14.8 10.4 9.4 10.9 11.9 14.2 13.4 12.1 17.0 20.8 9.6 10.3 6.7 9.9 12.3 20.1 14.1 8.2 5.5 22.7 10.1 6.2 14.0 16.6 5.7 15.1 11.9 13.9 15.1 18.9 5.6 5.9 10.7 6.7 16.6 74.9 40.4 12.3 8.8 8.9 9.4 5.1 8.9 7.1 17.6 10.1 15.7 16.7 16.7 16.8 10.8 13.5 16.4 15.4 5.9 15.1 12.6 22.6 25.5 11.9 16.5 22.1 20.1 23.2 13.4 14.7 16.4 13.4 16.6 16.4 17.9 18.3 36.5 26.3 34.2 12.6 9.5 7.6 10.7 6.8 24.4 2.0 38.4 5.0 25.4 7.0 20.2 14.7 0.0 19.9 75.2 19.5 33.5 9.2 11.6 25.2 25.4 27.6 26.4 16.8 4.0 8.9 13.8 21.9 6.4 22.4 7.4 28.1 14.4 6.7 17.3 6.3 25.8 34.6 9.8 42.9 36.6 95.5 34.6 21.7 45.5 BAALC ENSG00000164929 "BAALC, MAP3K1 and KLF4 binding" Q8WXS3 8 103140710-103230305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 121.3" "Cell type enhanced" "Detected in many" 16 "Ito cells: 27.0;Muller glia cells: 94.5" "Cancer enriched" "Detected in many" 8 "glioma: 139.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "NK-cell: 6.9" "Lineage enriched" "Detected in single" 25 "NK-cells: 6.9" "Cell line enhanced" "Detected in some" "AF22: 24.9;BJ hTERT+: 8.7;SCLC-21H: 13.6;SH-SY5Y: 10.0;U-87 MG: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027132, HPA068307" Approved Supported Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA027132: AB_10600985, HPA068307: AB_2685971" "unprognostic (1.68e-1)" "unprognostic (9.17e-3)" "unprognostic (1.40e-2)" "unprognostic (4.62e-4)" "unprognostic (1.75e-2)" "unprognostic (2.84e-2)" "unprognostic (1.39e-1)" "unprognostic (7.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.99e-2)" "unprognostic (4.17e-2)" "unprognostic (2.18e-2)" "unprognostic (7.58e-2)" "unprognostic (2.51e-3)" "unprognostic (2.76e-2)" "unprognostic (1.70e-1)" "unprognostic (9.27e-3)" 7.8 11.1 42.3 3.2 51.9 3.9 3.0 12.5 121.3 2.8 2.9 18.9 0.0 2.3 3.0 2.0 2.2 4.6 2.9 3.2 38.1 34.5 2.8 3.4 4.9 2.6 48.3 25.1 2.7 2.6 1.9 5.2 5.7 41.4 2.0 2.9 0.0 2.1 2.4 3.0 2.7 2.8 3.1 51.2 8.8 2.4 2.6 24.6 0.0 2.8 0.0 2.2 2.8 0.3 0.2 0.1 0.0 0.0 6.9 0.1 0.4 0.2 1.4 24.9 0.2 0.2 7.4 0.0 1.3 8.7 0.0 0.1 0.2 0.0 0.1 0.2 4.7 0.1 0.4 0.4 0.0 0.0 0.0 1.5 0.2 0.3 0.0 0.6 0.0 0.5 1.5 1.4 0.3 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.1 0.5 0.1 0.1 0.5 0.0 0.0 13.6 10.0 0.3 0.0 0.0 2.3 0.1 0.1 1.4 7.9 0.5 0.2 0.5 0.0 0.1 0.1 37.1 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.4 42.3 51.9 12.5 43.6 38.1 34.5 48.3 25.1 41.4 24.6 0.0 2.6 0.0 0.7 4.8 2.5 0.6 12.7 17.4 1.2 0.0 0.0 0.0 6.6 17.6 3.0 18.8 0.0 0.0 21.5 0.0 2.6 0.4 0.0 0.5 1.0 0.0 17.0 27.0 2.2 5.6 1.4 0.7 13.5 8.2 0.0 94.5 6.5 0.0 0.0 0.0 2.9 0.0 3.0 0.0 0.1 3.4 0.0 1.7 0.0 0.8 BABAM1 "C19orf62, FLJ20571, HSPC142, MERIT40, NBA1" ENSG00000105393 "BRISC and BRCA1 A complex member 1" Q9NWV8 19 17267350-17281249 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA054386, HPA068786, HPA077609" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: " "unprognostic (5.60e-2)" "unprognostic (1.08e-3)" "unprognostic (6.77e-2)" "unprognostic (1.06e-1)" "unprognostic (1.44e-1)" "unprognostic (2.18e-2)" "unprognostic (9.45e-3)" "unprognostic (2.05e-2)" "unprognostic (7.30e-2)" "unprognostic (2.03e-2)" "unprognostic (5.12e-2)" "unprognostic (7.21e-2)" "unprognostic (3.31e-3)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.79e-1)" "unprognostic (5.74e-2)" 23.2 26.7 39.8 24.2 33.6 37.3 23.7 32.5 50.0 25.6 25.6 24.5 18.7 25.5 24.9 20.5 26.3 22.0 26.8 36.8 35.2 33.3 24.0 31.2 21.6 30.7 34.4 33.8 23.6 29.2 22.2 15.7 31.9 25.8 22.7 23.8 20.8 30.5 25.5 72.7 25.0 23.4 23.9 23.3 29.1 24.5 24.6 22.2 34.5 19.2 33.5 31.3 21.4 19.8 44.7 51.6 51.6 50.1 33.2 55.2 59.7 35.4 19.9 20.1 19.1 22.5 16.0 45.9 21.3 28.4 43.1 43.0 22.8 42.5 25.2 50.9 29.5 19.2 17.7 23.6 29.5 27.7 36.1 37.6 22.1 26.4 27.6 18.3 39.7 28.3 24.2 20.6 28.5 17.0 23.6 36.2 36.1 36.8 29.6 31.1 29.0 39.9 37.7 52.6 29.9 42.9 26.9 26.6 33.2 31.6 17.5 19.5 35.4 25.8 27.0 23.3 24.1 23.7 32.1 26.0 26.2 16.6 32.0 35.4 39.7 47.5 33.1 37.2 52.6 24.6 50.0 50.1 51.6 45.4 46.0 43.4 44.7 42.0 43.8 51.6 43.3 39.2 38.6 12.6 33.2 43.4 42.8 55.2 59.7 39.8 33.6 32.5 50.0 35.2 33.3 34.4 33.8 25.8 22.2 11.9 33.8 59.1 31.8 31.0 19.2 29.8 35.7 16.0 21.6 33.2 13.7 144.3 86.2 64.8 47.6 38.0 52.1 23.3 63.0 136.2 53.0 40.9 45.1 42.0 86.6 15.9 42.1 35.6 36.2 68.8 33.9 46.9 62.4 98.2 53.3 27.8 60.0 57.5 41.8 72.1 12.0 38.8 52.6 40.7 69.5 36.1 132.2 58.6 59.6 34.3 BABAM2 "BRCC4, BRCC45, BRE" ENSG00000158019 "BRISC and BRCA1 A complex member 2" Q9NXR7 2 27889941-28338901 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "adrenal gland: 172.1" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 71.3;monocytes: 45.1;Proximal tubular cells: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017926, HPA048867" Enhanced Supported Cytosol NA NA Cytosol "HPA017926: AB_1845443, HPA048867: " "unprognostic (1.28e-1)" "unprognostic (2.30e-1)" "unprognostic (1.53e-3)" "unprognostic (1.61e-3)" "unprognostic (1.89e-1)" "unprognostic (2.68e-3)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.03e-1)" "unprognostic (2.38e-2)" "unprognostic (8.98e-2)" "unprognostic (2.13e-1)" "unprognostic (6.52e-2)" "unprognostic (4.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.74e-2)" "unprognostic (2.91e-2)" "unprognostic (1.22e-2)" 14.5 172.1 11.7 11.4 19.3 16.9 12.3 9.6 21.3 14.3 11.2 11.3 14.2 8.8 23.2 17.1 12.0 15.5 15.6 25.2 12.5 12.7 25.0 17.1 11.5 18.9 9.9 13.8 16.7 14.5 21.8 23.5 11.6 13.4 11.8 13.1 16.3 10.3 15.6 28.7 11.5 11.1 18.2 9.1 16.7 11.6 26.3 6.7 13.9 11.9 13.6 15.7 14.2 11.8 23.5 39.7 38.6 30.2 24.8 31.7 23.6 14.6 16.1 13.1 13.7 16.9 22.7 12.9 7.4 18.8 14.1 14.6 13.7 15.1 16.6 25.1 17.9 11.3 9.8 10.6 19.4 20.7 14.0 14.0 19.9 7.0 15.2 24.5 10.3 16.2 55.4 17.0 19.6 20.4 17.7 14.9 15.7 10.1 18.3 19.5 12.3 12.0 12.6 9.9 19.3 10.6 11.1 20.8 16.0 40.5 7.7 8.6 13.7 8.7 15.5 14.8 13.9 11.0 13.7 12.0 13.4 17.9 12.3 10.1 20.8 20.2 21.8 24.9 28.4 14.0 38.6 30.2 12.3 28.5 24.0 31.7 23.5 24.2 26.8 39.7 17.9 23.1 22.0 16.0 24.8 23.3 15.8 27.8 23.6 11.7 19.3 9.6 21.3 12.5 12.7 9.9 13.8 13.4 6.7 3.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 16.0 10.3 38.4 0.0 38.1 71.3 42.4 0.0 0.0 0.0 0.0 39.2 30.4 0.0 0.0 29.1 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 45.1 0.0 0.0 21.6 0.0 0.0 70.3 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 0.0 BACH1 "BACH-1, BTBD24" ENSG00000156273 "BTB domain and CNC homolog 1" O14867 21 29194071-29630751 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 165.1;Late spermatids: 300.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.7" "Group enriched" "Detected in all" 4 "granulocytes: 46.7;monocytes: 15.2" "Cell line enhanced" "Detected in all" "Karpas-707: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034949 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034949: AB_2674376" "unprognostic (1.57e-1)" "unprognostic (8.08e-3)" "unprognostic (2.64e-1)" "unprognostic (2.33e-2)" "unprognostic (6.00e-2)" "unprognostic (2.99e-1)" "unprognostic (9.84e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "unprognostic (5.79e-3)" "prognostic unfavorable (3.11e-5)" "unprognostic (5.63e-2)" "prognostic unfavorable (7.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.60e-1)" "unprognostic (4.19e-2)" "unprognostic (8.70e-2)" 23.3 7.8 7.9 15.5 13.1 44.7 10.3 4.7 8.8 13.5 12.8 9.6 6.7 9.9 16.0 10.0 18.6 8.9 15.6 10.7 8.0 5.8 11.7 17.6 25.2 21.9 10.8 5.5 9.5 12.5 5.3 9.2 28.8 11.1 14.9 7.8 9.2 12.2 5.3 30.7 22.9 17.9 15.9 16.0 22.9 9.5 20.6 11.1 14.3 11.3 12.6 14.0 19.4 15.8 4.0 7.6 46.7 15.2 2.1 4.4 4.0 7.6 3.1 9.7 2.5 7.6 22.2 6.1 8.4 20.1 8.1 9.1 6.4 10.6 9.1 6.8 7.6 8.5 4.0 5.8 11.2 14.4 7.5 4.8 28.0 6.5 6.6 10.1 8.0 10.5 11.4 17.2 15.9 23.8 9.6 4.2 5.0 14.1 48.1 11.1 2.7 6.8 4.7 14.9 3.0 3.2 7.0 23.0 11.7 4.3 6.0 4.0 4.6 4.5 8.6 10.6 10.1 6.3 9.8 10.7 8.0 11.1 8.6 4.2 27.9 17.8 9.8 6.5 10.0 23.9 17.9 15.2 11.3 1.6 12.4 1.3 3.2 2.7 1.4 7.6 4.0 3.9 1.9 46.7 2.1 13.3 1.8 4.4 4.0 7.9 13.1 4.7 8.8 8.0 5.8 10.8 5.5 11.1 11.1 26.8 15.4 19.9 36.3 52.4 17.0 19.0 17.8 16.0 27.3 14.0 17.7 11.1 6.6 16.3 165.1 28.5 21.5 0.0 14.0 13.5 23.3 45.2 45.3 15.7 19.4 12.7 29.6 28.8 52.8 300.7 12.4 74.4 20.3 39.7 16.5 10.6 22.1 14.0 13.4 9.8 11.9 32.3 23.6 21.8 17.9 50.7 33.2 13.8 9.3 37.3 BACH2 BTBD25 ENSG00000112182 "BTB domain and CNC homolog 2" Q9BYV9 6 89926529-90296908 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 187.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "naive B-cell: 15.4" "Lineage enriched" "Detected in many" 4 "B-cells: 15.4" "Group enriched" "Detected in some" 6 "Daudi: 52.7;U-698: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051384, HPA058384" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051384: AB_2681462, HPA058384: AB_2683700" "unprognostic (4.00e-3)" "unprognostic (3.17e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-4)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.42e-2)" "unprognostic (8.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (3.12e-3)" "unprognostic (4.22e-1)" "unprognostic (9.87e-3)" "unprognostic (2.10e-2)" "unprognostic (1.83e-1)" "unprognostic (2.03e-1)" "unprognostic (3.87e-4)" 2.9 2.1 5.3 29.8 5.6 18.5 4.1 11.4 6.9 5.4 2.2 6.3 1.0 1.3 6.8 2.1 1.9 3.0 2.3 2.6 5.2 2.9 1.7 5.8 5.8 26.7 5.2 4.0 6.3 4.0 5.8 1.9 2.4 4.9 3.7 1.7 0.9 5.2 2.2 7.9 5.4 6.5 2.8 5.2 7.6 1.8 3.4 6.9 26.9 2.0 2.4 20.6 4.8 3.3 15.4 0.2 1.8 0.0 1.5 3.7 0.4 0.3 0.0 1.9 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 52.7 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 1.2 0.0 0.0 3.4 2.1 4.6 0.0 0.1 1.0 0.0 0.5 0.0 0.4 7.2 1.3 0.9 0.0 0.1 1.7 4.9 0.1 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.7 0.0 0.0 3.5 0.1 30.9 0.2 0.5 0.4 1.8 0.0 0.7 0.4 0.0 0.8 2.1 0.8 0.7 0.2 15.4 3.7 2.4 0.0 1.5 0.0 0.2 0.1 0.4 5.3 5.6 11.4 6.9 5.2 2.9 5.2 4.0 4.9 6.9 0.0 0.3 43.2 8.5 6.6 5.6 2.0 0.0 0.0 3.4 3.5 39.3 0.1 0.0 4.4 17.2 1.1 0.0 0.0 2.4 0.2 5.3 14.0 0.0 2.4 0.5 187.5 0.0 2.5 0.3 5.3 5.5 0.9 3.3 0.0 0.1 0.6 3.8 0.0 4.2 0.0 1.9 0.0 1.7 0.0 1.5 6.8 0.0 5.1 0.0 3.1 BAG2 ENSG00000112208 "BCL2 associated athanogene 2" O95816 6 57172326-57189833 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 67.0;urinary bladder: 51.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 76.8;Early spermatids: 102.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018862, HPA019918" Enhanced Supported "Intermediate filaments,Cytosol" NA NA Cytosol "Intermediate filaments" "HPA018862: AB_2669957, HPA019918: AB_2670317" "unprognostic (3.93e-1)" "unprognostic (1.62e-1)" "unprognostic (2.60e-1)" "unprognostic (1.33e-1)" "unprognostic (5.63e-2)" "unprognostic (8.32e-3)" "prognostic unfavorable (6.72e-6)" "unprognostic (1.10e-1)" "unprognostic (7.79e-5)" "unprognostic (6.20e-3)" "unprognostic (4.71e-2)" "unprognostic (6.56e-2)" "unprognostic (6.07e-3)" "unprognostic (5.97e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (1.26e-4)" "unprognostic (6.24e-3)" 3.4 3.5 3.7 8.7 2.8 1.2 4.6 4.1 3.4 18.4 24.5 0.8 14.8 1.9 29.4 9.5 13.4 5.9 6.9 17.2 3.3 3.5 3.7 3.8 4.1 2.3 3.3 2.3 15.4 1.5 0.6 4.5 6.7 3.4 23.7 4.3 2.6 1.5 15.1 9.9 1.7 5.7 67.0 3.4 1.3 7.4 6.7 2.6 1.6 7.6 6.0 1.9 51.0 17.1 5.9 1.4 0.9 0.4 3.3 6.1 1.9 9.5 5.3 2.2 7.9 5.6 16.1 6.3 15.4 14.7 11.1 10.7 6.8 4.9 3.2 14.8 24.3 9.1 1.7 12.8 1.3 10.7 10.1 9.4 9.3 8.0 15.3 8.6 8.1 2.1 7.8 0.7 9.1 8.6 6.7 8.6 7.4 18.6 4.5 10.9 0.7 5.7 6.8 8.5 0.2 5.5 5.3 6.3 6.3 13.3 1.5 2.9 2.6 6.9 0.5 5.5 10.8 1.2 7.1 11.7 6.4 10.4 13.4 15.2 3.1 2.9 7.0 5.6 3.2 0.6 0.1 0.3 0.9 3.3 0.4 3.9 5.9 3.1 3.3 1.4 4.3 6.1 5.1 0.3 3.3 0.1 0.5 3.2 1.9 3.7 2.8 4.1 3.4 3.3 3.5 3.3 2.3 3.4 2.6 3.0 3.0 20.8 4.4 2.2 6.0 33.9 0.0 6.7 2.3 3.5 11.8 76.8 1.7 8.4 102.4 3.6 0.3 0.0 3.0 11.5 50.7 7.0 4.6 13.2 13.1 9.5 1.7 1.8 3.1 24.6 28.7 4.0 6.8 14.4 0.2 6.1 6.8 0.6 36.4 22.7 15.5 6.5 35.4 43.2 6.8 3.3 15.8 8.4 0.6 1.8 BAG3 ENSG00000151929 "BCL2 associated athanogene 3" O95817 10 119651370-119677819 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis Chaperone "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 115.2;vagina: 160.1" "Group enriched" "Detected in many" 5 "Basal glandular cells: 723.0;Cardiomyocytes: 186.4;Glandular cells: 269.5;Urothelial cells: 305.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.6" "Lineage enriched" "Detected in many" 7 "T-cells: 7.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018493, HPA020586" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 890000 "Plasma membrane, Cytosol" "HPA018493: AB_1845257, HPA020586: AB_1845258" "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (2.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (5.31e-3)" "unprognostic (4.51e-3)" "unprognostic (3.32e-2)" "unprognostic (1.98e-2)" "unprognostic (1.46e-2)" "unprognostic (1.30e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.46e-2)" "unprognostic (3.03e-2)" 17.8 14.1 18.8 7.7 25.7 2.7 38.3 18.4 20.7 11.7 14.1 7.3 6.5 6.3 10.1 10.6 23.3 8.7 17.0 38.2 20.6 14.3 16.8 10.1 14.3 5.9 20.9 4.5 7.3 9.3 27.6 8.8 16.5 27.4 14.4 6.7 5.5 14.6 12.9 115.2 18.5 5.6 20.4 35.8 4.4 15.1 8.1 20.6 1.3 11.1 32.7 12.8 14.0 160.1 0.3 0.8 0.4 1.1 0.2 7.6 1.0 26.5 30.2 8.5 10.9 21.9 15.4 15.8 24.3 20.6 18.6 16.0 12.8 13.0 1.0 11.6 20.8 24.2 39.6 8.6 42.8 12.9 13.0 14.2 1.4 8.1 15.9 18.6 0.0 6.1 15.5 24.8 13.5 21.4 19.8 20.7 4.7 11.3 6.6 18.4 38.0 1.4 5.9 3.3 8.9 34.6 0.1 12.0 4.6 14.0 6.0 1.5 1.4 9.6 17.1 12.5 9.6 10.7 3.5 25.8 9.8 8.5 13.2 34.6 6.1 3.6 0.6 18.3 0.4 7.4 0.0 1.0 0.0 1.2 1.1 2.0 0.3 4.4 1.5 0.8 0.0 7.6 2.7 0.4 0.2 0.5 0.2 3.0 1.0 18.8 25.7 18.4 20.7 20.6 14.3 20.9 4.5 27.4 20.6 20.8 36.3 0.9 723.0 70.5 2.3 186.4 10.2 29.4 46.6 7.0 17.7 35.8 23.2 16.0 20.3 50.1 18.0 0.0 22.4 39.6 80.3 269.5 24.1 13.7 29.0 1.6 36.8 27.6 7.2 25.2 20.8 15.4 52.3 5.4 12.1 30.3 26.4 8.2 22.6 33.1 1.0 19.4 68.0 17.1 15.1 66.6 61.4 5.7 10.6 305.7 BAG6 "BAT3, D6S52E, G3" ENSG00000204463 "BCL2 associated athanogene 6" P46379 6 31639028-31652705 "Predicted intracellular proteins" "Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 339.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020704, HPA045116, HPA053291" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 2000000 "Nucleoplasm, Cytosol" "CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103" "unprognostic (7.32e-2)" "unprognostic (2.96e-2)" "unprognostic (3.43e-1)" "unprognostic (7.67e-3)" "unprognostic (2.61e-1)" "unprognostic (6.00e-2)" "unprognostic (1.07e-3)" "unprognostic (2.14e-1)" "unprognostic (4.46e-1)" "unprognostic (1.34e-1)" "unprognostic (2.88e-2)" "unprognostic (9.98e-2)" "unprognostic (1.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.82e-2)" "unprognostic (6.05e-2)" "unprognostic (8.16e-2)" 20.8 30.1 16.1 18.4 21.7 16.9 18.1 22.1 31.2 23.9 23.8 22.3 17.9 38.2 25.1 38.6 19.9 23.8 21.4 25.5 15.1 14.1 20.6 41.8 25.7 18.1 15.9 15.6 22.0 22.2 6.6 20.7 27.0 17.5 20.5 30.7 24.4 20.9 19.6 50.5 22.3 31.0 17.3 13.2 23.7 26.1 101.8 16.2 39.9 22.9 30.4 27.1 18.3 19.3 4.8 8.4 8.2 7.5 3.2 6.3 3.1 1.9 14.4 16.8 3.4 8.4 13.0 3.8 3.4 2.7 3.3 3.6 35.8 1.6 2.5 26.0 27.8 20.7 2.4 2.0 29.5 5.4 4.1 39.5 11.1 1.8 22.7 12.6 3.3 33.0 10.4 11.9 2.9 3.9 15.0 9.7 20.4 21.0 11.6 24.1 5.6 2.0 19.6 2.1 3.2 2.6 4.9 2.3 4.6 14.4 5.2 2.4 4.5 1.3 4.1 3.3 4.3 30.2 27.7 1.9 11.4 8.7 2.0 3.3 15.2 20.0 22.1 15.5 2.7 3.6 8.2 5.7 6.6 6.3 7.5 5.0 4.4 4.4 4.1 4.5 4.8 3.5 4.2 5.8 3.2 6.8 8.4 3.0 3.1 16.1 21.7 22.1 31.2 15.1 14.1 15.9 15.6 17.5 16.2 44.7 36.5 27.4 30.3 28.5 26.7 70.2 43.3 36.1 39.8 34.9 17.7 53.0 26.6 57.4 195.1 37.0 85.3 23.3 43.3 57.5 32.9 30.2 48.4 36.0 49.4 47.7 73.6 38.1 38.8 339.6 30.8 35.7 27.0 30.7 49.7 29.6 55.0 57.5 37.1 40.2 39.7 38.8 37.2 93.9 52.8 31.0 99.9 35.4 49.8 33.1 BAIAP2 "BAP2, IRSp53" ENSG00000175866 "BAI1 associated protein 2" Q9UQB8 17 81035122-81117432 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 172.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023310, HPA027421" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023310: AB_1845264, HPA027421: AB_10602392" "unprognostic (2.20e-1)" "unprognostic (1.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.28e-2)" "unprognostic (1.73e-1)" "unprognostic (6.97e-3)" "unprognostic (3.73e-3)" "unprognostic (1.53e-1)" "unprognostic (6.77e-2)" "unprognostic (1.45e-2)" "unprognostic (4.23e-2)" "unprognostic (2.94e-1)" "unprognostic (7.04e-2)" "unprognostic (6.77e-2)" "unprognostic (7.15e-2)" "unprognostic (1.62e-2)" "prognostic unfavorable (7.58e-6)" 10.1 10.9 29.0 4.1 37.4 1.7 11.5 19.6 45.3 14.6 11.8 11.4 18.0 4.3 10.1 26.0 45.9 20.6 17.6 8.7 22.1 10.6 20.6 26.3 20.0 3.6 7.3 24.3 5.1 7.6 8.4 19.2 17.0 9.8 25.7 7.1 11.8 17.0 17.1 3.9 52.6 4.9 10.8 5.4 6.2 20.1 9.2 12.3 2.1 10.2 20.1 20.2 11.1 20.5 0.1 15.4 4.8 7.8 1.3 2.7 2.3 30.1 13.9 8.9 11.6 7.1 9.6 10.4 12.4 8.2 11.3 5.0 18.9 15.3 0.1 9.0 11.0 23.4 29.4 8.1 14.3 4.3 0.1 10.2 6.1 12.3 14.0 6.7 0.0 9.0 4.0 16.9 9.3 4.9 10.5 6.0 0.3 7.9 0.2 6.5 16.0 1.2 6.8 3.7 20.0 12.3 1.8 2.2 24.8 34.6 10.6 11.7 12.8 19.9 28.9 33.6 7.7 25.4 7.0 7.3 26.4 25.1 4.3 13.1 0.4 0.1 0.4 23.0 1.0 5.7 0.0 5.9 0.4 2.7 7.8 0.9 0.1 1.0 0.9 8.3 0.1 1.2 1.5 4.8 1.3 7.2 15.4 0.4 2.3 29.0 37.4 19.6 45.3 22.1 10.6 7.3 24.3 9.8 12.3 71.5 36.6 4.8 115.9 56.6 35.5 15.3 17.8 83.0 31.8 21.0 74.6 60.3 6.6 9.5 8.4 26.9 4.7 0.0 4.5 5.5 34.7 89.9 13.8 62.5 35.9 11.1 47.1 47.3 18.5 20.9 6.4 27.1 38.8 25.2 20.7 17.7 9.1 6.2 3.5 23.1 18.0 0.0 19.4 7.4 20.0 65.7 84.4 7.2 12.4 172.9 BAIAP2L1 IRTKS ENSG00000006453 "BAI1 associated protein 2 like 1" Q9UHR4 7 98291651-98401068 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 91.6;Urothelial cells: 132.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 27.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA019484, HPA021257, HPA023874, HPA029503" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330" "unprognostic (1.75e-1)" "unprognostic (1.86e-3)" "unprognostic (1.21e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.42e-2)" "unprognostic (1.00e-1)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" "unprognostic (8.31e-3)" "unprognostic (4.56e-2)" "unprognostic (1.34e-2)" "unprognostic (9.09e-2)" "unprognostic (2.79e-1)" "unprognostic (1.46e-1)" "unprognostic (1.44e-1)" 4.7 11.2 1.3 16.9 1.1 0.0 10.3 0.3 0.9 6.1 27.3 1.1 10.8 16.2 3.6 4.7 17.9 6.8 29.6 2.1 0.7 0.6 8.9 31.0 15.4 0.9 0.8 0.2 2.6 47.4 4.7 16.9 17.0 1.2 15.2 12.5 6.5 14.7 12.3 3.3 11.3 34.0 3.4 0.7 1.4 33.0 11.6 0.4 2.1 18.0 11.2 14.1 18.9 12.9 1.3 2.7 0.1 0.2 0.0 0.9 0.1 15.8 12.6 0.3 0.3 0.0 0.5 21.2 4.1 2.7 2.1 1.6 17.5 23.8 0.6 6.2 1.5 18.3 14.1 5.9 17.4 1.9 0.0 7.6 0.0 5.4 9.9 2.6 0.0 5.7 0.6 23.5 1.2 17.3 4.8 0.0 0.0 9.4 0.0 1.8 13.3 0.0 0.0 10.0 22.9 6.8 0.0 0.2 2.5 13.5 14.0 9.1 1.8 9.5 27.7 4.8 14.3 7.7 0.3 0.5 3.2 15.4 0.6 1.8 0.3 4.7 8.0 0.3 2.0 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.0 1.3 0.9 0.2 0.1 0.0 0.2 2.7 0.1 0.1 1.3 1.1 0.3 0.9 0.7 0.6 0.8 0.2 1.2 0.4 11.9 19.3 0.0 43.5 14.8 0.6 1.9 28.1 37.5 28.4 21.0 3.9 10.1 8.3 49.7 27.7 7.5 49.7 0.0 67.4 67.3 2.9 91.6 0.0 13.0 2.2 1.6 30.9 0.0 0.8 35.9 0.9 1.5 8.5 4.6 43.9 1.3 82.9 31.7 0.7 0.8 0.8 0.0 4.3 29.0 49.5 16.9 10.2 0.0 28.5 132.5 BANF1 BAF ENSG00000175334 "Barrier to autointegration factor 1" O75531 11 66002079-66004149 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB032896, HPA039242" Enhanced Supported Nucleoplasm,Cytosol NA NA 77000 Nucleoplasm Cytosol "CAB032896: AB_2061090, HPA039242: AB_2676409" "unprognostic (1.69e-1)" "unprognostic (4.46e-3)" "unprognostic (2.04e-1)" "unprognostic (9.59e-3)" "unprognostic (1.23e-1)" "unprognostic (3.70e-3)" "unprognostic (6.16e-3)" "unprognostic (8.39e-3)" "unprognostic (2.31e-1)" "unprognostic (5.07e-2)" "unprognostic (1.76e-2)" "unprognostic (4.57e-1)" "unprognostic (7.36e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "unprognostic (1.83e-3)" "unprognostic (6.39e-2)" 31.2 39.7 38.2 31.6 33.9 24.0 33.5 30.8 38.1 40.7 32.4 33.2 26.5 25.0 38.8 44.4 43.8 58.4 33.4 51.0 35.4 32.5 38.6 61.0 24.6 35.7 33.8 24.7 60.0 40.8 33.5 27.3 40.1 27.5 52.6 33.1 31.1 38.0 38.8 112.7 25.5 29.9 38.9 35.8 39.7 26.8 44.2 27.8 57.6 71.5 54.5 43.8 36.4 45.8 40.0 44.6 14.7 42.8 32.5 30.4 43.8 63.9 64.7 43.6 42.3 22.3 29.7 22.1 35.6 33.2 66.5 42.1 37.5 51.6 55.4 65.8 47.0 54.2 45.1 57.3 59.3 48.9 43.5 34.3 64.4 41.0 46.6 27.3 46.6 49.8 27.6 38.2 42.4 37.4 41.6 48.4 53.5 51.3 44.5 64.1 103.7 52.2 91.7 49.3 41.0 45.4 49.1 43.2 125.7 59.7 32.5 35.3 45.4 38.5 63.8 44.1 33.8 71.1 36.0 33.5 51.0 56.5 57.6 49.7 32.7 59.0 69.4 44.8 39.8 46.2 14.7 41.6 13.9 29.2 41.7 27.6 40.0 24.5 28.3 44.6 37.8 28.3 30.4 4.4 32.5 42.8 40.0 20.6 43.8 38.2 33.9 30.8 38.1 35.4 32.5 33.8 24.7 27.5 27.8 50.6 37.0 151.2 131.4 112.6 49.6 28.6 114.7 113.8 61.4 186.7 23.6 256.8 276.8 168.3 13.4 125.9 55.0 0.0 153.9 288.2 139.3 117.6 138.4 109.1 284.8 47.7 137.2 73.1 75.3 32.5 131.5 149.4 177.2 175.9 138.1 83.5 151.2 91.2 116.3 188.4 42.8 71.1 136.7 219.1 317.9 103.3 146.1 124.6 162.6 122.5 BANK1 "BANK, FLJ20706" ENSG00000153064 "B cell scaffold protein with ankyrin repeats 1" Q8NDB2 4 101411286-102074812 "Disease related genes, Predicted intracellular proteins" "B-cell activation" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0" "Cell type enriched" "Detected in many" 6 "B-cells: 268.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 15 "memory B-cell: 61.4;naive B-cell: 46.2" "Lineage enriched" "Detected in many" 17 "B-cells: 61.4" "Cell line enhanced" "Detected in some" "Daudi: 10.4;HEL: 8.1;HL-60: 7.3;U-266/70: 25.0" "Low region specificity" "Detected in many" HPA037002 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA037002: AB_10672383" "unprognostic (1.59e-2)" "unprognostic (2.08e-2)" "unprognostic (6.43e-2)" "unprognostic (1.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.73e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-2)" "unprognostic (1.01e-1)" "unprognostic (9.97e-2)" "unprognostic (4.25e-2)" "unprognostic (7.89e-2)" "unprognostic (2.80e-1)" "unprognostic (2.18e-1)" "unprognostic (2.75e-2)" "unprognostic (6.09e-3)" "unprognostic (1.75e-1)" 3.3 2.9 0.7 45.4 0.9 2.0 1.9 2.1 0.7 0.7 1.3 0.7 1.4 0.7 0.4 1.2 6.0 1.0 1.6 0.9 0.8 0.7 2.0 0.5 4.9 30.3 0.7 0.2 0.9 0.6 0.0 3.7 0.5 0.6 2.2 1.1 0.5 7.7 1.8 0.4 0.6 18.0 0.3 0.8 67.0 2.5 1.3 0.7 4.8 5.5 0.4 42.3 6.5 1.1 61.4 2.0 3.6 0.3 0.2 0.0 2.1 0.0 2.3 0.0 0.0 2.7 1.1 0.0 0.1 0.0 0.3 0.5 0.0 3.6 10.4 1.0 0.0 0.0 0.1 0.1 1.1 0.3 0.0 0.0 8.1 2.1 0.0 0.1 7.3 0.0 0.5 0.3 0.0 0.0 0.9 0.1 0.0 0.0 3.1 0.5 0.4 0.0 0.4 0.0 0.3 4.4 0.1 0.5 0.0 0.3 4.8 2.1 0.0 0.2 0.1 0.0 0.0 0.4 1.9 1.0 0.0 0.5 0.0 0.0 25.0 0.0 1.7 0.1 4.1 0.0 1.5 0.3 3.6 0.0 0.1 0.0 61.4 0.0 0.0 2.0 46.2 0.0 0.0 0.1 0.2 0.0 1.0 0.0 2.1 0.7 0.9 2.1 0.7 0.8 0.7 0.7 0.2 0.6 0.7 41.7 21.9 268.2 2.1 0.1 0.2 0.4 0.0 2.7 17.0 3.5 0.0 1.8 0.0 0.2 1.9 0.4 0.0 0.0 0.2 0.6 1.0 5.2 1.1 0.0 1.2 0.0 0.0 0.0 2.7 1.8 0.0 7.7 5.0 0.0 0.0 1.1 2.5 0.2 0.4 2.4 0.0 0.0 0.0 1.4 3.2 1.0 0.2 2.5 0.4 4.0 BAP1 "hucep-6, KIAA0272, UCHL2" ENSG00000163930 "BRCA1 associated protein 1" Q92560 3 52401013-52410350 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004322, HPA028814, HPA028815, HPA055560" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850" "unprognostic (1.52e-1)" "unprognostic (7.96e-2)" "unprognostic (1.96e-2)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (2.55e-2)" "unprognostic (9.41e-3)" "unprognostic (8.53e-3)" "unprognostic (1.33e-1)" "unprognostic (3.15e-1)" "unprognostic (4.64e-3)" "unprognostic (3.30e-3)" "prognostic favorable (3.29e-7)" "unprognostic (6.37e-2)" "unprognostic (1.91e-1)" "unprognostic (5.54e-2)" "unprognostic (2.92e-1)" 13.8 17.6 35.6 14.7 33.3 37.3 13.5 21.8 50.4 12.5 17.0 16.3 11.5 12.4 14.7 14.6 21.2 12.1 15.7 16.4 41.5 15.5 16.6 19.0 14.9 15.2 19.4 27.6 16.9 16.3 30.0 11.1 14.8 19.6 14.4 14.9 15.6 17.9 14.6 24.8 40.5 13.9 14.5 10.0 16.1 13.3 37.3 14.7 18.6 15.3 12.9 16.0 14.1 11.7 5.5 8.4 11.3 5.0 3.0 8.5 3.9 14.8 16.9 20.6 17.4 19.9 12.8 23.2 14.7 19.1 24.0 18.6 20.5 13.9 21.4 7.4 20.5 27.1 12.1 21.6 23.8 15.3 21.1 20.5 26.4 35.8 21.2 18.5 24.8 23.5 19.1 31.9 26.5 14.2 13.2 19.1 41.2 22.6 18.9 18.0 12.9 29.4 34.0 23.2 11.8 20.6 12.7 16.7 21.1 14.8 24.1 7.8 25.3 18.1 5.3 21.5 12.1 14.8 34.3 20.4 21.7 20.0 26.0 27.3 28.7 37.7 30.6 23.7 26.2 25.6 3.4 5.0 7.4 8.5 3.9 4.0 5.0 6.8 6.9 3.3 5.5 4.9 6.4 11.3 3.0 3.1 8.4 6.0 3.9 35.6 33.3 21.8 50.4 41.5 15.5 19.4 27.6 19.6 14.7 0.0 13.6 15.0 8.8 28.0 15.3 19.3 10.2 5.3 9.1 24.4 0.0 12.2 10.0 12.0 81.1 12.4 17.6 0.0 14.3 13.1 11.8 9.7 20.7 25.8 11.0 9.5 10.4 15.4 19.3 32.6 9.5 10.2 11.8 11.8 12.9 9.9 12.6 15.3 11.0 14.6 11.3 19.4 13.2 30.9 12.4 20.6 10.1 11.3 16.4 8.5 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375940-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 99.1;Suprabasal keratinocytes: 72.1;Urothelial cells: 102.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB033311, HPA064966, HPA068414" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984" "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.06e-4)" 0.1 0.0 0.3 1.6 0.5 0.0 6.0 0.6 0.9 8.7 4.4 1.4 0.3 7.1 0.6 1.8 49.8 6.8 5.0 0.1 0.5 0.4 1.9 0.1 0.5 0.1 0.7 0.2 1.0 6.9 0.0 0.6 1.5 4.1 1.5 1.9 0.0 78.3 0.7 1.0 11.2 7.9 0.0 1.6 0.0 2.6 1.2 0.2 0.4 0.5 40.7 36.4 0.2 22.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.4 7.8 0.0 1.9 0.0 60.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 0.0 1.5 0.0 2.3 0.0 0.0 0.0 7.7 0.3 0.0 0.0 14.7 0.0 0.1 0.1 0.0 0.0 7.4 0.0 0.1 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.9 0.5 0.4 0.7 0.2 4.1 0.2 0.0 1.4 0.0 99.1 38.2 0.4 0.4 2.5 6.7 6.8 0.0 0.0 10.6 6.6 18.2 6.5 0.3 27.5 0.0 0.6 6.4 2.3 15.2 0.0 0.0 1.6 0.0 1.7 0.0 0.0 1.3 0.0 0.8 10.1 0.0 12.2 0.8 5.0 22.1 0.4 1.4 0.2 0.0 0.7 0.0 1.1 72.1 3.5 0.0 15.8 102.1 BATF3 "JDP1, JUNDM1, SNFT" ENSG00000123685 "Basic leucine zipper ATF-like transcription factor 3" Q9NR55 1 212686418-212699985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.8" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8" "Group enriched" "Detected in many" 36 "dendritic cells: 16.5;monocytes: 26.8" "Cell line enriched" "Detected in some" 12 "HDLM-2: 93.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075858 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA075858: " "unprognostic (3.87e-2)" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (6.85e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (3.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.08e-1)" "unprognostic (6.47e-2)" "unprognostic (1.28e-2)" "unprognostic (1.75e-1)" "unprognostic (6.43e-10)" "unprognostic (9.88e-2)" "unprognostic (5.19e-2)" "unprognostic (3.90e-1)" "unprognostic (7.08e-2)" 10.4 1.3 6.7 6.3 9.4 5.4 3.5 0.4 5.2 2.0 2.4 3.3 0.2 1.4 1.8 0.4 1.8 2.6 3.8 4.1 5.5 2.1 2.6 2.3 7.2 8.7 9.5 2.8 3.1 3.2 1.2 1.3 4.6 4.3 2.3 1.6 0.5 2.2 1.2 1.5 1.1 4.3 3.7 4.7 9.5 3.2 1.1 7.1 5.0 2.1 2.6 4.9 3.0 6.0 0.2 16.5 0.6 26.8 0.3 0.4 2.4 0.3 0.9 0.1 0.0 0.0 0.6 0.7 0.5 1.1 1.1 1.2 0.0 0.3 0.0 0.2 0.0 1.8 0.0 1.1 0.2 0.8 93.1 2.2 0.0 0.3 0.0 0.2 4.2 0.6 0.1 0.0 2.2 0.3 0.1 0.0 7.7 0.1 1.1 0.2 0.0 3.2 1.7 0.4 0.0 1.5 0.6 0.4 0.0 1.0 0.0 0.2 0.1 0.3 0.0 0.0 0.4 0.0 3.0 0.0 0.5 2.1 0.1 2.4 0.1 0.2 0.5 1.5 3.8 1.1 0.0 4.1 0.0 0.0 18.0 0.0 0.2 0.0 0.0 16.5 0.0 0.0 0.0 0.6 0.3 26.8 0.0 0.4 2.4 6.7 9.4 0.4 5.2 5.5 2.1 9.5 2.8 4.3 7.1 3.0 1.1 0.5 2.2 5.0 0.1 0.3 0.0 4.0 2.3 0.0 0.0 0.8 0.0 0.7 0.3 5.8 0.0 0.0 0.3 36.2 8.5 6.6 4.7 0.2 4.6 0.0 0.0 6.2 10.5 0.8 0.9 24.9 1.7 98.2 0.0 0.2 1.3 0.0 0.0 0.5 0.4 0.0 25.8 1.1 4.3 2.5 3.8 1.0 0.0 0.9 BAZ2B WALp4 ENSG00000123636 "Bromodomain adjacent to zinc finger domain 2B" Q9UIF8 2 159318979-159616692 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cone photoreceptor cells: 292.6;Rod photoreceptor cells: 350.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 24.1;neutrophil: 54.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 54.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019819, HPA059292" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019819: AB_1845282, HPA059292: AB_2683968" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-2)" "unprognostic (4.94e-3)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" "unprognostic (5.49e-3)" "unprognostic (9.01e-2)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (1.27e-1)" "unprognostic (2.14e-1)" "unprognostic (3.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.14e-2)" 16.7 20.7 22.1 12.7 37.7 23.5 16.5 30.3 28.5 25.8 18.3 30.0 19.4 12.4 25.4 17.7 16.6 19.2 19.3 13.4 26.1 13.1 13.3 12.3 18.1 9.8 37.2 20.4 33.4 16.4 27.1 45.4 14.9 29.5 17.1 12.4 13.0 19.0 24.6 19.2 12.7 14.5 20.0 42.3 14.4 14.4 18.6 48.9 6.5 19.0 9.1 9.6 18.6 19.2 2.4 5.9 54.6 7.0 4.7 2.7 1.4 3.6 7.3 25.2 15.2 7.6 12.2 4.4 7.8 9.6 4.3 5.1 11.1 10.2 6.3 13.4 7.6 4.3 8.5 10.0 10.6 6.8 2.1 5.7 11.5 12.7 1.5 5.0 7.8 8.0 9.5 11.7 10.7 11.8 15.8 22.1 3.9 12.5 1.2 6.8 4.3 2.7 4.8 8.3 0.7 6.4 6.4 8.1 4.3 8.7 13.3 16.7 14.6 15.4 1.9 9.1 13.5 2.9 21.5 21.8 7.8 15.8 3.2 5.2 4.7 0.4 7.0 7.2 8.5 4.9 24.1 7.0 8.8 2.7 3.0 2.2 1.5 1.6 2.7 4.4 2.4 1.1 1.7 54.6 4.7 2.6 5.9 1.7 1.4 22.1 37.7 30.3 28.5 26.1 13.1 37.2 20.4 29.5 48.9 92.3 148.1 29.6 60.8 29.0 86.6 49.4 58.6 93.7 85.3 64.6 292.6 16.0 8.3 42.8 118.0 64.1 41.6 23.3 33.7 5.4 30.0 44.2 69.6 25.9 22.6 89.0 95.8 58.9 53.8 22.7 55.0 50.5 13.5 59.5 45.4 116.6 43.6 49.2 32.9 7.5 350.6 12.9 23.6 123.2 15.1 32.9 22.3 30.5 40.3 81.3 BBC3 "JFY1, PUMA" ENSG00000105327 "BCL2 binding component 3" "Q96PG8, Q9BXH1" 19 47220822-47232766 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 104.3;Glandular cells: 98.1;Suprabasal keratinocytes: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.1;neutrophil: 6.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.4" "Cell line enhanced" "Detected in many" "HHSteC: 19.0;NB-4: 21.8" "CAB007752, HPA070403" Approved Approved Cytosol NA NA Cytosol "CAB007752: AB_562336, HPA070403: " "unprognostic (4.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.31e-4)" "unprognostic (2.95e-2)" "unprognostic (4.74e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (1.93e-1)" "unprognostic (8.38e-3)" "unprognostic (7.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-2)" "unprognostic (4.66e-3)" "unprognostic (5.06e-2)" "unprognostic (3.57e-1)" "prognostic favorable (2.62e-5)" 6.8 5.4 4.0 4.7 2.9 9.4 6.5 14.0 7.2 6.3 8.9 1.4 2.3 5.9 5.4 3.7 8.2 5.0 8.0 5.8 4.9 3.9 4.6 5.9 19.0 11.8 3.6 4.3 5.2 11.8 1.6 2.5 5.6 3.4 9.8 4.9 4.5 9.2 4.2 28.6 9.4 6.6 5.7 2.8 7.4 7.9 3.2 3.0 13.3 6.2 1.7 3.2 8.2 3.0 0.2 0.4 6.4 1.0 1.0 1.1 0.3 2.4 5.3 5.9 1.2 1.4 2.7 14.4 3.8 5.2 0.9 2.3 1.5 4.0 9.3 1.7 0.9 1.6 0.8 0.8 3.4 0.1 6.0 10.3 2.6 1.8 10.2 19.0 0.4 8.8 6.5 5.5 2.0 1.8 2.4 6.6 2.8 6.7 5.9 0.6 5.4 1.0 21.8 3.7 4.1 0.7 2.6 0.8 10.7 0.2 0.8 1.0 8.9 1.7 3.6 11.4 4.9 1.2 7.3 4.4 1.1 7.3 0.1 1.2 9.6 2.1 5.8 1.7 1.4 4.0 6.1 0.9 0.5 0.9 1.0 0.8 0.2 0.2 0.6 0.4 0.0 1.1 0.7 6.4 1.0 0.8 0.1 0.5 0.3 4.0 2.9 14.0 5.7 4.9 3.9 3.6 4.3 3.4 3.0 8.9 9.0 16.4 66.9 104.3 5.5 2.4 10.2 0.0 4.5 7.0 0.0 3.5 0.0 40.9 10.7 7.0 29.7 0.0 34.2 4.0 6.6 98.1 12.7 3.2 6.7 0.0 20.5 1.8 9.7 2.4 5.8 17.3 60.8 13.6 20.7 2.7 47.6 21.8 3.9 2.1 4.0 6.5 26.4 0.5 1.3 125.3 17.2 27.7 19.1 48.3 BBS4 ENSG00000140463 "Bardet-Biedl syndrome 4" Q96RK4 15 72686179-72738476 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 65.6;Cone photoreceptor cells: 113.9;Rod photoreceptor cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039418 Approved Supported Cytosol NA NA Cytosol "HPA039418: AB_10672962" "unprognostic (3.47e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" "prognostic favorable (2.57e-4)" "unprognostic (3.54e-1)" "unprognostic (2.91e-1)" "unprognostic (8.76e-2)" "unprognostic (5.47e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (3.22e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.05e-1)" 8.9 15.5 11.1 8.5 16.6 7.3 12.4 10.7 17.9 14.9 10.6 17.2 9.8 5.6 14.1 18.0 8.1 19.9 10.4 11.9 11.2 13.6 17.5 13.6 11.4 8.0 12.1 14.5 14.8 11.1 16.9 31.3 8.6 23.8 23.8 8.8 29.8 7.8 11.0 17.2 10.1 8.0 12.9 13.2 7.6 10.5 25.7 10.2 13.1 18.0 6.0 8.3 12.4 9.6 6.0 3.8 4.8 4.0 13.0 7.9 3.5 3.2 8.5 18.9 8.0 9.3 11.5 5.0 6.4 13.5 6.4 8.3 4.4 11.0 5.2 13.8 5.5 4.9 4.8 4.9 5.3 5.8 5.4 6.0 6.1 7.6 4.9 7.7 5.4 4.8 10.7 7.4 9.1 7.2 9.6 4.9 9.9 13.3 4.6 10.0 5.7 5.0 5.1 26.4 6.6 3.8 3.4 9.4 6.5 10.9 8.1 9.1 10.7 11.4 8.3 16.7 7.6 11.3 6.1 6.9 7.4 5.7 34.8 3.6 9.6 9.3 11.0 8.3 8.1 9.9 4.8 2.4 3.8 6.9 4.0 6.7 5.5 5.8 7.2 2.0 6.0 6.1 7.9 2.0 13.0 2.9 3.8 6.8 3.5 11.1 16.6 10.7 17.9 11.2 13.6 12.1 14.5 23.8 10.2 17.9 19.2 5.4 6.8 2.7 38.9 17.1 5.1 65.6 25.0 12.2 113.9 7.7 5.0 12.8 13.1 4.5 3.9 0.0 9.8 4.9 9.3 9.0 12.8 6.2 6.7 20.6 4.1 7.4 6.3 4.2 14.7 6.7 5.0 4.6 7.1 36.7 7.2 6.5 19.1 7.1 86.0 0.0 10.3 48.3 54.1 2.5 4.5 8.7 4.7 1.7 BBX "HBP2, HSPC339, MDS001" ENSG00000114439 "BBX, HMG-box containing" Q8WY36 3 107522936-107811324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 761.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006049, HPA050646" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006049: AB_2667504, HPA050646: AB_2681200" "unprognostic (7.57e-3)" "unprognostic (1.49e-2)" "unprognostic (8.73e-2)" "unprognostic (3.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.49e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (9.84e-2)" "unprognostic (4.81e-2)" "unprognostic (8.62e-2)" "unprognostic (1.11e-3)" "unprognostic (7.22e-2)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" 10.6 22.6 13.1 11.0 20.6 11.2 10.8 12.8 15.1 14.3 13.2 15.4 27.8 6.7 15.1 28.3 10.2 13.2 12.7 11.5 14.8 11.6 14.9 7.3 10.8 10.4 24.5 9.0 21.0 9.0 35.7 39.6 17.8 17.5 17.4 7.3 9.1 11.8 25.1 8.5 7.5 9.4 14.0 26.7 14.1 9.6 43.9 25.5 13.5 19.3 8.0 10.1 15.9 15.6 33.7 16.3 25.2 17.5 25.2 26.1 11.4 18.6 17.3 14.9 22.3 13.3 19.4 12.2 17.7 18.3 16.1 17.9 1.9 15.2 9.7 22.2 11.2 18.4 13.0 16.7 21.5 24.4 12.5 7.8 14.5 14.0 4.1 15.8 19.9 9.0 16.2 15.8 16.2 32.6 22.7 13.5 11.7 6.7 14.6 13.6 6.2 11.2 2.0 7.3 0.2 14.7 15.9 14.1 11.0 10.2 14.1 10.7 10.9 31.3 3.1 15.4 16.0 12.4 4.5 17.7 19.8 14.7 7.3 12.6 6.2 4.1 11.0 17.9 10.3 11.5 25.2 9.1 21.6 22.6 9.2 26.1 32.8 20.3 22.8 12.7 33.7 25.7 21.1 14.9 25.2 17.5 16.3 13.4 11.4 13.1 20.6 12.8 15.1 14.8 11.6 24.5 9.0 17.5 25.5 59.6 69.7 91.3 125.6 75.7 90.3 93.6 76.5 44.2 45.5 90.7 60.9 172.5 41.4 69.4 761.4 73.0 16.6 46.7 65.1 74.7 80.3 95.3 31.2 27.6 41.9 162.1 63.8 57.1 54.0 372.5 144.7 68.9 64.1 36.1 33.3 141.5 56.6 43.5 193.7 88.0 61.1 142.3 128.8 73.5 118.0 66.0 165.9 68.7 36.0 108.0 BCAP29 "BAP29, DKFZp686M2086" ENSG00000075790 "B cell receptor associated protein 29" Q9UHQ4 7 107579977-107629170 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 226.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029215, HPA049694" Enhanced Approved Cytosol NA NA Cytosol "HPA029215: AB_10602331, HPA049694: AB_2680854" "unprognostic (3.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.82e-2)" "unprognostic (1.05e-2)" "unprognostic (5.42e-3)" "unprognostic (4.71e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.43e-2)" "unprognostic (7.22e-2)" "unprognostic (9.64e-2)" "unprognostic (2.31e-2)" "unprognostic (7.36e-2)" "unprognostic (8.34e-2)" "unprognostic (5.40e-2)" "unprognostic (2.78e-2)" "unprognostic (5.28e-3)" "unprognostic (1.81e-1)" 25.6 16.0 17.6 13.7 21.3 11.0 24.0 15.9 33.8 30.5 18.9 10.3 13.6 10.4 27.4 12.3 23.3 13.5 14.7 34.0 18.9 17.0 16.7 24.4 17.3 10.6 20.3 28.7 14.6 12.3 20.8 14.8 23.6 25.7 18.5 19.3 10.0 12.1 17.0 22.9 13.6 13.6 24.0 28.1 12.8 14.6 40.0 13.7 6.3 51.4 13.8 9.8 20.5 20.8 6.6 6.3 20.0 12.4 5.1 6.5 4.3 18.9 5.0 7.9 4.1 17.0 20.2 6.4 21.4 18.6 10.5 11.6 5.5 20.3 3.7 15.2 16.0 18.5 9.5 4.8 10.1 14.6 12.5 5.2 9.1 7.8 5.3 16.8 10.4 12.6 13.0 7.4 13.4 11.0 24.7 28.4 6.8 15.3 10.7 20.7 12.9 6.6 8.8 4.7 6.9 7.8 6.0 10.7 11.7 15.8 9.9 3.4 11.0 20.7 17.9 15.8 10.5 6.8 10.2 30.3 31.0 14.3 27.2 29.6 8.2 21.1 8.8 23.2 9.6 22.6 20.0 6.4 13.0 5.4 7.4 5.5 6.6 4.5 5.7 6.3 5.2 2.7 5.1 2.2 5.1 12.4 6.1 6.5 4.3 17.6 21.3 15.9 33.8 18.9 17.0 20.3 28.7 25.7 13.7 62.5 45.7 19.1 44.3 34.2 31.4 99.3 15.3 32.1 34.2 22.7 9.8 28.2 13.3 40.3 198.1 89.9 22.6 46.7 64.6 44.0 48.3 97.8 56.6 39.4 46.1 7.9 21.5 62.6 29.8 66.5 56.7 40.5 35.4 39.7 32.4 30.9 57.9 31.6 83.8 17.0 22.5 77.6 55.3 226.6 29.8 33.9 59.2 24.5 45.9 62.9 BCAR1 "CAS, CASS1, Crkas, P130Cas" ENSG00000050820 "BCAR1, Cas family scaffolding protein" P56945 16 75228187-75268053 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000443, HPA042282" Approved Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB000443: , HPA042282: AB_2677929" "unprognostic (5.44e-2)" "unprognostic (2.96e-1)" "unprognostic (1.61e-2)" "unprognostic (1.67e-2)" "unprognostic (2.17e-1)" "unprognostic (5.43e-3)" "prognostic unfavorable (9.11e-5)" "prognostic unfavorable (1.24e-4)" "unprognostic (2.15e-1)" "unprognostic (3.49e-2)" "unprognostic (5.18e-2)" "unprognostic (1.77e-2)" "prognostic favorable (4.55e-8)" "unprognostic (3.38e-1)" "unprognostic (3.60e-2)" "unprognostic (8.20e-2)" "unprognostic (2.20e-1)" 16.6 12.3 14.3 8.4 19.5 1.8 11.5 29.1 26.7 16.7 22.7 31.5 9.1 28.6 17.5 11.0 9.6 10.8 20.4 17.8 14.2 9.4 21.3 17.3 15.9 4.9 18.9 13.5 11.3 31.0 9.2 13.2 28.1 13.9 10.9 7.9 14.6 25.7 12.5 37.4 7.2 25.7 8.6 10.4 28.9 28.7 17.3 20.1 0.2 11.8 9.7 6.3 13.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 16.4 8.0 2.6 3.1 2.8 15.4 13.0 7.5 9.5 7.5 21.0 14.1 0.8 17.2 14.4 10.6 8.1 2.7 14.9 2.7 0.0 9.2 0.0 10.0 17.5 7.8 0.0 6.7 8.7 7.4 11.3 5.6 5.6 25.7 0.0 8.3 0.4 5.6 22.4 0.0 0.6 10.6 7.1 10.9 0.3 3.6 3.4 8.7 12.1 9.8 14.1 12.4 2.9 5.0 4.0 6.7 2.2 23.2 16.0 13.9 3.9 19.1 3.5 1.9 0.2 10.1 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 19.5 29.1 26.7 14.2 9.4 18.9 13.5 13.9 20.1 20.8 5.8 2.2 51.8 24.8 13.4 20.7 25.5 4.0 13.6 21.0 5.9 38.1 23.2 45.7 13.5 54.0 56.1 0.0 53.7 20.9 26.0 47.8 9.2 17.9 5.5 12.7 33.5 42.4 1.2 18.0 15.3 2.5 30.4 1.0 35.4 12.3 55.9 52.6 31.5 30.0 4.7 19.4 67.4 14.0 14.7 15.4 30.2 0.0 22.6 54.5 BCAR3 "AND-34, NSP2, SH2D3B" ENSG00000137936 "BCAR3, NSP family adaptor protein" O75815 1 93561786-93847150 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 59.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 102.8;Extravillous trophoblasts: 70.7;Sertoli cells: 71.1;Urothelial cells: 114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4;memory B-cell: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014858 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA014858: AB_1845302" "unprognostic (9.16e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.60e-3)" "prognostic unfavorable (8.41e-4)" "prognostic unfavorable (5.42e-4)" "prognostic unfavorable (8.92e-7)" "unprognostic (2.44e-1)" "unprognostic (3.66e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.51e-2)" "prognostic favorable (3.08e-7)" "unprognostic (2.13e-1)" "unprognostic (1.14e-1)" "unprognostic (7.05e-2)" "unprognostic (1.87e-1)" 26.0 10.4 10.1 11.6 14.2 0.9 23.1 8.6 8.1 10.2 14.1 10.0 6.2 12.4 5.7 5.9 8.9 9.4 15.5 10.6 10.6 8.0 15.5 11.0 12.8 11.8 11.7 5.6 11.2 4.1 4.5 4.6 59.5 10.6 11.2 15.7 10.1 20.5 14.5 19.5 13.3 14.8 10.6 9.7 5.4 15.2 7.3 8.0 2.6 10.0 6.6 11.7 12.7 17.7 4.5 1.7 4.4 1.1 0.0 0.3 0.1 15.3 6.6 12.4 0.9 5.4 4.2 10.7 15.9 27.8 13.1 8.1 1.1 11.5 2.5 5.5 24.5 17.1 9.6 0.3 20.6 11.5 1.1 0.3 0.0 4.8 2.8 9.7 0.1 0.0 5.0 22.8 13.6 46.2 12.7 14.4 0.3 0.4 0.1 35.5 2.3 0.3 0.0 3.9 6.7 22.9 1.0 17.9 0.3 34.4 19.5 0.4 1.0 7.7 8.3 9.9 5.0 9.3 0.6 16.9 19.6 5.0 8.3 21.0 1.3 0.5 0.3 2.9 0.0 7.1 4.4 0.0 0.1 0.0 1.1 0.0 4.5 0.1 0.0 0.8 2.5 0.0 0.3 0.0 0.0 0.0 1.7 0.3 0.1 10.1 14.2 8.6 8.1 10.6 8.0 11.7 5.6 10.6 8.0 3.0 7.4 7.4 102.8 8.8 1.0 6.7 7.6 10.7 9.1 14.0 0.0 23.0 23.2 11.1 8.4 17.3 20.2 0.0 5.6 70.7 9.3 24.4 3.5 9.4 10.3 20.6 14.3 5.5 4.3 11.2 9.5 8.1 18.6 16.2 20.7 4.3 17.7 20.7 1.1 15.6 0.4 71.1 19.3 3.2 2.9 8.9 15.8 0.0 10.0 114.7 BCAS4 "CNOL, FLJ20495" ENSG00000124243 "Breast carcinoma amplified sequence 4" Q8TDM0 20 50794894-50882676 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.9;lymphoid tissue: 31.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 114.6;B-cells: 70.5;granulocytes: 104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 28.9;naive B-cell: 28.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 38.9;U-698: 34.6" "Low region specificity" "Detected in all" HPA038812 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA038812: AB_10795141" "unprognostic (3.48e-1)" "unprognostic (1.60e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (8.35e-2)" "unprognostic (2.98e-1)" "unprognostic (2.47e-3)" "unprognostic (1.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.33e-1)" "unprognostic (2.35e-2)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-2)" "unprognostic (4.30e-2)" 1.8 2.3 7.3 29.1 12.9 3.9 4.5 6.2 12.8 4.8 4.2 2.3 4.2 2.4 5.4 7.2 4.7 3.6 3.8 3.1 13.8 7.5 7.0 1.4 3.8 28.5 7.1 9.2 3.0 3.6 9.2 5.4 5.0 5.2 7.7 1.9 8.8 4.9 7.1 2.1 2.1 8.6 6.0 2.0 12.2 4.5 5.1 2.2 9.2 5.9 0.0 31.6 7.6 5.3 28.9 7.0 0.6 0.1 6.9 12.9 5.3 4.9 8.9 0.7 3.9 1.4 3.7 1.5 6.4 5.8 4.6 3.3 4.2 3.0 38.9 2.4 2.7 9.3 7.4 4.4 9.3 2.7 2.5 3.9 0.2 3.5 3.5 2.0 0.0 0.2 1.2 5.4 3.5 1.7 5.8 0.2 3.1 0.1 0.2 1.6 17.3 1.5 0.1 3.2 0.7 7.2 12.2 1.2 0.4 2.1 4.5 4.0 4.1 10.0 9.6 0.2 3.5 19.0 0.4 0.2 5.0 7.3 5.0 1.5 0.6 2.9 34.6 2.0 0.3 0.4 0.6 0.1 0.1 6.2 0.1 3.5 28.9 3.8 7.5 0.1 28.7 12.9 10.3 0.6 6.9 0.1 7.0 3.1 5.3 7.3 12.9 6.2 12.8 13.8 7.5 7.1 9.2 5.2 2.2 20.8 114.6 70.5 24.1 1.8 5.8 14.8 5.1 37.5 33.0 8.7 2.0 24.9 34.9 9.7 1.3 1.6 0.0 0.0 2.7 3.1 14.6 11.2 104.6 0.2 2.6 7.9 32.2 1.3 1.5 0.4 1.4 1.4 5.0 1.8 2.2 6.9 6.3 0.0 2.8 3.3 5.5 6.5 14.6 3.0 10.6 2.0 9.2 25.8 1.2 21.3 BCCIP "BCCIPalpha, TOK-1" ENSG00000107949 "BRCA2 and CDKN1A interacting protein" Q9P287 10 125823546-125853695 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038011 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038011: AB_2675784" "unprognostic (1.05e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-2)" "unprognostic (1.38e-2)" "unprognostic (1.93e-3)" "unprognostic (2.51e-1)" "unprognostic (3.04e-2)" "unprognostic (6.62e-3)" "unprognostic (1.88e-1)" "unprognostic (1.30e-3)" "unprognostic (1.90e-3)" "unprognostic (4.75e-2)" "unprognostic (1.58e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" 24.0 25.0 27.9 28.8 28.0 32.3 33.4 28.0 30.2 20.8 23.0 15.0 27.8 19.7 21.1 35.9 27.6 21.3 17.9 28.7 28.7 21.3 35.0 45.9 19.0 27.6 23.6 22.0 28.0 29.2 19.8 27.6 19.8 33.5 27.3 26.3 14.4 34.7 26.7 132.7 19.3 23.5 29.7 35.6 27.2 28.2 28.6 24.1 24.6 26.0 32.0 28.7 24.0 47.9 30.9 30.7 16.1 35.4 26.0 33.8 19.0 54.8 28.5 32.4 35.8 18.5 20.4 27.1 29.5 28.3 36.5 34.0 46.6 36.9 38.6 18.6 27.0 27.5 30.5 55.3 41.8 51.2 35.5 37.5 38.8 24.6 51.4 23.4 53.2 24.7 20.9 25.3 43.5 46.1 27.8 34.7 36.5 42.8 19.8 30.9 32.8 34.4 53.8 25.0 46.3 43.1 33.0 34.1 23.1 32.3 26.4 17.2 17.6 22.0 36.2 36.2 27.6 19.5 23.7 23.2 17.1 30.1 25.1 53.1 20.3 22.6 57.4 33.5 27.8 13.1 12.4 28.7 16.1 24.6 34.7 33.8 30.9 28.2 26.8 30.7 28.9 31.9 28.6 4.7 26.0 35.4 26.5 29.7 19.0 27.9 28.0 28.0 30.2 28.7 21.3 23.6 22.0 33.5 24.1 59.6 61.1 29.0 39.2 59.4 23.5 74.2 22.9 92.3 78.5 22.7 21.6 35.7 66.3 28.3 8.2 26.2 18.0 23.3 38.0 30.2 29.3 38.3 25.5 42.9 32.0 15.9 24.8 24.5 28.9 7.7 34.2 29.8 21.9 35.1 20.2 25.8 38.2 14.0 29.4 48.8 23.1 25.8 31.5 79.8 108.7 45.7 28.3 24.9 31.1 42.9 BCDIN3D ENSG00000186666 "BCDIN3 domain containing RNA methyltransferase" Q7Z5W3 12 49836039-49843129 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039911 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA039911: AB_10673021" "unprognostic (2.21e-2)" "unprognostic (6.64e-2)" "unprognostic (2.70e-3)" "unprognostic (1.73e-2)" "unprognostic (1.68e-1)" "unprognostic (2.84e-2)" "unprognostic (9.96e-3)" "prognostic favorable (3.24e-4)" "unprognostic (2.30e-3)" "unprognostic (1.62e-3)" "unprognostic (2.12e-3)" "unprognostic (1.84e-1)" "prognostic favorable (1.03e-5)" "unprognostic (2.31e-2)" "unprognostic (3.15e-2)" "unprognostic (1.06e-1)" "prognostic favorable (1.06e-4)" 5.6 9.3 6.9 6.0 8.4 2.6 7.8 8.9 9.0 6.1 6.0 7.2 6.9 4.9 8.3 7.5 9.1 7.7 4.9 5.3 5.9 4.5 7.3 10.5 4.5 8.3 9.8 4.8 8.5 11.9 8.4 12.7 6.5 6.6 8.7 5.7 5.2 15.4 6.9 32.8 7.6 8.4 5.3 7.6 9.3 8.4 5.3 7.7 15.2 9.9 4.2 10.8 7.4 6.0 9.9 5.0 5.9 6.6 6.2 10.3 4.6 3.4 4.9 4.7 7.3 9.9 5.8 4.9 4.7 6.2 5.0 5.2 2.6 9.0 3.0 5.4 2.1 3.8 4.6 4.7 2.8 2.8 10.4 6.3 4.2 3.8 1.6 7.9 4.8 4.2 3.1 11.2 3.5 5.0 6.3 2.3 6.5 7.5 8.3 3.1 8.6 5.3 7.7 4.7 7.5 8.7 5.6 4.4 5.9 4.9 3.1 6.5 9.1 5.6 9.1 6.7 3.9 11.4 5.3 2.6 4.2 3.2 6.3 2.5 7.9 6.8 5.7 4.5 3.5 2.8 5.9 5.4 2.8 7.6 6.5 10.1 9.9 9.4 7.2 5.0 9.1 10.3 9.7 4.6 6.2 6.6 3.0 7.8 4.6 6.9 8.4 8.9 9.0 5.9 4.5 9.8 4.8 6.6 7.7 29.8 23.5 12.6 7.6 1.9 6.7 2.4 2.5 18.7 11.4 1.8 0.0 11.0 11.6 8.2 1.7 2.9 4.3 0.0 8.5 6.0 5.0 5.7 10.4 6.4 5.0 4.8 1.7 4.3 4.9 0.7 7.8 4.8 0.0 1.0 5.5 7.1 5.8 6.0 6.0 6.7 5.8 0.0 4.1 8.2 10.0 2.8 6.4 10.0 5.0 2.0 BCL2L14 "BCL-G, BCLG" ENSG00000121380 "BCL2 like 14" Q9BZR8 12 12049844-12211084 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 40.1;testis: 29.8" "Group enriched" "Detected in many" 11 "Early spermatids: 317.4;Late spermatids: 661.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Lineage enhanced" "Detected in single" "T-cells: 3.0" "Group enriched" "Detected in some" 4 "CAPAN-2: 5.1;NTERA-2: 3.9;OE19: 5.0;RT4: 4.7;SuSa: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040665, HPA059846" Enhanced Uncertain Cytosol NA NA Cytosol "HPA040665: AB_10964282, HPA059846: " "unprognostic (3.65e-4)" "unprognostic (4.95e-3)" "unprognostic (1.68e-2)" "unprognostic (2.02e-3)" "unprognostic (2.69e-1)" "unprognostic (2.70e-4)" "unprognostic (1.10e-1)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "unprognostic (4.59e-5)" "unprognostic (1.06e-2)" "unprognostic (1.06e-2)" "unprognostic (5.79e-6)" "unprognostic (3.83e-2)" "unprognostic (3.37e-2)" "unprognostic (2.82e-2)" "unprognostic (1.73e-8)" 0.1 0.1 0.1 5.3 0.2 0.0 0.3 0.1 0.1 0.3 17.6 0.1 0.1 11.5 0.1 0.4 0.4 0.2 7.7 0.1 0.1 0.1 0.3 0.3 1.3 1.6 0.1 0.1 0.4 11.2 0.0 0.1 0.1 0.1 1.6 13.3 0.1 0.8 0.1 0.1 0.1 40.1 0.1 0.1 0.9 7.8 29.8 0.1 4.1 0.1 0.3 1.2 2.5 0.2 0.9 0.0 0.1 0.2 0.0 3.0 0.3 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.9 5.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 5.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.1 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.7 0.9 1.4 0.7 0.0 0.0 1.0 0.3 0.1 0.0 0.0 0.0 3.0 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 2.9 0.0 2.6 0.3 0.3 0.4 2.5 2.7 4.5 1.8 0.0 0.1 0.0 0.3 317.4 0.3 31.5 0.0 6.6 0.0 0.4 3.1 0.0 0.0 0.2 0.0 6.4 0.0 0.0 661.8 5.2 0.0 0.0 6.4 42.7 0.0 3.3 17.5 3.5 0.0 0.7 6.5 0.0 5.2 2.7 0.4 0.1 0.0 26.4 7.8 BCR "ALL, BCR1, CML, D22S11, D22S662, PHL" ENSG00000186716 "BCR, RhoGEF and GTPase activating protein" P11274 22 23179704-23318037 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ito cells: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010421, CAB018545, HPA038337" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795" "unprognostic (7.46e-3)" "unprognostic (2.43e-2)" "unprognostic (2.15e-3)" "unprognostic (1.16e-1)" "unprognostic (5.35e-2)" "unprognostic (1.45e-1)" "unprognostic (5.08e-2)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (1.81e-1)" "unprognostic (9.46e-2)" "unprognostic (2.39e-2)" "prognostic favorable (9.15e-10)" "unprognostic (1.47e-1)" "unprognostic (7.10e-2)" "unprognostic (4.10e-2)" "unprognostic (7.43e-2)" 14.5 8.4 24.0 9.1 41.2 26.7 10.5 14.2 26.5 13.6 9.7 10.3 10.6 8.7 9.2 13.9 19.3 10.8 8.3 7.8 20.9 13.0 16.3 8.3 11.3 10.9 16.0 15.6 8.8 12.9 14.5 14.9 15.7 14.2 7.0 6.8 8.3 15.5 9.7 3.4 12.8 8.7 9.0 9.5 9.1 14.0 9.6 15.4 11.8 16.6 5.5 9.2 9.2 8.8 1.5 0.8 1.2 1.0 2.8 6.6 2.5 19.0 8.2 12.7 13.0 7.6 5.2 19.2 6.9 6.5 6.4 5.2 14.4 7.7 13.3 12.9 5.9 6.2 19.6 1.3 19.2 1.8 25.4 13.2 11.6 11.3 11.4 9.9 10.7 6.1 4.4 13.0 9.5 8.4 11.4 22.3 9.6 44.4 6.3 2.9 12.5 10.0 8.4 10.7 15.1 8.1 13.2 5.1 8.7 9.9 12.1 11.7 11.1 12.6 10.9 5.2 8.5 6.9 8.8 25.1 3.8 0.4 6.2 5.7 1.4 5.8 4.7 9.9 8.1 5.9 0.0 1.0 0.0 6.6 0.4 2.3 1.4 3.3 3.3 0.8 1.5 2.6 3.6 1.2 2.8 1.0 0.8 1.6 2.5 24.0 41.2 14.2 24.9 20.9 13.0 16.0 15.6 14.2 15.4 8.9 11.5 3.0 9.5 13.7 24.0 7.3 20.4 2.7 19.4 17.4 21.6 10.5 8.3 12.4 3.9 22.4 11.1 0.0 14.1 5.9 7.3 10.2 10.4 18.4 6.0 22.3 19.1 62.0 10.8 7.7 8.1 5.4 5.0 6.4 12.0 13.4 21.8 5.8 5.3 14.3 8.0 0.0 8.6 1.6 6.8 13.8 9.0 9.2 11.2 11.5 BDH2 "DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308" ENSG00000164039 "3-hydroxybutyrate dehydrogenase 2" Q9BUT1 4 103079435-103099883 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 139.1" "Cell type enhanced" "Detected in many" 16 "Distal tubular cells: 179.1;Proximal tubular cells: 617.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 41.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036028, HPA036029" Enhanced Supported Cytosol NA NA Cytosol "HPA036028: AB_10670674, HPA036029: AB_2674909" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (1.64e-1)" "prognostic favorable (5.21e-4)" "unprognostic (3.92e-1)" "unprognostic (2.28e-1)" "unprognostic (3.82e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.71e-1)" "unprognostic (2.04e-1)" "unprognostic (4.37e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.45e-13)" "unprognostic (2.54e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.75e-4)" "unprognostic (9.69e-3)" 12.4 33.1 22.6 7.7 26.0 2.8 17.6 9.6 18.5 15.7 18.9 14.8 12.3 36.7 11.6 18.8 10.4 16.6 13.5 14.9 26.6 15.4 139.1 39.3 13.8 6.0 38.2 15.6 26.2 8.3 23.5 14.8 8.1 29.0 13.0 11.2 27.0 10.2 15.2 6.9 7.9 34.8 10.2 29.7 6.7 11.8 7.2 32.4 10.4 25.1 12.0 7.6 11.0 11.8 9.5 7.5 1.4 4.1 11.6 18.5 7.5 2.6 4.5 25.9 7.8 27.1 30.1 3.7 6.2 16.0 5.9 10.0 3.6 10.3 10.7 10.9 9.5 2.4 1.2 13.4 10.0 6.8 6.3 8.1 2.0 6.6 11.8 17.4 6.2 3.1 24.0 9.4 10.1 2.3 27.0 19.9 17.7 6.5 3.4 22.7 1.4 27.8 6.1 7.8 2.4 2.1 20.1 25.0 6.3 41.3 5.0 3.5 12.5 11.0 5.8 7.0 11.4 5.2 5.1 12.2 7.0 3.7 4.4 2.4 6.5 6.5 11.0 9.3 7.5 5.8 1.4 4.1 0.2 11.9 1.8 12.8 9.5 12.1 11.3 5.8 9.0 14.2 15.3 0.3 11.6 0.3 7.5 18.5 7.5 22.6 26.0 9.6 18.5 26.6 15.4 38.2 15.6 29.0 32.4 29.8 52.6 3.4 39.4 27.0 1.3 8.5 38.2 22.7 33.0 102.9 0.0 6.7 179.1 38.9 1.1 24.3 37.4 0.0 19.3 13.9 51.4 21.0 18.5 63.8 17.7 3.2 22.0 28.3 13.2 2.1 64.7 10.3 21.9 19.8 19.9 45.8 21.4 14.1 73.2 617.5 2.2 12.9 24.2 0.7 1.7 23.3 2.9 17.3 23.0 33.1 BEGAIN KIAA1446 ENSG00000183092 "Brain enriched guanylate kinase associated" Q9BUH8 14 100537147-100587413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Cell type enriched" "Detected in many" 15 "Horizontal cells: 135.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "eosinophil: 6.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.8" "Group enriched" "Detected in some" 7 "HeLa: 21.8;SH-SY5Y: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002899 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA002899: AB_1078277" "unprognostic (2.98e-4)" "unprognostic (2.75e-3)" "unprognostic (2.66e-2)" "unprognostic (2.66e-4)" "unprognostic (2.77e-3)" "unprognostic (1.93e-2)" "unprognostic (5.16e-2)" "unprognostic (6.35e-2)" "unprognostic (3.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.15e-2)" "unprognostic (5.47e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (3.11e-1)" "unprognostic (2.75e-1)" "unprognostic (2.60e-1)" 1.8 5.5 16.4 1.1 10.8 6.4 1.5 24.9 21.6 1.3 1.3 0.9 0.0 4.6 2.0 1.8 1.4 3.0 2.5 1.5 15.3 7.1 0.9 0.8 1.0 1.3 4.4 6.0 3.5 13.0 2.3 8.2 3.1 3.6 2.6 0.9 2.1 2.8 2.7 0.9 1.3 3.0 1.7 2.0 3.3 1.0 2.6 1.4 5.4 1.0 0.4 1.3 0.8 0.6 0.6 1.0 6.8 1.5 0.0 0.4 0.1 0.3 1.3 0.7 4.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.2 0.2 1.0 0.1 0.2 0.0 0.0 0.0 0.4 2.0 21.8 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.5 0.0 0.0 0.3 0.2 0.0 0.0 1.7 0.1 0.6 0.5 0.1 0.7 0.0 0.1 2.7 0.0 0.0 1.2 53.1 1.2 0.0 1.2 0.0 0.3 5.4 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 3.8 1.0 0.1 1.3 0.1 6.8 0.0 1.5 0.0 0.6 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.0 1.4 1.0 0.0 0.1 16.4 10.8 24.9 17.3 15.3 7.1 4.4 6.0 3.6 1.4 0.0 1.1 0.0 1.4 2.2 1.5 1.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.0 0.3 0.6 0.7 0.0 6.9 0.2 1.4 0.5 9.2 0.0 0.2 135.1 0.0 0.0 0.0 0.6 1.7 0.7 1.7 1.8 0.0 0.7 4.1 0.0 6.3 0.0 2.4 0.0 0.3 0.9 0.4 1.8 0.1 0.0 0.2 0.3 BEND4 "CCDC4, FLJ35632, FLJ43965" ENSG00000188848 "BEN domain containing 4" Q6ZU67 4 42110938-42152878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 26.7" "Group enriched" "Detected in some" 7 "Muller glia cells: 10.2;Spermatogonia: 35.8" "Group enriched" "Detected in some" 43 "prostate cancer: 6.3;testis cancer: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "memory B-cell: 1.1;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 12 "B-cells: 3.3" "Cell line enhanced" "Detected in some" "HAP1: 23.9;HEK 293: 5.8;HEL: 14.6;MOLT-4: 8.9;SuSa: 11.8;U-698: 9.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036850 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA036850: AB_10600787" "unprognostic (3.62e-4)" "unprognostic (3.82e-1)" "unprognostic (4.82e-2)" "unprognostic (5.96e-3)" "unprognostic (2.97e-3)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (5.58e-2)" "unprognostic (6.71e-3)" "unprognostic (1.68e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (1.49e-1)" "unprognostic (4.58e-3)" "unprognostic (4.24e-1)" 0.4 0.3 3.9 5.0 1.0 1.6 0.3 0.2 2.6 0.2 0.6 0.0 0.0 0.5 0.4 0.2 0.3 0.2 0.4 0.3 2.8 1.9 0.3 0.5 1.0 3.7 2.8 1.1 0.6 0.3 0.1 3.8 0.8 1.8 6.4 0.7 0.2 0.8 0.2 0.2 0.2 2.8 0.4 0.4 4.8 0.5 26.7 0.3 4.8 0.3 0.0 3.0 0.7 2.3 3.3 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 23.9 0.0 0.0 0.0 5.8 14.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.0 0.0 0.0 8.9 0.0 4.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.9 1.0 0.2 2.6 2.8 1.9 2.8 1.1 1.8 0.3 0.0 0.0 0.9 0.1 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.2 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 35.8 0.0 0.0 0.0 0.0 0.0 BEND5 "C1orf165, FLJ11588" ENSG00000162373 "BEN domain containing 5" Q7L4P6 1 48727523-48776969 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 46.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 7.1;naive B-cell: 10.1" "Lineage enriched" "Detected in many" 5 "B-cells: 10.1" "Cell line enhanced" "Detected in some" "AF22: 4.2;HDLM-2: 13.6;JURKAT: 5.4;MOLT-4: 5.6;NTERA-2: 3.2;REH: 7.8;SH-SY5Y: 3.8" "Low region specificity" "Detected in many" "HPA054347, HPA058007" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA054347: AB_2682456, HPA058007: AB_2683577" "prognostic favorable (2.50e-5)" "unprognostic (1.36e-2)" "unprognostic (7.19e-3)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (4.42e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.41e-1)" "unprognostic (6.02e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.32e-2)" "unprognostic (4.28e-2)" "unprognostic (2.37e-3)" "unprognostic (3.35e-2)" "unprognostic (9.68e-2)" "prognostic favorable (8.30e-6)" 2.7 5.4 6.5 5.6 7.7 3.0 3.1 2.1 15.5 4.8 5.0 2.8 3.5 1.6 5.0 4.9 2.3 4.3 6.0 4.0 6.0 5.1 6.5 0.8 3.0 5.9 5.4 9.7 12.8 2.8 1.9 5.9 1.4 14.7 3.9 1.6 3.3 2.5 4.3 6.6 1.9 2.6 2.6 3.2 6.4 2.9 2.6 1.9 11.3 4.3 0.5 4.1 4.4 2.9 10.1 1.9 0.2 0.0 1.1 2.0 0.6 0.0 0.0 4.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 0.0 5.6 0.2 3.2 0.0 0.0 7.8 1.4 0.0 0.1 1.5 1.4 3.8 0.0 0.0 0.3 1.6 0.0 0.4 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.1 0.2 1.9 10.1 2.0 1.2 0.2 1.1 0.0 1.9 0.0 0.6 6.5 7.7 2.1 15.5 6.0 5.1 5.4 9.7 14.7 1.9 6.0 1.9 5.9 4.6 1.6 12.3 5.3 12.7 9.4 7.9 5.2 15.7 0.3 46.4 4.6 7.5 6.3 0.0 0.0 1.6 0.4 5.4 0.9 1.1 0.0 0.2 7.9 11.6 1.8 0.0 3.6 12.0 0.5 3.3 0.0 0.6 18.0 2.4 5.5 20.1 19.2 14.9 6.5 3.4 3.2 8.1 1.9 0.1 0.0 1.5 1.4 BEX1 ENSG00000133169 "Brain expressed X-linked 1" Q9HBH7 X 103062651-103064240 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 150.2;pituitary gland: 64.3" "Group enriched" "Detected in many" 4 "Bipolar cells: 321.5;Horizontal cells: 343.2;Muller glia cells: 473.7;Rod photoreceptor cells: 119.7" "Cancer enhanced" "Detected in many" "glioma: 111.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 60.3;HBF TERT88: 67.4;HL-60: 147.5;hTERT-RPE1: 104.5;SCLC-21H: 46.2;U-937: 46.2" "HPA045384, HPA078630" Approved Approved Cytosol NA NA Cytosol "HPA045384: AB_2679305, HPA078630: " "prognostic favorable (6.43e-4)" "unprognostic (1.51e-1)" "unprognostic (8.92e-2)" "unprognostic (2.94e-2)" "unprognostic (1.66e-1)" "unprognostic (7.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-2)" "unprognostic (5.28e-3)" "unprognostic (2.09e-1)" "prognostic favorable (8.16e-8)" "unprognostic (1.14e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (7.34e-2)" 1.8 37.4 66.4 2.8 65.1 16.3 1.9 44.7 150.2 1.8 3.0 6.2 0.0 3.3 7.7 25.2 1.6 10.1 1.8 3.6 77.4 81.0 4.5 3.0 2.1 1.7 38.9 67.8 9.5 30.9 48.1 64.3 1.5 35.8 3.8 3.1 4.7 2.2 2.9 1.3 1.5 3.9 3.3 24.3 2.3 5.0 27.5 12.0 0.0 12.1 0.0 1.5 1.5 0.4 2.4 0.2 6.4 0.5 1.7 3.1 1.5 0.0 0.0 3.7 0.0 0.0 0.0 0.1 2.1 0.0 40.6 60.3 0.0 0.0 0.0 0.0 15.1 13.0 0.0 0.0 0.0 67.4 0.0 0.1 12.3 0.0 8.0 0.7 147.5 0.2 0.9 0.0 8.8 0.0 104.5 0.0 11.8 0.0 0.0 8.1 0.0 27.7 0.0 33.6 9.3 6.0 0.0 0.0 0.7 0.0 0.0 46.2 26.6 0.0 0.0 0.1 0.6 0.0 41.7 0.0 0.0 13.9 0.1 1.5 7.2 0.2 0.0 5.4 46.2 2.6 0.6 0.5 6.4 0.7 0.1 0.7 1.2 2.0 1.2 0.1 2.4 3.1 1.4 1.2 1.7 0.4 0.2 0.9 1.5 66.4 65.1 44.7 89.0 77.4 81.0 38.9 67.8 35.8 12.0 0.0 0.3 0.5 7.8 7.7 321.5 8.2 20.4 0.0 1.2 5.2 37.3 0.3 61.3 6.4 9.3 2.8 0.4 0.0 11.5 0.1 0.4 6.9 0.0 0.0 1.3 343.2 76.4 28.8 7.5 16.7 7.5 0.3 6.8 1.8 0.4 473.7 10.3 2.3 2.5 12.7 119.7 0.0 2.2 15.4 14.7 5.6 0.5 0.0 0.9 1.4 BEX2 DJ79P11.1 ENSG00000133134 "Brain expressed X-linked 2" Q9BXY8 X 103309346-103311046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 79.2;epididymis: 67.1" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 354.8;Muller glia cells: 185.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 18.0;NK-cells: 21.3;T-cells: 26.8" "Cell line enhanced" "Detected in many" "GAMG: 18.6;hTCEpi: 31.0;NTERA-2: 29.9;SCLC-21H: 44.0;SH-SY5Y: 20.0" "HPA045384, HPA078630" Uncertain Uncertain Cytosol NA NA Cytosol "HPA045384: AB_2679305, HPA078630: " "unprognostic (7.56e-2)" "unprognostic (7.08e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (8.54e-7)" "unprognostic (3.21e-1)" "unprognostic (1.65e-1)" "unprognostic (4.27e-2)" "prognostic favorable (1.52e-4)" "unprognostic (7.36e-3)" "unprognostic (6.82e-2)" "unprognostic (8.22e-3)" "unprognostic (6.63e-2)" "prognostic favorable (3.05e-13)" "unprognostic (4.14e-3)" "unprognostic (6.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" 1.7 39.6 49.1 4.1 62.6 6.8 10.9 44.9 79.2 5.8 4.7 11.5 3.0 2.7 14.7 67.1 3.0 8.9 4.8 7.3 53.4 57.6 26.4 1.4 6.6 7.3 32.5 40.3 29.0 13.5 29.6 40.1 5.0 29.6 12.4 4.1 11.5 11.1 12.8 2.5 4.2 4.2 5.7 18.7 7.9 6.5 13.2 13.6 3.1 52.8 1.3 9.2 3.7 2.2 18.0 3.5 4.0 0.1 21.3 26.8 7.1 0.0 0.8 3.8 0.0 0.0 0.0 14.8 0.1 2.0 2.6 3.7 2.6 1.2 0.0 10.4 0.0 18.6 0.6 0.0 3.0 2.2 0.0 8.0 0.4 0.4 0.1 15.2 0.0 8.2 0.9 31.0 1.2 9.5 5.8 0.1 10.7 5.3 0.2 0.3 1.3 6.2 0.0 29.9 0.0 2.6 0.0 0.0 0.0 1.2 1.1 44.0 20.0 2.0 0.4 6.6 3.7 3.6 0.0 0.0 0.0 3.0 0.1 0.6 10.1 6.4 0.0 5.0 0.0 0.4 4.0 0.1 0.3 8.5 0.1 11.8 18.0 16.8 9.8 0.5 15.0 26.8 19.2 0.5 21.3 0.0 3.5 11.3 7.1 49.1 62.6 44.9 60.5 53.4 57.6 32.5 40.3 29.6 13.6 14.9 49.0 36.6 86.3 28.0 178.0 20.2 56.0 13.4 63.7 108.2 41.2 66.0 354.8 40.3 13.3 11.7 2.0 0.0 36.9 9.9 3.3 54.5 12.7 0.8 6.1 114.4 96.4 1.8 0.0 48.7 14.7 4.7 25.3 1.8 25.1 185.5 28.0 7.0 20.8 145.1 106.4 6.5 4.5 14.0 6.0 23.3 53.3 21.7 17.2 43.8 BEX3 "Bex, DXS6984E, HGR74, NADE, NGFRAP1" ENSG00000166681 "Brain expressed X-linked 3" Q00994 X 103376340-103378077 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 492.0;Cytotrophoblasts: 1286.1;Distal tubular cells: 1231.8;Proximal tubular cells: 518.5;Syncytiotrophoblasts: 672.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 18.8;naive CD4 T-cell: 40.8;naive CD8 T-cell: 18.8;T-reg: 32.3" "Lineage enriched" "Detected in many" 6 "T-cells: 40.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018886 Approved Supported Cytosol NA NA Cytosol "HPA018886: AB_1854453" "unprognostic (7.74e-2)" "unprognostic (6.56e-2)" "unprognostic (8.15e-3)" "prognostic unfavorable (7.23e-5)" "unprognostic (2.70e-1)" "unprognostic (1.93e-3)" "unprognostic (7.15e-2)" "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.10e-2)" "unprognostic (3.85e-3)" "unprognostic (2.00e-1)" "prognostic favorable (1.28e-4)" "prognostic unfavorable (3.48e-4)" "unprognostic (1.38e-1)" "unprognostic (3.32e-2)" "unprognostic (8.68e-2)" 21.1 66.1 73.2 9.4 84.2 6.7 22.2 47.1 92.1 28.9 15.2 22.7 30.8 7.7 35.4 134.6 16.0 36.8 18.8 42.9 71.3 87.4 49.8 23.0 22.0 6.7 63.7 75.8 92.7 28.4 39.7 51.5 49.3 82.6 40.8 14.4 18.5 23.4 59.1 4.7 9.0 9.8 29.8 65.2 20.0 13.3 28.1 33.5 10.6 57.0 8.9 7.3 22.7 20.0 1.2 3.5 3.7 0.9 6.4 40.8 17.1 23.6 35.6 68.9 26.0 62.3 70.3 29.3 26.9 47.3 34.9 56.0 37.2 27.7 0.0 49.7 33.3 27.1 9.9 47.5 33.4 38.0 0.1 32.1 10.8 56.4 10.4 46.4 0.1 4.4 72.2 29.9 46.4 43.5 67.1 53.9 25.4 0.0 0.1 66.0 56.5 25.1 0.3 85.7 0.0 26.2 0.0 39.9 0.0 38.5 44.6 45.0 45.0 29.6 0.4 40.0 47.5 16.6 3.7 32.0 22.3 14.5 43.1 12.2 0.2 0.1 0.1 45.6 0.0 21.6 0.0 0.9 0.2 1.0 0.2 0.6 1.2 18.8 5.0 1.5 0.3 40.8 18.8 3.7 6.4 0.1 3.5 32.3 17.1 73.2 84.2 47.1 79.7 71.3 87.4 63.7 75.8 82.6 33.5 303.7 174.8 0.0 0.0 0.0 0.0 0.0 0.0 42.8 191.1 492.0 0.0 1286.1 1231.8 145.0 0.0 0.0 0.0 0.0 62.7 356.7 0.0 0.0 15.1 0.0 151.7 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 3.6 0.0 0.0 61.4 0.0 0.0 518.5 0.0 0.0 0.0 0.0 0.0 0.0 672.6 0.0 0.0 0.0 BEX4 "BEXL1, FLJ10097" ENSG00000102409 "Brain expressed X-linked 4" Q9NWD9 X 103215092-103217246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 304.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 37.9;HMC-1: 45.9;K-562: 53.1" "Low region specificity" "Detected in all" "HPA045105, HPA051935" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045105: AB_10966792, HPA051935: AB_2681667" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.01e-2)" "unprognostic (2.55e-3)" "unprognostic (1.75e-3)" "unprognostic (3.69e-1)" "unprognostic (1.52e-1)" "unprognostic (1.06e-3)" "unprognostic (3.03e-1)" "unprognostic (6.33e-2)" "prognostic favorable (9.41e-4)" "unprognostic (1.62e-2)" "prognostic favorable (2.54e-14)" "unprognostic (1.62e-3)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" "unprognostic (5.33e-2)" 9.8 36.8 63.8 8.6 71.4 21.5 20.8 53.6 68.8 20.7 14.3 29.5 11.5 6.4 25.5 99.8 17.7 24.5 14.8 35.1 61.6 77.6 34.9 5.1 15.8 10.7 54.3 54.7 38.8 12.6 40.7 34.1 29.4 50.5 30.1 10.1 18.0 27.1 32.1 2.5 7.5 8.7 20.9 51.2 23.1 9.6 16.2 24.4 8.6 47.8 3.5 12.3 14.1 11.5 12.9 28.3 36.7 10.4 34.0 25.7 15.0 0.0 0.0 23.5 0.0 6.0 4.1 21.0 5.5 4.7 10.4 19.2 0.0 0.3 0.0 9.3 3.8 8.8 0.1 9.4 1.2 11.5 0.0 8.8 37.9 0.0 0.0 18.4 28.4 45.9 15.5 3.1 5.4 0.0 11.6 12.0 14.8 53.1 0.1 3.1 0.1 19.8 0.2 28.4 0.0 1.6 0.0 6.8 0.1 9.5 0.5 17.5 26.8 1.9 0.3 1.1 23.9 0.9 0.3 0.3 1.3 8.4 0.2 0.0 3.0 1.3 0.0 3.9 0.0 1.1 36.7 8.6 14.8 12.1 10.4 10.1 12.9 14.7 12.2 18.2 12.6 25.7 20.2 1.9 34.0 8.5 28.3 13.5 15.0 63.8 71.4 53.6 68.8 61.6 77.6 54.3 54.7 50.5 24.4 32.8 30.2 36.0 116.3 24.3 176.9 67.8 43.3 36.1 56.9 94.2 23.6 266.1 253.7 53.3 2.2 46.6 6.3 0.0 12.2 138.8 44.1 99.1 108.3 0.8 81.6 209.7 60.6 49.1 47.6 6.7 58.7 61.3 109.6 191.2 37.7 161.0 15.3 24.6 57.7 144.4 67.7 51.8 44.8 22.8 14.5 21.1 304.7 33.2 28.0 91.2 BFSP1 "CP115, CP94, filensin, LIFL-H" ENSG00000125864 "Beaded filament structural protein 1" Q12934 20 17493905-17569220 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 6 "Ito cells: 3.7;Late spermatids: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 6.1" "Group enriched" "Detected in many" 5 "NK-cells: 1.5;T-cells: 6.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.0;RPTEC TERT1: 18.2;SK-BR-3: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040748, HPA042038" Enhanced Supported "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA040748: AB_10963786, HPA042038: AB_10964054" "unprognostic (2.24e-3)" "unprognostic (1.99e-1)" "unprognostic (1.63e-1)" "prognostic favorable (1.39e-4)" "unprognostic (1.07e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-6)" "unprognostic (5.11e-2)" "unprognostic (5.53e-1)" "unprognostic (2.10e-4)" "unprognostic (1.75e-1)" "unprognostic (8.81e-2)" "unprognostic (3.35e-4)" "unprognostic (4.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.78e-2)" "unprognostic (7.50e-2)" 2.5 1.8 3.5 2.5 5.6 0.8 2.6 2.8 4.4 3.5 1.8 0.9 5.5 0.8 10.7 5.4 5.1 2.2 4.8 2.4 3.2 3.7 6.1 1.1 4.1 0.6 3.3 1.7 5.3 2.7 4.8 1.3 4.5 3.0 3.3 1.2 2.3 2.0 4.0 3.0 1.8 0.9 2.7 6.9 0.8 1.1 8.0 0.7 0.6 5.3 2.3 1.5 5.1 1.1 0.0 0.0 0.7 0.0 1.5 6.1 0.5 0.7 7.4 2.4 0.3 0.6 2.5 0.4 1.8 8.7 1.2 1.1 3.3 6.4 0.0 1.5 1.0 4.7 1.1 2.6 1.4 1.0 1.6 2.0 0.5 1.0 1.0 1.4 0.4 0.8 2.9 4.6 0.7 2.1 10.0 5.2 0.5 0.2 0.4 3.9 1.4 0.0 1.0 5.6 4.7 2.0 0.0 1.7 0.4 18.2 1.3 2.5 0.3 2.1 9.8 3.8 1.2 4.7 1.6 5.9 0.3 0.6 0.6 1.7 0.0 0.1 0.0 1.3 0.0 1.5 0.1 0.0 0.0 6.1 0.0 0.2 0.0 1.7 1.0 0.0 0.0 0.1 0.5 0.7 1.5 0.0 0.0 0.0 0.5 3.5 5.6 2.8 4.4 3.2 3.7 3.3 1.7 3.0 0.7 3.0 1.7 0.0 0.4 0.8 0.2 1.1 2.5 1.4 0.0 0.0 0.0 0.8 1.7 0.7 0.7 2.1 0.0 0.0 0.8 1.5 0.6 0.3 0.0 0.0 0.4 0.0 0.0 3.7 0.0 4.7 1.7 0.0 1.7 0.0 0.0 1.0 0.7 0.0 0.0 0.2 0.0 0.0 0.9 0.7 1.6 0.6 0.3 0.0 0.2 0.5 BFSP2 "CP47, CP49, LIFL-L, phakinin" ENSG00000170819 "Beaded filament structural protein 2" Q13515 3 133399995-133475222 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 12.7" "Group enriched" "Detected in some" 4 "B-cells: 10.7;Melanocytes: 5.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "T-reg: 12.7" "Lineage enriched" "Detected in single" 48 "T-cells: 12.7" "Group enriched" "Detected in some" 7 "Daudi: 5.7;U-698: 6.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA038464, HPA062959" Enhanced Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038464: AB_10672746, HPA062959: AB_2684912" "unprognostic (1.58e-3)" "unprognostic (7.47e-4)" "unprognostic (1.04e-2)" "unprognostic (2.32e-1)" "unprognostic (9.59e-2)" "unprognostic (4.04e-5)" "unprognostic (8.13e-2)" "unprognostic (5.57e-2)" "unprognostic (6.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.74e-2)" "unprognostic (4.70e-2)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "unprognostic (8.23e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.1 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 6.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 1.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.9 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 BHLHB9 "GASP3, KIAA1701, p60TRP" ENSG00000198908 "Basic helix-loop-helix family member b9" Q6PI77 X 102720688-102753540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 21.1" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 11.3;Cone photoreceptor cells: 11.8;Muller glia cells: 11.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000887 Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA000887: AB_2666130" "unprognostic (4.07e-2)" "unprognostic (4.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.70e-3)" "unprognostic (6.42e-3)" "unprognostic (2.36e-1)" "unprognostic (2.40e-3)" "unprognostic (5.06e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (2.74e-2)" "unprognostic (4.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.43e-1)" "unprognostic (7.46e-2)" "unprognostic (4.95e-2)" "unprognostic (8.88e-2)" 2.8 6.4 8.6 1.6 13.0 2.7 3.7 15.3 20.6 5.5 3.4 8.7 2.3 2.1 7.5 5.8 2.9 4.5 3.0 4.9 8.9 12.5 6.3 3.8 2.6 1.5 7.2 12.7 9.9 3.6 9.1 7.1 4.8 21.1 7.2 2.9 3.9 3.6 8.2 4.8 3.4 2.5 7.2 6.3 2.7 2.5 4.4 7.3 1.7 6.6 1.2 2.0 4.1 3.4 0.7 0.3 0.9 0.2 5.3 2.0 0.5 0.5 4.0 13.1 3.9 4.2 2.5 5.3 3.5 4.7 5.8 11.1 3.4 2.4 0.0 3.7 3.9 3.8 2.8 7.2 3.8 6.5 0.0 4.3 1.0 3.3 0.7 6.7 0.7 1.3 4.4 3.4 2.6 0.3 5.3 5.8 0.2 3.0 3.6 5.0 2.2 2.6 0.4 7.6 1.4 3.0 1.4 3.8 0.0 3.8 5.8 5.8 5.5 3.8 1.1 0.4 4.9 3.3 1.8 5.9 1.5 4.0 2.2 3.3 1.9 4.8 0.0 3.6 0.9 2.4 0.9 0.2 0.2 1.0 0.1 0.9 0.4 1.1 2.0 0.1 0.7 1.3 1.7 0.7 5.3 0.1 0.3 1.6 0.5 8.6 13.0 15.3 20.6 8.9 12.5 7.2 12.7 21.1 7.3 6.0 1.0 0.0 1.0 1.5 11.3 7.0 2.5 0.0 1.2 3.5 11.8 3.3 6.6 1.2 0.0 2.1 0.5 0.0 0.7 0.8 2.5 1.7 0.0 1.0 1.1 3.2 4.6 3.7 2.1 0.4 2.6 0.0 0.0 1.0 0.6 11.0 0.2 0.0 2.5 1.7 6.0 6.5 1.0 3.9 6.5 1.0 1.1 0.0 1.1 0.6 BHMT BHMT1 ENSG00000145692 "Betaine--homocysteine S-methyltransferase" Q93088 5 79111779-79132290 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "kidney: 105.9;liver: 216.2" "Group enriched" "Detected in some" 8 "Hepatocytes: 455.1;Proximal tubular cells: 647.0" "Cancer enhanced" "Detected in some" "liver cancer: 90.6;renal cancer: 50.4" "Region enhanced" "Detected in single" "hippocampal formation: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 8.4;NTERA-2: 3.6;SCLC-21H: 2.3" "Not detected" "Not detected" "HPA038285, HPA058310" Enhanced Supported Cytosol No NA 9200000 Cytosol "HPA038285: AB_10675791, HPA058310: AB_2683675" "unprognostic (2.61e-2)" "unprognostic (4.12e-1)" "unprognostic (4.45e-1)" "unprognostic (4.14e-3)" "unprognostic (5.62e-2)" "unprognostic (4.14e-1)" "prognostic favorable (7.32e-4)" "unprognostic (5.33e-2)" "unprognostic (1.51e-1)" "unprognostic (1.13e-1)" "unprognostic (9.66e-4)" "unprognostic (6.42e-2)" "unprognostic (8.26e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.60e-2)" "unprognostic (2.30e-3)" 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.1 1.5 0.0 105.9 216.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 4.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.4 0.0 1.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.3 0.0 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.2 2.5 0.0 0.0 15.7 0.0 0.0 66.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 455.1 0.0 0.0 0.0 3.7 9.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 647.0 0.1 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.3 BICC1 ENSG00000122870 "BicC family RNA binding protein 1" Q9H694 10 58513140-58831437 "Disease related genes, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.0" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 119.8;Collecting duct cells: 82.0;Distal tubular cells: 66.3;Ductal cells: 87.3;Leydig cells: 65.9;Proximal tubular cells: 113.1" "Cancer enhanced" "Detected in all" "renal cancer: 25.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "basophil: 8.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.7" "Cell line enhanced" "Detected in many" "A549: 19.9;BJ hTERT+: 21.1;CACO-2: 31.3;RPTEC TERT1: 49.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070797 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA070797: " "unprognostic (1.27e-1)" "unprognostic (1.57e-3)" "unprognostic (3.61e-1)" "unprognostic (1.96e-1)" "unprognostic (6.09e-3)" "unprognostic (1.72e-1)" "unprognostic (9.98e-3)" "unprognostic (1.79e-2)" "unprognostic (6.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.40e-3)" "unprognostic (7.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (6.23e-2)" "unprognostic (2.94e-2)" 11.8 5.7 1.1 5.7 1.5 0.2 9.4 0.5 2.5 9.8 5.1 1.1 4.8 1.0 7.8 12.3 8.1 7.1 11.6 12.1 1.1 1.4 43.0 2.5 5.8 5.2 0.9 2.2 19.0 24.2 0.8 4.6 3.2 2.1 7.8 3.9 18.7 4.8 4.1 22.4 6.5 2.8 6.0 3.9 2.7 3.2 4.9 0.8 0.8 5.1 7.5 3.2 8.6 10.4 0.1 1.1 8.7 0.3 1.0 0.2 0.1 0.0 19.9 0.3 0.0 6.4 8.3 0.0 13.1 21.1 11.9 14.3 31.3 4.2 0.0 13.8 13.3 3.1 0.2 2.1 2.3 16.7 0.0 2.0 0.0 2.6 0.0 4.1 0.0 0.0 12.9 0.7 9.3 10.1 14.9 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 1.3 0.0 5.0 0.0 49.5 2.4 0.0 2.5 0.0 0.1 1.1 0.8 0.0 0.2 0.0 2.9 2.7 0.5 1.6 0.0 0.0 0.0 8.4 0.0 2.7 8.7 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.2 1.0 0.3 0.9 0.1 0.1 1.1 1.5 0.5 2.5 1.1 1.4 0.9 2.2 2.1 0.8 0.0 0.3 0.5 1.1 6.4 0.1 2.2 119.8 17.4 2.3 82.0 0.0 0.4 66.3 87.3 4.0 0.4 0.0 0.0 3.1 0.2 29.2 2.0 0.0 0.5 2.7 0.0 3.5 5.5 0.6 2.2 65.9 0.5 20.3 1.8 1.0 7.5 22.7 0.0 47.0 113.1 0.2 6.5 13.7 0.0 2.1 4.1 3.4 0.0 0.8 0.1 BICD2 KIAA0699 ENSG00000185963 "BICD cargo adaptor 2" Q8TD16 9 92711363-92764812 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 65.5;Suprabasal keratinocytes: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023013, HPA024452" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA023013: AB_1845352, HPA024452: AB_1845353" "unprognostic (9.99e-3)" "unprognostic (1.98e-1)" "unprognostic (7.84e-3)" "unprognostic (2.81e-2)" "unprognostic (4.33e-2)" "unprognostic (2.86e-1)" "unprognostic (2.37e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (6.54e-3)" "unprognostic (8.12e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.39e-4)" "unprognostic (1.25e-1)" "unprognostic (2.26e-1)" "unprognostic (3.95e-1)" "unprognostic (1.39e-2)" 10.4 7.8 13.9 8.9 12.5 7.2 7.1 13.2 13.1 13.1 9.9 7.7 7.9 3.2 9.7 4.5 27.2 7.2 6.7 15.6 11.8 5.8 7.5 5.2 9.1 9.3 13.4 9.8 8.4 7.2 21.7 3.8 9.8 11.9 7.4 3.7 6.6 9.1 10.0 13.9 40.3 5.9 9.7 9.2 11.3 5.9 5.9 11.0 8.5 6.2 16.3 18.2 10.6 17.2 3.3 5.2 10.5 7.5 1.5 2.4 2.0 14.3 11.9 8.9 9.1 17.3 12.0 12.6 14.0 10.1 8.0 6.3 7.0 6.5 16.2 9.1 15.5 10.2 45.2 9.9 22.2 9.1 7.7 10.8 8.5 11.6 9.6 10.3 11.8 13.9 12.2 31.1 13.3 10.2 9.5 11.8 7.0 8.4 12.6 17.4 9.4 11.2 7.4 6.1 10.6 14.7 12.3 19.3 8.6 12.8 12.1 6.2 9.6 9.8 9.1 6.3 9.3 3.7 5.5 15.8 14.8 9.9 24.9 15.1 10.5 7.6 14.4 12.5 7.3 12.9 2.2 4.4 5.6 1.8 5.2 1.8 2.7 2.0 2.4 5.2 3.3 1.9 1.7 10.5 1.5 7.5 4.5 1.2 2.0 13.9 12.5 13.2 13.1 11.8 5.8 13.4 9.8 11.9 11.0 26.8 10.1 12.4 12.7 65.5 12.3 46.2 7.6 14.7 19.4 7.0 5.9 7.4 3.3 8.5 5.1 13.5 1.0 0.0 4.3 5.5 22.3 7.8 23.1 6.7 12.6 14.3 10.4 17.8 32.0 5.0 19.5 24.3 15.1 9.0 2.2 3.9 7.5 3.1 31.5 5.8 5.5 19.4 19.8 7.9 8.4 114.4 6.1 10.2 2.3 15.8 BICDL1 "BICDR-1, CCDC64, FLJ26450" ENSG00000135127 "BICD family like cargo adaptor 1" Q6ZP65 12 119989869-120094494 "Predicted intracellular proteins" "Neurogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 29.9;skin 1: 20.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 12.2;Distal tubular cells: 19.9;Proximal tubular cells: 20.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 27.4;MCF7: 14.8;SCLC-21H: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061116 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA061116: AB_2684433" "unprognostic (2.17e-1)" "prognostic favorable (6.50e-4)" "unprognostic (1.68e-3)" "unprognostic (3.05e-2)" "unprognostic (6.81e-4)" "prognostic favorable (3.15e-4)" "prognostic unfavorable (6.84e-4)" "unprognostic (5.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.63e-2)" "unprognostic (3.31e-3)" "unprognostic (7.26e-2)" "prognostic favorable (3.93e-5)" "prognostic favorable (1.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.15e-1)" 4.0 0.8 2.7 3.8 2.3 0.7 0.9 11.9 6.5 0.8 0.9 1.3 0.0 16.5 7.5 0.7 1.4 0.0 3.1 5.1 29.9 0.5 0.7 8.7 1.5 0.0 1.1 1.2 18.4 0.1 0.9 1.0 1.4 0.1 0.0 20.5 1.1 0.0 0.7 2.3 8.6 8.0 6.3 6.0 1.2 3.5 0.5 0.1 0.9 0.8 0.2 3.4 0.7 1.8 5.7 0.3 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 5.1 3.2 9.0 2.4 0.0 5.1 4.3 0.7 0.9 0.0 0.6 0.9 0.0 2.5 9.8 0.0 1.1 9.5 0.0 27.4 0.0 0.3 0.0 0.0 7.8 0.3 1.1 0.0 14.8 6.4 0.1 11.7 13.6 2.7 0.7 0.5 2.4 3.5 4.6 17.3 1.2 2.0 5.4 1.4 3.0 12.4 4.5 0.0 0.1 1.6 0.0 0.1 2.3 8.7 3.5 0.3 1.3 0.9 0.9 0.0 0.0 3.4 0.0 1.3 0.5 3.4 2.9 0.0 0.5 2.6 2.0 0.0 0.2 0.8 0.1 0.6 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.2 0.0 0.5 19.9 0.8 0.0 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.7 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 BICDL2 CCDC64B ENSG00000162069 "BICD family like cargo adaptor 2" A1A5D9 16 3027682-3036926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.1;pancreas: 54.1" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 19.4;Ciliated cells: 22.7;Club cells: 22.7;Collecting duct cells: 15.7;Ductal cells: 27.6;Exocrine glandular cells: 43.8;Pancreatic endocrine cells: 34.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "eosinophil: 2.6;neutrophil: 3.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.5" "Cell line enhanced" "Detected in some" "A-431: 6.5;BEWO: 11.5;CAPAN-2: 10.6;HaCaT: 16.5;MCF7: 16.0;RT4: 7.6;SK-BR-3: 8.2;T-47d: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043251 Approved Approved "Intermediate filaments,Actin filaments,Cytosol" No NA "Intermediate filaments, Actin filaments, Cytosol" "HPA043251: AB_10794925" "unprognostic (2.00e-1)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (6.06e-3)" "unprognostic (9.65e-5)" "unprognostic (5.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.75e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-2)" "unprognostic (2.05e-2)" "unprognostic (4.71e-2)" "unprognostic (8.56e-2)" "unprognostic (2.55e-2)" "unprognostic (2.38e-1)" "unprognostic (4.32e-2)" "prognostic favorable (9.04e-4)" 0.4 0.0 0.4 2.5 0.4 0.0 2.9 0.4 0.4 6.2 7.9 0.4 8.3 5.7 1.0 2.0 31.1 2.2 11.0 0.4 0.4 0.0 1.2 0.4 5.3 0.4 0.4 0.4 0.9 54.1 3.6 0.9 0.5 0.4 5.1 3.5 0.4 13.9 8.3 1.1 13.7 6.9 1.0 0.4 0.4 10.2 0.5 0.4 0.4 2.3 8.6 12.4 6.1 12.0 0.1 0.1 3.5 0.0 0.2 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.9 10.6 0.0 0.0 0.0 0.0 16.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.1 0.0 4.6 0.0 0.1 0.0 0.2 0.0 7.6 0.1 0.0 0.0 8.2 0.0 0.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 11.9 19.4 0.0 0.0 0.0 0.0 0.0 0.0 22.7 22.7 15.7 0.0 4.0 3.3 27.6 0.0 0.0 0.0 0.0 43.8 3.8 0.0 0.0 2.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 34.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 BID ENSG00000015475 "BH3 interacting domain death agonist" P55957 22 17734138-17774770 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 96.5;bone marrow: 55.0" "Cell type enriched" "Detected in many" 4 "monocytes: 750.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 44.3;eosinophil: 68.5;intermediate monocyte: 75.7;myeloid DC: 36.3;neutrophil: 96.5;non-classical monocyte: 92.8;plasmacytoid DC: 25.3" "Group enriched" "Detected in all" 6 "dendritic cells: 36.3;granulocytes: 96.5;monocytes: 92.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000722, CAB003771" Enhanced Supported Cytosol NA NA 2400000 Cytosol "CAB003771: AB_365478, HPA000722: AB_1078283" "unprognostic (1.59e-1)" "unprognostic (5.51e-2)" "unprognostic (5.02e-2)" "unprognostic (3.04e-2)" "unprognostic (4.27e-3)" "unprognostic (1.11e-2)" "unprognostic (3.84e-2)" "unprognostic (5.21e-3)" "unprognostic (1.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.50e-13)" "unprognostic (4.66e-3)" "unprognostic (1.59e-1)" "unprognostic (3.55e-3)" "unprognostic (2.18e-2)" 13.0 5.2 16.8 21.7 18.7 55.0 8.5 17.1 23.0 3.9 12.2 9.3 1.0 11.2 4.3 7.1 6.7 4.9 11.3 9.6 17.8 12.8 6.1 31.9 13.7 22.5 16.5 6.3 3.7 8.9 4.3 3.5 6.9 8.1 7.1 8.3 4.5 8.0 3.8 11.3 4.7 13.0 5.3 10.9 29.1 9.5 2.4 9.2 21.0 5.5 5.9 12.8 16.2 9.4 5.5 36.3 96.5 92.8 11.6 10.1 37.0 28.7 22.9 4.0 11.7 3.9 7.8 5.1 14.2 11.6 11.5 9.9 13.3 17.2 4.9 11.2 6.2 13.0 24.6 3.4 3.4 6.4 9.3 17.1 23.1 9.1 24.0 4.7 23.6 26.9 7.2 8.4 11.3 2.7 9.3 11.5 17.2 17.3 6.8 5.7 56.8 40.4 33.6 12.0 31.4 12.7 18.7 8.5 7.3 3.1 37.4 23.4 17.2 2.8 10.1 9.8 1.7 20.2 33.2 19.8 6.6 9.5 10.9 11.1 10.2 15.9 18.1 20.1 27.0 8.8 13.8 44.3 68.5 8.8 75.7 8.2 5.5 8.1 9.6 36.3 3.2 6.4 7.5 96.5 11.6 92.8 25.3 10.1 37.0 16.8 18.7 17.1 23.0 17.8 12.8 16.5 6.3 8.1 9.2 14.9 22.1 36.9 41.1 63.8 3.1 13.7 17.8 13.4 27.3 8.7 2.0 8.3 6.6 60.2 0.5 31.8 19.7 23.3 44.8 3.0 39.1 84.8 24.3 33.8 122.1 0.0 32.7 22.1 65.9 0.2 4.9 183.3 55.6 750.2 32.8 2.8 60.9 54.6 3.9 14.7 1.2 0.0 22.7 0.9 13.8 56.3 4.2 45.7 42.4 157.1 BIN1 "AMPH2, AMPHL, SH3P9" ENSG00000136717 "Bridging integrator 1" O00499 2 127048027-127107355 "Disease related genes, Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "skeletal muscle: 399.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 141.1;Proximal tubular cells: 176.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 37.0;MAIT T-cell: 32.5;memory B-cell: 32.2;memory CD4 T-cell: 38.4;memory CD8 T-cell: 36.9;naive B-cell: 34.1;naive CD4 T-cell: 36.2;naive CD8 T-cell: 34.4;NK-cell: 31.2;T-reg: 45.0" "Group enriched" "Detected in many" 9 "B-cells: 34.1;NK-cells: 31.2;T-cells: 45.0" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001945, HPA003894, HPA005437" Enhanced Supported Cytosol NA NA 1200000 Cytosol "CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284" "unprognostic (2.20e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" "unprognostic (9.65e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.55e-1)" "unprognostic (1.02e-3)" "unprognostic (1.85e-1)" "unprognostic (1.42e-3)" "unprognostic (1.26e-2)" "unprognostic (2.57e-1)" "unprognostic (2.41e-3)" "unprognostic (3.22e-3)" 9.5 12.1 21.0 6.7 26.8 3.7 4.2 10.3 24.9 6.2 5.4 36.2 3.6 5.3 5.6 7.3 8.8 7.8 6.4 3.1 24.8 15.2 10.3 4.9 4.6 9.3 26.8 15.8 6.8 5.3 7.3 4.9 6.5 17.3 9.2 4.4 7.9 4.9 7.2 399.9 2.7 5.0 11.6 22.1 10.4 6.1 3.1 26.8 0.0 4.7 30.8 7.3 9.0 7.9 34.1 4.0 1.1 0.6 31.2 45.0 22.4 15.1 8.3 10.1 11.9 30.1 24.2 3.4 4.6 10.0 11.0 7.2 32.0 9.4 0.0 14.2 8.6 6.4 2.0 4.4 7.5 2.9 1.7 1.2 4.4 13.7 2.1 27.2 0.0 0.8 22.1 1.8 23.8 4.3 14.4 14.9 1.5 0.9 0.5 13.5 0.3 1.4 12.7 7.5 33.8 9.5 3.5 11.1 1.4 38.9 0.0 6.6 18.7 16.7 6.5 5.1 11.2 0.4 2.8 17.7 12.7 12.5 16.1 15.3 0.4 0.4 0.0 18.7 0.8 5.8 0.1 0.6 0.1 37.0 0.3 32.5 32.2 38.4 36.9 2.8 34.1 36.2 34.4 1.1 31.2 0.5 4.0 45.0 22.4 21.0 26.8 10.3 24.9 24.8 15.2 26.8 15.8 17.3 26.8 8.9 10.6 66.3 7.8 16.6 141.1 4.5 33.1 0.0 4.5 14.0 117.8 1.6 31.5 12.8 13.4 15.7 11.3 0.0 26.0 3.7 58.0 22.0 2.3 15.3 125.1 28.6 44.2 12.9 18.1 43.3 72.8 30.7 21.9 1.8 25.6 20.3 17.5 21.0 28.7 176.2 129.8 12.9 30.2 1.1 7.5 7.9 2.4 89.9 41.2 8.1 BIRC2 "API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48" ENSG00000110330 "Baculoviral IAP repeat containing 2" Q13490 11 102347211-102378670 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005513, CAB020661" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" Nucleoplasm "CAB020661: , HPA005513: AB_1846746" "unprognostic (1.36e-1)" "unprognostic (3.29e-1)" "unprognostic (9.52e-3)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (7.02e-2)" "unprognostic (2.72e-2)" "unprognostic (1.04e-2)" "unprognostic (1.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.05e-2)" "unprognostic (3.02e-2)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (9.20e-2)" "unprognostic (5.00e-2)" "unprognostic (1.64e-2)" 20.9 25.8 19.1 23.3 24.1 25.9 57.0 20.5 28.5 25.1 22.2 18.4 18.7 19.3 24.6 31.1 18.6 17.0 21.1 39.2 19.1 18.3 24.3 36.8 34.0 47.2 23.3 15.8 21.5 40.8 22.0 27.3 24.3 22.3 19.6 22.2 14.3 21.9 22.1 38.8 17.3 24.4 23.8 26.3 27.6 19.0 19.7 15.5 51.2 18.9 17.3 21.9 22.2 20.2 5.8 12.6 37.5 16.6 12.2 12.0 9.8 9.8 7.3 11.3 8.8 14.3 19.9 7.2 38.3 14.6 22.0 13.4 9.1 24.6 10.9 37.9 17.5 12.3 10.9 7.3 10.1 26.4 14.5 3.7 10.9 5.4 11.0 14.6 6.6 7.0 12.7 19.7 12.5 16.1 20.3 15.0 6.6 9.8 0.0 39.5 3.1 6.9 5.8 5.4 11.8 7.1 3.5 14.7 7.2 17.0 11.4 4.7 6.2 13.3 8.1 11.4 18.1 12.8 8.0 24.6 46.5 10.5 14.0 24.6 4.5 6.1 7.4 10.0 8.3 33.8 31.7 16.6 37.5 9.1 15.2 7.5 5.8 8.7 8.4 12.6 5.6 11.3 11.3 25.5 12.2 16.3 7.6 12.0 9.8 19.1 24.1 20.5 28.5 19.1 18.3 23.3 15.8 22.3 15.5 38.7 40.9 33.3 88.5 59.6 24.1 51.6 63.7 60.2 44.3 61.1 27.5 32.6 36.5 42.3 11.1 49.4 69.1 23.3 63.8 22.6 51.4 66.2 61.2 138.2 36.5 19.1 46.6 67.5 96.7 7.4 33.6 60.1 49.0 85.6 48.7 27.5 44.2 49.9 27.3 66.5 29.1 25.8 53.9 31.1 41.3 54.8 29.4 45.8 37.3 65.0 BIRC3 "API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49" ENSG00000023445 "Baculoviral IAP repeat containing 3" Q13489 11 102317450-102339403 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.0;lymphoid tissue: 46.3" "Cell type enhanced" "Detected in many" 16 "granulocytes: 530.1;monocytes: 1925.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 32.9;naive B-cell: 32.9" "Group enriched" "Detected in many" 10 "B-cells: 32.9;T-cells: 17.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.4;Daudi: 33.7;HDLM-2: 31.9;hTERT-HME1: 33.6;U-266/70: 22.5;U-266/84: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002317 Enhanced Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002317: AB_1846748" "prognostic favorable (3.60e-4)" "unprognostic (2.89e-1)" "prognostic favorable (9.35e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (7.28e-4)" "unprognostic (5.83e-3)" "unprognostic (2.23e-1)" "unprognostic (3.88e-3)" "unprognostic (9.62e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.03e-4)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.66e-6)" "unprognostic (6.42e-2)" "unprognostic (6.23e-3)" "unprognostic (1.00e-1)" "unprognostic (3.85e-2)" 6.9 3.3 1.4 43.9 2.3 5.1 5.4 0.5 2.0 5.3 13.1 0.5 2.8 6.8 2.9 3.7 8.4 3.9 13.9 6.0 2.2 1.3 10.8 12.5 21.8 46.3 2.8 1.2 3.4 7.0 1.1 14.5 0.9 2.2 8.7 6.2 1.1 9.2 4.7 2.2 5.5 46.0 7.3 3.0 34.9 15.9 3.2 2.7 34.2 3.0 4.1 34.0 12.6 6.2 32.9 0.8 2.0 2.6 2.5 17.1 2.8 6.5 5.3 0.0 0.1 0.1 0.7 0.6 0.5 4.4 0.6 0.7 0.9 38.4 33.7 17.4 0.3 5.5 3.6 0.0 0.9 2.1 31.9 0.1 0.1 1.6 0.2 6.6 0.5 0.7 0.7 4.7 2.1 33.6 1.2 0.1 2.7 0.1 0.0 0.8 0.0 2.3 0.3 0.1 3.1 0.2 0.0 0.3 1.7 8.7 3.4 0.0 0.1 0.5 0.6 0.3 0.2 1.7 0.3 1.7 7.3 0.8 0.4 6.7 22.5 19.2 11.9 1.3 1.9 0.9 2.0 0.9 0.4 1.4 2.2 2.5 32.9 10.7 3.5 0.8 32.9 7.5 2.2 0.5 2.5 2.6 0.3 17.1 2.8 1.4 2.3 0.5 2.0 2.2 1.3 2.8 1.2 2.2 2.7 134.0 68.1 285.1 318.0 89.9 0.3 12.0 76.5 30.8 73.9 38.4 0.0 1.7 6.6 193.4 1.3 50.1 284.0 46.7 153.8 0.5 71.9 371.3 530.1 3.4 11.1 0.0 14.5 7.4 18.1 1.3 4.6 71.9 182.2 1925.2 27.1 0.1 190.8 361.2 2.1 8.8 0.0 0.0 133.5 0.5 0.4 73.9 0.5 89.3 29.9 164.7 BIRC7 "KIAP, ML-IAP, mliap, RNF50" ENSG00000101197 "Baculoviral IAP repeat containing 7" Q96CA5 20 63235883-63240507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.4;placenta: 13.6;retina: 21.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 56.9;Melanocytes: 25.3;Muller glia cells: 46.0" "Cancer enriched" "Detected in many" 10 "melanoma: 73.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 9 "T-cells: 2.0" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 63.7" "Not detected" "Not detected" "HPA047850, HPA061283" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA047850: AB_2680181, HPA061283: " "unprognostic (3.60e-1)" "unprognostic (7.94e-2)" "unprognostic (2.70e-2)" "unprognostic (1.78e-3)" "unprognostic (1.15e-1)" "unprognostic (8.11e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.62e-3)" "unprognostic (1.24e-2)" "unprognostic (6.90e-2)" "unprognostic (2.27e-1)" "unprognostic (8.82e-3)" "unprognostic (1.22e-2)" "unprognostic (4.77e-2)" "unprognostic (2.55e-2)" "unprognostic (4.84e-2)" 1.6 1.3 1.0 0.7 1.0 0.3 0.7 0.1 2.2 3.0 1.3 0.5 0.1 0.4 0.8 14.4 0.3 0.3 0.5 2.8 0.9 1.1 2.6 0.8 2.3 2.2 4.9 1.0 0.2 0.1 0.1 0.6 13.6 1.5 0.4 0.3 21.1 0.8 0.1 0.1 4.9 0.3 0.2 4.3 1.6 0.3 0.4 0.3 0.3 0.3 1.0 0.5 0.4 1.8 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.2 0.4 0.0 6.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 63.7 1.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.1 2.2 0.9 1.1 4.9 1.0 1.5 0.3 0.0 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.6 0.1 0.0 0.0 0.0 0.6 8.2 0.5 0.0 2.3 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 46.0 2.3 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 BLM "BS, RECQ2, RECQL3" ENSG00000197299 "Bloom syndrome RecQ like helicase" P54132 15 90717327-90816165 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 36.7" "Cell type enhanced" "Detected in many" 6 "B-cells: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005689 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005689: AB_1845372" "unprognostic (2.77e-1)" "unprognostic (3.82e-3)" "unprognostic (4.03e-2)" "unprognostic (2.98e-2)" "unprognostic (4.75e-2)" "unprognostic (9.89e-2)" "unprognostic (6.12e-5)" "unprognostic (2.82e-2)" "unprognostic (4.55e-3)" "unprognostic (5.24e-3)" "unprognostic (1.80e-3)" "unprognostic (9.12e-2)" "unprognostic (1.55e-15)" "unprognostic (6.53e-3)" "unprognostic (6.55e-2)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" 1.8 0.4 3.1 11.4 1.5 5.5 0.6 4.7 2.6 0.7 1.9 0.9 0.5 1.4 1.2 1.1 2.9 0.4 1.3 1.0 2.3 2.4 0.9 0.5 2.0 7.7 2.8 0.2 0.9 0.4 0.0 1.2 3.6 0.5 0.7 2.5 0.7 7.8 0.0 1.7 0.6 2.8 0.5 1.9 6.7 1.4 4.9 0.5 36.7 0.6 3.1 9.3 1.4 0.7 7.4 1.2 4.3 1.6 4.6 5.0 1.6 5.5 7.8 8.8 5.1 0.0 0.4 5.5 4.1 1.2 4.7 5.1 6.9 3.9 14.2 2.6 1.1 5.9 9.2 13.5 3.7 6.1 8.6 10.0 14.9 8.5 2.2 0.0 14.3 7.4 0.0 0.0 4.7 2.4 0.6 3.3 7.7 12.8 4.4 4.9 3.4 10.7 7.8 9.3 12.1 1.7 10.9 16.5 5.5 1.1 9.9 6.5 6.1 3.3 4.5 2.6 8.6 3.1 11.7 1.8 3.4 6.3 3.5 8.8 3.3 13.2 14.8 1.9 10.1 5.9 2.5 1.0 4.3 3.1 1.2 4.8 7.4 2.8 3.8 1.2 4.3 2.0 2.2 0.8 4.6 1.6 1.2 5.0 1.6 3.1 1.5 4.7 1.7 2.3 2.4 2.8 0.2 0.5 0.5 3.0 12.8 18.6 0.5 0.2 2.9 8.4 0.0 9.4 6.8 0.0 2.0 1.8 1.7 0.9 2.0 0.7 0.0 0.0 0.6 6.5 1.5 0.6 12.7 0.5 4.8 0.0 0.0 2.5 9.7 1.6 0.0 3.8 0.0 1.0 1.2 1.2 0.8 0.0 0.4 0.0 6.5 0.0 0.4 12.0 11.8 0.5 0.8 8.7 2.3 0.3 BLMH BH ENSG00000108578 "Bleomycin hydrolase" Q13867 17 30248195-30292056 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 67.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039548, HPA064307" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No 59000000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA039548: AB_10805479, HPA064307: AB_2685241" "unprognostic (6.85e-2)" "unprognostic (2.79e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (2.54e-2)" "unprognostic (3.91e-3)" "unprognostic (2.07e-1)" "unprognostic (2.05e-3)" "unprognostic (6.69e-3)" "unprognostic (1.95e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" 11.2 8.3 9.0 17.1 10.2 8.5 14.2 12.1 14.5 10.5 9.8 8.5 9.6 6.7 13.1 12.2 15.7 8.4 10.1 9.7 7.5 7.2 13.6 7.5 13.6 20.3 9.5 8.5 8.8 15.3 15.0 8.3 14.6 9.2 8.4 8.5 7.3 12.8 9.5 15.0 67.5 10.0 15.7 11.1 13.2 9.2 12.4 8.6 24.7 9.3 15.5 13.6 10.8 11.7 4.6 6.6 0.9 5.7 9.8 17.3 6.3 10.2 16.2 15.6 10.8 10.7 11.5 7.6 9.5 5.9 15.1 13.0 23.7 3.0 30.4 17.0 7.7 6.8 7.1 33.8 13.0 12.8 8.0 26.6 18.6 14.5 20.1 15.7 33.9 11.5 13.6 0.9 11.8 6.8 12.4 22.1 25.5 39.7 12.4 6.2 7.7 42.0 24.8 15.0 0.0 7.6 36.4 40.6 20.1 12.0 9.1 36.1 12.9 8.4 16.5 10.4 28.2 11.2 17.5 14.0 9.3 18.8 4.1 16.8 15.0 30.9 41.1 7.1 0.0 12.4 0.0 5.7 0.9 10.5 3.9 17.3 4.6 12.6 13.7 6.5 4.2 11.6 12.3 0.7 9.8 1.9 6.6 12.4 6.3 9.0 10.2 12.1 14.5 7.5 7.2 9.5 8.5 9.2 8.6 3.0 13.0 12.3 14.0 14.2 18.2 16.5 12.7 6.7 2.3 10.4 11.8 41.1 6.6 14.9 8.2 17.9 8.9 0.0 12.2 31.7 13.3 8.5 43.8 6.6 22.1 12.7 17.2 28.3 21.8 5.2 15.0 10.4 10.1 10.0 7.6 10.9 8.9 8.6 23.3 17.0 16.0 6.5 15.3 9.7 16.7 11.0 23.0 18.7 10.7 5.9 BLOC1S4 "BCAS4L, CNO, FLJ11230" ENSG00000186222 "Biogenesis of lysosomal organelles complex 1 subunit 4" Q9NUP1 4 6716055-6717671 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043840 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA043840: AB_10965701" "unprognostic (3.09e-1)" "unprognostic (8.40e-2)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (1.80e-1)" "unprognostic (3.53e-1)" "unprognostic (1.76e-1)" "unprognostic (9.24e-3)" "unprognostic (5.62e-3)" 14.6 15.5 9.2 11.8 11.5 13.6 11.4 10.7 14.4 15.4 15.2 9.5 10.1 14.6 13.8 14.3 14.1 12.3 15.7 9.6 9.3 7.7 13.6 13.8 8.7 16.9 8.6 9.4 19.1 18.4 8.4 9.8 23.2 9.8 13.7 9.4 13.3 10.8 11.2 16.6 10.7 15.8 8.2 7.4 17.7 13.3 14.0 8.9 20.9 16.8 10.1 15.5 12.3 10.9 6.1 3.8 13.7 4.8 2.5 9.6 1.8 10.1 7.0 10.6 10.8 8.3 10.7 21.3 8.3 9.1 7.7 6.8 6.2 11.0 9.7 8.9 7.3 10.9 7.0 5.9 9.5 6.0 7.7 9.7 14.8 6.7 15.3 10.2 7.1 13.9 10.1 9.5 6.1 5.3 7.6 7.1 8.5 19.3 8.9 8.0 10.1 11.6 24.9 13.8 7.5 13.9 12.1 11.7 8.6 10.6 9.0 9.1 12.3 6.9 4.9 14.7 8.5 15.6 13.9 7.9 7.2 6.3 8.3 10.3 13.2 12.8 12.9 8.0 13.2 11.3 2.5 3.1 13.7 5.1 4.8 5.2 6.1 6.2 5.5 3.8 4.9 9.6 5.3 1.8 2.5 3.1 3.7 5.1 1.8 9.2 11.5 10.7 14.4 9.3 7.7 8.6 9.4 9.8 8.9 6.0 5.1 27.0 27.5 20.9 29.5 4.2 20.4 2.7 5.7 22.7 5.9 58.7 21.6 5.7 1.1 19.4 21.8 0.0 6.1 79.4 30.2 31.7 3.5 20.5 30.4 28.6 10.9 31.9 17.1 1.4 30.0 14.2 28.7 3.6 24.1 29.5 8.6 35.1 21.2 38.7 22.8 6.5 20.2 10.9 16.4 21.8 53.0 42.0 23.3 27.1 BLVRA BLVR ENSG00000106605 "Biliverdin reductase A" P53004 7 43758680-43807342 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 210.4;monocytes: 171.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019709, HPA042865, HPA054322" Approved Supported Cytosol NA NA 1600000 Cytosol "HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450" "unprognostic (2.47e-2)" "unprognostic (8.38e-3)" "unprognostic (1.79e-2)" "unprognostic (2.16e-3)" "unprognostic (6.45e-3)" "unprognostic (5.01e-2)" "unprognostic (1.63e-2)" "prognostic favorable (8.65e-4)" "unprognostic (1.42e-1)" "unprognostic (1.75e-2)" "unprognostic (2.93e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-2)" "unprognostic (5.63e-3)" "unprognostic (3.18e-1)" "unprognostic (2.13e-3)" "unprognostic (4.56e-2)" 31.7 13.1 14.5 16.2 14.7 23.8 22.5 13.3 21.9 22.7 25.9 9.1 12.6 5.2 19.3 58.7 35.8 18.7 17.5 21.7 11.9 16.2 26.8 6.0 27.7 25.1 15.8 15.4 26.4 14.8 19.3 13.1 12.2 20.5 21.8 8.8 17.2 17.9 21.1 23.0 15.1 12.2 26.4 10.6 40.9 17.7 9.3 6.7 12.1 19.0 21.3 21.5 28.5 18.9 4.9 23.2 27.5 61.6 3.4 14.0 30.7 11.3 22.0 6.4 26.7 13.7 18.3 0.3 7.7 23.9 13.2 16.2 5.2 6.8 0.0 14.9 12.2 46.9 14.9 19.6 19.5 11.3 53.1 13.7 24.4 20.3 32.2 35.0 2.7 9.2 12.4 33.1 13.9 9.3 26.7 22.4 12.3 16.1 13.5 10.0 12.2 8.4 1.4 8.7 2.5 25.4 18.8 11.1 61.4 29.3 6.3 8.3 25.6 15.8 15.8 12.8 11.8 35.5 18.3 13.6 12.2 13.5 5.3 13.1 18.3 14.4 0.0 19.9 11.0 18.9 7.8 50.5 27.5 7.0 61.6 6.6 4.9 14.0 11.7 23.2 2.4 7.5 5.8 4.5 3.4 57.7 3.4 13.6 30.7 14.5 14.7 13.3 21.9 11.9 16.2 15.8 15.4 20.5 6.7 56.6 76.2 9.0 49.2 25.8 17.0 52.9 12.7 76.3 62.6 33.2 2.0 8.3 48.0 45.9 0.6 26.4 1.3 46.7 30.3 8.7 33.7 33.1 108.6 0.9 210.4 7.9 0.0 24.5 107.5 1.3 34.2 72.6 43.9 171.3 0.0 19.3 29.9 0.0 27.3 86.5 11.5 45.3 49.2 2.6 3.8 30.1 4.3 25.0 0.4 35.9 BLVRB "FLR, SDR43U1" ENSG00000090013 "Biliverdin reductase B" P30043 19 40447765-40465840 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 137.6" "Cell type enhanced" "Detected in all" 13 "Erythroid cells: 2523.0;Hofbauer cells: 895.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 73.4" "Group enriched" "Detected in all" 7 "dendritic cells: 54.8;monocytes: 73.4" "Cell line enhanced" "Detected in many" "A549: 81.2;K-562: 73.7;OE19: 64.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041698, HPA041937" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No 440000000 Cytosol "Nucleoplasm, Vesicles, Plasma membrane" "HPA041698: AB_10796781, HPA041937: AB_10794308" "unprognostic (1.86e-1)" "unprognostic (1.14e-2)" "unprognostic (4.23e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (1.20e-2)" "unprognostic (8.56e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" "unprognostic (2.02e-1)" "unprognostic (5.11e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" 36.9 17.9 10.9 12.8 12.2 137.6 28.9 3.5 10.9 17.0 26.7 7.7 18.5 20.9 14.1 19.6 45.3 14.6 19.0 31.0 8.2 8.6 31.8 72.4 37.3 30.0 11.7 9.6 21.3 19.4 5.7 5.6 32.2 13.8 22.9 7.7 17.5 27.1 22.1 43.4 16.7 26.4 22.1 9.7 47.1 31.1 7.6 7.9 6.6 24.3 42.9 24.4 29.9 22.1 8.6 54.8 9.1 73.4 4.0 5.3 34.4 34.2 81.2 1.1 12.1 11.3 10.9 9.6 4.3 12.7 5.9 11.5 15.9 31.1 11.5 33.5 7.7 19.2 11.0 4.1 9.4 1.2 19.5 3.5 17.5 12.2 9.6 26.1 0.2 5.1 10.6 17.9 7.9 4.4 6.0 6.2 4.3 73.7 20.9 6.9 53.2 0.9 1.0 0.3 64.3 22.7 8.1 3.8 18.6 7.4 23.1 0.0 1.8 13.1 34.7 13.2 1.6 33.7 2.6 6.7 15.8 16.9 24.2 2.3 11.4 13.4 4.3 41.1 6.9 6.1 5.0 73.4 2.6 4.6 33.7 4.4 8.6 4.0 4.0 54.8 5.4 4.2 3.3 9.1 4.0 16.9 11.5 5.3 34.4 10.9 12.2 3.5 10.9 8.2 8.6 11.7 9.6 13.8 7.9 205.4 126.9 50.2 283.1 114.9 10.9 116.8 180.9 95.0 73.9 92.5 5.9 76.7 225.5 197.9 7.2 54.2 483.6 2523.0 231.2 82.2 103.0 212.9 41.6 520.7 895.0 9.5 43.0 55.9 549.4 16.6 115.1 152.9 136.7 94.6 130.3 62.8 228.4 480.5 88.4 302.1 11.3 32.3 73.1 2.1 3.6 114.0 62.5 43.7 144.8 253.2 BMI1 "PCGF4, RNF51" ENSG00000168283 "BMI1 proto-oncogene, polycomb ring finger" P35226 10 22321211-22331484 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 132.9;Late spermatids: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 89.1;U-937: 104.6" "CAB011120, HPA030471, HPA030472" Supported Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Nucleoli, Cytosol" "CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090" "unprognostic (5.44e-1)" "unprognostic (2.98e-1)" "unprognostic (4.24e-2)" "unprognostic (4.37e-2)" "unprognostic (2.76e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (2.60e-8)" "unprognostic (9.43e-2)" "unprognostic (7.95e-2)" "unprognostic (7.84e-2)" "unprognostic (8.23e-2)" "unprognostic (1.56e-1)" "unprognostic (7.44e-2)" "unprognostic (9.73e-2)" "unprognostic (8.56e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-2)" 19.7 23.5 28.0 17.0 35.0 13.3 26.5 26.1 33.7 21.6 22.3 26.3 11.6 14.1 23.9 22.8 16.0 17.0 17.4 15.1 28.3 24.2 19.2 25.5 16.7 17.9 42.3 27.7 18.8 18.6 40.0 37.6 20.6 24.8 25.5 16.0 16.5 15.7 20.3 28.5 10.3 14.6 26.3 34.8 24.6 16.5 24.3 40.7 12.9 17.6 10.6 18.8 21.5 25.9 5.0 1.8 13.0 3.4 6.2 8.4 2.4 13.0 6.3 7.3 2.2 12.8 10.3 7.3 8.8 4.0 6.7 8.0 6.6 16.3 6.7 6.0 8.0 7.5 4.6 10.5 6.2 8.4 89.1 13.1 18.4 5.4 7.4 7.6 6.8 10.2 6.6 10.9 7.4 8.2 8.5 4.7 10.8 18.2 11.3 8.9 5.2 18.2 2.0 1.7 6.1 15.1 13.6 10.4 6.4 6.4 4.2 6.1 12.1 5.8 7.6 9.8 3.3 6.9 27.3 10.1 7.5 22.7 18.1 11.8 14.0 18.2 14.7 10.7 104.6 4.9 13.0 1.5 2.5 6.1 3.4 8.4 5.0 6.4 5.8 1.0 2.6 5.5 5.2 0.6 6.2 2.1 1.8 4.3 2.4 28.0 35.0 26.1 33.7 28.3 24.2 42.3 27.7 24.8 40.7 23.8 20.0 13.4 18.4 14.2 21.3 16.1 10.2 16.0 25.0 12.2 7.9 10.9 11.6 14.2 132.9 25.3 4.2 0.0 15.8 17.8 14.4 26.4 11.5 25.2 8.6 28.6 12.7 28.3 19.0 118.0 33.4 13.9 35.4 17.2 12.0 12.6 17.8 5.8 34.3 7.6 13.9 19.4 37.7 10.4 24.3 12.8 5.6 18.3 9.5 17.6 BMPR1A "ACVRLK3, ALK3, CD292" ENSG00000107779 "Bone morphogenetic protein receptor type 1A" P36894 10 86756601-86932838 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019398 Approved Approved Cytosol NA NA Cytosol "CAB019398: " "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (3.34e-1)" "unprognostic (9.61e-2)" "unprognostic (1.05e-3)" "unprognostic (9.34e-2)" "prognostic unfavorable (8.93e-4)" "unprognostic (3.64e-1)" "unprognostic (2.38e-2)" "unprognostic (1.53e-1)" "unprognostic (9.24e-2)" "unprognostic (9.42e-2)" "unprognostic (4.32e-2)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "unprognostic (1.01e-2)" "unprognostic (1.07e-1)" 8.9 7.0 9.4 7.9 12.4 0.9 10.7 14.1 9.2 19.4 20.6 10.9 7.7 6.2 16.3 12.3 8.4 10.9 10.8 11.0 7.7 6.1 8.2 4.6 7.4 2.9 7.3 7.6 16.1 10.6 10.0 14.0 7.4 8.5 12.8 9.3 10.9 12.6 14.2 8.4 11.3 9.8 16.5 12.2 3.4 12.1 7.8 9.2 0.3 19.4 7.8 5.7 16.0 11.4 1.8 1.1 3.6 0.8 0.9 1.4 0.3 7.3 3.7 14.3 12.1 7.5 4.8 2.5 7.4 7.7 4.3 5.1 6.2 6.4 2.2 3.4 9.4 3.1 7.8 6.3 8.0 6.4 2.4 3.6 2.8 3.5 10.3 4.0 3.8 19.7 4.2 3.4 5.8 4.3 6.4 0.0 4.1 4.4 1.5 5.0 3.1 2.6 3.1 7.7 2.6 1.7 0.0 5.6 0.0 8.9 6.9 1.4 4.6 8.2 4.2 4.9 18.2 7.1 1.9 3.7 3.1 5.0 6.4 6.8 0.4 6.8 2.8 2.7 2.6 2.5 2.0 0.8 0.6 1.4 0.5 0.9 1.8 1.4 1.2 0.3 1.5 1.0 1.1 3.6 0.9 0.6 1.1 0.7 0.3 9.4 12.4 14.1 9.2 7.7 6.1 7.3 7.6 8.5 9.2 32.8 24.8 0.0 6.7 10.8 6.0 19.0 10.2 13.4 9.1 10.4 19.6 10.0 1.7 9.8 0.6 2.1 9.0 0.0 8.1 0.7 13.3 12.9 15.0 7.2 2.7 11.1 17.3 8.0 4.0 1.7 31.1 3.5 8.5 1.0 13.6 12.9 7.7 3.5 29.4 4.7 19.0 6.5 14.1 2.3 3.6 8.5 4.2 0.0 10.0 4.2 BMT2 "C7orf60, DKFZp762M126, FLJ31818" ENSG00000164603 "Base methyltransferase of 25S rRNA 2 homolog" Q1RMZ1 7 112819147-112939916 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Collecting duct cells: 12.2;Extravillous trophoblasts: 24.3;Hofbauer cells: 7.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044405, HPA050733" Uncertain Approved Cytosol NA NA Cytosol "HPA044405: AB_10959783, HPA050733: AB_2681223" "unprognostic (5.26e-2)" "unprognostic (3.95e-2)" "unprognostic (2.86e-1)" "unprognostic (2.39e-1)" "unprognostic (2.48e-1)" "unprognostic (1.11e-1)" "unprognostic (7.61e-5)" "unprognostic (1.50e-3)" "unprognostic (1.61e-2)" "unprognostic (9.82e-3)" "unprognostic (1.68e-1)" "unprognostic (2.30e-1)" "unprognostic (1.04e-1)" "unprognostic (6.94e-2)" "unprognostic (1.13e-1)" "unprognostic (8.22e-2)" "unprognostic (9.10e-2)" 9.4 7.8 15.5 8.6 14.5 8.1 11.0 27.6 17.1 11.8 11.2 5.2 11.0 5.0 13.9 8.3 13.7 8.7 9.5 22.9 13.0 12.2 10.3 4.5 8.1 9.8 9.0 7.5 11.4 7.9 11.5 18.0 12.0 10.9 11.1 8.3 6.3 9.3 15.9 7.9 9.3 6.9 13.7 11.0 11.9 6.4 14.2 9.7 13.7 10.0 5.1 10.3 14.6 11.0 3.9 5.7 12.7 5.9 5.4 7.3 2.6 4.2 3.7 9.3 8.3 12.5 14.5 2.8 4.5 20.6 8.2 12.0 2.2 3.4 1.4 5.8 8.3 9.0 2.1 4.9 6.7 13.5 4.5 5.0 7.5 2.7 2.7 5.7 2.8 7.3 10.9 5.3 6.4 5.7 10.2 6.6 2.7 2.3 2.8 9.8 3.2 6.8 8.2 2.0 3.0 3.8 3.4 12.2 4.4 6.2 5.8 3.7 9.5 8.6 3.5 4.9 9.4 1.7 2.7 4.6 10.5 2.6 6.7 3.5 3.7 3.5 2.7 11.4 4.3 6.1 8.0 5.5 9.1 4.9 5.7 6.0 3.9 4.9 5.7 5.7 3.9 6.8 5.7 12.7 5.4 5.9 3.3 7.3 2.6 15.5 14.5 27.6 17.1 13.0 12.2 9.0 7.5 10.9 9.7 6.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 6.7 3.4 12.2 0.0 5.8 0.0 2.4 0.0 0.0 0.0 0.0 2.1 24.3 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.8 0.0 0.0 3.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 BNIP3 Nip3 ENSG00000176171 "BCL2 interacting protein 3" Q12983 10 131966455-131982013 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.7" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 391.8;Proximal tubular cells: 579.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 72.0;hTERT-RPE1: 56.2;U-87 MG: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003015, CAB011676" Supported Uncertain Cytosol NA NA Cytosol "CAB011676: , HPA003015: AB_1078290" "unprognostic (1.01e-3)" "unprognostic (1.42e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-3)" "unprognostic (6.57e-3)" "unprognostic (1.12e-1)" "unprognostic (2.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.37e-3)" "unprognostic (1.04e-1)" "unprognostic (3.29e-2)" "unprognostic (2.98e-1)" 19.3 12.0 18.3 4.0 18.6 3.0 8.7 13.5 28.3 7.7 4.6 13.0 5.1 4.0 6.0 11.4 8.1 6.0 7.9 43.3 16.9 14.6 27.6 53.4 6.7 4.6 16.5 14.2 19.3 122.7 6.0 7.3 13.0 22.6 18.2 2.9 5.2 19.2 6.6 48.0 9.0 4.5 6.0 13.3 4.9 6.4 6.0 11.1 3.3 10.8 6.2 4.0 9.2 7.3 6.1 3.0 5.1 3.5 2.2 23.4 8.9 72.0 5.8 4.2 11.7 11.2 11.9 21.6 17.6 16.3 13.3 38.0 1.2 1.6 0.1 28.6 10.1 15.5 4.4 8.8 25.0 50.1 3.8 6.7 2.5 3.7 16.7 15.0 3.3 2.0 8.2 6.3 12.9 13.1 56.2 9.2 4.5 6.6 0.2 21.7 5.7 1.6 18.4 3.5 0.5 17.5 4.0 2.1 6.1 14.5 1.2 5.5 12.9 3.6 7.4 10.0 18.6 4.5 4.6 10.5 18.8 6.3 7.0 13.9 12.3 10.5 10.0 68.2 0.1 3.2 2.2 3.5 5.1 9.8 2.3 10.4 5.7 13.9 10.3 3.0 6.1 23.4 15.4 0.9 2.2 3.1 2.3 13.2 8.9 18.3 18.6 13.5 28.3 16.9 14.6 16.5 14.2 22.6 11.1 44.7 40.9 23.1 75.3 26.6 87.6 141.4 101.9 89.7 48.9 80.3 37.3 149.9 255.4 174.2 61.9 44.2 3.5 0.0 75.7 295.7 56.6 118.1 0.0 391.8 65.8 314.6 77.8 54.6 21.8 85.4 65.0 16.1 32.1 39.7 6.7 125.3 189.3 1.9 97.2 579.1 50.2 38.8 23.8 33.5 100.7 11.4 206.9 25.4 4.8 42.9 BNIPL "BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753" ENSG00000163141 "BCL2 interacting protein like" Q7Z465 1 151036570-151047600 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.5;skin 1: 68.6" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 14.9;Suprabasal keratinocytes: 49.9;Urothelial cells: 20.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "T-47d: 33.1" "Group enriched" "Detected in some" 9 "basal ganglia: 1.4;cerebellum: 2.7" "Low region specificity" "Detected in some" HPA019946 Uncertain Cytosol NA NA Cytosol "HPA019946: AB_2732424" "unprognostic (2.62e-1)" "unprognostic (7.59e-3)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.50e-4)" "unprognostic (6.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.32e-3)" "unprognostic (3.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.88e-4)" "unprognostic (1.91e-1)" "unprognostic (8.43e-11)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" "prognostic favorable (4.32e-4)" "unprognostic (6.81e-2)" 0.1 0.1 0.2 0.1 0.2 0.3 6.4 0.2 0.2 9.7 0.1 0.1 9.4 0.1 0.6 0.6 42.5 1.0 0.1 0.2 0.2 0.0 0.5 0.2 6.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 3.2 0.1 3.4 0.1 0.3 7.1 21.0 0.7 68.6 0.2 0.8 0.1 0.1 0.6 1.0 0.1 0.2 2.7 25.8 23.2 5.0 18.2 1.8 0.8 3.2 0.6 0.5 1.7 0.4 0.3 0.2 0.5 0.6 0.3 0.3 0.6 0.3 0.0 0.2 0.1 1.1 0.4 0.6 0.5 0.0 0.1 1.3 0.7 0.2 0.4 0.8 0.8 0.9 0.5 0.2 0.1 0.5 0.6 0.0 2.4 0.1 0.2 0.9 0.0 0.9 0.5 0.5 0.2 1.5 0.6 0.9 0.5 0.7 0.4 0.3 0.2 0.3 0.5 0.3 1.1 0.5 0.4 0.7 0.2 1.9 33.1 0.2 0.7 0.7 0.4 0.2 0.1 1.5 1.1 3.1 0.0 0.2 0.6 2.7 0.6 0.7 1.7 0.6 1.4 0.5 1.0 1.2 0.3 1.8 1.0 0.6 3.2 0.5 0.6 0.8 0.6 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.1 14.9 12.1 0.0 5.4 13.6 0.4 0.3 0.0 9.4 10.3 10.4 0.0 1.5 0.0 0.0 5.9 0.3 0.4 0.0 0.0 0.3 1.3 6.2 0.0 0.0 0.3 0.0 0.0 3.7 1.2 0.9 0.9 0.8 3.3 0.0 0.1 0.5 0.0 0.0 0.0 0.3 1.4 0.0 0.2 0.5 0.1 49.9 2.2 0.8 0.2 20.9 BOLA3 ENSG00000163170 "BolA family member 3" Q53S33 2 74135398-74147994 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 267.6;Distal tubular cells: 298.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046393, HPA053162" Uncertain Supported "Nuclear bodies,Mitochondria,Cytosol" NA NA "Nuclear bodies, Mitochondria" Cytosol "HPA046393: , HPA053162: AB_2682063" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.83e-2)" "unprognostic (4.23e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.86e-3)" "unprognostic (8.03e-2)" "unprognostic (1.60e-2)" "unprognostic (4.03e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (9.90e-5)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (4.40e-1)" 18.5 16.1 23.2 11.7 26.0 18.0 20.4 15.6 29.8 11.0 24.0 7.5 12.1 18.4 10.0 13.8 12.6 11.2 12.5 56.8 18.9 21.0 22.0 15.7 14.1 14.7 24.1 18.1 6.9 27.8 12.8 12.3 7.7 17.6 11.5 19.7 11.9 21.5 14.2 57.2 5.9 15.3 14.4 15.8 8.8 16.8 8.2 10.6 7.7 12.1 27.9 11.1 8.9 9.1 14.3 20.7 3.4 9.7 15.2 32.0 13.9 23.4 30.5 11.1 10.9 20.5 19.5 27.5 21.9 12.9 24.4 16.7 39.6 10.9 15.5 20.0 18.9 24.6 12.4 25.5 31.2 21.9 30.4 42.0 19.7 21.2 60.4 18.4 38.6 9.7 15.5 23.9 23.6 29.4 11.2 18.0 34.7 41.2 18.4 26.3 36.1 32.2 28.8 16.3 45.3 46.9 21.2 28.9 31.8 32.2 23.7 16.8 10.0 15.5 25.6 27.0 15.4 14.6 24.5 9.9 20.2 34.5 22.5 43.4 16.9 29.7 21.2 21.3 31.0 18.1 3.4 4.8 1.1 23.2 9.1 25.3 14.3 32.0 24.5 12.1 12.4 28.0 24.1 0.9 15.2 9.7 20.7 27.8 13.9 23.2 26.0 15.6 29.8 18.9 21.0 24.1 18.1 17.6 10.6 8.9 28.0 16.4 39.3 20.1 27.8 267.6 56.0 46.8 30.7 80.3 15.7 50.8 298.4 83.8 13.0 34.9 78.6 186.9 96.3 140.3 38.4 51.5 25.3 87.3 98.4 25.4 73.1 36.2 31.6 5.4 30.5 28.8 94.5 91.0 107.7 29.9 82.6 51.8 43.5 165.7 37.6 19.4 43.8 63.5 96.7 14.8 18.7 29.9 160.6 37.4 BOLL BOULE ENSG00000152430 "Boule homolog, RNA binding protein" Q8N9W6 2 197726879-197786762 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 83.6" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 119.5;Late spermatids: 97.5;Spermatocytes: 256.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "T-reg: 4.7" "Lineage enriched" "Detected in single" 12 "T-cells: 4.7" "Cell line enhanced" "Detected in some" "MCF7: 1.6;U-266/70: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018678, HPA048813" Enhanced Supported "Nucleoli fibrillar center,Plasma membrane,Midbody ring,Cytosol" NA NA Cytosol "Nucleoli fibrillar center, Plasma membrane, Midbody ring" "HPA018678: AB_1845411, HPA048813: AB_2680529" "unprognostic (3.55e-2)" "unprognostic (1.69e-1)" "unprognostic (6.05e-2)" "unprognostic (3.08e-2)" "unprognostic (7.93e-2)" "unprognostic (3.20e-1)" "unprognostic (3.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.08e-1)" "unprognostic (9.49e-2)" "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 83.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.1 4.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.3 0.6 0.6 0.0 0.0 0.7 0.4 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.5 0.0 1.6 0.0 0.2 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.2 0.2 3.5 0.6 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.5 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 256.1 39.8 0.0 0.0 0.0 0.0 0.0 BORA "C13orf34, FLJ22624" ENSG00000136122 "Bora, aurora kinase A activator" Q6PGQ7 13 72727749-72756198 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.5" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 9.8;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040866 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA040866: AB_10794868" "unprognostic (9.93e-2)" "unprognostic (7.18e-2)" "unprognostic (4.57e-2)" "unprognostic (7.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-4)" "unprognostic (2.65e-2)" "unprognostic (2.82e-3)" "unprognostic (6.18e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-2)" "unprognostic (5.32e-12)" "unprognostic (7.04e-3)" "unprognostic (2.88e-1)" "unprognostic (9.93e-2)" "unprognostic (2.28e-2)" 3.7 3.0 2.3 10.9 3.2 10.9 6.8 5.8 4.2 3.3 9.0 1.8 6.3 6.9 3.1 5.9 7.1 3.2 3.2 2.3 2.6 2.2 4.3 4.3 7.7 11.8 4.3 1.5 3.1 5.6 0.8 6.3 6.8 4.4 4.0 9.1 2.2 4.6 6.7 2.1 6.1 10.6 3.5 5.3 8.9 5.5 7.0 4.6 26.5 5.0 5.8 12.4 5.6 4.5 5.0 5.7 7.2 5.4 4.6 8.3 3.7 22.3 3.9 12.7 8.6 1.6 1.6 9.0 7.5 6.7 11.8 12.9 10.3 12.9 14.6 4.3 4.3 6.9 9.6 11.4 7.3 15.7 13.5 6.3 18.0 6.3 8.4 1.5 33.9 11.7 1.3 1.9 5.3 11.6 2.6 9.8 15.5 8.2 6.3 8.5 5.2 15.2 9.8 5.6 23.3 4.6 11.1 7.5 6.5 4.0 5.8 3.4 4.0 7.5 7.3 5.4 10.1 4.9 12.4 3.5 3.3 7.5 5.7 9.5 5.4 4.9 10.5 9.2 16.1 8.2 7.2 3.1 1.6 6.6 5.4 5.8 4.6 5.7 6.4 5.7 5.0 4.7 8.3 0.7 4.6 3.3 3.2 5.9 3.7 2.3 3.2 5.8 4.2 2.6 2.2 4.3 1.5 4.4 4.6 3.0 3.2 2.4 1.3 0.6 1.9 0.2 0.0 2.7 2.3 1.8 2.0 3.9 0.0 1.5 1.0 0.2 2.3 0.0 2.2 9.8 0.7 1.4 1.1 0.0 3.8 7.9 0.0 3.1 5.1 0.8 0.9 2.9 0.0 1.8 1.9 1.0 1.4 2.6 1.1 0.5 2.1 12.9 1.9 1.2 4.7 1.0 2.4 2.5 4.0 1.3 BORCS7 "C10orf32, FLJ40752" ENSG00000166275 "BLOC-1 related complex subunit 7" Q96B45 10 102854223-102864961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA037648 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA037648: AB_10673634" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (1.35e-2)" "unprognostic (7.46e-3)" "unprognostic (3.16e-2)" "unprognostic (1.77e-1)" "prognostic favorable (9.08e-8)" "unprognostic (9.85e-2)" "unprognostic (1.77e-1)" "unprognostic (1.06e-1)" "unprognostic (1.67e-3)" 16.0 40.4 22.7 8.1 26.5 13.2 20.2 14.3 22.1 15.6 11.9 16.4 15.2 15.2 15.2 19.4 9.7 20.2 17.7 15.1 19.7 20.9 26.0 42.7 15.7 10.4 18.0 22.5 15.4 15.2 32.8 23.2 21.2 20.1 18.7 10.3 15.0 11.2 12.6 17.2 9.1 17.7 11.8 17.8 18.1 13.7 18.0 17.3 8.9 36.9 14.2 7.9 11.3 10.9 16.2 29.7 16.8 21.6 16.4 13.5 8.6 7.7 10.5 12.9 11.1 14.3 19.6 10.6 11.5 23.7 8.9 8.5 7.0 8.8 4.9 6.1 18.3 9.3 6.5 4.2 5.9 6.6 6.2 9.0 11.3 7.2 14.4 16.4 20.4 19.5 24.5 16.2 6.0 9.6 18.7 15.4 7.1 6.6 5.2 14.1 5.7 5.6 8.4 4.3 10.6 10.0 10.3 17.1 7.1 7.3 8.6 3.7 14.0 4.2 7.7 17.6 6.0 14.5 11.7 11.5 7.5 8.0 7.6 8.0 13.7 20.7 5.9 15.9 11.9 2.6 16.8 19.5 13.6 11.8 21.6 12.9 16.2 12.1 11.9 13.8 14.4 13.5 12.4 6.0 16.4 19.3 29.7 11.8 8.6 22.7 26.5 14.3 22.1 19.7 20.9 18.0 22.5 20.1 17.3 50.6 70.6 27.0 51.2 0.0 46.2 0.0 40.8 80.3 59.1 40.1 37.3 78.2 170.8 26.2 15.7 60.9 31.5 0.0 29.2 33.5 48.6 70.1 31.4 65.1 44.2 60.4 32.8 48.5 50.0 18.3 39.1 38.2 0.0 28.9 46.3 74.6 26.7 50.1 58.4 157.9 44.6 38.8 0.0 68.3 47.1 0.0 101.6 35.9 48.9 49.9 BORCS8-MEF2B MEF2BNB-MEF2B ENSG00000064489 "BORCS8-MEF2B readthrough" 19 19145567-19192158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 19 "Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 11.1;U-266/70: 11.2" HPA004734 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (2.74e-1)" "unprognostic (5.77e-3)" "unprognostic (8.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.46e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.75e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (6.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "unprognostic (5.29e-2)" 4.8 3.5 7.0 5.8 7.4 7.4 4.6 5.6 8.6 5.4 5.4 8.1 6.7 3.2 6.7 7.4 5.4 10.5 7.2 3.4 6.8 6.2 7.5 5.9 4.8 7.1 8.0 5.5 9.8 7.8 5.5 4.9 5.0 7.3 5.7 5.5 6.2 5.6 7.2 5.3 8.8 4.0 8.9 5.9 5.8 5.0 5.5 5.8 5.6 5.9 4.9 7.5 5.8 5.8 0.0 0.4 0.6 0.1 0.0 0.3 0.0 1.6 0.0 0.7 1.2 1.0 2.5 1.3 1.1 1.0 1.5 1.5 0.0 3.1 3.4 0.5 0.0 0.5 0.6 0.7 0.6 0.3 0.5 2.5 1.1 0.1 0.3 2.3 0.0 0.2 0.0 2.3 0.7 3.7 0.6 0.4 3.2 0.2 2.0 0.6 3.1 0.7 0.4 0.0 0.0 11.1 3.3 0.9 0.9 0.0 0.2 0.0 1.1 2.0 0.0 0.9 0.1 0.3 0.6 0.3 0.7 1.2 5.7 0.4 11.2 1.7 5.6 2.4 2.7 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.1 0.0 7.0 7.4 5.6 8.6 6.8 6.2 8.0 5.5 7.3 5.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 BRAF BRAF1 ENSG00000157764 "B-Raf proto-oncogene, serine/threonine kinase" P15056 7 140719327-140924928 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001328, CAB004552, HPA071048" Approved Approved Vesicles,Cytosol No No Vesicles Cytosol "CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336" "unprognostic (2.98e-3)" "unprognostic (5.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.66e-3)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.07e-2)" "unprognostic (4.23e-2)" "unprognostic (4.07e-2)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (1.91e-2)" "unprognostic (3.79e-3)" "unprognostic (2.08e-1)" "unprognostic (1.76e-1)" "unprognostic (8.01e-2)" "unprognostic (5.46e-2)" 13.1 12.1 20.1 16.5 20.4 27.8 14.2 29.9 21.5 12.4 12.3 9.5 12.5 9.3 15.3 17.0 11.8 11.5 12.0 13.6 13.2 12.2 13.7 12.8 15.9 13.3 9.9 17.8 16.8 13.2 28.9 24.8 13.7 15.3 14.5 11.0 10.7 11.6 16.6 12.9 15.6 10.5 13.0 10.9 12.3 12.0 24.9 12.2 13.5 16.6 7.5 12.1 18.6 18.1 2.6 1.9 7.5 2.4 7.0 5.6 1.1 5.5 4.7 6.9 8.3 8.4 11.0 11.1 6.2 6.6 5.0 7.2 5.1 6.0 9.5 4.8 6.4 8.0 3.1 6.1 4.9 9.3 8.8 5.0 6.2 4.6 4.7 7.2 10.0 6.2 7.3 5.6 5.3 11.1 7.4 5.8 7.1 9.7 17.1 8.8 2.9 13.3 10.5 6.4 5.4 3.0 8.7 5.9 7.7 4.9 10.7 8.1 6.8 7.2 4.4 6.5 7.1 4.1 6.8 8.6 5.5 4.2 11.7 5.0 19.8 11.2 15.2 8.9 10.1 5.9 3.3 2.0 7.5 3.1 1.7 2.1 2.6 3.0 2.4 1.6 2.6 5.6 2.8 4.1 7.0 2.4 1.9 2.7 1.1 20.1 20.4 29.9 21.5 13.2 12.2 9.9 17.8 15.3 12.2 20.8 34.2 19.5 20.3 19.2 29.1 12.7 5.1 24.1 25.0 24.4 33.4 12.4 6.6 10.9 55.6 17.1 7.5 0.0 8.6 10.3 13.1 23.9 24.3 8.7 7.9 23.8 18.4 8.6 14.8 30.8 15.3 17.2 15.1 10.0 8.1 11.8 12.5 6.6 9.6 9.6 32.5 6.5 17.3 33.7 23.0 21.0 63.2 17.5 8.1 23.8 BRAP "BRAP2, IMP, RNF52" ENSG00000089234 "BRCA1 associated protein" Q7Z569 12 111642146-111685986 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.9" "Group enriched" "Detected in many" 5 "Early spermatids: 224.1;Late spermatids: 273.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040357, HPA058820" Approved Supported "Nuclear membrane,Cytosol" NA NA Cytosol "Nuclear membrane" "HPA040357: AB_10967924, HPA058820: AB_2683827" "unprognostic (7.02e-2)" "unprognostic (2.37e-3)" "unprognostic (5.33e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.65e-6)" "unprognostic (2.14e-1)" "unprognostic (9.24e-3)" "unprognostic (2.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (3.66e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-2)" "unprognostic (8.08e-2)" 9.8 9.9 9.8 7.2 11.6 26.5 9.6 10.0 12.8 8.3 9.3 10.0 8.0 8.6 10.1 7.0 9.4 8.4 7.3 8.8 8.6 8.7 8.4 9.3 7.9 9.7 9.2 8.5 9.7 7.8 9.4 10.4 9.8 12.0 8.3 9.0 6.7 8.9 9.7 19.1 12.7 9.3 9.1 11.1 9.6 7.9 55.9 10.1 12.4 9.5 5.6 10.4 10.2 11.8 12.7 11.7 25.7 13.5 16.6 18.5 11.6 9.9 14.6 12.0 13.7 12.8 10.8 20.0 13.9 11.7 16.2 12.5 19.6 6.9 19.1 8.4 13.1 9.2 12.2 16.7 11.4 17.4 12.2 10.8 23.6 9.1 13.1 16.2 20.7 16.0 12.2 16.2 14.0 22.8 14.0 14.0 13.3 24.5 6.3 13.3 12.5 17.2 20.0 16.1 10.5 15.4 16.0 13.0 17.0 10.7 20.9 14.9 11.0 16.3 13.9 13.6 14.4 15.3 13.2 12.9 10.4 9.7 9.4 9.8 16.1 20.3 21.1 9.9 11.5 11.4 16.1 13.0 24.0 14.7 13.5 14.3 12.7 15.4 14.7 11.7 12.5 14.6 14.8 25.7 16.6 10.6 8.4 18.5 11.6 9.8 11.6 10.0 12.8 8.6 8.7 9.2 8.5 12.0 10.1 20.8 9.1 7.5 8.2 10.0 8.1 10.6 17.8 13.4 10.3 10.4 27.5 11.4 5.0 11.0 224.1 9.3 12.8 0.0 6.6 12.6 8.5 9.9 8.1 7.9 9.3 3.2 9.2 8.6 6.4 273.6 12.4 11.3 3.3 20.8 10.6 7.8 11.8 10.5 12.7 11.9 11.5 6.5 10.7 49.2 33.7 11.0 18.8 10.1 9.3 11.2 BRCA2 "BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11" ENSG00000139618 "BRCA2, DNA repair associated" P51587 13 32315474-32400266 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.2;testis: 16.9" "Group enriched" "Detected in many" 4 "Erythroid cells: 23.3;monocytes: 31.5;Spermatocytes: 75.1;Spermatogonia: 82.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026815 Uncertain Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA026815: AB_10602692" "unprognostic (9.36e-2)" "unprognostic (2.50e-1)" "unprognostic (4.50e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.97e-3)" "unprognostic (4.06e-2)" "unprognostic (3.07e-9)" "unprognostic (2.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.88e-1)" "unprognostic (1.32e-1)" 2.4 1.0 0.6 13.8 0.6 11.6 3.2 0.6 0.6 1.8 4.0 0.2 0.2 1.4 1.5 2.7 3.0 1.0 0.7 2.1 0.6 0.7 1.0 1.4 3.5 5.3 0.7 0.5 1.4 3.3 0.4 0.7 7.0 0.8 0.9 2.0 0.1 1.8 0.3 3.3 1.8 3.2 0.8 2.1 6.6 1.5 16.9 0.1 23.2 0.9 4.8 4.2 1.3 1.7 1.3 1.9 0.4 0.2 1.5 0.8 0.0 4.0 3.5 6.1 4.6 0.6 1.6 6.2 4.3 2.7 5.0 4.6 8.3 5.3 14.2 2.9 2.1 6.9 5.4 5.0 2.5 9.7 9.2 2.7 9.0 2.2 3.2 0.2 12.8 4.5 0.4 0.3 9.2 6.4 0.5 4.1 7.2 5.9 4.9 5.7 4.6 10.3 7.6 7.2 4.6 1.9 10.1 15.7 2.7 1.3 4.3 2.3 4.4 5.2 2.3 2.1 2.2 2.7 6.4 3.2 5.8 6.2 6.4 6.0 1.9 2.9 7.3 3.0 5.1 5.5 0.1 0.2 0.2 0.3 0.2 0.1 0.9 0.4 0.2 0.2 1.3 0.6 0.8 0.4 1.5 0.2 1.9 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.5 0.8 0.1 8.9 1.6 1.9 2.8 2.3 0.0 1.6 0.0 4.0 2.3 0.0 0.0 9.1 0.0 1.8 4.3 3.6 1.0 23.3 1.4 9.1 3.5 0.6 3.5 0.8 8.2 0.0 1.2 2.5 6.7 2.5 2.0 13.2 3.3 31.5 3.0 0.2 1.1 1.5 1.1 0.6 0.0 12.9 2.0 75.1 82.4 1.1 4.6 3.8 5.3 1.4 BRD7 "BP75, CELTIX1" ENSG00000166164 "Bromodomain containing 7" Q9NPI1 16 50313487-50368934 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042389, CAB046458, HPA060171" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214" "unprognostic (2.10e-2)" "unprognostic (9.52e-3)" "unprognostic (7.06e-2)" "unprognostic (3.39e-2)" "unprognostic (7.27e-2)" "unprognostic (1.62e-1)" "unprognostic (4.85e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.38e-4)" "unprognostic (2.15e-1)" "unprognostic (8.97e-2)" "unprognostic (9.46e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (3.59e-2)" "unprognostic (6.34e-2)" 23.5 26.9 38.8 33.7 39.0 42.2 39.1 34.5 35.9 24.5 30.7 32.4 26.4 23.4 29.0 38.1 37.3 27.1 24.4 41.2 35.3 31.9 29.9 22.9 27.9 32.1 38.4 26.9 26.8 36.5 53.3 35.1 37.9 42.6 29.5 30.3 22.2 26.9 30.7 37.9 31.2 31.1 27.2 48.1 32.1 29.0 41.5 36.4 46.1 31.2 26.5 36.4 24.5 40.0 8.8 11.2 9.6 6.8 12.3 12.1 3.7 22.3 19.7 34.7 20.6 14.7 14.6 22.9 18.4 18.2 29.1 13.2 33.1 22.8 33.4 19.3 16.3 18.1 20.7 31.7 18.5 33.6 15.1 26.3 22.6 15.8 45.7 17.3 31.1 25.0 10.6 27.9 14.9 25.8 17.7 19.3 33.2 32.6 10.7 17.7 14.5 35.2 42.0 27.2 23.6 18.8 43.4 32.6 24.2 25.4 15.8 27.0 21.9 22.3 21.7 15.0 31.0 13.0 28.3 19.4 18.5 22.5 15.2 17.8 5.1 1.9 57.1 14.5 22.7 18.3 8.2 6.8 9.6 8.8 5.7 6.8 8.0 8.9 8.1 5.4 8.8 10.1 12.1 4.0 12.3 5.1 11.2 8.5 3.7 38.8 39.0 34.5 35.9 35.3 31.9 38.4 26.9 42.6 36.4 35.7 59.7 42.5 27.5 45.1 90.5 31.9 48.4 50.9 36.4 47.1 62.8 63.5 91.2 20.0 32.8 31.4 37.2 46.7 19.9 40.7 28.7 42.0 15.0 35.5 26.0 85.8 34.5 23.9 27.0 15.6 30.2 35.5 25.3 14.4 38.2 74.8 20.8 37.0 26.5 46.0 113.1 51.8 22.1 155.1 163.9 55.3 60.5 24.9 35.5 64.3 BROX "C1orf58, FLJ32421" ENSG00000162819 "BRO1 domain and CAAX motif containing" Q5VW32 1 222712553-222735196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031445 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 190000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA031445: AB_10602697" "unprognostic (1.27e-1)" "unprognostic (4.32e-1)" "unprognostic (3.43e-2)" "unprognostic (4.60e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-1)" "unprognostic (3.31e-2)" "unprognostic (2.83e-2)" "unprognostic (2.52e-2)" "unprognostic (6.72e-2)" "unprognostic (4.27e-2)" "unprognostic (2.53e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.56e-2)" "unprognostic (1.83e-2)" "unprognostic (2.50e-2)" 24.0 21.1 22.7 15.7 25.3 33.0 22.2 21.6 24.9 17.8 23.6 22.0 13.8 19.8 18.2 15.6 30.1 17.7 18.3 14.9 22.5 20.2 22.6 21.0 18.5 22.7 30.2 22.7 21.4 16.2 28.3 21.8 28.1 29.6 17.0 23.7 11.8 21.3 17.9 23.7 23.5 33.0 16.8 27.5 22.9 23.2 12.6 30.1 24.4 25.0 22.5 19.7 21.1 19.8 8.8 13.4 30.9 21.7 14.2 15.3 8.5 25.6 15.4 9.5 8.3 13.9 14.8 18.5 17.6 22.1 14.5 16.7 8.6 33.6 8.5 21.2 21.8 7.9 22.6 10.6 16.9 22.2 10.6 9.5 12.7 17.2 8.5 15.7 14.5 12.1 13.0 16.7 18.1 21.6 16.6 13.1 5.6 19.2 11.7 17.8 7.7 6.1 7.5 12.0 21.1 18.4 6.4 28.9 19.1 17.2 25.6 10.7 16.9 19.3 22.2 13.1 9.5 26.9 14.9 18.9 20.0 11.6 20.6 19.9 8.8 14.7 7.7 16.2 12.3 18.2 30.9 15.8 18.3 12.0 21.7 13.3 8.8 15.3 12.0 13.4 8.3 10.3 13.0 27.3 14.2 21.0 7.5 13.8 8.5 22.7 25.3 21.6 24.9 22.5 20.2 30.2 22.7 29.6 30.1 68.5 33.2 19.3 26.5 43.0 16.4 34.1 30.6 77.6 30.7 48.8 7.9 23.9 48.0 33.6 16.0 24.8 34.2 46.7 28.3 27.0 25.7 39.8 15.1 22.1 32.3 33.4 30.6 33.7 50.9 16.7 22.5 40.8 47.2 35.1 45.9 31.0 43.0 40.3 30.1 41.6 19.5 51.8 26.8 21.8 22.2 40.8 43.1 43.7 38.4 39.3 BRPF1 BR140 ENSG00000156983 "Bromodomain and PHD finger containing 1" P55201 3 9731729-9748018 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003359 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003359: AB_1078217" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (6.47e-2)" "unprognostic (9.10e-2)" "unprognostic (3.42e-1)" "unprognostic (2.33e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (3.00e-1)" "unprognostic (3.72e-1)" "unprognostic (3.26e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (1.51e-3)" "unprognostic (4.86e-2)" "unprognostic (3.55e-1)" "unprognostic (6.87e-2)" "unprognostic (9.67e-3)" 10.5 7.7 6.2 10.4 8.1 29.2 10.7 16.5 13.1 10.7 9.5 10.4 5.0 6.8 14.4 8.9 10.7 12.9 10.7 7.0 5.4 4.2 8.2 5.3 10.7 12.3 8.3 7.0 12.5 9.2 11.3 9.5 9.9 7.5 9.0 6.3 9.6 12.1 8.5 11.1 14.2 10.5 8.3 5.1 12.2 9.2 23.7 11.4 24.3 12.0 7.8 11.4 11.5 9.4 1.2 3.5 2.3 1.8 9.3 4.2 1.3 5.4 8.5 8.4 4.1 5.3 4.5 43.2 6.7 4.5 7.9 5.9 7.5 4.6 9.4 3.1 6.7 7.8 4.6 8.5 6.8 5.7 9.9 9.1 12.1 16.9 5.0 6.2 17.1 11.3 5.7 5.7 11.7 7.0 4.4 6.1 9.8 12.8 9.5 4.9 13.1 10.7 14.1 10.7 4.0 8.0 14.4 5.9 6.5 4.2 8.6 5.0 7.8 7.3 5.2 6.2 5.5 5.3 16.7 7.7 9.4 8.0 8.0 12.4 7.7 8.6 17.4 7.3 14.1 8.0 2.2 1.8 2.3 2.7 1.6 4.2 1.1 2.1 2.5 1.5 1.2 2.5 2.9 1.3 9.3 1.5 3.5 1.3 1.3 6.2 8.1 16.5 13.1 5.4 4.2 8.3 7.0 7.5 11.4 14.9 10.6 4.5 4.7 12.6 4.4 3.5 0.0 4.0 7.9 7.0 5.9 3.6 0.0 3.6 1.6 7.5 4.4 0.0 4.7 4.6 4.1 4.4 8.1 2.4 5.5 7.9 9.8 8.6 4.8 0.4 6.1 5.2 1.7 1.0 5.0 4.5 4.3 2.9 5.6 1.8 3.8 6.5 4.7 15.8 11.7 16.2 3.1 7.5 5.8 5.5 BRWD1 "C21orf107, DCAF19, FLJ11315, N143, WDR9" ENSG00000185658 "Bromodomain and WD repeat domain containing 1" Q9NSI6 21 39184176-39321559 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030943, HPA030944, HPA030945, CAB034184" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161" "unprognostic (6.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (4.94e-2)" "unprognostic (5.01e-2)" "unprognostic (8.90e-2)" "unprognostic (2.26e-1)" "unprognostic (4.82e-3)" "unprognostic (5.45e-2)" "unprognostic (2.58e-3)" "unprognostic (6.48e-2)" "unprognostic (1.19e-1)" "unprognostic (3.88e-2)" "unprognostic (2.56e-2)" 10.9 16.7 33.0 15.4 36.8 13.4 16.3 15.5 40.2 12.3 12.0 14.3 10.5 8.8 13.0 21.1 10.2 11.8 9.9 12.9 29.1 32.9 13.9 21.8 10.0 12.9 24.3 17.7 16.2 17.2 12.8 12.0 15.2 13.4 13.2 11.5 13.0 9.3 11.8 14.6 11.9 9.6 13.1 16.1 9.6 9.9 17.2 10.5 22.4 17.7 9.3 13.2 12.1 11.6 8.5 7.2 11.6 6.1 10.2 11.1 3.8 10.2 4.1 10.1 5.6 6.5 9.8 10.4 5.9 6.9 4.6 5.4 3.9 7.0 32.9 6.2 8.0 5.5 5.1 9.4 6.8 7.3 7.6 7.7 22.3 7.2 7.1 8.2 12.3 6.3 6.7 11.2 6.3 16.0 10.7 6.8 21.0 16.5 16.6 6.4 7.9 8.4 14.5 10.6 12.4 5.8 14.9 7.8 10.4 5.6 6.6 8.0 10.3 12.6 15.2 8.7 3.9 12.9 17.2 7.5 6.1 2.9 3.5 4.4 18.5 12.7 16.0 7.3 13.2 4.8 4.4 5.2 11.6 10.7 6.1 8.3 8.5 9.2 11.0 7.2 6.3 11.1 9.0 5.7 10.2 3.8 6.8 10.3 3.8 33.0 36.8 15.5 40.0 29.1 32.9 24.3 17.7 13.4 10.5 44.7 40.4 19.5 36.5 56.1 63.7 54.9 17.8 49.5 39.8 17.4 110.0 50.0 38.1 24.8 41.9 37.6 30.2 23.3 30.0 38.8 37.9 51.4 31.3 31.6 22.1 69.9 34.0 33.2 35.6 16.8 40.0 27.5 28.7 23.4 35.9 35.9 32.0 28.1 42.1 28.1 103.4 25.8 37.3 85.4 77.1 61.5 83.5 38.9 34.2 55.4 BRWD3 "FLJ38568, MRX93" ENSG00000165288 "Bromodomain and WD repeat domain containing 3" Q6RI45 X 80670854-80809688 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012802 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012802: AB_2066662" "unprognostic (1.13e-2)" "unprognostic (2.14e-1)" "unprognostic (2.85e-1)" "unprognostic (3.17e-3)" "unprognostic (7.04e-3)" "unprognostic (2.00e-1)" "unprognostic (1.50e-1)" "unprognostic (7.18e-2)" "unprognostic (7.44e-2)" "unprognostic (2.75e-1)" "unprognostic (7.18e-2)" "unprognostic (1.62e-2)" "unprognostic (1.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.01e-1)" "unprognostic (3.35e-1)" 7.7 5.7 7.5 9.1 7.7 10.5 13.0 20.9 8.5 9.3 8.2 5.6 8.6 8.5 8.0 6.2 10.8 8.1 6.3 5.0 7.4 4.6 5.6 7.5 12.7 9.3 5.3 5.5 11.9 7.8 7.3 12.5 8.6 6.5 6.7 8.1 7.7 8.2 11.3 3.7 14.0 10.3 5.8 12.7 8.9 7.3 9.3 7.1 10.1 9.0 6.0 9.1 10.7 12.7 1.1 0.7 2.8 1.1 0.5 1.2 0.5 4.6 5.1 7.7 5.1 3.1 3.9 5.6 2.7 2.4 3.5 4.8 2.3 6.5 5.0 6.4 2.5 4.3 8.3 11.8 4.6 4.7 4.3 4.8 10.2 8.2 3.5 2.3 5.8 6.9 2.6 3.2 4.0 5.5 5.1 5.3 4.5 7.4 12.7 4.0 0.8 3.3 5.4 11.8 5.1 2.1 3.0 13.5 2.9 4.0 4.0 1.8 4.4 6.6 3.6 2.9 15.1 1.6 5.7 4.8 4.1 5.2 3.8 2.9 5.6 5.9 6.0 3.3 11.8 2.7 0.5 1.1 0.7 0.8 0.9 0.8 0.7 0.8 0.7 0.6 1.1 0.6 1.2 2.8 0.5 0.8 0.7 0.6 0.5 7.5 7.7 20.9 8.5 7.4 4.6 5.3 5.5 6.5 7.1 11.9 11.2 7.5 6.9 15.5 23.2 7.7 15.3 4.0 18.2 5.2 15.7 4.9 0.0 5.3 0.9 10.5 12.9 0.0 5.2 6.5 8.2 9.4 10.5 5.8 4.7 58.8 6.9 5.5 10.3 3.0 9.2 12.7 1.7 1.8 10.2 10.8 8.4 21.0 9.6 3.1 21.0 6.5 7.6 6.6 8.3 18.2 6.4 10.0 10.2 19.5 BSPRY FLJ20150 ENSG00000119411 "B-box and SPRY domain containing" Q5W0U4 9 113349541-113371233 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 67.7;salivary gland: 68.2" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 59.2;Exocrine glandular cells: 58.0;Pancreatic endocrine cells: 56.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 20.8" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 8.0" "Cell line enhanced" "Detected in some" "A-431: 18.1;CAPAN-2: 11.6;MCF7: 27.0;OE19: 31.4;RPMI-8226: 14.1;SK-BR-3: 13.6;T-47d: 13.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042889, HPA077485" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042889: AB_10795515, HPA077485: " "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "unprognostic (1.18e-1)" "unprognostic (2.20e-3)" "unprognostic (1.68e-1)" "unprognostic (2.10e-3)" "unprognostic (4.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (1.95e-2)" "prognostic favorable (4.56e-14)" "unprognostic (1.15e-3)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.70e-1)" 0.2 1.6 1.0 4.6 20.8 2.1 6.1 4.1 1.4 2.9 5.4 0.4 7.9 3.6 1.0 6.4 14.2 1.9 8.5 1.4 0.6 0.7 9.3 0.4 4.1 0.6 0.7 1.3 0.3 37.8 67.7 10.1 1.7 0.6 2.4 4.5 2.7 68.2 4.8 0.1 12.4 6.8 0.4 0.3 0.3 10.4 2.1 1.8 1.2 28.2 10.7 5.4 1.5 3.2 0.0 8.0 0.0 0.0 0.0 0.4 0.1 18.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.8 11.6 0.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 2.0 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 9.4 0.1 0.0 0.0 27.0 0.3 0.0 0.4 31.4 0.0 0.4 0.0 14.1 1.8 3.9 6.2 0.0 0.0 13.6 0.0 0.8 13.7 1.9 0.0 0.0 0.0 0.0 0.0 4.4 5.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.0 0.0 0.1 1.0 20.8 4.1 1.4 0.6 0.7 0.7 1.3 0.6 1.8 6.0 5.8 2.4 1.7 0.9 0.6 1.6 15.3 2.7 4.5 26.2 5.9 8.1 33.2 59.2 0.1 0.1 12.9 0.0 58.0 0.7 0.4 15.4 3.5 0.8 1.2 0.0 19.7 0.0 0.0 0.2 0.0 0.1 10.1 1.8 19.3 0.3 56.5 14.0 0.0 15.3 9.1 0.0 0.0 0.5 2.3 12.4 5.6 0.5 24.3 13.9 BST2 "CD317, tetherin" ENSG00000130303 "Bone marrow stromal cell antigen 2" Q10589 19 17402939-17405648 "CD markers, Plasma proteins, Predicted membrane proteins" "Antiviral defense, B-cell activation, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 101.0" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 338.9;Ito cells: 362.2;Leydig cells: 321.0;Peritubular cells: 394.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 79.0;Karpas-707: 76.6" HPA017060 Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA017060: AB_1845467" "prognostic favorable (6.69e-4)" "unprognostic (1.75e-1)" "unprognostic (8.42e-3)" "unprognostic (8.93e-3)" "unprognostic (4.87e-2)" "unprognostic (2.25e-1)" "unprognostic (2.26e-1)" "unprognostic (1.07e-1)" "unprognostic (3.25e-1)" "unprognostic (6.46e-2)" "unprognostic (6.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.56e-9)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" 29.6 72.2 8.4 31.1 9.8 13.6 27.9 2.5 7.6 14.4 12.0 5.6 24.8 6.9 13.4 36.7 8.6 26.8 30.1 13.9 7.9 4.9 24.7 30.8 44.9 16.6 10.0 5.2 101.0 6.9 0.3 8.6 31.5 8.8 15.6 4.8 8.4 11.4 17.5 6.0 3.2 14.0 11.3 9.0 32.9 12.3 8.5 9.4 10.3 10.3 5.9 12.3 14.0 42.4 26.2 74.1 35.8 66.4 57.9 32.6 54.5 39.6 0.0 0.1 18.3 0.0 0.1 6.3 0.1 3.1 58.6 79.0 18.6 35.8 30.8 43.3 24.4 1.8 0.1 26.7 2.9 1.8 33.9 0.2 0.4 64.3 18.1 33.6 14.5 39.0 0.1 0.0 19.4 0.0 0.5 14.9 0.7 17.5 76.6 0.0 10.9 6.9 25.4 20.1 0.0 51.4 12.9 0.1 64.2 13.9 0.1 0.0 0.1 40.5 1.5 48.8 1.6 30.7 20.5 0.1 0.2 1.4 0.0 0.4 39.6 51.6 20.4 0.1 57.4 0.2 35.8 61.6 21.0 32.6 66.4 30.8 21.0 27.5 30.2 50.7 26.2 22.5 25.6 20.3 57.9 59.3 74.1 24.8 54.5 8.4 9.8 2.5 7.6 7.9 4.9 10.0 5.2 8.8 9.4 53.6 16.5 81.0 13.1 29.5 0.0 4.5 50.9 14.7 38.7 47.1 0.0 7.1 31.5 19.8 9.9 239.7 1.6 0.0 1.0 55.9 84.0 7.2 225.9 155.9 338.9 0.0 1.2 362.2 153.7 4.5 321.0 191.2 70.9 239.0 1.4 1.3 2.2 3.5 394.2 0.7 1.9 161.7 150.2 1.4 1.2 22.8 11.0 126.9 2.6 30.3 BTBD11 "ABTB2B, FLJ33957" ENSG00000151136 "BTB domain containing 11" A6QL63 12 107318413-107659642 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 61.8" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 4.6;Peritubular cells: 3.9;Suprabasal keratinocytes: 6.8;Urothelial cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 7.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 19.3;Hep G2: 10.2;MOLT-4: 12.9;PC-3: 9.1;RT4: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055898, HPA061334" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055898: AB_2682964, HPA061334: " "unprognostic (3.40e-2)" "unprognostic (4.06e-1)" "unprognostic (2.37e-1)" "unprognostic (7.85e-2)" "unprognostic (8.78e-3)" "unprognostic (4.82e-2)" "unprognostic (3.52e-1)" "unprognostic (2.12e-1)" "unprognostic (1.52e-1)" "unprognostic (5.92e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.92e-8)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (3.33e-2)" "unprognostic (9.07e-3)" 0.9 1.1 3.7 2.4 6.6 3.3 2.7 4.6 10.2 6.8 1.0 2.2 3.2 1.1 1.3 1.5 24.1 0.8 1.2 1.0 2.9 9.4 3.7 1.4 1.0 4.0 8.3 3.0 0.6 1.2 61.8 3.2 2.0 19.0 3.1 1.0 1.7 6.2 1.6 0.9 8.4 1.6 1.0 4.9 1.5 1.0 1.1 1.2 24.8 14.4 9.5 9.0 2.3 7.9 0.3 1.3 2.8 0.8 0.3 7.2 1.2 0.1 19.3 3.9 0.0 1.5 0.4 0.0 0.4 0.0 0.2 0.0 0.2 3.1 0.0 4.8 0.1 1.8 7.0 3.9 7.3 0.2 0.0 1.2 0.0 0.1 10.2 0.0 0.1 0.0 1.6 3.1 0.0 2.3 3.0 0.5 8.0 0.0 0.0 0.1 0.6 12.9 1.5 4.0 0.4 9.1 0.0 6.2 0.0 0.0 8.7 5.0 1.9 0.0 0.2 0.0 0.4 0.4 0.5 0.8 0.0 0.2 0.0 1.5 0.0 0.0 0.0 5.1 2.0 0.0 1.3 0.8 1.1 2.1 0.3 7.2 0.1 2.4 1.4 1.3 0.3 3.0 2.7 2.8 0.3 0.6 0.2 1.1 1.2 3.7 6.6 4.6 10.2 2.9 9.4 8.3 3.0 19.0 1.2 0.0 0.0 0.0 3.1 4.6 1.0 1.7 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.8 0.0 0.5 0.3 1.6 3.4 0.0 0.8 0.0 0.6 2.0 0.0 0.0 0.0 0.3 0.2 0.0 3.9 0.6 0.3 0.0 1.1 0.0 0.0 6.8 0.3 0.0 0.0 3.8 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271306-122338162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 9.1;testis: 27.6;urinary bladder: 17.9" "Group enriched" "Detected in some" 19 "Early spermatids: 100.4;Late spermatids: 53.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 29 "T-reg: 2.8" "Lineage enriched" "Detected in single" 29 "T-cells: 2.8" "Cell line enriched" "Detected in some" 8 "RT4: 27.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Yes NA Nucleoli Cytosol "HPA040529: AB_2677022, HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.3 0.0 0.6 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.6 0.3 0.3 0.2 0.3 0.3 0.9 0.4 0.3 4.4 0.3 0.3 1.2 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 0.3 9.1 0.3 0.3 2.3 0.3 0.0 27.6 0.3 0.3 0.3 0.3 0.3 17.9 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.3 27.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.6 0.5 0.3 0.3 0.9 0.4 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.2 2.5 0.0 0.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.9 100.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 53.9 0.6 0.0 0.0 0.0 0.0 0.0 1.3 2.9 0.4 0.8 0.0 0.0 0.2 3.7 0.9 2.8 0.1 0.0 0.0 0.8 BTBD19 ENSG00000222009 "BTB domain containing 19" C9JJ37 1 44808482-44815585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 7.0;HUVEC TERT2: 6.4;TIME: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042633, HPA076404" Uncertain Uncertain Cytosol NA NA Cytosol "HPA042633: AB_2678091, HPA076404: AB_2686796" "unprognostic (4.69e-2)" "unprognostic (8.74e-3)" "unprognostic (1.82e-3)" "unprognostic (1.20e-4)" "unprognostic (5.32e-2)" "unprognostic (3.80e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.70e-1)" "unprognostic (1.53e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.18e-8)" "unprognostic (2.20e-3)" "unprognostic (2.78e-2)" "unprognostic (8.29e-2)" "unprognostic (1.70e-1)" 6.7 8.7 3.5 3.6 1.9 2.7 4.9 0.6 2.8 13.5 2.0 2.4 6.2 1.6 13.9 21.4 2.1 6.4 4.2 3.8 1.3 1.4 4.2 2.2 4.1 1.8 1.4 4.0 8.4 1.5 3.2 11.9 7.9 6.3 5.6 1.8 7.6 1.7 8.3 1.8 1.2 2.2 5.6 1.9 2.3 2.2 3.5 0.6 0.1 6.0 2.0 1.4 2.1 4.3 0.0 0.2 2.3 0.1 0.0 0.2 0.0 0.1 1.1 1.0 1.1 2.3 2.6 0.7 2.1 1.3 1.0 2.0 0.0 0.8 0.1 1.0 3.7 0.5 0.3 0.0 1.1 0.4 0.9 0.2 2.0 0.3 1.1 2.3 0.0 1.6 3.9 0.1 3.7 0.7 7.0 6.4 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.3 0.1 1.2 1.3 0.0 0.0 14.9 3.8 3.0 1.8 1.6 0.5 0.1 0.0 2.3 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 3.5 1.9 0.6 2.8 1.3 1.4 1.4 4.0 6.3 0.6 3.0 3.4 0.0 1.6 1.8 0.0 1.0 2.5 1.4 4.5 1.8 0.0 0.2 0.0 0.9 0.4 3.5 2.1 0.0 0.5 0.2 3.8 0.9 2.3 2.8 2.7 0.0 0.0 3.7 6.0 0.0 2.8 4.6 3.3 0.0 1.3 1.5 0.8 0.8 1.1 2.7 0.0 0.0 4.6 0.7 0.2 1.9 1.0 0.0 0.7 1.3 BTF3 "BTF3a, BTF3b, NACB" ENSG00000145741 "Basic transcription factor 3" P20290 5 73498408-73505635 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013007, HPA056420" Approved Supported Cytosol NA Yes 100000 Cytosol "CAB013007: , HPA056420: AB_2683125" "unprognostic (3.48e-3)" "unprognostic (2.11e-1)" "unprognostic (2.87e-3)" "unprognostic (1.86e-1)" "unprognostic (6.25e-2)" "unprognostic (1.41e-1)" "unprognostic (1.90e-3)" "unprognostic (1.78e-2)" "unprognostic (8.20e-3)" "unprognostic (5.18e-2)" "unprognostic (8.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (1.06e-1)" "unprognostic (2.87e-1)" "unprognostic (1.26e-2)" "unprognostic (2.16e-1)" 98.4 64.4 44.7 67.6 40.8 98.2 105.6 38.2 49.0 111.8 87.3 45.8 69.7 62.2 107.5 67.3 141.3 75.1 68.7 69.1 40.7 41.3 74.4 107.7 66.6 100.6 46.7 41.6 172.4 111.0 44.3 44.5 90.8 44.8 110.9 75.1 53.0 102.7 76.0 157.9 107.7 87.7 95.7 53.2 84.4 76.9 56.5 41.0 132.6 123.5 131.7 113.4 135.1 88.0 89.0 104.4 19.3 77.0 75.6 102.1 159.0 96.6 64.9 70.5 100.6 70.8 119.4 110.6 67.6 95.2 118.3 114.0 83.4 110.7 146.6 106.9 70.4 85.8 68.4 102.5 174.9 136.0 60.6 131.5 82.9 62.4 108.8 103.2 78.4 67.0 103.4 139.7 76.1 141.3 135.5 107.4 84.4 77.1 95.4 99.5 87.9 117.5 147.2 89.6 36.1 65.3 89.9 83.8 181.8 124.4 97.7 82.8 110.5 66.4 75.8 135.9 69.3 97.6 161.8 77.1 51.3 69.8 61.1 182.4 89.9 91.5 136.5 67.9 120.2 75.4 19.3 77.0 19.3 52.5 60.9 88.6 89.0 89.8 73.3 104.4 71.3 99.5 87.1 10.8 75.6 47.8 58.7 102.1 159.0 44.7 40.8 38.2 49.0 40.7 41.3 46.7 41.6 44.8 41.0 229.3 278.1 715.0 1745.8 1743.2 127.7 303.1 473.9 325.2 444.7 307.1 41.2 1161.2 771.0 802.1 569.6 816.5 667.0 303.7 1060.8 1748.3 874.0 889.8 408.6 437.5 930.1 81.0 569.4 571.5 843.2 380.0 1155.8 1046.3 750.8 1202.0 941.3 218.3 1129.2 785.5 795.5 944.8 96.9 633.8 1145.4 210.5 145.7 1707.3 1431.9 885.4 1216.6 1923.9 BTF3L4 MGC23908 ENSG00000134717 "Basic transcription factor 3 like 4" Q96K17 1 52056125-52090716 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067026 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA067026: AB_2685765" "unprognostic (6.12e-2)" "unprognostic (6.33e-2)" "unprognostic (5.09e-2)" "unprognostic (8.83e-3)" "unprognostic (1.42e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (6.73e-8)" "unprognostic (8.85e-2)" "unprognostic (5.59e-2)" "unprognostic (1.71e-3)" "unprognostic (2.61e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.43e-6)" "unprognostic (1.62e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (8.56e-2)" 22.3 29.1 20.6 14.8 22.1 26.7 26.2 25.5 52.3 17.5 12.8 17.2 8.4 7.1 19.5 16.7 20.3 19.6 12.5 28.4 23.7 22.4 18.5 20.8 19.6 38.8 20.4 23.8 29.2 47.6 21.0 24.3 19.1 16.7 15.7 12.6 16.5 26.4 13.5 36.9 19.3 9.8 22.4 23.1 14.1 14.2 19.2 14.6 20.7 22.9 13.6 20.4 19.0 16.2 23.2 34.1 32.2 36.0 21.3 28.2 27.9 28.0 6.8 33.5 17.5 18.1 23.3 34.7 27.8 28.0 31.9 34.4 12.4 14.7 26.2 28.0 19.5 37.7 16.4 32.3 21.7 40.9 18.1 22.6 30.0 12.5 18.5 49.6 33.2 20.8 23.9 30.0 29.5 41.7 26.5 25.2 21.7 22.6 16.7 28.6 12.0 22.9 19.7 59.6 21.8 15.0 15.2 39.0 30.8 30.8 22.6 26.4 29.9 32.5 30.1 40.0 38.8 27.2 35.6 18.4 18.0 19.5 23.2 32.7 29.3 48.3 25.6 15.6 25.9 22.6 24.1 35.4 32.2 15.0 36.0 20.1 23.2 21.7 15.4 34.1 22.1 25.4 19.4 15.1 21.3 31.0 16.1 28.2 27.9 20.6 22.1 25.5 52.3 23.7 22.4 20.4 23.8 16.7 14.6 32.8 18.2 57.0 77.6 95.7 41.1 40.3 43.3 40.2 31.8 66.3 31.4 99.7 142.6 93.1 81.2 49.3 16.0 93.5 69.0 113.3 65.9 74.4 22.0 66.1 115.8 36.5 50.2 45.4 117.9 13.6 67.0 77.6 74.2 55.9 28.5 42.6 74.2 28.1 52.3 110.7 28.6 58.2 77.3 111.6 14.3 140.0 122.0 50.7 33.3 87.5 BTG1 APRO2 ENSG00000133639 "BTG anti-proliferation factor 1" P62324 12 92140278-92145897 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 190.7" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 2444.1;Suprabasal keratinocytes: 2626.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005972 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005972: AB_1078303" "prognostic favorable (4.36e-5)" "unprognostic (1.43e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-3)" "unprognostic (1.10e-1)" "unprognostic (5.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (2.50e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.95e-7)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (5.79e-2)" "unprognostic (9.81e-2)" 52.0 22.1 11.5 58.3 13.4 126.9 114.4 66.8 10.4 41.7 40.1 5.5 21.9 15.5 30.1 22.0 28.7 27.9 39.9 49.2 11.9 8.1 22.2 58.1 85.6 190.7 10.4 8.2 29.1 64.2 17.6 17.1 23.4 13.3 28.7 18.1 21.0 19.0 25.9 31.6 70.6 34.3 26.0 24.6 77.1 26.4 19.0 8.9 148.9 15.7 14.3 58.2 54.2 35.2 58.3 6.6 94.3 14.0 47.1 95.2 26.1 7.0 8.8 9.7 1.1 36.3 50.4 4.2 7.9 17.4 5.3 5.3 5.2 2.4 7.5 1.6 8.3 8.4 4.8 3.2 8.8 9.9 9.0 6.8 1.5 6.1 2.7 36.8 5.5 2.6 43.0 26.7 12.1 37.5 23.5 10.6 5.0 5.2 10.0 6.0 7.2 3.9 17.7 2.3 7.7 10.0 13.4 5.4 2.3 16.3 14.6 5.4 10.8 9.8 7.6 25.5 7.8 32.0 12.8 3.4 6.0 1.8 4.6 4.8 13.8 7.4 12.5 4.7 4.4 6.7 22.3 13.6 94.3 17.0 10.6 20.1 44.5 34.3 29.8 6.6 58.3 95.2 39.1 52.3 47.1 14.0 6.2 39.2 26.1 11.5 13.4 66.8 10.4 11.9 8.1 10.4 8.2 13.3 8.9 89.3 164.0 1133.8 898.4 2444.1 509.3 99.7 695.5 18.7 63.7 165.7 184.6 344.9 271.9 357.5 306.7 258.8 666.0 140.2 222.2 261.3 225.7 728.6 288.8 235.3 359.2 400.5 434.2 206.2 468.4 134.9 265.8 682.9 933.0 1485.2 192.1 767.8 308.3 596.2 227.4 96.3 342.5 530.3 1116.5 68.9 113.5 2626.0 1122.8 1563.2 226.0 1040.3 BTK "AGMX1, ATK, IMD1, PSCTK1, XLA" ENSG00000010671 "Bruton tyrosine kinase" Q06187 X 101349447-101390796 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 77.5;lymphoid tissue: 37.0" "Cell type enhanced" "Detected in some" 19 "B-cells: 86.8;granulocytes: 203.6;Hofbauer cells: 50.3;Kupffer cells: 53.4;Macrophages: 53.0;monocytes: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 77.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 29.5;HEL: 40.9;HMC-1: 147.5;U-937: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001198, HPA002028, CAB016689" Enhanced Supported "Plasma membrane,Cytosol" NA NA 610000 "Plasma membrane, Cytosol" "CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306" "unprognostic (3.19e-2)" "unprognostic (2.51e-3)" "unprognostic (1.06e-2)" "unprognostic (3.66e-2)" "unprognostic (5.69e-2)" "unprognostic (3.76e-3)" "unprognostic (6.55e-2)" "unprognostic (3.58e-3)" "unprognostic (6.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (2.08e-3)" "unprognostic (7.80e-2)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (8.14e-2)" 7.3 2.4 3.3 23.5 5.6 14.0 2.6 0.8 3.6 2.3 3.0 4.7 0.3 2.2 1.9 2.6 2.4 2.0 3.7 3.3 3.3 2.5 2.2 2.5 10.7 25.1 5.4 1.2 1.2 1.5 0.2 1.4 3.2 4.1 2.5 4.5 1.5 3.2 1.0 1.0 2.5 12.9 3.3 10.8 37.0 3.1 1.3 6.3 4.0 1.7 1.8 36.7 5.8 2.0 13.7 13.2 77.5 20.7 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 16.4 147.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 11.5 0.2 0.0 0.0 12.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.3 0.2 14.0 0.0 21.4 0.0 77.5 11.3 19.3 0.0 18.1 0.0 13.7 0.0 0.0 13.2 13.7 0.0 0.0 4.5 0.0 20.7 6.0 0.0 6.1 3.3 5.6 0.8 3.6 3.3 2.5 5.4 1.2 4.1 6.3 3.0 12.8 86.8 0.1 0.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.2 0.6 0.0 23.3 0.0 0.4 0.5 0.0 203.6 0.0 50.3 0.0 0.0 1.3 53.4 0.0 0.3 53.0 3.3 52.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.4 1.6 0.3 1.6 0.8 0.0 0.1 BTRC "beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1" ENSG00000166167 "Beta-transducin repeat containing E3 ubiquitin protein ligase" Q9Y297 10 101354033-101557321 "Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031156, CAB032986" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB032986: AB_2243598, HPA031156: AB_2673764" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (8.88e-2)" "unprognostic (2.09e-1)" "unprognostic (3.55e-1)" "unprognostic (2.73e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-3)" "unprognostic (5.05e-1)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (2.23e-1)" 6.6 11.2 16.0 7.3 23.1 3.6 11.8 16.2 28.0 10.2 6.6 10.7 13.7 5.4 8.8 14.5 11.5 10.8 8.1 18.6 15.7 18.3 11.6 7.1 6.8 5.3 14.3 15.3 15.5 8.6 21.5 17.3 10.4 13.5 12.2 7.0 11.9 9.0 8.7 14.1 9.0 5.4 9.7 10.2 7.5 6.4 17.9 9.0 6.3 11.4 7.1 7.5 7.3 9.8 5.2 4.8 3.9 3.7 5.1 8.1 3.4 6.3 9.7 13.7 15.8 13.4 11.7 4.9 9.1 14.8 9.6 8.0 6.8 5.0 10.4 9.3 7.8 9.9 9.9 11.2 9.9 10.4 6.8 8.9 7.5 6.1 8.8 7.1 11.0 4.1 7.1 11.6 8.2 14.7 19.0 11.8 9.7 8.1 3.5 9.2 5.4 7.4 5.5 6.3 7.1 7.7 9.3 19.2 2.1 8.8 4.1 10.2 8.7 6.0 2.7 8.5 16.6 7.4 3.8 9.9 5.1 8.0 6.5 6.4 5.8 12.6 6.6 5.0 5.5 3.4 3.8 3.7 3.9 6.1 3.1 6.1 5.2 6.5 5.5 4.8 4.4 8.1 6.5 2.4 5.1 3.1 2.4 5.6 3.4 16.0 23.1 16.2 23.3 15.7 18.3 14.3 15.3 13.5 9.0 3.0 10.3 4.2 3.6 4.9 29.4 27.1 10.2 12.0 10.3 3.5 27.5 9.5 6.6 8.4 26.8 6.6 4.5 0.0 6.3 6.2 8.2 6.1 12.8 4.9 4.9 15.9 2.9 5.5 2.8 14.1 8.3 3.3 1.7 3.6 4.1 14.1 7.2 3.5 9.9 8.0 24.9 6.5 3.1 31.8 17.1 6.1 10.4 5.1 4.5 5.9 BUB1 "BUB1A, BUB1L, hBUB1" ENSG00000169679 "BUB1 mitotic checkpoint serine/threonine kinase" O43683 2 110637698-110678114 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 56.5;testis: 30.9" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "T-reg: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 68.1" "Not detected" "Not detected" HPA006123 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA006123: AB_1845498" "unprognostic (7.74e-2)" "unprognostic (3.45e-2)" "unprognostic (9.72e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.61e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (1.03e-5)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.26e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (1.76e-1)" "unprognostic (0.00e+0)" "unprognostic (2.45e-2)" "unprognostic (3.64e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" 1.1 0.9 0.5 15.8 1.0 8.9 0.6 0.3 1.0 1.2 2.8 0.4 0.0 2.4 0.7 2.3 5.8 0.5 1.0 1.1 0.5 0.5 0.9 0.8 2.1 11.6 0.6 0.2 1.0 0.7 0.0 0.4 2.4 0.5 0.7 4.3 0.4 1.4 0.0 0.5 1.8 3.1 1.4 1.3 7.9 1.8 30.9 0.1 56.5 0.6 5.7 12.1 2.5 2.0 1.8 2.4 3.0 0.2 1.4 6.1 1.1 30.3 8.9 23.4 14.7 1.0 1.7 12.4 15.8 10.4 27.5 20.8 18.7 17.5 20.6 9.8 9.1 25.8 13.3 29.9 11.5 34.2 16.3 14.6 68.1 9.5 14.9 0.2 19.6 19.3 0.4 0.7 21.2 10.5 3.9 16.1 23.1 29.8 43.0 22.5 10.0 32.8 16.4 22.6 10.8 16.9 21.8 20.0 31.4 5.6 9.6 15.7 6.8 11.2 9.6 8.5 14.9 7.5 16.6 6.6 12.5 20.5 9.4 21.9 22.5 21.1 25.3 8.5 15.2 22.0 3.0 0.0 0.7 0.6 0.2 0.9 1.8 2.5 1.0 0.8 1.4 1.6 1.5 0.0 1.4 0.1 2.4 6.1 1.1 0.5 1.0 0.3 1.0 0.5 0.5 0.6 0.2 0.5 0.1 0.0 1.0 7.8 0.2 0.5 0.0 0.8 0.0 1.4 2.3 0.0 0.0 1.3 0.0 0.2 8.3 0.0 0.0 0.0 0.0 8.1 0.3 0.2 0.0 0.2 6.6 0.0 0.0 1.3 1.3 4.7 0.3 1.7 0.0 1.0 0.9 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.0 68.0 14.1 0.4 0.6 2.5 2.0 0.9 BUB1B "Bub1A, BUBR1, MAD3L, SSK1" ENSG00000156970 "BUB1 mitotic checkpoint serine/threonine kinase B" O60566 15 40161023-40221136 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.5;testis: 25.6" "Group enriched" "Detected in many" 7 "Spermatocytes: 66.9;Spermatogonia: 28.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.8;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA008419 Supported Cytosol Yes Yes Cytosol "HPA008419: AB_1078308" "unprognostic (4.40e-2)" "unprognostic (2.23e-1)" "unprognostic (4.65e-2)" "unprognostic (2.44e-3)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (7.43e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.69e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.75e-2)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (3.94e-2)" 1.0 0.9 0.3 18.4 0.6 11.4 1.5 0.4 0.5 1.3 4.0 0.4 0.1 3.3 1.1 0.8 6.5 0.5 1.1 0.6 0.4 0.4 0.8 0.7 1.8 8.7 0.4 0.3 0.6 0.5 0.0 0.4 3.4 0.5 0.6 4.4 0.3 1.6 0.1 0.7 2.3 2.9 1.2 0.6 5.4 1.7 25.6 0.1 49.5 0.5 3.1 10.6 1.1 2.0 2.8 2.8 0.0 0.2 0.7 0.7 0.5 21.8 11.1 35.5 14.1 0.9 2.5 11.5 20.8 11.7 22.3 19.4 16.2 8.4 19.8 11.7 7.5 20.5 24.7 33.5 11.3 24.3 17.0 18.0 28.9 28.7 15.0 0.0 26.1 15.9 0.5 0.6 13.6 12.8 4.4 16.1 22.9 24.9 21.1 22.2 7.4 20.4 15.9 24.0 18.4 12.7 21.9 29.2 15.0 6.8 11.1 23.2 14.3 12.8 12.3 4.5 16.2 14.3 13.5 9.3 17.1 18.1 17.0 18.4 11.1 18.8 32.4 9.1 29.3 22.2 0.0 0.0 0.0 0.2 0.2 0.3 2.4 0.7 0.6 0.7 2.8 0.1 0.4 0.0 0.7 0.1 2.8 0.0 0.5 0.3 0.6 0.4 0.5 0.4 0.4 0.4 0.3 0.5 0.1 3.0 1.4 0.8 0.3 0.7 0.4 0.4 0.0 0.0 3.4 0.0 0.0 1.3 0.0 0.3 2.5 0.0 0.3 0.0 0.0 5.1 0.4 0.2 0.0 0.2 4.3 0.0 0.0 1.3 0.6 2.4 1.4 1.5 0.0 0.0 1.4 0.0 0.8 0.8 0.4 0.0 0.1 6.5 0.0 66.9 28.8 0.3 0.7 0.8 1.7 0.4 BZW2 "HSPC028, MST017, MSTP017" ENSG00000136261 "Basic leucine zipper and W2 domains 2" Q9Y6E2 7 16646131-16706523 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 104.4;skeletal muscle: 89.7" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 786.3;Syncytiotrophoblasts: 638.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022813, HPA026709" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Actin filaments, Cytosol" "HPA022813: AB_1845511, HPA026709: AB_10600752" "unprognostic (2.27e-3)" "unprognostic (1.77e-3)" "unprognostic (5.91e-2)" "unprognostic (4.79e-3)" "unprognostic (2.80e-2)" "unprognostic (7.08e-3)" "prognostic unfavorable (7.86e-8)" "unprognostic (9.13e-3)" "unprognostic (8.49e-3)" "unprognostic (2.81e-2)" "unprognostic (1.83e-3)" "unprognostic (3.37e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.00e-1)" "unprognostic (1.66e-1)" "unprognostic (6.77e-2)" "unprognostic (1.25e-1)" 10.6 7.2 4.2 7.8 8.5 10.1 13.5 3.4 8.9 7.9 13.6 3.4 22.0 7.7 7.6 7.6 17.9 7.1 6.1 70.8 4.4 2.8 8.4 10.2 8.1 11.4 3.5 5.8 6.4 12.3 1.8 5.7 104.4 2.5 9.8 16.2 13.2 10.1 25.3 89.7 16.8 8.0 16.6 2.8 8.4 15.6 3.5 3.4 14.5 13.6 41.1 11.1 16.8 10.3 17.2 37.3 1.7 20.3 20.1 23.6 16.3 17.0 16.5 28.1 40.6 13.8 24.4 25.2 24.3 32.0 24.1 25.6 40.0 25.9 39.7 29.0 18.8 17.6 35.5 33.1 27.8 31.9 5.3 19.1 24.8 18.7 22.5 14.3 33.8 15.6 18.7 15.1 21.0 38.8 18.7 34.3 29.2 47.3 8.6 19.5 20.0 17.1 39.2 28.7 50.3 34.2 20.6 18.4 41.8 22.8 31.1 36.0 21.2 9.6 85.9 12.8 33.8 37.8 29.4 19.5 19.1 24.1 28.0 26.8 16.5 17.2 56.0 9.3 42.6 68.2 0.9 17.4 1.7 11.0 20.3 17.9 17.2 16.1 14.9 37.3 15.8 23.6 19.5 0.7 20.1 14.5 14.4 11.9 16.3 4.2 8.5 3.4 8.9 4.4 2.8 3.5 5.8 2.5 3.4 20.8 55.0 24.4 57.3 51.2 48.9 247.1 10.2 32.1 46.6 45.4 60.9 187.5 49.7 33.5 5.3 35.0 23.9 0.0 56.6 786.3 42.5 23.4 20.7 12.2 59.0 6.4 29.3 9.8 28.9 4.8 11.2 28.7 23.6 49.5 35.3 13.3 39.9 31.7 9.2 14.7 83.3 6.5 31.1 4.7 3.8 45.0 638.0 16.2 80.3 79.3 C10orf62 bA548K23.1 ENSG00000203942 "Chromosome 10 open reading frame 62" Q5T681 10 97589727-97590934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 81.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 7737.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;Hep G2: 2.9;T-47d: 2.1" HPA072947 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA072947: AB_2686562" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-1)" "unprognostic (5.36e-2)" "unprognostic (3.62e-1)" "unprognostic (1.20e-1)" "unprognostic (3.63e-2)" "unprognostic (2.53e-2)" "unprognostic (2.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.5 2.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1574.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7737.3 36.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.3 0.0 6.5 0.0 33.1 18.8 0.0 0.0 0.0 0.0 0.0 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126670446 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3" "Group enriched" "Detected in some" 27 "Early spermatids: 96.0;Late spermatids: 93.2" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enhanced" "Detected in some" "SK-MEL-30: 49.5;U-2197: 15.1;U-266/84: 10.6;U-87 MG: 15.7;WM-115: 12.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 1.9 0.8 7.5 1.0 21.5 0.8 9.2 1.4 18.7 0.9 0.9 30.9 0.0 0.7 0.8 0.8 0.9 0.7 1.1 0.8 10.8 5.9 0.9 0.8 0.8 0.7 26.0 5.9 0.9 1.1 0.7 0.5 1.3 14.4 0.9 1.0 1.7 18.6 0.7 0.9 1.9 0.8 0.8 17.2 0.8 0.7 12.3 28.0 0.0 1.3 0.0 2.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.1 0.0 2.0 0.0 15.1 0.3 0.0 10.6 0.0 15.7 0.0 12.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 21.5 1.4 11.3 10.8 5.9 26.0 5.9 14.4 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 96.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 93.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.4 0.0 3.5 0.0 0.0 0.0 C11orf21 ENSG00000110665 "Chromosome 11 open reading frame 21" Q9P2W6 11 2295645-2303049 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0" "Cell type enhanced" "Detected in some" 23 "Cardiomyocytes: 60.5;granulocytes: 15.1;Kupffer cells: 14.3;Macrophages: 12.4;T-cells: 17.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 30.8;HL-60: 11.6;NB-4: 10.7;THP-1: 7.5;U-937: 13.1" HPA037607 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037607: AB_10672909" "unprognostic (5.25e-3)" "unprognostic (2.65e-4)" "unprognostic (1.35e-1)" "unprognostic (4.61e-3)" "unprognostic (4.32e-2)" "unprognostic (3.58e-4)" "unprognostic (8.98e-4)" "unprognostic (2.37e-3)" "unprognostic (1.87e-1)" "unprognostic (1.15e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (8.84e-4)" "unprognostic (8.50e-2)" "unprognostic (9.54e-2)" "unprognostic (3.55e-1)" "unprognostic (4.07e-2)" 1.5 0.4 0.7 8.7 0.5 30.4 0.7 0.2 0.7 1.5 0.8 1.7 0.8 0.2 1.6 1.3 0.7 1.0 5.4 15.6 0.4 0.4 1.0 1.3 5.2 8.5 2.2 0.9 0.7 0.6 0.0 0.8 0.8 1.0 0.8 0.8 1.4 9.3 0.1 0.4 0.8 3.3 0.6 1.4 16.0 2.0 0.9 1.0 6.4 1.1 2.7 11.5 1.0 0.9 2.6 7.3 29.5 23.2 9.5 10.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 30.8 0.0 0.1 0.3 11.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 13.1 0.0 29.5 6.3 18.7 10.6 13.1 7.3 2.0 3.6 8.4 7.3 2.6 5.4 7.5 5.5 9.5 23.2 0.7 2.6 6.4 0.7 0.5 0.2 0.7 0.4 0.4 2.2 0.9 1.0 1.0 0.0 6.2 1.9 0.0 0.3 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 15.1 0.0 3.4 0.0 0.0 1.3 14.3 0.0 0.0 12.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 17.5 0.0 0.0 C11orf45 "FLJ43646, MGC35558" ENSG00000174370 "Chromosome 11 open reading frame 45" Q8TAV5 11 128899565-128906035 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "Hofbauer cells: 8.1;Kupffer cells: 4.1;Late spermatids: 5.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;monocytes: 1.8;T-cells: 1.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 12.4;U-937: 9.6" HPA039716 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA039716: AB_10672892" "unprognostic (8.32e-2)" "unprognostic (3.93e-2)" "unprognostic (5.99e-3)" "unprognostic (1.35e-3)" "unprognostic (1.01e-1)" "unprognostic (9.93e-2)" "unprognostic (4.50e-5)" "unprognostic (1.97e-2)" "unprognostic (4.78e-2)" "unprognostic (3.10e-1)" "unprognostic (2.80e-1)" "unprognostic (9.27e-2)" "unprognostic (2.55e-9)" "unprognostic (2.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.87e-2)" "unprognostic (7.22e-2)" 0.7 4.9 1.1 0.3 5.3 0.4 0.7 0.0 1.0 0.9 0.4 1.2 0.3 0.4 3.3 0.9 2.1 5.0 0.7 0.9 1.6 0.2 2.8 0.3 1.1 0.7 4.1 4.7 3.7 2.1 1.2 0.6 1.7 3.6 0.0 8.0 0.6 0.1 1.5 1.6 2.0 1.0 1.8 0.6 1.7 1.8 0.4 3.5 0.0 1.8 0.0 1.1 0.6 2.4 4.8 0.0 0.0 0.1 0.4 1.8 0.8 5.1 1.9 4.8 6.9 6.2 0.0 3.5 0.4 4.4 2.5 2.5 12.4 0.9 0.0 1.2 0.3 3.0 0.0 0.2 0.0 0.0 0.3 1.7 1.4 0.8 4.1 1.1 3.8 0.0 0.3 2.1 1.3 2.7 2.5 2.0 1.0 3.5 1.2 5.0 0.5 4.4 1.2 0.0 0.2 2.0 5.7 0.4 1.4 0.8 4.1 0.6 0.0 7.1 0.0 0.8 0.1 0.0 0.0 0.9 9.6 0.2 0.0 1.8 0.0 0.3 0.8 0.7 0.4 0.5 0.5 3.5 0.4 1.1 0.7 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.3 0.0 1.0 2.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.6 1.4 0.0 0.0 0.0 0.7 2.1 0.2 0.1 1.1 0.0 8.1 0.0 0.0 0.0 4.1 5.7 0.0 2.6 0.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.9 0.6 1.0 0.0 0.0 0.7 C11orf74 "FLJ38678, HEPIS, NWC" ENSG00000166352 "Chromosome 11 open reading frame 74" Q86VG3 11 36594493-36659290 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 66.1" "Cell type enhanced" "Detected in all" 6 "Ciliated cells: 158.0;Early spermatids: 129.9;Late spermatids: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044880 Uncertain Approved Aggresome,Cytosol NA NA "Aggresome, Cytosol" "HPA044880: AB_10796908" "unprognostic (9.22e-3)" "unprognostic (6.79e-2)" "unprognostic (3.23e-2)" "unprognostic (7.47e-2)" "unprognostic (5.00e-3)" "unprognostic (1.13e-2)" "unprognostic (1.13e-2)" "unprognostic (9.86e-2)" "unprognostic (2.36e-1)" "unprognostic (3.65e-2)" "unprognostic (8.52e-2)" "unprognostic (1.92e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (3.24e-1)" 10.7 13.1 16.0 4.2 18.8 8.6 11.5 15.5 20.8 10.5 15.4 8.7 8.3 5.5 11.8 18.5 9.5 25.3 10.1 28.1 14.3 15.4 17.1 13.1 8.1 4.1 17.2 16.5 17.8 10.2 12.5 23.1 7.9 19.6 13.3 8.3 9.0 8.6 8.2 26.5 3.8 7.5 13.1 15.5 5.7 9.7 33.1 14.5 3.5 66.1 10.8 4.0 12.5 7.3 0.3 18.6 7.5 12.5 8.5 8.2 5.8 5.3 9.1 20.1 15.6 16.5 28.3 8.0 11.2 12.7 11.6 20.5 0.3 8.6 0.0 8.8 11.4 15.1 2.3 13.6 15.3 23.0 0.0 22.0 8.8 5.1 9.9 13.8 12.0 2.2 17.8 11.9 7.7 10.9 19.0 19.0 7.9 11.8 0.0 12.8 9.0 2.1 9.9 12.8 3.1 13.9 8.6 24.5 5.2 16.1 1.8 0.5 23.9 11.5 3.0 18.4 18.7 18.4 6.5 12.1 15.9 11.4 21.0 9.5 3.3 6.1 0.0 13.9 14.4 8.2 7.5 12.5 0.7 1.1 9.7 3.7 0.0 3.3 2.8 13.7 0.3 8.2 2.0 0.7 8.5 9.1 18.6 0.4 5.8 16.0 18.8 15.5 20.8 14.3 15.4 17.2 16.5 19.6 14.5 8.9 9.1 2.7 12.3 7.7 14.0 55.4 12.7 158.0 33.0 22.7 3.9 16.8 58.0 26.2 129.9 15.7 4.5 23.3 23.7 15.9 19.7 14.0 15.0 16.4 23.0 9.5 5.2 17.2 16.1 113.0 14.1 11.0 20.3 5.4 8.9 16.0 20.5 10.5 14.5 48.4 10.4 6.5 21.7 91.8 26.8 10.7 6.3 4.3 12.8 9.3 C11orf96 AG2 ENSG00000187479 "Chromosome 11 open reading frame 96" 11 43942505-43944338 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 152.0" "Cell type enhanced" "Detected in many" 19 "Peritubular cells: 445.9;Sertoli cells: 297.5;Smooth muscle cells: 1129.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 65.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038843 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" No NA "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA038843: AB_10673296" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.28e-2)" "unprognostic (8.15e-3)" "unprognostic (5.49e-2)" "unprognostic (3.42e-3)" "unprognostic (8.11e-3)" "unprognostic (1.15e-2)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (2.34e-5)" "unprognostic (2.65e-2)" "unprognostic (2.07e-1)" "unprognostic (1.18e-2)" "unprognostic (3.19e-2)" 68.2 81.2 4.9 23.4 17.4 3.4 42.6 2.6 10.5 39.7 32.2 3.3 6.6 12.4 35.1 41.5 16.3 69.3 70.0 34.3 8.8 7.9 17.9 67.7 61.9 4.9 7.6 4.7 152.0 18.1 3.8 14.2 14.6 32.8 28.6 6.2 7.6 2.3 12.8 38.2 10.1 17.2 22.9 15.3 12.7 31.3 41.7 4.2 0.0 16.7 14.0 2.3 62.9 32.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.4 0.6 0.7 0.0 0.0 0.0 0.7 0.8 0.5 0.0 0.3 3.3 0.2 1.4 0.0 0.0 0.7 65.3 0.0 0.0 6.0 1.9 0.0 0.7 0.9 3.1 1.3 0.8 0.0 7.6 0.0 1.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 17.4 2.6 7.1 8.8 7.9 7.6 4.7 32.8 4.2 6.0 166.6 0.0 14.6 82.5 15.3 5.3 0.0 1.4 2.3 0.0 2.0 1.1 0.0 2.2 3.5 30.5 0.0 0.0 0.5 3.5 142.9 42.4 12.8 2.5 3.3 1.6 0.0 114.8 6.9 5.8 199.6 9.5 165.4 0.0 0.0 2.3 2.8 0.0 445.9 0.0 7.6 297.5 1129.9 1.6 1.4 77.3 2.6 2.5 0.0 35.8 C12orf40 FLJ40126 ENSG00000180116 "Chromosome 12 open reading frame 40" Q86WS4 12 39626167-39908300 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 26.4" "Cell type enhanced" "Detected in some" 29 "Early spermatids: 7.1;Late spermatids: 4.1;Spermatocytes: 21.8;Spermatogonia: 4.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "K-562: 7.7" "Low region specificity" "Detected in single" HPA039032 Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039032: AB_2676316" "unprognostic (1.75e-1)" "unprognostic (2.76e-6)" "unprognostic (3.45e-1)" "unprognostic (1.96e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.5 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.8 4.7 0.0 0.0 0.0 0.0 0.0 C12orf60 MGC47869 ENSG00000182993 "Chromosome 12 open reading frame 60" Q5U649 12 14803572-14906586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.5" "Cell type enriched" "Detected in many" 7 "Early spermatids: 342.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043911 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043911: AB_10963941" "unprognostic (3.71e-2)" "unprognostic (7.02e-2)" "unprognostic (1.72e-1)" "unprognostic (6.39e-2)" "unprognostic (4.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (3.09e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-2)" 1.7 8.9 2.6 2.3 9.9 1.7 1.8 1.9 4.7 1.5 1.3 4.8 1.6 0.7 1.1 2.9 1.3 2.9 1.8 5.4 3.7 2.0 4.8 8.7 2.0 3.2 6.3 4.7 1.5 2.1 1.7 3.8 1.6 7.2 2.1 1.2 5.1 1.9 1.4 2.5 1.3 1.4 0.8 9.2 5.5 1.9 22.5 4.9 1.7 3.3 1.0 2.0 1.5 1.7 3.9 1.1 3.6 1.4 3.3 4.5 1.2 2.5 2.8 2.8 8.1 3.1 2.2 2.5 1.9 1.0 2.0 2.4 1.2 2.8 2.2 2.3 0.6 3.0 2.9 3.1 6.2 2.7 5.0 3.1 1.7 0.8 1.9 2.5 2.6 0.9 1.1 3.8 2.0 4.2 2.7 3.8 3.6 2.8 0.5 2.7 0.8 1.0 1.5 9.6 3.8 1.6 3.1 4.8 3.3 3.6 0.8 2.0 2.5 4.1 1.0 3.6 8.6 3.2 1.2 2.9 1.8 2.0 1.4 2.1 1.4 0.9 7.3 2.2 2.4 2.5 0.3 1.3 3.6 2.3 1.4 3.7 3.9 1.9 3.3 1.1 2.6 4.5 3.8 0.3 3.3 0.8 1.0 3.6 1.2 2.6 9.9 1.9 4.7 3.7 2.0 6.3 4.7 7.2 4.9 0.0 0.0 7.5 0.4 0.2 3.3 3.3 0.0 5.3 2.3 5.2 19.6 1.4 6.6 1.3 342.1 2.3 0.0 0.0 1.0 1.7 1.2 0.4 0.0 0.8 1.0 1.6 0.0 0.0 1.2 51.4 2.8 1.1 0.0 3.6 0.1 2.5 0.6 0.0 2.5 2.9 16.1 19.4 1.0 10.5 7.9 0.9 0.2 2.5 0.3 0.3 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123232916-123257959 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol No Yes "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favorable (7.82e-5)" 7.8 15.7 13.2 11.3 15.1 9.6 9.0 21.6 18.2 14.1 10.8 12.3 11.6 13.8 14.9 16.5 10.7 11.7 11.1 17.4 13.2 15.2 12.1 15.6 10.6 18.8 11.5 13.2 21.3 12.4 8.8 24.6 9.2 15.0 15.1 9.7 13.1 21.2 10.8 14.3 17.7 12.6 10.5 14.2 14.7 11.7 17.3 12.2 80.9 15.3 7.9 15.5 14.3 13.7 23.6 10.0 22.6 4.6 17.1 28.9 10.0 14.2 9.9 11.2 21.9 5.6 6.0 6.8 11.9 7.6 12.1 8.9 10.6 8.5 17.8 10.3 3.8 12.3 10.5 12.1 6.5 11.6 13.3 10.8 21.0 9.7 9.2 12.6 9.7 10.6 6.3 15.8 8.8 18.2 18.7 7.8 25.5 22.1 7.4 8.0 6.2 23.3 18.0 8.5 12.1 15.2 17.4 13.3 16.5 11.3 8.2 23.8 10.3 13.3 6.8 12.4 8.4 10.8 11.4 8.8 13.2 15.8 11.9 12.0 12.2 14.0 16.3 8.6 12.9 17.2 22.6 3.5 14.0 15.9 3.8 19.8 23.6 22.0 21.1 6.0 20.2 28.9 24.7 3.7 17.1 4.6 10.0 18.5 10.0 13.2 15.1 21.6 18.2 13.2 15.2 11.5 13.2 15.0 12.2 38.7 45.0 27.9 34.0 40.3 32.8 41.3 15.3 17.4 20.5 24.4 13.7 36.6 51.4 17.6 17.3 20.3 14.7 23.3 9.4 19.4 29.7 17.7 14.0 27.0 12.6 42.9 9.2 16.5 7.5 5.0 35.1 13.2 23.6 37.9 16.9 33.9 12.4 13.3 39.6 23.9 34.3 12.9 33.9 63.0 26.2 31.6 9.0 44.9 20.0 7.1 C12orf71 LOC728858 ENSG00000214700 "Chromosome 12 open reading frame 71" A8MTZ7 12 27081058-27082514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 4.1;bone marrow: 3.8;skin 1: 2.5;testis: 7.4" "Cell type enriched" "Detected in some" 8 "Early spermatids: 9.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "NK-cell: 4.1" "Lineage enriched" "Detected in single" 23 "NK-cells: 4.1" "Cell line enhanced" "Detected in some" "HDLM-2: 5.7;JURKAT: 2.1" "HPA038359, HPA058728" Uncertain Approved Cytosol NA NA Cytosol "HPA038359: , HPA058728: AB_2683800" "unprognostic (1.14e-1)" "unprognostic (9.86e-2)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (2.36e-1)" "unprognostic (6.78e-3)" "unprognostic (9.90e-2)" "unprognostic (3.13e-1)" "unprognostic (7.12e-3)" "unprognostic (1.02e-1)" "unprognostic (6.73e-3)" "unprognostic (1.96e-1)" "unprognostic (4.15e-8)" "unprognostic (4.85e-2)" "unprognostic (9.71e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.1 0.0 0.1 0.4 0.1 3.8 0.2 0.8 0.3 0.4 0.1 0.2 0.1 0.0 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.3 0.3 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.5 2.5 0.4 0.0 0.0 0.5 0.1 7.4 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.5 0.2 0.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 5.7 0.0 1.2 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.4 0.1 0.0 0.0 0.5 0.3 0.9 0.4 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.9 0.0 0.6 0.3 0.1 0.0 0.1 0.0 0.6 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 C14orf119 FLJ20671 ENSG00000179933 "Chromosome 14 open reading frame 119" Q9NWQ9 14 23094765-23100462 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003638 Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA003638: AB_2243669" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (2.91e-1)" "unprognostic (2.33e-2)" "unprognostic (5.26e-3)" "prognostic unfavorable (5.42e-5)" "unprognostic (1.23e-1)" "unprognostic (3.36e-2)" "unprognostic (1.65e-2)" "unprognostic (4.08e-3)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-2)" "unprognostic (3.61e-2)" "prognostic favorable (3.30e-5)" "unprognostic (1.63e-1)" 28.2 35.0 16.3 22.0 18.5 9.2 38.9 11.6 17.3 30.4 28.4 17.0 23.9 22.6 29.9 30.3 32.0 23.5 22.4 29.6 16.3 19.9 36.3 24.6 30.4 37.3 22.4 15.1 25.2 39.4 16.7 28.1 32.2 23.1 27.9 35.8 27.1 28.0 28.1 21.2 20.7 27.4 33.5 20.1 33.8 28.2 33.0 16.7 27.2 40.0 26.3 33.1 25.8 24.0 34.6 37.4 72.7 40.2 30.2 45.0 43.7 13.8 13.7 20.7 12.5 45.7 39.8 16.7 23.2 34.4 30.7 36.6 10.8 21.5 10.5 12.1 37.6 37.3 23.7 19.6 30.8 42.7 16.7 9.6 15.9 11.4 46.2 36.0 23.7 24.8 48.5 27.9 25.8 19.1 28.1 33.5 19.2 10.5 11.8 33.6 19.8 11.1 18.4 13.0 32.2 21.0 9.9 15.4 12.1 34.8 22.3 10.0 9.1 19.4 18.3 20.1 24.1 12.3 13.8 26.9 14.6 12.8 21.9 10.4 11.1 13.0 12.9 13.4 15.1 13.0 63.7 40.2 72.7 32.6 25.7 37.1 34.6 37.2 36.2 37.4 28.5 39.1 38.3 23.8 30.2 17.3 25.2 45.0 43.7 16.3 18.5 11.6 17.3 16.3 19.9 22.4 15.1 23.1 16.7 44.7 41.3 39.3 73.7 23.6 28.7 21.4 30.6 38.8 46.6 29.6 7.9 76.0 109.5 81.1 13.7 45.7 39.3 23.3 74.5 84.3 43.6 40.4 52.1 27.7 93.8 19.1 27.2 43.6 42.9 11.4 59.2 57.9 45.5 111.0 43.7 31.3 81.5 43.2 45.6 76.4 15.4 32.3 37.6 25.0 24.6 29.6 119.7 48.4 45.4 67.4 C14orf28 DRIP-1 ENSG00000179476 "Chromosome 14 open reading frame 28" Q4W4Y0 14 44897295-44907257 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 147.4;Late spermatids: 91.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059635 Approved Cytosol NA NA Cytosol "HPA059635: AB_2684091" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.23e-1)" "unprognostic (3.06e-6)" "unprognostic (1.18e-1)" "unprognostic (6.64e-3)" "unprognostic (2.37e-2)" "unprognostic (1.90e-2)" "unprognostic (2.25e-1)" "unprognostic (5.35e-2)" "unprognostic (3.13e-3)" "unprognostic (7.33e-2)" "unprognostic (3.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.30e-1)" "unprognostic (4.68e-2)" "unprognostic (2.01e-1)" 8.8 5.3 5.0 4.1 5.6 1.6 11.8 4.0 6.2 13.3 10.3 7.2 10.7 7.3 14.4 8.4 6.5 9.2 8.9 8.5 4.8 4.1 5.1 14.4 5.1 4.4 10.6 4.3 12.4 12.4 4.4 5.0 5.7 5.6 12.8 5.8 5.9 11.4 8.7 7.4 5.9 9.0 20.4 5.4 5.9 8.5 16.1 5.4 1.7 6.6 3.2 5.0 19.0 9.2 6.8 3.4 6.9 3.5 3.9 9.7 2.1 2.4 1.7 3.3 5.6 6.6 3.5 7.4 4.9 5.4 2.4 3.8 0.1 3.1 3.2 2.9 3.3 5.4 1.3 0.8 2.3 4.2 11.7 0.6 1.5 0.8 3.3 1.9 1.4 3.7 2.8 4.0 0.7 3.9 4.6 1.3 3.9 0.8 4.5 1.8 4.7 1.3 2.7 0.6 4.6 1.9 2.3 4.0 1.3 3.3 3.1 0.7 1.0 2.0 4.0 2.1 2.7 7.1 1.4 2.0 9.1 4.4 1.5 1.0 6.3 5.1 2.1 2.6 0.7 2.8 1.8 1.7 6.9 4.3 2.6 4.9 6.8 4.4 5.6 2.0 5.1 9.7 5.5 3.8 3.9 3.5 3.4 4.8 2.1 5.0 5.6 4.0 6.2 4.8 4.1 10.6 4.3 5.6 5.4 3.0 2.4 6.2 7.6 2.7 3.2 10.3 0.0 0.0 2.3 5.2 0.0 4.6 8.3 7.7 147.4 5.6 5.4 0.0 7.5 3.8 8.0 8.6 1.1 9.6 4.1 3.2 2.9 6.2 4.3 91.1 9.8 2.8 5.0 4.6 7.5 3.1 6.1 3.5 15.2 12.8 2.9 19.4 10.8 19.2 9.4 3.9 5.5 8.7 4.9 5.8 C15orf39 "DKFZP434H132, FLJ46337" ENSG00000167173 "Chromosome 15 open reading frame 39" Q6ZRI6 15 75195643-75212169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.7" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.9" "Group enriched" "Detected in many" 5 "dendritic cells: 5.7;granulocytes: 16.9;monocytes: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039961, HPA041907" Enhanced Enhanced Cytosol NA NA Cytosol "HPA039961: AB_10673024, HPA041907: AB_2677736" "unprognostic (3.53e-2)" "unprognostic (1.66e-1)" "unprognostic (4.57e-2)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (2.00e-1)" "unprognostic (2.20e-2)" "unprognostic (3.46e-2)" "prognostic favorable (7.94e-4)" "unprognostic (3.38e-2)" "unprognostic (2.74e-1)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (2.95e-1)" "unprognostic (1.14e-1)" 14.7 10.2 3.5 9.6 5.3 36.1 9.0 2.5 4.1 11.8 8.5 3.1 3.8 7.9 16.5 5.8 13.1 11.5 13.9 7.7 3.5 3.3 5.6 5.3 11.7 11.6 3.3 2.2 23.3 11.4 5.2 7.5 24.4 3.9 10.0 3.9 7.7 12.5 5.3 4.4 9.9 7.6 10.0 3.3 21.1 6.6 71.7 3.2 11.1 7.8 9.0 17.0 10.5 13.7 0.8 5.7 16.9 10.4 2.2 1.3 2.2 7.7 15.9 3.4 4.0 4.7 3.1 10.5 2.2 4.6 2.6 2.8 19.6 10.8 17.5 7.6 3.3 9.6 10.5 14.8 6.8 0.7 17.1 16.7 34.7 7.7 13.4 5.4 9.9 35.9 4.0 5.4 5.6 2.6 3.3 6.7 6.7 14.8 26.2 0.8 4.6 9.5 12.2 10.8 5.2 6.4 8.7 2.6 18.6 1.6 6.1 10.1 3.2 5.2 12.1 8.2 3.6 4.1 12.7 5.7 4.6 7.0 8.3 6.5 19.0 11.9 10.1 4.6 19.3 4.5 4.8 4.2 12.2 1.3 8.2 1.0 0.8 0.7 0.9 2.7 0.5 0.6 0.8 16.9 2.2 10.4 5.7 0.9 2.2 3.5 5.3 2.5 4.1 3.5 3.3 3.3 2.2 3.9 3.2 23.8 5.6 6.0 5.7 13.3 0.2 1.6 7.6 6.7 9.1 3.5 0.0 9.9 0.0 13.8 38.4 10.0 5.4 0.0 12.4 13.9 12.0 4.3 17.3 1.5 10.6 0.0 7.5 9.8 20.8 54.3 10.9 11.3 6.8 12.6 5.9 0.7 14.8 23.2 10.3 1.4 1.9 12.9 10.5 11.2 5.3 12.4 17.5 6.4 7.4 12.7 C15orf40 MGC29937 ENSG00000169609 "Chromosome 15 open reading frame 40" Q8WUR7 15 82988441-83011641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042980 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042980: AB_10964298" "unprognostic (8.30e-3)" "unprognostic (2.56e-2)" "unprognostic (3.96e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.17e-2)" "unprognostic (3.04e-2)" "unprognostic (8.65e-2)" "unprognostic (2.20e-2)" "unprognostic (8.55e-3)" "unprognostic (7.71e-2)" "prognostic favorable (4.35e-4)" "unprognostic (2.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-1)" "unprognostic (2.51e-2)" 13.5 16.3 14.3 11.1 15.4 15.1 13.5 15.9 15.8 10.9 13.9 15.0 16.3 16.3 9.6 24.2 10.8 10.6 10.1 9.0 13.1 9.1 17.2 16.3 9.2 16.0 13.2 13.8 13.9 16.7 12.3 14.1 9.0 12.7 10.3 10.0 11.9 13.8 12.1 13.4 18.2 16.8 10.6 10.5 13.8 11.3 14.3 10.3 14.3 16.0 11.9 12.5 9.9 10.4 27.9 18.8 27.0 14.1 26.5 24.7 12.2 9.1 11.6 7.6 10.4 9.7 9.0 7.3 6.0 9.8 5.9 6.8 8.4 16.3 10.0 8.4 4.6 14.8 17.8 16.9 12.5 6.8 19.0 11.8 9.4 15.6 9.6 9.6 15.6 10.0 7.9 17.6 9.9 11.3 8.0 10.3 26.4 12.8 16.6 5.7 9.4 13.3 8.5 13.4 14.2 7.9 17.9 10.8 13.3 10.2 14.4 18.7 11.4 16.0 11.5 22.6 10.3 14.5 9.3 6.6 12.9 18.1 9.7 10.8 15.4 23.4 18.9 16.2 16.1 14.0 27.0 14.1 18.8 19.3 13.6 21.1 27.9 20.5 19.9 13.2 24.4 24.1 20.7 15.1 26.5 12.6 18.8 24.7 12.2 14.3 15.4 15.9 15.8 13.1 9.1 13.2 13.8 12.7 10.3 26.8 23.8 25.3 23.3 10.6 26.7 10.1 43.3 62.9 50.0 24.4 11.8 40.7 79.6 40.9 25.5 18.5 46.7 23.3 48.5 24.2 18.6 24.2 25.6 32.6 26.7 28.6 27.6 20.9 27.8 25.0 30.8 31.9 25.3 40.5 29.1 29.3 50.2 27.1 33.9 93.6 27.5 19.4 15.3 101.2 55.6 13.4 29.7 32.4 31.5 21.3 C15orf59 "INSYN1, LOC388135, MGC131524" ENSG00000205363 "Chromosome 15 open reading frame 59" Q2T9L4 15 73735431-73752747 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 24.1;heart muscle: 16.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 8.5;Cardiomyocytes: 12.5;Muller glia cells: 6.8" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 11.6;fHDF/TERT166: 7.7;HEK 293: 7.9;NTERA-2: 4.9;SK-BR-3: 6.9;U-2 OS: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041563 Approved Approved Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "HPA041563: AB_10794670" "unprognostic (2.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.85e-2)" "unprognostic (2.36e-1)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" "unprognostic (3.37e-2)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (8.36e-2)" "unprognostic (2.67e-4)" "unprognostic (2.67e-2)" "prognostic favorable (5.38e-9)" "unprognostic (4.98e-2)" "unprognostic (5.19e-2)" "unprognostic (2.46e-4)" "unprognostic (1.20e-3)" 1.2 1.9 9.3 0.4 9.7 0.0 0.9 5.5 24.1 2.2 0.7 0.3 1.0 2.4 9.4 6.5 1.5 16.2 9.1 8.3 3.5 0.0 1.7 0.0 14.4 4.8 1.0 0.0 0.7 0.2 4.5 0.2 0.7 10.1 1.4 8.4 1.0 2.1 4.2 0.0 0.8 1.9 0.4 0.4 1.6 3.8 0.8 0.6 1.5 0.5 0.8 0.5 0.0 0.0 0.5 2.9 1.8 11.6 0.2 0.0 1.5 0.0 1.0 0.0 0.0 0.0 0.1 1.0 7.7 1.6 3.0 2.5 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.9 0.0 0.2 0.9 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.7 1.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.7 0.6 6.9 0.7 1.8 3.1 0.2 0.1 1.9 6.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.3 0.4 0.2 0.3 0.3 0.3 0.4 0.1 0.8 0.5 0.5 1.5 0.8 0.3 0.6 0.3 0.0 0.0 0.3 0.0 0.4 0.0 8.5 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.8 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C15orf61 LOC145853 ENSG00000189227 "Chromosome 15 open reading frame 61" A6NNL5 15 67521068-67530143 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062820 Approved Nucleoli,Vesicles,Cytosol "Secreted - unknown location" NA NA "Nucleoli, Vesicles" Cytosol "HPA062820: AB_2684874" "unprognostic (1.35e-1)" "unprognostic (9.42e-3)" "unprognostic (2.11e-1)" "unprognostic (5.41e-2)" "unprognostic (2.40e-1)" "unprognostic (2.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.87e-3)" "unprognostic (8.95e-2)" "unprognostic (4.01e-2)" "unprognostic (1.04e-2)" "unprognostic (8.45e-2)" "prognostic favorable (5.31e-5)" "unprognostic (2.42e-2)" "unprognostic (9.78e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" 9.9 10.0 10.8 4.7 18.1 11.0 17.9 14.5 17.2 5.5 6.0 2.4 5.6 7.5 6.3 5.9 5.5 5.2 5.1 21.0 8.7 7.2 8.4 6.4 7.2 7.5 6.9 10.9 7.9 20.7 8.8 10.9 5.8 7.3 7.2 6.4 5.9 7.0 6.4 45.8 8.4 5.0 7.0 5.8 5.0 6.6 25.2 5.5 3.6 7.7 16.9 3.7 4.6 8.0 7.2 7.2 10.7 6.6 5.1 9.8 5.0 4.2 4.6 1.2 5.1 5.4 7.8 3.3 1.9 3.4 3.5 2.8 3.5 3.0 3.6 4.1 2.1 4.1 5.0 4.6 1.3 2.9 2.1 10.9 3.8 3.5 4.6 3.5 4.7 3.2 8.1 3.5 1.1 4.3 2.5 1.6 11.1 4.3 8.0 1.1 2.4 3.8 7.7 1.9 3.4 5.8 5.2 2.6 13.1 2.5 3.0 6.8 5.1 3.3 3.2 5.8 2.3 2.8 7.2 1.6 4.7 7.2 5.9 4.8 7.6 11.0 8.7 2.0 9.2 2.4 8.6 6.6 10.7 7.0 5.2 8.0 7.2 9.2 6.9 6.9 5.6 9.8 7.9 0.8 5.1 4.4 7.2 5.6 5.0 10.8 18.1 14.5 17.2 8.7 7.2 6.9 10.9 7.3 5.5 20.8 9.1 25.1 28.7 59.6 71.3 69.8 20.4 6.7 7.9 15.7 35.3 35.6 68.0 21.1 136.1 26.6 30.6 0.0 25.8 25.7 33.5 30.2 33.5 33.8 26.4 12.7 26.0 17.2 20.2 22.0 38.0 16.0 35.4 7.2 47.0 62.2 24.4 38.6 24.1 54.0 68.8 32.3 28.3 136.2 21.8 53.2 17.2 31.9 43.0 15.6 C15orf65 FLJ27352 ENSG00000261652 "Chromosome 15 open reading frame 65" H3BRN8 15 55408548-55418764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 27.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 50.9;Early spermatids: 140.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6" "Cell line enhanced" "Detected in many" "hTCEpi: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067189 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA067189: AB_2685800" "unprognostic (2.77e-2)" "unprognostic (7.42e-2)" "unprognostic (7.50e-2)" "prognostic favorable (3.18e-7)" "unprognostic (1.59e-1)" "unprognostic (9.56e-3)" "unprognostic (1.16e-3)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.25e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-3)" "unprognostic (2.09e-1)" "unprognostic (1.81e-1)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" 3.4 3.1 6.5 0.9 7.4 0.8 5.4 2.4 6.7 7.7 5.2 3.7 5.4 2.9 3.7 11.2 3.4 13.7 5.3 7.0 6.0 7.6 11.2 1.9 3.8 2.2 5.2 6.8 4.6 11.0 6.2 17.2 1.2 12.0 5.8 6.2 2.8 27.6 5.3 8.7 2.4 2.5 3.7 3.4 1.9 7.8 11.3 4.6 1.7 7.1 0.6 1.8 3.6 1.5 2.3 0.6 6.5 1.6 0.0 0.7 0.4 0.8 1.7 2.9 1.8 4.5 6.7 0.5 1.6 2.2 1.4 2.8 0.0 1.5 1.3 4.4 5.2 3.5 1.3 0.0 2.7 0.5 2.4 2.0 1.2 10.1 0.4 8.8 2.9 1.6 2.8 14.9 4.2 1.2 7.8 2.7 0.0 2.3 4.3 6.2 2.2 0.1 9.3 0.9 5.3 3.3 0.5 0.0 11.2 7.6 0.0 7.9 4.8 2.0 3.4 12.8 1.6 6.9 2.8 1.9 2.4 0.9 2.5 0.9 1.9 5.0 1.2 6.2 7.2 1.2 6.5 1.1 3.9 0.5 1.6 0.0 1.9 0.1 0.7 0.6 2.3 0.1 0.0 2.1 0.0 0.8 0.2 0.0 0.4 6.5 7.4 2.4 6.7 6.0 7.6 5.2 6.8 12.0 4.6 3.0 0.6 0.8 3.6 1.1 0.8 7.3 2.5 50.9 4.5 5.2 0.0 1.0 14.9 7.1 140.3 3.6 2.1 0.0 9.6 1.1 3.1 4.5 4.6 1.0 2.5 3.2 3.5 3.1 1.9 6.8 4.0 0.2 3.3 1.0 16.7 3.6 7.0 11.5 5.3 16.8 7.5 6.5 2.8 5.8 2.8 1.5 0.0 0.0 4.6 1.7 C16orf45 FLJ32618 ENSG00000166780 "Chromosome 16 open reading frame 45" Q96MC5 16 15434295-15625028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 72.3" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 125.3;Late spermatids: 336.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 11.1" "Lineage enriched" "Detected in many" 4 "T-cells: 11.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 33.1;U-2197: 24.0;U-87 MG: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041114, HPA063757" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA041114: AB_10794542, HPA063757: " "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (1.67e-2)" "unprognostic (6.96e-2)" "unprognostic (3.79e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.53e-4)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (1.16e-2)" "unprognostic (3.64e-2)" "unprognostic (5.28e-2)" "prognostic favorable (1.75e-4)" "unprognostic (3.79e-3)" "unprognostic (8.31e-2)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" 11.5 10.2 38.8 6.8 27.6 1.3 8.4 30.6 72.3 28.4 10.4 10.1 3.8 5.9 21.3 12.7 14.2 12.3 14.6 28.7 39.2 30.4 9.4 12.9 6.0 4.1 21.8 33.8 26.1 5.6 2.2 11.3 1.4 61.3 15.0 6.2 8.5 6.5 17.8 25.5 4.9 4.4 21.5 12.5 5.3 7.6 13.8 12.0 0.0 5.7 4.4 3.0 14.2 10.7 2.7 0.5 0.6 0.1 0.2 11.1 1.5 0.4 10.7 4.5 0.4 20.2 17.2 0.0 5.8 20.1 5.2 2.9 0.0 0.2 0.0 1.3 33.1 12.7 0.0 1.2 1.6 2.7 0.2 0.2 2.5 4.1 0.3 6.6 0.0 4.4 8.4 1.7 11.6 0.2 8.6 8.0 4.7 0.1 0.1 7.7 6.4 1.4 0.2 5.7 0.1 4.1 0.3 6.1 0.0 2.8 1.8 8.9 8.7 0.3 2.9 1.8 0.8 0.1 0.1 4.6 11.7 6.0 24.0 2.9 2.0 4.6 0.0 41.3 0.0 2.8 0.1 0.1 0.2 11.1 0.0 2.0 2.7 2.1 6.2 0.5 1.6 2.0 3.3 0.6 0.2 0.1 0.3 2.7 1.5 38.8 27.6 30.6 52.4 39.2 30.4 21.8 33.8 61.3 12.0 0.0 0.3 0.0 14.8 7.9 42.1 49.5 5.1 17.4 12.5 1.8 13.7 0.0 26.6 13.2 125.3 26.0 0.0 0.0 72.8 0.0 29.8 4.3 11.5 11.9 0.8 17.5 15.6 17.8 3.2 336.0 18.4 10.9 13.5 18.0 0.0 7.6 41.6 0.0 45.3 7.0 15.7 12.9 42.0 35.1 15.8 5.1 0.1 1.8 0.0 8.8 C16orf46 FLJ32702 ENSG00000166455 "Chromosome 16 open reading frame 46" Q6P387 16 81053497-81077267 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 80.6;Late spermatids: 78.6;Spermatocytes: 32.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041136, HPA041379" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041136: AB_10795535, HPA041379: AB_10794666" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (2.59e-1)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (9.93e-2)" "unprognostic (1.81e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (1.93e-1)" "unprognostic (8.06e-2)" "unprognostic (1.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.53e-1)" "unprognostic (7.06e-3)" "unprognostic (8.72e-2)" 2.0 2.5 5.2 1.8 6.8 2.2 3.1 3.3 8.6 2.8 1.4 3.5 1.3 1.3 2.8 4.4 1.7 8.6 2.0 1.4 5.8 5.8 2.4 3.0 2.2 1.1 5.9 6.0 1.7 2.6 2.9 14.4 3.2 8.6 3.0 1.4 3.5 2.0 2.4 2.5 1.0 1.0 1.9 4.2 1.1 1.1 25.2 2.5 1.5 8.9 0.5 1.3 1.9 1.3 0.2 0.4 1.1 0.4 0.0 2.0 0.0 2.8 0.5 1.1 0.5 5.2 1.0 2.6 0.6 3.6 2.0 1.2 0.6 4.0 0.7 1.8 0.7 2.5 1.0 1.1 2.0 3.6 0.6 0.7 0.8 2.3 2.7 3.1 1.0 2.2 2.1 1.6 4.7 2.9 2.2 1.7 1.4 1.7 1.4 1.6 2.0 0.3 5.5 1.3 1.0 0.6 2.2 0.3 0.4 3.5 1.7 1.5 1.4 4.0 1.3 0.7 1.7 1.2 1.4 1.4 0.9 0.4 0.8 0.7 1.5 2.1 1.6 1.8 1.4 1.0 0.0 0.4 1.1 0.2 0.0 2.0 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 5.2 6.8 3.3 8.6 5.8 5.8 5.9 6.0 8.6 2.5 0.0 2.9 0.0 8.1 1.6 2.1 2.0 0.0 20.1 3.4 0.0 3.9 6.3 5.0 0.8 80.6 1.6 0.0 0.0 0.4 13.6 2.3 6.0 0.0 2.9 2.8 0.0 1.2 1.3 1.2 78.6 7.5 1.0 5.0 0.0 1.2 2.9 0.4 0.0 7.1 3.1 7.0 0.0 2.0 32.0 4.9 2.4 5.3 0.0 0.9 5.5 C16orf58 FLJ13868 ENSG00000140688 "Chromosome 16 open reading frame 58" Q96GQ5 16 31489471-31509309 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024406 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA "Nucleoli, Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA024406: AB_1845580" "unprognostic (1.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.25e-2)" "unprognostic (4.22e-1)" "unprognostic (6.21e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (9.89e-2)" "unprognostic (3.20e-1)" "unprognostic (1.58e-1)" "unprognostic (6.34e-3)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.24e-2)" 13.5 17.7 15.9 15.3 22.3 11.0 15.7 17.9 30.8 22.6 17.5 16.6 34.2 18.6 24.2 21.4 16.8 21.0 20.0 16.7 12.9 15.3 19.1 51.0 13.9 15.7 13.8 16.4 29.5 49.1 30.7 27.6 23.1 13.1 22.0 11.6 22.9 36.9 26.7 4.8 14.1 22.2 15.6 9.1 12.9 19.7 11.9 14.3 15.1 26.4 14.2 19.3 15.9 17.4 8.9 12.0 8.8 9.8 10.8 11.3 8.4 11.6 15.4 9.7 16.8 22.5 15.0 18.0 14.0 23.9 10.9 13.0 4.6 20.5 10.0 29.7 20.6 14.1 16.3 9.6 12.9 5.1 14.5 9.6 10.1 8.8 11.6 32.7 11.9 12.2 18.2 14.1 14.3 29.5 21.5 10.5 16.1 14.9 17.3 10.6 22.0 5.5 8.0 7.5 17.1 10.1 12.7 14.5 30.2 12.4 7.3 10.6 16.3 10.5 27.7 21.8 9.6 23.9 17.6 9.1 19.1 10.7 12.2 9.1 25.2 14.7 7.5 24.4 18.4 26.2 3.8 6.9 8.8 10.3 9.8 9.6 8.9 10.7 10.2 12.0 8.5 10.8 9.3 1.2 10.8 9.6 11.0 11.3 8.4 15.9 22.3 17.9 30.8 12.9 15.3 13.8 16.4 13.1 14.3 6.0 14.2 9.0 7.9 5.5 22.6 0.8 10.2 6.7 9.1 15.7 2.0 18.1 5.0 17.5 1.5 6.3 17.7 0.0 18.6 17.9 13.1 13.9 18.4 21.9 12.9 12.7 14.3 7.4 8.4 2.5 20.1 6.4 16.9 6.4 20.7 12.4 12.0 10.5 15.2 6.8 22.3 25.8 9.2 13.4 11.7 4.1 18.7 8.3 17.8 7.9 C16orf70 "C16orf6, FLJ12076, lin-10, LIN10" ENSG00000125149 "Chromosome 16 open reading frame 70" Q9BSU1 16 67109958-67148539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041131, HPA041214" Approved Approved "Nucleoli fibrillar center,Nuclear speckles,Cytosol" No No "Nuclear speckles" "Nucleoli fibrillar center, Cytosol" "HPA041131: AB_10795487, HPA041214: AB_10794267" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (3.23e-2)" "unprognostic (1.32e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (2.25e-1)" "unprognostic (3.74e-3)" "unprognostic (1.81e-2)" "unprognostic (6.29e-2)" "unprognostic (1.07e-1)" "unprognostic (4.38e-2)" "unprognostic (1.68e-1)" "unprognostic (2.15e-2)" 8.0 7.7 11.3 6.7 14.6 14.2 10.5 14.0 22.4 8.4 7.9 24.2 8.6 6.7 8.9 8.8 12.5 10.1 8.2 8.0 12.6 8.9 11.8 43.2 7.9 7.6 18.2 13.1 10.1 6.2 19.5 8.3 10.6 15.5 12.9 9.4 7.7 8.9 8.4 20.1 22.0 7.1 10.0 18.0 11.2 6.9 10.6 16.0 7.0 7.1 5.8 10.3 8.4 10.3 7.2 14.1 6.3 15.9 5.2 8.3 7.3 6.8 10.4 9.9 10.3 12.6 7.6 23.5 7.9 8.6 16.1 17.7 11.5 6.1 7.0 7.0 9.3 8.9 9.3 12.3 7.7 20.8 3.7 11.3 5.6 6.6 23.9 7.8 5.3 30.7 7.5 10.8 15.6 7.3 8.9 9.0 9.0 8.9 3.0 9.9 6.9 10.4 8.4 10.9 9.4 16.9 14.7 17.2 10.9 7.1 4.2 12.8 7.0 24.5 5.6 6.0 10.3 11.3 4.6 6.9 11.5 9.8 8.1 6.7 4.6 8.3 20.9 10.3 5.6 9.1 2.9 15.9 5.4 4.7 11.8 6.2 7.2 7.0 8.3 14.1 4.9 7.1 6.6 6.3 5.2 11.8 4.6 6.7 7.3 11.3 14.6 14.0 22.4 12.6 8.9 18.2 13.1 15.5 16.0 6.0 5.1 3.9 2.0 8.0 6.9 1.0 0.0 13.4 1.2 0.0 0.0 7.6 5.0 4.0 1.3 4.3 4.5 0.0 2.5 8.0 4.6 4.3 9.2 43.3 16.1 9.5 6.9 5.5 16.4 0.9 4.4 8.7 10.1 5.4 5.3 3.4 3.4 6.8 6.0 7.9 6.5 12.9 5.6 10.6 14.9 10.7 5.8 4.9 5.3 1.0 C17orf100 LOC388327 ENSG00000256806 "Chromosome 17 open reading frame 100" 17 6651718-6693202 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 18.4" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 26.3;Late spermatids: 35.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 11.6;SH-SY5Y: 11.5" HPA046824 Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA046824: AB_2679825" "unprognostic (9.24e-3)" "unprognostic (1.79e-1)" "unprognostic (3.16e-1)" "unprognostic (6.37e-3)" "unprognostic (1.56e-1)" "unprognostic (1.90e-2)" "unprognostic (1.19e-1)" "unprognostic (8.99e-2)" "unprognostic (2.69e-1)" "unprognostic (2.02e-3)" "unprognostic (2.58e-3)" "unprognostic (4.72e-2)" "unprognostic (5.54e-3)" "unprognostic (4.52e-2)" "unprognostic (9.68e-2)" "unprognostic (9.44e-2)" "unprognostic (7.65e-2)" 0.8 1.5 1.4 1.6 3.3 0.1 1.4 3.8 5.6 2.3 2.4 4.0 1.2 3.6 1.5 2.8 2.1 1.7 1.5 0.3 1.5 2.2 18.4 1.2 3.5 1.3 2.5 1.1 8.5 2.5 9.1 0.6 3.0 2.2 1.6 0.8 5.2 1.1 0.3 9.3 4.3 0.7 1.6 2.2 2.8 3.6 2.3 1.6 3.3 0.2 1.1 1.7 0.5 5.7 3.1 7.5 2.4 2.5 5.5 1.9 1.3 2.5 5.7 1.8 0.8 1.6 2.7 0.7 4.1 1.7 3.4 3.8 1.8 1.5 2.9 1.3 4.4 4.9 1.1 2.6 2.5 6.5 7.5 1.4 2.6 11.6 2.0 0.2 3.9 2.3 2.5 0.8 1.8 5.0 1.0 8.0 1.8 1.5 2.2 2.8 1.6 2.4 0.8 2.3 1.7 3.1 0.9 2.3 3.4 1.1 5.9 11.5 3.4 0.4 3.9 1.8 3.0 0.4 1.5 1.6 3.3 0.9 1.3 2.1 1.4 1.0 1.4 0.5 3.7 5.7 1.9 7.5 2.5 2.4 3.4 4.3 4.6 2.9 3.1 5.7 5.5 3.0 1.8 2.5 2.3 1.0 3.0 1.9 0.0 1.7 0.0 4.6 2.5 3.7 0.3 0.0 2.7 5.7 0.0 2.0 1.3 1.7 3.4 26.3 1.0 5.9 0.0 2.9 1.4 1.5 3.9 9.2 0.0 1.1 1.6 7.5 0.0 0.0 35.6 0.9 1.0 1.7 1.0 5.4 5.2 2.8 3.5 1.8 2.1 5.2 6.5 2.5 11.1 4.2 2.6 1.3 0.5 3.0 4.7 C17orf49 "BAP18, HEPIS, MGC49942" ENSG00000258315 "Chromosome 17 open reading frame 49" Q8IXM2 17 7014495-7017525 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 100.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022961, HPA024457" Supported Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (1.48e-2)" "unprognostic (1.67e-3)" "unprognostic (9.09e-2)" "unprognostic (5.15e-2)" "unprognostic (4.54e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (7.62e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-2)" "unprognostic (2.25e-2)" "unprognostic (1.49e-2)" "unprognostic (1.06e-9)" "unprognostic (5.68e-2)" "unprognostic (1.74e-1)" "unprognostic (1.41e-2)" "unprognostic (4.62e-2)" 28.3 21.9 32.7 30.7 29.1 55.4 25.8 24.9 32.1 21.4 20.7 20.9 13.9 18.5 19.1 29.9 29.7 27.2 25.6 25.6 28.4 24.5 23.3 34.3 30.4 45.2 25.9 21.1 19.0 25.1 20.8 20.9 29.7 19.7 20.4 23.2 22.5 22.7 16.8 32.7 30.2 19.2 18.4 23.1 44.6 18.4 21.8 17.9 60.4 31.4 30.7 53.7 25.7 18.8 52.3 78.9 48.8 49.8 82.3 48.3 40.4 18.3 24.5 38.8 30.0 27.7 39.4 13.3 10.0 16.4 20.1 16.5 12.0 15.2 17.7 27.7 23.9 6.5 15.3 9.6 19.4 15.4 61.7 25.6 15.9 7.8 23.1 20.8 10.1 21.3 24.7 26.2 15.0 30.4 14.5 31.4 14.4 5.8 50.6 24.5 21.0 16.6 33.9 12.9 21.1 14.4 10.4 11.4 25.6 22.7 12.3 10.6 30.1 17.6 9.1 17.7 14.6 11.5 13.1 17.1 11.7 14.5 19.7 25.4 18.2 10.3 5.9 18.3 15.1 16.7 48.8 37.6 34.4 47.0 49.8 29.8 52.3 48.3 47.0 57.6 50.6 32.3 35.7 34.3 82.3 37.1 78.9 47.9 40.4 32.7 29.1 24.9 32.1 28.4 24.5 25.9 21.1 19.7 17.9 3.0 10.1 19.8 5.3 9.3 1.0 0.4 0.0 4.0 7.9 1.8 0.0 9.5 14.9 15.3 0.1 9.3 5.6 0.0 20.0 13.6 6.9 2.7 17.4 1.5 9.7 0.0 29.4 8.0 8.7 1.0 3.7 18.0 23.6 100.0 10.0 2.0 18.7 13.6 1.4 3.7 3.9 6.5 15.5 4.6 18.8 10.3 8.7 20.8 16.0 4.6 C17orf53 MGC3130 ENSG00000125319 "Chromosome 17 open reading frame 53" Q8N3J3 17 44141906-44162476 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA synthesis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1" "Cell type enhanced" "Detected in some" 12 "Extravillous trophoblasts: 7.0;Late spermatids: 5.5;Spermatocytes: 8.9;Spermatogonia: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA023004, HPA023393, HPA024430" Uncertain Approved Nucleoplasm,Cytosol NA Yes "Nucleoplasm, Cytosol" "HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879" "unprognostic (1.72e-1)" "unprognostic (5.95e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.59e-1)" "unprognostic (7.37e-2)" "prognostic unfavorable (3.46e-4)" "prognostic unfavorable (9.39e-4)" "unprognostic (1.90e-1)" "unprognostic (2.89e-1)" "unprognostic (3.66e-4)" "unprognostic (2.86e-1)" "unprognostic (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (5.88e-2)" "unprognostic (3.65e-2)" "unprognostic (8.40e-2)" 2.0 0.7 0.5 3.5 0.4 13.4 2.0 2.8 1.4 1.2 1.5 0.6 0.5 1.4 1.3 1.1 4.0 0.9 1.4 1.9 0.8 0.7 0.8 0.8 1.3 2.4 0.5 0.2 1.3 1.2 0.7 0.7 2.3 1.0 1.0 1.7 0.6 1.1 1.1 1.8 2.4 2.2 1.1 0.5 1.9 1.0 32.1 0.4 8.2 0.5 1.5 4.8 0.8 1.7 1.4 3.7 0.9 1.1 0.3 2.0 0.6 7.5 9.5 7.5 6.7 0.6 2.1 8.9 5.9 5.2 11.5 12.6 9.7 4.7 8.1 5.3 5.2 12.0 6.6 9.7 9.4 10.2 9.1 12.2 5.2 8.7 6.5 0.3 5.7 6.5 1.7 1.4 14.2 7.1 1.5 4.8 8.9 11.7 10.6 5.6 5.6 13.5 8.5 5.1 3.5 9.3 8.5 12.0 10.0 2.7 6.1 4.7 2.7 3.6 3.6 2.9 8.9 7.2 6.6 2.2 11.1 8.7 7.5 8.6 6.1 10.2 7.0 5.2 4.4 6.3 0.0 1.1 0.9 1.1 0.8 0.4 0.8 0.8 0.2 0.4 1.4 0.6 0.4 0.0 0.3 0.4 3.7 2.0 0.6 0.5 0.4 2.8 1.4 0.8 0.7 0.5 0.2 1.0 0.4 0.0 0.0 0.5 0.6 1.6 0.2 0.8 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.5 2.5 0.1 0.0 0.0 0.2 7.0 0.7 0.3 0.0 0.2 2.5 0.0 0.0 0.0 0.0 5.5 0.3 0.0 0.0 0.0 0.2 0.5 0.7 0.0 1.1 0.2 0.0 0.0 0.3 8.9 13.0 1.0 1.5 0.0 0.6 0.3 C17orf58 ENSG00000186665 "Chromosome 17 open reading frame 58" Q2M2W7 17 67991101-67996431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 31.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 110.1" HPA023036 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023036: AB_10601144" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (6.66e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (7.65e-3)" "prognostic unfavorable (8.99e-4)" "unprognostic (7.45e-2)" "unprognostic (2.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.22e-2)" "unprognostic (6.69e-2)" "prognostic unfavorable (1.31e-10)" "unprognostic (1.16e-2)" "unprognostic (1.04e-1)" "unprognostic (5.00e-2)" "unprognostic (1.01e-1)" 11.1 6.8 10.7 6.2 9.3 3.5 17.3 8.8 11.5 29.0 8.3 5.7 8.3 4.1 15.4 8.1 6.5 8.1 6.6 8.9 7.7 6.3 6.3 9.1 6.2 3.1 7.4 5.0 6.3 10.4 5.2 3.6 33.3 5.2 7.8 7.5 5.7 5.3 4.0 6.9 3.7 6.1 11.8 5.5 5.1 6.6 4.8 4.4 1.1 6.9 4.5 6.8 11.0 11.7 3.6 5.2 9.5 6.3 3.2 3.0 2.2 5.3 5.3 5.3 6.5 3.8 9.8 4.2 2.2 6.4 3.9 6.4 3.1 7.0 7.1 5.1 1.8 7.0 2.8 12.0 4.8 9.6 12.8 12.1 4.6 2.0 9.7 6.1 3.9 8.5 5.3 5.8 3.8 8.9 4.4 18.4 6.3 9.8 11.1 3.8 7.1 0.7 5.2 6.0 13.0 5.6 1.7 5.8 9.5 4.9 3.6 3.9 7.2 3.4 31.5 11.5 6.8 8.9 4.6 3.4 3.4 3.5 2.4 4.6 22.3 16.3 6.3 8.5 6.9 5.9 9.5 3.8 6.3 3.0 3.6 1.0 3.6 1.1 2.4 5.2 0.8 0.5 1.2 1.5 3.2 6.3 0.2 0.5 2.2 10.7 9.3 8.8 11.5 7.7 6.3 7.4 5.0 5.2 4.4 0.0 1.7 3.7 5.6 4.2 8.6 4.4 5.1 18.7 2.3 10.4 9.8 23.3 19.9 9.6 0.6 13.6 8.0 0.0 8.1 18.2 27.4 13.3 12.7 13.1 15.0 4.8 3.5 11.1 7.5 1.4 3.4 8.9 8.5 27.9 13.0 29.6 8.9 10.5 4.9 15.0 13.6 6.5 10.3 6.0 3.6 7.3 12.8 4.6 9.5 6.0 C17orf75 "NJMU-R1, SRI2" ENSG00000108666 "Chromosome 17 open reading frame 75" Q9HAS0 17 32324565-32350023 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 76.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004061, HPA075333" Approved Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA004061: AB_1078337, HPA075333: " "unprognostic (4.21e-2)" "unprognostic (2.49e-2)" "unprognostic (3.32e-2)" "unprognostic (2.28e-1)" "unprognostic (1.51e-1)" "unprognostic (4.73e-2)" "unprognostic (1.07e-3)" "unprognostic (6.36e-2)" "unprognostic (3.29e-1)" "prognostic favorable (3.13e-4)" "unprognostic (1.92e-2)" "unprognostic (7.80e-2)" "prognostic favorable (1.33e-4)" "unprognostic (3.09e-1)" "unprognostic (1.29e-1)" "unprognostic (4.27e-2)" "unprognostic (5.60e-2)" 6.9 17.3 16.6 8.2 21.2 5.7 13.1 25.8 23.9 8.7 10.1 12.7 10.9 10.5 12.7 15.6 9.9 14.7 6.9 18.6 13.4 14.8 19.6 12.7 8.0 10.8 13.8 14.1 16.0 11.3 16.6 17.2 9.3 21.1 11.8 11.3 11.7 11.8 11.8 15.0 8.0 9.2 11.0 11.3 10.8 10.9 20.4 13.3 11.7 16.4 8.3 11.3 9.7 8.9 15.0 13.7 18.4 12.3 13.7 16.4 13.0 13.3 14.6 21.1 7.5 6.2 8.2 11.0 9.7 10.7 15.7 13.9 7.3 5.2 9.2 11.3 8.9 20.5 15.1 17.4 13.3 22.5 6.5 16.9 7.4 13.5 13.5 13.4 10.5 6.2 6.5 16.1 11.3 8.1 12.3 11.9 16.3 14.5 13.4 10.3 11.1 29.5 9.1 13.5 8.7 8.0 18.7 13.9 16.1 9.3 7.5 20.7 17.0 8.6 7.6 20.4 14.0 19.4 6.4 7.3 8.2 13.0 3.8 15.1 16.0 18.1 31.8 6.3 9.2 2.4 18.4 10.6 13.2 16.0 8.8 16.4 14.5 14.6 15.4 13.7 15.0 16.1 15.1 3.5 13.7 12.3 10.4 15.0 13.0 16.6 21.2 25.8 23.9 13.4 14.8 13.8 14.1 21.1 13.3 11.9 40.3 5.2 11.6 5.3 23.1 23.8 2.5 36.1 13.6 14.0 7.9 27.4 36.5 14.5 5.3 9.8 4.7 46.7 12.0 14.8 7.9 6.4 10.5 9.8 8.5 30.2 12.1 7.4 10.3 4.9 6.9 7.7 5.0 4.6 7.1 16.9 10.7 2.9 7.8 23.0 21.0 38.8 9.0 76.3 27.9 5.4 13.6 14.9 8.8 5.1 C17orf97 "LIAT1, LOC400566" ENSG00000187624 "Chromosome 17 open reading frame 97" Q6ZQX7 17 410327-431062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.2" "Group enriched" "Detected in many" 11 "Early spermatids: 432.9;Late spermatids: 984.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 8.9;U-2197: 11.8" HPA023583 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023583: AB_1853122" "unprognostic (6.62e-2)" "unprognostic (9.12e-3)" "unprognostic (2.64e-1)" "unprognostic (3.07e-3)" "unprognostic (7.73e-2)" "unprognostic (6.51e-2)" "unprognostic (6.91e-2)" "unprognostic (3.17e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-1)" "unprognostic (5.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.98e-3)" "unprognostic (7.70e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-2)" "unprognostic (4.19e-2)" 2.1 4.9 6.0 2.4 10.6 1.9 2.7 5.2 8.7 3.9 3.6 4.2 4.4 2.2 3.5 4.5 2.4 13.6 6.6 3.8 5.2 6.1 7.6 1.9 3.8 2.8 4.0 7.6 3.8 3.8 3.4 8.2 1.4 6.2 3.3 2.9 4.2 3.5 5.8 4.3 2.5 4.7 1.9 2.8 2.1 2.4 53.2 2.9 5.0 6.9 1.8 1.9 3.1 1.8 0.4 0.9 2.7 0.4 0.8 1.4 0.2 2.6 3.8 1.8 2.2 1.0 0.8 0.9 2.0 1.3 1.5 0.9 0.1 4.0 0.7 1.5 4.3 1.2 8.9 4.8 1.0 1.4 0.3 0.6 1.9 3.3 0.3 3.4 0.4 0.8 1.0 2.5 3.3 0.4 2.2 1.5 4.4 0.3 0.1 1.0 2.2 6.4 3.4 2.8 7.9 1.2 0.7 0.4 2.4 6.2 2.2 0.6 2.1 2.4 3.4 0.5 3.2 2.0 2.9 1.4 1.8 0.9 11.8 0.8 0.2 0.2 0.0 2.3 0.9 1.1 0.4 0.4 2.7 0.3 0.2 0.0 0.2 0.2 0.8 0.5 0.4 1.4 1.3 0.2 0.8 0.4 0.9 0.0 0.2 6.0 10.6 5.2 8.7 5.2 6.1 4.0 7.6 6.2 2.9 3.0 5.1 0.0 3.8 3.0 4.3 5.3 10.2 62.9 11.4 19.2 19.6 0.9 53.0 10.2 432.9 1.8 10.5 23.3 3.1 0.2 3.7 3.9 2.3 4.7 1.7 1.6 15.4 1.8 0.0 984.3 7.8 2.5 3.3 4.6 9.3 10.0 4.7 5.8 6.0 19.3 22.2 6.5 2.1 58.4 13.3 0.9 0.7 0.0 8.5 0.9 C18orf25 "ARKL1, MGC12909, RNF111L1" ENSG00000152242 "Chromosome 18 open reading frame 25" Q96B23 18 46173553-46266991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 54.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051314, HPA051899" Approved Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA051314: AB_2681438, HPA051899: AB_2681657" "unprognostic (1.44e-2)" "unprognostic (2.32e-1)" "unprognostic (2.08e-2)" "unprognostic (5.77e-3)" "unprognostic (4.46e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.97e-1)" "unprognostic (7.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.43e-1)" "unprognostic (5.80e-2)" "unprognostic (3.27e-2)" "unprognostic (1.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" 5.3 4.9 5.8 6.4 8.2 18.6 6.5 10.1 10.1 6.1 4.9 5.5 6.5 4.4 7.7 5.3 54.0 6.2 3.8 11.4 4.8 4.9 5.4 6.2 5.9 6.8 5.3 6.5 5.9 5.0 15.3 6.3 7.3 8.3 5.2 5.7 9.5 11.3 4.8 13.1 6.2 5.5 5.7 4.7 6.3 5.1 7.8 5.7 8.2 7.4 10.2 11.8 7.2 12.7 8.1 11.0 19.0 11.0 2.8 11.1 5.5 11.2 11.3 9.5 10.8 6.8 6.2 12.2 16.4 8.7 17.6 15.0 8.7 13.0 8.7 15.7 11.1 6.3 25.8 17.6 11.1 19.2 14.5 5.6 7.6 9.7 6.5 11.8 14.3 10.4 5.7 13.1 20.5 17.1 10.3 6.9 8.2 8.5 10.4 9.7 8.5 10.8 7.3 8.4 3.9 4.5 9.9 11.3 12.8 16.9 20.4 13.4 7.0 12.0 8.6 8.5 12.1 5.6 8.9 10.1 16.1 11.5 3.9 15.1 13.7 11.6 14.1 8.3 15.2 17.2 4.2 7.5 15.4 5.7 8.4 9.9 5.9 11.1 8.6 7.4 8.1 8.0 6.3 19.0 2.8 11.0 11.0 7.1 5.5 5.8 8.2 10.1 10.1 4.8 4.9 5.3 6.5 8.3 5.7 11.9 10.8 11.5 9.5 22.3 13.2 26.0 10.2 8.1 4.5 14.0 19.6 5.7 1.7 7.4 2.1 15.5 9.5 0.0 5.7 8.3 10.4 10.0 15.0 12.5 7.9 12.7 11.5 8.0 10.4 2.5 7.5 11.4 6.8 4.6 8.3 9.8 14.0 10.5 9.9 6.5 29.9 19.4 10.8 16.7 12.4 27.9 20.4 11.7 9.2 16.9 C19orf12 "DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43" ENSG00000131943 "Chromosome 19 open reading frame 12" Q9NSK7 19 29698886-29715789 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 57.4" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046930 Approved Supported Cytosol NA NA Cytosol "HPA046930: AB_10962836" "unprognostic (1.76e-1)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.01e-2)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.54e-1)" "unprognostic (9.94e-3)" "unprognostic (7.93e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (3.22e-1)" "unprognostic (1.22e-3)" 57.4 14.7 11.9 7.6 11.3 2.3 33.9 10.5 14.3 7.2 7.7 5.8 5.4 10.8 7.1 7.6 7.5 6.2 8.7 14.0 9.5 11.6 11.5 36.9 5.6 11.4 10.3 10.7 7.8 9.6 7.7 6.9 7.4 11.1 6.7 5.5 10.5 9.5 7.6 27.5 8.2 9.6 7.6 6.5 7.5 6.0 4.2 5.2 8.9 5.4 9.2 7.4 7.2 11.0 3.7 4.3 2.3 2.1 5.6 14.3 6.0 10.5 20.9 10.3 12.8 25.6 15.9 15.9 12.5 12.5 12.6 16.4 10.0 4.3 8.6 13.4 15.8 11.4 4.6 8.6 5.3 8.5 22.6 15.1 9.6 6.9 17.2 14.4 7.4 12.8 18.1 11.2 7.5 6.1 10.1 11.3 5.4 7.3 11.2 13.0 7.3 5.2 5.4 6.1 9.2 5.2 10.3 10.6 6.6 9.6 10.6 6.3 13.3 7.5 9.8 19.6 11.0 4.1 8.3 11.3 26.7 20.8 10.8 11.3 15.8 14.0 6.4 15.9 4.5 11.1 0.9 2.0 1.0 14.3 2.1 8.2 3.7 8.1 10.2 1.8 3.2 8.5 10.5 2.3 5.6 2.1 4.3 9.7 6.0 11.9 11.3 10.5 14.3 9.5 11.6 10.3 10.7 11.1 5.2 11.9 13.6 13.0 9.8 11.3 15.3 26.8 2.5 8.1 7.9 8.7 5.9 25.1 13.3 15.4 1.3 9.0 12.0 0.0 20.0 23.3 16.7 9.2 16.1 57.8 13.4 4.8 3.5 12.9 11.3 1.5 26.7 10.8 10.1 27.1 6.4 10.3 17.3 10.5 27.6 30.5 8.4 6.5 10.3 3.6 4.1 6.8 18.3 17.0 8.1 7.5 C19orf33 "H2RSP, IMUP, IMUP-1, IMUP-2" ENSG00000167644 "Chromosome 19 open reading frame 33" Q9GZP8 19 38304161-38305009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 105.8;tongue: 78.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1588.2;Exocrine glandular cells: 683.1;Mucus-secreting cells: 800.2;Pancreatic endocrine cells: 1532.5;Paneth cells: 1006.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 11 "myeloid DC: 15.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.1" "Cell line enhanced" "Detected in some" "A-431: 70.1;A549: 108.2;CAPAN-2: 66.8;HBEC3-KT: 64.8;hTCEpi: 67.9;OE19: 57.5;PC-3: 61.8" "HPA054406, HPA059696" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA054406: AB_2682478, HPA059696: AB_2684105" "unprognostic (9.31e-2)" "unprognostic (2.06e-1)" "unprognostic (4.34e-2)" "unprognostic (1.44e-2)" "unprognostic (3.92e-3)" "unprognostic (2.37e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.09e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (6.92e-2)" "unprognostic (5.50e-2)" "unprognostic (4.82e-2)" "unprognostic (1.61e-1)" "unprognostic (3.63e-2)" "unprognostic (6.01e-2)" 6.9 0.6 0.5 16.4 0.7 0.3 5.0 0.5 0.8 14.5 58.8 0.6 3.5 34.6 3.9 4.3 88.4 18.2 45.2 9.9 0.8 0.3 5.8 1.0 34.8 0.6 0.7 1.4 4.9 0.8 0.0 2.0 10.0 1.7 10.3 18.2 1.2 21.5 6.8 2.8 53.3 105.8 2.9 3.1 1.9 28.7 1.5 0.5 1.5 4.4 78.5 39.2 16.2 35.1 0.1 15.1 1.4 0.6 0.3 0.4 14.6 70.1 108.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 66.8 0.0 40.1 0.0 0.0 26.3 0.0 64.8 0.0 0.0 0.0 0.0 22.7 1.8 0.5 0.0 0.0 0.0 67.9 0.0 43.6 0.1 1.1 0.0 0.0 0.0 0.0 18.1 0.0 0.1 0.1 57.5 61.8 0.0 0.0 0.0 41.0 20.8 0.1 0.0 41.0 29.7 0.0 0.1 9.2 0.2 14.6 0.0 20.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.6 1.4 0.3 0.0 0.3 0.1 0.2 0.1 15.1 0.1 0.4 0.3 0.9 0.3 0.0 0.9 0.0 14.6 0.5 0.7 0.5 0.8 0.8 0.3 0.7 1.4 1.7 0.5 497.3 155.5 7.0 25.1 200.2 0.0 1.4 298.1 195.4 353.8 52.4 0.0 5.2 1.7 144.5 0.4 9.8 1588.2 0.0 683.1 1.0 5.6 22.7 39.1 0.0 1.3 0.0 73.3 4.9 1.6 2.8 3.7 8.2 1.7 4.6 800.2 0.0 1532.5 1006.5 0.0 21.6 0.0 0.0 5.0 1.4 1.9 304.5 2.6 0.0 506.3 112.5 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.7;bone marrow: 54.4" "Cell type enhanced" "Detected in many" 18 "Kupffer cells: 101.9;Macrophages: 32.6;monocytes: 24.4;Spermatocytes: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 19 "classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7" "Group enriched" "Detected in many" 19 "dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7" "Cell line enriched" "Detected in some" 4 "U-937: 32.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" No NA Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favorable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 2.7 1.2 2.1 6.9 4.0 54.4 1.8 0.7 3.1 2.0 1.3 4.8 0.0 1.3 0.9 4.0 0.9 2.6 2.1 5.6 2.4 2.1 1.4 2.3 12.8 19.6 4.2 0.6 1.6 1.3 0.3 1.0 1.9 3.8 1.6 1.0 1.5 1.0 0.8 2.3 0.6 1.7 2.3 6.3 22.3 1.2 15.0 3.7 4.1 0.7 0.5 2.0 2.8 3.5 2.1 26.2 37.3 58.7 1.2 0.8 20.7 1.5 0.0 0.1 0.3 1.5 0.8 0.1 0.2 0.0 0.3 0.6 0.1 0.2 3.8 0.3 0.0 0.1 0.1 0.2 0.2 0.2 1.7 0.4 0.2 0.0 0.0 1.1 2.5 0.4 4.1 0.4 0.7 0.2 0.1 0.1 0.4 0.2 8.1 0.1 1.4 0.1 5.9 0.3 0.2 0.3 2.8 0.0 1.9 0.0 0.1 0.2 0.1 0.8 0.0 0.6 0.1 0.1 5.6 0.0 0.0 0.0 0.7 0.0 4.9 2.3 1.1 0.0 32.8 0.0 1.2 44.3 26.1 0.1 48.7 0.2 2.1 0.1 0.1 26.2 1.2 0.8 0.2 37.3 1.2 58.7 0.5 0.3 20.7 2.1 4.0 0.7 3.1 2.4 2.1 4.2 0.6 3.8 3.7 0.0 2.6 12.3 0.3 0.7 0.0 0.6 0.0 2.7 1.2 1.8 2.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 1.1 0.6 1.1 0.4 2.3 0.9 21.2 0.0 0.0 0.0 101.9 5.3 0.9 32.6 1.7 24.4 0.5 2.3 0.2 3.5 0.7 0.4 1.0 6.5 0.1 27.0 15.8 0.6 0.6 0.8 0.3 0.6 C19orf66 "FLJ11286, IRAV, RyDEN" ENSG00000130813 "Chromosome 19 open reading frame 66" Q9NUL5 19 10086122-10093252 "Predicted intracellular proteins" "Antiviral defense" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.9;BJ hTERT+ SV40 Large T+ RasG12V: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042001 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042001: AB_10794167" "prognostic favorable (4.04e-4)" "unprognostic (1.21e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (2.19e-2)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (3.93e-1)" "unprognostic (6.57e-2)" "unprognostic (4.22e-3)" "unprognostic (2.34e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (8.96e-11)" "unprognostic (5.92e-2)" "unprognostic (1.81e-1)" "unprognostic (4.41e-3)" "prognostic favorable (1.35e-4)" 9.8 13.8 13.7 17.6 12.1 9.0 9.9 10.6 16.9 14.5 11.2 8.4 10.3 9.6 12.6 14.1 8.9 16.4 15.5 6.9 11.0 13.9 11.5 55.8 11.6 14.4 9.0 13.5 14.5 10.0 14.1 12.8 9.8 10.0 12.4 6.1 11.6 13.0 15.8 3.7 7.6 14.2 9.7 8.6 14.0 8.3 3.7 8.6 9.8 11.9 5.4 13.0 12.9 10.1 8.8 6.7 11.6 12.0 17.5 21.2 10.0 2.8 1.6 1.7 1.3 6.6 8.9 0.7 3.3 18.4 24.9 26.4 0.2 2.4 1.7 1.0 8.7 7.5 1.2 0.8 6.2 0.4 12.0 0.0 5.2 1.2 4.1 12.9 1.8 2.9 16.0 4.6 3.9 0.6 8.3 7.1 7.2 0.7 6.9 5.0 2.3 5.9 3.5 0.4 2.6 2.5 5.4 0.0 3.2 3.7 4.4 0.2 1.5 4.8 0.4 14.1 0.1 0.2 4.7 5.2 2.1 1.0 2.8 0.4 8.4 2.6 0.4 5.7 1.6 4.2 11.1 8.3 11.6 15.9 7.4 21.2 8.8 13.5 17.1 6.7 6.9 11.5 12.1 10.8 17.5 12.0 1.3 13.9 10.0 13.7 12.1 10.6 16.9 11.0 13.9 9.0 13.5 10.0 8.6 20.8 26.6 27.2 22.7 13.4 62.6 2.5 22.9 16.0 37.5 26.2 35.3 4.8 14.9 28.5 8.9 40.5 24.0 0.0 30.6 5.1 30.4 24.7 31.1 94.1 28.7 52.4 17.9 46.1 23.4 23.8 37.7 26.6 16.9 57.7 15.9 33.5 32.5 20.1 35.7 11.1 32.9 71.1 26.4 1.6 3.2 13.2 2.2 64.3 11.5 18.6 C19orf71 LOC100128569 ENSG00000183397 "Chromosome 19 open reading frame 71" A6NCJ1 19 3539154-3544030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 88.8" "Group enriched" "Detected in some" 58 "Early spermatids: 515.2;Late spermatids: 237.4" "Cancer enriched" "Detected in all" 5 "melanoma: 23.7" "Region enriched" "Detected in all" 4 "cerebellum: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HeLa: 27.3;SK-MEL-30: 16.6;WM-115: 59.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048654 Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Endoplasmic reticulum" "HPA048654: AB_2680480" "unprognostic (1.06e-1)" "unprognostic (1.21e-1)" "unprognostic (7.04e-3)" "unprognostic (7.37e-2)" "unprognostic (4.74e-2)" "prognostic favorable (2.35e-4)" "unprognostic (4.21e-1)" "unprognostic (2.00e-1)" "unprognostic (7.23e-2)" "unprognostic (3.13e-2)" "prognostic favorable (2.03e-5)" "unprognostic (6.19e-2)" "prognostic favorable (2.02e-5)" "unprognostic (5.52e-3)" "unprognostic (1.02e-1)" "unprognostic (3.84e-2)" "unprognostic (1.97e-3)" 1.6 2.3 1.6 4.1 2.2 5.1 1.6 9.8 2.2 1.7 1.6 2.0 1.6 4.7 2.5 1.9 1.6 2.6 1.6 1.6 1.6 1.3 3.5 1.6 2.1 4.9 1.8 1.9 2.8 4.2 0.0 4.5 1.6 1.7 2.2 0.0 1.6 7.6 1.6 1.6 7.4 3.9 1.6 1.6 5.2 3.2 88.8 1.8 1.6 6.3 1.6 1.6 1.7 1.6 0.3 0.5 0.0 0.2 0.0 0.7 0.1 5.3 4.4 1.4 2.0 0.0 0.0 2.9 3.4 0.0 0.0 0.0 2.7 1.6 0.9 2.6 0.0 7.4 4.8 0.0 0.2 0.0 5.4 2.6 0.7 27.3 0.8 0.0 0.7 3.4 0.0 0.0 0.1 0.0 1.6 0.0 2.5 3.7 4.9 0.0 3.8 1.1 1.7 1.2 0.1 1.3 1.8 2.1 5.0 0.0 2.1 3.4 3.1 5.9 3.0 16.6 0.7 3.3 1.7 4.5 2.7 3.6 8.2 3.1 3.9 1.0 1.4 8.1 3.2 59.5 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.2 0.5 0.0 0.1 1.6 2.2 9.8 2.2 1.6 1.3 1.8 1.9 1.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 515.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 237.4 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 6.5 0.0 2.8 1.5 0.0 0.1 0.0 0.0 0.0 C19orf73 FLJ10490 ENSG00000221916 "Chromosome 19 open reading frame 73" Q9NVV2 19 49118397-49119140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Basal glandular cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 12.7" HPA062719 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062719: AB_2684847" "unprognostic (3.02e-1)" "unprognostic (3.75e-2)" "unprognostic (2.25e-1)" "unprognostic (5.53e-2)" "unprognostic (2.04e-2)" "unprognostic (4.39e-3)" "unprognostic (2.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.92e-1)" "unprognostic (1.97e-3)" "prognostic favorable (1.58e-4)" "unprognostic (3.05e-1)" "unprognostic (9.00e-5)" "unprognostic (1.19e-1)" "unprognostic (6.70e-2)" "unprognostic (1.91e-1)" "unprognostic (5.13e-3)" 2.5 3.4 5.0 2.3 6.7 1.0 3.7 10.2 8.7 1.4 3.9 4.1 3.1 7.7 1.3 5.6 2.6 1.4 2.1 3.5 4.9 4.5 2.5 4.8 1.5 2.3 9.2 4.9 0.7 12.9 3.3 5.4 1.4 5.0 2.5 2.9 1.8 6.3 2.1 3.6 4.1 4.4 1.3 4.7 3.6 2.9 2.1 5.6 1.1 3.1 1.2 1.7 1.5 1.4 6.2 5.5 0.7 4.1 7.9 4.6 2.3 2.4 3.1 1.2 6.0 2.0 0.4 1.3 0.7 0.4 1.3 0.9 0.2 1.4 1.8 0.7 0.5 1.9 1.6 1.6 0.2 0.2 3.5 12.7 1.5 1.9 2.0 2.0 0.0 0.7 0.2 4.1 0.9 3.4 1.0 0.4 6.2 2.8 2.9 0.6 2.6 1.9 1.8 0.9 2.6 0.6 1.8 2.4 2.3 2.3 1.0 6.3 2.9 1.2 1.5 2.3 0.9 1.5 0.6 1.2 1.6 2.7 0.5 0.6 1.8 3.4 2.0 1.1 2.1 1.8 0.0 3.3 0.7 2.9 1.9 4.6 2.7 2.2 2.6 5.5 6.2 4.3 3.2 0.1 7.9 4.1 4.2 1.9 2.3 5.0 6.7 10.2 8.7 4.9 4.5 9.2 4.9 5.0 5.6 0.0 0.0 4.5 8.9 1.9 3.6 0.7 5.1 1.4 1.2 3.5 0.0 0.7 3.3 2.2 0.4 0.5 3.3 0.0 1.7 0.8 1.4 6.4 0.0 3.9 1.2 1.6 2.9 1.8 1.2 0.7 0.0 1.3 3.3 0.0 4.2 3.4 1.9 0.0 1.4 7.0 4.3 0.0 1.1 0.4 3.4 2.3 0.3 1.8 4.7 3.5 C1GALT1 "C1GALT, T-synthase" ENSG00000106392 "Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1" Q9NS00 7 7156934-7248651 "Enzymes, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 171.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "LHCN-M2: 81.9" "Low region specificity" "Detected in all" "HPA011294, HPA012819" Enhanced Approved "Nuclear bodies,Cytosol" NA NA 10000 "Nuclear bodies, Cytosol" "HPA011294: AB_1845623, HPA012819: AB_1845624" "unprognostic (1.52e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (7.38e-2)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.42e-5)" "unprognostic (2.03e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-1)" "unprognostic (3.28e-1)" "unprognostic (8.28e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-1)" 11.4 7.7 10.1 12.4 14.1 23.1 11.0 10.6 14.9 13.9 10.7 21.5 4.0 19.3 5.4 7.1 24.7 12.7 16.1 11.6 12.8 10.8 21.5 14.7 10.9 11.7 23.7 8.9 6.2 6.2 42.3 11.0 30.2 19.2 5.7 12.2 8.1 17.6 5.7 8.1 8.6 15.8 5.3 31.0 13.8 15.3 5.4 21.4 12.9 10.6 6.2 11.6 10.3 8.4 15.9 13.5 33.2 26.0 16.6 17.4 12.2 18.9 8.2 2.5 4.3 7.5 15.8 8.8 21.8 16.3 10.2 15.1 5.6 19.7 8.9 5.6 8.6 27.4 6.1 3.7 8.2 16.1 5.3 3.0 8.4 4.9 15.5 8.2 8.8 3.7 12.9 5.8 25.0 19.3 12.8 8.3 8.9 18.0 5.6 81.9 3.2 2.4 4.3 15.9 12.6 8.9 8.0 14.9 5.4 11.5 8.4 3.1 8.2 13.8 15.6 14.8 16.2 4.9 4.5 8.7 16.3 25.3 23.2 8.8 10.7 9.1 10.1 10.8 11.9 18.1 33.2 11.1 31.2 16.1 16.5 16.9 15.9 15.0 17.4 12.2 13.7 15.7 17.0 24.3 16.6 26.0 13.5 13.0 12.2 10.1 14.1 10.6 14.9 12.8 10.8 23.7 8.9 19.2 21.4 38.7 50.4 35.6 14.0 23.4 22.1 22.0 30.6 18.7 21.6 17.4 31.4 79.2 5.0 23.7 13.7 11.7 21.0 0.0 22.7 66.8 16.9 13.7 11.5 19.5 32.6 44.5 15.0 11.6 19.3 12.2 6.1 21.9 21.9 10.0 20.0 23.0 35.5 17.5 6.0 37.2 32.9 6.5 8.9 15.0 29.3 16.9 171.3 29.2 26.5 17.1 C1orf100 ENSG00000173728 "Chromosome 1 open reading frame 100" Q5SVJ3 1 244352635-244389663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 65.3" "Group enriched" "Detected in some" 119 "Early spermatids: 1095.9;Late spermatids: 535.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 51 "K-562: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031179, HPA031180" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA031179: AB_10599995, HPA031180: AB_10599026" "unprognostic (9.84e-2)" "unprognostic (2.14e-3)" "unprognostic (3.37e-2)" "unprognostic (9.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.49e-2)" "unprognostic (5.45e-3)" "unprognostic (2.17e-2)" "unprognostic (4.00e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-5)" "unprognostic (1.85e-2)" "unprognostic (2.08e-3)" "unprognostic (2.53e-2)" "unprognostic (1.79e-1)" "unprognostic (2.85e-1)" "unprognostic (1.27e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1095.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 535.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 6.9 1.6 0.0 0.0 0.0 0.0 0.0 C1orf109 FLJ20508 ENSG00000116922 "Chromosome 1 open reading frame 109" Q9NX04 1 37681570-37692249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 44.6;Suprabasal keratinocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027110, HPA027127" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA027110: AB_10611813, HPA027127: AB_1845628" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-3)" "unprognostic (1.71e-2)" "unprognostic (7.13e-3)" "prognostic unfavorable (1.76e-7)" "unprognostic (1.93e-1)" "unprognostic (1.48e-2)" "unprognostic (8.38e-2)" "unprognostic (1.73e-1)" "unprognostic (3.79e-3)" "unprognostic (9.96e-2)" "unprognostic (1.66e-2)" "unprognostic (2.25e-1)" "unprognostic (7.96e-3)" "unprognostic (1.69e-1)" 13.8 15.1 12.0 9.3 15.0 9.3 14.5 17.9 20.5 12.9 11.1 11.4 16.2 11.0 15.9 14.3 13.7 13.9 10.5 11.1 13.1 12.9 12.8 12.0 8.8 14.1 13.6 15.0 19.7 19.6 20.5 10.9 14.6 15.9 15.0 7.8 12.9 20.3 14.8 15.2 14.9 8.5 11.6 9.9 10.1 11.1 11.2 12.2 13.1 15.7 9.1 12.6 13.7 12.8 11.4 27.5 3.3 5.0 12.2 16.2 7.5 8.3 9.6 8.3 13.6 7.3 5.2 18.9 10.0 7.1 15.2 11.2 14.6 10.1 11.9 12.1 4.4 7.0 12.2 15.3 10.2 15.6 18.9 17.2 13.5 9.7 9.1 14.1 14.7 8.9 7.1 12.6 14.9 19.5 6.6 7.6 10.5 26.5 14.5 8.6 5.7 14.2 6.5 25.8 8.6 18.5 14.2 17.4 32.5 8.0 7.2 25.1 12.1 8.8 13.7 20.3 8.7 7.7 6.6 5.1 15.3 9.6 12.3 20.3 11.8 13.1 24.3 7.6 14.4 16.0 1.7 5.0 3.3 10.3 3.9 16.1 11.4 12.4 9.9 5.9 10.3 16.2 13.8 0.9 12.2 4.2 27.5 6.2 7.5 12.0 15.0 17.9 20.5 13.1 12.9 13.6 15.0 15.9 12.2 6.0 6.4 16.6 16.0 44.6 9.7 4.5 7.6 6.7 15.9 3.5 9.8 11.8 11.6 8.2 1.2 10.5 4.0 23.3 6.3 11.6 13.5 9.8 11.5 4.9 4.9 15.9 4.1 5.5 4.3 0.2 9.2 4.9 11.8 7.2 4.5 10.1 8.1 7.0 13.1 6.8 12.2 0.0 10.3 10.1 26.6 54.3 6.6 13.8 7.3 9.6 C1orf116 "FLJ36507, MGC2742, MGC4309, SARG" ENSG00000182795 "Chromosome 1 open reading frame 116" Q9BW04 1 207018521-207032756 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 163.8;Alveolar cells type 2: 71.9;Club cells: 78.5;Urothelial cells: 120.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 18.2;CAPAN-2: 32.4;HaCaT: 40.0;HBEC3-KT: 38.4;hTCEpi: 20.4;RPTEC TERT1: 18.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA011888, HPA011889" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 7900 "Plasma membrane, Cytosol" "HPA011888: AB_1853872, HPA011889: AB_1853873" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.68e-1)" "unprognostic (2.35e-1)" "unprognostic (5.78e-2)" "unprognostic (3.27e-1)" "unprognostic (5.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.18e-2)" "unprognostic (2.87e-3)" "unprognostic (7.09e-3)" "prognostic favorable (1.01e-5)" "unprognostic (5.17e-1)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (1.19e-1)" 0.2 0.3 0.2 1.6 0.2 0.0 4.1 0.2 0.4 7.1 8.3 0.3 0.2 8.4 1.0 1.1 49.4 0.6 14.0 0.2 0.3 0.1 4.3 1.1 42.8 0.2 0.2 0.2 0.5 7.0 0.0 0.9 1.4 0.4 18.8 2.7 0.3 12.5 1.9 0.3 14.4 16.5 0.6 0.2 0.4 20.3 0.4 0.2 0.4 6.8 16.0 37.1 6.1 12.3 0.0 0.0 0.7 0.0 0.1 0.0 1.8 18.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 32.4 0.0 2.1 0.0 0.0 40.0 0.0 38.4 0.0 0.0 0.0 3.3 0.3 0.5 0.0 0.0 0.2 0.0 20.4 0.0 11.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 11.8 1.0 0.0 0.0 0.0 18.7 4.8 0.0 0.1 0.3 3.6 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.8 0.2 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.4 0.2 163.8 71.9 0.0 39.9 18.4 0.0 42.3 28.1 41.5 78.5 10.4 0.0 0.0 13.3 21.7 4.8 0.0 31.1 0.0 21.6 0.0 0.5 57.3 5.8 0.0 0.2 0.0 10.3 0.0 0.0 3.3 0.3 0.6 0.0 0.0 16.3 0.0 41.6 7.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 20.5 0.0 0.0 7.4 120.4 C1orf123 FLJ20580 ENSG00000162384 "Chromosome 1 open reading frame 123" Q9NWV4 1 53214099-53220617 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043835 Uncertain Approved "Vesicles,Mitotic spindle,Cytosol" Yes No 380000 Cytosol "Vesicles, Mitotic spindle" "HPA043835: AB_10796797" "unprognostic (1.09e-2)" "unprognostic (5.91e-2)" "unprognostic (2.03e-2)" "unprognostic (4.55e-2)" "unprognostic (5.43e-2)" "unprognostic (1.53e-1)" "unprognostic (9.20e-3)" "unprognostic (2.27e-1)" "unprognostic (5.52e-2)" "unprognostic (9.37e-3)" "unprognostic (1.46e-1)" "unprognostic (3.05e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (6.31e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (2.43e-1)" 32.6 21.4 27.8 19.1 29.4 12.9 26.3 16.4 25.4 29.2 33.2 25.0 22.7 15.4 34.0 28.9 25.7 32.2 22.7 28.8 24.3 22.3 26.9 29.3 20.3 18.3 24.7 26.3 33.5 17.5 21.0 20.1 22.5 23.7 31.7 24.7 24.0 16.6 33.5 44.4 14.3 16.9 48.4 22.5 18.4 23.4 26.0 23.8 18.9 26.0 18.0 19.4 28.9 26.0 25.5 38.4 31.5 39.1 30.5 36.5 26.4 11.7 12.8 16.9 15.4 39.3 50.5 15.0 17.7 18.9 18.0 19.5 10.9 10.2 18.3 14.9 21.4 17.5 4.7 10.4 17.4 21.9 23.5 17.7 18.6 9.9 16.3 38.8 21.4 12.3 32.7 19.0 19.2 20.4 27.3 29.3 22.7 19.2 5.1 22.5 19.8 26.2 20.1 28.2 14.5 20.4 19.2 21.5 14.4 20.8 12.0 14.3 13.8 16.7 15.4 16.7 28.7 11.0 21.9 18.3 20.9 12.3 14.4 17.2 7.5 10.8 20.6 16.8 21.4 16.0 28.3 32.1 31.5 30.4 39.1 27.7 25.5 30.2 31.7 38.4 23.6 33.7 33.4 13.0 30.5 31.8 25.9 36.5 26.4 27.8 29.4 16.4 25.4 24.3 22.3 24.7 26.3 23.7 23.8 11.9 22.3 30.6 23.2 14.7 32.1 41.2 20.4 42.8 25.0 36.6 2.0 51.1 86.2 35.5 86.3 45.6 23.9 0.0 31.5 63.6 57.4 21.8 30.1 40.4 58.2 17.5 27.0 35.6 28.2 159.2 74.5 32.0 33.7 43.3 31.3 44.6 30.1 36.6 92.6 79.1 28.3 64.7 60.5 49.3 36.1 13.7 39.0 20.8 32.6 18.0 C1orf127 FLJ37118 ENSG00000175262 "Chromosome 1 open reading frame 127" 1 10946471-10982037 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 5.1;skeletal muscle: 17.3" "Cell type enriched" "Detected in some" 11 "Intestinal endocrine cells: 19.5" "Cancer enriched" "Detected in single" 9 "pancreatic cancer: 2.8" "Group enriched" "Detected in some" 4 "classical monocyte: 1.7;myeloid DC: 4.2" "Group enriched" "Detected in many" 30 "dendritic cells: 4.2;monocytes: 1.7" "Cell line enriched" "Detected in some" 4 "THP-1: 7.6" HPA027654 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA027654: AB_10611814" "unprognostic (1.82e-2)" "unprognostic (8.57e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-2)" "unprognostic (9.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-2)" "unprognostic (8.47e-2)" "unprognostic (1.59e-2)" "unprognostic (3.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.04e-1)" "unprognostic (4.03e-1)" 0.1 0.6 0.0 0.0 0.4 0.0 0.0 3.3 0.0 0.0 0.2 0.6 0.0 0.0 0.5 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.3 0.5 0.8 0.0 5.1 0.0 0.2 0.1 0.0 0.5 0.2 0.0 17.3 0.0 0.2 0.0 0.1 0.5 2.5 0.6 0.1 0.0 0.0 0.0 0.0 4.2 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 1.4 0.5 0.0 0.0 7.6 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.7 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 19.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 C1orf158 MGC35194 ENSG00000157330 "Chromosome 1 open reading frame 158" Q8N1D5 1 12746215-12763699 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 23.5;testis: 74.6" "Group enriched" "Detected in some" 13 "Ciliated cells: 105.7;Early spermatids: 148.7;Late spermatids: 65.2" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5" "Region enhanced" "Detected in many" "pons and medulla: 9.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA028396 Uncertain Cytosol NA NA Cytosol "HPA028396: AB_10603451" "unprognostic (1.11e-2)" "unprognostic (4.94e-3)" "unprognostic (4.62e-1)" "unprognostic (8.00e-2)" "unprognostic (4.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.45e-1)" "unprognostic (3.51e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.7 0.0 2.4 0.3 0.0 0.0 0.2 0.9 0.0 6.2 0.0 0.0 0.4 4.2 0.1 23.5 0.1 0.0 1.0 1.4 0.0 0.0 2.8 0.1 0.2 0.1 4.8 0.1 0.0 0.4 0.1 9.3 0.0 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.2 0.1 0.1 74.6 0.9 0.0 0.5 0.0 0.1 0.0 0.0 0.9 0.6 2.3 0.6 1.1 0.8 0.1 0.5 1.3 1.1 0.7 0.6 0.0 1.0 0.1 0.3 0.2 0.2 1.3 0.7 1.1 0.3 0.3 0.4 0.4 0.1 0.1 0.2 0.2 0.7 1.1 1.9 0.5 0.0 0.9 1.0 0.1 0.7 0.3 0.1 0.4 0.1 0.5 0.9 1.4 0.3 0.5 0.2 0.7 1.5 0.3 0.5 0.6 0.3 0.9 0.1 0.5 1.9 0.8 0.5 0.6 0.3 1.4 0.7 0.2 0.5 0.5 0.8 0.4 0.8 0.6 0.5 1.2 1.0 1.1 0.5 1.6 0.6 0.5 0.7 0.5 0.6 0.5 0.5 0.5 0.1 0.9 0.8 0.7 2.3 1.1 0.6 0.6 0.4 0.1 0.7 2.4 0.0 0.2 1.0 1.4 0.2 0.1 9.3 0.9 3.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 105.7 7.9 0.0 0.0 0.0 0.0 0.0 148.7 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 65.2 1.7 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.0 7.9 1.3 0.0 0.0 0.0 0.0 0.1 C1orf194 ENSG00000179902 "Chromosome 1 open reading frame 194" Q5T5A4 1 109105951-109113857 "Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 36.5;fallopian tube: 60.2;testis: 77.6" "Group enriched" "Detected in some" 10 "Ciliated cells: 776.3;Early spermatids: 1757.0;Late spermatids: 2679.4" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8" "Region enriched" "Detected in many" 5 "pons and medulla: 36.5" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "AF22: 4.5;RPTEC TERT1: 1.1;SCLC-21H: 6.3;U-87 MG: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031144, HPA049684" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA031144: AB_10602109, HPA049684: AB_2680849" "unprognostic (9.91e-3)" "unprognostic (7.60e-3)" "unprognostic (2.28e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.03e-1)" "unprognostic (1.14e-2)" "unprognostic (4.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.27e-2)" "unprognostic (9.21e-3)" "unprognostic (3.98e-3)" "unprognostic (1.52e-1)" "unprognostic (6.08e-6)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.27e-3)" 0.3 0.4 1.5 0.3 6.8 0.3 0.4 0.3 2.6 1.8 0.3 12.3 0.0 0.4 1.0 11.1 0.4 60.2 0.3 0.3 3.0 1.6 0.3 0.3 7.5 0.4 0.5 1.8 10.3 0.7 0.4 2.7 0.3 36.5 0.4 0.4 0.0 0.3 0.3 0.3 0.3 0.4 0.4 0.7 0.3 0.5 77.6 2.3 0.0 0.5 0.0 0.3 0.5 0.2 0.2 0.0 5.3 0.0 0.0 0.3 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 6.3 0.3 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 6.8 0.3 2.6 3.0 1.6 0.5 1.8 36.5 2.3 0.0 2.6 0.0 0.2 0.0 0.6 2.0 0.0 776.3 56.9 0.0 0.0 0.0 0.0 0.0 1757.0 0.0 0.0 0.0 0.2 0.0 0.2 1.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 2679.4 19.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 17.7 0.0 0.0 6.5 0.0 176.3 13.0 0.1 0.0 0.0 0.0 0.0 C1orf198 "DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710" ENSG00000119280 "Chromosome 1 open reading frame 198" Q9H425 1 230837119-230869589 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 178.6;Smooth muscle cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 44.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004798 Approved Supported Cytosol "Intracellular and membrane" NA NA Cytosol "HPA004798: AB_1848722" "unprognostic (7.44e-2)" "unprognostic (1.89e-1)" "unprognostic (1.17e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (2.64e-2)" "unprognostic (2.46e-1)" "unprognostic (1.52e-1)" "unprognostic (1.65e-1)" "unprognostic (2.32e-1)" "unprognostic (3.75e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.50e-5)" "unprognostic (3.53e-2)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (3.77e-2)" 22.6 8.8 25.7 6.6 30.4 2.9 18.6 5.2 31.9 23.4 12.9 66.2 3.5 7.4 17.4 10.2 10.2 13.8 20.4 26.9 27.5 19.4 8.2 6.7 41.9 8.3 44.9 16.2 18.2 17.2 17.1 3.4 19.3 37.4 11.8 7.7 9.1 12.0 21.5 39.0 17.3 7.8 29.2 57.4 10.6 13.0 4.4 36.7 1.5 14.8 6.8 5.7 12.9 10.9 2.8 2.3 10.6 3.6 4.2 3.9 6.6 7.0 5.4 14.8 10.0 28.3 20.8 25.4 13.0 21.0 6.8 6.9 17.2 4.0 8.4 8.3 44.9 3.4 4.6 7.8 2.8 5.1 27.7 7.3 1.3 5.1 5.7 12.1 4.3 1.3 24.9 4.5 2.6 3.0 14.8 4.3 5.4 2.7 2.9 4.7 4.8 3.4 2.1 17.2 15.9 4.4 8.0 10.5 1.9 5.4 8.5 8.5 13.7 6.6 8.8 4.6 8.3 11.2 3.8 3.2 11.1 11.2 2.5 7.7 5.3 2.4 2.5 2.9 2.7 31.0 10.6 1.7 0.5 2.8 3.6 3.5 2.8 1.9 1.1 2.3 1.9 3.9 3.2 1.4 4.2 1.7 0.3 0.8 6.6 25.7 30.4 5.2 26.8 27.5 19.4 44.9 16.2 37.4 36.7 178.6 21.0 0.8 9.8 23.1 1.9 33.8 28.1 6.7 20.5 10.4 9.8 14.6 1.7 37.4 9.1 10.2 1.6 0.0 22.6 26.6 56.3 16.9 2.3 3.9 9.4 23.8 5.2 11.1 2.2 7.3 12.4 2.8 62.4 4.6 9.7 11.2 26.6 3.5 8.5 4.8 4.4 32.3 73.1 5.7 4.2 25.3 10.8 0.7 6.0 16.2 C1orf21 PIG13 ENSG00000116667 "Chromosome 1 open reading frame 21" Q9H246 1 184387058-184629020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 238.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 11.4;memory CD8 T-cell: 5.9;naive CD8 T-cell: 5.9;NK-cell: 7.5" "Group enriched" "Detected in many" 12 "NK-cells: 7.5;T-cells: 11.4" "Cell line enhanced" "Detected in many" "HDLM-2: 23.3;Karpas-707: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026831 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026831: AB_1845636" "unprognostic (8.27e-2)" "unprognostic (7.45e-2)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (5.07e-2)" "unprognostic (1.18e-2)" "unprognostic (1.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.18e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (3.35e-8)" "unprognostic (1.81e-2)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (3.60e-2)" 12.0 15.9 16.8 7.5 9.5 2.1 25.2 17.5 18.8 20.2 18.5 4.4 16.7 8.7 17.3 14.2 14.1 10.1 9.2 20.0 12.5 8.8 4.1 7.5 12.2 3.5 8.3 13.3 13.9 4.7 12.6 7.6 5.7 11.8 17.8 13.1 10.7 5.1 18.9 51.7 30.1 15.8 25.2 7.6 8.2 10.7 4.1 5.4 1.5 4.4 13.6 3.9 22.0 23.5 0.0 0.7 0.2 0.1 7.5 11.4 2.1 0.6 0.1 3.6 0.3 11.4 9.4 6.1 3.2 3.1 2.0 1.8 0.0 0.3 0.0 0.0 3.6 0.7 2.0 2.3 2.6 1.9 23.3 3.7 0.1 1.0 0.0 4.5 2.0 1.0 11.3 7.7 2.3 2.0 8.2 2.4 3.5 0.0 17.7 3.1 2.4 2.3 0.6 5.4 4.8 0.6 3.0 3.8 3.5 0.0 1.2 2.1 5.4 1.6 1.4 6.6 3.4 0.2 0.2 2.3 4.1 2.1 6.2 3.9 11.0 5.1 0.0 4.1 3.3 4.7 0.0 0.1 0.0 11.4 0.0 1.1 0.0 1.9 5.9 0.7 0.0 0.6 5.9 0.2 7.5 0.0 0.2 0.0 2.1 16.8 9.5 17.5 15.9 12.5 8.8 8.3 13.3 11.8 5.4 35.7 88.4 1.5 208.9 135.5 27.4 78.1 28.1 17.4 53.4 1.8 0.0 92.1 6.6 5.0 34.6 101.3 150.2 0.0 16.6 76.1 45.1 118.1 9.3 55.0 34.1 25.4 18.4 81.6 6.3 26.6 70.8 10.1 60.8 32.5 59.7 30.7 19.0 164.9 18.0 5.7 8.7 19.4 53.8 2.3 16.6 127.2 238.0 44.5 61.0 172.9 C1orf216 FLJ38984 ENSG00000142686 "Chromosome 1 open reading frame 216" Q8TAB5 1 35713875-35719472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 22.3;Rod photoreceptor cells: 26.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028299, HPA031343" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028299: AB_10601122, HPA031343: AB_2673834" "unprognostic (1.17e-1)" "unprognostic (2.43e-2)" "unprognostic (9.84e-2)" "unprognostic (1.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (2.23e-1)" "unprognostic (3.81e-1)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.86e-1)" "prognostic unfavorable (7.68e-10)" "unprognostic (3.31e-1)" "unprognostic (3.08e-1)" "unprognostic (2.48e-1)" "unprognostic (5.93e-2)" 4.3 4.4 12.5 2.1 10.5 1.1 2.4 5.0 22.1 4.7 3.5 1.0 4.1 5.0 2.1 2.5 3.0 4.0 12.1 9.7 0.7 1.8 3.1 2.4 7.0 3.5 1.2 2.0 1.8 1.6 3.1 2.0 1.1 4.4 5.1 2.9 1.2 7.0 5.2 2.2 1.2 3.4 1.4 2.5 2.4 1.4 2.5 3.2 0.1 3.7 0.8 7.3 3.0 3.4 8.0 4.4 5.7 20.1 14.8 2.9 9.8 11.5 14.5 13.9 4.7 7.3 4.3 7.1 14.3 11.9 3.3 10.9 6.4 12.5 14.0 5.2 25.7 11.7 1.3 7.6 12.7 17.0 15.1 8.2 10.4 3.3 10.7 9.4 3.2 10.2 11.6 15.5 5.6 5.1 10.9 6.4 3.7 6.8 3.4 5.8 3.5 5.0 4.0 5.9 5.9 9.3 1.9 19.0 2.7 3.6 5.7 11.2 11.8 9.4 8.8 10.1 3.5 8.7 3.2 11.8 12.3 18.4 0.0 3.2 0.1 5.9 3.7 1.9 2.5 4.7 7.3 3.2 1.4 1.1 4.4 0.1 0.8 2.7 0.7 1.6 3.0 0.0 2.1 0.0 2.9 5.4 18.4 6.4 0.0 0.0 1.2 1.8 13.7 2.0 0.0 5.5 10.2 6.0 0.0 0.0 2.4 1.2 4.7 1.8 4.6 1.7 6.9 22.3 1.7 5.5 4.0 6.8 7.8 5.4 15.1 8.2 0.0 16.2 2.2 0.0 19.4 0.7 26.6 0.0 6.9 2.8 2.2 4.0 0.9 5.0 0.3 1.4 C1orf228 "MGC33556, NCRNA00082, p40" ENSG00000198520 "Chromosome 1 open reading frame 228" Q6PIY5 1 44674692-44725591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.0;testis: 17.9" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 46.8;Early spermatids: 45.0;granulocytes: 81.7;Late spermatids: 39.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 8.6;MOLT-4: 7.1;NB-4: 10.1;U-937: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034769 Uncertain Uncertain Cytosol NA NA Cytosol "HPA034769: AB_10670979" "unprognostic (2.01e-5)" "unprognostic (4.28e-3)" "unprognostic (7.27e-2)" "prognostic favorable (8.64e-4)" "unprognostic (9.23e-2)" "unprognostic (7.43e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.49e-2)" "unprognostic (9.34e-3)" "unprognostic (1.22e-2)" "unprognostic (9.38e-2)" "unprognostic (1.25e-10)" "unprognostic (1.99e-4)" "unprognostic (1.50e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-3)" 0.9 2.2 6.3 0.7 11.2 4.3 1.5 3.2 6.8 1.7 1.0 5.6 3.9 0.7 3.1 6.8 1.3 14.0 1.5 0.6 6.5 2.4 1.4 7.0 2.0 1.5 1.4 7.5 4.5 1.4 3.0 5.4 0.8 7.7 1.8 0.9 3.3 1.6 1.4 0.5 1.7 0.8 0.9 2.4 0.8 1.4 17.9 5.4 0.2 1.3 0.0 1.0 0.8 0.8 1.4 6.2 10.4 2.7 0.5 2.3 1.8 0.2 0.3 2.0 0.1 0.7 2.6 0.5 0.0 0.3 0.5 0.3 0.5 4.3 0.3 0.3 0.9 1.0 0.5 0.0 0.0 0.0 1.1 0.2 1.0 2.6 0.6 0.2 8.6 5.1 2.0 0.3 0.8 0.0 1.5 0.2 0.3 0.1 0.8 0.2 0.1 7.1 10.1 0.1 0.6 0.1 3.7 0.2 2.4 0.9 0.0 1.4 0.9 0.0 1.4 1.1 1.4 0.4 4.5 0.0 0.3 0.3 0.4 0.0 0.3 0.3 0.2 0.3 13.7 0.4 10.4 2.7 7.5 0.3 0.8 0.1 0.7 1.5 1.0 1.3 1.4 2.2 2.3 1.2 0.5 0.1 6.2 0.1 1.8 6.3 11.2 3.2 6.8 6.5 2.4 1.4 7.5 7.7 5.4 6.0 5.0 14.5 0.4 0.7 1.1 0.0 0.0 46.8 9.1 0.0 11.8 0.3 0.0 0.0 45.0 0.0 0.3 0.0 0.0 0.1 0.7 0.4 81.7 3.2 10.7 1.6 9.8 0.0 15.0 39.8 0.3 6.1 0.0 0.0 0.6 6.1 0.0 0.0 0.7 0.0 4.3 6.5 0.3 2.3 14.3 0.6 0.1 1.0 0.6 0.1 C1orf35 "MGC4174, MMTAG2" ENSG00000143793 "Chromosome 1 open reading frame 35" Q9BU76 1 228100726-228105411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046175 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Plasma membrane" Cytosol "HPA046175: AB_10959459" "unprognostic (1.12e-1)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.71e-4)" "unprognostic (6.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.64e-2)" "unprognostic (5.44e-3)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "prognostic favorable (7.38e-4)" "unprognostic (6.12e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.79e-6)" "unprognostic (2.70e-1)" "unprognostic (8.58e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" 10.1 12.7 14.3 15.6 17.0 12.7 12.0 23.9 15.7 12.5 11.2 11.6 16.1 12.5 13.7 10.6 17.3 14.9 8.1 8.0 13.8 10.0 10.6 10.2 11.0 12.5 17.7 13.6 19.0 21.0 12.5 10.0 12.4 15.0 13.2 6.4 10.4 19.1 16.1 14.0 24.1 11.3 13.3 9.2 12.6 13.2 8.8 13.2 14.6 12.4 6.9 12.0 12.8 13.9 20.2 26.7 21.9 18.4 17.6 21.5 10.3 9.6 10.7 6.9 4.1 3.7 3.8 16.1 7.4 3.4 6.6 4.9 9.7 9.2 9.4 16.2 2.6 4.6 10.8 6.5 7.2 2.5 10.7 34.4 5.8 7.5 9.5 6.3 13.0 7.4 3.4 8.6 6.3 6.1 3.9 7.3 10.9 14.8 5.2 4.9 11.3 17.3 16.7 13.5 12.2 25.0 12.3 10.9 15.6 5.8 7.2 12.1 11.4 7.0 11.2 9.6 2.1 13.3 12.3 6.3 5.3 7.7 13.8 15.7 9.7 5.0 8.7 6.4 7.7 8.2 6.3 16.3 21.9 16.2 18.4 20.9 20.2 18.1 17.7 20.4 16.7 21.5 18.1 2.2 17.6 17.5 26.7 18.0 10.3 14.3 17.0 23.9 15.7 13.8 10.0 17.7 13.6 15.0 13.2 20.8 19.0 30.7 27.5 59.3 48.2 15.4 12.7 17.4 11.4 36.6 17.7 65.7 38.1 35.0 3.0 27.0 34.4 23.3 34.3 47.2 35.1 28.5 24.3 19.5 36.1 44.5 25.2 28.3 24.7 2.6 47.5 35.5 30.4 27.1 35.6 37.2 33.3 33.4 43.9 30.1 49.8 64.7 30.0 35.6 47.1 70.4 23.7 36.7 41.6 21.3 C1orf68 "LEP7, XP32" ENSG00000198854 "Chromosome 1 open reading frame 68" Q5T750 1 152719522-152720470 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 123.1" "Cell type enriched" "Detected in some" 14 "Suprabasal keratinocytes: 68.4" "Group enriched" "Detected in some" 13 "head and neck cancer: 2.4;melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HaCaT: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA057942 Approved "Plasma membrane,Cytosol" NA NA 61000 "Plasma membrane" Cytosol "HPA057942: " "unprognostic (1.73e-1)" "unprognostic (7.46e-2)" "unprognostic (9.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 123.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 68.4 0.0 0.0 0.0 0.0 C1orf74 "FLJ25078, URLC4" ENSG00000162757 "Chromosome 1 open reading frame 74" Q96LT6 1 209779208-209784559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 11.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028496 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA028496: AB_10602698" "unprognostic (3.25e-1)" "prognostic unfavorable (8.52e-6)" "unprognostic (8.41e-3)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (1.75e-2)" "unprognostic (9.98e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (4.95e-1)" "unprognostic (2.81e-1)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (1.07e-1)" "unprognostic (5.40e-2)" 2.5 3.9 5.7 5.5 8.5 2.3 5.8 10.4 8.9 2.7 3.8 5.8 4.0 3.3 2.3 5.2 10.4 2.8 2.3 4.1 3.7 2.9 4.9 4.1 2.2 9.8 5.1 4.6 2.5 4.5 4.5 6.5 3.4 4.8 4.6 5.2 3.9 5.1 2.7 2.3 15.0 4.1 2.4 4.9 4.9 3.9 3.9 5.0 4.9 3.2 0.0 5.7 3.9 4.7 6.3 5.5 5.9 1.9 2.8 2.9 1.9 5.6 3.0 1.9 1.1 2.6 3.0 4.4 3.2 4.2 4.0 4.1 6.0 4.4 6.0 1.9 2.1 2.4 11.5 1.2 9.4 4.7 5.9 3.9 4.0 2.2 0.5 3.6 5.5 1.8 1.8 8.3 4.9 8.1 3.3 2.3 8.2 7.8 4.4 3.4 2.9 4.6 5.7 8.0 4.0 5.1 4.9 9.1 8.4 3.4 4.9 7.7 8.2 4.4 3.4 4.9 4.6 5.3 2.9 2.2 3.4 3.9 3.5 5.2 4.0 4.1 6.6 3.0 4.6 4.7 5.9 1.6 1.4 2.9 1.9 2.1 3.8 1.4 2.3 3.2 6.3 2.4 2.8 1.1 2.8 1.0 5.5 1.2 1.9 5.7 8.5 10.4 8.9 3.7 2.9 5.1 4.6 4.8 5.0 3.0 2.1 1.4 6.1 1.9 1.4 2.0 0.0 1.4 1.2 0.0 0.0 3.1 6.6 1.7 0.0 0.6 2.0 0.0 1.8 5.7 0.6 4.8 1.1 2.0 2.3 1.6 3.5 1.3 0.3 0.2 2.3 0.8 0.0 1.8 4.4 2.3 2.7 2.6 0.0 4.8 1.2 0.0 0.4 3.7 3.6 4.3 3.3 0.0 2.9 11.4 C1orf94 MGC15882 ENSG00000142698 "Chromosome 1 open reading frame 94" Q6P1W5 1 34166883-34219131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 24.6" "Cell type enhanced" "Detected in some" 29 "Early spermatids: 53.5;Late spermatids: 24.4;Spermatocytes: 12.2" "Cancer enriched" "Detected in single" 10 "glioma: 1.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 11.4;U-87 MG: 33.0" "Low region specificity" "Detected in many" HPA045805 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA045805: AB_10969626" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (9.77e-2)" "unprognostic (4.09e-2)" "unprognostic (1.65e-2)" "unprognostic (2.31e-1)" 0.0 0.1 0.6 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 24.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.2 1.8 0.5 0.7 0.5 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 53.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 12.2 0.5 0.0 0.0 0.0 0.0 0.0 C1QTNF1 "CTRP1, FLJ90694, GIP, ZSIG37" ENSG00000173918 "C1q and TNF related 1" Q9BXJ1 17 79022814-79049788 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.5" "Group enriched" "Detected in many" 5 "Ito cells: 145.5;Sertoli cells: 103.5;Smooth muscle cells: 105.0;Syncytiotrophoblasts: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 84.6;BJ hTERT+: 19.8;HHSteC: 32.0;HSkMC: 17.0;U-87 MG: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB025429, HPA051101" Uncertain Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 314000000 30000 "Nucleoplasm, Cytosol" "CAB025429: , HPA051101: AB_2681343" "unprognostic (2.58e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (1.20e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" "unprognostic (7.11e-2)" "unprognostic (3.18e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-2)" "unprognostic (7.48e-2)" "unprognostic (9.81e-3)" "unprognostic (5.83e-2)" "prognostic unfavorable (9.09e-9)" "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (1.95e-2)" 62.4 18.3 1.7 7.4 4.3 0.4 60.5 1.3 5.1 14.3 10.3 5.2 30.8 2.5 11.0 14.2 10.2 14.4 19.1 77.5 2.0 4.1 9.5 19.4 9.7 16.6 4.8 2.5 25.2 7.5 10.1 4.2 34.0 7.6 13.3 3.3 19.6 13.8 51.8 11.9 8.6 6.1 6.9 2.5 14.3 6.1 8.8 2.8 1.3 26.9 13.3 5.0 14.8 27.5 0.5 0.3 1.9 0.3 1.2 0.4 0.0 0.0 8.2 0.0 0.0 84.6 7.6 0.0 4.2 19.8 1.8 3.5 0.6 4.0 0.0 0.4 1.2 5.2 0.2 0.2 0.1 1.3 0.0 0.9 0.0 3.1 0.4 32.0 0.0 0.0 17.0 0.0 3.8 0.2 2.6 2.4 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.9 8.6 0.0 5.5 0.1 0.0 0.1 0.3 1.6 2.7 0.4 7.9 0.3 0.0 0.0 0.3 9.0 0.2 1.0 1.2 0.0 0.0 0.0 20.0 0.0 0.8 1.9 0.3 0.5 0.3 0.2 0.2 0.2 0.4 0.2 0.1 0.5 0.2 0.4 0.4 1.2 0.2 0.3 0.0 0.0 1.7 4.3 1.3 4.2 2.0 4.1 4.8 2.5 7.6 2.8 0.0 1.1 0.0 0.6 5.8 0.0 9.4 10.2 0.0 0.0 1.8 0.0 17.3 0.0 13.9 0.1 10.5 1.3 0.0 5.3 1.2 14.4 1.2 0.0 1.5 2.3 0.0 4.6 145.5 10.5 0.0 9.8 0.7 3.3 19.0 6.8 0.5 3.2 2.9 3.2 0.0 0.3 103.5 105.0 0.0 0.7 4.0 39.6 0.5 4.5 0.5 C1R ENSG00000159403 "Complement C1r" P00736 12 7080209-7092607 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 370.2" "Group enriched" "Detected in many" 5 "Fibroblasts: 462.9;Hepatocytes: 1385.8;Leydig cells: 1057.9;Peritubular cells: 364.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4" "Group enriched" "Detected in many" 6 "granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "ASC diff: 181.7;ASC TERT1: 92.7;BJ hTERT+: 80.0;BJ hTERT+ SV40 Large T+ RasG12V: 49.3;HSkMC: 107.4" "Low region specificity" "Detected in all" "HPA001251, HPA001551" Uncertain Uncertain Nucleoplasm,Cytosol "Secreted to blood" NA NA 14000000000 "Nucleoplasm, Cytosol" "HPA001251: AB_2666252, HPA001551: AB_10754818" "unprognostic (1.55e-2)" "unprognostic (8.97e-2)" "unprognostic (3.46e-2)" "unprognostic (1.92e-1)" "unprognostic (1.47e-2)" "unprognostic (2.66e-2)" "unprognostic (1.94e-2)" "unprognostic (2.05e-1)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (1.94e-14)" "unprognostic (3.54e-2)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.59e-2)" 45.8 17.4 2.6 18.1 3.8 0.0 82.0 1.4 2.8 36.7 24.5 2.4 11.2 5.0 27.2 66.8 38.1 33.3 46.7 49.5 1.9 1.8 27.5 370.2 25.3 46.8 3.5 2.0 103.5 11.4 1.4 6.3 10.3 4.6 47.8 15.3 17.7 12.8 13.2 16.0 10.7 14.4 53.2 6.2 35.1 19.8 39.3 1.9 2.3 30.6 20.7 15.1 46.8 83.8 0.4 0.0 2.5 0.4 3.2 3.4 0.8 0.1 1.5 0.1 1.3 181.7 92.7 0.1 20.4 80.0 24.2 49.3 0.2 0.3 0.0 0.6 15.9 1.6 0.3 1.7 0.8 3.4 1.9 0.1 0.0 0.6 0.6 34.9 0.1 0.2 107.4 0.5 11.0 0.8 18.4 0.4 0.1 0.0 2.5 3.1 0.0 0.9 0.1 0.8 0.0 0.1 1.1 0.5 0.1 0.1 0.9 0.0 0.3 14.7 0.4 0.4 0.2 0.0 0.0 0.0 5.8 0.9 26.7 0.1 0.1 0.4 0.0 8.3 0.1 0.8 0.0 0.4 2.0 1.6 0.1 2.0 0.0 1.4 3.4 0.0 0.4 2.8 2.9 2.5 3.2 0.0 0.0 1.4 0.8 2.6 3.8 1.4 2.8 1.9 1.8 3.5 2.0 4.6 1.9 20.8 84.7 28.4 53.6 48.5 0.2 14.6 168.2 6.7 34.2 17.4 2.0 2.9 3.3 164.2 3.5 51.3 0.3 23.3 39.1 4.8 462.9 14.1 9.3 1385.8 10.3 0.0 0.0 128.9 25.4 9.4 1057.9 10.1 50.6 2.8 0.6 15.1 74.1 0.6 364.9 5.0 0.9 168.1 97.8 5.7 4.1 35.0 4.3 13.1 0.7 9.8 C1S ENSG00000182326 "Complement C1s" P09871 12 6988259-7071032 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 351.6" "Cell type enhanced" "Detected in many" 21 "Hepatocytes: 2464.3;Leydig cells: 1104.9;Peritubular cells: 601.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 6.2" "Lineage enriched" "Detected in single" 17 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "ASC diff: 99.3;ASC TERT1: 132.1;BJ hTERT+: 42.1;HSkMC: 70.1" "Low region specificity" "Detected in all" "CAB016722, HPA018852" Supported Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 93000000000 13000000000 Nucleoplasm Cytosol "CAB016722: , HPA018852: AB_1847112" "unprognostic (2.72e-3)" "unprognostic (7.31e-2)" "unprognostic (9.37e-2)" "unprognostic (1.39e-2)" "unprognostic (1.05e-2)" "unprognostic (9.63e-2)" "prognostic favorable (7.73e-4)" "unprognostic (6.38e-2)" "unprognostic (1.16e-1)" "unprognostic (6.14e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (7.44e-15)" "unprognostic (2.02e-2)" "unprognostic (5.68e-3)" "unprognostic (1.19e-2)" "unprognostic (5.39e-2)" 48.7 16.6 3.3 18.7 4.1 0.0 55.7 1.9 3.1 35.3 31.1 2.9 12.7 6.8 32.2 50.0 38.3 46.4 47.2 34.4 2.5 1.1 18.0 351.6 31.4 21.1 6.3 3.2 98.8 15.5 1.9 6.0 8.5 6.5 52.1 18.6 26.1 14.6 12.4 18.2 14.7 19.2 47.6 8.8 32.5 24.6 37.2 2.3 3.2 30.5 22.7 18.8 48.6 73.0 0.2 0.1 6.2 0.3 0.2 0.1 0.0 0.0 2.2 0.1 1.3 99.3 132.1 0.4 17.9 42.1 9.5 17.4 0.0 0.2 0.0 2.4 22.2 2.5 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.6 4.7 29.9 0.2 0.1 70.1 0.3 7.7 0.5 11.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.1 10.9 0.2 0.2 2.1 0.0 0.0 0.0 4.4 0.3 16.9 0.0 0.0 0.0 0.1 9.5 0.1 0.2 0.6 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.1 6.2 0.2 0.1 0.1 0.0 0.0 3.3 4.1 1.9 3.1 2.5 1.1 6.3 3.2 6.5 2.3 14.9 34.2 18.3 17.5 67.8 0.6 21.4 152.8 6.7 20.5 3.5 0.0 2.9 1.7 170.0 5.7 37.8 0.0 46.7 37.9 3.5 388.0 7.4 4.7 2464.3 7.1 4.8 0.0 105.6 49.3 8.8 1104.9 9.4 84.4 1.8 0.0 15.1 43.6 0.0 601.8 4.1 0.9 135.8 123.7 5.0 4.1 47.0 2.2 4.3 0.0 3.0 C20orf194 DKFZp434N061 ENSG00000088854 "Chromosome 20 open reading frame 194" Q5TEA3 20 3249305-3407625 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Cone photoreceptor cells: 190.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052103, HPA067418" Approved Approved "Nucleoli fibrillar center,Cytosol" No No "Nucleoli fibrillar center, Cytosol" "HPA052103: AB_2681727, HPA067418: AB_2685835" "unprognostic (9.77e-2)" "unprognostic (8.39e-2)" "unprognostic (5.03e-3)" "unprognostic (1.83e-1)" "unprognostic (1.18e-1)" "unprognostic (4.26e-2)" "unprognostic (1.66e-2)" "unprognostic (7.64e-2)" "unprognostic (6.41e-2)" "unprognostic (1.68e-1)" "prognostic favorable (1.68e-4)" "unprognostic (2.97e-1)" "prognostic favorable (7.68e-4)" "unprognostic (9.58e-3)" "unprognostic (3.70e-1)" "unprognostic (2.00e-1)" "unprognostic (7.52e-2)" 15.2 13.4 18.5 6.9 20.1 4.6 11.9 20.3 21.9 12.6 11.8 25.3 7.3 5.8 12.5 9.7 11.7 12.8 11.3 19.4 16.3 17.2 14.2 3.7 13.3 5.7 16.5 20.3 17.2 7.5 8.5 10.4 12.2 17.4 12.2 6.4 10.9 6.0 16.5 36.8 7.5 6.0 17.2 23.0 9.5 9.1 13.5 16.9 4.6 13.2 4.0 4.3 12.2 11.0 1.6 3.5 1.0 3.0 0.0 1.7 0.7 2.9 2.7 7.4 3.6 15.5 17.2 0.8 7.0 7.8 4.6 5.9 0.0 3.2 0.0 1.9 9.2 5.9 3.5 2.8 6.8 6.4 0.6 1.4 0.8 1.0 7.3 7.3 0.9 0.4 13.9 5.3 6.1 5.3 6.6 9.2 2.6 1.4 0.0 6.7 1.3 1.8 4.8 2.2 1.6 1.8 2.1 6.8 0.0 6.0 6.1 1.5 4.4 3.1 5.5 9.0 6.7 5.2 8.4 10.2 5.8 2.6 3.6 3.3 0.0 0.0 0.0 1.8 0.8 4.4 1.0 3.0 0.0 1.7 1.5 1.0 1.0 1.3 1.7 3.1 1.6 0.5 1.3 0.0 0.0 1.4 3.5 1.4 0.7 18.5 20.1 20.3 21.9 16.3 17.2 16.5 20.3 17.4 16.9 26.8 8.6 2.2 6.0 6.2 33.0 22.9 7.6 17.4 9.1 12.2 190.5 1.3 1.7 6.4 22.4 15.5 0.3 0.0 4.0 4.9 11.6 4.8 13.9 2.1 16.8 28.6 0.0 26.4 28.8 5.8 18.4 17.8 8.5 7.2 0.0 11.7 8.0 2.6 12.7 5.7 14.2 12.9 14.7 18.2 20.0 5.0 1.5 4.5 0.0 4.3 C20orf24 "PNAS-11, RIP5" ENSG00000101084 "Chromosome 20 open reading frame 24" Q9BUV8 20 36605734-36612557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057387 Uncertain Approved Cytosol NA NA Cytosol "HPA057387: AB_2683425" "unprognostic (2.14e-1)" "unprognostic (4.75e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-3)" "unprognostic (3.88e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.56e-6)" "unprognostic (4.47e-3)" "unprognostic (3.89e-1)" "unprognostic (2.90e-1)" "unprognostic (2.37e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "unprognostic (9.98e-2)" 17.0 19.7 15.1 18.5 16.3 25.1 29.1 11.9 21.1 15.8 31.1 10.9 15.2 21.9 11.8 18.1 55.5 10.8 25.1 24.2 14.3 14.0 35.6 71.1 21.4 24.4 15.0 11.7 9.5 27.6 15.4 8.5 19.3 12.6 13.3 26.5 9.8 21.5 17.9 70.0 13.6 26.1 14.6 12.7 26.2 20.0 19.0 11.3 20.4 21.6 42.3 28.3 14.3 20.4 10.0 15.8 41.3 24.2 6.1 11.9 7.7 36.1 27.2 9.0 12.0 21.6 12.4 24.2 22.7 12.4 21.7 19.7 74.4 45.6 15.7 56.2 19.4 40.6 26.9 19.3 35.4 20.7 11.8 20.1 37.4 38.6 81.4 25.3 39.3 18.4 15.5 37.5 31.3 17.8 11.1 19.8 16.5 25.5 37.0 20.4 24.5 23.0 50.8 16.5 35.5 58.1 18.4 23.2 39.4 18.7 27.0 16.7 12.6 32.7 84.8 28.4 14.9 17.9 32.4 22.4 32.4 22.3 33.5 34.3 23.7 38.2 26.5 35.0 45.9 17.2 7.2 24.2 29.9 6.2 12.4 6.2 10.0 7.4 9.6 15.8 8.1 9.0 6.7 41.3 6.1 14.7 10.8 11.9 7.7 15.1 16.3 11.9 21.1 14.3 14.0 15.0 11.7 12.6 11.3 32.8 18.6 61.3 37.0 155.3 30.6 0.0 104.4 17.4 23.9 0.0 23.6 72.8 0.0 0.0 42.7 44.2 136.6 23.3 0.0 105.9 54.2 76.8 47.1 249.1 216.1 12.7 52.7 58.9 146.9 62.8 40.6 64.6 67.4 0.0 79.2 49.6 0.0 118.5 40.3 0.0 29.0 58.2 32.8 171.5 84.7 183.9 113.4 69.2 118.3 184.6 C20orf27 FLJ20550 ENSG00000101220 "Chromosome 20 open reading frame 27" Q9GZN8 20 3753508-3768387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.7" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 123.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 64.7" "Group enriched" "Detected in many" 5 "classical monocyte: 28.1;intermediate monocyte: 46.6;myeloid DC: 38.5;non-classical monocyte: 42.2" "Group enriched" "Detected in all" 5 "dendritic cells: 38.5;monocytes: 46.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047483 Approved Approved Nucleoplasm,Cytosol NA NA 87000 "Nucleoplasm, Cytosol" "HPA047483: AB_2680064" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.21e-3)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (1.69e-5)" "unprognostic (8.36e-2)" "unprognostic (2.07e-1)" "unprognostic (4.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (6.18e-6)" "unprognostic (1.80e-1)" "unprognostic (2.16e-1)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" 23.1 9.7 10.2 11.8 64.7 51.9 17.2 4.9 15.8 12.0 22.6 7.7 3.7 10.3 16.9 10.9 14.4 18.7 26.6 7.3 9.2 14.4 5.0 5.4 8.4 13.5 14.5 6.1 20.9 8.5 3.9 5.3 6.7 13.7 18.3 4.9 5.0 9.0 7.1 11.2 9.6 9.4 22.3 5.7 13.4 21.2 6.0 13.2 6.0 5.4 7.9 6.1 27.4 10.3 7.8 38.5 1.1 46.6 5.8 8.5 13.8 34.4 36.4 5.7 24.3 11.9 6.5 9.0 8.9 5.9 16.5 12.1 24.9 13.1 21.6 8.7 10.4 22.0 29.7 15.3 22.3 6.3 5.0 27.4 12.2 7.4 44.4 8.5 17.5 5.4 9.2 9.4 21.0 10.5 5.7 11.1 15.8 21.7 13.6 8.5 48.7 23.1 41.7 24.6 24.1 49.5 17.9 14.0 25.5 10.3 12.6 25.7 11.7 8.1 36.1 17.8 2.7 8.0 22.0 6.8 23.1 16.0 36.6 27.2 10.5 17.5 16.0 6.8 33.3 11.3 0.2 28.1 0.4 5.9 46.6 8.5 7.8 7.0 7.8 38.5 7.3 8.0 7.8 1.1 5.8 42.2 7.3 6.4 13.8 10.2 64.7 4.9 15.8 9.2 14.4 14.5 6.1 13.7 13.2 0.0 3.5 24.6 18.0 21.5 9.4 2.8 7.6 1.4 2.3 10.4 2.0 15.9 24.9 31.1 8.2 25.0 10.5 70.0 26.1 38.9 26.3 9.4 23.0 14.7 123.1 1.6 15.1 13.5 94.5 13.7 30.2 60.1 35.4 4.6 10.2 20.0 28.5 16.4 23.3 27.0 12.7 64.7 66.1 18.7 30.1 28.7 6.1 16.2 30.3 20.0 C21orf2 "A2, LRRC76, YF5" ENSG00000160226 "Chromosome 21 open reading frame 2" O43822 21 44328944-44339402 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA damage" "Ciliopathy, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030283, HPA030284, CAB034126, CAB034128" Supported Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700" "unprognostic (1.84e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (9.73e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.49e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.98e-1)" "unprognostic (2.79e-1)" "unprognostic (1.32e-2)" "unprognostic (1.06e-1)" 18.8 13.4 19.8 11.3 21.6 19.7 9.2 10.3 23.4 13.8 14.7 18.2 14.3 13.4 12.6 19.1 6.9 14.7 13.2 11.3 19.5 16.6 18.0 11.6 12.8 12.4 16.4 19.1 15.2 14.5 7.4 17.6 12.4 13.2 12.3 3.9 14.3 16.1 17.2 21.0 22.3 15.4 5.8 12.6 16.1 21.1 16.7 11.2 10.9 16.4 8.1 13.0 8.1 7.0 10.8 21.7 1.2 8.5 12.1 9.7 4.9 8.0 3.4 3.2 4.2 2.1 1.4 12.9 4.2 2.5 1.7 0.9 6.1 2.4 5.8 8.4 1.4 3.4 3.8 0.6 0.8 0.4 8.8 8.4 6.0 2.7 7.1 2.8 6.5 6.5 2.0 1.5 0.7 1.5 2.9 1.0 4.4 7.3 10.0 1.0 9.9 7.1 15.9 8.1 4.1 5.2 18.1 4.2 12.9 1.9 11.8 8.6 7.9 5.8 1.4 6.9 2.0 6.2 14.3 4.7 3.6 4.7 3.9 3.1 16.3 8.6 4.0 8.9 13.1 6.5 1.2 7.1 1.0 7.1 8.5 8.5 10.8 7.3 9.7 7.3 8.6 8.5 8.2 0.9 12.1 6.2 21.7 4.0 4.9 19.8 21.6 10.3 22.4 19.5 16.6 16.4 19.1 13.2 11.2 3.0 16.5 25.0 18.4 14.4 43.7 2.2 35.7 32.1 9.1 12.2 35.3 25.4 66.3 24.9 73.3 10.0 27.6 0.0 51.4 12.3 38.1 21.2 19.5 18.1 31.3 35.0 31.6 9.2 14.5 196.9 24.5 17.6 40.5 31.5 29.6 34.1 20.6 31.1 29.7 36.0 24.8 12.9 18.9 40.3 10.9 13.6 27.3 20.8 31.8 18.6 C22orf31 "bK747E2.1, HS747E2A" ENSG00000100249 "Chromosome 22 open reading frame 31" O95567 22 29058672-29061844 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.4;testis: 12.7" "Group enriched" "Detected in some" 15 "Early spermatids: 55.4;Late spermatids: 34.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.4" "Not detected" "Not detected" "HPA000604, HPA068522" Uncertain Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA000604: AB_1079086, HPA068522: " 0.0 0.4 0.9 0.0 3.4 0.0 0.4 0.4 0.9 0.5 0.3 0.2 0.4 1.6 0.5 0.5 0.0 0.0 1.0 0.2 0.2 0.0 0.2 0.0 0.8 1.1 0.0 0.2 0.4 0.0 0.2 0.3 0.5 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.6 12.7 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.2 0.0 0.8 0.0 0.9 0.8 0.0 0.0 0.4 0.6 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.9 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.7 0.6 0.0 0.0 0.0 0.0 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: AB_2668414" "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favorable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.4 2.5 3.5 7.2 4.6 1.9 2.2 5.2 4.6 5.2 4.4 4.1 3.6 5.2 13.7 3.6 5.3 7.7 4.4 2.2 2.1 8.1 3.7 20.4 3.3 2.9 6.1 5.8 29.8 2.3 4.6 9.7 3.6 5.7 3.2 7.8 8.4 9.3 4.8 9.1 6.5 14.1 1.3 8.4 6.9 4.1 3.2 5.9 5.1 2.2 11.0 6.2 2.2 11.7 3.3 1.4 20.6 7.8 3.9 4.8 1.6 5.7 9.1 4.1 2.4 2.0 3.0 10.1 5.3 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 6.0 6.2 2.2 1.4 9.5 14.6 2.0 2.5 13.4 4.5 1.8 35.3 0.8 3.3 2.8 2.6 5.0 25.7 0.0 2.4 1.2 2.0 2.9 2.3 4.3 7.9 20.6 1.2 15.4 12.9 1.5 2.0 9.7 6.8 7.2 5.5 4.8 4.2 10.1 1.4 3.3 29.7 6.5 3.1 2.3 1.9 9.5 0.9 8.7 4.5 1.6 C2CD5 "CDP138, KIAA0528" ENSG00000111731 "C2 calcium dependent domain containing 5" Q86YS7 12 22448583-22544546 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 49.1;Early spermatids: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046194 Approved Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA046194: AB_10965327" "unprognostic (2.59e-1)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.17e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-3)" "unprognostic (1.08e-3)" "unprognostic (1.17e-2)" "unprognostic (8.47e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-3)" 10.2 11.2 18.9 16.3 26.6 11.8 13.6 48.5 30.7 13.1 18.5 10.0 10.0 17.8 15.6 12.3 10.4 15.8 15.4 8.8 14.6 16.5 15.7 7.8 11.2 13.8 13.5 22.8 17.4 12.3 23.3 26.2 9.3 26.9 10.3 20.0 13.3 12.7 10.0 8.0 11.7 14.8 12.7 10.8 15.0 19.2 12.9 12.9 18.7 15.5 4.9 14.3 11.7 11.8 7.3 6.1 15.3 14.1 12.8 8.0 4.3 8.5 8.4 18.8 10.2 12.5 16.6 12.0 9.4 10.2 17.7 21.1 9.3 11.4 9.7 4.2 8.8 9.8 7.6 12.0 7.7 24.7 15.7 12.5 12.0 9.2 8.3 11.5 16.1 14.5 9.5 5.6 11.3 20.0 16.8 12.7 13.5 7.8 6.3 11.4 9.1 15.2 24.8 37.5 16.7 6.4 13.3 20.9 13.1 10.5 7.0 8.7 7.6 8.5 8.4 8.9 29.1 11.1 10.8 11.0 10.6 8.6 9.5 9.9 5.1 3.9 15.6 6.6 12.3 7.8 15.3 6.1 2.9 5.5 13.5 7.2 7.3 8.0 5.4 6.1 5.0 7.2 5.7 6.2 12.8 14.1 3.5 8.0 4.3 18.9 26.6 48.5 30.7 14.6 16.5 13.5 22.8 26.9 12.9 8.9 15.8 5.2 3.6 6.2 28.7 13.9 15.3 22.7 25.0 5.2 49.1 3.1 5.0 3.0 54.5 7.1 12.3 0.0 4.0 1.7 6.8 5.4 17.3 7.4 7.1 17.5 15.5 20.3 28.5 14.0 8.1 12.0 6.8 1.8 19.2 6.7 2.8 10.5 7.4 5.1 45.1 6.5 6.1 10.3 6.1 4.8 2.2 7.0 15.3 3.9 C2orf66 UNQ6411 ENSG00000187944 "Chromosome 2 open reading frame 66" Q6UXQ4 2 196805002-196810276 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 7.0;pituitary gland: 6.4" "Cell type enriched" "Detected in some" 12 "Early spermatids: 27.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 9.4;RT4: 3.5;TIME: 3.9" HPA020869 Uncertain Uncertain Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA020869: AB_1851545" "unprognostic (1.19e-1)" "unprognostic (4.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.19e-1)" "unprognostic (3.48e-2)" "unprognostic (1.61e-2)" "unprognostic (6.80e-3)" "unprognostic (3.05e-2)" "unprognostic (1.95e-1)" "unprognostic (4.10e-3)" "unprognostic (4.54e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-5)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (1.86e-2)" 7.0 4.0 0.4 0.2 0.7 0.2 1.0 0.1 0.4 0.0 0.2 0.0 0.1 1.2 0.1 1.1 0.4 0.7 0.4 2.8 0.3 0.0 0.2 0.0 0.7 0.3 0.6 0.0 6.4 0.1 0.3 0.4 0.0 0.2 0.0 2.8 0.3 0.1 0.0 0.2 0.0 2.6 0.1 0.2 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.4 1.1 0.5 0.3 0.0 0.5 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 1.1 0.2 0.3 0.6 9.4 1.0 0.1 0.0 0.1 0.8 0.7 1.4 0.2 0.2 0.2 0.8 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 3.5 0.4 0.2 0.0 0.1 0.1 0.4 0.0 0.0 3.9 0.3 0.3 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 C2orf91 ENSG00000205086 "Chromosome 2 open reading frame 91" Q6ZV80 2 41935368-41954266 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;lung: 4.7" "Cell type enhanced" "Detected in single" 22 "Alveolar cells type 1: 3.0" "Cancer enriched" "Detected in single" 9 "testis cancer: 0.8" "Region enhanced" "Detected in some" "midbrain: 5.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AN3-CA: 5.2;HDLM-2: 17.9" HPA042517 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" Nucleoplasm "HPA042517: AB_10795508" "unprognostic (9.49e-3)" "unprognostic (2.24e-2)" "unprognostic (1.73e-1)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (8.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (3.92e-2)" "unprognostic (1.16e-1)" "unprognostic (4.79e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (7.61e-2)" "unprognostic (2.78e-2)" "unprognostic (1.47e-1)" 0.3 2.1 0.3 0.3 1.3 1.5 0.3 0.3 0.8 0.4 0.3 0.8 0.2 0.0 0.4 1.0 0.3 0.3 0.3 0.5 0.3 0.4 0.9 0.3 4.7 0.9 5.1 0.2 0.4 0.4 0.4 0.5 0.2 1.9 0.8 0.2 0.8 3.5 0.2 0.2 1.3 0.3 0.2 2.2 0.6 1.3 1.1 0.2 0.2 0.2 0.2 0.6 0.2 0.3 1.2 1.4 2.8 1.2 1.2 0.9 0.3 0.2 0.4 0.7 5.2 0.2 0.1 0.3 0.1 0.1 0.0 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.0 0.1 0.1 17.9 0.3 0.2 0.4 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 1.8 0.1 0.3 0.1 0.1 0.3 0.4 0.1 0.0 0.6 0.1 0.1 0.3 0.2 1.8 0.0 0.0 0.2 0.9 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.2 1.3 1.2 1.4 0.6 0.9 0.5 0.6 0.7 0.5 1.4 1.2 0.7 0.9 2.8 1.2 1.0 1.3 0.4 0.3 0.3 1.3 0.3 0.8 0.3 0.4 5.1 0.2 1.9 0.2 3.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 C3orf14 HT021 ENSG00000114405 "Chromosome 3 open reading frame 14" Q9HBI5 3 62318973-62336213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 111.9;Spermatocytes: 148.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 106.9" "Low region specificity" "Detected in all" HPA048286 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA048286: AB_2680340" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "unprognostic (3.69e-3)" "unprognostic (6.91e-2)" "unprognostic (9.19e-2)" "unprognostic (5.76e-5)" "unprognostic (1.57e-3)" "unprognostic (2.67e-1)" "unprognostic (9.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.33e-5)" "unprognostic (8.19e-2)" "unprognostic (1.73e-2)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" 3.8 14.7 28.2 5.6 23.6 1.0 35.0 16.4 31.2 5.0 3.9 7.7 2.5 3.3 5.5 6.8 11.0 4.1 6.8 4.6 20.9 22.0 9.6 2.9 6.4 5.0 19.9 20.5 8.2 6.3 2.3 19.0 4.8 25.9 17.8 4.1 4.1 5.0 5.6 1.0 12.0 2.7 6.8 15.2 3.0 6.1 20.9 8.1 1.2 9.2 3.8 8.2 13.5 3.4 3.7 6.7 5.2 21.0 0.7 6.1 2.1 0.0 5.8 7.0 0.0 5.1 7.4 5.4 9.5 5.7 12.0 11.9 0.0 8.5 0.0 0.0 6.4 24.7 1.5 0.0 6.0 9.2 0.0 4.0 5.1 0.0 0.0 3.4 0.0 11.2 3.3 8.1 13.5 11.1 0.2 5.8 0.0 0.6 0.1 11.8 106.9 0.0 0.0 8.8 8.4 12.0 0.0 0.0 2.9 9.8 16.3 12.3 10.4 6.3 22.6 8.7 6.1 9.2 5.8 0.1 5.9 0.0 27.4 9.4 5.8 0.0 0.0 5.7 0.0 20.5 5.2 4.3 0.4 0.2 14.3 0.1 3.7 3.6 2.8 4.6 1.1 1.0 0.7 0.3 0.7 21.0 6.7 6.1 2.1 28.2 23.6 16.4 31.2 20.9 22.0 19.9 20.5 25.9 8.1 20.8 10.2 2.7 19.7 32.6 31.2 4.5 7.6 4.0 19.4 21.0 3.9 16.3 51.4 31.3 111.9 11.7 2.6 0.0 47.7 18.9 20.3 22.1 1.1 3.0 27.0 35.0 84.0 4.9 7.8 44.2 13.0 19.5 43.9 83.8 2.6 27.9 29.7 0.0 9.9 34.8 23.1 0.0 15.5 148.6 37.5 25.1 8.2 4.4 3.8 17.0 C3orf18 G20 ENSG00000088543 "Chromosome 3 open reading frame 18" Q9UK00 3 50558025-50571027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 26.3;Early spermatids: 47.6;Late spermatids: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;NK-cells: 2.1;T-cells: 7.7" "Cell line enhanced" "Detected in many" "HDLM-2: 29.8" "Group enriched" "Detected in many" 4 "cerebellum: 31.6;olfactory region: 33.8" "Low region specificity" "Detected in all" HPA012105 Approved Approved Cytosol No No Cytosol "HPA012105: AB_1845717" "unprognostic (9.29e-3)" "unprognostic (1.46e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (8.19e-2)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (1.05e-2)" "unprognostic (1.64e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-3)" "unprognostic (1.29e-2)" "prognostic favorable (2.80e-9)" "unprognostic (7.65e-2)" "unprognostic (4.49e-1)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" 5.1 6.7 10.0 3.4 12.3 1.2 6.2 34.5 20.1 6.0 6.1 8.0 2.2 2.2 8.0 5.1 5.0 8.4 6.0 25.3 8.1 9.7 6.0 3.0 4.1 3.9 11.4 9.3 14.0 6.1 19.2 7.4 2.6 10.3 8.5 3.2 11.9 7.3 11.0 32.4 2.8 2.9 10.4 6.9 4.1 5.2 9.8 6.1 1.8 6.9 7.2 4.0 6.8 4.9 2.9 0.9 0.8 0.5 2.1 7.7 3.0 1.1 1.7 1.9 0.4 6.6 5.9 0.6 6.9 10.8 6.3 4.6 0.1 1.7 1.4 1.7 9.4 6.0 0.1 0.0 2.7 3.3 29.8 0.2 2.8 3.9 0.5 3.3 0.0 3.8 5.8 0.4 6.1 0.3 5.1 1.2 4.5 0.6 1.3 3.7 0.2 0.2 0.9 2.4 1.2 7.7 0.6 0.2 1.6 0.3 0.2 2.2 10.3 1.8 0.4 0.1 2.3 2.1 0.8 0.3 6.4 5.0 11.5 0.8 1.8 1.5 0.2 9.1 3.1 0.1 0.0 0.5 0.8 6.3 0.2 7.7 2.9 5.5 6.0 0.5 1.8 6.4 7.7 0.0 2.1 0.1 0.9 2.5 3.0 10.0 12.3 34.5 20.1 8.1 9.7 11.4 9.3 10.3 6.1 0.0 0.6 0.0 1.5 1.0 9.2 26.3 0.0 1.4 2.3 1.8 7.9 0.4 3.3 1.8 47.6 1.6 0.0 0.0 1.6 0.5 4.1 0.6 0.0 1.7 1.4 1.6 1.7 2.5 0.3 47.3 4.4 0.4 0.0 15.4 0.3 8.9 0.7 0.0 3.9 1.8 15.9 12.9 3.0 2.8 1.7 0.4 0.1 2.2 0.1 0.1 C3orf20 DKFZP434N1817 ENSG00000131379 "Chromosome 3 open reading frame 20" Q8ND61 3 14675099-14773034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 30.9" "Group enriched" "Detected in some" 27 "Early spermatids: 16.4;Late spermatids: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "Daudi: 5.7;HEL: 12.2;U-698: 9.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039584 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039584: AB_10795152" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (5.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.76e-3)" "unprognostic (1.81e-1)" "unprognostic (7.82e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (9.08e-2)" "unprognostic (4.74e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-4)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 30.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 5.7 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 12.2 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 2.0 0.0 0.5 0.8 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 C3orf33 "AC3-33, FLJ31139" ENSG00000174928 "Chromosome 3 open reading frame 33" Q6P1S2 3 155762617-155806351 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037663 Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA037663: AB_10672610" "unprognostic (1.18e-1)" "unprognostic (9.39e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-3)" "unprognostic (1.31e-1)" "unprognostic (7.27e-2)" "unprognostic (6.31e-3)" "unprognostic (3.28e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic favorable (6.48e-7)" "unprognostic (3.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.24e-2)" "unprognostic (1.56e-1)" 4.3 16.9 6.7 3.1 7.9 2.3 6.8 9.2 9.5 5.0 3.6 6.5 5.0 4.1 6.1 9.7 2.5 5.4 3.5 9.3 7.6 7.9 9.4 4.1 5.2 2.8 5.6 11.0 6.9 19.4 11.7 8.6 2.1 7.9 7.2 3.4 5.5 4.5 6.6 5.6 1.6 2.8 11.1 5.0 2.8 4.3 6.2 6.9 1.7 13.4 2.4 1.7 4.0 6.3 2.3 3.0 3.0 1.8 6.1 7.7 3.4 6.0 8.5 4.0 5.6 0.3 5.1 1.8 2.5 4.0 2.5 6.1 2.9 7.7 1.1 6.2 2.6 3.8 0.9 4.1 0.1 4.6 2.9 6.0 3.7 1.4 7.8 7.1 5.0 1.2 4.0 4.5 2.7 5.3 3.3 4.3 6.3 5.8 2.9 4.3 4.4 5.3 4.5 5.4 5.5 1.9 5.4 2.2 5.9 14.1 2.8 3.1 4.1 5.8 7.8 5.2 2.2 10.7 6.6 2.7 2.9 2.1 6.1 6.5 4.9 4.6 0.0 2.1 4.7 2.9 3.0 1.8 0.2 6.2 1.6 7.7 2.3 4.9 5.5 3.0 2.2 6.2 6.4 0.1 6.1 1.1 2.4 3.2 3.4 6.7 7.9 9.2 9.5 7.6 7.9 5.6 11.0 7.9 6.9 3.0 7.9 0.0 5.1 1.1 7.9 9.8 2.5 5.3 7.9 0.0 5.9 3.0 5.0 3.2 5.2 2.2 1.3 0.0 2.9 2.5 4.6 4.0 6.9 3.0 2.2 6.4 3.5 1.3 0.3 4.2 5.8 1.6 1.7 0.0 3.1 15.6 1.6 3.4 7.4 5.3 7.0 0.0 3.1 11.3 17.2 1.3 3.1 2.5 4.1 2.0 C3orf36 FLJ22173 ENSG00000221972 "Chromosome 3 open reading frame 36" Q3SXR2 3 133928145-133929812 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "lung: 8.2;seminal vesicle: 14.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 6.6;HeLa: 1.7;TIME: 5.2" HPA046432 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA046432: AB_2679664" "unprognostic (3.56e-1)" "unprognostic (3.28e-2)" "unprognostic (1.87e-1)" "unprognostic (5.29e-3)" "unprognostic (4.64e-4)" "unprognostic (5.05e-3)" "unprognostic (8.18e-5)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.03e-2)" "unprognostic (1.15e-2)" "unprognostic (2.22e-1)" "unprognostic (7.85e-2)" "unprognostic (4.79e-3)" "unprognostic (2.08e-1)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" 1.1 1.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 1.3 0.0 0.6 1.1 0.8 0.7 0.0 0.0 1.9 0.0 8.2 0.1 0.0 0.0 0.7 1.6 0.2 0.1 2.3 0.3 0.4 14.7 0.0 0.1 1.4 1.0 0.0 1.5 0.8 0.0 2.7 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf38 MGC26717 ENSG00000179021 "Chromosome 3 open reading frame 38" Q5JPI3 3 88149743-88168729 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 252.0;Late spermatids: 238.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 59.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034736, HPA034737" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034736: AB_2674307, HPA034737: AB_10671505" "unprognostic (1.93e-1)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (1.48e-2)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (2.26e-3)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "prognostic favorable (3.55e-4)" "unprognostic (9.28e-3)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.95e-2)" "unprognostic (2.88e-3)" "unprognostic (1.63e-1)" "unprognostic (4.57e-2)" "unprognostic (3.67e-2)" 12.2 11.7 13.7 12.8 16.1 35.2 12.3 12.9 12.8 11.6 11.9 13.6 8.4 9.5 11.5 10.7 14.6 10.7 9.4 9.7 11.3 11.1 10.2 13.5 10.6 19.2 15.1 9.4 12.1 9.3 7.1 15.8 12.5 11.4 11.2 11.2 9.0 10.6 10.2 9.7 11.6 11.4 10.9 11.3 17.0 10.1 33.2 13.5 29.5 11.6 9.0 17.1 12.4 11.6 20.0 17.7 25.8 24.2 17.1 17.4 15.3 6.4 6.7 13.2 7.0 8.8 8.0 6.1 10.5 12.6 15.7 21.3 7.7 8.9 8.7 9.4 9.7 7.5 4.7 9.5 7.7 13.6 15.6 4.5 10.6 5.2 6.5 12.6 14.5 9.2 11.4 7.8 10.5 9.0 10.3 9.0 9.5 6.7 10.0 17.0 7.5 14.6 6.1 16.0 12.1 7.6 9.2 4.6 8.2 10.4 8.8 4.0 5.8 9.6 5.3 15.8 11.2 10.2 11.1 8.2 9.8 10.7 59.4 11.5 9.2 13.6 12.9 7.6 11.5 9.2 25.8 16.8 17.5 13.5 24.2 17.4 20.0 12.6 13.8 17.7 15.9 12.6 12.8 7.5 17.1 19.7 12.3 15.1 15.3 13.7 16.1 12.9 12.8 11.3 11.1 15.1 9.4 11.4 13.5 17.9 6.9 32.0 16.6 10.4 21.8 5.6 0.0 14.7 11.4 5.2 21.6 19.3 16.6 14.7 252.0 8.7 11.8 0.0 12.0 18.8 15.4 14.2 13.9 7.4 23.4 6.4 15.5 8.6 17.2 238.1 15.3 21.8 15.1 27.1 10.7 22.8 11.6 13.3 14.2 9.8 21.7 12.9 12.2 25.9 12.0 12.3 21.4 28.7 9.0 18.6 C3orf49 ENSG00000163632 "Chromosome 3 open reading frame 49" Q96BT1 3 63819362-63848636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Group enriched" "Detected in some" 12 "Early spermatids: 19.9;Late spermatids: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 4.7" "Not detected" "Not detected" HPA053582 Uncertain Approved Vesicles,Centrosome,Cytosol NA NA Cytosol "Vesicles, Centrosome" "HPA053582: AB_2682199" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (4.81e-2)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-1)" "unprognostic (2.14e-2)" "unprognostic (9.29e-3)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.61e-3)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (5.79e-2)" "unprognostic (1.07e-1)" 0.4 0.1 0.5 0.4 1.0 0.9 0.4 1.8 4.0 0.4 0.4 0.4 0.4 1.3 0.5 0.4 1.7 0.4 0.4 0.8 0.5 0.5 0.4 0.6 0.6 0.4 0.4 0.4 1.2 1.3 0.0 0.4 0.4 0.4 0.4 0.0 0.4 0.5 0.4 2.6 2.0 0.4 0.4 0.4 0.4 0.3 3.6 0.4 0.4 0.7 0.4 0.4 0.5 0.4 1.1 0.5 1.7 0.9 2.2 1.1 0.1 0.7 2.0 1.0 1.3 0.0 0.3 1.2 1.7 0.0 0.1 0.0 1.2 1.0 2.6 0.4 0.0 0.7 1.1 0.0 0.1 0.3 1.5 1.8 2.2 4.7 0.5 0.0 0.8 0.8 0.2 0.1 0.0 0.1 0.5 0.0 0.9 1.3 1.2 0.0 4.4 1.2 1.2 1.3 1.2 0.4 1.7 1.1 2.5 0.1 1.1 1.2 0.8 0.3 2.6 0.3 0.3 0.7 1.0 1.5 0.8 1.0 1.7 2.0 0.8 2.4 0.5 2.7 3.7 1.0 1.7 0.6 0.2 1.1 0.4 0.4 0.6 0.6 0.8 0.4 1.1 1.1 1.0 1.2 2.2 0.9 0.5 0.8 0.1 0.5 1.0 1.8 1.3 0.5 0.5 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.3 0.1 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 C3orf52 "FLJ23186, TTMP" ENSG00000114529 "Chromosome 3 open reading frame 52" Q5BVD1 3 112086335-112131004 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 41.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 112.5;Glandular cells: 75.6;Syncytiotrophoblasts: 62.7;Urothelial cells: 119.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 14.9;U-698: 20.8" "HPA007678, HPA008119, HPA011968" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826" "unprognostic (8.86e-2)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-3)" "unprognostic (3.49e-4)" "unprognostic (2.54e-1)" "unprognostic (1.39e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.71e-2)" "unprognostic (3.76e-6)" "unprognostic (3.14e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-2)" "unprognostic (9.59e-2)" 1.1 1.0 0.3 5.3 0.7 0.4 1.9 0.3 0.4 1.0 9.1 0.0 6.9 2.8 1.7 1.5 2.7 1.0 12.4 3.0 0.4 0.4 7.1 0.5 6.3 0.8 0.3 0.0 0.6 41.2 0.0 8.7 6.1 0.5 5.4 9.0 0.6 3.9 9.6 1.5 22.3 12.7 4.2 0.3 0.8 10.6 1.0 0.0 20.8 10.7 4.3 3.6 6.1 6.1 0.8 0.8 0.0 0.0 0.0 2.7 1.0 8.7 1.4 2.4 0.0 0.3 0.0 3.2 6.9 2.9 4.0 4.6 14.9 4.7 0.3 1.3 2.0 4.6 6.2 2.8 1.7 7.6 0.0 2.3 6.0 2.0 0.7 1.8 0.0 0.0 0.5 3.5 3.6 6.1 2.8 0.9 0.0 1.5 1.5 3.0 0.6 0.2 0.0 5.2 5.6 1.9 0.2 7.9 0.0 7.1 7.7 0.3 0.6 2.6 2.7 2.5 2.9 4.0 0.0 2.2 1.4 2.4 0.0 0.0 5.5 0.0 20.8 1.2 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.4 0.8 2.7 1.3 0.5 0.3 1.5 0.6 0.0 0.0 0.0 0.8 0.0 1.0 0.3 0.7 0.3 0.4 0.4 0.4 0.3 0.0 0.5 0.0 14.9 7.7 0.5 112.5 28.8 0.0 1.4 5.1 13.4 22.7 17.4 0.0 15.2 0.0 29.6 24.4 0.3 14.6 0.0 31.2 16.0 1.7 75.6 0.0 0.0 1.6 0.0 11.3 0.6 0.3 18.2 0.3 0.3 1.7 4.6 32.5 0.0 53.5 5.9 0.4 1.7 0.0 0.0 3.3 1.8 5.5 29.4 62.7 0.8 5.4 119.7 C3orf70 ENSG00000187068 "Chromosome 3 open reading frame 70" A6NLC5 3 185078050-185153014 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 26.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 17.4;Melanocytes: 37.1;Peritubular cells: 46.7" "Cancer enhanced" "Detected in many" "glioma: 10.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "RH-30: 4.7;SCLC-21H: 19.5;SK-BR-3: 8.4;WM-115: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041861 Uncertain Approved Cytosol NA NA Cytosol "HPA041861: AB_10804119" "unprognostic (1.45e-1)" "unprognostic (2.17e-3)" "unprognostic (3.92e-3)" "unprognostic (2.77e-1)" "unprognostic (2.31e-1)" "unprognostic (6.62e-4)" "unprognostic (5.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-1)" "unprognostic (5.98e-3)" "unprognostic (9.91e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.06e-1)" "unprognostic (8.48e-2)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" 4.6 2.3 14.4 4.7 13.8 0.9 2.0 7.9 18.2 7.2 12.1 11.1 7.9 5.3 12.1 6.1 10.1 6.8 6.1 3.3 11.1 10.2 1.6 1.3 2.4 1.3 11.4 7.1 5.9 1.1 4.0 1.4 2.9 10.5 10.2 8.2 5.2 5.5 16.4 1.5 2.9 6.5 26.6 11.1 4.2 4.4 7.5 7.0 0.0 2.4 1.0 1.7 13.2 3.3 1.2 1.2 3.4 1.6 1.7 1.1 0.5 0.0 0.1 2.3 0.0 0.0 0.1 0.1 3.0 0.1 0.5 0.0 1.4 0.0 0.0 0.0 0.3 0.1 0.1 1.0 0.0 0.2 0.0 0.8 2.5 0.1 0.7 0.0 0.4 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 1.0 2.2 0.2 0.1 4.7 0.1 0.0 0.5 19.5 0.2 0.9 8.4 0.5 0.1 0.6 2.2 0.8 0.0 2.3 0.1 1.5 0.0 0.0 0.0 0.0 0.0 10.5 3.4 1.2 1.7 0.8 1.0 1.0 1.0 0.8 0.8 0.6 1.2 1.0 1.1 3.3 1.7 1.6 1.2 0.7 0.5 14.4 13.8 7.9 9.6 11.1 10.2 11.4 7.1 10.5 7.0 0.0 0.0 1.5 0.2 3.7 17.4 1.2 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.1 1.0 2.3 4.0 0.0 0.2 0.6 2.3 0.3 0.0 0.0 3.1 3.2 1.2 4.9 0.6 1.2 3.1 0.0 37.1 1.0 8.1 1.3 0.2 0.0 46.7 0.0 6.2 6.5 15.8 7.9 12.5 1.6 0.7 0.0 5.3 0.3 C4orf22 ENSG00000197826 "Chromosome 4 open reading frame 22" Q6V702 4 80335720-80963756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.0;fallopian tube: 19.8;testis: 34.8" "Cell type enhanced" "Detected in some" 25 "Ciliated cells: 163.3;Early spermatids: 74.5;Spermatocytes: 40.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 8.4;pons and medulla: 22.0" "Cell type enhanced" "Detected in some" "memory B-cell: 1.2;naive B-cell: 2.1" "Lineage enhanced" "Detected in single" "B-cells: 2.1" "Cell line enhanced" "Detected in some" "A-431: 3.2;BJ: 4.0;hTERT-RPE1: 6.3;LHCN-M2: 2.4;SCLC-21H: 2.7;U-251 MG: 2.6" "Low region specificity" "Detected in many" HPA043383 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043383: AB_10797140" "unprognostic (4.77e-4)" "unprognostic (1.52e-1)" "unprognostic (4.06e-2)" "unprognostic (1.45e-2)" "unprognostic (7.24e-2)" "unprognostic (3.27e-1)" "unprognostic (6.93e-2)" "unprognostic (5.90e-2)" "unprognostic (2.67e-3)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.61e-2)" 0.1 0.1 1.4 0.1 8.4 0.1 0.3 0.6 0.2 0.9 0.1 5.1 0.1 0.3 0.4 7.8 0.2 19.8 0.3 0.1 2.8 2.5 0.4 0.1 5.9 0.3 0.1 0.1 3.5 0.1 0.1 1.2 0.1 22.0 0.2 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.2 0.4 0.1 0.1 34.8 2.4 2.9 0.7 0.0 0.2 0.1 0.0 2.1 0.5 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 1.9 0.0 4.0 0.7 0.1 0.1 0.0 0.0 1.1 0.0 1.4 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 1.0 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.4 8.4 0.6 0.2 2.8 2.5 0.1 0.1 22.0 2.4 0.0 1.0 0.0 0.1 0.0 0.6 0.0 0.0 163.3 23.9 0.0 0.0 0.0 0.0 0.0 74.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 40.9 2.3 0.0 0.0 0.0 0.0 0.0 C4orf48 ENSG00000243449 "Chromosome 4 open reading frame 48" Q5BLP8 4 2041993-2043970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 78.4;brain: 37.2" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 378.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 38.6;NB-4: 27.7;PC-3: 83.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052447 Uncertain Approved Cytosol "Secreted to blood" NA NA 32000 Cytosol "HPA052447: AB_2681837" "unprognostic (7.96e-2)" "unprognostic (2.57e-3)" "unprognostic (2.08e-1)" "unprognostic (3.20e-2)" "unprognostic (4.01e-2)" "unprognostic (8.26e-2)" "unprognostic (4.85e-3)" "unprognostic (2.51e-3)" "unprognostic (2.28e-3)" "unprognostic (1.80e-1)" "unprognostic (1.95e-2)" "unprognostic (5.55e-2)" "unprognostic (3.42e-2)" "unprognostic (5.38e-3)" "unprognostic (2.68e-1)" "unprognostic (5.55e-2)" "unprognostic (3.17e-3)" 11.4 7.8 25.5 9.7 22.2 5.6 4.8 7.7 37.2 3.4 19.7 18.2 3.2 6.5 4.1 3.0 1.2 3.2 3.1 3.8 26.4 26.2 5.2 2.5 4.7 8.7 24.8 15.6 2.9 16.8 5.6 19.8 5.3 14.9 3.9 3.1 4.3 5.1 4.3 3.3 3.7 16.6 2.4 30.7 9.6 9.8 13.9 15.7 1.2 2.2 0.7 2.4 2.6 2.6 29.8 49.4 67.5 78.4 4.5 31.0 28.4 7.8 6.5 1.3 6.1 0.6 0.9 8.7 7.5 1.5 1.4 1.3 4.4 4.7 1.0 7.3 0.2 2.5 2.2 0.1 0.8 0.4 4.7 38.6 2.5 3.5 2.5 1.3 5.1 17.3 0.7 1.4 0.3 0.0 0.4 1.4 4.3 8.1 0.0 0.9 4.8 5.7 27.7 3.9 0.4 83.8 13.2 2.0 2.5 1.2 2.9 10.5 14.8 3.7 0.1 10.1 0.1 2.0 2.4 6.4 3.6 7.8 2.7 8.4 5.9 5.1 0.0 3.6 3.1 5.0 11.5 78.4 67.5 21.5 50.6 22.0 29.8 27.8 23.9 44.2 22.6 16.0 16.7 59.0 4.5 44.0 49.4 31.0 28.4 25.5 22.2 7.7 37.2 26.4 26.2 24.8 15.6 14.9 15.7 0.0 3.4 61.1 5.3 19.5 14.6 6.1 17.8 6.7 3.4 190.1 0.0 7.5 59.7 304.2 76.9 29.1 185.6 23.3 194.2 111.5 25.9 12.6 109.2 8.9 199.3 17.5 225.6 114.2 260.9 247.7 17.8 117.6 310.4 64.9 97.5 43.9 199.3 378.7 26.5 6.8 11.5 12.9 12.8 61.7 167.2 8.8 11.0 64.3 73.8 9.2 C5orf42 "FLJ13231, Hug, JBTS17" ENSG00000197603 "Chromosome 5 open reading frame 42" Q9H799 5 37106228-37249428 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 59.6;Ciliated cells: 113.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036775, HPA036776" Approved Approved Cytosol NA NA Cytosol "HPA036775: AB_10669914, HPA036776: AB_2675308" "unprognostic (3.06e-1)" "unprognostic (2.00e-1)" "unprognostic (4.96e-2)" "unprognostic (4.13e-3)" "unprognostic (1.65e-1)" "unprognostic (1.44e-2)" "unprognostic (1.38e-3)" "unprognostic (5.88e-2)" "unprognostic (3.13e-2)" "unprognostic (6.20e-3)" "unprognostic (3.02e-1)" "unprognostic (5.31e-2)" "unprognostic (2.72e-2)" "unprognostic (2.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.44e-2)" "unprognostic (2.09e-1)" 7.1 8.3 9.2 6.4 12.3 3.6 9.5 14.9 12.6 8.7 7.5 7.5 9.8 2.9 10.3 11.5 6.6 10.4 8.4 6.9 9.6 9.4 10.2 4.4 8.3 6.3 9.5 9.3 14.2 7.8 17.7 19.6 8.5 9.5 11.6 5.6 6.9 8.7 10.3 6.3 6.5 4.9 9.6 9.5 5.7 6.4 11.6 9.5 12.0 17.6 5.4 4.8 8.7 9.1 3.1 2.5 0.6 0.2 1.5 1.5 0.2 4.1 2.1 6.4 4.4 7.3 7.4 2.7 3.7 3.1 4.3 3.9 3.2 5.0 1.1 2.7 3.6 8.1 1.6 1.8 2.5 5.0 2.6 1.7 2.6 14.8 2.0 3.7 0.0 1.3 5.8 3.8 4.8 2.8 6.0 4.3 2.6 0.0 0.8 8.7 0.1 3.0 3.6 1.5 0.0 1.6 2.8 11.0 0.0 4.1 1.2 3.3 2.0 34.2 0.2 2.2 4.9 1.7 2.2 6.2 7.1 4.5 2.3 3.2 1.2 0.0 1.2 1.8 0.1 2.9 0.6 0.2 0.0 1.5 0.1 1.5 0.6 0.9 0.8 0.5 3.1 0.8 1.2 0.1 1.5 0.1 2.5 0.0 0.2 9.2 12.3 14.9 12.6 9.6 9.4 9.5 9.3 9.5 9.5 59.6 16.1 1.5 7.4 3.7 36.1 0.0 10.2 113.8 52.4 0.0 27.5 5.3 0.0 0.0 20.6 6.7 2.0 0.0 0.0 4.4 12.1 7.2 12.7 4.7 5.1 23.8 6.3 19.6 4.6 16.8 25.0 4.7 13.5 0.0 3.8 21.9 0.0 0.0 32.5 0.0 32.6 19.4 9.2 33.4 14.7 4.4 3.0 4.9 4.7 5.2 C5orf51 LOC285636 ENSG00000205765 "Chromosome 5 open reading frame 51" A6NDU8 5 41904188-41921636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043779, HPA063816" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043779: AB_2678666, HPA063816: AB_2685130" "unprognostic (6.64e-2)" "unprognostic (2.24e-2)" "unprognostic (9.92e-2)" "unprognostic (6.92e-3)" "unprognostic (3.93e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (1.90e-4)" "unprognostic (4.98e-2)" "unprognostic (1.59e-1)" "unprognostic (4.90e-3)" "unprognostic (2.10e-2)" "unprognostic (4.58e-2)" "unprognostic (1.01e-1)" "unprognostic (3.97e-1)" "unprognostic (3.75e-1)" "unprognostic (2.30e-2)" "unprognostic (1.67e-2)" 16.6 12.4 15.9 12.7 21.5 3.4 15.9 20.5 21.3 14.7 12.5 23.5 12.6 10.5 14.9 21.9 16.2 11.4 12.2 12.8 16.0 17.5 15.3 14.0 10.7 13.1 20.6 12.3 22.1 11.9 24.1 18.6 17.2 25.1 16.5 12.6 13.2 12.9 15.4 7.2 14.1 11.9 16.8 22.1 12.8 11.5 9.4 18.5 16.2 19.0 6.9 14.0 18.9 13.5 5.6 6.8 21.0 7.4 5.6 7.4 7.9 7.4 5.7 11.7 24.4 24.0 18.9 12.8 8.8 15.3 12.5 13.4 5.7 7.7 8.0 10.9 9.8 21.8 4.8 15.4 8.3 18.1 10.7 4.7 7.7 17.3 8.5 29.1 9.8 5.9 18.4 12.1 14.6 16.9 8.0 10.7 9.7 13.7 13.8 13.2 7.7 9.2 10.1 11.6 4.5 3.1 8.1 16.2 12.4 8.3 7.2 7.1 11.1 28.1 13.5 14.5 10.9 15.0 10.1 7.7 14.9 8.9 11.2 8.5 7.0 11.3 8.2 16.5 17.3 10.5 21.0 6.9 6.6 4.7 5.6 6.0 5.1 5.5 5.0 6.8 5.6 7.4 4.9 4.7 5.6 7.4 4.1 3.9 7.9 15.9 21.5 20.5 21.3 16.0 17.5 20.6 12.3 25.1 18.5 29.8 8.6 14.5 7.4 8.9 9.2 13.4 12.7 10.7 9.1 14.0 5.9 11.0 8.3 9.8 9.1 9.0 5.1 0.0 6.7 10.7 9.3 9.4 4.7 16.3 12.5 7.9 10.4 8.6 16.1 8.9 8.3 6.7 6.8 10.8 9.2 14.5 7.3 5.8 7.4 10.8 9.0 12.9 11.3 6.6 7.8 11.5 14.1 5.0 7.4 9.1 C6orf10 TSBP ENSG00000204296 "Chromosome 6 open reading frame 10" Q5SRN2 6 32288526-32371912 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 28.6" "Cell type enriched" "Detected in some" 12 "Early spermatids: 313.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SuSa: 1.1;U-2197: 1.3" HPA047479 Approved Cytosol NA NA Cytosol "HPA047479: " "unprognostic (1.00e-1)" "unprognostic (2.24e-1)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (2.42e-1)" "unprognostic (8.19e-2)" "unprognostic (6.56e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 C6orf106 "dJ391O22.4, FLJ22195" ENSG00000196821 "Chromosome 6 open reading frame 106" Q9H6K1 6 34587288-34696859 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 106.1;Late spermatids: 212.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034489, HPA034490" Approved Supported "Nuclear speckles,Centrosome,Cytosol" NA NA "Nuclear speckles" "Centrosome, Cytosol" "HPA034489: AB_10669991, HPA034490: AB_2674186" "unprognostic (3.76e-2)" "unprognostic (2.51e-1)" "unprognostic (7.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.41e-1)" "unprognostic (1.32e-1)" "unprognostic (8.40e-2)" "unprognostic (9.94e-2)" "unprognostic (7.57e-2)" "unprognostic (5.68e-2)" "unprognostic (3.55e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (1.05e-1)" "unprognostic (1.53e-1)" 16.5 10.7 12.5 13.7 12.7 7.5 15.2 22.5 18.7 9.5 22.4 6.3 6.7 9.1 9.0 15.5 13.7 8.6 15.9 60.4 11.2 10.0 23.9 35.2 16.9 10.1 14.4 6.8 11.6 12.0 14.1 7.3 11.1 9.0 9.0 9.5 10.3 12.6 16.1 66.3 10.4 14.9 12.3 7.8 9.1 10.0 20.7 8.2 5.8 15.7 26.6 13.3 13.4 11.4 8.6 4.1 18.2 7.3 5.7 9.2 4.7 28.7 13.1 13.1 19.2 31.4 17.3 15.4 19.6 23.0 23.5 29.4 25.7 13.5 33.0 14.8 19.4 32.4 28.7 38.0 16.5 29.9 46.4 14.8 27.6 15.3 24.5 30.7 23.1 30.8 11.6 34.6 23.5 21.5 16.0 18.5 13.8 31.0 14.1 13.2 17.2 16.2 16.0 12.0 46.9 11.8 12.7 16.7 17.5 18.3 28.9 15.6 12.2 29.3 14.3 28.8 28.2 18.1 19.5 18.6 19.5 14.9 20.3 19.5 20.1 45.6 25.6 7.0 20.6 22.5 18.2 3.5 7.3 9.1 6.3 4.8 6.7 6.6 7.2 4.1 8.6 3.6 5.7 4.5 5.7 7.3 2.2 9.2 4.7 12.5 12.7 22.5 18.7 11.2 10.0 14.4 6.8 9.0 8.2 26.8 40.4 23.1 14.9 22.1 17.6 73.3 25.5 33.5 25.0 7.0 19.6 11.7 11.6 14.3 106.1 21.5 21.1 0.0 18.7 6.9 9.9 26.1 25.4 53.9 13.4 12.7 24.1 9.2 17.2 212.0 18.1 18.4 15.1 29.7 17.2 9.4 28.1 19.0 20.8 26.9 18.0 6.5 18.6 9.9 14.0 28.2 18.1 17.3 12.7 30.7 C6orf132 bA7K24.2 ENSG00000188112 "Chromosome 6 open reading frame 132" Q5T0Z8 6 42101118-42142619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 118.2;Glandular cells: 119.1;Pancreatic endocrine cells: 145.1;Urothelial cells: 193.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 20.6;CACO-2: 18.8;CAPAN-2: 15.6;OE19: 61.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044588 Enhanced Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA044588: AB_10794293" "unprognostic (7.09e-2)" "unprognostic (8.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.24e-3)" "unprognostic (1.60e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (6.78e-2)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (4.90e-4)" "unprognostic (1.31e-1)" "unprognostic (4.26e-3)" "unprognostic (1.04e-2)" "unprognostic (5.53e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" 1.3 0.5 0.2 3.7 0.2 0.2 4.2 0.3 0.3 13.3 20.9 0.2 1.4 15.7 0.7 1.2 66.1 2.6 15.5 0.5 0.2 0.1 6.2 0.6 5.9 0.2 0.2 0.2 1.4 20.8 1.1 2.2 3.1 0.2 6.8 5.3 0.2 16.6 4.0 1.2 24.8 37.2 0.7 0.2 0.2 16.2 0.4 0.2 0.6 12.5 49.3 54.3 4.8 17.5 2.1 1.9 3.5 1.3 0.9 1.2 0.7 20.6 0.2 0.0 0.0 0.1 2.4 10.2 1.2 1.5 2.9 3.0 18.8 15.6 0.0 2.2 2.0 0.0 13.9 0.0 6.2 1.9 1.7 2.9 1.0 1.8 4.2 0.7 0.0 0.0 1.4 11.7 2.2 3.3 1.1 0.0 0.1 0.5 0.2 0.6 7.2 0.2 0.1 1.4 61.4 0.5 0.0 0.0 0.1 2.2 9.3 1.1 0.0 1.8 12.6 0.0 1.5 9.2 0.1 0.3 0.1 1.3 5.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.9 1.3 1.7 0.8 0.8 0.6 1.0 0.8 0.8 1.4 2.1 0.9 1.2 3.5 0.9 0.5 1.9 0.5 0.7 0.2 0.2 0.3 0.3 0.2 0.1 0.2 0.2 0.2 0.2 41.7 17.6 0.0 50.1 46.6 0.8 3.6 40.8 61.6 53.4 48.8 19.6 10.6 0.0 41.6 12.9 0.5 80.5 0.0 118.2 0.5 8.4 119.1 1.1 0.0 0.7 4.8 7.0 1.8 1.6 91.9 0.6 1.2 11.8 5.4 33.6 0.5 145.1 43.5 1.4 5.6 7.4 0.0 2.1 4.3 8.3 71.6 3.4 2.2 37.9 193.5 C6orf47 "D6S53E, G4" ENSG00000204439 "Chromosome 6 open reading frame 47" O95873 6 31658298-31660772 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;fHDF/TERT166: 6.4;HBEC3-KT: 9.0;HEK 293: 7.5;RT4: 8.7;U-2 OS: 6.4" "Low region specificity" "Detected in all" HPA045281 Uncertain Approved Cytosol NA NA Cytosol "HPA045281: AB_10961000" "unprognostic (5.99e-2)" "unprognostic (5.71e-2)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (9.92e-2)" "unprognostic (6.74e-2)" "unprognostic (2.09e-1)" "unprognostic (3.24e-2)" "unprognostic (3.27e-1)" "unprognostic (5.04e-2)" "unprognostic (2.93e-2)" "unprognostic (1.15e-1)" "unprognostic (1.66e-3)" "unprognostic (6.78e-3)" "unprognostic (2.38e-1)" "unprognostic (7.73e-2)" "unprognostic (3.59e-3)" 7.3 9.1 5.4 7.7 7.1 3.4 14.0 7.7 10.2 8.1 11.7 8.3 9.8 2.6 10.8 18.4 14.2 8.9 13.9 13.6 5.1 4.9 10.3 9.2 14.3 16.0 6.1 4.8 11.7 18.7 2.7 8.0 8.7 6.0 9.0 10.0 9.7 9.2 10.5 11.8 23.3 14.8 15.4 6.3 13.0 10.2 4.0 5.3 11.5 11.3 10.9 11.8 11.5 8.3 3.5 1.5 1.7 2.1 0.0 3.0 1.1 0.0 5.8 0.0 4.3 7.3 1.0 0.0 0.5 0.4 1.8 0.5 0.0 0.8 1.9 4.6 6.4 0.0 0.0 0.0 9.0 0.2 0.1 7.5 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.9 5.0 8.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.8 6.4 0.0 0.0 4.2 0.2 0.7 2.0 0.0 2.5 0.0 0.8 1.6 3.0 2.1 0.1 3.5 1.1 0.5 0.5 0.0 2.1 1.9 1.7 0.0 0.0 1.5 2.1 1.1 5.4 7.1 7.7 10.2 5.1 4.9 6.1 4.8 6.0 5.3 6.0 10.4 11.6 21.5 22.2 16.6 1.2 17.8 0.0 5.7 12.2 7.9 15.4 21.6 19.9 0.0 10.8 34.2 0.0 25.4 12.5 13.0 20.0 11.5 7.8 16.4 6.4 6.4 12.9 13.5 0.0 15.0 15.3 8.5 18.0 18.2 14.3 22.8 25.9 20.5 18.2 12.3 32.3 15.2 0.9 8.3 23.5 19.9 20.0 22.3 44.3 C6orf62 "DKFZP564G182, FLJ12619, XTP12" ENSG00000112308 "Chromosome 6 open reading frame 62" Q9GZU0 6 24704861-24720836 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Kupffer cells: 306.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030564, HPA030566" Supported Approved Cytosol NA NA Cytosol "HPA030564: AB_10600000, HPA030566: AB_10599425" "unprognostic (2.07e-2)" "unprognostic (2.92e-1)" "unprognostic (7.10e-2)" "unprognostic (6.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (1.18e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.04e-4)" "unprognostic (4.16e-3)" "unprognostic (3.94e-2)" "unprognostic (3.08e-2)" "unprognostic (9.01e-2)" "unprognostic (4.03e-1)" "unprognostic (1.93e-2)" "prognostic favorable (3.62e-6)" 38.9 38.3 46.0 42.8 49.9 37.8 52.0 34.3 50.1 30.7 35.4 31.4 49.9 30.8 31.0 42.6 33.1 32.0 41.9 27.8 38.2 40.5 35.1 49.0 54.6 67.6 50.0 36.7 37.8 52.9 35.6 33.6 37.9 33.9 33.6 31.3 33.8 47.4 52.6 31.1 33.7 38.6 28.8 36.4 58.3 38.9 46.0 38.1 75.2 41.5 28.1 56.5 35.6 34.2 48.4 48.7 64.0 62.3 52.7 65.3 103.5 23.0 14.3 17.6 29.8 22.2 28.7 19.3 27.4 35.8 41.3 44.2 17.9 20.8 26.6 43.2 32.1 40.8 19.3 20.1 26.8 45.8 44.8 9.7 27.9 23.3 24.0 37.9 33.9 33.4 22.3 54.1 27.9 37.2 27.6 31.9 16.6 24.5 19.9 38.7 19.1 26.0 51.0 19.4 14.1 14.5 20.9 19.1 26.7 24.6 34.9 29.8 16.8 32.8 37.4 49.7 20.6 32.8 27.2 28.3 37.4 18.1 14.1 37.2 46.8 73.7 33.1 13.4 46.9 36.1 47.7 62.1 64.0 55.7 62.0 58.6 48.4 57.4 60.6 47.7 41.8 57.6 65.3 44.2 52.7 62.3 48.7 53.4 103.5 46.0 49.9 34.3 50.1 38.2 40.5 50.0 36.7 33.9 38.1 77.4 66.5 104.0 40.4 51.1 48.9 29.1 107.0 54.9 46.6 89.0 47.1 43.9 31.5 55.4 110.4 61.6 88.0 93.5 64.0 46.9 51.8 87.1 54.3 110.1 83.6 39.7 92.1 86.5 306.8 40.0 50.0 84.3 47.2 83.8 78.0 40.4 70.7 77.0 44.6 54.9 60.4 51.8 42.8 83.7 91.8 48.9 62.9 96.5 75.2 51.5 C7orf25 MGC2821 ENSG00000136197 "Chromosome 7 open reading frame 25" Q9BPX7 7 42908726-42912305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 7 "Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 20.9;eosinophil: 12.3;neutrophil: 6.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 20.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020120, HPA049635" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020120: AB_1845755, HPA049635: AB_2680837" "unprognostic (6.29e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-2)" "unprognostic (4.83e-2)" "unprognostic (1.13e-3)" "unprognostic (2.23e-2)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (1.66e-2)" "unprognostic (1.73e-1)" "unprognostic (5.25e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.26e-1)" "unprognostic (2.66e-1)" "unprognostic (3.87e-2)" "unprognostic (3.05e-3)" 4.8 6.5 7.6 3.8 7.6 2.4 6.1 7.1 11.0 5.0 5.2 6.3 2.6 2.1 5.3 11.0 5.2 6.5 5.9 5.8 9.2 8.6 7.7 5.9 4.8 5.2 10.0 9.1 7.2 5.1 12.6 6.5 5.8 12.2 8.2 3.4 4.0 5.0 9.2 5.7 3.9 5.3 5.8 9.6 5.2 5.3 11.0 5.3 5.8 7.7 4.5 3.8 5.3 4.4 2.1 1.4 20.9 1.9 1.6 2.2 1.1 3.5 9.1 3.3 4.9 4.6 2.5 3.6 7.0 2.6 4.6 4.2 5.9 4.6 9.2 5.4 6.7 6.7 6.0 3.5 6.2 5.3 4.4 8.7 4.8 9.3 3.6 8.4 3.6 3.1 5.1 4.2 4.6 4.7 2.3 3.5 5.9 6.1 2.1 3.8 6.6 1.9 3.5 4.0 3.2 11.8 2.2 3.5 3.8 2.6 8.7 4.1 4.6 10.3 3.1 3.6 4.8 4.1 3.5 9.4 4.6 5.3 5.0 4.4 4.9 10.9 2.8 4.3 4.6 9.9 20.9 1.9 12.3 1.5 1.8 2.2 2.1 1.1 1.4 1.4 1.7 1.6 1.6 6.4 1.6 1.7 0.6 0.8 1.1 7.6 7.6 7.1 11.0 9.2 8.6 10.0 9.1 12.2 5.3 0.0 0.6 0.8 0.4 0.2 1.0 0.5 0.0 1.4 0.0 3.5 3.9 0.6 1.7 0.8 0.0 0.1 0.0 0.0 1.0 0.2 0.3 0.5 0.0 0.6 0.2 0.0 0.0 1.8 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.3 0.9 0.0 0.7 1.0 0.5 0.0 0.4 1.2 1.2 0.4 0.7 0.0 0.0 0.1 C7orf26 MGC2718 ENSG00000146576 "Chromosome 7 open reading frame 26" Q96N11 7 6590017-6608726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042899, HPA052175" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Nucleoli, Intermediate filaments, Cytosol" "HPA042899: AB_2678218, HPA052175: AB_2681750" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (4.51e-2)" "unprognostic (2.50e-2)" "unprognostic (2.18e-2)" "unprognostic (5.22e-2)" "unprognostic (4.28e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "prognostic favorable (6.95e-5)" "unprognostic (4.72e-2)" "unprognostic (2.26e-3)" "unprognostic (4.41e-1)" "unprognostic (1.03e-2)" "unprognostic (3.40e-3)" "unprognostic (1.55e-1)" 19.8 17.1 13.4 21.7 17.7 29.2 20.0 20.6 26.9 19.0 17.9 21.1 21.5 19.4 23.0 15.4 14.7 19.9 15.6 12.8 14.4 14.1 15.4 18.4 19.3 24.1 18.8 20.2 20.6 23.9 17.2 16.6 14.0 15.4 21.1 11.5 16.4 21.2 16.6 18.7 21.9 16.4 19.6 13.1 27.3 18.6 16.8 16.1 31.7 18.3 18.5 20.6 17.6 19.6 4.2 6.4 4.6 3.4 3.3 6.1 1.9 11.1 9.4 6.6 15.4 10.7 6.0 8.7 6.7 5.9 9.7 6.0 8.7 4.7 13.3 8.8 5.0 18.5 12.4 8.7 6.2 4.4 5.1 12.6 4.9 5.9 9.2 12.6 11.8 15.9 6.9 9.3 5.8 6.1 5.2 10.6 14.4 12.9 10.1 5.7 18.8 10.2 24.4 13.0 5.6 12.5 20.9 5.2 11.2 6.3 9.8 8.6 16.0 6.5 21.7 9.0 7.1 9.9 17.8 7.6 8.1 26.6 8.8 14.6 12.3 12.1 12.2 5.4 13.1 23.8 1.1 3.4 4.6 4.7 3.3 6.1 4.1 5.7 6.0 2.6 4.2 5.9 4.9 3.4 3.3 3.3 6.4 5.4 1.9 13.4 17.7 20.6 26.9 14.4 14.1 18.8 20.2 15.4 16.1 8.9 7.5 6.1 8.2 13.5 6.1 5.3 10.2 4.0 5.7 1.8 5.9 10.4 0.0 7.5 5.8 9.3 8.4 0.0 8.8 9.1 9.3 8.5 1.1 6.4 11.6 4.8 12.1 14.7 10.3 3.2 7.5 9.8 6.8 4.6 12.3 6.7 9.2 10.5 8.1 6.3 6.1 6.5 13.2 11.2 13.8 11.2 8.1 14.6 10.2 6.0 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134697-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 60.9" "Group enriched" "Detected in many" 17 "Early spermatids: 399.0;Late spermatids: 665.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 18.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA020346 Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 2.4 6.2 1.5 4.8 3.1 1.3 2.3 4.0 1.6 3.3 5.1 2.9 2.0 3.3 3.3 2.9 2.4 2.6 3.7 3.1 1.9 1.5 2.6 1.2 2.8 7.0 2.0 2.2 4.6 1.8 4.3 2.1 1.1 2.3 3.2 3.6 4.1 6.0 2.3 0.9 1.8 3.9 2.4 2.9 3.7 3.4 60.9 2.4 5.9 4.6 0.9 3.3 3.5 5.1 3.0 5.9 2.3 1.3 2.8 2.8 0.9 2.8 2.0 4.5 5.2 1.8 1.0 2.5 1.2 4.9 3.7 5.6 3.9 2.7 7.2 1.9 2.2 14.6 1.1 5.0 1.4 4.0 3.4 4.9 3.4 0.2 5.2 4.3 5.5 8.3 3.1 3.9 3.0 0.7 2.6 0.7 6.2 5.1 4.0 0.9 0.0 5.6 7.0 1.8 6.6 1.8 7.0 5.2 1.1 2.5 3.6 1.3 3.8 1.2 4.9 4.6 6.6 0.8 9.2 1.0 2.3 6.2 0.0 1.8 18.0 5.7 10.3 0.7 5.3 10.6 1.4 1.3 2.3 1.7 0.6 2.3 3.0 1.1 1.5 1.7 2.1 2.8 2.2 0.1 2.8 0.8 5.9 2.8 0.9 1.5 3.1 4.0 1.6 1.9 1.5 2.0 2.2 2.3 2.4 0.0 5.3 2.9 2.3 1.0 0.9 1.0 2.5 5.3 0.0 0.0 0.0 2.8 3.3 1.0 399.0 2.2 2.5 0.0 3.4 2.1 2.5 0.9 0.0 1.0 2.4 0.0 4.1 1.8 5.0 665.4 6.6 2.9 3.3 4.6 2.8 7.7 3.2 6.5 4.9 0.6 0.5 0.0 2.1 31.4 12.4 0.5 1.9 4.3 6.0 0.9 C8orf37 "BBS21, CORD16, FLJ30600, RP64" ENSG00000156172 "Chromosome 8 open reading frame 37" Q96NL8 8 95244919-95269201 "Disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease mutation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024198 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA Cytosol "Plasma membrane, Cell Junctions" "HPA024198: AB_1845775" "unprognostic (7.90e-2)" "unprognostic (1.98e-2)" "unprognostic (5.68e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (2.72e-3)" "unprognostic (4.20e-3)" "unprognostic (2.04e-2)" "unprognostic (8.94e-2)" "unprognostic (1.81e-1)" "unprognostic (1.76e-1)" "unprognostic (6.11e-3)" "unprognostic (2.32e-1)" "unprognostic (1.09e-1)" "unprognostic (6.72e-3)" "unprognostic (2.02e-1)" "unprognostic (1.33e-2)" "unprognostic (3.29e-1)" 4.8 5.6 7.9 5.8 9.9 2.4 6.4 9.8 8.0 6.7 3.1 10.5 2.9 2.6 6.5 8.6 3.3 10.5 4.0 7.0 8.7 7.1 6.6 4.9 4.3 5.6 7.4 6.9 13.0 3.8 10.1 9.9 4.9 7.9 5.6 2.8 4.6 4.3 7.1 2.9 4.2 3.3 6.2 9.2 4.4 3.2 4.5 9.5 3.8 6.7 1.6 5.1 4.0 4.4 3.9 1.9 2.3 1.4 2.7 2.3 0.8 4.0 6.7 5.5 2.9 1.9 5.2 1.6 1.8 4.1 2.3 3.1 1.0 9.0 8.2 4.3 3.0 5.8 3.4 2.3 4.6 5.1 2.6 2.1 6.4 4.0 3.0 2.2 1.3 3.6 5.2 2.2 2.7 7.7 6.0 3.5 4.9 3.3 4.8 3.0 3.1 6.8 1.6 1.7 8.3 4.6 3.6 2.9 2.1 5.1 1.8 5.4 5.2 3.7 0.7 3.1 4.3 6.4 1.2 2.9 2.9 3.7 2.5 1.8 4.4 4.2 5.5 5.6 3.1 3.6 1.3 1.4 0.6 1.2 0.9 2.1 1.9 1.4 1.3 1.9 3.9 1.4 2.3 2.3 2.7 0.7 0.9 0.5 0.8 7.9 9.9 9.8 8.0 8.7 7.1 7.4 6.9 7.9 9.5 3.0 1.6 0.8 3.1 0.8 1.6 3.9 0.0 9.4 4.5 7.0 2.0 2.0 6.6 1.5 8.2 1.0 0.0 0.0 2.4 2.4 2.2 1.7 0.0 3.2 1.2 3.2 0.0 1.3 1.6 8.0 2.8 1.1 1.7 2.8 0.0 5.7 1.0 0.0 2.8 3.7 3.6 0.0 2.1 4.4 3.6 1.6 0.7 0.0 0.4 1.0 C8orf48 FLJ25402 ENSG00000164743 "Chromosome 8 open reading frame 48" Q96LL4 8 13566843-13568287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7;testis: 17.3" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 23.2;Late spermatids: 38.1;Spermatocytes: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 13.1;U-87 MG: 11.2;WM-115: 8.4" "Low region specificity" "Detected in all" "HPA026107, HPA027440" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA026107: AB_10600765, HPA027440: AB_10601678" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (5.07e-2)" "unprognostic (9.01e-2)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (4.84e-3)" "unprognostic (7.70e-2)" "unprognostic (1.76e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-1)" "unprognostic (1.41e-3)" "unprognostic (7.74e-4)" "unprognostic (1.78e-1)" "unprognostic (8.42e-3)" "unprognostic (8.70e-2)" 2.7 0.7 3.6 1.2 11.7 0.1 3.7 0.8 2.9 3.0 1.3 0.9 0.2 0.9 2.3 6.0 1.4 3.9 2.5 4.0 2.8 1.6 4.1 1.7 2.4 1.2 1.7 3.0 2.1 1.2 0.5 1.5 2.8 2.8 2.2 1.0 2.4 2.2 1.0 0.9 2.7 0.9 1.9 1.1 1.1 1.9 17.3 1.5 0.0 8.9 0.3 0.5 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.1 1.7 0.0 5.9 5.9 0.0 5.2 5.8 2.8 4.8 0.0 0.0 0.0 0.0 2.7 13.1 0.6 0.2 1.0 5.5 0.0 0.5 0.5 0.0 0.0 2.1 0.0 0.9 1.9 3.5 3.8 1.0 0.7 3.6 0.0 0.1 0.0 7.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 3.1 0.0 0.2 5.8 2.0 0.0 0.0 1.6 4.9 4.8 5.7 4.6 0.0 0.0 0.0 11.2 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 11.7 0.8 2.9 2.8 1.6 1.7 3.0 2.8 1.5 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 1.4 1.2 0.0 2.0 0.0 0.0 2.6 23.2 0.5 0.0 0.0 1.0 0.0 3.1 0.0 0.0 0.5 0.1 0.0 0.0 1.3 0.0 38.1 4.6 0.0 5.0 0.0 0.0 0.9 0.3 0.0 2.8 2.4 4.3 6.5 4.1 9.9 2.0 0.4 0.0 0.0 0.0 0.1 C8orf59 ENSG00000176731 "Chromosome 8 open reading frame 59" Q8N0T1 8 85214076-85220421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044805, HPA071903" Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA044805: AB_2679095, HPA071903: AB_2686469" "unprognostic (1.61e-2)" "unprognostic (2.98e-1)" "unprognostic (4.51e-1)" "unprognostic (1.63e-3)" "unprognostic (2.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-3)" "unprognostic (1.63e-1)" "unprognostic (1.69e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (2.29e-1)" "unprognostic (3.84e-3)" 28.1 28.2 25.3 25.3 21.9 33.0 46.1 18.9 26.5 33.0 38.4 12.6 36.3 28.1 32.0 45.5 44.8 28.7 25.8 41.5 20.6 24.1 32.3 47.1 20.8 30.7 26.3 27.2 45.1 35.1 19.5 36.0 27.7 24.4 35.5 27.7 14.7 37.8 36.2 43.9 24.8 37.1 33.7 27.0 32.2 36.9 16.7 25.7 39.1 43.5 53.6 32.0 39.1 35.2 33.3 42.7 21.3 25.3 36.5 38.0 23.9 38.9 19.9 29.6 19.2 18.4 35.7 23.2 26.0 25.0 30.4 30.0 23.2 33.8 9.7 21.5 17.2 28.5 27.2 20.5 28.5 34.3 27.4 22.4 57.6 18.8 34.2 21.8 21.6 26.1 30.2 33.9 19.6 24.8 33.1 25.8 35.0 25.8 24.0 25.2 30.7 47.7 40.6 8.5 88.2 34.8 20.4 24.8 44.2 29.5 25.0 10.0 21.5 19.7 32.4 35.7 37.3 37.3 32.3 19.7 19.4 40.7 21.5 24.6 27.9 32.7 45.8 38.7 27.7 21.5 21.3 20.5 13.4 24.7 25.3 29.5 33.3 32.7 30.1 34.8 29.9 38.0 36.3 5.1 36.5 21.5 42.7 32.1 23.9 25.3 21.9 18.9 26.5 20.6 24.1 26.3 27.2 24.4 25.7 80.4 65.2 124.2 47.1 48.2 25.9 26.3 86.6 147.2 103.5 34.9 9.8 86.5 56.3 152.0 93.6 67.1 76.6 46.7 240.4 102.1 84.3 40.2 75.1 136.0 90.6 22.3 36.9 108.6 132.2 20.6 173.2 92.3 54.0 180.3 112.7 58.4 213.9 84.2 122.0 90.6 33.5 155.2 88.6 128.1 91.8 40.0 64.3 104.7 101.8 39.3 C8orf76 FLJ14825 ENSG00000189376 "Chromosome 8 open reading frame 76" Q96K31 8 123219957-123241398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 128.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 59.8" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023708: AB_1845785" "prognostic unfavorable (9.95e-4)" "unprognostic (1.61e-1)" "unprognostic (9.71e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (4.47e-3)" "unprognostic (1.48e-2)" "unprognostic (2.49e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (5.95e-11)" "unprognostic (1.54e-2)" "unprognostic (1.94e-1)" "unprognostic (3.26e-1)" "unprognostic (2.71e-2)" 11.9 15.4 13.5 11.4 21.8 13.8 14.5 18.5 15.2 12.0 13.5 11.5 27.0 11.8 9.2 16.1 16.4 9.5 11.2 11.1 11.5 11.8 10.1 19.3 10.2 15.9 11.8 10.6 9.8 12.3 8.5 24.0 15.5 10.9 11.5 15.8 12.5 13.9 23.7 16.9 10.0 12.5 10.8 9.4 15.9 10.4 7.4 14.4 18.8 13.9 9.9 18.3 10.3 10.7 12.7 17.2 24.4 18.9 13.4 18.6 11.0 8.5 7.9 7.4 5.2 7.2 6.7 5.0 8.1 7.9 9.5 9.6 7.2 6.3 5.9 8.9 7.7 7.1 6.6 8.4 4.4 10.8 9.3 12.0 6.9 3.6 10.1 13.1 3.6 5.7 4.9 8.6 8.5 7.1 5.7 8.4 9.3 9.8 4.6 7.8 25.0 10.5 8.2 6.0 20.9 13.8 5.6 3.8 6.7 8.1 7.1 9.7 9.1 8.1 59.8 8.5 7.9 7.3 8.8 4.6 5.4 10.4 5.8 6.6 6.1 6.7 6.3 5.8 8.2 5.8 15.9 16.7 24.4 13.3 18.9 13.9 11.2 14.5 16.8 17.2 12.7 13.9 13.7 9.8 13.4 15.3 14.9 18.6 11.0 13.5 21.8 18.5 15.2 11.5 11.8 11.8 10.6 10.9 14.4 11.9 1.3 15.7 15.3 11.9 7.9 4.8 5.1 14.7 5.7 1.8 9.8 23.3 5.0 14.4 2.3 5.8 16.8 0.0 10.4 25.8 12.4 15.5 21.9 9.8 20.4 128.7 23.7 8.0 17.1 3.0 11.8 16.5 13.5 19.0 12.8 10.2 13.7 14.4 7.1 7.9 7.1 19.4 4.5 13.1 19.3 10.0 33.6 13.8 14.0 34.2 C9orf116 "MGC29761, PIERCE1, RbEST47" ENSG00000160345 "Chromosome 9 open reading frame 116" Q5BN46 9 135495181-135501734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 63.3;testis: 47.8" "Group enriched" "Detected in many" 5 "Ciliated cells: 473.8;Early spermatids: 387.4;Late spermatids: 493.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 22.6;T-47d: 23.4;U-2197: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021439, HPA065287" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021439: AB_1845799, HPA065287: AB_2732732" "unprognostic (9.02e-2)" "unprognostic (1.36e-2)" "unprognostic (1.93e-1)" "prognostic favorable (3.53e-5)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (4.23e-1)" "unprognostic (2.58e-1)" "unprognostic (5.30e-2)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (4.23e-3)" "unprognostic (3.86e-2)" "unprognostic (8.75e-2)" "unprognostic (1.03e-1)" "unprognostic (1.02e-1)" 1.5 7.2 8.0 1.0 9.2 1.0 2.2 1.5 6.2 4.1 1.1 6.2 8.2 1.1 3.3 22.1 1.0 63.3 2.7 1.5 9.6 9.3 7.8 1.5 9.8 0.9 4.9 4.9 9.3 4.5 3.3 7.6 1.5 19.9 2.0 1.3 1.7 2.0 5.0 1.4 1.2 1.0 1.3 2.6 1.0 1.8 47.8 2.6 0.1 6.7 0.2 1.2 2.2 0.3 1.7 0.9 0.1 2.6 1.8 4.2 1.1 5.9 10.3 4.5 7.1 2.0 4.3 0.9 4.0 2.9 4.9 3.3 3.9 6.0 1.0 5.4 2.7 2.7 4.1 5.0 2.2 4.2 0.3 4.6 0.0 11.4 11.9 5.6 0.8 2.8 3.0 1.7 2.4 0.8 4.0 2.3 4.8 5.5 0.8 2.3 22.6 3.0 1.0 9.6 9.3 12.1 4.7 2.2 3.7 11.6 4.3 4.4 4.7 5.7 2.4 0.6 2.2 23.4 1.0 1.1 2.8 3.7 24.2 1.5 2.7 6.6 0.9 8.4 0.3 0.8 0.1 2.6 0.0 1.9 1.6 4.2 0.7 1.3 1.4 0.9 1.7 2.4 1.8 0.0 1.8 0.4 0.4 1.6 1.1 8.0 9.2 1.5 6.2 9.6 9.3 4.9 4.9 19.9 2.6 8.9 5.6 0.0 2.5 0.8 4.6 1.4 7.6 473.8 29.6 14.0 13.7 9.7 10.0 23.1 387.4 1.5 0.7 0.0 7.0 1.8 2.7 2.3 1.1 1.6 3.1 3.2 1.2 0.6 1.9 493.5 7.5 1.9 0.0 3.6 1.0 6.5 9.2 1.4 7.1 40.0 15.4 0.0 1.0 87.1 20.2 0.3 3.8 0.0 1.7 1.4 C9orf24 "bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1" ENSG00000164972 "Chromosome 9 open reading frame 24" Q8NCR6 9 34379019-34397832 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 47.6;fallopian tube: 76.2;testis: 23.7" "Group enriched" "Detected in many" 10 "Ciliated cells: 1197.9;Early spermatids: 656.4;Late spermatids: 2140.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 17.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Hep G2: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053008 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053008: AB_2682015" "unprognostic (3.62e-3)" "unprognostic (9.06e-3)" "unprognostic (1.00e-1)" "prognostic favorable (3.23e-5)" "unprognostic (7.66e-2)" "unprognostic (1.21e-2)" "unprognostic (2.40e-1)" "unprognostic (1.25e-1)" "unprognostic (2.72e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.33e-1)" "unprognostic (6.39e-3)" "unprognostic (1.50e-1)" "unprognostic (7.43e-3)" "unprognostic (4.72e-2)" "unprognostic (1.90e-2)" 1.5 1.2 12.7 1.0 20.0 0.8 1.0 1.5 10.8 3.3 1.6 12.2 0.0 2.1 1.3 7.2 1.1 76.2 1.0 4.8 11.2 11.0 1.9 1.0 10.3 0.9 5.3 6.4 6.2 1.5 0.8 3.1 0.9 47.6 1.5 1.3 0.0 2.0 1.1 1.6 1.2 4.3 1.2 2.0 0.9 1.4 23.7 3.0 0.0 1.2 0.1 1.0 0.9 0.0 0.6 0.4 0.1 0.1 0.9 3.6 0.5 0.8 0.0 1.6 0.6 0.3 0.0 1.3 0.6 0.6 0.3 1.4 1.4 0.0 0.3 0.6 0.0 0.7 1.2 0.5 0.2 0.0 2.3 1.3 0.0 1.6 4.1 0.0 0.1 2.0 0.3 0.2 0.4 0.0 0.5 0.6 1.0 0.0 0.6 0.2 0.0 1.3 0.9 0.6 1.2 0.9 0.6 0.1 0.1 0.5 0.1 1.6 0.6 0.0 0.4 0.1 0.1 1.1 0.0 0.0 1.3 1.0 0.5 0.9 2.5 1.4 0.4 1.4 0.2 2.5 0.0 0.0 0.0 1.1 0.1 0.0 0.6 1.3 0.4 0.4 0.0 3.6 1.1 0.1 0.9 0.0 0.0 1.7 0.5 12.7 20.0 1.5 10.8 11.2 11.0 5.3 6.4 47.6 3.0 6.0 13.7 0.0 2.6 1.9 1.0 34.3 2.5 1197.9 128.5 7.0 0.0 0.5 61.3 0.5 656.4 1.0 15.5 0.0 1.3 0.2 0.5 2.8 8.1 2.9 0.4 0.0 11.6 1.8 0.3 2140.7 9.8 2.5 0.0 0.0 9.8 1.2 0.3 6.2 6.7 5.7 0.8 32.3 0.3 10.8 3.8 0.9 0.5 0.0 16.4 1.7 C9orf40 FLJ10110 ENSG00000135045 "Chromosome 9 open reading frame 40" Q8IXQ3 9 74946581-74952886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 43.7;Spermatocytes: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042167 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA 290000 "Nucleoplasm, Cytosol" Centrosome "HPA042167: AB_10797382" "unprognostic (2.10e-1)" "unprognostic (7.65e-2)" "unprognostic (2.94e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (6.12e-2)" "unprognostic (1.11e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" "unprognostic (6.15e-3)" "unprognostic (6.78e-3)" "unprognostic (3.74e-2)" "unprognostic (4.21e-2)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" 6.2 4.0 8.3 9.7 8.0 9.0 18.8 8.1 12.4 5.1 9.9 5.6 2.8 14.3 5.2 3.0 5.2 3.6 5.0 3.6 7.4 8.4 4.1 5.1 2.8 8.4 8.4 5.6 4.2 3.5 6.6 4.4 6.5 6.7 3.9 9.2 2.2 3.0 4.8 4.7 3.5 18.7 4.9 11.2 5.4 3.6 31.1 5.1 10.5 3.0 3.4 8.0 5.0 16.0 1.8 0.9 5.3 0.5 0.0 2.1 0.3 16.8 3.7 9.7 3.9 3.9 5.1 18.1 13.5 4.2 9.4 10.2 1.0 5.3 15.3 4.0 3.3 15.8 5.0 7.6 0.7 15.1 20.6 11.8 8.1 6.8 6.4 3.2 9.7 12.9 2.5 5.1 5.2 3.7 3.8 2.9 11.2 11.4 10.4 12.3 4.7 17.1 11.4 11.4 8.9 11.4 16.0 7.6 3.7 3.9 4.1 10.6 4.7 5.9 5.0 4.0 9.0 6.1 7.5 3.7 8.5 9.6 11.6 11.7 20.0 14.9 9.7 6.5 10.9 9.1 1.8 0.2 5.3 1.0 0.4 0.4 1.8 1.1 1.0 0.2 1.3 2.1 1.3 0.5 0.0 0.5 0.9 1.2 0.3 8.3 8.0 8.1 12.4 7.4 8.4 8.4 5.6 6.7 5.1 3.0 0.3 6.0 3.5 2.2 7.2 43.7 0.0 1.4 0.0 3.5 7.9 15.9 1.7 2.7 9.5 8.6 12.7 0.0 2.7 19.6 4.0 2.4 0.0 3.4 9.3 1.6 1.2 9.2 3.3 1.3 4.0 1.7 1.7 3.6 4.9 4.5 2.9 8.6 4.9 1.4 13.1 0.0 4.2 46.8 10.7 4.5 10.3 3.2 15.2 3.8 C9orf43 MGC17358 ENSG00000157653 "Chromosome 9 open reading frame 43" Q8TAL5 9 113410054-113429684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 39.4" "Group enriched" "Detected in some" 7 "Early spermatids: 78.7;Late spermatids: 167.1;Spermatocytes: 82.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA021310 Approved Cytosol NA NA Cytosol "HPA021310: AB_1845825" "unprognostic (2.91e-2)" "unprognostic (9.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.18e-1)" "unprognostic (2.63e-1)" "unprognostic (6.58e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (8.90e-2)" "unprognostic (1.97e-2)" "unprognostic (5.96e-3)" "unprognostic (1.51e-1)" "unprognostic (7.32e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-2)" "unprognostic (1.63e-1)" 0.5 1.6 1.5 0.4 2.4 1.8 1.3 2.1 2.3 0.5 0.4 1.6 0.2 0.4 0.4 1.6 0.5 0.9 0.6 0.4 1.4 0.8 1.0 1.7 0.5 0.6 0.8 1.9 1.0 3.5 1.3 3.8 0.5 1.6 0.7 0.5 1.0 0.9 0.7 0.4 0.8 0.5 0.3 1.8 0.6 0.6 39.4 1.0 0.6 1.0 0.0 0.6 0.5 0.5 1.5 1.3 2.3 1.5 1.0 2.1 0.8 1.2 1.2 0.6 1.9 1.5 0.8 0.9 0.6 1.1 1.7 1.3 1.3 1.0 3.3 1.1 0.3 3.8 2.4 0.7 1.7 0.7 2.7 0.5 2.9 2.1 0.6 1.3 0.5 0.4 1.8 2.6 2.2 2.6 1.1 1.5 3.9 1.7 3.1 0.9 2.4 1.4 0.8 0.9 1.5 3.9 0.8 0.7 1.9 1.8 0.6 3.1 0.7 3.0 1.4 1.7 1.4 4.1 0.3 0.2 2.6 0.6 1.7 2.6 2.0 3.6 5.0 1.4 1.1 0.9 0.0 0.7 0.0 1.5 1.5 0.0 1.5 0.8 2.1 0.8 0.8 1.4 2.1 2.3 1.0 0.3 1.3 0.1 0.8 1.5 2.4 2.1 2.3 1.4 0.8 0.8 1.9 1.6 1.0 0.0 0.0 0.8 0.5 0.6 1.7 0.0 0.0 10.7 2.3 0.0 0.0 0.4 1.7 0.3 78.7 0.3 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.3 167.1 2.0 0.6 0.0 1.0 0.0 2.3 1.1 0.0 1.4 0.7 2.6 0.0 0.0 82.6 16.0 0.0 0.0 0.0 0.0 0.5 C9orf72 "DENNL72, MGC23980" ENSG00000147894 "Chromosome 9 open reading frame 72" Q96LT7 9 27546545-27573866 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Autophagy "Guanine-nucleotide releasing factor" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 77.6;Kupffer cells: 86.3;Macrophages: 73.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 8.0;classical monocyte: 15.5;intermediate monocyte: 21.8;myeloid DC: 11.7;neutrophil: 15.6;non-classical monocyte: 16.5" "Group enriched" "Detected in all" 5 "dendritic cells: 11.7;granulocytes: 15.6;monocytes: 21.8" "Cell line enhanced" "Detected in many" "AF22: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023873 Uncertain Supported "Vesicles,Midbody ring,Cytosol" "Secreted - unknown location" NA NA "Vesicles, Cytosol" "Midbody ring" "HPA023873: AB_1845834" "unprognostic (1.78e-2)" "unprognostic (5.01e-2)" "unprognostic (7.63e-2)" "unprognostic (9.78e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (1.99e-3)" "unprognostic (2.45e-1)" "unprognostic (2.05e-2)" "unprognostic (2.16e-2)" "unprognostic (9.81e-2)" "unprognostic (1.44e-2)" "unprognostic (9.29e-2)" "unprognostic (1.10e-1)" "unprognostic (2.89e-2)" "unprognostic (9.13e-2)" 10.0 11.2 9.7 14.2 17.6 19.1 8.0 31.2 21.3 7.4 6.0 10.9 6.7 5.8 10.7 10.6 5.8 14.6 8.9 7.4 9.4 14.6 4.2 14.0 13.0 10.7 11.0 10.7 19.5 8.4 6.7 15.3 10.3 20.0 13.3 7.1 9.4 5.3 5.9 11.0 6.2 6.1 7.6 11.5 13.7 6.5 14.8 6.7 8.0 11.0 3.2 7.3 9.7 6.3 1.7 11.7 15.6 21.8 2.9 2.5 4.4 2.8 2.5 21.1 3.2 4.3 5.3 3.2 4.1 3.5 2.6 1.3 0.3 1.0 7.2 2.7 3.6 5.4 2.2 6.0 5.2 1.9 13.1 2.5 3.4 7.5 2.1 6.6 2.3 3.7 5.6 6.4 0.6 11.9 2.5 5.5 7.4 6.5 13.1 3.1 0.5 4.4 3.5 10.2 4.7 11.6 1.7 6.3 3.2 2.0 2.5 7.2 17.7 2.7 3.1 2.6 8.3 2.6 2.0 4.7 0.0 10.6 6.2 2.7 3.4 10.2 4.7 8.0 7.6 2.6 8.0 15.5 1.0 0.9 21.8 1.7 1.7 1.4 1.2 11.7 1.2 2.5 1.5 15.6 2.9 16.5 1.8 1.8 4.4 9.7 17.6 31.2 21.3 9.4 14.6 11.0 10.7 20.0 6.7 14.9 17.1 6.9 37.1 31.9 22.0 12.8 5.1 77.6 12.5 7.0 19.6 18.4 1.7 6.9 1.7 10.8 3.9 0.0 8.3 6.2 12.4 25.8 16.1 7.8 23.9 11.1 10.9 6.7 86.3 3.3 5.8 73.0 18.6 19.8 9.9 46.1 6.4 8.6 3.5 4.1 28.5 0.0 20.6 30.7 19.3 25.5 28.9 10.9 5.2 35.5 C9orf84 FLJ32779 ENSG00000165181 "Chromosome 9 open reading frame 84" Q5VXU9 9 111686173-111795008 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 33.0" "Group enriched" "Detected in some" 5 "Early spermatids: 46.5;Spermatocytes: 81.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 15 "granulocytes: 4.1" "Cell line enriched" "Detected in some" 5 "U-2 OS: 22.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA032108 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA032108: AB_10669884" "unprognostic (2.63e-1)" "unprognostic (1.83e-4)" "unprognostic (9.12e-2)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (9.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.22e-2)" "unprognostic (1.65e-1)" "unprognostic (8.14e-2)" "unprognostic (2.30e-1)" "unprognostic (8.33e-5)" "unprognostic (6.93e-2)" "unprognostic (2.84e-1)" "unprognostic (3.77e-1)" "unprognostic (7.31e-2)" 0.1 2.9 0.1 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.0 0.3 0.6 0.2 0.0 0.1 0.1 0.1 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 1.1 33.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.2 0.2 4.1 0.0 0.1 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.8 1.1 0.4 0.0 0.0 0.3 0.0 0.0 22.4 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.1 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 3.0 0.0 0.0 0.1 0.0 0.6 1.2 0.0 1.4 1.2 0.0 2.0 0.0 13.3 0.0 46.5 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.6 0.0 11.5 2.8 0.0 0.0 0.0 0.0 0.2 0.9 0.0 3.5 0.0 0.3 6.5 0.0 81.0 5.5 0.0 0.0 0.0 0.0 0.7 CAB39 "CGI-66, MO25" ENSG00000135932 "Calcium binding protein 39" Q9Y376 2 230712845-230821075 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037112, HPA076632" Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA 130000 "Nucleoli fibrillar center" Cytosol "CAB037112: AB_1078367, HPA076632: " "unprognostic (4.36e-3)" "unprognostic (1.42e-1)" "unprognostic (2.17e-2)" "unprognostic (1.71e-1)" "unprognostic (3.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.50e-2)" "unprognostic (2.84e-2)" "unprognostic (9.16e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (1.04e-1)" "prognostic favorable (9.05e-6)" "unprognostic (1.59e-1)" "unprognostic (2.92e-1)" "unprognostic (8.93e-2)" "unprognostic (1.36e-1)" 28.8 16.7 24.5 25.8 24.0 22.1 22.2 22.4 35.0 16.5 26.1 16.8 14.0 23.4 19.3 18.3 28.3 15.5 20.8 34.2 25.4 26.0 27.4 18.9 20.9 25.8 28.4 27.6 17.0 16.3 22.3 15.2 21.0 32.8 20.9 28.4 13.9 22.4 16.7 82.2 21.8 28.8 26.3 28.0 21.5 22.6 19.6 17.8 20.9 22.0 26.6 28.1 22.9 30.8 3.6 3.6 12.4 5.1 11.6 8.4 2.6 38.1 8.9 12.1 10.3 15.0 18.9 13.8 22.0 27.6 13.9 14.6 10.8 42.1 9.9 17.4 19.1 23.5 17.7 13.5 41.4 28.4 41.4 10.6 26.5 11.5 11.5 12.8 36.6 30.9 13.3 24.2 17.8 39.6 15.9 17.2 13.8 44.2 9.2 13.2 13.3 17.0 22.7 12.1 15.7 15.7 19.8 18.1 9.7 25.9 31.1 13.2 8.1 16.5 20.7 17.5 14.3 5.1 21.3 21.7 19.7 7.5 20.7 17.9 11.9 9.0 16.1 14.0 21.4 16.1 4.5 4.5 6.9 6.0 5.1 6.2 3.6 7.5 7.7 3.6 3.1 6.0 8.4 12.4 11.6 4.7 2.7 7.1 2.6 24.5 24.0 22.4 35.0 25.4 26.0 28.4 27.6 32.8 17.8 59.6 38.6 17.5 38.6 86.8 14.7 64.8 17.8 32.1 27.3 48.8 31.4 17.2 24.9 23.5 9.2 26.8 67.3 46.7 27.9 15.6 25.8 65.5 19.7 24.9 49.6 27.0 19.5 29.4 89.4 9.5 16.1 63.1 28.7 19.0 42.5 38.5 52.1 44.6 30.1 33.9 35.6 12.9 24.5 24.6 27.0 74.4 19.3 38.8 27.6 68.0 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662961-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 33.1;testis: 18.6" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 163.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favorable (1.79e-4)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 1.5 1.2 6.3 0.7 5.7 0.5 2.1 0.4 6.8 6.1 1.6 9.5 3.0 1.0 5.2 7.6 0.9 33.1 3.8 0.7 8.1 7.3 2.6 0.9 10.3 0.9 8.1 5.8 4.1 1.6 10.0 5.2 1.4 13.7 5.9 1.3 1.5 1.7 3.7 0.6 0.8 0.9 3.0 14.8 1.9 0.9 18.6 5.6 0.0 1.9 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.4 1.6 0.3 0.5 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 0.9 0.9 0.5 0.1 0.0 0.1 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 5.7 0.4 6.8 8.1 7.3 8.1 5.8 13.7 5.6 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 163.3 13.6 3.5 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CABIN1 "KIAA0330, PPP3IN" ENSG00000099991 "Calcineurin binding protein 1" Q9Y6J0 22 24011192-24178628 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043296 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043296: AB_10794657" "unprognostic (8.52e-2)" "unprognostic (3.16e-1)" "unprognostic (2.74e-2)" "prognostic favorable (9.57e-5)" "unprognostic (3.43e-2)" "unprognostic (3.06e-3)" "unprognostic (1.04e-2)" "unprognostic (2.92e-2)" "unprognostic (6.21e-2)" "unprognostic (3.75e-1)" "unprognostic (3.46e-3)" "unprognostic (1.01e-1)" "prognostic favorable (2.94e-4)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-3)" "unprognostic (7.79e-2)" 14.4 14.6 15.9 18.5 22.9 34.2 13.4 47.2 29.2 17.5 17.3 23.3 22.6 17.6 24.9 17.2 12.4 23.7 16.9 15.4 14.7 13.2 18.2 13.7 19.7 22.4 12.7 17.4 16.6 18.2 24.4 24.9 12.0 17.8 17.6 11.4 19.0 18.6 24.2 10.2 20.7 16.7 18.0 10.9 21.2 18.6 24.4 10.8 22.5 27.0 10.6 19.3 14.1 14.2 4.1 2.7 15.9 3.7 4.8 7.0 2.0 12.5 9.2 12.5 11.0 11.4 13.2 17.7 10.6 9.3 8.6 9.8 11.3 6.2 14.7 5.9 10.6 11.1 12.0 14.9 9.7 7.7 24.5 14.6 12.6 10.4 23.7 5.4 29.0 13.7 11.2 6.3 10.5 7.9 10.3 14.3 13.3 26.1 8.1 4.9 16.2 13.7 31.5 7.8 17.7 6.6 13.4 9.2 18.3 7.8 12.8 16.2 13.9 13.2 9.2 13.4 11.9 8.2 13.1 11.6 19.9 15.6 7.6 7.6 14.2 8.4 8.9 9.3 13.9 8.3 5.9 3.7 12.9 5.5 2.5 6.2 2.5 4.2 7.0 2.3 4.1 5.0 4.6 15.9 4.8 1.7 2.7 3.2 2.0 15.9 22.9 47.2 29.2 14.7 13.2 12.7 17.4 17.8 10.8 20.8 35.7 15.2 7.4 7.3 31.7 10.2 5.1 20.1 6.8 8.7 84.4 11.7 6.6 9.2 12.4 12.9 12.3 0.0 8.3 5.7 12.0 8.0 17.3 8.2 18.8 31.8 14.3 15.4 12.9 11.5 19.8 12.6 10.1 19.8 10.9 13.3 9.9 3.5 18.7 6.2 52.5 19.4 22.6 37.5 30.6 8.3 18.8 34.6 12.1 6.4 CABYR "CBP86, CT88, FSP-2" ENSG00000154040 "Calcium binding tyrosine phosphorylation regulated" O75952 18 24138956-24161603 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 91.1" "Group enriched" "Detected in some" 47 "Early spermatids: 2235.7;Late spermatids: 2707.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 6.3;memory B-cell: 6.6;naive B-cell: 7.1;neutrophil: 2.9" "Group enriched" "Detected in many" 5 "B-cells: 7.1;granulocytes: 6.3" "Cell line enhanced" "Detected in many" "SiHa: 18.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040703, HPA047801" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040703: AB_2677087, HPA047801: AB_2680159" "unprognostic (1.18e-3)" "unprognostic (4.18e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "unprognostic (5.26e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.46e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (7.24e-3)" "unprognostic (1.58e-1)" "unprognostic (3.21e-4)" "unprognostic (2.52e-2)" "unprognostic (5.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 0.8 1.2 3.9 0.7 3.2 0.7 2.3 0.7 4.8 3.0 0.7 3.5 0.0 0.7 1.5 1.2 1.0 1.8 1.0 0.5 3.6 2.1 0.6 0.5 0.6 0.8 3.1 3.0 0.9 0.7 0.4 9.5 0.7 5.4 1.0 0.8 0.6 0.9 1.0 0.6 1.1 0.7 1.7 2.3 0.7 0.8 91.1 2.9 0.0 0.7 0.0 0.7 1.5 0.6 7.1 0.7 6.3 0.5 1.3 1.0 0.4 3.4 9.1 2.5 1.3 2.9 7.1 10.9 6.1 3.9 7.5 8.2 1.8 6.8 0.1 5.0 9.1 0.3 3.3 2.6 5.3 8.1 0.4 4.1 0.2 4.9 2.0 4.0 0.3 0.4 8.6 8.5 9.8 2.6 3.7 2.2 0.4 0.0 0.2 2.0 1.0 0.1 0.3 8.1 0.4 5.3 0.5 0.3 0.1 3.3 4.2 5.3 6.6 18.6 3.8 0.3 1.6 8.6 0.9 1.2 0.6 1.8 2.5 0.1 0.2 0.2 0.0 3.6 0.7 0.3 6.3 0.5 1.0 0.4 0.3 0.2 6.6 0.5 0.5 0.2 7.1 0.4 1.0 2.9 1.3 0.5 0.7 0.2 0.4 3.9 3.2 0.7 4.8 3.6 2.1 3.1 3.0 5.4 2.9 0.0 0.0 0.0 0.8 0.2 1.9 0.3 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.6 2235.7 0.0 0.0 0.0 0.2 0.4 0.4 0.1 0.0 0.0 0.5 0.0 0.0 0.6 0.0 2707.1 21.6 0.0 1.7 0.0 0.0 0.0 0.2 0.2 20.5 0.0 1.8 19.4 0.4 52.7 14.1 0.0 0.0 0.0 0.0 0.1 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 30.8" "Cell type enhanced" "Detected in single" 15 "Cardiomyocytes: 1.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.6 3.0 17.9 2.1 19.7 3.1 0.5 3.9 22.5 0.6 0.8 1.3 0.0 0.6 0.6 4.4 1.1 2.3 0.6 0.6 30.8 5.8 3.8 0.6 0.6 1.4 2.4 10.6 0.5 0.6 0.5 0.2 0.8 4.2 0.5 0.8 0.5 0.5 0.5 0.6 0.5 1.1 1.0 5.2 0.9 0.8 2.8 2.4 0.0 0.6 0.0 1.0 0.6 0.1 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.9 0.1 0.0 0.0 0.0 1.1 1.4 0.0 2.3 0.1 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 0.1 0.0 0.0 7.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 17.9 19.7 3.9 22.5 30.8 5.8 2.4 10.6 4.2 2.4 0.0 0.0 0.0 0.0 0.1 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964910-67033398 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;prostate: 16.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Glandular cells: 3.0;Intestinal endocrine cells: 7.5;Muller glia cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 97.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 159.8" "HPA005803, HPA065370" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005803: AB_2667439, HPA065370: AB_2685480" "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.7 1.8 16.0 0.8 32.3 0.7 8.1 3.5 37.8 1.2 0.9 11.4 0.2 1.0 1.2 0.8 0.8 6.2 1.2 0.7 9.6 12.9 0.8 0.7 8.0 0.7 7.5 7.1 0.7 1.2 4.9 0.1 1.6 6.8 16.5 0.8 0.1 0.9 2.4 0.8 0.9 0.9 2.0 4.2 0.7 1.7 0.9 10.3 0.0 0.7 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 3.9 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 10.3 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 3.9 1.7 0.0 0.0 0.1 2.1 0.0 2.7 3.9 97.2 0.9 2.5 0.0 10.0 9.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 32.3 3.5 13.0 9.6 12.9 7.5 7.1 6.8 10.3 3.0 2.2 0.0 1.1 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.2 0.1 0.2 3.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 CACNG6 ENSG00000130433 "Calcium voltage-gated channel auxiliary subunit gamma 6" Q9BXT2 19 53992288-54012669 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 11.4;skeletal muscle: 45.4" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 5.3;Horizontal cells: 1.6;Spermatogonia: 1.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 96 "basophil: 11.4;eosinophil: 7.8" "Lineage enriched" "Detected in single" 114 "granulocytes: 11.4" "Cell line enhanced" "Detected in some" "A549: 12.7;EFO-21: 22.3;HHSteC: 5.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056615 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA056615: AB_2683192" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (7.07e-2)" "unprognostic (8.58e-2)" "unprognostic (2.89e-2)" "unprognostic (2.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.72e-1)" "unprognostic (1.53e-1)" "unprognostic (6.07e-8)" "unprognostic (9.79e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.2 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.4 0.0 45.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 12.7 0.3 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 1.1 0.0 22.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 5.8 0.0 0.1 0.1 0.0 0.0 0.0 2.1 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.2 1.5 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.9 0.0 2.6 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.0 11.4 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 CACTIN "C19orf29, cactin, fSAPc, NY-REN-24" ENSG00000105298 "Cactin, spliceosome C complex subunit" Q8WUQ7 19 3610641-3626815 "Predicted intracellular proteins" "Immunity, Innate immunity, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042504, HPA042548" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA042504: AB_10797501, HPA042548: AB_10794760" "unprognostic (1.18e-1)" "unprognostic (7.90e-3)" "unprognostic (1.09e-1)" "prognostic favorable (3.69e-5)" "unprognostic (5.93e-2)" "unprognostic (2.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (7.22e-3)" "unprognostic (3.88e-2)" "unprognostic (4.98e-3)" "unprognostic (5.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.55e-3)" 16.1 14.4 18.3 19.4 17.8 19.8 16.2 19.2 19.9 11.8 12.4 13.1 12.3 14.5 14.2 9.6 11.9 13.0 13.0 10.3 14.2 10.9 11.9 14.8 11.7 16.5 14.3 9.9 21.4 14.9 8.9 11.1 11.3 13.4 13.4 8.5 10.3 15.5 12.8 28.6 22.0 16.2 12.2 9.8 23.0 15.7 14.4 15.0 13.9 12.6 11.9 12.7 11.3 18.5 2.1 4.3 0.8 2.9 0.9 3.7 1.3 14.5 8.4 7.1 12.1 5.2 5.2 10.8 10.5 4.2 6.3 7.0 8.3 6.6 12.2 9.0 6.5 7.4 13.6 7.4 8.7 3.8 12.3 9.8 7.6 11.5 9.9 7.3 10.2 11.1 5.0 8.5 5.8 4.1 3.8 9.0 10.7 16.8 13.7 3.3 8.8 18.3 8.9 15.2 8.9 9.9 19.4 9.2 11.5 5.8 7.4 9.8 13.7 11.7 8.3 8.4 4.0 6.6 11.8 11.6 8.5 10.7 18.5 18.2 21.0 14.0 13.5 10.5 16.5 11.4 0.0 1.2 0.0 3.7 2.9 1.3 2.0 1.8 1.7 1.0 2.1 2.0 2.5 0.8 0.9 0.4 4.3 1.4 1.3 18.3 17.8 19.2 19.1 14.2 10.9 14.3 9.9 13.4 15.0 0.0 2.4 4.2 3.8 5.4 4.8 2.8 10.2 0.0 1.2 1.8 2.0 3.0 0.0 4.6 2.1 3.0 4.6 0.0 4.2 4.4 3.7 4.6 4.6 4.3 4.4 0.0 1.2 3.1 4.1 3.6 5.5 2.8 1.7 9.0 5.6 5.6 4.8 3.5 5.3 2.8 5.6 0.0 4.5 9.1 9.1 6.9 2.7 3.5 5.2 3.5 CACYBP "S100A6BP, SIP" ENSG00000116161 "Calcyclin binding protein" Q9HB71 1 174999163-175011715 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 117.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025753, HPA057038" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 360000 Cytosol Nucleoplasm "HPA025753: AB_1845878, HPA057038: AB_2683318" "unprognostic (4.70e-3)" "unprognostic (9.92e-2)" "unprognostic (5.55e-2)" "unprognostic (2.22e-1)" "unprognostic (1.25e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.12e-6)" "unprognostic (1.50e-2)" "unprognostic (2.03e-2)" "prognostic favorable (1.39e-5)" "unprognostic (4.55e-2)" "unprognostic (1.87e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.41e-1)" "unprognostic (4.44e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" 15.1 15.9 38.3 20.3 39.7 24.6 36.2 36.1 46.5 16.0 16.7 10.7 12.5 13.3 14.0 22.5 13.9 15.6 12.7 13.0 36.9 39.1 23.4 18.5 13.3 25.2 33.8 22.8 26.5 10.1 21.4 17.2 19.1 33.1 17.0 18.6 7.9 11.8 17.2 29.8 12.6 14.0 14.4 29.0 13.3 11.7 23.3 27.5 16.2 19.1 12.6 23.9 16.6 117.2 26.7 20.1 17.3 30.2 25.3 29.0 25.8 30.3 21.0 30.9 13.2 10.3 11.6 19.9 23.3 13.8 30.2 22.1 21.6 19.0 32.0 24.3 16.5 21.7 16.6 38.5 17.0 31.3 16.9 23.5 24.0 20.7 23.1 7.8 32.2 15.1 7.8 10.5 24.8 15.0 15.6 21.2 28.8 48.0 18.0 21.7 11.3 49.5 29.5 29.4 45.8 9.8 22.4 22.0 36.9 21.5 24.3 21.3 20.5 15.8 27.7 24.0 43.6 21.5 28.2 10.9 17.2 18.4 24.0 37.3 17.4 50.0 71.0 14.4 28.3 19.9 17.3 16.1 15.9 19.0 24.4 22.1 26.7 27.5 23.0 20.1 20.4 29.0 25.7 8.7 25.3 30.2 16.6 28.5 25.8 38.3 39.7 36.1 46.5 36.9 39.1 33.8 22.8 33.1 27.5 80.4 34.1 105.0 107.7 103.9 56.2 89.6 38.2 80.3 52.4 33.2 58.9 184.6 129.3 83.6 75.6 64.3 63.7 23.3 82.6 245.4 120.8 92.6 91.1 35.8 172.4 28.6 114.6 40.5 47.3 21.9 79.7 120.6 102.9 341.8 42.9 55.2 88.9 53.2 69.3 119.5 79.1 32.3 106.6 100.9 149.2 74.9 120.0 115.4 82.3 81.3 CADM3 "BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1" ENSG00000162706 "Cell adhesion molecule 3" Q8N126 1 159171609-159203313 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.5;placenta: 43.1" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 103.2;Fibroblasts: 46.4;Horizontal cells: 33.4;Melanocytes: 23.6;Muller glia cells: 35.4" "Cancer enhanced" "Detected in many" "glioma: 27.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 19.8;HSkMC: 66.3;hTERT-HME1: 35.5;U-2 OS: 9.9;WM-115: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002981, CAB025746" Enhanced Supported Approved Cytosol "Intracellular and membrane" NA NA 790000 Cytosol "CAB025746: , HPA002981: AB_1078916" "unprognostic (1.74e-2)" "unprognostic (8.26e-2)" "unprognostic (1.34e-2)" "unprognostic (1.33e-2)" "unprognostic (9.32e-2)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (6.12e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (5.52e-2)" "unprognostic (2.59e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (5.75e-4)" 8.9 5.4 23.3 8.5 41.0 0.9 6.1 88.4 96.5 18.0 8.8 6.9 0.7 3.2 2.2 1.6 7.2 3.2 4.1 4.3 23.2 27.4 1.1 1.1 2.9 7.8 18.5 22.4 1.2 2.0 1.0 7.4 43.1 30.4 1.7 8.9 4.5 2.6 3.6 2.0 7.7 6.4 4.1 9.6 7.6 2.8 2.4 4.6 0.0 4.8 0.7 5.9 10.2 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.3 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 19.8 0.0 0.0 66.3 0.0 0.0 35.5 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.1 0.0 0.0 1.5 0.0 0.0 2.6 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 41.0 88.4 55.6 23.2 27.4 18.5 22.4 30.4 4.6 0.0 0.3 0.0 0.0 6.0 103.2 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.1 4.0 0.0 0.0 0.0 0.4 46.4 0.1 0.0 0.0 1.0 33.4 0.0 4.3 0.0 4.7 0.6 0.0 23.6 0.0 0.0 35.4 0.0 0.0 0.0 0.0 7.5 0.0 3.9 0.9 1.7 3.8 0.6 0.0 0.0 0.0 CALB2 CAL2 ENSG00000172137 "Calbindin 2" P22676 16 71358713-71390438 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 50.6;brain: 118.9" "Group enriched" "Detected in many" 6 "Exocrine glandular cells: 89.2;granulocytes: 237.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.2;HEL: 24.0;HMC-1: 52.2;U-2 OS: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000106, HPA007305, HPA007306" Enhanced Supported Enhanced Cytosol NA NA 6400 Cytosol "CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385" "unprognostic (1.10e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.78e-5)" "unprognostic (1.75e-3)" "unprognostic (5.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.59e-1)" "unprognostic (4.55e-3)" "unprognostic (4.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.06e-3)" "unprognostic (1.35e-2)" "unprognostic (5.54e-4)" "unprognostic (1.97e-3)" "unprognostic (6.30e-2)" "unprognostic (4.72e-2)" "unprognostic (1.04e-2)" 50.6 11.6 10.1 5.1 7.5 0.9 18.2 31.2 9.9 1.7 8.9 1.7 0.0 1.7 1.4 3.0 3.0 2.4 2.0 2.2 5.9 74.2 0.9 0.9 2.1 0.9 17.7 7.5 5.6 1.4 0.9 3.0 0.9 118.9 1.1 6.0 4.9 2.1 1.3 1.0 1.0 2.7 2.7 7.5 0.9 1.2 14.6 1.5 0.0 0.8 0.2 1.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.7 6.6 0.0 0.2 0.0 1.3 0.2 0.1 0.2 0.0 0.0 8.2 0.0 0.1 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.2 0.0 0.0 52.2 0.0 0.0 0.5 0.1 0.1 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 14.9 0.1 1.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 7.5 31.2 9.9 5.9 74.2 17.7 7.5 118.9 1.5 8.9 11.1 0.0 0.0 0.2 3.5 0.3 0.0 2.7 0.0 0.0 5.9 0.0 0.0 1.7 2.1 0.1 0.0 0.0 89.2 0.1 0.4 0.1 237.6 0.0 0.1 28.6 0.0 0.0 0.0 2.3 5.8 0.0 5.0 0.0 0.0 2.5 10.4 0.0 0.0 0.0 6.7 0.0 0.3 0.3 3.6 0.0 0.1 0.0 0.0 0.1 CALCOCO1 "calphoglin, Cocoa, KIAA1536" ENSG00000012822 "Calcium binding and coiled-coil domain 1" Q9P1Z2 12 53708517-53727745 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 42.9;HSkMC: 41.0;hTERT-RPE1: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038313, HPA038314" Approved Enhanced Vesicles,Cytosol NA NA 11000 Cytosol Vesicles "HPA038313: AB_10675794, HPA038314: AB_10672587" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" "unprognostic (3.11e-2)" "unprognostic (8.42e-2)" "unprognostic (3.03e-1)" "unprognostic (3.63e-2)" "unprognostic (1.30e-1)" "unprognostic (9.66e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-1)" "unprognostic (2.62e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-3)" "unprognostic (8.01e-2)" "unprognostic (2.80e-1)" "unprognostic (5.63e-3)" "unprognostic (9.88e-3)" 31.6 18.9 30.9 13.6 45.6 14.2 27.7 88.2 46.5 22.5 34.9 27.7 23.5 13.7 27.3 29.7 24.0 25.5 28.0 44.8 32.1 15.4 19.7 14.6 35.0 13.6 28.8 25.3 29.1 26.0 36.9 28.1 23.2 30.3 26.1 15.6 27.1 33.0 33.8 59.2 54.4 20.3 35.8 20.5 22.1 30.7 14.4 38.7 11.1 22.5 20.4 16.3 34.6 23.0 8.1 5.4 34.7 10.3 8.3 14.7 10.1 4.8 4.8 6.9 8.6 42.9 28.6 4.7 9.0 21.4 7.8 10.0 2.0 17.0 1.9 9.7 24.0 3.8 5.1 3.3 9.1 6.8 7.8 5.9 3.4 9.8 1.6 22.2 1.4 7.8 41.0 21.0 7.8 6.7 48.7 14.1 8.8 2.8 15.9 13.6 2.0 3.9 4.8 1.5 4.1 5.2 4.8 4.1 6.2 11.6 2.9 4.3 7.6 6.7 2.5 9.2 14.6 7.6 4.3 15.6 3.1 4.6 3.6 1.4 15.8 5.0 0.7 15.3 1.6 4.3 34.7 9.2 33.4 12.7 10.2 9.3 6.7 9.0 10.1 5.4 8.1 8.0 8.6 32.6 8.3 10.3 4.0 14.7 10.1 30.9 45.6 88.2 46.5 32.1 15.4 28.8 25.3 30.3 38.7 32.8 11.8 13.7 16.2 28.7 34.6 9.9 30.6 16.0 12.5 21.0 33.4 18.1 5.0 13.9 41.1 16.9 10.4 0.0 10.0 7.3 22.0 19.8 7.0 15.3 13.6 25.4 27.4 28.3 20.2 37.9 44.0 16.8 18.6 14.4 19.4 30.7 17.0 16.1 38.9 9.8 41.6 19.4 16.5 19.5 7.7 44.4 38.1 21.8 12.3 12.9 CALCOCO2 "MGC17318, NDP52" ENSG00000136436 "Calcium binding and coiled-coil domain 2" Q13137 17 48830988-48866522 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "Early spermatids: 1039.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022989, HPA023019, HPA023195" Enhanced Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916" "unprognostic (3.71e-1)" "unprognostic (2.87e-1)" "unprognostic (3.84e-2)" "unprognostic (3.37e-2)" "unprognostic (4.90e-2)" "unprognostic (4.46e-2)" "unprognostic (2.05e-1)" "unprognostic (2.28e-1)" "unprognostic (3.88e-1)" "unprognostic (2.15e-1)" "unprognostic (2.41e-1)" "unprognostic (4.03e-2)" "unprognostic (3.52e-2)" "unprognostic (1.06e-1)" "unprognostic (3.80e-2)" "unprognostic (7.57e-2)" "unprognostic (5.65e-2)" 70.5 30.8 20.6 21.0 29.5 22.2 50.8 22.1 28.1 38.5 40.2 26.8 32.7 27.0 39.4 35.6 41.3 36.1 28.4 55.5 24.8 16.6 36.6 48.7 42.6 28.2 36.8 24.8 37.7 22.7 24.6 46.3 26.5 32.3 37.3 42.1 46.9 30.0 31.8 70.1 31.3 35.2 47.8 42.8 29.5 35.5 51.8 37.3 25.0 48.4 32.3 26.0 46.4 74.2 18.0 22.0 44.4 40.7 33.2 34.2 24.7 26.1 17.0 7.1 13.8 53.4 38.8 20.7 25.4 34.2 29.5 33.1 31.7 17.2 8.8 25.5 30.9 25.3 14.5 17.4 21.6 35.6 40.4 14.4 8.4 10.7 12.3 61.5 28.3 42.8 57.1 32.2 31.2 22.8 28.2 21.6 27.8 15.3 26.9 25.5 7.6 24.3 15.1 2.2 58.1 20.9 16.2 35.1 16.6 11.3 8.4 2.9 6.1 7.9 5.2 22.6 15.2 33.2 15.9 20.8 32.3 9.8 19.7 17.9 23.9 33.2 6.2 19.5 14.4 13.1 30.2 36.2 36.3 19.8 39.5 18.9 18.0 17.7 20.3 22.0 16.6 18.1 19.6 44.4 33.2 40.7 11.1 34.2 24.7 20.6 29.5 22.1 28.1 24.8 16.6 36.8 24.8 32.3 37.3 107.2 75.4 30.8 67.1 32.4 15.1 160.6 33.1 26.8 58.0 31.4 47.1 45.2 31.5 40.5 1039.6 77.2 83.2 46.7 36.8 36.5 44.4 46.5 96.0 48.3 25.2 7.9 48.4 86.5 94.6 158.0 65.0 55.1 25.3 5.4 41.0 41.8 31.7 46.5 69.6 36.5 63.8 71.1 51.5 110.9 26.2 40.9 68.0 44.8 56.5 57.2 CALHM2 FAM26B ENSG00000138172 "Calcium homeostasis modulator family member 2" Q9HA72 10 103446786-103452402 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 63.7;Hofbauer cells: 47.4;Leydig cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.8;BJ: 18.8;BJ hTERT+: 19.1;fHDF/TERT166: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014706 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA014706: AB_2243916" "unprognostic (2.45e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (2.48e-1)" "unprognostic (3.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (8.85e-2)" "unprognostic (5.78e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (8.59e-2)" "unprognostic (2.47e-1)" "unprognostic (3.56e-1)" "unprognostic (4.74e-1)" 24.2 10.5 3.7 10.2 3.8 1.8 28.7 1.9 7.1 34.1 9.2 3.9 8.0 5.6 36.0 18.4 13.4 19.7 18.2 17.0 3.9 2.2 5.7 3.7 11.1 15.9 4.8 5.4 32.5 4.5 1.9 4.0 23.6 4.8 18.2 4.0 10.7 7.6 10.0 8.9 8.9 9.0 19.8 5.5 24.4 7.2 14.1 3.1 3.0 11.0 9.2 10.8 19.9 24.1 7.1 36.6 11.2 47.9 14.0 21.5 17.1 5.3 3.8 0.9 1.2 14.3 23.8 4.6 18.8 19.1 5.8 8.2 1.6 2.6 1.6 2.1 21.5 0.3 2.5 1.9 0.0 1.1 0.2 10.8 3.8 1.1 0.3 6.5 0.6 0.3 8.1 0.0 1.7 0.0 10.8 6.8 4.1 0.8 10.0 3.7 12.3 1.4 1.7 2.4 1.1 3.4 4.5 1.5 3.6 0.5 0.4 2.7 1.2 0.7 3.1 1.0 0.4 0.6 1.2 12.1 1.8 2.3 6.4 1.3 1.5 3.5 1.9 15.9 11.8 0.3 11.2 22.7 0.4 21.5 42.2 17.5 7.1 14.8 17.6 36.6 1.5 2.9 11.2 0.9 14.0 47.9 4.2 18.9 17.1 3.7 3.8 1.9 7.1 3.9 2.2 4.8 5.4 4.8 3.1 3.0 1.1 3.4 2.8 4.7 0.0 2.8 2.5 0.0 0.0 3.5 0.0 2.0 0.0 3.1 0.8 20.4 0.0 0.0 0.2 63.7 23.4 0.8 8.1 0.0 47.4 0.0 1.2 28.3 27.5 0.8 42.3 14.7 8.5 1.8 0.0 0.3 0.2 0.0 15.2 0.3 0.0 19.4 29.8 0.7 0.2 3.3 16.0 17.3 0.0 1.0 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206110 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.0;gallbladder: 28.4;intestine: 91.6" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 174.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 39.2;non-classical monocyte: 44.0" "Lineage enriched" "Detected in many" 10 "monocytes: 44.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: AB_2681346" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 2.4 2.5 1.8 12.0 1.1 0.8 2.2 2.6 1.0 3.2 40.3 2.2 7.7 34.0 1.5 7.8 5.1 7.3 28.4 1.4 2.6 0.7 12.6 12.3 3.1 2.6 0.9 1.3 2.3 5.3 0.0 3.1 2.1 8.4 4.3 21.8 3.1 1.9 6.7 1.4 1.7 91.6 2.7 1.0 5.3 5.4 2.4 0.6 1.1 1.5 1.3 1.3 1.9 2.0 0.0 4.5 1.8 44.0 0.0 0.0 2.8 2.5 7.8 5.7 3.5 0.6 1.0 4.0 1.6 1.5 2.6 2.6 14.9 16.1 2.5 2.0 1.1 2.3 10.8 12.8 2.3 1.0 2.1 12.4 4.1 13.3 5.2 2.3 3.5 5.5 1.1 3.4 1.5 2.2 2.1 2.9 5.2 3.9 2.9 0.6 7.2 5.7 7.7 4.9 12.0 2.3 8.5 5.6 5.1 0.9 4.3 2.9 3.4 2.5 2.3 6.8 1.8 1.7 3.4 2.5 3.8 3.5 6.6 6.3 10.6 6.3 7.0 2.4 6.9 1.3 0.0 6.5 0.0 0.0 39.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.8 0.0 44.0 0.2 0.0 2.8 1.8 1.1 2.6 1.0 2.6 0.7 0.9 1.3 8.4 0.6 0.0 1.0 0.9 0.6 1.3 8.8 0.3 15.3 174.0 26.1 3.5 0.0 0.4 0.0 2.0 4.8 1.9 38.6 0.0 3.9 0.4 1.0 1.2 0.0 7.2 3.1 7.9 7.5 6.7 11.9 0.0 3.4 3.4 0.0 0.0 15.0 1.7 1.8 38.6 6.3 5.8 2.2 0.0 0.3 0.0 0.5 1.8 0.1 1.8 18.3 1.1 CALML5 CLSP ENSG00000178372 "Calmodulin like 5" Q9NZT1 10 5498697-5499555 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "salivary gland: 129.5;skin 1: 212.5" "Cell type enriched" "Detected in some" 6 "Suprabasal keratinocytes: 341.5" "Group enriched" "Detected in many" 6 "breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "A-431: 95.2" "Not detected" "Not detected" HPA040725 Enhanced Approved "Plasma membrane,Cytosol" NA NA 75000000 "Plasma membrane, Cytosol" "HPA040725: AB_10793863" "unprognostic (7.68e-3)" "unprognostic (5.06e-3)" "unprognostic (5.64e-2)" "prognostic favorable (2.59e-5)" "unprognostic (4.82e-2)" "unprognostic (2.67e-1)" "unprognostic (1.37e-1)" "unprognostic (8.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.79e-1)" "unprognostic (1.71e-1)" "unprognostic (4.99e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 8.0 0.3 0.2 6.7 0.2 0.2 0.2 0.0 1.0 0.2 4.8 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 129.5 0.2 1.8 212.5 0.2 0.2 0.2 0.2 0.0 0.2 0.2 3.1 0.2 10.9 8.2 0.2 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.2 24.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 341.5 0.0 0.0 0.0 1.4 CAMK1 CaMKI ENSG00000134072 "Calcium/calmodulin dependent protein kinase I" Q14012 3 9757342-9769992 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Differentiation, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 60.5;blood: 59.4" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 76.7;Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "eosinophil: 59.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 59.4" "Cell line enriched" "Detected in many" 4 "HMC-1: 94.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031904, HPA051409" Approved Approved Cytosol NA NA 550000 Cytosol "CAB031904: AB_630964, HPA051409: AB_2681473" "unprognostic (4.43e-2)" "unprognostic (3.05e-1)" "unprognostic (1.68e-1)" "unprognostic (1.29e-1)" "unprognostic (1.11e-1)" "unprognostic (3.06e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.53e-2)" "unprognostic (3.32e-1)" "unprognostic (9.74e-2)" "unprognostic (1.37e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "unprognostic (7.76e-2)" "unprognostic (1.72e-1)" "unprognostic (3.67e-2)" "unprognostic (3.01e-1)" 27.1 60.5 28.0 11.7 26.0 3.5 34.1 12.4 31.2 9.5 10.7 4.4 5.8 6.8 12.6 10.5 7.1 12.6 8.9 10.2 21.4 14.0 13.1 20.7 9.2 10.4 10.3 19.9 21.5 4.5 7.4 7.9 5.1 10.1 18.6 8.1 6.8 5.1 15.1 4.7 3.3 8.3 18.4 7.2 7.1 8.1 13.4 5.6 0.6 7.0 3.7 10.4 9.5 10.3 0.0 3.2 59.4 9.2 0.7 0.4 0.9 0.1 3.7 3.0 0.0 15.4 5.7 7.5 8.8 4.9 10.1 9.6 5.4 0.6 0.2 2.0 5.9 1.5 0.6 0.0 1.1 6.3 0.1 21.6 11.9 7.0 7.5 8.6 1.0 94.0 6.0 0.9 14.2 1.5 8.3 8.4 0.2 1.5 0.2 3.7 2.2 0.0 8.7 2.1 0.1 5.8 0.0 0.1 0.2 6.0 0.6 1.0 3.8 1.5 0.1 0.8 1.3 0.9 15.2 4.4 4.6 5.7 6.5 11.0 0.1 0.0 0.2 9.8 3.3 0.6 3.3 4.8 59.4 0.0 9.2 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.2 0.7 9.2 0.1 0.4 0.9 28.0 26.0 12.4 31.2 21.4 14.0 10.3 19.9 10.1 5.6 0.0 1.9 6.4 17.8 4.4 8.1 0.0 10.2 1.4 2.3 10.4 2.0 0.4 8.3 13.1 1.5 22.7 2.0 0.0 3.6 1.0 11.6 14.9 31.0 21.2 76.7 0.0 5.8 17.8 40.5 3.9 33.4 50.8 5.0 19.0 1.3 30.9 6.0 3.5 42.5 35.3 8.0 58.2 35.0 1.1 1.1 3.3 0.7 7.5 5.5 10.8 CAMK1D CKLiK ENSG00000183049 "Calcium/calmodulin dependent protein kinase ID" Q8IU85 10 12349482-12835545 "Enzymes, Plasma proteins, Predicted membrane proteins" "Inflammatory response, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 148.3;Cone photoreceptor cells: 369.1;Rod photoreceptor cells: 206.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 31.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 31.8" "Cell line enhanced" "Detected in many" "HDLM-2: 47.7;U-266/70: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007266 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007266: AB_1078389" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-3)" "unprognostic (4.23e-1)" "unprognostic (2.32e-2)" "unprognostic (6.90e-3)" "prognostic favorable (1.67e-4)" "unprognostic (1.06e-1)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (7.40e-2)" "unprognostic (1.35e-2)" "unprognostic (6.55e-2)" "unprognostic (1.65e-1)" "unprognostic (4.66e-2)" "unprognostic (2.56e-3)" 5.1 5.3 20.9 10.5 22.1 6.6 4.0 23.4 33.5 8.3 11.5 4.6 10.0 3.8 3.3 3.3 8.7 4.3 6.8 13.8 18.6 7.2 2.2 11.5 7.6 9.3 5.8 17.8 2.6 17.0 1.3 2.5 3.2 5.0 4.9 12.9 11.9 4.5 15.4 1.7 18.5 5.5 5.6 4.9 10.5 3.4 6.2 6.8 20.8 13.6 2.9 12.5 8.1 7.0 7.1 4.2 31.8 3.7 1.4 2.3 1.3 0.1 2.6 3.0 0.2 1.8 0.6 0.2 0.4 0.9 0.6 0.9 3.6 2.0 1.4 0.3 0.2 1.5 1.4 3.6 0.5 0.5 47.7 1.8 5.7 8.5 0.2 0.5 0.1 5.2 0.1 2.3 1.2 0.1 6.4 0.3 3.1 0.1 0.2 0.7 3.0 11.1 2.3 2.0 0.0 1.2 8.5 1.6 2.6 0.1 2.8 4.6 2.1 5.7 2.1 0.0 0.4 1.5 1.4 0.1 2.5 3.7 7.9 1.7 22.0 6.9 4.8 3.7 3.7 0.0 8.3 2.2 31.8 1.8 3.1 1.9 5.6 1.6 2.3 4.2 7.1 1.9 1.3 13.9 1.4 3.7 1.4 0.5 1.3 20.9 22.1 23.4 33.5 18.6 7.2 5.8 17.8 5.0 6.8 3.0 28.0 44.7 7.2 20.4 148.3 10.3 15.3 20.1 29.6 1.8 369.1 0.2 0.0 7.8 7.2 8.3 8.8 0.0 19.1 0.7 22.0 3.5 22.0 11.0 15.1 42.9 15.4 11.1 39.3 7.4 21.9 37.1 3.3 24.4 26.1 18.0 9.6 35.1 57.3 0.5 206.3 25.8 9.2 3.9 9.6 36.0 0.2 10.2 29.3 16.3 CAMK2A "CAMKA, CaMKIINalpha, KIAA0968" ENSG00000070808 "Calcium/calmodulin dependent protein kinase II alpha" Q9UQM7 5 150219491-150290291 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "brain: 105.7;skeletal muscle: 50.1" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 3.1;Cardiomyocytes: 11.0;Fibroblasts: 2.8;Melanocytes: 3.3" "Cancer enriched" "Detected in single" 13 "glioma: 6.0" "Group enriched" "Detected in all" 6 "amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;SCLC-21H: 9.6;SuSa: 2.6;U-87 MG: 8.1" "Group enriched" "Detected in all" 4 "amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1" "Low region specificity" "Detected in all" "CAB004330, HPA051783, HPA051785, HPA053973" Supported Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 21000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (7.20e-3)" "unprognostic (6.47e-3)" "unprognostic (6.16e-3)" "unprognostic (4.85e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-3)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (3.07e-1)" "unprognostic (1.05e-1)" "unprognostic (4.49e-2)" "unprognostic (1.41e-2)" "unprognostic (2.00e-8)" "unprognostic (2.71e-4)" "unprognostic (1.68e-1)" "unprognostic (1.70e-2)" "unprognostic (1.36e-3)" 1.3 1.7 60.7 1.3 50.6 1.3 1.1 1.4 105.7 1.8 1.3 3.7 0.0 1.2 2.1 1.4 1.9 1.7 1.3 3.7 74.6 10.5 1.6 1.2 1.5 1.2 5.1 39.8 1.3 1.1 1.1 0.4 1.3 2.4 1.6 1.3 0.0 1.2 1.4 50.1 1.6 1.3 2.5 1.7 1.2 1.3 1.2 2.3 0.0 1.2 0.0 1.1 1.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 0.0 0.5 1.3 0.8 0.7 0.0 0.1 0.0 0.2 0.6 0.1 2.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.5 0.2 1.7 0.0 1.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 9.6 0.0 0.1 0.2 0.3 2.6 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 8.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 60.7 50.6 1.4 99.6 74.6 10.5 5.1 39.8 2.4 2.3 0.0 0.0 0.0 0.0 3.1 0.1 11.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.4 0.8 0.0 0.0 1.1 0.0 0.2 1.3 0.2 0.0 0.0 0.0 CAMK2B "CAM2, CAMK2, CAMKB" ENSG00000058404 "Calcium/calmodulin dependent protein kinase II beta" Q13554 7 44217150-44334577 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7" "Cell type enriched" "Detected in many" 11 "Bipolar cells: 838.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006849, HPA026307, HPA051783, HPA051785, HPA053973" Enhanced Supported Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA 680000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (1.88e-3)" "unprognostic (4.49e-2)" "unprognostic (3.55e-3)" "unprognostic (1.36e-2)" "unprognostic (5.25e-2)" "unprognostic (2.90e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-1)" "unprognostic (1.17e-2)" "unprognostic (1.60e-2)" "unprognostic (5.23e-7)" "unprognostic (7.04e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (3.95e-2)" 1.4 8.1 20.6 1.4 46.7 1.2 2.0 60.1 81.9 1.2 1.4 4.0 0.7 1.7 1.3 18.8 2.0 1.8 1.2 39.2 36.5 18.0 1.7 3.5 1.2 1.8 10.3 21.3 1.1 3.3 5.6 9.9 1.1 13.4 3.0 1.4 2.7 1.8 2.2 70.7 1.8 1.6 1.2 4.1 1.3 2.4 2.3 4.8 0.0 7.7 2.4 2.0 1.1 0.0 1.3 1.0 3.2 1.2 3.2 1.2 0.8 0.0 0.3 0.2 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.9 0.2 0.1 0.1 0.2 0.8 0.0 1.1 2.4 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 5.3 0.0 0.2 0.1 0.0 2.4 0.1 0.9 0.1 0.0 0.0 42.0 2.2 0.2 0.0 0.0 0.1 1.9 0.2 0.2 0.2 0.4 0.2 0.0 0.5 0.4 0.1 0.2 0.0 0.2 3.2 0.7 1.0 0.8 0.9 1.2 1.1 1.0 0.5 0.5 1.3 1.2 1.1 2.0 3.2 1.2 1.0 0.9 0.8 20.6 46.7 60.1 42.4 36.5 18.0 10.3 21.3 13.4 4.8 0.0 0.0 0.0 27.8 1.0 838.1 74.9 2.5 0.0 0.0 0.0 43.2 0.0 8.3 0.0 0.8 0.6 0.0 0.0 0.0 0.1 0.4 2.6 4.6 4.4 0.2 57.2 39.0 0.0 1.2 2.1 1.7 0.0 1.7 0.0 0.0 14.1 0.1 0.0 0.0 0.8 46.7 0.0 0.9 0.0 1.7 0.4 0.2 0.0 0.0 0.7 CAMK2D CAMKD ENSG00000145349 "Calcium/calmodulin dependent protein kinase II delta" Q13557 4 113451032-113761927 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 243.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 67.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026281, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 140000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (2.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.13e-1)" "unprognostic (7.49e-2)" "unprognostic (2.19e-1)" "unprognostic (5.09e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "unprognostic (7.81e-2)" "unprognostic (7.91e-3)" "unprognostic (2.62e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-2)" "unprognostic (1.87e-1)" "unprognostic (1.90e-2)" 22.8 12.9 47.7 18.3 13.0 2.8 23.5 50.2 30.6 11.0 18.2 7.4 28.6 13.6 11.6 9.4 15.6 9.6 14.8 77.1 17.9 21.4 9.6 17.6 14.7 17.5 14.0 23.8 12.9 7.4 33.7 7.0 9.3 12.5 16.3 19.0 9.9 9.4 48.3 48.5 10.8 19.2 26.2 16.0 8.4 17.6 9.4 8.5 11.2 11.6 9.8 14.5 21.5 22.6 18.5 11.2 0.6 8.8 6.4 9.7 5.2 1.0 14.5 16.1 5.4 35.2 67.4 5.7 34.1 22.8 13.4 11.6 9.8 4.1 20.9 5.0 23.7 17.0 0.5 10.0 5.3 13.7 8.0 2.5 0.0 5.3 11.2 17.9 0.0 0.0 43.0 7.3 10.4 25.8 21.3 11.9 2.6 0.8 9.3 25.3 3.9 2.1 0.8 2.3 13.9 5.4 4.0 18.9 0.1 13.7 9.9 4.3 4.4 4.6 6.9 4.6 14.0 0.1 5.6 7.1 35.5 8.4 15.1 6.7 7.3 3.6 17.9 18.3 1.3 16.7 0.0 8.8 0.0 5.1 5.1 9.7 8.0 5.0 5.6 11.2 18.5 5.8 4.9 0.6 6.4 1.7 0.0 9.3 5.2 47.7 13.0 50.2 25.6 17.9 21.4 14.0 23.8 12.5 8.5 38.7 29.9 22.6 16.0 16.4 72.0 243.3 58.6 20.1 28.4 27.9 82.5 0.4 5.0 6.4 2.9 29.8 57.0 0.0 17.5 0.4 34.7 31.3 9.3 49.4 15.8 68.3 99.5 19.6 16.8 4.5 18.7 21.0 5.0 2.8 82.1 41.3 11.4 45.6 18.7 17.7 71.5 6.5 33.3 2.9 4.4 27.9 0.9 17.5 41.1 16.3 CAMK2G CAMKG ENSG00000148660 "Calcium/calmodulin dependent protein kinase II gamma" Q13555 10 73812501-73874591 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 94.2;Cytotrophoblasts: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "granulocytes: 39.8" "Cell line enhanced" "Detected in all" "PC-3: 46.3;SK-BR-3: 58.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040656, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 170000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (8.63e-3)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (3.46e-3)" "unprognostic (4.27e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-2)" "unprognostic (2.36e-1)" "unprognostic (2.48e-1)" "unprognostic (6.25e-2)" "unprognostic (2.92e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (2.48e-1)" "unprognostic (8.28e-2)" "unprognostic (9.64e-2)" "unprognostic (4.62e-2)" 9.1 8.8 27.4 9.4 20.7 17.4 6.8 22.2 53.8 9.0 37.3 13.3 9.7 19.7 20.1 9.1 20.6 13.2 10.6 6.7 22.8 24.4 11.6 5.9 10.7 8.9 26.8 31.2 6.4 5.7 8.0 6.0 15.8 38.6 18.5 15.5 8.5 12.4 29.8 73.0 9.1 18.1 29.6 29.8 11.0 14.2 3.8 13.4 4.4 6.4 7.6 8.7 26.5 10.8 4.2 7.1 39.8 5.6 9.8 9.2 5.0 11.1 8.0 7.3 13.9 5.3 8.7 8.6 7.6 13.2 10.6 8.7 12.5 12.0 8.2 8.1 9.8 4.1 17.4 5.7 6.5 8.4 7.5 6.8 5.6 6.2 5.6 2.6 7.6 9.5 4.6 5.9 10.5 7.3 16.3 9.0 10.6 6.1 12.4 5.8 7.8 12.7 11.4 5.3 6.8 46.3 11.6 7.6 4.3 5.5 16.2 3.8 8.8 4.4 58.3 3.7 5.6 10.9 4.8 11.0 7.9 12.7 4.2 10.3 3.8 4.5 7.7 8.4 21.9 2.8 8.5 5.6 39.8 7.5 2.3 9.2 4.2 8.4 8.0 7.1 3.9 8.1 7.9 36.4 9.8 4.0 2.4 8.1 5.0 27.4 20.7 22.2 53.8 22.8 24.4 26.8 31.2 38.6 13.4 14.9 9.4 11.5 7.6 8.4 55.8 6.1 15.3 6.7 9.1 7.0 94.2 130.5 11.6 10.6 1.9 18.0 50.5 0.0 17.2 36.6 11.5 7.3 16.1 7.8 22.8 25.4 23.0 12.3 13.6 2.3 11.8 10.5 11.8 5.4 20.0 16.3 16.9 51.8 17.7 27.0 74.1 45.3 50.6 0.5 10.6 11.0 67.9 22.4 26.2 10.7 CAMKK1 "CAMKKA, DKFZp761M0423, MGC34095" ENSG00000004660 "Calcium/calmodulin dependent protein kinase kinase 1" Q8N5S9 17 3860315-3894891 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.9;salivary gland: 27.1" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 36.4;Rod photoreceptor cells: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 18.2;U-87 MG: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009111, HPA028062" Approved Supported Cytosol No No Cytosol "CAB009111: AB_2068406, HPA028062: AB_1845954" "unprognostic (1.39e-2)" "unprognostic (2.13e-1)" "unprognostic (8.66e-3)" "unprognostic (4.40e-3)" "unprognostic (2.94e-3)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" "unprognostic (4.47e-3)" "unprognostic (8.23e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.65e-4)" "unprognostic (1.98e-1)" "unprognostic (1.59e-1)" "unprognostic (7.19e-2)" "unprognostic (8.70e-2)" "unprognostic (8.36e-2)" "unprognostic (3.10e-1)" 4.3 10.2 15.3 5.1 21.4 3.7 4.7 23.2 38.9 4.1 3.2 2.2 4.0 3.1 7.5 5.2 4.2 3.7 3.8 5.7 13.8 6.8 1.5 1.0 4.0 2.5 5.5 16.0 6.0 7.5 5.0 10.1 2.3 11.2 3.3 3.1 2.5 27.1 11.2 2.2 7.8 3.7 6.2 2.2 4.3 2.9 6.1 5.0 1.7 7.2 2.3 2.5 5.6 4.9 0.1 1.6 5.6 4.1 0.0 1.0 1.1 4.9 8.5 0.9 4.3 3.1 5.5 0.3 3.4 3.7 3.3 1.5 3.1 1.5 3.0 3.7 6.6 3.4 14.7 2.3 4.2 2.0 0.1 7.8 3.4 18.2 1.1 3.1 0.5 2.7 4.2 3.6 6.2 2.1 2.9 1.5 4.4 2.6 0.1 1.6 1.3 4.1 1.9 1.0 7.2 8.1 2.1 3.7 3.4 3.5 3.1 5.0 2.8 1.3 10.2 2.2 0.5 3.9 1.1 2.0 5.7 7.7 7.3 2.8 0.4 0.2 0.1 20.8 2.9 0.7 0.0 1.8 3.6 0.6 3.9 1.0 0.0 0.6 0.5 1.6 0.1 0.6 0.3 5.6 0.0 4.1 0.8 0.0 1.1 15.3 21.4 23.2 38.9 13.8 6.8 5.5 16.0 11.2 5.0 6.0 15.1 8.5 1.9 3.3 36.4 5.7 0.0 1.4 5.7 1.8 15.7 0.2 0.0 0.4 0.0 4.4 0.5 0.0 1.4 0.1 4.5 1.4 16.2 0.2 3.8 7.9 4.1 3.1 1.9 0.4 1.1 3.6 8.5 0.0 1.4 3.8 0.8 0.0 1.1 0.0 24.1 0.0 2.0 0.1 1.4 4.6 0.2 0.7 2.3 0.8 CAMKK2 "CAMKK, CAMKKB, KIAA0787, MGC15254" ENSG00000110931 "Calcium/calmodulin dependent protein kinase kinase 2" Q96RR4 12 121237691-121298308 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 125.5" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 58.8;Late spermatids: 64.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 125.5" "Group enriched" "Detected in many" 5 "classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5" "Group enriched" "Detected in all" 5 "dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017389, HPA063713" Approved Supported Supported Cytosol NA NA Cytosol "HPA017389: AB_1845956, HPA063713: " "unprognostic (5.08e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-1)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (1.12e-1)" "unprognostic (2.62e-3)" "unprognostic (2.80e-2)" "unprognostic (1.93e-1)" "unprognostic (7.76e-2)" "unprognostic (5.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.75e-1)" "unprognostic (4.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" 11.7 6.5 19.7 7.8 30.2 13.8 8.8 125.5 45.5 9.0 9.5 7.1 2.6 12.8 8.6 5.3 8.3 11.8 6.3 6.9 11.2 5.1 7.1 8.9 9.6 6.9 6.2 17.3 10.5 5.8 6.4 4.1 7.5 9.1 12.2 9.7 6.2 7.5 13.2 5.1 9.1 13.2 10.3 6.2 14.1 7.6 3.6 5.8 5.2 6.1 4.5 7.2 7.2 7.4 2.2 7.2 26.1 19.4 3.6 2.2 6.3 12.5 9.4 7.0 13.5 21.1 19.7 10.7 10.4 11.0 8.5 7.8 9.8 5.4 19.4 8.7 21.0 6.0 10.4 8.6 11.2 6.7 13.3 16.9 9.6 6.3 9.6 14.3 21.9 9.2 12.7 16.6 8.0 18.2 11.5 19.9 14.8 11.1 10.5 8.2 12.1 24.3 18.0 5.1 10.5 10.7 15.8 8.2 17.2 8.2 14.0 26.9 10.8 13.6 7.3 8.6 5.9 18.2 26.8 14.5 7.0 5.7 5.9 5.7 40.3 23.9 14.7 13.1 15.4 6.9 0.7 14.2 26.1 2.1 19.4 2.2 2.2 1.7 1.9 7.2 1.2 1.5 1.7 17.2 3.6 16.5 1.6 1.3 6.3 19.7 30.2 125.5 45.5 11.2 5.1 6.2 17.3 9.1 5.8 8.9 3.5 4.1 5.1 7.0 21.6 7.0 20.4 8.1 6.8 8.7 2.0 7.4 3.3 8.7 15.7 17.5 18.2 0.0 9.0 6.7 12.5 10.8 5.8 18.3 7.1 58.8 33.0 12.9 13.9 64.8 19.0 13.7 8.5 15.4 15.9 5.1 7.5 11.5 29.7 8.4 6.4 19.4 21.3 0.7 2.4 5.3 2.9 7.1 15.6 5.8 CAMSAP1 "DKFZp434F195, FLJ31228" ENSG00000130559 "Calmodulin regulated spectrin associated protein 1" Q5T5Y3 9 135808487-135907228 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Cone photoreceptor cells: 320.0;Rod photoreceptor cells: 218.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020527, HPA024161" Approved Supported "Mitotic spindle,Cytosol" Yes No "Mitotic spindle, Cytosol" "HPA020527: , HPA024161: AB_1845967" "unprognostic (3.18e-3)" "unprognostic (4.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.57e-2)" "unprognostic (6.00e-2)" "unprognostic (1.43e-2)" "unprognostic (1.79e-3)" "unprognostic (1.22e-1)" "unprognostic (2.75e-1)" "unprognostic (6.13e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-2)" "prognostic favorable (3.09e-5)" "unprognostic (1.12e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (2.66e-3)" 8.0 8.6 12.4 6.5 15.7 10.5 8.3 23.9 21.7 7.6 6.3 14.3 7.2 4.1 9.5 6.9 22.0 9.8 6.5 9.2 11.2 10.8 5.2 4.8 8.2 6.6 10.4 9.9 13.5 9.5 8.9 9.4 6.5 12.2 8.0 4.7 24.2 7.3 8.6 32.7 10.4 4.3 8.6 10.3 6.2 6.2 20.8 9.2 10.0 5.7 14.4 11.4 7.6 10.0 2.4 1.1 3.8 1.6 1.0 2.1 1.2 9.3 13.7 22.7 16.0 5.3 4.6 11.1 7.5 6.3 8.2 6.3 12.0 8.2 4.3 10.9 9.5 10.6 19.1 11.9 8.2 6.3 14.6 6.6 6.2 15.4 6.0 8.1 10.8 9.4 6.2 10.4 10.5 14.5 7.9 9.2 9.6 12.8 9.4 10.7 16.6 10.0 6.7 13.0 11.2 10.0 19.7 18.9 10.5 8.3 11.5 24.8 24.4 9.7 7.1 10.5 7.8 9.9 9.0 11.3 15.7 12.4 11.5 12.8 4.7 8.8 11.8 10.2 7.4 9.0 3.8 1.5 0.3 1.1 1.6 2.1 2.4 1.8 1.7 0.9 0.5 1.3 1.9 0.5 1.0 1.3 1.1 1.4 1.2 12.4 15.7 23.9 21.5 11.2 10.8 10.4 9.9 12.2 9.2 6.0 3.8 6.0 12.6 20.1 32.5 12.2 5.1 16.0 15.9 3.5 320.0 10.0 0.0 10.2 8.6 7.9 3.0 23.3 7.6 3.1 5.4 12.1 5.8 7.3 9.4 15.9 12.1 4.9 9.2 13.6 5.5 8.9 11.8 10.0 3.8 16.5 12.6 3.5 5.6 3.8 218.3 12.9 9.0 16.3 32.4 27.7 4.7 3.2 3.8 24.1 CAMSAP2 "CAMSAP1L1, KIAA1078" ENSG00000118200 "Calmodulin regulated spectrin associated protein family member 2" Q08AD1 1 200739558-200860704 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026304, HPA026511, HPA027302" Enhanced Supported "Microtubule ends,Cytosol" NA NA "Microtubule ends" Cytosol "HPA026304: AB_1852376, HPA026511: AB_1852378, HPA027302: AB_1852380" "unprognostic (1.19e-1)" "unprognostic (9.98e-3)" "unprognostic (1.44e-1)" "unprognostic (9.52e-2)" "unprognostic (7.96e-3)" "unprognostic (4.82e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.34e-2)" "unprognostic (5.41e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "unprognostic (1.56e-1)" "unprognostic (2.92e-2)" "unprognostic (1.38e-3)" "unprognostic (1.95e-1)" "unprognostic (8.23e-3)" "unprognostic (9.56e-2)" 11.6 11.9 12.8 4.5 15.2 0.1 7.4 16.8 29.7 11.3 5.8 16.6 5.9 2.7 14.4 7.7 8.1 6.6 8.9 7.7 13.0 11.9 8.9 5.0 10.5 2.3 10.3 11.1 14.5 3.9 20.7 6.1 13.0 17.4 8.2 4.7 8.6 5.0 10.0 5.4 9.0 2.7 11.6 10.2 5.6 5.0 10.1 7.0 1.8 13.8 5.3 4.1 13.1 7.4 0.1 0.5 0.7 0.6 0.0 1.4 0.1 11.4 7.7 10.7 9.6 8.6 11.5 12.3 11.6 10.0 9.4 7.8 5.6 6.9 0.0 6.6 12.8 8.6 10.3 11.0 17.1 11.3 6.8 5.6 0.6 11.7 2.5 9.7 0.7 2.9 8.3 26.4 15.0 58.9 10.1 14.2 1.0 1.4 3.6 15.1 6.0 0.1 0.2 10.0 3.5 11.0 4.6 11.8 5.2 8.0 8.5 5.6 10.0 17.0 10.6 9.6 13.6 10.1 0.6 16.9 15.4 9.1 9.5 14.3 7.3 12.1 6.1 11.1 1.8 11.6 0.7 0.6 0.0 0.3 0.1 0.4 0.1 1.4 0.0 0.5 0.0 1.4 0.4 0.0 0.0 0.1 0.2 0.8 0.1 12.8 15.2 16.8 16.3 13.0 11.9 10.3 11.1 17.4 7.0 56.6 33.7 0.0 26.4 71.0 45.8 78.1 5.1 5.3 47.8 14.0 13.7 14.9 1.7 13.5 26.4 49.5 1.6 0.0 7.0 14.2 39.9 20.8 4.7 5.0 8.6 47.7 11.3 33.2 11.8 27.7 26.4 18.8 18.6 2.8 2.4 58.6 14.1 2.5 42.8 4.5 15.4 25.8 43.3 21.7 16.2 43.0 33.4 1.9 3.3 28.4 CAMTA1 KIAA0833 ENSG00000171735 "Calmodulin binding transcription activator 1" Q9Y6Y1 1 6785324-7769706 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036342, HPA036343" Approved Supported Cytosol NA NA Cytosol "HPA036342: AB_2675072, HPA036343: AB_10671839" "unprognostic (1.11e-1)" "unprognostic (6.31e-2)" "unprognostic (5.80e-2)" "unprognostic (4.14e-3)" "unprognostic (3.10e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "prognostic favorable (4.10e-4)" "unprognostic (3.90e-3)" "unprognostic (8.84e-2)" "unprognostic (1.35e-3)" "unprognostic (2.17e-2)" "unprognostic (9.19e-3)" "unprognostic (1.42e-1)" "unprognostic (9.03e-3)" 18.4 24.3 31.6 12.2 30.7 12.1 21.7 24.4 37.1 16.5 30.2 19.9 13.2 28.3 20.0 46.7 22.7 16.8 17.7 58.1 26.4 27.6 36.7 37.2 16.5 13.3 31.2 26.5 17.1 18.6 22.0 17.6 14.3 47.5 22.2 27.1 25.0 27.1 29.6 48.0 12.9 30.4 38.4 23.9 15.7 21.5 23.0 19.4 14.7 30.8 20.5 17.5 31.3 18.7 19.8 32.3 28.3 32.4 10.3 18.1 18.9 22.0 12.4 34.6 17.5 17.9 27.4 9.7 23.9 18.4 25.8 21.9 15.0 28.0 18.3 18.8 25.0 17.3 13.7 18.0 24.7 36.9 13.7 19.6 20.6 29.4 29.2 29.1 15.6 15.0 18.3 17.2 18.6 28.7 22.3 28.7 26.1 14.4 24.9 29.7 21.3 20.7 42.9 23.9 28.1 14.6 13.9 30.8 40.5 34.8 12.9 35.8 28.9 16.9 25.2 36.8 26.0 13.6 19.6 16.7 18.4 15.6 18.9 14.8 19.0 23.5 49.2 27.5 35.2 10.3 27.5 32.4 28.3 11.5 19.4 12.5 19.8 18.0 14.2 30.6 16.2 14.7 12.8 6.6 10.3 14.7 32.3 18.1 18.9 31.6 30.7 24.4 37.1 26.4 27.6 31.2 26.5 47.5 19.4 50.6 45.6 87.6 306.4 275.2 103.9 495.7 107.0 68.3 46.6 181.5 237.6 60.6 354.8 147.0 138.1 160.0 190.4 46.7 180.4 116.8 142.3 320.6 54.3 215.1 94.9 149.4 125.6 81.6 94.6 111.6 70.8 142.3 226.0 196.6 153.7 60.0 175.4 166.1 120.9 611.1 144.7 135.8 271.7 133.0 213.0 247.2 73.7 58.9 164.9 354.7 CAMTA2 KIAA0909 ENSG00000108509 "Calmodulin binding transcription activator 2" O94983 17 4967992-4987652 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027835, HPA051147" Supported "Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol" NA NA Nucleoplasm "Vesicles, Actin filaments, Mitochondria, Cytosol" "HPA027835: , HPA051147: AB_2681362" "unprognostic (2.82e-1)" "unprognostic (3.06e-1)" "unprognostic (1.11e-2)" "unprognostic (1.01e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (2.78e-2)" "unprognostic (7.08e-2)" "prognostic favorable (6.00e-8)" "unprognostic (3.42e-2)" "unprognostic (9.02e-2)" "unprognostic (3.73e-2)" "unprognostic (1.20e-1)" "unprognostic (4.56e-2)" "unprognostic (1.19e-1)" 9.8 6.4 27.0 9.2 25.2 6.4 5.4 63.6 44.9 6.2 8.0 6.4 3.8 7.3 6.2 3.1 8.4 6.8 6.1 8.0 33.8 17.4 5.5 4.2 8.8 6.2 11.7 19.1 6.7 11.7 14.8 21.3 5.1 18.5 6.8 8.0 5.5 8.7 9.1 20.1 8.6 9.0 10.5 6.5 8.7 8.0 9.0 8.8 2.7 6.5 2.9 6.5 6.5 4.7 1.3 2.2 5.7 8.1 1.1 2.7 2.1 8.0 14.4 2.7 3.8 18.1 12.6 5.6 7.8 8.7 7.4 6.6 3.6 2.2 9.5 7.6 12.2 6.3 8.2 10.2 12.2 4.2 13.3 13.2 6.0 7.8 4.0 10.4 3.5 25.8 8.7 15.3 7.0 11.0 9.0 12.3 7.4 9.7 8.7 6.9 5.3 6.2 2.2 0.4 9.6 6.0 5.4 3.0 3.7 8.4 8.5 3.7 3.2 4.9 9.0 2.4 4.8 7.9 3.5 16.3 5.9 3.5 6.2 12.7 4.4 4.7 3.4 14.4 7.0 5.7 1.0 2.2 1.8 2.7 3.0 2.1 1.3 1.2 2.5 1.4 0.9 1.8 2.0 5.7 1.1 8.1 2.2 1.1 2.1 27.0 25.2 63.6 44.9 33.8 17.4 11.7 19.1 18.5 8.8 3.0 13.7 8.3 3.5 6.2 12.1 5.9 15.3 5.3 3.4 10.4 9.8 5.2 1.7 6.8 29.0 6.9 16.3 0.0 9.8 6.8 6.8 5.5 12.7 11.9 7.7 33.4 10.9 14.1 9.2 39.5 9.5 8.0 3.3 8.2 13.1 4.3 9.1 12.4 8.9 10.5 9.6 12.9 12.3 5.2 7.6 9.2 10.4 10.2 9.5 3.4 CAND1 "DKFZp434M1414, KIAA0829, TIP120, TIP120A" ENSG00000111530 "Cullin associated and neddylation dissociated 1" Q86VP6 12 67269281-67319951 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055748, HPA062833, HPA069053" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 4200000 "Nucleoplasm, Golgi apparatus, Cytosol" "HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074" "unprognostic (1.50e-2)" "unprognostic (1.60e-1)" "unprognostic (1.39e-3)" "unprognostic (2.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.02e-2)" "unprognostic (2.17e-2)" "unprognostic (3.02e-1)" "unprognostic (3.38e-3)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" "unprognostic (2.88e-1)" "unprognostic (1.58e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" 21.3 26.7 28.7 19.1 38.3 19.6 27.0 34.6 32.6 23.9 20.0 17.5 17.0 19.7 22.8 29.9 26.6 20.6 19.0 15.2 24.8 27.0 25.4 27.7 18.7 25.4 23.3 29.0 29.0 22.1 33.2 27.1 23.3 33.2 24.1 21.7 15.8 19.6 22.0 11.1 29.5 19.5 22.4 21.5 20.2 19.3 26.9 23.8 39.4 27.0 17.0 30.2 21.1 22.1 11.9 7.8 6.1 10.1 14.7 15.2 4.3 22.5 23.2 35.4 25.1 27.2 21.3 23.8 22.4 19.4 23.7 20.9 21.5 12.9 48.7 19.6 22.4 14.9 21.6 38.0 25.5 27.2 18.4 22.8 27.4 18.7 20.3 17.8 32.3 15.6 20.1 19.4 21.6 20.0 29.1 22.0 23.9 21.7 27.3 25.5 22.1 29.2 21.9 37.4 17.4 16.2 28.6 30.4 20.6 21.8 38.5 36.4 18.1 27.9 25.7 18.1 31.1 27.6 14.9 18.7 18.8 12.2 12.9 16.9 9.0 11.0 41.5 22.4 19.2 19.3 6.1 5.0 5.5 11.6 5.9 14.1 8.6 14.2 12.7 7.8 11.9 15.2 12.7 2.2 14.7 10.1 6.6 14.7 4.3 28.7 38.3 34.6 31.8 24.8 27.0 23.3 29.0 33.2 23.8 56.6 27.6 42.6 43.5 51.6 88.5 14.7 45.9 34.8 29.6 41.8 110.0 31.5 11.6 27.1 2.8 38.6 46.3 0.0 24.9 36.0 41.4 44.6 7.0 41.5 27.1 82.6 43.6 38.1 40.0 7.7 63.9 30.4 32.1 52.3 46.0 63.0 29.9 24.6 57.3 27.3 106.8 25.8 34.2 72.7 42.4 55.8 37.3 47.9 38.5 52.1 CAND2 "KIAA0667, TIP120B, Tp120b" ENSG00000144712 "Cullin associated and neddylation dissociated 2 (putative)" O75155 3 12796472-12871916 "Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 76.2" "Cell type enriched" "Detected in many" 6 "Early spermatids: 98.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 18.4;REH: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005777 Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "HPA005777: AB_2667431" "unprognostic (6.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.52e-3)" "unprognostic (6.09e-2)" "unprognostic (4.22e-1)" "unprognostic (2.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.67e-2)" "unprognostic (2.00e-2)" "unprognostic (9.03e-2)" "unprognostic (6.36e-3)" "unprognostic (1.03e-1)" "unprognostic (4.78e-5)" "unprognostic (1.31e-2)" "unprognostic (2.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.96e-3)" 2.9 2.8 6.4 1.4 7.6 1.4 1.4 7.2 11.8 2.3 3.2 3.7 0.5 1.5 3.7 2.6 2.6 3.6 2.1 17.8 4.7 4.3 1.7 1.7 1.9 1.4 2.7 5.5 3.3 2.5 6.4 4.9 1.4 3.1 3.0 1.4 4.2 2.2 3.4 76.2 1.6 1.7 5.2 2.2 2.2 2.1 11.4 2.6 0.1 2.4 11.1 1.2 3.0 5.0 1.2 0.2 0.7 0.5 0.0 2.2 0.6 0.7 1.5 5.8 0.2 0.2 0.1 0.3 1.7 0.6 3.1 4.3 0.8 0.3 0.9 1.7 0.8 0.8 0.2 6.4 0.1 2.8 1.6 18.4 1.3 2.2 1.2 4.9 0.1 0.1 1.3 0.3 3.1 0.1 3.3 0.7 6.8 4.7 0.9 0.9 3.0 2.3 0.7 4.1 0.4 1.8 11.4 1.1 0.9 0.2 1.3 3.9 5.2 0.1 0.8 1.0 1.1 1.7 5.6 0.4 0.9 1.0 0.9 1.2 1.5 9.0 8.7 0.5 1.1 1.9 0.0 0.5 0.0 1.2 0.2 0.6 1.2 0.6 2.2 0.1 0.5 1.3 0.9 0.7 0.0 0.1 0.2 1.6 0.6 6.4 7.6 7.2 11.8 4.7 4.3 2.7 5.5 3.1 2.6 3.0 0.6 0.0 0.7 0.3 13.3 3.6 0.0 0.0 1.2 1.8 9.8 0.1 0.0 0.6 98.3 1.0 0.0 0.0 0.0 0.1 1.3 0.4 0.0 2.1 3.2 12.7 0.0 1.8 0.0 17.8 4.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 9.6 0.5 2.5 0.0 1.7 1.4 3.8 0.1 0.1 0.7 0.0 0.3 CAP1 CAP ENSG00000131236 "Cyclase associated actin cytoskeleton regulatory protein 1" Q01518 1 40040233-40072649 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 201.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 203.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030124 Approved Approved Cytosol NA NA 270000000 Cytosol "HPA030124: AB_10600799" "unprognostic (1.80e-3)" "unprognostic (1.23e-3)" "unprognostic (5.68e-2)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (1.44e-6)" "unprognostic (5.37e-2)" "unprognostic (4.87e-1)" "unprognostic (1.98e-1)" "unprognostic (3.33e-3)" "unprognostic (1.09e-1)" "unprognostic (6.22e-2)" "unprognostic (1.39e-1)" "unprognostic (7.08e-2)" "unprognostic (1.26e-1)" "unprognostic (3.44e-1)" 70.0 31.8 33.3 68.7 41.0 74.6 42.4 16.6 37.4 40.1 58.2 42.7 25.2 37.9 69.4 28.9 60.9 44.6 36.9 27.2 28.6 26.6 56.6 52.0 58.2 63.7 37.2 26.9 44.5 22.6 29.7 22.5 74.4 39.5 42.0 57.7 31.3 39.8 39.7 20.6 37.1 58.9 62.9 42.7 79.9 44.6 39.0 30.0 62.4 40.2 32.6 83.1 53.3 40.8 27.4 70.6 201.2 106.1 37.2 57.6 115.5 44.9 19.5 24.7 14.6 35.1 32.9 36.8 79.7 48.2 45.0 45.4 28.1 47.8 35.0 32.5 65.6 30.8 28.3 29.6 58.4 62.1 46.7 17.5 54.8 21.5 22.1 32.3 33.8 156.3 33.6 30.1 68.7 38.9 50.7 37.9 20.3 20.4 23.5 67.3 13.3 26.8 18.5 40.0 33.0 21.9 20.3 32.8 21.4 47.6 47.6 11.7 24.6 33.9 39.3 54.2 51.1 18.2 203.6 67.5 38.5 35.0 20.1 67.5 19.2 37.6 32.1 50.6 37.7 50.4 95.4 60.2 201.2 57.6 88.9 45.3 27.4 41.7 55.1 70.6 26.3 35.4 47.9 128.3 37.2 106.1 27.7 55.1 115.5 33.3 41.0 16.6 37.4 28.6 26.6 37.2 26.9 39.5 30.0 113.2 90.0 165.3 126.1 99.7 40.3 13.7 86.6 73.6 78.5 108.2 25.5 179.9 94.5 335.8 422.5 137.1 167.8 0.0 239.7 381.4 126.1 105.8 219.9 66.5 383.8 39.7 73.1 171.2 376.6 351.4 81.4 395.6 94.5 634.8 120.1 147.6 544.5 150.5 166.2 105.9 41.2 161.7 157.2 125.6 45.8 116.1 198.9 232.9 110.6 183.3 CAP2 ENSG00000112186 "Cyclase associated actin cytoskeleton regulatory protein 2" P40123 6 17393216-17557792 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 165.7" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 110.1;Ciliated cells: 48.2;Sertoli cells: 32.3;Smooth muscle cells: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "LHCN-M2: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050530, HPA054147" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA050530: AB_2681159, HPA054147: AB_2682400" "unprognostic (7.27e-2)" "unprognostic (5.71e-3)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (4.86e-1)" "unprognostic (2.23e-2)" "unprognostic (9.94e-2)" "unprognostic (3.58e-2)" "unprognostic (7.72e-2)" "unprognostic (1.65e-1)" "unprognostic (6.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-1)" "unprognostic (8.05e-2)" "unprognostic (1.75e-3)" 5.8 4.1 13.8 3.0 20.1 0.7 3.9 7.5 26.4 5.6 7.7 1.9 2.0 1.9 9.2 5.9 7.0 5.8 3.8 31.2 19.9 8.7 3.3 2.0 2.1 1.1 5.3 17.3 2.1 1.6 3.2 1.7 6.2 8.6 8.4 3.6 2.9 2.5 10.1 165.7 0.9 2.6 13.1 2.0 1.6 3.3 1.1 1.3 0.0 2.3 14.5 1.3 4.6 6.4 0.0 0.0 0.0 0.0 0.0 2.9 0.1 5.1 8.1 15.7 18.7 0.1 0.0 3.4 18.5 13.5 15.2 13.9 2.6 2.3 0.0 17.4 19.8 21.3 2.7 6.9 6.9 22.1 0.0 2.6 0.0 5.2 8.8 1.5 0.0 0.0 1.1 3.4 7.7 3.3 24.9 0.7 0.0 0.0 0.0 32.1 8.3 0.0 0.0 5.9 0.2 4.6 1.7 20.8 0.3 8.0 2.1 2.0 3.9 6.2 20.1 10.9 30.1 22.2 3.7 0.0 12.3 11.7 0.3 16.2 0.0 0.0 0.0 4.1 0.0 16.8 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 20.1 7.5 26.4 19.9 8.7 5.3 17.3 8.6 1.3 3.0 1.0 0.0 3.5 1.6 13.5 110.1 2.5 48.2 5.7 1.8 3.9 14.9 3.3 2.4 0.1 1.0 0.0 0.0 0.6 10.7 8.2 1.4 0.0 1.8 1.9 7.9 5.8 4.9 0.0 0.0 0.6 0.0 0.0 0.0 1.1 5.0 3.6 2.0 4.6 16.1 2.0 32.3 40.1 0.1 2.1 0.6 31.4 0.0 1.5 0.7 CAPN1 "CANP, CANPL1, muCANP, muCL" ENSG00000014216 "Calpain 1" P07384 11 65180566-65212006 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 90.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005992 Enhanced Supported Cytosol NA NA 28000000 Cytosol "HPA005992: AB_1845924" "unprognostic (2.07e-1)" "unprognostic (2.15e-1)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (4.06e-2)" "unprognostic (1.10e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (7.23e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.33e-1)" "prognostic favorable (7.06e-8)" "unprognostic (5.70e-3)" "unprognostic (1.51e-1)" "unprognostic (1.86e-1)" "unprognostic (2.98e-1)" 22.0 15.6 9.6 23.8 11.6 18.2 18.8 17.7 20.1 25.8 33.3 8.4 23.0 25.4 19.3 30.2 86.9 28.1 39.1 21.4 8.8 11.2 27.8 21.3 19.4 19.5 10.8 9.7 21.4 24.9 13.3 14.1 38.1 16.8 27.3 17.0 15.8 39.7 24.3 24.2 38.9 49.9 16.5 7.7 21.3 20.7 8.3 6.7 32.1 37.5 50.2 53.7 33.7 35.2 16.7 22.8 34.5 24.8 15.7 19.6 28.5 48.4 25.8 7.4 16.4 13.4 17.1 22.5 14.4 22.9 17.0 13.0 16.4 43.6 12.1 24.1 27.3 19.8 71.6 9.6 60.8 5.5 12.9 7.6 28.9 14.9 16.0 13.4 6.8 40.6 18.8 32.7 14.4 7.0 16.0 29.0 8.8 17.2 9.8 13.8 31.1 13.3 21.5 21.3 24.8 23.4 13.2 7.6 7.3 23.0 90.0 13.3 9.8 15.2 58.9 13.9 8.3 25.3 13.4 25.2 13.2 9.0 28.2 6.5 6.0 4.4 14.4 23.1 8.3 14.3 34.3 24.8 34.5 19.6 23.7 15.7 15.6 15.5 17.7 22.8 16.7 9.1 12.5 15.8 15.7 14.0 17.9 16.6 28.5 9.6 11.6 17.7 20.1 8.8 11.2 10.8 9.7 16.8 6.7 23.8 24.7 31.9 110.9 53.1 6.6 17.9 68.8 30.8 33.0 73.3 19.6 201.3 33.2 164.8 0.5 23.3 141.6 0.0 101.4 88.1 42.3 51.8 46.1 31.0 78.5 20.6 42.6 26.4 45.7 0.4 40.3 38.8 45.5 146.9 72.1 33.2 133.6 105.2 47.7 26.9 15.0 38.8 36.4 0.5 2.0 60.2 164.4 49.8 101.5 141.7 CAPN10 ENSG00000142330 "Calpain 10" Q9HC96 2 240586716-240617705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004170, HPA056098" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004170: AB_1078381, HPA056098: AB_2683037" "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (9.29e-3)" "unprognostic (6.09e-2)" "unprognostic (5.44e-3)" "prognostic favorable (8.47e-5)" "prognostic unfavorable (4.78e-6)" "unprognostic (7.48e-3)" "unprognostic (7.94e-2)" "unprognostic (1.31e-2)" "prognostic favorable (7.94e-5)" "unprognostic (1.46e-1)" "unprognostic (1.11e-2)" "unprognostic (1.19e-1)" "unprognostic (6.88e-2)" "unprognostic (5.76e-2)" "unprognostic (5.58e-3)" 9.2 11.8 16.8 12.9 15.1 10.9 6.6 20.5 15.7 8.3 13.6 12.8 10.0 20.8 11.3 8.0 9.7 9.8 10.2 11.5 15.9 10.7 14.2 9.3 8.4 15.3 11.2 18.1 10.0 13.0 8.6 13.2 7.3 11.1 10.6 12.2 12.4 14.6 10.7 6.5 19.5 16.2 8.3 8.1 21.0 15.0 10.7 13.7 15.1 9.3 5.6 13.2 8.3 7.0 1.5 2.0 7.7 1.8 5.8 2.2 0.8 5.2 7.9 7.8 6.0 3.0 2.5 13.6 6.7 2.8 4.5 4.3 5.8 12.5 4.0 2.3 2.3 6.3 8.9 2.0 4.5 2.3 15.1 13.8 7.3 13.1 10.1 4.9 4.7 10.3 2.2 3.1 4.7 1.9 4.6 3.3 11.5 8.1 5.0 1.8 4.6 10.5 18.0 11.7 6.3 5.5 10.0 5.5 8.4 7.0 6.2 19.7 15.4 4.3 6.1 8.5 2.7 3.1 5.8 5.8 7.7 6.6 6.2 8.0 12.3 2.8 7.1 7.3 8.6 7.2 1.7 1.8 3.3 2.0 1.0 0.5 1.5 1.3 2.0 0.8 1.5 1.2 1.8 7.7 5.8 1.1 2.0 2.2 0.8 16.8 15.1 20.5 15.7 15.9 10.7 11.2 18.1 11.1 13.7 3.0 5.9 3.7 6.1 4.0 12.5 8.1 12.7 4.0 3.4 8.7 13.7 4.1 6.6 11.8 1.3 5.5 7.8 0.0 7.9 4.3 3.7 7.6 23.0 3.0 5.9 46.1 10.9 4.9 3.2 2.0 8.3 7.0 1.7 9.0 4.9 11.6 11.2 3.5 8.9 5.1 16.7 0.0 6.2 12.1 8.0 4.5 4.6 5.0 6.0 6.0 CAPN2 "CANPL2, CANPml, mCANP" ENSG00000162909 "Calpain 2" P17655 1 223701593-223776018 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 366.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024470 Approved Approved Supported Cytosol NA NA 1500000 Cytosol "HPA024470: AB_1845925" "unprognostic (2.77e-2)" "unprognostic (1.27e-3)" "unprognostic (2.03e-1)" "unprognostic (3.39e-2)" "unprognostic (2.12e-1)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (1.10e-1)" "unprognostic (2.85e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.21e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.61e-1)" "unprognostic (2.63e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (6.21e-4)" 56.2 41.0 23.8 20.7 22.2 11.1 61.1 26.1 20.9 40.3 44.8 18.3 23.3 14.5 29.1 44.5 56.3 40.1 58.9 33.0 26.5 13.1 41.6 13.3 58.6 18.2 27.4 18.2 32.4 26.8 53.7 12.7 26.4 23.8 27.2 44.4 16.5 62.5 31.9 48.1 16.5 22.7 35.7 32.3 15.9 48.2 17.2 24.7 5.0 29.9 39.7 35.9 28.3 38.8 9.0 41.6 1.7 29.1 6.0 28.7 28.2 46.1 29.6 9.5 6.3 31.7 44.0 9.1 43.7 63.5 31.8 18.1 23.4 37.2 0.0 14.4 48.5 25.0 28.9 10.2 69.1 29.6 11.8 10.6 0.8 15.1 2.9 28.5 2.4 1.5 23.5 22.4 49.5 26.5 57.1 63.0 0.0 13.3 12.4 93.6 0.9 0.1 2.1 5.2 5.7 38.7 3.9 31.0 0.7 54.8 2.7 2.0 11.0 22.5 61.5 13.6 24.0 9.3 11.1 96.9 29.8 24.7 25.6 56.0 3.7 6.9 0.1 74.6 5.2 32.7 1.7 29.1 1.7 28.7 19.5 24.5 9.0 20.0 27.7 41.6 3.6 6.4 17.4 1.5 6.0 17.5 1.9 19.9 28.2 23.8 22.2 26.1 20.9 26.5 13.1 27.4 18.2 23.8 24.7 366.3 110.0 19.7 85.8 42.0 12.0 35.9 96.8 180.7 191.1 50.6 31.4 18.1 154.2 234.2 86.1 110.2 114.4 0.0 171.9 77.1 101.6 155.1 26.6 6.0 36.6 12.7 23.6 33.2 58.4 173.5 71.7 66.7 106.3 13.6 104.2 15.8 261.3 139.7 64.7 17.0 17.0 38.8 112.7 3.0 3.2 24.1 6.9 57.7 90.7 256.2 CAPN5 "ADNIV, HTRA3, nCL-3, VRNI" ENSG00000149260 "Calpain 5" O15484 11 77066932-77126155 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.5;intestine: 47.8" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 114.7;Mucus-secreting cells: 72.0;Paneth cells: 69.1;Undifferentiated cells: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.8" "Lineage enriched" "Detected in single" 5 "T-cells: 4.8" "Cell line enhanced" "Detected in many" "OE19: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033237, HPA072319" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033237: AB_2069673, HPA072319: AB_2686512" "unprognostic (6.81e-3)" "unprognostic (1.31e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (3.47e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-1)" "unprognostic (2.21e-2)" "unprognostic (5.35e-3)" "unprognostic (4.64e-1)" "unprognostic (3.17e-3)" "unprognostic (8.58e-3)" "unprognostic (3.25e-1)" "unprognostic (2.31e-2)" "unprognostic (2.30e-3)" 3.9 7.1 5.6 19.5 5.4 1.5 3.9 6.3 10.8 7.4 34.1 6.0 4.8 32.7 6.3 8.3 18.3 6.6 49.5 4.4 5.4 4.6 8.7 26.8 2.8 1.2 3.7 7.0 15.4 3.2 0.7 3.3 2.6 10.2 9.3 27.9 7.4 4.7 7.5 1.8 1.9 47.8 9.3 4.1 2.2 29.3 22.0 2.3 0.6 3.1 4.6 7.3 9.8 6.3 0.2 0.7 0.0 0.9 0.0 4.8 2.1 0.3 5.5 3.7 3.6 13.9 13.4 0.3 5.5 9.6 5.7 4.2 3.2 1.6 0.2 4.0 9.6 6.5 0.2 1.5 0.4 2.4 0.3 0.3 1.1 0.1 0.3 3.5 0.1 0.3 6.6 0.6 9.2 2.2 8.0 6.6 2.6 0.1 0.1 10.6 7.7 0.9 0.1 3.1 44.2 4.3 0.8 12.5 0.2 1.9 6.9 0.2 6.7 1.3 1.0 2.5 2.4 0.8 0.0 13.7 11.1 6.6 15.3 0.7 0.4 0.7 0.0 5.7 0.1 2.6 0.0 0.7 0.0 4.8 0.9 0.4 0.0 0.5 1.6 0.7 0.2 2.4 2.5 0.0 0.0 0.2 0.3 0.0 2.1 5.6 5.4 6.3 10.8 5.4 4.6 3.7 7.0 10.2 2.3 0.0 0.3 0.8 0.2 1.4 1.5 1.7 28.1 4.0 7.9 22.7 0.0 0.0 1.7 9.0 0.9 2.1 114.7 0.0 29.7 0.4 6.2 2.3 0.0 37.5 0.8 1.6 21.5 2.5 1.8 1.1 11.5 1.2 6.8 0.0 72.0 6.4 15.2 69.1 4.2 5.9 1.8 0.0 2.2 0.4 2.3 0.6 0.0 0.0 49.0 1.4 CAPN6 "CalpM, CANPX, CAPNX" ENSG00000077274 "Calpain 6" Q9Y6Q1 X 111245103-111270523 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 62.9;placenta: 173.5" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 165.5;Syncytiotrophoblasts: 117.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 25.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 1.2;plasmacytoid DC: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HDLM-2: 10.1;NTERA-2: 15.8;SuSa: 14.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA040259 Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA040259: " "unprognostic (1.27e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-2)" "unprognostic (5.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.93e-2)" "unprognostic (8.39e-3)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (9.45e-3)" "unprognostic (5.12e-1)" "unprognostic (6.25e-2)" "unprognostic (7.67e-2)" "unprognostic (6.50e-2)" "unprognostic (5.02e-3)" "unprognostic (2.66e-1)" "unprognostic (6.30e-2)" 1.7 0.0 0.2 1.7 0.2 0.0 6.0 0.3 0.3 3.9 4.2 0.2 23.4 0.2 18.2 62.9 2.4 2.9 2.6 0.4 0.2 0.0 5.1 0.4 0.3 1.1 0.2 0.4 1.9 4.1 0.0 0.2 173.5 0.3 3.6 2.2 2.1 5.6 21.7 1.7 1.0 1.3 2.0 0.3 1.0 7.2 2.8 0.2 0.5 1.7 4.7 2.9 1.4 2.6 0.1 2.0 0.8 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 15.8 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.3 0.4 0.3 0.0 14.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.4 0.3 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.3 10.2 0.0 0.0 7.0 0.0 35.2 3.3 5.0 0.0 0.0 0.0 0.0 0.6 165.5 2.6 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 2.7 0.0 20.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 117.5 0.0 0.0 0.3 CAPN7 PalBH ENSG00000131375 "Calpain 7" Q9Y6W3 3 15206152-15252918 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Rod photoreceptor cells: 99.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004745, HPA046617" Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA004745: , HPA046617: AB_2679721" "unprognostic (2.70e-2)" "unprognostic (2.79e-1)" "prognostic favorable (4.85e-5)" "unprognostic (1.85e-1)" "unprognostic (1.69e-2)" "unprognostic (1.41e-2)" "unprognostic (2.22e-3)" "unprognostic (2.72e-1)" "unprognostic (1.42e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (5.29e-2)" "unprognostic (1.12e-3)" "unprognostic (3.24e-2)" "unprognostic (7.84e-2)" "unprognostic (5.66e-2)" "unprognostic (1.05e-2)" 16.3 15.0 9.7 12.8 13.4 10.5 18.9 21.7 13.7 18.6 15.5 11.1 14.3 11.8 17.6 15.9 13.4 16.7 10.4 13.8 9.2 8.9 14.8 17.6 17.9 20.0 11.4 8.4 20.6 15.9 20.4 29.0 14.7 11.7 14.7 11.7 15.9 15.9 12.7 33.7 14.9 14.5 19.5 14.1 12.1 15.2 12.1 12.3 19.3 22.6 11.1 14.5 17.7 14.5 6.6 5.1 8.7 7.0 5.8 10.0 5.0 8.7 11.5 9.6 6.0 16.9 13.2 32.8 11.3 13.0 14.1 10.8 8.2 6.3 15.1 7.9 12.8 8.7 6.1 14.1 14.5 12.3 14.4 11.1 18.9 16.2 10.8 12.6 15.1 9.6 9.0 21.2 18.3 9.1 13.4 10.0 14.6 18.2 15.9 13.6 12.7 10.7 6.3 9.2 12.7 11.3 6.2 16.0 10.4 10.5 16.0 7.8 10.1 18.4 10.0 12.5 12.8 17.6 15.9 8.9 12.8 9.7 16.5 13.1 11.1 22.0 7.7 11.6 11.1 11.0 6.3 5.4 8.7 6.4 4.4 10.0 6.6 7.0 5.2 5.1 5.9 9.6 8.8 3.2 5.8 7.0 4.3 5.1 5.0 9.7 13.4 21.7 13.7 9.2 8.9 11.4 8.4 11.7 12.3 11.9 17.6 15.2 14.2 19.1 41.7 27.4 7.6 45.5 27.3 1.8 53.0 17.3 8.3 10.3 11.3 16.8 10.2 23.3 14.8 10.3 16.0 16.9 15.1 14.3 10.6 52.4 20.1 15.4 12.4 11.7 23.0 15.2 20.3 12.6 9.8 37.3 10.8 7.0 24.8 12.2 99.8 38.8 22.8 22.4 14.7 20.3 21.9 17.0 10.3 7.3 CAPNS1 "30K, CANP, CANPS, CAPN4, CDPS" ENSG00000126247 "Calpain small subunit 1" P04632 19 36139575-36150353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006872 Approved Approved Nucleoplasm,Cytosol NA NA 50000000 "Nucleoplasm, Cytosol" "HPA006872: AB_1078382" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.94e-2)" "unprognostic (1.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.03e-1)" "unprognostic (2.82e-3)" "unprognostic (1.25e-3)" "unprognostic (2.04e-2)" "unprognostic (6.40e-2)" "unprognostic (1.17e-1)" "unprognostic (5.53e-2)" "unprognostic (7.10e-3)" "unprognostic (1.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-2)" 67.8 59.4 58.7 49.6 53.1 47.1 54.4 29.9 92.0 74.8 87.8 50.8 45.3 61.3 50.1 48.8 111.9 74.9 70.6 137.2 55.7 61.0 104.0 67.5 70.7 74.0 56.6 52.0 63.0 45.1 72.3 48.6 48.1 71.5 59.8 69.6 62.8 61.4 71.8 95.7 30.9 95.6 69.2 47.4 63.6 50.4 49.2 27.8 45.4 71.4 65.9 87.3 56.7 57.9 13.4 25.7 11.3 33.2 9.6 20.3 8.1 40.6 102.1 25.6 36.5 61.8 75.7 5.2 33.3 71.2 68.0 52.8 23.1 60.5 14.6 49.4 110.9 24.2 21.7 30.6 81.6 57.8 61.6 15.0 17.0 30.8 38.9 71.8 16.8 43.0 81.0 50.9 43.9 62.5 83.0 73.8 18.0 20.5 59.0 103.3 53.5 30.1 30.6 14.7 78.2 51.8 15.9 20.7 27.1 127.6 41.0 17.3 21.8 40.1 57.0 15.8 33.7 33.2 27.7 47.7 60.4 45.9 20.1 33.4 21.1 28.0 13.1 68.5 23.1 51.6 8.8 22.5 9.3 20.3 31.4 13.0 12.9 14.3 16.2 19.8 13.4 8.8 11.8 11.3 9.6 33.2 25.7 14.0 8.1 58.7 53.1 29.9 92.0 55.7 61.0 56.6 52.0 71.5 27.8 116.1 91.8 59.6 67.7 27.2 19.1 134.0 140.1 65.6 69.4 155.3 0.0 63.2 53.0 186.3 77.2 116.2 213.8 23.3 219.3 74.8 68.1 79.4 62.3 66.0 137.4 15.9 103.5 152.2 233.3 179.9 86.3 85.5 37.1 193.8 203.5 55.8 195.6 175.4 71.5 84.9 23.3 45.3 70.7 91.6 5.5 25.2 58.6 61.8 108.1 99.3 CAPNS2 "MGC12536, MGC14804" ENSG00000256812 "Calpain small subunit 2" Q96L46 16 55566672-55567687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 56.0;skin 1: 44.1;tongue: 45.6" "Group enriched" "Detected in some" 12 "Basal keratinocytes: 78.1;Suprabasal keratinocytes: 130.6" "Group enriched" "Detected in many" 15 "cervical cancer: 19.6;head and neck cancer: 26.3;lung cancer: 10.2;melanoma: 5.8;urothelial cancer: 21.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "eosinophil: 6.9;intermediate monocyte: 2.1" "Group enriched" "Detected in many" 9 "granulocytes: 6.9;monocytes: 2.1" "Cell line enriched" "Detected in some" 10 "hTCEpi: 71.5" "Not detected" "Not detected" "HPA059749, HPA076768" Enhanced Approved Cytosol NA NA Cytosol "HPA059749: AB_2732639, HPA076768: AB_2732322" "unprognostic (3.26e-2)" "unprognostic (6.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.77e-3)" "unprognostic (4.14e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (7.21e-2)" "unprognostic (3.38e-2)" "unprognostic (3.62e-1)" "unprognostic (2.42e-2)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.69e-1)" 0.1 0.0 0.1 0.1 0.4 0.2 3.4 0.1 0.1 5.8 0.1 0.1 0.1 0.0 0.4 0.1 56.0 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.3 0.0 0.2 6.7 0.1 0.6 44.1 0.1 1.3 0.1 0.1 0.0 0.1 0.1 0.3 0.1 45.6 14.6 12.3 10.8 0.0 0.5 6.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 71.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 6.9 0.0 2.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 9.0 78.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 1.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 130.6 1.9 0.0 0.0 8.1 CAPRIN1 "caprin-1, GPIAP1, M11S1, RNG105" ENSG00000135387 "Cell cycle associated protein 1" Q14444 11 34051683-34101156 "Predicted intracellular proteins" Differentiation "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 388.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018126, HPA063617" Approved Enhanced Cytosol NA NA Cytosol "HPA018126: AB_1849929, HPA063617: AB_2685062" "unprognostic (3.79e-1)" "unprognostic (3.85e-2)" "unprognostic (3.51e-3)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (8.67e-8)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-3)" "unprognostic (2.90e-1)" "unprognostic (2.87e-2)" "unprognostic (2.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" 36.7 34.5 32.7 32.0 37.5 38.4 41.5 45.8 48.7 40.4 32.0 34.0 31.2 30.2 42.6 31.6 36.1 40.8 28.7 34.4 32.1 30.5 35.8 27.8 30.8 36.0 27.5 35.7 41.0 30.6 61.2 33.4 36.8 29.7 32.4 40.4 26.2 35.3 37.7 43.8 29.8 31.3 42.6 38.3 35.5 28.3 80.0 30.3 64.3 35.1 32.9 38.8 41.5 32.9 14.3 26.0 15.8 28.2 21.6 20.7 17.7 33.3 40.3 60.3 34.8 46.5 47.7 31.3 43.1 43.4 50.5 47.3 36.7 20.5 53.8 25.9 52.5 42.9 45.1 76.7 50.3 61.5 32.2 41.2 42.0 40.5 32.1 28.5 66.6 32.0 41.9 28.0 31.9 59.6 44.6 50.3 37.6 53.6 25.5 53.5 26.8 57.8 13.0 30.8 39.4 38.1 45.2 82.2 23.8 32.1 63.6 40.0 39.1 48.5 26.6 23.8 38.8 46.8 28.7 48.0 42.6 30.4 43.3 48.6 27.9 40.2 58.2 30.5 29.5 48.4 15.8 21.2 8.8 14.1 27.4 20.7 14.3 16.6 17.3 26.0 12.8 17.5 16.5 9.4 21.6 28.2 14.2 19.4 17.7 32.7 37.5 45.8 48.7 32.1 30.5 27.5 35.7 29.7 30.3 32.8 37.9 34.4 36.0 69.0 37.6 50.0 22.9 29.4 25.0 61.1 17.7 40.7 26.6 49.7 388.5 43.6 38.1 0.0 51.9 49.7 45.8 44.7 16.2 39.2 50.8 23.8 69.0 39.3 61.9 214.2 44.3 47.7 37.1 45.9 46.6 33.8 61.1 43.8 68.2 37.4 30.5 38.8 45.4 146.7 72.4 63.7 38.3 31.9 57.5 69.7 CAPRIN2 "C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140" ENSG00000110888 "Caprin family member 2" Q6IMN6 12 30709552-30754951 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039746 Supported Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA039746: AB_10672902" "unprognostic (7.45e-2)" "unprognostic (6.38e-2)" "unprognostic (2.83e-3)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-1)" "unprognostic (8.91e-2)" "unprognostic (9.90e-2)" "unprognostic (3.09e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.50e-5)" "unprognostic (1.91e-1)" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "prognostic favorable (8.36e-4)" 5.5 7.8 12.5 5.3 20.6 9.3 5.0 19.9 15.7 7.3 5.3 4.4 9.5 4.0 8.6 10.5 3.6 4.9 6.1 17.4 11.8 19.0 6.5 5.3 6.5 5.4 11.2 11.6 8.3 5.5 22.4 11.0 4.2 18.2 7.4 5.7 6.1 3.1 10.0 5.6 10.6 4.6 8.4 11.5 6.7 6.5 22.3 9.4 4.3 5.7 3.9 5.0 6.1 8.1 4.1 4.2 7.5 1.5 2.6 5.4 0.9 4.5 3.2 6.0 5.1 6.0 6.3 3.6 8.5 7.1 3.7 5.0 1.7 2.9 2.7 7.5 8.8 7.4 3.6 3.2 13.8 6.7 4.0 3.5 11.1 5.2 6.4 3.3 1.7 1.1 7.3 5.5 11.8 9.5 15.4 8.3 4.9 0.7 2.7 8.7 0.9 2.2 2.9 7.1 2.4 9.7 1.0 9.1 1.3 1.6 16.4 7.5 4.6 3.1 2.2 3.6 15.0 2.0 0.5 11.2 7.1 3.9 21.6 15.5 5.2 3.6 2.4 8.6 0.5 4.6 7.5 1.5 1.2 4.4 0.6 5.4 3.7 2.8 4.6 0.6 4.1 3.1 2.8 0.3 2.6 0.7 4.2 1.8 0.9 12.5 20.6 19.9 13.7 11.8 19.0 11.2 11.6 18.2 9.4 20.8 23.0 1.4 4.6 6.4 28.8 21.4 0.0 18.7 9.1 3.5 21.6 6.4 8.3 4.4 7.4 8.5 5.1 0.0 9.6 1.5 5.4 2.6 20.9 5.9 7.7 11.1 16.0 7.4 6.1 10.7 6.4 4.6 3.3 3.6 3.0 12.2 21.7 2.6 8.1 9.5 36.8 6.5 7.7 7.5 23.0 4.0 10.3 5.2 3.2 2.4 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine 19 5911707-5915877 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4;fallopian tube: 116.0" "Cell type enriched" "Detected in many" 8 "Ciliated cells: 1030.6" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Region enhanced" "Detected in all" "pons and medulla: 71.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 36.6;U-266/70: 10.1" "Low region specificity" "Detected in many" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favorable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favorable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 2.6 4.1 8.0 4.3 14.7 4.3 2.8 1.4 3.3 12.4 3.3 34.4 15.6 3.1 9.1 49.4 2.8 116.0 13.6 2.0 13.4 6.6 8.9 5.0 25.4 4.4 8.0 7.8 26.7 6.5 2.5 7.5 17.7 71.4 9.4 2.0 3.3 7.7 12.7 2.0 5.7 5.0 2.9 7.5 7.6 9.4 2.1 17.9 0.4 7.8 0.9 2.5 8.8 11.3 4.9 4.0 5.2 2.2 5.3 4.8 2.4 1.1 1.1 0.7 3.5 1.3 1.8 2.2 0.6 0.4 0.2 0.3 0.8 7.5 0.8 2.2 0.9 0.5 1.4 0.3 0.3 0.1 2.4 1.0 0.6 2.2 2.0 1.2 0.6 1.8 2.3 2.1 0.2 0.5 2.5 0.5 2.6 0.5 2.9 0.4 2.1 1.4 2.0 0.6 8.8 5.7 1.7 0.3 2.3 1.0 3.2 0.7 2.6 0.5 36.6 3.7 2.0 2.3 2.3 1.0 0.6 0.4 2.7 9.7 10.1 3.4 0.7 4.3 1.0 1.4 3.3 2.2 1.6 4.8 1.8 2.6 3.1 3.0 3.6 2.1 4.9 2.4 2.0 5.2 5.3 1.6 4.0 3.2 2.4 8.0 14.7 1.4 3.3 13.4 6.6 8.0 7.8 71.4 17.9 11.9 16.8 0.8 29.9 4.2 2.2 1.9 0.0 1030.6 124.0 115.1 3.9 21.6 29.9 26.7 4.7 3.8 3.9 0.0 5.2 16.2 21.6 27.6 5.8 0.0 4.6 6.4 18.4 0.0 0.0 4.0 4.4 4.4 10.1 1.8 19.7 7.2 24.2 2.9 4.6 3.6 3.9 6.5 4.2 0.5 0.4 3.6 17.2 0.0 7.4 100.9 CAPZA2 "CAPPA2, CAPZ" ENSG00000198898 "Capping actin protein of muscle Z-line alpha subunit 2" P47755 7 116811070-116922049 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007470, HPA007643" Uncertain Approved "Endoplasmic reticulum,Cytosol" No No 19000000 "Endoplasmic reticulum" Cytosol "HPA007470: AB_1845985, HPA007643: AB_2667886" "unprognostic (1.37e-2)" "unprognostic (2.25e-3)" "unprognostic (4.16e-2)" "unprognostic (3.16e-1)" "unprognostic (1.53e-1)" "unprognostic (2.63e-3)" "prognostic unfavorable (9.34e-5)" "unprognostic (1.90e-2)" "unprognostic (1.80e-2)" "unprognostic (2.15e-1)" "unprognostic (2.08e-3)" "unprognostic (2.52e-1)" "prognostic favorable (3.65e-6)" "unprognostic (1.40e-1)" "unprognostic (1.08e-1)" "unprognostic (2.91e-3)" "unprognostic (6.58e-2)" 32.4 17.7 23.6 15.8 22.6 33.6 18.5 17.6 30.2 17.7 26.3 10.7 13.5 16.9 20.6 16.4 25.9 14.9 17.6 36.4 26.7 20.6 40.9 29.2 23.2 16.6 22.1 15.9 17.3 13.8 12.9 16.4 26.1 27.1 21.8 20.6 11.8 14.4 18.3 47.1 11.6 30.6 30.3 19.6 26.0 17.8 12.4 13.7 17.7 24.5 21.0 14.0 31.5 15.0 6.6 14.8 32.0 22.8 7.1 7.8 17.7 13.1 8.9 8.7 11.3 16.6 17.6 4.8 13.1 18.4 13.1 15.0 6.5 16.9 9.0 21.4 18.4 16.8 8.2 8.9 10.7 20.4 9.7 7.1 13.5 8.9 10.8 10.2 8.9 18.2 14.1 12.0 10.7 10.1 15.9 27.6 5.7 8.9 15.6 25.7 6.4 11.6 15.1 12.8 13.5 7.8 8.3 11.7 17.7 30.5 11.2 9.2 10.5 12.1 45.7 12.4 11.5 6.4 10.4 10.2 21.1 6.7 16.6 12.2 12.3 9.0 17.1 12.5 12.7 14.9 19.9 16.4 19.2 5.5 20.1 6.1 6.6 6.5 5.7 14.8 6.0 6.4 6.5 32.0 7.1 22.8 8.2 7.8 17.7 23.6 22.6 17.6 30.2 26.7 20.6 22.1 15.9 27.1 13.7 68.5 67.4 96.3 183.9 215.9 99.6 196.7 68.8 42.8 60.3 162.3 25.5 129.4 437.7 161.9 6.6 193.4 141.9 93.5 141.3 163.7 177.2 113.8 124.6 101.1 274.2 101.7 116.2 221.6 215.0 12.9 69.0 242.4 172.1 184.0 86.3 127.8 150.8 154.3 104.3 362.3 90.2 90.5 201.3 35.1 43.4 191.2 120.5 90.6 83.0 173.2 CAPZB ENSG00000077549 "Capping actin protein of muscle Z-line beta subunit" P47756 1 19338776-19485539 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Late spermatids: 2817.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031531 Approved Approved Nucleoplasm,Vesicles,Cytosol No No 35000000 "Nucleoplasm, Cytosol" Vesicles "HPA031531: AB_10603556" "unprognostic (7.52e-2)" "unprognostic (2.13e-1)" "unprognostic (5.25e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.85e-4)" "unprognostic (4.55e-2)" "unprognostic (7.70e-2)" "unprognostic (3.08e-1)" "unprognostic (4.15e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.57e-4)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (4.00e-1)" "unprognostic (3.78e-1)" 29.6 24.8 57.1 38.4 47.3 27.9 28.1 23.0 39.7 34.8 84.1 34.3 19.3 29.2 40.3 28.2 41.8 29.2 29.3 80.3 53.8 40.7 29.3 37.5 29.7 50.4 53.5 33.6 38.6 24.9 23.7 18.1 36.9 29.5 42.2 43.5 30.4 23.7 35.9 160.5 27.0 43.7 49.5 72.0 42.1 32.6 70.5 22.3 51.2 34.2 35.3 54.3 56.9 32.3 39.8 55.6 155.9 96.3 27.1 57.2 78.0 48.6 29.0 52.2 37.5 71.6 92.3 36.7 82.9 86.5 73.5 75.7 36.1 68.7 33.6 36.2 103.6 44.9 41.4 44.8 57.2 82.8 52.9 31.8 65.9 38.9 56.3 73.5 43.6 108.9 85.1 47.7 62.9 59.6 63.2 66.9 39.9 23.4 48.1 73.4 34.6 48.3 50.8 39.2 64.8 31.4 43.7 36.7 44.2 92.7 28.1 31.8 24.5 48.7 40.8 54.8 49.6 44.8 38.2 68.9 49.5 40.7 81.1 39.4 29.8 35.7 42.4 65.0 57.5 53.4 53.8 54.4 155.9 49.1 79.4 41.8 39.8 51.1 52.3 55.6 29.1 43.1 46.1 87.8 27.1 96.3 30.2 57.2 78.0 57.1 47.3 23.0 39.7 53.8 40.7 53.5 33.6 29.5 22.3 92.3 61.8 162.3 259.9 138.7 89.2 77.5 127.4 100.4 63.7 96.0 39.3 284.3 252.0 312.1 989.2 166.8 227.5 23.3 225.6 329.7 194.7 191.6 142.2 80.4 668.4 73.1 135.5 131.3 269.2 2817.9 215.4 313.1 136.7 740.4 212.2 119.4 260.5 192.9 284.2 184.2 70.1 239.3 175.9 100.8 73.9 159.6 286.2 286.6 157.4 234.8 CARD10 "BIMP1, CARMA3" ENSG00000100065 "Caspase recruitment domain family member 10" Q9BWT7 22 37490362-37519542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.6" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 21.7;Enterocytes: 29.9;Pancreatic endocrine cells: 26.6;Paneth cells: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.1;U-2197: 36.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029359, HPA055612" Approved Approved "Vesicles,Intermediate filaments,Cytosol" No No "Vesicles, Intermediate filaments" Cytosol "HPA029359: AB_10601354, HPA055612: AB_2682861" "unprognostic (9.12e-3)" "unprognostic (2.28e-1)" "unprognostic (7.51e-2)" "prognostic favorable (3.47e-4)" "unprognostic (4.54e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (7.73e-6)" "unprognostic (3.66e-2)" "unprognostic (7.70e-2)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "unprognostic (3.68e-2)" "unprognostic (2.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.34e-1)" "unprognostic (4.31e-2)" "unprognostic (9.69e-2)" 8.1 6.8 3.5 4.5 2.3 0.0 10.2 1.5 2.7 5.7 16.4 2.4 4.1 23.7 9.8 6.4 6.8 5.9 14.1 7.6 1.7 1.1 14.0 10.5 7.0 2.4 1.6 1.3 6.8 8.9 1.6 1.7 4.9 3.8 5.6 6.2 5.6 12.6 3.2 8.0 7.3 33.6 4.1 1.3 3.3 7.0 11.1 1.3 0.7 5.6 13.5 3.9 4.9 9.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 13.1 9.6 1.8 1.3 0.0 3.9 8.7 1.2 2.8 5.6 4.4 6.0 9.4 0.0 4.7 2.3 5.4 18.5 2.1 24.1 1.7 0.0 5.2 0.3 6.1 9.2 2.4 0.2 0.8 1.3 5.0 10.7 13.8 4.5 11.3 0.0 1.3 0.0 4.2 4.5 0.0 0.8 3.1 7.1 5.8 0.0 17.2 1.3 8.3 2.3 0.6 1.0 9.2 4.1 0.9 2.2 4.4 0.7 14.9 4.2 12.3 36.1 6.9 0.0 0.0 0.0 13.4 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 3.5 2.3 1.5 2.7 1.7 1.1 1.6 1.3 3.8 1.3 0.0 1.3 0.0 3.4 7.6 0.2 3.1 10.2 0.0 1.2 3.5 0.0 0.1 1.7 21.7 7.8 14.7 29.9 0.0 17.3 1.5 1.1 3.6 0.0 3.9 0.1 0.0 7.5 12.3 0.0 4.3 0.0 0.4 5.0 0.0 17.6 0.0 26.6 21.0 0.7 10.5 0.1 0.0 1.2 0.5 3.4 3.3 0.0 0.0 8.1 7.1 CARD14 "BIMP2, CARMA2, PSORS2" ENSG00000141527 "Caspase recruitment domain family member 14" Q9BXL6 17 80169992-80209331 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.1;skin 1: 17.3;tongue: 12.3" "Cell type enhanced" "Detected in some" 5 "Ciliated cells: 4.0;Glandular cells: 4.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 7.3;SK-BR-3: 10.0;T-47d: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA023388 Supported Aggresome,Cytosol NA NA Cytosol Aggresome "HPA023388: AB_1846020" "unprognostic (9.79e-3)" "unprognostic (3.86e-2)" "unprognostic (4.26e-1)" "unprognostic (1.05e-5)" "unprognostic (2.65e-2)" "unprognostic (1.37e-2)" "unprognostic (2.92e-4)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (2.63e-1)" "unprognostic (3.01e-1)" "unprognostic (5.48e-2)" "unprognostic (1.62e-8)" "unprognostic (2.52e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-1)" 0.4 1.9 0.4 0.9 0.4 0.1 3.2 0.4 0.7 4.0 0.4 0.4 0.4 2.1 0.8 1.0 12.1 0.3 0.6 0.4 0.4 0.3 0.7 1.1 0.7 1.0 0.4 0.4 1.0 0.4 0.0 0.4 3.0 0.6 2.1 0.0 0.4 6.2 3.6 0.6 17.3 1.6 0.4 1.5 1.8 0.5 0.8 0.4 0.4 0.4 12.3 10.7 1.3 5.8 2.0 0.0 0.0 0.5 0.0 0.4 0.1 3.9 0.6 0.6 0.2 0.0 0.0 3.9 0.2 0.0 0.0 0.0 1.6 0.1 0.0 0.4 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.8 0.0 2.0 0.2 0.0 0.3 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.3 1.3 0.0 7.3 0.0 0.0 0.1 2.6 0.5 0.0 1.6 0.4 0.0 3.1 0.5 0.1 0.0 10.0 1.6 0.6 22.0 0.0 0.2 0.1 0.5 0.4 0.0 2.1 0.2 0.1 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.3 2.0 0.2 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.4 0.4 0.4 0.7 0.4 0.3 0.4 0.4 0.6 0.4 0.0 1.4 0.0 3.4 1.5 0.8 0.8 2.5 4.0 1.2 0.0 0.0 0.2 0.0 0.6 0.6 0.5 0.0 0.0 2.0 0.3 0.5 4.0 0.0 0.0 0.7 0.0 0.0 0.6 3.2 0.0 0.3 0.7 1.7 0.0 0.0 2.2 1.3 0.0 0.4 0.0 0.9 0.0 0.0 0.7 0.4 2.6 1.3 0.0 0.1 3.3 CARF "ALS2CR8, CaRF, FLJ21579, NYD-SP24" ENSG00000138380 "Calcium responsive transcription factor" Q8N187 2 202912214-202987063 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 42.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034557, HPA043191" Approved Approved "Nucleoli fibrillar center,Vesicles,Cytosol" NA NA Vesicles "Nucleoli fibrillar center, Cytosol" "HPA034557: AB_10601663, HPA043191: AB_2732503" "unprognostic (4.63e-2)" "unprognostic (3.11e-1)" "unprognostic (1.30e-1)" "unprognostic (1.93e-2)" "unprognostic (6.09e-2)" "unprognostic (8.65e-3)" "unprognostic (1.12e-1)" "unprognostic (2.13e-3)" "unprognostic (4.39e-2)" "unprognostic (1.10e-1)" "unprognostic (7.58e-3)" "unprognostic (1.08e-1)" "unprognostic (6.12e-2)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.55e-2)" 8.3 8.7 9.8 7.9 15.0 7.1 11.5 10.7 18.2 9.4 8.8 18.3 9.3 6.7 15.4 15.4 8.2 11.1 8.8 7.4 12.1 8.7 10.5 6.5 7.6 11.8 18.4 14.5 13.9 8.1 12.0 18.8 7.4 19.1 10.3 9.0 10.7 8.9 11.1 7.9 11.4 9.4 10.2 15.8 10.5 8.8 27.3 16.3 16.4 15.4 3.8 11.1 12.8 9.7 4.1 2.4 1.7 2.6 11.9 6.0 1.0 2.4 2.3 6.2 5.4 4.5 8.9 4.7 3.8 4.4 3.9 3.5 3.2 6.1 3.7 1.6 4.4 4.3 4.4 3.1 2.5 4.2 2.8 1.8 6.6 2.9 1.6 3.9 3.3 3.0 8.2 5.4 3.3 8.5 9.5 2.3 13.6 2.6 15.4 5.9 4.8 6.9 5.5 2.6 1.6 3.4 4.7 4.3 3.0 6.8 2.6 4.4 4.8 4.1 2.3 1.8 8.1 3.4 6.6 2.8 7.2 1.9 4.6 2.4 13.8 7.7 4.1 6.1 3.9 4.4 1.7 1.4 1.1 3.2 2.6 3.6 2.9 3.3 2.9 1.5 4.1 4.7 3.2 0.6 11.9 1.6 2.4 6.0 1.0 9.8 15.0 10.7 18.2 12.1 8.7 18.4 14.5 19.1 16.3 8.9 20.7 4.4 2.8 2.9 33.1 6.1 10.2 20.1 19.4 14.0 17.7 3.4 10.0 3.1 13.4 3.3 4.2 0.0 2.1 7.3 4.2 1.7 19.7 3.0 3.2 25.4 1.7 7.4 7.0 9.8 10.0 5.3 1.7 1.8 4.2 8.4 2.7 3.5 8.9 3.9 30.4 6.5 3.4 42.4 7.7 2.4 1.5 7.9 5.2 1.8 CARMIL1 "CARMIL, dJ501N12.1, FLJ20048, LRRC16, LRRC16A" ENSG00000079691 "Capping protein regulator and myosin 1 linker 1" Q5VZK9 6 25279078-25620530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 20.9;Collecting duct cells: 33.2;Distal tubular cells: 39.7;Proximal tubular cells: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 20.9;RPTEC TERT1: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029038, HPA029039" Enhanced Supported Cytosol NA NA Cytosol "HPA029038: AB_10601668, HPA029039: AB_10611382" "unprognostic (2.34e-2)" "unprognostic (9.45e-2)" "unprognostic (2.07e-2)" "unprognostic (4.71e-2)" "unprognostic (3.94e-2)" "unprognostic (2.22e-1)" "unprognostic (1.66e-3)" "unprognostic (3.82e-1)" "unprognostic (4.02e-1)" "unprognostic (7.15e-3)" "unprognostic (8.25e-3)" "unprognostic (5.86e-2)" "unprognostic (1.28e-3)" "unprognostic (3.08e-2)" "unprognostic (2.53e-1)" "unprognostic (1.07e-1)" "unprognostic (2.31e-1)" 8.1 7.2 10.1 7.1 12.3 1.2 9.3 20.0 10.3 8.2 15.3 4.5 8.0 20.8 5.2 10.7 7.7 8.2 11.7 7.5 9.0 5.5 12.8 3.3 11.3 13.7 5.8 8.3 8.3 6.4 9.8 7.0 6.6 6.5 5.2 14.2 7.1 10.0 10.7 1.4 8.3 30.5 7.9 6.2 4.3 10.3 20.8 3.5 6.7 7.7 4.8 7.6 8.7 9.6 4.1 2.6 0.0 3.1 1.5 3.0 0.5 7.5 7.6 2.1 2.7 2.0 1.0 7.4 2.6 5.8 2.8 4.9 8.2 5.7 2.6 8.5 4.1 8.2 8.3 8.2 7.3 2.0 6.5 4.3 6.3 8.9 1.0 5.6 0.2 1.0 1.1 5.0 5.3 8.2 3.4 0.1 1.0 0.2 2.1 1.7 5.9 0.4 0.0 2.9 13.4 3.2 0.9 1.3 20.9 21.6 6.9 5.5 1.2 11.5 19.8 7.5 6.5 4.8 0.2 0.1 2.1 3.6 9.7 2.6 0.3 0.1 4.2 3.2 2.3 7.6 0.0 1.1 0.0 0.0 1.3 0.2 0.7 0.4 0.2 1.1 4.1 3.0 0.5 0.0 1.5 3.1 2.6 0.0 0.5 10.1 12.3 20.0 10.3 9.0 5.5 5.8 8.3 6.5 3.5 17.9 20.9 0.0 0.0 0.0 0.0 0.0 0.0 6.7 7.9 33.2 0.0 16.5 39.7 13.8 0.0 0.0 0.0 0.0 13.6 6.5 0.0 0.0 8.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 6.4 0.0 0.0 13.5 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 CARS CARS1 ENSG00000110619 "Cysteinyl-tRNA synthetase" P49589 11 3000922-3057613 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 92.3;Early spermatids: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737" Enhanced Enhanced Cytosol NA NA 110000 Cytosol "CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033" "unprognostic (9.10e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-3)" "unprognostic (1.43e-1)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (8.00e-2)" "unprognostic (5.51e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (1.48e-1)" "unprognostic (3.46e-1)" 24.9 15.9 15.8 15.8 17.7 9.0 15.9 9.5 29.1 13.4 16.3 19.1 11.1 15.9 14.0 10.7 16.0 10.8 14.2 12.5 15.3 18.7 10.7 22.1 15.1 17.2 23.3 15.9 14.5 42.5 14.9 15.9 14.0 23.0 10.8 17.6 7.4 20.3 14.8 24.6 18.8 17.8 21.0 16.1 14.8 22.8 13.4 17.3 9.8 23.0 14.5 22.7 14.4 19.4 8.3 13.3 18.0 23.9 16.4 18.1 11.6 7.4 3.8 4.9 14.8 19.3 17.8 4.4 19.1 21.8 13.2 23.9 9.3 17.9 11.6 5.6 24.1 0.0 19.2 16.2 21.7 18.2 33.8 3.7 6.5 6.5 7.1 46.3 13.5 14.4 29.3 17.1 11.4 12.7 0.0 17.4 28.8 10.9 41.0 13.0 11.3 9.5 0.0 18.5 26.5 6.8 4.6 8.2 14.5 0.0 12.5 10.6 14.1 4.7 13.4 20.9 3.8 0.0 0.0 6.0 5.4 5.1 13.5 0.2 30.5 27.8 7.4 0.0 7.1 10.7 7.7 12.0 8.8 15.2 10.5 13.0 8.3 13.6 13.6 13.3 6.0 7.5 12.1 18.0 16.4 23.9 5.2 18.1 11.6 15.8 17.7 9.5 29.1 15.3 18.7 23.3 15.9 23.0 17.3 17.9 31.5 21.7 25.4 12.8 11.7 6.7 2.5 92.3 27.3 10.4 5.9 18.8 8.3 35.4 93.7 13.7 18.6 0.0 34.2 34.8 12.6 16.1 20.7 16.8 18.9 14.3 18.3 13.5 15.1 39.9 11.5 14.7 8.5 14.4 16.9 10.8 37.5 21.0 18.0 13.4 10.0 6.5 14.1 39.5 24.2 10.5 27.0 24.2 14.3 35.5 CASK "CAGH39, FGS4, LIN2, TNRC8" ENSG00000147044 "Calcium/calmodulin dependent serine protein kinase" O14936 X 41514934-41923645 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.3" "Lineage enriched" "Detected in many" 11 "granulocytes: 26.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001949, HPA023857" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB001949: , HPA023857: AB_1846035" "unprognostic (6.30e-2)" "unprognostic (3.78e-2)" "unprognostic (1.48e-1)" "unprognostic (2.48e-3)" "unprognostic (1.56e-1)" "unprognostic (1.29e-1)" "unprognostic (1.42e-3)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (6.11e-5)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.72e-2)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "unprognostic (2.85e-2)" 9.1 15.9 13.9 18.8 12.7 9.8 13.2 14.2 15.7 11.1 22.1 20.0 7.1 27.1 12.2 13.7 17.2 9.9 16.0 7.0 12.1 12.8 14.6 10.8 10.3 13.6 16.3 8.5 13.9 14.2 11.1 9.8 13.4 11.9 10.7 23.8 10.4 15.9 7.7 5.8 12.8 32.9 12.1 10.1 9.6 16.2 2.9 14.3 30.9 9.3 8.1 14.0 11.8 13.1 0.6 0.3 26.3 0.8 2.4 2.3 0.3 10.9 14.0 13.4 8.0 9.1 7.4 4.3 9.6 8.0 5.6 5.2 30.1 17.9 0.1 4.9 11.9 10.2 22.0 14.7 9.8 9.4 9.7 8.2 0.0 12.6 10.6 9.4 1.7 1.5 8.4 26.9 10.7 13.7 11.3 4.6 6.4 0.8 8.5 12.2 12.8 3.1 0.7 12.3 15.8 9.1 5.1 33.0 5.2 12.7 23.8 12.3 6.5 18.0 7.2 5.5 22.6 7.7 0.3 5.3 10.5 10.7 9.0 5.3 3.3 2.1 3.7 10.3 1.2 6.7 26.3 0.8 4.8 0.5 0.7 0.5 0.4 0.6 0.8 0.2 0.6 0.7 0.7 1.1 2.4 0.4 0.3 2.3 0.3 13.9 12.7 14.2 14.2 12.1 12.8 16.3 8.5 11.9 14.3 11.9 14.8 0.9 33.3 29.0 40.5 6.5 10.2 20.1 14.8 7.0 21.6 1.6 43.1 13.2 0.8 10.8 22.7 0.0 12.7 0.7 17.5 19.6 0.0 13.0 16.2 47.7 13.3 4.9 3.5 0.2 9.2 6.8 10.1 0.0 30.6 11.9 17.9 28.1 8.9 17.0 26.0 19.4 14.4 1.6 1.9 28.4 1.4 12.5 36.5 26.9 CASKIN1 "ANKS5A, KIAA1306" ENSG00000167971 "CASK interacting protein 1" Q8WXD9 16 2177180-2196525 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 30.4" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 19.0;Cone photoreceptor cells: 7.9;Horizontal cells: 39.7;Muller glia cells: 18.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;HDLM-2: 17.0;HEK 293: 3.8;SCLC-21H: 7.8;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055990, HPA076882, CAB079050" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB079050: , HPA055990: AB_2682997, HPA076882: " "unprognostic (4.91e-2)" "unprognostic (2.48e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (8.02e-2)" "unprognostic (6.58e-2)" "unprognostic (4.59e-1)" "unprognostic (2.21e-4)" "unprognostic (2.67e-2)" "unprognostic (2.62e-1)" "unprognostic (9.70e-3)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.39e-1)" 1.1 1.8 17.7 1.2 18.1 1.1 1.4 15.0 30.4 1.5 1.2 2.3 0.0 1.2 1.5 1.3 1.2 1.4 1.2 2.5 16.4 12.8 1.3 1.1 1.1 1.1 12.4 11.7 1.2 1.5 1.9 1.4 1.2 11.1 1.8 1.2 1.8 2.5 1.4 1.3 2.2 1.3 1.2 2.8 1.1 1.3 1.8 4.0 0.0 1.6 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 4.6 0.0 0.0 2.2 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.9 0.0 0.0 0.0 1.2 0.3 0.0 17.0 3.8 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.1 0.1 0.0 1.3 0.0 1.0 0.8 0.0 0.0 0.9 0.0 0.4 0.2 0.0 7.8 3.8 0.1 0.2 0.2 0.2 1.0 0.5 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 18.1 15.0 21.7 16.4 12.8 12.4 11.7 11.1 4.0 0.0 0.0 0.0 0.2 0.3 19.0 2.3 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 39.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.6 0.2 0.0 0.0 0.0 5.1 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 0.0 CASP1 "ICE, IL1BC" ENSG00000137752 "Caspase 1" P29466 11 105025443-105035250 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.2;lymphoid tissue: 40.7" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 83.5;Kupffer cells: 119.3;Macrophages: 125.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 38.4;HBEC3-KT: 18.2;HHSteC: 20.6;U-937: 45.4" "Region enhanced" "Detected in many" "olfactory region: 22.8" "Low region specificity" "Detected in all" "CAB002685, HPA003056" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB002685: , HPA003056: AB_1846037" "unprognostic (1.21e-3)" "unprognostic (3.02e-1)" "unprognostic (9.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (5.24e-2)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (6.67e-2)" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (9.03e-2)" "unprognostic (2.30e-2)" "unprognostic (3.18e-1)" "unprognostic (5.19e-2)" 7.4 3.9 6.6 15.1 17.0 8.2 6.9 3.5 7.0 4.1 12.8 2.2 2.9 34.0 3.0 4.2 10.6 4.3 7.3 4.9 9.3 3.0 6.4 5.8 20.5 16.2 16.7 2.6 4.4 3.4 0.2 3.7 8.7 13.3 6.1 13.9 3.7 7.0 3.2 1.6 9.9 37.2 5.2 17.4 40.7 5.6 1.5 11.0 4.1 3.7 5.6 9.0 9.7 13.2 7.3 39.6 40.5 64.2 11.1 34.3 31.2 0.4 0.1 0.0 1.8 2.0 4.3 0.3 1.9 38.4 4.8 13.5 0.0 0.2 6.2 0.8 2.2 8.9 2.7 0.0 18.2 1.1 4.0 0.0 0.3 0.2 0.4 20.6 7.2 0.0 7.3 12.9 3.9 10.6 12.6 2.1 0.1 0.0 0.0 1.1 0.0 0.2 10.1 0.0 0.0 0.1 6.0 0.1 4.9 0.1 3.0 0.1 0.1 5.7 0.4 8.4 0.0 0.4 16.7 2.4 4.4 0.2 0.4 0.5 0.0 1.7 0.0 2.8 45.4 0.9 12.3 42.8 23.2 25.4 64.2 34.3 7.3 18.1 22.0 39.6 6.0 9.9 16.4 40.5 11.1 64.0 1.4 22.2 31.2 6.6 17.0 3.5 7.0 9.3 3.0 16.7 2.6 13.3 11.0 17.9 35.4 32.0 33.0 23.1 0.0 2.6 12.7 12.0 11.4 10.4 0.0 1.3 1.7 15.7 0.0 24.1 33.9 0.0 11.7 1.0 13.1 5.7 15.1 1.7 83.5 0.0 5.8 17.8 119.3 0.2 3.1 125.6 5.0 34.3 32.1 0.0 4.7 49.2 3.2 1.0 0.1 0.0 5.4 0.0 0.0 19.4 0.9 48.4 29.9 41.4 CASP14 "MGC119078, MGC119079, MICE" ENSG00000105141 "Caspase 14" P31944 19 15049384-15058293 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Hydrolase, Protease, Thiol protease" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 109.4" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 83.9" "Cancer enhanced" "Detected in many" "cervical cancer: 62.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "hTCEpi: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010059, HPA027062" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA 2200000 "Nucleoplasm, Cytosol" Mitochondria "CAB010059: AB_626800, HPA027062: AB_2672101" "unprognostic (1.17e-2)" "unprognostic (6.44e-3)" "unprognostic (6.22e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (9.42e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (2.68e-1)" "unprognostic (4.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.97e-1)" 0.2 0.2 0.2 0.0 0.3 0.0 1.9 0.2 0.3 17.9 0.2 0.0 0.8 0.0 1.1 0.3 1.2 0.1 0.0 0.2 0.3 0.2 0.4 0.3 0.2 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.5 0.0 7.7 0.0 0.0 0.8 2.7 0.3 109.4 0.2 0.0 0.2 0.1 0.2 1.6 0.0 2.3 0.2 0.9 0.0 0.6 4.0 0.8 0.5 2.3 0.6 0.1 0.6 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.6 0.4 0.4 0.2 0.4 0.3 0.6 0.4 0.1 0.8 0.5 0.4 2.3 0.1 0.2 0.5 0.6 0.0 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 16.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 83.9 0.6 0.0 0.0 0.1 CASP4 "ICE(rel)II, ICH-2, TX" ENSG00000196954 "Caspase 4" P49662 11 104942866-104969436 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 82.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA027588, CAB037167" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "CAB037167: AB_258864, HPA027588: AB_10603781" "unprognostic (1.19e-2)" "unprognostic (3.73e-1)" "unprognostic (3.44e-1)" "unprognostic (1.99e-2)" "unprognostic (7.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.26e-2)" "unprognostic (1.56e-2)" "unprognostic (5.31e-2)" "unprognostic (2.71e-1)" "unprognostic (2.38e-3)" "unprognostic (8.39e-3)" "prognostic unfavorable (3.27e-11)" "unprognostic (6.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-2)" "unprognostic (4.08e-3)" 10.6 6.3 0.5 9.7 0.5 6.1 9.4 0.0 0.0 4.7 3.5 8.9 3.5 5.9 14.1 5.8 7.3 4.9 0.5 0.5 6.7 16.5 14.0 10.5 1.0 7.5 16.8 0.0 3.0 10.7 5.8 4.0 11.2 1.9 1.6 10.4 8.8 4.3 2.0 19.0 8.2 0.2 4.2 11.3 8.2 8.0 20.5 29.3 82.8 43.2 29.6 35.7 46.8 6.4 2.1 0.0 2.8 13.7 31.4 5.3 11.0 21.6 17.8 25.0 5.3 29.1 3.3 23.8 14.3 21.5 10.7 0.0 19.1 17.0 3.8 0.1 8.6 1.6 13.9 33.8 8.7 4.2 28.5 28.6 21.2 29.7 21.3 30.9 0.1 0.2 0.0 13.5 0.6 5.0 10.2 0.0 14.4 6.3 3.8 4.1 2.9 14.9 10.2 0.1 0.0 10.2 7.2 10.1 0.2 2.9 12.7 16.0 18.8 6.5 16.5 7.7 0.0 0.0 0.0 9.6 19.8 13.1 14.9 39.1 7.0 31.5 43.2 34.6 20.5 24.2 30.1 29.3 20.0 14.8 22.0 82.8 29.6 33.5 4.9 35.7 46.8 56.6 57.5 87.2 53.6 49.6 0.0 3.6 40.8 72.3 54.6 21.0 0.0 113.8 13.3 118.8 0.5 68.8 12.0 0.0 164.0 65.7 45.5 29.4 33.5 26.8 101.8 0.0 20.1 65.1 148.5 1.3 27.0 95.5 28.7 63.1 28.2 1.9 153.2 9.9 19.4 30.9 0.1 6.5 22.7 0.2 0.6 40.1 96.9 117.6 17.5 68.0 CASP6 MCH2 ENSG00000138794 "Caspase 6" P55212 4 109688622-109703583 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 42.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003775, HPA011337, HPA024303" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052" "unprognostic (1.07e-1)" "unprognostic (1.91e-1)" "prognostic favorable (2.64e-5)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-3)" "unprognostic (9.87e-2)" "unprognostic (2.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.15e-2)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (8.74e-3)" "unprognostic (2.18e-1)" "unprognostic (2.41e-1)" "prognostic favorable (9.93e-4)" 8.1 6.1 3.6 6.7 4.3 5.3 14.3 2.8 3.8 6.9 25.5 2.8 4.5 23.4 5.9 4.3 8.7 5.3 11.7 4.9 4.0 2.0 11.0 14.3 5.6 8.5 5.0 1.6 7.0 13.0 2.3 6.4 4.3 4.5 8.1 19.5 3.4 8.0 10.3 3.4 6.5 42.8 14.0 6.6 9.1 9.2 2.7 4.3 14.5 11.2 3.3 8.4 8.2 12.7 4.4 8.0 8.5 7.0 5.6 21.3 8.0 12.6 4.1 8.5 7.7 6.2 6.1 12.6 7.1 4.9 6.4 6.9 6.8 26.1 1.3 8.3 7.3 8.9 5.9 10.1 11.2 5.1 20.1 6.6 11.1 3.7 6.0 5.0 11.1 7.9 6.7 8.4 6.1 1.5 8.6 12.1 15.1 14.4 39.6 10.3 7.1 28.7 7.0 6.5 8.7 7.5 10.0 5.4 6.9 21.0 12.0 9.0 6.7 7.5 13.6 4.2 10.7 5.8 4.1 10.2 7.1 7.5 3.4 8.0 5.8 10.5 1.4 9.2 13.4 3.6 8.5 5.3 6.3 4.9 4.8 5.3 4.1 17.8 9.3 6.0 4.4 21.3 11.8 1.1 5.6 7.0 8.0 16.4 8.0 3.6 4.3 2.8 3.8 4.0 2.0 5.0 1.6 4.5 4.3 14.9 13.4 8.5 9.5 9.6 5.2 3.3 30.6 25.4 20.5 19.2 5.9 16.7 8.3 35.9 2.0 9.2 52.0 0.0 40.5 34.0 12.1 6.6 9.3 17.8 17.1 0.0 56.7 6.2 8.6 1.6 11.8 8.5 1.7 25.2 48.2 12.8 42.5 56.1 9.2 26.3 1.3 6.5 6.9 1.7 8.3 10.2 4.8 12.8 64.3 7.8 CASP8 "Casp-8, FLICE, MACH, MCH5" ENSG00000064012 "Caspase 8" Q14790 2 201233443-201287711 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 52.5" "Cell type enhanced" "Detected in many" 5 "T-cells: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001302, CAB002047, HPA005688, HPA006191" Approved Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535" "unprognostic (5.21e-3)" "unprognostic (2.10e-1)" "unprognostic (1.83e-2)" "unprognostic (9.69e-3)" "unprognostic (2.09e-1)" "unprognostic (5.60e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.10e-1)" "unprognostic (4.79e-2)" "prognostic favorable (1.25e-4)" "unprognostic (7.75e-2)" "unprognostic (5.11e-2)" "prognostic unfavorable (1.27e-6)" "unprognostic (7.67e-3)" "unprognostic (2.43e-1)" "unprognostic (2.53e-1)" "unprognostic (4.53e-3)" 14.1 10.6 2.0 31.6 2.6 27.1 10.2 1.4 1.8 7.9 18.5 3.9 7.0 9.6 9.6 12.0 11.7 9.1 12.1 4.4 2.1 2.3 16.4 14.8 17.1 28.3 3.9 1.1 8.2 7.6 1.8 5.9 12.3 3.2 9.8 8.7 4.4 9.6 8.4 2.7 7.4 34.7 5.1 5.0 37.7 7.4 3.8 2.7 43.7 6.7 10.7 43.4 9.6 7.3 13.8 13.7 52.5 17.0 22.2 26.4 12.0 14.5 12.4 3.6 10.1 10.1 14.8 5.6 6.4 6.3 7.6 12.6 16.6 25.4 1.6 14.1 4.9 13.7 7.4 7.9 7.6 15.1 9.4 7.2 14.2 10.1 15.8 8.2 11.0 15.4 12.8 18.8 14.4 11.3 6.4 7.2 12.3 12.7 31.6 6.9 6.0 14.3 11.6 5.9 8.0 11.1 10.8 7.5 25.9 14.3 16.2 1.1 0.5 8.3 13.8 8.2 3.5 3.6 8.6 9.0 8.2 8.6 4.3 5.0 28.7 12.8 9.9 12.3 14.8 7.7 20.7 13.0 24.9 25.0 17.0 23.1 13.8 20.5 26.4 13.7 7.8 13.3 16.9 52.5 22.2 15.6 6.1 24.0 12.0 2.0 2.6 1.4 1.8 2.1 2.3 3.9 1.1 3.2 2.7 23.8 26.1 34.1 10.1 6.6 1.5 1.6 7.6 16.0 18.2 5.2 9.8 7.5 13.3 9.0 5.6 7.1 19.8 0.0 7.3 10.3 3.8 8.1 23.2 10.4 11.2 0.0 4.1 5.5 25.6 0.7 2.3 21.7 6.8 19.8 13.0 0.1 9.6 12.7 0.7 20.0 0.4 0.0 1.4 0.7 0.4 6.8 2.9 55.4 12.1 12.7 CAST ENSG00000153113 Calpastatin P20810 5 96525267-96779595 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 201.9" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 948.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009491, HPA036881, HPA036882, HPA075906" Enhanced Enhanced "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA 18000000 "Endoplasmic reticulum, Cytosol" "Plasma membrane" "CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: " "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.91e-2)" "unprognostic (4.68e-2)" "unprognostic (1.45e-1)" "unprognostic (3.79e-1)" "unprognostic (4.53e-3)" "unprognostic (1.94e-2)" "unprognostic (6.11e-3)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.66e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.16e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (4.98e-4)" 38.3 20.7 10.4 25.0 16.3 22.1 32.0 8.7 21.7 38.0 44.6 10.5 18.6 25.6 24.8 25.9 87.4 19.5 25.5 98.5 11.9 10.6 27.2 38.2 29.5 21.1 14.3 12.5 26.9 14.8 22.3 25.3 52.6 24.8 30.0 34.5 12.7 38.7 23.2 201.9 40.7 56.3 36.2 18.7 21.7 22.2 21.2 15.6 10.1 25.6 51.2 34.1 42.2 57.0 24.5 32.7 12.4 48.0 18.3 26.6 27.2 48.5 40.0 6.8 17.7 41.1 76.6 24.0 34.6 49.0 27.7 36.1 9.9 29.6 7.0 32.7 46.9 41.3 82.6 12.9 47.1 33.5 45.1 12.2 9.0 42.4 11.7 31.6 5.9 15.7 34.6 43.6 39.7 64.9 38.7 30.9 5.4 7.5 22.7 33.7 15.3 2.9 0.2 5.3 13.2 14.9 2.7 23.0 12.0 55.0 20.5 28.7 6.9 35.3 19.4 22.6 16.2 11.8 6.4 41.1 37.8 16.1 25.2 34.9 7.6 20.2 3.3 42.9 3.2 10.4 2.5 48.0 7.0 26.6 29.0 25.2 24.5 23.9 26.5 32.7 22.7 12.2 16.3 12.4 18.3 32.2 9.0 24.2 27.2 10.4 16.3 8.7 21.7 11.9 10.6 14.3 12.5 24.8 15.6 375.2 182.6 82.4 358.6 212.9 34.7 740.0 140.1 410.9 277.5 102.9 17.7 150.3 112.7 215.3 948.1 166.8 282.7 280.4 218.0 79.9 187.6 259.7 169.0 148.0 103.8 12.7 136.3 108.6 206.2 312.7 159.3 211.5 124.9 235.4 207.6 36.8 240.8 170.9 137.6 98.2 16.9 90.5 162.6 20.9 10.1 220.1 117.7 139.5 143.0 490.4 CASZ1 "castor, cst, FLJ20321, SRG, ZNF693" ENSG00000130940 "Castor zinc finger 1" Q86V15 1 10636604-10796650 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 573.3;Rod photoreceptor cells: 490.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 9.7;HDLM-2: 10.5;SCLC-21H: 16.3;SK-BR-3: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028222, HPA029927" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028222: AB_10600106, HPA029927: AB_10601564" "unprognostic (1.20e-1)" "unprognostic (5.06e-2)" "unprognostic (4.67e-2)" "unprognostic (7.49e-3)" "unprognostic (4.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.55e-4)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (1.03e-5)" "unprognostic (3.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.51e-2)" "unprognostic (1.56e-1)" 3.4 0.9 0.3 2.5 1.5 2.8 6.0 0.3 0.7 6.1 20.7 0.5 14.7 8.8 11.0 2.4 9.9 3.4 13.8 9.9 0.2 0.2 4.5 1.4 7.4 0.8 0.8 0.3 1.7 4.4 0.0 4.0 1.2 0.9 12.1 2.4 19.8 17.0 17.4 29.9 25.3 27.1 8.0 0.2 1.2 9.2 1.0 0.8 0.2 1.9 14.4 6.2 7.2 7.2 0.5 3.5 1.9 2.2 1.6 1.6 0.4 9.7 0.8 1.8 1.7 0.0 0.0 0.4 0.3 0.1 0.3 0.4 2.1 2.2 0.4 2.0 0.4 0.8 8.4 1.9 1.9 0.1 10.5 3.3 0.7 1.6 2.2 0.3 1.1 3.1 0.1 7.2 0.1 0.6 0.0 0.3 1.5 0.0 0.0 0.0 5.2 0.6 7.0 0.2 5.1 0.5 0.8 1.2 0.1 1.6 4.0 16.3 1.5 2.5 15.4 0.2 0.7 8.2 1.0 0.1 0.0 1.4 0.8 0.2 0.0 0.0 1.0 0.0 3.0 0.1 1.9 0.2 1.2 1.6 0.4 0.7 0.4 0.6 1.1 0.6 0.5 0.0 0.5 0.4 1.6 2.2 3.5 0.3 0.4 0.3 1.5 0.3 0.7 0.2 0.2 0.8 0.3 0.9 0.8 26.8 20.0 0.0 17.1 29.3 11.2 21.0 10.2 14.7 7.9 14.0 573.3 0.5 3.3 12.2 0.4 11.7 41.1 0.0 7.7 0.8 2.6 37.9 4.6 4.0 1.0 130.3 39.6 6.7 0.3 0.9 0.0 1.8 1.7 10.8 33.5 24.9 13.7 29.1 6.3 1.0 490.7 0.0 7.1 1.7 2.3 53.4 0.6 3.2 22.9 24.5 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Group enriched" "Detected in many" 7 "Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.5 0.2 1.8 0.8 0.0 4.2 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.7 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.3 0.0 0.8 0.0 0.5 0.5 0.1 0.8 0.0 1.4 0.0 4.3 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.8 2.0 0.1 0.4 0.6 0.4 0.9 0.2 0.7 0.4 0.0 0.3 0.0 1.0 0.7 0.0 0.8 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 0.0 2.4 1.7 1.9 2.3 1.1 2.4 2.5 0.0 0.0 1.8 0.0 1.0 0.0 0.8 23.9 1.5 14.0 0.0 0.6 0.2 1.5 1.8 1.1 0.5 2.8 1.6 1.7 1.8 0.8 27.8 1.7 2.6 0.0 1.8 1.5 1.9 0.5 3.5 2.1 1.1 1.1 0.0 1.0 31.9 2.7 1.6 1.1 2.5 2.0 1.4 CAVIN2 "cavin-2, PS-p68, SDPR, SDR" ENSG00000168497 "Caveolae associated protein 2" O95810 2 191834302-191847255 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 384.1;Alveolar cells type 2: 70.0;Club cells: 150.2;granulocytes: 170.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 9.9;neutrophil: 8.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 9.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 28.2;HEL: 20.6;HUVEC TERT2: 64.0;LHCN-M2: 99.1;TIME: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA039325, HPA062122" Enhanced Enhanced "Plasma membrane,Cytosol" Yes No 160000000 "Plasma membrane" Cytosol "HPA039325: AB_10805473, HPA062122: AB_2684688" "unprognostic (6.85e-3)" "unprognostic (1.37e-1)" "unprognostic (1.24e-1)" "unprognostic (4.47e-2)" "unprognostic (2.83e-1)" "unprognostic (1.46e-1)" "unprognostic (3.19e-2)" "unprognostic (6.14e-2)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (2.90e-1)" "prognostic favorable (8.45e-5)" "prognostic unfavorable (3.69e-4)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (4.39e-3)" 60.3 8.9 4.9 10.1 8.3 1.8 37.8 2.8 6.1 26.1 32.6 2.8 14.5 3.9 23.9 17.4 18.2 19.5 45.3 46.5 7.1 5.3 15.9 10.4 57.9 20.1 8.9 5.6 20.4 7.6 3.2 4.3 11.6 5.8 19.3 8.9 9.8 6.9 11.2 35.7 3.8 10.6 39.3 7.1 52.9 8.8 7.2 4.4 0.3 34.5 20.1 2.8 33.2 34.5 0.1 1.0 9.9 0.8 0.4 0.1 39.0 0.0 3.5 1.2 0.0 0.1 0.6 0.0 0.7 0.6 0.1 0.2 0.0 0.0 0.0 4.5 28.2 0.0 0.6 0.0 5.5 0.4 0.0 0.0 20.6 0.2 7.8 8.0 0.0 0.0 1.5 3.6 0.6 1.7 0.4 64.0 0.0 7.4 0.0 99.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 26.0 0.0 2.2 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.8 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 8.9 0.4 0.4 1.0 0.1 39.0 4.9 8.3 2.8 6.1 7.1 5.3 8.9 5.6 5.8 4.4 384.1 70.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 150.2 0.0 0.0 0.1 5.0 1.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 170.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CBFB PEBP2B ENSG00000067955 "Core-binding factor beta subunit" Q13951 16 67029116-67101058 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 101.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038852 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038852: AB_10795358" "unprognostic (1.05e-1)" "unprognostic (1.18e-2)" "unprognostic (1.30e-1)" "unprognostic (3.22e-2)" "unprognostic (4.66e-2)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.83e-4)" "unprognostic (1.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.11e-1)" "unprognostic (4.46e-3)" "unprognostic (1.88e-2)" "prognostic unfavorable (2.89e-8)" "unprognostic (1.03e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" 15.9 10.9 15.9 26.4 25.1 20.5 15.0 9.5 14.3 15.4 10.6 23.3 11.8 8.8 15.3 10.2 20.5 14.3 16.3 21.5 16.2 13.2 12.1 14.4 16.1 32.6 23.6 12.4 17.3 13.6 40.4 18.8 13.2 17.5 14.6 11.1 13.7 19.6 10.3 33.3 14.8 12.2 11.7 22.4 18.2 17.1 7.3 24.2 42.2 17.0 14.8 31.0 15.9 18.8 6.5 9.1 20.5 9.2 14.8 7.0 5.1 15.6 10.5 9.2 14.9 6.7 8.6 14.7 18.2 10.9 17.2 15.2 21.0 18.0 34.7 17.4 15.5 7.2 15.6 16.4 10.2 23.2 11.9 9.4 24.1 9.0 16.7 9.6 31.4 51.9 8.7 7.0 19.2 14.8 9.1 13.9 17.2 25.6 12.4 17.8 11.9 32.3 16.8 9.0 8.3 14.8 65.6 39.7 29.5 12.1 14.0 13.5 12.1 46.7 7.1 18.6 11.3 6.4 22.6 19.3 26.7 18.3 15.1 24.4 17.0 30.2 101.5 20.3 21.6 24.0 20.5 7.4 7.4 6.7 9.2 7.0 6.5 6.6 7.0 9.1 6.4 6.3 5.3 4.6 14.8 6.1 3.3 7.0 5.1 15.9 25.1 9.5 14.3 16.2 13.2 23.6 12.4 17.5 24.2 8.9 19.8 29.2 37.0 49.9 4.5 15.4 15.3 13.4 17.0 38.4 11.8 12.1 23.2 14.4 4.4 17.4 7.3 0.0 24.0 26.0 32.1 38.3 26.6 14.0 33.8 9.5 18.2 27.0 43.0 5.7 22.2 46.5 49.0 10.8 12.4 12.3 47.8 5.8 19.8 9.8 14.2 12.9 24.7 13.4 16.3 55.2 14.2 54.9 11.5 52.5 CBL "c-Cbl, CBL2, RNF55" ENSG00000110395 "Cbl proto-oncogene" P22681 11 119206276-119313926 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004350, HPA027956" Enhanced Supported Cytosol NA NA Cytosol "CAB004350: AB_2244054, HPA027956: AB_10601094" "unprognostic (2.52e-1)" "unprognostic (1.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-2)" "unprognostic (2.92e-1)" "unprognostic (4.10e-3)" "unprognostic (9.75e-2)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.03e-2)" "unprognostic (5.23e-2)" "unprognostic (5.21e-2)" "unprognostic (5.27e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" 9.9 5.5 9.1 17.0 11.1 11.1 8.8 10.7 12.0 6.2 7.5 8.7 3.0 5.7 9.9 5.3 7.5 7.4 6.3 5.9 8.0 9.6 5.5 4.0 10.3 16.3 8.1 6.9 6.3 5.6 16.6 4.1 9.1 9.3 5.3 7.5 6.4 5.4 7.1 3.9 7.4 8.6 10.6 8.9 13.3 7.3 32.3 5.1 40.9 6.0 5.5 15.6 7.6 7.7 1.8 3.3 11.8 3.7 0.6 1.9 1.0 6.3 4.8 16.9 10.6 5.1 6.0 10.0 6.9 7.2 6.7 6.6 10.3 7.9 15.1 6.2 8.7 13.8 9.3 11.6 5.9 14.7 8.6 2.7 15.5 3.7 3.1 6.2 18.0 17.7 5.3 6.5 17.0 18.4 7.1 16.5 14.8 12.5 6.3 12.0 6.9 9.6 10.1 8.8 5.7 5.4 10.4 8.5 2.8 5.9 5.1 2.3 7.1 12.8 5.6 4.6 12.1 5.8 15.2 13.7 10.4 7.4 7.2 9.0 2.1 3.1 12.3 4.2 15.6 7.4 0.8 3.2 2.4 1.3 3.7 1.1 1.8 1.6 1.3 3.3 1.8 1.8 1.9 11.8 0.6 3.1 1.8 1.4 1.0 9.1 11.1 10.7 12.0 8.0 9.6 8.1 6.9 9.3 5.1 8.9 8.8 18.8 4.9 16.0 12.4 5.9 7.6 1.4 4.5 10.4 43.2 5.2 1.7 5.8 22.7 17.8 6.3 0.0 5.8 8.0 8.0 6.2 3.5 2.6 15.0 12.7 8.1 19.0 52.9 32.8 7.2 29.9 15.1 5.4 4.3 17.5 8.7 8.6 12.0 3.1 33.8 25.8 17.6 38.1 26.2 19.2 5.8 20.0 4.5 9.5 CBLB "Cbl-b, RNF56" ENSG00000114423 "Cbl proto-oncogene B" Q13191 3 105655461-105869552 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018327, HPA019880" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA018327: AB_1846097, HPA019880: AB_1846099" "unprognostic (2.65e-1)" "unprognostic (9.42e-2)" "unprognostic (1.72e-2)" "unprognostic (2.38e-1)" "unprognostic (5.89e-3)" "unprognostic (2.80e-2)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" "unprognostic (7.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.29e-2)" "unprognostic (1.50e-2)" "unprognostic (1.43e-2)" "unprognostic (8.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.20e-2)" "unprognostic (3.09e-2)" 38.4 9.0 3.7 19.5 4.9 15.5 16.3 24.4 3.8 13.7 18.7 5.9 7.7 9.3 13.8 12.2 8.3 12.5 13.4 27.5 3.8 4.8 7.4 6.7 16.3 19.1 4.4 1.9 17.7 6.8 3.4 13.5 25.4 7.9 12.9 8.0 11.6 9.1 6.3 10.3 8.5 13.8 25.6 5.7 16.4 12.4 9.2 5.2 11.6 13.5 7.0 18.0 24.9 24.1 5.1 3.1 2.8 2.1 10.3 9.9 1.6 1.6 2.3 7.7 3.8 8.9 9.0 5.0 5.8 2.9 1.7 2.7 2.9 2.0 3.6 4.0 3.0 2.7 2.9 1.0 1.0 2.1 2.8 2.9 2.0 12.0 1.9 13.1 1.4 1.5 8.6 3.1 4.5 12.3 6.4 5.6 3.7 2.1 11.7 3.6 2.1 2.0 0.9 2.7 2.0 3.3 4.2 2.3 0.6 4.1 7.4 6.0 6.5 6.8 0.8 8.9 5.6 1.7 2.9 3.1 23.9 2.0 3.2 1.4 6.6 0.6 5.7 6.4 1.2 1.5 0.7 1.5 2.8 9.9 0.9 8.8 2.2 5.1 5.6 1.3 5.1 4.4 8.0 1.0 10.3 2.1 3.1 5.6 1.6 3.7 4.9 24.4 3.8 3.8 4.8 4.4 1.9 7.9 5.2 14.9 6.7 21.6 6.8 9.6 44.8 39.9 0.0 10.7 6.8 12.2 25.5 8.9 5.0 6.0 27.4 22.6 8.7 0.0 6.9 53.5 21.6 9.6 8.1 6.7 12.2 3.2 12.1 39.3 11.3 9.0 6.9 10.4 15.1 5.4 16.2 7.4 11.7 7.0 10.3 3.1 27.4 6.5 19.9 9.8 15.8 6.0 38.0 52.3 10.7 3.0 CBR1 "CBR, SDR21C1" ENSG00000159228 "Carbonyl reductase 1" P16152 21 36069941-36073166 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 176.1" "Cell type enhanced" "Detected in all" 8 "Distal tubular cells: 641.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA018433, CAB034291" Enhanced Approved Nucleoplasm,Cytosol NA NA 12000000 Nucleoplasm Cytosol "CAB034291: AB_2070856, HPA018433: AB_1846109" "prognostic favorable (2.18e-4)" "unprognostic (9.78e-2)" "unprognostic (3.25e-2)" "unprognostic (2.14e-1)" "unprognostic (6.47e-3)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" "unprognostic (6.37e-2)" "unprognostic (4.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.20e-2)" "unprognostic (4.00e-1)" "prognostic favorable (4.75e-4)" "unprognostic (2.37e-1)" "unprognostic (2.47e-1)" "unprognostic (6.13e-3)" "unprognostic (2.47e-2)" 9.6 22.9 31.7 8.4 41.6 3.7 8.5 12.0 35.8 14.6 63.4 75.9 6.5 176.1 9.3 17.1 40.2 9.6 15.1 7.8 37.7 24.7 35.2 77.2 11.7 8.5 57.3 25.2 10.4 8.0 8.9 7.9 11.7 51.6 16.7 16.8 10.4 23.1 15.0 8.7 34.4 118.1 11.6 48.1 10.0 41.4 5.7 41.9 3.6 11.3 29.8 14.3 12.4 17.1 17.0 29.9 17.1 51.4 19.1 29.2 37.0 25.3 39.1 4.8 12.3 25.1 25.4 0.2 28.5 20.5 15.6 18.7 14.4 14.9 6.4 18.8 26.5 30.1 18.7 9.8 27.9 12.0 31.5 23.1 19.1 22.8 9.8 14.4 10.6 17.6 12.4 35.2 15.1 6.6 17.9 16.6 0.0 0.0 4.7 14.3 25.1 5.3 11.1 0.0 0.0 28.6 0.0 0.1 17.7 41.4 12.7 14.0 12.5 27.5 40.0 32.4 3.9 18.9 14.8 16.7 17.5 7.4 44.3 20.6 32.0 57.9 0.1 32.1 10.6 25.3 1.8 36.6 17.1 18.1 51.4 15.3 17.0 22.7 16.9 29.9 15.6 29.2 21.4 2.5 19.1 38.6 10.4 22.7 37.0 31.7 41.6 12.0 35.8 37.7 24.7 57.3 25.2 51.6 41.9 113.2 54.7 13.0 59.4 113.9 11.9 19.9 81.5 111.1 96.7 90.7 2.0 102.1 641.6 73.2 5.9 17.8 131.2 46.7 60.9 77.8 54.3 48.6 34.6 203.8 78.0 3.2 37.1 54.6 65.5 2.9 113.6 47.2 86.0 102.8 58.6 65.5 81.3 71.8 124.5 200.8 7.4 25.8 60.8 4.2 11.3 108.0 74.6 30.9 77.6 42.0 CBR3 SDR21C2 ENSG00000159231 "Carbonyl reductase 3" O75828 21 36134912-36146566 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 68.2" "Group enriched" "Detected in many" 4 "Basal glandular cells: 23.4;Basal keratinocytes: 63.1;Glandular cells: 36.1;Leydig cells: 62.7;Melanocytes: 62.4;monocytes: 36.1;Peritubular cells: 71.1;Smooth muscle cells: 20.3;Suprabasal keratinocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 43.6" "Low region specificity" "Detected in all" HPA018434 Uncertain Approved Nucleoplasm,Cytosol Yes NA "Nucleoplasm, Cytosol" "HPA018434: AB_1846110" "unprognostic (3.64e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.22e-2)" "unprognostic (6.12e-2)" "unprognostic (2.98e-2)" "unprognostic (3.75e-1)" "unprognostic (9.10e-2)" "prognostic unfavorable (5.95e-6)" "unprognostic (3.13e-1)" "unprognostic (1.80e-1)" "unprognostic (3.99e-3)" "unprognostic (1.94e-1)" 9.2 1.5 5.4 3.0 13.9 0.9 12.2 3.1 4.7 8.6 3.8 1.4 4.1 2.4 5.5 8.8 27.6 4.1 4.9 4.9 3.6 2.9 1.6 0.4 3.5 3.4 3.8 6.1 9.3 1.2 0.3 1.2 2.2 2.5 7.2 2.9 3.3 21.8 4.2 2.4 16.3 2.6 10.5 2.3 1.5 2.7 4.3 2.7 0.9 2.3 68.2 14.1 7.1 8.0 11.9 1.2 0.4 0.5 4.9 17.9 6.2 12.2 3.5 1.5 3.1 12.0 18.6 2.4 13.4 15.9 15.4 12.3 0.1 2.6 0.0 3.9 13.7 5.4 5.7 2.0 2.7 6.2 16.7 6.4 0.5 3.7 0.1 1.0 0.0 0.0 2.6 0.3 10.7 1.4 7.4 9.3 1.4 0.0 0.1 4.5 9.2 1.1 5.4 1.2 3.8 15.5 2.6 2.9 23.9 5.1 5.2 0.8 1.1 10.2 12.5 19.5 0.8 3.7 1.4 6.4 10.0 0.8 11.2 12.9 0.6 0.2 0.0 10.4 0.3 17.9 0.0 0.3 0.0 1.2 0.2 1.5 11.9 13.0 4.0 1.2 10.6 17.9 12.3 0.4 4.9 0.5 0.3 5.1 6.2 5.4 13.9 3.1 4.7 3.6 2.9 3.8 6.1 2.5 2.7 0.0 2.7 0.0 23.4 63.1 0.2 0.2 5.1 5.3 11.4 0.0 0.0 0.9 8.3 3.3 0.5 11.3 1.1 0.0 0.6 0.2 7.7 36.1 5.7 0.0 7.4 0.0 0.0 8.6 3.7 1.1 62.7 5.6 62.4 36.1 8.9 1.4 2.1 1.1 71.1 0.0 0.4 0.0 20.3 0.4 0.2 40.8 0.2 1.3 2.9 11.5 CBX7 ENSG00000100307 "Chromobox 7" O95931 22 39120167-39152674 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 24.0;U-266/70: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011574, HPA048677, HPA056480" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB011574: AB_726005, HPA048677: AB_2680490, HPA056480: AB_2683146" "prognostic favorable (6.18e-4)" "prognostic favorable (3.63e-4)" "prognostic unfavorable (3.73e-4)" "unprognostic (9.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.48e-3)" "unprognostic (4.76e-3)" "unprognostic (1.45e-2)" "unprognostic (3.86e-2)" "unprognostic (1.11e-3)" "prognostic favorable (1.04e-4)" "unprognostic (3.03e-3)" "prognostic favorable (2.45e-5)" "unprognostic (3.90e-1)" "unprognostic (1.26e-1)" "unprognostic (3.10e-1)" "unprognostic (1.63e-2)" 17.6 23.1 26.1 14.2 34.3 4.0 14.0 45.0 44.7 20.1 29.3 17.2 24.1 12.3 27.8 21.9 18.0 24.7 19.1 36.5 23.9 19.5 17.6 6.4 19.1 17.2 18.7 29.5 36.9 15.0 33.4 17.1 6.2 19.7 27.1 10.6 21.1 24.0 44.0 38.6 15.4 15.8 35.9 12.9 22.0 18.8 6.5 19.9 4.5 16.9 10.8 15.1 26.2 21.1 3.7 0.7 5.5 0.9 1.7 5.1 1.6 4.5 1.9 0.9 7.4 9.1 3.5 2.4 4.3 5.3 2.4 2.8 0.9 3.1 0.7 5.1 3.2 4.3 1.7 0.6 2.0 1.8 24.0 2.4 0.1 3.1 0.4 3.1 1.1 9.5 1.7 3.0 1.1 0.5 3.0 0.7 3.7 1.1 12.2 1.8 4.3 1.6 0.5 0.5 5.7 3.3 1.8 1.5 6.5 1.2 1.8 2.4 0.6 2.2 3.2 4.9 1.6 3.9 1.8 1.7 4.0 7.6 4.0 1.9 20.8 11.7 2.8 8.1 1.8 1.7 0.6 0.5 4.8 3.7 0.1 3.8 2.9 4.0 4.0 0.1 3.7 5.1 4.8 5.5 1.7 0.9 0.7 3.8 1.6 26.1 34.3 45.0 44.7 23.9 19.5 18.7 29.5 19.7 19.9 6.0 8.3 29.6 11.6 4.0 49.8 60.2 22.9 4.0 13.6 14.0 33.4 2.9 8.3 2.8 7.4 14.7 7.2 0.0 3.3 1.2 8.4 9.8 10.4 10.9 3.7 57.2 4.1 20.3 12.3 6.4 32.5 5.5 18.6 10.0 8.0 16.2 2.9 3.5 26.2 11.0 57.0 45.3 27.8 3.9 2.7 4.3 3.0 17.5 6.2 6.3 CC2D1A "FLJ20241, MRT3" ENSG00000132024 "Coiled-coil and C2 domain containing 1A" Q6P1N0 19 13906201-13930879 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 103.9;Rod photoreceptor cells: 91.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005436, CAB015220" Supported Supported "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB015220: , HPA005436: AB_1078884" "unprognostic (8.66e-2)" "unprognostic (1.31e-2)" "unprognostic (2.55e-1)" "unprognostic (2.34e-1)" "unprognostic (1.07e-1)" "prognostic favorable (7.02e-4)" "unprognostic (7.00e-2)" "unprognostic (1.59e-3)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (2.61e-3)" "unprognostic (4.07e-2)" "unprognostic (1.23e-3)" "unprognostic (6.67e-3)" "unprognostic (1.97e-1)" "unprognostic (9.22e-2)" "unprognostic (1.71e-2)" 11.2 9.5 19.1 14.5 18.7 9.1 12.0 30.5 22.2 11.4 28.7 13.6 15.3 43.2 10.1 10.0 18.2 16.9 16.6 10.4 17.8 21.3 12.6 16.2 11.9 9.5 15.8 20.1 11.5 30.0 17.3 18.7 12.2 16.1 14.2 14.7 13.3 32.7 16.9 18.7 28.6 35.3 11.1 12.6 11.3 21.0 10.1 13.7 10.6 12.0 13.6 13.7 13.1 14.1 2.4 3.0 4.1 5.2 1.6 4.8 2.0 22.0 9.4 3.1 12.8 6.3 5.2 9.9 7.7 9.5 12.5 12.0 12.8 6.7 11.6 12.7 7.7 7.4 16.2 5.8 11.8 4.3 16.9 32.1 5.7 11.5 8.0 10.5 4.8 17.0 6.3 14.3 7.7 5.1 7.8 8.5 11.7 5.9 9.6 4.0 23.4 11.2 12.9 7.0 19.3 16.7 11.5 7.0 9.2 8.5 16.9 11.5 6.7 10.2 15.5 11.6 2.4 11.4 9.0 7.9 9.6 4.9 21.2 9.3 16.3 7.2 6.1 12.2 15.9 8.7 3.9 3.2 4.1 4.8 5.2 1.9 2.4 2.3 2.1 3.0 1.3 1.2 2.7 2.8 1.6 4.8 2.5 1.9 2.0 19.1 18.7 30.5 22.2 17.8 21.3 15.8 20.1 16.1 13.7 8.9 8.8 14.0 13.1 8.0 56.5 6.9 20.4 12.0 12.5 10.4 88.4 18.0 8.3 19.1 1.3 9.0 103.9 0.0 24.0 9.0 8.9 14.8 17.3 8.9 12.5 28.6 32.1 8.0 8.2 4.2 59.5 10.5 6.8 15.4 39.0 14.3 21.2 66.6 82.0 4.7 91.0 12.9 7.6 7.7 11.1 12.0 17.8 16.6 42.1 15.7 CCBE1 "FLJ30681, KIAA1983" ENSG00000183287 "Collagen and calcium binding EGF domains 1" Q6UXH8 18 59430940-59697380 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 28.0" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 14.3;Ito cells: 12.3;Rod photoreceptor cells: 42.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "hippocampal formation: 10.0" "Group enriched" "Detected in some" 7 "basophil: 9.6;neutrophil: 2.7" "Lineage enriched" "Detected in single" 11 "granulocytes: 9.6" "Cell line enhanced" "Detected in many" "BJ: 26.8;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+ RasG12V: 25.7;HBF TERT88: 30.8;hTERT-HME1: 41.8;LHCN-M2: 46.9;TIME: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA041361, HPA041374" Uncertain Supported "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA041361: AB_10796667, HPA041374: AB_10794515" "unprognostic (3.09e-1)" "unprognostic (5.01e-2)" "unprognostic (9.54e-5)" "unprognostic (1.66e-2)" "unprognostic (2.40e-2)" "unprognostic (5.68e-5)" "unprognostic (2.31e-2)" "unprognostic (2.03e-1)" "unprognostic (4.54e-2)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" "unprognostic (2.17e-2)" "unprognostic (3.62e-3)" "unprognostic (4.04e-3)" "unprognostic (1.64e-1)" "unprognostic (7.45e-2)" "unprognostic (2.02e-2)" 10.0 12.6 2.4 3.8 1.1 0.4 3.5 0.4 2.0 16.8 15.8 0.6 8.2 0.8 12.1 2.8 2.3 6.9 6.9 2.1 10.0 0.5 3.1 4.3 16.5 3.6 0.4 2.1 28.0 0.8 0.4 2.6 0.3 1.7 3.0 2.3 9.1 1.0 3.5 10.6 3.3 3.0 4.9 0.3 0.3 1.7 2.1 1.3 0.2 1.0 0.0 0.7 2.9 5.1 0.8 0.4 9.6 0.3 0.8 0.3 0.2 5.2 0.4 0.0 0.0 4.2 13.1 8.2 26.8 27.5 19.5 25.7 0.0 0.1 0.1 0.0 10.6 4.6 0.5 0.0 17.3 30.8 0.1 0.1 0.0 0.1 0.1 9.7 0.1 0.0 8.8 0.7 15.2 41.8 8.4 0.9 0.0 0.0 0.1 46.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.5 0.1 0.2 0.0 0.0 0.2 2.0 0.0 0.1 25.2 0.0 2.7 3.9 0.0 0.1 0.0 0.0 1.3 0.1 0.6 9.6 0.3 0.8 0.3 0.2 0.2 0.4 0.2 0.2 0.1 0.8 0.3 0.3 2.7 0.8 0.2 0.4 0.2 0.2 2.4 1.1 0.4 2.0 10.0 0.5 0.4 2.1 1.7 1.3 3.0 2.2 0.0 1.1 4.0 7.2 0.8 2.5 1.4 3.4 0.0 7.9 0.6 0.0 0.1 0.5 0.7 0.0 0.0 0.2 0.6 3.1 1.1 1.1 0.0 0.3 14.3 0.0 12.3 1.5 0.2 8.9 0.5 6.8 0.0 0.0 1.1 0.5 0.0 0.4 0.0 42.0 0.0 4.1 0.0 0.7 3.8 0.7 0.0 0.0 0.7 CCDC102B "ACY1L, AN, C18orf14, FLJ23594, HsT1731" ENSG00000150636 "Coiled-coil domain containing 102B" Q68D86 18 68715209-69055189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 33.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 113.6;Late spermatids: 49.0;Sertoli cells: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.8;BJ hTERT+: 20.8;fHDF/TERT166: 18.7;HSkMC: 11.5;Karpas-707: 7.4" "Not detected" "Not detected" "HPA040623, HPA048194" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA040623: AB_10805715, HPA048194: AB_2680309" "unprognostic (3.92e-2)" "unprognostic (1.62e-1)" "unprognostic (5.58e-2)" "unprognostic (9.50e-3)" "unprognostic (7.13e-2)" "unprognostic (3.50e-1)" "unprognostic (7.87e-3)" "unprognostic (1.36e-1)" "unprognostic (5.59e-2)" "unprognostic (8.62e-3)" "unprognostic (1.95e-1)" "unprognostic (6.04e-2)" "prognostic unfavorable (2.90e-6)" "unprognostic (2.21e-2)" "unprognostic (2.12e-2)" "unprognostic (8.00e-3)" "unprognostic (3.13e-3)" 8.7 4.2 6.4 4.7 7.1 1.3 4.4 3.2 8.0 4.2 4.8 4.9 2.9 2.3 4.0 6.4 4.7 2.9 16.9 4.7 6.0 5.4 5.9 3.3 16.4 11.5 7.0 5.0 3.3 3.1 3.2 5.0 33.7 8.7 4.0 6.1 4.0 3.2 2.2 2.1 2.9 3.9 6.4 9.3 3.3 4.7 4.3 7.0 1.7 6.8 5.0 2.9 16.9 4.0 0.9 11.5 0.4 0.3 1.3 2.6 0.3 0.0 0.0 2.9 0.2 2.7 10.8 0.2 0.6 20.8 0.2 0.3 0.1 0.3 0.1 0.4 18.7 0.3 0.2 0.1 0.2 0.3 0.9 0.3 0.6 0.0 0.9 5.3 0.1 0.3 11.5 0.4 0.3 2.6 0.4 0.1 1.4 0.0 7.4 1.7 0.0 0.4 0.2 0.6 0.1 0.3 0.9 0.2 0.3 0.1 0.0 1.3 1.1 0.1 0.0 0.0 1.2 0.2 0.9 2.9 0.4 0.2 0.1 0.2 3.2 0.2 0.5 1.5 1.2 1.8 0.0 0.1 0.4 1.4 0.3 1.3 0.6 0.8 1.1 0.3 0.9 2.6 1.6 0.0 1.3 0.2 11.5 0.3 0.3 6.4 7.1 3.2 8.0 6.0 5.4 7.0 5.0 8.7 7.0 0.0 2.1 0.5 0.6 0.6 5.6 7.4 0.0 1.4 3.4 3.5 5.9 0.7 5.0 0.6 113.6 4.5 0.0 0.0 1.5 0.5 3.6 0.5 2.3 0.6 3.0 6.4 0.0 4.3 2.2 49.0 30.0 3.1 0.0 2.8 0.2 10.8 0.3 0.3 8.5 4.5 12.2 77.6 22.5 1.6 2.7 0.5 0.2 1.0 0.4 0.5 CCDC103 "CILD17, FLJ13094, FLJ34211, PR46b" ENSG00000167131 "Coiled-coil domain containing 103" Q8IW40 17 44899142-44905390 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 19.6;testis: 35.5" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 12.8;RPTEC TERT1: 10.0;U-87 MG: 11.3" HPA043131 Approved Cytosol NA NA Cytosol "HPA043131: AB_10796686" "unprognostic (9.40e-3)" "unprognostic (1.75e-1)" "unprognostic (5.60e-2)" "unprognostic (1.99e-2)" "unprognostic (4.50e-2)" "unprognostic (7.43e-2)" "unprognostic (2.80e-1)" "unprognostic (2.34e-1)" "unprognostic (1.27e-1)" "unprognostic (4.35e-2)" "unprognostic (4.69e-1)" "unprognostic (1.05e-1)" "unprognostic (3.60e-1)" 0.6 2.3 2.6 0.9 6.3 0.6 1.2 0.5 4.7 1.4 0.9 2.9 1.6 0.5 1.7 2.8 0.4 19.6 2.8 0.4 2.5 3.0 2.7 0.7 1.9 0.3 1.5 3.9 3.5 0.8 1.9 2.1 0.5 4.3 0.9 0.7 1.6 1.2 1.5 0.3 0.7 0.4 1.2 1.0 0.4 0.9 35.5 1.0 0.2 3.5 0.1 0.5 0.7 0.4 0.8 2.5 3.0 3.7 0.7 0.4 2.4 2.2 12.8 1.9 2.4 2.8 2.3 1.6 1.0 3.8 1.8 1.3 2.4 4.2 0.3 2.1 0.9 5.5 3.9 0.8 1.8 1.0 7.9 1.4 0.6 2.7 0.0 1.8 1.6 0.3 1.6 3.0 1.9 0.7 3.7 1.3 0.9 1.7 0.3 0.1 2.4 0.0 0.7 0.4 2.1 1.9 0.3 0.7 0.5 10.0 1.3 5.1 1.0 0.5 0.4 2.3 1.1 3.4 1.7 1.0 0.8 2.0 1.0 1.9 0.4 0.5 0.4 11.3 0.8 0.3 1.2 3.7 3.0 0.3 1.9 0.4 0.0 0.0 0.4 2.5 0.8 0.4 0.3 0.5 0.7 1.7 0.8 0.1 2.4 2.6 6.3 0.5 4.7 2.5 3.0 1.5 3.9 4.3 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CCDC106 HSU79303 ENSG00000173581 "Coiled-coil domain containing 106" Q9BWC9 19 55641062-55653161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 11.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041925, HPA043219" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041925: AB_2677750, HPA043219: AB_2678368" "unprognostic (5.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.71e-1)" "unprognostic (5.16e-2)" "unprognostic (9.19e-2)" "unprognostic (2.82e-1)" "unprognostic (8.11e-2)" "unprognostic (1.21e-2)" "unprognostic (4.88e-2)" "unprognostic (8.74e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.28e-1)" "prognostic favorable (7.54e-11)" "unprognostic (5.03e-2)" "unprognostic (7.88e-2)" "unprognostic (3.26e-1)" "unprognostic (8.69e-2)" 15.9 18.7 31.6 8.7 43.9 4.4 14.5 27.2 29.8 13.9 10.4 14.3 10.5 7.2 13.2 11.2 13.0 12.5 14.2 18.0 32.3 21.2 23.5 19.2 10.4 14.8 20.3 14.4 20.9 13.8 19.2 17.5 8.8 15.2 14.7 5.2 12.4 18.0 19.6 34.1 9.3 8.3 20.0 15.1 15.6 13.0 15.9 10.8 13.7 18.0 6.5 14.1 16.9 10.0 11.1 9.0 0.0 2.4 0.6 3.4 1.5 3.9 15.5 6.8 11.9 4.9 4.7 0.9 3.4 6.0 11.9 10.0 3.3 6.1 11.5 2.7 6.3 0.3 3.4 11.5 7.4 3.4 0.6 39.5 12.2 10.4 5.9 14.7 0.8 7.0 7.5 0.9 2.8 0.6 8.3 3.7 7.5 8.9 7.4 5.8 1.0 7.3 4.8 3.2 0.4 8.6 11.5 3.5 7.9 12.3 0.3 7.5 14.0 2.7 19.4 6.7 4.2 8.4 7.9 4.1 3.7 3.8 0.3 2.5 4.4 1.5 14.9 9.9 3.9 0.2 0.0 2.4 0.0 0.5 1.6 1.5 7.8 0.5 0.7 3.0 11.1 3.4 2.0 0.0 0.6 0.1 9.0 0.3 1.5 31.6 43.9 27.2 29.4 32.3 21.2 20.3 14.4 15.2 10.8 0.0 2.2 8.3 7.6 2.3 21.3 19.5 12.7 0.0 1.2 19.2 3.9 11.2 34.9 16.1 3.0 11.3 5.5 0.0 6.3 12.7 8.9 4.6 9.2 14.9 14.5 35.0 4.7 5.5 7.8 1.5 13.0 7.1 3.3 18.0 7.0 18.8 9.0 5.8 17.7 41.5 7.1 12.9 7.2 5.9 19.6 3.1 7.3 3.8 4.7 2.0 CCDC112 MGC39633 ENSG00000164221 "Coiled-coil domain containing 112" Q8NEF3 5 115267188-115296831 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.4" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 227.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 50.4" "Low region specificity" "Detected in all" "HPA045120, HPA050621" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in male reproductive system" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA045120: AB_2679222, HPA050621: AB_2681191" "unprognostic (1.88e-2)" "unprognostic (5.10e-2)" "unprognostic (4.63e-2)" "unprognostic (5.60e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.32e-6)" "unprognostic (4.30e-2)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (3.33e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (1.51e-6)" "unprognostic (7.00e-2)" "unprognostic (2.79e-2)" "unprognostic (8.61e-2)" "unprognostic (4.10e-3)" 5.5 4.3 9.7 5.7 13.2 7.0 7.7 12.6 12.8 6.5 9.8 7.0 4.3 8.1 6.6 7.3 6.3 4.9 3.9 6.4 11.0 9.0 3.5 1.7 6.1 4.8 9.7 7.6 2.9 13.2 6.5 12.1 3.0 12.6 7.7 10.6 1.9 6.8 8.6 4.5 5.5 6.8 7.7 14.0 5.3 7.0 40.4 11.8 3.7 4.7 3.2 4.7 7.1 4.8 5.3 11.0 11.6 5.5 3.1 3.8 2.1 5.4 2.7 5.5 8.7 3.5 6.8 1.3 4.9 2.6 3.7 4.3 1.2 3.1 6.7 4.1 3.4 5.5 3.5 5.7 2.8 7.8 5.3 4.4 4.4 4.1 1.7 4.7 5.8 2.3 3.1 3.4 4.8 6.4 4.3 5.7 6.1 1.8 5.5 4.9 4.2 8.7 5.0 6.0 5.1 4.8 9.3 6.8 50.4 3.6 2.0 8.3 10.8 5.3 3.4 14.6 3.9 5.7 8.5 5.6 4.9 3.3 9.3 6.8 6.1 5.9 1.4 3.3 4.6 2.9 0.2 5.5 11.6 3.4 4.4 3.8 3.2 2.6 2.9 5.9 5.3 3.4 2.3 3.6 3.1 5.0 11.0 0.1 2.1 9.7 13.2 12.6 12.8 11.0 9.0 9.7 7.6 12.6 11.8 14.9 12.3 12.3 4.6 12.6 28.3 14.6 2.5 12.0 9.1 5.2 9.8 0.6 5.0 24.4 6.8 8.0 11.9 0.0 22.6 1.7 8.5 6.1 9.2 2.6 28.4 9.5 38.9 6.7 23.9 13.4 3.7 28.0 13.5 42.3 28.0 10.3 27.1 14.0 3.9 2.9 24.3 12.9 13.0 227.3 60.7 19.7 0.5 5.3 31.6 3.4 CCDC117 FLJ33814 ENSG00000159873 "Coiled-coil domain containing 117" Q8IWD4 22 28772674-28789301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 75.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000826 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA000826: AB_1078417" "unprognostic (1.71e-1)" "unprognostic (2.04e-2)" "unprognostic (1.61e-3)" "unprognostic (9.07e-2)" "unprognostic (3.84e-2)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" "unprognostic (1.35e-2)" "unprognostic (8.43e-2)" "unprognostic (7.74e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-3)" "unprognostic (8.25e-2)" 10.7 14.2 12.3 13.6 13.6 19.2 25.2 19.3 12.7 15.9 13.1 9.6 16.6 12.1 15.3 8.9 11.5 10.7 10.0 9.0 12.2 10.6 10.3 26.1 12.5 17.0 14.6 8.3 14.9 13.3 12.4 14.1 20.7 11.9 13.0 11.9 9.5 21.0 16.5 20.2 9.1 10.9 15.2 13.1 13.8 12.3 35.9 15.4 24.2 18.1 7.4 20.1 12.3 31.3 13.4 13.9 14.0 13.9 23.3 15.2 12.6 8.7 7.3 14.9 14.5 9.7 8.5 11.8 8.9 10.9 15.5 13.7 11.0 4.2 27.5 4.0 8.1 6.6 9.2 21.8 3.5 14.8 14.9 14.4 11.2 8.3 16.2 6.6 17.9 14.4 5.8 7.7 8.9 5.5 6.9 10.7 9.1 15.6 12.2 6.9 11.3 10.5 14.5 12.1 15.7 3.5 21.2 23.5 11.9 6.9 3.4 5.7 7.6 13.7 12.9 5.5 18.4 16.0 7.7 6.2 19.5 13.4 6.1 6.8 28.6 29.7 23.1 6.8 9.7 8.2 10.7 13.9 14.0 10.2 12.3 10.5 10.0 8.6 9.9 13.9 13.4 15.2 12.2 6.7 23.3 11.7 12.2 10.7 12.6 12.3 13.6 19.3 12.7 12.2 10.6 14.6 8.3 11.9 15.4 20.8 11.0 24.2 10.8 9.4 7.3 9.2 12.7 13.4 9.1 14.0 13.7 14.4 6.6 8.8 75.2 13.7 8.4 23.3 8.7 15.2 15.8 18.4 17.3 38.0 8.0 3.2 19.7 11.6 16.2 24.0 11.8 9.1 16.9 4.6 12.4 5.4 9.2 11.5 7.4 8.4 14.4 0.0 16.0 44.0 41.7 9.5 20.6 14.9 11.8 16.4 CCDC121 "FLJ13646, FLJ43364" ENSG00000176714 "Coiled-coil domain containing 121" Q6ZUS5 2 27625639-27629012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.5" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 32.1;Early spermatids: 126.1;Late spermatids: 35.6;Spermatocytes: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 12.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA051791 Uncertain Approved "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA051791: AB_2681611" "unprognostic (1.52e-1)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (3.93e-1)" "unprognostic (1.28e-1)" "unprognostic (4.71e-3)" "prognostic favorable (4.12e-4)" "unprognostic (4.03e-2)" "unprognostic (1.23e-1)" "unprognostic (5.65e-4)" "unprognostic (7.78e-2)" "prognostic favorable (1.87e-5)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (7.86e-2)" "unprognostic (5.42e-2)" 4.4 3.6 7.4 2.0 12.2 1.4 5.9 7.0 10.3 5.8 3.6 5.5 6.7 2.6 5.5 5.3 5.9 8.3 3.0 6.3 9.0 5.2 6.2 3.2 4.5 2.3 13.3 6.0 11.7 3.9 8.3 7.3 3.8 9.3 7.3 3.5 3.4 5.7 8.5 3.6 3.3 3.0 4.6 10.8 4.3 3.8 27.5 11.2 1.0 8.1 1.7 2.5 4.4 3.0 3.1 1.7 12.5 4.0 2.6 3.0 1.3 3.7 4.3 5.9 6.5 10.7 4.8 7.3 1.9 1.0 1.9 0.9 3.2 3.4 1.9 3.1 1.2 5.7 3.5 4.3 1.5 2.1 2.6 4.6 1.2 2.5 4.1 2.0 1.7 3.4 1.6 5.2 1.1 2.8 3.3 3.9 0.9 5.0 2.6 2.8 3.1 1.3 1.7 6.1 4.7 2.1 6.3 14.3 3.2 4.1 2.9 7.7 8.8 1.5 7.2 2.3 5.0 5.9 4.0 2.1 1.7 6.4 1.4 5.2 1.6 1.7 2.8 4.2 2.4 2.1 2.0 2.4 12.5 0.6 3.4 1.7 3.1 1.9 0.7 1.7 2.7 3.0 2.2 5.1 2.6 4.0 0.5 0.3 1.3 7.4 12.2 7.0 10.3 9.0 5.2 13.3 6.0 9.3 11.2 6.0 1.6 0.0 1.3 0.6 4.9 2.8 5.1 32.1 2.3 0.0 19.6 2.5 6.6 2.8 126.1 4.2 1.3 0.0 1.0 1.9 1.9 1.0 0.0 1.5 1.6 3.2 1.2 4.3 0.3 35.6 8.1 2.5 1.7 1.0 1.2 11.6 1.5 0.0 6.3 2.9 10.0 12.9 0.7 33.1 10.9 1.0 1.5 1.5 1.7 0.7 CCDC124 ENSG00000007080 "Coiled-coil domain containing 124" Q96CT7 19 17933016-17943991 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041708, HPA046765" Supported Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041708: AB_2677628, HPA046765: AB_2679793" "unprognostic (9.39e-2)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.32e-2)" "unprognostic (1.02e-1)" "unprognostic (3.20e-2)" "unprognostic (1.34e-1)" "unprognostic (2.04e-2)" "unprognostic (1.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.19e-1)" "unprognostic (3.71e-2)" "unprognostic (3.22e-1)" 32.2 21.8 28.8 23.1 25.7 28.1 16.3 16.8 34.4 15.0 22.3 16.8 16.5 20.0 29.0 17.8 22.0 13.6 20.0 34.8 26.5 22.3 18.1 24.4 15.5 16.2 26.4 23.8 15.5 29.4 14.0 12.3 16.3 18.5 17.6 7.6 16.1 34.7 19.9 96.8 20.6 21.2 20.5 20.2 20.7 26.7 14.0 13.3 13.6 19.1 29.0 14.1 17.0 33.2 30.2 39.1 31.9 42.4 32.4 42.2 28.7 48.4 34.5 11.8 23.3 7.9 6.1 38.8 24.3 8.0 13.0 11.0 25.9 20.3 37.1 35.3 10.2 8.5 18.6 13.0 23.3 3.8 38.9 71.4 30.7 27.0 30.0 15.4 34.4 21.2 9.7 15.5 13.2 12.6 7.4 13.6 24.7 39.3 15.7 6.7 47.8 33.7 43.8 26.7 16.7 59.2 33.3 21.5 40.5 10.6 17.6 23.6 33.9 17.0 19.7 24.2 5.0 18.0 12.9 28.8 22.1 27.5 42.3 37.6 22.2 23.4 35.7 27.4 41.8 27.7 27.4 39.0 31.9 42.2 42.4 33.5 28.2 32.8 38.8 39.1 30.2 26.1 31.6 9.5 32.4 30.2 34.5 36.9 28.7 28.8 25.7 16.8 30.4 26.5 22.3 26.4 23.8 18.5 13.3 17.9 4.5 43.2 45.5 80.4 21.8 12.6 28.1 6.7 9.1 69.8 2.0 86.3 116.0 142.5 25.0 54.0 90.6 0.0 172.9 115.7 72.5 52.7 27.6 49.5 97.5 9.5 58.6 41.1 56.9 74.0 30.2 52.2 91.1 104.6 46.2 32.1 165.3 48.0 38.9 105.4 17.4 19.4 59.2 31.6 40.5 96.0 69.2 45.4 56.2 62.5 CCDC138 FLJ32745 ENSG00000163006 "Coiled-coil domain containing 138" Q96M89 2 108786757-108885477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 57.6;Early spermatids: 83.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049899, HPA054223" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049899: AB_2680941, HPA054223: AB_2682420" "unprognostic (2.34e-1)" "unprognostic (3.74e-2)" "unprognostic (3.22e-2)" "unprognostic (3.04e-1)" "unprognostic (2.83e-2)" "unprognostic (1.64e-2)" "unprognostic (2.24e-5)" "unprognostic (2.89e-1)" "unprognostic (1.01e-4)" "unprognostic (2.56e-1)" "unprognostic (1.64e-1)" "unprognostic (5.77e-2)" "unprognostic (7.06e-4)" "unprognostic (7.88e-2)" "unprognostic (4.73e-2)" "unprognostic (2.69e-1)" "unprognostic (8.93e-2)" 2.6 2.5 5.7 5.0 7.0 6.1 4.8 13.5 8.2 3.1 3.9 4.9 1.6 2.1 6.0 2.8 5.5 8.6 3.8 2.3 6.8 5.0 3.6 5.5 2.8 8.1 4.3 5.1 3.7 3.5 2.3 7.4 2.8 8.0 3.1 4.8 1.9 3.3 2.1 2.1 4.8 3.4 3.3 6.4 3.2 3.7 19.4 6.5 19.5 2.3 2.9 7.2 4.3 6.1 5.4 8.1 3.1 2.1 3.2 4.8 2.4 8.3 3.8 13.2 6.8 1.1 1.2 8.4 3.6 1.1 8.7 6.3 12.4 4.9 20.0 5.4 1.1 4.3 7.1 9.5 4.9 7.8 4.6 12.3 9.2 7.2 10.3 1.3 12.6 1.4 0.8 1.5 10.2 3.0 1.3 4.5 8.7 17.5 9.3 4.4 4.6 17.9 8.6 19.6 4.5 4.0 11.9 12.5 12.2 4.8 6.6 9.3 9.1 7.9 4.3 6.3 8.5 4.6 6.1 2.8 5.5 9.7 3.5 7.6 2.9 6.7 20.9 2.3 9.8 5.4 3.1 0.9 1.3 2.1 2.1 3.9 5.1 2.8 4.0 0.9 5.4 4.1 4.8 0.5 3.2 0.8 8.1 4.1 2.4 5.7 7.0 13.5 8.2 6.8 5.0 4.3 5.1 8.0 6.5 0.0 3.5 2.9 3.2 2.2 7.3 0.8 0.0 57.6 12.5 1.8 7.9 3.8 1.7 3.0 83.9 2.2 0.5 0.0 1.2 4.4 3.0 0.9 4.6 1.8 1.9 6.4 5.2 1.3 0.6 22.1 3.4 1.3 1.7 1.0 2.1 1.5 2.7 0.0 1.8 1.7 6.9 0.0 2.3 18.5 21.2 2.5 1.1 4.3 2.6 2.4 CCDC15 FLJ13215 ENSG00000149548 "Coiled-coil domain containing 15" Q0P6D6 11 124954121-125041489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.2;testis: 19.4" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 34.8;Erythroid cells: 23.3;Spermatocytes: 93.6;Spermatogonia: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040450, HPA041738" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA040450: AB_10794031, HPA041738: AB_10794675" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (8.81e-2)" "unprognostic (1.85e-1)" "unprognostic (2.50e-1)" "unprognostic (4.59e-4)" "unprognostic (2.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.04e-2)" "unprognostic (9.05e-3)" "unprognostic (3.25e-2)" "unprognostic (9.38e-3)" "unprognostic (1.33e-2)" "unprognostic (3.14e-1)" "unprognostic (5.04e-2)" "unprognostic (1.66e-1)" 1.9 1.3 2.2 2.5 3.9 3.2 5.2 1.2 2.4 1.6 2.2 2.2 0.3 1.3 2.2 2.9 2.4 2.1 1.5 0.9 1.9 1.2 1.2 2.4 2.6 2.0 1.6 0.8 1.7 2.3 1.7 3.8 1.6 1.6 3.0 1.6 1.5 7.7 2.2 0.8 3.7 1.8 1.2 3.3 2.5 1.5 19.4 2.3 16.2 1.3 2.6 2.9 2.6 2.2 1.5 1.1 6.7 1.7 2.3 3.9 1.3 4.7 0.9 6.4 0.0 0.5 1.8 0.0 5.2 6.4 4.9 6.1 0.1 4.0 5.6 4.6 1.8 9.8 3.8 2.7 3.5 8.9 4.7 1.1 6.9 0.8 1.5 0.2 2.0 4.0 0.4 2.5 10.2 5.1 0.9 3.7 7.2 4.6 5.8 10.3 1.0 4.2 2.3 1.5 4.1 5.9 5.3 11.7 1.8 0.7 2.0 3.6 3.2 3.0 0.3 1.3 3.2 7.3 1.8 2.6 10.1 2.3 4.4 6.4 1.4 1.5 4.9 1.4 11.3 6.7 6.7 1.3 1.7 2.4 1.7 2.5 0.8 2.2 3.9 0.4 1.5 3.1 3.4 0.8 2.3 1.7 1.1 3.7 1.3 2.2 3.9 1.2 2.4 1.9 1.2 1.6 0.8 1.6 2.3 3.0 1.4 0.9 1.3 4.4 4.7 0.6 0.0 4.0 3.4 0.0 0.0 0.4 0.0 2.0 34.8 3.0 0.0 23.3 2.9 0.2 1.7 1.4 9.2 1.0 2.8 3.2 1.2 0.6 3.3 21.2 4.0 2.6 3.3 0.0 1.2 3.4 1.3 0.0 2.1 0.7 2.5 6.5 2.0 93.6 24.9 3.3 0.1 2.2 0.6 0.3 CCDC152 LOC100129792 ENSG00000198865 "Coiled-coil domain containing 152" Q4G0S7 5 42756801-42802360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 52.8;pituitary gland: 24.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 56.6;Muller glia cells: 33.6;Spermatocytes: 65.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 10.6;JURKAT: 10.6;U-2 OS: 19.2;U-266/84: 12.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036240 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036240: AB_10671242" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (3.14e-2)" "unprognostic (1.44e-3)" "unprognostic (3.24e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (6.25e-3)" "unprognostic (9.08e-2)" "unprognostic (1.16e-1)" "unprognostic (7.29e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-3)" "unprognostic (5.40e-2)" "unprognostic (4.63e-2)" "unprognostic (2.14e-3)" 4.0 6.0 7.5 2.5 10.2 1.6 3.0 1.0 8.4 2.1 2.3 4.1 0.5 5.0 2.7 1.9 2.0 1.6 6.1 4.6 7.1 3.2 3.6 52.8 3.2 8.6 4.9 5.5 8.2 2.1 0.0 24.3 2.8 20.9 2.1 0.3 1.9 2.1 0.3 1.5 3.1 12.4 0.6 8.8 6.9 1.9 5.7 8.5 8.5 1.7 0.5 3.0 2.9 3.1 3.6 10.0 0.3 0.7 6.2 6.1 1.3 0.3 0.1 0.8 0.1 2.7 3.5 0.0 4.6 0.1 0.0 0.3 0.0 0.2 0.0 0.3 2.0 3.4 3.6 0.0 0.0 0.4 0.0 0.3 0.2 10.6 4.4 2.7 0.1 0.0 4.4 0.0 1.9 0.0 7.0 1.4 10.6 0.5 1.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.3 5.3 0.0 0.1 0.0 4.2 0.4 0.1 0.1 0.2 19.2 4.4 0.1 0.1 12.8 0.1 5.6 0.1 0.1 0.1 0.1 0.1 4.0 0.7 4.9 2.2 3.0 5.0 0.7 3.6 4.0 6.1 0.3 6.2 0.3 10.0 1.9 1.3 7.5 10.2 1.0 8.4 7.1 3.2 4.9 5.5 20.9 8.5 56.6 31.3 4.9 0.2 3.3 13.9 8.1 0.0 6.7 13.6 1.8 0.0 1.3 0.0 0.6 5.7 3.5 2.3 0.0 1.0 1.0 10.4 0.3 9.2 4.0 2.3 31.8 1.2 4.9 10.5 5.3 6.1 2.9 3.3 1.0 2.5 33.6 2.0 2.9 7.1 0.5 2.2 0.0 6.6 65.5 22.6 3.4 1.5 10.9 1.2 0.3 CCDC153 LOC283152 ENSG00000248712 "Coiled-coil domain containing 153" Q494R4 11 119189638-119196769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.1;fallopian tube: 15.8;pituitary gland: 20.0" "Cell type enriched" "Detected in many" 7 "Ciliated cells: 151.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 15.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.1" "Cell line enhanced" "Detected in many" "T-47d: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041497 Uncertain Uncertain Cytosol NA NA Cytosol "HPA041497: AB_10794378" "unprognostic (4.66e-2)" "unprognostic (1.86e-2)" "unprognostic (3.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-3)" "unprognostic (5.19e-2)" "unprognostic (9.43e-3)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (2.92e-3)" "unprognostic (1.15e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-3)" "unprognostic (1.98e-3)" 1.4 1.1 2.2 0.6 4.8 3.8 0.8 0.5 0.9 1.4 0.6 2.0 0.5 0.5 1.1 5.3 1.5 15.8 3.1 2.0 2.6 3.9 1.5 0.6 5.2 0.5 0.5 0.5 1.7 0.5 3.3 20.0 1.3 9.8 0.5 0.6 0.5 0.7 1.6 0.5 1.4 0.8 0.7 1.2 0.8 1.6 2.8 2.4 0.5 1.1 0.5 0.9 0.7 0.5 0.4 1.6 15.1 2.4 0.3 0.6 0.7 2.2 3.0 1.8 1.8 0.3 0.3 4.4 1.3 1.5 0.6 0.7 4.9 7.7 1.5 6.4 0.3 2.2 1.6 0.4 1.5 0.1 3.0 2.5 7.2 2.2 3.3 1.1 2.3 0.9 0.7 1.0 1.6 0.4 2.4 1.5 1.6 2.1 2.9 0.1 8.9 1.5 2.2 0.9 3.2 5.2 2.0 2.5 1.4 0.5 2.2 2.4 1.2 3.0 1.5 1.7 1.2 13.1 2.7 3.0 3.3 2.6 2.0 2.7 1.2 1.8 1.2 1.5 1.3 4.0 0.4 2.4 3.8 0.3 1.5 0.2 0.4 0.2 0.4 1.6 0.4 0.6 0.5 15.1 0.3 1.5 1.6 0.4 0.7 2.2 4.8 0.5 0.9 2.6 3.9 0.5 0.5 9.8 2.4 0.0 6.7 0.0 1.3 2.5 0.0 0.2 0.0 151.3 20.5 7.0 0.0 3.5 0.0 0.8 2.5 1.5 3.3 0.0 1.8 2.9 1.3 0.9 0.0 1.3 3.1 0.0 1.7 3.1 3.5 4.8 0.3 3.4 3.3 5.4 2.7 0.9 1.0 7.0 2.5 2.9 1.9 6.5 6.2 6.6 3.4 1.9 2.7 0.0 1.8 2.0 CCDC159 ENSG00000183401 "Coiled-coil domain containing 159" P0C7I6 19 11344684-11354944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 270.6;Late spermatids: 182.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.8" "Low region specificity" "Detected in all" "HPA047126, HPA054655" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA047126: AB_10961722, HPA054655: AB_2682558" "unprognostic (1.46e-1)" "unprognostic (3.05e-3)" "unprognostic (2.35e-3)" "prognostic favorable (1.87e-7)" "unprognostic (5.02e-2)" "unprognostic (1.06e-3)" "unprognostic (9.23e-3)" "unprognostic (2.40e-2)" "unprognostic (6.68e-2)" "prognostic favorable (9.46e-4)" "prognostic favorable (1.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.97e-2)" "unprognostic (5.09e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-2)" "prognostic favorable (8.62e-4)" 7.9 24.6 21.0 13.4 35.1 22.2 10.9 15.5 28.6 14.8 12.9 30.6 28.3 17.8 13.9 21.1 11.8 14.2 19.0 13.6 22.8 11.9 13.4 18.9 12.8 14.7 38.5 22.9 19.2 15.1 34.3 20.8 7.3 28.0 24.7 9.5 17.7 14.5 17.4 6.3 14.6 14.3 12.5 24.2 24.1 16.1 28.2 43.5 7.5 17.8 8.5 11.2 13.7 12.6 9.9 16.5 21.2 28.0 15.7 15.2 11.8 2.2 2.0 1.7 5.2 6.8 9.9 1.7 3.7 3.9 4.4 5.9 0.6 2.4 1.9 9.6 7.0 1.3 1.9 1.0 5.9 2.7 9.2 1.4 4.5 1.6 2.4 12.0 1.7 6.8 11.8 15.6 3.2 4.3 4.6 12.3 3.4 4.0 21.8 2.2 2.8 2.7 3.6 0.9 3.1 7.4 3.0 0.0 12.2 4.0 3.2 0.7 2.8 3.7 4.3 6.8 3.2 6.3 7.5 8.1 3.5 1.0 6.0 3.4 20.0 4.8 3.8 4.7 9.2 5.0 21.2 28.0 19.1 12.1 23.6 11.7 8.1 8.2 11.0 16.5 9.9 7.5 5.9 13.2 15.7 16.4 4.3 15.2 11.8 21.0 35.1 15.5 28.6 22.8 11.9 38.5 22.9 28.0 43.5 14.9 9.9 9.0 13.1 6.6 11.2 9.8 12.7 21.4 14.8 17.4 39.3 4.9 21.6 7.6 270.6 9.1 14.8 0.0 8.4 4.4 8.4 23.8 33.5 9.6 20.4 6.4 10.4 12.9 26.0 182.1 10.6 15.7 11.8 13.6 10.6 14.8 7.5 23.0 12.7 31.6 28.9 0.0 8.2 4.8 3.8 7.0 5.0 21.5 8.1 17.5 CCDC167 "C6orf129, dJ153P14.2" ENSG00000198937 "Coiled-coil domain containing 167" Q9P0B6 6 37482920-37499922 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.0" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 242.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 9 "U-698: 175.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045215 Uncertain Approved Cytosol NA NA Cytosol "HPA045215: AB_10962866" "unprognostic (1.82e-1)" "prognostic favorable (7.59e-4)" "unprognostic (6.99e-2)" "unprognostic (3.66e-1)" "unprognostic (2.86e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.73e-1)" "unprognostic (7.67e-2)" "unprognostic (3.41e-3)" "unprognostic (2.71e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (1.71e-7)" "unprognostic (1.57e-1)" "unprognostic (4.06e-1)" "unprognostic (2.44e-1)" "unprognostic (1.95e-1)" 6.4 10.3 16.1 11.6 18.9 12.7 10.2 11.3 15.5 12.6 10.5 12.8 11.4 6.3 8.7 25.2 13.6 11.5 6.2 17.3 13.8 12.1 10.2 29.5 7.0 23.0 18.1 9.1 4.6 14.9 6.9 8.4 9.6 15.8 12.2 13.0 5.0 16.2 7.7 10.5 6.5 8.2 16.7 22.8 15.1 7.5 18.8 16.9 32.1 11.5 11.2 35.5 8.7 8.7 24.8 9.9 23.6 6.0 8.6 70.0 26.4 3.1 7.2 16.6 11.5 4.5 8.0 6.1 3.7 3.0 5.8 6.5 7.6 4.7 17.1 8.5 6.3 11.3 2.4 10.7 8.7 5.9 14.2 19.7 8.1 3.1 19.1 4.8 7.9 3.2 3.7 18.0 6.2 5.7 4.1 18.0 18.0 5.0 14.9 9.9 10.3 14.8 6.5 0.9 9.0 4.6 9.2 5.9 12.6 7.9 6.2 11.3 13.3 5.6 5.5 8.7 15.2 6.0 8.2 4.5 3.9 7.6 2.1 3.8 11.0 10.7 175.0 3.7 17.0 10.9 4.8 6.0 23.6 26.1 5.9 31.1 24.8 43.5 32.8 9.9 17.0 20.1 19.4 1.8 8.6 4.9 6.3 70.0 26.4 16.1 18.9 11.3 15.5 13.8 12.1 18.1 9.1 15.8 16.9 6.0 10.1 32.8 22.2 12.6 8.6 42.5 33.1 16.0 7.9 14.0 7.9 52.7 26.6 58.7 80.7 18.0 15.3 140.2 43.7 96.5 31.5 33.2 15.0 109.5 77.5 14.3 24.2 29.4 18.3 242.2 12.0 25.9 52.3 29.7 18.8 29.8 51.7 14.4 17.7 66.3 8.5 6.5 20.8 95.7 92.0 13.2 24.8 54.9 25.8 27.3 CCDC168 "C13orf40, FLJ40176" ENSG00000175820 "Coiled-coil domain containing 168" Q8NDH2 13 102729369-102759070 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 23.7" "Cell type enriched" "Detected in some" 32 "Early spermatids: 828.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.6;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0" "HPA048184, HPA058793, HPA078547" Uncertain Approved Nucleoli,Centrosome,Cytosol NA NA "Nucleoli, Centrosome" Cytosol "HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: " "unprognostic (2.06e-1)" "unprognostic (7.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-4)" "unprognostic (2.09e-2)" "unprognostic (3.68e-2)" "unprognostic (2.74e-1)" "unprognostic (5.05e-2)" "unprognostic (3.61e-1)" "unprognostic (2.89e-3)" "unprognostic (1.73e-1)" "unprognostic (1.44e-5)" "unprognostic (2.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.85e-1)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.2 0.7 0.1 0.0 0.0 1.6 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 1.3 1.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.3 828.1 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.8 26.2 2.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.3 0.0 0.0 0.1 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.1;pituitary gland: 6.6;testis: 8.2" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 13.4;Cone photoreceptor cells: 7.9;Early spermatids: 7.0;Rod photoreceptor cells: 11.8;Spermatocytes: 16.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;SCLC-21H: 1.7" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.2 0.1 0.9 0.2 2.9 0.5 0.2 17.1 3.3 0.2 0.9 1.2 0.0 0.3 0.2 1.0 0.2 1.3 0.5 0.2 0.8 0.5 0.4 0.2 0.5 0.2 0.8 0.9 0.2 0.1 0.3 6.6 0.1 3.0 0.2 1.8 0.6 0.2 0.2 0.2 0.3 0.9 0.2 0.4 0.4 0.2 8.2 1.5 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.4 0.9 2.9 17.1 3.3 0.8 0.5 0.8 0.9 3.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.4 1.2 0.0 7.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 11.8 0.0 0.0 16.5 1.3 0.0 0.0 0.0 2.6 0.0 CCDC18 NY-SAR-41 ENSG00000122483 "Coiled-coil domain containing 18" Q5T9S5 1 93179919-93278730 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0" "Group enriched" "Detected in many" 4 "Spermatocytes: 128.6;Spermatogonia: 37.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028035 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028035: AB_10601795" "unprognostic (8.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-1)" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (1.49e-4)" "unprognostic (4.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.44e-2)" "unprognostic (3.41e-2)" "unprognostic (1.63e-2)" "unprognostic (3.50e-2)" "unprognostic (3.64e-13)" "unprognostic (4.94e-2)" "unprognostic (9.19e-2)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" 3.8 2.3 2.7 20.0 4.3 13.4 4.6 3.7 2.7 2.2 3.2 0.4 2.9 2.5 1.8 4.0 3.2 1.8 1.7 2.6 3.4 1.9 2.0 3.0 3.8 11.9 1.7 1.8 2.8 1.5 0.7 4.8 1.9 2.6 1.9 4.1 1.3 2.0 3.1 6.2 3.1 3.4 2.3 3.8 6.0 2.3 12.6 2.5 15.8 2.1 2.8 8.2 2.9 3.3 12.2 11.9 6.0 3.9 1.1 2.7 0.5 15.7 5.3 12.4 3.9 3.0 3.2 6.5 9.8 5.2 10.1 10.3 2.7 5.4 20.4 5.5 5.2 9.9 7.5 5.4 7.7 14.7 10.1 7.1 14.0 11.3 4.8 1.1 14.5 6.5 2.1 0.6 7.6 7.5 2.8 6.5 9.2 14.9 15.8 13.4 2.2 6.9 5.9 11.3 4.3 6.6 9.0 14.8 6.0 4.9 7.1 5.5 3.5 13.9 7.1 4.1 5.8 3.4 8.5 5.0 11.9 8.4 7.6 11.1 6.8 8.8 12.3 2.5 13.0 3.1 3.4 3.8 5.3 2.4 3.9 2.7 8.8 2.2 2.1 1.6 12.2 1.7 2.0 6.0 1.1 3.5 11.9 2.2 0.5 2.7 4.3 3.7 2.7 3.4 1.9 1.7 1.8 2.6 2.5 17.9 11.1 17.6 6.5 3.7 2.4 8.1 0.0 6.7 4.5 3.5 3.9 2.6 0.0 1.9 17.7 3.7 1.7 0.0 2.6 5.8 6.8 3.3 18.5 2.9 7.2 1.6 0.0 4.3 12.4 8.5 5.8 19.5 3.3 9.0 2.5 1.1 1.8 3.5 6.0 1.0 0.6 6.5 5.7 128.6 37.7 6.4 2.4 14.1 3.1 6.4 CCDC184 "C12orf68, LOC387856" ENSG00000177875 "Coiled-coil domain containing 184" Q52MB2 12 48183584-48185926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Group enriched" "Detected in many" 4 "Early spermatids: 51.8;Sertoli cells: 45.3" "Cancer enhanced" "Detected in many" "glioma: 6.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 4.2;AF22: 9.9;hTERT-RPE1: 3.8;SH-SY5Y: 6.7;U-2 OS: 4.0;U-87 MG: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039947, HPA041715" Uncertain Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA039947: AB_2676764, HPA041715: AB_2677634" "unprognostic (2.02e-1)" "unprognostic (1.16e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.61e-2)" "unprognostic (4.59e-1)" "unprognostic (1.33e-2)" "unprognostic (6.65e-2)" "unprognostic (9.79e-2)" "unprognostic (8.38e-2)" "unprognostic (1.03e-2)" "unprognostic (1.07e-1)" "unprognostic (5.87e-4)" "unprognostic (1.08e-2)" "unprognostic (2.39e-2)" "unprognostic (2.55e-1)" "unprognostic (2.36e-2)" 2.0 11.4 9.0 2.3 14.4 0.8 1.3 14.9 30.5 3.0 1.8 2.2 0.1 1.1 6.1 1.3 1.7 1.3 3.3 1.9 9.3 17.6 1.3 1.3 1.5 1.0 11.5 10.6 8.8 1.3 8.7 7.3 5.1 23.7 1.6 1.5 0.8 0.9 2.3 2.2 1.5 2.1 3.6 3.6 1.4 1.5 5.1 0.4 0.0 1.2 0.5 0.8 2.1 1.8 0.0 0.3 0.6 0.2 0.0 1.2 0.3 0.0 4.2 9.9 0.4 0.8 0.8 0.0 0.3 1.8 0.5 0.8 0.5 0.1 0.0 0.2 0.3 2.6 0.1 1.0 0.2 0.1 2.3 0.2 0.0 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.1 0.0 3.8 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 6.7 0.8 0.1 0.2 0.2 0.0 0.0 0.2 1.1 4.0 0.0 0.2 0.0 0.0 0.0 5.0 0.0 1.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 1.2 0.4 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 9.0 14.4 14.9 30.5 9.3 17.6 11.5 10.6 23.7 0.4 0.0 0.0 0.0 0.2 0.0 2.3 0.6 0.0 9.4 1.2 0.0 0.0 0.7 0.0 0.2 51.8 1.0 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.9 4.8 5.1 8.6 0.0 10.9 0.3 0.0 0.0 0.0 0.0 2.8 0.2 0.0 2.1 0.0 6.6 45.3 2.7 5.6 0.9 0.0 1.3 0.0 0.0 0.0 CCDC189 "C16orf93, MGC104706" ENSG00000196118 "Coiled-coil domain containing 189" A1A4V9 16 30757423-30762710 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.7" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 91.0;Early spermatids: 152.5;Late spermatids: 229.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041806, HPA046289, HPA075094" Approved Approved Cytosol NA NA Cytosol "HPA041806: AB_2677684, HPA046289: AB_2679615, HPA075094: " "unprognostic (5.84e-2)" "unprognostic (3.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.45e-4)" "unprognostic (3.60e-2)" "unprognostic (5.41e-3)" "unprognostic (7.76e-5)" "unprognostic (1.66e-2)" "unprognostic (1.82e-2)" "unprognostic (5.11e-3)" "unprognostic (2.15e-4)" "unprognostic (1.22e-3)" "unprognostic (1.06e-7)" "unprognostic (1.75e-3)" "unprognostic (2.14e-1)" "unprognostic (6.63e-2)" "unprognostic (3.41e-2)" 1.0 4.2 4.7 3.1 5.3 11.0 4.8 0.9 6.4 3.2 2.8 2.9 5.5 2.0 2.2 15.0 1.2 15.6 4.2 0.8 5.5 6.8 4.5 0.9 5.5 1.9 7.5 3.3 3.1 3.0 4.4 10.3 1.2 7.6 3.0 3.1 2.3 3.4 5.1 0.4 1.8 1.4 1.3 1.3 1.9 2.0 23.7 2.2 2.3 6.3 1.6 3.4 1.7 0.8 1.2 13.0 6.2 3.1 1.8 1.1 0.8 7.2 5.0 1.5 5.9 1.6 1.9 0.4 2.8 1.0 3.0 2.3 0.4 5.4 0.3 4.8 2.1 1.6 9.1 0.8 4.5 1.2 0.8 11.8 1.9 10.3 3.1 0.3 3.0 2.1 0.4 0.4 5.5 4.5 4.5 2.2 2.0 2.7 1.3 2.1 3.7 3.1 6.0 2.3 2.2 2.7 3.1 1.9 5.6 6.7 0.1 5.1 1.8 3.0 8.3 1.9 1.5 8.2 3.8 1.9 1.5 1.3 2.6 2.8 3.9 2.2 2.7 8.8 7.7 0.7 1.2 1.3 6.2 0.2 1.4 1.1 1.2 0.0 0.2 1.8 0.1 0.0 0.4 0.6 1.8 3.1 13.0 0.1 0.8 4.7 5.3 0.9 6.4 5.5 6.8 7.5 3.3 7.6 2.2 0.0 1.9 0.0 3.2 0.0 0.4 0.0 0.0 91.0 6.8 7.0 3.9 2.0 5.0 3.3 152.5 1.0 0.0 46.7 2.6 0.9 1.0 5.3 1.1 0.8 4.0 0.0 2.4 0.0 1.5 229.1 6.9 2.3 0.0 4.6 2.2 3.3 1.5 0.9 4.6 6.2 11.7 0.0 0.0 45.1 9.6 0.0 2.1 1.0 1.7 3.0 CCDC198 "C14orf105, FLJ10650" ENSG00000100557 "Coiled-coil domain containing 198" Q9NVL8 14 57469301-57493867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 25.8;kidney: 75.8;pancreas: 21.8" "Group enriched" "Detected in some" 5 "Collecting duct cells: 54.1;Distal tubular cells: 58.0;Proximal tubular cells: 165.1" "Cancer enhanced" "Detected in many" "renal cancer: 25.1" "Region enhanced" "Detected in single" "pons and medulla: 1.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "A549: 9.3;RPTEC TERT1: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029202 Uncertain Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA029202: AB_10600754" "unprognostic (1.45e-1)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.21e-1)" "unprognostic (5.45e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.92e-4)" "unprognostic (6.07e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-3)" 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.6 0.1 0.6 0.1 0.0 1.6 0.7 0.4 25.8 0.1 15.3 17.7 0.1 0.1 0.2 75.8 17.7 0.1 0.0 0.1 0.0 6.1 21.8 0.0 0.1 0.1 1.5 0.1 0.0 0.0 0.1 0.8 0.1 0.4 0.1 0.0 0.3 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.3 0.1 2.7 1.9 4.5 0.9 3.4 5.0 3.6 0.0 9.3 0.0 0.3 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.9 0.9 0.4 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.3 0.3 0.1 0.2 0.1 0.2 0.1 0.0 0.2 27.7 0.4 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.3 0.7 0.5 0.1 0.1 0.3 0.4 0.3 1.4 0.3 0.2 3.1 0.9 0.6 2.1 0.4 2.6 2.1 4.2 3.0 0.2 2.7 3.5 5.0 4.5 3.4 0.6 1.9 5.0 3.6 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 1.5 0.0 3.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 58.0 18.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 165.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC22 "CXorf37, JM1" ENSG00000101997 "Coiled-coil domain containing 22" O60826 X 49235467-49250526 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport, Ubl conjugation pathway" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000229, HPA000888" Uncertain Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000229: , HPA000888: AB_1078420" "unprognostic (1.24e-2)" "unprognostic (1.96e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-1)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.68e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (4.57e-3)" "unprognostic (3.61e-2)" "unprognostic (4.99e-2)" "unprognostic (6.99e-2)" "unprognostic (2.57e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-3)" 11.5 15.4 12.1 18.2 14.9 26.0 16.3 20.7 16.5 12.5 11.8 13.7 17.2 16.3 14.8 12.3 15.8 13.7 11.9 12.9 12.2 9.8 13.9 14.2 19.8 24.7 12.2 15.9 13.7 20.3 12.1 13.5 11.0 11.8 15.2 8.6 12.8 19.2 21.3 23.0 15.1 15.3 14.6 12.4 23.9 14.2 4.5 14.1 25.0 13.0 15.5 17.9 12.6 12.3 12.4 23.5 13.9 22.1 6.1 13.9 15.1 10.6 9.3 5.7 19.8 5.3 5.4 12.2 6.4 4.6 7.1 8.2 9.4 9.3 3.9 9.5 5.6 8.5 8.7 6.2 10.4 2.9 10.3 13.8 4.2 8.8 8.8 9.0 11.7 7.4 5.0 9.0 9.4 5.2 3.6 7.0 8.0 8.2 7.0 5.0 33.1 8.6 13.8 6.6 5.4 13.7 12.5 9.3 17.1 5.6 5.4 6.8 5.2 9.7 11.4 8.5 6.1 17.8 11.6 7.7 9.3 10.0 11.3 6.6 12.7 6.9 7.1 10.1 22.1 7.2 5.1 22.1 13.9 12.0 19.2 13.1 12.4 12.5 13.9 23.5 11.6 11.4 12.9 1.8 6.1 15.7 9.3 12.9 15.1 12.1 14.9 20.7 16.5 12.2 9.8 12.2 15.9 11.8 14.1 0.0 4.1 16.0 7.9 4.9 9.9 2.0 15.3 2.7 9.1 10.4 5.9 12.2 13.3 12.2 0.1 7.1 12.3 0.0 6.4 12.3 8.4 6.3 11.5 6.4 27.5 1.6 6.4 9.8 16.7 0.0 7.5 14.7 6.8 16.2 14.4 9.3 7.9 7.2 7.1 10.2 7.6 6.5 10.3 0.0 0.7 5.8 16.9 11.3 12.2 7.4 CCDC24 MGC45441 ENSG00000159214 "Coiled-coil domain containing 24" Q8N4L8 1 43991359-43996528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 52.2;Intestinal endocrine cells: 34.9;Spermatocytes: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035424, HPA061710" Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA035424: AB_2674619, HPA061710: AB_2684591" "prognostic favorable (3.06e-5)" "unprognostic (1.47e-1)" "unprognostic (1.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.65e-2)" "prognostic favorable (3.18e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.92e-2)" "unprognostic (6.38e-2)" "unprognostic (2.81e-1)" "unprognostic (7.00e-3)" "unprognostic (3.00e-1)" "unprognostic (1.74e-2)" "unprognostic (6.91e-2)" "unprognostic (1.51e-1)" "unprognostic (7.84e-2)" "unprognostic (2.15e-3)" 1.8 5.5 9.3 2.6 9.8 1.1 5.1 3.0 9.8 7.2 5.0 3.2 18.9 3.7 4.9 6.6 2.6 20.3 13.1 1.5 6.4 8.0 8.9 3.0 3.2 2.6 5.5 9.6 3.4 6.0 9.6 14.5 2.4 5.2 7.2 4.1 6.5 8.4 14.7 1.5 0.9 3.3 3.4 3.3 3.0 4.9 15.4 1.7 0.6 8.8 1.0 2.5 4.7 2.1 6.8 0.8 1.4 4.0 0.5 0.6 0.5 5.1 3.1 1.4 1.6 1.4 1.0 3.1 0.2 2.2 1.6 2.8 2.0 15.0 4.2 5.9 0.6 4.6 5.3 0.8 7.4 1.5 4.4 1.8 2.1 1.9 0.6 1.6 0.7 3.7 0.3 0.7 5.2 0.5 5.0 1.3 1.6 0.9 1.6 2.2 4.5 0.3 1.6 3.1 4.7 2.6 1.3 0.0 0.8 6.2 2.0 3.4 3.0 4.6 2.6 2.9 3.1 7.8 0.1 0.4 2.4 7.0 1.8 0.7 0.6 2.0 0.9 6.3 0.6 2.0 0.0 0.7 1.4 0.6 4.0 0.3 6.8 0.2 0.2 0.8 3.0 0.0 0.0 0.6 0.5 3.1 0.6 0.0 0.5 9.3 9.8 3.0 9.8 6.4 8.0 5.5 9.6 5.2 1.7 3.0 7.4 0.5 8.2 1.0 8.8 0.8 12.7 52.2 19.4 8.7 5.9 4.7 18.3 7.1 16.4 0.7 6.3 0.0 6.4 1.7 3.3 6.8 2.3 2.1 2.9 3.2 34.9 1.8 3.2 8.5 2.0 1.8 3.3 4.6 12.1 9.5 5.4 8.6 2.8 8.0 14.2 0.0 2.4 48.8 19.5 0.6 2.1 0.0 13.0 8.4 CCDC25 FLJ10853 ENSG00000147419 "Coiled-coil domain containing 25" Q86WR0 8 27733311-27772653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023256 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA023256: AB_2072067" "unprognostic (1.43e-1)" "unprognostic (5.48e-2)" "unprognostic (3.10e-3)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (6.62e-3)" "unprognostic (2.34e-1)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (8.49e-3)" "unprognostic (3.50e-1)" "unprognostic (2.69e-2)" "prognostic favorable (1.11e-7)" "unprognostic (3.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-1)" 12.7 25.4 16.8 10.6 22.4 4.0 16.7 14.2 26.1 10.3 26.0 13.1 12.0 32.5 13.2 14.2 13.7 14.6 11.3 11.1 16.5 14.0 21.5 30.4 8.5 12.8 19.9 15.8 10.9 16.0 15.6 12.7 9.9 29.4 11.4 15.1 9.8 14.1 12.4 23.3 10.9 39.7 10.5 19.0 12.1 18.0 12.0 17.2 9.7 17.8 13.8 12.8 13.2 10.5 19.2 18.9 14.9 13.2 13.8 21.8 9.1 24.0 13.1 13.2 12.3 11.8 17.1 8.9 20.2 19.6 12.5 12.3 5.4 8.6 26.0 14.0 10.2 10.7 11.4 11.7 19.7 18.1 9.7 7.8 32.4 12.3 9.4 19.8 11.3 10.5 19.1 13.1 13.5 19.0 14.3 26.8 17.0 15.2 12.5 13.9 8.8 27.5 9.6 18.9 23.9 7.3 9.0 22.4 13.7 16.4 14.1 7.6 21.2 13.6 10.5 20.6 10.4 12.0 6.4 21.6 11.5 18.2 19.6 10.6 13.6 15.9 9.5 17.8 15.1 11.8 14.9 10.4 7.3 14.6 13.2 19.8 19.2 21.2 17.8 12.1 14.0 18.8 20.9 4.0 13.8 12.5 18.9 21.8 9.1 16.8 22.4 14.2 26.1 16.5 14.0 19.9 15.8 29.4 17.2 23.8 29.3 26.0 34.6 19.1 41.2 55.6 56.0 65.6 43.3 50.6 11.8 67.5 92.9 63.1 135.8 56.8 64.2 23.3 117.7 46.6 43.3 42.8 61.3 122.8 39.7 52.4 25.4 48.5 33.2 96.8 43.7 30.4 35.4 50.5 50.8 46.3 68.5 45.6 44.6 91.6 36.5 45.3 35.0 69.9 62.9 19.4 35.5 34.9 50.9 23.7 CCDC27 FLJ32825 ENSG00000162592 "Coiled-coil domain containing 27" Q2M243 1 3746460-3771645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 81 "testis: 53.3" "Group enriched" "Detected in some" 46 "Early spermatids: 60.7;Late spermatids: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "THP-1: 6.2" HPA044395 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA044395: AB_10962987" "unprognostic (1.36e-1)" "unprognostic (6.67e-3)" "unprognostic (3.23e-4)" "unprognostic (3.13e-2)" "unprognostic (3.42e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (7.18e-2)" "unprognostic (1.20e-1)" "unprognostic (2.17e-2)" "unprognostic (2.54e-3)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "unprognostic (2.28e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 CCDC3 DKFZp761F241 ENSG00000151468 "Coiled-coil domain containing 3" Q9BQI4 10 12896625-13099652 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 89.3" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 44.5;Peritubular cells: 57.0;Sertoli cells: 32.3;Smooth muscle cells: 95.9;Suprabasal keratinocytes: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.5;HAP1: 13.6;HDLM-2: 22.3;hTERT-RPE1: 10.7;U-2 OS: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062425 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA Nucleoplasm Cytosol "HPA062425: AB_2684759" "unprognostic (2.26e-1)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (5.08e-2)" "unprognostic (3.11e-2)" "unprognostic (2.99e-2)" "unprognostic (5.56e-3)" "unprognostic (5.41e-2)" "unprognostic (4.25e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.54e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.88e-2)" 37.1 5.0 14.0 2.5 9.0 0.2 33.6 4.9 15.0 23.0 4.2 2.9 3.4 2.9 16.2 18.6 26.9 21.8 89.3 11.0 8.0 3.0 4.2 8.5 8.0 12.3 4.3 8.7 39.1 2.9 3.8 4.2 9.6 3.2 14.3 3.4 8.8 2.8 10.3 12.0 55.7 5.5 11.8 3.4 9.8 5.8 11.0 3.1 10.4 8.3 9.6 2.0 12.4 14.2 0.1 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.2 1.2 6.7 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.5 0.0 7.5 1.3 13.6 2.5 0.4 22.3 5.7 0.0 0.2 0.0 0.5 0.0 0.0 1.7 1.6 0.3 0.0 10.7 0.6 0.5 0.0 0.1 0.7 0.1 0.0 3.7 1.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 2.6 1.1 4.9 0.7 0.0 3.3 0.0 0.0 0.0 0.0 14.8 0.8 0.2 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 14.0 9.0 4.9 15.0 8.0 3.0 4.3 8.7 3.2 3.1 0.0 0.0 0.0 6.2 44.5 1.0 4.4 0.0 0.0 1.2 0.0 0.0 0.2 1.7 0.0 0.2 8.3 0.0 0.0 0.0 0.1 9.1 1.9 0.0 0.2 0.3 0.0 0.0 8.0 0.0 1.1 20.8 1.6 13.5 0.0 0.0 0.5 0.1 0.0 57.0 0.3 1.9 32.3 95.9 0.0 3.8 32.5 0.2 0.0 0.0 1.0 CCDC43 FLJ31795 ENSG00000180329 "Coiled-coil domain containing 43" Q96MW1 17 44673069-44689779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 50.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023078, HPA023391" Enhanced Enhanced Cytosol NA NA Cytosol "HPA023078: , HPA023391: AB_1846146" "unprognostic (6.05e-2)" "unprognostic (8.91e-2)" "unprognostic (8.75e-3)" "unprognostic (3.58e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (3.42e-5)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.89e-1)" "unprognostic (1.14e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.11e-1)" 10.4 10.4 14.3 8.5 15.6 13.8 10.0 14.9 14.7 7.9 9.3 9.8 7.2 9.1 8.2 9.0 10.7 7.6 6.1 16.3 13.8 10.4 11.2 7.5 7.5 9.6 11.9 9.2 7.3 9.4 12.3 5.8 14.2 14.4 9.8 12.0 6.9 8.9 7.6 50.6 8.8 8.8 8.6 14.4 9.8 8.5 7.3 9.6 10.9 10.8 17.1 10.9 9.1 7.8 11.5 17.5 10.7 17.9 15.8 14.7 10.0 12.3 14.8 14.1 12.4 9.6 14.3 25.9 18.9 11.2 18.6 18.3 20.0 13.3 21.6 14.7 15.3 13.3 9.7 23.2 21.8 27.1 26.3 27.0 19.3 24.4 29.4 17.3 27.0 14.6 12.8 22.2 19.3 26.4 12.8 18.0 17.8 20.3 15.1 18.8 15.3 26.3 19.2 14.5 11.7 19.1 17.1 35.5 18.6 19.0 8.1 14.2 14.0 13.8 11.1 19.1 22.2 28.4 18.4 15.5 23.1 17.0 13.7 25.0 15.4 19.4 25.0 16.9 15.8 16.4 10.5 16.0 10.7 12.9 17.9 11.9 9.3 12.2 14.3 17.5 11.5 12.0 13.0 3.3 15.8 11.7 12.4 14.7 10.0 14.3 15.6 14.9 14.7 13.8 10.4 11.9 9.2 14.4 9.6 11.9 16.0 19.3 8.6 11.7 21.9 35.1 12.7 21.4 21.6 8.7 9.8 36.1 33.2 19.2 0.6 20.0 10.5 23.3 21.3 38.6 13.5 9.4 32.3 12.4 26.9 20.6 17.2 16.5 17.8 2.7 13.0 21.6 20.3 18.0 14.4 17.4 18.5 10.5 12.0 25.8 19.2 6.5 17.6 3.5 10.4 9.8 21.2 12.1 19.9 7.1 CCDC50 "C3orf6, DFNA44, Ymer" ENSG00000152492 "Coiled-coil domain containing 50" Q8IVM0 3 191329077-191398670 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 95.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 95.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001336 Approved Supported Cytosol NA NA Cytosol "HPA001336: AB_1078421" "unprognostic (5.01e-2)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "unprognostic (8.77e-3)" "unprognostic (1.73e-2)" "unprognostic (8.29e-2)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.03e-2)" "unprognostic (2.51e-2)" "unprognostic (4.48e-2)" "unprognostic (3.17e-3)" "unprognostic (2.05e-2)" "unprognostic (7.79e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-2)" "unprognostic (7.57e-2)" "unprognostic (4.19e-1)" 35.2 17.5 15.8 23.7 15.5 5.1 41.4 11.7 14.2 19.3 21.7 17.2 21.7 14.0 23.4 21.6 20.4 21.7 29.6 22.7 14.9 11.0 25.1 38.5 22.3 22.7 15.9 9.3 28.9 31.1 17.1 14.7 20.3 14.6 20.5 15.4 16.2 21.4 20.8 19.2 14.3 22.3 37.5 14.5 32.5 21.2 18.7 14.4 11.7 25.5 14.4 23.4 30.4 23.8 20.1 95.0 0.3 3.4 3.5 3.2 2.4 18.1 6.1 23.7 6.2 21.4 18.9 8.2 33.7 33.9 24.4 24.5 12.9 7.2 3.5 41.7 19.0 18.1 20.9 18.9 15.1 36.6 26.5 9.2 2.4 8.1 14.7 31.5 8.8 9.6 15.1 20.2 19.2 43.7 21.1 37.3 0.0 8.1 19.6 21.5 6.3 0.0 5.6 8.4 1.8 25.9 13.7 13.2 17.7 26.4 7.9 5.5 8.4 11.9 13.0 23.3 18.0 9.0 8.0 38.0 24.0 20.1 17.3 43.2 30.3 13.1 0.2 12.9 0.0 19.3 0.0 3.4 0.3 0.9 3.1 0.4 20.1 1.0 0.6 6.6 10.0 0.2 0.2 0.3 3.5 1.6 95.0 3.2 2.4 15.8 15.5 11.7 14.2 14.9 11.0 15.9 9.3 14.6 14.4 23.8 43.3 93.1 45.7 41.7 25.2 41.5 25.5 26.8 37.5 48.8 25.5 23.8 26.6 123.8 150.0 131.0 36.2 23.3 67.7 32.2 50.3 53.5 2.3 68.0 68.1 23.8 21.9 146.7 48.0 71.8 64.2 56.9 50.6 136.1 27.9 30.7 134.9 31.6 71.1 48.2 14.5 58.2 61.2 66.3 24.9 28.4 28.0 20.3 30.2 52.0 CCDC57 "FLJ00130, FLJ23754" ENSG00000176155 "Coiled-coil domain containing 57" Q2TAC2 17 82101460-82212830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 565.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 5.2;naive CD8 T-cell: 10.7" "Lineage enriched" "Detected in many" 6 "T-cells: 10.7" "Low cell line specificity" "Detected in many" "HPA023315, HPA023326, HPA023342, HPA023344" Approved Approved "Microtubules,Centriolar satellite,Cytosol" NA NA Microtubules "Centriolar satellite, Cytosol" "HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162" "unprognostic (2.51e-3)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (9.92e-3)" "unprognostic (1.25e-1)" "unprognostic (2.11e-3)" "unprognostic (1.33e-1)" "unprognostic (1.56e-2)" "unprognostic (3.19e-2)" "unprognostic (2.16e-1)" "prognostic favorable (5.55e-5)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.28e-6)" "unprognostic (5.19e-2)" "unprognostic (1.53e-1)" "unprognostic (2.04e-1)" "unprognostic (3.80e-3)" 5.5 9.0 12.9 10.4 14.1 12.1 14.1 20.3 16.6 9.9 8.5 7.6 17.1 11.8 14.2 13.7 4.2 14.9 11.2 4.7 9.3 6.8 13.0 6.8 8.8 7.9 5.4 13.7 14.0 13.7 15.9 22.7 5.8 8.9 14.9 5.2 16.7 13.6 13.8 6.2 8.9 8.9 11.3 3.8 7.7 11.4 23.7 8.8 10.6 19.8 5.2 9.6 7.9 7.2 0.6 1.6 1.9 0.6 0.4 10.7 1.5 4.4 9.1 4.8 6.3 2.9 5.3 5.7 3.5 3.5 2.6 2.2 2.7 7.1 2.4 3.3 2.8 2.6 10.6 1.3 6.3 1.4 2.5 9.5 3.9 15.2 5.8 3.8 3.8 5.0 5.3 5.0 4.9 6.4 5.9 3.1 3.5 5.0 1.3 1.7 6.6 7.2 7.3 1.6 2.6 3.7 4.1 2.0 3.3 4.9 5.6 16.5 10.3 3.1 15.0 5.9 3.1 8.8 4.4 3.2 10.1 9.2 4.3 6.9 9.7 1.0 0.8 7.8 4.3 3.9 0.5 0.6 0.7 0.9 0.2 0.4 0.6 0.8 1.2 0.5 0.6 5.2 10.7 1.9 0.4 0.1 1.6 0.3 1.5 12.9 14.1 20.3 16.6 9.3 6.8 5.4 13.7 8.9 8.8 23.8 60.8 37.4 20.2 10.4 19.7 3.1 17.8 48.2 48.9 27.9 39.3 31.4 8.3 13.7 115.3 5.7 26.4 0.0 15.5 30.4 7.5 25.4 34.6 86.9 26.3 23.8 41.0 8.0 35.8 565.2 7.5 30.7 32.1 26.2 34.7 9.8 13.9 23.2 9.6 7.5 66.2 6.5 10.3 10.8 5.3 15.9 10.4 40.5 26.6 15.3 CCDC6 "D10S170, H4, PTC, TPC, TST1" ENSG00000108091 "Coiled-coil domain containing 6" Q16204 10 59788763-59906656 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019049, HPA019051" Enhanced Supported Cytosol No No Cytosol "HPA019049: AB_1846163, HPA019051: AB_1846164" "unprognostic (1.88e-2)" "unprognostic (1.72e-2)" "unprognostic (4.41e-2)" "unprognostic (1.25e-3)" "unprognostic (5.98e-3)" "prognostic favorable (5.48e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.39e-2)" "unprognostic (2.45e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.95e-4)" "unprognostic (4.08e-1)" "unprognostic (4.69e-2)" "unprognostic (2.23e-1)" "unprognostic (2.56e-1)" "unprognostic (9.95e-2)" "unprognostic (4.19e-2)" 13.7 13.3 22.8 11.7 41.8 12.8 20.7 13.8 27.1 23.0 23.9 11.3 10.7 20.4 28.4 16.6 33.2 23.6 16.2 11.2 17.0 18.1 19.4 10.9 15.5 18.7 13.8 17.6 19.8 22.5 16.8 13.7 13.3 14.5 18.7 18.4 9.6 25.5 14.0 18.2 26.0 20.4 28.1 11.8 14.5 16.6 12.6 12.3 10.6 19.1 14.8 20.7 21.7 23.8 7.1 7.3 0.2 3.4 1.2 2.3 1.4 16.0 14.5 7.3 16.3 11.1 16.8 14.9 7.9 10.5 7.9 9.4 28.2 31.6 13.8 12.0 13.2 4.6 23.9 14.6 14.4 11.9 20.7 7.3 11.2 11.8 17.1 13.5 12.8 10.6 12.1 19.1 13.2 32.5 11.2 11.7 7.9 8.4 8.9 10.3 21.6 5.3 7.4 11.7 15.2 9.9 7.2 12.0 8.7 13.3 13.8 7.5 6.5 10.0 42.1 8.8 9.9 26.7 6.9 11.9 7.4 13.6 11.4 13.2 4.7 5.4 6.3 11.7 24.5 4.6 0.0 2.9 0.0 1.5 3.4 1.8 6.7 2.3 2.1 7.3 7.1 2.2 1.6 0.2 1.2 1.9 1.9 2.1 1.4 22.8 41.8 13.8 27.1 17.0 18.1 13.8 17.6 14.5 12.3 92.3 20.4 12.6 42.6 84.3 14.0 14.2 28.1 20.1 47.8 24.4 39.3 32.1 24.9 42.8 25.1 15.7 40.4 0.0 56.0 14.6 20.6 38.1 27.8 19.1 20.3 15.9 25.9 19.6 29.9 60.3 22.7 22.5 15.1 11.8 37.1 11.8 47.6 17.5 18.4 30.5 42.9 19.4 21.8 2.6 20.8 70.0 22.5 13.4 39.3 38.3 CCDC66 DKFZp686C0433 ENSG00000180376 "Coiled-coil domain containing 66" A2RUB6 3 56557161-56621818 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 158.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044185, HPA051937" Approved Supported "Cell Junctions,Midbody ring,Centriolar satellite,Cytosol" Yes No "Centriolar satellite" "Cell Junctions, Midbody ring, Cytosol" "HPA044185: AB_10965852, HPA051937: " "unprognostic (2.28e-2)" "unprognostic (7.74e-2)" "unprognostic (7.37e-2)" "unprognostic (2.90e-1)" "unprognostic (5.28e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.68e-3)" "unprognostic (2.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.05e-3)" "unprognostic (5.48e-3)" "unprognostic (6.85e-3)" "unprognostic (1.81e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-1)" "unprognostic (6.81e-3)" 8.4 7.5 9.3 7.6 11.7 6.5 12.0 31.0 15.1 11.7 11.0 9.6 7.6 5.9 12.7 12.7 6.7 12.9 7.6 8.4 9.8 6.4 9.2 4.6 7.7 10.1 10.8 10.6 14.7 7.1 10.1 32.9 7.6 11.0 9.7 9.4 7.8 9.1 10.9 11.9 5.7 7.7 11.1 11.2 8.7 8.0 8.6 12.9 11.9 12.1 5.7 10.2 11.0 9.7 2.6 1.1 7.0 2.2 5.0 14.1 2.7 5.5 1.9 6.2 3.7 9.3 5.6 4.9 7.1 6.5 9.4 8.3 4.3 4.4 15.5 1.6 3.8 6.1 3.1 3.4 6.5 10.5 5.5 4.2 9.7 8.6 4.9 6.6 12.4 3.6 5.4 9.4 7.8 5.5 8.3 5.9 7.9 9.0 2.4 7.2 4.5 9.9 7.9 10.1 4.7 7.7 3.3 5.3 8.3 5.6 1.9 2.3 4.3 8.6 5.5 5.3 5.5 1.9 5.4 3.2 7.0 5.5 6.5 9.6 5.0 5.3 8.3 5.2 14.2 5.5 7.0 1.5 3.3 4.3 1.9 5.6 2.6 7.4 5.3 1.1 1.7 8.6 6.2 0.3 5.0 2.2 1.0 14.1 2.7 9.3 11.7 31.0 15.1 9.8 6.4 10.8 10.6 11.0 12.9 20.8 19.9 24.5 21.3 25.0 66.8 26.9 25.5 57.6 35.2 21.0 102.1 17.7 24.9 17.3 158.6 28.7 8.0 23.3 9.1 11.3 30.0 13.3 33.5 7.5 16.2 49.3 20.2 27.0 26.2 74.4 50.0 20.8 25.3 43.3 9.4 34.0 13.6 10.2 44.9 16.5 99.9 32.3 30.2 49.7 45.4 25.7 13.7 47.3 13.6 9.5 CCDC68 SE57-1 ENSG00000166510 "Coiled-coil domain containing 68" Q9H2F9 18 54901509-54959508 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 73.4;Enterocytes: 61.4;Pancreatic endocrine cells: 55.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.1;HHSteC: 10.8;HSkMC: 11.9;RT4: 8.0;TIME: 21.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040865, HPA048197" Supported Approved "Golgi apparatus,Cytosol" No NA "Golgi apparatus" Cytosol "HPA040865: AB_2677176, HPA048197: AB_2680310" "unprognostic (1.36e-2)" "prognostic unfavorable (4.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.38e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (2.65e-2)" "unprognostic (6.29e-2)" "unprognostic (2.71e-1)" "unprognostic (1.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.13e-1)" "prognostic favorable (5.28e-4)" "unprognostic (1.77e-2)" "unprognostic (9.71e-2)" "unprognostic (6.12e-2)" "unprognostic (2.38e-1)" 5.6 3.0 1.2 7.7 2.4 0.3 5.8 0.6 4.7 5.5 20.7 0.8 3.1 14.8 4.5 2.5 2.1 2.6 9.1 5.7 1.7 1.7 5.6 9.9 15.2 2.3 2.0 4.7 15.4 2.8 0.5 15.7 23.9 4.4 5.2 13.9 9.3 2.2 13.0 7.7 1.0 40.1 2.1 1.6 5.8 10.5 7.4 0.1 0.0 3.5 2.1 1.0 3.0 4.2 0.8 0.6 1.1 2.2 0.5 1.0 0.5 8.1 2.5 0.0 0.0 2.4 6.7 0.0 0.2 3.2 0.5 0.5 4.4 4.8 0.0 6.0 0.0 0.0 0.1 0.6 5.2 0.4 0.0 1.2 0.6 2.9 0.9 10.8 0.0 0.0 11.9 0.0 2.5 0.1 0.0 3.8 0.0 0.0 0.1 0.3 0.6 0.0 0.1 0.0 5.8 2.8 0.2 0.0 0.2 0.9 8.0 0.0 1.9 2.5 0.8 0.1 1.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 1.1 0.7 0.7 0.4 0.8 0.6 0.6 0.6 0.5 0.4 0.8 0.9 1.0 0.7 0.5 2.2 0.6 0.5 0.5 1.2 2.4 0.6 4.7 1.7 1.7 2.0 4.7 4.4 0.1 17.9 9.3 0.5 9.7 0.2 0.0 3.2 5.1 4.0 14.8 1.8 0.0 1.7 1.7 4.7 73.4 26.3 61.4 0.0 31.6 2.2 5.8 20.5 8.1 5.7 0.3 0.0 5.8 29.4 2.7 24.0 3.1 0.2 0.0 1.8 16.2 3.4 55.0 38.6 0.7 4.3 0.0 6.5 0.7 1.2 1.5 0.0 5.0 0.0 17.1 3.6 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.5" "Group enriched" "Detected in many" 8 "Early spermatids: 397.3;Late spermatids: 669.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Yes No Nucleoli "Mitotic spindle, Cytosol" "HPA075536: AB_2686755" "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 2.1 2.1 3.2 3.8 3.6 2.8 2.2 4.8 3.6 2.3 2.1 4.2 4.3 2.0 3.4 5.1 2.0 1.7 1.9 2.3 2.6 1.9 1.9 1.7 2.0 2.8 4.2 1.5 2.7 2.3 2.1 8.5 1.8 3.0 2.1 2.3 1.8 2.0 3.2 2.0 2.0 1.8 2.1 5.4 2.0 2.0 65.5 3.2 3.4 2.7 0.3 2.2 2.3 2.3 2.4 1.7 0.1 0.6 2.9 5.9 0.5 2.6 2.9 0.8 3.6 2.5 1.9 1.3 2.3 0.9 0.8 2.5 0.6 3.8 1.9 1.2 1.6 2.3 1.3 1.4 1.4 3.2 6.8 0.3 1.1 2.0 0.7 4.3 1.1 1.9 1.8 0.7 1.7 0.7 1.6 1.0 3.0 1.5 6.7 3.3 0.4 0.8 0.6 0.7 1.4 2.8 1.6 3.7 0.3 2.4 0.6 1.9 1.9 0.4 0.5 1.6 1.1 1.9 1.5 3.9 2.0 2.4 2.6 1.3 2.1 1.4 2.0 2.6 7.5 1.1 0.0 0.6 0.1 3.4 0.3 3.3 2.4 5.3 2.9 0.3 1.2 5.9 3.9 0.1 2.9 0.3 1.7 3.5 0.5 3.2 3.6 4.8 3.6 2.6 1.9 4.2 1.5 3.0 3.2 6.0 7.5 0.8 1.0 1.6 8.6 6.7 0.0 1.4 4.5 1.8 3.9 0.6 1.7 3.1 397.3 2.3 1.4 0.0 3.0 1.0 1.2 0.8 11.6 0.0 1.6 0.0 2.9 0.0 0.0 669.2 8.9 2.3 1.7 1.0 2.0 2.7 2.3 0.0 6.7 0.6 25.0 12.9 1.0 70.9 6.1 1.0 0.1 1.5 1.7 0.6 CCDC71L "C7orf74, FLJ36031" ENSG00000253276 "Coiled-coil domain containing 71 like" Q8N9Z2 7 106656765-106660996 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.9" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 44.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067925 Approved Approved "Golgi apparatus,Actin filaments,Cytosol" NA NA "Golgi apparatus, Actin filaments" Cytosol "HPA067925: AB_2685925" "unprognostic (1.51e-1)" "prognostic unfavorable (9.08e-4)" "unprognostic (7.26e-2)" "unprognostic (1.10e-2)" "unprognostic (1.78e-2)" "unprognostic (1.95e-3)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (2.38e-3)" "unprognostic (6.03e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.53e-6)" "unprognostic (3.34e-2)" "unprognostic (3.72e-1)" "unprognostic (2.26e-1)" "unprognostic (6.35e-2)" 19.5 5.2 2.4 13.2 2.2 8.8 10.6 0.6 3.8 7.8 8.4 2.5 5.8 4.3 10.3 6.5 6.3 19.7 9.2 6.3 3.5 2.3 9.0 42.9 11.2 10.8 1.8 2.7 13.4 6.3 3.2 3.7 4.0 2.3 9.3 4.0 8.1 16.5 4.9 6.7 3.2 8.3 7.0 2.4 17.0 9.0 12.7 2.2 35.3 9.1 2.9 6.8 12.5 10.8 2.3 2.4 7.3 1.2 1.6 2.9 0.8 10.4 2.2 3.2 3.8 7.3 7.0 0.0 16.2 20.7 6.3 6.8 0.3 6.6 7.1 5.6 27.1 12.0 1.1 1.5 4.6 5.2 16.5 3.8 0.8 0.4 0.0 11.5 3.5 8.5 5.9 2.8 2.8 1.6 13.2 21.7 4.0 23.5 17.4 7.4 3.0 4.7 5.5 7.0 0.8 7.7 6.5 0.9 1.4 3.2 0.6 1.4 9.7 10.3 3.7 22.4 7.1 1.7 4.3 9.6 14.0 1.3 1.6 6.2 17.0 1.5 5.7 10.8 4.6 15.3 7.2 1.0 3.0 2.0 0.8 1.5 2.3 1.6 1.5 0.7 1.7 0.8 1.2 7.3 1.6 1.2 2.4 2.9 0.8 2.4 2.2 0.6 3.8 3.5 2.3 1.8 2.7 2.3 2.2 3.0 12.3 4.9 31.2 7.2 4.0 5.3 5.1 8.1 0.0 5.2 2.0 2.4 10.0 6.8 0.9 15.0 9.7 0.0 9.3 5.7 23.0 9.8 11.5 26.7 7.5 6.4 6.3 32.5 11.1 1.6 20.1 12.8 11.8 6.4 6.2 4.5 10.3 11.5 16.6 3.9 4.8 0.0 44.3 5.6 3.6 4.4 2.7 7.9 9.0 13.3 CCDC8 "3M3, DKFZp564K0322, PPP1R20" ENSG00000169515 "Coiled-coil domain containing 8" Q9H0W5 19 46410372-46413584 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.4" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 25.5;Distal tubular cells: 33.2;Leydig cells: 65.6;Peritubular cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.6" "Cell line enhanced" "Detected in many" "AF22: 12.0;AN3-CA: 14.3;HSkMC: 13.1;K-562: 12.5;RH-30: 16.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041993 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041993: AB_10795388" "unprognostic (3.05e-3)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.39e-3)" "unprognostic (3.69e-1)" "unprognostic (6.64e-2)" "unprognostic (5.16e-2)" "unprognostic (7.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (5.72e-2)" "prognostic favorable (1.72e-5)" "unprognostic (5.43e-3)" "unprognostic (5.77e-2)" "unprognostic (4.09e-2)" "unprognostic (4.18e-3)" 2.7 13.3 3.0 2.1 3.8 0.6 7.6 0.9 2.3 18.9 2.4 5.1 6.2 0.8 15.5 17.3 2.9 19.0 9.7 18.9 3.1 2.3 7.9 0.7 7.1 0.9 2.4 2.9 39.4 19.2 8.5 9.9 5.6 4.6 12.1 1.1 10.0 8.7 7.5 3.0 2.2 1.6 6.7 2.0 1.8 1.7 9.0 2.6 4.2 11.8 2.6 1.4 4.8 5.8 0.4 0.3 3.6 0.4 0.2 0.2 0.1 1.2 0.1 12.0 14.3 3.2 4.0 5.8 6.1 0.0 1.4 0.6 0.0 0.1 0.1 8.2 4.8 0.2 0.1 0.1 9.5 0.6 0.0 6.0 0.0 0.1 0.6 10.7 0.0 0.1 13.1 0.0 3.4 10.0 0.2 0.0 0.1 12.5 0.0 4.4 0.0 0.0 0.8 8.7 0.0 0.0 0.4 16.2 0.0 10.5 0.0 1.9 0.1 0.0 0.0 0.0 9.7 0.1 2.9 1.1 0.8 3.2 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.4 0.2 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.6 0.2 0.3 0.3 0.1 0.1 3.0 3.8 0.9 2.3 3.1 2.3 2.4 2.9 4.6 2.6 0.0 0.6 0.0 5.7 0.8 0.0 25.5 10.2 2.7 6.8 10.4 0.0 5.8 33.2 11.1 0.3 0.4 0.0 0.0 0.9 7.8 9.9 0.5 1.1 0.0 1.5 0.0 0.0 1.3 0.0 1.3 65.6 0.9 1.7 0.0 0.0 13.3 5.9 0.0 54.5 0.8 0.4 12.9 7.2 0.3 4.5 0.1 1.7 0.0 0.0 0.5 CCDC82 FLJ23518 ENSG00000149231 "Coiled-coil domain containing 82" Q8N4S0 11 96352769-96389956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 343.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038704, HPA070631" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA038704: AB_10674835, HPA070631: " "unprognostic (3.04e-1)" "unprognostic (1.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.37e-1)" "unprognostic (9.94e-3)" "unprognostic (5.94e-2)" "unprognostic (3.68e-1)" "unprognostic (3.41e-1)" "unprognostic (7.68e-3)" "unprognostic (1.42e-1)" "unprognostic (9.84e-2)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" 19.4 12.5 22.8 14.6 32.7 12.1 15.3 34.5 29.6 13.6 12.7 18.3 6.7 9.8 18.4 12.2 9.0 14.9 13.9 10.4 23.7 9.0 13.7 17.8 15.7 17.4 31.9 20.3 16.5 13.5 11.7 22.3 14.3 25.6 12.2 11.6 8.1 11.9 13.7 10.8 10.5 15.5 14.1 26.0 16.5 13.6 19.4 35.5 7.5 15.9 6.2 15.8 15.4 16.9 14.3 12.2 28.6 10.8 22.7 19.2 11.0 5.4 8.2 25.4 9.8 16.9 14.5 9.4 21.2 13.1 13.9 20.4 13.5 19.1 11.3 20.0 11.0 23.0 12.8 9.0 7.7 20.7 19.3 5.5 23.1 17.6 11.5 12.1 18.1 15.4 8.8 4.1 28.1 10.6 13.1 16.6 11.6 13.8 12.3 18.7 0.2 15.3 17.6 5.0 9.6 5.9 10.5 21.6 10.1 10.6 14.2 4.0 10.8 11.7 1.2 10.4 17.8 1.9 9.0 19.2 24.8 13.6 20.6 11.2 4.2 12.6 16.5 7.4 14.3 17.5 28.6 8.3 15.5 16.5 10.2 17.2 14.3 17.6 16.1 8.9 12.1 19.2 18.2 11.6 22.7 10.8 12.2 18.4 11.0 22.8 32.7 34.5 29.6 23.7 9.0 31.9 20.3 25.6 35.5 17.9 35.6 25.2 24.5 27.1 51.9 30.7 12.7 84.3 29.6 29.6 94.2 15.2 23.2 29.3 343.9 53.7 8.0 0.0 15.0 15.4 39.1 12.2 38.3 31.4 21.5 30.2 19.0 33.2 26.0 42.3 40.6 33.9 25.3 42.3 7.7 32.4 24.5 11.5 40.3 27.0 45.9 32.3 28.9 80.2 51.2 17.9 6.9 39.2 8.6 18.0 CCDC83 "CT148, FLJ42119, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 27.7" "Group enriched" "Detected in some" 11 "Early spermatids: 142.1;Late spermatids: 149.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "MCF7: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.8 0.8 0.3 0.6 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.7 0.3 0.3 0.2 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.3 7.9 0.1 0.4 0.0 1.3 0.0 0.1 0.0 0.1 0.6 0.3 0.1 0.1 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.4 0.8 0.6 0.3 0.6 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.3 0.5 1.8 0.3 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 142.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.4 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 13.1 1.3 0.0 0.0 0.0 0.0 0.0 CCDC88B "BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3" ENSG00000168071 "Coiled-coil domain containing 88B" A6NC98 11 64340223-64357534 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 10.1;HMC-1: 40.7;Karpas-707: 10.6;THP-1: 16.2;U-937: 11.7" "Not detected" "Not detected" HPA026652 Approved Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA Centrosome "Nucleoplasm, Cytosol" "HPA026652: AB_1846168" "unprognostic (1.18e-2)" "unprognostic (3.33e-3)" "unprognostic (3.65e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (1.55e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.77e-2)" "unprognostic (7.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.83e-2)" 3.5 2.5 5.2 29.5 5.4 32.5 2.7 23.7 2.8 2.6 6.1 4.5 6.9 3.2 2.0 1.3 4.2 2.5 8.5 2.3 4.1 2.6 2.0 1.6 11.4 18.6 8.6 2.2 1.3 2.1 0.7 1.6 1.4 6.5 2.9 2.9 1.7 7.5 8.9 0.8 1.9 11.1 1.3 7.2 26.6 3.3 7.3 6.5 16.8 1.9 2.7 20.8 4.1 2.8 3.0 3.5 11.3 6.5 7.1 4.6 1.6 0.1 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 1.6 9.3 1.4 0.5 0.2 0.8 0.0 0.2 0.0 10.1 0.0 7.0 1.8 0.5 0.4 4.3 40.7 0.0 0.0 0.1 0.0 0.6 0.2 3.0 0.2 10.6 0.3 0.4 5.8 3.6 0.3 1.7 0.2 5.5 0.1 8.6 0.1 0.1 2.3 0.0 0.0 0.2 0.5 0.0 1.2 16.2 0.0 0.0 0.3 0.0 0.1 2.3 0.7 7.5 0.5 11.7 0.2 3.6 6.5 7.6 4.6 4.7 1.4 2.2 2.7 3.8 2.1 3.0 2.6 3.2 11.3 7.1 3.1 3.5 0.8 1.6 5.2 5.4 23.7 2.8 4.1 2.6 8.6 2.2 6.5 6.5 0.0 12.5 29.6 3.8 2.4 39.7 11.9 0.0 8.1 3.4 8.7 0.0 2.6 0.0 11.0 9.4 4.3 33.2 0.0 24.8 4.1 2.6 3.4 25.5 7.2 12.7 0.0 17.3 8.0 22.4 10.9 1.4 23.3 5.0 22.6 20.8 11.7 25.7 31.7 0.7 2.3 4.4 0.0 2.3 12.5 1.5 1.4 1.1 31.6 17.9 14.8 CCDC9 DKFZP586M1019 ENSG00000105321 "Coiled-coil domain containing 9" Q9Y3X0 19 47255980-47273701 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 47.5;Late spermatids: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045624, HPA072007" Enhanced Approved Cytosol NA NA Cytosol "HPA045624: AB_10961402, HPA072007: AB_2686482" "unprognostic (4.53e-3)" "unprognostic (1.75e-1)" "unprognostic (3.70e-3)" "unprognostic (8.22e-2)" "unprognostic (7.47e-2)" "unprognostic (1.15e-2)" "unprognostic (8.35e-3)" "unprognostic (1.45e-1)" "unprognostic (4.99e-1)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (9.78e-2)" "unprognostic (2.58e-1)" "unprognostic (2.45e-2)" "unprognostic (1.02e-1)" "unprognostic (7.46e-3)" "unprognostic (4.02e-1)" 17.4 16.9 10.1 18.4 13.5 38.3 16.0 14.9 15.0 18.0 16.1 13.0 20.6 14.8 31.2 19.6 15.0 16.2 17.4 15.6 10.6 7.1 14.3 16.0 18.0 14.3 14.7 10.4 23.4 35.1 16.2 14.9 21.8 13.2 19.3 9.8 17.9 14.7 19.8 23.2 23.5 14.0 28.2 9.3 16.8 17.3 23.3 15.6 11.1 19.0 13.1 13.3 21.8 23.2 2.3 2.9 7.8 2.7 2.0 3.6 0.8 11.6 11.9 9.4 10.4 3.0 8.2 10.7 16.3 7.2 10.0 11.0 12.6 9.2 5.3 4.4 10.7 8.3 11.0 8.6 6.9 5.5 14.1 5.3 13.7 10.9 9.5 9.6 5.5 14.3 8.7 10.3 9.5 8.9 8.5 6.6 6.8 18.6 27.3 6.6 14.0 6.4 48.6 10.4 19.3 4.7 11.4 9.0 6.0 4.5 8.5 3.6 9.3 22.1 16.0 8.6 8.1 13.3 11.4 9.0 11.6 10.4 6.9 13.7 9.1 15.7 8.0 10.8 7.5 8.9 0.8 2.5 3.8 2.9 2.7 1.5 1.4 2.3 2.4 1.9 2.3 2.4 1.7 7.8 2.0 1.7 2.9 3.6 0.8 10.1 13.5 14.9 15.0 10.6 7.1 14.7 10.4 13.2 15.6 6.0 1.7 12.0 13.6 12.5 2.0 2.2 0.0 1.4 1.2 1.8 3.9 4.4 5.0 6.6 47.5 6.7 8.1 0.0 9.8 7.2 5.1 9.2 8.1 2.9 5.1 0.0 3.5 3.1 7.5 57.5 4.0 6.3 6.8 10.0 6.5 1.5 9.3 4.3 3.5 5.4 7.0 6.5 14.4 2.6 5.9 15.6 12.8 6.9 5.8 11.9 CCDC97 "FLJ40267, MGC20255" ENSG00000142039 "Coiled-coil domain containing 97" Q96F63 19 41310189-41324883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043320, HPA043572" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA043320: AB_10964344, HPA043572: AB_10962488" "unprognostic (9.25e-3)" "unprognostic (7.26e-2)" "unprognostic (1.68e-1)" "unprognostic (5.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.09e-4)" "unprognostic (8.40e-2)" "unprognostic (1.91e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (4.51e-2)" "unprognostic (2.16e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-1)" "unprognostic (7.92e-2)" "unprognostic (1.65e-2)" 20.4 15.3 15.5 20.7 18.8 21.5 16.8 16.1 24.7 21.3 16.7 26.7 17.8 15.1 21.3 26.6 22.9 24.5 15.8 16.4 14.6 14.1 16.5 13.3 15.4 23.2 16.0 16.2 27.4 20.6 20.8 21.9 22.9 18.6 19.0 12.6 20.9 21.1 17.2 28.8 21.5 18.4 15.6 21.0 24.2 17.3 39.9 16.8 27.7 17.9 20.4 27.2 17.7 19.7 13.6 7.6 14.6 13.3 11.5 16.8 8.3 13.1 28.9 15.3 17.8 20.2 16.2 11.1 8.9 7.2 14.1 12.1 17.1 12.7 12.6 9.6 7.4 9.5 9.0 21.0 17.7 10.8 23.0 20.3 11.5 13.0 11.2 15.4 19.0 24.9 15.7 22.8 16.4 13.8 11.6 9.7 13.9 14.6 24.1 13.4 9.6 17.3 4.6 7.1 16.0 10.4 19.6 12.2 9.1 12.9 25.2 13.8 12.2 19.8 21.9 8.7 10.7 14.9 14.5 11.5 12.2 12.3 6.3 14.7 24.8 21.2 12.1 11.6 14.0 16.1 9.0 8.3 9.7 15.3 9.2 16.8 11.3 10.3 10.9 6.8 13.6 11.4 10.0 14.6 11.5 13.3 7.6 8.5 8.3 15.5 18.8 16.1 24.7 14.6 14.1 16.0 16.2 18.6 16.8 11.9 7.9 9.3 10.0 4.0 11.7 5.9 10.2 6.7 3.4 8.7 11.8 9.6 6.6 10.7 2.5 7.5 12.9 0.0 22.5 4.4 7.6 7.8 16.1 4.9 13.4 9.5 11.1 10.4 11.6 7.8 11.8 7.7 1.7 18.0 11.1 6.4 17.7 2.9 10.6 7.2 8.8 0.0 8.3 20.6 11.7 5.1 15.3 16.0 9.6 10.9 CCDC9B "C15orf52, FLJ43339" ENSG00000188549 "Coiled-coil domain containing 9B" Q6ZUT6 15 40331452-40340967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.7;Collecting duct cells: 19.2;Ductal cells: 27.2;Pancreatic endocrine cells: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 6.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.7" "Cell line enhanced" "Detected in many" "HaCaT: 37.9;hTERT-RPE1: 35.2;WM-115: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040484, HPA041834" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040484: AB_10794742, HPA041834: AB_10795643" "unprognostic (5.57e-3)" "unprognostic (1.85e-1)" "unprognostic (2.60e-3)" "unprognostic (2.33e-2)" "unprognostic (1.48e-2)" "unprognostic (2.68e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-2)" "unprognostic (2.50e-1)" "unprognostic (1.04e-3)" "unprognostic (1.55e-1)" "unprognostic (3.48e-1)" "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" 2.8 4.8 3.6 9.4 5.8 1.5 4.5 3.4 6.2 9.4 29.6 6.3 38.1 5.7 11.5 14.1 19.8 5.0 12.3 30.5 5.8 3.2 5.1 2.1 6.8 1.7 6.7 4.7 2.6 12.0 9.7 4.8 2.3 5.7 10.3 7.6 12.9 13.9 40.6 35.0 7.7 8.3 16.2 3.6 2.5 11.0 5.3 6.3 0.3 21.3 16.1 6.1 13.0 7.2 0.5 0.5 6.7 0.6 0.9 0.3 0.4 14.9 2.1 0.0 0.1 0.3 1.5 0.8 4.5 4.5 5.1 5.0 0.1 13.9 0.1 6.4 14.6 18.5 37.9 0.0 12.4 4.8 0.0 0.1 4.5 17.7 1.4 2.7 0.0 0.9 1.8 2.8 2.2 6.4 35.2 3.6 0.2 0.0 0.2 8.6 0.0 0.1 0.0 0.1 7.0 4.0 0.0 1.3 0.0 15.3 0.8 0.0 1.1 2.7 6.0 2.6 0.0 0.6 0.7 19.1 9.5 15.2 2.5 11.9 0.0 0.0 0.1 11.5 0.8 43.1 6.7 0.6 0.6 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.5 0.3 0.2 1.2 0.9 0.2 0.5 0.0 0.4 3.6 5.8 3.4 5.3 5.8 3.2 6.7 4.7 5.7 6.3 11.9 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 19.2 0.0 0.0 1.7 27.2 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CCHCR1 "C6orf18, HCR" ENSG00000204536 "Coiled-coil alpha-helical rod protein 1" Q8TD31 6 31142439-31158238 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 50.1" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 64.7;Late spermatids: 110.5;Spermatocytes: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054167 Supported Cytosol NA NA Cytosol "HPA054167: AB_2682403" "unprognostic (6.68e-2)" "unprognostic (7.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (3.11e-3)" "unprognostic (2.23e-3)" "unprognostic (1.99e-1)" "unprognostic (2.74e-1)" "unprognostic (5.36e-3)" "unprognostic (1.65e-1)" "unprognostic (2.07e-1)" "unprognostic (3.85e-3)" "unprognostic (1.06e-1)" "unprognostic (4.35e-2)" "unprognostic (3.57e-1)" "unprognostic (4.17e-2)" 2.4 2.7 5.6 2.8 6.2 1.2 3.1 5.2 6.4 3.7 4.5 2.9 9.1 9.4 6.3 5.6 3.9 8.0 2.9 2.5 4.0 2.7 4.3 2.9 3.0 5.5 4.1 5.6 5.5 7.6 1.7 2.5 1.5 4.5 5.3 3.2 3.4 3.5 6.8 10.1 7.0 5.9 3.9 2.6 3.4 6.6 50.1 3.8 4.3 6.2 3.1 4.2 3.4 4.0 2.0 3.4 1.4 2.1 2.5 4.3 2.3 22.0 1.7 6.2 0.9 3.8 4.5 5.8 1.9 0.6 0.3 0.7 8.8 0.4 2.9 10.5 4.9 13.8 0.9 0.3 8.9 0.9 3.2 14.1 10.4 7.3 6.7 2.2 0.2 6.9 5.8 1.0 4.1 0.9 4.5 4.7 16.3 4.1 6.1 2.6 1.6 3.8 11.6 0.3 0.8 0.1 7.0 8.3 5.4 5.7 2.2 17.4 2.9 7.2 0.0 1.8 3.8 2.4 5.5 0.6 9.2 2.9 0.2 5.5 14.3 8.2 11.9 1.9 2.5 0.9 0.3 2.1 1.4 2.9 0.9 2.5 1.3 2.6 4.3 1.5 2.0 4.0 4.0 0.6 2.5 1.2 3.4 4.0 2.3 5.6 6.2 5.2 6.4 4.0 2.7 4.1 5.6 4.5 3.8 3.0 3.2 4.8 12.9 8.7 8.6 6.9 7.6 8.1 9.1 3.5 0.0 2.2 10.0 8.2 64.7 4.9 32.8 0.0 9.4 6.0 6.1 6.6 0.0 5.7 5.9 14.3 28.2 1.8 4.6 110.5 9.2 3.6 6.8 12.6 26.1 5.8 8.3 10.5 11.0 7.3 1.9 6.5 4.7 80.8 16.7 5.1 1.1 4.6 28.1 6.4 CCNA2 "CCN1, CCNA" ENSG00000145386 "Cyclin A2" P20248 4 121816444-121823933 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 122.3" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 70.0;Extravillous trophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 6.8" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 6.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB000114, HPA020626" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB000114: AB_563675, HPA020626: AB_1847376" "unprognostic (4.02e-2)" "unprognostic (1.93e-1)" "unprognostic (7.66e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "prognostic unfavorable (9.17e-5)" "prognostic unfavorable (4.27e-4)" "unprognostic (3.92e-3)" "unprognostic (2.65e-2)" "prognostic unfavorable (4.43e-6)" "unprognostic (8.38e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (6.07e-2)" "unprognostic (1.59e-1)" 3.2 1.5 1.3 18.6 1.7 21.6 1.8 5.1 1.2 2.5 6.3 1.0 0.8 6.6 2.2 2.1 11.7 1.7 2.4 3.2 1.8 1.8 1.7 1.6 3.4 15.6 1.6 0.8 4.5 0.9 0.5 3.2 12.0 1.3 2.2 7.8 1.0 2.1 0.8 1.1 4.2 7.4 2.4 1.8 8.9 2.9 8.4 0.8 122.3 1.4 18.8 18.4 2.5 5.1 0.3 0.9 0.6 0.3 1.7 6.8 1.9 38.7 10.1 27.7 11.8 1.5 3.8 22.7 27.1 11.9 36.0 26.8 22.0 24.1 35.7 7.3 14.2 12.7 13.1 34.8 15.9 29.7 17.1 16.1 28.6 13.4 21.3 0.3 43.1 20.3 1.0 1.2 14.9 8.9 5.7 21.5 19.0 40.7 35.9 28.5 13.9 54.9 25.0 21.8 24.3 11.3 25.2 53.7 17.4 10.2 7.7 11.8 12.5 14.2 17.4 7.5 21.7 14.5 18.3 12.7 16.9 25.7 17.8 25.8 22.8 24.1 40.9 9.7 43.9 18.7 0.0 0.3 0.6 0.2 0.1 0.1 0.3 2.0 1.4 0.9 0.1 0.0 0.5 0.3 1.7 0.3 0.1 6.8 1.9 1.3 1.7 5.1 1.2 1.8 1.8 1.6 0.8 1.3 0.8 0.0 0.6 0.0 0.7 2.5 1.1 0.7 0.0 2.7 1.2 0.0 11.8 5.7 0.0 0.3 4.8 0.7 1.5 70.0 0.2 72.3 3.3 1.1 0.0 1.5 21.0 0.0 1.2 2.5 7.5 1.5 0.9 2.9 1.7 0.0 3.1 1.3 0.4 1.5 1.1 0.0 14.2 0.0 0.9 6.1 7.9 1.1 7.1 3.2 6.4 1.3 CCNB1 CCNB ENSG00000134057 "Cyclin B1" P14635 5 69167010-69178245 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 71.4" "Cell type enriched" "Detected in many" 9 "Extravillous trophoblasts: 610.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB000115, CAB003804, HPA030741, HPA061448" Enhanced Enhanced Cytosol Yes Yes Cytosol "CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522" "unprognostic (4.12e-2)" "unprognostic (2.75e-2)" "unprognostic (1.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.78e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.54e-7)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.43e-2)" "unprognostic (1.63e-2)" "unprognostic (2.49e-3)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (2.44e-1)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.15e-3)" 3.2 4.6 2.7 23.9 4.8 20.5 4.6 6.5 5.6 4.4 9.9 1.6 1.6 9.3 3.5 2.8 28.8 3.3 3.5 1.9 3.5 4.2 4.6 2.9 3.4 23.6 4.0 4.2 3.7 4.0 1.6 2.6 12.1 11.5 2.6 14.2 1.7 5.3 1.7 2.0 6.4 8.7 6.4 2.5 9.1 7.1 21.7 1.3 71.4 6.3 23.3 30.1 5.3 7.5 13.2 5.1 2.4 4.1 6.5 14.7 5.5 58.6 40.6 55.8 49.6 2.9 5.0 131.7 26.0 19.5 68.6 58.1 60.0 55.4 36.1 31.7 23.9 78.7 37.0 56.1 56.8 77.0 35.4 27.7 22.9 33.9 41.4 0.9 19.9 26.2 2.2 3.6 39.3 27.4 6.3 36.6 35.4 27.6 28.7 55.8 55.9 27.2 23.7 31.0 19.5 25.8 28.7 40.2 37.0 25.1 21.7 28.4 17.9 44.7 21.1 19.2 32.8 40.3 20.9 15.3 15.3 49.7 27.6 64.9 14.4 26.6 50.4 21.2 34.9 47.0 2.4 1.8 1.2 2.8 4.1 4.0 13.2 7.6 6.7 5.1 8.6 2.5 2.4 1.0 6.5 1.9 4.2 14.7 5.5 2.7 4.8 6.5 5.6 3.5 4.2 4.0 4.2 11.5 1.3 0.0 0.3 5.2 4.8 10.2 4.2 1.5 2.5 13.4 4.5 5.2 2.0 53.5 1.7 5.3 63.8 1.8 2.9 46.7 1.2 610.8 11.3 3.6 2.3 3.0 50.4 0.0 1.2 6.2 6.0 9.4 2.8 4.4 3.3 3.6 4.6 2.8 2.5 0.0 2.5 4.3 2.9 6.5 3.1 28.8 70.2 6.4 34.7 4.4 11.5 2.7 CCNB2 HsT17299 ENSG00000157456 "Cyclin B2" O95067 15 59105078-59125045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.2;testis: 73.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 102.4;Erythroid cells: 163.5;Extravillous trophoblasts: 106.5;Spermatocytes: 88.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 4 "T-reg: 17.8" "Lineage enriched" "Detected in many" 6 "T-cells: 17.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008873, CAB009575" Enhanced Enhanced "Golgi apparatus,Cytosol" Yes Yes Cytosol "Golgi apparatus" "CAB009575: AB_2072392, HPA008873: AB_1078604" "unprognostic (2.69e-2)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.96e-2)" "unprognostic (1.77e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.83e-4)" "prognostic unfavorable (4.63e-4)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (4.48e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (3.98e-2)" "unprognostic (4.44e-1)" 2.0 1.1 0.4 21.0 0.4 24.7 2.5 0.3 0.6 1.8 5.5 0.5 0.2 5.2 1.0 1.5 11.3 0.5 1.6 1.2 0.4 0.4 1.0 1.0 1.9 12.0 0.4 0.3 0.8 0.7 0.0 0.4 6.7 0.4 1.1 6.3 0.4 2.1 0.6 0.4 3.6 5.1 2.0 1.3 5.2 3.0 73.9 0.2 70.2 0.8 10.3 16.0 1.8 3.4 1.8 2.3 0.7 0.1 3.0 17.8 1.8 28.7 25.3 41.6 10.3 1.9 3.8 22.1 23.8 15.3 36.9 30.4 40.9 17.7 26.7 17.3 15.4 21.6 35.5 39.3 20.2 34.9 27.7 21.1 34.6 29.6 23.2 0.5 25.7 22.3 1.4 2.7 15.9 20.3 7.2 25.0 33.0 34.9 42.9 27.8 20.9 29.3 37.5 30.7 12.4 15.0 34.3 58.9 27.1 11.6 20.3 25.9 17.5 32.6 17.7 21.5 34.0 30.7 25.7 13.0 18.4 31.2 20.2 45.3 19.1 28.7 47.5 12.0 58.9 25.9 0.0 0.1 0.6 0.1 0.0 0.2 1.8 3.9 4.1 2.3 0.9 0.0 0.1 0.7 3.0 0.0 0.1 17.8 1.8 0.4 0.4 0.3 0.6 0.4 0.4 0.4 0.3 0.4 0.2 0.0 1.1 7.8 1.0 4.2 0.0 0.3 0.0 1.4 2.3 0.0 0.0 26.7 0.0 0.4 102.4 0.4 1.7 163.5 0.2 106.5 1.1 1.7 0.0 0.8 25.3 0.0 2.9 3.1 10.7 30.4 4.0 4.2 0.0 3.6 5.5 0.0 0.5 1.7 1.8 0.0 0.2 0.0 0.0 88.2 36.6 5.4 13.6 3.2 12.4 2.0 CCNC CycC ENSG00000112237 "Cyclin C" P24863 6 99542380-99568973 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Cyclin, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010499, HPA069322" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB010499: AB_2244021, HPA069322: AB_2686120" "unprognostic (1.48e-2)" "unprognostic (1.21e-2)" "unprognostic (1.85e-3)" "unprognostic (6.34e-2)" "unprognostic (1.92e-2)" "unprognostic (1.95e-3)" "unprognostic (2.09e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-2)" "unprognostic (1.92e-1)" "unprognostic (7.10e-2)" "prognostic favorable (8.12e-4)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (3.83e-2)" 18.0 21.1 14.5 16.8 20.4 13.7 23.8 23.2 24.3 15.6 17.3 8.7 21.8 19.8 13.5 28.1 26.5 11.7 24.7 12.0 14.9 16.9 31.5 47.4 16.2 23.4 13.6 12.6 13.5 35.6 20.8 31.8 24.4 17.6 18.2 15.9 12.4 37.0 20.9 13.1 15.4 22.6 17.3 12.1 21.1 20.2 8.6 10.0 27.3 30.7 16.8 21.9 17.5 15.5 20.1 15.0 21.5 13.9 17.7 26.6 18.8 27.3 8.1 15.7 30.6 11.8 16.1 39.4 19.9 23.9 24.1 30.9 31.3 16.1 53.6 21.4 16.4 23.9 17.9 24.0 26.9 38.2 13.5 25.8 33.2 13.6 27.3 21.2 37.1 10.9 15.9 16.4 17.0 21.4 16.7 23.9 29.8 45.0 20.0 21.1 13.9 13.5 27.4 21.0 16.7 13.5 23.3 26.4 21.3 31.2 30.9 23.6 14.4 10.0 22.6 23.2 24.4 13.2 35.5 19.1 13.3 17.7 13.9 29.2 14.2 21.8 46.0 22.4 26.5 16.3 21.5 12.9 10.7 14.2 13.9 26.6 20.1 17.9 14.5 15.0 16.0 20.1 15.7 2.5 17.7 10.4 15.0 18.0 18.8 14.5 20.4 23.2 24.3 14.9 16.9 13.6 12.6 17.6 10.0 41.7 32.8 32.0 84.7 66.6 40.4 13.7 50.9 26.8 37.5 22.7 21.6 96.3 71.3 107.0 19.5 44.4 29.0 0.0 162.8 75.7 39.3 116.5 32.3 46.4 37.2 23.8 41.9 33.7 29.7 33.8 20.8 32.2 55.6 39.7 33.7 45.2 119.1 24.6 23.7 103.7 40.3 19.4 43.4 58.1 15.7 59.0 147.5 37.4 38.8 113.6 CCNG2 ENSG00000138764 "Cyclin G2" Q16589 4 77157151-77433388 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 16.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034684 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034684: AB_10669894" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (1.46e-2)" "unprognostic (2.29e-1)" "unprognostic (5.73e-2)" "unprognostic (8.15e-2)" "unprognostic (8.40e-3)" "unprognostic (1.72e-2)" "unprognostic (1.20e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (8.57e-4)" "unprognostic (2.04e-1)" "prognostic favorable (2.47e-5)" "unprognostic (7.98e-2)" "unprognostic (2.20e-1)" "unprognostic (2.28e-1)" "unprognostic (1.05e-3)" 18.4 8.1 11.3 13.5 15.1 25.9 26.7 53.0 17.2 15.1 12.3 8.9 9.6 8.6 16.4 10.7 45.2 8.0 10.4 6.3 9.6 5.4 23.0 3.4 12.8 21.4 7.3 10.6 12.5 7.2 8.8 7.7 20.0 7.3 26.1 11.0 12.2 18.4 10.5 7.5 12.8 9.8 13.5 7.4 14.2 7.7 8.0 7.8 25.3 17.3 7.2 22.6 20.3 18.6 4.8 2.2 16.0 2.3 1.6 4.6 0.6 10.3 1.3 23.4 12.4 15.5 19.9 15.8 8.7 25.2 6.8 12.8 1.5 15.1 20.9 14.1 8.1 6.5 7.5 6.1 28.9 13.2 14.5 4.1 1.7 6.0 3.0 8.1 3.1 21.9 16.8 14.4 3.2 7.1 22.9 10.2 12.4 1.0 12.8 12.5 4.0 14.2 6.6 2.3 5.0 1.4 8.2 22.8 1.3 43.0 28.8 6.2 19.9 10.3 16.4 6.1 14.6 12.2 4.7 9.5 9.3 9.5 6.7 1.4 9.5 7.2 14.8 6.5 4.9 4.6 11.4 1.5 16.0 0.8 2.0 1.9 2.7 1.2 0.8 1.5 4.8 0.9 0.5 6.5 1.6 2.3 2.2 4.6 0.6 11.3 15.1 53.0 17.2 9.6 5.4 7.3 10.6 7.3 7.8 11.9 10.5 50.6 33.0 33.0 67.4 4.0 5.1 4.0 4.5 52.4 21.6 23.6 72.9 23.7 0.6 35.4 27.6 0.0 17.2 86.4 68.4 86.4 38.1 1.6 26.8 23.8 16.0 31.9 38.3 0.9 25.6 27.7 54.0 67.7 29.5 17.3 37.9 17.5 25.8 40.8 46.6 64.7 34.8 5.2 10.0 23.3 13.2 22.4 13.5 38.8 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747445-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 17.4;seminal vesicle: 15.7" "Cell type enhanced" "Detected in some" 6 "Distal tubular cells: 3.3;Mucus-secreting cells: 3.3;Muller glia cells: 4.2;Paneth cells: 2.9;Undifferentiated cells: 3.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: AB_2683086" "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favorable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.3 0.7 3.4 5.6 3.5 0.3 0.3 8.4 4.7 1.2 5.8 3.5 17.4 7.8 0.2 0.7 0.5 0.8 5.2 0.6 3.9 2.6 3.8 0.3 0.7 1.7 3.9 0.5 0.3 7.4 0.4 0.9 0.5 4.1 1.7 6.5 1.5 8.4 15.7 0.7 0.7 8.9 0.4 7.2 0.8 5.5 1.4 3.9 7.0 0.8 0.7 2.1 2.4 0.3 0.3 0.1 0.7 0.1 0.2 2.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.4 0.0 0.6 24.0 0.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.4 1.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 3.7 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.3 0.1 2.7 0.3 2.1 2.1 0.0 0.3 1.8 0.9 0.3 0.2 0.1 0.1 2.7 0.3 3.4 3.5 8.4 2.8 3.9 2.6 3.9 0.5 4.1 3.9 0.0 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.4 1.7 0.0 1.7 0.0 1.4 0.1 0.0 0.9 1.1 0.0 0.1 1.6 1.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 3.3 4.2 1.2 2.9 0.0 0.3 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 3.5 0.6 CCNQ FAM58A ENSG00000262919 "Cyclin Q" Q8N1B3 X 153587919-153600045 "Disease related genes, Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 61.3;Extravillous trophoblasts: 78.8;Syncytiotrophoblasts: 101.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050137, HPA059843" Uncertain Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA050137: AB_2681029, HPA059843: AB_2684140" "unprognostic (3.94e-1)" "unprognostic (1.94e-2)" "unprognostic (7.36e-2)" "unprognostic (2.92e-1)" "unprognostic (5.08e-2)" "unprognostic (1.02e-2)" "unprognostic (1.47e-3)" "unprognostic (2.12e-1)" "unprognostic (8.50e-3)" "unprognostic (2.08e-2)" "unprognostic (1.57e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (8.75e-2)" "unprognostic (2.31e-1)" "unprognostic (2.71e-2)" "unprognostic (5.25e-2)" 3.1 5.7 4.2 6.1 12.8 4.2 9.7 3.7 11.1 4.5 5.2 6.4 4.2 6.1 3.7 10.5 5.1 5.1 4.0 14.7 7.9 6.5 6.3 5.0 10.9 9.5 6.1 4.1 9.5 3.0 6.4 6.4 7.3 5.7 6.1 3.5 8.0 6.8 10.3 4.0 5.0 4.9 6.7 7.3 5.4 2.7 7.4 3.9 4.9 4.2 8.7 5.2 4.5 7.4 1.9 6.8 2.3 1.1 4.8 1.4 19.8 15.5 6.0 21.3 11.0 5.6 9.4 12.0 10.5 11.4 11.7 14.9 7.1 16.1 23.2 12.7 17.2 12.9 19.8 11.4 11.8 9.8 20.1 3.9 9.3 11.4 9.7 13.6 9.4 7.4 10.2 7.7 8.5 5.2 9.7 8.4 4.8 7.8 9.7 23.1 9.5 16.6 7.6 21.5 26.2 10.8 9.7 8.4 8.7 8.5 7.9 10.4 6.2 9.7 14.0 6.4 3.5 12.4 6.9 10.1 14.3 22.3 18.1 11.2 10.6 20.4 9.1 21.2 7.4 0.0 2.3 6.8 4.0 2.1 1.8 7.4 3.7 2.8 1.9 6.2 4.0 2.8 1.4 1.1 1.0 1.9 4.8 1.4 3.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 5.7 7.0 0.0 36.5 61.3 22.4 0.0 0.0 0.0 0.0 32.2 78.8 0.0 0.0 2.3 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 39.7 0.0 0.0 27.4 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 101.1 0.0 0.0 0.0 CCNT2 ENSG00000082258 "Cyclin T2" O60583 2 134918235-134959342 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005559 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA005559: AB_1078608" "unprognostic (2.49e-2)" "unprognostic (1.19e-1)" "unprognostic (9.57e-2)" "unprognostic (1.25e-1)" "unprognostic (4.92e-2)" "unprognostic (2.65e-3)" "unprognostic (1.85e-2)" "unprognostic (1.00e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.44e-4)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.33e-1)" "unprognostic (8.51e-2)" "unprognostic (9.94e-2)" "prognostic favorable (3.28e-4)" 15.8 14.1 21.0 15.2 19.9 32.5 21.1 30.5 22.2 16.4 14.2 16.9 17.8 17.6 22.6 20.9 15.4 16.1 12.9 14.2 16.1 14.3 12.9 20.8 17.5 18.9 18.6 16.2 22.8 24.0 25.1 29.6 17.9 20.0 18.0 16.7 11.5 16.9 19.4 14.5 20.3 17.2 18.0 17.1 19.8 18.9 15.8 19.1 23.0 18.7 9.4 18.2 18.9 19.5 3.8 4.9 6.9 4.5 6.2 8.4 3.4 6.7 3.4 22.1 8.2 11.0 11.2 16.8 9.3 7.7 8.9 11.1 9.1 7.8 11.1 7.1 7.7 4.3 8.8 13.2 7.0 13.0 5.9 8.9 11.9 8.7 12.8 10.8 10.7 10.6 10.2 14.0 8.7 10.8 11.5 13.0 8.4 9.9 11.4 10.3 4.6 11.8 16.0 17.9 5.6 7.0 11.5 7.9 8.8 13.7 18.7 15.1 12.5 6.9 8.0 10.7 16.8 8.4 13.1 11.8 11.5 12.6 4.9 6.8 8.1 4.9 11.6 7.1 8.6 9.7 6.9 3.7 4.5 4.3 4.5 5.3 3.8 4.8 5.1 4.9 3.1 8.4 6.4 4.8 6.2 2.3 4.5 5.9 3.4 21.0 19.9 30.5 22.2 16.1 14.3 18.6 16.2 20.0 19.1 23.8 24.2 24.6 28.3 13.4 32.7 19.5 17.8 9.4 20.5 14.0 31.4 9.1 6.6 13.6 4.7 18.2 17.4 0.0 13.0 7.4 12.5 26.7 10.5 18.4 8.6 39.7 17.7 20.3 12.9 11.8 13.0 20.9 8.5 14.4 14.5 16.7 12.3 17.5 20.8 4.8 32.8 19.4 11.3 16.8 19.9 15.8 11.4 20.0 14.3 38.3 CCSER2 "FAM190B, KIAA1128" ENSG00000107771 "Coiled-coil serine rich protein 2" Q9H7U1 10 84328558-84518521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 17 "Early spermatids: 1964.7;Late spermatids: 4316.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037481, HPA037482" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037481: AB_10672385, HPA037482: AB_10671501" "unprognostic (4.06e-3)" "unprognostic (4.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.71e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-1)" "unprognostic (5.60e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-1)" "unprognostic (3.02e-2)" "unprognostic (1.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.83e-2)" "unprognostic (8.56e-2)" "unprognostic (1.33e-1)" "unprognostic (5.74e-2)" 14.9 8.7 18.5 7.9 18.2 7.3 16.7 22.1 21.8 16.4 18.3 17.9 11.4 9.4 15.7 13.1 22.7 9.2 10.3 42.9 19.6 18.2 9.9 10.5 13.3 9.0 21.7 15.9 11.8 9.9 11.8 8.8 15.3 28.3 12.6 10.4 9.4 10.3 13.5 46.2 13.0 15.5 24.2 22.2 8.2 10.6 45.7 15.2 11.8 19.9 14.6 9.1 17.1 11.9 5.2 4.4 5.2 3.0 14.6 15.0 5.4 8.1 6.3 7.5 16.6 11.1 18.2 5.3 9.8 16.3 6.1 12.0 3.5 8.7 5.4 6.4 18.1 9.8 7.0 5.6 6.2 9.2 17.9 3.5 1.9 3.0 4.4 10.2 2.8 4.1 8.8 9.0 9.9 31.9 15.9 16.7 10.3 2.5 16.6 11.0 5.0 4.9 2.0 3.2 2.8 5.1 5.1 3.8 2.0 5.5 8.7 2.3 4.2 5.4 3.6 16.8 10.9 6.6 1.4 14.9 18.4 8.4 9.1 10.3 16.8 5.6 4.3 11.9 3.7 7.9 2.7 3.0 5.2 14.9 2.8 15.0 5.2 11.1 13.7 2.9 5.0 10.0 10.5 4.2 14.6 2.2 4.4 6.7 5.4 18.5 18.2 22.1 21.8 19.6 18.2 21.7 15.9 28.3 15.2 38.7 32.6 20.4 45.4 31.4 85.2 186.4 7.6 17.4 23.9 15.7 29.5 20.9 31.5 27.4 1964.7 54.3 18.1 0.0 40.4 16.4 42.3 44.4 13.9 19.5 18.3 58.8 15.6 33.2 15.6 4316.6 47.8 31.8 25.3 47.7 24.3 49.5 27.2 14.1 56.3 21.9 51.3 12.9 46.9 67.4 64.1 41.0 57.2 64.8 16.6 56.7 CCT2 Cctb ENSG00000166226 "Chaperonin containing TCP1 subunit 2" P78371 12 69585334-69601570 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 1208.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003197, HPA003198" Enhanced Supported Cytosol NA NA 9100000 Cytosol "HPA003197: AB_1078425, HPA003198: AB_1078424" "unprognostic (1.79e-3)" "unprognostic (2.35e-1)" "unprognostic (1.40e-3)" "unprognostic (1.53e-1)" "unprognostic (4.42e-2)" "prognostic unfavorable (8.38e-4)" "prognostic unfavorable (3.61e-9)" "unprognostic (5.28e-3)" "unprognostic (2.15e-2)" "unprognostic (1.08e-2)" "unprognostic (5.34e-2)" "prognostic unfavorable (3.67e-4)" "unprognostic (6.53e-3)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.63e-1)" "unprognostic (7.21e-2)" 29.4 32.1 25.7 28.3 31.4 45.8 33.8 39.2 37.0 25.0 27.0 23.1 21.0 20.7 27.8 18.0 32.1 28.0 21.9 30.8 25.0 29.9 46.0 39.7 22.5 33.6 24.7 22.2 30.7 28.6 29.1 28.2 29.5 45.3 27.5 34.8 19.6 21.6 22.1 46.6 22.6 22.2 32.8 23.1 33.3 25.1 81.7 20.3 55.7 34.8 41.2 40.5 31.4 32.0 29.7 28.2 10.3 25.3 23.2 29.5 24.5 38.8 60.4 53.9 51.4 24.9 28.3 61.6 42.4 31.1 69.7 43.1 81.2 18.9 85.4 41.1 34.2 45.1 38.4 83.9 48.3 85.3 46.9 61.5 62.1 47.3 49.8 27.9 76.2 40.3 24.7 30.9 67.2 39.6 49.2 46.0 48.5 75.4 25.6 64.1 57.3 71.1 66.5 75.2 41.8 62.7 57.4 58.6 56.6 58.2 72.8 52.1 44.3 44.0 49.1 43.4 47.1 63.5 56.9 29.6 36.7 44.7 42.9 63.5 31.1 58.5 90.1 31.8 53.6 44.6 10.3 15.4 4.4 19.1 25.3 29.5 29.7 22.4 24.9 28.2 24.2 26.6 27.9 1.5 23.2 22.0 25.8 23.8 24.5 25.7 31.4 39.2 37.0 25.0 29.9 24.7 22.2 45.3 20.3 32.8 39.6 80.5 170.6 121.3 47.6 82.2 33.1 129.8 88.7 76.8 74.6 168.3 77.9 183.9 1208.4 68.7 26.9 23.3 110.8 169.5 100.8 92.3 104.9 40.4 113.2 39.7 101.8 50.3 35.5 299.4 71.1 66.7 43.9 92.0 70.4 64.2 130.9 28.1 62.6 104.8 51.3 84.1 111.8 459.2 324.1 102.6 128.3 61.2 136.6 138.0 CCT3 "Cctg, TRIC5" ENSG00000163468 "Chaperonin containing TCP1 subunit 3" P49368 1 156308968-156367873 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006543 Approved Approved "Plasma membrane,Cytosol" NA NA 4000000 "Plasma membrane, Cytosol" "HPA006543: AB_1078426" "unprognostic (2.14e-2)" "unprognostic (3.20e-3)" "unprognostic (1.66e-1)" "unprognostic (6.00e-3)" "unprognostic (8.39e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (3.87e-7)" "unprognostic (4.43e-3)" "unprognostic (2.78e-1)" "unprognostic (1.16e-1)" "unprognostic (5.44e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (7.16e-2)" "unprognostic (5.76e-2)" "unprognostic (5.67e-2)" "unprognostic (1.10e-1)" 38.8 68.8 37.6 41.8 43.2 26.9 51.2 54.5 51.4 35.1 42.1 46.2 33.8 37.9 50.4 34.8 56.1 52.2 29.2 41.5 36.7 41.6 60.8 61.9 30.9 48.1 43.5 32.8 53.0 59.0 56.7 55.9 39.2 43.0 38.1 50.0 35.3 34.4 41.4 66.4 38.2 39.5 59.7 41.2 41.6 41.9 49.8 47.6 62.1 60.0 49.9 60.7 44.8 82.4 34.8 39.3 14.2 30.5 30.8 45.1 43.9 50.4 57.6 39.3 37.7 43.7 32.5 51.3 47.2 37.5 74.7 46.0 57.0 46.8 83.4 55.0 39.5 47.6 47.6 124.4 61.4 63.9 44.7 78.3 52.9 46.8 45.0 32.2 65.4 44.5 41.2 36.8 67.1 62.5 36.7 63.2 50.4 90.7 30.2 44.3 46.9 86.0 40.1 79.6 99.6 83.5 69.2 39.8 90.3 54.8 32.0 53.3 55.0 43.5 76.7 42.1 66.0 67.8 80.1 43.6 30.4 45.4 31.8 84.1 56.1 99.6 124.1 35.4 41.7 49.3 14.2 25.3 11.2 31.2 30.5 41.6 34.1 34.7 34.2 39.3 34.8 45.1 37.8 3.6 30.8 30.2 25.5 35.5 43.9 37.6 43.2 54.5 51.4 36.7 41.6 43.5 32.8 43.0 47.6 50.6 46.8 129.4 183.9 128.7 109.7 102.4 58.6 127.2 85.3 85.5 100.1 202.7 96.2 186.6 88.8 105.6 80.4 23.3 158.9 172.8 109.3 142.8 72.6 72.7 143.2 69.9 120.2 69.3 70.6 169.9 77.3 80.0 106.3 208.2 75.5 134.0 167.6 87.7 82.7 157.7 195.7 116.4 117.4 367.9 233.1 139.6 154.4 96.5 112.5 146.5 CCT4 Cctd ENSG00000115484 "Chaperonin containing TCP1 subunit 4" P50991 2 61868089-61888804 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029349 Supported Supported Nucleoplasm,Cytosol NA NA 3400000 Cytosol Nucleoplasm "HPA029349: AB_10600800" "prognostic unfavorable (2.03e-4)" "unprognostic (2.80e-2)" "unprognostic (6.46e-2)" "unprognostic (1.74e-3)" "unprognostic (5.03e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (9.37e-12)" "unprognostic (1.28e-3)" "unprognostic (2.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-2)" "unprognostic (5.18e-2)" "unprognostic (2.00e-1)" "unprognostic (3.96e-1)" "unprognostic (2.14e-2)" 35.1 42.3 34.8 33.3 38.7 32.4 63.3 41.2 40.6 37.7 36.2 26.0 34.4 26.7 43.1 32.6 47.9 44.6 25.3 49.0 31.4 33.7 43.1 37.6 28.7 54.1 42.1 33.9 66.4 65.9 39.7 32.8 37.7 40.0 37.6 35.4 21.5 32.1 35.9 52.5 37.5 28.1 42.5 39.7 36.2 38.1 49.4 37.7 55.6 50.0 40.8 50.9 39.3 93.4 30.3 31.4 13.7 29.8 31.6 39.1 34.6 42.4 49.6 33.1 30.7 27.5 42.0 55.7 38.9 27.9 56.2 37.8 86.2 30.9 68.5 39.6 27.8 58.7 30.7 64.9 49.8 59.4 33.6 63.8 43.7 25.7 54.1 24.8 53.7 29.3 35.6 34.7 45.2 47.2 43.0 46.9 35.4 62.1 22.1 47.8 38.2 46.3 73.9 59.5 58.0 44.2 52.6 51.8 46.3 39.1 29.3 28.9 24.3 28.2 36.0 50.2 40.7 26.1 39.8 29.4 31.3 45.5 23.2 63.0 33.9 45.3 116.2 31.0 62.2 40.9 13.7 19.0 7.5 27.8 27.2 35.7 30.3 29.6 33.3 31.4 27.5 39.1 38.0 2.7 31.6 29.8 20.3 30.7 34.6 34.8 38.7 41.2 40.6 31.4 33.7 42.1 33.9 40.0 37.7 68.5 48.3 130.2 269.5 135.5 48.5 42.1 68.8 100.4 55.7 69.8 13.7 227.3 114.4 153.0 142.9 101.6 46.8 23.3 113.0 234.5 111.0 163.9 94.6 76.0 145.9 30.2 134.7 81.6 97.3 43.3 81.7 92.2 89.4 124.4 81.3 55.3 126.9 70.2 91.9 129.9 47.9 90.5 130.6 212.4 146.7 132.2 151.0 116.1 119.0 187.2 CCT6A "CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20" ENSG00000146731 "Chaperonin containing TCP1 subunit 6A" P40227 7 56051630-56063989 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 179.4" "HPA042996, HPA045576, HPA049949" Supported Approved Cytosol NA NA 7400000 Cytosol "HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968" "prognostic unfavorable (4.04e-4)" "unprognostic (5.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.81e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (8.45e-4)" "prognostic unfavorable (9.00e-10)" "unprognostic (1.19e-2)" "unprognostic (3.17e-1)" "unprognostic (1.67e-2)" "unprognostic (3.24e-2)" "unprognostic (4.82e-2)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.35e-1)" "unprognostic (1.20e-1)" "unprognostic (1.78e-1)" "unprognostic (9.44e-3)" 32.9 36.5 35.3 35.8 36.1 32.0 62.4 43.7 40.4 26.2 29.1 19.6 28.4 29.8 31.7 23.7 39.5 29.7 22.9 49.3 34.7 39.8 43.2 45.7 22.6 42.0 36.8 26.8 33.4 42.9 48.3 33.7 33.9 34.9 30.2 35.4 16.4 27.3 32.2 72.3 32.6 28.6 35.3 35.8 36.7 32.3 27.0 26.5 41.1 38.2 41.4 44.0 37.1 83.7 24.0 35.3 11.8 34.2 26.6 29.9 25.8 179.4 41.1 24.7 37.3 17.4 21.9 28.5 33.9 19.2 33.4 27.0 46.2 22.6 55.6 26.3 21.8 60.2 38.2 50.6 38.9 46.3 31.2 38.4 34.8 39.9 40.6 18.9 49.8 28.3 18.7 22.4 33.7 33.6 26.5 32.8 25.4 76.0 14.0 37.7 22.2 38.3 43.5 52.3 40.3 54.8 35.3 25.3 32.0 37.6 34.4 33.1 33.2 30.0 51.2 29.9 39.5 37.6 38.4 27.5 23.0 44.1 76.2 69.7 17.2 35.4 68.7 23.0 44.3 76.0 6.9 25.0 11.8 22.4 31.6 29.9 24.0 23.5 24.4 35.3 17.8 24.0 25.4 3.1 26.6 34.2 19.6 24.2 25.8 35.3 36.1 43.7 40.4 34.7 39.8 36.8 26.8 34.9 26.5 83.4 81.3 76.7 149.2 96.7 57.8 100.5 58.6 236.9 216.1 45.4 25.5 172.0 74.6 212.7 12.0 112.8 57.1 0.0 237.7 208.2 81.7 105.7 127.1 61.8 133.8 36.5 97.8 66.9 79.5 15.6 65.3 122.3 55.6 225.4 84.4 73.1 209.1 73.7 85.2 112.3 50.9 58.2 92.9 81.2 184.0 95.9 167.2 86.7 111.5 124.2 CCT6B "Cctz2, TSA303" ENSG00000132141 "Chaperonin containing TCP1 subunit 6B" Q92526 17 34927859-34981078 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "testis: 71.5" "Group enriched" "Detected in many" 21 "Early spermatids: 252.6;Late spermatids: 121.4;Spermatocytes: 273.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 14.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA042996, HPA045576, HPA049949" Uncertain Approved Cytosol NA NA Cytosol "HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968" "unprognostic (1.56e-1)" "unprognostic (1.72e-2)" "unprognostic (2.99e-3)" "unprognostic (6.11e-2)" "unprognostic (3.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.12e-3)" "unprognostic (3.61e-2)" "unprognostic (1.75e-1)" "unprognostic (1.44e-3)" "unprognostic (9.56e-3)" "unprognostic (3.61e-2)" "unprognostic (4.82e-7)" "unprognostic (1.24e-1)" "unprognostic (4.30e-1)" "unprognostic (4.23e-4)" "unprognostic (1.49e-1)" 1.3 1.7 1.0 0.7 2.8 1.5 2.7 1.3 1.9 1.1 0.7 2.4 1.9 0.6 0.9 3.2 0.8 1.3 0.6 0.8 1.3 1.0 1.9 2.6 0.5 0.6 1.6 1.7 1.2 1.2 1.3 1.3 0.4 2.0 1.3 0.5 1.3 1.5 1.3 2.2 1.3 0.6 0.8 2.2 0.7 0.9 71.5 0.8 0.7 1.4 1.1 0.8 0.9 0.7 2.5 6.2 2.2 2.7 3.8 2.7 1.3 0.9 1.2 3.2 1.4 4.2 2.6 1.1 1.6 6.6 2.8 3.9 0.8 2.5 6.0 0.6 2.9 2.0 1.2 0.2 0.9 0.8 0.7 2.4 0.9 0.2 0.7 5.7 2.8 0.9 3.5 1.7 0.3 3.3 0.5 0.7 1.0 0.6 6.2 3.0 2.3 0.6 6.2 1.7 0.4 0.8 2.9 1.5 14.4 1.7 1.0 3.7 1.8 2.9 1.2 4.9 0.7 2.4 2.9 0.7 1.2 0.1 1.5 0.8 5.5 1.2 5.8 1.3 1.8 1.6 0.0 2.7 2.2 1.6 2.7 1.7 2.5 1.8 1.1 6.2 2.3 2.7 2.6 0.1 3.8 2.6 1.4 0.9 1.3 1.0 2.8 1.3 1.9 1.3 1.0 1.6 1.7 2.0 0.8 0.0 1.9 0.0 1.9 2.2 1.5 3.8 2.5 6.7 3.4 1.8 0.0 1.3 3.3 2.6 252.6 0.7 0.7 0.0 7.0 0.4 2.6 1.9 2.3 3.4 1.3 0.0 0.0 1.3 2.2 121.4 10.0 1.5 5.0 0.0 2.5 8.3 2.3 0.9 3.9 5.5 2.4 0.0 1.4 273.4 9.7 2.3 0.7 0.5 1.7 3.0 CCT7 "Ccth, Nip7-1" ENSG00000135624 "Chaperonin containing TCP1 subunit 7" Q99832 2 73233420-73253021 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008425 Approved Approved Cytosol NA NA 5900000 Cytosol "HPA008425: AB_1078428" "unprognostic (5.02e-3)" "unprognostic (9.51e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (4.60e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (4.37e-3)" "unprognostic (8.76e-2)" "unprognostic (3.17e-1)" "unprognostic (4.24e-2)" "unprognostic (3.78e-1)" "unprognostic (1.41e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (3.07e-3)" "unprognostic (3.12e-2)" 35.1 55.7 33.5 34.6 46.3 27.0 54.2 52.2 46.9 34.9 36.3 32.4 29.5 28.7 46.5 42.3 43.6 47.4 32.7 56.5 36.4 36.1 38.9 48.0 29.4 47.0 35.8 37.1 51.3 56.1 45.3 34.9 34.3 36.1 41.2 43.7 27.6 33.2 41.2 82.1 32.7 28.9 51.0 33.5 36.1 36.9 80.6 28.6 49.0 44.0 52.5 51.5 37.5 61.6 53.1 49.4 29.1 45.6 42.7 54.8 62.6 46.9 78.5 45.0 48.9 33.1 27.5 57.7 40.7 38.7 72.1 45.4 127.9 33.4 89.8 27.1 44.1 66.4 40.3 100.5 65.1 79.8 49.8 89.3 59.2 50.1 91.4 37.2 68.9 46.3 42.4 37.2 70.2 86.6 38.0 64.6 54.7 76.2 32.7 60.6 75.1 80.2 96.1 63.9 65.2 56.6 73.3 110.2 64.4 52.0 45.6 64.1 39.0 35.3 51.2 48.8 43.6 29.1 40.0 39.7 49.2 58.8 30.3 80.6 37.6 38.8 83.0 40.1 81.6 53.8 29.1 31.5 17.9 48.5 42.3 53.8 53.1 50.1 48.5 48.4 49.5 54.8 51.0 9.6 42.7 45.6 49.4 43.3 62.6 33.5 46.3 52.2 46.9 36.4 36.1 35.8 37.1 36.1 28.6 53.6 40.0 72.2 131.1 61.4 74.2 94.3 63.7 78.9 58.0 55.8 17.7 167.9 92.9 145.6 274.6 80.9 50.6 0.0 121.4 180.5 69.8 91.5 72.7 60.6 117.8 77.9 72.3 48.5 53.7 195.8 97.0 56.1 70.9 128.0 80.8 110.9 124.2 49.1 100.8 99.6 59.3 71.1 100.9 234.3 136.3 64.4 139.2 70.8 109.5 98.1 CCT8 "C21orf112, Cctq, PRED71" ENSG00000156261 "Chaperonin containing TCP1 subunit 8" P50990 21 29055805-29073797 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018520, HPA021051, HPA029426" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" No No 2700000 "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (4.25e-3)" "prognostic unfavorable (1.56e-5)" "unprognostic (8.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" "unprognostic (1.02e-2)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (8.26e-2)" "unprognostic (3.50e-2)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" 33.5 62.5 28.9 36.1 43.8 28.2 39.7 47.9 46.4 34.5 33.7 15.7 41.9 29.6 37.4 36.4 47.6 33.6 23.6 43.9 33.0 36.0 43.6 42.1 33.2 48.8 28.8 39.2 39.3 47.2 35.4 42.6 41.0 39.6 30.9 38.3 17.0 34.7 38.6 68.4 35.5 30.1 38.3 29.5 39.8 35.2 30.2 30.2 66.6 36.1 52.0 57.6 38.5 47.8 25.6 41.7 17.5 38.1 22.8 27.2 33.9 50.1 28.5 36.5 26.2 27.0 37.2 40.7 40.2 25.7 45.7 38.2 60.4 31.1 99.2 27.0 27.8 56.9 20.3 75.2 46.5 52.0 41.9 39.1 137.2 34.3 26.9 28.0 67.8 38.4 28.3 28.7 53.8 44.7 33.6 43.6 44.2 105.7 58.0 46.6 26.0 51.0 26.5 65.7 50.2 35.5 45.9 71.9 61.7 46.7 26.4 36.6 26.3 39.5 41.7 34.5 40.6 37.3 59.4 31.5 26.0 73.4 24.4 50.1 37.8 72.8 78.2 30.4 77.1 39.6 17.5 33.7 16.7 18.5 36.9 25.5 25.6 24.0 24.3 41.7 19.2 27.2 24.5 3.7 22.8 38.1 24.6 26.6 33.9 28.9 43.8 47.9 46.4 33.0 36.0 28.8 39.2 39.6 30.2 59.6 50.7 145.9 155.3 127.2 80.5 66.6 81.5 101.7 63.7 71.5 17.7 231.9 122.7 173.0 13.3 94.7 74.3 23.3 120.5 222.9 82.2 111.0 110.8 53.3 152.3 73.1 93.1 52.2 97.5 17.8 77.9 129.4 109.6 186.7 93.1 81.5 121.5 94.7 87.4 163.4 64.8 103.5 99.4 175.3 178.0 114.8 238.6 86.3 148.0 143.1 CD109 "CPAMD7, DKFZp762L1111, FLJ38569" ENSG00000156535 "CD109 molecule" Q6YHK3 6 73695785-73828316 "CD markers, Plasma proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "parathyroid gland: 203.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 36.9;Endothelial cells: 28.0;Hofbauer cells: 36.5;Suprabasal keratinocytes: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 62.8;BJ hTERT+: 38.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008992, HPA015723" Enhanced Supported "Plasma membrane,Cytosol" NA NA 120000000 "Plasma membrane" Cytosol "HPA008992: , HPA015723: AB_2732415" "unprognostic (2.28e-1)" "unprognostic (1.03e-1)" "unprognostic (7.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.17e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-3)" "unprognostic (1.23e-3)" "unprognostic (7.49e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-3)" "unprognostic (8.81e-2)" "prognostic unfavorable (2.65e-4)" "prognostic unfavorable (7.96e-5)" "unprognostic (9.50e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (4.68e-4)" 27.4 1.5 1.6 1.9 2.2 1.9 6.5 0.4 1.9 15.0 7.1 3.4 2.0 1.5 22.5 8.5 22.4 3.4 2.4 8.2 1.8 1.4 3.5 1.4 14.5 1.4 1.7 1.4 2.8 1.2 203.4 0.6 5.0 3.0 7.1 2.1 0.6 4.2 2.2 4.1 12.4 2.4 12.6 4.5 1.7 1.5 3.3 2.8 6.3 1.7 16.8 4.7 8.7 8.0 0.3 2.6 1.4 0.4 0.6 0.4 0.3 9.4 8.5 0.5 0.0 12.9 62.8 0.0 8.6 38.5 2.8 6.2 0.0 5.5 0.0 5.3 17.7 6.2 26.6 0.9 17.2 3.8 2.6 1.5 3.3 6.9 1.4 2.7 0.0 0.0 17.3 13.7 5.3 21.5 9.9 20.3 1.0 0.0 0.0 12.9 0.2 0.2 0.0 0.6 0.0 5.5 0.7 2.4 11.6 1.2 1.1 0.0 0.0 19.5 0.1 8.4 0.4 0.2 1.5 18.8 26.9 3.7 4.8 7.4 0.1 5.3 0.0 10.8 0.0 23.8 0.6 0.4 0.3 0.2 0.2 0.1 0.2 0.3 0.2 2.6 0.3 0.4 0.2 1.4 0.6 0.2 1.4 0.1 0.3 1.6 2.2 0.4 1.9 1.8 1.4 1.7 1.4 3.0 2.8 3.0 1.7 0.8 6.2 36.9 0.3 11.1 0.0 2.7 12.5 0.0 0.0 0.3 1.7 0.1 18.2 28.0 0.0 0.0 0.0 0.4 7.8 5.8 2.3 0.4 36.5 0.0 0.0 19.0 2.8 17.2 0.6 15.3 21.9 4.6 0.0 0.0 0.3 0.0 0.0 15.9 0.1 0.0 14.6 0.7 3.2 38.1 1.1 2.2 0.0 6.4 CD163L1 "CD163B, M160, SCARI2, WC1" ENSG00000177675 "CD163 molecule like 1" Q9NR16 12 7346685-7479897 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 6.9;Melanocytes: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 9.2;HDLM-2: 8.2;HUVEC TERT2: 8.9;TIME: 8.3;U-87 MG: 19.4" HPA015663 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA 170000 "Centrosome, Cytosol" Nucleoplasm "HPA015663: AB_2072575" "unprognostic (1.25e-3)" "unprognostic (1.77e-1)" "unprognostic (1.42e-2)" "unprognostic (7.46e-3)" "unprognostic (2.29e-2)" "unprognostic (7.79e-2)" "unprognostic (9.39e-2)" "unprognostic (4.44e-3)" "unprognostic (1.07e-1)" "unprognostic (8.35e-2)" "unprognostic (1.08e-1)" "unprognostic (3.08e-1)" "unprognostic (1.26e-6)" "unprognostic (8.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.69e-1)" 5.0 1.7 1.2 19.1 1.2 0.0 2.5 0.8 1.6 1.4 9.2 0.3 1.0 5.5 1.2 8.5 1.8 1.3 2.6 3.2 1.2 1.0 1.7 1.5 2.8 14.6 1.1 0.7 1.0 1.0 0.1 1.4 6.8 3.3 1.4 15.1 2.7 2.5 1.4 1.1 1.4 18.4 1.8 1.0 31.2 2.6 4.6 0.2 9.5 1.7 6.4 12.9 4.3 1.2 0.2 0.7 0.7 0.8 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.0 0.3 0.0 0.8 1.8 0.2 0.8 0.0 1.4 0.0 0.3 0.8 9.2 0.0 0.0 1.1 1.4 8.2 0.0 0.0 0.4 1.2 0.0 0.5 0.0 0.3 0.0 0.2 3.3 0.6 8.9 0.0 0.1 4.7 5.2 0.0 0.0 6.6 0.2 0.0 0.0 1.5 1.5 1.8 0.0 0.0 1.2 5.6 4.3 6.8 0.0 0.3 0.0 5.5 8.3 3.0 2.7 0.3 0.0 0.1 0.1 0.0 19.4 0.4 5.7 0.0 0.8 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.8 1.6 1.2 1.0 1.1 0.7 3.3 0.2 0.0 0.0 0.0 0.0 1.1 2.9 0.7 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 2.2 0.7 0.0 0.0 1.2 0.3 0.5 0.1 0.0 0.4 6.9 0.0 0.0 0.0 4.1 1.1 0.0 3.3 13.5 0.0 0.0 1.0 2.0 1.1 0.0 0.0 1.7 19.4 8.0 3.4 0.7 1.1 0.2 0.0 0.0 0.1 CD164L2 ENSG00000174950 "CD164 molecule like 2" Q6UWJ8 1 27379176-27383380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.8" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 62.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HaCaT: 3.6;HBEC3-KT: 3.9;hTCEpi: 5.4;SK-BR-3: 4.9;T-47d: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062915 Enhanced Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA062915: AB_2684903" "unprognostic (8.97e-3)" "unprognostic (2.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "prognostic favorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (4.47e-2)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (4.07e-2)" "unprognostic (5.91e-6)" "unprognostic (1.33e-2)" "unprognostic (6.42e-2)" "unprognostic (1.34e-2)" "unprognostic (2.71e-2)" 0.1 0.1 0.2 0.1 0.5 0.0 2.3 0.1 0.4 3.2 0.4 0.7 1.2 0.0 0.4 12.6 13.4 26.8 0.1 0.1 0.4 0.4 0.4 0.3 7.4 0.1 0.1 0.6 3.3 0.3 0.4 5.8 0.1 1.1 2.4 0.2 1.0 12.9 0.3 0.1 8.1 0.1 0.1 0.1 0.1 0.2 1.0 0.4 0.1 0.9 5.9 6.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 3.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.7 2.0 0.1 0.0 0.0 0.1 1.0 0.0 1.0 0.0 0.0 4.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.4 0.4 0.4 0.1 0.6 1.1 0.4 0.0 3.0 0.0 8.0 2.6 0.0 0.6 0.0 62.9 4.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.5 0.0 0.0 0.0 3.1 CD1B CD1 ENSG00000158485 "CD1b molecule" P29016 1 158327951-158331531 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 188.8" "Cell type enriched" "Detected in some" 6 "Macrophages: 17.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "myeloid DC: 16.3" "Lineage enriched" "Detected in many" 6 "dendritic cells: 16.3" "Cell line enriched" "Detected in some" 5 "MOLT-4: 112.0" HPA021824 Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" Cytosol "HPA021824: AB_1846262" "unprognostic (7.72e-3)" "unprognostic (1.55e-4)" "unprognostic (1.66e-5)" "unprognostic (1.04e-2)" "unprognostic (1.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.89e-4)" "unprognostic (2.27e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (9.53e-2)" "unprognostic (3.23e-1)" "unprognostic (3.52e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (3.53e-2)" 0.8 0.1 0.2 1.9 0.2 0.0 0.6 0.2 0.2 0.8 0.6 0.3 0.2 0.0 0.3 0.2 0.9 0.7 1.3 0.2 0.2 0.0 0.6 0.3 1.7 4.0 0.2 0.2 0.3 0.3 0.0 0.2 0.2 0.2 0.2 5.6 0.2 0.6 0.2 0.2 6.2 0.8 0.3 0.2 1.9 0.9 0.2 0.2 188.8 0.4 0.4 2.4 0.5 0.8 0.0 16.3 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 112.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 17.4 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 CD207 "CLEC4K, Langerin" ENSG00000116031 "CD207 molecule" Q9UJ71 2 70830214-70835822 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.5;skin 1: 42.3" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 3.5;Macrophages: 1.5;Melanocytes: 5.0;monocytes: 2.8;Suprabasal keratinocytes: 4.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "myeloid DC: 4.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 4.0" "Cell line enriched" "Detected in some" 4 "AN3-CA: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002222, HPA011216" Enhanced Uncertain Cytosol No NA Cytosol "CAB002222: AB_563850, HPA011216: AB_1078453" "unprognostic (1.45e-2)" "unprognostic (8.28e-3)" "unprognostic (9.34e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-3)" "unprognostic (1.05e-1)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-1)" "unprognostic (7.92e-4)" "unprognostic (2.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" 0.5 0.1 0.1 1.8 0.1 0.0 1.4 0.1 0.1 2.4 1.7 0.1 0.1 1.6 1.1 0.4 9.7 0.3 2.9 0.3 0.1 0.1 0.2 0.9 3.7 0.2 0.1 0.1 0.2 0.2 0.0 1.1 0.1 0.1 1.0 1.1 0.4 1.2 0.2 0.1 42.3 2.6 0.1 0.1 1.5 0.4 0.4 0.1 3.3 0.2 11.3 16.5 0.3 1.9 0.0 4.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 14.1 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 1.9 0.0 0.0 0.0 0.3 2.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 CD2AP CMS ENSG00000198087 "CD2 associated protein" Q9Y5K6 6 47477789-47627263 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 12.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003267, HPA003326, CAB004352" Enhanced Supported "Plasma membrane,Centriolar satellite,Cytosol" NA NA 160000 "Plasma membrane" "Centriolar satellite, Cytosol" "CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457" "unprognostic (5.98e-2)" "unprognostic (1.08e-2)" "unprognostic (1.75e-2)" "unprognostic (1.74e-1)" "unprognostic (1.31e-1)" "unprognostic (1.77e-2)" "unprognostic (1.74e-3)" "unprognostic (1.19e-1)" "unprognostic (6.71e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (2.21e-1)" "unprognostic (3.09e-3)" "unprognostic (6.12e-3)" "unprognostic (1.74e-1)" "unprognostic (1.84e-1)" "prognostic favorable (7.57e-5)" 15.2 9.9 5.3 18.0 7.6 6.6 11.9 13.6 6.1 13.2 23.5 6.2 19.0 31.0 13.2 12.9 20.1 8.0 14.7 7.3 4.9 5.3 31.3 19.2 17.3 8.0 5.8 4.0 9.9 19.3 24.0 14.4 17.2 7.3 15.0 20.9 6.6 17.5 19.4 8.7 13.0 31.9 9.5 7.7 17.0 22.3 8.7 6.4 55.1 13.3 13.3 13.8 16.9 15.5 1.3 12.2 3.7 0.7 3.8 2.4 0.7 20.6 8.2 2.6 5.3 3.6 5.2 20.5 5.1 6.2 6.9 8.8 13.5 14.7 26.8 21.4 6.6 9.0 7.8 8.5 12.7 11.3 10.7 13.7 14.8 6.9 12.0 4.8 8.2 5.7 3.7 12.0 6.6 9.6 13.4 11.1 9.0 25.9 8.6 6.2 6.5 15.7 3.1 7.6 25.1 3.0 8.4 6.6 12.2 43.5 37.0 7.8 3.0 10.2 13.7 9.9 12.2 13.0 5.3 13.2 13.9 11.7 4.4 14.3 6.5 10.9 19.2 14.9 4.5 7.1 1.9 0.7 3.7 1.5 0.5 2.4 1.2 1.4 1.5 1.5 1.3 1.3 2.0 0.1 3.8 0.4 12.2 1.1 0.7 5.3 7.6 13.6 6.1 4.9 5.3 5.8 4.0 7.3 6.4 89.3 52.6 27.4 48.2 28.6 9.7 13.7 22.9 75.0 93.3 68.0 15.7 42.2 18.3 68.4 7.7 43.2 159.3 23.3 85.1 12.7 11.4 76.4 23.1 21.5 15.6 14.3 53.6 31.3 20.7 8.4 15.5 17.8 13.5 11.8 79.7 12.1 114.0 81.8 10.3 48.5 13.3 25.8 18.6 22.2 31.1 35.9 34.2 20.0 51.8 104.3 CD2BP2 "LIN1, PPP1R59, Snu40, U5-52K" ENSG00000169217 "CD2 cytoplasmic tail binding protein 2" O95400 16 30350766-30355361 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041508, HPA061309" Enhanced Enhanced "Nuclear speckles,Cytosol" Yes No "Nuclear speckles" Cytosol "HPA041508: AB_2677523, HPA061309: AB_2684476" "unprognostic (5.66e-2)" "unprognostic (7.50e-3)" "unprognostic (1.47e-1)" "unprognostic (2.82e-2)" "unprognostic (1.65e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.71e-2)" "unprognostic (1.16e-1)" "unprognostic (9.76e-2)" "unprognostic (2.30e-2)" "unprognostic (7.47e-2)" "unprognostic (2.09e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-2)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" 24.6 33.0 23.6 27.8 24.4 17.8 22.5 27.6 43.4 24.2 25.4 27.4 31.8 25.8 32.3 29.0 23.1 30.0 35.6 27.4 23.1 23.7 24.8 18.2 22.3 30.2 23.2 27.3 29.7 30.9 46.3 30.3 22.3 20.3 25.8 21.3 20.8 27.4 40.7 31.7 22.0 22.6 28.1 20.6 32.0 24.5 23.4 19.8 26.8 29.8 25.9 36.5 22.9 19.9 38.2 28.1 51.3 39.0 29.2 37.6 29.9 21.7 26.5 22.4 20.2 18.7 17.8 19.0 24.2 29.2 27.6 29.7 20.2 26.3 33.6 30.0 26.3 25.4 24.0 22.8 28.4 22.2 19.9 26.8 14.2 25.1 23.7 26.9 20.1 26.3 19.1 24.1 30.6 19.7 19.0 28.6 25.2 16.0 25.9 27.6 52.3 27.7 17.1 30.1 17.0 15.7 41.1 18.6 25.3 22.4 21.9 18.4 35.2 16.2 28.7 16.3 19.3 27.2 16.3 20.4 31.9 22.2 16.0 21.1 43.5 31.6 30.9 21.8 18.7 26.0 36.3 26.3 46.2 31.7 30.8 25.1 36.2 25.8 29.4 23.3 38.2 21.8 26.9 51.3 29.2 39.0 28.1 37.6 29.9 23.6 24.4 27.6 43.4 23.1 23.7 23.2 27.3 20.3 19.8 29.8 25.3 41.6 42.3 25.5 27.7 23.3 38.2 32.1 18.2 34.9 19.6 52.1 51.4 70.2 14.8 35.4 46.6 23.3 84.6 47.7 31.5 34.5 47.3 12.4 61.0 11.1 31.7 24.5 37.6 11.3 32.8 32.5 37.1 107.4 29.5 41.6 75.5 63.1 33.6 64.1 25.0 38.8 44.3 34.6 43.2 26.6 74.1 50.1 29.2 46.0 CD300A "CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60" ENSG00000167851 "CD300a molecule" Q9UGN4 17 74466416-74484796 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 81.1;brain: 28.7;lymphoid tissue: 57.8" "Group enriched" "Detected in some" 4 "granulocytes: 57.8;Hofbauer cells: 101.1;Kupffer cells: 71.3;Macrophages: 86.9;T-cells: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 42.2;NB-4: 17.2;RPMI-8226: 33.2" "HPA010971, HPA011645" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 2800000 "Plasma membrane" "Vesicles, Cytosol" "HPA010971: , HPA011645: AB_1846988" "unprognostic (1.99e-1)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.01e-1)" "unprognostic (1.04e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.17e-2)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (5.97e-2)" "unprognostic (5.45e-3)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" 8.6 4.5 9.8 16.0 17.7 11.9 4.4 2.2 11.5 2.0 4.8 3.7 0.0 6.0 1.9 1.3 2.1 2.1 7.7 3.4 7.3 4.2 3.0 7.5 10.6 19.0 20.1 0.3 1.5 2.1 0.3 3.0 6.9 12.6 2.8 4.7 2.3 3.0 1.3 1.1 2.3 7.4 6.0 28.7 57.8 2.4 1.5 17.4 4.1 1.9 0.5 6.0 5.4 2.1 2.2 19.4 81.1 45.7 52.1 29.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 17.2 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 81.1 20.4 57.3 29.5 45.7 6.2 2.2 6.1 8.7 19.4 0.6 2.3 7.1 71.6 52.1 44.2 18.1 0.3 19.2 9.8 17.7 2.2 11.5 7.3 4.2 20.1 0.3 12.6 17.4 0.0 11.9 15.7 0.0 0.8 0.0 0.4 2.5 0.0 1.2 0.0 0.0 0.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.0 0.5 0.1 57.8 0.8 101.1 0.0 0.0 3.1 71.3 0.0 0.0 86.9 3.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.5 0.5 1.3 25.9 0.0 0.1 CD320 "8D6, 8D6A" ENSG00000167775 "CD320 molecule" Q9NPF0 19 8302127-8308356 "CD markers, Disease related genes, Predicted membrane proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 76.2;RPMI-8226: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014500, HPA073489" Approved Approved Cytosol NA NA 400000 Cytosol "HPA014500: AB_1846295, HPA073489: AB_2686609" "unprognostic (9.97e-2)" "unprognostic (2.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.54e-3)" "unprognostic (2.17e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (4.19e-2)" "unprognostic (7.13e-2)" "unprognostic (1.31e-1)" "unprognostic (9.35e-3)" "unprognostic (1.25e-1)" "unprognostic (2.03e-1)" "unprognostic (1.07e-1)" "unprognostic (8.92e-2)" "unprognostic (3.14e-1)" "unprognostic (9.90e-2)" 23.1 20.1 13.1 13.4 14.9 6.3 39.0 12.6 19.1 12.0 23.2 9.7 10.5 16.6 15.8 58.1 11.4 14.9 28.9 20.7 13.2 18.7 15.2 16.3 15.1 18.0 18.0 8.5 14.0 27.6 7.6 11.9 38.0 19.9 19.7 14.2 18.6 16.5 12.8 14.0 6.4 17.4 11.9 11.9 32.8 21.3 23.7 9.3 14.3 22.4 9.3 8.6 12.1 19.6 10.3 25.0 0.8 0.6 18.0 51.3 15.0 12.9 13.3 2.9 38.0 9.6 5.0 6.9 6.8 9.2 13.7 10.5 14.2 7.8 11.7 21.3 5.0 10.2 8.3 0.0 10.8 2.6 16.4 40.7 5.6 11.4 20.2 6.4 10.7 14.2 4.7 2.5 7.9 6.6 6.1 13.3 7.9 17.1 40.3 5.3 12.2 11.3 76.2 20.7 11.4 55.5 14.0 4.0 69.2 10.2 0.3 27.5 11.9 14.1 6.0 17.2 2.2 0.4 4.8 7.5 15.7 11.6 23.4 21.4 38.4 24.0 12.7 11.2 39.3 17.0 0.0 0.6 0.0 51.3 0.6 29.2 10.3 34.0 27.4 1.1 9.9 23.1 26.0 0.8 18.0 0.4 25.0 21.7 15.0 13.1 14.9 12.6 19.1 13.2 18.7 18.0 8.5 19.9 9.3 11.9 19.7 29.0 24.5 16.5 50.8 27.1 10.2 12.0 10.3 17.4 31.4 32.9 11.6 46.3 20.5 85.7 13.4 0.0 15.8 39.7 26.8 49.2 11.5 17.1 23.7 20.6 48.9 51.0 3.8 41.6 20.1 5.8 37.1 6.4 31.5 18.4 22.6 66.2 15.9 39.0 37.7 12.9 31.4 119.7 28.0 12.3 29.6 35.5 88.5 19.2 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 187.6" "Cell type enriched" "Detected in some" 18 "T-cells: 153.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 30 "gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2" "Lineage enriched" "Detected in many" 37 "T-cells: 46.7" "Group enriched" "Detected in some" 53 "JURKAT: 24.1;MOLT-4: 64.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: AB_2676044" "prognostic favorable (6.33e-4)" "prognostic favorable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 1.1 0.6 0.4 7.1 0.4 0.5 0.8 0.3 0.3 0.7 2.3 0.4 0.4 2.0 0.9 0.6 1.5 1.1 1.9 0.6 0.4 0.4 1.2 0.9 2.4 17.2 0.5 0.2 0.7 0.7 0.0 0.5 0.4 0.3 1.0 1.6 0.9 2.9 0.3 5.9 0.6 8.1 0.2 0.8 11.5 2.4 0.5 0.2 187.6 1.4 1.7 19.2 2.5 1.1 0.1 0.2 1.2 0.2 0.2 46.7 14.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.8 0.2 0.0 0.2 64.5 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.2 0.2 43.5 0.1 25.6 0.1 36.1 37.1 0.1 0.1 37.6 46.7 1.2 0.2 0.1 0.2 34.2 14.1 0.4 0.4 0.3 0.3 0.4 0.4 0.5 0.2 0.3 0.2 3.0 8.6 0.8 0.0 2.1 0.1 0.4 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.8 1.3 0.1 0.0 0.0 6.2 2.8 0.4 0.0 2.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.3 0.2 0.0 2.0 0.2 153.8 0.0 0.0 CD48 "BCM1, BLAST, hCD48, mCD48, SLAMF2" ENSG00000117091 "CD48 molecule" P09326 1 160678746-160711851 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.3;lymphoid tissue: 86.3" "Group enriched" "Detected in many" 5 "B-cells: 233.4;granulocytes: 88.9;Hofbauer cells: 87.6;Kupffer cells: 195.5;Macrophages: 131.8;T-cells: 297.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 38.9;HMC-1: 43.5;U-266/70: 92.1;U-266/84: 61.5" "CAB002497, HPA055146" Enhanced Supported "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 2600000 "Plasma membrane" "Nucleoli fibrillar center, Cytosol" "CAB002497: AB_563586, HPA055146: AB_2682716" "prognostic favorable (3.91e-4)" "unprognostic (1.72e-3)" "prognostic favorable (4.17e-4)" "unprognostic (1.58e-3)" "unprognostic (2.36e-1)" "unprognostic (1.71e-3)" "unprognostic (2.09e-2)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (3.21e-1)" "unprognostic (4.69e-2)" "unprognostic (9.38e-2)" "unprognostic (8.51e-2)" 5.5 1.4 1.0 44.6 0.9 23.1 2.8 0.6 0.7 3.2 5.0 0.5 1.1 3.2 1.9 2.5 7.3 2.1 4.8 1.8 1.0 1.0 3.6 3.1 15.4 86.3 1.6 0.3 2.3 1.5 0.0 1.3 2.2 0.8 2.8 5.7 2.4 13.9 1.5 1.3 1.2 21.2 1.7 3.8 66.6 5.0 1.3 0.2 50.8 2.9 3.6 58.0 8.6 2.6 34.6 53.6 35.8 74.1 24.9 57.9 81.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 4.6 43.5 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 14.2 0.0 0.0 13.5 6.7 0.0 0.0 0.0 0.8 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 61.5 15.8 0.0 11.7 0.0 28.2 52.2 35.8 42.4 74.1 57.9 34.6 48.3 48.8 53.6 27.9 49.7 52.5 13.4 24.9 73.5 9.4 36.4 81.3 1.0 0.9 0.6 0.7 1.0 1.0 1.6 0.3 0.8 0.2 0.0 14.8 233.4 0.5 4.8 0.0 0.8 5.1 4.0 2.3 3.5 0.0 0.7 1.7 0.1 0.0 0.7 0.0 23.3 0.2 0.7 3.1 0.2 88.9 1.8 87.6 0.0 1.2 8.6 195.5 0.4 1.7 131.8 37.1 8.2 0.0 0.0 0.1 0.0 0.4 1.5 0.0 0.0 0.7 0.4 0.1 2.6 0.3 297.5 0.0 0.3 CD79B "B29, IGB" ENSG00000007312 "CD79b molecule" P40259 17 63928740-63932354 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 138.8;lymphoid tissue: 56.6" "Cell type enriched" "Detected in many" 8 "B-cells: 486.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 100.6;naive B-cell: 138.8" "Lineage enriched" "Detected in many" 6 "B-cells: 138.8" "Cell line enhanced" "Detected in some" "Daudi: 117.7;REH: 38.7;U-698: 161.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009178, CAB009751, HPA044107" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: " "unprognostic (3.90e-3)" "unprognostic (1.61e-3)" "unprognostic (5.21e-2)" "unprognostic (3.45e-3)" "unprognostic (4.22e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (9.25e-3)" "unprognostic (3.89e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (2.87e-2)" "unprognostic (2.50e-3)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (2.75e-1)" 1.7 0.7 0.4 50.6 0.4 11.1 1.2 0.3 0.4 0.6 1.7 0.3 0.3 0.7 0.6 0.5 2.6 0.6 1.4 3.4 0.4 0.2 2.3 1.7 1.3 56.6 0.4 0.3 0.6 1.6 0.0 9.0 0.5 0.3 1.0 1.3 0.8 8.9 0.9 1.2 0.9 22.4 0.5 0.4 56.0 1.8 0.6 0.3 3.7 1.4 1.7 46.6 4.5 0.9 138.8 4.2 0.5 25.0 3.4 9.2 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 38.7 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.8 0.1 0.0 0.4 0.0 0.0 5.9 5.7 161.1 0.0 0.2 0.0 0.5 1.1 0.0 4.2 16.5 4.8 100.6 5.4 2.8 4.2 138.8 3.7 2.2 0.5 3.4 25.0 0.6 9.2 9.0 0.4 0.4 0.3 0.4 0.4 0.2 0.4 0.3 0.3 0.3 0.0 2.2 486.9 0.3 3.9 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 7.1 0.0 23.3 0.0 0.4 4.3 0.3 15.0 0.5 4.7 0.0 1.2 62.0 14.1 1.1 1.1 3.5 20.3 1.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 3.3 0.7 0.1 2.8 0.3 34.6 0.0 0.1 CDAN1 "CDA-I, CDAI" ENSG00000140326 "Codanin 1" Q8IWY9 15 42723544-42737128 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039404, HPA040787" Supported Enhanced "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039404: AB_10673530, HPA040787: AB_2677137" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.79e-3)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "unprognostic (7.71e-2)" "prognostic unfavorable (1.07e-4)" "unprognostic (7.17e-2)" "unprognostic (9.82e-2)" "unprognostic (1.24e-1)" "unprognostic (2.95e-2)" "unprognostic (1.26e-1)" "unprognostic (4.35e-3)" "unprognostic (2.05e-1)" "unprognostic (1.16e-1)" "unprognostic (9.20e-3)" "unprognostic (2.04e-1)" 6.5 9.0 8.4 9.8 8.1 14.4 9.8 16.2 9.7 11.8 6.8 8.7 9.4 6.0 11.0 9.6 7.1 9.1 7.2 5.2 6.4 4.4 6.3 6.7 6.6 8.0 8.3 7.4 21.7 9.6 9.1 9.5 6.7 5.8 11.4 5.5 9.3 10.6 10.1 6.6 10.1 6.9 9.3 5.1 8.1 8.0 14.7 8.6 14.7 9.0 3.3 8.2 10.2 12.2 0.3 0.8 3.7 0.3 0.0 0.6 0.1 6.9 4.7 6.5 9.3 5.8 5.0 7.8 9.2 3.9 9.0 6.5 11.8 3.7 3.3 10.2 5.1 8.8 13.7 6.9 4.1 2.6 8.5 6.4 12.6 8.5 4.6 4.3 9.2 11.9 6.8 4.7 5.6 4.1 5.5 6.8 11.5 16.0 5.1 7.3 3.8 7.1 12.2 3.2 6.7 7.6 10.3 8.1 2.9 2.8 6.9 5.3 6.1 7.2 10.1 1.5 4.3 7.7 13.8 4.9 9.5 8.5 7.7 10.5 10.1 10.6 7.5 4.9 13.8 7.7 3.7 0.3 1.7 0.5 0.1 0.6 0.1 0.4 0.5 0.0 0.3 0.4 0.3 0.4 0.0 0.0 0.8 0.1 0.1 8.4 8.1 16.2 9.7 6.4 4.4 8.3 7.4 5.8 8.6 0.0 3.0 0.8 1.7 1.6 3.1 2.2 5.1 1.4 1.2 7.0 3.9 2.6 0.0 1.4 0.3 2.2 1.6 0.0 1.5 1.2 1.9 1.8 1.1 2.4 1.8 1.6 4.6 4.9 4.4 0.9 4.0 1.3 0.0 1.0 2.0 4.8 1.5 0.0 4.6 1.1 4.1 19.4 1.0 4.2 1.9 1.1 1.8 2.5 2.7 1.4 CDC123 "C10orf7, D123" ENSG00000151465 "Cell division cycle 123" O75794 10 12195965-12250589 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037830, HPA057540" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA037830: AB_10671368, HPA057540: AB_2732614" "unprognostic (5.35e-3)" "unprognostic (9.06e-2)" "unprognostic (2.42e-1)" "unprognostic (5.09e-3)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.16e-7)" "unprognostic (2.63e-1)" "unprognostic (2.22e-1)" "unprognostic (3.20e-2)" "unprognostic (2.74e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (2.42e-6)" "unprognostic (5.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.88e-2)" "unprognostic (6.19e-2)" 26.1 28.0 30.8 28.8 50.8 35.7 25.5 24.6 35.0 25.8 32.0 24.2 16.3 21.5 26.1 27.2 34.1 25.3 18.4 36.5 28.5 25.1 33.2 45.1 21.5 34.7 25.9 27.6 19.5 26.0 18.4 26.9 28.8 36.6 20.7 31.8 16.1 22.4 22.9 29.2 29.8 24.7 30.2 24.9 36.2 21.8 22.5 24.6 39.0 24.4 20.5 41.9 29.2 23.4 43.7 40.7 66.4 34.0 32.3 38.8 40.6 31.0 41.6 29.7 36.0 28.6 28.2 24.4 27.0 18.8 39.0 42.0 57.5 39.8 53.6 28.5 34.1 25.3 35.0 54.1 49.5 32.6 37.6 42.5 41.8 33.6 52.7 35.3 32.6 36.3 30.1 25.8 49.3 29.2 19.4 42.6 69.8 43.0 25.8 33.9 28.7 41.6 27.4 52.3 47.7 15.6 43.3 24.8 47.6 35.7 18.1 15.3 30.2 28.9 37.6 33.5 27.3 39.2 36.8 45.7 24.1 29.5 36.6 34.1 25.4 46.6 65.8 30.2 31.2 15.6 28.6 28.7 66.4 31.4 32.4 32.4 43.7 35.3 34.6 40.7 42.1 29.0 30.9 64.6 32.3 34.0 33.2 38.8 40.6 30.8 50.8 24.6 35.0 28.5 25.1 25.9 27.6 36.6 24.6 29.8 31.0 35.7 38.0 48.1 27.6 45.3 30.6 52.2 30.7 33.2 5.9 108.7 72.9 73.7 3.9 34.2 23.6 0.0 72.5 115.3 36.6 29.6 47.4 34.5 85.2 25.4 20.1 36.2 19.4 7.0 38.6 50.4 43.9 112.8 26.7 40.1 66.8 37.7 43.2 54.7 26.4 38.8 43.2 42.1 28.9 64.6 64.9 50.3 44.3 45.3 CDC14A "cdc14, Cdc14A1, Cdc14A2, DFNB105" ENSG00000079335 "Cell division cycle 14A" Q9UNH5 1 100345001-100520278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Hearing" "Hydrolase, Protein phosphatase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.2" "Group enriched" "Detected in many" 6 "Early spermatids: 165.7;Late spermatids: 161.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 30.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023783 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA023783: AB_1846352" "unprognostic (3.72e-2)" "unprognostic (2.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (1.54e-3)" "unprognostic (1.38e-1)" "unprognostic (9.27e-4)" "unprognostic (4.88e-3)" "unprognostic (6.30e-2)" "unprognostic (3.97e-3)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (6.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (6.66e-2)" 6.2 2.4 5.8 6.5 5.5 13.7 12.2 1.8 6.2 7.7 11.8 4.8 2.2 7.2 15.1 4.8 3.4 13.7 3.6 4.1 8.8 3.5 6.6 2.4 12.3 15.4 3.8 5.4 5.8 6.7 9.8 8.1 7.6 4.6 10.0 6.3 8.3 7.7 3.9 4.3 5.6 22.6 5.0 3.2 9.6 6.0 38.2 4.7 12.0 6.1 3.4 11.3 5.8 8.4 4.8 6.1 11.6 3.7 3.9 13.0 4.1 2.2 1.8 5.9 6.7 2.2 1.6 4.1 2.9 1.9 2.9 2.3 6.2 1.9 1.1 2.1 1.7 2.3 1.7 4.0 1.6 2.9 2.3 9.9 4.0 1.7 2.0 0.8 5.4 7.1 1.3 0.4 3.1 1.0 1.4 5.1 2.4 30.6 3.5 4.2 1.0 4.3 6.0 3.6 1.4 2.3 4.7 7.6 1.1 2.0 5.1 1.1 1.9 3.0 2.9 4.0 3.0 1.3 7.0 2.2 1.6 3.6 2.7 1.7 1.7 0.6 1.7 1.9 5.0 0.9 11.6 3.7 8.4 7.3 3.3 13.0 4.8 11.3 8.4 3.5 3.1 11.0 5.8 5.5 3.9 2.3 6.1 5.6 4.1 5.8 5.5 1.8 6.2 8.8 3.5 3.8 5.4 4.6 4.7 3.0 5.6 2.2 4.2 3.3 0.2 5.3 0.0 28.1 5.7 1.8 3.9 1.7 0.0 2.7 165.7 9.3 12.8 0.0 1.7 0.8 4.7 6.6 14.0 1.5 2.3 0.0 4.6 6.2 4.6 161.3 4.6 4.3 5.0 5.4 4.7 9.1 2.5 8.7 0.7 1.7 3.6 0.0 2.8 1.9 3.0 2.0 1.8 10.2 2.7 2.3 CDC20 "CDC20A, p55CDC" ENSG00000117399 "Cell division cycle 20" Q12834 1 43358955-43363203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.0;testis: 73.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB004525, HPA045842, HPA055288" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773" "unprognostic (1.66e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-2)" "unprognostic (2.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.00e-8)" "unprognostic (9.06e-3)" "unprognostic (1.17e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (8.55e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.29e-2)" 1.3 1.2 0.6 16.6 1.1 20.2 1.8 0.8 1.3 2.1 6.2 2.8 0.4 5.8 1.1 1.6 17.8 0.4 1.9 1.2 0.9 0.5 2.2 1.2 1.8 13.4 1.1 0.7 0.9 0.5 0.0 0.4 3.9 1.2 0.8 7.0 0.4 2.9 0.4 0.6 4.6 6.4 2.8 1.2 7.8 4.4 73.2 0.7 42.0 1.2 11.7 21.7 1.9 4.2 4.5 0.9 0.8 0.1 9.8 11.2 2.7 52.6 25.7 35.9 23.4 1.2 3.2 34.4 24.4 21.9 71.2 38.0 40.3 43.8 30.5 14.3 22.4 25.1 37.1 39.2 46.6 59.5 23.9 29.0 44.6 25.4 24.9 0.3 31.1 16.3 1.0 2.2 49.4 44.8 6.2 30.1 29.3 20.1 21.0 32.2 20.4 29.9 19.1 45.4 25.1 34.6 43.5 49.3 19.3 17.3 14.0 21.2 10.4 43.1 29.2 13.5 28.8 20.5 39.4 15.6 21.3 50.0 23.6 75.6 16.1 14.3 31.6 15.3 38.8 31.7 0.0 0.1 0.0 0.4 0.0 0.0 4.5 3.3 3.6 0.9 0.9 0.1 0.3 0.8 9.8 0.0 0.2 11.2 2.7 0.6 1.1 0.8 1.3 0.9 0.5 1.1 0.7 1.2 0.7 0.0 0.6 16.2 2.0 9.3 0.0 0.7 0.0 2.7 1.2 0.0 0.0 13.4 0.0 2.1 97.6 0.7 3.2 70.0 0.3 127.9 4.1 2.0 0.0 1.0 30.9 0.0 0.0 8.0 5.0 7.0 2.6 5.2 0.0 2.8 2.9 0.2 0.7 0.0 1.8 2.1 2.6 0.0 1.4 74.9 48.1 7.3 8.9 1.3 15.5 2.6 CDC34 "E2-CDC34, UBC3, UBE2R1" ENSG00000099804 "Cell division cycle 34" P49427 19 531712-542092 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 170.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002382, CAB005109, CAB047311, HPA074334" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370, HPA074334: " "unprognostic (4.65e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (2.84e-1)" "unprognostic (5.73e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (2.20e-1)" "unprognostic (3.11e-1)" "unprognostic (3.83e-2)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (3.02e-2)" "unprognostic (8.87e-3)" "unprognostic (9.68e-2)" "unprognostic (7.82e-3)" "unprognostic (3.33e-2)" 16.5 15.9 21.3 11.3 19.1 24.7 20.4 25.7 30.9 16.0 20.5 19.5 10.5 15.4 13.3 13.4 15.6 14.5 13.6 35.6 21.1 18.2 12.1 36.0 13.0 9.9 18.5 19.8 17.0 37.4 11.3 17.0 24.9 16.2 17.2 10.6 15.3 26.4 18.5 63.9 19.0 13.2 18.6 14.3 12.7 15.7 43.6 15.0 12.2 13.1 17.0 8.7 19.2 16.4 2.9 2.8 11.5 4.5 1.5 4.1 1.3 18.7 18.8 24.1 19.8 10.9 10.5 24.1 16.9 13.0 18.2 19.0 29.0 11.5 10.3 17.7 12.0 11.0 13.0 18.9 14.2 9.3 16.9 50.8 9.5 12.4 31.4 27.3 13.4 11.6 13.5 21.3 15.4 16.1 14.3 21.7 14.6 40.8 20.8 12.0 26.9 18.3 17.9 30.4 13.9 18.2 16.9 12.4 17.4 13.7 11.2 31.4 23.3 14.7 15.2 28.0 20.7 12.2 19.8 17.7 13.3 15.9 30.9 22.5 20.7 15.9 13.8 18.2 19.0 13.7 4.5 3.5 6.2 2.3 3.4 1.7 2.9 3.2 4.1 2.8 1.7 2.5 2.4 11.5 1.5 4.5 2.3 3.1 1.3 21.3 19.1 25.7 30.9 21.1 18.2 18.5 19.8 16.2 15.0 0.0 4.8 9.7 16.8 41.6 35.9 25.8 38.2 1.4 1.2 14.0 23.6 38.5 11.6 17.9 55.3 20.2 34.4 0.0 17.3 40.4 28.2 30.2 0.0 35.2 23.7 15.9 12.7 14.7 12.6 170.3 16.7 12.9 18.6 10.0 25.9 67.6 35.7 21.2 14.2 15.9 36.1 12.9 30.1 18.4 52.8 47.8 52.7 10.0 21.2 26.8 CDC37 P50CDC37 ENSG00000105401 "Cell division cycle 37" Q16543 19 10391134-10420121 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003928, CAB004214" Supported Supported Cytosol NA NA 260000 Cytosol "CAB004214: AB_627232, HPA003928: AB_1846373" "unprognostic (2.40e-1)" "unprognostic (1.06e-1)" "unprognostic (1.27e-1)" "unprognostic (2.33e-2)" "unprognostic (2.46e-3)" "unprognostic (6.21e-2)" "unprognostic (1.37e-1)" "unprognostic (7.90e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-3)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.84e-2)" "prognostic favorable (2.33e-4)" "unprognostic (5.80e-2)" "unprognostic (1.23e-1)" "unprognostic (3.02e-2)" 47.3 29.7 33.0 41.6 33.0 41.8 42.0 35.8 46.8 31.9 35.5 17.8 32.7 31.8 36.3 34.8 37.9 30.1 42.8 49.5 28.1 31.3 33.6 35.6 38.2 33.4 26.6 36.4 34.4 34.2 26.8 24.2 34.3 32.9 31.5 27.7 21.6 37.0 34.4 148.6 29.3 31.3 28.7 23.0 43.5 34.0 23.4 29.8 32.6 33.5 50.7 34.6 33.0 48.0 33.2 45.2 40.0 46.0 40.2 52.3 53.0 53.0 35.3 19.1 27.2 26.3 23.0 24.6 63.1 28.7 39.8 34.2 40.4 21.0 31.7 51.2 38.5 23.5 33.2 25.7 41.0 27.6 25.4 76.0 60.2 28.6 57.1 41.5 34.8 27.6 28.0 22.5 46.4 21.0 22.9 50.9 27.9 46.6 38.4 30.7 50.5 34.7 85.8 46.6 33.7 62.6 34.6 25.6 36.3 36.4 34.7 22.3 32.5 29.6 31.3 27.0 15.3 21.4 37.7 56.6 46.7 26.8 63.8 50.3 52.4 51.4 39.3 36.6 56.7 37.6 29.2 46.0 40.0 52.3 45.8 47.3 33.2 42.3 46.9 45.2 29.1 33.0 38.1 26.6 40.2 44.1 38.4 44.0 53.0 33.0 33.0 35.8 46.8 28.1 31.3 26.6 36.4 32.9 29.8 50.6 99.5 87.5 97.4 132.0 73.1 60.9 76.5 69.6 87.6 61.1 37.3 164.7 86.2 190.3 86.2 167.5 121.6 0.0 172.9 359.8 113.1 81.0 130.6 39.4 190.0 84.2 78.0 142.4 66.8 195.7 98.4 192.0 131.6 208.2 93.0 57.2 218.0 128.9 97.2 64.3 78.6 77.6 140.1 60.9 70.4 116.9 202.8 124.6 108.6 144.2 CDC37L1 "CDC37B, FLJ20639, HARC" ENSG00000106993 "Cell division cycle 37 like 1" Q7L3B6 9 4679559-4708398 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HDLM-2: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021175 Approved Supported Cytosol NA NA Cytosol "HPA021175: AB_10959752" "unprognostic (1.18e-2)" "unprognostic (8.52e-2)" "unprognostic (2.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (2.38e-2)" "unprognostic (3.66e-3)" "unprognostic (2.71e-2)" "unprognostic (9.89e-2)" "unprognostic (7.82e-3)" "unprognostic (2.78e-2)" "unprognostic (7.97e-2)" "prognostic favorable (2.66e-7)" "unprognostic (8.54e-2)" "unprognostic (1.91e-1)" "unprognostic (2.91e-2)" "unprognostic (4.28e-2)" 14.9 12.6 10.4 7.1 15.4 5.6 10.5 12.4 14.9 12.2 10.0 7.1 11.2 7.8 10.9 12.0 15.8 10.1 11.6 28.6 11.2 12.6 13.4 42.0 8.4 9.0 10.0 9.9 12.4 15.1 9.3 13.7 7.5 17.3 13.0 6.5 6.2 9.4 11.1 58.8 8.1 8.0 17.9 8.8 6.3 9.5 10.8 8.9 7.0 12.2 14.0 7.2 18.0 16.1 10.7 6.2 14.8 6.8 8.1 20.7 7.9 7.2 6.6 3.5 5.6 12.7 9.4 5.4 8.6 5.9 5.2 6.0 2.1 4.5 4.6 2.4 6.2 3.5 3.2 3.9 5.2 5.1 54.0 3.3 12.3 7.2 5.7 7.6 4.9 5.1 6.0 6.8 3.9 6.2 5.8 3.7 4.2 1.4 7.2 5.8 3.5 3.8 10.2 8.9 4.8 2.3 3.1 4.3 2.6 7.4 3.0 10.1 5.0 6.3 5.2 4.2 4.7 4.2 4.7 4.0 7.9 3.7 4.4 5.6 5.6 8.8 3.4 7.0 3.5 2.5 14.8 5.7 11.0 13.3 5.3 13.1 10.7 13.4 14.0 5.4 10.5 20.7 18.5 6.8 8.1 6.8 6.2 12.1 7.9 10.4 15.4 12.4 14.9 11.2 12.6 10.0 9.9 17.3 8.9 26.8 16.5 11.2 38.4 58.5 28.6 62.3 20.4 17.4 17.0 15.7 31.4 15.6 41.4 28.4 8.6 17.6 12.9 0.0 36.2 13.7 33.8 56.3 23.1 91.2 10.4 19.1 17.1 15.4 11.2 3.9 33.4 16.0 38.8 13.6 14.9 28.6 23.9 11.5 34.3 49.1 21.9 32.3 48.6 69.4 49.7 50.2 28.3 26.1 10.7 43.1 CDC42BPG "DMPK2, HSMDPKIN, kappa-200, MRCKgamma" ENSG00000171219 "CDC42 binding protein kinase gamma" Q6DT37 11 64823387-64844569 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Club cells: 12.5;Enterocytes: 10.6;Paneth cells: 14.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 9 "cerebellum: 19.4" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 19.5;HaCaT: 14.6;MCF7: 19.7;RT4: 12.0;SK-BR-3: 12.1;T-47d: 11.9" "Region enriched" "Detected in single" 4 "cerebellum: 5.9" "Low region specificity" "Detected in single" "HPA027382, HPA061836" Enhanced Supported Cytosol NA NA Cytosol "HPA027382: AB_1846378, HPA061836: AB_2684622" "unprognostic (3.26e-2)" "unprognostic (1.58e-1)" "unprognostic (6.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.21e-1)" "unprognostic (2.50e-1)" "unprognostic (4.68e-1)" "unprognostic (5.27e-2)" "unprognostic (3.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.26e-1)" "unprognostic (1.81e-1)" "prognostic favorable (5.99e-13)" "unprognostic (2.60e-2)" "unprognostic (1.55e-1)" "unprognostic (2.14e-2)" "unprognostic (3.99e-3)" 0.5 2.7 0.8 2.1 0.5 1.1 3.5 19.4 0.8 2.9 9.1 0.8 6.3 8.2 1.0 8.0 14.3 2.9 10.5 0.5 0.7 0.0 3.5 0.5 4.2 0.7 0.5 0.5 1.5 7.9 7.0 6.5 13.0 2.0 4.4 3.4 1.0 14.3 7.6 0.5 22.4 19.7 1.6 0.8 0.8 8.5 2.5 0.7 1.8 3.9 8.1 7.7 5.4 6.3 0.4 0.0 0.0 0.0 0.2 1.0 0.1 5.6 0.8 0.5 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 7.6 4.8 0.1 2.8 0.0 0.2 14.6 0.9 5.7 0.0 0.2 2.2 0.4 3.1 2.4 0.0 0.1 1.4 0.0 7.2 0.1 0.1 0.0 0.0 2.3 3.8 0.0 0.0 19.7 0.1 1.0 1.8 5.3 0.8 0.8 0.3 2.7 3.4 12.0 10.4 0.5 1.8 12.1 0.3 2.9 11.9 0.2 0.0 0.0 2.1 0.0 0.0 1.4 1.3 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.2 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.8 0.5 19.4 0.8 0.7 0.0 0.5 0.5 2.0 0.7 8.9 6.4 0.0 2.3 5.8 0.0 1.6 2.5 6.7 12.5 1.8 0.0 4.8 0.0 1.7 0.5 0.0 10.6 0.0 5.3 4.1 0.6 2.1 1.1 0.0 0.9 0.0 3.5 0.0 0.0 0.4 0.0 0.2 0.0 1.8 3.3 0.9 2.8 14.0 0.0 0.3 0.0 0.0 0.5 1.7 1.1 7.0 5.6 0.0 3.8 2.0 CDC42EP2 "BORG1, CEP2" ENSG00000149798 "CDC42 effector protein 2" O14613 11 65314818-65322429 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 52.2;Pancreatic endocrine cells: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 13.3;intermediate monocyte: 29.8;neutrophil: 46.1;non-classical monocyte: 21.7" "Group enriched" "Detected in many" 13 "granulocytes: 46.1;monocytes: 29.8" "Cell line enhanced" "Detected in many" "PC-3: 28.8;U-2197: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038562 Approved Supported Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA038562: AB_10671745" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (9.91e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (4.73e-3)" "prognostic unfavorable (2.89e-5)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.01e-1)" "unprognostic (5.36e-2)" "unprognostic (8.57e-3)" "unprognostic (3.81e-1)" "unprognostic (1.68e-1)" "unprognostic (2.66e-2)" "unprognostic (3.67e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-2)" 47.2 5.1 7.7 11.8 37.7 2.1 32.1 3.2 15.4 15.9 11.2 39.1 4.7 12.6 13.9 6.3 11.5 12.7 20.5 11.4 10.7 6.6 9.9 6.5 15.0 8.8 31.4 8.9 10.5 7.9 2.2 4.3 16.9 19.7 8.5 4.5 2.5 4.1 8.3 7.0 4.6 10.6 11.6 24.4 15.3 12.0 2.4 24.7 0.0 17.3 7.0 3.2 18.6 16.2 0.2 2.8 46.1 29.8 0.0 0.1 3.9 5.1 6.2 2.2 3.6 8.4 13.5 0.7 5.3 19.3 5.9 7.2 10.4 9.9 0.9 13.2 11.8 2.2 6.1 2.5 14.1 1.8 1.9 3.3 1.2 8.4 7.1 22.8 0.3 0.7 6.1 1.8 16.2 14.9 3.1 14.7 1.2 2.3 3.2 5.4 8.2 0.9 0.8 3.6 11.3 28.8 1.3 1.2 1.8 11.2 2.8 0.7 2.3 11.2 9.4 1.0 1.1 1.8 0.4 16.1 4.3 4.3 31.3 2.2 1.1 1.8 1.7 6.8 0.4 3.3 0.0 13.3 0.5 0.1 29.8 0.1 0.2 0.0 0.0 2.8 0.0 0.0 0.0 46.1 0.0 21.7 0.2 0.0 3.9 7.7 37.7 3.2 15.4 10.7 6.6 31.4 8.9 19.7 24.7 0.0 0.0 1.9 5.3 11.3 13.9 5.5 0.0 2.7 1.2 12.2 0.0 0.3 3.3 52.2 0.2 23.9 11.6 0.0 35.2 2.8 27.9 5.9 5.7 0.9 1.2 3.2 1.7 27.0 22.4 0.9 17.3 9.0 11.8 10.8 4.4 0.8 47.9 10.5 12.7 2.2 4.1 38.8 17.8 1.4 2.5 8.8 1.4 0.7 3.8 33.6 CDC45 "CDC45L, CDC45L2" ENSG00000093009 "Cell division cycle 45" O75419 22 19479459-19520612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 88.0;Erythroid cells: 46.7;Spermatocytes: 23.9;Spermatogonia: 49.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 87.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000614, CAB009459" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA Yes Nucleoplasm "Centrosome, Cytosol" "CAB009459: AB_2078507, HPA000614: AB_1078487" "unprognostic (5.56e-2)" "unprognostic (6.12e-3)" "unprognostic (1.17e-3)" "unprognostic (3.42e-3)" "unprognostic (3.57e-1)" "unprognostic (7.42e-2)" "prognostic unfavorable (6.95e-6)" "unprognostic (6.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (8.94e-4)" "unprognostic (7.28e-2)" "unprognostic (0.00e+0)" "unprognostic (7.62e-3)" "unprognostic (2.02e-1)" "unprognostic (8.52e-2)" "unprognostic (1.10e-1)" 0.9 0.9 0.3 8.4 0.5 15.7 0.9 0.3 0.6 1.3 3.4 0.3 0.2 2.2 0.6 1.4 6.2 0.4 0.8 1.6 0.7 0.3 0.8 1.4 1.3 7.5 0.4 0.2 0.7 0.5 0.1 0.4 3.5 0.4 0.7 4.3 0.2 1.3 0.2 0.4 2.1 3.1 1.1 0.4 4.2 1.8 43.5 0.2 25.4 0.5 7.2 10.2 1.3 1.9 0.7 0.9 1.6 0.5 1.8 3.2 1.9 13.2 11.1 13.9 10.9 0.6 1.3 5.9 16.4 7.7 18.9 18.8 8.5 7.4 14.8 5.8 4.9 7.5 12.8 14.8 10.8 17.0 18.0 25.0 19.8 12.6 9.3 0.7 28.7 10.9 0.4 0.5 14.5 6.5 1.8 9.5 15.3 87.8 18.7 11.0 17.7 23.3 13.6 4.2 25.7 8.4 19.4 23.1 6.5 4.4 12.7 18.0 9.5 8.9 9.8 2.8 6.5 6.4 12.8 3.6 14.8 23.7 11.2 14.9 6.4 11.8 17.2 7.8 14.4 19.7 0.0 0.2 0.0 2.2 0.0 0.0 0.7 1.4 2.3 0.6 0.0 1.0 0.7 1.6 1.8 0.5 0.9 3.2 1.9 0.3 0.5 0.3 0.6 0.7 0.3 0.4 0.2 0.4 0.2 0.0 0.0 0.8 0.4 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.9 88.0 0.3 0.4 46.7 0.0 16.8 1.0 0.2 0.0 0.0 6.2 0.0 0.0 3.7 0.6 6.1 0.6 0.9 0.0 0.0 0.8 0.0 0.1 0.0 0.7 0.0 0.0 6.5 0.9 23.9 49.8 1.6 4.1 1.3 2.5 0.4 CDC6 CDC18L ENSG00000094804 "Cell division cycle 6" Q99741 17 40287633-40304657 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.0" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 23.3;Extravillous trophoblasts: 27.7;Spermatogonia: 23.0;Syncytiotrophoblasts: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 5 "dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "SK-BR-3: 86.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA050114, HPA065070" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Nucleoplasm, Cytosol" "Cytokinetic bridge, Mitotic spindle" "HPA050114: AB_2681021, HPA065070: AB_2732729" "unprognostic (1.29e-1)" "unprognostic (7.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.97e-2)" "unprognostic (7.12e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (5.96e-8)" "unprognostic (2.31e-3)" "unprognostic (1.46e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (5.47e-2)" "unprognostic (3.00e-15)" "unprognostic (1.86e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (3.88e-2)" 1.8 2.9 3.1 10.8 2.6 16.8 1.5 2.3 6.0 2.7 5.8 0.8 2.7 5.3 1.9 1.6 9.0 1.3 5.4 1.6 1.9 1.4 1.8 5.1 2.8 10.6 1.0 1.5 1.5 3.6 1.1 1.2 9.4 0.8 1.4 5.6 0.2 3.2 4.1 0.9 2.3 7.9 2.4 1.6 7.7 2.7 14.8 1.2 30.0 1.3 5.0 10.1 4.1 3.0 0.7 6.2 0.2 0.3 2.2 3.4 1.2 25.4 17.6 21.3 15.1 1.1 2.3 19.5 27.8 8.3 24.4 29.5 20.0 11.4 20.6 17.4 5.9 14.1 37.1 18.4 12.6 24.3 10.9 14.5 16.7 21.0 17.9 0.7 22.8 10.3 0.6 0.9 28.2 16.9 2.6 7.3 14.2 30.5 19.3 11.8 13.3 33.1 5.5 17.5 15.1 6.5 24.4 51.9 19.4 4.0 28.7 14.6 13.1 25.3 86.7 8.6 17.4 17.6 19.8 6.1 17.6 25.2 28.8 32.9 8.1 17.5 39.7 15.2 15.1 19.2 0.1 0.3 0.0 1.3 0.0 0.9 0.7 1.2 2.1 1.4 0.7 0.9 2.1 0.2 2.2 0.0 6.2 3.4 1.2 3.1 2.6 2.3 6.0 1.9 1.4 1.0 1.5 0.8 1.2 0.0 1.3 2.2 1.1 3.8 0.0 0.6 0.0 0.0 1.2 0.0 0.0 12.0 0.0 1.2 1.4 0.5 1.1 23.3 0.6 27.7 2.4 1.1 0.0 0.9 6.8 0.0 0.0 1.8 1.3 0.2 2.6 1.3 0.0 0.0 1.7 0.3 1.2 2.9 0.7 0.2 0.3 12.9 1.0 11.4 23.0 1.4 14.0 2.5 4.6 2.0 CDC73 "C1orf28, FIHP, HRPT1, HRPT2, parafibromin" ENSG00000134371 "Cell division cycle 73" Q6P1J9 1 193121997-193253901 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002326, CAB016359, HPA069324" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016359: AB_628102, HPA002326: , HPA069324: " "unprognostic (4.41e-2)" "unprognostic (6.22e-2)" "unprognostic (1.90e-2)" "unprognostic (5.30e-2)" "unprognostic (2.88e-3)" "unprognostic (3.53e-2)" "unprognostic (2.48e-3)" "unprognostic (5.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.40e-1)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (5.44e-3)" "unprognostic (3.47e-1)" "unprognostic (2.49e-1)" "unprognostic (6.73e-3)" "unprognostic (2.98e-3)" 23.4 20.0 18.1 16.8 22.9 21.0 20.1 25.6 22.6 20.4 20.1 14.5 16.3 12.0 26.8 15.2 20.6 14.9 16.4 21.4 18.4 15.0 18.8 17.1 17.2 16.6 19.7 15.9 23.3 14.5 27.1 24.8 17.3 19.4 26.9 16.2 13.6 17.3 19.0 44.5 15.0 14.5 25.6 23.9 16.0 15.7 16.3 22.1 20.6 27.1 14.1 15.8 26.8 35.0 6.6 6.7 10.2 7.0 9.0 12.5 5.2 13.4 12.1 16.0 10.3 15.0 14.6 12.3 14.5 14.1 17.6 15.4 8.3 16.0 17.5 10.3 17.8 9.7 13.2 14.5 13.7 21.5 11.1 6.9 12.7 10.9 8.0 14.1 17.2 12.7 11.9 13.3 16.5 15.8 15.6 14.9 10.0 19.2 14.2 23.5 12.4 14.1 8.5 15.4 19.8 4.5 12.6 9.7 16.7 20.6 9.4 4.8 13.2 18.1 22.4 20.7 18.6 19.2 12.5 16.6 17.1 4.0 14.5 14.8 13.3 9.9 14.4 10.3 10.6 29.9 6.6 7.0 10.2 9.3 6.8 12.5 6.6 9.2 9.2 6.7 5.4 8.4 8.7 7.4 9.0 5.7 4.9 9.3 5.2 18.1 22.9 25.6 22.6 18.4 15.0 19.7 15.9 19.4 22.1 32.8 20.1 34.3 31.1 33.1 31.2 36.4 20.4 20.1 19.4 31.4 33.4 21.8 28.2 29.4 11.9 30.1 16.2 23.3 28.5 34.0 29.2 33.5 39.4 14.3 28.0 20.6 10.9 22.1 25.9 6.1 31.1 38.8 27.0 47.7 15.3 33.5 28.2 13.1 33.9 26.4 36.3 25.8 57.1 56.5 32.0 30.6 31.8 29.8 16.1 23.2 CDCA3 "GRCC8, TOME-1" ENSG00000111665 "Cell division cycle associated 3" Q99618 12 6844793-6852066 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.6;lymphoid tissue: 51.0" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 53.0;Erythroid cells: 46.7;Extravillous trophoblasts: 60.9;Spermatocytes: 57.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.8" "Cell type enhanced" "Detected in many" "T-reg: 7.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA026587 Approved Cytosol NA Yes Cytosol "HPA026587: AB_1846386" "unprognostic (3.05e-1)" "unprognostic (1.32e-1)" "unprognostic (9.85e-2)" "unprognostic (1.63e-2)" "unprognostic (2.42e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (6.51e-5)" "prognostic unfavorable (9.77e-5)" "unprognostic (3.88e-2)" "unprognostic (1.27e-1)" "unprognostic (1.80e-3)" "unprognostic (8.81e-2)" "unprognostic (0.00e+0)" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.11e-1)" "unprognostic (4.94e-2)" 1.6 1.9 1.0 19.2 1.8 9.9 1.9 8.8 2.2 2.0 17.3 1.2 1.2 15.5 2.3 2.0 6.9 1.0 2.9 2.2 1.1 1.6 1.3 0.9 1.9 10.8 1.3 0.7 3.7 0.6 0.3 6.9 4.7 1.2 2.2 5.3 0.7 2.4 0.4 0.7 4.3 34.6 2.0 1.4 5.2 2.4 18.2 1.1 51.0 1.3 8.5 15.1 1.6 2.8 1.6 2.3 0.5 0.6 0.8 7.7 0.9 30.1 21.8 22.3 13.5 1.3 2.0 25.9 19.9 12.2 32.8 22.9 32.3 26.0 16.7 2.5 15.0 23.8 20.8 14.3 13.7 32.6 25.1 15.9 15.0 14.6 21.0 0.2 11.1 14.3 0.9 1.1 17.6 9.6 8.0 13.9 11.8 12.4 10.9 31.2 23.6 16.2 12.9 26.1 20.3 16.9 16.4 19.4 9.4 10.9 8.5 3.4 6.7 18.0 16.8 6.2 24.9 6.6 10.8 6.1 16.0 20.7 10.4 33.4 5.6 5.6 26.1 7.5 13.9 28.1 0.0 0.6 0.0 0.5 0.3 0.8 1.6 1.3 1.9 0.7 0.8 0.6 1.2 0.5 0.8 0.5 2.3 7.7 0.9 1.0 1.8 8.8 2.2 1.1 1.6 1.3 0.7 1.2 1.1 0.0 0.3 0.8 1.2 2.6 10.5 1.0 0.0 0.0 0.0 0.0 53.0 3.3 0.0 0.9 5.9 0.4 9.5 46.7 0.3 60.9 2.6 1.0 4.6 0.8 15.7 6.4 1.2 3.1 3.5 5.4 1.7 2.7 0.0 1.8 5.7 1.4 0.3 0.8 0.4 0.7 18.0 6.5 0.4 57.5 14.9 1.6 7.1 0.8 10.9 0.6 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 38.3" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 133.3;Spermatogonia: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064971 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes Nucleoplasm "Plasma membrane, Cytosol" "HPA064971: AB_2685395" "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (4.19e-4)" "prognostic unfavorable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 4.5 2.6 1.7 11.5 2.6 38.3 4.1 8.3 3.2 8.7 3.7 2.6 4.5 4.1 5.6 4.0 16.6 4.1 4.2 2.4 1.5 1.3 2.8 3.0 5.1 9.1 2.7 1.4 5.0 6.2 1.6 1.9 12.4 3.3 4.6 2.7 3.3 5.3 2.2 1.3 21.8 4.4 3.1 2.3 6.7 3.6 12.8 2.3 24.9 5.1 11.2 15.0 3.7 8.8 7.4 4.2 8.3 4.3 10.6 14.7 5.5 15.2 15.9 18.4 13.9 3.1 5.2 24.1 22.8 7.0 17.9 15.7 19.4 19.5 20.0 12.5 8.0 13.7 24.5 12.8 26.3 10.5 21.9 10.1 12.7 13.6 16.2 3.9 22.4 10.7 3.7 8.2 13.8 13.0 6.0 12.1 17.5 13.9 20.8 12.4 37.4 20.8 15.1 13.6 13.3 36.4 20.2 26.8 7.4 6.0 17.7 10.8 13.3 21.8 8.8 17.5 8.5 17.2 15.1 18.7 15.9 20.2 21.7 30.2 7.7 9.5 20.5 13.3 11.4 26.2 0.9 3.6 8.3 10.9 3.9 13.3 7.4 11.4 14.7 3.9 5.2 6.8 8.0 1.3 10.6 4.3 4.2 8.9 5.5 1.7 2.6 8.3 3.2 1.5 1.3 2.7 1.4 3.3 2.3 0.0 2.1 10.4 19.9 57.1 3.0 0.6 0.0 8.1 3.4 1.8 0.0 53.6 3.3 12.9 6.4 9.0 1.1 23.3 6.2 133.3 12.5 7.7 28.8 2.1 21.5 12.7 2.9 7.4 6.2 4.3 7.8 10.6 16.9 10.8 4.4 3.4 9.1 3.5 5.6 1.4 2.7 6.5 10.3 31.0 64.2 58.6 21.6 17.5 6.0 48.5 CDCA7 "FLJ14736, JPO1" ENSG00000144354 "Cell division cycle associated 7" Q9BWT1 2 173354820-173368997 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.4" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 40.4;Leydig cells: 49.8;Peritubular cells: 32.5;Undifferentiated cells: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 9.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 61.8" "Group enriched" "Detected in many" 4 "basal ganglia: 8.3;olfactory region: 21.4" "Low region specificity" "Detected in all" HPA005565 Supported Nucleoplasm,Cytosol No Yes "Nucleoplasm, Cytosol" "HPA005565: AB_2078680" "unprognostic (1.67e-3)" "unprognostic (2.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" "unprognostic (2.16e-1)" "unprognostic (1.44e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (7.54e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.96e-2)" "unprognostic (2.83e-1)" "unprognostic (8.97e-3)" "unprognostic (0.00e+0)" "unprognostic (4.53e-3)" "unprognostic (1.96e-1)" "unprognostic (2.04e-1)" "unprognostic (2.47e-2)" 1.1 0.6 1.2 28.0 1.5 9.7 1.8 0.5 1.4 8.3 12.3 2.8 2.6 14.9 7.9 1.7 12.9 2.3 6.6 0.9 2.0 1.4 0.8 0.4 1.3 17.2 1.3 2.2 1.1 2.9 0.0 0.4 7.3 3.4 3.2 14.8 1.1 3.3 0.6 4.3 8.3 16.4 1.5 2.0 2.9 7.6 8.1 2.0 71.4 0.9 10.5 24.0 2.3 8.0 2.6 4.2 0.3 0.7 3.6 9.4 2.7 9.8 7.6 17.9 19.4 0.8 3.3 18.7 6.0 2.1 14.2 16.0 11.7 12.6 27.6 7.6 3.6 5.5 10.3 28.4 10.7 20.7 13.2 15.6 6.2 5.5 14.8 0.9 40.4 5.9 2.7 0.9 7.7 6.5 1.8 6.4 36.5 14.9 6.3 4.1 7.9 61.8 40.7 21.1 23.4 5.3 43.7 13.6 17.5 6.9 8.7 5.2 9.2 9.4 3.1 5.0 16.7 0.0 15.9 2.9 9.3 4.0 3.0 10.9 1.7 3.7 38.8 5.8 22.5 7.8 0.0 0.7 0.0 1.4 0.0 0.5 2.6 3.9 7.6 4.2 0.3 0.3 1.4 0.3 3.6 0.0 0.6 9.4 2.7 1.2 1.5 0.5 1.4 2.0 1.4 1.3 2.2 3.4 2.0 0.0 1.1 1.4 12.6 18.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.4 1.1 6.7 0.0 0.2 21.5 2.6 2.4 0.0 0.0 8.9 0.0 11.7 0.0 0.8 1.8 49.8 1.6 3.3 0.0 19.1 0.6 0.7 7.0 32.5 0.0 0.0 0.0 4.3 9.4 30.1 13.9 8.5 6.9 66.1 1.7 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900900-21946084 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.9" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 5 "olfactory region: 22.0" "HPA027169, HPA074623" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058, HPA074623: " "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 6.2 1.2 3.7 19.9 9.6 24.2 8.0 6.5 4.2 8.4 9.0 7.8 3.9 5.2 11.1 3.6 6.0 7.0 5.4 12.5 3.9 2.5 2.7 4.5 7.3 18.7 6.2 4.0 13.9 17.4 1.0 1.6 2.2 3.7 7.6 10.2 5.8 10.5 8.0 2.7 13.6 8.7 6.6 3.0 9.3 12.7 12.6 5.3 47.9 20.0 5.1 16.5 6.0 9.4 38.5 21.8 11.8 1.3 0.8 9.7 3.3 19.7 6.8 6.4 0.1 3.5 4.5 0.0 16.2 13.9 12.6 17.9 2.5 18.0 41.3 5.3 13.9 25.1 12.2 10.1 16.6 25.5 0.0 6.7 9.9 20.1 1.6 4.5 25.9 0.1 8.3 3.0 9.7 28.5 13.0 24.8 32.3 13.6 0.0 9.7 7.4 32.7 9.3 36.5 3.9 8.4 32.9 22.9 27.5 3.5 3.7 23.5 19.2 7.3 4.5 7.4 8.5 11.0 11.7 10.5 13.8 17.0 23.9 19.5 21.3 14.6 53.4 13.2 35.0 13.5 0.3 0.6 11.8 0.6 0.9 0.1 28.6 1.9 0.9 4.3 38.5 9.7 3.9 1.1 0.8 1.3 21.8 2.7 3.3 3.7 9.6 6.5 4.2 3.9 2.5 6.2 4.0 3.7 5.3 17.9 20.3 28.9 22.5 24.2 0.2 26.3 2.5 6.7 31.8 0.0 2.0 0.5 3.3 6.7 2.6 3.7 1.5 0.0 5.3 0.2 4.3 7.7 8.1 3.4 9.6 12.7 10.3 2.5 10.2 3.6 3.7 3.5 8.5 0.0 26.4 2.4 4.9 3.5 2.5 0.0 2.1 12.9 12.3 2.7 61.1 6.8 0.2 2.5 24.4 3.9 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880600-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 46.8" "Cell type enhanced" "Detected in single" 37 "Proximal tubular cells: 3.3" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6" "Cell type enhanced" "Detected in some" "neutrophil: 8.3" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 8.3" "Cell line enhanced" "Detected in some" "K-562: 9.4;NTERA-2: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.7 0.5 46.8 1.0 24.6 2.8 0.7 0.5 23.7 0.5 0.8 0.0 0.0 0.6 0.9 1.2 0.7 0.5 0.7 0.5 15.9 3.5 10.5 0.5 0.6 1.6 1.2 15.6 0.6 1.1 1.0 0.5 0.8 1.5 1.0 1.2 0.0 0.5 0.1 0.5 1.9 1.5 0.8 0.6 0.8 0.9 3.7 2.6 0.0 1.9 0.0 1.7 0.5 0.5 4.1 0.9 8.3 1.1 0.1 0.8 1.1 2.5 0.9 0.5 0.8 0.4 0.0 1.6 0.0 0.9 0.3 0.7 0.0 0.9 1.3 0.3 0.3 0.2 0.3 0.1 0.6 0.0 0.1 0.3 0.5 0.7 2.5 0.0 0.0 1.6 0.6 0.7 0.0 0.0 0.0 0.2 0.8 9.4 2.3 0.0 1.5 0.8 0.5 13.9 0.2 0.5 0.3 0.3 0.4 0.5 0.5 3.1 0.3 0.0 0.4 0.5 2.7 0.5 0.9 1.7 0.1 0.8 0.8 0.3 2.8 1.0 4.4 1.0 1.0 0.8 1.3 0.2 0.4 0.2 0.7 0.6 4.1 0.4 0.2 0.1 2.5 0.3 0.5 8.3 0.1 1.1 0.9 0.8 1.1 46.8 24.6 0.5 23.7 15.9 3.5 1.2 15.6 1.5 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 88.4" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 280.4;Extravillous trophoblasts: 116.8;Spermatocytes: 104.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 6.1;T-reg: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA003387, CAB003799" Enhanced Supported Nucleoplasm,Cytosol NA Yes Cytosol Nucleoplasm "CAB003799: AB_344898, HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favorable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (1.10e-6)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 4.1 2.2 0.8 17.8 2.4 17.8 4.4 0.7 1.6 4.2 6.5 1.1 3.4 6.1 2.9 4.8 19.0 1.5 2.4 2.3 0.9 0.7 3.1 1.7 5.7 15.1 1.7 0.6 2.2 1.0 0.5 4.4 13.3 1.2 1.5 8.3 1.0 3.8 2.9 1.0 4.9 8.3 2.7 2.5 8.3 5.0 13.8 1.2 88.4 1.8 16.7 20.1 3.2 6.9 0.9 1.7 0.0 0.2 6.1 5.7 1.8 48.9 18.6 49.6 19.6 3.2 5.0 20.4 37.0 27.0 45.2 43.6 43.6 43.3 44.9 14.4 10.1 16.6 30.5 33.7 21.5 47.1 31.9 24.6 23.5 18.4 25.3 0.6 36.0 24.3 0.9 2.1 29.2 28.5 10.3 27.1 29.6 35.9 55.3 50.2 13.0 45.3 25.9 21.8 29.6 39.3 39.4 46.2 22.0 17.2 16.3 23.3 20.4 24.9 37.8 19.2 28.1 40.8 22.1 11.1 19.3 41.2 20.3 50.6 21.7 34.8 40.5 16.6 40.4 23.9 0.0 0.0 0.0 0.5 0.2 0.5 0.9 1.5 2.7 0.5 0.5 0.5 1.5 0.0 6.1 0.2 1.7 5.7 1.8 0.8 2.4 0.7 1.6 0.9 0.7 1.7 0.6 1.2 1.2 0.0 2.7 2.2 3.6 35.3 1.0 0.5 0.0 14.7 7.9 17.4 0.0 11.0 3.3 0.7 8.8 4.5 1.7 280.4 0.0 116.8 5.1 1.0 0.0 0.8 46.3 0.0 2.9 9.8 15.3 6.3 2.0 8.8 1.7 1.8 4.0 1.0 0.3 0.0 0.7 2.1 0.5 0.0 1.4 104.2 29.6 16.3 18.4 7.0 5.6 6.0 CDK11A "CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE" ENSG00000008128 "Cyclin dependent kinase 11A" Q9UQ88 1 1702730-1724324 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 104.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB010467, HPA025061, HPA073626" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: AB_2686619" "unprognostic (6.25e-2)" "unprognostic (8.32e-2)" "unprognostic (1.47e-2)" "unprognostic (2.74e-1)" "unprognostic (9.32e-3)" "unprognostic (3.54e-2)" "unprognostic (2.25e-3)" "unprognostic (7.97e-2)" "prognostic unfavorable (5.06e-4)" "unprognostic (1.28e-1)" "unprognostic (5.58e-3)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.15e-6)" "unprognostic (1.97e-1)" "unprognostic (5.98e-2)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" 14.3 14.9 17.2 23.7 26.9 39.7 13.0 35.2 32.7 12.5 16.4 14.3 6.1 29.2 16.5 8.5 12.1 12.6 10.2 10.2 19.4 8.4 11.7 12.5 19.0 20.3 22.6 9.0 16.2 12.9 12.2 27.5 12.9 17.1 14.4 14.6 11.6 12.7 10.3 21.5 15.1 34.9 13.1 26.0 24.2 15.7 16.4 25.1 14.9 14.6 7.6 22.4 13.5 15.2 7.4 11.8 33.5 6.3 4.4 5.5 1.4 16.3 9.9 7.1 6.5 9.4 7.5 7.0 16.1 7.2 8.0 9.4 12.3 15.0 17.4 9.9 4.7 10.4 12.2 6.5 8.4 6.4 13.3 10.6 15.5 18.5 11.0 6.2 17.3 22.4 8.7 5.7 7.0 4.6 9.7 13.8 9.4 18.1 14.6 6.7 9.2 8.0 13.6 9.9 10.0 8.4 14.7 10.8 8.4 6.5 7.4 7.9 11.4 14.1 16.6 19.3 3.6 11.1 7.2 14.0 12.6 12.3 5.6 8.9 20.4 14.8 21.9 4.3 14.0 4.0 16.7 6.3 7.7 5.5 3.4 4.2 6.2 4.7 4.2 2.0 7.4 4.7 4.0 33.5 4.4 3.7 11.8 4.5 1.4 17.2 26.9 35.2 32.7 19.4 8.4 22.6 9.0 17.1 25.1 47.6 54.9 22.4 11.6 12.5 31.1 1.2 12.7 53.5 58.0 14.0 25.5 13.8 8.3 17.1 29.6 20.3 32.5 23.3 13.2 19.0 13.9 10.7 79.0 12.3 10.9 38.1 8.7 11.6 8.2 11.1 32.8 22.6 10.1 23.4 23.2 20.4 21.0 46.0 20.1 9.6 39.2 12.9 9.1 104.7 84.3 12.8 25.5 25.5 18.6 12.9 CDK13 "CDC2L, CDC2L5, CHED, KIAA1791" ENSG00000065883 "Cyclin dependent kinase 13" Q14004 7 39949646-40099580 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059241 Uncertain Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Nuclear speckles" "Golgi apparatus, Cytosol" "HPA059241: AB_2683956" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (2.72e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-1)" "unprognostic (4.18e-3)" "unprognostic (3.42e-2)" "unprognostic (8.09e-2)" "unprognostic (1.13e-2)" "unprognostic (3.77e-2)" "unprognostic (8.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.21e-1)" "unprognostic (3.33e-2)" "unprognostic (3.53e-1)" "unprognostic (3.53e-2)" 16.9 15.3 16.0 29.0 14.5 26.7 20.4 23.3 18.2 16.6 18.3 16.4 14.2 11.3 20.3 17.7 20.9 18.1 20.2 13.6 14.3 11.3 14.7 17.5 19.6 21.9 16.5 15.1 24.2 15.3 26.3 15.3 14.8 12.0 15.5 15.5 14.9 17.6 14.5 19.4 16.7 16.3 16.4 11.5 17.4 14.5 20.2 15.7 31.2 23.1 14.6 21.5 18.5 23.6 14.0 3.9 7.9 3.4 5.0 5.0 1.4 15.7 9.4 16.4 15.6 14.8 14.5 11.3 12.6 13.7 11.6 14.6 9.8 10.9 28.6 7.4 13.2 20.4 19.2 13.4 11.1 17.1 14.0 9.9 12.7 11.5 8.8 14.2 19.3 13.9 8.5 14.9 13.2 17.7 13.3 13.6 13.3 21.4 19.8 12.0 8.1 15.3 13.7 23.7 11.1 11.0 17.0 10.9 11.5 10.9 16.0 11.7 17.0 16.0 34.7 11.4 22.2 14.2 24.1 16.1 16.0 15.3 10.3 17.1 16.4 13.8 23.6 11.7 17.5 20.4 7.9 2.7 4.4 5.0 2.2 3.4 7.6 4.8 3.7 1.5 14.0 4.9 4.9 7.6 5.0 3.4 3.9 4.3 1.4 16.0 14.5 23.3 18.2 14.3 11.3 16.5 15.1 12.0 15.7 41.7 63.7 28.9 17.1 19.1 42.3 25.6 30.6 34.8 47.8 29.6 66.8 11.5 6.6 19.1 10.7 22.5 15.9 0.0 13.4 7.5 19.4 16.3 16.2 20.7 11.6 35.0 18.0 20.3 23.2 7.0 24.2 18.3 13.5 15.4 17.7 26.6 24.2 10.5 16.6 11.1 68.4 6.5 15.6 31.4 31.5 22.8 10.2 22.5 18.8 21.7 CDK14 "PFTAIRE1, PFTK1" ENSG00000058091 "Cyclin dependent kinase 14" O94921 7 90466424-91210590 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 44.0;Horizontal cells: 163.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 7.5;memory B-cell: 9.8;naive B-cell: 5.3;neutrophil: 5.6" "Group enriched" "Detected in many" 9 "B-cells: 9.8;granulocytes: 7.5" "Cell line enhanced" "Detected in many" "Karpas-707: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015267 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015267: AB_1855249" "prognostic favorable (5.86e-4)" "unprognostic (3.96e-1)" "unprognostic (1.91e-2)" "unprognostic (2.09e-3)" "unprognostic (1.18e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-1)" "unprognostic (4.48e-2)" "unprognostic (3.60e-2)" "unprognostic (3.09e-2)" "unprognostic (2.77e-3)" "unprognostic (2.91e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (7.79e-4)" "unprognostic (2.46e-1)" "unprognostic (2.86e-1)" "unprognostic (4.39e-3)" 8.2 4.7 19.8 7.1 19.4 6.1 8.3 28.6 34.9 10.6 5.2 3.7 0.6 2.7 8.6 3.2 3.1 12.0 11.9 11.5 25.8 15.5 19.8 12.7 9.2 10.9 17.3 17.4 14.9 14.2 3.8 14.2 5.9 22.8 11.3 3.4 4.3 7.7 7.0 5.4 2.7 3.8 7.4 7.0 7.5 7.4 7.2 4.5 0.9 13.1 1.6 11.9 6.9 6.7 9.8 0.9 7.5 0.7 0.1 0.2 0.6 7.1 0.0 14.3 1.8 13.4 13.7 3.3 6.0 5.7 3.7 4.0 0.1 3.5 25.4 0.7 5.9 5.4 2.1 0.7 8.4 7.1 0.0 3.4 0.0 4.7 0.1 6.2 7.2 0.1 9.7 2.1 10.9 3.9 6.1 4.7 0.1 0.1 31.3 7.4 0.0 0.0 2.8 9.0 0.0 3.9 19.5 19.7 19.3 1.9 1.9 3.2 9.2 15.2 0.0 0.3 6.7 1.9 3.6 11.5 15.9 20.4 13.3 9.2 17.7 13.5 18.1 6.0 9.5 15.5 7.5 0.3 0.5 0.0 0.7 0.0 9.8 0.0 0.0 0.9 5.3 0.0 0.0 5.6 0.1 0.5 0.1 0.2 0.6 19.8 19.4 28.6 34.9 25.8 15.5 17.3 17.4 22.8 4.5 17.9 3.2 27.7 7.4 0.7 5.1 11.1 10.2 4.0 13.6 10.4 0.0 0.2 6.6 9.4 44.0 2.1 0.0 0.0 5.8 0.1 12.5 8.3 0.0 9.6 4.0 163.7 1.7 1.3 5.1 27.0 14.4 4.6 5.0 1.0 0.1 8.8 9.4 0.2 14.9 18.1 9.5 0.0 6.6 3.8 6.5 1.1 0.0 0.5 0.0 2.3 CDK16 "FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1" ENSG00000102225 "Cyclin dependent kinase 16" Q00536 X 47217860-47229997 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 91.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000974, HPA001366, CAB016535" Approved Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Microtubules, Cytosol" "Plasma membrane" "CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584" "unprognostic (2.37e-3)" "unprognostic (6.93e-2)" "unprognostic (2.96e-2)" "unprognostic (1.16e-3)" "unprognostic (8.80e-2)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.02e-6)" "unprognostic (2.85e-1)" "unprognostic (5.59e-2)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (1.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.89e-3)" "unprognostic (2.55e-1)" 22.0 20.1 32.3 13.9 25.0 26.6 17.6 51.5 49.0 17.2 19.3 15.5 17.0 16.4 14.8 12.8 23.8 18.8 14.1 47.3 29.2 18.0 19.9 12.7 14.0 10.8 22.0 21.1 16.7 18.6 22.8 14.9 18.6 28.5 12.7 14.7 13.7 20.1 16.1 91.2 17.0 15.3 18.2 14.8 12.0 14.7 28.7 12.1 10.4 20.9 36.3 12.6 12.9 12.1 8.5 13.5 8.5 10.7 6.3 7.7 5.7 40.6 31.2 30.0 44.3 22.0 18.9 30.0 19.4 23.9 29.5 22.0 35.1 19.8 9.8 12.4 34.7 54.7 23.1 31.9 41.3 19.9 11.7 50.6 10.6 43.9 27.3 28.6 11.1 24.9 23.6 26.4 41.8 50.5 24.7 26.4 10.3 15.7 16.7 25.8 35.4 9.7 25.6 23.5 15.4 33.8 10.3 23.7 17.1 22.2 32.3 25.4 19.2 52.6 40.7 20.0 36.5 36.3 13.7 26.5 19.8 32.4 30.1 23.1 13.2 12.8 9.5 17.4 52.0 22.1 3.1 8.8 8.5 4.8 10.7 6.2 3.8 6.2 7.7 11.6 8.5 5.6 5.8 4.2 6.3 9.6 13.5 6.0 5.7 32.3 25.0 51.5 49.0 29.2 18.0 22.0 21.1 28.5 12.1 0.0 6.7 15.3 27.9 28.8 24.3 37.2 15.3 4.0 4.5 29.6 3.9 23.1 46.4 30.2 25.1 15.7 50.5 0.0 32.2 31.3 23.1 37.6 5.7 14.8 21.7 28.6 26.9 20.3 19.6 46.6 15.8 10.3 32.1 12.6 30.7 16.0 41.5 33.6 12.4 28.2 12.9 0.0 19.8 18.1 16.8 30.4 21.7 10.2 41.6 53.3 CDK17 "PCTAIRE2, PCTK2" ENSG00000059758 "Cyclin dependent kinase 17" Q00537 12 96278261-96400560 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 44.5;TIME: 53.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015325 Approved Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA015325: AB_1855090" "unprognostic (4.35e-1)" "unprognostic (2.79e-1)" "unprognostic (2.70e-1)" "unprognostic (3.56e-1)" "unprognostic (1.50e-1)" "unprognostic (4.96e-3)" "unprognostic (5.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.23e-2)" "unprognostic (2.75e-2)" "unprognostic (2.44e-1)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.09e-6)" "unprognostic (4.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.92e-2)" "unprognostic (1.70e-2)" 16.3 9.1 20.6 13.9 47.0 31.5 14.7 17.8 35.7 11.8 12.9 23.6 3.4 9.2 20.7 7.5 11.7 10.9 12.9 9.4 25.3 17.3 9.2 12.4 15.9 15.2 23.8 21.0 12.9 8.0 9.9 7.3 24.3 14.8 11.4 9.8 5.7 7.5 9.3 7.3 9.1 9.3 23.4 19.6 15.8 7.9 19.9 28.0 29.6 9.4 6.1 16.6 11.0 10.7 9.6 5.3 29.1 4.7 16.5 14.8 8.6 4.9 4.2 11.0 2.9 5.4 14.3 7.8 11.1 15.7 9.8 9.3 2.5 2.9 7.4 7.7 8.0 5.3 4.5 6.5 6.9 13.4 7.8 5.0 10.6 2.8 3.5 11.7 5.6 6.1 10.3 7.1 14.5 26.2 17.4 44.5 6.3 7.7 6.0 22.1 3.0 5.3 8.8 4.8 2.4 7.3 9.3 5.9 6.3 11.6 4.2 5.7 3.9 6.5 6.1 8.1 8.7 4.6 5.1 53.3 8.7 3.3 4.6 6.0 8.5 6.5 7.9 3.3 2.4 6.4 29.1 3.4 8.9 12.7 4.7 13.7 9.6 10.4 14.4 5.3 8.8 14.8 12.6 12.8 16.5 4.6 3.9 8.1 8.6 20.6 47.0 17.8 24.6 25.3 17.3 23.8 21.0 14.8 28.0 14.9 6.2 24.4 8.9 23.8 10.8 8.9 5.1 9.4 10.3 8.7 15.7 10.0 0.0 4.6 2.7 42.9 6.0 0.0 3.2 25.8 15.5 10.4 17.4 8.9 10.5 4.8 14.5 35.6 15.3 3.2 9.2 9.4 16.9 7.2 7.4 20.2 5.7 3.5 8.9 6.9 9.2 6.5 27.8 6.5 7.6 22.6 11.4 27.7 5.5 11.8 CDK2 ENSG00000123374 "Cyclin dependent kinase 2" P24941 12 55966769-55972784 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 78.7;Extravillous trophoblasts: 67.5;Melanocytes: 82.7;Syncytiotrophoblasts: 142.8" "Cancer enhanced" "Detected in all" "melanoma: 88.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 107.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013115, HPA066915" Enhanced Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB013115: AB_2536375, HPA066915: AB_2685748" "unprognostic (2.36e-2)" "unprognostic (2.60e-1)" "unprognostic (3.71e-2)" "unprognostic (1.83e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.94e-4)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.48e-2)" "unprognostic (1.31e-1)" "unprognostic (4.67e-2)" "unprognostic (5.38e-3)" "unprognostic (4.69e-3)" "prognostic unfavorable (1.46e-10)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (6.75e-2)" 10.7 7.6 4.5 20.8 6.5 18.7 11.5 4.2 4.3 12.6 11.6 3.5 6.0 6.1 10.7 6.4 13.6 10.8 12.6 10.1 5.4 2.2 8.3 16.7 19.5 12.2 6.0 2.0 14.2 8.3 5.2 4.2 49.0 7.3 10.8 9.1 51.2 9.3 9.9 10.8 14.6 9.3 11.8 5.0 12.5 10.1 7.8 5.1 39.3 9.5 10.7 14.7 16.7 10.1 9.3 10.8 5.2 3.9 4.5 7.6 4.3 16.8 9.1 20.1 11.1 4.1 5.3 37.0 21.0 11.0 26.2 24.5 19.2 16.3 16.1 15.8 7.8 10.5 10.8 15.3 9.2 26.6 18.9 15.0 18.5 15.1 7.3 1.3 14.6 13.4 2.8 2.3 17.7 6.1 7.6 13.2 16.7 17.5 14.7 18.1 13.0 30.3 12.4 8.0 11.5 13.6 29.6 19.3 12.1 7.6 16.6 8.3 10.7 24.0 8.8 107.8 12.0 19.0 10.7 7.3 18.1 17.5 13.9 15.3 8.3 9.6 20.0 10.3 10.7 15.6 5.2 3.6 3.1 7.0 3.9 7.0 9.3 3.2 5.0 2.7 6.1 3.0 5.3 1.7 4.5 1.6 10.8 7.6 4.3 4.5 6.5 4.2 4.3 5.4 2.2 6.0 2.0 7.3 5.1 14.9 3.7 5.2 20.1 24.8 0.0 2.6 12.7 5.3 9.1 1.8 0.0 78.7 1.7 10.5 0.4 15.0 2.1 0.0 5.0 67.5 17.6 10.9 10.4 8.9 11.6 1.6 5.2 8.6 4.8 0.2 13.8 6.3 82.7 47.7 6.3 3.8 9.0 0.0 4.2 3.8 3.4 0.0 14.4 2.9 7.7 27.5 142.8 5.7 6.8 18.0 CDK3 ENSG00000250506 "Cyclin dependent kinase 3" Q00526 17 76000906-76005999 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "Basal keratinocytes: 2.4;Distal tubular cells: 1.7;Ductal cells: 1.4;Exocrine glandular cells: 2.0;Melanocytes: 3.3;Pancreatic endocrine cells: 2.0;Suprabasal keratinocytes: 2.4" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA007420 Uncertain Approved Cytosol NA NA Cytosol "HPA007420: AB_1078490" "unprognostic (6.77e-2)" "unprognostic (1.26e-1)" "unprognostic (3.69e-2)" "unprognostic (1.87e-3)" "unprognostic (6.41e-2)" "unprognostic (1.10e-3)" "unprognostic (1.61e-2)" "unprognostic (1.56e-1)" "unprognostic (8.12e-3)" "unprognostic (1.34e-1)" "unprognostic (9.80e-5)" "unprognostic (1.19e-2)" "unprognostic (6.75e-7)" "unprognostic (4.25e-2)" "unprognostic (1.63e-2)" "unprognostic (4.68e-1)" "unprognostic (4.47e-4)" 4.1 3.7 2.7 4.7 2.4 5.5 4.7 4.2 2.4 4.9 4.8 6.5 5.6 5.7 4.0 5.0 4.8 2.6 2.8 3.0 5.9 13.0 5.3 5.5 3.0 6.7 5.9 4.2 8.3 5.0 10.3 5.3 5.2 4.5 0.9 14.7 9.1 4.1 3.9 8.8 5.2 5.6 8.2 5.4 3.8 5.1 1.2 1.8 1.5 1.5 1.7 2.7 1.6 4.2 7.8 11.6 6.1 6.8 8.1 24.2 5.3 3.4 5.9 5.5 6.1 8.9 6.4 4.7 4.6 4.8 9.9 9.3 3.9 3.9 3.3 14.9 13.3 15.5 6.0 5.7 4.6 13.6 7.3 8.6 5.2 4.3 10.6 6.5 4.0 5.9 4.6 3.8 10.9 5.4 20.7 5.8 3.7 8.5 10.0 5.1 5.9 5.5 14.1 8.4 22.6 3.5 11.4 2.6 12.2 15.7 9.5 5.5 16.1 9.5 6.8 5.6 9.6 7.2 6.0 4.9 4.7 3.9 0.0 1.5 0.0 2.1 1.0 0.2 1.2 1.6 1.2 1.8 0.3 2.7 0.5 1.5 1.7 0.6 1.6 2.7 1.6 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.3 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 CDK4 PSK-J3 ENSG00000135446 "Cyclin dependent kinase 4" P11802 12 57747727-57756013 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 10 "HBEC3-KT: 128.1;LHCN-M2: 141.4;RH-30: 445.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006024, CAB013116, CAB069405" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane, Nucleoli" "CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497" "unprognostic (8.88e-2)" "unprognostic (2.53e-1)" "unprognostic (5.27e-2)" "unprognostic (9.01e-2)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.09e-7)" "unprognostic (7.39e-2)" "unprognostic (3.23e-3)" "unprognostic (2.93e-2)" "unprognostic (3.19e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.32e-1)" "unprognostic (1.67e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-2)" 32.2 43.1 13.8 22.2 15.7 24.0 45.0 13.1 17.9 36.3 28.2 20.1 22.8 15.2 51.4 28.1 29.9 31.0 32.3 27.4 14.5 12.1 24.0 36.9 26.8 26.4 18.3 13.7 61.4 54.4 18.9 34.2 25.0 16.0 37.2 26.9 26.2 29.3 24.1 27.8 25.6 20.7 34.1 13.5 27.2 23.9 24.6 17.5 29.2 54.3 32.1 27.5 33.6 30.9 29.6 25.5 2.6 19.9 15.8 32.1 22.2 9.5 11.1 14.6 13.0 13.4 11.8 9.8 5.5 18.0 24.4 20.2 15.8 9.1 13.9 10.0 8.6 14.4 7.4 20.2 128.1 18.5 6.8 9.3 13.0 7.5 11.1 15.7 14.7 9.0 11.6 9.4 14.9 17.2 16.6 15.6 13.3 13.8 12.0 141.4 13.9 14.1 12.0 17.2 10.0 11.2 12.6 445.0 12.9 7.6 15.1 13.3 12.4 9.8 7.4 14.7 10.5 9.8 17.9 7.1 11.4 10.8 12.9 11.1 6.0 9.7 21.4 10.5 13.7 13.7 1.7 14.3 2.6 26.2 19.9 27.0 29.6 23.1 23.7 21.0 28.1 32.1 28.5 1.2 15.8 12.0 25.5 16.6 22.2 13.8 15.7 13.1 17.9 14.5 12.1 18.3 13.7 16.0 17.5 20.8 25.0 32.0 62.9 79.7 15.3 0.5 48.4 4.0 23.9 45.4 9.8 64.6 59.7 71.7 10.1 44.2 11.3 23.3 53.6 108.9 77.4 41.8 68.1 32.1 111.7 17.5 43.8 34.4 23.2 6.8 59.2 34.0 50.6 54.1 33.5 51.3 55.4 7.0 59.4 66.3 15.3 32.3 54.2 25.9 40.3 75.3 39.1 34.1 78.3 32.5 CDK5RAP3 "C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114" ENSG00000108465 "CDK5 regulatory subunit associated protein 3" Q96JB5 17 47967810-47981774 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022141, HPA022882, HPA027883" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Cytosol "Nucleoli, Vesicles" "HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797" "unprognostic (4.27e-2)" "unprognostic (1.01e-3)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "unprognostic (5.98e-2)" "unprognostic (7.19e-3)" "unprognostic (3.84e-1)" "unprognostic (4.44e-2)" "unprognostic (7.55e-2)" "unprognostic (2.06e-1)" "unprognostic (2.59e-3)" "unprognostic (1.92e-2)" "prognostic unfavorable (3.61e-5)" "unprognostic (8.35e-3)" "unprognostic (2.30e-1)" "unprognostic (9.58e-2)" "prognostic favorable (7.31e-5)" 15.5 19.7 20.8 30.0 38.3 21.2 22.5 35.7 31.9 21.1 21.2 27.1 39.4 24.1 26.2 45.4 20.8 26.1 22.0 14.4 23.2 16.7 23.2 31.0 18.8 22.0 31.3 25.8 28.9 51.9 29.4 41.3 15.4 27.3 24.2 25.5 25.1 44.0 26.4 10.7 16.8 25.8 18.4 18.2 32.3 28.6 40.1 29.5 32.3 29.7 16.5 24.6 20.0 18.5 22.8 26.9 27.2 33.5 22.4 22.3 21.0 21.6 35.0 19.4 34.6 16.2 16.3 34.7 15.8 19.3 16.0 14.8 27.4 21.1 26.1 32.8 16.5 10.9 21.3 12.5 17.8 17.9 38.6 16.6 12.5 41.6 37.1 18.2 14.7 13.9 18.6 15.1 14.4 28.3 19.1 15.5 52.1 14.7 24.3 16.3 41.5 40.0 23.8 11.6 26.0 15.1 21.4 32.6 29.6 15.9 27.3 13.2 31.7 12.3 11.0 15.9 20.3 25.0 19.2 12.4 13.3 11.8 16.0 20.3 31.9 30.1 16.2 16.6 20.4 16.1 9.1 33.5 27.2 20.9 32.7 22.3 22.1 20.0 18.5 26.9 22.8 18.1 19.9 15.7 22.4 32.5 24.4 19.0 21.0 20.8 38.3 35.7 31.9 23.2 16.7 31.3 25.8 27.3 29.5 23.8 60.0 43.9 57.3 29.9 50.5 21.5 53.5 68.3 54.6 38.4 29.5 59.3 43.1 46.8 30.4 31.5 56.4 0.0 58.8 47.0 41.2 53.4 67.1 47.9 55.2 54.0 59.1 22.1 38.3 29.6 37.7 41.1 43.9 48.7 49.8 44.7 36.9 56.1 28.0 39.9 50.6 32.3 28.5 71.6 40.3 22.6 51.5 51.6 47.6 51.4 CDK6 PLSTIRE ENSG00000105810 "Cyclin dependent kinase 6" Q00534 7 92604921-92836594 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 74.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 219.8;Late spermatids: 186.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 93.5;REH: 45.7" "Low region specificity" "Detected in all" "HPA002637, CAB004363" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004363: AB_627242, HPA002637: AB_1846432" "unprognostic (1.29e-1)" "unprognostic (5.98e-3)" "unprognostic (9.07e-2)" "unprognostic (2.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.24e-2)" "unprognostic (3.39e-1)" "unprognostic (2.42e-3)" "unprognostic (7.19e-2)" "unprognostic (7.78e-3)" "prognostic unfavorable (3.86e-6)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.09e-1)" "unprognostic (7.88e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (2.33e-5)" 6.6 11.3 6.0 9.1 7.5 22.5 5.9 2.4 6.0 7.8 10.0 9.6 5.7 7.5 6.0 5.9 8.5 4.6 7.8 6.6 6.9 4.2 6.5 7.5 7.3 7.4 7.0 5.2 5.0 10.0 25.7 4.2 20.5 7.5 6.1 9.2 4.4 10.9 6.1 2.0 11.6 9.4 9.8 7.5 6.3 10.8 5.4 8.0 74.6 4.3 9.2 10.3 6.7 9.0 3.6 5.6 6.5 4.8 3.9 7.1 2.3 6.2 2.9 8.0 5.1 2.3 2.6 1.7 6.4 4.0 3.2 3.0 7.8 4.8 4.8 3.7 4.3 2.0 3.8 4.4 9.2 7.6 10.5 3.1 12.0 5.5 7.5 1.4 7.4 0.6 2.6 5.0 4.3 20.4 3.0 1.2 19.6 11.5 13.3 5.7 1.2 93.5 0.8 2.5 7.9 2.6 45.7 28.1 8.1 4.4 0.1 4.2 27.3 0.7 2.2 3.7 6.1 0.1 12.3 4.7 10.5 16.5 4.1 12.9 7.1 0.1 6.4 1.5 25.5 13.9 4.9 1.9 6.5 5.2 3.9 5.9 2.0 5.5 5.6 4.0 3.6 7.1 4.0 1.1 3.9 4.8 5.6 2.8 2.3 6.0 7.5 2.4 6.0 6.9 4.2 7.0 5.2 7.5 8.0 23.8 3.0 11.9 19.5 53.5 0.2 14.8 25.5 4.0 27.3 21.0 0.0 42.7 8.3 31.7 219.8 24.1 11.0 0.0 20.1 3.4 21.6 18.1 24.3 18.4 15.0 0.0 16.1 7.4 23.4 186.0 4.6 21.9 18.6 20.8 46.7 0.5 63.1 14.0 3.2 5.1 0.0 6.5 22.1 2.6 46.4 44.2 14.8 20.3 68.3 23.3 CDK7 "CAK, CAK1, CDKN7, MO15, STK1" ENSG00000134058 "Cyclin dependent kinase 7" P50613 5 69234795-69277430 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 97.9;Extravillous trophoblasts: 285.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004364, HPA007932, HPA008453" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Plasma membrane, Cytosol" "CAB004364: AB_627243, HPA007932: AB_1078492, HPA008453: " "unprognostic (3.12e-2)" "unprognostic (1.23e-1)" "unprognostic (4.87e-2)" "unprognostic (4.53e-2)" "unprognostic (3.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.49e-3)" "unprognostic (1.64e-2)" "unprognostic (7.77e-3)" "unprognostic (1.81e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (3.40e-2)" "prognostic unfavorable (9.42e-7)" "unprognostic (2.61e-1)" "unprognostic (2.38e-1)" "unprognostic (3.86e-2)" "unprognostic (1.55e-2)" 7.9 12.9 10.9 6.2 15.2 44.1 14.0 10.8 14.7 9.4 12.7 6.0 6.3 15.8 9.4 8.6 23.4 18.5 16.5 8.1 11.5 9.3 13.8 10.6 10.1 8.8 7.6 9.7 7.7 9.1 3.3 16.2 22.9 11.2 11.2 14.8 6.6 13.2 6.5 15.9 15.4 9.8 12.1 9.2 7.9 13.9 29.0 7.8 12.1 20.0 15.6 15.5 10.7 11.7 15.6 15.0 22.4 11.3 12.4 15.3 7.8 3.6 7.7 1.8 0.5 2.4 11.6 14.7 6.4 7.7 10.7 17.4 16.6 1.9 2.8 10.1 1.7 12.4 2.5 1.4 2.8 5.8 1.3 7.0 0.4 8.1 7.9 0.4 6.7 3.2 14.3 13.8 9.0 2.8 9.4 13.5 15.6 10.3 4.5 4.9 0.7 4.0 14.7 1.7 3.7 7.4 6.6 0.4 1.1 1.6 1.0 0.6 6.5 1.5 5.8 3.4 6.4 11.6 0.6 2.6 0.0 3.2 0.9 5.1 4.8 8.4 3.7 0.8 4.0 0.8 7.3 10.9 22.4 8.6 11.3 14.8 12.4 12.9 15.3 15.0 15.6 11.1 13.2 10.0 12.4 8.0 11.2 12.8 7.8 10.9 15.2 10.8 12.7 11.5 9.3 7.6 9.7 11.2 7.8 14.9 10.4 2.4 16.5 51.3 6.3 8.9 5.1 48.2 10.3 5.2 11.8 97.9 13.3 21.5 6.2 11.3 9.2 0.0 19.0 285.4 10.2 19.9 15.1 6.6 21.2 1.6 2.9 6.7 8.2 3.6 6.9 10.2 6.8 9.0 11.4 9.0 22.5 14.0 6.7 20.7 8.2 25.8 12.2 25.4 15.8 36.6 54.0 9.6 11.8 28.6 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885773 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.3;placenta: 105.6" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 482.4;Extravillous trophoblasts: 1267.0;Syncytiotrophoblasts: 1874.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 26.1;non-classical monocyte: 60.3" "Lineage enriched" "Detected in many" 12 "monocytes: 60.3" "Cell line enhanced" "Detected in many" "EFO-21: 8.4;HeLa: 8.7;RPMI-8226: 11.4;SH-SY5Y: 23.3;SiHa: 16.3;SK-MEL-30: 8.9" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 53.6 20.7 3.3 5.4 11.9 3.4 13.0 0.9 9.2 10.6 6.9 18.4 3.9 3.3 8.3 5.2 9.9 8.5 7.7 6.9 8.5 5.4 22.7 3.0 5.1 1.8 28.7 4.9 30.9 7.9 1.5 4.0 105.6 11.5 7.2 1.9 8.3 3.1 5.9 27.6 3.0 7.9 6.3 27.9 7.1 7.4 4.3 14.5 0.3 2.0 7.6 2.1 11.2 9.8 0.0 5.0 1.4 60.3 0.0 0.3 2.5 0.1 0.0 1.1 0.0 0.3 0.3 1.2 0.2 0.4 0.2 0.0 2.2 0.2 0.0 8.4 0.1 0.1 0.3 0.2 0.2 0.1 3.8 0.8 0.1 8.7 0.0 2.3 0.0 1.0 1.7 1.1 0.0 0.1 0.1 0.2 0.0 1.8 0.6 0.3 0.0 0.0 4.0 7.5 0.3 2.7 1.5 0.0 11.4 0.5 0.0 2.5 23.3 16.3 0.2 8.9 0.6 0.1 1.9 0.3 0.0 1.6 0.0 0.0 4.9 0.0 0.0 0.0 1.3 4.6 1.4 0.2 0.2 0.1 26.1 0.3 0.0 0.1 0.1 5.0 0.0 0.2 0.0 0.3 0.0 60.3 0.0 0.1 2.5 3.3 11.9 0.9 5.6 8.5 5.4 28.7 4.9 11.5 14.5 3.0 7.2 0.8 96.5 9.5 7.1 23.0 22.9 5.3 10.3 29.6 5.9 482.4 13.3 9.2 178.7 49.1 4.0 0.0 0.5 1267.0 69.5 86.8 0.0 3.0 79.4 7.9 102.1 54.6 16.1 196.4 68.7 19.6 33.7 1.0 14.2 61.0 3.5 2.5 41.8 39.1 25.4 32.3 35.6 1.4 2.7 10.3 1874.3 3.9 5.2 72.7 CDKN2C "INK4C, p18" ENSG00000123080 "Cyclin dependent kinase inhibitor 2C" P42773 1 50960745-50974633 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 70.0;Sertoli cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 53.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005303, CAB018398, HPA019057, HPA019764" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866" "unprognostic (4.07e-2)" "unprognostic (1.47e-3)" "unprognostic (2.89e-1)" "unprognostic (4.86e-2)" "unprognostic (6.70e-2)" "unprognostic (4.76e-3)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (2.28e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.70e-10)" "unprognostic (2.55e-2)" "unprognostic (2.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.24e-1)" 42.1 12.6 5.9 10.7 7.9 14.9 31.7 4.3 5.7 13.1 13.0 8.7 7.7 6.6 17.1 13.9 11.5 8.4 13.7 20.1 5.7 3.1 7.4 3.3 7.9 11.0 13.7 5.3 22.5 9.4 23.1 5.7 3.1 3.9 10.3 5.7 6.0 5.4 12.2 9.2 8.5 7.9 15.1 7.5 8.5 5.3 5.3 8.9 54.2 8.0 4.9 9.8 17.4 21.7 3.4 7.4 12.2 2.5 6.0 14.1 3.8 14.0 5.8 1.1 19.4 20.0 2.9 0.2 13.4 13.6 22.5 19.8 0.3 4.8 27.6 12.1 11.4 8.2 1.7 13.0 1.7 11.1 16.7 17.5 20.9 44.3 3.5 1.0 14.5 9.6 1.0 0.3 6.1 2.6 8.5 5.9 22.9 9.4 0.0 13.0 3.5 18.7 7.0 0.0 5.3 14.2 22.3 18.3 0.0 7.1 5.9 9.8 23.0 18.3 12.8 4.3 0.1 6.3 49.3 4.7 25.8 10.0 15.6 0.2 28.3 26.9 22.7 0.0 53.0 22.8 12.2 2.5 11.0 5.2 1.4 6.0 3.4 7.7 6.8 6.1 1.9 4.3 4.1 0.2 6.0 0.6 7.4 14.1 3.8 5.9 7.9 4.3 5.7 5.7 3.1 13.7 5.3 3.9 8.9 0.0 4.6 5.3 2.5 9.0 4.2 12.5 2.5 2.7 2.3 3.5 15.7 1.1 14.9 3.3 3.6 5.3 3.9 70.0 3.1 11.0 20.6 2.5 16.1 6.0 22.5 4.8 8.1 17.2 19.7 5.3 36.5 11.2 6.8 24.4 4.8 27.8 4.0 4.0 44.9 26.6 9.7 84.1 18.6 5.1 6.8 9.8 1.6 33.8 3.9 1.0 CDKN2D "INK4D, p19" ENSG00000129355 "Cyclin dependent kinase inhibitor 2D" P55273 19 10566462-10569059 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.1;bone marrow: 119.4" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 111.8;Spermatogonia: 87.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 32.8;MOLT-4: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011201, HPA043546" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB011201: AB_261049, HPA043546: AB_2678545" "unprognostic (3.08e-1)" "prognostic favorable (1.02e-4)" "unprognostic (3.57e-2)" "unprognostic (1.49e-2)" "unprognostic (3.29e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.08e-1)" "unprognostic (1.08e-2)" "unprognostic (6.55e-2)" "unprognostic (3.28e-1)" "unprognostic (1.50e-1)" "unprognostic (3.27e-3)" "unprognostic (9.90e-2)" "unprognostic (4.52e-1)" "unprognostic (4.43e-2)" "unprognostic (1.40e-1)" 5.5 4.7 27.9 6.8 24.2 119.4 4.1 14.3 28.7 2.6 3.9 4.2 0.5 3.9 2.4 2.5 3.8 3.0 4.0 8.4 22.9 17.9 2.7 2.1 6.6 11.1 14.3 14.3 2.8 2.8 2.6 3.4 4.8 11.8 2.5 3.6 2.4 3.2 3.0 6.3 6.0 3.5 4.6 5.7 9.7 2.8 10.9 3.6 18.6 1.8 2.8 8.4 4.2 2.4 17.3 16.0 44.1 10.7 11.9 11.3 9.5 11.0 1.7 5.7 3.7 3.0 4.7 1.4 7.3 8.6 8.1 7.1 2.2 2.7 3.1 2.4 7.7 8.2 2.3 1.9 1.8 2.9 12.3 4.6 32.8 2.0 3.6 3.5 3.3 26.6 1.9 6.1 4.1 3.1 6.7 2.2 19.5 1.3 27.0 8.0 1.5 40.4 17.3 1.1 8.5 8.5 6.6 5.5 1.8 3.6 0.9 8.0 4.2 5.1 3.9 5.6 1.1 3.5 8.7 1.7 9.6 4.9 15.8 10.8 16.9 5.7 5.7 10.1 5.6 6.8 35.9 5.6 23.5 10.0 6.8 8.0 17.3 8.3 11.3 5.4 15.9 7.9 9.4 44.1 11.9 10.7 16.0 6.7 9.5 27.9 24.2 14.3 28.7 22.9 17.9 14.3 14.3 11.8 3.6 6.0 9.5 48.4 13.8 20.6 28.1 8.5 2.5 5.3 3.4 5.2 11.8 2.4 8.3 6.0 15.3 15.3 5.8 46.7 4.3 7.1 11.0 10.0 20.7 3.0 8.7 44.5 6.9 20.3 36.0 8.5 6.6 24.1 28.7 10.8 5.8 17.7 9.9 10.5 5.6 3.4 29.5 19.4 30.3 111.8 87.1 29.0 4.1 44.9 3.6 23.8 CDKN3 "CDI1, KAP" ENSG00000100526 "Cyclin dependent kinase inhibitor 3" Q16667 14 54396849-54420218 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 80.3" "Cell type enriched" "Detected in many" 4 "Early spermatids: 2056.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 16.1" "Group enriched" "Detected in all" 5 "NK-cells: 5.8;T-cells: 16.1" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005285, HPA039311, HPA058874" Enhanced Cytosol NA Yes Cytosol "CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842" "unprognostic (3.46e-2)" "unprognostic (9.95e-2)" "unprognostic (5.79e-2)" "unprognostic (6.78e-3)" "unprognostic (2.73e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-3)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.50e-3)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.46e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.71e-1)" "unprognostic (7.30e-2)" "unprognostic (7.92e-2)" "unprognostic (4.31e-2)" 2.4 1.0 1.6 6.5 1.7 12.8 1.5 1.5 2.5 1.0 4.5 0.2 0.2 3.8 0.9 1.1 4.4 0.7 0.9 3.0 1.4 1.9 1.0 1.1 1.1 8.8 1.7 1.9 0.9 0.7 0.0 1.0 2.3 2.8 0.9 5.8 0.9 1.7 0.1 3.9 1.8 4.0 2.2 1.0 2.3 1.8 80.3 0.3 18.3 1.1 6.4 9.5 2.1 1.8 2.0 1.6 1.1 1.4 5.8 16.1 2.9 55.2 21.2 16.3 16.3 2.7 3.3 9.4 13.2 19.5 28.2 31.2 16.0 27.6 27.2 9.7 20.6 29.7 40.7 24.7 16.0 52.7 32.6 11.9 13.8 15.3 26.4 2.0 17.2 9.8 1.2 1.0 17.6 30.7 9.9 17.9 26.4 6.9 34.8 33.8 39.3 23.8 14.0 5.7 54.1 46.0 14.8 14.4 5.9 14.9 12.1 6.7 8.5 24.2 14.3 10.5 12.8 29.6 14.7 6.5 12.5 42.9 19.7 31.2 8.4 9.7 18.7 20.9 24.9 22.8 0.0 1.3 1.1 1.2 1.4 0.6 2.0 5.2 4.3 1.6 0.9 2.7 2.2 0.9 5.8 0.9 1.2 16.1 2.9 1.6 1.7 1.5 2.5 1.4 1.9 1.7 1.9 2.8 0.3 0.0 0.0 0.8 3.1 8.2 1.4 9.3 0.0 0.0 1.2 1.8 2.0 9.8 0.0 2.8 2056.4 2.0 2.9 256.9 2.1 27.0 6.6 2.2 6.9 1.8 31.5 4.8 7.5 4.9 7.5 483.1 19.8 5.7 1.7 3.6 6.2 1.2 2.0 6.2 9.9 1.7 2.3 0.0 2.1 159.2 36.4 5.6 3.4 7.0 12.8 1.4 CDO1 ENSG00000129596 "Cysteine dioxygenase type 1" Q16878 5 115804733-115816954 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 142.1;seminal vesicle: 53.7" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 255.3;Hepatocytes: 126.0;Syncytiotrophoblasts: 403.0" "Group enriched" "Detected in many" 6 "glioma: 33.6;liver cancer: 74.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 20 "memory CD4 T-cell: 4.1;T-reg: 1.2" "Lineage enriched" "Detected in single" 41 "T-cells: 4.1" "Cell line enhanced" "Detected in some" "AF22: 23.0;ASC diff: 28.4;ASC TERT1: 11.0;GAMG: 8.3;HAP1: 8.1;NTERA-2: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036573, HPA057503" Enhanced Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036573: AB_10696658, HPA057503: AB_2683451" "unprognostic (2.34e-2)" "unprognostic (3.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.91e-5)" "unprognostic (1.14e-3)" "unprognostic (2.63e-1)" "unprognostic (7.23e-2)" "unprognostic (9.28e-3)" "unprognostic (6.69e-2)" "unprognostic (1.58e-1)" "unprognostic (2.74e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-1)" "unprognostic (2.06e-2)" 31.9 6.2 9.3 1.7 11.2 0.8 9.9 7.6 9.4 3.4 1.5 3.7 36.4 1.0 3.1 42.6 1.8 4.9 3.7 7.6 7.3 9.0 1.7 142.1 3.9 2.3 6.5 5.5 8.7 4.7 1.0 6.5 17.7 14.5 4.0 1.3 19.2 2.8 53.7 3.5 1.1 1.1 2.6 5.3 1.8 1.2 5.0 4.3 0.0 2.8 2.5 1.6 2.4 2.1 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 23.0 0.0 28.4 11.0 0.1 0.6 0.2 2.2 2.2 0.0 0.0 0.0 0.0 0.2 8.3 0.0 8.1 0.0 3.2 0.0 4.0 0.7 0.0 0.6 0.1 0.0 0.0 4.1 0.0 0.3 0.0 0.6 2.9 0.0 0.0 0.0 2.6 0.0 0.5 0.1 8.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 2.0 0.0 2.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 9.3 11.2 7.6 9.4 7.3 9.0 6.5 5.5 14.5 4.3 0.0 2.2 0.0 0.5 0.7 16.3 1.6 0.0 0.0 0.0 1.8 5.9 255.3 0.0 6.0 5.8 3.2 0.0 0.0 0.2 7.4 16.4 1.0 0.0 126.0 20.1 1.6 1.7 21.5 4.9 8.9 84.3 0.2 1.7 1.0 0.0 31.8 0.5 0.0 35.3 0.6 2.9 12.9 3.3 1.5 0.2 1.1 403.0 0.0 0.0 0.1 CDPF1 "C22orf40, LOC150383" ENSG00000205643 "Cysteine rich DPF motif domain containing 1" Q6NVV7 22 46244011-46250679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018823 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA018823: AB_1853018" "unprognostic (1.98e-2)" "unprognostic (5.06e-3)" "unprognostic (1.42e-2)" "prognostic favorable (3.13e-5)" "unprognostic (2.20e-1)" "unprognostic (1.51e-1)" "unprognostic (1.85e-3)" "unprognostic (1.83e-3)" "unprognostic (2.09e-1)" "unprognostic (2.56e-3)" "unprognostic (4.69e-3)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" 7.3 12.7 10.4 9.4 10.9 5.3 7.8 10.6 12.4 10.1 11.4 11.4 5.3 7.0 12.4 11.8 6.0 11.9 8.3 14.1 10.4 6.8 9.4 8.5 9.4 9.0 10.7 9.5 11.2 8.5 8.0 11.1 7.9 10.9 11.0 6.0 10.3 15.5 11.8 12.3 7.7 9.4 8.2 8.7 11.6 9.9 4.0 10.9 12.9 11.2 5.2 9.6 8.1 12.2 8.9 11.6 11.0 8.5 8.3 11.6 7.3 5.5 4.1 6.6 9.6 4.2 7.3 5.5 3.0 4.4 6.1 5.7 0.7 5.7 5.6 3.2 2.2 3.5 6.4 3.0 1.0 3.7 5.3 10.5 3.0 6.2 6.2 7.6 8.1 4.5 7.9 5.9 4.5 5.5 5.0 4.5 10.5 5.8 7.1 4.3 4.0 10.0 5.8 5.1 7.9 4.0 6.4 2.7 12.1 4.6 1.8 3.3 8.0 3.7 6.6 6.3 2.7 7.1 3.4 3.5 11.5 7.3 6.4 3.7 7.0 3.3 4.4 5.3 5.9 11.2 1.5 6.5 11.0 10.1 8.0 9.5 7.3 9.9 8.9 5.5 8.9 11.6 8.4 1.7 8.3 8.5 11.6 7.4 7.3 10.4 10.9 10.6 12.4 10.4 6.8 10.7 9.5 10.9 10.9 6.0 3.8 10.4 2.2 1.5 4.5 4.7 5.1 8.1 2.3 7.0 0.0 11.4 6.6 8.3 0.8 7.1 2.0 0.0 9.8 8.3 4.9 4.0 13.9 4.3 8.2 0.0 4.1 4.3 3.7 0.2 4.6 4.0 5.0 11.8 3.3 4.4 6.3 0.0 7.4 5.4 4.8 12.9 7.3 2.4 7.0 1.8 3.8 7.2 4.9 1.8 CDR2L HUMPPA ENSG00000109089 "Cerebellar degeneration related protein 2 like" Q86X02 17 74987632-75005800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.0" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 21.1;Pancreatic endocrine cells: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 27.4;U-138 MG: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022015 Enhanced Approved Cytosol NA NA Cytosol "HPA022015: AB_1846462" "unprognostic (4.60e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-2)" "unprognostic (3.85e-2)" "unprognostic (2.17e-1)" "unprognostic (7.36e-3)" "unprognostic (9.22e-2)" "unprognostic (1.78e-2)" "unprognostic (9.11e-2)" "unprognostic (2.11e-1)" "unprognostic (4.21e-2)" "unprognostic (1.84e-1)" "unprognostic (5.89e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" 9.5 6.1 7.0 4.2 18.7 0.8 20.1 40.0 14.3 6.8 9.9 19.1 4.2 31.0 14.3 2.1 4.3 6.8 12.9 8.3 11.7 8.3 6.9 2.3 8.9 1.8 22.0 6.9 2.4 6.3 4.3 4.1 10.2 21.9 5.4 2.7 2.7 10.2 8.3 3.2 3.1 15.8 8.3 25.1 2.2 17.7 5.6 14.0 0.0 3.2 1.0 1.7 7.0 10.1 0.3 0.1 0.0 0.4 0.0 0.1 1.5 6.3 18.2 4.0 8.5 7.2 6.3 1.8 9.3 4.1 5.4 6.9 10.8 5.9 0.0 9.8 16.1 4.9 17.0 4.8 2.2 3.6 0.1 8.2 0.0 11.3 6.9 4.1 0.7 0.3 3.7 3.6 12.9 1.3 3.9 11.6 1.4 2.7 0.9 5.7 5.7 0.8 0.6 5.3 15.1 9.0 2.9 6.2 2.7 14.3 4.0 7.0 23.8 11.7 27.4 0.8 2.5 7.5 1.2 8.2 28.1 6.0 17.6 5.8 0.9 0.5 0.0 7.8 2.2 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.4 0.1 0.0 1.5 7.0 18.7 40.0 14.3 11.7 8.3 22.0 6.9 21.9 14.0 14.9 0.0 0.0 1.9 5.4 2.4 3.6 15.3 2.7 2.3 5.2 0.0 2.2 13.3 10.7 5.4 10.0 0.7 0.0 6.2 0.4 7.5 5.2 0.0 0.0 1.2 0.0 4.7 4.9 0.3 21.1 2.6 1.0 1.7 1.0 3.2 0.8 19.1 0.0 2.5 1.8 2.5 0.0 7.3 2.1 1.9 2.0 1.9 0.0 0.6 11.5 CDV3 H41 ENSG00000091527 "CDV3 homolog" Q9UKY7 3 133573730-133590261 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 485.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 153.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029761, HPA029762, HPA029763" Enhanced Enhanced "Nucleoli,Plasma membrane,Cytosol" NA NA 220000 Cytosol "Nucleoli, Plasma membrane" "HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679" "unprognostic (1.17e-2)" "unprognostic (1.22e-1)" "unprognostic (4.06e-2)" "unprognostic (4.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.21e-6)" "unprognostic (1.20e-1)" "unprognostic (3.30e-1)" "unprognostic (8.45e-3)" "unprognostic (3.29e-3)" "unprognostic (1.13e-1)" "unprognostic (2.36e-1)" "unprognostic (7.83e-2)" "unprognostic (1.48e-2)" "unprognostic (9.87e-2)" "unprognostic (7.59e-3)" 46.4 26.5 20.7 45.7 22.4 44.9 38.1 13.2 22.3 25.6 29.5 20.2 16.2 18.5 27.0 26.1 34.1 22.0 25.4 50.5 19.0 18.3 26.2 40.2 34.3 47.6 22.5 20.6 32.8 34.4 25.6 22.5 34.8 24.4 24.6 23.9 18.7 24.6 16.7 106.6 23.1 27.7 33.1 25.4 56.6 31.4 38.2 21.5 61.1 33.9 32.5 52.1 43.8 37.2 10.6 14.2 14.7 11.1 5.3 20.8 4.5 50.8 11.8 20.9 13.8 24.2 29.9 24.8 28.1 36.6 28.2 28.0 29.3 20.5 65.0 42.7 31.4 32.6 22.0 29.9 28.1 52.8 41.5 11.3 38.4 13.0 17.9 37.7 42.7 24.7 28.3 29.5 25.1 67.9 20.0 35.5 19.3 27.6 43.7 40.7 14.6 34.9 24.7 21.1 22.1 15.2 21.3 27.8 52.1 29.6 20.7 16.6 12.5 26.7 19.9 33.4 31.3 64.3 26.2 43.9 30.1 28.4 23.8 27.8 63.8 47.8 153.1 16.8 25.9 17.4 11.5 9.6 14.7 12.2 10.7 12.8 10.6 11.7 12.4 8.5 6.5 9.4 14.4 8.7 5.3 11.1 14.2 20.8 4.5 20.7 22.4 13.2 22.3 19.0 18.3 22.5 20.6 24.4 21.5 53.6 71.1 101.7 142.6 129.7 20.9 78.7 53.5 28.1 42.1 80.3 9.8 43.1 31.5 38.9 281.1 76.6 64.9 0.0 75.3 62.7 68.5 184.4 43.9 86.4 99.8 22.3 45.3 81.0 95.3 485.8 31.7 84.0 52.3 32.5 44.7 88.5 74.6 39.3 33.6 39.1 27.1 25.8 54.6 20.4 24.7 112.0 29.4 62.3 47.8 220.3 CDX4 ENSG00000131264 "Caudal type homeobox 4" O14627 X 73447254-73455245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skin 1: 5.3;testis: 3.3" "Cell type enhanced" "Detected in some" 22 "Spermatogonia: 1.4;Suprabasal keratinocytes: 1.0" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 2.0;SuSa: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043714, HPA056528" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA043714: , HPA056528: AB_2683166" "unprognostic (1.97e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.4 1.0 0.0 0.0 0.0 0.0 CEBPE CRP1 ENSG00000092067 "CCAAT/enhancer binding protein epsilon" Q15744 14 23117304-23119616 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 87.1;bone marrow: 29.4" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 6.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Cell type enriched" "Detected in single" 201 "eosinophil: 87.1" "Lineage enriched" "Detected in single" 237 "granulocytes: 87.1" "Group enriched" "Detected in some" 4 "HL-60: 59.4;NB-4: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002928, CAB005113" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB005113: AB_631240, HPA002928: AB_1078494" "unprognostic (1.33e-2)" "unprognostic (4.76e-2)" "unprognostic (4.19e-2)" "unprognostic (2.04e-1)" "unprognostic (5.01e-2)" "unprognostic (1.66e-3)" "unprognostic (2.84e-1)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (5.69e-2)" "unprognostic (9.03e-2)" "unprognostic (2.22e-1)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.57e-2)" "unprognostic (8.19e-2)" 0.3 0.0 0.1 0.8 0.2 29.4 0.1 0.1 1.3 0.1 0.1 0.1 0.1 1.4 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.1 0.2 2.7 0.2 0.3 0.1 0.1 0.1 0.0 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 1.9 0.1 0.3 7.7 0.4 0.1 0.1 2.6 0.1 0.1 0.8 0.2 0.1 0.0 0.1 87.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 10.6 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 30.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.3 87.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 1.3 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.6 1.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CELA3A "ELA3, ELA3A" ENSG00000142789 "Chymotrypsin like elastase family member 3A" P09093 1 22001656-22012539 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 2051 "pancreas: 2541.2" "Cell type enriched" "Detected in some" 31 "Exocrine glandular cells: 30160.2" "Cancer enriched" "Detected in some" 2497 "pancreatic cancer: 1481.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "MOLT-4: 21.6" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA028086: AB_2672482, HPA045650: AB_2679407" "unprognostic (1.27e-1)" "unprognostic (2.71e-1)" "unprognostic (1.79e-1)" "unprognostic (6.32e-2)" "unprognostic (2.67e-1)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 2541.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 29.3 0.0 0.0 0.0 30160.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.8 0.3 0.0 0.0 164.1 0.0 0.0 964.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CELA3B "CBPP, ELA3B" ENSG00000219073 "Chymotrypsin like elastase family member 3B" P08861 1 21977021-21998642 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 196 "pancreas: 1614.4" "Cell type enriched" "Detected in some" 24 "Exocrine glandular cells: 12399.8" "Cancer enriched" "Detected in single" 1218 "pancreatic cancer: 408.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA028086: AB_2672482, HPA045650: AB_2679407" "unprognostic (2.89e-1)" "unprognostic (4.01e-3)" "unprognostic (6.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (6.40e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 1614.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 5.9 5.3 8.2 3.0 2.3 3.2 0.9 0.6 5.0 1.7 1.3 2.5 1.5 2.2 1.2 1.8 1.8 1.7 5.4 2.7 5.5 2.7 1.5 2.2 1.6 1.0 0.5 0.0 2.5 4.1 2.4 4.9 4.0 1.3 1.9 3.2 2.3 2.4 1.5 0.0 2.7 2.5 3.6 2.5 5.6 0.4 2.6 2.2 1.5 1.4 0.9 3.5 3.6 0.9 4.3 0.0 3.6 3.2 1.8 3.5 0.8 0.3 3.7 2.6 2.8 3.7 2.9 1.6 2.3 1.0 4.9 4.8 2.5 1.9 4.8 0.6 5.1 2.5 1.8 3.1 3.0 2.0 3.7 2.2 2.8 1.4 5.9 3.2 3.0 8.2 2.3 1.7 5.3 2.9 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 65.6 0.0 4.9 0.0 12399.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.0 0.9 0.0 0.0 105.6 0.0 0.0 510.5 7.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 CELSR2 "ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3" ENSG00000143126 "Cadherin EGF LAG seven-pass G-type receptor 2" Q9HCU4 1 109250019-109275750 "G-protein coupled receptors, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.7;skin 1: 27.8" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 92.2;Muller glia cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 25.2;HaCaT: 24.9;MCF7: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013952 Uncertain Approved Cytosol NA NA Cytosol "HPA013952: AB_1846518" "unprognostic (4.46e-3)" "unprognostic (1.07e-2)" "unprognostic (3.00e-2)" "unprognostic (4.71e-2)" "unprognostic (2.19e-1)" "unprognostic (5.30e-2)" "unprognostic (3.51e-2)" "unprognostic (2.98e-1)" "unprognostic (1.33e-1)" "unprognostic (1.59e-2)" "unprognostic (1.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.94e-2)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-2)" "unprognostic (5.16e-2)" 1.5 2.3 12.6 1.1 16.0 0.9 5.4 9.2 31.7 6.9 1.8 13.7 3.4 1.4 3.1 4.3 10.9 18.8 1.8 5.3 17.1 8.1 5.6 1.2 1.8 1.3 10.0 15.4 1.2 4.8 7.8 2.3 1.6 8.3 3.5 1.4 5.4 6.4 10.4 9.3 27.8 1.5 2.4 14.1 1.0 2.0 11.0 8.6 0.5 10.9 2.7 3.2 2.3 6.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 7.0 6.6 25.2 4.6 0.0 0.0 6.8 0.8 0.6 1.5 0.4 1.0 0.2 1.2 5.7 0.5 1.2 24.9 6.5 4.0 0.8 0.1 2.7 0.5 6.0 1.4 0.5 0.3 3.2 0.1 9.8 0.6 0.4 5.7 0.3 4.0 4.1 0.3 0.0 28.7 0.7 0.3 8.1 0.8 1.2 6.4 2.3 0.3 5.5 2.4 10.2 4.8 3.8 8.5 5.4 6.2 8.0 1.6 0.0 0.0 4.6 0.4 6.2 1.6 0.4 0.3 1.4 0.5 2.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 16.0 9.2 31.7 17.1 8.1 10.0 15.4 8.3 8.6 8.9 5.3 0.0 4.8 14.0 7.2 9.4 5.1 2.7 4.5 17.4 3.9 1.9 1.7 2.2 4.9 0.8 0.5 0.0 0.4 1.0 1.0 2.1 1.1 5.9 0.9 92.2 1.7 0.0 0.0 5.3 3.1 0.5 10.1 0.0 0.3 32.3 1.7 0.0 18.0 2.7 5.2 6.5 2.0 0.9 3.4 19.9 0.5 0.0 1.2 5.7 CENPE "KIF10, PPP1R61" ENSG00000138778 "Centromere protein E" Q02224 4 103105806-103198409 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein, Motor protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.3;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 93.5;Spermatocytes: 69.2;Spermatogonia: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA042294 Enhanced Approved Nucleoplasm,Microtubules,Cytosol NA Yes "Microtubules, Cytosol" Nucleoplasm "HPA042294: AB_10797386" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "unprognostic (5.64e-3)" "unprognostic (2.55e-2)" "unprognostic (1.65e-1)" "unprognostic (3.44e-2)" "unprognostic (2.40e-8)" "unprognostic (2.49e-3)" "unprognostic (1.59e-2)" "unprognostic (3.38e-1)" "unprognostic (4.88e-5)" "unprognostic (1.15e-2)" "unprognostic (0.00e+0)" "unprognostic (9.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (2.37e-1)" 2.7 0.9 0.6 9.4 1.5 11.3 0.7 0.2 1.3 1.0 2.1 0.5 0.0 1.9 0.7 1.9 5.9 0.5 0.8 2.5 2.0 0.8 1.3 0.6 1.4 7.3 1.9 0.6 0.7 0.5 0.1 0.4 3.1 1.4 0.7 2.7 0.2 2.2 0.8 0.4 2.2 2.4 1.4 1.3 3.3 1.6 6.6 0.6 25.1 0.6 5.9 6.4 1.5 1.9 0.6 0.5 5.7 3.0 0.8 1.4 0.2 20.9 6.0 21.9 10.6 1.5 3.4 4.3 19.1 9.6 14.3 9.5 9.5 11.4 14.2 4.9 7.0 10.0 9.4 15.7 7.7 22.6 17.7 5.8 16.7 12.6 6.9 0.2 19.8 9.7 1.0 0.6 11.4 9.6 3.2 12.0 13.0 17.3 17.0 18.3 7.6 15.6 8.9 7.0 8.5 9.4 10.5 20.5 4.7 4.0 4.2 10.1 6.0 16.9 11.8 4.6 8.8 6.7 7.0 13.0 13.8 14.5 14.3 19.5 8.3 14.2 14.8 7.7 11.1 14.6 5.7 0.1 0.7 0.2 0.6 0.0 0.6 0.4 0.4 0.2 0.2 0.1 0.3 0.1 0.8 3.0 0.5 1.4 0.2 0.6 1.5 0.2 1.3 2.0 0.8 1.9 0.6 1.4 0.6 3.0 2.1 0.0 1.0 3.2 7.1 1.4 0.0 0.0 1.2 0.0 7.9 2.4 0.0 0.4 3.4 2.8 0.5 93.5 0.0 22.1 1.5 1.3 6.9 0.8 11.2 0.0 1.2 4.3 7.3 0.7 0.9 5.5 0.0 8.2 1.4 1.4 1.3 0.6 2.5 0.0 2.5 0.0 2.5 69.2 47.7 2.5 3.0 2.5 4.7 0.6 CENPI "CENP-I, FSHPRH1, LRPR1, Mis6" ENSG00000102384 "Centromere protein I" Q92674 X 101098218-101163681 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.3" "Cell type enhanced" "Detected in some" 13 "Extravillous trophoblasts: 3.8;Hofbauer cells: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061297 Supported "Nuclear bodies,Cytosol" NA Yes "Nuclear bodies" Cytosol "HPA061297: AB_2684471" "unprognostic (3.10e-3)" "unprognostic (9.71e-2)" "unprognostic (1.86e-2)" "unprognostic (3.51e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (5.78e-6)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (3.62e-3)" "unprognostic (1.20e-3)" "unprognostic (4.51e-2)" "unprognostic (2.50e-13)" "unprognostic (1.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.42e-1)" 2.6 1.8 1.5 10.8 4.7 9.1 4.0 1.7 2.9 3.7 3.9 3.6 0.0 4.0 4.1 2.2 7.1 2.7 2.8 1.7 1.8 1.4 1.5 1.6 2.9 7.7 3.3 1.8 4.5 1.2 0.3 1.3 3.6 2.6 1.8 5.3 1.2 2.0 0.8 1.5 4.5 3.8 4.3 4.3 4.0 3.3 4.6 2.7 18.3 1.3 4.1 11.0 3.1 3.7 2.6 2.9 4.8 2.8 3.2 3.3 1.2 16.8 11.6 14.4 11.1 1.8 3.3 6.4 18.3 9.8 18.6 37.6 15.6 10.8 12.4 6.5 7.2 28.7 9.9 21.0 9.7 26.0 7.7 5.3 7.6 16.6 5.9 0.2 10.0 8.4 1.3 0.8 24.6 3.1 5.3 15.8 9.0 5.3 22.8 17.9 11.9 9.9 3.6 11.1 8.0 14.4 9.3 20.8 8.0 4.6 10.1 9.2 4.8 22.4 6.3 3.8 13.7 6.3 3.2 6.4 17.5 14.7 16.2 14.5 3.7 8.5 14.0 6.9 13.4 13.5 2.2 2.1 2.3 2.0 2.8 1.3 2.6 2.0 2.6 1.0 2.1 1.6 1.7 4.8 3.2 2.6 2.9 3.3 1.2 1.5 4.7 1.7 2.9 1.8 1.4 3.3 1.8 2.6 2.7 0.0 0.0 0.8 0.0 0.2 0.4 0.4 0.0 0.0 1.2 0.0 0.0 0.8 0.0 0.1 0.1 0.2 0.0 0.0 0.0 3.8 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.6 0.6 0.0 0.3 0.0 0.0 1.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.2 1.0 0.1 0.2 0.0 0.5 0.0 CENPM "C22orf18, CENP-M, MGC861, Pane1" ENSG00000100162 "Centromere protein M" Q9NSP4 22 41938721-41947164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;lymphoid tissue: 41.5" "Cell type enhanced" "Detected in many" 11 "B-cells: 48.5;Ciliated cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 19.5;T-reg: 23.3" "Group enriched" "Detected in many" 7 "B-cells: 19.5;T-cells: 23.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042404, HPA056500" Enhanced Enhanced Cytosol NA NA Cytosol "HPA042404: AB_2677981, HPA056500: AB_2683156" "unprognostic (3.78e-2)" "prognostic favorable (3.40e-5)" "unprognostic (7.15e-3)" "unprognostic (2.65e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.50e-5)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (5.99e-7)" "unprognostic (9.54e-3)" "unprognostic (2.44e-1)" "unprognostic (8.73e-2)" "unprognostic (5.61e-2)" 1.6 1.4 1.1 31.9 0.9 18.2 3.8 1.9 1.2 1.7 6.9 1.1 0.4 6.0 1.4 2.2 8.9 9.6 4.3 3.2 1.0 0.8 2.1 1.4 4.2 17.0 1.0 0.4 1.4 0.6 0.0 0.4 3.4 0.8 1.2 3.7 1.1 3.3 0.9 0.5 6.3 7.2 1.1 0.9 9.7 4.5 13.5 0.4 41.5 0.9 5.5 18.8 3.2 3.3 19.5 0.3 0.8 0.1 2.9 23.3 4.0 22.2 22.9 12.8 8.4 1.0 0.9 5.5 11.0 5.7 19.3 19.7 26.5 11.9 28.9 8.3 5.7 12.5 8.6 9.6 11.2 4.8 8.3 40.1 13.5 24.5 18.4 1.0 25.6 15.4 0.8 0.8 12.4 5.8 2.0 7.2 26.8 10.2 28.0 11.2 34.4 25.5 26.8 6.9 13.5 17.0 24.6 12.8 30.1 7.8 13.3 14.7 2.8 16.9 10.1 5.8 2.2 9.6 16.7 3.6 18.8 28.1 12.4 18.2 15.0 10.4 26.7 6.5 21.4 20.5 0.8 0.1 0.0 3.2 0.0 4.3 13.1 9.4 4.1 0.3 19.5 1.8 2.4 0.5 2.9 0.0 0.2 23.3 4.0 1.1 0.9 1.9 1.2 1.0 0.8 1.0 0.4 0.8 0.4 0.0 4.3 48.5 2.2 1.8 2.1 0.4 0.0 109.7 1.2 0.0 0.0 14.1 14.9 1.9 2.9 0.3 4.9 23.3 0.6 28.0 3.1 1.8 2.3 0.8 35.5 3.2 7.5 4.3 3.1 4.0 1.1 6.5 6.8 2.8 35.1 0.1 1.4 8.6 0.4 0.2 0.5 0.0 0.0 37.0 36.7 0.9 7.3 17.3 19.2 3.8 CENPV "CENP-V, p30, PRR6" ENSG00000166582 "Centromere protein V" Q7Z7K6 17 16342534-16353656 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Paneth cells: 96.8;Spermatogonia: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.6;memory B-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 33.0;HEK 293: 27.0;JURKAT: 32.1;NTERA-2: 32.4" "Low region specificity" "Detected in all" "HPA042529, HPA042616" Enhanced Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA042529: AB_10793882, HPA042616: AB_10794050" "unprognostic (7.64e-2)" "unprognostic (4.41e-2)" "unprognostic (5.92e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (6.47e-2)" "unprognostic (1.21e-1)" "unprognostic (4.00e-2)" "unprognostic (7.73e-3)" "unprognostic (7.93e-2)" "unprognostic (4.09e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-2)" "unprognostic (2.54e-2)" "unprognostic (3.60e-3)" 4.6 5.6 13.7 4.0 14.7 6.2 6.6 12.0 17.3 4.2 19.5 6.7 2.8 13.6 8.0 5.5 1.3 9.1 3.5 5.7 10.2 10.1 5.2 14.6 2.5 2.3 7.8 11.8 9.1 5.9 3.7 7.3 2.2 5.8 4.6 11.5 2.4 1.6 6.4 25.4 0.9 29.1 6.1 7.3 1.5 18.0 10.6 6.1 22.5 4.0 2.9 2.1 3.2 2.3 3.3 1.0 3.6 0.0 0.0 1.0 0.3 3.1 6.2 33.0 16.6 0.9 0.8 5.7 2.6 2.6 8.3 6.4 6.2 1.4 12.6 5.3 1.9 1.5 0.9 21.3 0.2 5.2 0.0 27.0 2.9 1.6 12.2 9.3 3.0 0.0 2.4 0.8 10.0 5.8 0.9 4.6 32.1 5.1 0.0 2.4 0.5 23.6 10.0 32.4 20.5 0.0 17.0 1.2 1.4 1.9 4.7 17.7 13.5 6.6 0.1 1.5 15.9 0.1 7.4 0.3 0.0 2.7 0.3 0.0 0.0 0.0 7.3 0.0 4.1 0.2 0.0 0.0 3.6 0.3 0.0 0.1 3.3 0.1 0.1 0.7 0.3 1.0 0.9 0.0 0.0 0.0 1.0 0.2 0.3 13.7 14.7 12.0 17.3 10.2 10.1 7.8 11.8 5.8 6.1 0.0 2.4 6.0 17.3 0.9 40.2 3.7 28.1 4.0 6.8 1.8 3.9 11.5 26.6 7.1 12.4 3.6 48.0 0.0 20.1 10.7 2.9 19.6 5.7 43.9 5.4 11.1 37.8 1.3 2.2 6.1 8.1 2.7 8.5 1.0 52.7 28.8 13.5 96.8 11.0 31.1 13.8 25.8 15.6 48.8 116.2 2.3 5.4 4.3 71.8 42.2 CEP120 "CCDC100, FLJ36090" ENSG00000168944 "Centrosomal protein 120" Q8N960 5 123344885-123423592 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028823, HPA051556" Uncertain Approved Microtubules,Cytosol NA NA Microtubules Cytosol "HPA028823: AB_10601355, HPA051556: AB_2681533" "unprognostic (3.65e-1)" "unprognostic (9.94e-2)" "unprognostic (3.69e-2)" "unprognostic (1.49e-1)" "unprognostic (1.10e-1)" "unprognostic (2.97e-2)" "unprognostic (4.41e-1)" "unprognostic (1.15e-1)" "unprognostic (2.83e-2)" "unprognostic (5.74e-2)" "unprognostic (1.82e-2)" "unprognostic (1.51e-1)" "unprognostic (4.94e-3)" "unprognostic (1.05e-1)" "unprognostic (1.69e-1)" "unprognostic (9.44e-3)" "unprognostic (1.58e-1)" 13.3 12.9 8.6 15.2 12.8 9.2 12.1 22.9 10.8 13.1 11.1 12.5 14.4 7.9 15.7 11.3 9.3 13.5 11.6 9.5 10.0 11.6 10.7 12.7 11.4 16.1 11.2 9.8 24.3 11.0 9.8 18.1 8.9 11.4 11.7 9.6 13.9 9.8 12.0 7.3 6.9 11.8 12.0 12.0 13.9 8.6 19.4 10.9 28.4 11.7 6.0 15.6 13.0 14.2 3.6 1.6 5.5 2.4 1.6 5.4 1.7 7.7 8.7 9.6 14.2 9.6 12.3 9.8 9.2 12.0 10.3 17.2 7.3 7.0 10.9 8.5 7.1 16.2 6.2 9.4 9.9 16.6 21.8 6.0 5.4 7.2 6.3 10.1 6.9 9.4 9.3 10.5 13.8 16.4 7.7 8.7 10.0 5.5 19.5 9.9 3.6 12.1 11.6 4.6 3.2 6.5 7.1 13.3 6.8 5.7 4.5 10.5 8.7 8.1 4.3 13.4 11.0 6.3 15.3 6.4 10.8 8.8 6.0 11.6 13.0 9.9 10.7 9.3 12.6 10.5 5.5 1.2 2.6 2.0 2.4 2.7 3.6 3.4 2.7 1.5 3.1 2.9 4.9 0.8 1.6 0.8 1.6 5.4 1.7 8.6 12.8 22.9 10.8 10.0 11.6 11.2 9.8 11.4 10.9 11.9 9.3 8.1 3.5 5.3 9.1 8.4 0.0 32.1 13.6 7.0 27.5 3.4 1.7 2.4 6.8 7.1 3.2 0.0 4.1 3.7 5.3 3.6 2.3 5.8 4.8 7.9 2.4 3.1 10.7 3.9 10.9 6.0 8.5 7.2 4.2 6.8 3.7 3.5 13.1 2.9 15.8 6.5 6.4 14.4 9.1 1.6 1.9 10.2 3.3 3.0 CEP126 KIAA1377 ENSG00000110318 "Centrosomal protein 126" Q9P2H0 11 101915015-102001058 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 47.3" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 254.3;Horizontal cells: 96.9;Spermatocytes: 115.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 10.0;EFO-21: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038381, HPA038399" Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038381: AB_10669780, HPA038399: AB_10670157" "unprognostic (7.61e-2)" "unprognostic (6.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.02e-2)" "unprognostic (9.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.55e-4)" "unprognostic (1.52e-2)" "unprognostic (5.77e-2)" "unprognostic (9.55e-2)" "unprognostic (7.72e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.30e-2)" "unprognostic (3.41e-1)" "unprognostic (9.61e-2)" "unprognostic (6.99e-3)" 7.6 11.1 9.0 2.4 20.2 2.4 8.3 16.8 14.8 7.9 4.2 5.0 4.2 2.0 9.1 6.7 5.3 17.5 4.9 4.5 9.6 8.3 3.8 1.4 6.1 3.3 7.5 10.2 11.4 5.0 6.4 47.3 2.6 12.4 6.6 4.8 3.2 3.2 7.6 2.3 8.5 2.7 7.3 9.2 3.1 4.0 19.2 8.9 0.5 7.4 1.5 2.5 3.9 9.7 2.5 4.8 1.4 0.5 3.3 2.0 0.5 0.9 2.2 1.1 1.3 10.0 5.5 0.5 2.1 1.8 1.0 0.9 0.6 3.0 1.3 9.5 1.9 4.4 0.9 1.3 2.4 0.9 3.1 1.5 0.3 3.7 1.2 1.1 0.2 0.3 1.9 4.7 1.3 2.8 5.1 3.0 1.3 0.3 0.4 2.5 1.1 1.1 0.3 0.8 1.1 1.7 0.2 1.1 0.2 2.0 1.2 2.7 4.2 1.3 1.9 0.3 2.0 3.7 0.4 1.7 3.3 1.9 1.0 2.2 2.2 1.2 0.2 3.2 0.3 1.3 0.7 0.5 1.0 2.0 0.1 0.9 1.8 1.2 1.6 0.4 2.5 1.7 1.7 1.4 3.3 0.2 4.8 0.3 0.5 9.0 20.2 16.8 14.8 9.6 8.3 7.5 10.2 12.4 8.9 8.9 7.0 0.5 4.6 0.0 17.6 7.5 5.1 254.3 43.3 17.4 43.2 1.2 3.3 2.0 13.5 3.0 0.0 0.0 0.3 0.7 3.5 2.8 0.0 0.0 0.3 96.9 64.4 3.1 0.0 6.9 49.8 1.4 0.0 0.0 10.3 26.8 1.0 0.0 48.1 4.4 47.8 6.5 1.6 115.1 25.4 0.0 0.1 7.0 1.3 2.0 CEP128 "C14orf145, C14orf61" ENSG00000100629 "Centrosomal protein 128" Q6ZU80 14 80476983-80959517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 61.2" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 22.7;monocytes: 15.4;Spermatocytes: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.6;T-cells: 9.6" "Cell line enhanced" "Detected in many" "Karpas-707: 25.8;MOLT-4: 22.1;U-266/70: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000602, HPA001116, HPA018498" Uncertain Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite" Cytosol "HPA000602: , HPA001116: AB_1078323, HPA018498: AB_1845560" "unprognostic (6.13e-3)" "unprognostic (5.82e-2)" "unprognostic (1.65e-2)" "unprognostic (3.49e-2)" "unprognostic (4.32e-2)" "unprognostic (5.93e-2)" "unprognostic (2.64e-2)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (1.87e-1)" "unprognostic (3.42e-1)" "unprognostic (1.94e-2)" "unprognostic (2.60e-3)" "unprognostic (1.21e-1)" "unprognostic (3.37e-1)" "unprognostic (2.45e-1)" "unprognostic (1.48e-1)" 3.8 2.0 5.2 6.5 7.6 10.5 7.5 13.6 5.4 3.4 3.6 4.2 2.7 3.2 4.0 2.2 4.4 4.8 2.0 3.1 3.8 2.5 2.4 2.0 3.8 8.1 6.9 3.1 4.4 2.1 4.2 8.6 2.3 4.5 2.9 3.3 2.3 4.5 3.2 3.1 5.1 3.0 4.0 5.5 6.3 3.1 9.0 6.8 61.2 5.7 3.1 9.1 6.0 4.4 2.2 8.6 1.7 0.8 1.1 9.6 0.8 6.0 3.2 2.9 2.3 0.7 1.1 1.5 6.9 2.0 4.0 4.0 2.1 3.5 14.0 1.2 2.0 2.6 3.2 3.1 2.0 7.7 7.9 1.9 2.7 3.9 1.1 0.3 2.7 3.6 0.2 0.5 5.7 3.1 0.7 3.0 7.1 3.3 25.8 3.7 3.8 22.1 1.4 2.2 1.6 4.0 3.9 7.0 11.0 0.8 3.1 3.7 1.7 5.5 2.2 1.2 2.9 2.5 2.1 2.8 8.8 4.8 2.4 6.7 46.5 1.8 6.2 2.5 3.7 3.0 0.0 0.8 1.7 2.9 0.3 2.3 2.2 3.2 2.2 2.5 0.9 2.8 1.3 0.1 1.1 0.5 8.6 9.6 0.8 5.2 7.6 13.6 5.4 3.8 2.5 6.9 3.1 4.5 6.8 3.0 3.2 6.7 2.4 3.5 6.7 3.9 0.0 22.7 9.1 3.5 2.0 1.0 0.0 1.2 6.1 1.7 0.0 0.0 1.0 7.0 1.9 0.6 2.3 0.0 2.2 6.4 1.2 1.3 0.0 3.1 1.4 5.5 3.3 15.4 0.6 7.1 0.8 0.0 1.4 0.4 15.0 6.5 2.0 17.7 3.4 1.5 1.9 4.1 1.2 1.3 CEP162 "C6orf84, KIAA1009, QN1" ENSG00000135315 "Centrosomal protein 162" Q5TB80 6 84124241-84227635 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 72.3;Early spermatids: 103.7;Spermatocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030170, HPA030171, HPA030172, HPA030173" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206" "unprognostic (1.75e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-3)" "unprognostic (2.95e-4)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.21e-3)" "unprognostic (1.57e-3)" "unprognostic (3.98e-2)" "unprognostic (2.87e-3)" "unprognostic (3.27e-2)" "unprognostic (6.32e-2)" "unprognostic (3.58e-1)" "unprognostic (1.44e-3)" 5.9 4.3 4.2 5.3 6.0 3.8 5.4 9.4 7.8 6.4 6.3 4.8 6.6 2.1 9.1 4.4 4.1 7.2 5.2 4.0 4.5 2.6 7.7 2.6 5.3 4.6 4.8 3.2 7.9 4.1 9.6 19.1 4.5 5.8 4.7 4.9 2.7 5.5 4.6 4.1 4.1 4.2 6.4 7.6 5.8 4.9 14.4 6.4 11.6 7.7 2.1 4.2 7.3 5.4 2.5 1.8 2.2 1.3 0.1 2.6 0.8 2.9 1.3 8.8 9.5 5.2 7.8 5.5 3.3 3.2 4.7 5.8 3.8 4.0 3.2 3.2 2.6 8.4 4.6 5.1 3.1 7.5 8.1 3.6 5.8 5.9 2.8 2.9 6.3 5.6 3.6 2.3 4.8 1.8 6.3 5.2 4.8 11.8 3.7 3.4 1.5 1.6 4.1 5.8 2.1 2.1 9.0 11.3 1.7 3.5 2.7 6.0 7.5 2.4 1.4 2.5 6.6 3.1 4.6 4.2 4.7 4.2 4.1 3.7 2.9 3.9 1.9 2.9 3.5 5.8 0.0 1.3 1.5 1.9 1.2 2.6 2.5 1.5 1.7 0.7 1.6 1.2 2.0 2.2 0.1 1.0 1.8 0.3 0.8 4.2 6.0 9.4 7.8 4.5 2.6 4.8 3.2 5.8 6.4 29.8 14.5 5.0 6.4 0.0 5.2 7.6 0.0 72.3 12.5 8.7 11.8 5.8 5.0 10.5 103.7 6.3 5.1 23.3 6.2 4.6 5.0 3.5 17.4 2.6 4.7 27.0 10.9 8.6 5.6 39.3 10.9 6.1 0.0 1.8 4.5 11.2 5.3 14.0 11.3 5.0 13.8 12.9 3.6 62.7 22.4 0.0 3.2 7.5 5.2 3.3 CEP170 "FAM68A, KAB, KIAA0470" ENSG00000143702 "Centrosomal protein 170" Q5SW79 1 243124428-243255348 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.7" "Group enriched" "Detected in many" 37 "Early spermatids: 1512.0;Late spermatids: 3749.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042151, HPA045597, HPA045787" Uncertain Enhanced "Mitotic spindle,Centrosome,Cytosol" Yes No Centrosome "Mitotic spindle, Cytosol" "HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453" "unprognostic (2.97e-1)" "unprognostic (2.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (7.60e-2)" "unprognostic (6.83e-5)" "unprognostic (8.05e-2)" "unprognostic (9.88e-3)" "unprognostic (7.09e-2)" "unprognostic (3.52e-2)" "unprognostic (6.65e-2)" "prognostic unfavorable (1.30e-9)" "unprognostic (2.21e-2)" "unprognostic (2.17e-1)" "unprognostic (6.49e-3)" "unprognostic (9.62e-3)" 9.5 6.1 13.7 10.8 13.2 36.5 6.8 27.7 23.2 7.4 5.4 11.4 3.1 3.1 9.1 5.2 5.5 6.4 11.1 8.6 12.8 11.2 3.8 6.7 8.4 7.3 19.3 13.7 13.3 2.8 2.8 10.8 9.8 20.2 5.0 4.2 3.3 4.2 5.5 9.3 4.2 4.7 7.4 25.8 7.8 4.2 53.7 18.0 11.6 14.4 3.3 8.9 8.6 6.6 9.4 8.4 12.3 10.1 2.8 4.7 2.1 6.0 5.1 13.2 11.1 8.2 15.9 2.9 16.1 9.6 12.1 11.5 3.2 5.9 4.5 9.9 13.7 4.1 3.0 11.3 6.9 17.3 10.0 6.5 4.7 4.8 2.2 7.1 8.2 8.8 10.0 1.9 38.6 16.9 27.7 28.2 2.7 11.3 4.7 15.3 1.3 5.0 4.4 16.6 1.2 14.5 9.0 9.4 1.5 2.5 1.0 19.1 25.7 8.2 0.7 7.7 10.8 2.8 11.2 31.1 22.6 6.7 12.1 18.5 4.6 5.9 9.0 12.0 7.5 51.9 3.5 8.3 7.6 1.9 10.0 2.7 3.6 3.8 1.6 8.4 9.4 4.7 2.7 12.3 2.8 10.1 5.5 2.9 2.1 13.7 13.2 27.7 15.8 12.8 11.2 19.3 13.7 20.2 18.0 17.9 16.6 13.7 4.2 13.5 41.1 19.0 7.6 25.4 11.4 12.2 5.9 3.1 0.0 18.9 1512.0 31.0 0.7 0.0 6.1 6.7 26.8 3.3 22.0 6.8 31.5 42.9 10.4 18.4 34.9 3749.4 40.9 70.8 21.9 31.5 1.9 11.4 19.1 0.0 33.2 2.1 18.3 25.8 15.7 71.0 23.8 10.0 1.6 7.0 1.6 3.1 CEP170B "Cep170R, FAM68C, KIAA0284" ENSG00000099814 "Centrosomal protein 170B" Q9Y4F5 14 104865280-104896770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 216.0;Rod photoreceptor cells: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000871, HPA059017" Enhanced Approved Microtubules,Centrosome,Cytosol NA NA Cytosol "Microtubules, Centrosome" "HPA000871: AB_2666124, HPA059017: AB_2683883" "unprognostic (1.09e-1)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (2.38e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (4.96e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (4.41e-4)" "prognostic favorable (3.26e-4)" "unprognostic (1.62e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (1.17e-2)" 10.3 8.8 19.9 7.3 26.3 1.3 10.9 25.9 39.7 6.6 18.0 5.3 9.1 24.7 7.4 5.0 14.7 8.5 15.1 4.9 18.5 12.4 9.9 9.4 8.0 2.1 8.9 19.7 4.6 25.4 9.0 10.5 4.8 13.5 10.3 8.9 5.3 17.5 12.5 4.6 35.0 24.6 6.7 6.5 3.8 23.2 10.9 6.0 0.2 10.1 6.2 5.6 8.8 11.2 0.0 0.0 0.0 0.0 0.0 0.6 0.2 10.8 9.1 0.7 8.6 3.7 2.7 20.2 8.6 3.4 4.3 2.9 9.6 6.7 0.0 10.5 6.5 3.0 24.2 2.0 10.1 1.1 4.0 4.2 0.0 9.6 6.2 7.4 0.0 8.9 2.6 12.9 4.5 6.7 3.4 4.3 0.0 2.7 0.1 3.7 23.1 0.0 0.1 2.9 15.6 7.9 3.6 0.0 2.6 4.3 18.6 2.3 2.4 12.8 7.6 11.5 1.5 13.1 1.6 9.5 6.9 7.6 19.0 5.7 0.4 0.0 0.0 5.5 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 19.9 26.3 25.9 39.7 18.5 12.4 8.9 19.7 13.5 6.0 8.9 15.4 0.0 10.8 21.2 17.6 3.3 28.1 5.3 4.5 17.4 216.0 2.8 1.7 10.8 0.6 3.6 52.0 0.0 20.6 6.3 3.5 18.4 5.7 10.6 1.2 38.1 21.2 6.7 0.3 1.0 3.4 2.9 8.5 1.8 37.4 11.8 23.7 32.3 8.1 4.3 113.9 6.5 6.7 1.4 3.8 21.5 5.6 0.0 25.2 19.3 CEP192 "FLJ10352, KIAA1569, PPP1R62" ENSG00000101639 "Centrosomal protein 192" Q8TEP8 18 12991362-13125052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039392, HPA040503" Uncertain Supported Centrosome,Cytosol Yes No "Centrosome, Cytosol" "HPA039392: AB_10697549, HPA040503: AB_10670919" "unprognostic (6.94e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-3)" "unprognostic (6.87e-3)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (9.00e-2)" "unprognostic (6.61e-2)" "unprognostic (1.28e-1)" "unprognostic (7.89e-2)" "unprognostic (2.39e-1)" "unprognostic (4.54e-2)" "unprognostic (1.66e-3)" 7.6 6.5 7.9 14.9 11.8 16.3 8.3 14.5 11.8 8.8 7.7 11.1 7.1 6.7 13.6 9.3 7.6 8.8 9.9 7.1 8.1 4.7 6.9 6.1 8.7 11.0 8.7 11.8 17.4 9.5 10.4 11.1 7.8 11.8 8.0 9.4 7.9 10.4 6.6 6.2 8.2 9.6 9.5 7.6 8.4 8.2 16.4 9.8 18.3 11.1 6.0 12.2 12.1 8.6 3.9 1.8 2.1 4.9 0.9 3.5 1.0 9.9 5.4 14.7 7.6 6.4 10.0 4.7 7.0 9.2 11.1 11.8 7.4 4.4 11.2 4.7 7.0 8.0 4.9 12.7 6.6 13.1 4.4 4.5 10.2 8.2 3.8 3.3 16.1 7.9 6.9 2.5 9.2 8.5 6.3 9.0 8.1 14.0 7.5 8.6 5.0 13.9 7.0 4.6 18.5 3.3 12.0 11.5 5.8 3.8 10.1 10.7 6.0 11.1 5.5 3.4 7.2 4.4 8.4 9.0 8.7 20.6 9.9 9.5 5.1 7.3 12.8 5.6 7.3 8.4 1.5 2.1 1.5 3.2 1.5 2.4 1.8 2.1 2.0 0.9 3.9 2.3 3.5 2.1 0.9 4.9 1.8 1.8 1.0 7.9 11.8 14.5 11.8 8.1 4.7 8.7 11.8 11.8 9.8 8.9 10.9 5.9 3.9 1.6 11.7 21.4 7.6 4.0 10.3 7.0 21.6 3.5 0.0 3.9 21.9 3.5 4.9 0.0 3.1 2.7 3.0 5.3 2.3 4.7 3.8 11.1 0.0 7.4 9.4 9.5 9.5 5.4 1.7 11.8 9.1 6.6 4.0 5.8 13.1 1.1 16.3 25.8 3.5 19.1 21.3 2.8 1.6 10.1 6.4 7.1 CEP295 KIAA1731 ENSG00000166004 "Centrosomal protein 295" Q9C0D2 11 93661639-93730358 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038595, HPA038596, HPA038597" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038595: AB_2676104, HPA038596: AB_10672720, HPA038597: AB_2676106" "unprognostic (1.35e-2)" "unprognostic (3.08e-1)" "unprognostic (7.66e-2)" "unprognostic (5.56e-2)" "unprognostic (5.73e-2)" "unprognostic (4.08e-3)" "unprognostic (6.03e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (3.73e-2)" "unprognostic (4.99e-4)" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (2.18e-2)" 8.4 7.4 15.8 12.1 15.4 19.6 11.7 30.6 20.5 10.0 10.0 6.1 9.4 8.6 10.5 11.2 8.4 7.7 7.6 6.5 12.1 8.1 7.6 6.3 8.6 14.1 10.7 14.7 12.2 8.1 8.5 24.5 8.5 12.1 10.6 9.8 5.1 7.9 9.4 13.4 12.5 9.2 7.8 13.8 11.7 8.0 15.5 15.0 11.6 12.3 5.2 9.9 10.7 8.9 6.3 3.0 9.1 3.1 2.7 3.0 0.6 7.2 6.7 17.2 14.8 8.1 7.9 8.5 9.4 6.9 9.0 10.5 12.3 14.0 2.2 14.0 5.9 12.4 13.6 8.7 6.9 9.1 10.4 6.8 13.2 19.4 6.1 4.9 11.9 13.0 5.7 4.1 8.4 7.5 8.5 7.4 12.2 14.9 14.0 11.3 6.2 6.1 19.6 5.8 13.7 6.9 12.3 16.4 8.9 7.3 12.8 10.3 9.7 14.8 10.0 2.7 11.7 16.4 6.5 7.5 8.4 11.0 15.1 7.2 5.2 11.3 14.7 5.0 14.0 11.5 4.1 3.1 5.7 2.8 1.5 2.2 5.0 2.5 1.9 1.3 6.3 3.0 2.5 9.1 2.7 2.0 3.0 1.7 0.6 15.8 15.4 30.6 20.5 12.1 8.1 10.7 14.7 12.1 15.0 8.9 14.7 0.0 2.0 0.0 27.0 7.8 2.5 9.4 10.3 5.2 25.5 9.3 3.3 6.5 78.2 6.3 2.6 23.3 6.8 9.1 4.6 3.6 15.1 3.2 6.9 17.5 3.5 5.5 8.6 15.5 11.8 4.8 0.0 4.6 7.0 7.8 5.0 4.3 13.4 3.0 37.3 6.5 1.4 39.0 17.0 0.0 5.5 6.4 6.4 2.2 CEP57 "KIAA0092, Translokin, TSP57" ENSG00000166037 "Centrosomal protein 57" Q86XR8 11 95789965-95832693 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 393.9;Late spermatids: 289.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018315 Approved Approved Microtubules,Cytosol "Intracellular and membrane" NA NA Microtubules Cytosol "HPA018315: AB_1846537" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (1.45e-2)" "unprognostic (2.66e-1)" "prognostic favorable (7.24e-4)" "unprognostic (1.69e-1)" "unprognostic (2.25e-2)" "unprognostic (8.10e-2)" "unprognostic (9.04e-3)" "unprognostic (7.93e-2)" "unprognostic (2.38e-3)" "unprognostic (7.81e-2)" "unprognostic (1.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.35e-1)" "unprognostic (6.69e-3)" "unprognostic (3.25e-1)" 16.8 13.7 12.9 25.9 20.6 21.6 17.4 27.9 16.2 25.6 33.8 6.9 19.2 27.0 18.5 18.8 18.2 16.5 22.9 14.0 13.3 14.1 14.9 34.4 19.0 28.9 12.6 15.2 27.2 24.5 13.6 26.1 13.3 15.0 21.5 15.6 10.5 14.1 22.3 12.6 15.8 28.8 22.2 14.6 19.8 15.3 24.3 12.7 46.5 23.4 15.7 23.9 27.5 18.3 17.2 15.5 17.6 11.0 18.6 25.3 13.0 11.4 5.6 19.7 14.7 8.4 17.4 15.6 13.0 21.0 18.0 20.4 20.4 24.6 20.6 18.2 9.6 10.9 19.3 14.8 12.9 19.1 16.2 9.9 28.4 16.5 16.9 15.5 28.8 17.1 11.7 18.4 18.4 35.4 17.4 14.9 22.8 18.3 11.4 14.3 5.6 31.0 38.0 10.0 13.1 13.0 19.4 23.6 17.3 15.2 12.7 9.5 13.7 15.5 15.3 16.4 13.8 15.7 18.6 8.4 15.7 12.7 23.0 12.4 8.4 16.2 23.0 6.5 32.1 13.6 11.3 9.1 17.6 16.5 11.0 21.2 17.2 21.0 18.8 11.9 16.2 20.2 19.2 8.5 18.6 9.1 15.5 25.3 13.0 12.9 20.6 27.9 16.2 13.3 14.1 12.6 15.2 15.0 12.7 50.6 42.7 43.2 31.6 32.3 71.9 38.6 71.4 64.3 47.8 27.9 33.4 35.9 46.4 28.1 393.9 35.2 19.7 46.7 22.5 43.0 29.6 24.9 26.5 62.1 28.5 54.0 27.6 16.0 29.7 289.2 31.4 34.0 16.9 23.4 30.2 26.4 24.1 28.1 33.6 27.0 58.6 64.7 29.2 42.3 38.3 28.0 32.2 42.4 40.6 24.0 CEP57L1 "bA487F23.2, C6orf182, MGC21731" ENSG00000183137 "Centrosomal protein 57 like 1" Q8IYX8 6 109095110-109163932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Spermatocytes: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040378 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040378: AB_10794028" "unprognostic (5.93e-3)" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-2)" "unprognostic (1.11e-1)" "unprognostic (3.41e-2)" "unprognostic (4.69e-3)" "unprognostic (3.63e-2)" "unprognostic (7.25e-2)" "unprognostic (1.27e-1)" "unprognostic (2.33e-1)" "unprognostic (9.97e-2)" "unprognostic (2.42e-5)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (8.48e-2)" "unprognostic (1.72e-1)" 11.9 9.3 10.6 7.3 13.5 8.9 11.4 13.9 16.1 11.3 8.8 8.1 8.6 8.4 9.6 10.9 8.0 7.1 9.3 10.4 8.9 6.9 8.1 11.8 8.4 8.1 10.2 10.5 9.3 7.5 18.5 13.5 9.7 13.5 7.1 11.1 7.0 7.4 7.3 7.8 6.8 7.6 10.7 12.8 7.2 7.8 24.6 11.8 6.3 8.7 6.1 6.9 7.6 9.1 7.4 6.9 14.6 10.3 13.4 8.2 5.2 8.3 3.6 11.0 11.2 10.5 17.4 8.9 19.3 10.5 17.1 19.6 5.5 7.3 7.4 8.9 9.8 15.0 4.4 7.6 7.1 27.1 9.4 7.4 15.9 8.7 5.7 9.7 13.0 7.0 10.0 5.5 14.6 14.6 9.5 14.9 25.1 28.8 25.8 15.7 5.6 14.5 11.3 3.6 6.8 7.1 12.0 8.3 7.4 8.1 3.5 8.5 6.9 9.4 7.1 6.3 7.6 8.9 20.8 7.2 11.3 6.8 11.9 20.1 7.5 8.5 11.8 10.7 20.1 9.1 14.6 6.3 7.4 6.1 7.1 6.2 4.0 6.0 8.2 6.7 7.4 5.8 8.2 3.6 13.4 10.3 6.9 8.0 5.2 10.6 13.5 13.9 16.1 8.9 6.9 10.2 10.5 13.5 11.8 6.0 4.0 2.2 6.5 3.0 6.0 8.1 2.5 12.0 7.9 5.2 19.6 7.0 6.6 6.5 36.0 8.7 4.2 23.3 4.7 11.0 11.8 3.3 4.7 4.9 8.4 4.8 5.2 6.7 4.4 26.1 16.1 5.9 8.5 8.2 2.6 9.4 5.0 5.5 11.7 10.4 12.0 12.9 12.8 72.6 5.0 3.9 7.1 6.9 4.5 3.0 CEP70 "BITE, FLJ13036" ENSG00000114107 "Centrosomal protein 70" Q8NHQ1 3 138494344-138594538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 163.4;Late spermatids: 214.6;Spermatocytes: 140.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0" "Group enriched" "Detected in many" 8 "B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036941, HPA036942" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA036941: AB_10670567, HPA036942: AB_10670957" "unprognostic (1.61e-1)" "prognostic favorable (2.93e-4)" "unprognostic (2.27e-2)" "unprognostic (3.59e-2)" "unprognostic (3.31e-2)" "unprognostic (3.44e-2)" "unprognostic (1.95e-2)" "unprognostic (9.92e-3)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (5.01e-3)" "prognostic unfavorable (9.60e-5)" "unprognostic (8.90e-3)" "unprognostic (8.07e-3)" "unprognostic (1.46e-1)" "unprognostic (8.71e-3)" "unprognostic (6.43e-2)" 5.5 8.3 11.0 5.7 15.8 3.5 9.0 14.7 15.6 20.8 12.2 7.1 22.8 35.7 14.0 14.8 10.2 20.3 8.9 11.3 10.9 15.9 17.0 18.8 11.5 4.2 12.6 10.2 14.4 17.4 16.6 27.8 2.7 14.4 14.3 12.1 12.6 6.1 28.7 10.6 4.6 11.5 14.0 19.1 3.9 8.6 41.5 15.3 24.2 26.2 6.7 4.5 13.3 9.1 2.9 0.2 0.5 0.1 3.6 6.4 2.0 21.6 4.5 10.7 13.0 6.7 7.5 10.0 4.3 8.1 6.0 8.9 6.3 11.8 5.1 10.3 8.0 22.8 9.6 9.7 8.6 13.5 9.0 6.4 14.6 10.5 8.2 10.5 0.7 5.4 40.3 5.0 4.5 11.2 16.0 8.6 16.8 10.6 17.1 9.8 8.2 15.3 0.8 6.3 5.7 10.2 16.9 13.9 13.1 11.4 9.7 13.0 8.5 22.5 5.4 25.5 12.8 27.1 7.1 5.0 4.4 8.4 9.0 5.2 15.9 8.7 17.4 9.8 1.4 15.0 0.4 0.1 0.2 4.2 0.1 5.0 2.9 3.4 3.7 0.1 2.0 5.9 6.4 0.5 3.6 0.0 0.2 2.0 2.0 11.0 15.8 14.7 15.6 10.9 15.9 12.6 10.2 14.4 15.3 29.8 54.7 0.8 31.2 8.7 15.6 23.2 17.8 48.2 38.7 19.2 33.4 5.9 61.3 18.3 163.4 7.1 4.6 0.0 15.5 3.6 6.2 27.5 19.7 12.4 2.2 20.6 15.0 4.9 0.8 214.6 9.2 3.3 10.1 1.0 9.5 19.7 13.7 7.0 12.0 17.0 29.1 6.5 11.8 140.5 9.1 7.0 8.0 4.9 22.3 24.8 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234153-26279038 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 26.8;Spermatocytes: 43.5;Spermatogonia: 37.7;Syncytiotrophoblasts: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 15.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Approved "Nucleoli,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoli, Golgi apparatus" "Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavorable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.1 2.7 4.8 3.8 11.0 12.4 3.1 7.7 8.8 2.4 3.7 15.5 4.6 3.5 2.6 3.3 5.6 2.7 2.6 19.4 5.5 4.0 3.8 3.7 3.2 5.3 20.4 4.9 2.4 3.3 4.4 4.7 3.6 7.8 3.0 4.5 4.0 3.5 2.5 87.8 8.4 3.3 2.9 10.4 4.3 3.7 26.8 13.5 12.1 5.4 5.5 6.6 3.0 3.8 2.4 3.8 15.6 5.0 2.1 3.4 2.8 13.5 6.7 10.8 11.5 3.0 2.8 21.3 6.9 3.2 9.5 10.2 8.6 12.7 12.9 9.4 2.8 5.2 12.0 12.1 5.7 9.6 9.4 10.5 18.2 13.2 9.1 3.1 16.6 20.2 1.4 5.7 8.0 5.8 4.5 4.2 17.5 24.5 18.0 7.0 4.9 15.9 20.2 10.5 6.7 11.2 16.3 12.6 12.0 4.8 2.1 18.4 8.5 9.7 8.1 8.0 6.2 7.4 11.9 4.9 7.8 13.0 9.1 10.6 14.2 20.7 16.1 4.8 29.3 14.7 3.4 4.6 15.6 3.0 4.4 2.5 2.4 2.0 2.3 3.8 1.3 1.8 3.4 0.5 2.1 5.0 1.3 3.2 2.8 4.8 11.0 7.7 8.8 5.5 4.0 20.4 4.9 7.8 13.5 0.0 2.1 0.0 4.2 6.2 9.6 26.8 2.5 1.4 4.5 5.2 11.8 2.0 6.6 1.7 0.8 1.8 3.9 0.0 1.1 3.6 2.1 2.2 2.3 2.5 4.3 0.0 1.7 1.8 5.2 2.3 1.4 4.0 1.7 4.6 3.1 1.3 2.1 3.4 0.4 0.8 10.1 0.0 1.0 43.5 37.7 5.4 34.9 3.5 4.7 3.2 CEP89 "CCDC123, FLJ14640" ENSG00000121289 "Centrosomal protein 89" Q96ST8 19 32875925-32971991 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039382, HPA040056" Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA039382: AB_2676479, HPA040056: AB_10671048" "unprognostic (4.23e-2)" "unprognostic (7.50e-3)" "unprognostic (1.97e-1)" "unprognostic (1.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.78e-5)" "unprognostic (1.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.04e-2)" "unprognostic (1.80e-2)" "unprognostic (4.00e-2)" "unprognostic (1.74e-1)" "unprognostic (4.48e-2)" "unprognostic (6.53e-2)" "unprognostic (3.03e-1)" "unprognostic (2.47e-2)" 10.1 9.5 8.5 8.3 12.1 6.8 11.6 16.4 14.4 12.9 10.5 12.5 9.7 6.4 17.0 11.3 10.1 14.8 8.3 8.8 8.1 6.4 9.8 5.6 9.4 8.9 7.9 8.4 17.1 9.0 11.3 20.2 8.8 9.1 15.0 7.4 10.2 10.3 10.2 10.5 10.7 7.4 11.4 6.6 7.7 8.1 8.4 8.4 10.1 11.8 5.0 7.6 10.2 11.4 7.7 5.1 12.7 6.1 2.8 6.9 2.1 13.4 18.5 12.9 11.0 7.0 8.2 7.4 10.9 7.3 19.3 14.8 6.6 8.4 5.6 5.9 11.1 10.9 7.8 12.6 8.8 13.4 14.5 7.7 4.3 12.9 6.4 5.6 5.9 4.3 9.8 12.2 18.2 11.9 7.9 14.4 7.7 6.5 8.2 8.9 10.2 6.7 4.6 5.5 7.5 6.0 7.5 7.0 4.8 8.8 7.6 18.2 13.4 11.1 7.7 6.3 8.2 5.9 4.9 9.2 14.0 12.4 11.9 11.0 4.1 6.3 5.0 12.0 5.6 10.5 12.7 4.4 2.1 4.0 6.1 6.9 4.7 4.2 3.4 2.4 7.7 4.1 4.7 5.3 2.8 3.0 5.1 4.4 2.1 8.5 12.1 16.4 14.4 8.1 6.4 7.9 8.4 9.1 8.4 26.8 13.6 12.6 9.2 4.5 15.3 15.3 12.7 62.9 25.0 19.2 17.7 8.4 10.0 16.5 11.6 11.7 6.4 23.3 14.2 9.1 9.9 6.2 16.2 5.3 10.2 19.1 9.4 14.1 5.7 5.9 15.0 9.9 5.0 12.6 9.6 10.1 12.8 2.9 12.0 12.2 38.5 0.0 11.3 21.5 13.2 4.0 3.5 7.1 7.7 4.3 CEP97 "FLJ23047, LRRIQ2" ENSG00000182504 "Centrosomal protein 97" Q8IW35 3 101723925-101770562 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 46.8;Spermatocytes: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002980 Uncertain Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite" Cytosol "HPA002980: AB_1848820" "unprognostic (7.36e-2)" "unprognostic (4.70e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (3.33e-2)" "unprognostic (2.01e-3)" "unprognostic (1.00e-1)" "unprognostic (2.85e-1)" "unprognostic (4.04e-1)" "unprognostic (5.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.12e-3)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.79e-1)" "unprognostic (1.05e-1)" 3.8 4.3 7.5 5.2 11.8 6.6 4.1 15.2 11.8 4.5 3.9 12.1 3.6 2.5 5.7 4.1 3.8 8.7 3.5 3.5 7.9 4.9 3.5 2.9 3.7 6.5 15.3 7.0 5.4 3.1 10.2 9.9 4.1 12.8 3.9 3.7 3.0 4.1 3.6 4.8 4.1 3.9 6.6 8.1 4.3 3.5 20.0 14.8 10.8 5.3 1.7 6.8 4.7 4.1 2.7 1.3 5.1 1.1 0.9 2.5 0.8 9.4 5.6 9.6 7.0 5.4 4.2 2.9 10.3 7.2 7.9 9.8 2.4 4.5 8.2 4.7 5.7 6.3 6.5 7.2 5.6 13.5 9.1 3.5 4.7 6.2 1.7 2.6 5.9 7.4 2.5 4.5 6.8 5.8 4.1 4.3 8.4 3.8 14.9 9.7 2.8 9.7 3.0 3.4 3.3 7.5 7.1 13.4 5.6 2.6 3.7 18.5 7.6 5.5 3.5 4.9 5.3 6.1 5.1 4.4 10.8 8.0 3.2 7.4 9.4 8.5 14.9 4.4 5.4 10.6 5.1 0.4 1.9 2.2 0.1 1.8 2.7 1.9 1.3 0.5 1.7 1.3 1.1 3.1 0.9 1.1 1.3 2.5 0.8 7.5 11.8 15.2 11.8 7.9 4.9 15.3 7.0 12.8 14.8 3.0 3.8 2.2 2.1 4.1 12.6 5.9 5.1 46.8 12.5 1.8 11.8 3.0 3.3 4.0 15.4 4.4 0.9 0.0 1.8 2.4 5.6 2.2 9.2 3.6 2.3 17.5 4.1 4.3 3.5 5.6 7.2 1.1 8.5 2.8 3.4 21.1 3.1 0.0 7.1 2.5 13.4 12.9 5.9 30.7 8.3 3.1 1.6 4.5 3.3 1.0 CERKL RP26 ENSG00000188452 "Ceramide kinase like" Q49MI3 2 181536676-181680665 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5" "Cell type enhanced" "Detected in some" 21 "Ciliated cells: 52.2;Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 20.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 11 "cerebellum: 49.5;pons and medulla: 13.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 26.5;HL-60: 14.7;JURKAT: 17.0;MOLT-4: 35.5;NB-4: 31.3;SCLC-21H: 23.9;THP-1: 14.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 31.8" "HPA035443, HPA035444, HPA043203" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: " "unprognostic (7.52e-3)" "unprognostic (6.13e-3)" "unprognostic (2.09e-1)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (2.71e-3)" "unprognostic (2.59e-1)" "unprognostic (1.39e-2)" "unprognostic (2.76e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.25e-4)" "unprognostic (4.54e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (3.07e-2)" "unprognostic (8.45e-2)" 1.2 0.6 1.2 9.2 2.0 14.4 1.1 49.5 2.5 3.7 1.7 4.2 0.4 3.1 1.0 5.3 0.6 5.8 4.1 0.5 2.9 1.3 8.1 1.3 5.0 13.8 0.6 1.4 2.9 0.8 0.1 2.1 2.0 13.7 1.0 0.0 6.8 1.0 0.4 0.5 0.5 6.4 0.4 1.0 17.9 2.8 1.1 1.1 0.4 0.9 0.4 1.1 4.3 1.3 4.0 5.2 12.6 12.7 4.7 6.9 4.2 0.0 0.5 0.6 0.0 0.0 0.1 0.0 4.2 0.1 0.1 0.1 0.0 0.1 4.4 0.0 0.1 2.6 2.6 0.1 0.1 0.1 0.0 0.4 26.5 0.3 0.0 0.1 14.7 0.7 0.2 0.3 0.1 0.2 4.0 0.0 17.0 0.0 4.7 0.0 0.0 35.5 31.3 0.6 0.0 0.2 7.6 2.2 0.6 0.3 0.0 23.9 0.7 0.0 0.0 0.1 0.2 0.0 14.8 2.4 1.2 0.6 0.1 1.0 11.4 6.4 2.0 0.9 9.9 10.8 2.0 4.7 12.6 4.5 12.7 3.7 4.0 6.4 6.9 5.2 3.4 3.5 4.5 0.7 4.7 10.9 2.9 1.4 4.2 1.2 2.0 49.5 2.5 2.9 1.3 0.6 1.4 13.7 1.1 3.0 0.3 0.0 0.1 0.0 0.4 0.7 0.0 52.2 7.9 0.0 17.7 0.0 8.3 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 7.8 20.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 CERS6 LASS6 ENSG00000172292 "Ceramide synthase 6" Q6ZMG9 2 168455862-168775137 "Predicted membrane proteins" "Inflammatory response, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 9.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044683, HPA063527" Approved Uncertain Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA044683: AB_10965059, HPA063527: AB_2685030" "unprognostic (2.17e-2)" "unprognostic (1.87e-1)" "unprognostic (3.92e-3)" "prognostic unfavorable (7.31e-4)" "unprognostic (3.24e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.28e-1)" "unprognostic (1.11e-2)" "unprognostic (9.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.93e-2)" "unprognostic (2.38e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-2)" "unprognostic (2.41e-1)" "unprognostic (4.80e-2)" 12.3 13.5 17.7 12.2 17.5 9.6 14.2 28.0 23.2 12.3 24.4 6.5 19.8 22.4 17.4 17.0 12.7 9.8 9.7 26.9 14.5 15.9 12.1 11.7 9.4 12.5 11.0 15.9 15.6 7.3 15.8 14.6 8.3 9.2 12.2 27.1 13.4 6.9 17.1 9.4 20.0 28.3 11.0 8.5 6.9 21.0 11.0 8.1 25.1 24.1 7.4 7.5 11.8 30.5 0.8 9.0 0.7 1.7 1.1 1.7 0.5 5.9 5.3 9.5 10.9 23.6 17.6 0.0 6.0 6.1 6.4 8.7 8.4 13.2 0.0 8.7 5.4 9.1 11.3 12.2 13.9 10.8 0.0 8.4 10.9 5.7 6.0 20.7 22.9 5.3 19.5 40.1 13.5 10.6 6.4 3.2 16.3 5.8 0.0 13.3 6.5 20.1 6.4 8.8 12.8 7.8 15.6 18.0 10.3 6.1 17.9 13.2 15.9 5.8 15.0 3.1 8.2 13.3 13.1 1.8 16.5 6.9 4.5 10.3 0.1 0.0 0.0 10.8 12.2 11.0 0.7 1.7 0.0 0.3 1.2 0.6 0.2 0.6 0.3 1.3 0.8 1.7 1.3 0.2 1.1 1.0 9.0 0.0 0.5 17.7 17.5 28.0 23.2 14.5 15.9 11.0 15.9 9.2 8.1 6.0 10.1 10.9 40.4 96.7 20.6 40.6 30.6 25.4 18.2 10.4 0.0 0.5 0.0 12.6 4.2 12.7 42.8 0.0 20.1 0.8 10.8 29.9 10.3 41.4 21.3 35.0 99.7 14.7 43.8 2.7 18.4 31.6 10.1 96.4 94.8 31.2 14.0 35.1 37.4 8.4 2.3 64.7 18.6 3.9 3.0 81.1 0.5 8.6 107.7 39.9 CES2 "CE-2, CES2A1, iCE" ENSG00000172831 "Carboxylesterase 2" O00748 16 66934444-66945096 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "esophagus: 46.7;intestine: 146.9;liver: 78.6" "Group enriched" "Detected in many" 4 "Enterocytes: 912.6;Hepatocytes: 449.6;Paneth cells: 448.9;Undifferentiated cells: 459.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA018897 Enhanced Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA 7500000 "Golgi apparatus" "Endoplasmic reticulum, Cytosol" "HPA018897: AB_1846558" "unprognostic (8.15e-3)" "unprognostic (1.82e-2)" "unprognostic (1.32e-1)" "unprognostic (2.67e-3)" "unprognostic (2.74e-2)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (1.31e-1)" "unprognostic (6.93e-2)" "unprognostic (7.99e-2)" "unprognostic (1.73e-3)" "unprognostic (2.66e-2)" "prognostic favorable (1.50e-5)" "unprognostic (8.01e-2)" "unprognostic (1.53e-1)" "unprognostic (4.14e-2)" "unprognostic (1.38e-1)" 5.8 15.3 8.5 8.8 11.7 2.4 5.1 13.0 15.9 9.5 42.3 12.1 11.2 146.9 7.0 11.9 46.7 6.1 14.5 15.2 7.4 6.6 22.5 78.6 6.7 4.6 8.2 10.7 8.4 12.0 10.0 6.8 7.3 10.3 9.7 42.6 13.0 12.7 7.9 11.6 8.9 117.3 10.4 5.6 7.8 10.9 8.5 8.2 9.0 11.7 14.1 12.1 7.6 11.6 6.9 8.9 5.0 10.6 7.9 10.7 5.2 6.9 9.1 9.6 12.8 9.5 8.9 7.3 7.9 12.8 9.3 11.9 9.8 11.5 8.1 7.9 10.3 7.0 18.0 7.0 19.9 7.3 7.2 9.7 7.9 5.2 18.4 13.4 10.4 14.0 12.9 37.7 13.2 22.1 11.5 6.9 5.7 11.1 6.0 15.7 4.4 9.3 8.7 5.2 7.5 9.2 11.0 9.7 9.5 26.4 12.1 6.2 8.2 25.8 6.5 6.7 3.9 11.2 12.9 8.5 12.3 6.5 7.6 5.9 12.0 14.3 9.6 18.9 8.2 9.2 4.7 10.4 4.7 10.1 7.8 9.2 6.1 7.7 10.7 8.9 6.9 9.5 8.6 5.0 7.9 10.6 7.7 6.8 5.2 8.5 11.7 13.0 15.9 7.4 6.6 8.2 10.7 10.3 8.2 29.8 24.0 25.9 13.7 17.3 28.5 25.4 137.6 42.8 12.5 50.6 19.6 13.0 31.5 21.9 1.5 9.8 912.6 0.0 29.5 5.6 12.7 14.5 27.6 449.6 16.6 27.0 23.2 25.2 27.6 1.3 17.3 13.9 10.1 5.4 141.3 17.6 37.9 448.9 17.0 124.1 22.7 32.3 11.3 42.6 10.2 17.9 11.3 18.7 459.3 15.2 CES4A "CES8, FLJ37464" ENSG00000172824 "Carboxylesterase 4A" Q5XG92 16 66988589-67009758 "Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 32.3" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 49.5;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HDLM-2: 19.8" "Not detected" "Not detected" HPA035701 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA035701: AB_10696357" "unprognostic (6.34e-2)" "unprognostic (2.09e-1)" "unprognostic (3.18e-1)" "unprognostic (3.26e-2)" "unprognostic (1.99e-1)" "unprognostic (6.20e-2)" "unprognostic (2.12e-2)" "unprognostic (2.04e-2)" "unprognostic (5.78e-3)" "unprognostic (3.93e-2)" "unprognostic (2.02e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.35e-6)" "unprognostic (1.20e-1)" "unprognostic (2.23e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-3)" 3.2 3.6 12.9 2.4 11.8 2.2 3.6 8.7 13.8 2.6 1.7 8.5 3.5 2.3 1.6 13.0 2.2 32.3 2.0 3.2 9.1 2.6 3.9 11.7 3.1 1.4 5.8 13.7 2.1 3.0 3.3 10.0 2.2 7.2 2.1 1.7 2.1 4.2 3.5 5.8 13.9 2.3 1.4 2.4 1.5 2.3 2.0 9.9 0.0 5.0 1.0 2.0 2.4 1.6 0.9 1.6 0.0 5.0 0.0 1.6 1.3 0.3 1.2 0.1 0.0 1.0 0.9 0.0 0.1 0.4 0.1 0.0 0.0 1.5 0.0 0.1 1.5 0.0 0.7 0.0 0.2 0.0 19.8 0.0 0.0 0.9 0.0 0.1 0.0 4.7 1.6 3.3 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 3.5 0.2 0.0 1.2 0.0 0.2 0.9 0.9 4.3 2.1 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 4.6 1.3 0.0 1.8 0.0 0.0 0.0 2.1 0.0 0.7 3.3 0.9 0.9 1.6 1.1 1.6 0.0 1.2 0.2 0.0 0.0 5.0 1.5 0.4 1.3 12.9 11.8 8.7 13.8 9.1 2.6 5.8 13.7 7.2 9.9 0.0 10.7 2.7 3.8 4.7 21.1 2.7 7.6 49.5 6.8 5.2 13.7 3.5 1.7 0.9 1.4 0.4 4.0 0.0 1.4 0.4 4.1 3.9 9.2 19.7 4.5 0.0 8.6 1.3 3.8 0.8 12.7 2.9 0.0 6.4 1.7 12.1 0.9 5.8 12.0 1.0 16.1 0.0 1.0 27.7 4.8 4.5 3.8 2.9 2.6 4.8 CFAP157 C9orf117 ENSG00000160401 "Cilia and flagella associated protein 157" Q5JU67 9 127706989-127716002 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 348.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 19.8;pons and medulla: 30.2" "Cell type enriched" "Detected in single" 11 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "A549: 9.3;HeLa: 7.6;MCF7: 6.6;SCLC-21H: 6.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA021474, HPA021786" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021474: AB_1845801, HPA021786: AB_1845802" "unprognostic (1.69e-1)" "unprognostic (2.80e-2)" "unprognostic (2.41e-2)" "prognostic favorable (1.45e-4)" "unprognostic (3.02e-1)" "unprognostic (1.58e-1)" "unprognostic (4.71e-3)" "unprognostic (1.49e-1)" "unprognostic (3.14e-4)" "unprognostic (7.72e-2)" "unprognostic (4.93e-4)" "unprognostic (9.32e-3)" "unprognostic (4.95e-3)" "unprognostic (5.71e-4)" "unprognostic (4.34e-2)" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" 0.4 0.4 3.1 0.3 19.8 0.3 0.3 0.1 0.4 5.3 0.3 7.0 1.6 0.2 1.0 24.0 0.8 44.8 0.6 0.4 4.6 5.8 0.4 0.3 6.1 0.4 0.0 0.0 4.4 0.9 0.2 4.4 0.3 30.2 0.4 0.2 0.0 0.5 1.3 0.4 0.6 0.3 0.2 0.5 0.4 0.4 11.5 3.5 0.0 0.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 9.3 0.9 1.2 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.9 1.3 1.4 1.4 0.0 2.3 4.6 0.0 0.0 0.0 3.4 1.1 0.9 7.6 2.3 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.5 0.0 2.8 3.1 0.7 0.0 6.6 1.3 0.5 0.9 1.7 4.9 2.0 0.9 1.5 0.0 0.4 6.4 1.1 1.9 3.6 0.7 0.2 3.2 0.3 1.7 1.9 1.5 5.0 0.8 1.0 2.6 1.2 0.8 0.7 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 19.8 0.1 0.3 4.6 5.8 0.0 0.0 30.2 3.5 8.9 10.9 0.0 0.2 0.0 0.6 0.0 0.0 348.0 51.2 0.0 0.0 0.0 1.7 0.3 44.7 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.3 0.2 0.2 0.0 0.0 0.0 0.3 61.4 0.3 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.7 0.3 0.2 0.0 0.0 11.4 1.1 0.0 0.0 0.0 0.2 0.1 CFAP36 "BARTL1, CCDC104, MGC15407" ENSG00000163001 "Cilia and flagella associated protein 36" Q96G28 2 55519604-55545879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 1061.9;Spermatocytes: 279.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008994, HPA017061" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008994: AB_2275429, HPA017061: AB_1846129" "unprognostic (8.11e-2)" "unprognostic (3.21e-3)" "unprognostic (1.24e-1)" "unprognostic (3.36e-2)" "unprognostic (7.98e-2)" "unprognostic (3.68e-1)" "unprognostic (4.65e-3)" "unprognostic (7.79e-2)" "unprognostic (1.51e-2)" "unprognostic (1.58e-2)" "unprognostic (3.66e-3)" "unprognostic (7.63e-2)" "unprognostic (8.57e-3)" "unprognostic (4.94e-2)" "unprognostic (3.35e-2)" "unprognostic (1.56e-3)" "unprognostic (2.96e-1)" 13.0 22.7 34.6 9.9 46.6 7.3 25.3 16.7 39.4 23.3 16.7 10.2 18.1 7.8 24.4 39.1 12.3 32.7 21.1 15.4 28.6 34.9 32.4 9.1 15.1 11.0 27.7 29.5 29.3 15.8 32.8 47.1 10.6 36.7 22.1 12.1 13.5 10.6 24.6 6.5 8.1 8.4 19.7 19.3 8.8 16.6 66.4 14.4 8.9 39.9 7.7 9.8 21.7 13.3 8.0 6.2 6.3 2.9 5.5 25.2 8.3 18.1 14.3 15.6 20.3 20.6 39.8 9.4 11.4 23.4 17.6 14.7 10.8 6.7 6.5 26.7 14.9 26.4 12.0 12.0 15.9 22.7 15.7 23.8 9.5 14.1 11.2 22.6 17.6 11.9 19.6 25.9 23.8 28.2 46.6 19.5 13.6 12.0 5.4 22.2 13.5 10.6 19.6 7.9 11.8 14.4 8.3 18.5 6.8 35.8 10.2 23.4 11.8 15.5 8.0 21.0 8.4 13.0 6.1 10.0 18.0 11.0 18.6 15.4 9.6 4.4 2.2 30.4 8.0 8.2 6.3 2.1 6.2 9.1 2.3 17.5 8.0 25.2 14.5 2.7 5.2 21.0 12.8 2.4 5.5 2.9 6.2 13.7 8.3 34.6 46.6 16.7 39.4 28.6 34.9 27.7 29.5 36.7 14.4 44.7 27.1 4.3 48.0 0.0 37.3 31.9 35.7 182.0 50.0 33.2 7.9 12.5 77.9 54.5 1061.9 38.3 4.5 0.0 53.7 20.8 26.9 36.9 36.0 7.2 22.4 22.3 16.4 30.1 6.5 151.0 69.6 14.2 0.0 22.6 15.7 95.2 35.5 14.0 63.6 119.5 74.3 58.2 36.3 279.8 29.1 0.0 6.5 20.3 10.7 27.7 CFAP54 "C12orf55, C12orf63, FLJ31514, FLJ44112" ENSG00000188596 "Cilia and flagella associated protein 54" Q96N23 12 96489571-96875555 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7;testis: 15.1" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 65.5;Alveolar cells type 2: 54.7;Ciliated cells: 195.4;Club cells: 78.5" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 16.5;pons and medulla: 30.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 10.8;TIME: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039897 Enhanced Approved Microtubules,Cytosol NA NA Microtubules Cytosol "HPA039897: AB_10674427" "unprognostic (1.87e-4)" "unprognostic (3.63e-2)" "unprognostic (8.07e-2)" "unprognostic (7.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.55e-2)" "unprognostic (2.75e-2)" "unprognostic (2.91e-2)" "unprognostic (6.16e-2)" "unprognostic (8.40e-2)" "unprognostic (2.86e-1)" "unprognostic (2.36e-1)" "unprognostic (3.55e-5)" "unprognostic (2.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.26e-2)" "unprognostic (8.00e-2)" 1.0 0.9 3.4 1.9 16.5 4.5 1.4 1.0 3.4 2.0 1.4 9.5 1.8 2.3 3.3 8.6 1.2 8.9 1.5 0.9 5.3 3.6 1.4 1.5 8.1 1.9 1.3 3.1 3.8 0.7 1.3 11.7 0.9 30.7 1.7 1.5 0.3 1.8 1.9 1.8 2.9 1.5 1.9 1.7 1.9 1.6 15.1 5.2 0.0 2.4 0.5 1.6 1.0 1.1 2.7 1.6 3.7 1.4 1.5 1.7 0.1 1.6 0.8 1.4 1.8 0.8 1.2 1.2 1.4 0.3 0.4 0.6 0.8 2.4 1.4 2.1 0.5 1.3 1.3 0.7 0.4 0.5 2.3 1.0 1.4 3.1 0.8 0.2 2.7 1.7 0.4 0.5 2.0 0.8 2.9 10.8 1.3 0.7 5.0 1.4 0.7 1.2 2.4 2.4 0.6 1.5 1.5 1.5 1.7 3.1 1.9 2.4 1.7 1.3 0.8 1.5 1.6 2.3 0.7 12.9 2.5 3.0 2.2 2.4 5.6 2.4 1.1 1.7 1.2 1.7 3.7 1.4 1.4 1.7 0.9 1.4 1.4 1.3 1.3 0.4 2.7 1.6 1.5 3.7 1.5 1.1 1.6 1.0 0.1 3.4 16.5 1.0 3.4 5.3 3.6 1.3 3.1 30.7 5.2 65.5 54.7 0.9 0.2 0.0 3.0 0.8 0.0 195.4 78.5 0.0 21.6 0.2 0.0 0.0 22.0 1.6 0.0 0.0 0.0 0.2 0.3 0.2 34.9 0.0 0.2 0.0 1.2 0.0 0.6 12.3 0.3 0.0 0.0 0.0 0.0 10.9 0.2 0.0 0.0 0.0 7.8 0.0 0.0 11.1 6.9 0.0 0.0 0.0 0.0 0.3 CFAP57 "FLJ32000, WDR65" ENSG00000243710 "Cilia and flagella associated protein 57" Q96MR6 1 43172149-43254358 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.6;testis: 29.2" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 156.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 12.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 6.9;HDLM-2: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002736, HPA028623" Enhanced Approved Cytosol NA NA Cytosol "HPA002736: AB_2272982, HPA028623: AB_10603234" "unprognostic (1.15e-2)" "unprognostic (2.29e-3)" "unprognostic (2.16e-1)" "prognostic favorable (6.02e-4)" "unprognostic (2.50e-2)" "unprognostic (3.71e-1)" "unprognostic (2.42e-2)" "unprognostic (1.02e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (2.05e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-2)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-2)" "unprognostic (7.78e-2)" 0.4 0.4 1.6 0.3 6.7 0.2 0.6 0.1 1.8 1.6 0.3 4.2 0.0 0.3 1.0 9.1 0.4 25.6 0.5 0.4 3.6 2.7 1.5 2.7 4.7 0.2 0.3 1.4 7.1 0.9 0.4 5.9 0.5 12.7 0.7 0.3 0.3 0.5 0.5 0.4 0.9 0.3 0.3 0.4 0.2 0.4 29.2 0.4 0.0 1.9 0.0 0.3 0.5 0.2 3.2 2.4 0.7 4.8 1.2 1.5 1.4 2.9 1.0 0.8 0.6 0.2 0.2 0.9 1.1 1.8 1.4 1.4 0.9 1.2 0.3 1.3 2.4 0.8 6.9 0.4 0.9 2.6 4.5 0.2 0.4 0.6 0.6 0.5 0.0 0.3 0.2 1.2 1.1 0.4 1.9 2.0 0.4 0.2 0.1 0.2 0.1 0.3 0.3 1.4 0.2 0.1 0.4 1.0 0.2 3.0 0.5 1.2 0.5 1.4 0.2 1.1 0.8 1.7 0.5 3.9 0.2 1.5 0.7 0.8 0.4 0.6 0.3 0.3 0.8 0.9 0.5 1.1 0.7 1.4 2.0 1.4 2.2 1.4 1.2 2.4 3.2 1.3 1.3 0.0 1.2 4.8 1.9 1.5 1.4 1.6 6.7 0.1 1.8 3.6 2.7 0.3 1.4 12.7 0.4 6.0 0.3 0.0 0.1 0.0 0.4 0.4 0.0 156.6 10.3 0.0 5.9 0.8 0.0 0.3 22.1 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.1 1.6 0.0 0.6 0.0 21.6 0.9 0.0 0.0 3.6 0.0 0.5 0.2 0.0 0.7 1.4 0.8 0.0 0.0 18.7 3.3 0.0 0.0 0.0 0.0 0.1 CFAP58 "bA554P13.1, C10orf80, CCDC147, FLJ35908" ENSG00000120051 "Cilia and flagella associated protein 58" Q5T655 10 104353764-104455090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 10.9;testis: 17.5" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 104.4;Early spermatids: 40.7;Late spermatids: 47.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 6.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 55 "granulocytes: 5.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.2;U-2 OS: 10.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036555, HPA071938" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA036555: AB_10673622, HPA071938: " "unprognostic (5.32e-1)" "unprognostic (2.59e-1)" "unprognostic (6.26e-2)" "unprognostic (1.57e-3)" "unprognostic (5.41e-3)" "unprognostic (1.01e-1)" "unprognostic (9.62e-2)" "unprognostic (5.64e-2)" "unprognostic (3.11e-1)" "unprognostic (2.18e-1)" "unprognostic (8.93e-2)" "unprognostic (3.15e-1)" "unprognostic (1.65e-1)" "unprognostic (3.97e-2)" "unprognostic (6.81e-2)" "unprognostic (4.19e-2)" "unprognostic (1.59e-1)" 0.3 0.5 0.8 0.6 2.0 0.4 0.3 0.7 1.0 3.0 0.3 2.9 0.3 0.1 2.3 0.3 0.3 10.9 0.3 3.0 1.4 1.5 0.3 0.3 2.1 0.3 0.3 0.3 2.0 0.3 1.5 1.9 0.4 6.8 0.4 0.0 0.6 0.3 0.4 1.4 0.2 0.3 0.8 0.3 0.3 0.1 17.5 0.7 0.3 0.8 0.3 0.4 0.3 0.7 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.2 0.6 0.2 1.7 5.2 1.0 2.8 0.0 0.0 4.0 0.4 0.6 3.0 0.3 0.0 0.3 3.2 0.4 0.2 0.9 1.2 0.0 0.6 0.5 0.7 0.6 2.2 0.8 2.8 2.2 1.7 0.1 1.1 1.2 1.4 0.0 0.0 1.1 0.3 0.0 0.0 0.4 0.3 0.5 0.6 0.0 0.6 0.4 0.0 0.2 0.9 1.2 0.3 0.6 3.4 1.1 10.9 0.6 3.0 0.4 0.1 0.2 1.2 1.3 3.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.8 2.0 0.7 1.0 1.4 1.5 0.3 0.3 6.8 0.7 0.0 0.3 0.0 0.1 0.0 0.0 6.1 0.0 104.4 17.0 0.0 0.0 0.1 0.0 0.2 40.7 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.1 0.0 47.0 0.6 0.0 0.0 0.0 0.0 0.6 0.4 0.0 1.1 0.0 0.3 0.0 0.6 14.9 1.9 0.0 0.1 0.0 0.0 0.1 CFAP65 "CCDC108, DKFZp434O0527, MGC35338" ENSG00000181378 "Cilia and flagella associated protein 65" Q6ZU64 2 219002846-219041527 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.3;fallopian tube: 29.2;testis: 20.4" "Group enriched" "Detected in many" 4 "Ciliated cells: 53.5;Early spermatids: 163.7;Late spermatids: 138.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.1" "Region enhanced" "Detected in many" "pons and medulla: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.4;SCLC-21H: 1.5;SH-SY5Y: 4.0;U-87 MG: 2.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 13.1" "HPA055156, HPA063406" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA055156: AB_2682720, HPA063406: " "unprognostic (3.95e-2)" "unprognostic (1.80e-1)" "unprognostic (9.88e-3)" "prognostic favorable (6.08e-5)" "unprognostic (2.18e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-1)" "unprognostic (3.76e-3)" "unprognostic (3.71e-1)" "unprognostic (3.03e-1)" "unprognostic (5.58e-3)" "unprognostic (1.43e-1)" "unprognostic (6.62e-3)" "unprognostic (8.04e-2)" "unprognostic (2.81e-2)" "unprognostic (9.60e-2)" "unprognostic (6.60e-2)" 0.2 0.4 1.8 0.3 6.4 0.3 0.3 0.0 2.1 2.2 0.4 5.4 0.3 0.3 0.9 6.0 0.2 29.2 0.6 0.2 2.9 3.2 0.5 0.2 3.6 0.3 0.4 1.2 4.2 0.6 0.3 6.1 0.2 16.3 0.3 0.5 2.8 0.4 0.4 0.2 0.2 0.7 0.2 0.6 0.3 0.6 20.4 2.5 0.0 1.3 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.5 0.0 1.1 0.2 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 2.4 0.1 0.0 0.0 0.0 1.2 0.0 1.5 4.0 0.0 0.1 0.7 0.6 1.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.8 6.4 0.0 2.1 2.9 3.2 0.4 1.2 16.3 2.5 0.0 3.4 0.0 0.1 0.0 0.7 0.0 7.6 53.5 12.5 0.0 11.8 0.0 0.0 0.4 163.7 0.0 0.5 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.1 0.0 28.1 0.0 0.0 138.9 0.6 0.0 0.0 0.0 25.9 0.8 1.4 0.0 0.7 0.9 20.7 0.0 0.0 15.4 4.1 0.0 0.0 0.0 3.4 0.0 CFAP77 "C9orf171, FLJ46082" ENSG00000188523 "Cilia and flagella associated protein 77" Q6ZQR2 9 132410043-132573317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 30.9;testis: 22.0" "Group enriched" "Detected in some" 6 "Ciliated cells: 66.9;Early spermatids: 92.0;Late spermatids: 37.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 5.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.8;SH-SY5Y: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021329, HPA024647, HPA061069" Enhanced Approved Cytosol NA NA Cytosol "HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657" "unprognostic (7.28e-4)" "unprognostic (5.68e-2)" "unprognostic (5.25e-2)" "prognostic favorable (7.31e-4)" "unprognostic (1.70e-2)" "unprognostic (1.74e-1)" "unprognostic (3.01e-1)" "unprognostic (2.31e-2)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (1.77e-1)" "unprognostic (2.41e-3)" "unprognostic (2.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (7.95e-2)" 0.2 0.2 1.6 0.2 4.5 0.2 0.2 1.6 0.3 1.6 0.2 8.4 0.0 0.2 0.7 8.8 0.2 30.9 0.2 4.2 2.5 2.5 0.2 0.2 5.5 0.2 0.1 0.0 9.7 0.3 0.2 1.7 0.2 8.9 0.2 0.2 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 22.0 1.6 0.0 0.3 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.4 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.8 0.0 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.2 1.8 6.6 0.0 0.0 0.0 0.5 0.3 0.0 0.6 1.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.5 1.6 0.1 2.5 2.5 0.1 0.0 8.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.9 5.7 0.0 0.0 0.0 0.0 0.0 92.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.5 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 2.4 0.0 0.0 10.7 2.3 0.0 0.1 0.0 0.0 0.0 CFL1 CFL ENSG00000172757 "Cofilin 1" P23528 11 65823022-65862026 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 3975.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013086, CAB033687, CAB037077, HPA053761" Approved Supported Cytosol NA NA 470000000 Cytosol "CAB013086: AB_2533565, CAB033687: AB_1121774, CAB037077: AB_1078547, HPA053761: AB_2682251" "unprognostic (1.14e-1)" "unprognostic (2.37e-2)" "unprognostic (7.69e-3)" "unprognostic (4.32e-3)" "unprognostic (3.14e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.59e-3)" "unprognostic (2.52e-1)" "unprognostic (5.88e-3)" "unprognostic (6.57e-3)" "unprognostic (2.09e-1)" "unprognostic (6.19e-3)" "unprognostic (1.72e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.06e-1)" 95.5 58.2 107.4 126.1 98.4 164.2 64.2 88.0 157.9 60.6 162.4 100.1 42.3 167.5 95.9 54.2 89.3 63.7 90.1 60.0 112.0 88.7 98.3 136.6 86.3 128.0 93.3 66.0 57.0 35.0 49.5 47.2 86.0 94.3 56.6 146.0 54.6 60.7 73.0 37.3 63.1 194.0 119.7 104.7 148.2 90.3 43.7 66.6 185.1 54.1 70.8 150.2 78.9 59.0 93.6 199.7 167.7 182.9 108.6 160.6 310.0 149.1 120.9 137.2 106.8 84.6 87.4 72.8 154.1 141.6 181.6 108.9 68.9 128.8 110.5 122.2 204.5 124.0 115.1 99.3 147.5 136.1 115.3 45.7 143.0 93.3 77.3 90.0 123.6 205.5 96.2 104.0 154.0 80.2 106.6 193.3 70.6 63.3 117.3 191.3 141.8 185.5 203.3 146.7 139.5 92.7 137.9 63.5 148.8 135.4 97.6 65.2 145.2 82.1 124.4 116.1 80.3 148.5 98.7 155.1 150.6 115.2 190.2 146.3 84.7 130.1 149.6 155.6 78.6 140.7 85.0 154.1 165.2 160.6 172.7 125.1 93.6 128.8 144.9 199.7 88.9 96.6 126.1 167.7 108.6 182.9 152.3 155.9 310.0 107.4 98.4 88.0 157.9 112.0 88.7 93.3 66.0 94.3 66.6 229.3 264.2 803.2 1036.2 1198.6 195.6 68.1 463.7 159.3 188.8 493.7 55.0 1193.4 756.0 1960.0 391.6 649.3 1740.8 140.2 1718.7 2033.8 752.0 677.1 583.2 411.8 2593.2 192.3 748.0 687.5 1170.3 280.2 326.2 1493.8 934.6 3975.7 1283.0 362.3 2224.1 1460.5 472.7 935.3 92.2 413.9 796.3 147.3 358.7 1107.9 1448.8 1231.5 1117.5 1121.8 CFL2 NEM7 ENSG00000165410 "Cofilin 2" Q9Y281 14 34706769-34714823 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 88.5;skeletal muscle: 185.9" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 498.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037078, HPA045599" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 90000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB037078: AB_259128, HPA045599: AB_2679383" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.02e-2)" "unprognostic (2.80e-3)" "unprognostic (3.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.48e-2)" "unprognostic (1.27e-1)" "unprognostic (1.65e-2)" "unprognostic (3.13e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (2.16e-5)" 14.0 16.5 15.9 8.8 17.7 5.0 6.7 13.6 16.6 13.7 23.2 25.8 9.2 4.7 21.3 10.2 20.7 11.2 7.2 88.5 19.0 14.5 8.7 33.0 7.8 3.7 22.7 10.6 12.9 3.0 9.3 4.5 10.3 28.9 22.4 8.6 7.8 5.4 31.8 185.9 2.6 6.7 38.1 24.6 4.2 11.9 6.9 20.1 0.5 9.0 30.8 3.4 34.7 9.3 8.5 2.9 3.6 1.8 3.2 5.8 1.6 17.8 16.1 10.4 6.7 10.6 39.5 5.8 31.2 36.0 29.9 31.9 12.1 7.7 6.4 12.8 49.7 22.4 3.5 22.1 6.6 52.7 0.9 9.2 1.3 19.1 28.6 17.3 1.6 1.0 29.9 2.3 25.5 14.1 21.0 29.6 0.9 2.0 5.1 36.7 5.0 1.3 0.9 3.4 3.1 24.8 1.1 32.9 1.0 10.8 3.7 2.1 8.9 20.3 4.4 10.5 8.0 9.7 1.6 26.0 29.8 19.8 14.0 14.9 7.1 4.6 2.4 10.9 2.4 7.0 3.6 1.8 2.1 3.7 1.8 5.8 8.5 4.3 4.0 2.9 5.0 3.4 3.5 0.7 3.2 0.8 2.8 3.6 1.6 15.9 17.7 13.6 16.6 19.0 14.5 22.7 10.6 28.9 20.1 98.3 34.5 15.9 86.3 17.7 51.4 498.3 15.3 6.7 14.8 21.0 19.6 25.2 51.4 41.2 2.2 46.0 0.9 0.0 34.0 52.6 52.9 52.5 5.7 99.2 13.2 73.1 9.1 43.6 14.0 6.5 52.9 10.4 28.7 7.2 3.4 80.2 30.0 4.2 92.6 79.1 57.2 32.3 125.1 51.4 51.5 16.9 17.8 14.9 3.7 53.3 CFLAR "c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT" ENSG00000003402 "CASP8 and FADD like apoptosis regulator" O15519 2 201116104-201176687 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 475.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 79.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 79.2" "Cell line enhanced" "Detected in all" "U-266/70: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019044, CAB022157, CAB025216" Uncertain Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "Nuclear bodies" "CAB022157: , CAB025216: , HPA019044: AB_10696204" "unprognostic (4.61e-2)" "unprognostic (5.32e-2)" "unprognostic (2.49e-1)" "unprognostic (1.44e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.79e-4)" "unprognostic (7.46e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (3.08e-2)" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (7.83e-2)" "unprognostic (9.13e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-2)" 35.4 17.6 13.7 29.8 17.4 66.8 31.6 26.9 12.6 20.5 25.7 13.5 31.3 17.5 24.7 27.6 21.0 19.2 22.1 58.1 14.7 7.7 24.9 18.9 58.5 34.3 16.8 8.9 14.6 14.3 9.1 18.7 28.3 12.6 23.2 17.7 20.9 21.8 27.4 113.7 16.7 26.8 30.5 13.8 35.7 19.4 10.9 14.8 17.2 31.2 26.2 31.4 24.1 33.7 5.3 6.6 79.2 12.6 8.7 11.8 7.8 5.2 10.7 7.7 4.5 24.0 18.4 9.5 13.3 23.3 8.8 10.8 12.4 19.7 1.4 12.7 15.5 10.7 3.9 2.4 10.1 14.1 39.4 7.5 7.9 9.2 20.1 16.7 5.9 26.3 20.0 10.0 14.9 13.1 10.8 44.7 1.8 26.7 33.2 16.0 4.4 2.7 23.5 2.6 4.2 8.2 2.8 1.9 11.3 11.0 10.8 1.7 3.1 9.0 7.9 10.5 5.4 5.6 11.0 48.4 18.5 7.7 6.8 6.5 55.3 18.2 8.9 13.1 4.8 9.1 16.3 12.1 13.5 11.7 12.3 10.3 5.3 10.1 11.0 6.6 4.0 6.4 8.3 79.2 8.7 12.6 4.6 11.8 7.8 13.7 17.4 26.9 12.6 14.7 7.7 16.8 8.9 12.6 14.8 419.9 201.2 84.2 185.4 48.7 8.5 172.6 96.8 283.7 216.1 66.3 29.5 63.9 63.0 138.6 55.5 265.4 108.1 23.3 63.2 34.2 70.8 195.5 77.6 86.3 61.3 12.7 91.3 184.1 115.5 33.0 48.1 149.2 92.8 261.5 56.6 31.3 121.1 80.7 46.7 84.8 29.0 38.8 55.6 14.4 10.1 75.3 58.6 209.9 41.3 475.0 CGAS "C6orf150, cGAS, MB21D1" ENSG00000164430 "Cyclic GMP-AMP synthase" Q8N884 6 73413515-73452276 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity" "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 32.0" "Cell type enriched" "Detected in some" 4 "monocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 18.6;RH-30: 21.5;RPMI-8226: 22.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA031700, HPA031702" Enhanced Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite" Cytosol "HPA031700: AB_10601693, HPA031702: AB_2673999" "unprognostic (2.49e-1)" "unprognostic (2.36e-1)" "unprognostic (4.61e-2)" "unprognostic (4.95e-2)" "unprognostic (2.49e-2)" "unprognostic (1.81e-1)" "unprognostic (4.84e-3)" "unprognostic (1.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.25e-2)" "unprognostic (2.20e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.27e-7)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-1)" 6.5 2.0 2.9 10.5 4.5 18.5 8.1 1.2 3.9 4.7 3.7 3.4 2.1 4.1 5.5 2.8 5.3 3.9 4.3 3.2 2.8 2.9 2.5 1.9 9.6 11.8 7.2 0.6 3.4 3.8 2.3 1.8 4.8 4.4 6.6 3.1 2.2 4.2 2.9 1.9 1.8 5.2 3.6 4.7 12.8 3.5 1.7 4.3 6.2 3.9 4.2 15.5 6.6 32.0 6.3 12.5 13.3 12.9 3.0 6.0 3.9 8.9 3.0 0.1 0.1 0.6 1.3 0.0 4.5 1.9 5.9 6.5 9.9 6.8 0.1 9.8 2.1 3.2 4.6 5.0 0.0 6.3 14.9 0.0 7.8 3.8 0.0 2.1 6.0 5.5 0.9 1.6 5.8 0.0 0.0 1.8 0.0 0.0 18.6 4.3 3.7 0.0 13.6 2.9 1.1 5.5 11.6 21.5 22.6 0.0 3.7 0.1 0.0 7.9 0.2 4.7 0.1 0.0 16.2 2.1 0.0 4.3 3.9 0.1 4.0 8.8 0.1 0.0 8.6 5.9 13.3 9.2 13.2 4.6 12.9 3.6 6.3 6.0 4.6 5.4 4.8 1.4 2.6 5.8 3.0 7.8 12.5 5.8 3.9 2.9 4.5 1.2 3.9 2.8 2.9 7.2 0.6 4.4 4.3 3.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 3.5 0.6 0.0 0.0 4.7 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 47.7 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CGB1 ENSG00000267631 "Chorionic gonadotropin beta subunit 1" A6NKQ9 19 49035610-49036895 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "pancreas: 8.4" "Cell type enriched" "Detected in single" 125 "Syncytiotrophoblasts: 58.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HMC-1: 20.5" "HPA038925, HPA038934" Uncertain Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.9 0.0 0.1 0.1 0.0 0.0 0.5 0.3 4.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.5 0.0 0.0 0.0 CGB2 ENSG00000104818 "Chorionic gonadotropin beta subunit 2" 19 49031912-49033238 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.1;testis: 4.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 33.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 25.4;U-266/70: 10.2;U-266/84: 12.3" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.05e-2)" 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 1.1 1.0 0.9 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.1 1.4 0.4 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.3 4.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 3.4 0.0 0.4 0.0 0.0 0.1 0.0 25.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.7 0.0 3.0 10.2 12.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 6.5 0.0 0.5 1.1 0.0 33.4 0.0 0.0 0.0 CGB3 CGB ENSG00000104827 "Chorionic gonadotropin beta subunit 3" P0DN86 19 49022869-49024333 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 6.7;placenta: 15.0" "Cell type enriched" "Detected in some" 38 "Syncytiotrophoblasts: 724.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9;testis cancer: 4.2" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Cell line enriched" "Detected in some" 20 "BEWO: 39.7" "CAB000042, CAB010884, HPA038925, HPA038934" Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (1.39e-1)" "unprognostic (7.88e-2)" "unprognostic (6.92e-2)" "unprognostic (1.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 6.7 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 1.3 0.5 0.0 0.0 0.1 0.2 0.0 1.9 0.7 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 724.1 0.0 0.0 0.0 CGB5 HCG ENSG00000189052 "Chorionic gonadotropin beta subunit 5" P0DN86 19 49043884-49045311 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 105.2" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 16.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "BEWO: 46.9;U-251 MG: 21.3" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (1.38e-1)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "prognostic unfavorable (1.18e-5)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.47e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 12.7 105.2 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.2 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.0 21.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 CGB7 CG-beta-a ENSG00000196337 "Chorionic gonadotropin beta subunit 7" P0DN87 19 49054275-49058860 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 8.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;HaCaT: 5.7;HBEC3-KT: 4.8;hTCEpi: 6.9;U-251 MG: 10.4" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (9.53e-2)" "unprognostic (1.99e-1)" "unprognostic (1.87e-1)" "unprognostic (3.53e-1)" "unprognostic (4.60e-5)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (8.37e-2)" "unprognostic (2.88e-2)" "unprognostic (4.80e-2)" "unprognostic (8.83e-4)" "unprognostic (1.54e-1)" "unprognostic (3.89e-8)" "unprognostic (1.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.05e-1)" "unprognostic (9.28e-2)" 0.3 0.2 0.3 0.3 0.3 0.0 0.8 0.3 1.5 1.7 0.3 0.3 3.7 0.3 1.2 0.5 4.0 1.0 2.0 2.0 0.4 0.2 1.0 0.3 0.8 0.3 0.3 0.3 0.9 2.5 0.0 2.7 3.7 1.3 4.6 0.0 0.8 1.3 3.9 6.4 8.1 0.3 0.3 0.3 0.3 0.0 1.5 0.3 0.3 0.9 2.2 0.3 2.4 2.7 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.8 0.2 1.5 0.0 0.2 7.1 0.6 0.0 1.4 1.2 1.2 2.6 0.0 0.1 1.3 2.1 5.7 0.2 4.8 0.5 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.4 6.9 0.4 0.7 1.6 0.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.0 0.1 0.1 1.4 0.1 0.1 1.7 1.0 0.2 0.2 2.3 2.3 0.0 10.4 0.3 0.4 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.3 1.5 0.4 0.2 0.3 0.3 1.3 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 49.1 0.0 0.0 0.0 CGB8 ENSG00000213030 "Chorionic gonadotropin beta subunit 8" P0DN86 19 49047638-49049106 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 85 "pituitary gland: 7.0;placenta: 22.2" "Cell type enriched" "Detected in some" 15 "Syncytiotrophoblasts: 37.1" "Cancer enhanced" "Detected in some" "testis cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 61.9;U-251 MG: 21.5" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.35e-2)" "unprognostic (1.72e-1)" "unprognostic (7.44e-3)" "unprognostic (4.70e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 22.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.3 1.4 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.9 0.0 0.2 0.0 1.2 2.6 0.2 21.5 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 CHAC2 GCG1 ENSG00000143942 "ChaC cation transport regulator homolog 2" Q8WUX2 2 53767792-53775196 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049235 Approved Approved Cytosol NA NA Cytosol "HPA049235: AB_2680686" "unprognostic (2.22e-1)" "unprognostic (1.31e-1)" "unprognostic (2.11e-2)" "unprognostic (3.91e-3)" "unprognostic (1.61e-2)" "unprognostic (4.74e-3)" "prognostic unfavorable (3.80e-7)" "unprognostic (5.52e-2)" "unprognostic (1.74e-2)" "unprognostic (1.30e-2)" "unprognostic (1.36e-2)" "unprognostic (3.09e-2)" "unprognostic (4.28e-6)" "unprognostic (1.52e-1)" "unprognostic (1.79e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-1)" 7.2 8.6 6.5 7.1 6.2 9.3 3.6 4.3 4.4 2.6 6.8 2.1 7.7 11.4 2.4 4.4 8.4 1.8 5.3 10.3 6.2 6.1 8.3 9.8 3.4 9.6 5.0 4.2 1.8 4.8 1.5 6.7 1.7 6.9 2.8 6.1 2.8 4.1 4.6 9.8 2.0 9.0 3.5 4.8 10.2 7.0 16.4 3.7 9.5 3.7 4.2 9.8 5.7 5.1 6.6 2.5 1.8 0.9 1.4 6.7 3.0 19.1 6.4 6.8 6.0 3.4 1.7 1.4 8.8 1.8 6.3 7.5 4.4 4.9 16.3 12.9 3.8 9.5 6.9 15.4 10.5 11.1 34.3 13.4 12.9 8.6 7.2 5.2 15.2 5.9 2.1 3.1 11.7 8.9 1.7 12.3 11.3 13.2 9.6 8.3 6.2 18.0 12.7 8.8 8.3 11.5 13.8 14.5 16.5 8.7 5.2 8.5 2.4 10.2 7.6 4.0 4.3 4.6 6.0 5.4 3.7 13.3 14.2 14.2 9.6 12.3 13.9 5.0 19.2 5.1 1.8 0.5 1.1 5.2 0.9 5.5 6.6 5.7 5.8 1.1 5.4 6.7 6.1 1.4 1.4 0.7 2.5 5.1 3.0 6.5 6.2 4.3 4.4 6.2 6.1 5.0 4.2 6.9 3.7 0.0 1.4 11.5 2.8 3.1 0.8 2.8 5.1 1.4 2.3 1.8 0.0 1.7 10.0 5.8 5.3 3.7 2.6 0.0 7.1 0.7 1.6 2.9 1.1 7.5 6.6 1.6 0.0 2.5 1.0 1.7 2.6 2.8 3.3 8.2 3.4 3.3 6.4 0.0 3.9 5.6 5.5 0.0 3.4 26.1 5.1 3.0 0.3 6.9 9.2 3.9 CHAF1A "CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150" ENSG00000167670 "Chromatin assembly factor 1 subunit A" Q13111 19 4402662-4445018 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 46.7;Spermatocytes: 48.8;Spermatogonia: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.2" "Group enriched" "Detected in many" 4 "dendritic cells: 15.2;granulocytes: 4.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015186 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB015186: AB_628065" "unprognostic (1.91e-1)" "prognostic favorable (8.22e-5)" "unprognostic (2.49e-1)" "unprognostic (4.71e-2)" "unprognostic (2.06e-1)" "unprognostic (1.89e-3)" "unprognostic (5.30e-3)" "unprognostic (8.78e-2)" "unprognostic (2.06e-2)" "unprognostic (2.12e-2)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.54e-2)" "prognostic favorable (4.15e-6)" "unprognostic (1.71e-1)" "unprognostic (2.11e-3)" "unprognostic (4.03e-2)" 5.3 5.3 6.3 14.6 7.3 28.2 5.3 12.6 8.8 4.7 7.2 4.9 8.6 6.9 4.7 5.1 11.5 4.7 5.2 4.0 6.1 3.9 3.0 4.5 4.6 13.3 5.5 5.6 4.6 4.4 3.3 4.3 7.5 5.4 6.5 7.2 4.1 7.8 8.1 12.2 11.3 7.0 6.8 4.8 8.2 5.6 20.4 4.9 27.8 3.3 9.8 11.5 6.7 5.9 1.7 15.2 4.3 2.4 1.0 0.8 0.9 21.4 14.7 24.5 15.4 2.4 3.0 12.6 20.4 8.4 17.3 19.6 17.8 7.7 33.1 8.5 6.5 9.8 16.9 20.9 13.9 20.5 19.0 22.9 20.6 21.9 14.0 1.2 23.8 16.8 1.7 2.9 14.2 6.1 3.2 8.1 18.5 24.8 30.0 10.6 12.4 38.4 13.3 27.3 11.0 12.2 28.6 19.4 18.9 4.5 25.6 17.4 13.5 14.0 9.9 8.1 16.1 8.7 17.8 5.8 14.3 12.5 24.2 24.7 15.1 22.3 31.8 12.0 30.7 16.8 2.9 2.3 4.3 0.5 2.4 0.4 1.7 0.6 0.1 2.0 0.8 0.6 0.4 1.2 1.0 0.4 15.2 0.8 0.9 6.3 7.3 12.6 8.8 6.1 3.9 5.5 5.6 5.4 4.9 0.0 4.6 11.2 5.5 8.7 12.5 5.0 2.5 5.3 2.3 5.2 2.0 15.4 1.7 5.7 5.6 3.3 3.8 46.7 5.9 33.8 3.7 3.9 2.3 3.9 10.3 1.6 1.7 2.5 2.8 5.3 2.8 8.7 1.7 12.6 6.2 5.0 5.1 0.0 3.5 2.1 8.4 32.3 3.4 48.8 120.2 13.0 12.2 5.7 10.0 4.1 CHD5 ENSG00000116254 "Chromodomain helicase DNA binding protein 5" Q8TDI0 1 6101793-6180123 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.4;pituitary gland: 22.3;testis: 16.4" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 60.3;Early spermatids: 202.3;Horizontal cells: 212.9;Late spermatids: 67.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 17.0;U-2 OS: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015809 Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA015809: " "unprognostic (5.03e-4)" "unprognostic (1.89e-1)" "unprognostic (2.47e-3)" "unprognostic (9.40e-6)" "unprognostic (1.91e-2)" "unprognostic (2.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.95e-2)" "unprognostic (6.64e-4)" "unprognostic (1.34e-1)" "unprognostic (1.34e-4)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" 1.1 7.9 19.8 1.3 17.1 1.0 1.0 12.1 41.4 1.2 1.4 0.7 0.0 1.3 1.2 1.2 1.5 1.2 1.2 1.6 15.3 10.1 1.3 1.0 1.2 1.0 4.3 19.1 1.1 1.4 1.3 22.3 1.0 8.0 1.9 1.3 2.3 1.2 4.8 1.2 1.0 1.4 1.2 1.6 1.1 1.2 16.4 0.8 0.0 1.0 0.0 1.0 1.1 0.4 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.2 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 1.5 0.0 0.1 0.3 1.3 0.0 0.0 0.0 0.0 17.0 0.2 0.2 0.0 0.0 0.0 2.9 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.8 17.1 12.1 34.2 15.3 10.1 4.3 19.1 8.0 0.8 0.0 0.0 0.0 0.0 0.1 60.3 1.7 0.0 0.0 0.0 3.5 11.8 0.0 0.0 0.0 202.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 212.9 0.0 0.0 0.0 67.4 0.9 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.4 0.0 48.3 0.0 0.9 3.4 17.0 0.4 0.0 0.0 0.0 0.0 CHD9 "BC022889, FLJ12178, KIAA0308" ENSG00000177200 "Chromodomain helicase DNA binding protein 9" Q3L8U1 16 53055033-53329150 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Cone photoreceptor cells: 473.2;Rod photoreceptor cells: 752.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 42.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042053, HPA049420, HPA066155" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: " "unprognostic (3.57e-2)" "unprognostic (3.73e-2)" "unprognostic (3.44e-3)" "unprognostic (2.42e-1)" "unprognostic (4.34e-2)" "unprognostic (4.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.68e-1)" "unprognostic (7.75e-3)" "unprognostic (2.87e-2)" "unprognostic (3.39e-1)" "unprognostic (2.35e-2)" "prognostic favorable (1.84e-4)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (5.09e-2)" "unprognostic (2.87e-1)" 18.0 12.6 14.5 12.5 17.3 30.3 15.7 49.3 19.6 18.5 13.8 6.6 17.4 8.0 14.2 15.0 14.4 13.5 11.6 12.2 15.9 8.2 16.8 12.3 12.3 9.2 16.0 12.3 18.8 12.9 28.1 39.9 12.3 15.1 13.7 11.5 8.9 17.8 15.3 17.1 14.4 11.1 11.6 20.1 11.6 13.4 7.0 18.7 15.6 17.7 11.2 9.4 13.9 15.1 16.4 42.9 23.7 12.7 12.1 8.8 1.7 5.8 6.8 15.2 12.3 11.3 16.6 2.6 10.7 7.9 5.7 2.5 3.7 5.2 7.8 7.0 8.8 3.9 7.1 7.9 5.6 8.0 2.7 5.9 11.0 6.5 2.4 7.9 15.2 9.2 11.5 5.6 8.3 10.5 7.6 8.4 4.4 12.9 2.6 7.1 2.3 7.6 3.5 5.5 1.7 5.2 26.8 18.2 3.3 3.4 5.5 6.4 7.2 9.5 3.1 7.9 5.7 3.4 7.0 16.2 10.7 5.4 3.9 7.1 8.1 5.6 13.6 7.6 6.6 10.5 23.7 9.2 8.9 5.7 7.6 8.8 12.5 3.9 6.2 5.4 16.4 3.1 4.4 3.0 12.1 12.7 42.9 1.9 1.7 14.5 17.3 49.3 19.6 15.9 8.2 16.0 12.3 15.1 18.7 65.5 56.6 64.3 103.8 50.8 251.0 33.9 43.3 68.3 67.1 85.5 473.2 14.5 39.7 49.7 11.6 77.2 66.9 46.7 32.4 24.2 77.4 86.0 91.5 61.4 61.8 208.2 84.2 88.4 58.8 14.5 100.4 67.6 64.1 74.9 67.1 159.3 29.5 60.4 116.0 47.5 752.2 58.2 73.1 79.9 36.0 65.6 20.8 48.9 69.8 73.2 CHIC1 BRX ENSG00000204116 "Cysteine rich hydrophobic domain 1" Q5VXU3 X 73563200-73687102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA052062" Uncertain Approved "Nuclear speckles,Vesicles,Cytosol" NA NA "Nuclear speckles, Vesicles" Cytosol "HPA026782: AB_1846654, HPA052062: AB_2681714" "unprognostic (9.85e-3)" "unprognostic (3.91e-2)" "unprognostic (3.10e-2)" "unprognostic (9.95e-2)" "unprognostic (6.22e-2)" "unprognostic (1.91e-1)" "unprognostic (1.57e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-3)" "unprognostic (2.65e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.37e-2)" "unprognostic (2.19e-1)" "unprognostic (3.51e-1)" "unprognostic (2.76e-2)" 5.6 13.9 11.0 7.1 16.3 1.5 7.5 14.7 17.6 14.6 8.2 8.5 7.7 4.7 11.1 7.9 5.1 8.7 9.2 10.3 11.7 13.2 12.4 3.4 5.6 7.2 11.2 13.8 11.8 4.1 13.3 18.2 4.4 16.8 9.9 8.6 6.8 5.1 13.0 4.6 6.0 5.9 10.7 15.4 7.7 4.9 3.3 12.5 3.7 12.8 2.6 6.8 7.4 10.1 1.1 0.2 1.0 0.3 1.2 3.0 0.6 4.0 4.2 2.1 2.7 6.1 8.3 0.0 4.6 6.1 3.8 4.6 2.8 5.2 1.9 6.4 4.1 7.5 1.2 3.0 2.2 8.4 4.7 3.7 2.8 3.4 0.0 3.9 0.0 5.5 5.7 2.7 7.1 3.8 4.8 5.3 1.9 0.7 18.5 7.3 0.6 1.6 0.0 6.6 0.0 4.1 1.6 5.4 1.2 4.7 2.0 1.2 1.7 5.2 2.5 5.5 3.8 2.0 1.1 6.2 4.4 4.2 8.6 2.8 5.2 13.0 0.0 6.4 3.0 3.3 1.0 0.1 0.0 1.9 0.1 3.0 1.1 1.5 1.9 0.0 1.1 1.5 2.0 0.0 1.2 0.3 0.2 1.2 0.6 11.0 16.3 14.7 17.6 11.7 13.2 11.2 13.8 16.8 12.5 3.0 7.8 2.7 4.2 2.4 10.0 9.8 7.6 2.7 4.5 3.5 5.9 0.0 0.0 3.2 3.3 6.8 1.4 0.0 2.9 0.0 5.0 5.6 4.7 1.7 1.2 12.7 0.0 5.5 1.0 1.6 2.8 1.5 5.0 1.0 6.3 5.0 2.1 5.8 8.5 8.4 6.8 0.0 3.6 2.1 1.9 4.0 0.0 5.7 2.9 3.8 CHKB "CHETK, CHKL" ENSG00000100288 "Choline kinase beta" Q9Y259 22 50578949-50601455 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Congenital muscular dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 73.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 14.7" HPA018797 Approved Approved Cytosol NA NA Cytosol "HPA018797: AB_1846666" "unprognostic (6.03e-4)" "prognostic favorable (4.66e-4)" "unprognostic (4.31e-2)" "unprognostic (2.63e-2)" "unprognostic (2.14e-1)" "unprognostic (1.42e-2)" "unprognostic (3.25e-3)" "unprognostic (1.70e-2)" "unprognostic (2.00e-1)" "unprognostic (7.84e-2)" "unprognostic (5.23e-3)" "unprognostic (5.43e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (1.33e-1)" "unprognostic (9.54e-2)" "unprognostic (1.30e-2)" "unprognostic (2.18e-3)" 14.1 13.6 12.7 18.9 14.4 14.8 13.0 21.3 13.4 12.9 15.1 13.8 10.4 9.8 10.1 12.5 10.7 16.2 13.6 10.6 10.7 6.8 14.3 9.3 12.6 8.7 14.7 6.1 9.1 8.4 21.9 19.2 12.3 12.7 11.7 6.9 12.8 13.4 12.5 7.8 10.5 16.9 8.0 9.5 18.5 14.8 19.9 15.8 8.5 14.5 6.6 16.5 12.1 10.9 13.6 21.2 15.0 23.9 20.6 18.6 19.5 3.7 1.0 3.0 1.1 3.2 2.1 10.4 4.4 8.8 1.8 2.5 0.0 1.4 1.8 3.4 0.0 1.6 1.7 1.6 0.9 0.3 1.5 4.3 2.4 2.2 0.8 14.7 3.0 6.2 1.0 5.4 0.7 3.7 3.6 9.2 3.9 1.2 4.8 4.9 3.4 2.6 8.4 0.5 2.5 0.6 3.4 0.4 10.4 4.0 2.5 1.5 4.3 3.5 3.4 3.1 2.2 1.2 1.8 2.8 1.7 3.7 1.6 1.3 7.9 0.7 2.3 3.0 2.3 1.8 5.7 23.9 15.0 16.3 21.9 15.5 12.9 15.2 17.3 21.2 13.6 14.4 13.3 5.7 20.6 14.2 19.5 18.6 19.5 12.7 14.4 21.3 13.4 10.7 6.8 14.7 6.1 12.7 15.8 6.0 23.3 12.0 2.2 4.2 5.1 5.9 17.8 10.7 14.8 7.0 3.9 7.5 3.3 26.9 9.1 6.3 18.0 0.0 20.9 12.0 5.8 1.9 18.5 5.5 12.8 7.9 15.1 10.4 20.2 21.1 2.3 8.8 3.3 73.9 16.6 2.8 23.5 23.0 2.8 4.3 4.8 6.5 8.2 11.1 8.7 5.5 7.1 16.0 15.6 1.8 CHM "DXS540, REP-1, TCD" ENSG00000188419 "CHM, Rab escort protein 1" P24386 X 85861180-86047562 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003231, CAB016171" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016171: AB_2229397, HPA003231: AB_1078518" "unprognostic (6.50e-3)" "unprognostic (1.80e-1)" "unprognostic (1.67e-1)" "unprognostic (1.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.40e-1)" "unprognostic (6.20e-3)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.97e-3)" "unprognostic (4.18e-2)" "unprognostic (6.15e-2)" "unprognostic (2.44e-1)" "unprognostic (7.60e-3)" 12.6 18.8 13.9 9.7 23.2 3.2 11.2 17.8 22.9 14.3 9.3 9.0 8.3 6.6 14.5 7.1 9.7 15.9 10.4 9.9 12.6 11.0 17.7 10.9 9.9 9.2 9.3 12.1 11.8 8.3 20.2 31.9 13.2 17.9 11.3 9.3 7.5 10.4 10.8 16.3 8.1 8.0 12.5 12.1 10.8 10.2 6.6 11.9 14.6 15.6 8.4 8.7 12.1 10.4 7.4 4.6 6.2 7.1 4.9 6.0 3.9 9.0 6.0 6.1 4.1 10.1 10.7 3.9 10.7 9.0 7.5 8.3 4.8 8.4 3.1 13.9 7.7 26.3 5.2 13.3 6.0 12.9 6.2 6.4 1.8 8.7 4.9 8.0 7.6 13.6 8.1 5.7 12.1 15.4 8.3 12.8 5.2 6.4 10.7 11.6 2.6 4.7 2.8 9.2 6.3 9.8 5.0 11.0 4.7 7.0 5.3 5.5 8.4 12.9 4.5 10.1 8.9 3.3 3.7 9.1 9.6 6.8 33.3 5.3 4.0 14.7 4.4 10.3 6.5 8.3 6.2 5.8 4.0 5.5 7.1 5.0 6.6 4.4 5.6 4.6 7.4 5.8 6.0 3.2 4.9 5.6 4.6 5.5 3.9 13.9 23.2 17.8 22.9 12.6 11.0 9.3 12.1 17.9 11.9 3.0 8.3 7.5 14.7 6.2 34.6 10.2 17.8 20.1 12.5 15.7 7.9 8.1 16.6 13.3 0.6 14.3 7.3 0.0 10.7 8.0 11.8 18.5 16.1 11.3 13.6 22.3 18.0 14.7 19.4 0.9 14.4 13.8 5.0 11.8 10.6 28.5 13.0 8.6 11.7 27.6 21.2 45.3 13.7 2.9 10.7 6.5 15.3 13.6 8.8 12.6 CHML REP-2 ENSG00000203668 "CHM like, Rab escort protein 2" P26374 1 241628853-241640254 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029627, HPA029628, HPA062967" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269" "unprognostic (1.63e-1)" "unprognostic (6.84e-2)" "unprognostic (3.57e-1)" "unprognostic (8.00e-2)" "unprognostic (2.46e-1)" "unprognostic (5.66e-2)" "prognostic unfavorable (9.23e-5)" "unprognostic (1.90e-2)" "unprognostic (3.37e-2)" "unprognostic (8.01e-3)" "unprognostic (3.02e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.03e-3)" "unprognostic (1.09e-1)" 6.5 3.8 6.0 5.7 10.5 10.8 7.7 3.6 18.0 6.0 6.4 3.1 1.4 3.8 7.6 5.0 6.1 7.2 5.6 5.1 5.3 5.1 6.5 21.1 12.5 10.0 4.9 13.1 13.3 5.6 8.5 8.2 30.7 4.2 3.7 6.1 2.0 5.8 3.0 7.1 6.5 6.5 5.6 3.7 9.3 5.6 9.9 2.2 14.8 11.0 2.2 5.1 5.2 6.6 1.6 2.9 3.0 1.3 0.5 1.4 0.2 17.6 5.5 8.6 6.8 2.6 7.8 16.8 7.0 3.5 6.1 4.2 10.0 3.3 4.8 10.7 4.6 5.0 3.6 12.0 7.6 11.4 9.3 11.0 6.4 22.4 7.0 5.2 15.2 8.3 6.5 3.4 8.1 8.4 4.3 4.7 13.2 17.2 6.0 7.2 6.9 10.0 10.2 11.4 6.7 17.8 15.3 10.6 16.3 6.1 11.0 11.0 18.2 8.8 6.8 7.6 8.8 7.9 9.9 9.6 12.5 24.3 6.3 13.2 7.0 17.2 5.2 12.2 9.2 19.3 3.0 0.9 0.6 0.5 1.3 0.8 1.3 0.3 0.4 0.8 1.6 1.4 1.1 0.1 0.5 0.8 2.9 0.1 0.2 6.0 10.5 3.6 18.0 5.3 5.1 4.9 13.1 4.2 2.2 44.7 6.5 11.1 3.4 7.6 2.6 16.1 2.5 1.4 9.1 0.0 0.0 19.5 5.0 11.7 10.8 6.8 4.2 0.0 17.8 19.9 5.1 3.9 3.5 1.9 6.4 4.8 6.4 3.1 10.7 16.3 9.8 20.4 16.9 13.6 4.0 2.9 18.3 2.8 17.0 2.1 4.3 12.9 10.3 5.9 12.3 6.4 16.8 4.4 4.3 4.2 CHMP2A "BC-2, CHMP2, VPS2, VPS2A" ENSG00000130724 "Charged multivesicular body protein 2A" O43633 19 58551566-58555124 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041153, HPA042031" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 Cytosol "Nucleoplasm, Plasma membrane" "HPA041153: AB_10964358, HPA042031: AB_10961727" "unprognostic (1.80e-1)" "unprognostic (4.70e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (2.54e-1)" "unprognostic (3.86e-2)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-2)" "unprognostic (2.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.98e-1)" "unprognostic (2.21e-1)" "unprognostic (3.09e-2)" "unprognostic (4.23e-2)" "unprognostic (2.71e-2)" 40.7 59.6 52.5 37.3 56.7 55.1 41.2 36.3 44.8 39.0 53.2 37.8 50.4 43.5 36.9 61.7 57.4 41.9 60.4 80.6 45.0 40.1 64.8 66.5 36.4 55.8 48.2 38.7 36.9 59.8 46.9 39.1 79.2 38.5 35.2 49.2 33.0 62.4 64.8 75.7 54.9 72.0 42.4 48.5 43.4 45.2 29.4 35.1 34.0 49.8 53.9 44.4 42.5 34.0 17.5 30.5 117.2 34.7 17.0 29.4 24.9 18.0 48.6 15.7 14.4 24.3 30.5 19.4 16.7 34.7 8.9 9.7 14.3 26.9 4.8 24.7 27.9 25.8 14.7 12.9 31.9 7.6 16.1 106.0 11.8 35.6 21.9 47.1 19.5 18.5 35.3 45.3 13.9 44.7 30.4 25.8 22.8 14.0 23.1 26.9 30.5 24.7 18.1 6.5 50.0 37.3 10.7 13.5 36.2 38.8 41.0 18.5 31.4 27.2 36.4 20.0 10.3 27.9 20.0 29.0 45.6 6.6 13.2 19.3 58.9 64.4 15.7 32.1 23.2 29.9 33.5 34.7 46.6 20.2 31.7 17.0 17.5 22.3 22.7 30.5 15.8 15.7 17.7 117.2 17.0 31.6 27.8 29.4 24.9 52.5 56.7 36.3 44.8 45.0 40.1 48.2 38.7 38.5 35.1 92.3 99.1 97.2 231.9 147.1 67.2 100.3 152.8 155.2 81.9 157.1 15.7 253.5 374.7 261.4 89.0 137.1 466.3 70.0 457.0 242.2 112.6 224.1 116.8 190.9 235.9 49.3 149.1 122.8 143.9 66.0 134.3 151.3 204.1 239.9 215.7 135.6 375.5 326.1 125.2 436.3 71.4 84.1 139.8 101.7 97.9 173.4 384.7 105.5 183.9 310.0 CHMP2B "CHMP2.5, DKFZP564O123, VPS2B" ENSG00000083937 "Charged multivesicular body protein 2B" Q9UQN3 3 87227271-87255548 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 108.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035069, HPA052754" Uncertain Approved Cytosol NA NA Cytosol "HPA035069: AB_10602798, HPA052754: AB_2681936" "unprognostic (7.83e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (2.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "unprognostic (9.78e-2)" "unprognostic (8.69e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (5.76e-2)" "prognostic favorable (1.74e-6)" "unprognostic (6.52e-2)" "unprognostic (2.29e-1)" "unprognostic (6.41e-3)" "unprognostic (1.21e-1)" 21.8 21.5 20.1 17.6 23.5 36.5 22.1 12.5 35.9 23.6 32.4 21.4 19.2 30.1 28.2 20.5 30.9 20.1 23.4 26.2 20.8 22.0 30.9 36.1 21.5 17.7 29.5 21.0 22.9 23.5 14.7 41.7 45.1 30.7 29.2 30.5 14.7 22.7 25.4 30.1 22.9 45.8 24.8 52.6 22.3 24.3 13.3 25.6 14.5 35.5 26.3 16.4 30.7 25.3 21.2 22.4 53.4 24.8 11.4 20.0 14.3 16.8 18.3 6.2 3.9 11.4 9.2 8.0 13.3 16.9 11.0 14.2 14.3 27.6 6.0 9.4 14.3 10.1 8.6 8.1 9.2 13.3 10.6 8.5 7.4 6.6 5.8 10.0 9.9 10.3 7.0 15.6 10.9 14.8 10.6 8.4 7.4 4.4 9.1 11.8 12.1 9.6 4.1 8.1 20.3 16.4 5.1 7.7 5.8 8.3 17.3 2.4 2.5 13.0 10.6 20.2 7.5 9.5 3.0 7.6 10.2 9.4 108.6 9.0 9.2 13.6 10.3 11.2 5.7 7.3 42.8 20.8 53.4 11.9 24.8 16.0 20.0 14.9 14.6 22.4 21.2 14.1 13.7 40.3 11.4 24.7 12.8 20.0 14.3 20.1 23.5 12.5 35.9 20.8 22.0 29.5 21.0 30.7 25.6 77.4 53.5 37.2 193.5 117.3 17.0 65.5 58.6 95.0 73.9 47.1 3.9 64.1 117.7 128.3 5.1 42.3 109.6 46.7 227.8 159.4 64.8 193.3 71.7 54.0 75.6 35.0 44.9 35.6 51.1 4.0 61.2 79.5 38.8 48.7 61.4 189.8 186.7 138.6 90.5 117.0 14.1 71.1 49.5 56.6 68.8 127.2 151.3 45.3 63.1 267.1 CHMP5 "C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60" ENSG00000086065 "Charged multivesicular body protein 5" Q9NZZ3 9 33264879-33282069 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033874, HPA042883, HPA056437" Enhanced Supported Microtubules,Midbody,Cytosol Yes No "Microtubules, Cytosol" Midbody "CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (9.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.32e-1)" "unprognostic (4.56e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-2)" "unprognostic (4.71e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.66e-1)" "prognostic favorable (2.87e-7)" "unprognostic (2.22e-1)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (7.31e-2)" 29.7 37.5 48.0 24.3 48.6 18.8 36.2 39.9 49.4 28.3 39.0 28.1 28.4 38.1 28.2 36.3 39.2 31.4 30.6 35.1 45.1 45.2 55.6 39.2 35.6 26.1 44.1 47.5 26.5 19.9 36.4 34.8 55.7 47.4 40.8 40.9 19.8 26.0 30.2 27.1 25.6 51.9 27.5 49.2 33.0 37.3 21.2 37.0 24.9 42.0 26.1 26.0 33.7 33.5 12.4 27.8 51.2 24.6 18.1 16.6 18.1 31.3 23.4 23.8 15.4 36.4 33.2 22.2 31.4 35.5 50.0 55.6 17.7 19.9 16.9 34.7 29.5 34.3 13.6 24.9 25.6 40.6 35.0 17.5 14.2 47.2 19.3 31.7 18.0 28.0 35.3 47.4 33.6 31.4 41.2 26.0 23.9 15.2 22.4 39.4 14.3 18.6 55.7 21.9 24.1 28.8 11.5 21.1 11.2 41.1 17.1 11.7 30.0 31.8 18.8 28.7 29.1 19.2 28.4 25.9 25.1 26.2 21.4 27.7 14.9 29.6 19.5 36.1 12.4 16.0 31.5 20.1 40.2 10.7 21.6 11.5 12.4 14.3 14.0 18.3 10.6 13.2 12.5 51.2 18.1 24.6 27.8 16.6 18.1 48.0 48.6 39.9 49.4 45.1 45.2 44.1 47.5 47.4 37.0 83.4 48.3 59.3 129.0 167.0 61.8 57.1 91.7 144.6 67.1 104.7 25.5 150.8 242.1 116.7 177.9 132.6 173.1 93.5 75.7 146.8 116.0 157.2 58.7 60.2 136.7 25.4 77.0 73.1 86.4 27.4 86.3 96.9 111.3 216.4 117.4 120.4 122.7 207.0 98.3 256.7 46.8 84.1 128.8 87.4 65.0 206.5 216.6 61.2 74.2 224.1 CHMP7 MGC29816 ENSG00000147457 "Charged multivesicular body protein 7" Q8WUX9 8 23243637-23262000 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 76.1" "Cell type enhanced" "Detected in many" 4 "B-cells: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 31.7" "Group enriched" "Detected in all" 12 "B-cells: 15.2;T-cells: 31.7" "Cell line enhanced" "Detected in all" "Daudi: 24.9;U-698: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036119 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036119: AB_10673000" "unprognostic (2.94e-3)" "unprognostic (1.64e-1)" "unprognostic (7.59e-3)" "unprognostic (4.51e-2)" "unprognostic (2.47e-1)" "unprognostic (2.83e-3)" "unprognostic (9.00e-2)" "unprognostic (1.84e-1)" "unprognostic (6.44e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (8.98e-3)" "unprognostic (1.88e-2)" "unprognostic (6.80e-3)" "unprognostic (2.06e-1)" "unprognostic (7.54e-2)" "unprognostic (2.30e-1)" 6.4 12.7 7.3 29.2 7.4 15.4 11.0 10.5 9.2 7.5 9.2 5.6 6.4 8.1 10.0 4.5 7.5 7.3 7.6 9.8 6.3 8.0 6.9 7.4 7.2 48.8 7.8 5.8 8.1 12.4 4.4 7.0 5.3 7.3 7.4 7.3 4.1 12.5 7.9 13.8 7.5 13.7 9.8 6.5 26.2 10.5 7.0 6.8 76.1 7.7 5.9 43.3 9.3 13.7 15.2 1.3 1.8 1.9 1.8 31.7 11.8 3.9 5.3 2.9 4.9 2.7 2.7 3.3 3.3 2.3 4.7 4.0 6.1 3.0 24.9 3.9 2.3 4.5 3.7 2.7 3.9 1.8 6.7 5.0 5.2 6.9 3.2 2.4 1.3 7.5 2.3 2.7 4.6 1.3 2.6 3.8 10.8 5.8 3.4 2.7 3.9 4.4 5.8 4.7 3.8 4.1 1.8 2.4 3.4 2.4 5.1 3.7 3.6 2.5 3.7 1.4 1.6 4.0 2.8 4.3 5.8 3.8 4.1 2.5 9.9 5.2 29.8 4.5 4.2 4.3 0.4 1.9 1.8 2.5 1.7 5.2 14.6 16.6 7.7 1.3 15.2 31.7 17.9 1.7 1.8 1.2 1.1 17.3 11.8 7.3 7.4 10.5 9.2 6.3 8.0 7.8 5.8 7.3 6.8 6.0 6.4 49.8 13.7 12.0 9.2 11.6 7.6 5.3 4.5 14.0 3.9 13.5 16.6 17.9 32.6 9.8 13.9 0.0 13.8 15.6 10.2 11.9 11.5 6.4 13.8 12.7 13.2 6.2 6.3 8.9 9.2 9.2 15.1 12.6 11.8 18.4 16.4 10.8 9.9 16.1 10.1 6.5 13.4 14.2 15.2 9.4 17.3 8.7 9.9 17.6 CHN1 "ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2" ENSG00000128656 "Chimerin 1" P15882 2 174799363-175005369 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 145.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 88.1;Horizontal cells: 73.1;Muller glia cells: 49.1" "Cancer enhanced" "Detected in all" "glioma: 18.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 9.0;memory CD8 T-cell: 2.9;T-reg: 10.0" "Lineage enriched" "Detected in single" 35 "T-cells: 10.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 60.2;BJ hTERT+ SV40 Large T+ RasG12V: 30.4" "Low region specificity" "Detected in all" HPA036111 Approved Cytosol NA NA Cytosol "HPA036111: AB_10671241" "unprognostic (3.18e-3)" "unprognostic (4.19e-2)" "unprognostic (9.69e-2)" "unprognostic (3.42e-3)" "unprognostic (1.92e-1)" "unprognostic (2.65e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "unprognostic (3.71e-2)" "unprognostic (1.34e-2)" "unprognostic (5.29e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (7.31e-3)" "unprognostic (4.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.46e-2)" 3.8 5.2 63.4 3.4 60.8 1.0 2.4 9.1 145.3 4.7 2.5 4.4 0.2 1.7 3.9 15.1 3.2 2.9 4.7 5.2 74.0 21.4 2.1 1.4 7.1 7.4 21.4 51.7 2.8 1.9 31.7 5.2 14.4 23.0 7.2 2.6 3.1 1.4 4.6 1.2 1.9 1.8 5.5 5.1 2.7 2.1 7.5 9.1 0.0 4.0 0.0 7.2 4.5 1.2 0.2 0.2 0.0 0.0 0.1 10.0 1.1 0.0 3.3 14.9 4.2 4.6 21.2 0.1 14.4 60.2 20.7 30.4 0.1 1.9 0.1 0.4 21.7 10.4 0.5 19.0 0.4 8.3 0.2 8.3 2.6 4.9 1.4 10.2 1.4 0.3 18.8 0.5 10.0 3.2 4.6 7.6 7.1 0.1 0.6 15.2 2.8 6.8 0.6 17.6 0.5 5.1 2.2 21.0 0.1 0.2 0.1 18.4 19.9 11.4 0.1 1.7 9.7 0.7 0.3 2.3 8.8 1.3 2.8 5.2 1.7 8.0 0.2 1.9 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.7 0.2 9.0 2.9 0.0 0.0 1.3 0.3 0.0 0.1 0.0 0.2 10.0 1.1 63.4 60.8 9.1 135.3 74.0 21.4 21.4 51.7 23.0 9.1 3.0 3.4 1.9 0.3 3.9 88.1 6.1 0.0 1.4 4.5 3.5 25.5 1.1 0.0 0.2 17.1 14.0 0.0 0.0 0.5 1.0 16.0 0.7 0.0 0.6 2.4 73.1 2.4 6.2 0.0 18.2 2.8 1.0 6.8 0.0 0.0 49.1 0.6 0.0 4.9 0.0 13.5 12.9 26.9 17.0 14.5 3.1 1.7 4.4 0.0 0.3 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 59.6" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.5;Early spermatids: 2.2;Late spermatids: 3.1;Leydig cells: 2.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 8 "T-cells: 4.9" "Cell line enhanced" "Detected in some" "U-266/70: 4.1;U-266/84: 10.0;U-87 MG: 11.6" "Group enriched" "Detected in many" 4 "basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4" "Region enriched" "Detected in all" 6 "olfactory region: 208.8" "HPA017282, HPA057559" Enhanced Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA017282: AB_1846687, HPA057559: " "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 2.3 1.9 0.8 2.1 6.8 0.0 1.1 0.5 0.8 0.3 2.3 0.5 4.0 1.5 0.7 1.1 1.4 0.5 0.8 3.4 1.3 8.2 4.7 0.0 0.3 0.3 1.4 0.8 0.5 0.0 0.5 2.1 1.7 8.6 8.2 3.4 1.4 0.6 1.8 1.3 2.1 0.9 0.4 2.2 12.3 0.7 59.6 1.1 0.1 0.9 4.3 1.1 1.1 1.1 0.4 0.6 0.0 0.1 0.4 4.9 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.1 0.0 2.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.6 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.0 1.1 0.9 1.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.1 10.0 0.3 11.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 4.9 0.4 0.3 0.8 0.1 0.2 0.0 1.1 0.0 0.4 0.1 0.6 1.0 0.3 0.8 6.8 0.5 0.8 1.3 8.2 1.4 0.8 8.6 1.1 0.0 0.0 0.0 0.6 3.5 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.2 2.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.2 1.1 1.7 1.9 0.5 1.0 0.0 0.3 CHORDC1 "CHP-1, CHP1" ENSG00000110172 "Cysteine and histidine rich domain containing 1" Q9UHD1 11 90201160-90223364 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 100.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041040 Approved Approved Cytosol NA NA 51000 Cytosol "HPA041040: AB_10794185" "unprognostic (2.29e-3)" "unprognostic (3.08e-1)" "unprognostic (5.26e-2)" "unprognostic (3.10e-2)" "unprognostic (3.27e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (4.93e-7)" "unprognostic (1.84e-1)" "unprognostic (1.04e-3)" "unprognostic (5.27e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (4.23e-2)" "unprognostic (2.63e-1)" "unprognostic (2.59e-1)" "unprognostic (1.52e-1)" 13.9 17.8 24.9 18.1 31.9 17.8 22.2 29.9 30.7 12.5 10.9 9.0 10.6 10.6 13.8 17.3 13.1 13.2 12.4 17.1 23.6 24.6 11.0 16.2 12.4 21.3 37.8 12.9 19.8 9.5 14.1 47.6 21.3 33.7 14.8 13.2 6.1 9.6 13.0 12.9 12.4 9.0 12.8 39.8 15.3 12.1 13.1 40.2 14.2 16.8 8.7 23.3 14.9 100.9 12.6 11.9 7.9 12.5 14.5 15.5 9.3 9.4 27.3 9.1 6.0 8.8 4.9 13.8 11.8 3.9 11.3 10.0 38.9 7.5 16.7 19.8 5.0 22.5 12.9 26.6 6.2 14.0 14.8 13.5 16.4 15.9 18.5 6.9 11.7 11.0 1.8 7.2 10.7 12.5 6.6 8.9 10.2 24.0 7.4 13.4 4.8 10.9 16.0 10.7 32.8 22.7 16.4 5.7 9.2 9.4 4.3 8.7 3.7 13.0 10.5 4.7 11.5 17.4 5.5 8.5 8.4 18.6 12.7 13.9 3.4 26.7 13.3 2.6 17.3 7.6 6.8 7.7 7.9 12.0 12.5 12.9 12.6 13.1 12.5 11.9 10.8 14.0 13.3 2.3 14.5 8.0 9.2 15.5 9.3 24.9 31.9 29.9 30.7 23.6 24.6 37.8 12.9 33.7 40.2 17.9 24.3 33.4 113.0 62.8 44.2 28.5 2.5 52.2 37.5 10.4 127.6 34.0 10.0 19.8 71.4 32.2 10.7 0.0 14.1 67.3 45.9 65.4 86.4 13.9 34.7 62.0 65.9 11.6 17.8 51.1 30.2 35.8 27.0 28.9 14.1 20.9 20.9 17.5 29.4 18.8 54.7 12.9 42.6 80.0 39.0 71.5 42.6 45.9 12.5 68.6 CHPF "CHSY2, CSS2" ENSG00000123989 "Chondroitin polymerizing factor" Q8IZ52 2 219538947-219543787 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 137.8;Extravillous trophoblasts: 162.1;Syncytiotrophoblasts: 259.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035123 Approved Supported Vesicles,Centrosome,Cytosol "Intracellular and membrane" NA NA Cytosol "Vesicles, Centrosome" "HPA035123: AB_10602799" "unprognostic (1.13e-3)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.65e-3)" "unprognostic (2.55e-3)" "unprognostic (1.86e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.37e-1)" "unprognostic (6.59e-3)" "unprognostic (7.74e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (6.79e-2)" "unprognostic (1.64e-1)" "unprognostic (6.55e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.96e-4)" 8.6 14.1 9.7 8.4 11.8 1.4 6.8 8.5 19.4 22.1 8.6 11.3 23.0 18.4 17.0 24.6 7.9 9.2 17.1 36.3 12.2 10.7 11.3 52.1 11.6 5.4 9.0 10.5 38.1 60.7 16.3 36.9 62.7 10.4 19.3 3.8 27.4 31.6 19.9 4.3 9.0 13.3 9.1 8.3 4.5 15.6 34.2 7.0 3.8 17.9 7.4 10.6 11.9 8.5 1.3 11.1 6.9 0.1 2.1 3.0 0.8 18.8 3.7 2.8 23.5 10.7 16.9 32.2 19.1 16.2 5.4 5.0 10.4 16.6 5.9 41.2 18.5 18.6 24.1 1.8 11.5 0.8 9.1 6.5 2.1 5.3 45.1 15.0 1.8 12.4 22.6 20.4 5.5 5.3 19.7 0.0 2.0 13.0 14.4 5.1 29.5 0.2 4.9 11.6 6.4 14.5 0.0 8.9 11.5 6.5 8.5 6.9 10.6 9.2 9.0 26.2 5.5 3.0 6.4 0.4 20.1 11.0 24.0 9.9 17.4 5.3 2.7 18.4 1.9 20.3 2.1 0.0 6.9 2.4 0.1 3.0 1.3 1.9 1.6 0.0 0.1 2.2 0.8 0.0 2.1 0.0 11.1 1.2 0.8 9.7 11.8 8.5 19.4 12.2 10.7 9.0 10.5 10.4 7.0 0.0 14.6 4.5 19.1 12.9 13.8 27.7 25.5 2.7 6.8 71.5 9.8 137.8 8.3 48.8 3.2 3.5 16.9 0.0 70.1 162.1 52.1 34.2 10.3 49.9 16.5 41.3 41.2 6.7 1.3 5.7 23.0 2.8 64.1 2.8 36.9 62.9 60.3 26.6 59.4 16.4 11.4 25.8 16.5 11.6 5.5 9.7 259.5 7.5 11.3 28.6 CHPF2 "ChSy-3, CSGlcA-T, KIAA1402" ENSG00000033100 "Chondroitin polymerizing factor 2" Q9P2E5 7 151232489-151238827 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020992 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA020992: AB_1847267" "unprognostic (8.31e-2)" "unprognostic (2.14e-3)" "unprognostic (1.02e-3)" "unprognostic (1.14e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (4.07e-1)" "unprognostic (1.71e-1)" "unprognostic (4.54e-2)" "prognostic favorable (2.51e-4)" "unprognostic (1.04e-1)" "unprognostic (2.68e-3)" "unprognostic (2.24e-1)" "unprognostic (1.49e-1)" "unprognostic (3.22e-2)" "unprognostic (8.59e-3)" 13.5 29.3 13.4 19.0 12.9 22.6 19.1 13.1 20.2 15.3 14.4 11.4 20.7 14.9 19.5 16.9 13.3 14.9 17.6 18.8 13.7 12.5 14.9 20.7 17.4 23.4 11.4 17.4 14.4 23.7 16.7 41.5 18.6 11.8 18.5 10.8 12.2 25.4 19.8 7.9 14.2 17.1 17.3 9.4 28.1 20.1 12.9 11.1 16.2 17.5 7.4 13.7 18.9 12.8 2.7 9.5 9.9 5.6 2.6 5.7 3.7 9.0 7.4 5.0 14.5 17.4 17.3 7.5 19.1 29.8 10.4 12.7 4.9 15.4 2.7 33.8 30.3 14.2 11.4 2.2 13.6 4.5 10.4 6.8 2.9 8.1 6.8 16.3 5.8 24.2 26.4 7.7 9.8 3.5 21.6 16.3 4.6 2.7 8.0 16.5 14.9 5.4 22.9 6.6 3.8 8.6 5.1 2.9 9.1 10.1 7.2 5.4 9.6 10.2 10.1 4.8 3.9 3.9 9.6 22.2 11.6 1.9 15.3 16.1 14.8 2.1 4.0 42.1 7.8 15.6 1.2 5.6 7.9 5.7 5.1 5.4 2.7 3.1 5.1 6.3 2.7 2.2 2.3 9.9 2.6 5.0 9.5 3.4 3.7 13.4 12.9 13.1 20.2 13.7 12.5 11.4 17.4 11.8 11.1 8.9 10.2 11.5 4.8 4.0 9.5 1.6 12.7 4.0 4.5 10.4 3.9 9.1 1.7 10.3 0.5 4.7 10.2 23.3 14.5 12.1 9.7 9.5 5.8 8.3 11.2 23.8 8.1 13.5 11.6 0.7 15.8 8.5 6.8 7.2 10.1 4.3 14.8 15.9 14.2 3.3 6.9 19.4 6.2 3.4 1.7 3.9 8.6 12.1 8.1 8.9 CHRM1 ENSG00000168539 "Cholinergic receptor muscarinic 1" P11229 11 62908679-62921807 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.7;prostate: 28.2;salivary gland: 25.3" "Group enriched" "Detected in some" 6 "Glandular cells: 2.0;Melanocytes: 3.3;Mucus-secreting cells: 2.1" "Cancer enriched" "Detected in some" 16 "prostate cancer: 27.9" "Group enriched" "Detected in many" 10 "amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MCF7: 4.9;OE19: 15.2" "Group enriched" "Detected in many" 9 "amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8" "HPA014101, CAB022366" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022366: , HPA014101: AB_1854210" "unprognostic (3.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.89e-2)" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-1)" "unprognostic (8.57e-4)" "unprognostic (4.88e-1)" "unprognostic (6.43e-2)" "unprognostic (1.75e-1)" 0.5 3.7 13.2 0.8 22.0 0.5 3.2 0.2 34.7 0.6 1.3 0.5 0.0 1.0 0.7 0.6 0.8 0.8 0.7 0.6 14.2 1.7 0.7 0.6 2.9 0.6 1.4 14.0 0.5 1.2 1.0 0.1 0.8 0.1 28.2 1.3 1.3 25.3 0.6 0.6 2.6 1.3 0.6 0.3 0.6 1.9 0.6 1.8 0.0 0.8 0.0 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.1 0.1 15.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.4 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 22.0 0.2 34.7 14.2 1.7 1.4 14.0 0.1 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 49.1" "Cell type enriched" "Detected in single" 11 "Muller glia cells: 4.3" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 72 "RH-30: 43.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory region: 1.4" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: AB_2732603, HPA065404: AB_2732734" "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 49.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST10 HNK-1ST ENSG00000115526 "Carbohydrate sulfotransferase 10" O43529 2 100391860-100417656 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 14.9;Bipolar cells: 11.4;Muller glia cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "B-cells: 2.3;dendritic cells: 3.1;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012884, HPA051545" Approved Approved Cytosol "Intracellular and membrane" NA NA 290000 Cytosol "HPA012884: AB_1846710, HPA051545: AB_2681529" "unprognostic (5.40e-3)" "unprognostic (3.62e-2)" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (3.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.89e-2)" "unprognostic (1.44e-1)" "unprognostic (1.78e-1)" "unprognostic (4.54e-2)" "prognostic favorable (4.05e-4)" "unprognostic (8.02e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-2)" "unprognostic (3.73e-2)" "unprognostic (3.06e-2)" "unprognostic (3.27e-1)" 4.1 6.7 14.6 3.9 18.7 2.6 5.0 12.6 28.2 6.2 4.1 12.1 2.4 2.2 11.4 13.5 4.1 9.7 5.3 10.1 12.4 9.5 4.4 1.2 7.8 4.0 9.8 12.2 12.9 5.3 8.8 8.6 7.8 9.3 8.1 2.4 7.3 5.5 5.4 5.1 1.6 2.5 11.7 8.9 3.7 3.4 5.8 7.6 3.1 9.8 1.6 5.1 5.8 4.9 2.3 3.1 0.0 0.0 0.1 3.5 1.0 0.1 7.7 15.3 7.8 4.7 6.6 7.7 8.8 6.3 12.1 7.8 0.1 4.5 10.6 7.7 5.3 21.5 0.0 10.7 1.1 7.8 15.0 11.3 5.4 4.2 11.9 5.6 10.9 14.3 4.8 1.5 5.7 1.0 5.8 9.5 10.3 15.7 0.0 5.1 2.4 9.7 8.7 22.5 0.1 9.4 7.0 9.4 0.1 3.3 3.4 16.5 13.5 0.6 0.0 12.2 11.3 4.1 15.1 8.6 8.4 13.4 6.3 8.1 0.0 0.0 10.9 10.3 9.8 9.9 0.0 0.0 0.0 3.5 0.0 1.3 2.3 0.6 2.9 0.6 1.8 0.8 2.3 0.0 0.1 0.0 3.1 0.0 1.0 14.6 18.7 12.6 24.8 12.4 9.5 9.8 12.2 9.3 7.6 14.9 1.9 0.8 1.0 0.8 11.4 4.7 0.0 1.4 7.9 1.8 0.0 4.2 3.3 3.0 0.4 3.3 0.0 0.0 2.5 8.4 3.1 1.0 0.0 0.0 4.8 6.4 1.7 0.0 1.2 0.0 2.0 1.1 0.0 5.4 0.0 17.6 1.9 0.0 4.9 1.0 4.3 0.0 2.5 1.1 4.5 0.5 1.1 2.5 0.0 0.1 CHST15 "BRAG, GALNAC4S-6ST, KIAA0598" ENSG00000182022 "Carbohydrate sulfotransferase 15" Q7LFX5 10 124007666-124093607 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 49.7;Kupffer cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.4" "Group enriched" "Detected in many" 10 "granulocytes: 29.4;monocytes: 15.4" "Cell line enhanced" "Detected in many" "Karpas-707: 27.6;REH: 36.3;U-266/70: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017584 Approved Approved Centrosome,Cytosol NA NA 560000 Cytosol Centrosome "HPA017584: AB_1849437" "unprognostic (1.19e-1)" "unprognostic (2.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-2)" "unprognostic (4.12e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (3.02e-2)" "unprognostic (2.40e-2)" "unprognostic (7.62e-3)" "unprognostic (7.90e-2)" "unprognostic (8.16e-2)" "prognostic unfavorable (2.22e-7)" "unprognostic (6.47e-3)" "unprognostic (7.80e-2)" "unprognostic (4.63e-3)" "unprognostic (5.26e-3)" 16.4 10.0 8.7 17.0 20.6 5.7 10.7 3.4 17.9 9.8 15.4 6.6 4.0 8.8 8.6 10.8 11.3 13.1 11.7 6.4 11.3 5.3 9.0 11.9 13.9 35.4 6.5 9.6 35.0 12.6 2.9 7.7 5.9 9.2 8.5 8.3 14.4 8.2 13.4 11.0 8.3 12.5 9.5 9.0 31.5 11.4 4.8 8.7 2.8 19.3 6.1 12.6 12.5 12.0 2.1 2.0 29.4 15.4 0.0 0.1 3.2 12.8 8.7 3.2 0.7 3.2 1.7 0.0 2.6 3.5 1.4 2.0 0.2 7.0 0.0 8.5 10.7 0.9 14.7 0.6 8.5 1.2 0.0 2.4 0.0 3.9 6.4 1.0 0.0 16.6 1.0 9.8 4.0 3.4 3.5 2.8 0.0 0.0 27.6 7.0 7.1 0.0 0.0 2.8 1.9 0.0 36.3 4.4 8.5 7.1 1.2 0.3 0.7 7.0 3.9 0.0 8.4 2.9 0.0 3.3 0.3 0.1 10.1 0.4 25.1 6.0 6.9 0.1 0.0 0.0 0.0 8.8 6.2 0.0 14.0 0.0 2.0 0.0 0.0 1.8 2.1 0.1 0.0 29.4 0.0 15.4 2.0 0.1 3.2 8.7 20.6 3.4 17.9 11.3 5.3 6.5 9.6 9.2 8.7 20.8 11.1 9.7 14.5 14.9 4.4 2.2 7.6 9.4 9.1 19.2 0.0 1.5 0.0 8.2 24.2 10.8 0.0 0.0 0.6 1.9 2.7 14.0 5.7 6.4 9.4 0.0 1.7 49.7 47.8 27.7 9.5 23.2 1.7 1.8 0.0 0.1 5.9 0.0 1.8 0.3 0.3 19.4 11.3 8.4 9.2 10.2 0.8 2.2 0.0 15.2 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119331-143124014 "Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9" "Group enriched" "Detected in many" 4 "Muller glia cells: 106.5;Sertoli cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.4" "Group enriched" "Detected in many" 4 "monocytes: 11.4;NK-cells: 4.8" "Cell line enhanced" "Detected in many" "ASC diff: 20.5;ASC TERT1: 21.0;HEL: 16.2;HHSteC: 42.2;HMC-1: 19.4;HSkMC: 22.1;U-266/70: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: AB_2668861" "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 6.5 2.6 8.2 11.6 16.6 20.0 4.1 9.8 15.1 4.6 3.1 6.5 2.6 3.6 6.4 2.7 2.0 1.6 3.1 2.6 7.3 10.4 4.8 1.6 5.1 10.2 10.6 5.8 3.6 2.0 1.5 5.5 15.3 14.0 7.6 2.3 5.9 4.0 15.9 2.7 3.0 4.9 6.0 32.9 17.0 5.4 2.3 4.8 24.7 5.4 0.1 8.1 7.4 5.4 1.4 1.8 0.8 11.4 4.8 0.8 0.9 0.0 0.1 1.0 0.9 20.5 21.0 0.0 1.1 3.2 0.8 0.7 0.0 0.0 0.2 0.7 0.7 1.1 0.0 0.7 2.7 0.4 0.2 0.5 16.2 0.0 0.0 42.2 0.4 19.4 22.1 3.4 1.0 3.5 1.2 1.2 2.5 1.8 1.0 5.3 0.0 3.0 4.1 5.8 0.0 2.7 0.1 0.3 0.0 0.6 0.7 1.3 0.0 0.2 0.0 1.8 1.0 0.0 0.6 4.2 2.5 1.4 3.3 4.7 18.6 0.2 1.1 4.8 3.1 12.8 0.7 0.6 0.8 0.4 4.5 0.0 1.4 0.1 0.2 1.8 1.0 0.8 0.6 0.3 4.8 11.4 0.1 0.5 0.9 8.2 16.6 9.8 15.1 7.3 10.4 10.6 5.8 14.0 4.8 0.0 0.0 14.2 7.0 2.2 20.1 1.2 0.0 0.0 2.3 3.5 2.0 0.4 0.0 0.3 0.1 6.4 0.0 23.3 0.2 0.3 7.1 9.4 11.5 0.0 2.8 1.6 0.0 4.3 6.4 0.4 11.8 13.0 16.9 9.0 0.0 106.5 3.5 0.0 2.1 0.0 19.2 90.5 5.5 0.0 1.9 0.5 0.8 8.7 0.0 15.6 CHST3 "C6ST, C6ST1" ENSG00000122863 "Carbohydrate sulfotransferase 3" Q7LGC8 10 71964365-72013564 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ito cells: 14.7;Leydig cells: 19.0;Peritubular cells: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 28.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047523, HPA055704" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 510000 "Golgi apparatus, Cytosol" "HPA047523: AB_2680075, HPA055704: AB_2682891" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.13e-3)" "unprognostic (1.16e-3)" "unprognostic (2.44e-1)" "unprognostic (4.67e-2)" "unprognostic (4.79e-2)" "unprognostic (7.53e-2)" "unprognostic (7.99e-2)" "unprognostic (3.71e-2)" "unprognostic (2.83e-3)" "unprognostic (5.99e-2)" "unprognostic (1.40e-2)" "unprognostic (2.65e-2)" "unprognostic (7.77e-2)" "unprognostic (2.56e-2)" "unprognostic (2.54e-3)" 22.2 11.6 9.2 7.0 19.4 0.7 12.0 2.9 11.6 10.4 9.0 19.4 4.8 1.7 13.7 7.4 8.4 13.6 6.2 11.9 11.3 5.1 8.6 1.8 6.3 2.2 30.1 5.5 25.0 6.1 1.9 4.0 10.0 15.6 10.7 3.3 5.7 6.3 19.5 13.6 7.1 4.0 21.0 16.2 2.9 11.6 19.4 25.2 0.5 7.3 4.8 2.2 7.5 18.5 0.2 0.3 0.8 0.1 0.1 0.2 0.0 6.8 7.4 3.8 9.3 17.3 6.8 0.1 14.5 13.9 8.9 6.0 6.4 13.7 0.0 10.0 17.0 7.2 8.9 3.3 9.9 7.2 0.2 2.5 0.0 12.8 6.1 8.8 0.0 0.0 9.4 11.5 8.8 12.1 17.4 2.6 0.3 2.0 0.0 9.4 0.2 0.0 0.0 1.6 0.2 2.4 0.0 4.6 0.0 12.6 7.0 0.2 3.8 11.0 0.2 10.6 4.8 0.8 1.4 5.4 11.0 12.7 18.3 28.8 0.0 0.0 0.0 8.0 0.0 7.7 0.3 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.8 0.1 0.0 0.3 0.1 0.0 9.2 19.4 2.9 11.6 11.3 5.1 30.1 5.5 15.6 25.2 0.0 3.4 0.0 4.0 2.5 0.0 8.9 5.1 1.4 3.4 7.0 0.0 3.5 3.3 8.2 0.4 3.6 0.0 0.0 2.4 2.2 5.7 3.7 1.1 0.0 0.7 0.0 0.0 14.7 0.6 2.1 19.0 0.4 8.5 1.0 0.0 6.6 7.7 0.0 20.5 2.8 0.0 6.5 9.6 0.5 0.7 2.0 0.9 0.0 0.0 1.4 CHTF18 "C16orf41, C321D2.4, CHL12, Ctf18" ENSG00000127586 "Chromosome transmission fidelity factor 18" Q8WVB6 16 788046-800737 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 20.9;Extravillous trophoblasts: 16.6;Spermatogonia: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 28.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040976, HPA056209" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040976: AB_2677232, HPA056209: AB_2683066" "unprognostic (3.83e-2)" "unprognostic (4.97e-2)" "unprognostic (4.25e-2)" "unprognostic (9.35e-2)" "unprognostic (4.59e-2)" "unprognostic (3.02e-3)" "unprognostic (1.80e-3)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.19e-1)" "unprognostic (4.00e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (1.43e-8)" "unprognostic (2.07e-2)" "unprognostic (1.55e-1)" "unprognostic (9.89e-2)" "prognostic favorable (2.78e-4)" 2.4 3.1 8.3 6.7 5.6 16.8 3.1 11.1 4.7 5.0 5.3 4.1 4.1 6.1 4.1 2.8 5.1 3.2 2.4 1.7 2.7 2.3 2.6 2.0 2.9 4.4 4.4 4.6 5.2 3.1 0.7 2.4 4.1 3.5 3.2 1.7 4.0 4.0 2.6 2.4 8.3 7.2 1.8 2.3 5.9 6.7 11.3 4.3 15.5 3.1 3.8 7.3 2.9 3.6 1.0 1.4 4.6 3.0 2.1 2.4 0.7 8.0 3.9 3.2 2.6 0.3 0.2 28.4 5.1 1.4 2.6 1.8 7.0 6.2 9.1 5.3 0.8 1.3 9.0 0.7 3.9 0.0 5.1 11.6 4.0 4.6 3.6 0.0 2.5 7.9 0.1 0.5 2.5 1.3 0.3 2.2 9.5 6.0 3.0 0.6 15.5 9.7 9.3 4.2 1.8 4.8 17.5 8.2 11.8 0.8 2.3 4.2 5.4 3.7 8.2 2.7 0.4 6.0 6.0 1.4 3.8 14.0 6.9 6.8 7.2 2.4 5.1 1.2 3.6 6.6 4.6 0.6 0.0 2.4 3.0 1.5 0.4 1.1 1.9 1.4 1.0 1.3 0.3 0.3 2.1 1.6 0.8 1.4 0.7 8.3 5.6 11.1 4.7 2.7 2.3 4.4 4.6 3.5 4.3 3.0 3.4 3.7 3.2 4.7 20.9 3.6 0.0 2.7 3.4 1.8 2.0 10.9 1.7 2.4 1.0 1.8 0.9 0.0 3.3 16.6 3.3 1.0 4.6 1.8 5.4 6.4 6.3 2.5 2.1 1.1 1.7 2.9 0.0 0.0 3.3 2.8 1.6 0.0 1.4 0.7 6.7 0.0 3.3 13.3 23.5 1.8 7.2 2.5 3.3 1.4 CHUK "IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16" ENSG00000213341 "Conserved helix-loop-helix ubiquitous kinase" O15111 10 100188298-100229619 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001402, CAB004240, CAB018564" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (3.74e-2)" "unprognostic (3.01e-1)" "unprognostic (3.02e-2)" "unprognostic (5.93e-2)" "unprognostic (4.02e-2)" "unprognostic (2.09e-1)" "unprognostic (8.58e-2)" "unprognostic (8.39e-2)" "unprognostic (6.73e-2)" "unprognostic (1.49e-1)" "prognostic favorable (1.27e-4)" "unprognostic (2.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-3)" "unprognostic (2.22e-1)" 16.6 16.6 14.0 14.3 18.9 21.3 14.2 16.0 15.8 11.8 15.0 13.0 13.9 16.1 14.7 12.4 13.5 12.0 11.7 14.5 13.3 17.6 27.2 35.8 14.0 20.8 17.9 6.9 11.4 14.5 19.6 18.2 14.2 16.4 12.9 17.6 9.5 13.9 12.5 23.6 11.0 20.6 16.1 18.6 18.7 15.1 12.5 15.6 22.5 14.5 11.7 15.5 13.8 13.6 3.7 3.4 7.2 4.8 4.0 4.3 1.4 15.8 13.5 13.8 20.6 13.3 12.0 10.6 20.3 20.0 19.0 23.2 15.1 9.4 21.6 12.0 13.8 13.2 15.8 23.0 10.7 21.3 22.9 19.9 14.3 10.7 16.6 11.4 26.4 21.1 9.6 11.5 21.8 21.4 13.2 13.5 17.9 16.2 17.9 20.6 9.6 20.9 16.3 9.0 12.7 9.9 13.7 15.4 9.8 12.0 10.3 8.3 12.3 11.0 8.5 17.6 11.4 17.0 16.2 14.1 11.9 13.4 12.9 23.0 21.1 19.0 21.0 13.0 21.5 9.4 2.6 3.0 5.1 2.4 4.8 4.0 3.7 3.0 4.3 3.4 2.1 3.3 4.2 7.2 4.0 3.2 2.1 2.8 1.4 14.0 18.9 16.0 15.8 13.3 17.6 17.9 6.9 16.4 15.6 11.9 7.8 9.0 4.9 17.5 5.0 6.9 5.1 4.0 4.5 5.2 2.0 5.5 10.0 6.6 6.7 8.3 8.3 0.0 10.3 6.5 5.6 8.2 8.1 13.0 9.4 12.7 5.8 6.2 17.2 6.1 5.8 10.7 6.8 11.8 6.3 4.8 7.9 6.6 5.6 15.3 4.8 19.4 8.1 8.0 13.6 16.7 11.6 7.5 6.0 10.9 CHURC1 "C14orf52, FLJ33064, My015" ENSG00000258289 "Churchill domain containing 1" Q8WUH1 14 64914361-64944591 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040072 Approved Approved Cytosol NA NA Cytosol "HPA040072: AB_10963788" "unprognostic (2.94e-1)" "unprognostic (2.42e-1)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.80e-1)" "unprognostic (2.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.64e-2)" "unprognostic (4.64e-1)" "unprognostic (6.78e-3)" "unprognostic (2.12e-1)" "unprognostic (1.99e-1)" "unprognostic (3.51e-2)" "unprognostic (6.67e-2)" "unprognostic (3.04e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" 31.8 32.7 25.9 25.5 31.8 25.5 27.6 15.7 36.6 31.1 30.0 31.4 25.8 20.8 28.5 27.3 28.5 22.5 22.7 45.5 23.9 23.2 29.3 36.5 21.0 30.0 29.2 23.7 32.1 27.1 25.5 34.8 24.6 35.4 26.7 25.5 21.5 20.8 28.7 53.4 22.5 28.3 34.8 36.9 33.0 27.4 19.5 26.8 40.7 25.0 29.6 28.6 32.8 23.6 41.6 41.8 80.6 37.1 31.3 62.3 35.3 39.3 21.0 20.1 15.6 26.0 27.9 24.0 29.4 25.9 16.5 18.9 11.6 25.9 24.2 20.1 25.1 26.0 29.1 17.7 23.8 18.2 26.2 8.8 23.0 16.8 26.1 23.8 12.9 23.0 33.2 18.1 14.9 29.0 27.7 17.8 36.3 10.1 21.2 20.3 32.9 24.1 21.5 11.1 47.0 34.8 21.4 22.2 14.3 23.4 28.4 10.6 12.7 20.2 22.2 28.8 19.5 35.9 27.3 22.7 15.2 30.0 16.6 18.7 18.0 15.7 53.4 16.7 15.3 18.2 41.4 37.1 38.2 32.6 36.6 37.1 41.6 49.3 38.4 28.8 36.6 49.5 41.1 80.6 31.3 35.2 41.8 62.3 35.3 25.9 31.8 15.7 36.6 23.9 23.2 29.2 23.7 35.4 26.8 95.3 71.3 115.0 55.3 52.0 67.3 50.2 86.6 136.5 67.1 94.2 41.2 80.9 111.0 137.5 37.7 93.1 93.8 70.0 194.1 73.0 73.0 53.0 92.5 165.4 79.3 50.9 86.2 108.1 188.2 17.2 96.4 111.9 79.2 226.4 95.1 142.7 189.7 95.1 114.2 134.8 70.2 129.4 127.4 95.6 74.2 57.6 75.1 104.4 111.3 60.7 CIAO1 "CIA1, WDR39" ENSG00000144021 "Cytosolic iron-sulfur assembly component 1" O76071 2 96266132-96273349 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017882 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017882: AB_1846738" "unprognostic (2.34e-1)" "unprognostic (4.68e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (4.13e-5)" "unprognostic (1.55e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (9.86e-2)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.26e-2)" "unprognostic (2.15e-2)" 19.8 39.7 23.6 22.2 27.6 11.1 21.4 17.9 31.9 22.1 18.4 19.9 22.3 20.4 19.4 16.5 24.0 22.3 18.3 26.1 18.3 18.2 25.4 32.5 17.7 17.7 19.2 22.7 20.4 22.2 30.6 17.8 22.2 24.5 16.4 21.1 19.2 22.0 23.5 26.1 16.3 18.5 21.5 19.7 21.8 19.3 19.1 19.0 21.6 19.4 12.2 26.0 19.9 16.9 29.6 39.8 33.1 39.7 25.9 35.2 38.5 20.8 21.0 16.0 14.8 20.6 16.7 26.1 16.1 17.1 26.0 25.7 35.7 15.5 22.1 34.2 19.9 27.8 16.0 24.6 23.8 18.8 11.7 40.6 17.0 15.6 38.6 13.3 19.7 15.5 16.7 19.1 21.6 27.1 15.8 29.0 18.5 21.7 15.1 17.6 33.1 19.6 18.5 22.4 20.7 42.6 19.8 14.1 25.6 17.1 19.6 17.2 19.7 10.0 27.4 19.2 20.8 13.7 14.5 14.9 16.3 23.2 19.3 21.3 20.7 21.8 19.6 21.1 19.2 15.9 30.6 35.3 33.1 32.7 29.3 35.2 25.3 28.7 34.9 39.8 29.6 28.5 34.2 32.4 25.9 39.7 24.0 27.6 38.5 23.6 27.6 17.9 31.9 18.3 18.2 19.2 22.7 24.5 19.0 26.8 26.1 20.5 22.6 25.8 22.9 22.2 15.3 44.2 28.4 14.0 13.7 47.9 33.2 34.2 15.1 24.5 20.7 0.0 29.2 49.0 27.1 21.4 34.8 26.0 40.8 25.4 15.1 16.0 26.9 18.2 18.7 27.5 18.6 45.1 16.9 17.9 30.2 11.5 15.6 66.2 22.6 32.3 23.1 34.8 37.9 30.2 41.6 30.4 20.6 36.3 CIB3 KIP3 ENSG00000141977 "Calcium and integrin binding family member 3" Q96Q77 19 16161368-16173525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 5.4;bone marrow: 4.8;testis: 3.8" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 22.7;Late spermatids: 6.6" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.9" "Cell type enhanced" "Detected in some" "eosinophil: 5.4" "Lineage enriched" "Detected in single" 9 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "HMC-1: 9.2;MCF7: 4.4;NB-4: 2.8;THP-1: 2.6;U-937: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043553, HPA043995" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043553: AB_10964566, HPA043995: " "unprognostic (8.43e-2)" "unprognostic (7.26e-5)" "unprognostic (3.18e-2)" "unprognostic (2.62e-1)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.25e-1)" "unprognostic (3.14e-1)" "unprognostic (2.93e-2)" "unprognostic (3.05e-1)" "unprognostic (5.68e-2)" "unprognostic (3.42e-1)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.8 0.0 4.8 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 3.8 0.0 0.7 0.1 0.0 0.1 0.6 5.4 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 9.2 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.0 2.8 0.4 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 4.1 0.0 1.9 0.1 5.4 0.0 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 CIP2A KIAA1524 ENSG00000163507 "Cell proliferation regulating inhibitor of protein phosphatase 2A" Q8TCG1 3 108549869-108589644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Exocrine glandular cells: 6.4;Extravillous trophoblasts: 10.7;Hofbauer cells: 6.7;monocytes: 5.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039570 Approved Supported "Plasma membrane,Cytosol" NA Yes Cytosol "Plasma membrane" "HPA039570: AB_10796329" "unprognostic (2.02e-1)" "unprognostic (1.54e-2)" "unprognostic (2.31e-3)" "prognostic unfavorable (6.24e-5)" "unprognostic (3.10e-2)" "unprognostic (1.07e-2)" "unprognostic (1.91e-7)" "unprognostic (2.80e-3)" "unprognostic (2.53e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.18e-4)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (9.11e-3)" "unprognostic (3.73e-1)" "unprognostic (2.11e-1)" "unprognostic (1.25e-1)" 2.1 2.3 2.5 8.5 6.3 10.4 3.6 6.3 6.2 3.2 3.1 2.6 0.8 2.0 3.2 1.8 4.0 1.8 2.0 2.7 2.9 2.1 2.2 1.6 2.2 10.2 2.0 3.2 3.8 1.8 1.8 3.0 3.3 2.4 3.0 4.4 2.2 2.3 1.4 2.0 1.9 2.7 2.5 2.4 5.5 2.0 8.5 1.5 21.5 1.9 1.5 8.0 4.0 2.7 1.9 0.3 0.7 1.1 0.0 1.6 0.6 18.9 5.6 15.9 10.2 0.7 1.5 6.5 14.4 6.8 17.1 20.1 6.8 8.5 12.8 5.0 5.2 13.0 9.7 5.4 5.1 31.2 4.0 5.3 15.3 7.8 5.1 0.2 9.8 11.0 0.6 1.0 13.3 5.5 2.8 7.6 5.9 9.4 20.7 16.7 3.9 11.8 8.8 16.4 7.1 9.8 13.6 14.8 7.0 5.2 5.3 7.7 10.2 10.6 4.2 5.9 9.7 7.1 7.0 5.5 17.6 19.9 5.3 17.3 4.8 5.3 21.2 7.8 10.7 17.9 0.6 0.3 0.7 0.0 0.5 1.3 1.2 0.7 0.3 0.0 1.9 0.7 1.6 0.0 0.0 1.1 0.3 0.8 0.6 2.5 6.3 6.3 6.2 2.9 2.1 2.0 3.2 2.4 1.5 8.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 3.5 0.0 2.5 1.7 2.4 0.0 0.0 0.0 0.0 6.4 10.7 0.0 0.0 3.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 CIPC KIAA1737 ENSG00000198894 "CLOCK interacting pacemaker" Q9C0C6 14 77098097-77117287 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA000644 Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA000644: AB_1079206" "unprognostic (3.93e-2)" "unprognostic (6.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (6.67e-3)" "unprognostic (3.73e-2)" "unprognostic (1.74e-1)" "unprognostic (2.31e-2)" "unprognostic (3.20e-1)" "prognostic favorable (1.77e-10)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "unprognostic (1.13e-1)" "unprognostic (1.21e-1)" 8.9 7.3 20.8 5.9 20.7 3.1 11.4 29.0 24.2 12.8 14.1 27.9 9.9 7.5 10.7 10.0 15.5 21.2 6.7 26.1 21.6 17.5 10.4 10.9 7.9 5.8 22.2 14.9 7.1 7.1 15.8 9.4 6.6 20.5 18.3 14.1 10.6 13.3 18.2 77.7 8.6 7.9 11.8 21.6 6.3 7.1 8.0 23.4 3.4 14.4 13.1 7.1 11.4 8.8 11.4 7.2 7.7 6.7 7.6 5.8 4.2 6.2 8.3 17.6 11.8 7.2 5.7 10.9 4.2 6.5 7.4 6.8 6.6 13.4 15.3 4.0 6.6 6.9 9.5 16.4 6.3 10.2 7.9 4.4 10.2 6.3 6.1 6.8 5.6 7.5 6.6 12.6 7.3 4.6 10.0 8.6 12.4 8.8 6.2 5.6 13.5 13.2 6.8 7.4 14.3 7.2 13.3 7.7 9.2 7.6 10.5 25.1 9.3 7.4 12.1 9.7 7.8 18.9 5.7 10.3 4.9 10.5 6.9 5.0 5.5 3.8 7.4 9.3 4.8 10.3 5.8 5.8 2.1 3.7 6.7 5.8 11.4 5.2 3.9 7.2 9.4 5.6 3.9 7.7 7.6 4.8 2.7 5.3 4.2 20.8 20.7 29.0 22.4 21.6 17.5 22.2 14.9 20.5 23.4 14.9 13.6 0.8 7.0 8.0 24.6 44.8 7.6 14.7 14.8 10.4 55.0 5.6 8.3 4.2 8.7 5.8 18.6 0.0 4.7 3.7 6.0 7.5 1.1 23.6 12.8 11.1 16.7 6.7 14.3 9.9 3.7 5.8 8.5 3.6 15.6 18.9 3.9 10.5 13.4 4.9 36.3 12.9 9.5 14.9 6.1 8.5 11.3 3.9 9.5 5.8 CIT "CITK, CRIK, KIAA0949, STK21" ENSG00000122966 "Citron rho-interacting serine/threonine kinase" O14578 12 119685790-119877291 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3;brain: 35.0" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 82.5;Early spermatids: 63.4;Late spermatids: 28.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019082, HPA048812, HPA075506" Uncertain Approved Cytosol NA NA Cytosol "HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752" "unprognostic (5.64e-2)" "unprognostic (5.00e-2)" "unprognostic (8.16e-2)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (3.55e-2)" "unprognostic (3.61e-6)" "unprognostic (6.02e-2)" "unprognostic (7.78e-2)" "unprognostic (4.42e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-2)" "unprognostic (2.55e-3)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (1.70e-1)" "unprognostic (3.30e-1)" 1.4 4.4 14.7 3.3 14.0 15.3 1.6 12.7 35.0 1.6 4.6 2.9 0.0 4.0 1.3 1.5 3.2 0.9 1.6 1.0 9.8 5.7 5.7 1.4 3.0 3.4 3.2 21.9 0.7 0.7 1.2 2.9 2.6 7.4 1.0 5.3 0.6 1.3 1.0 1.3 5.1 3.5 2.6 5.0 5.6 3.5 8.3 9.5 5.9 1.5 0.1 4.9 1.7 1.7 0.4 0.0 0.0 0.1 0.0 1.2 0.8 15.1 13.7 12.0 11.3 1.1 3.3 7.1 11.7 9.7 12.2 9.2 8.7 6.3 11.0 6.3 9.0 6.0 9.5 8.2 6.8 16.9 7.8 6.0 13.9 8.8 5.4 0.1 7.3 12.8 0.7 0.8 14.6 9.0 4.4 9.3 12.2 8.8 9.3 11.5 7.6 13.2 11.1 6.5 5.7 9.3 12.1 21.9 3.6 2.4 6.7 8.6 4.7 19.4 3.8 9.2 6.3 13.7 5.3 7.1 15.3 14.1 10.4 12.7 6.3 7.1 7.5 10.1 8.1 23.6 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 14.7 14.0 12.7 35.0 9.8 5.7 3.2 21.9 7.4 9.5 6.0 8.8 0.8 0.6 3.0 7.4 1.6 0.0 1.4 9.1 8.7 82.5 0.9 0.0 0.2 63.4 1.1 0.4 0.0 0.7 4.0 1.1 0.3 1.1 0.8 2.9 0.0 1.7 1.3 1.9 28.5 1.1 1.0 3.3 0.0 1.1 15.4 0.1 0.0 1.1 5.7 15.0 0.0 0.4 11.5 3.5 1.1 0.8 2.5 1.6 1.0 CITED1 MSG1 ENSG00000125931 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1" Q99966 X 72301638-72307187 "Predicted intracellular proteins" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 247.1;pituitary gland: 62.8;testis: 89.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 13.8;Late spermatids: 28.3;Sertoli cells: 12.9" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 134.9" "Region enriched" "Detected in many" 5 "hypothalamus: 18.9" "Cell type enhanced" "Detected in some" "eosinophil: 2.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AN3-CA: 17.9;SK-MEL-30: 71.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049051 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049051: AB_2680612" "unprognostic (7.04e-2)" "unprognostic (3.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" "unprognostic (8.81e-2)" "unprognostic (5.67e-4)" "unprognostic (3.40e-1)" "unprognostic (9.55e-2)" "unprognostic (4.60e-3)" "unprognostic (4.38e-2)" "unprognostic (6.33e-3)" "unprognostic (1.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.62e-1)" "prognostic favorable (6.10e-4)" "prognostic favorable (3.95e-4)" "unprognostic (2.99e-2)" 0.5 0.6 3.5 0.5 2.2 0.4 6.0 0.9 2.8 1.3 0.5 0.3 5.3 0.5 1.0 247.1 0.4 0.5 0.4 0.4 2.4 18.9 0.6 0.4 0.5 0.4 1.1 0.9 0.5 0.6 0.4 62.8 0.4 2.7 2.1 0.4 27.8 0.4 1.2 0.4 0.4 0.5 1.7 0.5 0.4 0.4 89.9 0.0 0.0 1.7 0.0 0.4 0.4 0.0 0.0 0.8 2.2 0.5 0.0 1.1 1.1 0.1 0.1 0.7 17.9 0.8 0.0 0.6 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 6.4 0.4 0.0 1.8 2.5 0.3 0.2 0.0 0.0 0.1 3.5 0.3 0.2 0.2 0.3 0.0 0.0 0.1 0.7 0.1 0.1 0.2 0.0 1.4 1.0 0.1 1.2 0.0 1.2 0.9 0.0 0.2 8.1 4.2 0.1 1.6 71.3 0.1 0.5 0.4 0.0 0.1 0.7 0.1 0.3 0.1 0.1 0.1 0.1 0.2 1.7 0.0 0.5 2.2 0.4 0.0 1.1 0.0 0.2 0.6 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 3.5 2.2 0.9 2.8 2.4 18.9 1.1 0.9 2.7 0.0 0.0 0.0 0.0 1.0 0.1 3.2 0.3 2.5 0.0 0.0 3.5 5.9 0.1 0.0 0.0 13.8 0.2 0.1 0.0 0.7 0.0 0.2 8.6 0.0 0.0 0.1 0.0 1.2 0.0 0.0 28.3 6.9 0.0 3.3 0.0 0.1 0.8 0.4 7.2 2.8 0.3 3.5 12.9 0.3 6.8 3.7 0.0 0.0 0.0 0.1 0.9 CKAP2 "FLJ10749, LB1, se20-10, TMAP" ENSG00000136108 "Cytoskeleton associated protein 2" Q8WWK9 13 52455429-52476628 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 42.3;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 140.2;Spermatocytes: 150.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA008410, HPA027821" Enhanced Enhanced Microtubules,Cytosol No Yes Microtubules Cytosol "HPA008410: AB_1846832, HPA027821: AB_10602208" "unprognostic (1.85e-1)" "unprognostic (2.09e-3)" "unprognostic (2.44e-2)" "unprognostic (4.07e-3)" "unprognostic (1.39e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.38e-2)" "unprognostic (4.24e-2)" "unprognostic (1.69e-2)" "unprognostic (8.30e-2)" "unprognostic (6.60e-3)" "prognostic unfavorable (1.90e-5)" "unprognostic (2.01e-2)" "unprognostic (5.20e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" 4.6 9.2 7.1 12.1 12.2 42.3 4.4 16.4 9.9 4.3 6.7 1.9 2.3 9.0 4.2 5.2 14.7 3.0 4.1 5.3 5.8 7.8 5.0 3.2 5.0 13.5 5.9 5.8 3.5 2.4 3.4 10.9 10.2 16.1 4.6 7.4 1.4 6.7 3.6 5.8 10.4 7.0 6.5 5.5 12.4 4.2 22.1 5.2 49.2 5.0 10.3 14.8 8.1 6.6 15.2 16.1 30.4 12.8 2.5 15.7 4.2 19.5 10.6 42.5 21.0 5.5 5.5 10.7 32.3 19.1 37.7 24.3 15.2 24.8 37.6 5.2 24.0 17.6 23.0 29.2 16.4 52.6 25.4 24.1 33.9 11.9 10.8 2.3 33.6 13.8 4.0 6.8 17.6 23.2 11.2 22.8 16.1 14.2 15.6 41.5 9.2 23.1 16.6 25.1 30.5 11.2 22.2 24.4 16.4 11.5 10.7 13.0 16.9 18.2 13.4 9.9 22.5 14.7 16.2 15.0 10.9 16.8 17.0 32.3 9.2 13.5 46.3 7.6 17.6 28.7 30.4 7.2 10.4 5.4 10.4 4.8 12.2 8.2 6.4 7.5 15.2 6.5 5.5 2.2 2.5 12.8 16.1 15.7 4.2 7.1 12.2 16.4 9.9 5.8 7.8 5.9 5.8 16.1 5.2 6.0 3.2 36.9 3.9 13.4 9.9 7.3 0.0 2.7 9.1 1.8 5.9 24.3 8.3 5.2 32.6 9.8 4.5 140.2 5.2 34.8 11.3 2.6 16.1 4.3 26.4 1.6 6.9 16.5 20.7 39.9 6.9 16.4 0.0 14.4 7.9 12.3 2.8 3.5 15.9 6.7 5.8 6.5 6.2 150.2 65.4 13.4 8.4 11.7 11.3 2.4 CKAP2L "FLJ40629, radmis" ENSG00000169607 "Cytoskeleton associated protein 2 like" Q8IYA6 2 112736607-112764677 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.4;lymphoid tissue: 38.3" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 8.9;Spermatocytes: 31.7;Spermatogonia: 32.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA039407, HPA040057, HPA070737" Uncertain Supported "Mitotic spindle,Cytosol" Yes Yes "Mitotic spindle" Cytosol "HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (4.69e-3)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.59e-2)" "unprognostic (5.75e-5)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (9.57e-6)" "unprognostic (2.42e-1)" "unprognostic (0.00e+0)" "unprognostic (7.37e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" 1.5 0.7 0.6 9.2 0.6 13.4 1.3 0.7 0.6 0.6 1.8 0.0 0.3 1.5 0.5 1.4 3.8 0.7 0.1 2.3 0.6 0.5 0.7 0.7 1.2 5.3 0.6 0.2 0.6 0.6 0.0 0.5 3.2 0.2 0.6 2.4 0.0 1.0 0.0 0.6 1.5 2.4 0.9 0.6 2.2 0.9 9.0 0.1 38.3 0.6 5.9 6.0 0.9 0.7 1.0 0.8 1.8 0.7 1.6 1.8 0.4 20.1 4.0 15.9 7.2 0.9 1.5 3.2 16.7 13.9 17.4 16.6 3.8 5.9 13.8 6.9 6.5 21.7 7.8 9.1 8.8 29.3 19.2 4.0 23.0 5.6 3.2 0.0 10.8 13.8 0.4 0.8 21.8 12.4 4.5 7.9 10.1 6.1 20.2 14.1 2.9 13.1 4.1 6.8 8.6 13.2 9.5 16.7 3.6 2.9 7.9 8.8 5.5 6.8 5.6 5.8 6.2 5.5 5.0 5.6 19.3 15.0 15.3 12.2 4.3 8.4 11.8 8.3 7.8 30.2 0.8 0.5 0.7 0.5 0.7 0.4 0.9 1.2 1.1 0.5 1.0 0.5 0.7 1.8 1.6 0.7 0.8 1.8 0.4 0.6 0.6 0.7 0.6 0.6 0.5 0.6 0.2 0.2 0.1 3.0 1.1 0.8 1.6 3.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 8.9 0.4 0.3 0.0 0.0 5.4 0.0 0.0 1.8 2.1 0.8 0.0 1.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 31.7 32.2 1.5 0.8 1.5 1.0 0.9 CKAP4 "CLIMP-63, ERGIC-63, P63" ENSG00000136026 "Cytoskeleton associated protein 4" Q07065 12 106237877-106304279 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 34.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 34.6" "Cell line enhanced" "Detected in many" "BJ: 74.6;BJ hTERT+: 94.1;fHDF/TERT166: 112.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000278, HPA000792, HPA001225" Enhanced Uncertain "Nuclear speckles,Cytosol,Cytoplasmic bodies" NA NA 11000 "Nuclear speckles, Cytosol" "Cytoplasmic bodies" "HPA000278: AB_1078527, HPA000792: AB_1078526, HPA001225: AB_2666241" "unprognostic (5.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (7.13e-2)" "unprognostic (2.44e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (6.61e-5)" "prognostic unfavorable (5.61e-4)" "unprognostic (5.02e-2)" "unprognostic (9.66e-3)" "unprognostic (1.95e-1)" "unprognostic (6.23e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.20e-3)" "unprognostic (6.97e-2)" "unprognostic (1.29e-2)" "unprognostic (3.66e-2)" 13.0 23.8 7.1 15.3 4.9 39.5 27.2 6.9 8.4 42.3 19.2 6.5 24.8 8.1 23.7 35.2 47.3 17.2 26.6 32.9 5.7 8.0 18.3 42.1 22.2 28.5 6.3 5.4 28.6 55.2 12.7 12.0 30.6 6.8 23.9 20.5 13.2 34.4 28.0 11.1 20.8 10.7 20.4 5.8 16.7 23.0 10.3 4.2 4.0 18.6 30.0 27.8 25.8 21.4 4.2 2.3 34.6 7.5 0.1 1.0 2.4 11.4 14.4 17.5 18.9 34.1 30.4 10.1 74.6 94.1 36.5 42.0 6.1 2.6 0.7 13.6 112.3 12.4 20.8 12.7 11.3 26.3 0.4 7.4 0.0 8.3 11.9 25.4 0.1 0.2 29.1 15.5 30.9 22.4 46.3 42.6 0.8 0.0 1.5 34.6 3.8 0.5 0.4 10.1 6.0 17.5 5.3 12.6 0.9 11.1 10.3 5.7 6.4 13.2 9.0 7.1 16.4 10.1 5.2 36.3 28.8 15.9 11.9 21.0 4.0 0.0 8.1 20.7 1.4 25.1 34.6 7.5 8.7 0.5 2.7 0.7 4.2 0.7 0.4 2.3 1.6 1.0 0.9 12.7 0.1 4.1 0.0 0.2 2.4 7.1 4.9 6.9 8.4 5.7 8.0 6.3 5.4 6.8 4.2 20.8 24.5 3.0 33.7 48.7 12.8 42.1 43.3 5.3 21.6 22.7 9.8 24.4 5.0 32.4 0.9 24.8 13.4 0.0 75.4 79.1 87.2 68.6 19.5 49.1 19.2 44.5 39.7 49.7 37.3 1.1 63.3 14.9 32.1 6.4 162.0 23.7 51.4 5.8 57.7 9.1 18.4 12.9 46.7 2.5 12.2 62.9 22.1 3.2 60.8 36.8 CKB CKBB ENSG00000166165 "Creatine kinase B" P12277 14 103519659-103523111 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 158.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 2313.9;Horizontal cells: 4762.4;Muller glia cells: 3352.8;Rod photoreceptor cells: 2841.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "non-classical monocyte: 50.0" "Lineage enriched" "Detected in many" 17 "monocytes: 50.0" "Cell line enhanced" "Detected in many" "CACO-2: 54.3;HEK 293: 138.1;SCLC-21H: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001254, CAB047313" Enhanced Supported Cytosol No No 50000000 Cytosol "CAB047313: , HPA001254: AB_1078528" "unprognostic (9.97e-2)" "unprognostic (1.33e-3)" "unprognostic (4.25e-3)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (3.62e-2)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (4.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.68e-3)" "unprognostic (9.89e-3)" "prognostic favorable (4.02e-8)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.67e-2)" "unprognostic (2.13e-1)" 32.4 27.3 75.4 10.4 114.6 3.1 5.3 94.3 158.5 29.1 121.5 51.4 23.8 17.6 37.3 8.9 28.6 35.7 17.8 36.4 60.7 43.2 26.7 3.4 12.8 3.6 63.4 93.3 15.8 10.2 20.3 9.7 3.7 63.3 107.5 55.0 43.9 18.3 92.1 19.1 14.4 17.5 53.2 31.9 3.6 66.7 22.1 50.9 0.0 19.8 7.8 3.9 43.0 13.0 0.0 2.9 1.4 50.0 0.0 0.1 0.9 0.3 6.8 27.5 1.4 0.2 0.2 0.5 2.9 0.0 0.3 0.1 54.3 0.8 0.0 3.3 2.1 1.1 6.0 7.9 0.1 0.0 1.2 138.1 10.2 30.3 18.6 1.2 0.0 8.4 1.1 0.0 0.2 0.1 0.4 0.0 0.6 17.8 0.4 0.4 2.3 0.2 0.3 10.7 4.6 21.4 1.8 0.5 28.2 5.0 0.2 78.6 32.3 5.8 1.0 2.1 2.0 2.5 4.2 0.1 0.1 5.3 0.5 12.9 1.3 0.3 0.9 0.7 0.2 1.0 0.3 0.1 1.4 0.0 5.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.1 0.0 50.0 0.0 0.1 0.9 75.4 114.6 94.3 152.7 60.7 43.2 63.4 93.3 63.3 50.9 181.7 96.3 15.9 251.5 136.6 2313.9 490.2 117.2 301.2 83.0 108.2 1798.5 3.2 1933.1 99.3 397.5 36.5 717.3 0.0 37.5 9.9 100.2 316.9 28.8 6.8 6.9 4762.4 449.5 67.5 3.0 120.4 281.6 32.2 172.1 122.6 614.3 3352.8 99.2 2059.7 1024.0 69.5 2841.9 58.2 193.9 161.4 92.5 153.2 34.8 12.1 562.9 194.5 CKS1B "CKS1, ckshs1" ENSG00000173207 "CDC28 protein kinase regulatory subunit 1B" P61024 1 154974653-154979249 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 303.7;Extravillous trophoblasts: 535.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol NA Yes "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: AB_2666948, HPA030762: AB_10670044" "unprognostic (1.06e-2)" "unprognostic (1.62e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (7.89e-4)" "unprognostic (1.34e-1)" "unprognostic (2.59e-2)" "prognostic unfavorable (2.94e-5)" "unprognostic (2.01e-3)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.63e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (3.19e-1)" "prognostic unfavorable (6.03e-7)" "unprognostic (3.12e-2)" "unprognostic (1.44e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.37e-1)" 25.3 14.5 13.5 13.4 19.0 36.4 24.8 4.2 14.6 15.6 17.4 12.4 19.8 14.7 14.7 13.8 28.2 15.2 14.1 16.5 15.3 8.0 16.6 29.5 12.9 23.8 29.5 8.8 14.2 12.8 8.3 9.4 35.6 15.9 11.7 18.8 7.5 12.8 13.1 5.9 22.6 22.9 12.5 19.8 18.0 14.7 22.8 21.5 30.2 15.5 19.3 25.5 11.1 23.3 23.9 30.4 2.2 32.8 9.0 12.2 8.7 59.7 82.4 61.8 33.5 8.9 9.2 49.4 27.8 21.6 60.4 48.4 79.6 88.4 56.9 47.6 18.4 33.9 55.5 61.2 39.9 56.8 51.1 39.7 38.5 36.7 55.9 2.7 46.3 35.4 5.3 17.3 51.6 71.6 12.4 30.3 39.5 62.5 77.4 45.4 59.4 43.4 35.8 78.4 57.4 74.4 43.7 50.9 72.9 21.5 21.9 25.2 63.7 42.0 39.9 46.0 74.9 53.4 64.8 16.8 39.2 40.6 32.4 66.2 47.8 92.7 80.3 24.9 39.5 54.1 0.7 4.4 2.2 7.0 26.0 8.4 23.9 9.9 9.5 7.2 22.6 12.2 11.5 0.6 9.0 32.8 30.4 10.6 8.7 13.5 19.0 4.2 14.6 15.3 8.0 29.5 8.8 15.9 21.5 11.9 26.6 58.1 85.2 193.2 2.1 8.9 68.8 40.2 40.9 27.9 0.0 103.2 68.0 71.4 12.5 39.5 35.7 303.7 98.8 535.3 106.1 48.1 20.7 75.7 110.7 1.6 19.7 30.1 33.8 18.8 70.5 54.9 108.0 55.9 35.3 15.6 87.5 41.8 43.2 64.8 2.4 19.4 106.1 117.9 120.7 178.0 110.3 47.9 49.4 87.8 CKS2 ENSG00000123975 "CDC28 protein kinase regulatory subunit 2" P33552 9 89311198-89316703 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.6;testis: 103.2" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 581.2;Spermatogonia: 464.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 54.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol NA Yes "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: AB_2666948, HPA030762: AB_10670044" "unprognostic (8.30e-2)" "unprognostic (3.00e-1)" "unprognostic (1.50e-2)" "unprognostic (2.80e-2)" "unprognostic (2.96e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (3.57e-3)" "unprognostic (7.04e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (2.13e-3)" "unprognostic (1.44e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" 4.8 22.4 4.2 22.7 6.1 38.1 10.7 4.0 7.5 3.6 10.8 3.0 16.7 10.8 4.6 4.4 20.4 2.8 4.7 3.3 6.1 3.2 11.0 10.2 9.5 24.6 5.2 4.3 3.9 2.6 7.0 2.2 12.4 5.0 4.8 10.7 3.2 4.4 7.6 3.6 6.1 9.3 4.1 5.4 12.6 6.8 103.2 3.6 41.6 4.6 13.5 20.8 8.1 16.7 18.3 54.6 12.4 7.5 11.6 17.9 6.5 84.0 72.1 44.1 29.5 13.0 11.9 32.2 50.1 27.0 55.5 44.5 29.6 41.8 63.0 29.7 18.7 98.8 59.2 52.9 38.6 63.9 49.1 42.8 31.9 52.8 78.5 5.6 65.0 36.4 4.3 8.9 39.7 35.1 21.2 51.3 51.9 38.0 55.2 71.1 63.1 51.0 114.6 64.4 99.0 66.6 44.2 48.5 37.6 43.5 19.3 37.4 22.3 41.6 40.4 40.4 43.2 48.6 37.8 29.1 24.0 45.6 58.0 72.8 44.8 90.7 50.8 35.4 37.7 34.1 10.5 5.9 12.4 7.0 7.5 7.9 18.3 9.6 6.7 6.5 13.5 5.2 6.8 4.2 11.6 4.1 54.6 17.9 6.5 4.2 6.1 4.0 7.5 6.1 3.2 5.2 4.3 5.0 3.6 35.7 93.0 97.3 70.9 248.9 4.2 55.0 5.1 12.0 17.0 14.0 0.0 149.0 19.9 15.2 25.4 26.7 39.1 350.4 9.7 329.6 72.5 59.4 147.1 19.5 152.7 0.0 117.0 28.3 40.0 59.4 23.9 84.8 133.3 33.3 56.8 24.6 23.3 46.9 15.6 148.6 6.0 45.3 99.9 581.2 464.7 261.3 166.8 40.1 104.9 59.3 CLASP2 KIAA0627 ENSG00000163539 "Cytoplasmic linker associated protein 2" O75122 3 33496245-33718356 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 95.1;Cone photoreceptor cells: 147.3;Horizontal cells: 87.4;Rod photoreceptor cells: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067071 Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA067071: AB_2685775" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (7.24e-3)" "unprognostic (5.46e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (1.27e-2)" "unprognostic (4.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-2)" "unprognostic (2.60e-3)" "unprognostic (3.25e-2)" "prognostic favorable (1.48e-6)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (1.07e-2)" "unprognostic (5.72e-2)" 7.9 14.5 20.6 6.5 31.6 6.0 9.0 45.4 67.1 13.0 8.9 50.7 3.4 5.6 11.7 6.7 10.2 9.4 10.0 22.0 19.1 16.8 10.4 6.1 8.6 7.9 33.4 22.1 16.1 6.5 11.6 16.1 8.7 44.7 9.8 7.7 13.4 6.5 12.4 31.7 7.3 6.7 11.2 29.7 7.7 6.8 6.5 37.3 4.1 8.1 4.9 8.6 8.0 7.5 8.4 8.7 4.7 8.4 12.3 7.2 5.6 7.2 16.2 18.5 15.6 12.1 11.9 13.4 13.7 13.0 16.2 17.5 9.4 7.6 24.1 8.0 10.7 10.4 6.4 24.0 10.9 19.7 19.4 17.0 23.7 14.3 8.3 5.8 23.3 20.3 7.3 10.9 17.4 16.7 9.4 15.6 15.0 23.1 13.8 17.4 4.0 17.2 10.0 13.8 7.3 10.3 18.6 17.5 13.1 10.3 8.3 15.6 26.4 15.9 12.4 13.7 15.7 11.7 20.8 14.9 12.7 11.1 9.5 15.1 9.8 18.3 20.0 11.5 16.2 16.1 4.7 5.9 3.3 4.8 6.3 7.2 8.4 4.2 4.5 8.7 5.6 5.7 5.2 1.2 12.3 8.4 8.3 4.5 5.6 20.6 31.6 45.4 38.7 19.1 16.8 33.4 22.1 44.7 37.3 6.0 9.4 14.3 7.0 18.7 95.1 34.3 17.8 9.4 12.5 14.0 147.3 10.5 1.7 5.7 2.3 12.1 7.3 0.0 5.9 6.5 12.4 12.6 11.5 12.2 13.1 87.4 13.8 14.7 32.0 2.6 13.3 16.7 15.1 9.0 10.0 36.3 7.3 7.0 12.7 9.9 124.9 6.5 18.9 10.8 13.8 26.8 10.8 17.0 10.1 7.8 CLBA1 C14orf79 ENSG00000140104 "Clathrin binding box of aftiphilin containing 1" Q96F83 14 104985775-105010482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 14.9;Ciliated cells: 34.8;Collecting duct cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042052, HPA061117" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA042052: AB_2677822, HPA061117: AB_2684434" "unprognostic (1.49e-2)" "unprognostic (4.04e-2)" "unprognostic (4.84e-2)" "unprognostic (2.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.49e-1)" "unprognostic (5.77e-2)" "unprognostic (9.43e-3)" "unprognostic (1.78e-1)" "unprognostic (8.21e-2)" "unprognostic (3.50e-2)" "unprognostic (2.30e-1)" "unprognostic (4.39e-3)" "unprognostic (3.12e-2)" "unprognostic (1.11e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" 2.1 5.3 5.4 2.6 12.5 2.0 6.6 3.5 13.5 7.6 3.4 5.2 11.8 2.3 6.8 15.1 5.1 18.9 6.5 2.4 6.2 6.5 8.9 6.1 7.4 1.8 3.3 5.9 6.8 11.3 13.2 15.3 2.4 5.3 7.6 3.5 7.6 6.3 8.3 1.3 9.2 2.2 4.4 2.1 2.4 5.9 23.9 1.8 1.8 17.6 1.0 2.3 4.2 3.3 1.8 2.3 2.4 1.1 1.0 1.4 0.5 4.0 7.3 2.2 6.9 2.2 3.3 3.4 3.3 3.1 4.0 1.8 0.7 7.2 0.4 7.0 3.3 2.1 8.8 0.8 4.9 2.5 3.3 2.6 0.3 6.3 0.3 7.9 1.7 1.8 2.1 11.4 4.3 8.5 6.8 2.3 3.5 2.4 1.1 2.3 13.8 0.7 5.2 2.9 4.0 7.0 2.6 1.2 2.3 8.6 2.4 14.4 7.5 4.7 2.1 3.8 1.5 15.0 2.5 2.4 5.0 2.3 10.1 2.5 1.4 0.9 0.3 6.4 0.5 3.5 1.8 1.1 0.4 1.4 1.1 0.3 1.2 1.4 0.3 0.5 1.8 0.6 1.3 2.4 1.0 1.0 2.3 0.6 0.5 5.4 12.5 3.5 13.5 6.2 6.5 3.3 5.9 5.3 1.8 14.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 34.8 4.5 15.7 0.0 1.2 3.3 6.2 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 2.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 4.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 CLCN2 "ClC-2, CLC2, EJM6" ENSG00000114859 "Chloride voltage-gated channel 2" P51788 3 184346185-184361651 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 21.0;intestine: 20.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 10.2;Enterocytes: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009397, HPA014545, HPA024108" Approved Approved Cytosol NA NA Cytosol "CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883" "unprognostic (1.13e-1)" "unprognostic (4.01e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (4.67e-8)" "unprognostic (1.72e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-1)" "unprognostic (2.50e-3)" "unprognostic (1.19e-1)" "unprognostic (4.40e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (1.35e-1)" 1.6 5.4 4.9 2.6 8.3 1.3 1.6 8.8 6.3 2.8 20.2 16.9 5.1 11.6 4.5 5.0 1.7 2.8 21.0 1.5 6.3 3.1 3.7 1.8 1.3 1.0 15.3 4.1 6.1 5.9 4.4 4.0 1.5 8.9 2.6 14.0 15.6 3.7 9.0 1.2 2.2 11.8 2.4 10.8 1.6 2.7 11.9 9.8 0.1 3.2 1.3 1.3 2.2 2.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 8.0 2.8 2.3 6.2 2.1 1.8 5.4 2.9 1.6 2.9 1.8 15.1 2.7 2.8 8.0 1.4 7.5 14.0 3.3 3.1 0.9 2.5 4.0 2.5 5.8 6.4 1.3 1.0 2.5 3.4 2.5 2.5 2.9 1.3 2.7 3.0 1.0 1.4 1.0 4.4 0.8 1.3 3.5 6.7 4.4 5.0 2.2 9.6 3.5 6.1 3.9 2.3 3.0 10.5 4.7 1.6 8.5 1.1 1.3 1.5 4.4 7.1 7.0 3.8 4.8 1.7 2.6 4.8 6.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 8.3 8.8 6.3 6.3 3.1 15.3 4.1 8.9 9.8 3.0 2.6 0.0 0.7 0.9 2.2 1.1 10.2 4.0 1.2 0.0 0.0 0.9 0.0 3.5 2.4 0.5 30.8 0.0 1.8 0.4 1.0 0.6 1.1 0.4 0.5 1.6 2.9 1.8 0.0 1.3 4.9 0.4 0.0 1.0 3.6 1.8 1.8 7.8 4.6 2.2 2.6 0.0 0.8 3.3 1.6 0.4 1.3 0.0 6.5 0.3 CLCN5 "ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN" ENSG00000171365 "Chloride voltage-gated channel 5" P51795 X 49922615-50099235 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.1" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 8 "dendritic cells: 6.6;monocytes: 1.8" "Cell line enhanced" "Detected in many" "CACO-2: 25.4;RH-30: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000401, HPA003213" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane" Cytosol "HPA000401: AB_1078531, HPA003213: AB_2666843" "unprognostic (3.33e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.57e-1)" "unprognostic (7.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.54e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.20e-4)" "unprognostic (3.59e-2)" "prognostic favorable (2.05e-8)" "unprognostic (7.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" 4.4 4.1 2.5 2.4 2.9 2.1 3.4 9.4 3.4 2.3 3.1 2.6 4.7 5.0 9.8 26.7 3.7 4.6 7.6 2.2 3.1 2.8 46.1 15.8 4.7 3.0 2.6 2.5 10.8 6.7 2.6 8.3 7.3 5.9 2.7 3.7 7.6 4.0 3.5 5.6 6.2 6.4 3.8 4.3 3.0 4.0 5.9 2.3 1.2 3.6 4.0 2.3 2.4 3.1 0.2 6.6 0.5 1.8 0.3 0.4 0.5 1.8 2.8 2.2 3.3 8.4 5.3 4.7 1.5 0.8 1.0 1.2 25.4 1.7 1.8 0.8 1.7 5.6 1.5 6.8 0.8 1.6 0.7 4.6 1.8 1.4 6.6 4.0 2.3 3.4 3.1 1.1 2.6 3.8 0.8 3.6 2.4 2.7 2.7 2.9 1.8 0.8 0.7 3.2 4.2 1.4 1.1 39.3 2.8 3.8 2.9 3.8 2.7 2.2 2.2 3.1 8.7 1.9 1.1 1.8 1.0 2.1 7.8 0.9 2.3 6.9 4.1 1.7 3.8 5.1 0.1 1.8 0.0 0.2 1.5 0.3 0.2 0.4 0.4 3.8 0.2 0.1 0.1 0.5 0.3 0.3 6.6 0.0 0.5 2.5 2.9 9.4 3.4 3.1 2.8 2.6 2.5 5.9 2.3 8.9 5.9 1.5 1.6 6.4 19.5 1.6 5.1 5.3 0.0 12.2 2.0 5.2 10.0 3.7 1.1 3.8 10.9 0.0 2.9 2.2 5.7 3.1 2.3 21.7 8.9 7.9 0.0 0.6 9.5 0.0 4.9 8.9 3.3 5.4 5.7 2.8 5.8 6.2 12.4 32.4 4.3 0.0 3.3 1.0 0.7 8.3 4.2 0.0 6.4 4.6 CLCN6 "CLC-6, KIAA0046" ENSG00000011021 "Chloride voltage-gated channel 6" P51797 1 11806096-11843144 "Plasma proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032097 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA032097: AB_10670827" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (8.83e-2)" "unprognostic (2.08e-1)" "unprognostic (3.84e-3)" "unprognostic (1.51e-3)" "unprognostic (6.49e-2)" "unprognostic (7.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.71e-3)" "unprognostic (3.44e-1)" "unprognostic (2.13e-2)" "unprognostic (6.91e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (3.65e-2)" 11.2 14.6 18.9 11.5 18.7 12.2 8.6 18.0 27.9 9.2 8.7 22.4 8.6 9.6 12.8 14.2 6.3 10.7 8.1 15.7 15.0 20.6 10.0 9.1 10.6 11.1 16.4 17.8 21.4 6.6 8.4 14.8 9.6 32.4 11.3 7.8 13.1 6.7 8.7 11.2 10.0 9.1 10.8 15.9 10.6 8.5 16.1 14.5 4.3 10.7 5.0 9.5 7.7 8.2 10.1 3.2 4.2 4.6 2.0 3.2 1.1 5.6 5.3 12.0 10.1 12.9 13.4 3.7 4.7 9.2 6.6 10.3 8.1 13.8 8.1 3.9 4.4 16.4 8.4 7.9 8.8 5.9 3.6 4.2 8.4 10.5 10.7 16.7 4.7 7.9 9.2 5.2 12.4 7.0 8.0 5.9 8.4 10.6 11.7 6.7 3.1 4.8 12.7 8.0 2.7 4.2 6.1 6.6 7.4 8.7 4.7 5.2 8.3 3.2 5.1 11.0 8.8 4.5 8.4 7.1 6.2 7.0 10.5 3.3 7.0 4.3 20.8 7.6 9.4 4.5 4.2 4.6 1.5 2.6 3.7 1.5 8.0 2.1 3.2 2.7 10.1 2.3 2.1 3.9 2.0 4.6 3.2 1.4 1.1 18.9 18.7 18.0 27.9 15.0 20.6 16.4 17.8 32.4 14.5 17.9 20.5 11.3 3.3 3.1 18.5 21.8 10.2 8.1 6.8 3.5 13.7 3.2 0.0 3.6 12.5 5.6 5.4 0.0 3.9 2.2 5.2 4.1 2.3 5.5 6.5 25.4 6.3 8.0 8.2 7.4 6.9 10.1 1.7 5.4 2.9 7.8 4.2 3.5 6.7 3.0 16.0 0.0 4.2 9.7 9.4 2.8 3.4 2.5 3.0 3.5 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 22.9 14.0 27.7 21.6 12.5 14.2 19.6 20.0 27.7 14.8 18.3 9.0 19.2 13.6 38.0 24.3 17.6 10.8 35.1 21.2 7.5 18.7 5.2 13.2 22.2 16.8 18.7 25.2 58.3 15.6 16.8 21.5 21.7 17.9 9.3 27.7 28.1 9.4 12.3 11.1 19.9 7.8 15.6 8.3 30.8 11.4 18.7 8.1 8.3 22.8 19.6 6.6 28.1 32.1 6.6 14.3 20.1 26.1 24.1 17.7 18.4 36.7 15.7 14.5 43.6 16.2 33.3 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 32.8 39.6 30.5 103.2 128.0 19.7 48.0 12.7 16.0 23.9 26.2 23.6 44.0 24.9 18.4 58.8 63.1 19.7 46.7 14.2 132.7 70.7 85.5 35.8 18.7 31.6 14.3 27.5 54.0 25.9 62.2 47.8 38.0 108.0 43.3 18.8 28.6 24.0 11.5 43.9 18.2 31.4 51.8 126.4 168.0 50.6 171.8 80.1 103.6 17.1 110.7 CLEC4E "CLECSF9, mincle" ENSG00000166523 "C-type lectin domain family 4 member E" Q9ULY5 12 8533305-8540963 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2" "Group enriched" "Detected in some" 8 "Kupffer cells: 144.8;Macrophages: 65.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 22.8;neutrophil: 81.7" "Group enriched" "Detected in many" 17 "granulocytes: 81.7;monocytes: 22.8" "Group enriched" "Detected in some" 4 "NB-4: 5.8;RPTEC TERT1: 16.3" "Not detected" "Not detected" HPA004935 Uncertain Uncertain Cytosol NA NA Cytosol "HPA004935: AB_2667299" "unprognostic (3.05e-2)" "unprognostic (2.01e-2)" "unprognostic (8.91e-2)" "unprognostic (3.76e-1)" "unprognostic (1.76e-1)" "unprognostic (9.71e-3)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.62e-1)" "unprognostic (1.51e-1)" "unprognostic (8.44e-2)" "unprognostic (2.29e-1)" 8.4 3.0 1.1 20.9 2.4 37.7 17.5 1.2 2.2 3.4 1.4 0.0 1.1 0.1 1.2 1.6 1.7 4.2 6.7 5.9 1.3 1.2 6.2 3.5 25.6 41.2 2.8 0.6 1.0 3.3 0.0 1.7 1.7 9.0 1.6 0.5 1.1 1.2 0.6 2.7 0.7 1.9 3.2 5.3 34.2 1.8 3.3 0.8 0.7 12.8 0.9 1.1 2.2 2.2 0.0 2.9 81.7 22.8 0.0 0.0 4.5 0.1 0.6 0.4 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.1 2.0 0.1 0.2 2.6 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.3 0.3 0.0 0.7 0.1 0.0 1.7 0.1 0.6 0.7 0.1 0.2 0.1 0.0 0.1 0.0 5.8 0.5 0.0 0.1 0.1 0.2 0.1 16.3 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.0 0.5 1.3 0.6 0.1 1.1 0.1 0.2 0.1 0.1 1.6 0.5 0.1 0.0 22.8 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 81.7 0.0 0.1 0.1 0.0 4.5 1.1 2.4 1.2 2.2 1.3 1.2 2.8 0.6 9.0 0.8 0.0 6.6 1.4 0.0 0.0 0.0 0.3 7.6 1.4 3.4 1.8 0.0 0.0 0.0 4.5 0.3 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 5.8 0.0 0.0 11.6 144.8 1.1 0.9 65.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 12.9 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 CLEC4F "CLECSF13, FLJ39110, KCLR" ENSG00000152672 "C-type lectin domain family 4 member F" Q8N1N0 2 70808643-70820600 "Predicted membrane proteins" Endocytosis Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 9.8;Horizontal cells: 4.8;Rod photoreceptor cells: 7.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 9 "intermediate monocyte: 7.9;non-classical monocyte: 5.8" "Lineage enriched" "Detected in single" 11 "monocytes: 7.9" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;BEWO: 2.1;HAP1: 1.7;SH-SY5Y: 1.4;T-47d: 3.1" "Not detected" "Not detected" HPA056101 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA056101: " "unprognostic (8.14e-3)" "unprognostic (3.73e-2)" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (4.91e-2)" "unprognostic (5.41e-2)" "unprognostic (3.66e-2)" "unprognostic (2.07e-2)" "unprognostic (9.29e-2)" "unprognostic (3.45e-1)" "unprognostic (2.68e-4)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-2)" "unprognostic (9.59e-2)" "unprognostic (2.44e-1)" 3.1 0.0 0.5 3.2 0.5 0.0 2.1 0.7 0.7 1.8 4.2 0.5 6.8 2.5 2.9 1.4 1.5 1.5 7.0 1.5 0.5 0.1 1.2 2.4 9.0 1.8 1.2 0.5 1.3 0.5 0.0 1.4 0.5 0.5 2.9 1.3 0.8 3.3 2.7 1.4 2.3 7.6 2.0 0.5 6.8 0.7 2.0 0.5 0.9 0.6 0.5 2.0 1.5 2.5 0.0 0.7 0.0 7.9 0.0 0.0 0.6 0.0 0.1 0.1 6.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.6 0.5 0.5 0.7 0.5 0.5 0.1 1.2 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.3 0.7 0.0 1.7 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CLEC5A "CLECSF5, MDL-1" ENSG00000258227 "C-type lectin domain containing 5A" Q9NY25 7 141927357-141947007 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.8" "Group enriched" "Detected in some" 4 "Hofbauer cells: 18.6;Macrophages: 57.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "classical monocyte: 11.5" "Lineage enriched" "Detected in many" 8 "monocytes: 11.5" "Group enriched" "Detected in some" 23 "HL-60: 15.2;U-937: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA054137 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA054137: AB_2732582" "unprognostic (6.89e-2)" "unprognostic (1.07e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" "unprognostic (1.69e-2)" "unprognostic (4.56e-2)" "unprognostic (1.33e-5)" "unprognostic (4.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.58e-3)" "unprognostic (1.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.23e-2)" "unprognostic (1.64e-1)" 1.4 3.2 1.8 7.3 2.4 35.8 0.8 0.8 2.5 1.7 0.4 1.9 0.6 0.4 0.8 0.5 1.4 1.2 2.0 3.8 7.6 3.1 2.9 2.1 13.9 0.3 2.4 0.5 2.7 2.6 1.4 1.1 2.7 8.2 0.9 0.5 0.8 2.7 0.8 0.3 2.7 0.3 1.5 4.8 2.1 0.4 0.9 4.8 1.1 1.4 4.9 1.4 1.9 1.1 0.0 0.5 1.4 11.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.0 11.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 1.9 1.8 2.4 0.8 2.5 7.6 3.1 2.4 0.5 8.2 4.8 0.0 7.4 0.0 0.0 1.6 0.0 0.3 2.5 5.3 9.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 2.3 0.0 18.6 0.0 0.0 0.0 3.8 0.2 0.0 57.4 1.7 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.3 0.2 0.0 0.0 0.0 CLIC1 "G6, NCC27, p64CLCP" ENSG00000213719 "Chloride intracellular channel 1" O00299 6 31730581-31739763 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020825, CAB040557" Enhanced Supported Cytosol NA NA 78000000 Cytosol "CAB020825: , CAB040557: " "unprognostic (7.26e-2)" "unprognostic (9.32e-2)" "unprognostic (2.78e-3)" "unprognostic (7.29e-2)" "unprognostic (6.93e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (8.90e-7)" "unprognostic (2.58e-2)" "unprognostic (8.51e-2)" "unprognostic (8.71e-3)" "unprognostic (1.19e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (8.11e-5)" "unprognostic (4.51e-2)" "unprognostic (2.89e-1)" "unprognostic (1.35e-2)" "unprognostic (7.31e-2)" 64.5 22.9 7.4 33.7 11.3 35.3 41.1 2.5 8.3 38.7 50.3 9.0 27.1 24.5 30.0 29.2 59.0 26.3 60.8 35.5 7.9 7.7 70.8 28.3 58.6 59.6 13.9 3.7 34.8 30.3 11.1 17.0 72.3 12.1 42.2 43.5 20.0 37.7 33.6 18.3 45.0 54.9 31.5 13.6 79.9 34.8 16.7 9.2 52.9 46.1 37.4 58.5 49.2 40.0 39.0 30.5 70.9 39.4 33.5 37.2 67.9 27.2 12.6 20.8 10.8 13.8 29.2 10.3 12.1 24.9 22.2 18.7 29.0 20.5 11.2 17.7 43.2 28.1 16.4 15.5 36.3 30.1 8.9 8.1 21.3 10.8 25.0 17.9 37.2 30.2 18.1 19.2 37.5 35.9 24.5 37.2 10.5 24.6 35.5 42.7 18.1 17.3 48.5 1.8 29.7 18.5 3.0 11.3 26.3 50.0 17.0 3.9 4.6 10.0 11.6 16.9 15.1 8.0 52.7 24.6 31.0 21.9 9.6 38.3 11.6 21.7 15.0 15.0 28.1 31.9 45.8 36.5 48.1 37.2 39.4 30.3 39.0 22.5 34.5 30.5 30.4 7.0 21.9 70.9 33.5 33.8 17.2 31.0 67.9 7.4 11.3 2.5 8.3 7.9 7.7 13.9 3.7 12.1 9.2 65.5 61.3 354.7 452.1 853.4 0.0 16.5 257.4 207.5 94.4 225.1 0.0 468.2 510.6 945.1 18.6 330.4 596.8 70.0 880.9 648.8 394.1 631.9 536.3 52.1 938.8 0.0 366.1 247.4 525.8 10.3 216.6 766.3 497.7 307.4 477.4 70.1 1089.0 792.5 176.8 468.7 6.7 200.5 405.4 19.4 13.4 811.1 479.0 498.6 571.6 861.7 CLIC2 XAP121 ENSG00000155962 "Chloride intracellular channel 2" O15247 X 155276211-155334657 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 62.3;vagina: 66.1" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 83.4;Alveolar cells type 2: 48.6;Endothelial cells: 49.6;Kupffer cells: 47.8;monocytes: 118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5" "Group enriched" "Detected in many" 14 "dendritic cells: 24.5;monocytes: 9.5" "Group enriched" "Detected in some" 5 "HDLM-2: 37.3;K-562: 20.2;Karpas-707: 18.6;RPMI-8226: 31.8" "Low region specificity" "Detected in all" "HPA047381, HPA060101" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 290000 "Plasma membrane, Cytosol" Nucleoplasm "HPA047381: AB_2680022, HPA060101: AB_2684204" "unprognostic (3.27e-2)" "unprognostic (5.21e-3)" "unprognostic (9.70e-2)" "unprognostic (7.25e-2)" "unprognostic (9.71e-2)" "unprognostic (3.78e-2)" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.95e-1)" "unprognostic (1.74e-1)" "unprognostic (1.97e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (1.97e-2)" "unprognostic (2.97e-2)" "unprognostic (6.63e-2)" "unprognostic (1.54e-1)" 26.5 3.7 3.8 7.5 6.1 3.4 24.1 2.6 4.8 15.5 6.8 0.6 3.3 4.0 11.3 10.5 10.4 6.5 9.8 9.4 3.7 3.4 5.4 6.3 31.0 15.6 7.5 1.4 12.5 2.6 2.0 7.8 4.5 6.8 9.1 6.9 3.0 5.4 3.2 10.3 5.2 7.3 10.2 5.2 32.1 4.7 5.6 4.3 6.9 62.3 8.7 12.4 14.0 66.1 0.0 24.5 0.6 9.5 1.1 0.1 1.0 0.2 0.0 0.4 0.3 0.3 2.1 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 37.3 0.2 5.2 0.1 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.2 0.0 0.2 20.2 18.6 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 31.8 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.7 0.6 0.7 0.3 1.2 1.6 0.0 0.9 1.1 0.6 0.0 1.8 0.1 0.0 9.5 0.1 0.0 0.0 0.1 24.5 0.0 0.0 0.0 0.6 1.1 6.5 2.5 0.0 1.0 3.8 6.1 2.6 4.8 3.7 3.4 7.5 1.4 6.8 4.3 83.4 48.6 0.8 0.7 11.7 1.1 2.8 0.0 2.7 10.3 0.0 0.0 0.0 0.0 0.0 0.1 49.6 0.0 23.3 0.2 0.1 22.3 0.4 3.5 1.0 4.8 0.0 1.2 19.0 47.8 0.4 12.7 29.8 16.9 118.2 0.0 0.0 0.1 0.0 8.9 0.2 0.3 6.5 4.8 0.0 0.0 12.0 0.0 2.2 0.0 1.4 CLIC4 "CLIC4L, DKFZP566G223, H1, huH1, P64H1" ENSG00000169504 "Chloride intracellular channel 4" Q9Y696 1 24745357-24844324 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 262.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 13.0;naive B-cell: 11.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008019, HPA060804" Enhanced Supported Cytosol NA NA 20000000 Cytosol "HPA008019: AB_1846946, HPA060804: AB_2684370" "unprognostic (7.35e-3)" "prognostic unfavorable (8.31e-4)" "unprognostic (5.54e-2)" "unprognostic (7.60e-2)" "unprognostic (2.92e-2)" "unprognostic (9.48e-2)" "unprognostic (6.78e-3)" "unprognostic (1.63e-2)" "unprognostic (5.50e-2)" "unprognostic (4.03e-3)" "unprognostic (1.98e-2)" "unprognostic (7.01e-2)" "prognostic favorable (1.48e-5)" "unprognostic (2.75e-3)" "unprognostic (2.17e-1)" "unprognostic (1.22e-2)" "unprognostic (3.82e-3)" 45.3 16.9 20.6 26.3 26.7 7.6 35.4 4.5 20.0 52.1 46.4 41.6 23.2 8.9 68.0 27.4 42.0 34.7 29.7 77.4 23.5 16.5 71.2 19.9 40.8 12.9 28.2 13.0 37.6 13.5 10.8 6.1 53.7 22.3 51.9 19.1 29.1 18.2 45.2 20.9 12.6 19.3 87.2 33.6 15.1 33.4 20.9 26.4 7.1 17.7 11.2 15.0 106.7 42.3 13.0 5.3 2.2 5.1 0.0 0.3 3.3 26.4 3.0 26.7 21.2 36.4 79.4 15.4 71.8 67.3 30.4 36.9 5.9 13.9 17.3 41.8 92.7 9.1 9.6 18.2 17.7 76.7 4.3 8.6 6.6 8.2 10.1 51.0 2.2 0.8 36.6 30.7 43.4 44.0 50.2 50.3 9.4 5.1 16.8 87.1 4.4 4.1 3.3 26.1 5.7 13.7 10.4 31.5 6.3 31.1 6.8 5.0 12.8 18.9 8.1 52.4 28.5 7.2 13.4 78.4 56.0 21.4 24.7 27.4 10.2 14.0 14.1 41.2 18.6 16.9 0.7 5.1 2.2 0.3 4.1 0.0 13.0 0.3 0.2 5.3 11.9 0.2 0.2 1.1 0.0 3.3 1.6 0.0 3.3 20.6 26.7 4.5 15.8 23.5 16.5 28.2 13.0 22.3 26.4 14.9 26.2 47.7 48.0 54.7 3.4 162.6 25.5 2.7 13.6 14.0 9.8 55.0 34.9 32.8 34.8 119.6 4.5 0.0 36.5 153.1 125.4 76.4 39.3 31.1 35.9 1.6 9.2 88.4 26.6 20.0 26.4 47.9 123.2 68.5 15.5 9.3 48.8 8.0 82.4 262.2 21.6 45.3 178.4 35.6 29.6 45.5 148.1 6.9 2.9 26.7 CLIP1 "CLIP, CLIP-170, CLIP170, CYLN1, RSN" ENSG00000130779 "CAP-Gly domain containing linker protein 1" P30622 12 122271432-122422632 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.5" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 400.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004399, HPA026678" Approved Supported "Microtubule ends,Cytosol" NA NA 7700 "Microtubule ends, Cytosol" "CAB004399: AB_671001, HPA026678: AB_1846954" "unprognostic (1.18e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" "unprognostic (4.91e-2)" "unprognostic (6.28e-2)" "unprognostic (2.28e-1)" "unprognostic (1.20e-1)" "unprognostic (4.73e-2)" "unprognostic (2.51e-1)" "unprognostic (7.62e-2)" "unprognostic (2.31e-2)" "unprognostic (8.97e-2)" "unprognostic (3.26e-2)" "unprognostic (5.50e-2)" "unprognostic (2.63e-1)" "unprognostic (3.37e-1)" "unprognostic (2.52e-3)" 14.4 12.6 9.8 9.1 10.9 6.4 11.7 44.5 11.5 11.6 19.5 4.3 13.9 5.7 14.3 10.1 24.8 7.5 7.7 11.8 9.3 7.5 10.0 15.2 10.0 5.8 6.5 9.5 6.3 9.1 37.8 10.9 36.5 8.7 13.2 7.1 6.7 11.8 15.1 96.5 16.8 9.1 31.1 7.2 5.9 9.6 6.1 6.9 3.7 24.1 25.9 10.1 22.2 16.6 5.3 5.4 18.2 10.6 3.9 7.2 3.7 15.5 19.7 12.2 12.3 10.4 16.1 21.3 22.3 21.2 15.1 9.5 9.1 7.7 7.0 15.0 28.8 19.4 20.0 7.7 9.1 17.1 29.3 5.6 2.3 13.1 9.6 20.8 8.1 12.9 10.6 31.5 17.4 26.3 20.2 15.1 6.2 8.7 4.8 15.1 9.0 5.0 2.8 4.6 6.7 17.5 4.6 9.4 3.5 13.6 17.9 4.7 3.0 47.7 11.7 19.5 11.0 10.1 4.8 29.2 11.5 12.4 26.9 14.5 5.3 4.2 4.2 19.7 4.1 7.9 3.6 6.5 5.2 7.2 10.6 5.4 5.3 6.7 6.5 5.4 3.6 5.0 3.7 18.2 3.9 8.6 3.5 5.8 3.7 9.8 10.9 44.5 11.5 9.3 7.5 6.5 9.5 8.7 6.9 125.0 126.6 21.9 132.8 59.6 59.4 113.6 43.3 131.2 134.2 41.8 41.2 101.8 6.6 54.0 137.2 49.6 24.3 0.0 56.4 29.4 46.1 121.3 69.5 39.3 33.9 125.5 13.4 48.5 34.8 68.2 33.1 51.6 52.3 30.7 18.9 36.4 75.0 24.6 58.4 10.5 41.9 71.1 40.1 21.2 29.5 125.3 400.9 27.1 21.5 189.8 CLMN "FLJ12383, KIAA0500, KIAA1188" ENSG00000165959 Calmin Q96JQ2 14 95181940-95319906 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 153.5;Late spermatids: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 11.9;SK-BR-3: 13.7;T-47d: 11.5;WM-115: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012634 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "HPA012634: AB_1846973" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (4.20e-2)" "unprognostic (6.07e-2)" "unprognostic (8.88e-2)" "unprognostic (4.31e-1)" "unprognostic (4.18e-2)" "unprognostic (7.24e-2)" "unprognostic (8.31e-2)" "unprognostic (2.64e-1)" "unprognostic (1.29e-3)" "unprognostic (3.09e-2)" "prognostic favorable (2.68e-7)" "unprognostic (8.27e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (9.91e-3)" 14.1 2.3 11.0 5.9 36.3 2.0 13.0 3.1 20.1 7.8 15.3 31.6 5.6 4.6 5.6 11.0 4.3 8.2 8.3 3.7 13.0 5.6 18.9 18.8 5.2 2.3 38.1 8.0 3.5 18.1 4.7 3.4 9.2 17.2 8.0 17.6 7.1 9.4 7.9 4.6 3.5 6.9 4.5 14.5 3.6 10.0 33.4 34.0 0.0 6.6 1.8 2.9 7.3 7.1 3.8 3.0 7.2 8.4 0.0 0.1 2.1 5.2 7.0 1.1 0.2 4.3 1.9 0.4 0.1 0.0 0.3 0.2 0.6 8.8 0.0 0.8 0.0 11.9 4.6 0.5 3.1 0.0 3.5 1.3 0.1 0.2 4.1 0.4 0.0 0.1 2.1 3.1 1.4 5.0 1.7 3.6 1.9 0.0 1.0 2.6 4.5 0.2 0.4 0.4 6.3 1.7 3.9 3.8 2.3 3.4 8.6 1.4 1.4 1.8 13.7 7.0 1.1 11.5 0.3 1.0 0.1 3.2 0.0 0.2 1.4 0.1 4.8 2.5 2.1 13.1 6.0 8.4 0.7 0.0 3.0 0.0 3.8 0.0 0.0 1.8 2.2 0.0 0.1 7.2 0.0 1.8 3.0 0.0 2.1 11.0 36.3 3.1 20.1 13.0 5.6 38.1 8.0 17.2 34.0 14.9 4.3 9.8 28.6 5.6 59.5 42.8 43.3 50.9 12.5 55.8 13.7 1.6 23.2 46.5 153.5 5.6 41.0 0.0 41.2 1.5 4.6 50.7 4.6 61.4 7.5 36.5 22.4 1.8 17.1 245.4 20.8 7.6 3.3 6.4 64.0 3.2 40.2 35.1 10.3 17.9 25.8 103.5 91.4 4.1 16.6 2.3 2.4 2.2 48.8 39.4 CLNS1A "CLCI, ICln" ENSG00000074201 "Chloride nucleotide-sensitive channel 1A" P54105 11 77514936-77637805 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017840, HPA031707, HPA031708, HPA032045" Approved Supported Nucleoplasm,Microtubules,Cytosol No No Cytosol "Nucleoplasm, Microtubules" "CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123" "unprognostic (1.30e-1)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (1.30e-2)" "unprognostic (5.12e-3)" "unprognostic (5.09e-2)" "unprognostic (9.63e-2)" "unprognostic (5.56e-2)" "unprognostic (2.06e-3)" "unprognostic (5.56e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.05e-1)" "unprognostic (9.19e-2)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" 22.6 44.7 43.0 31.3 37.3 27.8 36.4 24.5 45.6 30.0 31.9 41.8 26.2 22.1 29.3 47.4 41.5 34.5 29.9 33.2 37.2 39.5 26.8 90.9 20.8 41.2 45.3 31.2 49.2 44.9 26.5 28.9 29.0 38.5 28.7 35.7 29.6 28.2 27.4 43.1 24.4 26.3 26.1 48.5 32.5 28.5 21.7 31.7 47.0 40.5 36.8 45.1 31.9 28.8 33.4 45.9 12.8 34.1 31.8 32.7 30.6 24.2 23.8 39.8 29.6 29.8 42.9 16.1 21.4 33.0 34.9 31.5 58.2 34.7 54.7 35.6 25.9 27.4 29.5 48.1 44.4 42.8 30.6 29.3 53.6 30.0 33.5 25.1 79.3 24.9 34.4 51.9 30.7 58.4 34.6 39.6 33.7 70.3 16.9 34.2 36.0 52.0 64.7 37.6 81.2 44.8 28.1 77.5 58.6 25.2 34.0 40.6 46.2 28.8 32.7 19.8 30.1 44.4 34.7 25.9 26.1 31.9 50.8 20.6 34.0 47.3 58.6 10.3 29.8 20.9 12.8 33.1 12.2 21.0 34.1 24.0 32.1 26.8 23.1 45.9 33.4 32.7 27.5 2.3 31.8 28.7 28.2 23.0 30.6 43.0 37.3 24.5 45.6 37.2 39.5 45.3 31.2 38.5 31.7 14.9 16.9 79.3 88.6 73.5 68.6 66.7 50.9 33.5 48.9 55.8 47.1 114.2 71.3 64.7 13.3 56.2 37.1 0.0 75.8 112.7 69.2 58.1 76.2 62.5 82.7 55.6 30.5 48.5 94.8 10.9 81.1 78.8 72.6 146.9 56.2 179.4 61.9 45.6 64.3 70.3 55.1 51.8 46.4 90.1 100.9 75.3 67.4 77.1 110.2 89.9 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit" O76031 15 65148219-65185342 "Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.9" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 189.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: AB_2680312" "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favorable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 10.4 12.8 11.3 8.9 12.7 7.7 10.2 10.9 10.7 11.7 13.4 11.2 4.7 9.3 9.8 10.3 15.5 8.9 9.6 15.9 10.7 9.2 16.8 50.9 9.4 8.8 12.8 8.1 10.8 10.6 11.0 6.3 10.6 9.8 9.7 8.9 7.4 8.9 7.1 25.8 15.6 12.6 10.8 9.7 9.7 9.9 9.3 12.6 17.8 12.9 14.7 10.2 12.5 9.5 7.7 9.8 11.4 7.1 8.2 9.2 4.4 5.3 9.1 8.0 10.1 8.5 11.0 8.6 6.1 6.9 6.8 7.1 9.1 7.5 16.6 5.2 8.2 5.0 11.5 29.3 8.1 7.3 6.5 5.3 12.5 8.9 11.5 12.2 15.9 7.3 13.1 11.2 6.2 11.9 7.8 8.6 9.0 11.4 5.9 7.9 6.8 7.5 14.1 9.0 10.6 4.1 14.8 9.5 17.1 12.7 12.4 7.0 5.7 8.3 13.3 9.0 11.0 6.1 13.5 7.5 6.9 6.0 5.5 5.7 6.3 9.6 8.7 6.7 20.2 5.3 3.5 7.1 10.3 7.6 5.7 7.0 7.7 6.7 5.6 6.4 7.2 9.2 7.3 11.4 8.2 5.1 9.8 5.7 4.4 11.3 12.7 10.9 10.7 10.7 9.2 12.8 8.1 9.8 12.6 32.8 28.6 14.9 17.9 17.1 27.3 62.7 28.1 33.5 33.0 31.4 13.7 35.1 18.3 32.5 87.1 17.9 15.6 0.0 27.4 27.2 19.7 20.0 15.1 79.9 19.8 30.2 9.9 22.1 23.9 189.0 26.7 16.0 16.9 26.2 22.4 24.3 27.3 17.5 28.0 28.4 24.1 25.8 16.0 33.9 29.6 26.3 74.6 19.1 23.3 18.4 CLTB Lcb ENSG00000175416 "Clathrin light chain B" P09497 5 176392455-176416569 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Pancreatic endocrine cells: 1144.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 105.2;MCF7: 93.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003692, HPA036458" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA 350000 Vesicles "Plasma membrane, Cytosol" "CAB003692: AB_425372, HPA036458: AB_2675136" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (4.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (1.83e-2)" "unprognostic (1.74e-2)" "unprognostic (1.93e-1)" "unprognostic (7.42e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (7.89e-5)" "unprognostic (3.55e-1)" "unprognostic (7.50e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-2)" 20.4 24.1 29.7 18.7 26.7 13.5 16.0 27.5 47.9 27.7 34.7 14.2 11.4 35.4 15.0 15.7 94.2 12.7 28.4 65.7 26.4 26.9 20.3 15.0 15.6 12.2 25.9 22.7 24.3 19.7 17.9 19.8 61.2 28.7 16.8 18.1 19.4 22.2 19.3 93.7 81.8 41.1 27.1 15.4 14.2 39.6 9.9 10.1 14.3 17.2 55.4 31.2 26.1 45.3 4.3 9.9 28.0 9.9 7.4 11.6 3.6 33.3 16.0 4.5 19.4 10.2 7.7 37.4 43.0 16.8 27.3 19.6 20.7 15.6 7.3 25.4 19.3 11.0 31.9 7.7 105.2 10.7 49.9 14.3 4.9 23.8 12.7 16.1 7.8 13.1 8.2 36.7 14.9 17.7 5.5 12.8 5.9 9.3 18.7 15.0 93.6 12.2 11.8 3.7 28.0 23.9 13.3 8.1 24.0 14.4 13.6 19.6 6.7 20.5 22.5 14.6 5.5 9.2 15.0 27.6 9.9 14.8 17.9 24.3 14.9 10.3 9.8 7.9 16.6 11.2 2.8 9.9 28.0 7.2 7.5 3.7 3.1 6.4 7.0 9.9 4.3 5.2 5.5 18.7 7.4 9.7 8.0 11.6 3.6 29.7 26.7 27.5 47.9 26.4 26.9 25.9 22.7 28.7 10.1 53.6 23.2 58.1 196.8 563.1 275.7 186.4 73.9 9.4 29.6 78.5 60.9 109.8 114.4 340.2 7.2 90.2 537.2 23.3 397.9 474.5 139.4 165.3 48.4 90.4 99.6 317.8 145.7 58.9 80.5 11.0 113.1 120.4 209.2 73.9 265.3 88.8 1144.6 526.1 122.0 193.6 54.8 77.6 222.4 15.8 14.4 701.9 323.2 77.3 199.5 331.8 CLTC "CLTCL2, Hc" ENSG00000141367 "Clathrin heavy chain" Q00610 17 59619689-59696956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB010389, CAB011571, CAB017155, HPA059143" Approved Enhanced "Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol" Yes No 51000000 "Vesicles, Endosomes, Lysosomes" "Mitotic spindle, Cytosol" "CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924" "unprognostic (1.56e-1)" "prognostic unfavorable (7.35e-4)" "prognostic favorable (7.65e-4)" "unprognostic (1.03e-1)" "unprognostic (2.62e-1)" "unprognostic (5.23e-3)" "prognostic unfavorable (5.54e-4)" "unprognostic (1.11e-1)" "unprognostic (6.43e-2)" "unprognostic (1.09e-1)" "unprognostic (3.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.02e-4)" 39.5 45.7 47.4 35.1 57.6 30.7 57.9 59.1 83.6 38.1 45.0 25.1 47.7 27.9 38.7 52.3 32.1 30.9 34.1 39.9 47.1 53.7 48.6 46.0 46.5 60.7 53.9 59.3 29.8 23.3 96.1 30.0 51.5 57.0 38.9 48.9 22.7 28.6 54.4 44.2 30.5 27.7 45.8 47.8 28.0 34.2 29.4 28.8 28.0 43.7 26.6 31.2 37.1 40.6 10.0 24.6 13.9 24.6 12.3 15.6 13.1 47.4 71.8 35.4 35.0 59.8 48.8 40.5 51.0 53.8 45.7 47.8 44.0 29.2 33.0 58.6 72.4 50.6 31.3 52.8 42.4 61.1 35.5 28.4 54.1 45.4 68.2 45.7 37.0 31.3 46.1 26.0 69.5 44.8 36.0 50.5 16.9 53.9 46.8 71.2 84.6 21.9 11.0 30.5 43.4 41.9 19.5 59.3 40.0 51.2 67.3 31.8 37.8 31.6 20.7 30.2 47.8 49.2 23.3 64.5 83.9 50.1 40.0 52.2 36.8 51.7 30.5 61.5 25.1 51.2 10.5 20.9 13.9 12.7 24.6 15.6 10.0 11.7 13.7 24.6 9.1 10.0 11.0 13.4 12.3 20.7 16.1 14.5 13.1 47.4 57.6 59.1 83.6 47.1 53.7 53.9 59.3 57.0 28.8 92.3 94.7 38.0 37.2 56.7 86.7 68.8 86.6 72.3 81.9 73.3 56.9 86.9 23.2 67.8 20.6 66.0 118.0 93.5 84.2 40.6 77.3 84.0 65.9 162.9 151.0 81.0 115.9 156.5 173.7 53.1 68.4 90.2 50.6 62.3 109.9 47.7 89.2 73.7 88.1 105.0 55.3 77.6 61.2 51.7 37.2 69.4 90.3 33.1 108.8 72.3 CMA1 ENSG00000092009 "Chymase 1" P23946 14 24505353-24508265 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 15 "granulocytes: 52.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "T-reg: 1.5" "Lineage enriched" "Detected in single" 4 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "HL-60: 1.7;SuSa: 2.5;U-937: 3.1" "Low region specificity" "Detected in single" "CAB000363, HPA052634" Enhanced Supported "Cytosol,Cytoplasmic bodies" "Secreted to blood" NA NA 3000000 "Cytoplasmic bodies" Cytosol "CAB000363: AB_2083616, HPA052634: AB_2681892" "unprognostic (1.37e-1)" "unprognostic (2.27e-3)" "unprognostic (2.04e-1)" "unprognostic (7.07e-3)" "unprognostic (1.48e-2)" "unprognostic (1.19e-1)" "unprognostic (5.79e-2)" "unprognostic (2.21e-1)" "unprognostic (8.91e-3)" "unprognostic (4.19e-3)" "unprognostic (1.29e-4)" "unprognostic (2.52e-3)" "unprognostic (7.78e-2)" "unprognostic (7.37e-2)" "unprognostic (4.98e-3)" 12.3 0.2 0.2 2.9 0.2 0.0 15.9 0.2 0.2 7.3 6.2 0.2 1.2 0.1 2.9 6.0 8.3 1.0 10.0 10.3 0.2 0.2 2.0 0.8 1.1 1.6 0.2 0.2 0.6 0.9 0.5 0.5 0.7 0.3 6.0 6.9 3.0 5.9 1.3 1.2 13.0 5.3 6.2 0.2 0.5 2.4 2.7 0.2 1.0 0.4 7.9 3.9 4.1 2.0 0.3 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 1.5 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.9 1.0 1.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.8 2.5 0.0 0.8 1.4 0.0 0.2 0.3 0.3 0.8 0.9 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 CMAS ENSG00000111726 "Cytidine monophosphate N-acetylneuraminic acid synthetase" Q8NFW8 12 22046174-22065674 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Syncytiotrophoblasts: 445.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039905 Supported Uncertain Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA039905: AB_10795237" "unprognostic (5.54e-2)" "unprognostic (4.10e-2)" "unprognostic (4.25e-1)" "unprognostic (5.39e-3)" "unprognostic (1.94e-2)" "unprognostic (3.99e-2)" "unprognostic (2.30e-2)" "unprognostic (4.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.44e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (2.27e-1)" "unprognostic (1.91e-2)" "unprognostic (3.65e-1)" "unprognostic (2.03e-1)" 8.1 28.2 28.1 9.6 31.6 17.6 14.9 16.3 39.3 12.1 34.3 14.5 17.1 29.4 12.8 32.0 33.2 10.0 11.0 18.1 28.8 33.4 12.8 31.9 7.9 9.8 33.9 27.3 11.9 18.6 14.6 14.3 20.2 34.3 17.0 33.1 10.2 14.8 12.9 18.2 12.9 32.9 13.3 18.0 8.5 12.9 30.2 14.8 6.4 10.9 11.9 12.4 11.8 17.2 12.2 19.5 19.4 18.9 22.8 19.9 15.0 19.4 15.8 19.4 9.2 15.3 19.1 28.2 13.6 15.0 14.8 15.7 35.3 22.6 17.3 13.4 11.6 27.3 15.9 11.4 18.9 20.0 22.8 14.4 52.1 12.8 17.7 14.3 13.7 27.7 12.8 18.0 18.8 28.1 20.2 19.6 18.8 32.7 8.8 26.2 25.6 15.8 32.0 46.8 21.8 21.9 11.2 20.3 16.4 17.6 21.4 7.8 13.7 10.7 19.0 15.3 40.7 26.1 18.9 14.2 16.7 13.8 14.7 24.9 6.1 7.8 23.0 27.2 10.8 16.8 10.3 17.9 19.4 13.7 18.9 17.8 12.2 18.6 18.1 19.5 12.1 16.8 17.4 1.8 22.8 16.5 12.3 19.9 15.0 28.1 31.6 16.3 39.3 28.8 33.4 33.9 27.3 34.3 14.8 11.9 13.7 19.0 62.8 26.0 35.2 62.1 28.1 46.8 28.4 22.7 3.9 144.0 64.6 44.6 10.3 38.6 126.2 116.8 73.5 117.3 40.1 92.3 22.0 56.7 56.8 33.4 40.0 38.6 32.1 12.9 23.6 27.0 42.2 49.5 94.4 20.7 65.2 133.3 26.2 64.8 17.4 19.4 37.0 79.6 93.5 38.9 445.4 22.3 85.9 97.2 CMIP ENSG00000153815 "C-Maf inducing protein" Q8IY22 16 81445170-81711762 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 53.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054424, HPA066710" Approved Supported Nucleoplasm,Cytosol NA NA 360000 "Nucleoplasm, Cytosol" "HPA054424: AB_2682484, HPA066710: AB_2685708" "unprognostic (6.84e-2)" "unprognostic (1.99e-1)" "unprognostic (2.89e-2)" "unprognostic (3.76e-1)" "unprognostic (3.02e-2)" "unprognostic (9.83e-3)" "unprognostic (2.28e-2)" "prognostic unfavorable (9.47e-7)" "unprognostic (1.60e-1)" "unprognostic (1.64e-1)" "unprognostic (3.10e-2)" "unprognostic (6.04e-2)" "unprognostic (4.12e-2)" "unprognostic (3.42e-2)" "unprognostic (9.08e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.59e-1)" 19.1 19.7 34.3 25.6 27.9 19.6 15.4 13.1 46.5 28.5 26.5 13.0 7.1 33.5 15.5 14.1 26.5 20.3 27.8 9.3 28.1 35.7 15.8 11.4 18.8 17.2 19.4 30.6 17.7 16.5 8.9 26.4 23.8 19.4 13.4 20.0 7.8 15.5 14.0 6.3 24.5 40.5 19.1 15.7 18.0 28.2 11.0 13.2 20.8 11.3 10.2 16.1 22.2 37.2 0.8 0.5 5.7 1.7 0.5 1.0 0.9 11.5 38.6 7.6 3.9 4.0 3.2 15.7 8.4 5.7 5.3 2.3 13.0 23.8 5.2 7.2 6.9 7.1 11.8 4.9 27.9 5.1 3.3 3.6 24.9 7.3 22.7 4.0 7.6 53.9 3.2 11.9 9.8 12.7 8.1 14.6 9.3 21.6 4.5 3.2 11.6 13.3 9.6 6.0 11.3 8.2 24.1 2.5 5.0 6.6 11.4 40.2 8.0 19.6 7.3 2.4 8.0 5.6 10.2 10.0 8.5 9.1 8.2 7.6 5.7 4.4 22.5 10.1 9.0 3.4 4.8 1.7 2.1 1.0 1.2 0.5 0.1 0.2 0.3 0.5 0.8 0.1 0.5 5.7 0.5 0.3 0.5 0.2 0.9 34.3 27.9 13.1 33.7 28.1 35.7 19.4 30.6 19.4 13.2 11.9 17.6 24.6 49.5 95.4 16.2 6.5 63.7 42.8 20.5 14.0 0.0 39.9 6.6 19.3 59.6 46.7 44.3 0.0 21.1 99.7 24.7 54.5 44.9 29.6 29.0 23.8 69.3 63.8 68.0 71.8 44.0 48.6 11.8 32.5 109.8 7.8 43.7 25.9 134.7 36.3 3.2 12.9 17.6 5.6 13.4 125.5 74.1 20.3 36.4 103.9 CMYA5 "C5orf10, DKFZp451G223, myospryn, SPRYD2, TRIM76" ENSG00000164309 "Cardiomyopathy associated 5" Q8N3K9 5 79689877-79800240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 119.1;skeletal muscle: 329.3" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 3073.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.6;RT4: 3.1;THP-1: 10.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA074081, HPA077831" Enhanced Approved "Nuclear speckles,Vesicles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Cytosol" "Vesicles, Plasma membrane" "HPA074081: , HPA077831: " "unprognostic (5.53e-2)" "unprognostic (9.91e-3)" "unprognostic (1.21e-2)" "unprognostic (1.49e-2)" "unprognostic (9.01e-4)" "unprognostic (7.00e-2)" "unprognostic (7.39e-2)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.75e-1)" "unprognostic (5.04e-1)" "unprognostic (1.93e-1)" "unprognostic (1.93e-2)" "unprognostic (6.30e-3)" "unprognostic (3.88e-2)" "unprognostic (7.69e-2)" "unprognostic (9.74e-2)" 2.4 0.2 0.3 0.0 0.3 0.0 0.9 0.3 0.4 0.4 0.4 0.0 0.0 0.0 1.4 2.6 2.0 0.5 0.2 119.1 0.3 0.3 0.6 0.3 0.3 0.0 0.3 0.0 3.6 0.2 2.2 1.1 0.3 0.3 1.4 0.0 0.0 2.4 0.5 329.3 0.5 0.2 1.1 0.4 0.2 0.3 0.2 0.1 0.0 2.3 54.0 2.5 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.0 1.0 1.3 0.4 0.1 0.1 0.2 0.2 0.4 0.1 0.0 1.9 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.2 0.0 0.1 1.6 0.4 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 2.6 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 3.1 0.1 0.0 0.1 0.0 0.2 0.2 2.0 10.7 0.0 0.1 0.4 0.0 0.3 0.2 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.1 8.9 3.2 0.0 15.7 1.1 1.4 3073.8 2.5 8.1 15.9 24.4 0.0 14.8 14.9 0.5 0.1 0.7 0.0 0.0 0.4 2.5 3.7 5.2 1.1 2.0 1.8 205.0 1.7 0.6 0.3 1.1 13.8 1.1 0.0 0.0 0.0 10.8 0.4 0.0 12.7 11.5 2.6 0.0 0.9 0.2 1.1 4.6 27.5 0.5 0.0 12.0 CNBP "CNBP1, DM2, RNF163, ZCCHC22, ZNF9" ENSG00000169714 "CCHC-type zinc finger nucleic acid binding protein" P62633 3 129169484-129183922 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063097 Approved Nucleoplasm,Cytosol NA NA 43000 Nucleoplasm Cytosol "HPA063097: AB_2684939" "unprognostic (1.74e-1)" "unprognostic (3.11e-2)" "unprognostic (4.84e-1)" "unprognostic (3.35e-2)" "unprognostic (6.28e-2)" "unprognostic (7.38e-2)" "unprognostic (7.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (6.39e-2)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.72e-3)" "unprognostic (4.62e-3)" "unprognostic (1.89e-1)" "unprognostic (2.03e-1)" "unprognostic (2.51e-1)" "unprognostic (1.58e-1)" 54.2 52.8 36.4 33.6 33.7 35.9 46.6 43.5 35.6 58.1 47.1 34.5 40.5 32.4 54.5 49.4 55.6 40.9 48.5 78.2 33.0 32.0 38.0 71.6 47.5 40.6 39.7 30.3 67.4 65.4 39.3 33.5 41.5 33.3 62.3 37.1 41.3 48.9 50.9 182.1 46.7 40.6 71.9 38.0 43.2 43.1 32.1 33.1 39.0 67.3 81.1 41.2 76.1 63.5 74.3 60.3 120.1 84.1 61.7 83.4 172.9 61.7 36.6 53.4 42.3 53.4 45.8 42.2 48.6 77.1 53.0 60.9 53.6 43.5 82.2 41.7 45.2 38.9 46.5 69.8 56.3 71.9 55.1 50.8 79.4 37.8 57.7 53.2 85.1 45.7 44.3 66.2 37.1 134.1 36.1 46.7 46.4 59.4 56.6 55.5 73.9 78.8 62.6 65.1 55.1 61.9 69.3 49.6 97.9 54.9 59.5 72.8 58.3 38.3 37.9 103.0 32.6 43.6 58.6 49.2 39.3 38.7 53.9 49.1 53.2 48.4 129.3 40.5 58.4 51.8 93.4 84.1 96.8 64.1 63.8 80.6 74.3 77.4 68.9 60.3 62.7 83.4 72.0 120.1 61.7 48.9 35.1 73.9 172.9 36.4 33.7 43.5 35.6 33.0 32.0 39.7 30.3 33.3 33.1 241.2 236.8 168.8 346.4 466.2 151.2 559.4 112.1 211.5 257.0 75.0 31.4 228.5 316.7 172.7 25.7 265.4 148.7 46.7 254.5 331.1 308.6 248.1 302.0 134.8 219.0 87.4 164.4 125.8 185.1 30.7 292.6 305.9 301.9 415.6 158.2 306.6 196.4 147.3 300.5 191.8 122.5 258.7 447.2 255.1 271.9 512.9 243.9 251.4 182.3 305.2 CNDP2 "CN2, CPGL, FLJ10830, HsT2298, PEPA" ENSG00000133313 "Carnosine dipeptidase 2" Q96KP4 18 74495816-74523454 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 371.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 76.6;RPMI-8226: 98.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026196, HPA036898, HPA036899" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 2400000 "Nucleoplasm, Cytosol" "CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371" "unprognostic (2.81e-2)" "unprognostic (9.96e-2)" "unprognostic (3.28e-1)" "unprognostic (1.19e-3)" "unprognostic (2.57e-2)" "unprognostic (5.06e-2)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.49e-1)" "unprognostic (9.31e-2)" "unprognostic (1.56e-3)" "unprognostic (1.15e-1)" "prognostic favorable (3.50e-6)" "unprognostic (2.37e-3)" "unprognostic (4.65e-3)" "unprognostic (1.51e-1)" "unprognostic (1.34e-1)" 19.0 11.5 31.0 19.1 36.0 6.1 16.9 10.4 33.0 39.4 37.6 45.2 27.0 51.3 12.5 35.3 20.4 38.9 25.9 11.6 31.1 26.4 89.0 66.4 22.1 23.0 36.1 24.1 11.4 27.6 15.7 13.7 28.8 27.2 34.7 22.2 14.1 16.9 32.7 7.5 11.8 71.1 10.4 39.4 39.2 27.2 6.5 32.5 10.9 43.9 11.6 21.4 28.4 12.0 29.6 49.0 12.5 44.4 31.4 23.9 30.3 10.2 13.9 10.1 9.5 12.3 7.3 42.4 10.8 10.2 14.8 14.8 8.0 11.1 13.0 13.7 11.7 11.6 15.6 15.3 20.5 10.6 19.4 6.0 12.9 7.0 12.8 18.0 25.2 20.1 11.0 15.8 12.8 23.1 8.4 12.9 15.6 13.6 76.6 9.8 11.5 13.4 12.1 15.2 6.8 8.3 14.6 11.6 98.6 58.2 43.1 11.0 5.8 8.4 60.2 14.4 25.2 25.2 10.4 13.5 15.9 13.5 3.5 7.2 14.3 58.7 17.3 10.8 18.4 13.2 7.8 30.0 12.5 21.8 44.4 23.8 28.9 17.6 20.3 49.0 29.6 19.1 20.7 4.4 31.4 43.1 43.0 23.9 30.3 31.0 36.0 10.4 33.0 31.1 26.4 36.1 24.1 27.2 32.5 68.5 54.2 53.8 35.3 8.1 33.7 22.9 91.7 60.2 38.7 113.4 15.7 128.9 159.2 142.6 2.2 45.9 105.2 0.0 136.1 106.3 20.6 56.1 11.5 102.8 184.6 41.3 62.7 36.8 86.2 3.2 17.3 82.3 16.9 112.8 71.7 80.3 99.7 74.1 15.6 371.2 24.6 12.9 15.9 4.8 7.3 8.4 91.2 36.3 82.5 47.4 CNEP1R1 "C16orf69, FLJ38101, NEP1-R1, TMEM188" ENSG00000205423 "CTD nuclear envelope phosphatase 1 regulatory subunit 1" Q8N9A8 16 50024410-50037088 "Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042815, HPA077906" Uncertain Supported Cytosol NA NA Cytosol "HPA042815: AB_10794765, HPA077906: AB_2686868" "unprognostic (4.11e-2)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.43e-3)" "unprognostic (1.80e-1)" "unprognostic (3.42e-2)" "unprognostic (8.53e-2)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (3.37e-3)" "unprognostic (5.09e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" 15.4 12.7 14.5 16.3 15.0 25.1 17.0 19.1 17.2 10.6 11.3 12.2 4.0 10.9 13.0 17.1 17.2 10.9 13.5 14.3 12.8 12.6 12.5 12.9 14.1 19.7 17.7 11.9 12.9 13.6 11.7 17.3 18.5 14.0 10.6 16.7 14.9 12.2 10.7 10.5 13.9 12.9 13.9 12.9 21.4 11.9 22.4 14.1 12.4 8.4 10.3 18.6 12.8 12.6 5.5 9.6 28.7 18.7 6.3 9.6 7.2 7.6 7.3 8.6 9.2 17.4 16.8 12.9 15.6 11.9 15.1 9.1 7.6 11.0 8.8 11.7 12.8 10.2 12.2 7.1 7.7 19.2 6.3 8.4 4.1 4.4 12.0 11.9 5.5 12.8 12.5 13.0 9.8 7.8 11.8 10.3 11.1 5.0 5.1 19.1 2.2 10.5 13.9 6.5 3.3 9.9 13.3 11.6 8.8 10.1 5.2 6.9 8.0 14.6 6.0 5.5 7.9 5.2 6.7 13.4 14.7 11.7 13.8 5.5 8.3 7.4 10.4 8.2 5.6 11.9 7.4 12.2 8.6 9.6 15.7 8.9 5.5 7.6 7.0 9.6 4.9 7.6 8.9 28.7 6.3 18.7 3.8 7.4 7.2 14.5 15.0 19.1 17.2 12.8 12.6 17.7 11.9 14.0 14.1 3.0 8.5 0.9 3.2 9.4 5.2 9.8 2.5 4.0 7.9 7.0 3.9 15.7 3.3 4.7 1.3 8.7 5.2 0.0 4.7 22.0 11.6 2.4 12.7 5.6 13.1 6.4 4.6 6.7 19.2 2.2 5.5 13.5 15.1 10.0 3.9 10.8 4.5 5.8 7.4 5.0 9.4 6.5 10.3 23.3 17.0 8.5 12.0 10.9 5.2 3.3 CNGB1 "CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45" ENSG00000070729 "Cyclic nucleotide gated channel beta 1" Q14028 16 57882340-57971116 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Olfaction, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 79.8" "Group enriched" "Detected in some" 12 "Cone photoreceptor cells: 312.2;Rod photoreceptor cells: 1014.1" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 2.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.6" "Cell line enhanced" "Detected in some" "EFO-21: 3.0;RPMI-8226: 3.4;SCLC-21H: 9.6;SiHa: 5.6;SK-BR-3: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039159, HPA060355" Approved Vesicles,Cytosol No NA Cytosol Vesicles "HPA039159: AB_10795579, HPA060355: " "unprognostic (5.52e-3)" "unprognostic (4.51e-3)" "unprognostic (1.06e-1)" "unprognostic (2.73e-3)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (8.56e-4)" "unprognostic (3.08e-1)" "unprognostic (9.84e-2)" "unprognostic (2.83e-1)" "unprognostic (2.14e-4)" "unprognostic (5.42e-2)" "unprognostic (1.01e-3)" "unprognostic (5.20e-2)" "unprognostic (1.88e-1)" "unprognostic (4.57e-2)" "unprognostic (9.07e-2)" 0.2 7.2 13.1 3.0 3.0 0.7 0.2 0.2 6.3 0.2 1.7 0.0 0.0 0.5 0.2 0.5 0.2 0.4 0.8 0.2 7.1 11.0 0.2 0.2 0.4 0.7 1.3 4.0 0.1 1.5 0.0 0.5 1.2 4.2 0.2 1.2 79.8 0.3 0.4 0.1 0.5 1.8 0.2 0.7 0.2 0.2 1.3 0.0 0.0 0.2 0.0 0.4 0.3 0.2 0.4 0.3 2.6 0.3 0.3 0.4 0.0 0.6 1.2 0.0 0.2 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.2 0.2 3.0 0.0 1.0 0.0 0.0 2.5 0.0 0.2 0.0 0.6 1.8 1.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 0.2 0.0 0.1 0.0 0.4 0.0 0.1 0.6 0.1 0.2 0.0 0.2 0.1 0.0 3.4 0.0 1.2 9.6 0.1 5.6 2.8 0.0 0.2 0.1 0.1 0.7 0.3 0.5 0.4 0.1 0.2 0.6 0.1 0.1 0.3 0.1 0.6 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.4 0.4 0.2 2.6 0.3 0.3 0.3 0.0 0.0 13.1 3.0 0.2 6.3 7.1 11.0 1.3 4.0 4.2 0.0 0.0 0.0 0.0 0.5 0.0 44.0 0.8 0.0 0.0 0.0 0.0 312.2 4.7 0.0 0.2 1.5 0.0 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.4 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 0.3 0.0 0.0 0.0 1014.1 0.0 0.0 0.4 0.6 0.0 1.1 0.0 0.0 0.1 CNKSR1 "CNK, CNK1, KSR" ENSG00000142675 "Connector enhancer of kinase suppressor of Ras 1" Q969H4 1 26177403-26189886 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 2.1;memory CD4 T-cell: 2.4;naive CD4 T-cell: 1.4;T-reg: 2.6" "Group enriched" "Detected in many" 8 "B-cells: 2.1;T-cells: 2.6" "Cell line enhanced" "Detected in many" "A-431: 11.6;BEWO: 10.1;CAPAN-2: 18.0;HaCaT: 13.3;hTCEpi: 11.5;OE19: 10.1;SK-BR-3: 11.6;T-47d: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA030847 Uncertain Approved Cytosol NA NA Cytosol "HPA030847: AB_10601100" "unprognostic (2.73e-3)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (5.07e-2)" "unprognostic (1.03e-1)" "unprognostic (3.15e-1)" "unprognostic (1.61e-2)" "unprognostic (5.26e-2)" "unprognostic (1.37e-1)" "unprognostic (3.68e-1)" "unprognostic (2.49e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-2)" "unprognostic (3.27e-2)" "unprognostic (2.91e-1)" "prognostic favorable (5.91e-4)" 0.7 0.0 1.0 3.5 1.4 0.0 4.5 5.4 1.1 4.4 19.1 0.8 12.8 8.6 1.9 11.9 15.4 6.1 13.3 0.7 1.4 1.2 10.0 2.9 10.2 0.7 0.9 0.7 2.5 27.6 10.2 12.6 32.4 1.2 10.3 5.4 0.7 15.7 18.9 17.7 11.9 22.6 1.0 1.3 1.3 7.3 1.5 0.7 1.9 20.6 11.9 15.9 6.1 5.3 2.1 0.0 0.0 0.0 0.2 2.6 0.5 11.6 0.0 0.2 0.1 0.2 0.0 10.1 0.3 0.0 0.4 0.0 1.8 18.0 1.9 6.0 0.0 0.1 13.3 0.3 8.5 0.3 0.4 0.6 0.3 4.3 5.0 0.1 0.1 0.2 0.0 11.5 0.0 3.3 0.0 0.0 0.4 1.5 0.1 0.0 5.4 0.1 0.6 5.2 10.1 1.1 0.1 0.1 0.0 1.1 6.8 2.5 0.6 0.0 11.6 0.2 4.6 11.0 0.0 0.0 0.0 1.8 0.7 0.1 4.1 0.7 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 0.3 1.4 0.1 0.0 0.2 0.0 0.0 2.6 0.5 1.0 1.4 5.4 1.1 1.4 1.2 0.9 0.7 1.2 0.7 14.9 4.5 0.8 13.0 13.1 2.6 0.8 12.7 14.7 6.8 33.2 2.0 27.4 1.7 10.6 0.4 0.7 23.3 0.0 10.9 12.0 1.3 14.9 0.0 0.0 2.3 0.0 17.9 1.3 0.0 0.4 1.1 0.7 1.7 1.8 17.9 1.1 17.6 24.6 0.7 0.3 3.0 0.0 1.9 2.3 4.0 9.9 27.1 0.0 18.3 22.5 CNKSR3 "FLJ31349, MAGI1" ENSG00000153721 "CNKSR family member 3" Q6P9H4 6 154387504-154510659 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 17.4" "CAB037133, HPA049651" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "CAB037133: AB_477217, HPA049651: AB_2680841" "unprognostic (3.07e-1)" "unprognostic (3.25e-2)" "unprognostic (1.57e-1)" "unprognostic (2.34e-1)" "unprognostic (5.62e-2)" "unprognostic (1.25e-2)" "unprognostic (1.37e-1)" "unprognostic (5.78e-2)" "unprognostic (1.98e-1)" "unprognostic (1.40e-1)" "unprognostic (4.67e-3)" "unprognostic (4.90e-2)" "prognostic favorable (6.00e-4)" "unprognostic (4.23e-2)" "unprognostic (8.79e-2)" "unprognostic (1.57e-3)" "unprognostic (3.38e-1)" 9.4 2.2 4.2 5.5 5.8 1.6 5.8 1.8 5.0 7.6 12.5 11.6 6.0 8.7 15.8 8.3 19.4 6.5 9.2 8.9 5.3 3.4 17.0 20.0 6.3 3.5 8.0 2.5 10.0 26.6 1.5 4.5 8.2 8.3 8.3 5.5 12.6 7.5 7.7 2.2 6.7 13.5 15.3 8.2 7.6 6.7 8.6 7.7 0.6 4.1 8.7 6.6 9.8 10.2 0.9 1.4 3.6 0.6 0.9 0.5 0.2 0.3 4.0 2.8 5.6 5.0 3.8 0.3 4.9 3.0 8.6 7.1 17.4 0.4 0.1 5.4 5.3 2.8 1.7 8.3 0.5 4.5 0.0 5.1 13.3 0.8 9.6 2.2 0.0 3.0 5.1 2.7 3.3 3.4 1.5 2.7 1.1 1.7 0.1 2.3 1.1 0.1 0.3 2.0 3.3 5.2 3.8 4.9 6.4 10.0 2.8 1.7 10.7 2.2 1.2 1.0 1.3 0.0 1.2 3.1 0.8 2.5 6.4 3.2 0.1 0.0 0.1 0.1 0.3 3.7 2.1 0.6 1.2 0.5 0.4 0.4 0.5 0.4 0.4 0.4 0.9 0.5 0.5 3.6 0.9 0.4 1.4 0.3 0.2 4.2 5.8 1.8 5.0 5.3 3.4 8.0 2.5 8.3 7.7 11.9 38.5 0.9 13.6 23.6 1.9 30.2 12.7 13.4 18.2 24.4 0.0 6.3 8.3 14.8 39.4 28.7 27.4 0.0 10.4 0.8 14.6 10.7 5.7 55.0 1.5 0.0 41.5 67.5 7.6 11.1 5.5 5.1 30.4 1.0 21.1 27.8 10.1 15.8 9.9 24.5 1.8 0.0 6.6 1.1 5.3 20.8 18.0 5.1 11.5 8.8 CNN2 ENSG00000064666 "Calponin 2" Q99439 19 1026581-1039068 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 231.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049095 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA 39000000 Cytosol "Nucleoplasm, Actin filaments" "HPA049095: AB_2680627" "unprognostic (2.52e-2)" "unprognostic (2.69e-1)" "unprognostic (1.74e-1)" "unprognostic (4.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.56e-1)" "unprognostic (4.58e-2)" "unprognostic (6.56e-2)" "unprognostic (3.60e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (4.70e-7)" "unprognostic (1.28e-2)" "unprognostic (1.87e-1)" "unprognostic (2.50e-1)" "unprognostic (1.54e-1)" 36.6 6.5 1.3 46.2 2.5 44.2 29.2 2.0 3.0 38.2 16.9 5.4 22.2 5.5 35.5 24.5 39.4 25.0 40.1 18.7 1.5 1.5 24.6 15.8 54.7 61.5 3.5 1.5 81.1 26.8 1.9 6.9 21.5 4.8 35.6 7.8 26.3 40.9 34.4 6.1 21.3 17.7 28.2 2.9 59.4 21.1 15.9 2.1 37.0 68.1 27.3 78.6 37.9 51.2 33.6 29.3 115.7 26.3 27.1 57.0 43.1 36.9 12.5 34.9 43.4 18.0 34.3 27.1 33.5 37.1 42.3 32.9 43.0 32.0 24.4 34.4 60.5 9.9 36.5 20.7 53.5 28.2 16.9 1.7 16.9 20.1 33.6 72.2 15.8 39.0 58.3 25.5 26.8 20.2 69.2 23.8 18.4 10.1 38.0 34.4 7.0 1.4 14.5 43.1 30.0 5.5 8.3 12.3 27.5 41.6 44.5 0.0 2.4 42.4 5.8 4.8 26.6 42.1 26.6 58.3 23.2 24.0 35.4 34.1 17.7 13.5 48.5 13.6 19.0 37.0 61.3 18.6 81.0 34.8 24.2 57.0 33.6 43.7 46.4 29.3 30.8 37.3 36.3 115.7 27.1 26.3 13.0 45.6 43.1 1.3 2.5 2.0 3.0 1.5 1.5 3.5 1.5 4.8 2.1 56.6 58.7 76.0 231.3 86.7 0.2 4.8 15.3 20.1 38.7 34.9 9.8 9.0 53.0 56.6 0.4 15.5 36.0 0.0 120.7 81.2 48.8 45.2 57.8 28.4 49.6 0.0 14.8 38.1 67.6 0.6 7.5 75.9 13.5 120.8 32.3 0.8 137.6 21.2 72.2 4.0 6.6 32.3 72.9 1.7 3.1 76.8 9.5 91.5 26.0 151.9 CNN3 ENSG00000117519 "Calponin 3" Q15417 1 94896949-94927278 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 9.7;naive CD4 T-cell: 11.1" "Group enriched" "Detected in many" 14 "B-cells: 9.7;T-cells: 11.1" "Cell line enhanced" "Detected in many" "LHCN-M2: 95.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009849, HPA051237" Enhanced Enhanced "Actin filaments,Cytosol" NA NA 320000 "Actin filaments" Cytosol "CAB009849: AB_2276410, HPA051237: AB_2681399" "unprognostic (8.47e-2)" "unprognostic (5.19e-2)" "unprognostic (5.22e-2)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (2.85e-2)" "unprognostic (8.87e-2)" "unprognostic (5.20e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (2.37e-1)" "unprognostic (3.77e-3)" "unprognostic (2.33e-2)" "unprognostic (8.71e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.99e-4)" 49.3 78.5 53.4 27.9 53.9 1.2 82.7 25.3 44.7 55.1 36.3 30.8 20.8 45.4 74.0 31.4 53.6 39.4 55.3 33.0 46.8 40.3 74.2 50.6 59.0 28.6 45.3 27.0 61.5 28.0 21.6 33.5 88.5 67.8 38.8 30.2 47.5 32.9 48.9 16.1 16.6 33.4 68.6 78.2 30.8 30.6 21.1 41.9 9.3 44.3 18.4 17.2 48.7 74.5 9.7 0.1 0.4 0.1 0.7 11.1 2.6 44.9 8.7 49.6 43.7 35.5 31.9 22.0 21.7 43.0 36.6 58.1 40.2 4.0 0.0 50.1 28.0 36.3 12.9 36.2 19.3 53.0 0.1 12.8 2.0 6.1 30.4 66.0 0.0 0.0 29.8 3.0 45.2 10.5 64.1 32.8 2.9 0.4 4.1 95.4 0.0 2.1 0.1 38.1 0.0 4.7 0.0 59.2 0.2 47.7 18.7 3.0 30.4 18.1 7.7 30.7 38.7 13.9 4.5 20.1 24.5 42.0 9.0 70.6 5.0 2.9 0.1 5.3 0.0 36.7 0.1 0.0 0.0 1.9 0.1 3.1 3.9 2.0 1.1 0.1 9.7 11.1 7.6 0.4 0.7 0.1 0.0 0.0 2.6 53.4 53.9 25.3 43.6 46.8 40.3 45.3 27.0 67.8 41.9 140.0 65.4 13.7 201.6 69.5 9.8 33.1 81.5 65.6 75.1 120.4 19.6 195.8 369.7 231.6 114.0 306.3 50.5 23.3 214.4 29.9 297.7 266.3 13.9 115.7 19.8 1.6 69.5 399.0 29.8 108.9 254.3 14.6 187.3 8.2 41.2 367.2 119.5 39.1 359.2 359.0 12.3 258.7 319.2 10.3 37.5 68.0 172.1 10.1 89.1 330.4 CNNM1 ACDP1 ENSG00000119946 "Cyclin and CBS domain divalent metal cation transport mediator 1" Q9NRU3 10 99329099-99394330 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 16.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 30.2;Early spermatids: 76.6;Horizontal cells: 47.7;Late spermatids: 66.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 6 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "A549: 17.4;BJ hTERT+: 6.6;BJ hTERT+ SV40 Large T+: 6.1;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HAP1: 7.8;OE19: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040408 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040408: AB_10793963" "unprognostic (9.04e-4)" "unprognostic (2.93e-1)" "unprognostic (1.70e-1)" "unprognostic (7.60e-4)" "unprognostic (4.08e-3)" "unprognostic (9.51e-2)" "unprognostic (6.01e-2)" "unprognostic (2.27e-2)" "unprognostic (6.03e-2)" "unprognostic (1.94e-1)" "unprognostic (3.09e-2)" "unprognostic (2.45e-1)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (4.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.03e-1)" 0.6 2.5 3.4 0.7 15.5 0.5 1.3 8.1 12.7 2.0 1.0 0.3 1.1 1.2 2.1 3.7 1.4 2.4 1.0 0.5 2.8 5.0 2.4 0.8 0.6 0.5 2.1 7.1 5.4 1.7 0.4 4.2 0.5 4.8 3.6 1.2 0.7 1.0 2.1 0.5 2.5 1.2 1.5 1.0 0.5 1.6 16.8 2.3 0.0 0.5 0.2 0.6 2.2 1.2 0.1 0.1 0.2 0.0 0.1 1.3 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 2.5 6.6 6.1 10.4 0.0 4.0 0.0 0.0 1.2 0.1 1.6 7.8 0.0 4.4 0.0 0.8 1.7 2.6 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.3 2.3 0.2 0.0 0.8 6.7 0.7 0.0 0.0 0.0 0.8 0.0 2.0 5.6 1.8 0.4 0.8 0.5 0.0 0.0 0.0 0.6 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.1 0.2 0.1 0.0 0.1 0.0 0.0 3.4 15.5 8.1 12.4 2.8 5.0 2.1 7.1 4.8 2.3 0.0 0.0 0.0 3.4 2.1 30.2 1.1 0.0 0.0 0.0 1.8 13.7 0.0 0.0 0.4 76.6 0.7 0.0 0.0 1.3 0.0 0.5 2.4 0.0 0.0 0.0 47.7 0.0 2.5 0.0 66.1 2.0 0.0 1.7 0.0 0.0 0.8 1.8 0.0 2.5 0.5 3.3 0.0 0.3 1.1 1.4 0.9 0.0 0.0 0.0 2.2 CNNM3 ACDP3 ENSG00000168763 "Cyclin and CBS domain divalent metal cation transport mediator 3" Q8NE01 2 96816245-96833911 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016711 Supported Approved Cytosol NA NA Cytosol "HPA016711: AB_1847394" "unprognostic (1.50e-2)" "unprognostic (6.96e-2)" "unprognostic (2.71e-2)" "unprognostic (3.21e-2)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (3.03e-1)" "unprognostic (1.59e-1)" "unprognostic (8.32e-3)" "unprognostic (3.64e-1)" "unprognostic (5.31e-3)" "unprognostic (7.35e-2)" "unprognostic (3.36e-1)" "unprognostic (1.06e-1)" "unprognostic (4.48e-2)" 8.1 10.7 8.6 6.4 11.5 5.2 8.6 25.0 11.2 8.9 13.3 16.9 7.4 17.4 10.7 5.3 7.5 12.0 15.0 5.9 10.0 5.2 8.6 20.7 8.8 7.2 14.5 9.7 11.6 27.9 28.9 15.7 10.3 11.4 8.9 8.3 13.1 11.4 9.9 9.9 7.7 15.1 10.7 7.0 9.5 12.3 11.4 15.9 13.8 10.0 2.4 10.2 9.9 8.2 3.0 1.8 5.5 3.3 2.1 5.4 1.3 6.9 7.3 6.0 9.8 7.5 3.6 18.3 4.9 4.2 4.7 4.7 18.8 11.7 7.8 17.0 3.8 5.3 8.1 9.1 6.4 3.0 7.7 22.0 10.6 9.2 19.0 6.6 9.1 7.8 3.6 7.8 6.3 5.6 5.7 5.7 6.4 9.6 12.5 1.8 9.2 8.5 8.9 8.3 10.2 8.5 10.5 8.4 9.7 7.6 9.5 19.3 11.7 6.3 9.6 5.3 8.6 9.7 6.7 2.7 4.2 11.9 6.1 6.8 12.5 12.1 5.7 2.4 8.7 4.2 2.7 1.4 5.5 5.4 0.6 2.9 3.0 2.8 4.4 0.4 2.8 2.5 2.7 3.0 2.1 3.3 1.8 4.6 1.3 8.6 11.5 25.0 11.2 10.0 5.2 14.5 9.7 11.4 15.9 8.9 3.7 4.2 2.8 1.1 17.9 14.3 10.2 4.0 3.4 0.0 7.9 4.3 0.0 3.6 6.3 2.3 4.9 0.0 3.6 2.0 2.4 5.7 0.0 12.9 2.2 31.8 4.1 4.3 2.6 1.1 2.3 0.8 3.3 1.0 6.4 8.9 2.9 0.0 3.9 1.6 12.9 12.9 3.3 3.4 7.5 1.4 1.4 2.5 6.9 2.2 CNOT1 "AD-005, CDC39, KIAA1007, NOT1, NOT1H" ENSG00000125107 "CCR4-NOT transcription complex subunit 1" A5YKK6 16 58519951-58629886 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046577, HPA049664" Approved Supported Cytosol NA NA 210000 Cytosol "HPA046577: AB_2679706, HPA049664: AB_2680844" "unprognostic (1.30e-2)" "unprognostic (6.86e-2)" "unprognostic (9.25e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-2)" "unprognostic (7.11e-2)" "unprognostic (3.58e-2)" "unprognostic (2.19e-1)" "unprognostic (6.43e-2)" "unprognostic (6.99e-2)" "unprognostic (1.83e-2)" "unprognostic (6.63e-2)" "unprognostic (1.33e-3)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (5.53e-2)" "unprognostic (1.52e-1)" 20.4 26.5 14.9 31.5 16.5 18.2 18.8 24.2 16.8 21.3 26.6 16.7 26.6 24.3 22.2 19.1 45.6 19.0 15.4 15.5 14.2 9.0 18.8 20.9 19.6 24.1 19.0 12.3 22.6 21.8 39.6 25.4 23.2 16.1 15.9 26.6 17.3 28.3 27.2 32.6 27.4 31.4 20.0 13.6 25.8 22.7 53.9 18.1 45.1 20.2 22.6 32.6 26.9 26.0 15.4 14.6 18.8 20.9 14.6 19.2 10.6 26.4 31.1 23.8 19.0 11.5 14.7 27.3 20.9 18.3 24.1 18.0 35.2 16.0 40.3 10.1 16.0 14.0 26.1 38.0 21.4 32.7 15.0 20.8 31.3 25.7 40.2 15.7 48.2 35.2 14.2 14.7 28.0 33.0 14.6 18.7 22.8 36.6 11.8 16.2 10.7 37.3 12.6 24.6 17.7 27.1 47.5 41.0 25.6 13.6 37.3 19.7 12.7 71.2 24.1 11.9 22.8 14.5 25.3 21.0 17.7 17.6 13.3 18.3 27.0 27.2 81.8 18.8 20.6 16.4 18.3 11.6 13.0 14.6 15.9 19.2 15.4 14.1 14.6 14.6 14.2 12.6 13.5 18.8 14.6 20.9 7.4 14.8 10.6 14.9 16.5 24.2 16.8 14.2 9.0 19.0 12.3 16.1 18.1 14.9 40.5 34.1 27.4 42.1 27.5 15.5 43.3 46.8 39.8 22.7 27.5 30.8 8.3 26.3 70.8 29.5 51.6 46.7 40.6 26.0 23.4 33.4 30.2 35.2 31.0 38.1 34.7 27.0 46.6 26.6 23.0 34.4 18.6 27.9 57.2 18.1 34.7 23.0 30.4 19.2 22.3 32.3 23.9 105.1 59.6 41.0 31.7 34.6 59.2 59.6 CNOT10 "FLJ12890, FLJ13165" ENSG00000182973 "CCR4-NOT transcription complex subunit 10" Q9H9A5 3 32685145-32773875 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 66.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035614, HPA041450" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA035614: AB_10669975, HPA041450: AB_2677487" "unprognostic (3.75e-1)" "unprognostic (4.57e-2)" "unprognostic (4.45e-3)" "unprognostic (6.01e-2)" "unprognostic (9.88e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.88e-1)" "unprognostic (1.50e-1)" "unprognostic (5.09e-3)" "unprognostic (1.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (8.75e-3)" "unprognostic (3.43e-1)" 12.3 12.6 11.3 15.2 12.4 16.6 14.0 14.2 13.4 13.4 14.0 12.5 12.8 10.8 19.8 13.5 14.8 16.1 9.8 13.0 10.5 9.4 13.1 13.5 11.4 14.7 9.7 11.9 14.7 14.0 16.0 23.0 11.3 13.3 13.1 15.7 12.2 12.0 10.9 13.5 14.9 14.7 12.8 10.5 15.1 12.2 40.5 10.9 30.2 13.8 11.9 17.4 13.0 12.6 15.0 14.1 16.0 21.0 9.0 18.5 11.2 8.4 9.5 9.9 9.3 4.8 5.5 66.1 7.1 7.2 10.2 11.5 7.2 7.3 13.9 4.8 5.1 6.6 7.4 11.7 9.4 10.2 12.0 12.0 17.8 8.6 6.9 14.0 14.6 6.9 4.0 8.5 11.2 14.9 6.8 8.3 13.0 18.5 10.8 5.9 6.9 13.0 7.1 14.9 9.8 9.1 13.2 6.7 13.8 6.5 9.9 5.6 10.9 10.5 14.8 8.6 7.3 14.4 16.6 5.1 6.3 9.0 8.3 11.8 11.2 22.9 13.9 6.5 11.1 7.6 12.8 11.2 16.0 11.4 15.7 12.3 14.8 18.5 13.6 14.1 15.0 18.5 16.2 8.8 9.0 21.0 7.8 14.4 11.2 11.3 12.4 14.2 13.4 10.5 9.4 9.7 11.9 13.3 10.9 14.9 21.4 14.3 5.8 9.3 15.9 10.8 7.6 32.1 15.9 14.0 31.4 11.6 5.0 11.2 42.3 11.4 11.8 0.0 11.7 14.6 9.8 6.0 10.4 8.5 10.3 14.3 15.0 11.1 14.8 29.1 8.9 12.9 11.8 47.7 8.3 8.0 9.9 14.4 9.9 5.6 18.7 6.5 10.6 35.7 32.4 12.7 6.9 18.3 13.6 6.7 CNOT2 "CDC36, NOT2, NOT2H" ENSG00000111596 "CCR4-NOT transcription complex subunit 2" Q9NZN8 12 70242994-70354993 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067711 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA067711: AB_2685893" "unprognostic (5.00e-2)" "unprognostic (2.12e-1)" "unprognostic (6.95e-2)" "unprognostic (3.60e-2)" "unprognostic (3.48e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (7.36e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.32e-1)" "unprognostic (9.70e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.28e-1)" "unprognostic (5.58e-2)" "unprognostic (5.97e-2)" "unprognostic (6.23e-2)" 27.8 19.9 18.9 24.6 23.8 44.5 24.9 53.3 24.7 24.0 21.7 21.9 21.6 20.1 37.5 25.8 22.5 20.6 18.8 20.1 18.7 16.2 21.8 24.1 25.9 24.8 23.8 21.2 26.8 20.5 25.0 41.2 30.1 19.8 24.3 24.9 20.5 21.6 21.9 27.6 36.7 24.4 25.5 23.4 26.8 18.8 16.3 24.8 46.1 22.7 20.9 28.8 24.8 24.5 28.8 33.1 37.1 36.5 32.2 41.3 27.2 19.8 18.9 32.1 20.2 17.7 20.0 26.7 22.0 26.6 24.5 21.0 24.2 19.3 42.6 20.3 25.1 15.7 19.6 22.3 21.6 27.5 20.4 20.2 28.0 17.4 22.7 18.9 36.1 25.0 21.8 24.3 23.0 28.0 36.8 25.9 26.4 25.5 24.7 21.3 21.4 41.2 25.8 27.3 20.3 20.2 32.0 26.5 25.8 22.7 40.0 21.4 25.3 25.9 21.0 18.5 28.7 26.8 30.0 18.9 22.9 15.7 20.9 17.7 22.6 25.8 33.7 23.4 17.7 17.9 37.1 26.0 28.3 29.4 36.5 32.8 28.8 31.9 32.9 33.1 27.6 38.0 41.3 15.1 32.2 29.3 23.0 29.7 27.2 18.9 23.8 53.3 24.7 18.7 16.2 23.8 21.2 19.8 24.8 38.7 39.2 30.3 33.3 45.3 61.2 26.6 50.9 44.2 40.9 34.9 53.0 39.0 28.2 41.8 19.7 42.9 38.2 23.3 38.7 40.0 42.0 37.1 73.0 29.8 35.6 49.3 55.7 44.8 51.1 6.5 42.3 42.3 30.4 26.2 38.5 47.8 37.7 41.8 43.9 21.7 50.2 38.8 47.0 33.9 39.8 56.0 29.6 65.4 35.5 38.9 CNOT3 "KIAA0691, LENG2, NOT3, NOT3H" ENSG00000088038 "CCR4-NOT transcription complex subunit 3" O75175 19 54137717-54155708 "Cancer-related genes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 72.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006408 Approved Approved Cytosol NA NA Cytosol "HPA006408: AB_1078543" "unprognostic (1.23e-1)" "unprognostic (2.54e-1)" "unprognostic (1.75e-2)" "unprognostic (1.40e-1)" "unprognostic (4.86e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (9.06e-2)" "unprognostic (1.43e-2)" "unprognostic (2.65e-2)" "unprognostic (9.30e-3)" "unprognostic (4.08e-3)" "prognostic unfavorable (2.77e-4)" "unprognostic (2.18e-1)" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" "unprognostic (2.66e-2)" 18.1 25.2 25.5 23.6 26.4 21.4 20.2 46.8 27.9 22.1 20.7 24.5 27.7 21.3 25.0 26.5 22.1 23.6 19.7 16.2 21.9 15.6 21.3 20.2 17.9 23.9 25.5 20.8 28.0 22.7 27.6 30.2 24.2 20.3 23.3 17.5 20.7 22.4 31.4 20.2 25.2 21.4 22.0 16.7 26.3 21.9 34.4 26.9 33.6 26.3 14.3 23.3 23.8 29.9 3.2 6.7 8.4 3.1 1.6 3.6 2.9 13.8 22.3 23.2 13.3 8.6 8.8 16.2 13.0 22.5 17.4 15.6 14.3 12.0 17.1 8.3 15.0 14.3 14.6 25.7 12.6 18.1 17.6 72.5 26.5 14.5 12.7 15.0 15.1 18.6 11.0 12.2 15.5 26.3 12.6 13.8 13.0 19.5 16.0 12.8 17.1 18.7 8.9 14.1 28.5 17.9 18.7 17.8 11.1 11.7 28.1 15.0 12.6 25.1 18.1 8.2 18.0 10.3 16.2 12.3 14.8 17.1 7.9 17.6 15.1 16.4 23.6 12.9 11.6 15.6 1.4 3.1 5.2 3.6 2.2 2.5 2.9 2.4 3.2 2.8 3.2 2.7 2.6 8.4 1.6 2.6 6.7 2.5 2.9 25.5 26.4 46.8 27.9 21.9 15.6 25.5 20.8 20.3 26.9 11.9 9.0 17.1 14.7 8.9 17.3 1.7 12.7 12.0 11.4 7.0 15.7 23.7 8.3 12.8 7.4 10.5 14.4 0.0 12.6 22.9 13.5 16.1 3.5 7.6 14.1 15.9 13.8 12.9 7.9 5.4 15.8 7.2 5.0 16.2 15.2 11.3 13.1 20.1 8.9 8.1 17.8 6.5 11.2 44.2 39.9 8.7 41.9 12.5 11.9 14.8 CNOT6 "CCR4, Ccr4a, KIAA1194" ENSG00000113300 "CCR4-NOT transcription complex subunit 6" Q9ULM6 5 180494412-180578405 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044568 Approved Approved Cytosol NA NA Cytosol "HPA044568: AB_10797257" "unprognostic (9.41e-3)" "unprognostic (1.40e-1)" "unprognostic (2.03e-3)" "unprognostic (2.55e-1)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.35e-2)" "unprognostic (1.79e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-1)" "unprognostic (4.03e-2)" "unprognostic (3.57e-2)" 10.2 10.1 19.2 15.4 20.2 14.4 13.3 43.9 18.7 12.0 16.4 11.7 9.7 16.2 13.1 12.4 19.6 13.3 12.7 13.0 15.9 11.1 14.1 8.6 13.0 14.3 12.3 14.0 14.8 10.3 13.4 12.7 17.6 12.9 13.9 16.2 14.3 13.4 10.9 8.3 14.4 20.6 13.4 12.3 17.0 13.7 17.6 14.9 25.1 12.6 10.0 18.4 16.9 24.5 2.2 2.5 3.4 5.8 2.1 4.5 1.7 11.1 13.4 27.6 22.0 4.6 5.3 28.5 8.1 5.5 10.9 13.0 16.3 16.4 11.8 12.5 5.3 15.1 11.7 23.0 27.2 12.8 34.5 11.5 12.8 18.1 10.5 6.8 14.9 9.4 4.4 13.2 8.0 17.0 10.2 13.2 13.9 13.6 11.4 10.0 22.9 18.9 9.0 8.1 11.2 6.4 17.5 13.9 8.4 12.0 22.1 20.2 17.1 13.8 18.5 11.8 14.1 23.1 15.1 14.3 11.6 13.4 8.4 14.4 7.4 13.3 12.5 11.0 20.5 9.5 1.5 2.6 3.4 3.8 4.1 4.0 2.0 3.3 2.3 2.4 2.2 4.5 4.4 2.2 2.1 5.8 2.5 2.3 1.7 19.2 20.2 43.9 18.7 15.9 11.1 12.3 14.0 12.9 14.9 26.8 12.0 6.7 5.5 19.3 18.0 9.6 10.2 8.1 6.8 10.4 21.6 7.9 1.7 10.2 5.2 11.9 11.1 0.0 7.8 9.9 10.4 14.0 2.3 5.7 10.6 17.5 13.9 14.7 16.7 7.5 12.0 13.1 10.1 8.2 14.3 13.1 12.9 5.8 17.7 11.8 15.3 25.8 7.3 39.4 56.2 19.4 9.6 12.9 15.1 12.9 CNOT6L "Ccr4b, DKFZp434K098" ENSG00000138767 "CCR4-NOT transcription complex subunit 6 like" Q96LI5 4 77713387-77819615 "Enzymes, Predicted intracellular proteins" "mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 51.3" "Cell type enhanced" "Detected in many" 5 "T-cells: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042688 Uncertain Supported Cytosol NA NA Cytosol "HPA042688: AB_10794384" "unprognostic (3.91e-1)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.10e-2)" "unprognostic (2.56e-1)" "unprognostic (3.72e-2)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (5.06e-2)" "unprognostic (6.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (4.51e-2)" "unprognostic (7.95e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-3)" 13.6 7.8 8.6 21.5 8.2 15.3 11.0 11.1 9.2 7.8 7.3 7.0 4.6 7.5 11.4 6.3 10.2 7.1 8.3 7.5 6.0 5.7 7.7 10.8 12.7 19.2 7.6 7.3 8.8 10.8 14.6 10.0 12.3 6.7 8.4 8.9 10.3 9.9 7.4 9.1 12.2 11.5 8.4 6.9 23.4 7.9 7.3 5.6 51.3 9.1 6.2 21.1 10.7 10.3 7.5 6.1 20.2 9.3 7.4 10.0 4.4 8.8 5.7 7.2 4.8 8.5 7.4 7.1 7.0 9.3 6.3 8.6 2.2 9.9 15.3 8.9 9.8 5.0 5.7 9.3 9.7 8.5 15.3 5.2 14.3 7.9 6.4 5.4 14.2 12.6 4.8 12.6 7.1 13.0 6.0 20.0 11.1 11.9 20.5 7.3 6.0 26.2 7.2 3.3 7.0 1.8 6.5 20.4 10.9 7.2 10.0 8.9 4.3 12.1 11.1 4.9 8.8 3.5 7.3 21.7 6.1 6.8 11.5 3.8 26.3 11.2 19.0 6.6 6.2 4.5 20.2 4.7 10.2 10.0 7.0 10.0 5.3 7.5 7.8 4.5 7.5 7.3 8.5 6.7 7.4 9.3 6.1 6.0 4.4 8.6 8.2 11.1 9.2 6.0 5.7 7.6 7.3 6.7 5.6 20.8 16.0 29.6 11.9 51.4 38.1 14.5 22.9 14.7 28.4 34.9 37.3 22.8 51.4 5.9 3.4 42.7 16.9 0.0 10.5 7.4 21.1 30.3 36.9 27.0 14.9 30.2 25.2 41.7 40.3 2.8 17.3 33.5 23.6 14.4 31.3 20.1 8.9 14.0 12.0 17.0 40.7 32.3 31.7 19.1 30.9 57.7 20.4 121.5 23.0 16.3 CNPY2 "Cnpy2, HP10390, TMEM4, ZSIG9" ENSG00000257727 "Canopy FGF signaling regulator 2" Q9Y2B0 12 56309842-56316336 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 396.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038465, HPA038466" Supported Supported Cytosol "Intracellular and membrane" NA NA 62000 Cytosol "HPA038465: AB_10967609, HPA038466: AB_10672646" "unprognostic (3.83e-2)" "unprognostic (5.62e-2)" "unprognostic (2.49e-1)" "unprognostic (2.46e-2)" "unprognostic (4.33e-2)" "unprognostic (2.20e-1)" "unprognostic (1.17e-3)" "unprognostic (1.46e-1)" "unprognostic (7.68e-2)" "unprognostic (2.04e-3)" "prognostic favorable (8.37e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (2.32e-8)" "unprognostic (1.91e-1)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (5.06e-2)" 17.8 31.4 19.0 16.1 23.8 14.0 27.3 17.3 24.1 29.9 23.7 23.3 40.1 23.0 21.1 46.4 19.1 26.1 19.9 16.9 19.0 20.4 26.7 53.2 17.3 14.9 21.2 21.8 25.7 59.9 19.9 39.3 39.7 21.6 23.4 24.2 18.9 46.2 33.4 10.9 12.3 26.4 16.8 22.5 20.2 23.6 13.7 20.4 13.0 38.0 15.5 16.2 19.7 17.4 33.1 35.3 22.2 36.4 30.1 38.7 33.7 16.2 29.3 21.0 19.3 57.3 22.4 42.5 18.5 36.9 34.5 24.6 39.0 29.1 15.1 32.0 39.9 18.0 23.7 26.2 20.7 20.1 18.3 24.5 14.5 30.9 34.3 28.5 27.3 22.3 26.0 31.5 28.4 32.0 49.5 27.9 21.2 23.2 39.1 23.7 26.7 16.7 32.3 21.5 33.0 41.8 19.7 17.2 32.0 26.8 12.5 22.6 13.3 27.2 27.2 27.2 28.3 25.7 60.1 15.0 15.1 11.5 16.4 22.1 19.2 25.5 11.4 28.0 26.7 24.1 22.2 36.4 18.3 33.4 26.1 38.7 33.1 37.2 35.2 35.3 27.6 37.9 34.3 5.2 30.1 15.9 34.3 31.2 33.7 19.0 23.8 17.3 24.1 19.0 20.4 21.2 21.8 21.6 20.4 44.7 80.8 67.3 61.3 48.7 74.0 8.5 150.3 68.3 56.9 96.0 60.9 216.3 44.7 170.3 31.1 66.5 86.5 23.3 146.9 396.1 82.6 106.0 90.0 177.6 129.7 55.6 136.3 84.7 56.3 11.1 96.1 63.5 116.4 114.6 123.9 72.9 148.7 108.7 94.0 116.9 81.3 25.8 72.2 66.7 41.7 47.0 197.7 84.1 139.6 60.7 CNRIP1 "C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924" ENSG00000119865 "Cannabinoid receptor interacting protein 1" Q96F85 2 68284171-68320051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.2" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 71.9;granulocytes: 120.1" "Cancer enhanced" "Detected in all" "glioma: 14.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 79 "basophil: 11.1" "Lineage enriched" "Detected in single" 79 "granulocytes: 11.1" "Cell line enhanced" "Detected in many" "HEL: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035337 Approved Cytosol NA NA 50000 Cytosol "HPA035337: AB_10601359" "unprognostic (1.23e-1)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.85e-1)" "unprognostic (1.31e-1)" "unprognostic (1.20e-1)" "unprognostic (6.51e-2)" "unprognostic (3.52e-2)" "unprognostic (2.86e-2)" "unprognostic (4.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.04e-2)" "unprognostic (3.63e-2)" "unprognostic (1.69e-1)" "unprognostic (3.38e-3)" 26.6 8.6 26.9 7.1 21.9 6.4 11.8 28.3 42.2 15.3 7.3 7.5 2.0 4.9 15.7 8.0 6.3 9.3 10.3 8.8 26.9 22.4 5.0 3.8 10.0 5.7 16.0 22.9 24.5 2.6 2.7 7.2 14.7 12.7 10.1 6.3 10.9 3.3 11.6 7.8 3.6 7.0 11.8 10.8 10.8 5.7 4.0 6.5 0.1 4.1 3.0 4.1 9.3 13.6 0.1 0.0 11.1 0.1 0.0 0.1 0.1 0.0 0.3 3.0 0.0 11.5 8.5 0.0 11.5 8.9 10.4 7.5 0.0 0.0 0.0 0.4 11.0 7.9 0.0 0.2 0.1 11.0 0.0 2.8 53.5 0.8 0.0 12.1 0.0 7.6 7.9 0.0 6.9 4.0 6.4 16.0 0.0 0.0 0.0 7.5 0.0 0.0 0.1 5.2 0.0 5.3 0.0 4.7 0.0 0.0 0.0 15.8 16.0 0.8 0.0 8.8 0.0 0.0 0.5 17.0 7.3 4.7 6.4 16.7 0.0 0.0 0.0 5.8 0.0 5.3 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 26.9 21.9 28.3 31.9 26.9 22.4 16.0 22.9 12.7 6.5 0.0 7.0 0.0 0.4 11.4 71.9 1.9 0.0 0.0 1.2 0.0 21.6 1.3 0.0 0.3 0.6 60.8 0.0 23.3 0.2 8.9 42.3 0.7 120.1 0.5 43.9 27.0 0.0 30.1 16.8 1.5 42.0 12.4 35.4 3.6 0.0 23.6 0.9 0.0 40.0 0.0 41.8 45.3 56.7 0.4 0.2 9.4 1.7 2.2 0.0 0.9 CNTLN "bA340N12.1, C9orf101, C9orf39, FLJ20276" ENSG00000044459 Centlein Q9NXG0 9 17134982-17503923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 58.9;Spermatogonia: 51.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.9" "Lineage enriched" "Detected in many" 4 "monocytes: 6.9" "Cell line enhanced" "Detected in many" "HEL: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007201, HPA036728, HPA036729" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240" "unprognostic (1.97e-2)" "unprognostic (2.81e-3)" "unprognostic (1.81e-1)" "unprognostic (2.48e-1)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (7.71e-2)" "unprognostic (1.68e-1)" "unprognostic (7.71e-3)" "unprognostic (5.07e-3)" "unprognostic (1.06e-1)" "unprognostic (6.65e-2)" "unprognostic (2.47e-1)" "unprognostic (5.38e-2)" "unprognostic (3.35e-2)" "unprognostic (1.37e-1)" "unprognostic (5.80e-2)" 13.2 5.6 4.3 5.2 5.1 12.5 7.4 15.5 4.5 16.6 8.6 4.2 6.7 2.2 22.6 6.0 6.0 8.0 7.4 4.9 4.2 3.8 5.0 20.0 5.4 4.8 4.9 2.6 15.2 3.6 10.0 13.2 6.1 6.3 9.8 4.0 7.0 3.8 6.3 5.9 3.5 4.4 11.9 8.1 8.6 4.4 8.2 6.8 4.4 5.5 5.8 2.8 11.7 13.5 0.3 1.5 0.8 6.9 1.2 0.2 0.5 5.9 4.1 9.0 5.1 4.5 10.5 0.3 7.0 4.7 5.2 7.2 0.3 2.0 4.3 1.1 4.8 5.7 0.3 10.4 2.9 8.2 0.2 3.7 25.5 8.7 1.5 4.9 3.5 5.6 6.6 1.5 4.4 4.3 4.9 7.4 1.6 0.9 1.0 8.3 0.5 2.8 5.6 7.0 1.0 7.7 4.2 8.3 2.1 3.0 1.5 5.7 5.9 8.5 0.2 2.2 3.7 1.7 8.9 5.4 7.2 2.8 7.8 6.0 3.6 4.3 0.1 3.4 4.4 3.2 0.6 2.7 0.1 0.1 3.3 0.0 0.3 0.2 0.1 1.5 0.3 0.1 0.1 0.8 1.2 6.9 1.5 0.2 0.5 4.3 5.1 15.5 4.5 4.2 3.8 4.9 2.6 6.3 6.8 6.0 14.5 0.8 12.1 7.8 9.1 10.6 5.1 2.7 2.3 8.7 0.0 1.5 5.0 7.5 13.2 20.3 1.3 23.3 10.4 4.0 13.6 3.2 7.0 35.9 15.7 19.1 2.4 19.6 34.5 6.5 42.3 18.3 8.5 26.2 2.6 25.0 4.2 0.0 29.0 6.3 8.4 12.9 15.0 58.9 51.1 4.8 0.8 3.2 3.0 3.5 CNTRL "CEP1, CEP110" ENSG00000119397 Centriolin Q7Z7A1 9 121074863-121177610 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 156.6;Spermatocytes: 334.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 35.4" "Low region specificity" "Detected in all" "HPA020468, HPA020480, HPA051583" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542" "unprognostic (4.33e-3)" "unprognostic (2.89e-3)" "unprognostic (2.09e-2)" "unprognostic (7.97e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.21e-5)" "unprognostic (1.05e-2)" "unprognostic (3.22e-3)" "unprognostic (3.74e-3)" "unprognostic (2.02e-1)" "unprognostic (1.78e-2)" "unprognostic (5.47e-2)" "unprognostic (3.60e-3)" "unprognostic (9.83e-3)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" "unprognostic (1.13e-2)" 7.7 4.7 5.5 22.2 11.7 24.0 6.8 10.9 8.7 8.4 5.5 4.9 5.9 3.8 7.3 6.4 5.6 8.4 5.1 4.4 6.6 4.3 4.0 3.8 9.3 20.3 8.1 4.1 10.6 5.2 4.0 17.3 5.8 7.0 7.2 5.5 4.4 6.3 8.6 2.8 5.2 8.8 5.7 9.7 14.8 7.1 30.2 9.8 26.7 6.2 4.2 19.2 8.6 7.1 12.7 10.5 15.0 6.9 4.8 10.4 2.5 5.4 3.6 10.2 7.3 1.5 2.3 1.8 3.8 2.8 3.0 2.6 2.1 6.0 25.1 1.5 2.7 5.4 11.5 3.4 2.3 4.9 15.1 2.6 13.1 6.7 2.5 2.1 35.4 15.9 1.4 1.7 3.1 7.6 1.3 6.5 10.4 8.4 14.3 2.9 3.5 13.9 12.1 3.5 7.0 3.0 13.1 15.4 7.2 1.4 2.5 3.8 5.8 12.9 2.3 2.9 1.8 4.9 17.0 4.8 3.2 5.5 4.9 7.0 10.0 10.9 17.0 2.6 14.6 7.2 12.2 6.9 15.0 7.5 4.5 5.7 10.8 7.7 5.5 3.4 12.7 9.3 6.6 2.7 4.8 5.8 10.5 10.4 2.5 5.5 11.7 10.9 8.7 6.6 4.3 8.1 4.1 7.0 9.8 26.8 26.2 35.1 12.7 3.0 28.2 7.0 5.1 156.6 48.9 3.5 35.3 1.5 3.3 3.8 56.2 14.4 2.1 0.0 5.2 2.1 5.9 3.8 49.9 2.0 22.5 28.6 8.1 12.3 34.6 27.0 12.7 37.9 8.5 22.6 7.3 7.0 5.3 3.5 11.3 1.1 64.1 38.8 5.1 334.4 72.6 5.0 0.7 29.8 5.2 4.7 CNTROB "LIP8, PP1221" ENSG00000170037 "Centrobin, centriole duplication and spindle assembly protein" Q8N137 17 7932101-7949918 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.2" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023319, HPA023320, HPA023321, HPA023325" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.26e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (9.88e-4)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (3.47e-3)" "unprognostic (1.48e-2)" "unprognostic (8.63e-2)" "unprognostic (4.47e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-1)" "unprognostic (2.16e-2)" 9.0 7.4 7.5 9.2 10.1 18.4 9.3 11.2 12.7 13.0 10.9 9.8 9.9 6.8 21.3 12.6 11.0 10.4 9.0 7.1 9.5 8.0 9.2 8.7 15.0 8.4 9.3 9.9 11.4 11.0 16.5 9.6 9.9 9.9 9.9 12.5 10.3 9.6 8.6 6.8 16.9 9.1 16.3 7.0 9.9 8.4 51.2 6.4 16.0 10.4 6.2 11.2 9.3 10.0 2.1 7.6 9.4 3.4 3.4 3.5 2.6 22.3 14.7 21.9 12.1 9.3 12.8 7.1 19.5 18.3 27.3 20.9 12.4 8.3 23.0 10.3 17.0 12.2 18.0 17.0 13.6 30.6 22.6 13.3 15.2 24.0 9.8 13.7 14.1 23.6 11.7 10.1 19.2 19.4 13.2 16.8 23.1 11.0 11.3 18.9 7.2 21.4 13.6 4.9 8.1 11.5 22.8 15.1 8.6 12.6 6.9 7.2 12.9 15.8 8.1 6.2 12.2 11.0 9.0 13.7 15.3 13.0 20.6 26.8 17.3 11.6 15.9 13.1 18.1 21.7 9.4 2.5 1.0 2.9 3.4 2.6 2.1 2.2 3.5 1.7 1.5 1.4 2.4 0.4 3.4 1.4 7.6 2.9 2.6 7.5 10.1 11.2 12.7 9.5 8.0 9.3 9.9 9.9 6.4 6.0 15.8 4.5 6.8 7.0 5.8 3.0 5.1 4.0 7.9 12.2 7.9 3.3 1.7 4.4 2.1 5.8 3.6 0.0 6.0 3.6 5.0 5.0 18.4 3.4 5.7 3.2 2.9 5.5 5.9 3.4 4.9 7.2 3.3 0.0 5.6 5.3 5.0 3.5 7.4 2.6 6.5 0.0 3.5 40.6 8.3 7.5 2.1 4.9 7.3 4.1 COG3 SEC34 ENSG00000136152 "Component of oligomeric golgi complex 3" Q96JB2 13 45464898-45536630 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040353, HPA054470" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA040353: AB_10794027, HPA054470: AB_2732585" "unprognostic (1.75e-1)" "unprognostic (3.03e-3)" "unprognostic (1.75e-1)" "unprognostic (4.04e-3)" "unprognostic (9.69e-2)" "unprognostic (2.86e-2)" "unprognostic (2.18e-2)" "unprognostic (4.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (9.53e-4)" "unprognostic (5.82e-2)" "unprognostic (1.21e-2)" "unprognostic (4.49e-2)" "unprognostic (7.06e-3)" "unprognostic (1.13e-1)" "unprognostic (8.25e-2)" "unprognostic (1.71e-1)" 12.5 17.4 8.7 17.1 14.0 10.9 17.0 19.7 14.5 16.9 17.1 13.0 22.4 13.2 16.9 20.6 14.4 14.0 12.8 12.5 8.9 9.4 16.5 46.2 12.1 11.7 9.3 10.0 17.9 29.4 10.9 22.6 32.9 11.5 20.9 20.7 12.9 28.3 25.2 12.5 14.7 18.8 13.3 10.1 14.8 15.6 9.9 11.2 17.4 18.5 8.7 18.5 14.8 14.8 5.1 7.2 7.4 4.6 4.9 8.0 3.8 5.4 4.9 9.5 8.6 12.6 14.5 9.1 9.1 13.0 10.6 8.9 7.2 10.1 7.5 4.1 10.8 7.9 12.0 7.8 9.2 16.2 5.8 6.4 8.4 6.0 12.6 15.6 12.3 8.1 10.8 13.9 7.0 25.1 12.9 10.3 7.4 5.4 4.6 12.7 8.4 6.8 11.6 7.8 27.4 6.0 8.0 5.6 7.0 9.9 8.9 4.7 8.6 5.9 11.6 12.1 9.4 7.9 12.8 9.6 5.1 4.0 9.5 5.8 6.5 3.5 7.8 9.8 6.2 9.1 7.4 4.1 7.3 7.5 4.6 8.0 5.1 5.8 6.4 3.1 4.9 6.6 6.1 3.7 4.9 2.9 7.2 6.2 3.8 8.7 14.0 19.7 14.5 8.9 9.4 9.3 10.0 11.5 11.2 8.9 31.8 15.2 12.2 14.1 9.4 16.9 20.4 9.4 23.9 12.2 13.7 12.4 13.3 9.4 12.9 12.1 27.1 23.3 32.9 15.5 10.8 25.6 16.2 73.3 9.8 9.5 21.4 20.3 20.8 7.4 13.0 14.6 10.1 6.4 43.3 5.2 18.0 34.5 12.7 11.9 10.4 6.5 9.9 11.5 6.6 14.1 27.5 17.5 21.4 19.0 COL12A1 COL12A1L ENSG00000111799 "Collagen type XII alpha 1 chain" Q99715 6 75084326-75206051 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 136.8" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 71.5;Leydig cells: 55.8;Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 164.5;SiHa: 97.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA009143, HPA010021" Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA 4300000 Vesicles Cytosol "HPA009143: AB_1847095, HPA010021: " "unprognostic (2.60e-2)" "unprognostic (2.80e-3)" "unprognostic (7.92e-2)" "unprognostic (8.27e-3)" "unprognostic (1.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (3.47e-3)" "unprognostic (1.38e-1)" "unprognostic (4.30e-1)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "prognostic unfavorable (1.69e-9)" "unprognostic (1.03e-3)" "unprognostic (1.81e-1)" "unprognostic (3.16e-3)" "unprognostic (1.92e-2)" 53.1 5.6 0.9 33.1 1.3 0.0 136.8 0.4 2.0 65.0 23.0 0.5 14.8 4.2 64.6 18.1 29.2 14.9 16.3 17.1 1.1 1.1 7.6 1.5 22.2 23.5 2.0 1.5 52.0 4.1 1.5 1.9 2.6 1.6 12.3 8.7 2.4 5.9 21.4 21.6 16.8 14.1 32.4 1.4 5.0 6.9 10.6 0.4 1.0 8.2 15.0 4.4 24.8 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 35.2 19.7 3.3 32.0 26.7 22.0 30.7 3.2 0.0 0.0 3.3 164.5 0.4 7.0 0.0 3.3 20.8 0.0 0.1 0.0 11.9 0.0 13.1 0.0 0.0 29.6 0.6 4.9 6.0 21.3 3.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.8 0.0 1.8 0.0 2.7 0.0 1.1 1.6 0.0 0.0 97.7 2.5 0.0 1.9 15.5 0.0 0.0 9.5 11.8 5.0 10.6 0.0 0.0 0.0 3.2 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.4 2.0 1.1 1.1 2.0 1.5 1.6 0.4 71.5 6.1 0.0 0.6 18.3 0.2 2.8 0.0 2.7 7.9 3.5 0.0 0.4 0.0 0.8 19.1 3.6 0.0 0.0 3.8 0.6 25.9 1.3 1.1 0.0 0.7 0.0 0.0 5.5 0.0 9.7 55.8 1.7 20.3 0.0 0.0 0.0 4.6 0.0 12.4 0.8 0.0 45.3 24.5 0.2 0.6 11.4 0.6 0.0 0.0 0.3 COL16A1 ENSG00000084636 "Collagen type XVI alpha 1 chain" Q07092 1 31652247-31704319 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 46.4;Leydig cells: 40.6;Muller glia cells: 43.8;Peritubular cells: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 38.8;ASC TERT1: 30.0;BJ hTERT+: 32.9;fHDF/TERT166: 30.0;HSkMC: 28.4;U-2197: 27.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027237 Uncertain "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 530000 Cytosol "Plasma membrane" "HPA027237: AB_10600699" "unprognostic (2.25e-2)" "unprognostic (9.88e-2)" "unprognostic (5.64e-2)" "unprognostic (8.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.00e-1)" "unprognostic (3.99e-2)" "unprognostic (2.04e-1)" "unprognostic (4.48e-3)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (4.00e-9)" "unprognostic (9.62e-2)" "unprognostic (6.13e-2)" "unprognostic (4.60e-2)" "unprognostic (2.15e-2)" 18.0 7.3 7.0 12.7 9.0 0.2 10.8 2.8 8.2 63.1 17.3 10.2 12.5 6.1 31.0 15.2 9.3 8.3 15.9 9.1 9.6 6.2 3.4 1.0 7.2 3.1 9.9 10.2 62.6 2.6 1.3 7.3 8.2 8.8 29.3 4.6 12.5 15.3 38.1 4.2 26.9 8.6 45.2 15.7 3.9 10.5 10.0 10.3 1.5 11.8 7.9 5.0 26.1 28.3 0.2 0.0 0.7 0.1 0.1 0.4 0.0 0.0 0.5 0.0 0.0 38.8 30.0 4.1 17.8 32.9 4.3 4.5 0.1 3.1 0.0 0.5 30.0 0.6 13.9 0.0 18.3 1.0 0.0 0.0 0.0 2.0 6.0 12.9 0.0 0.1 28.4 12.6 12.3 6.7 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.4 0.7 2.1 0.3 2.6 0.1 0.3 0.0 0.0 16.0 16.0 27.5 0.3 0.0 0.0 0.0 10.9 0.0 1.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.7 0.1 0.1 0.0 0.0 0.0 7.0 9.0 2.8 7.1 9.6 6.2 9.9 10.2 8.8 10.3 8.9 3.8 0.0 13.1 27.2 2.6 7.0 0.0 8.1 4.5 17.4 2.0 1.4 0.0 4.5 10.5 2.2 4.5 0.0 0.6 3.1 46.4 3.8 6.9 0.0 1.1 0.0 26.6 6.7 0.8 17.8 40.6 1.5 13.5 0.0 14.2 43.8 1.2 2.5 85.9 0.8 1.9 0.0 25.8 8.8 1.8 18.4 1.8 0.0 4.5 10.6 COL21A1 ENSG00000124749 "Collagen type XXI alpha 1 chain" Q96P44 6 56056590-56394094 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 36.4;Ciliated cells: 58.9;Extravillous trophoblasts: 52.2;Fibroblasts: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 18.9;BEWO: 6.1;HSkMC: 19.2;SuSa: 9.3" HPA031212 Supported Cytosol "Secreted to extracellular matrix" NA NA 180000 Cytosol "HPA031212: AB_10599941" "unprognostic (1.69e-1)" "unprognostic (4.53e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-1)" "unprognostic (1.21e-1)" "unprognostic (9.32e-3)" "unprognostic (6.84e-2)" "unprognostic (9.04e-3)" "unprognostic (1.54e-3)" "unprognostic (2.17e-1)" "unprognostic (5.29e-2)" "unprognostic (3.10e-1)" "unprognostic (1.26e-3)" "unprognostic (3.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.27e-3)" 3.9 1.6 6.6 2.1 2.3 0.3 3.0 5.1 3.6 25.8 11.3 5.2 7.9 0.8 20.0 7.0 3.3 7.6 3.9 4.5 8.5 2.5 1.4 1.5 7.4 0.7 3.6 4.6 3.9 2.1 0.8 3.6 26.4 6.9 5.4 2.2 5.9 4.4 10.9 2.3 6.3 2.6 24.2 5.3 0.7 5.7 3.8 5.8 0.0 2.1 4.1 0.8 10.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.6 0.1 0.0 1.0 18.9 6.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.6 0.1 0.0 19.2 0.7 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.6 2.3 5.1 3.6 8.5 2.5 3.6 4.6 6.9 5.8 0.0 1.0 0.0 2.3 5.3 0.0 36.4 0.0 58.9 12.5 0.0 0.0 17.6 0.0 0.0 3.5 3.4 0.0 0.0 0.0 52.2 33.7 0.1 0.0 0.0 5.4 0.0 0.0 4.3 0.8 1.1 14.1 1.0 5.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 6.6 0.2 0.6 3.6 19.5 0.0 0.0 1.5 COL25A1 ENSG00000188517 "Collagen type XXV alpha 1 chain" Q9BXS0 4 108808725-109302752 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.4;retina: 22.1;testis: 23.6" "Group enriched" "Detected in some" 16 "Early spermatids: 89.3;Late spermatids: 22.6;Rod photoreceptor cells: 75.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HeLa: 31.5" "Low region specificity" "Detected in many" HPA029107 Approved "Endoplasmic reticulum,Vesicles,Cytosol" NA NA "Vesicles, Cytosol" "Endoplasmic reticulum" "HPA029107: AB_10600802" "unprognostic (1.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.18e-1)" "unprognostic (8.87e-5)" "unprognostic (2.43e-2)" "unprognostic (3.20e-1)" "unprognostic (7.62e-3)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (3.53e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-1)" "unprognostic (5.30e-3)" "unprognostic (2.82e-3)" "unprognostic (9.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" 9.0 0.8 6.7 0.2 4.4 0.0 5.1 0.8 3.4 1.6 0.9 0.4 0.9 4.0 2.1 3.5 0.8 1.4 3.1 2.0 4.7 2.1 2.9 3.2 0.9 0.1 0.8 0.0 1.6 0.9 3.9 17.4 0.4 2.5 0.9 0.4 22.1 6.7 1.4 1.4 1.1 3.1 1.5 0.9 1.0 0.9 23.6 1.5 0.0 3.7 0.1 0.0 1.6 3.4 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.9 0.0 0.1 0.0 2.3 4.2 31.5 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.2 4.0 0.0 0.5 0.0 1.2 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.4 0.8 3.4 4.7 2.1 0.8 0.0 2.5 1.5 0.0 0.0 0.0 0.0 0.0 1.9 0.8 0.0 0.0 1.2 1.8 3.9 0.0 0.0 0.0 89.3 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.6 0.0 1.3 0.0 22.6 0.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 75.2 0.0 3.4 3.2 1.5 0.1 0.0 0.0 0.0 0.0 COL28A1 ENSG00000215018 "Collagen type XXVIII alpha 1 chain" Q2UY09 7 7356203-7535853 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 16.0;Cone photoreceptor cells: 17.7" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.3;U-266/70: 14.2;U-266/84: 3.8;WM-115: 6.9" "Region enriched" "Detected in single" 8 "olfactory region: 4.5" "Not detected" "Not detected" "HPA043844, HPA060468" Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cytosol" "HPA043844: AB_2732508, HPA060468: AB_2684288" "unprognostic (6.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.28e-1)" "unprognostic (8.71e-3)" "unprognostic (1.89e-2)" "unprognostic (5.63e-3)" "unprognostic (2.61e-2)" "unprognostic (7.58e-2)" "unprognostic (2.72e-2)" "unprognostic (7.69e-2)" "unprognostic (3.90e-3)" "unprognostic (2.33e-2)" "unprognostic (3.45e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (2.48e-3)" "unprognostic (3.09e-2)" 2.7 3.7 1.0 7.0 1.1 0.3 3.1 2.4 1.6 10.2 11.8 0.6 11.5 1.3 2.9 16.2 14.7 5.5 5.7 7.0 1.3 2.2 2.8 1.9 1.3 1.0 9.8 0.2 2.9 5.8 0.1 12.2 0.5 6.1 5.8 4.7 12.8 19.3 6.2 5.6 2.1 6.6 16.0 7.9 0.3 5.7 3.2 0.2 0.2 1.4 10.2 0.9 8.4 14.2 0.6 0.3 1.6 0.2 2.1 1.0 0.0 2.0 0.0 0.0 0.0 0.2 1.1 0.3 0.1 0.6 0.0 0.0 1.6 0.6 0.3 0.1 0.1 1.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.3 0.1 0.2 0.0 0.3 2.0 0.2 0.3 0.0 0.9 1.2 0.5 0.0 0.1 0.0 3.3 0.1 0.2 0.0 0.1 1.0 0.0 0.5 0.1 0.9 1.0 0.0 0.7 1.8 0.0 14.2 3.8 0.0 0.2 0.8 6.9 0.5 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.6 0.4 1.0 1.6 2.1 0.1 0.3 0.0 0.0 1.0 1.1 2.4 1.3 1.3 2.2 9.8 0.2 6.1 0.2 0.0 2.6 0.0 0.1 0.2 4.6 0.8 0.0 16.0 5.7 3.5 17.7 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.5 0.1 1.1 0.0 0.1 4.8 0.0 3.1 0.0 0.8 0.9 0.0 0.0 0.0 0.3 2.4 0.5 2.8 0.7 0.3 4.5 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.3 0.1 COL6A1 ENSG00000142156 "Collagen type VI alpha 1 chain" P12109 21 45981737-46005050 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 779.8;Leydig cells: 326.8;Peritubular cells: 236.2;Smooth muscle cells: 211.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.0;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 94.0;ASC TERT1: 191.4;BJ: 71.8;HHSteC: 83.5;HSkMC: 139.9;U-138 MG: 104.8" "Low region specificity" "Detected in all" "HPA019142, HPA029401" Enhanced Approved Cytosol "Secreted to extracellular matrix" NA NA 250000000 Cytosol "HPA019142: AB_1847093, HPA029401: AB_10601361" "unprognostic (3.45e-1)" "unprognostic (4.09e-2)" "unprognostic (8.71e-2)" "unprognostic (1.72e-1)" "unprognostic (5.79e-3)" "unprognostic (2.12e-1)" "unprognostic (6.27e-2)" "unprognostic (1.09e-2)" "unprognostic (4.47e-2)" "unprognostic (3.69e-2)" "unprognostic (6.06e-3)" "unprognostic (3.86e-1)" "prognostic unfavorable (1.07e-8)" "unprognostic (5.16e-2)" "unprognostic (7.39e-2)" "unprognostic (3.53e-3)" "prognostic unfavorable (4.54e-4)" 73.4 10.8 6.8 45.5 7.1 0.1 85.4 31.9 9.1 100.7 111.6 5.1 34.7 17.1 98.8 75.0 54.5 64.7 89.7 39.7 6.0 5.6 10.2 9.9 21.6 24.7 4.8 5.4 83.0 13.5 6.2 19.8 65.7 9.2 59.6 9.9 18.6 23.1 36.4 20.0 28.2 33.8 147.8 4.7 15.9 40.9 20.2 5.5 9.4 15.9 23.4 12.8 86.9 49.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 1.5 2.4 7.8 94.0 191.4 0.3 71.8 46.4 18.5 6.5 1.2 4.9 0.0 5.9 40.4 14.6 0.3 1.0 0.1 1.5 0.0 1.1 0.0 0.2 0.4 83.5 0.0 0.1 139.9 0.0 46.0 0.6 1.6 0.4 0.0 0.0 0.0 4.7 0.1 0.0 0.2 1.7 1.0 20.2 0.0 1.5 0.3 0.1 0.8 0.0 3.1 6.6 0.0 1.3 0.8 0.3 0.3 0.0 104.8 7.0 28.7 27.4 0.0 0.0 0.0 37.4 0.5 9.1 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.3 1.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.8 7.1 31.9 9.1 6.0 5.6 4.8 5.4 9.2 5.5 0.0 8.0 0.0 9.3 108.5 14.9 33.6 2.5 1.4 7.9 8.7 0.0 9.8 3.3 23.9 4.1 30.5 0.9 0.0 2.7 15.4 779.8 4.8 1.1 11.4 20.9 14.3 1.7 138.1 4.8 7.9 326.8 5.6 140.0 3.6 0.0 22.6 7.8 0.3 236.2 11.6 2.3 181.1 211.6 2.6 4.7 78.5 17.4 2.5 0.6 2.4 COL6A2 ENSG00000142173 "Collagen type VI alpha 2 chain" P12110 21 46098097-46132849 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Fibroblasts: 1607.7;Leydig cells: 560.6;Peritubular cells: 443.7;Smooth muscle cells: 512.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 7.6;MAIT T-cell: 5.1;memory CD8 T-cell: 3.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 14 "T-cells: 7.6" "Cell line enhanced" "Detected in many" "ASC diff: 95.7;ASC TERT1: 177.1;BJ: 85.2;BJ hTERT+: 79.3;HHSteC: 93.9;HSkMC: 126.5;U-138 MG: 92.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA007029, HPA030920, HPA038799" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 8900000 Cytosol "Plasma membrane" "HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214" "unprognostic (3.53e-1)" "unprognostic (3.76e-2)" "unprognostic (3.20e-2)" "unprognostic (4.87e-2)" "unprognostic (2.92e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-1)" "unprognostic (5.28e-3)" "unprognostic (2.11e-2)" "unprognostic (1.68e-2)" "unprognostic (1.56e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (8.72e-14)" "unprognostic (2.13e-2)" "unprognostic (7.61e-2)" "unprognostic (2.31e-2)" "unprognostic (2.22e-3)" 81.2 8.7 1.5 65.0 2.7 0.2 116.7 1.8 2.7 103.5 112.6 4.7 75.0 15.3 127.2 160.3 55.5 66.5 179.8 90.6 2.1 1.3 9.6 9.1 38.7 38.3 3.2 3.8 76.1 14.8 2.7 11.8 52.6 8.8 81.0 9.8 23.5 33.4 81.4 30.6 37.8 38.1 231.3 5.8 23.6 49.0 33.2 1.8 9.8 19.9 58.5 17.2 107.2 76.1 0.0 0.0 0.0 0.0 0.5 7.6 0.7 0.7 0.9 2.8 2.5 95.7 177.1 0.8 85.2 79.3 21.6 9.9 0.1 3.3 0.0 6.4 61.1 13.9 0.0 0.6 0.0 1.7 0.0 0.9 0.0 0.0 0.0 93.9 0.0 0.3 126.5 0.0 40.8 0.8 0.0 0.0 0.0 0.0 0.0 8.6 0.4 0.0 0.1 1.5 0.0 10.4 0.0 5.4 0.1 0.0 0.0 0.0 4.4 3.3 0.0 0.0 1.6 0.1 0.5 0.0 92.4 10.8 34.0 21.0 0.0 0.0 0.0 47.2 0.0 13.1 0.0 0.0 0.0 7.6 0.0 5.1 0.0 0.7 3.8 0.0 0.0 0.8 2.1 0.0 0.5 0.0 0.0 0.1 0.7 1.5 2.7 1.8 2.7 2.1 1.3 3.2 3.8 8.8 1.8 3.0 1.1 0.0 4.5 146.1 0.1 6.7 0.0 0.0 1.2 7.0 0.0 14.3 0.0 14.0 3.2 42.2 0.0 0.0 0.3 22.5 1607.7 10.7 0.0 0.9 32.2 0.0 0.0 166.3 6.8 7.6 560.6 4.3 172.1 3.6 0.0 3.9 6.9 0.0 443.7 0.2 0.4 291.1 512.9 2.7 10.7 122.7 33.8 8.7 0.2 2.5 COMMD1 "C2orf5, MGC27155, MURR1" ENSG00000173163 "Copper metabolism domain containing 1" Q8N668 2 61888724-62147247 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034633, HPA049223" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034633: AB_10601800, HPA049223: AB_2680680" "unprognostic (6.08e-2)" "unprognostic (2.34e-2)" "unprognostic (2.83e-1)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.22e-2)" "unprognostic (5.58e-2)" "unprognostic (1.07e-1)" "unprognostic (4.93e-1)" "unprognostic (3.41e-2)" "unprognostic (2.26e-1)" "unprognostic (2.07e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (1.27e-1)" "unprognostic (5.51e-2)" "unprognostic (2.77e-1)" 19.6 26.2 18.6 23.2 22.3 14.2 22.8 26.7 21.4 20.1 16.6 16.7 21.2 18.2 21.0 26.2 25.3 18.0 16.8 41.7 16.1 15.2 25.4 28.8 15.6 17.3 17.8 22.4 19.9 32.8 15.0 30.0 21.2 16.8 19.0 19.0 17.9 26.6 24.3 32.1 21.0 14.4 24.7 19.9 16.1 19.5 26.8 19.0 16.3 23.6 20.3 19.7 17.6 19.5 33.0 42.7 17.1 36.5 31.2 31.8 35.7 10.1 13.1 15.1 11.6 19.4 22.6 12.9 12.2 20.8 24.9 18.2 22.4 9.3 18.0 10.5 22.8 20.9 7.9 8.2 15.0 26.9 19.4 10.0 14.0 7.7 24.7 16.7 21.7 11.0 16.4 17.4 12.1 14.4 18.2 25.0 10.5 8.5 29.5 26.3 19.1 16.7 38.6 12.8 8.4 18.0 12.0 19.6 20.6 22.6 11.2 9.0 10.2 13.8 23.4 12.4 15.4 14.8 9.5 11.7 22.4 19.3 13.9 18.7 12.9 10.1 22.4 13.2 19.3 19.5 16.5 36.5 17.1 25.1 30.8 24.6 33.0 28.4 27.7 42.7 30.7 27.2 29.0 3.0 31.2 26.2 39.6 31.8 35.7 18.6 22.3 26.7 21.4 16.1 15.2 17.8 22.4 16.8 19.0 32.8 32.7 37.2 66.2 48.3 32.5 159.4 33.1 25.4 28.4 33.2 9.8 110.1 109.5 64.2 152.9 54.2 32.7 46.7 56.9 62.1 58.0 45.1 56.6 57.1 88.4 27.0 20.7 56.4 36.8 131.8 38.3 63.2 79.2 174.1 26.2 26.9 53.3 36.5 46.7 157.5 28.9 32.3 61.3 74.2 54.8 54.0 123.1 40.5 29.2 54.2 COMMD3-BMI1 ENSG00000269897 "COMMD3-BMI1 readthrough" 10 22316388-22329542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 20.9" "HPA030471, HPA030472, HPA036584" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Nucleoli, Cytosol" "HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803" "unprognostic (8.63e-2)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" 8.5 12.4 4.5 6.6 9.1 2.8 6.9 5.1 8.5 9.7 11.9 4.7 8.3 4.9 4.0 5.9 9.4 8.3 4.3 14.3 4.7 4.1 5.5 6.9 8.0 5.0 6.6 4.7 4.3 11.4 5.7 8.7 4.7 5.7 5.0 2.8 4.2 8.3 14.6 22.8 4.8 7.6 7.0 7.3 7.3 7.6 23.4 6.6 12.3 3.7 7.6 6.4 12.0 5.4 25.0 30.3 25.7 25.8 18.8 21.6 26.6 3.6 13.1 4.6 0.5 5.3 3.6 0.7 3.7 4.1 2.0 5.2 7.2 1.4 1.8 5.5 12.4 9.8 1.7 4.9 8.0 0.6 14.5 1.6 5.0 2.7 3.2 16.3 0.4 2.3 6.4 4.5 7.2 3.8 8.0 5.1 20.9 1.0 5.1 0.6 3.5 14.9 0.5 0.5 8.6 4.1 4.2 5.1 4.0 2.0 4.5 0.4 1.6 7.1 1.7 1.5 1.4 3.2 3.6 6.7 1.6 5.1 0.3 1.0 11.1 13.4 5.9 2.5 11.1 1.6 25.7 25.8 17.2 15.1 23.5 16.6 25.0 16.1 14.7 30.3 21.9 11.0 12.2 3.8 18.8 17.8 29.2 21.6 26.6 4.5 9.1 5.1 8.5 4.7 4.1 6.6 4.7 5.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COMMD4 FLJ20452 ENSG00000140365 "COMM domain containing 4" Q9H0A8 15 75335891-75343224 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 188.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039935, HPA066957" Uncertain Supported "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA039935: , HPA066957: AB_2685754" "unprognostic (7.77e-2)" "unprognostic (3.07e-3)" "unprognostic (1.03e-1)" "unprognostic (6.57e-3)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (1.49e-1)" "unprognostic (2.60e-1)" "unprognostic (9.11e-2)" "unprognostic (1.78e-3)" "unprognostic (2.01e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-3)" "unprognostic (2.51e-1)" "unprognostic (2.27e-1)" "unprognostic (1.96e-1)" "unprognostic (5.07e-2)" 15.9 35.2 16.1 20.7 17.5 20.4 16.2 12.6 23.1 14.4 19.5 21.7 22.2 21.9 20.7 26.2 17.7 15.7 30.1 16.6 13.9 12.9 25.1 28.1 24.3 17.4 15.6 15.4 13.7 15.2 14.9 16.2 23.7 14.1 15.2 15.9 20.9 30.8 16.6 13.2 15.2 20.1 16.7 16.6 19.3 18.3 32.7 14.7 30.4 20.3 27.4 17.3 16.4 14.5 17.3 26.0 14.6 22.3 26.9 33.4 13.8 33.0 51.4 23.6 30.6 10.4 14.9 23.2 25.7 23.9 44.2 44.8 29.6 44.3 21.2 24.3 19.3 43.2 34.8 45.0 26.8 22.3 15.5 57.6 25.1 41.3 32.6 18.4 19.5 24.7 16.7 14.3 28.6 5.5 12.5 21.9 22.7 25.8 30.8 34.0 39.2 16.8 21.7 33.2 17.2 30.2 29.8 38.3 27.8 22.5 29.3 19.0 27.9 33.3 25.2 39.2 18.6 38.7 34.9 20.3 31.3 29.8 31.5 45.0 22.0 50.3 24.2 34.5 40.5 30.1 10.8 17.3 14.6 33.4 22.3 20.8 17.3 20.9 24.6 19.0 15.8 12.6 19.7 3.6 26.9 18.7 26.0 30.9 13.8 16.1 17.5 12.6 23.1 13.9 12.9 15.6 15.4 14.1 14.7 26.8 47.9 31.3 40.5 24.0 37.8 16.8 45.9 40.2 38.7 33.2 29.5 61.9 49.7 56.4 6.7 33.7 52.0 93.5 68.4 86.4 38.0 26.7 40.5 35.8 108.1 15.9 29.3 41.1 37.2 14.5 45.5 42.5 35.4 27.9 48.2 66.0 63.1 63.1 32.2 74.2 42.9 45.3 32.0 188.6 61.8 26.8 42.4 34.6 54.0 32.5 COMMD5 "FLJ13008, HCaRG, HT002" ENSG00000170619 "COMM domain containing 5" Q9GZQ3 8 144841042-144853736 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046905 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046905: AB_2732535" "unprognostic (2.95e-2)" "unprognostic (7.62e-2)" "unprognostic (2.63e-1)" "unprognostic (1.16e-1)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (5.05e-3)" "unprognostic (6.82e-2)" "unprognostic (3.24e-1)" "unprognostic (9.35e-2)" "unprognostic (2.25e-1)" "unprognostic (7.97e-3)" "unprognostic (1.25e-2)" "unprognostic (8.58e-2)" "unprognostic (3.43e-1)" "unprognostic (2.02e-1)" "unprognostic (7.73e-3)" 24.7 22.3 18.2 16.7 18.1 27.6 14.6 26.0 22.9 15.2 19.1 18.1 17.7 17.8 16.6 15.3 18.9 15.9 17.0 20.9 18.4 17.1 18.0 21.8 20.0 21.0 23.8 12.2 13.4 20.3 11.0 18.3 16.3 15.9 15.8 10.5 16.4 22.4 17.4 16.0 17.5 15.5 17.9 18.5 22.2 16.9 11.7 16.8 17.7 23.6 14.3 19.0 20.2 15.1 29.3 36.6 36.3 42.6 32.0 33.8 31.8 15.8 18.6 9.1 12.1 11.2 9.0 8.1 9.2 9.9 15.8 12.5 11.4 12.5 11.0 20.6 11.1 9.1 10.8 11.3 15.2 6.8 14.3 15.9 23.0 17.9 18.9 15.1 7.8 20.0 11.9 13.9 10.7 8.1 7.6 12.1 4.0 16.4 20.3 12.7 28.9 7.0 8.1 13.8 22.2 37.9 9.1 10.5 16.8 15.2 14.2 21.4 18.6 15.4 9.4 13.2 6.3 18.2 14.6 11.1 12.0 23.5 16.7 18.0 8.5 9.0 10.1 16.5 14.5 15.3 28.5 42.6 36.3 29.3 34.6 26.1 29.3 22.8 28.7 36.6 26.1 22.8 25.3 25.7 32.0 21.8 13.4 33.8 31.8 18.2 18.1 26.0 22.9 18.4 17.1 23.8 12.2 15.9 16.8 11.9 16.7 22.5 17.6 24.6 12.1 9.5 15.3 26.8 7.9 15.7 11.8 30.3 33.2 41.3 2.8 30.6 23.3 0.0 35.0 21.2 23.7 27.3 25.3 16.8 60.7 11.1 19.1 24.5 32.2 1.2 17.3 27.5 25.3 40.5 13.4 18.4 39.9 17.3 21.9 30.5 13.8 12.9 15.1 10.9 13.2 26.2 27.7 26.3 16.7 24.3 COMMD8 FLJ20502 ENSG00000169019 "COMM domain containing 8" Q9NX08 4 47450796-47463719 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035887 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035887: AB_10600702" "unprognostic (9.04e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (5.13e-2)" "unprognostic (2.51e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.07e-2)" "unprognostic (4.24e-2)" "unprognostic (3.47e-2)" "unprognostic (1.78e-1)" "unprognostic (3.78e-2)" "prognostic favorable (2.71e-5)" "unprognostic (1.06e-1)" "unprognostic (2.10e-1)" "unprognostic (7.76e-2)" "unprognostic (7.13e-2)" 11.4 14.0 14.7 13.9 21.3 13.1 10.9 9.5 18.8 9.7 12.5 5.7 7.7 13.1 9.7 17.3 21.1 8.3 10.0 19.1 14.1 14.0 32.5 16.1 15.1 21.4 13.9 15.0 8.4 10.4 15.5 20.5 20.0 11.3 9.2 13.4 6.5 9.8 9.2 7.7 12.5 17.1 12.8 11.6 14.5 10.0 16.9 10.9 15.2 15.7 19.7 17.5 15.5 12.7 21.1 32.7 39.8 36.4 23.9 22.9 27.9 12.5 6.9 6.1 3.1 13.0 18.6 8.5 18.9 12.6 12.4 16.9 11.6 14.8 20.1 15.9 17.8 28.1 6.7 19.6 15.4 22.5 11.8 8.8 11.5 7.8 9.0 17.8 28.1 14.9 16.0 20.8 11.8 13.2 11.6 15.7 13.3 8.5 8.2 30.2 7.0 16.7 22.9 4.2 8.5 9.1 8.4 14.0 4.3 35.6 10.3 12.1 6.1 7.8 6.4 15.0 11.2 11.8 18.7 12.9 17.8 17.1 15.8 22.5 8.7 10.4 16.1 19.3 37.0 12.8 39.8 26.2 29.5 21.3 34.9 22.9 21.1 19.6 21.1 32.7 18.8 18.5 21.0 12.9 23.9 36.4 15.3 22.0 27.9 14.7 21.3 9.5 18.8 14.1 14.0 13.9 15.0 11.3 10.9 20.8 13.9 28.1 10.6 20.0 18.5 38.3 10.2 52.2 19.4 27.9 3.9 74.5 91.2 38.2 28.4 22.9 18.0 0.0 40.4 94.8 31.8 6.4 32.3 10.2 81.6 6.4 20.2 20.9 60.2 8.5 50.3 51.3 11.8 59.5 20.0 25.7 23.9 21.5 38.2 147.8 18.8 19.4 34.0 66.9 52.6 26.2 88.4 57.3 24.6 7.3 COMMD9 "FLJ31106, HSPC166" ENSG00000110442 "COMM domain containing 9" Q9P000 11 36269284-36289449 "Predicted intracellular proteins" "Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009142 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA009142: AB_1847105" "unprognostic (1.56e-2)" "unprognostic (4.75e-3)" "unprognostic (7.57e-2)" "unprognostic (4.40e-3)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-3)" "unprognostic (2.62e-1)" "unprognostic (6.15e-2)" "prognostic favorable (8.54e-4)" "unprognostic (4.94e-2)" "unprognostic (2.40e-1)" "unprognostic (6.08e-3)" "unprognostic (7.24e-2)" "unprognostic (1.71e-1)" "unprognostic (7.31e-3)" "unprognostic (1.88e-1)" 26.9 25.4 28.0 15.8 25.4 32.6 18.5 18.1 36.9 14.3 15.0 26.5 9.5 16.2 12.4 20.4 18.4 16.2 15.8 23.1 25.4 25.7 34.5 28.0 20.4 24.8 27.7 23.8 15.8 23.3 19.4 18.9 18.9 22.8 12.6 19.1 16.0 16.7 11.1 43.6 19.6 16.4 17.0 28.4 26.0 14.8 14.6 17.2 24.7 19.8 21.1 23.6 16.6 12.2 22.5 66.3 28.8 66.2 14.8 18.9 46.4 10.8 13.0 14.3 15.0 22.1 15.5 7.9 13.0 16.9 29.7 28.0 10.5 9.3 12.6 13.0 25.9 23.0 16.1 25.1 17.5 28.1 15.1 29.5 6.9 24.3 18.3 20.8 26.9 20.8 19.5 19.7 16.2 10.0 15.4 24.3 17.0 17.0 13.6 23.3 14.0 17.9 18.7 15.2 21.4 27.6 19.8 32.4 14.9 30.9 10.2 17.5 19.6 18.6 18.5 16.6 12.2 40.4 10.3 16.2 18.0 13.8 42.7 19.0 9.6 19.5 14.2 20.7 25.4 17.2 12.2 66.2 28.8 16.8 59.6 15.7 21.8 16.2 16.1 66.3 22.5 18.7 15.7 7.4 14.8 47.5 25.0 18.9 46.4 28.0 25.4 18.1 36.9 25.4 25.7 27.7 23.8 22.8 17.2 20.8 21.9 17.1 14.2 13.6 18.7 25.5 10.2 6.7 7.9 17.4 9.8 36.2 66.3 59.6 7.5 21.8 19.7 0.0 40.5 47.0 19.1 4.8 18.5 15.5 95.4 4.8 24.6 15.4 46.2 23.1 16.4 57.6 23.6 52.3 18.1 27.7 40.4 17.5 11.0 51.2 20.1 12.9 11.8 28.8 29.3 18.9 20.8 27.7 23.0 8.8 COMTD1 FLJ23841 ENSG00000165644 "Catechol-O-methyltransferase domain containing 1" Q86VU5 10 75233969-75236030 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 57.2" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 363.3;Exocrine glandular cells: 216.7;Paneth cells: 207.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 14.9;HEK 293: 22.9;PC-3: 31.9;RPMI-8226: 17.8;U-266/70: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042165 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus" "Plasma membrane, Cytosol" "HPA042165: AB_10794042" "unprognostic (2.53e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (9.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.23e-2)" "unprognostic (8.08e-3)" "unprognostic (9.35e-2)" "unprognostic (6.74e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.12e-1)" "unprognostic (2.35e-1)" 2.5 5.2 1.3 5.8 1.4 2.9 5.7 3.6 2.2 4.8 14.1 0.5 9.7 17.9 2.0 5.9 20.0 1.6 6.4 8.0 1.2 1.6 12.6 14.9 4.4 4.1 1.9 1.7 2.2 57.2 3.2 5.3 7.8 2.2 3.1 2.1 3.2 21.2 9.1 19.6 7.3 22.9 1.9 1.0 3.4 16.1 1.5 0.6 2.7 7.0 14.4 6.0 2.4 7.5 6.6 15.7 3.8 9.3 7.3 12.5 7.1 4.9 0.9 0.2 0.9 0.2 0.4 14.9 1.4 0.4 0.1 0.3 1.2 4.4 14.0 2.8 0.3 0.7 7.1 0.4 1.2 0.0 2.1 22.9 0.5 1.3 2.4 0.7 2.7 2.4 0.3 1.9 0.0 1.2 0.3 0.0 1.8 5.6 2.7 0.0 3.3 3.9 8.3 0.7 3.9 31.9 7.3 0.7 17.8 1.0 0.2 5.4 1.3 1.5 11.5 3.0 0.1 6.7 0.3 1.2 0.3 4.3 0.5 1.6 15.3 3.2 6.8 0.3 2.3 0.3 0.0 8.9 3.8 12.1 9.3 12.5 6.6 11.7 12.2 10.1 4.7 3.8 6.7 1.8 7.3 8.9 15.7 9.0 7.1 1.3 1.4 3.6 1.7 1.2 1.6 1.9 1.7 2.2 0.6 17.9 14.4 22.9 33.2 26.2 5.2 26.2 48.4 2.7 4.5 50.6 9.8 24.6 122.7 126.7 1.3 10.8 363.3 0.0 216.7 64.2 12.7 34.1 12.7 75.5 32.8 1.6 38.7 19.0 24.7 2.2 8.9 19.4 35.4 37.9 104.6 5.8 134.6 207.0 6.7 96.3 26.7 32.3 19.1 2.1 2.3 33.4 25.4 25.5 104.0 43.9 COPA HEP-COP ENSG00000122218 "Coatomer protein complex subunit alpha" P53621 1 160289273-160343400 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" Hormone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028024 Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA NA 260000 "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA028024: AB_10603787" "unprognostic (1.59e-2)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.77e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-2)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.42e-2)" "unprognostic (3.14e-1)" "unprognostic (2.21e-1)" "unprognostic (5.03e-2)" "unprognostic (3.10e-1)" "unprognostic (2.05e-2)" "unprognostic (8.70e-2)" "unprognostic (2.03e-1)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" 38.3 32.7 29.2 28.9 41.0 22.9 32.4 43.1 48.4 46.3 34.3 53.2 24.5 38.4 37.0 33.1 28.4 31.5 28.6 38.4 33.3 35.2 36.3 64.3 33.8 26.6 42.7 29.3 36.8 47.8 49.1 57.4 45.1 56.2 35.3 39.9 28.8 42.1 33.9 40.5 28.7 50.3 40.4 42.8 36.6 32.8 21.2 35.8 36.0 42.8 21.0 34.1 30.3 27.5 15.4 31.4 25.1 29.1 18.1 21.2 25.3 28.2 22.2 23.6 22.9 60.8 50.1 27.7 38.9 46.3 33.2 39.2 28.9 19.3 20.8 25.3 59.1 19.1 28.5 27.2 28.0 38.3 23.6 18.4 23.9 30.6 30.4 45.7 29.1 25.1 46.8 17.1 44.3 41.3 41.1 38.9 19.9 22.1 23.3 39.6 20.7 18.7 12.6 25.8 37.2 26.0 16.8 27.1 32.0 27.2 26.8 19.6 24.8 44.0 38.7 41.1 41.4 43.1 39.3 45.8 25.0 19.5 33.5 25.5 38.4 26.6 32.1 32.6 15.2 37.2 25.1 29.1 20.1 17.1 27.3 21.2 15.4 14.3 18.3 31.4 12.1 13.2 15.2 10.8 18.1 27.9 13.3 17.5 25.3 29.2 41.0 43.1 48.4 33.3 35.2 42.7 29.3 56.2 35.8 71.5 41.2 52.3 29.9 25.0 49.9 41.1 48.4 53.5 42.1 38.4 76.6 33.9 11.6 44.6 11.0 42.1 70.4 0.0 43.3 55.4 50.4 56.4 43.9 64.8 46.0 42.9 53.2 53.4 85.0 4.5 65.9 62.1 25.3 31.5 79.0 38.2 46.4 45.6 53.4 38.5 48.0 38.8 52.3 37.9 23.8 27.9 57.9 41.5 60.4 44.0 COPB1 COPB ENSG00000129083 "Coatomer protein complex subunit beta 1" P53618 11 14443440-14500027 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012338, HPA043954, HPA064403" Supported Enhanced "Golgi apparatus,Vesicles,Cytosol" NA NA 400000 "Golgi apparatus, Vesicles, Cytosol" "CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258" "unprognostic (2.35e-1)" "unprognostic (1.02e-3)" "unprognostic (1.36e-2)" "unprognostic (4.76e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (6.91e-4)" "prognostic unfavorable (5.63e-7)" "unprognostic (4.69e-3)" "unprognostic (3.42e-2)" "unprognostic (3.60e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (8.94e-2)" "unprognostic (1.78e-2)" "unprognostic (3.02e-2)" "unprognostic (8.00e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" 30.9 33.0 18.4 23.5 20.8 31.2 55.4 23.7 23.6 32.5 26.6 15.5 42.0 25.9 32.2 33.0 32.2 28.3 25.1 34.8 18.9 16.8 37.6 56.6 38.4 53.9 22.6 15.5 31.3 52.2 40.1 43.5 52.3 22.2 31.9 31.3 17.2 43.4 41.7 21.9 24.7 33.1 39.7 26.1 29.8 30.2 21.7 20.6 46.0 37.7 26.7 28.0 28.2 27.3 26.7 33.9 27.9 30.4 28.0 39.6 24.8 31.6 27.2 29.1 21.8 48.6 56.4 23.5 48.0 50.4 42.8 50.4 21.0 49.3 30.8 21.6 60.6 40.7 34.9 32.7 32.2 53.0 28.8 27.2 32.7 19.5 31.9 43.2 30.0 33.3 39.3 42.5 28.6 54.3 39.4 44.7 17.3 24.2 25.3 53.9 23.8 27.2 18.5 15.1 38.7 29.5 22.3 40.1 20.9 38.6 29.3 18.7 20.0 37.2 30.1 24.6 35.1 27.3 26.2 45.4 41.2 21.3 44.4 26.1 13.6 22.9 33.9 31.1 18.8 38.4 27.3 24.9 27.9 32.2 30.4 39.6 26.7 27.5 32.9 33.9 22.6 27.6 28.6 20.5 28.0 30.3 20.4 29.3 24.8 18.4 20.8 23.7 23.6 18.9 16.8 22.6 15.5 22.2 20.6 101.3 47.9 37.9 48.3 34.6 27.2 25.8 35.7 141.8 100.1 41.8 25.5 57.0 34.9 66.2 10.9 46.0 51.5 46.7 71.3 60.9 51.3 55.0 62.5 55.0 54.4 17.5 42.1 54.6 45.5 9.5 47.2 47.5 20.3 64.9 78.6 33.3 79.8 38.6 51.9 43.9 26.9 51.8 41.8 89.3 61.5 31.2 97.8 51.7 43.2 51.2 COPB2 "beta'-COP, betaprime-COP" ENSG00000184432 "Coatomer protein complex subunit beta 2" P35606 3 139355600-139389732 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036867, HPA058180" Approved Approved Cytosol NA NA 1000000 Cytosol "HPA036867: AB_10672271, HPA058180: AB_2683630" "unprognostic (3.37e-2)" "unprognostic (2.04e-1)" "unprognostic (9.38e-2)" "unprognostic (6.93e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.41e-7)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (8.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.44e-2)" "unprognostic (1.14e-1)" "unprognostic (6.05e-2)" "unprognostic (4.95e-2)" 28.7 40.8 21.9 22.3 26.2 12.1 28.7 31.7 29.0 39.5 32.4 22.6 40.3 26.1 33.0 44.7 35.9 28.9 26.2 31.4 21.6 18.9 42.1 67.5 29.1 20.1 26.0 16.6 36.0 65.5 41.2 72.2 51.7 28.7 35.5 33.8 20.5 46.5 28.6 20.6 23.5 37.1 30.0 21.1 31.3 29.9 21.1 25.7 33.1 40.4 27.4 31.2 30.0 26.5 22.6 36.4 35.9 34.4 27.4 23.5 22.6 53.5 21.5 31.6 28.5 63.6 58.6 27.7 64.2 61.0 41.5 51.3 40.2 20.4 21.7 59.4 68.0 37.6 28.5 35.9 34.3 52.1 37.4 24.6 32.6 34.1 38.4 38.1 29.0 37.4 41.0 31.2 32.6 33.8 48.2 40.0 19.6 21.3 26.3 49.1 32.4 14.5 17.8 28.7 53.3 23.7 19.6 25.6 37.3 38.1 38.8 22.4 20.6 63.1 57.2 35.4 44.7 45.6 31.3 46.6 23.3 18.8 34.4 22.5 41.1 24.5 38.3 39.0 16.5 36.0 35.9 28.4 30.1 22.9 34.4 23.2 22.6 20.4 23.5 36.4 16.3 15.9 20.0 26.9 27.4 32.3 17.0 21.9 22.6 21.9 26.2 31.7 29.0 21.6 18.9 26.0 16.6 28.7 25.7 53.6 34.0 32.0 34.0 17.4 34.8 47.2 33.1 93.7 52.4 19.2 29.5 71.4 34.9 71.2 24.9 41.9 41.4 0.0 72.1 64.7 71.0 57.8 43.9 43.3 46.9 39.7 61.3 37.4 38.0 5.8 50.6 31.5 20.3 57.7 71.8 55.4 68.4 28.8 47.0 37.2 44.9 19.4 46.7 47.7 43.0 13.0 111.3 34.9 36.6 37.8 COPG1 COPG ENSG00000181789 "Coatomer protein complex subunit gamma 1" Q9Y678 3 129249606-129277773 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037866, HPA037867, HPA045712" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No 110000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428" "unprognostic (8.86e-2)" "unprognostic (2.22e-2)" "unprognostic (4.22e-3)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (1.22e-6)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-3)" "unprognostic (3.29e-1)" "unprognostic (1.23e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (2.99e-1)" "unprognostic (1.60e-1)" 25.2 39.4 21.1 22.2 28.0 20.1 37.3 23.6 50.3 43.3 42.1 24.3 50.6 34.2 27.6 66.5 29.5 24.4 34.5 33.4 24.2 26.7 32.4 72.1 36.5 39.4 23.0 21.6 28.6 75.6 47.6 49.7 49.3 34.9 45.1 45.1 22.4 59.9 45.5 24.1 24.3 32.4 29.1 20.7 29.0 36.3 23.6 16.2 26.9 33.0 22.0 27.7 19.9 24.1 15.7 31.9 34.9 33.0 31.1 31.8 26.0 32.7 16.7 24.4 21.1 57.2 46.4 26.0 53.5 51.1 36.9 46.7 30.6 20.4 18.0 31.2 75.9 30.0 19.8 20.1 31.5 40.2 21.9 8.3 29.9 22.1 49.4 52.1 22.6 32.2 48.4 27.8 29.5 48.7 40.6 33.2 13.9 10.4 43.6 44.4 49.8 13.2 23.1 14.5 48.1 20.5 14.4 22.9 34.8 46.0 27.3 15.2 17.8 41.1 30.7 49.0 28.0 34.0 33.1 44.8 20.1 19.1 42.4 20.6 34.1 16.2 31.6 49.1 17.3 38.5 34.9 26.8 20.2 26.2 33.0 31.8 15.0 23.7 25.7 31.9 15.7 18.5 21.6 21.3 31.1 29.7 29.4 23.6 26.0 21.1 28.0 23.6 50.3 24.2 26.7 23.0 21.6 34.9 16.2 14.9 29.8 27.4 13.9 7.8 8.7 19.3 17.8 16.0 18.2 26.2 3.9 52.4 36.5 39.6 7.8 19.4 69.2 46.7 40.7 53.3 25.8 24.8 14.0 53.3 34.3 4.8 37.1 35.6 31.0 3.1 38.0 19.0 21.9 44.1 67.9 14.2 35.7 37.4 29.4 28.8 7.5 19.4 17.3 21.1 16.4 8.9 60.4 20.1 38.2 17.5 COPRS "C17orf79, COPR5, HSA272196, TTP1" ENSG00000172301 "Coordinator of PRMT5 and differentiation stimulator" Q9NQ92 17 31851864-31859337 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 410.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA052552 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA052552: AB_2681868" "unprognostic (1.65e-2)" "unprognostic (4.88e-2)" "unprognostic (2.46e-1)" "unprognostic (4.01e-3)" "unprognostic (3.12e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.69e-4)" "unprognostic (6.88e-2)" "unprognostic (3.10e-1)" "unprognostic (4.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.01e-2)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (3.11e-2)" 20.9 19.0 32.6 9.7 31.0 6.3 30.3 23.0 37.6 15.3 24.2 11.8 15.6 8.0 15.2 57.3 10.5 24.9 14.9 24.7 28.2 35.5 22.7 31.0 12.3 9.2 29.7 31.3 24.3 20.7 12.2 18.9 9.4 23.9 27.5 13.6 16.0 14.6 23.5 19.9 7.8 7.9 21.2 16.0 8.1 14.1 75.0 14.4 2.6 28.1 11.2 12.7 16.1 18.5 5.8 4.5 3.5 3.5 0.0 3.0 0.4 21.0 27.8 14.0 14.3 22.9 22.1 9.8 23.7 29.8 27.2 27.8 17.4 5.7 12.0 13.3 28.3 53.7 12.7 24.6 14.2 30.9 4.1 36.9 3.3 16.0 20.4 23.4 11.2 9.6 14.1 18.7 36.6 20.1 29.7 14.5 16.1 16.3 10.0 29.6 18.3 16.6 35.6 10.6 13.7 14.0 13.3 26.0 21.7 15.9 13.1 12.6 9.8 14.0 6.8 21.6 12.7 22.3 12.0 8.1 71.6 19.4 25.5 32.8 17.1 15.9 12.1 37.4 10.4 9.6 3.5 3.5 0.0 1.1 3.3 3.0 3.8 1.1 0.2 4.5 5.8 0.6 0.7 1.2 0.0 1.6 1.8 1.5 0.4 32.6 31.0 23.0 37.6 28.2 35.5 29.7 31.3 23.9 14.4 20.8 8.8 21.9 52.7 30.6 43.8 64.8 45.9 28.1 9.1 82.0 9.8 25.3 190.6 93.7 161.6 50.8 5.1 0.0 70.1 45.2 52.1 108.4 3.5 85.5 75.8 25.4 18.9 44.2 26.0 212.9 57.8 35.0 55.6 70.3 14.8 79.2 64.6 3.5 61.2 173.3 30.2 19.4 62.1 410.0 65.8 27.7 22.9 10.1 19.7 32.5 COPS3 "CSN3, SGN3" ENSG00000141030 "COP9 signalosome subunit 3" Q9UNS2 17 17246820-17281293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 228.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021997, HPA050557" Approved Supported Nucleoplasm,Cytosol NA NA 29000 Nucleoplasm Cytosol "HPA021997: AB_1847152, HPA050557: AB_2681176" "unprognostic (3.35e-2)" "unprognostic (3.98e-3)" "unprognostic (1.84e-2)" "unprognostic (6.29e-2)" "unprognostic (6.39e-2)" "unprognostic (1.33e-1)" "unprognostic (2.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.91e-3)" "unprognostic (2.11e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (1.56e-4)" "prognostic unfavorable (8.65e-5)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.40e-1)" "unprognostic (3.03e-3)" 15.2 15.2 16.3 15.7 21.9 51.9 16.3 20.8 24.7 15.4 15.4 15.7 14.9 13.9 14.3 14.1 21.0 12.1 10.0 22.7 17.5 18.8 16.1 21.0 11.7 18.7 17.4 15.2 16.0 26.2 17.6 21.8 21.7 26.7 16.5 17.1 11.9 17.1 15.7 69.4 15.7 13.3 16.9 15.9 14.3 15.8 39.5 11.8 31.4 15.2 24.4 21.9 16.1 14.0 28.1 45.2 37.7 35.8 32.3 33.0 38.2 35.5 33.4 26.2 22.7 12.6 17.2 16.0 27.7 17.0 40.1 32.3 54.7 13.3 49.2 22.5 22.0 18.0 26.0 35.5 27.5 45.6 19.6 50.5 34.3 25.9 23.5 21.5 29.4 39.1 15.5 20.9 27.8 27.9 12.0 23.2 28.7 27.9 18.3 25.3 35.7 54.1 37.3 23.4 39.7 21.5 40.8 46.8 25.6 16.1 15.6 20.5 17.9 24.3 11.3 22.0 78.7 17.0 19.8 16.6 24.4 27.4 44.1 47.3 14.7 19.0 26.3 21.2 29.3 24.6 20.8 30.5 29.4 27.6 35.8 31.9 27.2 32.2 31.6 45.2 28.1 32.2 30.5 37.7 32.3 34.6 21.8 33.0 38.2 16.3 21.9 20.8 24.7 17.5 18.8 17.4 15.2 26.7 11.8 29.8 15.5 44.7 36.9 48.1 21.8 44.5 22.9 17.4 23.9 14.0 13.7 80.5 28.2 39.9 106.3 32.3 14.2 46.7 44.5 69.1 35.2 30.0 39.3 20.8 57.9 23.8 36.0 25.8 31.1 49.2 36.8 45.3 33.7 49.5 34.2 38.1 31.1 11.5 35.7 27.3 28.6 19.4 42.4 228.3 92.9 41.7 87.3 52.2 37.2 29.3 COPS7A CSN7A ENSG00000111652 "COP9 signalosome subunit 7A" Q9UBW8 12 6723741-6731875 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026915 Supported Supported Nucleoplasm,Cytosol NA NA 66000 Nucleoplasm Cytosol "HPA026915: AB_1847156" "unprognostic (3.50e-1)" "unprognostic (1.33e-2)" "unprognostic (3.95e-3)" "unprognostic (3.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.96e-3)" "unprognostic (3.91e-2)" "unprognostic (4.26e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" 24.1 26.0 31.6 16.6 38.1 8.8 20.5 29.6 59.5 18.2 18.5 25.0 14.1 15.8 20.1 27.9 29.1 25.8 20.1 42.2 29.6 27.9 26.2 29.6 18.8 14.6 31.6 36.9 20.1 23.1 33.9 24.3 25.4 45.3 24.7 17.5 23.8 22.1 24.5 44.6 20.9 14.1 24.2 22.5 16.2 18.1 14.9 13.9 9.2 26.1 29.6 17.6 22.7 17.6 13.7 27.1 35.9 28.4 11.5 16.5 17.8 19.0 20.2 9.7 9.5 28.9 34.6 23.7 23.6 30.8 23.8 24.2 14.1 26.7 13.3 10.2 31.4 13.9 15.4 13.2 24.0 22.9 18.1 14.6 12.4 13.9 17.8 25.0 12.9 7.6 32.1 23.3 28.1 56.0 29.2 18.5 8.1 8.8 5.4 33.4 15.4 7.5 8.1 26.2 26.1 18.6 5.1 19.9 13.1 20.2 19.2 5.5 13.1 15.5 19.7 25.9 24.8 8.4 18.8 19.0 25.4 13.3 22.4 22.7 6.1 6.6 10.7 43.3 16.7 27.8 29.4 23.1 35.9 15.9 28.4 16.5 11.3 13.7 14.2 27.1 13.7 14.2 14.0 18.7 11.5 22.5 16.8 12.1 17.8 31.6 38.1 29.6 59.5 29.6 27.9 31.6 36.9 45.3 13.9 14.9 13.7 11.2 25.7 12.4 36.3 32.7 15.3 20.1 13.6 22.7 5.9 63.6 56.3 39.4 3.2 19.1 15.8 0.0 43.6 48.1 31.9 27.1 16.1 22.1 54.8 28.6 12.1 22.1 21.6 5.1 21.3 20.6 11.8 61.3 17.1 41.3 38.6 17.5 24.1 38.4 19.6 38.8 24.7 18.1 34.3 12.2 49.4 13.8 17.8 22.0 COPS8 "COP9, CSN8, MGC1297, SGN8" ENSG00000198612 "COP9 signalosome subunit 8" Q99627 2 237085312-237100466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 79.4;U-138 MG: 94.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036485 Uncertain Supported Nucleoplasm,Cytosol NA NA 110000 Nucleoplasm Cytosol "HPA036485: AB_10670720" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (8.74e-2)" "unprognostic (1.07e-3)" "unprognostic (1.20e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (4.70e-5)" "unprognostic (1.34e-2)" "unprognostic (8.03e-2)" "unprognostic (2.04e-1)" "unprognostic (6.85e-2)" "unprognostic (2.70e-1)" "unprognostic (2.41e-2)" "unprognostic (7.36e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-1)" "unprognostic (8.82e-2)" 20.1 23.1 25.2 15.6 37.0 15.7 17.9 15.2 33.8 20.6 14.0 16.7 8.6 7.7 20.9 18.3 12.5 18.0 19.9 37.8 31.7 27.9 24.2 15.6 12.3 13.5 23.6 25.8 23.7 10.8 18.2 15.0 19.8 28.1 16.6 11.7 18.6 12.7 18.1 64.5 12.3 9.7 25.4 21.3 10.4 13.5 20.8 15.4 14.8 17.5 20.3 14.5 18.0 13.2 32.4 26.9 26.1 25.9 32.2 36.2 31.7 9.6 8.2 17.9 8.9 51.6 40.8 11.9 17.0 17.0 17.5 19.5 5.4 9.8 6.7 6.5 18.5 27.7 7.3 17.6 23.2 24.6 15.6 11.3 9.7 10.5 18.9 35.6 12.5 5.8 67.3 26.8 17.6 79.4 21.8 20.5 14.4 13.4 6.4 55.4 9.2 15.4 12.9 15.9 10.5 12.0 11.8 21.4 13.3 21.6 7.8 8.8 15.2 10.2 8.8 25.4 15.0 10.2 10.3 21.5 94.0 15.8 18.4 18.4 12.4 10.3 21.3 29.4 7.7 23.7 21.9 22.8 26.1 29.7 25.0 36.2 32.4 31.7 33.8 26.9 26.9 30.8 32.1 7.0 32.2 25.9 19.4 33.1 31.7 25.2 37.0 15.2 32.3 31.7 27.9 23.6 25.8 28.1 15.4 29.8 19.5 35.0 43.5 67.0 53.6 97.2 33.1 32.1 15.9 31.4 25.5 54.6 121.0 57.0 21.2 51.6 12.7 0.0 35.9 64.8 116.7 38.2 42.6 21.7 53.3 33.4 20.2 38.1 30.8 17.3 67.3 28.8 119.8 55.1 14.7 79.9 40.5 17.5 71.1 72.0 46.0 58.2 89.6 85.8 92.6 56.3 37.2 45.7 18.5 34.8 COPS9 "CSNAP, MYEOV2" ENSG00000172428 "COP9 signalosome subunit 9" Q8WXC6 2 240126563-240136807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 422.7;Exocrine glandular cells: 329.4;Hofbauer cells: 279.6;Pancreatic endocrine cells: 292.2;Proximal tubular cells: 474.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044845 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044845: AB_10962975" "unprognostic (6.05e-3)" "unprognostic (1.44e-1)" "unprognostic (7.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (3.72e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (1.79e-2)" "unprognostic (1.26e-1)" "unprognostic (1.25e-3)" "unprognostic (9.02e-2)" "unprognostic (3.02e-1)" "unprognostic (3.71e-1)" "unprognostic (2.26e-2)" "unprognostic (3.03e-1)" "unprognostic (4.37e-2)" 31.9 29.1 81.6 20.6 73.2 24.0 40.9 22.6 61.6 29.1 27.6 22.7 20.5 25.6 17.2 53.2 34.5 23.5 25.4 62.3 75.8 44.7 30.5 23.5 17.8 26.7 64.3 24.3 23.2 64.3 8.9 27.6 17.6 32.9 25.9 18.9 19.0 43.3 26.5 86.9 20.6 24.5 21.1 52.6 22.6 25.8 18.8 25.9 26.5 34.7 41.6 19.8 23.5 20.9 68.2 79.9 90.7 67.7 52.4 82.0 79.9 27.2 36.9 29.1 30.4 40.3 33.0 26.8 39.4 27.6 25.9 33.2 26.7 24.5 7.5 11.9 35.9 41.3 21.9 25.7 36.5 17.9 31.9 94.9 22.6 38.0 82.7 32.1 22.6 21.3 38.7 30.2 19.3 24.1 24.0 37.9 38.6 26.0 16.4 37.6 58.8 36.2 70.6 44.3 34.3 80.7 28.6 39.1 23.5 32.0 47.0 33.8 33.9 20.7 28.2 42.1 23.5 26.0 44.2 30.6 34.3 38.3 43.6 37.4 33.6 28.5 38.0 42.7 26.9 33.7 90.7 67.2 87.6 68.6 66.6 68.0 68.2 71.2 70.1 62.6 52.8 62.6 70.5 24.1 52.4 67.7 79.9 82.0 79.9 81.6 73.2 22.6 61.6 75.8 44.7 64.3 24.3 32.9 25.9 119.1 114.6 0.0 0.0 0.0 0.0 0.0 0.0 123.1 102.4 261.7 0.0 149.7 422.7 189.2 0.0 0.0 0.0 0.0 329.4 162.4 0.0 0.0 57.0 0.0 279.6 0.0 0.0 0.0 0.0 0.0 0.0 87.4 0.0 253.3 0.0 0.0 292.2 0.0 0.0 474.2 0.0 0.0 0.0 0.0 0.0 0.0 110.6 0.0 0.0 0.0 COQ10A FLJ32452 ENSG00000135469 "Coenzyme Q10A" Q96MF6 12 56266858-56270966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068931 Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA Cytosol "Endoplasmic reticulum, Golgi apparatus" "HPA068931: AB_2686061" "unprognostic (4.55e-2)" "unprognostic (4.88e-3)" "prognostic unfavorable (5.46e-4)" "unprognostic (8.99e-3)" "unprognostic (2.77e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-1)" "unprognostic (2.86e-3)" "unprognostic (6.09e-2)" "unprognostic (8.57e-2)" "prognostic favorable (2.06e-4)" "unprognostic (5.03e-2)" "prognostic favorable (3.44e-4)" "unprognostic (1.67e-1)" "unprognostic (8.07e-2)" "unprognostic (7.20e-2)" "unprognostic (1.15e-1)" 2.9 12.4 5.0 2.3 6.8 2.2 3.1 7.6 7.3 3.7 2.9 4.8 5.9 1.9 3.6 7.7 4.3 5.2 3.2 43.5 4.5 5.4 7.2 12.8 3.5 3.4 5.6 3.9 4.5 5.5 6.0 9.9 1.7 4.8 4.1 2.7 14.0 6.5 5.6 103.7 2.2 2.9 3.7 3.6 3.8 2.6 2.4 3.0 4.9 5.4 46.1 6.2 2.7 3.3 11.7 6.8 8.0 1.1 5.0 8.6 3.6 2.5 10.3 10.0 6.5 5.7 5.8 4.2 3.6 8.6 12.7 12.7 8.0 3.8 14.7 8.2 9.0 3.6 2.4 11.5 2.0 7.6 2.3 12.8 6.8 9.4 8.3 7.8 5.4 4.2 6.0 3.4 9.4 3.7 8.0 6.6 10.4 4.5 6.1 11.8 3.3 7.7 19.3 8.5 1.8 6.0 16.6 10.9 9.7 7.0 1.5 14.5 15.6 12.3 2.6 3.8 7.7 4.0 6.0 4.7 2.4 7.1 6.7 3.6 12.8 13.7 7.2 7.1 5.1 1.8 8.0 1.0 0.9 7.7 1.1 7.9 11.7 7.1 8.2 1.7 6.7 8.6 8.4 0.4 5.0 0.8 6.8 4.6 3.6 5.0 6.8 7.6 7.3 4.5 5.4 5.6 3.9 4.8 3.0 3.0 7.4 6.1 12.1 11.8 17.4 115.4 7.6 12.0 4.5 10.4 15.7 5.0 44.7 2.4 0.1 9.6 2.1 0.0 4.0 5.9 8.0 4.7 4.6 14.0 4.4 30.2 15.5 2.5 1.6 1.4 7.8 2.5 11.8 1.8 2.8 21.7 2.5 3.4 15.9 11.0 30.0 38.8 18.9 1.7 17.7 9.3 2.5 13.4 4.5 4.3 COQ10B FLJ13448 ENSG00000115520 "Coenzyme Q10B" Q9H8M1 2 197453423-197475308 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046057 Approved Approved Cytosol NA NA Cytosol "HPA046057: AB_2679518" "unprognostic (9.17e-2)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (1.82e-3)" "unprognostic (8.28e-3)" "unprognostic (5.76e-3)" "unprognostic (4.55e-1)" "unprognostic (2.93e-1)" "unprognostic (7.18e-2)" "unprognostic (6.00e-2)" "unprognostic (4.13e-2)" "unprognostic (3.99e-1)" "unprognostic (2.87e-3)" "unprognostic (1.64e-1)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (3.13e-3)" 24.5 34.0 19.3 14.5 18.2 34.0 21.8 13.3 23.2 15.1 16.8 16.6 13.0 13.9 19.2 14.6 16.7 14.9 23.2 28.7 18.7 18.8 30.1 34.3 17.3 15.3 18.3 14.1 15.2 25.0 20.4 23.0 33.1 20.6 16.1 18.2 17.6 17.4 16.3 16.0 13.3 22.3 25.5 17.3 17.7 17.8 9.1 12.6 11.5 18.7 16.2 16.4 21.1 14.1 14.8 11.7 40.6 17.8 13.9 24.1 16.0 6.9 6.7 4.9 8.6 23.5 16.8 11.4 18.2 26.3 19.6 21.9 13.4 8.4 6.5 15.6 14.6 24.5 6.4 7.0 9.7 22.4 12.8 6.0 9.3 9.6 15.7 19.7 7.5 21.7 18.7 15.1 18.6 13.3 10.7 10.6 9.5 7.8 17.5 18.7 9.1 8.1 11.7 7.5 8.2 13.7 6.2 7.2 8.5 21.1 18.9 3.1 6.1 8.3 11.0 22.6 18.1 7.8 10.6 11.1 19.4 6.7 21.6 13.0 16.7 23.6 7.3 24.2 7.3 14.9 27.3 13.6 24.4 20.7 15.6 23.3 14.8 20.0 20.5 11.7 11.5 21.1 21.4 40.6 13.9 17.8 7.4 24.1 16.0 19.3 18.2 13.3 23.2 18.7 18.8 18.3 14.1 20.6 12.6 17.9 14.5 31.9 92.5 93.8 29.4 27.1 22.9 29.4 15.9 38.4 39.3 28.2 109.5 35.0 38.1 42.3 36.8 46.7 40.9 38.0 47.3 53.4 59.9 32.1 27.7 60.4 25.8 20.9 18.3 14.4 19.0 38.3 67.4 32.5 31.3 50.9 41.3 28.1 28.7 58.7 32.0 45.3 69.0 19.3 34.7 93.2 145.4 45.8 12.3 83.8 COQ2 "CL640, FLJ26072" ENSG00000173085 "Coenzyme Q2, polyprenyltransferase" Q96H96 4 83261536-83284914 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Disease mutation, Neurodegeneration, Parkinsonism, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 45.2;Kupffer cells: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056599, HPA068727" Approved Approved Cytosol NA NA Cytosol "HPA056599: AB_2683184, HPA068727: AB_2686022" "unprognostic (8.26e-2)" "unprognostic (7.40e-3)" "unprognostic (3.95e-3)" "unprognostic (1.55e-1)" "unprognostic (9.22e-2)" "unprognostic (5.59e-2)" "unprognostic (1.26e-2)" "unprognostic (1.52e-1)" "unprognostic (4.09e-1)" "unprognostic (4.16e-2)" "unprognostic (2.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.56e-2)" "unprognostic (3.73e-1)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (2.46e-1)" 6.6 25.5 4.9 8.4 7.0 8.9 9.9 1.9 6.0 7.4 12.1 5.8 8.4 7.8 8.0 10.2 13.1 5.4 7.4 17.5 4.3 4.1 8.0 14.9 9.8 9.0 6.5 3.4 8.0 5.9 6.7 12.3 7.2 5.0 6.6 12.5 5.2 12.7 8.5 21.8 13.8 8.2 5.8 6.7 14.1 4.8 6.6 6.7 2.9 10.1 23.9 9.2 6.2 7.4 3.6 11.8 6.0 17.4 3.7 2.0 6.8 11.7 6.9 6.8 12.9 5.3 5.4 4.8 7.6 12.6 14.5 17.0 4.8 17.0 7.9 5.6 13.5 11.5 9.1 11.5 12.4 18.3 8.1 7.3 7.1 9.0 6.7 5.8 14.4 34.2 8.0 7.9 7.0 12.1 4.3 14.4 4.5 4.6 9.5 13.4 12.1 3.8 9.7 5.0 13.9 9.7 6.6 5.3 10.2 21.1 5.7 4.8 3.1 8.7 11.1 3.9 3.2 7.1 7.9 10.0 6.8 7.1 5.1 10.6 2.8 2.3 4.7 13.3 16.9 9.3 1.1 16.3 2.3 1.6 14.4 1.2 3.6 1.8 1.5 11.8 3.5 1.3 2.0 6.0 3.7 17.4 6.2 2.0 6.8 4.9 7.0 1.9 6.0 4.3 4.1 6.5 3.4 5.0 6.7 0.0 3.4 11.8 9.6 6.0 5.2 17.1 5.1 2.7 6.8 8.7 0.0 20.5 26.6 5.8 0.6 3.6 9.6 0.0 9.5 25.6 5.4 9.8 0.0 11.4 45.2 1.6 4.6 12.9 48.6 0.6 3.4 26.3 6.8 1.0 15.2 12.9 4.7 14.0 4.6 8.2 4.2 0.0 4.7 4.3 14.5 11.0 10.4 10.0 23.9 8.9 COQ9 "C16orf49, DKFZP434K046" ENSG00000088682 "Coenzyme Q9" O75208 16 57447425-57461275 "Disease related genes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 86.0" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 184.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040918 Supported Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA040918: AB_10794154" "unprognostic (9.18e-2)" "unprognostic (3.60e-2)" "unprognostic (2.34e-2)" "unprognostic (1.29e-2)" "unprognostic (2.14e-3)" "unprognostic (2.57e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-1)" "unprognostic (2.59e-1)" "unprognostic (9.78e-2)" "unprognostic (2.34e-2)" "unprognostic (1.46e-1)" "prognostic favorable (9.03e-11)" "unprognostic (7.40e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.23e-2)" 8.8 19.3 11.5 7.8 12.4 3.7 9.3 11.2 13.8 7.9 17.9 9.4 14.7 17.6 7.2 9.9 16.6 9.5 11.3 46.1 9.5 8.8 28.8 29.1 5.8 6.4 9.7 8.6 6.9 12.6 23.6 8.9 8.1 8.8 10.4 14.5 12.2 17.7 14.5 86.0 9.4 23.7 22.1 6.9 5.3 13.6 8.9 8.5 5.4 11.8 31.1 9.4 16.3 8.4 13.6 23.3 14.7 24.1 15.2 18.7 14.1 11.9 24.4 6.6 16.6 13.3 10.3 7.9 11.6 9.1 16.4 9.2 14.8 15.6 14.5 22.4 10.1 12.6 25.6 19.1 20.3 10.3 7.8 16.5 10.0 16.7 22.7 14.7 12.7 16.4 17.1 26.6 13.0 25.4 10.9 18.2 12.8 19.2 6.6 9.8 17.0 10.5 9.2 10.9 25.9 32.2 21.4 21.8 37.3 25.5 13.3 20.9 21.1 39.3 37.9 19.2 6.1 21.8 14.2 12.5 11.9 14.7 12.9 14.6 16.1 9.9 17.3 16.6 18.3 13.5 11.5 19.3 14.7 13.9 24.1 14.4 13.6 12.0 12.2 23.3 12.0 13.0 18.7 6.0 15.2 23.5 14.5 16.8 14.1 11.5 12.4 11.2 13.8 9.5 8.8 9.7 8.6 8.8 8.5 11.9 17.6 19.3 15.0 7.4 15.8 75.0 50.9 26.8 17.0 24.4 15.7 61.9 184.1 42.5 28.2 16.5 72.4 0.0 25.5 19.3 14.4 15.7 6.9 45.9 33.9 19.1 26.5 16.5 14.0 20.8 19.5 12.8 27.0 30.7 42.6 24.6 24.1 37.4 19.1 80.1 22.7 12.9 16.7 66.0 31.1 9.8 65.8 15.2 58.3 17.0 CORO1A "coronin-1, HCORO1, p57" ENSG00000102879 "Coronin 1A" P31146 16 30182827-30189076 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 204.4;bone marrow: 94.9;lymphoid tissue: 99.8" "Group enriched" "Detected in many" 5 "B-cells: 445.3;Hofbauer cells: 429.4;Kupffer cells: 429.2;Macrophages: 313.3;monocytes: 310.2;T-cells: 809.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 86.3;HL-60: 60.2;HMC-1: 104.2;JURKAT: 54.9;MOLT-4: 58.2;NB-4: 68.9;RPMI-8226: 90.9;U-698: 56.3;U-937: 76.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046473, HPA051132" Enhanced Approved Cytosol NA NA 130000000 Cytosol "CAB046473: AB_10602363, HPA051132: AB_2681355" "unprognostic (4.17e-3)" "unprognostic (3.64e-3)" "unprognostic (3.86e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.41e-1)" "prognostic favorable (4.42e-4)" "unprognostic (1.99e-2)" "unprognostic (8.27e-3)" "unprognostic (8.26e-3)" "unprognostic (4.30e-1)" "unprognostic (1.54e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.74e-7)" "unprognostic (2.55e-1)" "unprognostic (2.37e-2)" "unprognostic (7.16e-2)" "unprognostic (2.01e-1)" 6.4 4.9 12.7 58.9 10.8 94.9 4.4 7.8 13.6 2.9 5.0 6.0 0.2 8.3 3.0 3.0 4.7 5.9 8.6 4.8 10.4 7.8 4.9 3.8 13.7 99.8 9.6 8.2 2.2 2.7 0.6 3.0 4.8 7.3 3.3 2.9 2.2 12.3 1.6 1.3 3.4 28.7 4.1 9.0 92.0 8.5 1.1 7.5 86.0 3.6 3.2 64.8 15.8 3.1 41.6 67.7 204.4 67.5 39.1 66.4 101.2 0.2 0.3 1.0 2.1 0.0 0.0 0.5 0.2 0.0 0.5 0.2 0.0 0.6 86.3 0.5 0.0 0.1 0.4 0.4 1.0 0.1 27.6 0.2 9.1 0.0 1.3 0.1 60.2 104.2 0.3 0.0 0.4 0.0 0.0 0.1 54.9 0.1 44.4 0.3 7.3 58.2 68.9 0.4 0.2 0.6 31.7 1.6 90.9 0.1 0.4 1.6 1.2 0.2 10.4 0.2 0.0 0.1 35.0 0.1 0.4 0.8 0.2 0.2 34.5 45.5 56.3 0.3 76.3 0.6 52.5 58.3 204.4 53.7 67.5 50.5 41.6 48.4 52.2 67.7 41.6 46.6 48.1 105.8 39.1 66.3 38.2 66.4 101.2 12.7 10.8 7.8 13.6 10.4 7.8 9.6 8.2 7.3 7.5 20.8 52.4 445.3 1.0 10.1 1.2 1.2 17.8 5.3 7.9 1.8 0.0 4.1 0.0 3.5 0.4 3.6 1.1 0.0 0.8 13.9 9.4 0.7 83.0 2.1 429.4 0.0 5.8 20.9 429.2 0.4 0.6 313.3 30.4 310.2 1.7 0.8 6.6 28.8 0.0 3.7 0.7 6.5 7.2 0.0 0.9 8.0 4.1 809.5 1.3 1.0 CORO1B coronin-2 ENSG00000172725 "Coronin 1B" Q9BR76 11 67435510-67443821 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 281.3;Paneth cells: 280.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017616, HPA040113, HPA070456" Enhanced Supported "Plasma membrane,Cytosol" NA NA 200000000 "Plasma membrane, Cytosol" "CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268" "unprognostic (1.94e-1)" "unprognostic (2.40e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.65e-4)" "unprognostic (1.02e-1)" "unprognostic (8.23e-3)" "unprognostic (1.49e-3)" "unprognostic (7.22e-2)" "unprognostic (1.86e-1)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-2)" "unprognostic (8.58e-3)" "unprognostic (1.85e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (6.64e-3)" 26.0 24.0 12.6 20.6 16.1 9.7 21.6 9.7 19.0 25.8 37.0 20.3 23.1 35.0 28.7 34.0 31.2 25.6 35.3 15.2 12.6 11.0 27.5 36.4 21.6 23.3 15.9 10.7 21.2 24.2 15.4 16.1 29.2 14.3 31.4 19.1 20.5 42.5 27.4 9.2 16.7 44.7 20.5 14.8 34.7 29.8 13.9 16.5 16.1 31.6 23.3 20.0 25.8 20.8 4.2 17.5 10.9 47.1 2.4 12.3 11.7 18.7 18.5 8.9 18.2 23.2 20.3 13.4 13.3 28.3 22.9 17.4 30.9 28.0 0.6 28.0 18.9 23.3 16.3 10.0 17.7 4.1 4.2 8.7 13.2 12.1 13.2 37.1 0.2 28.5 27.4 15.9 19.3 9.0 14.5 29.0 11.6 9.7 2.0 13.0 53.7 2.9 1.5 11.5 46.2 17.5 2.6 9.4 3.3 15.4 23.5 10.2 12.6 12.6 34.4 41.4 6.6 43.1 15.1 22.8 15.7 11.3 21.2 8.3 0.3 0.6 3.0 25.2 1.8 15.8 10.9 22.9 1.7 1.9 47.1 1.4 4.2 9.3 3.0 17.5 1.4 5.3 2.3 10.9 2.4 45.8 13.5 12.3 11.7 12.6 16.1 9.7 19.0 12.6 11.0 15.9 10.7 14.3 16.5 3.0 2.1 39.3 50.5 24.7 11.1 1.4 28.1 0.0 3.4 45.4 7.9 80.7 51.4 101.4 6.0 45.0 241.3 0.0 92.1 190.3 39.9 57.7 28.7 19.5 220.1 14.3 95.0 41.7 89.7 3.0 36.5 74.8 67.4 281.3 138.0 26.4 112.4 280.5 32.5 63.3 12.8 51.8 44.5 6.9 5.9 27.0 125.9 76.7 99.3 62.6 CORO2A "IR10, WDR2" ENSG00000106789 "Coronin 2A" Q92828 9 98120975-98192640 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;intestine: 36.1" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 38.2;Enterocytes: 69.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 10.9;monocytes: 7.0;T-cells: 11.1" "Cell line enhanced" "Detected in many" "BEWO: 32.3;OE19: 26.3;SK-BR-3: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041161, HPA041302" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041161: AB_10795537, HPA041302: AB_10794195" "unprognostic (4.49e-3)" "unprognostic (3.44e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.39e-3)" "unprognostic (1.64e-1)" "unprognostic (3.73e-2)" "unprognostic (5.73e-2)" "unprognostic (2.79e-1)" "unprognostic (1.52e-1)" "unprognostic (4.50e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (1.87e-2)" "unprognostic (6.40e-3)" 1.6 0.8 1.2 6.9 1.8 8.1 2.9 9.3 2.4 3.9 22.0 0.7 1.3 20.8 2.0 2.2 13.6 2.7 27.7 1.5 1.3 3.0 1.4 2.9 7.5 1.6 2.6 1.3 1.5 1.4 2.8 5.2 3.5 3.3 9.0 7.9 1.2 5.4 1.9 0.9 6.3 36.1 1.9 0.6 3.8 6.6 11.4 0.6 5.6 1.1 3.6 6.6 7.7 6.2 0.6 0.7 10.9 7.0 1.5 11.1 1.4 3.9 1.4 0.3 0.9 0.6 0.6 32.3 0.3 0.3 1.0 1.6 8.9 0.6 0.0 4.5 0.6 1.5 11.0 3.7 6.0 0.6 3.2 0.8 0.1 5.6 7.9 1.3 3.6 0.3 0.2 7.4 0.5 9.1 0.3 0.3 4.7 3.1 1.8 0.1 2.9 0.7 3.6 4.1 26.3 1.0 2.8 0.0 0.1 0.6 11.1 0.8 1.1 2.0 21.8 0.7 7.6 2.5 6.0 0.3 0.1 4.8 0.1 1.1 0.3 1.8 0.3 0.2 1.2 1.3 7.7 1.5 10.9 2.4 3.0 5.5 0.6 4.1 3.8 0.5 0.6 2.7 3.5 1.1 1.5 7.0 0.7 11.1 1.4 1.2 1.8 9.3 2.4 1.3 3.0 2.6 1.3 3.3 0.6 11.9 23.8 0.9 17.5 6.0 1.5 1.2 38.2 20.1 35.2 0.0 3.9 8.5 0.0 3.0 2.2 1.9 69.1 0.0 4.5 31.7 3.1 14.5 0.0 3.2 5.8 1.6 6.9 1.3 11.0 3.0 0.0 4.9 0.0 0.0 14.0 0.5 13.8 17.3 0.4 1.4 1.5 0.0 1.9 0.5 3.2 8.7 13.3 8.7 25.7 26.0 COTL1 CLP ENSG00000103187 "Coactosin like F-actin binding protein 1" Q14019 16 84565594-84618077 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Chaperone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 206.6;lymphoid tissue: 103.0" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 1310.7;Hofbauer cells: 547.8;Kupffer cells: 920.9;Macrophages: 713.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 110.8;eosinophil: 160.2;intermediate monocyte: 190.1;myeloid DC: 117.3;neutrophil: 86.8;non-classical monocyte: 206.6" "Group enriched" "Detected in all" 5 "dendritic cells: 117.3;granulocytes: 160.2;monocytes: 206.6" "Cell line enhanced" "Detected in many" "WM-115: 130.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008918, CAB062328" Enhanced Supported Cytosol NA NA 28000000 Cytosol "CAB062328: AB_2084785, HPA008918: AB_2668176" "unprognostic (2.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (3.21e-3)" "unprognostic (8.95e-2)" "unprognostic (2.43e-1)" "unprognostic (1.14e-1)" "unprognostic (7.70e-2)" "unprognostic (5.99e-2)" "unprognostic (5.43e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (5.48e-2)" "unprognostic (7.73e-2)" "unprognostic (3.35e-3)" 28.6 9.9 20.4 68.1 19.5 57.7 13.7 12.4 18.1 7.6 16.5 25.3 2.4 22.0 13.2 8.4 8.2 13.2 18.7 7.2 19.6 24.9 34.3 12.4 26.6 103.0 28.9 8.1 10.8 7.5 5.1 13.1 29.4 23.2 11.8 16.7 30.8 7.7 7.6 5.1 5.1 26.1 16.2 27.8 92.3 29.6 8.0 13.4 33.0 10.1 5.2 62.0 29.3 7.6 28.5 117.3 160.2 206.6 30.8 32.5 108.3 53.9 45.1 103.2 108.9 11.8 32.7 31.1 47.0 30.4 37.1 14.4 61.2 83.8 15.0 14.4 35.3 22.1 27.2 6.3 37.0 37.4 0.1 7.9 28.1 9.5 16.1 33.5 31.5 111.6 26.1 5.9 35.7 32.0 23.3 17.6 33.3 2.6 6.2 22.0 8.7 9.7 19.0 12.7 17.8 46.1 1.0 3.5 0.9 54.4 23.0 16.3 0.8 43.8 10.5 23.4 12.7 7.9 25.7 45.3 53.5 30.4 17.1 34.2 1.2 5.6 12.2 41.8 15.4 130.2 29.6 110.8 160.2 3.6 190.1 4.8 28.5 23.0 21.7 117.3 13.2 10.3 12.1 86.8 30.8 206.6 6.0 32.5 108.3 20.4 19.5 12.4 18.1 19.6 24.9 28.9 8.1 23.2 13.4 3.0 13.5 259.5 72.9 56.3 9.5 4.4 17.8 2.7 6.8 73.3 229.7 114.0 33.2 49.7 5.6 83.4 40.6 0.0 29.3 1310.7 47.3 43.2 143.7 4.2 547.8 23.8 139.8 242.5 920.9 6.9 7.5 713.2 91.1 125.4 65.3 16.9 70.8 14.4 15.2 238.6 41.0 6.5 62.8 2.9 18.1 33.4 144.5 177.7 122.8 153.6 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 89.2;Late spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.32e-6)" "prognostic favorable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 7.3 14.1 5.9 8.4 5.9 5.4 13.3 8.9 6.2 16.3 11.3 12.3 5.4 17.3 7.1 9.0 5.6 14.1 11.9 11.5 13.1 9.3 12.0 10.3 11.3 13.6 10.3 10.6 9.7 7.7 14.5 10.2 13.0 6.5 8.6 12.3 13.9 5.9 7.2 9.1 9.0 7.0 8.9 27.6 7.3 7.6 19.9 12.2 10.2 13.8 4.4 7.4 9.2 12.3 11.0 29.1 6.9 6.0 7.0 7.1 6.0 7.2 11.2 7.2 10.1 7.8 10.7 11.0 8.8 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 0.0 14.3 5.2 7.2 8.7 8.0 89.2 7.6 5.3 4.5 10.4 9.8 16.5 34.9 8.0 33.1 4.9 19.0 0.0 7.5 14.8 5.1 7.4 4.7 8.9 9.4 0.0 12.1 4.9 3.8 61.2 2.0 5.4 5.0 4.6 14.2 2.8 8.6 11.0 6.3 11.4 11.6 0.0 5.1 14.6 15.9 9.2 13.5 5.3 15.1 11.8 COX19 MGC104475 ENSG00000240230 "COX19, cytochrome c oxidase assembly factor" Q49B96 7 898778-975599 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021226 Approved Supported Cytosol NA NA Cytosol "HPA021226: AB_1847176" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (1.05e-2)" "unprognostic (3.76e-2)" "unprognostic (5.22e-2)" "unprognostic (1.05e-1)" "unprognostic (2.13e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-1)" "unprognostic (5.60e-2)" "unprognostic (4.79e-2)" "unprognostic (3.36e-2)" "unprognostic (2.37e-3)" "unprognostic (2.49e-2)" "unprognostic (1.64e-1)" "unprognostic (2.74e-1)" "unprognostic (9.14e-3)" 8.1 22.1 11.9 9.4 15.8 16.6 9.6 25.4 13.3 8.6 10.2 14.5 10.8 15.7 9.2 8.5 10.2 15.0 8.3 9.5 11.3 9.7 10.6 9.9 8.8 11.4 18.5 10.4 12.7 16.4 13.9 13.7 8.4 14.1 10.8 10.5 8.0 13.3 9.0 18.9 16.5 13.3 8.7 12.6 13.6 13.4 11.2 15.3 8.5 10.5 12.4 11.6 9.2 9.9 12.5 15.0 15.1 9.9 10.1 15.2 7.6 14.3 3.6 4.3 5.4 3.1 4.6 8.3 6.3 4.6 5.8 4.8 9.7 8.1 7.0 2.2 3.8 8.7 9.7 4.5 4.7 4.7 2.2 7.3 3.1 4.4 7.5 9.9 7.3 6.8 5.4 9.9 4.5 10.4 5.7 3.6 7.1 8.9 6.0 3.6 8.7 3.3 7.9 11.1 16.3 9.6 7.6 0.8 3.5 4.8 6.2 5.6 5.6 3.7 14.9 11.5 7.2 7.8 17.5 4.3 5.6 7.9 6.3 9.8 7.3 5.2 7.2 5.1 10.3 9.5 15.1 9.9 13.9 11.2 9.7 11.8 12.5 12.1 10.1 8.4 12.2 15.2 14.3 9.5 10.1 9.9 15.0 11.1 7.6 11.9 15.8 25.4 13.3 11.3 9.7 18.5 10.4 14.1 15.3 11.9 18.4 21.7 30.1 21.9 18.7 12.3 33.1 26.8 14.8 29.6 11.8 23.3 13.3 32.2 5.2 19.6 27.7 0.0 30.0 34.1 18.9 24.5 34.6 25.1 23.5 14.3 43.0 24.5 18.6 1.7 18.1 28.2 20.3 40.5 28.9 29.4 36.3 31.7 13.4 17.4 25.8 6.5 21.1 17.2 30.6 22.5 35.0 42.4 28.2 37.2 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354814 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 66.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 23.6;Late spermatids: 19.1;Spermatocytes: 77.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.6;SCLC-21H: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.3 0.0 0.4 0.6 0.6 0.7 0.5 0.3 0.6 0.2 3.3 0.2 0.2 0.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.5 0.5 0.2 0.2 0.6 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.6 0.2 3.5 0.7 0.6 0.2 0.2 1.8 0.2 0.2 0.7 0.2 0.0 66.5 0.3 0.2 0.2 0.2 1.2 0.2 0.4 1.3 1.4 5.7 1.0 1.6 0.9 0.8 2.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.1 22.6 0.1 0.2 0.2 0.3 1.8 0.7 0.2 0.2 0.8 0.7 0.0 1.7 0.1 0.3 0.2 1.8 0.2 2.5 0.4 0.5 1.7 0.0 0.1 0.4 0.2 0.0 0.5 0.1 0.2 0.6 2.3 0.5 0.1 0.0 0.2 0.0 0.4 9.7 0.3 0.3 0.1 0.0 0.6 0.4 0.0 0.4 0.3 0.5 0.1 0.2 1.5 1.2 0.1 0.1 0.3 0.2 1.9 1.0 1.0 0.8 0.5 0.5 0.7 0.7 0.6 0.3 1.3 0.7 0.9 5.7 1.6 0.7 1.4 0.6 0.8 0.4 0.6 0.3 0.6 0.2 0.5 0.4 0.2 0.6 0.3 0.0 0.3 0.0 0.6 0.5 2.1 0.4 0.0 0.0 0.0 0.0 3.9 0.5 0.0 0.6 23.6 0.0 3.2 0.0 0.6 0.2 0.4 0.2 0.0 0.0 0.1 3.2 1.2 0.0 0.0 19.1 0.6 0.0 0.0 0.0 1.3 0.9 5.6 3.5 0.0 0.0 4.1 0.0 0.0 77.8 1.3 0.4 0.3 0.0 4.4 2.5 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.0;skin 1: 41.0" "Cell type enhanced" "Detected in some" 18 "Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0" "Low region specificity" "Detected in single" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" NA Yes 480000 Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (1.31e-4)" 2.7 2.3 0.1 0.4 0.4 0.2 2.8 0.1 0.4 8.1 1.1 0.3 0.1 0.1 1.1 1.2 18.0 0.2 0.2 4.4 0.1 1.2 1.2 0.2 0.8 0.3 0.1 0.1 1.8 6.9 0.1 1.1 8.8 0.9 0.3 0.1 0.6 4.4 0.1 0.3 41.0 0.5 0.7 0.7 1.7 0.2 2.2 0.1 0.8 0.1 12.3 2.3 1.7 6.7 0.4 0.4 1.6 0.4 1.5 0.4 0.1 19.4 1.0 0.0 0.0 0.1 0.3 0.0 15.6 29.6 15.9 3.9 0.1 1.7 0.0 3.0 6.6 16.1 1.1 0.0 8.6 16.5 0.0 0.0 0.0 6.3 0.4 0.4 0.0 0.0 0.2 13.9 1.4 2.0 55.9 0.0 0.0 0.0 0.0 60.1 0.0 0.0 0.0 0.1 0.1 2.3 0.0 16.1 0.0 7.5 0.8 0.0 0.0 10.3 4.9 0.1 6.3 0.1 0.0 11.9 3.9 32.8 1.3 1.5 0.0 0.0 0.0 59.0 0.0 0.1 1.0 0.4 0.4 0.4 0.1 0.2 0.3 0.2 0.3 0.0 0.4 0.3 0.3 1.6 1.5 0.2 0.4 0.3 0.1 0.1 0.4 0.1 0.3 0.1 1.2 0.1 0.1 0.9 0.1 3.0 0.3 0.0 0.5 15.8 0.0 0.3 0.0 2.7 2.3 0.0 0.0 3.7 0.0 0.5 0.3 0.1 0.0 0.0 45.1 1.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 27.0 7.9 0.0 0.0 0.9 CPEB1 "CPEB, FLJ13203" ENSG00000214575 "Cytoplasmic polyadenylation element binding protein 1" Q9BZB8 15 82543201-82648861 "Predicted intracellular proteins" "mRNA processing, Translation regulation" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.0" "Cell type enhanced" "Detected in many" 15 "Late spermatids: 16.0;Spermatocytes: 18.2;Spermatogonia: 47.3" "Cancer enriched" "Detected in some" 6 "testis cancer: 14.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.5" "Group enriched" "Detected in many" 27 "B-cells: 1.8;T-cells: 3.5" "Cell line enhanced" "Detected in many" "SK-MEL-30: 16.1;U-2197: 46.5;U-87 MG: 17.0" HPA040396 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040396: AB_2676960" "unprognostic (3.97e-2)" "unprognostic (1.01e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-2)" "unprognostic (7.51e-3)" "unprognostic (1.97e-3)" "unprognostic (9.50e-3)" "unprognostic (8.17e-2)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" 2.1 5.6 7.5 1.6 10.8 0.5 2.1 11.9 15.7 5.2 5.3 9.4 0.2 1.6 4.2 8.7 4.0 9.2 4.3 2.9 6.2 6.2 1.6 0.8 1.9 0.8 12.4 9.0 15.4 1.6 1.4 8.3 0.6 13.0 2.7 2.9 3.9 1.4 4.4 2.2 1.5 2.2 3.9 7.7 0.9 2.6 32.0 8.1 0.0 2.7 0.0 0.8 5.5 3.8 1.8 0.0 0.0 0.0 0.0 3.5 0.6 0.0 1.5 0.1 0.1 1.1 0.1 0.0 1.2 0.1 0.8 0.6 0.0 0.0 0.0 2.8 0.4 8.7 0.0 2.2 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.8 0.0 1.0 0.6 0.0 1.5 0.0 0.1 0.0 3.3 3.7 0.0 0.5 0.0 0.2 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.6 1.0 4.0 0.2 16.1 5.2 0.0 0.5 0.0 8.4 3.4 46.5 2.5 2.3 5.9 0.6 17.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.7 1.8 0.3 1.8 0.0 0.5 1.2 3.5 0.0 0.0 0.0 0.0 0.0 0.6 7.5 10.8 11.9 15.7 6.2 6.2 12.4 9.0 13.0 8.1 0.0 0.0 0.0 0.3 0.7 10.3 1.2 0.0 4.0 0.0 0.0 9.8 0.0 0.0 0.1 10.9 0.0 0.0 0.0 0.0 0.0 2.1 0.1 1.1 0.0 0.2 11.1 0.0 0.0 0.0 16.0 3.7 0.2 5.0 0.0 0.0 4.5 0.2 0.0 2.1 0.3 3.5 6.5 2.3 18.2 47.3 0.5 0.1 0.0 0.0 0.1 CPEB2 ENSG00000137449 "Cytoplasmic polyadenylation element binding protein 2" Q7Z5Q1 4 15002674-15070153 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 76.2;Suprabasal keratinocytes: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072513 Approved Cytosol Yes No Cytosol "HPA072513: AB_2686529" "unprognostic (6.59e-2)" "unprognostic (4.21e-3)" "unprognostic (4.75e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.80e-2)" "unprognostic (2.36e-2)" "unprognostic (5.67e-3)" "unprognostic (1.33e-1)" "unprognostic (1.65e-1)" "unprognostic (4.58e-2)" "unprognostic (2.06e-1)" "unprognostic (8.62e-2)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" 10.0 7.5 18.5 6.0 21.5 23.0 13.6 11.5 21.0 8.8 11.5 28.7 13.2 9.6 8.2 9.4 13.6 7.1 10.7 7.8 17.4 16.2 13.5 18.9 9.5 6.4 27.2 17.4 7.9 5.4 23.8 6.4 7.4 16.4 10.2 10.7 20.7 8.9 21.9 7.1 23.0 9.5 10.8 21.7 6.6 10.8 37.4 27.6 3.6 6.1 7.8 7.2 8.3 12.6 0.4 0.7 2.4 0.4 1.3 1.6 0.3 1.3 8.3 0.8 0.3 6.2 11.4 1.4 4.6 3.1 2.9 2.1 0.2 1.6 0.8 0.9 4.2 5.4 1.5 1.8 1.0 1.8 2.3 0.6 0.2 6.4 1.4 2.9 0.3 1.1 5.6 5.5 7.0 6.8 3.6 2.6 0.1 0.1 6.0 11.8 0.6 0.1 1.8 0.8 2.4 1.2 0.1 0.6 0.3 25.2 1.1 0.7 4.6 1.5 1.0 4.7 3.9 0.6 5.3 5.1 10.4 0.9 6.5 2.5 3.9 0.5 0.4 8.5 4.7 3.8 0.0 0.4 1.7 0.5 0.4 1.6 0.1 0.8 0.5 0.7 0.4 0.9 0.3 2.4 1.3 0.2 0.3 0.2 0.3 18.5 21.5 11.5 21.0 17.4 16.2 27.2 17.4 16.4 27.6 29.8 13.9 5.8 9.4 76.2 7.6 18.3 15.3 1.4 6.8 29.6 25.5 1.1 1.7 3.5 47.6 11.4 23.2 0.0 4.2 1.2 11.0 8.7 10.4 21.2 9.1 14.3 9.8 12.9 15.4 15.5 5.8 12.2 50.6 2.8 10.9 6.1 5.9 11.9 7.8 10.3 19.0 0.0 13.4 14.7 3.1 113.2 1.1 6.4 6.6 14.4 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291087 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;liver: 39.5" "Group enriched" "Detected in many" 4 "Early spermatids: 216.8;Late spermatids: 321.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 16.1;U-266/70: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070942 Approved "Nucleoplasm,Plasma membrane,Midbody,Cytosol" NA No Cytosol "Nucleoplasm, Plasma membrane, Midbody" "HPA070942: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favorable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favorable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 3.1 6.1 11.9 3.0 10.9 2.9 5.0 33.4 24.6 4.0 3.8 4.4 5.5 4.8 3.3 6.8 6.0 3.3 3.4 7.0 10.7 11.5 7.0 39.5 3.6 3.0 10.3 15.1 5.8 5.4 6.6 8.6 2.8 16.4 6.5 4.2 3.0 10.2 8.0 23.4 5.3 4.6 3.4 4.6 4.1 4.5 20.5 7.0 0.3 9.3 5.4 3.4 3.3 4.5 1.8 0.9 6.5 1.5 0.5 0.7 0.5 1.2 0.3 0.4 2.7 0.7 0.7 1.1 1.2 0.9 1.7 1.4 0.9 2.7 1.4 1.3 0.5 0.8 3.4 1.1 0.9 0.9 1.6 1.4 1.9 1.8 1.0 2.0 0.9 2.0 0.7 2.1 1.0 3.1 1.5 1.5 1.9 1.3 16.1 0.7 0.9 1.2 1.1 0.2 1.8 1.3 1.6 2.3 2.8 1.6 0.5 2.0 0.7 1.1 3.1 2.0 1.4 3.9 2.0 1.2 0.8 0.9 0.6 1.0 9.0 2.4 1.5 0.4 3.0 0.2 6.5 1.1 2.2 0.7 1.4 0.5 1.8 0.4 0.7 0.9 0.5 0.4 0.4 1.3 0.5 1.5 0.6 0.3 0.5 11.9 10.9 33.4 24.6 10.7 11.5 10.3 15.1 16.4 7.0 6.0 6.5 0.8 3.2 7.8 25.2 21.8 5.1 2.7 3.4 12.2 47.1 1.8 5.0 2.1 216.8 6.0 7.5 0.0 2.3 1.3 3.9 15.1 3.5 66.1 4.2 28.6 19.0 11.6 22.6 321.1 5.5 7.7 5.0 6.4 9.1 2.5 3.1 3.5 7.4 2.5 21.8 0.0 3.1 11.2 6.8 12.2 1.0 2.5 5.2 5.3 CPNE2 CPN2 ENSG00000140848 "Copine 2" Q96FN4 16 57092537-57148367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.6" "Cell type enhanced" "Detected in many" 8 "Ito cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041132 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA041132: AB_2677316" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.93e-3)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (9.14e-2)" "unprognostic (2.10e-3)" "unprognostic (8.78e-3)" "unprognostic (2.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.53e-3)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" 14.1 3.9 8.4 4.6 15.1 22.8 11.4 7.9 15.4 16.4 12.0 40.6 1.1 2.0 8.8 3.1 6.4 12.0 5.6 5.9 10.6 11.6 4.8 4.3 15.5 8.2 20.8 9.8 5.1 3.3 3.7 4.9 11.5 12.9 5.1 11.9 4.6 3.7 7.4 4.9 4.0 6.6 10.5 13.5 6.0 3.7 15.3 20.1 0.2 5.8 2.2 3.2 6.4 8.3 0.0 2.1 4.0 4.2 0.5 1.2 0.9 8.4 16.3 25.2 13.9 4.5 4.4 4.2 9.2 14.6 21.1 14.8 4.5 9.8 5.0 8.5 13.9 11.7 13.3 9.9 5.5 11.5 6.2 5.8 2.1 6.5 3.8 8.2 1.7 0.2 4.2 6.2 8.2 4.0 15.8 31.0 2.8 5.6 0.1 5.3 3.9 2.5 24.7 5.7 4.1 3.5 31.5 7.9 4.2 14.0 3.2 0.5 10.2 11.7 2.5 7.0 11.9 2.7 33.7 21.8 19.3 10.5 4.8 11.9 1.2 1.0 11.3 12.5 7.4 13.5 0.0 4.2 1.9 0.7 1.2 0.7 0.0 0.4 1.2 2.1 0.0 0.3 0.6 4.0 0.5 0.4 0.1 0.5 0.9 8.4 15.1 7.9 15.4 10.6 11.6 20.8 9.8 12.9 20.1 17.9 6.1 2.9 13.5 2.1 0.0 2.2 2.5 1.4 2.3 5.2 0.0 0.6 5.0 3.9 14.0 20.4 28.0 0.0 3.4 2.1 10.4 9.0 0.0 1.6 20.0 0.0 3.5 72.4 21.2 4.7 6.4 6.9 6.8 3.6 15.7 3.3 5.9 21.0 7.1 1.6 0.0 32.3 14.4 0.5 1.7 3.8 0.7 4.4 15.9 9.9 CPNE3 ENSG00000085719 "Copine 3" O75131 8 86514427-86561498 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 66.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029552 Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA 52000 "Nucleoplasm, Cytosol" "Nucleoli, Mitochondria" "HPA029552: AB_10600703" "unprognostic (5.63e-3)" "unprognostic (1.47e-1)" "unprognostic (2.95e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (6.58e-2)" "unprognostic (8.40e-2)" "unprognostic (4.76e-2)" "unprognostic (3.50e-1)" "unprognostic (1.19e-1)" "unprognostic (8.64e-3)" "unprognostic (2.77e-1)" "prognostic favorable (5.07e-4)" "unprognostic (1.15e-1)" "unprognostic (4.33e-1)" "unprognostic (1.65e-3)" "unprognostic (1.13e-2)" 26.5 16.6 21.3 9.8 18.0 35.1 20.6 18.8 13.5 26.0 16.4 20.9 13.2 15.1 28.6 12.6 40.5 15.9 14.6 24.4 17.6 19.7 29.8 25.5 16.9 22.6 19.7 10.5 26.7 24.1 25.4 28.9 16.1 17.0 22.4 16.5 21.0 20.6 15.3 10.4 18.7 19.5 20.9 18.7 18.3 16.9 9.7 14.1 30.5 33.6 21.8 29.7 25.4 20.0 14.6 31.4 28.2 24.3 15.0 18.3 14.4 34.6 12.3 8.5 11.0 32.7 25.5 6.9 16.7 24.9 14.0 15.8 7.9 11.9 9.5 11.1 20.3 8.5 26.8 18.2 17.7 25.2 10.1 14.3 1.5 9.0 9.4 11.3 0.8 0.8 17.3 19.2 15.5 20.6 22.6 17.1 4.9 8.5 18.3 17.2 13.4 16.6 0.5 3.2 28.7 17.8 7.9 7.7 44.4 18.1 24.9 18.0 14.1 14.6 66.7 10.5 10.2 25.4 2.6 18.2 12.5 12.2 16.6 12.9 13.2 15.8 2.6 18.0 3.6 11.5 10.8 16.7 26.4 18.3 19.1 14.2 14.6 14.8 12.8 30.8 14.1 13.3 14.3 28.2 15.0 24.3 31.4 10.5 14.4 21.3 18.0 18.8 13.5 17.6 19.7 19.7 10.5 17.0 14.1 128.1 76.8 40.4 87.4 72.7 16.8 108.0 79.0 77.6 69.4 66.3 13.7 59.5 84.6 63.4 1.1 55.4 37.1 23.3 72.9 45.8 62.4 110.2 8.1 86.6 42.9 42.9 48.1 57.7 74.2 2.2 79.4 49.0 50.6 32.5 53.7 70.1 62.4 52.6 82.4 99.4 16.5 58.2 55.6 3.0 10.0 79.5 65.2 47.5 69.8 73.5 CPNE4 "COPN4, CPN4" ENSG00000196353 "Copine 4" Q96A23 3 131533555-132285410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;prostate: 35.7" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 17.1;Glandular cells: 18.5;Intestinal endocrine cells: 4.7" "Cancer enriched" "Detected in some" 6 "prostate cancer: 22.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 33 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "A549: 9.9;AF22: 9.3;Karpas-707: 2.8;RT4: 3.1" "Low region specificity" "Detected in many" "HPA032036, HPA078300" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA032036: AB_10600898, HPA078300: AB_2732377" "unprognostic (7.38e-2)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (1.22e-4)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (8.81e-3)" "unprognostic (3.40e-1)" "unprognostic (2.69e-2)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-2)" "unprognostic (9.10e-3)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (1.35e-1)" "unprognostic (2.51e-1)" 1.4 1.4 7.0 0.8 11.6 0.8 0.7 0.4 27.2 1.0 1.1 2.5 0.7 1.6 0.9 1.6 1.1 1.2 0.7 1.9 17.5 5.3 2.1 0.8 1.2 0.7 1.3 11.8 0.7 0.8 3.8 9.5 0.7 3.1 35.7 1.0 0.1 1.1 6.0 0.6 1.0 1.4 1.2 4.6 1.8 1.4 2.3 3.6 0.0 1.1 0.0 0.7 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 9.9 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 2.8 1.3 0.6 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.6 3.1 1.4 0.6 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.2 2.3 0.3 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 7.0 11.6 0.4 27.2 17.5 5.3 1.3 11.8 3.1 3.6 0.0 0.0 0.0 0.4 0.2 0.8 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.5 18.5 0.0 0.0 0.1 1.6 4.7 0.0 0.0 3.6 0.3 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 1.2 0.5 0.0 0.8 1.2 1.1 0.1 0.0 0.0 0.0 0.8 CPNE5 "COPN5, CPN5, KIAA1599" ENSG00000124772 "Copine 5" Q9HCH3 6 36740775-36840002 "Plasma proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.1;brain: 50.3;heart muscle: 28.6" "Cell type enhanced" "Detected in many" 16 "B-cells: 43.6;Cardiomyocytes: 20.4;granulocytes: 11.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 50.3" "Group enriched" "Detected in some" 82 "memory B-cell: 27.1;naive B-cell: 12.9" "Lineage enriched" "Detected in single" 111 "B-cells: 27.1" "Group enriched" "Detected in some" 4 "Daudi: 33.0;HUVEC TERT2: 13.6;U-266/70: 11.4;U-266/84: 9.1;U-698: 15.5" "Region enhanced" "Detected in many" "basal ganglia: 100.1" "Region enhanced" "Detected in many" "basal ganglia: 166.9" HPA031369 Enhanced Approved Cytosol NA NA Cytosol "HPA031369: AB_10601801" "unprognostic (5.71e-3)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.73e-2)" "unprognostic (1.04e-1)" "prognostic favorable (2.87e-5)" "unprognostic (1.07e-1)" "unprognostic (3.07e-2)" "unprognostic (9.57e-2)" "unprognostic (1.21e-3)" "unprognostic (2.45e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (6.00e-5)" "unprognostic (1.68e-2)" "unprognostic (3.80e-1)" "unprognostic (2.00e-1)" "unprognostic (3.57e-1)" 1.8 1.1 8.1 12.5 50.3 1.1 1.7 1.9 49.4 1.8 4.2 1.3 0.0 3.9 3.7 1.0 1.8 11.3 1.7 28.6 3.7 4.9 1.3 0.5 1.5 14.3 3.6 12.8 2.3 1.0 0.8 3.6 1.3 3.3 2.9 3.6 4.1 2.0 2.2 0.5 1.0 2.9 3.6 3.0 7.1 3.4 11.8 6.2 0.1 1.4 0.0 20.3 5.5 1.9 27.1 0.1 0.2 0.1 0.0 0.1 2.2 0.5 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.1 33.0 0.3 0.4 1.6 0.3 0.1 0.2 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 2.4 13.6 0.1 0.1 0.9 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.6 0.1 0.0 0.5 3.1 0.2 0.4 0.0 1.3 11.4 9.1 15.5 0.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 27.1 0.1 0.0 0.0 12.9 0.0 0.0 0.2 0.0 0.1 0.1 0.0 2.2 8.1 50.3 1.9 20.4 3.7 4.9 3.6 12.8 3.3 6.2 0.0 5.1 43.6 0.1 0.6 9.8 20.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.9 2.8 5.1 0.0 0.2 0.0 0.6 0.2 11.6 0.4 0.4 0.0 4.1 3.7 1.5 3.5 0.0 0.2 3.3 0.0 0.8 1.0 0.2 10.5 0.4 0.0 1.1 0.0 0.3 0.6 1.4 0.1 0.0 0.5 1.5 0.1 CPPED1 "CSTP1, FLJ11151" ENSG00000103381 "Calcineurin like phosphoesterase domain containing 1" Q9BRF8 16 12659799-12804017 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 85.5;Syncytiotrophoblasts: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 93.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 45.3;HMC-1: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040938, HPA041970" Uncertain Supported "Plasma membrane,Cytosol" No No 380000 Cytosol "Plasma membrane" "HPA040938: AB_10673443, HPA041970: AB_2677774" "prognostic unfavorable (9.72e-4)" "unprognostic (1.70e-1)" "unprognostic (2.04e-3)" "unprognostic (1.05e-2)" "unprognostic (1.13e-3)" "unprognostic (3.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.67e-2)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (6.26e-2)" "unprognostic (3.64e-1)" "prognostic favorable (1.62e-9)" "unprognostic (5.05e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-3)" "unprognostic (2.40e-2)" 10.9 11.5 8.3 14.3 14.3 9.5 8.5 2.7 11.8 9.2 13.8 20.8 7.4 16.3 8.2 6.2 23.1 7.2 8.9 10.7 11.2 9.5 26.2 31.4 10.4 21.2 20.7 7.7 6.4 4.1 4.3 6.5 36.6 17.6 9.1 11.9 10.2 15.1 7.3 6.4 6.8 20.5 10.0 22.1 27.4 8.1 18.2 13.1 5.8 11.1 8.4 16.9 9.8 9.6 1.5 23.1 93.6 43.7 1.9 1.8 14.6 1.5 9.5 1.0 2.5 4.0 8.5 0.1 17.4 4.7 9.3 7.6 4.6 4.9 2.3 18.0 12.6 4.1 0.1 0.0 4.3 9.7 5.3 2.6 19.7 1.4 45.3 2.5 0.0 42.8 8.5 0.9 0.8 6.7 0.0 13.9 3.2 6.8 1.4 22.8 1.9 1.7 9.1 2.8 0.7 1.3 3.7 6.1 4.9 14.1 3.0 5.0 3.3 0.0 15.8 6.2 5.2 3.4 4.3 20.8 13.5 2.8 0.0 0.0 0.0 0.3 3.6 3.0 10.0 2.8 6.1 30.6 19.3 1.3 43.7 1.1 1.5 1.1 1.4 23.1 1.0 0.3 0.8 93.6 1.9 40.6 5.6 1.8 14.6 8.3 14.3 2.7 11.8 11.2 9.5 20.7 7.7 17.6 13.1 8.9 18.4 13.0 2.9 4.0 3.6 8.2 7.6 10.7 6.8 14.0 7.9 85.5 51.4 33.8 2.3 11.3 13.5 0.0 10.9 10.0 9.3 3.3 52.1 38.5 44.3 9.5 5.8 7.4 74.6 2.3 14.4 42.4 6.8 27.9 7.5 12.5 30.7 13.6 22.6 51.8 5.5 25.8 4.2 1.6 11.5 4.0 110.3 7.4 10.6 1.4 CPSF7 "CFIM59, FLJ12529" ENSG00000149532 "Cleavage and polyadenylation specific factor 7" Q8N684 11 61402641-61430031 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041094 Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041094: AB_10794187" "unprognostic (6.87e-3)" "unprognostic (8.31e-2)" "unprognostic (1.94e-1)" "unprognostic (4.79e-3)" "unprognostic (1.07e-1)" "unprognostic (9.41e-3)" "prognostic unfavorable (9.83e-4)" "unprognostic (5.35e-2)" "unprognostic (2.07e-3)" "unprognostic (7.95e-2)" "unprognostic (2.59e-1)" "unprognostic (3.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.71e-1)" "unprognostic (2.38e-1)" "unprognostic (6.18e-2)" 23.3 25.6 23.2 24.3 39.0 34.5 25.6 31.6 49.5 26.9 25.4 35.4 34.9 22.6 41.6 33.5 27.0 31.6 19.9 20.9 25.0 19.9 25.2 33.6 24.0 28.5 24.3 24.9 40.5 29.0 36.1 47.8 26.9 29.2 27.6 25.5 33.2 28.4 28.4 36.7 33.9 27.6 32.5 27.2 33.9 26.9 31.3 28.5 45.6 36.0 19.8 32.3 27.1 26.3 10.4 10.5 14.2 8.3 8.5 12.9 7.4 26.5 26.7 37.4 29.6 20.3 18.0 26.3 22.1 21.2 29.4 22.6 31.1 22.9 39.9 23.8 23.6 25.0 32.9 35.8 25.3 36.0 26.4 18.3 33.6 34.4 24.9 20.5 40.6 29.9 19.0 20.7 31.2 45.7 17.9 19.8 26.0 40.3 25.6 21.2 32.2 40.2 33.1 36.7 18.5 21.1 37.9 29.5 32.9 22.0 33.0 25.5 26.0 29.4 26.0 27.2 23.9 36.0 17.5 20.0 32.6 27.9 30.5 22.8 35.5 41.7 46.0 19.0 19.6 23.9 14.2 7.4 9.2 12.2 8.3 12.9 10.4 9.7 12.3 10.5 10.0 10.7 10.8 14.0 8.5 6.1 8.9 6.6 7.4 23.2 39.0 31.6 49.5 25.0 19.9 24.3 24.9 29.2 28.5 32.8 20.5 21.7 16.3 20.6 18.3 9.8 15.3 13.4 11.4 15.7 37.3 22.8 14.9 14.1 22.1 17.5 17.6 0.0 12.1 14.6 16.6 19.0 23.1 26.1 17.2 30.2 21.4 21.5 32.9 20.3 25.3 18.3 3.3 32.5 20.4 26.4 16.1 8.6 23.7 13.4 21.7 38.8 24.7 32.5 26.8 23.1 23.0 19.1 24.2 20.1 CPTP "GLTPD1, MGC10334" ENSG00000224051 "Ceramide-1-phosphate transfer protein" Q5TA50 1 1324756-1328897 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 124.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056832 Approved Approved Cytosol NA NA Cytosol "HPA056832: AB_2683251" "unprognostic (9.00e-2)" "unprognostic (2.19e-1)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (7.01e-2)" "unprognostic (1.94e-2)" "unprognostic (1.37e-1)" "unprognostic (1.90e-1)" "unprognostic (3.35e-1)" "unprognostic (1.52e-2)" "unprognostic (1.32e-2)" "unprognostic (2.79e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.27e-1)" "unprognostic (3.21e-2)" "unprognostic (1.25e-2)" "unprognostic (5.27e-2)" 9.8 8.7 8.0 9.2 7.6 3.7 8.1 7.2 13.8 10.7 14.9 6.0 12.0 21.4 7.0 21.9 20.5 6.1 9.6 43.1 9.3 5.8 19.1 38.9 6.8 9.0 8.1 7.2 6.4 14.5 9.0 3.7 10.4 9.2 8.4 6.2 5.3 46.4 15.0 51.7 13.9 21.1 4.3 5.7 13.4 15.7 28.2 4.8 12.0 8.8 18.4 13.7 6.6 10.2 4.9 1.8 8.6 1.9 1.8 7.6 1.9 18.8 6.8 3.3 6.0 3.2 2.7 5.4 10.0 5.3 9.4 6.2 9.2 10.6 7.5 11.6 4.5 6.2 14.1 2.6 5.8 3.5 8.9 9.1 5.6 7.3 9.2 8.1 5.3 5.7 5.2 4.6 9.9 2.8 4.7 5.0 4.9 8.2 4.5 3.1 6.9 5.9 6.3 3.0 4.9 30.3 7.4 5.5 21.6 7.6 5.0 7.8 8.2 8.0 25.3 17.0 1.8 9.0 3.7 8.4 10.1 7.1 11.0 8.1 10.0 7.6 7.8 9.7 8.0 3.0 2.9 1.9 8.6 2.6 1.0 1.5 4.9 3.2 2.5 1.3 1.9 1.9 1.5 2.7 1.8 1.8 1.8 7.6 1.9 8.0 7.6 7.2 13.8 9.3 5.8 8.1 7.2 9.2 4.8 0.0 2.7 4.5 8.0 0.0 9.0 20.5 5.1 0.0 2.3 7.0 0.0 16.1 33.2 22.4 50.8 7.5 50.3 0.0 21.2 17.4 2.9 9.5 0.0 25.1 14.5 22.3 5.8 12.3 5.7 124.6 11.2 3.0 0.0 19.8 18.5 16.0 34.5 10.5 9.2 13.5 6.2 12.9 2.0 9.4 5.3 0.0 16.4 6.9 21.5 7.5 CRABP2 CRABP-II ENSG00000143320 "Cellular retinoic acid binding protein 2" P29373 1 156699606-156705816 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 154.2;tongue: 80.5" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 286.6;Glandular cells: 140.0;Suprabasal keratinocytes: 166.6;Urothelial cells: 412.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 163.8;MCF7: 62.5;T-47d: 126.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004135 Supported Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA004135: AB_1846516" "unprognostic (1.17e-2)" "unprognostic (9.30e-2)" "unprognostic (3.07e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (1.75e-2)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" "unprognostic (6.45e-2)" "unprognostic (7.79e-2)" "unprognostic (7.23e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.19e-13)" "unprognostic (3.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" 4.9 1.1 1.0 1.7 3.2 0.7 16.8 1.3 2.1 66.8 1.3 1.2 38.5 0.0 13.9 2.8 154.2 13.1 2.8 1.2 0.9 2.1 1.4 0.2 0.7 0.4 0.8 2.9 5.9 0.8 2.7 5.0 7.0 3.7 6.7 0.7 7.9 10.6 28.0 0.5 25.7 0.9 8.8 1.1 0.8 0.5 1.1 0.9 2.1 2.2 80.5 33.5 10.0 66.6 0.1 0.0 0.4 0.0 0.0 1.3 0.5 10.4 0.5 12.0 0.1 15.6 23.4 0.0 22.2 163.8 1.8 2.2 18.6 38.6 0.1 11.0 23.6 0.2 13.6 2.9 0.0 0.5 0.2 0.8 0.0 1.4 0.1 3.1 0.0 0.2 7.4 1.1 2.6 0.0 1.4 0.0 0.2 0.1 0.2 0.2 62.5 0.1 0.1 14.4 1.2 5.9 0.1 0.0 0.3 0.2 0.4 29.8 2.1 0.3 38.7 0.1 23.5 126.9 0.0 0.0 0.4 6.8 3.7 1.3 1.0 2.2 0.1 3.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.2 0.0 0.1 1.3 1.2 0.4 0.0 0.0 0.0 0.0 0.5 1.0 3.2 1.3 2.1 0.9 2.1 0.8 2.9 3.7 0.9 0.0 1.6 0.0 100.3 57.8 1.7 0.6 0.0 4.0 10.3 15.7 2.0 42.7 0.0 12.0 2.0 4.3 0.4 0.0 4.5 5.4 286.6 140.0 0.0 0.0 8.9 0.0 0.0 10.4 0.0 0.7 18.4 1.0 59.1 0.0 0.5 0.8 11.9 0.0 35.3 0.0 0.5 0.0 22.7 1.4 6.6 166.6 15.1 2.9 0.6 412.9 CRADD RAIDD ENSG00000169372 "CASP2 and RIPK1 domain containing adaptor with death domain" P78560 12 93677375-93894840 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 112.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005337 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005337: AB_2085481" "unprognostic (1.07e-2)" "prognostic favorable (9.06e-5)" "unprognostic (9.65e-3)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (3.10e-1)" "unprognostic (3.79e-2)" "unprognostic (8.99e-2)" "unprognostic (1.54e-1)" "unprognostic (7.89e-2)" "unprognostic (6.06e-2)" "unprognostic (3.18e-2)" "prognostic favorable (4.04e-9)" "unprognostic (2.57e-2)" "unprognostic (6.86e-2)" "unprognostic (2.08e-1)" "unprognostic (3.02e-2)" 7.8 15.9 11.0 4.4 14.2 7.1 10.4 12.5 10.4 8.8 9.3 11.5 16.7 14.8 10.6 11.9 9.9 8.3 9.6 35.7 12.3 8.9 14.8 31.4 7.5 7.1 9.8 9.7 8.5 9.7 18.7 21.2 6.5 13.3 9.4 7.5 11.3 10.3 8.8 22.1 8.0 15.4 12.2 11.5 8.3 9.5 15.0 13.2 9.7 8.6 15.5 5.5 10.2 8.4 8.6 7.6 25.3 12.2 10.8 15.0 6.8 6.1 14.0 6.9 7.9 10.1 18.3 8.8 7.1 8.8 6.3 7.4 13.1 2.5 11.1 4.4 8.2 4.8 6.4 7.5 9.4 8.1 11.6 10.1 5.8 6.0 9.6 10.4 5.3 5.7 16.6 14.3 10.1 7.9 6.6 7.5 12.4 16.6 5.3 7.4 9.9 7.8 9.6 8.9 7.0 10.8 13.2 3.6 15.3 6.1 4.6 10.8 10.3 9.6 9.5 17.0 7.0 16.8 10.5 8.0 14.6 7.2 6.9 7.1 12.4 6.7 10.2 6.8 7.9 6.9 24.9 6.9 25.3 14.7 8.3 13.0 8.6 10.3 15.0 5.6 7.2 11.1 8.2 19.4 10.8 12.2 7.6 11.5 6.8 11.0 14.2 12.5 10.4 12.3 8.9 9.8 9.7 13.3 13.2 8.9 4.6 9.0 8.0 6.5 5.7 37.0 5.1 13.4 9.1 7.0 7.9 12.5 19.9 14.5 112.7 14.5 24.0 23.3 19.6 10.0 9.7 13.0 4.6 34.4 9.8 22.3 7.5 9.8 10.0 23.6 16.4 8.8 3.3 9.0 11.8 14.3 16.5 17.6 22.3 46.2 14.1 6.5 17.8 29.5 10.6 7.0 9.0 12.5 12.9 7.4 CRAMP1 "CRAMP1L, KIAA1426" ENSG00000007545 "Cramped chromatin regulator homolog 1" Q96RY5 16 1612325-1677908 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041752 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA041752: AB_10796459" "unprognostic (3.67e-1)" "unprognostic (9.97e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.41e-2)" "unprognostic (2.25e-3)" "unprognostic (5.78e-4)" "unprognostic (4.17e-2)" "unprognostic (8.53e-3)" "unprognostic (6.01e-2)" "unprognostic (1.55e-2)" "unprognostic (9.93e-2)" "unprognostic (3.86e-3)" "prognostic favorable (4.93e-4)" "unprognostic (8.57e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" 8.5 6.4 9.2 10.5 9.3 13.9 11.6 24.2 11.0 8.4 8.8 11.1 5.1 7.2 11.4 8.3 8.6 9.9 6.5 7.2 8.6 5.4 6.5 4.7 9.2 8.0 9.7 10.5 12.3 9.2 10.2 10.9 8.4 9.4 9.8 7.1 9.8 8.4 9.5 8.9 13.7 8.4 8.8 7.9 9.4 8.5 21.9 9.8 18.1 11.8 4.4 7.5 10.6 11.7 0.8 2.1 0.5 0.6 2.5 1.9 0.5 5.3 8.7 11.0 10.4 7.4 7.4 12.8 6.2 5.5 8.5 6.1 8.0 9.1 5.3 6.0 7.1 5.1 9.0 13.2 6.4 7.8 6.4 13.7 8.4 10.0 4.9 5.4 11.8 13.6 6.4 8.7 10.1 8.2 8.1 8.4 12.0 11.2 4.2 4.6 8.8 7.8 7.3 8.8 3.5 5.4 30.3 5.2 9.3 5.6 5.4 11.5 8.2 9.3 7.7 4.9 8.2 6.2 16.4 9.5 8.1 7.9 6.9 7.9 7.1 10.2 13.6 2.8 7.9 7.2 0.4 0.6 0.0 1.9 0.6 0.9 0.8 0.6 0.6 0.3 0.8 0.9 0.9 0.5 2.5 0.2 2.1 0.3 0.5 9.2 9.3 24.2 11.0 8.6 5.4 9.7 10.5 9.4 9.8 14.9 13.4 0.0 4.3 0.0 7.3 0.0 7.6 5.3 15.9 8.7 17.7 3.5 1.7 4.1 21.2 4.3 3.9 0.0 1.6 2.5 3.3 6.1 4.7 3.4 4.4 3.2 2.4 8.6 6.5 7.6 4.0 2.8 0.0 1.8 8.7 4.5 5.3 3.5 6.3 1.4 17.5 6.5 0.0 13.5 19.0 0.0 4.5 6.4 6.4 4.2 CREB3 "Luman, LZIP, sLZIP" ENSG00000107175 "CAMP responsive element binding protein 3" O43889 9 35732335-35737004 "Predicted membrane proteins, Transcription factors" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 350.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030978 Supported Cytosol NA NA Cytosol "HPA030978: AB_2673683" "unprognostic (1.73e-3)" "unprognostic (9.72e-2)" "unprognostic (9.32e-2)" "unprognostic (5.62e-3)" "unprognostic (3.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (4.29e-2)" "unprognostic (4.63e-2)" "prognostic favorable (5.40e-4)" "unprognostic (1.13e-1)" "unprognostic (1.65e-1)" "prognostic favorable (3.77e-5)" "unprognostic (1.48e-1)" "unprognostic (1.61e-1)" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" 15.7 25.1 23.7 12.0 27.6 5.6 19.4 18.5 30.2 25.4 20.3 17.6 28.2 12.8 20.9 22.5 15.0 23.9 25.2 16.3 19.4 21.3 21.3 42.3 15.9 15.3 23.1 17.1 20.2 26.3 22.1 23.1 19.5 17.3 32.9 16.7 17.4 31.7 37.6 12.6 9.9 14.6 26.0 19.6 13.0 20.5 23.0 14.0 9.1 24.4 9.4 14.9 22.0 17.6 17.7 19.4 14.8 16.9 15.9 21.8 15.7 12.3 11.5 12.1 9.1 25.6 16.7 8.0 22.5 36.1 24.1 25.0 12.8 6.0 4.4 9.9 32.9 26.7 4.8 7.8 18.6 15.9 16.5 6.5 3.4 10.2 5.8 32.6 5.7 6.8 14.6 15.3 23.4 22.9 19.7 14.7 8.5 4.9 7.5 24.7 6.1 5.8 2.0 7.6 9.0 15.1 6.5 5.3 5.6 19.4 6.0 5.7 7.8 9.0 8.0 5.3 10.3 12.2 2.4 15.7 16.0 9.0 11.5 13.8 4.3 5.3 5.3 16.7 2.0 17.3 14.8 16.9 6.3 19.2 16.0 20.7 17.7 16.8 21.8 17.9 12.3 13.7 13.4 7.7 15.9 12.8 19.4 18.5 15.7 23.7 27.6 18.5 30.2 19.4 21.3 23.1 17.1 17.3 14.0 26.8 16.2 9.0 41.3 31.8 28.3 10.1 38.2 41.5 27.3 15.7 11.8 41.9 28.2 83.0 124.3 32.4 52.9 0.0 61.5 45.7 42.8 65.2 31.2 20.3 32.9 4.8 25.3 19.0 14.8 350.3 27.9 22.7 47.2 58.7 42.1 33.3 62.6 30.3 39.6 55.4 13.8 32.3 53.6 60.7 24.6 19.8 51.0 26.6 24.2 39.6 CREBL2 ENSG00000111269 "CAMP responsive element binding protein like 2" O60519 12 12611827-12645108 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043738 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA043738: AB_10795041" "unprognostic (2.87e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (7.51e-2)" "unprognostic (7.38e-2)" "unprognostic (4.51e-1)" "unprognostic (1.44e-1)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (5.82e-3)" "unprognostic (6.73e-2)" "prognostic favorable (2.26e-5)" "unprognostic (6.31e-2)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.53e-1)" 21.9 77.6 24.3 16.5 31.9 3.0 18.9 21.4 24.6 16.4 13.4 14.6 13.5 13.2 11.4 17.5 10.4 14.9 16.4 14.3 19.8 23.0 28.7 28.2 18.5 18.8 20.2 19.8 22.6 14.2 31.7 31.5 13.8 19.7 17.1 14.2 20.5 15.4 14.4 6.6 14.1 13.3 12.0 20.0 20.2 14.1 17.1 18.3 8.6 25.9 6.7 16.6 17.7 14.0 2.0 4.2 3.6 8.7 1.6 8.1 2.2 5.5 7.2 6.3 7.1 22.3 22.6 12.2 10.9 18.4 8.0 11.1 5.2 8.1 4.8 4.2 13.2 12.2 4.7 9.5 8.3 13.7 26.8 5.7 3.8 7.2 6.3 14.6 5.3 7.1 14.6 15.0 9.4 15.5 27.5 11.7 3.8 3.8 7.6 13.5 8.9 2.8 4.4 18.9 5.3 6.6 3.8 10.9 3.0 15.4 16.1 7.4 8.5 11.0 5.4 19.0 28.5 3.0 6.1 9.4 11.1 7.1 10.9 10.7 6.4 8.5 1.2 13.2 4.6 11.4 1.7 3.8 3.6 2.8 8.7 5.0 1.5 5.5 4.4 4.2 2.0 5.5 4.5 0.7 1.6 3.6 2.1 8.1 2.2 24.3 31.9 21.4 24.6 19.8 23.0 20.2 19.8 19.7 18.3 23.8 21.6 14.3 16.0 19.7 16.9 12.3 22.9 16.0 12.5 31.4 2.0 14.7 34.9 16.6 23.6 20.4 18.6 0.0 19.2 14.9 18.4 35.5 10.3 38.9 36.4 35.0 28.8 22.7 83.1 5.0 33.4 54.7 32.1 45.9 18.1 28.7 18.7 10.5 33.2 48.0 11.0 38.8 9.1 30.0 17.4 25.5 23.0 15.3 15.1 19.2 CRELD1 AVSD2 ENSG00000163703 "Cysteine rich with EGF like domains 1" Q96HD1 3 9933822-9945413 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026964 Uncertain Approved Nucleoli,Cytosol "Intracellular and membrane" NA NA 16000000 Cytosol Nucleoli "HPA026964: AB_10602210" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (2.69e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.03e-1)" "unprognostic (3.59e-1)" "unprognostic (2.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.92e-2)" "unprognostic (4.59e-2)" "unprognostic (1.14e-2)" "unprognostic (6.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.89e-1)" "unprognostic (3.78e-2)" 21.8 22.9 31.6 15.3 32.4 7.3 27.3 52.2 45.1 9.9 22.4 12.0 17.1 12.5 15.1 17.8 13.1 20.1 15.8 50.2 25.6 24.9 16.6 23.5 15.8 11.0 17.2 30.7 19.7 15.2 21.9 32.4 15.1 27.2 25.4 11.4 10.0 19.4 32.2 24.4 11.6 13.1 19.5 19.4 11.9 14.8 11.1 22.3 5.9 45.7 7.4 8.2 17.8 15.6 10.5 13.7 11.5 12.5 13.4 14.3 10.4 2.8 5.2 8.5 4.4 14.4 9.4 47.1 10.4 3.1 2.6 4.9 5.0 8.5 3.4 22.9 7.2 12.1 1.8 4.1 7.5 1.8 6.7 3.9 3.1 6.7 11.8 28.8 1.1 12.0 9.6 13.9 6.4 5.9 31.4 11.8 5.2 3.7 4.1 2.5 6.8 2.0 8.4 2.3 11.6 3.5 2.1 1.2 8.1 11.0 4.9 3.4 11.0 4.8 4.5 9.3 11.7 11.5 6.8 8.2 5.0 8.1 6.6 2.5 4.7 6.0 6.3 11.1 3.5 5.3 11.5 11.4 9.4 14.2 11.6 14.3 8.9 10.5 13.7 8.2 10.5 14.2 12.7 1.8 13.4 12.5 13.7 8.0 10.4 31.6 32.4 52.2 45.1 25.6 24.9 17.2 30.7 27.2 22.3 17.9 13.7 10.7 19.5 8.7 20.8 34.7 33.1 8.1 7.9 15.7 15.7 20.0 6.6 17.7 5.8 15.0 14.7 0.0 3.9 9.2 21.7 31.7 20.7 11.5 18.5 30.2 25.9 16.0 7.8 7.9 29.7 10.2 11.8 19.0 14.9 21.0 8.8 15.0 24.8 8.2 15.0 25.8 14.1 49.7 11.9 10.8 18.5 12.1 14.1 16.3 CRIP1 CRIP ENSG00000213145 "Cysteine rich protein 1" P50238 14 105486317-105488947 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 1: 911.2;Ciliated cells: 2667.4;Club cells: 874.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 110.7;CAPAN-2: 61.7;HaCaT: 66.8;HDLM-2: 47.3;HeLa: 54.3;OE19: 188.5;T-47d: 86.8" "Low region specificity" "Detected in all" HPA042462 Approved Approved "Nuclear speckles,Plasma membrane,Centrosome,Cytosol" NA NA "Nuclear speckles, Cytosol" "Plasma membrane, Centrosome" "HPA042462: AB_10794277" "unprognostic (2.97e-3)" "unprognostic (1.27e-3)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.39e-1)" "unprognostic (2.93e-3)" "unprognostic (4.33e-1)" "unprognostic (3.33e-1)" "unprognostic (3.20e-2)" "unprognostic (2.60e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (3.26e-3)" "unprognostic (5.10e-2)" "unprognostic (2.66e-1)" "unprognostic (7.51e-3)" "unprognostic (2.14e-1)" 44.3 3.3 3.8 37.5 4.9 5.5 97.2 3.2 4.0 37.7 44.0 4.5 65.3 25.7 20.0 83.0 28.4 23.7 33.8 45.5 4.5 4.7 20.4 2.6 56.7 53.0 4.7 4.5 11.2 4.2 1.1 7.3 38.5 4.8 11.7 13.2 9.9 21.8 71.0 12.9 48.8 106.3 25.9 5.1 16.6 20.3 7.5 1.9 24.2 32.0 83.4 58.3 18.4 18.9 111.4 79.3 56.3 49.4 56.9 121.1 75.8 0.0 110.7 0.7 0.1 1.9 1.4 10.3 0.2 0.0 1.5 0.0 3.4 61.7 33.4 0.6 29.5 0.4 66.8 0.0 0.0 0.1 47.3 0.0 2.6 54.3 18.6 0.4 0.0 0.0 0.6 0.0 3.6 0.0 0.1 0.0 10.8 0.0 0.0 0.0 0.9 1.7 0.3 1.0 188.5 5.7 26.2 0.0 6.9 0.0 0.0 2.9 0.2 0.4 0.1 0.0 0.1 86.8 15.9 0.2 0.0 0.1 0.8 0.0 0.0 0.0 2.8 0.0 0.0 0.1 19.4 43.3 56.3 47.7 38.5 32.7 111.4 92.1 51.4 79.3 43.6 21.9 25.7 2.9 56.9 49.4 62.1 121.1 75.8 3.8 4.9 3.2 4.0 4.5 4.7 4.7 4.5 4.8 1.9 911.2 276.7 125.9 1.0 165.7 0.0 0.8 2.5 2667.4 874.7 48.8 0.0 0.5 1.7 9.2 2.8 10.9 494.0 0.0 2.8 3.1 16.3 0.4 486.4 0.8 53.8 0.0 73.6 27.0 188.7 20.7 23.3 296.9 350.9 697.9 172.6 0.2 20.6 407.1 8.9 2.2 0.0 219.9 30.1 0.1 10.4 219.9 1.3 239.7 156.7 2.6 CRKL ENSG00000099942 "CRK like proto-oncogene, adaptor protein" P46109 22 20917426-20953749 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000532, HPA001100" Uncertain Enhanced Nucleoplasm,Cytosol NA NA 1500000 Nucleoplasm Cytosol "HPA000532: AB_2666019, HPA001100: AB_1078569" "unprognostic (5.54e-2)" "unprognostic (2.66e-1)" "unprognostic (5.87e-2)" "unprognostic (2.40e-2)" "unprognostic (3.06e-2)" "unprognostic (1.59e-1)" "unprognostic (1.92e-2)" "unprognostic (6.51e-2)" "unprognostic (2.35e-2)" "unprognostic (4.60e-1)" "unprognostic (2.71e-1)" "unprognostic (5.99e-2)" "prognostic unfavorable (8.82e-6)" "unprognostic (8.40e-2)" "unprognostic (1.43e-1)" "unprognostic (9.52e-2)" "unprognostic (1.61e-2)" 16.4 15.2 25.0 18.1 24.1 41.9 18.4 34.0 31.7 17.8 19.9 26.4 12.3 20.2 18.9 12.8 25.2 19.9 13.6 22.6 22.6 23.8 16.4 24.9 19.0 21.3 24.6 26.1 26.9 21.7 22.2 17.9 25.1 20.7 18.8 18.7 16.7 14.5 19.1 48.1 22.7 19.1 18.6 23.6 19.6 14.3 12.6 19.8 35.7 16.6 17.8 24.7 17.7 24.6 11.7 14.8 19.2 21.5 11.0 19.7 16.8 11.5 6.9 15.6 12.2 10.5 6.8 16.8 7.8 9.6 12.1 13.7 11.4 5.2 14.8 6.3 8.2 8.3 14.8 18.2 12.5 14.4 12.5 17.8 20.5 7.5 12.5 10.5 21.8 10.5 6.8 16.6 10.5 18.0 9.9 10.6 12.0 89.5 12.2 9.7 10.8 12.7 10.2 12.2 12.0 7.5 16.5 24.7 3.5 8.0 10.1 10.1 12.9 13.1 11.6 9.5 19.5 9.9 12.2 8.5 19.2 21.9 7.2 9.8 11.8 11.3 17.3 14.2 9.3 11.7 13.4 13.0 19.2 17.5 12.5 18.9 11.6 15.8 17.5 14.8 11.7 19.7 18.4 14.1 11.0 21.5 7.4 12.8 16.8 25.0 24.1 34.0 31.7 22.6 23.8 24.6 26.1 20.7 19.8 8.9 16.2 15.6 11.6 48.1 16.8 20.3 10.2 10.7 10.3 5.2 13.7 17.3 1.7 6.8 20.7 14.3 12.4 23.3 7.3 32.0 16.2 13.4 1.1 21.2 15.0 17.5 19.5 18.4 13.7 43.2 14.1 11.1 23.6 10.8 21.5 16.0 9.1 8.6 14.5 8.4 12.7 12.9 11.1 11.6 11.3 52.8 22.8 10.0 14.5 17.4 CRLF3 "CREME9, CYTOR4" ENSG00000176390 "Cytokine receptor like factor 3" Q8IUI8 17 30769388-30824776 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 43.6" "Cell type enhanced" "Detected in many" 4 "T-cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007596 Enhanced Approved "Plasma membrane,Cytosol" NA NA 830000 "Plasma membrane, Cytosol" "HPA007596: AB_1847241" "unprognostic (1.02e-1)" "unprognostic (9.79e-2)" "unprognostic (7.12e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-1)" "unprognostic (1.55e-1)" "unprognostic (2.52e-2)" "unprognostic (9.22e-2)" "unprognostic (1.00e-2)" "unprognostic (3.10e-2)" "unprognostic (5.81e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.31e-7)" "unprognostic (3.35e-1)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (6.51e-2)" 8.7 4.8 8.8 22.7 8.3 16.7 7.3 12.4 9.4 6.9 7.0 5.9 3.9 5.5 6.3 3.6 15.4 6.1 7.0 5.8 7.5 6.6 5.3 5.4 9.7 28.6 6.6 9.3 5.8 5.5 5.1 6.9 12.3 7.3 6.6 7.4 4.4 7.5 3.9 3.8 10.7 11.3 6.1 8.7 22.0 5.9 9.6 6.7 26.7 5.7 4.5 27.8 10.3 9.3 15.9 13.9 43.6 21.8 12.9 35.7 25.2 6.2 6.9 4.3 9.0 7.9 6.2 6.5 5.9 5.8 11.5 12.1 9.2 4.3 20.9 8.9 7.3 11.2 11.0 7.3 4.9 13.9 9.8 13.4 8.8 6.1 6.0 4.4 11.5 6.5 3.7 6.9 9.3 7.9 4.5 11.2 18.8 22.1 22.2 7.2 3.8 25.5 12.7 8.6 10.5 4.6 11.3 14.0 12.3 7.6 5.3 3.1 7.3 6.3 9.5 6.5 9.5 7.2 5.8 5.9 6.7 8.3 10.8 14.4 9.3 7.7 14.0 6.4 9.5 7.4 15.5 18.8 43.6 13.0 19.2 13.7 15.9 18.3 14.6 13.9 14.9 35.7 26.4 38.3 12.9 21.8 7.2 20.1 25.2 8.8 8.3 12.4 9.4 7.5 6.6 6.6 9.3 7.3 6.7 0.0 8.4 28.2 5.7 20.0 17.5 3.7 2.5 9.4 3.4 7.0 13.7 16.5 5.0 4.9 13.2 9.0 6.3 0.0 4.6 15.0 7.1 4.7 22.0 3.0 15.6 6.4 3.5 6.2 19.7 16.0 6.1 21.7 5.0 16.2 2.9 3.5 6.7 3.5 3.9 3.7 22.3 12.9 8.2 10.9 22.3 24.3 38.3 45.7 3.5 7.0 CRMP1 "DPYSL1, DRP-1" ENSG00000072832 "Collapsin response mediator protein 1" Q14194 4 5748084-5893058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.1;pituitary gland: 23.0" "Group enriched" "Detected in some" 6 "Bipolar cells: 117.0;Horizontal cells: 198.6;Muller glia cells: 68.8" "Cancer enhanced" "Detected in all" "glioma: 37.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "naive B-cell: 2.5" "Lineage enriched" "Detected in single" 25 "B-cells: 2.5" "Cell line enhanced" "Detected in some" "AF22: 20.8;HAP1: 29.8;NTERA-2: 21.6;REH: 56.6;RH-30: 33.4;SCLC-21H: 43.3;SH-SY5Y: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035640, CAB037313" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "CAB037313: AB_1078571, HPA035640: AB_10670838" "unprognostic (1.56e-1)" "unprognostic (7.22e-2)" "unprognostic (5.14e-2)" "unprognostic (8.08e-3)" "unprognostic (2.80e-1)" "unprognostic (2.22e-1)" "unprognostic (1.84e-2)" "unprognostic (1.20e-1)" "unprognostic (2.79e-1)" "unprognostic (9.71e-2)" "prognostic favorable (4.54e-4)" "unprognostic (2.26e-1)" "unprognostic (8.52e-3)" "unprognostic (1.21e-2)" "unprognostic (2.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.60e-3)" 1.8 8.2 24.2 2.5 21.7 0.7 1.0 32.0 63.1 3.3 2.0 5.9 0.1 1.5 11.7 0.7 2.7 4.3 4.3 2.6 22.2 23.9 2.4 0.9 4.2 1.8 9.9 18.1 6.9 4.8 0.9 23.0 4.6 12.3 3.0 1.9 4.6 2.6 3.1 1.0 3.3 2.5 11.6 4.7 1.4 3.5 2.8 4.5 0.0 2.4 0.9 1.3 2.9 1.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 20.8 0.7 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 7.0 0.5 29.8 0.0 0.0 0.5 0.2 0.0 1.0 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 21.6 0.0 0.6 56.6 33.4 5.0 0.0 0.0 43.3 27.4 0.0 0.1 0.3 14.6 0.2 0.0 1.7 1.0 7.2 0.6 0.6 3.8 0.5 0.0 2.5 0.2 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 21.7 32.0 34.2 22.2 23.9 9.9 18.1 12.3 4.5 0.0 1.4 0.0 0.0 0.3 117.0 0.8 0.0 0.0 0.0 0.0 17.7 0.1 0.0 0.0 1.0 2.7 0.0 0.0 0.0 0.1 3.1 0.4 0.0 0.0 0.4 198.6 2.4 0.0 0.0 3.8 0.6 0.0 1.7 0.0 0.0 68.8 0.7 0.0 0.4 0.0 20.1 6.5 2.5 0.6 9.8 0.1 0.2 0.0 0.0 0.0 CRTAP "CASP, LEPREL3, P3H5" ENSG00000170275 "Cartilage associated protein" O75718 3 33113979-33147773 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 172.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 67.8" "Group enriched" "Detected in all" 5 "dendritic cells: 55.8;monocytes: 67.8" "Cell line enhanced" "Detected in many" "ASC diff: 122.6;ASC TERT1: 80.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043598, HPA044150" Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Secreted to blood" NA NA "Intermediate filaments, Actin filaments, Cytosol" "HPA043598: AB_10960991, HPA044150: AB_10959594" "unprognostic (5.29e-2)" "unprognostic (2.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.85e-3)" "unprognostic (7.36e-2)" "unprognostic (4.73e-3)" "unprognostic (4.28e-2)" "unprognostic (1.87e-1)" "unprognostic (9.97e-2)" "unprognostic (4.62e-2)" "unprognostic (3.70e-1)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-1)" "unprognostic (9.93e-2)" "unprognostic (1.28e-3)" 59.2 33.4 16.3 13.4 22.2 13.6 63.2 5.4 14.1 57.5 39.4 23.3 32.7 12.8 54.2 41.1 42.8 35.1 43.5 37.0 16.8 13.1 25.7 16.8 35.9 37.8 24.2 13.0 48.5 13.3 14.6 7.6 25.4 13.8 54.5 19.7 35.4 16.4 42.2 23.9 24.6 18.8 66.1 22.8 17.6 25.2 26.1 19.0 5.1 34.1 25.8 18.3 62.4 59.7 7.6 55.8 5.5 67.8 6.9 12.9 30.8 9.1 18.1 5.7 17.8 122.6 80.3 33.0 20.0 43.7 24.3 23.2 6.1 5.2 6.4 22.4 38.0 19.6 11.8 10.1 15.3 17.6 15.8 15.7 10.0 14.2 6.3 36.7 6.4 8.2 64.0 31.4 21.9 27.9 47.3 25.5 4.0 8.5 12.3 24.5 7.8 2.3 6.6 6.8 9.8 24.7 8.5 16.7 12.3 19.0 6.1 1.2 9.2 13.5 11.9 28.8 13.8 12.8 15.9 16.6 31.9 13.6 17.3 21.1 8.9 30.1 0.9 25.0 13.0 17.4 2.1 67.8 4.9 6.9 26.3 10.0 7.6 10.1 7.7 55.8 6.8 5.8 5.4 5.5 6.9 7.8 15.0 12.9 30.8 16.3 22.2 5.4 14.1 16.8 13.1 24.2 13.0 13.8 19.0 8.9 42.6 18.6 27.6 53.7 18.7 29.5 25.5 4.0 19.4 36.6 7.9 42.5 10.0 19.9 1.0 55.3 18.1 0.0 27.7 59.7 94.1 20.8 46.2 44.4 93.2 33.4 5.8 103.2 172.9 2.2 132.3 73.7 75.9 27.9 22.6 17.7 20.2 10.5 136.2 43.7 10.5 109.9 117.1 1.4 7.9 40.8 23.5 20.8 33.1 22.1 CRTC1 "FLJ14027, KIAA0616, MECT1, TORC1" ENSG00000105662 "CREB regulated transcription coactivator 1" Q6UUV9 19 18683677-18782333 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.7" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022035, HPA063619" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane, Cytosol" "HPA022035: AB_1847255, HPA063619: " "unprognostic (5.95e-3)" "unprognostic (2.57e-1)" "unprognostic (9.94e-2)" "unprognostic (8.62e-3)" "unprognostic (9.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.04e-1)" "unprognostic (5.57e-2)" "unprognostic (2.27e-1)" "unprognostic (6.68e-2)" "prognostic favorable (1.80e-5)" "unprognostic (3.37e-2)" "prognostic favorable (3.83e-5)" "unprognostic (6.83e-3)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (2.03e-2)" 8.6 7.7 26.0 7.4 38.8 3.2 3.8 40.7 30.1 5.0 4.4 6.5 4.3 6.5 6.8 5.6 3.1 10.5 5.5 5.6 17.7 7.8 6.6 4.5 5.7 6.3 6.4 18.1 6.7 10.0 8.4 11.3 6.4 6.0 7.0 2.6 5.1 8.8 9.4 12.4 5.5 6.2 4.3 4.8 8.1 8.0 7.5 10.2 1.9 7.4 1.1 3.7 4.6 3.5 4.1 3.8 1.8 3.4 1.1 3.0 1.3 4.4 8.1 5.9 9.4 5.5 4.6 16.7 4.9 3.3 4.7 4.5 5.4 5.8 6.2 10.4 4.6 3.3 4.8 1.8 3.0 1.1 2.7 14.1 5.2 7.2 8.9 5.3 7.1 14.6 7.5 2.9 4.0 1.2 6.2 2.6 6.4 4.1 5.7 2.6 16.1 4.6 8.1 7.6 2.3 11.9 7.3 2.6 6.8 2.9 7.9 10.8 9.7 5.5 5.2 5.8 2.0 5.8 4.3 4.7 5.3 8.2 9.7 5.6 3.8 3.0 4.1 6.2 7.7 4.0 1.5 3.4 1.8 1.7 1.3 1.8 2.3 2.7 3.0 3.0 4.1 2.3 1.8 1.7 1.1 1.9 3.8 1.8 1.3 26.0 38.8 40.7 30.1 17.7 7.8 6.4 18.1 6.0 10.2 0.0 4.0 4.2 9.5 2.4 24.9 14.0 5.1 2.7 2.3 17.4 25.5 8.5 10.0 3.6 0.7 4.5 5.1 0.0 5.3 2.1 5.4 3.0 2.3 3.4 7.8 41.3 18.4 1.3 5.4 1.7 8.6 3.7 3.3 1.8 6.9 8.9 2.6 8.6 4.6 4.3 14.1 0.0 8.2 2.9 7.2 1.8 8.7 5.1 4.8 2.5 CRTC3 FLJ21868 ENSG00000140577 "CREB regulated transcription coactivator 3" Q6UUV7 15 90529925-90645345 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 16.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043735, HPA063691" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043735: AB_10794286, HPA063691: AB_2685092" "unprognostic (7.60e-2)" "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.51e-1)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (6.48e-2)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (2.23e-1)" "unprognostic (5.22e-3)" "unprognostic (4.67e-2)" "unprognostic (9.32e-2)" "unprognostic (9.51e-2)" "unprognostic (2.30e-1)" 22.3 14.0 13.7 17.0 20.9 11.4 26.6 15.0 16.2 21.2 22.2 27.5 15.3 8.9 23.9 14.5 15.1 19.4 21.5 17.2 14.0 9.7 10.7 11.7 19.2 21.7 24.1 10.9 45.9 13.9 17.1 9.6 20.2 15.7 18.2 11.7 17.4 19.9 22.0 16.1 15.8 13.7 31.8 20.3 13.1 14.2 15.3 23.6 12.8 22.7 9.2 18.1 24.0 29.6 5.3 2.1 16.0 2.5 3.3 6.6 3.0 4.8 8.0 5.5 8.9 11.9 8.8 25.1 6.2 9.0 9.8 9.3 6.6 4.9 0.1 4.5 12.8 8.1 8.2 8.8 5.4 7.7 8.4 10.2 12.3 40.0 3.0 13.5 3.2 21.1 9.9 8.7 8.1 10.9 7.2 7.0 5.5 6.5 2.8 7.2 5.6 1.3 4.6 2.0 1.4 3.7 4.2 8.8 0.2 3.5 10.3 10.1 8.9 18.1 6.0 10.1 6.0 6.0 6.0 8.6 10.9 8.0 10.0 7.1 3.8 5.1 3.7 4.5 6.4 5.2 16.0 2.5 1.4 3.7 0.8 4.2 3.1 4.5 4.0 1.6 5.3 6.6 4.1 0.5 3.3 0.3 2.1 4.2 3.0 13.7 20.9 15.0 16.2 14.0 9.7 24.1 10.9 15.7 23.6 6.0 8.6 37.4 23.2 20.9 21.6 13.4 17.8 0.0 4.5 12.2 25.5 12.1 1.7 12.0 22.9 18.0 6.4 0.0 9.4 36.5 23.1 23.5 23.1 13.5 13.5 54.0 15.0 20.9 19.7 14.7 24.7 21.3 16.9 8.2 10.0 20.4 9.0 10.5 41.1 8.4 55.7 45.3 38.4 7.7 16.5 21.0 14.9 30.5 11.3 31.1 CRY2 ENSG00000121671 "Cryptochrome circadian regulator 2" Q49AN0 11 45847118-45883248 "Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 128.4;Horizontal cells: 95.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037577 Supported Supported "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA "Nuclear speckles" Cytosol "HPA037577: AB_10672497" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "prognostic unfavorable (1.67e-4)" "unprognostic (1.31e-2)" "unprognostic (9.16e-2)" "unprognostic (3.09e-2)" "prognostic favorable (6.82e-5)" "unprognostic (1.48e-3)" "unprognostic (1.67e-1)" "unprognostic (5.07e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.01e-1)" "prognostic favorable (6.44e-15)" "unprognostic (8.13e-3)" "unprognostic (1.89e-1)" "unprognostic (4.24e-2)" "unprognostic (2.24e-1)" 17.4 13.3 18.2 8.8 27.4 17.2 16.7 29.8 36.5 17.7 12.1 15.4 10.5 7.6 16.2 12.4 11.2 20.8 18.7 39.5 15.6 13.1 15.7 27.8 15.7 6.7 12.7 15.0 26.3 23.4 20.6 16.4 9.3 11.5 15.0 7.3 35.5 14.4 17.1 58.2 24.3 8.5 18.7 10.4 9.2 12.2 17.4 9.6 5.9 23.6 22.4 10.3 17.4 10.6 7.8 5.2 7.6 10.6 10.4 10.4 7.1 1.2 3.6 5.6 6.6 15.2 7.7 12.2 4.3 7.8 5.5 4.1 5.8 2.9 8.3 3.4 9.0 5.3 7.4 5.3 4.5 3.8 8.8 4.8 5.5 6.3 8.0 5.8 6.7 7.5 9.0 6.7 4.2 6.8 6.3 3.8 6.5 10.6 14.3 4.9 4.5 5.7 8.0 15.1 15.2 4.3 9.7 8.0 3.9 4.0 6.8 9.0 3.4 7.2 6.6 3.7 7.4 8.8 4.7 4.8 7.8 4.8 11.9 3.0 13.3 9.1 6.9 4.8 2.9 4.7 5.7 5.0 7.6 8.7 7.1 7.2 7.8 8.4 9.3 5.2 7.7 10.3 10.4 2.6 10.4 10.6 3.8 6.9 7.1 18.2 27.4 29.8 36.5 15.6 13.1 12.7 15.0 11.5 9.6 11.9 15.6 3.2 9.8 15.0 128.4 29.0 12.7 14.7 13.6 7.0 25.5 6.2 24.9 3.9 19.1 8.3 11.3 0.0 4.0 4.6 16.6 11.6 14.9 37.0 3.3 95.3 6.8 9.2 9.4 7.2 29.1 7.2 15.1 2.8 5.4 32.7 4.7 6.5 37.4 10.5 25.6 19.4 17.6 21.0 12.7 15.3 7.8 4.5 4.5 9.5 CRYAA "CRYA1, HSPB4" ENSG00000160202 "Crystallin alpha A" P02489 21 43169008-43172805 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Chaperone, Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 45.5" "Cell type enhanced" "Detected in single" 35 "Muller glia cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 140 "Hep G2: 28.9" "HPA037737, HPA038430" Supported Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA037737: AB_2675639, HPA038430: AB_2732478" "unprognostic (3.68e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYAA2 ENSG00000276076 "Crystallin alpha A2" 21 6560714-6564489 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "kidney: 34.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 200 "Hep G2: 28.9" "HPA037737, HPA038430" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA037737: AB_2675639, HPA038430: AB_2732478" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYAB "CRYA2, HSPB5" ENSG00000109846 "Crystallin alpha B" P02511 11 111908565-111923722 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Eye lens protein" "Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 743.1;skeletal muscle: 581.1" "Cell type enhanced" "Detected in many" 16 "Basal glandular cells: 1730.9;Cardiomyocytes: 6792.5;Proximal tubular cells: 5845.1" "Group enriched" "Detected in all" 6 "glioma: 426.4;renal cancer: 575.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 235.7;fHDF/TERT166: 76.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002053, CAB040560, HPA057100" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 12000 "Plasma membrane, Cytosol" "CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337" "unprognostic (1.06e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.90e-5)" "unprognostic (2.46e-2)" "unprognostic (3.02e-2)" "unprognostic (8.41e-3)" "unprognostic (9.29e-3)" "unprognostic (7.35e-2)" "unprognostic (8.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.68e-2)" "unprognostic (7.02e-2)" "unprognostic (3.68e-2)" "unprognostic (7.92e-2)" "unprognostic (8.83e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.70e-5)" 107.4 11.5 47.8 16.7 82.3 2.1 69.5 24.8 153.7 22.4 23.6 132.9 7.2 5.5 14.8 25.9 41.9 13.5 14.0 743.1 65.9 44.0 151.8 3.8 8.4 3.9 139.2 29.7 8.8 6.6 3.3 8.6 16.1 80.7 30.3 12.9 23.3 30.6 75.1 581.1 18.1 6.2 45.2 168.0 5.5 11.6 3.9 101.8 0.0 40.7 94.1 9.2 16.2 53.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.4 235.7 10.3 1.6 6.5 0.2 0.1 0.2 0.1 0.0 0.0 3.9 76.9 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 1.2 0.6 2.0 0.0 0.0 8.2 1.0 0.0 0.5 5.1 0.0 0.0 0.5 0.2 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.8 3.5 5.8 0.5 0.0 0.1 30.5 10.9 0.8 0.3 0.1 0.0 0.0 0.6 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 82.3 24.8 48.5 65.9 44.0 139.2 29.7 80.7 101.8 77.4 5.5 0.9 1730.9 155.3 11.4 6792.5 86.6 2.7 1.2 1270.1 17.7 2.9 573.6 165.7 20.3 23.3 0.0 0.0 10.0 5.8 309.0 1331.1 0.0 0.8 5.4 9.5 6.8 56.4 0.3 11.1 211.7 26.8 458.9 6.4 0.0 1097.1 19.7 0.0 176.4 5845.1 41.9 135.8 899.5 10.0 0.7 135.6 27.9 0.5 0.0 203.0 CRYBG1 "AIM1, ST4" ENSG00000112297 "Crystallin beta-gamma domain containing 1" Q9Y4K1 6 106360808-106571978 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.7;placenta: 96.6" "Group enriched" "Detected in many" 11 "Cytotrophoblasts: 184.0;Syncytiotrophoblasts: 501.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 9 "pons and medulla: 10.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.1;HBEC3-KT: 40.2;hTERT-HME1: 31.1" "Region enriched" "Detected in single" 5 "olfactory region: 5.1" "Low region specificity" "Detected in single" "CAB026378, HPA030948, HPA030949" Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671" "unprognostic (1.66e-1)" "unprognostic (3.44e-2)" "unprognostic (9.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.40e-1)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (3.69e-3)" "unprognostic (5.61e-2)" "unprognostic (8.97e-2)" "unprognostic (3.53e-2)" "unprognostic (8.89e-2)" "unprognostic (8.60e-2)" "unprognostic (3.25e-2)" 4.6 0.8 0.6 6.8 0.7 6.5 11.3 0.6 0.9 7.4 7.4 1.6 2.5 7.6 1.5 10.8 61.7 2.0 2.0 0.9 1.1 0.6 9.8 3.6 4.0 5.6 0.7 0.7 2.0 5.5 5.0 0.9 96.6 10.3 12.6 5.9 16.0 10.2 4.3 0.8 16.6 7.6 4.4 0.8 6.5 2.5 1.8 0.5 2.3 1.8 24.6 35.8 11.5 13.1 6.8 8.7 3.1 4.4 5.7 10.9 3.9 10.6 0.0 0.0 0.0 9.0 32.1 3.3 1.5 11.8 3.4 3.2 0.7 3.8 16.7 0.7 7.3 4.8 17.2 0.1 40.2 1.7 22.7 0.7 0.0 0.5 5.2 4.2 10.1 0.0 16.0 23.5 6.5 31.1 0.0 14.7 13.2 0.5 2.4 9.2 1.2 2.9 4.0 0.1 0.0 7.1 5.0 0.1 0.1 5.4 25.3 0.7 0.0 6.5 11.1 0.1 1.0 5.5 7.7 4.2 3.9 0.5 0.0 10.6 1.8 1.4 18.2 18.4 12.8 8.3 0.3 3.8 0.4 8.1 4.4 10.9 6.8 10.5 8.9 8.7 3.8 6.7 6.3 3.1 5.7 4.4 1.0 9.9 3.9 0.6 0.7 0.6 0.9 1.1 0.6 0.7 0.7 10.3 0.5 11.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 23.9 31.4 0.0 184.0 3.3 8.8 0.0 0.0 0.0 0.0 10.8 7.2 0.0 0.0 1.1 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 16.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 501.8 0.0 0.0 0.0 CRYGA "CRY-g-A, CRYG1, CRYG5" ENSG00000168582 "Crystallin gamma A" P11844 2 208160740-208163576 "Predicted intracellular proteins" "Eye lens protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-138 MG: 1.3" "Not detected" "Not detected" HPA043386 Supported Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.49e-1)" 0.1 0.0 1.0 0.1 1.8 0.0 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.1 0.1 0.9 1.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 0.1 1.5 0.9 1.1 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGB CRYG2 ENSG00000182187 "Crystallin gamma B" P07316 2 208142573-208146168 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "ovarian cancer: 1.1;testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.1;NTERA-2: 2.8;SuSa: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA043386 Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (6.73e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.5 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGC CRYG3 ENSG00000163254 "Crystallin gamma C" P07315 2 208128137-208129830 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 5.4" "Group enriched" "Detected in some" 4 "Early spermatids: 1.6;Late spermatids: 2.9;Spermatocytes: 1.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8;ovarian cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;CACO-2: 1.0;EFO-21: 2.0;U-2 OS: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA043386 Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.89e-1)" "unprognostic (2.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 CRYGD CRYG4 ENSG00000118231 "Crystallin gamma D" P07320 2 208121607-208124501 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "ovary: 17.7" "Group enriched" "Detected in some" 8 "Early spermatids: 10.1;Muller glia cells: 30.9" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "HEL: 15.4" "Not detected" "Not detected" "HPA041269, HPA043386" Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA041269: AB_2732491, HPA043386: " "unprognostic (4.49e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" 0.2 0.2 4.2 0.2 2.0 2.3 0.2 0.0 2.5 0.2 0.2 0.3 0.0 0.4 0.2 0.2 0.3 0.3 0.2 0.6 2.1 4.3 0.2 0.2 0.2 0.2 4.0 1.6 17.7 0.2 0.2 0.4 0.5 1.9 2.0 0.2 2.1 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.2 0.5 1.4 0.5 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.2 2.0 0.0 2.5 2.1 4.3 4.0 1.6 1.9 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 CRYGS CRYG8 ENSG00000213139 "Crystallin gamma S" P22914 3 186538441-186546702 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 15.1;cervix, uterine: 21.8" "Cell type enhanced" "Detected in some" 5 "Rod photoreceptor cells: 3.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035103, HPA063539" Supported Uncertain Cytosol NA NA Cytosol "HPA035103: AB_10696367, HPA063539: " "unprognostic (5.52e-4)" "unprognostic (1.29e-3)" "unprognostic (1.44e-2)" "unprognostic (5.45e-2)" "unprognostic (4.90e-2)" "unprognostic (5.85e-2)" "unprognostic (4.79e-2)" "unprognostic (1.73e-2)" "unprognostic (4.76e-2)" "unprognostic (1.12e-1)" "unprognostic (5.84e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.72e-9)" "unprognostic (1.10e-1)" "unprognostic (9.53e-2)" "unprognostic (3.67e-1)" "prognostic favorable (2.73e-4)" 1.6 1.9 3.6 1.8 2.7 4.0 3.4 15.1 3.3 21.8 1.8 3.5 1.6 1.7 2.7 3.8 1.6 1.3 1.6 1.6 4.1 4.1 2.2 1.8 2.6 4.2 4.2 1.6 2.2 1.8 1.9 1.6 1.6 3.0 1.6 3.7 5.8 1.8 2.9 1.6 3.0 1.8 2.3 3.2 3.6 2.4 1.8 1.6 6.0 1.6 3.2 3.3 1.6 1.6 0.3 0.6 0.2 0.2 0.0 2.1 0.1 1.0 2.0 3.7 3.1 3.6 5.6 0.5 0.5 1.2 1.3 2.5 0.4 1.5 3.8 4.1 2.7 1.6 3.2 1.7 2.8 5.5 3.2 4.9 5.0 1.4 1.9 1.4 2.9 3.4 5.9 3.8 1.2 2.1 5.4 4.2 4.2 1.0 2.2 3.0 1.2 2.6 1.5 0.2 1.7 1.6 4.3 0.8 1.8 1.5 2.3 1.7 1.6 2.6 2.5 1.0 3.0 2.0 1.7 4.5 1.4 1.1 1.6 2.7 4.6 2.3 5.3 1.9 1.9 2.7 0.0 0.2 0.0 1.4 0.0 2.1 0.3 1.9 0.8 0.4 0.1 0.2 0.4 0.2 0.0 0.0 0.6 0.2 0.1 3.6 2.7 15.1 3.3 4.1 4.1 4.2 1.6 3.0 1.6 0.0 1.7 0.5 0.2 0.2 1.0 2.2 2.5 0.0 1.2 0.0 2.0 0.1 0.0 0.4 0.1 0.7 0.4 0.0 0.2 0.1 0.5 0.2 1.1 1.1 0.3 1.6 0.0 1.8 0.0 1.0 0.3 1.6 0.0 0.0 0.9 0.5 0.3 0.0 0.7 0.0 3.0 0.0 0.6 1.4 0.7 0.1 0.2 1.3 1.0 0.1 CRYM DFNA40 ENSG00000103316 "Crystallin mu" Q14894 16 21238874-21303083 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.7;brain: 61.3;heart muscle: 45.9" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 521.3" "Cancer enhanced" "Detected in many" "prostate cancer: 14.6" "Region enhanced" "Detected in many" "basal ganglia: 61.3" "Cell type enriched" "Detected in single" 26 "plasmacytoid DC: 23.7" "Lineage enriched" "Detected in single" 26 "dendritic cells: 23.7" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 31.2" "Group enriched" "Detected in many" 12 "amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0" "Low region specificity" "Detected in all" "HPA019086, HPA030619" Enhanced Supported Cytosol NA NA 110000 Cytosol "HPA019086: AB_1847260, HPA030619: AB_2673551" "unprognostic (1.32e-1)" "unprognostic (2.93e-3)" "unprognostic (8.96e-2)" "unprognostic (1.44e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.88e-1)" "unprognostic (5.75e-3)" "unprognostic (2.81e-1)" "unprognostic (7.37e-2)" "unprognostic (2.05e-2)" "unprognostic (5.95e-2)" "unprognostic (2.11e-3)" "unprognostic (7.79e-3)" "unprognostic (2.49e-2)" "unprognostic (1.87e-3)" "unprognostic (1.31e-1)" 1.4 0.5 7.6 0.5 61.3 0.5 1.0 15.6 21.2 1.8 2.2 0.0 0.0 0.7 0.8 0.3 2.3 0.5 2.3 45.9 6.5 2.1 17.8 4.2 2.7 0.5 1.0 15.5 0.5 0.8 0.6 3.3 0.3 0.1 10.5 2.6 1.0 4.8 0.3 4.0 1.4 1.0 2.0 0.9 0.5 0.6 1.6 1.2 0.0 0.5 0.0 1.5 8.3 0.8 0.9 23.7 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.6 0.2 1.6 0.0 0.0 0.0 0.4 7.2 0.0 0.7 0.0 0.0 0.7 0.3 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.3 3.2 0.5 0.1 0.0 0.0 0.2 31.2 0.0 1.2 1.7 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.2 0.2 2.7 0.0 0.0 0.0 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.3 7.6 61.3 15.6 20.7 6.5 2.1 1.0 15.5 0.1 1.2 0.0 15.3 1.5 24.8 2.1 5.8 124.1 5.1 20.1 22.7 14.0 3.9 0.0 14.9 0.1 17.0 1.0 5.3 0.0 0.0 0.0 2.2 17.1 1.1 6.0 0.1 1.6 12.6 0.6 0.0 9.6 0.0 0.9 32.1 1.0 19.3 521.3 0.2 0.0 0.0 111.6 17.7 0.0 1.0 4.4 6.3 1.1 0.1 0.0 7.9 58.9 CRYZ ENSG00000116791 "Crystallin zeta" Q08257 1 74705482-74733408 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 100.0;liver: 79.8" "Cell type enhanced" "Detected in many" 12 "Collecting duct cells: 151.8;Distal tubular cells: 192.3;Hepatocytes: 184.9;Proximal tubular cells: 384.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 98.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021921, HPA023290" Approved Supported Cytosol NA NA 7200000 Cytosol "HPA021921: AB_1847262, HPA023290: AB_1847263" "unprognostic (3.64e-2)" "unprognostic (3.38e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.32e-3)" "unprognostic (5.79e-2)" "unprognostic (6.29e-2)" "unprognostic (1.04e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-1)" "unprognostic (6.38e-3)" "unprognostic (2.19e-1)" "unprognostic (1.35e-3)" "unprognostic (3.12e-1)" "unprognostic (7.50e-2)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" 6.0 13.4 7.5 4.6 5.4 0.2 8.8 4.2 5.9 19.8 12.6 3.9 27.1 11.3 11.9 29.1 9.7 11.5 15.7 10.4 6.0 9.0 100.0 79.8 7.1 4.8 6.5 3.5 9.4 26.1 13.2 17.2 3.7 11.1 13.8 4.9 9.4 5.9 21.9 5.6 5.6 19.8 14.1 6.8 5.4 9.5 4.9 5.9 7.1 17.1 7.9 5.8 14.8 15.8 18.2 8.9 4.7 8.6 14.4 21.7 9.0 2.5 24.8 12.8 3.6 14.8 16.2 8.7 8.0 12.7 11.6 13.1 19.4 10.3 13.9 14.1 15.5 20.4 6.9 10.4 10.1 19.0 16.0 4.2 5.8 7.7 38.8 7.8 4.9 11.9 7.5 9.0 18.6 3.4 10.9 9.7 7.7 18.2 5.0 24.2 5.8 8.9 8.3 9.6 20.2 16.2 5.7 12.1 5.1 98.3 7.9 3.5 6.3 1.8 13.5 8.7 15.0 12.1 1.6 4.7 2.8 7.0 8.7 12.0 3.6 6.9 6.8 22.8 1.9 7.9 4.7 5.2 0.9 18.2 7.7 14.7 18.2 17.9 16.7 8.9 13.7 15.7 16.7 0.8 14.4 8.6 7.5 21.7 9.0 7.5 5.4 4.2 5.9 6.0 9.0 6.5 3.5 11.1 5.9 26.8 16.9 14.3 23.5 15.9 2.5 25.7 89.2 16.0 12.5 151.8 2.0 12.7 192.3 42.4 0.3 8.0 12.3 0.0 28.1 14.2 21.7 10.3 13.9 184.9 15.3 0.0 6.4 11.6 12.5 1.1 19.2 10.6 10.1 10.0 13.2 6.8 30.1 9.1 19.4 384.2 2.6 0.0 15.9 1.4 6.8 18.4 6.1 15.2 13.3 12.7 CRYZL1 "4P11, QOH-1" ENSG00000205758 "Crystallin zeta like 1" O95825 21 33589341-33643926 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019120, HPA029399, CAB034129" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865" "unprognostic (1.54e-1)" "unprognostic (4.69e-2)" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.55e-1)" "unprognostic (9.19e-2)" "unprognostic (2.73e-1)" "unprognostic (2.57e-3)" "unprognostic (2.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-2)" "unprognostic (8.16e-3)" "unprognostic (1.59e-1)" "unprognostic (1.28e-3)" 18.9 17.6 32.6 14.1 27.6 18.4 19.4 36.6 32.4 20.5 21.5 24.8 13.2 13.4 26.9 18.0 17.6 17.2 15.1 17.9 26.4 23.0 21.6 16.0 14.5 14.7 30.8 19.4 20.4 13.6 18.5 27.7 19.3 25.2 17.3 18.8 17.2 15.2 21.7 15.5 20.9 13.3 19.8 29.9 13.2 15.6 28.9 27.0 18.2 22.6 9.7 13.4 20.8 15.6 27.5 30.7 24.8 26.1 31.5 33.8 18.2 20.9 9.3 26.6 19.6 14.4 20.9 13.5 15.0 21.6 19.2 17.3 13.6 16.7 14.8 13.6 18.3 14.9 11.7 14.0 15.4 17.6 13.7 14.7 27.2 19.9 12.3 22.7 17.1 17.4 19.6 13.6 20.3 15.9 25.4 24.1 24.4 20.1 15.4 17.9 10.7 16.5 17.7 18.6 21.7 12.6 15.9 21.3 20.4 27.1 18.9 11.6 18.3 19.7 9.9 21.4 23.3 19.7 12.7 25.4 15.6 14.9 12.8 11.6 25.3 34.8 16.1 20.3 12.8 17.3 21.7 25.2 24.8 24.2 26.1 25.9 26.5 25.9 22.5 30.7 27.5 33.8 27.4 14.4 31.5 23.7 24.2 20.3 18.2 32.6 27.6 36.6 32.4 26.4 23.0 30.8 19.4 25.2 27.0 29.8 15.9 13.6 40.2 20.9 45.3 22.7 35.7 21.4 19.4 29.6 29.5 59.3 41.4 31.7 56.7 31.7 21.2 0.0 25.5 34.3 29.6 18.4 62.5 10.9 28.8 44.5 20.2 20.3 22.2 20.6 40.9 28.3 35.4 34.3 18.6 41.5 22.8 28.1 38.5 36.3 49.0 19.4 44.3 79.9 15.5 18.7 37.3 25.5 29.9 33.3 CSDC2 PIPPin ENSG00000172346 "Cold shock domain containing C2" Q9Y534 22 41560763-41577741 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 84.8;ovary: 48.5" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 64.6;Muller glia cells: 39.5;Proximal tubular cells: 29.3;Sertoli cells: 71.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HeLa: 8.1;U-2 OS: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003073, HPA076549" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003073: AB_1078578, HPA076549: AB_2686807" "unprognostic (9.42e-2)" "unprognostic (5.52e-2)" "unprognostic (3.66e-3)" "unprognostic (1.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.52e-1)" "unprognostic (3.93e-2)" "unprognostic (1.60e-1)" "unprognostic (2.70e-3)" "unprognostic (2.35e-2)" "unprognostic (1.93e-1)" "unprognostic (3.72e-1)" "prognostic favorable (6.42e-4)" "unprognostic (8.86e-3)" "unprognostic (6.08e-2)" "unprognostic (1.02e-1)" "unprognostic (9.09e-3)" 2.5 39.0 4.7 2.1 9.6 1.1 1.2 30.5 15.3 16.8 2.6 2.7 5.5 1.6 18.4 2.0 2.2 4.1 2.6 84.8 6.0 8.5 9.9 1.2 2.8 1.1 9.0 6.0 48.5 25.5 1.1 4.1 1.3 17.7 5.3 1.4 5.6 1.4 11.7 1.5 1.1 1.5 9.1 10.5 1.2 1.6 11.1 3.4 0.0 1.1 0.3 1.0 5.8 6.2 1.0 1.0 1.7 1.1 0.4 1.6 0.7 0.0 0.1 1.0 0.1 0.0 0.0 0.1 2.3 0.1 0.0 0.0 0.6 0.0 0.0 0.3 3.1 0.3 0.1 0.0 0.0 0.0 0.0 2.1 0.0 8.1 0.9 2.4 0.0 0.0 1.3 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.7 0.1 0.0 0.0 0.1 0.7 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.1 29.6 0.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 1.0 1.0 1.7 1.3 1.1 0.5 1.0 0.8 0.7 1.0 1.0 1.5 0.7 1.0 0.4 0.9 0.2 1.6 0.7 4.7 9.6 30.5 14.7 6.0 8.5 9.0 6.0 17.7 3.4 0.0 0.0 0.0 0.2 0.2 8.1 64.6 0.0 1.4 0.0 7.0 2.0 0.1 16.6 0.3 1.1 0.1 0.0 0.0 9.2 0.1 1.9 0.1 0.0 0.0 0.2 6.4 0.0 0.6 0.0 3.6 4.9 0.0 1.7 0.0 0.0 39.5 2.3 0.0 2.5 29.3 3.1 71.1 22.6 0.2 0.2 0.1 0.2 0.0 0.0 0.0 CSDE1 "D1S155E, UNR" ENSG00000009307 "Cold shock domain containing E1" O75534 1 114716913-114758676 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 266.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 226.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018846, HPA052221" Supported Enhanced "Plasma membrane,Cytosol" NA NA 13000 "Plasma membrane, Cytosol" "HPA018846: AB_1847266, HPA052221: AB_2681767" "unprognostic (2.84e-1)" "unprognostic (9.18e-3)" "unprognostic (4.86e-3)" "unprognostic (3.30e-3)" "unprognostic (2.83e-2)" "unprognostic (4.51e-2)" "unprognostic (5.32e-3)" "unprognostic (5.16e-2)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (2.40e-1)" "unprognostic (4.69e-2)" "unprognostic (4.67e-2)" "unprognostic (1.18e-1)" "unprognostic (5.17e-3)" "unprognostic (2.54e-2)" 71.2 31.4 33.5 25.8 33.2 37.9 42.1 29.6 35.4 39.0 64.7 29.6 35.9 29.5 46.4 38.9 58.8 30.3 29.4 64.2 33.2 31.7 37.4 39.5 34.2 31.4 41.6 31.4 43.9 37.2 50.3 38.4 38.8 44.4 52.6 32.9 32.0 43.2 42.0 266.5 33.8 46.5 88.3 42.4 32.2 39.9 41.5 35.1 39.6 55.7 73.9 31.9 75.4 45.5 43.9 59.0 57.9 65.2 48.1 62.3 80.5 61.7 21.8 38.8 38.7 44.3 57.6 54.3 54.6 40.8 36.8 29.9 31.9 18.7 48.7 46.1 52.0 21.5 26.3 43.0 42.4 53.7 59.5 29.4 47.8 39.7 28.2 39.2 35.5 28.5 41.8 46.2 44.0 58.1 50.0 42.0 41.2 48.4 32.0 44.9 226.5 47.5 22.7 73.9 26.0 29.4 35.6 120.2 22.9 29.2 48.7 48.0 31.8 53.4 44.6 41.3 42.8 22.9 56.7 50.6 43.5 60.0 57.0 59.9 48.9 53.2 54.6 56.2 40.3 132.6 46.4 57.7 57.9 40.9 60.8 55.5 43.9 52.2 49.7 59.0 34.7 62.3 52.3 40.9 48.1 65.2 23.0 56.7 80.5 33.5 33.2 29.6 35.4 33.2 31.7 41.6 31.4 44.4 35.1 184.6 166.5 131.5 180.2 192.1 123.0 534.2 132.5 139.2 159.3 122.1 55.0 150.1 192.3 174.5 301.0 172.2 163.0 93.5 175.1 175.9 149.1 211.7 211.6 144.5 141.9 93.8 210.9 124.6 242.4 459.7 149.8 180.0 209.2 170.5 206.0 141.9 193.9 122.8 212.2 179.3 91.0 161.7 255.2 219.6 163.8 204.6 228.3 138.0 172.8 220.6 CSE1L "CAS, CSE1, XPO2" ENSG00000124207 "Chromosome segregation 1 like" P55060 20 49046246-49096960 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 153.6;Spermatogonia: 127.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002140, HPA038059, HPA038060" Enhanced Enhanced Nucleoplasm,Cytosol No No 64000 Nucleoplasm Cytosol "CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812" "unprognostic (4.01e-2)" "unprognostic (3.15e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.91e-5)" "unprognostic (4.86e-1)" "unprognostic (4.91e-2)" "prognostic unfavorable (2.42e-8)" "unprognostic (3.44e-2)" "unprognostic (1.45e-2)" "unprognostic (2.63e-2)" "unprognostic (2.72e-3)" "unprognostic (2.54e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (2.59e-1)" "unprognostic (4.84e-1)" "unprognostic (5.71e-1)" "prognostic unfavorable (6.91e-4)" 15.7 18.9 19.5 18.7 23.7 13.7 21.2 24.9 31.3 17.5 14.2 13.4 14.0 12.0 19.5 15.5 25.5 17.3 11.8 17.8 20.0 17.7 18.8 18.7 12.8 24.0 27.3 19.4 18.7 17.3 23.2 16.8 23.1 24.2 16.7 18.4 8.4 15.5 17.0 34.3 20.9 12.4 21.7 31.3 12.6 17.1 50.9 21.0 27.0 14.7 28.1 25.3 18.3 17.5 12.8 14.8 9.4 15.9 16.8 18.0 12.8 36.2 25.2 30.9 23.7 12.0 15.5 33.4 28.6 15.2 90.0 38.2 82.4 29.3 37.1 38.4 18.1 36.5 42.0 45.3 53.7 86.0 6.0 22.0 25.7 29.7 39.9 7.3 28.3 14.2 8.6 20.2 44.0 25.5 12.4 29.7 20.7 36.3 14.7 33.7 12.4 34.1 14.6 25.9 30.3 37.6 21.7 50.8 28.9 19.8 25.3 27.2 15.8 45.7 49.5 16.2 24.5 41.3 18.5 19.1 48.0 40.3 28.2 40.5 8.6 20.8 34.8 28.6 22.9 25.5 9.4 11.8 2.7 11.0 15.2 16.5 12.8 16.8 13.4 14.8 10.4 18.0 15.3 3.3 16.8 15.9 6.6 14.4 12.8 19.5 23.7 24.9 31.3 20.0 17.7 27.3 19.4 24.2 21.0 6.0 23.2 18.2 20.7 26.9 14.3 23.5 35.7 21.4 18.2 26.2 9.8 56.3 11.6 28.2 61.2 21.5 7.8 0.0 23.0 50.5 21.6 15.7 4.6 23.2 26.0 14.3 5.2 20.9 15.1 39.7 23.6 19.3 25.3 29.7 9.1 21.8 23.6 10.5 29.7 17.0 11.9 38.8 19.1 153.6 127.3 30.2 60.8 16.6 18.2 20.0 CSGALNACT1 "ChGn, CSGalNAcT-1, FLJ11264" ENSG00000147408 "Chondroitin sulfate N-acetylgalactosaminyltransferase 1" Q8TDX6 8 19404161-19758029 "Enzymes, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 57.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 41.5;Endothelial cells: 33.7;Glandular cells: 33.6" "Cancer enhanced" "Detected in all" "prostate cancer: 22.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 20.1;granulocytes: 10.3;T-cells: 25.5" "Cell line enhanced" "Detected in some" "A549: 29.0;BJ hTERT+: 16.3;GAMG: 11.7;RPTEC TERT1: 20.3;U-2197: 18.5;U-87 MG: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068462 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "HPA068462: " "unprognostic (8.90e-2)" "unprognostic (1.57e-2)" "unprognostic (4.66e-2)" "unprognostic (2.58e-1)" "unprognostic (6.03e-2)" "unprognostic (3.17e-3)" "unprognostic (9.78e-2)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-2)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (1.22e-2)" "unprognostic (1.89e-1)" "unprognostic (2.38e-2)" "unprognostic (1.46e-3)" "unprognostic (1.02e-2)" 13.8 8.7 22.7 6.0 15.4 6.8 7.2 3.8 21.4 13.0 3.8 9.2 4.0 2.8 7.1 5.9 21.2 8.7 10.8 23.8 17.7 8.2 5.3 2.3 7.9 10.5 9.1 18.7 38.6 10.9 4.2 5.9 25.1 7.0 21.7 2.1 2.6 5.8 7.3 3.9 4.2 4.2 17.2 8.6 6.3 5.4 2.7 10.3 4.0 57.7 4.5 6.1 18.9 9.7 20.1 1.7 10.3 1.2 3.2 25.5 4.8 0.7 29.0 0.2 0.0 4.8 1.1 3.7 0.6 16.3 0.1 0.1 1.4 0.3 0.0 0.0 0.0 11.7 0.3 0.0 0.0 0.1 3.6 0.2 0.0 8.3 0.7 2.1 0.0 0.0 0.4 0.7 0.1 0.1 0.0 5.5 0.0 0.0 0.0 0.0 1.2 1.1 0.1 0.0 3.6 0.9 0.1 0.0 0.0 20.3 0.7 0.1 0.1 8.5 3.4 1.1 0.6 0.0 0.0 0.3 0.4 0.4 18.5 0.2 0.1 0.0 0.0 13.4 1.6 5.6 0.0 1.2 10.3 2.5 0.0 0.3 20.1 11.5 3.9 1.1 6.2 20.6 5.2 7.1 3.2 0.1 1.7 25.5 4.8 22.7 15.4 3.8 21.4 17.7 8.2 9.1 18.7 7.0 10.3 3.0 1.4 8.2 8.2 3.9 0.4 41.5 0.0 2.7 1.2 12.2 9.8 1.4 1.7 3.7 5.5 33.7 0.0 0.0 1.5 13.5 20.0 33.6 0.0 0.0 12.0 17.5 2.9 20.3 21.2 5.9 4.9 5.1 11.8 0.0 0.0 0.9 3.0 0.0 11.3 0.0 1.0 6.5 7.2 0.1 0.0 2.8 7.0 2.2 0.0 2.1 CSK ENSG00000103653 "C-terminal Src kinase" P41240 15 74782057-74803198 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.2" "Cell type enhanced" "Detected in many" 6 "B-cells: 91.8;Kupffer cells: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011203, HPA026488, HPA028425" Approved Approved Enhanced Vesicles,Cytosol No No 1500000 "Vesicles, Cytosol" "CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899" "unprognostic (1.05e-1)" "prognostic favorable (5.14e-5)" "unprognostic (2.59e-3)" "prognostic favorable (8.22e-4)" "unprognostic (4.15e-2)" "unprognostic (4.11e-2)" "unprognostic (1.87e-1)" "unprognostic (2.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-1)" "unprognostic (4.12e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.74e-4)" "prognostic favorable (1.07e-4)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "unprognostic (6.29e-2)" 9.3 8.0 9.5 39.3 11.0 19.9 12.6 18.7 13.4 12.1 13.5 11.8 7.3 16.1 13.9 6.4 33.3 10.6 11.2 14.0 9.8 8.5 8.0 20.9 15.6 67.2 11.1 7.4 10.5 6.7 6.6 10.4 8.8 12.2 9.8 8.9 9.8 13.2 7.0 8.7 14.9 26.2 8.5 10.9 62.7 13.1 8.1 10.6 62.7 8.1 9.5 47.4 17.4 13.2 35.6 22.8 49.6 46.8 16.3 30.7 19.9 12.9 18.3 9.0 14.7 8.6 6.6 7.7 8.7 8.4 16.6 11.8 16.7 12.0 58.0 11.5 7.8 15.4 13.5 18.8 17.5 4.7 28.1 23.2 49.1 6.7 16.7 11.9 25.6 62.6 9.3 8.7 11.8 10.6 8.3 12.5 27.4 14.1 20.2 9.8 21.9 18.4 15.1 11.1 11.7 13.1 20.5 7.7 42.3 7.6 28.8 14.9 10.3 11.3 23.7 15.1 6.0 16.3 37.8 10.8 20.1 10.6 15.7 15.0 10.8 21.8 59.2 10.4 49.0 13.6 20.7 19.7 49.6 23.4 42.4 20.0 29.4 20.3 23.1 22.8 35.6 15.7 18.4 39.1 16.3 46.8 13.2 30.7 19.9 9.5 11.0 18.7 13.4 9.8 8.5 11.1 7.4 12.2 10.6 3.0 11.6 91.8 7.2 8.2 16.5 8.1 12.7 5.3 6.8 8.7 5.9 6.3 1.7 8.5 10.0 11.5 27.7 0.0 12.0 11.0 7.6 9.3 25.5 25.0 46.4 27.0 9.1 12.3 77.9 2.1 8.3 44.5 8.5 36.9 25.3 6.5 15.2 17.3 7.8 6.8 4.1 6.5 8.5 3.8 11.3 8.0 4.7 60.9 22.8 10.5 CSNK1A1 "CK1, CK1a, CK1alpha, CKIa, CKIalpha" ENSG00000113712 "Casein kinase 1 alpha 1" P48729 5 149492197-149551552 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 741.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016680, HPA051334" Uncertain Approved Cytosol NA NA Cytosol "CAB016680: AB_1614518, HPA051334: AB_2681446" "unprognostic (4.27e-3)" "unprognostic (5.85e-3)" "prognostic favorable (1.15e-4)" "unprognostic (7.39e-2)" "unprognostic (2.66e-1)" "unprognostic (3.14e-1)" "unprognostic (1.27e-2)" "unprognostic (5.56e-2)" "unprognostic (4.38e-1)" "unprognostic (8.31e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (5.47e-2)" "unprognostic (1.56e-1)" "unprognostic (7.92e-2)" "unprognostic (4.41e-2)" "unprognostic (6.28e-3)" "unprognostic (6.92e-2)" 33.5 35.8 26.0 26.9 35.2 71.0 40.2 32.0 39.3 33.8 38.2 28.2 40.5 23.2 41.0 29.4 66.1 31.8 36.0 45.7 24.4 26.1 24.0 30.1 37.5 27.3 28.0 29.8 31.7 23.9 46.9 30.9 28.7 38.0 38.1 31.4 25.5 38.5 39.3 51.4 48.4 31.8 45.8 33.9 23.6 34.2 28.6 24.1 38.6 32.0 53.1 41.1 45.0 40.0 28.6 40.6 47.4 39.6 34.2 41.9 40.8 36.9 24.7 41.6 39.4 43.0 52.7 44.5 52.8 50.2 41.2 43.4 48.1 50.1 19.7 58.5 56.1 44.2 37.8 29.3 71.1 63.0 28.5 17.7 26.7 28.6 22.1 38.7 41.8 43.0 43.1 73.8 46.2 74.5 45.6 47.4 35.6 22.5 29.7 46.4 23.2 38.3 16.9 21.8 40.9 60.2 28.7 33.0 22.4 28.7 64.4 32.1 28.9 39.2 52.6 64.3 38.5 49.3 36.4 47.0 48.5 25.5 32.1 50.3 27.6 35.4 30.4 45.3 30.4 58.6 47.4 36.6 35.4 29.0 38.7 33.1 28.6 36.7 32.9 40.6 23.4 39.9 34.0 31.1 34.2 39.6 24.2 41.9 40.8 26.0 35.2 32.0 39.3 24.4 26.1 28.0 29.8 38.0 24.1 137.0 158.5 75.9 513.8 608.0 132.0 46.4 73.9 278.4 290.0 109.9 60.9 146.8 77.9 135.8 55.7 139.6 98.3 23.3 160.7 185.9 198.0 381.5 112.3 94.7 120.9 143.0 124.9 225.9 143.6 66.9 96.4 139.7 145.1 118.2 136.8 145.0 155.3 98.2 105.0 78.9 100.0 155.2 201.9 125.6 93.5 741.0 293.5 102.2 111.1 404.2 CSNK1A1L MGC33182 ENSG00000180138 "Casein kinase 1 alpha 1 like" Q8N752 13 37103259-37105664 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 10.5;testis: 9.0" "Group enriched" "Detected in some" 8 "Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 40 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 42 "granulocytes: 10.5" "Not detected" "Not detected" HPA051334 Uncertain Cytosol NA NA Cytosol "HPA051334: AB_2681446" "unprognostic (1.23e-2)" "unprognostic (1.59e-1)" "unprognostic (3.19e-2)" "unprognostic (3.54e-2)" "unprognostic (2.40e-2)" "unprognostic (5.40e-2)" "unprognostic (8.90e-2)" "unprognostic (3.47e-1)" "unprognostic (1.47e-3)" "unprognostic (4.50e-1)" "unprognostic (2.02e-1)" "unprognostic (2.28e-3)" "unprognostic (3.45e-1)" "unprognostic (2.38e-1)" 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.0 0.0 0.0 0.0 0.0 0.1 0.2 10.5 0.2 0.1 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 10.5 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.0 1.5 1.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.1 0.5 0.0 0.0 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 1.8 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.4 1.1 2.4 0.2 0.0 0.0 1.0 CSNK1E "CKIE, CKIepsilon, HCKIE" ENSG00000213923 "Casein kinase 1 epsilon" P49674 22 38290691-38318084 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 208.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB009626, HPA026288" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009626: AB_2084517, HPA026288: AB_1847276" "unprognostic (2.32e-1)" "unprognostic (8.41e-2)" "unprognostic (5.14e-2)" "unprognostic (5.01e-3)" "unprognostic (1.95e-2)" "unprognostic (4.50e-3)" "prognostic unfavorable (8.20e-5)" "unprognostic (2.08e-3)" "unprognostic (3.69e-1)" "unprognostic (1.22e-1)" "unprognostic (9.63e-2)" "unprognostic (4.16e-3)" "prognostic unfavorable (4.67e-6)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "unprognostic (2.58e-1)" "unprognostic (3.25e-3)" 28.5 22.9 30.7 18.3 32.5 21.4 28.6 40.1 42.6 26.4 21.5 32.3 15.7 19.0 37.3 27.3 23.4 28.0 22.1 28.8 31.7 22.3 17.3 11.8 28.4 17.3 28.6 30.1 38.1 25.4 56.2 29.2 33.1 28.7 26.2 17.4 30.5 23.9 23.1 26.3 35.3 17.1 24.0 23.2 20.9 21.8 13.0 33.9 13.3 21.4 14.2 17.4 25.5 28.8 3.7 15.7 4.8 1.8 5.9 4.0 1.2 23.6 11.5 31.3 30.0 15.7 24.1 23.6 30.9 39.5 28.1 27.3 14.8 18.5 17.8 13.5 29.1 18.9 20.2 23.7 42.7 20.4 28.4 51.7 5.7 38.1 11.3 32.3 12.4 15.2 23.0 36.2 42.8 58.0 36.9 29.8 15.6 12.6 36.8 27.1 15.8 17.3 15.3 22.9 17.2 16.7 32.4 22.4 27.9 25.8 19.9 46.4 18.2 26.3 27.3 30.8 19.4 13.9 18.1 33.9 25.5 27.8 14.7 24.6 16.5 23.6 25.1 37.8 14.0 42.6 3.8 1.8 3.4 3.4 0.8 4.0 2.5 3.8 3.4 1.8 3.7 2.1 3.1 4.8 5.9 0.6 15.7 1.7 1.2 30.7 32.5 40.1 38.8 31.7 22.3 28.6 30.1 28.7 33.9 35.7 17.1 22.2 117.4 69.8 122.3 44.0 38.2 16.0 23.9 22.7 56.9 29.6 6.6 26.6 42.8 62.1 10.7 0.0 35.7 33.5 53.2 138.6 3.5 18.6 19.2 68.3 60.3 44.8 14.9 42.7 79.1 18.5 57.3 11.8 40.8 105.4 42.3 29.6 62.2 4.1 58.4 71.1 106.1 6.0 9.6 91.6 104.9 13.4 31.9 208.0 CSNK1G1 CK1gamma1 ENSG00000169118 "Casein kinase 1 gamma 1" Q9HCP0 15 64165517-64356259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 121.0;Late spermatids: 209.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018209 Supported Cytosol NA NA Cytosol "HPA018209: AB_1847278" "unprognostic (9.10e-2)" "unprognostic (8.09e-2)" "unprognostic (1.20e-1)" "unprognostic (2.65e-2)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.02e-1)" "unprognostic (8.63e-2)" "unprognostic (3.75e-2)" "unprognostic (7.51e-2)" "unprognostic (8.16e-3)" "unprognostic (1.31e-1)" "unprognostic (2.59e-2)" "unprognostic (2.41e-1)" 7.2 7.8 10.2 11.9 15.1 11.6 8.7 12.2 10.6 8.7 7.4 7.6 11.6 7.0 11.1 9.9 15.7 10.8 7.8 5.6 8.9 7.6 8.6 6.0 8.4 9.6 6.6 4.7 8.5 8.8 10.4 16.1 7.2 7.2 6.8 7.9 10.1 8.2 14.5 6.5 10.4 6.8 11.1 5.3 8.2 6.8 41.3 7.3 11.8 11.5 5.6 11.2 8.3 10.6 4.1 4.1 8.8 5.1 5.3 8.0 2.4 5.1 10.9 7.9 10.2 6.8 9.3 7.2 6.4 6.6 10.9 9.8 8.7 10.1 8.1 3.5 10.1 11.4 11.9 20.6 12.9 12.8 15.4 5.3 7.6 8.7 5.8 7.8 14.0 9.0 8.2 17.2 11.1 15.9 9.5 11.9 8.4 9.2 8.5 9.8 7.1 7.1 4.4 7.4 6.8 5.7 12.0 9.9 6.5 8.8 20.8 12.8 7.8 8.4 5.1 7.4 13.6 8.9 5.5 12.8 9.9 11.9 7.9 7.9 9.8 18.9 6.9 9.2 10.3 6.1 0.9 3.6 5.6 5.7 5.1 8.0 3.6 5.1 4.1 2.7 4.1 5.1 4.7 8.8 5.3 4.3 4.1 3.9 2.4 10.2 15.1 12.2 10.6 8.9 7.6 6.6 4.7 7.2 7.3 26.8 9.9 7.1 8.7 10.3 44.6 6.5 5.1 16.0 13.6 5.2 64.8 5.8 1.7 8.2 121.0 8.4 8.4 0.0 6.1 7.4 8.9 7.9 3.5 4.0 9.4 9.5 21.9 9.2 9.7 209.9 5.8 10.3 6.8 10.0 10.0 6.9 9.1 7.0 9.6 8.7 29.5 6.5 8.5 27.2 18.4 13.7 3.4 7.7 10.3 10.1 CST6 ENSG00000175315 "Cystatin E/M" Q15828 11 66011841-66013505 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 124.5" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 86.4;Ciliated cells: 56.2;Collecting duct cells: 55.8;Pancreatic endocrine cells: 216.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 171.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A-431: 26.8;CAPAN-2: 74.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB019316, HPA044963" Enhanced Approved "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 110000000 "Plasma membrane" Cytosol "CAB019316: , HPA044963: AB_2679158" "unprognostic (3.01e-2)" "unprognostic (5.10e-2)" "unprognostic (1.14e-1)" "unprognostic (3.59e-2)" "unprognostic (5.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (5.02e-1)" "unprognostic (8.89e-3)" "unprognostic (1.29e-3)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (5.89e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-2)" "unprognostic (2.59e-2)" 0.6 0.2 0.1 1.5 0.1 0.2 8.7 0.4 0.2 5.5 0.2 0.0 1.4 0.1 0.3 0.8 11.3 4.3 0.7 2.4 0.1 0.2 1.0 0.1 27.2 1.2 0.1 0.0 1.3 0.2 0.5 0.4 26.5 0.2 0.9 0.1 1.1 1.3 26.5 0.7 124.5 0.2 0.2 0.2 0.2 0.2 1.0 0.0 2.8 14.6 13.6 4.4 0.5 3.7 0.4 0.9 0.0 1.6 0.0 0.2 0.7 26.8 0.0 0.0 0.1 0.0 0.0 8.0 0.2 0.0 0.0 0.0 0.1 74.8 0.0 0.4 0.9 0.0 0.9 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 7.5 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.7 0.1 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.2 0.0 86.4 6.7 0.0 1.2 1.0 0.0 1.0 0.0 56.2 26.1 55.8 0.0 5.9 0.0 14.5 0.1 0.1 0.0 0.0 19.3 11.2 1.9 1.4 21.8 0.0 43.3 0.0 0.0 0.0 0.3 0.5 0.0 6.5 5.0 1.8 0.0 0.8 216.2 0.0 0.4 0.2 0.0 0.0 0.4 1.4 16.7 24.1 53.7 0.0 0.0 5.4 CSTA "STF1, STFA" ENSG00000121552 "Cystatin A" P01040 3 122325244-122341972 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 312.4;tongue: 421.9" "Cell type enhanced" "Detected in many" 16 "Kupffer cells: 712.6;monocytes: 1063.2;Syncytiotrophoblasts: 279.5" "Cancer enhanced" "Detected in all" "head and neck cancer: 405.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 20 "classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6" "Group enriched" "Detected in many" 193 "dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 33.8;hTCEpi: 149.9;THP-1: 93.6;U-698: 59.6;U-937: 29.8" "CAB000469, HPA001031, CAB047315" Enhanced Approved Nucleoplasm,Cytosol No No 39000000 "Nucleoplasm, Cytosol" "CAB000469: , CAB047315: , HPA001031: AB_1078610" "unprognostic (5.22e-3)" "unprognostic (6.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.07e-2)" "unprognostic (7.79e-3)" "prognostic favorable (5.86e-4)" "unprognostic (4.46e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (7.99e-2)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (8.89e-2)" "unprognostic (3.43e-2)" "unprognostic (9.24e-3)" "unprognostic (1.99e-1)" 2.0 0.2 0.3 4.4 0.8 19.8 4.5 0.2 0.5 55.4 0.4 0.2 1.1 0.0 4.7 1.7 312.4 0.2 0.7 1.0 0.3 0.0 0.4 3.4 6.8 4.8 1.1 0.2 1.8 0.2 0.0 0.3 1.3 0.5 1.3 0.1 0.3 57.4 0.7 0.7 28.2 0.3 0.4 0.7 2.0 2.2 0.3 0.6 2.2 0.3 421.9 99.0 1.5 93.5 0.1 54.6 36.0 74.6 0.2 0.2 32.0 1.7 0.1 0.0 0.4 3.9 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.7 0.0 10.5 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.8 0.8 13.6 0.2 3.8 149.9 0.3 14.7 0.0 0.0 0.1 0.1 3.6 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.8 0.0 0.0 1.6 0.9 1.2 0.0 0.1 93.6 0.0 0.2 2.4 0.0 0.1 0.0 0.2 59.6 3.2 29.8 0.0 0.7 74.6 2.2 0.0 37.5 0.2 0.1 0.1 0.1 54.6 0.0 0.0 0.1 36.0 0.2 21.6 1.0 0.1 32.0 0.3 0.8 0.2 0.5 0.3 0.0 1.1 0.2 0.5 0.6 6.0 27.0 9.0 93.6 74.1 0.0 0.0 2.5 30.8 34.2 0.0 0.0 203.1 0.0 2.0 0.2 3.5 1.3 0.0 19.8 10.9 5.6 14.2 12.8 90.0 136.3 0.0 0.0 8.0 712.6 0.6 9.5 248.7 8.5 1063.2 0.5 0.0 27.6 1.1 3.5 0.5 0.0 32.3 4.2 0.1 0.1 179.2 279.5 4.3 0.8 83.6 CSTB "CST6, EPM1, PME, STFB" ENSG00000160213 "Cystatin B" P04080 21 43772511-43776445 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8" "Cell type enhanced" "Detected in all" 7 "Hofbauer cells: 2667.6;Urothelial cells: 2153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 68.7;RT4: 87.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017380, CAB047320, HPA058557" Enhanced Supported Nucleoli,Cytosol NA NA 6100000 Cytosol Nucleoli "CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755" "unprognostic (1.69e-1)" "unprognostic (3.35e-1)" "unprognostic (2.09e-1)" "unprognostic (3.05e-2)" "unprognostic (3.05e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (6.66e-5)" "unprognostic (1.90e-1)" "unprognostic (1.32e-1)" "unprognostic (2.14e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (3.63e-1)" "unprognostic (4.88e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" 21.1 7.5 5.6 6.1 5.9 3.2 13.6 3.0 5.3 57.8 8.8 4.4 3.9 5.6 6.1 6.4 365.3 6.0 7.2 6.5 4.6 5.0 9.6 17.3 17.2 11.2 5.3 4.9 7.8 5.0 3.2 7.6 5.2 5.8 7.1 7.2 7.8 65.2 6.2 4.8 9.4 7.5 6.3 5.1 7.4 10.4 4.1 4.1 8.6 11.6 138.8 130.6 14.0 81.5 11.4 43.2 25.4 69.1 7.7 22.3 21.3 55.9 16.9 5.6 7.1 29.8 24.5 13.9 12.1 14.1 7.7 7.6 13.0 31.4 4.5 9.4 18.8 68.7 10.0 12.9 13.5 4.8 18.8 15.3 12.6 13.0 15.0 26.7 3.1 10.6 26.0 14.1 21.0 10.5 14.4 10.6 4.3 9.3 25.0 11.2 14.1 3.9 9.7 13.5 37.6 29.2 6.5 3.1 51.3 22.0 87.3 5.3 4.8 15.9 8.5 34.0 2.8 7.9 7.8 16.3 12.7 6.6 11.9 7.6 6.1 10.8 8.4 55.4 14.7 8.9 16.8 28.2 16.9 14.5 45.9 13.3 11.4 18.6 15.0 43.2 9.7 13.2 13.0 25.4 7.7 69.1 5.3 22.3 21.3 5.6 5.9 3.0 5.3 4.6 5.0 5.3 4.9 5.8 4.1 163.8 245.7 187.7 333.5 342.3 67.2 88.0 305.8 447.0 218.4 394.3 33.4 255.6 455.9 484.2 8.1 312.8 471.8 23.3 431.0 773.3 255.1 459.8 223.9 313.1 2667.6 63.5 229.7 229.6 443.8 23.5 353.0 857.1 447.1 1223.7 177.1 98.3 684.5 378.7 310.4 313.1 54.5 116.4 179.2 37.0 105.4 520.9 336.5 191.8 261.7 2153.8 CTBP2 ribeye ENSG00000175029 "C-terminal binding protein 2" P56545 10 124984317-125161170 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023559, HPA023564, CAB031916, HPA044971, CAB079018" Approved Approved Approved Cytosol NA NA Cytosol "CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: AB_2679161" "unprognostic (8.69e-2)" "unprognostic (1.27e-2)" "unprognostic (4.14e-2)" "unprognostic (1.41e-2)" "unprognostic (6.84e-3)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (5.60e-3)" "unprognostic (1.46e-1)" "unprognostic (2.12e-1)" "unprognostic (3.24e-2)" "unprognostic (3.99e-3)" "prognostic favorable (1.70e-4)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.62e-1)" 13.9 13.1 14.5 9.6 16.3 9.0 29.8 23.5 11.8 31.1 20.9 22.5 17.8 19.8 29.0 21.2 16.3 23.3 17.4 10.9 16.1 12.3 15.4 3.1 17.3 6.5 19.2 11.8 24.1 24.5 12.9 13.6 14.9 15.6 22.9 17.9 28.6 19.9 18.5 11.4 8.6 19.4 23.7 15.1 12.1 19.9 14.5 16.8 3.1 43.3 11.6 6.1 16.7 23.8 0.3 6.5 15.4 11.6 19.7 5.3 2.6 25.2 28.7 25.4 21.1 13.6 13.5 14.0 19.8 23.1 18.7 21.3 17.8 29.9 0.0 10.2 19.8 11.8 20.0 25.2 31.7 14.1 0.1 19.1 18.6 18.9 0.4 28.6 7.8 14.9 11.5 25.2 19.3 38.6 24.8 23.7 1.5 0.7 0.1 11.6 28.1 0.8 8.0 19.1 26.4 18.4 22.5 10.6 0.2 22.0 11.5 7.8 22.3 19.2 16.9 25.4 20.6 11.9 13.0 19.1 11.3 14.3 16.1 16.9 0.4 1.5 0.0 14.1 0.1 11.1 15.4 5.1 9.2 5.3 5.0 0.6 0.3 0.2 1.4 6.5 0.2 0.3 2.3 8.5 19.7 11.6 5.5 0.1 2.6 14.5 16.3 23.5 11.8 16.1 12.3 19.2 11.8 15.6 16.8 29.8 25.6 10.4 75.3 41.9 161.2 28.5 48.4 85.6 56.9 36.6 149.2 17.7 58.0 61.2 23.4 58.3 50.5 0.0 53.0 54.5 41.8 75.6 16.3 1.0 26.4 101.7 52.8 64.4 53.8 28.9 55.8 44.0 55.6 46.9 71.1 60.5 66.1 43.2 73.2 31.8 100.9 58.2 65.1 9.1 33.4 34.8 16.1 21.8 82.1 78.5 CTBS CTB ENSG00000117151 Chitobiase Q01459 1 84549606-84574480 "Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 6 "basal ganglia: 7.6" "CAB017043, HPA023594, HPA048810" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 380000000 Cytosol "CAB017043: , HPA023594: AB_1847311, HPA048810: " "unprognostic (7.76e-2)" "unprognostic (1.28e-2)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (9.36e-2)" "unprognostic (3.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.76e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (9.23e-2)" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.08e-2)" "unprognostic (4.89e-2)" "unprognostic (3.12e-1)" "unprognostic (4.04e-2)" 6.4 6.9 4.0 8.8 4.4 9.7 15.3 4.4 3.5 5.3 5.8 3.3 8.1 3.7 6.2 16.4 4.8 5.2 8.0 13.1 4.5 4.4 10.4 22.3 15.6 28.1 5.8 2.3 5.1 15.0 6.5 10.4 6.9 8.1 8.1 5.1 4.7 18.5 12.5 4.3 8.4 7.2 6.7 10.0 12.6 6.1 3.5 4.4 5.5 5.9 4.9 5.1 5.5 5.2 0.8 0.4 3.2 1.6 0.7 0.6 0.2 1.8 0.6 0.4 0.4 5.6 6.7 1.4 1.3 4.5 0.6 1.7 0.2 2.2 2.4 0.5 2.8 0.7 0.8 0.1 1.7 1.9 2.2 0.6 1.5 0.3 0.3 3.4 1.6 0.8 4.9 3.3 1.6 2.5 4.0 1.9 1.0 1.4 4.4 1.3 0.1 1.0 1.8 0.4 0.4 0.6 0.5 0.7 1.6 4.0 0.9 0.3 0.8 0.5 1.8 2.1 1.1 1.0 1.7 2.9 2.3 0.2 3.1 1.4 1.3 0.4 0.7 1.6 2.2 1.6 1.8 0.8 1.5 0.2 0.9 0.4 0.5 0.4 0.3 0.4 0.8 0.3 0.6 3.2 0.7 1.6 0.4 0.4 0.2 4.0 4.4 4.4 3.5 4.5 4.4 5.8 2.3 8.1 4.4 8.9 16.0 29.6 25.9 27.0 5.8 5.1 30.6 26.8 20.5 22.7 39.3 20.5 36.5 15.7 2.6 28.2 17.1 0.0 16.9 19.2 19.6 41.9 43.8 58.7 42.5 3.2 22.2 45.4 70.4 3.0 19.5 43.1 6.8 23.4 21.5 19.9 17.2 21.0 23.0 38.3 40.1 12.9 14.4 7.5 9.8 21.7 21.4 17.5 16.9 25.3 CTC1 "AAF132, C17orf68, FLJ22170" ENSG00000178971 "CST telomere replication complex component 1" Q2NKJ3 17 8224821-8248095 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052436 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052436: " "unprognostic (6.47e-2)" "unprognostic (1.06e-2)" "unprognostic (6.16e-3)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.20e-3)" "unprognostic (3.96e-1)" "unprognostic (2.07e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "prognostic favorable (6.49e-5)" "unprognostic (2.89e-3)" "unprognostic (3.24e-1)" "unprognostic (5.76e-2)" "unprognostic (1.47e-1)" "unprognostic (1.77e-2)" "unprognostic (1.66e-2)" 9.9 10.0 9.9 15.2 12.2 18.0 12.2 28.5 15.3 10.3 11.3 12.4 8.7 8.9 15.6 12.7 8.2 10.5 10.7 7.0 6.8 7.5 11.8 14.4 13.8 24.1 9.7 7.4 14.5 14.5 12.2 18.5 7.9 9.2 11.2 12.2 11.5 11.0 12.2 5.0 15.5 15.7 13.4 7.4 25.0 9.9 8.8 10.6 32.9 12.5 4.0 23.0 9.1 10.6 6.1 4.6 5.1 2.4 2.7 6.3 2.0 2.5 5.6 5.2 4.9 16.4 3.9 6.5 3.0 3.2 4.3 2.9 4.3 7.6 9.2 3.0 5.1 3.1 8.6 6.1 4.4 2.7 6.7 5.9 4.5 5.4 5.5 2.8 1.4 14.2 3.9 4.9 5.6 7.7 8.5 7.6 13.4 4.3 3.1 3.0 3.3 15.6 6.2 4.3 8.3 1.4 7.4 2.0 5.9 10.9 5.9 4.6 5.3 5.8 7.6 5.0 10.2 4.6 4.3 10.0 1.4 3.2 3.2 3.4 6.5 3.8 6.1 2.6 5.5 3.9 3.6 1.6 2.4 4.7 1.9 4.4 5.0 4.5 4.1 1.5 6.1 6.3 5.8 5.1 2.7 2.4 4.6 3.5 2.0 9.9 12.2 28.5 15.3 6.8 7.5 9.7 7.4 9.2 10.6 0.0 12.0 11.5 2.6 1.6 5.9 3.9 5.1 2.7 3.4 5.2 35.3 5.2 1.7 3.0 2.7 3.1 3.3 0.0 3.3 3.5 2.5 3.2 5.8 8.1 3.3 1.6 6.4 3.7 9.7 4.3 4.0 3.2 0.0 6.4 5.5 2.3 4.5 5.3 2.1 1.5 17.7 0.0 2.8 4.3 4.4 1.8 9.3 7.0 3.2 3.3 CTCFL "BORIS, CT27, dJ579F20.2" ENSG00000124092 "CCCTC-binding factor like" Q8NI51 20 57495966-57525652 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 114.6" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 33 "HMC-1: 33.3;K-562: 45.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA001472 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA001472: AB_1078583" "unprognostic (2.50e-1)" "unprognostic (4.01e-2)" "unprognostic (7.70e-2)" "unprognostic (1.85e-5)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-2)" "unprognostic (5.26e-3)" "unprognostic (3.60e-1)" "unprognostic (2.20e-1)" "unprognostic (9.00e-2)" "unprognostic (4.16e-2)" "unprognostic (4.75e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.84e-2)" 0.2 0.1 0.1 0.1 0.4 1.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.3 0.1 0.1 0.1 0.4 0.0 0.5 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.1 35.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.1 1.0 4.3 0.8 0.8 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 1.2 0.1 0.1 0.2 1.8 0.7 1.2 0.6 0.7 0.5 1.3 0.4 0.5 0.3 2.1 0.7 0.8 4.3 0.8 0.8 1.0 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.4 18.5 114.6 0.0 0.0 0.0 0.0 0.1 CTIF KIAA0427 ENSG00000134030 "Cap binding complex dependent translation initiation factor" O43310 18 48539046-48863217 "Predicted intracellular proteins, Transporters" "Nonsense-mediated mRNA decay, Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 32.8;Bipolar cells: 29.8;Peritubular cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016865, HPA024801" Uncertain Supported Cytosol NA NA Cytosol "HPA016865: AB_1852311, HPA024801: AB_1852312" "unprognostic (5.84e-2)" "unprognostic (5.86e-2)" "unprognostic (2.27e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (1.44e-1)" "unprognostic (8.86e-2)" "unprognostic (1.95e-3)" "unprognostic (2.77e-3)" "unprognostic (1.35e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-1)" "unprognostic (2.34e-3)" "unprognostic (7.33e-3)" 40.7 15.7 17.3 8.0 21.9 5.2 18.2 28.8 34.5 10.3 12.8 12.4 6.2 6.6 12.3 7.2 19.2 8.5 16.7 18.1 17.2 23.4 9.1 12.7 12.8 4.1 19.7 24.5 29.8 9.2 9.6 12.1 10.1 22.7 9.5 5.0 10.0 11.9 13.4 16.0 7.2 7.5 15.6 23.1 7.1 11.0 8.0 16.3 0.9 9.9 4.7 3.7 12.7 13.0 0.1 0.8 0.8 0.7 0.0 1.4 0.1 2.3 2.5 3.4 4.4 8.8 4.7 1.9 11.9 10.0 9.5 8.6 2.6 1.4 0.0 2.7 16.3 3.9 5.0 2.5 6.7 4.1 0.0 2.0 1.0 5.6 6.1 16.8 1.8 3.4 6.5 11.1 5.9 10.6 6.8 6.7 3.0 2.8 7.4 6.0 1.2 0.6 1.4 1.7 2.5 2.1 1.2 3.9 3.0 2.8 3.2 7.3 7.4 4.2 4.5 3.4 3.0 2.8 2.3 13.4 8.8 8.2 2.6 2.1 2.5 2.9 0.0 7.7 1.2 3.8 0.8 0.7 0.7 1.4 0.4 0.3 0.1 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.1 17.3 21.9 28.8 34.5 17.2 23.4 19.7 24.5 22.7 16.3 32.8 3.0 2.9 1.8 3.0 29.8 14.1 5.1 4.0 5.7 7.0 15.7 1.2 6.6 4.8 10.1 6.2 4.6 0.0 4.2 2.0 8.0 2.3 4.6 17.3 3.8 11.1 3.4 6.7 6.2 13.8 23.3 3.3 3.3 1.0 2.6 3.3 5.9 3.5 47.7 5.4 6.5 6.5 6.4 1.8 1.0 1.9 1.0 0.0 2.9 2.8 CTNNBL1 "C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L" ENSG00000132792 "Catenin beta like 1" Q8WYA6 20 37693955-37872129 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 296.8;granulocytes: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 76.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004742, HPA027906, HPA027907" Approved Enhanced Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362" "unprognostic (2.81e-1)" "unprognostic (3.42e-1)" "unprognostic (8.80e-2)" "unprognostic (1.88e-3)" "unprognostic (1.93e-1)" "unprognostic (2.55e-2)" "unprognostic (1.44e-1)" "unprognostic (5.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (2.06e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (2.81e-1)" "unprognostic (5.31e-2)" 21.0 14.7 19.6 25.8 21.4 27.3 18.9 20.9 21.3 20.3 23.5 18.4 31.7 16.1 25.4 25.2 18.9 21.0 17.7 25.6 17.5 15.8 19.3 35.3 19.3 26.9 17.9 14.7 21.7 14.6 14.5 22.6 22.4 17.5 19.4 18.1 16.1 15.5 34.3 27.3 20.1 19.7 23.8 16.6 49.5 25.9 35.5 20.6 31.0 15.9 15.5 29.7 22.2 29.3 24.9 31.4 60.3 29.1 21.7 18.2 18.4 15.6 14.4 13.8 10.8 10.0 8.3 21.9 10.0 10.5 24.1 21.3 53.9 12.7 17.4 14.7 10.1 23.3 16.8 18.6 23.7 26.0 8.4 9.2 57.1 7.9 26.3 10.4 18.0 76.0 8.7 14.1 13.6 13.6 8.4 14.3 25.0 15.4 7.2 12.8 12.9 29.2 24.0 12.5 17.6 21.0 20.6 26.8 13.1 10.5 13.1 11.1 13.3 17.4 24.9 17.6 13.4 12.3 14.5 10.6 24.1 14.4 15.8 16.2 8.4 10.6 20.3 17.0 11.3 12.7 60.3 22.3 27.9 15.8 29.1 15.0 24.9 15.4 16.2 31.4 23.4 15.5 16.6 4.9 21.7 28.7 24.7 18.2 18.4 19.6 21.4 20.9 21.3 17.5 15.8 17.9 14.7 17.5 20.6 26.8 26.6 37.0 27.7 20.3 25.3 35.5 20.4 21.4 31.8 17.4 17.7 122.6 31.5 25.9 296.8 26.1 24.4 0.0 30.3 56.0 26.8 18.9 250.2 39.2 44.0 17.5 20.1 31.3 29.7 86.0 31.7 43.3 25.3 129.0 23.0 28.3 25.6 19.8 31.5 32.3 21.0 19.4 40.1 76.5 43.0 19.6 44.3 32.4 19.5 18.6 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971840-11904043 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 18.0;Cholangiocytes: 38.2;Early spermatids: 21.0;Late spermatids: 23.3;Muller glia cells: 39.5" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.1;MCF7: 8.2;SK-BR-3: 5.4;U-266/84: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339, HPA071124" Enhanced Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "CAB037339: , HPA015077: AB_2669150, HPA071124: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 1.7 2.4 30.9 1.8 26.3 1.4 2.8 21.6 74.3 1.7 1.8 16.6 0.0 1.7 1.6 1.9 1.6 1.7 4.8 6.0 26.0 17.7 1.5 1.7 2.4 1.6 22.8 20.2 2.1 12.5 1.5 5.7 1.9 11.0 2.6 1.9 2.6 1.7 1.7 1.6 1.5 2.0 1.6 13.3 5.7 1.9 4.2 14.7 0.0 1.7 0.0 1.5 1.6 0.1 0.0 0.0 0.8 0.4 0.0 0.3 0.6 0.0 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 15.4 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.6 30.9 26.3 21.6 29.1 26.0 17.7 22.8 20.2 11.0 14.7 0.0 0.0 0.0 0.0 0.0 18.0 8.4 38.2 0.0 0.0 1.8 0.0 0.0 3.3 5.4 21.0 0.3 0.0 0.0 5.4 0.0 0.0 3.6 0.0 0.0 0.1 7.9 4.7 0.0 0.0 23.3 1.4 0.0 0.0 0.0 0.0 39.5 3.5 0.0 0.0 0.3 2.6 0.0 0.0 1.4 3.1 0.0 0.0 0.0 0.0 0.1 CTPS1 "CTPS, GATD5" ENSG00000171793 "CTP synthase 1" P17812 1 40979335-41012565 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Immunity, Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017111, HPA051322" Enhanced Approved "Actin filaments,Cytosol" NA Yes Cytosol "Actin filaments" "CAB017111: , HPA051322: AB_2681441" "unprognostic (6.60e-2)" "unprognostic (4.44e-2)" "unprognostic (3.21e-2)" "unprognostic (2.00e-3)" "unprognostic (2.14e-1)" "unprognostic (8.37e-2)" "unprognostic (1.42e-2)" "unprognostic (9.72e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (2.04e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-1)" "unprognostic (8.21e-3)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" "unprognostic (1.89e-2)" 7.1 10.0 4.5 10.8 7.8 9.7 5.1 5.9 9.8 14.4 23.6 5.8 16.3 4.3 25.9 8.4 11.3 21.9 13.4 6.7 4.7 5.1 8.6 26.4 7.0 9.4 7.9 4.7 10.1 6.3 16.8 5.4 7.7 6.2 14.4 9.8 9.1 56.5 19.6 13.2 5.8 13.5 35.8 5.1 7.5 9.0 11.8 6.7 14.6 4.5 11.3 13.2 21.3 9.5 6.0 12.8 0.0 7.3 6.6 7.0 3.8 21.2 19.5 27.6 22.2 7.6 9.5 43.4 37.4 16.1 41.1 27.7 38.3 18.9 39.9 17.0 17.1 11.3 15.0 29.5 27.9 41.1 16.7 22.4 24.4 26.0 12.1 25.0 32.5 19.2 10.4 15.1 42.5 30.6 7.2 18.6 29.3 24.5 17.6 28.7 11.9 35.1 12.1 37.7 17.8 23.2 27.1 33.5 25.8 20.7 19.4 37.1 18.1 23.3 25.1 9.3 28.3 8.7 45.0 15.2 27.2 35.6 18.3 46.4 11.4 13.3 35.5 17.8 25.9 28.3 0.0 4.0 0.0 4.6 7.3 6.6 6.0 5.3 4.8 12.0 3.9 4.4 7.0 0.0 6.6 6.1 12.8 6.6 3.8 4.5 7.8 5.9 9.8 4.7 5.1 7.9 4.7 6.2 6.7 6.0 20.2 17.3 10.5 7.1 9.9 4.2 20.4 2.7 5.7 5.2 5.9 14.6 1.7 15.2 22.6 7.3 2.8 0.0 15.1 21.5 6.6 4.3 1.1 24.5 9.6 11.1 2.9 2.5 2.4 21.2 10.0 6.0 1.7 12.6 2.6 5.2 14.2 0.0 23.3 9.6 4.2 38.8 14.4 9.3 42.5 6.5 4.7 5.7 5.2 5.8 CTPS2 ENSG00000047230 "CTP synthase 2" Q9NRF8 X 16588003-16712936 "Enzymes, Predicted intracellular proteins" "Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017437, HPA075930" Uncertain Approved Mitochondria,Cytosol NA NA 14000 "Mitochondria, Cytosol" "HPA017437: AB_1847326, HPA075930: " "unprognostic (1.40e-1)" "unprognostic (6.69e-2)" "unprognostic (3.37e-2)" "unprognostic (7.38e-2)" "unprognostic (1.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (6.57e-3)" "unprognostic (8.52e-2)" "unprognostic (4.31e-3)" "unprognostic (4.43e-1)" "unprognostic (1.89e-2)" "unprognostic (7.22e-2)" "unprognostic (6.04e-2)" "unprognostic (8.93e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.56e-4)" 10.0 12.0 7.8 11.5 11.9 7.8 13.5 14.3 9.9 17.5 13.3 14.8 10.8 15.6 22.0 10.2 9.6 12.1 11.9 7.2 8.6 7.1 8.1 13.4 8.3 7.9 9.1 6.1 17.9 14.9 22.9 8.5 8.3 9.3 12.8 12.6 14.1 11.8 9.7 5.5 9.2 12.8 14.0 12.3 7.1 11.3 4.4 10.8 11.5 11.8 8.4 10.6 11.8 11.2 1.6 3.3 1.1 6.1 3.8 2.4 1.4 7.6 7.0 11.4 9.5 5.8 4.4 0.1 4.2 3.5 6.8 6.3 7.0 8.0 0.2 13.5 4.3 6.2 6.2 16.0 7.7 8.2 0.0 10.6 4.3 9.8 10.2 3.0 3.1 0.1 4.8 2.6 6.4 5.4 7.7 9.1 0.1 6.1 0.3 6.2 10.1 0.1 2.4 19.6 2.8 8.2 0.1 6.6 2.4 7.3 8.5 7.1 13.1 13.3 1.0 7.6 12.9 18.5 8.9 5.8 3.6 1.9 9.4 3.6 0.2 0.1 25.3 2.8 2.7 3.9 0.4 1.5 1.1 1.3 0.8 2.4 1.6 2.2 1.4 3.3 1.4 1.7 1.7 0.1 3.8 6.1 2.2 2.0 1.4 7.8 11.9 14.3 9.9 8.6 7.1 9.1 6.1 9.3 10.8 8.9 7.0 3.7 5.0 2.9 4.9 5.2 10.2 4.0 9.1 5.2 0.0 2.9 3.3 8.7 2.8 4.9 6.0 0.0 8.4 6.2 3.9 4.8 5.8 7.5 4.5 6.4 10.9 6.7 4.9 5.8 8.3 2.6 8.5 9.0 7.4 3.4 10.3 11.0 3.9 2.2 4.4 6.5 4.1 0.0 0.2 3.3 1.3 3.8 8.1 4.8 CTSF "CATSF, CLN13" ENSG00000174080 "Cathepsin F" Q9UBX1 11 66563463-66568841 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 256.1;Muller glia cells: 186.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "NK-cells: 7.5;T-cells: 9.7" "Cell line enhanced" "Detected in many" "HSkMC: 28.4;SK-MEL-30: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002141, HPA031431" Approved Uncertain "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 3600000 Cytosol "Vesicles, Plasma membrane" "CAB002141: AB_563471, HPA031431: " "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (7.22e-3)" "unprognostic (2.25e-2)" "unprognostic (6.72e-2)" "unprognostic (2.67e-2)" "unprognostic (2.76e-2)" "unprognostic (3.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.69e-2)" "unprognostic (9.12e-2)" "prognostic favorable (8.92e-7)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (2.42e-1)" 28.1 29.4 24.7 8.0 29.0 1.8 31.1 38.4 47.1 37.3 23.8 32.6 25.2 5.8 38.1 29.8 12.9 34.3 37.3 34.5 25.3 20.5 29.8 45.4 17.3 8.5 28.0 26.0 68.2 23.1 42.6 15.9 20.2 25.4 32.3 8.1 35.0 35.5 37.8 35.8 19.7 9.4 34.6 22.4 10.4 17.8 37.1 30.1 0.8 18.6 14.2 6.3 22.2 21.5 2.1 1.1 0.5 0.7 7.5 9.7 2.4 0.1 9.3 5.0 13.0 21.5 8.7 3.6 6.6 16.7 6.8 4.8 0.0 8.3 0.0 11.1 14.4 0.3 0.9 8.6 2.8 3.6 2.2 0.0 0.3 3.8 0.0 12.0 0.1 5.1 28.4 9.7 1.5 1.1 20.3 4.3 2.7 2.9 1.5 8.5 1.9 0.1 1.1 0.6 5.0 3.4 0.0 1.9 1.6 6.1 0.2 6.0 6.5 17.5 2.0 52.8 0.5 13.3 0.8 2.8 2.8 2.7 3.2 0.7 8.9 0.1 0.0 6.6 0.1 4.1 0.0 0.7 0.4 6.5 0.7 7.0 2.0 5.6 7.3 0.8 2.1 9.7 5.5 0.5 7.5 0.3 1.1 1.7 2.4 24.7 29.0 38.4 47.1 25.3 20.5 28.0 26.0 25.4 30.1 11.9 14.1 3.4 58.6 35.3 99.1 43.9 35.7 2.7 5.7 34.9 39.3 22.1 13.3 8.5 123.6 24.1 0.0 0.0 6.6 8.1 75.7 48.4 9.2 51.3 13.1 127.1 11.5 49.7 15.8 256.1 134.9 9.9 148.5 2.8 3.1 186.2 8.9 1.9 114.5 30.7 63.2 77.6 43.8 164.4 36.6 22.1 19.8 19.2 3.0 26.5 CTSH "ACC-4, ACC-5, ACC4, ACC5, CPSB" ENSG00000103811 "Cathepsin H" P09668 15 78921058-78949574 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 82.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 1152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 42.8" "Group enriched" "Detected in all" 5 "B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.1;HaCaT: 31.5;OE19: 31.0;RT4: 119.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000458, HPA003524" Enhanced Supported "Vesicles,Cytosol,Cytoplasmic bodies" "Intracellular and membrane" NA NA 10000000 "Vesicles, Cytosol, Cytoplasmic bodies" "CAB000458: , HPA003524: AB_1846075" "unprognostic (6.47e-2)" "unprognostic (4.65e-3)" "unprognostic (1.05e-1)" "prognostic favorable (6.90e-4)" "unprognostic (4.37e-2)" "unprognostic (1.93e-1)" "unprognostic (7.18e-2)" "unprognostic (3.30e-3)" "unprognostic (2.22e-1)" "unprognostic (5.96e-2)" "unprognostic (4.10e-2)" "unprognostic (3.89e-2)" "unprognostic (6.63e-3)" "unprognostic (3.83e-1)" "unprognostic (4.42e-2)" "unprognostic (2.70e-3)" "unprognostic (1.79e-3)" 16.7 10.6 9.5 24.2 7.0 5.4 23.9 4.5 9.8 25.1 11.4 17.7 14.7 10.6 10.3 17.1 7.8 13.1 29.2 16.5 14.8 6.7 66.7 18.7 82.6 65.4 12.1 11.6 14.6 25.8 12.3 6.5 7.7 9.4 18.6 6.6 6.7 15.4 15.9 7.0 13.5 16.6 9.8 10.8 20.3 15.6 6.7 15.7 6.6 8.5 4.8 34.8 39.6 13.5 20.6 41.2 1.4 42.8 1.3 7.6 27.3 16.2 1.1 0.4 4.8 1.1 0.0 5.3 1.6 0.6 2.8 1.5 7.1 43.1 5.7 1.8 0.1 3.1 31.5 2.0 7.8 2.3 24.0 0.1 0.1 0.2 16.5 1.7 0.0 1.1 0.8 2.2 0.0 0.0 11.8 0.2 0.7 11.6 0.0 3.9 1.7 3.7 10.0 1.2 31.0 0.3 0.0 0.3 0.9 9.9 119.7 0.5 1.2 7.0 3.9 9.7 2.3 1.6 5.4 2.2 0.0 1.0 0.0 0.7 0.1 12.4 3.1 0.0 10.5 1.7 0.0 42.8 0.4 1.4 28.3 7.6 20.6 4.1 2.1 41.2 12.0 0.4 0.7 1.4 1.3 17.0 4.2 3.1 27.3 9.5 7.0 4.5 9.8 14.8 6.7 12.1 11.6 9.4 15.7 220.3 1152.3 144.6 210.0 21.5 0.8 25.2 351.6 270.4 197.9 349.0 3.9 16.6 71.3 153.3 17.1 109.7 15.8 0.0 128.8 33.6 30.0 89.1 30.2 82.9 261.0 0.0 8.7 15.4 160.1 15.9 67.6 392.5 75.9 476.1 19.5 21.1 69.6 11.5 5.6 352.9 5.6 19.4 17.8 5.0 52.9 16.3 19.6 25.4 37.0 308.4 CTSV "CTSL2, CTSU" ENSG00000136943 "Cathepsin V" O60911 9 97029679-97039643 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 154.7" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 114.1;Extravillous trophoblasts: 136.0;Syncytiotrophoblasts: 56.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 15.7" "Group enriched" "Detected in many" 42 "dendritic cells: 15.7;NK-cells: 4.2" "Group enriched" "Detected in many" 9 "BEWO: 92.0;SuSa: 118.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017112 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 260000 "Nucleoli fibrillar center, Cytosol" "Nucleoplasm, Plasma membrane" "CAB017112: " "unprognostic (2.40e-1)" "unprognostic (2.74e-2)" "unprognostic (1.50e-1)" "prognostic favorable (8.41e-4)" "unprognostic (7.29e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (2.83e-5)" "unprognostic (7.04e-3)" "unprognostic (6.06e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.87e-4)" "unprognostic (1.86e-2)" "unprognostic (1.78e-1)" "unprognostic (2.41e-2)" "unprognostic (1.33e-1)" "unprognostic (3.04e-3)" "prognostic unfavorable (2.39e-4)" 0.7 0.0 0.4 0.6 0.7 0.0 3.5 0.4 1.0 23.0 1.4 2.0 0.4 0.5 1.5 1.5 9.8 0.6 0.5 0.2 0.8 0.6 9.7 0.4 0.6 0.2 1.5 0.7 0.4 1.1 1.1 0.9 8.7 1.6 0.5 1.6 4.3 5.0 0.6 0.5 25.0 0.6 0.2 3.0 0.2 1.1 32.4 1.0 154.7 0.7 6.3 2.7 0.2 9.9 0.2 15.7 0.2 0.0 4.2 0.0 0.1 5.9 1.8 2.0 5.3 0.1 0.0 92.0 0.0 0.0 1.3 1.0 12.1 5.9 0.0 0.5 0.0 8.8 11.4 9.8 7.2 1.9 0.0 1.3 0.2 0.6 1.8 0.0 0.0 0.8 0.0 2.4 0.3 0.3 0.1 0.4 1.7 0.2 0.0 2.3 2.2 0.1 0.0 12.2 12.0 1.7 0.0 4.4 0.1 1.8 0.7 0.5 0.9 6.0 2.1 2.1 118.9 3.8 0.7 0.0 0.3 6.0 0.0 0.6 1.2 3.2 0.1 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.2 4.2 0.0 15.7 0.0 0.1 0.4 0.7 0.4 1.0 0.8 0.6 1.5 0.7 1.6 1.0 0.0 0.6 1.5 13.2 27.0 4.4 0.8 0.0 0.0 3.4 1.8 9.8 114.1 1.7 1.2 1.5 1.5 1.2 0.0 0.7 136.0 2.6 7.1 0.0 0.0 11.8 0.0 1.7 0.6 0.0 9.6 3.7 1.6 0.0 0.0 0.9 4.5 0.6 1.7 1.1 11.1 26.0 6.5 0.8 34.6 32.6 10.5 56.3 0.0 3.7 6.4 CTTN EMS1 ENSG00000085733 Cortactin Q14247 11 70398404-70436584 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "Cell line enhanced" "Detected in many" "A-431: 129.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011235, HPA057242" Supported Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" NA NA 34000000 "Plasma membrane, Cytosol" "Golgi apparatus, Vesicles" "CAB011235: , HPA057242: AB_2683379" "unprognostic (6.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.05e-1)" "unprognostic (3.13e-2)" "unprognostic (5.81e-2)" "prognostic unfavorable (2.19e-6)" "prognostic unfavorable (4.45e-4)" "unprognostic (6.10e-2)" "unprognostic (2.39e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-3)" "unprognostic (1.20e-1)" "unprognostic (1.50e-2)" "unprognostic (6.97e-2)" "unprognostic (2.79e-1)" "unprognostic (3.72e-3)" "unprognostic (1.94e-1)" 37.5 53.6 33.0 19.7 36.7 5.7 32.0 33.3 41.1 41.3 35.3 42.3 33.7 37.1 48.8 40.2 49.4 35.5 56.2 37.3 28.5 23.5 47.2 24.9 30.5 13.7 45.0 32.0 46.3 40.0 28.9 38.3 32.3 37.2 38.9 32.4 24.4 38.0 38.5 31.5 52.9 39.2 43.1 36.0 21.4 51.3 30.2 38.6 7.7 36.0 44.5 26.7 33.2 38.2 0.1 0.8 4.6 0.2 0.0 0.4 13.9 129.8 28.6 9.7 11.1 16.4 25.6 15.9 27.8 27.8 24.5 19.4 37.8 32.8 5.1 27.6 35.5 26.3 28.9 11.5 29.2 18.0 10.2 11.7 0.5 21.3 17.6 35.3 0.1 6.9 36.1 20.6 27.1 15.3 25.7 20.5 0.1 14.6 1.0 24.1 35.5 0.2 1.8 10.5 47.6 17.5 0.0 11.9 4.1 27.4 42.3 8.0 13.6 20.3 27.9 46.2 18.1 22.8 0.5 25.6 21.7 13.8 33.6 18.5 2.2 1.5 0.3 43.1 0.1 29.5 1.4 0.2 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.4 0.0 4.6 0.0 0.2 0.8 0.0 13.9 33.0 36.7 33.3 41.1 28.5 23.5 45.0 32.0 37.2 38.6 41.7 43.8 5.9 84.2 135.0 34.6 57.8 68.8 50.9 53.4 127.4 17.7 73.0 54.7 124.2 9.3 75.2 104.4 23.3 191.8 75.9 68.3 111.3 5.8 37.6 9.6 36.5 71.5 68.7 5.4 16.3 95.5 8.6 116.4 9.0 107.2 38.3 199.6 136.8 93.0 111.0 30.1 58.2 106.6 31.2 52.1 152.9 88.9 6.9 79.7 167.3 CTTNBP2 "C7orf8, CORTBP2, KIAA1758, Orf4" ENSG00000077063 "Cortactin binding protein 2" Q8WZ74 7 117710651-117874139 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 53.0;granulocytes: 134.2;Horizontal cells: 69.9;Muller glia cells: 122.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "non-classical monocyte: 9.6" "Lineage enriched" "Detected in single" 22 "monocytes: 9.6" "Group enriched" "Detected in some" 6 "HEL: 27.5;HMC-1: 36.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009151, HPA044654" Enhanced Approved "Midbody ring,Cytosol" Yes No "Midbody ring, Cytosol" "CAB009151: AB_2088281, HPA044654: AB_2679037" "unprognostic (6.28e-2)" "unprognostic (2.90e-1)" "unprognostic (5.11e-2)" "unprognostic (1.81e-3)" "unprognostic (1.21e-1)" "unprognostic (3.64e-1)" "unprognostic (7.38e-2)" "unprognostic (3.28e-4)" "unprognostic (3.83e-1)" "unprognostic (7.98e-2)" "unprognostic (7.93e-3)" "unprognostic (1.20e-1)" "prognostic favorable (3.71e-5)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.45e-3)" 11.2 3.9 10.7 1.8 17.6 0.7 4.7 8.3 15.5 10.7 3.9 22.1 2.0 3.3 11.4 9.4 14.0 7.2 6.6 2.4 13.5 9.1 11.5 3.8 3.2 1.0 16.2 9.9 5.4 13.1 21.9 5.8 3.4 15.5 6.6 5.0 5.0 5.2 4.0 1.1 2.5 3.3 9.5 14.3 4.2 1.8 2.2 16.8 0.0 9.8 1.7 2.1 4.8 4.9 0.0 0.4 0.0 9.6 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.0 27.5 0.2 0.0 0.1 0.0 36.6 0.1 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.1 5.2 0.0 3.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.5 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 10.7 17.6 8.3 15.3 13.5 9.1 16.2 9.9 15.5 16.8 3.0 4.5 0.0 3.0 1.6 26.3 2.9 10.2 1.4 6.8 7.0 53.0 2.5 1.7 4.0 1.1 8.7 0.5 0.0 3.8 1.2 2.3 1.4 134.2 1.0 7.0 69.9 1.7 26.4 7.5 2.7 0.9 6.4 6.8 1.8 0.5 122.7 0.8 2.6 1.1 14.3 3.3 0.0 3.5 0.4 0.4 0.3 0.9 0.7 6.0 1.1 CTTNBP2NL DKFZp547A023 ENSG00000143079 "CTTNBP2 N-terminal like" Q9P2B4 1 112396181-112463456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007301 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA007301: AB_1847693" "unprognostic (1.81e-1)" "unprognostic (1.52e-1)" "prognostic favorable (1.14e-4)" "unprognostic (4.21e-3)" "unprognostic (4.54e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-2)" "unprognostic (1.22e-1)" "unprognostic (2.61e-2)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (1.05e-1)" "prognostic favorable (8.08e-4)" "unprognostic (1.38e-1)" "unprognostic (1.63e-1)" "unprognostic (9.99e-2)" "unprognostic (5.12e-2)" 18.8 5.3 10.0 9.8 13.0 0.5 15.0 10.6 12.4 12.9 15.3 14.4 5.0 7.5 18.3 7.6 20.0 8.8 17.0 8.9 10.1 7.9 10.3 5.5 16.5 5.7 10.8 7.8 10.1 4.7 9.6 9.3 20.1 10.2 9.5 15.2 9.7 10.8 10.0 4.4 20.0 12.3 13.9 18.7 10.1 8.5 5.8 11.0 2.6 8.9 7.2 9.5 13.6 15.6 0.5 10.6 0.1 3.3 0.0 2.3 0.5 9.6 3.6 11.9 5.6 8.0 10.6 4.0 15.2 14.3 9.9 9.8 2.7 4.9 1.5 6.1 11.4 4.9 7.9 7.7 10.5 11.6 3.1 3.7 2.0 6.2 2.1 9.3 0.7 3.6 12.5 6.4 12.2 10.7 11.4 24.0 2.6 1.8 1.4 13.6 2.8 1.3 0.2 7.6 2.7 5.6 2.3 11.1 0.0 15.0 7.2 5.8 6.1 11.8 2.4 6.1 11.9 1.9 0.8 30.9 9.9 11.7 10.1 7.1 0.1 1.3 0.0 10.3 0.9 26.0 0.0 3.3 0.0 0.0 2.6 0.0 0.1 0.0 0.0 10.6 0.5 0.0 0.0 0.1 0.0 0.5 4.6 2.3 0.5 10.0 13.0 10.6 12.4 10.1 7.9 10.8 7.8 10.2 11.0 53.6 19.0 8.2 19.2 34.5 10.1 7.5 5.1 14.7 44.3 21.0 5.9 13.6 3.3 29.9 2.4 60.8 30.5 23.3 18.9 10.6 17.4 23.0 18.5 1.0 12.3 4.8 7.9 35.0 23.6 2.1 9.8 40.9 15.1 45.1 23.1 11.4 36.6 31.6 10.6 16.6 8.8 19.4 14.6 14.2 15.0 53.1 21.3 1.0 17.2 51.7 CUEDC1 ENSG00000180891 "CUE domain containing 1" Q9NWM3 17 57861243-57955323 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 17.6" "Lineage enriched" "Detected in many" 10 "dendritic cells: 17.6" "Cell line enhanced" "Detected in many" "T-47d: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023050, HPA024836" Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA023050: AB_1847332, HPA024836: AB_1847333" "unprognostic (4.46e-1)" "unprognostic (3.76e-3)" "unprognostic (4.77e-2)" "unprognostic (4.87e-3)" "unprognostic (4.04e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (2.65e-5)" "unprognostic (6.69e-2)" "unprognostic (1.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "prognostic favorable (8.46e-4)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (2.52e-2)" "unprognostic (2.65e-2)" 9.8 10.6 11.7 8.6 19.3 5.2 9.3 8.5 16.6 22.3 18.5 39.1 11.8 5.0 13.4 13.9 21.2 21.6 12.9 24.2 12.6 12.1 12.0 3.7 13.7 4.4 30.0 8.0 6.4 11.6 7.1 11.5 7.8 18.5 13.0 7.2 19.3 19.1 18.4 48.9 5.5 7.3 19.2 18.7 6.6 12.2 2.9 28.3 2.5 11.2 15.8 4.7 15.4 10.4 0.0 17.6 1.8 1.3 0.1 0.0 0.1 8.3 25.9 27.1 4.8 4.4 8.1 0.9 5.9 12.0 12.5 9.0 4.7 32.2 0.1 24.2 11.4 10.6 6.7 2.9 12.7 4.4 16.3 5.0 0.3 16.8 3.9 10.7 0.1 2.0 8.3 7.7 7.2 6.1 11.0 6.0 0.1 0.3 0.1 11.4 4.7 0.4 0.2 0.9 9.6 7.1 0.8 7.0 1.2 8.5 5.5 11.2 6.1 2.5 2.7 10.2 4.8 37.5 0.9 7.6 33.4 21.1 9.1 13.1 0.0 0.1 0.1 14.5 1.1 26.6 0.6 0.4 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.1 1.3 17.6 0.0 0.1 11.7 19.3 8.5 15.4 12.6 12.1 30.0 8.0 18.5 28.3 17.9 5.1 1.3 13.8 3.7 32.2 15.6 10.2 12.0 10.3 21.0 60.9 0.6 6.6 20.2 0.3 8.4 4.5 0.0 22.5 0.2 10.6 18.5 0.0 2.9 14.5 9.5 3.4 2.5 9.7 2.3 6.4 6.8 5.0 3.6 4.6 25.1 20.7 0.0 4.9 7.1 59.5 6.5 10.4 0.0 0.4 2.0 0.6 0.0 5.5 15.4 CUEDC2 "C10orf66, MGC2491" ENSG00000107874 "CUE domain containing 2" Q9H467 10 102423245-102432661 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036544, HPA041829" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036544: AB_10670111, HPA041829: AB_2677694" "unprognostic (2.10e-1)" "unprognostic (2.80e-2)" "unprognostic (7.31e-2)" "unprognostic (4.24e-2)" "unprognostic (9.78e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (3.48e-3)" "unprognostic (4.34e-1)" "unprognostic (1.67e-1)" "unprognostic (8.38e-2)" "unprognostic (1.58e-2)" 18.8 26.2 29.9 14.9 28.5 13.0 16.2 22.0 49.7 19.8 20.3 19.0 18.5 10.8 19.6 20.8 17.1 25.1 22.7 38.7 25.5 22.3 20.1 18.2 14.9 15.3 27.5 29.5 27.9 23.3 24.4 16.7 14.6 25.4 20.7 12.6 17.5 21.5 22.4 61.6 13.2 11.2 23.6 23.6 15.1 16.3 13.5 18.2 16.5 20.0 25.5 15.8 17.1 14.9 37.4 50.1 35.5 50.5 38.2 36.1 36.0 15.1 17.4 27.2 32.0 22.7 29.2 10.2 12.8 41.3 27.5 21.1 5.4 15.3 25.3 27.3 21.4 12.5 15.0 17.6 27.7 13.6 22.5 17.9 15.6 14.8 5.4 38.4 11.9 10.6 34.4 25.8 26.8 26.7 53.0 28.3 31.6 12.1 25.3 30.8 16.3 27.8 26.6 9.3 11.7 10.9 32.3 33.3 13.0 27.9 7.0 13.5 32.3 8.6 8.5 26.1 11.7 25.9 19.0 16.2 13.7 13.0 17.4 17.1 31.3 25.3 16.8 24.8 41.7 10.9 34.1 50.5 35.5 32.3 39.7 36.1 34.8 32.1 33.7 50.1 37.4 32.0 30.7 19.2 38.2 24.6 43.3 35.7 36.0 29.9 28.5 22.0 49.7 25.5 22.3 27.5 29.5 25.4 18.2 29.8 21.6 30.6 36.9 28.2 50.1 49.7 40.8 20.1 20.5 43.6 23.6 56.6 68.0 58.9 15.1 40.5 20.8 23.3 40.9 25.8 56.9 34.1 50.7 37.6 66.4 63.5 53.5 53.4 50.0 29.8 52.9 44.6 49.0 116.4 32.4 74.4 42.9 31.6 56.6 125.1 35.9 38.8 58.4 59.4 29.7 29.5 38.1 34.6 33.3 28.6 CUL5 VACM-1 ENSG00000166266 "Cullin 5" Q93034 11 108008733-108107776 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002185, CAB017787" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "CAB017787: , HPA002185: AB_1078587" "unprognostic (5.66e-2)" "unprognostic (6.58e-2)" "unprognostic (7.16e-3)" "unprognostic (1.30e-1)" "unprognostic (5.54e-2)" "unprognostic (1.62e-1)" "unprognostic (2.32e-2)" "unprognostic (2.80e-1)" "unprognostic (5.97e-3)" "unprognostic (1.78e-1)" "unprognostic (9.17e-2)" "unprognostic (1.77e-2)" "prognostic favorable (1.06e-5)" "unprognostic (3.83e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" 11.6 13.2 10.8 9.0 14.8 25.0 13.4 17.1 19.3 13.1 10.8 12.7 11.0 9.0 13.6 10.7 11.2 10.9 8.7 14.8 11.3 10.6 16.7 15.3 9.7 10.2 12.5 12.3 13.2 11.2 17.8 14.6 12.6 19.5 12.9 9.5 11.2 11.4 10.9 41.6 11.5 11.2 11.8 13.1 12.5 10.3 6.5 12.7 23.1 14.6 15.1 10.0 10.8 13.6 6.4 5.9 4.1 6.7 4.0 6.2 3.6 9.9 4.6 14.1 10.8 9.2 14.9 7.0 10.5 11.6 9.7 10.9 14.9 11.7 14.0 19.7 13.2 10.2 12.8 13.1 8.8 14.2 9.0 8.0 13.1 4.5 11.1 16.0 14.8 10.7 11.7 12.0 10.1 13.5 12.8 13.3 11.6 16.9 5.2 15.2 5.5 14.2 12.9 7.3 12.8 8.3 10.3 10.5 15.2 12.2 15.1 10.2 14.5 14.3 15.3 8.5 9.1 22.2 12.2 13.8 18.0 8.4 12.6 11.3 5.3 4.1 18.3 7.0 16.9 11.4 1.9 6.7 4.1 5.4 5.2 4.9 4.4 5.6 5.3 5.9 6.4 6.1 6.2 1.2 4.0 6.0 5.9 4.0 3.6 10.8 14.8 17.1 19.3 11.3 10.6 12.5 12.3 19.5 12.7 53.6 34.4 27.0 23.9 26.6 50.6 88.7 33.1 37.5 45.5 29.6 62.8 30.3 43.1 26.2 4.6 34.6 14.7 0.0 20.3 17.7 27.7 25.8 41.6 48.1 23.5 52.4 16.9 35.6 42.9 4.5 28.4 34.3 13.5 32.5 24.0 34.1 23.7 24.6 35.7 61.7 57.0 19.4 25.4 26.9 46.3 26.5 30.0 28.7 26.5 28.6 CUL9 "H7AP1, KIAA0708, PARC" ENSG00000112659 "Cullin 9" Q8IWT3 6 43182175-43224587 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 68 "Early spermatids: 532.1;Late spermatids: 1222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016434, HPA052004" Approved Approved Cytosol No No Cytosol "HPA016434: AB_1848125, HPA052004: AB_2681690" "prognostic favorable (5.28e-4)" "unprognostic (1.47e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.20e-3)" "unprognostic (1.56e-1)" "prognostic favorable (2.37e-5)" "unprognostic (3.05e-3)" "unprognostic (1.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.29e-1)" "prognostic favorable (8.07e-4)" "unprognostic (8.22e-3)" "unprognostic (2.03e-1)" "unprognostic (2.68e-1)" "unprognostic (2.31e-1)" "unprognostic (9.94e-2)" "prognostic favorable (4.87e-4)" 6.2 9.2 11.7 9.5 13.9 12.8 6.9 12.5 13.8 7.4 8.5 12.9 7.3 8.2 11.2 6.5 11.5 10.7 8.5 5.5 10.0 6.4 7.7 5.6 7.5 11.7 10.0 9.8 9.5 8.6 13.2 15.9 5.0 9.2 8.3 5.1 11.2 8.7 9.3 6.0 16.1 10.2 7.7 6.9 10.1 8.7 12.5 10.4 10.8 10.9 4.9 10.8 12.0 7.0 1.1 1.1 0.5 0.9 0.3 2.6 1.0 7.5 5.6 3.1 7.4 8.8 5.2 4.2 3.0 5.4 4.9 4.6 1.8 3.2 6.3 5.9 4.8 4.4 5.5 2.6 6.4 2.3 7.6 2.4 6.9 6.0 2.8 5.7 4.3 11.4 7.1 13.5 4.0 3.6 4.3 7.1 11.1 3.6 8.4 4.3 7.0 8.7 6.3 0.5 14.7 3.6 12.9 2.1 6.2 3.7 7.9 5.3 7.6 4.0 4.9 6.8 2.8 8.3 9.8 6.5 12.3 8.5 3.6 5.7 8.0 7.5 5.1 3.1 7.7 5.5 0.0 0.9 0.3 1.2 0.5 1.3 1.1 0.7 2.6 1.1 0.8 0.6 1.4 0.5 0.3 0.4 0.9 2.5 1.0 11.7 13.9 12.5 13.8 10.0 6.4 10.0 9.8 9.2 10.4 0.0 8.0 4.4 2.2 5.7 9.5 4.4 12.7 4.0 4.5 3.5 11.8 2.7 3.3 3.1 532.1 5.8 7.4 0.0 5.4 1.5 2.8 1.9 2.3 5.5 10.6 11.1 5.8 9.2 5.7 1222.3 10.3 4.6 3.3 4.6 6.5 9.5 4.8 0.0 7.8 4.6 10.0 12.9 3.9 9.3 9.7 4.8 2.2 4.9 6.2 2.4 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.1" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038619, HPA058231" Enhanced Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649, HPA058231: " "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 11.6 4.9 5.7 9.8 8.7 7.9 9.8 3.5 6.5 5.3 5.9 7.2 3.5 4.4 4.9 8.0 6.2 5.1 5.8 13.2 5.9 4.7 5.3 11.0 5.1 7.9 8.6 6.6 4.6 4.5 3.5 3.6 4.5 5.5 6.0 6.4 6.9 5.7 5.4 122.1 5.8 6.2 11.6 7.4 9.2 6.0 14.1 8.3 9.2 4.3 25.1 7.3 13.5 11.4 32.8 24.2 47.1 19.4 25.5 36.3 19.3 9.5 20.5 7.2 21.9 26.8 12.3 3.9 7.8 10.1 7.9 8.9 9.4 7.3 34.7 7.0 13.3 3.9 8.2 14.7 13.0 8.8 10.2 14.0 11.5 9.2 14.8 12.4 21.3 5.6 12.7 8.1 12.6 26.2 9.8 13.5 20.2 10.1 7.7 5.9 6.6 19.1 22.0 7.2 9.7 7.7 13.0 8.5 13.3 8.3 3.9 2.4 5.4 3.6 5.7 9.8 10.4 9.1 12.2 7.5 3.3 4.4 3.6 10.3 12.7 16.5 24.3 10.8 45.8 2.9 26.5 19.4 47.1 27.2 15.2 28.3 32.8 25.9 25.9 21.0 29.0 36.3 27.8 30.8 25.5 18.5 24.2 24.7 19.3 5.7 8.7 3.5 6.5 5.9 4.7 8.6 6.6 5.5 8.3 8.9 12.2 21.9 13.0 10.8 16.5 35.8 10.2 20.1 10.3 5.2 7.9 15.9 18.3 14.6 8.1 21.5 4.9 0.0 15.0 10.7 15.3 11.4 30.0 20.2 18.3 11.1 11.6 22.7 17.8 6.8 12.0 15.9 28.7 27.9 7.8 17.8 10.1 10.1 15.2 24.5 27.1 19.4 15.6 105.8 35.1 9.5 11.3 20.1 9.7 10.7 CWC22 "EIF4GL, fSAPb, KIAA1604, NCM" ENSG00000163510 "CWC22 spliceosome associated protein homolog" Q9HCG8 2 179944876-180007113 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036748 Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA036748: AB_10669913" "unprognostic (1.90e-1)" "unprognostic (7.10e-2)" "unprognostic (7.30e-2)" "unprognostic (6.14e-2)" "unprognostic (4.96e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (3.15e-1)" "unprognostic (1.31e-2)" "unprognostic (3.30e-2)" "unprognostic (3.84e-2)" "unprognostic (4.80e-2)" "prognostic unfavorable (7.76e-5)" "unprognostic (1.74e-1)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-3)" 20.4 14.2 15.8 17.3 16.8 18.1 19.2 33.5 24.6 21.1 17.0 10.5 13.5 12.4 21.5 14.3 18.4 17.6 15.5 14.8 17.5 11.9 17.2 20.7 14.7 21.3 14.4 19.6 25.4 14.7 21.8 25.0 17.8 17.0 20.4 15.2 9.1 15.4 14.7 20.2 15.9 17.4 23.6 19.0 20.5 15.4 10.9 16.3 26.5 20.7 17.6 21.7 21.8 23.8 12.4 9.9 26.4 11.9 10.9 16.4 8.2 9.6 6.0 16.8 11.2 12.2 14.5 12.8 12.8 15.1 15.8 15.4 13.5 12.2 19.0 11.5 9.2 13.8 10.6 15.9 11.9 23.9 16.7 14.0 25.4 7.8 18.4 12.0 35.3 14.2 9.5 14.5 19.8 26.9 10.3 11.7 13.2 27.6 11.7 10.3 9.7 18.4 18.4 25.8 11.6 9.7 17.0 20.8 14.2 10.9 12.2 11.5 15.6 10.5 8.4 14.6 18.8 6.3 22.4 10.0 13.5 11.5 8.8 13.2 10.3 10.8 23.2 12.1 14.3 13.5 26.4 9.5 21.5 12.3 11.9 12.4 12.4 13.3 14.5 9.9 11.3 16.4 12.8 15.9 10.9 8.9 6.3 11.3 8.2 15.8 16.8 33.5 24.6 17.5 11.9 14.4 19.6 17.0 16.3 17.9 26.0 19.8 23.6 16.9 14.6 25.2 22.9 52.2 35.2 10.4 23.6 15.7 8.3 21.1 1.2 21.7 10.5 0.0 16.6 14.4 15.9 13.2 26.5 12.4 12.1 12.7 15.0 15.4 19.7 1.5 21.6 21.4 3.3 21.6 15.8 16.3 16.2 16.7 17.3 14.4 16.9 45.3 13.2 25.1 21.5 16.3 20.7 17.5 13.5 15.4 CWF19L2 FLJ32343 ENSG00000152404 "CWF19 like 2, cell cycle control (S. pombe)" Q2TBE0 11 107326345-107457844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038166 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA038166: AB_10669518" "unprognostic (1.38e-1)" "unprognostic (9.41e-2)" "unprognostic (1.37e-1)" "unprognostic (7.35e-2)" "unprognostic (7.17e-2)" "unprognostic (6.42e-2)" "unprognostic (8.78e-2)" "unprognostic (1.63e-1)" "unprognostic (4.19e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (4.48e-2)" "unprognostic (1.26e-1)" "unprognostic (4.74e-2)" "unprognostic (1.76e-2)" 16.5 9.9 19.0 18.2 24.4 11.5 18.4 43.7 25.1 23.0 13.6 5.6 14.9 8.0 17.7 13.9 11.5 13.2 9.8 11.3 16.2 10.7 18.2 13.3 11.4 14.8 16.3 16.9 23.8 9.6 17.7 27.9 13.2 17.9 16.6 10.3 5.1 11.4 14.6 29.1 13.0 11.3 14.9 23.5 18.0 11.1 9.0 21.7 15.8 15.8 9.2 16.8 21.0 47.4 19.4 12.5 22.2 6.8 11.2 13.9 2.8 6.2 5.1 11.1 5.3 9.2 10.4 8.3 8.2 7.7 6.5 8.7 11.9 14.8 10.9 15.8 5.8 8.3 15.3 12.2 6.3 11.4 12.1 6.8 12.1 5.9 7.7 6.0 14.2 10.2 5.3 11.1 7.5 11.3 7.5 8.7 6.6 18.2 6.3 9.4 4.6 10.9 12.9 10.4 10.4 7.3 9.6 10.6 14.6 7.6 7.8 6.4 5.3 12.0 9.0 4.5 9.7 12.1 6.8 7.9 10.8 8.7 5.6 7.3 3.4 6.2 10.8 3.2 14.0 9.9 22.2 6.8 11.8 9.8 6.0 10.8 17.6 11.4 9.7 2.9 19.4 13.9 10.6 13.0 11.2 6.3 12.5 9.7 2.8 19.0 24.4 43.7 25.1 16.2 10.7 16.3 16.9 17.9 21.7 35.7 53.5 49.4 17.3 15.9 90.9 22.6 50.9 24.1 46.6 78.5 90.3 21.2 28.2 18.3 2.6 43.6 16.9 0.0 16.0 18.5 22.2 6.0 44.0 50.5 13.8 65.2 12.6 47.9 27.5 6.2 50.3 29.7 13.5 26.2 20.7 53.3 13.8 22.9 60.1 37.1 129.6 38.8 23.1 49.8 46.9 11.7 14.2 43.6 20.3 6.7 CXorf38 MGC39350 ENSG00000185753 "Chromosome X open reading frame 38" Q8TB03 X 40626921-40647554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050120 Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA050120: AB_2681024" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "unprognostic (2.91e-1)" "unprognostic (6.98e-2)" "unprognostic (1.37e-1)" "unprognostic (3.15e-1)" "unprognostic (1.48e-3)" "unprognostic (7.59e-2)" "unprognostic (1.46e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (7.30e-4)" "unprognostic (1.23e-1)" "unprognostic (1.71e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.73e-2)" "prognostic favorable (1.44e-8)" 12.5 12.5 6.5 14.2 9.6 11.7 11.7 8.2 7.2 11.6 14.3 9.7 13.9 10.1 12.5 13.9 9.4 13.0 8.8 11.2 7.7 6.1 11.1 11.2 14.4 25.3 8.5 7.2 12.4 9.6 16.5 9.4 12.5 8.8 8.5 9.7 7.8 11.0 19.3 7.1 9.1 14.6 8.9 10.9 18.3 8.2 4.8 9.0 17.3 16.5 7.5 16.4 12.2 9.9 9.0 13.7 21.3 21.9 6.7 9.8 9.4 9.5 5.0 5.1 4.0 5.7 9.8 3.0 6.6 9.1 8.2 8.6 6.7 13.5 16.7 6.2 9.8 14.1 6.5 6.2 11.0 7.6 23.2 10.3 10.6 5.7 3.5 9.8 18.9 17.0 8.3 7.2 11.6 10.8 7.3 9.9 13.5 4.7 12.0 14.9 9.4 12.4 12.0 4.7 6.5 11.7 10.4 11.1 11.9 9.5 15.2 6.1 8.2 13.0 6.2 7.2 10.5 10.6 7.9 11.4 10.2 6.4 7.7 5.4 13.7 5.0 7.2 13.2 8.9 6.9 9.5 16.1 21.3 9.6 15.0 9.6 6.8 8.8 7.0 13.7 9.0 7.9 7.4 20.4 6.7 21.9 5.9 9.8 9.4 6.5 9.6 8.2 7.2 7.7 6.1 8.5 7.2 8.8 9.0 8.9 7.8 31.3 8.0 3.2 12.9 5.3 17.8 4.0 5.7 15.7 17.7 7.6 6.6 21.5 0.7 9.9 12.4 0.0 26.3 7.9 7.4 10.5 16.2 8.5 32.3 14.3 7.0 8.6 31.7 0.4 8.9 29.9 3.3 45.9 14.1 12.3 28.2 17.5 4.9 11.2 7.7 6.5 5.6 3.7 6.5 4.6 6.9 24.2 12.1 25.2 CXXC5 "HSPC195, RINF, WID" ENSG00000171604 "CXXC finger protein 5" Q7LFL8 5 139647299-139683882 "Predicted intracellular proteins" Transcription "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 68.2" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 594.9;Horizontal cells: 511.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "MAIT T-cell: 10.2;memory B-cell: 27.7;naive B-cell: 29.3;NK-cell: 21.8;plasmacytoid DC: 19.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036508, HPA058148" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036508: AB_10673620, HPA058148: AB_2683621" "unprognostic (3.08e-2)" "unprognostic (9.03e-2)" "prognostic favorable (2.40e-4)" "prognostic unfavorable (4.10e-7)" "unprognostic (2.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-3)" "unprognostic (2.28e-2)" "unprognostic (2.12e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-2)" "unprognostic (2.63e-2)" "unprognostic (8.02e-2)" "unprognostic (1.44e-1)" "unprognostic (7.26e-2)" "unprognostic (1.57e-1)" 12.3 9.5 22.4 9.3 19.9 22.2 9.2 68.2 38.8 17.5 10.2 39.3 5.1 6.0 9.9 18.0 10.1 18.1 11.4 15.8 23.9 16.7 25.6 33.8 9.0 15.5 30.9 21.7 5.4 24.9 18.2 18.6 10.4 25.4 8.1 7.9 14.2 30.0 11.7 39.7 9.8 9.1 8.4 36.7 18.1 11.4 19.0 27.5 20.5 12.5 7.7 13.5 9.6 9.9 29.3 19.1 0.7 2.1 21.8 10.2 3.4 9.4 8.0 8.8 3.3 12.4 17.0 3.4 6.2 9.5 2.7 5.4 17.6 9.6 12.5 27.6 16.5 16.3 10.9 1.8 4.8 1.3 1.3 3.1 18.6 7.1 12.3 5.3 4.1 0.6 6.1 1.1 4.5 1.3 26.2 0.7 0.4 17.4 2.0 19.5 24.7 4.4 13.2 10.7 10.3 2.2 8.0 18.1 19.1 20.3 6.9 28.2 29.1 2.2 57.1 4.6 20.4 31.2 19.5 3.9 22.2 4.4 10.5 5.5 7.5 15.6 23.6 33.4 1.4 12.2 0.3 2.1 0.1 3.2 0.4 10.2 27.7 0.3 2.3 1.8 29.3 0.2 0.9 0.7 21.8 0.1 19.1 0.4 3.4 22.4 19.9 68.2 38.8 23.9 16.7 30.9 21.7 25.4 27.5 44.7 16.8 79.0 14.3 23.4 189.2 39.2 91.7 25.4 18.2 139.6 23.6 2.7 268.5 104.4 594.9 41.3 10.1 23.3 127.1 18.5 63.9 34.4 20.8 98.7 39.4 511.7 17.9 26.4 25.4 156.4 36.2 34.8 57.3 50.5 49.6 220.2 83.9 5.8 28.7 146.6 42.7 12.9 77.3 5.4 7.8 18.2 31.5 24.5 24.3 15.8 CYB5A CYB5 ENSG00000166347 "Cytochrome b5 type A" P00167 18 74250847-74292016 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 266.8" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 1827.0;Hepatocytes: 3445.7;Proximal tubular cells: 3021.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 154.8;RT4: 67.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006333, HPA047548, HPA058547" Enhanced Enhanced Vesicles,Cytosol No No 780000 "Vesicles, Cytosol" "CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750" "unprognostic (1.88e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.23e-4)" "unprognostic (1.08e-2)" "unprognostic (1.41e-1)" "unprognostic (9.14e-2)" "prognostic favorable (4.15e-4)" "unprognostic (7.79e-3)" "unprognostic (1.11e-1)" "unprognostic (3.33e-2)" "unprognostic (2.68e-2)" "unprognostic (1.65e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (4.64e-2)" "unprognostic (8.54e-2)" 25.0 13.2 4.3 11.0 5.8 1.5 39.4 6.9 5.9 7.5 68.2 4.3 38.5 37.7 4.9 16.0 8.3 7.0 34.8 14.5 4.1 3.7 76.2 266.8 67.0 9.2 6.5 3.4 25.1 75.3 10.1 6.5 7.2 5.2 13.5 9.0 6.2 7.6 54.9 4.3 11.4 70.7 21.2 11.5 10.3 18.0 12.2 5.5 4.6 4.6 7.9 4.3 21.6 18.8 34.9 16.9 2.1 12.9 10.2 38.0 13.5 10.0 17.2 9.0 0.0 154.8 27.5 12.0 6.9 15.1 14.8 22.3 20.3 11.0 12.3 4.9 12.7 7.3 22.5 0.0 9.5 11.8 22.9 11.9 4.5 9.4 53.8 24.0 8.6 5.9 46.1 7.6 8.4 4.3 8.9 8.1 11.0 7.3 4.6 12.4 18.1 4.8 10.3 4.0 14.2 11.2 12.0 2.9 0.2 14.8 67.5 25.7 10.7 6.7 18.4 8.2 8.0 36.4 8.2 7.6 0.0 11.6 3.5 8.8 3.2 13.3 3.8 9.1 2.4 8.5 1.1 9.6 2.1 16.7 10.8 38.0 28.5 18.7 19.6 16.9 34.9 18.4 23.1 1.1 10.2 12.9 14.8 14.4 13.5 4.3 5.8 6.9 5.9 4.1 3.7 6.5 3.4 5.2 5.5 592.6 899.4 80.0 70.0 87.0 10.0 73.8 919.7 746.8 1341.0 799.1 3.9 200.0 1827.0 177.8 6.0 109.5 224.5 0.0 443.4 144.1 156.3 120.6 38.2 3445.7 88.8 7.9 157.7 172.5 116.8 12.6 146.4 67.3 86.0 370.7 201.7 22.6 370.4 256.3 140.7 3021.0 12.1 51.8 70.7 13.6 36.0 195.7 37.2 60.9 256.7 159.2 CYB5B CYB5-M ENSG00000103018 "Cytochrome b5 type B" O43169 16 69424525-69466266 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 130.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007893 Approved Approved "Endoplasmic reticulum,Centriolar satellite,Cytosol" NA NA 1600000 "Endoplasmic reticulum" "Centriolar satellite, Cytosol" "HPA007893: AB_1847369" "unprognostic (1.13e-1)" "unprognostic (4.47e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (2.87e-3)" "unprognostic (4.35e-3)" "unprognostic (3.87e-1)" "unprognostic (1.44e-2)" "unprognostic (1.52e-2)" "unprognostic (3.10e-1)" "prognostic favorable (6.38e-5)" "unprognostic (9.69e-3)" "unprognostic (4.66e-2)" "unprognostic (3.78e-2)" "unprognostic (1.30e-2)" 21.3 130.7 29.6 15.4 33.1 5.9 17.1 12.0 37.9 16.6 29.0 22.8 12.6 21.9 20.5 24.6 21.4 19.2 14.7 18.0 23.1 22.0 26.9 26.5 18.3 20.1 21.6 24.4 19.9 12.8 26.3 16.2 24.6 34.3 17.1 38.2 20.2 14.8 16.7 19.9 16.0 31.2 19.9 20.8 20.7 15.4 14.0 16.0 26.0 19.9 17.6 23.5 24.3 16.0 24.8 44.2 35.8 28.3 32.3 46.0 32.4 29.6 94.4 38.9 24.0 18.0 24.0 16.6 26.6 37.1 44.6 42.2 65.8 36.4 27.1 26.8 25.7 36.3 35.3 37.0 38.5 50.8 14.4 14.1 13.0 17.0 76.7 26.6 26.8 29.0 20.6 19.4 52.8 25.3 18.9 42.0 31.3 21.0 13.1 27.3 38.6 43.9 32.6 28.8 27.6 12.9 41.6 21.5 29.7 59.5 34.0 22.8 11.7 70.8 13.6 22.5 20.9 26.3 21.5 18.9 25.7 21.2 17.0 23.4 15.9 35.1 82.9 26.5 22.3 29.7 35.8 20.3 24.3 39.3 28.3 32.2 24.8 29.6 30.8 24.8 22.6 24.6 29.2 6.1 32.3 20.1 44.2 46.0 32.4 29.6 33.1 12.0 37.9 23.1 22.0 21.6 24.4 34.3 16.0 41.7 38.5 39.4 44.1 44.3 21.6 21.7 25.5 52.2 42.1 59.3 5.9 140.9 66.3 51.1 13.9 49.6 69.8 23.3 62.0 75.3 41.2 33.1 58.9 43.3 55.7 28.6 22.5 36.2 27.6 17.2 41.1 44.4 59.1 64.9 68.4 45.7 54.3 63.1 41.8 46.7 30.4 45.3 42.2 31.1 48.5 36.9 50.0 71.0 55.0 45.3 CYB5R1 "humb5R2, NQO3A2" ENSG00000159348 "Cytochrome b5 reductase 1" Q9UHQ9 1 202961869-202967280 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 119.2" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 166.3;Syncytiotrophoblasts: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010641, HPA014147" Enhanced Approved Mitochondria,Cytosol NA NA 860000 Mitochondria Cytosol "HPA010641: AB_1078600, HPA014147: AB_1847370" "unprognostic (6.36e-2)" "unprognostic (8.51e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.14e-4)" "unprognostic (1.86e-2)" "unprognostic (4.34e-2)" "unprognostic (8.46e-2)" "unprognostic (1.28e-1)" "unprognostic (4.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (2.89e-1)" "unprognostic (1.73e-2)" "unprognostic (2.33e-1)" "unprognostic (6.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.69e-1)" 9.6 14.5 7.8 5.0 8.4 3.9 16.9 6.2 11.0 11.6 7.5 8.7 10.6 4.4 10.1 32.3 13.7 16.4 9.2 33.9 7.3 9.2 15.5 18.4 10.1 11.7 10.0 9.1 10.8 11.1 16.3 11.1 63.8 11.9 10.5 5.0 15.7 14.4 10.1 119.2 28.5 6.9 10.6 7.4 10.8 18.6 20.1 6.7 11.7 13.5 26.4 10.0 13.6 10.1 20.2 21.9 25.7 33.3 17.2 26.5 28.8 8.5 5.3 4.7 9.6 43.9 10.1 46.1 17.1 16.2 11.2 10.0 4.4 10.1 5.3 14.6 17.1 6.2 47.3 3.8 14.7 7.4 7.6 9.7 3.0 6.5 5.0 15.8 2.6 7.6 16.2 48.7 12.3 6.7 9.5 7.3 6.6 8.9 9.6 40.2 10.0 3.2 2.3 3.1 7.7 10.3 5.4 22.7 11.3 10.6 10.2 4.0 5.0 9.6 32.0 13.9 10.7 14.8 5.8 7.1 12.8 5.4 4.8 9.5 9.0 10.6 2.5 14.1 4.0 9.5 11.6 33.3 25.6 16.7 24.2 22.2 13.6 19.3 17.8 21.9 20.2 26.5 18.8 25.7 17.2 15.7 15.1 19.1 28.8 7.8 8.4 6.2 11.0 7.3 9.2 10.0 9.1 11.9 6.7 20.8 24.3 13.0 30.5 166.3 19.6 98.7 33.1 58.9 20.5 27.9 27.5 100.3 6.6 35.7 4.3 29.5 11.9 23.3 41.7 159.6 29.6 19.2 27.7 36.0 54.2 9.5 18.4 23.4 39.9 5.4 27.6 33.5 60.8 9.0 10.9 56.4 53.6 10.5 29.4 32.1 25.9 12.9 34.0 24.6 2.7 137.6 245.4 17.5 14.2 47.8 CYC1 UQCR4 ENSG00000179091 "Cytochrome c1" P08574 8 144095027-144097525 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 145.2" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 693.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 151.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001247 Supported Approved "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA 110000 Mitochondria "Nucleoplasm, Nuclear bodies, Cytosol" "HPA001247: AB_1078602" "unprognostic (3.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.66e-2)" "unprognostic (1.25e-1)" "unprognostic (6.52e-2)" "unprognostic (1.39e-1)" "unprognostic (3.92e-3)" "unprognostic (6.23e-2)" "unprognostic (1.98e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "prognostic favorable (5.89e-6)" "unprognostic (6.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (3.13e-2)" 16.0 31.3 16.2 13.2 20.1 19.5 12.1 19.1 32.1 13.0 33.3 13.4 14.4 38.1 13.9 10.1 36.2 15.5 13.1 92.1 16.6 14.1 44.8 55.9 11.2 16.5 18.0 18.6 15.0 21.4 17.9 10.6 16.0 17.7 16.5 25.3 13.3 23.3 17.2 145.2 17.7 42.6 16.3 11.8 18.3 22.4 13.9 11.5 21.5 21.7 43.8 18.5 19.9 14.4 34.9 76.7 22.1 60.0 30.2 26.1 58.5 22.2 50.5 13.4 28.0 11.1 12.4 25.9 12.8 15.7 32.7 21.5 35.3 27.9 31.6 29.0 17.1 15.9 33.0 29.3 25.4 12.3 19.3 38.8 33.9 42.7 32.3 20.0 20.0 22.1 18.0 31.9 20.8 41.4 11.0 19.0 21.9 30.8 28.2 17.1 80.0 37.4 18.5 15.6 62.7 151.5 33.0 18.0 55.3 26.9 35.9 36.1 15.9 35.8 49.5 26.3 7.7 40.7 30.7 14.4 20.9 44.6 23.0 39.0 31.4 22.8 23.4 26.6 34.1 26.6 22.1 59.7 15.9 24.1 60.0 25.4 34.9 20.1 25.8 76.7 29.4 19.7 25.4 5.8 30.2 44.8 42.9 26.1 58.5 16.2 20.1 19.1 32.1 16.6 14.1 18.0 18.6 17.7 11.5 17.9 24.8 104.2 137.8 138.6 109.2 340.1 175.8 33.5 25.0 75.0 76.6 235.5 693.0 191.2 55.0 98.8 477.2 70.0 250.0 197.5 112.8 124.7 59.9 203.6 217.6 82.6 140.6 55.3 91.9 71.2 82.3 127.4 170.4 267.9 288.6 98.9 227.1 319.6 85.2 391.4 75.4 71.1 158.3 73.6 93.6 143.2 198.1 79.6 481.1 207.2 CYFIP2 PIR121 ENSG00000055163 "Cytoplasmic FMR1 interacting protein 2" Q96F07 5 157266079-157395595 "Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.8;brain: 44.2;kidney: 69.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 150.1;Distal tubular cells: 147.6;Horizontal cells: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 52.0;JURKAT: 35.9;MOLT-4: 49.3;U-266/70: 38.4;U-698: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB055519, HPA068106, HPA071459" Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum" "Plasma membrane, Cytosol" "CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (7.07e-2)" "prognostic unfavorable (2.42e-6)" "unprognostic (3.76e-1)" "unprognostic (4.58e-2)" "unprognostic (1.14e-1)" "unprognostic (6.91e-3)" "unprognostic (3.97e-2)" "unprognostic (5.25e-2)" "prognostic favorable (1.18e-4)" "unprognostic (3.81e-2)" "prognostic favorable (3.21e-12)" "unprognostic (2.90e-1)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.49e-2)" 1.9 6.6 28.6 13.4 31.7 22.8 1.7 39.1 44.2 1.8 4.3 7.7 1.6 3.1 3.5 12.3 2.1 4.9 4.7 5.1 28.7 20.4 69.7 8.2 5.9 25.9 16.2 27.2 2.7 3.6 30.6 13.2 4.4 15.8 3.2 5.0 4.7 2.2 3.5 3.1 1.8 6.4 2.9 7.9 15.8 9.5 2.6 8.9 28.5 5.4 0.0 25.7 6.0 1.7 13.7 15.6 30.1 42.8 17.4 32.1 22.9 0.0 8.1 12.5 7.0 0.2 0.3 20.0 1.4 2.5 0.6 1.8 1.5 0.1 52.0 3.6 0.8 1.8 0.1 9.9 6.7 1.5 11.8 15.6 6.6 10.6 6.0 1.0 6.9 18.4 1.4 2.7 2.0 0.1 4.9 2.1 35.9 0.1 20.9 1.7 1.9 49.3 1.3 5.5 0.1 2.1 12.2 0.3 24.8 6.6 7.4 18.1 7.2 0.1 7.1 1.1 12.7 4.8 0.2 2.9 0.4 5.3 1.7 1.3 38.4 9.6 36.6 5.5 8.3 2.9 17.4 4.3 30.1 32.1 20.0 22.9 13.7 23.3 27.7 6.2 13.4 24.7 28.1 14.4 17.4 42.8 15.6 18.4 22.9 28.6 31.7 39.1 38.3 28.7 20.4 16.2 27.2 15.8 8.9 3.0 24.0 31.6 2.0 1.0 56.1 15.1 10.2 6.7 11.4 150.1 15.7 28.2 147.6 8.4 15.2 2.7 5.3 0.0 1.4 38.9 2.1 1.2 2.3 30.8 4.7 85.8 13.8 7.4 5.4 14.9 1.7 6.2 6.8 13.6 5.6 10.9 2.5 9.9 6.3 46.6 33.3 0.0 7.1 2.3 11.5 1.3 17.6 48.4 8.8 1.4 CYGB "HGB, STAP" ENSG00000161544 Cytoglobin Q8WWM9 17 76527356-76551175 "Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 88.6;Melanocytes: 74.2;Sertoli cells: 90.5;Smooth muscle cells: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 25.0;Hep G2: 19.1;HHSteC: 38.0;HSkMC: 31.0;SH-SY5Y: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017757, HPA061642" Approved Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA017757: AB_1847410, HPA061642: AB_2684573" "unprognostic (6.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.97e-2)" "prognostic favorable (2.55e-5)" "prognostic unfavorable (1.85e-4)" "unprognostic (3.36e-2)" "unprognostic (3.31e-3)" "unprognostic (2.01e-1)" "unprognostic (7.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.08e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.34e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (7.76e-2)" 48.1 16.1 6.2 9.5 8.3 1.1 34.4 10.9 11.6 13.3 19.0 1.5 8.4 15.2 8.8 8.4 12.5 8.8 24.1 43.4 4.2 11.2 6.9 13.6 17.8 9.5 6.3 5.5 11.2 7.6 8.5 5.0 10.0 17.7 22.8 7.0 23.7 10.4 9.4 17.1 8.2 17.8 17.6 3.5 8.0 13.1 9.3 2.2 1.1 22.0 11.4 3.4 35.1 41.5 4.4 0.4 2.4 0.3 2.5 1.3 0.5 0.0 0.3 0.6 0.1 25.0 7.4 8.4 0.2 0.6 0.1 0.3 0.0 0.1 0.0 8.1 0.7 0.1 0.2 0.0 10.7 0.0 0.0 0.0 0.1 0.1 19.1 38.0 0.0 0.0 31.0 2.3 0.8 0.8 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.2 41.5 0.0 0.0 0.8 1.9 0.0 0.2 0.0 1.0 0.5 0.1 0.0 0.4 0.0 0.1 0.0 0.1 3.2 0.0 0.3 0.4 0.5 0.2 0.3 3.4 0.4 0.2 0.4 4.4 0.7 1.3 2.4 2.5 0.2 0.0 0.5 0.5 6.2 8.3 10.9 11.6 4.2 11.2 6.3 5.5 17.7 2.2 3.0 1.3 0.0 1.2 9.6 24.0 3.4 0.0 25.4 10.3 0.0 0.0 0.9 0.0 0.8 0.7 16.2 0.0 0.0 0.2 0.5 13.7 0.7 0.0 0.9 0.4 7.9 0.0 3.7 0.0 1.1 88.6 3.5 74.2 0.0 0.0 17.5 0.2 0.0 21.9 0.0 10.0 90.5 44.5 1.0 1.2 5.8 2.4 0.5 0.0 0.6 CYP26B1 P450RAI-2 ENSG00000003137 "Cytochrome P450 family 26 subfamily B member 1" Q9NR63 2 72129238-72148038 "Disease related genes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4" "Group enriched" "Detected in many" 8 "Leydig cells: 70.2;Peritubular cells: 216.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 8.2;HaCaT: 12.1;RH-30: 15.6;U-2 OS: 17.3;U-2197: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012567 Uncertain Approved Cytosol "Intracellular and membrane" No No Cytosol "HPA012567: AB_1847429" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (2.19e-4)" "unprognostic (3.46e-2)" "unprognostic (4.40e-1)" "unprognostic (2.17e-4)" "unprognostic (8.41e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (7.55e-3)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.55e-1)" "unprognostic (9.44e-3)" "unprognostic (2.04e-2)" 16.6 2.6 8.3 2.1 7.8 0.1 7.7 25.0 23.9 5.8 2.4 1.2 1.6 3.6 1.5 1.6 3.4 2.7 1.2 6.0 2.5 1.5 4.2 0.7 2.7 4.4 3.4 10.0 4.9 0.2 0.9 5.2 3.2 35.4 1.3 1.2 1.2 5.1 7.5 7.6 20.5 2.4 1.5 0.6 1.9 0.5 13.8 1.1 4.9 9.2 2.2 2.8 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.9 0.0 0.1 8.2 3.1 4.9 0.7 0.1 0.2 0.2 1.5 0.4 0.0 0.4 0.6 2.4 12.1 6.9 0.0 0.1 0.0 2.2 0.0 4.9 0.6 0.1 0.0 0.2 0.0 0.4 0.0 0.2 2.5 0.9 3.3 0.4 0.1 0.7 2.3 0.0 0.1 0.0 0.1 0.8 0.0 15.6 0.0 0.0 1.2 0.5 0.1 2.7 0.0 2.9 1.0 0.2 0.7 0.0 1.3 17.3 7.6 2.6 0.0 0.9 0.0 5.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 7.8 25.0 23.9 2.5 1.5 3.4 10.0 35.4 1.1 0.0 0.0 2.9 1.1 13.1 0.1 1.1 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.1 1.6 0.0 0.0 0.0 0.7 3.7 0.3 0.0 0.2 0.1 0.0 1.7 17.2 4.5 4.9 70.2 0.0 6.8 0.0 0.0 5.4 0.2 0.0 216.0 0.0 0.0 0.0 5.6 1.4 3.0 8.4 0.1 0.0 0.0 0.1 CYP27A1 "CP27, CTX, CYP27" ENSG00000135929 "Cytochrome P450 family 27 subfamily A member 1" Q02318 2 218781749-218815293 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 149.0" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 367.9;Hofbauer cells: 155.3;monocytes: 143.3" "Cancer enhanced" "Detected in all" "liver cancer: 176.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 38.2;neutrophil: 30.6" "Group enriched" "Detected in many" 20 "granulocytes: 30.6;monocytes: 38.2" "Cell line enhanced" "Detected in some" "Hep G2: 74.3;HSkMC: 14.2;RPTEC TERT1: 18.9;SK-MEL-30: 30.5;WM-115: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059155 Enhanced Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA059155: AB_2683933" "prognostic favorable (1.05e-4)" "unprognostic (4.21e-2)" "unprognostic (2.34e-1)" "unprognostic (1.83e-3)" "unprognostic (3.71e-3)" "unprognostic (1.31e-2)" "prognostic favorable (8.62e-6)" "unprognostic (6.04e-2)" "unprognostic (1.73e-1)" "unprognostic (4.04e-1)" "unprognostic (1.25e-3)" "unprognostic (8.76e-3)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (7.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 14.4 12.3 6.3 4.7 13.4 0.7 5.5 2.4 7.5 6.5 21.9 16.9 24.9 21.0 5.0 5.4 3.5 9.2 5.1 6.9 8.3 6.2 12.6 149.0 22.4 5.6 19.9 5.7 9.5 2.4 6.3 7.1 2.0 12.1 11.6 6.0 15.1 10.0 21.5 10.0 3.9 36.8 5.0 18.8 3.1 3.5 3.7 15.7 3.7 3.1 4.0 7.6 5.5 5.7 0.1 1.7 30.6 38.2 0.0 0.1 10.0 0.0 0.0 0.7 0.0 1.3 0.9 0.1 0.8 3.0 1.0 2.1 3.7 0.1 0.0 1.5 2.1 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.0 0.1 74.3 4.3 0.1 0.0 14.2 0.1 0.0 0.0 3.5 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.7 0.1 18.9 0.0 0.0 0.0 0.0 0.0 30.5 0.7 0.5 0.7 1.7 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 11.9 0.0 38.2 0.1 0.0 4.3 0.0 0.1 0.0 0.1 1.7 0.0 0.0 0.0 30.6 0.0 0.3 0.2 0.0 10.0 6.3 13.4 2.4 7.5 8.3 6.2 19.9 5.7 12.1 15.7 3.0 28.2 0.9 44.4 4.6 13.8 5.0 17.8 14.7 12.5 3.5 25.5 0.9 8.3 9.2 0.9 7.1 46.1 0.0 10.8 0.5 20.2 45.1 2.3 367.9 155.3 9.5 23.5 19.6 15.9 0.6 44.0 31.1 47.2 143.3 9.0 29.6 6.6 19.3 25.1 66.2 13.7 0.0 8.5 0.3 0.0 2.8 1.0 2.5 18.7 20.0 CYP2B6 "CPB6, CYP2B, CYPIIB6" ENSG00000197408 "Cytochrome P450 family 2 subfamily B member 6" P20813 19 40991250-41018398 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 137.3" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 326.3" "Cancer enhanced" "Detected in many" "liver cancer: 28.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;OE19: 4.9" "Not detected" "Not detected" "CAB033866, HPA048124, HPA062973" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914" "unprognostic (1.86e-1)" "unprognostic (1.23e-2)" "unprognostic (1.13e-2)" "unprognostic (6.13e-2)" "unprognostic (4.59e-2)" "unprognostic (4.63e-2)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (9.43e-2)" "unprognostic (5.44e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 3.0 137.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 1.8 3.1 0.8 0.7 0.9 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.3 0.0 0.1 1.5 0.0 0.3 0.3 0.2 0.1 7.0 0.4 0.1 0.1 0.3 0.6 0.4 0.7 0.4 0.4 0.4 0.4 0.0 0.4 0.3 0.1 0.3 0.5 0.7 0.4 0.1 0.2 0.1 0.8 1.8 0.6 4.9 0.4 0.2 0.5 0.4 1.7 0.1 0.9 0.2 0.3 0.1 0.5 0.3 0.7 1.1 0.8 0.6 0.3 0.7 0.5 0.3 0.7 0.9 0.2 1.1 0.3 3.1 0.8 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.1 1.9 0.5 0.8 2.7 0.7 0.3 1.8 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.2 2.5 1.4 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.9 46.7 0.2 0.0 0.0 0.1 0.0 326.3 0.0 0.0 0.0 10.4 11.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 7.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.2 0.6 CYP3A4 CYP3A3 ENSG00000160868 "Cytochrome P450 family 3 subfamily A member 4" P08684 7 99756960-99784265 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 45 "intestine: 145.3;liver: 464.6" "Cell type enriched" "Detected in some" 45 "Hepatocytes: 2276.5" "Cancer enriched" "Detected in some" 240 "liver cancer: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0" "CAB033671, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "CAB033671: AB_782375, HPA072245: , HPA075539: " "unprognostic (4.55e-2)" "unprognostic (8.95e-2)" "unprognostic (8.08e-2)" "unprognostic (1.63e-1)" "unprognostic (5.89e-2)" "unprognostic (5.37e-2)" "unprognostic (7.07e-3)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" "unprognostic (4.92e-2)" "unprognostic (3.78e-2)" "unprognostic (6.42e-2)" "unprognostic (1.89e-8)" "unprognostic (2.59e-1)" "unprognostic (1.75e-2)" "unprognostic (9.79e-2)" "unprognostic (6.82e-2)" 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 145.3 0.1 0.1 56.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 464.6 0.1 0.1 0.1 0.1 0.1 6.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 126.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.6 0.2 0.6 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.0 1.9 0.4 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.5 0.0 0.1 4.5 0.3 0.0 0.0 0.0 2.2 6.7 0.0 0.5 2.6 5.0 0.5 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.4 0.0 0.7 0.1 0.7 0.1 0.7 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.6 0.6 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.3 1.0 0.3 0.0 0.3 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 2.6 46.7 0.8 0.0 0.0 0.5 0.0 2276.5 0.0 0.0 0.0 39.3 50.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.9 CYP3A43 ENSG00000021461 "Cytochrome P450 family 3 subfamily A member 43" Q9HB55 7 99828013-99866102 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 32.5" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 6.3;granulocytes: 2.3;Hepatocytes: 6.8;Late spermatids: 2.5" "Cancer enriched" "Detected in single" 18 "liver cancer: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "HPA066463, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA066463: AB_2685670, HPA072245: , HPA075539: " "unprognostic (1.20e-3)" "unprognostic (4.74e-2)" "unprognostic (3.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.52e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.68e-2)" "unprognostic (1.44e-1)" "unprognostic (2.38e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.23e-2)" "unprognostic (6.46e-2)" "unprognostic (5.90e-2)" "unprognostic (3.10e-1)" "unprognostic (6.37e-4)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.9 0.1 0.0 0.1 0.1 0.1 0.0 0.2 32.5 0.1 0.1 0.1 0.1 0.1 8.0 0.0 2.2 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.5 1.6 0.6 0.3 0.6 0.2 0.1 0.0 0.9 0.3 1.1 0.2 0.2 0.0 0.2 0.2 0.2 1.2 0.7 1.5 0.3 0.3 0.1 1.3 0.2 0.0 0.7 0.2 0.5 0.9 1.5 1.3 0.3 0.9 1.3 0.0 0.7 0.0 0.0 0.6 0.5 0.1 1.0 1.0 0.0 0.0 0.0 0.6 0.4 0.3 0.0 0.9 0.0 0.2 0.8 1.6 0.5 0.4 0.6 1.7 0.0 0.7 0.5 0.0 1.6 0.5 0.2 1.1 0.7 1.1 1.2 0.1 0.8 0.4 0.2 1.5 0.6 0.4 0.6 0.2 0.3 0.3 0.3 0.2 0.1 0.6 0.5 0.5 1.6 0.3 0.2 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.3 6.8 0.1 1.6 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.9 0.2 0.3 0.0 0.0 0.0 0.0 CYP3A5 "CP35, P450PCN3, PCN3" ENSG00000106258 "Cytochrome P450 family 3 subfamily A member 5" P20815 7 99648194-99680026 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 72.9;liver: 73.4;stomach 1: 21.3" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8" "Cancer enhanced" "Detected in many" "liver cancer: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (2.13e-1)" "unprognostic (4.36e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.73e-1)" "prognostic favorable (3.72e-5)" "unprognostic (1.37e-3)" "unprognostic (1.21e-2)" "unprognostic (7.29e-3)" "unprognostic (3.85e-1)" "unprognostic (4.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" "unprognostic (2.39e-4)" "unprognostic (6.58e-3)" 1.0 3.3 0.4 2.0 0.5 0.0 1.3 0.6 0.6 1.9 32.6 0.6 1.0 30.3 0.7 0.5 5.2 0.5 8.2 0.4 0.4 0.0 6.8 73.4 2.4 0.8 0.4 0.4 0.6 12.1 0.0 1.8 0.6 0.8 4.9 5.1 0.4 0.6 1.3 0.4 4.3 72.9 0.6 0.5 0.4 21.3 0.7 0.4 0.5 0.4 2.2 4.0 3.0 2.7 0.0 0.2 0.1 0.6 0.0 0.7 0.2 0.0 2.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 8.3 5.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.3 0.2 23.6 0.0 0.1 0.0 0.6 0.5 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.5 0.6 0.6 0.4 0.0 0.4 0.4 0.8 0.4 11.9 11.3 11.2 107.3 41.0 13.1 1.0 346.5 14.7 12.5 3.5 11.8 1.3 0.0 58.0 1.7 2.5 640.5 46.7 44.6 1.0 3.8 166.5 9.3 330.1 0.6 7.9 52.5 9.8 8.3 0.0 2.3 4.6 3.3 7.2 117.1 6.0 69.5 210.5 2.5 4.2 20.2 0.0 3.5 6.8 4.2 51.6 1.3 12.9 85.2 352.8 CYP3A7 "CP37, P450-HFLA" ENSG00000160870 "Cytochrome P450 family 3 subfamily A member 7" P24462 7 99684957-99735196 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 82.6" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 135.0" "Cancer enriched" "Detected in some" 43 "liver cancer: 38.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (8.10e-3)" "unprognostic (1.45e-1)" "unprognostic (3.12e-1)" "unprognostic (5.47e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (8.28e-2)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-11)" "unprognostic (2.02e-2)" "unprognostic (5.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.34e-3)" 0.1 0.4 0.1 0.1 0.0 0.0 2.6 0.1 0.1 0.0 0.7 0.0 0.0 0.1 0.3 0.1 0.2 0.0 3.9 0.0 0.1 0.0 2.8 82.6 0.6 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.4 3.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 135.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.4 0.1 0.0 0.0 4.9 3.7 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 CYP3A7-CYP3A51P ENSG00000282301 "CYP3A7-CYP3A51P readthrough" P24462 7 99685226-99735093 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 73.9" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 7.6" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.3;U-87 MG: 2.6" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 73.9 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.5 0.0 0.3 0.5 1.6 0.5 0.2 4.3 0.0 0.6 0.2 0.0 0.0 0.0 1.3 0.1 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.9 1.4 1.9 0.0 0.0 0.5 0.3 0.4 0.4 0.0 0.4 0.5 0.0 0.8 0.5 1.1 0.1 0.2 1.2 0.5 0.2 0.5 0.2 0.1 0.4 1.5 0.0 0.0 0.4 0.2 0.0 0.5 0.6 0.6 0.0 0.1 0.4 0.3 0.5 0.5 0.6 0.9 0.7 0.1 2.6 0.7 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYTH2 "ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like" ENSG00000105443 "Cytohesin 2" Q99418 19 48469032-48482314 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 195.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014872, HPA060662" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 11000 Cytosol "Golgi apparatus, Plasma membrane" "CAB014872: , HPA060662: AB_2732652" "unprognostic (2.28e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.72e-1)" "unprognostic (4.97e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.66e-1)" "unprognostic (2.83e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (2.33e-2)" "unprognostic (9.19e-2)" "unprognostic (3.14e-1)" "unprognostic (1.22e-1)" "unprognostic (1.24e-1)" "prognostic favorable (3.21e-4)" 13.5 14.2 12.7 14.1 13.6 8.0 19.5 11.4 24.4 21.9 11.7 12.9 14.8 23.2 15.4 15.9 18.8 15.0 25.5 8.3 12.4 7.4 19.2 8.9 15.2 10.0 13.2 18.9 14.4 17.3 35.1 21.0 21.1 12.4 18.0 9.7 13.5 24.2 14.4 7.4 19.9 23.0 12.2 8.7 13.0 19.2 42.0 13.5 18.4 46.2 15.1 10.6 15.6 15.9 4.1 5.6 11.1 4.0 1.8 6.1 3.2 9.0 13.7 41.7 9.4 6.3 5.5 7.6 7.1 6.5 7.6 7.2 7.5 12.3 5.9 7.5 6.2 6.3 11.4 8.0 8.7 4.9 9.0 10.9 8.4 17.2 8.0 5.7 5.1 11.5 7.0 14.9 9.5 6.1 35.0 9.8 8.8 8.3 20.9 10.1 7.3 8.5 37.3 4.5 8.1 5.7 10.9 6.3 4.1 13.0 19.7 12.2 12.0 7.8 21.9 6.0 13.5 10.3 6.9 10.6 16.5 8.4 3.9 10.1 20.8 11.0 3.9 6.0 10.2 11.5 4.1 4.0 3.3 4.1 3.0 2.7 4.1 5.3 6.1 3.3 2.7 4.9 3.4 11.1 1.8 3.9 5.6 5.3 3.2 12.7 13.6 11.4 24.4 12.4 7.4 13.2 18.9 12.4 13.5 26.8 33.9 13.7 98.2 40.8 35.5 10.1 58.6 50.9 33.0 38.4 23.6 40.9 29.9 73.0 195.8 42.1 25.3 0.0 81.0 38.9 34.0 62.5 16.3 7.8 38.3 20.6 25.0 36.8 22.1 127.7 34.5 34.4 33.7 73.1 30.9 37.8 102.2 41.6 34.6 39.6 55.8 51.8 45.9 70.2 46.4 41.5 119.3 32.0 31.1 126.1 CYTH3 "ARNO3, cytohesin-3, GRP1, PSCD3" ENSG00000008256 "Cytohesin 3" O43739 7 6161776-6272644 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.6" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 38.8" "Cancer enhanced" "Detected in all" "melanoma: 47.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.9" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9" "Cell line enhanced" "Detected in many" "WM-115: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013979 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA013979: AB_1855799" "unprognostic (6.58e-2)" "unprognostic (1.37e-2)" "unprognostic (1.65e-2)" "unprognostic (5.75e-3)" "unprognostic (1.27e-3)" "unprognostic (1.27e-2)" "unprognostic (2.32e-2)" "unprognostic (2.63e-1)" "unprognostic (8.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (1.73e-2)" "unprognostic (2.20e-1)" "unprognostic (4.41e-2)" "prognostic unfavorable (2.63e-5)" 24.0 9.1 10.9 6.6 14.4 6.1 22.0 14.2 17.6 10.4 16.4 7.0 5.7 15.1 13.0 8.1 13.4 12.6 13.9 21.1 11.4 7.2 8.8 3.0 14.0 5.4 9.4 10.7 11.0 6.6 9.4 7.1 66.6 9.4 6.8 6.7 17.8 8.6 8.7 12.3 15.6 18.5 15.2 8.5 7.5 9.2 26.0 6.5 2.9 20.4 10.8 5.0 7.7 16.5 0.6 1.8 0.7 0.4 3.3 5.9 0.4 21.6 5.5 5.2 3.6 24.5 29.0 7.4 12.8 11.2 12.7 12.1 8.4 10.8 2.9 7.8 25.8 16.4 20.4 3.6 9.3 8.5 0.2 5.1 0.8 6.5 1.0 11.6 0.9 1.4 20.5 4.2 6.7 9.8 5.7 2.2 4.3 3.4 0.4 9.2 3.5 0.7 3.8 3.6 2.9 7.4 3.8 14.0 1.6 9.8 2.6 3.4 6.5 7.9 27.8 22.5 4.7 1.7 6.1 8.0 8.7 23.2 9.4 7.8 1.0 0.3 3.0 2.8 2.3 35.5 0.7 0.4 0.0 2.2 0.2 5.9 0.3 1.0 2.4 0.4 0.6 0.1 1.5 0.3 3.3 0.4 1.8 0.8 0.4 10.9 14.4 14.2 17.6 11.4 7.2 9.4 10.7 9.4 6.5 14.9 8.0 2.4 1.7 13.5 4.8 16.5 2.5 2.7 3.4 3.5 7.9 12.6 5.0 3.3 9.9 14.7 7.5 0.0 2.4 7.4 14.4 3.0 12.7 1.5 9.9 14.3 2.9 16.0 2.7 12.1 15.3 4.6 30.4 1.0 5.8 8.8 6.4 5.3 12.4 1.0 1.8 38.8 24.0 19.5 10.5 9.9 12.7 5.0 6.9 1.6 CYTH4 "CYT4, cytohesin-4, PSCD4" ENSG00000100055 "Cytohesin 4" Q9UIA0 22 37282027-37315345 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.3;lymphoid tissue: 53.9" "Cell type enhanced" "Detected in some" 11 "granulocytes: 55.4;Hofbauer cells: 64.0;Kupffer cells: 57.8;Macrophages: 83.4;T-cells: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 12.1;HMC-1: 50.8;THP-1: 33.3;U-266/70: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004065, HPA071573" Approved Supported "Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol" NA NA "Plasma membrane" "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA004065: , HPA071573: AB_2686418" "unprognostic (4.30e-3)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" "unprognostic (9.28e-3)" "unprognostic (9.25e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (5.84e-2)" "unprognostic (3.30e-3)" "unprognostic (1.23e-1)" "unprognostic (3.31e-2)" "unprognostic (8.42e-2)" "prognostic unfavorable (2.41e-8)" "unprognostic (3.70e-2)" "unprognostic (1.92e-2)" "unprognostic (5.56e-2)" "unprognostic (2.07e-1)" 13.6 6.6 7.0 32.0 9.2 24.2 7.6 1.5 4.2 2.9 5.0 7.0 0.9 4.1 3.9 6.5 3.2 5.5 8.3 9.2 4.7 3.7 5.1 4.5 14.8 27.4 10.3 2.6 2.5 3.1 1.1 3.7 13.5 6.9 4.0 4.8 4.6 10.3 2.1 2.1 3.0 13.2 6.0 9.9 53.9 5.4 2.3 7.5 12.9 3.6 2.9 22.9 12.0 3.2 8.0 27.2 52.3 31.4 11.4 15.1 16.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.1 0.0 0.8 0.0 0.0 0.2 0.0 1.8 0.0 3.5 0.0 0.0 0.0 12.1 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 4.5 0.0 0.0 0.3 0.4 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 0.0 0.0 10.3 1.3 1.6 6.9 4.1 0.1 3.7 15.6 21.6 15.1 26.4 10.6 7.8 8.3 11.9 12.4 8.0 8.0 10.6 52.3 11.4 31.4 27.2 7.5 16.1 7.0 9.2 1.5 4.2 4.7 3.7 10.3 2.6 6.9 7.5 3.0 12.5 18.1 0.7 2.2 0.0 1.6 0.0 0.0 3.4 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.6 2.1 0.3 55.4 0.8 64.0 0.0 0.0 2.5 57.8 0.0 0.6 83.4 6.8 1.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.1 1.9 0.8 48.9 0.0 0.6 CYTIP "B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP" ENSG00000115165 "Cytohesin 1 interacting protein" O60759 2 157414619-157488961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.4;lymphoid tissue: 92.9" "Cell type enriched" "Detected in many" 4 "monocytes: 788.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.6;HDLM-2: 11.7;Karpas-707: 39.9;RPMI-8226: 12.2;U-266/70: 68.0;U-266/84: 25.5" "Region enhanced" "Detected in single" "basal ganglia: 0.4" "Not detected" "Not detected" HPA007191 Approved Approved Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA007191: AB_1855801" "unprognostic (3.61e-3)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "prognostic favorable (9.12e-4)" "unprognostic (5.71e-2)" "unprognostic (1.36e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.41e-2)" "unprognostic (1.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (5.49e-2)" "unprognostic (5.43e-2)" "unprognostic (3.78e-2)" 9.4 1.4 1.4 33.3 1.6 32.3 3.9 0.8 1.0 4.4 9.7 1.6 0.8 9.3 3.1 4.2 6.6 2.8 5.8 3.8 1.5 1.5 4.1 3.9 26.8 92.9 3.1 0.6 2.9 3.1 0.0 1.5 1.3 2.0 2.4 5.0 3.1 11.5 3.1 1.4 2.1 17.4 2.1 4.3 48.3 14.4 3.3 1.3 40.5 3.2 3.8 61.8 24.1 3.2 21.9 13.0 48.5 53.3 19.9 53.4 31.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 39.9 0.2 0.0 0.0 1.6 0.1 0.2 0.0 0.0 0.0 12.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 68.0 25.5 6.6 0.6 1.8 0.0 48.5 8.4 24.5 30.6 27.8 30.9 21.9 32.4 28.9 13.0 21.1 53.4 40.7 48.2 19.9 53.3 6.7 31.3 31.6 1.4 1.6 0.8 1.0 1.5 1.5 3.1 0.6 2.0 1.3 3.0 16.4 102.3 1.0 18.5 0.0 2.0 5.1 0.0 2.3 1.8 0.0 0.5 13.3 0.2 1.2 1.2 0.5 23.3 1.7 9.8 8.5 0.5 6.9 1.0 24.4 0.0 1.7 4.9 80.4 1.7 0.0 153.9 79.2 788.1 1.9 0.0 0.2 0.0 0.0 0.8 0.0 0.0 3.2 0.0 0.2 15.6 2.5 190.7 1.5 0.1 DAAM1 KIAA0666 ENSG00000100592 "Dishevelled associated activator of morphogenesis 1" Q9Y4D1 14 59188646-59371405 "Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 415.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 18.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026605, HPA064789" Uncertain Approved "Plasma membrane,Cytosol" NA NA 450000 "Plasma membrane, Cytosol" "HPA026605: AB_1847464, HPA064789: AB_2685352" "unprognostic (2.81e-1)" "unprognostic (9.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.74e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-1)" "unprognostic (1.76e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (6.40e-2)" "unprognostic (1.98e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.77e-4)" "unprognostic (5.01e-2)" "unprognostic (3.29e-1)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" 13.8 8.0 13.8 9.4 9.3 3.7 9.3 17.3 13.3 14.6 11.4 6.3 7.4 4.5 16.9 7.0 19.2 8.4 6.0 17.3 10.2 6.7 6.0 10.7 9.7 8.8 5.6 13.6 8.6 8.2 25.6 9.6 12.4 8.7 10.9 7.8 16.9 12.0 10.5 6.0 25.6 7.7 19.5 10.0 10.2 9.1 5.8 7.2 4.1 7.1 14.1 13.8 15.3 13.1 10.7 18.3 4.9 3.1 6.9 3.8 1.9 13.1 1.3 9.1 2.3 6.0 4.2 11.8 1.7 1.7 3.5 3.7 6.8 10.9 13.6 3.5 4.1 7.2 27.2 8.5 6.6 2.9 6.0 3.0 5.1 3.4 8.1 3.7 5.7 2.7 2.8 6.7 3.0 2.9 7.0 7.7 6.7 8.3 6.7 2.1 11.3 4.8 2.8 4.9 8.1 3.9 4.5 7.7 1.3 4.5 10.3 14.1 3.1 11.5 16.8 10.2 6.1 22.3 1.2 7.7 2.7 5.3 6.1 1.5 1.5 1.7 15.9 3.6 1.0 6.5 4.9 2.1 2.5 2.6 2.4 3.1 10.7 3.3 2.4 2.4 4.7 2.7 2.7 2.6 6.9 3.1 18.3 3.8 1.9 13.8 9.3 17.3 13.3 10.2 6.7 5.6 13.6 8.7 7.2 32.8 24.8 21.7 108.9 415.1 111.0 118.9 30.6 65.6 52.4 27.9 290.6 30.5 19.9 42.3 28.7 59.1 37.1 186.9 81.9 21.8 46.3 89.2 25.4 41.2 26.6 184.3 84.3 111.7 17.1 11.1 55.8 14.9 86.0 24.4 50.3 117.4 130.6 38.6 69.6 11.3 180.1 32.3 49.5 32.1 44.8 290.2 28.6 20.2 36.8 75.2 DAAM2 KIAA0381 ENSG00000146122 "Dishevelled associated activator of morphogenesis 2" Q86T65 6 39792298-39904877 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 83.3" "Cell type enriched" "Detected in many" 5 "Sertoli cells: 148.8" "Cancer enhanced" "Detected in all" "melanoma: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 29 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.8" "Cell line enhanced" "Detected in some" "HSkMC: 25.8;JURKAT: 13.8;LHCN-M2: 25.3;SK-MEL-30: 31.3;WM-115: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051300, HPA054630" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA051300: AB_2681430, HPA054630: AB_2682549" "unprognostic (7.53e-2)" "unprognostic (6.02e-3)" "unprognostic (4.49e-2)" "unprognostic (7.93e-2)" "unprognostic (8.24e-2)" "unprognostic (4.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.05e-3)" "unprognostic (1.33e-1)" "unprognostic (5.89e-2)" "unprognostic (2.17e-1)" "unprognostic (5.24e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.67e-2)" "unprognostic (8.54e-2)" "unprognostic (7.94e-2)" "unprognostic (8.54e-4)" 21.5 17.8 34.8 6.7 43.0 1.7 7.8 4.4 52.2 9.3 6.4 83.3 8.0 7.6 7.5 8.5 28.3 8.9 5.9 6.1 40.4 25.2 5.9 4.0 8.4 2.8 42.8 24.8 7.3 5.2 3.5 2.1 9.4 41.3 8.7 7.1 5.1 4.3 17.6 23.8 4.4 8.9 13.7 48.8 15.5 7.0 8.7 51.9 0.0 5.0 2.1 2.2 4.6 4.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.7 0.1 0.1 4.4 5.9 1.0 0.5 0.4 0.0 0.0 0.2 6.6 2.1 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 4.1 0.0 0.0 25.8 0.0 0.1 0.0 7.2 0.0 13.8 0.0 0.0 25.3 0.0 0.6 0.0 0.7 1.3 0.0 0.0 4.6 3.5 0.0 0.0 0.9 1.0 0.0 0.3 31.3 5.6 0.0 0.0 0.2 9.6 2.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 34.8 43.0 4.4 28.9 40.4 25.2 42.8 24.8 41.3 51.9 8.9 9.8 0.0 0.8 1.5 1.7 2.1 0.0 2.7 6.8 0.0 0.0 0.4 0.0 0.4 3.6 2.0 0.0 0.0 3.0 0.4 11.3 0.8 0.0 1.0 0.2 0.0 0.0 3.1 15.2 4.2 21.9 3.1 8.5 0.0 0.0 8.2 0.4 0.0 20.8 0.0 1.5 148.8 28.3 0.7 1.1 1.0 0.2 0.0 0.0 1.0 DAD1 OST2 ENSG00000129562 "Defender against cell death 1" P61803 14 22564905-22589269 "Cancer-related genes, Predicted membrane proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028882 Uncertain Approved Cytosol NA NA 14000 Cytosol "HPA028882: AB_10602214" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (2.02e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (9.43e-3)" "unprognostic (3.06e-2)" "unprognostic (6.09e-2)" "unprognostic (1.99e-2)" "unprognostic (9.64e-2)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (3.08e-1)" "unprognostic (1.93e-1)" "unprognostic (1.37e-3)" 48.1 64.7 47.9 36.4 49.4 26.4 61.2 19.3 39.5 59.0 46.7 55.9 93.6 39.7 49.8 118.7 61.2 56.5 54.9 55.2 45.9 43.1 85.1 123.6 48.4 54.6 51.5 25.1 55.4 114.1 35.6 57.0 54.6 51.9 48.3 51.5 43.5 81.9 100.1 39.7 35.6 73.4 49.6 65.3 57.4 48.0 56.7 33.6 84.6 107.0 50.7 52.2 49.3 43.4 80.2 121.1 75.3 65.9 61.5 95.6 122.5 47.9 45.1 37.1 50.3 101.4 72.9 32.1 51.4 62.3 45.6 64.6 28.3 69.1 30.3 33.0 59.0 51.9 44.0 38.4 49.3 73.2 41.1 35.1 29.6 26.4 112.8 70.7 41.3 43.0 54.1 66.3 47.7 61.5 52.1 66.5 29.4 22.3 71.7 67.1 58.8 19.6 50.5 22.8 106.4 73.8 27.5 31.4 39.5 67.1 39.7 28.5 35.7 39.0 55.9 56.6 46.6 33.7 42.2 50.3 39.8 31.9 48.3 32.3 53.7 62.2 39.1 36.0 29.0 57.4 66.0 65.9 68.1 86.7 56.2 85.1 80.2 90.9 81.7 62.0 71.2 95.6 83.8 75.3 61.5 47.8 121.1 83.5 122.5 47.9 49.4 19.3 39.5 45.9 43.1 51.5 25.1 51.9 33.6 148.9 165.4 142.8 161.3 176.2 21.8 136.5 170.7 219.5 109.2 242.5 25.5 222.0 182.4 458.8 135.7 237.6 168.9 23.3 362.6 309.7 253.7 161.4 292.5 226.5 313.4 20.6 130.4 183.0 140.5 70.6 198.5 173.2 313.8 230.0 162.7 174.4 363.0 131.9 187.0 354.4 32.8 148.8 195.7 167.4 132.2 188.6 241.7 163.9 144.2 147.6 DALRD3 FLJ10496 ENSG00000178149 "DALR anticodon binding domain containing 3" Q5D0E6 3 49015488-49022293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 129.7;Late spermatids: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036862 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA036862: AB_10673507" "unprognostic (2.76e-2)" "unprognostic (8.44e-3)" "unprognostic (3.56e-1)" "prognostic favorable (9.03e-4)" "unprognostic (3.77e-1)" "unprognostic (1.52e-1)" "unprognostic (3.33e-3)" "unprognostic (1.19e-2)" "unprognostic (5.33e-2)" "unprognostic (9.52e-2)" "unprognostic (8.07e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.79e-5)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" 9.4 14.1 9.3 13.9 9.0 4.4 21.6 10.2 11.9 11.3 9.5 7.7 14.9 7.2 7.7 14.7 13.1 34.3 14.2 8.6 8.6 7.3 16.0 9.3 10.8 9.1 7.2 9.4 13.5 29.3 12.6 11.1 8.7 6.3 8.4 7.5 8.4 13.2 18.5 7.5 13.0 10.2 6.5 5.1 8.5 9.9 32.0 6.8 21.1 21.1 13.5 12.7 9.5 14.1 17.7 8.2 7.3 9.3 14.5 19.2 9.3 6.2 8.5 5.3 10.5 15.4 20.5 6.6 5.3 14.3 8.8 8.4 6.0 7.8 2.5 7.5 14.0 7.6 4.1 7.0 13.5 6.1 3.8 4.7 2.7 7.9 11.2 10.0 7.5 5.4 13.8 14.0 11.0 24.6 22.3 13.5 5.8 2.1 6.2 8.5 10.6 3.4 5.1 8.9 12.9 8.1 1.7 0.7 17.9 23.3 9.8 3.4 11.4 5.7 15.8 11.9 9.3 11.2 8.3 8.4 3.4 5.4 12.1 4.7 19.9 10.9 1.3 13.0 3.5 6.7 7.1 7.7 3.7 10.2 9.3 18.8 17.7 17.0 12.7 8.2 15.5 14.4 9.3 7.3 14.5 8.6 5.6 19.2 9.3 9.3 9.0 10.2 11.9 8.6 7.3 7.2 9.4 6.3 6.8 14.9 9.8 15.9 21.0 22.8 29.2 1.2 15.3 65.6 19.4 26.2 17.7 23.7 31.5 33.6 129.7 14.3 30.3 0.0 34.6 30.0 20.5 9.2 24.3 5.8 17.2 38.1 18.3 15.4 10.8 227.2 22.5 15.9 20.3 29.7 19.2 23.2 22.0 17.5 17.3 36.2 53.2 45.3 15.5 91.9 33.3 29.7 15.3 17.5 25.0 13.2 DARS ENSG00000115866 "Aspartyl-tRNA synthetase" P14868 2 135906677-135986100 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020451, HPA029804, HPA029805" Enhanced Enhanced Cytosol NA NA 160000 Cytosol "HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994" "unprognostic (6.13e-2)" "unprognostic (8.16e-3)" "unprognostic (5.54e-2)" "unprognostic (5.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (2.39e-6)" "unprognostic (2.98e-3)" "prognostic unfavorable (7.57e-4)" "unprognostic (6.00e-3)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.24e-5)" "unprognostic (1.04e-1)" "unprognostic (9.12e-2)" "unprognostic (3.94e-3)" "unprognostic (2.00e-1)" 30.3 29.7 35.0 27.6 35.5 19.7 34.9 18.0 28.3 27.6 25.4 25.6 26.9 14.8 30.1 26.7 44.4 26.9 19.6 29.8 29.0 28.8 34.6 35.5 19.7 32.3 32.1 25.6 34.0 27.0 26.4 24.5 31.7 23.8 31.0 20.3 20.6 26.6 28.3 45.1 30.6 21.4 42.4 33.8 29.8 23.6 12.8 25.0 42.0 33.0 33.1 36.7 45.3 30.2 48.6 30.5 11.2 18.8 36.6 42.7 30.6 47.9 19.7 16.8 17.8 18.8 23.6 38.6 24.0 26.9 26.3 25.8 42.5 20.9 56.0 37.6 19.7 19.2 27.7 25.8 31.0 47.8 25.6 23.1 34.1 19.5 44.1 24.3 45.5 22.7 22.7 25.1 29.3 26.5 33.6 14.5 26.3 36.5 17.9 21.8 22.5 34.9 39.2 19.8 19.5 18.8 42.6 36.6 39.1 31.6 18.7 12.0 22.8 18.4 16.7 18.7 18.0 18.3 32.5 10.8 23.0 23.0 16.9 23.8 49.3 26.8 60.2 36.2 34.7 14.2 6.0 18.8 11.2 27.5 18.3 41.2 48.6 41.3 36.0 30.5 43.8 42.7 37.0 7.3 36.6 14.0 29.2 36.9 30.6 35.0 35.5 18.0 23.8 29.0 28.8 32.1 25.6 23.8 25.0 56.6 49.0 70.0 90.1 67.0 59.0 74.7 38.2 48.2 51.2 43.6 31.4 98.6 77.9 93.1 1.7 54.2 20.6 23.3 71.9 123.6 68.6 66.4 31.2 58.6 82.4 50.9 37.0 53.4 79.2 4.0 64.2 52.3 59.1 111.0 39.3 83.6 78.4 23.0 72.2 75.2 23.7 51.8 71.3 25.1 45.4 63.2 114.1 63.3 53.4 76.3 DAZAP1 MGC19907 ENSG00000071626 "DAZ associated protein 1" Q96EP5 19 1407569-1435687 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004201, HPA004631" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 1700000 Nucleoplasm Cytosol "HPA004201: AB_1078627, HPA004631: AB_1078626" "unprognostic (1.50e-1)" "unprognostic (3.19e-2)" "unprognostic (7.69e-2)" "unprognostic (2.29e-1)" "unprognostic (7.31e-3)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.83e-1)" "unprognostic (2.30e-1)" "unprognostic (6.13e-2)" "unprognostic (1.09e-1)" "unprognostic (8.11e-3)" "unprognostic (2.72e-3)" "unprognostic (2.40e-3)" "unprognostic (8.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.21e-3)" 22.1 15.0 11.4 33.1 14.2 37.1 32.9 16.1 19.4 15.2 21.4 22.2 17.2 28.3 17.8 11.0 30.9 16.0 13.5 26.7 11.5 9.2 17.1 38.1 18.7 29.2 16.8 12.4 20.7 28.3 11.9 11.4 22.2 13.3 15.9 15.6 16.8 17.0 12.0 31.4 20.2 28.7 17.7 10.9 28.5 22.0 46.8 15.0 43.8 15.9 22.6 21.0 21.4 27.7 7.1 6.1 4.3 7.5 6.5 7.1 3.1 53.2 19.4 13.0 23.7 5.8 7.1 37.4 24.0 12.0 19.7 16.2 19.3 26.4 62.8 14.8 11.7 9.6 30.1 17.2 22.9 16.7 43.9 27.2 32.3 18.6 19.6 13.5 39.1 27.8 7.0 15.1 13.4 24.6 8.4 17.2 26.7 48.1 33.2 12.3 21.8 68.5 34.8 40.2 19.6 19.6 49.4 20.8 38.7 14.8 18.1 25.9 23.3 15.9 25.0 28.9 17.7 22.7 52.2 18.6 16.2 22.0 28.3 52.5 39.3 40.3 49.8 19.6 38.1 24.8 3.2 5.5 4.3 6.5 7.5 7.1 7.1 6.0 6.9 4.9 5.5 6.0 6.4 2.4 6.5 5.2 6.1 6.1 3.1 11.4 14.2 16.1 19.4 11.5 9.2 16.8 12.4 13.3 15.0 8.9 25.1 51.6 76.4 61.6 49.4 34.3 33.1 10.7 18.2 24.4 33.4 33.1 19.9 45.8 41.0 31.5 47.0 23.3 47.1 91.4 34.5 63.8 26.5 38.1 42.1 25.4 31.8 30.7 39.5 45.6 25.9 40.6 38.8 24.4 62.3 27.0 52.0 42.1 22.3 37.7 38.4 25.8 48.4 128.2 37.5 65.5 57.7 39.8 68.9 92.5 DBNDD1 "FLJ12582, MGC3101" ENSG00000003249 "Dysbindin domain containing 1" Q9H9R9 16 90004865-90020128 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6;skeletal muscle: 39.7" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 13.8;Exocrine glandular cells: 16.0;Horizontal cells: 28.6;Pancreatic endocrine cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 14.4" "Lineage enriched" "Detected in many" 6 "B-cells: 14.4" "Cell line enhanced" "Detected in many" "MCF7: 47.7" HPA043018 Uncertain Approved "Nuclear speckles,Cytosol" No No "Nuclear speckles" Cytosol "HPA043018: AB_10794921" "unprognostic (1.07e-1)" "unprognostic (8.40e-2)" "unprognostic (8.70e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-2)" "unprognostic (4.18e-2)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.07e-2)" "unprognostic (9.52e-2)" "unprognostic (1.54e-1)" "unprognostic (2.86e-2)" "prognostic favorable (2.75e-7)" "unprognostic (1.03e-1)" "unprognostic (5.67e-1)" "unprognostic (2.44e-2)" "unprognostic (2.00e-2)" 2.1 6.9 21.5 2.3 13.7 0.8 4.7 16.1 31.6 2.6 2.0 6.5 1.9 1.9 1.4 9.6 13.9 3.9 3.9 3.4 15.7 14.6 6.9 6.2 3.0 3.9 17.6 9.4 3.1 14.1 6.3 3.0 0.6 19.2 3.7 1.8 3.9 11.9 3.8 39.7 3.9 1.2 1.6 6.8 1.6 4.3 1.1 4.5 0.0 3.6 2.3 4.7 2.0 2.3 14.4 0.1 0.6 0.0 0.0 2.5 0.8 7.8 12.0 1.1 14.5 0.3 0.1 8.6 1.7 2.2 3.5 1.7 11.7 6.4 0.0 1.0 0.3 3.3 8.2 12.7 0.3 3.4 0.0 23.1 0.0 1.7 19.1 0.5 0.1 1.3 0.3 1.0 6.1 0.0 8.1 15.2 0.2 2.2 0.1 1.2 47.7 0.0 9.9 20.3 5.7 5.1 4.8 11.0 0.2 19.8 1.5 17.5 18.7 1.9 1.7 14.9 3.3 11.3 1.3 12.2 2.8 5.5 0.1 7.8 0.0 0.1 0.0 1.2 0.9 6.9 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.6 0.4 0.0 14.4 2.5 0.4 0.0 0.0 0.0 0.1 0.0 0.8 21.5 13.7 16.1 31.6 15.7 14.6 17.6 9.4 19.2 4.5 3.0 1.3 0.8 0.5 0.3 1.3 2.2 7.6 1.4 2.3 8.7 0.0 0.1 8.3 13.8 0.0 0.6 0.3 0.0 16.0 0.2 0.2 4.5 0.0 2.0 0.3 28.6 5.8 1.8 0.0 0.0 1.1 0.0 3.3 0.0 2.1 5.1 15.0 2.9 0.4 7.3 1.2 0.0 0.7 0.0 1.9 0.9 0.0 0.0 0.6 1.0 DBNDD2 "C20orf35, HSMNP1" ENSG00000244274 "Dysbindin domain containing 2" Q9BQY9 20 45406057-45410610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 160.5;skeletal muscle: 84.2" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Ciliated cells: 9.4;Club cells: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "dendritic cells: 15.0;monocytes: 9.3;T-cells: 7.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043991 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043991: AB_10966212" "unprognostic (6.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.79e-3)" "unprognostic (2.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.31e-3)" "unprognostic (8.24e-2)" "unprognostic (5.44e-2)" "unprognostic (3.06e-1)" "unprognostic (3.71e-2)" "unprognostic (2.47e-1)" "unprognostic (1.41e-3)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (2.52e-2)" "unprognostic (3.48e-1)" 12.2 7.8 56.5 9.9 64.9 2.1 15.3 21.3 88.8 11.0 26.4 132.3 5.0 16.6 14.9 13.6 18.3 17.7 10.2 68.4 85.1 47.3 5.9 2.5 13.9 5.8 98.2 31.5 6.5 6.7 18.4 5.0 13.2 51.8 14.2 28.4 3.1 9.0 29.1 84.2 10.4 19.4 31.0 160.5 5.0 13.3 3.0 70.7 2.7 4.8 10.5 8.2 16.8 8.2 0.3 15.0 0.3 9.3 0.6 7.9 3.5 21.7 3.9 3.1 22.0 2.0 0.9 4.4 12.8 13.9 10.7 7.3 10.5 29.8 0.3 2.2 12.6 4.0 32.2 21.5 1.1 6.6 0.1 12.6 18.1 16.8 9.5 12.9 0.9 27.6 0.3 3.7 4.0 3.8 18.7 7.3 18.6 1.3 0.4 0.8 27.6 1.5 1.3 4.1 14.3 23.2 0.0 0.3 0.2 30.6 0.4 7.2 3.7 4.4 2.4 27.5 2.3 30.1 5.6 11.7 0.4 21.3 14.2 13.9 0.3 0.4 0.1 1.5 0.1 3.1 0.0 8.4 0.0 7.9 9.3 2.9 0.1 6.9 5.8 6.0 0.3 6.4 6.0 0.3 0.6 5.0 15.0 5.8 3.5 56.5 64.9 21.3 62.5 85.1 47.3 98.2 31.5 51.8 70.7 3.0 0.3 0.0 0.1 0.0 0.0 1.0 0.0 9.4 4.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.2 1.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 DBNL "ABP1, HIP-55, SH3P7" ENSG00000136279 "Drebrin like" Q9UJU6 7 44044640-44069456 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Endocytosis, Immunity, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "monocytes: 471.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020265, HPA027735" Enhanced Supported Nucleoplasm,Cytosol NA NA 15000000 Cytosol Nucleoplasm "HPA020265: AB_1850723, HPA027735: AB_10603790" "unprognostic (9.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.12e-5)" "unprognostic (2.25e-1)" "unprognostic (6.18e-3)" "unprognostic (1.83e-1)" "unprognostic (5.88e-2)" "unprognostic (8.92e-2)" "unprognostic (5.76e-3)" "unprognostic (5.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (1.46e-1)" "unprognostic (9.51e-2)" 23.9 19.6 21.2 45.4 17.4 34.1 20.5 11.4 24.0 23.9 21.0 19.6 23.5 17.9 22.0 21.8 65.6 19.1 32.7 18.0 18.3 18.8 18.9 18.4 23.6 49.8 19.1 23.8 15.2 19.2 16.7 18.5 25.8 16.1 21.0 15.2 17.2 23.4 22.3 15.9 26.2 23.2 25.2 19.8 46.8 24.7 13.0 15.8 31.0 18.2 32.0 52.3 23.6 31.6 46.7 66.0 64.1 73.7 31.6 35.4 80.5 19.6 28.6 17.9 19.4 22.3 14.4 16.6 32.3 27.0 32.2 27.1 28.7 27.4 44.0 23.5 35.2 40.3 34.9 10.4 37.8 12.1 23.5 12.1 14.9 21.4 16.3 22.7 22.3 27.8 13.6 15.1 30.6 10.7 21.0 22.1 27.5 18.7 15.3 30.5 28.5 39.9 25.1 14.6 20.2 24.2 22.2 14.6 21.8 20.8 27.4 21.8 28.9 22.0 43.3 6.9 13.4 31.9 31.1 35.3 26.5 24.0 15.3 37.4 35.9 15.4 24.6 24.9 25.3 62.6 39.2 66.3 50.2 35.4 73.7 28.0 46.7 26.7 28.8 63.9 45.8 27.0 28.2 64.1 31.6 71.0 66.0 31.3 80.5 21.2 17.4 11.4 24.0 18.3 18.8 19.1 23.8 16.1 15.8 41.7 39.3 122.1 30.1 15.7 32.3 28.5 25.5 16.0 19.4 29.6 33.4 67.1 38.1 80.6 8.5 35.4 50.3 46.7 64.8 122.0 37.7 30.1 63.6 19.2 155.2 38.1 36.4 29.4 130.7 6.2 34.2 90.1 52.3 471.5 44.3 39.0 78.0 73.7 31.8 24.0 36.5 6.5 39.1 19.9 13.0 23.3 73.0 66.0 34.9 51.4 DCAF12L1 "KIAA1892L, WDR40B" ENSG00000198889 "DDB1 and CUL4 associated factor 12 like 1" Q5VU92 X 126549383-126552851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 22.6;testis: 30.9" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 15.4;Late spermatids: 30.6;Spermatogonia: 12.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "EFO-21: 17.6;U-2 OS: 9.8" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (2.62e-5)" "unprognostic (2.88e-1)" "unprognostic (1.19e-1)" "unprognostic (3.40e-1)" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (1.74e-1)" 0.2 0.1 0.2 0.0 0.1 0.0 0.7 0.1 0.1 0.5 0.1 0.0 6.2 0.0 0.6 22.6 0.1 4.3 4.3 0.1 0.1 0.4 3.3 0.1 0.1 0.0 0.1 0.0 1.5 0.1 0.0 0.6 0.0 0.3 1.0 0.0 0.5 0.1 3.9 0.1 0.1 0.1 2.5 0.1 1.5 1.6 30.9 0.0 0.3 0.9 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.8 0.0 0.0 0.0 3.4 12.5 0.0 0.0 0.0 0.0 0.0 DCAF12L2 WDR40C ENSG00000198354 "DDB1 and CUL4 associated factor 12 like 2" Q5VW00 X 126163499-126166097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 15.7;epididymis: 53.6;testis: 15.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HAP1: 5.9;NTERA-2: 4.9;U-2 OS: 8.1" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (1.16e-4)" "unprognostic (8.83e-3)" "unprognostic (2.93e-1)" "unprognostic (2.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-1)" "unprognostic (3.34e-3)" "unprognostic (1.16e-1)" "unprognostic (8.47e-4)" "unprognostic (1.56e-2)" "unprognostic (4.05e-2)" "unprognostic (3.86e-2)" "unprognostic (2.51e-1)" 1.1 1.2 1.1 0.1 1.9 0.1 2.3 0.5 2.1 1.9 0.9 0.0 15.7 0.1 2.4 53.6 0.5 3.0 0.2 0.4 1.0 3.9 0.4 0.1 0.2 0.2 1.0 1.7 1.9 0.2 2.4 1.3 0.1 1.3 2.0 0.2 0.2 0.6 5.6 0.4 0.5 0.5 2.0 0.8 0.2 0.7 15.8 0.1 0.0 0.4 0.0 0.3 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.5 2.1 1.0 3.9 1.0 1.7 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCAF13 "DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1" ENSG00000164934 "DDB1 and CUL4 associated factor 13" Q9NV06 8 103414714-103443453 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Ubl conjugation pathway" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044504 Uncertain Supported "Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Centrosome, Cytosol" "HPA044504: AB_2678963" "prognostic unfavorable (4.06e-4)" "unprognostic (4.39e-2)" "unprognostic (1.70e-1)" "unprognostic (4.46e-3)" "unprognostic (3.57e-2)" "unprognostic (7.86e-3)" "prognostic unfavorable (8.05e-6)" "unprognostic (5.92e-3)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.54e-3)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (8.63e-2)" 18.4 20.5 13.8 18.1 15.7 10.6 20.2 11.3 14.3 16.0 16.7 13.0 12.9 13.1 18.1 16.7 24.0 15.3 10.7 15.9 12.4 11.8 35.2 26.5 12.4 18.4 16.5 12.1 20.9 28.9 15.7 34.6 21.2 16.2 16.4 18.5 7.4 15.9 11.3 21.1 13.7 16.8 15.3 13.9 20.4 14.7 25.3 15.0 26.4 17.1 22.6 24.3 16.9 15.5 28.6 26.4 10.3 22.1 24.0 27.2 20.2 25.3 22.8 21.3 21.7 15.5 18.0 16.0 18.9 14.5 18.0 18.5 22.4 24.8 35.3 32.4 19.8 17.8 19.1 28.8 24.2 34.9 33.6 20.5 48.7 13.7 25.4 17.7 19.9 21.0 14.6 16.7 26.5 44.1 11.3 24.9 24.3 32.7 15.5 27.3 20.6 37.8 21.0 32.6 71.8 35.6 24.6 25.9 36.3 26.2 21.2 27.2 25.8 11.8 18.5 21.4 19.6 28.6 13.7 16.4 18.3 29.5 23.6 25.3 17.1 29.8 49.9 24.7 43.6 23.4 8.6 18.6 10.3 18.4 22.1 25.2 28.6 19.8 19.7 26.4 22.1 19.8 20.2 2.0 24.0 16.0 13.7 27.2 20.2 13.8 15.7 11.3 14.3 12.4 11.8 16.5 12.1 16.2 15.0 14.9 14.2 31.8 57.7 70.6 19.2 17.3 7.6 14.7 31.8 31.4 23.6 50.1 33.2 41.0 33.6 28.9 16.1 0.0 42.0 61.5 36.1 25.3 40.3 14.7 39.5 15.9 13.9 17.2 15.4 10.8 22.5 25.0 25.3 30.7 16.0 25.8 34.4 10.5 16.6 66.3 19.8 12.9 36.3 85.0 87.9 67.2 28.4 26.3 25.4 52.2 DCAF16 "C4orf30, FLJ20280" ENSG00000163257 "DDB1 and CUL4 associated factor 16" Q9NXF7 4 17800655-17810758 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042487 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042487: AB_10795505" "unprognostic (2.23e-3)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" "unprognostic (3.97e-1)" "unprognostic (8.02e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (6.40e-4)" "prognostic favorable (5.78e-4)" "unprognostic (5.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" "unprognostic (3.19e-2)" "unprognostic (1.78e-1)" "unprognostic (8.72e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-3)" "prognostic favorable (7.67e-4)" 13.0 13.1 12.7 12.1 20.5 23.3 19.8 19.4 19.7 18.5 13.1 22.5 9.9 12.0 26.9 16.5 11.5 16.1 11.3 11.8 13.9 15.7 11.3 6.8 12.6 16.7 14.4 16.2 29.6 16.0 17.8 25.8 14.8 19.0 16.9 14.8 17.1 15.2 13.0 16.2 22.4 14.0 17.2 16.0 13.3 13.6 19.2 16.3 30.6 15.7 7.0 18.3 16.3 14.6 4.8 3.0 9.7 2.8 3.6 6.3 2.2 12.2 2.6 14.3 15.0 4.1 7.2 7.9 8.0 9.5 9.6 11.4 7.5 10.0 13.9 6.4 7.4 7.8 6.2 8.4 8.5 14.3 4.7 7.7 19.4 8.8 12.2 9.9 17.0 7.9 9.4 7.0 12.2 12.1 6.5 6.6 13.7 20.8 23.1 5.5 4.6 18.7 16.4 11.8 3.6 7.7 19.8 16.4 8.9 4.1 9.7 21.4 17.2 8.5 2.3 9.2 7.6 8.4 4.7 8.3 11.2 8.8 12.3 10.1 10.3 4.1 17.3 9.2 11.9 7.5 9.7 2.4 3.4 4.5 2.8 5.9 3.7 5.0 4.9 1.5 4.8 6.3 5.9 1.8 3.6 1.9 3.0 3.4 2.2 12.7 20.5 19.4 19.7 13.9 15.7 14.4 16.2 19.0 16.3 17.9 19.0 9.0 15.5 22.6 11.8 14.8 15.3 21.4 17.0 8.7 5.9 14.1 11.6 8.6 14.8 12.1 7.1 23.3 6.7 7.7 16.1 12.3 16.2 5.7 6.4 14.3 16.8 11.6 9.7 9.1 19.5 9.6 10.1 5.4 16.5 23.4 8.7 5.8 20.8 5.0 13.6 12.9 13.2 24.2 17.2 18.4 10.3 15.2 13.0 14.3 DCAF7 "HAN11, SWAN-1, WDR68" ENSG00000136485 "DDB1 and CUL4 associated factor 7" P61962 17 63550461-63594266 "Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022948, HPA022962" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022948: AB_1858820, HPA022962: AB_1858821" "unprognostic (7.75e-2)" "unprognostic (3.31e-1)" "unprognostic (1.37e-3)" "unprognostic (3.78e-2)" "unprognostic (1.03e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.86e-1)" "unprognostic (2.28e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.40e-2)" "unprognostic (1.97e-1)" "unprognostic (9.95e-2)" "unprognostic (4.18e-2)" 17.0 18.4 27.6 25.8 24.8 7.9 15.6 20.8 27.3 21.1 22.9 27.1 22.5 24.9 19.4 19.4 20.5 19.6 20.1 17.1 24.9 22.3 26.7 20.9 23.5 25.5 22.2 16.5 17.1 20.0 39.2 19.0 25.7 19.4 22.4 25.7 21.1 18.0 24.5 11.5 15.8 26.7 18.8 24.4 28.8 19.8 32.5 22.2 47.1 21.9 13.0 30.3 20.7 16.2 10.2 12.1 13.6 17.3 10.0 13.6 8.4 11.3 16.1 28.4 18.1 9.8 8.1 7.5 11.4 10.1 12.6 10.7 11.8 12.4 21.0 9.2 11.3 13.2 12.2 23.6 16.0 16.3 8.0 15.1 27.4 10.4 13.8 10.2 30.4 15.9 6.8 10.6 7.3 16.9 15.3 19.7 17.9 28.8 9.8 16.0 13.9 32.8 14.7 9.2 19.8 21.9 26.3 33.8 11.9 18.5 17.3 27.4 50.6 10.3 20.0 13.4 26.3 14.7 24.8 20.7 20.9 9.6 10.5 18.7 10.3 13.2 11.3 11.9 19.8 12.4 11.5 12.6 13.6 13.6 15.0 11.0 9.4 9.5 10.5 12.1 10.2 8.7 9.2 5.5 10.0 17.3 9.0 6.6 8.4 27.6 24.8 20.8 27.3 24.9 22.3 22.2 16.5 19.4 22.2 41.7 48.2 37.3 25.6 27.8 52.6 21.4 45.9 42.8 25.0 64.6 72.6 40.4 19.9 43.3 50.6 38.7 48.4 23.3 39.3 40.6 25.0 38.1 58.9 33.4 49.0 62.0 69.2 51.5 52.9 14.3 32.5 48.5 25.3 52.3 48.0 47.3 45.5 31.6 35.7 39.4 51.4 58.2 30.0 54.4 26.8 30.5 18.1 51.0 51.9 37.2 DCAF8 "FLJ35857, H326, WDR42A" ENSG00000132716 "DDB1 and CUL4 associated factor 8" Q5TAQ9 1 160215715-160262531 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA027218, HPA027381" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027218: AB_10602586, HPA027381: AB_1858808" "unprognostic (3.47e-1)" "unprognostic (1.86e-1)" "unprognostic (4.39e-3)" "unprognostic (1.02e-2)" "unprognostic (2.25e-1)" "unprognostic (1.87e-2)" "unprognostic (3.29e-1)" "unprognostic (1.87e-2)" "unprognostic (3.13e-2)" "unprognostic (9.34e-3)" "prognostic favorable (4.71e-4)" "unprognostic (5.42e-2)" "prognostic unfavorable (3.74e-5)" "unprognostic (3.30e-1)" "unprognostic (7.42e-2)" "unprognostic (3.98e-1)" "unprognostic (1.56e-3)" 26.6 28.7 26.3 21.6 29.5 21.2 26.4 37.6 38.3 22.2 28.0 39.6 31.6 25.0 28.7 38.2 24.6 27.6 29.0 35.8 25.9 20.0 25.6 42.2 23.0 25.5 30.1 29.2 29.8 34.6 45.3 33.1 21.5 31.7 23.8 19.0 29.3 29.0 44.9 86.4 28.8 26.1 26.8 23.8 28.6 28.6 20.8 32.5 25.7 36.9 27.2 22.7 28.0 21.6 26.6 17.8 22.4 21.6 24.9 26.6 14.4 17.1 21.5 24.4 22.0 30.7 23.3 21.3 20.4 28.9 17.1 15.3 22.6 29.8 19.0 38.3 23.1 12.6 21.3 11.8 19.2 10.8 43.5 23.2 21.1 30.1 17.7 25.0 17.6 27.0 27.6 20.3 15.2 22.1 19.0 26.4 24.6 19.0 35.0 15.8 16.3 22.7 17.6 17.5 22.6 21.4 22.3 14.4 37.1 19.6 30.6 16.6 16.0 34.2 38.3 22.9 24.7 35.9 26.7 31.7 21.1 10.9 12.9 18.8 57.5 39.2 30.9 23.5 16.6 17.2 22.4 17.5 18.1 26.6 16.9 26.1 23.7 23.6 25.0 14.8 26.6 26.2 23.8 19.9 24.9 21.6 17.8 24.3 14.4 26.3 29.5 37.6 38.3 25.9 20.0 30.1 29.2 31.7 32.5 53.6 45.7 13.9 17.0 16.4 43.6 50.1 22.9 48.2 38.7 24.4 60.9 25.4 53.0 18.8 1.7 23.6 23.7 0.0 18.8 17.5 22.0 14.7 31.4 60.2 20.7 38.1 24.1 17.2 29.6 1.9 25.9 19.5 13.5 30.7 19.1 36.1 17.3 10.5 30.8 27.6 56.3 12.9 25.5 27.5 17.9 21.1 37.1 28.0 19.0 8.2 DCBLD1 "dJ94G16.1, MGC46341" ENSG00000164465 "Discoidin, CUB and LCCL domain containing 1" Q8N8Z6 6 117453817-117569858 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA059667 Approved Approved Cytosol NA NA 11000000 Cytosol "HPA059667: AB_2684099" "unprognostic (1.00e-1)" "prognostic unfavorable (6.44e-5)" "unprognostic (1.08e-1)" "unprognostic (3.23e-3)" "unprognostic (2.47e-1)" "unprognostic (2.29e-3)" "unprognostic (1.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.74e-2)" "unprognostic (8.99e-2)" "unprognostic (5.69e-3)" "unprognostic (6.33e-2)" "prognostic unfavorable (8.57e-8)" "unprognostic (6.99e-2)" "unprognostic (4.72e-2)" "unprognostic (7.44e-2)" "unprognostic (1.36e-1)" 15.5 5.2 6.6 7.9 5.6 0.7 12.2 5.1 8.9 12.9 10.6 4.2 10.4 9.0 7.9 6.2 7.9 3.9 12.8 8.2 4.8 3.7 6.1 13.2 15.6 6.3 4.7 3.2 3.2 13.1 12.2 12.6 12.1 7.0 7.6 8.7 4.5 7.1 9.6 17.8 4.3 12.7 7.1 10.2 5.8 10.5 7.6 3.2 1.2 8.8 7.0 5.1 10.5 12.2 0.0 1.2 0.0 0.7 1.0 3.5 1.2 3.1 7.3 2.6 2.9 4.6 5.8 7.4 18.2 24.0 15.5 11.8 15.3 6.9 0.0 9.1 7.8 19.3 7.3 5.0 8.1 16.4 1.4 3.8 2.7 7.6 24.9 20.0 3.9 2.3 6.6 19.0 14.0 13.3 17.9 21.5 2.7 5.8 2.8 20.2 2.5 0.0 2.6 1.9 8.6 3.0 0.0 0.5 1.8 3.4 3.8 7.9 0.1 13.4 1.5 2.1 3.9 1.9 5.2 15.9 0.0 18.8 5.2 7.9 7.8 2.1 2.1 7.8 3.9 6.8 0.0 0.5 0.0 1.7 0.7 0.3 0.0 2.4 3.5 0.6 0.0 3.0 3.5 0.0 1.0 0.3 1.2 2.2 1.2 6.6 5.6 5.1 8.9 4.8 3.7 4.7 3.2 7.0 3.2 14.9 13.1 5.2 2.9 4.6 5.6 3.2 12.7 5.3 15.9 5.2 5.9 23.0 1.7 5.2 22.6 7.8 9.7 0.0 4.2 4.8 5.1 3.1 1.1 7.9 5.0 4.8 4.1 13.5 5.1 7.0 0.9 6.3 8.5 1.0 7.1 1.2 7.9 7.8 0.4 2.1 3.0 12.9 17.6 1.5 13.6 5.3 15.2 6.1 9.3 5.3 DCBLD2 "CLCP1, ESDN" ENSG00000057019 "Discoidin, CUB and LCCL domain containing 2" Q96PD2 3 98795941-98901689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 66.0;Cone photoreceptor cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 59.8;hTERT-RPE1: 84.9;LHCN-M2: 99.6;RPTEC TERT1: 62.4;U-87 MG: 76.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016909 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 1800000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA016909: AB_1847510" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" "unprognostic (2.64e-1)" "unprognostic (5.97e-3)" "unprognostic (9.29e-3)" "unprognostic (8.31e-3)" "unprognostic (1.06e-3)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.32e-5)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.76e-2)" "unprognostic (3.93e-2)" "unprognostic (1.59e-3)" 13.1 14.6 4.5 6.4 7.2 1.1 19.3 9.7 9.6 12.0 13.1 5.1 8.1 2.7 16.8 9.2 8.8 13.9 11.7 24.2 4.5 6.2 11.3 9.2 13.1 3.2 6.7 3.5 19.0 6.4 17.6 12.7 9.9 6.5 11.2 6.8 19.3 11.1 14.7 6.6 7.7 5.2 16.7 7.1 2.1 8.6 33.8 7.3 8.1 18.7 6.3 3.6 15.1 6.8 0.6 1.2 1.7 0.5 0.1 1.1 0.2 6.8 50.2 6.7 5.3 9.0 21.4 2.9 15.5 7.4 10.6 12.0 4.2 21.9 0.0 48.8 26.6 32.5 6.4 3.0 25.2 24.4 0.1 1.0 2.4 1.6 6.4 5.5 1.1 1.1 8.4 3.9 30.4 59.8 84.9 6.9 0.9 0.4 0.6 99.6 1.8 0.9 0.6 4.7 0.0 17.4 1.0 12.7 0.6 62.4 1.8 1.8 3.1 4.2 0.8 18.1 4.8 3.4 0.9 11.4 27.3 21.9 6.9 54.2 0.8 1.1 0.9 76.2 0.4 11.8 1.2 0.5 1.7 0.0 0.1 0.0 0.6 0.1 0.1 0.5 0.2 1.1 0.1 0.9 0.1 0.3 1.2 0.0 0.2 4.5 7.2 9.7 9.6 4.5 6.2 6.7 3.5 6.5 7.3 29.8 44.4 4.5 12.4 20.3 11.2 66.0 12.7 18.7 20.5 17.4 72.6 9.6 0.0 20.3 2.5 7.1 0.9 0.0 7.0 8.2 18.1 10.1 36.9 18.7 3.5 12.7 3.5 4.9 1.6 3.6 20.4 2.6 8.5 1.8 7.3 44.0 17.8 3.5 47.4 6.9 49.1 0.0 19.1 15.8 23.3 13.7 3.3 0.0 10.7 5.9 DCDC2 "DCDC2A, DFNB66, KIAA1154, NPHP19, RU2" ENSG00000146038 "Doublecortin domain containing 2" Q9UHG0 6 24171756-24358052 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Neurogenesis" "Ciliopathy, Deafness, Disease mutation, Nephronophthisis, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 37.0;kidney: 46.4;pancreas: 22.7" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 61.1;Ciliated cells: 60.2;Collecting duct cells: 75.0;Distal tubular cells: 48.0;Ductal cells: 106.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 20.2;EFO-21: 14.1;Hep G2: 22.9;RPTEC TERT1: 74.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031582, HPA031583, HPA031584" Enhanced Enhanced "Microtubules,Mitotic spindle,Centriolar satellite,Cytosol" NA NA "Mitotic spindle, Cytosol" "Microtubules, Centriolar satellite" "HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945" "unprognostic (8.65e-2)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (6.70e-2)" "unprognostic (1.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (5.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.99e-2)" 0.1 0.9 1.1 0.2 1.5 0.0 3.5 0.3 0.9 1.6 0.3 0.2 1.0 0.3 3.4 37.0 0.2 5.8 7.7 0.2 1.3 1.7 46.4 1.8 3.9 0.0 0.6 0.5 2.1 22.7 7.6 4.3 1.7 1.8 1.5 0.3 2.8 0.9 3.7 0.5 0.2 0.2 0.4 0.5 0.1 1.1 3.7 0.2 0.2 8.4 0.0 0.2 1.0 0.1 1.2 0.5 1.3 0.4 1.0 0.5 0.2 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.2 0.0 1.5 0.1 0.0 0.4 0.0 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.4 0.3 0.5 0.2 0.2 0.5 0.5 0.3 0.3 1.2 0.4 0.4 1.3 1.0 0.2 0.5 0.2 0.2 1.1 1.5 0.3 0.9 1.3 1.7 0.6 0.5 1.8 0.2 17.9 11.8 0.0 0.6 0.1 0.0 0.3 61.1 60.2 10.3 75.0 0.0 0.3 48.0 106.8 23.9 0.0 0.0 0.0 7.2 0.0 0.3 1.1 0.0 1.0 0.5 0.0 3.5 0.0 0.0 11.0 0.3 0.0 0.0 3.6 3.4 1.9 20.8 2.9 0.4 39.0 0.0 0.0 0.3 7.7 2.2 0.1 0.1 0.0 1.2 0.5 DCLK1 "DCAMKL1, DCDC3A, DCLK, KIAA0369" ENSG00000133083 "Doublecortin like kinase 1" O15075 13 35768652-36131306 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 76.5" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 84.2" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.7;ASC TERT1: 15.8;fHDF/TERT166: 12.9;GAMG: 19.8;HAP1: 10.0;HSkMC: 14.6;NTERA-2: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012405, HPA015040, HPA015655" Enhanced Approved Nucleoplasm,Cytosol NA NA 11000 Nucleoplasm Cytosol "CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265" "unprognostic (2.29e-1)" "unprognostic (2.56e-1)" "unprognostic (7.45e-2)" "unprognostic (1.30e-2)" "unprognostic (1.99e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-1)" "unprognostic (7.72e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (1.93e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-4)" 13.9 3.3 14.3 4.2 25.0 1.1 8.6 8.6 76.5 12.2 3.5 8.6 0.5 2.0 6.4 5.8 5.8 3.3 7.1 5.8 21.9 21.9 1.9 1.2 3.0 4.3 11.9 22.5 6.4 2.1 1.5 7.4 1.1 13.9 4.7 4.4 0.5 2.5 4.7 1.9 4.7 2.7 17.0 10.4 4.6 2.5 2.2 8.5 0.0 2.1 1.4 2.9 5.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 16.7 15.8 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 12.9 19.8 0.0 10.0 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 0.0 14.6 7.3 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.7 0.0 0.2 0.0 1.1 0.0 0.5 0.0 4.1 2.5 0.0 0.0 1.2 6.1 0.0 0.0 0.0 0.0 3.4 4.3 0.7 0.1 0.0 0.0 1.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 25.0 8.6 45.8 21.9 21.9 11.9 22.5 13.9 8.5 8.9 1.1 0.0 1.0 13.5 2.2 5.1 0.0 4.0 4.5 3.5 3.9 0.0 0.0 0.0 1.3 2.9 0.0 0.0 0.0 0.0 9.3 0.5 0.0 0.0 0.1 9.5 0.0 0.6 0.3 0.9 19.2 0.0 13.5 0.0 0.0 84.2 0.3 0.0 3.9 0.2 2.1 6.5 16.8 1.6 0.7 8.4 0.0 0.0 0.0 1.3 DCP1B FLJ31638 ENSG00000151065 "Decapping mRNA 1B" Q8IZD4 12 1946054-2004535 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 5 "T-cells: 19.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039709 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA039709: AB_10672901" "unprognostic (9.60e-2)" "unprognostic (7.19e-3)" "unprognostic (4.37e-3)" "unprognostic (2.13e-1)" "unprognostic (7.00e-2)" "unprognostic (1.08e-1)" "unprognostic (8.94e-2)" "unprognostic (3.26e-1)" "unprognostic (3.13e-1)" "unprognostic (1.53e-2)" "unprognostic (5.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" "unprognostic (3.98e-2)" "unprognostic (1.46e-1)" "unprognostic (1.84e-2)" "unprognostic (7.42e-2)" 7.3 14.3 8.6 7.1 9.9 2.4 7.4 10.7 8.4 11.0 17.9 6.7 5.6 4.8 18.1 9.8 6.1 11.5 9.2 3.2 10.3 4.9 6.5 7.2 6.4 7.0 7.6 8.2 12.9 8.5 8.5 19.8 6.0 6.1 11.7 8.4 7.5 7.2 11.6 8.7 6.2 7.7 29.1 8.5 7.5 9.9 15.8 7.5 10.0 8.0 1.7 7.1 14.4 8.2 3.8 3.9 2.6 3.4 4.0 19.1 3.8 0.1 3.3 6.0 4.6 7.7 9.7 10.1 4.0 8.0 5.1 6.4 0.2 5.2 8.0 1.5 5.9 4.4 0.0 4.1 4.2 4.5 13.5 4.4 3.4 2.5 4.8 10.3 4.7 3.9 7.3 7.1 4.6 4.0 10.7 8.4 6.3 2.0 3.3 6.2 4.1 6.5 3.9 13.2 2.9 1.4 3.8 2.9 1.4 6.0 0.0 0.9 4.4 3.5 2.9 3.0 14.0 2.9 4.4 4.9 2.5 9.0 5.7 4.1 2.8 2.1 5.5 5.9 3.1 6.2 2.6 2.1 0.2 7.9 3.1 9.7 3.8 8.0 7.6 3.9 3.8 6.3 8.0 0.4 4.0 3.4 2.0 19.1 3.8 8.6 9.9 10.7 8.4 10.3 4.9 7.6 8.2 6.1 7.5 6.0 2.9 0.0 3.7 0.8 6.1 2.0 2.5 4.0 4.5 7.0 9.8 4.7 11.6 6.0 42.8 3.6 4.2 0.0 3.7 4.0 4.7 2.7 5.7 5.5 5.1 6.4 2.4 2.5 3.4 13.7 5.2 2.7 1.7 6.4 5.3 4.7 4.6 5.9 8.9 6.3 6.2 0.0 3.3 19.5 8.2 2.0 2.4 7.5 6.3 3.4 DCPS "HINT-5, HSL1, HSPC015" ENSG00000110063 "Decapping enzyme, scavenger" Q96C86 11 126303752-126345749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039632, HPA058597" Supported Supported Nucleoplasm,Cytosol NA NA 1400000 Nucleoplasm Cytosol "HPA039632: AB_10794200, HPA058597: AB_2683770" "unprognostic (1.45e-1)" "unprognostic (5.48e-3)" "unprognostic (1.76e-1)" "unprognostic (3.55e-2)" "unprognostic (5.22e-2)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.90e-1)" "unprognostic (5.57e-2)" "unprognostic (1.91e-2)" "unprognostic (4.83e-2)" "unprognostic (5.00e-2)" "unprognostic (5.25e-2)" "unprognostic (2.24e-2)" "unprognostic (8.04e-2)" "unprognostic (7.67e-2)" "unprognostic (3.40e-2)" 11.1 13.1 6.8 14.4 8.2 13.5 9.2 8.5 14.5 12.1 10.6 6.8 8.0 7.8 12.4 9.6 14.4 9.9 13.9 10.9 5.5 6.1 13.3 39.6 9.9 18.5 6.3 5.8 11.8 17.2 7.0 9.5 14.1 6.8 12.7 11.7 13.3 17.4 9.4 21.8 11.3 9.7 11.3 7.1 21.9 9.6 13.4 6.5 22.0 12.7 18.5 22.1 15.1 9.8 13.2 39.5 3.2 14.3 7.8 14.6 7.1 9.5 6.0 7.5 12.4 5.8 7.8 6.3 5.1 7.5 7.8 7.9 11.3 19.7 13.0 19.2 8.1 5.1 11.2 10.6 16.0 5.2 24.7 5.7 19.1 6.8 9.8 12.6 20.5 17.3 7.9 10.1 9.9 13.5 3.9 10.4 10.9 7.7 22.4 8.5 13.8 13.0 23.5 5.2 51.3 20.6 9.1 11.0 24.8 7.5 10.7 9.7 7.4 15.4 12.6 9.3 4.7 21.4 12.8 6.6 12.2 5.7 5.8 9.5 9.0 8.3 13.5 3.5 35.5 30.7 1.7 9.2 3.2 8.8 14.3 8.2 13.2 8.5 9.0 15.4 9.0 6.0 6.8 0.5 7.8 12.6 39.5 14.6 7.1 6.8 8.2 8.5 14.5 5.5 6.1 6.3 5.8 6.8 6.5 11.9 12.8 34.4 16.6 6.2 6.5 4.5 53.5 16.0 5.7 40.1 0.0 37.0 48.0 17.0 5.4 8.7 5.2 0.0 25.4 38.8 12.7 9.2 16.2 22.8 26.1 3.2 7.0 7.4 13.7 1.7 15.8 10.4 16.9 14.4 9.7 7.8 16.6 14.0 17.3 10.8 7.1 19.4 11.3 11.2 28.0 7.9 22.7 27.7 13.4 19.7 DCTD ENSG00000129187 "DCMP deaminase" P32321 4 182890060-182917936 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035894 Approved Approved Nucleoplasm,Cytosol NA NA 13000 "Nucleoplasm, Cytosol" "HPA035894: AB_10673488" "unprognostic (1.26e-1)" "unprognostic (9.80e-3)" "unprognostic (3.15e-2)" "unprognostic (3.78e-3)" "unprognostic (3.13e-3)" "unprognostic (2.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.59e-3)" "unprognostic (2.62e-2)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.20e-1)" "prognostic favorable (1.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-1)" 24.8 46.2 24.7 19.9 23.8 12.9 27.3 11.6 28.3 27.1 20.4 17.3 22.6 16.4 26.0 20.1 30.9 25.9 40.9 25.8 22.5 22.2 25.7 47.6 25.8 29.4 21.1 20.3 35.9 51.7 28.3 25.3 18.9 21.3 23.7 21.5 30.0 26.4 22.8 24.8 19.4 19.1 27.4 25.6 24.9 27.2 11.8 16.7 15.0 52.9 21.3 26.0 24.5 25.1 31.9 24.8 23.7 25.7 30.8 36.8 22.7 22.7 21.0 21.4 19.8 32.4 44.3 28.1 43.9 39.2 31.5 19.5 21.3 44.2 7.9 10.9 42.7 21.5 11.3 15.6 27.4 29.0 38.3 11.8 36.5 12.2 25.3 34.8 35.5 22.9 36.8 29.2 27.6 28.8 31.9 26.9 17.5 36.2 79.2 41.8 16.6 23.0 21.7 17.0 9.2 18.3 25.1 15.3 15.3 25.4 27.3 21.2 13.1 20.7 17.9 20.5 20.8 13.7 18.6 31.3 26.2 20.2 12.6 33.4 30.4 16.4 10.1 28.9 23.3 30.8 23.7 22.0 19.7 29.2 25.7 36.8 31.9 25.6 29.7 24.8 21.7 25.5 26.7 1.6 30.8 24.9 19.1 21.9 22.7 24.7 23.8 11.6 28.3 22.5 22.2 21.1 20.3 21.3 16.7 11.9 15.0 31.7 28.8 22.6 4.3 20.6 38.2 18.7 11.4 31.4 3.9 16.6 31.5 61.9 6.3 32.1 15.5 23.3 47.4 19.9 41.7 29.4 22.0 38.0 48.4 3.2 13.9 25.2 29.6 13.2 40.9 29.6 25.3 38.7 28.6 31.5 60.2 10.5 33.2 34.1 6.3 32.3 28.2 9.3 15.4 20.1 6.1 27.4 29.9 34.5 DCTN3 DCTN-22 ENSG00000137100 "Dynactin subunit 3" O75935 9 34613545-34620523 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044905 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA044905: AB_10960996" "unprognostic (3.38e-1)" "unprognostic (4.13e-2)" "unprognostic (3.47e-1)" "unprognostic (6.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.92e-3)" "unprognostic (9.88e-2)" "unprognostic (4.41e-2)" "prognostic favorable (2.10e-5)" "unprognostic (1.26e-3)" "unprognostic (4.24e-3)" "prognostic favorable (5.76e-11)" "unprognostic (3.06e-1)" "unprognostic (2.25e-1)" "unprognostic (3.22e-1)" "unprognostic (4.43e-2)" 26.4 32.5 42.4 16.2 49.1 46.5 30.4 33.7 58.3 25.7 23.3 20.7 22.2 21.4 24.6 25.5 33.7 31.7 23.1 42.8 36.3 37.4 32.8 32.4 21.1 21.9 35.8 48.4 32.6 33.7 29.8 36.3 23.0 37.4 27.4 20.6 27.5 32.4 28.6 69.1 37.9 18.3 28.0 26.2 19.4 23.7 16.2 22.0 42.6 32.4 37.1 29.2 22.5 24.9 28.5 44.6 62.3 45.9 29.9 56.0 46.8 34.2 28.8 26.8 28.0 23.8 33.3 11.0 29.3 27.4 40.9 32.2 18.4 12.9 15.8 18.4 38.5 14.3 13.7 24.3 30.7 26.2 49.5 30.5 10.5 51.0 15.8 25.8 27.6 32.1 29.3 26.6 28.2 18.5 20.0 26.9 29.8 12.5 32.8 35.6 28.2 34.7 74.5 8.1 14.4 46.5 17.5 14.5 21.7 19.7 12.2 8.9 22.9 21.7 20.0 11.2 8.2 26.8 31.7 24.4 25.8 20.9 29.2 28.4 22.2 28.7 10.5 40.5 16.1 52.4 62.3 44.0 59.3 35.2 44.2 32.0 28.5 37.8 37.2 44.0 28.3 29.9 35.7 38.4 29.9 45.9 44.6 56.0 46.8 42.4 49.1 33.7 58.3 36.3 37.4 35.8 48.4 37.4 22.0 29.8 31.8 49.9 82.5 90.2 76.0 72.8 63.7 57.6 43.3 76.8 23.6 100.4 175.8 103.7 8.3 78.7 68.5 210.2 135.3 93.0 101.4 62.7 86.5 74.9 115.9 69.9 71.7 73.1 79.5 15.7 95.8 80.9 141.7 86.6 53.8 145.8 101.0 66.0 115.2 170.3 63.4 58.2 101.0 73.5 71.3 124.6 83.4 96.6 55.1 72.9 DCTN6 WS-3 ENSG00000104671 "Dynactin subunit 6" O00399 8 30156297-30183640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024049, HPA024558" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoli, Cytosol" "Plasma membrane" "HPA024049: AB_1847524, HPA024558: AB_1847525" "unprognostic (1.28e-1)" "unprognostic (8.32e-3)" "unprognostic (1.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.69e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (7.84e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-2)" "unprognostic (9.26e-2)" "prognostic favorable (5.42e-4)" "unprognostic (1.06e-1)" "unprognostic (3.10e-1)" "unprognostic (7.54e-2)" "unprognostic (1.43e-1)" 29.5 34.6 41.4 15.6 39.4 23.3 32.6 23.6 43.6 21.0 20.6 27.4 15.4 14.2 24.1 27.2 24.1 18.0 20.0 44.5 37.7 35.2 32.8 27.5 20.3 15.3 42.3 36.3 26.3 19.5 31.0 27.7 32.7 41.4 21.9 22.5 16.5 20.3 23.7 20.4 17.5 15.6 26.0 46.2 16.8 19.3 13.9 30.3 15.4 33.7 18.2 17.9 25.7 18.8 7.4 19.8 9.5 15.9 10.2 11.2 6.9 19.1 18.3 23.3 12.2 21.1 29.2 14.9 26.1 30.1 25.4 26.7 11.9 12.8 14.2 28.0 27.2 23.8 14.2 16.1 22.0 30.0 11.4 12.5 20.4 15.8 18.6 16.3 11.5 17.4 24.6 31.4 18.2 19.5 22.1 22.7 20.5 22.8 15.7 27.0 14.5 21.3 16.6 18.9 32.2 11.7 11.4 17.5 12.4 36.1 18.8 38.1 21.6 15.2 18.6 25.8 12.3 18.0 16.3 21.8 13.8 48.3 11.3 18.5 6.7 7.4 18.4 25.5 13.2 24.0 9.5 14.1 4.9 8.6 15.9 9.8 7.4 7.8 10.1 16.8 5.5 9.0 11.2 4.5 10.2 15.1 19.8 8.7 6.9 41.4 39.4 23.6 43.6 37.7 35.2 42.3 36.3 41.4 30.3 23.8 31.2 37.4 81.1 50.8 33.7 73.4 45.9 57.6 37.5 41.8 13.7 76.0 104.5 78.2 11.6 53.1 26.3 0.0 74.2 71.3 55.9 41.2 46.1 41.8 61.9 25.4 39.2 44.2 46.4 7.3 74.8 51.6 65.8 65.9 27.4 43.3 77.1 38.6 70.7 114.8 36.3 51.8 70.0 42.8 48.2 55.6 170.3 40.5 29.2 81.2 DCTPP1 "CDA03, MGC5627, RS21C6, XTP3TPA" ENSG00000179958 "DCTP pyrophosphatase 1" Q9H773 16 30423619-30430075 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002832 Uncertain Approved Nucleoplasm,Cytosol NA Yes 270000 "Nucleoplasm, Cytosol" "HPA002832: AB_1080615" "prognostic unfavorable (1.64e-5)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (6.28e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-1)" "unprognostic (4.35e-2)" "unprognostic (2.43e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.71e-9)" "unprognostic (1.10e-3)" "unprognostic (8.78e-3)" "unprognostic (1.10e-2)" "unprognostic (2.53e-1)" 15.3 15.8 14.8 25.0 13.2 12.5 20.7 15.5 19.2 12.1 37.4 10.3 11.3 20.7 14.1 14.4 19.7 18.9 28.1 23.3 12.1 12.6 27.0 25.3 11.2 27.6 13.3 16.6 16.6 25.2 16.4 7.7 16.3 11.4 15.4 40.3 10.6 20.5 21.1 28.3 16.1 22.9 13.9 11.3 22.5 16.4 9.9 7.8 21.3 22.6 26.0 25.0 13.2 13.0 47.3 30.9 19.0 24.5 23.1 26.2 25.3 26.6 32.7 14.9 19.2 4.2 5.7 13.8 12.8 7.7 19.4 19.8 24.6 22.8 36.1 27.0 8.0 12.4 21.0 30.9 25.1 24.3 19.0 48.8 21.0 15.0 32.0 5.5 37.5 32.8 6.6 14.3 21.6 12.5 5.9 19.9 19.4 26.4 12.7 13.7 46.5 44.5 42.1 19.7 27.0 26.4 63.2 16.6 47.0 22.4 17.3 31.8 18.0 8.5 30.5 12.0 10.2 26.3 16.1 10.0 15.0 13.4 19.3 23.0 8.4 25.0 46.0 9.9 31.2 17.5 19.0 12.4 11.7 18.8 22.1 26.2 47.3 24.2 21.3 28.7 40.2 21.8 21.0 1.5 23.1 24.5 30.9 24.1 25.3 14.8 13.2 15.5 19.2 12.1 12.6 13.3 16.6 11.4 7.8 17.9 14.6 32.0 37.1 80.1 23.9 33.1 61.1 20.1 19.4 41.8 7.9 81.7 107.8 107.5 10.2 47.2 79.9 0.0 108.6 68.9 31.5 41.3 31.1 18.1 68.6 14.3 37.0 25.2 16.6 36.0 18.1 35.6 45.5 108.2 103.3 19.7 78.9 105.2 18.7 54.0 16.3 19.4 35.0 2.8 33.6 70.1 23.2 25.9 124.8 43.2 DCUN1D1 "DCUN1L1, RP42, SCCRO, SCRO, Tes3" ENSG00000043093 "Defective in cullin neddylation 1 domain containing 1" Q96GG9 3 182938074-182985953 "Predicted intracellular proteins" "Ubl conjugation pathway" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 95.0" "Cell type enriched" "Detected in all" 4 "Late spermatids: 9862.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035911 Uncertain Approved Nucleoplasm,Cytosol NA NA 70000 Nucleoplasm Cytosol "HPA035911: AB_10673489" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (1.44e-3)" "unprognostic (6.06e-2)" "unprognostic (5.93e-2)" "unprognostic (1.72e-2)" "unprognostic (9.34e-2)" "unprognostic (9.25e-3)" "unprognostic (4.98e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-3)" "unprognostic (1.52e-1)" "unprognostic (2.12e-1)" "unprognostic (5.01e-2)" "unprognostic (3.52e-1)" 5.0 5.2 7.9 5.0 7.1 6.9 4.8 9.3 8.3 4.5 4.9 4.1 2.7 4.9 5.4 4.9 6.7 4.3 4.6 5.5 7.4 5.0 7.2 11.2 4.3 5.0 9.3 6.8 4.7 3.6 4.6 14.6 4.5 8.0 6.1 4.8 2.8 4.9 5.4 14.7 5.2 6.5 8.1 9.2 5.2 4.2 95.0 7.6 7.2 6.7 5.2 6.0 8.4 4.9 7.4 10.7 17.3 9.8 11.2 8.0 5.7 23.3 10.4 13.9 6.0 14.7 14.5 11.8 15.0 16.9 16.9 16.6 15.3 17.4 27.4 33.0 14.0 25.5 13.1 11.6 12.0 22.5 22.4 6.3 26.4 8.1 6.4 9.3 15.5 19.9 10.3 14.7 9.4 8.9 12.5 11.6 16.8 8.8 14.4 12.3 12.5 15.2 8.3 11.3 17.6 9.5 12.0 14.7 18.1 12.2 16.5 10.1 10.1 26.3 18.9 14.1 15.3 38.7 12.6 11.2 10.5 10.1 14.3 17.6 11.9 22.0 27.8 13.2 14.7 15.1 9.4 9.1 17.3 7.8 9.8 7.5 7.4 6.4 7.7 10.7 4.7 7.5 7.9 15.0 11.2 6.3 8.2 8.0 5.7 7.9 7.1 9.3 8.3 7.4 5.0 9.3 6.8 8.0 7.6 20.8 25.6 17.1 21.7 38.5 14.2 28.2 17.8 20.1 27.3 45.4 9.8 16.2 31.5 26.1 2225.5 18.8 26.6 46.7 26.5 15.7 27.7 32.3 28.9 42.3 24.9 17.5 25.8 17.8 32.1 9862.3 80.3 36.4 11.8 45.1 19.9 16.6 27.2 23.4 60.5 33.6 20.5 77.6 25.5 86.4 52.0 37.1 16.7 25.3 19.6 34.8 DCUN1D2 "C13orf17, FLJ10704, FLJ20092" ENSG00000150401 "Defective in cullin neddylation 1 domain containing 2" Q6PH85 13 113455819-113490952 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039349 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039349: AB_10673240" "unprognostic (3.09e-1)" "unprognostic (1.35e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (7.43e-2)" "unprognostic (7.68e-2)" "unprognostic (4.33e-2)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (2.02e-2)" "prognostic favorable (5.65e-5)" "unprognostic (1.21e-2)" "unprognostic (7.20e-2)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.69e-2)" "unprognostic (1.25e-2)" 4.9 4.5 6.2 6.0 7.0 7.8 4.6 24.0 13.3 4.1 4.3 6.5 3.4 3.1 6.2 6.6 4.7 4.0 4.9 59.1 5.9 7.2 4.3 4.0 3.8 4.6 7.2 5.9 5.5 4.5 3.5 7.1 5.2 9.7 3.9 4.5 6.2 4.5 4.5 65.6 9.1 5.4 5.2 8.5 4.9 4.3 5.6 6.1 5.3 3.3 7.5 4.9 3.8 3.7 3.5 2.7 10.9 2.2 2.8 4.1 1.8 6.9 4.3 7.2 5.5 5.3 4.7 5.6 5.4 6.6 5.1 5.8 15.3 4.2 5.0 1.7 6.2 8.0 10.0 7.8 4.1 7.3 3.2 13.1 8.4 19.6 4.1 2.8 12.9 6.3 6.9 6.8 5.7 4.6 3.5 4.3 6.9 4.7 4.8 4.9 4.9 8.7 21.2 4.6 5.0 6.8 9.2 12.0 6.6 3.8 4.5 32.2 7.2 4.1 14.5 4.0 5.3 8.3 6.1 7.1 6.7 9.1 5.1 7.7 14.2 6.0 10.0 15.3 5.7 4.5 10.9 1.9 3.6 3.1 1.7 4.1 3.5 2.8 1.9 2.7 1.9 3.0 1.6 1.5 2.8 2.2 0.3 2.9 1.8 6.2 7.0 24.0 13.3 5.9 7.2 7.2 5.9 9.7 6.1 14.9 17.0 2.7 1.7 5.3 7.7 67.8 0.0 5.3 13.6 3.5 15.7 2.0 1.7 1.6 5.2 4.6 3.6 0.0 1.2 1.1 4.5 2.6 4.7 3.9 1.2 17.5 6.3 6.2 4.0 4.5 6.6 3.5 5.0 0.0 4.3 4.4 1.8 0.0 5.3 2.1 9.9 0.0 3.3 3.4 4.8 6.5 2.2 2.6 3.7 2.5 DCUN1D3 "DKFZp686O0290, FLJ41725, MGC48972, SCCRO3" ENSG00000188215 "Defective in cullin neddylation 1 domain containing 3" Q8IWE4 16 20854925-20900384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 38.4" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 30.6;ASC TERT1: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041983, HPA043511" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041983: , HPA043511: AB_2678521" "unprognostic (9.34e-2)" "unprognostic (4.56e-2)" "unprognostic (3.47e-2)" "unprognostic (1.33e-2)" "unprognostic (4.24e-2)" "unprognostic (8.71e-2)" "unprognostic (5.90e-2)" "unprognostic (1.73e-1)" "unprognostic (1.81e-1)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.31e-2)" "prognostic unfavorable (5.41e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (5.31e-2)" "unprognostic (2.42e-1)" 19.2 9.9 4.3 6.0 4.6 2.7 17.2 7.9 5.6 7.5 6.0 5.5 3.2 3.4 7.7 5.9 8.5 6.6 9.6 8.9 2.5 2.8 10.0 17.4 9.7 3.1 5.2 3.0 5.3 6.6 6.4 9.5 9.4 6.7 6.6 4.1 6.3 3.9 4.5 38.4 7.1 4.9 11.9 3.9 4.5 6.4 7.9 3.8 1.5 4.8 11.5 4.5 6.7 15.8 1.4 1.6 4.8 2.5 2.6 2.7 1.0 2.7 4.8 2.4 5.2 30.6 23.1 3.3 9.1 7.9 4.6 6.3 6.0 5.2 1.7 7.4 8.9 2.8 3.7 2.8 3.8 6.2 2.3 1.9 1.4 3.8 8.7 8.0 2.2 13.9 15.2 5.2 8.7 4.9 4.9 12.6 1.7 1.6 4.7 9.3 3.7 2.0 3.2 5.7 2.3 1.6 3.4 2.7 1.7 4.0 2.8 2.2 3.0 3.5 3.9 2.1 3.0 2.6 1.0 6.2 9.8 3.4 4.1 2.4 4.0 2.3 1.2 10.4 2.3 5.0 4.8 1.4 1.2 1.7 2.5 1.7 1.0 1.2 2.7 1.6 1.4 1.5 2.7 1.9 2.6 2.2 1.2 1.0 1.0 4.3 4.6 7.9 5.6 2.5 2.8 5.2 3.0 6.7 3.8 11.9 17.1 0.0 12.6 27.8 12.1 4.0 5.1 0.0 6.8 8.7 33.4 3.0 0.0 3.5 50.8 14.3 4.3 0.0 4.4 1.7 12.7 8.1 0.0 12.9 2.1 12.7 19.4 10.4 7.1 34.5 10.0 8.0 11.8 0.0 4.7 5.2 3.9 0.0 9.2 4.0 23.2 6.5 12.2 4.6 3.5 19.7 4.2 4.3 3.8 16.9 DCX "DBCN, DC, LISX, SCLH, XLIS" ENSG00000077279 Doublecortin O43602 X 111293779-111412429 "Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.1;testis: 6.4" "Cell type enriched" "Detected in some" 12 "Rod photoreceptor cells: 22.7" "Cancer enriched" "Detected in some" 5 "glioma: 5.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 34.6;SH-SY5Y: 14.2" "Region enriched" "Detected in many" 9 "olfactory region: 90.9" "Region enriched" "Detected in all" 5 "olfactory region: 130.1" HPA036121 Enhanced Supported Approved Cytosol NA NA Cytosol "HPA036121: AB_2674950" "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (7.36e-2)" "unprognostic (4.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (2.00e-2)" "unprognostic (7.18e-2)" "unprognostic (3.24e-2)" "unprognostic (2.33e-3)" "unprognostic (3.67e-1)" "unprognostic (4.90e-4)" "unprognostic (5.02e-3)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" 0.8 1.1 7.0 0.7 9.2 0.7 3.2 0.7 17.1 0.7 0.6 0.9 0.0 0.7 4.1 3.6 0.6 0.6 0.8 0.7 4.2 5.4 0.5 0.5 0.6 0.7 2.5 6.7 0.6 0.8 0.5 1.0 0.6 3.7 0.5 0.8 0.0 2.2 0.6 0.5 0.7 0.7 0.6 3.0 0.6 1.2 6.4 2.3 0.0 0.6 0.0 0.5 0.6 0.3 0.3 0.4 0.6 0.2 0.7 0.4 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 34.6 14.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.2 0.1 0.4 0.3 0.3 0.2 0.1 0.3 0.3 0.3 0.6 0.7 0.0 0.4 0.1 0.0 7.0 9.2 0.7 10.8 4.2 5.4 2.5 6.7 3.7 2.3 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.2 0.0 1.4 0.0 22.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DDAH1 DDAH ENSG00000153904 "Dimethylarginine dimethylaminohydrolase 1" O94760 1 85318481-85578363 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.6" "Cell type enhanced" "Detected in many" 8 "Proximal tubular cells: 219.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.3;naive B-cell: 1.0" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 36.9;SH-SY5Y: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006308, HPA071064" Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 140000 "Plasma membrane, Cytosol" Nucleoli "HPA006308: AB_1847532, HPA071064: " "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "prognostic favorable (5.99e-4)" "unprognostic (6.82e-2)" "unprognostic (1.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.02e-2)" "unprognostic (3.62e-2)" "unprognostic (1.56e-1)" "prognostic favorable (5.21e-6)" "unprognostic (5.37e-2)" "unprognostic (9.06e-2)" "unprognostic (5.81e-2)" "unprognostic (1.56e-2)" 4.3 14.3 43.9 5.8 44.9 0.7 6.6 14.4 37.2 7.7 22.1 20.7 4.3 21.1 6.0 33.8 4.9 18.4 12.2 6.4 29.5 24.1 61.6 39.9 11.8 1.1 24.9 37.0 3.4 13.8 13.0 7.2 3.1 13.8 13.1 21.4 4.1 8.5 6.2 13.8 2.8 19.9 7.4 8.1 4.1 15.6 9.3 11.0 0.0 14.1 1.0 1.2 6.0 3.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 18.3 2.3 6.5 1.2 10.9 9.2 0.8 21.7 13.2 7.7 8.2 26.1 4.9 0.0 9.1 24.6 7.6 5.3 23.5 4.5 9.9 0.0 9.0 0.0 6.2 9.1 3.9 16.7 1.0 7.7 0.4 6.5 4.1 9.8 12.3 0.0 0.0 1.8 19.8 1.5 0.8 0.0 7.8 36.9 6.8 0.0 15.2 0.2 33.0 13.7 18.3 35.6 2.8 16.5 2.6 9.7 8.9 1.2 24.0 6.8 5.5 1.6 15.1 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 43.9 44.9 14.4 37.2 29.5 24.1 24.9 37.0 13.8 11.0 32.8 31.3 4.2 4.0 12.2 2.7 11.4 68.8 30.8 13.6 66.3 3.9 1.7 106.1 15.6 17.1 4.5 78.7 0.0 26.7 0.8 23.5 37.8 0.0 94.3 0.9 0.0 32.8 9.2 2.2 18.4 14.7 1.5 11.8 1.0 77.8 59.7 34.2 73.6 70.4 219.6 8.0 12.9 18.9 5.0 5.6 12.5 0.7 3.3 85.4 6.5 DDHD2 "KIAA0725, SAMWD1, SPG54" ENSG00000085788 "DDHD domain containing 2" O94830 8 38225218-38275558 "Disease related genes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015202, HPA023143, HPA023147" Supported Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "CAB015202: , HPA023143: AB_1847534, HPA023147: AB_1847535" "unprognostic (1.49e-3)" "unprognostic (2.40e-1)" "unprognostic (1.40e-1)" "unprognostic (1.04e-1)" "unprognostic (2.64e-1)" "prognostic favorable (7.72e-4)" "unprognostic (4.54e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (2.63e-2)" "unprognostic (1.04e-1)" "unprognostic (4.49e-2)" "unprognostic (3.01e-3)" "unprognostic (3.21e-2)" "unprognostic (2.46e-1)" "unprognostic (7.88e-2)" "unprognostic (1.49e-1)" 20.1 14.3 24.5 13.5 27.1 9.4 14.9 34.4 48.1 18.9 13.5 23.2 10.6 15.3 16.6 18.7 16.9 15.5 13.9 21.3 26.6 25.1 17.4 9.1 13.0 13.8 28.6 24.9 24.3 16.4 17.3 15.4 11.8 27.5 18.6 13.4 20.0 13.6 23.8 21.4 12.5 17.1 16.7 37.3 12.5 11.0 16.8 17.9 8.8 15.0 9.3 16.4 14.9 13.3 13.3 5.5 3.7 4.0 13.2 12.3 5.9 25.3 11.5 26.3 12.8 10.6 14.2 8.5 8.0 14.4 19.2 17.2 13.8 10.0 10.1 11.2 13.8 11.9 9.8 14.8 14.8 29.3 8.6 10.1 36.1 15.9 13.2 9.1 4.2 5.7 7.3 11.9 11.9 12.4 12.3 22.6 13.6 25.5 11.0 12.0 5.4 28.5 6.3 5.9 4.1 6.9 15.2 22.7 6.9 10.4 15.2 9.5 14.8 19.5 10.3 9.8 8.6 11.9 11.4 20.6 11.0 14.6 10.9 12.7 11.8 10.5 23.0 17.9 8.2 15.5 2.1 3.1 3.7 9.6 4.0 10.7 8.3 8.6 10.6 5.5 13.3 9.5 6.7 0.3 13.2 2.8 3.0 12.3 5.9 24.5 27.1 34.4 48.1 26.6 25.1 28.6 24.9 27.5 17.9 20.8 6.5 6.9 8.7 12.2 24.1 21.0 5.1 2.7 9.1 19.2 17.7 10.4 19.9 10.2 3.8 11.7 9.0 0.0 9.6 9.6 9.7 8.5 20.7 4.7 6.4 50.9 15.1 12.3 7.6 7.6 18.7 8.5 18.6 18.0 8.3 15.8 12.0 7.0 19.4 7.8 5.0 6.5 8.3 13.0 30.2 9.4 5.4 17.3 7.8 6.2 DDI2 MGC14844 ENSG00000197312 "DNA damage inducible 1 homolog 2" Q5TDH0 1 15617500-15669044 "Plasma proteins, Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043119, HPA043225" Approved Enhanced Nucleoplasm,Cytosol NA NA 170000 "Nucleoplasm, Cytosol" "HPA043119: AB_2678326, HPA043225: AB_2678369" "unprognostic (1.93e-1)" "unprognostic (8.03e-2)" "unprognostic (1.26e-1)" "unprognostic (3.38e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-3)" "unprognostic (3.04e-2)" "unprognostic (1.63e-2)" "unprognostic (3.31e-3)" "unprognostic (8.31e-3)" "unprognostic (1.02e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-3)" "unprognostic (7.56e-2)" "unprognostic (1.84e-1)" "unprognostic (7.63e-2)" "unprognostic (3.77e-2)" 14.8 8.1 5.1 10.5 7.1 10.5 15.0 8.7 8.4 8.7 10.8 8.2 9.8 9.0 12.3 9.6 19.4 7.7 8.3 12.5 5.8 4.7 10.4 24.9 10.2 9.1 6.7 5.2 8.3 9.4 14.8 8.0 11.5 7.5 12.1 7.9 11.5 13.5 13.8 54.8 13.3 9.2 8.0 6.5 9.9 6.9 4.3 6.0 11.1 7.6 11.7 16.4 12.1 12.3 3.8 5.4 0.8 2.3 2.0 3.5 1.4 7.5 4.4 8.0 8.3 11.0 8.7 7.8 4.7 3.6 4.2 3.6 10.7 6.9 19.0 5.6 5.2 3.1 8.0 17.4 7.6 7.1 8.7 11.6 14.8 7.4 10.5 4.7 19.6 7.5 8.6 9.1 7.8 8.4 5.2 8.5 12.4 23.8 7.0 5.1 5.1 11.3 6.5 7.6 11.2 3.6 10.7 11.3 11.2 5.9 6.3 9.8 5.4 8.8 14.4 13.1 9.4 7.5 5.1 7.4 6.0 5.2 6.8 5.8 6.6 8.0 15.4 4.7 14.3 4.7 0.7 2.3 0.4 3.3 2.1 2.9 2.6 2.5 2.6 2.3 3.8 2.8 3.5 0.8 2.0 1.6 5.4 2.3 1.4 5.1 7.1 8.7 8.4 5.8 4.7 6.7 5.2 7.5 6.0 8.9 15.2 11.9 12.2 13.6 23.7 23.0 12.7 29.4 22.7 3.5 13.7 17.5 1.7 6.8 1.5 12.1 15.1 46.7 6.6 16.1 13.9 22.6 1.1 54.8 13.2 33.4 14.5 16.0 21.2 0.4 11.8 12.5 15.1 6.4 22.4 8.0 12.5 3.5 6.3 16.5 36.7 6.5 12.3 10.0 7.8 17.7 33.6 12.7 20.1 12.7 DDIAS "C11orf82, FLJ25416, FLJ38838, noxin" ENSG00000165490 "DNA damage induced apoptosis suppressor" Q8IXT1 11 82899975-82958277 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.6;testis: 16.3" "Cell type enhanced" "Detected in some" 12 "Kupffer cells: 5.3;Spermatocytes: 12.0;Spermatogonia: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038540, HPA038541" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA038540: AB_10672648, HPA038541: AB_2676071" "unprognostic (2.53e-1)" "unprognostic (2.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (3.86e-6)" "unprognostic (4.65e-3)" "unprognostic (1.01e-3)" "unprognostic (8.24e-3)" "unprognostic (2.04e-4)" "unprognostic (4.72e-2)" "unprognostic (1.11e-16)" "unprognostic (7.17e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-1)" "unprognostic (9.13e-2)" 1.3 1.0 0.8 6.1 0.8 7.0 1.7 0.8 1.2 1.9 2.3 1.2 0.2 1.3 1.5 2.6 5.5 1.0 0.4 2.6 0.9 0.7 1.0 2.3 3.1 5.0 0.8 0.6 1.3 0.9 0.0 0.5 2.5 1.0 0.9 2.0 0.2 2.1 0.2 10.1 2.3 1.9 1.5 0.9 5.5 1.1 16.3 0.9 17.6 0.8 9.5 5.9 1.8 1.8 2.0 4.5 5.8 10.7 1.9 0.7 3.2 6.0 9.6 9.9 7.2 1.0 1.5 7.3 11.5 4.9 12.8 14.9 9.4 7.6 7.4 17.3 2.6 10.1 11.6 16.7 7.2 17.7 13.4 9.0 10.5 4.9 4.2 0.1 12.9 9.3 0.3 0.7 16.1 7.4 1.1 6.0 9.2 10.6 12.8 11.3 8.8 12.1 10.5 11.8 16.7 11.0 9.0 19.2 9.5 2.7 10.1 7.4 10.0 7.1 7.2 2.7 10.1 7.8 5.4 2.8 12.8 17.4 33.7 14.0 7.3 19.1 25.7 4.0 9.3 12.1 0.6 10.7 3.9 0.5 8.3 0.3 1.1 0.3 0.7 4.5 2.0 0.7 0.4 5.8 1.9 7.8 1.4 0.5 3.2 0.8 0.8 0.8 1.2 0.9 0.7 0.8 0.6 1.0 0.9 0.0 0.0 4.6 0.8 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 1.4 0.0 0.5 2.7 0.0 0.0 0.0 0.5 4.3 0.0 0.3 0.0 0.5 2.2 0.0 0.0 1.3 5.3 1.6 0.3 1.6 0.0 0.0 0.2 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.3 12.0 15.1 0.0 0.2 0.0 0.6 0.9 DDIT4 "Dig2, FLJ20500, REDD-1, REDD1, RTP801" ENSG00000168209 "DNA damage inducible transcript 4" Q9NX09 10 72273920-72276036 "Predicted intracellular proteins" "Antiviral defense, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 159.3" "Cell type enhanced" "Detected in all" 5 "Muller glia cells: 589.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 66.5;hTCEpi: 225.6;hTERT-HME1: 82.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034507, HPA034508" Approved Supported Cytosol NA NA Cytosol "HPA034507: AB_2674199, HPA034508: AB_10601206" "unprognostic (2.84e-3)" "unprognostic (1.05e-3)" "unprognostic (1.06e-1)" "unprognostic (2.59e-1)" "unprognostic (7.91e-3)" "prognostic unfavorable (5.42e-4)" "unprognostic (7.65e-2)" "unprognostic (1.62e-3)" "unprognostic (2.90e-1)" "unprognostic (4.96e-3)" "prognostic unfavorable (2.78e-4)" "unprognostic (9.72e-2)" "prognostic unfavorable (2.54e-6)" "unprognostic (8.52e-2)" "unprognostic (1.12e-1)" "unprognostic (5.92e-2)" "unprognostic (1.66e-1)" 29.0 43.9 27.3 28.0 28.0 35.5 88.2 23.1 27.1 38.7 18.7 6.4 14.4 7.5 16.3 13.5 37.0 14.5 21.7 23.0 28.2 8.4 13.6 27.5 33.7 26.5 45.5 11.6 73.4 159.3 5.4 16.4 16.2 34.4 15.8 5.1 10.2 41.2 29.2 29.5 21.0 13.0 11.7 22.8 17.5 19.6 8.1 34.9 30.8 13.4 11.1 34.5 37.8 47.7 25.9 40.5 9.7 2.5 70.6 57.1 40.9 12.8 9.3 1.9 17.3 12.5 7.2 5.6 3.9 4.3 1.4 5.8 1.0 27.8 1.4 11.8 0.6 1.8 15.1 2.6 66.5 3.2 20.8 3.4 1.5 21.0 6.9 49.5 4.3 6.3 30.4 225.6 6.0 82.9 13.2 5.5 3.3 12.4 34.6 5.0 5.3 2.6 6.0 0.4 6.2 2.1 1.5 2.1 24.6 11.9 3.0 3.4 4.8 9.2 14.6 52.1 4.5 2.0 9.7 11.4 0.4 3.7 0.8 2.1 24.6 13.6 3.8 24.8 9.8 2.9 9.2 1.6 9.7 50.4 2.5 48.6 17.9 32.8 27.8 7.2 25.9 57.1 42.9 5.3 70.6 2.0 40.5 24.0 40.9 27.3 28.0 23.1 27.1 28.2 8.4 45.5 11.6 34.4 34.9 11.9 40.9 153.5 238.2 203.1 78.2 12.9 58.6 36.1 63.7 57.6 74.6 7.9 51.4 226.4 2.3 154.0 50.8 23.3 146.9 35.2 109.4 154.5 397.0 55.0 80.1 28.6 71.9 166.3 61.3 4.7 81.7 238.1 376.2 53.3 48.9 589.5 133.5 28.1 120.6 9.0 131.0 71.1 402.1 1.9 4.3 219.8 15.9 277.0 34.0 244.9 DDN KIAA0749 ENSG00000181418 Dendrin O94850 12 48995149-48999309 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 40.8;skeletal muscle: 73.8" "Group enriched" "Detected in some" 4 "Collecting duct cells: 3.5;Ito cells: 1.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 10.6;RPMI-8226: 20.1;SCLC-21H: 10.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "amygdala: 228.1;basal ganglia: 257.7;cerebral cortex: 232.0;hippocampal formation: 236.4;olfactory region: 128.1" HPA060952 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060952: AB_2684396" "unprognostic (2.80e-2)" "unprognostic (3.19e-3)" "unprognostic (4.56e-2)" "unprognostic (8.10e-3)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (6.20e-5)" "unprognostic (8.61e-4)" "unprognostic (2.12e-1)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (5.08e-2)" "unprognostic (1.37e-6)" "unprognostic (1.72e-2)" "unprognostic (5.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.53e-2)" 0.7 0.7 40.5 0.8 40.8 1.3 0.7 0.0 38.5 0.7 0.7 0.2 0.0 0.7 0.7 3.8 1.0 0.7 0.7 0.9 30.5 2.0 4.8 0.7 0.7 0.9 2.9 9.3 0.7 0.8 0.8 0.0 0.7 0.0 1.6 0.7 0.0 0.7 0.7 73.8 0.8 0.8 0.7 0.0 0.8 0.8 0.8 1.2 0.0 0.7 0.0 0.8 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.3 0.3 0.2 0.6 0.0 0.0 0.1 0.1 0.1 0.1 0.2 4.5 0.4 0.0 0.2 0.0 0.0 1.6 10.6 0.0 0.1 0.5 4.8 2.3 0.5 1.0 0.0 5.5 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 3.5 0.2 0.1 5.3 6.0 0.1 0.8 1.4 4.9 0.3 20.1 0.0 0.1 10.6 1.0 0.2 0.5 0.2 0.1 0.3 0.7 0.1 0.2 0.5 0.2 0.0 1.2 2.3 4.7 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 40.5 40.8 0.0 31.9 30.5 2.0 2.9 9.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 DDO ENSG00000203797 "D-aspartate oxidase" Q99489 6 110391771-110415562 "Enzymes, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 14.1;Muller glia cells: 9.1;Proximal tubular cells: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.9;myeloid DC: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 10.9;RPMI-8226: 14.2;U-937: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037525, HPA037526" Enhanced Enhanced Cytosol NA NA Cytosol "HPA037525: AB_2675523, HPA037526: AB_10672352" "unprognostic (1.37e-1)" "unprognostic (1.54e-1)" "unprognostic (6.51e-2)" "unprognostic (1.30e-2)" "unprognostic (2.00e-1)" "unprognostic (3.28e-2)" "unprognostic (3.71e-2)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (2.91e-1)" "unprognostic (6.97e-2)" "unprognostic (1.43e-1)" "prognostic favorable (8.69e-5)" "unprognostic (3.51e-4)" "unprognostic (3.36e-3)" "unprognostic (1.27e-3)" "unprognostic (9.06e-2)" 3.7 11.0 5.2 1.1 12.1 1.6 3.3 1.9 5.5 2.7 3.6 10.8 4.9 8.6 2.7 5.4 1.2 6.1 3.9 21.0 6.9 3.4 12.3 12.8 3.9 1.3 8.0 6.1 1.2 5.5 18.6 1.9 2.1 8.0 2.9 3.9 2.3 4.9 3.2 11.3 0.8 7.9 5.6 7.7 2.6 1.9 0.4 8.2 0.0 3.3 5.7 0.5 3.6 1.6 0.0 7.3 0.1 4.9 1.7 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.1 5.0 1.2 0.8 0.0 0.0 0.0 0.7 0.7 10.9 0.0 0.0 0.0 2.2 4.5 0.0 4.6 0.0 3.9 1.6 0.0 0.0 0.1 0.0 2.5 0.1 2.2 0.0 0.0 0.0 1.8 4.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.8 14.2 0.0 4.5 0.1 0.1 0.0 0.4 0.6 0.0 0.7 1.0 0.8 1.0 0.1 0.0 2.3 0.1 0.3 0.0 1.9 15.8 0.0 0.1 4.6 0.0 0.0 4.9 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 1.7 1.6 0.0 0.0 1.5 5.2 12.1 1.9 5.5 6.9 3.4 8.0 6.1 8.0 8.2 0.0 0.0 0.0 0.8 0.0 0.0 14.1 0.0 1.4 0.0 0.0 2.0 0.1 3.3 2.8 0.0 0.3 2.7 0.0 1.9 0.1 0.3 0.3 0.0 4.4 1.8 0.0 4.1 2.5 4.0 0.0 0.3 1.1 0.0 1.0 5.9 9.1 1.2 6.0 0.0 9.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.5 0.3 DDX1 DBP-RB ENSG00000079785 "DEAD-box helicase 1" Q92499 2 15591178-15631111 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing" "Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 352.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012280, HPA034502, HPA034503" Enhanced Supported Nucleoplasm,Cytosol NA NA 46000 Nucleoplasm Cytosol "CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025" "unprognostic (9.94e-2)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (8.36e-3)" "unprognostic (9.28e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (9.09e-9)" "unprognostic (2.55e-1)" "unprognostic (2.05e-1)" "unprognostic (4.81e-3)" "unprognostic (3.89e-2)" "unprognostic (2.03e-1)" "prognostic favorable (9.69e-4)" "unprognostic (3.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.94e-2)" "unprognostic (1.20e-3)" 23.8 28.2 29.3 17.6 35.0 17.1 30.1 35.3 37.2 25.1 24.5 15.0 20.5 21.0 24.3 25.6 27.7 21.0 15.8 47.6 34.7 25.3 35.8 35.2 17.8 16.0 24.5 36.9 23.6 27.6 42.1 41.2 28.1 35.1 22.2 28.1 14.8 23.9 24.5 67.5 24.5 25.9 31.0 21.0 17.1 24.1 19.2 23.0 23.0 29.6 24.8 21.5 26.1 19.8 18.7 22.8 19.2 25.1 23.0 26.6 19.9 19.3 29.7 42.2 31.5 36.7 32.2 48.7 40.7 34.2 40.1 33.8 47.4 20.0 50.3 19.8 46.9 29.6 29.5 57.7 39.1 42.5 21.4 37.5 55.1 39.7 59.7 27.6 45.0 25.9 25.0 26.9 33.4 32.1 25.4 36.1 23.8 56.0 16.6 39.5 27.1 24.6 34.0 54.3 48.9 25.1 29.7 63.9 36.4 45.9 39.0 34.1 42.6 27.8 29.4 37.0 31.6 20.4 19.1 29.1 33.7 34.8 21.1 45.9 21.7 37.7 67.9 30.3 36.1 31.3 19.2 20.0 11.5 20.2 25.1 21.3 18.7 23.4 23.4 22.8 18.0 26.6 23.6 3.1 23.0 23.2 19.5 21.6 19.9 29.3 35.0 35.3 37.2 34.7 25.3 24.5 36.9 35.1 23.0 74.5 45.2 27.6 50.5 35.7 56.6 352.9 63.7 95.0 68.2 85.5 49.1 96.2 121.0 87.1 11.9 56.2 48.4 23.3 104.7 96.0 66.4 31.2 54.4 106.7 46.5 42.9 50.1 40.5 25.3 12.7 67.3 39.1 47.2 31.5 56.7 55.3 88.0 59.6 73.6 95.2 67.2 58.2 49.9 167.4 57.2 36.9 67.1 26.6 62.9 32.7 DDX20 "DP103, GEMIN3" ENSG00000064703 "DEAD-box helicase 20" Q9UHI6 1 111755245-111768016 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 81.7" "Group enriched" "Detected in many" 13 "Early spermatids: 570.4;Late spermatids: 538.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005516, CAB015427" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB015427: AB_629518, HPA005516: AB_1849612" "unprognostic (3.71e-2)" "unprognostic (5.25e-2)" "prognostic favorable (9.85e-5)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (6.35e-6)" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (7.46e-3)" "unprognostic (4.21e-1)" "unprognostic (5.22e-2)" "unprognostic (1.05e-3)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (4.23e-1)" "unprognostic (1.30e-2)" 3.1 2.8 2.9 2.7 4.3 5.9 9.8 5.8 5.1 2.7 2.6 1.8 2.6 2.0 4.0 2.9 2.6 3.7 1.7 2.0 4.3 1.6 2.7 2.4 4.1 3.8 2.4 1.9 3.9 2.9 4.0 3.9 2.7 3.4 2.9 2.6 1.2 2.6 2.7 5.1 2.5 3.5 2.9 5.6 4.5 2.8 81.7 3.3 5.1 3.2 1.7 4.1 2.9 5.0 11.9 7.4 12.7 7.4 10.5 14.1 7.8 11.4 4.7 12.2 11.0 8.8 7.0 11.4 11.2 8.7 16.1 15.7 7.0 4.0 26.8 8.8 7.6 5.7 9.2 14.4 11.3 18.0 12.2 13.0 13.0 9.2 7.2 8.8 12.8 9.6 7.0 9.9 13.7 13.9 4.5 11.1 10.5 12.4 9.8 12.2 10.8 15.7 13.0 15.3 6.9 9.6 15.4 20.1 6.7 10.5 9.0 12.7 11.5 10.8 13.5 18.0 10.6 8.4 13.6 9.8 9.8 14.5 17.5 13.0 4.9 6.9 20.5 10.2 13.2 22.1 12.7 7.0 6.9 10.0 7.3 13.3 11.9 11.7 11.8 7.4 10.1 14.1 12.3 5.0 10.5 7.4 5.2 11.7 7.8 2.9 4.3 5.8 5.1 4.3 1.6 2.4 1.9 3.4 3.3 11.9 6.5 3.7 7.8 9.6 12.2 5.9 2.5 13.4 12.5 5.2 2.0 8.6 3.3 8.9 570.4 7.1 2.4 0.0 6.0 6.8 4.8 3.0 7.0 4.9 8.0 6.4 4.1 3.7 9.1 538.8 15.3 8.7 1.7 3.6 5.7 6.3 6.3 2.9 12.4 6.9 8.9 6.5 10.3 41.2 25.6 6.4 4.2 7.0 5.8 5.5 DDX24 ENSG00000089737 "DEAD-box helicase 24" Q9GZR7 14 94048291-94081245 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 103.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002554 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA002554: AB_1078631" "unprognostic (7.48e-2)" "unprognostic (3.02e-2)" "unprognostic (8.95e-2)" "unprognostic (2.12e-1)" "unprognostic (2.31e-1)" "unprognostic (4.06e-3)" "unprognostic (8.81e-2)" "unprognostic (2.66e-3)" "unprognostic (2.77e-1)" "unprognostic (2.28e-2)" "unprognostic (1.60e-3)" "unprognostic (4.13e-2)" "prognostic favorable (3.06e-9)" "prognostic unfavorable (2.89e-4)" "unprognostic (6.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.66e-2)" 18.0 45.5 19.7 13.7 41.3 53.3 18.5 31.4 40.8 17.4 20.9 21.9 14.3 13.6 23.2 103.0 20.1 18.9 21.3 28.6 25.0 31.3 36.3 30.1 16.4 27.4 22.0 29.0 21.4 12.5 8.3 32.0 11.2 38.7 16.0 14.6 17.4 15.9 17.7 28.5 23.4 12.6 17.9 21.8 18.1 15.0 38.5 17.4 14.3 25.3 11.8 25.8 21.7 14.9 4.1 3.1 10.6 3.3 6.2 5.3 5.0 3.8 1.1 7.2 4.6 4.3 5.7 1.7 10.8 9.1 14.1 12.7 1.4 2.5 17.9 4.1 2.4 4.2 2.5 7.4 0.6 15.4 7.8 0.4 9.5 2.1 5.8 3.6 13.7 4.2 0.9 4.1 2.6 2.5 4.7 2.3 3.4 4.9 5.3 6.0 10.8 4.1 11.7 4.8 1.2 0.1 5.5 16.7 2.1 10.2 1.4 5.7 5.3 10.6 2.6 5.0 1.3 4.2 4.9 6.9 4.0 2.7 5.1 3.3 2.1 13.8 19.3 5.8 7.5 3.1 10.6 3.3 2.5 5.0 2.6 1.4 2.9 2.9 3.0 2.0 4.1 5.3 5.3 2.6 6.2 2.5 3.1 3.3 5.0 19.7 41.3 31.4 40.8 25.0 31.3 22.0 29.0 38.7 17.4 157.8 151.6 175.7 121.2 162.3 169.0 198.2 58.6 192.7 154.7 139.6 123.7 76.5 230.5 124.3 63.9 107.4 65.5 116.8 86.3 59.9 133.4 81.0 147.1 96.2 75.0 219.3 93.7 105.0 83.4 46.7 214.3 119.2 94.5 181.3 57.7 131.2 82.3 69.1 230.2 135.3 189.8 161.7 156.5 383.4 396.2 127.2 131.4 217.1 54.9 94.1 DDX25 GRTH ENSG00000109832 "DEAD-box helicase 25" Q9UHL0 11 125903348-125943702 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport" "Developmental protein, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.3;testis: 64.2" "Group enriched" "Detected in some" 5 "Early spermatids: 250.3;Spermatocytes: 190.6" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "JURKAT: 16.8;NTERA-2: 11.4;SCLC-21H: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020137 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020137: AB_1847552" "unprognostic (5.78e-3)" "unprognostic (9.75e-3)" "unprognostic (7.93e-2)" "unprognostic (5.09e-3)" "unprognostic (1.11e-2)" "unprognostic (1.78e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-3)" "unprognostic (6.24e-5)" "unprognostic (2.57e-1)" "unprognostic (2.44e-3)" "unprognostic (3.89e-1)" "unprognostic (3.44e-3)" "unprognostic (1.44e-1)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.69e-1)" 0.7 2.8 8.7 0.8 13.2 0.9 0.8 7.9 17.3 0.8 0.8 2.0 0.0 1.0 0.9 0.9 0.8 0.9 0.8 0.7 8.4 7.1 2.7 0.8 0.8 0.8 4.8 8.9 1.2 1.8 2.6 7.1 0.9 5.9 0.9 0.8 2.3 0.8 1.0 0.8 1.6 0.8 0.7 3.4 0.9 1.0 64.2 3.0 0.0 4.3 0.0 0.8 0.7 0.2 0.6 0.5 3.3 0.3 1.3 0.5 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.2 1.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.8 0.0 0.3 0.0 0.5 1.6 0.0 11.4 0.5 0.0 0.4 0.0 0.0 0.0 0.1 9.2 2.1 0.1 0.0 1.6 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 2.1 0.3 0.6 0.3 0.2 0.2 0.4 0.5 0.2 0.1 0.6 0.4 0.3 3.3 1.3 0.2 0.5 0.1 0.1 8.7 13.2 7.9 12.5 8.4 7.1 4.8 8.9 5.9 3.0 0.0 0.3 0.0 0.7 0.1 18.2 0.8 0.0 0.0 0.0 0.0 15.7 0.0 3.3 0.1 250.3 0.9 0.0 0.0 0.2 0.1 0.3 0.5 0.0 0.5 0.1 15.9 0.0 0.6 0.0 41.7 3.4 0.1 0.0 0.0 0.0 16.0 0.1 0.0 4.6 1.8 16.0 0.0 0.1 190.6 24.5 0.0 0.0 0.0 0.0 0.1 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68021274-68023442 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Syncytiotrophoblasts: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol No No "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: AB_2682200" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favorable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 9.8 12.7 6.2 6.7 8.3 19.7 7.1 6.0 12.9 8.3 7.2 6.4 6.8 5.2 7.5 7.3 9.7 7.1 7.0 9.2 5.2 5.9 8.9 12.4 5.8 18.4 6.4 5.1 8.6 13.3 6.8 4.6 17.1 6.6 6.1 6.0 7.8 6.3 5.2 16.2 9.9 7.9 5.3 3.0 11.1 7.0 11.5 2.7 14.6 10.2 7.3 10.6 8.0 4.8 17.8 18.0 22.9 19.1 17.0 22.9 16.6 6.1 9.2 4.5 5.4 6.3 3.5 10.6 4.2 6.3 10.7 7.6 8.9 9.8 23.2 6.5 5.2 5.8 11.2 6.4 10.2 6.3 3.1 10.6 8.4 4.8 9.2 8.5 13.1 9.0 6.9 11.2 8.8 8.1 3.7 5.9 15.7 14.9 3.6 4.7 13.8 13.7 18.5 11.1 6.3 6.8 13.5 4.2 24.8 7.5 7.2 9.5 6.4 17.2 4.9 9.3 5.4 9.5 14.4 4.2 4.7 4.0 6.7 6.9 8.2 9.9 22.3 5.8 10.1 6.4 17.7 19.1 22.9 15.7 18.8 17.3 12.6 14.6 16.9 18.0 17.8 22.9 16.9 6.3 17.0 18.5 9.0 13.8 16.6 6.2 8.3 6.0 12.9 5.2 5.9 6.4 5.1 6.6 2.7 6.0 5.0 7.5 13.5 8.1 4.8 3.1 2.5 2.7 5.7 3.5 0.0 24.0 11.6 9.5 5.9 6.0 1.7 0.0 8.5 9.4 4.2 3.1 3.5 9.7 15.4 3.2 4.6 4.3 10.3 3.1 4.6 6.6 6.8 11.8 2.8 7.2 7.2 4.5 3.2 14.6 3.4 12.9 4.1 20.6 15.1 9.4 83.5 10.1 5.8 10.3 DDX3X "DBX, DDX14, DDX3, HLP2" ENSG00000215301 "DEAD-box helicase 3, X-linked" O00571 X 41333284-41364472 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 631.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059585" Supported Supported Approved Nucleoplasm,Cytosol NA NA 110000 Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073" "unprognostic (2.42e-2)" "unprognostic (1.11e-1)" "unprognostic (8.01e-3)" "unprognostic (1.66e-1)" "unprognostic (8.12e-2)" "unprognostic (6.43e-2)" "unprognostic (1.17e-3)" "unprognostic (1.88e-1)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.25e-2)" "unprognostic (2.05e-1)" "unprognostic (1.51e-1)" "unprognostic (2.95e-1)" "unprognostic (4.77e-1)" "unprognostic (9.44e-2)" "unprognostic (2.93e-2)" 80.9 49.3 26.1 40.0 34.5 49.3 46.5 31.1 36.2 52.4 43.3 35.1 21.3 29.5 56.4 25.9 53.5 56.3 42.6 47.6 30.8 24.5 55.6 77.9 45.3 40.4 41.4 29.0 60.1 30.9 68.7 60.2 79.9 37.9 30.0 29.2 30.8 37.4 26.5 63.4 42.2 54.0 57.2 53.9 46.1 43.0 27.0 39.0 49.2 45.6 44.0 42.6 55.8 50.2 13.1 20.5 32.0 21.6 17.3 21.5 17.9 45.8 51.1 47.7 26.2 56.2 47.7 29.1 33.5 47.1 34.4 27.6 52.5 30.9 0.5 23.9 37.4 41.4 31.0 58.3 47.1 57.3 27.2 45.4 29.2 50.8 31.5 29.2 54.7 52.5 34.5 33.4 57.9 56.0 38.5 53.9 25.7 53.6 28.9 31.9 34.7 34.4 17.1 45.9 24.4 20.6 40.4 50.8 37.4 32.4 61.9 32.6 49.4 75.8 38.9 40.1 50.2 35.0 37.2 48.6 35.5 37.9 37.9 39.7 33.7 40.0 45.3 35.7 33.2 33.6 22.5 20.2 17.5 14.8 21.1 21.5 13.1 14.5 16.3 20.5 9.0 16.3 15.1 32.0 17.3 21.6 6.9 14.3 17.9 26.1 34.5 31.1 36.2 30.8 24.5 41.4 29.0 37.9 39.0 80.4 161.8 98.4 138.2 234.8 74.1 130.3 81.5 65.6 85.3 55.8 123.7 79.4 36.5 59.8 317.8 170.8 178.1 116.8 73.8 80.3 155.2 122.4 162.7 142.1 107.7 57.2 176.3 120.3 200.6 631.6 61.5 160.4 121.4 72.1 136.1 88.8 86.2 143.8 59.1 71.7 117.4 71.1 155.5 15.7 55.7 291.5 144.6 132.3 100.9 182.7 DDX3Y DBY ENSG00000067048 "DEAD-box helicase 3, Y-linked" O15523 Y 12904108-12920478 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 237.5;Late spermatids: 436.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 41.3;HEL: 42.1;U-266/84: 34.9;U-698: 30.7" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059583" Enhanced Supported Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: " "unprognostic (3.89e-2)" "unprognostic (1.70e-1)" "prognostic favorable (4.70e-5)" "unprognostic (6.50e-2)" "unprognostic (4.74e-2)" "unprognostic (2.22e-2)" "unprognostic (4.17e-2)" "unprognostic (3.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (7.87e-2)" 12.0 10.5 4.9 29.5 14.1 46.1 8.7 17.0 16.3 0.4 24.4 12.6 31.5 7.6 0.4 29.7 12.2 0.4 14.2 10.8 5.6 7.1 8.9 26.5 20.0 17.7 5.7 0.0 0.4 14.5 0.4 12.2 14.0 20.2 26.7 15.8 15.1 20.4 32.6 17.7 8.4 16.0 40.7 6.2 34.3 8.9 41.9 0.0 26.9 10.8 21.4 19.3 14.4 0.0 6.1 8.8 6.5 7.1 6.5 8.4 3.8 0.1 7.7 0.0 0.0 0.0 0.0 5.6 18.9 13.5 10.0 12.3 0.0 0.0 41.3 0.0 18.6 0.0 0.0 0.0 0.0 17.6 10.3 0.0 42.1 0.0 12.4 9.9 0.0 0.0 10.5 11.8 0.0 0.0 0.0 0.0 4.2 0.0 0.0 11.8 0.0 16.3 0.0 7.5 0.0 0.0 0.0 5.0 7.6 10.6 11.4 12.4 0.0 0.0 0.0 13.8 12.7 0.0 9.8 13.5 15.5 0.0 0.0 12.4 22.3 34.9 30.7 1.9 0.0 0.0 1.6 6.2 5.7 8.4 7.1 7.7 6.1 6.4 7.1 8.8 5.9 7.8 6.5 6.5 6.5 4.6 2.5 5.7 3.8 4.9 14.1 17.0 16.3 5.6 7.1 5.7 0.0 20.2 0.0 44.7 70.4 32.3 85.6 83.6 48.4 24.1 12.7 117.8 50.0 8.7 39.3 34.0 5.0 8.7 237.5 56.2 0.0 0.0 0.2 11.4 45.1 53.9 88.1 0.6 15.6 39.7 15.3 28.3 37.0 436.7 35.9 93.0 25.3 15.4 3.7 57.0 8.2 0.0 37.1 14.7 46.4 19.4 59.7 36.2 65.8 70.3 31.6 51.1 0.0 62.4 DDX51 ENSG00000185163 "DEAD-box helicase 51" Q8N8A6 12 132136594-132144335 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039503 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA039503: AB_10796328" "unprognostic (2.84e-3)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (8.66e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (4.88e-1)" "unprognostic (3.05e-3)" "unprognostic (5.31e-2)" "unprognostic (3.97e-2)" "unprognostic (2.48e-1)" "unprognostic (4.69e-2)" "unprognostic (3.28e-1)" "unprognostic (1.65e-3)" 10.5 8.5 12.7 12.7 17.1 17.2 10.3 23.5 18.9 8.8 8.4 11.8 10.6 7.8 11.5 12.2 8.5 12.4 10.0 8.1 11.6 9.9 9.5 7.2 8.9 11.1 10.5 16.9 19.6 14.8 10.1 9.8 7.2 11.8 9.3 7.3 8.9 10.7 12.4 13.8 18.0 8.2 10.4 10.5 10.6 9.3 6.7 12.0 9.5 9.9 7.1 10.4 9.3 8.6 2.5 2.3 2.6 2.1 1.6 2.0 1.0 6.2 10.1 4.2 5.3 4.0 3.9 8.0 4.8 2.9 7.2 3.0 6.2 3.1 10.9 4.2 2.9 1.7 6.6 10.5 7.7 3.5 2.6 10.1 12.9 5.4 2.0 4.9 9.0 7.5 3.4 5.7 4.0 3.6 8.1 3.8 12.2 9.5 3.6 2.1 6.2 11.0 18.5 7.4 5.3 17.4 13.1 5.8 12.1 4.9 5.0 10.3 5.4 5.3 7.5 5.3 3.7 6.6 8.3 6.7 2.7 8.3 6.6 11.1 10.2 5.9 12.8 5.6 6.9 6.3 1.1 2.1 1.2 2.0 1.0 0.7 1.5 1.3 0.9 0.6 2.5 1.2 1.6 2.6 1.6 1.0 2.3 0.6 1.0 12.7 17.1 23.5 18.9 11.6 9.9 10.5 16.9 11.8 12.0 3.0 15.9 3.0 6.8 11.1 27.9 4.0 10.2 4.0 13.6 3.5 23.6 6.0 1.7 4.0 0.9 7.7 3.5 0.0 4.5 4.9 6.5 7.3 5.8 6.4 4.9 31.8 8.1 7.4 6.2 0.7 7.8 5.7 10.1 3.6 8.3 11.1 5.4 7.0 7.8 2.9 27.4 0.0 6.4 5.7 9.4 12.3 3.4 6.9 12.1 5.8 DDX53 "CAGE, CT26" ENSG00000184735 "DEAD-box helicase 53" Q86TM3 X 22999961-23003589 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 11.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 47.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.6;K-562: 6.3;RPMI-8226: 3.3;U-2197: 2.1;U-266/84: 14.1" "Low region specificity" "Detected in many" HPA003186 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003186: AB_1078637" "unprognostic (5.76e-1)" "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.4 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.0 8.8 0.0 0.0 0.0 0.0 0.0 DDX58 "DKFZp434J1111, FLJ13599, RIG-I" ENSG00000107201 "DExD/H-box helicase 58" O95786 9 32455705-32526324 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 47.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012643, HPA047193" Uncertain Approved "Plasma membrane,Cytosol" No No "Plasma membrane" Cytosol "CAB012643: , HPA047193: AB_2679978" "unprognostic (1.10e-1)" "unprognostic (4.65e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (5.46e-4)" "unprognostic (2.45e-1)" "unprognostic (2.37e-1)" "unprognostic (8.15e-2)" "unprognostic (4.57e-2)" "unprognostic (2.82e-1)" "unprognostic (6.48e-3)" "unprognostic (1.00e-2)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.22e-2)" "unprognostic (3.68e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" 27.7 8.2 5.7 14.5 7.9 5.6 11.3 4.2 5.7 9.9 9.5 5.2 9.1 7.2 12.7 11.7 10.8 7.6 10.3 7.1 6.0 5.1 14.7 8.5 13.7 14.3 6.3 4.5 9.2 7.7 6.6 10.2 14.8 7.5 12.1 8.1 5.5 12.4 5.8 8.3 10.7 16.1 10.8 7.7 13.8 8.0 4.5 6.4 35.4 13.0 7.4 9.7 9.9 9.4 4.9 2.0 24.8 5.7 6.1 6.5 3.0 2.9 1.1 1.6 0.9 3.9 4.1 2.5 1.8 8.9 45.5 47.6 1.2 2.6 0.8 3.2 1.6 14.7 2.4 1.8 2.0 6.4 7.3 0.6 2.8 2.5 2.0 3.2 1.8 2.2 2.8 0.7 5.2 1.6 3.5 8.3 2.2 0.6 0.6 6.0 0.4 2.6 4.7 1.3 0.6 1.3 2.4 1.2 0.3 6.9 1.6 1.2 0.8 2.6 1.1 5.0 1.1 1.9 1.6 9.4 1.4 1.3 1.1 0.9 0.1 0.5 0.6 2.0 0.8 0.9 8.5 3.8 10.3 6.2 5.7 5.5 4.8 5.6 5.6 2.0 4.9 5.1 5.6 24.8 6.1 3.9 0.1 6.5 3.0 5.7 7.9 4.2 5.7 6.0 5.1 6.3 4.5 7.5 6.4 20.8 9.1 5.4 4.4 3.8 3.7 4.4 2.5 8.1 6.8 1.8 2.0 4.5 0.0 17.2 2.0 14.5 14.6 0.0 10.6 6.7 5.1 4.6 4.7 6.4 5.0 6.4 2.9 8.6 6.9 0.0 6.1 6.7 0.0 2.8 2.9 9.4 12.8 5.8 5.6 6.5 2.7 6.5 6.6 0.5 1.5 4.6 2.1 9.2 1.9 4.3 DDX6 "HLR2, RCK" ENSG00000110367 "DEAD-box helicase 6" P26196 11 118747766-118791149 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004668, HPA024201, HPA026644" Approved Supported "Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Cytosol "CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582" "unprognostic (1.26e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-1)" "unprognostic (3.40e-2)" "unprognostic (4.12e-2)" "unprognostic (5.82e-2)" "prognostic unfavorable (6.56e-4)" "unprognostic (3.43e-1)" "unprognostic (1.48e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (7.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.91e-3)" "unprognostic (1.88e-1)" "unprognostic (9.58e-2)" "unprognostic (4.55e-2)" 29.8 23.0 25.0 24.1 41.0 43.3 25.1 41.9 39.2 26.9 23.2 29.4 14.5 17.1 30.1 22.9 31.8 23.4 17.5 26.8 25.5 25.1 22.8 24.6 23.4 32.2 21.9 27.1 38.2 27.9 30.9 43.2 26.1 29.6 24.9 20.8 25.4 26.8 22.9 43.8 23.9 24.1 27.8 30.4 30.6 21.2 19.9 24.0 46.0 27.9 19.4 42.8 33.0 25.7 12.2 6.5 17.8 10.3 7.2 12.6 5.7 11.9 16.3 26.3 25.9 23.1 23.7 17.2 16.2 21.3 15.1 14.4 23.7 18.4 27.4 17.1 26.5 15.1 19.1 30.6 23.7 24.4 20.6 6.1 52.9 10.5 19.3 15.3 37.9 20.4 25.0 17.5 22.4 36.4 19.9 24.0 18.5 24.3 39.8 21.3 32.6 27.5 17.6 18.7 16.9 12.0 30.3 21.3 21.9 17.7 31.0 17.4 24.0 30.6 24.6 9.7 20.6 28.7 14.9 27.4 25.1 13.8 14.3 16.3 12.4 16.1 32.7 10.0 18.2 21.4 10.5 4.1 11.6 10.1 5.7 12.6 11.4 9.9 10.4 4.7 12.2 12.4 10.8 17.8 7.2 10.3 6.5 8.9 5.7 25.0 41.0 41.9 39.2 25.5 25.1 21.9 27.1 29.6 24.0 56.6 60.1 71.3 62.3 26.9 78.4 105.7 35.7 40.2 43.3 41.8 47.1 31.3 26.6 28.5 3.7 65.3 48.0 46.7 30.5 30.1 37.5 44.5 49.8 37.6 33.8 58.8 82.4 58.9 51.1 8.2 50.0 42.0 32.1 73.1 55.4 81.3 38.8 65.4 42.5 35.6 75.0 38.8 41.9 66.1 72.8 26.7 64.0 103.8 45.4 65.9 DDX60 FLJ20035 ENSG00000137628 "DExD/H-box helicase 60" Q8IY21 4 168216293-168318807 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 22.8;BJ hTERT+ SV40 Large T+ RasG12V: 22.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA046952 Approved Supported "Intermediate filaments,Cytosol" No No Cytosol "Intermediate filaments" "HPA046952: AB_10963572" "unprognostic (4.05e-2)" "unprognostic (2.87e-1)" "unprognostic (7.22e-3)" "unprognostic (7.71e-2)" "unprognostic (2.30e-1)" "unprognostic (2.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.15e-2)" "unprognostic (3.06e-1)" "unprognostic (8.69e-3)" "prognostic unfavorable (3.35e-4)" "unprognostic (1.65e-1)" "unprognostic (4.03e-2)" "unprognostic (2.48e-1)" "unprognostic (3.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.44e-1)" 18.0 8.3 4.1 18.5 5.0 4.4 9.0 1.3 3.8 11.4 14.8 4.3 5.1 8.8 10.8 15.2 10.7 8.1 11.5 8.5 3.7 3.5 10.0 8.8 21.6 18.7 4.2 3.2 20.3 5.5 8.8 6.7 25.5 5.6 11.6 14.3 9.0 15.6 6.2 5.6 7.9 16.7 11.2 6.1 18.9 29.2 5.7 3.9 23.2 14.5 6.0 9.3 8.2 7.2 4.1 2.5 3.2 6.3 7.6 10.0 3.5 5.6 1.2 2.8 1.1 2.1 7.8 3.2 1.9 13.7 22.8 22.1 0.0 12.4 0.0 1.1 3.0 10.5 4.7 0.3 4.5 6.6 4.3 0.6 8.8 4.8 0.0 10.3 3.3 2.2 7.0 2.0 5.8 1.3 5.5 8.5 4.2 0.0 1.7 2.8 0.3 5.0 2.4 0.5 0.8 1.6 3.4 1.5 0.1 6.7 3.4 0.6 0.6 3.6 1.0 13.7 0.2 0.9 4.2 5.6 1.4 1.5 0.5 1.4 1.0 0.2 0.0 4.3 3.8 4.0 3.2 2.8 2.6 8.5 5.1 10.0 4.1 6.7 8.0 2.5 3.3 6.8 8.5 2.8 7.6 6.3 0.2 5.5 3.5 4.1 5.0 1.3 3.8 3.7 3.5 4.2 3.2 5.6 3.9 32.8 6.2 5.0 4.0 3.8 0.7 7.1 10.2 14.7 12.5 12.2 0.0 6.4 5.0 7.0 1.7 10.3 10.7 0.0 5.9 8.5 5.0 3.8 26.5 3.8 5.8 0.0 2.9 15.4 4.1 1.4 7.5 8.8 3.3 0.0 13.6 8.0 8.7 7.2 8.9 3.3 3.0 6.5 3.8 0.9 0.7 2.4 2.4 10.1 5.8 3.1 DDX60L FLJ31033 ENSG00000181381 "DExD/H-box 60 like" Q5H9U9 4 168356735-168537786 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.5" "Group enriched" "Detected in all" 4 "granulocytes: 22.5;monocytes: 7.8" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 23.3" "HPA043211, HPA055501" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043211: AB_10794390, HPA055501: AB_2682838" "unprognostic (8.86e-2)" "unprognostic (2.77e-1)" "unprognostic (1.16e-1)" "unprognostic (2.45e-1)" "unprognostic (2.38e-1)" "unprognostic (3.20e-2)" "unprognostic (1.05e-1)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.70e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.13e-1)" "unprognostic (8.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.69e-1)" 12.7 5.0 2.8 13.1 3.1 33.0 9.9 1.4 3.2 7.2 8.4 3.2 2.7 6.0 9.2 7.9 3.8 6.9 6.7 6.0 2.4 2.4 4.5 6.0 25.8 17.7 3.8 1.4 7.3 5.1 4.4 5.2 32.6 3.4 5.0 6.5 6.8 7.0 5.7 3.3 4.3 14.0 5.3 4.2 11.9 9.5 2.7 3.1 25.3 5.8 3.5 8.1 4.9 6.8 1.6 2.4 22.5 7.8 1.7 3.7 1.6 6.1 3.6 1.4 0.6 3.7 10.8 7.0 6.2 13.1 23.3 16.2 0.0 14.5 0.1 0.3 6.3 12.7 2.4 0.6 3.7 6.8 3.5 0.5 13.6 4.0 0.3 4.5 5.5 3.4 3.0 1.1 8.4 0.7 4.9 16.4 3.1 0.2 0.1 14.9 0.1 4.9 3.5 0.3 0.6 3.1 2.7 3.2 0.0 2.2 3.6 0.2 1.9 11.0 1.3 6.2 0.2 1.0 7.8 17.5 1.2 8.2 2.9 2.1 5.9 0.9 0.0 4.1 16.5 1.8 1.6 4.0 3.5 2.7 6.3 3.7 0.9 2.7 2.7 2.4 1.6 2.2 2.3 22.5 1.7 7.8 0.0 3.6 1.6 2.8 3.1 1.4 3.2 2.4 2.4 3.8 1.4 3.4 3.1 8.9 7.9 0.0 2.1 0.9 1.3 8.1 5.1 12.0 3.4 3.5 21.6 4.5 0.0 6.8 10.7 13.1 11.6 0.0 8.7 29.4 7.0 2.6 8.1 5.4 22.5 0.0 0.0 9.2 23.2 3.6 3.1 29.7 0.0 26.2 13.2 3.2 17.0 14.0 3.9 3.3 16.8 6.5 3.3 0.5 1.3 2.0 5.9 8.7 3.8 1.4 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90052092 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 120.2" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 338.2;Proximal tubular cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 132.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol No No 740000 Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavorable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favorable (6.06e-4)" 26.9 45.7 13.2 18.1 17.6 9.2 15.6 10.3 14.5 13.0 29.0 10.4 11.8 32.4 11.9 13.7 16.2 8.5 12.6 70.0 15.4 9.0 44.8 120.2 12.9 14.0 12.5 12.8 12.7 14.4 22.2 16.8 5.8 13.6 11.0 22.9 9.5 15.7 9.9 37.9 12.5 42.7 11.5 11.9 20.1 12.7 17.0 14.5 20.3 15.0 32.1 15.3 11.6 10.6 23.4 52.3 37.2 42.8 19.8 31.3 27.8 10.5 6.0 17.8 20.1 12.5 20.3 3.8 9.3 16.1 6.1 9.5 2.4 10.5 8.1 7.4 11.1 5.5 8.0 6.6 9.4 10.2 12.2 0.7 19.3 5.4 9.6 15.6 4.2 4.0 16.0 7.3 4.8 8.1 15.1 18.0 12.9 20.1 16.0 29.0 12.1 12.0 6.2 1.1 22.4 18.2 10.2 4.7 14.4 29.8 26.6 0.8 6.7 14.0 132.5 11.1 0.5 17.0 10.9 16.3 10.3 4.9 13.5 5.5 8.1 6.1 9.5 9.8 9.6 13.1 15.0 31.5 10.2 21.4 42.8 22.6 23.4 20.1 21.8 52.3 19.2 21.3 21.0 37.2 19.8 37.2 20.4 31.3 27.8 13.2 17.6 10.3 14.5 15.4 9.0 12.5 12.8 13.6 14.5 71.5 50.7 52.5 52.8 36.7 12.7 229.8 79.0 71.0 51.2 68.0 2.0 44.0 338.2 106.7 118.9 49.7 161.9 0.0 82.2 42.9 47.8 37.6 48.5 196.2 104.2 30.2 100.6 52.2 85.9 33.7 79.1 96.9 81.0 80.2 84.9 41.0 80.5 101.7 48.4 333.3 6.5 71.1 40.1 118.4 23.4 35.9 34.3 71.9 118.0 55.4 DEF8 FLJ20186 ENSG00000140995 "Differentially expressed in FDCP 8 homolog" Q6ZN54 16 89947925-89968060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041745, HPA049434" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041745: AB_2677650, HPA049434: " "unprognostic (4.99e-2)" "unprognostic (1.01e-1)" "unprognostic (9.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" "unprognostic (8.24e-2)" "unprognostic (1.91e-3)" "unprognostic (9.96e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-2)" "prognostic favorable (1.35e-7)" "unprognostic (1.39e-2)" "prognostic favorable (1.95e-8)" "unprognostic (9.05e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.09e-1)" 18.0 15.9 25.4 22.4 23.0 25.3 15.6 42.4 30.6 12.6 16.4 15.4 19.4 12.0 17.1 14.1 22.5 14.3 16.3 23.7 23.7 24.8 14.9 12.2 15.4 42.8 28.0 29.0 18.2 22.5 19.0 18.0 11.5 20.5 14.5 9.2 13.9 21.4 18.9 19.5 27.4 13.6 17.6 23.6 16.6 15.2 8.8 15.0 4.8 14.5 13.6 32.4 15.5 23.8 23.0 27.4 32.0 16.7 5.3 11.5 11.1 15.2 31.2 14.2 19.2 14.6 15.5 16.2 23.7 20.2 35.1 16.4 33.0 18.5 18.5 17.9 16.1 14.3 10.1 16.7 28.1 15.6 4.5 47.6 8.3 16.6 47.2 15.8 6.0 13.2 17.4 23.3 25.1 14.8 15.5 26.2 17.1 27.2 6.3 20.8 55.7 11.7 18.2 17.9 7.1 31.9 24.4 10.4 15.8 18.8 14.7 21.0 21.6 38.2 14.3 13.3 7.8 13.3 19.5 26.2 20.3 22.2 10.8 25.1 12.3 8.7 23.2 21.7 15.5 23.7 2.3 16.7 32.0 11.5 13.4 10.5 19.6 9.6 8.4 10.7 23.0 6.6 6.4 22.5 5.3 7.6 27.4 11.4 11.1 25.4 23.0 42.4 30.6 23.7 24.8 28.0 29.0 20.5 15.0 0.0 11.3 33.5 18.0 39.8 22.8 26.6 25.5 8.1 10.3 14.0 25.5 26.2 24.9 43.1 5.6 26.4 18.2 0.0 79.2 44.9 34.3 30.7 9.3 20.2 55.6 28.6 20.7 25.8 24.7 16.0 19.5 29.4 43.9 64.1 14.3 13.8 83.0 14.4 31.5 36.3 23.3 19.4 41.1 5.6 9.0 47.8 27.1 16.2 13.2 19.7 DENND1A "FAM31A, FLJ21129, KIAA1608" ENSG00000119522 "DENN domain containing 1A" Q8TEH3 9 123379654-123930152 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020481 Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA020481: AB_2092106" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "unprognostic (2.00e-1)" "unprognostic (4.25e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.19e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (2.48e-3)" "unprognostic (5.63e-2)" "prognostic favorable (4.11e-5)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (9.66e-2)" "unprognostic (4.31e-2)" 11.4 12.2 17.4 13.9 19.8 32.5 10.0 18.6 21.2 10.9 14.8 12.8 10.3 15.8 13.3 9.0 11.3 13.0 10.5 10.3 15.9 12.8 16.4 14.5 9.4 11.6 11.8 14.9 12.0 8.9 20.1 19.0 23.9 13.9 11.0 14.1 14.5 8.5 11.8 11.0 9.3 17.2 14.4 10.1 20.2 9.9 12.1 13.2 10.6 15.5 5.6 9.5 10.6 17.4 1.5 8.4 11.2 15.2 0.5 1.3 3.2 14.8 8.8 7.9 14.9 5.4 8.5 36.8 14.4 21.8 12.3 10.7 12.0 6.6 11.9 3.0 11.6 16.3 8.4 6.7 10.5 12.0 5.0 5.1 5.6 21.3 8.8 7.2 6.7 3.8 7.8 9.5 10.2 17.5 4.3 10.9 11.6 15.4 9.2 9.9 8.5 8.0 9.7 15.7 17.2 13.4 12.5 7.7 10.1 6.1 5.3 16.8 13.7 11.6 7.7 9.0 5.4 10.5 17.0 5.1 13.3 5.1 15.5 7.5 14.0 10.9 8.2 11.2 13.4 8.8 11.2 15.2 2.8 1.3 10.1 0.7 1.1 0.9 0.6 8.4 1.5 0.6 0.7 9.3 0.5 8.2 1.3 0.4 3.2 17.4 19.8 18.6 21.2 15.9 12.8 11.8 14.9 13.9 13.2 0.0 1.0 7.3 2.3 4.5 15.9 7.7 7.6 1.4 1.2 15.7 15.7 8.6 5.0 4.0 28.4 10.1 17.6 0.0 4.4 27.4 5.2 4.7 4.6 12.1 14.5 30.2 11.5 7.4 15.9 67.9 13.6 10.8 3.3 2.8 6.6 13.5 5.2 10.7 10.6 11.5 12.3 0.0 5.2 3.4 1.1 2.5 7.3 3.8 6.7 3.1 DENND1B "C1orf218, FAM31B, FLJ20054, MGC27044" ENSG00000213047 "DENN domain containing 1B" Q6P3S1 1 197504748-197775696 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042586 Uncertain Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA042586: AB_2678064" "unprognostic (8.79e-2)" "unprognostic (1.58e-1)" "unprognostic (4.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.39e-1)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (9.54e-2)" "unprognostic (7.79e-3)" "unprognostic (3.99e-2)" "unprognostic (3.13e-2)" "unprognostic (5.36e-2)" "unprognostic (6.11e-2)" "unprognostic (5.61e-3)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-2)" 5.9 3.9 6.2 12.7 8.3 6.4 8.7 3.9 5.6 5.7 13.0 1.4 8.8 7.5 3.6 6.4 9.0 3.1 5.4 7.3 4.9 4.9 7.9 6.6 7.3 7.8 4.0 2.7 5.6 8.7 9.9 15.9 3.6 3.7 7.5 7.8 6.4 9.9 15.8 6.5 3.8 21.6 4.1 3.5 7.7 6.1 4.4 2.6 17.9 8.2 6.5 11.7 6.9 6.8 2.3 2.0 5.0 0.6 5.8 3.6 0.7 6.0 1.5 1.7 2.9 0.8 4.5 2.7 4.6 3.2 2.9 1.7 1.6 3.9 11.0 2.4 7.1 1.7 3.1 2.7 3.4 2.5 8.3 3.0 4.0 3.0 0.8 2.4 12.9 4.9 1.5 4.6 1.1 3.2 8.8 1.2 6.4 3.0 17.1 2.8 1.1 6.9 6.6 0.6 1.5 1.5 4.3 1.5 8.6 7.1 5.7 3.0 4.7 7.1 4.8 1.2 2.9 2.0 11.3 3.4 0.3 2.8 0.1 2.7 8.7 0.0 5.6 3.0 5.3 5.3 5.0 0.3 2.3 2.1 0.6 1.1 2.3 1.4 3.3 1.5 0.7 0.8 1.5 1.0 5.8 0.6 2.0 3.6 0.7 6.2 8.3 3.9 5.6 4.9 4.9 4.0 2.7 3.7 2.6 38.7 11.5 19.6 20.9 7.4 19.3 24.6 12.7 4.0 12.5 14.0 23.6 8.1 14.9 8.1 25.6 4.8 51.6 0.0 19.9 7.7 8.9 21.4 63.5 14.3 17.9 4.8 13.8 8.0 21.7 19.7 22.2 29.4 15.1 13.6 24.1 7.1 17.6 42.1 12.4 13.2 13.8 0.0 2.9 8.0 13.3 10.7 6.2 33.8 22.4 47.8 DENND1C "FAM31C, FLJ22757" ENSG00000205744 "DENN domain containing 1C" Q8IV53 19 6467207-6482557 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.7;lymphoid tissue: 32.9" "Cell type enhanced" "Detected in many" 10 "B-cells: 28.3;Erythroid cells: 23.3;granulocytes: 16.1;T-cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 13.2;HEL: 8.8;HMC-1: 27.4;MOLT-4: 8.4;THP-1: 8.1;U-937: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042758, HPA042839" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042758: AB_10962357, HPA042839: AB_10959898" "unprognostic (5.94e-2)" "unprognostic (1.41e-3)" "unprognostic (4.26e-2)" "unprognostic (1.93e-3)" "unprognostic (1.21e-1)" "unprognostic (1.72e-3)" "unprognostic (3.91e-2)" "prognostic favorable (1.23e-4)" "unprognostic (7.76e-3)" "unprognostic (4.45e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (8.95e-4)" "prognostic favorable (7.51e-14)" "unprognostic (1.37e-3)" "unprognostic (1.27e-1)" "unprognostic (4.53e-2)" "prognostic favorable (5.62e-4)" 2.1 1.3 1.5 22.0 2.5 14.1 2.0 0.5 1.6 1.0 2.8 2.5 0.0 3.4 1.0 1.5 1.7 1.7 3.4 1.0 1.3 1.3 2.2 2.0 5.2 30.1 3.1 0.6 0.8 1.0 0.0 1.1 1.3 2.2 1.7 0.8 1.4 5.4 0.8 0.6 1.0 12.1 0.8 2.7 31.3 3.5 0.5 2.7 32.9 1.8 1.2 25.2 3.0 1.5 16.3 12.2 19.0 20.6 14.1 26.7 20.2 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 13.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 8.8 0.0 0.9 0.0 4.3 27.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 5.7 0.1 0.0 8.4 6.7 0.0 0.3 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.1 0.0 18.3 0.0 10.4 11.6 19.0 26.7 20.6 23.4 16.3 19.1 22.9 12.2 13.7 24.8 21.6 17.6 14.1 20.0 7.1 21.9 20.2 1.5 2.5 0.5 1.6 1.3 1.3 3.1 0.6 2.2 2.7 3.0 4.8 28.3 0.0 0.3 0.0 0.9 2.5 2.7 0.0 1.8 0.0 0.1 1.7 0.4 0.6 0.0 1.1 23.3 0.0 0.2 0.2 0.0 16.1 0.0 12.9 0.0 0.0 1.8 9.9 0.4 0.0 9.2 3.3 3.6 0.6 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.3 0.2 0.7 0.1 0.2 32.3 0.8 0.1 DENND2D "FLJ22457, RP5-1180E21.2" ENSG00000162777 "DENN domain containing 2D" Q9H6A0 1 111187174-111204535 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 51.0;lymphoid tissue: 67.6" "Cell type enhanced" "Detected in many" 8 "T-cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 44.8;MAIT T-cell: 38.2;memory CD4 T-cell: 32.5;memory CD8 T-cell: 45.6;naive CD4 T-cell: 51.0;naive CD8 T-cell: 48.4;NK-cell: 45.1;T-reg: 13.7" "Group enriched" "Detected in all" 6 "NK-cells: 45.1;T-cells: 51.0" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;MOLT-4: 52.9;SK-BR-3: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043630, HPA048642" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043630: AB_2678589, HPA048642: AB_2680474" "unprognostic (1.72e-3)" "prognostic favorable (1.67e-4)" "unprognostic (2.60e-2)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic favorable (2.70e-4)" "unprognostic (5.09e-2)" "unprognostic (8.10e-2)" "unprognostic (1.35e-1)" "unprognostic (4.66e-3)" "unprognostic (3.09e-2)" "unprognostic (1.02e-1)" "unprognostic (9.61e-2)" "unprognostic (3.80e-3)" "unprognostic (5.45e-2)" "unprognostic (2.75e-2)" "prognostic favorable (8.66e-5)" 8.9 11.1 0.9 42.9 2.6 3.5 6.5 0.8 1.6 4.9 10.4 1.4 4.9 6.4 2.4 5.9 19.5 6.4 9.9 2.5 1.0 1.0 11.4 9.3 11.5 42.0 2.6 0.8 3.0 7.5 8.8 8.0 20.2 1.9 9.2 6.9 3.7 21.1 4.7 1.3 7.9 13.8 1.3 3.2 33.8 9.0 5.1 1.8 39.2 8.0 7.0 67.6 15.7 8.2 8.2 3.2 3.5 3.5 45.1 51.0 29.6 10.4 0.4 0.0 0.0 2.6 1.0 0.1 0.6 0.0 1.1 0.2 3.1 5.1 11.1 3.7 1.6 0.0 3.3 0.0 0.5 1.1 21.0 0.0 3.3 0.7 0.0 3.9 0.0 3.4 3.1 2.3 0.3 0.0 3.5 0.1 4.2 0.0 3.5 0.3 8.9 52.9 0.3 0.0 13.2 1.4 1.3 0.0 16.1 3.7 11.3 3.7 0.0 3.7 34.3 1.2 0.0 10.1 10.5 0.0 0.0 0.0 0.0 0.0 3.2 1.3 8.3 0.0 9.3 0.0 0.8 3.5 2.3 44.8 2.5 38.2 7.2 32.5 45.6 3.2 8.2 51.0 48.4 3.5 45.1 1.8 2.4 13.7 29.6 0.9 2.6 0.8 1.6 1.0 1.0 2.6 0.8 1.9 1.8 6.0 15.6 29.2 15.0 4.4 0.0 0.9 7.6 18.7 18.2 19.2 0.0 1.2 16.6 23.6 26.8 2.9 16.1 0.0 14.1 2.1 4.1 21.1 17.3 4.9 46.9 0.0 5.8 9.2 28.5 38.6 1.1 9.9 6.8 1.0 23.6 0.0 13.8 14.0 0.4 21.0 0.5 0.0 0.7 13.0 0.7 3.4 9.6 105.1 20.4 26.5 DENND3 KIAA0870 ENSG00000105339 "DENN domain containing 3" A2RUS2 8 141117278-141195808 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.9" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 145.9;Kupffer cells: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 18.0;neutrophil: 22.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 22.2" "Cell line enhanced" "Detected in many" "HDLM-2: 27.4;HeLa: 33.9;U-937: 24.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024491, HPA041668" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA024491: AB_2671581, HPA041668: " "unprognostic (2.27e-1)" "unprognostic (9.62e-2)" "unprognostic (9.47e-3)" "unprognostic (1.66e-1)" "unprognostic (6.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (7.07e-3)" "unprognostic (2.71e-2)" "unprognostic (2.25e-2)" "unprognostic (7.74e-2)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (4.51e-2)" "unprognostic (5.42e-2)" 21.8 6.2 12.2 21.7 15.2 75.9 17.6 1.7 12.3 10.4 17.0 11.5 2.3 5.5 10.3 6.1 6.8 8.3 12.0 8.8 12.1 8.5 12.2 3.9 30.1 27.8 15.9 7.7 8.9 4.7 4.5 5.8 13.0 13.7 9.0 7.4 7.1 10.2 8.3 12.9 8.3 12.7 7.8 21.9 24.7 9.1 4.6 11.8 3.4 11.4 3.5 20.6 9.5 9.8 2.4 2.2 22.2 5.4 1.4 0.4 1.6 6.9 6.3 0.4 1.3 1.9 2.9 1.1 4.0 11.7 1.6 1.3 1.9 6.6 1.8 10.4 7.4 3.3 3.5 1.8 4.3 1.2 27.4 1.6 7.2 33.9 0.6 1.7 7.2 1.1 0.2 2.2 1.8 2.3 4.0 9.2 3.4 0.0 17.7 1.2 2.1 1.0 10.0 0.4 1.3 8.3 1.2 0.3 6.9 6.6 2.4 2.0 1.3 0.8 0.5 0.5 3.3 2.9 11.6 7.3 0.3 3.2 4.6 0.1 3.6 15.7 0.5 1.1 24.9 0.4 9.3 2.9 18.0 0.4 4.5 0.4 2.4 0.3 0.1 2.2 2.3 0.0 0.1 22.2 1.4 5.4 0.0 0.1 1.6 12.2 15.2 1.7 12.3 12.1 8.5 15.9 7.7 13.7 11.8 145.9 32.8 17.6 6.5 14.0 4.7 7.8 12.7 9.4 19.4 21.0 3.9 0.6 1.7 2.8 4.9 20.2 7.4 0.0 3.1 0.5 4.2 8.9 10.4 0.0 19.6 1.6 4.6 19.6 50.4 1.5 1.4 26.4 8.5 21.6 7.6 0.6 7.1 3.1 0.7 2.1 0.3 38.8 16.5 7.0 7.2 8.0 0.5 10.2 3.6 4.9 DENND4C "bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF" ENSG00000137145 "DENN domain containing 4C" Q5VZ89 9 19230435-19373545 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014917, HPA015096" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles, Cytosol" "HPA014917: AB_2261659, HPA015096: AB_1845831" "unprognostic (4.57e-2)" "unprognostic (1.73e-2)" "unprognostic (6.81e-2)" "unprognostic (1.71e-1)" "unprognostic (1.87e-2)" "unprognostic (1.48e-1)" "unprognostic (2.43e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "prognostic favorable (3.51e-5)" "unprognostic (3.27e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" 31.5 14.0 7.4 11.2 9.4 5.8 17.8 17.7 10.4 18.8 17.9 7.3 17.5 17.4 15.0 12.7 15.8 12.5 9.9 13.7 8.0 5.7 10.2 10.1 16.3 7.2 9.1 6.7 16.3 16.0 16.9 18.2 14.6 8.4 14.9 14.5 10.4 16.9 12.2 11.5 20.5 18.4 19.1 8.9 9.8 13.8 9.0 9.6 14.3 12.9 8.3 11.0 22.3 17.7 3.0 4.0 8.5 2.1 8.1 10.2 3.4 11.7 11.1 8.0 10.4 17.6 21.3 14.6 6.7 10.2 7.2 9.6 5.5 7.8 5.0 5.7 8.9 8.3 6.3 9.3 5.6 8.8 32.9 5.3 22.9 12.8 6.4 8.7 5.3 13.1 8.3 12.9 6.3 10.8 14.6 13.4 6.6 6.1 5.8 9.2 4.5 9.3 11.8 6.0 15.5 5.5 8.4 4.6 7.2 18.9 22.7 8.1 5.9 6.0 13.7 4.8 7.6 8.4 7.2 12.5 6.4 3.6 6.9 7.0 3.9 9.5 2.7 5.3 5.2 3.5 8.5 2.1 2.5 7.8 1.1 10.2 2.5 6.7 7.8 4.0 3.0 6.1 7.3 1.1 8.1 1.1 4.0 4.8 3.4 7.4 9.4 17.7 10.4 8.0 5.7 9.1 6.7 8.4 9.6 8.9 8.6 1.4 14.5 45.4 21.5 10.4 15.3 14.7 15.9 15.7 56.9 22.1 1.7 8.0 6.3 18.3 23.8 0.0 10.6 11.1 15.5 14.1 25.5 9.6 17.4 22.3 19.0 46.1 20.6 4.0 17.3 19.5 20.3 3.6 23.6 16.7 9.8 17.3 19.1 3.7 17.8 0.0 11.1 2.4 6.4 43.2 13.5 12.2 23.9 17.1 DENR "DRP, DRP1, SMAP-3" ENSG00000139726 "Density regulated re-initiation and release factor" O43583 12 122752774-122771064 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021783 Approved Approved Cytosol NA NA 120000 Cytosol "HPA021783: AB_2670820" "unprognostic (3.65e-2)" "unprognostic (7.00e-2)" "unprognostic (5.69e-2)" "unprognostic (7.33e-3)" "unprognostic (6.62e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (2.23e-3)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (3.75e-1)" "unprognostic (1.02e-3)" "prognostic unfavorable (8.57e-6)" "unprognostic (1.32e-1)" "unprognostic (1.26e-1)" "unprognostic (2.65e-1)" "unprognostic (1.35e-1)" 19.5 23.2 23.3 28.3 23.8 19.3 27.1 21.7 36.8 19.1 20.8 12.0 24.8 20.9 20.8 23.6 33.6 17.8 23.1 20.1 22.5 26.1 22.4 26.2 16.8 28.6 24.9 30.3 19.2 21.6 56.5 23.7 27.9 23.2 23.6 21.2 13.2 24.5 24.9 42.5 23.1 21.8 30.4 16.4 24.5 19.0 11.7 14.8 35.5 24.0 28.4 26.9 22.6 22.2 15.5 15.5 57.7 20.8 14.8 17.7 13.7 34.6 19.6 25.0 25.3 15.7 23.4 21.6 31.6 17.5 27.7 19.3 27.1 12.9 31.0 33.6 22.2 21.5 26.6 29.2 27.6 37.6 28.0 21.0 37.9 11.6 19.3 20.5 42.5 31.5 20.3 27.5 25.5 34.3 26.2 26.8 34.7 39.4 11.5 29.6 22.8 41.8 40.5 50.5 20.7 40.2 37.3 29.3 19.7 26.9 30.7 28.6 20.6 43.9 13.0 32.1 26.2 41.3 23.8 26.0 26.2 31.3 29.5 31.5 18.9 43.7 50.1 24.9 30.9 28.9 57.7 11.7 18.5 13.8 17.2 16.0 15.5 15.0 13.8 15.5 14.0 17.7 15.5 13.9 14.8 20.8 13.8 15.7 13.7 23.3 23.8 21.7 36.8 22.5 26.1 24.9 30.3 23.2 14.8 65.5 34.4 63.8 54.7 63.8 36.1 60.9 28.1 57.6 48.9 45.4 39.3 61.7 54.7 64.0 15.8 42.7 36.0 0.0 53.2 110.1 42.8 48.2 41.6 44.5 50.4 52.4 81.4 37.4 44.5 7.7 46.6 50.8 25.3 55.1 49.0 36.6 67.8 45.6 43.2 53.7 34.1 19.4 47.3 51.6 143.1 56.8 50.7 52.4 54.2 44.1 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6;placenta: 71.5" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 17.8;Extravillous trophoblasts: 18.7;Spermatocytes: 32.0;Syncytiotrophoblasts: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: AB_2686534" "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favorable (2.42e-4)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (3.08e-4)" "prognostic unfavorable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.6 0.6 0.6 3.7 1.5 7.9 0.6 0.8 1.4 1.2 3.3 0.6 0.1 4.8 0.9 0.5 5.2 0.4 19.0 0.4 0.8 0.8 3.3 0.9 1.0 6.9 2.3 0.7 0.6 0.5 0.0 0.3 71.5 1.4 0.5 4.6 0.4 1.3 0.1 0.2 2.1 5.1 0.5 3.2 3.3 2.0 17.0 1.2 21.6 1.5 2.3 7.6 0.9 2.2 1.0 0.6 3.3 0.3 1.4 6.4 0.9 24.0 8.2 25.0 15.2 0.5 0.8 27.4 6.5 4.4 11.5 15.0 13.6 15.3 13.7 16.1 2.0 14.9 8.0 20.0 14.6 15.5 19.5 14.5 17.1 9.4 16.9 0.4 14.4 16.7 0.5 1.5 3.7 5.4 2.2 10.6 14.7 12.2 18.8 10.1 15.1 23.2 12.6 18.4 5.2 13.3 25.8 20.3 11.7 9.3 12.0 13.9 6.4 15.3 5.5 7.2 11.7 10.2 11.5 4.9 4.9 14.4 3.9 16.5 9.5 16.6 27.1 6.1 21.2 13.6 3.3 0.3 1.7 0.5 0.0 0.4 1.0 2.2 1.5 0.6 0.1 0.3 0.3 0.0 1.4 0.0 0.1 6.4 0.9 0.6 1.5 0.8 1.4 0.8 0.8 2.3 0.7 1.4 1.2 0.0 2.6 0.8 0.8 4.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 1.9 0.0 0.3 1.4 0.1 1.7 0.0 0.2 18.7 0.4 0.5 3.5 0.0 5.2 0.0 0.0 0.0 1.2 1.8 0.3 2.2 0.0 0.0 1.0 0.2 0.7 2.0 0.0 0.5 0.0 6.5 0.4 32.0 8.7 1.8 39.2 0.0 6.3 0.3 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 30.9;Early spermatids: 98.0;Extravillous trophoblasts: 40.1;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 27.2;RH-30: 20.6;SiHa: 18.8;U-2197: 17.5" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 2.0 1.9 2.5 8.2 2.7 5.0 6.8 6.7 0.4 0.0 1.9 8.1 2.3 4.7 5.4 1.9 6.0 0.0 7.5 1.3 7.9 9.4 1.6 4.4 5.6 2.4 2.9 2.9 2.1 2.7 0.0 0.0 3.0 0.0 27.2 0.5 0.0 7.1 2.4 3.8 0.0 0.0 20.6 0.0 1.6 0.6 0.8 2.1 18.8 3.3 16.3 2.7 0.8 2.3 0.0 3.2 5.4 17.5 5.2 0.0 0.0 0.0 1.2 0.0 15.9 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 0.0 0.0 0.0 8.3 30.9 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.3 3.3 0.4 98.0 0.1 8.6 0.0 0.5 40.1 1.6 0.8 2.3 19.4 2.7 0.0 3.4 2.5 0.3 6.3 1.4 2.4 1.7 1.8 1.0 0.0 1.0 0.0 1.1 11.2 0.0 0.0 1.4 27.7 7.6 6.5 1.3 0.0 2.1 0.7 DESI1 "D15Wsu75e, FAM152B, PPPDE2" ENSG00000100418 "Desumoylating isopeptidase 1" Q6ICB0 22 41598028-41621096 "Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Group enriched" "Detected in many" 5 "Early spermatids: 685.0;Late spermatids: 303.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053415 Approved Approved "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA053415: AB_2682141" "unprognostic (1.07e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-2)" "prognostic favorable (7.70e-4)" "unprognostic (2.31e-2)" "unprognostic (6.16e-3)" "unprognostic (8.75e-3)" "unprognostic (9.27e-2)" "unprognostic (3.97e-2)" "unprognostic (6.27e-2)" "unprognostic (1.80e-2)" "unprognostic (1.42e-1)" "unprognostic (2.31e-3)" "unprognostic (2.65e-2)" "unprognostic (1.55e-1)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" 12.9 14.5 24.6 12.6 25.4 8.4 13.4 17.0 33.3 11.7 11.9 22.8 9.5 14.5 10.4 15.1 19.7 11.3 11.5 30.3 24.3 19.7 19.5 69.2 14.0 13.2 23.5 16.3 12.7 13.2 15.7 10.0 11.8 18.3 13.4 14.0 9.7 13.2 14.4 14.6 15.9 16.1 14.5 22.4 11.3 12.6 29.2 19.0 9.7 9.7 14.6 16.8 10.8 9.2 6.2 7.4 10.6 12.5 2.8 7.3 5.5 7.0 7.6 7.6 10.4 10.7 12.9 4.3 14.4 9.3 13.4 9.9 10.0 4.5 27.2 10.0 16.6 7.1 10.4 20.1 16.1 14.1 12.2 15.3 6.1 14.1 8.4 13.2 23.9 8.3 11.0 18.8 16.4 15.4 11.0 20.2 9.5 17.7 30.9 10.6 9.0 5.4 7.3 7.5 26.7 11.5 7.4 3.2 27.8 16.8 4.6 5.4 2.8 13.9 15.3 9.8 9.0 5.0 7.8 20.4 9.9 7.2 10.4 7.0 11.4 8.8 13.0 24.6 10.6 13.1 9.5 9.3 10.6 5.0 12.5 6.4 6.2 6.2 5.9 7.4 5.4 5.6 6.5 5.5 2.8 8.2 4.4 7.3 5.5 24.6 25.4 17.0 33.3 24.3 19.7 23.5 16.3 18.3 19.0 8.9 13.9 25.3 26.2 7.7 21.3 44.5 10.2 6.7 9.1 8.7 5.9 24.8 33.2 44.8 685.0 20.4 35.5 0.0 26.0 35.1 19.1 35.6 10.4 60.6 45.6 20.6 18.9 16.0 22.9 303.8 17.5 21.6 13.5 65.9 16.1 16.2 45.9 21.8 9.9 43.5 8.8 25.8 18.2 109.0 21.3 11.5 69.9 20.8 23.8 53.6 DET1 FLJ10103 ENSG00000140543 "DET1, COP1 ubiquitin ligase partner" Q7L5Y6 15 88494440-88546675 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Microtubules" "Cytokinetic bridge, Cytosol" "HPA048873: AB_2680541" "unprognostic (9.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (3.17e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (6.64e-2)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (2.82e-3)" "unprognostic (2.62e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (4.67e-2)" 6.0 9.3 5.5 4.3 7.0 1.9 6.4 5.5 6.8 9.5 6.3 8.2 7.0 5.5 15.9 9.1 3.8 9.6 7.8 8.8 4.3 4.2 5.4 4.5 4.3 4.2 5.0 6.1 17.9 10.1 7.1 6.4 5.6 5.9 8.5 5.6 12.6 6.7 7.4 13.8 4.4 5.9 11.4 5.1 4.4 5.5 3.6 4.6 10.7 6.8 4.1 6.4 7.7 6.0 5.3 7.6 2.9 7.4 3.4 6.6 3.8 2.0 6.8 9.7 7.1 4.8 7.3 1.9 6.6 7.1 5.8 6.1 1.4 6.5 4.0 5.1 8.4 5.7 3.2 11.0 2.0 5.0 0.3 7.0 7.6 3.8 2.4 7.6 2.9 1.6 6.2 7.3 2.7 7.9 4.9 4.5 4.1 9.5 4.8 7.3 3.2 4.1 3.2 4.4 3.2 2.1 4.8 8.0 4.9 3.0 6.0 3.7 5.9 7.4 2.6 16.6 7.1 3.7 6.0 3.6 5.9 4.6 6.0 6.1 2.8 2.0 2.6 6.6 4.9 5.2 0.0 4.8 2.9 5.3 7.4 3.9 4.8 4.6 4.7 7.6 5.3 6.6 5.4 0.7 3.4 4.6 4.1 5.1 3.8 5.5 7.0 5.5 6.8 4.3 4.2 5.0 6.1 5.9 4.6 3.0 2.4 1.7 2.1 0.6 11.9 1.6 0.0 4.0 1.2 3.5 9.8 5.5 1.7 2.6 0.4 2.1 2.6 0.0 3.3 5.7 3.9 1.2 0.0 2.8 3.7 6.4 2.9 1.3 1.2 0.4 4.0 2.3 3.3 4.6 2.5 6.5 2.5 0.0 3.5 1.9 7.2 0.0 3.1 4.8 8.5 1.1 3.4 0.5 2.9 1.3 DEXI MYLE ENSG00000182108 "Dexi homolog" O95424 16 10928891-10942460 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041511 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA041511: AB_10796675" "unprognostic (4.14e-1)" "unprognostic (8.52e-2)" "unprognostic (1.29e-1)" "unprognostic (9.70e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (1.19e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "unprognostic (1.47e-2)" "prognostic favorable (4.23e-4)" "unprognostic (5.21e-2)" "unprognostic (1.33e-3)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.75e-2)" "unprognostic (1.83e-2)" 15.0 25.2 15.7 8.0 20.8 4.1 10.7 14.0 27.5 12.2 13.9 9.8 12.7 11.1 11.7 18.5 12.9 14.5 11.6 32.2 13.1 13.6 13.3 26.3 9.5 9.9 18.8 12.3 15.9 18.0 22.1 12.9 13.3 21.3 13.6 6.6 13.7 15.4 16.6 81.6 10.3 11.1 12.1 9.4 12.7 10.6 8.9 11.9 13.7 18.4 10.6 8.1 10.9 10.5 4.0 2.4 8.2 0.7 3.9 7.0 1.2 9.5 13.9 7.5 13.2 30.6 16.9 6.9 14.7 15.4 9.7 9.2 6.5 10.0 11.3 22.2 16.6 10.5 12.4 8.8 15.8 8.3 26.6 19.8 5.6 9.1 27.5 17.6 9.6 10.7 17.1 18.3 9.4 11.0 15.7 13.9 16.2 12.8 11.4 10.7 16.8 11.9 10.5 10.5 11.8 14.5 11.1 9.9 17.3 11.9 7.1 15.5 13.6 14.0 15.5 11.7 6.6 12.3 16.8 15.2 9.8 10.5 23.0 9.6 15.1 11.6 3.3 8.6 20.7 11.0 1.7 0.6 8.2 6.0 0.7 5.6 0.6 5.2 7.0 0.4 4.0 6.4 6.0 0.7 3.9 0.3 2.4 3.9 1.2 15.7 20.8 14.0 27.5 13.1 13.6 18.8 12.3 21.3 11.9 6.0 8.9 13.4 27.4 29.7 18.1 0.0 48.4 8.1 2.3 26.2 11.8 20.0 64.6 22.3 6.3 18.5 9.7 0.0 31.5 17.9 28.6 35.2 1.1 87.3 33.0 22.3 14.3 38.1 12.3 11.5 69.6 8.7 15.1 16.2 13.5 38.1 25.7 13.9 80.6 56.2 12.9 19.4 35.5 2.4 2.7 28.4 9.7 18.1 16.8 37.0 DFFA "DFF-45, DFF1, DFF45, ICAD" ENSG00000160049 "DNA fragmentation factor subunit alpha" O00273 1 10456522-10472526 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002679, HPA018859, HPA019938, HPA025230" Supported Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623" "unprognostic (1.23e-1)" "unprognostic (2.63e-1)" "unprognostic (1.06e-1)" "unprognostic (3.59e-2)" "unprognostic (1.57e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (9.46e-4)" "unprognostic (1.55e-1)" "unprognostic (9.24e-3)" "unprognostic (3.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "prognostic favorable (1.57e-9)" "unprognostic (1.21e-2)" "unprognostic (3.46e-2)" "unprognostic (3.89e-2)" "unprognostic (1.88e-1)" 17.8 19.9 22.9 15.6 23.0 7.9 20.9 20.4 20.7 16.6 15.1 22.5 19.1 16.5 18.4 14.4 24.2 18.6 15.3 17.2 20.7 19.9 23.7 18.9 15.5 15.6 26.4 18.9 22.5 19.8 25.7 17.2 27.2 26.1 17.0 17.3 15.0 16.3 18.4 16.8 14.8 14.7 22.4 24.1 14.8 16.8 13.4 21.9 16.7 18.0 13.0 21.4 18.7 26.1 14.1 10.7 7.2 9.9 14.1 14.4 8.9 14.6 14.6 12.6 14.3 10.7 10.2 6.1 20.9 13.5 21.8 16.3 34.9 19.4 31.3 13.5 17.6 12.2 12.1 24.3 24.8 22.1 12.4 16.8 15.6 15.2 13.9 17.5 19.0 10.4 12.7 12.5 34.4 27.8 12.0 16.6 15.7 27.8 7.1 15.4 18.6 18.7 8.6 11.0 11.1 17.1 16.1 15.1 15.8 19.6 11.3 14.9 14.5 19.5 17.0 23.0 11.4 10.9 6.6 17.3 10.3 14.0 18.8 13.8 8.8 12.3 45.6 10.9 18.1 15.5 1.3 9.9 7.2 14.4 8.0 10.9 14.1 9.7 12.4 9.2 13.7 10.2 12.3 1.5 14.1 9.7 10.7 13.5 8.9 22.9 23.0 20.4 20.7 20.7 19.9 26.4 18.9 26.1 21.9 41.7 29.3 39.4 29.8 30.6 18.3 22.1 28.1 32.1 35.2 17.4 102.1 83.5 31.5 40.0 25.0 27.1 15.1 0.0 33.8 52.0 19.4 20.0 24.3 27.7 36.5 19.1 32.8 30.7 19.8 58.1 27.9 18.5 10.1 44.1 12.4 21.1 39.9 7.0 30.4 45.1 30.9 19.4 20.0 31.2 30.4 35.5 55.5 24.9 25.7 31.2 DGAT2 ENSG00000062282 "Diacylglycerol O-acyltransferase 2" Q96PD7 11 75759512-75801535 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 104.3;blood: 68.9;liver: 81.3" "Cell type enhanced" "Detected in many" 19 "Early spermatids: 192.0;Hepatocytes: 104.6;Late spermatids: 49.3;Spermatocytes: 45.4;Spermatogonia: 49.4" "Cancer enhanced" "Detected in many" "liver cancer: 19.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "eosinophil: 26.3;neutrophil: 68.9" "Lineage enriched" "Detected in many" 16 "granulocytes: 68.9" "Cell line enhanced" "Detected in many" "ASC diff: 30.3;HDLM-2: 22.0;Hep G2: 22.9;OE19: 44.2" "Low region specificity" "Detected in all" HPA013351 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA013351: AB_1847630" "unprognostic (2.28e-1)" "unprognostic (3.69e-1)" "unprognostic (9.38e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (3.63e-1)" "unprognostic (4.99e-2)" "unprognostic (1.10e-2)" "unprognostic (7.59e-2)" "unprognostic (4.46e-1)" "unprognostic (4.12e-3)" "unprognostic (2.87e-1)" "unprognostic (2.99e-1)" "unprognostic (1.49e-7)" "unprognostic (2.03e-1)" "unprognostic (2.85e-1)" "unprognostic (2.74e-2)" "unprognostic (5.60e-2)" 104.3 1.3 1.9 12.5 6.8 1.7 30.4 0.1 4.2 1.0 11.8 0.6 0.4 3.6 0.5 0.6 6.3 0.7 6.3 6.0 1.0 1.2 1.0 81.3 1.8 16.1 0.6 1.2 0.6 1.3 0.4 0.6 0.5 1.0 1.0 1.4 1.2 9.9 0.6 1.3 34.1 8.1 0.9 0.6 3.7 3.3 13.6 0.5 1.0 2.4 3.9 4.5 4.0 2.7 1.5 1.1 68.9 4.2 0.0 0.0 0.9 4.6 2.3 0.1 4.0 30.3 2.4 0.3 0.4 0.5 0.6 0.3 16.7 4.9 7.4 6.2 0.1 4.4 0.1 0.6 2.3 1.6 22.0 0.4 0.5 1.6 22.9 0.3 2.6 2.6 10.1 12.4 2.7 3.9 1.6 0.4 7.5 0.4 10.1 0.2 3.0 1.7 5.7 1.3 44.2 10.9 0.0 0.0 8.7 0.4 12.9 8.3 0.5 4.2 0.7 1.0 1.0 1.6 9.3 0.5 5.3 2.6 0.1 3.2 5.9 13.2 9.9 3.8 8.4 9.0 3.0 4.2 26.3 0.0 0.8 0.0 1.5 0.0 0.0 1.1 1.2 0.0 0.0 68.9 0.0 0.8 0.3 0.0 0.9 1.9 6.8 0.1 4.2 1.0 1.2 0.6 1.2 1.0 0.5 6.0 4.8 3.4 0.8 1.0 0.6 3.4 0.0 1.4 1.2 0.0 2.0 0.5 0.0 1.4 192.0 0.3 0.4 0.0 0.4 0.1 0.8 2.0 0.0 104.6 2.3 1.6 1.2 1.3 5.6 49.3 2.0 1.7 1.7 0.0 5.0 0.5 2.1 2.6 0.7 1.7 0.0 6.5 0.3 45.4 49.4 6.9 0.7 0.0 3.4 4.2 DGCR8 "C22orf12, DGCRK6, Gy1, pasha" ENSG00000128191 "DGCR8, microprocessor complex subunit" Q8WYQ5 22 20080232-20111877 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 46.8;Rod photoreceptor cells: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076916, HPA079351" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA076916: , HPA079351: " "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" "unprognostic (2.75e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.34e-1)" "unprognostic (5.72e-3)" "unprognostic (2.83e-1)" "unprognostic (1.09e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.02e-2)" "unprognostic (4.20e-1)" "unprognostic (4.68e-2)" "unprognostic (2.26e-2)" 7.9 7.8 9.9 10.3 10.1 10.1 9.4 29.8 14.1 9.7 10.3 11.8 13.4 7.6 14.5 8.1 11.7 11.5 10.5 7.8 10.0 6.9 7.9 7.9 8.1 8.9 10.6 9.7 13.9 15.2 11.6 16.8 17.9 10.4 9.5 7.9 11.3 10.5 10.3 19.9 11.3 10.1 12.6 7.4 10.3 10.0 22.4 10.9 11.1 9.8 11.9 9.0 11.5 12.6 1.7 3.3 1.2 6.8 3.2 4.6 2.7 12.1 8.6 11.2 6.6 4.4 7.2 14.3 11.7 7.0 7.9 5.6 9.2 6.2 10.8 6.5 10.9 5.3 11.7 10.2 9.7 6.9 10.6 15.1 11.8 9.1 7.5 11.7 21.7 9.8 5.7 12.2 8.3 6.1 7.3 6.9 6.6 41.6 7.9 9.2 7.8 13.0 6.4 10.9 8.8 6.5 15.6 11.9 3.7 4.8 11.4 12.5 8.0 10.7 6.3 6.8 7.0 6.0 9.3 10.3 11.6 9.7 7.2 11.8 4.4 6.0 10.9 8.6 9.9 11.2 0.0 2.1 1.2 4.5 1.9 3.5 1.7 2.2 4.6 2.9 1.5 2.3 2.6 0.4 3.2 6.8 3.3 2.7 2.7 9.9 10.1 29.8 14.1 10.0 6.9 10.6 9.7 10.4 10.9 6.0 9.3 8.0 4.5 8.5 34.3 2.5 5.1 6.7 6.8 5.2 37.3 11.0 0.0 5.6 46.8 6.7 6.3 0.0 8.7 9.5 5.6 7.7 3.5 11.3 4.6 41.3 7.0 8.6 7.0 31.3 17.0 3.8 5.0 6.4 9.2 15.8 8.6 6.0 9.9 2.8 59.4 6.5 4.7 16.9 13.0 8.2 11.3 6.9 8.2 4.7 DGKD "DGKdelta, KIAA0145" ENSG00000077044 "Diacylglycerol kinase delta" Q16760 2 233354507-233472104 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 22.3;U-698: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027530, HPA049101" Approved Supported Cytosol NA NA Cytosol "HPA027530: AB_2672320, HPA049101: AB_2680630" "unprognostic (1.84e-1)" "unprognostic (2.19e-2)" "unprognostic (7.76e-3)" "unprognostic (1.92e-2)" "unprognostic (5.69e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (1.69e-5)" "unprognostic (2.25e-1)" "unprognostic (1.17e-3)" "unprognostic (6.03e-2)" "unprognostic (5.76e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.07e-8)" "unprognostic (1.78e-1)" "unprognostic (7.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.94e-3)" 5.9 3.6 10.0 10.9 12.4 26.3 5.3 34.3 7.9 3.7 7.8 8.9 12.4 8.1 5.8 12.6 2.7 5.5 8.0 6.4 9.6 4.3 3.1 3.3 9.3 14.0 11.7 4.3 8.6 3.0 2.3 3.7 8.9 7.2 6.0 8.4 6.2 4.9 8.0 25.4 2.9 10.9 7.3 11.1 10.3 19.4 17.4 8.3 4.5 7.6 1.3 13.5 5.6 10.1 6.6 1.0 5.9 2.0 1.8 3.4 2.5 3.2 8.1 4.7 3.0 2.2 2.2 7.3 1.9 1.7 1.8 1.9 14.0 3.2 5.9 1.0 3.1 12.6 3.3 5.2 2.3 3.0 8.8 4.9 8.2 22.3 4.7 2.8 7.1 8.9 3.1 5.0 2.3 4.5 3.4 2.0 5.7 5.8 1.3 2.0 3.1 5.7 7.4 2.5 6.0 4.6 11.6 8.8 4.7 1.5 3.8 7.3 5.3 6.6 3.6 3.4 3.8 1.5 12.6 1.9 3.9 7.2 2.4 5.9 4.7 3.0 22.6 3.4 11.0 3.1 1.7 2.0 5.9 3.3 0.8 1.6 6.3 1.0 2.9 1.0 6.6 2.3 3.4 2.0 1.8 1.4 0.6 0.5 2.5 10.0 12.4 34.3 7.9 9.6 4.3 11.7 4.3 7.2 8.3 29.8 37.4 31.8 6.6 7.9 25.6 18.6 0.0 6.7 18.2 0.0 58.9 13.3 0.0 3.3 11.9 19.6 32.0 0.0 4.0 0.6 5.8 15.0 5.7 5.4 5.7 7.9 2.4 4.9 15.7 31.1 6.1 9.8 8.5 2.8 25.7 12.8 16.0 12.4 4.2 2.0 45.5 19.4 18.6 14.0 24.0 3.1 2.1 19.2 17.3 7.8 DGKE "DAGK6, DGK" ENSG00000153933 "Diacylglycerol kinase epsilon" P52429 17 56834099-56869567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 167.4;Cone photoreceptor cells: 178.7;Rod photoreceptor cells: 165.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 43.5;MOLT-4: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017167 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017167: AB_1847638" "unprognostic (1.19e-2)" "unprognostic (2.11e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.92e-5)" "unprognostic (4.20e-2)" "unprognostic (4.87e-2)" "unprognostic (3.37e-1)" "unprognostic (4.27e-2)" "unprognostic (1.19e-3)" "unprognostic (4.75e-2)" "unprognostic (6.07e-3)" "unprognostic (2.68e-1)" "unprognostic (2.55e-2)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-1)" "unprognostic (3.69e-3)" 7.8 4.9 7.8 8.3 17.7 5.5 5.2 21.3 18.6 9.5 7.4 4.4 5.6 5.4 13.3 8.9 5.0 8.2 9.4 4.9 7.4 9.2 4.2 4.9 8.1 9.3 5.6 10.0 7.3 6.5 9.5 14.5 5.5 9.9 8.9 7.0 17.4 4.3 7.3 2.4 3.4 7.1 9.3 6.8 12.7 6.4 12.5 5.4 14.5 8.3 2.5 8.6 6.5 15.3 2.4 2.4 1.2 0.8 1.9 4.5 0.8 1.7 1.6 1.5 0.1 0.3 0.5 0.7 2.9 2.3 2.0 2.3 3.8 2.1 2.5 3.6 1.5 1.0 2.1 3.6 1.6 4.1 8.0 4.7 3.2 4.0 2.5 1.7 6.2 4.5 0.9 2.0 2.1 4.2 1.8 2.7 7.4 2.6 43.5 2.4 2.5 14.5 3.5 1.1 2.2 4.9 4.5 6.3 5.9 2.0 3.8 2.4 1.6 2.3 1.2 0.1 1.0 2.7 3.0 2.4 0.5 2.7 0.8 0.4 5.7 11.7 1.7 1.7 3.6 0.1 0.3 0.5 0.0 2.7 0.4 2.0 2.4 1.9 2.3 0.6 0.9 1.9 2.5 1.2 1.9 0.8 2.4 4.5 0.8 7.8 17.7 21.3 18.6 7.4 9.2 5.6 10.0 9.9 5.4 3.0 5.9 2.2 10.2 7.9 167.4 5.5 15.3 1.4 4.5 15.7 178.7 3.2 0.0 6.5 13.1 23.3 3.4 0.0 4.0 2.2 4.3 13.9 0.0 3.8 1.9 7.9 10.9 32.5 5.6 7.4 4.0 4.1 3.3 2.8 7.1 13.8 4.9 5.5 4.9 0.0 165.4 6.5 10.3 25.4 18.5 5.8 2.9 13.8 4.6 8.8 DGLUCY "C14orf159, FLJ39975" ENSG00000133943 "D-glutamate cyclase" Q7Z3D6 14 91060333-91225632 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.9" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 26.8;Collecting duct cells: 27.9;Cytotrophoblasts: 25.8;Hofbauer cells: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 57.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041423, HPA052932" Approved Supported Cytosol NA NA Cytosol "HPA041423: AB_10795540, HPA052932: AB_2681991" "unprognostic (5.02e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (4.28e-4)" "unprognostic (1.28e-1)" "unprognostic (2.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (9.48e-5)" "unprognostic (3.56e-1)" "prognostic favorable (7.28e-4)" "unprognostic (2.30e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.77e-15)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.75e-2)" "unprognostic (2.57e-3)" 12.5 18.7 23.4 15.9 23.1 10.7 9.3 27.3 22.6 14.6 16.7 18.1 16.0 13.8 16.8 13.1 16.0 21.9 12.5 63.9 18.8 16.6 20.1 13.1 13.7 11.2 20.1 19.2 13.4 9.3 29.3 14.2 9.2 19.0 13.3 17.0 11.3 17.4 22.3 82.9 13.9 12.3 20.0 18.5 17.3 18.9 12.2 21.6 11.2 16.8 29.1 14.1 19.4 11.4 9.4 19.8 57.9 19.3 5.6 12.0 7.0 2.7 7.5 3.8 9.2 15.7 14.9 10.0 2.9 8.1 9.0 9.3 4.8 21.6 18.7 21.7 8.6 11.8 8.3 10.5 11.4 3.7 10.3 4.4 12.5 3.8 6.2 23.0 12.8 18.3 22.9 4.9 4.9 1.9 11.9 16.0 10.5 6.2 25.5 8.5 0.7 10.0 12.1 7.7 0.3 0.7 17.2 7.4 13.6 15.3 11.8 10.6 5.4 4.8 8.4 3.5 4.1 14.9 10.8 11.4 2.7 2.4 8.0 2.7 14.7 10.4 6.3 14.0 16.7 1.8 13.7 13.6 8.1 8.8 19.3 9.0 9.4 5.9 7.2 19.8 7.0 4.9 6.0 57.9 5.6 15.5 6.2 12.0 7.0 23.4 23.1 27.3 22.6 18.8 16.6 20.1 19.2 19.0 21.6 26.8 16.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 10.3 27.9 0.0 25.8 18.3 11.9 0.0 0.0 0.0 0.0 5.1 13.7 0.0 0.0 7.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 12.6 0.0 0.0 7.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.4 15.5 4.5 7.5 2.4 3.2 8.6 6.4 2.6 9.7 7.5 12.2 6.8 16.8 8.7 3.5 5.4 7.9 8.9 6.9 11.5 3.8 8.4 9.2 7.5 12.0 6.8 12.7 6.8 3.1 7.1 11.7 12.3 3.1 7.0 11.4 14.0 3.1 5.9 19.8 12.0 12.2 10.2 12.7 6.1 15.2 5.9 17.7 5.8 4.9 5.4 6.3 8.6 9.2 4.2 5.8 8.2 6.4 3.0 8.9 5.5 8.4 9.3 5.9 10.9 28.4 4.6 14.0 8.1 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 3.0 9.6 9.5 6.4 4.9 5.7 12.1 7.6 9.4 1.2 7.0 3.9 12.0 5.0 6.6 2.1 6.7 0.7 0.0 4.4 9.6 6.0 5.0 8.1 106.1 6.9 3.2 1.2 2.5 5.3 2.3 2.6 3.4 11.8 3.6 4.4 4.8 5.2 2.9 2.1 20.1 4.2 0.0 9.9 7.9 8.0 3.3 2.4 5.0 6.2 4.1 DHPS MIG13 ENSG00000095059 "Deoxyhypusine synthase" P49366 19 12675717-12681902 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hypusine biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014461, HPA029413" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA014461: AB_1847651, HPA029413: AB_10602217" "unprognostic (4.17e-2)" "unprognostic (2.55e-2)" "unprognostic (2.05e-2)" "unprognostic (2.61e-1)" "unprognostic (3.10e-1)" "unprognostic (1.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-2)" "unprognostic (4.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (1.56e-1)" "unprognostic (8.83e-2)" 16.4 30.3 26.9 18.6 31.2 17.0 24.8 43.3 38.8 20.7 25.7 27.5 25.3 23.1 20.9 16.9 21.3 32.3 18.2 26.0 26.3 28.0 23.4 30.3 18.9 24.2 27.5 28.0 34.8 32.0 28.8 32.6 23.2 22.4 24.1 24.5 20.2 24.8 24.6 65.1 25.6 21.5 24.5 29.1 19.5 24.2 13.3 26.3 31.9 24.9 22.9 26.9 23.5 19.2 39.6 29.5 35.8 30.5 27.8 38.1 29.7 20.6 15.3 24.8 13.1 11.1 18.5 5.8 13.3 19.5 25.4 25.6 10.9 10.1 21.4 15.1 14.5 23.4 12.6 17.0 18.8 17.6 18.8 12.0 14.3 16.7 14.2 13.7 17.1 22.9 14.8 23.2 15.3 26.5 25.8 17.8 42.8 13.0 15.3 18.5 41.1 30.4 24.8 19.4 27.0 26.0 20.2 9.3 30.9 19.5 11.1 32.4 43.9 13.4 19.5 22.6 15.7 18.0 28.6 8.9 29.9 12.1 29.2 20.2 48.8 52.5 14.5 18.4 21.0 28.2 14.5 27.0 35.8 24.7 24.2 25.9 39.6 28.9 25.6 29.0 36.9 38.1 28.1 9.7 27.8 30.5 29.5 34.3 29.7 26.9 31.2 43.3 38.8 26.3 28.0 27.5 28.0 22.4 26.3 38.7 21.2 44.9 67.5 49.3 77.6 7.7 22.9 34.8 9.1 31.4 43.2 43.4 72.9 48.6 15.6 35.9 36.2 0.0 32.3 43.6 36.5 53.0 23.1 29.4 38.0 39.7 39.6 18.4 36.3 21.8 41.7 38.3 47.2 71.3 54.9 114.9 45.5 63.3 32.5 75.5 92.9 45.3 55.6 29.6 70.0 44.5 60.1 50.3 52.4 59.7 DHRS1 "FLJ25430, MGC20204, SDR19C1" ENSG00000157379 "Dehydrogenase/reductase 1" Q96LJ7 14 24290598-24299833 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000599, HPA076886" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA000599: AB_1078655, HPA076886: " "unprognostic (2.08e-3)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (2.75e-1)" "unprognostic (3.57e-1)" "unprognostic (6.57e-2)" "prognostic favorable (1.18e-5)" "prognostic favorable (6.83e-4)" "unprognostic (3.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (9.88e-2)" "unprognostic (2.25e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" 6.5 8.9 3.0 6.1 5.0 3.3 7.4 6.3 6.0 8.6 12.0 9.8 8.4 16.1 6.7 8.9 35.7 5.4 10.2 3.7 2.7 3.1 8.5 47.1 6.7 4.8 3.6 5.3 4.2 10.7 11.5 5.2 4.1 6.0 5.5 5.4 7.1 14.0 15.6 1.8 20.8 25.7 4.8 4.4 6.3 6.1 2.8 3.7 5.6 6.6 25.6 16.5 6.0 13.0 10.4 10.7 17.3 9.5 4.2 11.7 4.7 11.1 2.7 2.9 1.1 6.8 7.2 0.7 4.0 8.8 9.5 10.3 1.0 10.9 5.2 1.7 6.2 1.5 9.1 2.2 18.5 4.6 3.5 2.3 1.6 6.5 17.6 3.2 3.1 1.2 6.5 10.9 2.3 1.7 7.7 7.1 4.3 3.2 5.0 7.7 4.5 1.2 1.1 0.5 8.9 4.0 4.0 2.0 7.2 7.3 4.2 2.5 1.9 5.7 7.7 1.9 2.1 3.9 0.9 2.7 0.7 1.8 1.1 1.3 2.8 2.2 2.5 3.4 2.7 0.9 10.0 8.7 17.3 6.9 9.5 7.5 10.4 7.5 6.3 10.7 7.0 7.6 4.2 5.7 4.2 5.9 6.4 11.7 4.7 3.0 5.0 6.3 6.0 2.7 3.1 3.6 5.3 6.0 3.7 20.8 17.9 18.2 23.9 29.2 10.8 13.9 45.9 16.0 18.2 33.2 17.7 40.2 33.2 24.7 15.1 15.7 74.2 0.0 26.8 7.7 17.9 21.4 5.8 70.1 24.0 14.3 18.5 14.1 11.6 27.0 18.7 16.2 43.9 11.8 37.9 14.1 42.2 46.0 19.4 44.2 44.1 25.8 21.7 26.2 9.3 40.0 21.9 26.1 38.6 36.3 DHRS11 "MGC4172, SDR24C1" ENSG00000278535 "Dehydrogenase/reductase 11" Q6UWP2 17 36591798-36600806 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "intestine: 88.0" "Cell type enhanced" "Detected in many" 16 "Cone photoreceptor cells: 121.7;Enterocytes: 380.9;Paneth cells: 114.5;Undifferentiated cells: 112.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041226, HPA048236, HPA053623" Enhanced Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 11000 Cytosol "Golgi apparatus" "HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209" "unprognostic (2.00e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-2)" "unprognostic (3.74e-1)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (1.80e-2)" "unprognostic (3.67e-1)" "unprognostic (5.94e-2)" "unprognostic (1.33e-2)" "unprognostic (4.11e-2)" "prognostic favorable (3.24e-4)" "unprognostic (1.45e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-2)" "unprognostic (9.35e-2)" 1.3 0.6 1.2 4.1 2.4 0.4 0.7 0.5 5.7 0.4 38.7 0.4 0.4 42.7 0.4 0.1 1.2 1.1 1.4 2.0 0.5 2.5 1.7 0.1 0.0 0.0 2.4 0.1 2.8 1.5 0.2 0.0 1.6 0.5 12.4 2.8 2.1 0.8 2.0 0.8 88.0 0.9 0.1 0.0 1.1 2.2 0.3 0.0 1.3 1.3 1.0 0.4 0.0 0.9 0.2 0.9 0.7 0.1 2.7 0.1 6.7 6.0 2.9 7.6 0.6 1.8 5.6 2.0 1.4 6.5 5.9 9.8 5.4 0.7 1.4 2.0 2.7 7.0 6.1 4.2 6.6 3.5 11.6 1.7 5.8 18.9 3.1 2.0 0.6 0.9 3.9 4.5 3.3 1.4 5.0 6.9 15.8 5.9 3.5 5.9 6.5 3.6 2.2 7.9 2.3 8.1 7.1 11.2 6.6 5.7 6.1 2.6 7.2 7.4 16.6 4.7 10.2 1.8 1.8 0.9 9.3 4.9 5.1 9.7 8.1 2.3 3.3 4.8 2.9 0.4 0.5 0.9 1.0 0.7 0.1 0.4 1.0 0.6 0.1 0.9 1.3 0.9 0.5 0.1 0.1 0.2 2.7 0.1 0.0 1.0 1.9 6.8 3.8 17.5 8.4 0.0 1.4 0.0 7.0 121.7 6.4 49.7 8.1 18.9 4.8 380.9 23.3 9.9 3.7 2.7 10.9 0.0 11.5 3.0 15.9 11.6 3.1 2.2 23.8 3.7 2.3 18.6 4.6 59.2 11.6 6.1 114.5 4.9 26.7 62.6 0.0 3.5 26.3 5.2 5.3 5.8 1.3 112.5 13.2 DHRS7B "CGI-93, DKFZp566O084, MGC8916, SDR32C1" ENSG00000109016 "Dehydrogenase/reductase 7B" Q6IAN0 17 21123364-21193265 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012132, HPA016873" Uncertain Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "HPA012132: AB_1847658, HPA016873: AB_1847657" "unprognostic (1.90e-1)" "unprognostic (3.16e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.98e-8)" "unprognostic (9.83e-2)" "unprognostic (1.18e-1)" "unprognostic (3.46e-1)" "unprognostic (1.45e-1)" "unprognostic (5.02e-3)" "unprognostic (2.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.81e-1)" "prognostic favorable (3.95e-5)" "unprognostic (1.20e-2)" "unprognostic (6.26e-2)" "unprognostic (9.20e-2)" "unprognostic (3.97e-1)" 15.9 17.8 14.0 10.3 14.5 2.5 16.2 11.1 15.2 17.6 14.2 11.9 16.7 14.4 13.5 25.3 12.8 15.4 16.3 17.9 11.8 13.2 23.1 18.4 13.9 14.0 14.5 14.8 11.8 18.9 31.2 11.4 14.2 12.9 14.8 15.2 16.5 17.5 10.5 23.7 15.7 18.3 12.7 11.1 11.5 14.7 30.5 9.1 8.0 19.7 15.8 10.9 10.7 12.8 4.2 11.7 15.0 20.4 4.1 5.7 7.5 8.6 10.2 3.7 8.1 10.0 6.8 6.5 8.2 4.6 6.0 11.0 12.8 9.1 3.6 12.6 7.0 4.7 12.2 5.4 13.5 8.5 6.9 17.6 5.0 7.5 11.0 5.5 2.7 3.7 5.3 9.0 7.7 11.7 3.0 5.8 6.4 3.0 4.5 7.0 17.7 3.0 10.8 5.2 28.1 4.4 5.0 9.9 6.3 20.0 10.5 2.0 4.4 10.2 9.1 8.8 31.4 6.1 5.7 2.9 5.0 3.5 15.1 9.3 2.5 3.8 6.7 7.9 10.3 7.5 9.7 18.9 15.0 3.8 17.9 3.4 4.2 3.8 2.5 11.7 3.6 4.1 3.6 13.5 4.1 20.4 5.0 5.7 7.5 14.0 14.5 11.1 15.2 11.8 13.2 14.5 14.8 12.9 9.1 14.9 14.9 16.4 24.6 14.4 20.5 12.2 25.5 28.1 14.8 27.9 29.5 44.8 14.9 40.1 48.5 21.9 30.7 23.3 34.3 26.4 19.3 22.8 8.1 16.3 25.9 17.5 6.9 28.8 12.3 16.2 20.8 11.7 18.6 19.8 19.0 29.9 27.5 22.4 32.9 21.4 35.7 6.5 16.9 44.2 20.3 16.3 43.1 16.6 21.2 17.9 DHRSX "DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6" ENSG00000169084 "Dehydrogenase/reductase X-linked" Q8N5I4 X 2219516-2502805 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003035, HPA075955" Approved Uncertain "Mitotic spindle,Cytosol" "Secreted to blood" NA NA Cytosol "Mitotic spindle" "HPA003035: AB_1080631, HPA075955: " "unprognostic (7.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.95e-2)" "unprognostic (4.65e-3)" "unprognostic (8.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.08e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (1.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.69e-2)" 7.3 9.5 21.5 3.1 26.7 2.9 55.7 21.5 25.3 32.1 7.3 1.2 1.2 4.6 25.1 6.4 3.2 7.5 6.7 37.8 23.7 3.4 34.6 18.9 5.8 3.2 21.8 16.9 25.0 15.2 5.5 24.2 32.7 28.3 7.7 6.5 1.2 10.8 5.7 6.3 4.9 6.5 5.3 26.5 5.9 8.6 3.4 23.6 1.2 8.1 1.2 2.7 6.1 27.4 12.2 18.3 30.0 21.1 8.7 9.1 10.0 4.5 20.9 14.1 6.5 17.6 11.1 10.6 10.4 17.7 8.0 10.8 15.6 9.9 7.3 13.4 12.3 18.7 2.2 9.7 8.4 5.7 13.4 15.1 7.0 11.0 11.6 20.3 3.8 5.7 13.6 10.4 6.9 6.9 13.6 6.3 8.1 7.7 3.6 12.8 5.2 13.9 5.3 3.4 6.1 5.8 5.4 7.4 2.0 8.6 11.2 13.4 13.4 9.9 11.8 7.7 9.0 5.1 6.0 8.5 8.8 2.1 4.9 6.1 4.2 0.0 18.8 5.8 5.0 3.9 6.5 21.1 17.1 8.4 15.7 8.9 12.2 7.6 7.0 18.3 10.6 7.2 6.0 30.0 8.7 9.5 14.8 9.1 10.0 21.5 26.7 21.5 25.3 23.7 3.4 21.8 16.9 28.3 23.6 17.9 9.4 13.4 20.7 9.4 8.8 20.9 25.5 6.7 5.7 24.4 9.8 36.6 11.6 44.5 0.4 12.8 31.3 0.0 70.9 36.4 20.8 43.3 18.4 46.5 34.3 3.2 18.5 11.6 15.9 1.8 22.5 27.2 11.8 47.7 19.0 8.0 61.5 28.1 23.7 35.4 5.9 19.4 14.4 9.7 17.2 5.6 89.7 13.4 22.6 17.1 DHX29 DDX29 ENSG00000067248 "DExH-box helicase 29" Q7Z478 5 55256245-55307722 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Helicase, Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038317, HPA038318" Approved Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA038317: AB_10673169, HPA038318: AB_10672589" "unprognostic (3.43e-2)" "unprognostic (5.09e-1)" "unprognostic (2.21e-2)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.80e-1)" "unprognostic (2.37e-3)" "unprognostic (1.72e-1)" "unprognostic (6.66e-2)" "unprognostic (1.76e-2)" "unprognostic (3.79e-2)" "unprognostic (1.30e-1)" "unprognostic (4.57e-3)" "unprognostic (4.01e-1)" "unprognostic (3.85e-1)" "unprognostic (4.78e-3)" "unprognostic (9.40e-2)" 14.6 16.2 15.1 12.2 16.6 9.8 16.3 22.0 16.9 17.3 18.4 9.2 20.2 11.3 17.4 12.8 18.5 13.6 11.7 22.1 12.8 9.6 22.4 20.6 15.2 11.8 13.7 11.9 13.8 15.3 30.3 30.7 17.7 16.3 18.9 13.3 7.8 15.2 24.3 31.8 15.9 14.7 18.5 13.1 14.3 14.8 10.2 16.6 15.6 20.9 12.0 11.9 19.9 14.4 18.5 25.9 32.4 19.6 16.0 18.8 6.3 22.1 15.6 13.0 17.2 21.5 18.0 16.0 23.7 18.7 17.4 18.1 12.7 14.5 13.0 21.6 26.5 22.8 16.4 20.5 23.0 25.0 5.2 11.6 11.9 14.5 8.9 12.3 7.9 12.7 15.8 14.2 18.6 11.2 12.2 22.9 10.6 14.5 9.9 20.8 15.3 13.9 8.0 11.1 6.4 17.5 6.8 20.5 21.4 15.1 15.3 12.1 8.3 23.4 12.9 11.7 13.7 18.3 14.7 20.0 16.0 13.5 14.3 17.2 9.5 14.3 17.6 19.7 13.8 18.0 32.4 16.3 15.9 13.5 16.4 15.1 18.5 16.9 15.0 12.1 17.6 18.8 15.8 15.2 16.0 19.6 25.9 13.9 6.3 15.1 16.6 22.0 16.9 12.8 9.6 13.7 11.9 16.3 16.6 65.5 35.2 25.3 32.1 33.4 77.9 67.4 48.4 33.5 66.0 61.1 39.3 58.7 46.4 45.2 32.2 35.9 31.5 93.5 53.9 43.6 42.1 40.8 30.1 40.5 36.0 39.7 36.9 21.5 25.0 13.6 43.1 37.1 27.0 36.1 33.2 34.7 50.0 25.9 49.8 84.5 77.5 51.8 44.2 87.3 127.3 41.5 68.0 27.7 35.1 33.6 DHX30 "DDX30, FLJ11214, KIAA0890" ENSG00000132153 "DExH-box helicase 30" Q7L2E3 3 47802909-47850195 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034806 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA034806: AB_10601364" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "prognostic favorable (1.37e-6)" "unprognostic (4.12e-2)" "unprognostic (1.43e-1)" "unprognostic (2.81e-1)" "unprognostic (2.22e-1)" 18.4 18.7 22.1 18.5 31.1 23.6 18.3 31.2 43.5 22.3 17.8 26.9 15.5 17.3 23.3 14.8 21.0 24.8 17.9 21.3 19.1 19.8 18.6 19.3 16.7 22.0 20.4 28.0 27.1 21.2 37.3 24.8 20.6 23.6 20.4 13.0 22.0 20.4 23.6 27.1 26.2 16.1 18.8 15.3 21.2 18.7 54.4 18.4 23.8 20.1 15.2 16.9 18.6 17.6 9.9 13.0 9.8 10.5 8.2 16.1 11.6 8.1 20.7 20.5 21.1 9.5 7.9 14.0 15.4 13.2 26.6 19.2 23.8 17.4 26.5 12.1 15.0 18.5 12.5 30.3 21.5 9.5 18.0 36.3 23.1 30.5 23.2 16.5 21.5 24.0 13.8 13.7 28.1 19.8 10.5 17.3 24.5 32.5 17.1 12.4 22.0 27.3 23.6 22.8 10.8 35.4 18.2 11.0 23.5 13.3 20.7 16.9 22.5 15.0 21.4 11.1 10.3 15.0 22.6 12.0 16.1 20.9 18.1 28.2 20.7 25.8 24.0 16.7 18.8 19.9 9.8 10.1 7.2 15.0 10.3 13.0 9.9 12.7 16.1 13.0 9.3 12.1 13.0 1.5 8.2 10.5 7.8 14.3 11.6 22.1 31.1 31.2 43.5 19.1 19.8 20.4 28.0 23.6 18.4 35.7 44.3 33.3 22.5 16.1 46.6 31.3 35.7 42.8 28.4 48.8 41.2 35.6 56.3 33.4 93.4 33.1 32.4 23.3 31.3 18.8 20.4 23.6 23.1 43.3 30.5 55.6 38.5 23.4 27.7 89.2 23.0 28.0 18.6 25.2 23.6 39.2 38.5 29.6 28.3 56.9 46.8 32.3 19.4 136.8 41.1 17.3 24.7 23.5 30.9 22.7 DHX36 "DDX36, KIAA1488, MLEL1" ENSG00000174953 "DEAH-box helicase 36" Q9H2U1 3 154272546-154324497 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 381.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035399 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035399: AB_10670115" "unprognostic (8.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.86e-1)" "unprognostic (3.50e-3)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (8.80e-3)" "unprognostic (1.03e-1)" "unprognostic (7.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.94e-2)" "unprognostic (3.90e-2)" "unprognostic (2.72e-1)" "unprognostic (5.09e-2)" "unprognostic (5.27e-1)" "unprognostic (4.96e-2)" "unprognostic (1.37e-1)" 16.3 14.0 11.5 14.1 27.5 12.6 15.7 19.0 21.3 17.9 14.7 10.3 12.4 10.7 20.4 10.6 14.5 14.3 13.7 23.9 13.4 12.7 16.7 17.1 14.6 17.0 12.2 15.0 20.0 13.7 34.0 36.2 16.4 20.1 15.7 12.2 9.3 15.5 20.5 53.4 14.7 14.3 15.1 13.7 18.9 13.4 28.3 11.3 24.3 20.4 13.4 17.1 20.7 15.6 6.3 5.9 3.1 5.7 4.8 6.9 1.1 27.0 18.5 25.1 14.4 11.9 16.7 12.5 17.7 17.8 20.2 24.1 18.8 21.8 26.2 28.7 15.5 18.6 17.5 23.6 15.0 31.8 25.1 15.6 19.0 15.9 10.7 20.2 26.4 16.7 18.8 12.7 21.6 26.6 11.0 17.3 16.3 17.8 15.1 18.6 13.2 21.8 5.8 33.4 14.4 17.8 22.7 21.2 37.8 14.5 19.2 23.6 25.1 18.4 19.6 25.7 17.9 20.1 13.5 19.5 21.2 13.4 19.8 35.3 28.4 18.3 37.9 17.1 13.9 22.4 1.9 2.7 3.1 6.9 2.8 4.4 4.7 6.1 4.7 2.3 6.3 5.8 6.0 1.1 4.8 5.7 5.9 5.4 1.1 11.5 27.5 19.0 21.3 13.4 12.7 12.2 15.0 20.1 11.3 53.6 78.8 70.6 103.5 82.5 148.4 52.9 61.1 50.9 96.7 57.6 121.7 106.5 33.2 60.5 381.7 74.4 34.4 23.3 54.3 56.1 68.1 82.0 99.5 71.8 54.2 146.2 88.2 62.6 59.6 255.9 102.4 80.8 50.6 65.9 47.0 93.9 58.1 42.4 114.2 44.2 123.0 77.6 80.4 174.2 142.0 72.6 309.5 99.1 47.7 105.0 DHX57 DDX57 ENSG00000163214 "DExH-box helicase 57" Q6P158 2 38797729-38875934 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 120.8;Late spermatids: 273.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036160 Uncertain Approved "Nucleoli,Intermediate filaments,Microtubules,Cytosol" NA NA "Intermediate filaments, Microtubules" "Nucleoli, Cytosol" "HPA036160: AB_10670711" "unprognostic (6.78e-2)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (2.03e-3)" "unprognostic (3.25e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (3.32e-6)" "unprognostic (1.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.45e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (3.88e-2)" "unprognostic (7.03e-3)" "unprognostic (1.77e-1)" 9.6 11.2 9.7 8.5 16.7 7.0 10.4 11.9 16.4 14.1 9.4 9.9 9.8 4.2 13.9 17.1 8.4 11.2 9.5 9.3 9.6 11.0 11.2 7.2 7.9 9.2 8.9 9.5 13.2 9.5 18.9 17.9 11.2 13.1 10.5 9.2 11.6 7.8 14.2 11.5 11.1 6.9 11.8 7.7 9.9 7.9 27.7 8.3 13.9 11.8 8.1 11.1 10.5 8.3 7.1 5.2 1.7 10.1 3.3 6.0 4.2 16.9 13.6 15.3 11.5 10.1 12.4 12.5 11.8 11.7 11.2 11.1 10.9 5.2 5.0 11.9 12.0 12.7 8.8 17.2 13.1 18.5 20.5 12.7 9.7 9.2 14.9 9.1 10.2 5.6 11.8 7.9 14.5 9.1 7.9 14.9 3.7 12.4 7.1 12.1 12.4 10.2 9.4 19.0 7.3 8.1 5.1 20.2 9.8 10.3 6.5 12.6 18.6 11.8 12.2 13.8 11.2 8.6 5.6 11.5 11.2 13.0 8.5 12.7 7.4 8.3 2.1 8.7 7.1 7.4 1.7 10.1 1.7 4.5 6.9 6.0 5.7 4.0 3.5 5.2 7.1 4.8 3.0 0.5 3.3 8.0 1.7 3.3 4.2 9.7 16.7 11.9 16.4 9.6 11.0 8.9 9.5 13.1 8.3 3.0 7.5 8.2 2.2 2.4 23.0 5.9 5.1 28.1 13.6 22.7 53.0 6.0 0.0 6.9 120.8 4.3 1.6 23.3 6.4 5.8 5.6 1.6 10.4 5.7 6.1 17.5 11.3 9.2 13.6 273.7 14.7 9.5 1.7 5.4 5.5 11.2 6.9 3.5 13.1 4.9 28.3 0.0 3.9 15.2 6.4 2.3 2.4 6.9 5.1 1.3 DHX58 "D11LGP2, LGP2" ENSG00000108771 "DExH-box helicase 58" Q96C10 17 42101404-42112733 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "monocytes: 65.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;SK-MEL-30: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018670, HPA019570" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "HPA018670: AB_1847665, HPA019570: AB_1847666" "prognostic favorable (3.45e-4)" "unprognostic (1.03e-2)" "unprognostic (3.56e-3)" "unprognostic (1.54e-2)" "unprognostic (2.45e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-3)" "unprognostic (5.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.15e-1)" "unprognostic (6.02e-2)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (8.65e-2)" "unprognostic (8.01e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 12.7 16.3 6.7 15.3 7.8 11.1 9.8 2.8 8.4 7.9 9.8 9.6 15.0 8.2 9.6 16.2 8.7 12.0 12.6 5.3 6.5 5.3 11.0 20.9 21.7 14.4 5.9 9.0 12.9 7.4 4.3 9.6 7.0 8.2 10.6 5.0 13.4 18.0 17.1 6.9 7.8 10.5 9.2 7.9 17.1 9.1 10.7 5.1 17.2 7.5 5.6 12.9 10.9 7.6 6.4 7.6 8.6 12.0 7.6 7.1 5.9 1.2 0.0 0.0 0.7 6.2 5.4 0.2 1.7 11.9 24.6 28.8 0.1 7.7 0.1 1.8 2.8 5.6 1.0 0.1 1.9 0.9 4.8 0.1 2.0 1.1 0.4 7.0 1.8 4.6 8.7 3.2 2.1 2.1 4.3 2.9 12.5 0.0 6.8 1.3 0.0 11.0 2.3 0.2 0.3 0.0 4.0 0.0 0.5 2.7 4.5 0.2 0.0 0.8 3.1 14.0 0.0 4.2 1.9 1.2 1.2 0.0 0.4 0.6 2.3 1.9 0.1 2.5 1.7 1.3 3.1 9.9 8.6 4.5 12.0 6.5 6.4 6.4 4.0 7.6 4.9 7.1 5.3 4.0 7.6 10.5 2.5 5.5 5.9 6.7 7.8 2.8 8.4 6.5 5.3 5.9 9.0 8.2 5.1 8.9 4.3 2.7 4.8 1.3 0.6 0.8 5.1 8.1 6.8 7.0 0.0 2.8 1.7 4.9 5.4 4.5 2.4 0.0 6.0 2.8 2.8 5.0 1.1 10.5 8.8 0.0 0.0 5.5 6.0 8.3 8.1 5.0 3.3 65.9 2.8 2.0 5.1 4.9 8.5 3.8 0.6 0.0 2.3 9.6 0.7 1.4 0.7 7.7 1.6 1.8 DICER1 "Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1" ENSG00000100697 "Dicer 1, ribonuclease III" Q9UPY3 14 95086228-95158010 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "RNA-mediated gene silencing" "Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000694, CAB068185" Approved Supported Cytosol NA NA Cytosol "CAB068185: AB_2665650, HPA000694: AB_1078661" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (6.75e-2)" "unprognostic (9.62e-2)" "unprognostic (1.96e-2)" "unprognostic (7.73e-2)" "unprognostic (1.21e-1)" "unprognostic (8.52e-3)" "unprognostic (5.73e-2)" "unprognostic (9.22e-2)" "unprognostic (4.22e-2)" "unprognostic (9.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.04e-3)" "unprognostic (3.74e-2)" 23.2 12.5 18.4 22.4 33.3 20.5 23.2 28.5 29.9 19.0 18.1 31.4 22.4 13.0 20.8 20.6 23.4 18.5 16.2 15.3 22.0 14.1 19.5 23.6 22.4 20.3 29.7 19.6 23.8 19.8 26.9 30.9 29.9 23.2 20.3 19.7 14.5 19.5 18.9 28.0 20.7 17.3 19.0 26.8 20.7 17.1 20.6 32.0 17.0 23.8 14.7 20.3 20.7 24.1 2.5 1.8 10.7 7.2 1.2 3.3 1.0 12.9 13.6 25.4 9.4 6.6 9.9 20.1 10.7 6.5 6.8 8.3 17.2 10.0 14.7 11.6 10.0 7.1 15.3 20.1 10.1 14.4 22.7 9.0 22.2 7.4 12.4 6.6 13.6 13.6 9.2 8.3 9.2 14.1 5.9 10.2 11.6 9.3 13.1 11.5 18.2 15.2 9.0 7.2 9.1 6.7 12.1 20.8 8.1 9.1 20.7 21.1 11.9 10.8 11.1 12.2 14.1 12.6 10.0 10.1 5.3 10.5 10.2 12.0 14.9 21.3 20.8 5.5 11.0 9.4 3.1 3.0 1.2 1.6 3.1 3.3 1.9 1.5 1.2 1.8 2.5 1.5 1.3 10.7 1.2 7.2 1.6 1.6 1.0 18.4 33.3 28.5 29.9 22.0 14.1 29.7 19.6 23.2 32.0 50.6 47.2 32.6 39.2 24.4 99.7 34.3 38.2 32.1 51.2 43.6 53.0 39.4 5.0 30.3 19.8 39.1 29.6 23.3 19.9 20.7 34.6 55.9 11.5 50.5 41.7 101.7 44.3 41.1 94.2 12.0 50.3 46.8 21.9 19.0 30.6 35.0 28.4 23.0 49.5 22.6 68.5 32.3 35.0 34.9 52.5 24.1 21.5 23.0 31.6 49.7 DIDO1 "BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333" ENSG00000101191 "Death inducer-obliterator 1" Q9BTC0 20 62877738-62937952 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004374, HPA049904" Supported Approved Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "CAB004374: AB_2093108, HPA049904: AB_2680944" "unprognostic (9.56e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-1)" "unprognostic (7.47e-2)" "unprognostic (2.68e-1)" "prognostic favorable (5.13e-4)" "unprognostic (9.92e-3)" "unprognostic (4.57e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "prognostic favorable (3.88e-4)" "unprognostic (2.20e-2)" "unprognostic (1.50e-3)" "unprognostic (1.06e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-2)" "unprognostic (9.82e-2)" 25.1 15.9 19.7 21.5 21.3 22.8 26.9 38.1 23.2 29.7 24.0 27.0 26.7 18.4 33.2 26.9 20.7 29.2 27.0 23.2 17.9 14.7 18.2 18.3 22.9 27.5 22.9 18.8 37.4 21.4 28.0 25.1 30.6 17.6 24.3 19.2 27.0 26.3 25.5 27.6 34.0 25.2 27.5 17.5 25.8 21.2 24.1 23.1 35.1 25.1 20.5 29.6 26.1 35.6 9.7 8.6 20.9 7.6 10.1 15.3 7.1 11.7 9.1 15.3 8.7 7.9 9.7 8.2 8.9 7.6 33.3 9.7 39.0 12.3 11.7 12.4 10.9 19.3 18.5 13.9 17.3 21.6 6.4 9.4 16.8 15.0 27.8 10.0 15.0 17.4 10.0 23.8 11.5 6.5 7.6 9.1 22.5 16.4 10.7 8.4 11.4 30.3 13.2 12.2 14.4 13.3 21.5 19.6 7.4 5.5 10.5 18.9 11.2 17.9 17.4 11.7 9.6 17.3 17.2 11.3 27.2 19.0 9.0 12.6 7.1 4.6 15.6 12.4 7.6 9.8 20.9 5.6 15.1 12.9 7.6 13.3 9.7 11.3 12.3 4.1 8.2 15.3 14.1 8.6 10.1 5.8 8.6 9.0 7.1 19.7 21.3 38.1 23.2 17.9 14.7 22.9 18.8 17.6 23.1 23.8 26.7 14.9 30.5 21.5 23.5 22.9 17.8 49.5 23.9 24.4 31.4 23.6 19.9 15.5 30.5 21.1 20.9 0.0 12.0 13.2 18.7 23.2 22.0 17.4 12.1 36.5 18.5 19.6 13.2 7.9 32.5 16.3 20.3 17.2 22.7 15.8 17.0 21.0 31.8 9.2 22.1 6.5 17.6 18.9 31.8 22.3 16.5 26.1 20.8 28.8 DIMT1 "DIMT1L, HSA9761" ENSG00000086189 "DIM1 dimethyladenosine transferase 1 homolog" Q9UNQ2 5 62387254-62403939 "Enzymes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042944 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA042944: AB_2678234" "unprognostic (1.58e-1)" "unprognostic (2.27e-1)" "unprognostic (6.02e-3)" "unprognostic (7.16e-2)" "unprognostic (8.95e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (8.88e-2)" "unprognostic (1.18e-2)" "unprognostic (1.62e-1)" "unprognostic (5.31e-2)" "unprognostic (3.70e-1)" "prognostic unfavorable (8.90e-12)" "unprognostic (8.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (5.15e-2)" 16.7 14.0 18.9 16.7 17.0 10.6 18.9 11.5 23.5 18.6 11.8 12.4 11.8 11.0 16.2 11.9 20.1 14.2 15.3 19.7 19.1 17.0 11.9 16.3 11.7 22.5 18.8 8.5 17.8 28.4 8.9 13.4 16.7 12.3 18.8 9.5 10.0 16.1 18.3 17.9 12.2 11.9 24.6 20.2 22.1 10.2 10.7 9.8 16.3 19.0 19.0 19.2 21.7 13.2 7.9 7.7 5.0 5.6 7.0 13.2 6.1 14.6 8.8 16.1 21.0 11.9 15.8 16.0 18.7 7.1 14.5 15.4 14.2 15.6 30.1 17.2 13.9 15.7 11.4 10.8 11.1 18.4 21.3 18.9 20.6 11.5 11.8 14.3 16.9 15.9 13.7 9.0 14.1 13.8 14.4 12.6 19.8 20.9 13.9 14.8 14.7 24.9 26.1 15.5 6.5 18.5 16.1 16.2 41.5 13.1 13.5 18.0 15.8 16.0 15.0 16.0 12.0 12.1 15.9 13.9 10.0 10.4 14.2 25.6 18.4 19.1 27.1 15.2 30.5 14.8 5.0 3.1 2.3 7.7 5.6 11.7 7.9 10.4 9.3 5.0 6.6 13.2 11.0 0.8 7.0 4.3 7.7 9.3 6.1 18.9 17.0 11.5 14.7 19.1 17.0 18.8 8.5 12.3 9.8 3.0 7.4 18.2 65.3 45.2 5.5 27.9 22.9 13.4 21.6 14.0 9.8 38.5 18.3 24.9 5.1 26.8 3.6 0.0 19.6 38.1 27.3 43.1 12.7 10.9 28.5 0.0 4.6 16.5 16.1 3.6 26.7 17.5 27.0 21.6 11.7 6.0 17.2 2.9 19.1 22.7 4.1 6.5 49.9 12.6 21.1 33.1 29.9 25.4 15.7 57.8 DIP2C KIAA0934 ENSG00000151240 "Disco interacting protein 2 homolog C" Q9Y2E4 10 274190-689668 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 3.8;T-cells: 1.3" "Cell line enhanced" "Detected in many" "U-2197: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030264, HPA059325" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA030264: AB_10600903, HPA059325: AB_2683979" "unprognostic (1.72e-2)" "unprognostic (3.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (8.32e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (1.58e-1)" "unprognostic (2.00e-1)" "unprognostic (6.28e-3)" "unprognostic (5.94e-2)" "unprognostic (3.65e-2)" "prognostic favorable (2.46e-6)" "unprognostic (8.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.09e-3)" "unprognostic (9.10e-3)" 15.4 8.1 19.9 5.0 25.0 0.9 9.9 23.0 24.7 12.6 20.8 21.2 6.4 6.2 14.1 7.8 12.2 9.1 11.3 17.3 16.3 10.1 19.2 11.5 6.7 3.4 21.7 14.4 18.1 10.4 10.4 7.4 6.3 16.5 11.5 6.3 13.0 5.6 12.7 38.2 5.5 7.3 16.1 14.9 4.5 8.3 9.4 23.1 0.0 7.3 2.9 2.5 11.6 13.0 3.8 0.5 0.1 0.3 0.3 1.3 0.4 0.4 4.0 7.5 4.0 12.7 13.9 6.2 8.9 5.6 6.8 5.6 1.1 1.2 0.3 2.4 14.3 1.8 0.1 4.6 0.7 4.2 0.2 4.1 0.1 2.7 1.2 6.2 0.0 5.6 11.3 3.6 4.3 0.0 10.8 1.5 0.1 0.0 0.8 5.1 10.9 0.4 0.0 1.9 3.4 1.6 6.2 3.1 1.2 4.9 4.6 3.8 5.4 1.5 3.2 12.8 4.1 4.3 0.0 0.1 7.3 1.9 21.7 2.9 0.5 8.6 4.6 9.2 0.2 4.1 0.0 0.3 0.0 0.4 0.0 0.4 2.6 0.8 1.0 0.0 3.8 1.2 1.3 0.1 0.3 0.0 0.5 0.5 0.4 19.9 25.0 23.0 24.7 16.3 10.1 21.7 14.4 16.5 23.1 8.9 4.3 3.7 4.5 7.0 18.1 25.0 22.9 8.1 6.8 3.5 21.6 4.4 0.0 6.9 11.0 6.0 2.8 0.0 3.5 3.4 12.1 4.9 19.7 21.7 4.7 1.6 10.4 8.0 3.5 3.8 10.6 2.0 21.9 1.0 4.1 20.4 6.5 0.0 18.4 14.7 18.0 6.5 17.8 21.3 16.5 3.3 3.2 1.0 6.1 8.1 DIRAS3 "ARHI, NOEY2" ENSG00000162595 "DIRAS family GTPase 3" O95661 1 68045896-68051631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9;ovary: 33.2;pituitary gland: 35.2" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 16.7;Distal tubular cells: 54.7;Exocrine glandular cells: 17.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 49.9" "Group enriched" "Detected in some" 18 "plasmacytoid DC: 2.1;T-reg: 1.8" "Group enriched" "Detected in many" 20 "dendritic cells: 2.1;T-cells: 1.8" "Cell line enhanced" "Detected in some" "HHSteC: 7.5;HSkMC: 15.7;TIME: 9.7;U-251 MG: 7.9;U-87 MG: 15.2" "Low region specificity" "Detected in all" "HPA028483, HPA028557, HPA029384" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343" "prognostic favorable (9.21e-4)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (1.69e-2)" "unprognostic (1.15e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (7.86e-2)" "unprognostic (8.35e-2)" "unprognostic (4.33e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.34e-1)" "unprognostic (4.99e-1)" "unprognostic (1.24e-2)" "unprognostic (5.07e-3)" 1.0 10.2 2.0 0.2 49.9 0.0 2.4 0.9 2.9 2.3 1.6 1.0 0.0 3.4 1.2 5.4 1.3 1.3 5.9 5.7 1.3 8.7 3.2 4.5 2.3 0.0 1.3 1.1 33.2 9.9 8.8 35.2 0.0 17.3 2.3 0.1 2.4 1.3 1.1 1.0 1.1 1.2 0.3 1.7 1.2 1.9 2.4 0.5 0.0 1.6 0.3 0.1 1.2 1.9 0.0 2.1 0.0 0.0 0.0 1.8 0.0 0.0 1.3 1.4 0.0 4.8 3.6 0.5 4.0 1.4 0.3 1.1 0.0 0.7 0.0 0.2 4.2 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.6 0.0 7.5 0.0 0.0 15.7 0.1 0.6 0.0 0.0 0.9 0.2 0.2 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.0 0.1 0.5 0.1 0.0 9.7 0.0 0.4 0.2 7.9 2.5 0.0 0.0 15.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.8 0.0 2.0 49.9 0.9 2.9 1.3 8.7 1.3 1.1 17.3 0.5 0.0 2.6 0.0 16.7 2.9 0.6 4.8 10.2 1.4 3.4 3.5 9.8 0.7 54.7 2.0 0.0 0.6 0.0 0.0 17.0 0.1 10.6 3.2 0.0 2.6 0.1 0.0 15.5 1.8 0.0 0.0 6.4 0.2 5.0 0.0 0.3 0.7 3.6 0.0 1.4 5.0 5.6 0.0 2.6 0.0 0.2 2.5 0.3 0.0 0.6 2.1 DIS3 "dis3p, EXOSC11, KIAA1008, RRP44" ENSG00000083520 "DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease" Q9Y2L1 13 72752169-72782096 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 123.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039281, HPA058762" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039281: AB_10795583, HPA058762: AB_2683810" "unprognostic (1.61e-1)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" "unprognostic (8.97e-2)" "unprognostic (8.14e-2)" "unprognostic (1.51e-2)" "unprognostic (1.49e-1)" "unprognostic (2.84e-1)" "unprognostic (6.38e-2)" "unprognostic (8.68e-2)" "unprognostic (1.32e-3)" "unprognostic (3.35e-3)" "unprognostic (1.02e-1)" "unprognostic (2.37e-2)" "unprognostic (3.69e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-1)" 25.5 14.7 11.7 17.6 24.8 23.8 22.4 23.4 19.4 20.3 18.8 11.6 17.0 11.8 18.0 19.3 23.1 17.8 16.0 21.6 12.4 13.6 20.2 25.6 19.3 22.2 13.9 17.0 23.4 15.3 15.8 22.8 26.3 18.7 18.0 15.6 9.8 17.4 19.3 19.9 17.3 17.9 17.5 12.9 22.8 16.2 27.7 14.6 23.7 21.3 19.1 23.0 26.7 19.3 6.9 6.8 11.1 9.7 10.3 10.0 5.0 15.7 7.4 14.5 12.2 15.5 18.5 9.6 14.1 17.2 14.4 17.7 11.2 13.2 19.2 12.3 14.4 9.1 13.1 19.8 16.2 23.4 15.7 14.6 22.5 15.8 10.1 19.3 38.0 13.1 19.3 11.4 16.3 21.6 14.4 15.4 14.7 15.0 8.1 17.5 5.5 16.1 18.7 13.6 24.1 8.7 13.0 11.1 8.7 14.4 12.7 13.1 17.3 11.5 9.7 13.6 15.8 9.3 17.4 14.3 8.7 7.1 9.8 14.8 15.6 17.5 15.4 24.4 18.1 12.6 11.1 5.5 7.8 6.5 9.7 9.4 6.9 8.5 7.3 6.8 6.0 8.1 7.6 3.4 10.3 7.6 4.3 10.0 5.0 11.7 24.8 23.4 19.4 12.4 13.6 13.9 17.0 18.7 14.6 32.8 30.4 16.8 29.7 22.7 38.6 24.2 25.5 37.5 45.5 8.7 27.5 20.7 19.9 16.8 123.4 38.3 15.1 0.0 17.3 19.4 13.5 23.6 32.4 21.2 12.8 30.2 29.2 25.2 16.2 100.0 26.7 13.6 11.8 31.5 15.2 20.6 18.9 2.9 26.5 13.6 39.7 6.5 19.6 23.7 35.3 27.4 18.9 21.0 18.6 45.4 DIS3L "DIS3L1, FLJ38088, KIAA1955, MGC4562" ENSG00000166938 "DIS3 like exosome 3'-5' exoribonuclease" Q8TF46 15 66293217-66333898 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041805 Approved Supported "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA041805: AB_10796783" "unprognostic (2.57e-1)" "unprognostic (5.37e-2)" "unprognostic (1.12e-1)" "unprognostic (3.99e-2)" "unprognostic (3.16e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.59e-3)" "unprognostic (1.86e-1)" "unprognostic (3.42e-3)" "unprognostic (2.66e-1)" "unprognostic (6.18e-2)" "unprognostic (9.58e-2)" "unprognostic (3.40e-1)" 13.7 15.4 18.7 14.7 16.6 11.8 14.5 15.7 16.4 13.7 11.8 20.7 19.1 9.0 14.7 15.5 10.6 15.5 10.0 20.1 17.3 17.0 14.2 15.2 10.8 14.0 19.4 10.8 16.2 24.4 24.9 18.9 9.0 17.7 14.7 10.3 15.4 14.4 16.3 29.4 9.4 9.0 15.2 19.6 11.1 10.5 15.4 14.0 19.3 18.0 9.4 12.8 12.5 9.7 9.1 10.5 7.8 13.1 14.1 13.2 8.0 8.6 19.6 5.9 7.8 7.4 10.1 8.3 6.4 7.0 9.5 8.0 9.6 5.8 30.6 7.0 7.7 8.4 14.6 14.6 5.1 7.0 8.0 13.4 18.0 12.7 10.9 5.6 17.4 6.3 4.1 5.8 2.6 8.5 5.5 7.3 9.9 10.4 7.4 8.5 6.3 7.8 10.2 9.3 6.9 10.8 11.7 25.5 17.9 3.1 9.8 10.1 9.8 13.0 4.3 7.2 5.9 6.4 11.6 9.5 11.0 10.4 4.5 11.0 6.5 20.3 14.7 3.7 23.0 4.4 7.8 5.9 5.1 9.9 7.1 12.8 8.5 9.5 13.2 10.5 9.1 11.6 9.6 0.7 14.1 13.1 7.5 8.8 8.0 18.7 16.6 15.7 16.4 17.3 17.0 19.4 10.8 17.7 14.0 6.0 14.4 12.9 4.8 3.8 15.3 28.6 17.8 10.7 9.1 3.5 3.9 14.6 5.0 4.9 5.0 7.1 4.3 0.0 3.1 3.8 8.8 4.7 16.1 15.7 8.3 9.5 2.9 3.7 8.2 7.9 18.4 10.3 1.7 10.0 8.9 16.6 3.3 5.8 19.1 8.4 19.5 19.4 8.5 27.9 15.2 4.6 3.1 10.4 13.5 2.7 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479166-11537584 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;testis: 7.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;NTERA-2: 3.4;SCLC-21H: 3.2;SH-SY5Y: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054579: AB_2682529" "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.9 1.9 7.3 1.1 10.0 0.9 0.9 4.1 17.4 0.9 1.0 9.0 0.0 1.3 1.1 0.9 0.8 1.0 0.8 0.8 7.3 5.7 0.9 0.8 0.9 1.2 4.0 6.5 0.9 1.6 0.8 4.2 0.8 5.1 1.6 0.9 5.4 0.9 0.8 0.8 0.8 1.3 1.0 2.1 1.1 1.2 7.5 6.8 0.0 0.9 0.0 1.0 0.9 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 7.9 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.8 0.0 2.0 0.0 0.2 3.2 11.0 2.4 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 10.0 4.1 12.9 7.3 5.7 4.0 6.5 5.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DIXDC1 "Dixin, KIAA1735" ENSG00000150764 "DIX domain containing 1" Q155Q3 11 111927144-112022584 "Predicted intracellular proteins" "Wnt signaling pathway" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.2" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 98.2;Horizontal cells: 114.4;Spermatocytes: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "eosinophil: 8.6" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 23.4;TIME: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039658 Supported Cytosol NA NA Cytosol "HPA039658: AB_2676611" "unprognostic (1.93e-1)" "unprognostic (2.90e-2)" "unprognostic (8.93e-3)" "unprognostic (2.84e-1)" "unprognostic (2.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-1)" "unprognostic (1.41e-1)" "unprognostic (7.23e-2)" "unprognostic (1.59e-1)" "unprognostic (7.85e-2)" "unprognostic (5.11e-2)" "prognostic favorable (6.89e-5)" "unprognostic (4.10e-2)" "unprognostic (2.11e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (4.19e-5)" 9.7 10.4 8.8 4.5 16.1 0.0 8.6 52.2 15.7 11.5 7.4 20.2 4.9 2.9 14.3 11.0 8.4 12.3 7.0 12.7 8.7 9.9 6.4 4.7 5.1 1.0 16.1 10.2 9.5 3.9 10.2 8.9 5.9 10.8 14.1 5.7 6.8 4.7 22.0 6.6 4.2 3.9 24.9 9.2 3.1 4.8 10.1 16.2 0.0 6.5 1.7 1.0 17.4 18.0 0.1 0.1 8.6 0.2 0.1 0.9 0.2 0.4 2.0 5.3 10.0 16.7 9.7 1.1 4.1 2.8 1.6 2.8 0.3 1.1 0.8 1.1 11.3 1.8 0.5 2.3 1.2 1.6 3.2 2.0 0.4 3.0 5.3 2.5 2.7 0.3 7.9 10.5 3.4 23.4 11.7 16.3 2.1 2.6 0.3 6.4 0.4 1.7 2.4 3.2 0.4 3.6 0.8 1.5 3.2 6.6 0.1 4.4 9.1 3.0 2.5 1.4 2.4 3.7 1.0 26.5 7.2 3.1 1.3 6.7 0.6 2.8 0.4 3.9 7.0 2.5 0.0 0.2 8.6 0.6 0.0 0.1 0.1 0.5 0.6 0.0 0.1 0.9 0.8 0.7 0.1 0.1 0.1 0.0 0.2 8.8 16.1 52.2 12.4 8.7 9.9 16.1 10.2 10.8 16.2 14.9 10.1 0.0 13.7 5.7 18.5 26.9 10.2 25.4 13.6 17.4 98.2 1.3 13.3 5.7 16.4 14.3 2.3 0.0 6.7 4.7 25.2 9.8 1.1 19.4 1.7 114.4 2.4 56.4 3.4 12.0 36.8 2.6 11.8 1.8 13.3 32.0 6.9 6.6 34.6 10.7 68.4 12.9 30.8 82.9 14.2 3.6 1.1 0.9 4.8 2.7 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11963106-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 94.7;heart muscle: 297.4" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 489.8;Muller glia cells: 1823.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 90 "T-cells: 8.9" "Cell line enhanced" "Detected in many" "BJ: 60.1;BJ hTERT+: 93.0;fHDF/TERT166: 87.0;hTERT-RPE1: 54.3;TIME: 49.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" No No 15000000 Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 4.8 21.7 44.9 3.5 94.7 1.3 6.8 32.5 60.3 25.8 7.3 12.1 4.1 4.9 7.8 5.6 8.8 4.9 17.9 297.4 49.6 23.5 5.1 2.7 17.8 3.1 19.1 45.8 10.8 5.7 10.9 6.6 7.5 24.7 16.8 4.6 10.7 9.1 22.3 2.7 8.3 7.3 12.0 32.9 9.0 7.0 8.9 25.5 0.0 4.7 2.5 2.6 10.5 7.8 0.0 0.0 0.0 0.0 0.0 8.9 0.6 0.2 1.8 2.6 0.0 2.2 4.4 0.0 60.1 93.0 26.6 30.3 1.3 0.4 0.0 6.6 87.0 14.2 9.2 0.2 25.9 10.2 0.0 0.0 0.0 0.2 0.0 17.0 0.0 0.0 6.7 8.7 9.0 22.3 54.3 28.2 0.0 0.0 0.0 36.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 9.2 0.0 0.0 7.8 0.2 0.0 0.0 7.3 0.0 0.0 49.9 15.8 12.4 1.6 15.5 0.0 0.0 0.0 2.6 0.0 14.8 0.0 0.0 0.0 0.8 0.0 8.9 0.0 0.8 5.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 44.9 94.7 32.5 46.5 49.6 23.5 19.1 45.8 24.7 25.5 3.0 4.8 0.0 55.5 40.5 22.0 489.8 0.0 4.0 20.5 0.0 11.8 0.4 0.0 0.6 98.7 37.6 0.0 0.0 0.2 0.6 30.9 9.6 1.1 0.0 15.3 12.7 1.7 47.3 1.0 66.1 19.0 2.3 60.8 0.0 0.0 1823.0 1.0 0.0 54.1 0.0 52.9 187.5 74.5 0.5 1.3 12.9 0.7 4.9 0.1 2.6 DLEC1 "CFAP81, DLC1" ENSG00000008226 "Deleted in lung and esophageal cancer 1" Q9Y238 3 38039205-38124025 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.1;fallopian tube: 23.2;testis: 28.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 68.3;Club cells: 21.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019077 Enhanced Supported Cytosol NA NA Cytosol "HPA019077: AB_1847724" "unprognostic (1.24e-4)" "unprognostic (3.60e-3)" "unprognostic (2.11e-1)" "unprognostic (1.09e-3)" "unprognostic (2.32e-1)" "unprognostic (1.76e-3)" "unprognostic (2.50e-3)" "unprognostic (8.54e-3)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (9.53e-2)" "unprognostic (7.62e-2)" "unprognostic (8.70e-4)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-2)" "unprognostic (1.94e-4)" 0.8 0.3 1.3 0.7 8.3 1.1 0.5 0.0 0.6 3.3 0.6 6.1 3.5 0.7 1.1 21.1 0.3 23.2 1.3 0.3 1.7 2.5 0.3 0.3 10.0 1.7 0.5 0.2 6.3 0.2 0.6 14.2 0.3 9.8 0.8 0.6 0.8 0.6 1.8 0.2 0.7 0.7 0.3 0.6 0.7 0.6 28.9 1.7 0.0 0.8 0.0 0.6 0.4 0.1 0.2 0.1 0.9 0.4 0.1 1.1 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.2 0.2 0.5 0.0 0.2 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.3 0.0 0.4 0.2 0.1 3.4 0.5 0.0 0.0 0.0 0.2 0.1 2.8 0.5 0.2 0.3 1.7 0.5 0.2 0.1 0.3 0.0 0.0 0.5 0.3 0.0 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.8 0.2 0.4 0.2 1.1 0.0 0.1 0.1 0.2 0.0 0.9 0.1 0.1 0.1 0.2 0.1 1.3 8.3 0.0 0.6 1.7 2.5 0.5 0.2 9.8 1.7 3.0 4.8 0.0 0.6 0.5 1.1 0.6 0.0 68.3 21.6 0.0 0.0 0.1 0.0 0.1 2.7 0.3 0.7 0.0 0.2 0.1 0.6 0.5 2.3 0.2 0.4 0.0 1.2 0.0 0.0 4.3 0.9 0.9 0.0 1.0 0.4 0.1 0.1 0.8 0.0 0.0 0.5 0.0 0.2 8.4 1.0 0.3 0.1 0.5 0.0 0.4 DLGAP4 "DAP4, KIAA0964, SAPAP4" ENSG00000080845 "DLG associated protein 4" Q9Y2H0 20 36306336-36528637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 64.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054105, HPA056378" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA054105: AB_2682381, HPA056378: " "unprognostic (1.11e-1)" "unprognostic (1.42e-1)" "unprognostic (9.00e-2)" "prognostic unfavorable (2.24e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.73e-6)" "unprognostic (1.23e-1)" "prognostic favorable (9.88e-5)" "unprognostic (1.28e-1)" "unprognostic (2.18e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" 18.8 16.6 25.7 14.3 32.9 4.5 18.0 16.2 31.9 19.0 20.1 9.0 14.9 13.5 23.1 13.1 16.8 18.5 17.0 25.9 23.7 12.7 10.2 11.0 21.6 9.8 9.5 20.7 18.9 30.2 7.7 10.2 16.9 8.8 15.7 10.1 15.4 19.3 21.2 58.0 27.1 13.6 27.2 6.8 14.5 12.2 12.6 10.9 8.3 13.8 16.8 10.8 29.0 15.0 16.1 13.5 19.5 13.1 6.9 12.5 9.1 14.1 12.9 15.8 13.0 15.0 24.6 15.9 21.4 19.6 21.0 14.6 19.4 9.1 4.0 11.6 30.0 18.6 13.7 4.2 21.9 15.7 6.4 1.5 9.1 6.6 13.1 21.7 3.6 7.9 16.2 17.0 24.8 17.4 16.3 20.6 5.7 6.3 11.0 15.8 10.6 7.4 13.9 6.8 10.4 27.6 7.4 4.2 5.5 9.8 7.0 10.4 14.3 14.0 28.5 17.6 16.8 16.3 6.4 20.7 64.1 19.5 27.5 11.7 3.8 2.7 4.3 25.6 4.6 25.1 2.1 12.8 19.5 12.5 13.1 9.8 16.1 11.3 8.7 11.3 14.9 8.8 7.0 18.5 6.9 12.6 13.5 8.7 9.1 25.7 32.9 16.2 31.9 23.7 12.7 9.5 20.7 8.8 10.9 14.9 18.6 15.9 41.2 59.0 31.9 25.0 25.5 17.4 13.6 12.2 7.9 19.6 6.6 45.3 63.3 34.3 19.2 0.0 47.9 41.6 32.7 58.9 11.6 16.3 24.9 69.9 60.7 24.5 18.1 119.1 27.6 21.1 10.1 63.1 29.8 36.4 66.0 24.6 24.8 16.3 27.9 71.1 41.0 13.6 16.2 62.7 46.1 15.0 16.9 46.3 DLGAP5 "DLG1, DLG7, HURP, KIAA0008" ENSG00000126787 "DLG associated protein 5" Q15398 14 55148112-55191678 "Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.1" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 140.2;Spermatocytes: 61.2;Spermatogonia: 32.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 8.3" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA005546 Enhanced Supported "Centriolar satellite,Cytosol" Yes Yes "Centriolar satellite, Cytosol" "HPA005546: AB_1078677" "unprognostic (2.24e-1)" "unprognostic (1.77e-1)" "unprognostic (1.19e-3)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.42e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.52e-6)" "prognostic unfavorable (7.85e-4)" "unprognostic (6.15e-3)" "unprognostic (3.55e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.06e-2)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" "unprognostic (1.93e-2)" 1.4 0.9 0.3 11.4 0.4 16.2 0.5 0.3 0.5 1.3 3.3 0.2 0.2 2.9 0.9 1.0 8.7 0.3 1.3 0.7 0.2 0.3 1.1 0.8 2.1 10.6 0.3 0.2 0.7 0.4 0.0 0.3 3.3 0.3 0.5 4.1 0.3 1.5 0.2 0.5 1.9 4.1 1.3 0.3 6.6 2.2 13.0 0.2 65.1 0.4 6.4 11.4 1.7 2.4 1.1 0.4 0.4 0.0 1.3 8.3 1.2 37.6 15.0 39.4 17.7 0.9 3.9 12.2 21.9 14.5 32.4 30.9 12.2 20.8 21.9 12.1 12.7 13.0 23.4 25.2 17.5 42.6 26.4 12.4 22.5 14.1 10.5 0.1 22.0 13.8 0.8 0.6 15.2 7.3 5.2 35.6 22.5 18.2 22.0 30.1 18.1 27.7 11.2 20.3 16.8 15.6 21.7 38.1 10.1 10.6 12.2 20.1 11.3 23.3 8.8 8.6 17.5 19.6 8.2 13.8 14.5 38.0 14.0 25.1 5.4 11.7 29.1 10.1 15.7 23.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.1 2.3 0.4 0.1 0.5 0.2 0.4 1.3 0.0 0.0 8.3 1.2 0.3 0.4 0.3 0.5 0.2 0.3 0.3 0.2 0.3 0.2 0.0 0.3 8.5 0.2 1.0 0.0 0.3 0.0 1.4 1.2 0.0 0.0 1.3 0.0 0.4 10.7 0.0 0.2 140.2 0.0 19.8 1.0 0.2 0.0 0.8 8.6 0.0 0.0 1.8 4.5 4.6 0.9 2.2 0.0 0.0 1.3 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.0 61.2 32.3 0.4 1.6 1.5 2.5 1.1 DMAP1 "DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4" ENSG00000178028 "DNA methyltransferase 1 associated protein 1" Q9NPF5 1 44213455-44220681 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028419, CAB033018" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033018: AB_2230431, HPA028419: AB_2672597" "unprognostic (1.91e-3)" "unprognostic (2.79e-3)" "unprognostic (4.90e-2)" "unprognostic (6.52e-2)" "unprognostic (4.80e-2)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.72e-2)" "unprognostic (7.32e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" "unprognostic (1.86e-2)" "unprognostic (2.29e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (3.09e-1)" "unprognostic (2.04e-2)" 12.7 31.7 21.5 17.6 22.4 12.5 12.6 21.3 31.5 12.8 13.8 20.4 15.6 13.5 14.0 14.9 12.9 19.8 11.7 20.3 20.7 18.3 14.9 16.1 12.9 17.2 18.0 19.4 23.3 19.9 25.3 15.7 14.3 17.9 13.9 11.9 19.2 21.1 15.2 30.5 18.0 12.7 17.0 15.8 16.7 13.8 13.8 17.0 15.2 18.1 14.3 13.6 12.7 11.4 18.6 15.4 23.2 14.8 26.5 23.1 15.0 12.4 13.2 18.7 9.8 9.7 9.2 21.6 11.0 14.8 26.7 23.1 21.6 15.6 18.7 15.0 17.7 10.5 10.2 16.6 14.2 14.2 14.9 26.9 17.1 23.6 21.3 17.6 16.8 13.1 14.4 15.8 22.0 12.7 17.2 17.2 17.9 11.9 17.2 15.5 14.4 23.4 21.1 26.6 6.4 16.9 23.8 18.9 20.3 14.0 15.8 17.4 14.4 20.7 14.9 21.0 18.9 12.3 19.4 16.5 7.6 22.9 17.4 22.2 20.9 12.5 14.9 14.3 16.7 12.4 23.2 14.8 14.1 21.2 13.1 21.6 18.6 21.4 21.8 15.4 18.6 19.6 19.3 6.4 26.5 10.5 12.4 23.1 15.0 21.5 22.4 21.3 31.5 20.7 18.3 18.0 19.4 17.9 17.0 29.8 27.9 19.5 20.8 17.1 38.2 20.9 20.4 26.8 14.8 10.4 23.6 62.4 24.9 28.1 32.9 20.7 35.1 46.7 36.4 27.8 20.5 10.0 26.5 17.4 28.6 22.3 52.2 18.4 21.5 52.0 16.7 14.0 16.9 27.1 25.6 36.1 20.7 25.9 16.6 28.1 52.1 6.5 19.6 25.4 33.4 15.6 43.8 20.0 24.0 11.9 DMKN ZD52F10 ENSG00000161249 Dermokine Q6E0U4 19 35497220-35513658 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 365.3" "Cell type enriched" "Detected in many" 5 "Suprabasal keratinocytes: 7442.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Cell type enhanced" "Detected in many" "NK-cell: 11.1" "Group enriched" "Detected in many" 5 "NK-cells: 11.1;T-cells: 7.0" "Cell line enhanced" "Detected in many" "A-431: 32.0;CACO-2: 39.6;CAPAN-2: 34.0;HBEC3-KT: 51.9;RPTEC TERT1: 51.3" HPA029406 Enhanced Approved Nucleoplasm,Cytosol "Secreted in other tissues" NA NA 29000000 "Nucleoplasm, Cytosol" "HPA029406: AB_10603661" "unprognostic (5.70e-2)" "unprognostic (2.36e-2)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-2)" "unprognostic (3.82e-2)" "unprognostic (3.23e-1)" "unprognostic (1.03e-1)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.37e-6)" "unprognostic (3.50e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" 1.4 1.1 0.6 0.5 4.7 0.6 23.9 0.7 2.0 54.8 1.2 1.1 2.5 1.0 5.6 9.2 25.3 8.7 0.6 1.4 0.7 1.1 11.3 0.8 8.8 0.5 0.9 0.6 11.7 29.5 4.7 13.3 1.7 9.5 5.0 1.0 9.5 8.2 9.1 2.4 365.3 1.2 0.9 0.9 0.6 1.8 0.8 2.3 3.1 25.9 62.9 16.9 3.5 27.5 1.7 0.2 0.0 0.0 11.1 7.0 1.2 32.0 5.2 0.0 0.0 1.3 2.0 9.0 0.1 4.3 0.2 0.3 39.6 34.0 0.0 13.0 0.3 1.6 18.0 9.8 51.9 0.4 0.1 9.5 0.0 0.0 8.8 1.5 0.0 0.1 17.8 14.0 0.9 30.2 3.0 0.0 0.0 0.1 0.0 0.1 28.0 0.0 0.0 28.8 23.3 2.1 0.0 0.0 1.3 51.3 21.2 0.1 0.0 7.8 0.0 3.1 8.6 13.0 0.0 0.0 5.0 15.2 0.1 0.1 0.2 0.0 0.2 4.2 0.0 0.3 0.0 0.0 0.0 7.0 0.0 6.1 1.7 0.6 3.4 0.0 0.2 0.1 2.4 0.0 11.1 0.0 0.2 0.0 1.2 0.6 4.7 0.7 2.0 0.7 1.1 0.9 0.6 9.5 2.3 98.3 94.2 3.7 121.7 1442.2 1.4 15.2 94.3 261.0 92.1 193.7 0.0 0.7 195.6 125.9 15.0 6.0 1.3 0.0 120.1 1.1 57.3 55.5 7.0 2.0 1.0 0.0 47.4 5.5 0.8 67.8 12.0 5.1 290.1 4.6 4.2 9.3 137.6 5.8 14.9 4.4 0.7 0.0 14.2 7.1 16.4 7442.2 1.9 5.3 11.0 72.7 DMPK "DM, DM1, DM1PK, DMK, MDPK, MT-PK" ENSG00000104936 "DM1 protein kinase" Q09013 19 45769717-45782552 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.6" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 44.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007164, HPA008905" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA007164: AB_1078687, HPA008905: AB_1078685" "unprognostic (7.44e-2)" "unprognostic (2.66e-1)" "unprognostic (1.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.29e-1)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-1)" "prognostic favorable (9.39e-5)" "unprognostic (1.93e-1)" "unprognostic (1.60e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (4.24e-3)" 9.0 18.7 5.1 9.7 6.3 1.7 4.9 8.8 6.2 16.5 23.4 4.4 15.6 8.7 21.2 15.0 31.2 13.7 20.3 56.7 5.0 5.3 4.9 2.2 6.5 4.1 4.8 6.5 8.4 33.3 3.1 10.7 6.8 5.6 16.3 3.8 22.0 6.1 19.7 79.6 5.1 11.3 65.1 4.2 5.3 12.0 5.9 4.0 1.1 6.1 36.6 5.0 44.9 8.2 1.5 0.0 0.0 0.8 0.3 2.2 0.0 7.2 10.2 12.1 7.5 8.2 11.5 7.3 16.4 12.1 6.6 6.4 1.2 3.9 2.3 2.5 18.7 5.3 10.7 3.5 1.6 2.5 11.4 10.7 0.9 12.7 1.7 8.0 0.1 4.1 16.6 5.7 5.7 2.8 16.3 3.0 1.2 7.2 5.9 9.5 8.1 1.1 2.8 7.2 3.2 2.2 3.7 44.7 3.8 3.5 8.4 6.5 10.5 8.9 18.8 5.3 6.9 15.4 3.6 9.2 7.7 7.6 7.2 12.0 11.4 9.7 2.3 7.0 1.0 10.7 0.0 0.0 0.0 2.2 0.8 0.5 0.3 0.7 0.2 0.0 1.5 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 5.1 6.3 8.8 6.2 5.0 5.3 4.8 6.5 5.6 4.0 0.0 2.1 0.9 7.0 7.1 4.9 3.1 2.5 0.0 2.3 3.5 7.9 2.3 1.7 2.4 1.4 6.0 3.6 0.0 15.0 1.5 12.7 3.3 0.0 0.9 0.7 4.8 9.7 10.4 1.2 1.4 6.6 0.5 6.8 0.0 5.5 2.2 5.0 3.5 21.9 22.0 7.6 58.2 23.7 6.3 6.0 5.9 1.4 5.0 3.6 3.7 DMXL1 ENSG00000172869 "Dmx like 1" Q9Y485 5 119037772-119249138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036431, HPA036432" Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA036431: AB_10669791, HPA036432: AB_2675120" "unprognostic (2.47e-1)" "unprognostic (4.84e-2)" "unprognostic (7.87e-3)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-1)" "unprognostic (6.77e-2)" "unprognostic (1.40e-1)" "unprognostic (4.88e-2)" "unprognostic (5.93e-2)" "unprognostic (2.26e-1)" "prognostic favorable (5.16e-5)" "unprognostic (4.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.12e-2)" "unprognostic (5.18e-2)" 17.8 10.4 9.3 14.0 14.1 29.3 16.1 14.2 15.4 12.0 11.6 15.4 9.6 8.3 15.7 8.5 13.0 12.0 10.3 10.2 8.9 5.6 18.8 9.6 13.9 12.5 11.5 11.4 17.4 20.1 21.3 14.1 9.5 18.9 35.9 9.8 13.3 13.6 10.9 10.9 21.4 13.1 13.0 10.9 11.5 12.4 9.2 13.1 18.1 17.9 6.8 13.8 14.3 12.4 11.2 9.5 4.6 9.0 1.5 3.8 2.6 9.5 7.4 8.5 8.6 9.1 12.1 9.0 7.9 7.9 8.0 9.4 8.9 5.9 18.6 8.2 10.1 12.4 5.8 9.3 9.4 10.4 14.3 9.3 13.1 12.9 3.1 7.6 8.5 11.4 9.6 5.3 9.2 7.7 8.2 10.4 11.7 11.0 12.6 6.4 6.0 11.4 4.9 4.6 3.3 4.5 9.0 15.6 7.2 6.2 11.1 7.9 8.0 13.6 5.0 12.2 9.4 8.2 9.9 10.0 9.5 8.0 9.5 8.3 11.9 8.4 16.2 11.8 8.4 7.6 4.6 5.5 3.9 2.9 4.9 3.6 9.7 2.3 2.4 3.8 11.2 3.8 2.1 4.5 1.5 9.0 9.5 2.8 2.6 9.3 14.1 14.2 15.4 8.9 5.6 11.5 11.4 18.9 13.1 26.8 15.3 22.9 15.7 12.0 36.2 22.4 2.5 12.0 14.8 15.7 23.6 9.9 14.9 9.5 6.0 13.4 14.6 0.0 17.5 7.5 11.6 51.6 13.9 13.4 14.8 20.6 5.8 9.2 20.5 7.4 14.1 17.3 32.1 27.1 11.4 17.3 12.1 11.9 14.5 27.0 22.4 12.9 15.0 15.6 19.2 16.4 13.6 14.9 10.1 10.7 DNAAF1 "CILD13, FLJ25330, LRRC50, ODA7, swt" ENSG00000154099 "Dynein axonemal assembly factor 1" Q8NEP3 16 84145287-84178767 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.3;testis: 49.6" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 520.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.1" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1" "Cell type enhanced" "Detected in some" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 3.5;Karpas-707: 8.8;PC-3: 2.7;SK-BR-3: 2.5;U-266/70: 7.4;U-266/84: 4.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA041166, HPA074239" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nuclear speckles" "HPA041166: AB_10794190, HPA074239: AB_2732250" "unprognostic (5.25e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-2)" "prognostic favorable (2.14e-4)" "unprognostic (1.42e-1)" "unprognostic (9.99e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (7.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-5)" "unprognostic (2.70e-2)" "unprognostic (4.61e-3)" "unprognostic (1.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-4)" "unprognostic (7.51e-4)" 0.8 1.2 3.5 0.6 9.4 1.5 0.5 0.1 1.5 2.1 0.6 5.3 1.5 0.4 1.0 13.3 0.9 21.3 0.5 0.4 4.6 6.5 0.7 2.0 3.7 0.9 0.5 1.5 4.2 0.4 0.7 6.1 1.5 11.1 0.4 0.4 0.9 0.5 0.6 0.6 0.5 0.6 0.4 1.0 7.2 0.5 49.6 1.2 0.0 1.2 0.0 0.4 0.8 0.0 0.5 1.0 5.5 0.8 0.9 2.1 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 3.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.1 1.3 0.2 0.0 0.0 2.5 0.1 0.1 0.9 0.0 0.0 0.4 0.0 0.0 0.0 7.4 4.8 0.7 0.2 0.4 0.0 3.6 0.8 0.4 0.4 0.6 0.1 0.0 0.2 0.1 0.4 0.5 0.8 0.8 5.5 0.9 0.4 1.0 2.1 0.9 3.5 9.4 0.1 1.5 4.6 6.5 0.5 1.5 11.1 1.2 0.0 17.2 2.2 1.6 0.6 1.4 0.6 2.5 520.6 108.1 3.5 51.1 0.2 0.0 1.0 67.6 1.4 0.0 0.0 0.3 0.4 0.9 0.8 3.5 0.4 1.9 0.0 0.0 3.1 2.7 16.2 1.1 4.8 82.7 1.0 0.0 2.1 1.3 0.0 0.4 0.7 53.5 0.0 0.4 118.6 19.6 0.3 0.3 0.0 0.0 0.7 DNAAF2 "C14orf104, CILD10, FLJ10563, KTU, PF13" ENSG00000165506 "Dynein axonemal assembly factor 2" Q9NVR5 14 49625174-49635230 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002894, HPA004113" Enhanced Supported Cytosol NA NA Cytosol "HPA002894: AB_1078316, HPA004113: AB_1078315" "unprognostic (3.88e-2)" "unprognostic (2.11e-1)" "unprognostic (7.57e-2)" "unprognostic (5.85e-2)" "unprognostic (1.19e-2)" "unprognostic (1.65e-1)" "unprognostic (9.50e-2)" "unprognostic (1.75e-2)" "unprognostic (2.53e-2)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "unprognostic (2.25e-2)" "prognostic favorable (6.74e-7)" "unprognostic (6.72e-2)" "unprognostic (2.54e-1)" "unprognostic (5.04e-2)" "unprognostic (3.44e-2)" 3.4 5.7 4.3 3.9 9.1 2.5 5.8 5.9 4.9 4.6 7.1 4.8 2.3 7.6 4.2 13.8 5.3 9.2 6.1 4.1 5.5 5.2 7.0 9.5 9.7 4.9 4.0 3.8 14.6 7.0 3.6 7.3 3.7 10.7 4.0 4.7 2.9 5.3 3.0 5.4 2.9 6.8 3.0 3.8 3.9 4.8 48.1 3.2 4.8 5.4 8.5 4.3 4.3 3.5 12.6 6.2 7.2 5.8 13.7 11.5 5.3 10.3 6.2 13.7 10.6 6.7 7.8 13.0 5.6 6.2 6.2 6.9 6.0 10.0 15.2 8.9 3.7 5.1 11.4 11.2 7.8 7.8 10.5 6.7 7.7 4.6 10.3 5.2 12.4 6.5 5.1 8.5 5.3 7.3 6.4 6.4 8.4 11.5 10.4 6.1 12.8 8.1 12.9 14.9 10.8 11.3 10.2 10.6 5.1 8.8 8.7 20.9 15.6 8.3 9.1 9.9 9.0 10.3 5.0 5.2 5.9 16.6 6.0 6.9 20.9 13.0 12.5 2.2 7.7 6.4 6.7 5.5 7.2 8.7 4.7 10.4 12.6 9.8 11.5 6.2 9.7 9.5 9.3 2.1 13.7 5.8 5.6 9.1 5.3 4.3 9.1 5.9 4.9 5.5 5.2 4.0 3.8 10.7 3.2 3.0 3.5 17.3 19.1 36.5 7.1 7.3 5.1 22.7 2.3 12.2 0.0 18.3 26.6 23.9 17.8 15.2 14.4 0.0 21.0 26.5 18.1 14.8 11.5 20.2 12.2 3.2 9.2 20.3 9.1 5.0 17.0 10.4 18.6 9.0 15.1 8.0 21.7 14.0 15.6 29.9 11.8 6.5 13.8 17.7 14.3 38.5 10.4 17.3 20.2 14.2 DNAAF4 "CILD25, DYX1C1, EKN1, FLJ37882" ENSG00000256061 "Dynein axonemal assembly factor 4" Q8WXU2 15 55410525-55508234 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 26.6" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 187.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.1" "Low region specificity" "Detected in all" HPA051048 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051048: AB_2681325" "unprognostic (5.97e-4)" "unprognostic (3.60e-2)" "unprognostic (1.69e-1)" "unprognostic (7.45e-4)" "unprognostic (1.74e-1)" "unprognostic (5.30e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-2)" "unprognostic (8.24e-2)" "unprognostic (2.91e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (5.29e-2)" "unprognostic (3.85e-2)" "unprognostic (3.06e-2)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" 1.8 3.0 11.4 1.8 14.7 1.6 4.9 1.8 8.0 4.3 2.1 3.2 5.9 1.1 7.0 15.3 1.8 15.7 3.4 1.6 9.2 7.8 7.2 1.0 6.2 1.5 4.2 8.9 4.8 3.5 13.6 26.6 1.2 9.1 3.2 1.5 6.9 2.4 3.2 1.3 2.4 1.3 3.1 3.7 2.0 1.7 14.6 4.5 0.1 14.3 0.9 1.3 2.8 2.0 2.9 4.2 4.3 1.8 0.7 1.1 0.4 6.5 4.4 4.7 10.1 1.9 3.3 1.5 0.9 2.4 3.1 3.6 0.9 2.6 0.5 4.2 2.0 5.0 1.8 1.8 2.6 3.7 2.0 2.1 2.3 2.8 1.5 1.8 5.0 4.1 2.0 5.5 7.5 2.8 4.9 7.0 2.1 0.7 0.3 4.6 2.3 0.9 4.3 2.6 10.1 3.6 0.8 2.3 0.8 17.1 2.3 4.8 10.5 4.3 1.1 5.8 4.4 6.0 1.2 2.3 5.0 2.5 4.1 4.8 1.8 4.8 1.4 8.2 1.0 1.1 0.0 1.8 1.3 0.6 1.2 0.4 2.9 0.9 0.7 1.2 2.6 1.1 0.8 4.3 0.7 1.2 4.2 0.9 0.4 11.4 14.7 1.8 8.0 9.2 7.8 4.2 8.9 9.1 4.5 11.9 15.9 0.0 0.0 0.0 0.0 0.0 0.0 187.4 28.4 12.2 0.0 1.6 5.0 11.3 0.0 0.0 0.0 0.0 4.4 1.1 0.0 0.0 2.3 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 DNAAF5 "CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2" ENSG00000164818 "Dynein axonemal assembly factor 5" Q86Y56 7 726701-786475 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020243 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020243: AB_1848750" "unprognostic (9.77e-2)" "unprognostic (9.53e-3)" "unprognostic (2.55e-1)" "unprognostic (2.57e-1)" "unprognostic (8.22e-3)" "prognostic unfavorable (8.42e-4)" "prognostic unfavorable (3.83e-4)" "unprognostic (8.07e-3)" "unprognostic (2.02e-1)" "unprognostic (7.59e-2)" "unprognostic (8.26e-2)" "unprognostic (1.93e-1)" "unprognostic (1.47e-3)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "unprognostic (8.70e-3)" 11.5 13.0 9.3 13.5 11.4 10.7 12.3 17.4 14.2 15.5 16.3 14.7 10.3 12.0 18.4 13.9 16.7 23.4 15.4 18.8 11.6 8.6 15.0 18.2 9.9 11.8 9.5 7.6 20.6 22.5 14.4 21.1 12.1 10.4 16.1 9.9 14.0 17.6 14.3 33.9 12.0 13.6 13.9 9.2 12.5 13.0 14.8 9.4 20.7 15.9 11.2 14.2 15.6 12.4 3.3 4.6 1.4 2.8 3.0 4.7 1.9 30.7 24.4 7.3 16.9 4.8 5.3 18.4 6.4 6.2 8.0 7.6 24.3 16.4 18.9 9.3 6.7 19.1 18.7 13.4 16.1 6.2 3.2 22.8 4.6 14.5 17.5 6.6 14.0 8.4 6.4 6.9 10.0 7.4 5.3 10.8 9.6 29.3 3.9 5.8 30.3 8.3 12.6 26.8 10.2 19.4 15.4 2.3 13.0 9.3 13.0 15.3 25.4 10.5 25.9 7.4 8.7 22.8 11.8 9.0 4.5 16.0 15.3 14.3 7.7 9.2 10.9 9.8 14.8 23.3 0.0 1.9 1.4 2.2 2.8 3.3 1.6 3.5 4.7 2.7 3.3 3.3 2.5 0.0 3.0 2.0 4.6 0.8 1.9 9.3 11.4 17.4 14.2 11.6 8.6 9.5 7.6 10.4 9.4 17.9 7.8 0.0 5.2 0.0 5.8 12.5 5.1 14.7 7.9 8.7 25.5 6.8 13.3 6.0 0.5 5.6 3.8 0.0 3.6 11.2 5.1 3.9 0.0 8.2 5.0 9.5 3.5 5.5 8.2 1.3 6.6 2.7 0.0 0.0 10.5 9.1 8.6 0.0 8.1 8.6 16.1 0.0 3.9 6.7 20.0 0.0 3.8 2.2 11.2 3.5 DNAH17 "DNAHL1, DNEL2, FLJ40457" ENSG00000187775 "Dynein axonemal heavy chain 17" Q9UFH2 17 78423697-78577394 "Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 39.4" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 44.2;Cone photoreceptor cells: 82.5;Early spermatids: 36.7;Late spermatids: 24.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.0;MOLT-4: 4.8" "Not detected" "Not detected" "HPA024354, HPA076261" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA024354: AB_1847911, HPA076261: AB_2732305" "unprognostic (4.98e-4)" "unprognostic (2.26e-1)" "unprognostic (2.30e-3)" "unprognostic (8.70e-3)" "unprognostic (6.66e-2)" "unprognostic (9.23e-2)" "unprognostic (3.72e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.20e-3)" "unprognostic (8.35e-3)" "unprognostic (1.58e-10)" "unprognostic (5.25e-2)" "unprognostic (1.54e-1)" "unprognostic (5.12e-1)" "unprognostic (6.04e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.1 0.0 39.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.0 0.0 10.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 6.0 0.3 0.5 0.2 0.6 44.2 2.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 36.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 24.9 0.6 1.3 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 7.2 0.0 0.2 16.2 0.5 0.1 0.0 0.0 0.0 0.1 DNAH7 KIAA0944 ENSG00000118997 "Dynein axonemal heavy chain 7" Q8WXX0 2 195737703-196068812 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7;fallopian tube: 19.4;pituitary gland: 25.2" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 127.2;Cone photoreceptor cells: 66.8;Early spermatids: 40.0;Rod photoreceptor cells: 42.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "neutrophil: 2.0;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.0;granulocytes: 2.0" "Cell line enhanced" "Detected in some" "PC-3: 10.6;RPTEC TERT1: 5.0" "Low region specificity" "Detected in many" "HPA034724, HPA044070" Enhanced Supported Cytosol NA NA Cytosol "HPA034724: AB_10670977, HPA044070: AB_2678798" "unprognostic (1.71e-1)" "unprognostic (2.81e-2)" "unprognostic (2.65e-2)" "unprognostic (1.04e-2)" "unprognostic (3.56e-1)" "unprognostic (1.58e-2)" "unprognostic (6.74e-3)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.24e-1)" "unprognostic (7.76e-2)" "unprognostic (2.52e-3)" "unprognostic (3.98e-2)" 1.0 2.6 6.8 1.4 9.9 0.7 1.9 0.6 6.4 3.3 1.9 4.6 4.3 0.9 2.2 12.9 1.1 19.4 1.9 1.4 7.1 5.8 4.5 1.2 9.5 0.9 3.4 3.5 3.9 4.2 3.6 25.2 0.9 21.7 1.9 1.6 1.8 1.8 2.5 0.6 0.9 1.9 1.2 2.1 0.8 1.5 18.3 2.3 0.0 5.9 0.0 1.0 1.3 0.5 0.3 2.0 2.0 0.0 0.1 0.2 0.2 0.6 2.4 0.5 0.2 1.4 0.9 0.2 0.2 1.4 0.5 0.6 0.5 1.7 0.0 0.7 0.5 1.8 0.1 0.0 0.3 0.4 0.0 1.4 0.0 3.0 0.7 0.2 0.1 0.2 0.3 0.4 2.1 0.4 3.2 0.0 0.0 0.6 3.3 0.9 2.4 0.0 0.1 0.5 1.2 10.6 0.1 0.6 0.8 5.0 0.3 1.1 1.9 0.6 0.4 0.2 0.2 1.0 0.2 0.0 1.3 0.4 2.1 0.6 2.6 2.4 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.1 2.0 0.1 0.0 2.0 0.0 0.2 6.8 9.9 0.6 6.4 7.1 5.8 3.4 3.5 21.7 2.3 0.0 6.7 0.0 1.1 0.8 1.7 1.2 0.0 127.2 17.0 1.8 66.8 0.0 0.0 1.9 40.0 0.7 2.1 0.0 0.6 0.0 0.9 2.2 0.0 0.0 0.1 1.6 0.0 0.6 0.0 20.2 0.6 0.5 1.7 0.0 0.6 2.7 0.8 0.0 1.4 2.2 42.3 0.0 0.5 26.9 4.3 1.1 0.1 0.0 0.4 0.6 DNAJA1 "dj-2, hdj-2, HSJ2, HSPF4, NEDD7" ENSG00000086061 "DnaJ heat shock protein family (Hsp40) member A1" P31689 9 33025211-33039907 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 189.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001306, CAB033665" Approved Supported Microtubules,Cytosol NA NA Cytosol Microtubules "CAB033665: AB_2094242, HPA001306: AB_1079043" "unprognostic (3.11e-2)" "unprognostic (5.05e-2)" "unprognostic (5.14e-2)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (9.80e-2)" "unprognostic (3.17e-2)" "unprognostic (2.88e-2)" "unprognostic (5.58e-2)" "prognostic favorable (5.39e-4)" "unprognostic (1.69e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.40e-4)" "unprognostic (3.27e-1)" "unprognostic (2.65e-1)" "unprognostic (1.25e-1)" "unprognostic (4.70e-2)" 29.0 46.7 46.5 26.1 47.2 42.7 57.2 31.6 53.3 30.4 18.7 20.7 25.5 14.4 27.6 27.9 17.1 34.8 28.2 22.2 42.5 51.7 36.0 71.9 30.7 23.8 56.5 30.8 30.7 19.5 47.3 40.2 35.0 49.6 29.8 21.7 9.0 18.9 23.0 14.5 13.1 15.9 29.0 42.4 22.3 20.8 42.2 51.5 24.1 47.0 15.3 28.1 27.9 189.5 36.6 60.0 50.0 69.0 31.6 37.2 49.5 38.7 69.6 56.4 19.5 39.2 25.5 32.3 40.1 32.4 72.2 56.2 46.1 18.0 39.8 30.8 27.2 40.9 17.7 81.1 24.1 62.3 56.0 23.6 31.9 85.7 58.4 18.8 36.6 37.5 15.6 24.9 27.1 8.7 35.1 43.0 17.4 49.6 17.4 41.3 31.7 61.1 80.7 54.8 39.1 48.6 45.0 20.2 20.4 40.4 23.0 35.8 39.1 53.9 34.9 17.9 44.0 16.3 35.6 36.8 25.8 44.1 29.3 53.2 11.2 34.7 42.1 33.8 32.0 22.1 33.3 40.1 43.3 28.5 56.0 33.3 36.6 35.6 31.4 35.7 32.7 37.2 34.7 50.0 31.6 69.0 60.0 30.1 49.5 46.5 47.2 31.6 53.3 42.5 51.7 56.5 30.8 49.6 51.5 199.5 144.3 123.6 875.9 235.0 170.2 172.5 48.4 514.0 273.0 78.5 196.3 237.2 145.9 218.2 352.5 305.0 136.1 70.0 158.2 280.3 289.7 362.1 422.8 118.0 203.3 114.4 374.9 98.8 133.8 169.3 91.7 282.9 269.9 316.6 116.6 133.1 170.5 185.9 89.1 138.6 144.4 103.5 321.4 400.4 214.4 232.0 388.8 169.6 115.9 335.9 DNAJA2 "CPR3, DNAJ, DNJ3, HIRIP4" ENSG00000069345 "DnaJ heat shock protein family (Hsp40) member A2" O60884 16 46955362-46973788 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049789, HPA060538" Approved Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA 31000 "Nucleoli, Cytosol" "Intermediate filaments" "HPA049789: AB_2680883, HPA060538: AB_2684315" "unprognostic (7.68e-3)" "unprognostic (1.05e-2)" "unprognostic (4.77e-2)" "unprognostic (3.67e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (2.81e-4)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.53e-2)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.19e-9)" "unprognostic (9.22e-2)" "unprognostic (2.28e-1)" "unprognostic (9.22e-2)" "unprognostic (4.69e-2)" 25.0 29.2 32.3 18.0 36.5 23.6 22.8 29.8 44.2 21.7 21.1 17.1 20.3 22.3 25.6 33.6 23.4 20.3 18.9 37.9 30.5 27.1 31.2 39.0 17.7 21.4 25.5 27.6 26.1 18.9 29.0 18.9 22.1 31.5 25.6 21.9 18.4 19.1 24.9 43.7 22.3 23.8 26.9 21.2 24.1 20.3 33.0 18.7 20.8 25.4 31.8 23.2 24.5 23.5 13.6 10.5 14.5 14.0 14.3 18.9 10.2 11.0 13.1 13.2 11.2 18.1 17.5 20.2 14.4 17.3 21.6 10.3 11.4 11.5 17.7 11.6 15.4 9.3 17.2 21.1 14.8 25.2 4.2 17.6 13.0 6.4 24.1 21.8 19.7 18.2 18.6 17.2 12.5 11.9 19.0 14.9 7.2 14.9 6.0 18.2 12.0 14.1 27.5 20.1 10.1 19.5 16.4 24.3 21.0 26.0 11.7 18.1 11.6 17.0 25.9 15.6 13.6 10.0 15.4 15.3 12.9 8.1 9.2 12.0 14.8 10.1 23.8 13.5 17.1 10.7 13.0 11.5 14.5 11.9 14.0 15.4 13.6 16.1 13.3 10.5 10.4 16.0 15.7 12.1 14.3 12.0 7.4 18.9 10.2 32.3 36.5 29.8 44.2 30.5 27.1 25.5 27.6 31.5 18.7 47.6 31.0 65.5 60.6 112.8 37.1 86.5 28.1 80.3 42.1 38.4 17.7 68.7 76.3 62.0 53.0 41.0 64.6 0.0 54.2 58.1 44.1 43.1 53.1 50.8 51.1 35.0 49.8 31.3 41.3 44.4 46.3 47.7 69.2 64.1 46.0 56.2 58.4 56.1 55.5 78.9 37.8 51.8 68.0 155.1 97.9 105.3 144.2 46.5 47.8 68.8 DNAJA4 PRO1472 ENSG00000140403 "DnaJ heat shock protein family (Hsp40) member A4" Q8WW22 15 78264086-78282196 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 63.2;skeletal muscle: 69.0" "Group enriched" "Detected in many" 5 "Early spermatids: 661.6;Late spermatids: 1220.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.7;HeLa: 18.6;RT4: 34.6;SCLC-21H: 22.3;SiHa: 17.4;THP-1: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004646, HPA041790" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004646: AB_426011, HPA041790: AB_2677674" "unprognostic (8.41e-2)" "unprognostic (2.48e-1)" "unprognostic (3.00e-2)" "unprognostic (8.20e-3)" "unprognostic (1.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.86e-2)" "unprognostic (7.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.08e-7)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (9.01e-2)" "unprognostic (2.93e-2)" 7.3 10.1 29.6 7.6 33.7 28.6 7.6 20.1 25.8 8.6 8.7 10.5 10.4 7.8 5.1 25.3 9.1 21.7 6.6 63.2 22.3 33.8 7.7 1.9 7.0 6.0 26.0 28.1 3.6 3.2 9.5 11.9 5.5 29.2 15.4 10.6 7.2 6.8 9.6 69.0 15.5 9.0 10.7 16.0 5.1 10.8 26.8 14.9 2.0 6.3 15.2 6.9 12.6 62.3 1.9 1.1 2.7 1.0 0.4 4.7 1.6 13.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.2 0.0 17.7 0.0 0.1 1.3 0.0 12.8 0.0 0.0 0.0 0.0 0.0 7.9 18.6 0.0 4.0 0.0 8.6 1.5 1.7 1.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.0 5.8 0.1 0.0 0.0 0.0 0.0 34.6 22.3 0.0 17.4 3.5 1.5 1.0 13.4 16.0 0.2 0.0 3.7 1.6 0.1 0.2 0.9 0.0 0.0 1.7 0.0 0.0 0.8 2.7 1.8 0.9 2.6 1.9 2.5 2.5 1.1 0.4 4.7 3.9 0.0 0.4 1.0 0.6 1.4 1.6 29.6 33.7 20.1 25.8 22.3 33.8 26.0 28.1 29.2 14.9 6.0 4.5 10.8 119.2 25.5 16.8 36.3 2.5 131.2 36.4 7.0 76.6 1.2 1.7 1.2 661.6 9.0 34.2 93.5 2.1 3.7 10.3 173.0 37.9 0.2 13.8 6.4 96.0 7.4 7.3 1220.8 9.5 17.6 49.0 1.8 23.3 9.8 3.7 22.8 10.6 5.0 21.2 6.5 7.7 27.5 21.6 40.8 5.7 8.5 16.9 141.9 DNAJB4 HLJ1 ENSG00000162616 "DnaJ heat shock protein family (Hsp40) member B4" Q9UDY4 1 77979175-78017964 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 89.8" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 28.6;HUVEC TERT2: 43.5;LHCN-M2: 73.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004995, HPA028383, HPA028385" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944" "unprognostic (1.21e-1)" "unprognostic (4.36e-2)" "unprognostic (2.19e-1)" "unprognostic (5.50e-3)" "unprognostic (3.40e-2)" "unprognostic (4.76e-3)" "unprognostic (4.32e-3)" "unprognostic (3.93e-3)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (2.00e-1)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (7.12e-3)" "unprognostic (1.01e-2)" 23.3 39.0 19.2 8.4 20.7 4.9 16.6 22.7 24.1 21.3 12.7 7.2 9.3 5.4 20.8 10.1 25.0 11.7 25.2 42.0 18.0 16.8 16.0 15.5 21.7 7.0 25.7 9.1 15.3 18.5 16.4 19.1 19.5 23.8 19.4 9.4 5.1 7.0 12.2 33.3 7.6 8.8 23.0 29.5 30.3 11.9 7.8 22.5 2.8 35.1 29.4 5.1 22.1 89.8 3.6 5.0 4.5 1.9 3.1 7.2 2.6 1.4 2.8 3.5 2.1 15.3 28.6 1.6 27.8 7.1 12.4 14.0 0.9 1.8 2.1 4.7 13.2 5.1 2.1 4.5 2.4 21.2 2.3 1.2 1.0 8.3 6.7 20.8 0.5 0.5 11.8 6.7 16.0 4.6 6.9 43.5 0.7 4.5 1.5 73.8 0.1 0.6 1.5 2.2 0.4 1.3 1.1 6.2 1.3 2.9 0.7 2.5 0.8 3.2 2.3 2.6 3.8 0.9 0.9 20.7 17.5 4.3 12.4 3.6 1.3 0.4 1.8 2.3 1.2 3.0 4.5 1.7 2.7 2.6 1.7 4.4 3.6 3.2 3.1 1.7 3.0 7.2 5.1 0.4 3.1 1.9 5.0 4.2 2.6 19.2 20.7 22.7 24.1 18.0 16.8 25.7 9.1 23.8 22.5 56.6 4.6 13.3 77.1 37.1 28.0 82.6 10.2 30.8 20.5 17.4 64.8 46.9 31.5 10.5 126.4 66.1 19.8 23.3 12.8 18.9 83.6 23.4 57.5 18.1 15.9 28.6 20.5 33.2 21.3 48.4 22.7 19.0 62.4 6.4 4.0 35.7 14.8 17.5 32.9 22.8 56.8 25.8 119.1 21.1 13.2 34.4 151.4 15.2 6.5 27.1 DNAJB5 Hsc40 ENSG00000137094 "DnaJ heat shock protein family (Hsp40) member B5" O75953 9 34989641-34998900 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 99.4" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 37.5;Smooth muscle cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "myeloid DC: 7.7;neutrophil: 7.6" "Group enriched" "Detected in many" 5 "dendritic cells: 7.7;granulocytes: 7.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023818, HPA050794" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023818: AB_1847793, HPA050794: AB_2681241" "unprognostic (1.41e-2)" "unprognostic (3.87e-1)" "unprognostic (2.53e-3)" "unprognostic (5.21e-2)" "unprognostic (1.86e-1)" "unprognostic (3.54e-2)" "unprognostic (7.31e-2)" "unprognostic (2.79e-1)" "unprognostic (2.57e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-2)" "unprognostic (1.89e-1)" "unprognostic (1.17e-1)" "unprognostic (4.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.00e-3)" 7.2 6.3 5.9 5.1 7.2 0.9 2.6 8.6 13.0 6.5 19.1 6.2 9.2 3.8 18.5 9.7 15.7 9.6 8.7 29.3 6.6 6.3 3.7 2.0 3.7 2.2 4.7 3.4 6.5 3.1 2.2 8.6 1.4 6.0 13.8 6.2 5.7 3.7 26.2 99.4 1.5 6.1 29.9 4.5 5.6 11.3 8.1 3.5 1.6 4.4 38.0 2.9 23.0 3.6 0.7 7.7 7.6 1.5 0.5 1.3 0.7 2.5 2.1 13.4 7.1 7.9 6.1 1.5 11.2 8.2 17.3 15.4 1.5 0.6 2.4 2.8 12.3 18.2 0.3 5.1 8.8 14.7 3.5 1.6 0.9 3.1 0.7 9.1 0.3 8.1 8.9 0.6 10.2 5.1 7.7 11.0 4.6 0.2 5.2 13.9 1.8 4.2 3.6 6.3 1.1 4.5 3.2 13.9 1.3 2.4 0.2 5.7 9.3 6.0 0.3 1.3 12.1 2.2 0.8 4.9 8.3 18.2 4.3 3.4 1.9 1.3 1.7 9.5 1.0 8.9 0.1 1.5 0.0 0.4 0.4 1.3 0.7 0.3 0.1 7.7 0.3 0.5 1.1 7.6 0.5 0.1 0.2 1.3 0.7 5.9 7.2 8.6 8.5 6.6 6.3 4.7 3.4 6.0 3.5 6.0 1.0 0.9 1.9 1.8 4.1 37.5 2.5 1.4 1.2 0.0 5.9 0.1 0.0 2.1 5.3 5.2 0.7 0.0 3.0 0.5 3.1 1.5 0.0 1.1 4.7 1.6 0.0 2.5 1.5 5.1 1.4 2.8 5.0 1.0 0.0 12.0 4.2 0.0 7.4 3.7 2.5 6.5 19.4 8.0 0.9 2.6 0.7 0.8 0.0 0.6 DNAJB6 "LGMD1D, MRJ" ENSG00000105993 "DnaJ heat shock protein family (Hsp40) member B6" O75190 7 157335381-157417439 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 839.6;Urothelial cells: 816.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004670, HPA024258, HPA058593" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767" "unprognostic (4.37e-1)" "unprognostic (1.62e-2)" "unprognostic (3.22e-2)" "unprognostic (9.26e-3)" "unprognostic (6.66e-3)" "unprognostic (4.68e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.01e-2)" "unprognostic (8.41e-2)" "unprognostic (3.19e-1)" "unprognostic (6.33e-2)" "unprognostic (2.24e-1)" "unprognostic (1.54e-1)" "unprognostic (6.45e-2)" "unprognostic (1.52e-1)" 24.0 23.1 38.0 17.9 35.0 51.3 40.5 42.2 41.3 17.1 25.5 21.7 19.1 14.5 23.3 38.8 33.2 20.9 17.3 37.0 31.7 32.2 24.5 16.7 19.4 16.4 37.6 32.2 22.8 18.8 17.2 20.2 24.4 37.7 19.5 17.2 15.3 20.1 25.6 96.9 34.2 15.6 31.7 33.9 17.2 16.8 38.3 35.2 12.2 17.9 23.5 21.9 23.4 51.9 32.7 30.4 74.3 48.1 35.5 42.1 55.0 37.8 23.0 28.0 28.3 28.4 25.8 25.9 42.6 34.9 39.7 43.6 31.3 38.3 14.6 80.3 31.5 36.1 24.3 19.0 29.8 61.6 29.2 26.0 26.1 13.9 22.1 26.2 19.3 22.0 22.6 28.9 30.0 14.3 39.9 29.5 15.7 42.3 14.6 50.8 25.7 48.2 38.1 56.0 26.8 30.7 26.0 20.2 20.3 32.7 23.2 16.9 44.7 33.3 26.1 31.1 60.4 19.0 27.4 36.7 25.1 19.1 59.7 36.6 28.0 39.9 17.1 35.7 44.5 31.7 70.6 41.5 48.8 36.2 41.6 36.1 32.7 33.2 37.2 30.4 28.1 42.1 39.3 74.3 35.5 48.1 27.6 38.9 55.0 38.0 35.0 42.2 41.3 31.7 32.2 37.6 32.2 37.7 35.2 44.7 57.9 61.6 535.0 672.2 87.1 103.2 40.8 135.1 83.0 92.5 76.6 239.3 164.2 120.8 82.9 125.4 92.1 46.7 61.0 198.1 160.4 315.0 212.0 42.7 149.9 89.0 185.4 94.5 124.0 94.1 139.8 162.9 268.2 444.6 63.2 102.0 105.0 73.7 190.2 165.4 87.6 97.0 208.1 297.0 373.7 839.6 425.0 152.3 79.1 816.5 DNAJB9 MDG1 ENSG00000128590 "DnaJ heat shock protein family (Hsp40) member B9" Q9UBS3 7 108569568-108574850 "Predicted intracellular proteins" "Unfolded protein response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Melanocytes: 322.2;Syncytiotrophoblasts: 476.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 34.1;Karpas-707: 31.1;U-266/70: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040967, HPA041553" Supported Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Cytosol" "HPA040967: AB_10794430, HPA041553: AB_10794300" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (4.75e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (5.37e-2)" "unprognostic (5.13e-2)" "unprognostic (3.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (2.68e-3)" "unprognostic (1.91e-1)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (8.76e-2)" 13.7 28.9 11.6 9.7 14.1 16.7 14.6 8.6 15.4 18.2 11.1 10.0 33.7 11.1 12.6 31.4 8.7 12.8 10.8 24.2 11.6 18.7 29.2 54.3 16.1 13.3 14.0 11.4 14.6 47.9 6.9 31.0 51.2 15.7 14.2 9.6 10.1 32.2 29.5 29.4 7.6 10.8 10.7 14.7 10.8 11.9 18.5 10.6 5.4 37.4 7.2 14.2 18.1 13.5 10.0 30.1 25.8 7.7 9.9 24.0 11.4 2.5 2.9 4.0 4.6 11.2 8.1 8.9 9.4 11.4 5.2 6.3 2.9 4.9 3.4 10.5 2.9 16.4 3.1 4.5 2.3 5.4 3.6 2.4 1.8 2.1 9.0 34.1 2.7 3.6 5.7 18.0 3.0 16.9 11.8 5.4 2.0 2.6 31.1 8.1 3.7 2.5 3.1 4.0 3.0 1.6 1.6 4.1 17.7 4.3 1.6 2.8 5.9 3.5 15.8 17.3 11.8 2.9 3.7 6.2 5.5 2.6 6.8 3.3 54.8 17.5 3.9 4.8 3.5 5.0 25.8 7.7 3.5 14.1 5.8 24.0 10.0 15.4 14.1 5.7 8.1 8.9 10.2 2.1 9.9 6.2 30.1 8.9 11.4 11.6 14.1 8.6 15.4 11.6 18.7 14.0 11.4 15.7 10.6 3.0 24.5 55.9 74.7 164.9 35.2 49.9 33.1 12.0 26.1 50.6 7.9 92.1 41.4 36.7 250.3 25.6 26.9 46.7 40.0 74.4 81.3 107.9 93.2 138.2 37.2 19.1 63.8 27.0 30.2 167.7 35.4 38.7 322.2 17.2 22.8 79.9 42.7 35.1 43.5 139.7 27.0 38.8 75.0 129.5 59.0 138.6 476.2 51.1 13.6 74.9 DNAJC13 "KIAA0678, RME8" ENSG00000138246 "DnaJ heat shock protein family (Hsp40) member C13" O75165 3 132417526-132539032 "Predicted membrane proteins" "Protein transport, Transport" Chaperone "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036923, HPA036924" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA036923: AB_10672480, HPA036924: AB_2675386" "unprognostic (3.35e-3)" "unprognostic (7.47e-2)" "unprognostic (9.16e-2)" "unprognostic (1.20e-2)" "unprognostic (9.71e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (3.68e-2)" "unprognostic (3.38e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (8.36e-4)" "unprognostic (1.92e-1)" "unprognostic (4.81e-3)" "unprognostic (2.15e-1)" "unprognostic (1.71e-1)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" 23.3 17.8 20.4 15.1 14.4 20.5 16.2 18.0 19.9 20.8 23.1 8.1 23.3 14.5 25.0 18.7 22.3 16.8 13.1 20.5 19.9 11.0 23.6 12.1 17.7 14.9 11.5 17.8 20.1 12.2 21.1 12.3 22.9 17.3 17.8 18.8 10.2 16.1 24.6 20.0 13.7 20.1 26.3 12.5 19.4 16.0 10.3 16.4 13.0 20.6 13.8 13.6 24.5 32.4 2.2 5.7 3.4 7.0 1.7 2.1 1.6 14.8 8.5 11.7 5.9 27.2 24.2 7.1 16.2 30.3 15.7 17.4 9.5 9.5 7.8 10.3 21.9 21.1 12.2 10.8 11.7 22.0 8.9 3.0 9.6 8.6 6.3 14.4 9.6 9.5 17.6 8.6 14.2 17.7 12.0 22.0 12.8 5.4 13.0 22.2 11.4 7.9 4.6 6.8 12.9 7.7 7.7 8.3 6.2 14.2 15.7 4.2 6.9 15.4 8.1 17.5 10.4 12.7 9.1 20.4 17.8 9.2 17.3 6.9 7.4 7.2 10.6 18.6 6.8 13.0 3.4 5.2 0.7 1.9 4.3 1.8 2.2 2.0 1.7 5.7 1.4 1.5 2.1 1.2 1.7 7.0 2.7 1.1 1.6 20.4 14.4 18.0 19.9 19.9 11.0 11.5 17.8 17.3 16.4 11.9 18.7 7.5 6.2 6.0 10.4 41.1 10.2 14.7 11.4 12.2 31.4 6.7 1.7 7.9 1.3 15.5 16.5 0.0 7.9 6.5 10.3 11.3 11.5 7.8 17.4 63.5 13.8 16.5 39.6 1.9 14.1 18.3 27.0 9.0 13.3 13.4 10.9 11.5 20.1 15.8 11.0 6.5 10.3 3.4 12.3 6.6 4.2 6.1 12.1 10.5 DNAJC18 MGC29463 ENSG00000170464 "DnaJ heat shock protein family (Hsp40) member C18" Q9H819 5 139408588-139444491 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.4" "Group enriched" "Detected in many" 20 "Early spermatids: 425.4;Late spermatids: 1065.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036538, HPA060154" Approved Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "HPA036538: AB_10670802, HPA060154: AB_2684212" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (2.73e-3)" "unprognostic (8.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "prognostic favorable (5.89e-4)" "unprognostic (8.09e-2)" "unprognostic (1.69e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (6.96e-2)" "unprognostic (1.97e-2)" 4.1 4.0 8.2 2.9 15.7 1.9 4.3 10.7 19.5 4.7 3.3 12.4 0.7 1.8 7.6 4.9 3.9 4.9 4.2 6.3 8.7 8.7 4.5 1.2 4.5 3.3 8.8 11.7 10.7 2.3 6.5 7.1 4.1 16.2 4.9 3.0 3.4 2.1 5.9 8.4 2.2 2.4 6.8 9.0 2.9 2.4 51.4 7.5 1.2 5.1 1.7 2.6 3.4 3.3 3.5 2.0 2.1 2.0 6.0 6.7 1.4 1.6 1.8 11.3 10.4 6.3 6.7 1.2 3.4 7.5 6.0 11.0 4.0 1.3 7.5 9.3 5.3 13.3 2.9 6.3 10.2 6.3 17.0 8.4 5.1 3.8 1.9 5.0 0.6 2.5 9.0 1.3 10.0 6.1 10.2 8.2 2.9 2.2 7.3 8.9 0.9 2.2 2.4 7.8 0.6 2.5 6.2 12.3 1.2 3.6 1.8 10.5 11.0 3.5 1.4 7.7 15.2 1.6 3.8 10.5 8.0 0.0 2.4 7.2 8.7 11.4 4.0 4.3 3.8 3.4 1.9 2.0 2.1 2.2 1.3 3.2 3.5 3.2 4.1 1.5 3.5 3.2 2.0 0.6 6.0 0.7 2.0 6.7 1.4 8.2 15.7 10.7 19.5 8.7 8.7 8.8 11.7 16.2 7.5 3.0 4.6 2.2 8.0 1.3 29.0 8.8 0.0 2.7 7.9 1.8 9.8 3.8 1.7 4.8 425.4 11.3 0.5 0.0 0.9 3.3 5.4 2.7 9.2 0.0 2.4 15.9 12.1 12.9 3.1 1065.4 13.0 2.6 5.0 4.6 2.5 14.5 2.5 1.4 17.7 2.9 18.4 19.4 8.5 37.2 4.9 1.0 3.9 3.2 1.2 2.6 DNAJC2 "MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin" ENSG00000105821 "DnaJ heat shock protein family (Hsp40) member C2" Q99543 7 103312474-103344873 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chaperone, Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 178.0;Spermatocytes: 193.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020454 Approved Supported Cytosol NA NA Cytosol "HPA020454: AB_1859492" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (5.53e-2)" "unprognostic (2.20e-2)" "unprognostic (1.11e-1)" "unprognostic (7.71e-2)" "unprognostic (2.13e-3)" "unprognostic (2.13e-3)" "unprognostic (1.63e-2)" "unprognostic (5.35e-2)" "unprognostic (2.21e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (1.11e-1)" "unprognostic (2.30e-1)" "unprognostic (3.51e-1)" "unprognostic (3.28e-1)" 12.8 12.5 12.8 21.5 14.2 37.0 13.6 12.9 16.8 13.3 15.0 5.1 10.7 14.3 13.4 12.5 13.6 11.8 11.5 13.6 11.4 11.0 16.2 25.2 10.7 15.5 13.3 12.7 16.4 13.2 12.2 28.5 13.8 16.1 12.0 13.0 5.6 12.6 9.1 29.4 12.7 18.6 13.1 12.2 19.7 12.8 30.6 15.7 17.6 13.0 12.0 13.6 16.6 16.5 9.1 7.1 28.6 9.1 10.0 8.8 3.7 17.6 12.7 7.3 14.0 5.9 8.2 15.0 12.2 8.8 13.6 10.1 19.0 13.0 24.9 19.5 8.3 19.5 12.0 19.8 8.8 20.8 13.3 16.3 18.5 12.1 16.1 10.6 32.5 14.7 7.1 7.7 15.8 14.2 5.6 8.8 9.4 42.7 16.3 11.0 29.5 30.9 33.6 26.2 19.3 19.8 19.9 15.1 23.2 8.0 8.4 14.4 13.4 16.4 22.9 12.6 14.6 9.7 16.5 10.5 13.5 21.6 29.1 23.7 17.4 22.8 50.0 9.6 33.8 16.8 28.6 6.0 5.5 7.6 6.5 8.4 7.8 7.6 7.9 5.9 9.1 8.8 8.8 2.4 10.0 9.1 7.1 8.1 3.7 12.8 14.2 12.9 16.8 11.4 11.0 13.3 12.7 16.1 15.7 23.8 46.0 38.8 57.0 57.5 25.3 25.8 25.5 49.5 63.7 21.0 39.3 37.3 29.9 31.3 178.0 30.7 27.2 0.0 40.1 63.7 36.8 49.2 51.0 26.6 35.1 20.6 33.9 14.7 21.3 21.3 36.5 37.8 18.6 32.5 34.3 18.6 41.4 28.1 29.4 26.7 27.3 38.8 35.8 193.5 136.9 54.3 46.3 33.1 42.7 70.8 DNAJC21 "DNAJA5, GS3, JJJ1" ENSG00000168724 "DnaJ heat shock protein family (Hsp40) member C21" Q5F1R6 5 34929593-34958964 "Disease related genes, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040789 Approved Supported Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA040789: AB_10794147" "unprognostic (1.37e-1)" "unprognostic (6.01e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (1.42e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.77e-3)" "unprognostic (3.04e-2)" "unprognostic (6.68e-3)" "unprognostic (5.99e-2)" "unprognostic (6.02e-2)" "unprognostic (9.27e-3)" "unprognostic (1.54e-1)" "unprognostic (3.26e-1)" "unprognostic (2.57e-1)" "unprognostic (6.02e-2)" 13.8 12.2 13.5 12.1 16.5 15.9 20.9 17.2 16.0 20.7 17.9 7.9 13.6 11.6 16.0 11.6 20.1 11.0 10.5 26.7 12.1 11.7 19.0 19.3 13.3 16.6 16.2 12.2 13.6 17.0 16.6 18.7 19.2 17.6 16.6 14.4 6.7 15.4 14.5 50.6 11.6 13.3 23.1 14.5 12.9 15.4 41.9 17.0 17.2 16.5 18.9 14.2 23.8 25.2 5.8 4.8 8.3 3.5 7.5 6.3 1.9 14.3 9.9 12.8 16.9 16.5 19.8 23.8 19.2 15.5 15.1 10.1 16.8 17.3 30.3 8.7 17.7 19.3 10.3 15.0 19.2 17.8 17.9 11.2 16.4 38.0 14.1 27.1 23.5 15.9 14.0 18.1 16.9 27.6 10.9 14.1 11.2 25.5 23.9 11.1 12.1 20.1 17.8 8.9 15.9 8.8 18.3 31.8 13.4 15.4 18.3 7.0 7.2 51.0 24.0 16.1 15.1 16.4 26.3 17.2 19.1 19.0 11.5 15.2 17.2 15.5 20.6 15.6 28.6 10.1 4.0 2.9 8.3 3.6 2.4 5.1 5.8 5.1 3.2 4.8 3.7 5.2 5.1 0.6 7.5 3.5 4.6 6.3 1.9 13.5 16.5 17.2 16.0 12.1 11.7 16.2 12.2 17.6 17.0 71.5 99.0 29.6 53.2 32.7 48.1 137.7 43.3 29.4 46.6 34.9 41.2 41.7 74.6 18.3 74.9 35.9 26.2 0.0 26.3 24.2 33.6 57.4 8.1 50.8 21.3 71.5 17.3 35.0 23.5 29.9 37.4 29.5 35.4 47.7 33.5 29.1 23.4 29.8 35.7 52.4 61.9 12.9 29.3 68.3 51.3 40.8 54.9 29.8 33.3 61.6 DNAJC24 "DPH4, JJJ3, ZCSL3" ENSG00000170946 "DnaJ heat shock protein family (Hsp40) member C24" 11 31369840-31431849 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 159.5;Late spermatids: 169.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020025, HPA025237" Approved Approved Cytosol NA NA Cytosol "HPA020025: AB_1847801, HPA025237: AB_1847802" "unprognostic (2.07e-1)" "unprognostic (3.73e-2)" "unprognostic (2.27e-2)" "unprognostic (9.74e-2)" "unprognostic (3.58e-2)" "unprognostic (1.76e-1)" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (2.21e-2)" "unprognostic (1.49e-1)" "unprognostic (3.50e-1)" "unprognostic (1.28e-1)" "unprognostic (3.56e-1)" "unprognostic (2.74e-1)" "unprognostic (9.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-1)" 10.4 10.7 13.0 8.8 21.6 3.7 10.2 16.4 17.4 9.1 8.9 9.4 7.4 7.2 10.7 9.9 10.7 6.8 9.2 20.2 12.7 13.4 10.5 9.8 7.6 10.6 12.3 11.1 8.4 13.3 9.7 21.8 8.4 14.7 9.9 7.7 8.9 9.0 10.1 25.6 14.1 8.1 11.9 13.5 9.0 8.7 8.2 12.8 7.1 11.8 9.5 9.5 11.2 7.0 5.1 4.3 7.5 4.5 3.5 8.1 3.2 4.2 5.5 9.8 7.0 7.3 9.7 4.8 11.0 6.9 6.3 6.0 4.4 4.5 5.3 5.9 7.3 9.5 5.3 6.1 7.2 10.3 13.6 10.6 6.3 9.5 4.3 9.0 11.9 9.4 8.8 8.5 3.9 12.1 8.5 8.4 9.3 12.0 9.8 12.0 4.7 8.9 5.7 4.6 6.0 6.4 5.8 18.2 5.5 7.5 4.3 4.5 6.5 10.6 7.1 7.9 5.4 9.8 7.2 9.9 12.1 8.3 14.0 13.4 11.4 9.8 7.3 17.9 6.0 12.8 7.5 2.9 2.1 6.1 4.5 8.1 4.2 5.6 5.2 2.1 5.1 7.3 7.4 2.3 3.5 2.6 4.3 3.9 3.2 13.0 21.6 16.4 17.4 12.7 13.4 12.3 11.1 14.7 12.8 3.0 6.1 11.7 6.2 10.8 10.4 16.5 2.5 2.7 9.1 3.5 9.8 7.7 3.3 7.3 159.5 6.3 4.4 0.0 7.9 8.5 8.6 7.0 4.7 9.7 7.1 22.3 6.9 7.4 6.5 169.1 8.3 9.6 11.8 4.6 3.4 30.3 8.5 7.0 8.9 7.8 13.6 0.0 8.5 14.4 18.1 7.2 5.3 15.0 4.9 7.1 DNAJC25 bA16L21.2.1 ENSG00000059769 "DnaJ heat shock protein family (Hsp40) member C25" Q9H1X3 9 111631352-111654351 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 41.9" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019122 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019122: AB_1853155" "unprognostic (3.07e-1)" "unprognostic (7.42e-2)" "unprognostic (8.94e-3)" "prognostic favorable (3.73e-4)" "unprognostic (2.08e-2)" "unprognostic (5.66e-2)" "unprognostic (1.60e-2)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (9.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.09e-2)" "unprognostic (2.52e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-1)" "unprognostic (8.30e-2)" "unprognostic (5.19e-2)" 5.1 10.2 3.3 3.9 4.6 1.9 5.8 4.5 4.2 3.4 5.1 2.5 5.7 4.6 4.1 7.7 3.4 3.8 3.6 6.7 4.3 3.8 7.8 41.9 3.5 4.1 2.7 2.3 5.7 7.0 7.4 9.0 4.4 3.3 5.9 3.0 3.6 9.7 4.0 3.6 2.4 6.9 5.0 2.9 2.9 3.7 4.2 1.9 1.4 4.3 2.4 2.2 6.4 4.5 0.6 1.1 1.2 1.9 0.4 0.8 0.3 2.6 2.0 1.4 2.4 14.7 6.6 5.4 10.2 4.9 4.0 4.0 3.9 1.7 2.3 4.0 7.0 6.3 8.6 1.5 2.9 3.9 1.9 2.0 2.3 0.0 7.9 4.8 4.3 3.4 5.7 8.3 3.1 5.9 3.2 3.3 1.3 4.6 2.0 5.1 2.9 1.3 0.2 2.5 5.1 4.8 2.2 7.5 2.1 8.4 2.9 2.4 1.3 5.7 8.0 3.6 2.6 4.2 1.1 6.4 4.9 2.2 13.1 5.8 3.7 5.6 1.3 8.4 2.1 4.3 0.0 0.1 1.2 0.6 1.9 0.2 0.3 0.5 0.0 0.5 0.6 0.5 0.2 0.8 0.4 1.0 1.1 0.8 0.3 3.3 4.6 4.5 4.2 4.3 3.8 2.7 2.3 3.3 1.9 6.0 11.0 14.5 13.2 9.4 7.7 9.0 7.6 13.4 12.5 10.4 19.6 11.8 11.6 13.6 7.8 4.9 17.6 0.0 14.1 18.7 13.1 26.6 1.1 75.4 10.9 12.7 16.6 6.7 5.0 1.4 9.5 7.9 11.8 4.6 14.9 3.9 11.0 7.4 9.6 10.7 20.2 12.9 11.3 29.8 11.9 8.2 11.6 7.9 10.9 17.1 DNAJC27 "RabJS, RBJ" ENSG00000115137 "DnaJ heat shock protein family (Hsp40) member C27" Q9NZQ0 2 24943636-24972094 "Predicted intracellular proteins" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 30.4" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 74.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036815, HPA036816" Uncertain Approved Cytosol NA NA Cytosol "HPA036815: , HPA036816: AB_10673506" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (4.53e-2)" "unprognostic (3.09e-1)" "unprognostic (5.17e-3)" "unprognostic (5.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.13e-1)" "unprognostic (4.60e-2)" "unprognostic (7.44e-4)" "unprognostic (8.84e-2)" "prognostic favorable (8.48e-5)" "unprognostic (3.35e-1)" "unprognostic (3.66e-1)" "unprognostic (3.05e-2)" "unprognostic (1.78e-3)" 6.0 5.6 6.7 3.4 13.8 5.3 5.9 9.4 15.7 5.6 4.1 6.8 1.9 3.2 6.6 8.1 3.7 5.7 4.8 7.3 6.7 8.0 6.1 3.1 4.4 4.1 9.5 6.5 10.9 3.6 7.6 10.2 4.6 19.0 5.5 4.6 4.9 3.2 5.2 6.5 4.5 3.3 5.0 8.3 4.1 3.7 30.4 8.2 3.6 5.3 2.4 3.9 4.1 6.1 1.4 0.8 2.9 1.2 4.5 1.9 0.9 4.6 2.0 4.3 4.4 6.2 5.2 3.3 3.6 5.3 3.8 3.3 2.1 2.1 4.3 0.8 2.5 3.2 3.7 3.3 2.2 3.9 1.9 2.6 2.7 2.4 1.9 3.9 2.4 3.8 3.9 3.8 3.0 5.9 4.3 1.5 5.2 1.8 4.0 4.1 1.7 4.3 4.2 2.8 1.6 1.8 2.7 8.7 2.4 3.6 2.5 1.6 5.6 3.3 2.6 4.9 4.8 2.3 1.8 1.4 5.0 3.6 2.6 3.2 10.4 3.7 5.2 2.5 4.0 2.1 0.0 0.8 2.9 1.0 0.5 1.9 1.4 1.2 0.8 0.8 1.1 1.6 1.8 0.2 4.5 1.2 0.4 1.1 0.9 6.7 13.8 9.4 15.7 6.7 8.0 9.5 6.5 19.0 8.2 8.9 7.7 4.2 5.9 1.8 22.7 19.8 5.1 22.7 2.3 7.0 35.3 3.3 3.3 2.4 37.0 4.1 3.2 0.0 2.2 1.6 4.0 4.1 10.4 2.5 2.9 35.0 14.9 5.5 2.4 25.8 8.1 4.3 1.7 3.6 4.6 11.7 1.3 0.0 6.0 2.2 22.5 0.0 12.8 74.8 19.0 2.9 3.5 5.7 4.3 3.0 DNAJC6 "KIAA0473, PARK19" ENSG00000116675 "DnaJ heat shock protein family (Hsp40) member C6" O75061 1 65248219-65415869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chaperone, Hydrolase, Protein phosphatase" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 91.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 29.6;Cardiomyocytes: 26.1;Erythroid cells: 23.3;Horizontal cells: 49.3;Rod photoreceptor cells: 21.6" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 21.2;HEL: 56.7;K-562: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031182, HPA054917" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA031182: AB_10611957, HPA054917: AB_2682641" "unprognostic (6.99e-2)" "unprognostic (2.00e-3)" "unprognostic (3.19e-1)" "unprognostic (7.94e-7)" "unprognostic (1.59e-1)" "unprognostic (7.61e-3)" "unprognostic (1.87e-4)" "unprognostic (2.98e-1)" "unprognostic (1.89e-1)" "unprognostic (4.14e-1)" "unprognostic (4.22e-3)" "unprognostic (1.53e-1)" "prognostic favorable (2.81e-4)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" "unprognostic (8.67e-3)" 2.1 12.1 18.6 2.2 28.5 5.0 2.0 24.2 91.4 2.2 2.8 26.9 0.0 2.3 1.9 1.8 1.7 2.4 2.3 9.0 25.0 26.7 8.5 1.6 2.7 1.6 28.8 23.8 1.9 3.4 2.1 7.5 8.0 40.5 2.5 3.0 2.2 1.7 2.1 1.6 2.1 2.3 2.2 28.7 3.2 2.9 3.2 21.1 0.0 3.0 0.0 1.7 1.8 0.6 0.5 0.5 0.0 0.0 0.6 1.5 0.3 3.5 1.0 0.0 1.6 0.8 0.2 8.4 7.1 11.6 11.7 11.5 0.9 0.1 3.4 0.6 2.9 2.9 0.9 5.1 1.1 9.2 21.2 2.4 56.7 1.9 0.2 0.0 1.9 1.4 1.0 0.8 1.1 5.0 2.2 0.2 2.8 22.0 0.4 2.4 0.6 0.7 0.0 2.3 0.0 0.8 0.0 1.7 0.1 8.9 0.0 14.2 9.7 4.1 5.6 1.9 14.1 2.7 0.1 2.2 1.7 1.2 0.2 2.0 2.1 1.4 1.0 4.8 1.4 2.9 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.5 0.9 0.0 0.0 0.4 0.6 0.0 0.6 0.0 0.5 0.0 0.3 18.6 28.5 24.2 37.4 25.0 26.7 28.8 23.8 40.5 21.1 0.0 0.3 0.0 0.2 1.1 29.6 26.1 0.0 0.0 0.0 0.0 13.7 4.8 1.7 0.8 1.8 0.7 0.0 23.3 0.6 1.9 1.7 1.3 0.0 0.0 1.1 49.3 6.9 0.0 0.0 1.4 0.0 0.8 6.8 1.8 1.3 3.1 0.4 0.0 0.0 5.9 21.6 0.0 2.3 1.0 2.3 0.3 6.2 0.0 0.5 0.1 DNAJC7 "TPR2, TTC2" ENSG00000168259 "DnaJ heat shock protein family (Hsp40) member C7" Q99615 17 41976433-42021376 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023015, HPA052395" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023015: AB_1847804, HPA052395: AB_2681811" "unprognostic (3.21e-2)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (8.40e-2)" "unprognostic (1.16e-1)" "unprognostic (5.31e-3)" "prognostic unfavorable (3.35e-4)" "unprognostic (7.71e-2)" "unprognostic (2.58e-2)" "unprognostic (1.90e-2)" "unprognostic (2.48e-2)" "unprognostic (8.37e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (2.32e-2)" "unprognostic (8.93e-3)" 22.9 24.2 42.0 27.6 49.3 24.7 28.3 36.6 44.1 22.2 30.5 25.0 21.0 21.5 18.6 32.3 31.4 19.3 19.9 30.6 36.5 38.6 36.9 30.8 21.8 30.1 38.1 30.5 26.4 29.0 37.7 38.2 24.4 48.2 20.4 29.0 21.0 21.0 22.1 44.3 28.0 22.4 18.9 28.9 23.7 22.0 25.2 32.9 31.8 26.5 29.0 40.9 24.3 33.5 15.8 48.1 14.0 21.2 17.8 16.2 13.2 19.7 33.8 31.8 23.7 19.5 32.8 27.1 20.4 29.0 38.7 31.0 39.0 20.1 30.6 24.3 29.5 28.2 29.8 49.9 36.6 46.2 27.3 70.0 24.6 28.9 54.2 27.9 35.7 22.4 27.2 21.6 35.5 33.4 26.1 30.4 32.1 37.7 21.7 32.7 16.5 38.5 29.6 31.0 19.7 24.7 27.0 36.3 27.0 29.0 25.9 30.9 24.3 17.1 50.8 24.9 36.8 28.5 29.8 23.9 21.2 20.1 22.2 33.8 15.8 35.8 28.3 23.0 26.1 22.5 14.0 20.6 13.6 13.2 21.2 14.6 15.8 14.6 15.1 21.6 15.0 14.4 13.8 8.9 17.8 20.4 48.1 16.2 13.2 42.0 49.3 36.6 44.1 36.5 38.6 38.1 30.5 48.2 32.9 32.8 34.7 92.6 81.7 58.2 80.9 58.1 45.9 41.5 25.0 62.8 127.6 95.7 97.8 80.1 64.8 73.4 61.4 23.3 115.2 83.9 52.6 65.4 55.4 49.4 90.4 60.4 106.9 57.1 81.0 35.7 62.5 108.0 45.5 127.2 54.6 91.4 101.3 56.8 57.7 112.8 125.2 45.3 55.4 75.7 114.1 60.1 106.1 79.9 63.5 83.9 DNAL4 "dJ327J16, PIG27" ENSG00000100246 "Dynein axonemal light chain 4" O96015 22 38778508-38794198 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 73.8;Late spermatids: 143.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003647 Approved Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Nucleoli, Cytosol" "HPA003647: AB_1078712" "unprognostic (8.45e-2)" "unprognostic (8.15e-3)" "unprognostic (2.35e-1)" "unprognostic (3.14e-3)" "unprognostic (3.74e-1)" "unprognostic (1.52e-1)" "unprognostic (6.46e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.07e-1)" "prognostic favorable (1.20e-6)" "unprognostic (1.60e-1)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.83e-2)" 8.2 11.4 24.1 9.6 21.9 3.9 13.7 8.6 19.8 17.8 10.1 8.5 19.7 7.3 9.8 15.0 12.3 33.5 12.7 9.9 17.7 15.2 16.0 7.1 12.8 7.5 9.5 15.7 15.8 14.9 19.2 19.3 11.9 7.9 13.2 9.2 13.1 16.4 16.3 4.4 11.4 8.0 7.7 6.4 7.5 11.1 36.5 9.7 13.2 26.1 6.6 8.6 8.4 9.1 12.6 14.8 17.5 11.2 15.7 16.6 8.1 8.9 4.5 9.1 8.2 11.7 11.8 0.0 3.8 7.4 5.9 6.5 2.8 10.5 2.2 8.3 5.5 6.8 4.3 5.7 10.1 4.2 5.5 7.5 1.3 1.3 3.1 18.6 7.1 1.9 9.5 33.2 7.8 14.2 15.5 8.4 10.9 2.6 4.5 7.3 11.1 6.6 7.1 3.6 13.3 3.7 6.5 3.9 2.9 12.4 5.3 12.9 6.9 7.9 6.1 15.4 6.9 11.0 6.9 5.1 5.4 5.5 8.1 3.8 2.8 0.8 1.0 16.1 2.4 5.2 15.6 9.6 12.8 13.5 9.5 16.6 8.7 11.2 12.1 9.8 12.6 13.3 11.0 17.5 15.7 11.2 14.8 10.2 8.1 24.1 21.9 8.6 19.8 17.7 15.2 9.5 15.7 7.9 9.7 6.0 8.0 3.7 11.7 4.9 13.6 3.6 15.3 28.1 12.5 3.5 2.0 23.5 26.6 24.0 73.8 4.5 8.0 0.0 13.8 16.6 7.6 8.9 15.0 2.9 12.2 11.1 12.1 9.8 3.8 143.7 10.9 4.9 8.5 6.4 13.8 10.1 16.3 8.6 7.1 15.7 13.1 6.5 4.4 52.4 14.3 9.3 16.6 6.5 13.4 10.8 DNM1L "DRP1, DVLP, DYMPLE, HDYNIV, VPS1" ENSG00000087470 "Dynamin 1 like" O00429 12 32679200-32745650 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Endocytosis, Necrosis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009952, HPA039324" Approved Enhanced Vesicles,Cytosol NA NA 10000000 Cytosol Vesicles "CAB009952: AB_2093533, HPA039324: AB_2676443" "unprognostic (2.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.10e-3)" "unprognostic (1.12e-1)" "unprognostic (5.09e-1)" "unprognostic (4.06e-2)" "prognostic unfavorable (6.27e-6)" "unprognostic (8.68e-2)" "unprognostic (2.25e-2)" "unprognostic (1.04e-2)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (7.48e-2)" "unprognostic (1.57e-2)" 15.4 16.2 24.9 14.8 34.4 22.3 14.3 40.5 37.8 13.0 14.5 12.4 14.9 12.3 16.5 16.5 19.8 13.3 11.9 25.4 26.1 28.1 19.4 12.8 11.2 13.8 23.4 23.2 14.1 9.8 28.7 18.8 16.0 27.9 19.3 16.0 12.1 11.1 21.1 25.6 11.8 11.0 21.7 21.7 11.6 12.2 23.1 14.9 13.4 15.2 17.4 15.8 16.9 12.2 5.9 17.0 5.0 14.6 7.2 7.9 7.1 21.3 21.4 22.4 23.0 18.2 18.6 43.4 24.1 18.5 22.8 21.1 29.9 16.4 28.8 16.9 21.7 23.3 19.3 23.6 27.7 27.4 15.2 19.2 32.8 20.6 16.5 15.0 23.2 17.3 16.8 14.1 24.0 24.8 21.9 27.5 15.0 23.6 12.5 26.0 8.3 9.2 19.5 47.3 13.6 10.5 15.7 42.2 19.7 19.2 29.5 19.6 20.1 25.6 17.6 18.7 52.0 20.2 15.9 24.8 19.4 19.6 45.5 22.3 8.8 23.7 30.0 18.9 15.6 14.7 5.0 9.7 3.1 5.6 14.6 6.8 5.9 6.0 5.9 17.0 5.2 7.3 7.9 1.7 7.2 13.6 5.4 6.1 7.1 24.9 34.4 40.5 37.8 26.1 28.1 23.4 23.2 27.9 14.9 35.7 38.5 29.4 27.6 26.7 71.7 69.9 20.4 26.8 40.9 24.4 123.7 25.6 26.6 27.7 51.2 34.9 15.4 0.0 21.8 50.9 25.9 26.7 49.7 14.8 27.0 119.2 29.3 25.2 33.3 58.7 24.7 32.4 13.5 44.1 18.9 66.0 35.1 14.0 28.7 19.5 150.0 19.4 37.0 66.2 50.8 24.1 30.1 27.7 23.8 31.5 DNM2 "CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII" ENSG00000079805 "Dynamin 2" P50570 19 10718079-10833488 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Phagocytosis" "Hydrolase, Motor protein" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054246 Supported Approved "Golgi apparatus,Cytosol" NA NA 500000 "Golgi apparatus, Cytosol" "HPA054246: AB_2682427" "unprognostic (2.30e-1)" "unprognostic (5.23e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "prognostic favorable (8.91e-4)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.03e-1)" "unprognostic (3.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.75e-2)" "unprognostic (5.35e-2)" "unprognostic (5.47e-2)" "unprognostic (5.40e-3)" "unprognostic (2.68e-1)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" 23.8 32.6 18.5 29.3 31.2 53.4 20.4 25.7 29.7 20.1 51.4 57.5 46.0 32.1 20.4 16.8 29.9 19.7 27.0 35.0 20.8 18.0 38.5 25.1 39.2 28.2 48.3 18.0 17.9 32.2 19.5 20.0 32.3 32.2 24.0 42.5 24.5 24.7 37.7 46.6 40.6 50.8 18.6 43.1 37.6 48.2 23.3 36.4 39.1 23.5 21.1 41.5 35.7 31.5 3.4 11.1 8.6 9.8 10.1 5.8 4.6 35.0 29.0 21.3 16.9 22.0 21.5 27.3 23.5 22.3 34.8 29.6 28.9 23.2 25.5 42.3 25.3 16.6 30.8 29.0 25.5 29.2 31.2 23.0 48.9 25.9 32.3 27.1 26.8 46.4 22.1 19.7 26.6 25.1 21.2 33.8 26.3 39.3 43.9 21.4 42.5 37.3 25.6 24.2 41.6 35.2 37.9 23.1 28.7 22.9 52.9 30.7 20.1 26.8 23.0 16.8 24.8 18.4 32.0 30.6 38.3 13.0 53.7 31.0 36.4 37.1 23.5 28.6 41.1 18.9 3.0 4.5 8.6 5.6 8.2 5.1 3.4 4.2 5.8 5.3 3.1 2.4 4.1 8.5 10.1 9.8 11.1 4.8 4.6 18.5 31.2 25.7 29.7 20.8 18.0 48.3 18.0 32.2 36.4 29.8 21.1 33.5 15.2 20.6 26.5 23.8 15.3 5.3 18.2 48.8 21.6 21.9 43.1 30.7 37.5 27.5 130.4 0.0 27.6 96.1 18.2 17.4 18.5 18.7 42.3 41.3 20.7 20.3 22.9 75.8 15.5 40.5 18.6 50.5 92.3 16.0 35.8 87.7 26.2 31.5 27.7 25.8 19.8 8.0 13.3 27.6 26.5 39.9 56.9 19.7 DNMBP "ARHGEF36, KIAA1010, Tuba" ENSG00000107554 "Dynamin binding protein" Q6XZF7 10 99875577-100009919 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037878, HPA058216" Uncertain Approved "Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol" Yes No "Nucleoli, Golgi apparatus, Cytosol" "Nuclear bodies" "HPA037878: AB_10675622, HPA058216: AB_2683640" "unprognostic (3.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.95e-6)" "unprognostic (3.92e-2)" "unprognostic (4.13e-1)" "unprognostic (9.79e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (8.67e-3)" "unprognostic (4.03e-2)" "unprognostic (5.07e-3)" "unprognostic (6.52e-2)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "prognostic favorable (6.15e-4)" 11.0 4.8 3.7 8.3 3.6 5.8 8.4 9.2 4.4 13.0 24.9 3.2 23.0 14.5 15.6 11.1 8.2 9.2 10.2 6.0 3.1 2.6 11.1 8.6 6.6 4.5 2.3 3.0 13.8 22.3 24.6 5.0 8.5 3.5 11.6 13.8 8.5 7.2 23.3 10.2 20.0 38.3 15.9 3.1 6.2 15.3 8.6 2.3 30.4 7.1 8.8 7.7 17.4 16.8 4.3 0.8 1.6 2.7 5.3 1.7 1.2 10.4 8.6 7.8 12.3 14.3 12.1 1.9 18.9 18.3 9.2 8.9 5.8 15.9 10.9 8.1 14.4 5.0 8.3 9.1 10.8 12.9 0.5 2.8 1.5 9.7 4.0 7.4 1.0 0.7 5.6 2.4 11.3 10.0 32.4 21.9 3.5 1.4 0.0 18.5 1.3 1.8 2.0 7.5 7.3 5.2 2.2 8.0 0.5 15.6 9.1 1.3 1.8 3.1 0.8 2.3 11.3 0.6 1.0 26.3 6.9 6.6 5.5 12.3 0.9 0.6 15.3 6.5 3.4 5.1 0.0 1.8 0.4 1.7 2.7 1.6 3.0 0.4 1.2 0.8 4.3 0.4 0.8 1.6 5.3 2.7 0.6 0.0 1.2 3.7 3.6 9.2 4.4 3.1 2.6 2.3 3.0 3.5 2.3 8.9 8.3 4.9 7.1 31.1 6.5 5.2 12.7 26.8 14.8 12.2 33.4 6.4 3.3 6.0 1.0 10.8 34.6 0.0 12.4 1.0 11.3 5.5 2.3 13.1 4.1 12.7 3.5 9.2 12.7 2.5 12.7 7.5 3.3 0.0 25.4 3.3 13.5 23.0 8.5 2.9 24.9 0.0 8.2 2.1 8.5 39.9 3.1 1.5 22.8 17.8 DNPEP "ASPEP, DAP" ENSG00000123992 "Aspartyl aminopeptidase" Q9ULA0 2 219373527-219400022 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 334.9;Late spermatids: 344.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036398, HPA044860" Enhanced Supported Cytosol NA NA 6200000 Cytosol "HPA036398: AB_10970915, HPA044860: AB_10961275" "unprognostic (3.71e-1)" "unprognostic (6.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.75e-1)" "unprognostic (2.54e-3)" "unprognostic (3.34e-2)" "unprognostic (2.44e-1)" "unprognostic (3.49e-2)" "unprognostic (1.61e-1)" "unprognostic (6.13e-2)" "unprognostic (1.67e-1)" "unprognostic (5.63e-3)" "unprognostic (3.49e-1)" "unprognostic (2.50e-1)" "unprognostic (1.85e-3)" 20.1 12.3 8.8 15.5 10.4 7.2 20.0 7.2 9.3 16.5 30.4 8.6 13.8 27.9 15.1 13.3 16.9 15.3 16.6 22.9 10.4 6.8 21.2 33.5 15.5 11.7 10.5 7.2 19.4 19.0 9.7 11.0 28.5 9.4 21.0 15.8 15.9 18.7 14.7 36.6 14.6 50.3 12.9 6.8 17.5 15.2 33.7 9.3 11.3 15.0 20.0 17.4 20.7 13.1 11.6 16.1 5.8 15.0 15.7 15.7 10.9 16.2 8.9 5.5 16.2 14.5 12.0 43.5 8.1 16.4 21.1 22.4 24.6 21.4 10.0 17.5 16.8 27.1 15.9 6.5 18.5 7.6 19.4 4.7 16.0 9.1 26.7 38.6 13.3 11.5 19.5 19.7 21.7 18.2 13.6 14.4 13.4 18.0 15.9 10.8 35.3 20.2 14.8 9.0 23.2 5.6 26.3 12.5 13.1 11.8 25.3 6.9 9.3 9.4 31.1 11.4 10.0 9.1 14.7 8.0 20.3 16.8 10.6 11.6 17.9 10.5 7.0 28.9 12.7 8.6 5.8 13.2 5.4 13.6 15.0 15.4 10.2 11.0 15.0 16.1 11.6 12.0 15.7 1.0 15.7 12.2 5.8 12.6 10.9 8.8 10.4 7.2 9.3 10.4 6.8 10.5 7.2 9.4 9.3 11.9 15.6 23.5 61.6 34.3 15.9 28.8 33.1 8.1 11.4 24.4 31.4 76.5 41.4 49.0 334.9 40.7 74.6 0.0 57.6 79.5 42.3 44.7 24.2 41.8 45.2 9.5 46.1 28.8 28.6 344.5 48.6 32.0 30.4 58.7 90.9 28.2 48.4 66.2 38.5 58.6 36.0 25.8 49.1 17.0 16.6 39.1 55.5 30.8 58.7 65.4 DNPH1 "C6orf108, dJ330M21.3, rcl" ENSG00000112667 "2'-deoxynucleoside 5'-phosphate N-hydrolase 1" O43598 6 43225629-43229484 "Predicted intracellular proteins" "Nucleotide metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 381.3;Proximal tubular cells: 791.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 93.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029675, HPA029676" Enhanced Approved Nucleoplasm,Cytosol No No 370000 Nucleoplasm Cytosol "HPA029675: AB_10599998, HPA029676: AB_10599424" "unprognostic (1.12e-2)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (8.24e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (2.61e-1)" "unprognostic (7.72e-2)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (2.25e-2)" "unprognostic (1.49e-1)" "unprognostic (1.74e-1)" "unprognostic (5.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (5.10e-2)" 17.4 25.5 24.1 16.2 27.5 10.1 8.4 7.0 18.7 11.9 39.3 15.0 10.2 53.1 12.3 13.2 19.3 19.5 18.5 12.0 17.3 16.7 48.7 34.7 10.0 14.8 17.2 14.0 13.7 38.8 17.2 9.3 7.3 13.4 13.1 9.7 16.9 22.4 11.8 40.8 10.7 51.0 10.4 10.4 18.8 22.2 5.4 10.8 14.6 14.2 19.2 19.3 12.2 8.9 44.1 36.2 0.9 46.7 7.5 52.6 19.5 32.0 23.5 3.6 15.2 2.6 8.1 11.4 7.8 2.8 5.3 7.0 9.6 11.7 23.1 12.4 2.6 0.2 16.4 2.8 6.2 1.5 12.3 55.9 10.8 21.5 27.2 6.2 9.1 7.1 5.1 7.9 1.6 4.8 2.1 6.9 16.9 24.6 41.0 4.2 53.1 8.7 22.9 7.3 93.7 14.3 14.8 4.9 58.5 9.1 11.0 14.2 17.1 7.2 19.1 15.7 1.2 26.3 30.5 8.6 4.0 7.0 9.1 15.3 28.7 13.1 18.0 2.5 12.3 6.3 0.1 23.3 0.9 9.2 46.7 16.7 44.1 30.4 16.2 36.2 38.2 27.2 18.3 0.8 7.5 33.2 27.4 52.6 19.5 24.1 27.5 7.0 18.7 17.3 16.7 17.2 14.0 13.4 10.8 26.8 33.9 82.4 72.2 54.5 10.6 78.7 186.0 178.0 37.5 109.9 2.0 50.2 381.3 174.9 0.5 25.1 264.9 0.0 92.9 48.7 52.6 77.9 34.5 174.5 265.7 6.4 62.2 33.2 57.1 2.2 62.2 60.3 104.6 40.5 164.0 37.3 143.5 157.8 56.3 791.8 15.3 0.0 47.4 5.4 42.8 64.4 27.0 27.7 262.6 70.6 DNTT TDT ENSG00000107447 "DNA nucleotidylexotransferase" P04053 10 96304396-96338564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Terminal addition" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 171.0" "Group enriched" "Detected in some" 4 "Early spermatids: 10.3;Late spermatids: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "naive B-cell: 1.2;naive CD4 T-cell: 4.5" "Group enriched" "Detected in many" 15 "B-cells: 1.2;T-cells: 4.5" "Group enriched" "Detected in some" 5 "MOLT-4: 49.7;REH: 172.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036532, HPA044194" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036532: , HPA044194: AB_10960525" "unprognostic (4.24e-1)" "unprognostic (1.00e-1)" "unprognostic (2.60e-2)" "unprognostic (1.86e-2)" 0.0 0.0 0.1 0.1 0.3 24.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 2.7 0.0 171.0 0.6 0.0 2.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 49.7 0.0 0.0 0.0 0.0 172.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 DOCK10 "KIAA0694, ZIZ3" ENSG00000135905 "Dedicator of cytokinesis 10" Q96BY6 2 224765090-225042445 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.7;lymphoid tissue: 27.6" "Cell type enhanced" "Detected in many" 11 "granulocytes: 34.8;Horizontal cells: 92.2;Kupffer cells: 46.3;Macrophages: 38.8;monocytes: 40.5;T-cells: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 31.6;HDLM-2: 21.5;TIME: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058106 Enhanced Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA058106: AB_2683606" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.03e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-3)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (3.44e-2)" "unprognostic (3.80e-1)" "unprognostic (3.22e-3)" "unprognostic (3.39e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-1)" "unprognostic (7.72e-2)" 4.2 7.6 17.1 16.7 28.8 8.8 4.0 3.0 18.4 9.5 5.9 27.6 0.0 4.1 3.4 1.4 3.4 2.5 6.4 1.8 24.3 14.7 2.9 5.4 7.3 23.9 33.3 9.6 15.9 1.8 1.9 1.4 2.5 23.2 2.0 6.7 1.1 4.1 2.0 1.3 5.0 8.5 4.4 37.7 26.5 6.1 2.3 35.5 27.6 2.7 1.3 18.4 6.6 3.7 6.8 6.2 2.6 9.6 12.8 10.5 4.0 0.0 8.9 2.8 0.0 3.7 7.9 0.0 19.0 15.5 9.1 6.8 0.0 0.0 0.2 0.0 12.0 31.6 0.2 0.0 0.0 7.3 21.5 0.0 0.2 1.9 0.0 0.1 1.8 0.9 1.8 0.2 13.2 5.2 3.6 9.0 2.9 0.0 17.9 15.3 0.8 3.2 2.5 1.1 0.0 2.1 4.3 4.1 2.6 0.4 0.0 0.1 2.3 0.0 0.0 1.9 0.5 0.6 8.2 20.1 9.9 2.4 4.7 6.4 0.0 0.0 0.0 14.0 12.2 4.2 2.6 2.8 0.2 6.2 8.2 6.4 6.8 10.5 8.8 6.2 3.8 10.4 9.0 0.1 12.8 9.6 2.6 7.5 4.0 17.1 28.8 3.0 18.4 24.3 14.7 33.3 9.6 23.2 35.5 3.0 10.8 18.5 0.5 4.1 5.6 0.8 0.0 4.0 4.5 5.2 0.0 0.2 1.7 0.1 1.7 2.2 0.0 0.0 0.0 0.1 2.3 0.5 34.8 0.9 29.1 92.2 2.4 2.5 46.3 2.2 0.6 38.8 8.5 40.5 2.7 1.3 0.3 0.0 0.0 0.2 2.0 12.9 8.6 0.1 0.2 3.6 0.7 37.4 3.3 0.6 DOCK3 "KIAA0299, MOCA, PBP" ENSG00000088538 "Dedicator of cytokinesis 3" Q8IZD9 3 50675241-51384198 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 20.8;Early spermatids: 10.4;Horizontal cells: 31.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 7.6;GAMG: 7.5;HMC-1: 6.1;JURKAT: 7.2;U-87 MG: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037543, HPA037544" Enhanced Supported Enhanced Cytosol NA NA Cytosol "HPA037543: AB_10672495, HPA037544: AB_10670383" "unprognostic (1.02e-1)" "unprognostic (1.11e-1)" "unprognostic (1.78e-3)" "unprognostic (6.35e-8)" "unprognostic (2.63e-1)" "unprognostic (3.02e-2)" "unprognostic (4.64e-2)" "unprognostic (3.67e-1)" "unprognostic (1.91e-1)" "unprognostic (7.99e-2)" "unprognostic (2.36e-3)" "unprognostic (1.34e-2)" "unprognostic (1.45e-2)" "unprognostic (5.83e-5)" "unprognostic (7.96e-2)" "unprognostic (6.19e-2)" "unprognostic (1.24e-1)" 1.6 5.5 15.3 1.7 19.8 1.6 1.7 24.2 38.9 1.7 2.3 11.6 1.9 1.7 2.1 2.7 4.2 2.2 1.9 4.6 11.5 9.8 1.9 1.3 1.8 1.8 9.1 17.6 1.7 2.0 15.8 9.2 1.5 13.1 3.8 1.9 1.8 3.2 5.0 4.3 4.0 1.7 3.1 8.5 1.8 1.7 9.0 10.7 0.0 17.4 0.0 1.9 2.0 0.7 0.7 0.7 0.2 2.0 0.6 1.3 0.0 0.1 0.2 0.2 7.6 0.0 0.0 3.3 0.1 0.2 0.4 0.3 0.2 0.5 0.0 0.6 2.4 7.5 0.5 5.1 0.0 0.1 4.3 5.3 0.1 1.3 0.1 0.1 0.2 6.1 0.1 0.1 0.2 0.0 0.4 0.0 7.2 0.0 0.1 0.6 0.2 0.0 0.0 2.5 0.3 2.4 0.0 0.7 0.0 0.4 0.7 4.7 0.0 0.3 4.3 0.1 5.5 0.1 0.0 0.5 0.2 2.1 0.2 2.7 0.3 0.0 0.0 10.1 1.0 0.1 0.0 0.1 0.2 0.5 0.4 0.5 0.4 0.4 0.2 0.1 0.7 1.3 0.5 0.2 0.6 2.0 0.7 0.1 0.0 15.3 19.8 24.2 25.3 11.5 9.8 9.1 17.6 13.1 10.7 0.0 1.1 0.0 0.1 0.0 20.8 6.7 0.0 0.0 1.2 0.0 2.0 0.0 1.7 0.0 10.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 31.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 4.9 0.0 1.4 3.5 2.9 0.1 0.0 0.0 0.0 0.0 DOCK4 "FLJ34238, KIAA0716" ENSG00000128512 "Dedicator of cytokinesis 4" Q8N1I0 7 111726110-112206411 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 44.7;Horizontal cells: 89.0;Ito cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.4" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 19.2;HUVEC TERT2: 36.4;TIME: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071516 Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoli, Plasma membrane" "Golgi apparatus, Cytosol" "HPA071516: AB_2686407" "unprognostic (1.37e-1)" "unprognostic (4.18e-1)" "unprognostic (1.53e-1)" "unprognostic (2.48e-2)" "unprognostic (7.10e-2)" "unprognostic (2.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" "unprognostic (5.78e-2)" "unprognostic (7.06e-2)" "unprognostic (3.66e-1)" "unprognostic (5.71e-2)" "unprognostic (1.89e-2)" "unprognostic (9.48e-2)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" 10.7 6.5 16.5 10.0 28.2 2.3 6.8 11.7 28.2 9.1 4.4 21.0 2.0 2.8 7.9 4.4 4.4 8.7 7.9 6.9 22.2 10.1 7.3 13.9 25.5 3.7 18.2 12.4 14.2 5.0 4.7 4.0 10.8 12.2 6.5 4.9 1.7 4.4 3.9 6.7 3.5 3.2 10.7 20.3 3.2 3.1 3.5 21.8 0.0 5.8 2.7 3.6 5.7 5.2 0.2 0.3 6.4 1.2 0.1 0.1 0.2 0.0 1.7 4.1 3.3 3.4 5.0 2.3 0.4 4.5 0.8 1.3 0.0 0.0 0.3 3.4 1.0 0.9 0.2 0.6 3.9 3.5 1.2 6.7 0.1 2.8 5.7 2.4 0.5 0.2 2.6 0.4 19.2 9.9 1.2 36.4 1.6 0.0 10.3 1.7 0.4 0.8 0.2 2.2 0.5 7.0 0.2 3.0 1.6 2.8 0.1 0.9 3.2 2.5 2.1 2.5 3.8 0.3 0.1 31.4 3.2 1.5 6.1 1.3 0.4 0.1 0.3 0.3 0.8 7.1 0.2 0.7 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 6.4 0.1 0.2 0.3 0.0 0.2 16.5 28.2 11.7 18.2 22.2 10.1 18.2 12.4 12.2 21.8 44.7 5.0 0.5 3.6 4.6 26.2 11.6 2.5 12.0 21.6 3.5 21.6 0.2 0.0 1.4 2.4 32.2 0.7 0.0 0.3 0.2 6.0 9.4 2.3 14.9 13.6 89.0 10.5 40.5 15.6 1.1 5.2 17.3 8.5 8.2 0.7 4.4 1.0 9.9 7.8 1.1 10.3 12.9 3.3 0.7 1.7 2.4 0.0 0.0 0.8 1.6 DOCK5 FLJ21034 ENSG00000147459 "Dedicator of cytokinesis 5" Q9H7D0 8 25184723-25418082 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 87.6;Melanocytes: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 22.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017719, HPA056837" Approved Enhanced Cytosol No No Cytosol "HPA017719: AB_1847820, HPA056837: AB_2683253" "unprognostic (2.16e-1)" "unprognostic (3.55e-3)" "unprognostic (1.25e-2)" "prognostic favorable (1.91e-4)" "unprognostic (8.44e-2)" "unprognostic (1.24e-1)" "unprognostic (2.61e-2)" "unprognostic (2.88e-2)" "unprognostic (1.69e-2)" "unprognostic (4.21e-2)" "unprognostic (4.18e-3)" "unprognostic (3.00e-1)" "prognostic unfavorable (1.18e-6)" "unprognostic (2.81e-1)" "unprognostic (3.07e-1)" "unprognostic (1.30e-2)" "unprognostic (2.25e-1)" 5.5 4.3 12.1 10.4 30.3 26.2 7.2 3.3 18.2 6.3 11.5 38.8 12.1 14.9 6.3 7.8 4.3 7.6 9.6 8.0 15.1 7.6 4.8 16.2 10.7 4.7 35.0 9.4 10.4 5.7 6.3 10.8 15.6 18.8 9.4 13.4 10.8 7.9 14.3 3.3 7.1 17.0 5.3 17.0 21.9 9.2 7.8 33.8 0.6 18.5 2.3 2.7 5.6 5.8 0.0 1.6 22.0 4.6 0.3 0.3 0.2 10.4 21.8 2.1 0.2 5.1 5.5 7.9 25.3 12.9 6.2 4.9 3.1 7.5 0.3 2.3 19.6 6.9 18.2 2.4 16.0 9.9 3.4 3.2 10.5 18.8 7.7 5.9 2.4 11.6 3.7 6.5 6.9 10.2 6.8 5.3 0.5 0.1 0.5 6.0 6.0 0.3 4.7 2.2 11.6 6.9 0.1 4.9 0.2 4.5 6.1 1.6 0.7 13.3 7.3 2.4 1.9 2.3 2.3 15.9 10.7 7.5 13.2 9.1 0.5 0.1 0.2 13.8 5.5 13.4 7.6 1.9 2.6 0.3 3.8 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.2 22.0 0.3 4.6 0.2 0.0 0.2 12.1 30.3 3.3 18.2 15.1 7.6 35.0 9.4 18.8 33.8 41.7 40.4 5.2 9.8 16.5 8.1 12.0 30.6 24.1 28.4 14.0 2.0 22.6 0.0 10.3 0.8 6.8 50.5 0.0 10.5 87.6 24.9 31.8 30.1 25.8 13.1 1.6 16.8 10.4 55.4 2.6 26.7 42.6 81.0 2.8 23.5 26.2 31.4 24.6 45.3 2.7 1.6 12.9 7.6 0.7 5.5 6.4 17.2 6.4 19.8 11.1 DOCK6 "KIAA1395, ZIR1" ENSG00000130158 "Dedicator of cytokinesis 6" Q96HP0 19 11199295-11262481 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 124.5;Ito cells: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 33.2;TIME: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049423, HPA049424" Approved Supported Cytosol NA NA Cytosol "HPA049423: AB_2680760, HPA049424: AB_2680761" "unprognostic (2.69e-2)" "unprognostic (2.27e-1)" "unprognostic (9.51e-2)" "unprognostic (3.35e-2)" "unprognostic (4.72e-3)" "prognostic favorable (9.09e-4)" "unprognostic (2.54e-2)" "unprognostic (4.91e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-2)" "unprognostic (2.57e-1)" "unprognostic (7.89e-2)" "unprognostic (1.25e-3)" "unprognostic (2.76e-1)" "unprognostic (1.51e-1)" "unprognostic (5.41e-2)" "unprognostic (2.95e-1)" 17.8 4.9 6.4 5.1 7.9 0.0 12.8 3.3 8.5 7.1 12.6 6.7 6.5 10.3 11.0 8.6 9.3 4.9 8.8 10.5 6.1 2.3 12.2 7.3 19.7 3.6 8.1 2.0 5.8 8.1 3.7 6.2 11.1 6.7 7.1 4.5 10.2 7.4 5.8 9.8 18.2 11.7 13.4 5.5 7.1 10.3 5.4 5.3 1.3 14.5 8.6 7.6 7.3 22.9 1.5 0.0 0.0 0.5 0.0 0.3 0.2 6.8 4.2 4.9 3.9 3.6 5.3 7.8 2.0 3.3 2.0 3.1 8.0 5.4 0.4 12.5 3.4 1.9 4.0 2.1 10.7 1.2 5.8 3.3 1.3 0.9 6.0 5.9 2.0 6.7 4.0 6.4 3.6 8.4 3.9 33.2 0.1 7.2 0.0 4.4 15.4 0.0 6.8 6.1 6.2 8.0 0.4 3.3 6.5 3.3 9.5 0.2 8.7 2.0 2.0 3.7 3.4 2.4 3.6 32.9 3.7 3.9 8.4 3.6 0.6 0.1 6.6 3.1 1.5 3.2 0.0 0.3 0.0 0.3 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 6.4 7.9 3.3 8.5 6.1 2.3 8.1 2.0 6.7 5.3 3.0 15.9 0.8 4.8 5.8 1.2 124.5 5.1 5.3 11.4 24.4 0.0 0.2 1.7 4.8 3.0 37.9 11.2 0.0 5.9 1.1 7.8 7.5 4.7 5.8 3.6 0.0 11.6 55.3 4.4 0.9 20.8 1.4 3.3 0.0 12.5 3.7 8.0 11.4 8.9 1.9 2.3 19.4 10.8 1.7 3.9 10.0 0.5 0.7 9.0 8.2 DOCK8 "FLJ00026, FLJ00152, FLJ00346, ZIR8" ENSG00000107099 "Dedicator of cytokinesis 8" Q8NF50 9 214854-465259 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 40.5;lymphoid tissue: 61.0" "Cell type enhanced" "Detected in many" 6 "B-cells: 83.1;Cone photoreceptor cells: 72.6;Kupffer cells: 113.9;Macrophages: 79.1;monocytes: 79.4;T-cells: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 17.3;HL-60: 17.2;MOLT-4: 16.1;NB-4: 27.2;REH: 20.2;RT4: 17.9;THP-1: 51.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003218, HPA073349" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria,Cytosol NA NA Centrosome "Nucleoplasm, Mitochondria, Cytosol" "HPA003218: AB_1078695, HPA073349: " "unprognostic (1.56e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-2)" "unprognostic (7.55e-3)" "unprognostic (3.31e-1)" "unprognostic (6.28e-3)" "unprognostic (1.79e-1)" "unprognostic (8.12e-2)" "unprognostic (2.72e-2)" "unprognostic (6.72e-2)" "unprognostic (1.90e-1)" "unprognostic (3.89e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.91e-1)" "prognostic favorable (6.89e-6)" 6.7 12.9 5.6 27.4 8.4 20.8 6.1 1.2 4.1 3.1 3.9 9.2 0.9 3.9 3.0 4.3 6.0 4.1 8.2 2.9 6.3 3.3 7.5 3.9 16.8 35.3 10.2 2.3 2.5 6.4 7.6 3.5 10.4 8.1 4.9 4.1 4.4 10.5 2.4 1.7 3.3 15.0 3.4 13.6 43.5 4.9 7.2 8.9 61.0 5.1 3.0 27.1 10.5 4.0 7.3 15.4 40.5 21.5 6.6 5.5 6.4 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.5 0.4 17.3 1.2 0.0 0.0 0.7 0.2 0.1 0.0 5.9 0.6 0.0 0.0 0.0 0.0 17.2 2.3 0.1 3.2 0.0 0.0 0.0 0.0 0.0 3.7 8.7 0.0 1.0 16.1 27.2 0.1 0.0 0.2 20.2 0.0 6.7 0.0 17.9 0.0 0.0 0.0 0.2 1.2 0.3 0.4 51.7 3.4 0.0 0.1 0.2 0.0 3.5 0.0 0.0 0.0 10.9 0.3 14.2 14.7 16.7 4.6 15.1 3.8 7.3 5.5 4.8 15.4 6.8 4.4 4.2 40.5 6.6 21.5 4.4 5.3 6.4 5.6 8.4 1.2 4.1 6.3 3.3 10.2 2.3 8.1 8.9 8.9 31.0 83.1 1.5 5.7 0.2 2.0 22.9 1.4 3.4 7.0 72.6 44.4 1.7 0.8 24.2 4.8 0.5 0.0 5.9 3.1 2.9 1.1 23.2 2.5 50.8 0.0 8.1 3.1 113.9 11.5 2.8 79.1 8.5 79.4 8.9 1.0 1.4 17.5 0.4 8.7 3.8 12.9 14.4 15.4 4.1 3.3 35.7 76.2 1.0 3.0 DOHH "HLRC1, MGC4293" ENSG00000129932 "Deoxyhypusine hydroxylase" Q9BU89 19 3490822-3500940 "Enzymes, Predicted intracellular proteins" "Hypusine biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041953, HPA076271" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041953: AB_10795386, HPA076271: " "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (8.63e-2)" "prognostic favorable (2.24e-4)" "unprognostic (3.66e-1)" "unprognostic (2.01e-2)" "unprognostic (9.45e-2)" "unprognostic (7.26e-2)" "unprognostic (4.65e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.58e-4)" "unprognostic (9.87e-3)" "unprognostic (1.14e-3)" "unprognostic (4.35e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.76e-3)" 8.1 6.5 10.5 6.6 13.0 9.3 3.4 5.5 13.0 3.9 5.5 6.9 2.6 18.9 3.7 4.1 4.1 3.1 4.9 5.1 14.9 9.1 6.0 6.4 4.0 4.5 18.2 6.2 3.8 7.6 3.8 3.9 3.8 8.4 5.1 2.0 3.2 6.0 4.0 23.1 7.0 12.3 2.4 25.5 5.9 7.3 4.2 6.1 4.7 2.9 7.8 4.5 3.1 4.7 11.6 11.0 1.8 6.6 6.9 12.3 4.4 9.2 11.0 1.7 3.6 0.9 1.1 7.4 8.8 1.8 4.3 3.4 15.3 3.8 7.2 6.9 1.3 3.9 9.6 2.7 3.0 0.9 10.6 12.4 7.5 6.2 18.2 3.5 10.0 10.5 1.2 3.0 4.2 1.8 1.5 2.2 8.0 16.3 8.5 1.7 10.5 10.8 11.4 9.8 3.7 14.9 12.3 4.0 10.4 2.6 5.2 10.5 7.7 6.2 5.5 8.8 0.8 7.5 5.5 5.0 5.4 7.4 14.3 16.1 11.3 8.2 9.6 6.4 22.8 6.4 1.1 5.3 1.8 6.2 6.2 8.1 8.1 8.5 12.3 8.7 11.6 12.3 10.4 0.3 6.9 6.6 11.0 9.6 4.4 10.5 13.0 5.5 13.0 14.9 9.1 18.2 6.2 8.4 6.1 6.0 2.1 18.5 14.9 20.9 17.4 7.1 10.2 1.4 2.3 5.2 9.8 25.8 18.3 21.7 7.1 12.1 9.7 0.0 18.5 26.0 13.9 16.8 13.8 8.2 19.0 23.8 12.6 11.1 7.2 17.2 13.0 8.6 18.6 24.4 11.0 13.1 19.1 14.4 14.2 23.9 11.8 0.0 13.7 11.1 12.3 24.1 29.1 12.8 16.1 15.3 DOK1 p62dok ENSG00000115325 "Docking protein 1" Q99704 2 74549026-74557554 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 36.8;Hofbauer cells: 43.1;Macrophages: 32.0;monocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004224, HPA048561" Approved Supported Cytosol NA NA 74000 Cytosol "CAB004224: AB_627447, HPA048561: AB_2680443" "unprognostic (2.40e-2)" "unprognostic (2.07e-2)" "unprognostic (2.60e-1)" "prognostic favorable (8.42e-4)" "unprognostic (9.86e-3)" "unprognostic (1.28e-1)" "unprognostic (7.10e-2)" "prognostic favorable (4.64e-4)" "unprognostic (7.57e-2)" "unprognostic (1.85e-2)" "unprognostic (1.89e-2)" "unprognostic (3.15e-2)" "prognostic unfavorable (3.16e-6)" "unprognostic (8.65e-2)" "unprognostic (2.40e-2)" "unprognostic (1.37e-1)" "unprognostic (1.20e-2)" 13.2 4.9 4.7 11.2 6.0 15.7 13.3 1.3 3.3 6.2 5.9 5.3 2.6 4.3 7.0 3.6 3.4 5.5 8.0 5.0 4.9 4.2 4.7 2.3 8.0 9.5 6.9 2.8 6.7 10.9 5.5 3.1 5.0 5.4 5.6 5.1 3.1 4.1 5.0 2.0 2.2 7.2 4.7 6.7 15.5 6.6 4.5 5.2 14.5 8.8 1.3 10.8 5.0 7.7 6.9 13.9 17.9 16.1 7.4 5.6 9.9 2.1 0.7 2.0 1.6 4.4 4.8 1.9 4.3 2.7 1.3 2.1 0.7 2.3 1.0 6.9 4.2 3.4 0.3 2.9 1.2 0.8 31.8 3.0 13.6 1.9 0.1 3.7 7.8 14.6 4.6 0.0 10.9 5.0 6.8 1.8 5.1 4.2 2.9 3.2 2.3 6.2 17.0 4.2 3.3 0.9 5.0 4.0 1.6 1.0 1.9 0.9 3.8 1.4 0.2 3.4 0.9 1.5 11.4 3.5 10.7 6.2 5.8 1.0 4.5 3.3 0.0 10.3 11.1 1.8 10.8 15.1 11.3 4.9 14.3 4.1 6.7 3.9 4.2 13.9 6.9 3.6 3.6 17.9 7.4 16.1 2.9 5.6 9.9 4.7 6.0 1.3 2.8 4.9 4.2 6.9 2.8 5.4 5.2 8.9 12.0 9.9 0.9 1.8 0.2 1.7 7.6 1.4 2.3 5.2 0.0 1.8 0.0 10.7 0.2 6.2 5.4 0.0 7.9 3.7 7.3 2.8 36.8 0.5 43.1 1.6 2.9 12.9 28.1 0.0 4.6 32.0 3.3 47.7 5.6 9.1 8.8 7.2 5.6 3.4 0.5 6.5 6.2 0.5 1.7 1.4 1.9 15.2 6.9 1.4 DOK2 "Dok-2, p56dok-2" ENSG00000147443 "Docking protein 2" O60496 8 21908873-21913860 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 138.5" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 113.3;Kupffer cells: 141.8;Macrophages: 166.3;T-cells: 159.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 138.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 10.1;HEL: 21.6;HMC-1: 46.4;JURKAT: 8.4;THP-1: 16.7;U-937: 16.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB004379, HPA005507, HPA066571" Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 1200000 Cytosol "Nucleoplasm, Nuclear bodies, Golgi apparatus" "CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749" "unprognostic (5.39e-2)" "unprognostic (8.84e-3)" "unprognostic (8.72e-3)" "unprognostic (1.74e-3)" "unprognostic (2.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.34e-1)" "unprognostic (7.22e-2)" "prognostic favorable (4.31e-4)" "unprognostic (2.22e-1)" "unprognostic (4.19e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.88e-1)" "unprognostic (1.24e-2)" "unprognostic (3.19e-1)" "unprognostic (2.80e-1)" 13.6 3.3 0.6 14.2 0.6 8.4 3.5 0.5 0.6 2.4 4.4 0.4 2.1 3.5 2.0 5.9 3.8 2.8 4.8 3.8 0.6 0.7 2.7 4.6 14.0 12.3 1.5 0.2 2.4 2.3 0.0 1.5 5.3 1.4 3.9 1.6 2.6 2.9 0.6 1.4 1.8 5.9 3.4 2.2 28.6 3.2 1.9 0.7 17.9 1.8 2.7 13.5 4.4 9.8 1.4 38.9 138.5 55.9 27.1 52.8 60.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 21.6 0.0 0.0 0.0 0.1 46.4 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.3 1.9 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 16.2 0.0 44.9 45.1 138.5 39.0 55.9 18.0 1.4 27.4 29.5 38.9 0.6 15.4 19.1 3.4 27.1 49.3 0.7 52.8 60.8 0.6 0.6 0.5 0.6 0.6 0.7 1.5 0.2 1.4 0.7 3.0 27.3 13.0 0.5 10.2 0.0 1.7 0.0 2.7 2.3 3.5 0.0 0.6 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.9 5.1 0.2 36.8 0.9 113.3 0.0 0.0 4.3 141.8 0.0 0.3 166.3 18.6 8.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.1 0.3 1.7 7.4 0.8 159.2 0.0 0.9 DOK3 FLJ22570 ENSG00000146094 "Docking protein 3" Q7L591 5 177501907-177511274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 47.5;bone marrow: 51.8;lymphoid tissue: 50.0" "Cell type enhanced" "Detected in some" 14 "granulocytes: 17.4;Hofbauer cells: 49.3;Kupffer cells: 45.9;Macrophages: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 47.5" "Group enriched" "Detected in many" 6 "B-cells: 12.7;granulocytes: 47.5;monocytes: 23.2" "Cell line enhanced" "Detected in many" "Daudi: 41.4;HMC-1: 33.7;REH: 51.0;U-698: 40.9;U-937: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA077312 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" NA NA 750000 "Plasma membrane" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA077312: AB_2732339" "unprognostic (2.21e-2)" "unprognostic (1.14e-2)" "unprognostic (2.05e-2)" "unprognostic (5.74e-3)" "unprognostic (2.32e-2)" "unprognostic (1.34e-3)" "unprognostic (4.17e-2)" "unprognostic (2.20e-1)" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.82e-11)" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (1.55e-1)" "unprognostic (3.78e-2)" 6.9 2.4 2.7 22.6 7.1 51.8 4.7 2.7 3.3 1.4 2.4 1.5 0.4 3.6 1.4 2.5 2.4 3.3 2.4 2.2 3.6 2.2 2.3 4.0 10.9 26.3 6.1 0.7 2.0 1.8 0.4 1.4 4.0 4.1 2.1 1.8 2.3 4.1 1.0 1.3 1.0 10.8 2.4 7.6 50.0 2.9 3.1 2.9 1.9 1.7 0.6 21.7 4.8 1.5 12.7 4.8 47.5 23.2 0.1 0.1 7.8 1.4 2.2 1.5 1.8 0.9 0.1 4.0 1.2 0.2 4.0 3.7 3.3 0.6 41.4 0.9 1.0 2.0 2.5 3.4 2.1 1.9 7.5 4.5 6.7 5.2 0.6 0.3 15.6 33.7 0.5 1.3 4.5 0.4 0.4 0.7 3.3 4.6 18.2 1.4 3.8 0.7 19.7 3.8 0.4 3.9 51.0 3.1 0.3 1.2 1.5 2.2 1.4 0.5 0.6 1.8 1.4 3.5 22.1 0.9 3.8 3.6 1.9 1.4 3.7 4.0 40.9 0.8 29.5 0.7 4.7 20.6 19.9 0.1 20.4 0.1 12.7 0.0 0.1 4.8 6.7 0.0 0.0 47.5 0.1 23.2 0.3 0.0 7.8 2.7 7.1 2.7 3.3 3.6 2.2 6.1 0.7 4.1 2.9 0.0 9.3 13.0 0.1 0.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.5 0.4 0.1 17.4 0.0 49.3 0.0 0.0 8.0 45.9 0.0 0.6 19.8 1.7 1.0 0.1 0.5 0.0 0.0 1.1 0.0 0.6 0.0 0.4 3.0 1.9 0.3 0.8 0.0 0.6 0.1 DOK4 FLJ10488 ENSG00000125170 "Docking protein 4" Q8TEW6 16 57471922-57487327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 96.4;Paneth cells: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "gdT-cell: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 5 "granulocytes: 4.3;T-cells: 1.4" "Cell line enhanced" "Detected in many" "A549: 26.0;CACO-2: 29.5;SH-SY5Y: 67.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008348, HPA055849" Supported Approved Cytosol NA No Cytosol "HPA008348: , HPA055849: AB_2682942" "unprognostic (3.44e-2)" "unprognostic (2.04e-2)" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (3.66e-1)" "unprognostic (9.71e-2)" "unprognostic (5.35e-2)" "unprognostic (1.39e-1)" "unprognostic (1.13e-2)" "unprognostic (3.00e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-1)" "unprognostic (2.58e-3)" "unprognostic (4.30e-2)" "unprognostic (2.21e-1)" "unprognostic (4.42e-3)" "unprognostic (1.18e-3)" 5.0 4.6 7.8 9.5 4.5 0.7 13.6 15.6 6.9 14.2 29.2 2.0 17.7 24.4 9.9 11.8 15.5 8.1 21.0 7.3 5.0 6.9 27.1 25.8 12.3 1.9 3.4 4.7 12.8 14.8 7.2 10.1 6.6 5.2 12.9 16.9 8.4 7.5 15.0 3.1 22.7 51.5 9.6 2.1 5.1 19.9 8.4 2.9 1.9 8.6 12.9 6.3 8.8 14.1 0.5 0.1 4.3 0.0 0.1 1.4 0.2 2.7 26.0 4.2 7.5 5.9 6.5 4.7 4.9 6.5 3.5 1.0 29.5 14.7 0.2 21.4 10.2 2.0 5.8 2.5 1.3 1.5 0.7 1.9 6.0 7.6 17.0 8.4 0.0 0.6 4.5 4.0 4.6 0.5 7.8 5.3 1.0 1.9 1.2 4.1 2.6 0.3 1.1 2.6 12.5 1.1 2.4 2.2 0.3 18.2 1.0 20.8 67.9 4.0 1.7 1.2 19.6 1.5 1.1 5.6 0.6 4.4 1.7 0.2 0.8 1.0 0.2 1.9 1.3 2.6 0.0 0.0 0.0 1.4 0.0 0.6 0.1 0.3 0.2 0.1 0.5 0.4 0.3 4.3 0.1 0.0 0.0 0.1 0.2 7.8 4.5 15.6 6.9 5.0 6.9 3.4 4.7 5.2 2.9 11.9 12.3 0.5 6.3 7.0 16.3 2.7 28.1 0.0 2.3 14.0 0.0 0.6 5.0 12.9 1.1 5.7 96.4 0.0 20.6 6.2 7.5 4.9 0.0 16.1 0.8 7.9 3.5 5.5 0.6 1.1 12.4 0.7 3.3 1.0 23.3 2.5 22.2 60.2 11.3 38.2 0.8 6.5 4.7 0.2 2.3 15.7 0.5 1.0 23.3 5.2 DOK6 "DOK5L, HsT3226, MGC20785" ENSG00000206052 "Docking protein 6" Q6PKX4 18 69401055-69849087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell type enriched" "Detected in some" 7 "Bipolar cells: 239.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.4;Hep G2: 10.9;RPMI-8226: 10.5;SCLC-21H: 4.8;SH-SY5Y: 10.9;SuSa: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041099, HPA063534" Approved Approved "Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" "HPA041099: AB_2677299, HPA063534: AB_2685032" "unprognostic (5.83e-2)" "unprognostic (1.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (2.77e-2)" "unprognostic (2.59e-1)" "unprognostic (1.55e-1)" "unprognostic (1.90e-2)" "unprognostic (8.62e-2)" "unprognostic (5.99e-2)" "unprognostic (1.04e-2)" "unprognostic (4.60e-3)" "unprognostic (2.13e-4)" "unprognostic (2.30e-3)" "unprognostic (2.88e-2)" "unprognostic (4.49e-3)" "unprognostic (1.09e-3)" 2.1 1.6 21.3 1.6 11.3 0.6 1.3 6.8 22.1 3.8 1.5 0.9 0.3 1.0 3.0 1.4 1.7 1.7 5.8 10.2 19.2 9.2 8.7 4.4 4.2 1.2 13.7 13.1 4.2 0.7 3.4 1.1 9.9 14.0 3.5 1.3 5.5 1.7 4.2 0.6 1.2 1.3 6.6 2.7 1.8 1.3 2.8 2.7 0.0 4.1 0.0 1.2 5.2 6.6 0.0 0.0 0.0 0.0 0.9 0.9 0.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 10.9 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 10.5 0.0 0.0 4.8 10.9 0.0 0.0 0.0 8.1 0.0 0.0 0.0 4.1 0.6 0.0 1.5 0.3 0.0 0.0 3.1 0.0 3.2 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.1 0.5 0.0 0.9 0.0 0.0 0.3 0.4 21.3 11.3 6.8 17.1 19.2 9.2 13.7 13.1 14.0 2.7 0.0 0.0 0.0 0.1 0.2 239.6 6.5 0.0 0.0 2.3 0.0 13.7 0.0 1.7 0.0 32.5 0.7 0.0 0.0 0.0 0.0 5.3 0.1 0.0 1.0 0.0 9.5 0.0 0.0 0.3 23.0 1.4 0.3 0.0 0.0 0.0 4.1 0.0 0.0 6.3 7.8 12.7 0.0 2.7 0.7 0.1 0.5 0.0 0.0 0.0 0.1 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947619 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA066767: AB_2732751, HPA068706: AB_2732118" "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.88e-5)" "unprognostic (6.13e-3)" 11.0 20.2 7.9 7.8 13.8 1.4 9.5 7.0 18.6 9.8 8.6 14.9 7.1 8.8 12.4 16.8 10.9 10.8 10.8 12.0 7.6 9.9 17.5 22.0 10.6 10.6 8.1 6.7 13.2 16.9 19.2 8.0 19.5 16.3 12.3 8.0 14.2 15.5 12.8 7.9 11.4 10.9 11.1 5.9 11.6 12.4 22.4 6.0 12.5 11.0 11.9 12.1 10.4 7.3 9.4 14.2 5.6 16.4 9.8 13.7 9.0 5.1 19.3 6.8 10.1 20.2 10.7 9.3 10.8 17.5 13.3 9.9 15.1 8.2 2.8 5.7 15.6 18.8 36.7 9.3 13.5 6.9 4.7 8.1 3.5 13.3 10.9 20.5 3.8 6.3 14.8 12.5 14.3 7.9 7.8 12.9 4.1 8.6 4.6 14.3 25.4 3.1 3.2 8.8 14.8 12.0 3.2 9.0 11.2 11.9 7.8 6.3 7.0 14.3 11.8 6.3 6.7 20.6 5.1 10.7 12.0 4.3 15.1 8.8 4.4 10.8 2.9 11.3 3.5 9.1 2.3 13.5 5.6 10.2 13.3 9.1 9.4 9.2 11.2 14.2 9.2 12.1 12.3 2.1 9.8 16.4 8.1 13.7 9.0 7.9 13.8 7.0 18.6 7.6 9.9 8.1 6.7 16.3 6.0 6.0 2.6 1.5 3.2 1.5 9.0 3.0 7.6 6.7 3.4 7.0 7.9 21.7 0.0 14.1 10.7 8.3 6.2 0.0 12.3 14.0 5.6 3.1 1.1 8.3 11.4 4.8 1.2 17.2 6.9 2.8 11.2 2.7 3.3 1.8 3.8 11.2 10.4 5.8 5.6 7.2 6.5 0.0 4.1 24.0 14.9 1.1 15.2 1.9 5.5 1.7 DONSON "B17, C21orf60, C2TA, DKFZP434M035" ENSG00000159147 "Downstream neighbor of SON" Q9NYP3 21 33559542-33588708 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 44.4;Spermatocytes: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039558, HPA049033" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA039558: AB_2676570, HPA049033: AB_2680608" "unprognostic (9.90e-3)" "unprognostic (1.01e-3)" "unprognostic (6.58e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.22e-4)" "unprognostic (4.00e-2)" "unprognostic (5.93e-3)" "prognostic favorable (2.17e-4)" "unprognostic (1.25e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.77e-2)" "unprognostic (1.66e-1)" "unprognostic (2.07e-1)" "unprognostic (8.83e-2)" 6.4 3.5 4.1 9.2 8.0 9.4 10.2 7.8 5.6 6.8 7.1 3.3 3.5 6.1 6.7 5.8 8.3 6.3 5.9 7.5 5.5 4.4 5.6 16.2 5.2 11.1 4.7 4.0 13.5 5.7 11.7 6.9 12.2 8.1 5.7 7.4 4.4 4.8 4.3 5.9 9.1 9.3 5.4 5.2 8.2 5.8 24.0 3.0 26.4 5.0 8.1 10.7 4.5 9.7 0.7 0.5 0.1 0.9 0.4 1.4 0.3 27.4 6.4 13.5 11.8 4.2 7.8 10.5 21.9 9.5 16.8 19.1 18.0 7.5 14.9 5.7 10.9 12.7 8.2 18.2 7.8 18.5 14.9 15.7 27.9 14.1 16.3 3.1 14.8 6.8 5.5 2.5 19.0 4.6 5.0 10.7 7.8 26.6 26.0 14.4 5.6 13.5 5.3 14.0 13.1 7.9 12.1 27.9 15.9 7.5 7.4 14.7 6.1 32.9 10.5 9.6 7.0 13.8 7.5 6.2 16.0 11.2 11.7 15.4 23.6 23.2 24.5 8.9 19.8 18.0 0.0 0.3 0.1 1.4 0.9 0.7 0.2 1.4 0.6 0.2 0.7 0.8 0.1 0.0 0.4 0.0 0.5 0.6 0.3 4.1 8.0 7.8 5.6 5.5 4.4 4.7 4.0 8.1 3.0 3.0 3.4 0.8 7.7 7.2 3.5 3.4 7.6 0.0 1.2 3.5 9.8 8.0 1.7 3.0 44.4 4.5 2.7 0.0 4.0 22.1 6.4 4.6 8.1 5.5 7.6 6.4 1.2 8.6 2.7 16.6 9.5 5.1 6.8 3.6 3.8 2.4 3.7 2.9 13.1 4.2 2.7 0.0 8.1 53.1 21.1 8.5 13.8 5.7 5.1 8.1 DPF1 "BAF45b, NEUD4, neuro-d4" ENSG00000011332 "Double PHD fingers 1" Q92782 19 38211006-38229714 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 31.6" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 18.4;Early spermatids: 23.8;Horizontal cells: 42.9;Late spermatids: 17.6" "Cancer enhanced" "Detected in some" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 15.7;SCLC-21H: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049148 Enhanced Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA049148: AB_2680653" "unprognostic (7.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.38e-2)" "unprognostic (4.11e-3)" "unprognostic (8.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-4)" "unprognostic (1.40e-2)" "unprognostic (2.72e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-3)" "unprognostic (2.87e-2)" "unprognostic (1.11e-16)" "unprognostic (2.56e-1)" "unprognostic (3.75e-1)" "unprognostic (6.96e-2)" "unprognostic (8.20e-4)" 1.1 1.5 11.8 1.5 15.7 1.0 0.9 6.4 31.6 0.8 1.0 0.9 0.0 0.9 1.0 0.8 0.8 1.0 1.0 1.0 12.4 7.7 0.8 0.8 1.0 1.1 4.5 11.3 0.9 0.9 0.9 1.3 1.1 2.0 0.9 0.9 0.0 1.2 0.8 1.1 1.2 1.0 1.3 2.1 1.1 0.8 2.5 1.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.5 3.0 12.8 9.3 0.9 0.6 1.3 3.8 2.2 6.5 5.5 2.1 0.3 5.8 2.6 2.9 2.6 2.3 15.7 2.1 2.9 5.5 3.0 1.9 1.4 0.8 0.3 1.4 1.6 0.7 0.0 3.8 1.2 0.8 1.2 4.4 4.3 0.3 6.1 4.9 3.1 0.3 2.3 1.0 3.5 5.8 6.5 1.2 0.6 1.1 18.5 6.4 4.2 0.4 0.8 1.6 1.9 0.3 1.4 9.4 3.0 2.2 3.4 2.3 7.7 7.7 4.9 2.0 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.8 15.7 6.4 19.6 12.4 7.7 4.5 11.3 2.0 1.2 0.0 0.0 0.0 0.0 2.1 18.4 1.1 0.0 1.4 0.0 0.0 7.9 0.1 0.0 0.0 23.8 0.3 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 0.2 42.9 0.0 0.0 0.0 17.6 0.6 0.0 0.0 0.0 0.0 2.6 0.1 0.0 2.5 0.0 2.9 0.0 1.3 4.9 6.8 1.0 0.1 0.0 0.0 0.0 DPH3 "DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2" ENSG00000154813 "Diphthamide biosynthesis 3" Q96FX2 3 16257978-16264972 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035287 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035287: AB_10604113" "unprognostic (2.49e-2)" "unprognostic (8.80e-2)" "unprognostic (2.84e-2)" "unprognostic (3.30e-2)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (2.83e-1)" "unprognostic (5.06e-2)" "unprognostic (5.83e-2)" "unprognostic (4.13e-1)" "unprognostic (5.90e-3)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (1.19e-2)" "unprognostic (6.44e-2)" 17.6 13.9 15.7 10.6 14.8 8.0 21.3 10.7 15.0 12.6 15.3 8.9 8.2 12.4 13.2 13.0 12.6 11.5 12.1 15.4 14.2 17.3 17.9 27.4 12.5 10.0 19.3 6.9 15.8 9.1 7.6 19.3 17.3 18.6 11.0 10.4 5.6 7.2 13.6 33.2 5.4 32.8 17.3 17.4 15.3 12.0 13.2 12.6 12.8 14.4 10.1 9.0 15.3 12.8 7.3 11.3 25.6 15.6 7.2 10.6 8.7 5.3 7.9 16.9 10.4 31.3 22.9 13.5 15.6 12.5 14.7 17.2 9.7 3.3 5.1 5.2 19.1 12.8 3.3 15.5 9.9 17.7 25.7 10.6 8.5 6.3 10.8 19.7 12.6 8.5 15.8 13.2 20.0 8.7 9.4 13.4 9.3 14.6 8.8 20.8 7.0 9.4 8.2 13.6 8.4 8.2 6.7 11.1 7.9 13.1 4.3 3.7 10.8 7.2 3.6 17.7 14.6 6.9 12.4 15.6 12.7 7.9 22.3 12.9 6.9 22.8 6.8 18.2 14.2 10.9 15.3 12.0 17.8 8.6 15.6 10.6 7.3 9.2 10.4 11.3 6.6 7.8 9.1 25.6 7.2 14.4 4.5 8.1 8.7 15.7 14.8 10.7 15.0 14.2 17.3 19.3 6.9 18.6 12.6 17.9 19.0 32.8 34.6 45.8 11.4 33.0 25.5 25.4 27.3 15.7 11.8 40.7 34.9 45.9 86.0 30.1 55.8 23.3 49.9 63.0 35.9 36.4 50.8 35.8 86.6 6.4 17.1 26.4 41.7 53.8 19.0 47.4 27.0 82.0 20.7 14.9 53.2 34.5 14.9 37.6 13.9 12.9 28.0 54.9 41.1 45.8 67.6 32.4 15.6 45.1 DPP3 ENSG00000254986 "Dipeptidyl peptidase 3" Q9NY33 11 66480013-66509657 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035780, HPA035781" Approved Supported Cytosol NA NA 2600000 Cytosol "HPA035780: AB_2674778, HPA035781: AB_10669529" "unprognostic (5.74e-2)" "unprognostic (1.16e-3)" "unprognostic (2.62e-3)" "unprognostic (4.77e-2)" "unprognostic (1.99e-1)" "unprognostic (5.44e-3)" "unprognostic (1.67e-3)" "unprognostic (1.25e-3)" "unprognostic (1.73e-2)" "unprognostic (9.87e-2)" "unprognostic (1.02e-2)" "unprognostic (3.87e-1)" "unprognostic (5.85e-2)" "prognostic favorable (1.34e-4)" "unprognostic (1.81e-2)" "unprognostic (3.43e-1)" "unprognostic (5.66e-2)" 10.4 13.0 5.2 16.8 12.1 10.9 16.9 13.7 11.5 7.3 18.5 9.1 10.3 15.3 10.5 6.8 15.6 7.1 15.7 8.4 9.3 5.9 18.4 31.1 9.8 20.0 9.5 10.6 5.1 11.6 11.2 6.9 10.9 7.4 10.3 16.9 5.7 17.6 8.5 15.8 9.4 15.5 10.0 10.6 12.5 11.8 15.5 6.7 16.1 10.5 10.8 14.0 11.4 8.6 7.5 19.7 12.2 24.4 18.2 17.9 9.9 28.7 25.1 11.6 12.9 9.7 10.5 18.1 16.3 22.0 22.1 14.8 31.5 24.2 16.8 55.7 18.4 18.9 26.0 18.5 20.0 14.3 31.8 8.4 21.8 11.7 18.5 15.0 26.4 36.4 14.8 19.6 16.6 8.2 9.6 16.9 17.7 15.2 10.0 20.1 32.7 30.7 26.9 19.7 28.3 15.3 21.7 11.7 27.5 19.0 24.8 22.0 18.9 13.9 16.3 21.8 11.4 25.2 15.4 17.5 13.3 14.4 14.5 15.9 8.4 15.2 19.1 17.6 12.6 16.2 9.6 11.3 12.2 13.7 24.4 8.4 7.5 10.3 11.4 19.7 7.2 6.3 9.2 2.0 18.2 16.0 13.7 17.9 9.9 5.2 12.1 13.7 11.5 9.3 5.9 9.5 10.6 7.4 6.7 14.9 10.4 20.5 13.8 5.4 10.0 2.8 15.3 9.4 4.5 22.7 9.8 41.2 11.6 43.1 21.0 5.5 31.6 0.0 53.9 28.6 7.1 11.6 1.1 12.4 33.3 6.4 17.9 4.3 7.9 5.3 2.0 12.8 15.1 46.9 17.1 16.1 36.9 21.5 4.9 22.4 61.1 12.9 4.6 7.5 22.2 5.3 30.1 14.9 23.0 17.3 DPP8 "DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141" ENSG00000074603 "Dipeptidyl peptidase 8" Q6V1X1 15 65442463-65517704 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008706 Approved Supported Cytosol NA NA Cytosol "HPA008706: AB_1078665" "unprognostic (3.65e-1)" "unprognostic (2.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-2)" "unprognostic (2.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.52e-2)" "unprognostic (1.81e-1)" "unprognostic (4.09e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (7.58e-2)" "unprognostic (8.56e-2)" "unprognostic (2.59e-1)" 15.6 16.1 16.4 14.9 18.8 16.2 13.9 22.9 24.9 15.5 14.5 15.0 12.7 18.0 15.9 13.9 13.1 11.1 12.4 18.8 15.1 14.6 16.0 9.9 13.3 16.0 15.4 11.8 16.2 11.7 22.2 14.5 15.9 21.7 13.5 15.8 13.9 15.6 20.8 30.5 14.2 16.5 16.2 17.5 17.2 13.2 29.9 15.8 22.5 17.4 12.5 16.0 16.2 13.2 10.7 8.1 20.0 10.8 6.1 10.3 5.3 9.6 15.6 10.3 10.3 11.6 16.6 8.8 15.5 18.4 13.9 13.4 6.7 8.3 17.0 12.2 19.4 9.5 17.9 19.8 11.2 17.1 14.3 12.3 16.3 12.0 6.4 12.1 21.0 16.1 12.4 10.7 11.3 10.7 11.7 15.2 13.2 11.1 15.8 17.1 7.8 11.2 7.7 7.0 9.8 8.0 14.9 19.0 16.5 11.4 21.0 7.3 12.9 10.1 10.2 15.6 10.6 9.4 12.6 19.2 18.7 13.0 8.8 16.5 20.5 26.8 17.2 14.1 21.2 13.4 20.0 9.1 11.1 9.9 9.2 10.3 9.2 8.6 9.5 8.1 10.7 8.6 9.2 18.3 6.1 10.8 7.5 8.9 5.3 16.4 18.8 22.9 24.4 15.1 14.6 15.4 11.8 21.7 15.8 32.8 24.7 23.1 12.5 11.8 24.3 36.8 25.5 22.7 27.3 14.0 35.3 16.6 19.9 19.2 44.1 27.4 20.3 0.0 26.0 12.3 17.3 17.3 25.6 14.7 18.7 27.0 24.9 43.0 34.3 48.6 27.0 25.3 21.9 30.7 28.3 29.5 29.2 21.0 27.6 24.1 27.0 19.4 17.5 62.7 22.3 17.7 14.8 26.2 24.3 20.9 DPP9 ENSG00000142002 "Dipeptidyl peptidase 9" Q86TI2 19 4675224-4724673 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 64.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036059 Approved Supported Cytosol NA NA Cytosol "HPA036059: AB_10671240" "prognostic favorable (4.96e-4)" "unprognostic (4.16e-2)" "unprognostic (2.03e-1)" "prognostic favorable (6.21e-5)" "unprognostic (5.67e-2)" "unprognostic (8.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.23e-1)" "unprognostic (8.85e-2)" "unprognostic (6.38e-2)" "unprognostic (1.93e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (3.38e-8)" "prognostic favorable (7.72e-5)" "unprognostic (1.55e-1)" "unprognostic (4.22e-1)" "unprognostic (1.80e-1)" 18.1 11.9 11.7 24.3 14.0 25.8 13.7 13.0 12.5 12.6 16.3 14.2 15.8 18.3 15.3 10.5 17.4 11.6 13.5 19.7 11.0 7.2 13.5 38.6 19.3 20.7 14.7 7.1 13.5 15.5 9.5 9.8 15.2 11.7 14.0 13.1 14.2 13.1 12.9 46.4 21.5 18.9 14.2 9.3 21.0 14.7 7.1 13.9 24.3 14.6 16.3 17.0 16.0 21.7 10.3 9.0 10.0 10.5 13.4 13.8 8.0 23.8 19.0 5.6 8.8 8.6 12.1 10.2 14.0 18.7 23.6 15.4 17.1 18.5 11.3 10.6 18.1 15.9 16.3 11.4 64.4 14.5 14.5 11.1 8.3 10.4 14.6 13.2 14.4 18.0 9.2 15.0 36.9 21.9 20.2 21.3 7.9 11.3 25.3 20.4 6.5 16.7 9.3 11.5 9.4 28.3 10.5 12.0 13.2 12.3 16.4 8.0 7.2 12.0 21.9 9.2 6.1 6.0 12.0 17.1 21.2 9.2 32.8 27.9 17.6 18.3 11.3 20.7 16.7 17.7 10.0 8.8 9.4 13.8 10.5 10.5 10.3 6.4 11.2 9.0 6.8 6.3 9.9 4.7 13.4 7.8 4.3 11.3 8.0 11.7 14.0 13.0 12.5 11.0 7.2 14.7 7.1 11.7 13.9 26.8 29.1 13.7 11.9 7.0 17.1 12.0 10.2 10.7 11.4 3.5 35.3 10.0 3.3 10.7 1.5 13.5 25.1 0.0 10.9 15.2 7.6 11.0 16.2 35.9 17.2 22.3 12.0 16.5 14.6 2.5 9.2 20.7 5.0 59.5 15.3 8.4 19.7 21.0 8.9 4.5 30.0 19.4 8.1 7.6 6.9 4.8 13.0 18.7 13.7 11.9 DPPA4 FLJ10713 ENSG00000121570 "Developmental pluripotency associated 4" Q7L190 3 109326141-109337572 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.3;lymphoid tissue: 35.8" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 18.3;Extravillous trophoblasts: 16.9;Syncytiotrophoblasts: 5.1" "Cancer enriched" "Detected in single" 218 "testis cancer: 59.0" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 10.3" "Lineage enriched" "Detected in single" 11 "dendritic cells: 10.3" "Group enriched" "Detected in some" 4 "HAP1: 22.5;NTERA-2: 83.0;SuSa: 32.3" "CAB020678, HPA035249, HPA035250" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Cytosol" "CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536" "unprognostic (2.07e-2)" "unprognostic (2.53e-2)" "unprognostic (3.80e-1)" "unprognostic (2.53e-1)" "unprognostic (8.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.52e-1)" "unprognostic (9.83e-2)" "unprognostic (2.02e-2)" "unprognostic (6.60e-2)" "unprognostic (2.48e-2)" "unprognostic (3.03e-8)" "unprognostic (5.28e-2)" "unprognostic (5.04e-2)" "unprognostic (5.56e-2)" "unprognostic (3.85e-2)" 0.1 0.1 0.2 0.3 1.0 8.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.6 0.1 0.2 1.3 0.6 0.8 0.3 0.0 0.0 0.0 0.0 2.2 4.2 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 8.1 0.0 35.8 0.1 0.0 1.0 0.4 0.1 0.9 10.3 0.0 0.0 0.7 0.2 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.2 0.0 0.7 0.0 10.3 0.0 0.1 0.2 1.0 0.1 0.3 0.6 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.3 0.2 1.1 1.0 1.4 0.0 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 2.1 0.0 5.1 0.7 0.0 0.3 DPYSL2 "CRMP2, DHPRP2, DRP-2, DRP2" ENSG00000092964 "Dihydropyrimidinase like 2" Q16555 8 26514022-26658178 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 137.0" "Cell type enhanced" "Detected in many" 5 "Ito cells: 240.0" "Cancer enhanced" "Detected in all" "glioma: 89.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1" "Group enriched" "Detected in many" 6 "dendritic cells: 25.5;monocytes: 26.7" "Cell line enhanced" "Detected in many" "ASC diff: 61.4;Karpas-707: 63.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002381, CAB018719" Supported Supported "Plasma membrane,Cytosol" NA NA 3900000 Cytosol "Plasma membrane" "CAB018719: AB_2085366, HPA002381: AB_1847244" "unprognostic (2.88e-2)" "unprognostic (1.01e-2)" "unprognostic (9.51e-2)" "unprognostic (3.16e-3)" "unprognostic (8.23e-2)" "unprognostic (1.68e-2)" "unprognostic (1.51e-1)" "unprognostic (9.95e-3)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (1.79e-2)" "unprognostic (4.13e-2)" "unprognostic (5.58e-2)" "unprognostic (9.32e-3)" "unprognostic (1.23e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (5.41e-5)" 31.6 21.7 53.5 13.4 48.1 3.0 21.3 51.8 137.0 14.6 12.2 54.7 3.9 7.1 14.2 8.1 12.0 14.7 18.0 27.2 52.9 48.6 12.1 11.2 45.3 9.9 56.5 45.4 25.8 7.5 5.1 7.2 25.6 46.9 9.8 12.4 8.2 6.5 10.3 10.9 10.2 9.7 19.9 70.1 19.0 8.5 7.5 44.9 5.8 7.7 5.2 12.3 14.0 13.1 3.2 25.5 0.6 26.7 4.0 4.6 8.8 4.7 23.1 22.8 12.1 61.4 28.3 2.2 9.3 21.8 8.9 11.6 9.0 6.9 7.1 6.8 29.2 18.0 4.6 23.9 9.3 8.5 16.1 2.0 8.1 8.8 12.6 39.4 1.7 3.3 35.1 13.5 24.4 14.2 28.8 17.9 5.6 0.2 63.2 8.9 3.0 13.7 1.7 17.8 15.3 4.5 18.3 9.1 4.7 15.0 5.5 10.4 21.9 11.3 0.1 6.1 15.7 1.7 3.2 32.2 20.3 8.2 16.8 4.0 8.9 9.1 5.6 29.4 10.6 10.3 0.4 24.0 0.2 3.5 26.7 1.2 3.2 3.1 2.3 25.5 1.7 1.6 2.1 0.6 4.0 16.2 15.1 4.6 8.8 53.5 48.1 51.8 68.4 52.9 48.6 56.5 45.4 46.9 44.9 122.1 67.9 17.3 0.8 35.8 104.6 86.8 104.4 17.4 31.8 21.0 29.5 12.9 3.3 17.3 2.6 134.9 3.1 0.0 1.6 9.2 59.6 1.1 19.7 13.4 46.2 133.5 58.3 240.0 207.1 6.4 100.9 92.1 114.7 101.8 73.9 141.1 9.7 3.6 84.1 17.3 36.8 135.8 60.8 3.1 8.5 29.5 3.8 8.7 6.6 1.1 DPYSL3 "CRMP4, DRP-3, ULIP" ENSG00000113657 "Dihydropyrimidinase like 3" Q14195 5 147390811-147510056 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 91.4" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 312.2;Peritubular cells: 193.4;Rod photoreceptor cells: 109.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 119.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010948 Approved Approved Cytosol NA NA 170000 Cytosol "HPA010948: AB_1847245" "unprognostic (3.92e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-3)" "unprognostic (1.39e-1)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (5.99e-2)" "unprognostic (6.92e-2)" "unprognostic (4.72e-2)" "unprognostic (2.08e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.87e-9)" "unprognostic (1.14e-2)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.23e-4)" 21.7 7.2 22.9 18.9 20.4 0.5 14.1 6.7 31.0 26.8 39.7 20.9 31.4 6.8 38.8 28.0 28.8 20.1 33.9 18.5 23.7 24.7 2.5 1.8 16.2 6.1 16.7 15.2 33.0 2.2 1.0 4.2 7.1 27.0 40.0 14.3 32.3 7.1 61.4 22.1 7.3 12.9 91.4 24.7 9.1 15.0 12.1 15.9 0.3 7.2 15.5 9.6 45.6 18.9 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 6.1 11.0 0.0 0.4 11.3 0.2 5.8 27.8 12.4 16.5 19.1 0.5 0.0 1.6 16.8 6.5 0.6 2.2 0.2 13.8 2.6 5.0 0.0 5.3 0.0 11.2 0.0 0.0 2.1 0.1 26.6 10.5 31.2 35.3 0.0 0.0 0.2 7.0 0.0 0.0 0.1 23.4 0.0 9.1 0.0 23.4 0.0 10.9 2.4 8.2 119.4 0.0 0.0 1.9 15.9 0.1 0.1 15.4 9.0 6.8 22.0 21.3 19.8 3.5 0.0 8.3 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 22.9 20.4 6.7 12.5 23.7 24.7 16.7 15.2 27.0 15.9 0.0 3.2 0.0 2.8 8.4 12.5 5.2 2.5 4.0 5.7 0.0 312.2 0.1 0.0 3.6 14.1 50.5 0.0 0.0 7.4 0.2 38.0 9.9 1.1 0.2 1.5 4.8 6.3 29.4 0.6 13.2 39.7 1.1 18.6 0.0 0.0 22.9 10.7 0.0 193.4 0.0 109.3 0.0 35.1 1.4 2.6 7.2 0.3 0.0 0.0 3.4 DPYSL5 "CRAM, CRMP-5, CRMP5, Ulip6" ENSG00000157851 "Dihydropyrimidinase like 5" Q9BPU6 2 26847747-26950351 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.1" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 80.5;Early spermatids: 30.8;Late spermatids: 97.8" "Group enriched" "Detected in some" 15 "glioma: 17.7;testis cancer: 8.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 41.9;HAP1: 34.9;SCLC-21H: 50.0;SH-SY5Y: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034544, HPA072387" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034544: AB_10671228, HPA072387: AB_2686516" "unprognostic (1.07e-4)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (3.64e-6)" "unprognostic (3.94e-1)" "unprognostic (6.21e-2)" "unprognostic (6.12e-2)" "unprognostic (2.66e-1)" "unprognostic (1.54e-1)" "unprognostic (3.54e-2)" "unprognostic (1.35e-1)" "unprognostic (1.77e-2)" "unprognostic (5.67e-3)" "unprognostic (3.62e-2)" "unprognostic (1.08e-1)" "unprognostic (2.43e-1)" 1.2 4.7 6.1 1.6 18.4 1.1 1.1 7.8 36.6 1.4 1.6 43.5 0.0 1.7 1.2 1.1 1.3 1.2 1.1 1.1 10.3 11.3 1.2 1.1 1.1 1.1 24.3 8.8 1.1 1.1 1.1 2.8 1.2 21.9 1.3 1.5 1.6 1.1 1.1 1.2 1.2 1.7 1.6 47.1 1.1 1.1 10.3 19.7 0.0 1.1 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 41.9 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 1.1 0.0 34.9 0.0 0.0 0.0 7.6 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.0 29.6 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 18.4 7.8 11.8 10.3 11.3 24.3 8.8 21.9 19.7 0.0 0.0 0.0 0.3 0.0 9.2 5.3 0.0 0.0 0.0 0.0 80.5 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.3 0.0 0.1 7.9 0.0 0.0 0.0 97.8 1.4 0.2 1.7 0.0 0.0 15.6 0.0 0.0 1.1 0.0 12.4 0.0 0.0 3.2 2.3 0.3 0.0 0.0 0.0 0.1 DQX1 FLJ23757 ENSG00000144045 "DEAQ-box RNA dependent ATPase 1" Q8TE96 2 74518131-74526336 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 41.0" "Cell type enhanced" "Detected in some" 15 "Enterocytes: 21.9;Mucus-secreting cells: 12.7;Paneth cells: 11.8;Undifferentiated cells: 10.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HBEC3-KT: 5.9;Hep G2: 16.6;hTCEpi: 6.1;OE19: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039158 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039158: AB_10960125" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (9.95e-2)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-1)" "unprognostic (4.54e-2)" "unprognostic (1.68e-1)" "unprognostic (7.67e-2)" "unprognostic (2.21e-2)" "unprognostic (0.00e+0)" "unprognostic (1.13e-2)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.16e-3)" 0.1 0.0 0.1 2.1 0.2 0.0 0.1 0.1 0.1 0.8 13.3 0.2 0.1 14.7 0.1 0.1 3.7 0.2 3.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.2 5.1 0.1 0.6 0.1 0.1 1.5 41.0 0.3 0.1 0.2 2.9 0.1 0.1 0.2 0.1 0.7 1.5 1.1 1.4 0.7 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.6 0.1 5.9 0.0 0.0 0.3 0.4 0.1 16.6 0.0 0.2 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.3 14.1 0.0 0.1 0.1 0.1 0.0 1.1 0.0 0.1 0.0 2.3 0.0 1.1 0.6 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 5.3 1.2 0.0 2.0 1.2 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.5 0.1 11.8 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.9 0.0 10.6 0.2 DRAP1 NC2-alpha ENSG00000175550 "DR1 associated protein 1" Q14919 11 65919257-65921561 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 722.4;Suprabasal keratinocytes: 887.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006790 Uncertain Approved Cytosol NA NA Cytosol "HPA006790: AB_1078702" "unprognostic (1.69e-2)" "unprognostic (1.02e-2)" "unprognostic (1.01e-1)" "unprognostic (3.01e-2)" "unprognostic (1.84e-2)" "unprognostic (4.06e-2)" "unprognostic (4.89e-3)" "unprognostic (5.58e-2)" "unprognostic (8.47e-2)" "unprognostic (4.23e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.96e-5)" "unprognostic (1.62e-1)" 39.1 41.0 45.9 39.7 43.2 41.8 22.4 43.1 53.5 22.0 27.2 28.4 17.1 30.2 27.2 19.4 32.3 20.2 27.2 41.0 40.5 36.6 23.9 27.7 24.7 34.0 37.1 40.6 24.3 39.1 21.6 25.2 24.6 33.3 25.9 12.7 18.9 27.7 28.4 84.4 31.2 26.6 28.4 32.7 38.5 25.1 46.9 30.8 40.2 40.3 42.0 25.8 25.2 23.8 21.6 30.9 45.7 84.6 31.2 24.6 16.7 59.3 23.1 13.1 25.6 12.9 25.3 7.8 69.1 34.6 43.4 28.6 8.5 34.5 15.3 31.4 53.1 51.3 25.5 5.1 34.3 18.9 22.2 7.6 18.6 9.4 8.2 23.1 15.4 25.2 15.7 14.2 46.6 31.6 25.9 16.2 16.1 7.9 29.2 47.6 29.7 27.8 26.8 19.1 9.1 63.2 25.1 11.2 32.9 14.0 7.5 14.2 15.5 16.4 17.7 35.3 6.8 22.2 12.9 46.9 56.3 51.9 108.4 63.7 24.0 20.1 15.9 55.5 9.9 77.5 21.5 20.6 45.7 23.5 50.3 21.5 21.6 21.5 24.6 30.9 19.8 21.3 22.9 27.3 31.2 84.6 22.6 24.4 16.7 45.9 43.2 43.1 51.1 40.5 36.6 37.1 40.6 33.3 30.8 6.0 32.8 129.7 134.1 722.4 51.3 29.0 56.0 14.7 29.6 123.9 33.4 120.9 240.4 172.6 96.4 114.7 101.6 140.2 148.1 133.9 210.1 153.2 236.3 90.4 270.5 60.4 145.8 80.4 126.4 50.8 166.0 269.4 234.5 261.5 87.1 51.3 208.3 108.7 162.6 190.4 38.5 90.5 180.3 150.9 179.1 887.9 145.9 174.4 99.6 356.0 DRD1 ENSG00000184845 "Dopamine receptor D1" P21728 5 175440039-175444208 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 34.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 40.8;Horizontal cells: 31.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 24.2" "Region enriched" "Detected in many" 9 "basal ganglia: 147.4" "Region enriched" "Detected in many" 13 "basal ganglia: 95.6" "HPA013393, HPA017304" Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA013393: AB_1847833, HPA017304: " "unprognostic (2.74e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-3)" "unprognostic (1.28e-1)" "unprognostic (1.15e-6)" "unprognostic (6.69e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (8.60e-4)" "unprognostic (5.86e-2)" "unprognostic (5.43e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" 0.7 1.5 1.9 0.2 34.5 0.0 0.1 0.1 12.0 0.7 0.7 0.4 0.0 0.5 0.4 0.7 0.7 0.6 1.1 0.3 1.0 0.6 0.7 2.6 1.8 0.1 0.5 1.6 0.3 0.0 0.0 0.1 2.5 0.3 2.7 0.9 2.1 0.1 1.2 0.1 0.1 0.3 0.4 0.1 0.4 0.4 0.1 6.8 0.1 0.1 0.0 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 24.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 34.5 0.1 5.3 1.0 0.6 0.5 1.6 0.3 6.8 0.0 0.0 0.0 0.0 0.1 40.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 31.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRG1 NEDD3 ENSG00000185721 "Developmentally regulated GTP binding protein 1" Q9Y295 22 31399523-31530634 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 86.8" "Group enriched" "Detected in all" 4 "Early spermatids: 642.5;Late spermatids: 488.7;Spermatocytes: 203.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001218 Enhanced Supported "Nuclear bodies,Cytosol" No No "Nuclear bodies, Cytosol" "HPA001218: AB_1078704" "unprognostic (4.94e-1)" "unprognostic (3.33e-2)" "unprognostic (1.17e-3)" "unprognostic (5.26e-2)" "unprognostic (4.66e-2)" "unprognostic (3.49e-3)" "prognostic unfavorable (7.71e-4)" "unprognostic (3.68e-2)" "unprognostic (1.54e-1)" "unprognostic (2.32e-3)" "unprognostic (8.69e-3)" "unprognostic (1.55e-3)" "unprognostic (4.80e-2)" "unprognostic (1.35e-1)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (2.25e-1)" 14.5 18.1 12.3 10.6 18.1 11.9 15.3 14.1 20.9 12.7 10.5 13.3 11.7 9.3 13.6 17.6 13.4 14.7 8.4 18.5 11.2 12.7 15.3 15.7 9.4 11.1 12.6 14.9 15.7 16.4 14.2 11.9 19.6 17.2 13.5 13.3 14.3 17.0 13.3 47.0 11.9 10.1 14.9 10.9 11.7 12.4 86.8 9.9 23.6 17.8 12.1 15.7 15.0 10.5 29.4 25.2 25.1 27.1 25.0 27.6 24.8 22.3 18.5 22.9 18.9 20.6 24.3 18.3 20.9 25.5 39.5 33.2 30.1 11.5 32.9 11.4 26.3 18.8 19.1 39.4 25.5 43.1 15.3 47.9 21.2 21.2 30.4 29.6 51.0 20.0 20.7 19.0 32.0 48.5 20.2 27.3 18.6 27.3 14.2 30.2 26.2 20.3 26.1 18.2 34.3 20.6 28.1 36.5 28.8 25.8 20.5 24.5 15.3 23.5 23.5 29.9 22.9 17.6 22.6 15.2 17.8 23.6 17.8 23.5 19.3 21.7 31.7 17.3 22.5 22.8 13.7 23.9 25.1 20.5 27.1 23.8 29.4 22.1 25.2 25.2 21.7 24.7 23.9 5.4 25.0 19.9 22.1 27.6 24.8 12.3 18.1 14.1 20.9 11.2 12.7 12.6 14.9 17.2 9.9 17.9 12.5 30.5 35.8 34.3 19.4 44.6 22.9 17.4 14.8 26.2 23.6 110.4 54.7 49.0 642.5 35.9 23.9 23.3 39.8 84.2 28.3 31.7 33.4 30.9 52.4 14.3 10.9 31.9 29.8 488.7 33.1 24.0 16.9 36.9 29.8 16.4 39.9 28.1 35.0 47.3 15.4 58.2 31.1 203.2 83.0 28.1 97.9 27.4 38.4 40.9 DRG2 ENSG00000108591 "Developmentally regulated GTP binding protein 2" P55039 17 18087886-18107971 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007716 Approved Supported Nucleoplasm,Vesicles,Cytosol No No "Vesicles, Cytosol" Nucleoplasm "HPA007716: AB_1078705" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "prognostic favorable (1.56e-4)" "unprognostic (1.26e-3)" "unprognostic (7.86e-2)" "unprognostic (8.85e-2)" "unprognostic (5.72e-2)" "unprognostic (8.49e-2)" "unprognostic (1.25e-1)" "unprognostic (2.88e-3)" "prognostic unfavorable (7.34e-4)" "unprognostic (3.10e-1)" "unprognostic (2.18e-1)" "unprognostic (1.49e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" 19.9 19.9 16.1 17.5 21.8 17.4 19.3 14.7 30.8 19.3 19.3 22.9 16.6 19.2 23.5 22.8 21.6 25.2 18.2 22.4 15.7 17.0 19.1 31.9 15.7 21.2 17.6 16.1 27.6 23.9 20.6 18.8 22.4 17.9 21.1 13.4 18.4 21.7 21.7 33.3 19.4 17.9 18.3 17.1 20.7 17.6 14.6 17.2 21.6 23.6 21.2 25.6 20.5 18.0 12.6 18.4 17.0 20.9 20.0 19.8 14.0 14.9 21.4 7.3 7.2 13.6 14.5 13.9 10.6 10.5 17.2 16.0 22.7 9.0 14.5 13.8 12.2 9.2 15.9 12.0 14.6 11.6 12.8 32.9 6.3 11.4 12.6 14.8 5.8 10.1 16.1 13.0 17.2 14.5 10.0 16.3 19.5 11.1 5.7 10.0 16.9 15.4 9.7 5.4 21.2 15.8 16.6 17.7 26.9 10.2 8.8 4.1 11.8 10.5 6.2 12.9 45.9 12.4 8.8 12.2 8.3 7.9 9.7 17.4 6.5 7.9 8.1 12.0 10.6 15.2 11.6 15.9 17.0 19.8 17.2 16.4 12.2 14.7 15.8 18.4 12.6 14.0 15.3 2.1 20.0 20.9 10.3 18.3 14.0 16.1 21.8 14.7 30.8 15.7 17.0 17.6 16.1 17.9 17.2 0.0 7.7 15.6 18.9 14.8 10.8 3.2 15.3 4.0 6.8 7.0 2.0 32.2 24.9 23.5 5.9 15.7 22.3 0.0 23.6 33.6 16.4 17.5 11.5 14.5 28.1 6.4 20.7 15.4 16.4 10.0 19.8 15.6 11.8 24.4 16.3 18.8 21.1 14.0 23.0 22.6 13.8 6.5 19.6 11.2 10.4 10.2 32.8 24.2 20.9 12.6 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364181-49396016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "adrenal gland: 13.9;brain: 8.0" "Cell type enriched" "Detected in single" 4 "Melanocytes: 1.7" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 8.2;SH-SY5Y: 37.4;U-2197: 13.5" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low region specificity" "Detected in all" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.2 13.9 0.0 0.4 0.2 0.3 0.1 0.4 3.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.1 2.0 0.6 0.0 0.0 0.0 0.9 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.3 0.2 0.3 2.0 0.6 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DROSHA "Etohi2, HSA242976, RN3, RNASE3L, RNASEN" ENSG00000113360 "Drosha ribonuclease III" Q9NRR4 5 31400497-31532196 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, RNA-mediated gene silencing" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031150 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031150: AB_2673761" "unprognostic (8.37e-3)" "unprognostic (1.81e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.40e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (3.11e-1)" "unprognostic (4.08e-2)" "unprognostic (9.08e-2)" "unprognostic (1.86e-1)" "unprognostic (5.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (6.94e-2)" "unprognostic (2.32e-2)" 15.7 16.8 18.4 17.7 32.1 12.2 16.1 33.7 33.7 17.4 16.3 19.1 12.2 15.9 22.3 25.8 16.0 18.2 14.1 15.2 16.6 15.1 15.3 11.7 13.9 17.8 13.6 16.4 26.7 17.8 23.9 38.9 17.0 18.9 17.2 19.2 23.7 17.5 19.2 23.6 16.0 17.5 16.9 19.4 16.8 16.0 12.8 16.4 25.6 21.9 13.4 19.8 18.2 16.2 4.7 6.4 3.3 4.8 4.8 6.4 3.1 12.4 15.7 17.4 23.6 9.3 11.4 25.1 16.5 8.1 15.4 11.5 16.5 16.2 14.0 19.0 12.1 17.9 10.9 21.4 12.5 17.2 13.1 15.1 17.2 51.6 11.9 8.4 19.2 51.4 8.9 8.8 17.2 8.3 11.8 13.1 15.0 21.8 6.6 13.4 12.4 18.5 14.4 16.4 10.1 12.6 16.8 33.3 10.1 8.7 14.2 9.1 12.0 41.9 17.2 10.1 16.2 15.8 11.1 11.4 14.9 17.3 13.3 15.6 12.1 19.8 15.4 10.3 21.7 14.2 1.8 2.4 3.3 5.2 2.6 5.5 4.2 5.4 6.0 5.2 4.7 6.4 4.4 0.8 4.8 4.8 6.4 5.1 3.1 18.4 32.1 33.7 33.7 16.6 15.1 13.6 16.4 18.9 16.4 11.9 14.7 3.0 4.6 3.2 18.2 21.0 7.6 20.1 15.9 5.2 0.0 6.6 3.3 7.2 2.5 6.2 7.3 0.0 7.0 6.4 7.4 5.0 9.2 5.1 6.7 6.4 10.9 9.2 7.8 4.3 10.0 3.2 1.7 9.0 10.1 10.5 7.8 8.6 12.4 4.2 16.8 6.5 4.7 5.8 8.4 3.0 4.1 5.7 10.0 5.1 DSE "DS-Epi1, DSEPI, SART2" ENSG00000111817 "Dermatan sulfate epimerase" Q9UL01 6 116254173-116444860 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 85.3;Macrophages: 81.1;monocytes: 97.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 8.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014764, HPA052151" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA014764: AB_1856587, HPA052151: AB_2681746" "unprognostic (1.28e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (1.38e-1)" "unprognostic (3.23e-3)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.02e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (6.34e-4)" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.19e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "unprognostic (1.10e-2)" 32.3 10.6 7.4 22.3 10.7 13.1 34.8 5.4 7.7 16.0 12.8 4.9 9.9 5.3 11.7 18.5 13.5 15.3 12.9 16.1 8.1 4.3 11.2 10.4 17.7 13.1 9.8 4.5 21.0 4.0 15.4 20.9 21.7 13.1 13.0 7.1 14.3 9.3 9.4 8.5 16.9 10.7 12.8 16.1 24.9 7.6 10.9 9.0 8.3 8.7 10.9 8.3 14.6 29.4 3.6 8.9 2.5 3.9 0.2 1.1 1.2 10.5 2.3 7.9 7.4 21.5 14.2 9.0 12.5 29.4 15.7 23.1 0.0 3.0 0.3 1.1 21.8 15.8 20.3 1.1 29.4 20.6 10.9 4.8 0.7 3.4 0.1 24.0 0.5 0.5 30.1 12.7 17.4 17.1 8.2 9.2 2.7 0.2 4.8 7.5 0.3 1.4 0.6 4.2 0.0 0.6 1.8 7.3 5.0 10.4 0.7 2.6 2.0 12.1 0.0 0.3 5.7 0.1 1.2 3.4 15.9 4.6 3.9 10.0 1.0 0.3 0.5 8.4 1.3 1.8 0.7 3.1 0.1 1.0 3.9 0.6 3.2 0.9 0.4 8.9 3.6 1.1 0.4 2.5 0.2 2.2 4.2 0.2 1.2 7.4 10.7 5.4 7.7 8.1 4.3 9.8 4.5 13.1 9.0 14.9 2.6 18.6 20.6 46.1 4.1 7.0 5.1 18.7 18.2 3.5 0.0 2.0 6.6 4.0 39.9 11.9 0.0 0.0 7.5 3.7 35.5 14.2 22.0 3.8 39.5 1.6 1.2 57.7 85.3 19.2 50.9 81.1 10.1 97.4 0.7 3.9 9.5 0.0 28.3 6.1 3.0 32.3 29.2 2.6 5.1 34.9 4.1 6.5 1.0 42.4 DSN1 "C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13" ENSG00000149636 "DSN1 homolog, MIS12 kinetochore complex component" Q9H410 20 36751791-36773818 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 90.5;Spermatogonia: 91.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002813, HPA030627" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol" Yes Yes Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol" "HPA002813: AB_1078343, HPA030627: AB_2732460" "unprognostic (3.60e-2)" "prognostic favorable (4.49e-4)" "unprognostic (5.22e-3)" "unprognostic (1.13e-3)" "unprognostic (2.00e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (4.16e-5)" "unprognostic (3.93e-1)" "unprognostic (9.35e-2)" "unprognostic (5.51e-2)" "unprognostic (2.98e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.92e-2)" "unprognostic (2.53e-1)" "unprognostic (2.58e-2)" "unprognostic (2.84e-1)" 6.7 10.4 5.6 15.6 7.4 11.6 8.2 5.4 7.2 5.1 8.6 4.1 9.5 6.3 9.5 12.0 9.1 5.0 8.1 6.2 5.1 4.7 5.8 8.6 6.1 11.0 4.8 3.9 5.3 5.4 3.6 7.6 12.9 5.1 6.5 10.3 10.1 9.7 8.1 4.6 7.3 8.8 5.9 4.1 11.6 7.0 27.2 4.1 21.2 6.3 11.4 13.8 5.8 5.5 10.9 25.4 21.7 5.9 5.6 6.5 3.7 13.0 11.8 13.9 11.1 5.5 7.2 9.2 16.0 13.6 24.6 27.7 20.5 17.0 15.1 10.7 8.7 27.2 17.2 13.0 12.6 23.5 6.6 8.3 29.4 11.3 13.7 1.2 16.8 13.0 2.7 3.6 17.0 5.4 4.0 12.0 16.4 11.4 12.5 16.1 9.3 21.5 13.0 6.5 23.6 20.9 16.9 42.4 10.0 6.2 7.8 14.3 6.5 19.9 20.5 9.7 10.8 20.9 11.3 6.2 22.5 13.7 22.0 17.2 10.5 14.1 17.1 18.9 15.2 16.0 21.7 3.6 7.5 4.4 5.9 4.9 8.8 4.8 5.8 3.9 10.9 5.9 5.5 6.5 5.6 5.0 25.4 6.5 3.7 5.6 7.4 5.4 7.2 5.1 4.7 4.8 3.9 5.1 4.1 6.0 4.1 9.3 10.2 4.4 8.0 4.1 2.5 10.7 10.3 5.2 27.5 42.7 6.6 5.2 6.3 5.8 6.4 0.0 5.6 29.3 7.5 7.5 3.5 4.5 12.6 6.4 2.4 9.8 3.7 5.8 8.1 6.1 1.7 8.2 9.0 4.8 4.7 5.7 7.1 2.9 15.8 0.0 7.2 90.5 91.3 6.4 39.7 6.4 10.5 10.8 DST "BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2" ENSG00000151914 Dystonin Q03001 6 56457987-56954628 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Basal glandular cells: 1024.4;Basal keratinocytes: 2104.0;Cone photoreceptor cells: 1319.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;monocytes: 1.7;NK-cells: 2.1" "Cell line enhanced" "Detected in many" "hTCEpi: 94.5;hTERT-HME1: 70.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030200 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules" Cytosol "HPA030200: AB_10601901" "unprognostic (4.87e-3)" "unprognostic (1.29e-1)" "unprognostic (3.40e-1)" "unprognostic (1.54e-1)" "unprognostic (1.25e-2)" "unprognostic (3.60e-2)" "unprognostic (5.78e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (2.75e-2)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.39e-2)" "unprognostic (5.13e-3)" "unprognostic (1.46e-1)" "unprognostic (2.66e-1)" "unprognostic (7.62e-2)" 26.5 29.2 43.4 11.7 57.1 2.5 59.2 43.6 52.4 53.8 31.5 32.1 11.5 15.1 53.6 21.7 37.1 19.4 16.8 28.1 41.2 36.2 18.0 26.6 29.4 5.4 56.5 28.9 30.3 14.0 32.1 28.2 15.1 53.9 22.6 17.4 8.4 23.6 25.3 57.5 81.8 16.9 53.6 54.9 12.8 14.8 11.7 66.5 6.1 7.6 33.6 7.7 19.7 23.7 0.6 5.3 0.3 1.7 2.1 0.4 0.3 12.2 5.9 7.9 4.4 13.1 20.7 4.5 16.5 15.8 6.8 7.6 3.4 3.2 1.9 6.8 37.2 6.8 8.6 6.7 29.0 13.5 11.6 9.9 3.4 10.6 6.2 11.8 3.3 0.0 9.1 94.5 16.6 70.1 11.9 12.9 1.9 2.8 8.1 17.7 3.4 1.0 1.3 6.0 6.8 4.3 0.0 6.1 2.8 20.6 15.8 10.5 7.9 7.0 2.4 11.2 14.1 3.7 5.3 34.5 15.1 12.7 7.2 13.6 9.1 6.4 1.0 10.7 1.8 7.2 0.3 1.7 0.0 0.3 1.3 0.1 0.2 0.4 0.0 3.2 0.6 0.1 0.2 0.1 2.1 1.0 5.3 0.0 0.3 43.4 57.1 43.6 52.4 41.2 36.2 56.5 28.9 53.9 66.5 312.7 10.2 2.2 1024.4 2104.0 540.0 729.3 79.0 49.5 257.0 52.4 1319.4 36.7 6.6 171.1 26.9 93.9 163.1 23.3 56.2 11.1 132.5 139.6 16.2 67.6 21.5 290.8 43.1 50.3 48.7 7.9 123.4 67.7 204.1 62.3 71.1 216.1 150.7 84.2 143.2 6.7 103.8 64.7 142.4 7.1 9.1 749.3 22.2 6.1 19.2 121.2 DSTYK "DustyPK, KIAA0472, RIP5, RIPK5" ENSG00000133059 "Dual serine/threonine and tyrosine protein kinase" Q6XUX3 1 205142505-205211566 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 84.2;Melanocytes: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044140 Approved Uncertain "Nuclear speckles,Intermediate filaments,Cytosol" NA NA "Nuclear speckles, Intermediate filaments" Cytosol "HPA044140: AB_10965031" "unprognostic (1.42e-2)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (1.02e-3)" "unprognostic (1.39e-1)" "unprognostic (2.66e-1)" "unprognostic (1.43e-2)" "unprognostic (9.01e-2)" "unprognostic (1.81e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (3.26e-2)" "unprognostic (7.80e-2)" "unprognostic (1.93e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (8.73e-5)" 6.4 9.2 13.8 4.4 13.3 19.6 8.2 20.4 16.4 8.4 6.5 6.8 4.2 3.3 10.5 7.4 6.7 9.2 5.4 5.7 10.7 9.0 9.3 2.5 7.3 5.4 8.1 11.8 14.0 5.9 22.0 11.0 7.1 12.2 7.2 4.6 9.2 6.2 8.8 14.6 14.0 4.8 8.8 11.0 7.0 5.3 11.5 9.2 7.1 8.4 3.6 5.3 7.6 6.4 3.5 3.1 9.8 3.5 4.8 5.1 1.6 6.9 4.5 4.9 5.9 7.1 12.0 3.4 8.7 8.7 9.1 6.2 2.0 3.8 5.1 2.6 14.6 5.0 4.9 5.3 5.6 9.3 2.4 5.7 9.3 6.0 2.2 6.4 2.6 5.0 7.0 8.5 9.3 8.9 10.9 6.6 3.7 12.0 3.5 7.2 4.7 2.0 2.3 5.2 1.3 5.4 1.8 8.8 4.5 6.1 4.4 2.7 5.3 7.4 7.7 24.3 5.9 5.6 3.4 6.6 5.7 5.7 8.6 5.7 3.6 2.5 3.0 6.6 3.6 20.3 9.8 3.5 6.0 4.6 2.5 4.3 2.7 3.4 3.8 3.1 3.5 5.1 3.7 5.1 4.8 1.8 2.3 2.0 1.6 13.8 13.3 20.4 16.4 10.7 9.0 8.1 11.8 12.2 9.2 26.8 13.3 11.1 5.8 13.3 46.4 9.5 12.7 29.4 17.0 15.7 31.4 5.9 5.0 10.9 8.6 14.9 3.2 23.3 7.8 4.9 18.1 8.2 23.1 7.4 7.8 84.2 12.2 24.5 20.2 17.3 15.3 13.1 86.0 10.0 5.8 50.7 8.5 3.5 17.0 6.2 34.9 25.8 12.0 20.0 12.7 12.2 2.2 14.9 7.6 5.6 DTD1 "bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68" ENSG00000125821 "D-tyrosyl-tRNA deacylase 1" Q8TEA8 20 18587893-18766644 "Enzymes, Predicted intracellular proteins" "DNA replication" "DNA-binding, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 137.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA 180000 "Nucleoli, Cytosol" "HPA040981: AB_10673268" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (1.82e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-3)" "unprognostic (9.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.81e-1)" "unprognostic (6.84e-2)" "unprognostic (1.32e-1)" "unprognostic (9.09e-3)" "unprognostic (2.42e-1)" "unprognostic (8.44e-2)" "unprognostic (2.59e-2)" "unprognostic (8.53e-2)" 14.9 17.7 25.2 13.6 26.5 13.6 19.7 22.4 35.4 13.5 13.7 22.2 10.5 10.6 14.4 17.2 18.8 14.5 11.1 16.7 24.7 29.5 20.1 9.4 13.7 15.5 25.2 30.4 19.1 19.7 20.3 23.7 12.7 27.3 13.6 16.0 17.1 17.6 12.4 22.5 17.6 9.8 15.0 30.9 12.7 16.3 20.6 14.4 4.8 29.5 24.9 17.4 13.4 12.6 20.9 27.5 29.9 20.6 16.4 22.5 12.6 18.7 21.1 20.8 20.4 8.9 16.6 11.6 16.6 15.4 13.2 14.5 13.8 14.7 0.0 11.4 15.4 18.5 10.6 16.6 35.2 13.9 9.1 11.9 20.9 4.8 22.9 28.2 16.2 11.3 13.1 28.3 14.9 55.0 11.3 22.4 3.6 13.0 24.4 19.2 27.5 3.4 29.5 19.3 14.2 46.5 0.0 31.0 15.8 20.1 10.1 28.5 21.5 8.9 24.7 42.8 9.5 14.0 10.1 22.1 17.5 9.5 22.3 22.4 19.6 19.4 10.4 12.0 19.0 14.5 29.9 14.5 10.4 22.2 20.6 22.2 20.9 21.7 22.5 27.5 17.8 16.0 16.7 17.1 16.4 20.5 6.4 16.1 12.6 25.2 26.5 22.4 35.4 24.7 29.5 25.2 30.4 27.3 14.4 32.8 20.0 24.2 32.6 20.9 39.1 17.3 30.6 25.4 17.0 40.1 2.0 25.2 36.5 64.2 24.1 30.8 7.3 0.0 76.4 30.7 25.8 26.4 41.5 10.4 41.2 41.3 22.3 24.5 20.4 17.6 16.7 29.6 40.5 48.7 19.7 48.4 68.4 24.6 18.4 51.2 30.2 0.0 17.5 60.6 137.5 31.1 10.4 30.5 24.3 23.6 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.6 10.8 18.5 9.2 1.1 2.3 9.1 15.9 9.9 15.1 22.5 6.7 11.2 9.6 6.0 6.1 9.7 9.9 24.4 13.4 21.8 11.6 11.7 15.3 14.3 8.1 0.0 20.1 9.6 1.0 0.4 24.4 13.0 2.7 6.9 17.0 18.2 19.6 17.4 5.1 26.8 9.2 21.4 9.6 12.5 21.3 32.7 18.5 4.3 8.8 11.6 18.2 15.1 14.5 6.5 19.7 12.4 9.2 3.7 15.1 11.3 15.6 17.9 7.2 11.2 22.2 7.6 13.3 14.6 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 7.8 0.4 2.1 0.0 6.1 2.5 0.0 1.2 0.0 0.0 7.5 0.0 0.2 17.8 1.8 0.5 23.3 0.0 13.2 1.2 0.2 0.0 0.0 3.9 0.0 0.0 1.3 0.3 7.9 1.1 1.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 35.9 19.1 1.5 1.3 1.9 2.9 0.0 DTX1 "hDx-1, RNF140" ENSG00000135144 "Deltex E3 ubiquitin ligase 1" Q86Y01 12 113056709-113098028 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 9.7;lymphoid tissue: 13.3" "Cell type enriched" "Detected in many" 15 "Horizontal cells: 162.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "Daudi: 40.9;REH: 16.8;U-698: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051249, HPA055275" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA051249: , HPA055275: AB_2682769" "unprognostic (2.13e-3)" "unprognostic (3.20e-3)" "unprognostic (4.24e-4)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.59e-3)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (9.55e-2)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.02e-5)" "unprognostic (2.41e-2)" "unprognostic (4.70e-1)" "unprognostic (1.63e-1)" "unprognostic (4.78e-3)" 9.7 2.3 6.1 8.9 7.0 3.2 3.9 7.3 8.3 0.8 0.7 1.1 0.5 1.6 2.0 0.5 1.2 1.7 1.0 2.7 5.4 5.9 1.7 6.4 0.5 13.3 3.7 4.2 0.5 2.0 0.0 2.2 0.9 4.6 0.8 0.2 1.4 3.2 0.5 0.5 0.5 2.2 0.5 1.1 9.8 1.0 4.9 0.5 0.5 1.3 0.5 8.1 0.5 0.5 2.3 0.0 0.0 0.0 1.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 1.7 0.0 0.8 0.0 0.0 16.8 0.0 1.0 0.0 0.0 1.0 2.7 0.1 0.1 1.0 0.0 0.0 0.1 0.4 0.0 1.6 0.0 0.0 0.2 0.0 41.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.0 0.0 2.3 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.2 6.1 7.0 7.3 7.1 5.4 5.9 3.7 4.2 4.6 0.5 0.0 0.0 2.9 0.0 0.9 1.5 0.7 0.0 0.0 0.0 1.8 7.9 0.0 6.6 1.6 0.6 0.7 0.0 0.0 0.0 0.0 0.8 0.1 6.9 10.5 0.6 162.1 0.0 0.0 0.0 1.1 7.2 0.0 3.3 0.0 0.0 10.3 0.2 0.0 7.1 0.0 2.1 0.0 0.9 0.7 1.2 0.4 0.0 0.0 0.0 0.0 DTX3L "BBAP, RNF143" ENSG00000163840 "Deltex E3 ubiquitin ligase 3L" Q8TDB6 3 122564238-122575203 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 34.2;BJ hTERT+ SV40 Large T+ RasG12V: 42.4;GAMG: 32.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010570 Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA010570: AB_1847877" "unprognostic (8.15e-2)" "unprognostic (7.36e-3)" "unprognostic (5.04e-2)" "unprognostic (3.74e-3)" "unprognostic (9.51e-2)" "unprognostic (9.22e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (9.23e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (8.99e-4)" "unprognostic (2.76e-2)" "unprognostic (2.33e-2)" "unprognostic (7.77e-2)" "unprognostic (9.28e-2)" "unprognostic (3.33e-2)" "unprognostic (2.61e-2)" 32.3 13.0 5.9 22.7 8.4 8.1 11.2 2.0 6.8 14.2 18.5 5.9 6.0 14.8 14.0 12.8 17.9 12.0 15.1 21.5 5.0 5.1 17.3 39.2 21.3 18.3 6.4 3.3 21.7 18.5 10.3 13.9 22.2 6.5 20.9 12.1 7.6 13.9 9.8 14.6 6.2 31.8 10.8 9.7 35.2 12.4 4.9 6.9 24.8 23.9 8.0 18.3 17.0 22.1 6.4 6.5 21.9 13.6 7.8 10.2 6.7 11.1 3.4 1.0 2.9 4.6 10.6 3.8 2.9 10.7 34.2 42.4 3.3 11.4 1.2 5.7 4.7 32.9 11.2 3.4 4.6 7.5 9.4 1.3 9.7 2.6 3.5 9.0 4.9 7.6 9.1 5.5 5.1 2.9 6.5 6.4 6.2 1.2 6.9 2.5 3.4 12.0 3.5 0.6 3.4 6.3 13.4 7.8 2.1 8.7 7.2 1.4 1.5 6.0 2.7 21.6 0.7 3.1 6.3 7.9 3.9 5.5 0.3 3.7 2.5 1.4 5.9 6.8 6.5 4.0 12.5 8.5 8.7 9.3 13.6 10.2 5.9 7.8 10.0 6.5 6.4 7.1 7.6 21.9 7.8 13.5 0.7 7.4 6.7 5.9 8.4 2.0 6.8 5.0 5.1 6.4 3.3 6.5 6.9 29.8 25.5 10.7 7.5 7.9 0.2 4.4 20.4 16.0 15.9 7.0 0.0 3.1 0.0 21.6 1.5 16.6 25.5 0.0 27.9 13.8 9.6 16.0 15.1 50.5 24.2 0.0 17.7 24.5 34.9 0.6 7.8 19.5 5.0 20.8 21.5 5.0 28.4 11.5 8.5 11.1 0.2 32.3 6.6 0.9 0.7 5.3 1.5 13.4 16.9 18.6 DUS2 "DUS2L, FLJ20399, SMM1" ENSG00000167264 "Dihydrouridine synthase 2" Q9NX74 16 67987746-68079320 "Predicted intracellular proteins" "tRNA processing" "Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 82.3;Late spermatids: 66.4;Spermatocytes: 44.7;Syncytiotrophoblasts: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042560, HPA043528" Enhanced Enhanced Cytosol NA NA Cytosol "HPA042560: AB_10965170, HPA043528: AB_10959753" "unprognostic (2.21e-1)" "unprognostic (5.06e-2)" "unprognostic (1.91e-1)" "unprognostic (1.23e-2)" "unprognostic (8.12e-2)" "unprognostic (1.63e-2)" "unprognostic (1.23e-2)" "unprognostic (9.84e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-1)" "unprognostic (1.53e-1)" "unprognostic (3.18e-1)" "prognostic favorable (3.50e-5)" "unprognostic (1.44e-2)" "unprognostic (8.05e-2)" "unprognostic (1.58e-1)" "unprognostic (1.81e-1)" 6.9 8.2 7.0 12.5 11.3 8.6 6.7 7.6 15.0 6.4 9.2 12.8 5.1 6.1 10.1 5.4 13.6 6.1 5.8 5.9 7.0 6.2 7.0 10.3 7.6 18.3 9.2 10.5 6.0 5.1 11.1 6.6 10.3 9.5 6.2 9.1 9.9 7.2 5.7 10.3 11.6 11.2 8.5 7.9 18.4 7.1 32.2 10.8 6.9 6.3 8.8 21.0 8.5 8.1 23.9 8.7 34.2 13.7 7.9 5.1 6.1 9.6 15.4 6.4 10.2 5.3 10.3 11.8 9.4 9.1 20.1 13.7 16.0 17.6 23.3 8.8 10.0 6.3 14.0 16.2 16.6 16.3 3.5 9.8 8.1 9.3 12.5 9.0 8.5 10.4 9.3 12.2 17.0 16.4 8.7 13.2 18.2 9.1 4.1 9.8 15.1 9.4 12.1 7.0 9.8 8.6 15.8 8.0 15.8 10.4 6.8 7.9 7.2 18.8 6.5 4.1 9.1 15.1 4.2 8.2 9.2 8.6 7.9 7.8 10.9 14.4 21.6 6.3 12.0 5.2 4.9 11.8 34.2 4.0 10.3 3.9 23.9 2.7 4.3 8.7 17.3 4.0 3.6 11.1 7.9 13.7 3.3 5.1 6.1 7.0 11.3 7.6 15.0 7.0 6.2 9.2 10.5 9.5 10.8 8.9 2.9 6.7 1.9 2.4 3.7 1.8 2.5 2.7 0.0 7.0 7.9 25.0 5.0 8.8 82.3 4.2 4.0 0.0 4.8 14.7 4.1 1.5 6.9 8.5 12.4 14.3 4.1 8.0 11.8 66.4 3.4 5.6 3.3 10.8 5.1 4.5 7.9 3.5 7.4 7.9 2.7 6.5 4.0 44.7 11.1 2.3 51.4 5.0 6.3 1.7 DUS3L "DUS3, FLJ13896" ENSG00000141994 "Dihydrouridine synthase 3 like" Q96G46 19 5784832-5791238 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA041854, HPA041944, HPA062846" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: AB_2684879" "unprognostic (1.25e-2)" "unprognostic (7.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.64e-3)" "unprognostic (6.08e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (1.87e-1)" "unprognostic (4.19e-1)" "unprognostic (3.55e-2)" "unprognostic (7.35e-3)" "unprognostic (4.25e-3)" "unprognostic (7.73e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" 9.1 9.4 7.4 11.4 9.4 25.4 9.5 7.1 13.2 8.9 12.4 13.7 8.7 16.6 13.1 7.7 12.3 11.1 11.1 7.8 6.0 5.0 9.9 17.5 7.9 12.6 8.3 6.7 11.8 17.6 4.7 8.6 11.1 7.8 11.8 4.6 12.4 12.4 10.1 14.3 17.5 14.4 7.6 7.5 12.5 12.3 42.5 8.1 15.6 11.7 10.3 11.1 8.8 9.7 13.5 19.2 4.3 18.6 15.8 16.6 9.9 11.0 10.9 3.2 11.0 0.9 1.4 10.3 3.7 2.1 3.9 2.9 16.9 5.1 11.2 14.0 1.5 4.4 7.1 2.6 3.6 0.6 8.2 24.9 7.3 5.6 6.3 5.5 16.4 21.6 3.4 3.8 4.3 3.1 0.5 2.6 7.4 19.6 0.0 2.0 14.3 13.7 16.7 11.2 4.0 29.5 7.1 6.5 13.7 1.6 7.9 10.9 11.0 3.8 6.4 7.2 0.7 4.5 13.4 3.4 5.5 9.7 16.3 15.7 32.2 23.7 10.7 5.3 17.0 6.2 4.3 13.2 3.4 14.8 18.6 16.6 10.2 11.0 13.5 18.7 13.5 15.1 14.4 1.5 15.8 14.4 19.2 12.5 9.9 7.4 9.4 7.1 13.2 6.0 5.0 8.3 6.7 7.8 8.1 8.9 10.6 15.2 16.4 13.1 6.5 2.6 5.1 5.3 6.8 1.8 11.8 16.8 6.6 8.9 27.8 8.0 10.1 0.0 19.1 14.3 10.1 6.1 35.7 6.8 13.3 11.1 7.5 3.7 5.6 6.6 11.8 9.4 5.0 3.6 9.4 4.5 10.0 6.6 6.0 5.6 10.1 19.4 10.8 36.1 10.8 11.2 18.2 10.0 13.6 13.2 DUS4L "DUS4, PP35" ENSG00000105865 "Dihydrouridine synthase 4 like" O95620 7 107563484-107578464 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044301 Approved Approved Cytosol NA NA Cytosol "HPA044301: AB_10967460" "unprognostic (7.95e-2)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (5.66e-2)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (2.56e-3)" "unprognostic (2.29e-2)" "unprognostic (9.21e-3)" "unprognostic (7.74e-3)" "unprognostic (6.72e-3)" 4.5 6.2 9.4 7.0 10.4 2.9 7.8 5.0 8.2 5.5 5.7 7.5 6.2 4.8 5.7 10.4 5.5 6.0 4.7 10.1 8.0 7.7 9.9 9.0 3.9 5.0 10.3 6.2 7.8 5.4 8.0 5.1 4.8 7.6 7.8 5.7 5.7 5.1 4.8 7.1 7.1 5.2 5.3 11.0 4.3 5.4 7.7 6.6 6.6 8.5 5.9 5.7 6.2 4.5 1.5 1.3 0.5 1.3 1.2 2.4 0.7 6.5 3.0 3.0 1.8 1.2 2.0 3.9 1.9 2.6 2.8 2.7 3.4 5.4 7.0 3.6 1.5 7.4 2.0 3.1 4.0 4.3 2.1 2.6 2.5 1.6 3.7 3.0 4.8 0.4 2.0 5.4 2.7 9.2 3.2 4.1 6.6 8.7 2.6 4.3 4.8 6.6 8.4 4.3 5.2 5.4 3.6 2.7 7.9 5.4 3.4 2.7 6.8 3.1 6.4 5.4 3.9 3.1 3.8 2.9 4.0 3.2 3.0 4.4 4.9 6.0 7.9 4.3 6.8 4.8 0.0 1.2 0.1 1.4 1.3 1.6 1.5 2.3 1.2 1.3 0.7 1.9 2.4 0.5 1.2 0.7 1.1 1.7 0.7 9.4 10.4 5.0 8.2 8.0 7.7 10.3 6.2 7.6 6.6 6.0 4.6 5.6 7.5 4.5 8.8 8.0 2.5 22.7 6.8 10.4 3.9 7.9 6.6 8.7 20.0 2.7 3.8 0.0 13.9 7.4 4.2 5.5 13.8 8.9 6.1 3.2 9.2 4.9 4.6 17.7 4.0 4.9 3.3 5.4 4.5 13.0 11.5 5.3 3.5 13.2 9.1 12.9 4.2 11.2 10.9 3.4 3.1 3.8 5.5 6.4 DUSP1 "CL100, HVH1, MKP-1, PTPN10" ENSG00000120129 "Dual specificity phosphatase 1" P28562 5 172768090-172771195 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Stress response" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 326.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 326.0" "Cell line enhanced" "Detected in many" "HHSteC: 43.7;hTCEpi: 76.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069577 Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA069577: AB_2686156" "unprognostic (1.51e-1)" "unprognostic (1.24e-1)" "unprognostic (9.73e-2)" "unprognostic (8.17e-2)" "unprognostic (4.64e-1)" "unprognostic (1.58e-3)" "unprognostic (4.18e-2)" "unprognostic (6.94e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (3.11e-5)" "unprognostic (2.69e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-3)" 158.4 78.0 12.4 68.5 14.0 89.7 91.8 17.4 14.9 81.4 37.1 32.4 48.5 9.4 55.4 71.6 82.7 94.8 138.8 49.2 12.5 11.4 29.8 115.4 135.0 43.5 30.6 9.7 69.4 34.4 26.6 40.8 93.7 29.3 67.1 34.2 61.0 38.1 192.8 54.8 116.1 27.6 65.0 29.5 36.1 53.6 45.9 18.7 10.8 90.4 104.1 46.9 69.0 109.7 2.4 11.5 326.0 31.8 4.5 9.8 14.0 2.1 5.5 1.7 2.4 38.1 22.3 2.9 35.4 10.3 23.8 9.6 6.0 2.6 0.7 10.3 24.8 27.4 0.9 1.7 8.7 11.2 19.4 4.7 0.4 12.0 2.5 43.7 0.2 0.8 21.3 76.4 10.8 17.6 12.4 7.4 1.5 1.8 13.9 15.3 2.5 1.1 1.0 1.5 1.6 1.6 41.1 3.2 6.4 16.9 1.1 7.5 3.1 9.6 16.3 1.2 7.6 1.4 0.4 19.5 16.9 8.4 16.4 2.7 2.9 1.6 0.6 15.1 0.3 0.6 33.3 24.6 69.8 3.9 25.0 9.8 2.4 3.5 4.0 11.5 2.1 1.7 1.9 326.0 4.5 31.8 0.6 2.8 14.0 12.4 14.0 17.4 14.9 12.5 11.4 30.6 9.7 29.3 18.7 381.2 398.8 474.0 769.9 1136.9 64.0 181.6 236.9 45.5 126.3 200.7 25.5 239.6 48.0 361.0 67.1 510.4 567.7 46.7 76.6 355.3 824.5 763.6 295.5 297.9 967.3 46.1 687.8 403.9 1172.3 21.1 356.4 1745.4 514.5 55.9 830.1 603.1 188.6 648.8 292.4 25.4 177.1 756.7 886.8 11.8 23.0 1710.3 486.7 546.6 309.1 534.2 DUSP10 "MKP-5, MKP5" ENSG00000143507 "Dual specificity phosphatase 10" Q9Y6W6 1 221701424-221742176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 35.4" "Cell type enhanced" "Detected in many" 9 "granulocytes: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.2;HaCaT: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016758 Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA016758: AB_1847880" "unprognostic (1.55e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-1)" "unprognostic (6.65e-2)" "unprognostic (3.83e-2)" "unprognostic (2.85e-3)" "prognostic favorable (5.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.89e-2)" "unprognostic (9.68e-2)" "unprognostic (2.38e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (8.88e-3)" "unprognostic (1.97e-2)" 7.4 4.7 6.0 7.1 11.2 23.2 8.2 5.9 11.1 5.7 10.8 21.1 0.3 2.1 4.9 2.7 7.0 8.5 7.6 3.8 7.2 4.0 2.8 35.4 8.0 9.0 14.0 5.6 2.8 18.3 1.8 2.5 4.5 8.4 3.6 4.9 8.5 9.5 1.7 21.0 8.0 6.2 9.7 10.1 6.4 4.5 3.9 14.1 5.6 5.3 10.6 8.6 8.5 4.1 0.8 5.4 4.6 4.2 15.1 12.7 1.6 6.1 2.6 0.2 0.2 19.2 9.9 0.2 4.1 10.8 6.9 5.3 0.1 1.7 4.8 1.4 10.7 5.0 42.3 0.9 4.0 6.0 12.3 0.5 8.2 1.2 0.7 4.5 3.6 5.6 13.8 2.9 7.4 7.5 3.2 0.2 1.2 0.8 1.7 6.5 0.1 0.7 2.8 0.6 1.3 0.3 0.4 11.7 0.3 2.3 3.7 15.8 1.2 0.5 0.5 17.5 2.5 0.9 2.1 1.5 3.5 0.9 5.3 5.1 2.9 2.0 2.6 5.4 1.6 3.6 4.6 4.2 0.2 3.6 3.7 3.3 0.7 2.5 2.5 5.4 0.8 0.8 1.5 0.3 15.1 1.4 0.2 12.7 1.6 6.0 11.2 5.9 11.1 7.2 4.0 14.0 5.6 8.4 14.1 0.0 1.7 1.9 12.6 45.2 4.5 3.3 10.2 8.1 6.8 3.5 19.6 2.2 0.0 27.3 29.1 6.3 1.0 0.0 7.8 2.7 8.3 10.9 135.7 50.4 22.0 1.6 42.1 1.8 11.0 2.7 23.0 23.9 21.9 13.6 9.9 13.5 21.9 0.0 12.0 0.7 32.3 0.0 5.1 3.8 2.0 36.1 2.9 29.9 2.2 14.4 DUSP14 "MKP-L, MKP6" ENSG00000276023 "Dual specificity phosphatase 14" O95147 17 37489831-37513501 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 152.9;Basal keratinocytes: 159.6;Cytotrophoblasts: 141.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 10.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.7;HBF TERT88: 18.3;U-138 MG: 8.7;WM-115: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019911 Approved Approved Nucleoplasm,Cytosol NA NA 44000 "Nucleoplasm, Cytosol" "HPA019911: AB_1847888" "unprognostic (1.32e-1)" "unprognostic (3.06e-1)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (4.60e-1)" "unprognostic (3.22e-2)" "unprognostic (3.43e-3)" "unprognostic (2.02e-3)" "unprognostic (2.18e-1)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (3.81e-1)" "prognostic unfavorable (6.97e-9)" "unprognostic (7.93e-2)" "unprognostic (1.97e-1)" "unprognostic (1.73e-1)" "unprognostic (1.41e-3)" 4.7 3.7 3.3 2.1 6.6 1.1 3.9 1.8 8.0 3.3 1.0 1.5 0.1 0.7 2.7 1.2 7.2 11.7 5.1 2.6 2.3 2.1 6.5 2.4 1.0 1.9 2.5 3.0 2.9 1.7 3.3 11.6 2.6 1.4 1.4 1.6 2.8 1.1 1.7 8.4 0.9 3.5 2.7 1.7 1.0 3.5 0.8 2.3 8.3 6.1 4.3 1.9 1.0 0.5 0.0 3.2 0.0 0.4 0.4 0.5 1.7 0.1 0.4 0.8 0.0 0.5 1.5 8.2 6.2 10.9 12.7 0.9 1.9 0.1 0.7 5.9 0.1 1.4 0.1 4.8 18.3 0.1 0.6 0.0 1.1 2.0 0.8 0.4 1.3 4.8 2.9 3.8 2.0 0.6 0.2 0.2 0.4 0.0 8.0 0.3 0.8 0.2 0.2 0.0 0.0 0.7 0.5 0.2 2.7 0.7 1.3 0.1 0.4 0.7 1.2 3.2 0.6 1.0 0.8 8.7 2.0 0.1 4.1 0.0 0.2 0.1 0.0 0.0 10.5 0.0 0.0 0.9 0.4 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.3 0.2 3.2 0.4 0.0 0.0 0.0 0.5 6.0 4.8 5.9 152.9 159.6 6.2 14.2 5.1 52.2 26.1 7.0 7.9 141.3 24.9 33.6 35.0 22.7 0.0 0.0 13.2 71.8 47.7 52.8 87.4 10.2 17.0 14.3 2.4 14.7 2.8 40.7 12.7 10.4 59.1 43.3 1.0 9.0 46.1 1.1 5.6 11.8 18.7 0.0 52.6 28.9 29.2 80.9 56.8 6.4 0.8 72.6 DUSP15 "bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY" ENSG00000149599 "Dual specificity phosphatase 15" Q9H1R2 20 31847637-31870747 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 75.1" "Group enriched" "Detected in many" 5 "Distal tubular cells: 232.1;Early spermatids: 237.5;Late spermatids: 743.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive B-cell: 1.6" "Lineage enriched" "Detected in single" 14 "B-cells: 1.6" "Cell line enhanced" "Detected in some" "CACO-2: 5.4;REH: 17.7;SH-SY5Y: 5.1;SK-MEL-30: 4.4;U-2 OS: 4.3" "Low region specificity" "Detected in all" HPA076649 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA076649: AB_2686811" "unprognostic (3.84e-2)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (9.01e-3)" "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (1.47e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (1.48e-5)" "unprognostic (7.31e-2)" "prognostic favorable (5.40e-7)" "unprognostic (2.79e-2)" "unprognostic (1.93e-1)" "unprognostic (3.11e-3)" "unprognostic (2.55e-1)" 1.1 2.1 2.8 0.6 4.0 0.5 1.3 1.2 3.7 1.6 0.8 4.2 6.9 0.9 1.4 10.4 0.6 0.7 1.1 2.7 2.8 3.1 15.4 0.6 0.8 1.0 4.9 2.3 2.1 1.8 10.6 2.7 1.1 5.9 1.9 0.5 5.3 2.1 9.3 2.4 0.7 1.0 2.3 5.2 1.0 1.1 75.1 1.4 0.0 3.5 0.1 0.6 0.7 0.8 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 1.6 0.0 0.3 0.0 0.0 0.0 0.9 0.0 5.4 0.1 1.1 2.2 0.3 3.0 0.0 0.4 0.0 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 3.8 0.7 0.0 0.0 17.7 2.1 0.1 0.0 0.0 2.5 5.1 2.9 0.0 4.4 0.2 1.3 1.1 0.0 0.0 4.3 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.0 1.2 3.7 2.8 3.1 4.9 2.3 5.9 1.4 0.0 0.0 0.0 1.0 0.6 0.5 2.0 2.5 0.0 0.0 17.4 3.9 0.0 232.1 1.7 237.5 0.7 0.0 0.0 0.9 0.1 2.4 0.7 0.0 0.0 0.5 6.4 1.7 3.1 0.0 743.6 8.1 0.8 6.8 1.0 0.0 2.7 0.9 0.0 10.3 33.5 0.2 0.0 1.0 85.0 5.2 0.1 0.1 0.0 0.0 0.1 DUSP28 "DUSP26, VHP" ENSG00000188542 "Dual specificity phosphatase 28" Q4G0W2 2 240560054-240564014 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047456, CAB069448" Uncertain Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB069448: , HPA047456: AB_10961145" "unprognostic (1.88e-2)" "unprognostic (9.29e-2)" "unprognostic (4.86e-2)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (7.56e-3)" "unprognostic (4.13e-3)" "unprognostic (3.71e-2)" "prognostic favorable (1.84e-4)" "unprognostic (9.85e-2)" "unprognostic (1.80e-3)" "unprognostic (6.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-3)" 1.8 2.8 2.7 3.0 3.4 7.9 3.5 6.3 3.7 3.1 2.6 3.3 6.5 2.9 2.6 5.0 3.5 3.1 4.4 16.3 2.8 2.7 3.2 3.4 2.5 6.1 3.5 2.4 2.6 10.2 2.6 5.0 3.2 2.8 4.3 2.8 2.7 3.7 2.4 21.2 4.9 4.2 4.3 2.2 5.9 4.2 8.2 2.3 2.6 4.4 13.4 4.2 2.8 4.5 3.8 3.3 10.7 2.1 2.7 3.3 2.0 1.7 1.6 2.2 2.6 1.4 0.8 2.4 1.9 1.2 1.5 1.1 1.0 4.5 2.7 1.0 1.2 2.3 5.1 1.7 0.7 1.6 3.4 6.4 3.9 3.4 2.5 1.0 2.5 6.7 1.7 1.8 1.0 1.3 2.9 0.7 3.9 2.7 3.3 1.3 1.9 3.1 4.0 1.4 2.6 1.4 3.8 4.8 3.6 1.1 2.9 4.9 2.7 1.8 1.9 2.2 1.4 2.4 4.4 1.7 3.5 2.9 2.2 1.7 13.2 3.8 4.4 2.2 1.9 2.8 10.7 2.1 0.7 2.7 1.4 3.0 2.1 2.8 2.8 1.2 3.8 3.3 3.0 3.6 2.7 1.5 3.3 2.2 2.0 2.7 3.4 6.3 3.6 2.8 2.7 3.5 2.4 2.8 2.3 0.0 5.0 5.1 6.9 3.3 6.3 12.9 12.7 6.7 1.2 12.2 3.9 6.4 13.3 4.1 27.6 3.1 11.8 0.0 5.1 4.0 4.1 8.4 6.9 6.6 10.0 7.9 8.1 2.5 10.3 29.8 2.8 7.0 6.8 8.2 8.1 7.4 3.9 11.8 1.4 11.2 6.6 6.5 5.6 41.1 17.6 4.6 5.8 12.5 10.1 6.8 DUSP3 VHR ENSG00000108861 "Dual specificity phosphatase 3" P51452 17 43766121-43778988 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 242.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063616 Supported Nucleoplasm,Cytosol NA NA 1300000 Nucleoplasm Cytosol "HPA063616: AB_2685061" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-1)" "unprognostic (8.54e-2)" "unprognostic (1.04e-3)" "prognostic unfavorable (3.00e-4)" "unprognostic (4.83e-2)" "unprognostic (8.98e-2)" "unprognostic (5.13e-1)" "unprognostic (6.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.40e-3)" "prognostic favorable (5.49e-5)" "unprognostic (2.67e-3)" "unprognostic (5.45e-2)" "unprognostic (1.94e-1)" "unprognostic (1.37e-2)" 17.1 17.8 23.1 10.2 20.8 4.6 22.0 14.3 28.6 12.8 28.4 11.1 16.7 13.4 17.5 18.7 23.6 10.6 19.3 64.0 21.5 18.1 27.1 39.9 17.2 9.0 17.6 19.1 9.1 19.2 27.5 11.4 15.0 17.1 22.6 13.1 14.3 11.1 36.6 106.9 8.9 15.2 31.1 12.7 14.5 19.6 8.0 10.8 1.2 13.9 22.8 6.5 20.7 24.1 1.7 19.5 5.2 17.0 0.9 1.7 5.8 10.5 19.2 7.4 7.9 21.6 11.6 6.3 8.0 19.2 18.8 22.8 18.4 7.1 1.6 12.7 15.0 39.0 9.2 11.4 9.8 19.9 3.6 8.7 5.3 8.8 15.0 26.4 0.6 5.6 10.7 17.8 14.5 12.6 20.6 13.1 5.4 4.8 1.8 21.9 7.6 2.7 2.7 3.4 15.1 14.0 3.4 22.3 4.0 26.1 11.2 4.1 7.5 9.4 6.3 23.6 21.3 28.1 14.9 13.6 21.3 14.5 30.2 13.2 9.8 13.0 0.4 25.3 7.5 7.1 5.2 17.0 3.5 1.0 8.9 1.7 1.7 1.5 1.2 19.5 1.6 1.2 1.1 4.1 0.9 10.8 8.2 0.9 5.8 23.1 20.8 14.3 28.6 21.5 18.1 17.6 19.1 17.1 10.8 23.8 16.8 7.2 42.9 19.9 16.3 242.3 48.4 14.7 9.1 40.1 23.6 14.4 34.9 42.9 73.8 32.1 42.0 0.0 50.5 17.5 18.4 41.2 38.1 99.4 73.0 19.1 34.9 27.6 34.5 128.1 13.6 40.3 10.1 32.5 17.6 14.8 50.2 28.1 24.8 69.4 16.6 32.3 35.5 2.4 2.9 25.2 37.6 6.4 14.6 32.8 DUSP6 "MKP-3, PYST1" ENSG00000139318 "Dual specificity phosphatase 6" Q16828 12 89347232-89353271 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 125.0" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 270.1;granulocytes: 438.5;Kupffer cells: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 125.0" "Group enriched" "Detected in many" 11 "granulocytes: 125.0;monocytes: 79.7" "Cell line enhanced" "Detected in many" "AN3-CA: 82.0;NB-4: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017566, HPA053188, HPA064692" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB017566: AB_647991, HPA053188: , HPA064692: " "unprognostic (7.35e-2)" "unprognostic (1.50e-2)" "unprognostic (5.77e-2)" "prognostic favorable (7.21e-4)" "unprognostic (2.35e-3)" "unprognostic (2.10e-3)" "unprognostic (3.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.63e-2)" "unprognostic (1.67e-2)" "unprognostic (3.15e-3)" "unprognostic (2.09e-1)" "unprognostic (5.91e-3)" "unprognostic (1.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-2)" "unprognostic (2.84e-1)" 37.7 7.5 7.2 15.9 11.7 41.3 24.1 3.4 14.7 11.6 12.4 6.2 5.8 6.1 9.8 8.7 12.0 15.4 25.1 16.2 10.5 6.5 17.1 38.4 28.2 13.3 6.9 7.4 7.5 12.2 15.0 13.7 19.7 7.9 17.4 15.3 44.4 64.3 6.3 12.0 8.5 14.6 11.3 7.1 28.4 10.3 4.8 6.4 6.1 21.0 13.3 17.8 15.2 6.9 1.2 9.2 125.0 79.7 1.2 0.9 32.4 1.1 1.1 24.4 82.0 21.1 18.0 0.0 8.8 11.2 1.8 1.3 7.2 1.3 0.0 2.1 3.7 3.4 9.4 0.1 22.0 2.5 0.1 0.1 3.6 0.2 11.4 15.0 15.7 40.2 3.5 7.7 15.5 14.5 18.4 40.7 0.4 0.0 3.8 5.6 0.5 0.5 58.8 14.8 28.0 20.0 40.0 3.0 1.5 25.2 23.7 0.4 17.4 0.2 0.1 46.7 8.7 1.2 8.8 10.9 6.0 0.1 1.1 4.2 0.6 3.2 0.1 24.9 11.1 38.0 125.0 49.5 22.4 0.9 79.7 0.4 0.2 0.2 0.3 9.2 1.2 0.1 0.3 22.5 1.2 74.4 1.2 0.6 32.4 7.2 11.7 3.4 14.7 10.5 6.5 6.9 7.4 7.9 6.4 95.3 270.1 20.5 66.1 80.7 1.2 8.1 53.5 22.7 111.5 171.0 31.4 63.9 14.9 10.9 1.1 97.2 31.9 0.0 11.9 2.9 29.6 20.6 438.5 128.2 43.3 1.6 18.4 173.1 216.2 1.4 1.4 140.4 11.8 1.8 11.0 9.0 12.3 7.4 3.2 23.5 2.0 25.8 8.5 1.2 1.1 21.7 41.2 18.5 12.8 23.4 DUSP8 "C11orf81, FLJ42958, HB5, HVH-5" ENSG00000184545 "Dual specificity phosphatase 8" Q13202 11 1554044-1571920 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 101.5;Cone photoreceptor cells: 45.2;Horizontal cells: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;MCF7: 6.2;SH-SY5Y: 5.5;U-251 MG: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020071 Approved Approved Cytosol NA NA Cytosol "HPA020071: AB_1847903" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (4.00e-2)" "unprognostic (1.35e-1)" "unprognostic (7.58e-3)" "unprognostic (6.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (4.04e-3)" "unprognostic (1.82e-1)" "prognostic favorable (2.75e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (8.65e-2)" "unprognostic (6.30e-2)" 6.3 2.2 18.8 3.2 18.8 7.5 3.5 20.0 30.2 1.9 4.3 4.2 1.4 1.7 5.9 4.8 3.5 4.0 5.4 5.7 16.6 9.3 2.6 3.7 3.6 3.5 5.5 11.2 2.2 12.7 1.7 10.8 2.8 5.1 3.0 4.1 2.7 5.1 2.7 6.1 3.2 6.3 9.3 3.6 6.3 4.3 2.4 5.1 0.0 2.6 2.2 2.3 2.7 1.6 0.1 0.1 0.0 0.0 0.0 0.7 0.0 1.8 0.8 1.0 0.1 0.0 0.1 2.2 0.1 1.2 0.4 1.2 0.0 0.0 0.1 0.0 0.3 0.0 1.2 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.4 0.0 0.1 0.1 0.0 1.8 0.0 6.2 0.0 0.4 0.0 0.0 1.9 0.1 0.1 0.7 0.0 0.2 0.0 5.5 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.0 2.3 0.0 0.1 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 18.8 18.8 20.0 30.2 16.6 9.3 5.5 11.2 5.1 5.1 3.0 0.6 0.0 5.6 8.8 101.5 5.2 5.1 0.0 0.0 12.2 45.2 0.1 1.7 6.9 0.2 2.2 22.7 0.0 9.6 0.4 4.5 12.8 0.0 0.4 0.4 85.8 40.5 1.3 0.0 0.0 0.6 0.3 5.0 1.8 20.2 16.0 9.8 17.5 0.4 1.1 36.7 6.5 5.1 0.2 0.4 4.3 4.9 1.3 16.8 9.8 DUX4 ENSG00000260596 "Double homeobox 4" Q9UBX2 4 190173774-190185942 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.4" "Group enriched" "Detected in some" 21 "Early spermatids: 4.1;Late spermatids: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4" HPA058451 Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus, Cytosol" "HPA058451: AB_2683722" 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.5 0.3 0.0 1.1 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 2.5 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 3.7 0.7 0.0 8.0 10.4 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DXO DOM3Z ENSG00000204348 "Decapping exoribonuclease" O77932 6 31969810-31972292 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.8" "Group enriched" "Detected in many" 5 "Early spermatids: 374.6;Late spermatids: 209.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046708 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA046708: AB_2679764" "unprognostic (4.56e-2)" "unprognostic (2.21e-1)" "unprognostic (1.80e-1)" "unprognostic (4.07e-3)" "unprognostic (1.93e-1)" "unprognostic (2.00e-3)" "unprognostic (3.43e-3)" "unprognostic (4.18e-3)" "unprognostic (3.10e-2)" "unprognostic (2.64e-3)" "prognostic favorable (5.87e-4)" "unprognostic (4.29e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (9.17e-2)" "unprognostic (7.24e-2)" "unprognostic (2.01e-1)" "unprognostic (2.23e-3)" 4.3 18.4 8.3 8.0 11.0 4.2 7.0 15.5 12.4 7.1 5.0 6.5 8.6 7.8 6.4 6.4 4.0 7.9 6.0 8.4 7.7 6.5 8.5 8.7 5.1 4.3 9.0 6.5 10.5 12.3 9.4 12.4 4.7 7.4 7.6 4.2 5.8 5.5 6.8 5.6 3.4 4.1 6.3 4.9 7.2 7.6 32.8 7.3 3.4 8.8 4.7 4.3 6.4 5.5 2.2 3.2 1.5 1.9 3.0 3.3 1.5 3.0 1.3 0.5 14.3 1.7 1.0 1.5 1.7 2.7 4.5 3.7 2.2 2.9 1.0 3.2 5.8 0.8 4.1 1.5 3.2 1.6 1.9 4.4 2.0 2.9 2.9 3.9 0.0 2.7 2.2 2.9 1.8 3.0 2.2 6.6 1.1 2.5 3.2 1.8 4.4 0.1 2.4 0.7 1.9 0.1 0.1 2.0 1.8 5.3 0.8 7.4 5.6 3.3 1.4 3.7 0.5 0.0 4.5 0.9 0.8 4.9 2.8 3.7 1.9 3.4 2.4 2.6 4.6 2.2 0.0 1.0 1.5 1.1 1.9 3.3 1.4 1.4 1.8 3.2 2.2 1.3 1.6 0.6 3.0 1.2 1.2 0.6 1.5 8.3 11.0 15.5 9.4 7.7 6.5 9.0 6.5 7.4 7.3 6.0 11.1 11.2 13.5 7.6 12.9 6.5 7.6 8.1 6.8 3.5 15.7 12.3 16.6 7.5 374.6 6.3 6.1 0.0 10.8 7.9 10.8 9.4 5.8 9.7 5.9 4.8 15.5 6.7 4.9 209.7 16.4 6.7 11.8 4.6 7.0 16.2 6.4 8.6 11.7 11.7 14.7 12.9 10.8 58.1 11.8 4.8 16.8 13.1 6.8 7.3 DYNC1H1 "CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22" ENSG00000197102 "Dynein cytoplasmic 1 heavy chain 1" Q14204 14 101964510-102056443 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Motor protein" "Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003742, CAB010443" Enhanced Supported Centrosome,Cytosol NA NA 120000 "Centrosome, Cytosol" "CAB010443: AB_2093483, HPA003742: AB_1078713" "unprognostic (2.58e-1)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (4.65e-2)" "unprognostic (4.66e-2)" "unprognostic (5.49e-2)" "prognostic unfavorable (3.03e-7)" "unprognostic (8.93e-2)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.09e-6)" "unprognostic (1.63e-2)" "unprognostic (8.73e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-3)" 23.3 17.2 24.3 13.9 42.9 21.1 12.7 43.9 53.4 16.9 18.4 35.0 10.2 13.9 18.6 12.5 18.3 15.5 16.1 26.6 26.1 26.6 11.2 9.4 14.6 14.0 29.1 23.4 24.7 15.4 28.1 16.4 14.8 51.5 16.7 11.9 15.5 18.0 18.6 44.5 42.0 13.8 17.7 30.3 15.4 15.5 17.2 12.6 15.1 18.1 11.1 12.9 19.1 12.8 2.7 6.3 4.5 6.0 7.8 4.7 3.3 24.2 36.4 20.0 15.4 44.9 29.3 12.2 21.1 19.6 24.9 21.9 15.4 12.3 13.9 17.3 28.7 18.2 22.2 19.6 23.6 9.0 12.0 11.8 9.9 23.7 25.1 20.4 14.6 10.4 19.0 12.5 58.6 43.8 18.4 27.2 17.4 8.6 16.0 28.2 23.8 9.5 3.6 12.1 10.4 45.0 9.1 21.0 8.0 20.1 38.7 22.8 18.5 27.8 14.1 18.3 10.3 11.7 6.3 59.6 29.5 12.6 40.7 28.7 11.0 11.1 9.4 40.6 8.7 18.1 3.6 3.4 2.5 4.6 6.0 4.7 2.2 3.0 4.0 6.3 2.7 3.6 4.2 4.5 7.8 3.9 3.3 3.0 3.3 24.3 42.9 43.9 53.4 26.1 26.6 29.1 23.4 51.5 12.6 116.1 83.2 18.6 34.8 46.5 118.7 165.8 38.2 78.9 83.0 73.3 131.6 39.7 11.6 96.5 11.8 85.7 77.8 0.0 70.2 36.3 58.5 39.8 31.3 31.8 36.0 173.2 68.5 46.6 49.4 11.3 65.3 61.6 67.4 110.0 56.8 57.8 107.3 66.6 67.1 39.6 100.6 84.1 73.1 83.0 71.1 56.0 31.2 49.0 49.4 39.7 DYNC1I2 "DIC74, DNCI2" ENSG00000077380 "Dynein cytoplasmic 1 intermediate chain 2" Q13409 2 171687409-171748420 "Predicted intracellular proteins" "Host-virus interaction, Transport" "Motor protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033836, HPA040619, HPA053987" Supported Supported "Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol" NA NA 33000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Microtubules" "CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-2)" "unprognostic (8.15e-2)" "unprognostic (8.90e-2)" "unprognostic (1.37e-3)" "unprognostic (2.51e-3)" "unprognostic (6.30e-3)" "unprognostic (1.23e-1)" "unprognostic (1.89e-2)" "unprognostic (1.40e-2)" "unprognostic (4.19e-1)" "prognostic favorable (8.04e-4)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (1.35e-3)" "unprognostic (6.42e-2)" 33.4 32.9 39.6 22.5 53.2 10.8 35.5 30.1 50.0 36.1 33.0 50.0 20.1 28.8 43.1 29.3 37.5 26.5 32.0 34.3 45.2 38.3 43.5 21.8 27.3 18.5 59.3 37.9 40.6 23.3 35.8 29.9 40.2 58.7 33.7 35.8 15.1 28.3 34.7 41.3 27.9 27.7 43.7 92.7 25.8 26.5 28.6 49.2 27.9 31.2 23.5 24.3 36.7 31.8 23.5 35.3 51.7 30.8 18.9 19.9 11.5 20.0 12.9 40.1 14.7 37.2 35.9 22.7 35.2 27.5 29.7 32.4 22.4 20.0 18.4 31.0 41.8 40.7 20.4 31.5 33.8 39.0 6.9 14.2 16.1 16.6 25.3 18.6 18.3 17.3 27.8 32.2 36.7 23.7 41.6 52.0 18.0 25.3 5.1 58.6 12.6 15.6 14.9 18.5 29.5 13.2 15.8 36.1 13.3 39.5 32.3 25.1 28.3 19.5 15.7 20.9 31.9 15.3 17.9 56.3 45.3 22.5 18.0 21.0 6.3 12.0 14.9 30.8 14.9 33.1 51.7 30.8 14.7 16.9 30.1 18.0 23.1 19.5 19.6 21.4 23.5 17.6 16.7 1.8 18.9 29.4 35.3 19.9 11.5 39.6 53.2 30.1 45.7 45.2 38.3 59.3 37.9 58.7 49.2 184.6 55.8 68.6 52.1 45.0 68.0 67.4 196.1 111.1 96.7 160.5 60.9 85.6 111.0 177.4 58.5 118.7 140.2 70.0 139.8 89.1 77.0 39.2 96.2 130.7 90.2 76.3 80.9 188.4 142.1 30.8 119.0 94.7 33.7 151.5 111.3 91.1 161.5 106.7 129.7 165.2 120.2 109.9 79.3 209.8 92.5 52.4 96.7 52.4 94.0 47.0 DYNC1LI1 DNCLI1 ENSG00000144635 "Dynein cytoplasmic 1 light intermediate chain 1" Q9Y6G9 3 32525971-32570874 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 165.8;Spermatogonia: 163.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035013 Approved Supported Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA035013: AB_10600807" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.78e-2)" "unprognostic (2.25e-2)" "unprognostic (1.55e-1)" "unprognostic (5.38e-2)" "prognostic unfavorable (9.19e-9)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (7.26e-3)" "unprognostic (5.02e-2)" "unprognostic (1.05e-2)" "unprognostic (2.21e-2)" "unprognostic (2.14e-2)" "unprognostic (5.51e-2)" "unprognostic (4.58e-2)" "unprognostic (2.27e-2)" 16.1 11.6 15.8 14.8 18.6 27.5 18.9 24.5 28.0 13.4 13.8 12.7 9.2 11.6 17.0 11.6 13.9 14.7 14.1 40.1 16.3 23.4 18.4 15.9 16.3 15.8 18.3 16.4 15.2 18.6 16.8 18.9 14.9 26.5 18.6 14.2 14.1 12.0 12.9 41.1 32.1 13.0 19.7 16.6 18.1 13.8 34.0 11.7 19.3 12.8 16.6 17.2 15.5 13.5 6.2 15.3 29.8 25.1 7.5 6.1 10.7 13.3 14.5 22.5 14.1 13.0 15.3 62.3 20.7 28.6 37.5 30.8 15.3 11.6 16.8 14.1 21.0 17.8 6.9 22.6 16.2 35.8 15.8 15.6 22.2 10.6 13.6 16.0 25.1 13.0 12.3 13.0 26.4 20.7 13.7 24.1 19.2 25.7 15.5 20.0 10.7 19.2 11.1 23.3 12.9 19.5 17.0 12.0 17.5 15.3 12.3 9.7 14.3 14.6 18.0 15.6 18.9 15.0 14.7 17.9 20.7 17.4 17.9 20.8 11.2 28.2 27.2 11.5 21.8 16.0 11.3 13.3 11.7 5.2 16.8 5.4 6.1 5.6 5.7 15.3 6.2 3.9 5.0 29.8 7.5 25.1 8.4 6.1 10.7 15.8 18.6 24.5 28.0 16.3 23.4 18.3 16.4 26.5 11.7 23.8 24.1 30.7 27.6 38.1 44.2 87.1 12.7 57.6 42.1 14.0 17.7 31.9 39.7 46.8 67.1 34.6 15.3 46.7 40.4 30.5 29.2 19.6 16.2 24.9 36.1 62.0 29.6 23.4 32.9 26.8 24.2 50.1 27.0 83.0 18.0 30.8 44.9 17.3 26.9 37.2 71.7 45.3 37.1 165.8 163.3 43.8 9.3 28.0 13.6 14.0 DYNC1LI2 DNCLI2 ENSG00000135720 "Dynein cytoplasmic 1 light intermediate chain 2" O43237 16 66720893-66751798 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057201 Approved Centrosome,Cytosol NA NA Centrosome Cytosol "HPA057201: AB_2683366" "unprognostic (6.03e-2)" "unprognostic (2.40e-2)" "unprognostic (8.28e-2)" "unprognostic (1.57e-2)" "unprognostic (5.35e-2)" "unprognostic (2.80e-1)" "unprognostic (7.58e-2)" "unprognostic (3.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (6.51e-3)" "unprognostic (4.77e-2)" "unprognostic (1.92e-1)" "unprognostic (7.70e-3)" "unprognostic (1.34e-1)" 26.5 21.4 63.8 16.8 63.5 16.7 19.0 28.8 43.3 23.0 24.4 61.2 17.6 19.5 23.9 19.5 23.7 17.9 22.5 26.6 68.3 48.3 20.3 13.0 20.8 11.0 75.0 28.9 22.1 20.2 44.7 19.3 21.1 51.1 25.3 28.7 13.6 20.8 24.5 17.2 23.1 19.8 30.1 89.5 15.5 22.6 14.9 55.0 6.7 28.8 7.9 12.6 20.4 20.0 9.0 12.1 16.3 17.1 8.2 14.9 7.9 15.1 16.0 23.8 21.3 30.8 30.5 21.6 24.9 20.0 20.4 26.6 21.6 15.0 6.3 19.9 24.4 14.8 22.1 18.2 17.8 30.0 4.3 13.1 7.8 18.5 20.4 17.1 8.2 11.6 19.9 24.5 23.5 16.3 28.7 28.6 6.6 12.7 8.4 26.4 10.8 5.1 10.8 14.3 16.9 27.8 11.3 50.3 7.6 20.3 21.4 23.9 16.7 45.0 9.8 28.9 17.9 11.8 8.3 36.3 26.5 13.2 12.9 16.9 10.7 7.8 12.6 22.8 8.0 16.6 10.1 17.1 16.1 13.4 9.8 14.9 5.2 11.3 10.7 12.1 9.0 9.6 9.1 16.3 8.2 13.1 7.6 10.9 7.9 63.8 63.5 28.8 43.3 68.3 48.3 75.0 28.9 51.1 55.0 95.3 106.1 25.9 55.1 58.7 77.3 44.2 50.9 123.1 95.5 26.2 31.4 49.4 6.6 70.7 85.1 86.2 65.1 0.0 50.4 50.0 55.7 71.0 34.8 29.3 26.9 101.7 101.8 51.5 44.8 54.2 58.7 48.5 65.8 19.0 68.1 106.0 84.7 57.5 75.7 38.3 61.1 116.4 75.0 66.6 52.2 61.1 70.9 23.5 54.7 68.6 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109431-103479863 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 35.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 167.3;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 86.1;Spermatocytes: 64.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Group enriched" "Detected in many" 5 "NK-cells: 2.9;T-cells: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.0" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA039015: AB_2676309, HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favorable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 7.3 5.7 6.3 3.8 8.9 1.4 8.4 13.2 9.3 11.5 4.8 5.5 11.0 4.1 11.3 9.6 3.9 14.6 7.8 3.7 7.1 7.1 8.5 2.6 10.2 2.6 4.8 7.9 11.4 5.1 24.2 35.7 3.9 11.2 7.6 2.6 6.2 4.5 10.7 1.6 5.7 3.4 7.8 5.1 4.8 4.2 14.3 5.2 1.1 10.7 3.0 2.4 6.1 6.6 0.5 0.4 0.4 0.2 2.9 2.2 0.0 1.0 2.2 5.7 2.8 8.0 18.0 0.3 3.2 5.2 5.4 5.8 1.2 1.1 0.0 4.5 6.2 2.5 4.3 4.4 6.0 4.3 0.0 4.1 0.8 3.7 0.1 7.7 1.7 1.0 11.2 2.3 12.1 13.9 8.4 2.1 1.1 0.1 0.0 6.9 4.1 0.5 0.4 1.5 0.0 6.1 0.0 4.7 0.1 5.8 0.7 4.1 2.9 5.1 1.4 2.4 1.4 5.3 1.1 5.1 6.5 2.6 6.1 2.1 0.0 0.0 0.0 1.9 5.2 1.9 0.4 0.2 0.0 0.9 0.1 2.2 0.5 0.7 1.1 0.4 0.3 0.8 1.1 0.0 2.9 0.1 0.2 0.0 0.0 6.3 8.9 13.2 9.3 7.1 7.1 4.8 7.9 11.2 5.2 0.0 12.5 0.0 11.5 6.0 22.2 9.4 2.5 167.3 23.9 26.2 106.0 0.3 1.7 5.6 13.4 9.0 0.0 0.0 3.1 0.4 14.8 5.9 3.5 0.8 2.0 30.2 16.6 6.7 1.5 6.5 19.2 3.8 8.5 0.0 0.8 17.7 6.8 1.1 17.3 14.8 86.1 19.4 11.3 64.2 10.4 4.8 0.5 2.5 0.9 5.7 DYNC2LI1 "CGI-60, D2LIC, DKFZP564A033, LIC3" ENSG00000138036 "Dynein cytoplasmic 2 light intermediate chain 1" Q8TCX1 2 43774039-43810010 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 111.1;Early spermatids: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062905 Approved Approved Cytosol NA NA Cytosol "HPA062905: AB_2684899" "unprognostic (3.46e-1)" "unprognostic (3.25e-1)" "unprognostic (1.75e-1)" "unprognostic (2.49e-2)" "unprognostic (2.89e-2)" "unprognostic (4.05e-2)" "unprognostic (1.84e-3)" "unprognostic (9.85e-2)" "unprognostic (2.87e-2)" "unprognostic (1.22e-1)" "unprognostic (1.85e-2)" "unprognostic (1.91e-1)" "prognostic favorable (2.73e-5)" "unprognostic (1.06e-1)" "unprognostic (1.48e-2)" "unprognostic (4.32e-2)" "unprognostic (4.60e-2)" 11.2 18.2 16.9 8.9 32.2 4.4 23.3 8.1 25.3 24.2 10.7 9.8 22.7 13.1 25.1 34.0 8.5 38.1 14.7 11.5 17.2 18.0 35.2 9.3 16.4 6.5 13.9 24.8 29.2 11.8 25.5 39.8 9.6 28.7 15.3 13.0 13.2 11.5 22.4 12.0 11.0 11.2 14.3 19.0 7.5 11.9 29.0 13.0 5.9 24.3 9.0 6.8 11.4 10.4 5.1 4.0 13.3 5.1 3.2 3.9 2.2 8.7 4.9 8.8 5.6 14.4 28.9 7.6 4.9 10.6 5.8 5.4 1.7 6.1 5.0 10.8 6.4 7.4 5.8 4.2 7.0 6.7 6.4 9.0 3.9 2.4 6.3 13.9 7.4 6.4 17.0 10.1 11.5 5.3 17.7 7.9 6.0 11.8 2.4 8.0 4.5 3.7 8.5 4.0 11.4 5.1 5.1 8.2 1.5 47.7 7.6 6.1 10.9 5.5 3.0 6.1 8.8 8.5 7.0 5.5 5.1 4.6 6.2 4.0 9.1 5.0 1.2 11.3 1.9 5.4 13.3 3.0 2.8 2.5 5.1 2.6 5.1 3.1 3.4 4.0 3.2 3.9 3.4 1.3 3.2 3.8 2.5 1.9 2.2 16.9 32.2 8.1 25.3 17.2 18.0 13.9 24.8 28.7 13.0 17.9 12.6 6.4 15.0 8.7 18.8 11.9 17.8 111.1 18.2 50.6 27.5 16.5 76.3 18.8 99.7 8.3 10.3 0.0 19.5 7.9 24.6 13.1 17.3 6.4 10.7 15.9 12.2 14.7 3.9 21.2 30.8 6.0 21.9 1.0 18.6 27.4 13.8 21.2 31.8 69.2 36.0 19.4 7.1 86.9 14.7 8.0 7.8 2.5 13.0 12.4 DYNLL1 "DLC1, DLC8, DNCL1, hdlc1, LC8, PIN" ENSG00000088986 "Dynein light chain LC8-type 1" P63167 12 120469850-120498493 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport" "Activator, Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 2849.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA Yes 650000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (2.88e-2)" "unprognostic (5.63e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (4.41e-3)" "unprognostic (4.64e-2)" "unprognostic (6.17e-3)" "unprognostic (1.61e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (7.97e-7)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (7.91e-2)" "unprognostic (1.62e-1)" 45.5 48.5 128.5 34.4 97.8 21.9 54.3 48.4 120.5 50.6 61.8 61.9 31.1 31.6 47.2 64.9 113.7 107.1 46.7 44.2 124.1 105.2 49.7 40.7 40.3 41.2 92.9 90.7 49.0 45.7 30.4 46.4 49.8 67.4 39.9 64.5 24.8 34.0 54.9 15.0 117.3 38.9 75.2 93.6 30.4 45.1 59.4 56.8 35.4 37.1 84.3 65.6 59.0 63.0 55.0 80.6 73.6 55.0 46.7 63.4 50.8 78.6 89.9 89.2 68.4 78.4 83.2 28.7 108.9 50.3 88.9 53.4 84.7 53.1 44.1 58.8 104.0 87.0 71.0 106.0 91.0 88.9 58.4 69.4 43.1 64.5 114.6 79.2 45.0 71.7 50.5 97.5 66.6 54.7 98.8 92.3 47.8 54.0 50.9 117.3 104.1 58.6 97.8 73.2 101.0 104.9 59.9 46.2 54.7 127.0 72.9 61.3 45.3 88.7 77.1 98.8 97.4 76.4 65.8 71.0 68.5 58.5 60.4 93.7 30.6 58.8 43.8 75.9 70.3 87.6 73.6 49.5 63.6 37.7 51.4 28.7 55.0 39.0 39.0 49.1 36.5 25.2 31.5 9.1 46.7 55.0 80.6 63.4 50.8 128.5 97.8 48.4 120.5 124.1 105.2 92.9 90.7 67.4 56.8 181.7 88.8 250.9 293.4 819.1 137.3 144.1 321.0 1203.2 211.5 378.6 78.5 490.2 943.3 628.7 1147.1 421.8 466.9 116.8 472.1 694.2 640.5 264.0 307.3 460.6 658.6 81.0 461.6 421.7 304.4 2849.5 478.4 414.2 565.2 861.2 700.1 95.2 648.6 662.9 659.7 842.5 153.7 362.2 584.0 638.3 583.5 1407.5 841.8 195.6 373.7 348.8 DYNLL2 "Dlc2, DNCL1B, MGC17810, RSPH22" ENSG00000264364 "Dynein light chain LC8-type 2" Q96FJ2 17 58083415-58095536 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 366.0;Late spermatids: 723.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (7.22e-2)" "unprognostic (7.76e-2)" "unprognostic (3.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.93e-1)" "unprognostic (3.72e-2)" "unprognostic (6.78e-2)" "unprognostic (2.91e-2)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "prognostic favorable (5.26e-4)" "unprognostic (1.24e-1)" "prognostic favorable (1.12e-12)" "unprognostic (2.87e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-1)" "unprognostic (7.02e-2)" 15.4 28.3 38.6 11.1 55.2 9.9 11.6 41.1 41.1 12.9 14.5 22.6 16.3 16.2 12.0 15.6 11.9 13.5 13.3 43.8 32.2 40.2 28.1 23.1 11.8 9.4 48.3 28.7 14.4 11.8 36.2 15.0 19.7 40.6 20.6 13.7 15.5 19.2 18.8 64.8 12.6 15.6 14.3 32.5 11.2 12.7 19.0 27.2 7.6 22.0 15.1 11.8 9.9 16.4 1.5 0.8 3.5 3.0 1.5 3.1 0.8 20.7 14.1 29.1 13.2 18.1 10.0 46.3 21.0 8.4 10.2 8.0 31.3 10.1 18.6 23.9 13.0 12.2 11.2 13.4 16.6 17.6 18.3 9.7 20.1 8.3 18.3 14.4 21.5 12.5 10.0 11.4 11.8 9.4 10.7 6.7 15.8 20.0 11.3 9.8 31.4 24.3 8.9 20.0 13.7 14.5 22.5 17.1 7.7 8.8 22.7 19.9 15.9 18.8 7.6 16.0 15.7 22.5 10.1 12.2 20.1 25.3 13.3 15.4 21.2 25.7 22.7 10.3 17.3 14.0 3.5 1.1 2.0 2.6 0.6 2.9 1.3 2.1 2.3 0.5 1.5 2.2 3.1 1.7 1.5 3.0 0.8 1.4 0.8 38.6 55.2 41.1 41.1 32.2 40.2 48.3 28.7 40.6 27.2 11.9 49.9 27.4 30.9 43.6 58.8 158.5 38.2 14.7 29.6 57.6 37.3 88.3 26.6 31.4 366.0 29.3 47.1 23.3 27.0 62.0 29.2 30.1 22.0 85.9 36.0 66.7 64.5 22.1 21.7 723.4 27.3 23.1 62.4 27.1 52.5 69.7 32.5 40.3 25.1 66.7 36.2 25.8 38.5 40.0 41.2 40.3 50.2 19.2 44.1 28.3 DYRK1A "DYRK, DYRK1, MNBH" ENSG00000157540 "Dual specificity tyrosine phosphorylation regulated kinase 1A" Q13627 21 37365573-37526358 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015323, HPA015810" Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA015323: AB_1847922, HPA015810: AB_1847921" "unprognostic (2.71e-1)" "unprognostic (3.35e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-2)" "unprognostic (4.17e-2)" "unprognostic (1.41e-1)" "unprognostic (1.67e-1)" "unprognostic (9.28e-2)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (9.95e-2)" "unprognostic (7.39e-2)" "unprognostic (9.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (3.14e-1)" "unprognostic (1.40e-2)" 20.0 18.5 19.2 23.4 20.0 49.7 19.9 31.6 24.6 23.7 23.0 16.3 17.6 15.4 24.4 18.7 16.8 19.4 19.0 23.2 18.8 17.9 16.9 16.1 24.8 27.3 15.5 17.8 25.7 17.8 31.0 25.1 25.0 14.0 17.6 18.1 18.5 18.7 22.7 39.8 20.1 18.7 22.7 13.8 24.1 18.5 23.5 16.3 60.9 22.7 17.4 22.1 22.7 29.3 3.0 3.3 6.0 2.5 1.3 3.8 0.8 10.4 8.1 16.6 11.6 7.9 8.6 14.7 9.3 11.8 9.4 9.9 11.5 9.2 14.0 6.3 16.2 12.4 7.1 12.1 9.0 11.1 21.4 5.2 41.4 13.5 7.0 11.8 16.3 15.2 8.7 10.8 12.2 18.7 10.8 9.7 19.8 15.6 32.5 9.8 10.4 21.4 11.2 17.5 10.3 4.8 27.8 9.1 12.9 9.8 13.6 17.1 9.6 21.1 14.5 14.5 5.8 13.5 15.2 12.4 12.9 3.9 8.0 7.7 22.1 17.1 20.0 10.2 18.4 14.0 5.5 1.5 2.0 3.4 2.1 2.1 2.8 3.6 2.6 1.8 3.0 3.8 3.7 6.0 1.3 2.5 3.3 3.1 0.8 19.2 20.0 31.6 24.6 18.8 17.9 15.5 17.8 14.0 16.3 17.9 21.0 14.9 21.8 33.3 28.8 68.6 17.8 18.7 21.6 10.4 25.5 8.2 0.0 11.5 21.3 24.8 20.2 23.3 12.6 9.6 20.6 24.7 24.3 15.3 13.8 44.5 20.5 28.3 24.3 15.3 15.0 20.8 23.6 6.4 16.5 15.6 16.7 20.4 18.4 8.1 19.4 12.9 24.5 15.8 14.0 27.7 12.8 30.6 13.6 28.3 DYRK2 ENSG00000127334 "Dual specificity tyrosine phosphorylation regulated kinase 2" Q92630 12 67648338-67665406 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 72.1;Horizontal cells: 76.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027230, HPA056902" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027230: AB_1847925, HPA056902: AB_2683271" "unprognostic (5.86e-3)" "unprognostic (4.18e-1)" "unprognostic (4.08e-3)" "unprognostic (2.56e-3)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (7.83e-2)" "unprognostic (2.83e-2)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (2.12e-2)" "unprognostic (2.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "unprognostic (1.35e-1)" 12.2 5.3 4.5 20.1 4.8 8.6 8.1 4.4 6.6 10.1 21.3 4.1 8.3 13.7 14.6 9.6 9.6 9.1 16.9 26.1 4.7 3.2 6.3 4.6 10.1 17.9 4.0 3.3 7.6 8.5 3.6 4.4 13.0 5.0 7.1 15.3 6.6 7.2 6.6 23.7 9.4 26.0 11.2 5.3 10.3 14.0 4.4 3.9 34.3 7.6 12.5 17.2 11.1 12.2 2.7 1.9 5.9 1.3 6.9 6.8 1.6 13.8 7.8 11.7 8.4 5.9 8.1 9.4 14.1 9.2 6.9 3.9 10.3 7.7 25.8 17.4 20.3 4.2 16.1 9.3 5.5 7.4 11.1 12.2 4.1 5.2 3.9 2.3 9.4 9.1 6.6 7.9 18.6 14.9 11.7 3.8 11.0 5.1 13.5 8.8 7.9 8.0 4.6 10.1 9.0 12.6 21.5 11.6 11.4 8.0 17.4 15.5 18.3 5.9 7.9 8.1 8.3 5.4 7.9 5.7 11.0 10.4 7.5 11.1 6.5 1.0 14.3 10.5 6.4 11.3 3.2 0.5 5.9 5.2 1.3 4.0 2.7 3.9 6.8 1.9 2.7 3.3 6.1 0.7 6.9 1.3 0.8 3.1 1.6 4.5 4.8 4.4 6.6 4.7 3.2 4.0 3.3 5.0 3.9 8.9 12.2 6.4 9.1 10.1 17.2 33.5 22.9 12.0 10.3 1.8 21.6 2.7 0.0 17.2 0.4 10.5 72.1 0.0 15.8 6.4 18.2 11.3 5.7 4.7 14.1 76.3 23.6 6.2 11.6 1.6 10.6 9.8 8.5 6.4 50.5 15.3 15.6 48.2 12.4 7.5 21.9 12.9 21.1 2.5 8.7 14.2 3.8 21.0 26.7 28.1 DYRK3 "hYAK3-2, RED, REDK" ENSG00000143479 "Dual specificity tyrosine phosphorylation regulated kinase 3" O43781 1 206635536-206684419 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.2" "Cell type enriched" "Detected in many" 6 "Early spermatids: 160.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA075041 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA075041: AB_2686730" "unprognostic (6.51e-2)" "unprognostic (1.24e-2)" "unprognostic (3.36e-2)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-4)" "unprognostic (2.69e-1)" "unprognostic (3.91e-1)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (9.41e-7)" "unprognostic (2.38e-1)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (7.62e-3)" 7.1 2.7 4.2 4.2 3.5 6.2 7.7 1.3 2.7 5.6 2.7 2.6 3.7 1.2 7.6 5.1 2.7 6.2 12.8 16.3 6.0 3.4 3.4 7.4 5.0 1.6 2.6 2.0 7.6 5.2 2.8 11.2 1.2 4.6 4.5 1.5 4.1 5.5 3.0 2.1 2.0 2.1 7.5 2.7 1.8 3.7 38.2 3.1 5.1 11.9 3.0 1.7 5.4 7.6 0.0 6.1 0.0 0.1 0.0 0.3 0.0 2.5 3.5 0.8 4.9 8.7 7.8 0.1 8.2 18.1 7.5 9.7 0.2 1.3 3.7 1.2 9.6 13.2 0.7 4.2 6.6 8.0 0.0 2.8 5.4 4.4 0.8 13.8 3.7 3.5 5.5 4.3 12.9 35.7 7.7 5.8 5.7 10.4 0.7 11.5 0.9 8.2 2.1 6.9 0.2 6.5 20.4 2.6 0.0 2.4 0.1 5.0 3.7 7.3 0.3 10.0 1.0 0.9 0.9 4.3 15.7 5.9 7.6 6.8 2.9 1.1 4.4 9.3 4.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 4.2 3.5 1.3 2.7 6.0 3.4 2.6 2.0 4.6 3.1 3.0 5.1 0.5 10.3 5.8 0.1 10.3 2.5 13.4 5.7 1.8 9.8 0.0 0.0 3.0 160.9 4.2 0.0 0.0 1.9 0.1 7.3 3.2 0.0 1.1 0.9 0.0 2.4 2.5 1.5 27.7 3.7 1.9 8.5 1.8 0.3 3.0 1.4 0.0 1.8 1.0 7.4 6.5 10.3 17.6 3.4 3.1 0.3 0.0 0.2 3.5 DZIP1 "DZIP, KIAA0996" ENSG00000134874 "DAZ interacting zinc finger protein 1" Q86YF9 13 95578202-95644703 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 9 "Early spermatids: 313.9;Late spermatids: 570.8;Spermatocytes: 228.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054891, HPA057272, HPA070194" Uncertain Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Cytosol" "Centriolar satellite" "HPA054891: AB_2682631, HPA057272: AB_2683390, HPA070194: AB_2686233" "unprognostic (6.74e-3)" "unprognostic (7.65e-2)" "unprognostic (1.94e-1)" "unprognostic (4.64e-3)" "unprognostic (4.82e-2)" "unprognostic (5.52e-3)" "unprognostic (6.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.34e-2)" "unprognostic (8.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.41e-3)" "unprognostic (1.48e-1)" "unprognostic (3.64e-2)" "unprognostic (3.89e-3)" 5.0 6.3 17.2 4.4 17.4 0.4 3.7 13.9 16.1 11.5 6.7 4.1 3.8 2.2 16.2 10.7 6.2 10.7 8.5 3.8 13.1 18.1 16.2 1.7 4.0 3.6 8.7 13.5 24.2 9.6 0.9 8.9 4.6 8.8 7.7 3.7 5.8 3.2 13.3 1.7 1.1 2.6 12.3 5.6 2.8 3.6 27.3 4.5 0.6 1.7 1.8 3.5 5.0 5.2 0.4 0.2 1.2 0.2 0.3 0.3 0.0 1.3 5.0 16.9 17.2 13.1 16.3 3.4 12.2 14.2 13.7 16.5 0.1 0.0 0.0 2.8 9.7 6.2 0.0 11.2 4.5 15.5 0.9 10.0 15.6 3.8 10.6 9.1 0.0 0.1 11.5 0.3 4.2 5.6 22.2 9.2 1.1 0.0 0.0 10.0 0.0 0.0 0.0 7.7 0.0 0.4 0.0 11.6 0.0 13.1 1.8 4.2 11.0 9.3 0.0 0.5 20.8 0.0 5.8 0.7 13.6 6.6 1.8 10.0 0.0 0.0 0.0 3.5 0.0 2.4 1.2 0.2 0.2 0.3 0.1 0.2 0.2 0.1 0.2 0.0 0.4 0.1 0.3 1.1 0.3 0.1 0.2 0.1 0.0 17.2 17.4 13.9 16.1 13.1 18.1 8.7 13.5 8.8 4.5 0.0 0.0 0.0 1.1 0.6 17.7 2.9 0.0 17.4 5.7 1.8 3.9 3.9 6.6 13.1 313.9 2.7 0.0 0.0 0.2 1.8 10.6 0.5 0.0 0.0 0.5 6.4 0.0 3.1 0.0 570.8 35.9 1.2 3.3 3.6 0.0 6.2 0.8 0.0 41.1 19.5 1.2 19.4 13.2 228.9 7.0 0.9 1.5 0.0 0.0 0.3 E2F3 ENSG00000112242 "E2F transcription factor 3" O00716 6 20401906-20493715 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029779, HPA065012" Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA029779: AB_2732448, HPA065012: AB_2685403" "unprognostic (4.10e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.80e-3)" "unprognostic (2.96e-1)" "unprognostic (9.14e-2)" "unprognostic (8.99e-3)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "prognostic favorable (1.69e-4)" "unprognostic (1.14e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.63e-8)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (3.50e-1)" "unprognostic (5.99e-3)" 9.5 8.4 7.6 12.2 13.4 22.1 10.8 1.7 10.1 4.8 7.1 2.9 3.2 6.8 6.3 6.9 8.0 4.9 9.9 11.1 8.3 6.8 14.6 6.1 7.8 19.7 5.8 7.3 4.0 3.6 2.9 3.2 7.4 7.9 5.0 8.6 5.1 4.7 4.5 15.1 4.3 8.0 7.9 5.0 16.9 5.0 8.9 3.1 17.7 11.4 10.2 12.0 9.2 4.8 0.7 3.7 10.3 3.1 4.8 3.6 1.5 6.8 5.6 16.1 17.3 5.4 6.0 11.2 9.3 8.1 8.9 9.9 6.9 4.3 15.4 18.0 8.6 8.3 7.2 18.4 8.3 15.0 6.0 13.0 27.9 9.3 7.7 5.8 18.3 16.8 4.8 6.2 8.7 10.7 9.2 6.1 14.7 30.9 9.5 10.1 7.1 20.7 20.5 12.1 5.3 5.8 22.6 14.2 17.7 10.6 11.9 11.6 21.3 8.6 11.9 12.2 10.3 6.1 11.1 8.2 14.4 9.0 7.1 14.7 6.0 19.0 19.3 3.5 11.3 20.4 6.9 3.1 1.4 2.3 2.3 3.1 0.7 1.5 3.6 3.7 0.7 1.3 2.8 10.3 4.8 1.5 1.6 2.2 1.5 7.6 13.4 1.7 10.1 8.3 6.8 5.8 7.3 7.9 3.1 0.0 1.6 8.2 10.8 8.1 35.1 8.9 7.6 0.0 12.5 7.0 21.6 6.3 8.3 7.0 10.2 5.2 7.9 0.0 5.9 11.3 10.4 18.4 19.7 5.0 14.5 30.2 11.5 19.0 49.7 5.0 2.6 18.9 5.0 8.2 11.3 2.1 11.2 11.6 2.8 20.5 9.2 0.0 8.2 2.7 3.2 7.9 2.6 9.6 12.7 14.2 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.3" "Group enriched" "Detected in some" 5 "Ciliated cells: 8.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.9" "Lineage enriched" "Detected in single" 24 "T-cells: 2.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoli "Nucleoplasm, Cytosol" "HPA064882: AB_2685381, HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 1.0 0.4 0.4 7.2 0.2 11.5 0.3 0.2 0.4 1.6 3.6 0.2 0.2 3.3 1.2 1.4 8.2 0.9 2.0 3.4 0.2 0.2 0.4 0.5 0.8 6.1 0.2 0.2 0.7 0.3 0.0 0.2 4.0 0.2 0.6 4.8 1.2 1.8 0.9 11.5 2.6 4.6 0.7 0.2 2.4 5.1 4.7 0.2 30.3 0.3 8.0 12.5 3.4 2.1 0.0 0.1 0.0 0.0 0.0 2.9 0.4 14.2 4.2 4.4 6.1 0.2 0.6 18.9 7.9 2.2 9.3 10.1 14.7 4.7 14.1 3.3 2.5 5.5 12.6 10.7 1.0 8.4 9.5 8.7 4.9 2.4 4.0 0.0 7.4 11.8 0.2 0.0 1.9 0.6 0.5 13.0 10.1 10.3 13.7 3.7 6.9 14.6 9.3 4.0 16.1 6.0 15.9 8.2 9.5 4.0 9.6 3.8 4.3 3.5 7.0 0.8 2.4 4.8 8.0 2.5 4.5 5.6 11.0 7.1 4.7 9.5 17.9 5.7 14.7 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 1.5 0.0 1.0 0.0 2.0 0.0 8.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 23.3 0.0 1.4 0.6 0.0 0.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.1 0.3 0.2 0.0 2.6 0.6 EAPP "BM036, C14orf11, FLJ20578" ENSG00000129518 "E2F associated phosphoprotein" Q56P03 14 34515929-34539711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002916 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA002916: AB_1078715" "unprognostic (8.76e-3)" "unprognostic (1.27e-3)" "unprognostic (2.08e-3)" "unprognostic (1.94e-1)" "unprognostic (4.59e-2)" "unprognostic (1.64e-1)" "unprognostic (2.80e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.81e-1)" "unprognostic (6.38e-2)" "unprognostic (2.05e-1)" "unprognostic (7.80e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.64e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.96e-4)" "unprognostic (3.24e-2)" 30.1 32.8 24.4 23.1 23.5 53.4 36.5 32.4 30.1 30.0 35.0 20.6 25.3 24.7 27.9 33.0 26.3 28.5 19.9 19.9 22.8 26.4 30.1 34.4 20.5 23.2 21.8 25.3 37.3 22.5 31.1 28.1 33.8 27.8 29.4 36.8 21.6 27.3 27.8 41.3 39.1 43.2 23.8 20.9 26.5 23.5 21.6 24.2 34.8 34.1 22.6 24.8 27.7 31.2 36.8 19.3 50.2 26.2 33.6 42.3 24.8 15.1 18.6 17.4 10.2 20.7 21.2 27.1 14.0 21.5 17.5 18.4 8.8 20.2 15.9 19.9 17.0 10.5 14.3 12.8 18.6 20.7 19.8 11.3 11.6 14.6 37.1 28.2 20.6 12.9 24.3 24.0 10.0 26.0 23.2 17.4 22.5 11.5 17.7 16.3 35.5 28.5 16.7 10.2 28.3 20.9 18.1 20.9 15.9 21.1 20.7 14.0 15.5 19.8 19.2 29.8 17.5 33.4 13.2 18.8 9.2 7.8 11.8 9.0 22.4 25.0 16.9 8.6 11.4 11.5 40.7 22.0 45.2 24.8 20.1 29.7 36.8 31.1 28.0 19.3 33.7 31.8 28.8 50.2 33.6 26.2 16.9 42.3 24.8 24.4 23.5 32.4 30.1 22.8 26.4 21.8 25.3 27.8 24.2 20.8 44.0 56.1 67.2 41.2 75.1 29.7 53.5 104.4 45.5 78.5 29.5 102.7 147.6 71.8 11.9 52.6 81.1 23.3 74.0 64.7 52.1 52.3 71.6 87.3 51.6 23.8 63.4 45.4 51.6 7.4 82.8 55.7 86.0 63.1 99.8 110.6 51.5 112.6 88.8 94.6 66.9 71.1 50.1 103.2 38.4 58.2 158.4 91.3 92.5 44.8 ECD "GCR2, hSGT1" ENSG00000122882 "Ecdysoneless cell cycle regulator" O95905 10 73130155-73169055 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006465 Approved Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA006465: AB_2667595" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (2.19e-1)" "unprognostic (2.75e-2)" "unprognostic (4.71e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (1.22e-1)" "unprognostic (3.55e-2)" "unprognostic (6.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (7.05e-2)" "unprognostic (3.84e-2)" 23.2 22.3 22.2 22.4 23.8 34.8 23.2 34.7 27.0 20.4 18.6 21.8 20.0 15.6 23.7 20.9 21.2 17.0 20.6 18.8 17.9 16.9 22.4 23.6 17.7 21.4 23.4 16.7 24.1 21.1 32.5 32.1 23.4 25.5 21.8 18.1 16.7 21.4 21.3 19.9 23.3 16.8 19.9 19.4 20.5 18.5 25.4 23.1 32.7 24.2 18.7 22.4 22.1 20.7 20.4 16.8 23.3 26.3 25.4 27.2 15.7 18.9 13.7 15.6 23.6 14.3 14.2 12.8 14.8 23.3 24.2 28.4 24.8 20.0 14.9 14.6 14.5 18.1 15.9 16.6 17.6 24.9 12.1 16.2 18.8 11.2 17.7 21.7 22.4 12.6 15.9 14.7 20.3 25.6 18.7 25.8 13.6 19.4 10.5 22.8 16.0 20.1 12.4 15.9 17.7 39.7 14.9 17.3 8.1 19.4 14.1 6.9 12.9 13.4 30.5 19.0 16.8 17.5 10.8 15.8 10.6 21.4 11.3 17.0 12.2 8.2 25.4 19.7 18.8 9.0 15.0 19.3 20.9 21.8 20.5 23.2 20.4 20.6 21.4 16.8 18.6 27.2 19.4 23.3 25.4 26.3 11.5 19.7 15.7 22.2 23.8 34.7 27.0 17.9 16.9 23.4 16.7 25.5 23.1 26.8 8.9 6.1 23.3 9.7 13.9 10.5 10.2 6.7 23.9 7.0 23.6 20.2 6.6 13.1 32.2 15.5 8.9 23.3 10.7 12.7 11.4 10.9 18.5 8.1 14.5 19.1 10.4 18.4 16.5 7.8 14.7 9.4 13.5 8.2 9.7 9.9 12.3 3.5 12.4 10.3 12.4 6.5 12.7 27.0 12.6 9.5 27.8 13.1 7.3 23.3 ECM1 ENSG00000143369 "Extracellular matrix protein 1" Q16610 1 150508062-150513789 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Biomineralization, Mineral balance, Osteogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 80.6;Ito cells: 56.4;Melanocytes: 70.9;Pancreatic endocrine cells: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.2;myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 77.4;BJ hTERT+: 53.9;fHDF/TERT166: 50.8;hTEC/SVTERT24-B: 36.5;LHCN-M2: 39.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA027241, HPA076029" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 12000000000 Cytosol Nucleoplasm "HPA027241: AB_1847976, HPA076029: " "unprognostic (2.89e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-2)" "unprognostic (1.09e-1)" "unprognostic (6.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.15e-2)" "unprognostic (4.90e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.33e-2)" "prognostic unfavorable (1.51e-9)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.20e-5)" 16.1 2.5 0.9 1.8 1.3 0.1 11.0 0.9 4.2 37.9 2.8 0.1 7.4 1.5 10.5 133.2 257.1 3.3 30.7 11.6 0.9 1.0 2.5 16.7 3.8 0.2 1.0 1.7 3.0 0.8 0.3 2.0 20.2 4.2 2.6 3.1 1.6 28.7 2.9 3.5 11.5 2.0 5.3 0.8 3.6 2.1 5.9 0.0 0.0 1.8 45.5 107.2 6.0 46.6 0.0 1.8 0.0 1.2 0.0 0.4 1.3 6.2 0.6 2.3 0.0 14.0 77.4 2.1 22.7 53.9 14.2 18.6 0.3 3.5 0.1 0.2 50.8 1.6 13.1 0.0 2.7 14.9 0.1 0.1 0.9 0.8 0.1 3.9 0.0 23.5 6.8 0.1 36.5 1.3 20.9 3.9 0.1 4.8 0.1 39.5 0.0 0.0 0.7 0.2 26.5 0.7 0.3 17.0 0.1 0.5 0.0 0.1 0.0 5.2 0.1 19.4 1.1 0.0 6.0 1.0 30.1 4.5 3.4 4.9 0.1 0.2 0.2 15.8 2.1 4.0 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 1.3 0.9 4.2 0.9 1.0 1.0 1.7 4.2 0.0 0.0 0.6 1.4 1.8 13.1 0.7 1.1 12.7 0.0 2.3 3.5 0.0 1.3 0.0 4.8 0.2 4.4 0.2 0.0 3.7 26.0 80.6 1.0 10.3 0.6 16.0 1.6 0.0 56.4 2.1 0.0 9.2 4.8 70.9 0.0 0.3 0.8 42.0 0.0 20.8 0.0 1.1 12.9 16.1 0.5 0.4 16.7 9.2 0.0 0.2 5.8 ECSIT SITPEC ENSG00000130159 "ECSIT signalling integrator" Q9BQ95 19 11505916-11529174 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042979 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042979: AB_10964063" "unprognostic (9.88e-2)" "unprognostic (3.57e-3)" "unprognostic (2.93e-1)" "unprognostic (3.55e-3)" "unprognostic (2.27e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "unprognostic (1.24e-1)" "unprognostic (2.92e-1)" "unprognostic (2.18e-1)" "unprognostic (1.01e-2)" "unprognostic (4.08e-2)" "prognostic favorable (1.48e-9)" "unprognostic (2.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (5.95e-2)" 15.3 16.8 13.8 10.7 15.5 12.9 12.8 20.0 24.5 13.5 21.0 9.5 11.1 24.2 13.1 6.8 19.7 16.2 13.8 49.5 12.9 11.6 15.6 27.7 8.4 9.9 13.5 10.8 27.2 28.5 14.7 10.5 6.4 12.5 16.3 12.0 13.2 26.8 11.0 64.2 11.8 17.9 12.9 9.1 10.1 18.4 8.2 11.9 13.8 21.4 29.5 12.7 14.1 14.2 21.4 22.3 6.2 20.9 13.1 18.6 15.2 15.0 13.6 8.2 12.1 12.8 14.6 9.2 8.0 11.0 17.5 14.3 20.3 10.5 22.5 17.3 10.5 14.9 20.4 20.9 17.1 6.2 12.9 17.1 21.0 8.8 18.4 12.5 12.0 17.6 15.3 18.8 14.3 16.0 9.1 12.9 21.1 22.7 23.5 6.5 20.8 20.9 17.9 22.4 19.7 36.6 20.9 8.8 30.0 9.5 9.7 31.7 20.0 9.6 16.2 16.2 3.9 18.4 18.2 6.6 18.4 12.8 26.0 15.0 21.0 40.5 11.2 15.3 18.0 13.1 2.1 17.2 6.2 15.2 20.9 17.3 21.4 16.5 14.1 22.3 20.3 18.6 16.9 3.5 13.1 18.6 12.6 18.1 15.2 13.8 15.5 20.0 24.5 12.9 11.6 13.5 10.8 12.5 11.9 8.9 14.9 23.9 52.4 39.5 21.3 69.0 38.2 17.4 17.0 19.2 11.8 33.5 69.6 33.6 15.8 25.3 48.3 0.0 67.2 36.4 26.8 37.2 23.0 46.1 27.4 17.5 35.8 20.9 28.3 43.1 31.9 21.0 27.0 10.0 44.9 20.5 38.7 23.0 30.1 82.0 26.1 32.3 45.3 14.1 40.7 36.6 21.1 21.3 78.1 50.6 ECT2 ARHGEF31 ENSG00000114346 "Epithelial cell transforming 2" Q9H8V3 3 172750682-172821474 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Guanine-nucleotide releasing factor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.8" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 60.9;Erythroid cells: 70.0;Spermatogonia: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036363, HPA053261" Enhanced Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA036363: AB_2732472, HPA053261: AB_2682094" "unprognostic (3.83e-2)" "unprognostic (4.34e-1)" "unprognostic (1.27e-2)" "unprognostic (4.22e-3)" "unprognostic (4.49e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.82e-6)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.82e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (1.33e-1)" 6.4 6.0 5.4 9.9 7.2 16.3 7.4 11.1 7.6 9.0 11.0 2.6 2.1 9.1 4.6 2.8 14.9 3.2 6.6 4.2 5.4 5.0 10.1 4.3 8.9 9.6 6.7 5.8 3.2 4.1 4.0 6.1 11.1 10.2 4.1 16.1 2.4 9.0 2.7 2.9 7.0 7.6 7.2 8.4 8.7 9.2 14.7 6.8 50.8 5.7 9.3 10.8 8.0 6.5 2.8 2.6 10.4 3.2 1.3 3.6 1.0 46.2 33.0 26.1 13.5 2.7 5.6 13.0 20.5 16.8 30.8 30.0 18.3 49.1 11.5 31.2 12.0 29.5 20.4 21.0 13.1 42.1 16.4 11.6 7.2 18.1 9.3 1.2 11.1 8.3 1.8 2.2 18.3 18.7 8.7 13.2 17.1 7.4 16.9 24.3 16.3 11.3 8.3 21.2 38.3 18.0 8.1 25.6 14.8 23.4 10.8 17.4 11.2 25.9 29.5 10.4 13.7 49.1 8.3 11.4 15.0 14.4 20.1 42.6 8.3 11.1 21.7 13.2 9.7 19.5 6.8 3.2 1.3 1.8 2.8 1.9 2.2 2.4 1.6 2.4 2.8 1.2 1.8 10.4 1.3 1.2 2.6 3.6 1.0 5.4 7.2 11.1 7.6 5.4 5.0 6.7 5.8 10.2 6.8 6.0 2.7 9.0 4.3 17.3 3.4 3.1 7.6 10.7 4.5 3.5 60.9 4.9 0.0 9.0 2.7 6.4 3.2 70.0 7.9 13.0 7.0 8.8 0.0 1.5 6.1 0.0 4.6 5.5 3.1 2.3 0.9 5.1 6.8 1.8 10.8 2.9 14.3 3.5 1.4 1.9 13.4 0.0 3.3 33.1 37.4 11.2 3.2 1.5 6.2 7.8 EDARADD ENSG00000186197 "EDAR associated death domain" Q8WWZ3 1 236348257-236502915 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 22.7;granulocytes: 20.9;Syncytiotrophoblasts: 18.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 6 "basophil: 24.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 24.6" "Group enriched" "Detected in some" 4 "HMC-1: 37.6;RT4: 30.4" "Group enriched" "Detected in some" 5 "olfactory region: 0.7;thalamus: 0.8" "Low region specificity" "Detected in many" HPA018836 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018836: AB_1847984" "unprognostic (3.74e-1)" "unprognostic (3.10e-2)" "unprognostic (2.92e-1)" "unprognostic (2.12e-2)" "unprognostic (2.06e-3)" "unprognostic (3.12e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (2.57e-2)" "unprognostic (5.72e-2)" "unprognostic (3.00e-1)" "unprognostic (2.47e-1)" "unprognostic (1.90e-2)" "unprognostic (9.62e-3)" 0.9 0.4 0.5 2.4 0.5 0.2 5.8 0.3 0.4 1.1 1.1 0.1 13.7 0.2 0.9 13.0 7.2 1.0 1.3 2.2 0.4 0.4 2.5 0.6 1.7 1.2 0.5 0.0 0.7 5.5 0.0 0.4 6.4 0.1 11.3 0.2 1.7 3.6 16.6 0.3 5.7 0.7 3.6 0.4 2.9 6.4 4.0 0.2 4.5 6.4 5.3 6.8 15.6 9.9 0.1 0.3 24.6 0.2 2.9 4.0 1.1 0.0 1.8 0.1 0.0 0.0 0.0 7.7 0.0 0.0 0.7 0.4 0.4 0.0 0.0 0.0 0.1 2.0 4.2 3.0 4.5 0.7 6.0 3.6 0.0 0.0 0.6 0.0 0.1 37.6 0.0 1.3 0.5 0.4 0.0 0.0 0.9 0.2 0.0 0.0 0.3 0.1 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 30.4 0.2 0.1 0.0 0.6 0.1 0.2 7.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.6 0.2 0.0 2.1 0.2 2.7 0.1 3.2 4.0 0.3 0.1 0.3 2.1 0.2 2.9 0.1 0.0 2.9 1.1 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.0 0.1 0.2 0.0 2.2 0.8 6.8 6.2 0.0 2.8 5.1 1.4 6.8 0.0 0.0 22.7 3.3 1.2 4.8 1.8 0.0 0.0 0.8 12.0 2.0 3.1 20.9 0.0 3.1 0.0 0.0 4.3 2.7 5.8 0.3 0.7 11.8 6.4 0.0 0.4 1.0 0.0 0.4 0.2 0.0 0.0 1.7 3.1 3.4 4.5 18.9 5.0 0.0 5.8 EDF1 "CFAP280, EDF-1" ENSG00000107223 "Endothelial differentiation related factor 1" O60869 9 136862119-136866286 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Activator, Calmodulin-binding, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035642 Approved Supported Nucleoplasm,Cytosol NA NA 140000 "Nucleoplasm, Cytosol" "HPA035642: AB_10611959" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (3.58e-3)" "unprognostic (4.49e-2)" "unprognostic (2.32e-1)" "unprognostic (9.05e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (4.03e-2)" "unprognostic (2.65e-2)" "unprognostic (9.76e-2)" "unprognostic (1.83e-1)" "unprognostic (2.08e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" 49.5 68.5 77.7 58.3 67.3 55.6 71.0 68.2 75.2 51.6 68.7 35.1 75.3 106.6 55.0 60.9 68.4 57.3 66.7 83.2 66.5 61.8 65.4 107.5 47.2 75.3 64.9 64.2 72.1 273.4 44.5 64.4 47.7 62.3 64.1 46.5 38.2 123.3 96.5 175.4 69.4 102.3 64.3 71.9 48.8 61.9 49.5 44.8 43.6 64.5 75.1 51.5 51.9 57.7 78.2 116.5 58.0 70.5 68.6 83.6 85.4 63.7 85.8 47.8 48.5 47.7 50.3 94.1 73.7 49.9 59.8 46.7 69.4 44.7 56.1 68.7 64.1 53.3 77.2 37.2 56.4 22.0 60.6 45.3 39.0 108.0 94.3 94.9 66.4 53.4 49.7 72.6 46.8 54.6 55.8 57.4 50.9 56.4 72.7 51.1 139.7 59.2 105.8 50.4 99.2 73.6 52.1 69.8 113.2 79.3 68.2 61.3 58.9 76.9 108.4 74.5 33.0 104.7 93.4 69.5 65.4 49.4 70.7 68.5 42.0 70.1 47.2 85.4 40.0 59.8 45.7 70.5 58.0 69.9 59.9 77.2 78.2 74.8 72.1 70.8 71.9 66.9 68.8 28.2 68.6 48.9 116.5 83.6 85.4 77.7 67.3 68.2 75.2 66.5 61.8 64.9 64.2 62.3 44.8 211.4 257.9 360.4 480.4 463.8 134.8 270.5 479.0 235.5 258.2 298.4 37.3 561.0 978.2 614.3 98.1 432.9 1611.3 163.5 1109.8 593.2 450.9 513.8 287.2 695.8 501.5 89.0 425.8 343.1 356.1 224.5 538.4 426.7 499.4 906.3 749.8 223.0 954.5 1406.3 401.0 993.5 116.5 271.7 418.6 236.6 258.3 542.3 942.8 422.7 608.2 611.5 EDN2 ET2 ENSG00000127129 "Endothelin 2" P20800 1 41478775-41484673 "Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.8" "Cell type enhanced" "Detected in many" 18 "Basal glandular cells: 145.6;Collecting duct cells: 66.3;Glandular cells: 63.5" "Cancer enhanced" "Detected in many" "cervical cancer: 24.0" "Region enriched" "Detected in single" 12 "pons and medulla: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.6;EFO-21: 21.7;HeLa: 7.3;SCLC-21H: 10.4;SK-BR-3: 25.8;U-2 OS: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA028459 Uncertain Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA028459: AB_10602490" "unprognostic (2.71e-2)" "unprognostic (5.64e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.87e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-1)" "unprognostic (5.44e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (5.81e-4)" "unprognostic (5.59e-2)" "unprognostic (1.28e-2)" "unprognostic (8.47e-2)" "unprognostic (1.76e-1)" "unprognostic (6.14e-2)" "unprognostic (3.85e-1)" 0.5 0.2 0.0 0.9 0.2 0.3 2.2 0.0 0.1 15.1 13.6 0.4 1.4 4.5 1.8 6.3 17.4 2.3 0.4 1.9 0.0 0.0 4.0 0.8 18.4 0.1 0.0 0.0 0.8 3.2 0.1 1.1 0.4 2.6 9.7 1.3 1.4 4.3 1.0 0.9 8.9 27.8 0.2 0.0 0.1 0.9 0.7 0.1 0.0 1.3 4.0 13.7 1.2 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 8.6 0.0 21.7 0.0 0.0 1.1 0.0 0.1 0.0 2.4 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.5 0.2 0.0 0.0 0.8 5.1 5.8 0.4 10.4 0.0 0.2 25.8 0.0 0.5 0.5 0.0 0.0 0.0 10.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.1 6.0 1.0 0.0 145.6 27.0 0.0 0.4 5.1 1.4 0.0 66.3 0.0 0.0 0.0 6.2 0.0 0.0 10.9 0.0 0.9 0.0 0.5 63.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.5 6.7 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.5 0.0 0.0 3.3 23.3 EDNRA ENSG00000151617 "Endothelin receptor type A" P25101 4 147480917-147544954 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 62.6;seminal vesicle: 52.3" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 40.6;Peritubular cells: 64.0;Sertoli cells: 51.8;Smooth muscle cells: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;ASC TERT1: 14.5;HHSteC: 7.4;LHCN-M2: 17.2;SH-SY5Y: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013774, CAB018957" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB018957: AB_2039838, HPA013774: AB_1847994" "unprognostic (3.08e-2)" "unprognostic (6.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-2)" "unprognostic (7.20e-2)" "unprognostic (2.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.34e-3)" "unprognostic (2.88e-1)" "prognostic unfavorable (1.50e-7)" "prognostic unfavorable (3.93e-4)" "unprognostic (6.20e-3)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" 7.6 2.6 1.3 1.4 1.8 0.0 7.2 0.6 2.4 62.6 2.6 1.0 21.7 1.5 37.3 14.2 4.7 13.3 7.3 15.1 1.3 1.3 3.1 1.4 12.7 2.0 1.8 1.0 23.5 0.9 1.9 2.2 5.9 2.7 21.5 1.5 10.3 4.1 52.3 4.8 3.2 1.8 19.4 1.6 11.5 4.4 9.1 1.4 2.9 5.0 6.0 2.6 14.7 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 4.2 0.0 7.3 14.5 0.0 2.2 2.9 0.4 0.1 0.2 0.0 0.0 0.0 0.7 0.5 0.0 0.3 0.6 0.2 0.0 1.5 0.0 2.5 0.0 7.4 0.0 0.0 5.6 0.5 0.4 0.0 2.7 0.0 0.0 0.0 1.1 17.2 0.2 0.0 0.1 1.2 0.0 0.9 0.0 0.7 0.1 1.1 0.8 0.0 13.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.6 2.4 1.3 1.3 1.8 1.0 2.7 1.4 3.0 4.0 0.0 0.6 2.7 0.0 17.1 0.0 0.0 7.9 0.0 0.0 0.2 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.1 11.8 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 40.6 0.3 3.3 0.0 0.0 0.0 0.2 0.0 64.0 0.0 0.0 51.8 84.6 0.6 0.6 2.4 0.1 0.0 0.0 0.2 EDNRB "ETB, HSCR, HSCR2" ENSG00000136160 "Endothelin receptor type B" P24530 13 77895481-77975529 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.5" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 97.7;Ito cells: 106.8;Melanocytes: 104.6;Muller glia cells: 142.7;Sertoli cells: 213.4;Smooth muscle cells: 110.2" "Group enriched" "Detected in all" 7 "glioma: 41.1;melanoma: 127.7;renal cancer: 28.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.0;intermediate monocyte: 2.1" "Lineage enriched" "Detected in single" 21 "monocytes: 2.1" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 19.2;SK-MEL-30: 23.1;U-266/70: 15.1;WM-115: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017842, HPA027546" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB017842: , HPA027546: AB_2672327" "unprognostic (7.75e-2)" "unprognostic (6.73e-2)" "unprognostic (1.41e-3)" "unprognostic (2.59e-2)" "unprognostic (8.37e-2)" "unprognostic (2.45e-3)" "unprognostic (4.17e-3)" "unprognostic (5.43e-2)" "unprognostic (1.02e-1)" "unprognostic (1.38e-2)" "unprognostic (3.40e-2)" "unprognostic (3.01e-2)" "prognostic favorable (7.20e-5)" "unprognostic (1.59e-2)" "unprognostic (3.86e-2)" "unprognostic (4.58e-2)" "unprognostic (6.77e-3)" 25.4 23.2 22.2 10.3 29.8 0.8 23.1 10.3 30.7 8.1 7.2 13.6 2.3 10.9 7.7 3.6 4.9 6.0 8.5 23.7 16.7 16.4 22.3 26.5 28.4 15.6 24.2 8.1 4.9 6.4 7.7 6.3 67.5 33.2 14.9 7.7 51.0 13.4 4.4 6.7 5.1 11.9 7.4 33.4 16.0 5.8 3.1 12.4 0.0 17.6 2.0 2.9 10.9 8.2 0.0 0.0 0.0 2.1 0.0 0.0 0.4 2.0 0.0 25.2 0.0 19.2 0.7 0.3 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 23.1 3.4 0.0 0.1 0.1 0.2 0.0 0.0 0.1 15.1 8.5 0.0 0.4 0.0 48.1 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.2 29.8 10.3 11.9 16.7 16.4 24.2 8.1 33.2 12.4 11.9 38.2 0.0 1.0 13.2 3.2 7.3 0.0 2.7 4.5 0.0 5.9 14.3 0.0 0.0 2.4 97.7 0.0 0.0 0.0 10.2 27.8 2.5 5.8 0.5 10.9 0.0 0.0 106.8 21.3 1.8 73.9 9.2 104.6 0.0 0.0 142.7 0.1 0.0 2.5 0.0 3.4 213.4 110.2 0.3 1.4 6.4 4.8 0.0 0.0 1.4 EDRF1 "C10orf137, DKFZp586F1019, FLJ21617" ENSG00000107938 "Erythroid differentiation regulatory factor 1" Q3B7T1 10 125719515-125764143 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031820 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031820: AB_10600753" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (1.53e-1)" "unprognostic (3.64e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-2)" "unprognostic (8.84e-4)" "unprognostic (4.76e-3)" "unprognostic (8.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.63e-3)" "unprognostic (4.62e-2)" "prognostic unfavorable (3.16e-5)" "unprognostic (3.44e-3)" "unprognostic (5.51e-2)" "unprognostic (1.38e-1)" "unprognostic (7.68e-3)" 9.2 6.7 6.3 16.6 9.7 27.9 9.0 20.3 10.0 10.5 8.1 7.7 6.8 7.1 12.2 8.3 7.5 9.8 6.4 7.5 7.4 5.4 5.9 5.0 7.2 12.5 8.8 7.3 13.4 14.0 6.3 18.1 8.2 8.0 10.0 7.3 5.2 19.7 12.7 12.7 8.3 9.0 9.5 7.8 9.3 8.4 21.2 9.0 20.2 7.7 4.5 10.7 10.1 8.7 9.6 9.9 9.1 7.0 6.9 9.7 3.5 9.0 8.8 11.1 12.1 5.2 8.6 5.8 11.4 11.1 13.2 15.0 11.2 7.7 12.2 5.7 7.2 7.3 11.5 17.5 2.7 15.0 8.0 13.9 8.5 7.5 6.5 8.8 12.8 8.8 5.3 4.4 12.6 5.7 11.5 6.2 6.2 8.0 9.4 7.4 3.6 12.7 8.8 16.4 5.6 8.0 10.1 10.6 7.9 4.6 4.2 6.0 11.8 8.5 4.3 7.7 10.7 7.8 4.8 3.9 7.0 7.2 9.2 12.9 12.2 8.1 19.2 7.5 6.3 3.9 9.1 7.0 6.5 7.8 5.8 9.7 9.6 6.9 7.1 6.8 8.1 7.3 7.5 8.4 6.9 4.2 9.9 7.4 3.5 6.3 9.7 20.3 10.0 7.4 5.4 8.8 7.3 8.0 9.0 11.9 8.9 5.6 5.1 5.3 21.0 11.4 10.2 6.7 10.3 10.4 31.4 5.9 0.0 3.9 140.9 7.1 4.7 0.0 6.2 4.9 6.6 5.1 19.7 7.4 3.6 19.1 4.1 6.7 5.3 46.0 19.5 5.8 6.8 4.6 5.7 12.8 7.6 6.5 18.7 2.6 23.7 6.5 6.1 26.7 19.4 7.2 3.8 12.5 6.5 4.2 EEF1A1 "EE1A1, EEF1A, EF1A, LENG7" ENSG00000156508 "Eukaryotic translation elongation factor 1 alpha 1" P68104 6 73515750-73523797 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Transcription, Transcription regulation" "Elongation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051759, HPA053862, HPA056990" Supported Supported Cytosol NA NA Cytosol "HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302" "unprognostic (6.47e-2)" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (9.64e-2)" "unprognostic (1.39e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (3.13e-1)" "unprognostic (1.61e-1)" "unprognostic (2.77e-1)" "unprognostic (1.41e-1)" "unprognostic (3.47e-1)" "unprognostic (8.61e-2)" "unprognostic (1.65e-1)" "unprognostic (8.00e-2)" "unprognostic (2.04e-1)" "unprognostic (7.73e-2)" 134.1 124.1 80.2 136.0 75.6 140.9 182.0 103.3 106.2 149.6 133.3 94.9 93.7 81.7 152.0 127.3 136.4 143.1 102.4 88.2 71.5 58.0 130.9 123.1 169.6 135.6 74.3 93.2 240.8 227.6 106.3 111.2 89.1 79.7 115.0 114.7 105.0 133.3 123.6 51.3 139.8 101.6 121.6 108.6 111.3 121.5 129.9 71.6 125.1 132.4 143.1 169.7 151.1 134.8 258.9 209.7 54.6 187.6 184.6 366.8 517.5 112.5 142.8 202.7 276.8 415.8 687.9 161.3 168.6 435.4 216.3 207.7 221.5 155.8 459.7 225.6 285.0 151.5 119.5 247.5 322.3 208.6 80.2 154.9 171.6 116.4 246.7 361.0 318.9 187.4 594.2 548.2 159.2 537.5 445.1 292.9 213.7 317.1 145.4 261.3 150.1 136.5 334.3 216.8 150.1 99.2 272.1 341.5 515.3 277.9 238.6 166.4 184.6 84.5 198.8 333.7 240.5 135.1 515.5 243.4 92.4 131.6 68.4 191.4 163.4 145.2 108.0 95.9 264.6 145.2 54.6 187.6 20.8 198.7 165.4 366.8 258.9 288.8 250.9 209.7 199.5 323.8 277.8 17.0 184.6 169.0 161.7 202.9 517.5 80.2 75.6 103.3 106.2 71.5 58.0 74.3 93.2 79.7 71.6 2945.0 5104.7 7686.4 9440.3 8731.8 946.3 163.3 4537.5 2577.7 4487.2 2501.9 514.4 8108.2 8765.4 4837.4 1096.2 6221.3 1773.7 1425.0 9007.6 10117.9 6235.0 8187.7 3506.7 2998.1 5660.8 467.2 3719.4 4654.6 6431.4 1730.5 8270.0 6531.1 4848.6 19235.8 6485.3 1457.9 7817.3 5029.0 6780.9 10371.8 951.6 3479.5 5699.9 1275.5 709.3 8789.4 9271.7 8651.4 9249.6 10618.3 EEF1A2 "EEF1AL, HS1, STN, STNL" ENSG00000101210 "Eukaryotic translation elongation factor 1 alpha 2" Q05639 20 63488012-63499322 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 298.6" "Group enriched" "Detected in some" 5 "Bipolar cells: 100.4;Cardiomyocytes: 108.0;Horizontal cells: 254.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 9 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "HAP1: 56.2;HBF TERT88: 28.3;MCF7: 46.5;SCLC-21H: 29.6;T-47d: 24.1;U-2 OS: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034019, HPA051759, HPA053862, HPA056990" Approved Approved Nucleoli,Cytosol NA NA 55000000 Cytosol Nucleoli "CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302" "unprognostic (1.40e-2)" "unprognostic (6.82e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (2.90e-5)" "unprognostic (5.17e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (4.85e-1)" "unprognostic (1.68e-1)" "unprognostic (3.02e-2)" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (2.30e-1)" "unprognostic (1.86e-1)" "unprognostic (8.29e-3)" "unprognostic (1.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" 2.2 8.0 21.3 2.3 23.5 1.9 2.2 41.1 51.3 1.9 2.3 2.3 0.1 2.2 2.0 2.3 4.1 2.1 2.6 51.9 23.0 21.0 2.0 2.0 2.0 2.1 13.9 31.0 2.0 3.5 6.1 16.6 2.0 23.1 3.7 2.1 1.8 3.4 2.2 298.6 2.2 2.3 2.1 4.8 2.0 3.6 2.3 3.6 0.0 2.0 23.9 2.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.3 0.1 10.8 0.2 2.6 0.0 0.1 1.3 2.1 0.3 10.7 3.6 1.4 7.1 0.0 18.9 0.1 2.9 5.1 56.2 0.1 28.3 0.1 2.6 0.0 4.0 0.4 0.6 0.0 2.5 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.1 46.5 0.1 0.1 1.9 19.3 18.1 1.3 0.0 1.7 0.4 0.5 29.6 18.0 17.1 1.9 0.1 0.5 24.1 0.6 0.0 0.0 32.9 0.1 0.3 0.0 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 21.3 23.5 41.1 51.3 23.0 21.0 13.9 31.0 23.1 3.6 0.0 0.0 0.0 0.5 0.3 100.4 108.0 0.0 0.0 1.2 0.0 11.8 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.2 0.1 0.2 2.9 5.7 0.0 0.0 254.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 10.8 0.3 0.0 0.0 0.3 33.6 0.0 0.3 0.0 0.1 1.6 0.0 0.0 0.0 0.9 EEF1AKMT1 N6AMT2 ENSG00000150456 "EEF1A lysine methyltransferase 1" Q8WVE0 13 20728731-20773958 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 20.8;Cytotrophoblasts: 17.3;Distal tubular cells: 23.2;Proximal tubular cells: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040417, HPA042543" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040417: AB_2676973, HPA042543: AB_2678045" "unprognostic (4.14e-1)" "unprognostic (5.11e-2)" "unprognostic (8.57e-2)" "prognostic favorable (1.82e-4)" "unprognostic (9.14e-2)" "unprognostic (3.44e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (2.39e-3)" "unprognostic (3.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.81e-2)" "unprognostic (4.31e-2)" 12.1 14.1 15.2 8.9 13.8 3.9 13.4 20.9 14.1 12.2 9.4 9.5 8.6 5.9 14.8 19.9 8.0 15.2 8.4 12.4 12.2 14.7 11.5 17.3 7.8 8.1 14.3 14.7 14.5 10.3 9.1 19.1 8.5 11.7 14.1 8.1 10.6 12.8 12.7 15.5 7.2 5.9 12.5 16.2 8.1 8.1 8.2 14.0 11.3 12.9 8.2 8.6 8.9 8.6 10.7 8.8 0.7 4.4 13.1 11.2 5.7 5.8 4.5 3.8 6.2 16.0 16.6 9.3 7.8 5.9 6.8 3.6 6.3 6.6 9.5 5.8 8.4 3.1 4.8 5.1 6.6 7.1 6.1 4.5 12.2 2.1 12.0 8.8 24.1 2.5 11.3 5.9 5.1 11.4 7.7 12.2 8.3 7.1 1.3 19.3 16.2 8.0 21.5 6.5 10.7 3.4 10.1 4.1 1.8 9.7 6.8 8.7 5.2 6.6 3.3 8.6 3.3 3.5 22.3 7.1 4.7 0.0 10.5 3.4 1.8 3.4 10.3 4.0 16.7 3.3 0.0 4.4 0.7 7.7 3.3 8.1 10.7 9.0 7.6 7.2 4.9 11.2 9.8 0.6 13.1 3.4 8.8 9.5 5.7 15.2 13.8 20.9 14.1 12.2 14.7 14.3 14.7 11.7 14.0 20.8 8.6 0.0 0.0 0.0 0.0 0.0 0.0 13.4 14.8 7.0 0.0 17.3 23.2 10.0 0.0 0.0 0.0 0.0 9.0 11.0 0.0 0.0 3.5 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 6.4 0.0 0.0 7.5 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 EEF1AKMT2 "C10orf138, Efm4, METTL10" ENSG00000203791 "EEF1A lysine methyltransferase 2" Q5JPI9 10 124748149-124791870 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 24.1;Distal tubular cells: 56.3;Extravillous trophoblasts: 24.1;Proximal tubular cells: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA050138 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Vesicles, Cytosol" "HPA050138: AB_2681030" "unprognostic (1.64e-3)" "unprognostic (3.42e-2)" "unprognostic (1.34e-1)" "unprognostic (9.75e-2)" "unprognostic (7.19e-2)" "unprognostic (1.17e-1)" "unprognostic (2.33e-2)" "unprognostic (2.29e-3)" "unprognostic (9.04e-3)" "unprognostic (9.76e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.82e-4)" "unprognostic (3.90e-2)" "unprognostic (4.44e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (9.09e-2)" 11.5 11.8 17.6 13.2 19.0 13.0 17.3 25.2 18.0 11.1 12.0 12.5 17.3 6.2 11.8 18.3 10.1 11.7 10.7 14.0 13.8 12.6 16.5 17.8 9.0 9.8 12.3 14.2 16.4 11.3 15.7 15.4 10.2 12.1 12.5 13.3 9.6 15.0 12.2 28.4 10.5 11.2 13.0 14.8 9.6 12.5 28.6 13.3 8.3 17.7 12.1 12.0 9.3 12.5 9.8 6.7 6.0 5.2 10.4 10.8 5.7 19.0 5.0 8.0 10.6 5.0 12.3 6.1 8.9 15.3 12.5 11.6 5.6 13.8 11.5 5.1 7.9 6.4 6.4 7.2 5.8 18.3 11.9 3.8 7.5 5.9 5.9 10.6 11.6 5.5 6.8 7.4 6.2 14.5 9.5 8.4 9.7 11.5 14.5 15.0 6.9 7.3 11.6 8.0 6.7 7.9 3.3 7.8 4.4 5.9 3.8 2.1 7.9 4.8 6.2 14.7 5.6 8.1 12.6 8.5 5.2 6.6 5.8 14.2 6.8 6.0 11.9 7.2 5.4 6.4 6.0 5.0 3.5 8.1 5.0 10.5 9.8 8.8 8.5 6.2 6.6 10.8 8.5 1.5 10.4 5.2 6.7 9.9 5.7 17.6 19.0 25.2 18.0 13.8 12.6 12.3 14.2 12.1 13.3 3.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.5 10.4 0.0 24.1 56.3 16.7 0.0 0.0 0.0 0.0 17.6 24.1 0.0 0.0 2.3 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 19.8 0.0 0.0 16.1 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 EEF1AKMT4 ENSG00000284753 "EEF1A lysine methyltransferase 4" O60344 3 184249650-184259585 "Predicted intracellular proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 29.5" "Group enriched" "Detected in some" 4 "Club cells: 5.7;Collecting duct cells: 7.0;Distal tubular cells: 13.3;Ductal cells: 14.2;Exocrine glandular cells: 13.1;Pancreatic endocrine cells: 10.0;Proximal tubular cells: 17.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 2.1 1.7 0.2 3.3 0.8 1.8 1.9 0.3 0.5 1.3 4.2 0.0 2.5 2.5 0.6 0.5 4.1 0.4 1.4 2.4 0.4 4.2 29.5 2.3 2.5 0.2 0.0 1.7 8.3 1.0 3.1 8.4 0.8 1.6 2.3 0.8 5.7 2.7 5.4 2.4 4.3 1.1 0.1 3.7 1.6 13.0 0.6 4.8 6.9 4.5 3.7 1.3 1.6 4.9 10.1 1.2 12.0 3.4 7.6 5.6 13.1 6.9 1.6 4.4 2.4 1.6 10.1 1.5 2.9 2.3 2.2 12.9 2.0 15.6 10.3 1.7 12.2 4.9 7.4 7.5 1.3 6.1 8.7 4.1 4.4 8.2 2.9 10.8 3.5 2.0 9.1 2.6 4.5 1.0 1.9 5.2 7.4 14.5 1.1 20.6 4.4 13.1 3.3 17.2 13.1 9.2 2.2 12.6 2.7 3.2 8.0 2.7 3.0 23.7 5.8 2.4 19.9 5.0 1.4 2.6 3.5 6.1 7.6 8.7 17.5 15.4 2.1 17.9 2.7 0.0 12.0 1.2 4.3 9.7 4.8 4.9 4.6 4.2 10.1 3.2 3.3 5.2 0.2 3.4 6.2 9.0 7.6 5.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 5.7 7.0 0.0 0.0 13.3 14.2 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.8 0.0 0.0 10.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1AKMT4-ECE2 ENSG00000284917 "EEF1AKMT4-ECE2 readthrough" O60344 3 184249695-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "REH: 5.1" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 1.2 6.6 0.0 2.1 0.1 0.3 0.3 0.0 1.5 0.6 2.9 0.0 1.5 0.9 0.3 0.3 2.8 0.5 0.6 2.1 0.0 2.8 22.6 1.3 1.5 0.0 0.0 0.9 6.0 1.5 2.0 6.1 0.2 1.4 0.6 0.2 4.0 1.6 3.8 0.3 2.9 0.4 0.0 2.4 0.3 9.7 0.0 3.3 4.9 3.1 2.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1B2 ENSG00000114942 "Eukaryotic translation elongation factor 1 beta 2" P24534 2 206159585-206162928 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012477, HPA035029" Supported Approved "Nucleoli fibrillar center,Cytosol" NA NA 640000 "Nucleoli fibrillar center, Cytosol" "CAB012477: AB_732078, HPA035029: AB_2674422" "prognostic favorable (2.60e-4)" "unprognostic (3.12e-1)" "unprognostic (4.22e-2)" "unprognostic (6.44e-2)" "unprognostic (4.74e-2)" "unprognostic (2.70e-1)" "unprognostic (1.49e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (9.95e-4)" "unprognostic (2.70e-1)" "unprognostic (5.37e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.62e-6)" "unprognostic (2.38e-1)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (1.25e-2)" 42.9 33.9 37.6 72.1 32.6 93.8 78.8 18.8 37.1 46.7 80.3 23.3 37.8 55.8 41.4 43.9 71.7 42.1 54.1 40.7 30.2 26.4 36.9 72.4 41.9 171.3 35.9 20.7 73.2 252.4 9.1 19.4 34.6 35.3 41.6 49.1 19.3 93.2 60.0 122.3 59.4 58.3 59.7 36.1 58.7 40.4 27.3 22.4 58.3 44.2 101.5 69.2 63.1 79.0 88.9 55.0 6.2 29.4 46.5 95.3 121.3 27.8 34.6 40.7 38.0 58.1 98.5 86.6 56.0 57.5 59.3 39.4 76.3 47.7 79.7 37.7 66.1 33.3 36.1 53.9 66.7 54.0 24.6 49.6 56.6 48.9 102.9 77.6 112.1 50.6 99.4 79.2 44.0 100.0 58.6 62.2 65.8 77.9 66.5 65.6 58.0 99.4 93.1 56.5 64.7 59.0 74.4 79.4 101.0 64.1 54.7 41.0 42.0 22.4 48.8 54.5 49.6 29.8 138.8 43.9 31.3 41.7 40.7 53.1 71.8 58.8 90.9 36.4 76.2 23.7 6.2 28.2 3.5 37.2 29.4 68.4 88.9 66.4 49.4 55.0 69.7 95.3 76.8 4.1 46.5 23.1 53.5 35.1 121.3 37.6 32.6 18.8 37.1 30.2 26.4 35.9 20.7 35.3 22.4 184.6 288.1 1590.3 1462.2 1014.9 112.3 142.8 496.8 258.3 467.5 155.3 25.5 807.3 583.6 557.5 144.9 476.3 640.1 490.6 1616.2 1370.7 453.3 520.7 530.4 500.5 730.4 49.3 427.5 372.0 671.4 335.2 802.5 760.7 506.2 719.6 1295.6 92.1 954.4 764.5 454.7 995.5 89.9 265.1 669.9 134.7 214.8 1101.0 794.9 1001.9 1557.8 1242.4 EEF1E1 "AIMP3, P18" ENSG00000124802 "Eukaryotic translation elongation factor 1 epsilon 1" O43324 6 8073360-8102578 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 233.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA027901, HPA057866" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027901: AB_10611960, HPA057866: AB_2683547" "unprognostic (9.39e-3)" "prognostic favorable (3.16e-4)" "unprognostic (2.23e-1)" "unprognostic (2.36e-2)" "unprognostic (1.42e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.55e-7)" "unprognostic (1.79e-1)" "unprognostic (5.67e-2)" "prognostic favorable (3.24e-4)" "unprognostic (1.13e-1)" "unprognostic (1.76e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-1)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" 10.5 21.8 20.1 14.2 26.9 34.0 18.5 20.0 24.6 10.8 12.2 13.5 12.3 8.2 13.6 19.2 15.9 10.3 9.5 12.5 19.4 27.0 34.9 19.2 9.9 19.7 26.9 16.2 10.8 26.6 19.8 28.6 11.7 41.2 12.5 15.2 9.6 13.5 13.4 14.4 8.4 8.4 13.3 21.3 11.8 14.8 36.3 19.4 9.9 13.9 15.8 20.3 11.6 9.3 20.9 29.6 6.8 15.0 14.0 21.3 13.5 28.1 14.9 24.0 16.5 7.9 13.3 14.6 23.7 15.0 21.4 22.1 24.3 11.8 30.9 52.3 15.4 39.2 11.7 27.1 27.3 36.1 17.3 35.3 24.9 19.7 42.2 14.7 49.3 18.4 11.1 25.8 25.5 26.5 15.0 30.2 25.5 59.5 8.6 20.4 11.8 21.1 40.1 21.6 27.5 24.0 25.9 14.1 48.5 35.0 21.7 35.7 11.1 10.1 22.8 28.2 33.9 18.1 17.0 15.6 17.9 17.7 16.2 34.3 13.5 61.1 43.9 10.0 20.9 28.4 6.2 11.0 6.8 13.5 15.0 19.1 20.9 18.1 17.8 29.6 20.5 20.3 20.6 1.1 14.0 11.2 13.0 21.3 13.5 20.1 26.9 20.0 24.6 19.4 27.0 26.9 16.2 41.2 19.4 14.9 28.8 28.9 35.2 58.5 35.8 20.7 15.3 33.5 37.5 57.6 9.8 71.1 119.3 54.7 233.2 31.6 7.7 23.3 76.4 54.8 31.5 42.5 15.1 26.4 44.1 28.6 38.5 23.4 30.6 155.8 24.5 35.1 40.5 22.6 35.3 32.1 63.6 7.0 22.3 129.8 16.8 12.9 36.0 118.9 83.7 66.6 27.0 27.3 39.8 36.5 EEF2 "EEF-2, EF2" ENSG00000167658 "Eukaryotic translation elongation factor 2" P13639 19 3976056-3985469 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cancer-related genes, Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007795, HPA040534, HPA057351" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 9700000 "Plasma membrane, Cytosol" "CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417" "unprognostic (5.47e-2)" "unprognostic (9.59e-2)" "unprognostic (3.75e-1)" "prognostic favorable (1.81e-6)" "unprognostic (2.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.11e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-2)" "unprognostic (1.25e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.25e-5)" "unprognostic (4.46e-2)" "unprognostic (5.60e-2)" "unprognostic (6.82e-2)" "unprognostic (9.86e-2)" 104.2 84.9 64.0 66.7 57.1 92.7 77.5 55.7 96.2 93.4 91.3 55.8 80.8 95.4 100.1 75.1 115.1 83.4 88.6 104.1 51.6 44.4 65.5 161.0 67.7 108.9 51.4 38.3 167.1 395.7 45.1 72.3 63.7 47.5 105.6 41.3 67.7 191.3 64.4 260.8 87.2 100.9 112.3 46.8 85.4 98.5 70.9 32.4 123.4 127.1 112.5 108.3 111.8 94.7 84.9 60.0 10.0 58.4 48.3 76.3 83.7 95.2 68.4 39.8 105.1 106.7 192.3 57.3 74.9 101.4 71.7 70.6 107.8 44.2 199.0 44.6 69.1 31.9 72.3 62.8 116.0 38.0 49.6 104.2 50.8 65.7 110.7 156.0 109.1 88.4 248.2 122.7 63.1 97.7 104.2 74.2 97.5 99.1 146.7 43.6 138.2 97.9 83.7 105.3 34.4 69.2 109.1 59.2 126.5 59.0 85.2 109.0 101.3 47.1 94.3 135.0 39.5 91.9 132.7 88.9 51.4 53.7 104.4 115.2 157.4 105.6 99.0 76.6 137.2 67.0 10.0 58.4 8.3 38.6 45.8 68.7 84.9 67.7 50.8 60.0 70.7 76.3 59.4 6.1 48.3 43.8 50.5 58.4 83.7 64.0 57.1 55.7 96.2 51.6 44.4 51.4 38.3 47.5 32.4 205.4 339.7 970.0 885.9 1173.5 200.3 547.0 484.1 158.0 288.9 242.5 72.6 782.8 835.6 627.1 628.8 571.1 713.7 186.9 1561.0 1076.2 818.7 720.7 366.9 607.5 546.3 192.3 715.0 498.4 743.9 1007.5 933.7 543.3 612.4 762.0 931.2 218.1 963.4 716.9 782.8 713.6 97.3 575.6 971.3 259.8 261.2 1177.5 1039.5 756.1 908.5 772.4 EEFSEC "eEFSec, EFSEC, SELB" ENSG00000132394 "Eukaryotic elongation factor, selenocysteine-tRNA specific" P57772 3 128153454-128408646 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;GAMG: 10.3;SH-SY5Y: 8.8;SK-BR-3: 14.7;SK-MEL-30: 12.7;T-47d: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035795 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA035795: AB_10696512" "unprognostic (1.01e-1)" "prognostic favorable (2.98e-5)" "unprognostic (2.53e-1)" "unprognostic (1.32e-3)" "unprognostic (1.12e-1)" "unprognostic (3.03e-1)" "unprognostic (4.37e-3)" "unprognostic (6.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.84e-1)" "unprognostic (1.61e-2)" "unprognostic (3.83e-2)" "unprognostic (1.12e-2)" "unprognostic (4.31e-2)" "unprognostic (1.99e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" 8.2 6.8 5.6 7.9 7.9 3.1 7.9 8.4 9.8 11.6 8.6 9.3 7.3 2.5 10.8 5.4 8.0 9.4 7.1 18.7 7.6 6.4 9.4 18.1 7.1 15.5 5.4 4.2 11.5 8.4 23.9 9.2 9.7 6.9 9.0 4.9 7.2 10.7 11.2 20.3 15.9 15.7 10.0 5.0 9.2 6.9 11.5 6.2 17.2 8.4 6.7 10.5 7.7 7.9 7.1 10.9 7.3 7.8 9.7 7.0 3.8 0.4 0.1 3.4 1.4 0.1 0.2 0.4 0.0 0.2 0.2 0.2 0.3 5.7 12.4 0.1 3.1 10.3 0.9 0.3 0.1 0.1 0.3 0.2 0.0 0.1 0.1 4.9 0.2 0.3 0.1 0.1 3.4 0.1 0.1 0.2 0.0 0.0 0.2 2.9 0.1 6.2 0.3 0.4 0.0 0.1 0.2 0.2 0.8 0.0 0.0 0.3 8.8 0.0 14.7 12.7 0.3 7.9 0.5 0.0 0.1 0.0 0.1 0.2 0.4 0.6 0.3 0.1 0.4 0.2 0.5 7.5 7.3 6.7 7.8 5.6 7.1 5.9 5.8 10.9 5.8 5.6 6.5 0.0 9.7 6.2 4.6 7.0 3.8 5.6 7.9 8.4 9.8 7.6 6.4 5.4 4.2 6.9 6.2 0.0 5.9 11.8 7.7 5.7 8.7 9.4 0.0 2.7 1.2 15.7 2.0 19.4 13.3 5.9 21.8 7.1 5.5 0.0 6.2 14.9 10.0 7.4 27.7 11.9 13.0 12.7 10.9 6.2 6.0 63.4 12.0 8.6 11.8 3.6 8.7 8.3 5.4 0.0 8.1 21.4 6.6 25.8 7.5 26.5 16.0 8.7 24.8 10.2 8.7 5.6 EFCAB11 C14orf143 ENSG00000140025 "EF-hand calcium binding domain 11" Q9BUY7 14 89794669-89954777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.9" "Group enriched" "Detected in many" 7 "Early spermatids: 451.2;Late spermatids: 287.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA051209 Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA051209: AB_2681389" "unprognostic (1.03e-1)" "unprognostic (6.10e-3)" "unprognostic (2.36e-2)" "unprognostic (2.00e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-3)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (1.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (3.84e-7)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (8.45e-2)" 4.7 5.8 10.2 6.2 8.1 5.3 9.3 5.7 7.6 5.6 5.2 10.4 6.7 5.1 4.9 6.9 6.2 11.0 4.9 3.7 7.8 6.6 7.6 5.8 3.2 3.3 8.6 5.7 5.2 4.8 8.3 8.2 8.4 7.7 5.4 5.6 6.1 5.6 5.4 2.4 3.7 3.6 6.3 8.4 6.7 4.4 36.9 6.2 2.5 7.9 3.3 6.3 5.2 4.1 2.6 2.1 12.8 5.3 3.3 1.6 0.8 4.8 7.5 6.5 8.2 4.0 4.4 18.5 7.2 6.5 9.8 6.9 8.8 17.4 7.6 13.7 4.8 7.0 10.7 5.6 14.3 14.2 8.6 3.6 5.5 6.4 14.3 0.9 7.0 13.3 3.0 3.5 6.4 7.3 5.6 8.1 8.2 5.7 7.6 11.6 25.3 5.2 9.4 2.8 19.9 13.6 6.0 10.4 5.5 9.0 13.6 2.8 4.6 9.1 16.9 8.4 14.2 13.7 5.0 6.9 5.3 7.4 5.6 7.0 4.5 13.0 13.2 7.7 3.3 9.7 12.8 1.3 3.4 0.6 3.0 0.3 2.6 1.0 1.0 2.1 2.6 1.6 1.4 4.0 3.3 5.3 1.8 1.3 0.8 10.2 8.1 5.7 7.6 7.8 6.6 8.6 5.7 7.7 6.2 0.0 0.6 12.8 5.3 4.5 8.4 3.5 17.8 49.5 6.8 17.4 2.0 13.9 8.3 10.8 451.2 6.0 2.7 0.0 14.8 23.8 8.0 3.2 4.7 5.8 10.3 3.2 0.0 4.3 3.7 287.7 5.2 6.4 3.3 12.6 3.3 4.2 5.4 6.2 7.1 13.3 10.8 0.0 3.1 26.2 12.8 2.9 6.4 2.9 9.5 4.6 EFCAB13 "C17orf57, FLJ40342" ENSG00000178852 "EF-hand calcium binding domain 13" Q8IY85 17 47323290-47441312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 29.9" "Group enriched" "Detected in many" 4 "Early spermatids: 161.3;Late spermatids: 143.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "CAB002501, HPA021633, HPA023249, HPA026561" Uncertain Enhanced "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear speckles" "CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596" "unprognostic (1.66e-1)" "unprognostic (3.48e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.40e-1)" "unprognostic (7.43e-2)" "unprognostic (8.79e-3)" "unprognostic (8.75e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-5)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (8.10e-2)" "unprognostic (1.90e-3)" 4.1 2.8 2.9 12.2 3.4 3.4 6.5 2.8 3.8 6.5 4.7 2.3 3.5 4.8 8.9 4.4 2.4 4.2 4.1 3.5 2.3 1.5 7.5 4.0 3.1 4.3 3.6 0.4 5.5 2.8 8.4 7.6 5.4 3.2 9.3 3.4 2.6 5.4 2.0 1.3 2.2 6.3 9.9 3.5 4.6 3.5 20.0 2.7 2.4 14.9 0.7 4.3 5.5 29.9 5.6 1.0 5.3 2.1 0.8 2.6 0.8 0.9 4.0 1.7 0.2 2.1 7.3 3.1 2.2 0.5 0.7 1.2 1.7 5.6 0.3 6.6 0.8 0.0 1.1 0.0 0.4 4.0 0.2 0.6 5.2 3.3 0.5 2.1 4.0 0.6 1.3 1.9 2.7 0.0 5.0 4.5 4.1 1.5 9.9 2.4 0.1 1.7 2.3 0.9 2.8 3.2 4.7 1.3 1.8 9.2 3.2 1.2 0.6 1.2 0.1 2.6 1.3 6.6 4.7 1.6 0.3 1.3 0.4 1.1 10.2 7.0 0.9 6.3 7.8 4.3 5.3 2.1 0.6 1.1 1.2 0.9 4.3 0.9 0.6 1.0 5.6 2.6 1.2 0.0 0.8 0.7 0.4 0.1 0.8 2.9 3.4 2.8 3.8 2.3 1.5 3.6 0.4 3.2 2.7 8.9 2.1 2.0 1.7 0.7 2.3 3.8 0.0 5.3 1.2 0.0 0.0 0.2 0.0 0.7 161.3 6.3 0.5 0.0 0.7 0.2 1.3 1.0 5.8 0.8 1.7 3.2 2.9 3.7 2.1 143.2 1.7 1.3 0.0 1.8 0.2 1.1 1.2 0.0 3.5 0.8 2.6 0.0 2.3 34.1 7.9 0.5 0.0 0.0 0.6 1.0 EFCAB14 KIAA0494 ENSG00000159658 "EF-hand calcium binding domain 14" O75071 1 46675159-46719064 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011224, HPA011938" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA 58000 Cytosol "Nucleoli, Golgi apparatus" "HPA011224: AB_1852314, HPA011938: AB_1852317" "unprognostic (2.44e-1)" "unprognostic (5.90e-2)" "unprognostic (7.53e-2)" "unprognostic (2.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.39e-2)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (3.00e-1)" "unprognostic (1.13e-3)" "unprognostic (1.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.94e-1)" "unprognostic (2.46e-1)" 29.4 17.4 29.4 14.3 29.5 6.7 22.5 16.2 24.8 25.3 26.0 40.6 15.6 17.2 23.7 27.3 30.0 22.0 19.7 20.2 27.2 20.5 27.8 24.9 24.0 16.4 31.0 15.2 25.2 16.0 107.1 17.2 25.2 27.3 24.4 24.0 23.0 19.9 24.9 24.7 20.4 26.9 22.5 36.1 24.0 36.4 21.9 30.6 28.7 30.1 13.2 20.2 25.7 20.0 16.6 16.0 30.3 21.1 17.1 28.5 18.3 14.5 8.3 7.1 11.2 34.0 21.4 16.3 15.8 23.3 17.5 18.1 9.9 9.9 11.7 16.5 21.4 23.7 17.6 12.1 17.4 23.8 22.2 7.8 14.6 9.2 4.0 11.7 18.8 28.8 18.9 29.2 13.9 11.6 16.8 21.3 11.4 9.0 16.7 18.0 5.7 12.4 8.5 10.1 17.2 9.4 9.5 19.9 10.2 18.5 29.6 3.7 5.1 19.5 27.6 14.8 20.1 12.3 16.5 19.6 15.0 7.3 17.4 16.0 17.2 23.8 9.4 19.2 16.2 11.0 15.6 18.6 30.3 23.6 21.1 28.5 16.6 20.6 20.2 16.0 16.2 18.0 19.5 12.5 17.1 18.3 12.9 17.8 18.3 29.4 29.5 16.2 24.8 27.2 20.5 31.0 15.2 27.3 30.6 68.5 69.2 34.6 40.1 28.2 30.1 33.2 45.9 45.5 45.5 108.2 29.5 31.8 26.6 31.3 50.1 52.8 51.8 0.0 33.7 27.6 35.0 57.4 96.2 51.2 37.0 44.5 36.2 46.1 67.7 14.4 43.7 41.1 25.3 34.3 62.6 50.2 37.9 57.5 46.7 30.6 17.7 25.8 28.8 37.2 23.3 38.0 49.3 41.5 41.9 98.2 EFCAB2 "CFAP200, DRC8, MGC12458" ENSG00000203666 "EF-hand calcium binding domain 2" Q5VUJ9 1 244969705-245127164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 161.9;Early spermatids: 83.3;Late spermatids: 104.3;Spermatocytes: 117.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 34.8;THP-1: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031206, HPA031207" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA031206: AB_10599710, HPA031207: AB_10599946" "unprognostic (1.36e-2)" "unprognostic (9.04e-2)" "unprognostic (1.09e-1)" "unprognostic (2.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.21e-1)" "unprognostic (4.47e-2)" "unprognostic (9.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.02e-1)" "unprognostic (4.34e-3)" "unprognostic (8.41e-2)" "unprognostic (1.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.51e-4)" "unprognostic (4.88e-2)" 11.0 12.5 16.7 5.6 18.6 10.8 14.7 20.1 15.5 11.6 7.3 23.6 13.9 3.0 18.7 19.5 9.6 32.1 13.1 13.7 18.0 14.3 12.5 6.5 11.2 7.8 22.3 12.3 10.6 12.1 14.6 20.6 14.7 16.3 9.2 11.3 11.8 7.4 16.0 15.5 6.1 6.5 13.2 20.9 6.4 10.5 24.4 21.9 5.4 23.7 13.5 9.1 11.5 16.0 3.6 10.8 4.9 1.8 2.9 0.8 1.2 3.1 4.0 9.1 2.3 3.3 7.8 11.1 4.0 4.3 5.2 4.8 10.2 8.6 11.0 8.7 5.0 5.5 2.5 3.6 2.3 3.2 1.1 2.2 5.3 15.9 4.5 7.0 5.4 34.8 6.7 4.9 7.0 6.6 6.2 7.9 0.3 20.3 9.0 4.4 3.3 1.1 14.9 11.6 4.5 3.0 20.8 1.4 2.9 13.2 5.4 7.2 9.7 7.0 2.7 5.8 10.7 2.6 30.7 1.2 6.4 2.4 3.5 14.5 3.1 5.1 7.3 5.1 15.6 5.1 1.2 1.7 2.8 0.5 1.8 0.8 3.6 0.7 0.4 5.5 3.3 0.6 0.6 4.9 2.9 1.3 10.8 0.8 1.2 16.7 18.6 20.1 15.5 18.0 14.3 22.3 12.3 16.3 21.9 3.0 12.6 4.7 9.1 4.5 12.5 54.7 0.0 161.9 21.6 22.7 13.7 12.8 43.1 5.7 83.3 11.4 2.6 0.0 9.5 40.1 10.4 6.8 0.0 6.8 9.8 4.8 18.1 8.0 14.2 104.3 8.3 9.8 6.8 6.4 6.3 12.5 5.9 5.8 6.0 14.4 20.0 6.5 11.8 117.5 31.9 2.6 28.6 6.2 6.0 8.8 EFCAB7 "KIAA1799, RP4-534K7.1" ENSG00000203965 "EF-hand calcium binding domain 7" A8K855 1 63523372-63572693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 25.4;Sertoli cells: 25.8;Spermatocytes: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029611, HPA029612, HPA029613" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "Plasma membrane, Cytosol" "HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004" "unprognostic (8.81e-2)" "unprognostic (5.24e-2)" "unprognostic (5.13e-2)" "unprognostic (1.64e-1)" "prognostic favorable (3.65e-4)" "unprognostic (1.70e-2)" "unprognostic (6.53e-4)" "unprognostic (2.99e-1)" "unprognostic (5.81e-3)" "unprognostic (1.69e-1)" "unprognostic (6.28e-2)" "unprognostic (1.66e-1)" "unprognostic (3.78e-2)" "unprognostic (2.18e-1)" "unprognostic (6.97e-2)" "unprognostic (9.90e-2)" "unprognostic (2.73e-1)" 4.3 8.4 12.7 3.5 16.7 3.1 9.3 24.5 19.5 9.4 5.1 3.7 6.4 3.2 9.6 9.8 5.7 12.6 7.2 9.7 11.4 11.8 8.8 2.8 6.2 5.2 8.1 10.8 12.8 4.9 16.3 31.6 5.1 13.7 8.7 5.0 3.5 5.3 8.2 10.8 4.9 3.4 7.5 9.4 4.2 5.0 20.0 10.2 11.5 9.1 2.4 5.2 7.3 12.9 3.3 1.7 9.8 3.3 1.8 2.9 1.1 6.0 5.1 6.7 4.3 7.1 10.6 3.4 3.9 4.3 6.8 8.4 1.6 4.8 4.3 9.4 2.2 13.9 5.6 5.7 3.7 8.2 7.9 4.0 3.4 9.5 3.5 4.5 4.7 3.1 5.7 9.2 8.0 5.4 10.8 5.7 7.9 4.3 7.0 4.4 1.3 9.0 3.2 2.9 4.2 5.1 5.8 10.1 4.2 10.4 3.2 14.4 5.5 7.5 4.2 9.6 9.4 4.3 3.4 1.5 3.8 3.4 11.4 3.7 4.7 8.1 4.9 7.0 3.4 5.6 9.8 0.7 0.2 2.1 0.4 2.9 3.3 2.4 2.5 1.3 2.8 2.5 2.4 0.1 1.8 3.3 1.7 2.7 1.1 12.7 16.7 24.5 19.5 11.4 11.8 8.1 10.8 13.7 10.2 11.9 2.6 2.9 5.2 2.7 8.3 6.2 0.0 25.4 4.5 5.2 3.9 2.9 6.6 2.9 17.3 2.1 0.5 0.0 0.6 1.6 3.0 1.5 2.3 0.8 2.1 0.0 1.7 2.5 2.4 3.2 10.0 1.1 1.7 1.8 1.4 5.8 1.1 0.0 12.7 4.6 10.5 25.8 2.3 58.1 17.7 1.9 1.0 1.3 1.7 0.7 EFHD2 MGC4342 ENSG00000142634 "EF-hand domain family member D2" Q96C19 1 15409895-15430343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Pancreatic endocrine cells: 329.7;Urothelial cells: 408.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 45.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 79.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048961 Enhanced Approved Cytosol No No 35000 Cytosol "HPA048961: AB_2680572" "unprognostic (1.37e-3)" "unprognostic (3.69e-1)" "unprognostic (7.83e-2)" "unprognostic (4.44e-2)" "unprognostic (2.35e-1)" "unprognostic (3.82e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (9.11e-2)" "unprognostic (9.61e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (6.31e-9)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "prognostic favorable (2.70e-4)" "prognostic favorable (3.60e-5)" 12.9 21.8 16.1 35.4 15.4 69.3 8.7 13.3 41.2 9.3 24.8 7.0 7.5 39.5 11.8 6.2 18.4 10.3 21.2 7.2 19.6 15.3 7.4 10.4 19.2 31.8 14.2 22.0 9.2 26.8 4.0 10.1 16.4 56.5 14.6 14.8 6.8 11.1 10.3 3.3 10.8 45.0 8.7 8.2 48.9 42.8 28.5 7.1 17.1 14.7 7.5 27.2 20.6 12.9 1.4 9.7 45.0 11.9 9.4 15.6 4.9 79.3 20.2 2.0 5.3 3.2 7.0 10.6 10.1 9.7 9.6 9.2 7.8 21.9 17.3 32.2 7.0 12.4 19.4 5.4 17.9 6.2 21.5 10.6 4.1 4.7 12.3 5.2 21.0 36.2 5.5 6.1 19.6 5.0 4.5 12.4 7.9 9.8 8.4 5.9 7.9 10.8 40.6 2.6 10.9 25.2 14.5 18.5 13.7 5.6 16.7 4.5 3.5 8.9 7.7 16.5 1.6 3.3 22.8 23.2 14.3 15.2 44.3 16.3 5.7 13.4 7.4 19.9 41.9 19.3 4.7 11.9 16.3 15.6 11.1 4.5 1.3 3.6 7.2 9.7 1.4 1.7 6.7 45.0 9.4 9.3 3.4 2.3 4.9 16.1 15.4 13.3 41.2 19.6 15.3 14.2 22.0 56.5 7.1 3.0 16.4 40.3 77.9 58.7 1.0 5.9 28.1 9.4 11.4 21.0 9.8 17.6 16.6 55.1 72.9 39.4 263.4 0.0 225.6 181.1 21.9 96.0 44.9 17.8 193.0 0.0 59.2 29.4 182.4 177.9 9.2 155.3 21.9 97.4 131.4 3.2 329.7 122.8 6.3 27.0 4.2 45.3 23.7 5.9 4.9 59.8 44.6 86.3 90.1 408.3 EFL1 "EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1" ENSG00000140598 "Elongation factor like GTPase 1" Q7Z2Z2 15 82130230-82262763 "Predicted intracellular proteins" "Protein biosynthesis, Ribosome biogenesis" "Elongation factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 13.4;Club cells: 7.9;Pancreatic endocrine cells: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039654, HPA047110, HPA052345" Uncertain Approved Cytosol NA NA Cytosol "HPA039654: AB_2676610, HPA047110: AB_2797233, HPA052345: AB_2681794" "unprognostic (2.53e-1)" "unprognostic (2.04e-1)" "unprognostic (9.92e-3)" "unprognostic (8.99e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-1)" "unprognostic (2.64e-3)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (4.75e-3)" "unprognostic (3.56e-2)" "unprognostic (3.14e-1)" "prognostic favorable (1.50e-6)" "unprognostic (8.58e-2)" "unprognostic (2.96e-1)" "unprognostic (2.60e-1)" "unprognostic (7.05e-2)" 16.3 14.0 7.0 17.3 9.9 8.9 11.8 10.2 9.4 9.5 17.2 11.0 6.8 13.2 9.2 12.2 14.1 9.1 8.0 10.7 8.8 7.9 11.9 15.4 9.0 10.0 9.5 4.5 9.8 12.5 17.9 15.0 12.8 13.3 12.7 19.6 7.4 12.1 8.5 18.5 14.6 25.7 10.8 10.1 10.1 9.7 13.9 9.9 26.9 9.8 11.3 14.9 10.8 11.7 10.7 6.8 15.8 9.0 5.8 9.0 4.5 4.9 12.3 9.2 7.9 6.2 8.5 5.9 14.4 17.0 10.4 14.0 6.1 8.7 12.1 5.9 10.7 13.1 12.9 24.4 9.5 16.6 10.7 11.9 13.3 11.8 4.6 9.8 8.5 9.5 4.2 14.9 10.5 24.2 12.3 13.7 15.6 9.9 5.5 12.0 6.9 11.1 7.7 8.3 8.8 6.4 11.9 13.7 6.5 7.3 14.9 8.4 9.0 9.0 10.6 11.0 16.7 7.9 7.6 11.5 14.8 10.0 36.9 14.2 7.1 26.3 10.2 13.5 16.0 5.4 15.8 5.6 13.7 9.0 8.1 7.2 8.9 8.4 7.6 6.8 10.7 7.3 6.3 1.0 5.8 9.0 3.3 7.6 4.5 7.0 9.9 10.2 9.4 8.8 7.9 9.5 4.5 13.3 9.9 3.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 13.4 7.9 0.0 0.0 6.1 3.3 6.0 0.0 0.0 0.0 0.0 5.3 3.1 0.0 0.0 4.7 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.6 0.0 0.0 7.4 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 EFNA2 "ELF-1, EPLG6, LERK6" ENSG00000099617 "Ephrin A2" O43921 19 1286154-1300237 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 10.0;intestine: 30.3;liver: 14.2" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 1.3;Cardiomyocytes: 4.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;BEWO: 5.1;Hep G2: 9.5;NTERA-2: 5.5;REH: 7.3;SH-SY5Y: 17.2;U-2 OS: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067567 Approved Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA067567: AB_2732771" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (2.87e-3)" "unprognostic (1.96e-2)" "unprognostic (4.04e-2)" "unprognostic (3.90e-1)" "unprognostic (7.19e-2)" "unprognostic (2.34e-3)" "unprognostic (3.58e-2)" "unprognostic (6.82e-2)" "unprognostic (8.48e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (1.17e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-4)" "unprognostic (1.94e-1)" 0.2 0.1 1.5 3.4 2.2 0.2 0.1 1.5 2.0 0.1 10.7 2.0 0.0 12.0 0.2 0.1 0.4 0.1 10.0 0.1 1.0 1.6 0.3 14.2 0.1 0.1 1.2 0.5 0.1 0.1 0.1 0.3 0.2 1.1 0.1 2.3 1.9 0.1 0.2 0.2 0.1 30.3 0.2 0.9 0.2 0.6 0.6 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 1.7 0.0 0.0 5.1 0.2 0.0 0.0 0.0 3.6 0.0 0.0 2.4 0.0 0.0 0.0 2.3 0.0 0.0 0.1 2.2 0.0 0.0 9.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 5.5 2.4 0.0 7.3 0.6 0.1 0.0 0.1 0.0 17.2 0.2 0.0 0.1 0.7 0.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.2 1.5 2.0 1.0 1.6 1.2 0.5 1.1 0.7 0.0 0.0 0.0 0.0 1.3 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 EFNA5 "AF1, EPLG7, LERK7" ENSG00000184349 "Ephrin A5" P52803 5 107376889-107670895 "Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5;memory CD8 T-cell: 3.0" "Group enriched" "Detected in many" 7 "NK-cells: 2.5;T-cells: 3.5" "Cell line enhanced" "Detected in many" "AF22: 19.6;RPTEC TERT1: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013282, HPA054047" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB013282: AB_2533353, HPA054047: AB_2682355" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.15e-3)" "unprognostic (3.98e-3)" "unprognostic (2.74e-2)" "unprognostic (8.91e-4)" "unprognostic (9.46e-3)" "unprognostic (4.92e-1)" "unprognostic (2.28e-3)" "unprognostic (1.26e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.92e-7)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (1.27e-1)" 5.3 1.9 1.9 2.3 6.0 0.0 7.3 10.1 22.2 15.0 4.2 0.9 2.5 1.2 1.6 2.8 9.1 3.9 3.6 8.3 2.5 5.3 5.3 0.6 7.0 3.2 2.1 8.9 5.5 0.7 6.9 18.5 3.1 4.8 6.2 3.6 3.3 11.2 6.8 1.1 13.3 2.3 2.8 3.5 6.3 3.1 1.8 1.1 0.1 2.5 6.0 3.3 4.0 8.1 0.0 0.0 0.4 0.1 2.5 3.5 0.4 6.3 11.3 19.6 0.0 9.4 8.2 1.8 0.2 3.4 2.5 6.1 0.1 7.1 0.0 10.7 1.2 3.7 6.6 10.8 9.3 2.3 0.0 6.6 0.0 6.2 0.0 1.8 0.3 0.0 8.8 8.9 0.0 7.9 2.3 7.8 0.0 0.0 0.0 4.7 6.1 0.0 0.0 2.4 0.0 0.9 0.0 8.8 0.2 29.9 8.2 3.0 7.8 3.0 4.6 1.9 7.1 2.0 1.2 0.1 14.9 2.6 9.0 3.5 0.6 0.0 4.1 6.5 0.5 16.0 0.2 0.0 0.1 3.5 0.0 0.0 0.0 0.8 3.0 0.0 0.0 0.3 1.4 0.4 2.5 0.1 0.0 0.1 0.4 1.9 6.0 10.1 22.2 2.5 5.3 2.1 8.9 4.8 1.1 8.9 19.5 0.0 20.5 14.2 0.2 27.7 12.7 16.0 27.3 14.0 0.0 12.5 19.9 1.9 1.5 1.6 0.0 0.0 1.2 3.9 23.9 10.3 0.0 0.0 1.5 6.4 11.5 3.7 0.3 2.7 17.0 0.6 8.5 6.4 10.3 3.7 9.3 0.0 20.5 0.0 1.0 0.0 3.9 0.1 1.9 21.1 3.2 0.0 7.0 19.2 EFNB2 "EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228" ENSG00000125266 "Ephrin B2" P52799 13 106489731-106535662 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ito cells: 134.4;Muller glia cells: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Lineage enhanced" "Detected in single" "NK-cells: 1.5" "Cell line enhanced" "Detected in many" "AF22: 48.7;OE19: 27.9;SH-SY5Y: 24.4;U-87 MG: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008999, CAB009368" Supported Supported Nucleoplasm,Cytosol NA NA 760000 Nucleoplasm Cytosol "CAB009368: AB_2095700, HPA008999: AB_1078721" "unprognostic (1.70e-1)" "unprognostic (1.95e-3)" "unprognostic (1.72e-1)" "unprognostic (5.22e-3)" "unprognostic (4.52e-3)" "prognostic unfavorable (3.11e-6)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.43e-4)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (8.70e-5)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.30e-1)" "unprognostic (3.07e-1)" "unprognostic (4.62e-2)" "unprognostic (2.27e-3)" 15.7 4.9 11.2 8.2 11.0 0.8 21.8 8.3 14.0 13.2 23.1 5.8 13.1 13.9 10.8 5.2 11.4 13.6 11.2 11.8 10.4 6.5 9.3 11.8 50.1 7.8 6.2 11.5 8.4 3.7 5.7 6.1 27.7 5.2 11.8 18.4 15.2 12.7 20.6 6.6 14.3 20.6 10.5 5.0 9.3 21.3 7.2 5.9 7.3 11.2 8.8 5.9 7.7 12.4 0.2 0.0 0.4 0.0 1.5 0.0 0.0 11.6 1.1 48.7 0.0 0.1 0.3 0.1 5.3 3.3 5.3 3.0 11.8 17.8 0.0 5.1 1.6 0.4 13.9 1.8 6.8 5.7 0.0 10.4 0.0 4.0 0.0 1.0 3.8 0.3 2.2 12.2 0.2 10.4 2.6 6.6 0.1 0.0 0.0 5.7 2.0 0.1 0.0 2.6 27.9 2.3 9.8 1.9 0.0 7.5 1.5 3.4 24.4 2.0 1.0 0.0 14.3 0.6 0.1 5.2 10.4 0.0 0.3 11.9 0.1 0.0 0.0 21.9 0.2 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 11.2 11.0 8.3 14.0 10.4 6.5 6.2 11.5 5.2 5.9 6.0 29.4 1.9 48.4 73.8 9.4 7.4 7.6 9.4 12.5 24.4 0.0 1.1 0.0 6.9 0.4 80.4 63.8 0.0 1.2 2.6 17.1 25.9 18.4 0.4 1.0 6.4 48.6 134.4 8.6 0.5 0.3 1.3 30.4 0.0 38.0 92.0 27.1 53.7 0.4 0.0 2.8 0.0 20.3 0.6 3.2 75.2 1.6 3.2 27.5 75.5 EFR3A KIAA0143 ENSG00000132294 "EFR3 homolog A" Q14156 8 131904088-132013642 "Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 326.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022859, HPA023092, HPA023402" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA022859: AB_1848029, HPA023092: AB_2293240, HPA023402: AB_1848031" "unprognostic (4.79e-2)" "unprognostic (6.54e-2)" "unprognostic (6.42e-2)" "unprognostic (4.37e-3)" "unprognostic (2.77e-1)" "unprognostic (3.44e-2)" "unprognostic (3.04e-1)" "unprognostic (3.02e-1)" "unprognostic (1.51e-1)" "unprognostic (8.11e-2)" "unprognostic (5.89e-3)" "unprognostic (5.22e-2)" "unprognostic (3.46e-1)" "unprognostic (3.00e-1)" "unprognostic (3.29e-2)" "unprognostic (1.29e-1)" "unprognostic (2.21e-3)" 14.7 16.0 21.6 13.6 21.4 8.0 46.8 48.6 52.2 20.4 19.2 7.1 15.0 15.0 18.0 26.5 18.6 16.5 14.6 22.7 28.2 18.5 20.2 28.9 18.8 22.4 20.7 24.4 13.6 13.8 29.2 12.9 13.3 63.3 18.7 12.5 13.9 14.6 20.8 37.1 13.8 15.2 28.1 11.9 14.5 14.8 13.8 7.6 18.7 25.4 9.8 17.7 18.1 14.1 9.5 12.0 11.8 25.8 10.0 12.1 9.5 21.1 19.2 6.0 4.9 24.6 28.5 12.0 15.2 21.3 12.7 16.8 4.2 15.9 13.0 14.4 34.2 16.9 7.0 9.5 20.8 15.6 30.0 5.2 13.0 9.5 8.5 23.7 4.9 13.7 24.0 11.9 12.5 19.9 21.1 15.9 6.5 7.1 17.7 22.4 13.9 13.8 4.5 3.4 18.3 12.1 5.6 11.8 6.1 15.3 13.3 4.0 14.0 30.2 4.3 11.7 16.5 13.7 8.5 22.1 22.6 20.8 11.0 15.8 12.6 10.8 8.2 16.7 12.1 11.5 5.4 11.7 11.8 12.1 16.4 10.8 9.5 9.8 9.8 12.0 8.3 9.0 9.1 7.2 10.0 25.8 2.8 7.7 9.5 21.6 21.4 48.6 52.2 28.2 18.5 20.7 24.4 63.3 7.6 38.7 39.7 28.4 22.3 18.8 326.9 47.0 20.4 14.7 37.5 48.8 86.4 19.7 18.3 23.5 2.9 20.4 30.0 0.0 26.8 17.3 31.0 39.8 24.4 65.5 40.6 25.4 10.9 26.4 46.6 6.5 18.4 36.1 8.5 35.1 17.5 38.4 22.9 31.7 41.8 40.4 105.3 19.4 32.3 32.9 29.7 27.5 31.0 18.4 14.7 27.8 EFR3B "FLJ37871, KIAA0953" ENSG00000084710 "EFR3 homolog B" Q9Y2G0 2 25042130-25159137 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;retina: 21.1;skeletal muscle: 25.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 26.8;Cone photoreceptor cells: 21.6;Early spermatids: 15.3;Late spermatids: 37.7;Muller glia cells: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "AN3-CA: 9.0;BEWO: 10.6;SH-SY5Y: 9.4;SK-BR-3: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038089, HPA071831" Uncertain Supported "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA038089: AB_10672618, HPA071831: " "unprognostic (9.31e-2)" "unprognostic (3.92e-1)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.24e-3)" "unprognostic (3.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.32e-2)" "unprognostic (4.49e-6)" "unprognostic (4.83e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" 1.9 3.2 13.1 1.7 22.9 1.3 1.3 15.5 30.5 1.4 1.7 9.4 0.0 1.4 1.8 8.4 1.3 1.8 1.5 6.9 11.4 8.7 1.4 1.1 4.4 1.3 8.7 13.5 1.4 1.3 2.4 4.1 3.2 29.9 1.5 1.8 21.1 1.1 2.0 25.1 1.7 1.3 2.6 7.8 4.3 2.2 3.5 9.0 0.0 4.5 0.2 1.1 1.4 0.7 1.0 0.6 4.4 0.5 1.0 0.7 0.1 0.1 7.1 8.4 9.0 0.5 0.1 10.6 0.9 0.2 0.4 0.1 5.7 0.3 0.1 0.5 1.2 2.9 0.5 6.6 0.0 0.1 1.3 1.6 1.4 0.3 0.5 0.0 0.1 0.7 0.1 0.0 2.0 0.1 0.6 0.2 0.2 0.1 0.4 0.2 0.8 0.2 0.4 1.7 0.1 5.7 0.6 8.0 0.2 0.1 0.2 3.5 9.4 1.0 15.8 5.1 4.9 0.8 0.1 0.5 0.5 2.4 3.6 1.7 0.6 0.7 0.1 6.5 0.1 1.7 4.4 0.4 1.1 0.7 0.3 0.5 0.6 0.4 0.6 0.3 1.0 0.4 0.7 1.7 1.0 0.5 0.6 0.2 0.1 13.1 22.9 15.5 22.7 11.4 8.7 8.7 13.5 29.9 9.0 26.8 0.6 0.0 0.6 0.0 8.6 7.4 0.0 0.0 0.0 8.7 21.6 0.0 0.0 0.2 15.3 2.0 0.4 0.0 0.7 0.1 1.0 0.7 0.0 0.0 0.8 4.8 3.5 3.7 0.0 37.7 1.1 0.0 0.0 0.0 0.0 20.0 0.5 0.0 2.5 0.1 10.3 0.0 1.4 2.1 1.9 0.1 0.1 0.0 0.3 0.4 EFS "CASS3, EFS1, EFS2, HEFS, SIN" ENSG00000100842 "Embryonal Fyn-associated substrate" O43281 14 23356402-23365752 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 18.7;Syncytiotrophoblasts: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.2;AN3-CA: 15.4;BEWO: 23.7;SH-SY5Y: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001581, HPA001790" Approved Uncertain Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA001581: AB_2666367, HPA001790: " "unprognostic (9.58e-3)" "unprognostic (1.10e-2)" "unprognostic (3.68e-2)" "unprognostic (1.78e-1)" "unprognostic (6.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-1)" "unprognostic (3.85e-2)" "unprognostic (7.36e-2)" "unprognostic (2.15e-1)" "unprognostic (2.75e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.09e-5)" "unprognostic (3.44e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" 12.0 10.2 11.7 4.4 15.7 0.6 13.1 9.4 21.2 17.9 8.5 29.4 8.0 2.8 17.0 9.8 18.3 10.0 6.7 5.5 14.3 8.3 3.2 1.2 5.7 2.8 14.9 8.2 23.7 1.5 25.0 3.2 33.1 15.6 17.9 3.1 8.3 15.6 18.6 3.8 42.3 3.9 13.0 25.7 4.5 4.7 4.4 16.0 0.4 6.8 15.5 10.0 11.8 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 28.2 15.4 7.1 8.2 23.7 2.1 4.3 0.7 0.3 0.0 0.0 0.0 0.0 11.6 0.1 10.8 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 4.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 9.0 0.0 0.0 9.0 3.1 27.0 6.0 0.9 0.0 3.6 6.7 0.0 0.0 3.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 15.7 9.4 11.8 14.3 8.3 14.9 8.2 15.6 16.0 0.0 4.1 0.0 7.2 10.3 2.7 0.6 0.0 1.4 4.5 0.0 5.9 8.0 1.7 0.0 0.7 1.4 0.0 0.0 0.0 12.8 13.0 6.3 0.0 0.0 1.3 0.0 0.0 3.1 0.0 0.4 18.7 0.0 6.8 0.0 0.0 8.0 0.0 0.0 13.1 0.1 8.1 6.5 5.1 0.5 0.4 11.7 15.1 0.0 0.0 4.7 EFTUD2 "SNRNP116, Snrp116, Snu114, U5-116KD" ENSG00000108883 "Elongation factor Tu GTP binding domain containing 2" Q15029 17 44849943-44899662 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022021 Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA022021: AB_1848032" "unprognostic (4.28e-2)" "unprognostic (4.12e-2)" "unprognostic (1.98e-3)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (4.98e-2)" "prognostic unfavorable (2.71e-6)" "unprognostic (6.94e-2)" "unprognostic (4.52e-1)" "unprognostic (2.37e-1)" "unprognostic (4.11e-3)" "unprognostic (5.19e-2)" "unprognostic (5.48e-3)" "unprognostic (1.62e-2)" "unprognostic (5.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" 22.5 26.5 16.0 23.1 27.0 25.0 17.7 13.4 34.9 14.8 20.3 22.0 10.4 16.6 22.1 15.4 27.0 20.2 12.7 22.6 16.6 16.7 21.5 27.7 17.3 25.2 15.8 19.8 15.3 20.0 21.2 15.3 27.5 22.6 14.9 23.2 19.1 27.2 15.7 49.6 22.0 20.3 18.5 15.7 25.9 18.5 30.2 13.1 36.9 18.6 17.9 34.9 18.6 16.0 12.8 31.8 31.6 31.5 15.6 16.9 23.3 22.7 45.6 22.3 36.0 17.1 16.9 26.2 18.1 24.3 45.8 39.8 35.1 19.6 39.4 21.4 22.8 35.3 26.1 48.3 31.7 53.6 39.6 40.1 39.1 28.5 37.3 18.9 46.0 29.1 18.3 18.2 42.4 23.1 17.7 39.6 35.7 48.1 15.4 26.1 22.7 46.1 30.4 22.9 53.8 38.2 32.5 45.3 34.2 26.1 25.6 36.7 21.9 17.8 13.2 18.8 34.1 35.0 29.1 24.0 34.5 26.6 20.8 45.6 16.3 20.4 39.6 27.7 25.7 35.1 12.3 31.5 31.6 15.2 31.0 16.9 12.8 13.5 14.6 31.8 12.5 12.0 13.3 5.1 15.6 29.7 13.7 13.2 23.3 16.0 27.0 13.4 34.9 16.6 16.7 15.8 19.8 22.6 13.1 0.0 12.3 16.4 10.8 10.4 13.9 15.9 28.1 14.7 12.5 17.4 31.4 30.5 3.3 25.5 9.7 16.3 14.6 0.0 23.3 26.0 12.2 9.3 19.6 18.4 34.2 25.4 10.4 17.2 31.7 4.9 11.8 22.3 5.0 49.5 12.0 14.3 21.4 10.5 8.5 10.1 16.1 19.4 9.2 24.7 36.5 12.8 22.8 13.1 20.5 10.3 EGLN3 "HIFPH3, PHD3" ENSG00000129521 "Egl-9 family hypoxia inducible factor 3" Q9H6Z9 14 33924231-34462774 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 49.6;skin 1: 44.1" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 189.9;Cardiomyocytes: 91.5;Suprabasal keratinocytes: 202.4;Syncytiotrophoblasts: 86.2" "Cancer enhanced" "Detected in all" "renal cancer: 50.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 19.0" "Lineage enriched" "Detected in many" 16 "dendritic cells: 19.0" "Cell line enhanced" "Detected in many" "RH-30: 18.1;RPTEC TERT1: 15.5;RT4: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064895 Supported Cytosol NA NA Cytosol "HPA064895: AB_2685384" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" "unprognostic (1.75e-1)" "unprognostic (8.87e-2)" "unprognostic (6.88e-2)" "unprognostic (1.38e-2)" "prognostic unfavorable (2.14e-5)" "unprognostic (1.39e-3)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" "unprognostic (2.93e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.37e-1)" "unprognostic (5.21e-2)" "unprognostic (4.71e-2)" "unprognostic (6.30e-2)" 6.3 0.8 12.9 4.8 10.6 0.4 6.0 3.0 11.9 7.3 14.3 13.4 4.9 19.3 5.9 2.8 10.4 5.4 7.8 49.6 10.9 7.3 6.1 2.4 3.0 3.0 10.7 8.1 2.5 6.5 0.4 1.5 19.6 9.9 9.9 11.3 3.5 4.2 11.3 9.7 44.1 21.7 11.7 9.7 2.8 19.9 1.0 12.5 3.4 1.2 1.3 5.3 25.6 16.1 0.0 19.0 1.2 0.0 0.8 1.0 0.6 12.0 3.1 0.3 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.3 0.0 4.1 0.0 0.3 0.3 6.0 11.7 0.0 1.2 3.2 3.2 8.9 0.4 0.0 0.0 0.1 1.6 5.9 0.0 0.0 0.0 0.0 0.9 6.4 0.0 0.1 1.0 0.2 0.0 9.8 10.4 1.1 0.0 18.1 4.3 15.5 48.6 2.5 2.8 0.8 4.7 1.3 7.7 4.8 0.0 0.0 0.1 1.3 0.0 0.7 0.1 2.6 0.0 2.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.8 1.9 0.0 0.1 0.0 0.1 0.8 0.0 19.0 0.0 0.6 12.9 10.6 3.0 9.8 10.9 7.3 10.7 8.1 9.9 12.5 0.0 1.1 0.5 43.6 189.9 4.5 91.5 5.1 22.7 1.2 8.7 2.0 4.2 8.3 14.2 1.1 18.4 46.6 0.0 6.0 63.3 14.3 12.5 1.1 0.0 2.7 1.6 15.5 12.9 1.0 4.7 2.3 3.8 38.8 1.0 24.2 10.5 32.3 25.2 0.7 14.0 2.0 0.0 7.2 0.5 0.3 202.4 86.2 1.5 10.0 11.9 EHBP1 "KIAA0903, NACSIN" ENSG00000115504 "EH domain binding protein 1" Q8NDI1 2 62673851-63046487 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 215.6;Late spermatids: 370.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035468, HPA035469" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA035468: AB_10671513, HPA035469: AB_10601365" "unprognostic (5.39e-2)" "unprognostic (1.63e-3)" "unprognostic (8.78e-2)" "unprognostic (3.83e-3)" "unprognostic (1.43e-1)" "unprognostic (1.57e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.78e-1)" "unprognostic (1.95e-1)" "unprognostic (3.33e-2)" "unprognostic (3.14e-1)" "unprognostic (3.13e-3)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (1.95e-8)" 19.6 12.6 19.8 10.2 15.4 4.0 12.0 27.5 22.5 22.5 22.3 8.0 7.5 6.8 22.3 6.0 20.9 12.7 18.2 7.8 16.0 15.9 12.3 36.9 8.1 5.7 17.1 13.0 35.1 10.9 9.7 14.5 8.2 12.8 12.6 10.4 8.6 10.2 14.0 5.4 7.4 8.5 21.4 9.3 5.4 11.1 24.1 9.8 5.4 10.4 7.5 7.0 12.3 12.7 8.4 5.4 3.5 3.6 4.7 6.8 2.8 18.7 25.9 10.7 6.3 18.6 35.9 10.7 16.7 16.4 12.3 10.2 30.9 14.1 13.0 6.2 30.7 18.9 11.5 13.7 11.9 20.5 13.8 6.4 11.2 9.2 36.4 12.8 6.5 8.6 16.5 21.4 12.5 24.6 12.5 7.9 10.4 7.6 7.4 19.9 7.3 7.5 4.1 10.3 15.6 10.1 6.7 13.2 5.5 8.2 6.1 11.6 9.4 13.8 10.2 16.6 11.8 4.9 6.4 5.8 13.3 13.8 21.9 8.7 8.6 5.9 12.4 13.3 10.1 26.6 0.2 3.4 3.5 6.3 3.6 6.3 8.4 6.8 6.0 5.4 7.3 6.7 5.7 1.3 4.7 1.9 3.5 3.7 2.8 19.8 15.4 27.5 22.5 16.0 15.9 17.1 13.0 12.8 9.8 35.7 13.1 9.0 11.0 13.9 30.3 13.3 25.5 14.7 22.7 14.0 3.9 8.5 13.3 18.7 215.6 17.4 5.8 0.0 35.1 26.0 18.6 8.4 2.3 57.0 4.3 17.5 15.5 26.4 9.8 370.2 54.1 8.3 10.1 3.6 5.8 22.2 35.4 5.8 37.8 12.2 17.8 6.5 18.6 46.0 20.9 12.4 2.4 8.4 8.7 11.3 EI24 "EPG4, PIG8, TP53I8" ENSG00000149547 "EI24, autophagy associated transmembrane protein" O14681 11 125569216-125584687 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 164.6" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 494.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 117.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047165, HPA051029" Approved Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Golgi apparatus" "HPA047165: AB_2679965, HPA051029: AB_2681317" "unprognostic (2.04e-3)" "unprognostic (2.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.43e-2)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.02e-2)" "unprognostic (6.38e-2)" "unprognostic (6.74e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (3.50e-2)" "unprognostic (1.35e-1)" "unprognostic (4.58e-2)" "unprognostic (8.35e-2)" "unprognostic (2.07e-1)" "unprognostic (3.01e-1)" 13.4 10.2 13.3 8.9 16.2 4.6 16.7 11.2 22.1 12.7 17.0 14.4 13.8 11.3 13.6 12.9 22.7 12.1 15.8 16.4 10.6 10.7 14.6 55.5 12.1 11.2 12.0 11.1 13.1 34.2 164.6 9.2 11.9 11.0 13.7 18.9 13.2 20.9 14.3 26.5 17.2 16.1 15.9 9.2 10.5 17.7 10.4 10.5 9.9 12.0 14.2 13.0 16.2 12.9 8.5 15.5 5.4 7.3 6.5 10.0 4.9 24.5 18.7 21.4 25.8 35.2 26.8 26.8 25.2 19.1 17.4 15.7 28.4 49.7 24.7 42.9 23.7 18.5 28.4 32.5 53.0 22.6 6.5 20.6 117.9 13.4 26.6 26.2 26.6 12.8 25.0 48.6 26.1 38.7 17.2 36.7 13.5 53.5 10.1 24.4 17.3 12.1 13.6 28.2 63.6 20.5 17.8 25.3 21.0 29.0 44.0 20.0 19.2 29.5 35.2 9.5 37.0 71.9 26.5 30.5 22.4 15.2 15.7 20.4 6.3 12.7 32.2 9.8 40.8 29.8 4.1 7.3 5.4 8.2 7.0 8.1 8.5 6.5 10.0 11.6 7.3 9.4 7.6 0.9 6.5 5.1 15.5 9.0 4.9 13.3 16.2 11.2 22.1 10.6 10.7 12.0 11.1 11.0 10.5 29.8 34.7 29.8 114.2 107.2 57.4 55.7 129.9 9.4 27.3 104.7 35.3 140.6 122.7 154.4 19.7 84.2 53.8 0.0 158.4 174.0 83.1 141.9 27.6 494.9 92.4 77.9 94.5 65.1 44.4 33.9 66.2 50.8 86.0 34.3 100.9 68.5 153.1 52.6 67.8 102.8 30.5 45.3 89.6 92.8 109.0 158.6 117.2 35.1 116.3 136.4 EIF1AX "eIF-1A, eIF-4C, EIF1A, EIF4C" ENSG00000173674 "Eukaryotic translation initiation factor 1A, X-linked" P47813 X 20124518-20141844 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002561 Uncertain Supported Approved Cytosol NA NA Cytosol "HPA002561: AB_1078724" "unprognostic (1.91e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-2)" "unprognostic (9.69e-2)" "unprognostic (1.43e-2)" "unprognostic (1.26e-3)" "unprognostic (7.13e-3)" "unprognostic (2.22e-1)" "unprognostic (8.28e-2)" "unprognostic (1.02e-3)" "unprognostic (2.82e-2)" "unprognostic (4.73e-2)" "unprognostic (8.66e-2)" "unprognostic (2.23e-3)" "unprognostic (7.81e-2)" "unprognostic (1.61e-1)" "unprognostic (1.52e-1)" 30.9 23.2 22.0 23.7 28.8 28.3 53.4 35.4 57.3 26.1 23.6 14.5 23.9 22.7 33.8 18.7 32.6 24.7 18.4 29.2 21.4 19.5 31.0 32.0 22.1 20.9 23.5 23.5 37.0 33.0 28.7 19.8 24.7 29.0 19.5 16.9 12.0 25.2 25.0 61.5 22.5 18.9 32.5 34.1 16.5 22.7 18.0 23.7 14.8 25.7 24.6 17.2 29.3 33.9 31.1 30.2 12.6 19.9 27.2 30.9 23.8 46.2 26.2 20.2 26.8 19.7 26.9 16.4 41.4 15.2 22.7 17.9 37.6 22.2 43.4 27.8 27.3 21.2 19.9 35.5 35.9 35.4 17.7 58.7 19.2 32.9 32.0 13.8 51.0 27.1 12.6 22.1 34.9 54.9 15.0 31.5 14.1 49.6 24.4 22.2 22.6 31.4 32.0 52.4 19.6 43.5 25.9 46.4 46.3 17.8 25.9 23.4 26.2 43.9 34.3 27.2 30.4 27.9 21.7 18.0 27.6 17.1 89.8 30.9 16.7 31.5 51.4 18.8 23.4 20.8 12.6 19.1 11.5 23.1 19.9 30.2 31.1 26.5 27.1 18.3 27.7 30.9 25.8 4.7 27.2 19.2 30.2 20.3 23.8 22.0 28.8 35.4 57.3 21.4 19.5 23.5 23.5 29.0 23.7 98.3 94.3 135.4 291.6 421.9 162.4 89.0 132.5 107.1 166.1 109.9 88.4 168.6 159.2 183.9 401.5 152.7 92.4 46.7 198.9 430.4 186.0 298.0 159.4 317.5 176.9 96.9 160.6 121.5 132.4 74.9 133.5 136.3 146.8 92.0 191.7 167.0 198.1 98.2 136.5 205.2 118.8 142.3 222.6 52.6 114.6 498.3 189.8 92.0 263.5 304.6 EIF1AY ENSG00000198692 "Eukaryotic translation initiation factor 1A, Y-linked" O14602 Y 20575725-20593154 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 78.3;skeletal muscle: 124.6" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 345.1;Erythroid cells: 467.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.9;HEL: 46.5;U-266/84: 32.9;U-698: 74.6" HPA002561 Uncertain Supported Approved Cytosol NA NA Cytosol "HPA002561: AB_1078724" "unprognostic (4.31e-2)" "unprognostic (3.74e-1)" "unprognostic (2.14e-3)" "unprognostic (2.68e-2)" "unprognostic (1.12e-2)" "unprognostic (2.89e-2)" "unprognostic (4.18e-2)" "unprognostic (2.17e-2)" "unprognostic (4.10e-2)" "unprognostic (8.53e-3)" "unprognostic (2.89e-1)" "unprognostic (6.03e-2)" 5.9 8.3 7.0 18.6 8.3 29.2 5.0 4.5 10.9 0.0 12.6 10.0 22.2 9.0 0.1 20.2 9.9 0.0 10.5 78.3 6.5 10.4 9.1 23.0 13.3 22.8 8.2 0.0 0.1 15.0 0.2 11.4 10.3 13.4 17.4 16.1 8.8 13.1 22.9 124.6 4.2 17.9 28.2 9.2 45.8 6.5 13.1 0.0 28.7 6.2 48.9 15.9 8.9 0.0 22.1 23.0 44.5 8.0 7.8 11.9 5.0 0.1 5.5 0.0 0.0 0.0 0.0 11.6 12.3 8.3 8.6 8.5 0.0 0.0 37.9 0.0 6.5 0.0 0.0 0.0 0.0 11.8 20.4 0.0 46.5 0.0 13.8 8.5 0.0 0.0 4.6 9.4 0.0 0.0 0.0 0.0 12.8 0.0 0.0 13.7 0.0 30.0 0.0 8.2 0.0 0.0 0.0 15.5 15.1 12.0 14.4 11.0 0.0 0.0 0.0 8.4 16.5 0.0 6.5 12.2 6.6 0.1 0.0 13.3 22.9 32.9 74.6 2.5 0.0 0.0 10.0 6.7 9.3 5.2 7.7 7.3 19.2 9.5 6.1 5.7 22.1 11.9 9.0 44.5 7.8 8.0 23.0 10.9 5.0 7.0 8.3 4.5 10.9 6.5 10.4 8.2 0.0 13.4 0.0 29.8 47.1 119.4 60.3 48.5 15.1 345.1 22.9 49.5 51.2 50.6 9.8 109.0 74.6 30.4 26.6 37.2 2.6 467.2 0.3 42.0 36.5 59.3 86.9 0.9 30.7 6.4 17.0 39.3 60.3 8.8 39.7 51.5 64.1 79.4 12.1 66.9 34.6 8.6 41.1 80.0 20.6 38.8 56.6 53.4 88.1 44.3 77.6 62.3 1.0 56.7 EIF2A EIF-2A ENSG00000144895 "Eukaryotic translation initiation factor 2A" Q9BY44 3 150546678-150584242 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036256 Approved Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA036256: AB_10611961" "unprognostic (1.72e-1)" "unprognostic (2.09e-2)" "unprognostic (2.71e-3)" "unprognostic (3.36e-2)" "unprognostic (3.96e-3)" "unprognostic (7.05e-3)" "prognostic unfavorable (2.36e-5)" "unprognostic (2.11e-1)" "unprognostic (7.92e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.57e-6)" "unprognostic (6.30e-2)" "unprognostic (3.08e-2)" "unprognostic (3.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (3.39e-1)" 33.5 23.7 12.6 21.4 22.8 27.2 34.3 38.3 23.8 35.1 29.4 12.6 17.3 23.1 31.5 19.9 37.2 20.6 19.0 24.9 11.3 11.9 27.0 44.5 24.7 32.8 16.5 11.7 35.6 39.4 22.6 36.4 26.2 22.7 32.9 23.8 15.4 29.8 23.9 53.3 26.8 33.1 25.0 16.9 28.9 26.5 16.3 17.9 38.5 41.8 33.8 25.8 44.0 26.1 17.0 27.7 7.9 24.6 20.5 26.9 19.0 38.5 14.0 19.7 20.7 25.3 50.4 27.2 23.8 33.0 30.5 33.0 38.8 42.6 50.9 36.5 28.3 39.0 31.3 32.6 33.0 43.5 19.2 21.9 29.8 16.9 30.0 24.3 37.2 28.5 33.6 37.6 22.4 50.1 44.5 37.8 26.3 24.5 30.3 24.6 27.1 27.0 19.7 27.9 38.8 22.2 23.8 25.8 59.0 31.9 24.0 25.0 26.8 14.3 22.9 37.2 23.2 33.6 34.6 22.1 19.3 18.4 27.3 45.7 52.6 27.6 46.8 24.5 32.6 9.6 7.9 22.6 4.7 14.9 23.5 23.3 17.0 21.2 18.2 27.7 14.9 26.9 21.0 1.8 20.5 24.6 13.1 17.3 19.0 12.6 22.8 38.3 23.8 11.3 11.9 16.5 11.7 22.7 17.9 32.8 55.5 71.7 137.7 124.4 27.0 97.7 48.4 41.5 48.9 33.2 25.5 72.1 116.0 60.9 13.8 61.2 56.4 0.0 94.1 85.0 60.9 65.4 74.9 27.6 57.0 22.3 54.5 46.1 95.5 5.0 57.0 72.0 65.8 64.9 76.1 26.1 62.8 40.3 53.0 90.1 30.8 77.6 69.4 29.9 39.0 107.4 100.6 76.1 82.2 109.1 EIF2AK1 "HRI, KIAA1369" ENSG00000086232 "Eukaryotic translation initiation factor 2 alpha kinase 1" Q9BQI3 7 6022244-6059230 "Enzymes, Predicted intracellular proteins" "Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cytotrophoblasts: 180.9;Syncytiotrophoblasts: 310.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016496, CAB022082, HPA061675" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583" "unprognostic (7.15e-3)" "unprognostic (2.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.91e-1)" "unprognostic (6.70e-2)" "unprognostic (9.69e-3)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.36e-1)" "unprognostic (2.54e-1)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (1.99e-1)" "unprognostic (5.45e-2)" "unprognostic (9.02e-2)" "unprognostic (1.06e-2)" 21.0 38.2 31.7 25.4 32.7 62.8 26.9 23.9 41.1 22.8 34.5 31.0 20.8 26.5 22.6 28.6 28.4 23.4 21.5 40.0 29.9 30.0 32.0 46.3 22.1 23.3 33.3 30.3 23.0 32.4 61.9 25.4 43.9 33.4 26.4 34.9 23.4 46.4 26.3 31.6 28.9 29.9 17.8 35.6 25.4 34.7 16.3 22.6 37.1 29.0 17.4 29.6 22.4 20.1 11.7 7.5 17.4 7.4 10.4 10.6 4.8 41.8 26.4 21.2 32.2 20.3 18.4 27.9 21.6 19.7 19.3 24.5 24.2 28.3 32.8 23.7 23.7 34.7 29.6 27.5 19.7 24.9 20.3 42.2 33.8 28.7 36.4 16.7 28.7 30.9 14.7 24.9 18.2 19.7 20.4 20.5 25.9 54.0 31.7 18.1 41.9 15.7 36.7 26.6 24.4 29.8 34.7 22.3 38.5 24.6 20.5 26.4 47.5 41.5 55.5 18.4 30.9 41.8 35.2 19.6 11.1 41.5 19.5 22.9 32.3 32.2 33.5 22.4 37.9 32.1 10.6 7.4 17.4 9.5 5.9 6.4 11.7 7.4 10.6 7.5 7.7 8.6 7.7 4.1 10.4 6.5 6.6 8.8 4.8 31.7 32.7 23.9 41.1 29.9 30.0 33.3 30.3 33.4 22.6 35.7 43.2 44.9 27.9 21.2 28.0 44.8 43.3 34.8 29.6 41.8 15.7 180.9 56.3 48.3 6.9 22.4 43.3 116.8 39.3 64.2 22.2 37.8 19.7 55.5 47.3 30.2 37.0 20.3 29.0 11.9 31.9 31.4 23.6 59.5 60.3 40.2 46.9 35.1 35.3 51.5 23.0 12.9 17.0 32.5 42.3 19.6 310.3 35.0 47.0 25.5 EIF2AK2 "EIF2AK1, PKR, PPP1R83, PRKR" ENSG00000055332 "Eukaryotic translation initiation factor 2 alpha kinase 2" P19525 2 37099210-37157065 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003845, HPA019795, HPA063893" Approved Enhanced Cytosol NA NA Cytosol "CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144" "unprognostic (1.70e-2)" "unprognostic (2.26e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (1.77e-3)" "unprognostic (8.42e-2)" "unprognostic (8.02e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.19e-1)" "unprognostic (3.15e-3)" "unprognostic (3.33e-1)" "unprognostic (1.74e-1)" "unprognostic (4.65e-2)" "unprognostic (5.32e-2)" 25.5 14.2 15.9 16.3 15.5 36.4 13.9 16.4 19.0 14.7 13.7 9.9 9.3 14.5 17.2 21.5 12.1 12.8 15.4 10.7 13.7 19.2 12.2 11.5 13.7 10.7 14.3 15.0 18.7 11.7 19.2 21.1 18.2 17.3 15.0 12.8 10.2 23.0 17.8 7.1 6.7 15.2 16.2 14.0 15.5 14.3 5.1 12.8 14.1 13.6 8.1 10.6 14.8 15.5 8.8 6.9 27.6 10.8 8.6 9.9 3.3 23.3 12.0 7.4 9.3 8.1 11.2 14.6 12.3 17.7 39.0 37.6 13.7 13.9 12.5 16.1 13.5 46.4 13.9 12.7 12.5 17.5 27.4 6.7 13.7 9.1 8.9 8.0 13.0 0.1 9.1 4.9 15.6 11.3 6.8 9.7 5.5 9.5 12.6 8.8 10.4 16.7 6.7 7.7 3.9 8.6 16.9 18.1 6.2 7.3 9.0 8.3 8.8 15.1 11.0 23.7 6.5 5.6 3.7 12.5 15.8 16.8 6.8 19.8 9.3 15.3 0.2 7.6 8.9 13.8 17.1 8.2 11.1 8.9 10.6 9.0 8.8 7.5 8.1 6.9 7.0 6.1 7.5 27.6 8.6 10.8 4.7 9.9 3.3 15.9 15.5 16.4 19.0 13.7 19.2 14.3 15.0 17.3 12.8 62.5 27.7 15.7 36.6 17.3 37.2 25.3 33.1 53.5 58.0 21.0 13.7 40.9 18.3 31.1 1.7 56.2 26.2 0.0 42.4 72.4 35.3 31.0 39.4 15.8 34.3 44.5 14.5 29.4 21.6 2.1 52.9 24.7 20.3 23.4 22.2 48.9 41.0 24.6 79.2 28.5 24.1 38.8 34.2 2.6 3.4 8.8 34.1 30.2 26.2 36.3 EIF2AK4 "GCN2, KIAA1338" ENSG00000128829 "Eukaryotic translation initiation factor 2 alpha kinase 4" Q9P2K8 15 39934146-40035591 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation" "Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.9" "Group enriched" "Detected in all" 4 "dendritic cells: 32.9;monocytes: 9.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011811 Approved Approved Cytosol NA NA Cytosol "HPA011811: AB_2668543" "unprognostic (3.10e-1)" "unprognostic (4.78e-3)" "unprognostic (5.97e-2)" "unprognostic (7.18e-2)" "unprognostic (1.05e-2)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-2)" "unprognostic (6.47e-2)" "unprognostic (2.31e-2)" "unprognostic (5.11e-3)" 20.7 16.5 20.2 19.4 27.3 20.2 36.0 22.4 27.3 16.8 16.3 13.6 17.1 12.2 35.7 17.9 17.8 18.1 19.4 18.2 19.5 20.5 15.4 22.7 22.5 16.6 18.6 14.2 20.1 21.5 20.3 34.7 20.5 17.6 22.0 14.6 17.9 16.7 20.3 20.4 20.7 12.2 24.3 14.6 16.1 16.4 11.5 15.1 17.7 24.1 10.6 15.9 27.0 14.4 5.0 32.9 4.2 9.3 3.8 4.5 2.4 14.0 6.8 12.1 18.2 19.9 33.6 11.5 19.8 22.8 16.3 16.1 9.6 6.1 7.5 10.4 26.9 21.8 15.0 16.1 24.0 22.7 35.3 8.1 15.9 12.5 11.6 17.1 9.6 11.0 26.5 16.5 15.5 27.9 23.0 22.6 15.8 11.7 7.1 32.0 4.7 8.0 13.2 7.4 12.5 15.1 9.7 16.8 12.3 20.2 9.6 6.3 9.7 14.2 8.6 12.3 12.3 12.1 16.6 24.0 21.7 16.5 10.8 12.8 9.8 17.7 2.3 15.2 13.2 30.3 4.2 5.8 4.0 3.6 6.7 3.1 3.5 4.0 4.1 8.4 5.0 4.5 4.2 1.7 3.8 9.3 32.9 2.7 2.4 20.2 27.3 22.4 27.3 19.5 20.5 18.6 14.2 17.6 15.1 14.9 23.6 17.2 22.6 10.6 28.5 28.8 22.9 13.4 26.1 15.7 11.8 29.7 11.6 22.9 1.0 27.0 7.3 0.0 22.0 29.4 26.2 25.6 23.1 20.8 27.4 27.0 13.8 23.4 28.6 2.4 39.1 46.9 30.4 32.5 20.8 31.3 33.9 10.5 37.4 15.1 22.8 45.3 18.6 9.8 29.6 12.7 12.7 15.8 27.6 17.2 EIF2B1 "EIF-2B, EIF-2Balpha, EIF2B, EIF2BA" ENSG00000111361 "Eukaryotic translation initiation factor 2B subunit alpha" Q14232 12 123620406-123633766 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034258, HPA049509" Approved Approved Cytosol NA NA 8500 Cytosol "CAB034258: AB_2095995, HPA049509: AB_2680797" "unprognostic (2.14e-2)" "unprognostic (4.18e-2)" "unprognostic (2.78e-1)" "unprognostic (7.50e-2)" "unprognostic (1.22e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (6.75e-7)" "unprognostic (5.65e-2)" "unprognostic (7.24e-3)" "unprognostic (1.53e-1)" "unprognostic (7.27e-2)" "unprognostic (1.94e-2)" "prognostic unfavorable (1.78e-9)" "unprognostic (2.46e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.40e-2)" 27.9 29.5 24.0 27.8 29.0 27.5 27.6 35.6 33.4 24.1 26.4 25.7 24.6 24.3 32.3 27.3 30.2 27.3 27.2 21.1 22.6 20.3 22.8 30.2 21.3 32.7 29.9 28.0 32.7 29.2 22.0 29.0 29.8 26.8 25.8 28.0 21.7 25.6 28.0 34.9 44.3 27.6 33.8 24.3 30.1 24.9 29.1 26.9 33.3 25.2 30.5 36.6 28.0 27.3 23.2 35.6 42.3 38.2 22.6 26.6 32.6 19.0 16.8 17.9 18.8 16.5 16.6 18.7 23.5 13.2 22.8 16.5 21.2 12.0 36.1 28.1 17.3 10.2 19.2 27.5 17.9 23.9 29.4 30.0 25.9 23.9 18.8 15.5 36.4 32.6 15.0 22.2 19.5 13.8 19.3 20.8 23.4 46.1 12.1 20.8 16.9 29.2 37.6 29.4 20.5 22.0 30.8 21.8 27.3 15.0 16.0 22.3 25.3 17.3 17.4 21.6 17.4 31.5 21.9 19.9 15.8 19.2 22.6 21.8 32.9 34.5 53.3 23.1 24.7 22.6 32.5 32.7 42.3 22.5 38.2 20.4 23.2 22.9 23.1 35.6 20.3 23.7 21.8 3.6 22.6 34.5 22.4 26.6 32.6 24.0 29.0 35.6 33.4 22.6 20.3 29.9 28.0 26.8 26.9 14.9 18.7 29.4 15.7 18.1 18.6 17.5 30.6 17.4 15.9 17.4 7.9 60.3 24.9 22.5 6.1 24.3 18.4 0.0 35.1 48.7 19.2 11.7 40.4 10.4 33.0 15.9 20.8 18.4 17.5 3.6 23.3 21.9 18.6 28.9 13.7 33.2 25.6 18.7 15.6 17.7 20.4 32.3 23.7 42.2 41.1 17.9 43.1 21.0 20.2 14.3 EIF2B3 "EIF-2B, EIF2Bgamma" ENSG00000070785 "Eukaryotic translation initiation factor 2B subunit gamma" Q9NR50 1 44850522-44986722 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024213, HPA024218, HPA024219" Supported Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069" "unprognostic (2.12e-2)" "unprognostic (7.49e-2)" "unprognostic (4.37e-3)" "unprognostic (5.14e-2)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (4.55e-2)" "unprognostic (1.14e-2)" "unprognostic (7.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.36e-1)" "unprognostic (5.38e-2)" "unprognostic (6.98e-2)" "unprognostic (7.80e-2)" "unprognostic (5.69e-3)" "unprognostic (2.73e-2)" 16.5 18.3 12.9 9.2 14.6 7.1 16.1 22.2 16.5 11.6 10.1 13.1 11.2 6.6 13.1 10.1 11.8 9.6 7.5 22.5 10.7 11.1 11.9 20.7 8.8 9.9 13.7 11.1 12.3 18.5 23.3 26.7 7.3 16.0 10.6 10.6 12.3 17.9 11.9 52.1 10.5 6.6 14.8 12.1 9.8 9.1 13.7 12.3 11.1 9.8 13.7 12.4 12.2 10.9 11.3 21.9 2.3 21.4 14.1 15.4 12.5 14.0 11.5 12.7 10.8 15.6 18.7 15.2 22.8 17.4 23.4 22.2 16.6 8.4 36.8 16.8 17.1 18.7 8.3 26.8 19.3 28.7 12.7 24.6 18.2 12.7 15.9 19.8 27.9 10.4 12.9 10.5 25.6 29.2 11.1 21.5 12.3 41.8 12.8 25.3 9.7 26.8 12.2 17.7 16.0 22.9 21.7 21.3 26.2 12.0 6.6 23.0 8.4 23.0 26.5 14.5 17.5 10.3 13.0 11.5 15.2 18.2 22.3 29.5 13.3 15.0 27.5 11.8 23.5 18.1 1.0 14.3 2.3 12.2 21.4 14.4 9.5 12.0 13.5 21.9 11.3 15.2 15.4 1.2 14.1 18.5 15.4 9.9 12.5 12.9 14.6 22.2 16.5 10.7 11.1 13.7 11.1 16.0 12.3 6.0 19.5 8.2 17.8 12.2 13.2 75.1 12.7 46.8 21.6 5.2 19.6 21.5 24.9 16.9 18.8 15.6 5.1 0.0 13.7 17.9 16.5 14.5 24.4 19.1 22.1 20.6 3.5 3.7 11.6 7.7 24.5 15.7 16.9 41.5 6.1 17.0 12.9 5.8 23.7 17.7 20.5 25.8 39.1 38.7 23.0 13.0 12.5 10.0 7.9 13.1 EIF2B5 "EIF-2B, EIF2Bepsilon" ENSG00000145191 "Eukaryotic translation initiation factor 2B subunit epsilon" Q13144 3 184135038-184145311 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015412, HPA064370, HPA069303" Uncertain Enhanced Cytosol NA NA Cytosol "CAB015412: AB_831253, HPA064370: AB_2685249, HPA069303: AB_2686114" "unprognostic (3.28e-1)" "unprognostic (1.14e-2)" "unprognostic (9.05e-3)" "unprognostic (3.33e-2)" "unprognostic (1.15e-2)" "unprognostic (9.33e-2)" "prognostic unfavorable (3.38e-8)" "unprognostic (8.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.21e-2)" "unprognostic (3.80e-1)" "unprognostic (1.32e-2)" "unprognostic (9.97e-3)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (5.32e-2)" 15.2 20.1 15.3 15.4 20.2 10.6 21.5 24.5 25.8 15.1 18.8 17.8 24.3 17.3 16.3 14.9 24.3 15.4 14.0 21.5 13.0 16.1 17.5 27.5 15.6 20.1 20.8 15.1 16.0 19.1 27.0 21.2 20.6 17.7 20.4 23.7 15.3 23.2 21.0 47.2 22.8 18.2 17.5 14.7 21.1 19.6 11.9 17.3 20.9 17.4 16.9 26.9 19.1 18.3 12.7 10.3 10.9 8.4 11.2 17.2 6.5 24.4 11.2 13.8 15.0 13.9 11.4 14.9 14.6 15.6 21.4 18.2 18.4 12.3 22.2 16.9 14.3 28.0 18.9 24.7 17.0 21.9 19.9 20.3 36.3 11.4 16.1 10.8 27.4 19.3 9.5 15.4 12.9 13.4 11.0 15.3 22.3 19.6 19.4 15.1 20.5 20.0 19.1 18.6 29.8 20.8 21.7 16.6 25.0 19.5 21.6 14.9 16.5 12.5 39.7 16.2 11.5 36.7 27.2 14.2 13.0 15.2 12.3 28.0 16.7 23.1 28.3 15.5 29.4 16.2 7.2 8.4 10.9 7.6 7.4 10.5 12.0 11.9 12.7 10.3 12.7 17.2 10.7 1.6 11.2 7.7 5.0 9.5 6.5 15.3 20.2 24.5 25.8 13.0 16.1 20.8 15.1 17.7 17.3 23.8 20.7 22.3 31.6 27.4 19.3 21.5 10.2 18.7 30.7 34.9 7.9 33.4 44.7 20.0 2.6 22.5 23.8 23.3 31.3 23.2 16.4 34.3 16.1 23.6 22.0 33.4 44.0 16.0 16.5 2.1 17.0 20.5 18.6 34.3 24.5 13.3 21.9 14.4 13.8 25.8 15.0 12.9 21.7 13.4 13.0 25.3 32.3 23.6 26.5 37.1 EIF2D LGTN ENSG00000143486 "Eukaryotic translation initiation factor 2D" P41214 1 206571292-206612463 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028220 Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA028220: AB_10602022" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (4.09e-3)" "unprognostic (2.39e-1)" "unprognostic (2.20e-3)" "unprognostic (6.60e-2)" "unprognostic (1.45e-1)" "unprognostic (3.93e-1)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (3.54e-1)" "unprognostic (1.97e-1)" "unprognostic (8.32e-2)" "unprognostic (2.13e-2)" 19.4 22.3 12.3 14.6 17.0 15.7 25.0 16.7 14.5 23.6 22.2 19.4 23.7 12.1 24.5 21.1 22.3 25.2 19.0 15.2 13.5 9.0 19.6 20.0 15.4 19.9 19.7 10.0 36.2 38.1 19.7 17.3 15.2 14.9 22.8 18.9 18.1 26.9 18.3 27.7 19.2 15.2 22.6 14.5 16.0 21.9 13.1 18.5 29.3 29.3 20.0 21.7 21.0 21.1 19.2 16.6 5.6 13.1 16.4 21.3 10.5 20.3 12.6 10.3 8.9 30.5 40.2 12.5 11.5 23.9 20.9 20.6 10.2 17.8 34.6 8.9 23.5 6.7 14.5 16.7 26.1 18.6 11.3 21.5 12.1 15.1 19.3 33.6 21.9 12.5 36.5 34.8 16.6 33.1 26.7 26.5 25.4 28.1 16.3 18.2 16.0 19.6 10.2 8.4 15.3 19.3 15.9 22.1 38.1 21.2 7.6 9.7 8.9 10.1 27.2 24.5 16.1 20.8 17.3 18.5 11.6 11.6 5.3 15.3 14.9 8.3 24.2 15.6 14.9 8.6 5.6 10.3 1.6 11.8 9.2 15.9 19.2 16.4 14.5 16.6 15.5 21.3 15.3 0.2 16.4 13.1 8.8 14.5 10.5 12.3 17.0 16.7 14.5 13.5 9.0 19.7 10.0 14.9 18.5 14.9 13.7 22.9 30.1 12.8 10.6 8.4 2.5 18.7 18.2 10.4 3.9 33.5 21.6 16.0 30.3 18.0 8.1 0.0 17.2 21.7 17.7 20.5 17.3 7.9 19.3 3.2 4.7 20.3 12.6 10.3 26.7 12.8 16.9 25.2 12.2 9.4 16.1 11.5 25.8 24.5 13.6 19.4 17.6 23.3 9.3 20.3 21.4 20.8 31.5 23.6 EIF2S1 "EIF-2alpha, EIF2, EIF2A" ENSG00000134001 "Eukaryotic translation initiation factor 2 subunit alpha" P05198 14 67359997-67386516 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 211.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011663, HPA064885" Supported Enhanced Cytosol NA NA 52000 Cytosol "CAB011663: AB_2096478, HPA064885: AB_2685382" "unprognostic (1.86e-2)" "unprognostic (8.33e-2)" "unprognostic (4.31e-2)" "unprognostic (2.46e-2)" "unprognostic (3.78e-2)" "unprognostic (1.78e-3)" "prognostic unfavorable (4.73e-7)" "unprognostic (4.14e-3)" "unprognostic (4.49e-1)" "unprognostic (1.68e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (2.95e-1)" "unprognostic (1.21e-2)" "unprognostic (1.73e-1)" "unprognostic (4.65e-1)" "unprognostic (1.59e-2)" "prognostic unfavorable (7.11e-4)" 35.5 26.2 18.7 24.8 26.3 18.9 22.5 18.9 30.6 17.8 25.7 16.3 16.1 18.5 22.9 18.0 34.8 18.4 19.1 27.9 21.9 17.0 23.8 45.0 21.1 24.1 19.9 20.8 22.9 27.8 21.3 16.3 28.0 24.1 24.4 24.2 12.6 19.9 21.0 52.0 23.8 18.4 30.9 18.9 22.8 22.9 29.1 15.1 27.3 29.0 29.9 28.0 31.1 23.1 26.6 32.9 17.3 32.7 25.7 29.2 30.2 67.4 22.5 15.9 24.4 15.4 17.4 34.1 30.2 18.0 34.1 29.9 26.3 24.2 30.5 15.3 22.7 23.0 26.2 36.6 28.8 52.1 22.2 13.7 19.7 22.0 18.0 16.2 20.9 19.3 14.1 16.8 30.4 46.6 13.4 27.7 19.3 33.4 23.7 33.6 33.5 28.5 16.4 16.2 40.6 37.8 21.9 26.4 21.7 20.9 31.1 23.0 16.2 21.7 25.6 23.3 14.7 43.6 18.2 21.1 45.2 48.8 21.8 32.0 20.6 22.4 46.1 26.2 37.5 29.0 17.3 24.2 14.8 23.9 32.7 29.1 26.6 27.9 25.7 32.9 21.3 26.0 26.5 3.3 25.7 27.4 22.5 29.2 30.2 18.7 26.3 18.9 30.6 21.9 17.0 19.9 20.8 24.1 15.1 26.8 38.1 35.0 67.4 126.8 22.8 84.7 33.1 26.8 44.3 21.0 11.8 70.2 59.7 77.0 64.0 51.3 22.3 0.0 54.6 82.1 48.2 40.6 34.6 38.0 62.8 35.0 12.5 23.9 39.6 23.3 28.7 43.9 49.0 66.7 24.0 20.9 60.9 11.5 38.2 53.2 26.2 25.8 78.5 211.8 73.9 114.0 78.1 41.7 33.8 65.0 EIF3A "EIF3, eIF3-p170, eIF3-theta, eIF3a, EIF3S10, KIAA0139, TIF32" ENSG00000107581 "Eukaryotic translation initiation factor 3 subunit A" Q14152 10 119033670-119080823 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038315, HPA038316" Enhanced Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA038315: AB_10672588, HPA038316: AB_10673168" "unprognostic (8.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (3.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.16e-1)" "unprognostic (1.84e-1)" "unprognostic (9.38e-2)" "unprognostic (3.84e-3)" "unprognostic (9.07e-2)" "unprognostic (5.48e-3)" "unprognostic (8.07e-2)" "unprognostic (1.20e-1)" "unprognostic (9.07e-2)" "unprognostic (1.89e-2)" 36.7 27.4 19.6 29.4 20.2 41.4 42.4 22.4 22.3 27.8 29.2 21.7 32.3 26.0 33.4 26.0 35.7 22.7 25.0 36.7 19.9 18.6 28.2 41.5 24.6 39.0 24.2 20.1 29.2 61.9 35.8 33.2 33.7 25.5 26.9 26.4 14.4 31.4 31.6 92.3 36.0 29.2 49.3 29.8 29.8 34.1 18.6 22.6 45.8 28.6 33.6 28.7 40.5 38.9 15.0 20.2 21.6 29.7 14.2 27.6 13.9 50.9 38.6 31.8 43.5 34.6 50.2 24.7 46.4 48.3 29.9 30.1 36.3 33.7 59.8 17.3 38.3 23.6 51.3 41.4 35.6 42.7 32.8 34.0 51.4 29.8 40.3 39.6 75.1 38.2 43.4 40.1 44.1 76.0 50.3 33.9 24.4 52.6 39.5 38.6 30.2 31.1 35.5 30.5 19.8 19.7 32.1 68.8 28.5 28.7 43.1 14.9 31.5 36.5 34.4 48.1 28.7 22.0 48.1 49.7 29.1 26.9 30.3 67.1 34.2 37.5 58.9 30.8 74.2 19.9 21.6 21.2 12.6 16.5 23.9 19.1 15.0 19.9 14.9 20.2 13.3 13.9 15.0 5.7 14.2 29.7 11.6 27.6 13.9 19.6 20.2 22.4 22.3 19.9 18.6 24.2 20.1 25.5 22.6 217.4 278.3 92.9 185.7 270.3 56.3 294.1 114.7 196.7 246.9 61.1 58.9 145.7 23.2 129.2 164.6 122.4 96.0 93.5 158.7 131.5 136.7 213.5 137.9 165.4 112.9 41.3 135.5 80.4 187.8 87.8 100.7 140.0 140.0 160.5 137.9 70.1 165.5 84.2 110.7 43.0 50.4 58.2 140.5 137.2 105.1 318.1 211.0 121.1 152.2 227.0 EIF3B "eIF3b, EIF3S9, PRT1" ENSG00000106263 "Eukaryotic translation initiation factor 3 subunit B" P55884 7 2354086-2380745 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017562, HPA048983" Approved Approved Nucleoplasm,Cytosol NA NA 22000 Cytosol Nucleoplasm "CAB017562: AB_2246341, HPA048983: AB_2680588" "unprognostic (1.50e-3)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (3.92e-2)" "unprognostic (9.45e-3)" "prognostic unfavorable (2.20e-4)" "prognostic unfavorable (4.41e-9)" "unprognostic (4.64e-3)" "unprognostic (3.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (9.66e-6)" "unprognostic (2.38e-1)" "unprognostic (7.54e-2)" "unprognostic (9.00e-2)" "unprognostic (6.18e-3)" 27.5 27.3 16.5 28.9 21.8 38.7 28.8 20.0 26.2 23.5 33.3 22.4 25.7 20.3 29.6 24.1 38.8 28.6 26.2 32.1 15.8 16.5 24.3 51.4 21.7 29.6 22.2 19.4 31.2 66.6 24.2 20.3 34.6 21.1 26.0 24.0 18.0 34.1 24.2 72.3 39.8 23.9 33.0 16.5 31.6 29.7 45.2 19.0 44.9 23.1 34.3 35.9 32.9 29.7 6.5 8.0 3.7 7.3 16.5 9.5 4.4 85.9 44.0 18.2 49.4 20.6 18.7 45.1 30.3 22.7 34.5 32.4 57.4 33.7 50.2 25.0 32.1 48.8 46.9 50.1 39.8 38.1 15.0 58.8 38.2 42.7 38.7 29.1 46.5 28.4 23.2 26.3 37.3 39.3 18.2 27.7 23.4 97.1 23.4 31.5 61.0 22.4 52.3 56.8 30.1 39.6 27.7 36.9 51.7 22.1 39.4 41.6 31.1 32.0 71.3 17.3 33.2 47.4 51.6 29.2 26.7 58.9 40.9 54.5 25.9 34.7 50.9 30.3 52.2 65.1 1.8 7.3 3.7 7.6 6.8 9.5 6.3 7.4 8.4 7.8 6.5 8.8 8.9 0.6 16.5 5.8 8.0 8.7 4.4 16.5 21.8 20.0 26.2 15.8 16.5 22.2 19.4 21.1 19.0 23.8 61.0 27.4 38.7 57.1 36.2 30.7 28.1 24.1 48.9 26.2 60.9 54.0 3.3 33.5 9.1 45.4 29.7 0.0 52.8 53.4 38.1 43.4 16.2 53.9 42.2 49.3 45.8 70.6 38.4 13.9 40.6 33.2 15.1 16.2 54.8 41.2 58.1 20.1 35.0 25.4 44.8 25.8 40.6 29.9 34.0 68.4 69.1 28.9 53.9 38.6 EIF3C "eIF3-p110, eIF3c, EIF3S8" ENSG00000184110 "Eukaryotic translation initiation factor 3 subunit C" Q99613 16 28688558-28735730 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 85.6;Cardiomyocytes: 136.5;Ciliated cells: 303.8;Club cells: 163.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB034045, HPA047097, HPA049495, HPA050112" Supported Supported Cytosol NA NA Cytosol "CAB034045: AB_1122487, HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020" "unprognostic (2.42e-1)" "unprognostic (2.69e-2)" "unprognostic (2.07e-1)" "unprognostic (2.18e-1)" "unprognostic (5.84e-2)" "unprognostic (1.23e-1)" "unprognostic (1.85e-2)" "unprognostic (5.75e-2)" "unprognostic (7.23e-2)" "unprognostic (1.40e-1)" "unprognostic (3.90e-2)" "unprognostic (6.54e-3)" "unprognostic (3.53e-3)" "unprognostic (2.25e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "unprognostic (1.10e-3)" 30.0 24.4 22.2 20.9 33.5 21.2 30.2 24.3 34.8 24.4 31.8 18.1 14.5 23.6 41.5 26.5 30.1 31.0 32.0 32.3 35.9 20.8 30.1 51.7 22.8 21.8 20.9 33.4 42.3 38.1 63.8 21.4 20.0 26.9 20.3 29.3 18.8 54.7 27.9 114.0 32.3 25.0 33.3 19.8 20.7 25.4 47.2 17.5 25.6 32.8 46.4 29.3 24.9 23.6 28.5 50.5 20.6 49.1 37.9 36.1 52.5 25.9 41.1 57.1 69.0 51.0 62.5 88.0 65.8 49.2 78.0 56.0 82.0 49.2 61.1 86.5 42.1 52.4 32.0 48.1 81.1 88.1 26.6 48.6 70.1 66.9 106.2 63.3 108.3 54.1 71.8 49.1 49.6 79.9 34.2 89.1 64.3 75.8 58.0 41.9 95.5 86.4 31.5 95.3 40.8 64.3 88.0 87.6 60.2 41.3 57.1 53.9 82.6 55.6 77.2 63.8 37.3 77.0 44.6 79.0 55.4 55.0 26.1 42.9 50.3 38.3 123.1 58.7 42.8 56.6 10.7 44.9 20.6 31.1 47.8 36.1 28.5 32.9 33.0 50.5 27.4 33.3 30.3 3.8 37.9 49.1 23.7 34.0 52.5 22.2 33.5 24.3 34.8 35.9 20.8 20.9 33.4 26.9 17.5 62.5 85.6 6.9 7.9 10.5 7.0 136.5 7.6 303.8 163.8 5.2 39.3 3.1 1.7 2.6 2.4 5.3 5.1 0.0 2.9 2.5 4.2 4.2 36.0 3.9 2.8 0.0 5.8 6.7 4.9 1.3 6.1 4.8 5.0 1.8 3.5 2.4 3.5 4.9 4.9 3.7 15.5 0.0 6.2 3.0 3.4 12.0 4.7 6.2 5.8 6.5 EIF3CL ENSG00000205609 "Eukaryotic translation initiation factor 3 subunit C like" B5ME19 16 28379579-28403879 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 32.4;Cardiomyocytes: 31.6;Ciliated cells: 69.6;Club cells: 69.4" "Group enriched" "Detected in some" 5 "glioma: 0.8;ovarian cancer: 0.5;stomach cancer: 0.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 33.0;REH: 26.1" "HPA047097, HPA049495, HPA050112" Supported Approved Cytosol NA NA Cytosol "HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020" "unprognostic (1.22e-1)" "unprognostic (4.24e-2)" "unprognostic (2.40e-1)" "unprognostic (4.48e-3)" "unprognostic (1.98e-1)" "unprognostic (4.59e-2)" "unprognostic (1.75e-5)" "unprognostic (6.56e-2)" "unprognostic (1.64e-1)" "unprognostic (7.58e-2)" "unprognostic (1.48e-1)" "unprognostic (1.18e-3)" "unprognostic (3.59e-2)" "unprognostic (9.52e-2)" "unprognostic (1.41e-1)" "unprognostic (9.00e-3)" "unprognostic (3.58e-2)" 6.9 4.6 5.2 2.5 5.5 5.5 6.0 3.0 4.9 4.7 8.9 8.9 4.1 10.2 5.8 7.9 2.5 5.5 5.0 4.6 5.9 5.5 3.6 3.7 4.6 7.3 10.4 4.3 4.2 3.6 4.1 1.2 9.3 13.7 13.2 18.0 9.1 4.0 3.3 4.0 7.3 3.4 5.5 10.6 4.2 4.1 7.7 10.5 4.6 15.9 10.8 11.5 5.1 2.5 4.4 5.5 3.4 2.3 3.4 3.1 3.1 7.5 9.3 11.7 4.9 1.8 1.5 10.5 2.9 6.2 3.1 3.9 7.5 6.0 1.1 2.1 2.1 5.7 7.1 2.5 4.0 7.4 2.8 6.1 2.7 2.2 3.9 6.0 3.8 2.9 2.7 2.1 5.5 9.4 33.0 6.2 4.8 2.2 26.1 5.6 5.9 7.3 3.0 8.2 10.4 1.6 8.2 12.6 0.7 4.2 7.0 2.7 2.7 8.7 2.9 3.2 7.9 2.1 4.9 3.0 6.4 1.8 4.6 6.9 4.3 6.5 15.9 5.5 6.2 11.3 8.1 10.5 7.7 10.2 11.5 0.6 10.8 9.6 6.2 7.7 5.1 20.8 32.4 0.0 1.0 1.1 0.0 31.6 0.0 69.6 69.4 0.0 0.0 0.7 0.0 0.6 0.0 1.1 0.7 0.0 1.1 0.4 0.6 0.8 9.3 0.0 0.4 0.0 0.0 2.5 1.0 0.7 0.3 1.8 0.0 0.0 0.7 0.0 1.0 1.1 0.4 1.4 0.0 0.0 0.9 0.3 0.4 1.4 0.7 1.3 1.0 0.7 EIF3D "eIF3-p66, eIF3-zeta, eIF3d, EIF3S7" ENSG00000100353 "Eukaryotic translation initiation factor 3 subunit D" O15371 22 36510850-36529436 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045882, HPA063330, HPA066216" Approved Supported Cytosol NA NA Cytosol "HPA045882: AB_2679482, HPA063330: AB_2684988, HPA066216: AB_2685637" "unprognostic (4.98e-2)" "unprognostic (2.22e-1)" "unprognostic (8.74e-3)" "unprognostic (6.50e-3)" "unprognostic (1.39e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (8.10e-5)" "unprognostic (1.47e-1)" "unprognostic (2.58e-1)" "unprognostic (9.98e-2)" "unprognostic (5.54e-3)" "unprognostic (3.93e-2)" "unprognostic (5.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-1)" "unprognostic (5.22e-2)" "unprognostic (9.78e-2)" 49.5 28.2 15.7 30.2 21.3 38.1 47.9 22.6 23.6 51.6 43.1 25.7 27.6 27.0 46.1 32.7 57.8 42.1 30.1 27.2 15.0 13.4 35.3 36.6 29.8 55.0 19.6 17.6 60.7 87.2 32.7 20.9 42.3 18.0 50.3 35.7 27.7 40.7 28.8 55.5 49.1 41.1 46.7 19.8 51.3 39.7 28.9 20.7 65.9 55.4 41.2 61.9 52.7 38.6 70.5 72.2 19.2 51.5 51.6 82.8 93.2 50.5 29.0 31.1 34.0 41.6 81.7 48.7 39.1 53.1 54.9 53.4 45.1 28.7 66.3 29.1 45.1 34.6 39.2 54.1 63.3 57.6 35.7 51.9 36.9 27.2 34.4 74.0 85.6 37.5 73.0 73.8 60.8 87.4 62.8 59.3 22.5 39.9 33.3 62.6 31.2 29.5 44.0 33.2 83.0 23.0 53.6 50.4 50.4 55.2 36.9 24.9 33.5 26.6 53.9 53.9 33.5 34.5 77.1 40.9 44.0 38.6 33.2 54.7 41.7 28.1 54.8 43.9 53.4 41.5 19.2 51.5 18.7 46.8 47.2 74.9 70.5 67.3 55.4 72.2 68.4 82.8 66.9 13.5 51.6 44.5 41.6 79.7 93.2 15.7 21.3 22.6 23.6 15.0 13.4 19.6 17.6 18.0 20.7 56.6 72.4 159.2 243.6 189.1 35.2 57.4 81.5 107.1 114.9 43.6 29.5 181.1 127.6 151.9 94.7 143.3 79.9 46.7 180.3 210.5 124.8 153.0 180.4 35.5 189.4 23.8 108.3 93.3 173.2 31.0 128.3 141.8 123.2 322.8 135.0 62.3 176.5 133.3 101.8 105.6 36.1 71.1 168.5 83.0 82.7 188.6 205.8 184.9 189.3 250.4 EIF3E "eIF3-p48, eIF3e, EIF3S6, INT6" ENSG00000104408 "Eukaryotic translation initiation factor 3 subunit E" P60228 8 108201216-108435333 "Cancer-related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023973 Approved Supported Cytosol NA NA Cytosol "HPA023973: AB_1848083" "unprognostic (8.18e-2)" "unprognostic (4.28e-2)" "unprognostic (6.26e-2)" "unprognostic (1.51e-1)" "unprognostic (3.52e-3)" "unprognostic (6.93e-3)" "unprognostic (2.29e-2)" "unprognostic (2.57e-2)" "unprognostic (3.47e-1)" "unprognostic (1.96e-1)" "unprognostic (1.67e-3)" "unprognostic (3.63e-1)" "prognostic unfavorable (3.06e-7)" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.81e-1)" "unprognostic (2.77e-2)" 88.2 44.0 27.6 49.2 38.2 57.8 75.1 41.5 25.2 101.6 73.6 14.6 47.2 34.4 55.5 47.6 111.2 45.4 41.0 39.5 23.9 22.4 51.8 63.6 60.3 75.3 33.0 19.5 127.6 90.2 29.2 72.5 54.6 28.9 100.1 40.3 22.8 56.9 45.5 100.4 46.7 56.3 73.7 38.4 63.9 49.7 52.7 31.5 100.5 93.8 70.8 50.7 121.7 69.2 49.0 51.7 14.0 39.5 38.7 78.1 59.4 61.5 30.3 40.7 50.3 69.5 146.9 27.8 32.2 50.3 47.9 50.1 38.0 62.1 106.1 42.3 36.2 25.9 38.4 53.7 63.1 63.8 41.7 54.6 84.7 32.2 54.3 55.6 50.4 39.8 110.9 93.4 36.1 100.3 95.8 72.8 68.0 71.3 44.1 53.9 60.9 65.4 95.7 40.6 101.8 48.5 60.8 50.4 82.6 62.5 37.1 46.1 42.0 18.1 15.3 71.7 49.3 65.1 73.2 46.2 28.0 48.4 29.0 40.4 33.3 24.9 60.8 34.6 88.2 31.2 14.0 39.5 7.4 26.6 36.2 52.0 49.0 52.6 37.7 51.7 40.4 78.1 56.1 3.7 38.7 33.6 27.3 45.2 59.4 27.6 38.2 41.5 25.2 23.9 22.4 33.0 19.5 28.9 31.5 125.0 164.2 521.1 900.1 920.2 60.0 77.3 196.1 124.5 205.9 150.1 51.1 533.6 514.0 289.5 296.8 388.9 107.5 70.0 306.5 673.2 507.3 554.3 369.5 167.4 375.7 55.6 285.6 304.5 609.8 52.5 420.5 585.5 490.9 376.1 360.5 84.2 309.4 241.9 308.0 535.0 54.4 187.5 536.7 231.2 100.5 976.5 518.8 456.1 516.4 811.5 EIF3G "eIF3-delta, eIF3-p44, eIF3g, EIF3S4" ENSG00000130811 "Eukaryotic translation initiation factor 3 subunit G" O75821 19 10115017-10119918 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 1028.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 177.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041997 Approved Enhanced Cytosol NA NA 12000 Cytosol "HPA041997: AB_10804123" "unprognostic (1.80e-2)" "unprognostic (2.16e-2)" "unprognostic (9.00e-2)" "unprognostic (3.33e-2)" "unprognostic (2.22e-2)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.49e-1)" "unprognostic (1.73e-1)" "prognostic favorable (3.94e-4)" "unprognostic (4.90e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-1)" "unprognostic (2.40e-2)" "unprognostic (7.63e-2)" "unprognostic (1.91e-1)" "unprognostic (2.43e-1)" 41.6 29.0 20.2 34.2 21.5 34.1 36.1 18.1 28.4 41.1 41.2 27.0 30.3 29.8 40.2 34.6 37.7 34.1 47.0 52.3 19.0 18.4 30.5 45.0 28.2 40.1 22.6 18.5 63.6 88.6 30.9 24.8 34.9 19.3 41.9 17.6 25.6 57.1 35.5 141.1 40.2 30.1 39.1 24.3 36.7 38.9 51.0 23.4 46.4 42.3 49.7 40.3 46.2 48.7 47.1 58.4 31.4 60.6 80.3 70.8 74.7 25.5 21.7 16.7 22.0 22.2 28.5 21.4 21.9 30.7 34.5 32.1 35.5 13.8 26.3 31.4 26.1 15.7 19.7 20.2 32.9 14.3 23.7 61.5 46.6 21.9 35.5 37.0 36.6 24.6 34.1 24.3 24.3 23.4 22.3 24.6 33.1 41.8 31.3 20.7 34.3 39.8 177.9 40.8 16.3 46.8 32.2 16.4 34.7 21.9 22.4 21.6 42.0 14.5 19.1 34.3 9.9 16.8 32.4 24.2 29.9 16.9 32.4 41.5 92.6 67.3 29.3 22.5 40.2 28.5 31.4 60.6 25.3 54.6 44.4 70.8 46.7 59.0 59.1 58.4 47.1 60.3 54.1 11.7 80.3 35.6 45.9 64.9 74.7 20.2 21.5 18.1 28.4 19.0 18.4 22.6 18.5 19.3 23.4 41.7 79.8 229.1 225.9 202.7 38.3 40.8 122.3 78.9 77.3 102.9 17.7 402.8 159.2 159.9 356.5 161.9 178.9 23.3 266.1 265.8 177.6 154.0 126.9 95.5 198.8 20.6 124.7 129.5 241.3 1028.3 220.4 229.7 138.3 284.1 165.6 56.1 195.2 164.9 166.6 222.1 38.4 161.7 224.0 181.2 151.2 208.6 440.9 257.6 191.5 210.8 EIF3H "eIF3-gamma, eIF3-p40, eIF3h, EIF3S3" ENSG00000147677 "Eukaryotic translation initiation factor 3 subunit H" O15372 8 116642130-116766925 "Cancer-related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 200.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023117, HPA023553" Approved Approved Cytosol NA NA 3300000 Cytosol "HPA023117: AB_1848076, HPA023553: AB_1848077" "prognostic unfavorable (5.26e-4)" "prognostic unfavorable (8.07e-4)" "unprognostic (1.81e-1)" "unprognostic (1.15e-1)" "unprognostic (6.69e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (8.34e-4)" "unprognostic (3.63e-2)" "unprognostic (1.37e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-3)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.36e-2)" "unprognostic (1.48e-1)" "unprognostic (9.19e-2)" "unprognostic (1.11e-1)" 63.1 41.3 39.4 41.3 47.6 65.8 56.8 39.5 39.9 69.2 52.8 35.1 30.8 38.8 53.1 43.6 80.9 49.7 36.4 52.9 33.2 33.0 53.4 55.6 44.2 58.0 38.6 26.7 96.0 65.4 37.6 52.6 52.0 40.1 77.1 47.0 34.9 51.5 38.5 94.6 44.8 56.2 68.3 45.4 56.0 46.3 44.9 31.6 90.0 72.3 59.3 74.7 83.7 57.6 69.1 73.6 21.6 55.3 47.1 88.5 76.7 48.2 27.9 33.7 29.3 44.6 78.2 33.6 32.0 41.3 35.4 34.6 28.8 57.3 77.3 32.5 33.3 25.8 31.1 36.9 48.6 44.7 50.0 30.0 68.2 25.0 42.8 55.8 29.4 36.5 71.9 67.8 32.0 74.4 60.4 38.4 61.0 57.6 41.0 39.8 35.8 81.8 41.3 34.3 107.1 44.6 47.4 22.5 54.8 53.2 35.6 38.3 46.3 16.7 200.9 53.2 34.6 59.6 59.4 35.1 22.8 42.4 33.6 41.7 66.2 59.7 63.8 31.6 52.1 31.0 21.6 55.3 19.8 36.7 54.8 60.3 69.1 66.5 53.1 73.6 59.1 88.5 71.9 12.0 47.1 53.3 41.1 73.2 76.7 39.4 47.6 39.5 39.9 33.2 33.0 38.6 26.7 40.1 31.6 169.7 173.8 354.3 365.2 299.8 59.1 142.4 173.3 99.0 193.3 89.0 11.8 379.0 379.7 249.7 301.7 214.9 114.6 116.8 331.0 435.7 226.0 279.9 187.3 94.3 292.1 25.4 193.0 149.8 325.6 209.1 306.9 322.8 199.1 375.1 270.1 77.5 285.4 199.9 206.8 338.0 52.1 194.1 271.9 179.4 126.9 311.5 482.6 284.1 291.2 372.2 EIF3I "eIF3-beta, eIF3-p36, eIF3i, EIF3S2, TRIP-1" ENSG00000084623 "Eukaryotic translation initiation factor 3 subunit I" Q13347 1 32221928-32231604 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029939, HPA029940" Enhanced Approved Cytosol NA NA 16000 Cytosol "HPA029939: AB_10611109, HPA029940: AB_10600878" "unprognostic (4.48e-2)" "unprognostic (1.01e-1)" "unprognostic (7.82e-2)" "prognostic favorable (2.14e-4)" "unprognostic (3.86e-2)" "unprognostic (2.32e-2)" "prognostic unfavorable (4.21e-4)" "unprognostic (9.26e-2)" "unprognostic (1.28e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (4.81e-6)" "unprognostic (1.80e-1)" "unprognostic (2.93e-2)" "unprognostic (1.60e-1)" "unprognostic (8.47e-2)" 46.3 45.9 26.1 28.9 27.6 32.2 44.8 21.2 28.7 36.6 39.1 25.3 41.0 24.5 33.5 50.4 61.0 37.9 42.7 44.4 25.2 25.0 47.6 89.7 33.9 42.7 27.1 21.9 50.5 72.0 27.0 25.0 45.4 22.8 38.7 45.5 26.5 59.6 40.6 79.1 35.0 39.5 38.5 25.9 36.1 34.8 31.3 17.0 55.8 67.9 75.4 46.6 43.3 34.5 44.4 56.6 23.8 50.3 42.4 52.9 61.6 49.6 39.2 31.8 59.0 48.2 60.7 30.5 39.5 73.8 76.2 60.4 45.7 55.0 75.5 40.1 70.0 52.8 35.0 68.2 77.6 93.5 27.8 64.6 45.9 35.1 50.7 54.8 75.9 39.0 58.4 69.7 73.6 83.2 59.1 66.2 52.6 88.2 30.3 68.9 39.0 56.7 59.4 83.3 68.9 61.6 41.3 53.0 64.0 75.2 34.9 42.8 47.6 43.1 46.5 77.0 63.1 35.7 38.3 40.7 44.0 46.4 67.4 82.8 51.1 55.1 63.8 49.6 61.8 57.4 23.8 47.3 21.7 42.1 50.3 47.7 44.4 45.1 41.9 56.6 39.7 40.2 38.3 6.1 42.4 36.8 43.5 52.9 61.6 26.1 27.6 21.2 28.7 25.2 25.0 27.1 21.9 22.8 17.0 47.6 67.3 128.8 178.4 121.3 38.5 37.7 81.5 91.0 78.5 48.8 9.8 263.3 112.7 251.4 51.4 121.5 96.3 0.0 237.9 288.5 128.5 125.4 112.0 70.0 199.5 12.7 132.9 70.0 89.1 20.4 159.6 124.5 136.7 223.6 124.0 53.3 233.6 105.2 130.8 144.9 32.3 90.5 209.4 67.7 73.9 123.6 286.3 137.0 158.7 187.7 EIF3J "eIF3-alpha, eIF3-p35, eIF3j, EIF3S1" ENSG00000104131 "Eukaryotic translation initiation factor 3 subunit J" O75822 15 44537057-44563029 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 134.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050977 Approved Approved Cytosol NA NA 8600 Cytosol "HPA050977: AB_2681297" "unprognostic (4.47e-2)" "unprognostic (1.28e-1)" "unprognostic (7.68e-2)" "unprognostic (3.76e-2)" "unprognostic (1.72e-3)" "unprognostic (1.47e-3)" "unprognostic (2.33e-2)" "unprognostic (1.41e-2)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "unprognostic (3.43e-3)" "unprognostic (1.39e-2)" "unprognostic (1.97e-1)" "unprognostic (4.76e-1)" "prognostic unfavorable (4.96e-5)" 23.7 17.8 24.7 21.0 21.9 16.4 22.8 16.6 23.1 15.6 18.4 13.2 20.5 17.7 15.8 17.2 28.0 11.9 14.8 36.8 22.8 23.7 23.3 46.3 14.7 18.3 26.3 19.2 15.0 35.1 17.3 22.9 22.9 31.6 17.1 20.0 6.9 27.0 25.4 134.3 18.9 16.6 18.6 29.0 20.9 18.4 14.7 20.9 17.0 19.2 27.3 24.9 23.0 20.6 26.7 33.2 22.6 19.2 28.2 23.9 6.4 22.5 12.0 19.7 12.3 14.1 14.2 24.2 35.8 10.6 24.9 17.0 38.1 13.8 20.9 42.2 15.0 23.7 42.8 31.6 22.8 30.6 23.4 16.0 47.6 29.7 24.1 26.4 51.0 21.2 12.6 30.6 17.2 33.7 15.3 26.8 23.7 61.8 27.5 22.3 15.9 25.6 34.8 12.0 42.9 19.7 29.9 33.9 31.1 28.4 27.0 26.7 16.4 33.0 31.4 19.8 17.3 26.3 42.3 31.6 27.1 32.2 29.1 48.0 32.8 61.7 52.8 18.9 55.7 25.6 22.6 19.2 16.8 17.4 18.3 21.0 26.7 23.2 22.3 22.2 24.7 22.8 23.9 7.7 28.2 16.3 33.2 23.6 6.4 24.7 21.9 16.6 23.1 22.8 23.7 26.3 19.2 31.6 20.9 56.6 49.9 94.2 75.5 155.6 53.4 84.7 117.2 50.9 87.6 137.9 19.6 122.2 164.2 124.7 123.5 94.8 95.5 23.3 127.9 138.5 81.8 61.2 124.7 370.0 99.0 41.3 112.5 102.5 88.2 85.7 84.3 75.4 57.3 96.4 107.9 41.1 136.6 97.1 66.8 158.9 63.2 45.3 85.9 219.1 126.3 150.4 206.6 73.5 113.9 75.3 EIF3K "ARG134, eIF3k, EIF3S12, HSPC029, M9, PLAC-24, PRO1474, PTD001" ENSG00000178982 "Eukaryotic translation initiation factor 3 subunit K" Q9UBQ5 19 38619082-38636955 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045446, HPA054590" Uncertain Supported Cytosol No No Cytosol "HPA045446: AB_10962716, HPA054590: AB_2682534" "unprognostic (7.07e-3)" "prognostic favorable (1.31e-4)" "unprognostic (3.04e-2)" "unprognostic (2.10e-3)" "unprognostic (1.67e-2)" "unprognostic (3.16e-1)" "unprognostic (2.25e-2)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (7.06e-3)" "unprognostic (2.92e-2)" "unprognostic (4.26e-2)" "prognostic favorable (5.43e-4)" "unprognostic (1.82e-1)" "unprognostic (1.00e-1)" "unprognostic (6.49e-2)" "unprognostic (3.69e-2)" 37.7 30.1 33.1 39.0 32.8 47.1 43.3 23.9 48.6 34.0 53.7 29.5 36.8 46.1 34.0 37.2 48.2 39.9 39.0 84.0 29.4 28.0 58.2 45.6 28.1 47.5 34.1 25.0 43.2 57.2 36.3 31.0 27.4 32.5 37.8 54.0 43.7 50.8 38.6 111.4 45.2 57.1 43.4 26.6 39.5 42.8 17.5 19.4 50.6 42.1 92.9 55.7 42.9 36.6 52.1 72.7 26.3 57.7 37.7 58.7 74.9 24.6 76.7 20.7 33.2 34.5 35.6 25.1 18.2 31.2 39.9 37.1 49.8 21.7 50.6 21.3 30.8 24.0 22.3 40.2 47.3 31.2 24.4 34.5 34.4 26.4 34.7 37.4 55.4 31.7 38.3 41.5 27.5 47.5 21.5 38.8 27.8 37.0 45.9 33.8 37.9 30.2 28.6 19.6 83.0 39.0 39.9 33.8 40.3 38.9 55.4 26.2 26.3 20.0 69.7 30.3 22.1 26.7 46.8 21.8 25.3 25.5 15.6 33.8 45.6 46.2 44.4 21.3 55.7 28.3 25.6 52.5 26.3 39.4 57.7 49.7 52.1 48.4 45.8 72.7 44.1 50.5 44.7 14.5 37.7 56.6 42.4 58.7 74.9 33.1 32.8 23.9 48.6 29.4 28.0 34.1 25.0 32.5 19.4 86.4 153.5 393.0 459.7 351.5 72.9 408.5 364.3 158.0 194.5 205.9 62.8 355.0 930.1 261.1 129.6 308.0 619.8 163.5 393.6 405.5 280.9 347.2 240.4 220.9 579.7 22.3 313.1 267.7 590.9 197.6 245.7 507.4 442.1 347.2 471.6 167.1 301.0 457.7 187.7 700.5 126.0 200.5 353.3 115.5 75.1 399.5 379.8 422.7 593.8 537.0 EIF3M "eIF3m, FLJ29030, GA17, hfl-B5, PCID1, TANGO7" ENSG00000149100 "Eukaryotic translation initiation factor 3 subunit M" Q7L2H7 11 32583798-32606262 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031063 Approved Approved Cytosol NA NA 48000 Cytosol "HPA031063: AB_10602128" "unprognostic (4.40e-2)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (7.16e-2)" "unprognostic (3.18e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.28e-9)" "unprognostic (5.79e-3)" "unprognostic (2.27e-2)" "unprognostic (1.83e-2)" "unprognostic (4.14e-3)" "unprognostic (1.91e-1)" "unprognostic (5.89e-2)" "unprognostic (2.12e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-2)" "unprognostic (6.42e-2)" 44.3 46.1 25.4 36.8 30.9 41.0 47.1 19.3 32.2 49.0 35.1 17.3 26.5 26.2 40.2 38.9 48.7 52.0 29.1 34.3 23.3 23.0 50.0 54.5 30.8 47.7 23.4 21.9 80.9 60.6 34.0 33.1 44.7 28.3 44.3 35.0 18.8 32.5 30.3 48.8 35.1 37.8 39.2 26.4 45.0 37.1 43.5 19.6 84.1 55.1 54.7 48.1 59.8 34.6 36.5 64.0 15.4 53.2 33.3 38.5 39.4 29.0 37.6 30.0 38.1 40.1 57.8 44.3 30.3 42.1 46.7 45.5 48.4 21.5 75.5 20.9 34.5 40.1 37.1 52.2 55.0 58.5 25.4 64.7 34.0 30.6 51.1 58.1 78.9 48.9 51.7 62.5 31.4 77.3 39.3 52.3 40.6 67.0 26.4 51.1 34.2 39.3 83.0 32.9 39.1 58.2 32.3 75.8 35.2 50.9 55.0 23.2 35.9 21.5 40.8 46.4 34.5 45.2 47.3 24.4 29.3 33.4 62.0 91.1 32.4 40.7 55.1 26.3 48.1 28.7 14.3 53.2 15.4 26.5 45.8 36.3 36.5 36.6 33.4 64.0 29.2 38.5 34.8 6.3 33.3 33.3 38.4 37.9 39.4 25.4 30.9 19.3 32.2 23.3 23.0 23.4 21.9 28.3 19.6 77.4 57.3 141.1 205.6 189.1 44.1 38.3 56.0 54.9 75.1 57.6 19.6 216.5 111.0 149.6 121.1 121.7 46.7 46.7 216.8 238.7 136.9 115.7 153.7 66.1 176.7 9.5 69.5 81.6 264.9 43.2 124.0 180.6 104.6 164.1 128.3 52.2 174.4 87.7 113.1 160.4 36.8 71.1 155.2 89.9 83.3 196.7 203.2 160.3 148.5 209.0 EIF4A1 "DDX2A, EIF-4A, EIF4A" ENSG00000161960 "Eukaryotic translation initiation factor 4A1" P60842 17 7572706-7579005 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Helicase, Hydrolase, Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 1192.5;Suprabasal keratinocytes: 1078.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011689, HPA068286" Uncertain Approved Cytosol NA NA 2300000 Cytosol "CAB011689: AB_732122, HPA068286: AB_2685968" "unprognostic (1.49e-2)" "unprognostic (2.41e-1)" "unprognostic (8.00e-2)" "unprognostic (2.17e-1)" "unprognostic (2.49e-1)" "unprognostic (2.12e-3)" "unprognostic (7.25e-2)" "unprognostic (2.89e-2)" "unprognostic (2.72e-2)" "unprognostic (2.11e-2)" "unprognostic (2.65e-2)" "unprognostic (5.19e-3)" "prognostic unfavorable (1.76e-8)" "unprognostic (1.91e-1)" "unprognostic (5.96e-2)" "unprognostic (1.16e-1)" "unprognostic (1.13e-2)" 56.5 49.0 19.3 41.4 19.8 51.4 80.2 13.6 26.6 40.4 45.6 28.5 26.4 28.7 45.9 30.2 76.4 43.4 39.2 33.5 18.5 17.1 34.2 58.0 46.3 135.7 27.7 12.9 55.2 77.0 19.8 28.8 45.2 21.8 36.2 44.0 33.0 65.8 30.7 36.5 48.4 30.9 46.5 33.4 46.8 42.2 31.6 21.8 91.5 34.7 73.8 67.7 42.5 40.8 35.1 143.6 29.1 115.7 47.1 60.3 170.1 85.9 117.9 79.1 71.6 71.2 83.3 73.8 83.0 94.4 154.0 119.1 119.0 39.0 117.7 64.0 87.0 67.6 77.2 167.7 127.8 166.0 38.1 124.3 66.3 76.7 132.2 109.0 67.7 67.1 110.3 66.1 129.3 132.3 92.1 115.5 66.8 67.6 24.4 110.8 90.4 70.3 58.2 67.8 89.0 81.7 66.4 59.7 56.5 107.6 79.1 41.8 81.2 74.8 50.4 104.0 61.8 55.9 52.1 82.5 81.4 56.8 52.0 166.9 24.0 33.4 77.1 87.5 83.4 89.2 19.6 115.7 29.1 37.0 102.6 60.3 35.1 40.0 39.5 143.6 28.9 39.4 39.6 12.1 47.1 75.7 54.8 49.2 170.1 19.3 19.8 13.6 26.6 18.5 17.1 27.7 12.9 21.8 21.8 107.2 246.6 70.7 485.7 1192.5 106.4 4.8 71.4 168.6 257.0 69.8 110.0 292.0 129.3 287.6 27.4 250.8 114.3 0.0 199.9 314.2 406.1 269.6 140.3 57.2 188.0 100.1 111.9 143.1 130.1 33.1 149.0 241.8 688.4 127.2 116.0 108.1 249.6 126.3 102.6 131.4 109.7 148.8 550.1 57.5 86.6 1078.3 532.6 174.8 147.8 417.5 EIF4A2 "BM-010, DDX2B, EIF4A, EIF4F" ENSG00000156976 "Eukaryotic translation initiation factor 4A2" Q14240 3 186783205-186789900 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Helicase, Hydrolase, Initiation factor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB011690, HPA068286" Uncertain Approved Cytosol NA NA 1000000 Cytosol "CAB011690: AB_732123, HPA068286: AB_2685968" "unprognostic (1.49e-1)" "unprognostic (9.62e-2)" "unprognostic (3.78e-2)" "unprognostic (9.50e-3)" "unprognostic (2.82e-2)" "unprognostic (1.10e-2)" "unprognostic (4.46e-2)" "unprognostic (6.27e-2)" "unprognostic (4.32e-3)" "unprognostic (1.00e-1)" "unprognostic (6.39e-2)" "unprognostic (3.99e-2)" "unprognostic (6.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.03e-1)" "unprognostic (4.67e-2)" "unprognostic (2.62e-2)" 34.6 66.1 61.2 27.7 79.9 1.9 53.5 121.1 111.5 65.1 52.1 26.5 30.1 30.3 73.1 45.5 44.5 73.9 45.1 83.7 58.4 71.9 63.9 43.5 33.7 36.1 48.9 61.7 142.0 59.0 30.9 84.1 47.3 69.6 57.9 40.1 31.8 43.7 62.8 126.7 19.8 35.6 57.1 41.9 32.5 39.0 32.9 39.5 23.9 67.8 36.4 35.4 61.1 51.7 55.1 19.3 39.4 24.8 33.0 63.4 51.3 10.1 5.1 21.4 3.5 82.7 78.0 6.6 18.3 16.5 19.4 25.6 18.9 3.7 22.7 102.5 26.2 35.9 17.1 31.5 7.7 34.3 21.2 16.6 36.6 6.8 25.3 32.4 7.7 25.7 52.2 37.0 5.6 46.7 98.7 34.4 19.2 12.3 38.3 63.1 1.7 12.2 3.8 21.3 41.0 24.6 15.7 15.2 13.8 38.5 12.4 42.2 8.5 29.7 20.5 38.9 56.7 32.0 28.2 25.1 15.4 7.7 14.8 11.2 30.5 43.2 10.4 10.6 8.1 7.2 39.4 16.0 18.5 28.5 18.2 45.3 55.1 41.9 34.8 19.3 46.1 63.4 50.2 11.0 33.0 24.8 17.4 38.6 51.3 61.2 79.9 121.1 111.5 58.4 71.9 48.9 61.7 69.6 39.5 110.2 187.7 337.3 695.6 613.2 269.9 244.1 206.4 220.8 192.2 247.7 60.9 410.2 560.3 199.1 25.8 233.7 293.3 23.3 81.4 227.6 351.3 637.4 309.0 119.2 199.9 368.7 391.5 183.0 192.6 37.8 357.2 230.1 327.3 376.9 296.7 294.3 160.6 364.6 444.5 452.5 161.0 232.8 455.3 100.9 174.0 540.1 514.8 331.3 287.0 611.0 EIF4B ENSG00000063046 "Eukaryotic translation initiation factor 4B" P23588 12 53006158-53042209 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039072, HPA046164" Approved Enhanced Cytosol NA NA 50000 Cytosol "HPA039072: AB_2676333, HPA046164: AB_2679567" "unprognostic (1.91e-2)" "unprognostic (2.63e-2)" "unprognostic (4.50e-1)" "unprognostic (2.47e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" "unprognostic (2.68e-1)" "unprognostic (1.55e-2)" "unprognostic (2.83e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-1)" "unprognostic (1.55e-3)" "unprognostic (3.44e-1)" "unprognostic (3.57e-1)" "unprognostic (4.69e-1)" "unprognostic (8.20e-3)" 35.6 36.9 20.1 21.5 25.4 26.4 34.5 29.5 30.2 41.0 27.9 35.4 26.8 26.7 35.8 18.8 30.9 40.1 33.6 25.0 21.6 15.2 27.8 29.4 22.5 28.7 23.1 27.9 94.9 55.8 31.0 37.2 22.2 24.3 25.9 24.5 27.0 39.1 21.0 76.9 31.9 24.4 37.9 25.7 27.5 31.1 31.9 29.5 27.2 32.9 33.6 39.0 35.7 33.5 27.2 26.0 10.5 24.0 25.4 46.3 33.9 24.2 39.6 27.0 35.1 49.2 91.6 35.8 23.7 56.0 21.7 20.0 40.6 39.6 148.3 35.6 34.9 19.2 27.2 48.1 53.3 27.3 29.1 28.7 57.4 54.4 43.7 36.9 82.0 33.6 92.5 53.9 25.8 79.5 133.0 42.6 44.9 62.6 61.0 35.5 53.3 49.5 51.0 49.8 26.4 20.7 50.8 38.4 61.7 29.7 40.2 28.7 38.4 24.9 54.1 47.2 36.8 61.8 52.9 39.1 15.2 33.2 16.6 20.8 53.5 59.3 37.8 25.5 35.4 21.1 9.1 20.0 10.5 30.0 20.8 43.1 27.2 36.3 33.1 26.0 19.6 46.3 42.6 5.4 25.4 24.0 16.3 29.3 33.9 20.1 25.4 29.5 30.2 21.6 15.2 23.1 27.9 24.3 29.5 137.0 177.4 171.7 216.0 184.7 81.9 129.3 163.1 127.2 185.4 89.0 29.5 123.9 154.2 105.8 197.8 119.6 131.6 23.3 149.6 203.6 128.6 182.1 226.7 168.6 97.0 60.4 178.9 163.9 258.4 403.4 187.3 156.0 133.3 138.9 167.7 83.8 157.4 73.7 183.9 205.7 79.6 109.9 160.6 65.8 44.3 206.1 149.4 183.0 188.6 203.0 EIF4E "EIF4E1, EIF4EL1, EIF4F" ENSG00000151247 "Eukaryotic translation initiation factor 4E" P06730 4 98871684-98930637 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Autism, Autism spectrum disorder, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 945.1;Late spermatids: 1606.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004077, CAB016316, HPA068358" Supported Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA 580000 "Cytosol, Cytoplasmic bodies" Nucleoplasm "CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: " "unprognostic (3.07e-3)" "unprognostic (1.43e-1)" "unprognostic (6.53e-3)" "unprognostic (7.52e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-3)" "unprognostic (2.03e-5)" "unprognostic (6.55e-3)" "unprognostic (1.09e-2)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (5.40e-2)" "unprognostic (1.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" 22.3 26.8 25.7 20.1 35.3 25.2 23.1 40.8 38.4 21.4 27.2 23.3 19.1 19.8 21.7 21.4 39.6 19.9 18.8 23.0 26.0 29.9 29.3 26.2 18.8 24.4 27.7 28.4 18.8 16.1 24.7 25.6 21.8 35.3 19.9 33.2 15.4 23.2 21.0 29.8 19.1 19.5 24.8 31.0 19.4 20.6 39.1 23.4 22.4 33.4 27.1 34.2 22.1 24.2 31.3 25.4 36.6 32.0 32.6 32.2 30.0 25.8 22.7 38.7 25.7 22.0 23.2 23.2 49.3 30.9 40.8 30.7 30.4 32.7 52.4 15.9 30.3 25.5 13.1 53.2 37.0 49.9 34.5 15.5 35.6 15.8 27.7 19.0 51.2 27.0 16.5 23.7 31.4 24.9 23.4 31.3 26.3 59.2 24.5 36.1 22.2 47.4 19.8 30.4 50.5 21.1 30.0 26.2 23.3 35.9 23.0 32.8 21.6 22.9 48.8 15.9 27.2 23.8 20.2 23.0 29.5 31.7 26.5 39.7 18.3 46.5 47.4 26.4 26.3 33.4 23.3 22.3 36.6 26.3 25.9 30.5 31.3 29.2 27.0 25.4 26.9 32.2 31.9 16.2 32.6 32.0 21.4 28.7 30.0 25.7 35.3 40.8 38.4 26.0 29.9 27.7 28.4 35.3 23.4 29.8 42.3 104.6 137.6 321.7 85.9 22.3 43.3 40.2 38.7 57.6 33.4 94.3 217.2 77.3 945.1 55.4 92.4 93.5 59.1 125.0 82.5 155.3 50.7 67.4 112.0 81.0 62.0 39.3 59.2 1606.7 46.9 94.3 183.9 85.6 57.3 60.6 65.2 66.6 46.3 112.9 57.1 51.8 118.5 94.7 83.0 324.2 99.5 64.2 72.3 177.8 EIF4E2 "4EHP, EIF4EL3, IF4e" ENSG00000135930 "Eukaryotic translation initiation factor 4E family member 2" O60573 2 232550052-232583644 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019253, HPA077074" Enhanced Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA019253: AB_1848092, HPA077074: " "unprognostic (3.44e-2)" "unprognostic (2.70e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-2)" "unprognostic (1.63e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.38e-4)" "unprognostic (1.42e-1)" "unprognostic (5.62e-3)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" "unprognostic (1.21e-2)" "unprognostic (1.36e-2)" "unprognostic (7.74e-2)" "unprognostic (3.34e-3)" "unprognostic (1.88e-1)" "unprognostic (9.38e-2)" 19.0 22.9 27.9 24.0 24.4 25.4 19.4 27.1 38.1 17.6 30.7 18.4 17.0 24.4 26.2 18.2 32.1 18.5 20.0 21.3 25.8 14.8 29.8 43.2 20.4 21.0 18.6 27.2 22.0 26.2 16.3 25.0 26.8 26.3 19.9 35.7 16.1 27.3 15.9 77.6 23.8 25.2 25.3 27.0 25.4 26.7 25.2 21.5 18.1 19.1 24.8 27.1 20.0 21.2 13.5 38.9 49.6 46.8 14.1 24.1 29.7 27.9 23.2 28.4 21.0 20.9 28.6 43.9 37.7 20.4 26.0 26.6 25.6 26.5 27.4 10.7 36.7 30.7 23.9 32.0 32.8 32.7 24.5 26.4 37.5 25.1 33.9 25.4 52.4 35.5 24.5 24.6 27.3 19.7 26.5 42.2 13.4 35.2 9.3 29.3 45.1 21.3 44.5 45.3 31.0 19.4 18.4 63.2 17.9 52.1 33.4 27.7 37.9 20.1 23.3 24.0 32.0 22.2 36.8 38.5 24.4 32.1 25.4 27.8 17.5 16.6 36.1 27.3 28.9 21.1 49.6 45.1 40.7 14.8 46.8 11.8 13.5 15.1 15.4 38.9 12.2 12.9 13.1 29.5 14.1 41.7 15.2 24.1 29.7 27.9 24.4 27.1 38.1 25.8 14.8 18.6 27.2 26.3 21.5 38.7 52.3 42.4 59.6 33.8 19.5 33.6 71.4 34.8 31.8 33.2 17.7 120.6 63.0 146.2 103.8 31.0 104.8 0.0 131.7 170.6 55.5 66.8 42.7 102.9 110.3 19.1 63.4 46.1 84.3 214.1 35.4 81.8 28.7 140.7 94.2 22.7 139.4 87.7 36.4 98.2 18.3 25.8 36.6 47.9 59.9 44.7 152.5 45.7 76.5 86.7 EIF4EBP1 "4E-BP1, PHAS-I" ENSG00000187840 "Eukaryotic translation initiation factor 4E binding protein 1" Q13541 8 38030341-38060365 "Cancer-related genes, Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 94.7;salivary gland: 109.8" "Cell type enhanced" "Detected in many" 10 "Exocrine glandular cells: 638.8;Pancreatic endocrine cells: 291.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 53.5;eosinophil: 31.3;intermediate monocyte: 41.2;memory B-cell: 16.3;myeloid DC: 41.3;naive B-cell: 13.5;non-classical monocyte: 31.4;plasmacytoid DC: 31.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005032, CAB005039, HPA023501" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095" "unprognostic (1.55e-2)" "unprognostic (2.45e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (6.94e-2)" "unprognostic (2.69e-1)" "unprognostic (1.94e-2)" "unprognostic (3.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.16e-2)" "unprognostic (3.18e-3)" "unprognostic (7.21e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (4.57e-2)" "unprognostic (5.72e-3)" 17.7 3.4 2.5 4.9 3.6 9.2 21.7 1.8 3.2 5.5 15.4 2.0 7.7 6.2 5.3 2.1 22.2 5.0 7.0 9.4 2.2 1.8 6.0 39.6 6.9 7.4 4.3 1.4 9.3 94.7 1.7 2.2 8.7 2.8 7.4 4.6 2.8 109.8 8.0 38.4 4.9 9.0 7.1 4.2 9.3 10.6 3.0 2.7 2.7 3.7 12.6 9.2 11.3 11.1 16.3 41.3 31.3 53.5 4.0 7.6 28.0 20.5 10.6 3.1 18.5 4.0 3.5 13.7 22.8 10.7 12.4 19.8 7.0 5.3 8.0 15.9 11.3 7.5 11.0 10.4 18.6 7.4 6.2 33.7 47.1 4.8 9.7 42.0 15.2 7.6 9.8 30.4 13.7 25.7 3.9 19.8 5.5 25.7 21.5 5.2 12.9 13.3 37.0 23.1 10.4 42.9 11.7 13.1 28.4 4.6 2.0 43.4 33.0 4.6 7.5 53.8 2.0 10.1 17.9 18.6 7.4 24.5 22.0 17.3 31.0 16.8 9.2 17.4 27.0 16.1 5.1 53.5 31.3 3.9 41.2 3.5 16.3 4.5 4.0 41.3 13.5 3.6 3.6 4.7 4.0 31.4 31.3 7.6 28.0 2.5 3.6 1.8 3.2 2.2 1.8 4.3 1.4 2.8 2.7 8.9 8.8 22.0 33.9 66.1 3.6 36.7 76.5 18.7 7.9 19.2 2.0 28.3 24.9 210.7 13.0 33.7 22.3 46.7 638.8 158.3 47.3 50.3 18.4 91.8 194.5 0.0 38.6 74.3 87.1 71.0 40.3 79.1 69.2 40.5 88.6 11.9 291.0 56.1 18.0 71.9 1.8 12.9 44.1 1.1 21.0 74.5 32.3 24.2 76.7 54.2 EIF4G1 "EIF4F, EIF4G, p220, PARK18" ENSG00000114867 "Eukaryotic translation initiation factor 4 gamma 1" Q04637 3 184314495-184335358 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding, Translational shunt" "Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014774, HPA028487, HPA043866" Approved Enhanced Cytosol NA NA 17000 Cytosol "CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705" "unprognostic (4.14e-3)" "unprognostic (2.10e-2)" "unprognostic (6.01e-2)" "unprognostic (3.01e-2)" "unprognostic (2.25e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (4.27e-3)" "unprognostic (2.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.55e-3)" "unprognostic (7.06e-3)" "unprognostic (2.42e-1)" "unprognostic (7.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.33e-3)" 30.2 33.1 18.3 26.4 18.9 26.3 30.3 18.0 23.2 24.1 25.2 19.6 33.6 21.9 24.5 30.5 45.2 20.9 31.1 33.0 16.9 16.9 40.6 108.0 26.0 21.0 19.4 15.9 29.3 46.4 47.5 21.9 34.6 18.3 24.0 21.8 19.9 31.4 34.1 103.7 39.0 31.6 26.8 15.7 33.1 27.1 30.8 18.0 25.8 30.0 46.2 34.3 28.6 27.6 8.8 15.9 5.5 17.0 8.1 11.4 9.1 90.3 37.9 31.9 36.2 35.6 35.1 55.1 49.9 35.3 55.5 42.3 80.4 29.5 57.8 66.5 61.8 66.5 48.9 54.9 61.2 43.2 61.1 57.8 52.2 38.8 35.6 30.9 52.3 36.6 35.4 35.6 50.5 48.2 28.9 48.4 22.1 37.9 45.8 36.6 67.1 35.4 18.8 62.7 44.3 30.7 36.5 31.4 46.4 29.4 55.1 33.4 29.7 42.5 70.5 33.9 28.5 75.1 37.4 60.4 39.4 39.9 51.6 93.4 35.7 43.1 107.0 44.3 45.9 43.0 4.8 13.6 5.5 11.4 13.9 11.0 7.6 7.7 9.2 12.2 8.8 7.1 7.0 5.1 8.1 17.0 15.9 5.4 9.1 18.3 18.9 18.0 23.2 16.9 16.9 19.4 15.9 18.3 18.0 71.5 58.2 39.7 51.5 52.5 25.1 95.4 50.9 40.2 67.1 59.3 13.7 53.1 11.6 92.9 153.5 57.6 100.2 23.3 116.3 63.6 52.3 82.5 45.2 130.2 58.2 20.6 53.5 43.6 38.3 140.5 67.6 40.6 32.1 49.5 68.5 21.9 122.3 58.5 52.6 40.9 22.0 77.6 66.8 27.0 39.1 80.3 66.6 33.8 68.7 78.7 EIF4G2 "DAP5, NAT1, p97" ENSG00000110321 "Eukaryotic translation initiation factor 4 gamma 2" P78344 11 10797050-10809110 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005163, HPA006773, HPA016965" Approved Enhanced Cytosol NA NA 25000 Cytosol "CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100" "unprognostic (1.10e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (9.92e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (6.18e-5)" "unprognostic (1.25e-1)" "unprognostic (7.84e-3)" "unprognostic (5.42e-2)" "unprognostic (7.07e-2)" "unprognostic (2.63e-1)" "prognostic favorable (1.67e-4)" "unprognostic (1.02e-2)" "unprognostic (2.08e-1)" "unprognostic (6.16e-2)" "unprognostic (2.74e-1)" 86.2 86.5 81.0 73.8 78.4 124.4 122.8 76.8 84.8 94.3 102.2 64.5 70.2 57.5 108.8 85.3 125.4 83.5 82.4 199.1 83.8 85.7 121.2 115.8 84.6 71.3 92.0 66.4 81.3 76.1 117.7 118.9 187.1 96.8 90.8 90.2 69.5 84.4 97.1 162.7 84.2 102.0 113.1 104.8 120.0 83.9 60.5 65.5 110.6 110.0 81.9 96.5 107.8 98.9 48.4 57.5 87.4 72.2 44.5 52.7 114.7 106.7 87.3 118.2 64.3 80.4 89.6 80.0 99.1 106.8 93.1 62.3 92.0 127.2 61.3 59.6 123.0 67.6 64.0 129.0 92.6 121.2 99.6 54.2 78.1 55.3 67.3 68.8 119.3 67.1 72.1 69.6 55.1 70.3 78.4 99.8 57.5 60.3 69.0 111.1 53.0 88.9 40.9 82.5 71.2 85.3 82.1 69.0 39.2 73.2 161.4 44.1 71.1 115.9 77.4 59.8 79.6 68.1 52.0 96.3 112.8 74.0 95.5 83.0 33.3 101.6 94.0 65.3 68.6 119.5 50.2 60.0 87.4 42.3 70.9 52.7 48.4 45.7 47.8 57.5 40.6 40.4 41.6 42.9 44.5 72.2 28.5 50.3 114.7 81.0 78.4 76.8 84.8 83.8 85.7 92.0 66.4 96.8 65.5 300.7 242.9 205.7 326.9 562.6 127.4 347.3 186.0 165.9 205.9 139.6 115.8 281.4 207.2 310.1 126.1 303.6 306.8 46.7 318.9 312.1 251.4 276.0 194.1 191.7 247.1 155.7 237.7 196.4 207.0 110.8 193.3 240.5 237.8 222.8 201.5 149.9 422.5 243.1 226.3 255.2 114.5 129.4 327.4 202.8 214.2 550.8 883.2 197.1 182.5 470.4 EIF4G3 eIF4GII ENSG00000075151 "Eukaryotic translation initiation factor 4 gamma 3" O43432 1 20806292-21176888 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 138.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025031, HPA025039, HPA025041" Enhanced Approved Cytosol NA NA Cytosol "HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104" "unprognostic (1.29e-1)" "unprognostic (8.38e-2)" "unprognostic (4.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.00e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (9.60e-7)" "unprognostic (1.02e-1)" "unprognostic (6.95e-3)" "unprognostic (8.36e-2)" "unprognostic (4.23e-2)" "unprognostic (1.22e-1)" "unprognostic (1.78e-2)" "unprognostic (9.37e-2)" "unprognostic (3.21e-2)" "unprognostic (5.07e-2)" "unprognostic (1.14e-1)" 17.8 19.2 24.8 19.0 28.6 24.1 14.3 24.8 33.8 17.2 17.9 24.5 18.6 12.2 19.7 17.5 16.8 17.1 17.0 16.6 25.9 24.8 14.8 13.6 12.9 14.8 23.1 24.8 15.7 10.6 44.5 30.3 13.8 36.3 16.1 21.0 17.4 11.3 18.5 29.1 17.7 14.0 23.8 25.0 16.1 14.2 67.1 23.1 13.9 30.5 9.7 16.1 18.0 15.7 3.6 5.6 4.2 2.6 1.4 3.7 1.5 11.2 9.2 30.5 12.1 31.9 31.7 6.3 24.5 26.5 17.2 17.8 10.0 12.4 22.7 15.9 26.6 16.2 12.7 18.8 19.9 24.4 19.7 17.7 11.3 18.2 7.0 16.1 18.6 21.0 33.1 16.2 18.1 23.5 27.5 22.2 8.6 8.5 15.9 25.5 10.0 5.8 9.7 8.6 14.1 8.3 11.2 11.2 7.5 19.0 6.1 17.3 13.4 25.5 11.1 14.9 18.6 8.0 21.6 22.6 19.5 7.3 27.7 11.1 7.3 7.8 0.1 25.0 29.7 18.1 2.0 2.6 3.0 3.7 0.5 1.6 2.6 1.5 1.8 3.4 3.6 1.0 2.8 4.2 1.4 1.0 5.6 1.7 1.5 24.8 28.6 24.8 33.8 25.9 24.8 23.1 24.8 36.3 23.1 17.9 26.2 21.5 15.0 18.3 47.5 39.2 10.2 58.9 35.2 15.7 62.8 4.2 0.0 18.6 138.6 31.0 42.3 0.0 16.8 7.4 18.3 16.8 25.5 12.7 20.1 47.7 15.6 39.3 33.2 92.8 41.4 24.3 13.5 2.8 21.4 20.0 22.0 28.8 42.1 8.8 39.4 32.3 21.7 100.5 49.8 23.1 2.9 13.8 23.3 23.7 EIF4H "KIAA0038, WBSCR1, WSCR1" ENSG00000106682 "Eukaryotic translation initiation factor 4H" Q15056 7 74174245-74197101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 1039.9;Late spermatids: 2062.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030542 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 520000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA030542: AB_10601368" "unprognostic (2.83e-1)" "unprognostic (9.50e-2)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (3.89e-4)" "prognostic unfavorable (2.15e-4)" "unprognostic (1.61e-2)" "unprognostic (2.72e-3)" "unprognostic (1.79e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-2)" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.68e-2)" "unprognostic (1.27e-2)" 46.8 42.7 47.6 37.6 52.8 82.3 42.8 56.0 89.5 39.8 44.5 46.6 36.2 43.1 48.1 37.9 58.6 44.4 40.7 47.4 45.6 41.4 34.5 50.7 37.4 42.8 45.4 54.6 54.2 74.3 54.3 30.1 72.2 47.6 44.8 35.1 35.6 60.3 45.4 89.6 53.0 41.5 43.4 59.9 34.6 45.4 52.5 32.1 46.8 43.5 57.9 44.2 43.4 41.4 38.4 57.6 60.2 64.2 46.7 52.0 80.6 87.4 58.3 44.5 53.9 39.7 42.3 50.6 62.6 47.6 51.9 51.1 71.4 67.5 75.2 17.1 57.8 75.1 46.5 49.0 83.2 49.1 50.5 57.4 41.9 54.8 57.3 45.5 70.6 42.3 49.5 52.9 57.6 82.0 61.0 56.8 45.0 73.6 32.7 53.1 74.7 55.7 83.8 59.4 72.7 57.8 65.4 59.7 67.9 43.1 56.0 45.3 57.2 58.4 73.8 49.6 61.4 83.4 45.8 59.0 74.4 50.6 62.2 78.7 38.9 46.4 128.4 58.1 74.2 76.3 45.7 58.4 60.2 43.5 64.2 44.9 38.4 44.7 43.0 57.6 35.3 52.0 42.4 39.0 46.7 63.6 24.4 47.6 80.6 47.6 52.8 56.0 89.5 45.6 41.4 45.4 54.6 47.6 32.1 77.4 68.6 90.9 132.2 105.9 91.7 38.9 66.2 53.5 59.1 41.8 23.6 170.5 91.2 122.8 1039.9 93.3 74.9 46.7 138.2 310.9 112.7 87.9 121.1 74.9 110.6 92.2 86.8 73.6 90.7 2062.3 96.1 91.0 69.2 181.3 80.6 92.2 119.2 69.1 104.0 54.1 63.7 84.1 131.0 55.4 62.9 101.5 330.6 89.7 87.9 119.5 EIF5 ENSG00000100664 "Eukaryotic translation initiation factor 5" P55010 14 103333544-103345025 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 125.8" "Low region specificity" "Detected in all" "HPA000867, CAB004226" Supported Enhanced "Plasma membrane,Cytosol" NA NA 21000 Cytosol "Plasma membrane" "CAB004226: AB_627507, HPA000867: AB_1078731" "unprognostic (1.39e-1)" "unprognostic (3.13e-1)" "unprognostic (4.02e-2)" "unprognostic (6.47e-3)" "unprognostic (6.33e-2)" "unprognostic (3.02e-1)" "unprognostic (2.01e-1)" "unprognostic (5.59e-2)" "unprognostic (7.82e-2)" "unprognostic (3.92e-3)" "unprognostic (1.08e-1)" "unprognostic (2.70e-2)" "prognostic favorable (5.67e-7)" "unprognostic (2.76e-1)" "unprognostic (8.41e-2)" "unprognostic (5.43e-3)" "unprognostic (3.14e-2)" 35.7 31.9 36.5 20.8 41.1 67.7 34.4 31.5 47.2 21.3 32.5 25.5 18.8 31.7 27.6 23.5 34.0 27.6 26.2 34.1 37.9 34.2 37.9 78.4 27.3 37.2 37.1 33.3 24.7 32.1 30.1 26.7 31.9 39.3 23.4 32.5 19.2 28.5 32.8 59.4 22.7 31.5 39.5 36.9 31.1 28.2 39.1 27.0 29.6 40.1 30.5 31.1 29.1 37.9 96.7 96.6 90.1 74.3 86.8 90.5 102.2 21.9 25.7 29.9 13.5 26.0 23.1 31.7 32.3 35.1 33.4 25.4 37.8 23.4 22.8 20.5 29.0 28.7 29.4 37.6 32.7 57.0 18.5 15.0 20.2 13.6 19.9 27.1 36.5 17.4 24.7 22.0 29.5 40.4 27.9 33.5 16.7 41.9 21.8 27.5 31.4 24.8 12.1 15.6 41.9 49.1 21.1 38.9 14.2 19.7 71.4 26.7 18.7 32.4 24.3 26.2 29.2 23.2 16.8 25.4 26.8 18.2 34.0 33.7 65.4 125.8 47.8 26.3 25.7 31.1 83.4 74.3 90.1 74.1 73.2 82.6 95.9 76.0 69.3 70.7 96.7 90.5 76.1 80.3 86.8 73.8 96.6 62.3 102.2 36.5 41.1 31.5 47.2 37.9 34.2 37.1 33.3 39.3 27.0 134.0 134.2 172.4 275.5 302.0 187.9 268.9 94.3 211.5 160.3 69.8 174.7 201.6 182.4 188.8 177.9 189.8 216.8 116.8 244.5 166.6 191.4 206.1 270.4 218.5 155.2 166.8 191.4 125.2 135.3 526.7 118.5 188.0 145.1 271.5 121.6 154.4 191.1 147.3 163.4 197.4 198.0 116.4 294.0 384.8 335.3 231.9 412.9 139.6 161.2 208.2 EIF5A "EIF-5A, EIF5A1, MGC104255, MGC99547" ENSG00000132507 "Eukaryotic translation initiation factor 5A" P63241 17 7306999-7312463 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005042, HPA061298" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005042: AB_562281, HPA061298: AB_2684472" "unprognostic (3.72e-1)" "unprognostic (1.67e-1)" "unprognostic (8.10e-2)" "unprognostic (2.80e-1)" "unprognostic (6.95e-2)" "unprognostic (1.39e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (9.04e-4)" "unprognostic (4.10e-1)" "unprognostic (4.11e-2)" "unprognostic (1.64e-2)" "unprognostic (8.25e-2)" "prognostic unfavorable (1.63e-5)" "unprognostic (3.53e-1)" "unprognostic (2.79e-1)" "unprognostic (6.01e-2)" "unprognostic (7.65e-2)" 69.0 55.6 37.9 57.0 40.4 83.1 44.5 35.0 59.8 44.6 54.8 37.5 39.8 47.4 47.2 45.5 107.0 38.1 52.9 55.8 35.6 33.6 58.5 192.9 46.6 67.2 34.3 35.9 50.3 126.0 26.0 34.1 73.9 34.0 38.0 57.2 40.7 87.7 40.7 100.6 71.1 49.0 45.4 29.5 65.5 42.9 56.8 24.2 77.9 57.9 105.4 79.0 48.6 50.7 64.7 87.7 44.4 75.7 75.2 79.3 64.3 132.8 165.9 51.2 102.4 39.5 51.0 71.9 100.3 66.2 135.7 94.9 99.2 56.8 128.8 65.0 77.1 55.6 90.9 111.1 129.3 123.5 71.6 161.3 77.5 137.4 127.0 70.1 58.8 80.2 54.0 67.9 100.2 136.1 45.9 87.1 38.7 106.5 36.0 91.8 82.4 69.1 85.1 97.1 77.7 81.9 68.4 62.2 118.7 81.9 73.9 59.5 77.4 64.3 78.4 62.1 40.8 62.0 45.4 81.5 95.7 68.9 63.5 158.5 30.3 41.4 83.3 90.4 88.6 108.9 44.4 56.0 38.9 65.1 75.7 79.3 64.7 67.1 57.7 85.8 62.6 62.3 62.6 25.1 75.2 68.6 87.7 58.9 64.3 37.9 40.4 35.0 59.8 35.6 33.6 34.3 35.9 34.0 24.2 50.6 35.2 135.1 56.5 310.0 85.2 62.9 114.7 41.5 36.4 59.3 13.7 296.4 63.0 289.3 125.7 155.1 221.7 163.5 206.2 541.5 192.2 120.0 138.2 197.7 267.8 47.7 144.4 98.8 106.6 60.7 93.2 101.1 249.7 306.6 167.0 82.0 274.1 169.5 76.4 70.8 45.7 90.5 172.0 216.9 81.3 274.3 358.2 71.9 197.1 61.2 EIF5B "DKFZp434I036, FLJ10524, IF2, KIAA0741" ENSG00000158417 "Eukaryotic translation initiation factor 5B" O60841 2 99337353-99401326 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034648, HPA040095" Approved Approved "Plasma membrane,Cytosol" NA NA 11000 Cytosol "Plasma membrane" "HPA034648: AB_10601902, HPA040095: AB_2676843" "unprognostic (1.23e-1)" "unprognostic (6.94e-2)" "unprognostic (2.01e-1)" "unprognostic (5.03e-2)" "unprognostic (4.65e-2)" "unprognostic (5.88e-3)" "prognostic unfavorable (7.15e-10)" "unprognostic (6.80e-2)" "unprognostic (9.84e-3)" "prognostic favorable (8.99e-4)" "unprognostic (1.68e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.42e-6)" "unprognostic (6.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.43e-1)" "unprognostic (7.93e-3)" 24.5 16.0 25.2 22.4 32.6 11.5 22.6 27.7 26.0 23.7 25.1 10.5 19.9 14.8 19.4 28.7 30.8 14.5 15.0 61.7 26.0 22.3 28.8 32.1 17.9 19.2 26.9 23.0 22.3 24.6 26.8 27.5 26.4 28.5 26.0 20.3 7.1 22.3 29.1 105.8 25.3 19.3 31.5 37.6 27.0 20.7 22.6 33.8 17.8 18.2 29.2 22.8 40.1 31.9 15.9 20.2 11.6 12.1 14.1 14.9 4.5 34.1 17.1 19.5 25.4 23.7 28.1 32.4 30.2 19.0 20.1 20.1 39.3 24.4 39.2 26.2 22.4 23.9 19.6 34.1 29.2 35.6 23.6 20.4 47.1 17.5 51.7 18.8 46.0 29.1 18.9 20.6 27.9 28.6 17.3 29.2 24.1 51.9 19.6 28.9 27.7 29.1 42.7 30.4 22.5 25.2 25.5 29.1 31.9 41.2 28.7 16.6 15.7 16.4 37.8 24.3 38.8 15.3 30.4 32.0 31.3 30.7 16.3 26.8 14.6 20.6 32.0 22.7 51.1 23.0 11.6 8.8 9.8 12.7 9.5 14.9 15.3 13.4 12.5 6.4 15.9 13.2 14.0 2.3 14.1 12.1 20.2 9.0 4.5 25.2 32.6 27.7 26.0 26.0 22.3 26.9 23.0 28.5 33.8 101.3 209.4 134.1 138.3 285.5 99.2 532.6 145.2 179.3 205.9 326.2 47.1 126.1 122.7 191.6 558.1 145.8 91.2 116.8 202.2 178.1 139.3 179.5 165.5 428.2 118.4 73.1 151.6 136.2 112.7 88.6 115.3 122.6 135.0 171.3 133.7 81.8 227.8 86.3 165.2 160.8 108.6 271.7 161.7 293.6 551.3 283.8 151.7 127.0 125.6 200.5 ELAC1 D29 ENSG00000141642 "ElaC ribonuclease Z 1" Q9H777 18 50967991-50988121 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040867, HPA066483" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040867: AB_10697716, HPA066483: AB_2685675" "unprognostic (1.05e-2)" "unprognostic (1.65e-1)" "unprognostic (6.95e-3)" "unprognostic (1.75e-2)" "unprognostic (8.61e-2)" "unprognostic (5.96e-2)" "unprognostic (3.25e-1)" "unprognostic (3.03e-3)" "unprognostic (5.87e-2)" "unprognostic (2.82e-3)" "unprognostic (3.67e-3)" "unprognostic (6.36e-2)" "prognostic favorable (8.43e-8)" "unprognostic (3.54e-2)" "unprognostic (1.12e-1)" "unprognostic (2.59e-2)" "unprognostic (3.87e-2)" 8.7 15.0 7.7 7.7 9.7 3.3 9.4 7.1 11.9 8.0 9.1 12.8 12.1 7.6 11.3 20.1 7.5 10.0 9.6 7.2 7.3 8.3 12.4 15.2 7.6 11.2 7.6 7.2 8.8 19.5 17.1 15.7 12.3 8.7 9.9 10.8 13.7 20.1 12.2 6.8 7.7 11.7 8.3 7.1 10.8 10.1 16.7 3.9 10.1 15.6 7.0 9.9 8.7 6.6 14.2 12.4 7.8 9.1 16.1 15.7 8.1 7.0 4.9 13.0 11.0 14.6 6.2 5.5 7.8 10.3 7.3 5.2 1.8 6.7 5.5 5.4 7.2 5.8 7.2 4.0 8.2 5.0 12.0 1.1 6.8 1.8 1.3 8.6 17.0 4.9 7.8 6.6 3.9 9.1 5.8 7.6 8.0 6.9 13.8 12.9 3.2 5.9 5.1 6.5 6.0 2.2 6.7 4.6 10.2 8.5 3.0 7.7 8.8 6.4 1.1 12.4 5.7 6.0 13.1 6.7 9.6 5.0 2.8 5.2 12.9 10.8 7.3 8.9 5.7 12.0 4.1 7.8 7.8 13.2 9.1 14.6 14.2 12.7 12.9 12.4 13.6 12.4 15.7 0.9 16.1 8.7 10.4 10.0 8.1 7.7 9.7 7.1 11.9 7.3 8.3 7.6 7.2 8.7 3.9 6.0 6.2 8.5 4.6 2.2 7.1 5.6 5.1 10.7 3.4 3.5 2.0 20.4 16.6 12.5 16.4 5.8 8.8 0.0 12.0 13.8 5.4 6.3 8.1 13.9 13.7 4.8 9.9 8.0 6.6 12.8 4.6 5.2 5.0 10.8 8.3 10.8 10.1 7.0 6.7 17.7 7.4 0.0 5.9 27.3 9.4 3.0 15.8 5.0 9.5 3.4 ELAVL1 "Hua, HuR, MelG" ENSG00000066044 "ELAV like RNA binding protein 1" Q15717 19 7958579-8005659 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005256, HPA046298" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 210000 Nucleoplasm "Nucleoli, Cytosol" "CAB005256: AB_2096342, HPA046298: AB_2679618" "unprognostic (1.19e-1)" "unprognostic (9.66e-3)" "unprognostic (2.46e-2)" "unprognostic (3.98e-1)" "unprognostic (1.04e-1)" "unprognostic (6.37e-3)" "unprognostic (1.81e-2)" "unprognostic (8.44e-2)" "unprognostic (3.75e-2)" "prognostic favorable (4.93e-4)" "unprognostic (2.09e-1)" "unprognostic (1.59e-2)" "unprognostic (7.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 19.7 23.8 28.0 22.4 34.1 17.2 22.4 35.4 28.0 23.1 21.4 21.2 19.6 17.9 27.5 19.7 24.4 25.7 16.9 25.2 23.6 17.6 20.8 21.4 19.4 26.5 27.5 22.2 25.7 20.4 29.4 25.4 23.3 26.5 20.4 20.2 19.7 21.2 23.0 27.6 19.2 18.4 30.4 17.7 21.9 19.7 46.7 26.5 40.4 20.6 18.7 30.7 23.4 32.2 17.1 17.6 24.3 14.7 23.2 19.6 9.4 36.1 24.0 40.3 30.3 15.8 15.9 22.7 27.0 22.7 40.2 31.5 34.7 21.1 43.6 38.0 29.6 22.6 25.3 44.9 30.9 34.1 38.9 41.7 38.2 17.7 32.3 23.2 36.2 30.6 19.7 18.6 28.0 17.1 19.1 30.7 33.3 39.2 32.7 27.7 26.8 60.5 29.2 35.9 27.2 30.6 68.1 26.3 28.7 25.5 26.7 29.0 21.2 25.6 25.9 20.4 25.4 29.5 28.6 23.0 37.7 26.4 34.9 46.4 33.4 32.3 45.8 21.1 43.6 32.5 16.4 13.0 24.3 12.2 11.7 12.9 14.0 17.8 19.6 17.6 17.1 16.1 12.4 3.8 23.2 14.7 8.8 13.5 9.4 28.0 34.1 35.4 28.0 23.6 17.6 27.5 22.2 26.5 26.5 23.8 23.9 31.2 59.2 64.3 42.6 27.2 30.6 14.7 13.6 45.4 53.0 76.4 56.3 31.1 188.6 49.4 29.5 0.0 29.2 87.0 49.8 55.0 20.7 78.0 55.5 57.2 40.4 43.0 50.2 108.9 46.6 53.3 49.0 30.7 47.6 43.8 29.8 48.6 53.4 49.4 54.8 51.8 58.0 132.2 59.8 62.0 62.6 49.8 53.0 69.3 ELAVL2 "HEL-N1, HuB" ENSG00000107105 "ELAV like RNA binding protein 2" Q12926 9 23690104-23826337 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 30.7;testis: 45.3" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 154.0" "Cancer enhanced" "Detected in many" "testis cancer: 7.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 10.1;AF22: 15.6;SCLC-21H: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022222, HPA063001" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB022222: , HPA063001: AB_2684918" "unprognostic (3.51e-1)" "unprognostic (4.18e-2)" "unprognostic (2.05e-1)" "unprognostic (1.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-1)" "unprognostic (4.26e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.74e-4)" "unprognostic (3.98e-1)" "unprognostic (9.08e-4)" "unprognostic (8.30e-2)" "unprognostic (1.91e-2)" "unprognostic (2.12e-1)" "unprognostic (2.65e-1)" 1.0 2.4 8.7 1.0 13.4 1.4 1.1 18.3 27.5 1.0 1.3 0.7 0.0 1.0 1.5 1.4 1.1 1.0 1.1 1.0 8.1 19.2 1.4 0.8 1.1 1.0 16.3 18.9 2.1 0.8 1.2 2.5 0.9 30.7 1.2 1.5 0.5 1.0 1.0 1.0 1.5 1.1 1.1 5.0 1.0 1.0 45.3 1.1 0.0 1.2 0.0 1.0 1.6 0.3 1.8 1.1 5.1 0.9 1.4 1.3 0.1 10.1 0.1 15.6 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 4.2 6.5 0.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 4.0 0.0 4.7 0.0 0.1 0.0 0.3 0.5 2.2 0.0 0.0 0.0 4.1 0.0 4.9 0.0 5.6 0.1 0.0 0.0 52.1 4.9 0.1 0.1 0.1 4.2 0.2 0.7 0.0 0.1 3.4 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.6 2.7 0.9 1.6 0.5 0.6 0.6 1.0 0.5 0.4 0.4 1.8 1.1 1.3 5.1 1.4 0.5 1.1 0.6 0.1 8.7 13.4 18.3 27.5 8.1 19.2 16.3 18.9 30.7 1.1 0.0 0.0 0.0 0.3 0.9 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 34.9 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 15.9 4.1 0.0 0.0 30.7 2.8 0.0 0.0 0.0 0.7 2.7 0.0 0.0 1.4 0.0 9.6 0.0 0.3 12.2 154.0 0.6 0.0 0.0 0.8 0.8 ELL "C19orf17, ELL1, Men, PPP1R68" ENSG00000105656 "Elongation factor for RNA polymerase II" P55199 19 18442663-18522127 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 301.9;Late spermatids: 183.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004202, HPA046076" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA004202: , HPA046076: AB_2679526" "unprognostic (9.49e-2)" "unprognostic (1.38e-1)" "unprognostic (3.26e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (8.26e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-1)" "unprognostic (3.00e-2)" "unprognostic (6.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.57e-1)" "unprognostic (2.07e-1)" "unprognostic (5.12e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 19.9 7.7 5.1 13.4 9.9 38.4 10.8 17.0 9.7 11.9 13.5 7.7 8.6 10.4 12.6 9.5 9.3 9.1 10.9 9.5 5.8 4.4 9.8 11.6 14.2 10.7 6.2 3.5 12.7 14.6 6.2 10.5 27.0 6.3 10.4 4.4 9.1 10.6 9.0 20.3 13.3 10.9 10.0 5.1 15.9 9.3 31.7 7.7 11.0 7.8 7.2 13.6 18.5 13.2 3.1 8.6 17.2 5.6 2.1 7.9 3.3 8.9 4.4 2.3 4.9 2.5 3.2 17.0 7.1 6.3 5.4 5.2 5.0 7.1 11.3 8.8 4.7 3.7 6.3 3.4 7.8 2.7 9.2 8.0 6.8 4.4 4.3 3.8 7.4 8.7 6.5 6.7 7.0 5.5 4.2 3.8 6.2 9.4 15.6 2.8 7.6 8.7 8.1 7.7 5.4 12.6 7.5 3.7 11.9 3.8 6.3 4.2 4.6 5.2 9.0 7.7 3.1 4.5 9.3 6.3 6.3 4.9 8.6 6.6 25.5 16.0 8.4 8.3 12.6 8.9 0.3 5.6 3.8 4.7 4.1 7.9 3.1 2.9 4.2 4.7 2.3 1.9 2.9 17.2 2.1 2.1 8.6 3.0 3.3 5.1 9.9 17.0 9.7 5.8 4.4 6.2 3.5 6.3 7.7 6.0 6.7 6.0 22.3 24.8 4.1 4.0 10.2 6.7 3.4 3.5 3.9 37.4 10.0 7.0 301.9 11.7 10.5 0.0 7.0 14.6 16.0 13.8 10.5 13.4 16.6 1.6 18.9 8.6 11.5 183.8 6.1 13.8 6.8 11.8 9.0 4.2 8.8 2.9 2.8 5.7 3.5 19.4 28.8 19.0 21.8 26.6 57.4 11.4 6.4 18.6 ELMO2 "CED-12, CED12, ELMO-2, FLJ11656, KIAA1834" ENSG00000062598 "Engulfment and cell motility 2" Q96JJ3 20 46366049-46432985 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018811 Approved Supported Cytosol NA NA Cytosol "HPA018811: AB_1848126" "unprognostic (1.19e-2)" "unprognostic (4.24e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (3.71e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (8.81e-2)" "unprognostic (3.06e-2)" "unprognostic (1.92e-1)" "prognostic favorable (6.10e-4)" "unprognostic (4.53e-1)" "unprognostic (4.42e-2)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "unprognostic (3.99e-2)" "unprognostic (1.20e-2)" 12.6 14.9 23.8 11.9 30.0 28.1 10.6 39.8 32.6 14.8 9.9 34.8 5.2 7.8 12.7 17.5 18.0 13.5 9.4 13.1 25.4 17.1 12.6 8.5 13.7 15.5 21.5 16.8 11.6 17.5 30.1 13.9 13.2 20.6 18.1 9.3 13.8 11.6 22.8 16.8 18.6 9.3 19.5 20.4 17.5 9.1 18.5 22.6 12.3 13.0 7.0 16.3 11.4 13.8 5.3 13.4 38.3 27.6 21.9 22.3 15.6 4.8 14.3 17.0 14.0 29.9 19.3 8.7 11.2 15.5 15.8 15.5 19.3 5.5 6.0 18.1 18.8 26.8 11.5 14.4 16.8 12.3 9.9 6.4 9.8 9.3 14.1 22.6 5.4 20.9 18.9 15.0 16.8 12.0 10.9 12.7 14.8 9.7 20.1 14.7 12.7 10.7 14.0 6.5 9.1 14.0 9.1 16.6 12.0 15.5 11.2 10.3 9.3 16.2 14.4 21.8 16.9 11.1 21.8 14.7 32.8 18.6 13.3 7.3 8.1 12.1 6.2 13.5 8.8 9.9 38.3 10.1 16.3 18.4 19.3 22.3 4.3 16.5 17.4 9.6 5.3 10.7 12.0 11.1 21.9 27.6 13.4 10.8 15.6 23.8 30.0 39.8 32.6 25.4 17.1 21.5 16.8 20.6 22.6 3.0 15.1 5.1 4.6 4.2 7.9 8.6 7.6 0.0 3.4 1.8 27.5 4.8 0.0 4.0 3.0 6.2 2.6 0.0 2.9 4.4 5.8 7.4 8.1 2.4 11.7 11.1 7.9 4.3 5.1 4.9 10.3 5.0 6.8 9.0 2.4 15.4 4.5 3.1 12.0 3.3 8.3 25.8 7.1 6.7 13.9 5.8 3.4 13.8 2.1 3.4 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 51.1;pituitary gland: 20.8;skin 1: 34.7" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 30.4;Cone photoreceptor cells: 15.7;Horizontal cells: 35.0;Late spermatids: 14.0;Rod photoreceptor cells: 17.8" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 11.9;RH-30: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 1.5 4.2 10.7 1.5 41.1 1.3 4.1 12.8 51.1 1.5 1.4 1.7 0.0 1.4 1.6 1.3 1.2 3.6 1.2 4.8 13.8 14.3 4.7 1.3 1.6 1.3 8.7 15.2 1.2 1.2 1.2 20.8 1.2 14.8 2.1 1.3 1.4 1.3 1.2 2.8 34.7 1.3 1.4 6.6 1.2 1.2 2.9 3.9 0.0 1.3 0.0 1.2 1.1 0.1 0.9 0.7 2.4 0.9 1.8 0.5 0.2 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.2 3.5 0.4 2.2 0.3 0.4 0.0 1.8 0.1 0.0 0.1 1.2 0.1 0.0 0.4 0.1 0.0 0.0 0.1 11.9 1.5 0.0 0.1 0.8 0.1 0.0 0.1 0.5 0.0 1.8 0.0 27.1 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.3 0.0 0.7 0.1 0.0 0.0 3.6 0.0 2.1 1.6 0.9 0.6 0.4 0.6 0.4 0.5 0.5 0.2 0.2 0.9 0.4 0.5 2.4 1.8 0.6 0.7 0.4 0.2 10.7 41.1 12.8 26.9 13.8 14.3 8.7 15.2 14.8 3.9 0.0 3.8 0.0 0.4 0.0 30.4 3.6 0.0 8.1 2.3 0.0 15.7 0.1 0.0 0.0 8.5 0.7 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.8 0.1 35.0 0.0 0.6 0.3 14.0 0.3 1.4 0.0 0.0 0.0 6.5 0.0 0.0 0.4 3.6 17.8 0.0 0.5 0.9 0.4 2.8 0.0 0.0 0.0 0.3 ELMOD2 MGC10084 ENSG00000179387 "ELMO domain containing 2" Q8IZ81 4 140524158-140553770 "Predicted intracellular proteins" "Antiviral defense" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047600 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA047600: AB_2680098" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (6.70e-3)" "unprognostic (2.10e-3)" "unprognostic (4.91e-2)" "unprognostic (3.93e-1)" "unprognostic (1.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" "unprognostic (3.65e-1)" "prognostic favorable (1.17e-8)" "unprognostic (3.17e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (1.82e-2)" 11.6 20.8 9.2 11.9 14.0 8.5 16.7 14.0 10.6 13.8 17.9 10.4 24.7 14.4 15.4 15.8 13.9 13.9 10.9 18.0 10.4 11.2 20.6 19.3 14.5 13.9 13.6 9.2 13.0 17.2 20.2 24.1 17.3 13.6 15.5 15.2 12.1 13.5 21.2 8.4 10.5 31.0 12.4 14.4 11.6 12.1 9.1 12.3 18.2 19.6 10.5 11.2 12.1 11.6 6.0 10.6 17.0 7.8 7.8 8.6 4.8 6.6 7.4 15.2 11.6 15.9 18.4 9.8 15.8 15.0 8.8 10.6 7.3 14.2 10.9 7.0 9.8 10.7 6.1 14.4 10.0 10.9 10.5 8.5 8.9 5.8 9.4 14.5 13.6 8.0 12.6 16.7 7.4 7.7 13.9 9.6 13.3 11.4 18.0 15.0 4.8 14.8 4.7 8.0 9.7 6.1 17.4 11.7 7.0 12.7 10.6 7.2 26.8 10.3 10.6 11.3 17.8 10.4 5.7 9.6 20.3 7.3 9.4 16.2 18.9 26.8 13.8 14.8 10.8 15.2 2.6 7.2 8.7 7.5 7.8 8.6 3.8 6.9 8.3 6.1 6.0 7.1 7.0 17.0 7.8 5.9 10.6 8.0 4.8 9.2 14.0 14.0 10.6 10.4 11.2 13.6 9.2 13.6 12.3 26.8 15.3 5.2 9.6 8.1 19.0 12.3 5.1 25.4 5.7 17.4 17.7 19.0 1.7 20.2 2.0 11.7 15.3 0.0 22.7 7.3 13.3 8.8 19.6 24.6 17.2 14.3 8.7 11.1 17.4 1.0 12.0 13.4 16.9 11.8 12.5 18.5 21.7 12.2 10.3 15.1 22.8 6.5 6.1 25.6 19.4 10.2 16.8 10.7 10.8 4.8 ELOA "SIII, TCEB3, TCEB3A" ENSG00000011007 "Elongin A" Q14241 1 23743155-23762059 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 68.1;monocytes: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005910 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA005910: AB_1080227" "unprognostic (6.90e-2)" "unprognostic (5.99e-3)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.99e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.72e-1)" "unprognostic (8.84e-3)" "unprognostic (6.00e-2)" "unprognostic (4.94e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-3)" "unprognostic (2.90e-1)" "unprognostic (4.27e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 25.6 13.7 10.0 14.2 16.1 22.9 16.3 16.0 17.2 13.7 12.2 15.2 15.1 9.8 15.0 9.0 23.6 13.3 15.7 12.9 9.9 9.8 18.1 41.7 20.3 24.1 10.3 12.5 16.0 41.5 19.1 17.1 19.6 12.7 13.6 13.5 13.0 18.6 13.4 26.0 18.3 14.1 14.0 10.9 20.5 24.6 14.4 10.0 19.3 18.4 22.4 21.8 15.6 14.5 20.7 18.8 18.3 20.9 11.0 14.8 13.2 20.3 11.4 16.5 14.1 19.5 12.2 10.4 21.1 19.1 31.5 27.6 13.9 17.9 10.7 26.0 21.4 17.7 19.6 33.8 22.2 35.3 30.6 16.7 24.1 17.8 16.2 17.3 25.2 14.6 12.9 18.0 34.3 26.3 11.7 18.8 17.7 35.6 18.6 25.1 15.4 13.0 10.3 19.1 22.9 17.3 19.6 21.0 20.3 14.8 13.9 31.5 17.7 19.2 19.4 23.4 19.2 14.0 9.3 19.9 24.8 21.9 43.9 24.8 19.3 21.5 23.6 21.7 25.2 24.7 18.3 19.8 15.4 14.8 20.9 14.6 20.7 12.4 13.3 18.8 16.6 10.2 13.4 5.5 11.0 18.4 15.5 14.0 13.2 10.0 16.1 16.0 17.2 9.9 9.8 10.3 12.5 12.7 10.0 26.8 68.1 0.0 0.0 0.0 0.0 0.0 0.0 30.8 33.0 17.4 0.0 23.2 5.0 34.1 0.0 0.0 0.0 0.0 28.4 28.4 0.0 0.0 12.8 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 61.3 0.0 0.0 32.3 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 ELOF1 "ELF1, MGC4549" ENSG00000130165 "Elongation factor 1 homolog" P60002 19 11551147-11559236 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 392.9;Late spermatids: 1089.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045606 Uncertain Approved Cytosol NA NA Cytosol "HPA045606: AB_10965133" "unprognostic (4.32e-2)" "prognostic favorable (1.83e-4)" "unprognostic (4.38e-3)" "unprognostic (3.39e-1)" "unprognostic (1.26e-1)" "unprognostic (3.29e-1)" "unprognostic (2.22e-2)" "unprognostic (2.65e-2)" "unprognostic (5.35e-2)" "unprognostic (4.90e-3)" "unprognostic (4.62e-2)" "unprognostic (1.26e-1)" "unprognostic (5.85e-2)" "unprognostic (2.93e-3)" "unprognostic (1.76e-2)" "unprognostic (7.09e-2)" "unprognostic (1.12e-2)" 19.0 23.4 25.5 20.4 23.9 33.0 20.9 32.8 29.0 24.5 19.8 19.8 19.5 19.2 27.4 28.6 21.2 29.2 20.6 21.2 25.1 27.6 24.8 45.2 18.9 24.9 25.0 22.4 28.1 39.3 19.7 29.6 19.4 21.2 25.4 15.9 21.0 34.2 30.6 24.9 22.7 20.8 22.1 20.5 22.5 23.2 69.0 20.8 33.1 29.3 24.3 23.2 22.5 22.6 63.1 60.4 44.2 43.2 32.4 47.1 41.4 39.7 27.8 19.2 26.3 24.0 24.4 9.9 25.7 21.8 35.4 35.9 27.6 11.0 25.6 25.4 23.2 23.2 18.8 23.3 35.8 24.8 20.2 23.8 32.0 18.2 26.0 27.1 20.7 22.1 23.6 26.6 31.2 22.8 25.5 17.2 24.6 44.4 33.6 21.1 51.4 30.7 24.3 49.8 20.3 51.4 22.9 16.4 26.9 29.1 18.6 24.2 30.7 20.7 25.0 24.1 18.4 21.0 16.7 11.9 36.7 13.9 38.4 38.6 39.1 52.4 21.7 34.2 29.3 18.4 25.0 42.4 44.2 34.3 40.1 31.7 63.1 36.0 31.8 36.8 46.9 32.6 29.1 28.8 32.4 43.2 60.4 47.1 41.4 25.5 23.9 32.8 29.0 25.1 27.6 25.0 22.4 21.2 20.8 14.9 19.2 58.8 46.7 75.4 23.1 27.8 48.4 37.5 17.0 31.4 7.9 72.7 89.5 71.8 392.9 30.6 56.1 70.0 89.2 67.4 55.4 39.7 21.9 32.1 67.5 14.3 57.8 36.8 48.9 1089.7 68.4 55.3 65.8 68.5 40.1 38.1 80.9 45.2 67.1 73.2 12.4 25.8 57.7 100.8 69.2 71.0 60.8 54.3 43.4 34.6 ELOVL3 CIG-30 ENSG00000119915 "ELOVL fatty acid elongase 3" Q9HB03 10 102226328-102229589 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 24.6" "Cell type enhanced" "Detected in some" 11 "Ito cells: 1.3;Kupffer cells: 2.4;Smooth muscle cells: 2.0;Spermatogonia: 2.7" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 11 "classical monocyte: 9.4;intermediate monocyte: 3.1;myeloid DC: 2.6;non-classical monocyte: 6.6" "Group enriched" "Detected in many" 12 "dendritic cells: 2.6;monocytes: 9.4" "Cell line enhanced" "Detected in some" "ASC diff: 8.3;ASC TERT1: 8.3;HSkMC: 12.2;NB-4: 9.4;SiHa: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036236 Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA036236: AB_10601550" "unprognostic (1.52e-2)" "unprognostic (6.76e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (6.25e-5)" "unprognostic (8.23e-3)" "unprognostic (9.82e-2)" "unprognostic (2.17e-4)" "unprognostic (4.27e-2)" "unprognostic (2.28e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (5.36e-3)" "unprognostic (2.66e-9)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" 6.3 1.1 1.2 2.1 2.4 3.6 7.3 0.4 0.9 0.2 0.2 0.0 0.0 0.0 0.9 0.3 0.3 0.3 2.5 2.5 0.6 0.2 0.5 0.2 1.8 0.1 0.7 0.0 0.2 0.2 0.0 1.8 2.4 1.1 0.3 0.2 1.6 3.4 1.7 1.7 24.6 0.3 0.0 0.2 0.8 0.2 6.8 0.0 0.0 0.2 2.8 0.0 0.6 2.6 0.0 2.6 0.5 9.4 0.0 0.0 1.9 2.6 0.2 0.1 6.6 8.3 8.3 2.4 0.1 0.2 0.3 0.4 0.4 2.5 0.0 0.3 0.0 0.0 0.0 5.0 0.1 0.4 0.0 0.0 0.1 0.3 0.6 0.3 0.0 0.1 12.2 1.4 3.0 0.0 0.0 0.0 0.8 0.1 3.0 0.7 0.0 0.0 9.4 0.1 0.9 0.9 0.0 4.3 0.0 1.7 0.0 0.0 0.3 18.9 0.8 0.6 0.5 6.9 2.2 0.0 1.3 0.0 0.3 0.2 0.4 5.8 0.0 3.0 5.4 0.0 0.0 9.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.5 0.0 6.6 0.0 0.0 1.9 1.2 2.4 0.4 0.9 0.6 0.2 0.7 0.0 1.1 0.0 0.0 0.6 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.2 0.0 0.0 1.3 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.7 0.1 0.2 0.0 0.0 0.0 ELP1 "DYS, IKAP, IKBKAP, IKI3, TOT1" ENSG00000070061 "Elongator complex protein 1" O95163 9 108867517-108934116 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 19.7;Ciliated cells: 12.0;Collecting duct cells: 14.0;Exocrine glandular cells: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 26.9" "Lineage enriched" "Detected in all" 6 "granulocytes: 26.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021340, HPA049677, HPA050686" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216" "prognostic unfavorable (1.57e-4)" "unprognostic (8.71e-2)" "unprognostic (5.13e-2)" "unprognostic (4.21e-2)" "unprognostic (6.44e-2)" "unprognostic (4.49e-2)" "unprognostic (2.76e-2)" "unprognostic (1.55e-1)" "unprognostic (1.67e-1)" "unprognostic (4.02e-2)" "unprognostic (1.10e-2)" "unprognostic (2.80e-2)" "unprognostic (1.77e-3)" "unprognostic (1.69e-1)" "unprognostic (1.57e-1)" "unprognostic (2.27e-2)" "unprognostic (4.98e-2)" 10.4 33.0 18.7 10.6 22.9 10.8 13.1 37.6 19.9 13.0 11.5 17.2 11.4 8.2 15.7 17.3 9.8 15.1 10.3 15.3 14.8 15.2 13.0 14.7 11.2 12.8 20.9 17.3 26.4 12.9 41.3 42.3 11.2 20.5 13.1 12.6 15.0 12.0 12.8 11.6 15.7 11.2 14.4 16.7 13.3 11.3 11.7 19.3 12.1 15.4 8.3 13.2 10.4 13.4 2.1 2.7 26.9 2.6 4.0 4.2 1.9 9.2 17.9 15.4 10.0 17.0 16.3 12.6 15.2 10.5 15.5 12.3 16.8 6.8 17.0 6.9 13.6 17.9 23.9 23.6 19.0 17.1 16.0 14.8 9.9 27.8 45.5 12.6 19.3 8.9 12.4 13.3 21.6 20.4 15.7 13.3 21.4 23.4 12.0 14.2 15.8 16.5 12.0 19.6 23.7 17.9 14.4 20.7 10.6 11.7 12.0 18.7 15.0 16.7 16.7 10.3 17.4 21.7 8.7 12.7 8.9 10.3 19.8 15.1 11.4 25.5 8.6 14.9 12.8 12.0 26.9 1.7 2.5 3.1 2.0 4.2 2.1 3.0 4.0 2.7 1.4 2.9 3.6 0.3 4.0 2.6 1.3 2.4 1.9 18.7 22.9 37.6 19.9 14.8 15.2 20.9 17.3 20.5 19.3 11.9 19.7 0.0 0.0 0.0 0.0 0.0 0.0 12.0 5.7 14.0 0.0 5.6 0.0 5.7 0.0 0.0 0.0 0.0 18.1 5.2 0.0 0.0 2.3 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 8.8 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 ELP2 "FLJ10879, STATIP1, StIP" ENSG00000134759 "Elongator acetyltransferase complex subunit 2" Q6IA86 18 36129444-36180556 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002996, CAB020835" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB020835: , HPA002996: AB_1857552" "unprognostic (5.51e-2)" "unprognostic (1.29e-1)" "prognostic favorable (5.41e-4)" "unprognostic (6.66e-3)" "unprognostic (4.33e-2)" "unprognostic (4.54e-1)" "unprognostic (2.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.92e-1)" "unprognostic (6.74e-3)" "unprognostic (7.31e-3)" "unprognostic (7.07e-2)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (3.05e-2)" "unprognostic (1.14e-1)" "unprognostic (8.97e-2)" 21.3 19.8 16.5 21.0 22.4 10.5 32.9 23.2 23.6 23.2 19.8 21.6 29.6 14.0 32.3 29.7 15.0 27.2 18.7 21.0 15.8 16.2 17.8 41.0 16.1 17.1 18.6 18.0 46.3 26.7 22.0 43.6 18.7 21.3 28.0 15.4 22.5 19.7 27.4 34.7 23.7 15.6 22.5 18.0 18.1 18.3 19.4 21.7 23.5 20.2 14.1 20.5 25.2 19.5 17.1 14.2 13.4 18.2 17.3 18.8 11.1 10.2 7.4 13.8 12.4 19.6 29.7 15.3 21.2 30.8 17.8 23.9 7.7 9.5 21.5 14.8 17.7 12.0 14.6 17.6 15.7 25.4 9.7 9.5 8.3 12.8 13.3 21.5 26.9 8.9 24.1 18.1 17.7 28.9 27.0 19.9 14.9 13.9 11.4 18.9 12.3 12.9 11.6 16.4 7.9 5.6 21.1 16.6 15.0 16.2 23.9 11.0 21.0 19.9 7.8 31.0 20.8 10.0 13.6 11.7 16.2 9.4 5.9 10.8 13.7 10.8 19.9 13.6 14.5 13.9 13.4 9.7 7.7 10.9 14.3 15.3 17.1 14.7 12.8 14.1 14.3 18.8 16.4 1.6 17.3 18.2 14.2 14.4 11.1 16.5 22.4 23.2 23.6 15.8 16.2 18.6 18.0 21.3 21.7 44.7 27.4 28.6 43.3 29.2 46.3 43.6 7.6 32.1 17.0 33.2 41.2 30.6 24.9 22.1 41.1 26.0 16.0 0.0 19.2 32.9 31.9 48.4 34.8 60.6 20.2 31.8 23.7 20.9 21.8 50.5 40.3 23.1 21.9 40.5 17.8 30.7 16.3 7.0 34.3 14.6 46.5 6.5 29.7 35.8 30.7 32.0 33.3 27.7 22.4 34.1 ELP3 "FLJ10422, KAT9" ENSG00000134014 "Elongator acetyltransferase complex subunit 3" Q9H9T3 8 28089673-28191156 "Enzymes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation, tRNA processing" "Acyltransferase, RNA-binding, Transferase, tRNA-binding" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025297, HPA025812" Uncertain Enhanced Cytosol NA NA Cytosol "HPA025297: , HPA025812: AB_10601369" "unprognostic (1.29e-2)" "unprognostic (1.26e-2)" "prognostic favorable (9.25e-4)" "unprognostic (3.49e-3)" "unprognostic (5.73e-2)" "unprognostic (1.10e-1)" "unprognostic (6.95e-2)" "unprognostic (2.07e-2)" "unprognostic (7.66e-2)" "unprognostic (1.22e-2)" "unprognostic (3.89e-1)" "unprognostic (3.46e-2)" "prognostic favorable (1.31e-5)" "unprognostic (2.29e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" 14.8 15.3 18.7 11.5 23.4 6.7 19.4 20.0 27.4 33.4 14.8 21.8 35.2 10.8 27.3 14.4 12.8 18.6 17.5 16.0 17.7 19.0 19.1 22.8 13.6 15.4 17.6 13.6 18.9 12.6 14.3 17.4 12.7 23.3 15.9 18.0 13.9 11.1 36.1 28.8 13.4 12.3 16.0 15.8 16.1 12.1 15.0 15.5 16.0 19.9 13.8 20.3 14.7 12.0 16.2 12.2 11.6 18.2 15.8 20.8 11.0 14.5 15.2 11.6 11.1 17.2 15.1 8.3 7.5 13.6 17.7 15.8 12.6 6.2 27.4 11.8 14.4 15.7 9.9 12.8 17.8 20.9 4.9 5.3 18.4 10.1 20.9 15.4 9.9 13.7 15.9 27.6 12.1 18.7 12.8 16.5 21.3 20.7 17.0 18.0 9.0 21.1 16.9 13.1 14.0 5.3 16.0 11.3 10.5 17.6 12.0 7.0 12.2 8.5 7.3 14.3 11.1 13.9 11.5 11.6 12.1 15.9 12.6 10.8 7.2 11.5 21.0 12.0 11.2 12.3 11.6 10.1 8.2 19.4 14.4 20.8 12.5 16.6 18.3 11.8 16.2 15.0 17.0 2.8 15.8 18.2 12.2 15.6 11.0 18.7 23.4 20.0 27.4 17.7 19.0 17.6 13.6 23.3 15.5 3.0 10.1 10.4 6.7 2.4 6.7 14.6 7.6 13.4 12.5 7.0 21.6 12.5 6.6 10.5 5.9 8.7 7.7 0.0 8.6 12.1 6.4 6.2 8.1 14.7 13.2 14.3 1.2 9.8 11.5 2.7 7.8 7.2 1.7 7.2 8.1 8.7 8.4 8.6 9.6 11.1 11.1 0.0 6.6 11.4 16.1 2.0 8.7 11.5 9.9 5.1 ELP5 "C17orf81, DERP6" ENSG00000170291 "Elongator acetyltransferase complex subunit 5" Q8TE02 17 7251416-7259940 "Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 320.1;Late spermatids: 402.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023279, HPA052411" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023279: AB_1847613, HPA052411: " "unprognostic (3.73e-2)" "unprognostic (9.21e-3)" "unprognostic (1.24e-1)" "unprognostic (2.39e-3)" "unprognostic (7.72e-2)" "unprognostic (1.22e-1)" "unprognostic (7.70e-2)" "unprognostic (1.53e-1)" "unprognostic (7.83e-3)" "unprognostic (1.60e-2)" "prognostic favorable (2.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.83e-1)" "unprognostic (8.07e-2)" "unprognostic (2.71e-1)" "unprognostic (1.62e-1)" "unprognostic (2.30e-2)" 12.4 18.2 14.0 13.6 14.0 11.8 10.4 14.1 17.8 11.1 15.5 12.2 13.3 11.4 13.1 13.5 10.9 12.6 11.9 23.0 13.2 12.0 16.5 21.3 9.1 15.0 13.6 12.8 15.2 10.6 9.6 15.9 12.6 12.5 14.0 11.0 16.4 20.9 12.7 28.3 7.8 14.6 18.0 11.2 14.1 10.7 103.3 12.4 23.6 15.7 17.2 16.1 11.6 11.0 31.1 36.7 16.3 29.3 27.6 34.7 21.5 12.4 35.3 15.9 14.4 28.0 22.2 6.9 11.2 13.3 18.0 16.7 35.2 8.2 24.8 12.4 17.8 31.6 9.4 40.2 26.4 13.0 15.3 56.6 22.8 11.9 32.0 13.9 16.2 9.0 15.6 19.9 12.2 24.3 11.4 15.3 31.6 15.7 6.7 27.9 21.1 41.0 31.0 13.1 13.1 24.5 35.3 17.9 13.4 20.0 11.8 7.8 15.5 21.8 6.6 17.2 16.6 9.4 11.8 17.3 10.4 12.2 19.9 17.8 7.8 10.4 28.8 18.9 15.8 13.4 16.3 25.3 12.4 27.9 29.3 34.7 31.1 24.9 25.5 30.0 31.0 26.4 31.2 4.4 27.6 19.3 36.7 33.8 21.5 14.0 14.0 14.1 17.8 13.2 12.0 13.6 12.8 12.5 12.4 8.9 9.4 30.5 41.1 19.6 21.3 59.0 10.2 6.7 18.2 43.6 19.6 35.0 82.9 28.6 320.1 27.1 27.3 0.0 11.8 67.2 24.2 62.2 6.9 20.8 36.0 27.0 40.0 14.1 10.8 402.6 31.7 24.4 20.3 27.1 33.9 22.3 22.6 35.1 31.1 76.9 29.6 38.8 32.4 100.6 36.9 19.1 48.4 32.0 48.2 43.2 ELP6 "C3orf75, FLJ20211, TMEM103" ENSG00000163832 "Elongator acetyltransferase complex subunit 6" Q0PNE2 3 47495640-47513761 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046358, HPA064545" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA046358: AB_10961011, HPA064545: AB_2685282" "unprognostic (2.00e-3)" "unprognostic (2.27e-1)" "unprognostic (7.41e-3)" "unprognostic (2.41e-2)" "unprognostic (2.67e-1)" "unprognostic (8.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (1.24e-2)" "unprognostic (2.07e-2)" "unprognostic (5.38e-2)" "prognostic favorable (3.42e-6)" "unprognostic (1.54e-1)" "unprognostic (9.05e-2)" "unprognostic (2.30e-1)" "unprognostic (6.29e-2)" 10.8 25.9 15.6 16.3 18.5 8.8 15.3 23.2 24.6 12.8 13.3 22.7 19.0 13.3 17.5 22.1 14.2 16.0 13.3 17.0 16.3 15.7 16.4 18.7 11.6 17.5 16.7 21.8 20.8 18.8 16.6 18.8 12.9 19.9 18.1 13.0 18.5 14.8 17.5 23.6 14.7 11.7 16.4 18.6 14.9 13.9 24.9 13.6 23.7 17.8 13.7 17.8 15.5 11.9 20.4 19.5 10.4 12.0 18.4 21.3 14.2 16.9 16.0 21.5 21.7 17.3 16.0 12.2 20.5 14.2 26.2 23.8 15.6 18.0 32.0 12.8 17.7 24.8 10.5 20.8 29.9 16.1 17.8 16.1 28.9 24.8 17.4 19.0 21.8 18.0 17.2 16.2 29.9 19.1 15.3 22.6 27.6 30.2 10.0 26.1 18.7 26.0 24.8 25.7 16.4 27.5 13.1 10.4 19.5 18.4 15.0 19.2 18.7 17.5 14.1 10.6 18.2 19.2 17.6 14.7 26.9 19.2 13.9 25.6 21.1 27.7 29.3 13.9 26.7 27.4 10.4 12.0 8.4 19.5 11.0 15.1 18.7 18.3 19.5 15.0 20.4 17.3 17.4 1.7 18.4 7.6 19.5 21.3 14.2 15.6 18.5 23.2 24.6 16.3 15.7 16.7 21.8 19.9 13.6 6.0 10.5 27.4 16.0 7.4 23.6 21.6 25.5 14.7 13.6 31.4 13.7 38.8 51.4 24.8 6.1 18.9 16.3 0.0 20.7 32.8 14.8 8.1 21.9 25.2 24.9 36.5 16.7 25.8 14.9 10.7 21.3 12.1 15.1 23.4 12.0 39.0 16.7 14.7 28.7 36.1 25.6 6.5 19.3 55.3 23.8 7.3 22.4 26.2 20.4 7.3 EMC3 TMEM111 ENSG00000125037 "ER membrane protein complex subunit 3" Q9P0I2 3 9962537-10011116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 287.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042372 Approved Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA042372: AB_10795609" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.59e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-3)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-1)" "prognostic favorable (2.81e-6)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.71e-2)" "unprognostic (5.58e-2)" 41.8 31.5 19.8 17.2 27.1 35.4 24.7 17.2 28.0 17.6 25.0 18.6 23.5 23.2 19.4 19.6 31.3 18.8 17.7 28.3 18.6 21.5 33.0 47.2 22.3 12.7 23.6 20.6 16.3 27.2 25.5 15.9 19.6 27.9 20.8 23.2 16.3 26.0 21.9 54.7 25.4 24.8 20.2 21.9 17.1 23.1 52.6 19.2 15.0 37.7 22.4 20.3 27.3 25.4 25.0 35.1 41.6 46.1 28.1 40.2 51.4 13.5 28.8 10.8 6.5 69.2 27.2 36.4 27.9 24.2 17.5 19.0 19.7 21.7 10.8 20.4 31.6 33.7 19.1 18.4 16.5 18.1 29.3 18.5 17.7 21.9 12.8 29.9 19.9 20.0 31.9 29.8 30.5 17.6 22.4 21.7 11.9 22.5 31.7 25.8 33.4 10.5 9.9 12.0 28.9 19.7 13.7 15.2 32.1 21.2 24.6 7.7 15.5 19.9 29.9 17.9 11.9 25.3 16.3 24.8 17.5 14.7 18.9 28.3 17.1 44.3 21.9 37.0 14.7 21.9 38.4 46.1 41.3 27.4 36.2 28.3 24.9 27.2 31.2 35.1 25.0 19.9 26.8 41.6 28.1 34.7 31.5 40.2 51.4 19.8 27.1 17.2 27.9 18.6 21.5 23.6 20.6 27.9 19.2 50.6 63.5 44.0 48.5 45.0 39.0 97.2 56.0 62.9 61.4 43.6 37.3 43.1 39.7 83.4 287.9 55.4 60.4 256.9 103.9 42.9 46.8 56.5 32.4 82.2 88.7 22.3 20.3 42.4 51.0 67.2 46.6 55.9 55.6 120.8 32.8 60.4 90.0 70.2 35.3 57.8 53.0 58.2 48.9 135.1 54.3 53.1 71.7 50.4 50.0 70.1 EMC8 "C16orf2, C16orf4, COX4NB, FAM158B, NOC4" ENSG00000131148 "ER membrane protein complex subunit 8" O43402 16 85771758-85799608 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 178.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049476 Approved Supported Cytosol NA NA Cytosol "HPA049476: AB_2680784" "unprognostic (2.69e-1)" "unprognostic (2.62e-2)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.88e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (8.49e-4)" "unprognostic (1.30e-1)" "unprognostic (2.41e-1)" "unprognostic (2.67e-3)" "unprognostic (1.03e-1)" "unprognostic (6.91e-3)" "prognostic favorable (6.39e-4)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" 16.8 17.4 18.8 17.1 19.8 26.9 39.3 12.4 21.0 14.5 16.6 16.3 14.1 18.9 18.2 14.4 17.3 14.0 16.8 23.0 17.7 15.5 19.1 22.5 14.2 16.2 18.0 12.4 16.2 16.2 20.5 14.6 20.9 14.0 14.5 16.2 13.4 16.6 17.0 25.6 13.3 16.3 17.0 17.3 17.9 15.5 15.5 13.3 24.3 19.5 18.2 16.5 14.8 12.3 12.8 20.9 21.2 15.8 16.3 13.9 9.5 13.0 15.2 9.7 8.8 10.6 10.2 19.0 12.9 12.8 21.6 9.6 24.2 15.1 11.3 15.0 12.9 9.7 14.9 14.5 13.5 19.3 4.7 20.6 9.2 8.4 22.0 16.1 9.4 6.3 11.1 9.2 16.3 19.2 9.3 12.2 13.9 21.0 4.3 13.2 22.1 14.8 26.8 19.4 12.1 19.6 21.9 7.9 9.6 13.6 9.2 16.5 9.8 23.7 7.8 14.3 9.1 15.4 16.8 10.6 13.0 13.2 11.4 16.4 12.2 11.7 45.1 11.1 18.2 13.6 12.5 15.2 21.2 9.9 15.8 11.7 9.6 11.0 13.5 20.9 12.8 13.9 13.2 6.6 16.3 15.7 15.5 10.2 9.5 18.8 19.8 12.4 21.0 17.7 15.5 18.0 12.4 14.0 13.3 6.0 7.5 21.6 23.5 54.5 20.7 18.1 12.7 9.4 9.1 24.4 11.8 43.2 51.4 39.7 178.6 25.3 21.3 23.3 36.8 53.9 27.0 29.2 9.2 19.2 40.7 14.3 44.7 28.3 24.3 39.4 23.0 25.5 27.0 39.7 22.0 22.1 39.4 21.0 29.7 34.3 14.9 25.8 23.5 45.4 53.2 47.7 42.7 17.8 30.2 39.3 EME1 "FLJ31364, MMS4L, SLX2A" ENSG00000154920 "Essential meiotic structure-specific endonuclease 1" Q96AY2 17 50373220-50381483 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.3;epididymis: 10.6;testis: 21.9" "Cell type enhanced" "Detected in some" 13 "Extravillous trophoblasts: 4.0;Spermatocytes: 10.5;Spermatogonia: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 29 "basophil: 15.3" "Lineage enriched" "Detected in single" 29 "granulocytes: 15.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016127, HPA052188" Supported Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "CAB016127: AB_2278026, HPA052188: " "unprognostic (3.81e-1)" "unprognostic (7.72e-2)" "unprognostic (6.49e-2)" "unprognostic (2.45e-3)" "unprognostic (2.74e-1)" "unprognostic (1.94e-2)" "unprognostic (9.94e-5)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.02e-2)" "unprognostic (4.37e-3)" "unprognostic (2.83e-3)" "unprognostic (0.00e+0)" "unprognostic (9.82e-2)" "unprognostic (1.26e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-1)" 1.0 0.9 1.6 2.5 2.0 6.0 0.8 0.8 1.8 1.3 1.9 3.0 0.0 1.1 0.9 10.6 2.6 0.7 1.6 0.7 0.9 0.6 0.7 0.8 1.1 3.3 1.4 0.9 1.3 0.6 0.2 0.5 2.4 1.5 0.7 2.0 1.0 1.6 0.1 1.4 1.5 2.1 0.8 1.9 2.2 1.1 21.9 2.8 5.7 0.5 0.9 3.9 1.0 1.2 0.1 0.5 15.3 0.0 0.0 0.1 0.2 7.4 11.0 14.7 7.7 0.7 1.5 10.6 7.8 3.0 10.9 10.1 17.3 6.1 6.0 10.4 3.1 6.8 5.9 13.6 6.2 15.6 11.7 10.7 14.3 12.7 8.0 0.0 5.8 4.7 0.3 0.4 12.6 5.2 1.4 2.5 17.3 8.6 14.4 6.4 8.2 13.3 7.5 8.5 7.7 7.6 13.8 28.5 8.3 2.4 3.0 5.7 11.4 4.8 2.6 4.5 12.3 9.4 6.7 1.7 14.2 8.5 9.3 10.7 9.0 9.1 5.8 4.5 6.6 8.7 15.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 1.6 2.0 0.8 1.8 0.9 0.6 1.4 0.9 1.5 2.8 0.0 1.4 0.0 0.2 0.1 1.5 0.4 0.0 1.4 1.2 0.0 0.0 1.9 0.0 0.2 0.4 0.0 0.0 0.0 0.0 4.0 0.5 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.6 0.7 0.0 1.8 0.4 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.4 10.5 8.0 0.1 0.9 0.0 0.6 0.1 EML4 "C2orf2, ELP120, ROPP120" ENSG00000143924 "Echinoderm microtubule associated protein like 4" Q9HC35 2 42169350-42332548 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 60.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036687, HPA036688, HPA065337" Enhanced Supported "Intermediate filaments,Microtubules,Cytosol" NA NA 41000 Microtubules "Intermediate filaments, Cytosol" "HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "unprognostic (3.53e-3)" "unprognostic (1.79e-2)" "unprognostic (9.19e-2)" "unprognostic (8.61e-3)" "unprognostic (1.61e-2)" "unprognostic (2.96e-3)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 11.3 17.3 5.8 29.3 6.8 19.2 10.5 4.6 5.2 9.4 21.6 6.7 6.8 20.3 13.6 11.6 10.7 8.7 20.3 6.5 5.1 3.9 11.7 26.4 19.3 27.7 4.6 4.0 12.5 37.8 10.8 11.6 26.9 6.5 8.5 12.8 12.1 17.7 8.9 4.3 17.9 33.5 9.2 5.0 30.9 11.7 14.2 5.3 17.4 13.2 6.9 30.0 14.0 9.0 11.5 4.2 10.0 11.0 9.4 17.5 5.9 14.6 25.5 14.9 11.8 5.4 8.9 16.3 9.1 7.2 10.1 9.8 26.6 18.5 13.4 6.3 8.9 15.6 7.6 12.7 8.8 17.7 26.2 10.7 12.3 7.9 60.9 6.9 9.3 12.7 9.7 3.3 13.4 9.1 4.9 7.0 4.6 12.1 13.6 10.9 8.6 8.7 2.5 15.2 18.9 7.4 9.0 23.6 7.9 8.3 21.3 14.7 29.6 9.0 9.4 6.9 14.1 4.9 3.7 8.2 10.4 13.9 8.3 8.2 15.3 10.6 11.6 9.0 8.9 7.2 4.4 3.9 7.7 7.8 10.9 16.3 11.5 13.0 12.7 3.3 7.9 11.4 8.3 10.0 9.4 11.0 4.2 17.5 5.9 5.8 6.8 4.6 5.2 5.1 3.9 4.6 4.0 6.5 5.3 56.6 103.1 87.1 59.5 59.8 36.4 5.7 40.8 32.1 69.4 38.4 45.2 112.3 14.9 30.5 25.2 34.6 46.7 0.0 65.3 37.0 71.8 58.2 46.2 54.6 62.4 15.9 98.2 48.5 34.8 23.1 22.2 58.2 15.1 24.4 56.5 34.1 37.0 58.3 21.5 31.5 48.1 6.5 46.2 40.3 39.2 69.6 99.4 95.6 60.7 86.1 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580698 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 118.7" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 3868.0;Suprabasal keratinocytes: 1026.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 59.5;RT4: 40.9;SK-BR-3: 58.8;T-47d: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014711, HPA070816" Approved Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA014711: AB_1848147, HPA070816: " "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 16.5 2.0 5.0 7.9 5.1 0.0 26.2 3.4 4.7 14.8 10.4 3.4 6.1 4.2 7.3 13.8 35.7 7.4 7.3 14.0 5.5 3.0 3.1 47.5 118.7 5.7 5.4 2.5 14.0 3.2 19.9 3.2 23.5 5.3 11.1 10.0 10.8 9.9 5.8 7.7 40.2 6.6 12.8 3.4 5.3 9.3 5.6 4.1 2.2 7.5 26.4 18.4 10.6 16.3 1.3 1.1 4.1 1.1 1.4 1.0 0.4 6.3 8.8 3.6 4.3 8.2 7.1 7.2 9.1 8.4 5.5 8.3 28.8 22.3 0.0 2.9 10.9 4.0 28.3 9.3 11.2 7.3 0.0 5.9 0.0 18.5 15.7 1.4 0.0 0.1 4.3 3.0 7.3 0.7 1.2 2.3 0.0 2.1 0.6 15.2 59.5 0.1 0.1 4.2 10.3 2.1 1.6 4.2 13.8 1.2 40.9 5.1 5.8 11.2 58.8 3.3 11.0 35.9 1.4 1.2 17.6 7.6 5.9 5.0 0.1 0.2 0.0 7.7 0.1 17.2 3.4 1.0 1.0 0.8 0.8 1.0 1.0 0.8 0.7 0.5 1.3 0.9 0.9 4.1 1.4 1.1 1.1 0.8 0.4 5.0 5.1 3.4 4.7 5.5 3.0 5.4 2.5 5.3 4.1 3868.0 343.3 4.5 123.1 317.0 1.8 48.0 109.5 153.9 326.4 40.1 0.0 59.0 0.0 2.5 4.2 191.2 51.9 0.0 60.2 16.3 121.0 91.1 34.8 181.1 8.8 0.0 100.6 112.3 14.0 5.0 176.6 42.0 82.7 58.7 141.3 5.2 27.3 172.1 259.6 0.0 1.1 51.8 141.5 2.3 13.2 1026.6 40.2 4.3 139.9 220.6 ENAH "FLJ10773, MENA, NDPP1" ENSG00000154380 "ENAH, actin regulator" Q8N8S7 1 225486835-225653142 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 61.0" "Low region specificity" "Detected in all" "HPA028448, HPA028696" Enhanced Enhanced "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 18000 "Plasma membrane, Focal adhesion sites, Cytosol" "HPA028448: AB_10600766, HPA028696: AB_10611249" "unprognostic (2.56e-2)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.35e-2)" "unprognostic (5.61e-3)" "unprognostic (2.85e-1)" "unprognostic (1.21e-3)" "unprognostic (2.30e-1)" "unprognostic (2.23e-1)" "unprognostic (9.22e-2)" "unprognostic (4.71e-3)" "unprognostic (2.14e-1)" "unprognostic (2.24e-3)" "unprognostic (8.84e-2)" "unprognostic (5.83e-2)" "unprognostic (7.92e-2)" "unprognostic (2.93e-2)" 19.2 17.4 15.8 11.9 17.0 0.6 11.1 7.6 17.6 17.8 24.4 15.3 39.9 9.3 21.9 19.9 16.7 11.8 29.0 18.2 16.7 15.3 5.8 5.9 13.8 3.5 13.7 11.3 24.3 16.7 22.5 10.3 13.5 12.7 26.4 8.0 3.3 14.5 44.9 20.2 8.2 8.0 61.4 13.4 17.3 21.0 18.5 17.2 5.3 6.8 11.4 3.5 35.3 21.9 2.1 0.4 1.0 0.3 0.5 0.4 0.0 20.5 16.5 20.5 18.5 8.0 10.6 26.4 22.9 11.0 13.8 10.5 10.6 7.6 8.7 61.0 35.3 12.4 18.2 23.9 8.6 13.2 0.1 14.8 9.1 14.7 14.2 24.0 1.0 0.3 16.3 10.4 17.9 22.9 11.3 10.9 2.5 0.6 0.4 13.6 4.0 4.1 1.0 34.5 5.4 15.0 6.2 28.9 0.2 6.3 15.9 20.2 16.3 44.9 17.2 15.1 16.3 20.4 1.3 21.2 35.9 26.4 29.8 45.3 1.0 2.5 5.9 19.7 1.1 18.3 1.0 0.3 0.2 0.4 0.1 0.3 0.6 0.4 0.3 0.0 2.1 0.4 0.4 1.0 0.5 0.2 0.4 0.2 0.0 15.8 17.0 7.6 13.7 16.7 15.3 13.7 11.3 12.7 17.2 11.9 31.2 2.2 136.9 114.6 7.8 109.0 56.0 123.1 56.9 21.0 58.9 50.3 3.3 71.8 67.2 59.1 5.1 0.0 86.5 13.1 84.6 122.2 4.7 9.6 9.4 15.9 39.7 22.1 1.8 19.9 53.8 7.0 79.2 5.4 28.6 30.0 72.6 14.4 158.7 10.5 19.1 90.5 115.4 8.0 40.0 117.2 50.6 0.0 23.0 87.2 ENGASE FLJ21865 ENSG00000167280 Endo-beta-N-acetylglucosaminidase Q8NFI3 17 79074939-79088599 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 51.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021551 Enhanced Approved Centrosome,Cytosol No No Cytosol Centrosome "HPA021551: AB_1848156" "unprognostic (7.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (6.16e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-3)" "unprognostic (9.62e-2)" "unprognostic (4.09e-2)" "unprognostic (9.07e-2)" "unprognostic (7.00e-3)" "prognostic favorable (2.60e-4)" "unprognostic (4.79e-2)" "prognostic unfavorable (8.97e-6)" "unprognostic (8.38e-3)" "unprognostic (6.03e-1)" "unprognostic (2.06e-2)" "prognostic favorable (8.73e-5)" 10.0 10.1 9.5 20.7 18.4 8.9 11.4 7.0 13.9 10.9 15.1 12.4 8.8 20.3 11.4 6.8 6.5 10.6 8.6 10.3 9.3 5.8 9.2 10.2 10.1 10.7 16.8 8.5 16.3 9.3 11.3 9.8 8.1 13.6 12.3 12.5 10.7 12.1 9.6 35.4 11.9 17.3 7.3 11.9 24.9 11.4 3.9 14.0 8.1 13.6 7.0 9.1 17.5 51.4 0.2 0.7 0.0 1.1 0.0 2.1 0.6 4.5 9.8 3.4 6.3 3.6 1.5 6.6 3.5 1.8 2.9 2.0 5.2 5.0 0.0 4.2 3.5 4.8 6.8 5.4 3.8 1.6 2.7 7.3 4.1 10.0 3.1 2.7 4.7 7.8 4.1 5.3 2.5 2.8 5.6 3.0 8.9 5.9 2.9 1.8 3.9 0.4 4.5 1.5 9.5 8.8 8.6 11.7 3.0 1.5 12.9 2.9 5.7 5.6 25.9 2.6 5.3 9.1 4.4 3.9 5.6 4.2 4.8 3.4 6.9 1.2 2.0 2.3 8.7 4.0 0.0 0.7 0.0 0.0 1.1 0.9 0.0 0.1 0.4 0.7 0.2 0.0 0.0 0.0 0.0 0.5 0.6 2.1 0.6 9.5 18.4 7.0 13.9 9.3 5.8 16.8 8.5 13.6 14.0 0.0 13.6 6.4 3.8 3.9 10.7 4.8 7.6 0.0 6.8 10.4 33.4 4.2 0.0 3.5 1.5 6.5 16.4 0.0 3.6 3.8 4.8 7.4 4.7 10.6 7.5 7.9 25.1 9.8 10.8 1.0 3.1 8.2 0.0 5.4 15.9 5.6 2.5 11.5 1.8 1.7 24.7 12.9 6.0 2.2 1.4 5.1 5.6 5.7 18.8 4.1 ENKD1 "C16orf48, DKFZP434A1319" ENSG00000124074 "Enkurin domain containing 1" Q9H0I2 16 67662945-67667265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041163, HPA041478" Approved Supported "Plasma membrane,Centrosome,Cytosol" Yes No "Plasma membrane" "Centrosome, Cytosol" "HPA041163: AB_10794986, HPA041478: AB_10794668" "unprognostic (6.02e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-3)" "prognostic favorable (1.68e-4)" "unprognostic (4.41e-1)" "unprognostic (1.06e-1)" "unprognostic (3.78e-3)" "unprognostic (1.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (5.69e-2)" "unprognostic (6.58e-2)" "unprognostic (1.67e-1)" "unprognostic (2.44e-1)" "unprognostic (3.31e-2)" "unprognostic (2.23e-1)" "unprognostic (9.60e-2)" 8.5 7.7 4.9 5.9 7.0 3.8 6.6 5.0 6.9 10.4 11.7 6.1 18.6 4.7 11.2 14.2 8.2 14.5 11.0 6.1 5.4 5.2 10.9 4.7 8.9 2.9 4.5 4.4 10.9 38.8 23.7 12.0 4.8 8.3 12.7 3.6 7.9 11.7 12.6 6.0 7.2 5.1 12.9 4.3 6.1 7.3 19.6 6.4 7.1 20.4 5.2 4.9 12.9 6.4 0.6 4.2 3.0 1.3 0.7 1.5 0.5 6.9 4.8 11.4 5.3 3.8 3.9 5.6 5.5 3.4 4.4 5.4 3.5 10.7 2.6 9.4 3.4 0.0 8.2 2.9 6.6 5.5 4.0 6.6 2.6 14.5 8.2 6.1 4.6 3.6 3.4 4.7 6.0 5.5 10.3 3.5 8.7 4.3 1.7 2.2 3.5 5.0 19.3 5.4 7.3 1.9 17.9 1.2 19.3 4.6 0.7 11.5 12.5 11.7 1.1 6.0 2.7 10.3 6.6 9.3 5.4 7.6 10.1 0.1 12.6 5.6 2.8 8.1 6.9 1.6 0.0 1.3 0.0 0.3 0.5 1.5 0.6 1.2 0.7 0.5 0.0 0.8 1.1 3.0 0.7 0.7 4.2 0.0 0.5 4.9 7.0 5.0 6.9 5.4 5.2 4.5 4.4 8.3 6.4 20.8 15.6 0.8 6.2 6.2 3.6 5.0 17.8 36.1 2.3 8.7 3.9 2.8 1.7 11.9 28.8 9.0 2.0 0.0 9.2 2.1 7.0 5.2 1.1 14.7 4.2 3.2 12.7 11.1 3.8 14.5 12.0 2.9 5.0 2.8 5.9 9.5 8.2 0.0 13.4 5.9 10.8 6.5 6.6 20.2 7.3 4.5 2.9 1.9 4.4 2.4 ENO1 "ENO1L1, MBP-1, MPB1, PPH" ENSG00000074800 "Enolase 1" P06733 1 8861000-8879250 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Plasminogen activation, Transcription, Transcription regulation" "DNA-binding, Lyase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 2408.5;Muller glia cells: 2654.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018614, HPA068284, HPA068721, CAB069394" Supported Enhanced "Plasma membrane,Cytosol" NA NA 490000000 "Plasma membrane, Cytosol" "CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: AB_2732119" "unprognostic (6.51e-3)" "unprognostic (9.50e-3)" "unprognostic (3.56e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (2.71e-4)" "unprognostic (1.82e-2)" "prognostic unfavorable (1.30e-8)" "unprognostic (2.37e-2)" "unprognostic (5.58e-2)" "unprognostic (9.72e-2)" "unprognostic (1.67e-2)" "unprognostic (1.46e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (1.97e-1)" "unprognostic (2.22e-1)" "unprognostic (1.36e-3)" 68.6 57.7 92.7 94.9 109.6 121.8 73.4 46.6 119.4 47.3 63.8 74.6 21.7 71.3 44.9 24.2 138.2 52.2 55.0 45.2 79.1 70.7 180.4 165.4 64.8 80.3 74.9 62.7 58.2 31.6 52.7 35.5 70.5 88.6 38.6 66.4 62.6 106.1 69.1 45.0 74.6 70.3 84.0 56.4 80.0 44.3 31.7 48.8 98.8 55.4 91.0 119.3 73.5 62.9 38.7 114.1 22.1 105.4 55.5 63.7 159.3 182.3 159.4 76.9 65.8 64.4 71.9 69.7 99.1 109.9 213.7 200.9 102.1 105.9 131.5 132.4 119.3 87.5 90.0 130.6 264.6 218.0 89.7 138.0 111.0 161.9 126.7 96.7 221.2 68.4 74.2 80.3 169.2 257.3 161.8 136.8 67.1 121.6 51.4 138.5 90.3 83.4 118.4 83.9 65.5 160.0 86.4 114.6 214.7 252.9 43.5 104.0 64.2 116.3 169.4 122.3 96.7 84.8 66.3 125.1 148.0 131.1 126.2 168.6 146.8 104.1 199.5 229.8 181.4 124.2 13.9 105.4 20.8 52.3 75.8 59.1 38.7 55.8 53.8 114.1 32.7 45.6 47.8 22.1 55.5 72.4 31.2 63.7 159.3 92.7 109.6 46.6 119.4 79.1 70.7 74.9 62.7 88.6 48.8 259.1 414.8 250.1 443.8 370.0 168.1 63.1 310.8 202.1 440.2 575.7 66.8 1020.4 784.2 1640.5 217.6 199.3 508.9 23.3 1210.7 1855.9 354.5 232.4 289.9 288.6 1045.8 456.1 181.6 141.8 389.1 532.9 158.8 475.7 425.1 2408.5 221.4 2654.1 1226.2 336.6 126.9 717.5 187.6 148.8 217.3 150.6 148.2 305.6 837.7 297.2 410.6 403.0 ENO2 ENSG00000111674 "Enolase 2" P09104 12 6913745-6923698 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 119.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 242.1;Cone photoreceptor cells: 294.5;Horizontal cells: 405.2;Rod photoreceptor cells: 613.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5" "Group enriched" "Detected in many" 7 "B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 94.8;U-87 MG: 70.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000063, HPA068284, HPA068721, CAB073539, CAB079023" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 89000000 "Plasma membrane, Cytosol" "CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119" "unprognostic (8.96e-2)" "unprognostic (8.28e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.28e-1)" "unprognostic (7.95e-3)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.48e-1)" "unprognostic (9.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (7.89e-11)" "unprognostic (7.61e-2)" "unprognostic (3.06e-1)" "unprognostic (8.10e-3)" "unprognostic (1.24e-1)" 4.2 20.7 31.2 8.3 48.0 4.0 4.9 115.2 119.2 7.6 7.9 10.9 2.6 4.9 11.7 6.3 5.9 9.4 8.0 10.3 30.2 39.2 3.5 2.0 10.1 10.5 29.6 47.4 3.7 4.1 19.1 15.5 4.8 47.7 8.0 7.4 28.6 3.1 15.3 2.1 5.8 6.0 15.2 15.7 5.8 6.4 3.2 13.3 1.7 14.2 0.3 10.3 7.1 5.0 5.6 1.0 6.2 0.2 0.4 10.8 4.5 12.2 7.7 2.8 0.1 4.2 4.5 0.2 9.5 6.1 14.1 21.7 1.4 1.0 17.2 1.5 4.1 18.6 1.8 29.3 2.6 21.4 34.4 2.7 23.8 7.9 10.3 3.0 1.3 28.6 2.3 0.1 10.4 2.1 94.8 2.9 22.5 1.5 0.2 9.4 1.6 11.1 1.5 14.9 5.3 4.4 12.4 2.3 3.8 6.9 1.6 22.5 15.8 2.5 0.1 16.2 14.3 0.7 0.7 3.7 12.3 13.0 16.6 12.2 12.6 12.6 2.5 70.7 0.0 2.5 1.3 0.0 0.1 8.2 0.0 9.7 5.6 10.8 9.6 0.0 3.3 7.1 7.4 6.2 0.4 0.2 1.0 5.5 4.5 31.2 48.0 115.2 91.3 30.2 39.2 29.6 47.4 47.7 13.3 32.8 30.1 5.4 2.3 5.6 242.1 12.0 0.0 21.4 10.3 12.2 294.5 0.2 0.0 16.0 0.3 7.1 0.0 0.0 1.5 0.3 6.6 1.7 65.8 0.0 1.7 405.2 23.0 6.2 0.0 0.0 5.2 2.5 11.8 5.4 0.0 91.6 10.4 0.2 9.2 0.0 613.6 12.9 21.7 1.8 1.3 1.9 0.2 11.4 0.4 1.6 ENO3 ENSG00000108515 "Enolase 3" P13929 17 4948092-4957131 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "skeletal muscle: 638.2;tongue: 320.3" "Group enriched" "Detected in many" 8 "Cardiomyocytes: 511.6;monocytes: 134.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HDLM-2: 71.7;HeLa: 30.7;HMC-1: 30.3;RH-30: 49.3;RPMI-8226: 25.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA000793, HPA068284, HPA068721" Enhanced Supported "Plasma membrane,Cytosol" Yes No 100000000 "Plasma membrane, Cytosol" "HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119" "unprognostic (7.35e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (2.08e-2)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (6.04e-3)" "unprognostic (2.21e-2)" "unprognostic (4.63e-2)" "unprognostic (5.34e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "unprognostic (4.50e-2)" 7.6 0.3 0.2 0.6 0.2 0.7 0.5 0.6 0.2 0.2 0.4 0.0 0.1 0.8 0.4 8.5 8.6 0.4 0.1 38.3 0.2 0.1 0.5 5.0 0.4 0.5 0.2 0.0 0.4 0.3 0.3 0.5 0.2 0.1 2.1 0.1 1.2 11.8 0.1 638.2 0.3 0.7 0.4 0.2 0.8 0.4 0.5 0.0 0.6 4.8 320.3 10.5 0.3 0.3 13.3 21.0 27.1 24.8 18.5 23.3 36.0 2.9 6.3 2.9 2.7 2.5 0.7 6.9 5.1 0.7 0.3 0.3 3.0 2.0 5.4 7.0 0.4 0.9 3.7 1.0 0.4 0.3 71.7 5.8 5.2 30.7 4.5 0.9 1.6 30.3 4.2 1.0 0.5 1.0 2.6 0.3 6.2 2.4 9.9 1.5 1.6 1.9 6.3 3.7 0.8 2.6 8.5 49.3 25.8 0.7 1.9 1.8 6.9 3.3 2.8 3.7 2.0 2.6 1.7 1.6 3.0 5.7 1.3 3.8 7.0 3.9 4.4 1.7 5.1 3.0 13.5 15.6 27.1 21.8 22.5 14.7 13.3 18.7 20.3 21.0 11.1 12.3 19.7 19.7 18.5 24.8 16.6 23.3 36.0 0.2 0.2 0.6 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.0 2.6 2.9 1.0 1.8 3.2 511.6 0.0 0.0 2.3 5.2 3.9 4.3 0.0 1.4 1.3 2.2 4.3 0.0 0.7 3.1 3.6 1.0 8.1 38.1 4.4 3.2 0.0 3.1 3.8 2.7 0.3 4.5 1.7 134.3 2.3 1.5 1.3 1.7 0.4 5.4 2.4 6.5 0.9 8.6 3.9 1.6 2.7 4.3 2.1 0.6 ENOX2 "APK1, COVA1, tNOX" ENSG00000165675 "Ecto-NOX disulfide-thiol exchanger 2" Q16206 X 130623369-130903317 "Predicted intracellular proteins" "Biological rhythms, Electron transport, Growth regulation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000514, HPA003027" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA000514: AB_1078558, HPA003027: " "unprognostic (1.34e-2)" "unprognostic (7.02e-2)" "unprognostic (9.75e-2)" "unprognostic (1.08e-1)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (4.07e-2)" "unprognostic (6.07e-2)" "unprognostic (6.27e-3)" "unprognostic (5.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.09e-5)" "unprognostic (6.42e-2)" "unprognostic (4.60e-2)" "unprognostic (3.02e-1)" "unprognostic (1.38e-1)" 13.1 14.6 13.5 14.8 17.6 4.7 11.4 7.6 11.0 13.2 11.6 13.9 10.7 8.0 15.6 12.9 13.3 13.2 11.2 18.9 14.6 13.1 10.4 23.6 8.8 16.0 14.7 8.8 14.6 7.4 12.5 12.3 11.7 12.2 12.9 9.3 8.5 10.3 15.1 11.2 8.6 11.1 14.5 13.4 17.7 9.2 9.7 17.7 17.4 11.0 11.7 15.9 14.2 9.7 12.8 11.9 15.0 16.7 11.3 13.3 9.7 12.3 9.1 14.0 5.8 12.0 11.4 5.6 10.5 12.1 7.1 4.4 4.3 10.7 8.7 25.4 8.8 9.5 8.7 9.1 9.7 8.8 11.5 10.0 20.2 6.2 5.7 9.3 14.7 14.3 9.0 16.6 7.7 9.6 3.0 10.6 7.8 12.4 7.1 5.5 17.2 9.2 3.2 7.3 17.3 12.7 6.6 8.7 9.6 8.2 8.7 4.2 8.5 9.1 6.0 14.7 5.2 3.9 8.1 8.6 6.8 4.1 10.9 21.3 7.4 3.6 5.7 19.9 15.4 11.5 8.0 12.0 15.0 10.4 16.7 11.1 12.8 12.2 10.8 11.9 11.6 13.3 11.7 2.1 11.3 7.8 5.7 13.2 9.7 13.5 17.6 7.6 11.0 14.6 13.1 14.7 8.8 12.2 17.7 3.0 6.1 1.5 5.8 3.8 4.3 10.1 5.1 20.1 10.3 3.5 0.0 4.9 6.6 7.0 0.8 7.1 4.0 0.0 8.2 4.4 5.6 5.8 5.8 10.6 6.0 3.2 4.6 6.2 17.7 0.9 5.2 14.4 8.5 19.0 4.2 4.9 8.9 3.5 6.0 6.7 6.4 6.5 8.4 6.5 10.6 4.3 6.1 8.2 5.0 4.7 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)" Q9UJA9 6 46159187-46170971 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 116.5" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 68.3;Muller glia cells: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 13.4" "Lineage enriched" "Detected in many" 6 "T-cells: 13.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.7;HSkMC: 7.8;SuSa: 6.9;T-47d: 9.2;U-266/84: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 300000 Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favorable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favorable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favorable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.5 4.8 6.5 1.3 10.3 0.8 7.1 9.2 16.1 6.9 2.0 3.3 28.7 1.5 1.6 116.5 1.6 7.9 3.9 3.9 6.6 9.4 12.1 1.0 4.7 1.2 14.2 10.5 5.4 6.2 21.8 23.3 1.5 14.4 14.6 2.3 11.8 6.9 27.5 6.9 1.3 1.6 5.1 5.5 3.2 3.5 16.2 3.5 1.0 24.3 0.9 1.4 5.7 1.7 0.4 0.0 1.0 0.1 2.2 13.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.6 0.1 0.3 11.7 1.9 3.9 0.2 4.0 0.0 0.6 1.6 0.1 0.0 2.6 0.8 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 1.9 0.0 0.5 2.5 5.5 0.0 0.0 0.3 0.2 4.9 0.6 5.1 0.2 0.0 4.9 0.0 6.9 9.2 0.0 0.0 0.0 1.3 0.0 0.1 5.8 7.9 0.0 3.1 0.0 0.1 0.0 0.0 0.0 13.4 0.1 7.2 0.4 2.7 8.6 0.0 0.4 0.8 8.2 1.0 2.2 0.0 0.0 0.0 2.6 6.5 10.3 9.2 16.1 6.6 9.4 14.2 10.5 14.4 3.5 11.9 9.8 0.0 4.7 0.8 11.0 8.1 7.6 68.3 9.1 22.7 3.9 4.2 1.7 6.9 0.8 0.1 1.4 0.0 6.5 2.4 3.3 16.0 4.6 0.0 0.3 9.5 7.9 0.6 0.0 1.5 2.6 0.7 0.0 1.0 3.4 94.1 2.7 2.9 11.3 16.2 2.9 6.5 0.7 0.2 2.3 0.5 0.2 3.8 2.5 2.6 ENSA "ARPP-19e, MGC4319, MGC78563, MGC8394" ENSG00000143420 "Endosulfine alpha" O43768 1 150600851-150629612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 625.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 13 "U-698: 429.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051294 Uncertain Approved Nucleoplasm,Nucleoli,Microtubules,Cytosol NA NA 22000 "Nucleoplasm, Nucleoli" "Microtubules, Cytosol" "HPA051294: AB_2681425" "unprognostic (6.27e-2)" "prognostic favorable (8.24e-4)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (2.58e-1)" "unprognostic (8.24e-2)" "unprognostic (1.94e-3)" "unprognostic (1.82e-1)" "unprognostic (2.02e-1)" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (5.40e-2)" "unprognostic (2.21e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-1)" "unprognostic (7.64e-2)" "unprognostic (8.07e-3)" 30.3 26.4 48.9 26.9 48.9 46.8 33.0 33.8 69.3 31.7 31.8 28.0 26.8 34.4 29.7 45.4 66.3 26.3 28.5 30.0 42.4 37.9 31.7 32.3 28.6 30.0 42.0 39.0 27.7 30.5 33.0 25.2 37.5 34.6 23.9 30.4 28.5 29.4 22.8 67.7 49.8 34.0 27.3 38.3 23.8 28.7 12.8 27.3 25.8 35.2 42.9 35.5 31.7 36.3 34.4 39.5 49.5 33.6 33.0 33.2 38.4 14.7 7.7 10.8 10.4 6.9 5.7 11.7 6.6 6.7 9.9 8.4 8.7 11.1 13.2 11.0 5.3 6.2 11.9 8.7 14.7 7.3 22.8 12.1 18.9 10.9 6.6 4.6 15.2 24.4 4.5 9.1 10.3 13.2 5.5 9.3 10.5 14.4 27.8 6.6 31.8 15.0 12.4 21.6 17.4 9.6 14.6 9.0 16.4 13.0 13.0 16.2 10.2 9.4 19.8 10.3 9.5 27.1 22.4 9.8 7.4 13.7 8.8 17.1 15.6 22.7 429.6 10.2 17.7 9.7 28.7 30.7 49.5 32.2 33.6 28.9 34.4 27.0 33.2 39.5 31.8 22.3 32.9 29.0 33.0 31.9 30.2 29.8 38.4 48.9 48.9 33.8 69.3 42.4 37.9 42.0 39.0 34.6 27.3 38.7 144.0 138.7 185.4 169.1 60.1 89.1 79.0 109.7 114.9 78.5 43.2 247.9 215.5 139.6 6.0 100.3 151.4 46.7 132.7 150.0 85.0 114.8 218.3 71.0 175.6 63.5 125.5 52.8 77.7 11.1 79.7 128.3 97.8 625.8 119.8 57.9 90.7 136.8 97.9 148.1 46.3 71.1 92.7 22.2 27.4 250.8 320.0 133.9 128.5 226.6 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 48.1" "Group enriched" "Detected in some" 6 "Enterocytes: 107.0;Mucus-secreting cells: 160.6;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.1;OE19: 3.0;RPMI-8226: 8.8;T-47d: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favorable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.4 0.0 0.4 2.6 0.4 0.0 0.4 0.4 0.4 0.4 19.2 0.4 0.4 18.5 0.4 0.4 0.4 0.3 2.2 0.4 0.5 0.0 2.1 9.8 0.8 0.4 0.4 0.4 0.4 1.8 0.0 4.2 0.5 0.4 0.4 7.5 0.8 4.1 0.4 0.4 0.0 48.1 0.4 0.4 0.4 6.1 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.0 9.1 0.0 0.6 0.0 0.7 0.1 0.0 0.0 0.0 1.5 0.2 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 1.6 0.0 0.2 0.1 3.0 0.4 0.0 0.0 8.8 1.4 0.0 0.3 0.9 0.2 0.0 0.1 0.7 4.8 0.2 0.1 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.5 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 12.7 0.0 0.0 19.2 0.0 0.0 0.0 0.8 0.0 0.0 107.0 0.0 6.8 0.1 0.0 1.0 0.0 8.2 0.1 0.0 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 160.6 0.0 0.5 49.1 0.0 4.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 12.7 0.6 EOGT "AER61, C3orf64, FLJ33770" ENSG00000163378 "EGF domain specific O-linked N-acetylglucosamine transferase" Q5NDL2 3 68975214-69013961 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 39.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019460 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA019460: AB_1844628" "unprognostic (2.62e-1)" "unprognostic (3.72e-1)" "unprognostic (1.07e-1)" "unprognostic (1.95e-2)" "unprognostic (8.96e-2)" "unprognostic (6.30e-2)" "unprognostic (2.18e-3)" "unprognostic (6.66e-2)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" "unprognostic (1.68e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (8.97e-5)" "unprognostic (7.41e-2)" "unprognostic (4.67e-1)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" 14.9 5.8 3.4 10.1 4.4 3.0 11.9 2.5 4.8 16.8 12.1 4.4 10.2 4.8 23.3 10.4 15.1 11.4 18.1 18.2 3.9 3.6 6.6 5.5 15.8 9.6 4.2 5.0 12.7 7.8 3.9 5.5 15.2 5.1 18.9 5.8 8.7 14.0 24.0 28.0 6.1 7.7 29.4 4.9 10.2 10.1 7.4 2.4 8.3 5.4 14.2 7.3 27.0 9.8 1.7 3.4 5.5 2.2 3.3 9.2 1.8 8.2 2.8 5.4 6.6 7.7 15.2 4.0 11.2 13.7 7.1 9.4 3.7 4.7 0.4 1.7 12.1 6.1 2.7 3.7 14.6 9.0 26.7 2.6 8.6 6.3 5.3 8.6 4.8 3.6 12.6 12.4 9.2 11.7 8.7 39.1 0.3 2.3 5.1 23.8 2.1 0.7 1.5 6.3 2.7 1.3 0.3 5.7 3.5 6.1 19.0 0.5 3.0 12.9 1.0 10.1 6.0 2.8 6.6 20.7 20.1 6.1 2.3 10.8 2.6 8.4 4.0 8.0 7.5 11.2 5.5 2.2 0.0 3.0 1.9 3.5 1.7 4.8 6.4 3.4 1.2 4.1 4.1 0.3 3.3 0.7 0.6 9.2 1.8 3.4 4.4 2.5 4.8 3.9 3.6 4.2 5.0 5.1 2.4 11.9 10.1 1.5 10.1 6.4 2.2 13.7 7.6 8.1 14.8 1.8 15.7 0.8 0.0 4.0 13.9 15.0 2.5 0.0 7.0 3.8 7.5 7.5 0.0 3.8 5.9 0.0 5.8 21.5 5.1 12.0 2.8 7.7 8.5 9.0 3.4 1.3 9.0 2.9 38.2 1.5 4.8 0.0 23.8 1.1 2.4 4.0 0.7 4.4 2.5 5.8 EOMES TBR2 ENSG00000163508 Eomesodermin O95936 3 27715949-27722711 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.9;brain: 22.6;lymphoid tissue: 21.4" "Group enriched" "Detected in some" 8 "Erythroid cells: 23.3;T-cells: 32.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Region enriched" "Detected in some" 20 "cerebellum: 22.6" "Group enriched" "Detected in many" 7 "gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9" "Group enriched" "Detected in many" 102 "NK-cells: 17.9;T-cells: 16.5" "Cell line enhanced" "Detected in some" "HDLM-2: 10.2;JURKAT: 12.3;SCLC-21H: 5.7" "Region enriched" "Detected in some" 8 "olfactory region: 95.2" "Group enriched" "Detected in many" 13 "cerebellum: 44.2;olfactory region: 21.9" HPA028896 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA028896: AB_10601370" "unprognostic (1.53e-4)" "unprognostic (5.95e-3)" "unprognostic (3.01e-2)" "unprognostic (1.60e-4)" "unprognostic (4.13e-2)" "unprognostic (9.63e-4)" "unprognostic (4.29e-4)" "unprognostic (3.14e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-2)" "unprognostic (9.96e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (6.32e-3)" "unprognostic (1.49e-2)" 1.4 0.7 0.5 6.8 0.4 1.6 1.6 22.6 0.4 1.8 0.8 0.0 0.0 0.3 3.2 0.9 1.4 0.6 5.0 0.7 0.4 0.7 1.0 4.9 10.1 15.6 0.5 0.3 1.3 0.9 0.0 0.6 1.6 1.1 2.1 0.9 3.3 2.2 0.1 0.4 0.4 1.8 0.7 0.9 21.4 1.4 0.5 0.0 1.8 1.1 0.9 11.2 3.3 0.8 0.0 0.0 0.1 0.0 17.9 16.5 1.4 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 2.6 2.0 0.0 10.2 1.5 0.0 0.1 0.8 0.0 1.2 0.0 0.1 1.2 0.0 1.4 0.5 0.0 12.3 0.3 0.0 0.0 3.0 2.7 0.0 0.3 0.2 1.2 1.9 0.0 0.0 1.0 0.0 5.7 0.0 0.0 0.0 1.2 0.5 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 10.0 0.0 16.5 0.0 1.9 12.0 0.0 0.0 0.1 7.5 0.1 17.9 0.0 0.0 0.0 1.4 0.5 0.4 22.6 0.4 0.4 0.7 0.5 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 3.7 3.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 1.6 0.1 0.0 32.6 0.0 0.0 EPAS1 "bHLHe73, HIF2A, HLF, MOP2, PASD2" ENSG00000116016 "Endothelial PAS domain protein 1" Q99814 2 46293667-46386703 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Congenital erythrocytosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 200.8" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 341.0;Ito cells: 438.9;Smooth muscle cells: 281.4;Syncytiotrophoblasts: 292.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "basophil: 14.9;eosinophil: 7.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 14.9" "Cell line enhanced" "Detected in many" "BEWO: 46.9;BJ hTERT+: 46.2;HHSteC: 58.7;RT4: 58.1;TIME: 58.0;U-138 MG: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031200, HPA069697" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031200: AB_2673785, HPA069697: AB_2732139" "unprognostic (1.74e-1)" "unprognostic (9.47e-2)" "unprognostic (1.29e-2)" "unprognostic (2.74e-1)" "unprognostic (5.25e-2)" "unprognostic (1.75e-1)" "unprognostic (2.22e-2)" "unprognostic (8.67e-2)" "unprognostic (6.00e-2)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.29e-2)" "prognostic favorable (2.63e-4)" "unprognostic (6.66e-3)" "unprognostic (7.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-1)" 71.2 14.2 12.5 17.1 15.7 0.8 101.7 5.3 13.9 24.9 20.9 8.9 11.3 12.0 28.8 13.0 21.6 24.8 35.2 40.0 12.8 11.0 35.2 31.2 200.8 27.2 14.3 11.1 20.2 15.5 18.1 9.4 119.6 18.4 20.7 11.5 41.2 13.3 18.7 25.2 13.0 15.6 19.2 12.5 20.5 12.8 13.8 8.0 1.1 43.8 15.2 10.3 32.2 39.3 0.0 0.0 14.9 0.1 0.7 0.1 0.1 5.3 5.7 0.3 0.4 27.6 17.8 46.9 16.9 46.2 9.7 10.6 1.0 0.9 0.0 4.2 32.2 9.7 2.6 0.1 13.5 7.3 0.1 0.2 0.0 1.8 12.0 58.7 0.0 3.4 26.0 18.7 19.0 13.4 7.2 33.4 0.1 0.5 0.0 5.9 4.6 0.1 0.1 0.2 3.7 3.2 0.1 0.6 1.7 6.0 58.1 0.2 12.0 13.3 30.6 3.6 12.5 2.0 2.3 58.0 50.4 1.4 6.7 1.4 0.0 0.0 0.0 36.7 0.9 1.2 14.9 0.1 7.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 12.5 15.7 5.3 12.6 12.8 11.0 14.3 11.1 18.4 8.0 71.5 137.9 8.1 61.5 42.7 3.5 58.5 50.9 30.8 96.7 3.5 9.8 93.6 1.7 15.5 12.6 341.0 66.4 0.0 45.9 256.0 104.5 46.7 40.4 77.4 47.9 0.0 4.1 438.9 58.4 41.8 11.5 23.9 27.0 0.0 13.6 89.1 25.9 40.4 6.0 24.0 57.7 278.1 281.4 1.2 1.7 29.1 292.5 9.6 11.6 58.0 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 11 "cerebellum: 375.3" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes No 3400000 "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favorable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 9.2 9.6 3.3 19.4 10.2 28.0 9.6 59.7 11.6 8.2 12.4 2.0 9.8 9.3 10.5 5.7 10.8 5.5 7.9 7.5 3.3 4.8 10.0 13.2 11.0 25.4 3.9 3.0 12.3 10.4 9.1 9.0 8.7 10.3 8.3 12.5 14.6 10.1 10.8 15.0 8.9 14.6 9.2 5.8 13.5 14.0 7.9 6.9 42.2 8.1 8.8 19.8 11.3 12.4 9.9 3.0 30.1 2.1 5.7 15.9 7.7 7.4 1.8 18.6 8.8 1.5 0.2 6.2 1.9 2.8 2.3 2.9 4.9 9.0 13.8 5.0 2.5 3.8 3.4 23.2 1.8 2.5 24.8 7.1 39.5 5.6 8.0 2.9 13.4 26.4 0.5 5.4 2.2 4.0 5.7 4.1 22.1 37.2 11.0 0.0 2.5 21.7 8.8 19.5 12.3 2.9 33.4 8.2 19.8 2.2 9.5 25.1 18.6 5.8 5.5 12.6 6.6 4.2 5.2 0.4 0.1 3.9 3.6 3.8 16.5 21.4 24.7 3.5 13.8 2.1 17.2 2.1 12.6 8.5 0.7 9.6 9.9 12.4 9.3 2.4 9.3 14.8 8.9 30.1 5.7 0.8 3.0 15.9 7.7 3.3 10.2 59.7 11.6 3.3 4.8 3.9 3.0 10.3 6.9 17.9 64.9 30.6 6.3 9.3 105.3 20.1 30.6 22.7 21.6 15.7 129.6 2.3 14.9 15.8 13.9 14.5 25.2 116.8 16.1 3.2 3.3 11.2 23.1 28.8 6.5 20.6 40.0 20.3 22.1 13.3 2.0 11.5 0.0 11.8 25.9 13.2 25.6 22.4 2.1 10.5 166.4 12.9 4.7 8.6 53.0 14.6 3.4 42.8 28.3 11.5 EPB41L4B EHM2 ENSG00000095203 "Erythrocyte membrane protein band 4.1 like 4B" Q9H329 9 109171975-109320964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.1;pancreas: 59.8" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 67.5;Hepatocytes: 107.1;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 52.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 16.0;hTCEpi: 25.1;OE19: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042862 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042862: AB_10794534" "prognostic unfavorable (1.02e-4)" "unprognostic (6.58e-2)" "unprognostic (2.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" "unprognostic (6.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-1)" "unprognostic (6.20e-2)" "unprognostic (8.82e-4)" "unprognostic (1.46e-3)" "unprognostic (1.43e-1)" "unprognostic (4.65e-2)" "unprognostic (1.29e-1)" 6.5 4.2 7.3 1.2 14.6 0.0 4.8 4.9 11.4 1.1 18.4 1.5 7.1 15.1 0.7 5.9 0.7 3.2 1.8 3.5 2.9 3.5 1.9 28.1 1.7 0.2 1.6 6.8 4.7 59.8 3.3 0.9 1.1 2.7 2.2 18.7 2.4 8.0 3.5 2.2 5.6 16.1 0.3 2.2 0.2 9.4 2.7 1.3 0.4 14.6 1.3 1.2 1.2 1.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 4.2 5.3 0.3 0.4 0.4 0.0 16.0 0.5 0.2 1.8 0.9 9.0 4.2 0.0 1.1 0.5 4.5 6.9 10.6 5.6 2.0 4.4 2.5 0.0 1.7 12.8 1.1 0.2 0.0 0.1 25.1 0.7 8.6 0.5 0.1 3.9 0.1 0.0 2.6 10.7 0.1 0.1 6.9 30.4 7.8 0.0 0.0 0.2 6.4 6.4 6.6 0.7 1.7 11.1 0.0 3.3 2.6 0.0 0.2 3.8 3.9 1.2 1.5 0.0 0.0 0.0 2.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 14.6 4.9 11.4 2.9 3.5 1.6 6.8 2.7 1.3 6.0 3.2 0.8 4.6 10.2 8.3 14.9 22.9 16.0 5.7 7.0 0.0 3.3 0.0 3.2 8.7 0.7 67.5 0.0 18.0 1.6 2.2 9.9 0.0 107.1 0.5 36.5 49.7 4.3 1.6 1.5 12.4 0.2 1.7 0.0 52.8 1.8 12.8 37.4 2.5 0.6 1.0 0.0 0.4 1.4 14.8 21.0 1.6 0.0 34.5 5.7 EPB42 "MGC116735, MGC116737, PA" ENSG00000166947 "Erythrocyte membrane protein band 4.2" P16452 15 43197227-43221125 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape, Erythrocyte maturation" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 54.8;placenta: 16.1" "Cell type enriched" "Detected in many" 15 "Erythroid cells: 186.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 92 "HEL: 43.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040261 Supported Uncertain Nucleoplasm,Cytosol NA NA 7500000 "Nucleoplasm, Cytosol" "HPA040261: AB_10673441" "unprognostic (8.45e-2)" "unprognostic (4.66e-1)" "unprognostic (4.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.99e-1)" "unprognostic (1.54e-1)" "unprognostic (1.59e-3)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" "unprognostic (5.27e-3)" "unprognostic (1.31e-1)" "unprognostic (1.48e-5)" "unprognostic (1.70e-2)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (3.47e-3)" 7.5 0.4 0.4 0.4 0.9 54.8 1.3 4.3 1.0 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.5 0.6 1.9 0.4 0.9 0.5 0.9 5.5 0.3 0.5 0.3 0.8 0.3 0.3 0.3 16.1 0.7 0.5 0.3 0.3 0.3 0.3 1.3 1.1 1.0 0.3 0.3 5.3 0.5 2.4 0.3 0.5 1.2 0.3 0.5 1.6 4.5 0.0 0.3 0.2 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 4.2 0.4 0.9 4.3 1.0 0.4 0.9 0.5 0.3 0.7 0.3 0.0 0.0 0.5 1.2 1.6 3.7 0.3 2.5 0.0 0.0 0.0 5.9 3.3 0.0 0.0 7.7 0.6 1.1 186.9 0.0 1.9 1.7 1.0 4.6 0.5 1.0 6.4 0.0 1.3 0.3 8.0 2.6 0.8 1.7 0.0 0.8 2.8 0.0 1.7 0.7 0.0 7.8 6.5 1.2 12.1 3.8 2.5 5.6 4.4 0.6 1.6 EPGN "ALGV3072, EPG, epigen, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308473-74315307 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.3;esophagus: 39.6;tongue: 25.7" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 3.2;Basal keratinocytes: 5.4;Early spermatids: 1.7;Late spermatids: 2.2;Melanocytes: 1.7;Urothelial cells: 2.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "hTCEpi: 62.6;U-2197: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.40e-4)" 1.1 0.0 0.0 1.3 0.0 0.1 1.0 0.0 0.0 7.9 0.3 0.0 1.0 0.0 0.0 14.3 39.6 1.2 0.3 0.6 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.7 0.0 0.3 0.0 0.0 2.5 2.8 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 25.7 5.4 0.6 6.5 0.4 0.1 0.0 0.6 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.1 1.2 0.0 1.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.1 0.0 62.6 1.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.3 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 2.2 EPHA3 "ETK, ETK1, HEK, HEK4, TYRO4" ENSG00000044524 "EPH receptor A3" P29320 3 89107524-89482134 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 39.0" "Group enriched" "Detected in some" 5 "Fibroblasts: 12.2;Horizontal cells: 19.1;Peritubular cells: 7.8;Rod photoreceptor cells: 16.9;Sertoli cells: 6.5;Smooth muscle cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 66.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010462, HPA069390" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane, Plasma membrane, Cytosol" "Nucleoplasm, Actin filaments" "CAB010462: AB_2099218, HPA069390: " "unprognostic (1.48e-3)" "unprognostic (2.30e-2)" "unprognostic (4.95e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (1.47e-2)" "unprognostic (2.03e-1)" "unprognostic (9.10e-3)" "unprognostic (1.24e-3)" "unprognostic (7.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (3.63e-2)" "unprognostic (1.88e-2)" "unprognostic (4.05e-2)" "unprognostic (1.20e-2)" 9.7 1.1 2.3 1.7 4.5 0.2 5.1 1.3 8.7 12.3 5.8 0.6 1.4 2.2 13.9 1.3 6.3 2.6 17.2 10.0 2.2 2.5 1.5 4.4 2.7 3.0 2.5 3.4 4.2 2.8 1.2 3.4 17.5 11.9 39.0 5.9 5.4 3.8 6.8 1.7 1.7 3.5 17.3 2.9 1.2 3.7 1.3 2.0 0.0 16.3 6.0 3.0 11.8 12.2 0.3 0.1 0.5 0.1 0.3 0.2 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.8 0.0 0.0 4.1 0.0 0.0 0.6 0.7 0.0 1.3 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.8 0.0 0.0 0.0 0.6 0.0 0.5 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 2.3 4.5 1.3 8.7 2.2 2.5 2.5 3.4 11.9 2.0 0.0 0.0 0.0 0.3 0.5 1.5 2.1 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 1.3 1.1 0.0 0.0 0.0 0.1 12.2 0.1 0.0 0.0 0.1 19.1 0.0 0.6 0.0 1.3 2.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 7.8 0.0 16.9 6.5 20.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 EPHB1 "EPHT2, Hek6" ENSG00000154928 "EPH receptor B1" P54762 3 134597801-135260467 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 74.7" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 9.8;Early spermatids: 30.2;Late spermatids: 26.8;Muller glia cells: 16.2" "Cancer enriched" "Detected in many" 6 "glioma: 7.0" "Region enhanced" "Detected in all" "cerebellum: 74.7" "Group enriched" "Detected in some" 33 "neutrophil: 15.9;plasmacytoid DC: 15.4" "Group enriched" "Detected in many" 33 "dendritic cells: 15.4;granulocytes: 15.9" "Group enriched" "Detected in some" 4 "HDLM-2: 34.7;HMC-1: 20.6;RPTEC TERT1: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067740 Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA067740: AB_2685895" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.52e-1)" "unprognostic (1.41e-6)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-2)" "unprognostic (1.78e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-4)" 2.0 1.5 9.0 1.8 16.6 1.5 5.5 74.7 23.6 3.6 3.4 3.4 3.1 2.8 4.1 2.0 3.8 2.8 3.3 1.1 9.4 5.3 2.3 2.9 1.0 3.3 2.8 7.0 1.7 1.1 0.6 3.8 0.9 7.1 3.3 1.4 1.9 3.9 5.1 7.4 6.0 1.7 1.7 6.0 3.4 1.3 16.7 6.0 0.0 11.6 2.9 3.3 4.5 2.6 0.0 15.4 15.9 0.0 0.0 0.4 0.1 0.0 0.0 4.8 0.0 0.1 0.0 0.1 3.6 0.0 0.2 0.0 0.0 0.0 0.6 1.0 1.9 0.3 0.0 3.2 0.0 0.7 34.7 0.4 2.6 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.2 2.6 0.1 0.1 0.1 1.4 0.6 0.0 0.0 0.5 0.1 9.4 0.0 0.6 0.1 0.0 0.0 0.0 0.7 0.1 0.4 0.2 0.6 2.0 0.3 4.3 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 15.4 0.0 0.1 9.0 16.6 74.7 19.0 9.4 5.3 2.8 7.0 7.1 6.0 0.0 0.0 0.9 0.0 3.3 1.2 1.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.8 30.2 0.6 0.0 0.0 0.3 0.0 0.2 0.1 0.0 5.8 0.4 0.0 0.0 0.0 0.0 26.8 0.6 0.0 1.7 0.0 0.0 16.2 0.6 0.0 0.0 0.0 0.9 0.0 0.8 0.4 0.9 5.1 0.0 0.0 0.0 0.1 EPHX2 ENSG00000120915 "Epoxide hydrolase 2" P34913 8 27490779-27545564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism" "Hydrolase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.9;liver: 87.6" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 152.5;Proximal tubular cells: 198.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 39.2" "Lineage enriched" "Detected in many" 24 "T-cells: 39.2" "Group enriched" "Detected in many" 4 "JURKAT: 50.5;K-562: 17.8;OE19: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023094, HPA023660" Enhanced Enhanced Cytosol NA NA 720000 Cytosol "HPA023094: AB_1848214, HPA023660: AB_1848215" "unprognostic (1.30e-1)" "prognostic favorable (2.45e-4)" "unprognostic (2.99e-2)" "unprognostic (3.62e-2)" "unprognostic (1.76e-2)" "unprognostic (3.30e-3)" "unprognostic (1.26e-3)" "unprognostic (3.31e-3)" "unprognostic (1.46e-1)" "unprognostic (3.55e-2)" "unprognostic (4.14e-3)" "unprognostic (1.98e-1)" "prognostic favorable (1.98e-10)" "unprognostic (9.82e-2)" "unprognostic (1.73e-1)" "unprognostic (8.12e-2)" "unprognostic (2.26e-1)" 4.8 25.1 4.8 14.3 6.0 0.4 8.3 5.6 3.3 7.6 56.2 6.1 21.8 29.8 10.3 15.1 15.2 11.3 9.4 7.8 4.1 4.8 44.2 87.6 4.6 5.0 5.8 3.2 11.4 25.3 11.6 14.6 2.9 10.5 17.9 15.6 13.3 18.0 22.7 8.5 11.5 83.9 13.1 4.5 3.5 6.7 5.4 3.9 45.7 7.5 13.2 11.7 7.0 7.4 1.6 0.0 0.0 0.0 1.4 39.2 7.6 5.3 3.6 2.3 2.9 0.1 0.0 1.7 0.4 0.3 0.2 0.0 2.8 3.6 0.0 2.1 1.3 1.2 3.8 0.4 0.9 0.1 0.0 1.7 7.9 0.4 8.7 1.3 0.0 1.6 3.2 3.9 0.0 0.4 0.9 0.1 50.5 17.8 0.0 0.0 1.6 5.1 0.2 3.7 36.3 6.2 0.0 0.0 0.1 3.2 0.8 1.9 5.9 4.3 5.2 5.2 1.8 7.9 1.5 0.0 0.0 1.4 0.6 0.0 4.6 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 4.0 1.6 12.5 4.5 0.0 0.9 39.2 18.0 0.0 1.4 0.0 0.0 9.4 7.6 4.8 6.0 5.6 3.3 4.1 4.8 5.8 3.2 10.5 3.9 6.0 13.4 4.7 14.5 10.5 33.3 21.0 15.3 24.1 10.3 26.2 74.6 18.1 152.5 4.7 6.3 6.0 93.2 0.0 5.7 2.6 7.2 27.0 5.7 98.6 1.8 31.8 22.4 10.4 3.5 2.4 27.6 0.8 5.0 2.8 54.7 84.9 4.3 74.7 17.7 198.6 56.3 0.0 12.0 1.5 7.0 15.9 6.9 5.7 88.0 6.7 EPN1 ENSG00000063245 "Epsin 1" Q9Y6I3 19 55675226-55709858 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 273.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 71.6" "Low region specificity" "Detected in all" "CAB009729, HPA061136, HPA071503" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: " "unprognostic (6.93e-2)" "unprognostic (2.47e-1)" "unprognostic (5.30e-2)" "unprognostic (1.32e-1)" "unprognostic (7.94e-2)" "unprognostic (8.76e-2)" "unprognostic (1.23e-2)" "unprognostic (7.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.28e-1)" "unprognostic (6.16e-2)" "unprognostic (4.63e-2)" "unprognostic (1.05e-2)" "unprognostic (3.86e-3)" "unprognostic (1.57e-1)" "unprognostic (2.78e-3)" "unprognostic (7.92e-3)" 26.7 23.4 34.2 20.6 31.4 15.7 31.4 26.3 47.1 13.5 32.7 17.2 18.1 67.7 13.7 19.8 21.3 15.4 28.2 56.0 28.0 18.6 23.1 36.0 16.5 25.5 17.5 25.9 23.2 54.5 12.1 14.3 15.0 15.8 19.3 13.8 13.5 24.8 22.7 84.7 22.2 59.7 12.2 14.3 26.9 55.1 20.2 13.1 11.2 15.3 26.3 14.6 13.1 16.2 2.2 3.6 4.6 6.9 0.7 2.0 2.4 25.0 34.6 8.6 17.7 10.0 9.6 17.8 18.7 10.7 13.3 13.4 14.4 15.9 15.4 12.8 14.9 11.8 19.2 7.5 14.3 4.8 5.3 71.6 11.3 18.5 17.1 13.8 7.2 10.8 12.4 12.6 11.5 8.3 9.6 12.7 11.1 16.8 13.1 8.7 14.1 11.5 11.9 19.8 18.9 49.0 7.8 11.8 27.0 10.1 14.8 12.5 30.4 17.3 18.8 12.3 6.3 14.1 25.4 21.1 37.1 17.9 13.3 26.9 14.4 13.1 11.0 27.3 14.6 18.3 2.4 3.5 4.4 1.4 4.5 1.0 2.2 1.4 1.3 2.4 2.0 1.4 1.3 4.6 0.7 6.9 3.6 2.0 2.4 34.2 31.4 26.3 47.1 28.0 18.6 17.5 25.9 15.8 13.1 3.0 27.3 32.6 23.9 27.8 31.1 12.9 50.9 10.7 7.9 41.8 62.8 40.3 101.2 45.0 50.6 29.6 273.7 0.0 77.2 65.9 30.7 31.5 10.4 95.7 53.6 27.0 43.3 78.0 103.2 121.6 44.0 36.6 21.9 23.4 108.9 27.8 78.4 136.8 49.8 53.1 37.3 12.9 21.7 45.0 57.1 24.0 43.7 21.8 112.6 32.8 EPOP "C17orf96, LOC100170841, PRR28" ENSG00000273604 "Elongin BC and polycomb repressive complex 2 associated protein" A6NHQ4 17 38671703-38675421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5" "Cell type enhanced" "Detected in some" 17 "Ductal cells: 3.3;Exocrine glandular cells: 3.4;monocytes: 4.6;Pancreatic endocrine cells: 3.5;Syncytiotrophoblasts: 11.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 8 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 16.1;Hep G2: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055190, HPA056555" Enhanced Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA055190: AB_2682731, HPA056555: AB_2683172" "unprognostic (9.08e-2)" "unprognostic (3.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.75e-3)" "unprognostic (1.83e-1)" "unprognostic (1.84e-2)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (2.17e-2)" "unprognostic (2.63e-2)" "unprognostic (1.78e-10)" "unprognostic (8.97e-2)" "unprognostic (2.51e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" 1.2 2.0 2.5 1.5 5.1 0.4 1.1 0.0 13.5 0.3 0.2 0.0 2.5 0.2 0.7 0.7 0.7 0.4 0.8 0.4 1.1 0.3 3.4 0.4 2.4 0.3 3.2 0.1 3.6 3.0 0.0 1.2 0.4 0.7 0.3 0.2 0.5 1.2 0.1 1.0 0.2 0.5 0.8 0.6 0.5 5.8 0.8 1.7 0.1 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 2.9 3.5 2.3 16.1 0.5 0.1 3.9 0.6 0.2 0.7 1.1 3.5 1.1 5.6 3.9 0.4 2.0 2.4 7.5 1.5 1.2 5.8 5.7 1.2 0.6 18.4 1.0 0.6 3.0 0.3 2.6 0.7 1.5 1.5 0.5 6.3 3.8 8.7 0.4 4.7 5.0 1.6 0.5 1.9 3.2 12.0 1.3 12.2 0.4 0.7 3.5 5.4 1.9 2.6 0.6 3.9 3.8 2.3 0.8 0.6 0.7 0.7 0.6 4.6 5.0 7.1 1.3 8.3 2.3 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.8 0.0 1.4 0.0 3.3 0.0 0.0 0.0 0.0 3.4 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 3.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 EPRS "EARS, GLUPRORS, PARS, QARS, QPRS" ENSG00000136628 "Glutamyl-prolyl-tRNA synthetase" P07814 1 219968601-220046658 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding" "Disease mutation, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026490, HPA030052" Enhanced Enhanced Cytosol NA NA 29000 Cytosol "HPA026490: AB_1855979, HPA030052: AB_10601466" "prognostic unfavorable (7.25e-4)" "unprognostic (1.19e-2)" "unprognostic (3.94e-2)" "unprognostic (2.60e-2)" "unprognostic (7.98e-3)" "unprognostic (1.12e-2)" "unprognostic (3.41e-3)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.30e-1)" "unprognostic (7.13e-2)" "unprognostic (5.12e-2)" "unprognostic (2.32e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.62e-4)" 25.0 20.4 16.8 18.6 22.2 13.2 20.6 24.2 26.3 19.3 20.4 15.4 13.6 15.8 17.8 15.3 25.2 15.9 11.9 20.1 15.9 18.0 23.3 31.6 17.4 20.8 21.7 16.1 21.3 32.7 47.1 38.6 15.7 34.9 14.3 23.2 9.4 64.0 16.3 42.9 19.6 23.3 18.9 24.7 22.3 20.1 13.2 20.8 28.0 25.1 25.7 23.4 18.3 16.3 14.7 15.4 6.4 16.6 14.2 19.8 10.7 30.1 19.2 13.9 38.0 29.6 32.9 34.9 39.5 27.7 25.7 28.9 22.7 24.4 57.9 22.0 41.6 10.4 32.3 34.9 31.8 34.6 28.3 22.2 31.5 25.9 19.4 32.4 52.2 27.0 23.7 40.9 32.8 41.1 21.5 28.1 28.0 54.1 45.7 25.1 14.9 22.4 12.7 26.9 35.7 39.8 23.8 24.6 56.6 23.5 13.3 33.1 26.0 23.1 38.3 40.3 20.8 35.4 57.1 24.9 12.3 22.7 37.6 36.7 31.0 35.2 49.0 28.3 37.6 38.8 4.2 11.9 6.4 14.0 16.6 19.8 14.7 14.1 15.6 15.4 11.5 15.9 16.3 0.4 14.2 13.7 5.0 13.5 10.7 16.8 22.2 24.2 26.3 15.9 18.0 21.7 16.1 34.9 20.8 65.5 52.5 37.9 33.6 17.6 45.2 67.4 15.3 69.6 69.4 29.6 62.8 36.3 18.3 58.3 19.1 33.8 24.4 23.3 87.1 48.7 27.0 24.9 47.4 18.8 38.0 39.7 29.4 22.1 23.8 7.4 43.7 27.7 20.3 53.3 32.2 45.5 61.8 14.4 44.6 21.4 47.0 38.8 27.8 57.6 34.9 17.8 30.6 29.8 41.8 29.3 EPS15 "AF-1P, MLLT5" ENSG00000085832 "Epidermal growth factor receptor pathway substrate 15" P42566 1 51354263-51519328 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Host-virus interaction, Protein transport, Transport" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008451, CAB010164, HPA061431" Approved Enhanced Vesicles,Cytosol "Intracellular and membrane" NA NA 67000 "Vesicles, Cytosol" "CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: AB_2732662" "unprognostic (1.45e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (1.05e-2)" "unprognostic (7.72e-3)" "unprognostic (3.99e-1)" "unprognostic (1.42e-1)" "unprognostic (4.96e-3)" "unprognostic (9.26e-2)" "unprognostic (4.13e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.41e-1)" "unprognostic (5.36e-2)" "unprognostic (8.73e-3)" "unprognostic (2.13e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" 39.0 26.9 35.5 25.3 27.8 13.2 19.3 22.2 41.0 25.7 16.7 35.7 16.2 11.4 21.8 21.3 19.6 14.1 19.3 18.9 40.7 26.0 21.0 19.1 24.4 30.7 36.2 11.2 22.4 10.9 17.0 14.6 22.8 20.3 22.5 15.5 25.7 24.3 16.4 30.9 18.1 19.3 18.2 36.8 33.8 15.2 32.4 33.1 25.0 20.3 23.4 32.1 25.3 17.0 16.1 10.8 14.9 12.2 10.7 18.7 8.0 14.8 4.4 9.6 9.0 22.3 22.3 24.0 10.4 16.4 8.5 12.6 6.1 8.3 30.3 10.7 16.2 17.4 14.1 12.4 9.9 12.9 34.2 7.8 26.9 7.6 7.2 21.0 15.3 24.9 18.1 9.2 14.9 20.3 14.8 15.8 10.8 16.7 13.8 12.9 7.3 12.3 8.3 13.2 10.4 7.2 10.1 14.6 6.6 11.2 18.4 6.6 9.2 12.3 22.0 17.9 27.7 8.9 10.9 21.9 7.9 8.6 15.9 8.6 16.5 16.7 20.4 11.8 17.4 7.0 14.9 10.1 11.6 10.1 10.7 15.3 16.1 12.2 15.6 10.8 10.0 7.3 10.5 7.8 10.7 12.2 7.1 18.7 8.0 35.5 27.8 22.2 41.0 40.7 26.0 36.2 11.2 20.3 33.1 32.8 43.7 52.2 25.1 38.1 16.1 53.7 20.4 26.8 21.6 41.8 29.5 17.7 16.6 12.4 21.7 42.7 20.1 0.0 16.4 15.6 33.6 48.2 23.2 33.7 65.6 27.0 27.6 74.9 76.1 45.1 60.9 39.3 97.8 33.3 31.1 41.6 19.4 24.1 45.3 22.7 26.0 38.8 31.5 70.5 36.4 44.5 23.8 47.5 19.5 42.3 EPS8L1 "DRC3, FLJ20258, MGC23164, MGC4642" ENSG00000131037 "EPS8 like 1" Q8TE68 19 55072020-55087923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.9;placenta: 45.0" "Group enriched" "Detected in many" 4 "Syncytiotrophoblasts: 357.9;Urothelial cells: 188.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.3;BEWO: 32.6;SK-BR-3: 10.0;T-47d: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041851, HPA043545" Uncertain Supported Cytosol NA NA Cytosol "HPA041851: AB_2677706, HPA043545: AB_2678544" "unprognostic (1.91e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (7.18e-2)" "unprognostic (9.33e-2)" "unprognostic (2.54e-2)" "unprognostic (4.61e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.43e-2)" "unprognostic (5.84e-3)" "unprognostic (2.65e-2)" "unprognostic (3.85e-3)" "unprognostic (5.04e-3)" "unprognostic (3.02e-1)" "unprognostic (5.41e-3)" "unprognostic (2.63e-1)" 1.2 0.0 0.2 2.1 0.3 0.0 1.7 0.3 0.4 7.6 2.1 0.2 1.5 2.0 1.3 1.8 40.9 6.2 6.9 0.2 0.2 0.0 4.1 0.2 1.8 0.2 0.2 0.2 1.6 4.0 1.1 1.1 45.0 0.3 2.9 0.5 0.3 6.6 2.5 0.4 18.7 1.5 0.7 0.2 0.4 23.2 0.9 0.2 1.0 6.2 12.1 16.9 1.9 12.1 0.1 3.5 5.1 0.4 1.7 0.8 0.5 9.3 0.4 0.3 0.2 0.0 0.0 32.6 0.9 0.0 0.0 0.0 2.9 7.7 0.1 1.9 0.0 0.0 4.7 0.2 0.5 0.0 0.2 0.9 0.7 0.3 0.2 0.1 1.5 6.5 0.0 1.5 0.0 0.0 0.0 0.0 0.7 3.5 0.0 0.0 4.3 0.5 1.5 0.5 4.8 0.0 0.1 0.0 3.1 0.7 0.7 0.1 2.3 0.6 10.0 0.4 0.3 15.8 1.8 0.7 0.0 0.4 0.0 0.0 1.4 1.7 0.9 2.0 0.5 1.2 2.6 0.4 5.1 0.8 0.1 0.7 0.0 0.4 0.8 0.0 0.1 0.1 0.0 0.0 1.7 0.0 3.5 0.7 0.5 0.2 0.3 0.3 0.4 0.2 0.0 0.2 0.2 0.3 0.2 8.9 6.7 0.9 18.5 1.8 0.0 2.0 5.1 5.3 11.4 29.6 0.0 28.7 11.6 18.5 1.3 3.8 22.2 0.0 9.1 18.2 2.6 37.2 10.3 0.0 7.9 0.0 2.9 8.0 1.2 3.6 1.1 2.6 20.3 8.2 28.9 0.2 62.1 35.1 0.7 0.8 0.0 25.8 14.1 0.6 2.6 3.4 357.9 2.5 9.9 188.1 EPS8L2 "FLJ21935, FLJ22171, MGC3088" ENSG00000177106 "EPS8 like 2" Q9H6S3 11 694438-727727 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 73.3" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 131.0;Enterocytes: 200.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 8 "dendritic cells: 6.4" "Cell line enhanced" "Detected in many" "A-431: 46.7;BEWO: 46.2;CAPAN-2: 44.0;SK-BR-3: 54.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 13.6" HPA041143 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041143: AB_10794985" "unprognostic (1.39e-2)" "unprognostic (1.07e-1)" "unprognostic (7.58e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (6.87e-2)" "unprognostic (3.27e-2)" "unprognostic (1.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.92e-1)" "unprognostic (3.25e-2)" "unprognostic (2.51e-2)" "unprognostic (4.19e-1)" "unprognostic (2.79e-1)" "unprognostic (5.03e-2)" 1.7 3.0 2.0 6.4 3.3 0.0 12.4 6.9 2.5 11.6 31.5 1.2 23.9 38.7 4.6 10.1 53.3 5.3 21.7 1.0 1.3 1.6 30.4 38.3 18.0 0.4 1.7 0.5 3.9 11.6 1.8 4.3 39.6 3.6 8.4 6.0 2.7 26.2 17.6 0.7 22.8 73.3 2.4 2.4 0.5 18.0 7.2 1.5 0.9 29.5 29.4 33.7 6.9 19.2 0.2 6.4 0.7 0.1 0.1 0.1 0.1 46.7 14.3 0.0 0.3 0.5 3.2 46.2 4.1 4.2 6.1 2.6 10.7 44.0 0.1 17.1 4.3 1.1 24.8 0.1 24.8 1.4 0.1 0.9 0.0 5.3 19.2 3.5 0.0 0.0 1.7 16.6 1.8 4.3 2.5 0.0 0.0 0.3 0.2 0.7 15.0 0.1 0.2 0.5 14.6 4.6 0.1 0.1 0.3 21.7 11.7 0.1 0.1 14.6 54.0 0.1 3.2 20.4 0.0 0.3 2.5 5.8 1.5 0.3 0.1 0.2 0.1 1.3 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 6.4 0.0 0.1 2.0 3.3 6.9 2.5 1.3 1.6 1.7 0.5 3.6 1.5 131.0 60.0 7.3 23.9 17.5 0.8 3.6 53.5 33.5 51.2 85.5 0.0 43.8 23.2 45.5 1.0 3.0 200.0 0.0 70.5 25.8 7.1 28.6 6.9 55.5 4.3 0.0 42.1 0.6 1.3 1.7 16.7 3.2 13.5 3.6 61.8 8.9 66.1 98.2 11.0 84.7 0.7 0.0 5.1 0.7 4.1 21.3 77.3 21.0 62.0 26.8 ERAL1 HERA-B ENSG00000132591 "Era like 12S mitochondrial rRNA chaperone 1" O75616 17 28854938-28861067 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "monocytes: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021425, HPA024423" Supported Enhanced Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA021425: AB_1848228, HPA024423: AB_1848229" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (5.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.55e-1)" "unprognostic (8.37e-3)" "prognostic unfavorable (3.59e-4)" "unprognostic (8.20e-2)" "unprognostic (7.04e-2)" "unprognostic (2.70e-1)" "unprognostic (8.57e-3)" "unprognostic (5.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.49e-1)" "unprognostic (2.62e-1)" "unprognostic (5.79e-2)" 16.2 24.8 24.1 13.3 31.6 12.7 19.4 25.1 47.9 18.4 20.9 27.1 15.8 18.0 21.5 19.2 20.6 22.2 17.2 24.5 23.0 22.0 24.9 33.7 14.8 16.0 21.3 20.2 22.0 18.1 29.3 15.4 24.7 27.6 18.0 23.4 17.3 28.2 21.2 34.1 18.3 19.7 21.8 18.4 17.0 18.2 17.3 15.5 20.4 20.3 21.5 23.8 16.1 14.8 20.1 29.0 11.1 23.1 20.8 18.2 14.9 16.2 31.5 18.4 20.9 20.4 14.0 18.0 12.9 18.6 39.4 32.4 30.7 10.5 20.8 15.8 22.3 29.8 18.0 33.7 29.5 32.9 20.6 39.5 16.8 21.0 31.0 26.1 19.9 15.3 18.2 26.4 31.9 30.3 15.5 32.1 26.5 33.3 13.2 21.9 25.4 20.7 30.7 17.0 29.8 15.1 19.1 29.3 26.9 23.8 18.5 19.6 15.8 21.2 52.1 16.7 28.6 36.7 23.4 12.9 16.1 18.1 17.7 27.3 10.6 19.3 22.3 17.5 17.4 16.3 11.1 17.9 7.1 17.8 23.1 13.4 20.1 15.2 13.0 29.0 18.6 17.6 18.2 1.4 20.8 15.6 15.0 16.3 14.9 24.1 31.6 25.1 47.9 23.0 22.0 21.3 20.2 27.6 15.5 6.0 3.2 11.5 12.7 7.1 9.6 6.0 22.9 5.3 3.4 10.4 5.9 59.5 31.5 26.1 1.1 10.9 16.0 23.3 18.8 44.1 11.4 11.1 4.7 20.3 31.0 11.1 20.7 9.8 8.2 3.6 13.3 8.0 10.1 110.0 12.7 14.5 17.0 10.5 14.9 25.0 6.5 19.4 9.5 18.9 22.2 10.2 43.3 10.9 25.2 8.4 ERAP1 "A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP" ENSG00000164307 "Endoplasmic reticulum aminopeptidase 1" Q9NZ08 5 96760810-96808100 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025095, HPA042317" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 27000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB025095: , HPA042317: AB_2677946" "unprognostic (2.33e-3)" "unprognostic (3.45e-1)" "unprognostic (1.84e-3)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.38e-1)" "unprognostic (1.88e-3)" "unprognostic (5.37e-2)" "unprognostic (1.45e-1)" "unprognostic (7.94e-2)" "unprognostic (4.52e-2)" "unprognostic (3.23e-1)" "unprognostic (7.09e-2)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (5.14e-2)" 23.8 13.6 9.3 22.7 11.9 11.6 23.3 14.2 14.6 14.5 23.8 10.1 11.2 30.8 14.7 13.4 12.3 14.3 19.9 16.1 9.7 6.8 13.3 23.7 17.8 16.4 13.5 7.6 15.5 16.5 11.1 39.4 28.2 11.4 13.4 21.9 8.5 13.9 15.2 23.1 17.7 39.7 10.6 17.1 19.5 16.5 5.4 13.8 55.5 13.5 9.8 17.8 15.9 14.1 14.9 15.2 19.8 17.5 19.8 21.8 10.7 7.4 4.7 6.4 6.0 35.4 34.7 18.6 5.5 17.7 13.3 23.3 5.9 27.0 22.3 11.5 10.6 18.7 7.6 5.3 11.2 8.3 40.2 2.2 7.2 3.2 4.0 40.6 3.4 13.4 14.4 4.9 15.2 4.7 19.6 18.2 14.5 3.7 21.6 7.9 3.5 32.0 3.6 3.2 0.9 3.1 23.8 8.7 11.1 9.9 11.5 2.4 1.6 8.7 5.9 8.5 4.6 5.1 16.6 14.5 11.4 3.9 1.9 9.0 8.1 15.1 17.3 12.2 11.8 6.7 19.8 13.2 15.6 21.2 11.4 19.7 13.0 18.5 18.2 9.5 14.9 21.8 17.4 14.4 19.8 17.5 15.2 12.3 10.7 9.3 11.9 14.2 14.6 9.7 6.8 13.5 7.6 11.4 13.8 8.9 12.3 13.7 12.1 22.1 11.6 8.5 10.2 22.7 14.8 8.7 2.0 8.0 0.0 10.8 20.0 11.3 25.8 0.0 13.4 9.1 16.1 9.2 14.0 27.0 16.2 3.2 9.9 18.4 31.2 5.2 9.2 18.5 6.8 21.6 25.9 9.7 11.2 17.5 15.2 5.0 7.2 0.0 9.5 1.2 0.7 9.7 7.7 20.0 19.1 12.2 ERBB2 "CD340, HER-2, HER2, NEU, NGL" ENSG00000141736 "Erb-b2 receptor tyrosine kinase 2" P04626 17 39687914-39730426 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 129.1;Enterocytes: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 8.8" "Lineage enriched" "Detected in many" 4 "T-cells: 8.8" "Group enriched" "Detected in many" 41 "OE19: 366.2;SK-BR-3: 179.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 430000 "Plasma membrane" Cytosol "CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500" "unprognostic (1.97e-1)" "unprognostic (6.60e-3)" "unprognostic (6.21e-2)" "prognostic unfavorable (8.99e-8)" "unprognostic (2.96e-2)" "unprognostic (1.40e-2)" "unprognostic (1.97e-2)" "unprognostic (9.04e-2)" "unprognostic (1.79e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (9.17e-4)" "unprognostic (3.92e-1)" "prognostic favorable (2.41e-14)" "unprognostic (9.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-2)" "unprognostic (1.96e-1)" 5.8 2.4 5.2 10.4 7.0 0.1 20.1 4.2 7.0 19.1 46.5 9.1 55.2 21.6 14.9 18.7 40.9 22.7 26.6 24.8 6.3 3.1 37.5 21.5 17.6 3.7 5.1 5.6 19.3 16.2 27.7 8.1 60.8 7.5 23.6 16.6 15.9 28.7 58.1 8.9 35.3 47.2 10.9 4.5 4.0 17.1 6.5 3.7 2.8 35.7 20.8 22.9 19.7 20.3 1.3 0.3 2.1 0.4 0.9 8.8 2.2 2.1 2.5 2.9 1.8 3.5 2.4 3.9 1.5 2.5 3.3 2.8 1.9 5.8 0.1 3.1 3.5 1.8 6.7 0.1 3.4 1.5 0.2 2.2 0.1 2.0 3.1 2.0 0.0 0.0 2.4 3.2 2.0 1.2 3.2 1.3 0.1 0.3 0.1 2.4 3.3 0.3 0.1 5.2 366.2 0.6 0.2 1.1 0.3 3.4 6.7 0.5 0.1 2.9 179.8 0.9 3.7 5.0 0.1 0.1 1.7 2.2 2.1 0.9 0.3 0.1 0.1 0.1 0.0 5.6 1.6 0.4 0.8 8.8 0.3 0.7 0.9 0.5 2.5 0.3 1.3 1.0 2.5 2.1 0.9 0.2 0.2 0.4 2.2 5.2 7.0 4.2 7.0 6.3 3.1 5.1 5.6 7.5 3.7 38.7 34.4 1.3 21.0 12.5 4.3 13.5 30.6 10.7 15.9 129.1 11.8 9.7 6.6 27.1 0.3 4.6 93.2 0.0 22.3 75.4 11.0 33.4 0.0 10.4 3.5 6.4 15.0 12.3 2.4 0.7 17.0 1.8 10.1 1.0 56.6 30.9 26.2 42.1 21.5 20.7 5.9 0.0 10.3 7.1 5.3 16.6 19.0 2.2 63.0 28.1 ERC1 "CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2" ENSG00000082805 "ELKS/RAB6-interacting/CAST family member 1" Q8IUD2 12 990509-1495933 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 174.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019513, HPA019523, HPA024130" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014" "unprognostic (2.41e-1)" "unprognostic (4.00e-2)" "unprognostic (2.14e-1)" "unprognostic (5.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "unprognostic (5.50e-2)" "unprognostic (8.49e-2)" "unprognostic (2.53e-1)" "unprognostic (3.26e-2)" "unprognostic (1.04e-1)" "unprognostic (6.79e-2)" "unprognostic (3.75e-3)" "unprognostic (4.19e-2)" "unprognostic (3.01e-1)" "unprognostic (7.37e-2)" "prognostic unfavorable (7.01e-4)" 12.6 11.4 10.3 12.5 14.7 7.4 15.1 41.7 10.4 11.2 11.9 8.5 9.2 4.3 17.1 11.0 13.7 9.8 9.9 14.7 10.0 11.2 11.2 8.0 8.8 5.4 9.0 6.4 12.5 8.6 24.3 19.4 13.2 10.7 11.4 7.5 10.1 9.3 14.4 9.2 9.9 6.4 22.1 8.5 7.3 8.6 11.0 9.9 9.8 15.3 7.2 8.6 15.7 15.3 8.6 2.9 2.1 3.8 1.1 3.5 0.5 2.9 7.3 3.9 2.6 10.4 8.8 5.4 9.2 7.4 6.3 5.8 6.4 3.6 4.5 1.3 11.9 6.3 4.9 8.3 7.1 8.8 9.5 4.2 11.1 7.3 3.2 7.9 5.7 2.6 7.1 6.2 11.1 20.8 7.6 8.1 2.9 3.3 8.9 4.7 3.2 1.8 1.2 6.2 2.8 3.5 3.6 14.8 1.4 6.2 5.3 2.3 4.6 14.4 3.3 5.2 14.7 3.4 2.4 15.0 10.9 11.1 8.0 8.6 2.4 4.5 6.7 7.1 3.4 4.8 1.4 2.8 2.1 1.6 1.0 2.2 8.6 2.4 2.4 2.4 5.6 3.5 2.6 2.1 1.1 3.8 2.9 2.2 0.5 10.3 14.7 41.7 10.4 10.0 11.2 9.0 6.4 10.7 9.9 23.8 21.4 15.2 22.2 18.7 34.0 51.9 15.3 14.7 23.9 19.2 45.2 25.8 1.7 17.5 29.4 26.3 7.0 0.0 11.7 14.8 17.3 21.4 13.9 15.3 10.8 174.8 28.8 24.5 10.7 24.2 23.0 11.3 13.5 16.2 8.4 47.3 15.2 9.0 29.0 3.3 34.7 19.4 16.5 15.6 28.4 24.0 65.8 7.4 7.6 29.2 ERCC2 "EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD" ENSG00000104884 "ERCC excision repair 2, TFIIH core complex helicase subunit" P18074 19 45349837-45370918 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005375, HPA038057, HPA069266" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104" "unprognostic (1.10e-1)" "unprognostic (5.48e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-3)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.67e-3)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (1.06e-1)" "prognostic favorable (3.26e-4)" "unprognostic (3.36e-2)" "unprognostic (2.44e-3)" "unprognostic (1.94e-1)" "unprognostic (5.47e-1)" "unprognostic (8.99e-2)" "unprognostic (3.45e-2)" 7.4 15.6 11.4 10.6 17.7 6.7 7.1 9.5 23.8 9.4 8.1 11.7 7.8 7.9 11.7 6.0 6.7 10.0 10.1 7.9 9.4 9.1 8.7 13.2 6.5 9.9 8.2 10.5 9.5 13.1 12.9 10.9 7.2 14.0 8.2 6.4 12.5 9.5 11.8 15.9 10.7 7.1 11.2 5.3 9.7 8.3 17.2 7.8 10.8 10.2 5.1 8.3 9.3 6.6 7.8 17.2 5.0 13.9 11.3 9.8 8.7 12.6 6.2 12.9 18.1 7.7 9.1 6.8 18.0 12.4 23.3 17.9 14.3 8.7 4.5 10.3 17.5 8.5 6.5 9.0 15.1 8.9 10.9 14.8 7.7 11.7 15.1 16.3 12.2 13.6 10.5 2.4 26.6 15.1 13.0 13.5 13.0 18.6 5.1 16.0 6.1 7.1 8.1 5.9 11.6 10.9 13.8 9.2 3.8 6.7 11.2 7.5 8.2 16.0 11.3 6.4 10.2 10.7 16.2 17.5 22.3 12.2 9.4 40.0 11.9 6.8 6.5 6.6 7.4 9.8 0.0 13.3 5.0 7.7 13.9 9.8 7.8 7.4 7.4 17.2 5.8 7.1 7.4 0.4 11.3 10.9 8.3 7.4 8.7 11.4 17.7 9.5 23.8 9.4 9.1 8.2 10.5 14.0 7.8 6.0 4.3 3.6 3.9 5.6 0.0 6.0 10.2 6.7 5.7 5.2 0.0 9.4 11.6 7.6 4.1 3.8 2.9 0.0 7.0 10.0 6.8 3.5 0.0 11.5 9.8 0.0 6.9 9.2 7.3 2.2 6.1 4.6 3.3 1.8 7.8 0.0 6.2 3.5 7.4 11.3 0.0 0.0 5.2 33.8 11.0 5.0 4.0 2.9 7.7 3.3 ERCC6L "FLJ20105, PICH, RAD26L" ENSG00000186871 "ERCC excision repair 6 like, spindle assembly checkpoint helicase" Q2NKX8 X 72204657-72239047 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 2.5;Extravillous trophoblasts: 1.5;Spermatocytes: 1.7;Spermatogonia: 2.0" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "NK-cell: 5.3" "Lineage enriched" "Detected in many" 5 "NK-cells: 5.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050492 Approved Uncertain Nucleoplasm,Centrosome,Cytosol No No Centrosome "Nucleoplasm, Cytosol" "HPA050492: AB_2681145" "prognostic unfavorable (1.80e-4)" "unprognostic (2.93e-1)" "unprognostic (1.95e-2)" "unprognostic (5.76e-3)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (9.23e-6)" "unprognostic (8.63e-3)" "unprognostic (1.57e-2)" "unprognostic (1.99e-2)" "unprognostic (3.68e-5)" "unprognostic (4.61e-2)" "unprognostic (0.00e+0)" "unprognostic (2.97e-3)" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" 0.4 0.5 0.2 3.1 0.2 6.0 3.0 0.9 0.8 1.5 2.2 0.2 0.2 1.5 0.9 0.8 4.6 0.6 1.0 0.2 0.2 0.3 0.5 0.5 0.8 4.7 0.7 0.2 1.2 0.5 0.0 0.6 0.9 0.9 0.7 2.5 0.2 1.1 0.2 2.6 1.3 2.1 0.5 1.3 4.0 1.5 2.0 0.2 13.1 0.5 2.8 5.6 0.7 1.6 0.5 0.3 0.5 0.2 5.3 1.1 0.4 11.0 9.7 8.9 5.6 0.6 1.1 4.9 11.9 5.5 10.4 11.0 7.9 6.9 17.9 4.5 4.2 14.1 9.2 16.8 8.8 18.6 10.2 12.2 6.2 3.4 4.6 0.0 12.0 8.7 0.1 0.5 14.5 2.7 1.7 5.8 9.1 8.1 4.4 10.6 8.7 11.4 7.0 16.2 10.8 15.0 9.6 16.0 3.2 2.6 6.9 7.4 5.3 8.8 5.9 2.2 7.6 4.5 2.7 3.5 7.1 11.4 13.3 7.7 3.5 5.3 15.5 5.0 8.3 7.0 0.0 0.2 0.5 0.1 0.1 0.6 0.2 0.5 0.1 0.1 0.5 0.4 1.1 0.3 5.3 0.2 0.3 1.1 0.4 0.2 0.2 0.9 0.8 0.2 0.3 0.7 0.2 0.9 0.2 0.0 0.0 0.8 0.2 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 0.1 0.3 0.0 0.1 0.1 ERCC6L2 "C9orf102, FLJ37706, RAD26L" ENSG00000182150 "ERCC excision repair 6 like 2" Q5T890 9 95875701-96014571 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021260, HPA022422" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021260: AB_1859544, HPA022422: " "unprognostic (6.70e-2)" "unprognostic (2.40e-1)" "unprognostic (2.68e-1)" "unprognostic (1.28e-1)" "unprognostic (8.30e-2)" "unprognostic (3.62e-2)" "unprognostic (4.64e-2)" "unprognostic (3.92e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.32e-1)" "prognostic favorable (8.70e-5)" "unprognostic (3.63e-1)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (7.39e-2)" 13.5 13.9 14.6 12.7 17.4 7.6 13.6 21.8 19.3 17.7 12.9 13.2 13.9 10.4 18.7 11.8 11.6 11.4 11.8 13.3 14.0 9.7 12.4 11.7 12.7 15.0 15.3 12.2 21.7 10.6 26.2 22.0 11.7 16.1 15.5 11.5 11.0 11.2 12.7 13.9 10.1 13.5 16.1 12.1 15.8 13.4 12.5 15.4 29.7 20.3 7.1 12.4 17.4 13.8 7.3 12.7 4.3 5.3 5.1 12.9 4.0 11.4 14.6 17.3 12.4 6.8 11.6 8.3 10.2 10.4 10.4 11.9 11.2 5.1 13.0 5.7 14.6 14.9 14.3 16.6 7.1 15.4 9.3 8.0 11.7 11.1 7.2 6.6 14.9 11.6 10.3 7.3 12.8 10.2 9.6 9.7 13.4 15.1 7.3 10.7 9.2 12.4 5.6 12.9 12.3 8.8 11.6 22.5 4.6 8.8 10.5 16.2 12.4 7.2 7.6 7.3 9.4 7.1 7.7 10.2 11.7 14.9 14.4 12.0 4.9 7.4 6.2 11.3 7.1 16.9 3.2 4.4 4.3 8.7 5.3 8.4 5.7 8.3 9.3 4.8 7.3 12.9 9.4 2.7 5.1 4.2 12.7 9.9 4.0 14.6 17.4 21.8 19.3 14.0 9.7 15.3 12.2 16.1 15.4 14.9 15.2 4.7 11.1 4.4 0.0 15.9 7.6 21.4 18.2 0.0 0.0 4.5 0.0 7.6 6.2 7.2 5.9 23.3 7.0 2.8 7.5 8.6 15.0 6.0 5.5 0.0 4.7 8.0 9.1 3.0 24.7 10.6 3.3 8.2 7.1 0.0 6.3 3.5 26.2 2.8 0.0 19.4 10.3 15.2 9.6 3.9 4.0 12.8 5.6 7.5 ERG "erg-3, p55" ENSG00000157554 "ERG, ETS transcription factor" P11308 21 38380027-38661780 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 84.3;granulocytes: 22.1;Ito cells: 63.3" "Cancer enhanced" "Detected in all" "prostate cancer: 18.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "myeloid DC: 1.7;NK-cell: 1.0" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 1.0" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 43.7;MOLT-4: 14.3;REH: 46.4;TIME: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB018377, HPA046598" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB018377: AB_675518, HPA046598: AB_2679715" "unprognostic (2.14e-1)" "prognostic unfavorable (6.18e-6)" "unprognostic (6.44e-3)" "unprognostic (8.64e-3)" "unprognostic (5.65e-2)" "unprognostic (1.91e-1)" "unprognostic (9.03e-4)" "unprognostic (4.30e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-1)" "unprognostic (3.42e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (4.31e-3)" "unprognostic (3.88e-2)" "unprognostic (2.64e-2)" "unprognostic (5.63e-3)" 39.1 4.2 5.7 6.5 8.5 6.6 20.5 3.6 7.0 17.9 5.2 2.3 5.6 3.3 16.9 9.0 6.2 9.2 11.6 10.1 6.2 3.6 10.8 6.0 19.9 7.4 8.0 1.8 7.7 4.8 2.3 3.9 23.2 8.0 8.1 3.6 7.8 4.2 5.6 13.5 5.3 6.2 11.8 4.7 32.5 5.0 4.8 5.0 2.4 10.8 9.1 3.6 9.6 15.8 0.0 1.7 0.0 0.2 1.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 7.1 0.0 0.0 0.3 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.3 14.3 0.0 0.1 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 35.4 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 5.7 8.5 3.6 7.0 6.2 3.6 8.0 1.8 8.0 5.0 0.0 4.6 1.9 1.5 3.1 0.0 2.5 7.6 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.5 84.3 0.0 0.0 0.0 0.0 2.1 0.4 22.1 0.8 0.2 0.0 0.0 63.3 9.8 1.5 0.9 1.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.9 3.0 0.0 0.0 0.0 0.6 ERG28 "C14orf1, NET51" ENSG00000133935 "Ergosterol biosynthesis 28 homolog" Q9UKR5 14 75649791-75661189 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 130.3;Ductal cells: 84.3;Exocrine glandular cells: 97.0;Extravillous trophoblasts: 121.7;Syncytiotrophoblasts: 97.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043172, HPA063568" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043172: AB_10793942, HPA063568: AB_2685043" "unprognostic (2.68e-3)" "unprognostic (2.11e-2)" "unprognostic (4.55e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-1)" "unprognostic (1.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.66e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" "unprognostic (2.47e-1)" "unprognostic (3.01e-2)" "prognostic favorable (4.30e-5)" "unprognostic (1.28e-1)" "unprognostic (2.77e-1)" "unprognostic (9.58e-3)" "unprognostic (2.20e-1)" 6.4 20.0 14.2 6.3 16.3 8.1 12.6 9.2 25.5 11.8 11.7 16.3 10.5 14.9 11.3 29.6 23.7 12.4 11.8 9.4 13.6 15.5 17.6 48.3 19.3 9.4 11.9 10.4 15.0 12.4 16.5 13.2 15.6 17.9 15.5 11.2 26.2 15.4 10.6 6.6 15.6 16.9 10.5 18.2 7.1 9.5 52.2 9.6 7.5 24.3 21.3 15.6 9.2 13.5 18.1 18.2 11.8 6.0 14.2 22.0 13.9 14.2 8.0 16.3 12.6 11.0 20.6 10.1 5.8 18.0 11.3 19.5 12.3 34.1 6.0 8.5 7.2 22.7 15.8 14.3 24.8 13.0 11.3 9.5 6.5 8.2 17.4 16.1 7.1 9.8 25.7 21.4 16.2 9.1 9.1 13.1 16.7 5.8 14.8 7.8 28.0 10.8 7.9 15.8 22.8 13.0 8.7 11.0 12.0 37.1 18.5 14.0 7.8 14.7 12.6 8.7 15.0 21.0 10.6 9.4 6.2 12.5 5.9 5.8 9.7 11.3 13.1 9.9 10.5 10.4 11.8 6.0 8.9 20.1 5.9 19.8 18.1 22.0 20.9 14.2 15.3 20.2 20.1 3.2 14.2 5.9 18.2 19.4 13.9 14.2 16.3 9.2 25.5 13.6 15.5 11.9 10.4 17.9 9.6 20.8 41.5 0.0 0.0 0.0 0.0 0.0 0.0 33.5 20.5 57.6 0.0 130.3 41.4 84.3 0.0 0.0 0.0 0.0 97.0 121.7 0.0 0.0 4.7 0.0 53.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 65.9 0.0 0.0 61.2 0.0 0.0 38.9 0.0 0.0 0.0 0.0 0.0 0.0 97.3 0.0 0.0 0.0 ERH DROER ENSG00000100632 "ERH, mRNA splicing and mitosis factor" P84090 14 69380123-69398627 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002567 Approved Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA002567: AB_1078749" "unprognostic (2.42e-2)" "unprognostic (1.69e-1)" "unprognostic (3.42e-1)" "unprognostic (4.78e-2)" "unprognostic (9.34e-2)" "unprognostic (8.61e-3)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.93e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-3)" "unprognostic (2.31e-1)" "unprognostic (9.24e-2)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (9.32e-2)" "unprognostic (4.31e-2)" "unprognostic (2.39e-1)" 42.6 45.4 54.9 43.9 46.7 47.0 51.3 45.1 48.4 46.6 43.5 31.1 39.4 42.1 53.3 63.3 44.8 46.4 35.9 40.6 47.6 51.1 56.1 62.2 34.5 52.5 43.5 48.5 47.8 38.7 23.9 45.5 55.2 45.4 40.4 50.3 41.3 58.5 40.3 43.3 31.0 47.3 46.9 43.6 55.2 35.6 54.6 28.4 72.2 55.2 37.5 64.4 47.7 36.8 38.7 37.3 24.2 32.4 34.1 35.3 38.8 90.9 59.0 59.1 39.4 29.7 21.9 35.8 47.7 27.5 43.1 40.4 60.1 37.8 86.3 21.0 31.9 32.9 26.7 59.8 39.6 51.3 45.0 36.5 43.3 39.2 67.1 45.8 37.6 31.5 24.9 21.3 38.5 34.6 24.5 35.2 56.0 41.7 29.0 35.2 104.0 56.8 53.6 46.1 48.2 56.0 46.1 58.6 29.5 43.4 62.2 45.5 42.4 45.5 41.7 26.1 35.0 51.3 52.7 37.6 42.2 62.5 28.0 47.4 32.6 30.9 96.5 31.3 40.0 40.7 15.3 32.4 24.2 26.1 30.1 25.7 38.7 32.5 28.6 34.0 30.6 30.7 27.2 15.4 34.1 27.1 37.3 35.3 38.8 54.9 46.7 45.1 48.4 47.6 51.1 43.5 48.5 45.4 28.4 56.6 48.3 181.6 193.1 242.6 132.5 105.5 158.0 116.4 66.0 240.8 35.3 400.5 570.3 308.1 69.0 200.3 146.7 93.5 240.5 449.3 263.5 196.9 126.7 237.4 297.7 69.9 181.0 155.9 148.1 29.8 250.8 172.7 291.8 355.3 176.1 207.1 246.0 166.8 243.6 389.2 92.5 187.5 273.0 273.2 229.3 278.7 234.1 150.3 215.6 194.6 ERI3 "FLJ22943, PINT1, PRNPIP" ENSG00000117419 "ERI1 exoribonuclease family member 3" O43414 1 44221070-44355260 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 823.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027147, HPA029895" Approved Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA027147: AB_1855725, HPA029895: AB_2673239" "unprognostic (1.31e-1)" "unprognostic (2.39e-2)" "unprognostic (3.26e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (5.94e-2)" "unprognostic (6.21e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (6.48e-2)" "unprognostic (2.67e-1)" "unprognostic (6.70e-3)" "unprognostic (5.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (2.07e-1)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (2.07e-3)" 12.6 15.4 30.7 8.3 32.0 12.4 15.2 19.7 43.7 15.1 13.4 23.2 10.8 12.3 14.7 22.2 13.4 23.4 12.7 21.1 28.9 25.1 25.3 15.5 11.7 10.0 23.9 26.8 18.6 15.7 24.0 17.2 13.5 22.9 16.7 14.1 14.8 14.7 16.9 35.7 13.3 8.6 17.7 17.9 9.5 10.6 24.4 21.9 9.7 17.6 11.9 11.0 12.5 12.1 18.8 25.3 9.6 22.2 14.8 18.2 15.2 28.6 22.2 28.2 31.2 18.5 23.3 17.7 18.8 25.0 33.4 31.2 14.3 30.7 20.5 31.8 23.1 17.1 16.6 25.2 32.0 23.6 22.9 48.6 22.9 37.5 20.2 27.1 23.1 13.2 23.7 30.1 25.3 34.8 24.8 22.9 22.9 22.3 16.7 21.9 19.3 25.6 21.6 33.4 25.5 35.2 24.7 25.9 30.0 25.9 15.1 48.1 22.7 20.5 28.1 33.2 23.3 18.4 19.1 13.9 22.1 23.1 24.0 28.4 15.9 18.5 22.0 27.4 20.1 27.8 9.4 16.3 9.6 16.7 22.2 18.2 18.8 14.0 16.2 25.3 18.3 16.7 17.2 1.5 14.8 21.3 18.9 18.1 15.2 30.7 32.0 19.7 43.7 28.9 25.1 23.9 26.8 22.9 21.9 23.8 16.8 23.4 29.6 28.0 20.9 13.7 10.2 10.7 9.1 27.9 2.0 80.0 82.9 48.6 192.5 20.2 20.0 0.0 54.5 67.1 42.9 35.8 15.0 21.3 39.5 23.8 113.7 19.6 24.3 823.2 33.6 22.4 45.5 35.1 48.9 30.3 33.0 25.9 34.3 131.8 13.5 6.5 31.1 46.2 48.7 30.2 51.5 15.4 35.1 23.5 ERICH1 ENSG00000104714 "Glutamate rich 1" Q86X53 8 614746-738106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003725 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA003725: AB_1853023" "unprognostic (7.19e-2)" "unprognostic (1.38e-2)" "unprognostic (7.73e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-2)" "unprognostic (1.02e-1)" "unprognostic (7.51e-3)" "unprognostic (1.55e-1)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (5.11e-2)" "unprognostic (1.27e-1)" "unprognostic (8.63e-2)" "unprognostic (3.07e-1)" "unprognostic (1.42e-1)" 20.2 11.7 12.3 35.7 16.9 30.5 18.1 9.0 15.6 13.6 16.0 13.9 13.7 13.1 21.7 25.6 15.3 13.7 17.1 14.7 15.1 11.4 17.6 15.3 19.4 29.3 14.5 14.0 16.9 12.2 13.8 16.1 16.9 16.9 15.4 11.7 14.0 13.5 19.4 17.2 17.0 15.8 16.2 17.0 22.2 14.9 11.8 14.0 21.8 18.2 13.3 25.0 17.1 15.3 11.7 10.2 18.5 20.9 7.2 6.2 6.0 9.1 13.3 7.1 8.5 7.7 9.4 14.8 8.8 4.7 8.1 8.9 8.4 5.9 21.0 4.2 7.4 15.4 15.5 13.0 13.6 5.8 9.1 16.9 14.7 8.6 12.0 8.6 8.9 13.8 10.8 8.9 6.1 7.9 8.4 8.8 18.6 15.0 12.2 8.1 7.6 17.2 15.9 11.2 10.3 5.9 15.6 4.6 14.4 8.9 17.0 3.3 9.2 6.4 8.3 11.7 12.2 3.5 10.7 14.0 6.0 2.8 0.3 9.4 7.9 20.7 22.7 12.2 14.4 6.2 11.4 20.9 7.2 5.4 19.0 4.8 9.7 6.2 5.3 10.2 11.7 5.3 4.7 18.5 7.2 16.8 7.8 4.4 6.0 12.3 16.9 9.0 15.6 15.1 11.4 14.5 14.0 16.9 14.0 41.7 35.5 50.9 39.7 32.4 21.9 18.6 22.9 28.1 23.9 31.4 11.8 51.9 92.9 32.4 12.1 68.4 34.3 23.3 31.9 51.8 34.0 36.4 39.4 27.6 37.0 46.1 18.9 63.8 70.8 7.5 55.8 69.4 33.7 101.0 32.1 18.6 42.9 38.6 38.2 35.4 20.8 38.8 32.3 46.1 50.7 35.8 45.2 57.3 28.7 29.2 ERICH4 "C19orf69, LOC100170765" ENSG00000204978 "Glutamate rich 4" A6NGS2 19 41443158-41444765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 78.1" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 73.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "CACO-2: 4.8;Hep G2: 11.1;THP-1: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA042632, HPA048484" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042632: AB_2678090, HPA048484: AB_2680415" "unprognostic (1.41e-1)" "unprognostic (3.05e-1)" "unprognostic (9.52e-2)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" "unprognostic (4.03e-5)" "unprognostic (8.53e-2)" "unprognostic (7.54e-2)" "unprognostic (1.97e-1)" "unprognostic (3.09e-2)" "unprognostic (1.04e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 0.6 0.0 0.2 0.2 0.3 0.0 0.6 0.2 0.3 0.4 21.0 0.2 0.2 27.1 0.4 0.4 0.2 0.4 0.5 1.3 0.2 0.0 10.0 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.9 0.0 78.1 0.2 0.3 0.2 0.1 0.8 0.2 0.2 0.3 0.2 0.2 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 11.6 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 73.4 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064311-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 27.9;retina: 26.7" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 84.1;Ciliated cells: 72.3;Ductal cells: 42.6" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.3" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.3" "Cell line enhanced" "Detected in some" "A549: 6.5;HAP1: 6.0;HEK 293: 8.8;JURKAT: 11.6;RPTEC TERT1: 5.8;RT4: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favorable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favorable (9.38e-4)" 0.5 0.2 2.3 0.2 6.7 0.0 0.8 0.4 2.2 2.0 3.3 0.1 3.6 4.3 1.1 0.6 0.7 8.8 13.1 5.4 0.7 2.6 8.7 8.1 1.7 0.7 1.0 2.2 1.6 27.9 0.6 1.7 4.1 1.9 2.2 3.0 26.7 1.3 1.9 0.1 0.6 1.3 0.4 1.0 0.2 9.5 3.4 0.5 0.3 0.6 0.0 0.5 3.1 0.5 0.0 5.3 0.0 0.0 0.0 0.5 0.0 0.0 6.5 0.0 0.0 0.1 0.0 3.8 3.4 1.3 1.8 1.4 0.1 2.0 0.0 5.0 0.9 2.8 0.3 6.0 0.1 2.2 0.0 8.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 11.6 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.1 2.6 0.0 0.0 0.1 5.8 15.3 3.5 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 6.7 0.4 2.2 0.7 2.6 1.0 2.2 1.9 0.5 3.0 0.0 0.0 1.1 0.0 0.0 5.9 84.1 72.3 5.7 7.0 0.0 0.3 0.0 42.6 0.3 0.0 0.7 0.0 16.3 1.5 0.0 3.1 0.0 3.9 0.1 0.0 17.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 2.3 5.8 17.1 0.0 0.0 19.3 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 3.3 1.3 ERMAP "BTN5, RD, SC" ENSG00000164010 "Erythroblast membrane associated protein (Scianna blood group)" Q96PL5 1 42817088-42844993 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 21.6;Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 24.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA042573, HPA054672" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA042573: AB_10794282, HPA054672: " "unprognostic (9.46e-2)" "unprognostic (4.47e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-1)" "unprognostic (6.09e-2)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (7.48e-2)" "unprognostic (2.71e-3)" "unprognostic (6.46e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (8.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.48e-1)" "unprognostic (9.48e-2)" 10.0 14.1 9.3 6.7 10.4 25.7 8.4 2.5 9.3 9.3 7.9 12.4 12.2 6.4 9.4 16.7 8.3 10.2 7.4 4.7 9.3 6.3 7.8 13.1 9.8 4.4 10.4 8.3 6.2 11.7 9.8 12.3 12.0 10.8 9.4 8.3 11.8 10.2 8.0 4.0 9.2 9.4 6.5 14.6 8.6 7.8 4.2 11.9 4.8 13.1 3.2 8.1 9.7 8.0 2.4 8.1 3.0 7.1 3.5 5.0 2.9 3.5 4.7 1.5 4.7 5.3 15.5 1.3 7.0 11.7 6.2 6.2 1.9 6.4 3.1 2.5 7.3 2.9 4.4 1.6 2.1 5.7 5.1 5.6 24.9 3.4 1.5 6.6 3.6 12.9 9.4 7.9 2.9 6.8 11.4 4.0 3.8 16.9 3.1 5.7 2.3 1.7 1.3 3.6 2.2 2.6 1.7 2.1 2.9 5.3 5.4 3.3 2.4 6.0 2.2 2.6 2.6 4.4 13.3 6.3 4.7 2.8 3.9 3.2 1.4 2.7 1.3 3.8 3.8 3.0 0.5 6.8 3.0 2.1 7.1 1.2 2.4 2.3 2.2 8.1 1.3 2.0 2.3 2.1 3.5 4.5 2.3 5.0 2.9 9.3 10.4 2.5 9.3 9.3 6.3 10.4 8.3 10.8 11.9 11.9 10.4 0.8 3.1 3.4 1.2 1.7 7.6 6.7 7.9 3.5 21.6 2.5 1.7 3.0 3.2 3.5 2.6 23.3 6.2 1.1 3.6 2.6 2.3 11.6 7.0 11.1 5.2 2.5 11.9 18.9 2.6 6.6 5.0 1.8 5.6 5.0 4.1 3.5 3.9 2.9 3.8 0.0 1.9 0.0 0.9 3.3 2.4 0.9 6.6 0.9 ERMARD "C6orf70, dJ266L20.3, FLJ11152" ENSG00000130023 "ER membrane associated RNA degradation" Q5T6L9 6 169751622-169781584 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 35.6;Late spermatids: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041741 Approved Approved Cytosol NA NA Cytosol "HPA041741: AB_10804116" "unprognostic (2.66e-3)" "unprognostic (2.75e-1)" "unprognostic (2.33e-1)" "unprognostic (2.28e-2)" "unprognostic (1.18e-1)" "unprognostic (3.18e-1)" "unprognostic (2.24e-2)" "unprognostic (7.41e-3)" "unprognostic (1.96e-1)" "unprognostic (8.14e-2)" "unprognostic (1.66e-3)" "unprognostic (4.74e-2)" "unprognostic (3.06e-2)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.31e-2)" 12.6 14.4 11.9 16.6 15.6 10.6 13.2 12.4 16.0 10.9 10.1 17.5 18.6 8.6 21.8 25.0 10.1 13.3 11.0 7.2 10.0 9.3 12.1 16.4 9.9 16.6 10.9 14.6 18.7 13.3 14.1 17.7 13.6 12.1 12.0 11.1 16.1 15.4 15.6 13.0 21.8 12.4 12.8 11.7 16.7 10.1 27.4 11.8 15.5 14.8 12.1 15.8 11.2 9.9 7.1 7.0 2.2 13.4 7.3 9.8 6.3 4.0 5.0 9.3 14.2 10.7 12.3 3.7 5.3 10.5 6.4 6.8 3.3 9.4 7.7 5.4 7.7 7.9 11.7 4.3 11.8 6.7 8.1 4.7 10.2 7.4 3.3 15.0 12.6 6.8 12.9 13.0 6.5 18.1 10.8 7.2 13.1 9.6 10.3 10.5 7.4 5.9 11.3 3.1 9.0 4.0 7.4 6.3 11.9 10.0 4.6 3.3 6.2 8.3 10.1 4.1 8.1 6.4 14.1 5.5 5.1 3.0 8.0 5.7 11.0 12.5 6.8 7.8 10.4 8.1 2.2 5.7 1.9 6.9 11.1 6.9 6.2 7.2 7.5 7.0 7.1 8.1 7.5 0.9 7.3 13.4 5.3 9.8 6.3 11.9 15.6 12.4 16.0 10.0 9.3 10.9 14.6 12.1 11.8 3.0 12.0 3.0 3.8 3.7 11.1 2.0 0.0 18.7 5.7 5.2 9.8 10.7 10.0 8.2 35.6 3.6 3.3 0.0 7.4 7.0 5.6 2.3 2.3 7.4 5.2 4.8 5.8 7.4 7.1 38.1 4.0 4.0 3.3 4.6 2.8 12.8 4.6 2.9 4.2 6.8 10.5 6.5 5.2 27.7 15.3 2.8 5.9 3.8 3.9 3.1 ERMN "ERMIN, JN, KIAA1189" ENSG00000136541 Ermin Q8TAM6 2 157318625-157327713 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 106.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 2.2;Early spermatids: 1.2;Kupffer cells: 1.2;Macrophages: 1.1;T-cells: 1.9" "Group enriched" "Detected in some" 12 "endometrial cancer: 2.2;glioma: 9.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 6 "HAP1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038295, HPA038296" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA038295: AB_10805353, HPA038296: AB_10796217" "unprognostic (7.89e-2)" "unprognostic (9.06e-3)" "unprognostic (2.71e-2)" "prognostic favorable (6.93e-6)" "unprognostic (1.06e-1)" "unprognostic (2.02e-2)" "unprognostic (9.14e-2)" "unprognostic (1.79e-1)" "unprognostic (4.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.07e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-3)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (9.97e-3)" "unprognostic (5.76e-2)" 1.6 1.4 29.1 2.9 50.5 9.7 1.6 2.7 106.7 1.4 1.8 52.4 0.0 1.8 1.6 1.5 1.7 1.4 1.9 1.6 40.9 21.4 1.5 1.5 2.0 3.1 75.1 18.4 1.5 1.6 1.4 0.1 1.4 54.5 1.5 1.9 4.3 2.4 1.5 1.7 1.9 1.9 1.6 100.9 2.5 2.2 1.7 69.5 0.0 1.6 0.0 2.7 1.7 0.1 1.7 1.3 3.9 1.6 2.4 2.1 0.7 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 1.2 0.0 2.0 0.0 0.3 21.3 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.8 0.4 0.2 0.8 2.3 0.3 0.1 0.5 0.0 0.4 0.5 0.0 1.0 0.4 0.6 0.0 0.1 0.0 0.3 0.7 1.3 0.0 0.2 0.1 0.2 0.6 3.5 2.0 0.6 1.8 1.0 1.0 2.6 1.6 1.1 2.1 1.2 1.0 0.7 0.8 0.6 0.6 1.7 1.5 1.6 3.9 2.4 1.0 1.3 0.9 0.7 29.1 50.5 2.7 27.9 40.9 21.4 75.1 18.4 54.5 69.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.9 0.0 0.0 ERRFI1 "GENE-33, MIG-6, RALT" ENSG00000116285 "ERBB receptor feedback inhibitor 1" Q9UJM3 1 8004404-8026308 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 141.1;pancreas: 133.6" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 1158.6;Basal keratinocytes: 1103.5;Hepatocytes: 716.0;Suprabasal keratinocytes: 640.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.9" "Group enriched" "Detected in many" 7 "monocytes: 4.9;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HHSteC: 94.3;LHCN-M2: 72.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076543 Supported Cytosol NA NA Cytosol "HPA076543: " "unprognostic (2.13e-3)" "unprognostic (1.01e-2)" "unprognostic (2.34e-1)" "unprognostic (1.71e-2)" "unprognostic (2.50e-3)" "unprognostic (1.66e-3)" "unprognostic (2.27e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.47e-1)" "unprognostic (4.50e-2)" "unprognostic (2.10e-1)" "unprognostic (1.19e-3)" "unprognostic (1.11e-3)" "unprognostic (1.18e-1)" "unprognostic (2.34e-1)" "unprognostic (8.03e-3)" 38.6 8.8 4.4 6.3 6.3 0.6 27.8 9.6 7.0 17.5 13.6 5.4 8.4 6.8 15.9 9.6 13.6 12.2 27.3 8.8 4.7 2.5 32.6 141.1 15.5 7.7 7.5 3.7 29.7 133.6 7.7 41.9 33.7 8.1 9.3 5.1 12.0 14.5 5.9 68.3 20.2 26.5 22.9 12.5 2.1 22.3 7.4 5.2 0.6 19.4 4.7 3.8 20.0 19.5 0.4 0.3 0.2 4.9 0.0 1.3 0.2 13.4 7.9 3.4 4.6 32.4 24.3 35.5 13.2 3.8 2.4 2.9 3.5 35.4 0.2 7.9 4.4 16.9 2.9 0.9 23.3 11.3 0.4 2.6 0.2 2.3 41.0 94.3 0.1 0.5 32.9 23.5 8.1 19.7 34.6 6.2 0.5 0.9 0.1 72.0 5.7 0.0 0.8 8.1 10.5 19.8 1.1 38.4 0.2 11.4 4.3 2.3 1.4 2.6 6.0 4.1 25.1 4.1 0.3 8.7 9.6 5.6 8.0 18.5 0.2 0.1 0.2 36.9 0.6 8.8 0.0 0.4 0.0 1.3 0.1 0.2 0.3 1.2 1.3 0.2 0.4 0.9 1.2 0.2 0.0 4.9 0.3 0.6 0.2 4.4 6.3 9.6 7.0 4.7 2.5 7.5 3.7 8.1 5.2 205.4 106.1 3.4 1158.6 1103.5 8.8 38.3 122.3 92.3 168.4 26.2 13.7 65.0 26.6 64.8 18.3 16.0 90.3 0.0 96.3 48.0 90.0 430.0 13.9 716.0 8.9 3.2 104.9 36.8 11.3 51.0 48.1 13.8 67.4 1.0 17.1 35.7 105.2 28.1 36.0 45.8 9.2 6.5 58.9 10.4 22.8 640.6 216.6 5.7 21.0 466.7 ERVMER34-1 envMER34 ENSG00000226887 "Endogenous retrovirus group MER34 member 1, envelope" Q9H9K5 4 52722618-52751640 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 32.0;placenta: 26.9" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1" "HPA011423, HPA024053" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 5000000 Nucleoplasm Cytosol "HPA011423: AB_2668510, HPA024053: " "unprognostic (5.34e-2)" "unprognostic (1.29e-1)" "unprognostic (1.91e-3)" "unprognostic (5.86e-2)" "unprognostic (4.08e-4)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.88e-4)" "unprognostic (5.28e-2)" "unprognostic (2.99e-2)" "unprognostic (2.39e-3)" "unprognostic (2.62e-3)" "unprognostic (4.23e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-2)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" "unprognostic (1.82e-1)" 0.3 1.3 1.2 0.4 0.7 0.2 2.8 0.5 3.0 1.3 0.5 0.0 1.4 0.5 0.9 1.3 3.7 0.7 0.4 6.2 0.8 1.0 4.4 0.3 1.8 1.9 0.6 0.2 3.9 1.7 32.0 0.2 26.9 0.8 0.7 0.7 0.8 1.3 3.0 0.2 1.0 0.5 0.4 1.5 1.9 1.1 1.7 0.3 0.0 2.5 3.7 1.2 1.0 1.8 0.6 0.4 1.2 0.1 0.4 0.3 0.0 4.5 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 28.2 6.0 0.0 0.6 0.1 0.4 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 1.3 20.3 0.0 3.0 0.0 0.0 0.0 1.6 0.0 0.1 0.3 0.0 0.0 1.9 1.8 0.8 0.0 0.0 0.0 15.1 0.4 1.2 0.3 1.9 0.8 0.0 3.0 2.5 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.1 0.5 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.3 0.2 1.1 0.4 0.1 0.4 0.2 0.0 1.2 0.7 0.5 3.0 0.8 1.0 0.6 0.2 0.8 0.3 0.0 0.0 0.0 1.1 0.5 0.0 2.4 0.0 0.0 0.0 7.0 0.0 66.3 0.0 2.3 3.2 0.1 0.0 0.0 0.7 80.6 1.3 1.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.3 0.2 0.4 0.1 14.5 0.0 0.4 1.1 ERVV-1 "ENVV1, FLJ32214, HERV-V1" ENSG00000269526 "Endogenous retrovirus group V member 1, envelope" B6SEH8 19 53013921-53016122 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "placenta: 19.7" "Cell type enriched" "Detected in some" 31 "Syncytiotrophoblasts: 218.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 11.7;SuSa: 9.8" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (1.04e-3)" "unprognostic (7.32e-3)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.67e-2)" "unprognostic (9.92e-2)" "unprognostic (6.75e-2)" "unprognostic (4.34e-5)" "unprognostic (3.48e-2)" "unprognostic (5.80e-2)" "unprognostic (3.18e-1)" "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.2 0.0 0.0 0.0 ERVV-2 ENVV2 ENSG00000268964 "Endogenous retrovirus group V member 2, envelope" B6SEH9 19 53044738-53051076 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 105 "placenta: 85.9" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 3.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 19.1;SuSa: 12.9;T-47d: 5.4" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (3.14e-3)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (4.33e-9)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.60e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 85.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 ESD ENSG00000139684 "Esterase D" P10768 13 46771256-46797232 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039700 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 16000000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039700: AB_10697553" "unprognostic (3.05e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (7.66e-2)" "unprognostic (1.75e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.73e-2)" "unprognostic (3.31e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (1.49e-2)" "unprognostic (1.08e-1)" "unprognostic (2.91e-2)" "unprognostic (2.71e-2)" "unprognostic (2.18e-1)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" 58.5 30.9 32.0 28.6 29.8 24.2 44.5 23.7 32.0 54.4 37.3 29.0 34.2 31.8 53.2 50.4 54.1 40.6 30.3 45.6 30.7 29.3 58.8 82.2 28.2 31.4 31.7 32.1 61.3 24.9 27.5 47.5 26.4 28.6 55.2 41.7 32.5 31.5 45.2 47.4 29.7 38.4 50.8 37.4 31.1 32.1 32.4 26.7 65.5 78.9 50.9 31.7 62.5 36.9 30.1 48.7 15.1 37.1 29.8 35.7 26.4 22.1 12.9 39.1 26.9 45.9 75.9 10.5 31.9 46.3 44.5 34.7 21.8 27.2 25.2 9.6 38.2 33.3 22.7 43.0 37.7 57.0 28.8 44.7 32.6 13.0 33.5 37.6 63.6 14.0 51.8 35.0 28.7 38.7 53.7 41.7 43.5 31.8 6.8 73.6 21.7 56.4 42.3 10.1 28.7 24.5 44.9 23.0 17.0 63.1 9.0 19.4 22.0 14.2 12.1 25.6 28.1 23.2 36.5 27.8 16.4 19.4 31.5 29.4 4.6 9.9 21.8 35.4 36.5 21.9 7.7 37.1 15.1 15.0 31.5 24.6 30.1 30.0 23.0 40.8 25.3 35.7 27.9 4.3 29.8 28.0 48.7 24.9 26.4 32.0 29.8 23.7 32.0 30.7 29.3 31.7 32.1 28.6 26.7 50.6 42.5 68.7 203.4 119.1 47.0 89.2 124.9 77.6 61.4 146.5 39.3 134.7 305.1 153.5 36.2 95.8 72.1 46.7 90.4 115.2 195.1 96.4 94.6 148.9 197.0 20.6 104.5 112.3 138.2 18.5 247.9 128.5 156.9 100.0 108.9 147.8 82.8 115.8 198.7 400.9 62.5 148.8 210.1 67.4 44.1 113.0 62.2 82.2 173.0 130.7 ESRRB "DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2" ENSG00000119715 "Estrogen related receptor beta" O95718 14 76310712-76501837 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 14.5;retina: 50.2" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 14.7;Horizontal cells: 52.4;Late spermatids: 27.9;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.8;K-562: 9.7;U-266/70: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA074772 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074772: " "unprognostic (1.12e-1)" "unprognostic (1.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.92e-5)" "unprognostic (5.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.14e-1)" "unprognostic (1.48e-1)" "unprognostic (2.28e-2)" "unprognostic (2.24e-2)" "unprognostic (2.16e-2)" "unprognostic (4.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.46e-1)" "unprognostic (1.89e-1)" "unprognostic (2.12e-4)" "unprognostic (4.40e-2)" 0.2 0.1 0.3 0.0 1.0 0.0 0.6 0.3 0.6 0.1 0.0 0.8 0.3 0.0 0.1 0.4 0.1 0.1 0.0 7.8 0.3 0.4 14.5 0.1 0.1 0.9 0.5 0.4 0.0 0.2 0.0 0.3 0.1 1.3 0.2 0.0 50.2 0.1 0.4 9.5 0.0 0.1 0.0 0.5 1.2 5.1 2.0 0.2 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.5 0.5 0.0 0.1 0.0 0.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 9.7 0.4 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 1.0 0.1 0.5 4.9 1.4 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.0 0.3 0.6 0.3 0.4 0.5 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 1.6 5.5 0.0 0.0 0.0 0.0 2.0 0.0 11.6 0.0 14.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 52.4 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.3 40.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 ESYT2 "CHR2SYT, FAM62B, KIAA1228" ENSG00000117868 "Extended synaptotagmin 2" A0FGR8 7 158730995-158830253 "Plasma proteins, Predicted membrane proteins, Transporters" "Endocytosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002132 Approved Uncertain Cytosol NA NA 130000 Cytosol "HPA002132: AB_1078807" "unprognostic (2.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (5.72e-2)" "unprognostic (5.43e-2)" "unprognostic (9.01e-2)" "unprognostic (9.94e-2)" "unprognostic (1.72e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.13e-1)" "unprognostic (7.54e-2)" "unprognostic (6.70e-2)" "unprognostic (4.58e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (2.81e-5)" 33.3 25.6 15.3 16.2 23.5 19.6 27.3 21.7 26.3 26.7 27.9 17.8 21.6 15.8 31.2 31.0 32.5 28.3 31.1 28.4 16.1 17.5 20.6 16.7 26.1 18.0 15.6 16.7 41.6 23.2 29.7 22.0 35.2 20.6 21.1 22.6 23.4 26.7 31.4 34.5 24.5 22.5 37.8 14.9 13.2 19.4 13.3 12.1 29.0 30.5 24.3 23.2 30.5 27.6 1.4 3.6 2.0 2.3 6.6 8.5 2.9 29.6 17.8 5.7 6.0 19.2 22.3 19.0 14.0 14.3 11.2 12.6 9.9 39.0 9.1 16.2 25.1 23.1 14.8 8.2 14.7 10.8 9.4 8.4 7.5 14.2 10.5 19.6 26.9 17.2 16.1 18.3 12.6 16.9 22.5 13.2 24.8 16.1 30.8 18.2 24.9 27.9 19.5 9.1 20.0 17.2 23.8 11.0 11.2 19.0 12.7 16.7 9.2 44.6 36.1 20.3 13.9 13.1 29.5 20.4 12.4 6.5 54.7 17.8 21.1 5.4 8.9 30.7 28.0 36.5 2.0 1.9 1.5 8.5 2.3 4.7 1.4 7.1 6.0 3.6 1.0 6.7 7.9 1.2 6.6 1.5 2.4 5.8 2.9 15.3 23.5 21.7 26.3 16.1 17.5 15.6 16.7 20.6 12.1 35.7 32.5 9.0 10.9 41.0 15.1 25.8 22.9 36.1 33.0 45.4 15.7 24.1 3.3 13.5 11.2 41.4 27.1 23.3 17.1 22.4 41.1 18.3 11.6 17.4 18.3 12.7 20.3 25.2 23.8 3.0 32.5 22.6 49.0 10.8 29.5 15.2 24.1 5.8 51.2 8.2 10.6 32.3 52.8 10.9 10.0 45.2 34.1 25.9 22.5 21.4 ETAA1 ETAA16 ENSG00000143971 "ETAA1, ATR kinase activator" Q9NY74 2 67397319-67412089 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035048, HPA035049" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035048: AB_10670300, HPA035049: AB_2674430" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (5.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (3.39e-2)" "unprognostic (6.47e-2)" "unprognostic (5.53e-2)" "unprognostic (1.12e-2)" "unprognostic (8.33e-2)" "unprognostic (9.89e-2)" "unprognostic (1.87e-1)" "unprognostic (8.52e-3)" "unprognostic (9.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.01e-2)" "unprognostic (1.14e-2)" 9.3 23.4 6.4 11.0 11.3 6.6 14.7 14.0 10.6 15.4 11.7 6.3 9.4 7.2 14.6 13.9 12.0 13.9 15.7 9.4 8.7 5.5 17.5 11.1 11.3 14.8 9.7 10.4 15.6 16.2 14.2 13.9 8.8 10.7 11.6 9.2 6.1 12.4 13.7 11.4 12.4 11.1 10.6 8.5 11.8 10.5 11.3 10.3 19.2 15.9 9.7 9.8 11.6 12.7 7.5 4.4 3.4 5.2 4.2 7.4 3.1 9.1 7.0 12.0 10.8 9.4 13.0 9.8 9.8 13.0 10.4 10.1 5.6 11.1 17.1 5.4 8.0 14.7 11.2 10.1 11.8 15.0 10.0 8.1 9.5 17.0 8.2 8.9 9.4 9.0 10.2 16.9 7.7 12.1 16.6 16.5 14.0 7.7 7.4 14.3 4.1 13.9 10.4 12.2 14.7 7.7 10.1 19.1 7.9 12.7 6.0 10.1 20.1 9.9 9.1 9.3 12.3 7.9 4.6 11.4 14.2 10.9 6.7 11.4 8.3 7.4 13.8 13.2 10.0 10.7 3.4 2.5 2.0 5.5 4.1 6.0 7.5 5.1 3.2 3.1 7.0 7.0 6.2 0.2 4.2 5.2 4.4 7.4 3.1 6.4 11.3 14.0 10.6 8.7 5.5 9.7 10.4 10.7 10.3 20.8 16.0 0.0 6.9 2.2 4.8 8.5 17.8 22.7 10.3 12.2 0.0 5.7 10.0 15.6 0.3 3.1 4.2 0.0 15.9 5.0 7.6 6.2 5.8 8.2 4.1 4.8 10.3 7.4 5.1 1.5 11.2 6.7 1.7 9.0 6.1 5.2 16.4 3.5 12.4 10.0 4.3 0.0 3.1 11.4 7.8 2.3 1.7 5.0 6.0 4.7 ETNK1 "EKI, EKI1" ENSG00000139163 "Ethanolamine kinase 1" Q9HBU6 12 22625075-22690665 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 201.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010712, HPA029407" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA010712: AB_2668349, HPA029407: AB_2673026" "unprognostic (2.06e-1)" "unprognostic (7.48e-2)" "unprognostic (1.23e-3)" "unprognostic (2.19e-1)" "unprognostic (8.79e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (3.98e-3)" "unprognostic (8.30e-2)" "unprognostic (7.97e-3)" "unprognostic (2.01e-1)" "unprognostic (1.64e-2)" "unprognostic (4.53e-3)" "unprognostic (2.77e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-1)" "prognostic favorable (1.75e-4)" 15.7 17.7 15.2 41.1 19.4 13.7 16.9 19.7 22.2 12.9 33.2 16.4 14.6 27.2 16.6 24.1 14.7 13.1 27.3 10.4 15.6 23.9 22.0 30.2 19.6 18.5 17.2 15.8 17.2 14.9 15.8 30.6 13.4 18.9 13.8 19.5 15.9 16.7 14.7 8.2 17.8 24.5 10.0 17.1 18.3 53.7 22.3 17.5 33.4 17.6 8.2 16.5 14.2 18.6 16.2 10.7 28.1 17.6 14.0 15.7 13.4 6.7 14.0 15.6 14.4 11.3 11.4 11.6 8.0 6.0 8.3 8.6 10.8 17.1 20.1 7.2 5.2 8.7 5.1 13.7 3.8 15.0 16.7 11.1 16.6 6.2 9.3 10.8 15.9 15.3 7.4 3.7 11.2 9.5 13.3 10.3 7.9 19.9 8.5 11.0 4.6 17.3 32.4 30.2 8.7 9.2 15.6 13.8 16.1 13.8 9.2 5.0 8.8 8.7 7.6 12.5 22.4 11.8 15.4 8.8 6.6 10.6 8.9 12.0 6.2 7.7 21.6 8.4 10.4 11.0 28.1 11.7 12.1 12.9 17.5 12.7 16.2 14.1 11.9 10.7 13.0 15.7 15.5 11.5 14.0 17.6 9.7 15.3 13.4 15.2 19.4 19.7 22.2 15.6 23.9 17.2 15.8 18.9 17.5 44.7 25.1 40.9 63.3 128.1 40.4 11.0 53.5 72.3 35.2 41.8 47.1 27.9 23.2 26.3 201.9 28.7 55.0 0.0 39.6 20.3 28.6 70.5 33.5 38.4 37.5 25.4 103.9 27.6 78.9 26.1 22.5 44.7 64.1 22.6 52.6 21.4 29.0 46.1 20.1 26.4 35.5 38.8 44.3 47.7 15.1 148.8 63.0 39.2 36.0 60.2 ETS2 ENSG00000157557 "ETS proto-oncogene 2, transcription factor" P15036 21 38805307-38824955 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 580.2;Suprabasal keratinocytes: 425.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 16.5;granulocytes: 18.5;monocytes: 14.9" "Cell line enhanced" "Detected in many" "HEL: 60.5;hTCEpi: 55.4;hTERT-HME1: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003176 Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003176: AB_2666824" "unprognostic (2.06e-1)" "unprognostic (5.91e-2)" "unprognostic (9.16e-3)" "unprognostic (5.33e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.88e-3)" "unprognostic (7.36e-2)" "unprognostic (8.99e-3)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.89e-1)" "unprognostic (8.10e-2)" "unprognostic (7.10e-2)" 33.6 10.4 25.8 29.6 12.8 44.7 28.5 5.5 36.5 28.4 38.1 7.3 13.7 39.7 27.0 20.3 30.1 21.8 42.6 42.9 16.2 10.8 21.2 75.5 58.3 56.9 13.8 18.2 23.6 11.7 20.0 19.7 23.2 14.2 31.4 50.6 12.9 17.6 17.4 64.2 72.4 59.0 43.3 13.6 68.7 25.8 8.3 11.0 7.2 21.5 28.4 13.7 40.8 35.5 0.2 16.5 18.5 14.9 0.1 2.5 3.6 23.4 5.0 3.5 1.1 4.0 13.6 9.4 5.5 32.0 7.3 9.7 4.4 6.7 5.1 2.7 4.9 10.7 7.0 5.9 14.7 14.0 4.7 2.3 60.5 30.4 11.0 41.2 3.7 5.9 8.0 55.4 10.3 45.2 4.7 5.8 3.4 6.2 0.0 3.2 3.4 11.2 4.0 11.3 7.8 3.3 36.8 2.2 4.7 10.3 15.2 2.7 3.6 15.6 6.4 1.2 1.3 0.3 6.9 6.2 17.6 2.5 11.2 12.0 0.1 0.0 5.1 4.2 12.5 14.6 10.1 9.2 3.3 1.7 12.3 2.0 0.2 1.6 2.5 16.5 0.2 1.6 1.6 18.5 0.1 14.9 4.0 0.1 3.6 25.8 12.8 5.5 36.5 16.2 10.8 13.8 18.2 14.2 11.0 47.6 133.7 24.2 580.2 379.6 2.1 25.0 45.9 141.8 183.1 48.8 0.0 42.0 10.0 60.7 3.0 196.3 148.0 23.3 94.2 94.1 55.2 133.5 49.7 211.1 50.3 0.0 88.0 256.6 144.5 1.7 16.7 174.6 64.1 29.7 182.6 1.0 94.1 98.2 23.3 27.9 1.1 51.8 93.5 0.6 2.9 425.2 148.5 18.1 194.6 292.4 ETV6 TEL ENSG00000139083 "ETS variant 6" P41212 12 11649854-11895402 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 39.7;NB-4: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA000264 Enhanced Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA000264: AB_611466" "unprognostic (4.03e-3)" "unprognostic (3.08e-2)" "unprognostic (7.54e-3)" "unprognostic (2.60e-1)" "unprognostic (2.07e-1)" "unprognostic (1.35e-3)" "unprognostic (2.74e-2)" "unprognostic (4.02e-2)" "unprognostic (3.16e-1)" "unprognostic (9.46e-2)" "prognostic unfavorable (9.38e-5)" "unprognostic (1.15e-1)" "prognostic unfavorable (4.66e-8)" "unprognostic (1.33e-2)" "unprognostic (5.99e-2)" "unprognostic (8.92e-2)" "prognostic favorable (1.54e-5)" 17.2 8.9 5.1 20.0 7.6 32.8 20.4 1.6 9.1 10.5 14.5 6.0 9.8 7.2 10.8 14.2 11.3 8.9 15.3 6.7 5.6 3.8 9.2 9.6 16.0 13.4 6.0 3.1 10.5 10.4 8.4 8.7 7.7 7.4 14.9 11.0 8.0 41.9 12.4 6.9 23.9 14.6 25.0 9.4 17.8 9.7 4.7 5.7 30.6 10.0 10.0 19.9 19.0 15.8 2.9 6.2 11.4 7.1 2.4 2.2 1.3 2.6 3.5 3.2 5.6 2.5 2.3 3.9 1.9 3.3 2.5 3.0 0.2 12.4 2.2 1.9 3.3 3.0 3.4 1.4 5.9 3.1 39.7 0.7 14.0 1.9 1.3 3.1 14.7 15.3 4.6 3.7 2.5 5.2 4.9 7.6 10.2 1.0 7.4 2.3 1.7 8.3 21.1 5.3 2.7 0.9 2.3 3.1 5.7 5.8 16.5 0.6 3.3 3.8 3.7 3.6 5.4 1.2 9.3 8.6 5.7 4.9 1.9 4.1 3.3 2.5 1.2 3.7 0.1 6.5 5.6 5.7 6.6 1.5 6.6 2.0 2.9 2.2 1.4 4.1 2.3 1.3 0.8 11.4 2.4 7.1 6.2 1.4 1.3 5.1 7.6 1.6 9.1 5.6 3.8 6.0 3.1 7.4 5.7 6.0 8.1 21.4 28.1 13.3 1.9 7.5 17.8 28.1 22.7 14.0 5.9 11.8 1.7 15.2 4.5 23.5 22.5 0.0 30.8 3.6 10.8 33.7 10.4 9.3 17.1 0.0 31.2 38.6 48.1 3.6 7.2 48.8 27.0 40.5 26.8 4.8 31.2 24.9 10.3 7.9 4.0 19.4 28.8 0.6 7.0 19.6 7.2 14.6 20.4 60.6 EVA1B "C1orf78, FAM176B, FLJ10647" ENSG00000142694 "Eva-1 homolog B" Q9NVM1 1 36322031-36324154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 229.9;Ito cells: 91.4;Syncytiotrophoblasts: 134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 20.0;NB-4: 24.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041928, HPA043537" Approved Approved Cytosol NA NA Cytosol "HPA041928: AB_2677752, HPA043537: AB_2678538" "prognostic favorable (4.58e-4)" "unprognostic (5.66e-3)" "unprognostic (1.04e-3)" "unprognostic (3.20e-2)" "unprognostic (1.22e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (4.82e-4)" "unprognostic (1.45e-1)" "unprognostic (8.33e-2)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.79e-5)" "unprognostic (1.87e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" 7.2 5.9 3.3 5.0 2.6 3.1 10.6 1.7 3.7 9.4 4.4 2.5 4.1 8.9 9.8 3.8 4.1 5.1 4.2 7.7 2.4 1.1 10.5 2.8 6.3 8.1 3.4 1.7 8.9 1.9 1.3 2.0 23.3 3.2 7.4 0.5 2.9 7.8 4.3 3.6 6.9 8.1 6.4 3.4 10.4 3.9 5.1 2.9 2.6 9.2 1.7 2.5 5.4 8.3 0.0 1.1 5.8 2.1 3.5 2.2 0.3 2.8 1.7 1.4 2.6 5.2 14.7 7.6 20.0 13.6 3.4 3.8 2.9 2.0 0.4 6.6 5.8 0.7 4.4 0.1 0.7 0.7 2.3 4.9 2.6 1.8 2.3 11.1 0.1 1.5 13.1 0.0 4.2 0.4 5.3 5.2 0.7 0.9 1.0 2.2 3.3 0.1 24.7 1.6 0.2 7.7 1.6 0.3 4.2 2.7 0.6 1.1 3.4 2.0 2.2 7.9 2.2 0.3 1.8 8.8 5.4 0.6 7.9 2.2 1.1 0.3 0.6 3.2 1.6 4.4 5.8 2.1 0.0 0.4 0.8 1.4 0.0 0.8 1.2 1.1 0.0 0.0 0.1 3.7 3.5 0.3 0.0 2.2 0.3 3.3 2.6 1.7 3.7 2.4 1.1 3.4 1.7 3.2 2.9 0.0 0.0 6.9 16.7 14.3 0.0 1.6 2.5 0.0 1.2 7.0 0.0 44.7 1.7 17.7 5.6 44.2 0.2 0.0 12.8 229.9 52.8 37.6 4.6 0.4 40.9 0.0 0.0 91.4 28.8 20.1 46.9 15.6 11.8 6.4 0.0 10.9 23.2 0.0 45.6 6.3 0.5 25.8 41.1 9.3 2.4 10.8 134.9 9.5 0.2 17.8 EVC DWF-1 ENSG00000072840 "EvC ciliary complex subunit 1" P57679 4 5711197-5814305 "Disease related genes, Predicted membrane proteins" "Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 8.0;Melanocytes: 5.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 26.4;hTERT-HME1: 26.4;hTERT-RPE1: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008703, HPA016046" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008703: AB_1078765, HPA016046: AB_1848299" "unprognostic (1.69e-1)" "unprognostic (5.39e-2)" "unprognostic (1.15e-1)" "unprognostic (6.58e-2)" "unprognostic (6.61e-2)" "unprognostic (9.37e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-2)" "unprognostic (9.63e-2)" "unprognostic (2.82e-1)" "prognostic favorable (5.60e-9)" "unprognostic (3.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "prognostic unfavorable (9.47e-5)" 5.0 2.9 2.5 4.6 2.7 0.0 4.1 1.9 2.3 13.2 4.3 1.8 8.4 0.6 17.2 10.1 6.0 8.1 16.0 3.8 2.2 2.2 26.5 3.7 6.4 1.0 2.3 1.4 20.2 9.2 14.9 2.3 1.8 2.9 10.2 1.6 12.0 9.1 5.7 2.4 4.2 2.8 15.8 2.4 2.1 3.6 5.3 1.0 1.0 6.9 3.9 3.8 7.5 9.0 0.1 0.3 1.2 0.1 0.1 0.5 0.0 3.0 3.9 2.2 5.7 14.3 20.7 0.8 6.9 26.4 8.0 10.4 0.0 0.0 0.0 2.2 10.9 13.4 3.7 2.3 5.7 6.6 5.1 1.5 0.0 2.2 1.0 10.6 0.0 0.6 10.2 8.4 10.7 26.4 22.9 5.5 0.0 0.0 0.0 18.5 0.0 0.0 0.0 2.4 0.0 3.6 4.7 6.0 0.0 2.8 0.5 1.2 3.7 0.0 0.0 2.8 2.2 1.4 0.2 9.6 6.8 1.3 4.8 6.0 4.2 3.4 0.3 19.6 0.0 6.4 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.3 0.5 0.0 2.5 2.7 1.9 2.3 2.2 2.2 2.3 1.4 2.9 1.0 3.0 2.9 0.0 1.6 3.1 0.0 1.6 2.5 1.4 1.2 3.5 0.0 0.0 1.7 0.4 0.4 0.0 0.0 0.0 0.0 0.0 8.0 0.7 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.9 0.0 5.0 0.0 0.0 2.1 0.2 0.0 0.7 1.1 0.0 0.0 1.7 0.0 0.0 2.5 0.1 0.0 0.0 1.1 EVL RNB6 ENSG00000196405 Enah/Vasp-like Q9UI08 14 99971449-100144236 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 98.2" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 421.2;T-cells: 371.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 71.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018849, HPA019536, CAB033987" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180" "unprognostic (1.12e-3)" "unprognostic (5.03e-3)" "unprognostic (6.46e-3)" "unprognostic (2.70e-1)" "unprognostic (2.65e-1)" "unprognostic (2.27e-3)" "unprognostic (3.65e-2)" "unprognostic (2.35e-1)" "unprognostic (2.06e-1)" "unprognostic (6.35e-3)" "prognostic favorable (4.07e-6)" "unprognostic (3.50e-3)" "prognostic unfavorable (4.14e-6)" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-3)" "unprognostic (2.43e-1)" 14.5 15.0 50.9 37.0 57.8 19.9 28.5 57.4 66.2 11.8 12.4 20.7 10.7 12.7 23.6 25.1 11.2 18.0 20.1 19.7 42.4 43.3 12.4 24.4 28.4 63.5 34.8 31.4 23.3 17.1 9.8 28.6 13.5 26.2 16.4 12.0 24.2 20.0 16.5 12.8 15.6 18.7 29.4 23.1 44.2 15.2 13.2 20.3 98.2 11.0 7.5 55.8 18.3 9.3 7.8 2.5 14.2 8.7 9.3 20.6 5.4 4.1 3.6 27.6 8.3 5.6 16.0 16.0 5.4 6.9 3.5 4.9 0.2 2.8 7.8 7.2 4.9 3.0 0.1 13.0 9.4 4.4 8.4 8.2 12.8 2.9 2.2 4.6 3.8 30.4 8.5 4.8 2.4 9.4 7.8 9.6 29.8 6.4 0.5 3.9 5.6 71.4 20.5 5.8 3.6 5.4 17.2 14.3 1.3 4.5 0.1 33.5 19.7 3.8 5.9 1.6 6.8 4.6 11.3 5.9 2.9 4.6 18.0 3.0 14.6 11.0 21.9 3.9 6.5 4.7 1.5 1.5 14.2 11.6 7.6 8.9 6.2 13.6 11.0 2.5 7.8 16.5 14.6 0.3 9.3 8.7 0.4 20.6 5.4 50.9 57.8 57.4 66.2 42.4 43.3 34.8 31.4 26.2 20.3 26.8 48.9 156.1 17.2 18.4 110.7 4.1 20.4 32.1 12.5 12.2 379.0 17.5 26.6 12.5 2.9 40.5 1.7 0.0 11.9 10.1 19.8 14.8 16.2 95.1 134.9 73.1 8.1 33.2 56.1 8.6 23.0 74.9 25.3 0.0 0.9 52.0 14.3 1.1 46.7 11.5 421.2 6.5 20.8 13.4 26.7 27.5 12.2 371.9 1.5 13.9 EVPL EVPK ENSG00000167880 Envoplakin Q92817 17 76004502-76027452 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 21.6;Intestinal endocrine cells: 19.7;Suprabasal keratinocytes: 22.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 24.7;MCF7: 16.1;RT4: 35.7;SK-BR-3: 17.8;T-47d: 22.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB002220, HPA053969" Enhanced Supported "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "CAB002220: AB_563701, HPA053969: AB_2682326" "unprognostic (2.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (4.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-2)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-1)" "unprognostic (7.40e-3)" "unprognostic (2.64e-1)" "unprognostic (2.40e-2)" "unprognostic (2.31e-1)" "unprognostic (3.47e-1)" "unprognostic (7.93e-2)" "unprognostic (3.09e-2)" 0.2 0.0 0.0 2.3 0.1 1.1 1.2 0.0 0.3 11.6 5.7 0.1 2.8 4.8 1.9 1.3 69.9 0.9 4.1 0.0 0.0 0.0 4.8 0.0 5.7 0.2 0.0 0.0 0.4 2.4 1.8 1.1 2.3 0.1 3.2 0.7 0.7 10.9 4.5 0.5 43.7 7.8 2.1 0.2 0.1 1.9 0.3 0.1 0.4 6.3 43.1 46.1 5.0 21.6 0.4 1.7 1.9 0.3 1.6 1.4 0.0 11.2 9.5 0.0 0.1 0.1 0.0 4.0 0.1 0.0 0.0 0.0 1.2 6.8 0.0 0.0 0.0 0.0 24.7 0.0 3.1 0.0 0.0 0.0 0.2 7.0 7.1 0.0 0.0 1.8 0.0 5.1 0.1 0.0 0.0 0.0 1.6 0.0 0.5 0.0 16.1 0.4 1.5 0.0 5.1 4.3 4.6 0.0 0.1 7.4 35.7 0.4 0.0 4.7 17.8 0.0 0.0 22.5 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.0 1.0 0.3 0.7 0.6 0.3 0.7 0.2 0.2 0.5 0.1 0.4 1.4 0.6 1.9 1.6 0.2 1.7 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 17.9 21.6 0.0 4.0 10.4 0.0 2.2 5.1 6.7 11.4 5.2 0.0 0.1 1.7 3.7 0.0 0.0 12.7 0.0 0.5 0.1 0.7 3.8 11.6 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.9 0.6 1.7 0.0 3.7 0.0 5.7 6.8 1.8 2.9 0.0 0.0 0.5 0.1 1.1 22.6 0.0 0.0 9.3 10.3 EXO5 "C1orf176, DEM1, FLJ21144" ENSG00000164002 "Exonuclease 5" Q9H790 1 40508741-40516556 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 57.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028429 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028429: AB_2092105" "unprognostic (9.44e-2)" "unprognostic (7.36e-2)" "unprognostic (3.69e-2)" "unprognostic (6.65e-2)" "unprognostic (1.66e-1)" "unprognostic (3.23e-2)" "prognostic unfavorable (9.16e-6)" "unprognostic (4.65e-2)" "unprognostic (2.24e-3)" "unprognostic (1.91e-3)" "unprognostic (4.78e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (9.95e-3)" "unprognostic (4.36e-2)" "unprognostic (4.13e-1)" "unprognostic (9.85e-3)" "unprognostic (2.53e-1)" 8.6 9.1 9.9 8.6 12.4 6.5 16.9 13.9 10.4 8.6 8.4 5.5 11.1 6.9 11.7 8.9 8.5 8.4 7.5 10.3 8.5 5.9 9.9 10.7 8.3 12.3 6.4 10.2 7.5 8.1 8.4 6.9 8.1 6.5 8.9 8.4 7.3 9.0 11.8 6.2 8.2 10.0 12.5 6.1 13.8 7.2 10.1 7.5 15.7 7.3 5.8 16.9 8.6 10.8 11.8 7.9 16.4 9.8 8.6 14.9 7.0 5.5 2.0 5.0 8.3 3.3 3.0 3.4 7.5 1.9 6.8 8.2 3.5 6.7 7.5 4.7 4.8 7.7 6.9 4.8 5.0 8.2 2.5 3.1 6.5 9.4 4.9 4.1 0.0 6.5 3.1 3.2 9.4 3.5 2.0 4.3 5.3 7.5 0.0 9.7 2.3 10.2 5.1 7.5 0.9 0.8 7.8 16.9 2.9 3.4 8.6 6.0 5.3 9.7 3.5 6.2 7.9 4.9 57.6 4.7 4.7 14.1 10.5 7.3 2.2 6.9 0.0 0.6 2.0 9.3 7.5 6.6 16.4 14.9 9.8 12.3 11.8 10.4 10.7 7.9 9.8 12.8 12.4 11.3 8.6 7.2 6.4 13.4 7.0 9.9 12.4 13.9 10.4 8.5 5.9 6.4 10.2 6.5 7.5 0.0 1.7 1.4 0.9 0.8 3.0 0.8 2.5 2.7 2.3 7.0 3.9 3.8 0.0 4.1 0.9 2.5 1.7 0.0 2.1 4.4 2.5 0.7 5.7 1.8 4.4 3.2 1.2 1.8 1.5 0.8 3.1 2.1 1.7 5.4 3.0 4.3 2.6 2.0 1.8 2.1 3.2 6.5 2.3 3.9 3.2 0.9 1.6 2.2 3.7 0.3 EXOC1 "BM-102, FLJ10893, SEC3, SEC3L1, Sec3p" ENSG00000090989 "Exocyst complex component 1" Q9NV70 4 55853616-55905034 "Predicted intracellular proteins, Transporters" "Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037706, HPA044873" Uncertain Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Plasma membrane" "Microtubules, Cytosol" "HPA037706: AB_10670525, HPA044873: AB_2679125" "unprognostic (7.10e-3)" "unprognostic (4.48e-2)" "unprognostic (8.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.81e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (2.63e-4)" "unprognostic (2.84e-3)" "unprognostic (4.65e-2)" "unprognostic (2.04e-2)" "unprognostic (4.03e-3)" "unprognostic (1.55e-1)" "unprognostic (1.94e-1)" "unprognostic (3.11e-1)" "unprognostic (2.93e-2)" "unprognostic (6.24e-2)" "prognostic favorable (5.50e-5)" 21.2 19.7 20.7 21.0 24.0 12.9 25.3 22.8 40.7 18.4 20.2 18.2 14.6 18.9 20.8 24.6 32.7 18.3 17.9 19.8 26.9 23.6 18.7 11.4 26.2 29.2 24.7 22.8 18.2 14.9 29.7 20.0 23.4 30.7 16.8 22.4 12.9 20.3 19.2 14.6 31.6 20.5 18.4 29.1 23.7 17.5 18.5 21.5 19.1 19.0 15.8 21.9 18.8 21.4 7.3 11.7 16.4 18.1 10.1 9.2 6.3 11.5 6.7 12.1 13.9 20.9 26.2 8.1 16.3 16.5 13.4 14.1 4.6 20.2 11.2 11.5 17.5 16.2 13.9 9.8 13.0 19.3 5.9 6.8 10.3 8.4 5.4 19.7 11.2 14.7 21.1 17.8 13.9 15.4 17.4 21.8 8.7 14.8 11.0 29.0 7.3 8.1 11.4 7.6 16.6 12.8 9.5 9.0 9.0 14.9 12.7 9.0 16.0 9.8 16.1 13.5 10.8 10.2 12.1 26.2 16.6 13.6 14.2 14.0 13.3 6.6 9.9 21.6 12.5 15.7 15.2 12.1 10.4 5.8 15.7 7.5 7.3 8.2 8.2 11.7 6.7 7.4 5.4 16.4 10.1 18.1 5.3 9.2 6.3 20.7 24.0 22.8 40.7 26.9 23.6 24.7 22.8 30.7 21.5 38.7 29.4 13.7 12.5 30.9 45.5 26.4 20.4 44.2 26.1 21.0 29.5 53.7 16.6 18.4 31.3 32.2 30.4 0.0 17.4 27.7 28.1 16.9 34.8 9.7 35.9 27.0 21.4 41.7 40.5 10.6 19.8 36.1 38.8 19.8 26.7 45.2 26.5 28.1 22.3 14.0 30.3 32.3 21.4 27.7 34.1 34.9 42.8 18.8 25.1 19.6 EXOC3L2 "FLJ36147, XTP7" ENSG00000283632 "Exocyst complex component 3 like 2" Q2M3D2 19 45212621-45245431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "Ito cells: 57.1" "Group enriched" "Detected in some" 4 "basophil: 1.6;neutrophil: 2.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.5" "Group enriched" "Detected in some" 7 "HEL: 18.2;K-562: 16.8" "HPA041595, HPA061110" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" NA NA Vesicles "Nucleoplasm, Golgi apparatus, Cytosol" "HPA041595: AB_10794521, HPA061110: AB_2684431" 3.2 4.3 0.0 2.0 0.0 0.9 3.0 0.0 0.3 3.6 2.1 0.1 2.4 2.3 14.5 1.2 2.3 0.6 6.9 1.9 0.0 12.7 9.4 3.4 6.3 0.0 0.0 3.4 2.8 2.4 3.5 0.4 0.0 3.7 0.2 13.7 3.3 3.6 1.0 2.4 3.9 1.6 0.0 12.6 2.4 2.1 0.0 0.0 4.6 1.5 3.2 1.6 3.3 0.5 0.3 2.5 0.4 0.2 0.4 0.2 0.1 0.3 2.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.1 2.2 0.0 0.2 1.2 0.0 0.1 0.0 0.1 0.0 18.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 16.8 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.5 1.3 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.7 0.1 0.3 0.4 0.8 1.6 0.3 0.1 0.2 0.1 0.0 0.1 0.2 0.1 1.6 0.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.3 2.5 0.2 0.3 0.3 0.1 0.2 0.0 2.2 0.0 0.3 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 57.1 1.5 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.2 3.4 0.6 0.0 0.0 0.0 0.1 EXOC4 "KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p" ENSG00000131558 "Exocyst complex component 4" Q96A65 7 133253073-134066589 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Rod photoreceptor cells: 229.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031443, HPA031444" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA031443: AB_10602496, HPA031444: AB_2673886" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (2.05e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (8.63e-2)" "unprognostic (2.33e-1)" "unprognostic (4.40e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (9.78e-3)" "prognostic favorable (6.85e-5)" "unprognostic (5.91e-2)" "unprognostic (2.18e-1)" "unprognostic (3.37e-1)" "unprognostic (3.35e-2)" 21.2 23.7 18.5 17.7 22.3 10.5 19.4 25.7 24.4 20.8 17.0 19.7 22.2 11.2 25.8 20.6 21.5 24.2 16.8 16.5 14.7 15.4 15.6 15.2 16.5 12.6 14.2 19.3 27.7 26.5 28.5 31.2 16.4 22.0 16.9 18.8 19.3 20.5 18.8 50.7 24.4 13.7 20.8 18.7 17.9 16.3 17.2 17.3 34.7 22.9 18.3 22.1 26.3 20.6 8.3 16.3 8.1 12.7 18.4 12.4 10.4 17.8 14.7 20.4 20.1 23.9 25.0 7.1 13.1 21.9 11.9 15.7 8.5 25.2 13.4 9.5 24.6 17.5 11.4 10.9 17.9 19.8 20.4 13.1 10.8 15.5 8.9 26.3 14.2 11.8 24.3 22.4 17.0 31.5 26.4 20.3 17.8 15.5 13.4 22.1 11.7 25.8 15.7 15.3 21.5 13.8 11.5 18.1 24.1 19.2 16.0 15.9 25.1 19.7 18.2 21.1 24.0 12.0 13.4 22.0 13.3 7.0 14.0 14.3 21.3 13.0 13.0 39.3 16.7 20.2 8.1 12.0 6.9 11.8 12.7 10.5 8.3 12.3 12.4 16.3 8.0 10.1 10.4 4.0 18.4 10.5 7.3 12.4 10.4 18.5 22.3 25.7 24.4 14.7 15.4 14.2 19.3 22.0 17.3 20.8 21.1 11.9 14.2 16.8 35.3 24.9 7.6 18.7 15.9 14.0 88.4 13.6 3.3 12.9 23.1 21.5 15.8 0.0 15.7 13.8 11.9 17.0 8.1 14.4 15.6 47.7 16.7 24.5 30.4 20.6 16.1 18.0 13.5 12.6 21.4 20.6 13.9 17.5 17.7 13.3 229.7 12.9 10.8 18.1 12.6 14.9 9.4 20.8 18.4 16.9 EXOC6B "KIAA0919, SEC15B, SEC15L2" ENSG00000144036 "Exocyst complex component 6B" Q9Y2D4 2 72175984-72826041 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 51.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034546, HPA063991" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA034546: AB_2674218, HPA063991: AB_2685168" "unprognostic (5.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.18e-3)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "unprognostic (1.06e-2)" "unprognostic (9.34e-2)" "unprognostic (1.32e-1)" "unprognostic (2.16e-3)" "unprognostic (3.38e-2)" "unprognostic (2.61e-1)" "unprognostic (4.35e-3)" "unprognostic (4.38e-3)" "unprognostic (1.55e-1)" "unprognostic (1.18e-1)" "unprognostic (5.29e-2)" 12.1 14.2 17.9 5.7 23.0 1.9 9.5 19.8 23.3 10.2 7.2 18.0 6.0 8.4 11.8 7.5 16.5 8.7 7.8 51.7 18.3 14.4 8.8 4.8 7.9 3.8 18.5 17.0 17.4 6.0 18.6 11.2 34.7 19.8 9.7 7.0 7.3 7.6 10.9 11.2 27.5 10.7 11.6 15.0 6.0 8.0 7.7 20.4 3.1 11.7 7.8 7.3 9.5 12.6 3.0 1.7 3.2 2.0 1.6 3.4 1.2 11.0 8.4 7.8 9.4 22.4 9.3 13.5 8.1 11.5 7.0 4.6 11.4 1.7 2.9 5.1 13.5 10.5 18.5 6.5 13.4 10.2 2.1 5.3 8.5 5.9 6.5 12.1 1.2 2.9 7.9 19.5 7.9 12.4 11.1 11.4 4.5 0.9 0.0 9.2 3.8 3.2 1.5 8.1 7.6 4.7 1.7 14.0 1.1 6.8 26.0 3.9 3.4 13.9 4.3 5.6 9.0 3.0 1.1 12.6 8.2 7.0 6.9 4.9 2.9 2.9 0.0 9.5 0.6 6.5 3.2 1.9 0.2 2.7 1.7 2.1 2.4 2.1 1.7 1.7 3.0 2.4 3.4 0.0 1.6 2.0 0.6 2.6 1.2 17.9 23.0 19.8 22.8 18.3 14.4 18.5 17.0 19.8 20.4 0.0 5.5 0.0 9.0 23.2 16.7 77.2 15.3 8.1 2.3 8.7 23.6 12.0 5.0 7.6 41.6 13.1 12.8 0.0 10.1 10.9 6.2 6.3 8.1 4.9 4.0 15.9 2.9 9.2 9.1 4.0 7.8 4.5 5.0 1.0 4.1 9.1 8.3 8.6 7.1 4.1 9.9 0.0 8.9 8.7 4.8 32.6 20.6 2.5 3.8 7.8 EXOC7 "BLOM4, EXO70, Exo70p, KIAA1067, YJL085W" ENSG00000182473 "Exocyst complex component 7" Q9UPT5 17 76081017-76121576 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022840, HPA022842" Supported Approved "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA022840: AB_1848316, HPA022842: AB_1848317" "unprognostic (5.20e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "unprognostic (3.49e-2)" "unprognostic (2.37e-2)" "unprognostic (1.88e-1)" "unprognostic (1.30e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (7.39e-3)" "unprognostic (1.53e-2)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" "unprognostic (1.05e-1)" "unprognostic (1.18e-1)" 23.2 22.2 30.5 18.2 37.1 27.5 20.4 27.8 46.2 23.8 24.4 33.0 20.8 19.1 28.7 20.8 31.8 32.6 21.3 27.5 29.2 23.5 21.0 22.6 21.2 17.6 20.9 28.2 31.5 24.1 40.5 29.3 24.0 34.6 30.0 17.0 27.0 29.2 27.9 24.0 21.8 21.6 31.1 21.7 21.4 19.6 14.5 23.0 23.7 29.5 14.1 26.4 30.2 20.5 12.8 13.7 29.6 34.4 15.5 17.9 19.0 21.6 27.0 24.9 20.2 23.7 16.8 25.9 19.9 26.7 36.2 26.2 22.7 14.7 11.3 14.7 34.8 22.9 17.9 15.0 19.4 24.3 9.7 20.3 18.6 21.2 23.9 16.5 20.7 19.4 23.5 15.4 28.0 13.7 25.7 40.0 20.5 12.4 11.5 22.5 20.0 33.3 9.2 13.1 16.3 28.8 18.0 42.7 11.4 20.8 45.1 13.6 31.8 22.6 16.8 15.5 25.0 27.5 17.1 26.1 38.8 23.4 25.6 21.9 15.9 5.8 10.4 23.2 9.4 20.0 21.1 19.2 29.6 17.9 26.6 12.3 12.4 13.7 15.3 13.7 12.8 14.5 12.2 22.2 15.5 34.4 5.9 14.8 19.0 30.5 37.1 27.8 46.2 29.2 23.5 20.9 28.2 34.6 23.0 17.9 34.9 47.7 30.5 17.5 78.7 6.4 35.7 32.1 27.3 38.4 135.5 45.1 28.2 34.4 17.9 25.1 47.9 23.3 32.5 23.9 29.3 37.9 39.4 22.8 32.8 63.5 46.8 27.6 25.9 31.6 34.5 25.7 23.6 33.3 34.6 62.0 34.4 38.6 36.0 28.6 102.9 45.3 31.0 26.8 16.6 17.3 59.5 38.9 27.8 37.5 EXOC8 "EXO84, Exo84p, SEC84" ENSG00000116903 "Exocyst complex component 8" Q8IYI6 1 231332753-231337852 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027438 Approved Approved Cytosol NA NA Cytosol "HPA027438: AB_1848318" "unprognostic (3.85e-2)" "unprognostic (6.52e-2)" "unprognostic (1.11e-1)" "unprognostic (2.05e-2)" "unprognostic (4.83e-2)" "unprognostic (5.82e-2)" "unprognostic (4.85e-2)" "unprognostic (1.55e-1)" "unprognostic (2.34e-1)" "unprognostic (2.69e-1)" "unprognostic (2.09e-2)" "unprognostic (1.74e-1)" "unprognostic (8.39e-2)" "unprognostic (1.77e-1)" "unprognostic (3.79e-2)" "unprognostic (2.21e-2)" "unprognostic (1.04e-1)" 12.1 9.3 10.4 11.2 9.6 22.1 10.3 14.8 12.8 8.6 8.6 9.9 9.5 8.8 9.3 7.6 11.1 8.5 7.7 9.0 9.2 10.3 9.2 11.2 9.5 12.6 9.1 9.9 11.2 11.2 17.1 11.9 14.4 11.9 8.7 7.3 6.7 9.5 9.9 26.7 12.2 11.4 6.8 9.0 13.0 10.1 6.7 9.3 16.9 12.9 9.2 13.3 7.7 9.9 1.8 2.1 6.0 3.8 2.0 3.5 1.2 7.4 8.2 5.0 5.1 13.1 10.7 12.2 9.1 7.7 6.9 6.5 7.7 7.5 8.4 8.1 9.0 6.2 12.2 7.2 9.8 7.6 10.9 17.6 5.1 10.4 4.9 7.4 8.9 14.2 10.7 10.8 10.1 9.7 8.1 8.4 8.8 9.3 20.2 10.9 3.8 8.3 5.5 7.6 9.3 7.0 5.5 7.8 10.8 8.6 8.6 6.7 7.2 9.2 12.1 8.9 4.1 11.6 13.0 11.4 9.3 6.6 12.4 15.9 15.2 8.7 9.2 10.7 8.1 11.7 4.5 1.8 3.3 1.3 2.3 1.6 1.2 1.7 1.5 1.3 1.8 2.0 3.5 6.0 2.0 3.8 2.1 1.5 1.2 10.4 9.6 14.8 12.8 9.2 10.3 9.1 9.9 11.9 9.3 8.9 9.8 9.0 4.6 16.5 3.9 6.7 12.7 2.7 9.1 8.7 5.9 3.6 1.7 2.9 0.8 9.2 6.3 23.3 3.1 2.5 5.3 4.9 2.3 8.2 4.8 3.2 4.6 8.6 12.3 0.4 3.7 6.4 3.3 2.8 4.5 5.7 4.0 0.0 5.3 4.1 11.6 0.0 3.8 4.9 4.7 12.9 7.8 7.7 3.8 6.5 EXOSC10 "p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p" ENSG00000171824 "Exosome component 10" Q01780 1 11066618-11099881 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028470, HPA028484, CAB037141" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" No No "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250" "unprognostic (1.23e-2)" "unprognostic (3.46e-2)" "unprognostic (1.85e-2)" "unprognostic (1.62e-1)" "unprognostic (6.88e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (2.49e-6)" "unprognostic (3.36e-1)" "unprognostic (4.66e-2)" "unprognostic (2.52e-1)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (7.68e-3)" "unprognostic (3.43e-1)" "unprognostic (9.03e-2)" "prognostic favorable (5.27e-4)" "unprognostic (1.33e-1)" 28.2 21.8 30.4 22.1 31.9 30.8 27.9 58.8 34.7 24.8 22.0 31.9 22.4 18.5 27.0 22.9 27.6 22.7 18.3 18.3 27.8 16.2 22.4 18.2 20.8 26.0 31.5 26.3 31.2 24.2 23.1 32.1 23.5 24.3 22.1 25.9 20.4 24.6 20.5 27.3 33.2 22.7 25.6 23.2 26.0 25.2 20.3 32.7 28.2 20.8 12.5 29.9 23.6 24.6 21.0 21.6 24.8 26.4 27.5 25.9 22.3 23.4 15.0 31.5 12.1 16.8 18.6 18.0 23.2 17.1 40.9 37.2 22.1 34.4 23.7 15.1 22.0 18.2 23.4 34.8 25.9 37.6 26.5 34.8 34.4 29.5 22.4 16.5 27.9 27.4 14.6 22.4 40.1 23.7 15.3 25.4 21.2 36.1 21.9 22.5 13.2 27.4 25.8 20.8 18.0 18.0 28.3 26.8 20.7 24.0 12.0 20.3 19.9 25.0 21.7 27.8 23.1 18.9 25.8 23.0 21.9 22.7 19.6 27.1 13.3 20.8 46.9 22.3 41.7 26.2 24.8 18.2 14.6 22.2 23.4 25.9 21.0 23.1 22.1 21.6 19.9 19.8 22.0 3.6 27.5 26.4 11.0 21.8 22.3 30.4 31.9 58.8 34.7 27.8 16.2 31.5 26.3 24.3 32.7 26.8 16.5 14.1 12.2 11.7 15.3 5.6 10.2 32.1 35.2 5.2 45.2 23.7 8.3 21.4 12.5 17.4 11.3 0.0 27.7 27.8 14.3 7.5 18.6 8.1 21.3 20.6 8.6 12.9 13.8 5.4 27.3 19.0 11.8 23.4 14.7 5.6 24.4 11.9 21.5 6.7 34.8 12.9 11.3 20.9 22.8 11.7 19.0 16.2 16.2 8.0 EXOSC4 "FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p" ENSG00000178896 "Exosome component 4" Q9NPD3 8 144078626-144080647 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 251.1;Late spermatids: 557.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 91.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024792, HPA065103" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA024792: AB_1848325, HPA065103: " "unprognostic (2.32e-1)" "unprognostic (1.55e-2)" "unprognostic (3.06e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.58e-3)" "unprognostic (1.26e-1)" "unprognostic (8.36e-2)" "prognostic favorable (2.23e-4)" "unprognostic (4.32e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (2.71e-1)" "unprognostic (5.11e-2)" 12.3 16.7 12.8 11.4 17.6 13.8 8.9 13.9 20.6 8.1 12.0 10.5 13.6 15.8 9.8 10.4 14.5 10.0 9.3 16.5 11.4 11.2 14.9 21.5 8.7 11.4 11.5 13.0 10.3 15.0 8.0 10.2 11.5 12.0 12.1 6.5 11.6 28.0 14.7 12.1 12.7 11.1 6.7 9.3 13.4 13.9 45.0 9.7 14.8 10.8 10.4 11.1 8.7 7.8 24.7 38.2 19.0 31.8 17.1 16.1 18.8 10.3 22.9 4.1 9.8 3.5 2.7 11.2 8.2 3.4 6.4 6.5 16.0 7.3 6.3 12.0 3.4 4.6 8.6 7.5 8.9 1.9 8.3 25.5 9.0 17.1 17.7 5.9 6.7 10.8 3.8 9.2 7.4 5.9 2.5 3.3 6.9 14.1 4.3 5.2 37.9 10.4 13.3 10.6 11.0 91.9 4.6 6.7 16.3 6.1 10.6 12.9 17.0 10.2 13.2 18.8 2.2 15.0 10.2 3.2 6.6 14.5 15.8 13.8 11.4 13.6 7.9 9.5 10.8 10.3 19.0 31.8 12.5 15.9 29.4 16.1 22.0 12.4 15.4 29.8 24.7 15.9 15.4 9.2 17.1 16.1 38.2 13.7 18.8 12.8 17.6 13.9 20.6 11.4 11.2 11.5 13.0 12.0 9.7 8.9 24.2 15.2 27.4 83.9 8.8 18.2 20.4 18.7 12.5 26.2 7.9 39.9 104.5 49.6 251.1 24.8 32.9 0.0 40.1 34.1 31.5 24.7 13.9 52.3 40.4 6.4 24.9 20.9 31.4 557.6 17.3 24.1 33.7 54.1 29.8 14.1 51.1 45.6 19.8 81.3 6.8 12.9 40.6 52.4 33.8 76.9 40.3 13.8 40.1 33.2 EXTL2 ENSG00000162694 "Exostosin like glycosyltransferase 2" Q9UBQ6 1 100872372-100895998 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 175.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020716, HPA068921" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 83000000 Nucleoplasm Cytosol "CAB020716: , HPA068921: AB_2686058" "unprognostic (3.14e-1)" "unprognostic (6.34e-2)" "unprognostic (1.50e-2)" "unprognostic (8.20e-2)" "unprognostic (9.07e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (1.10e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (3.00e-1)" "unprognostic (3.17e-2)" "unprognostic (6.84e-2)" "unprognostic (7.83e-2)" "unprognostic (1.24e-2)" "unprognostic (4.34e-2)" 7.5 23.0 9.8 4.1 19.9 1.7 10.4 14.7 22.8 13.4 8.7 8.1 9.9 4.5 16.7 13.1 6.0 10.1 10.3 8.2 9.5 13.3 11.2 10.0 7.6 3.4 14.0 12.0 18.8 7.7 17.5 18.7 21.8 20.1 12.3 7.1 8.6 6.0 11.4 5.3 5.9 4.6 15.4 11.4 5.4 6.2 9.7 16.3 6.4 9.3 5.0 3.4 9.0 6.2 2.1 7.4 3.3 1.1 5.3 5.6 1.9 5.2 2.7 20.1 21.0 22.3 16.5 12.8 9.0 14.9 7.1 15.9 2.6 4.0 5.8 8.8 8.3 5.6 5.1 7.3 7.7 14.4 11.8 5.1 7.1 9.7 7.2 7.3 11.0 3.8 19.5 2.7 14.2 2.8 15.0 25.9 7.4 8.9 0.7 17.9 2.7 5.8 6.1 25.3 4.7 6.1 4.2 20.7 4.7 7.6 4.0 8.3 23.6 6.9 1.8 16.2 15.3 4.3 5.0 10.8 17.8 10.5 11.4 9.5 6.2 5.5 3.6 28.3 11.4 5.8 3.3 0.8 0.0 5.6 1.1 2.8 1.9 1.9 3.7 2.5 2.1 2.1 4.8 0.2 5.3 0.9 7.4 0.0 1.9 9.8 19.9 14.7 22.8 9.5 13.3 14.0 12.0 20.1 16.3 11.9 5.9 2.2 11.4 7.6 20.3 9.7 10.2 29.4 14.8 14.0 33.4 175.5 10.0 5.2 19.7 10.8 2.0 0.0 1.8 25.1 33.5 5.4 17.3 14.7 21.3 3.2 9.1 15.4 7.0 27.2 23.3 3.6 21.9 10.0 3.9 18.6 2.5 2.9 32.5 10.8 17.8 12.9 16.5 29.8 8.1 7.0 62.1 6.9 6.3 3.0 EYA2 EAB1 ENSG00000064655 "EYA transcriptional coactivator and phosphatase 2" O00167 20 46894624-47188844 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 47.4" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 40.0;Club cells: 18.2;Cytotrophoblasts: 21.2;Urothelial cells: 36.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 69.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "memory B-cell: 2.4" "Lineage enriched" "Detected in single" 16 "B-cells: 2.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 13.7;SCLC-21H: 20.9;SK-BR-3: 9.3;U-266/70: 38.9;U-266/84: 47.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027024, HPA059291" Uncertain Supported Cytosol NA NA Cytosol "HPA027024: AB_1848334, HPA059291: AB_2683967" "unprognostic (1.08e-1)" "unprognostic (5.71e-3)" "unprognostic (4.03e-1)" "prognostic favorable (4.30e-5)" "unprognostic (3.32e-2)" "unprognostic (1.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (2.54e-1)" "unprognostic (2.65e-1)" "unprognostic (7.06e-2)" "unprognostic (2.15e-1)" "unprognostic (2.78e-1)" "unprognostic (4.17e-3)" "unprognostic (1.56e-1)" 10.5 2.0 6.5 2.6 7.4 0.8 13.4 2.4 6.5 47.4 6.4 3.8 21.0 1.0 15.7 10.7 25.9 28.2 2.2 4.3 7.0 4.1 5.2 1.8 2.3 1.3 6.3 4.9 5.2 2.4 11.5 4.7 5.9 9.1 18.5 3.2 15.4 28.6 27.3 2.1 4.2 1.1 2.3 7.2 1.1 8.2 4.9 5.1 14.3 21.4 3.6 14.0 5.5 17.3 2.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.7 0.1 13.7 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 20.9 0.0 0.0 9.3 0.0 1.1 1.8 0.1 0.0 0.0 1.7 0.1 3.1 38.9 47.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.5 7.4 2.4 6.5 7.0 4.1 6.3 4.9 9.1 5.1 0.0 0.0 0.0 40.0 0.6 0.2 0.5 0.0 6.7 18.2 0.0 5.9 21.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.8 4.7 9.2 1.1 2.4 5.8 0.0 1.2 0.6 0.0 0.0 0.0 0.2 3.3 4.6 0.2 0.0 0.7 1.7 0.7 4.4 0.3 0.0 1.4 0.2 0.7 0.3 9.0 0.0 1.5 36.7 FAAH FAAH-1 ENSG00000117480 "Fatty acid amide hydrolase" O00519 1 46394265-46413848 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 68.0;Late spermatids: 88.3;Spermatocytes: 73.1" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 19.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.2;OE19: 10.7;RT4: 23.9;SK-BR-3: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007425 Approved Approved Cytosol NA NA Cytosol "HPA007425: AB_1078820" "unprognostic (6.12e-2)" "unprognostic (2.04e-1)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (1.72e-1)" "unprognostic (4.97e-2)" "unprognostic (2.00e-1)" "unprognostic (6.64e-3)" "unprognostic (2.91e-2)" "unprognostic (2.33e-1)" "unprognostic (4.39e-3)" "unprognostic (9.86e-2)" "prognostic favorable (4.25e-5)" "prognostic favorable (3.63e-5)" "unprognostic (2.66e-1)" "unprognostic (9.97e-2)" "unprognostic (5.00e-3)" 6.1 7.7 11.2 2.5 22.0 7.9 7.9 20.4 21.9 6.9 15.0 40.7 10.1 18.0 3.1 8.2 4.9 10.6 4.6 2.9 14.7 11.7 12.0 18.3 6.7 2.1 19.1 19.3 2.7 18.2 15.1 10.6 3.5 17.6 33.3 12.8 7.4 12.8 8.6 7.1 10.1 17.8 2.3 23.6 2.0 14.3 30.9 18.8 5.6 24.9 3.5 3.5 5.7 4.2 0.1 6.0 19.1 4.7 0.3 0.4 0.9 2.8 0.7 0.4 0.5 0.7 0.5 22.2 0.6 0.3 0.3 0.5 4.1 6.6 0.2 2.3 0.4 0.2 9.4 0.4 1.3 0.1 1.2 3.1 0.0 0.1 1.9 0.5 0.8 1.6 0.4 6.4 0.2 0.8 0.2 0.0 0.5 0.1 0.5 0.0 5.9 0.4 1.2 1.8 10.7 0.2 0.5 0.2 0.1 5.2 23.9 2.8 2.1 3.2 12.4 0.1 0.6 8.5 8.2 0.0 0.0 0.3 0.6 0.4 1.2 0.5 0.3 0.1 7.6 0.2 0.0 4.7 19.1 0.3 1.2 0.1 0.0 0.3 0.1 5.7 0.1 0.4 0.4 0.2 0.3 0.6 6.0 0.1 0.9 11.2 22.0 20.4 21.9 14.7 11.7 19.1 19.3 17.6 18.8 20.8 10.4 4.2 27.1 4.6 12.6 2.2 25.5 4.0 10.3 21.0 41.2 14.4 0.0 12.8 35.5 1.8 68.0 0.0 5.6 6.3 2.4 27.0 0.0 29.2 2.6 1.6 14.9 0.6 3.2 88.3 6.9 2.9 5.0 0.0 33.1 6.3 5.0 40.4 4.2 19.5 11.4 0.0 2.7 73.1 7.7 5.3 10.4 0.0 48.5 12.3 FAAP100 "C17orf70, FLJ22175" ENSG00000185504 "Fanconi anemia core complex associated protein 100" Q0VG06 17 81539885-81553961 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023954, HPA024626, HPA026532" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.91e-1)" "unprognostic (1.85e-2)" "unprognostic (4.87e-3)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (3.49e-2)" "unprognostic (1.05e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (9.85e-2)" "unprognostic (4.24e-1)" 11.4 10.0 7.7 21.1 8.6 9.8 13.4 33.2 10.9 9.0 12.2 13.4 9.6 13.0 11.1 13.6 11.7 11.0 22.6 9.0 6.9 7.1 11.7 19.3 9.6 20.0 8.4 7.6 12.7 20.1 9.7 14.1 9.6 6.9 12.5 5.5 12.8 15.9 11.9 9.4 16.8 14.0 14.0 7.0 23.8 11.1 11.3 5.9 16.7 15.1 14.5 15.5 9.9 9.2 6.1 6.5 2.3 6.1 4.7 5.3 3.6 7.7 14.1 6.4 17.9 7.6 8.0 9.8 7.9 3.7 9.4 5.8 9.1 9.4 13.8 6.4 10.0 9.4 10.0 3.2 9.4 2.2 3.9 10.3 9.4 14.0 12.4 7.9 10.1 11.1 9.6 7.1 6.9 8.0 12.1 17.9 14.4 13.6 11.2 4.7 14.8 15.6 16.4 7.5 8.9 6.1 14.1 6.5 12.4 7.0 13.7 14.0 11.6 5.7 16.3 6.7 6.9 17.7 13.4 15.1 20.6 13.2 5.4 12.7 13.0 1.0 6.5 5.6 6.4 9.5 0.0 6.1 2.3 5.3 5.6 4.1 6.1 3.4 3.6 5.9 4.7 3.2 2.5 0.9 4.7 2.8 6.5 3.6 3.6 7.7 8.6 33.2 10.9 6.9 7.1 8.4 7.6 6.9 5.9 3.0 9.8 8.8 3.2 0.0 9.8 7.1 10.2 2.7 4.5 14.0 3.9 5.1 3.3 7.3 1.5 5.2 6.4 0.0 6.0 3.9 7.2 4.7 0.0 10.0 7.3 6.4 7.0 8.6 16.4 2.2 4.6 4.7 0.0 4.6 9.1 6.0 7.5 3.5 4.9 5.6 4.5 0.0 4.7 7.4 6.7 0.0 2.6 5.0 8.1 3.2 FABP1 L-FABP ENSG00000163586 "Fatty acid binding protein 1" P07148 2 88122982-88128116 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 453.2;liver: 370.7" "Group enriched" "Detected in many" 5 "Enterocytes: 8164.5;Hepatocytes: 5503.1;Paneth cells: 3221.0" "Group enriched" "Detected in many" 14 "colorectal cancer: 175.1;liver cancer: 437.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.3" "Group enriched" "Detected in some" 7 "CACO-2: 26.2;Hep G2: 83.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002305, HPA028275" Enhanced Approved Nucleoplasm,Cytosol NA NA 32000000 "Nucleoplasm, Cytosol" "CAB002305: AB_563728, HPA028275: AB_10600909" "unprognostic (1.91e-1)" "unprognostic (7.91e-3)" "unprognostic (5.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.03e-2)" "unprognostic (2.35e-1)" "unprognostic (7.99e-2)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" 0.4 0.1 0.4 33.9 0.4 0.0 0.4 0.4 0.5 0.4 153.5 0.4 0.4 137.9 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.2 57.6 370.7 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 97.7 0.4 0.5 0.4 0.4 0.1 453.2 6.7 0.4 0.4 0.2 0.5 0.4 0.4 0.5 0.5 0.4 0.4 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 26.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 83.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.0 1.4 7.7 0.0 0.1 0.8 5.7 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.7 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.5 0.4 0.2 0.4 0.4 0.4 0.4 0.0 0.0 173.3 0.0 0.0 0.0 0.4 119.8 0.0 0.0 57.6 0.0 0.1 132.6 0.0 0.0 0.0 8164.5 140.2 0.0 0.1 0.0 0.3 133.2 5503.1 1.4 0.0 251.5 124.0 159.5 0.0 0.0 0.0 0.0 0.0 830.4 0.0 0.1 3221.0 0.0 668.9 0.0 0.0 0.0 0.0 0.1 0.0 1.1 51.0 1046.9 0.0 FABP2 I-FABP ENSG00000145384 "Fatty acid binding protein 2" P12104 4 119317250-119322390 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "intestine: 358.6" "Group enriched" "Detected in some" 5 "Enterocytes: 422.5;Mucus-secreting cells: 344.1;Paneth cells: 175.6" "Group enriched" "Detected in some" 9 "colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 2.1;neutrophil: 7.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.6" "Cell line enhanced" "Detected in some" "BEWO: 2.9;Hep G2: 2.5;NB-4: 3.9;RPMI-8226: 3.3;SH-SY5Y: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034607, CAB047325, CAB047326" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 46000 "Actin filaments, Cytosol" "Plasma membrane" "CAB047325: , CAB047326: , HPA034607: AB_10601317" "unprognostic (3.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (4.58e-1)" "unprognostic (1.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.69e-4)" "unprognostic (1.93e-1)" "unprognostic (1.02e-1)" 0.1 0.2 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 47.0 0.0 0.0 50.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 5.9 0.1 0.1 0.0 0.1 0.1 358.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.5 7.6 0.7 0.9 0.5 0.0 0.2 0.3 0.2 0.4 0.0 0.0 2.9 0.4 0.0 0.0 0.0 0.4 0.4 0.4 0.1 0.0 0.3 0.3 0.0 0.2 0.1 0.1 0.3 0.1 0.5 2.5 0.0 0.5 0.4 0.2 0.0 0.2 0.1 0.1 0.0 0.2 0.3 0.5 0.0 0.1 0.4 3.9 0.2 0.2 0.5 0.3 0.3 3.3 0.0 0.5 1.0 2.6 0.1 0.4 0.0 0.2 0.3 0.1 0.9 0.4 0.4 1.5 0.2 0.7 0.3 0.6 0.3 0.3 0.1 2.1 0.7 0.7 0.4 0.3 0.4 0.2 0.4 0.3 0.2 0.5 0.5 0.5 7.6 0.9 0.2 0.5 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 422.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 344.1 0.0 0.0 175.6 0.0 18.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 64.7 0.0 FABP5 "E-FABP, KFABP, PA-FABP" ENSG00000164687 "Fatty acid binding protein 5" Q01469 8 81280363-81284777 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 237.0;tongue: 204.1;vagina: 141.9" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1256.0;Hofbauer cells: 2357.3;monocytes: 1172.2" "Cancer enhanced" "Detected in all" "cervical cancer: 268.3;head and neck cancer: 288.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 93.8;MOLT-4: 91.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB017831, CAB040577, HPA051895" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 28000000 Cytosol "Plasma membrane" "CAB017831: , CAB040577: , HPA051895: AB_2681654" "unprognostic (8.76e-2)" "unprognostic (7.28e-2)" "unprognostic (1.54e-2)" "unprognostic (9.04e-2)" "unprognostic (1.33e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-3)" "unprognostic (4.03e-3)" "unprognostic (2.71e-1)" "unprognostic (3.13e-1)" "unprognostic (6.16e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (4.69e-10)" "unprognostic (1.99e-1)" "unprognostic (3.72e-1)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" 41.4 1.5 8.5 11.8 13.2 8.5 37.3 5.5 8.9 78.7 20.6 7.9 2.2 8.0 5.7 3.1 237.0 2.1 8.5 27.1 8.5 9.8 1.6 2.7 24.8 15.1 7.6 5.0 2.0 8.7 0.7 1.9 30.0 19.1 4.4 18.2 4.2 32.9 1.6 9.4 42.9 9.7 4.5 23.0 14.9 15.6 3.8 10.6 6.6 4.4 204.1 25.7 19.5 141.9 6.8 20.3 2.5 5.9 8.2 5.2 4.3 5.8 16.7 10.2 0.0 48.8 4.6 0.0 11.9 0.6 9.3 11.8 0.2 8.0 93.8 6.8 2.9 0.1 5.4 24.8 19.1 8.0 47.6 53.9 33.8 11.9 25.2 4.3 32.3 8.8 3.5 39.3 11.5 23.7 9.4 53.4 24.9 9.7 10.2 5.6 5.6 91.6 16.5 13.5 57.9 64.9 40.9 0.0 9.9 15.0 72.5 42.4 16.1 5.8 1.9 4.4 18.5 0.1 16.6 7.6 0.0 26.5 0.1 0.1 12.6 4.9 66.8 4.3 31.0 14.9 2.5 5.0 0.3 2.3 5.9 3.7 6.8 2.7 5.2 20.3 3.3 1.3 4.5 2.0 8.2 2.0 20.1 3.5 4.3 8.5 13.2 5.5 8.9 8.5 9.8 7.6 5.0 19.1 10.6 268.0 1256.0 87.2 58.7 107.4 21.2 2.8 2.5 100.4 708.6 21.0 43.2 16.9 3.3 27.1 23.0 313.1 94.4 0.0 20.3 209.8 84.3 44.5 54.3 0.8 2357.3 20.6 189.4 31.9 161.8 37.2 5.8 624.3 195.7 1172.2 116.5 252.2 31.0 459.1 4.9 0.8 41.8 355.7 66.0 131.8 169.3 147.4 22.5 71.0 321.9 172.7 FABP7 "B-FABP, BLBP" ENSG00000164434 "Fatty acid binding protein 7" O15540 6 122779475-122784074 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 62.7;breast: 26.8" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 827.1" "Group enriched" "Detected in many" 6 "glioma: 139.3;renal cancer: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1" "Group enriched" "Detected in some" 8 "AF22: 38.7;U-251 MG: 10.5;WM-115: 23.3" "Region enriched" "Detected in all" 6 "olfactory region: 1471.1" "Low region specificity" "Detected in all" "CAB025488, HPA028825, CAB058697" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130" "prognostic favorable (2.49e-4)" "unprognostic (1.56e-2)" "unprognostic (2.53e-3)" "unprognostic (5.80e-2)" "unprognostic (2.29e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.42e-2)" "prognostic unfavorable (1.65e-6)" "unprognostic (9.83e-2)" "unprognostic (1.30e-2)" "unprognostic (2.50e-1)" "unprognostic (8.66e-2)" 2.1 1.3 34.8 1.1 15.5 1.3 26.8 51.6 62.7 1.1 1.5 13.0 0.0 1.2 1.2 1.3 1.6 1.2 1.2 1.2 32.0 16.4 1.6 1.4 1.1 1.1 11.4 30.3 1.1 1.1 1.0 2.1 1.3 11.2 1.3 1.2 5.7 7.0 3.7 6.7 10.5 1.1 1.1 8.1 1.1 1.3 1.2 6.9 0.0 1.1 0.0 1.1 1.4 0.0 0.4 0.2 3.1 0.3 1.1 0.4 0.0 0.0 0.0 38.7 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.4 0.0 23.3 3.1 0.3 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.1 0.4 0.3 0.3 0.5 1.1 0.2 0.2 0.1 0.0 34.8 15.5 51.6 27.3 32.0 16.4 11.4 30.3 11.2 6.9 0.0 0.0 0.0 0.1 10.9 6.8 0.4 0.0 0.0 0.0 0.0 11.8 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 162.7 1.1 0.0 0.0 0.0 2.5 4.8 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 827.1 0.0 0.0 0.0 0.2 37.4 0.0 0.8 0.0 0.0 16.6 5.9 0.0 0.0 0.0 FADD "GIG3, MORT1" ENSG00000168040 "Fas associated via death domain" Q13158 11 70203163-70207390 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 83.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001464, CAB010209" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB010209: AB_2100622, HPA001464: AB_1848348" "unprognostic (2.08e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (6.91e-2)" "unprognostic (9.51e-2)" "unprognostic (3.89e-1)" "prognostic unfavorable (8.22e-5)" "unprognostic (7.25e-3)" "prognostic unfavorable (2.21e-5)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" "unprognostic (2.45e-3)" "unprognostic (2.78e-3)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "prognostic favorable (3.45e-4)" "unprognostic (7.29e-2)" 16.1 20.2 7.9 13.3 8.9 7.1 13.5 10.9 11.8 13.7 16.2 10.9 20.8 13.5 18.0 18.7 18.8 13.3 19.7 11.4 7.8 8.0 17.9 17.4 11.0 19.2 10.5 6.6 12.9 24.9 9.1 9.3 26.3 7.9 12.5 12.7 10.1 14.4 14.5 10.3 13.7 16.9 10.1 8.3 18.8 14.0 8.7 7.4 33.5 16.9 12.4 19.8 14.6 15.1 18.6 17.6 42.7 19.5 16.6 24.6 16.0 83.5 14.1 7.0 6.4 8.5 6.9 6.3 14.4 11.4 12.6 8.4 12.0 13.6 12.4 13.9 9.5 12.0 12.4 6.8 12.8 9.8 11.5 7.5 5.6 8.1 6.1 7.7 7.0 7.6 6.8 9.1 13.6 17.3 10.1 11.8 6.9 9.2 6.4 11.0 12.3 8.6 12.5 11.1 19.2 23.3 6.7 17.0 11.9 12.3 6.2 6.2 5.9 10.6 10.0 29.5 8.4 10.8 7.8 13.2 9.8 9.5 15.0 13.7 9.0 6.8 7.3 14.2 7.2 13.7 15.0 17.1 12.7 21.0 17.7 24.1 18.6 22.3 24.6 17.6 16.4 23.2 20.9 42.7 16.6 19.5 16.0 20.7 16.0 7.9 8.9 10.9 11.8 7.8 8.0 10.5 6.6 7.9 7.4 0.0 4.0 17.1 11.9 10.5 6.7 0.1 10.2 0.0 1.2 17.4 0.0 60.4 18.3 47.2 0.5 15.7 19.5 0.0 30.3 34.1 9.5 9.2 1.1 8.3 27.5 3.2 2.4 12.9 9.7 1.1 12.4 8.9 30.4 27.9 12.1 8.9 37.0 16.9 15.6 25.9 3.9 0.0 9.0 6.5 16.6 9.3 25.7 12.5 16.1 13.7 FAH ENSG00000103876 "Fumarylacetoacetate hydrolase" P16930 15 80152490-80186946 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 109.4" "Group enriched" "Detected in many" 4 "Hepatocytes: 250.1;Hofbauer cells: 63.7;Proximal tubular cells: 236.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 76.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041370, HPA044093" Enhanced Approved Nucleoplasm,Cytosol NA NA 230000000 Cytosol Nucleoplasm "HPA041370: AB_2677438, HPA044093: AB_2678806" "unprognostic (3.15e-1)" "unprognostic (5.65e-2)" "unprognostic (1.64e-1)" "unprognostic (6.16e-2)" "unprognostic (2.33e-3)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.19e-2)" "unprognostic (5.83e-2)" "unprognostic (2.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.80e-1)" "unprognostic (1.23e-1)" "unprognostic (2.17e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "unprognostic (2.93e-1)" "unprognostic (8.98e-2)" 32.1 17.8 4.6 6.1 3.6 4.7 22.8 2.3 3.3 4.7 8.6 3.1 8.3 4.1 5.1 14.8 4.4 6.8 7.1 6.8 4.1 2.8 18.9 109.4 7.9 6.2 4.0 2.1 7.2 6.5 4.8 4.4 2.3 3.5 4.9 3.4 2.4 5.3 5.4 7.7 2.4 7.6 4.4 5.9 6.0 3.3 9.7 3.0 2.3 4.2 4.9 3.9 4.1 6.1 0.1 16.0 16.9 11.7 3.6 5.8 6.1 4.5 7.6 3.1 3.9 14.7 15.1 7.8 5.8 13.3 6.2 5.3 4.6 8.4 0.0 9.6 12.2 8.6 6.7 11.2 13.9 6.0 2.9 6.3 38.8 4.5 23.8 76.6 18.3 21.5 26.1 8.6 5.3 9.6 20.3 8.6 8.9 16.2 8.3 11.5 6.9 5.0 9.1 2.2 3.5 8.7 2.8 4.5 29.1 17.8 5.5 0.1 1.9 6.5 18.0 18.2 5.3 13.7 12.5 29.9 11.3 7.1 6.0 9.8 7.6 15.5 3.1 23.5 42.9 6.3 16.9 11.7 1.9 5.8 4.9 1.5 0.1 1.6 3.9 16.0 0.0 2.0 1.8 0.7 3.6 4.8 1.2 1.5 6.1 4.6 3.6 2.3 3.3 4.1 2.8 4.0 2.1 3.5 3.0 3.0 14.4 5.2 13.1 6.1 0.4 12.0 10.2 5.3 4.5 31.4 0.0 32.5 44.7 8.5 6.3 2.5 15.8 23.3 3.1 9.0 17.2 8.6 42.5 250.1 63.7 0.0 4.1 11.1 20.0 10.6 9.2 23.1 18.6 3.6 11.8 3.5 4.6 14.4 7.4 236.8 0.3 0.0 8.1 1.5 2.1 5.0 18.4 8.7 22.4 12.8 FAIM "FAIM1, FLJ10582" ENSG00000158234 "Fas apoptotic inhibitory molecule" Q9NVQ4 3 138608606-138633376 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 61.9" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 189.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 45.4" "Low region specificity" "Detected in all" "HPA042440, HPA052209" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042440: AB_2677999, HPA052209: AB_2681761" "unprognostic (6.45e-2)" "unprognostic (8.21e-3)" "unprognostic (5.97e-2)" "unprognostic (1.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.31e-2)" "prognostic unfavorable (3.96e-5)" "unprognostic (4.84e-2)" "unprognostic (4.15e-2)" "unprognostic (9.23e-3)" "unprognostic (2.29e-1)" "unprognostic (2.63e-2)" "prognostic favorable (6.63e-4)" "unprognostic (4.76e-2)" "unprognostic (3.51e-1)" "unprognostic (3.43e-1)" "unprognostic (6.98e-2)" 13.7 6.6 12.3 6.7 11.6 2.6 19.0 7.8 9.9 24.5 6.8 10.2 38.5 4.7 9.6 15.1 8.8 28.5 9.0 4.7 12.2 12.5 15.4 6.0 7.6 7.2 13.9 7.1 8.4 27.5 7.2 15.4 6.1 10.7 11.4 6.0 9.1 7.2 61.9 6.1 6.2 4.2 7.2 19.6 3.7 6.7 5.4 9.1 13.2 15.2 9.3 9.6 10.3 13.2 13.9 5.0 11.1 2.6 13.9 9.1 3.4 26.9 5.3 0.5 4.8 5.2 9.8 19.4 8.3 5.0 8.8 7.6 9.1 7.9 0.0 7.4 10.9 10.2 7.1 23.1 4.7 10.0 22.1 24.1 5.1 14.6 13.1 5.8 0.0 1.6 13.7 9.3 3.3 5.1 5.4 9.5 1.9 3.3 6.9 5.4 10.2 0.1 22.8 10.5 0.8 5.3 27.2 6.3 0.7 14.0 13.4 9.1 7.7 14.8 8.2 20.8 6.0 13.9 6.7 5.8 1.8 4.2 9.0 4.0 0.0 0.1 45.4 7.3 0.0 7.2 11.1 2.4 1.7 9.1 2.6 8.5 13.9 5.0 7.2 5.0 7.9 3.4 8.5 0.3 13.9 1.7 3.5 5.4 3.4 12.3 11.6 7.8 8.2 12.2 12.5 13.9 7.1 10.7 9.1 17.9 15.6 9.3 23.8 9.6 27.4 4.5 63.7 87.0 36.4 24.4 62.8 37.0 26.6 49.3 9.6 10.8 2.0 0.0 43.5 25.4 17.6 19.1 40.4 10.2 24.6 14.3 20.3 8.6 3.5 11.1 16.1 5.5 15.1 23.4 8.3 34.0 31.2 0.0 18.7 19.0 189.9 0.0 19.6 16.8 2.2 11.4 12.2 9.6 11.5 23.3 FAM102A "bA203J24.7, C9orf132, Eeig1, SYM-3A" ENSG00000167106 "Family with sequence similarity 102 member A" Q5T9C2 9 127940579-127980513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036030 Approved Cytosol NA NA Cytosol "HPA036030: AB_10670675" "unprognostic (3.27e-1)" "unprognostic (1.66e-3)" "unprognostic (1.06e-3)" "unprognostic (4.69e-3)" "unprognostic (2.32e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-2)" "unprognostic (2.97e-1)" "unprognostic (8.36e-2)" "unprognostic (1.01e-2)" "unprognostic (9.28e-2)" "unprognostic (1.76e-1)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (1.25e-1)" "unprognostic (8.28e-3)" "unprognostic (6.98e-2)" 5.3 18.3 28.2 19.9 39.1 7.6 12.1 10.5 31.8 22.4 35.8 65.9 8.7 33.3 15.7 12.6 27.4 29.8 28.5 6.7 29.4 17.3 15.1 23.9 8.5 34.4 41.5 22.9 19.7 21.6 12.9 22.9 5.7 28.0 10.6 11.2 12.5 19.1 13.5 1.9 18.7 39.3 16.7 39.0 12.9 61.8 15.4 53.0 32.0 12.1 13.7 26.3 17.8 18.6 4.7 0.1 2.2 0.1 0.5 11.8 3.0 10.1 22.5 4.8 3.8 10.2 12.3 18.3 3.9 10.9 2.7 1.6 12.9 18.1 11.6 2.6 7.5 5.7 11.2 2.5 2.0 1.0 5.5 2.5 3.4 5.7 11.5 6.4 1.6 26.9 5.0 10.4 7.5 3.2 5.3 3.6 7.1 2.8 14.6 3.0 26.2 6.7 3.6 5.8 20.0 10.9 3.5 3.5 4.2 7.6 17.5 7.5 3.7 6.5 14.7 9.3 5.4 27.6 2.2 3.8 4.2 4.5 22.1 5.9 19.8 26.9 8.0 18.1 2.2 9.9 0.6 0.1 2.2 1.9 0.0 6.1 4.7 9.4 5.6 0.1 1.2 9.1 6.0 0.1 0.5 0.0 0.0 11.8 3.0 28.2 39.1 10.5 31.8 29.4 17.3 41.5 22.9 28.0 53.0 6.0 7.0 18.2 26.3 19.5 14.0 10.9 45.9 13.4 6.8 61.1 9.8 5.0 6.6 45.0 4.6 5.8 107.7 0.0 86.2 4.9 13.2 53.6 18.4 40.9 2.9 25.4 26.9 69.3 7.9 4.3 31.7 2.3 21.9 4.6 34.2 62.4 54.3 31.6 40.7 10.5 15.5 0.0 7.8 5.9 9.3 41.9 4.5 20.3 20.4 65.9 FAM102B "DKFZp779B126, SYM-3B" ENSG00000162636 "Family with sequence similarity 102 member B" Q5T8I3 1 108560089-108644900 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028451 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028451: AB_10602497" "unprognostic (1.30e-1)" "unprognostic (2.19e-1)" "unprognostic (4.08e-3)" "unprognostic (3.87e-2)" "unprognostic (1.11e-1)" "unprognostic (3.68e-3)" "unprognostic (1.87e-3)" "unprognostic (3.10e-1)" "unprognostic (2.62e-2)" "unprognostic (1.32e-2)" "unprognostic (2.17e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.47e-6)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" 11.6 5.2 11.8 10.4 11.4 19.0 11.3 23.3 20.0 8.5 13.8 3.8 6.6 11.4 7.5 8.2 6.5 6.7 15.7 9.2 15.6 14.3 4.6 5.1 8.1 8.8 12.6 19.0 10.5 5.8 12.1 7.3 6.0 11.4 8.5 15.7 5.5 13.5 9.6 2.3 4.2 11.5 11.4 10.2 8.6 7.9 8.8 5.0 9.4 6.7 4.3 8.4 16.4 18.0 0.9 2.7 5.7 2.3 0.7 1.4 0.5 3.6 2.6 5.4 2.8 9.7 5.9 3.5 2.2 2.9 3.4 5.8 0.9 3.7 4.0 2.0 5.6 3.5 7.2 18.2 0.7 4.4 2.6 2.6 5.7 20.5 0.4 2.5 7.3 11.0 3.1 0.8 5.0 0.3 6.9 2.2 6.8 13.8 22.8 7.9 15.1 4.7 5.3 4.2 8.7 13.4 10.8 13.6 0.8 0.9 4.3 17.5 5.1 8.7 15.2 4.5 4.0 3.2 12.1 0.4 5.5 10.4 4.7 8.2 4.1 1.0 3.8 8.1 5.8 2.9 5.7 1.1 1.0 1.0 2.3 0.6 0.9 1.0 1.4 2.7 0.9 0.7 0.5 1.0 0.7 0.9 0.5 0.8 0.5 11.8 11.4 23.3 20.0 15.6 14.3 12.6 19.0 11.4 5.0 0.0 2.1 0.0 2.1 5.5 4.6 1.2 10.2 2.7 2.3 1.8 0.0 2.1 1.7 1.7 9.2 5.8 7.1 0.0 5.3 2.1 7.3 2.6 7.0 0.8 8.9 0.0 6.9 6.7 22.2 4.5 13.3 16.8 5.0 10.0 10.0 1.2 4.3 10.5 19.4 0.4 0.9 0.0 3.9 1.7 6.0 3.1 2.9 5.0 13.0 4.6 FAM104A FLJ14775 ENSG00000133193 "Family with sequence similarity 104 member A" Q969W3 17 73207353-73236753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.8" "Group enriched" "Detected in all" 4 "Early spermatids: 1144.0;Late spermatids: 1283.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021459, HPA079514" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021459: AB_1848361, HPA079514: " "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (5.02e-3)" "unprognostic (3.23e-2)" "unprognostic (2.28e-2)" "unprognostic (3.05e-2)" "prognostic unfavorable (2.12e-7)" "unprognostic (5.19e-2)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (4.20e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.26e-10)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" 9.3 7.2 8.7 9.1 9.0 23.2 12.4 10.8 7.9 9.9 9.1 6.9 7.4 7.8 8.4 8.4 10.4 6.6 8.5 11.6 8.1 7.0 6.4 10.0 8.2 10.1 6.9 8.3 8.2 11.4 8.4 11.2 14.2 6.4 9.3 8.1 8.4 8.3 8.0 11.9 11.7 10.1 7.3 7.1 11.8 13.3 74.8 6.5 14.6 9.2 7.1 11.2 9.9 11.6 21.3 19.7 34.3 20.3 26.7 49.5 29.9 23.0 19.0 9.5 17.7 14.7 13.8 31.4 18.9 19.9 20.9 21.6 15.9 14.9 13.5 15.6 18.1 20.3 14.7 12.3 13.8 22.7 15.8 16.5 19.6 16.3 24.0 19.5 17.1 33.8 14.6 18.3 18.5 13.6 13.7 24.4 16.4 15.2 22.6 25.0 15.7 30.4 11.8 13.2 17.0 24.3 16.7 26.7 13.0 15.9 19.0 15.8 21.0 11.0 16.1 20.2 18.7 22.6 17.7 16.9 24.7 28.6 16.8 22.0 22.4 22.1 16.4 22.1 18.8 18.2 24.5 20.3 34.3 24.7 17.6 23.7 21.3 30.3 28.1 19.7 20.2 22.2 26.7 33.3 26.7 18.6 12.8 49.5 29.9 8.7 9.0 10.8 7.9 8.1 7.0 6.9 8.3 6.4 6.5 8.9 12.2 25.3 20.2 50.6 15.0 5.0 20.4 16.0 12.5 21.0 5.9 95.7 26.6 29.8 1144.0 18.8 18.8 23.3 22.0 52.3 27.1 25.6 28.8 17.8 31.7 25.4 19.0 11.1 20.2 1283.3 32.5 21.6 23.6 33.3 24.5 18.6 28.1 24.3 22.6 15.4 19.4 6.5 17.5 121.4 59.8 57.5 271.7 30.5 18.4 48.7 FAM105A "FLJ11127, NET20" ENSG00000145569 "Family with sequence similarity 105 member A" Q9NUU6 5 14581775-14615007 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 89.3;Hofbauer cells: 83.6;Intestinal endocrine cells: 59.1;Kupffer cells: 69.4;Spermatogonia: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 14.0;HMC-1: 44.0;OE19: 12.3;THP-1: 12.2;U-937: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046638 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA046638: AB_2679731" "unprognostic (1.47e-1)" "unprognostic (6.64e-3)" "unprognostic (1.92e-2)" "unprognostic (1.15e-3)" "unprognostic (6.26e-2)" "unprognostic (1.13e-3)" "unprognostic (2.33e-2)" "unprognostic (2.27e-2)" "unprognostic (6.44e-2)" "unprognostic (2.42e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.38e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.14e-1)" "unprognostic (8.79e-3)" 5.1 3.5 4.0 7.9 4.9 35.4 5.2 3.1 5.1 6.3 15.4 9.0 4.5 8.3 3.0 5.6 2.9 3.1 4.1 3.0 3.9 4.3 5.2 1.9 28.8 16.7 6.1 3.8 4.0 13.3 1.9 8.7 6.7 7.9 12.6 17.3 10.3 3.1 13.5 1.3 2.6 13.7 3.3 10.8 13.2 5.4 4.4 4.1 3.5 27.2 3.0 6.2 7.1 5.8 0.1 26.7 6.9 26.2 14.1 9.6 16.2 0.0 0.6 1.2 0.0 0.2 0.0 5.3 1.5 1.4 0.4 0.7 1.9 1.4 0.0 0.8 0.7 2.2 0.1 2.6 1.2 0.6 0.8 3.6 3.4 14.0 0.3 1.3 0.0 44.0 0.1 0.3 0.2 0.0 0.0 0.0 2.2 0.0 5.5 0.1 1.1 0.0 1.2 1.9 12.3 9.4 0.4 0.5 1.6 0.0 10.5 4.6 5.1 0.7 0.5 0.0 1.3 0.5 12.2 0.0 0.6 3.4 0.2 1.1 0.0 0.0 0.0 0.8 20.8 0.2 0.0 26.2 0.1 4.5 12.4 6.0 0.1 5.7 6.1 26.7 0.1 7.8 7.5 6.9 14.1 9.4 19.7 9.6 16.2 4.0 4.9 3.1 5.1 3.9 4.3 6.1 3.8 7.9 4.1 89.3 8.2 0.9 4.4 7.4 0.7 0.0 2.5 0.0 3.4 0.0 0.0 0.7 0.0 0.0 1.1 6.3 22.2 0.0 0.0 1.5 5.9 7.8 49.6 0.2 83.6 0.0 59.1 4.3 69.4 2.0 4.0 37.7 11.8 0.0 39.6 2.5 0.0 37.1 3.2 0.0 0.9 0.0 3.8 20.5 57.7 5.9 1.1 30.5 41.5 2.7 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7" "Group enriched" "Detected in all" 9 "granulocytes: 83.4;monocytes: 37.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol Yes Yes "Nucleoplasm, Vesicles" Cytosol "CAB034110: AB_1562838, HPA069240: AB_2686103" "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 5.2 3.6 1.7 17.7 4.2 7.4 7.7 1.9 3.9 6.5 8.8 2.0 7.7 10.0 4.0 6.1 22.1 1.9 6.9 4.8 1.7 2.5 4.8 3.9 15.2 18.7 2.1 1.9 2.6 3.5 9.3 5.1 11.1 3.6 11.1 3.4 3.1 12.7 10.5 3.7 39.9 9.2 1.3 1.6 15.1 5.5 2.8 1.3 22.9 7.7 8.0 18.9 7.8 9.7 1.9 5.8 83.4 37.7 1.0 6.4 3.2 12.7 3.4 1.9 3.6 2.2 0.9 13.4 4.0 2.2 2.6 2.3 7.5 8.0 4.1 1.8 2.5 3.6 20.7 1.6 10.5 2.1 3.3 1.1 8.6 2.2 1.9 1.0 2.3 3.0 0.6 13.1 3.5 3.5 0.8 1.7 3.8 4.6 10.3 2.3 7.6 6.5 6.4 2.5 8.2 5.9 6.5 3.4 5.4 1.9 9.2 3.7 4.4 3.4 40.4 1.8 0.8 16.7 3.5 2.2 6.1 4.5 5.5 4.4 3.8 3.2 1.7 0.9 6.1 4.4 83.4 4.4 24.8 2.2 25.1 2.0 1.1 4.0 4.6 5.8 1.9 4.9 4.7 2.5 1.0 37.7 0.6 6.4 3.2 1.7 4.2 1.9 3.9 1.7 2.5 2.1 1.9 3.6 1.3 0.0 6.5 19.9 14.7 29.0 0.2 2.4 5.1 4.0 0.0 10.4 0.0 36.4 1.7 8.3 6.0 5.8 6.9 46.7 5.2 131.1 4.7 17.7 52.8 0.8 17.4 4.8 10.4 18.4 36.5 13.5 3.1 27.8 6.8 6.4 7.5 0.2 10.7 8.0 1.8 2.1 2.5 6.5 5.2 1.9 5.3 32.1 26.2 26.2 7.8 20.9 FAM110B "C8orf72, MGC39325" ENSG00000169122 "Family with sequence similarity 110 member B" Q8TC76 8 57994509-58204279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 13.1;intermediate monocyte: 3.6;non-classical monocyte: 6.4" "Group enriched" "Detected in many" 11 "granulocytes: 13.1;monocytes: 6.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008318, HPA011781" Uncertain Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA008318: AB_1853892, HPA011781: AB_1853891" "unprognostic (2.07e-1)" "unprognostic (6.91e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.88e-8)" "unprognostic (4.09e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (2.02e-1)" "unprognostic (8.72e-2)" "prognostic favorable (1.44e-4)" "unprognostic (1.06e-2)" "prognostic favorable (4.31e-8)" "unprognostic (2.23e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.15e-4)" 6.5 3.1 15.7 4.1 12.2 4.1 9.9 23.7 18.4 8.8 6.1 5.0 24.3 2.3 8.9 6.8 3.0 9.1 7.9 21.7 10.3 14.4 6.6 6.0 4.1 2.0 8.0 5.9 8.2 3.0 16.7 4.1 5.0 7.9 10.0 3.2 9.5 8.5 19.8 17.1 3.0 3.3 10.4 11.5 30.8 5.5 14.7 4.9 0.0 8.6 3.4 2.1 7.9 9.4 0.3 0.9 13.1 6.4 0.0 0.2 0.5 0.0 1.1 4.1 0.1 1.8 0.7 1.6 7.8 9.1 5.5 2.5 0.0 0.1 0.0 1.5 5.5 4.9 0.0 3.7 0.0 4.2 0.0 3.8 0.7 1.2 4.5 6.3 1.0 0.2 6.6 1.5 0.2 3.4 0.7 0.0 1.8 0.0 0.1 4.1 0.1 0.0 2.7 3.9 5.4 1.7 0.0 4.6 0.0 13.5 0.8 4.0 4.4 0.0 0.5 0.2 5.0 3.6 0.4 0.0 3.9 2.5 0.0 2.7 1.7 0.0 0.0 1.8 0.0 4.5 0.0 1.4 13.1 0.0 3.6 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.2 0.5 0.0 6.4 0.0 0.1 0.5 15.7 12.2 23.7 11.8 10.3 14.4 8.0 5.9 7.9 4.9 0.0 5.6 0.0 14.2 8.8 8.8 21.8 2.5 1.4 1.2 22.7 2.0 1.5 6.6 5.9 2.2 4.7 0.0 0.0 2.5 15.0 22.7 10.6 4.6 5.7 4.3 6.4 6.9 15.4 8.1 1.4 9.2 6.3 15.1 0.0 0.0 25.5 2.6 0.0 13.8 6.1 5.4 32.3 22.3 1.7 1.5 3.6 1.3 0.5 0.0 6.7 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127410 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 43.9" "Cell type enhanced" "Detected in some" 9 "B-cells: 4.8;Basal keratinocytes: 3.8;Hofbauer cells: 3.4;Undifferentiated cells: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory B-cell: 5.7;naive B-cell: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 1.3 1.3 0.4 8.9 0.8 3.5 1.9 0.3 1.1 1.8 4.7 0.4 0.3 2.5 0.8 2.0 9.3 0.7 1.8 1.0 0.4 0.4 1.8 2.6 2.1 9.9 0.5 0.3 1.0 0.8 1.4 0.9 2.8 0.8 1.2 5.0 0.3 2.6 0.3 0.5 3.5 4.1 1.3 0.6 5.4 2.8 1.0 0.6 43.9 0.7 9.2 11.1 1.5 2.6 5.7 0.3 3.1 0.2 0.1 1.4 0.3 24.4 6.3 9.4 0.1 1.0 1.8 0.1 18.6 9.3 11.1 16.5 13.3 9.7 30.5 12.6 5.4 9.3 19.0 13.7 12.6 19.8 15.8 3.3 3.3 12.0 5.8 0.0 0.1 3.9 0.4 0.4 10.7 0.8 2.1 5.9 8.3 0.9 28.8 13.0 9.2 19.2 0.2 0.1 14.8 7.4 20.3 14.0 11.9 5.9 21.1 1.8 6.0 15.4 17.8 3.0 3.6 19.7 1.7 3.2 8.6 18.8 26.0 16.9 22.2 16.0 0.2 12.5 0.1 12.3 0.5 0.2 0.2 0.3 0.1 0.2 5.7 0.4 0.7 0.3 5.7 0.2 0.2 3.1 0.1 0.2 0.3 1.4 0.3 0.4 0.8 0.3 1.1 0.4 0.4 0.5 0.3 0.8 0.6 0.0 0.0 4.8 2.0 3.8 0.0 0.3 0.0 2.7 1.2 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.3 0.3 0.8 0.0 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 2.4 0.1 0.5 6.3 0.9 FAM114A1 Noxp20 ENSG00000197712 "Family with sequence similarity 114 member A1" Q8IWE2 4 38867677-38945739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 102.6;Peritubular cells: 109.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.1;intermediate monocyte: 6.3;myeloid DC: 4.3;neutrophil: 3.8;non-classical monocyte: 2.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.3;granulocytes: 3.8;monocytes: 6.3" "Cell line enhanced" "Detected in many" "ASC diff: 42.5;ASC TERT1: 44.4;BJ hTERT+: 50.7;fHDF/TERT166: 56.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA067948, HPA069104, HPA069701" Uncertain Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Golgi apparatus, Cytosol" Nucleoplasm "HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175" "unprognostic (2.13e-3)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (4.66e-2)" "unprognostic (9.40e-3)" "unprognostic (6.77e-2)" "unprognostic (2.54e-1)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.63e-6)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (3.44e-3)" 15.8 27.3 4.4 11.8 7.3 0.3 17.9 2.5 5.1 23.3 18.9 8.0 17.1 9.0 34.1 23.5 19.9 11.4 24.1 14.1 7.0 4.2 9.6 31.8 14.5 6.1 5.8 5.0 21.7 33.4 8.8 18.7 19.1 6.5 22.0 14.0 13.0 59.9 12.6 9.3 10.1 15.8 36.7 6.2 6.3 13.9 10.8 5.8 1.5 11.5 16.7 15.1 29.1 17.8 0.7 4.3 3.8 6.3 0.1 0.2 1.3 8.7 6.3 3.8 4.5 42.5 44.4 1.2 34.6 50.7 14.7 22.5 1.6 6.8 0.0 4.8 56.0 25.1 2.4 0.0 11.0 17.0 0.0 0.9 0.6 6.7 8.1 15.2 0.0 1.2 26.2 3.5 21.3 4.9 33.4 21.0 0.0 0.6 0.0 21.4 2.2 0.0 0.4 0.8 3.7 3.2 0.1 19.1 0.6 4.9 1.7 0.1 1.9 6.9 0.1 7.1 9.4 4.3 0.7 32.0 16.0 7.5 20.0 8.0 0.1 0.0 0.0 26.2 0.6 13.0 0.8 5.1 0.1 0.2 6.3 0.1 0.7 0.2 0.1 4.3 0.3 0.2 0.2 3.8 0.1 2.2 0.5 0.1 1.3 4.4 7.3 2.5 5.1 7.0 4.2 5.8 5.0 6.5 5.8 14.9 10.4 0.0 39.8 10.9 0.1 14.4 10.2 40.2 23.9 7.0 0.0 1.5 8.3 41.1 0.9 28.7 35.9 0.0 54.0 35.9 79.4 79.1 1.1 66.9 14.7 0.0 15.1 30.1 6.7 2.2 102.6 9.9 20.3 5.4 70.8 10.6 41.7 35.1 109.3 8.4 1.0 19.4 25.7 0.5 1.1 8.9 2.9 2.5 27.3 53.6 FAM118A "bK268H5.C22.4, C22orf8, FLJ20635" ENSG00000100376 "Family with sequence similarity 118 member A" Q9NWS6 22 45308968-45341955 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 117.8;Syncytiotrophoblasts: 101.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003902 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA003902: AB_1848368" "unprognostic (6.22e-3)" "unprognostic (1.19e-2)" "unprognostic (9.92e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (3.72e-2)" "unprognostic (7.61e-3)" "unprognostic (9.42e-2)" "unprognostic (6.11e-2)" "unprognostic (5.02e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.87e-6)" "unprognostic (9.76e-2)" "unprognostic (1.28e-1)" "unprognostic (4.50e-1)" "unprognostic (1.16e-3)" 8.4 7.9 9.8 14.3 17.3 11.7 14.7 14.6 12.0 10.5 13.9 9.6 10.3 12.2 15.5 41.7 10.8 6.5 15.3 13.9 12.1 7.7 8.4 8.8 10.0 29.0 10.2 5.0 13.8 8.2 32.9 22.7 11.4 11.7 23.7 7.6 12.1 14.6 18.6 20.0 23.9 16.0 14.5 8.1 14.5 12.5 22.1 10.7 14.0 14.4 6.6 17.9 17.3 13.3 8.3 15.7 6.5 8.6 5.9 13.9 4.7 5.5 4.0 4.6 5.9 4.0 4.2 12.9 4.1 6.1 5.9 5.2 11.6 5.2 24.7 3.2 3.7 3.1 19.4 6.2 5.4 5.6 5.5 16.2 13.3 5.9 7.8 5.9 12.0 3.5 4.7 5.5 7.9 5.2 3.4 3.5 7.1 19.8 26.2 2.5 12.3 7.5 23.1 3.9 21.4 5.9 9.2 3.4 8.6 2.9 13.8 10.4 13.1 4.7 8.8 11.0 7.9 4.3 6.1 4.0 4.4 14.9 5.4 5.2 14.4 2.8 12.7 5.4 8.0 8.1 4.5 8.6 2.5 7.0 7.1 5.6 5.3 8.6 8.6 10.9 8.3 13.9 10.0 6.5 5.9 5.6 15.7 11.4 4.7 9.8 17.3 14.6 12.0 12.1 7.7 10.2 5.0 11.7 10.7 8.9 14.2 13.7 31.5 20.0 18.7 9.3 2.5 6.7 15.9 7.0 17.7 58.0 0.0 6.5 117.8 21.5 14.0 0.0 5.5 5.9 27.7 19.4 1.1 13.4 11.6 6.4 31.6 28.8 12.1 47.6 33.1 23.9 1.7 55.9 15.3 12.1 4.4 16.7 22.3 2.8 15.5 0.0 18.4 65.8 35.3 8.7 101.1 25.4 14.6 32.2 FAM120A "C9orf10, KIAA0183, OSSA" ENSG00000048828 "Family with sequence similarity 120A" Q9NZB2 9 93451722-93566107 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019734, HPA055800" Approved Enhanced Cytosol NA NA Cytosol "HPA019734: AB_1848369, HPA055800: AB_2682925" "unprognostic (5.92e-2)" "unprognostic (2.15e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.03e-4)" "unprognostic (3.36e-1)" "unprognostic (2.33e-2)" "unprognostic (8.93e-2)" "unprognostic (5.84e-2)" "unprognostic (3.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.27e-2)" "unprognostic (3.71e-3)" "prognostic favorable (1.08e-7)" "unprognostic (8.16e-2)" "unprognostic (1.60e-1)" "unprognostic (2.64e-1)" "unprognostic (1.00e-2)" 25.7 35.1 23.3 28.6 19.1 15.7 23.0 22.1 21.8 26.1 27.0 14.9 32.2 21.3 33.2 17.2 26.0 24.2 24.1 22.1 20.5 11.0 21.2 33.2 25.7 26.4 18.4 12.6 25.5 34.4 40.6 16.8 24.6 20.0 17.4 26.0 15.9 27.7 22.4 71.5 17.6 23.6 23.3 17.7 21.7 25.3 7.5 17.7 19.5 19.8 23.8 17.6 46.5 33.1 4.7 6.6 15.2 9.2 4.2 7.5 3.5 47.1 38.7 8.8 25.2 26.4 33.2 27.6 33.2 29.3 25.5 18.8 12.5 29.3 30.8 19.0 41.8 20.3 51.0 23.4 38.8 19.9 30.6 17.0 16.8 34.6 19.8 29.6 28.5 23.0 32.2 24.2 28.9 46.4 25.3 36.4 21.9 19.2 25.9 27.6 52.8 27.9 16.2 11.3 56.6 36.3 16.3 23.5 25.8 31.0 28.5 23.6 14.5 37.5 45.7 22.7 9.1 24.8 18.7 37.6 27.8 20.0 34.0 36.1 20.4 20.0 11.9 30.0 25.8 24.6 3.0 7.1 5.0 5.4 8.1 5.1 4.7 5.2 5.6 6.6 4.1 3.6 5.1 15.2 4.2 9.2 4.6 7.5 3.5 23.3 19.1 22.1 21.8 20.5 11.0 18.4 12.6 20.0 17.7 41.7 72.9 25.7 37.7 90.8 28.8 107.4 79.0 48.2 76.2 71.5 47.1 61.6 18.3 44.8 23.5 54.4 108.9 23.3 65.0 83.1 53.6 103.2 47.4 158.9 64.4 38.1 88.2 64.4 144.2 6.4 61.9 69.8 50.6 35.1 160.3 34.0 71.4 70.2 61.5 66.1 29.6 38.8 67.9 13.1 13.5 99.9 86.5 44.8 129.3 93.7 FAM120B "CCPG, KIAA1838, PGCC1" ENSG00000112584 "Family with sequence similarity 120B" Q96EK7 6 170290703-170407065 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 32 "Early spermatids: 546.2;Late spermatids: 1520.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037518, HPA037519" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037518: AB_10671626, HPA037519: AB_10696935" "unprognostic (7.99e-3)" "unprognostic (7.81e-2)" "unprognostic (2.01e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-2)" "unprognostic (6.02e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-1)" "unprognostic (9.87e-2)" "prognostic unfavorable (1.60e-4)" "prognostic favorable (2.70e-4)" "unprognostic (1.41e-1)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (2.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" 18.4 20.6 18.5 21.1 28.7 10.7 20.5 28.4 27.7 20.5 16.6 28.5 16.3 15.8 28.3 24.1 16.5 26.8 18.1 18.4 18.1 22.8 17.3 15.6 18.3 16.7 20.6 19.5 23.4 17.0 24.7 32.0 19.5 26.1 22.4 18.6 19.1 21.4 21.2 25.7 18.4 16.2 20.1 21.1 16.9 16.9 20.7 20.4 24.7 22.3 15.3 22.0 19.8 16.3 7.4 9.2 14.7 13.6 15.9 10.2 8.5 5.9 6.1 9.3 11.1 13.4 13.0 5.5 10.0 11.7 8.9 8.9 5.4 4.6 8.4 6.0 14.3 10.4 7.1 9.6 11.5 11.7 12.1 5.9 8.9 5.7 7.1 12.0 8.8 7.2 15.7 12.3 8.2 10.9 15.6 13.7 9.4 9.8 6.9 14.9 12.2 6.4 7.9 4.6 12.3 4.2 5.5 8.7 8.7 9.2 5.3 6.6 10.1 8.6 7.7 3.0 12.0 7.6 17.6 11.6 3.8 6.3 10.0 6.9 8.5 7.1 8.9 10.4 7.3 13.9 14.7 8.1 10.0 8.3 9.0 9.5 6.6 7.9 8.9 9.2 7.4 10.2 8.1 13.9 15.9 13.6 5.3 8.4 8.5 18.5 28.7 28.4 27.7 18.1 22.8 20.6 19.5 26.1 20.4 20.8 14.5 2.7 4.7 3.2 15.0 15.7 15.3 14.7 13.6 14.0 31.4 8.9 0.0 8.3 546.2 15.3 8.6 0.0 8.0 6.4 6.5 11.1 9.3 7.6 9.5 6.4 9.2 11.1 8.2 1520.1 17.8 8.7 18.6 1.8 13.9 6.6 7.9 8.5 13.4 4.9 11.5 32.3 5.3 16.1 11.5 5.1 11.2 5.1 7.4 5.5 FAM124A FLJ30707 ENSG00000150510 "Family with sequence similarity 124 member A" Q86V42 13 51222334-51284241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.3" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 43.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HAP1: 13.3;HUVEC TERT2: 7.9;NTERA-2: 26.1;SH-SY5Y: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048182 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA048182: AB_2680301" "unprognostic (3.94e-3)" "unprognostic (8.76e-2)" "unprognostic (8.05e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-1)" "unprognostic (8.37e-2)" "unprognostic (2.59e-2)" "unprognostic (2.08e-3)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (7.38e-3)" "unprognostic (4.51e-2)" "unprognostic (4.54e-3)" "unprognostic (1.05e-2)" 5.3 3.5 7.7 4.7 19.6 0.7 2.6 2.6 15.0 3.3 7.2 40.3 0.3 1.4 3.8 8.4 2.4 3.6 4.3 7.1 13.5 7.4 6.7 1.5 3.3 1.5 29.1 7.7 1.3 2.7 1.2 1.5 6.2 18.8 6.5 2.6 3.8 12.4 8.1 1.8 1.9 2.1 8.9 25.3 13.2 4.1 2.3 26.7 0.3 2.8 0.6 1.1 4.1 1.8 0.8 1.0 2.7 0.9 1.2 0.8 0.3 0.0 1.2 0.9 0.8 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.4 0.0 0.0 1.6 0.1 13.3 0.1 0.1 0.0 2.0 0.0 0.3 0.0 1.0 0.6 0.8 0.3 0.1 0.4 0.0 0.0 7.9 3.5 0.1 0.0 0.0 0.2 3.2 0.2 26.1 0.2 2.0 0.7 0.0 1.9 0.0 0.1 1.9 10.0 0.4 1.6 1.5 2.0 0.2 0.7 0.1 0.0 0.9 0.7 0.9 0.2 0.0 0.0 1.2 2.3 1.1 2.7 0.8 0.8 0.8 0.6 0.8 0.6 0.5 0.6 0.4 0.8 0.7 0.7 2.4 1.2 0.9 1.0 0.6 0.3 7.7 19.6 2.6 11.8 13.5 7.4 29.1 7.7 18.8 26.7 0.0 0.0 0.0 2.1 0.7 7.7 8.9 0.0 2.7 0.0 1.8 47.1 0.0 3.3 1.9 3.5 6.8 0.0 0.0 0.7 0.0 0.9 1.6 1.1 0.0 0.2 6.4 0.0 6.7 0.3 3.3 0.6 0.5 3.3 0.0 0.0 3.4 0.8 0.0 0.4 8.4 43.8 0.0 2.1 0.0 1.4 0.1 0.0 0.0 0.0 0.4 FAM126A "DRCTNNB1A, HCC, HYCC1, hyccin" ENSG00000122591 "Family with sequence similarity 126 member A" Q9BYI3 7 22889371-23014130 "Disease related genes, Predicted intracellular proteins" "Cataract, Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042873 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042873: AB_2678207" "unprognostic (7.94e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-3)" "unprognostic (1.02e-1)" "unprognostic (1.96e-1)" "unprognostic (7.38e-2)" "unprognostic (3.54e-4)" "unprognostic (1.35e-1)" "unprognostic (9.76e-3)" "unprognostic (1.30e-2)" "unprognostic (7.23e-2)" "unprognostic (6.19e-2)" "prognostic unfavorable (6.04e-7)" "prognostic unfavorable (5.99e-4)" "unprognostic (1.87e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (9.03e-4)" 15.6 6.1 12.4 13.6 16.9 4.6 14.3 1.7 10.2 10.5 10.5 9.3 1.5 9.6 10.9 4.7 16.1 7.3 12.3 12.2 11.9 6.4 6.1 8.6 15.0 16.8 12.0 5.2 8.6 7.9 1.5 13.2 16.6 10.0 9.7 5.2 11.3 8.4 6.0 28.4 6.0 10.7 13.1 8.6 14.7 6.0 22.3 11.4 12.8 8.1 10.3 14.3 10.6 15.0 9.5 5.9 16.3 12.1 3.6 5.3 3.3 9.6 4.0 19.6 7.9 18.7 29.7 3.0 29.0 29.4 12.8 19.3 6.3 3.6 8.8 5.2 23.6 28.4 3.7 19.8 6.5 21.1 4.2 7.0 7.5 6.7 4.4 16.1 12.9 8.8 12.9 4.8 26.3 25.9 25.0 14.9 5.8 16.1 26.4 23.1 2.7 7.9 10.2 19.3 0.0 8.5 8.6 19.5 4.5 3.7 3.4 6.5 0.0 11.8 0.3 12.0 17.3 5.7 9.3 14.7 44.1 5.9 22.7 15.6 36.2 14.0 30.4 28.5 6.9 38.5 3.9 4.6 16.3 2.3 9.5 1.8 7.6 3.3 2.1 5.9 9.5 1.8 2.4 0.9 3.6 12.1 2.2 5.3 3.3 12.4 16.9 1.7 9.4 11.9 6.4 12.0 5.2 10.0 11.4 3.0 13.7 13.1 5.2 22.7 39.4 18.9 2.5 1.4 4.5 3.5 2.0 9.7 0.0 6.4 27.6 31.7 1.3 0.0 4.2 11.0 31.5 4.2 8.1 17.4 12.5 15.9 7.5 24.5 27.1 16.2 18.7 26.2 33.7 12.6 1.3 7.0 3.5 0.3 18.4 4.8 4.0 19.4 33.0 40.9 9.1 21.0 5.0 13.8 1.3 6.0 FAM129A "C1orf24, GIG39, NIBAN" ENSG00000135842 "Family with sequence similarity 129 member A" Q9BZQ8 1 184790724-184974550 "Cancer-related genes, Predicted intracellular proteins" "Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 129.1;urinary bladder: 90.3" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 641.6;monocytes: 234.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "neutrophil: 32.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 32.7" "Cell line enhanced" "Detected in many" "Karpas-707: 29.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA028172, HPA028231, HPA028657" Approved Supported "Plasma membrane,Cytosol" NA NA 40000 "Plasma membrane, Cytosol" "HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680" "unprognostic (4.61e-3)" "unprognostic (3.45e-2)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (2.77e-1)" "unprognostic (3.87e-1)" "unprognostic (3.23e-2)" "unprognostic (1.30e-2)" "unprognostic (1.68e-1)" "unprognostic (6.32e-2)" "unprognostic (4.12e-1)" "unprognostic (1.32e-1)" "unprognostic (2.94e-3)" "unprognostic (9.01e-3)" "unprognostic (4.38e-2)" "unprognostic (3.73e-2)" "prognostic unfavorable (4.52e-4)" 10.1 3.5 1.1 16.9 1.8 2.3 7.8 0.8 1.3 13.0 39.3 1.0 14.9 2.5 14.6 11.0 32.3 10.7 30.4 52.2 1.1 1.1 1.8 1.2 6.1 10.7 3.0 0.5 8.0 27.3 0.8 1.9 2.9 1.7 34.6 5.1 13.8 59.3 14.7 21.4 4.1 8.3 129.1 2.1 6.5 30.0 4.1 1.3 4.9 4.7 14.7 8.7 90.3 20.3 0.5 2.3 32.7 1.5 2.6 5.3 0.8 13.8 0.1 0.0 0.0 9.9 15.1 0.5 7.1 14.7 6.2 7.8 0.0 5.9 0.0 4.7 18.3 1.6 15.7 0.8 0.5 10.0 27.6 1.1 5.8 2.9 0.0 23.2 18.8 6.6 13.8 22.7 18.0 21.9 4.4 0.0 2.1 1.3 29.4 0.2 0.0 0.6 3.3 3.8 0.0 1.5 4.4 3.4 0.2 8.5 0.2 0.8 0.7 0.1 0.0 10.2 2.5 3.1 6.0 1.1 12.3 0.0 2.2 14.6 24.7 9.7 2.9 24.1 7.9 12.0 7.1 1.5 4.7 2.5 0.9 2.1 0.5 2.2 2.3 2.3 0.1 0.2 0.9 32.7 2.6 0.3 0.2 5.3 0.8 1.1 1.8 0.8 1.3 1.1 1.1 3.0 0.5 1.7 1.3 8.9 24.2 6.6 12.3 11.2 0.1 641.6 7.6 9.4 48.9 1.8 0.0 0.2 0.0 2.5 0.0 17.7 0.0 0.0 61.8 0.9 15.1 45.2 2.3 0.0 13.2 4.8 1.7 11.6 31.3 0.2 10.0 78.8 13.5 234.4 0.1 0.0 33.4 0.0 6.7 0.3 0.0 84.1 72.3 0.0 0.1 7.3 0.3 29.8 0.6 15.6 FAM129B "bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA" ENSG00000136830 "Family with sequence similarity 129 member B" Q96TA1 9 127505339-127578989 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 95.6;placenta: 103.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021284, HPA021417, HPA023261, HPA024312" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1200000 "Plasma membrane, Cytosol" Nucleoplasm "HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376" "unprognostic (3.05e-3)" "unprognostic (9.47e-2)" "unprognostic (1.14e-3)" "unprognostic (4.07e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (2.57e-3)" "unprognostic (1.40e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-3)" "unprognostic (6.45e-2)" "unprognostic (3.75e-2)" "unprognostic (1.24e-2)" "unprognostic (1.31e-1)" "unprognostic (8.40e-2)" "unprognostic (8.20e-3)" 7.8 17.9 4.5 8.4 5.6 5.1 6.7 6.5 4.2 19.1 13.9 4.2 12.3 11.9 9.6 7.3 95.6 8.9 22.9 8.2 4.8 4.1 9.9 5.5 24.0 5.1 6.9 3.1 9.3 24.8 6.8 5.7 103.7 9.1 12.8 7.2 9.4 23.6 11.7 4.1 17.3 17.1 10.5 7.0 6.8 13.8 5.4 4.2 1.3 39.8 44.6 48.8 11.8 28.3 0.0 2.4 0.5 3.7 0.0 0.5 1.7 22.1 25.3 5.1 6.7 15.6 30.4 24.0 44.1 41.0 24.4 15.1 8.0 24.5 0.0 17.5 49.8 30.1 37.0 4.4 32.6 8.1 4.2 4.7 3.8 37.5 8.3 30.8 0.1 10.8 33.2 20.5 40.1 14.1 44.9 36.6 1.4 7.1 0.2 46.1 26.1 0.2 6.2 5.3 38.1 33.3 2.6 17.3 11.6 20.9 17.8 8.2 3.8 36.0 25.7 15.6 7.6 16.9 1.2 47.3 25.1 10.9 31.5 36.4 0.4 0.8 0.0 70.6 3.6 46.3 0.5 3.7 0.0 0.2 1.3 0.0 0.0 0.5 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1.7 4.5 5.6 6.5 4.2 4.8 4.1 6.9 3.1 9.1 4.2 65.5 43.5 0.0 30.8 28.7 0.4 4.2 38.2 10.7 36.4 36.6 0.0 59.0 3.3 72.5 1.0 28.6 94.2 0.0 92.9 33.5 19.8 56.7 28.9 1.0 21.5 0.0 21.4 28.8 11.8 1.8 29.7 23.3 21.9 2.8 41.6 12.6 107.3 42.4 47.4 1.5 1.5 12.9 32.0 0.3 1.1 32.6 101.1 2.2 37.3 104.7 FAM129C "BCNP1, FLJ39802" ENSG00000167483 "Family with sequence similarity 129 member C" Q86XR2 19 17523301-17553839 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9" "Cell type enriched" "Detected in some" 37 "B-cells: 63.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 226 "memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2" "Group enriched" "Detected in many" 284 "B-cells: 19.5;dendritic cells: 37.2" "Group enriched" "Detected in some" 22 "Daudi: 29.8;REH: 15.0;U-698: 18.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043277 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043277: AB_10794391" "unprognostic (6.55e-5)" "unprognostic (3.03e-7)" "unprognostic (3.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-4)" "unprognostic (3.79e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-1)" "unprognostic (9.47e-4)" "unprognostic (8.42e-2)" "unprognostic (5.51e-5)" "unprognostic (3.39e-1)" "unprognostic (9.03e-3)" "unprognostic (6.08e-2)" "unprognostic (7.56e-3)" 0.5 0.2 0.2 37.9 0.2 12.1 0.2 0.3 0.2 0.2 0.6 0.0 0.0 0.0 0.2 0.0 2.2 0.2 0.5 0.6 0.2 0.2 0.5 0.3 0.9 17.4 0.2 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.4 9.9 0.2 0.1 0.2 12.3 0.0 0.3 28.5 0.4 0.5 0.0 2.5 0.5 0.4 35.4 3.0 0.4 19.5 37.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.7 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 1.1 63.2 0.7 0.1 0.1 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.1 0.0 0.1 0.0 0.0 1.3 0.3 0.4 0.0 0.4 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.9 0.3 0.1 0.0 0.0 0.3 FAM131B KIAA0773 ENSG00000159784 "Family with sequence similarity 131 member B" Q86XD5 7 143353400-143362770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell type enhanced" "Detected in some" 13 "Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4;Late spermatids: 2.9" "Cancer enriched" "Detected in many" 11 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 10.3;hTERT-RPE1: 6.5;NTERA-2: 16.8;PC-3: 16.1;SCLC-21H: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021371, HPA029992" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021371: AB_1852341, HPA029992: " "unprognostic (1.70e-1)" "unprognostic (7.26e-2)" "unprognostic (1.29e-1)" "unprognostic (5.61e-2)" "unprognostic (5.97e-2)" "unprognostic (2.54e-2)" "unprognostic (9.99e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (3.53e-2)" 1.5 2.1 10.0 2.0 12.4 0.9 1.2 37.2 47.1 2.7 2.0 15.1 0.0 1.7 4.4 1.0 1.7 1.6 1.4 1.1 9.1 6.8 1.1 0.9 1.5 1.3 14.6 12.3 1.0 0.9 6.4 0.4 0.9 13.8 1.0 2.2 0.0 0.9 1.0 7.7 0.8 2.1 5.6 18.6 1.1 1.4 1.2 11.3 0.0 0.9 0.0 1.1 1.2 0.5 0.0 0.2 0.0 0.5 0.1 2.1 0.2 0.0 0.1 5.0 0.0 4.1 5.2 0.0 0.2 1.2 0.8 0.2 10.3 0.0 0.0 0.0 0.3 0.0 0.2 2.0 0.4 0.7 2.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 6.5 0.9 0.1 0.0 0.0 0.7 0.0 0.0 0.3 16.8 0.0 16.1 0.0 0.0 0.0 0.0 0.0 16.4 0.5 0.2 1.2 0.0 1.1 0.0 0.0 0.7 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.1 3.3 0.1 0.0 0.3 0.0 2.1 0.5 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.2 0.0 0.0 0.2 10.0 12.4 37.2 25.0 9.1 6.8 14.6 12.3 13.8 11.3 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 2.4 0.6 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 FAM131C "C1orf117, FLJ36766" ENSG00000185519 "Family with sequence similarity 131 member C" Q96AQ9 1 16057769-16073632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.1" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 16.6;Horizontal cells: 36.5;Muller glia cells: 32.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 10.8;HEK 293: 7.0;PC-3: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031046 Uncertain Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA "Nucleoli, Intermediate filaments, Cytosol" "HPA031046: AB_2673711" "unprognostic (4.69e-3)" "unprognostic (4.98e-2)" "unprognostic (7.26e-2)" "unprognostic (2.46e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.63e-2)" "unprognostic (4.67e-4)" "unprognostic (2.82e-1)" "unprognostic (1.93e-2)" "unprognostic (1.75e-1)" "unprognostic (1.68e-1)" "prognostic favorable (9.33e-6)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.44e-1)" 0.7 7.8 5.6 0.6 4.0 0.5 1.1 41.1 9.1 1.1 1.0 7.7 0.0 0.7 1.0 1.4 1.2 1.1 1.4 5.2 5.0 6.5 10.4 2.2 0.6 0.5 10.7 3.8 1.2 7.1 2.0 5.6 0.7 8.7 0.8 0.6 0.8 6.3 1.6 0.6 3.2 0.8 0.9 17.7 0.6 1.6 1.3 4.9 0.0 1.7 0.0 1.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.3 10.8 0.4 0.6 0.0 0.0 0.0 1.0 0.9 1.2 2.7 0.2 2.4 0.0 0.4 0.5 2.7 1.2 1.4 0.3 0.4 0.0 7.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.9 3.8 0.7 0.3 0.0 0.0 0.1 2.2 0.0 0.0 0.5 2.2 8.0 0.0 0.0 4.6 0.8 0.0 1.5 3.1 0.4 1.3 0.3 0.0 0.3 0.0 1.7 0.2 3.8 0.0 0.0 1.7 0.1 0.0 3.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.0 41.1 7.1 5.0 6.5 10.7 3.8 8.7 4.9 0.0 0.0 0.0 0.3 0.2 3.5 1.6 2.5 0.0 0.0 8.7 3.9 0.0 16.6 2.6 1.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.0 36.5 3.4 0.6 0.0 1.3 0.0 0.0 0.0 4.6 0.0 32.7 0.4 0.0 0.0 0.3 2.0 0.0 0.3 0.6 1.9 1.0 0.0 0.0 0.0 0.4 FAM135A "FLJ20176, KIAA1411" ENSG00000082269 "Family with sequence similarity 135 member A" Q9P2D6 6 70412941-70561174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 225.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031743, HPA031744" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031743: AB_10600767, HPA031744: AB_10601101" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "prognostic favorable (8.00e-4)" "unprognostic (1.59e-1)" "unprognostic (1.66e-2)" "unprognostic (1.08e-1)" "unprognostic (6.69e-4)" "unprognostic (4.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "prognostic favorable (3.46e-4)" "unprognostic (3.99e-1)" "unprognostic (2.75e-1)" "unprognostic (6.26e-2)" "unprognostic (2.65e-2)" 5.8 4.3 6.4 9.2 6.8 1.7 5.3 14.0 10.7 9.6 13.3 4.0 5.3 14.9 7.7 4.9 33.8 5.4 8.8 5.2 5.4 5.2 9.6 5.5 5.5 4.1 6.1 7.1 8.0 6.9 16.4 13.8 22.7 8.5 18.9 13.0 4.2 10.4 6.7 5.7 14.2 27.9 4.8 8.9 4.5 12.3 11.0 6.0 4.1 4.8 13.1 10.6 7.6 14.4 3.9 6.3 3.3 5.3 5.4 2.2 1.5 5.9 3.4 7.7 4.8 3.6 2.6 6.9 1.9 3.8 2.1 3.5 6.7 4.8 10.6 13.9 1.4 10.1 5.8 7.6 4.8 3.6 5.1 6.3 4.8 3.7 5.9 4.4 8.9 5.0 2.3 11.1 4.0 11.1 2.6 5.5 3.4 7.6 5.5 2.4 0.7 1.6 4.2 5.0 7.1 2.8 5.2 24.2 5.0 7.9 3.2 8.1 2.4 2.3 2.1 2.3 5.1 1.4 4.0 2.7 1.8 4.6 1.7 4.4 6.6 7.5 4.3 1.3 8.1 3.2 3.3 4.3 0.2 1.5 3.5 1.9 3.0 1.4 0.6 6.3 3.9 2.2 1.3 1.2 5.4 5.3 1.0 1.7 1.5 6.4 6.8 14.0 10.7 5.4 5.2 6.1 7.1 8.5 6.0 26.8 12.2 1.4 9.5 14.2 18.2 9.4 15.3 8.1 5.7 19.2 27.5 2.2 5.0 5.8 24.9 10.0 28.4 0.0 10.7 1.2 5.9 32.9 8.1 5.7 5.1 225.6 22.4 9.2 14.2 17.3 14.4 13.1 5.0 9.0 26.1 12.8 13.3 30.0 12.4 6.8 27.5 6.5 6.6 25.1 8.2 29.4 6.9 3.9 19.4 11.2 FAM13A "ARHGAP48, FAM13A1, KIAA0914" ENSG00000138640 "Family with sequence similarity 13 member A" O94988 4 88725955-89111398 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 111.2;Syncytiotrophoblasts: 233.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2" "Cell line enhanced" "Detected in many" "ASC diff: 32.6" "Low region specificity" "Detected in all" "HPA038108, HPA038109" Uncertain Approved "Nucleoli,Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" Nucleoli "HPA038108: AB_2675837, HPA038109: AB_10672619" "unprognostic (1.14e-1)" "unprognostic (1.53e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.81e-1)" "unprognostic (8.20e-2)" "unprognostic (1.75e-1)" "unprognostic (1.46e-3)" "unprognostic (6.36e-2)" "unprognostic (4.71e-1)" "unprognostic (3.49e-3)" "unprognostic (1.90e-2)" "unprognostic (7.44e-2)" "prognostic favorable (4.28e-4)" 58.6 10.8 9.1 11.0 9.3 6.5 19.0 17.9 18.5 15.5 41.0 3.7 7.4 30.5 10.9 12.0 9.3 14.8 10.7 8.8 9.6 5.7 14.0 22.9 13.3 5.3 10.0 6.8 17.8 23.5 45.5 11.2 20.7 11.4 15.9 9.3 11.5 13.3 8.0 8.4 17.5 30.5 15.6 19.4 4.9 13.4 11.1 12.9 3.2 20.4 16.1 4.0 30.4 23.8 0.1 5.7 1.4 6.5 0.7 5.2 2.6 2.4 3.7 5.6 7.3 32.6 13.5 9.2 5.8 7.0 2.3 2.1 3.1 5.8 0.1 2.3 4.1 3.6 1.5 8.2 4.1 5.2 0.3 5.7 4.1 5.2 0.4 9.6 3.4 0.5 12.9 3.4 5.8 2.1 10.1 3.9 1.4 10.6 0.4 4.9 0.1 0.3 1.5 6.9 0.4 3.9 5.6 9.5 2.2 4.2 12.2 14.2 3.8 1.4 4.5 5.4 5.8 3.1 0.1 1.4 6.5 3.6 3.1 3.3 2.0 1.1 0.0 9.6 0.3 3.3 0.1 6.5 0.1 1.8 3.2 1.3 0.1 4.7 0.6 5.7 0.1 5.2 1.3 1.4 0.7 1.0 1.9 2.5 2.6 9.1 9.3 17.9 18.5 9.6 5.7 10.0 6.8 11.4 12.9 11.9 27.5 3.7 19.8 9.0 19.2 22.7 22.9 81.7 46.6 10.4 33.4 57.4 24.9 8.6 2.3 12.5 34.9 0.0 14.6 29.6 23.6 13.3 1.1 111.2 17.5 0.0 4.7 8.0 29.1 2.4 41.7 12.6 18.6 4.6 37.9 26.9 31.2 63.3 31.5 34.7 10.7 0.0 24.2 4.8 6.1 6.8 233.8 6.4 14.6 16.6 FAM13C FAM13C1 ENSG00000148541 "Family with sequence similarity 13 member C" Q8NE31 10 59246129-59363181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 36.1;Early spermatids: 31.6;Sertoli cells: 38.8" "Cancer enhanced" "Detected in some" "prostate cancer: 3.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 5.3;HSkMC: 6.9;hTERT-RPE1: 4.6;NTERA-2: 5.7;SCLC-21H: 11.4;SH-SY5Y: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037888 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037888: AB_10962981" "unprognostic (3.68e-1)" "unprognostic (6.10e-2)" "unprognostic (2.46e-1)" "unprognostic (6.69e-5)" "unprognostic (8.54e-2)" "unprognostic (4.56e-2)" "unprognostic (3.30e-2)" "unprognostic (1.06e-2)" "unprognostic (6.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-3)" "unprognostic (3.27e-1)" "unprognostic (4.51e-6)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (1.94e-3)" "unprognostic (4.66e-3)" 11.8 17.0 16.1 3.8 22.3 0.3 7.7 12.4 24.9 9.4 6.4 36.6 3.2 4.5 9.0 8.7 14.4 15.3 11.6 7.8 18.9 15.9 3.8 2.3 10.0 4.5 23.8 18.8 22.2 2.5 4.0 8.3 2.9 21.2 17.9 6.7 16.5 4.9 8.7 15.3 7.3 5.0 12.5 33.2 5.0 3.9 5.2 28.9 0.0 6.0 7.6 2.5 7.4 7.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 1.7 0.3 0.1 0.0 1.6 0.0 5.3 2.4 0.2 0.0 0.0 6.9 0.8 0.3 0.0 4.6 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 5.7 0.0 0.5 0.0 1.1 0.0 0.0 1.7 11.4 6.7 0.0 0.3 0.0 0.5 1.0 0.0 0.0 3.3 3.1 0.1 2.6 0.0 0.0 0.1 4.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 22.3 12.4 23.4 18.9 15.9 23.8 18.8 21.2 28.9 0.0 0.0 0.0 9.5 4.2 10.0 2.8 0.0 36.1 1.2 0.0 5.9 0.0 6.6 0.0 31.6 12.6 0.0 0.0 0.0 0.0 3.0 4.5 0.0 0.6 0.0 3.2 0.0 2.5 0.0 17.2 21.3 0.5 3.3 0.0 0.0 8.8 0.0 0.0 19.8 0.4 13.1 38.8 18.6 0.9 0.7 5.5 0.0 0.0 0.0 0.5 FAM151B UNQ9217 ENSG00000152380 "Family with sequence similarity 151 member B" Q6UXP7 5 80487969-80542563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 6.7;Kupffer cells: 6.8;Syncytiotrophoblasts: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.0;eosinophil: 2.2;intermediate monocyte: 1.1;myeloid DC: 3.5" "Group enriched" "Detected in many" 11 "dendritic cells: 3.5;granulocytes: 2.2;monocytes: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043805 Uncertain Approved Cytosol NA NA Cytosol "HPA043805: AB_10794287" "unprognostic (1.29e-1)" "unprognostic (7.11e-2)" "unprognostic (1.67e-3)" "unprognostic (1.28e-4)" "unprognostic (1.90e-2)" "unprognostic (4.46e-4)" "unprognostic (2.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.10e-2)" "unprognostic (9.63e-2)" "unprognostic (1.20e-1)" "unprognostic (3.44e-2)" "unprognostic (6.86e-3)" "unprognostic (1.13e-1)" "unprognostic (2.66e-1)" "unprognostic (2.50e-2)" "unprognostic (1.63e-1)" 2.8 4.6 5.2 2.4 7.7 13.1 2.5 4.5 7.2 3.1 1.8 2.2 0.2 1.7 3.3 4.8 2.5 4.4 3.2 3.0 8.5 3.6 5.5 3.7 2.9 2.9 3.1 4.8 2.5 6.8 3.0 6.9 5.6 3.2 3.0 2.3 2.5 3.4 2.1 2.6 1.7 1.4 3.1 2.9 3.0 2.0 3.2 2.0 0.0 2.8 0.3 1.6 2.7 2.4 0.0 3.5 2.2 2.0 0.1 0.2 0.5 0.1 2.8 1.2 5.1 4.3 6.4 2.0 2.2 3.2 1.7 4.0 0.2 2.2 0.0 0.5 5.7 5.8 1.4 1.8 0.5 1.5 0.5 1.0 0.7 1.0 0.8 1.9 0.7 2.8 2.9 2.0 2.2 0.1 3.5 2.8 0.6 0.1 0.8 3.0 2.2 0.4 0.5 0.1 0.5 1.0 0.6 4.2 0.7 2.0 1.0 0.5 1.4 0.8 2.1 2.2 0.4 3.1 2.3 1.3 0.3 0.3 0.0 0.8 0.2 1.3 0.0 3.0 2.3 1.9 0.0 2.0 2.2 0.0 1.1 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.5 5.2 7.7 4.5 7.2 8.5 3.6 3.1 4.8 3.2 2.0 0.0 0.0 0.0 0.6 0.2 0.7 1.6 5.1 4.0 1.2 3.5 0.0 6.7 0.0 1.2 2.7 0.5 0.1 0.0 1.8 5.3 2.3 0.8 1.1 0.0 4.5 1.6 0.0 0.6 6.8 1.5 1.1 2.5 0.0 0.0 0.7 0.8 0.4 0.0 0.4 3.4 0.4 0.0 0.7 2.8 1.0 0.9 6.6 0.0 0.2 0.5 FAM160A1 FLJ43373 ENSG00000164142 "Family with sequence similarity 160 member A1" Q05DH4 4 151409216-151663632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 33.6" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 10.5;Horizontal cells: 7.9;Suprabasal keratinocytes: 12.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "amygdala: 3.0;cerebellum: 7.5;pons and medulla: 4.8" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 5.8" "Lineage enriched" "Detected in single" 13 "dendritic cells: 5.8" "Cell line enhanced" "Detected in many" "A-431: 8.3;HeLa: 10.1;hTERT-HME1: 9.5;SiHa: 9.0;SK-BR-3: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046348 Enhanced Approved Cytosol NA NA Cytosol "HPA046348: AB_10966145" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.21e-3)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" "unprognostic (1.38e-1)" "unprognostic (5.33e-2)" "unprognostic (4.55e-2)" "unprognostic (1.52e-1)" "unprognostic (7.21e-3)" "unprognostic (1.30e-3)" "unprognostic (2.39e-1)" "unprognostic (1.51e-12)" "unprognostic (2.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (1.28e-1)" 1.4 1.2 3.0 3.4 0.8 1.5 3.8 7.5 0.9 6.3 5.2 0.6 10.4 1.7 6.1 5.9 13.1 2.8 4.9 6.5 0.7 0.7 7.0 1.6 5.4 0.1 0.6 0.0 3.7 23.7 11.1 9.4 1.8 4.8 4.5 3.3 10.0 11.1 12.5 33.6 12.6 9.0 1.8 0.7 0.7 2.3 3.5 0.0 0.9 11.4 22.0 10.0 6.2 5.0 0.0 5.8 0.4 0.0 0.1 0.1 0.0 8.3 0.7 0.0 0.2 0.0 0.0 3.1 0.4 2.0 0.8 0.2 3.6 3.1 0.0 0.9 0.1 2.8 7.6 2.2 6.3 1.3 0.0 3.6 0.0 10.1 0.8 0.0 0.0 0.1 0.1 6.3 0.0 9.5 1.9 0.1 0.7 0.0 0.0 0.5 1.2 0.0 0.0 2.9 2.6 0.8 0.0 2.1 0.3 4.4 5.7 1.4 0.4 9.0 7.9 0.0 2.5 3.4 0.0 0.0 0.6 3.7 0.2 1.4 0.0 0.0 0.0 2.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 3.0 0.8 7.5 0.9 0.7 0.7 0.6 0.0 4.8 0.0 3.0 1.3 0.0 6.2 10.5 0.0 1.6 0.0 0.0 6.8 0.0 0.0 0.3 0.0 1.3 1.8 0.3 3.4 0.0 1.5 0.5 0.3 5.9 1.1 0.5 0.2 7.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.0 3.7 1.2 0.0 0.0 0.3 4.5 0.0 0.3 2.1 4.1 12.7 1.4 0.0 1.4 6.8 FAM160B1 "bA106M7.3, KIAA1600" ENSG00000151553 "Family with sequence similarity 160 member B1" Q5W0V3 10 114821744-114899832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043624 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA043624: AB_10797145" "unprognostic (2.61e-1)" "unprognostic (2.47e-2)" "unprognostic (2.62e-1)" "unprognostic (8.45e-3)" "unprognostic (6.43e-2)" "unprognostic (9.87e-3)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (2.29e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (4.02e-6)" "unprognostic (3.41e-3)" "unprognostic (3.35e-1)" "unprognostic (2.10e-1)" "unprognostic (1.25e-2)" 15.9 13.3 9.9 12.1 13.1 40.9 31.0 10.2 15.7 11.7 10.8 6.1 11.8 11.2 18.4 10.6 9.8 13.4 11.0 18.1 7.7 5.9 7.4 16.8 13.4 18.7 5.9 8.5 15.1 10.8 13.6 11.4 14.4 7.0 10.0 7.6 8.5 9.6 11.0 42.6 9.4 13.4 18.7 6.7 12.1 10.9 16.0 5.2 17.7 12.9 7.2 8.8 13.6 19.7 3.4 3.2 15.0 2.7 3.9 8.7 2.0 9.0 5.1 5.6 8.3 13.7 15.7 6.4 16.5 16.6 9.9 8.0 1.8 3.6 5.5 4.9 15.5 2.5 6.2 2.7 6.8 11.7 18.5 5.2 2.2 8.9 4.0 10.0 5.8 7.5 12.2 6.6 7.4 12.0 21.3 13.2 11.5 2.9 14.2 18.4 4.3 10.0 5.8 3.6 2.7 3.5 8.7 9.2 3.7 6.7 5.6 1.2 5.0 7.3 7.9 8.5 6.9 3.1 3.4 13.2 6.1 3.9 17.8 5.8 5.4 1.5 6.4 7.9 14.8 5.7 15.0 2.7 3.9 5.0 2.1 3.7 3.4 6.8 8.5 3.1 3.2 3.8 5.0 13.6 3.9 2.3 3.2 8.7 2.0 9.9 13.1 10.2 15.7 7.7 5.9 5.9 8.5 7.0 5.2 14.9 7.2 2.9 5.4 6.3 13.1 13.7 5.1 5.3 5.7 3.5 11.8 9.9 1.7 8.9 20.4 15.8 12.8 0.0 8.4 8.6 13.4 13.2 2.3 25.6 5.4 9.5 7.5 22.7 17.0 26.1 26.4 6.1 3.3 4.6 8.1 10.1 11.9 4.2 20.8 5.7 16.3 6.5 8.5 10.4 4.8 4.3 10.5 10.7 5.2 8.8 FAM160B2 "FLJ21801, RAI16" ENSG00000158863 "Family with sequence similarity 160 member B2" Q86V87 8 22089159-22104898 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025040 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA025040: AB_1856049" "unprognostic (3.45e-1)" "unprognostic (2.08e-3)" "unprognostic (1.60e-1)" "unprognostic (8.85e-3)" "unprognostic (2.28e-2)" "prognostic favorable (4.56e-4)" "unprognostic (2.35e-2)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (8.38e-3)" "unprognostic (7.67e-3)" "unprognostic (3.38e-2)" "unprognostic (6.30e-2)" "unprognostic (1.08e-2)" "unprognostic (1.25e-1)" "unprognostic (2.75e-3)" 15.8 11.8 9.6 13.1 10.0 6.6 14.3 14.3 14.8 12.9 13.2 12.9 20.8 12.0 13.2 16.9 13.7 14.1 14.5 26.0 8.5 6.9 12.3 9.8 11.0 11.2 12.5 10.5 11.4 22.1 15.3 14.1 22.4 10.9 14.4 6.0 13.4 18.8 25.1 15.1 24.4 13.4 25.3 10.4 12.3 16.1 6.4 10.3 6.5 16.0 11.6 13.2 19.9 11.2 2.7 0.9 0.5 1.4 1.7 3.2 2.1 3.7 9.3 4.5 6.9 9.1 8.4 6.9 5.8 12.6 8.6 6.0 3.8 4.6 3.9 6.4 18.2 7.8 5.3 3.3 10.4 1.8 3.4 3.5 5.8 2.5 2.6 12.3 1.5 5.3 14.1 7.1 6.3 4.2 8.9 8.8 8.9 3.9 3.3 8.1 7.8 4.2 2.2 1.8 7.9 3.3 4.4 3.3 2.2 7.3 9.2 1.6 4.8 3.5 7.5 4.8 4.7 4.5 3.4 8.4 8.7 6.7 7.8 4.0 2.6 0.8 0.7 9.2 2.8 9.4 0.0 1.2 0.5 3.2 0.7 1.9 2.7 2.1 2.6 0.8 2.3 1.9 2.7 0.3 1.7 1.4 0.9 0.3 2.1 9.6 10.0 14.3 14.8 8.5 6.9 12.5 10.5 10.9 10.3 11.9 15.0 9.0 8.7 5.3 22.4 21.8 20.4 2.7 4.5 12.2 25.5 7.0 0.0 8.0 3.6 12.2 13.8 0.0 12.8 11.4 8.0 10.8 6.9 12.2 6.4 22.3 12.7 17.8 11.8 1.9 10.0 5.4 1.7 4.6 9.7 12.7 13.7 12.5 5.3 3.8 24.2 0.0 7.3 1.7 5.9 6.6 12.5 8.6 8.6 8.1 FAM162A "C3orf28, E2IG5" ENSG00000114023 "Family with sequence similarity 162 member A" Q96A26 3 122384176-122412334 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035856, HPA058113" Approved Enhanced Mitochondria,Cytosol NA NA 29000 "Mitochondria, Cytosol" "HPA035856: AB_10611965, HPA058113: AB_2683609" "unprognostic (1.17e-2)" "unprognostic (1.42e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" "unprognostic (3.99e-1)" "unprognostic (7.84e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (5.91e-3)" "unprognostic (8.74e-2)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (4.10e-2)" "prognostic favorable (3.93e-4)" 13.6 32.8 24.9 18.6 49.9 14.1 18.7 10.7 44.8 21.8 57.8 11.5 19.6 22.7 17.0 25.5 58.7 13.8 25.4 54.2 40.2 21.7 35.9 78.1 12.2 16.5 23.6 27.7 30.2 71.5 24.6 16.1 7.3 31.0 27.3 61.3 16.2 17.7 23.1 56.6 29.2 21.2 27.2 24.4 10.9 25.7 16.9 18.8 8.6 17.9 48.6 16.7 34.6 36.0 26.8 29.4 25.3 24.4 16.4 33.1 12.9 28.8 6.2 9.2 17.1 16.9 15.7 4.7 11.8 10.6 11.3 28.8 15.4 13.3 31.4 20.6 4.0 9.3 20.2 16.6 28.8 30.2 16.2 12.4 25.4 10.7 27.5 11.1 24.8 9.1 18.1 15.1 10.7 22.7 38.0 14.9 31.0 17.1 12.6 16.1 11.3 25.2 30.2 13.6 65.2 32.8 15.2 13.2 40.9 32.7 70.4 13.8 11.0 8.8 21.0 24.1 14.4 13.1 12.2 10.5 11.2 8.0 6.5 12.2 25.0 8.5 31.8 33.2 24.3 5.1 2.6 9.3 25.3 21.7 23.0 32.1 26.8 29.8 27.1 29.4 23.9 32.6 33.1 3.0 16.4 24.4 24.6 27.1 12.9 24.9 49.9 10.7 44.8 40.2 21.7 23.6 27.7 31.0 18.8 26.8 42.4 71.1 131.6 113.8 30.4 312.0 96.8 46.8 43.3 123.9 45.2 42.9 457.6 109.5 73.0 47.4 279.5 23.3 152.7 35.4 52.8 85.5 85.3 207.9 83.9 36.5 102.7 38.1 49.4 23.4 124.5 76.0 99.5 146.9 326.4 45.5 161.9 325.6 139.7 345.2 28.5 103.5 89.6 141.1 55.3 116.1 39.5 54.9 245.2 156.6 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133578415-133586197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 41.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 15.1" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "SH-SY5Y: 40.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067336 Enhanced Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: AB_2685825" "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 8.2 10.0 0.0 2.7 0.0 0.0 3.2 41.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.4 1.2 6.1 3.9 0.1 2.7 0.0 1.3 3.3 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.8 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM169A "KIAA0888, SLAP75" ENSG00000198780 "Family with sequence similarity 169 member A" Q9Y6X4 5 74777574-74866951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;epididymis: 23.6" "Group enriched" "Detected in many" 5 "Bipolar cells: 120.0;Collecting duct cells: 47.1;Cone photoreceptor cells: 133.5;Horizontal cells: 81.0;Muller glia cells: 163.2;Rod photoreceptor cells: 163.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.8;Hep G2: 15.5;SuSa: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041574 Enhanced Supported "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA041574: AB_10794382" "unprognostic (3.39e-1)" "unprognostic (2.25e-2)" "unprognostic (1.75e-4)" "unprognostic (5.87e-2)" "unprognostic (2.28e-2)" "unprognostic (1.46e-3)" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-2)" "unprognostic (2.72e-2)" "unprognostic (8.02e-2)" "unprognostic (3.51e-3)" "unprognostic (4.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" 0.7 4.2 9.9 1.4 13.5 1.5 1.1 11.0 21.8 1.7 1.9 5.2 2.9 0.7 3.8 23.6 0.9 3.8 3.0 2.2 9.4 14.2 6.7 3.1 0.8 2.5 9.6 10.3 3.4 2.0 10.7 8.3 1.2 10.4 6.4 3.0 11.3 1.9 7.0 0.8 0.7 1.0 1.0 11.1 2.5 2.1 15.5 4.6 3.7 9.6 0.0 2.5 4.1 1.1 1.4 0.5 0.0 0.0 0.8 4.0 1.2 5.1 4.6 3.3 4.4 0.0 0.0 22.8 0.7 1.7 3.5 3.5 2.1 3.4 0.0 2.3 0.0 9.4 3.7 6.8 10.3 3.6 3.8 7.8 1.4 0.8 15.5 0.1 0.0 0.0 0.1 10.9 0.8 5.1 0.5 0.0 5.0 0.0 0.0 2.0 1.5 4.9 0.0 8.2 1.4 2.5 7.1 2.1 0.3 3.2 8.2 2.0 2.7 8.6 3.9 0.6 15.6 3.7 1.0 0.0 0.2 3.3 0.0 3.7 12.6 11.7 0.0 0.4 0.0 0.4 0.0 0.0 0.0 2.7 0.0 4.0 0.8 1.6 2.5 0.0 1.4 3.5 3.4 0.0 0.8 0.0 0.5 0.9 1.2 9.9 13.5 11.0 17.1 9.4 14.2 9.6 10.3 10.4 4.6 0.0 0.0 0.9 4.9 0.2 120.0 1.2 0.0 2.7 3.4 47.1 133.5 4.4 3.3 1.6 12.3 0.6 1.3 0.0 0.0 0.4 0.4 6.7 1.1 2.9 0.4 81.0 3.4 0.0 0.6 22.2 4.6 0.0 1.7 1.0 1.2 163.2 2.0 0.0 3.9 2.0 163.5 0.0 0.3 18.9 10.7 0.1 0.2 5.1 0.6 3.4 FAM172A "C5orf21, DKFZP564D172" ENSG00000113391 "Family with sequence similarity 172 member A" Q8WUF8 5 93618069-94111699 "Predicted intracellular proteins, Predicted secreted proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012299, HPA045505" Approved Supported Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA012299: AB_1845724, HPA045505: AB_2679354" "unprognostic (1.12e-2)" "unprognostic (2.17e-1)" "unprognostic (3.10e-2)" "unprognostic (7.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (1.51e-1)" "unprognostic (1.57e-2)" "unprognostic (2.52e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.38e-1)" "unprognostic (6.56e-2)" "unprognostic (1.72e-2)" "unprognostic (1.03e-2)" 18.4 15.4 24.2 17.8 21.8 9.8 19.3 28.8 20.8 19.9 14.4 15.5 13.9 11.2 19.1 16.1 17.7 18.8 14.3 14.0 21.0 19.9 18.5 8.0 14.9 22.4 18.9 13.0 23.0 18.2 20.7 28.4 15.1 15.6 19.4 12.3 12.6 14.3 22.6 6.2 11.8 12.9 26.2 20.8 13.6 13.7 8.3 16.6 16.1 22.8 9.5 16.1 19.0 15.7 9.8 7.1 13.1 7.3 12.3 11.9 6.4 4.6 5.4 13.3 14.9 16.0 19.4 6.9 9.9 7.7 4.3 4.3 3.7 6.5 6.7 7.5 11.6 7.7 4.1 4.0 14.0 10.1 4.5 4.8 8.9 11.3 2.5 6.8 6.8 10.3 16.9 8.0 3.9 7.6 15.6 9.8 6.3 1.8 2.0 17.7 5.1 5.7 5.2 2.0 8.6 4.4 6.4 14.0 6.3 6.8 9.0 11.9 21.2 8.0 3.4 7.3 8.7 8.2 8.3 9.7 10.3 9.3 6.7 11.7 8.6 12.5 7.6 16.2 7.6 18.8 13.1 5.4 7.0 11.9 7.3 11.9 9.4 8.9 8.7 7.1 9.8 10.1 10.2 13.0 12.3 5.1 6.8 9.2 6.4 24.2 21.8 28.8 20.8 21.0 19.9 18.9 13.0 15.6 16.6 50.6 23.7 24.4 21.0 10.9 48.1 20.2 28.1 62.9 25.0 10.4 29.5 11.1 51.4 16.4 38.4 23.3 15.8 0.0 18.6 10.7 16.0 19.5 24.3 12.4 10.1 39.7 16.3 17.8 18.0 23.9 35.6 17.5 20.3 22.6 11.5 34.6 17.2 13.9 34.3 27.9 51.6 12.9 17.9 19.0 23.5 8.8 9.2 23.5 16.4 20.4 FAM173A "C16orf24, MGC2494" ENSG00000103254 "Family with sequence similarity 173 member A" Q9BQD7 16 720581-722601 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 314.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046262 Approved Approved Cytosol NA NA Cytosol "HPA046262: AB_10963070" "unprognostic (3.94e-2)" "unprognostic (8.78e-2)" "unprognostic (1.55e-1)" "unprognostic (2.61e-1)" "unprognostic (6.54e-2)" "prognostic favorable (8.88e-4)" "unprognostic (2.11e-1)" "unprognostic (4.49e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (4.02e-2)" "unprognostic (5.70e-2)" "prognostic favorable (4.24e-5)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (9.28e-2)" "unprognostic (3.60e-3)" 16.0 10.4 15.6 10.3 9.1 7.3 9.6 8.9 21.5 4.8 15.5 8.2 9.3 19.1 6.5 8.3 6.1 5.2 10.6 11.1 13.6 11.5 18.6 15.8 7.5 7.5 11.3 12.2 4.3 10.2 8.5 13.4 5.8 9.2 8.4 3.5 6.5 15.1 8.6 37.3 6.2 14.5 5.6 9.5 15.0 19.3 21.8 7.9 8.6 7.8 11.1 7.1 5.9 8.9 9.0 6.0 5.3 6.8 6.3 18.0 4.2 6.4 4.3 0.8 2.3 0.1 0.3 10.3 5.6 1.4 1.3 1.6 4.3 5.4 8.3 10.1 0.6 2.4 10.1 0.8 2.8 0.4 18.3 11.4 3.5 4.5 4.5 2.0 5.8 4.8 0.7 2.1 0.6 1.7 2.9 0.5 5.8 7.3 3.8 1.2 10.5 0.9 14.0 3.3 3.6 14.1 3.5 2.1 15.5 3.6 2.3 3.7 9.7 2.9 4.8 9.3 0.5 5.3 5.2 4.7 1.2 10.0 3.6 3.9 33.6 15.0 8.9 2.5 4.3 3.2 0.0 6.8 5.3 7.3 3.9 16.5 9.0 5.8 12.9 4.4 9.0 5.9 18.0 0.8 6.3 4.8 6.0 12.5 4.2 15.6 9.1 8.9 21.5 13.6 11.5 11.3 12.2 9.2 7.9 6.0 5.4 49.9 28.1 9.0 86.9 11.2 50.9 1.4 0.0 61.1 33.4 40.1 99.5 47.3 182.0 14.5 140.4 0.0 56.0 31.2 20.0 36.4 28.7 74.6 77.3 50.9 50.1 27.6 51.9 314.4 23.6 43.6 45.5 55.1 53.9 57.8 49.3 73.7 17.7 139.1 71.7 25.8 27.8 65.4 88.0 8.3 21.4 60.6 62.2 31.4 FAM174A "NS5ATP6, TMEM157, UNQ1912" ENSG00000174132 "Family with sequence similarity 174 member A" Q8TBP5 5 100535305-100586741 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 211.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 8 "neutrophil: 28.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 28.0" "Cell line enhanced" "Detected in many" "U-266/84: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019539 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA019539: AB_2293743" "unprognostic (2.34e-1)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (9.02e-3)" "prognostic unfavorable (2.57e-6)" "unprognostic (5.55e-3)" "unprognostic (3.06e-1)" "unprognostic (2.60e-1)" "unprognostic (3.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.73e-2)" "unprognostic (7.69e-2)" "prognostic favorable (5.48e-4)" "unprognostic (1.74e-1)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" 15.6 24.6 18.8 8.3 21.0 3.0 15.3 14.2 26.8 11.1 12.0 16.5 14.0 11.8 11.3 15.2 18.0 35.9 9.5 17.3 22.0 25.0 18.3 15.2 17.6 5.5 19.3 18.2 9.1 26.8 23.6 21.9 15.6 24.1 19.5 9.1 16.6 16.5 13.7 38.8 20.4 10.7 9.6 19.4 10.1 15.5 37.3 12.2 4.4 14.3 17.0 9.6 9.9 11.7 1.5 2.2 28.0 2.7 2.5 2.7 1.6 5.0 5.3 2.2 6.9 5.3 4.3 7.7 11.6 6.5 4.8 6.5 1.1 6.6 0.9 23.6 5.0 8.3 4.3 1.8 7.5 3.4 6.1 5.5 0.6 9.2 3.1 7.2 2.6 6.4 5.6 18.0 3.6 2.8 10.8 7.1 2.7 1.8 6.9 7.8 10.1 0.7 5.4 1.1 0.6 14.5 1.7 8.3 8.7 8.3 6.1 4.4 11.7 8.1 7.3 6.4 2.6 7.1 5.7 8.1 6.0 3.8 9.6 9.1 22.0 28.7 1.1 7.5 3.5 5.2 3.6 2.5 3.4 1.8 2.7 2.7 1.4 1.8 2.2 2.2 1.5 1.6 2.1 28.0 2.5 2.7 2.2 2.2 1.6 18.8 21.0 14.2 26.8 22.0 25.0 19.3 18.2 24.1 12.2 29.8 25.6 12.6 27.4 78.3 24.0 14.9 20.4 211.5 31.8 27.9 3.9 33.9 36.5 26.0 16.2 23.7 14.7 0.0 26.4 32.0 28.2 31.9 12.7 27.2 20.9 28.6 33.5 31.9 14.3 4.0 16.7 17.1 47.2 19.0 31.7 63.9 27.0 20.1 23.0 32.2 36.9 12.9 22.6 86.9 16.8 100.6 42.1 13.1 19.9 34.6 FAM184A "C6orf60, FLJ13942" ENSG00000111879 "Family with sequence similarity 184 member A" Q8NB25 6 118959763-119149387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.4" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 90.2;Spermatocytes: 64.6;Syncytiotrophoblasts: 222.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 15.9;HEK 293: 9.4;JURKAT: 13.4;K-562: 13.0;SCLC-21H: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034571, HPA034572, HPA041955" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768" "unprognostic (1.21e-1)" "unprognostic (4.11e-3)" "unprognostic (6.95e-2)" "unprognostic (3.40e-3)" "unprognostic (6.80e-2)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.18e-4)" "unprognostic (2.59e-1)" "unprognostic (3.19e-1)" "unprognostic (5.16e-4)" "unprognostic (8.38e-3)" "unprognostic (4.02e-2)" "unprognostic (9.11e-3)" "unprognostic (8.16e-3)" "unprognostic (5.70e-2)" "unprognostic (2.32e-1)" 4.0 2.8 14.2 3.7 13.7 0.6 6.1 13.9 16.0 2.8 3.0 4.6 0.4 3.8 3.9 3.6 2.6 3.9 2.3 2.4 11.3 10.5 6.7 6.4 15.3 4.9 9.1 10.0 7.1 5.1 14.2 15.4 31.4 11.9 4.0 1.9 2.7 2.9 4.1 1.2 2.3 2.6 3.1 4.6 1.0 1.7 23.2 7.1 0.1 8.5 1.1 5.8 2.1 2.0 0.5 0.0 0.0 0.2 0.3 1.9 0.0 0.1 0.2 15.9 1.6 0.2 0.2 0.0 0.5 0.3 0.5 0.8 2.1 1.2 1.1 0.0 0.2 6.0 0.0 4.9 0.0 0.2 1.2 9.4 0.5 1.4 7.0 0.1 0.0 1.5 0.3 0.2 0.1 0.0 0.3 0.0 13.4 13.0 0.5 0.2 0.3 0.3 0.0 5.3 0.6 1.2 0.0 0.0 0.0 0.1 0.1 10.4 7.7 0.5 0.5 1.5 3.0 2.1 1.8 0.2 0.8 0.4 0.1 4.0 4.0 4.3 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.2 0.2 0.6 0.5 0.2 0.0 0.0 0.1 1.5 1.2 0.0 0.3 0.0 0.0 1.9 0.0 14.2 13.7 13.9 12.9 11.3 10.5 9.1 10.0 11.9 7.1 44.7 90.2 0.0 6.1 2.2 36.7 3.9 5.1 60.2 31.8 3.5 27.5 45.2 14.9 0.8 12.9 1.9 0.1 0.0 1.0 13.5 5.0 0.9 5.8 3.4 4.9 12.7 5.8 3.1 0.3 5.4 3.4 0.8 0.0 0.0 0.0 12.5 0.5 0.0 6.7 1.3 27.8 6.5 2.3 64.6 15.4 3.0 222.8 4.1 0.4 1.0 FAM185A MGC35361 ENSG00000222011 "Family with sequence similarity 185 member A" Q8N0U4 7 102748971-102809225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020470, HPA029883" Uncertain Approved Cytosol NA NA Cytosol "HPA020470: AB_1853890, HPA029883: AB_10601903" "unprognostic (8.28e-2)" "unprognostic (2.28e-1)" "unprognostic (8.19e-2)" "unprognostic (1.20e-1)" "unprognostic (3.88e-3)" "unprognostic (6.06e-2)" "unprognostic (1.63e-2)" "unprognostic (1.59e-3)" "unprognostic (3.97e-2)" "unprognostic (4.45e-2)" "unprognostic (7.11e-2)" "unprognostic (2.03e-1)" "prognostic favorable (9.36e-5)" "unprognostic (3.64e-2)" "unprognostic (2.65e-1)" "unprognostic (2.13e-3)" "unprognostic (5.25e-2)" 3.7 4.6 6.6 3.0 4.9 3.6 3.8 9.3 6.3 5.6 4.3 4.4 4.1 2.3 3.8 3.1 4.4 3.1 3.4 4.2 4.2 2.3 4.0 9.4 4.8 2.3 5.1 6.0 4.7 3.7 8.7 4.8 2.8 4.0 5.2 4.3 6.1 5.1 8.4 9.5 4.6 3.1 3.7 4.5 3.0 5.9 2.2 5.1 3.0 3.8 2.4 2.7 4.4 4.0 3.3 2.6 7.5 3.0 1.2 2.2 0.9 1.4 3.5 1.6 4.1 0.6 1.7 4.2 0.9 1.7 1.6 0.5 3.4 2.9 0.0 2.2 1.2 4.3 3.6 2.3 2.4 1.6 1.8 2.0 0.2 0.4 4.2 1.0 2.9 0.4 0.0 2.7 1.0 1.2 3.3 2.0 1.1 2.1 1.5 1.7 2.7 1.4 0.3 1.8 2.7 0.0 0.3 0.1 10.2 0.8 2.5 1.4 3.0 3.4 5.4 0.4 0.9 3.3 0.0 3.6 0.4 1.7 2.5 0.5 4.9 1.6 0.6 0.7 0.9 0.0 0.0 3.0 3.3 2.1 2.2 0.9 3.3 1.4 2.2 2.6 1.9 1.3 1.5 7.5 1.2 1.0 2.4 1.6 0.9 6.6 4.9 9.3 6.3 4.2 2.3 5.1 6.0 4.0 5.1 3.0 1.0 2.4 5.9 3.8 7.7 4.4 10.2 2.7 6.8 0.0 9.8 11.6 16.6 3.7 3.1 4.5 2.3 0.0 2.0 4.9 3.3 3.1 0.0 5.9 4.0 4.8 1.2 4.3 1.3 1.9 6.6 1.9 6.8 1.8 2.2 3.5 2.2 0.0 4.9 9.1 21.2 12.9 2.8 5.2 3.6 4.0 6.8 4.9 3.5 5.1 FAM187A ENSG00000214447 "Family with sequence similarity 187 member A" A6NFU0 17 44899712-44905390 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.2;testis: 37.0" "Cell type enriched" "Detected in single" 67 "Ciliated cells: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 12.4;U-87 MG: 14.1" HPA043131 Approved Cytosol NA NA Cytosol "HPA043131: AB_10796686" 0.7 1.3 5.8 0.6 8.9 0.7 1.4 1.0 5.0 2.5 0.9 3.1 1.7 0.3 1.9 2.7 0.5 21.2 3.0 0.6 5.4 6.7 3.7 0.5 2.0 0.7 5.3 4.1 3.7 1.6 2.2 2.2 0.3 4.5 1.1 1.0 1.7 1.3 1.9 0.4 0.6 0.6 1.1 4.2 0.4 0.6 37.0 1.1 0.3 4.5 0.2 0.6 0.9 0.3 0.8 1.8 1.9 2.9 0.2 0.8 2.0 1.7 8.8 2.2 1.8 2.7 3.1 1.4 0.5 4.3 2.5 3.1 2.6 4.7 0.2 1.4 1.6 5.9 5.2 0.5 2.3 1.1 5.2 2.1 0.7 3.7 0.7 1.1 1.0 0.7 0.4 3.0 4.7 1.0 4.2 1.1 1.1 1.6 0.1 0.9 1.2 0.1 1.3 0.7 3.0 1.2 0.8 0.3 0.4 12.4 0.8 5.9 1.4 0.5 0.1 0.7 1.7 6.3 1.0 0.6 1.0 2.2 1.2 1.0 0.2 0.2 0.4 14.1 0.8 1.1 0.0 2.9 1.9 0.2 0.8 0.0 0.0 0.0 0.8 1.8 0.8 0.0 0.1 0.0 0.2 0.3 0.0 0.6 2.0 5.8 8.9 1.0 5.0 5.4 6.7 5.3 4.1 4.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM193A "C4orf8, RES4-22" ENSG00000125386 "Family with sequence similarity 193 member A" P78312 4 2536631-2732565 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043116 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043116: AB_10795767" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (1.17e-3)" "unprognostic (1.97e-1)" "unprognostic (3.66e-3)" "unprognostic (6.34e-3)" "unprognostic (1.02e-1)" "unprognostic (7.16e-2)" "unprognostic (4.84e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.38e-2)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (3.47e-2)" "unprognostic (5.55e-2)" "unprognostic (4.96e-3)" 17.1 14.1 17.8 25.5 17.7 22.4 19.7 33.0 23.2 17.4 14.5 18.2 21.3 15.3 23.5 16.0 12.1 16.4 17.2 11.9 16.7 14.3 12.4 13.7 20.2 17.3 18.0 11.8 23.7 17.4 20.4 21.5 15.3 16.1 16.4 11.9 18.8 16.4 19.3 18.1 16.6 15.8 16.0 13.9 17.0 14.7 29.1 17.2 26.3 15.4 13.7 16.0 14.6 30.7 2.5 3.9 5.7 6.3 3.2 2.9 1.0 7.1 9.0 16.7 9.5 10.2 10.5 9.1 11.0 9.4 10.8 9.1 9.1 11.7 14.0 6.8 11.9 13.3 6.2 11.6 7.8 8.9 8.7 7.6 21.0 11.1 9.4 12.4 12.6 14.8 11.5 8.3 10.6 10.8 9.8 10.6 8.4 14.7 15.5 8.8 7.5 20.5 20.5 13.7 7.1 10.2 20.3 8.8 6.9 7.2 9.4 14.7 12.6 9.3 6.5 9.5 9.4 12.0 13.0 14.3 16.5 9.8 8.9 14.2 15.7 11.5 13.6 9.3 10.6 11.7 5.7 2.2 1.8 2.2 1.5 1.5 1.5 1.9 2.9 1.4 2.5 1.9 2.7 4.2 3.2 6.3 3.9 1.4 1.0 17.8 17.7 33.0 23.2 16.7 14.3 18.0 11.8 16.1 17.2 11.9 15.6 2.7 6.0 8.4 24.2 13.1 0.0 4.0 21.6 1.8 45.2 5.9 1.7 7.9 6.7 12.6 11.6 0.0 6.5 5.7 10.8 9.1 8.1 4.9 7.5 14.3 13.8 10.4 8.2 11.0 15.8 11.3 13.5 8.2 9.0 15.4 8.7 9.0 13.8 2.2 24.7 6.5 10.0 29.8 28.5 8.7 4.7 6.4 8.9 6.4 FAM199X CXorf39 ENSG00000123575 "Family with sequence similarity 199, X-linked" Q6PEV8 X 104166620-104195902 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003093 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA003093: AB_1078597" "unprognostic (2.03e-3)" "unprognostic (4.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.18e-2)" "unprognostic (1.89e-2)" "unprognostic (6.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (1.18e-1)" "unprognostic (9.13e-2)" "unprognostic (6.07e-3)" "unprognostic (1.08e-2)" "unprognostic (4.73e-2)" "unprognostic (4.00e-2)" "unprognostic (2.39e-2)" 19.5 13.4 19.6 7.5 24.4 13.0 13.1 17.1 25.9 11.1 9.3 14.2 21.0 8.7 13.0 39.2 9.0 10.5 7.8 8.0 17.4 19.2 17.1 8.6 9.0 8.7 19.3 17.9 13.9 13.1 24.9 11.8 9.9 22.6 11.8 9.7 8.7 10.8 16.6 10.7 10.4 8.2 9.9 16.9 9.2 8.9 10.9 12.9 6.5 19.4 5.6 8.5 9.5 12.8 3.8 2.3 2.6 2.0 1.5 3.9 1.3 16.8 10.8 9.8 10.7 7.3 8.8 9.9 9.0 8.5 11.8 11.1 8.3 14.2 9.4 11.2 8.3 9.3 12.9 17.6 13.3 19.4 4.5 9.8 7.4 13.8 9.4 10.4 14.0 10.5 6.8 17.0 11.6 11.7 18.4 11.9 6.1 8.0 21.2 13.0 12.1 7.5 10.0 9.7 15.0 12.6 8.0 6.4 11.7 20.1 11.4 5.3 6.5 21.7 14.6 15.5 10.1 7.3 7.0 14.5 13.2 4.8 10.2 9.6 10.0 8.3 10.5 14.9 15.2 9.6 2.2 2.0 1.1 2.8 1.5 3.2 1.6 2.6 3.4 2.3 3.8 3.9 2.3 2.6 1.5 2.0 1.2 2.9 1.3 19.6 24.4 17.1 23.3 17.4 19.2 19.3 17.9 22.6 12.9 14.9 12.6 15.2 9.5 21.3 22.7 11.8 17.8 6.7 9.1 59.3 13.7 9.6 19.9 10.2 0.5 13.2 14.0 0.0 16.4 9.6 11.0 12.5 9.2 15.7 14.7 31.8 16.1 14.1 16.6 2.7 10.9 14.1 10.1 6.4 20.2 19.1 13.4 15.9 13.8 20.7 14.6 25.8 10.5 2.6 10.9 23.1 12.2 8.5 14.3 12.7 FAM206A "C9orf6, CG-8, FLJ20457, Simiate" ENSG00000119328 "Family with sequence similarity 206 member A" Q9NX38 9 108934181-108950744 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035917, HPA035918" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Cytosol" "Cytokinetic bridge" "HPA035917: AB_2674860, HPA035918: AB_10670593" "unprognostic (4.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.85e-1)" "unprognostic (4.00e-3)" "unprognostic (1.05e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-3)" "unprognostic (1.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.16e-2)" "unprognostic (3.50e-2)" "unprognostic (1.57e-2)" "unprognostic (3.25e-2)" "unprognostic (2.03e-1)" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 12.0 11.4 16.8 9.0 28.8 12.9 17.8 12.3 19.2 11.6 13.3 12.8 10.3 13.8 12.6 22.9 16.0 18.9 9.9 13.3 16.2 16.0 14.1 12.6 12.0 9.9 16.7 20.0 13.7 13.7 23.3 28.5 10.6 16.0 11.9 15.1 7.6 16.9 13.5 12.2 22.9 15.1 14.4 16.6 7.5 13.0 16.7 14.8 8.4 20.9 10.2 10.6 10.5 11.7 10.6 23.6 24.4 20.7 12.4 16.1 11.9 8.7 9.4 10.3 11.3 18.3 25.5 13.8 8.9 9.6 8.3 6.9 13.9 4.8 8.5 4.9 7.9 11.4 21.2 8.2 8.7 8.3 5.2 8.6 5.2 12.8 13.1 15.3 18.6 7.3 13.4 16.4 10.1 23.3 10.7 11.3 12.6 18.2 8.9 9.8 24.5 13.3 7.5 11.6 26.4 13.8 6.6 16.7 8.9 10.8 9.7 13.2 7.2 12.8 11.2 14.0 10.2 15.2 10.1 7.4 4.6 8.5 20.6 10.5 7.2 18.7 6.3 14.9 7.4 6.8 19.9 20.6 19.0 9.9 20.6 15.2 10.6 15.8 13.1 22.6 6.9 16.1 12.1 24.4 12.4 20.7 23.6 13.0 11.9 16.8 28.8 12.3 19.2 16.2 16.0 16.7 20.0 16.0 14.8 3.0 11.8 0.0 6.0 13.5 3.6 17.7 15.3 56.2 18.2 0.0 9.8 4.9 8.3 4.9 5.5 7.1 6.5 0.0 7.9 8.4 9.1 3.9 2.3 2.9 6.9 6.4 4.1 3.7 2.7 5.5 15.8 5.9 10.1 1.8 7.2 6.0 6.4 8.4 17.3 6.5 6.9 19.4 8.5 29.5 8.8 12.2 6.1 2.2 6.3 4.8 FAM208B "bA318E3.2, C10orf18, FLJ20360, KIAA2006" ENSG00000108021 "Family with sequence similarity 208 member B" Q5VWN6 10 5684838-5763740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038042, HPA038043, HPA061547" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558" "unprognostic (3.69e-2)" "unprognostic (3.13e-2)" "unprognostic (9.25e-2)" "unprognostic (8.83e-2)" "unprognostic (8.12e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.39e-1)" "unprognostic (9.21e-2)" "unprognostic (8.36e-2)" "unprognostic (8.85e-2)" "unprognostic (4.88e-3)" "unprognostic (2.90e-3)" "unprognostic (2.98e-1)" "unprognostic (3.50e-1)" "unprognostic (7.79e-3)" "unprognostic (5.23e-2)" 15.4 15.5 10.1 22.9 13.6 16.1 16.4 18.9 13.4 18.7 15.0 11.8 13.6 8.6 21.2 20.7 14.6 19.6 13.4 16.9 12.0 9.3 13.6 15.9 15.1 20.5 15.0 10.6 23.8 19.4 26.2 24.3 16.0 12.6 15.9 15.8 12.9 15.6 17.0 26.9 12.7 16.4 17.4 12.8 16.7 15.7 29.7 14.0 19.5 22.6 14.1 21.1 17.4 22.0 4.3 2.2 1.8 2.4 8.6 3.2 0.8 17.5 14.9 9.6 16.3 12.4 14.8 13.5 15.0 9.6 12.9 16.4 15.7 10.4 35.9 9.6 14.7 8.2 13.9 27.4 15.4 21.0 7.0 18.4 16.7 11.6 10.5 12.4 12.3 10.0 11.3 17.3 21.0 17.9 8.7 14.9 14.0 26.9 8.4 14.4 11.8 15.9 4.4 11.7 11.4 9.7 11.9 13.4 12.5 7.8 16.0 11.8 13.3 14.9 13.6 10.7 11.3 17.8 9.7 14.9 16.4 17.7 31.5 20.4 10.3 9.8 32.1 8.1 12.2 8.6 1.4 2.4 0.5 2.4 2.3 2.2 2.1 1.8 2.3 1.4 4.3 1.8 3.2 1.8 8.6 0.9 2.2 2.4 0.8 10.1 13.6 18.9 13.4 12.0 9.3 15.0 10.6 12.6 14.0 23.8 20.2 21.5 15.6 30.7 32.0 24.6 20.4 12.0 38.7 10.4 35.3 9.2 1.7 13.8 20.4 26.3 9.8 0.0 9.8 8.6 27.3 25.1 3.5 14.3 8.9 20.6 13.2 21.5 13.5 6.2 25.0 14.4 20.3 16.2 15.4 14.3 13.9 11.5 26.9 8.1 36.0 25.8 25.9 60.2 44.9 36.6 6.1 20.8 19.4 27.5 FAM210B "C20orf108, dJ1167H4.1, DKFZP434A1114" ENSG00000124098 "Family with sequence similarity 210 member B" Q96KR6 20 56358915-56368663 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 233.6;Peritubular cells: 146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042652 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA042652: AB_2678098" "unprognostic (3.29e-1)" "prognostic favorable (5.44e-4)" "unprognostic (3.24e-2)" "unprognostic (1.66e-3)" "unprognostic (1.26e-1)" "unprognostic (3.34e-2)" "unprognostic (9.45e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" "prognostic favorable (1.44e-10)" "unprognostic (1.08e-1)" "unprognostic (3.27e-2)" "unprognostic (1.84e-1)" "unprognostic (3.00e-1)" 19.8 47.7 13.2 9.3 22.8 30.5 29.0 13.4 12.3 23.4 18.1 10.9 24.0 10.7 22.3 24.7 24.4 18.5 29.5 48.1 13.0 12.9 15.2 43.2 16.3 11.8 15.2 9.3 50.5 21.8 13.1 15.1 17.6 13.7 30.9 13.8 21.4 29.0 33.5 54.2 17.5 15.0 19.9 11.1 12.2 16.3 11.1 9.7 5.9 19.8 25.7 12.3 22.8 30.9 1.9 2.8 10.3 5.6 2.2 4.0 1.5 4.8 1.9 7.5 18.2 21.7 24.6 14.6 6.0 13.4 10.9 12.6 3.4 2.4 0.4 3.1 10.2 6.3 14.1 4.0 17.2 18.4 0.7 6.3 3.0 4.4 32.5 14.3 0.3 1.9 21.0 19.3 6.2 8.8 12.7 17.5 2.6 22.5 3.2 13.3 5.0 2.5 1.3 6.3 7.1 11.8 0.0 15.5 3.8 5.6 5.7 10.4 18.7 14.5 31.7 73.1 16.7 14.0 2.7 12.1 9.8 6.5 15.6 3.6 2.5 2.6 0.1 7.8 1.9 6.3 3.3 3.8 10.3 2.9 5.6 2.2 1.9 3.4 4.0 2.8 1.8 3.6 3.4 1.7 2.2 2.4 2.4 3.7 1.5 13.2 22.8 13.4 12.3 13.0 12.9 15.2 9.3 13.7 9.7 14.9 21.1 2.2 74.0 22.0 7.6 52.5 68.8 1.4 14.8 15.7 37.3 61.4 54.7 24.7 0.6 24.8 25.3 233.6 16.9 19.6 25.7 58.3 19.5 106.8 25.0 1.6 48.9 44.2 41.8 2.6 61.9 18.3 35.4 32.5 26.7 25.1 32.5 7.0 146.3 38.9 16.9 19.4 28.4 1.2 10.4 28.4 35.0 13.1 32.1 44.8 FAM213B "C1orf93, MGC26818" ENSG00000157870 "Family with sequence similarity 213 member B" Q8TBF2 1 2586491-2591469 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 26.7;U-2197: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006403 Approved Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA006403: AB_1853870" "unprognostic (1.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.03e-1)" "unprognostic (2.83e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (3.09e-2)" "unprognostic (1.24e-3)" "unprognostic (2.76e-1)" "prognostic favorable (1.28e-4)" "unprognostic (5.22e-3)" "unprognostic (2.03e-1)" "unprognostic (7.91e-3)" "unprognostic (2.20e-2)" 6.0 9.1 14.7 5.7 14.9 3.8 4.6 7.4 20.0 7.9 15.4 6.2 5.2 22.0 4.5 6.7 5.7 10.5 23.7 3.2 15.0 15.5 7.4 3.5 6.0 5.8 11.7 11.0 7.1 4.6 4.4 4.3 8.4 10.7 5.7 7.4 9.0 5.3 7.7 1.8 6.1 20.2 4.8 6.5 7.4 11.7 3.3 4.7 5.4 5.2 0.9 5.2 6.3 3.5 2.1 2.2 1.5 2.3 7.5 6.3 3.2 7.7 4.3 4.4 4.8 2.1 2.4 0.6 7.0 2.9 6.6 2.9 3.1 9.1 2.0 7.1 4.5 2.7 6.5 3.9 4.9 2.2 5.8 2.0 4.8 3.3 4.9 5.1 2.7 1.4 3.5 2.5 4.6 1.7 3.1 9.3 3.6 6.5 3.1 6.6 5.6 6.3 1.2 5.3 9.0 16.6 6.9 6.5 5.1 6.9 3.9 5.9 9.8 6.0 26.7 8.0 1.1 4.6 1.0 13.5 5.8 6.7 22.9 2.6 2.9 4.3 1.4 5.4 9.2 1.1 1.5 2.0 1.1 3.8 2.3 6.3 2.1 4.2 4.1 2.2 1.5 3.5 5.4 1.5 7.5 2.0 1.0 5.6 3.2 14.7 14.9 7.4 20.0 15.0 15.5 11.7 11.0 10.7 4.7 3.0 1.7 3.9 4.5 3.7 11.0 4.5 12.7 10.7 6.8 33.2 0.0 0.4 6.6 24.6 0.6 11.6 37.6 0.0 8.8 0.4 4.0 3.7 0.0 2.6 8.0 22.3 15.1 12.3 4.9 1.1 4.9 7.6 6.8 8.2 25.7 6.0 31.4 38.2 3.9 11.8 5.2 19.4 8.1 0.9 11.1 4.5 0.6 6.9 32.8 7.0 FAM221A "C7orf46, DKFZp686F0810, FLJ45875, MGC72075" ENSG00000188732 "Family with sequence similarity 221 member A" A4D161 7 23680130-23703249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 46.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 11.6;GAMG: 15.8;MOLT-4: 15.0;SCLC-21H: 14.1;SH-SY5Y: 24.0" "Low region specificity" "Detected in many" "HPA019719, HPA026748, HPA026752" Enhanced Approved Cytosol NA NA Cytosol "HPA019719: AB_1853910, HPA026748: AB_1853911, HPA026752: AB_1853912" "unprognostic (1.28e-1)" "unprognostic (7.28e-3)" "unprognostic (6.03e-3)" "unprognostic (2.54e-1)" "unprognostic (3.33e-2)" "unprognostic (8.04e-2)" "unprognostic (8.51e-3)" "unprognostic (2.18e-3)" "unprognostic (3.10e-2)" "unprognostic (5.69e-2)" "unprognostic (3.75e-1)" "unprognostic (2.42e-2)" "unprognostic (9.30e-3)" "unprognostic (4.26e-2)" "unprognostic (1.11e-2)" "unprognostic (2.40e-1)" "unprognostic (1.81e-2)" 3.9 4.8 12.8 3.8 19.7 2.1 5.7 12.9 12.3 5.0 8.2 25.1 2.9 12.0 3.5 5.1 8.7 12.1 6.8 4.0 15.9 13.4 8.4 10.0 5.5 4.3 30.0 10.3 4.5 25.2 3.8 4.5 2.3 17.2 4.7 11.0 27.8 8.7 9.2 2.1 4.7 8.9 3.2 24.6 2.3 14.6 22.9 24.3 2.1 7.7 1.4 6.2 4.2 3.1 6.9 5.3 3.8 5.2 6.8 11.4 3.7 0.0 0.3 6.7 5.5 0.2 0.0 3.1 0.2 0.5 0.8 1.0 6.8 3.0 0.7 11.6 0.1 15.8 1.3 0.0 0.0 1.3 0.0 9.0 1.8 0.6 0.0 1.8 0.0 10.0 0.4 0.4 0.1 0.0 1.4 2.1 6.8 0.0 0.0 0.2 3.1 15.0 0.0 0.0 0.0 3.3 6.2 0.6 0.0 3.7 3.0 14.1 24.0 1.0 0.0 0.0 1.6 3.0 4.3 0.3 0.0 2.4 1.3 0.6 0.0 0.0 0.0 0.6 0.0 1.1 0.0 3.0 3.8 5.4 1.9 11.0 6.9 9.0 6.5 5.3 6.0 10.6 5.7 0.1 6.8 5.2 4.3 11.4 3.7 12.8 19.7 12.9 12.3 15.9 13.4 30.0 10.3 17.2 24.3 14.9 7.4 3.9 8.6 14.3 7.0 4.4 12.7 46.8 20.5 7.0 2.0 3.0 8.3 11.6 6.8 7.1 7.7 0.0 9.3 0.2 5.0 10.3 4.7 13.1 5.7 6.4 14.3 3.7 3.7 8.2 4.4 7.7 8.5 0.0 21.7 7.3 11.7 18.7 3.5 10.3 8.0 19.4 6.1 26.5 25.7 16.6 0.7 4.4 17.1 9.5 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630251-69633599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 15.7;Distal tubular cells: 10.0;Ductal cells: 23.4;Exocrine glandular cells: 15.9;Pancreatic endocrine cells: 15.7;Proximal tubular cells: 10.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.2" "Lineage enriched" "Detected in single" 25 "T-cells: 14.2" "Cell line enhanced" "Detected in many" "PC-3: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavorable (8.64e-4)" "prognostic unfavorable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favorable (9.72e-4)" 1.4 3.3 13.1 2.0 13.5 1.1 5.3 34.5 23.9 1.3 3.0 3.2 0.6 3.0 2.7 13.0 4.0 4.8 2.1 6.9 15.0 17.8 4.7 2.3 4.1 2.7 10.8 14.4 2.0 7.9 5.6 5.3 1.3 8.3 7.8 2.6 5.1 5.6 5.6 1.6 2.4 2.2 4.5 4.6 0.8 4.2 11.4 2.4 0.7 6.0 0.1 2.4 2.6 1.6 0.3 0.0 0.5 0.0 0.2 14.2 2.8 13.3 14.5 1.8 14.9 0.0 0.0 6.5 1.3 0.3 2.4 2.6 10.5 11.0 0.0 20.4 0.3 8.6 5.5 7.8 4.5 3.4 13.2 10.7 0.0 3.2 4.0 3.9 0.0 4.8 0.0 4.4 0.1 2.3 1.8 0.0 20.1 4.9 0.0 0.2 17.9 0.1 0.0 9.0 5.4 26.9 0.0 0.0 0.1 5.1 7.6 7.6 10.4 5.5 14.0 8.5 3.9 9.6 2.3 0.6 0.3 9.3 0.0 3.9 2.4 6.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 8.9 0.1 8.5 5.6 0.0 0.3 14.2 4.9 0.5 0.2 0.0 0.0 5.3 2.8 13.1 13.5 34.5 23.9 15.0 17.8 10.8 14.4 8.3 2.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 5.7 15.7 0.0 5.6 10.0 23.4 0.0 0.0 0.0 0.0 15.9 4.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 15.7 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 FAM43B FLJ44952 ENSG00000183114 "Family with sequence similarity 43 member B" Q6ZT52 1 20552439-20555010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 21.9;brain: 14.9;epididymis: 8.7" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 1.2;Distal tubular cells: 3.3" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;BJ hTERT+: 3.3;fHDF/TERT166: 6.7;Hep G2: 4.9;SCLC-21H: 6.0;SiHa: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050813 Approved Approved Cytosol NA NA Cytosol "HPA050813: AB_2681244" "unprognostic (1.51e-1)" "unprognostic (5.85e-2)" "unprognostic (2.80e-3)" "unprognostic (1.48e-1)" "unprognostic (5.97e-3)" "unprognostic (1.74e-1)" "unprognostic (8.33e-2)" "unprognostic (5.87e-4)" "unprognostic (1.86e-2)" "unprognostic (7.46e-2)" "unprognostic (8.85e-3)" "unprognostic (2.73e-1)" "unprognostic (1.78e-4)" "unprognostic (1.06e-2)" "unprognostic (6.05e-3)" "unprognostic (6.48e-2)" "unprognostic (2.12e-2)" 3.2 21.9 5.6 1.5 14.9 0.9 1.5 8.8 14.4 1.6 1.3 2.4 0.0 1.1 1.4 8.7 1.3 1.6 1.5 3.3 5.3 12.1 2.6 1.4 1.2 1.0 10.1 6.0 1.0 1.2 0.9 0.7 2.5 11.2 1.4 1.1 0.5 1.2 1.3 2.8 1.0 1.2 2.9 4.0 1.4 0.9 1.3 2.8 0.0 1.3 1.7 0.9 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 4.6 0.2 0.1 0.0 0.5 3.3 0.6 0.0 0.1 0.0 0.0 0.2 6.7 1.2 0.0 0.7 0.0 0.1 0.0 1.0 0.2 0.3 4.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.0 0.7 11.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 14.9 8.8 14.4 5.3 12.1 10.1 6.0 11.2 2.8 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.3 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 FAM45A ENSG00000119979 "Family with sequence similarity 45 member A" Q8TCE6 10 119104086-119137984 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041159 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA041159: AB_10793871" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (1.90e-1)" "unprognostic (3.12e-1)" "unprognostic (1.88e-2)" "unprognostic (2.13e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-2)" "unprognostic (4.46e-2)" "unprognostic (2.64e-2)" "unprognostic (6.68e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.20e-2)" 12.2 13.2 16.2 8.5 20.0 17.0 9.5 10.2 17.6 11.6 12.5 10.2 6.5 7.6 9.4 10.7 16.0 9.0 8.5 10.8 13.5 10.4 16.6 18.9 8.6 6.8 10.6 17.6 17.3 8.8 11.6 5.4 10.8 18.4 8.9 11.0 7.7 10.7 8.3 14.0 12.0 9.7 9.8 13.5 8.4 9.7 7.1 11.5 10.1 14.8 10.8 9.9 13.1 14.7 2.3 9.9 30.2 19.2 3.8 10.0 6.0 8.3 9.8 12.5 14.5 21.4 21.4 5.5 11.9 29.8 10.7 10.3 9.5 11.2 5.9 4.5 14.6 11.2 12.7 10.6 10.5 9.3 10.0 6.0 1.3 3.4 8.3 24.4 3.5 2.8 22.3 9.0 7.8 11.0 22.2 14.4 5.1 2.8 6.7 13.4 6.7 4.4 6.0 7.5 6.3 4.0 4.8 15.7 4.3 10.3 8.9 2.1 8.3 8.5 9.0 17.4 12.2 8.6 12.3 14.6 7.6 3.9 7.9 6.0 7.3 2.7 6.5 12.3 15.3 3.4 23.0 15.1 30.2 4.2 18.3 3.4 2.3 6.3 5.5 9.9 1.9 3.1 4.1 20.1 3.8 19.2 2.5 10.0 6.0 16.2 20.0 10.2 17.6 13.5 10.4 10.6 17.6 18.4 11.5 8.9 21.6 15.2 23.3 15.8 17.0 32.3 28.1 20.1 17.0 24.4 0.0 45.9 94.5 28.0 2.0 15.3 46.3 0.0 43.7 21.6 29.9 20.6 19.7 52.9 46.9 7.9 24.2 51.0 96.9 4.7 23.9 34.6 28.7 36.1 27.9 29.4 40.7 45.6 25.8 78.7 16.9 19.4 11.8 18.5 23.2 22.2 37.9 28.7 34.5 24.3 FAM46A "C6orf37, FLJ20037" ENSG00000112773 "Family with sequence similarity 46 member A" Q96IP4 6 81491439-81752774 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 106.4" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 311.3;Horizontal cells: 276.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 22.1;fHDF/TERT166: 25.4;HeLa: 25.1;HL-60: 28.8;THP-1: 49.6;U-937: 22.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA051067, HPA067140" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051067: , HPA067140: AB_2685788" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (5.39e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (2.62e-3)" "unprognostic (5.93e-2)" "unprognostic (2.48e-2)" "unprognostic (2.53e-1)" "unprognostic (1.03e-1)" "unprognostic (1.40e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (7.18e-2)" "unprognostic (6.38e-2)" "unprognostic (9.25e-2)" "unprognostic (9.66e-2)" 10.0 7.1 1.4 4.9 1.4 64.7 5.6 2.8 0.9 14.4 17.7 1.3 24.2 5.1 12.8 20.0 4.2 8.8 17.1 19.4 1.2 4.4 3.2 11.8 5.8 2.3 1.4 0.9 20.1 3.5 6.5 20.4 106.4 3.5 16.2 5.6 4.9 49.8 45.6 4.5 7.0 32.6 15.3 2.5 5.8 13.2 6.8 1.4 1.2 7.7 6.7 3.7 13.4 31.1 12.0 12.4 22.4 22.2 8.3 6.2 6.1 1.0 1.5 1.0 0.0 22.1 9.8 1.9 8.4 6.0 5.0 7.6 15.7 0.8 0.1 0.3 25.4 3.2 0.9 0.7 1.3 3.7 0.0 1.9 0.0 25.1 2.4 6.9 28.8 2.2 4.3 0.7 3.9 0.7 16.4 0.6 0.2 0.4 0.0 3.3 4.4 0.0 20.4 0.2 8.9 1.2 0.0 9.1 0.0 0.6 1.9 1.0 1.4 3.7 1.6 2.5 3.3 0.3 49.6 1.4 5.7 1.2 2.4 2.3 0.1 0.1 0.1 8.1 22.3 2.4 16.1 14.9 22.4 6.2 15.1 3.7 8.0 2.4 3.0 12.4 12.0 4.7 4.4 7.3 8.3 22.2 4.3 2.7 6.1 1.4 1.4 2.8 0.9 1.2 4.4 1.4 0.9 3.5 1.4 59.6 92.4 0.9 134.5 49.9 25.9 0.0 45.9 21.4 102.4 0.0 70.7 30.7 0.0 0.0 0.4 20.4 311.3 23.3 0.0 89.3 98.1 34.0 210.9 34.5 26.7 276.5 183.7 6.7 35.9 0.5 95.3 46.7 62.4 0.0 64.6 75.7 0.0 105.2 37.1 0.0 45.1 25.8 43.8 0.9 5.4 31.7 135.5 20.3 33.3 105.6 FAM47E "FLJ42946, LOC100129583" ENSG00000189157 "Family with sequence similarity 47 member E" Q6ZV65 4 76214040-76283780 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Ciliated cells: 75.0;Early spermatids: 25.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "naive B-cell: 3.1;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 3.1;dendritic cells: 2.3" "Cell line enriched" "Detected in many" 5 "OE19: 24.0" HPA053331 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-4)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (5.63e-2)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (3.73e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-8)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.04e-2)" "unprognostic (3.01e-2)" 5.5 6.8 12.5 0.8 8.5 1.2 8.9 2.4 14.8 3.7 3.2 9.2 4.4 4.3 2.4 15.5 1.6 23.5 5.1 3.2 10.1 13.7 9.1 11.2 4.8 0.9 10.7 15.5 1.2 9.7 9.9 10.3 10.0 12.1 5.2 3.8 2.7 5.4 4.0 9.5 2.0 4.2 3.0 13.3 1.8 6.0 9.2 6.2 0.0 13.2 1.5 0.9 2.6 1.1 3.1 2.3 0.1 0.4 0.1 0.5 0.1 0.4 2.0 1.8 0.5 1.4 0.2 0.4 0.2 1.3 0.3 0.4 2.3 1.7 0.1 0.5 0.7 4.1 0.6 0.8 0.4 0.7 1.8 0.1 0.1 1.1 3.3 0.8 0.4 0.3 0.8 0.5 0.5 0.5 0.7 0.2 0.2 0.2 1.1 0.6 2.8 0.1 0.2 0.4 24.0 0.9 0.3 0.5 0.3 2.5 1.6 3.1 2.2 0.8 1.0 0.3 0.5 1.0 0.2 0.5 0.4 0.4 1.1 0.3 4.4 1.0 0.1 1.3 0.2 0.6 0.0 0.4 0.1 0.2 0.0 0.5 0.2 0.2 0.1 0.2 3.1 0.4 0.1 0.1 0.1 0.4 2.3 0.0 0.1 12.5 8.5 2.4 14.8 10.1 13.7 10.7 15.5 12.1 6.2 8.9 1.6 0.5 2.2 0.6 11.4 6.2 5.1 75.0 7.9 0.0 11.8 2.2 8.3 5.8 25.0 1.5 5.4 0.0 6.9 0.9 1.5 4.2 0.0 3.0 0.7 1.6 7.5 2.5 0.0 3.1 0.6 0.0 1.7 0.0 4.9 4.3 5.1 2.9 0.4 7.8 6.9 0.0 1.2 10.9 3.9 0.3 2.9 0.0 2.7 1.6 FAM47E-STBD1 ENSG00000272414 "FAM47E-STBD1 readthrough" 4 76251721-76311129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 38.2;skeletal muscle: 41.3" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.7;Ciliated cells: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 17.1;Karpas-707: 23.8" HPA053331 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (3.52e-3)" "unprognostic (3.44e-1)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (5.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-2)" "unprognostic (1.91e-1)" "unprognostic (6.92e-6)" "unprognostic (5.59e-2)" "unprognostic (1.52e-1)" "unprognostic (3.77e-1)" 17.4 2.3 7.8 1.6 8.0 4.0 7.6 1.9 13.9 2.5 8.2 8.6 4.1 2.1 3.0 7.3 3.5 5.0 4.2 16.5 9.4 3.9 4.2 38.2 7.5 0.6 5.4 14.6 2.6 4.6 2.8 9.2 9.4 11.4 6.3 9.0 2.5 5.0 5.0 41.3 1.6 10.7 6.5 9.6 1.6 3.7 6.1 5.8 0.0 8.1 1.3 0.9 4.9 2.5 0.2 1.0 2.2 1.5 3.4 1.6 0.4 2.0 2.4 1.0 2.1 17.1 5.8 2.2 3.4 7.1 2.9 3.0 4.0 2.2 0.0 2.1 8.1 7.9 1.1 3.5 1.4 2.7 2.6 0.5 0.8 4.8 5.7 1.8 1.7 2.4 2.5 9.0 2.8 3.6 11.1 0.3 0.0 0.2 23.8 7.0 3.7 0.0 1.8 1.0 13.2 1.6 0.0 0.5 1.5 3.3 6.0 1.0 4.2 1.5 4.7 0.1 2.2 0.9 1.0 0.9 1.5 0.7 3.8 2.9 5.7 2.6 0.0 4.2 1.8 1.3 0.0 0.5 2.2 1.1 1.5 0.6 0.2 1.1 1.2 0.9 0.1 0.9 1.3 1.3 3.4 0.1 1.0 1.6 0.4 7.8 8.0 1.9 13.9 9.4 3.9 5.4 14.6 11.4 5.8 6.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM49B BM-009 ENSG00000153310 "Family with sequence similarity 49 member B" Q9NUQ9 8 129839593-130017129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.5;bone marrow: 80.1" "Cell type enhanced" "Detected in many" 7 "monocytes: 468.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009076 Enhanced Approved Nucleoplasm,Cytosol NA NA 990000 Nucleoplasm Cytosol "HPA009076: AB_1848402" "unprognostic (4.35e-2)" "unprognostic (5.22e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (2.80e-2)" "unprognostic (9.61e-3)" "prognostic unfavorable (3.02e-6)" "unprognostic (4.75e-2)" "unprognostic (2.44e-1)" "unprognostic (6.53e-2)" "unprognostic (3.25e-2)" "unprognostic (3.62e-1)" "prognostic unfavorable (3.09e-10)" "unprognostic (3.85e-3)" "unprognostic (1.95e-1)" "unprognostic (2.67e-1)" "unprognostic (2.46e-1)" 19.2 14.5 23.2 42.8 33.1 80.1 20.6 28.0 36.9 7.2 14.3 18.2 5.5 14.2 8.0 10.6 17.9 7.9 14.9 9.8 25.5 25.2 11.8 12.3 19.1 49.6 28.5 19.6 6.4 10.0 7.5 16.1 19.4 21.2 7.6 17.4 7.3 12.0 7.9 16.8 9.0 19.3 13.5 38.8 41.3 12.9 13.6 21.2 28.2 13.8 9.7 46.4 20.6 8.4 21.0 47.3 93.5 42.2 30.8 29.3 43.4 32.2 17.3 18.9 10.6 1.7 2.5 25.2 9.8 9.5 13.6 14.6 9.9 22.3 32.3 21.6 6.4 10.8 16.1 15.6 25.9 20.5 67.5 10.9 32.3 9.7 11.2 6.6 20.9 27.9 4.0 12.1 9.2 19.2 11.2 12.0 26.3 23.1 37.5 14.9 14.4 71.0 15.5 16.0 25.4 24.0 31.0 12.8 54.1 27.9 13.3 12.6 16.5 19.6 12.4 29.0 17.9 14.5 27.2 7.4 5.0 32.4 10.6 20.8 12.5 36.7 53.5 7.9 45.6 13.0 45.5 35.3 65.6 29.3 42.2 22.4 21.0 16.7 23.9 47.3 15.1 15.0 24.6 93.5 30.8 36.5 30.4 22.5 43.4 23.2 33.1 28.0 36.9 25.5 25.2 28.5 19.6 21.2 21.2 29.8 31.5 95.1 103.3 116.3 33.0 23.3 35.7 13.4 33.0 73.3 39.3 108.2 44.7 52.9 13.3 30.0 27.9 0.0 43.3 127.2 26.9 56.3 64.6 16.1 225.8 23.8 26.6 22.7 194.9 6.5 5.8 254.2 45.5 468.9 24.3 12.1 64.0 38.6 4.2 23.5 17.1 19.4 15.5 29.9 40.7 72.6 50.6 182.7 28.1 113.6 FAM53B "bA12J10.2, KIAA0140, smp" ENSG00000189319 "Family with sequence similarity 53 member B" Q14153 10 124619292-124744269 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037751, HPA037752" Approved Approved Cytosol NA NA Cytosol "HPA037751: AB_2675645, HPA037752: AB_10672285" "unprognostic (7.88e-2)" "prognostic favorable (4.96e-4)" "unprognostic (1.73e-2)" "unprognostic (2.92e-1)" "unprognostic (4.91e-1)" "prognostic favorable (1.97e-4)" "unprognostic (2.52e-2)" "unprognostic (5.03e-3)" "unprognostic (1.51e-2)" "unprognostic (4.02e-2)" "prognostic favorable (7.00e-6)" "unprognostic (1.93e-1)" "prognostic favorable (4.81e-7)" "prognostic favorable (3.26e-4)" "unprognostic (3.41e-1)" "unprognostic (2.03e-1)" "unprognostic (2.45e-2)" 12.1 14.2 13.8 20.0 20.1 20.9 8.2 15.4 20.2 9.9 10.9 32.4 11.5 14.9 17.8 5.1 11.3 11.5 8.5 11.9 17.6 10.9 8.0 3.1 11.8 28.6 21.5 12.0 17.6 5.7 14.6 9.6 7.3 12.8 6.4 7.0 12.2 14.3 8.2 36.9 11.9 14.1 12.5 19.7 16.5 8.2 10.4 30.2 37.7 14.4 7.9 23.7 8.1 5.8 9.5 2.8 4.5 3.6 1.0 10.7 4.0 5.8 6.7 5.1 14.6 6.1 3.2 14.9 2.8 3.5 3.0 2.6 3.4 3.5 21.7 5.9 3.3 2.9 11.6 6.8 8.2 1.3 25.9 7.5 9.9 3.2 8.5 4.1 8.7 6.7 3.1 8.6 2.7 4.4 3.7 4.8 11.2 7.7 9.0 2.9 10.5 10.2 11.6 3.4 4.9 6.1 18.5 1.9 9.6 2.4 10.2 7.0 6.7 2.4 9.6 31.6 2.1 3.8 11.2 2.5 3.6 3.2 3.7 5.6 1.4 2.9 13.2 2.7 7.1 1.9 1.2 3.1 2.9 10.7 3.0 5.1 4.8 4.6 5.5 2.0 9.5 1.8 3.2 4.5 1.0 3.6 2.8 5.0 4.0 13.8 20.1 15.4 20.2 17.6 10.9 21.5 12.0 12.8 30.2 8.9 13.0 7.5 5.1 3.2 4.8 13.4 2.5 8.1 5.7 3.5 9.8 3.7 1.7 2.4 13.7 6.3 18.0 0.0 3.5 4.2 4.5 2.6 4.7 3.2 11.2 1.6 14.5 21.5 23.1 4.1 5.2 5.2 8.5 7.2 15.1 2.8 2.8 13.3 9.9 3.7 22.3 0.0 2.5 7.1 6.8 5.0 0.7 13.4 12.4 4.4 FAM69A FLJ23493 ENSG00000154511 "Family with sequence similarity 69 member A" Q5T7M9 1 92832737-92961522 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 25.6;Syncytiotrophoblasts: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015718, HPA017281" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA015718: AB_1848405, HPA017281: AB_1848406" "prognostic favorable (8.96e-4)" "unprognostic (1.00e-1)" "unprognostic (6.17e-2)" "unprognostic (1.50e-3)" "unprognostic (1.43e-1)" "unprognostic (3.77e-3)" "unprognostic (3.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.19e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (1.45e-7)" "unprognostic (1.26e-2)" "unprognostic (5.99e-2)" "unprognostic (2.57e-1)" "unprognostic (1.66e-2)" 13.3 3.4 20.7 10.4 22.5 7.0 7.8 19.4 22.2 7.3 13.2 15.9 4.2 8.8 15.7 3.8 9.3 8.3 11.1 5.3 22.6 18.0 6.1 24.7 4.5 10.1 25.0 12.2 6.0 3.5 20.5 4.1 12.8 17.7 9.5 12.4 5.4 5.5 11.3 7.5 5.6 8.2 19.4 24.7 7.6 8.8 6.4 24.4 9.6 6.2 3.6 8.8 12.2 6.0 22.5 7.1 0.2 0.9 11.8 14.2 6.7 4.3 4.8 2.0 4.8 7.5 14.1 2.4 13.6 28.1 7.7 15.7 2.7 0.9 14.8 2.5 25.0 15.4 5.6 0.3 10.2 12.8 5.9 4.8 0.5 3.8 6.9 2.7 1.3 0.9 8.4 8.2 17.0 3.9 13.1 0.1 9.1 5.2 15.7 9.7 1.6 4.9 1.2 3.5 7.3 1.9 4.4 14.5 4.5 1.1 4.5 4.9 3.8 3.8 3.8 5.0 4.6 1.8 0.4 0.5 9.1 7.0 17.7 4.8 23.8 22.7 17.3 4.3 0.9 0.8 0.0 0.9 0.0 10.5 0.4 8.1 22.5 12.1 8.2 4.3 13.6 14.2 12.1 0.2 11.8 0.2 7.1 10.7 6.7 20.7 22.5 19.4 22.0 22.6 18.0 25.0 12.2 17.7 24.4 0.0 2.4 9.3 3.5 10.1 1.3 3.6 7.6 10.7 1.2 5.2 2.0 25.6 3.3 1.6 1.5 3.0 1.3 0.0 2.1 4.9 9.9 3.7 0.0 13.2 3.7 7.9 0.0 4.9 3.7 2.3 0.9 2.2 6.8 16.2 3.2 0.7 2.8 0.0 7.1 4.4 1.3 0.0 9.2 0.7 1.6 8.2 21.2 5.7 2.5 1.8 FAM71F1 "FAM137A, NYD-SP18" ENSG00000135248 "Family with sequence similarity 71 member F1" Q96KD3 7 128709061-128731743 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 146 "testis: 64.8" "Group enriched" "Detected in some" 103 "Early spermatids: 1001.4;Late spermatids: 1429.0" "Cancer enriched" "Detected in single" 23 "testis cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "NTERA-2: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA020636 Uncertain Cytosol No NA Cytosol "HPA020636: AB_1854739" "unprognostic (3.09e-2)" "unprognostic (3.39e-3)" "unprognostic (6.03e-2)" "unprognostic (5.25e-1)" "unprognostic (2.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-5)" "unprognostic (1.48e-1)" "unprognostic (2.18e-6)" "unprognostic (6.97e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-3)" "unprognostic (1.99e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 64.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 1.5 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1001.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1429.0 11.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.3 0.0 1.8 0.0 0.0 11.7 5.5 0.1 1.0 0.0 0.0 0.0 FAM72A "LMPIP, MGC57827, RP11-312O7.1, UGENE" ENSG00000196550 "Family with sequence similarity 72 member A" Q5TYM5 1 206186179-206204414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 14.9;Kupffer cells: 15.6;Late spermatids: 22.6;monocytes: 10.8;Spermatocytes: 13.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (3.61e-2)" "unprognostic (1.58e-1)" "unprognostic (1.80e-1)" "unprognostic (5.20e-5)" "unprognostic (3.61e-1)" "unprognostic (1.19e-3)" "unprognostic (1.01e-5)" "unprognostic (7.70e-3)" "unprognostic (1.45e-2)" "unprognostic (5.58e-3)" "unprognostic (2.87e-2)" "unprognostic (1.03e-1)" "unprognostic (4.44e-16)" "unprognostic (1.82e-1)" "unprognostic (1.94e-2)" "unprognostic (4.83e-2)" "unprognostic (3.89e-1)" 3.4 2.5 1.9 4.7 1.6 6.3 3.2 8.0 1.3 0.8 1.5 2.4 0.6 0.0 2.5 1.8 2.2 0.9 2.4 1.8 1.0 1.3 2.4 8.9 2.6 0.8 0.7 2.3 0.4 2.8 0.5 1.7 0.7 0.2 0.2 5.0 2.2 1.3 3.1 6.3 0.8 6.3 0.5 6.2 1.1 1.2 2.1 5.6 1.2 9.2 0.6 3.6 2.4 9.7 8.0 8.4 3.6 1.2 1.5 10.1 7.0 3.0 8.1 6.1 4.7 14.6 25.1 6.0 1.8 9.1 11.7 9.7 3.8 9.7 13.8 8.0 11.3 7.3 6.3 0.8 19.5 12.8 2.1 0.7 7.2 12.8 2.4 5.0 21.9 22.5 17.3 5.0 5.7 12.1 17.5 15.3 6.9 10.7 13.5 14.6 18.9 4.6 1.5 8.4 4.9 5.0 4.6 4.1 10.0 9.7 10.6 2.6 6.5 7.5 8.4 11.5 14.0 20.5 22.5 5.3 16.1 8.9 0.0 7.5 0.0 0.9 9.2 0.2 2.1 1.8 1.8 5.6 0.8 0.2 0.4 1.2 0.6 5.4 2.3 3.6 2.4 0.0 1.0 0.9 0.1 1.5 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.4 0.0 0.8 14.9 5.2 0.9 0.0 0.7 2.8 2.4 0.4 0.0 0.0 7.8 0.0 0.0 6.7 15.6 22.6 0.0 6.0 3.3 10.8 0.4 0.5 0.3 0.0 0.0 0.1 0.1 0.0 1.7 13.5 4.5 0.9 0.6 0.9 0.4 0.5 FAM72B RP11-439A17.6 ENSG00000188610 "Family with sequence similarity 72 member B" Q86X60 1 121167646-121185539 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 6.5;lymphoid tissue: 9.3" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 4.7;Spermatocytes: 14.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (8.53e-2)" "unprognostic (1.97e-2)" "unprognostic (1.63e-3)" "unprognostic (1.25e-3)" "unprognostic (4.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-4)" "unprognostic (8.22e-5)" "unprognostic (1.30e-2)" "unprognostic (1.79e-2)" "unprognostic (1.36e-4)" "unprognostic (2.46e-2)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-2)" "unprognostic (5.30e-2)" 1.0 0.8 1.3 4.1 1.0 6.5 0.6 5.1 1.0 0.5 1.0 1.3 0.4 0.2 3.0 0.5 1.0 0.2 1.6 0.9 0.3 0.4 0.8 9.3 1.4 0.4 0.1 1.5 0.1 1.4 0.2 1.3 0.5 0.0 0.0 2.1 1.3 0.7 1.4 3.2 0.9 3.6 0.2 7.9 0.9 0.9 0.8 3.3 0.1 2.4 0.8 1.4 1.1 12.0 4.4 7.4 3.6 0.7 1.1 5.8 6.4 2.7 7.5 6.3 0.1 6.3 26.6 8.9 1.2 7.4 7.5 10.1 3.6 11.6 17.6 7.5 11.5 4.9 5.3 0.4 20.0 10.3 0.6 0.4 5.9 12.0 1.9 4.5 22.2 15.0 16.4 5.4 5.0 10.0 16.5 13.9 6.5 9.1 15.0 15.9 12.2 2.9 1.4 8.0 4.6 4.8 3.8 3.7 7.9 5.0 15.6 1.5 6.2 10.5 12.0 11.3 14.6 18.2 26.3 5.5 21.7 14.3 0.0 2.4 0.0 0.0 0.9 0.0 0.8 0.4 0.5 3.3 0.3 0.0 0.1 0.1 0.8 1.1 0.4 1.4 1.1 0.0 0.0 3.7 0.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.7 1.0 1.7 0.0 0.2 1.9 0.5 0.0 0.0 0.0 0.9 0.0 0.0 3.1 0.6 1.2 0.6 0.7 0.0 3.6 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 14.9 3.4 0.9 0.1 1.0 0.4 0.0 FAM72C RP5-998N21.9 ENSG00000263513 "Family with sequence similarity 72 member C" H0Y354 1 143955364-143971965 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 3.6;lymphoid tissue: 6.4" "Cell type enhanced" "Detected in some" 16 "Extravillous trophoblasts: 3.6;Sertoli cells: 6.5;Spermatocytes: 10.0;Spermatogonia: 3.2" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 29.2" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" "unprognostic (6.45e-3)" "unprognostic (2.69e-2)" "unprognostic (2.21e-1)" "unprognostic (3.98e-3)" "unprognostic (9.46e-5)" "unprognostic (1.23e-3)" "unprognostic (4.36e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.95e-1)" "unprognostic (0.00e+0)" "unprognostic (2.95e-1)" "unprognostic (4.70e-2)" "unprognostic (5.82e-2)" "unprognostic (1.47e-2)" 0.1 0.0 1.6 3.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.1 1.9 0.0 6.4 0.4 1.1 0.4 0.0 1.0 1.7 2.2 0.6 8.6 5.0 6.1 2.7 0.3 0.8 5.9 4.3 1.4 5.8 4.5 0.8 10.4 20.6 5.7 0.5 5.5 8.3 8.1 2.6 6.3 7.1 4.8 8.9 4.4 1.5 0.3 18.1 8.1 0.2 0.0 4.5 11.9 1.3 2.5 16.6 15.5 9.7 0.3 0.6 10.7 14.0 4.9 9.7 3.3 13.6 4.4 14.6 1.0 1.1 3.1 5.6 4.2 2.4 2.3 6.6 6.0 15.6 1.7 4.6 7.6 6.0 9.4 20.3 29.2 12.2 2.5 11.3 2.9 0.0 1.0 0.0 0.1 0.3 0.0 1.1 0.4 0.5 0.4 0.0 0.1 0.0 0.0 1.7 0.6 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.0 0.0 0.0 0.2 3.6 0.3 0.0 0.0 0.0 1.3 0.0 0.0 1.8 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 10.0 3.2 0.3 0.2 0.0 0.0 0.0 FAM72D ENSG00000215784 "Family with sequence similarity 72 member D" Q6L9T8 1 145096000-145112696 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7" "Cell type enhanced" "Detected in some" 22 "Extravillous trophoblasts: 4.6;Spermatocytes: 17.9;Spermatogonia: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (2.70e-2)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (4.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.10e-3)" "unprognostic (5.88e-5)" "unprognostic (7.65e-4)" "unprognostic (6.72e-2)" "unprognostic (2.36e-2)" "unprognostic (1.22e-2)" "unprognostic (1.46e-1)" "unprognostic (0.00e+0)" "unprognostic (6.63e-2)" "unprognostic (1.72e-1)" "unprognostic (9.74e-2)" "unprognostic (6.50e-2)" 1.1 0.7 0.8 7.2 0.8 5.5 0.7 4.0 0.9 0.6 1.1 0.6 0.4 1.4 0.8 0.4 4.4 0.2 0.5 0.4 1.0 0.7 0.5 0.4 1.3 7.6 1.0 0.4 0.4 0.4 0.3 0.4 1.5 0.8 0.4 1.6 0.4 0.6 0.4 0.4 2.9 2.0 0.5 1.1 3.3 0.8 6.7 0.4 17.7 0.4 2.7 7.4 1.1 2.5 0.1 0.7 0.1 1.7 0.0 1.0 0.5 8.4 5.1 6.0 2.4 0.2 0.5 6.6 4.8 1.4 6.1 3.8 3.4 7.6 13.8 4.9 0.7 5.5 8.9 7.3 1.4 7.2 11.0 7.3 6.9 2.5 5.0 0.1 12.2 7.7 0.3 0.5 4.8 9.3 1.0 2.7 16.7 13.6 19.2 4.0 6.3 8.3 11.9 11.5 10.5 7.1 7.3 7.6 16.2 2.1 1.1 5.9 5.0 3.7 3.3 2.2 7.9 9.3 7.9 1.2 4.5 5.0 3.8 8.6 14.6 22.8 21.4 0.0 9.8 5.1 0.0 1.2 0.0 0.0 1.7 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.0 0.5 0.8 0.8 4.0 0.9 1.0 0.7 1.0 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.5 0.0 0.0 0.0 4.6 1.0 0.1 0.0 0.0 1.2 0.0 0.0 0.6 1.2 0.0 0.0 1.2 1.7 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 17.9 4.1 0.9 0.2 0.5 0.1 0.0 FAM76A MGC34648 ENSG00000009780 "Family with sequence similarity 76 member A" Q8TAV0 1 27725979-27763122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 122.7;Late spermatids: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044762, HPA077897" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044762: AB_10795886, HPA077897: AB_2686867" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (7.58e-2)" "unprognostic (2.07e-2)" "unprognostic (2.87e-1)" "unprognostic (2.18e-3)" "unprognostic (4.44e-3)" "unprognostic (2.18e-3)" "unprognostic (3.07e-2)" "unprognostic (1.04e-1)" "unprognostic (4.35e-3)" "unprognostic (5.22e-2)" "prognostic favorable (2.26e-4)" "unprognostic (6.32e-2)" "unprognostic (6.33e-3)" "unprognostic (2.30e-1)" "unprognostic (1.07e-2)" 22.1 8.6 10.6 12.2 17.2 14.3 14.1 17.9 18.3 14.7 12.8 17.4 8.4 10.2 15.9 16.6 13.9 13.8 15.3 13.8 11.3 11.4 13.7 13.8 13.1 11.3 9.5 16.1 14.6 14.4 11.7 19.5 12.8 14.3 12.9 16.2 15.7 12.4 16.8 39.7 15.4 12.1 17.8 11.9 12.1 13.8 28.5 10.9 13.6 18.7 17.8 13.8 14.0 14.1 13.6 14.6 13.7 12.2 12.0 16.0 6.4 8.8 7.1 8.1 8.4 10.3 9.0 14.7 8.3 8.7 12.3 12.1 8.1 11.9 16.1 5.4 9.2 11.6 11.7 10.2 9.1 9.6 8.3 7.7 5.0 10.0 9.5 8.3 7.9 7.8 9.1 9.9 13.4 13.6 6.2 6.1 8.7 9.4 15.2 8.8 8.5 18.7 7.3 12.8 8.5 7.1 11.4 9.7 9.1 9.7 12.7 11.8 5.3 9.5 10.3 9.9 10.4 7.4 3.1 6.5 14.6 6.3 16.8 5.7 13.9 15.1 13.2 9.0 10.4 6.2 10.0 12.2 13.7 14.7 12.1 15.6 12.2 15.3 14.0 10.4 13.6 14.5 16.0 8.3 12.0 12.1 14.6 11.3 6.4 10.6 17.2 17.9 18.3 11.3 11.4 9.5 16.1 14.3 10.9 26.8 17.1 25.3 8.5 16.9 27.1 13.2 7.6 26.8 9.1 22.7 25.5 23.1 18.3 9.7 122.7 11.3 8.6 23.3 8.5 9.5 13.4 4.4 10.5 15.3 10.5 27.0 4.1 20.9 15.6 84.8 15.5 14.5 37.1 7.2 9.5 20.5 8.4 8.5 35.0 12.4 35.8 19.4 17.9 20.0 49.8 23.6 38.0 17.8 8.5 3.9 FAM81A MGC26690 ENSG00000157470 "Family with sequence similarity 81 member A" Q8TBF8 15 59372693-59523549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell type enhanced" "Detected in many" 16 "Collecting duct cells: 29.6;Horizontal cells: 9.5;Melanocytes: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5;plasmacytoid DC: 12.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.5" "Cell line enriched" "Detected in many" 4 "Daudi: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001847, HPA065797" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001847: AB_2666462, HPA065797: AB_2685560" "unprognostic (3.43e-3)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.32e-3)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (1.43e-1)" "unprognostic (2.39e-1)" "unprognostic (8.90e-2)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (9.95e-3)" "unprognostic (1.08e-2)" "unprognostic (6.53e-2)" "unprognostic (3.76e-1)" "unprognostic (7.80e-2)" 1.0 0.8 13.7 3.1 14.0 0.4 1.8 1.2 32.2 8.4 5.2 3.2 0.7 3.0 3.3 5.7 1.0 7.8 2.1 1.9 16.1 8.7 8.7 0.8 1.1 5.7 5.6 17.7 1.1 2.5 0.6 3.3 1.1 3.7 3.1 6.6 1.2 3.3 2.2 0.9 1.5 1.8 1.7 4.3 1.8 3.1 2.2 1.9 0.0 2.7 0.0 6.6 0.9 1.1 2.6 12.5 0.4 0.6 0.1 0.0 0.3 5.8 8.5 0.6 0.1 0.2 0.1 3.5 0.3 0.0 0.6 1.7 1.0 1.0 37.3 0.2 0.1 8.2 4.5 4.8 1.4 1.1 0.4 2.5 0.0 5.7 0.3 0.0 3.1 0.8 0.0 0.9 0.2 0.4 0.4 0.0 1.5 0.1 0.0 0.5 2.0 0.0 0.1 0.5 1.5 3.1 0.8 8.6 0.9 1.9 2.1 1.8 0.5 3.4 0.1 5.5 0.4 1.5 1.9 0.2 1.4 4.4 1.7 6.3 0.0 0.0 0.4 1.4 1.2 3.9 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.5 2.6 0.0 0.0 0.4 0.1 0.0 12.5 0.0 0.3 13.7 14.0 1.2 32.2 16.1 8.7 5.6 17.7 3.7 1.9 0.0 2.2 1.9 0.9 0.5 0.0 6.2 0.0 6.7 1.2 29.6 0.0 0.1 5.0 0.4 0.4 0.6 0.7 0.0 0.2 1.1 0.4 2.1 1.1 0.0 1.1 9.5 1.2 0.0 0.3 0.4 0.3 0.7 8.5 0.0 0.9 1.0 0.3 1.9 0.0 0.1 0.1 0.0 0.9 0.1 1.3 0.4 0.0 0.0 3.7 0.9 FAM83D "C20orf129, CHICA, dJ616B8.3" ENSG00000101447 "Family with sequence similarity 83 member D" Q9H4H8 20 38926312-38953106 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.0;smooth muscle: 69.8" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 23.3;Extravillous trophoblasts: 36.2;Syncytiotrophoblasts: 127.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049333, HPA060854" Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Mitotic spindle" "Microtubules, Cytokinetic bridge, Cytosol" "HPA049333: AB_2680717, HPA060854: " "unprognostic (7.90e-3)" "unprognostic (4.34e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.44e-6)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.73e-5)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.81e-14)" "unprognostic (2.57e-3)" "unprognostic (5.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.87e-2)" 0.5 0.5 0.5 4.9 0.8 7.9 0.7 0.4 1.2 1.7 29.6 0.4 0.7 3.4 0.8 1.5 39.0 0.2 5.6 1.5 0.5 0.1 2.2 1.4 2.6 1.5 0.3 0.5 0.7 0.2 0.0 0.3 2.2 0.7 7.6 3.6 1.2 3.1 1.0 0.4 4.1 16.2 69.8 0.4 1.0 22.8 3.8 0.2 9.2 0.5 8.6 17.9 24.5 6.4 1.6 0.1 0.0 0.4 2.4 4.6 1.2 31.5 19.5 15.4 12.9 1.7 2.0 27.7 14.2 8.9 28.2 17.3 29.8 14.5 8.0 14.1 9.3 21.9 27.2 21.1 24.4 26.5 2.6 8.3 9.3 15.0 21.4 1.4 4.1 4.9 1.0 1.2 16.2 9.4 3.4 15.4 3.6 8.2 11.6 16.0 17.0 6.3 6.0 12.8 18.4 24.9 6.1 28.5 4.4 8.1 8.1 7.1 11.9 41.5 34.7 6.1 15.0 21.7 4.2 7.3 18.7 23.0 21.2 31.3 3.5 5.4 8.3 8.4 6.1 13.7 0.0 0.0 0.0 0.7 0.4 2.3 1.6 2.4 2.7 0.1 1.6 2.7 3.4 0.0 2.4 0.1 0.0 4.6 1.2 0.5 0.8 0.4 1.2 0.5 0.1 0.3 0.5 0.7 0.2 0.0 2.2 0.0 5.2 2.1 0.0 0.8 0.0 1.4 1.2 0.0 0.0 2.6 0.0 0.0 0.4 0.5 2.6 23.3 0.0 36.2 0.9 0.7 0.0 5.4 4.0 0.0 1.7 1.8 2.1 0.6 0.3 0.4 0.0 0.0 2.2 0.0 0.1 3.7 0.0 4.3 0.0 19.4 2.1 11.1 14.5 1.6 127.6 2.2 2.5 4.3 FAM83G "FLJ41564, PAWS1" ENSG00000188522 "Family with sequence similarity 83 member G" A6ND36 17 18968789-19004804 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 36.0;skin 1: 33.8;tongue: 28.9" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 69.0;Suprabasal keratinocytes: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA023369, HPA023940" Enhanced Approved Cytosol NA NA Cytosol "HPA023369: AB_1848415, HPA023940: AB_1848416" "unprognostic (2.12e-2)" "unprognostic (5.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.48e-2)" "unprognostic (1.42e-3)" "unprognostic (2.04e-2)" "prognostic unfavorable (8.29e-4)" "unprognostic (1.07e-3)" "unprognostic (1.14e-1)" "unprognostic (2.03e-2)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (5.65e-2)" "prognostic favorable (7.58e-6)" "unprognostic (9.68e-2)" "unprognostic (5.13e-2)" "unprognostic (3.74e-2)" 1.8 1.0 0.5 5.1 0.8 0.6 2.2 1.0 0.8 6.2 5.5 0.4 1.3 6.6 1.4 0.9 36.0 0.8 13.4 8.7 0.9 0.6 2.6 26.5 2.3 1.5 0.4 0.4 1.1 7.0 4.7 2.2 2.6 1.6 1.7 3.2 1.5 5.7 3.0 3.4 33.8 10.1 1.6 0.4 1.0 5.9 0.8 0.3 3.2 3.3 28.9 19.1 2.4 6.9 1.5 0.2 3.4 0.7 0.0 2.6 0.7 12.5 11.6 0.1 0.0 0.4 1.1 19.2 13.2 5.8 11.2 8.5 14.8 4.6 8.3 8.1 8.7 9.2 15.0 1.9 11.1 5.2 6.7 4.2 0.2 5.7 8.1 8.4 1.4 4.2 1.5 20.9 7.2 12.0 4.2 4.0 1.3 3.9 0.3 3.1 7.7 0.3 3.1 5.8 17.5 0.0 0.0 0.0 4.0 5.5 3.2 6.0 0.0 4.5 2.8 0.8 16.3 4.9 1.8 7.4 7.0 11.7 3.3 15.2 1.1 2.0 2.1 5.4 0.0 4.5 3.4 0.0 0.0 2.6 0.1 1.4 1.1 1.5 0.8 0.2 1.5 1.4 0.2 0.0 0.0 0.7 0.2 1.8 0.7 0.5 0.8 1.0 0.8 0.9 0.6 0.4 0.4 1.6 0.3 3.0 2.1 0.0 10.6 69.0 0.0 3.5 10.2 0.0 2.3 7.0 0.0 0.1 0.0 13.9 0.0 0.3 27.0 0.0 8.7 8.1 1.0 10.5 9.2 18.3 1.2 0.0 6.8 1.3 0.0 0.4 0.0 2.1 5.0 1.8 11.2 0.0 17.5 10.5 0.0 4.3 0.1 0.0 2.2 0.1 1.1 59.8 1.6 0.7 9.8 7.8 FAM83H FLJ46072 ENSG00000180921 "Family with sequence similarity 83 member H" Q6ZRV2 8 143723933-143733801 "Disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.2;lymphoid tissue: 30.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 19.7;MCF7: 27.0;RT4: 16.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA024505, HPA024604" Enhanced Approved Cytosol NA NA Cytosol "HPA024505: AB_1848417, HPA024604: AB_1848418" "unprognostic (3.80e-2)" "unprognostic (3.75e-3)" "unprognostic (6.87e-2)" "unprognostic (1.63e-2)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.93e-1)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (3.95e-2)" "unprognostic (9.69e-3)" "prognostic favorable (4.42e-4)" "unprognostic (5.54e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" 0.8 1.9 1.2 4.1 1.0 0.2 2.9 0.2 1.6 8.8 12.5 0.9 6.1 6.3 1.1 3.0 42.2 3.0 17.7 0.3 1.1 0.4 5.0 10.4 3.9 0.5 0.3 0.6 1.3 6.7 5.9 2.8 8.9 0.9 5.6 2.7 2.6 8.3 2.9 0.1 17.7 17.9 1.8 0.7 0.7 9.1 1.3 0.2 1.1 6.9 27.9 30.7 5.1 9.5 0.3 0.2 0.5 0.3 0.1 0.2 0.0 13.8 6.5 0.0 0.0 0.0 0.0 12.2 0.9 0.0 0.4 0.1 5.9 12.5 0.0 10.1 0.2 0.0 19.7 0.8 12.1 0.2 1.0 2.2 0.3 13.0 4.1 1.0 0.3 0.9 0.7 14.3 0.0 3.6 0.2 0.0 0.9 7.3 0.0 0.0 27.0 0.2 0.0 2.5 14.3 6.0 0.0 0.0 1.3 3.9 16.2 3.8 0.0 10.9 12.7 2.1 1.8 13.7 1.8 0.0 0.0 3.9 0.9 0.0 1.9 2.0 0.0 0.0 0.0 0.6 0.3 0.3 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.3 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 1.2 1.0 0.2 1.6 1.1 0.4 0.3 0.6 0.9 0.2 29.8 16.8 0.0 12.2 20.3 1.2 3.6 22.9 9.4 12.5 27.9 2.0 10.1 3.3 18.5 1.1 1.2 29.9 0.0 22.0 15.5 1.8 19.5 0.0 21.2 4.0 9.5 13.8 0.6 1.9 0.0 0.0 1.1 1.7 3.6 23.7 6.0 31.6 21.5 0.4 6.5 2.1 0.0 1.2 1.2 1.0 23.5 12.2 0.8 22.5 29.2 FAM96A "CIA2A, FLJ22875" ENSG00000166797 "Family with sequence similarity 96 member A" Q9H5X1 15 64072559-64094018 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040459, HPA063729" Approved Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" No No "Nucleoplasm, Cytosol" "HPA040459: AB_10796456, HPA063729: AB_2685105" "unprognostic (1.15e-1)" "unprognostic (8.49e-2)" "unprognostic (6.59e-2)" "unprognostic (3.58e-1)" "unprognostic (1.30e-1)" "unprognostic (8.07e-2)" "unprognostic (4.06e-3)" "unprognostic (5.02e-2)" "unprognostic (7.16e-2)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.48e-3)" "unprognostic (8.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-2)" "unprognostic (1.50e-2)" 13.6 32.3 11.2 19.1 12.8 17.0 13.9 9.0 10.3 8.5 24.3 13.6 17.7 31.3 8.1 14.9 13.6 8.3 14.0 20.6 11.2 10.8 39.4 89.7 18.1 22.7 15.2 8.0 7.8 27.0 10.6 15.4 25.2 11.2 17.2 20.2 10.7 16.5 15.7 28.2 7.6 45.5 6.4 14.9 25.2 17.9 8.9 13.8 20.5 30.1 18.3 19.3 14.6 9.0 51.8 63.7 23.7 48.6 11.8 21.3 38.2 19.9 29.3 17.9 11.2 15.2 18.7 11.8 15.7 17.5 21.0 22.3 28.9 32.3 33.2 27.7 9.9 27.9 22.1 35.0 15.4 17.9 27.1 18.9 27.0 26.5 27.1 12.0 43.7 23.4 14.7 15.5 13.6 12.2 14.3 21.2 18.7 36.9 25.7 14.8 33.8 16.6 37.9 26.0 24.9 15.6 26.8 23.7 73.5 27.1 23.5 19.2 14.5 12.5 28.6 30.4 20.8 21.0 45.8 12.7 16.7 23.7 19.0 33.8 24.9 58.7 29.8 20.2 79.2 15.8 16.2 48.6 16.9 10.1 44.1 12.4 51.8 15.3 13.5 42.6 48.8 12.3 11.6 23.7 11.8 36.7 63.7 21.3 38.2 11.2 12.8 9.0 10.3 11.2 10.8 15.2 8.0 11.2 13.8 35.7 30.8 96.4 18.3 15.9 7.2 70.8 79.0 45.5 40.9 33.2 3.9 101.5 140.9 70.9 2.4 23.8 94.1 0.0 74.8 83.9 35.7 38.2 19.7 217.6 196.6 14.3 55.4 41.1 140.8 3.6 15.3 99.6 40.5 211.0 97.7 14.5 84.6 87.7 7.8 151.8 6.7 12.9 23.7 21.4 49.8 19.2 74.3 58.6 129.3 21.4 FAM96B "CGI-128, CIA2B, MIP18" ENSG00000166595 "Family with sequence similarity 96 member B" Q9Y3D0 16 66932055-66934423 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041501, HPA041736" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041501: AB_10795123, HPA041736: AB_10793932" "unprognostic (2.49e-1)" "unprognostic (3.79e-2)" "unprognostic (8.06e-2)" "unprognostic (5.42e-3)" "unprognostic (3.93e-2)" "unprognostic (4.91e-2)" "unprognostic (4.98e-2)" "unprognostic (8.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.96e-2)" "unprognostic (5.10e-2)" "unprognostic (1.50e-1)" "unprognostic (9.84e-2)" "unprognostic (6.48e-2)" "unprognostic (1.12e-2)" 22.5 34.2 38.7 26.5 38.2 17.7 31.9 26.8 34.5 19.6 28.8 30.3 19.8 26.3 20.4 27.5 43.5 28.6 25.0 58.0 36.7 33.6 41.6 57.8 27.4 30.6 39.4 27.4 29.5 38.3 23.2 30.0 27.3 30.7 22.0 25.6 16.6 21.9 22.2 89.6 14.2 29.4 22.3 41.4 25.3 24.3 32.2 28.5 24.1 41.2 40.8 25.3 25.7 37.0 51.8 92.7 46.3 52.7 40.7 61.2 44.8 25.6 58.3 19.8 24.8 25.0 23.8 24.1 23.5 26.4 36.1 45.4 61.4 29.9 23.3 30.6 27.7 31.2 34.1 28.3 28.4 25.8 28.9 39.9 14.2 17.3 71.6 47.7 21.0 56.7 23.4 27.6 42.6 37.4 27.5 24.4 41.8 23.8 15.6 29.2 49.4 35.6 50.6 26.4 22.1 70.9 30.5 21.2 44.8 53.4 23.2 34.9 39.0 50.5 13.7 35.6 16.0 15.0 35.0 20.6 27.1 32.2 15.2 32.6 34.3 27.4 59.2 48.1 21.8 35.2 41.5 47.0 46.3 43.2 51.2 42.3 51.8 46.3 46.9 51.7 44.4 37.3 41.5 23.0 40.7 52.7 92.7 61.2 44.8 38.7 38.2 26.8 34.5 36.7 33.6 39.4 27.4 30.7 28.5 74.5 131.2 134.8 130.5 127.4 54.2 121.8 109.5 168.6 113.7 165.7 21.6 175.4 261.9 198.2 44.5 121.5 197.1 23.3 125.1 149.7 134.5 169.2 157.1 149.9 179.2 31.8 148.2 106.2 88.6 19.0 101.5 151.1 155.3 184.9 122.5 115.3 214.6 139.8 101.1 426.3 53.3 155.2 140.2 112.5 201.2 146.8 207.9 152.4 157.1 199.3 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favorable (5.53e-4)" 10.8 8.9 18.3 9.3 16.9 11.0 9.8 17.0 19.9 8.7 14.2 12.8 9.0 19.6 9.9 7.2 14.3 13.8 9.1 11.6 16.0 13.1 9.1 13.4 8.7 9.5 12.3 16.9 10.2 22.4 10.6 8.1 7.6 13.0 12.5 7.0 8.2 17.7 9.5 2.5 17.0 22.2 6.8 12.7 10.1 19.2 5.4 9.7 5.3 11.8 7.7 11.2 9.4 9.5 6.0 3.2 12.6 3.4 3.3 5.6 1.6 10.9 11.9 1.4 6.9 1.5 5.2 6.1 6.4 5.4 6.3 6.7 2.0 8.0 10.0 7.2 3.7 2.2 5.3 2.7 4.6 1.0 16.1 5.6 3.2 2.0 4.6 6.8 2.8 6.0 5.0 9.6 3.2 5.8 3.5 3.7 16.4 9.0 11.0 3.7 12.1 4.0 2.1 1.0 18.2 12.8 8.3 2.9 5.9 7.7 5.8 2.4 7.1 6.4 11.4 3.8 0.7 8.6 8.7 4.8 2.8 7.8 8.8 7.6 11.9 6.0 4.2 7.4 6.5 4.5 0.0 2.3 12.6 3.1 3.3 4.2 2.6 5.6 4.6 3.2 6.0 4.3 3.4 2.0 3.3 3.4 1.2 4.4 1.6 18.3 16.9 17.0 19.9 16.0 13.1 12.3 16.9 13.0 9.7 8.9 9.9 17.1 21.7 19.2 13.2 4.3 10.2 6.7 5.7 22.7 11.8 10.3 18.3 17.4 5.0 9.3 43.8 0.0 28.7 9.4 10.0 14.8 15.0 11.9 9.9 11.1 24.6 10.4 10.5 2.1 17.3 14.7 21.9 12.6 32.7 11.1 19.7 34.5 17.3 15.9 11.6 12.9 11.4 27.3 41.1 26.1 5.1 20.3 33.5 22.0 FAN1 "KIAA1018, MTMR15" ENSG00000198690 "FANCD2 and FANCI associated nuclease 1" Q9Y2M0 15 30903852-30943108 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048198 Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA048198: AB_2680311" "unprognostic (7.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (3.30e-2)" "unprognostic (6.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.53e-2)" "unprognostic (3.53e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.42e-6)" "unprognostic (3.73e-1)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" "unprognostic (1.29e-1)" 5.9 8.9 11.6 6.9 17.4 6.3 12.7 19.6 18.4 15.0 11.4 17.7 11.9 4.6 11.6 22.9 6.5 8.5 8.5 13.0 12.6 11.0 14.7 14.4 6.9 5.5 18.5 11.8 12.5 18.2 7.2 17.0 10.6 15.4 16.4 9.7 8.6 17.3 8.3 16.8 9.3 6.7 11.5 13.0 7.3 8.5 9.4 15.0 5.1 14.3 6.3 5.8 9.0 9.1 4.0 3.6 0.6 1.7 4.5 5.4 1.6 6.3 10.9 3.6 2.0 12.9 11.5 2.4 4.5 1.9 4.8 5.0 7.5 3.3 1.4 8.0 4.8 10.0 12.9 6.1 9.4 4.7 5.1 2.9 1.1 11.2 1.3 5.6 0.9 6.1 3.4 7.0 2.9 7.6 10.4 2.3 6.6 5.4 10.0 7.8 1.4 9.9 4.4 2.8 10.2 2.5 8.4 11.8 2.7 7.0 5.0 8.3 5.8 9.9 6.8 3.5 13.6 6.1 7.6 8.2 15.0 3.6 4.1 5.7 13.8 9.6 1.7 6.5 4.8 1.3 0.1 0.8 0.6 3.7 1.3 4.7 2.8 3.5 1.7 2.7 4.0 5.4 2.8 0.3 4.5 1.7 3.6 3.2 1.6 11.6 17.4 19.6 18.4 12.6 11.0 18.5 11.8 15.4 15.0 14.9 9.6 0.8 4.9 3.7 20.0 15.7 0.0 16.0 13.6 8.7 19.6 5.5 8.3 3.3 8.7 6.7 3.8 0.0 2.5 1.8 3.5 4.6 8.1 11.0 3.2 25.4 7.5 8.0 4.1 5.8 9.8 4.1 5.0 2.8 9.7 14.7 3.3 2.9 6.3 5.1 24.3 6.5 4.2 19.5 12.9 2.0 3.4 6.9 8.3 3.1 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "Fanconi anemia complementation group D2" Q9BXW9 3 10026414-10101930 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.4;testis: 23.3" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 46.7;Spermatocytes: 55.1;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 46.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" No No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: AB_2685110" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 2.0 1.3 0.8 10.3 2.6 12.2 2.4 1.6 2.7 1.7 2.9 1.1 1.0 2.2 2.2 1.8 4.7 2.4 2.5 1.1 0.8 0.9 2.3 1.0 2.4 9.5 1.3 1.2 3.5 3.5 0.6 1.1 5.3 1.4 2.2 4.9 1.6 3.3 0.4 3.0 3.3 6.2 1.2 2.0 7.3 2.4 23.3 1.6 24.4 1.6 5.6 14.6 2.2 2.4 6.8 3.7 5.3 2.6 2.1 2.9 1.0 8.7 9.3 17.8 5.0 0.9 1.4 46.0 8.0 3.6 11.5 9.4 6.9 8.7 17.1 3.8 2.6 9.5 7.6 18.3 6.2 11.5 8.1 12.4 23.3 14.3 6.6 0.1 17.3 14.6 0.4 1.0 13.0 7.2 1.6 6.9 14.7 14.2 19.6 8.7 10.0 14.4 6.7 21.4 6.7 6.5 15.8 14.5 12.1 4.0 9.8 4.9 9.8 9.8 7.7 3.1 13.5 11.8 11.0 4.0 9.6 11.0 5.8 11.6 8.3 16.3 28.9 5.5 17.8 16.3 5.3 1.4 3.7 1.5 1.0 1.3 4.9 2.0 1.2 0.9 6.8 2.5 1.9 3.3 2.1 2.6 3.7 2.9 1.0 0.8 2.6 1.6 2.7 0.8 0.9 1.3 1.2 1.4 1.6 0.0 0.3 9.7 2.8 4.0 2.8 1.6 0.0 1.4 1.2 1.8 9.8 6.6 0.0 1.6 4.4 1.5 0.7 46.7 2.9 12.7 1.3 2.2 1.1 1.0 5.0 0.0 1.2 3.7 3.4 5.6 2.0 5.2 3.3 7.2 2.0 0.8 1.4 2.8 1.4 0.5 5.8 19.4 0.8 55.1 32.4 2.4 5.8 3.8 5.0 2.3 FANCG "FAG, XRCC9" ENSG00000221829 "Fanconi anemia complementation group G" O15287 9 35073835-35080016 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 17.3;Spermatogonia: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008105, HPA045335" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" Nucleoli "CAB008105: AB_2231542, HPA045335: AB_2679292" "unprognostic (9.41e-2)" "unprognostic (2.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.83e-3)" "prognostic unfavorable (2.02e-4)" "unprognostic (8.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.27e-3)" "unprognostic (9.01e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.38e-7)" "unprognostic (1.14e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" 5.8 5.0 4.4 7.1 6.5 14.9 7.5 13.9 8.5 6.2 5.9 5.3 8.4 6.7 6.8 3.2 9.2 8.6 4.7 5.9 7.6 4.0 5.2 4.5 5.1 9.9 8.7 4.4 9.2 17.0 6.7 4.8 7.6 6.6 7.0 5.5 3.5 8.7 9.7 2.9 8.9 6.5 6.4 4.2 8.6 5.8 8.9 7.6 25.6 9.3 4.8 9.2 6.8 6.9 6.8 4.8 8.9 2.5 8.8 9.2 3.4 15.7 19.6 14.4 13.3 3.2 5.1 12.1 11.1 8.0 21.8 21.0 9.3 9.9 15.6 7.7 3.5 15.6 9.7 11.9 10.2 8.4 18.3 7.2 11.2 21.0 5.7 0.9 11.3 12.9 4.2 2.0 19.0 8.6 3.8 11.1 19.2 7.3 21.0 11.0 14.0 19.1 15.6 14.9 11.8 15.1 19.9 16.9 11.0 5.1 6.7 7.0 12.7 7.3 10.4 4.1 6.5 13.5 8.2 6.7 10.4 20.7 13.3 14.9 5.7 10.8 9.4 9.2 8.4 14.2 8.9 0.8 7.7 7.4 2.5 6.5 6.8 6.1 5.7 2.2 6.5 4.8 5.0 1.3 8.8 2.3 4.8 9.2 3.4 4.4 6.5 13.9 8.5 7.6 4.0 8.7 4.4 6.6 7.6 3.0 5.8 5.2 3.6 3.9 4.3 1.0 0.0 0.0 2.3 3.5 3.9 8.2 3.3 3.7 0.3 2.8 1.6 0.0 2.0 17.3 3.8 3.5 13.9 1.0 6.5 4.8 1.7 3.7 0.3 0.4 3.1 2.0 3.3 3.6 3.9 3.5 2.3 3.2 3.9 1.7 3.0 0.0 2.7 10.9 23.7 2.3 5.5 5.3 5.0 3.3 FARP1 "CDEP, MGC87400, PLEKHC2, PPP1R75" ENSG00000152767 "FERM, ARH/RhoGEF and pleckstrin domain protein 1" Q9Y4F1 13 98142562-98455176 "Predicted intracellular proteins" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 146.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.0;Hep G2: 38.9;SuSa: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000760 Approved Cytosol NA NA Cytosol "HPA000760: AB_1078816" "unprognostic (4.78e-3)" "unprognostic (1.65e-1)" "unprognostic (3.07e-1)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (2.30e-1)" "unprognostic (7.73e-2)" "unprognostic (6.91e-2)" "unprognostic (1.03e-1)" "unprognostic (6.09e-2)" "unprognostic (3.13e-1)" "unprognostic (1.08e-1)" "prognostic favorable (1.39e-5)" "unprognostic (4.89e-2)" "unprognostic (2.27e-1)" "unprognostic (2.18e-2)" "unprognostic (4.18e-2)" 10.4 16.5 21.3 9.1 14.6 1.4 28.3 4.6 19.0 18.3 22.9 11.2 16.0 6.5 16.5 26.2 5.9 15.4 15.1 10.7 16.0 13.1 43.4 38.4 29.3 9.2 11.7 20.0 11.0 32.7 14.1 17.5 22.2 17.2 23.9 10.6 16.8 27.2 21.9 14.0 8.0 8.0 18.8 19.7 9.5 17.2 8.1 10.6 1.5 28.7 3.9 3.6 17.7 18.7 2.2 0.1 0.3 0.2 0.0 0.8 0.2 0.2 3.2 14.6 20.6 4.2 8.3 7.1 22.0 14.4 12.4 11.0 25.3 9.8 0.0 8.5 38.0 3.0 0.4 6.1 6.0 21.0 0.3 6.3 0.1 11.4 38.9 11.3 0.0 0.1 9.7 2.7 3.6 0.8 7.2 8.1 0.3 0.0 0.2 8.5 5.5 0.8 0.1 6.9 12.2 3.8 7.6 5.7 0.4 27.5 14.2 6.2 13.6 2.7 5.8 15.6 36.2 8.3 0.0 7.8 13.5 5.2 9.1 11.1 0.2 0.2 0.1 6.2 0.4 9.3 0.3 0.1 0.0 0.3 0.2 0.0 2.2 0.8 0.6 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 21.3 14.6 4.6 19.0 16.0 13.1 11.7 20.0 17.2 10.6 41.7 19.0 0.0 50.6 6.2 10.5 7.3 86.6 34.8 33.0 54.1 43.2 5.7 68.0 39.8 146.6 12.9 5.1 0.0 30.5 4.8 23.7 58.1 12.7 60.4 41.7 28.6 29.9 24.5 15.8 95.9 17.5 9.1 27.0 29.7 8.4 34.6 40.5 2.9 27.6 120.7 16.8 19.4 27.7 5.4 7.7 2.5 3.8 2.9 13.2 39.6 FARP2 "FIR, FRG, KIAA0793, PLEKHC3" ENSG00000006607 "FERM, ARH/RhoGEF and pleckstrin domain protein 2" O94887 2 241356243-241494841 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031226, HPA055592" Approved Approved Cytosol NA NA Cytosol "HPA031226: AB_10602808, HPA055592: AB_2682856" "unprognostic (3.07e-1)" "unprognostic (1.39e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-1)" "unprognostic (1.37e-2)" "unprognostic (1.60e-2)" "unprognostic (1.70e-1)" "unprognostic (1.83e-1)" "unprognostic (2.19e-1)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (9.11e-2)" "unprognostic (6.31e-2)" "unprognostic (6.78e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-1)" 10.2 11.2 11.2 17.6 15.3 5.5 10.1 28.4 16.5 9.9 24.5 24.0 17.3 22.2 16.4 9.3 16.0 10.8 14.4 8.4 12.3 11.5 11.4 16.1 11.1 12.2 18.3 9.7 12.8 12.9 16.0 10.2 10.1 19.5 10.9 24.4 19.7 10.1 20.1 10.5 22.6 26.1 13.3 15.7 12.1 22.6 27.0 15.2 6.1 7.8 8.2 18.2 13.9 10.6 7.1 8.2 9.2 6.7 2.0 2.5 1.9 10.2 7.4 13.8 9.3 11.9 15.9 12.3 10.2 8.5 10.6 11.1 7.8 12.3 4.3 2.8 20.0 7.5 11.7 18.2 10.7 16.3 6.8 9.5 9.6 13.3 10.3 8.7 8.6 7.5 15.9 8.0 15.5 12.7 5.0 9.6 8.4 10.8 4.0 8.5 8.6 9.2 6.3 6.8 18.1 5.9 10.3 30.9 13.0 13.8 21.1 16.3 10.9 11.5 8.2 31.2 8.3 4.3 8.7 14.4 10.2 7.8 12.6 8.3 6.9 4.9 9.7 9.2 6.0 20.5 5.4 2.6 9.2 1.8 6.7 1.6 6.1 1.9 2.1 3.9 7.1 1.3 1.4 1.6 2.0 3.5 8.2 2.5 1.9 11.2 15.3 28.4 16.5 12.3 11.5 18.3 9.7 19.5 15.2 26.8 5.1 5.7 7.5 13.7 11.8 27.7 10.2 17.4 12.5 17.4 17.7 4.8 3.3 7.2 34.8 7.1 20.1 0.0 10.6 4.7 8.7 9.2 5.8 9.4 3.8 19.1 26.9 11.6 6.5 17.0 13.8 9.1 37.1 9.0 35.1 6.7 11.4 22.9 9.9 6.1 15.2 19.4 12.0 39.2 17.2 13.2 9.3 5.3 23.7 22.7 FARSA "CML33, FARSL, FARSLA" ENSG00000179115 "Phenylalanyl-tRNA synthetase alpha subunit" Q9Y285 19 12922479-12934037 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001911 Enhanced Approved Cytosol NA NA 11000 Cytosol "HPA001911: AB_1848427" "unprognostic (1.52e-1)" "prognostic favorable (8.23e-4)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.22e-4)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (4.93e-3)" "unprognostic (5.76e-2)" "unprognostic (2.86e-1)" "unprognostic (1.24e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-2)" "unprognostic (1.45e-3)" "prognostic favorable (8.32e-4)" "unprognostic (2.59e-1)" "unprognostic (8.25e-2)" "unprognostic (1.84e-2)" 18.0 20.7 24.8 23.6 29.5 23.5 15.4 24.6 49.2 17.7 24.0 18.3 14.9 22.1 16.1 13.1 26.6 21.2 16.3 24.9 23.9 30.1 23.0 39.6 13.4 27.6 25.6 28.1 19.1 26.7 17.8 21.0 22.9 29.1 18.5 15.0 14.8 25.1 20.4 33.3 27.8 18.8 15.3 17.2 21.2 18.9 17.1 18.6 32.7 24.4 15.2 22.0 19.5 15.2 34.7 42.2 28.9 41.2 38.3 40.2 39.7 29.1 27.6 11.1 23.9 7.7 7.3 20.0 21.0 13.6 30.1 23.7 33.8 12.4 32.3 33.8 11.8 12.2 22.4 27.0 24.0 11.0 18.9 40.7 25.3 24.3 26.7 25.0 48.8 33.4 10.0 17.7 23.2 18.7 9.9 16.3 32.9 38.2 6.8 12.6 39.2 57.9 60.7 34.6 18.1 46.9 30.0 11.5 41.4 15.8 17.2 34.8 31.9 14.1 24.4 14.9 5.4 19.2 29.7 15.6 24.5 10.8 37.2 39.0 45.2 38.5 33.6 22.2 44.1 25.3 17.3 39.2 28.9 32.5 41.2 40.2 31.9 32.0 30.2 42.2 34.7 32.9 31.2 2.5 38.3 30.4 34.1 29.4 39.7 24.8 29.5 24.6 49.2 23.9 30.1 25.6 28.1 29.1 18.6 8.9 21.3 25.9 20.3 22.6 23.5 22.1 2.5 13.4 13.6 22.7 9.8 74.5 49.7 50.2 3.9 18.0 20.6 23.3 40.4 65.4 18.4 19.3 23.1 22.9 56.1 17.5 21.9 17.2 26.9 7.5 17.5 19.2 32.1 52.3 22.0 19.4 40.6 24.6 12.4 43.4 13.0 6.5 20.6 14.6 41.5 25.7 80.9 27.7 31.6 19.5 FARSB "FARSLB, FRSB, PheHB" ENSG00000116120 "Phenylalanyl-tRNA synthetase beta subunit" Q9NSD9 2 222570536-222656337 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036677, HPA036678, HPA061398" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504" "unprognostic (9.95e-3)" "unprognostic (1.86e-3)" "unprognostic (7.02e-2)" "unprognostic (7.42e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.45e-10)" "unprognostic (8.89e-3)" "unprognostic (4.51e-2)" "unprognostic (3.63e-2)" "unprognostic (5.25e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.25e-4)" 15.7 10.8 11.9 12.6 23.5 11.5 16.0 15.1 28.5 11.6 17.3 13.7 5.9 15.9 14.2 11.7 19.1 10.8 7.2 13.4 13.7 15.1 11.7 18.3 9.0 12.0 11.6 18.0 16.7 18.6 15.0 15.7 8.8 29.4 11.2 20.7 9.6 12.3 11.5 33.2 14.1 11.5 14.9 9.7 10.3 13.9 15.6 11.2 15.6 11.9 17.1 14.2 11.8 12.0 16.3 16.0 1.2 11.4 18.5 20.0 14.6 22.2 13.1 15.3 20.0 14.0 20.1 23.6 22.7 14.4 22.5 18.4 33.2 12.3 10.9 17.3 16.6 18.7 18.8 29.4 25.5 33.1 16.3 15.2 25.1 14.8 21.1 21.8 36.5 10.4 13.4 20.0 25.6 39.4 8.0 21.2 19.3 37.7 22.6 27.3 20.8 21.8 20.7 19.5 26.9 16.4 21.5 36.8 35.4 18.4 14.6 24.8 8.1 9.5 16.7 19.6 19.5 15.5 15.4 11.5 19.3 15.9 27.6 27.4 10.8 10.8 39.9 15.0 24.6 20.1 0.2 8.5 1.2 11.4 10.3 16.8 16.3 15.4 14.0 16.0 14.0 20.0 17.2 0.9 18.5 11.4 8.0 13.3 14.6 11.9 23.5 15.1 28.5 13.7 15.1 11.6 18.0 29.4 11.2 6.0 5.4 20.0 16.1 11.0 15.1 26.0 2.5 16.0 10.3 21.0 3.9 30.6 29.9 19.9 43.7 9.9 12.3 0.0 26.1 35.9 12.8 11.4 4.7 16.2 24.6 3.2 20.1 7.4 9.7 57.3 14.1 10.8 6.8 9.0 19.0 9.8 18.6 7.0 18.7 20.7 17.1 6.5 16.5 59.3 37.3 12.4 18.5 13.3 40.3 12.0 FAS "APO-1, APT1, CD95, FAS1, TNFRSF6" ENSG00000026103 "Fas cell surface death receptor" P25445 10 88990582-89015785 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Apoptosis "Calmodulin-binding, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 40.1" "Group enriched" "Detected in all" 5 "granulocytes: 40.1;T-cells: 30.9" "Cell line enhanced" "Detected in many" "HDLM-2: 28.0;Karpas-707: 44.7" "Low region specificity" "Detected in all" HPA027444 Uncertain Supported "Nuclear bodies,Plasma membrane,Cytosol" "Secreted to blood" NA NA 11900000 450000 "Plasma membrane" "Nuclear bodies, Cytosol" "HPA027444: AB_10601378" "unprognostic (6.84e-2)" "unprognostic (2.88e-3)" "unprognostic (8.38e-3)" "unprognostic (1.94e-1)" "unprognostic (2.35e-2)" "unprognostic (9.56e-2)" "unprognostic (7.00e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (7.70e-2)" "unprognostic (1.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.52e-3)" "unprognostic (2.10e-1)" "unprognostic (2.32e-2)" "unprognostic (4.95e-3)" "unprognostic (1.65e-1)" 13.5 26.3 6.1 17.3 7.7 12.4 10.6 2.1 7.2 15.6 14.2 6.1 7.0 5.9 15.7 16.6 14.1 14.2 14.5 8.9 8.2 2.7 11.7 21.9 28.6 15.6 6.0 3.9 24.7 4.1 4.5 4.6 9.0 7.5 22.3 21.3 4.4 7.1 8.5 4.3 9.6 16.3 12.5 10.2 15.3 5.0 7.3 5.1 12.5 10.0 15.8 14.4 14.8 21.4 3.0 4.0 40.1 6.8 1.2 30.9 3.9 8.7 3.4 1.8 5.6 14.5 21.4 0.0 19.2 19.5 0.7 3.8 0.0 9.5 1.7 7.4 18.0 3.2 1.4 0.3 16.2 1.3 28.0 2.8 0.1 1.8 5.7 13.9 0.9 0.4 26.5 14.5 12.0 26.0 9.4 1.7 6.4 0.0 44.7 19.6 0.8 2.8 1.4 0.2 0.0 0.9 0.2 0.1 1.8 27.1 2.8 0.1 0.1 2.8 0.0 0.3 2.8 6.1 0.3 4.2 6.2 3.4 5.7 4.4 17.5 1.8 0.1 5.1 3.5 1.8 11.3 3.2 9.4 3.3 3.9 4.8 3.0 10.4 7.2 4.0 0.7 1.2 3.4 40.1 1.2 6.8 0.0 30.9 3.9 6.1 7.7 2.1 7.2 8.2 2.7 6.0 3.9 7.5 5.1 53.6 14.4 3.7 100.3 40.8 0.0 1.2 15.3 21.4 21.6 8.7 0.0 0.4 0.0 6.7 5.4 8.4 12.0 0.0 3.8 0.2 34.9 22.7 3.5 15.3 5.0 1.6 8.1 2.5 6.9 3.5 17.5 12.7 11.8 20.8 15.0 17.1 4.3 0.0 13.1 11.5 0.7 6.5 33.4 4.8 1.3 38.3 0.3 37.9 23.2 22.7 FASN "FAS, SDR27X1" ENSG00000169710 "Fatty acid synthase" P49327 17 82078333-82098332 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 147.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 103.0;Hepatocytes: 169.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 155.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005192, HPA006461, CAB015417, HPA056108" Enhanced Enhanced "Plasma membrane,Cytosol" No No 1600000 "Plasma membrane, Cytosol" "CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039" "unprognostic (3.35e-2)" "prognostic unfavorable (1.42e-5)" "unprognostic (9.69e-3)" "unprognostic (4.09e-2)" "unprognostic (3.46e-3)" "unprognostic (1.55e-2)" "unprognostic (3.09e-2)" "unprognostic (4.74e-3)" "unprognostic (3.15e-1)" "unprognostic (3.15e-1)" "unprognostic (2.87e-3)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.16e-5)" "unprognostic (4.50e-2)" "unprognostic (9.62e-2)" "unprognostic (1.35e-2)" "unprognostic (7.03e-3)" 147.6 7.8 8.2 14.2 11.5 11.1 57.5 19.1 23.0 6.6 27.7 17.0 14.1 8.2 4.7 14.2 17.1 4.3 19.4 6.3 7.9 6.7 3.7 30.8 26.8 9.8 7.3 11.5 6.4 10.4 6.7 15.3 8.4 21.7 28.8 3.4 7.6 16.9 10.8 7.5 17.2 6.5 4.6 8.4 5.1 11.9 6.6 8.8 1.9 5.1 10.7 5.4 8.0 6.6 0.5 1.4 0.0 0.8 0.2 1.9 0.8 23.6 24.8 11.5 7.9 18.7 12.7 24.7 4.7 6.1 5.0 9.2 25.9 16.1 7.9 3.9 3.6 14.0 19.7 11.1 21.7 0.9 3.7 48.3 16.3 18.5 34.6 5.3 8.8 2.5 12.1 5.7 12.7 3.0 1.7 5.6 7.4 24.6 7.0 1.7 40.9 9.5 14.0 22.4 3.7 14.4 8.5 6.5 15.6 5.6 30.3 28.7 16.0 6.9 155.8 12.6 4.4 27.8 16.8 9.7 7.3 15.1 6.0 11.3 9.5 2.1 8.1 4.4 9.6 10.8 0.0 0.8 0.0 1.2 0.5 0.7 0.5 1.9 1.4 1.4 0.2 0.7 0.6 0.0 0.2 0.4 1.1 0.6 0.8 8.2 11.5 19.1 23.0 7.9 6.7 7.3 11.5 21.7 8.8 23.8 103.0 0.8 10.3 6.9 24.9 4.8 25.5 6.7 10.3 10.4 5.9 28.9 3.3 18.9 1.2 4.5 20.8 23.3 24.9 65.8 10.4 65.5 12.7 169.2 11.7 28.6 17.4 11.1 6.9 1.3 15.3 5.0 16.9 8.2 18.9 12.3 16.1 17.5 10.6 5.5 9.5 0.0 9.6 1.9 13.9 12.0 24.7 10.7 18.3 17.5 FAT4 "CDHF14, CDHR11, FAT-J" ENSG00000196159 "FAT atypical cadherin 4" Q6V0I7 4 125316399-125492932 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Endothelial cells: 11.1;Fibroblasts: 9.3;Ito cells: 30.7" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 12 "NK-cells: 1.1" "Cell line enhanced" "Detected in many" "ASC diff: 12.3;ASC TERT1: 9.1;fHDF/TERT166: 8.9;HSkMC: 10.5;HUVEC TERT2: 11.1;TIME: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052819 Approved Approved Cytosol NA NA 7900000 Cytosol "HPA052819: AB_2681963" "unprognostic (1.18e-1)" "unprognostic (1.77e-1)" "unprognostic (7.99e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (2.81e-4)" "unprognostic (6.17e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (2.78e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.89e-4)" "unprognostic (2.38e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-3)" 3.8 0.5 0.9 0.8 0.7 0.0 3.2 0.0 0.5 4.4 7.1 0.3 2.7 0.6 1.9 2.1 4.1 5.0 1.0 0.4 2.6 2.0 5.3 0.1 0.9 5.3 0.5 6.7 0.4 2.5 3.6 1.9 1.0 2.3 1.1 1.4 2.4 3.3 0.6 2.1 2.4 0.1 3.9 0.2 3.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 6.0 0.6 12.3 9.1 0.0 2.0 2.4 1.0 1.0 0.0 0.3 0.0 2.5 8.9 1.2 0.0 2.2 2.5 0.6 0.0 1.0 1.3 2.5 0.0 4.0 0.8 0.0 10.5 1.4 0.5 5.5 7.2 11.1 0.0 0.0 1.6 5.0 0.1 0.4 0.0 0.4 0.0 0.2 0.7 1.2 0.0 0.1 0.0 0.1 1.2 0.3 0.0 0.0 0.3 0.0 0.0 17.3 6.1 1.7 2.1 0.9 0.2 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.1 1.4 1.3 5.3 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.7 0.8 11.1 0.0 0.0 0.2 0.0 9.3 0.1 0.0 6.8 0.2 0.0 0.0 30.7 2.4 0.0 5.5 0.0 3.3 0.0 0.0 1.2 0.2 0.0 4.6 0.6 0.1 0.0 3.9 0.0 0.6 0.5 0.0 0.0 0.0 0.0 FAU "asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30" ENSG00000149806 "FAU, ubiquitin like and ribosomal protein S30 fusion" "P35544, P62861" 11 65120628-65122473 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059015 Supported Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No "Endoplasmic reticulum, Cytosol" Nucleoli "HPA059015: AB_2683881" "unprognostic (1.81e-3)" "unprognostic (3.47e-2)" "unprognostic (2.89e-1)" "unprognostic (2.91e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-3)" "unprognostic (1.97e-1)" "unprognostic (5.40e-2)" "unprognostic (1.26e-1)" "unprognostic (7.06e-3)" "unprognostic (7.77e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-2)" 79.7 95.0 90.6 84.9 76.2 186.7 95.4 50.9 80.9 103.6 134.8 77.6 63.4 77.8 84.0 80.5 115.2 100.0 87.2 133.9 70.0 58.9 88.0 162.9 77.5 182.6 78.9 40.8 176.0 202.8 27.5 56.1 73.2 46.6 123.5 53.0 67.8 97.3 76.7 190.8 86.8 93.8 97.5 72.4 130.9 79.2 53.6 53.2 126.8 121.5 83.6 149.5 122.0 136.6 291.3 169.7 90.9 119.0 116.3 253.8 346.5 78.9 52.0 46.0 72.8 45.0 67.3 63.0 45.1 43.9 63.2 40.1 58.8 79.3 94.1 122.5 38.7 42.6 69.8 42.6 60.1 26.3 69.0 65.3 75.8 54.7 80.7 82.8 89.8 83.6 82.9 100.1 54.3 73.9 60.2 48.7 91.0 70.7 111.5 33.4 98.7 103.8 181.4 126.5 59.2 86.7 101.0 36.8 184.5 58.2 44.7 64.0 64.3 35.0 101.3 140.8 28.6 90.5 124.6 46.0 57.2 66.0 88.2 72.0 121.3 115.2 160.1 69.3 70.0 64.7 90.9 119.0 70.6 128.9 107.0 176.1 291.3 212.1 165.5 132.1 281.7 253.8 198.1 78.9 116.3 92.8 169.7 153.8 346.5 90.6 76.2 50.9 80.9 70.0 58.9 78.9 40.8 46.6 53.2 595.5 951.7 2941.4 2547.1 3351.7 327.7 460.8 1579.6 745.5 1039.6 909.0 184.6 1889.5 1737.5 1225.7 710.1 1573.3 1664.2 1027.9 2337.8 2188.3 1714.1 2189.0 1307.1 1658.9 1928.3 179.6 1179.1 1412.4 2371.4 1489.6 2116.5 2866.9 2014.3 2418.4 1788.3 428.5 1806.3 2457.4 1155.5 1844.9 362.4 1099.5 2206.1 745.0 649.0 3667.7 2335.8 2033.7 2040.2 2956.6 FBN1 "FBN, MASS, MFS1, OCTD, SGS, WMS" ENSG00000166147 "Fibrillin 1" P35555 15 48408306-48645849 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hormone" "Aortic aneurysm, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 69.8" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 91.8;Fibroblasts: 78.5;Leydig cells: 218.7;Peritubular cells: 213.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 36.9;ASC TERT1: 79.9;fHDF/TERT166: 68.5;HSkMC: 43.2;hTERT-RPE1: 35.7;U-138 MG: 35.1;U-2197: 51.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002670, HPA017759, HPA021057, CAB058696, CAB068188" Enhanced Approved Cytosol "Secreted to blood" NA NA 540000000 Cytosol "CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586" "unprognostic (3.97e-2)" "unprognostic (1.55e-2)" "unprognostic (2.40e-2)" "unprognostic (9.50e-2)" "unprognostic (1.51e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-2)" "unprognostic (4.79e-2)" "unprognostic (7.82e-2)" "unprognostic (1.50e-2)" "unprognostic (2.78e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (7.44e-5)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.25e-2)" "unprognostic (8.69e-3)" "prognostic unfavorable (5.11e-4)" 34.2 5.4 2.1 7.8 2.7 1.8 10.9 1.0 2.8 24.6 11.1 3.5 10.7 2.2 18.4 25.6 22.1 12.1 15.5 24.3 2.5 2.3 2.9 1.9 10.7 5.8 2.8 2.6 20.4 2.5 2.6 3.3 69.8 3.1 11.8 6.9 13.4 5.7 7.8 15.4 6.6 6.9 21.5 3.8 11.3 7.2 13.6 1.6 1.9 17.9 16.3 4.9 22.8 11.2 0.8 0.8 1.8 0.6 1.1 0.6 0.2 0.0 0.8 3.3 3.7 36.9 79.9 0.0 28.8 10.4 8.6 5.5 0.0 0.0 0.0 1.3 68.5 0.0 0.1 0.6 0.1 7.8 3.3 0.2 0.3 14.7 0.0 20.8 0.1 0.0 43.2 0.0 22.7 2.6 35.7 9.2 0.2 0.0 0.0 9.2 0.0 0.2 0.0 0.6 0.0 1.1 0.0 2.8 0.0 1.0 0.0 0.0 2.1 0.0 0.3 0.0 2.7 0.0 0.2 17.4 35.1 1.0 51.0 6.0 0.2 0.1 0.0 23.5 0.0 2.3 1.1 0.5 0.7 0.5 0.3 0.4 0.5 0.4 0.4 0.2 0.8 0.5 0.6 1.8 1.1 0.6 0.8 0.3 0.2 2.1 2.7 1.0 2.8 2.5 2.3 2.8 2.6 3.1 1.6 0.0 2.2 0.0 1.1 22.8 4.5 9.3 0.0 5.3 10.3 12.2 0.0 91.8 0.0 0.2 6.3 21.7 0.0 0.0 0.5 16.3 78.5 0.5 1.1 0.6 13.5 0.0 0.0 38.1 1.0 15.7 218.7 4.4 40.5 3.6 0.0 0.5 2.0 0.0 213.6 0.6 0.1 25.8 44.7 3.0 2.1 18.1 55.0 0.0 0.0 0.1 FBN2 "CCA, DA9" ENSG00000138829 "Fibrillin 2" P35556 5 128257909-128659185 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "placenta: 175.9" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 251.0;Syncytiotrophoblasts: 136.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;non-classical monocyte: 5.0" "Lineage enriched" "Detected in many" 5 "monocytes: 5.0" "Cell line enhanced" "Detected in many" "HHSteC: 38.0;HSkMC: 27.1;hTERT-HME1: 59.9;HUVEC TERT2: 33.7" "Region enhanced" "Detected in single" "olfactory region: 2.6" "Low region specificity" "Detected in some" "HPA012853, CAB026401" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 4600000 Cytosol Nucleoplasm "CAB026401: , HPA012853: AB_1848588" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (7.29e-3)" "unprognostic (1.79e-3)" "unprognostic (6.74e-2)" "unprognostic (2.33e-1)" "unprognostic (4.92e-3)" "unprognostic (9.41e-2)" "unprognostic (1.06e-2)" "unprognostic (4.66e-1)" "unprognostic (1.12e-1)" "unprognostic (8.69e-2)" "unprognostic (8.60e-5)" "unprognostic (1.04e-2)" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (7.41e-5)" 0.3 7.9 0.3 1.0 0.3 1.6 0.1 0.2 0.3 1.5 0.7 0.4 1.0 0.2 2.9 0.6 1.1 0.6 0.2 6.7 0.2 0.5 0.2 0.2 0.2 1.3 0.2 0.4 0.9 0.1 0.0 1.3 175.9 0.4 1.0 0.8 6.2 0.4 0.9 0.2 0.3 0.5 0.8 0.4 0.6 0.5 4.6 0.2 0.3 0.9 0.4 0.7 0.4 1.2 0.0 1.1 0.6 5.0 0.0 0.0 0.4 0.0 4.5 16.4 0.0 2.7 4.7 3.4 17.9 0.0 15.9 11.9 0.0 0.0 0.0 0.0 23.9 0.0 2.7 10.6 2.7 14.9 0.0 4.2 0.0 7.5 0.0 38.0 2.3 0.0 27.1 1.4 6.7 59.9 5.1 33.7 0.0 0.0 0.0 9.8 0.0 0.0 0.9 7.1 0.0 5.4 5.1 5.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 14.0 0.0 5.0 0.0 6.4 12.2 18.3 0.0 0.0 0.0 0.0 1.9 0.0 6.7 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 5.0 0.0 0.0 0.4 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.4 0.4 0.2 0.0 0.3 0.0 0.1 0.0 0.0 11.3 0.0 0.0 2.3 0.0 0.0 251.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 27.7 3.3 1.5 0.0 0.0 29.6 0.0 0.0 0.0 12.9 5.3 1.1 1.8 1.7 0.0 0.0 3.1 0.1 0.0 2.1 0.0 0.0 6.5 0.2 12.7 3.8 0.4 136.7 0.0 0.0 0.1 FBP2 ENSG00000130957 "Fructose-bisphosphatase 2" O00757 9 94558720-94593793 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 33.7;skeletal muscle: 134.7;tongue: 45.6" "Cell type enhanced" "Detected in some" 29 "Exocrine glandular cells: 1.2;Spermatogonia: 3.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 36 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;CACO-2: 3.6;HMC-1: 4.0;MCF7: 5.3;OE19: 5.0;PC-3: 3.7;SiHa: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA012513, HPA077371" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA012513: AB_1848446, HPA077371: " "unprognostic (3.88e-2)" "unprognostic (3.54e-4)" "unprognostic (2.38e-1)" "unprognostic (6.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-2)" "unprognostic (9.40e-4)" "unprognostic (3.95e-3)" "unprognostic (5.11e-2)" "unprognostic (2.39e-2)" "unprognostic (4.69e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.48e-4)" 2.0 0.4 0.1 0.0 0.1 0.0 0.2 0.1 0.9 0.1 0.1 3.8 4.4 1.0 0.1 1.0 1.6 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 1.2 4.1 0.1 0.0 33.7 0.2 0.0 5.0 1.4 1.8 134.7 0.1 0.1 0.1 0.2 0.1 9.0 0.4 0.0 0.0 0.2 45.6 2.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.0 2.5 0.0 0.0 7.1 0.0 0.0 0.1 0.0 3.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 2.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 5.0 3.7 0.0 0.0 0.1 0.0 2.4 0.6 0.1 4.9 1.1 0.0 0.2 0.4 0.1 0.0 0.0 2.3 2.2 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.7 0.1 0.1 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 0.1 0.0 0.0 0.0 FBRSL1 KIAA1545 ENSG00000112787 "Fibrosin like 1" Q9HCM7 12 132489551-132585188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 34.7" "Low region specificity" "Detected in all" HPA049880 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA049880: AB_2680930" "unprognostic (2.02e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-2)" "unprognostic (7.75e-2)" "unprognostic (3.21e-1)" "unprognostic (2.59e-2)" "unprognostic (1.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-3)" "prognostic unfavorable (9.82e-4)" "prognostic favorable (1.17e-4)" "unprognostic (1.13e-1)" "unprognostic (3.39e-1)" "unprognostic (1.09e-2)" "prognostic favorable (7.21e-4)" 7.6 4.7 4.3 4.9 6.6 5.2 3.2 13.0 9.9 3.4 4.9 2.9 2.9 7.0 4.8 4.6 4.5 4.7 9.6 4.4 4.8 3.1 4.3 5.2 4.2 4.5 9.8 5.5 5.1 12.7 3.9 7.9 4.5 4.5 5.4 1.8 5.0 9.7 4.4 17.9 4.7 7.3 2.9 2.9 10.9 6.1 6.1 4.5 8.0 4.0 2.9 8.6 4.5 3.2 2.8 3.6 4.1 2.0 0.7 1.9 0.9 4.6 7.5 3.4 6.0 1.4 1.8 26.1 4.4 1.1 2.8 1.7 13.6 2.7 7.0 7.7 1.3 2.5 8.7 3.6 2.2 0.9 6.1 18.5 9.0 4.3 10.3 3.0 9.4 9.8 1.6 4.2 2.8 1.9 2.5 2.7 6.0 19.5 1.6 1.2 11.9 12.2 34.7 9.4 3.1 13.2 19.3 3.9 4.9 2.3 4.3 13.9 10.7 4.2 6.6 5.3 1.5 7.2 9.7 4.3 3.1 8.0 5.8 5.5 9.5 4.9 4.6 3.5 9.5 3.9 2.3 1.5 4.1 1.2 1.3 1.3 2.8 1.2 1.2 1.2 2.6 1.1 1.6 1.7 0.7 2.0 3.6 1.9 0.9 4.3 6.6 13.0 9.9 4.8 3.1 9.8 5.5 4.5 4.5 3.0 6.9 0.8 5.2 8.1 22.6 11.3 5.1 5.3 3.4 10.4 39.3 5.8 6.6 5.3 1.3 6.2 15.4 23.3 6.5 4.7 5.2 12.1 1.1 16.3 5.8 11.1 29.7 8.6 12.1 0.4 15.0 8.0 5.0 4.6 19.2 8.6 8.3 15.9 14.5 4.9 22.2 6.5 5.1 6.3 6.1 9.2 9.6 5.7 17.7 7.6 FBXL14 "Fbl14, MGC40195" ENSG00000171823 "F-box and leucine rich repeat protein 14" Q8N1E6 12 1565993-1594165 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Early spermatids: 38.0;Late spermatids: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053889 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA053889: AB_2682293" "unprognostic (8.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.82e-1)" "unprognostic (4.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.27e-1)" "unprognostic (5.90e-2)" "unprognostic (8.98e-2)" "prognostic favorable (9.04e-6)" "unprognostic (5.60e-3)" "unprognostic (1.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.12e-3)" 6.0 6.0 12.5 8.1 13.0 7.4 4.9 10.2 15.8 5.9 11.7 9.3 4.2 7.3 5.1 3.4 7.2 9.2 7.5 5.7 11.4 9.3 5.4 4.8 6.2 10.4 9.7 7.2 6.8 17.4 9.9 11.3 6.2 7.9 5.2 5.3 6.2 8.2 6.8 3.4 3.6 8.0 3.7 10.5 8.9 14.1 20.1 9.9 21.2 9.4 1.8 6.2 6.3 19.4 3.8 0.6 2.2 0.5 2.4 4.6 0.5 7.8 11.5 3.4 6.0 3.0 3.1 10.1 1.8 3.3 1.7 1.9 12.1 10.4 10.8 2.1 2.0 2.9 5.5 2.8 4.2 0.3 17.8 13.1 13.3 3.3 3.8 3.9 10.0 9.8 4.8 2.0 3.2 2.7 3.1 3.0 9.4 5.4 30.9 2.1 8.6 10.0 5.0 14.3 4.5 4.8 8.8 5.5 6.8 2.8 7.3 6.5 6.4 4.3 6.8 6.7 3.7 5.2 8.4 4.2 3.9 11.9 4.8 6.3 3.6 3.9 13.4 8.2 6.0 5.8 2.2 0.5 0.0 0.4 0.4 0.4 0.9 1.4 1.5 0.6 3.8 1.5 0.7 1.1 2.4 0.5 0.6 4.6 0.5 12.5 13.0 10.2 15.8 11.4 9.3 9.7 7.2 7.9 9.9 0.0 0.0 0.0 0.4 0.0 3.9 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 38.0 1.0 0.7 0.0 0.5 0.1 0.3 0.6 0.0 0.9 0.6 9.5 0.0 3.1 0.3 69.2 0.3 0.4 0.0 1.0 0.7 2.7 0.2 0.0 1.4 0.6 2.9 0.0 0.0 1.2 0.2 0.0 0.1 0.0 1.1 0.2 FBXL18 "Fbl18, FLJ11467" ENSG00000155034 "F-box and leucine rich repeat protein 18" Q96ME1 7 5431335-5513798 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036049 Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA036049: AB_2674918" "unprognostic (2.86e-3)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.26e-2)" "unprognostic (8.73e-3)" "unprognostic (1.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.98e-4)" "unprognostic (1.50e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-3)" "unprognostic (1.04e-2)" "unprognostic (3.69e-1)" "unprognostic (8.28e-4)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" "unprognostic (7.30e-4)" "unprognostic (1.73e-3)" 6.4 6.2 11.0 7.2 15.0 8.5 3.7 10.8 17.7 3.0 4.6 8.1 4.3 5.6 5.1 3.4 6.1 4.4 3.3 5.0 10.2 8.0 4.3 3.6 4.4 5.7 6.6 12.3 4.3 8.0 6.2 4.8 4.2 7.6 5.0 3.2 5.6 5.3 3.8 10.8 10.2 5.0 4.3 5.4 5.4 4.6 5.7 7.7 4.3 4.8 2.8 5.6 4.8 3.2 3.4 2.5 8.9 4.0 3.9 2.7 1.8 9.3 12.3 3.5 7.5 3.2 3.4 6.1 5.6 2.9 3.5 3.7 9.3 6.0 4.3 6.8 2.7 6.6 14.8 4.1 9.8 2.6 3.3 5.1 2.2 9.3 3.0 2.4 4.8 3.6 2.8 5.3 5.4 2.6 2.6 4.1 2.7 6.8 3.8 2.4 9.8 2.5 3.0 11.3 3.3 10.2 6.3 6.8 2.3 2.2 4.9 7.6 10.6 8.7 14.8 2.9 4.5 14.5 2.9 9.5 11.5 16.5 8.4 8.5 5.1 6.3 3.3 5.9 5.9 13.6 7.9 3.5 1.3 2.7 3.2 2.7 2.1 1.7 2.5 2.5 3.4 1.9 2.4 8.9 3.9 4.0 2.5 2.0 1.8 11.0 15.0 10.8 17.7 10.2 8.0 6.6 12.3 7.6 7.7 6.0 4.5 0.8 1.7 2.3 8.8 3.9 2.5 2.7 7.9 0.0 3.9 3.2 0.0 1.8 1.1 1.6 2.6 0.0 2.1 2.5 2.3 1.3 2.3 1.7 1.3 1.6 4.6 1.8 3.2 0.0 1.4 2.2 0.0 2.8 1.9 4.8 1.7 2.6 0.7 1.0 6.4 0.0 1.4 2.6 5.1 2.9 1.8 2.9 3.8 1.6 FBXL22 "Fbl22, FLJ39626" ENSG00000197361 "F-box and leucine rich repeat protein 22" Q6P050 15 63597353-63602428 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 65.9;smooth muscle: 68.0" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 10.5;Muller glia cells: 9.8;Peritubular cells: 10.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 8.0;SCLC-21H: 9.1;U-937: 5.7" "HPA047624, HPA054627" Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047624: AB_2680107, HPA054627: AB_2682548" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (3.03e-2)" "unprognostic (1.29e-2)" "unprognostic (1.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (1.07e-3)" "unprognostic (1.90e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" 1.9 0.4 0.4 5.5 0.4 0.0 1.1 0.6 0.7 31.4 26.0 0.0 20.8 1.4 65.9 7.6 11.9 10.5 31.1 10.3 0.4 0.4 0.6 0.4 0.7 0.2 0.4 0.3 7.1 0.4 0.0 0.4 1.0 0.2 20.1 2.9 1.9 3.3 24.0 2.2 0.7 4.1 68.0 0.4 0.4 6.3 4.2 0.0 0.0 0.6 1.0 0.4 38.2 4.8 1.5 4.3 0.5 0.2 2.0 2.9 0.5 1.2 2.2 0.3 1.3 0.7 0.9 0.1 0.4 0.1 0.5 0.0 1.4 1.6 0.5 1.1 0.2 0.8 1.3 0.7 0.4 0.0 1.3 0.9 0.4 1.5 3.5 0.2 0.5 0.2 0.5 0.3 0.1 0.7 0.1 0.2 3.7 0.0 1.9 0.0 8.0 1.2 1.0 2.5 1.3 0.8 1.1 0.0 3.9 0.3 0.4 9.1 0.3 1.1 1.8 0.3 0.0 3.2 0.9 1.3 0.6 1.8 0.8 0.4 1.2 2.0 1.3 0.9 5.7 1.3 0.4 0.1 0.0 1.2 0.1 1.6 1.5 1.3 1.4 0.0 1.2 2.9 1.0 0.5 2.0 0.2 4.3 0.1 0.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.3 0.2 0.0 0.0 0.0 2.2 1.7 0.1 10.5 7.2 5.1 0.0 1.2 7.0 3.9 0.6 8.3 0.9 0.6 0.6 1.3 0.0 1.0 0.7 0.6 1.4 0.0 3.6 0.7 0.0 4.7 5.5 1.5 0.2 0.3 0.4 0.0 0.0 5.6 9.8 0.6 3.5 10.6 2.1 2.5 0.0 1.3 3.9 3.4 0.6 0.5 0.5 3.6 0.5 FBXO10 FBX10 ENSG00000147912 "F-box protein 10" Q9UK96 9 37510892-37576349 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 30.0;Late spermatids: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.9" "Lineage enriched" "Detected in many" 5 "B-cells: 5.9" "Cell line enhanced" "Detected in many" "AF22: 18.0;HHSteC: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002863, HPA072721" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002863: AB_10965996, HPA072721: " "unprognostic (2.40e-1)" "unprognostic (2.43e-2)" "unprognostic (5.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.98e-1)" "unprognostic (3.44e-3)" "unprognostic (1.96e-2)" "unprognostic (1.80e-1)" "unprognostic (5.49e-2)" "unprognostic (9.84e-2)" "unprognostic (2.93e-5)" "unprognostic (1.91e-1)" "unprognostic (2.61e-2)" "unprognostic (2.08e-1)" "unprognostic (1.00e-1)" "unprognostic (2.74e-1)" "unprognostic (1.99e-1)" 3.8 7.5 4.8 7.5 8.3 1.2 3.4 4.4 12.1 3.6 6.7 4.9 6.3 2.8 5.0 16.9 4.7 2.8 4.5 4.3 6.3 5.9 3.9 4.0 3.5 7.7 4.0 6.7 3.1 7.4 6.4 20.8 3.1 3.9 4.0 2.9 5.3 15.0 5.2 27.0 2.9 4.8 5.0 3.1 10.1 3.6 12.2 3.3 2.9 11.7 6.0 7.7 4.5 2.9 5.9 0.8 0.0 0.2 0.2 1.1 0.5 1.6 4.1 18.0 4.6 8.4 3.0 1.4 3.2 5.6 3.9 5.9 2.3 1.1 10.5 1.1 3.3 1.6 0.1 6.5 1.5 2.9 5.8 5.2 2.1 3.8 2.0 25.8 5.5 0.7 6.9 1.2 3.5 2.3 2.6 5.5 1.0 7.2 2.9 6.9 1.4 2.1 1.8 8.3 2.4 1.5 4.1 7.9 1.3 2.2 1.1 3.8 9.6 2.0 2.5 2.2 5.5 1.0 5.7 4.3 2.8 4.9 2.5 2.2 3.6 2.8 1.7 2.4 2.2 2.6 0.0 0.1 0.0 0.7 0.2 0.7 5.9 1.1 0.7 0.0 3.2 0.1 0.1 0.0 0.2 0.2 0.8 0.2 0.5 4.8 8.3 4.4 12.1 6.3 5.9 4.0 6.7 3.9 3.3 0.0 0.6 6.1 0.1 0.2 3.3 1.4 0.0 1.4 0.0 1.8 3.9 0.3 0.0 1.2 30.0 0.6 0.0 0.0 1.3 0.7 0.6 0.6 0.0 0.9 3.2 3.2 5.2 6.7 0.3 29.3 0.9 0.0 1.7 1.0 0.5 1.5 1.4 0.0 1.4 1.3 0.9 0.0 0.9 3.1 1.9 0.5 0.2 0.0 0.3 0.3 FBXO16 FBX16 ENSG00000214050 "F-box protein 16" Q8IX29 8 28348287-28490318 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 22.9;pituitary gland: 42.3" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 26.8;Cone photoreceptor cells: 33.4;Rod photoreceptor cells: 42.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 8 "dendritic cells: 11.5" "Cell line enhanced" "Detected in many" "AF22: 15.7;Karpas-707: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058676, HPA076472" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Vesicles, Plasma membrane, Cytosol" "HPA058676: AB_2683795, HPA076472: " "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (3.37e-3)" "unprognostic (5.56e-3)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (2.55e-3)" "unprognostic (4.95e-3)" "unprognostic (6.49e-2)" "prognostic favorable (6.70e-5)" "unprognostic (3.41e-3)" "unprognostic (4.90e-2)" "unprognostic (7.15e-2)" "unprognostic (1.71e-2)" "unprognostic (4.85e-2)" "unprognostic (2.72e-2)" "unprognostic (2.07e-1)" 0.9 2.3 7.3 1.3 17.6 2.6 3.4 15.8 9.9 5.4 2.0 1.1 7.6 2.6 1.8 22.9 1.1 5.7 2.1 2.0 4.2 6.8 4.0 7.2 1.9 1.5 4.4 7.5 1.2 6.3 7.2 42.3 1.0 6.3 4.3 2.6 4.6 5.9 7.3 1.1 0.8 3.8 1.2 2.1 1.7 2.7 4.8 1.4 0.0 8.7 0.2 3.3 1.9 1.1 0.6 11.5 1.4 0.3 0.1 0.5 0.2 12.3 2.6 15.7 6.1 0.4 0.0 0.4 0.1 0.6 2.4 4.6 2.4 3.6 4.7 5.7 0.1 6.5 4.1 1.7 2.5 2.4 1.9 2.9 2.2 0.2 1.3 0.3 2.7 1.6 0.2 8.4 0.6 2.6 1.1 0.0 4.0 0.8 18.1 1.0 4.1 0.3 3.7 3.4 1.6 3.6 0.1 3.7 7.2 3.3 2.1 10.2 4.3 0.4 2.5 6.8 2.9 10.9 4.6 0.5 1.3 4.8 2.8 2.2 4.0 3.5 3.9 5.3 0.6 2.8 0.5 0.3 0.1 0.2 0.2 0.5 0.4 0.4 0.3 0.9 0.6 0.2 0.3 1.4 0.1 0.2 11.5 0.3 0.2 7.3 17.6 15.8 9.9 4.2 6.8 4.4 7.5 6.3 1.4 3.0 2.6 0.0 2.3 0.1 7.9 2.0 5.1 26.8 6.8 3.5 33.4 0.5 6.6 4.5 8.6 0.0 0.0 0.0 3.9 0.2 0.9 2.7 0.0 2.4 2.0 4.8 9.8 0.6 1.0 8.4 1.1 0.0 0.0 0.0 1.9 7.8 2.9 0.0 0.7 4.0 42.0 0.0 1.2 7.4 3.4 0.0 0.0 0.0 0.8 1.0 FBXO2 "Fbg1, Fbs1, FBX2, Nfb42, OCP1" ENSG00000116661 "F-box protein 2" Q9UK22 1 11637018-11655785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7;pancreas: 52.5" "Cell type enriched" "Detected in many" 5 "Exocrine glandular cells: 606.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 1.4;T-cells: 3.1" "Cell line enhanced" "Detected in some" "CACO-2: 21.1;HBEC3-KT: 18.5;Hep G2: 44.2;SiHa: 83.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005472 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA005472: AB_2667332" "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-1)" "unprognostic (8.13e-3)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.30e-2)" "unprognostic (1.18e-2)" "unprognostic (1.41e-1)" "unprognostic (5.44e-2)" "unprognostic (1.68e-2)" "prognostic favorable (3.45e-6)" "unprognostic (5.26e-2)" "unprognostic (5.21e-2)" "unprognostic (4.82e-2)" "unprognostic (1.64e-1)" 1.7 21.8 49.7 2.6 39.2 1.2 7.9 21.1 48.3 2.1 1.8 13.2 2.1 13.7 1.5 6.4 3.6 3.6 2.9 2.6 33.1 32.6 6.9 11.0 3.0 2.5 40.0 23.0 2.2 52.5 17.7 20.2 1.3 25.7 5.1 1.3 2.7 21.7 7.6 1.3 6.6 4.9 1.7 31.4 2.2 3.8 4.4 24.3 1.1 3.7 0.0 3.8 2.6 2.9 1.4 0.1 0.0 0.0 0.0 3.1 0.6 6.9 2.1 0.0 6.8 0.1 0.0 1.0 0.3 0.6 0.1 0.0 21.1 2.0 0.0 8.7 0.0 1.8 0.0 0.7 18.5 0.0 0.1 0.2 0.0 0.2 44.2 0.9 0.0 0.0 0.6 3.4 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.2 0.0 0.0 0.0 1.6 0.5 0.7 0.9 83.5 0.0 0.8 0.7 4.1 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.4 0.3 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 3.1 1.4 1.2 2.9 0.1 1.1 1.8 2.6 0.0 0.0 0.0 0.0 0.8 0.6 49.7 39.2 21.1 30.3 33.1 32.6 40.0 23.0 25.7 24.3 0.0 1.0 6.6 52.3 17.4 10.7 2.4 17.8 5.3 5.7 45.4 2.0 0.6 72.9 20.7 1.7 0.6 0.0 0.0 606.0 3.5 2.4 21.4 4.6 87.3 0.4 27.0 1.2 2.5 1.6 1.8 32.2 1.2 42.2 5.4 0.0 65.1 127.3 0.0 38.2 5.8 10.3 0.0 1.9 11.4 10.4 8.7 0.8 12.9 0.0 22.5 FBXO3 "FBA, FBX3" ENSG00000110429 "F-box protein 3" Q9UK99 11 33740939-33774543 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002467 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002467: AB_2666602" "unprognostic (1.87e-1)" "unprognostic (2.81e-1)" "unprognostic (6.07e-2)" "unprognostic (1.25e-1)" "unprognostic (3.71e-1)" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (8.53e-2)" "unprognostic (5.21e-2)" "unprognostic (2.42e-1)" "unprognostic (1.47e-1)" "unprognostic (7.36e-2)" "prognostic favorable (2.46e-9)" "unprognostic (6.96e-2)" "unprognostic (1.92e-1)" "unprognostic (1.27e-1)" "unprognostic (3.19e-2)" 18.2 16.0 18.4 8.7 33.9 14.1 17.4 27.7 30.3 16.1 13.3 17.1 11.5 11.2 16.4 15.8 21.1 15.0 13.5 28.1 17.3 19.3 29.3 25.3 12.2 10.3 15.2 15.4 18.8 16.5 35.9 21.8 15.3 27.8 16.6 15.0 16.7 17.0 16.9 67.6 18.4 16.3 19.0 12.4 12.6 14.6 15.1 15.2 18.6 21.6 24.2 16.6 15.9 16.6 11.1 8.4 13.0 9.2 15.7 22.8 10.4 11.5 10.4 14.1 15.0 17.1 13.5 8.5 13.8 13.9 11.3 14.1 11.8 11.7 7.7 9.8 15.0 13.9 20.1 18.8 18.3 18.9 7.7 26.1 3.9 16.3 9.6 10.9 9.1 9.3 13.6 18.6 7.7 12.4 16.5 14.8 5.7 13.4 15.5 12.6 7.8 6.7 5.3 7.1 26.2 16.0 5.2 31.6 10.9 16.3 14.7 20.0 11.0 19.6 13.5 10.1 14.2 19.5 7.0 13.5 14.0 12.3 19.7 11.6 8.7 11.3 13.1 12.5 7.1 13.7 13.0 7.8 11.1 15.1 7.5 16.6 10.9 17.9 17.0 8.4 11.1 22.8 15.9 8.4 15.7 9.2 4.3 21.4 10.4 18.4 33.9 27.7 30.3 17.3 19.3 15.2 15.4 27.8 15.2 32.8 15.0 18.2 54.0 43.4 58.2 36.0 12.7 33.5 18.2 24.4 25.5 19.9 48.0 41.8 83.0 29.3 20.5 0.0 22.0 24.3 25.4 28.3 16.1 34.2 10.5 54.0 23.0 30.1 12.0 42.2 27.6 14.1 27.0 9.0 18.0 50.1 28.5 19.9 25.5 47.3 42.8 58.2 31.1 51.9 29.8 59.0 30.6 33.2 16.2 46.2 FBXO31 "FBX14, Fbx31, FBXO14, MGC15419" ENSG00000103264 "F-box protein 31" Q5XUX0 16 87326987-87392142 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA030150 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA030150: AB_10670559" "unprognostic (4.85e-1)" "unprognostic (5.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.53e-2)" "unprognostic (4.04e-1)" "unprognostic (2.25e-1)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.16e-5)" "unprognostic (3.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.57e-3)" "unprognostic (2.26e-3)" 25.7 11.5 10.5 6.1 12.1 5.4 22.3 39.7 18.7 10.4 14.1 5.9 9.3 9.0 13.3 7.4 10.8 11.1 6.7 17.2 8.3 8.2 5.3 11.3 5.6 6.3 6.9 10.4 13.9 13.5 8.8 16.6 5.4 8.5 9.4 6.4 7.9 10.3 12.0 50.4 8.9 11.4 14.8 4.6 5.3 8.3 9.1 5.6 4.5 6.0 7.0 5.4 12.2 22.6 2.4 0.9 1.4 0.7 0.2 3.7 1.4 4.9 9.4 3.1 8.5 16.2 9.8 9.2 8.6 8.6 8.6 4.5 8.5 4.2 11.5 9.5 9.1 4.3 7.6 6.0 7.2 5.8 5.3 11.1 3.9 5.7 23.9 9.1 3.7 3.3 11.6 6.1 11.2 10.6 5.6 5.2 6.0 11.0 4.5 4.5 7.1 8.7 5.0 6.1 5.1 8.4 11.3 3.7 4.9 3.8 3.5 14.6 7.1 19.2 3.9 5.9 2.4 6.1 3.2 7.2 8.3 6.3 7.8 6.7 10.5 8.1 14.3 6.6 6.9 5.1 1.4 0.6 0.2 1.0 0.6 1.8 2.4 1.7 2.4 0.4 1.6 1.8 1.9 0.9 0.2 0.7 0.9 3.7 1.4 10.5 12.1 39.7 18.7 8.3 8.2 6.9 10.4 8.5 5.6 0.0 2.9 3.7 4.3 13.1 12.3 19.4 0.0 4.0 1.2 5.2 31.4 8.8 0.0 3.1 6.9 8.4 17.0 0.0 4.3 2.7 7.1 3.8 0.0 23.7 3.5 0.0 8.6 3.7 5.1 22.2 7.5 1.9 3.3 4.6 10.4 3.9 3.7 11.5 10.6 4.4 11.8 19.4 9.0 13.5 5.1 11.3 6.1 5.0 13.6 3.5 FBXO32 "ATROGIN1, Fbx32, MAFbx" ENSG00000156804 "F-box protein 32" Q969P5 8 123497889-123541206 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 200.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 172.4;Cardiomyocytes: 242.3;Glandular cells: 165.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5" "Group enriched" "Detected in many" 7 "granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6" "Cell line enhanced" "Detected in some" "GAMG: 17.4;HDLM-2: 59.1;hTERT-RPE1: 20.6;U-251 MG: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058955, HPA065209" Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA058955: , HPA065209: AB_2685433" "unprognostic (2.55e-1)" "unprognostic (3.62e-1)" "unprognostic (1.80e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (8.58e-3)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (7.97e-3)" 3.5 1.5 2.4 4.9 5.1 0.8 13.2 1.0 3.8 5.6 31.1 8.9 14.4 2.6 25.3 5.8 8.1 15.8 16.6 26.1 2.9 2.1 1.5 1.0 1.7 4.1 10.2 2.5 9.5 2.0 0.9 5.6 4.9 7.3 19.7 8.0 4.2 8.0 23.1 200.5 3.7 6.5 36.9 8.8 1.7 10.8 3.5 7.6 0.2 9.0 15.1 3.1 24.8 16.1 0.6 0.2 2.9 0.3 4.4 7.6 1.4 1.7 0.3 0.0 0.0 3.8 0.9 0.6 0.3 3.9 0.2 0.4 0.0 1.0 0.0 1.1 2.9 17.4 0.1 0.0 0.3 0.3 59.1 1.3 0.0 2.0 0.0 5.2 0.0 0.2 7.6 2.6 0.9 1.1 20.6 0.2 0.8 0.1 0.5 0.2 0.4 0.2 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.5 0.1 0.3 0.4 6.7 6.8 0.4 6.6 0.1 0.2 1.1 0.3 0.3 17.7 6.1 0.8 0.1 4.5 0.0 0.8 2.9 0.3 0.0 3.7 0.2 3.6 0.6 5.1 5.4 0.2 0.6 6.0 7.6 0.2 4.4 0.2 0.1 4.5 1.4 2.4 5.1 1.0 3.8 2.9 2.1 10.2 2.5 7.3 7.6 0.0 3.0 0.9 172.4 10.2 7.9 242.3 2.5 2.7 20.5 7.0 33.4 13.8 8.3 11.6 2.6 7.7 43.7 23.3 26.4 10.2 11.3 165.2 0.0 1.5 4.9 20.6 98.1 0.6 3.2 2.7 36.8 2.9 42.2 1.0 40.8 51.7 39.4 23.2 57.7 3.3 92.8 19.4 73.6 5.4 1.3 5.5 91.3 21.0 19.3 65.2 FBXO38 "Fbx38, FLJ13962, MOKA, SP329" ENSG00000145868 "F-box protein 38" Q6PIJ6 5 148383935-148442836 "Disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034821, HPA041444" Approved Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA034821: AB_10669897, HPA041444: AB_2677484" "unprognostic (7.72e-2)" "unprognostic (5.75e-3)" "unprognostic (1.95e-2)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.70e-2)" "unprognostic (7.06e-2)" "unprognostic (5.43e-3)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (2.03e-1)" "unprognostic (6.29e-2)" "unprognostic (2.21e-3)" "unprognostic (1.31e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (4.70e-3)" 23.2 19.3 13.8 17.7 21.2 12.6 20.6 20.8 21.1 22.3 18.4 20.0 20.4 13.8 25.2 18.2 17.6 16.7 16.9 24.1 18.8 13.8 19.2 25.7 20.7 19.0 16.3 18.8 19.2 16.9 29.2 34.1 19.7 24.6 22.2 19.3 16.4 19.4 18.7 28.5 19.3 18.4 18.2 17.8 24.8 18.8 20.0 18.9 26.9 18.1 17.1 21.7 21.7 18.0 5.5 8.1 13.7 14.8 8.0 7.9 4.9 8.6 9.2 14.3 10.4 16.1 18.2 7.5 11.3 21.6 16.1 22.1 13.5 10.6 12.5 11.1 18.2 17.0 12.1 14.9 14.2 19.4 13.7 9.6 7.4 13.5 9.1 16.1 20.0 12.2 17.5 12.2 15.4 15.2 17.2 21.6 11.7 8.2 13.6 15.7 3.5 12.6 9.5 6.7 9.6 14.0 11.3 20.9 12.5 15.6 10.1 12.8 12.5 15.0 10.1 14.5 12.8 10.6 14.6 14.0 14.7 5.3 7.7 12.5 16.7 16.8 10.7 14.6 11.5 11.1 13.7 6.3 9.0 5.9 8.6 6.3 5.5 5.5 5.7 8.1 4.8 5.7 7.2 12.0 8.0 14.8 3.9 7.9 4.9 13.8 21.2 20.8 21.1 18.8 13.8 16.3 18.8 24.6 18.9 14.9 40.8 7.0 5.2 3.0 9.8 16.2 7.6 16.0 10.3 10.4 9.8 6.2 5.0 7.4 7.9 6.7 8.0 0.0 5.8 5.5 6.0 8.8 15.1 17.3 11.1 12.7 9.2 13.5 25.7 2.1 8.3 15.0 3.3 4.6 9.8 5.6 8.7 8.6 17.3 7.5 9.2 0.0 4.7 22.1 7.5 3.3 10.3 6.9 9.1 7.1 FBXO41 "Fbx41, KIAA1940" ENSG00000163013 "F-box protein 41" Q8TF61 2 73254682-73284431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 10.8;Horizontal cells: 6.4;Intestinal endocrine cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055246, HPA058386" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA055246: AB_2682758, HPA058386: AB_2683701" "unprognostic (1.15e-3)" "unprognostic (9.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (5.76e-4)" "unprognostic (1.74e-2)" "unprognostic (5.85e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-1)" "unprognostic (7.97e-3)" "unprognostic (7.55e-2)" "unprognostic (9.13e-3)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-2)" 1.5 3.6 21.9 5.9 19.3 4.2 2.1 21.7 33.3 1.2 2.1 1.7 0.9 2.2 1.9 3.6 1.6 2.0 2.7 1.1 18.8 10.6 0.8 1.1 2.2 9.4 5.9 17.8 2.5 4.1 9.8 7.3 1.1 6.8 3.0 2.4 0.8 3.7 3.3 0.6 3.4 2.7 2.1 2.1 7.5 2.5 2.4 3.5 2.1 1.5 0.0 9.0 2.8 0.8 0.5 0.9 0.0 2.6 1.1 0.7 0.4 3.6 1.8 0.6 0.0 0.1 0.1 0.8 0.7 0.6 1.2 1.5 4.1 2.1 27.0 0.1 0.1 2.7 3.0 3.8 2.4 1.2 11.2 0.3 8.2 4.1 1.7 0.9 12.4 6.3 1.5 0.9 0.0 0.9 3.3 0.2 7.4 1.6 4.4 1.2 0.9 4.3 11.6 2.7 1.3 1.6 15.2 7.0 13.1 0.8 1.3 9.4 3.5 4.6 2.0 2.9 0.2 2.6 5.2 0.2 4.2 3.7 3.8 0.7 5.3 2.2 12.8 1.1 13.7 1.7 0.0 0.5 0.0 0.6 2.6 0.7 0.5 0.4 0.0 0.9 0.2 0.4 0.4 0.0 1.1 0.1 0.7 0.2 0.4 21.9 19.3 21.7 33.3 18.8 10.6 5.9 17.8 6.8 3.5 0.0 1.1 1.7 0.3 0.2 10.8 1.7 2.5 1.4 0.0 1.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.2 0.1 0.6 0.7 2.3 0.0 1.7 6.4 11.5 1.3 2.6 0.9 0.3 0.9 1.7 1.8 0.0 0.6 1.0 0.0 0.7 0.0 2.2 0.0 0.5 0.5 1.7 0.3 0.0 1.3 0.4 0.1 FBXO45 Fbx45 ENSG00000174013 "F-box protein 45" P0C2W1 3 196568611-196589059 "Predicted intracellular proteins" "Neurogenesis, Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040730 Uncertain Approved Cytosol NA NA Cytosol "HPA040730: AB_10959311" "unprognostic (7.17e-3)" "unprognostic (1.14e-1)" "unprognostic (8.37e-2)" "unprognostic (1.01e-2)" "unprognostic (8.14e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.61e-5)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.13e-2)" "unprognostic (9.48e-3)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.16e-5)" "prognostic unfavorable (4.93e-5)" "unprognostic (5.18e-2)" "unprognostic (1.66e-1)" "unprognostic (6.93e-2)" "unprognostic (1.65e-1)" 6.3 5.6 15.6 7.2 15.0 14.6 9.4 19.0 19.4 6.2 8.4 12.5 4.0 6.6 6.2 4.0 11.5 4.8 5.7 4.5 15.5 12.0 4.9 8.4 5.6 7.7 13.5 11.1 6.7 6.7 13.7 7.8 6.7 11.8 6.6 9.1 3.5 5.9 5.8 15.3 15.8 6.2 6.3 14.9 6.0 6.8 14.4 13.3 6.7 4.7 7.7 12.0 7.3 11.4 2.0 4.4 3.8 3.3 1.6 4.8 1.2 19.9 3.8 8.1 10.2 5.4 5.4 9.6 8.9 4.1 7.0 7.3 10.6 6.8 8.4 15.4 5.7 10.5 8.6 15.4 10.1 13.1 12.2 6.9 15.4 7.0 6.6 5.2 20.5 7.9 2.7 11.5 8.0 14.8 3.7 7.7 13.8 18.4 18.0 7.8 20.0 11.9 9.6 12.6 17.9 14.8 10.2 10.6 20.4 5.9 8.2 16.5 11.3 9.6 16.8 10.2 7.4 28.9 13.8 7.6 8.2 8.9 11.8 23.9 17.7 29.5 23.7 7.1 26.6 7.8 3.8 3.1 3.1 2.8 2.9 4.6 1.8 2.8 1.6 3.7 2.0 2.6 3.0 1.2 1.6 3.3 4.4 4.8 1.2 15.6 15.0 19.0 19.4 15.5 12.0 13.5 11.1 11.8 13.3 11.9 2.6 9.3 5.6 8.8 18.5 9.0 2.5 6.7 2.3 3.5 13.7 2.2 0.0 4.2 11.6 5.2 4.6 0.0 6.4 3.8 3.8 11.6 1.1 7.9 5.0 12.7 16.7 6.2 11.1 12.9 5.2 6.5 5.0 2.8 7.9 7.7 6.2 3.5 6.0 2.7 9.8 0.0 5.6 26.8 24.3 11.8 1.6 4.5 7.4 15.6 FBXO46 "20D7-FC4, Fbx46, FBXO34L" ENSG00000177051 "F-box protein 46" Q6PJ61 19 45710629-45730904 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049390 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA049390: AB_2680742" "unprognostic (9.02e-3)" "unprognostic (1.01e-2)" "unprognostic (2.82e-2)" "prognostic unfavorable (2.13e-5)" "unprognostic (9.33e-2)" "prognostic favorable (5.44e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.08e-1)" "unprognostic (2.06e-1)" "unprognostic (6.13e-2)" "prognostic favorable (8.11e-4)" "unprognostic (9.77e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (5.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (5.09e-6)" 7.4 7.4 13.8 12.9 13.1 10.4 9.8 10.4 15.7 11.2 10.3 8.6 10.6 9.6 15.7 10.0 20.7 10.7 7.3 8.7 13.3 4.8 7.6 10.5 7.7 17.2 13.9 10.1 17.1 12.6 8.4 10.4 12.3 10.2 10.1 9.7 8.6 11.0 9.0 12.8 12.8 11.4 10.9 9.7 15.8 13.3 11.5 13.0 13.6 12.8 9.2 17.1 10.0 12.4 5.9 2.6 7.1 2.3 1.1 3.7 1.2 7.0 11.0 8.5 9.9 2.2 4.0 9.7 3.7 2.1 2.9 3.4 9.1 9.3 12.3 5.0 2.0 4.2 10.3 6.3 4.7 2.2 15.1 13.3 10.0 37.1 4.9 3.3 4.4 12.9 3.3 4.3 5.0 3.1 7.5 4.4 15.3 7.8 15.0 2.4 6.7 10.2 5.1 5.4 6.6 3.8 13.8 4.7 11.4 3.5 8.5 8.5 7.5 5.9 12.5 4.9 8.5 10.6 5.5 4.9 6.3 5.7 3.4 6.0 14.4 19.9 8.2 7.0 6.2 5.1 7.1 2.3 2.3 3.7 1.8 2.5 4.0 2.8 2.5 1.5 5.9 2.6 3.0 6.7 1.1 2.1 2.6 2.6 1.2 13.8 13.1 10.4 15.7 13.3 4.8 13.9 10.1 10.2 13.0 8.9 4.5 6.0 9.3 23.1 2.8 4.5 7.6 5.3 4.5 7.0 2.0 7.1 1.7 5.5 2.3 4.5 10.4 0.0 4.2 13.6 3.8 7.1 3.5 16.3 3.1 11.1 7.0 4.9 4.3 2.2 5.2 3.6 5.0 3.6 11.7 4.0 5.8 11.8 1.8 1.7 2.7 0.0 3.9 6.0 3.8 31.2 10.4 4.8 8.6 9.6 FBXO7 "Fbx, FBX7, PARK15" ENSG00000100225 "F-box protein 7" Q9Y3I1 22 32474676-32498829 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Erythroid cells: 373.8;Late spermatids: 465.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032113, HPA032114, CAB034296" Uncertain Supported Nucleoplasm,Cytosol NA NA 430000 "Nucleoplasm, Cytosol" "CAB034296: AB_2102563, HPA032113: AB_2674156, HPA032114: AB_10696202" "unprognostic (3.99e-2)" "unprognostic (1.53e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.36e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-2)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.45e-2)" "unprognostic (2.28e-1)" "unprognostic (2.53e-1)" "prognostic favorable (2.66e-10)" "unprognostic (3.33e-2)" "unprognostic (1.65e-1)" "unprognostic (7.02e-2)" "unprognostic (1.79e-3)" 22.9 27.8 25.5 16.2 28.6 92.9 27.7 14.5 30.6 23.7 22.5 55.9 17.0 20.1 22.5 29.6 18.5 28.3 18.8 16.3 29.3 26.2 43.3 51.2 24.9 26.0 39.9 18.2 27.7 26.9 27.6 23.2 31.8 33.4 23.0 22.7 35.9 18.6 23.6 12.4 20.7 28.4 24.0 52.7 29.5 20.6 42.1 24.4 33.3 77.6 16.4 24.4 19.7 26.3 22.0 25.4 60.4 21.7 28.6 33.0 24.9 21.7 15.3 20.0 22.5 30.9 29.4 14.5 18.7 33.8 29.6 35.2 15.1 14.8 20.0 15.6 31.9 26.1 14.5 29.0 23.9 30.4 34.3 26.3 27.6 16.7 23.4 37.7 35.9 24.6 24.6 38.7 26.0 20.0 27.2 31.8 16.0 21.9 26.0 32.0 16.0 17.9 22.5 7.8 29.1 11.4 17.6 21.2 24.1 33.9 22.8 29.3 19.2 23.3 18.7 65.9 29.6 10.4 19.0 22.2 15.5 22.1 14.9 14.6 18.4 19.4 19.2 29.1 18.3 61.7 60.4 18.9 39.8 27.6 21.7 33.0 22.0 25.3 27.0 25.4 19.6 22.4 24.3 7.2 28.6 20.7 16.7 30.7 24.9 25.5 28.6 14.5 30.6 29.3 26.2 39.9 18.2 33.4 24.4 38.7 25.9 50.0 58.7 41.1 27.1 13.4 68.8 16.0 21.6 47.1 17.7 76.9 82.9 65.2 233.2 55.5 48.7 373.8 68.0 90.0 53.6 57.0 55.3 76.9 64.6 31.8 64.9 51.5 51.5 465.0 41.7 49.7 113.1 151.5 41.6 38.9 60.2 45.8 46.0 104.8 33.7 45.3 50.5 117.2 135.2 37.9 59.8 62.3 42.8 67.6 FBXO8 "FBS, FBX8" ENSG00000164117 "F-box protein 8" Q9NRD0 4 174236658-174284264 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002885 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002885: AB_1078835" "unprognostic (8.17e-2)" "unprognostic (6.59e-2)" "unprognostic (2.46e-1)" "unprognostic (3.18e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (7.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-2)" "unprognostic (3.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.25e-1)" "prognostic favorable (1.29e-7)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" 16.8 18.5 13.5 9.2 14.1 7.3 16.4 19.4 14.0 15.6 17.3 14.0 10.7 13.4 13.1 19.5 16.4 15.1 13.1 19.1 13.3 12.0 20.2 43.5 11.8 9.5 14.6 10.1 15.7 22.6 16.5 26.9 27.1 14.3 16.8 15.3 14.7 13.3 13.1 7.4 16.0 18.9 18.8 14.7 13.9 14.7 10.0 14.0 18.2 19.9 6.5 12.4 20.6 18.2 12.6 8.6 19.2 8.9 9.8 15.5 7.8 4.8 3.2 6.6 2.2 14.9 16.3 5.2 9.9 9.1 6.6 6.7 2.5 8.6 3.7 9.4 6.4 5.6 3.1 4.4 5.7 7.0 11.1 10.0 3.2 5.5 4.0 11.4 4.4 3.6 9.3 14.2 6.0 8.0 11.8 6.5 4.1 6.8 19.1 8.6 4.8 4.5 4.6 1.8 7.8 3.4 2.7 4.3 5.8 10.2 2.0 6.2 40.1 4.4 7.8 11.0 6.7 4.4 4.8 7.4 3.8 3.7 11.0 5.5 9.9 4.7 3.1 13.0 3.2 5.3 19.2 6.2 12.7 12.3 7.8 15.5 12.6 14.2 12.1 8.5 10.7 13.5 11.8 6.2 9.8 8.9 8.6 15.0 7.8 13.5 14.1 19.4 14.0 13.3 12.0 14.6 10.1 14.3 14.0 3.0 11.4 16.0 15.8 18.3 11.9 9.0 12.7 18.7 13.6 21.0 5.9 29.9 43.1 14.8 14.7 16.8 18.2 23.3 9.7 44.8 19.0 18.2 2.3 50.0 18.5 17.5 11.6 19.0 16.9 4.1 16.1 8.5 10.1 19.8 20.1 20.7 11.1 19.3 24.8 32.6 16.1 12.9 14.7 33.3 17.4 27.5 74.9 17.5 13.4 20.6 FBXW8 "FBW6, FBW8, FBX29, FBXO29" ENSG00000174989 "F-box and WD repeat domain containing 8" Q8N3Y1 12 116910956-117031148 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 45.5;Late spermatids: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038850, HPA038851" Supported Supported Cytosol NA NA Cytosol "HPA038850: AB_2676238, HPA038851: AB_10673479" "unprognostic (2.63e-2)" "unprognostic (1.13e-1)" "unprognostic (9.03e-2)" "unprognostic (1.48e-2)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (3.35e-2)" "unprognostic (2.17e-1)" "unprognostic (2.39e-2)" "unprognostic (4.30e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (6.20e-2)" "unprognostic (6.34e-2)" "unprognostic (2.55e-1)" 10.5 10.6 8.5 16.2 9.5 5.6 10.4 8.2 9.5 13.1 9.0 12.3 14.7 6.2 16.4 14.1 9.5 11.5 15.5 8.9 6.8 6.6 8.1 8.8 9.2 9.3 6.8 6.2 15.5 18.4 17.3 21.5 16.7 8.2 10.4 8.9 11.7 18.4 11.8 8.6 11.3 8.7 11.0 7.5 9.0 11.1 12.4 7.3 11.3 17.4 7.9 13.8 10.6 10.3 5.3 2.2 3.9 1.9 6.8 3.0 1.5 5.9 10.8 9.4 6.8 8.9 12.8 6.1 12.7 11.5 7.9 7.9 3.5 3.9 9.4 4.5 13.8 4.4 6.3 6.5 3.8 6.6 14.8 5.6 4.6 4.5 3.3 14.2 5.7 3.7 11.9 3.6 7.4 16.3 12.3 8.9 7.9 5.9 4.0 7.5 14.2 4.2 4.0 10.9 2.7 6.9 7.1 4.4 8.0 6.0 9.7 8.7 24.8 8.3 2.6 5.1 8.1 10.5 4.9 11.6 7.0 3.4 7.8 3.6 15.4 8.9 8.5 10.9 3.7 11.5 0.3 1.6 3.9 3.0 1.6 2.7 5.3 1.6 1.9 2.2 4.4 1.1 1.9 0.2 6.8 1.9 2.2 2.4 1.5 8.5 9.5 8.2 9.5 6.8 6.6 6.8 6.2 8.2 7.3 0.0 5.4 2.2 2.5 1.6 9.2 2.6 0.0 5.3 7.9 1.8 23.6 7.9 1.7 3.6 45.5 2.9 1.0 0.0 3.9 5.0 3.0 2.5 2.3 2.4 3.7 1.6 8.7 0.6 2.2 65.4 8.6 2.6 0.0 1.0 3.9 4.7 2.3 3.5 4.9 1.6 14.0 0.0 3.1 4.4 5.6 1.3 5.6 2.2 3.7 3.0 FBXW9 "Fbw9, MGC10870" ENSG00000132004 "F-box and WD repeat domain containing 9" Q5XUX1 19 12688053-12696643 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042087 Approved Approved Cytosol NA NA Cytosol "HPA042087: AB_10794168" "unprognostic (4.46e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-2)" "unprognostic (1.65e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-3)" "unprognostic (4.69e-3)" "unprognostic (4.91e-2)" "unprognostic (2.97e-2)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" "unprognostic (2.71e-2)" "unprognostic (4.02e-2)" "unprognostic (6.08e-3)" "unprognostic (8.04e-2)" "unprognostic (2.61e-1)" "unprognostic (8.42e-3)" 4.0 8.3 5.6 5.1 7.7 6.2 6.8 6.3 10.8 7.1 5.7 4.2 6.5 7.6 5.4 11.0 10.3 22.6 8.6 3.4 6.0 6.6 8.3 5.4 9.4 4.8 3.7 7.2 6.3 7.4 4.6 7.0 4.5 7.0 6.8 3.3 5.4 12.0 6.7 2.5 10.2 5.3 3.2 2.5 3.8 6.1 30.4 4.9 7.3 9.0 10.6 5.9 4.8 5.6 3.3 12.0 0.4 8.2 4.6 6.1 5.3 11.2 7.7 5.1 7.4 2.2 3.8 6.2 3.7 3.8 7.9 6.5 4.2 7.0 2.8 9.7 3.3 1.9 10.3 4.9 7.0 1.4 2.0 13.0 3.3 8.7 7.0 5.1 8.4 2.0 5.1 11.3 5.5 2.7 4.8 6.2 6.6 8.0 1.9 1.8 23.5 9.0 10.9 8.6 6.0 7.3 4.8 3.5 15.8 7.0 3.4 11.8 14.0 5.5 11.7 5.1 1.7 11.6 6.3 3.0 4.7 4.4 5.7 5.8 11.7 4.9 3.0 5.8 3.1 3.0 0.0 8.2 0.0 3.2 7.8 5.3 3.3 3.5 2.4 12.0 3.2 3.3 2.3 0.4 4.6 5.1 3.4 6.1 5.3 5.6 7.7 6.3 10.8 6.0 6.6 3.7 7.2 7.0 4.9 3.0 4.8 0.0 4.5 5.4 2.2 0.8 5.1 50.9 10.3 1.8 5.9 12.6 5.0 12.5 3.9 3.6 3.6 0.0 13.9 6.5 4.7 2.7 0.0 3.2 6.1 0.0 4.6 6.7 5.0 7.4 2.3 3.3 3.3 3.6 8.1 4.7 8.9 3.5 4.2 12.4 5.7 6.5 2.2 25.0 15.7 7.2 5.4 3.5 11.1 4.3 FCHO1 KIAA0290 ENSG00000130475 "FCH domain only 1" O14526 19 17747718-17788568 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4" "Cell type enhanced" "Detected in many" 6 "B-cells: 10.4;granulocytes: 9.2;Kupffer cells: 12.6;Macrophages: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 28.2;RPMI-8226: 19.4;U-937: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041653, HPA062981" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041653: AB_10795641, HPA062981: AB_2684915" "unprognostic (3.02e-1)" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (4.54e-3)" "unprognostic (3.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (5.48e-3)" "unprognostic (1.72e-9)" "unprognostic (3.76e-3)" "unprognostic (1.18e-1)" "unprognostic (2.21e-1)" "unprognostic (9.77e-3)" 2.2 2.3 13.6 13.7 18.9 18.9 1.9 11.4 15.2 1.1 2.7 30.2 0.0 3.7 1.8 1.8 1.5 1.9 4.5 1.1 17.8 11.7 1.0 2.7 3.4 22.6 23.0 10.0 2.2 0.9 0.8 2.6 1.4 10.8 1.4 2.6 0.6 2.7 1.2 0.9 13.4 4.0 2.1 15.9 13.7 3.5 4.3 23.3 16.4 1.2 0.0 17.3 5.1 1.0 9.9 10.4 25.7 9.5 4.1 5.7 4.4 0.4 5.4 3.5 2.5 0.1 0.1 3.5 0.5 0.1 0.1 0.2 0.7 0.6 28.2 8.1 0.2 0.6 1.1 1.7 1.0 0.1 12.4 0.9 2.2 0.7 2.8 0.3 6.9 4.8 0.0 0.1 0.1 0.2 0.2 0.7 14.0 11.0 13.5 0.0 7.8 16.0 12.5 1.7 6.6 13.4 13.6 0.1 19.4 0.1 0.5 0.6 1.3 0.1 2.8 0.4 0.4 2.7 7.0 0.5 0.1 2.0 0.5 0.2 8.6 3.9 15.2 0.4 17.4 0.3 6.9 6.6 6.5 5.2 9.5 4.5 8.8 5.7 4.5 9.7 9.9 5.5 4.4 25.7 4.1 7.2 10.4 5.2 4.4 13.6 18.9 11.4 15.2 17.8 11.7 23.0 10.0 10.8 23.3 0.0 1.0 10.4 0.4 0.0 6.7 0.8 2.5 0.0 0.0 1.8 0.0 2.7 0.0 0.4 1.0 0.8 0.8 0.0 0.0 3.7 0.4 0.2 9.2 0.0 6.5 0.0 1.2 3.7 12.6 0.0 2.3 11.9 1.7 4.6 1.4 0.2 1.4 0.0 8.1 0.0 0.7 0.0 0.4 0.7 1.7 0.5 0.7 5.4 1.0 0.1 FCHO2 ENSG00000157107 "FCH domain only 2" Q0JRZ9 5 72955981-73090522 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.9" "Group enriched" "Detected in many" 8 "granulocytes: 15.9;monocytes: 4.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037685, HPA037686, HPA077850" Enhanced Approved Vesicles,Centrosome,Cytosol NA NA Centrosome "Vesicles, Cytosol" "HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: AB_2686860" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "unprognostic (1.01e-2)" "unprognostic (1.10e-1)" "unprognostic (6.59e-2)" "unprognostic (2.68e-3)" "unprognostic (4.99e-2)" "unprognostic (6.25e-2)" "unprognostic (1.31e-1)" "unprognostic (5.67e-2)" "unprognostic (6.56e-3)" "unprognostic (1.21e-1)" "prognostic favorable (7.00e-5)" "unprognostic (1.43e-1)" "unprognostic (3.27e-3)" "unprognostic (9.59e-2)" "unprognostic (1.76e-1)" 32.2 9.6 10.7 10.0 12.2 8.3 18.0 23.1 18.3 16.2 18.3 8.9 15.3 15.5 23.7 13.0 30.2 14.6 15.7 12.5 11.2 7.0 18.6 16.0 22.8 18.5 10.8 9.5 16.1 11.1 17.5 11.4 19.2 10.9 12.6 16.1 9.9 17.1 12.6 17.7 15.2 20.8 16.6 11.9 18.9 12.2 10.5 12.4 3.2 22.4 11.7 11.8 14.6 22.5 0.7 1.1 15.9 4.5 0.7 1.3 0.5 9.0 7.4 7.1 6.2 10.0 13.3 20.9 8.0 11.9 6.1 9.6 3.7 15.9 2.2 11.2 11.1 11.4 6.9 6.0 14.1 8.3 2.3 7.0 4.4 6.1 4.6 5.0 0.9 4.6 8.9 7.3 8.1 13.1 13.9 13.8 2.2 5.0 3.9 12.5 4.2 0.0 4.4 2.2 1.8 3.7 2.0 6.9 2.6 14.8 12.9 2.8 4.5 11.0 7.8 5.0 10.5 9.5 6.3 14.3 8.0 3.8 8.8 5.6 1.4 2.5 0.4 5.2 0.6 9.7 11.5 2.6 6.4 1.3 3.5 0.8 0.3 0.4 0.5 1.1 0.7 0.2 0.4 15.9 0.7 4.5 0.4 0.3 0.5 10.7 12.2 23.1 18.3 11.2 7.0 10.8 9.5 10.9 12.4 53.6 34.0 1.5 11.1 9.3 10.4 13.3 17.8 24.1 25.0 33.2 3.9 12.1 11.6 13.9 1.6 27.0 19.3 0.0 15.2 6.9 12.1 18.9 17.4 9.6 18.4 11.1 14.3 62.0 68.1 1.4 12.4 21.1 15.1 10.0 13.0 16.7 22.5 21.6 13.1 17.0 8.9 25.8 11.4 11.6 13.8 13.4 11.4 4.3 12.4 29.3 FCHSD1 FLJ00007 ENSG00000197948 "FCH and double SH3 domains 1" Q86WN1 5 141639302-141651419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043795 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043795: AB_10963435" "prognostic favorable (8.62e-4)" "unprognostic (4.08e-2)" "unprognostic (6.17e-2)" "unprognostic (5.28e-2)" "unprognostic (3.50e-3)" "unprognostic (8.56e-3)" "unprognostic (5.34e-2)" "unprognostic (9.61e-3)" "unprognostic (2.17e-2)" "unprognostic (2.66e-2)" "unprognostic (1.88e-3)" "unprognostic (1.50e-2)" "prognostic unfavorable (6.19e-6)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.77e-4)" "unprognostic (4.12e-3)" "prognostic favorable (1.21e-4)" 7.5 6.6 9.2 16.1 14.1 15.2 8.6 3.0 12.5 11.7 9.9 11.1 4.9 9.7 12.5 8.6 8.6 8.5 13.7 5.4 8.8 6.6 6.8 2.9 9.6 18.6 18.8 4.3 17.7 7.5 23.8 12.6 7.9 14.5 10.0 4.8 5.6 10.3 6.1 2.6 18.5 15.3 8.8 14.5 18.4 10.5 7.4 15.4 7.4 10.6 8.8 23.2 12.1 13.8 5.3 1.9 9.8 3.0 2.3 7.2 2.9 7.3 4.6 6.3 13.1 5.3 6.8 11.0 16.0 8.2 14.4 22.7 8.7 15.8 3.1 8.0 12.3 2.3 4.2 2.0 8.8 6.5 13.0 3.4 6.4 6.2 3.1 4.1 2.0 21.9 8.3 7.1 11.3 3.7 12.2 8.2 0.2 4.0 5.8 1.6 6.5 1.6 3.9 1.8 2.6 4.3 0.0 0.0 2.9 4.9 11.0 0.7 7.1 0.3 6.0 9.1 5.0 7.3 6.1 16.6 0.2 4.0 5.8 6.6 7.0 2.3 1.6 12.6 7.3 6.9 6.3 1.7 5.6 7.0 2.0 5.2 5.3 3.8 7.2 1.9 3.0 3.6 4.9 9.8 2.3 3.0 1.7 5.0 2.9 9.2 14.1 3.0 12.5 8.8 6.6 18.8 4.3 14.5 15.4 0.0 2.1 9.0 3.2 2.4 4.3 0.4 5.1 1.4 2.3 3.5 11.8 0.8 0.0 4.0 6.4 2.9 4.1 0.0 5.7 3.8 3.5 3.0 9.2 0.8 4.7 50.9 4.1 2.5 2.2 4.3 3.7 3.3 3.3 1.8 4.4 1.9 5.6 3.4 3.5 0.3 1.1 6.5 3.1 1.8 3.9 2.5 1.1 10.5 2.4 2.0 FCMR "FAIM3, TOSO" ENSG00000162894 "Fc fragment of IgM receptor" O60667 1 206904386-206923247 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9" "Group enriched" "Detected in many" 11 "B-cells: 125.3;T-cells: 41.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 99.6;T-cells: 60.0" "Group enriched" "Detected in some" 5 "RPMI-8226: 53.0;U-266/70: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA003910 Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 2400000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA003910: AB_1078798" "prognostic favorable (4.23e-4)" "unprognostic (1.16e-3)" "unprognostic (7.48e-2)" "unprognostic (3.06e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-3)" "unprognostic (1.15e-1)" "unprognostic (4.85e-3)" "unprognostic (1.03e-1)" "unprognostic (3.97e-1)" "unprognostic (3.23e-2)" "unprognostic (2.01e-1)" "unprognostic (8.15e-3)" "unprognostic (8.06e-2)" "unprognostic (2.12e-2)" "unprognostic (3.74e-2)" "unprognostic (5.05e-3)" 15.5 0.6 0.5 42.9 0.5 2.9 1.5 0.4 0.4 0.8 2.5 0.4 0.3 1.2 1.2 0.8 3.4 1.3 2.6 1.0 0.5 0.5 2.4 1.5 3.9 77.2 0.5 0.0 1.3 0.7 0.0 0.9 0.8 0.2 1.4 2.3 1.3 10.1 0.3 1.9 0.6 30.1 0.4 0.6 78.8 2.8 0.5 0.0 51.8 1.8 1.2 84.9 8.5 1.2 99.6 1.4 5.3 0.4 18.4 60.0 28.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.1 0.0 0.0 3.4 0.0 0.1 0.3 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 2.7 0.0 7.4 0.0 0.1 1.0 0.1 0.0 0.0 0.0 1.7 0.2 53.0 0.0 0.1 0.0 0.0 1.0 0.2 5.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 26.7 1.9 7.4 0.3 0.0 0.2 0.5 0.2 0.2 20.3 0.4 26.4 80.3 28.1 26.2 0.2 99.6 49.5 33.3 5.3 18.4 0.3 1.4 60.0 28.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.2 0.0 0.0 4.6 125.3 3.9 0.0 0.0 3.0 7.6 1.4 2.3 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 2.6 0.1 0.6 2.6 0.0 1.1 3.8 0.0 0.0 5.5 5.1 0.0 0.3 1.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.3 0.1 1.0 0.0 0.0 41.7 1.2 7.1 FCRLB "FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2" ENSG00000162746 "Fc receptor like B" Q6BAA4 1 161721563-161728143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.9;lymphoid tissue: 5.0" "Cell type enhanced" "Detected in many" 8 "Ito cells: 6.7;Proximal tubular cells: 10.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 7.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "basophil: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.1;Daudi: 7.4;fHDF/TERT166: 10.9;HMC-1: 9.4;PC-3: 5.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB026139 Uncertain Supported Cytosol "Intracellular and membrane" NA NA Cytosol "CAB026139: " "unprognostic (1.87e-1)" "unprognostic (1.20e-4)" "unprognostic (5.77e-3)" "unprognostic (7.49e-3)" "unprognostic (1.73e-3)" "unprognostic (2.95e-1)" "unprognostic (2.98e-2)" "unprognostic (1.18e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.60e-1)" "unprognostic (1.22e-2)" "unprognostic (2.25e-3)" "unprognostic (1.27e-1)" "unprognostic (9.92e-3)" "unprognostic (3.14e-2)" 0.5 0.2 0.2 3.4 0.3 0.0 0.3 1.0 0.8 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.2 1.4 0.6 0.3 2.4 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 1.2 0.0 0.2 0.7 2.7 0.2 0.3 0.8 0.2 0.4 1.5 0.2 0.2 0.2 0.2 0.3 0.2 5.0 0.8 0.2 4.9 0.6 8.9 0.2 5.3 2.7 0.6 0.7 0.1 0.0 0.3 0.5 0.8 0.0 4.6 6.1 1.5 1.5 0.1 0.2 7.4 0.2 10.9 0.3 0.1 0.2 0.4 4.0 0.1 0.3 0.2 0.1 0.2 0.2 0.0 9.4 1.4 0.0 2.7 0.2 0.5 1.3 0.0 0.4 0.3 0.2 0.4 0.0 2.6 0.2 0.0 5.5 0.0 0.5 0.3 0.2 0.2 0.0 0.0 0.0 0.2 2.3 0.3 0.0 0.0 0.8 1.6 0.7 1.7 0.8 0.0 0.0 2.9 3.3 0.4 0.8 8.9 0.1 2.4 2.7 0.1 1.0 4.6 1.6 1.5 0.6 4.9 0.8 1.2 1.5 5.3 0.2 0.0 0.0 0.6 0.2 0.3 1.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 2.2 1.0 1.0 0.0 1.6 0.0 0.0 0.0 3.5 0.0 1.8 5.0 1.1 0.1 1.1 0.0 0.0 1.0 4.6 0.7 0.4 0.0 0.8 1.3 0.0 1.2 6.7 2.4 0.0 0.0 2.3 1.7 0.0 0.0 3.1 0.9 0.0 0.4 10.5 0.4 0.0 1.4 2.7 1.2 0.4 0.7 2.2 0.0 0.7 FDPS ENSG00000160752 "Farnesyl diphosphate synthase" P14324 1 155308748-155320666 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 149.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028200 Approved Approved Nucleoplasm,Cytosol NA NA 2000000 Cytosol Nucleoplasm "HPA028200: AB_10612109" "unprognostic (1.23e-1)" "unprognostic (8.46e-3)" "unprognostic (2.47e-2)" "unprognostic (6.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (7.35e-4)" "unprognostic (4.21e-2)" "unprognostic (6.78e-3)" "unprognostic (1.64e-3)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (1.11e-2)" "unprognostic (8.25e-2)" "unprognostic (2.07e-1)" "unprognostic (5.65e-2)" "unprognostic (8.44e-2)" 21.0 57.8 19.3 17.6 26.5 16.5 19.8 12.8 32.2 19.0 25.0 22.6 14.5 45.9 18.0 21.7 41.4 16.7 18.8 19.6 18.6 23.4 23.7 100.8 25.7 19.2 19.5 24.3 15.2 27.5 15.6 12.3 20.2 47.3 16.5 29.7 20.5 29.2 12.9 15.7 29.3 32.3 18.9 23.0 17.7 23.4 15.1 16.5 25.1 19.5 41.7 27.3 13.7 20.8 41.1 39.7 49.4 37.1 45.3 45.5 48.3 36.0 19.6 72.1 26.0 16.9 62.0 25.7 17.2 34.1 27.5 44.8 31.7 85.9 27.5 41.9 15.0 65.7 40.3 42.9 149.6 25.8 15.0 30.7 15.9 35.0 38.3 27.8 25.8 18.3 44.1 23.7 43.7 22.0 12.5 47.9 40.8 28.5 74.2 28.6 38.7 33.0 25.1 43.3 26.8 28.7 28.5 31.3 76.3 72.5 24.1 28.1 24.0 17.7 32.3 29.7 42.9 23.3 70.2 34.8 15.4 18.9 9.5 31.4 31.5 24.2 49.1 15.0 27.6 24.2 30.5 36.0 49.4 39.4 37.1 35.0 41.1 34.8 39.8 39.7 34.2 31.5 39.3 16.5 45.3 27.2 31.4 45.5 48.3 19.3 26.5 12.8 32.2 18.6 23.4 19.5 24.3 47.3 16.5 68.5 144.0 64.8 78.5 32.6 65.5 1.4 107.0 85.6 83.0 50.6 58.9 177.4 116.0 154.2 171.3 113.0 197.2 93.5 286.2 162.6 57.3 89.5 62.2 111.9 95.6 52.4 68.5 133.8 57.6 52.3 56.4 56.4 91.1 217.4 74.5 75.0 194.9 143.8 66.1 113.5 78.0 71.1 63.8 41.9 15.5 52.2 120.0 77.8 106.3 110.3 FDXACB1 "hCG_2033039, LOC91893" ENSG00000255561 "Ferredoxin-fold anticodon binding domain containing 1" Q9BRP7 11 111874056-111881243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 35.1;Late spermatids: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039012, HPA061375" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039012: AB_10670916, HPA061375: " "unprognostic (2.91e-2)" "unprognostic (3.32e-3)" "unprognostic (1.32e-2)" "unprognostic (6.81e-7)" "unprognostic (1.32e-1)" "unprognostic (9.64e-2)" "unprognostic (2.05e-1)" "unprognostic (7.11e-3)" "unprognostic (3.95e-2)" "unprognostic (7.42e-2)" "unprognostic (3.67e-1)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (6.57e-2)" "unprognostic (4.42e-1)" "unprognostic (4.61e-2)" "unprognostic (1.79e-2)" 3.7 6.7 4.4 6.2 5.2 4.0 5.8 2.2 6.1 4.4 3.2 4.7 3.1 4.0 3.9 6.0 3.9 3.7 5.0 2.8 6.6 4.7 3.4 4.3 5.2 8.5 3.6 3.4 4.3 5.1 5.3 3.6 3.0 5.2 3.4 4.2 4.1 6.2 2.2 1.6 6.6 4.3 3.0 5.3 7.6 3.2 11.1 4.0 11.2 3.4 2.6 7.9 4.2 2.7 6.5 4.8 1.8 4.6 5.6 10.4 4.5 1.6 2.1 3.0 6.0 2.3 2.0 1.4 1.2 1.3 1.3 1.6 2.6 3.6 5.9 3.3 1.1 2.2 4.8 2.8 2.7 2.9 7.4 1.3 6.7 1.1 2.1 1.3 6.7 6.0 1.7 1.6 1.9 2.4 1.2 2.3 7.5 4.6 7.9 2.5 2.2 6.4 6.5 1.6 6.6 3.1 4.0 1.9 7.2 3.0 2.9 1.4 2.0 1.8 3.6 1.8 1.9 5.1 4.1 1.8 3.2 3.2 3.6 2.9 4.0 5.8 16.0 1.8 9.9 4.2 0.2 3.2 1.8 6.8 4.6 9.0 6.5 6.1 6.2 4.8 5.2 9.4 10.4 0.9 5.6 3.8 4.6 3.2 4.5 4.4 5.2 2.2 6.1 6.6 4.7 3.6 3.4 5.2 4.0 6.0 1.1 5.4 1.1 0.7 3.2 1.2 0.0 1.4 2.3 0.0 0.0 2.7 5.0 1.7 35.1 1.4 0.7 0.0 2.9 1.8 1.4 1.4 1.1 1.3 3.7 1.6 2.4 1.3 1.0 12.1 2.8 2.7 0.0 2.8 1.1 3.2 1.9 0.0 0.4 2.0 2.1 6.5 0.9 6.5 8.6 1.1 1.8 1.9 1.8 0.9 FEM1A ENSG00000141965 "Fem-1 homolog A" Q9BSK4 19 4791681-4801273 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 103.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016565, HPA063622" Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA016565: AB_1848489, HPA063622: AB_2685063" "unprognostic (4.62e-2)" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" "unprognostic (3.60e-1)" "unprognostic (2.42e-3)" "unprognostic (2.04e-1)" "unprognostic (6.74e-2)" "unprognostic (1.25e-2)" "unprognostic (9.21e-2)" "unprognostic (2.28e-3)" "unprognostic (6.25e-2)" "unprognostic (6.18e-5)" "unprognostic (3.72e-3)" "unprognostic (1.25e-1)" "unprognostic (1.91e-1)" "unprognostic (4.70e-2)" 3.0 2.4 3.3 2.2 4.4 3.3 4.0 4.1 5.0 2.0 2.7 3.0 0.9 2.2 2.7 4.0 4.2 2.1 1.9 8.6 3.3 2.6 2.2 4.4 2.3 3.8 3.2 2.5 2.1 4.2 4.4 2.3 4.5 3.1 2.8 2.0 2.7 3.1 2.1 103.9 6.9 2.3 2.3 2.2 2.7 2.2 2.2 3.2 4.2 2.1 18.6 3.0 2.5 2.3 7.2 6.8 9.1 8.2 6.8 6.9 4.2 7.2 5.0 4.7 10.1 5.2 3.1 6.8 4.3 3.6 7.0 4.9 7.8 3.3 8.2 4.4 5.3 3.8 7.5 8.2 7.2 4.6 9.7 9.4 8.0 4.0 5.8 7.9 13.2 10.3 4.5 11.1 5.4 7.8 3.3 5.0 11.3 11.7 15.8 4.8 7.3 11.0 4.8 14.4 4.5 12.1 10.3 6.1 8.6 6.3 9.3 15.2 10.8 5.7 10.8 8.1 3.8 8.3 11.5 7.0 6.4 4.6 10.0 11.4 18.4 15.2 7.1 6.6 9.5 9.0 9.1 7.3 7.1 6.9 8.2 6.0 5.3 5.5 6.3 6.8 7.2 5.0 5.7 6.6 6.8 7.3 6.6 3.9 4.2 3.3 4.4 4.1 5.0 3.3 2.6 3.2 2.5 3.1 3.2 23.8 42.3 20.9 12.5 17.9 16.3 5.6 7.6 16.0 21.6 1.8 15.7 18.1 11.6 9.6 4.0 8.8 10.0 23.3 10.1 12.1 7.1 11.5 22.0 13.9 11.0 11.1 12.6 14.1 17.0 2.7 8.3 8.1 3.3 15.4 14.8 11.4 9.9 7.0 7.8 7.9 17.0 6.5 10.3 12.1 5.7 25.7 22.7 12.1 11.9 15.0 FEM1B ENSG00000169018 "Fem-1 homolog B" Q9UK73 15 68277803-68295865 "Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 706.2;Late spermatids: 207.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041920, HPA042192" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041920: AB_10796788, HPA042192: AB_10796574" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.27e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-1)" "unprognostic (6.84e-2)" "unprognostic (1.89e-2)" "unprognostic (3.49e-3)" "unprognostic (1.35e-1)" "unprognostic (2.89e-2)" "unprognostic (4.67e-2)" 13.4 10.5 13.1 11.2 17.0 38.1 17.7 23.0 22.9 14.8 14.6 14.1 13.6 11.1 23.2 12.6 18.5 14.1 11.1 16.9 13.7 13.7 10.4 14.6 11.9 14.2 17.8 16.1 17.4 8.5 14.0 12.9 13.7 17.2 15.0 12.4 12.4 12.3 16.6 42.9 18.7 14.2 22.3 14.3 11.9 10.4 55.4 15.4 12.9 12.9 11.4 13.1 18.7 17.8 4.4 4.4 4.0 7.9 6.5 6.9 3.0 7.3 13.5 14.0 13.1 12.7 11.8 9.3 10.5 11.0 10.8 10.0 9.1 9.9 16.9 7.7 14.2 7.8 26.8 29.0 13.3 9.1 8.0 11.5 18.6 16.0 5.7 11.0 15.1 11.6 10.8 29.1 13.1 31.9 15.6 8.5 8.7 15.5 20.8 9.2 8.6 10.8 7.7 14.2 5.9 4.3 15.7 15.8 21.8 6.9 26.7 18.8 11.9 10.8 11.3 29.1 18.5 10.1 14.1 11.0 19.0 16.7 6.5 9.6 13.6 29.2 18.1 10.8 16.5 11.2 0.0 5.1 3.6 5.7 7.9 5.8 3.7 5.7 6.2 4.4 4.4 6.9 5.0 4.0 6.5 6.3 3.2 3.0 3.0 13.1 17.0 23.0 22.9 13.7 13.7 17.8 16.1 17.2 15.4 20.8 27.8 14.9 44.9 87.6 31.7 35.5 22.9 22.7 17.0 17.4 11.8 13.5 0.0 20.6 706.2 21.1 16.7 0.0 10.4 10.3 23.6 28.1 13.9 27.9 26.6 36.5 19.1 17.2 24.2 207.4 22.7 15.0 38.8 8.2 24.3 16.3 15.2 17.5 26.2 10.5 12.7 25.8 30.9 16.5 6.1 97.2 14.1 11.7 17.4 48.2 FER "PPP1R74, TYK3" ENSG00000151422 "FER tyrosine kinase" P16591 5 108747822-109196841 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 123.9;granulocytes: 91.4;Late spermatids: 142.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "RPMI-8226: 45.1" "Low region specificity" "Detected in all" "HPA007641, CAB022464" Approved Supported Cytosol NA NA Cytosol "CAB022464: , HPA007641: AB_1078845" "unprognostic (1.72e-1)" "unprognostic (1.66e-2)" "unprognostic (1.74e-1)" "unprognostic (2.46e-3)" "unprognostic (4.72e-2)" "unprognostic (5.65e-2)" "unprognostic (6.81e-2)" "unprognostic (7.39e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-3)" "unprognostic (7.36e-2)" "unprognostic (8.05e-2)" "prognostic favorable (5.55e-4)" "unprognostic (3.83e-3)" "unprognostic (3.22e-1)" "unprognostic (1.03e-1)" "unprognostic (3.99e-3)" 13.4 5.7 5.5 6.1 13.4 1.8 5.2 6.0 5.0 9.7 6.7 1.4 16.8 2.5 6.5 19.3 8.2 4.6 5.3 4.6 4.8 4.8 7.2 3.6 12.2 1.9 4.9 2.2 7.2 3.0 18.5 15.9 5.7 3.1 6.8 3.6 5.0 4.5 21.9 5.0 6.6 3.5 7.2 6.2 8.1 4.1 15.9 2.6 3.9 10.2 12.8 2.8 7.7 9.0 10.5 5.4 8.0 5.1 1.2 2.8 1.1 4.7 1.6 5.8 9.2 3.5 5.4 3.7 5.7 5.6 3.4 4.0 9.7 2.9 7.6 3.6 6.9 4.3 3.4 3.1 7.2 7.6 3.2 4.2 5.1 7.4 3.5 2.3 2.7 4.3 3.2 4.0 8.1 9.2 3.4 5.0 7.4 6.3 5.7 4.3 1.3 2.1 0.8 0.8 0.4 3.4 1.7 5.6 45.1 3.3 1.6 1.9 2.8 9.4 0.5 6.1 3.8 2.2 1.2 7.3 6.5 5.0 3.3 4.5 4.8 7.2 3.0 4.1 0.9 3.0 8.0 5.1 5.4 1.7 3.1 2.8 10.5 1.0 1.8 2.8 3.8 1.6 2.0 0.4 1.2 2.4 5.4 2.1 1.1 5.5 13.4 6.0 4.2 4.8 4.8 4.9 2.2 3.1 2.6 74.5 27.0 2.4 9.8 26.0 16.3 18.6 12.7 40.2 33.0 14.0 17.7 3.0 1.7 11.7 123.9 13.3 3.2 0.0 5.2 8.9 10.4 8.2 91.4 1.6 6.8 17.5 8.1 22.1 10.5 142.5 17.8 10.6 13.5 12.6 3.7 10.9 7.7 3.6 16.6 5.4 16.6 6.5 9.9 4.3 9.1 15.4 2.6 9.2 3.8 4.9 FERMT2 "KIND2, mig-2, PLEKHC1, UNC112B" ENSG00000073712 "Fermitin family member 2" Q96AC1 14 52857268-52952435 "Predicted intracellular proteins" "Cell adhesion, Cell shape, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "MAIT T-cell: 3.8" "Lineage enriched" "Detected in single" 39 "T-cells: 3.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040505, HPA072965" Uncertain Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 58000 "Focal adhesion sites" "Nucleoplasm, Cytosol" "HPA040505: AB_10673300, HPA072965: " "unprognostic (4.38e-2)" "unprognostic (4.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "unprognostic (4.89e-3)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.58e-1)" "unprognostic (1.99e-1)" "unprognostic (3.87e-2)" "unprognostic (3.96e-3)" "unprognostic (7.69e-2)" "unprognostic (3.14e-1)" "unprognostic (1.73e-3)" 45.9 7.2 15.5 12.3 14.3 0.1 24.4 7.9 12.8 24.1 36.6 12.7 16.0 4.2 41.6 14.2 20.6 22.2 22.2 21.8 18.3 7.5 18.4 35.3 18.1 5.4 15.0 9.1 23.3 6.7 5.8 7.2 37.9 10.7 24.1 11.5 11.0 7.1 41.3 14.5 5.0 11.0 56.7 12.9 11.7 21.4 10.2 15.5 0.6 13.3 6.2 2.1 49.5 16.5 0.0 0.0 0.0 0.0 0.0 3.8 0.0 4.8 4.3 22.8 10.4 37.3 30.7 19.0 32.6 21.1 38.8 24.5 7.3 3.9 0.0 11.1 33.3 7.6 2.1 17.7 2.4 29.2 0.0 4.9 6.8 19.5 8.6 47.9 0.1 2.8 29.5 5.2 21.3 28.3 17.7 20.0 3.7 0.1 34.4 29.0 5.9 1.6 0.1 14.4 0.0 11.3 0.8 23.2 0.0 13.6 4.5 1.4 29.3 34.5 7.7 8.0 24.2 6.7 0.2 25.0 30.6 21.0 24.3 12.0 5.1 6.1 0.1 7.0 0.0 7.3 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 14.3 7.9 12.4 18.3 7.5 15.0 9.1 10.7 15.5 71.5 50.2 0.0 111.7 16.6 32.8 53.2 20.4 14.7 37.5 38.4 35.3 69.7 26.6 48.1 59.4 87.9 0.0 0.0 28.6 138.3 102.2 34.3 56.6 71.6 9.0 14.3 0.0 120.9 9.2 20.6 69.3 6.2 43.9 8.2 0.0 57.0 23.6 0.0 164.4 37.4 57.4 148.8 146.8 3.4 10.0 7.0 85.8 4.3 0.0 35.6 FES FPS ENSG00000182511 "FES proto-oncogene, tyrosine kinase" P07332 15 90883695-90895776 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.8;lymphoid tissue: 49.7" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 40.6;Kupffer cells: 93.1;Macrophages: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 60.8" "Group enriched" "Detected in many" 4 "dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5" "Cell line enhanced" "Detected in many" "HEL: 21.3;HL-60: 19.0;HMC-1: 40.7;NB-4: 24.9;THP-1: 37.4;U-937: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001376 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA001376: AB_1078847" "unprognostic (1.07e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (2.31e-2)" "unprognostic (4.05e-3)" "unprognostic (7.33e-2)" "unprognostic (1.74e-1)" "unprognostic (2.22e-1)" "unprognostic (1.58e-3)" "unprognostic (1.35e-1)" "unprognostic (4.66e-2)" "unprognostic (5.15e-3)" "unprognostic (1.78e-3)" "unprognostic (2.53e-3)" "unprognostic (6.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-1)" 14.9 3.4 4.8 9.7 4.1 38.3 12.7 2.4 5.7 6.8 5.4 3.2 4.7 3.0 7.4 5.6 4.9 7.6 7.3 7.9 4.2 2.2 5.2 11.8 12.7 23.3 3.7 0.9 6.4 3.7 1.8 2.7 8.1 7.2 7.7 2.4 5.3 33.8 6.3 3.4 3.5 5.2 5.4 6.9 49.7 4.3 3.2 4.7 3.1 7.2 4.1 4.5 7.2 9.4 1.1 32.6 60.8 30.5 9.3 0.1 13.8 0.1 0.2 0.3 3.6 1.0 3.1 6.1 0.9 0.0 1.8 1.0 0.9 0.0 2.3 0.1 2.0 0.0 0.5 0.6 0.1 0.5 1.2 0.3 21.3 0.0 3.8 2.1 19.0 40.7 3.1 0.0 2.6 0.0 0.0 10.8 3.2 0.6 0.0 0.0 6.9 0.6 24.9 1.0 0.8 0.0 2.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.9 1.1 0.0 37.4 8.4 0.0 3.7 0.1 0.0 0.0 2.7 0.8 0.1 16.1 0.8 10.4 30.5 60.8 0.1 17.6 0.0 1.1 0.0 0.0 32.6 0.9 0.0 0.0 20.0 9.3 7.3 12.9 0.0 13.8 4.8 4.1 2.4 5.7 4.2 2.2 3.7 0.9 7.2 4.7 3.0 8.0 6.4 4.7 3.4 0.0 2.5 5.1 0.0 0.0 1.8 0.0 4.5 3.3 4.8 1.1 24.5 0.4 0.0 3.9 3.8 6.2 4.0 28.8 8.2 40.6 0.0 2.9 22.7 93.1 4.7 8.3 37.3 6.8 27.1 2.1 2.3 2.0 0.0 9.6 1.3 1.9 12.9 7.2 3.5 9.1 2.5 3.8 10.2 2.6 5.2 FEZ1 UNC-76 ENSG00000149557 "Fasciculation and elongation protein zeta 1" Q99689 11 125445745-125496317 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 123.4" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 101.7;Horizontal cells: 157.3;Melanocytes: 74.2" "Cancer enriched" "Detected in all" 10 "glioma: 68.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 30.8;MAIT T-cell: 18.0;memory CD8 T-cell: 8.9;naive CD8 T-cell: 7.7" "Lineage enriched" "Detected in many" 14 "T-cells: 30.8" "Cell line enhanced" "Detected in many" "AF22: 40.5;HBEC3-KT: 39.3;NTERA-2: 37.2;SCLC-21H: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038490, HPA076844" Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA038490: AB_10672647, HPA076844: " "unprognostic (5.68e-2)" "prognostic unfavorable (9.06e-5)" "unprognostic (7.40e-2)" "unprognostic (3.73e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-1)" "unprognostic (2.06e-1)" "unprognostic (8.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-1)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.14e-2)" "unprognostic (2.68e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" 6.6 5.6 48.3 4.4 50.1 1.3 4.3 28.2 121.4 6.4 5.1 58.8 0.2 2.9 6.9 4.0 5.9 4.1 9.4 12.4 54.2 38.2 2.7 7.4 10.0 3.5 68.2 29.8 6.0 1.4 5.0 2.3 6.0 43.4 6.6 5.3 1.4 2.4 12.9 1.7 3.5 3.5 13.0 123.4 3.9 2.5 7.2 51.4 0.0 2.2 0.0 2.9 16.8 2.1 0.0 0.4 2.1 0.5 1.0 30.8 5.0 0.0 0.0 40.5 0.0 26.7 24.4 0.0 6.3 8.2 1.6 0.3 0.0 0.0 0.0 7.4 11.9 3.9 0.1 18.4 39.3 0.9 3.2 0.3 18.6 0.0 0.0 22.6 0.0 0.1 19.9 9.1 7.3 19.4 0.1 17.9 0.0 2.5 0.2 1.9 1.0 0.1 0.0 37.2 0.2 0.4 0.0 0.0 0.0 0.0 14.2 39.7 4.1 0.1 0.0 0.6 15.2 3.0 18.2 16.0 0.1 1.0 0.0 5.3 0.4 0.1 0.0 4.4 0.0 17.1 2.1 0.5 0.0 30.8 0.1 18.0 0.0 1.1 8.9 0.4 0.0 0.4 7.7 0.6 1.0 0.0 0.0 0.0 5.0 48.3 50.1 28.2 97.4 54.2 38.2 68.2 29.8 43.4 51.4 0.0 6.9 1.7 4.4 7.1 15.1 101.7 0.0 1.4 3.4 0.0 2.0 5.7 23.2 2.7 52.4 14.0 0.0 0.0 0.3 1.2 36.9 3.0 0.0 0.6 68.8 157.3 5.2 53.4 15.9 52.7 23.6 1.6 74.2 1.0 0.0 65.9 0.5 0.0 33.2 1.1 13.4 19.4 30.1 11.8 7.0 4.8 3.5 9.6 0.0 1.6 FEZ2 ENSG00000171055 "Fasciculation and elongation protein zeta 2" Q9UHY8 2 36531805-36646087 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035978 Uncertain Approved "Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Golgi apparatus, Cytosol" "HPA035978: AB_10672235" "unprognostic (1.42e-1)" "unprognostic (5.02e-3)" "unprognostic (2.89e-1)" "unprognostic (1.15e-2)" "unprognostic (2.91e-2)" "unprognostic (1.94e-3)" "prognostic unfavorable (7.79e-6)" "unprognostic (1.09e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.65e-2)" "unprognostic (7.82e-3)" "unprognostic (7.07e-2)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" 31.7 23.4 28.7 12.0 25.3 8.1 18.6 20.1 31.2 18.3 17.2 28.0 6.0 13.1 20.4 13.1 20.4 13.1 14.6 28.5 26.1 22.6 21.4 18.4 16.5 13.1 27.6 21.6 18.3 6.8 14.2 8.5 29.6 29.3 15.6 18.4 19.0 9.7 22.1 51.0 9.1 18.7 26.9 33.8 17.8 12.2 12.6 25.4 9.4 14.8 12.2 12.1 15.5 13.5 1.7 13.6 4.7 3.5 3.1 1.5 0.7 15.6 9.4 12.8 5.4 25.4 33.6 10.1 39.8 20.4 24.4 15.5 6.5 5.1 9.7 24.5 51.5 10.7 6.2 10.8 13.7 26.7 2.2 5.9 7.9 3.3 10.8 12.2 7.9 2.0 32.2 11.8 15.0 18.1 16.7 34.9 2.3 8.5 3.0 45.1 5.5 4.8 6.8 6.7 9.0 14.8 3.2 11.6 3.3 19.4 15.3 0.3 11.7 9.8 8.1 9.5 15.0 2.8 9.8 40.5 15.3 8.1 8.4 23.1 2.3 2.7 6.6 15.2 5.5 21.5 2.4 3.5 4.7 1.5 3.3 1.0 1.7 1.1 0.8 3.6 1.0 1.3 0.5 4.0 3.1 1.9 13.6 1.3 0.7 28.7 25.3 20.1 28.8 26.1 22.6 27.6 21.6 29.3 25.4 50.6 29.1 13.8 81.0 27.8 33.3 36.3 12.7 30.8 70.5 55.8 43.2 85.1 48.0 58.2 4.3 78.7 55.8 0.0 26.7 74.7 58.7 87.3 23.1 32.1 80.7 20.6 23.1 93.3 74.8 4.9 50.3 60.5 54.0 36.9 29.6 75.8 51.7 37.4 62.2 31.6 34.6 58.2 52.3 13.0 27.6 28.1 150.6 28.0 32.6 117.0 FEZF1 ZNF312B ENSG00000128610 "FEZ family zinc finger 1" A0PJY2 7 122301394-122310691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.7;testis: 11.0" "Cell type enriched" "Detected in single" 5 "Spermatocytes: 2.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 58.8;SCLC-21H: 25.7" "Region enriched" "Detected in single" 11 "hypothalamus: 13.7" "Region enriched" "Detected in some" 9 "hypothalamus: 6.9" "HPA064639, HPA073693" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064639: AB_2685308, HPA073693: AB_2686626" "unprognostic (8.48e-2)" "unprognostic (3.41e-2)" "unprognostic (3.64e-1)" "unprognostic (3.43e-2)" "unprognostic (4.17e-1)" "unprognostic (4.10e-2)" "unprognostic (2.64e-3)" "unprognostic (2.54e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.6 0.2 6.4 0.2 4.9 0.2 0.2 0.0 2.0 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 1.0 16.7 0.2 0.2 0.2 0.2 2.0 0.0 0.3 0.2 0.2 3.1 0.2 0.0 0.3 0.2 1.4 0.6 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 11.0 3.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 58.8 1.4 1.0 0.0 0.0 0.0 0.0 0.1 25.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 4.9 0.0 2.0 1.0 16.7 2.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 FGD1 "FGDY, ZFYVE3" ENSG00000102302 "FYVE, RhoGEF and PH domain containing 1" P98174 X 54445454-54496166 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Melanocytes: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000911 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA000911: AB_1078853" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (8.74e-2)" "unprognostic (1.57e-2)" "unprognostic (2.94e-2)" "unprognostic (2.77e-3)" "unprognostic (1.49e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-2)" "unprognostic (4.92e-2)" "unprognostic (3.41e-2)" "unprognostic (9.40e-3)" 5.9 7.7 15.6 5.9 10.9 1.6 7.1 16.3 15.6 12.3 7.2 3.7 3.4 4.5 12.4 4.4 9.3 7.6 7.8 9.2 9.6 7.1 5.1 1.9 4.6 4.0 4.8 11.2 13.7 6.9 6.9 5.4 9.4 5.7 6.5 3.8 6.8 7.7 7.9 3.3 11.8 5.5 11.9 3.7 5.8 5.2 4.6 4.8 0.0 5.6 7.3 4.3 7.6 7.8 1.6 0.6 0.5 2.6 1.2 3.2 1.1 13.6 5.8 11.2 14.6 5.2 9.3 5.4 8.1 8.2 6.9 5.6 1.7 1.2 0.8 6.7 12.6 8.7 5.3 9.4 5.8 3.8 1.4 8.2 0.4 4.5 2.0 5.6 0.7 0.5 7.5 3.7 10.5 5.0 8.7 6.2 3.3 2.2 0.5 5.4 2.9 1.6 1.5 11.0 1.6 9.2 7.8 6.4 0.5 5.9 0.8 10.5 9.8 8.9 0.8 13.4 18.6 9.8 1.2 6.0 8.6 7.7 18.9 7.5 1.0 2.0 1.5 9.6 1.6 4.7 0.0 0.6 0.5 2.0 1.3 2.0 1.5 1.6 2.2 0.6 1.6 3.2 1.8 0.0 1.2 2.6 0.2 1.4 1.1 15.6 10.9 16.3 15.6 9.6 7.1 4.8 11.2 5.7 4.8 0.0 0.0 0.0 1.1 2.6 2.5 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.4 3.5 0.0 0.0 0.9 1.0 4.7 0.7 0.0 0.0 0.3 1.6 1.2 3.1 0.0 0.0 2.6 0.0 6.8 0.0 0.8 2.3 0.6 0.0 3.9 1.4 3.3 0.0 2.1 0.2 1.5 3.6 0.2 0.0 2.6 0.8 FGD3 "FLJ00004, ZFYVE5" ENSG00000127084 "FYVE, RhoGEF and PH domain containing 3" Q5JSP0 9 92947451-93036236 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.2;lymphoid tissue: 48.1" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 52.4;Late spermatids: 74.6;T-cells: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 21.0;Karpas-707: 29.2;RT4: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA020963, HPA021018" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA020963: AB_2670542, HPA021018: AB_2670564" "unprognostic (5.66e-3)" "prognostic favorable (5.51e-4)" "unprognostic (5.05e-3)" "unprognostic (1.75e-2)" "unprognostic (1.14e-1)" "prognostic favorable (2.23e-7)" "unprognostic (2.26e-1)" "unprognostic (1.03e-2)" "unprognostic (2.61e-2)" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.32e-1)" "unprognostic (8.56e-2)" "unprognostic (3.96e-1)" "unprognostic (1.60e-1)" "unprognostic (9.66e-2)" "unprognostic (1.22e-2)" 3.1 1.5 2.3 20.5 2.5 23.4 3.5 0.5 1.6 1.8 3.1 3.1 1.6 1.9 2.8 2.5 2.8 2.5 3.1 1.5 2.2 2.0 4.6 2.1 7.5 30.5 3.3 1.0 1.1 5.7 0.1 1.0 2.6 2.6 3.2 1.4 2.2 6.6 1.0 0.7 3.1 10.1 1.5 6.3 28.1 2.6 3.9 2.5 48.1 3.5 2.1 25.8 7.7 3.2 11.3 10.3 49.2 24.7 10.5 15.7 17.1 6.4 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 8.0 4.4 5.2 0.3 0.0 0.0 4.2 0.3 0.0 0.0 9.0 0.0 8.2 0.0 0.3 0.0 2.2 21.0 0.0 0.1 0.0 0.0 0.0 0.0 8.8 0.3 29.2 0.0 10.7 9.6 9.2 0.2 2.1 0.5 9.5 0.0 7.4 0.0 16.5 0.6 0.2 0.0 7.1 0.2 0.2 2.8 9.7 0.0 0.0 0.3 0.0 0.0 2.9 2.9 2.4 1.5 4.6 0.0 34.0 13.4 36.7 15.1 17.3 15.5 8.5 15.6 14.1 10.3 11.3 15.7 13.3 49.2 10.5 24.7 4.7 13.5 17.1 2.3 2.5 0.5 1.6 2.2 2.0 3.3 1.0 2.6 2.5 20.8 11.6 2.7 0.7 0.7 0.0 2.2 2.5 0.0 3.4 8.7 0.0 2.1 0.0 5.5 52.4 1.4 0.0 0.0 0.2 2.9 0.8 0.0 18.5 0.6 12.6 0.0 1.7 2.5 17.8 74.6 0.3 12.6 1.7 2.8 0.3 0.3 0.4 0.0 0.4 0.6 4.2 0.0 0.9 1.6 1.9 0.9 3.8 38.3 0.1 0.4 FGF12 "FGF12B, FHF1" ENSG00000114279 "Fibroblast growth factor 12" P61328 3 192139395-192767764 "Disease related genes, Predicted intracellular proteins" "Growth factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 381.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 11.8;NTERA-2: 8.1;SCLC-21H: 18.9;U-251 MG: 11.3;WM-115: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071557 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA071557: AB_2686417" "unprognostic (1.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (2.50e-5)" "unprognostic (1.75e-1)" "unprognostic (5.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (4.00e-2)" "unprognostic (9.19e-2)" "unprognostic (1.87e-7)" "unprognostic (2.41e-2)" "unprognostic (5.36e-2)" "unprognostic (5.59e-2)" "unprognostic (5.99e-2)" 1.2 21.5 8.8 0.7 15.8 0.6 1.0 17.7 31.9 0.9 0.9 1.9 0.0 1.0 1.2 0.7 1.5 1.5 0.9 75.7 6.8 4.1 2.0 0.9 1.2 0.7 5.1 15.8 1.1 4.9 0.7 2.9 0.8 22.3 1.3 0.8 1.1 3.6 4.2 1.1 0.7 0.7 1.0 2.7 6.8 0.9 1.7 2.8 0.0 1.4 0.0 0.7 0.8 0.8 1.1 0.3 1.2 0.4 0.5 0.4 0.1 0.0 0.8 11.8 0.0 0.0 0.0 0.1 0.0 0.1 1.1 1.4 0.0 0.1 0.6 5.7 0.2 0.2 0.1 0.0 0.0 1.3 0.1 0.1 2.4 5.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.0 3.3 0.0 0.0 8.1 5.4 0.2 0.0 0.1 0.0 3.7 1.4 18.9 0.0 0.0 0.4 0.0 1.4 0.9 0.2 0.3 4.9 2.5 0.0 11.3 0.1 1.8 0.0 1.0 0.0 13.7 1.2 0.2 0.5 0.2 0.3 0.4 1.1 0.2 0.2 0.1 0.5 0.4 0.3 0.6 0.5 0.4 0.3 0.3 0.1 8.8 15.8 17.7 31.9 6.8 4.1 5.1 15.8 22.3 2.8 0.0 0.0 0.0 4.3 0.6 77.1 381.1 0.0 1.4 3.4 5.2 3.9 0.1 6.6 0.7 15.9 4.9 0.0 0.0 11.4 0.2 0.8 1.0 0.0 0.0 0.1 31.8 0.0 8.6 0.3 21.4 6.4 0.0 1.7 0.0 0.0 2.9 4.0 0.2 1.1 0.2 13.0 0.0 0.5 2.1 6.1 0.1 0.0 0.0 0.0 1.4 FGF13 "FGF2, FHF2" ENSG00000129682 "Fibroblast growth factor 13" Q92913 X 138614731-139222777 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.7;parathyroid gland: 44.3;skeletal muscle: 37.0" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 22.0;Leydig cells: 24.2;Muller glia cells: 40.7;Peritubular cells: 23.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 7.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.4" "Cell line enhanced" "Detected in many" "AF22: 19.8;fHDF/TERT166: 17.1;HAP1: 18.1;RPMI-8226: 15.4;U-2197: 31.9;WM-115: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002809 Supported Cytosol NA NA Cytosol "HPA002809: AB_1078855" "unprognostic (3.23e-1)" "unprognostic (3.13e-2)" "unprognostic (5.42e-2)" "unprognostic (1.42e-2)" "unprognostic (1.87e-1)" "unprognostic (2.87e-3)" "unprognostic (9.92e-3)" "unprognostic (2.97e-3)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (5.22e-3)" "unprognostic (6.79e-2)" "unprognostic (4.96e-4)" "unprognostic (4.36e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" "unprognostic (7.48e-2)" 11.1 1.9 30.0 1.9 29.5 2.7 4.2 0.9 22.9 7.9 3.1 1.5 2.4 2.7 7.0 2.8 4.4 2.6 4.1 1.3 36.7 22.3 4.9 1.4 1.7 3.1 19.7 12.9 6.0 0.9 44.3 2.4 8.4 7.8 11.6 3.3 4.8 6.5 3.5 37.0 1.1 3.1 4.5 3.3 3.8 2.9 2.7 4.1 0.0 3.6 7.9 1.6 3.5 5.7 0.5 0.9 7.4 0.5 0.2 0.3 0.1 0.0 0.2 19.8 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 17.1 0.1 1.2 18.1 0.0 0.0 0.2 5.0 0.1 0.1 0.7 0.7 0.1 0.2 0.3 0.4 0.0 0.0 0.1 0.0 1.1 0.7 5.7 2.0 0.1 0.0 0.1 2.0 0.0 6.5 2.9 1.3 15.4 2.9 0.1 0.1 0.0 0.0 0.1 12.1 10.2 0.0 0.1 0.4 0.6 0.9 31.9 8.4 7.5 4.2 0.0 7.1 5.7 17.1 2.7 0.5 1.6 0.2 0.3 0.1 0.5 0.2 0.1 0.1 0.4 0.3 0.2 7.4 0.2 0.5 0.9 0.2 0.1 30.0 29.5 0.9 22.9 36.7 22.3 19.7 12.9 7.8 4.1 0.0 0.0 0.0 3.1 0.3 3.1 1.6 12.7 2.7 4.5 7.0 0.0 0.2 14.9 3.2 0.0 1.9 0.0 0.0 4.8 0.2 2.7 15.0 0.0 0.0 22.0 0.0 2.4 1.3 2.5 0.2 24.2 0.7 1.7 1.0 0.5 40.7 5.7 5.8 23.0 2.5 4.5 32.3 11.8 0.0 1.3 0.6 0.1 0.0 0.1 0.6 FGF5 ENSG00000138675 "Fibroblast growth factor 5" P12034 4 80266599-80336680 "Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 38.2" "Cell type enhanced" "Detected in some" 16 "Club cells: 1.2;Distal tubular cells: 1.7;Proximal tubular cells: 2.6" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "cerebellum: 38.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 20.2;BJ hTERT+: 38.1;fHDF/TERT166: 27.5;HBF TERT88: 28.7;LHCN-M2: 25.7;U-138 MG: 35.6;U-251 MG: 17.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB010313, HPA042442" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Secreted in brain" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010313: AB_2102677, HPA042442: AB_2678001" "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (8.49e-4)" "unprognostic (1.10e-1)" "unprognostic (2.91e-1)" "unprognostic (2.80e-3)" "unprognostic (6.87e-4)" "unprognostic (2.53e-1)" "unprognostic (1.69e-1)" "unprognostic (3.57e-3)" "unprognostic (1.17e-2)" "unprognostic (3.33e-16)" "unprognostic (3.02e-3)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" 0.1 0.1 0.1 1.7 0.1 0.5 0.1 38.2 1.3 0.1 3.1 0.0 0.0 0.4 0.4 0.1 1.3 0.1 9.2 0.3 1.6 0.2 2.3 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 1.3 0.1 4.1 0.2 0.1 0.0 0.1 0.0 0.5 0.4 2.8 2.4 0.3 0.1 0.8 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.7 1.7 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 7.2 0.0 20.2 38.1 5.3 3.9 0.0 0.0 0.0 0.0 27.5 0.4 0.0 0.0 7.0 28.7 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.0 2.0 0.0 15.6 7.5 9.0 1.8 0.0 0.0 0.1 25.7 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 6.5 35.6 1.4 1.7 17.0 0.0 0.0 0.0 2.0 0.0 0.7 1.7 0.3 0.3 0.4 0.2 0.5 0.2 0.3 0.4 0.2 0.7 0.5 0.5 0.9 0.2 0.2 0.7 0.2 0.0 0.1 0.1 38.2 1.3 1.6 0.2 0.2 0.2 4.1 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FHL1 "bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA" ENSG00000022267 "Four and a half LIM domains 1" Q13642 X 136146702-136211359 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 557.6;tongue: 239.4" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 1067.5;Early spermatids: 313.2;Late spermatids: 886.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 20.6" "Group enriched" "Detected in many" 4 "dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 58.7;fHDF/TERT166: 53.1" "Low region specificity" "Detected in all" "HPA001040, HPA001391, CAB020817" Enhanced Supported "Plasma membrane,Cytosol" NA NA 18000000 Cytosol "Plasma membrane" "CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542" "unprognostic (2.16e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "unprognostic (1.89e-1)" "unprognostic (1.61e-3)" "unprognostic (1.76e-2)" "unprognostic (2.51e-2)" "unprognostic (9.34e-2)" "unprognostic (7.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (1.72e-1)" "unprognostic (6.17e-3)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.05e-3)" "prognostic unfavorable (2.11e-4)" 61.9 4.1 7.6 11.0 9.5 0.7 30.6 6.3 7.2 31.5 30.6 3.9 10.0 5.0 25.5 27.7 43.2 14.2 11.7 79.0 6.1 8.1 3.3 2.5 13.7 2.5 5.5 8.1 6.7 2.4 13.4 5.0 13.5 4.4 23.4 10.0 13.5 16.5 30.1 557.6 4.9 11.4 77.7 4.3 2.5 22.1 5.7 3.0 0.6 18.2 239.4 22.1 47.0 14.3 3.4 12.5 0.7 0.4 20.6 11.4 6.2 0.0 9.6 13.3 12.5 29.0 11.7 0.2 37.3 58.7 7.5 18.1 0.0 2.7 0.1 13.0 53.1 21.0 0.1 25.8 31.8 6.3 0.1 29.7 0.1 7.9 0.0 27.2 0.0 6.2 21.7 5.2 9.0 28.6 3.1 7.8 7.3 0.0 5.6 17.5 0.4 5.2 0.3 4.1 0.0 11.3 14.6 0.5 7.9 0.2 0.0 9.4 14.1 1.4 0.0 2.7 5.6 0.0 0.5 22.0 34.7 16.1 1.3 9.3 1.5 3.2 0.2 2.6 0.3 3.8 0.0 0.4 0.0 3.2 0.0 8.6 3.4 11.4 4.5 1.8 2.3 7.6 2.3 0.7 20.6 0.0 12.5 1.2 6.2 7.6 9.5 6.3 7.2 6.1 8.1 5.5 8.1 4.4 3.0 44.7 16.0 6.4 17.4 50.3 30.5 1067.5 0.0 5.3 7.9 10.4 7.9 0.7 1.7 3.3 313.2 63.3 0.0 0.0 0.2 1.0 98.8 2.5 15.1 4.7 3.8 93.8 13.2 131.3 5.9 886.8 114.8 9.8 30.4 10.8 0.5 182.0 0.6 0.2 143.2 4.8 16.9 103.5 304.9 6.0 79.0 39.1 2.3 13.4 0.6 1.8 FHOD1 FHOS ENSG00000135723 "Formin homology 2 domain containing 1" Q9Y613 16 67229387-67247658 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.0;skeletal muscle: 61.1" "Cell type enhanced" "Detected in many" 5 "granulocytes: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024468 Approved Supported Cytosol NA NA 2500000 Cytosol "HPA024468: AB_1848568" "unprognostic (6.53e-3)" "prognostic unfavorable (9.57e-4)" "unprognostic (5.42e-2)" "unprognostic (2.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.18e-2)" "unprognostic (1.62e-1)" "unprognostic (1.81e-1)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.27e-2)" "prognostic unfavorable (1.90e-8)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-3)" "unprognostic (4.70e-2)" 8.3 7.5 2.5 5.1 4.4 2.9 7.9 4.7 2.8 4.2 5.3 2.5 3.8 3.3 3.9 4.7 2.5 3.4 5.6 3.7 2.3 1.3 4.8 2.3 12.5 4.4 4.0 0.7 12.9 3.4 2.5 2.5 5.8 4.2 4.2 2.6 4.0 5.7 4.0 61.1 2.5 3.9 3.5 5.6 38.0 2.9 2.2 3.0 2.7 8.2 11.1 5.8 2.6 3.5 0.5 2.0 2.2 3.0 1.3 1.4 2.1 4.4 12.1 4.5 3.6 18.4 11.1 15.3 9.3 7.8 10.7 10.4 8.3 5.8 5.3 6.8 6.8 3.4 5.4 5.2 7.6 5.3 4.1 8.4 23.6 4.7 9.0 4.9 9.7 43.3 13.7 1.0 16.5 1.5 9.3 16.6 7.4 12.1 3.3 6.7 15.2 6.5 17.4 6.8 4.1 3.8 7.5 10.2 12.5 3.3 1.8 1.4 7.5 14.7 8.5 8.5 4.7 9.0 7.7 19.3 14.6 8.5 8.9 7.5 11.2 11.5 7.7 30.0 9.2 13.3 1.5 3.0 0.5 1.1 1.2 1.4 0.1 1.3 1.0 2.0 0.5 0.8 0.6 2.2 1.3 1.0 1.2 1.2 2.1 2.5 4.4 4.7 2.8 2.3 1.3 4.0 0.7 4.2 3.0 11.9 22.9 5.2 1.5 5.0 1.0 10.9 10.2 4.0 7.9 5.2 7.9 7.5 0.0 2.8 0.7 15.0 6.7 0.0 5.1 4.0 10.5 2.8 40.3 0.8 16.0 1.6 8.7 28.8 21.7 1.1 9.8 15.8 3.3 16.2 13.9 2.9 5.7 2.9 10.3 1.0 0.8 25.8 15.0 1.5 2.7 3.1 1.6 12.9 14.4 1.0 FIGN ENSG00000182263 "Fidgetin, microtubule severing factor" Q5HY92 2 163593396-163736012 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 48.1;Peritubular cells: 32.2;Sertoli cells: 71.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 54 "basophil: 5.4" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "AF22: 17.2;SuSa: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034987, HPA057919" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA034987: AB_10669681, HPA057919: " "unprognostic (3.93e-2)" "unprognostic (8.30e-3)" "unprognostic (1.48e-1)" "unprognostic (7.68e-5)" "unprognostic (3.45e-2)" "unprognostic (8.98e-4)" "unprognostic (5.23e-3)" "unprognostic (7.65e-3)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (2.07e-2)" "unprognostic (3.24e-2)" "unprognostic (3.85e-3)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (4.10e-2)" "unprognostic (3.78e-2)" 8.5 7.6 9.6 2.9 13.7 2.8 5.2 5.1 11.9 6.8 5.9 5.5 3.7 2.1 3.3 5.0 2.9 4.5 4.4 10.1 8.8 4.3 7.2 7.9 4.3 2.5 8.7 4.7 14.3 7.2 1.8 12.1 4.4 7.7 4.8 3.4 4.3 8.4 9.9 3.6 3.2 3.6 5.6 9.1 8.7 4.5 4.4 10.5 0.0 3.1 3.0 1.6 4.1 6.3 0.0 0.0 5.4 0.0 0.0 0.0 0.0 5.6 2.0 17.2 0.0 0.0 0.0 6.3 2.2 1.5 1.6 3.0 0.0 2.0 0.0 6.2 2.4 3.2 0.8 5.7 2.4 1.3 0.0 4.2 0.0 3.9 4.1 1.4 0.0 0.0 0.8 2.1 3.1 8.4 2.5 3.7 0.0 0.0 0.0 4.7 1.4 0.0 0.0 7.3 0.4 2.7 0.0 5.8 0.0 4.0 1.9 2.7 2.3 0.0 1.6 1.5 10.1 1.8 0.0 0.3 7.1 6.5 0.0 4.6 1.0 0.0 0.0 2.1 0.0 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 13.7 5.1 11.9 8.8 4.3 8.7 4.7 7.7 10.5 6.0 5.3 1.4 0.1 1.6 15.3 16.8 10.2 6.7 3.4 12.2 0.0 18.1 1.7 2.5 2.7 0.7 0.0 0.0 1.3 5.9 6.3 0.9 0.0 11.3 1.2 6.4 0.0 7.4 0.0 4.2 48.1 0.2 16.9 0.0 0.0 6.5 1.7 0.0 32.2 6.3 1.9 71.1 13.9 0.2 0.6 0.4 14.1 0.0 0.0 0.0 FKBP14 "FKBP22, FLJ20731" ENSG00000106080 "FK506 binding protein 14" Q9NWM8 7 30010587-30026684 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isomerase, Rotamase" "Deafness, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013329, HPA026829" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA Cytosol "Nucleoplasm, Golgi apparatus" "HPA013329: AB_1848613, HPA026829: AB_10601651" "prognostic unfavorable (1.60e-4)" "unprognostic (1.12e-3)" "unprognostic (6.84e-2)" "unprognostic (1.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.41e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (6.06e-2)" "unprognostic (7.00e-2)" "unprognostic (6.99e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-3)" "prognostic unfavorable (4.25e-4)" 8.8 7.4 8.7 9.2 7.3 5.1 8.8 17.6 7.7 14.9 7.8 4.1 6.9 4.2 12.1 14.2 8.0 8.1 8.5 9.8 7.1 5.2 5.4 9.2 7.6 8.1 9.2 5.2 13.0 9.8 8.6 27.8 10.7 7.1 9.8 6.9 8.4 7.6 10.9 3.3 6.4 5.3 18.8 8.1 6.7 7.2 4.2 7.1 2.6 5.6 5.9 7.7 13.4 8.7 1.6 3.3 2.7 1.2 1.0 1.6 0.6 3.4 2.6 7.4 17.2 19.3 24.8 3.4 17.7 16.6 6.2 12.1 2.2 2.2 1.2 8.4 15.5 7.6 7.6 4.1 6.4 12.4 0.6 5.9 2.8 5.0 6.5 9.8 2.0 4.9 15.5 6.7 10.8 12.8 14.6 13.7 1.8 4.5 2.6 11.1 1.4 1.0 2.4 3.9 3.8 4.8 0.0 5.0 4.0 6.1 3.1 1.9 6.5 6.2 14.2 4.3 9.2 3.2 2.6 11.0 6.6 7.7 11.3 7.0 3.9 4.0 2.1 9.4 1.9 20.6 1.9 1.2 1.2 1.3 0.8 1.0 1.1 1.6 1.1 2.2 1.6 1.5 1.3 2.7 1.0 0.5 3.3 1.4 0.6 8.7 7.3 17.6 7.7 7.1 5.2 9.2 5.2 7.1 7.1 17.9 16.5 3.7 19.2 24.4 15.5 13.5 7.6 2.7 10.3 17.4 25.5 9.5 1.7 6.7 0.3 7.4 3.3 0.0 3.2 24.1 26.4 15.0 2.3 6.6 5.3 14.3 1.2 8.6 2.8 0.0 12.0 5.8 10.1 2.8 7.9 31.5 5.3 14.4 19.4 2.9 19.8 6.5 10.5 0.7 3.3 15.9 13.2 4.3 4.8 24.8 FKBP15 "FKBP133, KIAA0674, PPP1R76, WAFL" ENSG00000119321 "FK506 binding protein 15" Q5T1M5 9 113161006-113221361 "Predicted intracellular proteins" "Endocytosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 53.0;Kupffer cells: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007979 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA007979: AB_1848615" "unprognostic (2.81e-1)" "unprognostic (2.51e-1)" "unprognostic (2.55e-3)" "unprognostic (1.61e-3)" "unprognostic (2.54e-1)" "unprognostic (2.67e-1)" "unprognostic (2.16e-3)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-3)" "unprognostic (1.02e-1)" "unprognostic (6.45e-2)" "unprognostic (4.28e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (3.44e-2)" "unprognostic (5.62e-3)" 19.8 17.8 16.7 25.3 21.9 19.2 19.4 18.6 21.6 16.9 15.3 25.4 14.2 15.1 18.1 17.0 18.8 16.7 14.4 16.4 16.2 13.1 15.7 17.2 26.7 30.9 22.6 15.4 18.6 17.5 34.7 22.1 24.4 19.2 17.2 18.7 17.6 20.0 22.3 19.2 22.3 18.2 20.5 23.5 36.5 15.9 6.8 20.9 25.1 18.7 13.4 23.3 18.6 18.3 2.8 8.5 5.7 20.5 3.7 3.4 4.5 11.7 12.1 8.1 7.9 17.7 15.6 11.0 14.7 22.3 16.6 14.9 7.6 12.3 19.7 7.2 18.7 32.9 25.8 9.9 14.4 15.3 15.0 6.6 7.6 13.2 7.3 14.4 16.1 19.9 15.7 14.7 18.2 19.0 17.1 16.1 11.4 9.3 12.1 16.9 18.0 12.0 8.5 8.5 16.9 9.7 10.9 17.2 7.1 12.0 10.9 7.2 7.2 17.9 13.7 8.6 11.2 16.4 6.0 18.7 17.9 6.7 17.6 15.2 10.4 11.3 9.1 18.7 9.3 14.6 1.8 11.6 1.6 3.4 14.6 2.8 2.0 2.1 2.1 8.5 2.8 2.5 1.9 5.7 3.7 20.5 3.5 2.2 4.5 16.7 21.9 18.6 21.6 16.2 13.1 22.6 15.4 19.2 20.9 14.9 29.0 13.4 5.8 5.0 12.3 12.0 10.2 14.7 14.8 14.0 25.5 11.9 1.7 10.8 0.9 11.3 8.1 0.0 11.8 10.2 12.4 6.3 10.5 7.8 53.0 11.1 4.6 17.8 50.5 1.1 15.5 49.5 6.8 1.0 7.4 8.3 13.5 8.6 14.9 4.3 16.1 19.4 6.1 3.9 11.5 3.6 10.2 11.8 8.0 9.2 FKBP3 "FKBP-25, PPIase" ENSG00000100442 "FK506 binding protein 3" Q00688 14 45115600-45135319 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000864, CAB012232, CAB012520" Supported Supported Cytosol NA NA 980000 Cytosol "CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873" "unprognostic (7.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.18e-1)" "unprognostic (9.72e-2)" "unprognostic (1.25e-1)" "unprognostic (9.82e-3)" "unprognostic (3.58e-3)" "unprognostic (2.28e-1)" "unprognostic (5.04e-3)" "unprognostic (1.22e-3)" "unprognostic (7.47e-2)" "unprognostic (6.92e-3)" "unprognostic (1.00e-1)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" 11.7 13.2 28.1 10.2 40.7 9.8 15.5 25.1 32.1 12.0 14.6 11.4 8.3 13.2 9.9 20.4 14.6 8.8 9.1 31.3 26.0 24.4 16.5 20.5 8.0 14.6 23.2 23.8 9.9 10.9 15.0 17.1 14.0 22.9 17.9 15.2 6.6 10.7 12.2 113.3 11.3 13.9 12.8 19.6 9.9 10.6 13.5 22.4 12.7 12.4 24.2 16.5 12.7 9.3 19.5 27.5 13.5 17.4 15.4 19.4 13.0 37.3 41.6 60.6 31.9 27.0 29.4 23.9 23.0 26.4 36.3 40.1 36.3 32.1 19.9 24.3 25.9 20.6 31.1 45.0 29.6 51.9 28.7 26.8 16.4 32.3 46.9 26.6 28.2 17.7 27.7 30.9 21.1 19.7 33.6 47.3 31.7 23.6 15.1 43.1 45.6 45.3 37.9 30.7 41.9 39.5 43.6 44.7 24.2 58.1 43.2 37.0 14.5 36.8 22.9 35.2 47.7 53.6 21.2 30.4 27.8 48.1 14.5 17.6 25.4 45.1 31.0 16.8 19.5 25.9 11.6 14.6 13.5 13.0 17.2 15.7 19.5 17.5 17.6 21.8 13.6 16.8 18.8 2.3 15.4 17.4 27.5 19.4 13.0 28.1 40.7 25.1 32.1 26.0 24.4 23.2 23.8 22.9 22.4 38.7 36.9 49.1 82.5 42.5 68.8 177.9 45.9 77.6 69.4 89.0 9.8 264.9 213.9 116.4 165.9 49.2 61.3 0.0 64.1 95.4 67.9 74.9 51.0 84.7 113.7 38.1 53.9 39.3 36.8 297.6 74.8 68.0 65.8 155.9 63.2 57.4 80.6 52.6 91.9 168.1 44.8 103.5 53.3 145.7 112.4 41.9 138.0 47.9 83.1 70.8 FKBP4 "FKBP52, FKBP59" ENSG00000004478 "FK506 binding protein 4" Q02790 12 2794953-2805423 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "vagina: 209.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006148, CAB017441, HPA062857" Supported Enhanced Nucleoplasm,Cytosol NA NA 110000 Cytosol Nucleoplasm "CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883" "unprognostic (1.46e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.65e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.12e-5)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.72e-1)" "unprognostic (3.14e-1)" "unprognostic (3.89e-2)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (2.22e-1)" 16.2 21.6 26.0 13.7 30.7 13.3 40.7 50.4 31.9 19.9 22.6 22.8 36.2 13.1 20.1 30.7 34.2 25.7 16.4 20.4 25.0 32.5 31.6 31.3 15.8 11.7 44.7 23.4 23.9 30.3 30.1 19.5 32.0 39.4 30.2 25.3 11.5 30.1 31.6 33.5 25.3 16.1 26.4 25.2 11.5 25.3 36.0 42.1 15.6 47.1 16.5 18.5 17.4 209.6 13.8 6.0 10.9 13.7 8.4 14.0 9.9 15.3 34.2 9.9 16.6 12.3 7.3 47.5 15.1 5.4 25.0 16.9 34.0 18.8 20.5 4.3 9.7 17.4 21.1 61.5 20.5 30.1 37.5 39.4 22.6 25.1 12.0 9.5 17.6 6.2 6.6 18.8 29.5 29.6 14.9 14.5 20.8 20.7 29.3 10.0 44.1 30.9 16.0 84.3 45.3 24.7 18.6 17.4 12.3 21.0 19.6 14.3 20.5 17.5 47.8 7.6 64.7 64.4 12.0 7.7 12.3 38.7 13.8 38.0 7.3 11.2 30.3 10.9 26.4 12.5 10.9 10.8 5.9 12.5 9.8 14.0 13.3 11.1 11.8 6.0 13.8 11.8 13.7 1.5 8.4 13.7 5.3 10.1 9.9 26.0 30.7 50.4 31.9 25.0 32.5 44.7 23.4 39.4 42.1 6.0 8.6 47.9 182.5 127.9 60.2 11.7 40.8 16.0 12.5 50.6 70.7 148.6 131.0 77.3 90.2 33.8 86.8 0.0 22.4 85.7 62.6 189.3 39.1 41.9 54.7 92.2 101.7 12.3 15.0 26.1 32.2 42.7 87.7 52.3 61.6 41.8 62.2 84.2 36.4 112.7 51.3 84.1 88.6 179.1 92.0 116.1 186.7 20.2 77.5 121.3 FKBP8 "FKBP38, FKBPr38" ENSG00000105701 "FK506 binding protein 8" Q14318 19 18531751-18544077 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 972.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 32.5;neutrophil: 31.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 32.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025346, HPA045177" Supported Supported "Endoplasmic reticulum,Mitochondria,Cytosol" NA NA Mitochondria "Endoplasmic reticulum, Cytosol" "CAB025346: , HPA045177: AB_2679244" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (9.22e-2)" "unprognostic (2.54e-2)" "unprognostic (2.26e-1)" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "prognostic favorable (7.76e-4)" "unprognostic (8.51e-2)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (2.32e-1)" 44.3 38.1 75.9 27.5 82.1 82.5 26.5 43.4 113.7 35.2 31.9 41.2 34.6 31.1 31.4 27.2 48.7 39.3 34.5 43.4 69.6 62.1 28.9 42.7 34.3 31.1 55.3 54.3 56.1 60.4 28.8 42.2 36.6 51.2 36.5 12.9 31.9 73.1 46.1 56.7 35.1 31.6 34.6 46.3 36.7 31.9 49.5 26.9 32.1 38.8 24.2 30.7 36.3 45.8 4.3 4.3 32.5 6.9 3.1 6.6 9.1 36.9 26.5 20.8 39.5 21.5 33.8 52.2 29.9 31.9 22.9 31.8 25.1 50.5 21.2 48.7 36.7 15.4 20.1 12.8 41.7 6.5 25.8 60.9 19.8 34.6 30.2 37.0 19.6 43.6 44.1 40.2 20.6 13.1 44.1 23.5 41.3 41.4 50.5 19.9 61.6 35.6 58.7 42.5 33.2 38.5 37.4 17.3 72.4 30.8 24.2 23.1 42.1 21.0 17.3 37.3 16.5 20.4 57.2 27.4 28.7 26.2 55.9 22.7 38.6 22.2 24.6 64.8 31.5 25.4 6.3 5.6 32.5 6.0 5.8 5.5 4.1 6.1 6.6 4.3 4.3 4.7 5.3 31.0 3.1 6.9 4.3 6.0 9.1 75.9 82.1 43.4 113.7 69.6 62.1 55.3 54.3 51.2 26.9 8.9 1.4 107.1 128.1 84.6 57.2 2.0 71.4 2.7 5.7 96.0 13.7 219.4 210.5 151.9 314.6 76.6 289.8 233.6 111.8 173.9 174.8 132.3 54.0 55.9 208.7 93.8 197.7 79.8 159.9 972.7 188.7 127.3 192.3 254.3 108.6 104.6 130.6 224.5 155.6 222.1 41.3 97.0 149.9 203.6 97.7 103.1 261.7 163.0 127.0 126.6 FKRP "LGMD2I, MDC1C" ENSG00000181027 "Fukutin related protein" Q9H9S5 19 46746046-46776988 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043115, HPA060454" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA043115: AB_2678324, HPA060454: AB_2684281" "unprognostic (4.44e-2)" "unprognostic (5.20e-2)" "unprognostic (2.19e-2)" "unprognostic (8.37e-3)" "unprognostic (1.83e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "unprognostic (2.99e-2)" "unprognostic (4.59e-3)" "prognostic favorable (8.98e-4)" "unprognostic (3.53e-1)" "unprognostic (2.30e-2)" "unprognostic (2.53e-1)" "unprognostic (2.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.53e-2)" 13.7 10.7 12.4 12.5 17.5 12.6 9.6 7.4 25.2 10.5 11.5 12.8 13.7 7.8 15.7 8.7 8.3 12.7 10.1 13.1 9.8 12.2 10.7 10.8 11.6 11.0 11.5 11.1 13.3 13.2 12.9 16.9 16.5 14.1 13.6 7.3 13.0 17.8 13.2 23.6 9.6 9.7 13.4 9.1 14.7 10.3 13.0 11.1 8.8 13.5 7.8 7.9 12.3 10.2 6.9 5.0 5.4 4.2 5.6 4.5 2.4 8.4 18.1 12.4 8.7 11.0 12.2 11.1 21.6 14.6 8.9 14.0 11.5 14.7 7.6 12.1 12.4 14.7 9.0 4.6 10.1 8.2 14.9 15.4 8.0 8.7 7.2 9.7 6.2 13.8 13.5 8.7 10.9 10.7 10.4 11.6 4.2 8.0 7.7 8.9 3.8 4.5 15.2 12.1 5.3 4.5 12.3 7.7 2.8 5.6 18.1 8.5 16.2 10.8 5.3 7.1 8.6 6.4 4.9 11.9 13.2 14.0 4.8 17.3 8.2 9.8 7.2 10.7 5.0 17.6 3.4 4.2 2.5 4.1 2.5 2.8 4.6 3.0 4.5 2.6 6.9 3.7 4.5 5.4 5.6 2.6 5.0 1.6 2.4 12.4 17.5 7.4 25.2 9.8 12.2 11.5 11.1 14.1 11.1 8.9 6.1 0.8 4.3 0.7 9.7 13.7 7.6 10.7 6.8 5.2 5.9 7.9 5.0 4.3 7.3 3.9 3.5 23.3 2.1 4.7 4.1 3.6 1.1 13.4 6.3 3.2 7.5 9.2 11.4 9.9 5.2 1.8 5.0 4.6 4.6 6.8 4.9 3.1 3.9 5.8 10.7 6.5 4.7 9.1 4.3 1.4 15.7 5.0 3.6 3.4 FLAD1 "FAD1, PP591" ENSG00000160688 "Flavin adenine dinucleotide synthetase 1" Q8NFF5 1 154983338-154993111 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028476, HPA028486, HPA028563" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286" "unprognostic (2.64e-1)" "unprognostic (2.60e-1)" "unprognostic (2.72e-1)" "unprognostic (3.84e-2)" "unprognostic (7.34e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.31e-1)" "unprognostic (2.32e-1)" "unprognostic (8.08e-2)" "unprognostic (6.51e-2)" "unprognostic (9.74e-2)" "prognostic unfavorable (2.55e-6)" "unprognostic (1.67e-2)" "unprognostic (5.06e-2)" "unprognostic (5.50e-2)" "unprognostic (1.17e-2)" 16.5 16.5 20.3 15.5 18.9 12.1 17.4 15.9 20.8 14.1 16.4 19.3 14.7 19.6 15.9 21.2 19.8 16.7 11.8 16.1 18.2 10.4 19.0 36.5 13.5 20.0 20.8 15.6 14.5 19.0 13.6 12.0 18.5 15.9 18.7 19.0 16.1 16.2 16.3 26.3 23.3 23.9 17.6 12.4 22.9 16.1 19.1 18.9 15.7 20.8 18.4 22.0 15.5 15.4 25.1 24.5 15.2 24.1 14.9 26.4 22.7 13.0 20.9 13.3 22.7 11.6 8.6 25.4 9.9 8.2 14.4 12.4 18.6 16.1 15.2 20.0 9.1 7.5 17.1 25.6 20.5 9.4 15.8 19.2 12.3 16.6 13.1 15.9 17.8 16.1 12.3 26.9 16.4 17.6 7.0 16.7 16.3 19.8 12.4 12.2 28.1 12.2 12.5 29.1 28.4 21.7 20.7 6.6 34.9 13.7 18.2 22.5 30.9 15.5 35.1 19.5 27.0 30.0 27.1 10.5 9.1 12.5 11.6 15.5 19.4 24.0 26.2 10.9 14.5 14.5 15.2 23.0 14.8 24.0 20.9 26.4 25.1 22.1 22.7 24.1 20.5 20.5 20.2 5.2 14.9 24.1 24.5 23.3 22.7 20.3 18.9 15.9 20.8 18.2 10.4 20.8 15.6 15.9 18.9 8.9 8.8 15.9 13.2 23.6 15.2 34.3 20.4 16.0 11.4 24.4 5.9 36.7 26.6 22.3 20.5 11.2 23.6 23.3 24.5 35.2 12.7 16.8 8.1 24.5 24.6 14.3 11.5 9.8 14.6 61.7 9.5 14.0 13.5 41.5 18.3 19.0 20.5 17.5 9.2 27.4 14.7 6.5 13.3 20.0 17.9 24.1 30.1 16.0 19.9 17.0 FLCN "BHD, MGC17998, MGC23445" ENSG00000154803 Folliculin Q8NFG4 17 17212212-17237188 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 34.9" "CAB015158, HPA028760" Supported Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB015158: AB_2231645, HPA028760: AB_10601323" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (1.53e-2)" "unprognostic (1.74e-1)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.73e-2)" "unprognostic (1.32e-1)" "unprognostic (3.58e-2)" "unprognostic (3.90e-1)" "prognostic favorable (4.49e-4)" "unprognostic (6.45e-3)" "unprognostic (2.55e-3)" "unprognostic (1.92e-1)" "unprognostic (9.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.65e-1)" 11.9 15.3 23.6 10.8 41.6 15.6 13.9 49.4 26.9 18.0 21.3 18.5 10.4 25.0 22.1 15.8 11.0 14.5 17.6 17.2 17.2 8.6 9.6 15.5 15.6 11.6 24.2 13.5 25.2 13.7 6.1 20.3 13.3 18.1 15.4 10.7 14.8 10.5 14.8 22.7 12.6 20.2 15.4 14.8 16.5 15.3 12.5 29.1 6.6 15.8 3.9 8.0 15.0 14.8 6.0 2.4 10.5 6.8 4.5 5.0 3.1 5.9 14.5 5.3 6.9 17.4 9.9 7.9 5.3 8.9 8.5 11.8 11.0 4.9 2.9 7.4 6.4 19.6 6.9 6.5 3.3 4.4 5.6 5.5 6.0 4.3 6.3 16.1 2.2 16.8 14.6 11.4 13.3 9.9 7.7 6.9 4.3 8.2 7.7 8.1 7.7 3.9 3.7 5.4 8.2 3.6 8.0 24.7 3.4 5.1 6.6 6.5 4.1 5.6 3.4 9.3 34.9 5.1 4.2 8.1 20.0 8.7 27.6 7.0 3.8 3.6 2.8 12.7 5.1 7.9 3.6 4.7 2.8 2.9 6.8 4.1 5.3 3.5 2.5 2.4 6.0 3.9 3.4 10.5 4.5 2.2 2.4 5.0 3.1 23.6 41.6 49.4 26.9 17.2 8.6 24.2 13.5 18.1 29.1 23.8 13.0 15.9 10.7 16.4 17.0 17.3 7.6 4.0 4.5 7.0 74.6 8.1 1.7 10.3 10.9 10.1 26.4 46.7 7.2 5.4 15.2 11.3 1.1 20.2 14.4 44.5 24.6 23.4 23.7 13.4 25.9 13.7 10.1 5.4 9.4 18.9 9.6 12.2 19.1 4.3 16.8 19.4 11.4 5.2 10.2 15.8 28.3 11.3 10.6 11.6 FLII "FLI, Fli1, FLIL, MGC39265" ENSG00000177731 "FLII, actin remodeling protein" Q13045 17 18244836-18258916 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007084, HPA008903, CAB016132" Approved Enhanced "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 1800000 "Nucleoplasm, Centriolar satellite, Cytosol" "CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640" "unprognostic (8.09e-2)" "unprognostic (1.09e-2)" "unprognostic (6.89e-2)" "unprognostic (2.53e-2)" "unprognostic (4.22e-2)" "unprognostic (4.78e-2)" "unprognostic (1.88e-2)" "unprognostic (1.23e-2)" "unprognostic (4.91e-2)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-3)" "unprognostic (4.03e-2)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" 21.2 16.8 8.6 16.9 12.4 16.6 21.7 11.7 11.4 17.5 18.5 12.8 14.3 14.6 17.3 16.3 25.9 13.7 15.6 28.3 9.3 7.4 19.0 18.8 17.3 13.4 15.0 6.1 15.3 20.0 15.4 13.5 15.8 13.6 17.2 10.7 11.0 21.3 17.0 78.4 14.4 18.9 19.1 11.1 20.0 15.4 15.6 11.9 21.2 15.1 25.4 17.5 21.5 16.3 5.3 16.0 12.9 24.9 5.2 7.2 10.3 58.1 21.0 6.0 9.1 13.8 12.5 9.0 16.2 19.6 18.3 11.4 26.8 13.3 11.4 17.0 18.5 10.6 26.0 8.0 26.9 10.7 9.5 12.5 6.2 15.5 10.6 15.6 6.9 13.2 11.3 16.4 14.9 22.5 11.7 17.6 10.6 5.0 4.6 10.7 17.3 10.2 5.8 6.2 25.7 11.0 10.0 26.8 14.1 13.6 16.5 2.1 3.1 18.8 16.1 8.7 39.0 27.4 5.4 21.7 16.3 16.8 31.3 19.0 4.8 3.5 3.4 15.4 6.7 8.8 4.8 13.6 12.9 7.0 21.4 7.2 5.3 5.8 7.2 16.0 3.6 4.3 4.6 12.0 5.2 24.9 4.7 6.6 10.3 8.6 12.4 11.7 11.4 9.3 7.4 15.0 6.1 13.6 11.9 56.6 34.6 18.1 20.3 20.1 16.0 33.1 25.5 45.5 44.3 24.4 17.7 22.0 13.3 53.5 34.8 28.6 52.0 0.0 48.6 24.9 20.8 27.1 45.1 16.9 44.4 25.4 23.0 27.0 42.1 5.3 30.0 48.8 15.1 55.1 23.3 10.6 95.0 43.3 32.9 17.6 11.3 32.3 21.1 39.6 18.8 17.1 21.3 28.0 32.6 31.1 FLNA "ABP-280, FLN, FLN1, OPD1, OPD2" ENSG00000196924 "Filamin A" P21333 X 154348524-154374638 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cilium biogenesis/degradation" Actin-binding "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 396.7;urinary bladder: 276.1" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 470.6;Sertoli cells: 413.9;Smooth muscle cells: 354.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000356, HPA000368, HPA001016, HPA001115, HPA002925" Enhanced Approved Enhanced "Plasma membrane,Actin filaments,Cytosol" NA NA 2900000000 "Plasma membrane, Actin filaments, Cytosol" "CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869" "unprognostic (1.39e-1)" "unprognostic (9.40e-3)" "prognostic unfavorable (7.37e-4)" "unprognostic (3.68e-2)" "unprognostic (2.55e-1)" "unprognostic (6.05e-3)" "unprognostic (5.08e-2)" "unprognostic (1.08e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (3.23e-2)" "unprognostic (9.58e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (5.49e-3)" "unprognostic (1.78e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.88e-4)" 42.8 8.8 2.9 46.4 3.9 22.9 30.7 2.0 5.2 106.5 204.2 6.3 86.0 13.1 158.9 54.4 140.2 79.9 121.0 18.8 3.2 2.2 17.2 5.5 29.1 21.1 3.4 5.9 77.4 7.3 1.6 4.8 20.0 9.4 129.3 13.4 19.0 12.6 98.8 13.7 15.0 50.2 396.7 3.6 25.5 82.7 29.9 2.9 12.1 11.7 16.3 15.1 276.1 64.5 6.3 13.1 7.1 19.7 5.9 22.6 24.1 87.1 67.8 23.9 30.8 20.9 27.7 39.3 58.4 65.1 53.6 47.7 43.9 16.2 7.5 151.5 90.7 94.6 50.1 21.5 51.2 15.1 30.8 7.5 24.2 88.6 15.2 38.5 28.6 31.7 26.4 12.4 79.8 31.9 52.5 39.8 9.2 6.8 52.3 38.3 20.0 13.6 9.9 25.2 9.1 45.1 13.7 21.7 6.7 20.8 18.1 5.3 12.1 48.8 7.9 39.3 19.2 7.6 9.0 95.2 61.2 59.0 61.9 107.5 32.8 19.2 15.2 56.8 19.2 61.2 4.1 11.5 7.1 22.6 15.2 14.3 6.3 10.5 18.7 13.1 3.0 4.0 9.1 2.6 5.9 19.7 1.7 12.8 24.1 2.9 3.9 2.0 5.2 3.2 2.2 3.4 5.9 9.4 2.9 53.6 43.8 55.7 72.4 110.4 2.7 24.1 43.3 4.0 20.5 33.2 0.0 18.9 1.7 255.8 1.7 80.7 1.4 0.0 117.7 74.6 126.9 16.4 25.4 2.1 124.7 11.1 1.7 85.3 148.7 6.8 113.4 134.1 84.4 135.3 1.3 35.9 247.2 0.8 470.6 0.9 2.8 413.9 354.2 2.3 8.3 64.4 16.7 76.7 3.1 31.4 FLNB "ABP-278, FH1, FLN1L, LRS1, TABP, TAP" ENSG00000136068 "Filamin B" O75369 3 58008400-58172251 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Differentiation, Myogenesis" "Actin-binding, Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 215.6;Extravillous trophoblasts: 184.6;Pancreatic endocrine cells: 247.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 71.8;TIME: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004747, HPA004886, CAB019322" Enhanced Supported "Golgi apparatus,Plasma membrane,Actin filaments,Cytosol" NA NA 37000000 "Plasma membrane" "Golgi apparatus, Actin filaments, Cytosol" "CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600" "unprognostic (1.29e-2)" "unprognostic (1.08e-2)" "unprognostic (5.97e-2)" "unprognostic (6.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.05e-1)" "unprognostic (6.52e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (8.45e-5)" "unprognostic (9.23e-2)" "prognostic favorable (3.45e-6)" "unprognostic (4.38e-2)" "unprognostic (1.36e-1)" "unprognostic (6.65e-3)" "unprognostic (2.33e-1)" 24.7 17.8 7.8 25.3 10.6 2.2 30.0 12.6 7.4 21.3 33.5 17.2 49.6 19.4 36.1 47.4 18.6 17.3 16.0 7.7 10.6 8.5 20.6 29.2 14.1 9.4 16.1 5.3 22.9 22.4 25.6 7.8 36.0 13.2 35.8 28.5 20.1 25.5 44.0 7.7 28.9 50.2 39.7 24.3 12.1 21.2 11.7 13.5 49.3 28.2 12.0 13.0 32.8 34.7 3.8 15.9 7.4 1.2 5.9 4.9 1.2 20.2 34.7 3.5 5.1 2.4 4.1 61.2 7.5 6.1 16.9 17.3 34.7 34.8 3.3 2.8 26.6 27.5 33.4 6.5 48.2 16.5 18.3 3.2 2.8 29.5 16.8 17.5 2.4 10.0 6.5 20.9 23.4 71.8 20.0 57.0 14.8 4.6 1.0 10.5 4.4 7.3 5.8 5.4 22.4 30.1 3.2 0.9 2.8 22.5 34.6 3.9 3.6 38.3 21.0 4.2 26.8 17.3 6.7 80.8 4.4 13.8 52.7 26.9 0.7 0.2 2.6 16.4 4.4 4.6 7.4 0.3 4.2 0.5 0.8 2.6 3.8 1.6 0.7 1.2 1.6 4.9 3.5 0.1 5.9 1.2 15.9 1.7 1.2 7.8 10.6 12.6 7.4 10.6 8.5 16.1 5.3 13.2 13.5 47.6 33.3 5.1 35.9 45.0 2.7 10.5 58.6 54.9 44.3 45.4 37.3 23.5 0.0 81.2 15.8 61.2 215.6 0.0 57.7 184.6 26.7 99.5 24.3 46.4 13.6 1.6 47.3 130.8 11.4 17.1 15.0 10.9 5.0 17.2 70.6 10.0 247.2 108.7 26.2 6.8 10.9 0.0 12.0 1.9 5.1 45.2 41.6 7.5 60.6 62.1 FLNC "ABP-280, ABPL, FLN2" ENSG00000128591 "Filamin C" Q14315 7 128830377-128859274 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 546.8" "Cell type enriched" "Detected in many" 40 "Cardiomyocytes: 1815.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 80.1;fHDF/TERT166: 36.4;hTEC/SVTERT24-B: 39.6;U-2 OS: 34.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA006135, HPA071007" Enhanced Supported "Plasma membrane,Cytosol" NA NA 54000000 "Plasma membrane, Cytosol" "HPA006135: AB_1848602, HPA071007: " "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (4.47e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (2.80e-4)" "unprognostic (1.64e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (2.17e-5)" "unprognostic (1.03e-3)" "unprognostic (2.35e-2)" "unprognostic (1.35e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.69e-4)" "unprognostic (5.68e-3)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (3.73e-5)" 2.6 0.8 0.5 7.1 0.7 0.2 0.7 0.3 1.0 5.2 24.4 1.4 18.4 1.9 14.0 10.1 16.0 4.8 13.3 70.0 0.8 0.5 0.4 0.3 1.4 0.3 1.4 0.5 3.1 0.6 1.0 0.3 0.6 1.9 11.9 2.1 1.7 3.1 20.2 546.8 1.0 5.2 69.0 4.7 0.3 10.0 1.3 0.6 0.0 4.7 40.0 2.2 39.6 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 7.3 8.8 0.8 80.1 15.2 22.8 11.0 24.9 0.2 0.0 13.5 36.4 9.3 0.0 4.8 0.1 13.6 0.0 2.7 0.0 4.1 0.0 9.2 0.0 0.0 16.6 0.0 39.6 0.0 9.3 14.2 0.0 9.6 0.0 15.5 0.0 0.0 0.3 13.3 0.0 4.6 0.0 26.5 0.2 0.0 0.0 0.4 1.4 0.1 0.0 0.0 19.2 0.1 0.3 29.3 8.0 34.2 2.0 0.0 0.0 0.0 0.0 27.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.6 0.8 0.5 1.4 0.5 1.9 0.6 3.0 0.3 0.0 0.1 3.3 0.4 1815.4 0.0 0.0 3.4 1.8 0.0 0.3 0.0 0.6 0.2 6.2 0.0 0.0 0.2 0.7 11.9 1.4 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.0 4.9 0.8 5.0 0.0 0.0 0.1 1.8 0.0 9.9 1.0 0.1 0.0 45.3 0.2 0.4 4.0 1.6 0.0 0.0 0.4 FLRT3 ENSG00000125848 "Fibronectin leucine rich transmembrane protein 3" Q9NZU0 20 14322988-14337616 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.1" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 116.8;Basal glandular cells: 129.3;Club cells: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.6;hTCEpi: 29.4;RPTEC TERT1: 9.9;WM-115: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056033 Enhanced Supported "Plasma membrane,Cell Junctions,Cytosol" "Intracellular and membrane" NA NA 240000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA056033: AB_2683016" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.98e-1)" "unprognostic (1.14e-3)" "unprognostic (2.30e-1)" "unprognostic (6.00e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.85e-5)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (3.05e-1)" "prognostic favorable (1.49e-7)" "unprognostic (1.54e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-3)" "unprognostic (3.65e-1)" 7.3 4.3 3.4 2.2 7.4 0.1 2.7 27.5 18.9 3.8 5.0 0.7 3.2 12.4 2.6 5.5 2.5 2.7 5.6 1.6 9.3 4.1 43.1 28.9 26.2 0.2 2.3 5.3 11.9 2.3 4.6 2.1 2.0 2.9 12.7 1.0 1.9 1.5 16.4 2.1 6.9 6.0 3.9 2.3 0.8 9.7 1.7 0.7 4.8 8.5 1.8 0.4 12.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 15.6 0.0 0.0 0.0 0.0 1.5 0.4 0.1 0.0 8.5 3.1 0.0 0.5 0.3 0.0 4.4 0.0 4.6 0.1 0.0 1.0 0.0 0.2 0.1 1.3 0.0 0.0 2.7 29.4 0.0 5.5 0.0 0.0 0.1 0.0 0.1 3.0 0.2 1.9 0.0 5.1 3.4 0.0 0.0 0.1 0.0 9.9 1.9 0.3 3.2 0.0 0.0 4.9 9.2 0.2 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 7.4 27.5 18.9 9.3 4.1 2.3 5.3 2.9 0.7 202.5 116.8 0.0 129.3 7.7 13.3 0.9 17.8 22.7 126.3 21.0 5.9 0.3 11.6 18.8 0.0 1.6 2.0 0.0 13.0 0.0 5.4 11.3 4.7 7.8 0.2 6.4 10.9 1.8 0.0 0.2 3.4 0.9 5.0 2.8 1.0 0.5 9.4 2.9 0.4 41.7 2.9 0.0 0.1 0.0 0.0 14.4 0.0 0.5 1.5 9.0 FLYWCH1 DKFZp761A132 ENSG00000059122 "FLYWCH-type zinc finger 1" Q4VC44 16 2911937-2951208 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040753, HPA041001" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA040753: AB_10794880, HPA041001: AB_10794259" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" "unprognostic (2.93e-1)" "unprognostic (2.06e-3)" "unprognostic (1.71e-1)" "unprognostic (2.68e-2)" "unprognostic (3.51e-2)" "unprognostic (1.92e-1)" "unprognostic (7.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-3)" "unprognostic (6.61e-2)" "unprognostic (1.61e-1)" "unprognostic (3.84e-2)" "unprognostic (7.33e-2)" "unprognostic (2.19e-3)" "unprognostic (7.91e-2)" 15.6 16.6 13.1 12.6 17.2 12.5 10.2 24.4 27.4 13.6 12.2 17.7 9.5 14.7 14.3 13.4 11.8 11.9 15.0 16.7 12.1 15.9 10.1 5.9 10.7 11.6 15.8 18.5 21.4 12.2 22.6 12.2 9.5 18.8 13.9 4.7 25.3 14.4 15.6 28.1 22.8 14.4 14.1 16.2 19.9 11.0 5.1 10.9 8.5 11.5 8.4 10.3 17.1 15.7 4.6 1.6 2.3 1.6 0.9 5.5 2.1 5.1 18.1 4.1 12.3 6.7 6.9 12.6 9.5 7.5 4.8 4.9 3.0 16.7 12.5 25.4 7.2 7.9 10.7 3.4 6.4 1.0 20.8 10.3 4.2 15.2 10.0 15.1 5.5 14.6 6.1 20.2 10.1 7.4 8.9 6.8 8.4 9.3 13.3 3.7 12.2 12.6 6.7 6.7 3.8 12.4 22.2 6.2 22.4 5.6 3.5 8.9 8.3 10.0 10.9 12.7 2.4 8.5 10.1 12.7 8.1 7.4 15.6 6.3 19.7 16.9 11.2 8.8 9.1 9.4 2.3 1.6 0.6 3.0 0.7 4.9 2.0 4.5 5.5 1.6 4.6 3.9 3.4 0.2 0.9 0.8 1.0 2.2 2.1 13.1 17.2 24.4 27.4 12.1 15.9 15.8 18.5 18.8 10.9 0.0 3.4 2.2 9.5 11.0 41.7 10.2 10.2 4.0 2.3 21.0 33.4 15.4 1.7 6.0 0.4 11.3 5.9 0.0 5.7 6.9 10.4 4.2 0.0 5.5 7.4 31.8 2.4 11.1 13.3 0.9 10.3 5.3 8.5 9.0 4.4 16.6 5.4 3.5 13.4 4.8 36.2 0.0 15.1 0.7 3.2 12.2 7.3 7.2 6.2 5.9 FMN1 "DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289" ENSG00000248905 "Formin 1" Q68DA7 15 32765545-33194733 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 21.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 121.0;Cone photoreceptor cells: 208.1;Rod photoreceptor cells: 98.9" "Cancer enriched" "Detected in many" 9 "melanoma: 14.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 9.5;RH-30: 12.8;SK-MEL-30: 13.3;T-47d: 11.6;U-138 MG: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005465, HPA046786" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005465: AB_1859515, HPA046786: AB_10963545" "unprognostic (1.57e-1)" "unprognostic (5.92e-3)" "unprognostic (1.96e-1)" "unprognostic (2.10e-3)" "unprognostic (3.67e-2)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (2.84e-2)" "unprognostic (3.44e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "unprognostic (2.89e-2)" "unprognostic (3.73e-1)" "unprognostic (4.32e-1)" "unprognostic (7.61e-2)" 7.0 2.1 3.7 3.9 5.3 2.2 4.9 0.6 12.1 8.9 8.5 1.8 2.6 2.6 2.2 4.8 3.9 5.1 4.0 2.4 3.3 2.0 4.7 1.4 7.7 3.3 5.9 7.3 1.1 2.5 2.6 8.0 5.1 4.6 3.8 6.9 21.9 6.4 2.5 2.2 9.2 4.3 3.7 6.4 3.0 11.7 12.4 4.6 1.8 4.7 1.5 2.0 2.7 6.8 0.6 1.8 2.8 0.7 0.1 0.7 0.1 1.6 1.8 0.3 0.2 0.0 0.2 2.0 2.3 1.9 0.6 1.7 0.2 2.2 0.2 0.8 2.8 1.6 1.4 0.0 1.5 1.8 0.0 0.1 1.3 0.4 0.1 0.1 0.0 0.1 0.7 0.0 2.8 0.0 1.3 0.0 0.0 0.0 9.5 4.1 1.7 0.0 0.0 0.5 3.2 0.1 0.2 12.8 2.2 0.8 0.6 0.1 0.3 0.0 1.5 13.3 0.4 11.6 0.0 1.6 7.4 1.2 6.8 0.7 0.0 0.0 0.4 3.5 0.0 4.6 2.8 0.7 0.0 0.3 0.0 0.5 0.0 0.7 0.6 1.4 0.6 0.4 0.0 0.1 0.1 0.0 1.8 0.1 0.1 3.7 5.3 0.6 12.1 3.3 2.0 5.9 7.3 4.6 4.6 38.7 42.2 0.5 2.3 3.3 121.0 3.2 12.7 38.8 27.3 0.0 208.1 9.7 10.0 4.9 11.6 0.7 5.9 0.0 1.6 3.5 1.1 6.3 22.1 0.5 9.0 44.5 8.6 0.0 28.5 9.5 0.9 16.2 32.1 5.4 16.7 4.3 7.1 9.3 0.7 1.1 98.9 0.0 0.9 19.5 14.9 3.0 15.3 1.3 7.9 4.0 FMNL1 "C17orf1, C17orf1B, FMNL" ENSG00000184922 "Formin like 1" O95466 17 45221444-45247320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 107.4;lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 52.5;Kupffer cells: 54.4;Macrophages: 116.9;monocytes: 95.6;T-cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 50.4;MOLT-4: 34.6;U-266/70: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008129, HPA028288" Enhanced Approved Cytosol NA NA Cytosol "HPA008129: AB_1848963, HPA028288: AB_10612110" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (8.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.24e-2)" "unprognostic (2.01e-1)" "unprognostic (1.58e-1)" "unprognostic (5.44e-2)" "unprognostic (6.06e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "prognostic unfavorable (4.23e-8)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (3.46e-2)" "unprognostic (2.16e-1)" 8.6 3.8 10.7 29.7 9.6 107.4 7.5 8.1 16.1 4.6 5.2 4.2 0.8 5.8 2.6 5.8 4.5 6.1 9.1 5.8 13.4 6.0 4.2 3.6 22.2 38.1 6.1 6.4 3.1 3.6 3.6 7.4 7.4 7.2 4.3 4.1 3.3 8.4 2.3 2.5 4.2 14.9 4.3 6.2 45.9 6.6 2.7 3.3 56.6 3.9 4.1 22.8 11.3 4.6 3.5 4.3 22.3 5.6 5.4 7.6 3.5 4.2 8.3 0.0 0.4 0.0 1.9 0.4 0.5 1.1 3.1 2.3 0.4 1.9 13.1 4.3 0.1 3.3 0.7 0.0 0.1 1.0 22.9 1.1 7.6 12.3 0.6 8.9 19.7 26.8 1.4 0.3 4.1 1.8 4.3 0.0 14.6 0.6 50.4 2.3 2.7 34.6 20.4 0.4 0.5 0.2 21.9 2.9 23.4 0.8 0.5 2.6 1.2 2.5 0.4 1.0 0.7 2.4 16.1 1.0 0.2 3.0 0.5 18.5 42.1 18.5 13.4 0.3 16.1 0.6 6.8 5.1 8.2 7.0 5.6 4.7 3.5 5.5 7.6 4.3 3.3 3.6 4.8 22.3 5.4 4.2 2.5 6.0 3.5 10.7 9.6 8.1 16.1 13.4 6.0 6.1 6.4 7.2 3.3 3.0 4.8 52.5 2.8 5.5 4.0 1.9 2.5 1.4 1.2 1.8 0.0 0.4 0.0 1.1 2.0 2.9 0.0 0.0 0.8 1.0 10.7 1.9 23.0 0.5 43.3 3.2 1.2 8.6 54.4 0.7 4.9 116.9 42.2 95.6 0.1 0.9 0.4 0.0 0.0 0.6 1.2 6.5 3.8 0.5 1.7 5.4 2.1 97.0 0.2 1.4 FMNL2 "FHOD2, KIAA1902" ENSG00000157827 "Formin like 2" Q96PY5 2 152335237-152649834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7;non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 5 "monocytes: 4.2" "Cell line enhanced" "Detected in many" "BEWO: 57.7;hTERT-HME1: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005464 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA005464: AB_1848965" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (8.75e-3)" "unprognostic (3.06e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (9.04e-4)" "unprognostic (1.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (2.54e-1)" "unprognostic (4.66e-2)" "unprognostic (5.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.58e-1)" "unprognostic (3.73e-2)" "unprognostic (1.58e-1)" 15.1 13.6 26.2 7.0 44.6 0.8 9.4 18.3 55.0 8.5 6.6 55.0 1.4 5.8 13.6 10.2 4.6 6.7 11.1 4.8 32.0 20.6 9.7 5.3 17.9 8.2 63.4 27.9 35.9 7.4 17.8 10.2 35.9 39.2 8.9 8.4 5.4 20.1 8.2 31.0 4.0 5.5 10.7 74.1 12.0 8.2 5.8 56.7 1.3 14.5 3.2 5.4 9.1 11.6 0.0 0.9 0.0 4.2 0.0 0.1 0.0 4.1 4.4 13.8 7.6 16.7 18.1 57.7 4.2 8.7 7.5 10.6 4.7 0.2 0.0 9.0 3.6 16.2 4.7 6.6 13.5 12.0 0.0 7.0 0.0 2.8 20.2 4.8 1.1 0.2 11.8 8.4 14.5 37.5 14.6 13.2 1.9 0.1 0.1 4.1 1.1 0.2 1.3 8.8 3.6 8.9 7.4 2.9 6.0 21.9 2.9 14.1 11.5 3.6 1.3 14.6 12.2 0.3 0.4 14.7 11.4 0.3 3.8 7.2 0.4 0.1 0.0 10.5 0.9 23.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.2 0.9 0.1 0.0 26.2 44.6 18.3 36.7 32.0 20.6 63.4 27.9 39.2 56.7 23.8 23.4 0.8 14.1 23.5 20.5 2.8 2.5 10.7 23.9 10.4 0.0 30.2 11.6 15.8 18.3 19.7 1.4 0.0 5.9 11.6 29.6 14.2 1.1 1.3 36.8 0.0 7.9 16.0 47.8 6.5 32.5 31.0 6.8 4.6 3.0 3.6 8.9 0.0 38.9 6.3 1.3 6.5 9.0 6.2 6.9 14.8 22.5 1.9 6.6 10.1 FMNL3 "DKFZp762B245, MGC45819, WBP3" ENSG00000161791 "Formin like 3" Q8IVF7 12 49636499-49708165 "Predicted intracellular proteins" Angiogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 37.3;granulocytes: 26.6;monocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 24.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002552, HPA023201" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Vesicles, Plasma membrane" Cytosol "HPA002552: AB_1078862, HPA023201: AB_1848575" "unprognostic (2.97e-1)" "unprognostic (2.77e-3)" "unprognostic (4.97e-3)" "unprognostic (7.19e-2)" "unprognostic (5.42e-2)" "unprognostic (2.33e-3)" "unprognostic (5.37e-3)" "unprognostic (1.52e-2)" "unprognostic (2.83e-1)" "unprognostic (1.54e-1)" "unprognostic (6.67e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (3.58e-5)" "unprognostic (1.04e-1)" "unprognostic (2.31e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" 18.3 6.4 10.1 19.9 10.7 5.0 13.8 8.5 11.2 9.3 8.0 23.2 6.3 6.0 13.5 20.8 5.1 7.5 13.0 12.6 10.6 9.0 10.1 3.1 18.0 22.5 14.0 7.7 18.9 3.8 3.7 5.0 14.4 12.9 7.5 6.2 9.8 5.0 5.1 6.3 4.8 10.7 12.3 14.2 13.0 6.7 10.5 11.3 16.2 15.0 5.1 27.9 9.6 7.7 1.7 8.6 3.6 0.7 1.1 1.5 0.7 4.4 1.3 9.8 3.2 2.7 11.1 0.1 5.4 11.1 7.4 6.6 5.0 1.2 9.4 10.5 6.4 8.2 0.2 5.0 2.3 6.8 8.3 1.9 10.3 1.4 0.2 4.8 2.0 13.5 6.9 0.3 11.6 4.9 22.2 19.6 4.7 2.3 6.9 10.8 3.2 8.3 3.0 3.2 0.4 2.9 4.1 12.3 1.4 7.0 0.6 1.6 4.6 3.1 0.4 6.4 5.2 0.8 3.0 24.7 18.5 6.4 0.3 9.3 3.6 0.2 5.1 11.5 6.4 7.7 3.6 0.3 1.2 1.5 0.7 0.7 0.4 0.5 0.9 0.4 1.7 0.8 0.9 0.0 1.1 0.6 8.6 0.3 0.7 10.1 10.7 8.5 11.2 10.6 9.0 14.0 7.7 12.9 11.3 3.0 4.3 11.5 0.6 1.4 6.2 2.0 0.0 0.0 2.3 1.8 37.3 1.5 0.0 0.2 1.1 14.8 0.0 0.0 0.6 1.0 2.9 0.3 26.6 0.4 10.5 3.2 0.0 14.1 4.1 3.9 3.4 10.4 5.0 36.9 0.6 0.5 0.6 0.0 6.0 0.0 1.9 12.9 7.5 3.4 7.2 1.3 2.1 6.9 0.0 0.4 FMO4 FMO2 ENSG00000076258 "Flavin containing monooxygenase 4" P31512 1 171314208-171342084 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 33.8;liver: 42.2" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 24.9;Hepatocytes: 19.8;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 7.9;HSkMC: 9.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA049100, HPA072438" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA049100: AB_2680629, HPA072438: " "unprognostic (1.83e-2)" "unprognostic (1.17e-1)" "unprognostic (6.18e-2)" "unprognostic (3.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.13e-1)" "prognostic favorable (1.09e-4)" "prognostic favorable (7.45e-4)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (5.99e-2)" "unprognostic (2.90e-1)" "prognostic favorable (6.96e-4)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-3)" "unprognostic (1.95e-1)" 5.3 3.6 1.4 5.1 4.8 0.9 4.5 0.6 2.7 4.5 6.0 4.8 3.1 4.2 3.0 10.0 4.6 3.8 4.6 6.3 2.3 1.5 33.8 42.2 3.4 2.8 7.5 2.8 4.1 3.2 5.5 5.0 2.3 3.7 3.9 3.7 6.7 2.7 2.0 1.6 2.9 16.1 2.0 7.0 3.8 3.9 2.0 6.2 2.7 4.5 3.3 3.4 2.9 3.7 5.3 2.9 0.9 4.0 3.9 4.9 2.0 0.1 0.0 0.4 0.6 5.5 5.0 0.2 1.1 5.0 1.6 1.7 0.8 7.2 4.4 7.9 0.0 2.6 0.3 0.8 1.3 2.2 2.1 1.1 0.0 0.0 0.1 0.8 0.9 1.0 9.3 3.2 0.6 1.3 0.6 0.3 2.2 0.2 3.3 0.7 1.0 2.1 1.9 0.5 1.3 1.6 0.4 0.5 2.5 3.5 0.0 0.2 0.0 1.5 1.5 3.0 5.7 3.1 1.3 0.1 1.3 0.4 1.4 1.0 4.0 1.3 2.7 2.4 1.5 1.1 0.6 2.6 0.9 2.5 4.0 1.8 3.1 2.4 3.3 2.2 5.3 3.3 2.5 0.5 3.9 2.7 2.9 4.9 2.0 1.4 4.8 0.6 2.7 2.3 1.5 7.5 2.8 3.7 6.2 0.0 1.6 0.5 3.8 2.5 0.0 3.5 2.5 6.7 0.0 8.7 0.0 2.1 24.9 1.6 4.0 0.9 8.6 0.0 1.2 1.2 3.1 1.1 1.1 19.8 3.2 0.0 1.2 1.8 5.7 0.4 1.4 2.3 5.0 1.8 1.9 1.5 0.9 0.0 0.4 33.2 0.0 0.0 1.2 0.2 0.2 1.4 1.6 0.5 1.4 1.7 FMO5 ENSG00000131781 "Flavin containing monooxygenase 5" P49326 1 147175351-147243050 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 61.1;liver: 119.4;stomach 1: 38.6" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 117.2;Hepatocytes: 260.8" "Cancer enriched" "Detected in many" 7 "liver cancer: 43.0" "Group enriched" "Detected in many" 6 "basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Hep G2: 29.0;HMC-1: 6.6;THP-1: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012373 Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA012373: AB_1848975" "unprognostic (2.70e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (3.96e-2)" "unprognostic (2.43e-2)" "unprognostic (2.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-2)" "unprognostic (2.93e-1)" "unprognostic (1.13e-1)" "prognostic favorable (1.34e-6)" "unprognostic (3.77e-1)" "unprognostic (1.38e-1)" "unprognostic (1.85e-1)" "unprognostic (4.11e-2)" 1.1 2.4 1.1 1.9 5.5 0.2 8.6 0.6 4.5 1.3 61.1 1.5 0.8 12.5 1.0 1.3 0.7 1.1 8.5 1.0 1.3 0.5 9.0 119.4 17.0 0.8 17.1 0.5 1.0 11.9 8.8 4.9 0.6 5.2 1.9 8.2 0.5 9.7 0.6 0.4 4.2 53.6 0.9 7.1 1.2 38.6 1.2 6.0 0.2 1.1 1.5 0.5 1.9 0.8 9.2 4.9 6.2 12.1 1.0 2.0 3.6 0.1 0.7 0.5 0.1 1.9 0.5 0.7 0.4 0.4 0.2 0.6 0.4 1.5 0.3 0.5 0.4 0.1 0.3 0.0 0.0 0.0 1.0 0.1 1.2 0.0 29.0 0.6 1.0 6.6 0.9 0.1 0.3 0.0 0.3 0.4 0.2 0.1 0.1 1.1 1.0 0.2 0.5 2.1 3.6 0.5 0.3 0.3 0.2 2.4 0.4 0.4 0.2 0.6 2.0 0.9 1.0 1.4 7.4 0.7 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.7 0.3 0.2 6.2 12.1 3.5 2.0 5.6 0.3 3.6 0.5 0.6 4.9 9.2 0.3 1.3 1.2 1.0 1.6 2.4 1.4 3.6 1.1 5.5 0.6 4.5 1.3 0.5 17.1 0.5 5.2 6.0 8.9 48.6 8.5 3.5 1.4 2.0 1.4 117.2 21.4 13.6 14.0 0.0 1.2 6.6 4.3 5.9 2.7 52.0 0.0 5.1 0.9 1.3 4.1 5.7 260.8 3.2 3.2 6.4 3.1 10.1 4.1 2.6 2.6 27.0 0.0 25.3 0.3 5.7 28.1 1.4 41.5 1.3 0.0 0.8 1.8 0.7 1.4 1.1 4.3 16.4 6.2 FMR1 "FMRP, FRAXA, MGC87458, POF, POF1" ENSG00000102081 "Fragile X mental retardation 1" Q06787 X 147911951-147951125 "Disease related genes, Predicted intracellular proteins" "DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Disease mutation, Mental retardation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012444, HPA050118, HPA056084" Approved Enhanced Cytosol NA NA Cytosol "CAB012444: AB_732400, HPA050118: AB_2681023, HPA056084: AB_2683033" "unprognostic (4.11e-1)" "unprognostic (1.25e-3)" "unprognostic (1.89e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (6.45e-3)" "unprognostic (2.59e-2)" "unprognostic (1.26e-2)" "unprognostic (2.29e-2)" "unprognostic (3.30e-2)" "unprognostic (3.15e-3)" "unprognostic (6.56e-2)" "unprognostic (2.24e-1)" "unprognostic (1.55e-1)" "unprognostic (5.98e-2)" 14.9 13.3 24.8 14.9 21.1 28.3 14.3 32.6 25.7 16.0 14.5 17.7 14.4 13.3 21.2 33.2 13.9 18.3 12.3 15.0 22.2 19.0 26.5 30.3 15.3 15.7 23.3 22.8 23.4 11.5 27.8 20.5 49.9 18.9 15.4 15.0 14.0 12.7 19.6 7.8 17.7 15.9 18.3 23.1 20.1 13.2 14.5 19.2 21.7 29.0 9.8 16.1 17.1 27.3 5.3 3.4 7.3 3.5 4.9 7.4 2.4 15.0 13.5 14.1 9.5 8.7 7.0 11.3 8.2 8.6 13.1 23.8 14.9 14.3 30.1 33.9 10.1 15.3 26.1 22.5 10.1 14.7 11.8 15.7 8.5 25.2 13.9 9.0 9.3 5.3 7.6 5.8 11.1 10.4 8.0 10.9 8.3 5.2 20.0 11.7 19.6 10.5 6.9 6.3 10.5 7.7 11.8 40.5 12.7 15.3 40.5 12.5 8.1 9.4 8.6 12.1 20.4 7.6 8.5 10.4 10.7 9.2 13.1 20.4 21.5 21.4 32.4 9.7 16.1 5.6 2.8 2.7 6.6 6.0 3.5 7.4 4.7 3.9 6.6 3.4 5.3 5.0 5.8 7.3 4.9 3.2 2.8 4.7 2.4 24.8 21.1 32.6 25.7 22.2 19.0 23.3 22.8 18.9 19.2 53.6 28.2 11.2 14.2 27.8 32.9 34.1 10.2 22.7 25.0 21.0 11.8 29.8 16.6 12.9 0.8 23.7 20.0 0.0 8.5 37.5 23.5 17.7 19.6 32.7 13.8 66.7 14.3 16.5 24.3 2.3 27.9 14.5 33.7 6.4 14.6 37.0 11.3 18.1 28.0 32.1 28.8 6.5 25.5 8.4 16.8 28.2 34.1 16.0 14.2 22.9 FNBP1L "C1orf39, FLJ20275, TOCA1" ENSG00000137942 "Formin binding protein 1 like" Q5T0N5 1 93448131-93554661 "Predicted intracellular proteins" "Autophagy, Endocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 11.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.1" "Cell line enhanced" "Detected in many" "SuSa: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065273 Approved Supported Cytosol NA NA Cytosol "HPA065273: AB_2685452" "unprognostic (1.83e-1)" "unprognostic (4.28e-2)" "unprognostic (2.57e-3)" "unprognostic (8.46e-2)" "unprognostic (7.68e-2)" "unprognostic (8.65e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (5.89e-2)" "unprognostic (1.74e-1)" "unprognostic (6.35e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic favorable (4.72e-7)" "unprognostic (3.59e-2)" "unprognostic (5.64e-2)" "unprognostic (2.74e-2)" "unprognostic (1.78e-1)" 22.8 6.8 17.8 8.3 36.0 1.7 27.0 20.3 11.3 15.7 24.3 5.4 27.3 16.5 14.2 15.9 7.6 11.4 11.9 16.3 13.0 13.7 29.9 10.9 18.0 3.3 10.5 10.3 12.2 15.0 16.0 15.6 13.7 14.0 14.5 14.5 5.6 32.2 23.2 23.4 10.3 27.5 10.3 13.9 2.6 19.0 12.0 16.1 2.5 26.3 7.1 3.3 15.2 24.2 0.9 2.2 11.1 0.1 0.1 0.4 0.2 9.9 5.5 29.1 16.2 6.3 4.6 32.5 5.0 3.4 3.8 5.3 6.9 3.1 0.0 10.4 4.8 10.2 5.1 7.0 5.7 5.4 6.4 5.2 5.3 8.1 10.0 3.1 0.9 0.1 8.2 9.5 3.5 5.2 9.9 17.9 6.3 2.0 0.0 8.9 4.6 3.8 0.4 22.1 17.0 5.6 8.4 22.2 2.6 16.6 16.0 11.7 16.5 15.6 30.6 8.7 36.1 11.6 1.3 17.7 8.9 11.3 0.2 3.4 3.1 2.5 0.1 0.8 0.1 6.0 11.1 0.1 1.1 0.0 0.0 0.1 0.6 0.4 0.0 0.5 0.9 0.0 0.4 0.1 0.1 0.0 2.2 0.4 0.2 17.8 36.0 20.3 11.3 13.0 13.7 10.5 10.3 14.0 16.1 101.3 29.0 3.7 34.3 23.6 13.4 37.0 50.9 60.2 73.9 59.3 3.9 29.1 48.0 67.0 9.4 31.9 31.6 0.0 42.3 30.4 14.6 55.7 15.1 18.3 9.5 65.2 64.3 16.0 5.6 13.7 7.5 10.6 37.1 10.8 30.8 17.3 48.1 38.4 3.5 42.3 9.3 25.8 12.2 20.7 37.1 22.5 14.3 2.6 31.4 72.9 FNDC3A "bA203I16.5, FNDC3, KIAA0970" ENSG00000102531 "Fibronectin type III domain containing 3A" Q9Y2H6 13 48975912-49209779 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008927, HPA012555, HPA012825" Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Centrosome" Cytosol "HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985" "unprognostic (1.54e-1)" "unprognostic (1.34e-3)" "unprognostic (8.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (2.91e-2)" "unprognostic (5.71e-2)" "unprognostic (6.17e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-2)" "unprognostic (4.03e-2)" "prognostic favorable (4.25e-4)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (9.60e-2)" "unprognostic (6.14e-2)" 13.9 27.2 16.9 14.8 24.9 10.0 17.4 19.4 15.0 25.3 22.3 14.6 32.0 17.8 22.4 32.2 10.6 18.2 17.9 14.0 15.0 23.1 20.4 43.0 18.1 12.0 14.6 14.8 25.0 37.4 14.1 59.0 79.8 15.7 15.6 16.2 15.1 22.5 31.6 9.1 9.2 24.7 17.5 14.8 16.2 18.5 18.8 16.6 13.2 34.2 11.6 12.7 17.8 15.4 6.6 7.6 8.7 6.9 3.9 7.9 3.2 4.5 5.2 19.2 5.0 24.3 30.8 3.7 21.3 28.5 20.6 15.0 7.1 11.1 3.4 4.0 16.0 8.9 4.9 11.4 7.2 30.0 8.6 8.8 5.6 15.0 13.0 14.8 5.2 0.9 15.7 10.1 18.2 21.2 19.3 21.2 4.8 6.9 8.5 22.3 1.8 5.1 10.4 9.4 9.8 4.4 4.9 7.6 6.3 17.3 8.4 7.3 12.0 8.0 7.2 15.2 12.7 3.8 10.2 16.6 10.7 7.4 9.9 15.0 10.4 5.4 3.2 8.1 6.7 11.0 3.4 5.7 3.6 5.2 4.0 7.5 6.6 6.1 4.4 3.6 4.9 7.9 6.7 8.7 3.9 6.9 7.6 4.7 3.2 16.9 24.9 19.4 14.5 15.0 23.1 14.6 14.8 15.7 16.6 50.6 43.5 17.9 23.8 16.4 46.2 21.6 25.5 32.1 30.7 34.9 35.3 10.1 11.6 24.5 39.5 33.8 23.2 0.0 31.5 29.4 31.7 42.8 30.1 63.7 22.7 33.4 41.8 27.6 26.5 7.9 31.4 34.7 35.4 25.2 35.7 64.1 29.0 25.4 37.1 38.9 46.7 6.5 26.9 73.8 28.1 10.5 27.0 19.3 22.5 24.4 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.9;liver: 57.6" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 165.4;Hepatocytes: 113.4;Late spermatids: 388.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.0;ASC diff: 17.4;HUVEC TERT2: 20.9;SH-SY5Y: 16.3;TIME: 19.0;U-87 MG: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Aggresome, Cytosol" "HPA051804: AB_2681617, HPA063581: AB_2685048" "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavorable (6.11e-4)" 18.5 45.9 13.4 2.7 13.7 0.7 9.1 10.8 29.5 3.8 2.0 4.0 0.5 1.5 2.8 2.8 11.8 1.5 10.0 3.1 15.6 8.5 2.3 57.6 2.0 1.4 12.0 8.6 16.5 4.6 18.6 2.8 2.5 22.2 6.3 2.1 1.9 2.1 3.3 1.3 2.4 1.4 4.7 5.4 3.5 3.2 10.2 3.8 0.0 1.8 0.7 2.7 4.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 17.0 17.4 10.7 0.1 3.9 7.8 2.8 2.5 0.7 0.2 0.0 0.4 12.3 3.7 0.0 6.5 2.3 2.5 0.0 1.0 0.8 0.0 8.7 6.5 0.0 0.1 9.1 1.1 4.9 1.0 12.9 20.9 0.0 0.9 0.0 10.3 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.1 16.3 0.1 0.0 0.1 1.3 0.0 0.0 19.0 2.7 1.2 1.0 3.0 0.0 0.0 0.0 14.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.7 10.8 29.5 15.6 8.5 12.0 8.6 22.2 3.8 0.0 0.3 0.0 2.8 3.1 8.2 2.5 10.2 0.0 0.0 0.0 3.9 0.1 3.3 68.5 165.4 5.8 0.0 0.0 41.6 0.1 8.1 14.7 5.7 113.4 0.5 0.0 0.0 6.2 1.3 388.8 14.4 0.6 3.3 1.8 0.0 12.3 60.5 0.0 11.0 0.2 11.8 0.0 11.3 4.9 3.6 2.0 0.0 0.0 0.0 1.0 FNIP2 "FNIPL, KIAA1450, MAPO1" ENSG00000052795 "Folliculin interacting protein 2" Q9P278 4 158769138-158908049 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.8;myeloid DC: 3.1;non-classical monocyte: 9.4" "Group enriched" "Detected in many" 6 "dendritic cells: 3.1;monocytes: 9.4" "Cell line enhanced" "Detected in many" "HDLM-2: 62.4;U-266/70: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042779, HPA052758, HPA072420" Approved Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA042779: AB_10794386, HPA052758: , HPA072420: AB_2732200" "unprognostic (3.38e-2)" "unprognostic (2.26e-1)" "unprognostic (2.06e-2)" "unprognostic (4.02e-1)" "unprognostic (1.46e-1)" "unprognostic (3.56e-1)" "unprognostic (1.56e-1)" "unprognostic (2.18e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (7.93e-2)" "unprognostic (1.77e-1)" "prognostic favorable (3.96e-11)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (2.67e-1)" "unprognostic (7.10e-2)" 23.6 8.6 12.5 7.4 15.5 5.8 11.3 10.9 16.0 10.4 15.7 17.5 11.4 5.6 9.3 9.8 11.0 7.6 15.3 20.9 15.1 9.1 35.5 44.0 21.8 12.0 14.1 14.4 8.5 14.2 13.0 5.2 21.7 11.1 8.5 16.8 8.0 10.0 14.7 15.3 11.4 8.1 13.3 12.9 9.6 16.3 7.2 15.0 5.5 13.9 8.3 4.1 9.3 9.5 0.0 3.1 0.6 9.4 0.9 1.0 0.5 1.4 1.6 6.9 3.6 5.2 3.3 7.7 3.0 3.2 3.1 3.5 1.8 1.4 0.0 0.7 11.0 3.9 1.3 6.6 3.1 3.8 62.4 2.4 6.6 0.9 2.5 3.3 2.7 13.2 2.4 2.7 2.1 2.8 4.7 3.5 3.5 3.9 0.3 5.3 0.4 6.3 0.3 2.2 4.5 1.6 3.7 3.4 1.8 2.5 3.6 4.5 4.0 1.7 1.1 7.0 2.3 1.4 1.5 4.4 5.2 3.2 3.5 2.2 21.1 8.8 1.3 5.1 3.3 3.6 0.6 1.1 0.3 0.7 4.8 0.4 0.0 0.4 0.3 3.1 0.0 0.4 1.0 0.2 0.9 9.4 0.6 0.1 0.5 12.5 15.5 10.9 16.0 15.1 9.1 14.1 14.4 11.1 15.0 17.9 99.9 7.6 29.3 31.6 17.1 51.3 45.9 20.1 29.6 38.4 51.1 11.5 19.9 30.8 10.5 63.3 49.6 0.0 67.9 5.1 26.6 43.7 27.6 77.0 56.9 9.5 60.0 78.5 68.8 8.2 12.4 58.9 38.8 20.8 43.1 3.8 80.3 63.3 9.2 56.1 27.2 51.8 34.1 16.6 25.4 32.1 6.9 11.5 37.2 27.8 FNTA "FPTA, PGGT1A, PTAR2" ENSG00000168522 "Farnesyltransferase, CAAX box, alpha" P49354 8 43034194-43085788 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010149, HPA018830" Approved Approved Cytosol NA NA 220000 Cytosol "CAB010149: AB_2106299, HPA018830: AB_1848992" "unprognostic (2.09e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-1)" "unprognostic (1.86e-3)" "unprognostic (2.64e-1)" "unprognostic (4.70e-3)" "unprognostic (1.83e-2)" "unprognostic (3.69e-2)" "unprognostic (1.70e-2)" "unprognostic (5.37e-2)" "unprognostic (3.25e-2)" "unprognostic (4.10e-1)" "prognostic unfavorable (2.94e-12)" "unprognostic (3.63e-2)" "unprognostic (2.33e-1)" "unprognostic (3.19e-2)" "unprognostic (1.29e-3)" 32.5 21.5 25.3 20.9 31.9 15.3 29.8 21.2 28.8 26.7 25.7 36.9 25.0 23.7 23.7 29.4 28.0 22.9 18.1 32.6 25.6 23.1 24.0 30.5 22.7 27.4 43.3 23.8 21.5 26.0 17.9 24.7 32.6 33.4 25.1 22.5 14.1 23.6 25.9 45.2 29.7 20.4 23.9 75.9 22.9 20.9 18.3 36.8 26.0 25.4 26.8 28.1 27.1 29.8 11.7 11.7 11.1 8.9 13.9 11.9 5.3 24.0 11.9 16.5 5.3 29.0 37.8 13.7 14.0 16.4 16.4 15.1 19.3 18.6 28.3 10.8 17.6 21.8 13.2 20.3 23.3 19.3 7.4 13.4 22.1 8.1 16.6 37.8 9.0 11.9 29.2 38.1 11.8 33.8 23.7 28.1 15.3 26.8 16.6 18.0 2.8 21.6 13.8 28.5 20.4 8.7 18.9 26.2 15.2 22.5 17.9 9.8 15.2 18.2 15.1 24.0 19.5 19.2 17.1 22.6 5.5 7.2 22.3 14.9 15.6 13.1 27.6 14.5 17.5 12.9 3.0 6.6 11.1 8.7 8.9 10.3 11.7 9.1 11.7 11.7 11.6 11.9 11.9 1.6 13.9 6.7 11.0 11.5 5.3 25.3 31.9 21.2 28.8 25.6 23.1 43.3 23.8 33.4 36.8 53.6 16.9 34.6 70.9 78.0 21.6 35.9 28.1 41.5 27.3 31.4 35.3 121.1 59.7 61.9 33.1 51.7 30.3 23.3 61.0 105.3 62.9 62.6 32.3 25.4 71.6 19.1 30.9 49.1 38.3 40.9 44.5 50.7 89.4 75.7 36.2 36.3 57.6 42.1 56.6 40.2 53.7 51.8 48.7 59.3 32.4 83.6 173.5 55.4 39.1 62.6 FOXC1 "ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1" ENSG00000054598 "Forkhead box C1" Q12948 6 1609972-1613897 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Deafness, Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "retina: 32.7;salivary gland: 86.6" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 40.9;Ito cells: 36.2;Urothelial cells: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 6 "NK-cells: 1.4" "Cell line enhanced" "Detected in many" "AN3-CA: 39.8;HEK 293: 38.8;RPTEC TERT1: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040670 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040670: AB_10673412" "unprognostic (2.65e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.53e-4)" "unprognostic (3.22e-2)" "unprognostic (3.22e-2)" "unprognostic (1.24e-1)" "unprognostic (3.30e-2)" "unprognostic (1.54e-2)" "unprognostic (4.04e-3)" "unprognostic (1.58e-1)" "unprognostic (2.33e-3)" "unprognostic (9.55e-2)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.04e-1)" "unprognostic (3.83e-3)" "unprognostic (3.74e-1)" 7.7 4.4 2.6 1.3 3.4 1.0 9.4 2.3 3.4 6.6 1.4 2.8 3.2 1.2 2.4 3.8 3.8 3.4 9.8 9.5 3.2 2.1 12.9 1.4 3.8 1.6 4.5 2.3 4.8 2.8 2.2 6.5 3.1 6.5 6.0 1.3 32.7 86.6 4.9 3.6 7.1 1.2 2.1 3.9 0.9 1.1 4.6 2.6 2.8 3.7 4.2 2.9 5.7 4.6 0.0 0.0 0.2 0.1 1.4 0.0 0.0 7.3 0.8 0.2 39.8 1.8 2.1 1.2 3.7 4.4 2.3 1.9 2.8 1.5 0.0 4.3 2.2 1.7 8.4 3.8 2.7 1.9 2.3 38.8 1.5 2.2 1.3 1.2 0.5 2.6 7.0 3.8 3.2 3.6 1.2 3.4 0.2 1.0 0.0 1.0 1.6 0.0 0.8 0.1 3.7 3.2 0.0 1.6 0.2 15.6 5.6 1.5 3.4 4.6 0.0 2.6 2.1 1.1 0.6 0.8 5.1 3.1 2.6 3.9 0.1 0.3 0.0 1.4 1.9 4.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.0 2.6 3.4 2.3 3.4 3.2 2.1 4.5 2.3 6.5 2.6 0.0 1.1 0.0 25.0 15.8 0.0 5.6 0.0 26.8 14.8 10.4 0.0 4.5 1.7 3.4 0.4 40.9 0.0 0.0 15.0 0.4 3.6 7.7 0.0 0.0 1.1 0.0 0.0 36.2 0.3 0.9 15.0 1.4 1.7 0.0 0.2 0.3 11.8 0.0 26.5 4.6 0.0 0.0 27.0 0.2 1.9 5.6 0.7 0.0 0.3 55.7 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857681-2877155 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.5;testis: 40.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 16.5;Erythroid cells: 23.3;Extravillous trophoblasts: 15.0;Late spermatids: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB017832 Uncertain Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.95e-6)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.7 1.7 1.0 9.3 0.9 13.8 2.4 0.4 1.2 2.0 6.5 0.4 1.1 6.0 1.2 2.1 13.5 0.4 4.1 1.2 0.8 0.6 1.3 1.6 2.8 6.6 0.8 0.3 0.8 0.6 0.0 0.5 3.9 0.9 0.9 8.2 0.6 2.6 1.1 0.7 3.7 7.1 4.4 1.2 5.0 3.2 40.1 0.4 47.5 0.6 11.4 11.6 2.0 3.7 0.7 0.6 1.0 0.6 0.4 1.9 0.1 28.5 29.0 22.5 20.7 3.4 4.5 28.7 18.7 18.4 37.9 34.4 36.6 25.6 18.5 4.0 26.7 43.1 22.2 33.7 17.1 37.2 34.5 18.0 20.8 27.8 15.6 0.5 16.7 17.1 2.3 1.9 35.2 24.8 9.0 26.7 21.2 11.6 41.5 29.8 26.8 22.7 7.9 49.7 29.7 21.7 16.5 34.2 9.6 8.9 18.3 12.7 20.1 23.9 20.1 10.9 44.4 19.6 18.7 10.7 30.8 46.8 35.9 64.8 5.5 9.1 26.8 14.3 16.1 32.6 0.4 0.6 0.1 0.4 0.2 0.4 0.7 0.5 0.4 0.2 0.7 0.9 0.3 1.0 0.4 0.1 0.6 1.9 0.1 1.0 0.9 0.4 1.2 0.8 0.6 0.8 0.3 0.9 0.4 0.0 2.2 0.8 0.7 2.6 1.6 0.5 2.5 0.0 1.2 1.8 3.9 1.4 1.7 0.2 16.5 0.3 1.7 23.3 0.0 15.0 1.3 0.8 0.0 0.9 7.3 4.8 0.0 3.1 1.9 20.0 0.9 1.7 0.0 1.8 3.7 0.6 0.2 0.0 0.7 0.0 4.4 0.0 0.0 7.6 5.9 1.3 1.6 2.5 3.7 1.3 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277979-109309220 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.1" "Cell type enhanced" "Detected in some" 21 "Spermatocytes: 1.8;Spermatogonia: 2.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Region enriched" "Detected in single" 11 "basal ganglia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.4;SCLC-21H: 6.4;SH-SY5Y: 6.6;U-266/70: 9.1" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA050018: AB_2680992" "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.2 0.0 0.1 0.1 2.7 0.0 0.1 0.2 0.1 1.4 0.3 0.1 0.1 0.0 0.6 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.9 2.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.0 13.1 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 6.6 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.0 9.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.6 0.0 0.0 0.0 0.0 0.0 FOXO1 "FKH1, FKHR, FOXO1A" ENSG00000150907 "Forkhead box O1" Q12778 13 40469953-40666597 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 85.9" "Cell type enhanced" "Detected in many" 6 "Ito cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.3;Daudi: 20.4;HSkMC: 25.7;U-698: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001252, CAB022326" Approved Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022326: , HPA001252: AB_1078906" "unprognostic (4.72e-2)" "unprognostic (1.81e-1)" "unprognostic (8.54e-2)" "unprognostic (4.35e-1)" "unprognostic (2.42e-1)" "unprognostic (2.52e-1)" "prognostic favorable (3.74e-4)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (8.65e-3)" "unprognostic (1.71e-1)" "unprognostic (1.31e-1)" "prognostic favorable (1.33e-5)" "unprognostic (1.93e-1)" "unprognostic (5.44e-1)" "unprognostic (9.09e-2)" "unprognostic (9.63e-2)" 41.6 6.9 7.0 18.4 11.2 8.0 35.5 2.3 5.0 21.4 13.4 8.4 7.7 3.5 27.4 9.8 9.5 17.2 13.3 9.9 7.8 3.9 8.3 25.6 15.3 22.4 8.3 3.9 46.0 12.2 3.8 6.2 9.5 6.5 7.9 6.8 5.7 7.5 9.3 85.9 12.3 7.6 18.6 9.7 10.8 7.4 12.3 9.0 9.4 13.1 9.0 15.6 14.4 16.2 6.1 0.5 2.8 1.6 1.1 7.1 1.0 0.3 0.6 5.7 0.1 19.3 3.8 5.5 0.8 1.1 0.2 0.1 1.5 1.3 20.4 3.8 0.5 0.9 4.9 4.5 2.4 0.3 9.2 4.6 0.0 0.6 4.5 9.2 0.1 0.5 25.7 16.7 0.1 3.2 1.1 14.5 1.5 0.3 6.5 1.4 0.7 0.0 0.2 8.3 2.8 1.4 14.5 6.7 1.6 10.7 2.6 1.2 0.3 0.7 3.9 0.8 6.9 0.6 0.5 8.5 0.1 1.1 0.0 0.5 3.7 1.4 26.4 0.5 0.9 2.6 0.9 0.8 0.5 1.5 1.0 2.3 3.2 3.9 2.2 0.5 6.1 7.1 5.3 2.8 1.1 1.6 0.0 5.5 1.0 7.0 11.2 2.3 5.0 7.8 3.9 8.3 3.9 6.5 9.0 0.0 4.1 9.5 18.7 26.1 3.0 9.8 7.6 9.4 9.1 8.7 11.8 0.2 0.0 9.5 5.5 37.9 19.3 0.0 15.3 1.7 28.8 9.2 1.1 39.4 5.7 4.8 50.2 72.4 15.5 2.0 17.3 11.0 11.8 18.0 18.4 5.0 15.9 13.6 12.4 6.3 8.3 6.5 9.3 4.8 14.9 23.3 0.7 12.9 9.8 9.1 FOXO4 "AFX1, MLLT7" ENSG00000184481 "Forkhead box O4" P98177 X 71096197-71103535 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 98.6" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 207.8;Syncytiotrophoblasts: 257.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "BEWO: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039560, HPA040232" Enhanced Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039560: AB_2676572, HPA040232: AB_2676894" "unprognostic (4.64e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (4.79e-2)" "prognostic favorable (4.61e-4)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-2)" "unprognostic (2.13e-2)" "unprognostic (8.16e-2)" "prognostic favorable (3.46e-4)" "unprognostic (2.45e-2)" "unprognostic (2.07e-1)" "unprognostic (1.20e-1)" "unprognostic (1.75e-3)" 8.5 13.2 21.7 3.8 21.5 9.9 5.1 9.1 15.6 4.8 8.4 9.1 11.9 6.3 6.8 10.2 7.3 7.7 5.8 9.7 21.4 14.5 5.2 3.6 5.5 3.6 22.8 8.4 13.4 6.8 8.7 3.0 98.6 9.2 7.0 4.7 4.9 8.5 11.3 33.8 5.5 6.6 9.4 17.3 6.0 5.2 13.9 13.1 4.4 5.9 7.5 4.2 7.5 11.0 0.9 0.2 3.4 0.6 1.0 1.8 0.9 1.8 0.5 1.4 1.8 3.4 2.4 61.2 1.4 1.6 0.7 1.7 1.2 2.4 2.4 1.8 1.8 0.8 0.8 3.7 1.6 0.9 2.4 5.6 3.4 11.4 2.0 1.9 2.0 2.7 2.0 3.9 0.7 0.4 3.3 1.9 3.5 7.0 4.7 0.3 0.4 3.1 3.2 6.6 4.6 2.2 2.1 3.6 3.6 1.2 1.0 1.0 3.0 2.9 0.4 3.2 10.9 0.7 1.2 1.7 0.4 0.9 3.2 0.3 3.1 1.6 0.4 1.6 5.3 0.5 0.2 0.6 3.2 0.9 0.6 0.3 0.8 0.5 0.9 0.2 0.9 0.4 1.8 3.4 1.0 0.3 0.0 1.3 0.9 21.7 21.5 9.1 15.6 21.4 14.5 22.8 8.4 9.2 13.1 0.0 2.4 1.4 4.1 4.7 1.2 6.5 5.1 0.0 1.2 8.7 3.9 207.8 1.7 2.0 0.2 3.8 12.7 23.3 2.6 8.6 4.4 3.4 2.3 2.4 19.4 1.6 5.8 4.3 3.1 0.4 6.4 3.2 3.3 1.0 11.4 2.8 2.6 8.6 14.5 3.3 0.8 6.5 2.5 0.3 0.4 3.0 257.4 5.0 6.0 3.1 FOXP4 FLJ40908 ENSG00000137166 "Forkhead box P4" Q8IVH2 6 41546426-41602384 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 38.6;Mucus-secreting cells: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "CACO-2: 39.3;OE19: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007176 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007176: AB_1078911" "unprognostic (8.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.17e-6)" "unprognostic (3.20e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (9.72e-4)" "unprognostic (2.13e-2)" "unprognostic (7.86e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-3)" "unprognostic (9.31e-2)" "unprognostic (1.65e-1)" "unprognostic (2.41e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-1)" "unprognostic (1.95e-2)" 12.1 7.8 6.3 13.7 12.6 4.4 15.5 12.3 10.0 28.2 15.8 14.0 16.4 18.7 20.7 8.4 10.5 10.1 29.5 12.9 6.6 7.3 16.4 18.9 14.4 9.1 12.9 4.9 17.1 24.8 5.9 12.6 5.5 9.4 21.7 7.2 21.2 30.1 13.0 7.9 7.1 19.3 11.7 7.9 5.8 37.0 15.4 10.9 12.0 23.9 6.3 14.0 11.7 27.6 2.0 1.0 0.3 0.9 0.6 1.5 0.4 9.1 12.6 15.9 17.0 3.0 1.0 16.3 5.0 2.7 4.5 3.1 39.3 2.9 10.6 9.5 3.0 13.5 7.0 4.6 4.8 1.9 8.4 7.3 8.4 7.0 26.3 5.8 5.3 6.9 2.5 5.9 4.0 2.4 6.6 4.4 6.6 10.4 4.3 2.1 24.8 6.2 9.2 4.0 48.5 4.4 6.8 5.1 7.1 3.9 7.6 4.5 6.4 5.4 12.9 9.0 5.1 7.3 13.0 6.1 5.7 14.2 8.9 8.5 3.4 2.1 14.7 4.7 9.0 5.3 0.3 0.7 0.3 0.7 0.9 1.2 1.0 0.6 1.5 0.6 2.0 0.1 0.3 0.3 0.6 0.3 1.0 1.1 0.4 6.3 12.6 12.3 9.2 6.6 7.3 12.9 4.9 9.4 10.9 0.0 9.4 0.5 4.9 8.1 4.7 14.6 10.2 1.4 3.4 5.2 2.0 2.1 0.0 6.9 22.9 2.8 18.6 0.0 14.0 2.7 5.7 13.8 3.5 15.5 3.6 0.0 38.6 7.4 3.2 16.3 3.7 2.6 1.7 7.2 37.4 0.8 16.6 20.1 8.1 6.9 2.6 12.9 8.9 2.1 7.2 6.8 3.7 3.2 15.0 8.4 FOXS1 "FKHL18, FREAC10" ENSG00000179772 "Forkhead box S1" O43638 20 31844301-31845619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 28 "Peritubular cells: 53.4;Sertoli cells: 129.4;Smooth muscle cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.2;hTERT-RPE1: 13.3;RH-30: 11.1;U-2 OS: 14.8;U-251 MG: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042475 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042475: AB_10964265" "unprognostic (2.28e-1)" "unprognostic (8.05e-2)" "unprognostic (1.72e-2)" "unprognostic (5.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.86e-1)" "unprognostic (3.10e-2)" "unprognostic (4.23e-1)" "unprognostic (2.65e-1)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (1.10e-8)" "unprognostic (1.09e-3)" "unprognostic (2.04e-2)" "unprognostic (5.02e-2)" "unprognostic (9.00e-2)" 5.9 3.1 2.7 3.0 4.7 0.3 11.7 2.7 4.9 9.7 2.6 4.8 1.8 0.9 15.5 6.2 2.8 3.6 11.7 14.0 3.2 2.6 5.5 0.9 6.5 4.6 4.1 4.8 4.0 1.1 0.8 3.2 14.4 5.2 5.0 1.6 7.0 2.0 7.0 4.5 1.8 1.8 3.7 2.6 5.5 1.6 9.7 0.6 3.0 4.9 7.0 3.1 4.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 14.8 0.0 4.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.7 2.7 4.9 3.2 2.6 4.1 4.8 5.2 0.6 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.4 0.0 3.4 0.1 0.0 0.0 0.4 0.0 0.0 1.3 0.0 4.0 4.6 0.0 1.7 0.0 0.0 0.0 3.3 0.0 53.4 0.0 0.0 129.4 31.6 0.5 0.5 0.3 0.2 0.0 0.0 0.0 FP565260.1 ENSG00000275464 21 5130871-5154734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 17.2" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 10.8;Ductal cells: 8.0;Exocrine glandular cells: 6.9;Hofbauer cells: 5.1;monocytes: 5.4;Pancreatic endocrine cells: 7.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 38.1" HPA024573 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (4.43e-1)" "unprognostic (9.66e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-3)" "unprognostic (8.40e-3)" "unprognostic (5.16e-2)" "unprognostic (1.07e-2)" "unprognostic (9.34e-3)" "unprognostic (1.74e-2)" "unprognostic (5.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" 3.0 3.0 1.1 3.0 2.2 3.3 1.4 1.1 6.8 1.7 1.9 7.2 1.1 2.8 1.6 2.6 1.9 2.4 4.8 2.9 3.2 1.8 1.1 1.8 4.2 2.4 1.1 1.9 2.0 2.5 1.1 2.3 2.9 1.8 2.7 1.1 1.7 1.1 6.8 1.8 2.2 3.4 1.1 2.8 1.4 1.4 1.1 1.1 1.7 1.1 2.3 2.4 1.1 8.9 6.6 5.0 12.9 7.4 17.2 7.5 11.8 8.9 6.0 9.3 2.6 2.0 3.5 0.0 0.0 0.0 0.0 0.0 7.6 0.0 5.5 4.0 8.0 7.9 16.7 7.3 0.0 2.5 5.4 38.1 4.6 4.5 4.2 17.4 11.3 7.2 8.9 10.2 8.0 1.9 7.8 5.9 21.2 4.2 2.5 10.4 12.8 12.0 23.7 13.7 11.1 20.1 5.6 10.5 5.3 9.5 5.7 10.4 9.8 14.8 5.6 1.6 12.3 9.4 3.8 4.5 11.6 0.1 12.3 4.9 5.3 23.9 8.1 23.1 6.3 2.6 5.5 5.0 15.0 9.7 17.2 8.7 9.1 11.0 6.6 8.9 9.2 12.6 3.3 7.4 12.9 4.4 6.0 7.5 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 2.3 0.0 8.0 0.0 0.0 0.0 0.0 6.9 1.6 0.0 0.0 4.7 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 7.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 FRAT1 ENSG00000165879 "FRAT1, WNT signaling pathway regulator" Q92837 10 97319267-97321915 "Predicted intracellular proteins" "Wnt signaling pathway" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 24.7;Early spermatids: 30.0;Late spermatids: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 9.0;neutrophil: 11.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB046472, HPA055258" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB046472: AB_1849131, HPA055258: AB_2682763" "unprognostic (1.48e-2)" "prognostic favorable (5.92e-4)" "unprognostic (3.54e-1)" "unprognostic (1.13e-2)" "unprognostic (1.45e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.11e-2)" "unprognostic (4.44e-3)" "unprognostic (5.73e-2)" "unprognostic (2.50e-2)" "unprognostic (6.36e-3)" "unprognostic (1.89e-1)" "prognostic favorable (6.36e-5)" "unprognostic (6.38e-2)" "unprognostic (5.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.43e-2)" 5.2 3.7 3.0 8.0 4.0 14.9 3.9 5.8 5.8 3.9 6.9 3.4 5.0 7.4 3.6 2.0 3.8 4.0 6.8 3.5 3.3 4.5 2.9 12.6 6.6 18.7 4.4 3.1 3.4 6.7 4.1 2.8 6.5 4.9 4.9 3.3 2.8 6.1 5.9 5.7 4.9 9.9 2.6 2.7 16.2 8.2 21.6 3.3 9.7 2.7 3.3 4.3 3.5 4.7 0.6 1.1 11.2 2.2 0.2 0.8 0.5 0.9 1.5 1.7 8.1 2.3 1.1 1.8 0.9 3.5 0.7 0.7 0.2 1.0 5.2 1.8 0.6 1.2 2.4 1.3 1.7 0.1 4.6 2.5 4.5 0.8 2.1 0.8 1.7 4.9 1.0 2.5 0.3 1.1 3.3 1.4 7.4 1.9 3.8 0.5 4.9 4.6 9.2 2.3 5.6 6.6 3.8 0.4 3.4 0.6 1.1 0.9 2.7 1.2 2.5 1.7 1.8 9.4 6.4 1.3 0.4 0.5 1.3 0.4 3.5 2.0 1.8 0.6 8.3 0.0 1.0 2.2 9.0 0.6 1.4 0.4 0.5 0.5 0.8 1.1 0.6 0.8 0.6 11.2 0.2 1.6 0.7 0.3 0.5 3.0 4.0 5.8 5.8 3.3 4.5 4.4 3.1 4.9 3.3 3.0 4.3 6.7 0.8 1.0 24.7 3.1 7.6 4.0 0.0 1.8 0.0 0.4 0.0 1.2 30.0 3.6 2.8 0.0 1.6 1.2 0.7 2.6 0.0 14.3 3.4 3.2 4.1 2.5 15.1 51.1 1.1 5.9 3.3 0.0 4.5 4.4 1.2 2.9 1.8 0.8 8.4 0.0 0.8 1.2 0.6 1.4 1.9 4.9 2.2 1.8 FREM2 DKFZp686J0811 ENSG00000150893 "FRAS1 related extracellular matrix protein 2" Q5SZK8 13 38687129-38887131 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 13.9;lung: 11.2;thyroid gland: 12.2" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 19.8;Cholangiocytes: 7.6;Proximal tubular cells: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.2;HAP1: 8.2;MCF7: 5.9;RT4: 5.5;SK-BR-3: 5.0;SuSa: 24.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA028831 Uncertain Approved Cytosol NA NA 170000 Cytosol "HPA028831: AB_10603668" "unprognostic (1.71e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-1)" "unprognostic (6.24e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.25e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.23e-7)" "unprognostic (7.21e-2)" "unprognostic (1.40e-1)" "unprognostic (9.92e-2)" "unprognostic (3.14e-1)" 0.6 0.4 1.3 0.1 1.7 0.1 0.5 1.5 6.4 0.7 1.3 1.2 1.1 0.4 1.1 0.5 0.2 0.9 1.5 0.2 2.8 0.4 13.9 3.4 11.2 0.1 0.4 0.8 1.8 5.2 0.1 1.1 2.6 0.8 3.5 0.4 2.9 0.4 1.5 6.3 0.6 0.7 0.7 0.4 0.3 2.2 1.8 1.5 0.1 12.2 4.1 0.1 1.5 0.3 0.3 0.3 0.9 0.2 0.2 0.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 8.2 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.8 0.0 0.1 0.0 1.1 0.1 1.8 5.5 0.1 0.1 0.0 5.0 0.2 24.6 0.9 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.6 0.9 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.2 0.7 0.2 0.2 0.3 0.1 0.0 1.3 1.7 1.5 6.4 2.8 0.4 0.4 0.8 0.8 1.5 0.0 19.8 0.0 0.1 0.6 0.1 2.0 7.6 5.3 2.3 1.8 0.0 5.1 5.0 1.7 0.6 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 1.3 0.0 0.0 22.4 0.2 0.0 0.0 0.1 0.4 0.1 1.6 0.0 0.0 0.0 FRK "GTK, PTK5, RAK" ENSG00000111816 "Fyn related Src family tyrosine kinase" P42685 6 115931149-116060758 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 73.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 19.0;RT4: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB025217, HPA030479, HPA072590" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB025217: , HPA030479: AB_2732457, HPA072590: " "unprognostic (7.70e-3)" "unprognostic (1.99e-2)" "unprognostic (1.11e-1)" "unprognostic (4.68e-3)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (2.09e-1)" "unprognostic (1.58e-1)" "unprognostic (4.23e-2)" "unprognostic (5.82e-3)" "unprognostic (1.45e-1)" "unprognostic (7.54e-2)" "prognostic favorable (9.66e-7)" "unprognostic (1.52e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.10e-1)" 1.5 2.2 0.8 3.0 1.3 1.3 2.6 0.5 0.8 6.4 21.4 0.2 10.2 6.8 1.6 9.0 10.5 2.8 7.3 3.3 1.2 0.8 23.7 19.6 5.6 0.6 1.5 0.5 2.4 5.9 0.3 3.8 2.7 0.8 4.1 5.5 0.8 9.2 6.1 2.9 2.0 41.4 2.5 2.4 1.0 5.5 1.8 0.5 1.2 1.0 5.2 7.4 5.0 3.6 2.2 1.2 3.8 1.2 1.4 2.3 0.3 2.5 4.2 0.7 1.0 0.3 0.3 0.8 0.6 0.2 0.0 0.1 3.3 4.1 1.1 3.9 0.6 0.6 6.1 0.3 1.2 0.1 3.5 0.4 1.4 3.6 2.8 0.2 1.0 0.9 0.3 1.7 0.4 0.4 0.5 0.2 0.7 0.7 2.6 1.0 1.4 0.8 0.6 1.1 19.0 0.7 1.2 3.7 1.3 5.2 8.0 0.9 1.0 0.9 5.4 0.5 1.1 1.6 0.8 1.0 1.2 1.2 0.9 0.6 4.0 2.8 1.8 1.2 0.7 0.8 3.2 1.0 1.0 1.9 0.6 2.3 1.1 1.4 1.7 0.4 2.2 1.1 1.4 3.8 1.4 1.2 1.2 1.0 0.3 0.8 1.3 0.5 0.7 1.2 0.8 1.5 0.5 0.8 0.5 0.0 10.1 0.0 15.3 2.4 0.7 8.4 12.7 22.7 15.9 22.7 0.0 4.3 10.0 16.5 73.1 0.3 35.5 0.0 14.3 3.8 3.5 20.3 3.5 19.2 0.8 6.4 19.0 1.8 0.6 17.7 0.6 0.5 0.0 1.8 13.0 0.3 19.1 20.1 1.1 22.5 0.0 12.9 7.5 1.4 0.7 2.8 0.7 0.5 16.1 34.6 FRMD7 "FLJ43346, NYS, NYS1" ENSG00000165694 "FERM domain containing 7" Q6ZUT3 X 132076993-132128020 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5" "Cell type enriched" "Detected in single" 30 "Distal tubular cells: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5" "Region enriched" "Detected in single" 29 "olfactory region: 80.8" "Region enriched" "Detected in single" 103 "olfactory region: 45.5" HPA000886 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA000886: AB_1079269" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (1.64e-2)" "unprognostic (2.28e-1)" "unprognostic (2.18e-2)" "unprognostic (3.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.00e-1)" 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.4 1.1 0.0 1.1 0.0 0.1 0.0 0.1 6.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRMD8 "FKSG44, FLJ90369" ENSG00000126391 "FERM domain containing 8" Q9BZ67 11 65386599-65413525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 73.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002861 Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane, Centriolar satellite" "Nucleoplasm, Cytosol" "HPA002861: AB_1078878" "unprognostic (1.54e-1)" "unprognostic (4.07e-1)" "unprognostic (6.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (9.94e-5)" "unprognostic (9.12e-3)" "unprognostic (1.51e-2)" "unprognostic (6.36e-3)" "unprognostic (1.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.19e-3)" "unprognostic (1.47e-2)" "unprognostic (7.36e-3)" "unprognostic (3.34e-1)" "unprognostic (2.91e-2)" 14.6 11.9 7.8 18.5 12.1 13.1 15.2 8.9 10.3 12.5 15.1 11.4 6.9 13.6 10.5 12.2 23.9 14.6 17.4 10.0 8.0 5.4 10.5 12.0 15.1 17.3 17.0 8.5 8.9 20.9 5.7 8.2 12.2 11.7 10.7 8.2 7.8 18.6 10.9 12.0 24.3 16.5 8.1 8.9 29.0 11.7 11.3 14.6 16.6 12.4 16.6 21.8 11.0 18.1 10.9 11.4 19.7 14.9 6.5 14.3 9.0 6.9 8.9 3.6 8.4 9.8 5.1 6.4 7.9 7.4 6.8 5.3 8.5 11.6 8.6 17.1 11.2 4.8 12.3 4.6 6.9 2.9 14.3 4.2 11.9 8.2 4.6 5.3 6.7 18.6 6.4 5.5 6.5 3.5 3.7 10.9 8.9 9.9 9.7 7.5 9.5 10.0 9.8 4.0 5.2 11.7 13.4 6.7 9.8 5.6 8.8 7.8 5.4 6.0 24.8 18.9 3.4 9.0 5.5 9.5 7.7 8.0 10.4 4.8 16.7 8.5 8.1 6.7 4.2 53.0 0.8 9.7 13.4 11.5 11.0 12.7 10.9 8.4 14.3 9.1 9.2 7.8 8.4 19.7 6.5 14.9 11.4 8.9 9.0 7.8 12.1 8.9 10.3 8.0 5.4 17.0 8.5 11.7 14.6 3.0 7.2 17.5 19.3 48.2 5.9 7.5 20.4 8.1 6.8 12.2 0.0 5.8 6.6 18.7 22.7 21.1 26.9 23.3 24.9 13.0 14.4 20.4 13.9 9.6 13.4 4.8 12.5 45.4 16.7 3.9 5.8 17.4 18.6 19.0 17.0 3.2 25.9 13.1 6.7 4.2 4.6 6.5 16.0 4.1 8.6 73.0 9.5 21.7 11.2 33.0 FRYL "AF4p12, DKFZp686E205, KIAA0826, MOR2" ENSG00000075539 "FRY like transcription coactivator" O94915 4 48497361-48780322 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Mucus-secreting cells: 166.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 12.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031106, HPA031107" Supported Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA031106: AB_10600660, HPA031107: AB_10600536" "unprognostic (7.50e-2)" "unprognostic (9.72e-3)" "unprognostic (6.68e-3)" "unprognostic (3.22e-2)" "unprognostic (5.37e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (4.80e-2)" "unprognostic (4.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.62e-2)" "unprognostic (3.32e-2)" "unprognostic (1.66e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" 9.6 7.5 13.4 13.1 27.4 12.4 8.3 10.1 20.2 7.3 30.5 23.4 7.1 8.6 8.5 3.7 6.3 6.5 7.1 7.7 13.8 8.6 7.6 4.8 9.0 10.6 30.2 7.9 7.1 5.8 28.4 12.5 9.0 17.6 5.9 30.8 5.5 6.1 6.2 9.1 8.8 13.4 8.1 25.8 8.8 9.1 5.2 30.1 11.8 6.9 3.9 10.9 8.8 6.0 2.1 2.2 12.6 2.0 3.3 2.8 0.9 10.3 6.3 14.9 9.5 6.2 8.8 8.1 9.4 9.7 10.1 12.0 4.9 8.3 13.0 8.0 10.2 18.4 6.6 9.7 16.1 21.4 7.4 3.3 24.3 6.4 2.3 4.2 16.7 9.7 6.7 6.2 13.8 14.4 9.2 14.5 11.9 7.5 5.2 12.6 5.3 17.0 5.9 2.5 4.7 5.8 13.6 18.9 2.6 9.2 11.3 13.2 5.9 9.8 2.6 5.3 7.6 3.9 10.9 21.6 10.9 14.6 5.8 19.0 7.1 9.2 11.8 9.1 11.1 10.8 12.6 1.2 2.3 2.8 2.0 2.2 2.1 2.5 2.2 1.1 1.8 2.8 2.7 3.7 3.3 1.2 2.2 1.8 0.9 13.4 27.4 10.1 20.2 13.8 8.6 30.2 7.9 17.6 30.1 35.7 34.5 32.0 20.8 42.0 41.5 31.3 17.8 5.3 21.6 15.7 127.6 19.2 3.3 11.5 8.8 48.5 86.6 23.3 10.2 16.6 20.2 32.9 45.1 11.1 16.4 44.5 76.3 41.7 29.4 2.6 15.8 27.0 25.3 21.6 166.5 39.2 21.6 80.1 17.3 6.5 111.4 19.4 27.8 9.0 6.9 43.2 9.0 24.5 66.0 48.0 FSCN1 "FLJ38511, p55, SNL" ENSG00000075618 "Fascin actin-bundling protein 1" Q16658 7 5592823-5606655 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9" "Cell type enriched" "Detected in many" 9 "monocytes: 1791.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 82.1;K-562: 68.7;NB-4: 78.0;PC-3: 68.7;SH-SY5Y: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000121, HPA005723, CAB035991, HPA050654" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 4500000 Cytosol "Plasma membrane" "CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203" "unprognostic (1.91e-1)" "unprognostic (2.03e-2)" "unprognostic (3.12e-2)" "unprognostic (5.00e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (2.28e-4)" "unprognostic (6.31e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.15e-7)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (1.05e-2)" "unprognostic (6.93e-3)" 26.3 13.3 23.7 29.6 30.1 6.3 8.1 5.5 56.9 9.9 5.5 35.1 0.0 5.4 11.7 2.3 22.3 5.9 8.9 10.6 27.7 16.8 5.5 7.1 11.3 15.2 26.9 23.6 21.8 5.1 2.3 7.0 29.4 20.1 4.1 3.0 8.1 11.0 3.9 7.8 17.3 6.6 7.0 29.6 39.3 7.6 15.9 28.3 9.3 8.5 15.9 11.4 14.7 12.3 0.2 5.4 1.0 1.9 0.0 0.1 1.4 8.0 18.6 12.4 44.5 4.8 9.2 82.1 19.3 8.6 3.3 3.6 12.9 2.0 0.1 23.6 8.5 3.2 30.5 7.1 31.0 0.2 9.1 3.8 0.5 19.8 60.8 2.5 0.0 1.6 5.7 9.2 6.2 5.1 5.5 16.2 0.0 68.7 0.1 4.2 0.8 0.2 78.0 32.5 0.5 68.7 18.1 2.9 0.3 4.8 0.7 9.9 65.9 16.1 0.2 0.6 8.4 0.4 4.9 32.8 22.9 40.3 13.3 19.8 0.1 0.1 0.0 14.8 0.0 43.0 0.0 1.9 0.1 0.0 0.5 0.0 0.2 0.1 0.0 5.4 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 1.4 23.7 30.1 5.5 41.3 27.7 16.8 26.9 23.6 20.1 28.3 3.0 5.5 2.4 19.0 161.1 7.2 6.9 2.5 1.4 0.0 1.8 0.0 4.4 0.0 6.8 13.1 49.6 1.3 0.0 4.2 90.3 72.6 6.3 16.1 0.8 207.2 0.0 40.2 97.6 22.0 7.9 23.6 10.6 49.0 1791.8 0.7 69.1 10.4 0.0 8.5 0.2 2.3 0.0 16.5 4.7 9.0 128.6 12.2 4.3 0.9 28.3 FSD2 "RP11-127F21, SPRYD1" ENSG00000186628 "Fibronectin type III and SPRY domain containing 2" A1L4K1 15 82755362-82806070 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "heart muscle: 20.8;skeletal muscle: 54.0;tongue: 18.1" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 70.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 8.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA046263 Approved Cytosol NA NA Cytosol "HPA046263: AB_2679604" "unprognostic (2.80e-1)" "unprognostic (3.54e-1)" "unprognostic (6.63e-2)" "unprognostic (6.30e-2)" "unprognostic (7.71e-2)" "unprognostic (1.83e-1)" "unprognostic (5.97e-2)" "unprognostic (7.66e-2)" "unprognostic (1.07e-1)" "unprognostic (9.37e-2)" "unprognostic (3.05e-2)" "unprognostic (2.21e-1)" "unprognostic (1.07e-2)" "unprognostic (1.27e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-2)" "unprognostic (1.59e-2)" 1.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.6 0.7 0.1 0.0 20.8 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.4 1.0 0.0 54.0 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 18.1 1.4 0.0 0.1 1.4 0.8 2.3 0.9 0.8 2.2 0.5 1.3 1.3 2.0 2.4 0.0 0.0 1.2 1.3 0.0 0.0 0.0 1.1 2.1 4.1 0.9 0.0 1.1 5.0 0.0 0.0 0.4 0.7 5.4 2.3 5.7 1.8 0.0 1.4 0.9 0.1 0.2 0.0 0.6 1.4 0.0 1.7 2.0 3.7 0.0 1.2 0.7 2.4 1.9 0.8 1.1 1.3 1.5 1.0 0.2 2.3 1.9 1.7 1.0 1.0 1.5 1.0 1.7 1.8 0.8 3.0 1.6 1.1 1.8 8.5 3.6 1.4 1.8 4.9 0.7 2.3 0.8 0.8 1.0 0.7 0.8 1.4 1.1 0.9 0.8 1.1 2.2 1.1 1.1 0.8 0.9 0.8 1.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.0 1.0 0.3 2.6 70.6 2.5 0.0 1.2 0.0 5.9 0.0 0.0 0.0 1.6 0.6 0.0 0.0 0.3 0.1 0.2 0.3 1.1 0.0 0.2 11.1 1.2 0.0 0.8 1.8 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 3.6 0.0 0.3 0.7 0.2 0.5 0.2 0.0 0.0 0.3 FSTL1 "FRP, FSL1, OCC-1, OCC1, tsc36" ENSG00000163430 "Follistatin like 1" Q12841 3 120392293-120451253 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 309.5;Fibroblasts: 318.9;Leydig cells: 303.2;Peritubular cells: 254.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "basophil: 10.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 10.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 129.7;BJ: 150.5;fHDF/TERT166: 185.7;HBF TERT88: 124.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035251, HPA040815" Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 32000000 "Vesicles, Cytosol" "HPA035251: AB_10601906, HPA040815: AB_2732489" "unprognostic (2.60e-1)" "unprognostic (1.59e-3)" "unprognostic (8.84e-2)" "unprognostic (4.54e-3)" "unprognostic (4.10e-2)" "unprognostic (1.35e-1)" "unprognostic (9.88e-2)" "unprognostic (3.05e-2)" "unprognostic (1.19e-2)" "unprognostic (3.88e-2)" "unprognostic (3.54e-2)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (4.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.05e-2)" "unprognostic (4.47e-3)" 72.3 28.6 4.8 23.1 5.8 0.0 104.0 2.5 6.7 52.1 39.1 7.3 28.7 5.8 41.6 58.1 39.2 42.6 45.6 69.4 5.9 3.2 15.1 5.5 33.6 44.4 4.3 4.3 26.9 8.7 5.5 7.9 110.0 13.2 36.3 15.4 26.2 17.5 32.5 23.6 18.4 18.6 90.2 9.4 16.7 22.1 19.8 4.9 4.7 23.8 29.1 11.1 67.1 65.8 0.1 1.2 10.2 0.1 0.0 0.0 3.6 5.4 1.4 15.7 6.5 94.2 129.7 0.0 150.5 84.5 97.5 86.5 0.0 12.5 0.0 12.8 185.7 7.9 1.4 4.8 18.7 124.2 0.0 2.2 0.0 11.9 0.0 20.7 0.0 0.0 98.5 0.6 62.9 13.7 43.5 56.4 0.7 0.0 0.0 15.8 0.0 1.5 0.1 12.9 0.0 12.6 0.0 6.5 0.0 10.4 0.1 2.8 6.6 53.4 0.9 5.4 34.2 1.6 0.4 68.9 36.7 35.2 19.1 22.3 0.0 0.0 0.1 12.8 0.0 4.7 10.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 3.6 4.8 5.8 2.5 6.7 5.9 3.2 4.3 4.3 13.2 4.9 59.6 13.1 0.0 32.3 56.9 1.8 102.1 7.6 37.5 35.2 22.7 0.0 90.3 0.0 52.7 1.9 103.4 0.0 0.0 5.1 309.5 318.9 79.3 1.1 12.2 18.0 1.6 2.9 169.4 14.3 3.6 303.2 5.6 104.6 17.2 0.0 128.4 76.1 0.0 254.5 2.4 2.8 58.2 135.9 0.9 1.3 42.0 45.8 0.5 0.6 31.6 FTCD ENSG00000160282 "Formimidoyltransferase cyclodeaminase" O95954 21 46136262-46155567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" "Lyase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 126.8" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 338.0;Late spermatids: 92.6;Proximal tubular cells: 322.0" "Cancer enriched" "Detected in some" 8 "liver cancer: 87.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enriched" "Detected in single" 25 "T-cells: 2.5" "Cell line enriched" "Detected in some" 29 "Hep G2: 45.4" "HPA020073, HPA030928, HPA030929, HPA036114" Enhanced Approved "Plasma membrane,Cytosol" No NA 580000 Cytosol "Plasma membrane" "HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (4.62e-5)" "unprognostic (2.90e-2)" "unprognostic (1.13e-1)" "unprognostic (2.96e-1)" "prognostic favorable (1.70e-4)" "unprognostic (1.85e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-1)" "prognostic favorable (6.78e-5)" "unprognostic (1.80e-1)" "prognostic favorable (5.78e-4)" "unprognostic (3.80e-2)" "unprognostic (3.60e-1)" "unprognostic (9.37e-2)" "unprognostic (2.10e-1)" 0.2 0.0 0.6 0.2 1.6 0.0 0.2 0.2 0.7 0.2 0.3 0.2 0.2 0.3 0.2 2.0 0.2 0.0 0.2 0.2 0.5 0.4 25.9 126.8 0.2 0.2 0.4 0.2 0.2 1.0 0.0 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.1 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 45.4 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 2.5 0.1 0.6 1.6 0.2 0.7 0.5 0.4 0.4 0.2 0.2 0.2 0.0 0.0 24.9 0.0 0.1 1.0 1.0 68.8 0.0 0.0 8.7 0.0 0.0 39.7 0.0 75.4 0.6 0.0 0.0 0.0 0.0 0.8 0.5 0.0 338.0 0.1 3.2 0.0 22.7 22.3 92.6 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 322.0 0.4 0.0 0.1 10.7 12.2 0.4 0.0 6.9 0.0 0.0 FTL "MGC71996, NBIA3" ENSG00000087086 "Ferritin light chain" P02792 19 48965301-48966878 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Iron storage" "Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 1149.4" "Cell type enhanced" "Detected in all" 10 "Hofbauer cells: 67925.7;Kupffer cells: 48067.7;Proximal tubular cells: 39652.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "granulocytes: 1149.4;monocytes: 890.5" "Cell line enhanced" "Detected in all" "HHSteC: 575.7;HSkMC: 481.6" "CAB020769, HPA041602" Enhanced Approved Cytosol NA NA 240000000 Cytosol "CAB020769: , HPA041602: AB_2677575" "unprognostic (2.95e-1)" "unprognostic (2.64e-2)" "unprognostic (1.31e-1)" "unprognostic (1.56e-3)" "unprognostic (7.48e-2)" "unprognostic (5.28e-2)" "unprognostic (2.16e-3)" "unprognostic (6.17e-3)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (4.40e-5)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" 326.0 111.3 147.1 113.6 130.9 179.8 321.8 25.8 101.3 105.7 107.5 134.7 58.2 120.5 54.9 85.4 85.0 71.3 214.6 140.8 111.7 88.2 295.2 526.9 391.6 444.6 139.4 49.6 126.8 108.0 27.0 63.6 166.3 89.0 108.0 92.3 114.4 59.4 75.4 75.6 48.3 159.4 149.2 194.5 317.9 105.2 53.9 74.5 45.1 130.0 57.5 67.5 159.8 172.1 147.8 231.2 1149.4 890.5 41.5 86.1 674.1 18.7 285.4 21.4 32.7 370.5 384.5 38.3 48.6 286.4 70.1 158.0 62.5 76.1 14.3 93.6 290.5 153.7 11.2 17.5 28.8 63.3 192.3 11.3 37.8 74.5 408.6 575.7 88.8 127.3 481.6 39.1 119.3 52.5 104.8 101.5 17.2 69.9 29.9 138.3 4.5 24.5 51.9 38.8 330.4 29.2 20.5 14.5 147.1 44.5 11.9 27.4 15.9 127.8 7.0 26.6 121.4 4.1 185.8 75.9 76.8 40.4 98.5 66.5 129.3 285.0 13.3 81.5 93.7 134.3 488.0 642.5 675.8 63.9 890.5 72.6 147.8 71.3 68.3 231.2 132.2 86.1 74.8 1149.4 41.5 768.3 97.2 83.8 674.1 147.1 130.9 25.8 101.3 111.7 88.2 139.4 49.6 89.0 74.5 1045.2 3325.0 4263.9 4805.4 2481.8 468.5 679.4 4145.2 769.6 1043.0 1917.5 166.9 816.1 9070.4 3524.4 247.8 2245.5 2735.4 2149.2 5208.6 1016.5 4146.4 6478.0 2236.8 16333.4 67925.7 503.7 1551.5 4087.4 48067.7 879.3 3866.6 17106.8 4823.4 23991.6 2116.7 1184.6 7872.5 3673.3 1890.2 39652.4 496.5 1319.4 4074.7 56.3 327.7 1946.3 1256.7 2296.9 2288.6 7488.3 FTO "ALKBH9, KIAA1752, MGC5149" ENSG00000140718 "FTO, alpha-ketoglutarate dependent dioxygenase" Q9C0B1 16 53701692-54158512 "Disease related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 315.8;Club cells: 92.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017123, HPA041086, HPA068695" Enhanced Supported Vesicles,Cytosol No No 130000 Cytosol Vesicles "CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117" "unprognostic (9.74e-2)" "unprognostic (2.49e-1)" "unprognostic (9.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.88e-2)" "unprognostic (6.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-1)" "unprognostic (4.30e-3)" "unprognostic (6.11e-3)" 17.5 25.4 19.7 8.7 37.4 5.6 27.1 29.7 37.5 20.2 13.5 30.1 11.4 5.8 22.7 16.8 13.2 19.5 16.2 19.5 19.9 25.9 19.0 13.0 27.3 10.1 21.8 19.6 21.2 15.2 42.0 31.6 14.7 28.9 15.8 10.9 18.9 13.4 19.1 19.9 13.6 8.1 22.6 23.8 11.5 10.1 6.2 22.2 10.0 20.7 7.8 10.6 16.1 12.5 12.3 15.3 8.1 14.8 16.3 22.1 14.0 6.7 12.2 16.2 16.6 32.0 24.2 5.3 16.2 14.8 13.7 4.0 7.6 8.9 15.4 17.9 20.9 7.8 10.0 15.0 16.0 20.1 7.1 11.7 6.9 16.5 14.1 22.1 5.5 7.9 26.6 16.9 12.4 15.3 17.2 20.2 11.5 6.7 3.9 22.0 5.2 12.2 8.4 8.4 7.0 8.0 18.8 24.6 14.4 20.7 5.7 20.0 13.9 18.4 10.9 5.0 16.4 14.4 13.2 19.2 17.2 11.4 9.2 9.9 7.4 5.9 15.8 15.9 10.3 13.1 8.1 11.6 6.0 17.7 14.8 22.1 12.3 17.0 17.7 15.3 11.7 16.0 17.2 2.0 16.3 10.0 6.1 16.5 14.0 19.7 37.4 29.7 37.5 19.9 25.9 21.8 19.6 28.9 22.2 74.5 43.6 3.7 8.0 11.0 22.7 19.6 17.8 315.8 92.1 7.0 11.8 7.9 6.6 7.4 35.1 11.7 4.2 0.0 4.9 6.2 13.6 6.4 24.4 12.1 7.9 15.9 6.3 11.1 6.3 45.9 13.3 9.3 10.1 2.8 6.0 17.6 5.5 6.8 14.2 12.4 14.2 12.9 11.9 2.5 3.8 8.0 4.2 5.1 6.0 7.1 FTSJ1 "CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7" ENSG00000068438 "FtsJ RNA methyltransferase homolog 1" Q9UET6 X 48476021-48486364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002718 Approved Approved Cytosol NA NA Cytosol "HPA002718: AB_1078914" "unprognostic (2.56e-2)" "unprognostic (1.24e-2)" "unprognostic (1.44e-1)" "unprognostic (3.37e-1)" "unprognostic (2.13e-1)" "unprognostic (6.77e-2)" "prognostic unfavorable (1.74e-5)" "unprognostic (1.95e-2)" "unprognostic (2.39e-1)" "unprognostic (3.96e-3)" "unprognostic (2.06e-3)" "unprognostic (7.82e-2)" "prognostic unfavorable (5.24e-10)" "unprognostic (2.61e-1)" "unprognostic (1.49e-1)" "unprognostic (1.56e-2)" "unprognostic (1.23e-1)" 17.6 19.4 12.3 18.2 21.6 18.4 17.1 18.7 21.2 23.3 11.7 13.6 20.8 10.7 18.5 12.6 19.0 15.9 12.8 15.0 9.9 10.3 15.9 21.3 16.9 22.9 13.6 9.2 17.4 36.6 13.9 16.2 11.3 14.9 13.3 10.6 12.4 20.8 18.6 17.3 18.0 12.0 16.6 11.0 19.6 17.8 14.6 15.2 17.2 20.0 24.8 18.6 17.3 17.2 17.1 16.8 10.7 16.1 15.9 26.9 15.1 25.8 17.9 6.9 27.3 9.9 10.4 11.3 12.7 12.3 18.7 14.8 10.7 36.4 15.1 9.6 19.4 11.8 17.6 13.7 44.9 8.4 11.5 12.9 9.6 22.7 12.0 28.1 13.2 24.4 9.6 22.8 23.4 23.1 10.4 13.0 17.4 8.1 12.6 24.1 14.7 17.0 9.4 15.5 11.1 30.8 13.9 22.6 31.3 17.5 8.8 9.3 9.2 20.2 11.2 9.3 8.4 12.8 7.6 12.7 14.8 20.1 30.7 15.5 17.1 13.3 10.9 32.7 24.8 15.4 9.2 14.1 10.7 21.9 16.1 26.9 17.1 18.9 22.1 16.8 16.9 17.3 21.9 2.0 15.9 15.1 11.6 17.5 15.1 12.3 21.6 18.7 21.2 9.9 10.3 13.6 9.2 14.9 15.2 6.0 11.2 14.1 9.5 11.3 4.5 5.6 7.6 17.4 14.8 7.0 2.0 4.8 14.9 20.1 37.9 9.9 5.4 0.0 16.0 22.0 10.8 7.7 8.1 4.4 15.8 3.2 5.2 6.2 10.2 56.9 10.0 11.0 5.0 8.2 8.9 5.2 41.1 0.0 8.1 7.3 5.5 12.9 13.5 6.8 10.1 9.5 4.8 10.0 8.1 16.2 FUBP3 FBP3 ENSG00000107164 "Far upstream element binding protein 3" Q96I24 9 130578965-130638352 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047658, HPA058392" Uncertain Approved Nucleoplasm,Cytosol NA NA 6200 Nucleoplasm Cytosol "HPA047658: AB_2680114, HPA058392: AB_2683703" "unprognostic (1.23e-2)" "unprognostic (2.00e-2)" "unprognostic (1.91e-1)" "unprognostic (2.51e-1)" "unprognostic (5.67e-3)" "unprognostic (2.12e-2)" "unprognostic (2.29e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (3.12e-2)" "unprognostic (7.27e-2)" "unprognostic (4.66e-1)" "unprognostic (4.23e-2)" "prognostic favorable (4.39e-5)" "unprognostic (2.15e-2)" "unprognostic (3.24e-1)" "unprognostic (1.59e-1)" "unprognostic (5.23e-2)" 26.6 24.1 24.3 18.5 24.3 10.5 21.8 23.9 30.3 22.8 24.0 37.7 22.9 19.9 32.7 20.7 24.2 22.1 25.4 24.3 24.6 20.0 22.4 37.6 19.9 18.7 27.4 22.8 25.2 27.7 36.6 23.8 33.8 23.9 26.1 20.4 21.9 26.1 25.3 15.2 22.0 20.5 26.9 30.0 20.2 22.0 30.0 27.5 26.4 39.9 18.1 20.1 23.2 22.9 4.5 5.6 2.1 4.5 7.3 6.9 3.0 20.8 19.2 28.1 23.1 20.3 23.1 35.6 29.9 26.8 24.2 18.8 27.7 19.3 20.2 15.8 28.3 21.4 36.4 23.6 25.4 28.8 22.3 20.2 22.4 30.6 20.3 27.8 33.6 25.3 22.3 20.5 25.4 24.0 20.3 19.7 16.9 35.5 12.6 25.0 28.0 25.9 17.1 36.1 32.9 24.6 23.2 35.0 27.1 21.2 22.1 18.7 30.9 31.8 23.6 19.5 22.1 32.4 25.6 25.0 43.9 20.9 29.5 34.6 11.6 19.1 26.3 24.5 14.6 31.2 0.0 3.7 2.1 4.7 4.5 6.9 4.5 5.1 5.6 5.6 3.3 5.9 5.1 1.0 7.3 3.5 4.9 4.0 3.0 24.3 24.3 23.9 23.7 24.6 20.0 27.4 22.8 23.9 27.5 17.9 19.4 18.0 17.5 29.8 22.5 16.5 25.5 21.4 12.5 15.7 13.7 24.3 24.9 18.3 3.2 20.4 13.2 0.0 16.5 25.4 24.2 24.1 7.0 48.6 22.9 30.2 20.8 30.1 22.9 7.2 19.0 17.2 35.4 16.2 18.9 52.7 20.0 17.3 26.2 29.5 27.4 12.9 30.9 14.3 10.4 35.8 38.3 15.4 15.5 22.6 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705950 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.3;salivary gland: 58.1" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 43.3;Enterocytes: 109.6;Exocrine glandular cells: 41.1;Mucus-secreting cells: 39.5;Paneth cells: 73.7;Undifferentiated cells: 44.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "CAPAN-2: 34.7;OE19: 38.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favorable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.4 0.6 0.7 5.3 0.8 0.0 0.8 8.7 1.6 9.3 25.0 0.3 13.9 24.1 1.3 0.1 16.0 1.2 23.3 0.5 0.7 0.7 0.8 0.4 1.1 0.1 0.7 0.1 1.0 7.5 0.0 1.5 0.2 0.7 1.2 10.9 0.1 58.1 14.5 0.5 2.6 41.3 0.4 0.7 0.6 15.8 0.7 0.2 0.5 0.6 16.1 19.3 3.1 5.4 1.7 1.8 3.5 1.0 1.4 2.5 0.6 0.9 0.9 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.1 34.7 0.3 0.2 0.0 0.2 6.1 0.0 0.0 0.0 0.3 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.4 0.0 0.4 0.4 0.8 0.2 38.7 0.3 0.3 0.1 1.5 0.0 0.3 1.8 0.2 0.1 0.3 0.0 0.2 5.2 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.0 0.1 0.2 0.1 3.5 0.8 0.4 2.0 0.7 1.1 1.5 2.3 1.0 0.5 1.7 2.1 0.7 3.4 1.4 1.0 1.8 2.5 0.6 0.7 0.8 8.7 1.6 0.7 0.7 0.7 0.1 0.7 0.2 0.0 1.1 0.0 2.5 0.8 2.7 0.4 43.3 12.0 10.3 19.2 2.0 0.0 1.7 5.5 0.5 0.3 109.6 0.0 41.1 0.0 0.2 2.5 0.0 0.0 0.1 0.0 10.9 0.0 0.3 0.0 0.0 0.0 1.7 0.0 39.5 0.8 25.6 73.7 0.0 0.0 3.8 0.0 0.2 0.2 0.2 1.3 0.1 2.2 44.3 14.7 FUT8 ENSG00000033170 "Fucosyltransferase 8" Q9BYC5 14 65410592-65744121 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017129, HPA043410" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB017129: , HPA043410: AB_2678467" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (3.28e-2)" "unprognostic (1.65e-3)" "unprognostic (2.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.41e-1)" "unprognostic (8.81e-2)" "unprognostic (2.00e-2)" "unprognostic (1.33e-3)" "unprognostic (8.09e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-3)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" 7.2 7.6 16.2 12.0 21.1 3.3 9.4 24.1 18.1 6.7 9.8 29.1 16.1 15.4 8.7 5.0 6.5 14.0 10.1 5.2 19.8 12.9 6.2 2.9 7.0 11.2 20.5 11.2 7.2 10.5 6.2 5.2 18.8 17.3 5.4 10.4 7.1 33.7 13.7 3.5 4.9 15.1 9.5 39.8 8.5 27.6 13.1 23.6 8.4 7.5 2.4 15.2 14.4 5.6 13.5 2.2 0.5 1.7 12.0 8.2 2.5 34.4 6.8 3.3 30.3 14.6 11.0 20.5 11.1 17.0 7.7 8.6 5.3 12.7 9.2 9.5 10.9 21.2 2.6 7.8 3.0 11.8 34.0 3.4 9.2 2.5 6.9 7.5 2.0 7.6 27.7 2.0 10.6 5.0 33.8 19.5 4.5 3.4 7.8 5.5 17.7 9.8 5.1 4.4 16.0 23.9 6.7 2.9 5.3 13.8 9.7 7.0 5.3 5.9 2.8 2.4 20.7 2.8 3.3 42.5 10.1 10.9 4.5 8.9 15.7 6.0 21.9 20.5 3.6 3.2 0.5 1.7 0.5 3.5 0.6 3.5 13.5 5.6 5.1 2.2 6.8 6.1 6.0 0.2 12.0 1.1 2.2 8.2 2.5 16.2 21.1 24.1 17.3 19.8 12.9 20.5 11.2 17.3 23.6 11.9 33.3 42.9 6.7 10.8 10.6 5.6 10.2 16.0 22.7 12.2 3.9 38.8 0.0 7.7 28.3 11.3 6.8 0.0 28.1 24.2 15.8 5.7 7.0 3.2 11.0 7.9 5.2 15.4 12.1 10.9 11.8 7.0 1.7 1.8 17.5 35.8 36.1 8.5 12.7 7.8 8.0 0.0 10.3 31.6 26.2 8.5 11.8 13.8 9.4 4.6 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 2.9;Exocrine glandular cells: 1.6" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "MCF7: 4.2;OE19: 4.1;RT4: 9.5;SCLC-21H: 9.7;SK-BR-3: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: AB_2686323" "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 2.1 4.1 0.0 0.0 0.0 0.0 0.0 9.5 9.7 0.2 0.0 5.5 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 0.0 0.0 0.0 0.6 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 FUZ "FLJ22688, Fy" ENSG00000010361 "Fuzzy planar cell polarity protein" Q9BT04 19 49806869-49817376 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 116.2" "Group enriched" "Detected in many" 24 "Early spermatids: 1102.3;Late spermatids: 1611.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041779, HPA042196" Approved Approved Cytosol No NA Cytosol "HPA041779: AB_10793974, HPA042196: AB_10797383" "unprognostic (2.40e-3)" "unprognostic (1.31e-1)" "unprognostic (7.73e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-2)" "unprognostic (4.36e-3)" "unprognostic (9.67e-2)" "unprognostic (1.47e-1)" "unprognostic (1.97e-2)" "unprognostic (1.06e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.50e-5)" "unprognostic (1.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.70e-1)" 5.6 7.8 7.4 2.1 8.4 4.7 4.1 5.4 9.0 6.5 3.8 11.3 3.5 3.7 6.1 6.6 3.4 17.8 4.7 4.5 7.7 5.8 9.0 3.0 4.4 4.1 7.8 5.6 9.8 7.0 5.6 5.2 3.6 6.8 4.5 1.7 4.8 6.2 7.1 15.1 2.0 3.2 3.8 7.9 3.6 4.6 116.2 8.1 5.4 6.8 3.4 3.2 3.5 3.0 5.7 12.3 14.9 4.0 3.0 4.6 2.4 0.0 6.6 6.1 8.0 5.4 6.3 1.7 3.0 3.4 5.3 7.1 0.5 10.8 1.9 6.4 2.9 1.5 2.8 1.5 5.8 2.3 6.2 12.6 7.5 4.4 0.0 6.6 4.5 4.3 6.6 3.9 10.2 2.4 4.0 4.4 11.7 1.8 5.4 2.5 0.4 8.9 9.6 10.3 4.7 3.5 15.4 4.5 4.3 5.9 1.4 17.4 20.1 0.6 6.6 10.7 2.5 3.8 2.9 2.3 4.4 3.9 1.1 1.1 15.5 15.4 4.9 4.9 0.1 5.4 5.4 4.0 14.9 4.6 1.9 3.6 4.6 2.8 3.7 3.2 5.7 3.5 4.0 8.9 3.0 1.3 12.3 3.2 2.4 7.4 8.4 5.4 9.0 7.7 5.8 7.8 5.6 6.8 8.1 0.0 3.2 10.4 15.2 3.4 7.2 3.4 10.2 10.7 2.3 7.0 3.9 13.8 56.3 10.8 1102.3 4.4 2.0 0.0 4.5 9.6 10.8 10.5 10.3 5.1 11.5 9.5 2.4 9.2 6.0 1611.7 25.6 6.7 0.0 11.8 3.2 23.6 4.8 3.1 16.6 53.1 10.1 0.0 7.1 46.0 10.9 3.6 10.1 7.2 3.9 13.1 FXN "CyaY, FA, FARR, FRDA, X25" ENSG00000165060 Frataxin Q16595 9 69035259-69120427 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022164, HPA068304" Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "CAB022164: , HPA068304: AB_2685970" "unprognostic (3.38e-2)" "unprognostic (1.54e-1)" "unprognostic (7.47e-2)" "unprognostic (2.37e-3)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (2.53e-1)" "unprognostic (2.71e-3)" "unprognostic (1.10e-1)" "unprognostic (9.06e-2)" "unprognostic (1.67e-1)" "unprognostic (4.74e-2)" 8.7 19.9 10.8 9.1 9.8 21.9 11.8 13.9 11.0 8.3 9.3 12.3 11.6 6.6 12.4 11.7 9.2 9.6 7.2 20.2 8.7 10.1 10.2 40.2 9.5 12.8 11.7 8.5 16.8 25.9 18.8 8.6 8.4 10.5 9.9 11.6 12.1 11.9 13.6 25.1 5.2 7.2 16.6 8.9 12.9 9.2 13.3 9.7 3.7 11.1 9.5 9.6 10.5 7.9 15.8 17.7 2.0 18.5 24.2 28.3 19.1 11.3 9.6 15.8 7.6 7.2 10.7 15.3 8.2 7.3 12.6 9.7 5.1 7.4 20.4 6.4 8.5 13.0 12.4 18.6 18.8 15.9 23.8 21.3 28.6 6.3 37.8 12.4 20.9 12.5 11.9 15.2 12.6 13.7 4.5 16.8 12.6 21.5 20.0 11.6 11.1 5.9 9.2 21.3 23.1 19.2 14.1 10.8 13.9 14.5 9.4 12.2 5.5 8.4 5.5 8.6 11.6 6.2 6.5 10.0 8.3 14.4 10.8 11.9 5.6 4.8 12.1 3.9 17.3 8.2 2.0 16.7 0.1 21.5 18.5 16.3 15.8 22.0 21.2 17.7 10.3 28.3 27.1 0.8 24.2 14.1 15.0 17.0 19.1 10.8 9.8 13.9 11.0 8.7 10.1 11.7 8.5 10.5 9.7 3.0 11.5 20.6 17.3 8.7 6.2 39.9 7.6 5.3 3.4 14.0 3.9 35.6 18.3 16.1 2.0 11.7 3.1 0.0 12.7 16.7 14.6 12.0 6.9 60.1 30.0 0.0 6.9 8.0 14.6 4.6 14.7 15.5 16.9 14.4 11.5 8.3 15.0 0.0 12.4 20.7 1.0 12.9 17.6 3.8 31.7 7.0 12.2 13.1 15.6 11.9 FXR1 ENSG00000114416 "FMR1 autosomal homolog 1" P51114 3 180868141-180982753 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Myogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 215.4" "Group enriched" "Detected in all" 4 "Early spermatids: 827.9;Late spermatids: 1326.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018246, HPA055475" Approved Enhanced Cytosol NA NA Cytosol "HPA018246: AB_1849204, HPA055475: AB_2682828" "unprognostic (1.38e-1)" "unprognostic (1.59e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (1.04e-2)" "unprognostic (1.90e-3)" "prognostic unfavorable (2.70e-4)" "unprognostic (7.77e-3)" "unprognostic (9.20e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (7.85e-2)" "unprognostic (2.06e-1)" "unprognostic (2.02e-1)" "unprognostic (2.84e-2)" 12.4 13.8 13.0 7.6 16.1 13.7 11.7 14.8 15.0 11.5 14.3 10.5 11.4 7.5 14.7 10.1 13.4 11.7 8.9 36.1 13.7 14.3 10.1 11.3 8.5 9.4 19.4 9.6 16.9 11.4 11.4 17.3 12.7 18.1 13.1 7.4 6.5 10.2 11.8 215.4 7.7 7.9 12.3 23.4 9.1 10.5 39.1 19.4 17.2 16.2 22.7 10.0 15.6 28.8 13.8 14.9 11.4 14.0 11.0 21.8 9.4 36.1 16.8 36.4 28.2 28.0 32.0 16.5 28.8 29.5 32.4 32.1 24.7 18.3 18.5 47.6 19.8 51.2 17.5 29.3 17.6 45.4 24.4 19.7 18.8 22.2 28.2 29.9 11.6 15.5 33.7 20.2 16.3 39.1 48.6 32.6 18.2 15.0 22.5 40.7 13.0 22.1 19.6 41.0 22.4 18.5 15.4 46.5 19.7 24.9 11.3 15.4 19.7 24.9 29.0 37.2 53.4 40.3 22.4 25.9 24.4 27.3 15.2 56.5 21.0 26.3 22.0 25.5 16.8 31.1 8.9 12.9 10.0 12.9 14.0 13.6 13.8 13.8 11.7 14.9 9.5 17.6 14.4 11.4 11.0 10.2 10.5 21.8 9.4 13.0 16.1 14.8 15.0 13.7 14.3 19.4 9.6 18.1 19.4 59.6 64.8 54.7 82.6 69.6 69.6 196.5 38.2 131.2 89.9 33.2 53.0 80.5 49.7 73.6 827.9 71.9 29.3 93.5 65.6 84.4 66.3 54.2 121.5 58.7 58.6 82.6 51.6 52.2 63.0 1326.2 77.9 61.8 47.2 139.7 33.0 89.6 70.5 35.1 71.5 67.7 82.8 32.3 61.4 245.3 103.5 61.7 51.1 57.5 38.5 60.3 FXR2 FMR1L2 ENSG00000129245 "FMR1 autosomal homolog 2" P51116 17 7591230-7614871 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 55.0" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011205, HPA022997" Supported Supported Cytosol NA NA Cytosol "CAB011205: AB_476964, HPA022997: AB_1849208" "unprognostic (9.57e-2)" "unprognostic (1.23e-1)" "unprognostic (5.15e-3)" "unprognostic (2.61e-1)" "unprognostic (1.62e-1)" "unprognostic (7.56e-3)" "unprognostic (1.96e-1)" "unprognostic (3.50e-3)" "unprognostic (2.15e-1)" "unprognostic (2.18e-1)" "prognostic favorable (3.49e-6)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (2.46e-1)" "unprognostic (2.64e-1)" "unprognostic (7.79e-2)" "unprognostic (7.67e-2)" 10.4 13.6 15.9 7.4 22.5 5.8 7.5 21.2 25.2 9.6 9.5 14.5 11.2 9.2 9.7 8.3 11.1 9.0 7.4 31.9 16.1 18.1 11.1 9.6 10.5 8.5 18.8 18.5 10.2 11.2 19.2 13.9 10.6 22.4 11.8 8.0 13.5 10.9 13.2 55.0 9.1 8.5 11.7 15.1 8.4 7.8 13.5 18.2 8.3 9.4 9.5 9.8 8.9 8.3 2.4 3.1 6.0 2.2 2.1 4.6 1.9 15.6 20.7 19.2 20.0 16.5 11.3 14.8 23.5 19.6 34.0 23.7 11.5 5.1 14.6 15.7 15.9 15.0 17.2 25.2 10.6 22.9 16.4 27.1 8.2 18.1 6.6 16.1 0.1 17.7 10.5 15.7 25.8 25.1 19.2 11.7 11.6 14.6 5.0 16.8 7.8 11.2 8.0 11.5 8.0 11.2 16.4 11.6 8.9 12.5 5.5 11.5 21.3 15.9 10.7 15.9 19.0 11.0 6.1 10.9 15.9 10.1 10.4 27.7 8.4 7.5 6.5 18.3 6.7 20.9 6.0 2.0 5.8 2.4 2.2 3.2 1.1 3.8 4.6 3.1 2.4 3.1 3.3 5.1 2.1 1.4 2.1 3.8 1.9 15.9 22.5 21.2 25.2 16.1 18.1 18.8 18.5 22.4 18.2 29.8 14.1 7.3 9.7 10.2 43.8 35.9 5.1 6.7 10.3 15.7 29.5 13.4 1.7 9.2 1.4 9.7 12.2 0.0 8.0 9.8 8.1 11.6 2.3 9.7 7.8 60.4 9.2 14.1 7.8 2.0 8.9 6.9 0.0 7.2 10.3 21.1 13.8 11.0 14.5 6.6 51.7 6.5 9.2 14.4 22.4 12.5 14.3 6.1 8.0 8.3 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Group enriched" "Detected in many" 4 "Fibroblasts: 170.5;Hepatocytes: 393.6;Leydig cells: 398.4;Muller glia cells: 148.5;Peritubular cells: 120.6;Sertoli cells: 116.4;Smooth muscle cells: 231.4" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Cell line enhanced" "Detected in some" "ASC diff: 31.0;ASC TERT1: 9.0;HSkMC: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 31.0 9.0 0.8 3.7 0.1 0.0 0.0 0.0 0.2 2.4 1.0 0.0 0.1 0.6 0.7 0.4 0.0 2.2 0.9 0.4 0.0 1.2 3.5 0.2 0.2 12.8 0.0 0.1 0.3 0.3 0.1 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 1.8 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.2 0.1 4.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.6 0.4 5.1 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 0.0 0.0 3.7 5.1 26.2 1.4 0.3 2.5 5.3 0.0 24.4 3.9 1.3 0.0 0.1 1.2 6.0 1.3 0.0 4.2 1.5 170.5 2.1 0.0 393.6 4.2 0.0 0.0 49.1 11.0 5.1 398.4 4.1 50.6 0.0 0.4 148.5 1.6 2.5 120.6 0.0 7.0 116.4 231.4 3.8 11.7 23.8 2.4 4.9 0.6 2.3 FXYD6 ENSG00000137726 "FXYD domain containing ion transport regulator 6" Q9H0Q3 11 117836976-117877486 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 142.8" "Group enriched" "Detected in many" 4 "Ito cells: 132.6;Leydig cells: 220.4;Peritubular cells: 341.9;Sertoli cells: 349.3" "Cancer enriched" "Detected in all" 6 "glioma: 71.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "classical monocyte: 21.9" "Lineage enriched" "Detected in many" 6 "monocytes: 21.9" "Cell line enhanced" "Detected in some" "AF22: 37.9;HAP1: 25.0;RH-30: 15.7;SCLC-21H: 57.4;SH-SY5Y: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041334, HPA042284" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041334: AB_10970752, HPA042284: AB_2677931" "unprognostic (2.18e-3)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.31e-2)" "unprognostic (1.15e-1)" "prognostic favorable (5.87e-4)" "unprognostic (4.51e-2)" "unprognostic (3.78e-2)" "unprognostic (1.07e-2)" "prognostic favorable (5.97e-4)" "unprognostic (3.44e-2)" "prognostic favorable (4.38e-5)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.60e-4)" 12.9 38.7 41.2 9.5 46.2 3.1 8.1 49.1 142.8 24.3 52.0 30.2 9.2 7.6 54.8 19.0 9.8 26.7 29.0 25.6 35.4 51.6 12.3 10.4 21.5 8.5 18.4 59.5 82.8 9.5 3.5 28.5 5.6 20.2 35.6 11.7 11.9 9.8 22.9 11.0 3.9 16.3 58.5 12.8 42.8 17.6 23.2 18.5 2.9 15.9 6.4 5.9 38.1 13.9 0.0 3.6 0.5 21.9 0.0 0.3 5.1 0.0 0.2 37.9 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.4 0.1 25.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.4 1.6 0.1 7.6 0.0 0.0 0.0 15.7 0.2 0.9 0.0 57.4 32.7 0.0 0.1 1.3 10.9 0.6 0.6 0.0 0.0 9.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 21.9 0.0 0.0 5.3 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 5.1 41.2 46.2 49.1 78.8 35.4 51.6 18.4 59.5 20.2 18.5 6.0 2.1 0.0 2.7 6.0 2.1 4.8 2.5 2.7 1.2 0.0 2.0 0.8 1.7 5.2 2.2 57.8 0.0 0.0 0.3 1.1 30.7 2.3 0.0 0.4 57.8 1.6 12.0 132.6 22.4 8.6 220.4 9.7 15.1 3.6 0.0 51.6 0.6 0.0 341.9 0.0 3.0 349.3 63.8 1.4 3.2 3.3 1.1 0.0 0.0 1.4 FYN "MGC45350, SLK, SYN" ENSG00000010810 "FYN proto-oncogene, Src family tyrosine kinase" P06241 6 111660332-111873452 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Proximal tubular cells: 145.7;T-cells: 208.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "NK-cells: 15.3;T-cells: 43.2" "Cell line enhanced" "Detected in many" "U-2197: 105.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005034, CAB018387, HPA023887, HPA063770" Approved Enhanced "Plasma membrane,Cytosol" NA NA 2000000 "Plasma membrane" Cytosol "CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119" "unprognostic (8.62e-3)" "unprognostic (8.25e-2)" "unprognostic (2.11e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "prognostic favorable (1.84e-4)" "unprognostic (4.60e-2)" "unprognostic (2.89e-2)" "unprognostic (2.92e-1)" "prognostic favorable (4.78e-4)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.95e-2)" "unprognostic (3.10e-1)" "unprognostic (6.62e-3)" "unprognostic (2.40e-1)" 29.1 7.2 49.2 29.0 38.4 16.3 18.1 33.9 62.1 25.7 12.1 33.7 4.1 10.1 21.8 21.4 10.2 32.0 19.4 21.2 39.4 34.0 9.5 12.2 25.2 57.2 35.7 23.1 18.6 4.4 15.0 12.5 17.7 25.6 9.6 10.0 11.0 6.4 8.4 7.0 16.5 19.0 24.2 30.9 39.8 15.4 10.1 31.3 34.8 27.5 5.6 38.5 22.6 19.3 1.6 1.7 0.7 1.5 15.3 43.2 10.7 1.9 0.3 34.9 5.8 26.7 16.4 0.6 5.5 17.5 4.7 8.5 0.2 0.3 3.9 3.6 10.7 4.1 0.2 4.9 7.6 9.2 0.1 12.8 10.7 2.6 0.5 15.8 3.6 3.7 15.8 11.6 17.7 15.2 12.4 19.2 19.2 0.9 27.3 16.8 0.2 17.1 3.3 5.0 0.6 3.5 5.4 4.7 0.2 0.0 1.7 24.5 9.9 1.0 0.4 23.3 8.1 0.2 10.8 12.2 14.3 2.6 105.3 3.5 3.9 3.5 6.0 26.9 8.4 24.8 0.2 1.5 0.0 34.1 1.2 43.2 1.1 21.2 37.5 1.7 1.6 7.0 18.7 0.7 15.3 0.9 1.0 17.6 10.7 49.2 38.4 33.9 35.3 39.4 34.0 35.7 23.1 25.6 31.3 0.0 11.7 18.8 1.9 15.1 53.9 9.2 12.7 5.3 3.4 7.0 0.0 2.2 14.9 8.1 2.8 56.2 3.5 0.0 0.9 2.1 36.8 1.4 51.8 59.3 2.8 44.5 12.7 71.8 42.5 0.9 24.5 33.6 35.4 3.6 2.4 88.8 6.3 0.0 6.7 145.7 7.8 12.9 23.1 2.6 4.3 11.7 43.5 208.1 1.2 0.9 G2E3 "FLJ20333, KIAA1333, PHF7B" ENSG00000092140 "G2/M-phase specific E3 ubiquitin protein ligase" Q7L622 14 30559123-30620063 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.6" "Group enriched" "Detected in all" 7 "Early spermatids: 712.5;Late spermatids: 198.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001601 Uncertain Approved "Golgi apparatus,Vesicles,Cytosol" NA NA Cytosol "Golgi apparatus, Vesicles" "HPA001601: AB_1079198" "unprognostic (4.75e-2)" "unprognostic (6.31e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (9.10e-2)" "unprognostic (3.99e-2)" "unprognostic (5.44e-6)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (1.86e-1)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" 7.6 5.1 5.6 7.6 14.2 8.5 6.6 10.8 10.4 8.1 5.8 5.8 4.2 5.9 8.5 4.8 7.0 5.4 4.5 4.9 6.7 5.2 5.4 5.5 5.4 8.6 7.3 4.9 7.1 5.7 6.0 10.9 6.9 7.6 6.0 6.1 5.3 5.9 7.1 5.2 6.1 5.8 6.7 7.1 7.9 5.4 39.6 8.8 20.9 7.3 4.8 9.5 6.0 8.3 11.5 8.1 16.5 12.5 7.9 12.4 5.0 21.2 9.7 21.8 10.0 7.1 8.7 18.4 20.0 7.2 12.1 13.7 9.4 12.9 17.9 6.4 10.9 9.9 17.9 20.8 11.4 24.7 14.7 8.5 9.8 10.6 17.2 6.3 18.9 12.5 5.4 4.6 9.7 22.1 11.4 14.3 13.4 12.1 14.9 17.0 12.4 12.6 4.7 18.2 16.8 17.1 11.7 0.0 4.9 7.1 13.2 18.5 12.5 16.1 10.9 4.6 13.1 12.5 6.4 10.7 13.0 13.8 9.5 13.0 8.6 25.1 21.4 3.9 9.5 19.2 16.5 7.5 14.1 9.6 9.7 12.4 10.8 9.4 7.7 6.4 11.5 12.0 10.1 6.8 7.9 12.5 8.1 7.3 5.0 5.6 14.2 10.8 10.4 6.7 5.2 7.3 4.9 7.6 8.8 17.9 7.0 27.4 17.9 19.5 31.8 8.7 10.2 9.4 14.8 5.2 23.6 12.4 8.3 8.6 712.5 15.2 6.3 46.7 6.1 19.3 15.0 16.9 16.2 6.4 12.2 33.4 13.3 17.8 14.5 198.8 15.3 11.7 8.5 7.2 12.7 14.1 9.7 10.2 13.4 11.1 31.9 51.8 15.6 69.3 43.2 22.2 8.4 15.0 10.4 19.7 G3BP1 "G3BP, HDH-VIII" ENSG00000145907 "G3BP stress granule assembly factor 1" Q13283 5 151771045-151812785 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity, Transport" "DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004052, CAB037068" Supported Supported Cytosol NA NA 150000 Cytosol "CAB037068: AB_1840864, HPA004052: AB_1849348" "unprognostic (1.31e-1)" "unprognostic (3.94e-2)" "unprognostic (1.19e-3)" "unprognostic (1.28e-2)" "unprognostic (1.05e-1)" "unprognostic (3.09e-2)" "unprognostic (1.03e-3)" "unprognostic (1.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.36e-1)" "unprognostic (2.06e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.33e-4)" "unprognostic (1.97e-1)" "unprognostic (1.33e-1)" "unprognostic (2.11e-2)" "unprognostic (3.88e-2)" 36.7 27.5 21.1 29.1 23.7 12.2 29.7 24.3 21.4 28.5 23.4 27.7 19.6 18.1 29.9 19.3 40.7 26.5 20.7 24.8 21.7 21.2 30.7 44.1 25.9 36.8 31.8 16.7 38.2 30.6 29.9 29.9 27.9 24.9 24.5 27.2 22.6 24.1 19.7 66.4 25.3 22.8 27.0 27.4 28.9 20.6 27.4 25.8 57.1 28.9 37.0 42.3 27.7 34.8 25.6 19.9 19.5 19.1 29.4 40.0 32.1 37.7 29.5 36.4 15.9 46.4 25.2 42.0 37.5 34.0 48.4 57.5 54.2 49.0 70.5 55.2 34.8 42.3 35.9 54.9 72.8 63.5 19.5 26.4 43.6 27.3 36.3 26.5 54.5 28.8 25.1 39.8 42.1 41.7 19.8 39.9 28.5 34.1 34.8 47.4 20.3 45.9 24.2 40.6 27.5 30.3 42.2 46.0 33.6 31.8 37.6 34.4 24.9 35.5 51.7 54.3 35.9 41.3 30.3 43.4 35.0 40.8 33.1 68.1 21.7 29.9 55.5 26.3 42.0 63.1 19.5 13.9 13.0 25.7 19.1 40.0 25.6 34.4 28.7 18.0 21.9 33.0 32.9 6.1 29.4 16.8 19.9 34.0 32.1 21.1 23.7 24.3 21.4 21.7 21.2 31.8 16.7 24.9 25.8 17.9 30.0 62.3 74.5 212.8 33.8 51.5 48.4 65.6 61.4 61.1 15.7 86.5 66.3 65.2 35.3 78.7 31.9 23.3 45.9 73.7 92.5 76.9 72.7 138.2 69.1 54.0 48.1 74.9 78.1 21.9 60.1 59.1 82.7 88.4 55.3 50.3 51.8 38.6 53.7 64.9 35.6 38.8 106.6 46.3 99.0 224.2 56.3 61.0 68.9 82.6 G3BP2 KIAA0660 ENSG00000138757 "G3BP stress granule assembly factor 2" Q9UN86 4 75642782-75724525 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018304, HPA018425" Enhanced Enhanced Cytosol NA NA Cytosol "HPA018304: AB_1849350, HPA018425: AB_1849352" "unprognostic (2.42e-2)" "unprognostic (5.79e-2)" "unprognostic (8.70e-3)" "unprognostic (2.23e-1)" "unprognostic (6.98e-2)" "unprognostic (5.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.04e-1)" "unprognostic (6.83e-2)" "unprognostic (3.79e-1)" "unprognostic (7.38e-2)" "unprognostic (7.88e-2)" "prognostic favorable (6.65e-5)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (1.27e-2)" "unprognostic (6.99e-2)" 22.7 24.7 28.2 21.9 48.4 31.6 23.9 52.2 55.6 24.3 28.6 21.5 18.7 24.5 25.1 18.7 24.5 26.9 23.3 23.0 29.3 46.3 32.3 33.7 21.3 24.8 31.3 30.0 20.4 18.8 31.0 27.6 17.7 57.9 37.7 27.3 16.3 22.0 24.2 69.7 15.3 27.8 25.9 35.2 22.9 22.0 27.4 19.6 29.9 35.4 28.1 26.6 26.9 17.9 18.8 20.4 32.5 28.2 31.9 41.4 24.7 27.6 28.8 47.0 38.7 40.6 41.5 15.6 42.6 40.8 27.3 29.1 37.2 38.8 53.2 38.2 34.0 25.1 18.7 48.4 49.7 40.0 31.6 20.0 55.2 28.7 41.9 35.8 50.6 41.2 32.8 42.6 33.1 34.4 36.7 49.3 34.0 40.5 40.6 43.5 17.8 58.8 18.2 49.2 38.9 13.3 44.6 58.0 27.8 32.3 34.0 38.6 41.4 31.3 45.1 55.3 50.3 21.7 25.6 49.9 27.8 22.6 31.1 23.7 39.6 37.7 54.6 39.8 34.7 36.0 32.5 17.0 30.7 26.8 23.1 41.4 18.8 26.1 28.8 20.4 14.6 26.3 28.4 16.6 31.9 28.2 9.9 22.1 24.7 28.2 48.4 52.2 55.6 29.3 46.3 31.3 30.0 57.9 19.6 50.6 115.9 82.1 60.0 79.0 59.4 66.9 22.9 78.9 92.1 50.6 47.1 31.6 34.9 45.0 180.8 63.3 78.6 46.7 59.3 41.8 54.5 74.8 101.8 66.8 40.5 66.7 130.0 49.7 73.0 184.9 24.5 67.6 57.3 90.2 97.3 31.7 70.8 56.1 37.4 71.9 60.6 19.4 46.4 56.0 66.1 68.0 34.6 94.8 60.7 90.4 G6PD G6PD1 ENSG00000160211 "Glucose-6-phosphate dehydrogenase" P11413 X 154531391-154547572 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.1" "Cell type enhanced" "Detected in many" 6 "monocytes: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 77.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 77.3" "Cell line enhanced" "Detected in all" "A549: 229.1;MCF7: 86.9" "Low region specificity" "Detected in all" "HPA000247, HPA000834" Enhanced Enhanced "Centriolar satellite,Cytosol" No No 12000000 Cytosol "Centriolar satellite" "HPA000247: AB_1078978, HPA000834: AB_1078977" "unprognostic (1.73e-2)" "unprognostic (1.53e-3)" "unprognostic (1.13e-2)" "unprognostic (1.02e-1)" "unprognostic (7.78e-2)" "unprognostic (4.34e-2)" "prognostic unfavorable (9.45e-13)" "unprognostic (2.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-1)" "unprognostic (3.66e-1)" "unprognostic (2.89e-3)" "unprognostic (2.83e-1)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (7.25e-2)" 21.9 29.4 10.4 15.6 10.7 51.4 18.2 8.4 14.7 12.2 7.5 13.6 4.8 7.2 14.0 13.2 29.0 11.0 24.7 10.1 8.8 10.1 15.4 3.7 20.8 31.0 10.3 8.0 19.8 7.9 5.9 20.7 9.2 10.9 11.3 7.3 17.8 13.9 8.6 4.4 11.3 7.3 17.5 11.1 20.3 9.9 83.1 9.5 22.5 24.6 44.8 25.7 24.1 19.0 3.6 7.6 77.3 16.2 12.7 10.3 11.8 15.7 229.1 4.7 18.1 19.9 27.1 4.2 11.0 31.5 11.2 19.4 10.5 5.9 10.1 17.1 25.0 45.4 14.0 7.3 18.6 5.8 10.3 5.1 10.7 51.9 23.6 38.8 10.8 36.9 13.1 5.5 21.9 4.7 17.6 23.3 7.5 6.4 4.4 20.3 86.9 6.9 7.7 3.4 50.2 17.0 6.8 2.7 11.1 33.8 19.6 4.8 6.0 10.9 42.8 9.2 6.4 6.4 9.0 27.6 7.1 25.0 9.9 16.9 5.4 7.0 17.4 19.7 7.2 14.5 29.3 16.2 77.3 10.3 13.6 6.6 3.4 2.7 7.4 7.6 3.6 3.5 5.9 27.1 12.7 11.1 3.5 3.5 11.8 10.4 10.7 8.4 14.7 8.8 10.1 10.3 8.0 10.9 9.5 0.0 17.1 21.3 18.5 11.1 5.7 0.8 20.4 4.0 0.0 10.4 17.7 26.0 24.9 35.4 8.1 12.8 18.6 23.3 25.6 33.4 18.8 16.7 38.0 0.8 41.6 31.8 9.1 16.0 63.9 10.4 24.2 25.3 18.6 130.8 9.6 11.9 34.1 9.1 15.2 11.9 24.6 6.5 12.3 10.1 34.9 12.0 30.3 39.5 9.9 26.5 GAB1 ENSG00000109458 "GRB2 associated binding protein 1" Q13480 4 143336762-143474568 "Predicted intracellular proteins, RAS pathway related proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 38.0;U-266/70: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034333, HPA066404" Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB034333: AB_2107855, HPA066404: " "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.32e-3)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (1.79e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-1)" "unprognostic (1.35e-2)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.20e-1)" "prognostic favorable (3.91e-5)" "unprognostic (4.99e-2)" "unprognostic (2.70e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" 9.2 8.4 15.0 7.3 33.3 8.8 9.7 5.8 22.0 10.1 17.0 64.0 10.2 10.4 17.7 13.1 18.2 8.6 11.1 26.2 19.5 11.4 12.9 7.9 15.6 5.0 35.7 19.0 18.1 7.0 17.2 6.3 18.0 30.5 7.8 20.3 15.4 11.7 13.9 11.2 11.1 10.4 15.9 32.3 6.2 11.0 7.9 41.7 1.0 7.8 6.0 7.3 9.9 11.9 3.1 3.4 5.9 2.3 7.4 0.4 0.4 3.4 0.7 8.9 6.4 4.5 4.3 11.6 2.4 8.0 2.9 5.1 6.6 5.9 0.1 0.7 3.3 2.0 1.9 8.5 2.8 3.3 0.5 2.0 6.2 1.9 3.1 3.1 0.8 1.2 5.3 5.0 3.5 2.3 6.2 3.8 0.1 2.0 11.5 2.0 4.9 0.5 0.0 2.5 1.8 2.8 38.0 4.3 4.4 4.5 4.2 2.1 6.3 1.6 7.0 3.0 6.2 4.5 0.8 2.8 3.7 2.9 1.7 1.8 18.5 9.0 13.7 2.5 2.5 3.0 5.9 0.6 0.7 0.0 0.8 0.4 1.3 0.1 0.0 0.8 3.1 0.0 0.0 4.0 7.4 2.3 3.4 0.0 0.4 15.0 33.3 5.8 22.0 19.5 11.4 35.7 19.0 30.5 41.7 26.8 14.7 6.7 7.6 18.0 1.9 27.8 7.6 2.7 5.7 12.2 0.0 18.0 0.0 5.0 0.9 16.5 11.2 0.0 2.2 8.5 11.5 6.2 2.3 5.8 5.3 3.2 21.4 11.6 9.7 2.1 19.2 5.7 15.1 2.8 25.0 14.1 4.1 8.6 17.7 5.0 0.7 12.9 16.5 1.8 5.2 21.8 8.7 1.3 13.5 11.1 GABARAPL2 "ATG8, ATG8C, GATE-16, GATE16, GEF2" ENSG00000034713 "GABA type A receptor associated protein like 2" P60520 16 75566351-75577881 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036726 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA036726: AB_10672476" "unprognostic (3.29e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-2)" "unprognostic (7.00e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.58e-1)" "unprognostic (6.85e-2)" "unprognostic (2.13e-1)" "unprognostic (4.95e-2)" "unprognostic (9.86e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.95e-8)" "unprognostic (3.11e-3)" "unprognostic (3.84e-3)" "unprognostic (1.37e-2)" "unprognostic (3.85e-1)" 29.6 47.4 69.0 18.0 70.5 24.7 33.8 52.3 61.4 29.4 23.9 54.2 26.0 18.7 25.7 47.1 21.7 30.9 23.7 76.6 59.6 69.5 42.0 31.4 25.4 23.4 73.4 52.5 28.9 25.8 46.2 33.6 31.8 52.4 33.4 23.6 30.8 27.3 31.0 52.7 24.3 19.4 28.2 72.0 25.7 21.8 20.2 45.4 17.5 35.7 22.4 26.8 22.6 19.3 38.2 47.0 87.8 25.4 18.9 35.1 35.9 23.9 20.4 34.9 16.4 54.2 47.8 17.7 28.2 40.9 38.7 43.6 18.7 31.1 34.6 34.8 32.1 23.4 20.7 25.9 26.4 47.9 14.9 49.4 20.4 18.8 27.7 29.6 19.5 36.9 33.0 37.5 32.5 24.3 35.3 31.4 31.4 29.8 14.2 38.6 33.9 28.8 37.4 20.9 27.0 22.9 32.5 16.8 41.7 40.4 15.7 41.1 43.0 44.1 10.6 40.5 29.1 34.0 30.8 28.6 16.8 25.7 24.4 15.1 40.5 38.3 72.4 40.5 19.0 24.7 47.8 25.3 61.1 23.9 23.4 30.6 38.2 25.6 27.3 30.4 32.1 23.3 21.8 87.8 18.9 25.4 47.0 35.1 35.9 69.0 70.5 52.3 61.4 59.6 69.5 73.4 52.5 52.4 45.4 80.4 128.3 143.1 246.6 244.3 234.3 274.6 119.8 196.7 104.6 165.7 43.2 221.0 581.9 172.6 40.2 247.2 151.5 210.2 153.9 100.3 212.4 297.8 105.3 119.0 199.3 290.8 266.6 200.1 176.9 47.4 225.5 212.5 244.6 505.9 147.5 338.5 185.4 241.8 245.4 443.3 155.9 155.2 146.3 296.3 235.3 239.5 326.2 159.2 111.7 275.4 GABPB2 MGC29891 ENSG00000143458 "GA binding protein transcription factor beta subunit 2" Q8TAK5 1 151070578-151125542 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 26.5" "Low region specificity" "Detected in all" "HPA028471, HPA058483" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028471: AB_10602319, HPA058483: AB_2683730" "unprognostic (1.21e-1)" "unprognostic (7.03e-3)" "unprognostic (2.76e-2)" "unprognostic (9.95e-2)" "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" "unprognostic (4.65e-2)" "unprognostic (7.71e-2)" "unprognostic (1.98e-2)" "unprognostic (8.02e-2)" "unprognostic (1.75e-2)" "unprognostic (1.61e-2)" "unprognostic (2.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.90e-3)" 9.9 8.3 9.5 9.3 13.3 12.2 10.9 12.3 12.2 10.0 8.5 14.8 10.7 7.0 10.1 8.0 8.7 10.2 10.7 11.0 11.6 5.8 7.9 6.4 7.7 9.9 14.4 9.7 17.6 7.8 15.1 12.8 6.5 11.4 9.4 9.8 11.0 7.6 12.6 10.0 13.9 8.1 12.0 10.2 10.1 9.8 20.2 15.2 15.7 10.0 11.6 9.8 9.9 16.6 4.7 5.0 4.7 5.1 2.6 4.8 2.6 6.9 2.4 1.7 2.1 6.1 9.0 2.2 6.4 4.0 3.7 2.6 0.7 5.2 7.2 2.4 6.1 2.0 6.1 3.7 3.3 5.5 2.7 1.4 2.0 3.8 0.1 4.1 7.8 4.1 4.9 3.8 5.1 7.7 2.9 1.4 7.7 4.8 5.1 4.4 9.8 10.8 1.4 0.8 4.0 2.7 3.2 2.8 3.4 3.1 1.9 3.0 1.2 8.2 2.9 2.4 1.7 7.2 8.6 4.1 1.0 3.2 6.6 5.1 2.8 1.3 26.5 3.0 5.9 4.4 3.6 2.8 1.6 4.4 3.3 2.7 3.1 4.8 3.9 2.5 4.7 4.3 4.7 4.7 2.6 5.1 5.0 1.7 2.6 9.5 13.3 12.3 12.2 11.6 5.8 14.4 9.7 11.4 15.2 8.9 12.6 13.8 9.2 10.2 26.2 21.4 25.5 24.1 18.2 12.2 23.6 4.9 8.3 5.6 28.3 9.0 9.8 0.0 5.1 4.2 10.8 6.2 6.9 5.9 7.3 31.8 9.2 16.0 14.8 13.9 20.8 8.0 8.5 9.0 15.4 15.4 4.6 10.5 20.1 3.3 39.9 6.5 16.0 54.6 51.3 8.8 3.8 14.4 14.9 6.7 GAD1 GAD ENSG00000128683 "Glutamate decarboxylase 1" Q99259 2 170813213-170861151 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 53.9" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 9.8;Distal tubular cells: 6.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 10.8;HEL: 34.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "olfactory region: 888.9" "CAB004415, HPA048871, HPA058412, CAB078176" Enhanced Supported Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710" "unprognostic (1.28e-1)" "prognostic favorable (7.31e-4)" "unprognostic (1.87e-2)" "prognostic favorable (8.61e-4)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (4.97e-7)" "unprognostic (1.51e-1)" "unprognostic (7.72e-2)" "unprognostic (4.27e-4)" "unprognostic (6.75e-2)" "unprognostic (9.18e-3)" "unprognostic (6.90e-5)" "unprognostic (2.93e-2)" "unprognostic (6.57e-2)" "unprognostic (1.56e-2)" "unprognostic (3.08e-3)" 1.2 2.0 14.5 0.9 28.1 3.7 1.0 10.6 53.9 1.8 1.0 3.1 0.0 1.0 2.6 5.5 1.2 1.1 1.0 1.0 10.8 24.4 6.0 1.0 1.1 1.1 8.6 17.5 1.1 1.1 9.5 2.8 1.4 6.0 1.8 1.0 1.3 1.0 1.3 0.9 1.0 1.1 1.0 2.6 1.0 1.0 4.0 3.4 0.0 1.1 0.0 1.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.4 0.0 3.8 0.0 0.0 0.0 0.2 0.0 1.4 0.9 2.5 3.6 0.0 0.5 0.2 1.7 10.8 1.2 0.3 0.8 1.4 7.4 34.9 3.0 0.1 0.0 0.1 0.6 0.0 3.1 0.0 1.2 0.3 0.0 0.3 9.0 0.1 0.4 0.8 0.0 0.0 4.3 5.2 3.8 0.5 2.6 0.2 4.7 5.0 3.7 1.2 6.6 0.0 1.8 0.3 0.1 0.0 0.0 6.5 0.9 1.3 3.8 0.0 0.0 0.0 6.3 1.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 28.1 10.6 36.7 10.8 24.4 8.6 17.5 6.0 3.4 0.0 0.0 0.0 1.4 0.2 3.8 1.1 0.0 0.0 0.0 0.0 9.8 0.0 6.6 4.2 4.3 0.3 0.0 0.0 4.7 0.1 0.2 0.8 0.0 0.0 3.0 4.8 2.9 0.0 0.3 3.6 0.6 0.2 0.0 0.0 0.0 3.9 4.2 0.0 0.0 0.0 5.4 0.0 0.8 3.2 4.7 0.1 0.5 0.0 0.0 0.3 GADD45B "DKFZP566B133, GADD45BETA, MYD118" ENSG00000099860 "Growth arrest and DNA damage inducible beta" O75293 19 2476122-2478259 "Predicted intracellular proteins" "Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Smooth muscle cells: 2211.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029816 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029816: AB_10601325" "unprognostic (1.32e-1)" "unprognostic (4.51e-2)" "unprognostic (3.94e-3)" "unprognostic (5.06e-2)" "unprognostic (1.53e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (2.95e-1)" "unprognostic (2.79e-1)" "unprognostic (4.37e-2)" "unprognostic (1.09e-3)" "unprognostic (3.90e-2)" "unprognostic (8.27e-3)" "unprognostic (6.00e-2)" 50.5 37.3 10.3 24.6 33.8 142.2 34.2 6.7 26.4 20.0 29.2 17.9 4.1 9.7 14.2 10.7 17.6 34.3 44.6 59.0 22.5 15.6 26.2 143.6 49.8 14.7 17.1 3.9 36.3 45.5 16.7 27.5 22.6 32.4 27.2 6.6 26.6 28.1 36.9 38.4 22.1 12.3 14.5 32.8 14.7 27.1 12.4 13.1 6.7 53.9 29.5 13.7 35.0 15.0 12.2 13.5 45.1 14.9 14.9 22.6 10.1 21.4 4.3 0.5 2.9 16.3 12.6 1.3 21.9 6.4 17.3 8.9 6.0 8.3 10.2 14.9 10.8 6.2 11.9 1.1 7.3 4.2 7.8 3.9 1.1 4.7 2.3 27.7 2.3 7.1 20.4 4.7 5.2 25.8 18.7 6.8 1.1 0.5 27.8 17.8 6.9 2.6 11.4 2.6 2.1 9.2 9.9 7.9 16.0 7.8 3.9 0.2 0.2 24.4 18.3 7.0 10.0 9.7 17.2 27.9 17.3 15.9 12.3 27.3 12.5 9.2 4.2 4.2 6.9 5.6 11.7 11.8 45.1 22.6 14.9 20.4 7.4 15.8 17.3 11.9 12.2 14.1 18.5 34.5 14.9 11.6 13.5 19.1 10.1 10.3 33.8 6.7 26.4 22.5 15.6 17.1 3.9 32.4 13.1 393.1 604.5 105.2 327.2 303.6 9.8 755.2 165.6 246.3 216.1 48.8 5.9 91.9 162.5 250.0 1.5 410.0 221.1 0.0 188.1 49.6 617.1 761.5 748.2 106.8 373.8 12.7 81.8 133.2 143.4 1.7 68.4 643.2 490.9 244.3 77.7 120.7 209.6 203.4 27.6 91.0 27.0 174.6 2211.4 1.6 5.7 269.9 120.6 154.5 59.8 284.3 GADL1 ENSG00000144644 "Glutamate decarboxylase like 1" Q6ZQY3 3 30726200-30894765 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 21.6" "Cell type enhanced" "Detected in some" 18 "Club cells: 2.3;Collecting duct cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039160, HPA040229" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039160: AB_10796222, HPA040229: AB_10796118" "unprognostic (4.96e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (1.39e-2)" "unprognostic (5.60e-2)" "unprognostic (7.32e-2)" "unprognostic (5.05e-3)" "unprognostic (8.37e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-3)" "unprognostic (1.63e-1)" "unprognostic (1.98e-5)" "unprognostic (8.81e-2)" "unprognostic (4.54e-2)" "unprognostic (4.39e-1)" "unprognostic (1.06e-1)" 0.5 0.3 0.2 0.2 0.3 1.0 0.4 0.5 0.7 0.4 0.2 0.0 0.0 0.1 0.2 1.6 1.4 0.2 2.0 2.3 0.2 0.3 0.7 0.2 1.6 0.3 0.3 0.8 0.5 0.3 0.1 0.6 0.5 2.1 0.5 0.1 0.3 0.3 0.0 21.6 0.8 0.2 2.5 0.7 0.5 0.2 1.1 0.0 0.0 1.2 3.3 0.7 0.5 0.3 1.7 0.5 1.9 0.8 0.5 1.3 0.3 1.3 0.3 0.8 1.1 0.9 0.5 1.6 0.6 0.3 0.3 0.2 1.3 1.2 1.1 0.5 0.2 0.7 0.9 9.9 0.3 0.4 1.7 0.5 1.6 1.6 0.5 0.4 0.9 3.4 0.4 0.6 0.7 0.3 1.0 0.6 1.0 1.2 4.1 0.9 1.1 0.7 1.3 1.9 0.7 0.5 1.9 2.1 1.0 1.0 1.5 1.2 1.0 1.2 0.7 2.9 1.2 1.2 0.8 5.1 1.5 1.4 1.9 0.7 1.6 0.8 0.7 0.6 0.9 1.9 1.9 0.7 0.8 1.0 0.6 0.8 1.2 0.9 0.6 0.4 1.7 1.1 1.0 1.7 0.5 0.8 0.5 1.3 0.3 0.2 0.3 0.5 0.7 0.2 0.3 0.3 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GAGE1 CT4.1 ENSG00000205777 "G antigen 1" Q13068 X 49589496-49608536 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 36.8" "Cell type enriched" "Detected in some" 11 "Spermatogonia: 107.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "AN3-CA: 249.2" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.6 1.0 0.7 0.8 0.1 0.7 0.0 0.0 0.0 0.0 249.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.8 0.1 0.3 0.3 0.7 0.0 0.2 0.3 0.3 0.0 0.0 0.6 0.1 0.3 0.7 0.1 0.8 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 9.7 107.0 0.0 0.0 0.0 0.0 0.0 GAGE10 ENSG00000215274 "G antigen 10" A6NGK3 X 49303669-49319844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 3.9;pituitary gland: 3.1;testis: 2.9" "Cell type enhanced" "Detected in some" 28 "Leydig cells: 1.1;Peritubular cells: 1.1;Spermatocytes: 1.4;Spermatogonia: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.0;BJ hTERT+: 1.5;SuSa: 2.2;WM-115: 2.9" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (2.81e-2)" "unprognostic (2.26e-1)" "unprognostic (3.97e-1)" 0.0 0.0 0.6 0.0 1.8 0.1 0.8 0.5 0.3 0.0 0.2 0.0 0.5 2.0 0.0 1.7 0.1 0.5 0.5 0.5 0.0 0.0 0.0 0.6 0.4 3.9 0.0 0.0 3.1 0.0 0.4 0.3 0.2 1.1 0.2 0.0 0.0 1.4 0.2 0.3 0.0 2.9 0.8 0.2 0.0 0.1 0.0 0.7 0.0 0.5 0.1 0.5 0.3 0.0 0.0 0.6 7.0 0.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 1.0 0.0 0.0 0.2 0.0 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.2 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.3 0.0 0.1 0.5 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 4.9 0.1 0.0 0.0 0.0 0.1 GAGE12C ENSG00000237671 "G antigen 12C" A1L429 X 49532211-49539538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 23.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "U-2 OS: 7.8;U-266/84: 27.7" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.8 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12D ENSG00000227488 "G antigen 12D" A1L429 X 49541767-49549094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 23.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "U-2 OS: 7.8;U-266/84: 27.7" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.8 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 GAGE12E ENSG00000216649 "G antigen 12E" A1L429 X 49551333-49558649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 9.6" "Cell type enriched" "Detected in some" 12 "Spermatogonia: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.4;HeLa: 4.1;Karpas-707: 2.0;T-47d: 1.7;U-266/84: 4.4;WM-115: 2.0" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.6 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.0 0.5 0.3 0.0 0.0 0.7 4.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 11.5 0.0 0.0 0.0 0.0 0.0 GAGE12F ENSG00000236362 "G antigen 12F" "P0CL80, O76087, P0CL82" X 49551278-49568218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 16.2;testis: 58.6" "Cell type enriched" "Detected in single" 5 "Spermatogonia: 1.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "AN3-CA: 136.7;K-562: 133.6" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 58.6 0.0 0.0 0.0 0.0 7.0 8.5 3.1 9.1 9.6 14.7 16.2 1.1 0.0 0.0 136.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.5 6.9 0.9 0.0 0.1 0.0 7.9 0.0 0.0 0.0 17.0 0.9 9.1 3.1 3.9 7.5 2.5 7.0 10.3 7.2 0.0 6.2 8.5 7.5 0.9 9.6 6.3 8.5 14.7 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 GAGE12G ENSG00000215269 "G antigen 12G" "P0CL81, O76087, P0CL82" X 49570434-49577754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 33 "blood: 7.4;stomach 1: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 7.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "AN3-CA: 149.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 1.3 2.5 0.4 7.4 6.2 0.0 0.0 0.0 149.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.4 2.5 1.3 0.8 2.2 1.3 1.5 3.6 0.5 0.0 2.6 0.6 3.2 0.0 0.4 1.8 1.4 7.4 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12H ENSG00000224902 "G antigen 12H" A6NDE8 X 49579983-49587301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 223 "testis: 22.3" "Cell type enriched" "Detected in single" 12 "Spermatogonia: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 52 "A-431: 19.6;U-266/84: 58.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 58.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.0 0.0 0.0 0.0 0.0 GAGE12J GAGE11 ENSG00000224659 "G antigen 12J" A6NER3 X 49322057-49329384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 20.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AN3-CA: 48.3;K-562: 48.4" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 20.2 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.7 0.8 1.6 0.0 0.0 0.0 0.0 48.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 9.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.2 0.4 0.8 0.7 0.9 0.0 0.7 1.6 0.4 0.4 0.8 0.5 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 GAGE13 GAGE12A ENSG00000274274 "G antigen 13" X 49331616-49338952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 26.8" "Cell type enriched" "Detected in some" 10 "Spermatogonia: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AN3-CA: 129.9" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 129.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 13.9 0.0 0.0 0.0 0.0 0.0 GAGE2A "CT4.2, GAGE2" ENSG00000189064 "G antigen 2A" Q6NT46 X 49589529-49596827 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "testis: 46.7" "Cell type enriched" "Detected in some" 13 "Spermatogonia: 363.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Karpas-707: 19.6;T-47d: 67.6;WM-115: 74.4" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 1.0 0.7 0.4 0.7 0.5 0.6 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 19.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 67.6 0.0 0.0 11.0 2.4 0.0 0.0 0.2 2.9 0.0 0.6 0.0 74.4 0.4 0.6 0.1 0.1 0.7 0.0 1.0 0.5 0.6 0.0 0.4 0.5 0.2 0.0 0.5 0.6 0.7 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 27.8 363.5 0.0 0.0 0.0 0.0 0.0 GAGE2E GAGE8 ENSG00000275113 "G antigen 2E" X 49341192-49345922 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 52 "blood: 5.8;stomach 1: 18.4;testis: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 144.6;K-562: 69.2;T-47d: 35.0" HPA043232 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.4 4.9 0.0 0.0 0.0 2.5 2.6 0.7 1.2 0.7 5.8 0.2 0.0 0.0 0.0 144.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.2 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 35.0 0.0 0.4 8.9 0.3 0.0 0.0 0.1 2.6 0.0 0.1 0.0 15.2 0.7 1.2 0.3 1.0 0.0 0.0 1.5 0.4 2.2 0.0 2.5 4.9 0.0 0.7 0.7 0.0 2.6 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAL3ST4 FLJ12116 ENSG00000197093 "Galactose-3-O-sulfotransferase 4" Q96RP7 7 100159244-100168750 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.8" "Cell type enriched" "Detected in some" 6 "Hofbauer cells: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 26 "dendritic cells: 4.3;T-cells: 15.0" "Cell line enhanced" "Detected in many" "WM-115: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038137, HPA038138" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038137: AB_10697239, HPA038138: AB_2675854" "unprognostic (4.22e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (8.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (2.80e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (3.98e-2)" "unprognostic (9.67e-2)" "unprognostic (1.89e-2)" "unprognostic (5.36e-2)" 3.9 5.4 8.4 4.2 9.4 1.0 4.1 1.5 10.9 7.8 6.5 18.6 0.4 4.1 9.0 3.7 8.4 6.3 5.9 4.9 8.0 3.8 1.8 1.0 5.3 2.9 11.9 4.7 7.6 1.5 1.6 4.6 9.8 8.1 6.5 7.0 4.2 24.9 4.3 1.9 27.8 8.9 10.6 14.9 2.7 2.8 4.4 10.2 37.8 2.0 2.4 3.9 7.3 10.6 0.1 4.3 0.3 0.1 0.2 15.0 2.2 0.0 0.6 4.0 1.8 3.6 7.1 7.6 2.2 2.2 1.3 1.8 0.4 0.2 0.7 0.5 7.4 2.3 8.6 0.2 1.3 0.4 0.0 0.4 0.2 0.1 0.2 2.4 0.4 2.4 8.7 3.4 3.9 0.4 2.8 2.5 3.1 1.1 0.1 2.4 0.3 2.7 0.1 1.3 8.2 0.9 2.2 1.8 0.1 0.0 0.3 0.2 1.7 0.6 0.0 4.6 0.7 0.0 0.2 2.2 0.2 1.2 0.3 0.1 0.1 0.1 1.7 1.4 0.4 29.6 0.0 0.1 0.0 0.5 0.0 0.0 0.0 4.4 0.3 0.0 0.1 15.0 4.5 0.3 0.2 0.1 4.3 1.1 2.2 8.4 9.4 1.5 10.9 8.0 3.8 11.9 4.7 8.1 10.2 0.0 0.3 0.0 2.0 3.8 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.3 0.0 0.5 0.1 0.5 0.0 0.0 0.0 0.2 6.0 0.3 0.0 0.0 38.9 0.0 0.0 1.8 0.3 0.0 4.4 0.7 5.0 1.0 0.6 0.5 0.5 2.9 4.9 0.0 0.0 0.0 2.2 0.4 0.2 7.0 0.7 0.0 6.0 0.9 GALE SDR1E1 ENSG00000117308 UDP-galactose-4-epimerase Q14376 1 23795599-23800804 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 119.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007340 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA007340: AB_1078934" "unprognostic (1.65e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (1.41e-2)" "unprognostic (3.03e-3)" "unprognostic (1.17e-2)" "unprognostic (3.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.59e-1)" "unprognostic (2.65e-1)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (2.25e-1)" "unprognostic (7.51e-2)" "unprognostic (2.12e-1)" "prognostic favorable (2.68e-4)" "unprognostic (1.41e-2)" 4.4 5.5 4.8 5.6 6.1 1.8 5.0 4.3 8.7 9.1 22.3 3.2 12.4 20.0 3.0 6.0 26.2 6.4 34.7 3.7 4.0 4.1 18.2 26.1 7.7 3.9 3.7 5.2 2.4 15.9 7.7 3.5 29.4 3.5 4.8 23.8 5.5 32.1 6.9 1.7 3.9 30.4 4.1 3.6 8.6 46.7 3.4 2.6 3.7 2.3 9.8 19.6 8.1 8.4 3.1 10.6 2.0 18.6 19.4 5.2 4.7 16.3 19.7 7.9 12.5 2.9 4.2 7.7 11.2 15.2 19.9 14.9 18.0 55.1 3.9 15.8 6.5 26.7 18.2 7.0 28.7 15.1 8.3 4.5 11.0 10.0 19.5 30.1 4.7 3.3 8.9 15.1 18.3 46.0 20.1 17.0 8.5 12.2 1.0 14.1 17.5 7.8 5.1 2.2 23.0 19.2 9.3 7.7 4.9 32.2 11.0 3.1 7.0 20.3 18.4 19.9 9.4 13.5 3.9 9.3 14.5 21.7 14.9 13.7 5.1 12.2 5.1 15.4 20.2 7.8 1.1 7.7 1.7 5.1 15.5 5.2 3.1 3.1 4.1 10.6 1.0 3.6 2.5 2.0 19.4 18.6 3.0 5.1 4.7 4.8 6.1 4.3 8.7 4.0 4.1 3.7 5.2 3.5 2.6 11.9 33.5 8.2 17.9 6.8 14.3 3.1 40.8 12.0 19.4 38.4 15.7 47.8 29.9 42.8 20.5 9.8 92.2 0.0 103.0 85.9 6.3 18.2 10.4 31.8 81.7 7.9 11.6 9.2 3.7 5.1 4.4 12.2 23.6 29.7 119.4 20.6 62.8 84.5 3.2 64.1 13.1 0.0 5.3 14.6 9.7 4.3 80.6 7.5 58.2 38.3 GALK1 GALK ENSG00000108479 "Galactokinase 1" P51570 17 75751594-75765711 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" "Kinase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 36.7" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 107.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007094, HPA016960" Approved Approved "Golgi apparatus,Cytosol" NA NA 8600 Cytosol "Golgi apparatus" "HPA007094: AB_1078939, HPA016960: AB_1849430" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (1.81e-2)" "unprognostic (2.94e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.04e-2)" "unprognostic (1.06e-1)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (3.04e-1)" "unprognostic (1.71e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.62e-5)" 6.4 3.3 3.8 6.2 4.4 3.6 14.2 4.6 5.1 4.7 9.3 3.7 3.5 15.9 4.7 5.0 9.0 4.8 3.8 7.2 3.6 3.6 12.3 31.6 4.7 11.7 4.3 3.8 5.2 16.0 1.9 2.6 4.6 3.2 4.7 1.3 3.6 14.9 4.7 5.4 6.2 17.3 3.7 4.0 7.2 5.3 5.7 3.3 7.6 3.3 5.1 4.8 3.6 5.0 10.6 36.7 20.7 30.2 5.7 9.4 14.6 8.1 30.7 1.9 8.6 2.7 6.8 7.2 6.6 5.5 6.8 6.4 17.0 1.6 12.7 8.3 3.5 5.0 4.8 2.0 1.9 0.7 5.5 19.2 7.9 11.6 28.5 9.3 5.3 17.6 6.1 2.7 3.4 1.5 3.4 15.8 7.2 6.2 7.8 4.1 34.9 14.6 19.9 2.1 3.8 15.9 17.5 21.4 21.1 3.8 3.3 4.2 11.6 5.6 14.5 14.4 1.5 11.8 8.7 13.9 10.1 9.7 9.6 5.8 19.7 4.8 3.2 11.3 12.4 7.8 2.6 30.2 8.3 9.4 25.5 8.5 10.6 7.8 8.6 27.2 6.8 4.2 6.2 20.7 5.7 20.2 36.7 8.7 14.6 3.8 4.4 4.6 5.1 3.6 3.6 4.3 3.8 3.2 3.3 14.9 11.7 15.8 8.2 7.7 6.8 17.6 20.4 0.0 3.4 12.2 0.0 41.6 58.0 23.3 0.6 17.9 12.3 0.0 47.9 88.4 28.2 7.0 27.6 107.1 49.1 3.2 8.1 30.7 45.2 3.6 28.7 28.4 37.1 27.9 13.6 15.8 25.0 25.1 22.6 75.3 6.2 6.5 12.3 1.2 22.0 10.9 35.4 15.0 24.0 7.6 GALK2 GK2 ENSG00000156958 "Galactokinase 2" Q01415 15 49155656-49367869 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043564, HPA048267" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043564: AB_2678557, HPA048267: AB_2680335" "unprognostic (2.27e-2)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "prognostic favorable (7.31e-4)" "unprognostic (3.04e-1)" "unprognostic (9.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.95e-1)" "unprognostic (2.30e-1)" "unprognostic (8.67e-3)" "unprognostic (2.25e-2)" "unprognostic (2.43e-1)" "prognostic favorable (1.88e-5)" "unprognostic (2.33e-1)" "unprognostic (9.79e-2)" "unprognostic (2.13e-2)" "unprognostic (1.93e-1)" 12.7 24.9 10.2 9.2 15.3 6.5 12.4 15.7 15.3 14.7 16.3 15.3 25.6 21.5 16.0 9.9 11.5 13.5 9.9 14.2 11.3 10.3 32.3 28.4 12.7 8.0 16.2 9.4 11.5 18.5 19.4 34.2 10.8 15.3 11.1 17.9 13.2 12.2 16.3 12.5 11.6 17.9 11.8 13.9 12.8 13.9 9.2 14.8 14.6 16.7 10.9 11.5 10.3 11.6 9.6 10.4 24.2 11.3 12.8 23.1 8.7 6.3 7.4 3.4 4.5 8.8 13.7 10.0 6.6 8.8 6.6 7.8 9.4 6.7 2.0 5.3 6.9 8.2 9.3 13.5 9.4 9.3 11.4 4.0 11.8 7.0 7.9 9.6 8.1 3.7 7.1 17.3 7.0 17.5 7.6 13.3 4.9 11.8 11.5 7.1 6.8 5.9 6.5 1.4 19.3 7.1 7.2 4.2 30.6 12.2 6.0 4.1 2.7 7.3 15.2 12.4 7.1 7.5 7.9 7.2 6.4 4.4 26.3 6.2 9.5 32.7 3.9 10.0 31.1 8.8 24.2 10.6 18.6 12.8 11.3 13.6 9.6 13.1 12.6 10.4 6.7 10.5 10.7 5.4 12.8 10.8 9.2 23.1 8.7 10.2 15.3 15.7 15.3 11.3 10.3 16.2 9.4 15.3 14.8 3.0 9.3 11.5 12.7 4.9 12.6 1.1 30.6 30.8 9.1 5.2 35.3 12.4 24.9 15.8 5.0 7.1 15.5 23.3 11.4 23.6 8.9 10.4 2.3 24.2 17.8 14.3 8.6 22.7 14.6 3.1 10.6 11.0 13.5 13.6 22.6 10.3 11.8 17.0 10.6 37.9 24.8 0.0 7.5 19.1 5.4 5.5 21.5 10.8 15.8 9.5 GALNS "GALNAC6S, GAS" ENSG00000141012 "Galactosamine (N-acetyl)-6-sulfatase" P34059 16 88813734-88856970 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Dwarfism, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 7.1;granulocytes: 19.3;monocytes: 11.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026404, HPA042433, HPA074225" Supported Approved Cytosol "Intracellular and membrane" NA NA 2400000 Cytosol "CAB026404: , HPA042433: AB_2732499, HPA074225: " "unprognostic (3.16e-1)" "unprognostic (9.98e-2)" "unprognostic (4.03e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (3.66e-4)" "unprognostic (4.15e-3)" "unprognostic (1.32e-1)" "unprognostic (4.84e-3)" "unprognostic (2.00e-1)" "unprognostic (3.53e-2)" "unprognostic (4.12e-3)" "unprognostic (4.24e-2)" "unprognostic (5.54e-2)" "unprognostic (3.59e-2)" "unprognostic (6.84e-2)" 11.9 14.9 9.3 11.2 11.1 25.0 14.8 12.9 15.4 11.1 15.5 11.5 8.8 13.3 9.0 19.9 10.2 14.8 12.7 12.5 11.2 13.9 13.7 17.8 14.7 10.6 11.8 5.2 11.9 7.3 9.9 13.2 15.6 11.6 10.5 8.3 7.1 10.6 9.0 7.1 10.0 17.2 9.4 9.4 10.4 9.5 27.4 8.8 7.9 14.5 6.1 9.0 11.1 13.0 2.1 7.1 19.3 11.2 2.4 3.1 4.7 2.5 19.6 2.8 20.1 22.7 10.9 19.7 8.2 12.8 9.0 7.0 10.2 17.0 3.2 17.4 13.4 13.6 15.1 4.1 6.5 5.5 2.1 6.5 2.0 8.0 5.8 15.3 1.5 13.3 15.2 12.7 10.1 2.8 12.9 7.7 3.5 4.4 1.9 5.3 15.0 4.1 6.5 6.6 6.5 9.1 8.7 2.5 5.4 5.6 6.0 7.4 5.7 19.5 1.8 9.7 7.2 12.7 14.4 14.4 19.8 15.1 20.2 4.5 2.0 1.9 5.5 21.5 13.3 11.7 0.9 11.2 19.3 3.1 8.0 2.6 2.1 1.8 2.7 7.1 0.9 1.7 2.1 14.2 2.4 5.6 3.0 3.0 4.7 9.3 11.1 12.9 15.4 11.2 13.9 11.8 5.2 11.6 8.8 14.9 4.5 1.9 6.4 5.8 3.9 6.7 2.5 26.8 7.9 3.5 5.9 7.9 3.3 5.3 14.3 4.9 12.3 0.0 3.0 11.4 10.2 5.7 1.1 5.7 17.8 23.8 11.5 7.4 13.9 28.0 6.6 8.0 6.8 20.8 6.9 8.5 5.4 12.4 6.3 4.5 9.7 6.5 9.2 49.5 33.7 5.0 13.3 5.7 8.6 5.1 GALNT15 "GALNT7, GALNTL2, pp-GalNAc-T15" ENSG00000131386 "Polypeptide N-acetylgalactosaminyltransferase 15" Q8N3T1 3 16174649-16231992 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 66.7;brain: 52.3" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 19.5;Endothelial cells: 15.2;Ito cells: 39.9;Muller glia cells: 48.3" "Cancer enriched" "Detected in many" 5 "glioma: 21.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 44.9;ASC TERT1: 44.3;HSkMC: 33.7" "Group enriched" "Detected in many" 4 "cerebellum: 10.7;pons and medulla: 6.7" "Low region specificity" "Detected in all" HPA017076 Uncertain Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 25000 "Golgi apparatus" Cytosol "HPA017076: AB_1849458" "unprognostic (3.87e-1)" "unprognostic (4.84e-4)" "unprognostic (6.39e-2)" "unprognostic (8.77e-3)" "unprognostic (2.77e-1)" "unprognostic (2.52e-1)" "unprognostic (7.40e-4)" "unprognostic (4.24e-1)" "unprognostic (2.24e-1)" "unprognostic (8.28e-6)" "unprognostic (5.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.66e-2)" "unprognostic (1.37e-3)" "unprognostic (1.88e-1)" "unprognostic (8.51e-2)" "unprognostic (1.78e-3)" 66.7 5.3 7.6 2.6 17.4 1.1 22.8 2.3 31.5 3.9 8.6 28.1 1.1 2.8 3.5 3.3 11.4 5.3 5.2 7.3 14.8 6.6 8.3 2.8 3.1 3.4 38.9 8.4 8.4 3.2 1.6 1.0 35.5 24.8 4.9 3.8 1.3 8.0 4.1 17.3 11.6 5.3 10.5 52.3 12.8 4.6 8.1 19.9 0.0 6.3 1.6 1.5 16.6 23.5 0.6 0.9 0.9 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 44.9 44.3 0.0 1.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 33.7 0.0 0.4 0.5 0.3 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.2 7.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.0 0.6 0.4 0.2 0.9 0.3 0.3 0.9 0.3 0.3 7.6 17.4 2.3 13.6 14.8 6.6 38.9 8.4 24.8 19.9 0.0 1.7 0.0 0.5 0.5 0.8 1.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.5 15.2 0.0 0.0 0.0 0.0 2.9 1.2 1.1 0.2 0.1 0.0 0.0 39.9 0.6 10.6 1.7 0.2 0.0 0.0 0.0 48.3 0.2 0.0 0.7 0.0 3.1 0.0 1.2 10.2 0.5 0.6 0.0 0.0 0.0 0.1 GALNT16 "GalNAc-T16, GALNTL1, KIAA1130" ENSG00000100626 "Polypeptide N-acetylgalactosaminyltransferase 16" Q8N428 14 69259277-69357033 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 38.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 7.4;ASC diff: 9.8;hTEC/SVTERT24-B: 13.9;hTERT-RPE1: 14.2;SCLC-21H: 7.3;U-2 OS: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059136, HPA075325" Approved Approved Vesicles,Cytosol NA NA 250000 "Vesicles, Cytosol" "HPA059136: AB_2683919, HPA075325: " "unprognostic (9.71e-3)" "unprognostic (7.47e-2)" "unprognostic (4.02e-1)" "unprognostic (2.30e-2)" "unprognostic (6.71e-2)" "unprognostic (5.72e-3)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.62e-4)" "unprognostic (1.31e-2)" "prognostic favorable (5.23e-6)" "unprognostic (5.38e-3)" "unprognostic (3.34e-2)" "unprognostic (3.93e-2)" "unprognostic (7.96e-5)" 13.6 15.5 20.0 2.9 17.9 0.8 14.5 16.1 21.7 7.8 4.1 5.0 4.0 3.2 6.4 6.0 5.1 6.5 4.8 27.6 18.3 27.2 5.6 3.0 4.2 4.2 6.6 25.2 2.8 5.6 4.0 4.1 1.2 13.0 4.6 3.4 1.7 28.9 6.6 5.3 7.0 5.0 11.3 8.7 14.3 2.4 3.3 3.3 0.0 3.5 6.3 2.2 5.0 3.8 0.5 0.2 1.3 0.5 0.3 0.3 0.2 0.0 0.6 7.4 0.2 9.8 4.5 0.0 1.0 0.0 1.3 1.9 0.4 0.0 0.0 0.2 1.2 0.6 0.0 2.4 0.0 0.2 0.1 5.1 0.0 0.1 0.3 0.1 0.0 0.5 0.4 0.0 13.9 0.0 14.2 0.8 0.0 0.0 0.0 2.3 0.3 0.0 0.0 1.4 0.0 0.1 0.0 3.9 0.0 0.5 0.0 7.3 2.4 1.6 0.3 0.0 0.3 0.2 0.0 0.1 1.5 16.7 1.9 1.5 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.5 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 0.5 0.3 0.2 1.3 0.3 0.1 0.2 0.1 0.2 20.0 17.9 16.1 16.2 18.3 27.2 6.6 25.2 13.0 3.3 0.0 0.0 0.0 0.5 3.7 1.9 38.2 0.0 0.0 0.0 0.0 2.0 0.1 3.3 0.0 6.4 0.1 0.0 0.0 0.0 0.0 5.2 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.4 0.9 0.0 3.3 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.6 6.5 9.2 0.7 1.9 2.9 0.0 0.0 0.0 0.4 GALNT18 "GalNAc-T18, GALNT15, GALNTL4, MGC71806" ENSG00000110328 "Polypeptide N-acetylgalactosaminyltransferase 18" Q6P9A2 11 11270876-11622005 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 41.7;Cytotrophoblasts: 37.3;Endothelial cells: 34.9;Muller glia cells: 44.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "gdT-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "A-431: 18.9;HaCaT: 24.2;HBEC3-KT: 16.9;PC-3: 17.0;RPMI-8226: 17.7;SK-BR-3: 22.1;U-87 MG: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012955, HPA070681" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA 200000 "Golgi apparatus" "Vesicles, Cytosol" "HPA012955: AB_1849460, HPA070681: " "unprognostic (1.26e-1)" "unprognostic (2.80e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (7.37e-2)" "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (6.68e-2)" "unprognostic (6.04e-2)" "unprognostic (2.05e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-1)" "unprognostic (2.66e-3)" "unprognostic (3.54e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-1)" "unprognostic (1.81e-2)" 18.6 6.0 15.5 4.9 13.5 0.8 9.1 21.3 16.2 7.0 13.3 5.8 8.3 3.9 15.0 6.4 7.8 7.6 12.6 21.9 13.1 7.0 19.7 6.6 31.2 5.8 10.0 12.1 3.8 9.5 9.1 4.3 26.6 12.8 8.2 4.3 7.1 10.4 11.5 6.1 7.6 4.9 15.0 6.5 4.0 4.1 13.3 8.4 0.7 39.2 5.6 4.2 10.3 9.1 0.0 0.0 0.0 0.0 0.0 1.7 0.3 18.9 6.9 0.9 4.2 0.0 0.0 0.1 2.1 5.2 0.2 0.0 0.7 2.5 0.0 1.5 0.0 2.6 24.2 4.6 16.9 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 7.0 0.0 6.4 0.0 0.0 8.6 0.0 0.0 0.9 4.6 0.2 0.0 0.7 0.0 17.0 0.0 0.0 17.7 13.1 2.3 0.3 1.9 3.5 22.1 0.1 0.6 4.6 0.0 0.0 0.3 3.8 0.1 0.1 0.0 0.0 0.0 16.0 0.0 4.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 15.5 13.5 21.3 16.2 13.1 7.0 10.0 12.1 12.8 8.4 41.7 5.8 0.0 5.8 4.9 0.8 7.3 22.9 12.0 14.8 19.2 2.0 37.3 13.3 18.3 2.1 34.9 0.0 0.0 3.4 2.2 2.8 9.8 1.1 2.6 2.3 0.0 0.0 22.1 1.5 0.7 1.4 0.5 1.7 0.0 0.0 44.1 5.8 0.0 2.8 28.1 1.8 12.9 5.2 0.5 1.0 4.6 12.9 0.0 0.8 1.0 GALNT5 GalNAc-T5 ENSG00000136542 "Polypeptide N-acetylgalactosaminyltransferase 5" Q7Z7M9 2 157257598-157314211 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 145.9;Mucus-secreting cells: 66.8;Urothelial cells: 121.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "cerebellum: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 23.6;BJ: 15.5;BJ hTERT+: 27.8;CAPAN-2: 13.6;fHDF/TERT166: 32.4;HaCaT: 27.7;K-562: 16.0;LHCN-M2: 27.7;U-138 MG: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008963, HPA009035" Approved Approved "Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA 630000 "Golgi apparatus, Cytosol" "Nucleoli, Vesicles" "HPA008963: AB_1078942, HPA009035: AB_1078943" "unprognostic (6.34e-3)" "unprognostic (9.31e-2)" "unprognostic (2.11e-2)" "unprognostic (9.89e-2)" "unprognostic (3.19e-2)" "unprognostic (2.46e-2)" "unprognostic (4.63e-3)" "unprognostic (1.88e-1)" "unprognostic (1.09e-1)" "unprognostic (6.93e-2)" "unprognostic (4.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (6.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-3)" 0.4 0.2 0.2 1.5 0.2 0.5 1.1 28.2 0.2 7.5 12.0 0.7 0.0 2.3 0.5 0.5 9.0 0.2 17.1 0.9 0.4 0.2 0.3 0.2 15.5 0.0 0.2 0.0 0.3 1.5 0.0 6.8 0.1 4.4 1.6 16.1 0.3 18.9 0.2 0.2 0.5 8.4 0.8 0.3 0.3 15.2 0.5 0.0 0.1 0.3 12.2 11.7 2.3 6.6 0.2 0.1 0.2 0.1 0.1 0.5 0.0 23.6 2.6 0.0 0.0 1.0 8.3 0.0 15.5 27.8 0.2 0.6 1.1 13.6 0.0 0.0 32.4 0.0 27.7 0.5 5.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.5 0.0 0.0 0.0 16.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.1 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.2 28.2 0.2 0.4 0.2 0.2 0.0 4.4 0.0 145.9 29.7 0.0 10.3 0.7 0.0 0.4 2.5 5.3 36.4 0.0 0.0 0.0 0.0 0.8 5.1 0.0 18.6 23.3 2.9 0.0 2.1 7.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.6 3.3 2.8 66.8 0.0 31.4 31.7 0.0 0.0 0.0 0.0 0.1 2.6 0.2 0.1 0.0 0.0 20.7 121.3 GALT ENSG00000213930 "Galactose-1-phosphate uridylyltransferase" P07902 9 34638133-34651035 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" "Nucleotidyltransferase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004868, HPA005729" Enhanced Approved Cytosol NA NA 120000 Cytosol "HPA004868: AB_1079130, HPA005729: AB_1079131" "unprognostic (2.38e-1)" "unprognostic (8.92e-2)" "unprognostic (1.45e-3)" "unprognostic (1.54e-1)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.13e-1)" "unprognostic (3.97e-2)" "unprognostic (1.13e-2)" "prognostic favorable (3.11e-5)" "unprognostic (9.68e-2)" "prognostic favorable (6.25e-6)" "unprognostic (7.90e-2)" "unprognostic (2.74e-1)" "unprognostic (3.56e-1)" "unprognostic (7.75e-2)" 6.3 16.1 8.0 13.8 12.5 7.4 6.6 9.3 7.3 8.5 19.4 5.8 12.4 18.1 7.2 8.4 7.7 6.5 10.5 10.9 6.7 8.6 11.8 47.0 6.8 10.8 9.0 6.0 8.7 7.6 12.1 10.3 21.7 7.5 7.2 6.8 11.0 12.5 13.4 9.5 14.4 26.1 5.9 5.0 9.4 8.1 2.6 7.1 11.3 8.5 7.2 10.6 7.0 6.5 16.3 15.9 10.9 17.5 20.5 21.1 13.1 5.0 6.7 6.1 2.5 8.4 8.5 7.1 3.7 10.7 3.9 4.5 8.3 4.7 5.6 3.9 4.5 1.5 2.7 1.1 10.4 0.7 8.4 4.5 2.3 13.4 8.4 8.2 1.3 3.0 12.3 6.6 2.5 3.1 8.3 9.5 7.4 1.9 6.2 6.3 4.4 4.8 9.5 2.1 5.8 1.2 7.4 5.6 3.0 10.8 7.0 1.4 5.4 4.7 9.4 5.1 4.6 8.4 7.3 1.4 1.8 3.3 3.3 0.0 3.5 2.0 1.2 4.1 4.0 9.9 10.9 17.5 8.3 12.1 15.0 16.7 16.3 19.8 16.3 15.9 9.3 12.2 12.0 3.3 20.5 14.1 13.3 21.1 13.1 8.0 12.5 9.3 7.3 6.7 8.6 9.0 6.0 7.5 7.1 6.0 23.4 12.3 13.7 19.3 40.6 20.7 15.3 6.7 10.3 15.7 45.2 59.8 24.9 16.7 6.9 12.0 18.0 0.0 6.5 29.6 13.1 4.5 19.7 52.9 21.0 44.5 15.6 20.3 11.9 31.3 17.0 13.3 20.3 14.4 15.1 18.9 8.5 21.8 13.1 29.4 37.0 6.5 10.1 4.2 4.7 17.7 49.4 23.3 19.8 7.8 GANC ENSG00000214013 "Glucosidase alpha, neutral C" Q8TET4 15 42273233-42356935 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016949, HPA051522" Approved Approved Cytosol NA NA Cytosol "HPA016949: AB_1849465, HPA051522: " "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (2.24e-1)" "unprognostic (3.04e-3)" "unprognostic (2.51e-2)" "unprognostic (9.85e-2)" "unprognostic (2.49e-2)" "prognostic favorable (9.76e-4)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (1.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "unprognostic (3.14e-1)" "unprognostic (1.55e-2)" "unprognostic (3.74e-2)" 13.3 14.0 12.5 17.3 20.7 17.6 14.4 16.6 14.2 15.8 14.3 25.6 15.4 11.7 17.9 26.0 20.7 12.9 13.0 12.4 13.4 10.4 13.5 18.0 30.5 13.8 25.0 13.7 18.8 13.1 17.4 20.5 10.8 19.8 13.1 17.8 18.3 20.4 13.7 23.9 13.9 15.4 15.9 25.1 15.5 13.1 24.5 22.6 17.4 16.8 12.3 18.3 16.2 16.3 17.6 12.2 9.3 10.1 4.0 7.4 4.7 6.2 3.2 7.9 8.6 9.6 13.6 5.0 13.7 14.8 15.1 12.7 4.7 4.4 3.4 7.5 13.8 10.5 13.0 9.5 14.6 10.5 8.5 4.4 8.5 8.6 9.2 8.1 8.2 7.4 9.2 8.7 6.1 10.5 8.5 10.2 8.7 8.8 9.6 11.9 1.3 5.5 9.1 4.9 2.7 4.2 10.6 9.3 11.8 11.4 5.8 6.0 8.5 7.7 6.7 4.8 4.5 2.5 19.4 9.2 15.9 4.2 13.1 8.2 10.4 13.7 6.9 7.5 15.1 8.7 9.3 9.3 7.4 3.7 10.1 5.0 16.2 5.7 6.9 12.2 17.6 7.4 4.4 5.0 4.0 8.1 9.6 5.5 4.7 12.5 20.7 16.6 14.2 13.4 10.4 25.0 13.7 19.8 22.6 17.9 36.3 8.3 15.1 9.3 5.1 6.9 2.5 12.0 10.3 1.8 9.8 4.4 5.0 4.3 9.0 4.0 8.4 0.0 3.3 4.2 4.5 6.5 10.4 9.0 6.0 3.2 4.1 7.4 11.6 3.0 6.6 10.3 13.5 11.8 5.5 10.4 5.0 16.5 6.0 6.3 6.5 12.9 5.2 14.2 14.4 4.5 2.4 5.0 7.5 21.3 GAPDH GAPD ENSG00000111640 "Glyceraldehyde-3-phosphate dehydrogenase" P04406 12 6533927-6538374 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Glycolysis, Translation regulation" "Oxidoreductase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 1236.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005197, CAB016392, HPA040067, HPA061280" Supported Supported "Nuclear membrane,Vesicles,Plasma membrane,Cytosol" No No 2200000000 "Plasma membrane, Cytosol" "Nuclear membrane, Vesicles" "CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463" "unprognostic (3.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.58e-2)" "unprognostic (4.20e-1)" "unprognostic (9.73e-3)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.79e-6)" "unprognostic (2.89e-3)" "unprognostic (2.86e-1)" "unprognostic (2.06e-2)" "unprognostic (9.50e-3)" "unprognostic (4.52e-1)" "prognostic unfavorable (6.25e-10)" "unprognostic (2.33e-1)" "unprognostic (4.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.26e-2)" 50.0 59.4 104.1 57.6 101.0 195.5 38.4 58.0 151.3 49.4 73.3 80.7 24.0 75.8 37.3 46.8 146.9 50.2 58.0 215.1 95.0 95.5 88.4 221.0 41.3 90.1 111.8 58.0 62.0 27.0 66.1 46.1 98.2 115.9 48.3 76.7 74.5 60.8 63.2 1236.8 54.4 74.4 68.0 95.6 50.7 41.1 36.4 35.9 101.9 38.3 238.7 105.3 89.5 50.5 57.9 171.0 110.0 201.6 60.5 108.8 271.9 188.4 332.6 95.9 149.5 93.6 154.4 209.1 143.2 204.0 209.6 218.8 234.7 129.4 220.4 28.3 168.8 159.1 107.3 89.1 332.2 145.5 193.2 96.8 121.9 208.7 199.3 126.2 197.0 98.1 129.1 108.5 206.0 232.8 501.3 230.7 161.2 65.4 46.4 238.1 376.0 224.4 103.7 354.5 226.1 110.8 182.6 170.9 104.9 238.5 230.6 68.0 109.1 126.4 329.8 190.3 285.1 51.5 139.2 143.9 163.6 197.8 84.4 247.4 105.5 76.7 284.0 346.8 124.9 256.0 110.0 201.6 37.0 74.1 103.2 65.3 57.9 77.9 74.4 171.0 32.2 44.1 51.2 106.5 60.5 92.3 25.2 108.8 271.9 104.1 101.0 58.0 151.3 95.0 95.5 111.8 58.0 115.9 35.9 220.3 245.0 821.1 1485.4 1615.7 992.1 33.2 1355.4 275.7 444.7 970.1 392.7 4082.4 2934.5 4447.1 583.7 1564.4 2836.9 443.9 3299.5 7140.5 1484.6 1124.2 551.6 1346.2 3470.6 2218.3 1273.2 1144.2 2599.6 1556.8 823.5 2367.4 4003.5 3613.2 2061.2 5234.8 4742.6 2687.7 965.3 5345.0 1026.0 1131.8 2133.1 429.6 390.5 1399.2 3925.6 1271.1 3009.6 2464.1 GAPVD1 "DKFZP434C212, KIAA1521" ENSG00000165219 "GTPase activating protein and VPS9 domains 1" Q14C86 9 125261794-125367207 "Predicted intracellular proteins" Endocytosis "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029386, HPA029387" Uncertain Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA029386: AB_10599604, HPA029387: AB_10600311" "unprognostic (8.43e-3)" "unprognostic (3.84e-2)" "unprognostic (3.53e-1)" "unprognostic (1.97e-1)" "unprognostic (5.43e-2)" "unprognostic (4.04e-2)" "unprognostic (7.08e-2)" "unprognostic (1.31e-2)" "unprognostic (7.56e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "unprognostic (2.54e-3)" "unprognostic (2.77e-1)" "unprognostic (4.19e-2)" "unprognostic (1.67e-2)" "unprognostic (5.82e-2)" 17.6 16.2 16.0 14.9 18.6 26.6 16.9 25.7 21.3 17.5 16.1 20.9 18.0 10.8 19.1 14.0 24.3 16.0 13.7 15.4 15.5 14.1 17.6 14.5 20.5 15.1 21.1 15.6 18.9 14.1 30.3 20.2 23.3 20.1 14.7 13.2 16.4 15.9 17.2 31.6 23.5 14.6 17.4 15.3 17.3 14.6 32.1 20.2 18.6 24.8 12.2 19.9 16.2 17.7 10.4 14.8 19.2 17.8 13.6 14.8 10.0 11.6 12.2 11.5 10.7 14.0 15.3 16.8 13.1 15.0 15.2 12.8 19.3 8.4 15.6 7.1 16.4 15.2 23.8 23.9 13.7 16.2 14.3 14.3 17.7 29.9 9.5 16.5 21.0 30.0 10.9 13.4 18.0 14.6 9.9 18.0 12.6 34.4 8.7 12.6 17.1 15.7 9.2 11.7 21.1 13.9 13.8 25.2 15.1 8.7 12.0 15.4 10.3 19.1 17.7 10.4 12.1 21.7 11.0 18.9 10.8 7.9 19.1 13.9 11.1 21.0 16.1 13.2 12.0 13.8 18.6 15.0 18.0 13.7 15.6 13.4 10.2 14.2 14.8 14.8 10.4 14.2 14.7 19.2 13.6 17.8 5.6 10.9 10.0 16.0 18.6 25.7 21.3 15.5 14.1 21.1 15.6 20.1 20.2 101.3 47.6 9.5 14.1 28.3 29.0 55.7 15.3 50.9 35.2 26.2 49.1 33.2 8.3 14.4 33.5 20.2 12.1 23.3 16.7 19.4 21.6 17.0 15.1 13.9 23.4 33.4 12.1 23.4 25.4 10.0 21.3 27.3 16.9 16.2 16.0 21.3 17.3 14.0 22.6 13.4 38.0 19.4 22.1 63.7 35.1 32.2 56.1 19.1 16.1 22.1 GAREM1 "C18orf11, FAM59A, FLJ21610, GAREM" ENSG00000141441 "GRB2 associated regulator of MAPK1 subtype 1" Q9H706 18 32124877-32470484 "Predicted intracellular proteins" Mitogen "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 43.5" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 48.3;Urothelial cells: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 12.2;hTERT-HME1: 21.2;RT4: 18.0;SH-SY5Y: 14.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040709, HPA042046" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040709: AB_2677090, HPA042046: AB_2677818" "unprognostic (9.52e-2)" "unprognostic (4.13e-3)" "unprognostic (2.67e-2)" "unprognostic (3.32e-3)" "unprognostic (3.62e-1)" "unprognostic (5.53e-3)" "unprognostic (1.87e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (5.59e-2)" "prognostic unfavorable (6.73e-5)" "unprognostic (1.45e-1)" "prognostic favorable (5.49e-6)" "unprognostic (2.36e-1)" "unprognostic (2.56e-3)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 11.1 8.7 9.7 2.9 10.9 8.0 6.0 17.6 11.1 6.0 7.2 19.5 0.3 6.5 4.2 3.4 11.0 4.8 4.9 8.9 11.8 5.8 15.3 12.5 5.2 1.3 16.3 10.1 4.4 43.5 1.9 5.1 4.8 13.2 4.3 6.3 3.0 11.2 5.1 7.7 13.9 7.8 4.6 12.9 3.1 12.7 6.7 16.4 0.0 3.5 3.1 2.9 9.3 9.1 1.9 5.0 2.6 1.0 3.1 1.4 0.0 1.0 1.6 1.7 0.3 4.7 3.3 4.8 0.3 0.0 0.0 0.0 0.3 2.6 3.0 2.5 0.2 2.0 3.4 2.6 5.0 0.0 1.0 1.6 0.0 3.0 1.0 2.4 0.3 0.2 3.9 12.2 0.2 21.2 0.2 0.2 1.8 0.1 0.6 1.8 2.5 0.8 0.1 1.9 7.9 0.9 1.2 6.9 5.3 6.1 18.0 5.7 14.9 3.9 5.1 0.2 2.2 1.0 2.6 0.2 1.2 1.4 0.0 0.5 2.1 0.2 0.7 1.9 0.0 1.4 0.0 1.0 0.2 0.5 0.1 0.2 0.3 0.8 0.5 0.1 1.9 1.0 1.4 2.6 3.1 0.1 5.0 0.1 0.0 9.7 10.9 17.6 11.1 11.8 5.8 16.3 10.1 13.2 16.4 8.9 35.2 0.0 30.5 0.0 31.8 0.0 7.6 8.1 15.9 24.4 3.9 15.6 1.7 9.4 10.1 0.0 6.3 0.0 11.4 2.0 0.3 48.3 3.5 7.7 1.6 39.7 3.5 0.6 3.7 2.5 1.7 0.9 0.0 1.0 10.2 41.9 10.3 7.0 4.9 20.9 7.0 0.0 0.0 1.4 2.5 0.0 28.0 0.0 8.3 68.5 GAREM2 "FAM59B, FLJ00375, GAREML, KIAA2038" ENSG00000157833 "GRB2 associated regulator of MAPK1 subtype 2" Q75VX8 2 26173091-26189663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.2;parathyroid gland: 17.0" "Group enriched" "Detected in many" 5 "Distal tubular cells: 39.7;Muller glia cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 15.4;SH-SY5Y: 9.5;U-2 OS: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071575 Approved Cytosol NA NA Cytosol "HPA071575: AB_2686420" "unprognostic (1.70e-2)" "unprognostic (5.62e-2)" "unprognostic (7.61e-4)" "unprognostic (1.56e-2)" "unprognostic (8.27e-2)" "unprognostic (2.19e-1)" "unprognostic (2.90e-2)" "unprognostic (1.99e-1)" "unprognostic (2.12e-2)" "unprognostic (2.65e-1)" "unprognostic (1.33e-1)" "unprognostic (3.94e-2)" "unprognostic (1.15e-3)" "unprognostic (1.35e-1)" "unprognostic (3.22e-1)" "unprognostic (1.46e-2)" "unprognostic (1.04e-1)" 3.2 1.6 19.9 1.8 13.9 0.9 1.5 8.2 21.2 2.5 3.0 11.7 0.7 1.2 3.0 1.7 2.6 2.4 2.8 2.0 17.9 11.0 1.8 0.5 1.1 2.2 13.1 8.9 4.1 4.4 17.0 1.4 1.5 16.5 1.7 2.9 0.9 1.8 3.5 3.7 2.4 1.1 3.6 15.9 1.6 1.5 2.6 13.9 0.0 2.6 0.0 2.0 2.1 1.2 0.8 2.5 1.6 0.6 0.4 1.9 0.3 2.6 4.0 4.9 0.4 0.8 1.8 0.4 1.5 0.0 0.4 0.4 7.7 0.9 0.0 2.0 3.1 4.9 0.1 15.4 0.0 0.7 1.7 5.7 1.3 1.3 0.5 6.0 0.1 0.3 2.3 0.7 2.3 0.2 0.3 1.8 3.8 7.1 0.2 2.8 0.0 0.4 0.5 5.2 0.4 1.1 1.6 0.0 0.0 2.5 0.9 1.0 9.5 3.4 0.3 2.9 1.5 0.2 8.0 0.8 2.1 13.1 3.8 0.1 0.3 0.0 1.6 0.1 0.0 2.8 0.4 0.6 0.2 1.2 0.2 0.5 0.5 1.9 1.4 0.5 0.8 1.5 0.5 1.6 0.4 0.5 2.5 0.4 0.3 19.9 13.9 8.2 14.1 17.9 11.0 13.1 8.9 16.5 13.9 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 3.5 2.0 0.3 39.7 1.7 3.4 0.4 0.0 0.0 1.3 2.1 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.6 0.3 5.2 2.0 0.0 0.0 1.0 0.5 20.6 1.5 0.0 3.2 2.0 1.2 6.5 0.0 1.4 5.4 0.0 0.2 0.0 0.6 0.3 GARS "CMT2D, DSMAV, GlyRS, SMAD1" ENSG00000106105 "Glycyl-tRNA synthetase" P41250 7 30594681-30634033 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017896, HPA019097" Enhanced Supported Cytosol "Intracellular and membrane" NA NA 660000 Cytosol "HPA017896: AB_1849478, HPA019097: AB_1849480" "prognostic unfavorable (1.02e-4)" "unprognostic (2.46e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (2.04e-1)" "unprognostic (1.57e-3)" "prognostic unfavorable (8.95e-5)" "unprognostic (7.31e-3)" "unprognostic (4.76e-1)" "unprognostic (4.00e-3)" "unprognostic (1.77e-1)" "unprognostic (4.45e-2)" "prognostic unfavorable (1.70e-5)" "unprognostic (3.92e-1)" "unprognostic (3.40e-2)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.04e-5)" 25.8 27.3 24.5 26.2 28.5 24.6 32.4 31.1 44.7 21.5 23.7 17.0 11.5 17.2 24.1 23.3 43.7 18.6 18.4 25.7 21.1 26.8 27.6 57.2 27.9 28.0 22.9 28.4 35.4 49.4 44.4 33.3 24.3 37.6 17.2 30.2 14.1 28.7 21.6 35.6 33.2 18.1 30.1 17.6 23.5 30.5 29.7 14.9 28.6 31.4 33.9 38.4 22.8 25.7 22.5 26.4 21.2 27.2 15.3 27.6 21.2 33.5 16.6 14.8 52.3 27.6 41.5 28.0 50.2 45.5 25.9 52.5 22.1 16.8 56.5 15.2 61.1 40.7 26.6 36.8 31.9 45.6 13.5 17.2 26.1 13.6 18.6 87.7 38.4 23.1 39.5 56.0 37.1 44.1 18.4 33.2 52.5 51.7 65.9 41.1 20.7 33.4 26.6 39.8 31.0 31.8 16.9 13.0 43.9 29.7 15.2 17.8 29.9 13.4 37.6 71.4 27.6 33.5 58.9 30.4 12.3 41.3 24.7 31.7 65.2 54.6 66.5 43.0 58.2 57.8 21.2 19.0 17.7 23.2 25.8 23.7 22.5 23.7 25.1 26.4 19.3 25.5 27.6 5.6 15.3 27.2 18.0 25.9 21.2 24.5 28.5 31.1 44.7 21.1 26.8 22.9 28.4 37.6 14.9 38.7 27.4 35.6 34.3 29.9 23.3 30.7 25.5 14.7 27.3 19.2 21.6 41.1 28.2 79.9 48.1 24.6 13.9 0.0 131.2 61.8 33.2 32.2 40.3 27.0 39.9 17.5 25.2 31.9 25.5 44.0 21.6 32.4 32.1 57.7 36.9 20.2 111.3 7.0 21.5 31.8 15.7 12.9 30.0 71.9 80.1 24.1 33.3 25.4 22.3 44.7 GART "GARS-AIRS-GART, PGFT, PRGS" ENSG00000159131 "Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase" P22102 21 33503931-33543491 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Ligase, Multifunctional enzyme, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002119, HPA005779" Approved Approved Mitochondria,Cytosol NA NA 1300000 Cytosol Mitochondria "HPA002119: AB_1849482, HPA005779: AB_1849484" "unprognostic (3.77e-2)" "unprognostic (2.25e-2)" "unprognostic (4.51e-3)" "unprognostic (1.72e-2)" "unprognostic (2.30e-2)" "prognostic unfavorable (5.05e-5)" "prognostic unfavorable (9.82e-5)" "unprognostic (2.50e-2)" "unprognostic (2.76e-3)" "unprognostic (2.92e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.98e-3)" "prognostic unfavorable (3.95e-6)" "unprognostic (1.36e-2)" "unprognostic (2.31e-1)" "unprognostic (2.28e-1)" "unprognostic (1.57e-1)" 24.9 24.7 16.0 20.0 22.3 14.2 22.2 14.5 20.3 16.2 20.1 20.5 13.3 18.9 21.7 15.9 28.1 19.9 14.3 19.3 16.4 14.9 19.2 33.6 18.3 24.4 21.9 14.6 21.0 30.6 21.6 22.9 23.1 21.0 16.4 26.9 19.5 18.6 16.1 33.2 17.6 19.1 23.5 17.9 21.4 21.9 47.0 21.7 40.8 20.0 19.4 32.8 21.6 17.6 18.7 19.5 9.7 20.9 27.1 21.1 13.3 30.2 14.4 21.3 23.6 15.7 16.2 24.0 19.6 16.7 23.0 24.4 27.3 25.7 40.3 11.7 13.1 30.1 16.0 44.7 30.8 33.6 21.1 26.6 60.8 17.2 17.8 21.5 33.7 16.0 14.3 21.6 27.1 39.9 11.7 21.7 32.6 70.6 25.9 20.7 14.5 35.6 22.6 46.6 44.2 17.0 29.7 39.8 57.0 18.4 16.2 22.7 20.5 27.2 21.4 25.4 20.6 27.2 21.7 15.9 15.6 18.7 13.5 21.0 25.8 35.6 44.0 16.4 39.7 23.1 5.3 15.2 9.7 17.3 20.9 21.1 18.7 16.9 17.9 19.5 14.4 17.7 17.4 7.0 27.1 17.7 14.7 20.6 13.3 16.0 22.3 14.5 20.3 16.4 14.9 21.9 14.6 21.0 21.7 17.9 17.5 28.9 32.0 40.9 17.7 16.9 2.5 14.7 26.1 14.0 33.4 35.3 19.9 22.6 9.1 20.1 11.8 0.0 20.8 29.3 16.6 18.9 7.0 17.1 21.0 4.8 12.6 16.5 18.7 2.2 16.1 16.9 11.8 17.2 15.1 12.9 24.5 10.5 17.0 11.3 25.4 12.9 25.0 50.8 27.2 40.1 21.4 17.5 20.8 38.9 GAS2 ENSG00000148935 "Growth arrest specific 2" O43903 11 22625642-22813055 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell shape, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 10.9;Cholangiocytes: 10.2;Ciliated cells: 6.7;Hepatocytes: 20.2" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Hep G2: 19.9;JURKAT: 11.3;Karpas-707: 40.7;SCLC-21H: 11.9;U-266/84: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058904 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" Yes NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "HPA058904: AB_2683850" "unprognostic (5.48e-3)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (1.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-2)" "unprognostic (1.08e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.30e-5)" "prognostic favorable (6.13e-4)" "unprognostic (5.85e-2)" "unprognostic (4.22e-2)" "unprognostic (7.94e-2)" "unprognostic (3.58e-2)" 0.7 1.1 2.1 1.1 3.6 0.4 0.9 0.9 2.2 1.2 0.7 1.4 1.2 2.0 1.1 1.3 1.0 1.5 2.7 3.6 2.1 2.5 5.3 37.2 1.3 1.1 4.3 1.2 2.3 22.7 0.5 4.8 0.7 4.5 1.3 0.7 0.5 2.2 0.9 4.8 1.0 1.8 0.6 8.6 1.5 2.6 1.1 3.2 19.6 1.1 3.0 1.0 1.8 0.7 1.0 0.6 0.3 0.0 0.1 1.7 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 0.1 0.0 19.9 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 11.3 0.7 40.7 0.0 0.1 0.1 0.0 0.1 1.1 0.0 0.4 0.2 2.0 0.0 0.5 11.9 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.2 0.5 0.0 0.5 13.5 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 1.7 1.0 0.4 0.0 0.0 0.9 1.6 0.4 0.0 0.1 0.0 0.6 0.3 0.1 2.1 3.6 0.9 2.2 2.1 2.5 4.3 1.2 4.5 3.2 0.0 0.0 0.0 0.2 0.1 2.7 10.9 10.2 6.7 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.0 0.0 0.0 2.9 0.0 0.3 0.1 0.0 20.2 0.0 0.0 0.0 0.6 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.3 2.6 0.3 0.0 2.1 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.3 GAS6 "AXLLG, AXSF, DKFZp666G247, FLJ34709" ENSG00000183087 "Growth arrest specific 6" Q14393 13 113820549-113864067 "Predicted secreted proteins" "Growth regulation, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 328.9;Sertoli cells: 316.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 31.7" "Lineage enriched" "Detected in single" 51 "dendritic cells: 31.7" "Cell line enhanced" "Detected in many" "BJ: 56.3;BJ hTERT+: 81.4;HSkMC: 47.7;RPMI-8226: 77.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008275, HPA056080" Approved Approved "Centriolar satellite,Cytosol" "Secreted to blood" NA NA 8900000 920000 Cytosol "Centriolar satellite" "HPA008275: AB_1849497, HPA056080: AB_2683032" "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.97e-3)" "unprognostic (1.37e-1)" "unprognostic (7.40e-3)" "unprognostic (1.02e-1)" "unprognostic (2.09e-2)" "unprognostic (2.92e-2)" "unprognostic (1.51e-1)" "unprognostic (2.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.55e-1)" "unprognostic (4.81e-3)" "unprognostic (1.97e-1)" "unprognostic (2.16e-2)" "unprognostic (9.00e-2)" "prognostic unfavorable (8.93e-6)" 25.6 12.6 10.6 6.8 10.7 1.0 35.3 8.0 13.2 52.9 17.1 7.9 35.7 17.9 48.6 20.1 27.0 45.8 24.3 45.9 10.6 8.3 14.7 13.9 27.9 14.4 9.2 9.5 33.0 18.4 7.3 15.8 19.1 13.9 34.2 9.5 20.3 26.8 35.9 27.1 27.9 17.0 53.4 8.8 7.7 16.5 25.2 9.5 10.0 29.2 13.1 6.5 31.8 44.7 0.0 31.7 0.0 0.6 0.0 0.1 0.5 23.8 1.0 0.7 0.6 28.7 16.0 3.0 56.3 81.4 23.5 28.2 1.5 11.5 0.2 1.8 25.3 4.1 22.5 0.3 12.6 6.0 0.0 3.2 0.1 1.7 0.1 20.5 0.1 0.2 47.7 7.4 6.5 6.5 40.6 0.8 0.3 0.4 13.1 37.9 1.1 0.1 0.2 1.5 3.8 1.6 0.7 0.0 77.2 8.5 0.3 3.9 3.5 6.2 0.2 0.0 4.1 7.5 19.1 13.2 6.1 7.6 0.7 15.9 0.0 1.2 0.2 7.0 0.5 0.9 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 31.7 0.0 0.5 10.6 10.7 8.0 13.2 10.6 8.3 9.2 9.5 13.9 9.5 184.6 30.0 11.5 77.9 75.0 18.8 75.9 35.7 10.7 31.8 29.6 0.0 2.0 23.2 27.3 4.3 59.4 72.1 0.0 6.0 1.3 59.2 12.7 8.1 19.5 77.3 328.9 9.9 109.2 19.1 6.6 85.4 18.7 116.4 11.8 57.5 28.3 16.4 31.6 55.9 0.3 8.5 316.9 124.6 3.9 17.6 62.9 2.4 3.8 132.1 33.9 GAS8 "DRC4, GAS11" ENSG00000141013 "Growth arrest specific 8" O95995 16 90019629-90044975 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Ciliated cells: 84.3;Early spermatids: 174.5;Late spermatids: 126.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041311, HPA048238" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA041311: AB_2677402, HPA048238: AB_2680324" "unprognostic (2.23e-3)" "unprognostic (1.26e-1)" "unprognostic (1.73e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.73e-1)" "unprognostic (3.91e-1)" "unprognostic (1.96e-1)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.47e-1)" "prognostic favorable (7.67e-4)" "unprognostic (3.06e-2)" "prognostic favorable (1.09e-7)" "unprognostic (1.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.19e-2)" 7.1 11.1 8.5 6.5 13.2 2.3 7.6 13.5 12.2 11.7 6.8 10.0 10.8 4.1 12.7 16.2 7.8 26.5 11.6 21.0 8.7 9.8 12.4 6.3 9.9 4.0 8.9 8.9 12.8 12.9 23.2 22.0 3.5 10.1 8.9 4.6 11.0 16.2 12.6 18.8 4.2 4.2 8.4 7.5 4.2 7.6 16.1 6.4 1.7 15.5 5.5 5.2 6.6 5.1 2.5 4.8 4.3 5.0 0.0 3.7 2.3 10.8 8.8 1.1 5.5 5.1 4.0 9.4 2.2 5.5 8.9 2.6 8.8 8.3 0.6 6.0 4.5 5.4 10.8 3.6 6.4 2.0 0.0 6.5 2.3 5.6 10.0 5.8 1.3 1.8 5.2 3.7 6.7 3.1 3.8 5.3 3.8 8.7 1.2 3.8 26.1 1.5 5.5 7.3 6.9 4.6 0.4 10.2 0.6 11.2 5.3 9.3 6.7 11.5 6.2 13.1 1.0 11.7 5.1 3.7 5.5 6.4 3.0 5.1 2.0 3.3 0.0 14.0 1.7 9.6 4.3 3.1 3.7 1.8 5.0 1.8 1.2 2.8 3.7 4.4 2.5 2.3 2.0 4.0 0.0 3.1 4.8 3.5 2.3 8.5 13.2 13.5 12.2 8.7 9.8 8.9 8.9 10.1 6.4 20.8 9.9 0.5 4.2 1.0 8.8 6.4 28.1 84.3 15.9 21.0 19.6 2.6 11.6 14.7 174.5 4.5 4.3 0.0 9.6 3.0 3.3 6.4 2.3 3.6 3.3 25.4 5.8 4.9 0.0 126.7 13.0 3.3 5.0 1.8 5.4 11.4 10.1 3.5 7.1 23.0 25.1 6.5 3.7 18.9 13.6 2.3 1.4 0.0 5.0 4.8 GATA5 "bB379O24.1, GATAS" ENSG00000130700 "GATA binding protein 5" Q9BWX5 20 62463497-62475970 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 22.1;intestine: 23.6" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 4.1;Fibroblasts: 1.8;Ito cells: 4.3;Late spermatids: 1.5" "Cancer enhanced" "Detected in many" "stomach cancer: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.6;HEL: 5.0;K-562: 7.9;SiHa: 3.5;T-47d: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA067583 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA067583: AB_2685867" "unprognostic (2.21e-1)" "unprognostic (2.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.62e-1)" "unprognostic (8.34e-2)" "unprognostic (1.69e-2)" "unprognostic (5.70e-2)" "unprognostic (1.27e-2)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" 1.9 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 4.4 15.9 0.0 5.2 14.8 3.8 1.7 0.3 9.1 22.1 6.8 0.0 0.0 3.3 0.7 1.6 0.0 0.0 0.0 3.1 0.0 0.3 0.6 0.6 0.0 11.3 0.0 1.0 0.4 0.8 0.1 0.3 23.6 18.3 0.2 0.1 10.3 16.8 0.0 0.0 1.2 0.0 0.0 14.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.6 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.3 5.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.6 3.5 0.0 0.0 1.6 8.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.3 0.0 0.0 4.3 0.0 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.0 0.0 GBA2 "AD035, DKFZp762K054, KIAA1605, SPG46" ENSG00000070610 "Glucosylceramidase beta 2" Q9HCG7 9 35736866-35749228 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024026 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA024026: AB_1849530" "unprognostic (3.34e-2)" "unprognostic (2.90e-1)" "unprognostic (2.99e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (2.09e-2)" "unprognostic (3.99e-2)" "unprognostic (8.69e-2)" "prognostic favorable (6.00e-4)" "unprognostic (9.01e-3)" "prognostic favorable (1.24e-11)" "unprognostic (7.62e-3)" "unprognostic (2.94e-1)" "unprognostic (7.69e-2)" "prognostic favorable (6.60e-4)" 15.6 19.3 28.9 17.0 23.3 11.0 24.3 42.3 41.6 14.8 35.1 17.0 28.4 41.5 19.0 22.3 16.6 16.8 21.4 34.6 22.4 21.0 34.8 25.0 20.9 17.3 23.7 19.5 16.4 20.9 27.9 27.1 19.3 36.6 23.9 32.8 28.4 27.7 25.5 46.1 23.5 51.1 23.3 21.0 23.4 26.9 11.6 19.5 10.9 25.4 15.5 16.4 18.2 16.9 5.6 6.8 12.2 6.1 3.1 7.3 3.1 7.9 13.2 18.2 17.6 8.9 5.4 18.5 10.8 8.5 11.0 11.7 14.6 6.4 8.5 7.9 6.6 23.8 8.3 17.4 7.3 5.6 12.1 11.9 9.2 34.4 15.6 9.8 13.6 22.8 9.3 13.7 9.3 9.8 26.9 28.8 8.6 8.9 16.4 10.2 7.9 3.7 14.1 18.8 16.2 20.9 6.8 7.3 7.2 15.3 18.8 14.9 19.9 6.1 15.2 10.7 23.3 10.4 12.4 20.1 12.0 14.5 10.2 13.1 11.2 7.1 7.1 15.0 5.0 9.3 12.2 4.4 2.9 6.0 6.1 4.1 5.0 5.8 7.3 4.2 5.6 3.7 3.2 4.9 3.1 3.7 6.8 4.0 3.1 28.9 23.3 42.3 41.6 22.4 21.0 23.7 19.5 36.6 19.5 11.9 10.1 8.0 16.1 6.5 73.4 10.9 20.4 21.4 14.8 26.2 108.0 8.7 18.3 9.9 12.7 13.7 68.4 0.0 10.4 7.6 7.4 14.9 13.9 16.3 7.9 49.3 34.3 26.4 15.4 17.0 11.5 10.1 11.8 7.2 32.8 15.5 12.6 56.1 9.2 16.5 95.2 12.9 9.9 8.6 4.9 8.7 18.5 12.5 30.3 22.5 GBE1 ENSG00000114480 "1,4-alpha-glucan branching enzyme 1" Q04446 3 81489699-81762161 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 61.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038073, HPA038074, HPA038075" Enhanced Approved Cytosol NA NA 5900000 Cytosol "HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545" "unprognostic (3.10e-1)" "unprognostic (1.02e-3)" "unprognostic (6.76e-2)" "unprognostic (1.05e-2)" "unprognostic (3.48e-2)" "unprognostic (1.89e-1)" "unprognostic (9.01e-3)" "unprognostic (1.17e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (2.19e-2)" "unprognostic (5.68e-2)" "unprognostic (1.46e-1)" "unprognostic (5.36e-2)" "unprognostic (4.42e-1)" "unprognostic (2.83e-3)" "unprognostic (3.78e-3)" 23.1 22.4 2.2 7.8 4.2 5.6 19.2 4.2 4.6 6.4 7.7 5.2 5.2 4.1 8.4 4.9 7.5 4.9 11.5 19.7 3.6 4.3 14.0 36.3 11.3 7.5 7.9 3.4 8.2 5.7 8.2 11.6 11.4 8.4 5.7 4.5 9.9 8.0 10.1 56.9 5.9 6.3 7.2 6.1 8.0 4.5 4.6 4.1 5.4 6.5 11.2 4.5 9.6 10.0 11.6 13.6 14.5 11.4 13.0 7.2 6.1 12.1 7.3 2.4 34.9 61.4 46.7 4.4 20.2 28.8 12.1 20.6 1.4 3.2 13.6 8.9 24.8 7.2 1.4 2.0 9.3 28.6 6.4 1.1 4.2 15.2 4.5 42.3 14.3 3.7 34.4 6.9 19.5 20.1 30.5 26.9 1.6 3.3 7.9 39.4 3.5 2.4 17.0 2.4 3.4 11.2 4.5 11.1 16.0 8.6 4.1 1.2 1.6 13.2 3.8 4.1 3.7 2.7 11.8 37.3 25.1 5.9 17.6 18.6 36.1 4.1 5.0 40.9 9.6 10.2 6.3 11.4 14.5 5.6 10.4 5.4 11.0 6.0 5.9 13.6 11.6 7.0 7.2 11.0 13.0 10.8 4.5 5.0 6.1 2.2 4.2 4.2 4.6 3.6 4.3 7.9 3.4 8.4 4.1 14.9 11.3 7.2 17.9 27.2 15.9 51.9 15.3 13.4 10.3 29.6 0.0 25.8 34.9 29.0 29.2 28.5 9.6 0.0 21.8 58.4 22.2 15.3 42.7 67.1 23.2 28.6 21.2 14.1 14.5 11.6 16.1 15.1 23.6 12.6 6.9 9.6 34.4 6.8 12.4 46.6 16.8 32.3 41.6 6.5 5.1 18.6 45.9 10.0 7.3 12.4 GBP2 ENSG00000162645 "Guanylate binding protein 2" P32456 1 89106132-89150456 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 23.9;HDLM-2: 26.3;RT4: 33.0" "HPA042682, CAB045975" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB045975: AB_10584474, HPA042682: AB_2678113" "prognostic favorable (7.57e-4)" "unprognostic (2.92e-2)" "unprognostic (3.65e-2)" "unprognostic (3.02e-2)" "unprognostic (1.34e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.75e-3)" "prognostic unfavorable (5.73e-5)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.14e-10)" "unprognostic (7.75e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-2)" "prognostic favorable (1.10e-5)" 40.1 39.4 4.7 24.4 14.3 8.9 31.9 2.3 11.0 38.2 35.7 3.3 9.5 11.0 29.0 20.6 39.0 17.5 18.5 12.6 4.6 4.1 21.6 17.9 42.8 21.3 14.3 2.9 35.5 4.9 39.8 5.9 17.3 12.2 48.7 13.8 12.4 14.2 15.4 20.1 19.5 39.6 48.1 26.7 27.5 20.2 13.0 6.0 7.7 22.0 18.2 15.3 63.1 40.3 3.1 8.5 78.9 44.2 20.1 61.2 22.2 6.1 0.5 0.0 0.0 17.7 15.4 4.6 1.6 15.9 2.6 6.1 0.1 9.7 0.0 23.9 10.6 12.0 1.2 0.0 0.2 1.4 26.3 0.0 0.1 4.5 1.3 4.7 0.7 1.1 16.1 0.1 3.9 0.0 8.9 18.0 0.0 0.3 1.0 7.3 0.0 0.0 5.8 0.0 5.6 0.4 0.1 6.8 0.0 5.0 33.0 0.0 0.2 7.8 2.2 0.2 0.5 0.2 1.0 12.2 2.0 0.4 2.8 1.7 19.1 0.0 0.0 6.1 0.1 0.3 12.2 20.5 6.6 24.6 31.2 32.6 3.1 26.3 27.1 8.5 2.7 18.0 18.9 78.9 20.1 44.2 0.5 61.2 22.2 4.7 14.3 2.3 11.0 4.6 4.1 14.3 2.9 12.2 6.0 23.8 30.1 5.9 100.6 41.3 0.1 2.8 28.1 24.1 17.0 17.4 0.0 26.1 0.0 75.3 22.8 54.8 48.0 23.3 62.4 50.9 30.1 66.0 44.1 22.2 33.3 0.0 9.8 22.1 68.8 22.5 4.4 82.4 8.5 45.9 9.7 0.6 67.5 28.1 8.1 7.7 0.0 19.4 69.6 0.7 2.1 54.1 48.3 77.8 8.6 78.8 GCA GCL ENSG00000115271 Grancalcin P28676 2 162318840-162371595 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 188.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 41.1;neutrophil: 112.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 112.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035033, HPA035034" Enhanced Supported "Plasma membrane,Cytosol" NA NA 890000 Cytosol "Plasma membrane" "HPA035033: AB_10669854, HPA035034: AB_10669900" "unprognostic (9.62e-2)" "unprognostic (9.76e-2)" "unprognostic (3.33e-1)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.33e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-2)" "unprognostic (2.49e-2)" "unprognostic (1.20e-1)" "unprognostic (9.78e-2)" "unprognostic (6.56e-2)" "unprognostic (5.80e-2)" "unprognostic (3.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.32e-2)" 13.1 6.8 13.4 24.8 21.3 116.0 7.8 6.9 15.8 6.0 7.7 15.3 3.2 8.2 4.6 11.0 5.0 7.2 9.7 11.2 15.9 13.0 8.5 7.6 15.6 51.8 26.0 9.7 4.4 11.5 4.8 8.1 10.6 24.6 5.7 8.6 3.7 6.9 4.9 2.2 3.7 7.8 7.7 30.2 50.0 10.3 10.7 20.8 5.8 7.4 2.5 10.3 10.0 6.3 3.1 8.9 112.7 18.2 0.3 1.3 8.4 1.4 2.1 5.9 0.0 1.4 1.3 0.2 2.1 6.2 3.4 6.2 4.8 16.4 1.9 15.2 0.1 7.8 0.8 2.2 6.9 4.2 9.2 9.3 17.3 1.5 9.2 1.7 21.5 5.0 1.5 2.4 3.1 0.7 9.0 0.4 14.1 0.3 6.7 0.3 16.9 0.5 12.5 3.7 12.0 8.4 7.5 1.4 9.7 18.1 9.6 3.8 6.5 2.8 12.7 10.7 7.2 8.6 9.7 0.4 0.8 6.3 9.8 3.2 6.3 11.8 0.3 5.4 8.4 4.0 4.4 18.2 41.1 0.4 10.7 0.5 3.0 0.6 0.6 8.9 3.1 1.1 0.7 112.7 0.3 8.0 2.2 1.3 8.4 13.4 21.3 6.9 15.8 15.9 13.0 26.0 9.7 24.6 20.8 14.9 44.6 45.9 25.1 13.7 9.0 2.8 50.9 26.8 12.5 31.4 2.0 46.0 64.6 39.8 106.9 25.9 14.7 0.0 53.4 16.4 13.6 27.8 42.8 11.6 91.1 11.1 37.8 39.3 188.7 17.6 10.0 119.8 15.1 66.7 26.1 17.3 34.6 28.1 6.0 52.8 4.6 6.5 18.9 62.9 11.5 15.8 39.2 10.7 26.4 20.4 GCC1 "FLJ22035, GCC1P, GCC88, MGC20706" ENSG00000179562 "GRIP and coiled-coil domain containing 1" Q96CN9 7 127580618-127593611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 108.4;Late spermatids: 98.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019369, HPA021323" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus" "Plasma membrane, Cytosol" "HPA019369: AB_1849552, HPA021323: AB_1849554" "unprognostic (1.09e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.08e-2)" "unprognostic (4.81e-2)" "unprognostic (4.50e-3)" "unprognostic (1.17e-3)" "unprognostic (4.17e-3)" "unprognostic (1.22e-1)" "unprognostic (8.65e-2)" "unprognostic (9.96e-2)" 11.5 14.1 13.4 11.0 13.7 17.7 14.2 13.9 12.8 11.6 10.2 12.8 8.6 9.6 13.2 10.3 14.1 10.7 12.2 9.0 10.2 7.9 9.8 17.8 10.4 12.3 19.8 7.6 13.6 12.7 14.8 14.5 13.6 13.0 11.5 9.6 8.4 13.8 11.0 12.5 14.5 12.9 8.4 12.1 15.5 12.7 20.7 17.9 15.7 11.8 9.5 14.4 10.3 29.2 8.4 7.9 15.6 9.1 10.2 11.6 8.8 8.4 11.4 5.0 10.8 11.3 7.8 7.0 7.4 8.6 7.4 9.4 9.5 5.8 7.8 4.5 6.8 16.8 9.3 7.3 8.1 8.0 10.8 6.6 5.7 6.2 4.9 16.8 9.8 9.5 7.3 22.3 7.9 15.7 7.0 7.0 7.8 9.3 8.9 8.3 8.4 9.5 8.5 10.5 9.3 8.9 6.8 5.4 8.8 6.4 6.5 8.0 11.6 7.9 37.8 14.7 9.5 6.4 7.1 9.0 11.0 3.5 9.5 8.4 24.5 10.7 5.0 10.9 10.1 11.2 5.8 8.1 15.0 9.1 8.2 11.6 8.4 8.2 8.9 7.9 8.0 6.8 6.7 15.6 10.2 9.1 4.6 7.6 8.8 13.4 13.7 13.9 12.8 10.2 7.9 19.8 7.6 13.0 17.9 11.9 7.7 0.9 5.0 9.4 3.7 3.7 5.1 0.0 3.4 3.5 3.9 5.4 5.0 4.5 108.4 5.6 6.6 0.0 5.5 3.9 4.3 5.3 1.1 6.8 4.5 11.1 6.9 4.9 7.9 98.5 4.9 5.4 11.8 5.4 7.5 4.4 5.5 5.5 3.5 3.3 5.3 6.5 6.1 5.6 4.5 9.2 8.7 5.7 4.5 5.1 GCH1 "DYT14, DYT5, DYT5a, GCH, GTPCH1" ENSG00000131979 "GTP cyclohydrolase 1" P30793 14 54842008-54902852 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" "Allosteric enzyme, Hydrolase" "Disease mutation, Dystonia, Parkinsonism, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.8;liver: 58.2" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 82.5;Intestinal endocrine cells: 203.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 11.8;Daudi: 13.3;SH-SY5Y: 29.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 15.7" HPA028612 Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" No No Nucleoplasm "Nuclear membrane, Cytosol" "HPA028612: AB_10602135" "unprognostic (3.77e-2)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (2.39e-1)" "unprognostic (9.26e-2)" "unprognostic (1.27e-1)" "unprognostic (7.26e-2)" "unprognostic (1.75e-1)" "unprognostic (3.97e-1)" "prognostic favorable (8.69e-4)" "prognostic favorable (1.41e-4)" "unprognostic (1.23e-1)" "unprognostic (1.96e-2)" "unprognostic (7.22e-3)" "unprognostic (1.76e-2)" "unprognostic (2.23e-1)" "prognostic favorable (6.67e-4)" 4.8 5.2 1.3 5.7 4.5 26.8 2.1 0.6 1.1 2.2 5.5 1.2 1.5 7.5 1.8 1.9 3.8 1.3 1.6 1.5 1.6 4.3 7.9 58.2 11.6 6.7 2.9 0.7 1.4 3.2 0.3 2.5 2.5 2.8 2.9 4.0 5.2 2.5 4.7 1.4 2.5 9.1 2.0 1.7 10.0 4.2 3.6 1.1 13.0 2.3 2.0 8.5 2.9 2.5 1.6 3.0 0.4 11.5 2.3 3.2 1.3 1.9 0.6 0.7 3.5 0.0 0.0 11.8 0.0 1.2 0.8 2.2 0.9 0.6 13.3 3.3 0.1 1.8 2.0 5.7 0.9 0.0 5.2 5.0 0.3 0.2 1.9 5.7 0.0 1.2 1.4 1.6 1.9 0.0 0.0 0.4 9.1 0.8 0.0 0.0 6.8 7.2 0.2 1.1 2.9 4.5 5.9 1.4 0.0 1.7 2.8 5.9 29.7 2.5 1.5 0.7 0.3 5.7 1.6 0.2 0.1 2.0 3.7 2.3 5.7 4.3 3.2 2.5 4.6 0.0 0.0 3.0 0.2 3.0 6.3 2.5 0.8 1.6 2.1 3.0 1.6 3.2 1.8 0.4 2.3 11.5 0.1 2.3 1.3 1.3 4.5 0.6 1.1 1.6 4.3 2.9 0.7 2.8 1.1 3.0 4.5 8.1 28.1 66.2 0.0 3.3 5.1 2.7 7.9 5.2 2.0 1.8 6.6 8.3 0.4 11.7 16.0 23.3 8.1 40.5 8.2 17.3 0.0 82.5 5.6 0.0 203.8 6.2 24.0 0.6 0.3 13.3 10.1 6.4 15.2 0.3 9.8 14.0 4.6 38.4 0.2 0.0 15.5 1.1 4.7 66.6 3.5 22.3 8.9 32.9 GCK "HK4, MODY2" ENSG00000106633 Glucokinase P35557 7 44144271-44198170 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 46.8" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 5.5;Cardiomyocytes: 3.1;Fibroblasts: 3.9;Horizontal cells: 4.8;Muller glia cells: 3.0;Smooth muscle cells: 4.3" "Cancer enhanced" "Detected in some" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 4.4;naive CD4 T-cell: 4.8" "Group enriched" "Detected in many" 17 "B-cells: 4.4;T-cells: 4.8" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 12.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA007034, HPA007093" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA007034: AB_1079050, HPA007093: AB_1079051" "unprognostic (3.09e-1)" "unprognostic (2.99e-2)" "unprognostic (3.32e-2)" "unprognostic (6.64e-7)" "unprognostic (8.00e-2)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (2.68e-1)" "unprognostic (1.24e-1)" "unprognostic (5.48e-2)" "unprognostic (8.11e-3)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (2.01e-2)" "unprognostic (3.24e-1)" "unprognostic (4.36e-2)" "unprognostic (1.53e-1)" 1.1 0.5 3.2 0.7 2.8 0.0 0.7 9.5 3.7 1.4 1.4 1.3 0.7 0.3 1.5 1.5 0.7 2.3 0.9 7.1 2.1 7.5 0.7 8.7 0.7 0.7 2.9 1.2 2.2 2.9 0.0 46.8 3.3 1.6 0.8 0.5 0.8 0.7 1.6 0.7 1.2 0.7 0.7 1.7 0.7 0.9 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.9 4.4 0.2 0.0 0.0 0.0 4.8 0.7 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.6 0.4 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.6 0.9 0.0 1.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.3 2.2 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.6 4.4 1.6 0.4 0.2 0.7 4.8 0.9 0.0 0.0 0.0 0.0 0.0 0.7 3.2 2.8 9.5 2.4 2.1 7.5 2.9 1.2 1.6 0.7 0.0 0.0 0.0 0.7 1.0 5.5 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 3.9 0.3 0.0 0.6 0.6 4.8 2.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.0 0.1 0.0 2.1 0.0 0.8 0.0 4.3 0.2 0.9 0.1 0.7 0.0 0.0 0.1 GCKR ENSG00000084734 "Glucokinase regulator" 2 27496842-27523684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 60.9" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 76.9" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 12.7;Hep G2: 19.4;HUVEC TERT2: 6.2;TIME: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034098, HPA052227" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB034098: AB_2247323, HPA052227: " "unprognostic (3.31e-1)" "unprognostic (2.11e-3)" "unprognostic (2.27e-1)" "unprognostic (6.97e-2)" "unprognostic (1.68e-2)" "unprognostic (5.70e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (2.25e-3)" "unprognostic (1.65e-1)" "unprognostic (1.02e-7)" "unprognostic (6.51e-2)" "unprognostic (1.18e-1)" "unprognostic (9.27e-3)" "unprognostic (1.50e-2)" 0.2 2.0 0.1 0.1 0.3 0.2 0.1 0.2 0.2 0.1 0.4 0.1 0.1 0.2 0.1 0.3 0.4 0.0 3.9 0.5 0.1 0.0 0.2 60.9 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.5 3.1 0.9 0.2 0.1 0.1 0.1 0.2 0.1 0.1 2.4 0.8 2.6 1.2 1.7 0.9 0.7 0.2 0.4 0.4 0.2 0.3 0.2 0.1 0.0 0.1 0.3 0.0 0.4 0.1 0.2 0.5 0.7 0.2 0.2 0.2 0.0 0.0 0.1 0.0 12.7 0.5 19.4 0.8 0.1 0.4 0.3 1.0 0.5 0.1 2.2 6.2 0.0 0.0 0.2 0.2 0.1 0.1 0.7 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.5 0.1 3.8 0.1 0.3 0.6 0.2 0.4 0.1 0.2 1.2 0.1 0.2 2.6 1.2 0.3 0.6 1.0 0.6 0.8 0.4 0.4 0.1 2.4 0.9 0.8 2.1 1.7 0.3 0.8 0.1 0.7 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.3 0.4 0.0 0.0 9.0 0.0 0.0 0.3 0.0 76.9 0.1 0.0 0.0 1.3 1.9 2.8 0.3 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 102.4;Intestinal endocrine cells: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 3600000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favorable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.30e-2)" 15.8 11.1 12.9 9.0 16.0 14.4 13.0 5.4 15.1 6.8 16.2 21.6 8.2 18.9 9.2 5.3 20.0 29.1 14.9 7.4 13.1 10.6 15.4 69.2 12.9 10.1 21.6 12.2 6.2 12.4 6.6 5.4 6.2 13.0 13.0 12.2 5.2 11.2 10.1 7.0 8.6 14.8 11.9 13.6 16.8 14.8 5.2 17.5 3.1 14.1 32.4 10.6 34.4 12.3 1.6 4.2 2.2 1.9 8.0 2.3 0.6 7.3 49.2 4.0 9.5 4.8 2.2 5.4 3.7 6.0 2.8 3.3 7.2 17.1 14.0 7.1 3.3 21.5 10.5 12.3 27.1 3.8 11.0 7.6 9.3 9.5 42.0 5.5 12.3 5.8 3.4 11.5 3.1 14.1 3.7 4.2 12.3 5.1 4.4 1.3 7.7 10.5 4.9 7.5 68.1 4.6 3.5 2.5 12.3 9.1 45.4 11.7 5.7 6.2 10.0 6.5 6.1 6.8 5.8 5.9 2.5 8.8 6.4 5.5 5.9 9.1 8.1 6.3 8.8 4.2 2.2 1.1 0.6 1.2 1.9 0.8 1.6 1.0 2.3 4.2 1.0 0.6 1.3 0.5 8.0 1.8 3.0 1.6 0.6 12.9 16.0 5.4 11.9 13.1 10.6 21.6 12.2 13.0 17.5 0.0 3.7 7.8 42.9 30.9 12.8 17.8 25.5 48.2 47.8 0.0 23.6 5.2 10.0 12.8 1.4 13.5 19.9 46.7 11.0 6.5 8.7 44.8 2.3 102.4 19.8 7.9 212.1 9.2 60.1 1.0 6.1 16.4 8.5 6.4 16.3 13.8 17.1 8.5 8.9 19.8 4.0 12.9 10.3 3.3 8.1 21.8 6.5 10.7 13.8 89.1 GCLM GLCLR ENSG00000023909 "Glutamate-cysteine ligase modifier subunit" P48507 1 93885205-93909456 "Cancer-related genes, Predicted intracellular proteins" "Glutathione biosynthesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 210.2;Glandular cells: 272.8;Urothelial cells: 201.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009568, HPA023696, CAB040554" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (8.85e-3)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (4.64e-2)" "prognostic unfavorable (9.83e-6)" "unprognostic (2.37e-1)" "unprognostic (1.07e-1)" "unprognostic (3.53e-1)" "unprognostic (3.51e-2)" "unprognostic (3.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (2.34e-3)" 10.3 17.5 7.0 6.0 7.7 11.3 23.9 5.7 8.9 4.5 22.8 4.2 11.5 16.6 3.5 6.5 8.8 12.8 12.5 7.7 6.8 8.9 17.8 41.7 8.4 10.4 9.2 5.7 4.6 6.9 6.3 5.1 10.3 8.7 5.3 5.2 6.4 6.7 6.4 19.2 3.4 20.0 3.4 7.7 6.9 6.1 3.2 2.8 5.6 15.0 23.0 8.6 8.9 8.0 3.2 1.9 3.3 0.7 4.6 6.7 1.2 13.1 20.9 2.3 4.5 7.8 4.9 8.9 15.8 9.8 12.0 9.0 3.5 7.8 5.0 31.6 10.2 39.2 13.3 3.4 6.4 9.7 13.5 4.6 34.9 14.2 15.0 14.6 12.8 5.6 6.0 2.4 24.4 3.9 4.8 13.1 5.7 13.8 7.4 8.6 2.5 9.2 3.0 7.9 12.6 10.0 4.3 7.0 7.3 8.5 15.4 5.4 2.2 14.8 11.7 5.5 27.5 2.6 8.0 13.7 12.6 7.4 23.6 23.6 6.7 8.5 5.2 10.4 7.2 4.4 3.3 0.7 1.3 5.3 0.4 3.1 2.6 5.0 6.7 0.6 3.2 3.2 3.2 2.9 4.6 0.5 1.9 1.3 1.2 7.0 7.7 5.7 8.9 6.8 8.9 9.2 5.7 8.7 2.8 38.7 18.4 13.3 119.7 10.2 23.7 13.5 53.5 49.5 19.4 27.9 5.9 60.1 21.6 24.6 3.0 14.5 25.6 210.2 10.7 16.4 25.0 272.8 19.6 71.6 16.8 31.8 50.4 41.7 17.7 1.9 19.8 15.4 8.5 10.8 9.3 19.3 22.5 7.0 11.7 45.8 12.6 0.0 44.3 22.8 40.4 8.2 37.6 34.6 13.2 201.0 GCN1 "GCN1L, GCN1L1, KIAA0219" ENSG00000089154 "GCN1, eIF2 alpha kinase activator homolog" Q92616 12 120127203-120194710 "Plasma proteins, Predicted intracellular proteins" "Stress response, Translation regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018799, HPA019648, HPA024367" Enhanced Enhanced Cytosol NA NA 40000 Cytosol "HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569" "unprognostic (7.36e-2)" "unprognostic (2.10e-3)" "unprognostic (3.17e-1)" "unprognostic (2.60e-1)" "unprognostic (1.26e-1)" "unprognostic (3.14e-2)" "prognostic unfavorable (1.87e-8)" "unprognostic (5.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.20e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-1)" "unprognostic (6.35e-2)" "unprognostic (1.21e-1)" "unprognostic (2.34e-1)" "unprognostic (7.09e-3)" "unprognostic (1.43e-1)" 23.1 14.6 7.9 14.3 14.4 15.7 14.4 18.3 20.6 15.3 15.2 22.3 9.7 11.5 31.2 10.2 20.2 14.8 11.3 12.6 7.7 7.8 14.7 19.1 14.0 16.0 11.5 6.8 18.9 19.9 23.8 21.4 24.4 14.9 15.1 12.2 16.8 33.3 13.2 36.0 20.9 15.5 14.4 9.7 18.3 17.2 16.0 10.3 22.2 20.6 14.3 27.4 15.9 15.1 4.3 4.9 2.2 6.5 3.1 7.8 3.1 16.9 33.5 12.1 13.6 19.2 11.7 42.5 15.2 13.3 15.9 13.0 28.7 11.8 22.6 17.3 21.8 10.1 16.8 28.1 21.5 10.0 15.0 22.9 27.9 21.9 19.8 12.5 25.7 17.9 14.3 12.6 18.8 17.8 14.0 14.5 10.3 32.7 5.8 13.3 17.1 16.2 19.5 21.4 16.3 20.5 19.8 12.4 22.3 10.9 58.3 19.9 20.0 25.0 10.9 9.0 12.0 23.2 14.6 19.8 13.0 14.5 8.5 15.7 23.0 21.1 22.9 12.5 13.6 13.0 1.2 3.1 2.2 6.4 3.2 7.8 3.9 5.0 5.3 4.1 4.3 3.8 4.0 0.1 3.1 6.5 4.9 4.6 3.1 7.9 14.4 18.3 20.6 7.7 7.8 11.5 6.8 14.9 10.3 8.9 19.9 2.2 5.4 0.0 12.7 0.0 10.2 5.3 17.0 21.0 9.8 12.3 1.7 13.2 1.1 8.0 6.3 0.0 13.7 32.8 8.2 11.2 4.7 20.2 10.0 15.9 3.5 12.3 9.5 2.7 13.3 3.2 0.0 10.0 14.2 9.3 16.6 10.5 12.0 7.8 11.5 6.5 0.0 7.7 21.6 0.0 12.2 6.9 15.1 11.2 GCNT7 "C20orf105, dJ1153D9.2" ENSG00000124091 "Glucosaminyl (N-acetyl) transferase family member 7" Q6ZNI0 20 56491492-56525925 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 3.9;bone marrow: 9.6" "Cell type enhanced" "Detected in single" 33 "Early spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA052617, HPA059403" Uncertain Approved "Nuclear bodies,Vesicles,Cytosol" NA NA "Nuclear bodies, Vesicles" Cytosol "HPA052617: AB_2681886, HPA059403: " "unprognostic (3.57e-2)" "unprognostic (1.39e-1)" "unprognostic (7.74e-2)" "unprognostic (1.89e-1)" "unprognostic (3.96e-2)" "unprognostic (9.08e-2)" "unprognostic (3.10e-1)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (2.38e-1)" "unprognostic (9.69e-2)" "unprognostic (2.84e-2)" "unprognostic (2.16e-3)" "unprognostic (1.84e-1)" "unprognostic (1.74e-1)" "unprognostic (1.96e-1)" "unprognostic (8.69e-2)" 0.2 0.2 0.0 0.7 0.0 9.6 0.3 0.6 0.3 0.0 0.2 0.3 0.2 0.0 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.3 0.4 0.4 0.0 0.5 0.5 0.0 0.6 0.1 0.3 0.0 0.4 0.0 0.3 1.0 0.4 0.0 0.1 0.5 0.3 1.6 0.3 0.0 0.6 0.3 1.0 0.9 3.9 0.7 0.3 1.1 0.1 0.6 1.0 0.8 0.5 0.0 0.0 1.1 1.0 0.0 0.0 0.0 2.1 0.5 0.1 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.1 1.2 1.7 0.5 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 1.0 1.5 0.0 1.3 0.7 1.4 0.5 0.1 0.7 0.1 0.4 0.5 0.0 1.9 1.0 0.5 1.2 1.0 0.2 0.5 0.8 0.2 0.0 2.2 0.4 0.5 0.6 1.6 0.1 0.5 0.3 0.6 0.5 1.1 0.7 0.9 0.8 0.5 0.8 0.7 0.7 0.5 0.4 1.0 1.1 0.4 3.9 0.3 0.7 0.9 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GCSAML "C1orf150, FLJ44728" ENSG00000169224 "Germinal center associated signaling and motility like" Q5JQS6 1 247507058-247577690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 48.3;brain: 17.6" "Cell type enriched" "Detected in some" 27 "granulocytes: 214.1" "Cancer enriched" "Detected in single" 13 "prostate cancer: 1.9" "Region enriched" "Detected in some" 10 "cerebellum: 17.6" "Cell type enriched" "Detected in single" 439 "basophil: 48.3" "Lineage enriched" "Detected in single" 439 "granulocytes: 48.3" "Group enriched" "Detected in some" 73 "HEL: 28.5;HMC-1: 113.3" "Low region specificity" "Detected in single" "HPA027507, HPA027510" Uncertain Approved Cytosol NA NA Cytosol "HPA027507: AB_10600756, HPA027510: AB_2672309" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (4.07e-3)" "unprognostic (3.48e-2)" "unprognostic (1.72e-1)" "unprognostic (2.76e-4)" "unprognostic (3.21e-1)" "unprognostic (6.14e-2)" "unprognostic (5.42e-2)" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.81e-1)" "unprognostic (9.51e-3)" "unprognostic (3.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.24e-1)" "unprognostic (1.40e-2)" 3.7 0.3 0.4 1.1 0.4 2.4 1.6 17.6 0.4 3.8 2.1 0.2 0.0 2.2 2.4 2.2 1.9 0.6 2.7 1.3 0.4 0.5 0.5 0.4 5.6 1.1 0.5 0.0 0.3 0.5 0.1 0.4 0.3 1.7 9.5 2.4 0.4 1.0 0.9 0.5 1.2 2.5 6.6 0.9 0.5 1.4 5.3 0.0 1.4 0.4 2.4 1.5 3.4 9.4 0.1 0.0 48.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 113.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 48.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 17.6 0.4 0.4 0.5 0.5 0.0 1.7 0.0 0.0 7.9 0.0 0.0 0.6 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 6.7 0.1 0.0 0.0 0.0 0.0 0.3 1.3 214.1 0.0 0.2 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 6.9 1.6 0.5 0.0 0.0 0.0 0.0 GDAP1 "CMT2K, CMT4, CMT4A" ENSG00000104381 "Ganglioside induced differentiation associated protein 1" Q8TB36 8 74321130-74488872 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 42.1;Cone photoreceptor cells: 45.2;Horizontal cells: 44.5;Rod photoreceptor cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014266, HPA024334" Enhanced Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA014266: AB_1849581, HPA024334: AB_1849583" "unprognostic (3.19e-2)" "unprognostic (1.52e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (3.31e-1)" "unprognostic (4.36e-2)" "unprognostic (1.72e-2)" "prognostic favorable (2.68e-4)" "unprognostic (3.88e-1)" "unprognostic (4.17e-1)" "unprognostic (9.44e-3)" "unprognostic (2.44e-1)" "unprognostic (5.40e-2)" "unprognostic (3.29e-1)" "unprognostic (6.99e-2)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.73e-1)" 2.8 11.2 19.2 3.8 25.9 2.1 5.6 24.9 48.3 3.2 2.9 7.6 1.1 3.2 5.4 5.7 5.3 3.7 3.4 2.8 17.6 21.4 5.3 2.0 3.2 3.7 16.5 19.2 8.2 10.8 12.3 16.4 2.3 23.3 5.6 3.6 3.7 2.9 5.4 2.6 2.1 3.0 3.9 14.6 2.9 3.2 5.4 9.6 0.7 7.5 0.5 3.4 3.8 1.8 2.7 1.7 2.8 7.2 1.9 4.6 1.4 2.3 7.7 12.0 2.7 1.0 0.9 1.2 1.0 5.7 6.1 7.0 4.1 2.7 9.2 1.4 1.3 6.4 4.0 6.4 3.9 11.9 7.9 2.0 4.8 4.3 7.9 1.3 3.9 9.9 2.9 1.3 2.9 6.2 0.7 0.7 3.9 2.3 0.1 3.6 2.9 8.0 0.6 13.9 12.5 10.6 4.1 5.7 1.7 2.0 7.2 11.8 28.9 7.1 2.7 6.0 3.6 11.9 1.3 0.1 8.9 4.1 2.0 2.8 6.1 5.7 4.5 4.0 0.2 9.3 0.0 1.7 2.8 1.5 4.3 1.8 2.7 1.6 1.9 1.7 1.9 1.3 1.6 0.0 1.9 7.2 0.0 4.6 1.4 19.2 25.9 24.9 25.8 17.6 21.4 16.5 19.2 23.3 9.6 6.0 3.2 3.5 6.4 1.5 42.1 4.8 5.1 4.0 3.4 3.5 45.2 0.4 8.3 4.1 4.4 6.4 2.4 0.0 5.2 0.3 2.9 3.7 17.3 1.6 4.1 44.5 19.5 5.5 4.0 0.5 3.7 4.9 1.7 1.0 2.0 18.0 3.6 0.3 5.3 5.0 45.4 0.0 6.6 14.2 11.7 1.1 0.0 1.5 1.4 3.3 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113856 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 50.9;Extravillous trophoblasts: 52.5;Late spermatids: 201.8;Proximal tubular cells: 62.4" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "eosinophil: 1.6;neutrophil: 5.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 5.1" "Group enriched" "Detected in many" 5 "MCF7: 13.7;OE19: 16.9;SK-BR-3: 48.5" "Region enhanced" "Detected in single" "cerebellum: 0.9" "Low region specificity" "Detected in many" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 3.0 0.9 1.2 10.5 1.2 0.5 2.5 5.7 1.3 9.4 11.3 1.2 1.2 4.0 2.8 3.4 30.8 2.1 3.6 1.7 1.2 0.7 5.9 1.2 3.7 2.3 1.2 1.2 3.3 1.2 0.4 2.3 12.9 2.5 2.4 7.4 1.2 4.9 1.2 1.3 5.3 8.6 2.4 1.2 4.1 8.3 1.2 1.2 1.9 2.3 36.6 40.8 2.7 9.2 0.1 0.0 5.1 0.2 0.0 0.2 0.0 5.3 0.0 1.9 0.5 0.5 2.8 1.6 0.5 0.4 0.5 0.6 0.6 3.7 0.6 0.7 0.3 0.1 0.5 0.5 0.2 0.5 1.0 1.5 0.1 0.8 2.5 0.5 0.2 0.4 0.1 0.7 1.5 0.1 1.5 2.1 2.0 0.4 0.9 0.7 13.7 0.4 0.9 1.1 16.9 0.2 2.5 0.6 2.9 1.1 2.4 0.5 0.9 0.0 48.5 0.3 0.5 0.9 1.0 1.5 0.5 0.5 1.1 0.5 1.6 0.3 0.6 1.4 0.8 0.3 0.1 0.0 1.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 5.1 0.0 0.1 0.0 0.1 0.0 1.2 1.2 5.7 1.3 1.2 0.7 1.2 1.2 2.5 1.2 6.0 0.6 0.0 0.6 1.1 1.1 0.9 0.0 1.4 1.2 5.2 0.0 20.4 5.0 1.0 50.9 4.0 43.6 0.0 1.2 52.5 2.1 1.4 0.0 0.0 2.8 1.6 3.4 3.7 3.0 201.8 3.1 0.7 1.7 1.0 28.5 0.2 11.2 12.9 2.8 62.4 1.7 6.5 1.4 1.2 1.2 1.8 7.8 1.5 4.7 3.9 GDPGP1 C15orf58 ENSG00000183208 "GDP-D-glucose phosphorylase 1" Q6ZNW5 15 90233808-90245811 "Enzymes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA048189, HPA059841" Approved Approved Cytosol NA NA Cytosol "HPA048189: AB_2680307, HPA059841: AB_2684138" "prognostic favorable (6.32e-4)" "unprognostic (1.85e-1)" "unprognostic (2.17e-1)" "unprognostic (2.42e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-1)" "unprognostic (3.68e-2)" "unprognostic (4.46e-3)" "unprognostic (1.53e-1)" "unprognostic (3.00e-1)" "unprognostic (1.82e-2)" "unprognostic (2.93e-3)" "unprognostic (8.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.02e-3)" 3.9 9.2 9.8 5.7 9.8 5.1 4.8 9.9 12.4 4.4 10.7 8.0 7.2 10.1 5.0 7.5 6.2 9.4 6.0 10.8 12.9 7.1 7.7 12.2 5.8 6.1 5.9 11.6 6.1 9.1 11.9 10.2 2.1 8.8 7.5 14.8 7.2 9.9 10.0 12.5 4.5 9.4 5.8 5.1 8.2 6.9 9.5 8.4 8.5 7.6 3.1 7.8 7.2 3.9 8.3 4.6 7.4 5.2 6.7 7.8 2.9 3.3 13.0 1.6 4.8 5.0 1.0 4.4 3.0 1.9 4.0 3.8 3.8 12.9 8.1 5.9 2.3 2.9 5.5 5.1 3.4 1.6 7.2 8.7 7.2 7.5 5.5 5.3 3.9 4.8 1.3 2.4 2.8 1.5 4.5 4.6 4.8 2.6 3.2 2.3 7.4 2.9 1.9 2.0 9.9 5.4 5.1 1.2 4.1 4.6 6.4 5.1 2.3 4.8 7.4 5.0 3.1 8.5 4.0 4.6 2.1 2.3 3.0 2.9 6.6 7.6 3.6 4.6 3.3 3.8 6.8 4.6 2.2 6.6 5.2 5.6 4.8 6.2 7.8 4.1 8.3 6.7 6.2 7.4 6.7 4.1 4.6 7.5 2.9 9.8 9.8 9.9 12.4 12.9 7.1 5.9 11.6 8.8 8.4 0.0 2.7 1.4 1.9 0.0 3.8 6.0 12.7 4.0 1.2 7.0 5.9 2.1 3.3 3.5 1.8 0.7 4.0 0.0 5.3 1.0 1.0 1.9 3.5 4.4 3.7 1.6 5.2 1.8 2.8 1.9 2.6 3.4 0.0 1.8 3.8 3.3 3.8 5.7 2.1 4.4 3.5 0.0 0.5 2.7 2.7 0.3 0.3 2.2 3.7 1.6 GEMIN4 "DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97" ENSG00000179409 "Gem nuclear organelle associated protein 4" P57678 17 744414-753999 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 115.1;Late spermatids: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065699, HPA067891" Uncertain Supported "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA065699: AB_2685534, HPA067891: AB_2685918" "unprognostic (1.85e-1)" "unprognostic (3.36e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-2)" "unprognostic (1.60e-1)" "unprognostic (7.41e-3)" "unprognostic (2.00e-2)" "unprognostic (7.95e-2)" "unprognostic (1.98e-2)" "unprognostic (1.63e-1)" "unprognostic (1.89e-2)" "unprognostic (8.67e-3)" "unprognostic (4.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (4.74e-2)" "unprognostic (8.56e-3)" 10.8 6.5 6.4 5.9 5.1 10.5 10.1 15.0 7.2 11.1 6.9 5.4 11.3 6.1 10.5 5.9 12.0 9.5 9.9 9.1 5.5 3.3 5.4 9.9 8.0 12.8 5.8 4.0 13.5 8.5 4.1 5.2 7.6 5.4 11.2 5.0 6.8 9.1 8.8 10.5 29.5 7.6 8.7 4.2 11.4 10.7 36.7 6.5 20.5 20.1 8.7 11.4 10.4 9.9 11.7 8.3 1.5 9.6 6.9 13.4 8.4 18.8 33.5 11.2 16.8 7.1 9.1 14.0 10.8 7.6 19.7 17.5 19.0 10.3 33.2 14.5 9.3 10.5 24.0 21.1 20.3 15.8 12.5 31.5 11.9 17.8 10.6 5.1 12.6 16.4 8.7 10.3 16.1 11.4 6.8 11.0 19.6 16.5 13.9 10.5 13.4 20.7 7.1 10.8 15.9 14.4 22.4 5.3 15.6 8.4 14.0 11.7 9.5 11.1 11.5 5.1 8.4 12.2 9.2 8.7 12.2 11.1 15.7 26.1 2.3 5.1 19.0 10.5 17.9 13.9 1.5 6.1 0.3 7.6 8.5 13.4 11.6 8.2 8.0 8.3 11.7 10.0 9.8 0.8 6.9 9.6 4.8 5.5 8.4 6.4 5.1 15.0 7.2 5.5 3.3 5.8 4.0 5.4 6.5 14.9 4.1 9.0 11.8 18.1 2.2 26.3 2.5 2.7 9.1 0.0 0.0 6.9 3.3 6.8 115.1 4.7 1.6 0.0 5.7 6.8 6.2 5.1 1.1 4.3 4.8 4.8 1.2 3.1 5.2 121.1 10.6 3.2 5.0 5.4 4.7 2.0 7.3 0.0 6.3 1.9 1.3 0.0 4.7 13.7 10.5 14.1 3.3 3.8 8.1 9.1 GEMIN5 ENSG00000082516 "Gem nuclear organelle associated protein 5" Q8TEQ6 5 154887416-154938209 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037392, HPA037393" Uncertain Enhanced "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA037392: AB_2675453, HPA037393: AB_10672489" "unprognostic (1.14e-2)" "unprognostic (2.81e-3)" "unprognostic (5.41e-3)" "prognostic unfavorable (6.23e-5)" "unprognostic (5.44e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (9.91e-2)" "unprognostic (8.70e-2)" "unprognostic (3.61e-2)" "unprognostic (9.38e-2)" "unprognostic (5.11e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (9.40e-3)" "unprognostic (5.01e-2)" 17.7 10.5 9.4 13.8 13.2 6.4 17.0 11.2 11.7 12.9 10.8 16.5 12.1 7.0 14.4 10.2 11.3 13.2 8.6 14.8 9.5 10.4 10.3 12.3 9.5 14.9 14.0 10.5 18.3 15.4 17.1 15.1 9.9 10.4 12.8 10.1 9.1 10.4 13.3 23.0 15.3 8.6 14.6 11.4 11.0 9.6 13.8 12.5 19.7 11.9 11.0 14.5 12.4 10.9 6.1 4.6 2.9 4.0 4.5 7.3 3.4 8.7 12.9 8.4 19.5 9.1 7.7 10.9 8.5 5.2 14.9 11.1 21.3 7.8 23.0 10.8 8.1 15.4 9.3 24.9 15.5 20.4 4.5 11.7 13.9 8.5 12.8 5.1 24.1 8.1 5.8 7.2 20.7 12.4 5.4 12.1 5.6 22.0 5.6 11.1 11.9 13.0 9.7 11.8 6.8 10.2 16.9 16.5 19.1 6.2 6.0 11.1 7.7 9.8 10.9 6.9 8.7 12.9 5.6 7.3 13.5 9.6 10.1 19.0 5.7 8.6 18.1 5.7 20.0 11.8 0.0 3.1 2.9 4.5 4.0 7.3 6.1 4.2 4.3 4.6 5.0 6.3 6.6 0.3 4.5 3.9 3.4 3.9 3.4 9.4 13.2 11.2 11.7 9.5 10.4 14.0 10.5 10.4 12.5 0.0 5.4 5.1 4.3 9.2 6.0 11.3 2.5 1.4 19.4 3.5 0.0 3.7 0.0 5.3 1.9 6.8 1.8 0.0 3.6 3.5 7.1 4.1 1.1 7.3 4.0 15.9 1.2 6.2 11.6 3.0 10.0 2.9 6.8 5.4 3.0 7.1 3.1 0.0 12.4 3.8 3.9 0.0 7.1 7.9 17.9 13.9 1.7 4.3 5.4 3.4 GEMIN7 FLJ13956 ENSG00000142252 "Gem nuclear organelle associated protein 7" Q9H840 19 45079195-45091524 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052075 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA052075: AB_2681718" "unprognostic (3.32e-1)" "unprognostic (1.48e-2)" "unprognostic (3.84e-1)" "unprognostic (3.17e-2)" "unprognostic (1.60e-1)" "unprognostic (7.00e-2)" "prognostic unfavorable (5.86e-5)" "unprognostic (7.78e-2)" "unprognostic (2.17e-1)" "unprognostic (2.95e-1)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "prognostic unfavorable (9.64e-11)" "unprognostic (7.01e-2)" "unprognostic (4.54e-1)" "unprognostic (1.83e-1)" "prognostic favorable (8.00e-4)" 9.7 10.6 8.9 13.0 12.2 18.3 12.3 22.1 19.0 8.1 13.6 10.0 8.2 18.9 10.0 8.7 18.5 9.0 9.6 13.3 9.8 9.7 12.4 20.2 10.3 21.6 10.0 9.0 8.5 24.1 6.1 20.4 12.9 12.8 11.9 13.2 12.7 16.8 9.5 20.7 14.7 16.5 9.7 6.9 24.3 17.4 5.3 10.5 12.8 12.5 14.7 17.1 13.1 11.7 28.4 22.9 15.2 14.3 29.6 32.0 18.9 20.6 27.5 16.2 19.8 12.4 12.9 12.5 16.0 11.7 24.5 27.3 16.7 13.3 20.8 11.0 13.7 13.6 13.0 23.4 19.0 14.8 16.6 30.4 22.9 12.6 21.7 17.4 18.2 13.7 19.3 15.6 13.6 9.9 12.6 23.8 12.6 23.9 21.8 9.5 30.6 17.4 19.0 15.2 31.8 14.3 21.0 7.5 26.9 18.5 15.3 16.1 11.3 12.5 27.1 14.0 13.7 18.3 19.6 12.8 9.1 17.3 5.9 20.9 22.7 33.4 33.1 14.6 18.5 14.6 10.7 14.3 15.2 32.0 11.5 30.2 28.4 23.6 29.4 20.1 23.7 18.3 23.8 7.9 29.6 8.3 22.9 19.8 18.9 8.9 12.2 22.1 19.0 9.8 9.7 10.0 9.0 12.8 10.5 17.9 8.9 32.5 8.8 16.1 5.3 8.4 15.3 1.4 10.3 3.5 0.0 31.5 18.3 34.5 1.1 9.8 16.8 0.0 29.3 47.6 11.6 8.3 3.5 17.9 30.0 1.6 12.7 15.4 21.9 2.4 13.3 14.3 11.8 82.0 18.3 7.7 35.1 20.3 6.0 21.2 3.2 6.5 7.1 4.3 8.8 20.7 21.6 21.7 24.0 11.1 GEMIN8 "FAM51A1, FLJ20514" ENSG00000046647 "Gem nuclear organelle associated protein 8" Q9NWZ8 X 14008279-14029893 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028613 Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028613: AB_10602905" "unprognostic (7.10e-2)" "unprognostic (1.91e-3)" "unprognostic (1.83e-1)" "unprognostic (1.87e-3)" "unprognostic (2.58e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (7.78e-5)" "unprognostic (3.87e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-2)" "unprognostic (5.52e-2)" "unprognostic (2.40e-1)" "unprognostic (4.74e-2)" "unprognostic (4.23e-2)" "unprognostic (2.07e-2)" "unprognostic (7.75e-2)" "prognostic favorable (7.73e-5)" 13.4 13.5 14.5 12.9 17.0 12.0 19.9 12.3 20.0 16.5 13.9 24.0 27.3 9.0 21.5 16.9 13.2 22.8 16.4 15.5 14.8 14.0 16.7 12.9 14.5 16.0 16.6 14.7 28.9 22.2 18.7 27.4 10.3 21.0 13.1 11.9 16.8 24.7 30.2 7.6 15.7 10.0 17.1 23.3 12.5 13.6 8.2 12.7 14.6 21.3 7.9 13.2 12.7 13.0 11.3 15.4 0.8 6.9 9.9 15.2 7.5 6.3 6.4 7.5 1.8 12.2 18.7 3.7 6.0 6.7 5.2 3.6 3.3 11.0 14.8 14.2 4.9 6.0 8.5 4.6 10.4 5.0 7.9 9.5 3.8 4.7 7.4 7.1 9.0 8.0 15.0 17.2 9.0 15.7 16.0 11.2 11.4 6.6 13.1 7.8 8.5 9.1 14.2 8.1 7.5 3.7 13.9 5.2 26.3 8.7 6.3 7.4 20.5 6.4 11.9 7.0 17.2 16.3 9.0 8.5 3.8 2.2 11.1 2.4 8.9 4.4 9.3 8.8 5.5 2.2 0.6 6.7 0.2 9.4 6.4 11.6 11.3 15.2 8.9 12.2 9.8 13.1 9.8 0.8 9.9 6.9 15.4 8.4 7.5 14.5 17.0 12.3 20.0 14.8 14.0 16.6 14.7 21.0 12.7 6.0 6.2 8.5 10.4 6.8 3.1 5.0 7.6 13.4 13.6 8.7 0.0 12.2 16.6 18.2 14.8 7.7 3.9 0.0 10.4 14.3 8.3 6.0 5.8 5.9 9.6 9.5 3.4 4.3 4.8 0.8 9.5 5.5 1.7 8.2 9.9 6.0 11.9 5.8 8.1 30.7 5.6 0.0 8.0 4.4 5.3 8.3 7.0 6.4 10.3 7.1 GET4 "C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35" ENSG00000239857 "Golgi to ER traffic protein 4" Q7L5D6 7 876552-896436 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 3.9;Horizontal cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019765 Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nucleoli, Mitotic chromosome" "HPA019765: AB_1845750" "unprognostic (2.80e-2)" "unprognostic (2.40e-2)" "unprognostic (2.10e-2)" "unprognostic (9.66e-4)" "unprognostic (9.86e-2)" "unprognostic (8.64e-2)" "unprognostic (4.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-1)" "unprognostic (7.65e-2)" "unprognostic (8.18e-2)" "unprognostic (1.26e-1)" "unprognostic (5.93e-2)" "unprognostic (9.47e-2)" 13.7 39.8 22.4 14.8 21.4 28.5 15.3 22.1 23.5 10.3 15.5 20.9 19.0 21.8 12.3 23.8 18.8 14.6 12.8 18.7 16.4 15.4 27.8 37.5 12.2 15.1 22.9 21.5 16.5 32.6 11.3 32.9 21.7 18.9 16.8 9.9 15.2 25.0 21.9 53.7 29.7 20.9 12.6 18.9 16.9 22.2 32.0 22.7 12.5 16.0 21.8 12.5 14.3 17.3 23.3 31.5 28.9 30.7 24.9 27.3 21.9 26.3 13.0 9.1 13.4 4.7 3.3 28.9 7.3 5.2 9.4 9.4 35.3 33.0 9.7 7.7 4.2 26.2 16.8 10.2 8.0 4.1 3.9 17.5 5.3 10.2 19.9 10.4 9.1 9.9 4.9 9.7 8.2 5.4 7.1 7.4 11.3 34.5 9.0 5.2 20.0 6.9 21.9 32.7 15.6 19.5 14.5 1.6 10.4 8.3 15.6 16.5 17.8 6.7 24.9 10.6 11.6 18.9 16.2 7.4 6.9 15.6 16.0 10.0 13.6 8.5 12.5 7.1 15.7 17.5 16.8 27.4 28.9 24.2 24.7 23.7 23.3 26.5 24.0 27.7 23.2 26.0 27.3 21.1 24.9 30.7 31.5 24.5 21.9 22.4 21.4 22.1 23.5 16.4 15.4 22.9 21.5 18.9 22.7 0.0 1.9 0.0 0.2 0.9 0.8 0.4 0.0 2.7 3.4 0.0 3.9 0.9 0.0 0.6 3.6 0.1 1.6 0.0 0.6 0.6 0.3 0.4 1.1 0.0 0.6 7.9 0.0 0.0 0.3 1.5 0.0 2.5 0.0 0.0 1.9 0.2 0.8 0.0 0.0 0.6 1.1 0.0 0.2 0.5 1.0 0.9 1.4 0.9 1.7 0.8 GFER "ALR, ERV1, HERV1, HPO1, HPO2, HSS" ENSG00000127554 "Growth factor, augmenter of liver regeneration" P55789 16 1984207-1987749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Growth factor, Oxidoreductase" "Cataract, Deafness, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 165.5;Enterocytes: 236.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041227, HPA063553" Approved Enhanced Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA041227: AB_10795538, HPA063553: AB_2685038" "unprognostic (5.35e-2)" "unprognostic (2.11e-2)" "unprognostic (3.08e-1)" "unprognostic (4.42e-2)" "unprognostic (3.15e-1)" "unprognostic (2.63e-1)" "unprognostic (1.27e-2)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-2)" "prognostic favorable (4.06e-4)" "unprognostic (4.93e-2)" "unprognostic (3.64e-1)" "unprognostic (3.56e-1)" "unprognostic (1.09e-2)" 9.7 12.2 9.7 15.2 9.9 10.7 14.8 15.2 12.5 8.1 24.8 10.8 15.2 29.6 10.1 10.2 11.0 10.2 16.1 17.8 9.8 9.7 13.7 33.5 17.1 18.1 10.7 9.7 9.4 43.8 19.2 10.9 18.0 8.0 11.9 18.0 10.5 22.5 12.5 27.5 8.3 33.2 9.2 9.6 15.2 12.8 20.0 7.8 7.7 15.1 15.0 11.4 12.4 17.1 16.1 9.1 9.8 12.7 7.8 17.7 7.7 11.4 18.3 15.0 12.2 6.3 12.7 19.5 13.3 13.0 18.8 15.4 26.3 19.2 6.4 18.2 9.9 11.0 17.3 11.4 17.6 11.9 20.0 23.4 8.9 18.0 29.8 11.5 12.9 16.8 8.1 13.7 16.4 14.8 11.9 8.8 13.9 13.8 21.6 13.6 27.0 14.6 13.9 24.1 9.7 18.3 32.1 11.5 20.9 19.1 9.0 13.2 12.6 18.0 38.4 14.2 8.1 18.3 13.8 8.1 18.3 20.4 10.2 22.9 36.7 19.8 18.5 6.1 8.8 15.4 3.1 12.6 9.8 9.2 10.5 9.9 16.1 12.6 15.6 9.1 13.4 11.5 7.9 1.1 7.8 12.7 4.0 17.7 7.7 9.7 9.9 15.2 12.5 9.8 9.7 10.7 9.7 8.0 7.8 3.0 7.0 36.5 18.9 14.2 10.7 14.9 25.5 8.1 1.2 8.7 0.0 34.0 29.9 38.0 165.5 17.1 236.0 23.3 70.3 48.9 16.9 17.7 12.7 53.9 39.8 7.9 26.2 20.9 29.7 100.1 16.1 25.1 21.9 45.1 48.7 7.8 54.6 92.1 11.7 50.8 7.9 12.9 18.9 45.9 23.0 12.9 31.4 35.2 62.4 23.3 GFOD1 "ADG-90, C6orf114, FLJ20330" ENSG00000145990 "Glucose-fructose oxidoreductase domain containing 1" Q9NXC2 6 13357830-13487662 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 12.8;NK-cell: 11.4" "Group enriched" "Detected in many" 5 "granulocytes: 12.8;NK-cells: 11.4" "Cell line enhanced" "Detected in many" "HEL: 18.8;HMC-1: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029096 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted - unknown location" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029096: AB_10602320" "unprognostic (5.00e-2)" "unprognostic (1.34e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.29e-5)" "unprognostic (8.49e-2)" "unprognostic (1.95e-3)" "unprognostic (1.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.34e-2)" "unprognostic (3.11e-2)" "unprognostic (6.49e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.72e-5)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (4.66e-3)" 15.7 3.8 9.4 4.6 11.5 17.5 8.7 28.5 22.3 5.4 5.0 4.0 0.5 3.5 4.0 2.6 12.1 4.3 11.8 18.5 11.9 7.1 2.1 6.6 8.2 6.6 6.3 14.2 1.7 2.3 3.9 3.3 6.8 6.6 4.4 5.2 1.5 3.4 3.0 15.5 4.7 5.6 8.3 4.2 12.0 8.2 1.5 4.1 1.9 3.9 4.5 6.9 4.7 7.6 2.3 0.2 12.8 0.8 11.4 1.4 0.8 7.4 0.7 0.6 1.3 1.1 1.1 0.8 0.6 0.3 0.4 0.2 0.2 0.5 10.2 10.6 0.7 0.6 6.6 2.0 3.2 0.4 0.7 3.8 18.8 3.9 3.9 1.5 5.4 29.1 0.6 2.5 1.0 2.8 1.6 5.7 2.7 0.6 0.9 0.8 2.4 1.2 3.3 1.0 2.5 2.2 4.1 1.4 5.2 0.3 1.4 3.5 0.6 2.5 0.4 2.4 1.4 0.6 0.5 7.7 0.9 2.0 2.2 3.3 8.5 4.8 12.2 0.8 3.2 0.2 0.1 0.4 12.8 1.4 0.7 0.2 2.3 0.2 0.6 0.2 1.9 0.1 0.5 0.3 11.4 0.8 0.0 0.1 0.8 9.4 11.5 28.5 18.7 11.9 7.1 6.3 14.2 6.6 4.1 0.0 2.6 12.7 4.9 18.0 38.9 87.7 12.7 12.0 0.0 0.0 0.0 0.4 0.0 4.3 0.0 36.2 13.5 46.7 2.7 27.6 5.8 2.3 4.6 16.8 2.4 1.6 8.1 33.2 15.8 0.0 2.3 10.4 11.8 0.0 11.8 2.0 18.1 31.7 1.1 0.5 3.0 12.9 20.8 0.0 1.7 19.6 0.6 34.8 3.3 4.7 GFOD2 "FLJ23802, MGC11335" ENSG00000141098 "Glucose-fructose oxidoreductase domain containing 2" Q3B7J2 16 67674531-67719421 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040939, HPA041112" Uncertain Supported Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA040939: AB_10796564, HPA041112: AB_10794541" "unprognostic (9.80e-2)" "unprognostic (2.20e-1)" "unprognostic (2.06e-2)" "unprognostic (3.16e-3)" "unprognostic (4.62e-2)" "unprognostic (1.38e-1)" "unprognostic (2.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-2)" "prognostic favorable (5.95e-4)" "unprognostic (1.17e-1)" "prognostic favorable (8.66e-4)" "unprognostic (1.90e-1)" "unprognostic (1.76e-1)" "unprognostic (7.87e-2)" "unprognostic (9.64e-2)" 9.0 9.4 9.6 7.7 13.8 13.4 8.6 42.9 18.9 10.7 10.6 5.0 9.4 10.7 8.1 5.9 21.8 12.2 8.4 6.8 10.1 12.4 9.8 24.4 7.9 6.9 8.2 11.1 5.6 9.0 14.1 11.7 19.4 10.8 7.4 8.7 6.4 8.7 7.2 6.5 14.1 8.1 8.6 5.7 12.8 7.5 8.3 5.1 6.1 9.7 13.2 12.8 9.0 16.4 9.1 6.5 10.6 5.5 6.4 10.2 4.1 9.3 15.2 9.3 19.2 9.5 7.1 11.0 7.8 10.1 14.6 15.0 12.9 8.6 15.8 7.3 9.0 7.8 11.8 9.6 9.0 12.4 9.4 11.8 4.0 8.1 18.3 7.2 6.5 7.8 5.9 10.4 19.3 5.8 7.2 21.0 16.2 8.2 3.1 8.1 19.9 10.6 7.8 12.6 5.6 8.3 17.0 5.5 12.2 8.9 13.3 19.1 11.2 19.3 6.5 5.9 5.7 9.9 4.3 16.1 11.4 11.4 10.1 7.7 8.0 11.3 17.2 7.0 9.5 8.1 0.7 5.5 5.7 5.6 3.5 9.0 8.0 9.5 9.6 5.6 9.1 8.4 6.6 10.6 6.4 3.4 6.5 10.2 4.1 9.6 13.8 42.9 18.9 10.1 12.4 8.2 11.1 10.8 5.1 0.0 5.9 5.4 11.8 20.4 12.7 3.7 20.4 20.1 10.3 10.4 13.7 8.1 5.0 17.9 77.4 35.6 18.8 0.0 10.2 17.9 10.3 10.3 4.6 39.5 5.8 20.6 41.5 26.4 6.3 21.4 8.1 4.7 8.5 3.6 15.0 11.3 13.3 18.2 10.6 10.1 9.9 6.5 12.3 14.2 17.9 23.8 18.5 10.2 15.6 15.5 GFRA3 GFRa-3 ENSG00000146013 "GDNF family receptor alpha 3" O60609 5 138252379-138274671 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 23 "granulocytes: 27.5;Intestinal endocrine cells: 51.2;Late spermatids: 11.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 27.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020731 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA020731: AB_1849635" "unprognostic (1.22e-1)" "unprognostic (6.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.47e-3)" "unprognostic (2.77e-3)" "unprognostic (1.27e-1)" "unprognostic (7.65e-3)" "unprognostic (1.44e-1)" "unprognostic (1.33e-2)" "unprognostic (1.90e-5)" "unprognostic (2.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" 2.4 2.4 0.3 7.1 1.0 0.0 1.8 7.0 0.6 7.9 13.0 0.1 11.0 3.8 3.0 6.1 9.3 1.2 9.4 6.2 0.3 0.3 0.9 0.4 2.9 0.1 0.6 0.1 4.7 7.0 0.0 2.3 0.1 1.3 4.4 5.8 10.0 7.5 10.9 1.3 3.6 4.7 8.6 1.4 0.1 6.9 8.4 0.5 0.4 1.0 2.8 0.8 4.4 8.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 1.5 0.9 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 27.0 0.4 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 7.0 0.6 0.3 0.3 0.6 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.3 0.0 0.0 0.0 0.2 0.2 0.0 0.1 27.5 0.0 0.1 0.0 51.2 0.0 0.0 11.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 8.1 0.0 0.2 0.0 0.0 0.0 GHR GHBP ENSG00000112964 "Growth hormone receptor" P10912 5 42423777-42721878 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4" "Cell type enhanced" "Detected in many" 19 "Hepatocytes: 103.6;Syncytiotrophoblasts: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HSkMC: 13.6;T-47d: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045339, HPA057705" Enhanced Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" "Secreted to blood" NA NA 2200000 21000000 "Plasma membrane, Cytosol, Cytoplasmic bodies" "HPA045339: AB_2679294, HPA057705: AB_2683507" "unprognostic (2.18e-2)" "unprognostic (5.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.96e-2)" "unprognostic (3.12e-1)" "unprognostic (1.57e-1)" "prognostic favorable (2.73e-6)" "unprognostic (1.06e-1)" "unprognostic (3.92e-2)" "unprognostic (3.73e-2)" "unprognostic (6.15e-3)" "unprognostic (2.67e-2)" "unprognostic (1.67e-3)" "unprognostic (4.29e-4)" "unprognostic (7.82e-2)" "unprognostic (7.33e-4)" "unprognostic (8.35e-6)" 44.4 2.8 0.7 5.4 1.3 0.3 31.5 0.4 1.4 4.0 6.9 0.5 1.7 0.6 5.7 3.9 2.4 2.5 3.9 6.0 1.3 1.6 5.3 82.4 2.3 2.2 1.2 1.4 5.0 1.3 3.6 2.0 4.0 2.0 8.7 2.5 2.4 2.3 7.4 23.4 3.0 2.4 5.2 1.0 2.6 3.5 1.6 0.2 0.1 2.9 4.3 0.5 3.8 8.4 0.6 0.3 1.8 0.5 0.4 0.3 0.1 0.0 0.0 0.3 3.1 2.1 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.6 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 13.6 4.4 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 2.1 0.4 34.7 0.0 1.8 3.0 1.3 1.6 0.3 0.3 0.0 0.0 0.3 0.0 1.6 1.8 0.3 0.4 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.6 0.2 0.3 1.7 0.4 0.5 0.3 0.2 0.1 0.7 1.3 0.4 1.4 1.3 1.6 1.2 1.4 2.0 0.2 0.0 0.3 0.0 2.8 4.1 0.6 13.6 2.5 0.0 0.0 1.8 0.0 8.6 1.7 0.0 3.3 2.9 0.0 0.0 0.2 0.9 9.3 3.5 0.0 103.6 1.6 0.0 2.9 4.9 1.9 1.8 17.3 0.3 1.7 0.0 2.0 0.8 0.2 0.0 11.3 8.8 0.2 12.9 4.4 0.0 0.3 3.1 33.6 0.0 1.5 0.9 GID4 "C17orf39, VID24" ENSG00000141034 "GID complex subunit 4 homolog" Q8IVV7 17 18039292-18068404 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.2" "Group enriched" "Detected in many" 17 "Early spermatids: 643.1;Late spermatids: 883.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044348 Uncertain Approved Cytosol NA NA Cytosol "HPA044348: AB_10959602" "unprognostic (1.52e-1)" "unprognostic (4.19e-2)" "unprognostic (4.65e-1)" "unprognostic (4.67e-2)" "unprognostic (1.46e-1)" "unprognostic (1.38e-1)" "unprognostic (3.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (8.99e-2)" "unprognostic (2.39e-2)" "unprognostic (1.28e-1)" "unprognostic (3.64e-3)" "unprognostic (2.11e-1)" "unprognostic (8.68e-2)" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" 10.9 5.7 9.6 4.7 9.4 5.6 7.5 13.4 9.3 9.0 9.4 6.9 7.3 4.5 7.9 7.2 13.0 6.7 5.5 10.1 8.8 5.3 6.2 6.2 5.6 5.3 9.5 5.8 8.6 7.8 10.8 3.9 6.7 7.0 9.5 5.1 4.6 7.7 9.3 24.7 11.6 5.1 9.5 7.0 6.3 6.4 55.2 10.2 8.0 7.1 5.8 6.2 13.3 10.8 4.4 3.2 6.8 2.4 3.8 3.6 1.0 6.4 6.7 3.8 6.2 10.0 9.8 6.6 5.4 8.7 6.0 6.8 5.8 2.6 8.2 4.6 6.3 5.6 7.3 5.5 6.0 7.8 4.4 11.0 3.6 5.7 4.2 8.7 2.2 6.4 7.3 10.5 6.0 9.4 8.1 6.7 11.9 3.2 2.4 4.8 1.7 6.9 4.6 3.3 8.1 5.0 5.9 13.5 8.0 4.0 2.6 2.9 4.3 3.6 3.2 3.8 39.5 2.1 2.7 5.5 3.9 2.2 8.9 2.7 4.1 3.6 1.8 5.5 3.7 4.9 6.8 2.4 6.6 2.6 1.3 2.9 4.4 2.4 2.5 1.9 4.4 2.9 2.9 6.3 3.8 1.5 3.2 3.6 1.0 9.6 9.4 13.4 9.3 8.8 5.3 9.5 5.8 7.0 10.2 0.0 0.6 3.4 6.6 9.8 5.2 10.6 2.5 2.7 1.2 1.8 3.9 6.6 8.3 5.0 643.1 7.1 2.6 0.0 4.9 10.6 5.3 7.6 5.7 6.4 6.4 15.9 1.2 7.4 6.3 883.9 11.8 5.3 6.8 5.4 7.2 4.2 8.2 0.0 14.9 9.6 3.7 12.9 5.1 45.4 22.8 15.8 12.9 5.2 5.0 6.5 GIGYF2 "GYF2, KIAA0642, PARK11, PERQ2, PERQ3, TNRC15" ENSG00000204120 "GRB10 interacting GYF protein 2" Q6Y7W6 2 232697299-232860575 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 342.4;Late spermatids: 441.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050899, HPA054612, HPA059918, HPA065064" Approved Enhanced Cytosol NA NA Cytosol "HPA050899: AB_2681267, HPA054612: AB_2682542, HPA059918: AB_2684160, HPA065064: AB_2685417" "unprognostic (7.69e-2)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (1.52e-2)" "unprognostic (1.92e-2)" "unprognostic (8.61e-2)" "unprognostic (8.39e-3)" "unprognostic (2.99e-1)" "unprognostic (6.28e-2)" "unprognostic (1.27e-2)" "unprognostic (7.40e-3)" "unprognostic (8.01e-2)" "prognostic favorable (6.97e-5)" "unprognostic (7.53e-2)" "unprognostic (1.78e-1)" "unprognostic (1.20e-2)" "unprognostic (1.66e-1)" 22.8 22.1 20.7 16.5 19.4 15.2 19.7 33.0 21.7 17.9 17.5 25.0 21.2 15.9 23.7 15.0 18.6 17.8 13.7 21.3 19.2 15.7 23.1 13.7 15.7 15.4 21.4 15.6 24.6 26.5 47.5 38.1 18.1 21.5 19.4 16.9 18.1 21.4 21.7 41.5 23.4 17.2 22.3 27.5 18.9 18.2 53.4 22.0 19.2 22.4 17.7 17.3 20.8 20.5 10.1 9.8 21.5 14.6 9.8 9.9 5.2 16.1 15.6 18.2 18.9 24.8 23.9 20.4 20.4 17.5 14.9 16.1 14.5 13.5 9.7 5.4 15.2 24.3 17.1 21.7 16.4 18.4 22.6 16.2 35.7 16.1 22.0 15.6 28.9 22.8 15.0 16.9 18.0 25.7 15.9 16.7 13.5 33.3 10.8 17.1 17.1 18.9 10.3 18.5 13.3 11.5 19.3 36.0 13.2 14.0 24.7 16.2 13.5 20.5 15.0 15.8 14.5 14.5 20.2 24.2 15.9 13.5 17.8 15.7 21.9 14.6 19.1 14.4 17.0 15.4 21.5 8.6 10.8 7.9 6.7 9.9 5.6 6.5 7.2 9.8 10.1 7.8 5.9 11.2 9.8 14.6 7.6 9.6 5.2 20.7 19.4 33.0 21.7 19.2 15.7 21.4 15.6 21.5 22.0 53.6 54.8 27.6 28.8 14.0 49.5 79.9 15.3 61.6 68.2 34.9 56.9 27.8 21.6 26.2 342.4 38.3 25.7 23.3 23.5 17.9 19.7 31.1 16.3 26.2 24.4 46.1 18.4 16.5 31.6 441.2 34.8 21.3 25.3 20.8 23.6 40.9 25.2 10.5 34.6 14.6 38.4 25.8 20.2 92.6 88.6 16.8 61.2 19.8 26.2 38.2 GIPC2 "FLJ20075, SEMCAP-2" ENSG00000137960 "GIPC PDZ domain containing family member 2" Q8TF65 1 77979542-78138449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 48.7;Proximal tubular cells: 149.4;Undifferentiated cells: 50.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.9;naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 17 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.2;HaCaT: 4.9;Hep G2: 18.3;HUVEC TERT2: 19.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA051212, HPA062684" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051212: , HPA062684: AB_2684833" "unprognostic (1.72e-2)" "unprognostic (9.37e-2)" "prognostic favorable (5.49e-4)" "unprognostic (1.09e-2)" "unprognostic (1.43e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.35e-1)" "unprognostic (7.63e-2)" "unprognostic (2.22e-1)" "unprognostic (5.91e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.11e-6)" "unprognostic (6.55e-2)" "unprognostic (1.78e-1)" "unprognostic (4.18e-2)" "unprognostic (1.29e-1)" 6.4 17.0 0.8 3.2 0.9 0.0 4.0 0.4 1.0 2.6 27.0 0.3 0.2 19.6 5.4 4.5 5.7 1.4 8.1 3.1 0.5 0.5 21.3 10.4 3.2 2.2 0.5 0.3 3.7 24.7 3.3 2.5 1.6 1.3 2.1 7.8 1.5 6.9 1.0 1.8 2.7 64.0 1.4 0.6 22.7 3.0 2.2 0.4 0.1 1.5 4.9 1.4 2.5 5.1 0.1 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 5.2 0.0 0.8 0.0 0.4 0.9 4.1 2.7 1.2 0.0 0.4 0.0 4.9 0.0 0.0 2.7 0.1 0.0 0.6 0.0 18.3 1.0 0.0 0.0 0.8 0.0 2.9 0.1 0.0 19.3 0.0 0.0 0.1 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 1.0 0.6 0.0 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.4 1.0 0.5 0.5 0.5 0.3 1.3 0.4 0.0 2.2 1.3 2.0 11.4 0.4 2.6 25.5 12.0 3.4 8.7 2.0 5.2 28.2 9.6 1.7 13.7 48.7 0.0 29.0 1.9 1.6 0.5 0.0 39.9 10.0 0.0 2.9 11.1 0.6 0.5 1.1 0.2 0.0 1.8 34.6 0.0 18.0 31.7 0.0 149.4 0.5 0.0 1.3 0.5 0.2 19.1 1.4 0.5 50.7 5.6 GIT1 ENSG00000108262 "GIT ArfGAP 1" Q9Y2X7 17 29573469-29594054 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.6;Late spermatids: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004059, HPA004186" Enhanced Supported "Focal adhesion sites,Mitochondria,Cytosol" NA NA 53000 "Focal adhesion sites, Cytosol" Mitochondria "HPA004059: AB_1078966, HPA004186: AB_1078967" "unprognostic (3.66e-1)" "unprognostic (4.46e-2)" "unprognostic (3.24e-2)" "unprognostic (6.30e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.54e-6)" "unprognostic (3.00e-3)" "unprognostic (2.79e-1)" "unprognostic (5.23e-2)" "unprognostic (2.12e-2)" "unprognostic (3.08e-1)" "unprognostic (8.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.30e-2)" "unprognostic (2.10e-1)" "unprognostic (1.69e-1)" 13.0 8.5 34.0 11.1 38.1 8.0 9.4 18.9 43.4 7.8 9.8 15.6 2.2 11.6 10.0 5.3 13.2 14.0 10.2 12.2 41.5 16.4 7.0 3.7 12.0 12.6 19.2 21.8 13.6 14.3 10.2 8.1 13.8 15.0 8.4 6.9 7.8 11.9 10.3 10.0 20.2 10.9 8.7 11.9 11.1 9.5 42.9 19.8 10.8 11.0 4.5 9.7 9.8 7.5 1.8 4.7 3.0 6.0 5.6 4.9 3.6 17.5 29.4 14.5 25.8 11.6 7.3 16.8 8.7 8.6 10.5 9.4 11.9 6.6 13.3 14.0 11.4 18.8 29.1 15.2 22.4 5.4 17.1 18.2 9.6 14.4 10.6 14.1 12.1 7.9 8.9 25.8 12.1 18.9 15.0 19.5 17.8 7.8 11.5 7.5 18.1 38.2 16.3 10.8 17.8 7.0 29.1 19.4 19.9 9.5 9.7 30.5 26.1 12.3 28.6 43.0 10.8 14.0 16.2 24.0 10.0 14.5 22.0 17.5 9.6 13.2 14.5 16.5 10.4 16.8 0.3 3.6 3.0 4.7 6.0 2.2 1.8 4.5 4.9 4.7 1.7 3.7 2.7 1.2 5.6 3.7 4.0 2.9 3.6 34.0 38.1 18.9 43.4 41.5 16.4 19.2 21.8 15.0 19.8 3.0 1.0 13.7 6.2 24.2 14.0 7.6 0.0 8.1 1.2 5.2 9.8 4.4 1.7 7.1 78.6 27.4 16.3 0.0 8.1 6.7 8.8 8.0 1.1 2.1 7.3 11.1 14.3 14.7 7.8 70.1 13.3 9.2 8.5 4.6 14.3 9.7 8.1 10.5 9.9 5.0 9.3 12.9 5.1 10.4 10.9 24.6 3.0 7.7 13.7 6.7 GJB7 "bA136M9.1, CX25" ENSG00000164411 "Gap junction protein beta 7" Q6PEY0 6 87282978-87329278 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 29.4;Cytotrophoblasts: 7.7;Extravillous trophoblasts: 4.4;Syncytiotrophoblasts: 6.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.5;HDLM-2: 10.5;MCF7: 5.8;OE19: 6.7;RT4: 5.2;SuSa: 3.6" "Low region specificity" "Detected in many" HPA014392 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014392: " "unprognostic (8.30e-2)" "unprognostic (2.45e-1)" "unprognostic (3.06e-1)" "unprognostic (4.20e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-3)" "unprognostic (2.61e-1)" "unprognostic (5.13e-3)" "unprognostic (6.69e-3)" "unprognostic (1.59e-1)" "unprognostic (3.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.24e-1)" "unprognostic (5.64e-2)" "unprognostic (2.09e-2)" "unprognostic (3.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.0 4.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.1 0.5 0.0 0.7 0.1 1.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 5.8 0.0 0.1 1.8 6.7 0.0 0.2 0.0 0.0 0.0 5.2 0.1 0.0 1.2 0.0 0.0 3.6 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.1 0.6 1.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 29.4 0.0 0.0 0.0 7.7 0.0 0.0 0.6 0.0 0.0 0.0 0.2 4.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.1 0.0 6.1 0.0 0.2 0.1 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 23 "Sertoli cells: 155.2;Smooth muscle cells: 65.3;Spermatogonia: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" NA NA Nucleoli "Cell Junctions, Cytosol" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavorable (7.83e-4)" 7.3 0.8 2.2 4.1 3.4 1.0 4.7 8.2 4.2 14.8 23.0 2.8 7.0 1.6 24.2 3.1 3.2 5.0 5.4 10.0 3.3 1.8 1.5 0.9 6.5 2.3 2.5 4.0 2.2 1.3 2.6 0.7 28.5 3.4 8.2 2.8 3.7 1.7 17.0 5.4 1.9 4.8 27.5 2.2 0.9 7.8 8.0 2.9 1.4 5.3 2.9 1.7 12.6 10.4 1.2 1.0 4.7 1.0 1.9 1.0 0.4 17.4 9.0 22.7 7.8 3.0 4.7 8.9 19.4 15.3 20.9 22.5 5.2 9.7 0.1 1.0 18.1 28.6 4.5 11.8 6.0 29.4 0.1 8.8 0.1 4.8 0.5 1.8 0.1 0.7 3.2 0.6 15.9 5.3 7.8 7.1 3.9 0.8 0.2 12.1 0.1 2.8 1.7 10.2 0.0 7.7 16.5 28.8 0.1 5.0 7.3 4.3 9.9 2.2 0.1 6.5 15.3 4.7 2.7 5.9 18.5 17.9 8.4 16.5 0.1 4.5 12.9 6.4 0.1 17.3 4.7 1.0 1.1 0.9 0.6 0.8 0.9 0.7 0.6 0.3 1.2 0.9 1.0 3.9 1.9 0.7 1.0 0.6 0.4 2.2 3.4 8.2 4.2 3.3 1.8 2.5 4.0 3.4 2.9 0.0 0.0 0.0 1.6 1.8 1.0 18.1 0.0 0.0 0.0 1.8 2.0 0.3 0.0 1.3 1.3 11.7 0.0 0.0 0.0 2.1 5.7 1.2 0.0 0.0 1.2 12.7 0.0 6.2 0.8 0.0 1.4 0.0 3.3 1.0 0.0 0.4 0.6 0.0 2.1 0.3 1.0 155.2 65.3 10.2 32.0 2.6 0.5 0.0 0.0 1.4 GJC2 "CX46.6, CX47, GJA12, SPG44" ENSG00000198835 "Gap junction protein gamma 2" Q5T442 1 228149852-228159826 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 34.3" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 11.8;Peritubular cells: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "EFO-21: 9.9;SCLC-21H: 5.2;TIME: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069619 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA069619: " "unprognostic (2.67e-1)" "unprognostic (1.81e-2)" "unprognostic (6.42e-2)" "unprognostic (8.19e-3)" "unprognostic (4.24e-1)" "unprognostic (1.57e-1)" "unprognostic (6.94e-2)" "unprognostic (2.56e-1)" "unprognostic (4.99e-2)" "unprognostic (7.09e-2)" "unprognostic (7.88e-3)" "unprognostic (9.67e-2)" "unprognostic (6.09e-3)" "unprognostic (2.53e-2)" "unprognostic (7.36e-2)" "unprognostic (1.54e-1)" "unprognostic (2.02e-1)" 2.4 1.9 4.6 1.2 10.0 0.5 2.0 2.2 14.8 2.8 2.6 34.3 0.0 0.6 4.5 2.0 1.7 4.8 1.4 1.6 9.3 5.3 0.6 0.5 3.1 1.2 27.2 5.6 3.4 0.9 2.9 0.6 1.2 18.3 2.1 0.8 0.0 1.5 4.0 1.5 2.4 1.2 3.8 32.6 1.9 1.2 1.0 15.7 0.0 0.9 0.0 0.7 1.3 1.8 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.2 0.5 1.4 0.7 1.9 1.4 0.4 0.6 0.8 0.9 1.2 0.2 9.9 2.6 0.8 1.0 0.3 0.3 0.3 0.4 1.6 0.3 2.5 2.2 2.5 0.0 0.0 0.4 0.2 0.8 0.5 1.2 0.2 1.7 1.1 0.3 0.4 0.6 1.9 0.6 0.6 0.0 2.0 0.4 0.3 0.1 0.8 0.0 5.2 3.0 0.4 0.1 0.3 0.1 0.1 0.3 4.6 1.4 3.8 4.5 1.6 0.3 0.6 0.2 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 4.6 10.0 2.2 10.4 9.3 5.3 27.2 5.6 18.3 15.7 0.0 1.1 0.0 1.2 3.1 1.5 1.4 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.4 0.0 1.2 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.6 0.0 2.3 0.0 1.7 0.0 0.0 0.3 0.7 0.0 3.9 0.0 0.6 0.0 1.7 0.0 0.0 1.5 0.0 0.0 0.1 0.9 GK5 MGC40579 ENSG00000175066 "Glycerol kinase 5 (putative)" Q6ZS86 3 142157527-142225607 "Enzymes, Predicted intracellular proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042606, HPA057998" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042606: AB_10795509, HPA057998: AB_2683573" "unprognostic (7.79e-2)" "unprognostic (5.15e-2)" "unprognostic (2.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (3.60e-2)" "unprognostic (9.89e-3)" "unprognostic (3.13e-1)" "unprognostic (2.77e-2)" "unprognostic (1.76e-2)" "unprognostic (7.76e-2)" "unprognostic (2.03e-1)" "unprognostic (1.12e-2)" "unprognostic (2.10e-3)" "unprognostic (4.49e-2)" "unprognostic (1.32e-1)" "unprognostic (5.59e-3)" 6.1 12.2 5.6 5.7 7.2 10.8 10.9 9.0 9.4 11.5 10.9 8.4 11.5 14.4 10.9 14.8 7.9 7.2 8.3 5.4 5.5 4.1 5.7 3.1 6.2 3.5 9.3 6.0 11.5 4.8 5.4 20.3 3.7 12.6 13.5 11.8 6.7 14.8 14.7 5.0 8.8 14.0 9.4 11.6 3.5 8.1 6.2 5.3 4.6 7.4 4.2 6.1 8.5 6.7 1.3 1.1 3.6 5.3 3.8 3.8 0.5 11.0 2.8 4.0 2.7 8.3 15.9 6.9 3.7 2.6 4.1 2.6 4.2 6.1 8.0 3.3 3.5 4.5 4.7 4.6 3.5 5.4 2.8 4.4 5.2 6.6 3.1 4.5 5.9 6.9 6.5 3.1 2.7 3.6 2.6 2.3 9.2 4.5 4.9 7.3 7.1 5.2 4.9 2.6 7.4 3.2 4.9 4.3 2.9 4.2 6.9 3.9 2.9 10.2 10.8 3.3 2.5 15.0 3.9 2.5 3.2 2.7 7.1 4.0 5.1 4.9 8.1 5.8 3.7 5.4 3.6 1.1 0.7 3.8 0.9 1.9 0.5 1.3 1.4 0.8 1.3 1.0 1.7 3.2 3.8 5.3 1.1 0.6 0.5 5.6 7.2 9.0 9.4 5.5 4.1 9.3 6.0 12.6 5.3 35.7 27.8 0.0 11.1 3.5 30.1 9.3 15.3 21.4 27.3 26.2 27.5 11.1 6.6 12.3 2.0 5.9 31.1 0.0 17.9 6.4 7.8 21.5 8.1 11.1 5.0 14.3 26.9 2.5 10.0 3.6 31.4 8.2 3.3 1.0 51.9 13.2 13.9 39.1 43.9 5.1 35.7 25.8 4.9 4.2 4.7 3.4 5.7 17.5 38.6 11.6 GKAP1 "FKSG21, GKAP42" ENSG00000165113 "G kinase anchoring protein 1" Q5VSY0 9 83739421-83829516 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 98.8" "Group enriched" "Detected in many" 5 "Early spermatids: 991.0;Late spermatids: 314.1;Spermatocytes: 374.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035117, HPA035118, HPA066173" Enhanced Supported Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA035117: AB_2674473, HPA035118: AB_10671100, HPA066173: AB_2732740" "unprognostic (1.91e-1)" "unprognostic (2.94e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (9.62e-2)" "unprognostic (2.50e-1)" "unprognostic (2.52e-3)" "unprognostic (7.66e-3)" "unprognostic (3.04e-1)" "unprognostic (1.86e-2)" "prognostic favorable (6.96e-5)" "unprognostic (4.18e-1)" "prognostic favorable (1.05e-6)" "unprognostic (9.73e-2)" "unprognostic (1.38e-2)" "unprognostic (2.06e-1)" "unprognostic (6.24e-3)" 4.4 4.2 6.0 2.8 6.1 2.5 9.2 15.6 6.1 4.7 5.0 4.1 6.6 3.0 5.5 4.5 3.2 3.9 3.4 9.0 6.1 6.8 4.2 5.1 2.9 2.6 6.5 3.1 7.0 5.2 6.2 7.9 2.0 6.1 6.6 2.7 3.2 4.2 5.9 25.0 1.7 3.0 8.1 8.0 2.4 3.5 98.8 7.2 8.4 8.1 5.2 2.7 6.0 14.7 1.9 0.6 3.0 0.8 5.3 1.9 0.1 4.8 6.0 4.4 5.8 0.6 0.0 6.3 1.9 1.5 3.0 3.1 0.8 2.7 7.5 1.9 0.8 10.1 1.0 4.4 0.5 5.2 9.0 3.9 4.3 3.0 4.3 6.5 2.0 0.4 0.2 3.5 1.5 1.6 8.8 2.7 7.3 3.5 6.3 0.9 4.6 10.5 6.9 3.6 2.3 3.1 7.5 9.9 2.6 3.1 0.8 14.8 8.8 4.3 2.0 3.4 7.1 0.8 4.1 0.9 1.0 7.1 0.7 3.3 10.4 22.7 3.0 2.2 1.4 1.2 3.0 0.8 0.6 1.4 0.0 1.3 1.7 1.3 1.5 0.6 1.9 1.0 1.9 2.5 5.3 0.3 0.3 1.5 0.1 6.0 6.1 15.6 6.1 6.1 6.8 6.5 3.1 6.1 7.2 6.0 9.1 10.2 16.1 6.3 45.6 47.4 12.7 6.7 2.3 14.0 43.2 7.1 11.6 8.8 991.0 11.7 6.2 23.3 5.8 2.3 4.7 20.1 2.3 18.8 3.5 114.4 12.6 10.4 3.2 314.1 24.5 5.2 10.1 1.0 12.0 43.9 6.4 6.8 20.1 11.6 73.0 25.8 8.4 374.4 52.7 4.0 2.4 12.1 10.8 8.1 GLI1 GLI ENSG00000111087 "GLI family zinc finger 1" P08151 12 57460135-57472262 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 21 "Leydig cells: 27.3;Peritubular cells: 40.3;Sertoli cells: 12.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.2" "Cell line enhanced" "Detected in many" "AN3-CA: 12.2;BJ hTERT+: 7.8;NTERA-2: 7.9;RH-30: 35.9;U-266/70: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009460, HPA065172, HPA068903" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122" "unprognostic (4.97e-4)" "unprognostic (5.53e-2)" "unprognostic (1.26e-1)" "unprognostic (5.58e-3)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.00e-2)" "unprognostic (1.88e-1)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-8)" "unprognostic (4.59e-3)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-2)" 3.2 1.7 4.0 2.1 2.5 0.6 2.1 8.2 4.4 14.4 3.5 0.0 3.0 3.7 12.8 8.3 0.7 4.7 8.3 2.7 2.9 1.9 3.2 1.8 2.0 1.3 1.5 2.0 4.7 1.0 0.1 1.2 0.6 3.3 5.6 4.9 9.6 2.9 4.3 3.1 2.4 3.7 3.8 2.8 1.2 2.4 6.2 2.5 0.6 3.3 3.4 1.4 4.8 4.6 0.9 0.4 5.2 0.2 0.1 0.5 0.1 0.0 5.6 1.7 12.2 0.2 0.0 0.2 0.7 7.8 1.3 1.4 0.2 0.4 1.9 0.0 0.3 1.4 1.0 1.0 0.7 0.2 2.1 0.1 0.0 0.6 0.1 1.3 0.3 0.6 0.5 0.2 1.3 0.4 2.5 0.2 1.2 0.4 4.1 0.6 0.0 0.4 0.2 7.9 0.4 0.5 0.6 35.9 0.8 1.5 0.0 0.0 0.1 0.1 0.0 0.2 1.4 0.0 0.1 0.0 1.4 4.5 0.4 0.2 10.0 0.4 3.2 1.2 0.8 2.2 2.2 0.2 0.9 0.1 0.0 0.0 0.9 0.2 0.0 0.0 0.4 0.4 0.3 5.2 0.1 0.1 0.4 0.5 0.1 4.0 2.5 8.2 4.4 2.9 1.9 1.5 2.0 3.3 2.5 0.0 0.0 0.5 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 27.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 40.3 1.0 0.0 12.9 0.5 0.3 0.8 0.5 0.1 0.0 0.0 0.1 GLMN "FAP48, FKBPAP, GLML, GVM, VMGLOM" ENSG00000174842 "Glomulin, FKBP associated protein" Q92990 1 92246402-92298987 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031446, HPA031448" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA031446: AB_2797222, HPA031448: AB_2673888" "unprognostic (4.20e-2)" "unprognostic (3.47e-2)" "prognostic favorable (1.71e-4)" "unprognostic (7.37e-2)" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (7.32e-2)" "unprognostic (2.07e-3)" "unprognostic (4.59e-2)" "unprognostic (9.88e-2)" "unprognostic (1.81e-2)" "prognostic unfavorable (5.89e-8)" "unprognostic (7.33e-2)" "unprognostic (5.21e-2)" "unprognostic (1.89e-1)" "unprognostic (3.58e-1)" 4.9 6.6 12.5 8.1 14.8 9.0 10.3 21.3 19.5 7.4 6.8 6.6 5.1 5.1 11.5 8.6 10.1 6.3 5.7 7.2 9.4 6.9 6.4 5.2 5.3 10.6 6.8 13.2 8.3 4.7 8.5 13.6 7.9 8.6 7.6 7.3 13.9 4.9 6.9 7.5 13.5 6.6 6.9 8.0 7.6 5.8 11.2 5.7 13.3 9.0 4.8 12.1 7.9 6.9 2.5 2.0 1.4 1.4 9.0 5.5 1.9 12.2 4.7 15.8 8.7 5.6 8.9 14.6 8.5 7.1 10.7 9.6 9.7 4.9 12.4 13.8 5.1 15.3 9.3 8.3 7.8 15.5 8.8 11.7 16.6 9.4 9.6 5.6 20.9 8.7 6.9 4.5 12.5 5.7 4.2 11.5 10.8 13.7 7.6 14.0 2.8 12.8 15.9 24.1 5.8 8.6 11.1 21.7 8.6 12.1 11.9 14.6 7.6 14.9 14.1 8.9 9.2 6.7 20.2 7.2 7.8 7.5 13.3 12.8 6.7 9.2 15.7 2.9 21.1 4.5 0.0 0.7 1.4 3.2 1.4 5.5 2.5 3.5 3.9 2.0 1.5 3.1 3.6 0.2 9.0 0.8 1.4 2.7 1.9 12.5 14.8 21.3 19.5 9.4 6.9 6.8 13.2 8.6 5.7 8.9 8.8 10.0 10.8 7.9 25.7 7.5 5.1 1.4 4.5 12.2 96.2 13.1 1.7 5.2 1.5 6.8 2.0 0.0 4.5 9.1 10.4 6.7 8.1 2.0 7.2 25.4 10.3 4.9 2.4 1.0 11.5 5.3 8.5 4.6 4.2 13.3 4.5 2.9 7.4 6.8 128.0 6.5 8.1 13.0 28.1 7.9 13.2 20.1 3.9 6.3 GLO1 GLOD1 ENSG00000124767 "Glyoxalase I" Q04760 6 38675925-38703141 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HMC-1: 249.9" "Low region specificity" "Detected in all" "CAB040541, CAB040542, HPA059791" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 1600000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB040541: , CAB040542: , HPA059791: AB_2684126" "unprognostic (4.33e-2)" "unprognostic (1.09e-1)" "unprognostic (4.37e-2)" "unprognostic (1.08e-2)" "unprognostic (3.96e-3)" "unprognostic (2.51e-1)" "prognostic unfavorable (5.21e-4)" "unprognostic (5.09e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (8.71e-2)" "unprognostic (1.20e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (6.21e-2)" 22.2 30.5 42.1 19.5 42.3 11.4 32.0 25.4 42.3 27.1 42.1 19.7 22.9 48.1 25.3 49.2 28.2 31.5 17.8 39.2 37.8 37.7 37.1 65.3 30.7 31.6 38.9 29.7 37.6 25.9 33.2 12.6 26.7 40.6 74.0 22.7 21.7 21.7 28.2 57.5 31.3 64.3 28.9 37.6 25.6 21.3 12.9 21.4 19.8 32.6 42.5 24.3 28.6 24.7 25.9 28.6 8.5 15.6 10.8 24.4 14.7 18.5 8.6 24.8 24.6 11.8 21.3 21.9 16.2 15.4 22.8 23.8 20.9 7.1 20.7 12.8 12.9 27.2 12.3 21.2 20.9 28.9 18.8 32.7 30.6 11.1 19.5 17.7 11.6 249.9 18.2 12.9 21.6 15.5 14.9 24.6 14.7 24.1 13.8 21.3 15.7 18.1 14.8 17.8 16.6 16.9 15.8 30.0 13.5 20.8 14.1 19.3 19.5 11.4 15.9 30.5 17.8 18.4 58.4 10.1 17.8 16.4 15.4 25.6 10.9 20.5 56.8 6.4 30.1 28.5 8.5 9.8 6.9 18.0 15.6 24.4 24.7 18.1 18.3 18.3 25.9 17.1 17.9 1.2 10.8 12.1 28.6 15.7 14.7 42.1 42.3 25.4 42.3 37.8 37.7 38.9 29.7 40.6 21.4 122.1 136.6 86.9 79.7 57.5 55.3 121.3 48.4 88.3 91.0 85.5 19.6 91.3 210.5 107.2 3.6 70.9 36.2 0.0 64.3 264.4 68.8 192.8 67.2 86.8 68.4 65.2 35.1 200.1 112.1 4.7 77.6 69.2 99.5 129.8 41.3 160.8 66.2 35.7 103.3 107.3 50.7 45.3 65.9 11.9 15.7 77.0 61.2 59.9 55.5 125.1 GLOD4 "C17orf25, CGI-150, HC71" ENSG00000167699 "Glyoxalase domain containing 4" Q9HC38 17 757097-783390 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021623, HPA023246, HPA023248" Enhanced Approved Cytosol NA NA 3800000 Cytosol "HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (1.99e-1)" "unprognostic (2.11e-1)" "unprognostic (2.88e-1)" "unprognostic (3.35e-1)" "unprognostic (3.13e-2)" "unprognostic (6.27e-2)" "unprognostic (4.86e-2)" "unprognostic (1.96e-2)" "prognostic favorable (2.18e-6)" "unprognostic (6.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" 21.7 29.5 31.3 16.7 35.6 10.2 19.1 26.0 36.2 17.8 37.1 21.5 16.5 43.0 22.3 23.3 23.6 24.9 20.9 19.7 26.1 38.5 41.6 40.4 16.8 22.8 23.0 34.8 22.9 32.3 13.9 19.4 28.1 28.6 21.1 26.6 21.9 29.2 20.9 21.4 27.5 42.5 24.7 18.2 23.8 43.4 17.9 18.2 22.7 26.0 19.2 24.0 25.2 17.5 27.5 17.9 17.8 24.6 22.8 36.7 26.0 40.2 36.5 42.2 23.3 18.5 18.5 25.8 32.3 19.9 26.2 20.0 29.6 28.9 48.1 35.3 14.5 24.5 29.2 36.7 20.5 27.5 35.2 31.4 23.2 20.3 38.6 18.4 23.8 30.7 12.9 28.6 26.3 23.2 16.8 24.2 40.1 37.8 31.4 27.6 24.9 40.9 18.4 30.8 40.0 12.5 41.0 17.1 22.0 25.9 27.6 19.2 32.3 25.6 18.6 41.4 27.7 23.1 25.4 31.4 25.1 20.1 35.0 40.4 17.7 32.1 29.6 29.8 26.9 26.1 9.2 19.8 17.8 27.7 24.2 30.2 27.0 33.6 33.3 17.5 27.5 28.7 31.3 2.7 22.8 24.6 17.9 36.7 26.0 31.3 35.6 26.0 36.2 26.1 38.5 23.0 34.8 28.6 18.2 53.6 32.8 19.4 36.9 42.6 36.9 27.0 50.9 66.9 60.3 96.0 27.5 93.5 150.9 67.8 30.1 37.6 47.9 0.0 50.6 68.7 47.3 35.9 38.3 57.2 70.9 12.7 27.7 25.8 28.8 47.7 35.9 49.1 64.1 76.7 46.8 36.9 50.1 59.6 43.9 135.3 35.1 45.3 41.9 16.9 26.8 47.9 57.8 47.3 57.4 35.3 GLRX "GRX, GRX1" ENSG00000173221 Glutaredoxin P35754 5 95751319-95823005 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 94.4;skeletal muscle: 141.6" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 613.5;Extravillous trophoblasts: 605.3;Proximal tubular cells: 870.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 85.0;RPTEC TERT1: 65.0;U-87 MG: 69.9" "Low region specificity" "Detected in all" "CAB008634, HPA046431, CAB069419" Approved Supported "Plasma membrane,Cytosol" NA NA 13000000 "Plasma membrane, Cytosol" "CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (1.94e-2)" "unprognostic (4.81e-2)" "unprognostic (2.01e-2)" "unprognostic (2.22e-2)" "unprognostic (8.62e-3)" "unprognostic (9.31e-3)" "unprognostic (1.99e-2)" "unprognostic (1.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (2.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.61e-1)" 17.7 20.7 6.2 15.0 6.6 30.6 10.5 15.5 15.5 5.4 22.6 3.1 4.0 40.2 2.9 4.6 3.1 3.7 9.5 25.2 12.1 7.8 45.9 46.9 23.1 21.5 7.8 5.9 3.5 2.6 9.5 6.4 63.9 7.6 5.7 8.8 2.4 17.9 5.5 141.6 7.3 42.5 4.5 7.3 15.2 8.2 2.2 4.0 14.4 6.3 6.4 14.3 11.6 5.8 16.0 52.2 94.4 81.6 11.2 48.9 71.1 3.3 15.0 1.1 2.4 32.4 46.6 0.2 50.1 85.0 5.4 9.1 3.7 1.5 13.0 7.1 15.0 12.2 1.3 1.9 23.8 15.1 11.3 3.7 9.4 9.9 34.4 61.7 10.0 27.9 29.1 2.9 34.3 3.3 12.0 10.3 26.7 1.2 7.8 34.0 1.1 17.2 17.7 3.3 0.4 17.1 27.9 10.2 16.1 65.0 2.4 3.4 1.8 13.1 6.5 5.7 3.1 1.8 9.9 11.9 14.2 16.0 11.3 2.1 5.6 28.7 10.4 69.9 25.1 3.0 3.8 81.6 94.4 26.2 51.0 35.7 16.0 24.1 19.5 52.2 10.7 24.1 22.1 85.7 11.2 40.5 18.0 48.9 71.1 6.2 6.6 15.5 15.5 12.1 7.8 7.8 5.9 7.6 4.0 20.8 27.9 60.2 35.5 15.2 1.5 153.4 79.0 53.5 27.3 89.0 0.0 19.8 613.5 47.8 0.2 38.0 373.9 23.3 81.2 605.3 54.7 75.6 30.1 177.3 241.8 0.0 30.4 44.2 275.4 0.9 17.5 243.9 65.8 117.2 64.0 5.5 118.2 157.8 13.1 870.9 3.3 19.4 70.2 0.5 1.1 18.1 238.6 103.6 64.3 137.4 GLT1D1 FLJ31978 ENSG00000151948 "Glycosyltransferase 1 domain containing 1" Q96MS3 12 128853427-128984968 "Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.1;bone marrow: 25.4;liver: 24.7" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 11.5;Hepatocytes: 7.9;Kupffer cells: 11.4;Late spermatids: 34.0;Muller glia cells: 9.8" "Group enriched" "Detected in some" 6 "liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 23.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 23.1" "Group enriched" "Detected in some" 6 "MOLT-4: 12.4;NTERA-2: 18.0;SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039051, HPA039052" Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA039051: AB_10673299, HPA039052: AB_10672839" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (3.60e-2)" "unprognostic (3.47e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-1)" "unprognostic (4.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (2.20e-1)" "unprognostic (1.55e-3)" "unprognostic (2.41e-1)" 3.0 0.6 7.0 7.0 12.4 25.4 0.6 7.1 15.5 1.8 0.6 1.2 0.2 0.5 4.1 1.4 0.9 2.1 2.1 1.2 6.3 10.5 1.2 24.7 2.2 4.5 5.8 6.4 0.6 1.2 0.4 1.0 1.0 7.6 1.3 0.7 2.6 0.4 1.9 8.2 1.3 0.6 3.6 1.6 9.2 0.6 14.7 1.3 0.1 2.0 0.0 0.8 1.7 0.6 0.0 1.4 23.1 3.8 0.0 0.3 0.8 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.3 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.1 0.0 1.1 1.4 0.0 0.8 7.0 12.4 7.1 15.5 6.3 10.5 5.8 6.4 7.6 1.3 0.0 0.0 0.5 0.0 0.8 0.4 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.5 0.0 0.0 1.8 11.4 34.0 0.3 1.7 1.7 0.0 0.0 9.8 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.6 0.2 0.3 0.1 0.0 0.0 0.0 GLTP ENSG00000139433 "Glycolipid transfer protein" Q9NZD2 12 109850943-109880488 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 82.0;lymphoid tissue: 78.0;skin 1: 84.3" "Cell type enhanced" "Detected in many" 8 "Suprabasal keratinocytes: 418.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056461, HPA065503" Approved Supported Cytosol NA NA 280000 Cytosol "HPA056461: AB_2683138, HPA065503: " "unprognostic (1.18e-1)" "prognostic favorable (2.01e-5)" "unprognostic (7.46e-2)" "unprognostic (6.22e-3)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (6.63e-2)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (2.47e-1)" "unprognostic (3.03e-1)" "unprognostic (4.83e-2)" "unprognostic (4.46e-2)" "unprognostic (2.20e-1)" "prognostic favorable (4.17e-6)" "unprognostic (3.28e-2)" 7.0 5.8 11.4 6.1 16.4 6.6 10.5 4.7 19.3 21.8 13.2 31.3 6.6 5.4 5.4 13.4 82.0 4.9 5.4 6.4 15.9 9.7 13.7 4.5 9.2 7.0 22.4 8.9 5.9 7.7 5.7 3.4 7.9 14.8 8.0 11.8 4.0 21.2 8.0 6.1 84.3 8.2 7.1 48.7 7.4 7.6 4.0 24.7 6.2 8.9 60.6 78.0 10.8 38.5 11.8 23.2 16.7 32.3 21.2 26.7 17.2 14.2 10.2 5.9 6.3 14.1 16.3 4.3 17.7 22.0 13.7 11.6 4.0 5.5 12.6 9.5 21.7 6.7 17.6 9.1 20.8 19.6 12.8 8.1 8.2 6.2 6.1 12.4 8.8 9.7 12.0 26.2 24.5 17.4 20.8 23.0 13.1 3.7 8.7 20.1 19.7 11.9 7.2 10.6 11.8 13.8 10.7 14.0 13.2 7.7 42.9 7.5 7.5 11.1 29.0 9.4 5.7 13.5 3.1 31.4 15.7 8.5 23.1 13.3 11.5 9.6 8.6 31.7 9.2 9.7 16.7 32.3 16.5 26.7 30.8 16.2 11.8 16.1 23.3 23.2 11.4 10.5 18.8 15.8 21.2 24.8 3.7 17.6 17.2 11.4 16.4 4.7 19.3 15.9 9.7 22.4 8.9 14.8 24.7 23.8 58.2 25.4 91.0 129.1 11.8 13.3 20.4 29.4 52.4 41.8 13.7 64.4 169.1 34.4 12.2 35.0 79.9 0.0 49.6 16.3 33.4 71.1 19.7 11.9 31.9 12.7 31.2 28.3 40.0 9.7 21.3 47.5 57.3 45.9 41.0 15.1 42.3 35.1 17.0 25.6 11.6 38.8 41.8 17.0 22.0 418.8 176.1 43.3 42.2 95.9 GLUL GLNS ENSG00000135821 "Glutamate-ammonia ligase" P15104 1 182381704-182392206 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Angiogenesis "Ligase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Late spermatids: 6809.8;Muller glia cells: 5699.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 92.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 92.2" "Cell line enhanced" "Detected in many" "ASC diff: 141.5;ASC TERT1: 100.1;HSkMC: 86.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007316, HPA007571, CAB008636" Approved Supported "Plasma membrane,Mitochondria,Cytosol" NA NA 28000 "Mitochondria, Cytosol" "Plasma membrane" "CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980" "prognostic favorable (4.81e-4)" "unprognostic (1.52e-3)" "unprognostic (3.89e-1)" "unprognostic (3.32e-1)" "unprognostic (1.25e-1)" "unprognostic (9.52e-2)" "unprognostic (7.58e-2)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (8.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" "unprognostic (1.38e-2)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" "unprognostic (5.55e-2)" "unprognostic (4.53e-3)" 173.3 19.2 83.7 37.2 91.0 47.6 63.1 48.5 80.7 41.9 20.4 49.9 9.4 6.2 20.5 29.7 54.0 31.6 26.2 23.5 74.0 48.7 15.6 64.9 39.5 36.9 71.0 48.8 66.2 49.0 7.4 8.9 41.8 70.6 17.4 23.3 39.3 30.4 25.5 159.8 27.9 16.4 30.5 51.3 36.1 71.4 24.0 55.2 8.6 63.9 15.5 24.2 34.7 32.2 2.5 11.0 92.2 21.1 3.4 6.3 18.6 3.0 1.2 14.0 0.0 141.5 100.1 10.3 5.1 16.6 3.1 2.8 7.4 3.1 2.6 5.6 9.9 2.8 7.0 6.1 36.4 2.6 7.0 17.0 34.3 5.8 14.3 7.5 15.1 27.4 86.5 43.7 3.9 46.4 4.7 6.2 8.4 28.8 1.5 11.0 1.7 23.5 14.5 10.4 4.2 6.5 8.5 3.7 4.4 5.4 13.3 9.6 6.3 1.4 18.7 2.0 11.7 18.2 19.1 4.6 0.1 0.2 0.0 1.1 0.5 0.3 0.0 2.7 8.6 0.5 43.6 21.1 54.9 6.3 20.5 2.6 1.6 4.5 5.2 11.0 2.5 2.3 3.9 92.2 3.4 17.1 6.1 1.7 18.6 83.7 91.0 48.5 80.7 74.0 48.7 71.0 48.8 70.6 55.2 116.1 193.4 39.3 480.1 119.7 83.9 198.1 163.1 242.2 133.1 78.5 49.1 126.6 63.0 92.2 1437.2 175.0 45.7 210.2 99.7 54.7 230.2 354.1 758.5 179.4 734.4 41.3 312.5 129.5 692.2 6809.8 451.3 662.6 129.9 48.7 226.1 5699.1 116.5 83.4 352.5 40.4 128.3 90.5 209.3 38.8 52.4 112.0 196.8 96.9 130.8 1061.5 GLYATL1 "FLJ34646, MGC15397" ENSG00000166840 "Glycine-N-acyltransferase like 1" Q969I3 11 58905398-59043527 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 113.8" "Cell type enhanced" "Detected in some" 31 "Distal tubular cells: 91.2;Hepatocytes: 198.3;Proximal tubular cells: 523.1" "Group enriched" "Detected in some" 8 "liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "CACO-2: 3.9;Daudi: 9.7;RPTEC TERT1: 3.3;U-2197: 2.5" HPA039501 Supported Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (9.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.90e-5)" "unprognostic (3.93e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-1)" "prognostic favorable (3.69e-4)" "unprognostic (3.62e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.03e-5)" "unprognostic (1.50e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.1 27.7 113.8 0.1 0.0 0.2 0.0 0.2 0.2 0.9 0.1 0.0 0.5 2.1 0.0 0.5 1.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.0 0.1 1.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.4 1.3 0.0 0.5 0.2 1.1 0.9 3.9 0.0 9.7 0.0 0.7 0.8 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.6 2.2 0.0 0.2 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 3.3 0.0 0.2 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 1.2 0.1 2.5 1.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.3 17.8 0.0 0.0 14.0 0.0 0.0 91.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 198.3 0.0 0.0 0.0 1.8 6.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 523.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 GLYATL1B GLYATL1P3 ENSG00000255151 "Glycine-N-acyltransferase like 1B" 11 59086307-59094786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 4.9;breast: 12.5;lymphoid tissue: 4.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Group enriched" "Detected in some" 17 "memory B-cell: 1.9;naive B-cell: 4.9" "Lineage enriched" "Detected in single" 24 "B-cells: 4.9" "Cell line enhanced" "Detected in some" "Daudi: 4.9;JURKAT: 2.0;Karpas-707: 2.2;T-47d: 3.2;U-2197: 2.5;U-266/70: 5.0" HPA039501 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (5.20e-2)" "unprognostic (2.62e-1)" "unprognostic (2.11e-1)" "unprognostic (3.21e-4)" "unprognostic (3.45e-1)" 0.0 0.0 1.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.1 2.2 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.5 2.5 0.2 5.0 1.6 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLYCTK "HBEBP2, HBEBP4" ENSG00000168237 "Glycerate kinase" Q8IVS8 3 52287089-52293476 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 108.4" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 46.7;Hepatocytes: 151.6;Proximal tubular cells: 59.6" "Cancer enriched" "Detected in all" 6 "liver cancer: 52.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 19.0;Hep G2: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006913 Approved Approved "Golgi apparatus,Cytosol,Rods & Rings" NA NA Cytosol "Golgi apparatus, Rods & Rings" "HPA006913: AB_1078993" "unprognostic (1.51e-2)" "unprognostic (2.55e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.64e-4)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (7.73e-3)" "unprognostic (1.82e-1)" "unprognostic (3.36e-3)" "unprognostic (2.15e-1)" "unprognostic (3.30e-2)" "unprognostic (3.42e-1)" "unprognostic (3.77e-1)" "unprognostic (3.82e-2)" "unprognostic (9.00e-3)" 6.4 4.9 1.9 8.4 5.0 5.2 4.8 2.7 6.2 2.3 7.9 7.1 4.2 23.8 4.3 4.8 2.8 2.5 7.2 2.7 1.9 2.2 10.7 108.4 3.1 6.5 2.5 4.9 2.3 3.6 1.9 2.5 3.1 3.9 2.8 3.5 4.7 3.2 3.0 7.0 1.9 17.8 1.9 1.8 5.5 6.0 2.7 1.8 3.3 3.1 2.4 5.9 2.7 2.2 8.3 9.1 10.9 9.5 5.7 11.8 6.3 2.3 5.6 3.0 1.1 16.1 2.2 1.8 2.5 2.6 4.8 3.5 19.0 1.9 5.9 1.6 2.2 3.6 1.5 1.7 6.2 0.9 1.6 2.0 8.3 6.7 25.2 1.6 2.7 5.0 2.2 3.1 7.0 2.7 1.6 9.0 4.8 2.3 4.3 3.6 1.7 4.6 2.2 1.6 12.2 4.6 1.6 2.7 8.9 4.8 3.2 2.2 2.2 2.4 1.3 2.5 0.9 3.2 1.3 3.9 3.7 4.4 2.4 4.8 4.6 3.1 3.9 2.6 4.5 2.8 3.0 9.5 10.9 11.8 5.1 6.1 8.3 9.0 10.3 9.1 5.7 6.8 10.1 7.8 5.7 6.1 5.6 11.7 6.3 1.9 5.0 2.7 6.2 1.9 2.2 2.5 4.9 3.9 1.8 6.0 2.7 9.3 2.6 0.3 1.4 1.2 15.3 1.4 2.3 8.7 0.0 6.7 16.6 4.3 0.1 4.4 29.7 46.7 5.4 4.3 2.1 2.5 1.1 151.6 11.4 0.0 22.4 12.9 16.5 0.0 1.1 7.2 3.3 6.4 9.1 1.0 3.5 34.5 0.0 59.6 1.5 0.0 0.2 0.2 7.7 1.1 9.3 10.2 11.5 3.1 GLYR1 "BM045, HIBDL, N-PAC, NP60" ENSG00000140632 "Glyoxylate reductase 1 homolog" Q49A26 16 4803203-4847342 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017022, HPA048226, HPA050136" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028" "unprognostic (4.72e-1)" "unprognostic (1.65e-1)" "unprognostic (3.19e-2)" "unprognostic (8.20e-2)" "unprognostic (2.77e-1)" "unprognostic (1.97e-2)" "unprognostic (3.86e-2)" "unprognostic (3.18e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (1.41e-1)" "unprognostic (8.47e-3)" "prognostic favorable (8.74e-7)" "unprognostic (3.34e-1)" "unprognostic (4.38e-2)" "unprognostic (1.77e-1)" "unprognostic (2.86e-1)" 24.1 33.2 39.1 29.4 37.4 27.5 22.5 26.3 44.8 24.8 32.6 31.0 32.8 30.7 30.0 20.6 32.1 33.9 26.1 28.3 29.8 24.8 39.0 30.5 24.5 27.6 27.0 33.1 22.2 27.4 53.4 34.7 24.1 37.1 30.4 32.3 28.5 29.9 29.4 41.6 24.3 29.9 30.1 27.3 30.7 33.9 17.4 26.0 27.6 29.6 17.2 30.0 35.3 22.7 7.6 8.3 22.2 14.5 5.2 7.5 5.5 13.1 14.7 24.3 15.1 21.4 17.2 23.3 24.9 18.6 19.1 16.4 20.7 23.5 21.5 23.8 22.9 15.7 14.6 30.4 20.9 17.3 34.9 18.3 22.1 17.7 14.5 12.1 35.7 41.2 16.3 16.6 18.0 13.3 18.4 24.2 20.3 37.0 18.6 20.7 21.4 29.0 19.8 28.8 19.8 11.1 37.5 19.1 26.4 23.5 19.8 29.7 15.1 27.0 25.3 11.5 27.9 28.4 37.8 26.8 13.1 14.7 59.1 15.5 15.5 21.6 45.0 9.4 17.8 26.8 6.3 10.9 5.7 7.5 9.8 6.5 5.1 4.9 7.1 7.3 7.6 5.2 4.6 22.2 5.2 14.5 8.3 4.9 5.5 39.1 37.4 26.3 44.8 29.8 24.8 27.0 33.1 37.1 26.0 35.7 45.5 25.1 16.3 16.9 31.8 36.2 30.6 93.7 46.6 29.6 27.5 23.2 56.3 20.8 7.9 26.3 37.1 0.0 16.8 26.4 21.1 25.4 30.1 47.3 28.0 42.9 44.5 25.8 38.6 8.0 22.5 29.5 20.3 44.1 38.4 22.8 24.2 37.4 15.2 42.9 40.9 19.4 16.9 20.9 24.5 21.1 29.9 17.5 33.2 17.0 GM2A SAP-3 ENSG00000196743 "GM2 ganglioside activator" P17900 5 151212150-151270440 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease mutation, Gangliosidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 108.7" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 163.9;Hofbauer cells: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 15.9;dendritic cells: 19.0;monocytes: 19.4" "Cell line enhanced" "Detected in many" "BEWO: 44.5;HBEC3-KT: 61.5;hTCEpi: 61.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008063 Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 23000000 "Vesicles, Cytosol" "HPA008063: AB_1849842" "unprognostic (4.33e-2)" "unprognostic (8.97e-3)" "unprognostic (2.27e-1)" "unprognostic (3.01e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.77e-5)" "unprognostic (1.22e-1)" "unprognostic (1.72e-2)" "unprognostic (1.31e-2)" "unprognostic (1.50e-2)" "unprognostic (5.33e-3)" "unprognostic (9.81e-2)" "unprognostic (4.24e-2)" "unprognostic (4.42e-2)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" 55.8 16.1 17.8 15.5 18.8 9.6 15.2 8.1 15.2 20.5 10.3 31.7 6.4 8.4 9.5 17.3 39.5 8.8 12.6 13.8 18.0 12.6 7.5 13.2 24.8 30.2 22.4 13.0 12.2 9.3 11.7 5.6 108.7 18.9 11.9 14.5 14.1 13.3 10.4 3.9 42.8 11.2 10.9 35.9 28.5 8.2 8.9 15.3 21.9 7.1 25.9 39.7 21.0 32.0 15.9 19.0 4.2 19.4 1.9 3.3 8.0 4.6 3.0 3.2 15.3 21.3 10.6 44.5 7.3 15.8 4.0 5.5 6.3 5.4 15.0 7.7 5.6 11.0 12.7 3.5 61.5 5.8 8.4 2.2 2.4 3.8 7.7 5.2 3.9 25.2 14.2 61.3 5.2 3.5 5.6 5.8 19.1 2.3 6.5 6.3 1.9 8.2 3.7 2.2 2.3 6.9 3.7 1.5 9.4 3.9 9.1 0.8 2.9 6.0 28.4 12.0 11.7 6.5 4.6 5.1 10.0 3.9 8.2 2.2 16.2 19.3 41.1 11.4 6.2 4.1 3.5 19.4 1.1 1.9 6.5 1.4 14.9 2.3 2.0 19.0 15.9 3.3 2.5 4.2 1.9 1.4 13.7 2.4 8.0 17.8 18.8 8.1 13.9 18.0 12.6 22.4 13.0 18.9 15.3 14.9 23.1 14.7 13.3 13.3 4.5 26.2 0.0 13.4 12.5 17.4 2.0 45.1 1.7 5.8 0.4 6.3 4.6 0.0 6.9 163.9 8.0 7.4 66.0 16.3 98.1 6.4 3.5 7.4 38.4 1.1 7.5 34.4 8.5 55.1 5.0 8.0 5.4 3.5 13.1 4.5 3.1 0.0 5.7 1.4 4.9 20.8 43.8 3.8 5.6 32.5 GMEB2 "KIAA1269, P79PIF, PIF79" ENSG00000101216 "Glucocorticoid modulatory element binding protein 2" Q9UKD1 20 63587602-63627041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009706, HPA067455" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA009706: AB_1078996, HPA067455: AB_2685845" "unprognostic (4.55e-1)" "unprognostic (5.65e-2)" "unprognostic (3.16e-1)" "unprognostic (1.38e-3)" "unprognostic (1.36e-1)" "unprognostic (4.85e-2)" "unprognostic (2.77e-3)" "unprognostic (2.04e-1)" "unprognostic (5.47e-2)" "unprognostic (5.43e-2)" "unprognostic (2.01e-2)" "unprognostic (2.04e-2)" "unprognostic (6.86e-3)" "unprognostic (2.82e-2)" "unprognostic (3.84e-1)" "unprognostic (3.46e-1)" "unprognostic (2.29e-1)" 9.3 8.2 7.4 9.0 9.8 29.8 8.4 13.5 11.5 8.7 10.5 7.7 6.9 9.6 10.6 6.1 10.0 11.0 9.5 7.4 8.1 6.2 7.7 9.3 8.7 11.5 6.0 6.5 11.5 17.6 9.6 9.5 14.5 7.2 9.9 5.1 9.8 16.0 7.5 10.1 10.0 11.0 10.3 7.1 12.1 8.8 18.8 5.7 24.7 18.0 9.5 10.4 9.2 13.8 3.0 2.6 4.4 5.6 1.9 4.5 2.2 10.8 6.6 8.1 7.0 4.0 3.7 10.8 7.5 4.8 12.1 6.4 20.5 8.1 8.6 7.9 6.5 8.8 15.5 6.3 11.1 5.4 4.6 7.1 6.6 9.7 9.8 5.3 6.3 11.1 5.2 10.6 7.8 9.8 5.1 5.3 11.0 9.8 6.3 4.2 11.6 15.4 13.9 5.8 12.9 10.7 16.8 8.3 7.9 5.0 9.6 12.2 10.0 13.6 12.0 7.8 3.9 14.7 10.4 6.6 13.4 7.3 7.9 8.3 12.0 9.8 13.7 8.0 5.9 8.6 0.0 1.9 3.2 4.5 2.6 4.3 2.1 4.0 3.9 2.1 3.0 4.5 3.9 4.4 1.9 5.6 2.6 2.7 2.2 7.4 9.8 13.5 11.5 8.1 6.2 6.0 6.5 7.2 5.7 3.0 6.4 2.2 10.1 5.4 5.1 2.8 7.6 1.4 4.5 3.5 0.0 3.7 1.7 3.9 18.0 4.7 5.1 0.0 4.6 5.3 3.0 11.1 2.3 5.7 3.8 7.9 9.2 4.3 2.8 5.1 3.7 2.6 1.7 1.0 7.9 1.7 5.0 7.0 5.3 3.0 4.7 6.5 3.7 14.9 9.7 4.6 9.6 4.3 5.3 10.3 GMFB GMF ENSG00000197045 "Glia maturation factor beta" P60983 14 54474484-54489196 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Approved Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1000000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (7.93e-2)" "unprognostic (7.69e-3)" "unprognostic (4.81e-3)" "unprognostic (2.99e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.48e-2)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "prognostic favorable (9.48e-5)" "unprognostic (1.80e-1)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (9.09e-2)" 14.2 13.2 37.9 12.9 26.7 14.2 15.3 25.1 41.6 11.8 19.8 23.9 6.1 19.1 11.6 8.5 9.3 8.4 9.7 9.6 36.7 30.1 19.9 14.7 13.8 13.3 36.9 28.3 9.8 7.3 10.1 13.6 17.9 25.6 9.0 20.7 6.6 7.0 8.0 4.1 7.8 17.5 10.5 54.4 10.1 10.7 6.2 21.7 6.4 12.8 6.1 13.5 10.0 7.4 9.1 12.8 16.4 14.5 9.0 8.8 6.8 30.9 12.6 25.1 18.4 27.2 34.0 18.8 31.8 23.4 23.1 28.9 14.4 27.5 28.5 15.0 31.2 13.9 11.5 25.3 22.0 36.6 10.3 8.7 14.3 14.1 13.3 23.2 19.9 12.5 25.7 20.6 20.0 19.8 24.1 20.8 13.2 10.4 10.1 36.5 15.4 12.1 7.7 16.2 17.6 13.4 12.3 29.5 8.2 29.5 29.5 14.9 23.2 22.1 18.9 24.1 21.7 20.8 15.8 16.4 33.6 25.5 17.0 19.7 3.6 6.3 17.8 28.3 12.3 21.2 8.7 11.0 9.2 6.1 13.5 8.5 7.6 7.2 6.0 12.8 9.1 7.8 8.2 16.4 9.0 14.5 5.2 8.8 6.8 37.9 26.7 25.1 33.5 36.7 30.1 36.9 28.3 25.6 21.7 23.8 14.4 20.4 43.8 53.1 17.7 15.0 22.9 8.1 19.4 24.4 3.9 33.3 18.3 34.4 20.5 17.5 29.2 0.0 20.1 73.0 27.8 40.5 21.8 23.6 41.6 20.6 28.7 16.0 30.4 3.9 18.7 44.4 43.9 37.9 30.3 17.7 30.2 31.6 14.9 40.9 14.6 12.9 26.8 12.6 9.8 38.1 48.7 22.4 32.6 39.2 GMFG ENSG00000130755 "Glia maturation factor gamma" O60234 19 39328353-39342372 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5" "Cell type enhanced" "Detected in many" 8 "B-cells: 303.1;Hofbauer cells: 397.1;Ito cells: 301.4;Kupffer cells: 575.9;Macrophages: 461.8;T-cells: 456.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 77.0;JURKAT: 55.8;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Uncertain Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1500000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (1.22e-2)" "prognostic favorable (7.35e-4)" "unprognostic (2.37e-2)" "unprognostic (1.21e-3)" "unprognostic (9.93e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-1)" "unprognostic (4.84e-2)" "unprognostic (1.00e-1)" "unprognostic (2.09e-1)" "unprognostic (3.09e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.11e-6)" "unprognostic (3.01e-1)" "unprognostic (8.76e-3)" "unprognostic (1.06e-1)" "unprognostic (5.27e-3)" 22.6 6.1 7.3 29.6 7.4 80.9 16.8 2.2 4.8 6.0 8.8 4.0 1.7 5.3 4.4 9.4 6.4 7.3 8.7 7.5 6.0 4.9 9.4 9.7 28.5 42.2 8.6 2.3 4.7 3.6 1.1 3.1 18.0 5.8 6.1 7.9 4.9 8.1 2.3 5.4 4.2 17.8 6.8 8.2 86.0 5.9 2.9 5.6 109.5 9.8 7.0 37.1 11.1 7.5 39.1 57.2 276.5 79.4 41.6 88.0 106.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.8 33.5 0.3 0.0 0.0 0.2 0.0 0.1 0.1 11.3 0.0 36.4 0.0 0.5 0.6 39.0 77.0 0.1 0.0 0.0 0.1 0.1 2.0 55.8 1.3 59.8 0.3 0.0 35.5 43.6 0.0 0.0 0.0 49.0 0.4 21.9 0.0 5.2 0.1 0.0 0.1 0.2 0.2 0.0 0.1 76.8 20.0 0.0 0.4 0.1 0.1 3.4 11.6 38.3 0.2 52.7 0.3 185.2 79.4 178.1 37.7 72.3 40.0 39.1 56.7 46.6 57.2 35.0 55.9 46.4 276.5 41.6 78.9 22.2 88.0 106.7 7.3 7.4 2.2 4.8 6.0 4.9 8.6 2.3 5.8 5.6 26.8 152.0 303.1 2.8 16.6 0.0 3.1 10.2 16.0 31.8 0.0 0.0 3.0 0.0 0.8 9.5 165.1 0.3 23.3 0.6 3.4 16.0 1.1 229.0 5.5 397.1 0.0 0.0 301.4 575.9 18.8 1.7 461.8 70.9 127.2 0.3 0.3 0.3 0.0 0.4 3.9 0.0 45.3 14.6 8.1 3.0 12.9 4.6 456.6 0.3 1.4 GMIP ARHGAP46 ENSG00000089639 "GEM interacting protein" Q9P107 19 19629476-19643667 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 20.7;Kupffer cells: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042484, HPA045481" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042484: AB_2678018, HPA045481: AB_2679343" "unprognostic (7.54e-2)" "unprognostic (5.35e-3)" "unprognostic (3.10e-3)" "unprognostic (4.54e-3)" "unprognostic (1.44e-1)" "unprognostic (1.24e-3)" "unprognostic (1.23e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.85e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.97e-5)" "prognostic favorable (3.03e-4)" "unprognostic (4.92e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.15e-4)" 6.1 2.8 3.5 20.3 4.9 31.0 4.0 0.9 4.1 2.9 6.9 4.3 2.7 7.0 2.7 3.2 6.2 4.4 7.9 3.3 4.3 3.4 4.2 3.9 11.7 28.0 4.2 2.5 2.4 4.6 10.6 3.0 3.9 3.4 4.1 4.6 2.7 6.0 4.5 1.5 4.9 15.3 2.9 4.9 40.0 11.1 2.2 3.1 26.8 6.2 2.7 23.2 6.1 4.5 6.6 6.7 32.7 13.9 4.2 6.4 4.6 4.4 2.1 2.8 3.0 3.1 1.6 11.2 2.8 2.5 1.7 1.6 1.7 6.1 11.0 5.8 2.0 2.2 5.4 1.8 3.1 1.1 3.8 2.8 3.5 3.3 1.8 0.9 9.8 43.8 2.0 2.1 1.8 1.0 2.0 3.8 9.9 2.3 4.0 1.8 6.6 6.1 16.2 1.6 5.8 3.8 10.6 1.2 6.3 3.2 10.7 2.4 7.2 3.9 4.1 1.6 2.2 3.8 14.1 7.0 3.2 1.8 3.6 2.1 2.0 0.8 9.1 2.0 12.9 2.1 2.9 8.3 21.5 6.4 10.6 5.9 5.9 4.0 5.7 6.7 6.6 4.5 4.6 32.7 4.2 13.9 6.1 4.5 4.6 3.5 4.9 0.9 4.1 4.3 3.4 4.2 2.5 3.4 3.1 0.0 15.1 15.6 1.1 1.0 0.0 0.6 2.5 1.4 2.3 0.0 0.0 0.5 0.0 3.8 0.1 1.4 13.3 0.0 4.2 4.6 0.9 1.6 6.9 0.9 20.7 0.0 0.0 2.5 34.3 0.0 0.6 16.5 1.7 17.2 6.3 0.2 9.4 12.2 0.7 0.6 0.0 0.0 0.9 0.1 1.5 1.0 0.7 15.9 5.8 2.6 GMPS GATD7 ENSG00000163655 "Guanine monophosphate synthase" P49915 3 155870536-155944026 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" Ligase Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 191.9;Late spermatids: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046630 Approved Cytosol No No Cytosol "HPA046630: AB_2679727" "unprognostic (3.89e-2)" "unprognostic (2.02e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (5.54e-5)" "unprognostic (2.30e-1)" "unprognostic (1.35e-2)" "prognostic unfavorable (8.73e-7)" "unprognostic (1.71e-2)" "unprognostic (3.52e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.58e-2)" "unprognostic (2.79e-2)" "unprognostic (2.89e-2)" "unprognostic (3.78e-1)" "unprognostic (3.55e-3)" "unprognostic (8.79e-2)" 15.9 18.3 10.4 19.7 14.0 24.6 22.4 22.1 24.9 16.1 13.9 9.8 15.3 10.3 17.5 15.4 19.5 14.0 10.8 15.3 9.2 7.7 11.0 14.7 15.8 19.5 9.3 12.1 15.7 23.5 19.1 14.1 13.5 14.8 13.0 15.3 9.0 21.6 18.6 16.6 21.0 12.6 16.1 8.9 14.6 15.4 60.9 10.5 28.3 13.6 12.5 18.4 15.9 18.5 11.1 17.2 10.9 18.1 19.0 20.7 10.8 56.8 22.5 30.6 25.0 12.5 19.8 29.5 24.3 22.5 32.1 32.5 41.0 38.4 41.1 29.0 18.7 24.6 28.0 26.0 25.5 44.2 23.8 20.0 43.8 16.5 22.2 14.3 44.5 17.1 14.6 15.7 24.8 38.0 17.1 19.6 22.4 30.8 15.8 23.8 38.2 36.1 23.6 29.3 31.3 16.7 35.5 36.3 49.6 16.5 25.1 18.3 17.0 27.0 38.7 24.2 22.0 40.5 29.4 13.8 21.3 17.3 30.0 48.9 22.1 13.6 70.3 21.4 33.2 18.9 10.9 10.4 7.2 17.3 13.1 20.7 11.1 16.8 15.7 17.2 8.8 16.8 15.8 1.4 19.0 18.1 9.5 17.6 10.8 10.4 14.0 22.1 24.9 9.2 7.7 9.3 12.1 14.8 10.5 17.9 19.8 20.4 39.9 35.4 21.9 14.1 15.3 13.4 22.7 7.0 2.0 33.4 21.6 24.9 191.9 28.5 8.4 23.3 25.9 43.0 27.2 23.6 28.8 11.1 26.5 20.6 6.9 14.7 18.3 149.6 21.3 24.7 21.9 29.7 17.8 17.3 20.4 10.5 23.3 22.3 7.7 19.4 31.6 80.1 54.5 33.4 25.7 24.9 24.7 34.5 GNA12 gep ENSG00000146535 "G protein subunit alpha 12" Q03113 7 2728112-2844324 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 50.1;Syncytiotrophoblasts: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010046 Approved Supported Cytosol NA NA Cytosol "CAB010046: AB_2263416" "unprognostic (1.21e-1)" "unprognostic (1.19e-2)" "unprognostic (9.28e-2)" "unprognostic (1.54e-1)" "unprognostic (2.14e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (1.20e-6)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.36e-2)" "unprognostic (4.45e-3)" "unprognostic (7.90e-2)" "prognostic unfavorable (4.71e-5)" "unprognostic (1.22e-2)" "unprognostic (2.52e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.27e-4)" 19.4 15.0 26.5 12.3 22.8 10.5 11.9 12.9 22.5 13.7 11.9 19.4 5.2 5.9 13.8 5.9 9.2 12.1 11.0 17.6 22.9 19.3 7.6 7.3 10.4 14.2 25.2 11.4 21.9 13.4 9.5 13.8 27.2 22.1 11.4 7.4 7.4 8.8 14.2 5.4 4.4 8.5 16.8 24.4 11.7 9.1 11.5 18.2 4.6 7.7 3.9 11.4 13.3 12.8 4.7 4.3 2.5 3.1 0.2 1.8 0.9 15.1 8.4 8.7 13.0 14.0 11.2 24.1 12.8 15.0 14.0 16.1 8.0 10.8 3.2 8.8 15.1 29.4 6.9 5.9 13.2 9.5 38.7 6.0 6.6 4.5 8.4 16.4 1.0 5.9 10.8 7.2 16.3 11.1 14.4 14.8 4.7 7.3 10.2 12.5 7.2 1.7 6.0 12.2 3.9 14.6 11.5 10.0 6.5 5.1 10.4 6.9 10.0 7.2 10.9 5.4 13.0 6.0 9.1 17.4 15.3 18.3 14.9 21.0 7.3 8.5 2.9 16.4 9.8 14.9 2.5 1.3 0.2 0.6 3.1 0.9 2.7 1.5 0.8 1.1 4.7 1.4 0.2 0.3 0.2 0.8 4.3 1.8 0.9 26.5 22.8 12.9 19.7 22.9 19.3 25.2 11.4 22.1 18.2 6.0 13.2 10.9 3.2 6.3 5.3 11.6 7.6 5.3 6.8 1.8 11.8 50.1 3.3 6.5 11.9 12.1 4.0 23.3 8.8 13.6 14.6 7.1 0.0 12.7 23.5 7.9 7.5 21.5 21.9 9.8 15.8 10.8 20.3 23.4 5.3 11.2 10.7 4.2 17.7 7.7 10.8 0.0 15.5 8.6 7.8 3.1 144.9 5.3 4.7 2.4 GNA13 "G13, MGC46138" ENSG00000120063 "G protein subunit alpha 13" Q14344 17 65010715-65056839 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010087 Approved Supported Cytosol NA NA 4000000 Cytosol "HPA010087: AB_10601478" "unprognostic (2.55e-1)" "unprognostic (2.27e-1)" "unprognostic (1.33e-3)" "unprognostic (1.23e-3)" "unprognostic (8.21e-2)" "unprognostic (7.05e-2)" "unprognostic (4.22e-3)" "unprognostic (1.09e-1)" "unprognostic (7.77e-2)" "unprognostic (4.66e-1)" "unprognostic (1.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (1.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" 28.2 17.4 16.4 25.3 17.5 75.6 15.1 15.1 15.0 14.2 19.1 23.0 13.0 14.0 12.9 12.1 13.2 12.1 17.7 15.4 16.8 13.3 12.4 17.4 27.6 27.5 18.5 9.4 16.3 10.0 12.1 10.0 25.0 14.8 16.8 17.3 10.7 10.5 13.9 35.0 11.4 17.5 15.9 32.1 22.5 13.6 11.3 20.4 34.9 11.9 9.0 27.5 28.3 26.0 5.7 5.5 15.8 13.4 7.8 11.2 4.4 11.8 13.4 12.4 8.3 12.8 11.6 12.8 9.2 10.8 12.7 14.5 7.5 8.0 48.4 6.1 9.9 15.6 8.2 13.1 11.3 19.6 12.5 7.6 25.2 8.2 14.7 18.6 18.8 16.8 9.8 17.3 12.3 16.9 11.5 19.1 13.1 10.2 30.2 14.7 11.2 28.9 6.8 7.6 11.5 10.0 16.7 24.7 17.6 12.8 19.5 9.1 19.1 6.7 14.1 15.8 25.0 14.5 18.4 13.7 21.2 18.6 9.1 12.1 22.4 26.6 55.0 7.7 12.3 11.2 7.1 6.4 8.5 7.2 13.4 7.3 5.7 8.9 8.5 5.5 4.8 5.2 5.7 15.8 7.8 8.3 2.5 11.2 4.4 16.4 17.5 15.1 15.0 16.8 13.3 18.5 9.4 14.8 20.4 11.9 15.4 28.6 22.0 60.2 5.4 10.3 15.3 9.4 5.7 8.7 3.9 13.6 6.6 10.8 3.2 27.0 28.1 23.3 9.9 12.6 19.5 23.8 29.0 13.7 52.3 6.4 16.1 31.9 52.2 6.3 10.6 56.9 65.8 36.9 12.7 31.7 11.8 16.1 22.6 12.2 5.9 32.3 25.0 5.4 15.6 57.6 11.7 39.9 12.9 27.4 GNAI2 "GIP, GNAI2B" ENSG00000114353 "G protein subunit alpha i2" P04899 3 50226292-50259355 "Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007704 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 53000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA007704: AB_1849230" "prognostic favorable (1.03e-4)" "unprognostic (3.89e-1)" "unprognostic (3.35e-2)" "unprognostic (8.40e-3)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (2.59e-2)" "unprognostic (3.23e-1)" "unprognostic (1.08e-3)" "unprognostic (6.01e-2)" "unprognostic (7.00e-3)" "unprognostic (1.12e-1)" "unprognostic (6.24e-3)" "unprognostic (1.44e-1)" "unprognostic (4.30e-2)" "unprognostic (4.33e-2)" "unprognostic (1.38e-1)" 81.9 37.8 50.8 69.5 47.2 102.5 53.4 17.7 45.3 56.2 47.9 67.2 34.5 22.6 51.4 41.1 44.4 47.1 55.5 57.0 44.6 48.0 34.1 50.9 72.8 78.7 53.3 34.3 54.0 21.4 24.9 42.1 81.3 46.8 44.3 22.5 38.5 25.8 60.0 29.6 29.0 35.7 53.6 81.8 96.7 30.1 28.5 45.9 70.0 37.7 32.4 55.5 60.7 49.8 5.3 14.2 35.8 19.4 6.1 8.4 5.6 15.3 8.3 25.2 25.2 31.0 38.9 4.5 33.5 54.1 48.4 49.8 9.3 21.7 18.3 14.7 75.6 26.2 12.3 17.9 46.8 31.0 39.1 6.3 46.2 22.6 14.5 30.6 42.2 61.6 37.7 20.9 43.7 17.9 40.0 113.3 15.7 3.0 39.9 48.2 19.9 35.6 45.6 13.5 7.5 32.6 22.4 12.1 26.8 31.1 17.4 6.1 10.6 24.5 7.4 15.4 21.6 11.7 43.8 98.5 41.7 24.5 39.3 33.5 25.2 32.2 16.1 47.0 57.6 49.9 2.6 16.5 23.4 8.4 19.4 4.9 5.0 6.3 7.6 14.2 5.3 5.0 5.7 35.8 6.1 15.0 11.7 6.6 5.6 50.8 47.2 17.7 45.3 44.6 48.0 53.3 34.3 46.8 45.9 38.7 40.4 91.6 50.8 50.5 26.8 19.8 53.5 14.7 25.0 41.8 13.7 65.7 5.0 114.9 164.1 226.6 12.0 23.3 53.2 68.9 80.2 40.6 86.7 69.5 291.0 6.4 88.5 179.9 279.9 235.2 84.0 263.9 79.2 299.4 19.5 264.2 106.8 32.8 89.8 22.6 18.1 51.8 75.6 14.0 24.7 55.0 97.4 119.3 13.3 55.9 GNAL ENSG00000141404 "G protein subunit alpha L" P38405 18 11688956-11885685 "Disease related genes, Predicted intracellular proteins" Transducer "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.7" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 15.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 82.7" "Group enriched" "Detected in some" 4 "basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7" "Group enriched" "Detected in many" 5 "granulocytes: 1.7;T-cells: 4.2" "Cell line enhanced" "Detected in many" "Daudi: 18.4;HeLa: 18.8;U-2 OS: 9.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 13 "basal ganglia: 183.9" "CAB015464, HPA051160" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB015464: AB_831819, HPA051160: AB_2732564" "unprognostic (2.29e-3)" "unprognostic (7.43e-2)" "unprognostic (8.14e-3)" "unprognostic (3.41e-5)" "unprognostic (4.71e-2)" "unprognostic (9.58e-3)" "unprognostic (9.93e-3)" "unprognostic (1.87e-1)" "unprognostic (2.36e-1)" "unprognostic (7.17e-2)" "unprognostic (1.82e-3)" "unprognostic (6.05e-2)" "unprognostic (1.23e-3)" "unprognostic (1.09e-1)" "unprognostic (3.85e-2)" "unprognostic (4.26e-2)" "unprognostic (7.03e-2)" 7.2 1.5 17.8 3.0 82.7 0.7 4.2 2.7 18.1 8.0 3.7 3.2 3.3 1.6 6.7 2.4 8.2 4.1 4.6 2.2 7.1 7.6 4.2 1.3 2.5 5.1 6.6 5.3 3.2 1.3 1.0 20.7 2.9 8.8 9.9 3.7 2.1 4.6 18.1 18.3 7.0 2.0 9.9 3.3 1.8 2.1 6.2 11.3 0.9 8.0 1.4 5.7 9.5 7.7 0.4 0.2 1.7 0.2 0.5 4.2 1.4 0.5 6.1 7.4 0.5 0.6 0.1 0.8 0.1 0.2 0.5 0.0 6.5 1.1 18.4 1.2 0.1 4.2 0.3 6.9 5.9 0.0 3.8 6.3 0.1 18.8 3.7 0.0 0.2 0.4 0.9 8.8 0.0 0.1 0.3 0.0 0.2 1.6 0.2 0.2 0.2 0.2 0.5 6.1 5.0 0.1 0.1 1.0 0.2 0.4 0.2 6.9 0.1 8.6 0.4 2.1 1.8 0.2 0.2 1.0 0.7 9.7 0.3 1.8 0.3 0.1 0.1 0.3 0.2 0.2 1.1 0.2 0.4 4.2 0.1 0.1 0.4 0.5 2.9 0.0 0.3 0.2 2.2 1.7 0.5 0.1 0.2 0.1 1.4 17.8 82.7 2.7 12.7 7.1 7.6 6.6 5.3 8.8 11.3 3.0 5.1 0.0 10.1 9.4 6.7 3.4 0.0 13.4 7.9 3.5 15.7 0.4 1.7 0.4 3.6 4.4 1.4 0.0 2.7 2.8 5.6 4.9 5.7 1.3 0.9 3.2 0.0 0.6 0.3 2.2 0.9 1.3 13.5 0.0 0.2 0.9 1.2 2.0 2.8 3.8 3.1 6.5 13.9 1.9 5.3 6.6 0.5 1.3 1.2 12.9 GNAQ "G-ALPHA-q, GAQ" ENSG00000156052 "G protein subunit alpha q" P50148 9 77716087-78031458 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Transducer "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 18.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 18.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010036, HPA048886" Uncertain Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA 28000000 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB010036: AB_631536, HPA048886: AB_2680544" "unprognostic (2.10e-1)" "unprognostic (8.53e-2)" "unprognostic (1.45e-1)" "unprognostic (4.37e-2)" "unprognostic (1.87e-1)" "unprognostic (6.83e-3)" "unprognostic (1.05e-1)" "unprognostic (3.84e-2)" "unprognostic (2.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.11e-7)" "unprognostic (1.90e-1)" "unprognostic (3.13e-1)" "unprognostic (1.05e-1)" "unprognostic (2.01e-1)" 12.7 12.6 24.3 9.9 20.8 21.8 11.6 12.5 29.6 13.1 16.6 17.1 9.1 7.9 13.7 11.2 13.1 10.0 11.6 5.6 24.2 18.3 12.1 12.3 23.1 11.8 19.1 14.6 13.5 8.5 12.7 7.6 12.1 14.3 13.0 16.0 10.4 9.8 15.9 5.9 5.1 9.0 18.2 23.9 5.8 15.5 6.0 14.8 18.6 13.3 4.0 4.8 14.5 13.1 0.8 2.8 18.4 3.5 3.3 2.0 1.2 12.0 13.7 12.2 13.4 15.5 15.9 17.6 16.4 12.4 7.2 8.7 4.2 9.9 0.0 13.3 15.0 10.1 19.8 9.1 9.9 9.0 0.4 5.3 33.0 12.0 8.4 14.0 20.1 12.4 10.8 12.2 13.9 14.2 15.0 17.7 29.8 5.8 0.1 12.6 15.3 23.2 12.8 9.9 19.4 1.9 8.6 15.0 0.1 16.4 25.8 13.7 20.9 11.8 10.0 12.3 12.0 9.1 7.5 22.1 12.7 0.8 17.2 9.5 0.1 0.0 0.1 8.8 11.9 13.1 18.4 2.2 4.6 0.8 1.9 1.6 0.8 1.8 1.0 2.4 0.8 2.0 1.6 7.7 3.3 3.5 2.8 1.9 1.2 24.3 20.8 12.5 24.0 24.2 18.3 19.1 14.6 14.3 14.8 163.8 71.4 6.4 33.6 42.0 29.9 5.9 43.3 42.8 35.2 73.3 15.7 39.3 6.6 28.1 13.1 85.4 69.5 46.7 34.7 42.2 42.9 51.3 49.7 51.3 47.8 77.9 88.6 107.4 139.4 6.8 36.5 92.7 45.5 72.1 90.6 37.0 44.3 48.9 49.1 35.4 4.2 25.8 40.1 4.7 6.6 18.9 24.3 21.8 67.3 50.3 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 303.3;thyroid gland: 304.5" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 1781.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favorable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 56.2 79.0 84.2 34.4 44.5 42.1 87.4 86.0 107.4 43.2 42.3 25.4 27.0 33.2 37.2 44.7 41.0 43.6 34.4 106.0 71.0 144.0 39.6 35.3 46.6 44.6 75.8 64.7 43.6 118.1 120.9 303.3 49.8 85.6 36.3 31.5 42.7 171.6 31.1 172.9 26.3 34.9 40.5 61.4 36.9 42.4 18.2 27.4 56.0 304.5 80.6 41.0 37.3 44.6 27.3 41.5 29.9 36.2 25.3 24.2 24.6 9.7 32.8 55.4 25.8 94.2 43.0 49.8 56.4 51.6 64.5 46.3 95.8 50.6 32.0 87.9 73.2 46.2 42.3 50.8 75.1 43.7 21.1 30.6 35.6 49.9 62.7 43.5 20.7 22.4 51.3 38.2 31.3 42.2 51.2 48.9 39.5 31.2 43.7 42.5 133.6 105.4 50.6 17.6 6.4 34.7 64.9 48.5 56.5 51.7 38.7 68.7 157.4 78.4 77.9 62.9 50.7 59.5 56.7 53.7 85.7 77.0 30.8 53.1 76.8 49.5 67.6 37.6 10.1 43.7 29.9 24.8 29.5 20.7 35.7 22.1 26.7 22.0 22.2 37.8 27.3 21.3 24.2 29.1 25.3 36.2 41.5 23.3 24.6 84.2 44.5 86.0 107.4 71.0 144.0 75.8 64.7 85.6 27.4 205.4 224.1 189.5 151.9 115.9 363.0 884.0 242.0 250.3 255.9 247.7 53.0 672.6 376.4 220.5 577.5 343.9 323.7 303.7 196.1 292.5 221.9 260.9 133.0 165.2 333.8 1781.3 444.7 335.7 327.9 1338.6 245.7 276.8 210.9 147.9 250.3 861.2 313.5 239.3 185.3 130.9 175.1 207.0 226.4 48.2 25.4 103.0 1013.3 142.4 268.2 212.5 GNB1L "GY2, WDR14" ENSG00000185838 "G protein subunit beta 1 like" Q9BYB4 22 19783224-19854939 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034627, HPA034628" Approved Approved Cytosol NA NA Cytosol "HPA034627: AB_10600662, HPA034628: AB_10600440" "unprognostic (2.14e-1)" "unprognostic (5.56e-3)" "unprognostic (4.54e-3)" "unprognostic (2.58e-1)" "unprognostic (3.03e-1)" "unprognostic (3.34e-2)" "unprognostic (8.68e-4)" "unprognostic (1.09e-1)" "unprognostic (1.19e-1)" "unprognostic (4.26e-1)" "unprognostic (2.46e-1)" "unprognostic (2.99e-2)" "unprognostic (3.64e-5)" "unprognostic (9.80e-3)" "unprognostic (8.04e-2)" "unprognostic (2.88e-1)" "unprognostic (9.86e-2)" 6.1 6.4 6.9 12.4 10.3 7.7 8.7 11.6 16.1 7.4 7.2 5.7 8.2 18.6 8.9 7.1 9.8 8.0 5.7 5.8 6.9 5.7 5.2 5.4 6.2 9.9 6.1 9.9 7.6 12.8 3.1 6.0 11.3 5.4 7.7 2.8 4.6 9.4 7.5 13.9 12.6 10.0 4.3 5.5 13.2 8.9 6.1 4.9 30.3 8.3 4.6 8.6 7.9 8.2 11.6 12.8 14.5 7.3 10.9 16.1 7.6 7.0 5.4 1.6 4.8 0.5 1.0 4.4 4.8 1.4 2.4 2.3 9.7 2.8 9.6 3.2 1.1 1.1 13.6 1.1 2.3 0.3 6.1 18.3 5.7 6.7 4.7 1.5 6.5 1.6 0.8 1.1 2.1 0.8 0.5 0.9 4.4 34.4 3.7 0.4 10.0 14.5 9.4 2.7 2.0 9.2 7.6 4.4 2.1 0.2 2.9 3.2 3.5 1.9 4.7 8.2 0.3 1.2 1.7 2.2 5.4 6.6 8.8 4.9 4.8 4.0 5.0 5.9 5.9 1.8 5.5 5.9 14.5 13.7 7.3 13.2 9.6 13.3 10.4 9.5 11.6 13.0 11.7 5.9 10.9 5.5 12.8 16.1 7.6 6.9 10.3 11.6 16.1 6.9 5.7 6.1 9.9 5.4 4.9 3.0 4.1 5.2 5.4 19.6 7.7 1.2 0.0 0.0 3.4 0.0 11.8 12.9 3.3 4.4 25.3 3.6 4.4 0.0 2.9 11.0 6.9 3.8 12.7 2.6 9.4 0.0 0.0 1.8 4.7 4.7 3.1 7.4 13.5 6.4 2.9 2.5 4.9 3.5 4.6 4.1 4.1 6.5 6.2 4.1 11.4 14.2 3.9 10.2 4.5 3.9 GNE "IBM2, Uae1" ENSG00000159921 "Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase" Q9Y223 9 36214441-36277056 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.0;salivary gland: 45.3" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 95.4;Mucus-secreting cells: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007045, HPA027258" Approved Supported Cytosol NA NA Cytosol "HPA007045: AB_1079003, HPA027258: AB_1849873" "unprognostic (7.54e-2)" "unprognostic (1.61e-2)" "unprognostic (1.07e-3)" "unprognostic (7.28e-2)" "unprognostic (7.00e-2)" "unprognostic (1.85e-2)" "unprognostic (2.78e-3)" "unprognostic (5.39e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.88e-3)" "unprognostic (4.20e-2)" "prognostic favorable (9.28e-11)" "unprognostic (2.90e-1)" "unprognostic (8.28e-2)" "unprognostic (2.95e-1)" "unprognostic (1.72e-2)" 7.7 6.7 6.0 6.5 8.3 8.3 16.6 11.1 12.1 7.9 20.7 7.0 4.6 2.9 8.0 3.9 7.6 6.7 5.2 7.6 7.8 6.8 6.8 55.0 5.5 6.0 6.0 7.8 9.8 8.4 4.1 7.0 20.2 10.2 10.1 30.1 4.8 45.3 5.0 10.5 3.7 7.2 11.7 10.9 4.5 4.9 3.4 5.3 3.2 4.6 4.2 7.9 8.6 7.9 3.9 2.2 1.2 2.7 2.4 4.2 1.8 4.4 19.9 8.9 7.6 10.1 10.1 12.9 6.2 7.9 8.6 11.1 4.8 14.2 5.8 6.6 10.3 22.4 1.7 6.7 2.0 9.6 10.9 0.6 5.0 11.7 6.6 6.9 0.1 14.3 6.6 2.0 14.3 13.5 6.3 3.6 9.0 6.3 12.1 8.3 0.7 8.1 2.6 5.1 2.8 11.2 6.7 7.5 1.6 47.6 8.2 7.6 6.9 6.6 2.3 5.7 3.3 2.1 5.1 5.2 5.7 5.9 6.8 5.4 5.3 11.3 3.2 7.8 4.3 8.1 0.7 1.7 0.9 2.7 2.2 1.8 2.4 3.4 2.9 1.4 3.9 4.0 4.2 1.2 2.4 2.7 2.2 1.5 1.8 6.0 8.3 11.1 12.1 7.8 6.8 6.0 7.8 10.2 5.3 8.9 10.6 4.5 2.8 1.6 7.9 5.9 10.2 18.7 14.8 8.7 5.9 7.5 1.7 9.3 2.8 4.5 18.3 0.0 5.2 7.3 5.1 7.6 9.3 95.4 2.7 11.1 11.1 8.0 5.0 2.3 10.0 4.3 1.7 6.4 67.2 2.0 4.2 23.0 6.0 1.7 6.2 12.9 4.1 1.1 2.7 1.4 16.6 5.0 21.2 5.6 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530211-54561071 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 12.7 12.9 10.3 16.1 12.3 19.2 12.5 8.6 13.1 10.8 10.2 14.8 10.5 8.5 15.2 10.2 16.3 11.0 10.1 15.3 8.1 8.0 12.0 12.5 13.0 15.5 13.0 10.8 13.2 17.5 15.9 16.9 12.0 10.2 10.6 13.3 12.3 13.3 12.4 24.0 13.2 13.5 15.0 11.5 17.6 11.7 5.9 13.9 20.5 18.0 12.0 18.6 13.7 13.1 17.2 11.4 20.2 15.2 21.8 17.7 11.5 11.2 28.0 5.8 11.9 6.0 4.1 10.7 6.7 4.9 7.6 6.0 23.6 9.3 15.8 13.0 9.7 9.9 11.0 19.3 8.4 10.5 10.9 10.0 15.9 22.4 11.1 4.6 24.6 15.7 5.8 4.1 17.7 10.7 3.1 8.1 9.0 10.3 16.0 7.6 21.8 13.9 5.1 16.7 6.7 15.7 15.0 13.2 15.3 5.7 17.8 9.4 5.7 22.0 13.6 6.3 12.2 17.9 6.3 11.6 13.8 13.8 13.3 11.4 12.0 15.3 20.3 7.1 20.4 15.3 18.9 14.2 15.1 17.7 12.6 16.1 15.0 16.2 15.4 11.4 17.2 12.4 13.0 20.2 21.8 15.2 9.6 8.6 11.5 10.3 12.3 8.6 13.1 8.1 8.0 13.0 10.8 10.2 13.9 11.9 21.0 11.9 2.9 1.1 9.4 7.0 5.1 12.0 18.2 3.5 11.8 6.4 3.3 6.0 0.2 6.0 4.6 0.0 7.6 5.4 3.3 2.8 10.4 3.9 4.4 7.9 3.4 7.4 11.9 0.0 5.2 6.1 0.0 6.4 4.3 3.7 7.8 3.5 2.8 3.3 8.0 6.5 4.1 1.2 7.4 1.8 4.6 8.2 3.9 3.1 GNMT ENSG00000124713 "Glycine N-methyltransferase" Q14749 6 42960758-42963880 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "liver: 83.9;pancreas: 100.1" "Cell type enriched" "Detected in many" 34 "Hepatocytes: 729.0" "Group enriched" "Detected in many" 20 "liver cancer: 69.6;prostate cancer: 49.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 10.5;SCLC-21H: 12.4;T-47d: 7.9" "Region enriched" "Detected in some" 4 "cerebellum: 17.7" "Not detected" "Not detected" HPA027501 Enhanced Approved Cytosol NA NA 150000 Cytosol "HPA027501: AB_1849879" "unprognostic (1.53e-2)" "unprognostic (8.02e-4)" "unprognostic (3.11e-2)" "unprognostic (4.24e-3)" "unprognostic (3.91e-2)" "unprognostic (6.40e-4)" "prognostic favorable (1.86e-4)" "unprognostic (4.08e-6)" "unprognostic (1.01e-1)" "unprognostic (2.67e-2)" "unprognostic (1.63e-3)" "unprognostic (2.52e-1)" "unprognostic (3.50e-3)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (2.49e-2)" "unprognostic (4.92e-2)" 0.3 0.1 0.2 0.2 0.2 0.7 1.8 0.5 0.5 0.3 0.5 0.2 1.3 0.0 0.2 0.9 0.3 0.1 0.2 1.3 0.2 0.2 0.3 83.9 1.3 0.1 0.1 0.2 0.4 100.1 0.0 2.5 0.1 0.4 5.2 0.0 0.9 8.2 0.9 0.6 0.1 0.2 0.4 0.1 0.3 6.5 0.6 0.1 0.2 0.9 0.3 0.4 0.2 0.1 0.7 3.2 2.0 0.9 0.0 1.2 0.3 0.5 0.4 1.8 5.1 0.6 0.2 0.3 0.4 2.0 0.8 1.2 0.1 0.1 1.7 0.2 0.4 0.9 0.6 0.3 0.3 0.2 2.0 1.6 1.3 1.0 10.5 0.0 1.1 2.4 0.4 0.0 0.4 0.2 1.2 0.0 3.8 1.5 1.9 0.3 2.3 2.0 3.7 0.2 0.5 0.5 1.7 1.6 1.0 0.9 0.2 12.4 1.7 0.1 1.7 0.6 0.5 7.9 3.6 0.4 0.9 0.9 0.5 1.0 1.3 1.2 1.5 0.2 2.1 1.0 0.0 0.8 0.1 0.2 0.9 0.1 0.7 0.3 0.3 0.9 0.1 0.6 1.2 2.0 0.0 0.1 3.2 0.3 0.3 0.2 0.2 0.5 0.5 0.2 0.2 0.1 0.2 0.4 0.1 0.0 2.1 3.4 4.2 0.2 1.2 4.5 15.3 5.3 0.0 1.8 0.0 0.1 3.3 0.4 0.2 0.1 0.0 0.0 0.7 0.1 0.2 16.1 0.0 729.0 0.5 1.6 0.0 16.5 21.5 0.0 0.9 0.3 0.0 0.0 0.0 0.3 0.9 0.0 2.5 2.2 0.3 0.0 0.7 0.5 0.6 0.1 0.1 0.0 0.0 1.6 GNPTG "C16orf27, c316G12.3, CAB56184, GNPTAG" ENSG00000090581 "N-acetylglucosamine-1-phosphate transferase gamma subunit" Q9UJJ9 16 1351923-1364113 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004055 Approved Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 420000000 "Endoplasmic reticulum" Cytosol "HPA004055: AB_1079006" "unprognostic (4.37e-2)" "unprognostic (2.20e-2)" "unprognostic (1.84e-1)" "unprognostic (9.57e-3)" "unprognostic (2.70e-3)" "unprognostic (2.09e-1)" "unprognostic (3.03e-2)" "unprognostic (3.66e-1)" "unprognostic (1.69e-1)" "unprognostic (3.29e-1)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.14e-2)" "unprognostic (2.20e-1)" "unprognostic (2.31e-1)" "unprognostic (4.85e-2)" "unprognostic (2.07e-2)" 23.1 67.3 38.0 16.9 35.7 19.9 20.2 22.0 38.8 19.6 23.5 41.7 22.2 16.5 18.9 28.4 17.3 19.1 22.2 17.8 38.5 31.7 29.9 41.1 21.7 22.6 39.3 28.6 22.3 34.6 33.7 25.1 27.2 28.9 21.1 15.6 20.5 37.8 22.2 28.1 33.4 19.5 15.1 43.3 26.3 21.2 18.0 31.0 11.1 24.0 13.2 13.2 20.0 17.8 15.5 29.3 25.8 37.1 14.6 21.7 20.9 4.7 7.8 5.7 10.0 52.5 19.6 7.3 14.1 18.5 5.6 10.8 6.9 13.6 3.0 16.3 19.0 8.5 8.8 3.4 8.2 2.9 9.7 7.6 4.0 24.1 11.8 22.3 6.5 16.3 26.0 14.4 5.4 7.7 15.8 10.3 5.6 4.8 18.2 9.2 11.0 3.0 6.6 5.3 12.3 4.4 11.0 4.8 13.9 14.0 6.3 4.4 5.9 14.2 14.7 10.1 3.3 13.6 9.9 10.0 11.3 9.7 9.2 6.8 19.2 13.9 6.3 9.3 5.6 7.4 25.8 37.1 22.2 21.7 34.0 19.9 15.5 18.7 20.5 29.3 14.6 17.3 15.8 15.0 14.6 31.9 24.7 21.3 20.9 38.0 35.7 22.0 38.8 38.5 31.7 39.3 28.6 28.9 31.0 38.7 42.0 23.2 23.3 18.5 13.9 7.7 40.8 38.8 58.0 19.2 23.6 22.0 8.3 22.9 2.3 20.2 23.2 0.0 12.6 16.8 30.5 22.2 23.2 26.0 44.9 7.9 8.7 36.2 34.5 2.7 27.9 37.0 32.1 18.0 18.4 24.7 14.7 28.8 16.6 37.7 23.3 19.4 18.4 24.7 27.2 17.8 26.0 20.3 20.0 22.0 GOLGA8A "GM88, GOLGIN-67" ENSG00000175265 "Golgin A8 family member A" A7E2F4 15 34379068-34437466 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 196.5;Alveolar cells type 2: 83.2;Bipolar cells: 84.1;Ciliated cells: 85.6;Club cells: 217.2;Cone photoreceptor cells: 94.2;Horizontal cells: 79.4;Rod photoreceptor cells: 127.5" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 22.1;HeLa: 30.5" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (4.80e-2)" "unprognostic (1.26e-2)" "unprognostic (4.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.42e-2)" "unprognostic (2.10e-2)" "unprognostic (8.11e-3)" "prognostic favorable (7.58e-4)" "unprognostic (2.74e-2)" "unprognostic (4.37e-1)" "unprognostic (2.63e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "prognostic favorable (5.68e-6)" 2.6 4.7 3.6 5.1 4.4 3.1 5.8 20.1 3.5 6.3 3.5 5.8 5.3 18.0 4.1 3.7 3.6 2.9 3.9 3.7 2.6 0.4 2.3 6.5 3.3 7.4 3.3 8.0 2.4 0.7 4.6 0.8 6.7 5.3 2.6 18.4 4.0 1.2 3.8 8.3 3.3 8.3 5.7 0.6 2.6 5.3 0.7 0.0 0.8 0.0 2.7 0.2 0.0 1.0 6.0 1.7 6.0 0.0 0.0 1.3 9.3 0.0 1.6 0.7 10.5 0.0 0.0 1.7 1.1 3.5 9.8 4.3 3.1 2.5 9.1 3.6 22.1 30.5 6.6 0.7 8.4 6.0 0.0 9.0 1.0 0.2 1.0 0.1 3.3 20.0 18.7 4.2 1.9 2.3 15.4 3.2 2.9 3.3 9.0 5.3 7.5 3.5 6.2 8.1 3.8 6.2 4.2 1.0 0.0 1.6 5.1 4.9 7.5 1.7 0.0 1.6 18.0 5.9 2.5 2.3 18.0 1.6 0.0 0.0 0.8 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 196.5 83.2 10.2 10.7 23.2 84.1 26.4 2.5 85.6 217.2 1.8 94.2 2.3 0.0 3.8 22.3 15.7 6.7 0.0 2.2 2.8 11.6 7.7 12.8 0.9 2.1 79.4 15.4 14.1 6.5 5.4 29.1 11.1 21.9 1.8 9.1 17.7 4.1 6.0 19.8 0.3 127.5 0.0 17.9 29.0 20.5 18.9 2.7 13.8 11.7 7.5 GOLGA8B ENSG00000215252 "Golgin A8 family member B" A8MQT2 15 34525207-34588503 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 25.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 178.6;Club cells: 128.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "basophil: 2.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "HeLa: 14.6;Hep G2: 13.0;NB-4: 20.1" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (2.12e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.89e-1)" "unprognostic (2.43e-1)" "unprognostic (4.06e-2)" "unprognostic (7.90e-3)" "unprognostic (9.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.06e-1)" "unprognostic (1.60e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (2.14e-1)" "unprognostic (5.31e-3)" "unprognostic (2.31e-1)" "prognostic favorable (5.79e-4)" 2.6 3.4 0.0 2.8 0.6 6.8 4.3 2.5 2.7 2.5 2.0 0.0 4.1 6.1 0.8 3.8 2.8 1.6 0.0 0.7 3.0 2.3 4.5 8.0 0.0 9.0 25.2 0.1 4.9 0.9 5.4 0.1 4.6 5.2 1.8 3.3 5.4 0.5 0.0 5.2 4.0 5.3 16.4 3.1 3.0 1.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 2.0 2.3 0.2 4.3 2.4 4.7 6.1 1.9 0.6 2.1 3.5 2.2 2.9 0.0 4.1 2.0 0.2 1.7 0.8 1.9 1.8 3.0 7.1 0.3 14.6 13.0 3.5 1.8 2.3 6.7 2.7 1.3 3.9 2.4 2.1 3.3 0.7 0.2 1.9 1.0 0.9 20.1 2.7 4.1 3.9 0.1 0.0 0.3 1.8 4.1 3.2 4.9 1.0 0.3 2.2 3.4 1.9 3.9 0.0 3.1 7.4 0.9 3.3 1.4 1.3 3.0 1.0 0.9 0.8 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 178.6 44.8 21.6 8.2 19.5 41.4 30.9 17.8 53.5 128.5 29.6 68.7 5.9 1.7 7.8 32.7 8.9 3.2 0.0 11.0 3.6 7.6 6.5 9.2 25.1 1.4 42.9 6.9 12.9 8.1 3.9 36.5 6.7 20.3 9.0 8.5 9.4 15.0 3.5 35.3 2.2 68.6 12.9 8.1 34.9 26.8 12.9 2.4 37.1 6.9 6.0 GOLPH3L GPP34R ENSG00000143457 "Golgi phosphoprotein 3 like" Q9H4A5 1 150646225-150697144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 100.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072016 Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA072016: " "unprognostic (1.21e-1)" "unprognostic (2.61e-1)" "unprognostic (3.76e-3)" "unprognostic (3.24e-1)" "unprognostic (3.24e-2)" "unprognostic (1.82e-1)" "unprognostic (3.18e-2)" "unprognostic (4.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (9.88e-3)" "unprognostic (2.71e-1)" "unprognostic (3.36e-2)" "unprognostic (1.67e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.93e-2)" 16.5 19.4 16.0 10.2 14.6 4.9 18.6 20.7 16.7 21.6 26.5 10.5 26.2 15.7 19.3 30.0 36.6 24.6 14.8 11.7 10.6 15.5 21.3 13.0 14.5 10.5 12.2 11.0 22.7 30.4 16.8 30.8 14.1 15.9 19.2 32.6 16.5 25.4 22.4 16.1 17.3 20.2 14.9 11.0 15.0 19.5 14.9 12.1 21.1 30.7 11.7 20.8 21.6 22.2 10.6 11.7 7.1 3.1 16.2 13.1 4.9 7.1 7.0 3.9 2.2 9.9 7.2 6.4 6.6 10.1 7.3 10.4 3.1 12.8 9.0 9.6 4.7 4.7 6.2 6.4 5.6 8.8 6.1 7.1 10.0 3.8 4.1 8.7 8.2 8.0 4.8 9.6 7.6 16.4 8.5 10.6 6.2 8.1 5.8 4.2 7.3 6.9 3.5 7.4 13.3 6.8 4.8 4.5 10.2 8.4 4.8 6.0 5.7 3.4 9.6 4.8 10.0 7.3 9.1 8.4 2.4 3.9 3.1 5.5 7.3 6.4 100.5 7.0 8.5 3.2 7.1 1.5 2.7 9.7 1.3 13.1 10.6 9.8 9.5 8.1 8.8 12.9 9.6 1.3 16.2 3.1 11.7 10.3 4.9 16.0 14.6 20.7 16.7 10.6 15.5 12.2 11.0 15.9 12.1 8.9 6.4 8.2 8.5 11.4 8.0 9.7 22.9 37.5 15.9 12.2 5.9 18.7 21.6 17.4 12.4 12.1 29.9 0.0 32.0 12.8 8.8 22.2 11.5 9.7 10.3 0.0 20.2 16.0 9.1 9.7 15.3 8.2 15.1 19.0 40.8 13.4 21.9 31.9 18.7 20.3 12.7 0.0 8.2 11.2 3.2 15.6 25.7 10.0 31.6 23.8 GORAB "FLJ11752, GO, NTKL-BP1, SCYL1BP1" ENSG00000120370 "Golgin, RAB6 interacting" Q5T7V8 1 170532129-170553446 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027208, HPA027250, HPA027746" Approved Enhanced "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: " "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (4.75e-3)" "prognostic favorable (1.39e-4)" "prognostic unfavorable (5.26e-4)" "unprognostic (8.48e-3)" "unprognostic (2.94e-2)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (7.83e-12)" "unprognostic (2.52e-2)" "unprognostic (2.83e-1)" "unprognostic (7.71e-2)" "unprognostic (1.70e-1)" 7.7 14.7 8.4 9.4 9.2 0.5 10.6 8.7 9.5 10.7 9.4 4.8 7.0 4.8 8.8 10.5 6.3 6.8 6.7 8.2 7.4 7.8 7.2 11.1 6.8 9.6 6.3 8.1 12.6 9.7 6.5 20.6 9.4 8.7 11.1 10.4 6.3 8.8 13.1 3.3 6.5 7.0 6.4 11.1 10.4 5.6 8.6 7.3 8.7 10.5 4.2 9.7 10.4 10.0 6.2 7.3 1.2 7.4 7.9 9.4 5.5 5.1 5.0 9.6 3.6 12.9 9.6 6.3 7.8 12.1 6.9 7.2 3.2 8.8 7.5 9.0 7.9 4.5 6.5 9.5 4.6 9.2 8.0 2.9 5.0 6.5 4.0 8.7 6.6 5.1 8.3 4.5 7.4 6.9 8.6 5.4 4.3 6.8 3.7 7.3 1.2 9.5 6.0 8.5 11.6 6.3 5.7 6.4 10.0 6.2 3.8 2.5 5.3 6.5 7.9 18.2 6.4 5.0 11.7 6.9 11.0 5.8 4.3 10.8 6.7 7.3 6.6 9.2 6.0 9.8 1.0 7.4 0.0 4.7 7.4 7.4 6.1 8.3 7.2 7.3 6.2 7.3 6.2 1.2 7.9 5.7 4.6 9.4 5.5 8.4 9.2 8.7 9.5 7.4 7.8 6.3 8.1 8.7 7.3 0.0 10.7 6.0 2.9 2.5 3.9 6.7 7.6 1.4 6.8 5.2 2.0 5.2 3.3 9.4 1.6 7.4 5.1 0.0 5.3 5.6 10.4 4.1 12.8 5.8 6.3 4.8 0.0 3.7 6.3 2.6 13.0 3.9 3.3 10.0 6.4 3.4 5.8 7.0 6.0 4.4 7.2 6.5 8.5 13.1 7.7 1.4 4.7 5.7 6.0 2.7 GOT1 AST1 ENSG00000120053 "Glutamic-oxaloacetic transaminase 1" P17174 10 99396870-99430624 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Amino-acid biosynthesis" "Aminotransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 398.1;Distal tubular cells: 203.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064532, HPA072629" Enhanced Supported Nucleoplasm,Cytosol NA Yes 130000000 Nucleoplasm Cytosol "HPA064532: AB_2685279, HPA072629: AB_2686540" "unprognostic (6.40e-2)" "prognostic favorable (6.23e-4)" "unprognostic (5.99e-2)" "unprognostic (2.84e-2)" "unprognostic (2.82e-1)" "unprognostic (2.96e-2)" "unprognostic (5.25e-2)" "unprognostic (1.08e-3)" "unprognostic (6.67e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (1.79e-1)" "prognostic favorable (3.72e-13)" "unprognostic (1.93e-2)" "unprognostic (4.23e-1)" "unprognostic (6.85e-2)" "unprognostic (1.00e-1)" 3.3 14.0 15.7 3.6 32.1 2.0 5.9 22.9 56.4 13.5 12.0 9.7 5.9 14.7 3.4 7.0 10.3 4.6 12.2 116.9 19.4 19.0 34.6 82.9 3.5 3.4 17.8 16.4 3.8 8.2 15.9 4.9 3.7 49.9 5.9 14.7 9.0 12.4 7.2 102.1 4.5 12.7 5.4 7.7 3.6 10.1 9.3 4.7 3.3 11.7 31.3 7.1 4.9 4.0 10.6 21.4 3.9 16.8 11.4 15.6 8.8 17.2 9.6 11.3 28.6 8.7 7.5 32.0 14.2 26.1 24.7 27.1 21.7 14.1 16.9 4.9 11.9 21.0 21.7 25.8 18.7 27.4 5.8 11.0 6.4 12.3 28.2 46.5 18.3 11.0 11.9 20.2 21.0 57.1 16.8 12.0 11.2 16.5 26.5 15.8 15.6 9.8 13.8 7.2 27.0 13.4 10.7 10.8 17.6 43.2 9.5 4.9 7.2 10.7 15.2 52.9 17.4 29.0 6.3 5.5 6.3 14.1 6.8 16.2 18.9 22.3 17.3 16.6 9.6 8.4 2.4 5.3 3.9 12.4 14.7 11.4 10.6 13.5 12.9 12.9 10.2 10.2 14.5 0.5 11.4 16.8 21.4 15.6 8.8 15.7 32.1 22.9 56.4 19.4 19.0 17.8 16.4 49.9 4.7 14.9 14.4 29.9 39.5 10.5 86.5 398.1 96.8 26.8 14.8 69.8 58.9 29.8 203.9 43.4 86.1 13.5 75.3 46.7 27.1 14.9 9.9 11.6 32.2 145.9 26.2 71.5 18.9 17.2 11.6 9.5 10.3 9.5 47.2 14.4 30.8 29.4 25.5 30.3 13.4 123.7 55.6 12.9 14.1 28.9 11.5 9.2 46.1 12.1 50.2 36.7 GP5 CD42d ENSG00000178732 "Glycoprotein V platelet" P40197 3 194394821-194398354 "CD markers, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.2" "Group enriched" "Detected in many" 6 "dendritic cells: 1.1;T-cells: 2.2" "Cell line enriched" "Detected in some" 9 "HEL: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA072646 Approved Cytosol NA NA 400000000 Cytosol "HPA072646: " "unprognostic (3.74e-2)" "unprognostic (3.40e-1)" "unprognostic (5.22e-2)" "unprognostic (2.96e-2)" "unprognostic (1.74e-2)" "unprognostic (1.35e-3)" "unprognostic (1.69e-3)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" "unprognostic (2.80e-2)" "unprognostic (1.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (4.18e-2)" "unprognostic (3.14e-1)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" 0.3 0.0 0.4 2.1 0.5 1.6 0.3 0.3 0.3 0.6 0.3 0.3 0.3 0.0 0.3 0.3 0.3 2.5 0.3 0.3 0.4 0.6 0.3 0.6 0.9 3.7 0.3 0.3 0.8 0.3 0.0 0.4 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 0.9 0.3 0.3 1.7 0.2 0.3 0.3 0.3 1.0 0.3 1.9 0.3 0.5 0.1 1.1 0.2 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.4 0.1 0.1 2.0 2.2 0.1 0.0 0.0 1.1 0.0 0.4 0.4 0.5 0.3 0.3 0.4 0.6 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GP9 "CD42a, GPIX" ENSG00000169704 "Glycoprotein IX platelet" P14770 3 129060767-129062406 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5" "Group enriched" "Detected in some" 11 "Early spermatids: 14.0;Late spermatids: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 8.8;neutrophil: 7.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.8" "Cell line enriched" "Detected in some" 14 "HEL: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063182 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 68000000 "Plasma membrane, Cytosol" Nucleoplasm "HPA063182: AB_2684956" "unprognostic (1.70e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (3.80e-2)" "unprognostic (2.50e-2)" "unprognostic (3.24e-1)" "unprognostic (2.53e-2)" "unprognostic (8.47e-2)" "unprognostic (8.70e-2)" 0.2 0.1 0.1 0.1 0.1 10.0 0.1 0.0 0.6 0.4 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 5.0 0.8 0.1 0.1 0.4 4.8 0.0 0.8 0.2 0.5 0.1 0.0 0.3 1.5 0.4 0.1 0.4 0.2 0.0 0.6 0.2 0.0 0.1 0.0 0.1 24.5 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.6 3.0 0.1 1.5 8.8 0.6 0.0 0.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.6 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 7.5 0.0 0.0 1.5 0.0 27.1 0.1 0.1 0.0 0.6 0.8 0.1 0.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 13.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPAA1 "GAA1, hGAA1" ENSG00000197858 "Glycosylphosphatidylinositol anchor attachment 1" O43292 8 144082590-144086216 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 70.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077224 Approved Approved "Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Centrosome, Mitochondria" "HPA077224: " "unprognostic (2.53e-3)" "unprognostic (1.39e-1)" "unprognostic (3.06e-2)" "unprognostic (2.57e-2)" "unprognostic (2.49e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-3)" "unprognostic (2.64e-1)" "unprognostic (8.92e-2)" "unprognostic (1.67e-2)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (3.89e-1)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" 25.2 35.3 23.0 15.9 25.5 32.1 20.0 19.9 43.7 23.6 24.4 27.1 32.3 28.2 26.3 38.3 23.2 24.0 31.1 35.0 20.3 17.4 29.3 47.2 24.9 31.4 19.9 19.0 23.8 46.6 36.4 17.1 32.9 25.1 23.1 10.7 27.4 46.0 35.4 28.5 23.3 31.0 16.3 22.3 21.9 23.0 24.6 16.1 24.0 29.0 22.2 18.6 19.3 18.6 17.2 41.0 21.7 33.3 24.7 34.5 26.1 16.4 29.1 6.8 21.3 15.8 13.5 23.7 16.9 16.8 14.2 14.8 12.0 27.3 9.0 24.7 18.3 6.7 20.5 4.5 16.8 2.1 15.1 15.3 14.1 13.6 8.8 15.3 6.9 21.3 14.8 15.7 14.5 10.1 11.5 11.7 15.3 10.2 31.9 13.6 57.9 13.3 6.4 6.8 19.4 70.8 9.3 8.6 42.8 12.3 11.6 11.8 16.2 22.1 28.5 12.4 3.9 18.3 19.5 7.7 13.2 23.0 7.5 18.9 17.8 13.7 5.9 23.4 8.5 17.9 11.8 24.8 21.7 34.5 29.9 23.7 15.5 17.4 27.1 23.1 17.2 17.3 24.1 5.8 24.7 33.3 41.0 15.0 26.1 23.0 25.5 19.9 43.7 20.3 17.4 19.9 19.0 25.1 16.1 35.7 40.2 43.2 39.6 25.5 57.0 39.1 40.8 26.8 11.4 41.8 60.9 106.7 21.6 110.5 4.7 29.4 99.5 0.0 78.8 116.9 52.6 52.7 65.6 67.2 78.9 52.4 54.6 43.0 45.7 6.6 37.4 40.2 69.2 59.5 47.2 94.2 69.6 80.7 35.3 71.5 53.5 58.2 37.1 132.9 51.7 19.4 91.4 48.0 73.6 37.1 GPAT3 "AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324" ENSG00000138678 "Glycerol-3-phosphate acyltransferase 3" Q53EU6 4 83535914-83605875 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.2;kidney: 43.7" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 42.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029414, CAB033749" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB033749: AB_2224941, HPA029414: AB_10601562" "unprognostic (9.51e-2)" "unprognostic (1.43e-2)" "unprognostic (5.67e-2)" "unprognostic (1.70e-1)" "unprognostic (3.50e-3)" "unprognostic (2.61e-2)" "unprognostic (2.05e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (2.92e-1)" "prognostic favorable (2.71e-9)" "unprognostic (3.74e-1)" "unprognostic (3.45e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (8.21e-4)" 7.9 0.7 0.7 5.2 1.4 5.2 17.5 4.2 2.9 3.7 18.0 1.2 1.3 20.2 3.0 2.1 5.1 2.1 6.0 24.8 1.2 2.2 43.7 9.0 3.2 4.5 1.9 0.8 12.9 1.7 11.8 5.8 1.2 9.5 2.6 5.7 1.3 3.6 1.9 35.9 1.9 47.2 3.7 3.0 4.3 7.4 4.6 1.4 0.9 26.6 14.6 3.4 4.5 7.2 0.0 23.2 42.0 9.7 0.5 1.8 2.9 9.8 9.7 0.0 0.1 0.5 1.2 0.2 0.7 1.4 0.2 0.2 0.7 51.6 0.0 1.1 1.8 39.2 2.2 4.6 0.9 0.1 0.6 2.2 0.0 3.1 9.5 1.4 2.8 19.0 0.6 0.0 0.3 1.1 3.8 4.8 2.7 7.9 7.8 0.2 1.0 0.7 0.7 0.2 14.5 4.2 0.1 2.2 3.7 9.8 0.6 0.2 0.0 1.9 2.0 5.4 0.5 0.4 0.5 0.2 2.3 4.2 2.3 9.3 0.4 0.6 0.0 22.6 5.6 17.2 42.0 9.7 1.0 0.2 7.7 1.8 0.0 1.0 0.6 23.2 0.0 0.7 0.3 26.4 0.5 6.1 0.1 0.6 2.9 0.7 1.4 4.2 2.9 1.2 2.2 1.9 0.8 9.5 1.4 6.0 5.0 0.0 41.3 0.0 0.0 0.0 7.6 2.7 9.1 10.4 0.0 0.2 13.3 1.6 68.5 0.6 21.6 0.0 5.9 1.0 0.1 25.8 7.0 11.9 15.3 4.8 1.2 5.5 16.7 17.2 1.1 28.3 0.0 5.4 4.8 0.0 6.6 8.0 0.7 50.3 0.2 6.5 0.0 8.8 1.7 0.0 0.8 0.0 2.1 25.4 GPATCH2L "C14orf118, FLJ10033, FLJ20689" ENSG00000089916 "G-patch domain containing 2 like" Q9NWQ4 14 76151916-76254342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 149.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018856 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018856: AB_1845553" "unprognostic (5.98e-2)" "unprognostic (1.44e-2)" "unprognostic (7.07e-2)" "unprognostic (1.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.59e-2)" "unprognostic (6.63e-3)" "unprognostic (1.81e-2)" "unprognostic (2.89e-2)" "unprognostic (2.70e-1)" "unprognostic (2.05e-2)" "unprognostic (5.60e-2)" "unprognostic (5.81e-2)" "unprognostic (7.79e-2)" "unprognostic (2.14e-1)" "unprognostic (8.09e-2)" "unprognostic (1.81e-1)" 15.3 12.4 15.5 14.6 20.6 40.1 14.3 17.9 22.4 12.8 14.1 18.1 9.0 10.5 17.0 12.9 14.8 12.3 16.0 20.6 11.2 9.3 12.2 11.2 16.2 14.5 14.3 12.7 16.2 12.4 14.0 20.2 14.1 16.7 14.4 13.9 17.9 13.4 13.8 18.2 13.9 14.0 19.1 12.2 13.0 12.8 19.7 14.4 18.1 14.4 8.7 16.2 15.5 15.0 8.7 10.6 11.5 10.9 7.6 8.1 5.1 12.3 16.4 12.9 10.6 7.8 13.6 10.9 14.7 10.4 14.6 14.2 10.9 20.9 15.0 8.8 11.2 11.7 14.9 15.8 9.8 25.4 16.6 9.0 13.6 16.5 7.0 10.0 8.9 19.3 12.4 9.3 12.2 15.9 11.1 14.6 12.8 13.6 21.0 12.7 20.5 11.9 11.9 16.6 7.4 11.9 13.5 16.1 7.6 10.1 25.2 10.7 13.8 16.7 14.8 8.4 14.1 17.2 14.3 16.1 18.7 10.9 10.4 11.1 21.0 19.8 19.4 15.0 12.4 19.1 6.9 10.9 11.5 5.7 9.3 4.8 8.7 3.1 8.1 10.6 6.8 6.7 4.8 8.3 7.6 6.7 8.2 6.4 5.1 15.5 20.6 17.9 22.4 11.2 9.3 14.3 12.7 16.7 14.4 14.9 15.6 16.6 30.0 20.7 94.4 44.7 17.8 22.7 23.9 17.4 98.2 13.6 3.3 16.8 141.6 25.3 21.3 0.0 11.4 9.6 27.5 39.6 42.7 11.3 21.8 149.4 45.9 26.4 38.7 102.9 23.0 38.6 21.9 26.2 16.2 55.2 22.1 31.6 35.3 9.2 132.1 25.8 33.0 51.4 25.3 23.8 14.5 30.2 17.9 37.0 GPATCH3 "FLJ12455, GPATC3" ENSG00000198746 "G-patch domain containing 3" Q96I76 1 26890488-26900466 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032078, HPA054973" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA032078: AB_10603671, HPA054973: AB_2682656" "unprognostic (2.93e-2)" "unprognostic (1.33e-2)" "unprognostic (7.34e-2)" "unprognostic (9.63e-2)" "unprognostic (1.42e-1)" "unprognostic (9.44e-2)" "prognostic unfavorable (1.23e-7)" "unprognostic (4.37e-2)" "unprognostic (7.75e-2)" "unprognostic (6.46e-2)" "prognostic favorable (6.42e-4)" "unprognostic (3.77e-1)" "unprognostic (3.22e-3)" "unprognostic (2.31e-2)" "unprognostic (3.81e-2)" "unprognostic (2.59e-1)" "unprognostic (6.82e-2)" 11.7 14.5 13.1 10.2 13.6 31.8 13.0 19.5 20.9 9.4 11.7 15.8 11.8 13.0 11.8 14.5 11.6 10.3 12.0 9.6 11.6 10.9 10.9 14.8 10.5 12.4 12.6 10.8 11.8 11.8 12.0 10.1 13.3 13.6 10.3 10.1 10.1 10.4 10.5 21.5 16.0 11.7 10.4 12.1 15.4 12.0 17.2 16.2 16.9 10.1 10.5 11.7 10.5 12.2 12.4 17.4 22.4 16.8 8.1 16.0 12.8 8.9 7.4 7.0 11.1 6.7 6.5 9.5 7.0 8.0 14.1 12.3 9.8 10.7 8.3 7.8 6.9 7.4 9.4 11.6 12.9 7.4 9.3 17.5 16.0 16.2 20.8 9.5 11.1 11.2 10.0 12.0 14.1 7.5 6.1 9.1 11.3 18.8 11.0 5.8 8.2 9.4 21.6 16.3 10.4 11.2 12.0 9.9 13.2 7.1 4.9 9.2 11.3 13.6 12.0 20.9 7.9 10.6 11.6 9.3 9.1 10.5 12.2 7.9 14.2 19.4 11.0 8.2 16.0 7.9 22.4 16.8 19.7 16.0 13.7 12.9 12.4 13.3 14.0 17.4 12.1 14.0 13.2 7.1 8.1 15.8 13.3 11.4 12.8 13.1 13.6 19.5 20.9 11.6 10.9 12.6 10.8 13.6 16.2 3.0 4.6 13.4 4.8 8.7 5.6 3.1 2.5 2.7 2.3 0.0 11.8 13.7 5.0 9.3 0.6 6.8 9.9 0.0 10.7 8.1 6.2 3.7 5.7 5.1 9.5 4.8 10.9 8.0 7.6 1.0 4.9 7.3 8.5 18.0 4.7 5.6 8.3 7.0 6.7 6.7 4.8 6.5 7.1 8.9 22.9 8.5 25.2 10.2 5.2 4.2 GPBP1 "DKFZp761C169, vasculin" ENSG00000062194 "GC-rich promoter binding protein 1" Q86WP2 5 57173948-57264679 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037773 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Cytosol" "Plasma membrane" "HPA037773: AB_10671721" "unprognostic (1.53e-1)" "unprognostic (2.23e-2)" "unprognostic (1.57e-1)" "unprognostic (3.49e-1)" "unprognostic (8.30e-2)" "unprognostic (9.68e-3)" "unprognostic (1.24e-2)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (3.70e-1)" "unprognostic (5.93e-2)" "unprognostic (5.48e-2)" "unprognostic (3.75e-2)" "unprognostic (1.65e-1)" "unprognostic (4.89e-2)" "unprognostic (2.57e-1)" "prognostic favorable (4.15e-5)" 25.6 33.1 33.8 27.0 37.8 38.0 37.2 53.9 34.0 30.6 23.5 29.7 20.3 20.8 29.0 33.1 25.5 32.4 24.5 25.4 32.5 28.4 27.1 28.4 29.9 34.0 41.5 34.0 46.7 23.5 37.6 43.9 35.6 33.2 27.6 24.9 19.7 27.2 26.9 37.3 24.6 25.8 22.0 42.4 31.5 24.0 46.9 37.2 49.9 35.1 20.3 33.7 29.4 50.2 31.7 18.9 35.5 18.9 33.5 37.7 27.1 21.8 17.5 33.5 28.1 21.9 21.8 30.8 16.6 28.4 27.6 35.6 28.2 25.4 29.0 19.5 17.0 34.2 15.1 28.6 19.2 35.0 16.4 19.6 23.8 19.9 23.5 25.6 17.1 24.6 17.7 29.8 22.5 31.6 26.6 22.2 23.7 24.1 47.7 22.0 27.4 27.0 30.0 20.8 10.7 12.2 29.3 27.4 28.4 21.2 22.7 30.1 23.4 24.3 21.8 26.5 22.6 42.6 29.3 14.7 10.1 20.7 14.6 24.0 36.3 30.4 32.3 16.9 25.9 18.8 35.5 17.1 32.3 28.1 17.7 35.2 31.7 34.0 33.1 18.9 26.8 37.7 34.9 33.2 33.5 18.9 13.4 35.3 27.1 33.8 37.8 53.9 34.0 32.5 28.4 41.5 34.0 33.2 37.2 56.6 73.1 104.6 209.8 202.1 136.5 78.6 50.9 156.6 117.2 80.3 139.4 79.0 84.6 64.9 165.9 107.9 88.6 0.0 48.6 61.5 139.8 213.9 141.7 40.1 49.2 127.1 103.2 53.4 59.9 85.3 124.0 98.1 178.8 169.5 57.2 92.1 59.0 101.7 85.9 53.3 176.2 51.8 188.5 265.7 227.4 207.8 135.2 127.1 57.2 255.1 GPBP1L1 SP192 ENSG00000159592 "GC-rich promoter binding protein 1 like 1" Q9HC44 1 45627304-45688113 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028593 Approved Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites, Cytosol" "HPA028593: AB_10602906" "unprognostic (1.39e-1)" "unprognostic (8.41e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (6.35e-2)" "unprognostic (1.97e-3)" "unprognostic (2.42e-3)" "unprognostic (9.79e-2)" "unprognostic (3.91e-2)" "unprognostic (1.94e-3)" "unprognostic (1.12e-2)" "unprognostic (4.11e-1)" "unprognostic (1.25e-2)" "unprognostic (6.63e-2)" "unprognostic (4.51e-1)" "unprognostic (7.56e-3)" "unprognostic (6.13e-2)" 29.9 20.5 16.9 21.2 23.7 24.9 25.2 24.4 18.6 27.4 36.9 33.3 29.7 31.6 26.3 23.8 34.8 22.5 19.7 23.9 17.3 17.0 30.2 38.9 28.3 29.1 33.2 12.4 24.7 46.9 24.4 36.6 25.7 22.1 26.4 37.2 29.8 33.5 35.3 29.6 31.0 58.0 25.7 28.2 30.6 26.2 33.2 27.2 40.5 37.7 30.3 35.4 32.5 27.5 13.5 17.8 29.8 22.1 20.0 20.0 15.4 15.8 9.8 17.1 18.1 20.2 19.7 23.4 12.6 21.0 18.3 23.1 9.8 17.8 22.0 16.5 17.3 19.3 16.6 18.7 19.0 23.3 25.1 13.3 28.5 11.4 15.2 27.8 28.4 26.5 14.3 41.6 14.3 41.0 24.7 23.1 28.3 24.3 19.6 20.8 8.5 25.2 25.6 24.3 21.4 11.2 16.6 22.2 16.1 21.0 15.7 21.1 14.1 20.8 30.8 32.1 34.8 14.0 33.6 19.6 13.2 13.9 14.2 19.1 19.2 17.8 16.2 13.9 23.8 13.8 16.4 16.6 29.8 17.8 21.2 18.9 13.5 17.6 17.4 17.8 11.5 19.4 18.9 17.7 20.0 22.1 10.2 20.0 15.4 16.9 23.7 24.4 18.6 17.3 17.0 33.2 12.4 22.1 27.2 56.6 19.5 31.8 35.2 57.7 23.3 41.7 45.9 16.0 29.6 57.6 33.4 23.0 43.1 29.6 10.8 38.3 66.9 46.7 33.6 29.3 24.3 50.8 58.8 72.6 22.6 35.0 36.8 31.9 45.9 13.4 19.0 33.1 21.9 23.4 66.9 16.0 42.8 46.0 20.1 45.1 32.3 19.4 35.3 70.7 75.4 59.2 38.0 35.1 54.0 53.8 GPC1 glypican ENSG00000063660 "Glypican 1" P35052 2 240435671-240468078 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 142.6" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 181.5;Syncytiotrophoblasts: 85.9;Urothelial cells: 90.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030571, HPA070449" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 6500000 "Plasma membrane, Cytosol" "HPA030571: AB_10602322, HPA070449: " "unprognostic (1.22e-2)" "unprognostic (2.53e-2)" "prognostic unfavorable (5.78e-5)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.95e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (1.00e-2)" "unprognostic (2.15e-1)" "unprognostic (5.08e-3)" "unprognostic (2.28e-1)" "unprognostic (4.38e-1)" "unprognostic (1.91e-1)" "unprognostic (4.40e-2)" "unprognostic (2.92e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-2)" 13.6 22.8 32.4 7.2 21.0 1.9 8.1 42.7 33.6 11.5 8.1 10.1 9.5 5.4 9.6 9.8 26.3 7.8 7.1 40.7 26.5 11.9 8.5 11.0 7.4 4.0 8.8 22.5 14.1 18.1 5.8 14.4 20.2 13.6 29.5 4.0 6.3 16.3 17.6 62.9 142.6 4.9 12.0 8.3 5.2 6.5 20.0 10.5 1.7 4.5 24.3 10.7 10.5 15.2 0.9 0.1 0.0 0.0 0.1 0.8 0.3 16.2 22.4 5.3 13.9 16.2 15.6 21.6 39.0 19.4 4.5 5.3 7.9 18.2 0.4 5.4 41.3 24.7 44.9 2.8 27.7 0.9 7.8 2.4 0.0 20.6 9.8 23.3 0.3 1.5 13.7 18.1 10.1 5.3 9.5 2.3 0.8 0.1 0.8 11.5 8.5 0.3 0.1 8.3 1.8 5.0 2.9 24.2 3.7 3.6 26.3 5.3 3.5 25.5 22.5 2.3 5.0 7.1 1.6 10.9 24.3 41.2 11.5 16.1 0.1 0.1 0.1 17.3 0.4 27.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.2 0.1 0.9 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.3 32.4 21.0 42.7 33.6 26.5 11.9 8.8 22.5 13.6 10.5 14.9 6.7 0.0 52.5 40.8 12.0 50.2 22.9 8.1 23.9 24.4 2.0 58.0 6.6 25.6 0.6 3.7 0.9 0.0 9.3 181.5 28.8 15.7 4.6 19.2 8.0 23.8 0.0 15.4 0.0 2.1 17.5 2.7 33.7 2.8 4.3 27.8 13.4 0.0 7.1 2.2 4.9 25.8 16.5 0.5 4.9 40.4 85.9 0.7 2.7 90.8 GPC5 ENSG00000179399 "Glypican 5" P78333 13 91398607-92873682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;kidney: 14.8;testis: 11.3" "Cell type enriched" "Detected in some" 23 "Distal tubular cells: 54.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 11 "CACO-2: 31.4;HeLa: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040152, HPA044081" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA040152: AB_2676863, HPA044081: AB_2678801" "unprognostic (4.99e-3)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (9.93e-5)" "prognostic unfavorable (4.37e-4)" "unprognostic (4.46e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (9.49e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-5)" "unprognostic (2.19e-2)" "unprognostic (1.82e-6)" "unprognostic (3.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.11e-1)" "unprognostic (6.69e-3)" 0.8 3.8 11.8 1.1 18.3 0.8 0.7 3.1 18.9 0.6 1.5 2.9 0.1 0.7 0.6 0.9 0.6 0.8 1.6 2.3 11.8 6.0 14.8 2.9 6.5 1.0 7.3 5.6 1.5 0.8 0.6 7.7 1.4 19.4 0.9 1.5 0.0 0.8 1.5 0.6 0.7 0.8 0.8 4.4 0.7 0.9 11.3 6.6 0.0 2.7 0.0 0.7 0.6 0.3 0.5 0.4 0.3 1.8 2.0 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 18.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 2.2 0.1 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.1 1.2 0.4 0.2 0.0 0.5 0.3 2.0 1.8 0.0 0.0 0.2 11.8 18.3 3.1 8.6 11.8 6.0 7.3 5.6 19.4 6.6 0.0 2.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.1 54.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 GPER1 "CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR" ENSG00000164850 "G protein-coupled estrogen receptor 1" Q99527 7 1082208-1093815 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 22.2;Kupffer cells: 13.5;Paneth cells: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.3;intermediate monocyte: 4.2;myeloid DC: 8.4" "Group enriched" "Detected in many" 18 "dendritic cells: 8.4;monocytes: 4.3" "Cell line enhanced" "Detected in many" "AN3-CA: 10.1;Daudi: 10.6;Hep G2: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA016718, HPA027052" Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Nucleoli "Nucleoplasm, Vesicles, Cytosol" "HPA016718: , HPA027052: AB_10612112" "unprognostic (4.74e-2)" "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "prognostic favorable (1.17e-4)" "unprognostic (2.17e-1)" "unprognostic (6.17e-2)" "unprognostic (3.45e-1)" "unprognostic (6.38e-2)" "unprognostic (2.40e-1)" "unprognostic (1.23e-1)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.58e-1)" "unprognostic (7.26e-2)" "unprognostic (7.78e-2)" 14.2 10.9 12.1 3.6 13.2 1.2 11.5 5.1 11.1 6.4 7.1 5.6 3.5 2.0 5.4 1.8 5.5 4.8 3.2 6.0 8.3 6.2 7.4 19.5 25.6 6.4 8.6 8.7 3.3 4.0 1.8 4.7 13.3 6.1 6.8 3.7 5.2 4.2 11.8 8.6 2.8 2.6 5.5 4.1 6.5 23.9 2.2 8.6 1.3 16.5 2.3 2.8 6.4 7.2 0.3 8.4 0.0 4.3 0.0 0.0 1.6 0.9 0.4 0.2 10.1 2.5 2.4 1.0 5.8 3.9 1.8 3.3 0.2 0.2 10.6 1.0 7.3 0.1 0.5 0.1 0.0 0.2 2.2 1.8 0.0 1.3 19.4 0.3 0.1 0.7 1.3 0.0 1.1 0.0 1.4 0.5 0.2 0.1 0.1 0.4 0.7 0.0 0.3 1.9 2.0 6.9 0.9 0.0 0.0 0.2 0.0 0.1 4.0 0.0 0.4 2.1 0.8 0.2 0.1 1.4 0.4 2.6 6.1 1.8 0.0 0.0 3.6 3.4 0.2 0.2 0.0 4.3 0.0 0.0 4.2 0.0 0.3 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.6 12.1 13.2 5.1 11.1 8.3 6.2 8.6 8.7 6.1 8.6 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 2.2 1.3 0.0 2.8 0.5 1.4 0.7 0.0 22.2 0.5 0.0 1.2 0.6 13.5 0.6 2.6 1.7 0.0 0.0 2.5 4.3 0.8 8.2 1.1 3.0 0.4 0.0 4.1 0.3 3.1 0.3 0.0 0.0 1.5 0.0 GPI "AMF, NLK" ENSG00000105220 "Glucose-6-phosphate isomerase" P06744 19 34359480-34402413 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Gluconeogenesis, Glycolysis" "Cytokine, Growth factor, Isomerase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 321.8;Late spermatids: 797.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018655, HPA024305, CAB040563, HPA052171" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" No No 140000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748" "unprognostic (1.03e-1)" "unprognostic (8.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.38e-2)" "unprognostic (4.52e-2)" "unprognostic (6.45e-3)" "unprognostic (1.95e-2)" "unprognostic (8.52e-3)" "unprognostic (3.18e-1)" "unprognostic (1.45e-1)" "unprognostic (4.93e-2)" "unprognostic (2.75e-1)" "unprognostic (3.24e-3)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (2.60e-3)" "unprognostic (2.88e-2)" 62.1 66.6 43.4 27.6 58.2 83.3 34.8 62.6 88.7 20.6 36.6 20.8 23.7 48.2 21.1 20.6 45.3 24.2 33.5 107.2 42.0 45.6 51.3 77.9 19.6 29.6 39.3 64.3 22.5 21.4 66.9 33.7 20.4 50.2 23.7 37.2 36.2 34.6 33.9 144.7 29.4 44.3 34.2 22.8 23.1 26.7 19.7 19.0 23.8 26.1 68.5 32.6 32.5 25.2 16.2 26.3 74.8 40.9 14.5 27.5 24.6 76.8 108.3 9.5 74.2 31.2 23.2 22.7 29.7 23.5 37.5 45.2 61.0 27.3 50.7 44.1 29.0 25.5 53.6 57.3 64.5 42.6 56.3 23.2 65.0 52.2 64.2 20.2 84.2 42.4 31.8 26.7 44.2 23.0 47.4 35.0 34.4 33.1 40.1 26.3 65.2 36.6 29.5 25.7 69.7 38.4 34.3 25.1 95.7 46.9 51.8 51.9 30.2 59.8 105.5 21.6 17.8 23.9 26.9 30.1 14.2 31.2 40.1 45.7 74.2 42.1 46.0 47.2 64.1 28.6 38.5 22.9 74.8 22.5 35.2 27.5 16.2 20.7 25.5 26.3 13.3 17.5 20.7 1.6 14.5 40.9 8.7 21.6 24.6 43.4 58.2 62.6 88.7 42.0 45.6 39.3 64.3 50.2 19.0 26.8 40.2 23.1 22.0 23.0 92.5 198.3 38.2 21.4 25.0 54.1 70.7 38.6 97.8 77.9 321.8 30.6 90.3 0.0 57.9 60.0 36.8 27.8 22.0 68.1 78.6 224.1 61.2 47.9 41.6 797.8 34.2 41.9 33.7 45.9 67.6 28.6 75.7 25.9 28.7 79.1 62.2 19.4 38.7 6.9 7.6 28.7 32.8 47.1 102.1 32.5 GPN1 "ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1" ENSG00000198522 "GPN-loop GTPase 1" Q9HCN4 2 27628247-27651508 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036793, HPA036794, CAB037303" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230" "unprognostic (9.42e-2)" "unprognostic (1.44e-1)" "unprognostic (5.64e-2)" "prognostic unfavorable (2.88e-5)" "unprognostic (2.57e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.71e-5)" "unprognostic (3.50e-2)" "unprognostic (8.27e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-3)" "unprognostic (2.34e-1)" "unprognostic (1.21e-2)" "unprognostic (2.51e-1)" "unprognostic (1.13e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" 24.3 24.3 18.8 18.7 23.2 28.1 26.3 22.9 27.2 18.3 21.6 20.7 13.7 19.3 21.3 21.2 26.7 21.0 18.2 21.5 17.2 22.1 29.7 29.2 18.2 29.2 20.0 16.1 24.6 35.4 19.8 18.5 31.1 23.3 18.8 25.6 14.3 23.0 17.6 30.9 25.0 25.3 22.1 16.4 26.6 20.8 30.2 15.9 29.0 26.9 22.5 28.3 21.5 24.3 29.1 35.8 28.5 28.2 39.6 38.6 29.7 32.7 18.6 17.6 12.7 16.6 17.0 17.9 18.3 18.3 26.0 19.3 20.3 17.2 20.5 17.9 20.0 24.1 14.3 24.4 22.8 26.4 19.1 17.0 23.4 15.0 24.7 21.6 34.3 12.3 17.5 20.1 26.7 25.1 18.1 27.1 18.7 29.0 19.3 30.7 19.1 20.7 25.7 30.4 25.0 18.4 20.9 52.1 21.4 21.0 18.9 15.7 24.9 20.1 22.6 20.3 17.1 13.6 19.9 22.0 22.7 33.6 11.2 42.9 22.3 24.0 55.2 32.7 29.8 18.6 28.5 24.7 21.1 33.4 28.2 36.0 29.1 31.1 38.6 35.8 25.2 27.7 34.1 3.7 39.6 26.3 18.5 30.3 29.7 18.8 23.2 22.9 27.2 17.2 22.1 20.0 16.1 23.3 15.9 11.9 7.2 7.2 18.2 19.3 7.9 9.7 17.8 10.7 14.8 14.0 3.9 36.5 19.9 46.3 69.8 14.5 10.8 0.0 31.4 38.5 20.1 18.3 24.3 8.6 29.3 11.1 16.7 15.4 18.9 67.5 13.8 19.3 21.9 33.3 13.3 12.0 35.5 10.5 10.3 15.6 9.1 12.9 20.8 26.2 22.6 16.3 27.7 33.0 19.5 16.6 GPN3 "ATPBD1C, MGC14560" ENSG00000111231 "GPN-loop GTPase 3" Q9UHW5 12 110452484-110469268 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 166.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039764, HPA047793" Uncertain Approved "Nuclear speckles,Cytosol" Yes No "Nuclear speckles" Cytosol "HPA039764: AB_2676669, HPA047793: AB_2680157" "unprognostic (1.68e-3)" "unprognostic (1.11e-2)" "unprognostic (9.82e-2)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.27e-3)" "prognostic unfavorable (3.98e-5)" "unprognostic (5.50e-2)" "unprognostic (4.45e-2)" "unprognostic (2.70e-1)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" "prognostic favorable (2.65e-6)" "unprognostic (5.81e-2)" "unprognostic (2.85e-1)" "unprognostic (1.62e-1)" "unprognostic (2.27e-1)" 17.8 15.1 14.1 11.2 17.3 9.6 26.7 18.4 14.2 13.0 12.5 11.9 10.1 5.9 14.9 11.8 15.6 15.1 10.2 24.8 11.4 10.9 23.3 23.2 13.6 14.8 26.6 11.4 19.4 14.5 19.6 12.2 15.4 18.6 17.0 10.0 11.0 16.6 14.3 35.1 9.6 8.7 17.5 20.0 16.0 13.6 28.3 19.4 11.8 20.1 22.0 12.6 16.5 13.1 20.2 28.0 34.4 31.4 11.8 18.9 16.8 15.4 24.0 16.7 16.3 18.8 11.9 22.1 21.3 13.0 24.1 19.6 22.3 9.3 29.8 14.9 11.6 17.9 14.3 20.6 19.1 32.8 17.0 19.2 17.6 12.9 18.4 13.1 27.4 16.3 12.7 12.1 23.6 15.3 13.5 17.3 25.4 29.6 6.8 16.8 10.5 25.1 52.4 20.4 21.8 24.6 8.6 23.1 22.9 15.1 13.9 12.8 13.3 21.7 14.9 18.0 22.3 25.4 32.5 9.5 20.1 14.7 19.5 24.6 9.4 24.3 31.0 14.7 25.4 22.8 15.3 24.5 34.4 14.0 31.4 15.5 20.2 15.0 15.8 22.6 19.9 18.9 12.6 12.6 11.8 31.1 28.0 12.3 16.8 14.1 17.3 18.4 14.2 11.4 10.9 26.6 11.4 18.6 19.4 23.8 28.0 25.6 41.8 26.6 16.7 38.6 20.4 36.1 26.1 31.4 13.7 52.1 91.2 21.8 68.6 20.5 3.3 0.0 18.6 61.2 26.5 33.4 30.1 31.6 80.2 20.6 7.9 13.5 18.3 13.4 18.4 30.1 15.1 46.9 8.4 17.2 19.9 10.4 22.3 56.6 24.3 25.8 27.8 166.3 65.2 22.2 39.0 16.7 11.8 35.7 GPR142 PGR2 ENSG00000257008 "G protein-coupled receptor 142" Q7Z601 17 74367407-74372622 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;lymphoid tissue: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA031392 Uncertain Uncertain "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA031392: AB_10601935" "unprognostic (6.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (4.16e-2)" "unprognostic (4.85e-7)" "unprognostic (3.95e-2)" "unprognostic (7.72e-4)" "unprognostic (1.93e-1)" "unprognostic (1.68e-3)" 0.2 0.0 0.0 1.3 0.1 0.0 0.1 1.3 0.2 0.3 0.1 0.8 0.6 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5;stomach 1: 43.2" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 117.8;Melanocytes: 145.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 16.3;WM-115: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: AB_2683424" "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.5 10.1 9.3 6.6 34.5 2.6 3.0 15.1 17.3 3.2 11.4 6.1 2.2 4.0 2.6 13.1 6.7 2.5 5.9 6.8 15.5 9.4 19.8 7.3 3.3 5.9 7.7 11.5 3.0 16.9 8.0 3.2 4.7 27.4 8.0 4.2 4.9 3.7 8.8 5.1 13.4 5.1 7.8 6.9 5.3 43.2 2.6 9.9 1.6 8.3 0.8 3.8 6.6 3.6 1.5 0.8 9.6 6.8 4.7 7.0 1.9 0.7 0.4 1.0 2.5 5.7 3.2 0.6 4.3 1.5 0.7 2.4 0.3 0.4 2.4 1.4 3.0 1.5 0.4 1.4 1.3 2.4 0.9 1.7 2.6 1.4 0.2 1.1 0.9 1.4 4.6 3.6 2.1 0.7 4.6 1.1 3.4 0.4 6.2 4.8 0.7 1.7 1.2 0.6 2.6 1.7 2.1 6.2 1.2 2.4 1.6 6.7 5.7 1.3 1.0 2.2 3.1 0.4 0.4 3.1 3.1 1.2 4.5 0.6 16.3 2.3 0.4 3.6 0.8 10.8 1.5 2.9 0.1 2.4 5.4 2.2 1.3 4.4 4.0 0.8 1.5 3.5 5.4 9.6 4.7 6.8 0.5 7.0 1.9 9.3 34.5 15.1 16.2 15.5 9.4 7.7 11.5 27.4 9.9 11.9 2.2 11.7 2.9 37.9 30.8 21.8 2.5 0.0 10.3 10.4 117.8 1.2 1.7 2.0 0.3 9.0 0.3 0.0 5.0 1.0 7.7 3.4 1.1 16.1 5.9 47.7 12.2 20.9 36.6 0.9 13.8 21.7 145.1 1.8 0.2 15.6 5.6 0.0 30.1 34.6 22.9 0.0 10.8 3.3 2.6 25.0 0.7 17.9 1.1 1.5 GPR173 SREB3 ENSG00000184194 "G protein-coupled receptor 173" Q9NS66 X 53049091-53080615 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 6.4;Horizontal cells: 6.4;Intestinal endocrine cells: 3.4;Peritubular cells: 4.2" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 1.8" "Cell line enhanced" "Detected in many" "HAP1: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003905 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA003905: AB_1078922" "unprognostic (2.68e-1)" "unprognostic (2.33e-1)" "unprognostic (4.95e-3)" "prognostic unfavorable (2.88e-6)" "unprognostic (3.87e-2)" "unprognostic (8.58e-2)" "unprognostic (2.73e-1)" "unprognostic (1.47e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-2)" "prognostic favorable (2.33e-5)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.08e-4)" "unprognostic (2.83e-1)" "unprognostic (3.92e-2)" "unprognostic (6.95e-2)" 2.5 5.2 8.2 3.0 9.4 2.2 3.1 15.4 23.2 4.2 2.8 11.6 0.8 1.8 6.4 5.0 2.4 7.7 3.3 4.2 7.9 10.0 2.4 1.1 2.8 2.1 7.3 11.2 15.0 1.3 1.3 14.6 4.5 9.7 3.2 2.6 6.4 2.0 5.4 4.6 3.9 2.1 4.5 6.5 4.0 2.1 2.4 9.6 0.7 3.1 0.1 1.5 3.3 2.8 0.9 0.7 5.7 0.4 1.8 0.7 0.0 0.0 0.0 8.1 0.5 4.6 2.7 0.0 1.3 2.9 2.1 2.5 0.8 0.1 0.2 2.0 2.8 6.4 0.6 10.2 0.0 1.9 0.6 1.0 0.5 8.3 0.3 6.7 0.5 0.1 6.6 0.0 3.3 4.6 7.5 3.5 0.0 0.0 5.7 3.2 4.2 0.0 0.0 6.3 0.4 3.6 0.1 2.4 0.3 0.5 0.4 5.9 8.3 0.0 0.4 0.0 5.5 1.1 0.1 6.4 3.5 5.1 2.3 1.1 0.2 0.3 0.7 2.5 0.0 1.9 5.7 0.2 0.3 0.7 0.1 0.5 0.3 0.2 0.1 0.1 0.9 0.5 0.4 1.2 1.8 0.4 0.7 0.0 0.0 8.2 9.4 15.4 15.1 7.9 10.0 7.3 11.2 9.7 9.6 0.0 0.0 0.0 0.4 0.2 6.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.2 6.4 3.4 1.8 0.3 0.0 2.8 0.0 1.7 0.0 0.1 2.7 0.1 0.0 4.2 0.0 2.8 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 GPR20 ENSG00000204882 "G protein-coupled receptor 20" Q99678 8 141356500-141367267 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 71.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "intermediate monocyte: 3.7;non-classical monocyte: 5.4" "Lineage enriched" "Detected in single" 14 "monocytes: 5.4" "Cell line enriched" "Detected in some" 4 "EFO-21: 7.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.3" HPA071337 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA071337: " "unprognostic (4.47e-2)" "unprognostic (2.64e-3)" "unprognostic (5.18e-2)" "unprognostic (2.00e-2)" "unprognostic (7.47e-2)" "unprognostic (2.28e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (3.54e-1)" "unprognostic (2.13e-2)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (7.41e-2)" "unprognostic (5.50e-2)" "unprognostic (6.23e-2)" "unprognostic (4.07e-1)" 2.8 0.5 0.7 2.7 1.4 0.1 2.5 0.2 2.0 10.6 9.1 1.0 4.3 2.2 6.7 1.9 3.4 3.9 6.1 2.1 0.8 0.4 1.1 0.4 3.5 0.3 1.4 0.9 3.7 0.5 0.5 0.5 3.2 2.1 2.2 1.0 1.1 0.5 3.0 2.1 1.0 10.5 4.5 0.5 0.8 4.3 1.6 0.7 0.0 1.4 1.5 0.5 1.7 3.4 0.0 0.3 0.3 5.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 7.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.2 0.5 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 5.4 0.0 0.0 0.1 0.7 1.4 0.2 2.0 0.8 0.4 1.4 0.9 2.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 71.1 16.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71754050-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2;parathyroid gland: 29.6" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 11.0;Collecting duct cells: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "eosinophil: 3.7;neutrophil: 10.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.5" "Cell line enhanced" "Detected in some" "EFO-21: 13.0;HL-60: 12.5;MCF7: 10.8;NTERA-2: 21.5;RPTEC TERT1: 10.4;SH-SY5Y: 8.2;T-47d: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favorable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.7 4.5 14.9 1.7 23.2 14.5 4.3 4.4 15.4 3.4 1.0 5.8 1.7 0.6 5.5 3.3 2.7 7.7 1.2 3.5 12.8 12.4 3.2 0.9 2.4 5.5 10.6 8.8 5.0 2.6 29.6 5.1 2.0 5.9 5.7 0.7 3.3 1.7 5.1 1.8 1.9 0.7 3.3 16.8 3.7 2.4 4.2 3.6 0.0 6.8 1.2 0.5 2.1 2.8 0.0 0.2 10.5 0.8 0.0 0.4 0.1 0.0 0.8 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 13.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 12.5 0.7 0.0 2.2 0.0 0.9 0.0 0.0 2.7 0.0 0.0 0.0 10.8 0.9 0.2 21.5 0.0 0.0 0.0 0.0 0.0 10.4 5.8 2.3 8.2 2.8 0.0 0.0 2.9 7.5 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.8 3.7 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 10.5 0.0 0.1 0.0 0.0 0.1 14.9 23.2 4.4 9.9 12.8 12.4 10.6 8.8 5.9 3.6 0.0 1.4 0.0 4.0 1.6 11.0 2.8 5.1 2.7 2.3 12.2 3.9 1.1 1.7 0.4 0.1 0.0 0.0 0.0 0.0 1.1 0.9 4.5 0.0 0.0 1.0 0.0 1.2 0.0 5.1 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.4 0.0 1.1 0.0 0.3 0.0 0.4 0.2 0.9 1.5 0.2 0.0 0.0 1.8 GPR34 ENSG00000171659 "G protein-coupled receptor 34" Q9UPC5 X 41688973-41697277 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 60.8" "Cell type enhanced" "Detected in some" 23 "granulocytes: 35.9;Hofbauer cells: 198.9;Kupffer cells: 113.1;Macrophages: 46.2" "Cancer enhanced" "Detected in all" "glioma: 26.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 60.8;eosinophil: 25.3" "Lineage enriched" "Detected in many" 20 "granulocytes: 60.8" "Cell line enhanced" "Detected in some" "HMC-1: 5.0;JURKAT: 2.6;U-937: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010668, CAB025490" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB025490: , HPA010668: AB_1849294" "unprognostic (1.26e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-2)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.59e-2)" "unprognostic (9.81e-3)" "unprognostic (7.19e-2)" "unprognostic (1.74e-1)" "unprognostic (3.96e-1)" "unprognostic (2.72e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-3)" "unprognostic (3.18e-2)" 25.1 12.4 15.1 9.7 16.6 0.4 15.0 2.1 11.7 10.5 9.1 13.5 1.0 4.4 4.9 6.6 5.8 5.5 12.2 5.9 16.0 9.5 11.7 5.3 11.4 26.8 22.4 7.5 5.4 4.4 2.8 3.3 29.3 15.4 5.7 9.3 4.9 7.1 6.4 2.1 2.4 11.4 11.5 34.0 22.3 5.1 5.0 21.4 1.9 3.4 1.5 11.1 12.5 3.7 0.3 0.4 60.8 2.8 3.0 0.1 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 1.0 0.4 0.0 0.2 0.0 0.1 5.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.2 0.7 0.3 0.0 0.4 0.1 1.1 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 0.8 0.1 0.0 0.0 0.1 0.6 1.3 0.0 60.8 2.2 25.3 0.0 2.8 0.0 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.2 3.0 1.5 0.0 0.1 0.5 15.1 16.6 2.1 11.7 16.0 9.5 22.4 7.5 15.4 21.4 0.0 3.2 2.7 0.2 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.3 1.7 0.1 35.9 0.0 198.9 0.0 1.2 3.1 113.1 0.6 0.9 46.2 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 19.4 0.0 0.0 0.1 0.9 2.1 1.7 0.0 0.0 GPR37 "EDNRBL, hET(B)R-LP, PAELR" ENSG00000170775 "G protein-coupled receptor 37" O15354 7 124745997-124765627 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 62.4" "Cell type enriched" "Detected in many" 36 "Muller glia cells: 779.4" "Cancer enhanced" "Detected in many" "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.4;fHDF/TERT166: 22.0;hTCEpi: 9.8;SK-BR-3: 8.5;SuSa: 10.6;TIME: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042903, HPA068009" Approved Approved "Nuclear membrane,Cytosol" No No 48000 "Nuclear membrane, Cytosol" "HPA042903: AB_2678219, HPA068009: AB_2685940" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-2)" "unprognostic (7.29e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (6.19e-2)" "prognostic favorable (7.26e-4)" "unprognostic (6.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.16e-2)" "unprognostic (6.12e-3)" "unprognostic (2.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.71e-4)" 1.6 1.0 14.5 1.1 19.6 0.9 1.7 2.3 52.6 1.5 1.4 62.4 0.0 1.0 2.1 1.4 7.8 2.1 1.4 0.9 23.9 11.3 1.2 8.8 1.3 1.1 33.5 12.3 1.0 3.0 0.8 0.3 10.0 23.3 1.8 1.5 3.5 1.6 1.8 1.1 4.1 1.3 3.0 49.4 4.3 1.2 15.5 26.5 0.0 0.9 0.0 0.9 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 9.4 0.0 0.0 0.0 2.7 0.5 2.5 2.4 0.6 0.4 0.8 0.0 0.0 22.0 0.3 0.2 2.8 0.0 0.5 0.4 1.2 0.1 5.9 0.0 2.8 0.0 0.4 0.0 9.8 0.0 0.1 0.0 4.5 0.0 0.0 4.3 0.0 0.5 0.0 0.0 1.4 0.0 4.5 0.0 0.0 0.0 0.0 0.1 2.2 3.3 0.0 8.5 3.2 10.6 2.2 0.0 15.3 2.0 0.7 0.0 0.0 1.3 0.0 0.0 1.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 19.6 2.3 19.6 23.9 11.3 33.5 12.3 23.3 26.5 0.0 0.0 0.0 0.3 4.0 21.7 0.4 2.5 0.0 0.0 1.8 5.9 7.1 0.0 4.3 0.2 0.5 0.0 0.0 0.5 15.1 2.7 2.1 0.0 21.5 1.0 17.5 0.0 0.0 0.3 0.9 2.6 0.0 3.3 1.0 0.4 779.4 0.4 0.0 0.7 0.0 12.5 0.0 0.9 0.6 0.7 8.9 2.5 0.0 0.0 0.1 GPR63 "PSP24(beta), PSP24B" ENSG00000112218 "G protein-coupled receptor 63" Q9BZJ6 6 96794126-96837463 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Early spermatids: 21.8;Late spermatids: 26.5;Spermatocytes: 22.8;Spermatogonia: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 7.8;HHSteC: 12.8;Karpas-707: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039103 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039103: AB_10672841" "unprognostic (8.22e-2)" "unprognostic (2.77e-1)" "unprognostic (1.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (1.33e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (3.39e-1)" "unprognostic (2.53e-2)" "unprognostic (7.29e-3)" "unprognostic (3.00e-1)" "unprognostic (2.03e-3)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-2)" 1.8 3.4 3.8 3.1 11.0 0.8 1.6 7.5 10.7 3.3 3.9 1.6 1.0 5.1 1.9 1.5 2.0 2.8 2.7 1.9 3.2 2.2 1.4 0.5 1.4 0.9 2.2 6.4 4.0 5.0 3.9 4.3 2.5 10.1 3.3 6.2 2.5 1.7 2.2 1.0 1.7 3.6 3.6 1.4 1.3 4.1 8.0 5.2 2.5 2.3 0.0 0.9 2.2 4.8 0.8 0.9 2.6 0.6 1.4 1.1 0.1 0.0 0.1 1.5 0.3 2.2 0.8 0.4 0.9 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.1 1.2 1.1 4.9 2.3 0.0 7.8 3.8 4.7 0.4 0.0 12.8 2.9 0.5 2.4 0.4 0.0 3.5 0.3 0.0 7.0 3.4 19.2 0.4 0.4 2.2 0.0 5.0 0.0 0.7 0.0 1.8 3.8 0.3 0.2 2.3 1.4 0.3 3.1 0.5 1.7 1.2 0.6 0.0 1.3 2.0 0.2 1.8 1.5 0.8 0.1 0.8 1.8 1.0 0.8 0.6 0.2 0.6 0.2 0.3 0.7 1.1 0.6 0.1 0.8 1.0 0.9 2.6 1.4 0.2 0.9 0.3 0.1 3.8 11.0 7.5 10.7 3.2 2.2 2.2 6.4 10.1 5.2 0.0 0.0 0.0 0.8 1.6 1.1 0.5 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.4 21.8 0.1 0.0 0.0 0.8 0.6 0.9 1.0 0.0 0.0 0.2 0.0 2.9 1.8 0.0 26.5 3.1 0.0 1.7 0.0 0.4 0.3 0.5 0.0 4.6 0.0 0.2 0.0 1.1 22.8 9.3 0.3 0.1 0.0 0.5 0.3 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005124-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.4;lymphoid tissue: 40.8" "Cell type enhanced" "Detected in many" 19 "granulocytes: 306.4;Kupffer cells: 79.3;monocytes: 79.4;T-cells: 135.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 6.3;HEL: 6.8;HL-60: 8.1;HMC-1: 10.4;RH-30: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 9.8 3.1 1.8 12.1 6.4 15.2 2.3 0.7 3.0 1.9 2.4 0.9 0.9 2.3 2.2 2.2 2.3 2.2 4.1 2.3 6.0 2.1 4.0 6.9 10.6 13.1 8.2 0.0 1.7 1.8 0.8 6.2 3.6 6.3 2.9 2.3 1.2 2.6 0.9 0.9 1.2 7.7 3.3 15.7 40.8 2.5 1.5 6.2 12.5 1.8 2.3 8.9 4.8 2.3 4.3 5.9 19.1 13.7 21.3 30.4 9.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.8 0.0 0.0 0.3 8.1 10.4 0.4 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.2 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 14.6 9.1 19.1 16.5 12.8 30.4 4.3 8.4 12.6 5.9 4.0 4.4 9.7 6.9 21.3 13.7 2.7 4.0 9.4 1.8 6.4 0.7 3.0 6.0 2.1 8.2 0.0 6.3 6.2 3.0 35.3 38.9 0.4 3.8 0.0 0.3 5.1 1.4 2.3 0.0 0.0 0.2 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.1 1.5 0.2 306.4 1.0 60.2 0.0 0.0 4.3 79.3 1.0 0.6 64.5 3.3 79.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.3 0.0 0.1 4.5 0.3 135.4 0.0 0.1 GPRASP1 "GASP, GASP1" ENSG00000198932 "G protein-coupled receptor associated sorting protein 1" Q5JY77 X 102651366-102659083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.0" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 41.0;Cardiomyocytes: 21.2;Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.2" "Group enriched" "Detected in many" 5 "B-cells: 1.4;T-cells: 5.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 6.8;REH: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000161, HPA031061" Approved Supported Cytosol NA NA Cytosol "HPA000161: AB_2247872, HPA031061: AB_2673718" "unprognostic (3.92e-3)" "unprognostic (1.10e-1)" "unprognostic (2.07e-4)" "unprognostic (1.42e-1)" "unprognostic (3.32e-2)" "unprognostic (1.71e-3)" "unprognostic (3.57e-1)" "unprognostic (2.33e-2)" "unprognostic (1.58e-1)" "unprognostic (2.82e-1)" "prognostic favorable (1.77e-5)" "unprognostic (3.34e-1)" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.23e-2)" 3.5 16.6 19.0 3.7 34.3 2.5 4.0 28.2 37.0 8.9 7.2 4.3 1.6 1.9 18.2 8.1 3.3 8.7 5.5 10.6 19.9 18.3 5.2 1.4 3.8 6.2 7.9 30.3 29.9 3.0 22.4 16.1 2.2 20.6 12.0 3.5 4.0 5.1 13.4 4.0 2.2 4.1 11.7 6.6 6.8 3.5 2.9 5.6 0.9 11.9 0.8 5.4 6.3 6.3 1.4 0.6 0.0 0.0 0.3 5.2 1.0 0.4 0.8 2.6 1.6 2.6 2.7 1.5 2.7 0.2 4.1 6.8 0.3 0.5 0.0 0.6 5.6 0.4 0.7 0.8 0.1 5.9 0.0 0.3 0.2 0.7 0.7 2.1 0.3 0.4 3.5 1.1 5.0 0.4 0.7 0.4 2.6 0.5 0.2 6.4 0.6 5.3 0.2 1.8 0.4 0.9 8.1 2.6 0.0 0.4 0.6 2.6 4.1 0.9 0.4 0.7 2.2 0.4 1.3 0.8 1.3 1.6 0.8 0.4 0.4 0.7 0.0 0.6 0.4 1.7 0.0 0.0 0.0 1.3 0.0 2.9 0.6 2.4 1.0 0.0 1.4 5.2 4.8 0.0 0.3 0.0 0.6 1.8 1.0 19.0 34.3 28.2 37.0 19.9 18.3 7.9 30.3 20.6 5.6 0.0 2.2 0.8 4.4 3.2 41.0 21.2 0.0 0.0 5.7 5.2 35.3 0.3 0.0 0.2 0.3 4.5 0.1 0.0 0.2 0.1 3.8 5.1 2.3 0.6 0.3 6.4 5.8 7.4 0.0 0.5 14.1 1.2 1.7 0.0 0.0 14.1 0.4 0.0 14.5 1.1 18.4 6.5 8.1 1.2 0.8 0.6 0.1 4.1 0.6 1.4 GPRASP2 "FLJ37327, GASP2" ENSG00000158301 "G protein-coupled receptor associated sorting protein 2" Q96D09 X 102712176-102717733 "Predicted intracellular proteins" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 4.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017438 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA017438: AB_1849504" "unprognostic (8.74e-3)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (5.14e-3)" "unprognostic (4.60e-2)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.89e-2)" "unprognostic (2.99e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.71e-4)" "unprognostic (1.42e-1)" "prognostic favorable (4.60e-6)" "unprognostic (1.19e-2)" "unprognostic (9.03e-2)" "unprognostic (8.05e-2)" "prognostic unfavorable (6.63e-5)" 3.7 12.2 13.8 1.5 22.6 0.2 6.1 16.9 30.0 7.7 3.7 3.4 1.7 1.3 13.8 7.4 3.3 8.8 4.0 10.9 15.8 22.3 8.1 5.2 3.9 1.2 8.7 22.5 24.8 7.1 13.3 11.5 2.8 18.7 10.2 2.5 3.6 6.6 9.8 5.2 4.4 1.8 8.3 7.2 3.0 2.2 3.6 4.1 0.8 12.0 1.3 1.3 3.6 3.8 0.4 1.6 0.0 0.6 2.1 4.7 1.2 0.5 5.1 13.7 10.5 4.3 5.2 1.0 7.8 7.0 6.7 13.1 1.7 2.4 0.0 2.7 8.0 3.4 1.8 16.3 4.2 8.5 0.0 6.3 0.7 1.5 0.4 3.1 1.2 1.0 5.4 4.5 7.5 0.3 7.9 4.7 1.3 1.9 0.5 8.1 2.4 3.6 0.5 6.8 1.6 7.1 4.7 2.2 0.0 4.2 1.9 3.0 9.4 7.8 1.6 1.0 4.4 4.4 2.7 4.2 4.8 10.0 9.6 7.4 0.2 0.3 0.0 6.4 0.8 2.6 0.0 0.4 0.0 0.9 0.6 0.8 0.4 1.1 1.3 0.8 0.4 4.7 1.9 0.0 2.1 0.2 1.6 1.6 1.2 13.8 22.6 16.9 30.0 15.8 22.3 8.7 22.5 18.7 4.1 0.0 1.0 0.0 5.3 2.1 16.1 14.9 10.2 0.0 4.5 5.2 2.0 5.0 8.3 1.3 0.4 4.3 0.2 0.0 0.8 0.6 4.9 3.2 0.0 7.3 0.8 15.9 2.9 8.0 1.6 0.8 11.2 0.3 0.0 0.0 1.3 10.0 1.5 1.9 11.7 7.7 6.4 6.5 4.1 4.4 4.3 2.6 1.8 0.0 1.1 0.5 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 76.2" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 193.6;Hepatocytes: 148.3;Paneth cells: 149.7;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 31.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 9 "dendritic cells: 10.2;monocytes: 4.7" "Cell line enhanced" "Detected in many" "Hep G2: 24.0;HMC-1: 42.2;RPTEC TERT1: 56.9;RT4: 26.3;T-47d: 32.0" "Region enriched" "Detected in many" 9 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favorable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 4.3 4.1 5.2 2.2 5.3 0.0 7.7 31.1 5.7 19.7 15.4 4.4 17.0 10.0 5.8 9.9 5.3 12.5 17.6 7.7 5.3 2.6 43.8 46.1 11.5 2.8 4.8 4.9 12.3 76.2 12.0 3.4 4.5 6.1 15.1 6.2 18.0 16.8 11.7 25.4 9.2 15.2 3.9 4.6 5.1 44.7 4.4 4.1 1.9 42.2 10.2 3.5 12.6 8.0 0.7 10.2 0.1 4.7 0.0 0.1 0.3 4.6 16.7 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 21.4 0.0 13.3 0.1 5.4 14.7 2.2 0.3 0.0 0.0 2.7 0.0 1.2 24.0 4.9 0.0 42.2 0.4 7.6 0.0 0.0 22.7 0.0 0.0 1.2 0.3 0.0 5.2 0.1 4.5 2.7 23.1 19.4 0.0 0.0 1.1 56.9 26.3 8.1 0.7 0.8 1.8 0.0 10.9 32.0 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.1 0.6 0.1 0.0 1.7 0.1 0.0 3.4 0.0 0.7 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 4.7 10.2 0.0 0.3 5.2 5.3 31.1 5.7 5.3 2.6 4.8 4.9 6.1 4.1 3.0 48.9 1.5 39.6 12.0 0.8 193.6 68.8 22.7 18.2 129.1 0.0 0.7 24.9 53.1 0.1 8.7 61.7 0.0 58.9 7.1 19.9 46.9 10.3 148.3 9.6 4.8 43.7 25.8 8.5 0.5 16.7 4.2 3.3 5.4 47.3 18.8 37.9 149.7 20.8 51.6 0.8 142.3 56.7 0.4 3.0 9.8 21.2 1.5 44.1 40.9 GPS1 "COPS1, CSN1" ENSG00000169727 "G protein pathway suppressor 1" Q13098 17 82050691-82057470 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047448, HPA052848" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047448: , HPA052848: " "unprognostic (1.96e-1)" "unprognostic (5.89e-2)" "unprognostic (1.50e-1)" "unprognostic (9.65e-2)" "unprognostic (3.41e-1)" "unprognostic (2.19e-1)" "unprognostic (4.75e-3)" "unprognostic (2.18e-2)" "unprognostic (3.17e-1)" "prognostic favorable (3.06e-4)" "unprognostic (1.18e-3)" "unprognostic (1.92e-1)" "unprognostic (4.96e-3)" "unprognostic (4.07e-1)" "unprognostic (8.90e-2)" "unprognostic (1.45e-1)" "unprognostic (2.15e-1)" 23.5 23.9 27.2 19.3 28.2 23.6 18.8 27.7 47.2 20.5 18.7 33.3 19.8 22.4 21.5 21.1 22.2 24.5 19.2 33.4 28.7 26.7 29.6 39.9 17.2 21.6 28.7 25.9 25.3 34.4 23.2 22.3 20.8 28.0 23.2 12.0 25.1 37.1 28.9 67.1 26.5 19.7 16.8 23.7 20.7 21.9 36.0 18.2 32.3 25.3 29.8 20.6 19.5 17.0 26.1 37.3 25.2 34.5 29.7 44.0 36.0 27.1 50.8 18.9 24.7 13.4 12.9 26.8 18.3 14.7 29.1 24.1 44.4 17.0 13.5 16.5 18.3 21.2 20.7 18.0 23.4 9.9 8.9 64.3 22.8 28.5 49.2 22.3 24.8 22.1 18.5 17.2 25.7 15.4 11.7 30.3 23.4 21.3 15.6 16.1 53.7 42.2 28.2 24.0 26.2 38.0 26.0 26.0 21.9 17.9 28.4 32.5 50.9 18.6 34.5 27.0 15.1 39.1 22.5 17.2 29.1 34.5 22.4 29.3 28.7 12.0 14.2 22.7 16.0 26.1 19.6 34.5 25.2 33.0 31.7 34.5 26.1 34.8 33.0 37.3 24.5 25.0 31.2 5.4 29.7 28.6 25.7 44.0 36.0 27.2 28.2 27.7 47.2 28.7 26.7 28.7 25.9 28.0 18.2 11.9 21.9 21.6 19.7 22.2 28.4 50.0 28.1 32.1 18.2 19.2 23.6 60.9 51.4 48.6 24.6 27.5 66.9 23.3 60.4 58.8 33.4 21.0 24.3 47.8 53.5 46.1 39.6 30.7 32.4 58.5 27.9 36.5 32.1 45.9 33.5 36.5 43.4 45.6 29.7 84.8 24.9 6.5 35.6 48.3 48.5 26.2 45.2 25.8 42.2 17.0 GPSM2 "DFNB82, LGN, Pins" ENSG00000121957 "G protein signaling modulator 2" P81274 1 108875350-108934545 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 35.6" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 125.7;Syncytiotrophoblasts: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007327, HPA008408, CAB018962" Uncertain Supported Cytosol NA Yes Cytosol "CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939" "unprognostic (1.97e-1)" "unprognostic (6.80e-2)" "prognostic favorable (7.86e-5)" "unprognostic (1.37e-3)" "unprognostic (3.18e-2)" "unprognostic (1.97e-2)" "unprognostic (8.57e-6)" "unprognostic (7.12e-2)" "unprognostic (2.76e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.55e-3)" "prognostic unfavorable (3.02e-4)" "unprognostic (6.27e-3)" "unprognostic (1.00e-1)" "unprognostic (5.14e-3)" "unprognostic (6.00e-2)" 3.8 4.0 16.6 4.4 17.9 13.9 8.5 10.1 20.6 7.5 13.6 17.9 2.5 8.0 6.9 4.3 30.4 2.9 3.1 3.0 15.2 14.1 2.6 1.9 6.6 5.8 19.7 9.0 2.4 2.4 4.0 2.1 7.6 19.6 6.3 15.4 1.3 7.0 5.7 8.0 35.6 10.1 10.6 25.1 2.0 5.3 11.4 18.8 14.1 2.3 23.5 12.1 6.5 10.6 1.8 1.6 8.6 1.2 0.7 4.4 0.4 41.3 5.9 13.6 10.7 13.7 8.2 10.2 8.3 21.1 10.3 15.9 6.4 10.6 9.5 2.3 11.6 7.9 9.1 8.8 21.8 13.3 9.8 5.9 7.0 11.6 7.0 1.8 9.3 6.4 1.5 44.6 11.2 44.5 3.8 11.0 7.4 5.3 14.3 22.1 12.8 7.5 4.7 3.5 18.0 10.1 6.6 22.0 2.5 8.9 6.5 10.4 9.0 11.4 23.2 8.8 3.7 9.1 9.0 6.8 7.9 12.4 21.1 15.7 6.4 5.9 9.4 12.7 15.5 36.7 0.1 1.2 8.6 0.8 0.9 0.5 0.7 0.6 1.1 1.6 1.8 1.1 0.8 1.6 0.7 0.4 0.7 4.4 0.4 16.6 17.9 10.1 13.6 15.2 14.1 19.7 9.0 19.6 18.8 14.9 3.5 5.2 16.6 55.6 46.3 2.1 0.0 6.7 14.8 7.0 125.7 42.8 10.0 2.2 39.6 3.8 8.0 0.0 1.6 37.2 12.8 3.8 2.3 0.5 7.7 41.3 8.7 1.8 5.2 16.4 17.3 4.6 25.3 6.4 12.1 7.1 3.2 7.0 4.9 0.3 43.8 0.0 5.3 15.2 25.1 35.5 74.6 7.7 11.8 13.3 GPX2 GSHPX-GI ENSG00000176153 "Glutathione peroxidase 2" P18283 14 64939152-64942905 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 126.9;liver: 195.2" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 484.1;Hepatocytes: 821.3;Mucus-secreting cells: 410.2;Undifferentiated cells: 621.9;Urothelial cells: 833.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "OE19: 309.4" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Not detected" "Not detected" HPA003545 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003545: AB_10962695" "unprognostic (3.54e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.90e-3)" "unprognostic (4.75e-3)" "prognostic unfavorable (5.10e-4)" "unprognostic (2.96e-2)" "unprognostic (2.93e-2)" "unprognostic (7.87e-2)" "unprognostic (1.54e-2)" "unprognostic (8.45e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (6.66e-4)" "unprognostic (1.73e-2)" 0.1 0.0 0.1 23.8 0.2 0.0 0.8 0.2 0.1 5.5 50.4 0.5 2.0 14.4 0.3 1.0 53.0 0.6 126.9 0.2 0.1 0.2 29.4 195.2 2.0 0.1 0.1 0.1 0.9 7.0 0.0 0.2 0.1 0.2 16.8 71.6 0.1 59.7 4.1 0.3 3.9 35.4 5.6 0.2 0.1 57.8 0.4 0.1 0.5 0.2 44.0 7.4 56.3 15.0 0.2 0.0 0.5 0.8 2.4 0.1 0.0 0.0 71.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.4 0.0 0.1 19.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 66.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 309.4 0.0 0.0 0.0 0.0 0.0 47.5 21.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.5 2.4 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 11.8 173.3 8.9 0.1 0.4 484.1 2.7 2.3 22.7 0.0 0.1 10.0 152.1 13.5 0.5 203.5 0.0 233.6 0.1 0.4 34.2 13.8 821.3 0.0 0.0 110.6 14.1 19.9 38.7 0.9 0.3 0.0 5.4 410.2 0.0 220.5 261.9 0.0 18.9 0.6 0.0 1.0 0.5 0.0 8.4 0.0 6.9 621.9 833.9 GPX8 "EPLA847, UNQ847" ENSG00000164294 "Glutathione peroxidase 8 (putative)" Q8TED1 5 55160118-55167071 "Enzymes, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 185.8;Fibroblasts: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 52.6;fHDF/TERT166: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036720 Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA036720: AB_2675269" "unprognostic (4.85e-2)" "unprognostic (1.23e-2)" "unprognostic (6.53e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-2)" "unprognostic (9.74e-3)" "unprognostic (1.78e-2)" "unprognostic (1.63e-3)" "unprognostic (2.07e-2)" "unprognostic (4.34e-2)" "unprognostic (4.31e-2)" "unprognostic (8.68e-2)" "prognostic unfavorable (5.13e-9)" "prognostic unfavorable (7.96e-4)" "unprognostic (8.11e-2)" "unprognostic (1.16e-2)" "unprognostic (2.63e-2)" 12.6 7.1 0.8 5.8 1.0 0.0 12.2 0.5 0.7 31.4 6.8 1.7 17.3 1.3 23.6 34.5 13.3 13.2 11.2 12.1 1.0 0.9 13.7 2.6 7.3 5.6 1.1 0.9 31.5 5.0 4.5 3.2 40.9 4.0 24.2 4.7 17.8 7.3 16.7 5.0 5.1 4.4 14.1 3.3 7.5 4.9 10.2 0.5 0.7 28.4 11.0 5.4 15.8 19.7 1.0 0.7 2.4 0.5 0.6 0.9 0.2 7.1 5.9 13.0 12.6 34.3 39.0 7.1 36.2 52.6 20.4 40.7 0.6 16.2 0.0 38.6 49.2 17.4 6.1 7.7 10.5 28.0 0.0 3.2 0.3 10.6 1.3 10.8 0.0 0.0 27.6 10.5 12.4 6.5 19.2 23.6 0.0 0.2 0.0 23.1 2.2 0.0 0.0 5.9 0.2 8.4 0.0 7.4 0.0 12.5 0.2 0.0 0.3 12.1 0.9 12.8 15.5 11.6 0.7 21.2 10.9 12.0 16.1 19.4 0.0 0.0 0.0 17.3 0.0 23.6 1.4 0.5 0.3 0.5 0.3 0.5 0.6 0.5 0.5 0.2 1.0 0.9 0.9 2.4 0.6 0.3 0.7 0.2 0.2 0.8 1.0 0.5 0.7 1.0 0.9 1.1 0.9 4.0 0.5 0.0 0.6 0.0 4.8 6.4 0.0 2.6 0.0 14.7 13.6 24.4 0.0 48.1 5.0 12.0 0.4 13.5 0.0 0.0 34.7 185.8 64.1 2.1 4.6 0.0 9.1 0.0 0.0 19.0 0.0 0.2 47.5 1.3 23.6 1.8 3.6 6.6 18.2 0.0 37.4 0.2 0.2 12.9 11.2 0.1 0.1 5.4 11.1 0.7 0.8 1.8 GRAMD1A "FLJ90346, KIAA1533" ENSG00000089351 "GRAM domain containing 1A" Q96CP6 19 34994784-35026471 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008852, HPA012570" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA008852: AB_1079203, HPA012570: AB_2112577" "unprognostic (3.09e-2)" "unprognostic (4.62e-2)" "unprognostic (8.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.05e-1)" "unprognostic (2.87e-1)" "unprognostic (3.42e-3)" "unprognostic (5.96e-2)" "unprognostic (4.54e-1)" "unprognostic (5.70e-2)" "unprognostic (1.07e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.95e-12)" "unprognostic (2.04e-1)" "unprognostic (4.40e-1)" "unprognostic (2.90e-2)" "unprognostic (4.36e-2)" 15.6 19.1 14.6 21.4 14.0 17.1 19.4 13.8 18.1 16.8 13.2 10.4 17.4 13.0 16.9 12.9 7.8 17.2 13.8 17.2 15.9 12.0 13.3 11.0 27.5 42.0 13.7 12.2 21.8 44.1 11.5 14.9 14.1 16.6 15.6 7.5 11.5 45.3 17.2 35.7 6.8 10.9 21.3 12.8 21.1 16.1 11.7 12.1 17.9 12.7 11.5 12.1 17.3 21.4 1.1 4.1 13.1 14.9 3.8 5.5 2.5 5.5 42.9 8.4 16.6 9.8 11.2 7.0 6.7 11.1 9.0 8.9 16.2 4.8 3.1 13.4 10.0 7.9 3.6 8.7 13.2 3.4 13.3 15.2 9.2 10.6 14.9 19.8 6.5 14.7 19.8 8.2 6.4 10.9 14.2 29.2 20.5 10.0 2.2 6.2 5.3 14.8 8.0 13.2 11.0 4.8 14.0 2.6 3.9 9.6 1.0 12.7 25.6 6.8 5.1 11.0 7.7 7.8 7.2 15.9 14.4 7.4 2.9 9.5 2.4 7.9 7.6 9.5 7.2 10.7 13.1 4.5 3.6 2.9 7.3 5.5 0.5 3.9 2.1 4.1 1.1 2.9 4.2 9.8 3.8 14.9 1.4 3.1 2.5 14.6 14.0 13.8 18.1 15.9 12.0 13.7 12.2 16.6 12.1 20.8 34.1 13.4 49.1 18.4 13.5 8.1 0.0 16.0 14.8 15.7 15.7 10.8 3.3 29.5 0.8 46.6 1.8 0.0 49.7 25.1 19.4 49.8 9.2 6.7 44.3 7.9 37.8 51.0 37.3 1.8 23.9 26.0 32.1 235.4 12.5 28.8 44.0 10.5 23.7 11.5 14.9 12.9 32.0 0.0 2.7 13.4 27.7 41.5 18.6 48.2 GRAMD1C DKFZp434C0328 ENSG00000178075 "GRAM domain containing 1C" Q8IYS0 3 113828182-113947174 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 74.3;Late spermatids: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 5.1;naive B-cell: 4.1;neutrophil: 4.0" "Group enriched" "Detected in many" 11 "B-cells: 5.1;granulocytes: 4.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4;HUVEC TERT2: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012316 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA012316: AB_1849949" "unprognostic (2.73e-3)" "unprognostic (6.16e-3)" "unprognostic (3.27e-1)" "unprognostic (1.93e-1)" "unprognostic (5.50e-2)" "unprognostic (9.81e-3)" "unprognostic (1.43e-3)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (5.49e-2)" "prognostic favorable (4.22e-15)" "unprognostic (8.48e-2)" "unprognostic (9.96e-2)" "unprognostic (3.61e-2)" "unprognostic (2.09e-2)" 1.7 2.6 12.6 2.5 13.0 0.5 9.1 5.0 13.4 3.4 8.0 2.6 0.5 7.6 5.2 5.1 6.0 10.3 2.9 1.5 13.6 7.6 23.3 26.5 5.0 2.0 9.4 8.1 1.1 12.5 11.8 24.1 6.2 9.2 2.9 4.2 4.5 10.8 2.8 1.1 12.0 24.5 1.0 8.2 1.7 8.6 14.5 9.3 0.0 6.9 1.6 3.7 3.8 3.8 5.1 0.1 4.0 0.0 0.3 0.4 0.1 1.5 0.0 4.1 3.2 0.8 2.1 5.9 3.7 3.3 0.7 2.2 0.0 14.4 0.4 1.1 1.9 1.3 1.6 0.7 1.6 1.7 1.9 0.6 0.3 0.1 0.0 1.6 0.2 0.1 3.3 1.1 0.6 0.1 7.5 11.2 4.5 0.0 0.2 1.1 0.4 1.6 0.2 0.3 1.5 0.5 0.0 0.8 2.5 4.5 2.0 0.8 1.0 1.0 5.9 3.0 1.6 4.1 0.0 2.3 1.5 2.9 0.0 0.3 2.2 1.3 1.8 2.4 0.1 1.7 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.3 0.4 0.1 4.1 0.3 0.4 4.0 0.3 0.0 0.1 0.0 0.1 12.6 13.0 5.0 13.4 13.6 7.6 9.4 8.1 9.2 9.3 11.9 10.9 0.0 5.9 0.9 0.0 0.8 20.4 18.7 7.9 14.0 35.3 14.6 26.6 2.1 74.3 2.9 12.0 0.0 2.4 3.7 1.0 2.9 0.0 14.8 1.3 11.1 4.7 3.7 0.0 57.8 2.6 0.0 1.7 0.0 4.7 14.5 2.1 5.9 1.4 11.2 18.3 0.0 0.9 25.7 5.1 4.1 35.5 0.0 3.9 5.7 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159807-72197785 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.6;placenta: 49.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 65.5;Cytotrophoblasts: 93.9;Syncytiotrophoblasts: 123.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "myeloid DC: 2.3" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.3" "Group enriched" "Detected in some" 12 "BEWO: 59.5;SK-BR-3: 27.1" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (7.29e-2)" 0.1 0.0 2.0 0.2 4.5 0.0 6.8 1.1 1.0 3.1 0.7 1.2 9.8 0.6 0.4 24.6 1.0 8.2 0.8 0.1 2.9 6.5 1.9 0.1 9.7 0.2 1.1 0.1 1.1 1.0 0.2 0.9 49.2 3.9 1.2 0.5 1.0 1.8 4.0 0.3 1.5 3.6 0.1 1.0 0.1 0.4 0.7 0.9 0.2 7.7 1.3 1.1 0.3 0.6 0.0 2.3 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 27.1 0.0 2.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.5 1.1 1.0 2.9 6.5 1.1 0.1 3.9 0.9 65.5 13.3 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 3.5 0.0 93.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 1.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 123.0 0.0 0.0 0.0 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 89.7;Club cells: 84.2;Collecting duct cells: 38.4;Extravillous trophoblasts: 38.4;Syncytiotrophoblasts: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 4.8;memory CD4 T-cell: 2.6;memory CD8 T-cell: 3.9;myeloid DC: 2.5;naive CD4 T-cell: 5.1;naive CD8 T-cell: 3.1;NK-cell: 1.7;plasmacytoid DC: 6.5;T-reg: 3.8" "Group enriched" "Detected in many" 6 "dendritic cells: 6.5;NK-cells: 1.7;T-cells: 5.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 39.4;CAPAN-2: 26.5;fHDF/TERT166: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 8.3 12.0 30.8 5.2 31.6 1.3 29.5 10.2 25.3 27.5 21.8 38.7 9.7 22.5 24.0 11.9 7.7 26.8 8.7 9.2 38.8 15.9 25.9 18.0 7.8 5.1 21.8 28.3 21.1 6.8 9.0 7.2 44.3 26.4 14.2 23.4 14.9 15.5 20.9 2.8 17.5 26.1 17.6 29.7 4.3 12.9 3.3 31.8 3.6 35.6 3.7 8.6 11.6 11.1 0.8 6.5 0.5 0.7 1.7 5.1 2.1 21.4 1.2 1.0 4.8 21.7 7.5 6.5 22.5 39.4 10.7 14.6 1.0 26.5 0.0 9.7 25.2 0.2 5.5 0.3 9.1 11.4 1.8 1.6 1.0 2.5 1.3 5.1 0.0 0.7 12.6 4.1 9.8 3.3 13.5 0.0 0.0 0.0 0.0 18.5 2.2 0.0 0.3 1.1 4.9 1.5 0.4 6.4 5.0 14.4 23.8 0.4 0.0 4.1 2.3 7.0 5.1 8.1 1.3 1.9 2.1 0.7 3.9 4.2 1.4 1.1 0.0 0.4 0.0 6.4 0.5 0.5 0.0 4.6 0.7 4.8 0.8 2.6 3.9 2.5 0.4 5.1 3.1 0.5 1.7 0.5 6.5 3.8 2.1 30.8 31.6 10.2 25.3 38.8 15.9 21.8 28.3 26.4 31.8 14.9 17.1 0.0 0.0 0.0 0.0 0.0 0.0 89.7 84.2 38.4 0.0 23.4 19.9 13.1 0.0 0.0 0.0 0.0 7.5 38.4 0.0 0.0 3.5 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.8 0.0 0.0 18.5 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 GRAP2 "GADS, GRBLG, GrbX, Grf40, Mona" ENSG00000100351 "GRB2-related adaptor protein 2" O75791 22 39901082-39973721 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 138.0" "Group enriched" "Detected in many" 4 "granulocytes: 142.1;T-cells: 44.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 22.5" "Cell line enhanced" "Detected in some" "HEL: 14.4;JURKAT: 57.1;K-562: 13.9;MOLT-4: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA005788, CAB022073" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 260000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022073: , HPA005788: AB_1079021" "unprognostic (1.96e-4)" "unprognostic (1.82e-4)" "unprognostic (4.19e-2)" "unprognostic (8.91e-4)" "unprognostic (2.92e-2)" "unprognostic (5.56e-5)" "unprognostic (1.27e-2)" "unprognostic (8.41e-3)" "unprognostic (4.69e-2)" "unprognostic (9.29e-2)" "unprognostic (5.17e-3)" "unprognostic (2.83e-2)" "unprognostic (1.75e-3)" "unprognostic (2.10e-1)" "unprognostic (2.20e-2)" "unprognostic (1.34e-1)" "unprognostic (8.06e-2)" 1.6 0.4 0.3 7.7 0.7 7.6 1.5 0.3 0.4 1.1 2.3 0.6 0.4 2.9 2.3 1.6 1.6 1.2 3.5 2.8 0.6 0.4 1.2 1.8 6.4 12.6 0.9 0.4 1.0 0.8 0.0 0.6 1.1 0.6 2.4 1.9 1.2 2.4 1.2 0.5 1.4 6.2 2.0 2.2 13.2 2.9 2.4 0.3 138.0 1.3 1.5 11.3 3.0 1.9 2.1 0.4 2.5 0.2 1.7 22.5 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 14.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 57.1 13.9 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.8 0.2 0.0 19.5 0.1 14.4 1.0 14.4 21.1 0.4 2.1 12.2 22.5 2.5 1.7 0.1 0.3 12.0 25.9 0.3 0.7 0.3 0.4 0.6 0.4 0.9 0.4 0.6 0.3 0.0 10.7 1.3 0.0 1.4 0.7 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.1 0.0 23.3 0.2 0.0 1.1 0.6 142.1 1.7 0.2 0.0 1.2 1.8 1.8 2.1 0.3 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 4.4 1.5 1.0 0.1 44.5 0.0 0.3 GRB14 ENSG00000115290 "Growth factor receptor bound protein 14" Q14449 2 164492812-164621848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 17.7" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 77.9;Hepatocytes: 35.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.7;HUVEC TERT2: 10.8;RPTEC TERT1: 8.9;TIME: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022294, HPA035052, HPA035053" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022294: , HPA035052: , HPA035053: AB_2674432" "unprognostic (2.60e-1)" "unprognostic (6.34e-2)" "unprognostic (1.74e-2)" "unprognostic (6.75e-2)" "unprognostic (7.47e-2)" "unprognostic (8.33e-5)" "unprognostic (5.00e-2)" "unprognostic (3.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (8.33e-3)" "unprognostic (2.71e-1)" "unprognostic (1.89e-3)" "unprognostic (7.10e-2)" "unprognostic (5.19e-2)" "unprognostic (9.27e-2)" 1.6 2.9 1.0 1.2 1.5 0.0 6.0 0.7 3.6 0.8 1.2 0.0 1.1 1.2 0.6 7.5 1.7 0.5 0.3 10.8 5.7 1.1 8.3 17.7 0.7 0.1 0.9 2.0 2.4 6.0 0.0 1.8 2.2 1.4 0.8 0.4 1.2 1.0 0.5 3.2 0.5 0.8 0.6 0.6 0.6 1.1 3.1 0.4 0.0 5.5 3.0 0.1 0.6 1.1 0.0 0.0 0.4 0.1 0.0 0.0 3.0 0.9 5.7 0.4 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 2.4 0.6 0.0 3.5 0.0 1.0 0.4 0.9 1.6 0.4 0.0 4.9 0.0 0.3 1.4 0.1 0.0 0.0 0.4 1.0 2.1 0.0 1.9 10.8 0.0 0.0 0.1 1.7 2.3 0.0 0.0 2.1 0.2 1.4 0.0 0.0 0.1 8.9 0.4 3.4 0.4 0.0 0.3 0.0 1.1 0.6 0.0 13.5 0.2 1.5 0.0 0.1 0.5 0.1 0.0 3.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.0 1.0 1.5 0.7 3.6 5.7 1.1 0.9 2.0 1.4 0.4 0.0 4.8 0.0 0.3 0.1 0.1 16.1 15.3 0.0 0.0 15.7 0.0 0.1 77.9 7.2 1.3 0.8 0.0 0.0 2.9 0.1 0.2 0.5 0.0 35.1 0.0 0.0 0.0 1.8 0.6 2.1 8.6 0.1 18.6 1.0 2.7 0.1 6.3 0.0 16.3 12.2 0.8 12.9 0.0 0.7 2.1 0.0 0.1 0.0 0.2 0.1 GRB7 ENSG00000141738 "Growth factor receptor bound protein 7" Q14451 17 39737927-39747291 "Cancer-related genes, Predicted intracellular proteins" "Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 79.7;Glandular cells: 69.7;Syncytiotrophoblasts: 82.5;Urothelial cells: 65.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 4 "cerebellum: 7.4" "Cell type enriched" "Detected in single" 20 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enriched" "Detected in some" 5 "OE19: 193.7" "Region enhanced" "Detected in some" "cerebellum: 9.3" "Low region specificity" "Detected in all" "CAB005226, HPA057084, CAB073538" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330" "unprognostic (8.46e-2)" "unprognostic (2.06e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.60e-7)" "unprognostic (7.06e-3)" "unprognostic (2.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.85e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (3.10e-4)" "prognostic unfavorable (6.90e-4)" "unprognostic (2.59e-2)" "prognostic favorable (8.23e-5)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (5.49e-3)" "unprognostic (4.01e-2)" 2.9 0.1 0.1 2.8 0.6 0.0 16.1 7.4 1.2 6.7 12.7 0.3 25.0 6.7 2.6 8.1 53.9 14.5 16.3 0.8 0.2 0.1 23.4 5.2 12.3 0.1 0.1 0.4 3.1 20.5 5.8 3.7 42.6 1.6 10.2 6.4 0.7 14.0 25.5 0.5 19.1 12.4 2.0 0.1 0.3 7.2 2.3 0.3 0.5 8.5 6.5 17.2 7.2 11.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.6 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 4.9 2.8 0.0 0.4 0.0 0.1 2.6 0.0 1.8 0.0 0.0 0.2 0.0 0.6 4.3 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 193.7 0.4 0.0 0.0 1.9 2.2 1.6 1.1 0.0 2.1 42.8 0.0 2.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 7.4 1.2 0.2 0.1 0.1 0.4 1.6 0.3 20.8 10.0 0.0 79.7 34.0 0.0 2.0 15.3 17.4 7.9 21.0 0.0 27.0 8.3 29.6 0.0 0.5 18.0 0.0 16.9 18.8 1.9 69.7 1.1 4.0 2.5 0.0 13.8 0.0 0.0 0.0 2.6 0.9 5.0 2.8 16.8 0.3 20.5 24.6 1.1 8.6 0.0 0.0 1.0 0.4 0.2 36.6 82.5 0.9 22.1 65.1 GREB1 KIAA0575 ENSG00000196208 "Growth regulation by estrogen in breast cancer 1" Q4ZG55 2 11482341-11642788 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 74.9" "Cell type enhanced" "Detected in many" 18 "Leydig cells: 18.7;Peritubular cells: 51.9" "Cancer enhanced" "Detected in many" "prostate cancer: 17.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.1;Hep G2: 14.3;MCF7: 22.4;SH-SY5Y: 15.3;T-47d: 51.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024616, HPA027843, HPA028416" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344" "unprognostic (1.52e-2)" "unprognostic (4.63e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.23e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.68e-1)" "unprognostic (3.63e-2)" "unprognostic (7.51e-4)" "unprognostic (2.42e-2)" "unprognostic (3.34e-1)" "unprognostic (2.46e-3)" "unprognostic (4.80e-2)" 1.2 2.0 3.0 0.6 5.0 0.5 11.1 1.3 5.4 13.7 0.5 2.8 3.0 0.7 21.3 15.6 0.6 11.2 1.8 2.3 3.9 3.0 1.3 1.5 0.6 0.6 3.9 3.5 74.9 2.9 0.6 5.0 9.4 3.8 19.2 0.5 2.8 0.7 2.4 2.1 1.2 0.6 7.3 3.2 0.4 0.8 10.9 3.2 0.0 0.5 0.5 0.5 0.8 5.7 0.8 1.0 2.8 0.6 1.0 1.3 0.4 0.0 0.4 15.1 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.1 0.0 2.6 0.1 1.1 0.0 0.0 1.8 1.3 0.0 0.1 14.3 0.1 0.1 0.8 0.2 0.8 0.2 0.1 0.1 0.0 1.4 0.1 0.3 0.1 22.4 0.4 0.7 4.9 0.0 0.0 10.4 0.0 0.6 0.0 0.0 4.4 15.3 0.3 0.4 11.1 2.1 51.8 0.2 0.0 1.5 0.7 0.1 0.0 2.2 1.5 8.8 2.6 4.3 0.4 2.6 0.6 0.8 0.7 0.3 0.3 0.5 0.5 0.4 0.4 0.8 0.5 1.3 2.8 1.0 0.5 1.0 0.5 0.4 3.0 5.0 1.3 5.4 3.9 3.0 3.9 3.5 3.8 3.2 0.0 0.3 0.0 1.7 0.7 3.1 7.3 7.6 5.3 1.2 0.0 2.0 0.1 0.0 0.4 0.5 1.4 0.0 0.0 0.2 2.1 5.1 9.8 3.5 6.0 2.5 3.2 0.0 0.6 0.0 1.3 18.7 0.3 5.0 0.0 0.0 0.2 0.5 0.0 51.9 1.9 0.3 0.0 0.8 0.9 1.5 0.3 0.2 0.0 0.0 2.6 GRHPR "GLXR, PH2" ENSG00000137106 "Glyoxylate and hydroxypyruvate reductase" Q9UBQ7 9 37422666-37436990 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 172.0" "Cell type enhanced" "Detected in all" 9 "Hepatocytes: 748.4;Proximal tubular cells: 664.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022971, HPA078575" Enhanced Approved Nucleoplasm,Cytosol NA NA 1400000 Cytosol Nucleoplasm "HPA022971: AB_1849975, HPA078575: " "prognostic favorable (7.00e-5)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.64e-3)" "unprognostic (5.78e-3)" "unprognostic (3.04e-1)" "unprognostic (1.02e-3)" "unprognostic (1.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.49e-2)" "unprognostic (5.88e-2)" "unprognostic (2.36e-1)" "prognostic favorable (5.39e-9)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" 12.8 33.7 16.3 13.8 17.4 9.9 12.3 9.5 22.3 12.1 17.6 27.5 11.6 17.2 14.3 18.1 17.6 12.9 18.1 29.2 15.8 14.7 41.9 172.0 9.7 13.8 20.0 16.5 17.0 15.5 9.5 8.8 13.2 15.5 14.2 10.2 13.5 21.6 14.0 40.0 14.8 14.6 14.2 19.4 10.0 13.3 13.0 18.7 9.5 15.1 25.2 13.6 13.4 11.7 30.6 33.2 17.8 30.3 28.9 25.9 22.4 31.9 46.2 26.2 23.9 24.1 26.8 26.5 25.6 34.0 35.0 38.1 17.4 13.9 30.7 15.1 30.0 26.2 14.5 15.0 33.4 20.9 41.0 18.8 18.0 43.0 30.9 38.1 17.1 18.7 31.9 29.4 20.2 26.1 29.6 30.3 21.0 32.9 12.7 30.7 24.5 16.6 17.6 15.9 29.2 20.1 16.4 19.2 17.0 46.6 18.2 10.9 19.6 22.0 42.1 23.9 24.7 23.7 22.1 32.9 19.2 30.9 13.3 22.1 10.1 7.7 20.5 27.3 9.9 28.1 17.8 30.2 15.0 19.4 30.3 16.2 28.6 20.7 22.0 33.2 30.6 20.4 17.3 7.0 28.9 24.7 29.8 25.9 22.4 16.3 17.4 9.5 22.3 15.8 14.7 20.0 16.5 15.5 18.7 53.6 20.9 43.5 39.7 38.5 33.3 86.0 219.1 29.4 26.1 48.8 19.6 128.8 210.5 67.4 10.2 41.4 82.6 46.7 77.8 76.0 63.3 42.0 49.6 748.4 97.6 22.3 59.7 76.1 83.4 10.4 69.0 49.3 75.9 86.6 59.5 85.7 64.8 60.5 92.6 664.7 23.4 77.6 62.6 17.5 16.2 49.2 74.4 37.9 71.9 35.2 GRINA "HNRGW, LFG1, NMDARA1, TMBIM3" ENSG00000178719 "Glutamate ionotropic receptor NMDA type subunit associated protein 1" Q7Z429 8 143990058-143993415 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 331.5;monocytes: 538.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036980, HPA036981" Approved Approved "Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoli fibrillar center" Cytosol "HPA036980: AB_10696791, HPA036981: AB_10962980" "unprognostic (2.73e-3)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (7.01e-3)" "unprognostic (3.72e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-1)" "unprognostic (6.70e-2)" "unprognostic (8.19e-2)" "unprognostic (3.13e-3)" "unprognostic (1.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.43e-2)" "unprognostic (6.75e-2)" "unprognostic (5.72e-2)" 76.4 48.8 46.6 52.3 61.0 89.0 70.2 73.8 85.8 37.1 28.4 34.5 37.1 35.6 33.1 42.1 30.5 41.4 37.5 35.2 54.2 45.1 61.7 143.7 49.7 67.4 47.4 51.5 46.1 32.0 66.8 29.3 42.4 46.5 42.6 17.7 49.3 44.4 99.4 32.8 37.4 33.5 38.0 43.3 82.0 23.2 52.2 24.3 24.3 54.7 19.2 26.8 43.2 31.3 4.5 12.4 10.2 19.3 1.6 2.6 6.4 12.8 25.2 12.9 21.9 68.8 34.7 19.1 18.4 43.6 31.4 29.1 15.3 10.8 9.2 20.3 41.5 21.9 11.6 23.0 27.2 12.9 13.1 15.8 9.6 14.6 18.1 72.9 2.0 15.5 44.7 75.4 22.7 33.2 33.0 15.2 4.0 8.9 13.0 27.0 77.6 5.3 5.2 9.0 12.4 38.2 7.3 6.5 17.8 16.1 36.5 8.8 14.3 26.8 30.2 35.8 18.3 58.1 12.7 15.2 19.9 21.9 26.5 13.4 21.1 12.1 6.9 25.2 12.7 11.3 0.9 16.6 4.6 1.4 19.3 2.0 4.5 1.4 1.6 7.1 4.3 2.6 2.3 10.2 1.6 18.0 12.4 1.2 6.4 46.6 61.0 73.8 85.8 54.2 45.1 47.4 51.5 46.5 24.3 17.9 65.6 14.3 28.0 33.1 86.7 19.7 40.8 17.4 18.2 50.6 74.6 108.2 19.9 63.5 214.4 42.1 42.7 46.7 60.2 47.1 58.4 38.3 15.1 167.7 158.2 31.8 40.5 54.0 188.9 331.5 57.0 128.7 35.4 538.4 24.1 77.3 64.0 46.0 63.6 61.9 71.2 45.3 40.6 89.2 11.3 32.2 220.9 15.9 22.4 21.6 GRIP2 KIAA1719 ENSG00000144596 "Glutamate receptor interacting protein 2" 3 14489111-14556075 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 10.3;skeletal muscle: 25.7" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 9.4;Cardiomyocytes: 7.3;Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 21.1;Sertoli cells: 19.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.2;BJ hTERT+ SV40 Large T+ RasG12V: 3.3;NTERA-2: 3.6;PC-3: 10.2;SCLC-21H: 5.7;U-2 OS: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035673 Approved Cytosol NA NA Cytosol "HPA035673: AB_10669776" "unprognostic (1.48e-1)" "unprognostic (6.26e-3)" "unprognostic (2.43e-2)" "unprognostic (3.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.14e-3)" "unprognostic (1.87e-1)" "unprognostic (8.19e-2)" "unprognostic (9.14e-2)" "unprognostic (2.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.54e-1)" "unprognostic (2.44e-1)" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (5.82e-1)" "unprognostic (4.01e-1)" 0.5 0.8 3.2 0.4 2.6 0.0 0.5 0.7 6.0 0.4 0.4 1.2 1.9 0.1 1.3 0.5 1.7 0.3 1.0 10.3 3.2 1.5 0.1 0.2 0.1 0.0 3.3 2.0 0.2 0.1 0.1 3.0 1.1 0.4 0.7 0.6 0.4 0.2 25.7 1.4 0.4 0.6 0.0 1.0 2.7 0.4 1.0 0.0 0.0 4.6 0.4 0.5 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.5 0.3 0.0 0.5 5.2 0.6 3.3 2.0 0.0 0.0 1.3 0.3 0.9 0.3 1.2 0.0 0.0 0.0 0.4 0.0 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 2.4 10.2 0.0 0.1 0.0 0.0 0.0 5.7 1.1 0.5 0.0 1.8 1.9 0.0 0.0 0.0 0.3 3.9 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 9.4 7.3 0.0 0.0 1.2 0.0 13.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.1 0.0 4.1 0.6 0.0 3.4 3.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.1 21.1 19.4 0.5 0.0 0.8 0.0 0.1 0.0 0.0 0.0 GRIPAP1 "DKFZp434P0630, GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3" ENSG00000068400 "GRIP1 associated protein 1" Q4V328 X 48973720-49002264 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 200.3;Rod photoreceptor cells: 178.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000282, HPA000615" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA000282: AB_1079022, HPA000615: AB_1079023" "unprognostic (3.34e-1)" "unprognostic (2.86e-3)" "unprognostic (3.24e-3)" "unprognostic (3.93e-3)" "unprognostic (2.68e-1)" "unprognostic (1.23e-1)" "unprognostic (3.97e-3)" "unprognostic (1.01e-2)" "unprognostic (5.26e-2)" "unprognostic (3.65e-1)" "unprognostic (1.69e-3)" "unprognostic (1.06e-2)" "prognostic unfavorable (3.92e-7)" "unprognostic (4.24e-3)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "prognostic favorable (4.63e-7)" 7.3 10.1 12.4 10.0 19.5 14.0 7.1 24.8 20.6 7.3 7.3 7.4 6.8 8.3 7.5 12.0 7.0 9.9 6.4 7.8 9.4 8.6 6.6 8.5 9.0 10.5 9.7 20.8 8.8 7.7 11.7 12.9 7.0 12.9 7.5 6.9 8.7 7.7 7.4 7.0 10.9 11.1 7.0 10.7 13.1 8.5 8.0 9.0 7.4 8.6 3.2 10.6 7.5 8.6 11.5 10.0 21.2 12.2 12.9 9.1 7.0 12.8 20.6 14.8 30.9 8.9 6.9 13.3 10.6 13.2 13.7 13.0 11.1 11.4 19.5 6.1 10.4 14.8 18.5 18.4 11.6 11.1 22.8 9.4 15.8 26.2 11.6 15.4 16.8 28.3 7.1 16.7 18.3 13.6 12.8 12.5 16.8 11.4 25.8 12.6 23.8 14.6 22.7 17.4 9.2 11.2 16.4 22.3 15.6 13.7 16.0 13.1 14.6 22.4 9.0 13.1 22.6 20.5 33.8 14.7 7.2 11.5 14.8 8.6 15.7 12.2 13.7 12.6 25.6 12.4 18.8 12.2 16.9 8.9 10.9 7.5 9.4 9.1 8.4 9.8 11.5 8.0 8.3 21.2 12.9 9.9 10.0 7.2 7.0 12.4 19.5 24.8 16.8 9.4 8.6 9.7 20.8 12.9 9.0 8.9 24.3 31.8 12.5 7.2 62.3 12.2 15.3 18.7 27.3 17.4 200.3 16.9 24.9 14.3 7.6 19.5 20.6 0.0 16.0 8.2 11.2 13.6 42.7 16.3 15.3 65.2 20.8 14.7 26.5 10.3 15.8 21.1 6.8 26.2 16.7 22.1 15.6 20.9 18.0 14.6 178.1 19.4 12.2 7.1 7.9 12.4 21.9 20.1 13.2 17.2 GRM7 "GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87" ENSG00000196277 "Glutamate metabotropic receptor 7" Q14831 3 6770001-7741533 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.8;parathyroid gland: 11.3" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 22.5;Early spermatids: 24.2;Late spermatids: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015964 Uncertain Cytosol NA NA Cytosol "HPA015964: " "unprognostic (2.04e-2)" "unprognostic (7.03e-3)" "unprognostic (1.43e-1)" "unprognostic (9.37e-2)" "unprognostic (8.48e-3)" "unprognostic (2.58e-1)" "unprognostic (7.30e-2)" "unprognostic (3.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.46e-2)" "unprognostic (2.54e-1)" "unprognostic (6.84e-6)" "unprognostic (1.45e-1)" "unprognostic (2.82e-2)" "unprognostic (5.43e-2)" "unprognostic (2.59e-2)" 0.9 5.3 8.1 0.6 10.5 0.6 0.9 1.6 15.8 2.9 0.8 2.1 0.0 0.9 3.1 0.5 0.6 1.0 0.7 0.6 11.1 9.3 0.5 0.7 0.8 0.5 2.3 10.1 0.8 0.7 11.3 0.6 0.9 4.3 1.2 0.8 0.8 2.1 1.4 0.5 0.6 0.6 5.9 2.8 0.8 0.6 2.8 4.1 0.0 0.7 0.0 0.7 1.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 10.5 1.6 15.8 11.1 9.3 2.3 10.1 4.3 4.1 0.0 0.0 0.0 0.9 0.1 22.5 1.1 7.6 6.7 1.2 0.0 7.9 0.0 1.7 0.0 24.2 0.1 0.0 0.0 0.0 0.1 0.7 1.1 1.1 0.0 0.1 1.6 0.0 0.0 0.0 29.9 0.3 0.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.2 6.5 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.6 GSDMA "FLJ39120, GSDM, GSDM1" ENSG00000167914 "Gasdermin A" Q96QA5 17 39953263-39977766 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 35.7;tongue: 19.4" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 3.5;Hofbauer cells: 4.9;Kupffer cells: 6.0;Suprabasal keratinocytes: 2.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 1.9;T-cells: 5.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 7.3;hTCEpi: 5.0;hTERT-HME1: 9.8" "Not detected" "Not detected" "HPA023313, HPA064826" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 7100 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA023313: AB_1850378, HPA064826: AB_2685361" "unprognostic (1.32e-2)" "unprognostic (2.01e-1)" "unprognostic (2.95e-2)" "unprognostic (1.06e-1)" "unprognostic (3.62e-1)" "unprognostic (1.97e-1)" "unprognostic (7.77e-2)" "unprognostic (1.39e-1)" "unprognostic (3.24e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" "unprognostic (2.90e-2)" "unprognostic (1.06e-2)" "unprognostic (9.86e-2)" "unprognostic (7.45e-2)" "unprognostic (3.63e-2)" "unprognostic (3.79e-2)" 2.1 0.4 0.2 0.4 0.1 0.0 2.2 0.1 0.1 1.1 0.6 0.0 0.0 0.1 0.4 8.6 1.9 0.3 0.3 2.0 0.2 0.2 0.4 0.2 0.7 8.5 0.2 0.7 0.2 0.2 1.0 0.9 0.9 0.1 0.2 0.6 0.0 0.6 0.0 0.9 35.7 0.3 0.5 0.2 0.3 0.2 0.9 0.0 0.8 0.2 19.4 7.8 0.8 1.1 0.6 0.5 1.9 0.4 0.6 5.6 1.0 0.4 0.1 0.0 0.3 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.0 7.3 0.0 0.2 0.5 0.9 0.6 0.5 0.0 0.3 1.6 0.0 5.0 0.9 9.8 0.1 0.0 0.1 0.2 2.4 0.0 1.0 0.0 0.2 0.1 0.5 0.1 0.6 0.0 0.9 0.2 0.7 0.0 0.2 0.2 0.3 0.0 0.1 0.6 0.1 0.1 0.3 0.7 0.1 0.1 0.3 0.1 0.6 0.4 0.1 0.0 1.7 0.4 0.4 4.8 0.2 5.6 0.3 3.1 1.8 0.2 0.6 1.6 2.5 1.9 0.6 0.3 0.5 1.1 1.0 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 1.3 6.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 GSDMB "GSDML, PRO2521" ENSG00000073605 "Gasdermin B" Q8TAX9 17 39904595-39919854 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 71.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 65.9;Mucus-secreting cells: 26.1;Paneth cells: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "SK-BR-3: 103.0" "CAB013681, HPA023925, HPA052407" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819" "unprognostic (5.78e-2)" "prognostic favorable (3.41e-5)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "unprognostic (6.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.10e-1)" "unprognostic (6.44e-2)" "unprognostic (3.81e-1)" "unprognostic (8.72e-2)" "unprognostic (2.34e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (5.13e-11)" "unprognostic (1.88e-1)" "unprognostic (1.99e-1)" "unprognostic (8.91e-2)" "prognostic favorable (5.91e-9)" 4.0 0.0 1.3 13.3 2.0 1.3 2.8 4.8 1.7 2.1 33.1 1.4 2.0 25.2 1.3 1.7 1.3 1.3 14.4 1.3 1.3 0.6 2.2 17.1 2.4 3.5 1.3 1.3 2.0 2.8 0.0 1.3 1.8 1.3 3.5 22.4 1.3 1.3 2.7 1.3 2.8 71.3 3.9 1.3 4.7 18.1 1.4 1.5 1.6 2.9 1.3 2.8 4.1 4.5 0.8 0.0 1.8 0.0 0.1 2.8 0.4 0.4 0.3 0.6 0.1 1.5 1.0 0.6 0.4 0.2 0.1 0.4 0.3 12.2 0.6 0.5 0.3 0.2 1.6 0.3 0.3 0.9 2.5 0.4 0.2 0.1 0.1 0.4 0.0 0.1 0.6 2.0 0.5 0.7 1.0 0.2 2.0 0.2 0.7 0.1 0.1 0.6 1.3 0.1 3.9 0.4 0.6 0.2 0.9 0.0 0.4 0.2 0.3 0.1 103.0 0.3 3.1 0.5 0.4 0.3 0.4 0.7 1.1 0.2 2.2 1.9 0.6 0.1 0.4 0.0 0.0 0.0 1.8 1.1 0.0 0.0 0.8 2.8 1.4 0.0 0.0 2.6 0.6 0.7 0.1 0.0 0.0 0.4 0.4 1.3 2.0 4.8 1.7 1.3 0.6 1.3 1.3 1.3 1.5 3.0 11.8 4.2 1.2 1.6 2.1 2.4 12.7 2.7 4.5 5.2 3.9 1.2 0.0 1.6 4.4 1.4 65.9 0.0 7.0 0.6 1.4 1.5 1.1 8.1 0.3 1.6 5.8 0.0 1.9 3.3 1.1 1.1 3.3 1.8 26.1 2.0 7.3 57.5 1.8 0.0 2.3 0.0 2.1 0.5 1.1 3.0 0.2 2.5 15.0 5.0 GSDME "DFNA5, ICERE-1" ENSG00000105928 "Gasdermin E" O60443 7 24698351-24758113 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Necrosis "Deafness, Non-syndromic deafness, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 151.1;Distal tubular cells: 34.9;Hofbauer cells: 35.4;Syncytiotrophoblasts: 87.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 8.7;myeloid DC: 6.9;naive B-cell: 8.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011326, CAB019306" Approved Enhanced Cytosol NA NA Cytosol "CAB019306: , HPA011326: AB_1847629" "unprognostic (1.08e-1)" "unprognostic (1.77e-2)" "unprognostic (6.29e-2)" "unprognostic (6.36e-3)" "unprognostic (6.70e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.35e-2)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-3)" "unprognostic (1.48e-3)" "unprognostic (6.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.90e-2)" 8.1 6.5 7.7 2.2 10.3 0.5 6.1 5.9 12.1 12.0 14.5 7.8 0.5 6.1 18.4 12.8 4.2 9.9 6.7 7.4 7.5 8.8 10.7 3.6 4.0 4.0 9.3 4.5 14.1 2.3 2.2 4.5 27.1 10.1 5.9 2.1 9.0 2.0 17.7 5.1 1.8 31.3 12.2 25.4 1.5 2.7 9.9 5.0 0.8 11.7 4.0 2.9 9.5 7.0 8.7 6.9 0.0 2.1 0.0 0.1 0.7 9.7 7.2 3.1 13.3 17.0 9.6 5.3 7.6 20.4 8.0 11.3 7.4 0.3 0.1 6.8 21.0 26.7 6.6 1.8 33.5 14.0 0.0 0.7 0.2 12.6 15.0 14.3 0.0 0.5 10.5 24.5 14.1 33.8 23.9 13.5 4.4 0.9 1.6 17.8 0.1 0.6 0.2 3.3 0.0 5.1 0.0 10.9 0.0 24.1 6.9 0.1 19.6 12.0 0.2 13.3 8.3 0.7 0.8 9.1 7.6 13.3 10.2 9.1 0.8 0.2 4.7 22.9 0.0 1.9 0.0 2.1 0.0 0.0 0.2 0.0 8.7 0.1 0.0 6.9 8.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 7.7 10.3 5.9 9.5 7.5 8.8 9.3 4.5 10.1 5.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 5.2 0.0 151.1 34.9 1.5 0.0 0.0 0.0 0.0 0.8 19.3 0.0 0.0 0.0 0.0 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 14.4 0.0 0.0 1.3 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 87.5 0.0 0.0 0.0 GSK3A ENSG00000105723 "Glycogen synthase kinase 3 alpha" P49840 19 42230186-42242625 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase" "Alzheimer disease, Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004422, HPA028423" Approved Approved Cytosol NA NA Cytosol "CAB004422: AB_627680, HPA028423: AB_10612116" "unprognostic (5.46e-2)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.02e-4)" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (3.80e-3)" "unprognostic (2.27e-1)" "unprognostic (2.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.36e-1)" "unprognostic (2.69e-1)" "unprognostic (2.77e-2)" "unprognostic (4.49e-2)" "unprognostic (7.22e-2)" "unprognostic (8.22e-3)" 15.3 19.8 31.0 16.8 38.0 14.4 12.0 31.4 62.2 15.9 16.8 24.3 11.4 28.6 16.9 18.0 17.3 16.7 11.8 21.3 31.3 23.6 17.5 13.1 14.2 15.0 21.8 26.3 20.0 19.3 16.1 14.2 14.7 31.7 15.8 16.1 15.5 18.1 20.3 41.0 25.1 27.0 18.5 18.0 14.5 14.7 19.1 17.7 16.6 15.8 11.9 15.8 15.8 15.5 1.6 2.2 4.0 1.9 1.7 2.0 1.0 23.4 41.6 23.8 22.1 14.3 12.8 10.1 16.5 15.8 21.9 19.8 15.6 14.9 17.0 17.1 12.9 20.6 10.8 19.6 19.2 15.4 13.7 31.4 17.7 13.3 15.4 18.8 20.0 21.6 12.5 20.4 17.9 20.5 19.0 19.8 12.7 29.6 25.3 18.7 28.4 25.9 17.7 17.6 36.7 17.2 23.7 13.8 13.0 20.2 24.6 27.8 28.1 22.6 29.7 15.0 17.1 17.2 26.5 17.6 22.6 17.0 13.1 29.2 25.9 29.7 13.2 26.2 20.2 24.7 2.5 1.5 1.6 2.0 1.9 1.4 1.2 1.2 1.3 1.4 1.6 0.7 1.5 4.0 1.7 1.1 2.2 1.0 1.0 31.0 38.0 31.4 62.2 31.3 23.6 21.8 26.3 31.7 17.7 6.0 21.0 14.9 15.9 21.9 42.9 10.9 10.2 1.4 6.8 15.7 58.9 20.8 3.3 12.4 6.3 20.2 39.2 0.0 14.9 21.1 14.6 22.2 2.3 12.4 17.7 57.2 22.4 16.5 18.9 8.8 16.4 16.9 15.1 6.4 28.2 37.9 18.9 22.9 15.6 13.1 40.2 6.5 16.5 10.2 16.6 24.6 36.8 12.8 23.8 23.5 GSPT1 "eRF3a, ETF3A, GST1" ENSG00000103342 "G1 to S phase transition 1" P15170 16 11868128-11916082 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052488, HPA074588" Approved Approved Vesicles,Cytosol NA NA 150000 Cytosol Vesicles "HPA052488: AB_2681849, HPA074588: " "unprognostic (4.13e-2)" "unprognostic (1.66e-1)" "prognostic favorable (2.10e-5)" "unprognostic (1.64e-1)" "unprognostic (2.05e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (7.94e-4)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "unprognostic (1.74e-1)" "unprognostic (1.41e-3)" "unprognostic (1.65e-1)" "prognostic favorable (3.06e-5)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-3)" "unprognostic (3.13e-2)" 28.5 36.5 27.0 31.2 25.0 30.1 52.5 18.1 33.9 21.7 25.8 18.5 23.3 15.6 20.8 23.1 42.8 18.7 20.1 35.6 22.4 15.3 26.2 46.0 31.3 38.1 26.4 21.6 20.8 48.2 40.9 18.5 23.1 24.1 24.3 29.1 12.6 26.4 30.8 74.1 25.3 20.5 25.6 27.4 26.3 28.1 30.6 23.2 34.8 27.7 24.8 37.0 23.9 30.1 8.8 7.8 7.9 12.0 7.3 11.4 4.6 45.5 45.2 25.2 34.7 36.5 38.0 36.5 50.7 52.8 40.8 40.8 32.2 42.4 61.9 66.7 43.9 28.4 35.1 63.8 46.9 68.9 29.5 33.0 42.2 36.7 67.9 30.8 53.3 22.6 29.7 37.0 46.1 63.4 26.8 45.1 31.2 68.0 32.1 47.3 43.9 45.0 27.8 50.4 34.2 25.8 53.4 43.6 72.2 40.3 40.1 40.7 21.8 72.9 55.4 29.7 37.5 48.0 25.7 34.7 45.5 28.6 32.9 39.9 32.0 47.2 54.0 32.0 54.4 27.5 1.5 6.5 7.9 7.6 12.0 10.6 8.8 9.8 9.0 7.8 6.4 9.9 9.5 2.2 7.3 10.1 4.3 11.4 4.6 27.0 25.0 18.1 33.9 22.4 15.3 26.4 21.6 24.1 23.2 71.5 129.3 55.1 155.8 215.1 43.9 107.2 40.8 52.2 75.1 82.0 47.1 65.7 87.9 49.8 62.7 55.4 46.7 186.9 54.6 102.9 59.8 177.7 24.3 67.4 66.7 49.3 64.0 46.6 44.0 35.3 44.3 65.4 60.8 36.1 80.8 42.0 61.9 70.2 44.6 89.0 38.0 58.2 90.5 110.1 75.2 225.2 85.4 48.0 77.7 195.6 GSPT2 "eRF3b, FLJ10441" ENSG00000189369 "G1 to S phase transition 2" Q8IYD1 X 51743431-51746232 "Predicted intracellular proteins" "Cell cycle, Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 75.1;Late spermatids: 136.6;Muller glia cells: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 24.4;PC-3: 27.4;SuSa: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044769, HPA074588" Approved Enhanced Cytosol NA NA Cytosol "HPA044769: AB_10963577, HPA074588: " "unprognostic (8.55e-3)" "unprognostic (1.76e-1)" "unprognostic (2.81e-1)" "unprognostic (2.71e-3)" "unprognostic (3.39e-1)" "unprognostic (4.12e-2)" "unprognostic (1.54e-2)" "unprognostic (3.43e-1)" "unprognostic (1.39e-1)" "unprognostic (1.83e-1)" "unprognostic (1.21e-1)" "unprognostic (3.01e-1)" "unprognostic (1.72e-1)" "unprognostic (2.08e-2)" "unprognostic (1.54e-2)" "unprognostic (9.76e-3)" "unprognostic (1.07e-1)" 8.6 11.1 11.6 8.6 17.6 3.6 9.3 14.1 18.3 8.2 7.3 6.5 3.4 4.8 8.3 11.5 4.2 8.8 7.6 9.8 11.5 19.5 9.6 16.0 7.9 12.0 9.2 13.0 15.3 7.3 7.1 14.9 3.6 8.8 10.5 5.5 6.7 8.9 9.7 7.8 4.0 7.6 8.0 6.7 9.0 6.5 18.4 8.8 18.4 9.1 3.8 12.1 7.7 4.1 9.5 9.7 2.7 4.1 7.2 8.3 4.2 0.0 4.9 10.1 0.0 7.2 6.2 0.0 5.7 1.0 4.1 5.2 3.1 5.1 14.5 0.0 4.8 12.7 1.6 0.0 2.6 4.7 0.0 6.4 0.2 0.0 0.0 5.3 0.0 6.3 8.2 1.3 3.6 3.6 7.0 5.9 6.8 3.8 1.1 7.2 0.0 1.2 0.9 24.4 0.0 27.4 6.9 9.5 0.0 7.4 5.3 0.0 8.5 0.0 0.0 4.9 21.0 0.0 4.7 3.7 4.1 8.4 3.8 3.7 0.0 8.3 0.0 5.4 0.9 4.5 2.7 2.9 1.8 5.7 4.1 5.7 9.5 5.1 5.3 9.7 9.5 8.3 7.1 0.3 7.2 3.1 8.2 6.4 4.2 11.6 17.6 14.1 18.3 11.5 19.5 9.2 13.0 8.8 8.8 11.9 10.2 4.7 5.0 1.5 16.1 14.9 17.8 13.4 7.9 14.0 7.9 8.5 5.0 11.5 75.1 5.3 1.1 0.0 7.6 4.2 6.0 5.3 10.4 15.3 5.5 11.1 2.9 8.6 7.0 136.6 11.8 6.3 3.3 11.8 3.1 56.0 5.5 4.8 17.7 9.8 9.4 25.8 4.7 11.8 7.3 1.3 2.9 7.2 3.2 3.1 GSR ENSG00000104687 "Glutathione-disulfide reductase" P00390 8 30678061-30727999 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001538, CAB008632, HPA064806" Approved Supported Cytosol NA NA 110000000 Cytosol "CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: " "unprognostic (1.23e-1)" "prognostic favorable (3.37e-4)" "prognostic favorable (4.08e-5)" "unprognostic (2.89e-3)" "unprognostic (1.62e-1)" "unprognostic (3.50e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (4.15e-2)" "unprognostic (2.83e-2)" "unprognostic (6.92e-3)" "prognostic favorable (1.80e-4)" "unprognostic (2.31e-3)" "unprognostic (2.26e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" 8.9 14.4 6.8 10.7 9.1 7.9 6.2 9.1 11.8 18.6 18.7 7.1 18.4 20.4 13.2 12.0 19.4 8.8 17.3 11.9 5.0 5.7 27.9 17.8 10.8 9.7 4.9 6.0 11.8 17.6 22.9 7.2 8.9 6.8 16.4 17.2 10.9 12.0 17.4 14.7 6.5 31.8 9.3 4.5 13.6 17.7 7.9 4.2 17.0 9.2 11.8 12.0 23.9 14.5 2.5 4.7 19.0 5.7 2.6 7.3 2.1 11.6 49.4 8.0 6.2 8.6 9.7 7.7 5.2 11.5 7.4 10.0 14.5 6.2 22.8 25.8 6.7 22.0 13.1 12.1 11.3 8.2 5.9 11.2 23.0 17.1 48.5 23.2 7.0 37.0 16.1 7.1 11.1 4.5 8.1 10.5 14.5 19.0 10.1 16.7 10.6 24.7 8.2 14.2 48.3 8.8 9.4 9.2 11.0 14.8 29.6 6.1 7.8 7.2 16.8 12.5 11.2 7.2 8.0 14.3 3.1 8.6 7.3 7.7 5.6 6.2 14.7 9.9 9.9 10.1 19.0 4.6 11.5 4.2 4.2 7.3 2.5 3.8 4.6 4.7 2.0 2.4 3.1 6.5 2.6 5.7 2.9 3.2 2.1 6.8 9.1 9.1 11.8 5.0 5.7 4.9 6.0 6.8 4.2 3.0 21.0 15.2 10.5 3.8 6.1 21.4 30.6 9.4 14.8 12.2 15.7 11.8 8.3 9.6 6.9 8.0 61.3 0.0 17.1 5.3 5.4 23.6 5.8 37.6 15.4 3.2 32.7 15.4 38.4 14.1 6.6 12.8 8.5 5.4 52.8 11.8 14.3 34.0 10.3 14.4 7.5 6.5 6.2 1.2 4.4 4.6 5.4 11.3 38.8 23.0 GSTA1 ENSG00000243955 "Glutathione S-transferase alpha 1" P08263 6 52791664-52803910 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Oxidoreductase, Peroxidase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 614.0;Ciliated cells: 837.9;Exocrine glandular cells: 1419.6;Hepatocytes: 628.5;Pancreatic endocrine cells: 1010.1;Proximal tubular cells: 2005.4" "Group enriched" "Detected in many" 6 "liver cancer: 555.4;renal cancer: 135.0" "Region enriched" "Detected in single" 6 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "Hep G2: 89.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA 27800000 Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (4.84e-3)" "unprognostic (2.40e-2)" "unprognostic (3.40e-1)" "unprognostic (4.78e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-1)" "unprognostic (1.00e-2)" "prognostic favorable (8.66e-4)" "unprognostic (5.75e-2)" "unprognostic (6.90e-3)" "unprognostic (3.00e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.21e-1)" "unprognostic (4.26e-3)" "unprognostic (1.02e-1)" "unprognostic (2.16e-2)" 0.6 119.4 0.6 0.7 4.2 0.0 0.6 0.6 0.7 0.8 64.3 4.3 0.6 59.9 0.6 1.2 0.7 6.9 16.4 0.6 0.6 0.0 79.7 214.4 7.1 0.6 0.6 0.6 8.5 16.9 0.0 0.7 0.9 0.7 1.8 0.2 1.0 2.6 0.8 0.6 0.1 202.4 0.6 0.6 0.6 10.7 78.2 0.6 0.7 0.6 2.1 4.4 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 89.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.7 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 4.2 0.6 0.7 0.6 0.0 0.6 0.6 0.7 0.6 6.0 7.7 0.0 2.8 0.0 0.0 0.0 614.0 837.9 106.9 69.8 0.0 0.1 454.3 72.7 8.0 0.0 11.8 46.7 1419.6 0.0 0.0 51.4 2.3 628.5 0.1 0.0 2.9 23.4 22.6 21.8 60.7 4.4 0.0 22.6 33.3 0.0 1010.1 6.0 4.2 2005.4 0.0 0.0 0.0 5.6 3.4 0.0 0.5 4.3 29.3 42.0 GSTA2 GST2 ENSG00000244067 "Glutathione S-transferase alpha 2" P09210 6 52750089-52763569 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 63.4;liver: 192.2;pancreas: 54.1" "Cell type enhanced" "Detected in many" 15 "Cholangiocytes: 338.8;Ciliated cells: 780.3;Pancreatic endocrine cells: 549.6;Proximal tubular cells: 368.8" "Group enriched" "Detected in many" 16 "liver cancer: 124.6;renal cancer: 48.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CACO-2: 20.7;Hep G2: 15.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (6.43e-3)" "unprognostic (2.41e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (4.34e-2)" "unprognostic (1.91e-1)" "unprognostic (6.54e-2)" 0.2 1.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 6.4 0.2 0.2 13.4 0.2 0.3 0.2 0.0 9.9 0.2 0.2 0.0 63.4 192.2 5.3 0.2 0.2 0.2 0.3 54.1 0.0 0.2 0.3 0.2 0.7 0.0 0.2 0.3 0.2 0.2 0.0 27.6 0.2 0.2 0.2 1.5 14.1 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 20.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 15.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.5 0.3 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 5.9 0.5 0.1 0.0 0.0 0.0 338.8 780.3 46.6 15.7 0.0 0.0 180.8 6.3 4.5 0.0 0.0 0.0 201.6 0.1 0.0 5.3 0.0 50.4 0.1 0.0 0.0 1.3 1.6 6.5 1.1 1.3 0.0 9.0 0.4 0.0 549.6 0.0 0.4 368.8 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.1 1.0 GSTA3 ENSG00000174156 "Glutathione S-transferase alpha 3" Q16772 6 52896639-52909685 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9" "Group enriched" "Detected in some" 8 "Cytotrophoblasts: 121.8;Syncytiotrophoblasts: 430.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "pons and medulla: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;CACO-2: 1.2;HAP1: 2.3;HEK 293: 1.2;SK-BR-3: 2.1;SuSa: 5.2" "HPA004342, HPA048934, HPA053817" Approved Supported Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (7.51e-2)" "unprognostic (7.06e-3)" "unprognostic (3.10e-1)" "unprognostic (5.53e-2)" "unprognostic (4.38e-3)" "unprognostic (2.86e-3)" "unprognostic (1.81e-1)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (9.35e-2)" 0.2 36.5 0.2 0.2 0.6 0.0 0.7 0.3 0.2 0.9 0.2 1.0 0.2 0.0 0.3 6.6 0.2 32.4 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 0.2 0.2 3.8 0.2 1.1 0.2 51.9 2.1 0.2 0.0 0.5 0.6 0.2 0.2 12.5 0.2 0.2 0.2 0.2 1.0 6.4 0.3 0.2 0.2 0.9 0.2 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.2 0.2 0.2 0.2 0.2 2.1 0.3 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 33.5 10.3 0.0 0.0 121.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.4 0.2 0.0 1.1 0.2 13.5 0.0 0.0 0.0 0.0 1.3 1.4 0.0 23.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 8.5 430.9 0.0 0.0 0.0 GSTA5 ENSG00000182793 "Glutathione S-transferase alpha 5" Q7RTV2 6 52831655-52846095 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.3" "Cell type enriched" "Detected in single" 5 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004342, HPA048934, HPA053817" Uncertain Approved Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (1.97e-2)" "unprognostic (2.83e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 GSTM1 "GST1, H-B, MU" ENSG00000134184 "Glutathione S-transferase mu 1" P09488 1 109687814-109709039 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 163.2;seminal vesicle: 101.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 8.9;Ciliated cells: 9.4;Club cells: 11.4;Ito cells: 8.0;Kupffer cells: 10.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 63.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 26.9;HeLa: 32.1;HHSteC: 25.7;hTEC/SVTERT24-B: 23.2;HUVEC TERT2: 19.7;MOLT-4: 34.6" "CAB022669, CAB047357, HPA048652, HPA055972, HPA055973" Approved Approved "Cytokinetic bridge,Cytosol" NA NA Cytosol "Cytokinetic bridge" "CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (2.22e-2)" "unprognostic (5.35e-2)" "unprognostic (3.87e-3)" "unprognostic (3.20e-1)" "unprognostic (4.95e-2)" "unprognostic (1.03e-1)" "unprognostic (3.56e-2)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (6.55e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (2.12e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (4.72e-3)" 14.5 25.4 15.2 6.9 15.6 2.9 8.2 5.6 19.2 22.0 7.8 16.9 0.0 7.7 9.8 20.2 22.5 13.8 8.2 6.4 14.4 6.8 14.1 163.2 7.7 1.0 7.8 32.1 29.0 18.2 41.4 5.3 2.9 8.2 38.1 6.6 25.7 11.8 101.4 25.1 18.8 17.7 18.2 6.8 21.7 7.5 15.1 11.2 10.9 7.6 1.6 14.5 30.8 19.5 14.6 34.9 14.1 18.9 13.3 17.3 10.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 2.2 8.2 0.0 12.9 0.0 0.4 0.0 0.1 0.2 0.0 0.1 26.9 32.1 0.5 25.7 0.0 0.2 0.0 0.0 23.2 0.1 15.4 19.7 15.8 0.0 18.0 0.8 0.0 34.6 0.2 17.3 0.0 0.0 0.1 0.1 3.4 2.8 0.0 1.7 0.2 0.0 0.1 0.1 0.8 0.3 14.2 0.0 11.5 0.6 0.2 0.0 14.4 19.0 1.1 9.9 0.3 0.6 0.7 12.2 14.1 14.8 18.9 15.7 14.6 15.8 13.7 34.9 14.6 16.5 15.6 1.0 13.3 7.4 19.2 17.3 10.0 15.2 15.6 5.6 19.2 14.4 6.8 7.8 32.1 8.2 11.2 8.9 5.0 0.0 1.0 1.5 0.0 5.6 5.1 9.4 11.4 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 2.3 0.6 0.1 0.0 0.0 8.0 10.1 0.0 3.4 0.8 0.0 1.0 0.0 2.3 0.8 0.0 2.1 0.0 0.0 0.0 0.6 0.2 0.2 1.4 0.0 5.3 0.0 0.1 GSTM2 GST4 ENSG00000213366 "Glutathione S-transferase mu 2" P28161 1 109668022-109709551 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 56.8;Ciliated cells: 17.4;Club cells: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 41.4;HSkMC: 41.0" "CAB040547, HPA055972, HPA055973" Approved Supported Vesicles,Cytosol NA NA 930000 Cytosol Vesicles "CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (2.51e-3)" "unprognostic (1.28e-1)" "unprognostic (2.04e-2)" "unprognostic (2.57e-2)" "unprognostic (2.20e-1)" "unprognostic (5.04e-2)" "unprognostic (7.31e-2)" "prognostic favorable (9.70e-5)" "unprognostic (1.51e-2)" "unprognostic (7.43e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-1)" "unprognostic (1.48e-3)" "unprognostic (1.07e-2)" "unprognostic (1.87e-1)" "unprognostic (2.32e-1)" "unprognostic (2.14e-1)" 23.8 27.3 30.7 14.7 48.3 5.7 31.7 13.7 25.0 36.4 20.9 19.9 54.3 14.5 24.0 37.1 15.4 31.4 15.7 35.2 32.5 21.7 15.9 6.0 11.1 7.5 17.0 21.1 90.1 17.8 20.4 40.2 5.8 22.4 30.7 10.7 36.0 26.6 87.5 88.5 39.2 13.6 22.0 24.9 10.7 16.4 9.2 28.9 6.7 20.4 25.6 8.7 20.2 31.0 5.2 16.5 16.0 3.5 8.9 20.9 5.8 0.0 1.2 13.0 13.3 15.5 41.4 2.5 8.2 14.5 7.6 9.7 2.3 0.0 0.3 8.8 20.6 6.2 0.0 1.0 0.0 9.9 0.5 0.3 4.7 0.1 3.1 10.5 0.4 8.7 41.0 0.3 11.3 0.0 20.5 5.4 3.9 1.3 0.2 16.5 0.1 6.3 8.1 2.4 0.2 11.1 7.9 0.0 0.0 2.3 0.2 2.8 6.4 0.0 0.3 4.2 8.1 13.2 2.3 0.1 8.4 0.4 12.1 0.6 4.1 6.0 0.5 12.7 0.1 0.1 1.0 2.2 16.0 1.9 3.5 1.8 5.2 5.3 2.0 12.7 3.7 20.9 8.9 1.3 8.9 2.1 16.5 4.5 5.8 30.7 48.3 13.7 25.0 32.5 21.7 17.0 21.1 22.4 28.9 0.0 3.7 1.5 1.9 4.2 1.5 56.8 2.5 17.4 20.5 3.5 0.0 0.3 0.0 0.1 1.2 2.4 0.3 0.0 0.0 0.2 3.3 0.6 2.3 0.6 1.2 3.2 0.0 1.3 1.5 6.8 14.4 1.0 5.0 0.0 0.8 11.0 0.1 0.0 9.9 0.8 0.2 6.5 3.1 0.4 0.4 2.5 0.5 4.3 0.4 0.7 GSTM3 GST5 ENSG00000134202 "Glutathione S-transferase mu 3" P21266 1 109733932-109741038 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 115.3;testis: 96.0" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 1724.2;Late spermatids: 2908.0;Spermatocytes: 818.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.1" "Group enriched" "Detected in many" 7 "granulocytes: 4.1;T-cells: 11.1" "Cell line enhanced" "Detected in many" "SK-BR-3: 45.7;T-47d: 96.9;WM-115: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017130, HPA035190, CAB040583, HPA055972" Enhanced Approved Cytosol NA NA 560000 Cytosol "CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992" "unprognostic (2.13e-2)" "unprognostic (2.76e-2)" "unprognostic (1.95e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.28e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.89e-4)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (2.30e-1)" "unprognostic (6.16e-3)" "unprognostic (1.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.90e-2)" "unprognostic (3.48e-2)" 7.5 11.3 21.4 2.9 27.8 0.9 23.1 8.5 18.4 15.4 11.7 9.9 51.0 12.6 9.0 67.2 11.1 8.8 12.3 27.6 14.0 14.4 54.0 5.3 5.2 2.4 9.6 22.0 32.3 26.5 7.3 9.4 5.8 30.7 13.6 5.6 13.4 4.5 115.3 15.5 15.0 7.5 15.9 13.3 3.3 14.2 96.0 6.4 0.1 15.8 15.6 3.3 17.4 12.0 0.6 0.8 4.1 0.3 1.0 11.1 1.4 0.0 1.3 9.9 0.0 13.5 8.3 1.7 10.7 1.8 11.8 11.5 4.3 0.3 0.0 6.2 5.4 8.2 0.5 2.0 4.4 16.4 0.0 2.9 10.0 32.5 6.4 14.4 0.0 23.3 8.3 5.4 17.7 0.0 13.1 14.5 12.4 0.9 0.1 5.3 5.8 2.7 0.2 1.1 0.0 18.6 0.0 6.4 0.4 3.3 23.0 17.5 9.4 22.4 45.7 2.1 3.0 96.9 14.6 11.4 0.1 4.3 12.0 7.0 1.5 2.4 0.0 0.1 0.0 37.6 0.8 0.3 4.1 4.2 0.1 1.2 0.6 5.3 3.1 0.1 0.6 11.1 5.5 2.0 1.0 0.2 0.8 2.3 1.4 21.4 27.8 8.5 18.4 14.0 14.4 9.6 22.0 30.7 6.4 6.0 11.5 8.1 96.3 127.5 19.3 82.7 40.8 1.4 17.0 211.1 5.9 13.4 679.8 74.2 1724.2 31.5 27.6 0.0 131.2 7.7 152.1 47.5 9.2 2.5 8.6 14.3 48.5 54.0 6.6 2908.0 356.9 16.6 57.3 5.4 23.4 255.3 110.8 25.9 259.6 35.7 14.3 187.5 89.7 818.6 48.1 93.8 8.6 7.9 40.9 29.8 GSTM4 ENSG00000168765 "Glutathione S-transferase mu 4" Q03013 1 109656081-109674836 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 85.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "eosinophil: 69.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 69.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048652, HPA055972, HPA055973" Approved Approved "Cytokinetic bridge,Cytosol" NA NA 660000 Cytosol "Cytokinetic bridge" "HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993" "prognostic favorable (9.96e-5)" "unprognostic (1.96e-3)" "unprognostic (7.49e-2)" "unprognostic (9.92e-3)" "unprognostic (1.48e-1)" "unprognostic (1.08e-2)" "unprognostic (8.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.76e-2)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-1)" "unprognostic (1.41e-1)" "unprognostic (2.47e-2)" 12.5 17.6 14.0 12.3 20.2 3.6 10.9 12.9 24.7 12.6 33.2 18.0 9.4 85.3 12.1 15.3 15.9 11.0 14.5 14.7 13.7 12.3 27.2 22.0 7.4 10.1 14.8 16.9 31.4 12.2 23.1 9.9 5.1 15.8 14.7 23.2 20.5 15.4 26.3 47.4 10.6 77.2 19.0 16.1 16.2 14.7 11.8 14.0 4.0 14.9 14.5 12.8 22.2 14.2 3.6 7.8 69.8 3.0 2.5 3.1 2.3 5.3 2.4 4.3 32.5 9.7 15.0 5.5 1.7 14.0 4.1 5.4 17.1 0.6 5.0 6.7 7.7 8.0 5.5 11.1 5.8 2.6 7.4 0.0 10.9 10.1 15.3 15.8 3.7 13.2 9.5 5.8 5.2 0.0 11.5 3.3 12.9 5.0 7.5 2.8 5.0 3.1 16.4 3.3 22.5 13.0 6.7 2.4 7.3 16.0 3.8 3.1 7.2 0.0 28.2 21.8 3.4 7.6 8.0 1.4 4.7 18.7 5.2 2.5 11.2 19.6 0.4 15.6 5.5 13.3 2.0 2.9 69.8 2.7 3.0 1.6 3.6 2.0 3.1 7.8 2.8 2.0 2.3 0.4 2.5 0.7 2.7 2.8 2.3 14.0 20.2 12.9 24.7 13.7 12.3 14.8 16.9 15.8 14.0 8.9 2.4 13.5 21.7 16.1 5.5 25.8 25.5 10.7 7.9 29.6 0.0 18.5 86.2 40.9 2.6 9.0 85.7 0.0 50.8 15.9 20.4 8.2 20.7 21.9 30.0 4.8 6.9 16.0 14.6 4.7 27.9 17.0 38.8 15.4 33.9 22.1 36.3 28.8 23.3 64.5 4.7 32.3 32.0 5.7 6.9 13.4 7.3 17.8 57.6 10.4 GSTM5 ENSG00000134201 "Glutathione S-transferase mu 5" P46439 1 109712255-109775428 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "breast: 237.6;ovary: 66.1" "Group enriched" "Detected in many" 6 "Leydig cells: 132.9;Muller glia cells: 217.3;Peritubular cells: 119.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 5.7;T-cells: 1.9" "Group enriched" "Detected in some" 7 "fHDF/TERT166: 18.0;HHSteC: 7.7;HSkMC: 8.3" "HPA048652, HPA055972, HPA055973" Approved Uncertain "Cytokinetic bridge,Cytosol" NA NA Cytosol "Cytokinetic bridge" "HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (1.46e-2)" "unprognostic (8.64e-3)" "unprognostic (5.58e-2)" "unprognostic (1.42e-1)" "unprognostic (5.34e-3)" "unprognostic (8.09e-2)" "unprognostic (9.64e-4)" "unprognostic (1.31e-2)" "unprognostic (1.44e-1)" "unprognostic (9.16e-2)" "unprognostic (3.31e-1)" "unprognostic (1.92e-2)" "unprognostic (1.42e-2)" "unprognostic (3.74e-2)" "unprognostic (4.39e-2)" "unprognostic (3.03e-3)" "unprognostic (1.40e-1)" 5.8 3.5 25.7 2.6 23.4 1.6 237.6 15.8 24.6 27.2 4.2 14.0 4.7 2.1 14.0 12.0 4.8 19.8 9.0 4.8 24.9 6.2 2.9 2.1 5.7 2.6 4.9 17.9 66.1 2.7 1.6 2.7 1.6 8.9 12.8 4.0 23.0 3.9 11.9 2.4 3.7 3.5 9.8 11.0 3.5 3.9 5.1 11.9 0.0 2.6 2.1 3.2 10.5 16.1 0.0 5.7 0.6 0.2 0.7 1.9 0.9 0.0 0.0 0.0 0.0 1.6 1.6 0.3 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.1 0.1 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.2 0.0 0.7 0.0 5.7 1.9 0.9 25.7 23.4 15.8 24.6 24.9 6.2 4.9 17.9 8.9 11.9 0.0 0.3 0.0 0.5 6.0 2.0 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.2 0.8 0.0 0.0 0.0 0.1 12.3 0.1 0.0 0.0 0.2 0.0 0.0 7.4 1.2 9.9 132.9 0.6 10.1 0.0 0.0 217.3 0.0 0.0 119.5 0.0 5.8 25.8 7.6 1.9 1.1 5.6 0.0 0.0 0.0 0.1 GSTO1 "GSTTLp28, P28" ENSG00000148834 "Glutathione S-transferase omega 1" P78417 10 104235356-104267459 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 137.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 123.8" "Low region specificity" "Detected in all" "HPA037603, HPA037604" Enhanced Approved Nucleoplasm,Cytosol NA NA 200000000 Cytosol Nucleoplasm "HPA037603: AB_2675574, HPA037604: AB_10672283" "prognostic favorable (6.95e-4)" "unprognostic (9.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.83e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.23e-3)" "unprognostic (4.57e-2)" "unprognostic (7.65e-2)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.86e-2)" "unprognostic (1.29e-1)" "unprognostic (5.51e-3)" "unprognostic (5.82e-2)" 29.6 31.9 19.9 21.8 24.4 35.8 20.0 15.0 24.3 17.8 29.7 16.8 17.8 36.3 16.5 21.4 22.6 15.2 24.7 67.9 19.7 21.5 32.7 137.3 32.0 35.7 23.2 23.1 19.7 21.2 18.6 23.2 26.3 17.0 18.2 20.8 18.0 25.3 21.2 42.7 13.3 41.0 21.4 18.9 26.8 19.8 7.0 14.2 30.8 32.9 24.0 16.8 28.0 18.8 18.7 55.4 85.5 68.3 21.8 25.5 68.0 31.7 21.8 16.9 28.8 23.7 45.3 7.3 41.5 73.7 27.6 30.0 27.3 34.0 28.3 18.0 27.5 35.2 18.3 11.0 36.8 29.1 14.1 26.4 20.9 15.5 59.6 42.5 26.7 35.1 34.3 15.7 40.0 48.3 39.3 52.7 26.5 42.9 17.7 57.7 17.3 20.7 37.6 15.6 34.4 15.2 15.3 11.1 11.9 40.9 20.4 8.4 10.5 13.4 9.6 123.8 29.8 10.5 21.5 48.6 32.7 17.1 50.8 36.9 0.3 0.4 0.2 61.3 46.5 12.9 85.5 68.3 19.2 18.3 57.2 22.0 18.7 22.6 23.4 55.4 15.0 19.7 19.8 19.5 21.8 43.9 25.7 25.5 68.0 19.9 24.4 15.0 24.3 19.7 21.5 23.2 23.1 17.0 14.2 71.5 58.2 98.7 286.1 83.2 26.3 290.4 244.5 58.9 78.5 96.0 19.6 399.2 281.8 289.2 13.5 118.6 130.2 70.0 215.9 135.5 154.5 94.2 142.1 611.8 643.1 22.3 99.4 338.8 323.0 12.0 106.2 397.5 119.8 265.1 129.8 50.2 258.3 117.9 106.1 410.6 24.7 148.8 123.7 5.4 2.6 68.8 92.8 101.2 167.3 176.7 GSTP1 "FAEES3, GST3, GSTP" ENSG00000084207 "Glutathione S-transferase pi 1" P09211 11 67583595-67586656 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 252.4;OE19: 379.4" "Low region specificity" "Detected in all" "HPA019779, HPA019869" Enhanced Supported Mitochondria,Cytosol No No 120000000 "Mitochondria, Cytosol" "HPA019779: AB_1849799, HPA019869: AB_1849801" "unprognostic (9.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.24e-2)" "unprognostic (2.72e-2)" "unprognostic (1.06e-2)" "unprognostic (1.30e-3)" "unprognostic (3.27e-1)" "unprognostic (4.98e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-3)" "unprognostic (2.14e-3)" "unprognostic (9.37e-2)" "unprognostic (5.72e-2)" "unprognostic (7.78e-2)" "unprognostic (2.23e-1)" "unprognostic (6.72e-3)" "unprognostic (1.48e-1)" 24.2 25.3 20.2 23.8 21.7 46.2 39.5 15.5 19.8 51.8 51.9 23.5 125.4 35.2 43.5 41.9 181.6 60.8 51.1 45.3 18.3 23.5 44.2 5.9 61.0 39.4 25.5 19.9 33.4 60.7 44.1 33.8 57.9 46.0 37.0 17.9 59.9 50.2 110.8 33.7 58.5 34.0 30.1 22.8 25.1 48.5 15.4 15.4 29.8 91.6 131.5 75.6 40.8 79.5 25.3 191.4 12.4 168.2 70.1 40.7 167.2 57.6 78.7 38.4 59.6 29.7 33.5 35.4 25.2 33.9 38.5 30.0 144.5 60.6 0.1 57.9 39.9 34.5 84.4 103.5 111.0 10.9 40.2 37.6 2.8 57.2 0.0 44.0 18.9 33.7 41.5 252.4 30.7 29.7 28.5 57.8 41.6 62.5 16.1 30.1 0.2 43.4 52.9 73.4 379.4 33.8 40.5 6.4 0.1 61.4 0.1 13.0 37.2 35.3 11.5 114.2 31.7 0.1 31.9 31.1 17.8 45.2 37.2 18.2 10.0 62.4 21.1 20.2 31.4 36.9 2.3 168.2 12.4 40.7 125.7 15.0 25.3 18.4 33.3 191.4 24.3 15.3 27.3 7.0 70.1 79.4 76.2 18.3 167.2 20.2 21.7 15.5 19.8 18.3 23.5 25.5 19.9 46.0 15.4 1072.0 720.7 317.1 1402.4 769.0 173.6 263.2 1108.3 2518.8 1170.4 1167.2 31.4 2000.9 1530.2 1548.4 3.0 432.0 610.1 46.7 1274.3 1522.1 711.2 802.7 262.2 7.2 793.1 66.7 353.7 365.8 595.7 9.3 529.8 867.5 1452.6 2663.7 867.8 370.2 1415.0 772.2 376.2 1617.9 188.6 355.7 676.5 3.2 63.0 928.1 1376.1 396.6 983.6 3031.0 GSTT2B GSTT2P ENSG00000133433 "Glutathione S-transferase theta 2B (gene/pseudogene)" P0CG30 22 23957414-23961186 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "breast: 83.4" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 27.7;Muller glia cells: 19.5;Peritubular cells: 26.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 22.6;HHSteC: 33.3;SK-MEL-30: 23.0;T-47d: 25.5" HPA000750 Uncertain Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA000750: AB_1849804" "prognostic favorable (5.06e-4)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (7.13e-2)" "unprognostic (8.41e-3)" "unprognostic (2.58e-1)" "unprognostic (7.99e-2)" "unprognostic (1.15e-1)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (4.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.48e-2)" "unprognostic (2.19e-3)" 1.6 11.7 2.7 0.7 1.9 0.0 83.4 0.0 4.2 2.6 1.5 0.1 1.7 2.9 2.6 1.4 1.1 2.4 1.7 2.9 1.3 6.1 2.0 0.1 2.5 3.1 3.2 0.9 3.6 0.8 6.1 0.2 1.2 2.5 1.3 11.4 0.7 2.7 1.4 0.9 2.6 0.5 2.5 0.1 0.7 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.5 0.3 0.0 22.6 0.5 0.6 0.9 3.2 1.8 4.6 4.8 9.7 0.0 0.0 5.1 7.9 12.0 9.5 0.0 10.0 2.1 0.0 0.8 0.3 12.7 1.5 33.3 0.0 3.6 13.7 1.6 13.2 2.7 13.3 3.7 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.1 0.3 4.8 0.0 16.8 0.0 10.2 0.0 0.4 9.5 3.1 0.0 23.0 0.0 25.5 0.3 12.3 3.8 2.6 0.5 2.4 0.0 0.0 0.0 2.4 0.0 9.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 2.2 0.0 8.7 0.0 3.5 0.1 2.5 0.0 2.3 0.0 0.0 1.2 24.9 7.2 0.4 1.6 0.0 23.3 7.9 3.6 0.1 7.9 1.1 27.7 8.3 0.0 1.2 15.4 4.0 1.3 9.2 0.2 0.0 5.4 0.4 19.5 4.7 0.0 26.9 3.8 2.6 6.5 0.3 0.5 0.4 0.0 1.5 0.0 0.0 2.3 GSTZ1 "GSTZ1-1, MAAI, MAI" ENSG00000100577 "Glutathione S-transferase zeta 1" O43708 14 77320884-77331597 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Isomerase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 90.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 348.1;Late spermatids: 326.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004701 Approved Approved Nucleoplasm,Cytosol NA NA 62000 Cytosol Nucleoplasm "HPA004701: AB_1078990" "prognostic favorable (4.93e-4)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (2.16e-3)" "unprognostic (4.55e-1)" "unprognostic (3.03e-2)" "unprognostic (8.03e-3)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "prognostic favorable (3.73e-4)" "unprognostic (7.90e-2)" "unprognostic (1.73e-1)" "prognostic favorable (1.12e-7)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (4.12e-1)" "unprognostic (4.92e-2)" 4.6 12.9 5.6 5.9 6.8 2.8 8.5 2.1 9.0 5.0 8.1 10.8 7.5 8.1 4.1 9.5 9.0 5.5 8.0 5.5 5.4 5.0 8.9 90.4 4.4 10.7 6.9 6.9 2.8 7.1 9.3 5.1 11.0 5.8 8.0 8.0 9.5 22.5 4.7 14.8 7.4 7.2 3.8 7.9 5.0 5.9 18.2 5.2 8.6 8.3 14.3 8.9 4.9 4.5 8.2 15.3 7.2 16.0 3.4 5.6 5.0 6.5 12.5 9.9 7.0 6.3 8.7 16.8 4.1 4.2 7.7 10.9 4.2 16.5 14.6 5.9 4.8 4.8 8.4 6.7 7.9 7.4 7.7 6.7 7.1 4.8 8.9 9.9 2.6 5.9 8.1 8.6 4.4 7.5 4.3 6.6 8.7 5.9 13.5 5.1 60.8 4.0 5.5 2.9 22.6 10.0 7.0 10.4 11.3 11.7 8.0 10.9 9.9 9.1 18.2 12.9 5.8 29.7 3.9 4.5 6.0 20.4 6.8 3.0 10.1 10.8 12.8 15.6 4.0 7.5 6.6 11.1 7.2 1.9 16.0 1.9 6.4 3.4 2.8 15.3 8.2 2.9 2.4 1.1 3.4 13.5 10.4 5.6 5.0 5.6 6.8 2.1 9.0 5.4 5.0 6.9 6.9 5.8 5.2 6.0 8.1 12.7 18.0 11.8 6.8 12.0 50.9 10.7 5.7 8.7 3.9 76.5 39.7 34.9 105.1 8.7 47.2 23.3 59.7 57.9 10.6 19.8 3.5 348.1 39.6 15.9 27.6 9.8 28.3 326.5 10.9 14.4 16.9 35.1 36.9 20.9 39.0 38.6 5.6 58.4 11.2 0.0 10.3 33.5 24.7 12.3 63.7 7.7 45.9 17.7 GSX1 "Gsh-1, GSH1" ENSG00000169840 "GS homeobox 1" Q9H4S2 13 27792643-27794768 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "brain: 7.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "glioma: 3.9" "Region enhanced" "Detected in many" "hypothalamus: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA047096 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA047096: AB_2679929" "unprognostic (1.62e-1)" 0.1 0.1 1.6 0.1 3.2 0.1 0.1 0.9 4.0 0.1 0.1 2.5 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.7 7.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.9 1.5 0.7 7.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GTDC1 "FLJ11753, Hmat-Xa" ENSG00000121964 "Glycosyltransferase like domain containing 1" Q4AE62 2 143938068-144332568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036694 Approved Cytosol NA NA Cytosol "HPA036694: AB_10671709" "unprognostic (1.44e-1)" "unprognostic (1.22e-1)" "unprognostic (9.00e-3)" "unprognostic (3.36e-2)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.81e-7)" "unprognostic (8.01e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-1)" "unprognostic (6.22e-3)" "unprognostic (6.96e-2)" "prognostic unfavorable (6.60e-4)" "unprognostic (2.44e-1)" "unprognostic (8.23e-2)" "unprognostic (6.31e-3)" "unprognostic (1.89e-1)" 14.5 12.9 22.1 7.1 17.3 12.3 8.9 7.3 26.7 12.9 6.9 15.3 1.6 4.0 6.8 9.8 7.5 6.0 10.1 15.2 21.4 14.1 9.4 6.4 8.0 9.8 18.2 14.9 12.6 7.0 10.9 10.7 9.3 14.1 6.4 6.7 7.0 5.9 6.0 8.8 5.3 4.8 7.1 24.0 12.6 4.8 11.7 11.6 6.1 10.6 3.1 11.2 8.9 6.3 4.3 2.0 10.8 2.5 8.0 12.3 3.4 4.7 2.0 14.2 2.6 14.6 13.5 4.3 3.3 8.3 7.3 10.1 2.2 4.4 10.2 2.3 5.9 4.7 1.3 2.8 4.9 15.7 13.0 3.3 15.7 1.7 2.2 6.0 6.3 8.6 9.3 12.2 7.9 11.6 5.0 10.4 4.2 2.8 11.9 16.7 2.2 1.6 7.0 4.0 3.6 3.2 4.7 7.3 2.7 8.1 9.7 7.1 5.7 6.4 5.5 6.5 9.3 3.6 7.2 6.4 8.1 6.0 3.6 4.1 7.6 0.0 5.7 4.8 4.2 10.9 2.1 2.5 7.3 5.7 2.2 12.3 4.3 3.8 9.5 2.0 3.4 0.8 6.3 10.8 8.0 2.4 0.7 4.7 3.4 22.1 17.3 7.3 26.7 21.4 14.1 18.2 14.9 14.1 11.6 8.9 30.5 7.5 3.9 6.4 19.2 15.9 0.0 18.7 17.0 5.2 3.9 3.4 5.0 3.7 8.5 11.3 3.5 0.0 9.0 3.8 16.5 3.7 16.3 3.0 9.0 17.5 4.1 23.9 16.9 3.6 11.8 12.1 5.0 10.8 2.6 11.0 7.4 3.5 13.1 5.7 3.5 12.9 17.3 3.7 19.6 4.1 3.5 16.0 3.5 7.8 GTF2A1 TFIIA ENSG00000165417 "General transcription factor IIA subunit 1" P52655 14 81175452-81221377 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000869 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000869: AB_1080253" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (7.98e-3)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (6.04e-3)" "unprognostic (1.65e-1)" "unprognostic (1.14e-1)" "unprognostic (1.85e-1)" "unprognostic (7.49e-2)" "unprognostic (2.76e-1)" "unprognostic (3.87e-2)" "unprognostic (4.04e-2)" "unprognostic (2.44e-1)" "unprognostic (2.11e-1)" "unprognostic (5.88e-2)" 16.9 14.9 18.2 15.7 23.3 8.7 17.1 32.6 23.4 15.7 12.9 17.7 12.7 12.2 16.0 20.1 17.9 12.5 13.1 12.7 17.0 17.8 15.3 18.4 11.6 18.9 16.2 17.0 17.6 14.7 21.0 20.6 24.5 19.9 14.8 14.7 14.0 14.5 13.1 20.3 14.7 12.4 16.2 18.5 17.2 13.4 23.9 16.7 36.3 30.4 11.3 18.5 15.9 15.0 1.3 3.2 9.3 3.9 1.5 2.3 0.8 10.7 10.7 22.6 15.1 12.9 10.9 8.2 12.9 13.4 12.0 10.8 15.9 10.9 17.5 10.6 10.8 8.8 8.1 15.5 9.8 21.3 14.8 4.6 16.0 12.4 9.5 12.7 11.2 16.5 10.0 7.6 16.4 21.5 12.5 12.1 14.4 9.7 24.2 15.3 17.9 28.4 6.6 12.2 8.2 10.4 15.3 19.8 10.8 8.0 22.0 21.4 12.6 30.6 12.5 13.7 11.4 18.7 9.5 15.2 12.2 9.3 16.8 13.5 19.5 20.8 18.2 9.7 13.0 19.2 9.3 1.2 2.1 2.3 0.9 2.0 1.3 2.1 1.3 0.7 1.2 1.9 2.1 2.0 1.5 3.9 3.2 1.1 0.8 18.2 23.3 32.6 23.4 17.0 17.8 16.2 17.0 19.9 16.7 17.9 12.8 11.5 8.0 16.0 22.8 23.4 2.5 6.7 14.8 22.7 33.4 12.6 1.7 9.6 55.2 18.0 15.4 0.0 11.2 10.7 13.2 14.4 30.0 23.7 14.5 38.1 17.9 17.8 25.7 4.9 11.8 19.2 10.1 28.9 16.5 23.4 10.4 14.1 12.7 12.6 15.2 25.8 15.6 25.1 26.2 21.3 21.7 16.0 10.9 8.0 GTF2E2 "FE, TF2E2, TFIIE-B" ENSG00000197265 "General transcription factor IIE subunit 2" P29084 8 30578318-30658251 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004816, CAB009603, HPA025065" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658" "unprognostic (4.84e-2)" "unprognostic (7.38e-3)" "unprognostic (6.20e-3)" "unprognostic (9.09e-2)" "unprognostic (6.30e-2)" "unprognostic (4.38e-1)" "unprognostic (6.05e-3)" "unprognostic (8.69e-2)" "unprognostic (2.29e-1)" "unprognostic (4.72e-2)" "unprognostic (1.57e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (5.82e-7)" "unprognostic (8.25e-2)" "unprognostic (1.72e-1)" "unprognostic (1.05e-3)" "unprognostic (1.24e-1)" 19.0 21.9 11.4 16.2 17.0 7.5 26.7 21.2 13.1 16.4 19.1 10.7 15.1 16.8 17.7 15.8 20.0 12.3 11.7 12.7 11.1 10.9 14.7 21.1 13.4 20.3 11.6 12.2 24.2 44.6 14.1 22.5 14.5 11.9 14.2 14.4 12.1 12.6 13.8 9.9 14.8 26.2 16.3 11.6 17.2 20.9 31.0 11.7 21.4 17.2 10.6 22.0 16.9 27.5 16.4 8.0 5.6 4.2 8.7 7.9 2.6 21.7 17.6 12.2 12.8 32.9 29.4 9.2 23.6 21.4 19.4 24.8 10.5 15.6 28.1 20.1 21.0 28.1 15.4 20.0 22.0 25.9 12.5 11.8 14.0 12.3 24.9 32.0 6.7 12.4 21.5 29.2 20.8 21.2 19.4 26.7 21.0 26.9 17.3 30.4 14.7 32.8 16.9 13.7 26.3 21.2 17.3 13.2 14.0 21.0 14.9 9.4 12.2 13.1 8.8 18.4 16.8 8.5 8.3 20.3 12.8 13.3 10.8 16.0 17.7 24.0 30.4 20.2 11.6 16.9 3.0 4.2 5.6 3.9 3.3 4.2 16.4 6.0 7.9 7.2 9.3 5.9 5.9 2.2 8.7 3.3 8.0 6.7 2.6 11.4 17.0 21.2 13.1 11.1 10.9 11.6 12.2 11.9 11.7 0.0 9.6 39.5 36.7 42.6 8.9 7.8 17.8 21.4 11.4 14.0 9.8 36.2 16.6 26.8 61.8 21.5 30.5 0.0 29.1 39.9 29.8 60.5 11.5 25.6 31.1 4.8 12.7 27.6 20.2 43.8 36.5 28.3 20.3 76.7 19.8 7.3 37.7 23.2 66.4 35.1 13.8 25.8 30.9 56.0 82.0 40.7 51.9 30.9 21.8 88.4 GTF2IRD1 "BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12" ENSG00000006704 "GTF2I repeat domain containing 1" Q9UHL9 7 74453790-74602604 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 62.8" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 29.7;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044254 Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA044254: AB_10964747" "unprognostic (8.92e-2)" "unprognostic (6.94e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.71e-5)" "unprognostic (2.24e-1)" "unprognostic (3.35e-2)" "unprognostic (2.71e-3)" "unprognostic (3.77e-2)" "unprognostic (1.84e-2)" "unprognostic (6.26e-2)" "unprognostic (4.89e-3)" "unprognostic (3.31e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-3)" 4.6 7.6 4.3 5.1 6.8 0.6 6.3 4.4 7.8 9.4 8.2 8.2 9.2 7.0 7.4 8.7 16.4 7.0 8.6 7.7 3.9 5.5 9.3 3.6 7.2 2.6 8.5 5.3 8.6 10.0 21.1 25.3 5.3 6.6 8.2 5.5 21.6 11.3 8.3 62.8 15.6 5.2 12.1 5.6 1.6 8.8 4.5 5.7 1.3 16.4 12.9 7.3 10.5 13.2 0.6 1.8 2.7 0.5 0.6 0.7 0.1 9.3 5.9 12.9 14.1 10.4 5.1 0.1 4.0 10.6 7.8 8.2 10.2 13.4 2.4 3.0 8.0 19.2 5.4 10.2 4.7 5.8 0.1 6.1 0.4 19.9 11.4 33.4 0.1 0.3 7.1 19.2 5.4 22.6 18.3 4.0 4.7 6.8 0.0 8.7 11.8 1.2 8.2 10.3 11.3 6.1 12.6 7.5 8.7 14.8 6.5 10.6 14.5 9.8 17.8 8.7 6.8 10.6 9.3 2.2 8.1 8.3 5.2 9.0 0.5 1.4 3.9 3.3 0.1 6.5 1.2 0.5 0.5 0.3 0.2 0.3 0.4 0.7 0.2 1.8 0.6 0.3 0.4 2.7 0.6 0.1 0.6 0.2 0.1 4.3 6.8 4.4 7.8 3.9 5.5 8.5 5.3 6.6 5.7 8.9 8.0 0.0 9.4 7.0 29.7 7.2 7.6 10.7 4.5 8.7 31.4 0.9 10.0 6.4 0.5 2.7 3.3 0.0 8.1 1.4 4.6 16.3 2.3 2.6 2.2 20.6 4.1 1.8 2.4 0.0 3.7 4.0 6.8 1.0 4.0 5.6 8.5 2.9 5.3 12.4 38.9 0.0 4.6 0.0 5.1 5.8 2.4 0.0 6.8 14.2 GTPBP1 "GP-1, HSPC018" ENSG00000100226 "GTP binding protein 1" O00178 22 38705723-38738299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003166, HPA064702" Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nuclear bodies" "HPA003166: AB_10601476, HPA064702: AB_2685329" "unprognostic (1.42e-3)" "unprognostic (5.82e-3)" "unprognostic (1.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.94e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (3.17e-1)" "unprognostic (3.67e-2)" "unprognostic (1.56e-2)" "unprognostic (2.95e-2)" "unprognostic (2.88e-1)" "unprognostic (5.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.76e-2)" "unprognostic (3.40e-1)" "unprognostic (1.98e-3)" 18.0 17.1 16.0 22.1 20.6 86.0 16.5 24.9 24.9 16.2 17.4 26.8 20.8 20.6 19.6 15.6 19.3 22.7 20.6 19.5 17.2 14.1 15.9 14.7 24.8 20.9 20.6 21.7 25.9 21.0 23.1 23.1 15.6 17.2 20.8 17.9 28.8 18.7 19.9 28.5 23.0 21.2 20.3 16.1 25.5 18.8 17.2 22.7 18.3 23.1 12.6 23.6 23.6 16.5 7.2 5.0 12.1 7.3 3.4 7.7 4.3 13.6 5.0 18.2 14.6 6.4 9.5 9.0 12.4 14.1 19.4 16.6 10.4 7.2 12.8 4.8 13.0 8.7 12.3 21.5 13.9 10.7 21.8 15.6 22.7 16.2 7.4 12.0 26.7 11.5 10.2 10.6 15.5 24.3 10.6 10.4 9.5 13.6 27.1 10.6 5.6 15.0 11.6 13.2 7.6 9.6 29.1 18.5 15.9 6.7 10.9 24.9 8.7 15.5 10.2 9.5 8.0 9.3 11.4 12.5 10.5 10.6 7.7 9.9 25.1 8.6 17.9 10.0 13.6 8.3 3.6 4.3 5.5 7.5 7.0 6.6 7.2 5.5 7.7 5.0 6.6 4.1 5.7 12.1 3.4 7.3 2.6 4.9 4.3 16.0 20.6 24.9 24.9 17.2 14.1 20.6 21.7 17.2 22.7 8.9 6.7 27.3 30.2 24.6 30.9 8.8 7.6 10.7 7.9 12.2 21.6 6.3 5.0 10.4 3.5 11.1 28.2 23.3 16.8 6.5 11.3 34.0 13.9 11.9 7.7 19.1 15.5 9.2 16.8 4.1 15.0 12.5 10.1 33.3 18.9 10.6 15.3 14.0 18.0 5.4 39.1 25.8 20.2 16.1 5.9 29.9 15.9 18.5 10.5 39.6 GUCY1B1 "GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3" ENSG00000061918 "Guanylate cyclase 1 soluble subunit beta 1" Q02153 4 155758992-155807591 "Enzymes, Plasma proteins, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 71.6" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 6.0;Collecting duct cells: 8.7;Ductal cells: 14.1;Proximal tubular cells: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "intermediate monocyte: 5.6;non-classical monocyte: 17.8" "Lineage enriched" "Detected in many" 12 "monocytes: 17.8" "Cell line enhanced" "Detected in many" "HEL: 25.3;Karpas-707: 13.4;MOLT-4: 16.0;RPTEC TERT1: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010890, HPA020870" Approved Approved Cytosol NA NA 5200 Cytosol "CAB010890: AB_259911, HPA020870: AB_1850444" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (3.55e-2)" "unprognostic (9.10e-3)" "unprognostic (4.69e-2)" "unprognostic (1.41e-2)" "unprognostic (6.88e-2)" "unprognostic (6.69e-3)" "unprognostic (3.03e-3)" "unprognostic (1.47e-1)" "unprognostic (8.37e-2)" "unprognostic (2.84e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (7.35e-3)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.14e-1)" "unprognostic (6.36e-3)" 8.8 5.4 18.7 9.8 42.0 1.8 5.5 12.2 36.8 8.1 14.9 5.7 0.4 4.2 11.3 4.7 5.9 9.5 9.2 12.2 16.1 25.0 9.2 5.4 9.4 6.6 14.5 23.2 3.7 7.4 71.6 3.8 28.0 20.6 9.8 6.2 5.8 3.2 8.7 3.8 2.2 5.9 16.3 6.7 7.2 8.9 2.1 5.5 2.6 4.6 2.4 5.1 8.0 6.8 0.2 1.4 1.1 17.8 0.9 0.0 4.8 0.0 0.2 3.6 0.0 1.2 6.8 0.0 1.1 2.0 0.1 0.0 0.0 0.0 0.0 1.7 0.6 2.9 0.0 7.4 0.1 0.4 0.0 2.7 25.3 0.0 0.0 0.7 0.0 0.0 3.0 0.2 0.0 0.1 2.5 0.0 5.7 0.0 13.4 1.8 1.1 16.0 0.0 0.2 0.0 1.9 1.8 0.5 0.4 25.7 2.4 0.4 4.5 0.0 0.1 0.0 3.7 0.0 0.0 0.0 4.2 0.9 7.2 5.3 0.1 0.0 0.0 9.2 0.0 0.0 1.1 0.4 0.3 0.0 5.6 0.0 0.1 0.0 0.0 1.4 0.2 0.0 0.0 0.4 0.9 17.8 1.2 0.0 4.8 18.7 42.0 12.2 36.8 16.1 25.0 14.5 23.2 20.6 5.5 6.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.5 5.0 14.1 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.1 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 GUK1 ENSG00000143774 "Guanylate kinase 1" Q16774 1 228139962-228148984 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028118, HPA048587, HPA068324" Approved Uncertain Nucleoplasm,Cytosol NA NA 240000 Nucleoplasm Cytosol "HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: " "unprognostic (9.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.60e-3)" "unprognostic (7.91e-2)" "unprognostic (8.54e-3)" "unprognostic (1.24e-1)" "unprognostic (3.55e-3)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (7.32e-2)" "unprognostic (3.38e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (2.91e-1)" "unprognostic (5.41e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-2)" 44.6 38.2 106.4 32.5 76.0 76.7 43.0 25.2 74.4 31.5 33.3 30.1 27.3 41.5 26.3 34.1 77.0 28.0 42.5 61.6 93.1 43.9 31.9 43.5 34.6 39.0 60.0 52.9 24.7 62.2 12.8 26.0 29.2 40.1 25.5 12.1 37.4 66.5 29.4 35.8 59.6 42.1 34.8 49.6 36.1 44.3 22.2 34.9 27.5 31.6 29.3 24.1 45.9 44.5 43.9 97.7 110.1 62.9 55.8 83.7 84.5 57.5 20.3 9.0 27.7 27.1 32.6 45.0 38.4 19.7 22.4 17.6 11.6 40.1 21.7 45.6 25.0 18.8 38.3 7.7 42.1 2.4 33.0 59.7 12.9 50.1 25.2 49.3 14.6 22.7 45.2 25.7 15.6 12.6 16.1 30.2 47.0 34.7 34.7 18.3 48.0 65.8 31.5 28.1 28.2 88.0 25.2 16.9 57.6 21.1 27.1 29.6 53.1 24.7 42.4 49.6 2.4 31.3 31.5 52.7 40.9 27.0 59.9 63.1 32.0 34.6 24.0 51.5 23.8 41.2 55.5 57.1 110.1 77.3 59.8 75.2 43.9 64.8 83.7 48.9 36.6 48.7 61.1 74.9 55.8 62.9 97.7 64.6 84.5 106.4 76.0 25.2 74.4 93.1 43.9 60.0 52.9 40.1 34.9 56.6 78.2 181.8 216.6 586.3 182.4 113.0 193.6 93.7 91.0 225.1 675.4 207.7 588.6 495.6 100.8 397.7 599.7 607.3 597.7 329.8 327.6 443.3 180.0 320.2 368.6 103.3 258.9 305.7 236.3 483.4 216.3 309.1 492.6 406.6 288.0 169.2 724.2 491.0 229.1 543.7 445.9 245.8 394.4 82.0 73.0 629.1 219.5 279.1 243.7 436.5 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828788-2882820 "Enzymes, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 76.7;brain: 21.2;breast: 30.4" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 15.8;Intestinal endocrine cells: 19.5" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 17.1;Hep G2: 13.7;NTERA-2: 16.9;SK-MEL-30: 36.5;SuSa: 27.1" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: AB_2685323" "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favorable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 76.7 1.4 4.6 1.3 4.6 0.5 30.4 2.1 3.7 2.1 3.5 8.2 0.7 1.2 4.2 0.9 1.0 3.6 1.7 1.7 3.9 2.9 1.4 9.9 0.7 0.7 5.5 2.9 1.9 3.2 0.4 0.5 1.6 12.9 2.7 2.0 4.2 2.8 4.4 0.5 1.2 1.3 2.8 21.2 0.5 2.2 0.8 5.1 0.0 1.3 0.5 0.6 2.9 1.4 1.0 0.6 0.6 0.4 1.2 0.7 0.0 0.0 5.2 17.1 0.0 10.2 0.0 12.4 0.5 3.0 3.0 3.8 12.7 0.3 0.0 1.4 2.1 3.1 0.0 9.6 0.2 2.9 0.1 2.7 0.0 0.2 13.7 3.0 0.0 4.2 3.7 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.8 0.0 0.4 16.9 0.1 0.0 2.8 5.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 36.5 27.1 1.6 10.4 0.0 0.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.3 0.1 1.0 0.3 0.2 0.6 1.2 0.4 0.6 0.4 0.0 4.6 4.6 2.1 3.7 3.9 2.9 5.5 2.9 12.9 5.1 0.0 0.0 0.0 0.9 0.3 0.9 0.6 2.5 0.0 0.0 0.0 3.9 5.3 5.0 0.8 0.3 0.0 0.2 0.0 3.4 7.0 1.9 1.7 0.0 15.8 0.9 0.0 19.5 0.0 1.3 0.0 0.6 0.0 3.3 0.0 1.3 1.8 2.8 0.0 2.8 2.1 0.0 0.0 0.9 0.3 0.4 0.3 1.9 0.0 2.0 0.5 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140786 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 56.9" "Cell type enriched" "Detected in some" 311 "Erythroid cells: 1331.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "HEL: 57.0" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.1 0.0 0.2 0.1 0.4 56.9 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 1.7 1.3 3.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 4.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.3 0.4 0.2 0.2 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.2 0.9 0.1 0.2 0.2 1.5 0.2 0.6 0.2 0.2 0.2 0.3 0.0 0.8 0.2 0.4 0.1 0.5 0.2 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.3 0.0 0.0 1331.6 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GYS1 "GSY, GYS" ENSG00000104812 "Glycogen synthase 1" P13807 19 48968125-48993310 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.1" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007793, HPA041598" Enhanced Approved Microtubules,Cytosol NA NA 10000 "Microtubules, Cytosol" "CAB007793: AB_562291, HPA041598: AB_2677571" "unprognostic (3.37e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (6.83e-3)" "unprognostic (2.41e-2)" "unprognostic (1.12e-1)" "unprognostic (3.30e-2)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.46e-4)" "unprognostic (4.04e-2)" "unprognostic (6.76e-2)" "unprognostic (5.87e-3)" "unprognostic (3.81e-2)" 9.7 7.3 5.1 6.1 6.5 16.0 10.6 11.3 6.2 5.3 7.3 6.2 5.8 6.1 6.2 6.9 11.5 5.9 6.1 37.3 6.8 4.0 7.2 4.3 5.0 6.3 5.3 5.5 6.8 4.4 6.4 5.1 5.0 5.9 8.7 6.1 12.4 7.2 7.6 106.1 8.1 6.1 6.8 6.0 5.8 7.3 2.2 5.5 6.4 5.2 42.6 9.0 7.9 6.9 6.7 15.9 8.2 10.5 12.8 10.9 7.3 28.7 11.5 8.5 11.7 19.9 7.8 16.9 20.0 14.1 21.1 24.7 11.2 9.4 12.0 12.2 19.5 5.6 20.6 14.2 25.4 18.5 7.4 20.6 9.9 14.7 9.9 11.2 10.8 7.4 19.2 12.2 13.5 11.5 18.3 17.6 12.7 6.9 16.1 26.4 10.9 13.4 9.4 4.5 12.5 13.2 11.4 14.9 11.8 20.9 30.9 5.3 7.4 17.8 23.3 4.7 11.9 12.3 11.3 13.6 25.9 10.0 11.6 21.6 13.3 13.8 5.9 26.4 9.5 5.8 8.2 10.5 7.5 8.8 6.3 10.9 6.7 7.6 8.2 15.9 5.5 6.3 5.6 4.4 12.8 8.5 8.6 10.1 7.3 5.1 6.5 11.3 6.2 6.8 4.0 5.3 5.5 5.9 5.5 0.0 13.9 2.2 3.1 4.5 2.2 62.1 5.1 6.7 3.4 0.0 15.7 7.4 0.0 6.9 0.2 5.4 9.5 0.0 5.9 22.2 4.6 4.3 4.6 4.4 7.1 0.0 6.9 9.8 6.5 0.7 4.9 3.8 6.8 8.2 11.8 2.7 8.9 10.4 5.3 4.8 11.1 0.0 7.6 1.7 3.1 3.6 3.3 4.4 9.8 3.1 H2BFS ENSG00000234289 "H2B histone family member S" P57053 21 43565189-43565648 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.0" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (2.06e-2)" 1.1 0.9 0.2 7.4 0.3 1.8 2.6 0.3 0.8 1.8 1.7 0.4 1.1 2.3 2.4 4.3 4.9 4.2 4.2 4.9 0.5 0.5 4.0 3.3 12.2 0.1 0.5 2.2 4.2 0.0 0.0 4.5 0.4 5.3 1.8 0.8 3.0 2.1 1.0 0.4 3.0 1.8 0.7 5.7 2.0 7.9 0.0 65.0 2.6 7.1 6.1 2.1 1.3 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.1 3.3 0.6 0.9 2.2 0.9 2.4 2.6 1.3 3.2 2.0 4.6 1.1 0.6 8.8 0.8 2.5 2.5 0.2 0.7 0.9 2.2 3.6 0.6 5.0 0.2 0.3 0.9 4.5 2.5 0.4 0.6 0.0 1.2 0.3 0.4 23.7 2.8 0.9 6.1 1.0 2.2 0.3 4.1 2.6 0.8 0.5 8.7 0.7 0.7 3.5 2.5 10.5 3.2 2.1 0.5 11.1 1.4 0.9 1.7 23.4 1.1 0.6 7.6 23.8 5.0 1.1 11.8 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 H2BFS ENSG00000274559 "H2B histone family member S" 21 5972924-5973383 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 16.0" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 2.9;Ciliated cells: 4.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8" "HPA042205, HPA043013, HPA048671" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (3.37e-2)" "unprognostic (2.63e-1)" 0.4 0.3 0.5 1.0 0.0 0.0 1.0 0.9 1.4 1.3 2.9 3.3 2.8 2.8 0.0 0.0 2.2 0.3 2.3 0.2 1.2 0.0 0.8 3.7 0.9 1.9 0.0 0.0 0.0 1.8 0.7 0.6 1.1 0.9 1.6 1.0 1.2 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.1 3.3 0.6 0.9 2.2 0.9 2.4 2.6 1.3 3.2 2.0 4.6 1.1 0.6 8.8 0.8 2.5 2.5 0.2 0.7 0.9 2.2 3.6 0.6 5.0 0.2 0.3 0.9 4.5 2.5 0.4 0.6 0.0 1.2 0.3 0.4 23.7 2.8 0.9 6.1 1.0 2.2 0.3 4.1 2.6 0.8 0.5 8.7 0.7 0.7 3.5 2.5 10.5 3.2 2.1 0.5 11.1 1.4 0.9 1.7 23.4 1.1 0.6 7.6 23.8 5.0 1.1 11.8 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 11.9 2.9 0.9 0.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 1.0 0.0 0.0 0.0 1.8 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.6 H6PD GDH ENSG00000049239 "Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase" O95479 1 9234775-9271337 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 116.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 29.2;ASC TERT1: 33.5;HSkMC: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004824, HPA005440" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 91000000 Cytosol "HPA004824: AB_1079037, HPA005440: AB_1079036" "unprognostic (4.83e-3)" "unprognostic (3.91e-2)" "unprognostic (1.18e-1)" "unprognostic (3.49e-1)" "unprognostic (5.53e-3)" "unprognostic (2.86e-2)" "unprognostic (8.35e-2)" "unprognostic (5.18e-2)" "unprognostic (9.73e-2)" "unprognostic (1.26e-3)" "unprognostic (2.16e-2)" "unprognostic (7.35e-3)" "unprognostic (8.20e-2)" "unprognostic (3.61e-1)" "unprognostic (1.30e-1)" "unprognostic (8.65e-2)" "unprognostic (1.95e-1)" 18.3 16.1 4.1 10.7 5.5 4.8 12.2 4.1 6.3 16.6 11.9 10.5 8.2 6.3 22.0 18.0 11.1 15.6 11.9 11.9 3.7 3.0 7.0 116.9 12.2 11.1 6.8 2.6 38.3 10.6 8.0 8.7 14.9 6.0 11.6 5.3 11.8 29.8 8.1 24.7 20.7 10.4 10.2 6.6 10.7 9.9 12.4 5.5 16.2 12.6 12.9 14.1 12.2 10.1 4.5 3.7 4.1 6.3 3.1 4.7 3.0 3.9 3.2 2.8 10.5 29.2 33.5 2.7 3.9 9.8 2.9 4.6 0.6 8.1 4.3 4.6 6.1 3.7 4.1 0.7 1.9 4.3 12.9 0.9 0.0 1.0 2.6 16.3 1.4 1.7 32.9 3.8 7.0 4.6 6.5 13.4 2.4 1.1 7.5 5.7 2.3 1.5 3.2 1.5 2.9 1.9 0.5 0.3 3.6 3.8 1.6 0.9 5.0 5.2 4.1 4.9 2.0 3.1 7.0 13.3 10.1 1.7 2.5 1.1 10.0 2.9 1.0 16.9 6.3 6.4 3.5 6.2 0.9 4.7 6.3 3.7 3.5 3.5 4.1 2.8 4.5 3.4 3.2 4.1 3.1 5.8 3.7 2.8 3.0 4.1 5.5 4.1 6.3 3.7 3.0 6.8 2.6 6.0 5.5 23.8 29.3 11.2 11.1 12.7 18.1 13.0 58.6 10.7 12.5 19.2 25.5 9.0 0.0 15.8 0.8 14.7 15.1 0.0 18.5 6.5 24.0 16.2 3.5 132.8 11.5 15.9 7.5 17.8 18.0 1.5 44.5 10.3 11.8 64.9 15.2 11.2 20.1 17.5 34.6 8.2 11.5 0.0 9.2 4.7 4.6 11.2 4.9 13.8 24.1 11.4 HABP4 "IHABP4, SERBP1L" ENSG00000130956 "Hyaluronan binding protein 4" Q5JVS0 9 96450201-96491336 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.8" "Group enriched" "Detected in many" 11 "Early spermatids: 193.7;Late spermatids: 710.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.1;T-cells: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055969, HPA062366" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA055969: AB_2682991, HPA062366: " "unprognostic (1.67e-1)" "unprognostic (7.99e-2)" "unprognostic (2.12e-3)" "unprognostic (2.40e-1)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.36e-2)" "unprognostic (3.63e-2)" "unprognostic (3.49e-1)" "unprognostic (2.42e-2)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.25e-1)" "unprognostic (1.40e-1)" "unprognostic (4.93e-2)" "unprognostic (3.62e-2)" 13.2 11.9 31.2 6.1 44.8 1.7 6.5 14.1 40.6 7.9 5.5 12.4 1.5 3.0 8.2 6.8 7.2 5.3 8.1 19.1 26.1 24.9 23.5 5.7 6.1 6.8 27.1 20.5 11.7 4.8 13.8 7.4 3.4 31.6 8.3 4.2 8.4 4.1 10.6 9.4 6.1 3.3 10.6 19.4 5.0 5.0 21.8 13.0 0.4 11.2 2.2 4.9 7.6 6.5 4.1 0.1 0.3 0.8 1.0 4.0 0.7 7.3 8.4 10.7 11.4 23.7 20.3 7.6 10.0 11.2 7.5 8.2 12.5 12.3 3.7 5.0 14.8 24.0 5.4 8.9 1.9 6.1 4.5 5.3 1.4 4.0 20.8 12.1 0.3 1.5 8.2 3.4 8.6 6.8 11.5 5.3 4.3 1.7 11.1 13.5 7.5 0.1 2.3 5.0 10.3 8.2 3.8 9.3 0.1 12.8 3.2 6.8 4.6 5.3 3.2 15.9 8.3 2.3 1.6 9.1 10.4 2.4 19.0 8.4 7.0 6.9 1.6 8.3 2.9 15.3 0.0 0.1 0.0 1.4 0.3 1.4 4.1 4.0 3.2 0.0 1.7 2.8 2.8 0.3 1.0 0.8 0.1 3.0 0.7 31.2 44.8 14.1 33.8 26.1 24.9 27.1 20.5 31.6 13.0 0.0 6.1 3.4 7.8 10.2 22.0 10.6 15.3 1.4 9.1 17.4 0.0 2.2 14.9 3.7 193.7 17.8 0.8 0.0 5.0 6.7 7.8 8.5 1.1 5.0 5.5 22.3 12.6 13.5 1.5 710.5 12.7 4.0 16.9 3.6 0.9 17.1 4.8 0.0 22.3 39.6 11.3 6.5 17.6 18.6 5.9 6.9 1.1 7.5 1.1 5.1 HAL HIS ENSG00000084110 "Histidine ammonia-lyase" P42357 12 95972662-95996365 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 29.5;liver: 96.8;skin 1: 26.9" "Group enriched" "Detected in some" 13 "Erythroid cells: 46.7;Hepatocytes: 134.4" "Cancer enriched" "Detected in some" 11 "liver cancer: 23.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 20.1;neutrophil: 29.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 29.5" "Cell line enhanced" "Detected in some" "BEWO: 3.2;NB-4: 4.0;THP-1: 15.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038547, HPA038548" Enhanced Approved Cytosol NA NA 67000 Cytosol "HPA038547: AB_10669541, HPA038548: AB_10673175" "unprognostic (3.39e-1)" "unprognostic (4.46e-2)" "unprognostic (1.53e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (5.05e-2)" "unprognostic (2.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.33e-2)" "unprognostic (9.41e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-3)" "unprognostic (1.89e-2)" "unprognostic (3.74e-1)" "unprognostic (4.03e-2)" "unprognostic (2.87e-2)" 0.5 0.0 0.1 1.1 0.3 4.4 0.9 0.1 0.3 0.3 0.2 0.1 0.1 0.1 1.1 0.3 0.5 0.2 0.3 0.2 0.1 0.0 0.2 96.8 1.7 2.3 0.5 0.1 0.3 0.5 0.0 7.4 0.4 0.2 0.2 0.0 0.1 0.2 0.1 0.2 26.9 0.2 0.2 0.3 2.7 0.1 0.2 0.2 0.1 0.2 0.9 1.3 0.2 0.5 0.0 1.4 29.5 6.3 0.3 0.1 1.6 0.6 0.0 0.2 0.1 0.0 0.0 3.2 0.0 0.2 0.1 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.2 0.5 0.4 0.2 0.0 0.0 0.6 0.7 0.0 0.9 0.4 0.4 0.1 0.3 0.4 0.0 0.2 0.1 0.0 0.2 4.0 1.3 0.1 0.7 0.3 0.1 0.1 0.1 0.8 0.2 0.4 0.5 0.1 0.0 0.1 0.0 15.5 0.2 0.1 0.2 0.2 0.2 0.7 0.7 0.2 0.0 2.4 0.0 20.1 6.3 0.9 0.0 2.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 29.5 0.3 5.1 0.1 0.1 1.6 0.1 0.3 0.1 0.3 0.1 0.0 0.5 0.1 0.2 0.2 0.0 1.4 0.0 0.1 0.1 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 46.7 0.2 0.2 0.0 0.1 0.0 134.4 0.3 0.0 0.0 1.8 6.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.1 HAO2 "GIG16, HAOX2" ENSG00000116882 "Hydroxyacid oxidase 2" Q9NYQ3 1 119368779-119394130 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 60 "kidney: 65.1;liver: 90.2" "Group enriched" "Detected in some" 6 "Hepatocytes: 210.7;Proximal tubular cells: 261.6" "Group enriched" "Detected in some" 26 "liver cancer: 25.6;renal cancer: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;BJ hTERT+: 1.2;HL-60: 2.0;SiHa: 1.5;U-698: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050355 Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA050355: " "unprognostic (1.13e-1)" "unprognostic (1.68e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (6.22e-2)" "unprognostic (5.33e-3)" "unprognostic (2.80e-2)" "unprognostic (3.27e-1)" "unprognostic (3.15e-1)" "unprognostic (3.17e-1)" "unprognostic (1.41e-1)" "unprognostic (1.73e-1)" "prognostic favorable (4.92e-4)" "unprognostic (9.66e-2)" "unprognostic (1.79e-1)" "unprognostic (2.89e-2)" "unprognostic (5.14e-4)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 65.1 90.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.7 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.3 0.5 0.0 0.6 0.8 2.0 0.4 0.0 0.2 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.8 0.2 1.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.2 2.5 0.0 0.0 10.4 0.0 0.0 41.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 210.7 0.1 0.0 0.0 3.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HAP1 "HAP2, hHLP1, HIP5, HLP" ENSG00000173805 "Huntingtin associated protein 1" P54257 17 41717742-41734644 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;stomach 1: 23.3" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 5.8;Syncytiotrophoblasts: 13.2" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "REH: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023394, HPA076992" Enhanced Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA023394: AB_1850492, HPA076992: AB_2686822" "unprognostic (2.84e-3)" "unprognostic (3.74e-3)" "unprognostic (2.42e-2)" "unprognostic (2.30e-1)" "unprognostic (7.53e-2)" "unprognostic (4.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" "unprognostic (8.76e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.38e-1)" "unprognostic (2.46e-2)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-2)" "unprognostic (9.29e-2)" 0.7 3.2 11.7 1.1 16.2 0.8 2.0 5.6 13.1 4.8 1.3 3.8 2.2 5.2 4.6 3.5 0.9 2.8 3.1 0.6 10.1 30.5 1.1 1.2 1.4 0.9 6.6 6.6 1.0 2.2 0.5 6.8 3.1 15.5 1.6 1.4 0.4 3.4 3.0 1.0 1.6 2.5 1.7 8.3 3.3 23.3 3.4 2.2 0.0 7.2 0.0 1.0 0.9 1.2 1.2 0.8 2.6 0.6 1.5 1.0 0.1 0.1 1.5 0.7 1.5 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.9 0.1 0.1 0.5 0.1 0.2 6.3 3.3 0.2 0.0 0.0 1.6 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.8 9.0 0.4 45.8 0.0 1.7 0.3 0.5 0.2 0.0 0.3 0.2 0.0 0.8 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.6 0.6 0.5 0.6 0.3 0.4 0.5 0.5 0.6 0.2 1.2 0.8 1.0 2.6 1.5 0.6 0.8 0.8 0.1 11.7 16.2 5.6 9.3 10.1 30.5 6.6 6.6 15.5 2.2 0.0 1.7 0.0 5.8 2.7 1.4 2.0 0.0 2.7 2.3 0.0 2.0 1.2 0.0 0.3 0.2 2.5 0.2 0.0 0.8 0.6 2.3 3.9 0.0 0.8 0.4 0.0 0.0 0.6 0.8 0.0 0.3 1.9 0.0 0.0 0.2 0.8 0.8 0.0 0.7 0.0 1.2 0.0 1.0 0.0 4.5 2.8 13.2 0.7 1.0 3.1 HAPLN3 "EXLD1, HsT19883" ENSG00000140511 "Hyaluronan and proteoglycan link protein 3" Q96S86 15 88877288-88895626 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.4;lymphoid tissue: 23.6" "Cell type enriched" "Detected in many" 8 "Extravillous trophoblasts: 899.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 25.4" "Lineage enriched" "Detected in many" 5 "T-cells: 25.4" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;U-2 OS: 21.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039237 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA039237: AB_10805357" "unprognostic (1.67e-2)" "unprognostic (1.04e-3)" "unprognostic (2.57e-1)" "unprognostic (2.53e-2)" "unprognostic (3.27e-1)" "unprognostic (2.24e-2)" "unprognostic (4.21e-1)" "unprognostic (3.82e-1)" "unprognostic (3.37e-3)" "unprognostic (7.37e-3)" "unprognostic (1.13e-3)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.18e-13)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.12e-1)" 9.9 1.3 1.1 20.6 2.7 4.4 8.7 1.0 2.3 5.3 2.6 1.1 0.3 1.4 4.4 4.9 5.7 6.0 4.7 9.8 3.2 1.0 3.0 0.8 8.7 23.6 3.1 0.9 5.2 2.3 0.9 2.2 2.7 3.6 5.2 1.1 3.2 6.4 1.6 4.2 6.0 4.1 4.7 6.2 6.9 3.6 1.9 1.8 5.7 7.2 7.6 10.9 6.0 5.6 0.8 1.1 0.7 0.6 4.8 25.4 3.2 1.2 4.4 0.9 9.8 2.8 3.0 3.1 2.7 0.6 1.0 1.3 2.8 4.1 0.0 7.8 3.4 1.6 1.0 9.3 1.2 0.0 21.0 8.2 3.0 0.2 0.0 0.4 0.0 0.1 1.1 0.5 2.0 0.1 0.1 4.6 0.4 0.0 6.0 0.4 0.1 0.0 0.0 7.3 0.0 0.1 0.0 0.4 7.3 1.8 0.1 0.1 2.7 0.5 0.5 3.7 1.2 0.0 0.4 0.8 7.1 21.0 5.3 0.4 0.9 0.0 0.0 2.5 0.0 6.1 0.7 0.6 0.0 0.6 0.3 3.0 0.1 10.0 4.1 1.1 0.8 10.2 4.5 0.1 4.8 0.1 0.4 25.4 3.2 1.1 2.7 1.0 2.3 3.2 1.0 3.1 0.9 3.6 1.8 0.0 4.3 0.9 6.0 28.4 2.6 7.7 0.0 1.4 5.7 1.8 9.8 5.6 0.0 5.7 0.0 18.6 0.0 0.0 1.8 899.6 9.3 3.9 1.1 0.0 17.6 0.0 0.0 3.1 0.0 0.0 0.9 2.9 16.9 16.2 0.2 2.4 8.7 0.0 0.7 0.1 108.4 12.9 38.9 0.5 1.7 21.1 17.0 3.2 0.2 6.8 HARBI1 "C11orf77, FLJ32675" ENSG00000180423 "Harbinger transposase derived 1" Q96MB7 11 46602861-46617909 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 63.9;Late spermatids: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038671, HPA045457" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038671: AB_10675947, HPA045457: AB_2679332" "unprognostic (1.29e-1)" "unprognostic (6.82e-2)" "unprognostic (7.76e-2)" "unprognostic (2.65e-1)" "unprognostic (1.61e-1)" "unprognostic (3.95e-1)" "unprognostic (1.23e-5)" "unprognostic (2.10e-1)" "unprognostic (1.66e-2)" "unprognostic (9.58e-2)" "unprognostic (3.15e-1)" "unprognostic (6.34e-2)" "unprognostic (6.96e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (5.01e-2)" "unprognostic (1.13e-1)" 3.3 5.9 6.3 3.3 13.9 7.5 3.7 2.6 8.5 3.8 4.4 11.8 5.4 4.0 3.6 5.4 4.4 3.3 3.7 3.7 6.0 4.4 4.6 4.9 3.2 4.6 16.6 4.2 2.6 4.8 5.4 8.3 5.9 9.2 3.6 5.3 3.4 4.5 3.0 4.9 5.0 4.1 4.5 7.7 4.3 6.2 19.2 13.0 4.8 4.1 0.6 5.0 4.4 3.1 6.7 8.2 20.3 10.2 6.0 10.1 4.5 3.7 6.0 5.0 4.7 10.0 6.1 5.9 5.4 5.2 7.4 9.4 4.2 4.2 6.5 3.5 4.4 8.3 7.2 5.3 4.7 6.9 7.5 6.3 6.6 4.7 4.6 11.6 6.1 8.9 7.7 12.6 4.9 9.6 2.8 4.6 7.1 10.2 8.1 6.1 7.8 7.5 2.6 13.6 12.1 7.4 5.0 7.1 11.4 5.7 4.4 4.8 3.9 6.4 6.9 7.6 7.0 11.4 5.4 4.3 7.4 5.8 9.7 4.8 7.8 8.2 7.0 5.7 3.6 7.5 20.3 7.5 10.2 10.1 10.2 7.1 5.0 8.3 7.5 6.2 6.7 8.1 8.9 11.1 6.0 9.2 8.2 9.8 4.5 6.3 13.9 2.6 8.5 6.0 4.4 16.6 4.2 9.2 13.0 0.0 2.2 4.4 2.2 0.9 3.1 1.6 0.0 5.3 3.4 0.0 2.0 4.2 5.0 3.3 63.9 1.4 2.1 0.0 1.9 3.0 1.4 1.6 0.0 1.7 2.9 3.2 1.2 0.6 3.4 52.4 2.8 1.8 1.7 5.4 1.3 2.3 2.4 0.0 1.8 2.9 3.4 0.0 1.4 16.5 11.9 2.4 7.8 2.1 1.4 1.7 HARS USH3B ENSG00000170445 "Histidyl-tRNA synthetase" P12081 5 140673904-140691862 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036539 Approved Enhanced Cytosol NA NA 52000 Cytosol "HPA036539: AB_10669796" "unprognostic (9.35e-2)" "unprognostic (9.95e-2)" "unprognostic (1.62e-3)" "unprognostic (1.65e-2)" "unprognostic (2.33e-1)" "unprognostic (8.57e-2)" "prognostic unfavorable (1.96e-7)" "unprognostic (6.50e-2)" "unprognostic (1.46e-1)" "unprognostic (3.82e-2)" "unprognostic (1.28e-2)" "unprognostic (2.40e-1)" "unprognostic (3.46e-2)" "unprognostic (2.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.26e-2)" "unprognostic (1.36e-1)" 22.4 24.5 28.5 21.1 35.5 18.1 21.0 41.1 46.3 20.6 22.7 20.0 23.6 17.4 21.6 23.5 26.9 23.7 17.5 25.1 29.5 35.9 20.6 34.2 16.7 22.4 36.9 33.0 24.7 25.2 29.5 38.7 15.0 38.2 21.7 24.8 13.6 22.1 27.9 27.1 33.9 16.4 28.0 21.0 18.3 18.8 16.6 23.5 17.6 19.4 20.3 28.5 19.9 20.9 16.8 22.1 10.7 22.9 25.2 29.4 23.4 20.6 30.2 18.2 39.7 23.2 25.3 19.2 33.3 24.0 38.5 36.0 54.9 17.5 27.5 29.3 37.3 31.1 21.7 27.6 53.5 36.3 23.3 34.1 19.8 39.2 34.8 28.8 31.1 17.0 26.7 16.8 41.9 23.9 23.0 38.6 17.1 17.3 22.9 40.0 35.5 22.1 29.0 14.3 16.7 19.9 20.5 26.4 22.4 30.9 26.4 28.6 27.7 27.6 40.2 26.2 18.3 29.6 17.5 32.2 36.1 13.9 20.3 44.8 23.1 27.4 27.8 27.4 26.1 24.7 6.7 14.1 10.7 29.4 20.8 26.3 16.8 25.8 27.3 22.1 14.8 28.2 26.9 4.3 25.2 22.9 15.6 22.1 23.4 28.5 35.5 41.1 46.3 29.5 35.9 36.9 33.0 38.2 23.5 14.9 19.4 29.8 29.5 27.2 27.3 7.7 20.4 14.7 15.9 26.2 13.7 35.0 38.1 46.0 30.2 30.6 23.2 0.0 37.0 41.1 27.2 20.1 15.1 76.4 31.4 28.6 24.8 26.4 17.5 15.9 23.3 22.3 35.4 61.3 22.2 20.7 37.7 23.0 32.5 33.8 20.0 45.3 41.8 29.6 30.4 28.4 30.1 30.2 25.5 25.7 HARS2 "HARSL, HARSR, HO3" ENSG00000112855 "Histidyl-tRNA synthetase 2, mitochondrial" P49590 5 140691426-140699318 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035941 Approved Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA035941: AB_10671237" "prognostic unfavorable (6.49e-4)" "unprognostic (3.15e-2)" "prognostic favorable (6.19e-4)" "unprognostic (1.79e-2)" "unprognostic (1.78e-1)" "unprognostic (8.30e-3)" "prognostic unfavorable (2.92e-4)" "unprognostic (7.77e-2)" "unprognostic (1.88e-1)" "unprognostic (5.26e-2)" "unprognostic (1.58e-1)" "unprognostic (2.68e-2)" "unprognostic (1.85e-1)" "unprognostic (5.40e-2)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (1.31e-2)" 17.1 23.8 14.2 22.9 19.4 13.4 25.0 24.7 19.0 15.0 21.6 16.6 19.7 17.7 20.2 16.9 16.7 14.9 16.7 25.2 15.7 12.6 19.6 14.5 21.4 25.2 15.5 11.2 17.4 13.6 22.9 21.1 15.8 14.4 14.3 24.4 16.4 16.4 15.4 32.7 18.3 17.2 15.6 12.9 18.5 17.9 15.1 15.6 16.5 15.8 13.9 18.8 20.6 18.4 13.7 12.0 22.9 15.0 22.8 17.6 9.7 10.9 24.7 10.7 27.5 12.2 16.2 17.7 14.1 16.1 19.9 17.4 22.6 13.8 13.9 22.8 15.6 19.6 13.9 14.8 26.5 18.4 13.9 12.2 10.1 23.7 14.9 11.8 13.5 14.9 15.2 18.1 19.4 22.0 16.1 14.3 14.7 9.3 13.1 19.2 13.9 13.2 16.8 12.3 8.3 15.6 13.5 10.9 14.0 18.6 25.6 14.9 21.4 20.5 33.3 27.9 16.3 29.4 13.5 17.4 17.9 9.9 9.9 18.6 13.0 18.9 13.4 14.1 15.6 17.8 22.9 10.5 21.3 16.2 15.0 17.5 13.7 15.6 16.2 12.0 12.5 16.4 17.6 12.1 22.8 11.4 9.5 15.3 9.7 14.2 19.4 24.7 19.0 15.7 12.6 15.5 11.2 14.4 15.6 3.0 4.3 10.4 3.8 3.1 4.8 16.5 2.5 9.4 6.8 5.2 0.0 16.4 11.6 11.9 0.9 7.1 6.7 0.0 14.0 15.3 6.3 3.7 2.3 5.9 8.8 0.0 7.5 6.7 7.8 1.7 8.6 8.3 3.3 12.6 7.2 7.7 13.2 10.5 9.9 6.7 5.2 0.0 7.2 6.4 14.1 3.4 12.0 7.5 11.2 3.9 HAUS1 "CCDC5, FLJ40084, HEI-C, HsT1461" ENSG00000152240 "HAUS augmin like complex subunit 1" Q96CS2 18 46104332-46128333 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040601, HPA040652" Supported Supported Centrosome,Cytosol NA NA Cytosol Centrosome "HPA040601: AB_10794743, HPA040652: AB_10793966" "unprognostic (1.74e-2)" "unprognostic (1.89e-2)" "unprognostic (8.13e-3)" "unprognostic (1.92e-1)" "unprognostic (2.29e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.39e-1)" "unprognostic (4.76e-3)" "prognostic favorable (1.55e-4)" "unprognostic (3.75e-1)" "prognostic unfavorable (6.76e-4)" "unprognostic (5.97e-3)" "unprognostic (5.40e-2)" "unprognostic (9.79e-3)" "unprognostic (3.66e-2)" "unprognostic (7.96e-2)" 15.2 11.8 10.3 14.6 13.1 23.1 14.5 15.8 12.2 14.3 13.4 6.2 13.1 9.9 15.5 28.4 15.9 13.8 11.6 9.3 10.3 8.0 14.4 12.1 10.9 22.9 13.6 6.8 20.4 12.0 6.5 18.1 13.0 12.0 14.8 16.3 7.3 11.4 14.4 7.1 8.6 13.4 12.2 14.4 17.9 12.2 11.8 15.4 38.4 14.3 14.4 26.1 13.9 12.3 28.1 23.4 13.0 18.2 19.3 34.9 19.3 18.7 11.3 43.1 23.2 11.1 17.2 11.6 18.3 18.3 29.4 29.2 11.1 10.6 35.8 11.1 13.1 13.6 20.0 25.8 15.6 32.4 20.1 17.3 26.3 12.2 20.9 9.3 47.9 16.2 8.3 6.2 18.1 9.3 13.0 32.0 25.8 18.7 10.2 26.1 10.9 37.9 23.0 27.5 9.0 6.7 38.1 30.9 25.6 23.2 13.2 20.3 21.1 17.0 5.9 13.8 17.8 8.6 23.3 18.0 17.2 11.7 7.4 19.1 12.0 18.2 33.2 11.0 40.7 19.6 4.4 18.2 13.0 16.0 16.4 17.7 28.1 21.6 18.9 21.6 23.7 15.4 18.1 2.0 19.3 12.7 23.4 34.9 19.3 10.3 13.1 15.8 12.2 10.3 8.0 13.6 6.8 12.0 15.4 11.9 12.6 27.6 18.2 15.5 4.5 8.7 15.3 30.8 33.0 14.0 3.9 42.3 14.9 32.5 5.8 26.6 9.0 0.0 37.0 91.5 29.6 7.0 28.9 7.7 44.3 11.1 11.6 17.8 38.3 8.6 21.0 31.9 20.3 43.3 22.2 18.1 25.9 10.5 24.4 18.9 8.0 19.4 16.5 51.9 57.7 13.6 19.8 25.9 26.4 6.7 HAUS2 "C15orf25, CEP27, FLJ10460, HsT17025" ENSG00000137814 "HAUS augmin like complex subunit 2" Q9NVX0 15 42548810-42569994 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039965 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA039965: AB_10673025" "unprognostic (5.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (6.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-3)" "unprognostic (1.47e-3)" "unprognostic (1.62e-2)" "unprognostic (2.24e-1)" "unprognostic (2.17e-1)" "unprognostic (1.17e-3)" "unprognostic (1.33e-1)" "unprognostic (6.81e-3)" "unprognostic (4.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.22e-1)" "unprognostic (2.62e-3)" 18.7 11.3 13.1 12.1 11.5 49.9 18.6 13.3 15.4 9.9 11.9 11.1 5.6 8.9 14.0 10.4 12.8 9.7 9.3 10.8 14.1 13.6 10.3 11.0 16.8 16.6 14.6 13.9 12.1 12.1 8.4 9.9 11.6 13.1 8.8 10.8 8.5 10.5 8.5 13.5 11.8 9.5 12.3 18.7 11.2 9.7 13.7 11.7 18.4 10.1 11.8 13.0 10.8 14.0 10.3 7.2 7.5 13.5 4.4 8.7 4.3 11.4 6.1 11.2 7.2 5.6 6.4 10.9 11.7 7.0 11.0 9.3 12.4 7.3 7.4 5.7 6.4 10.7 19.3 11.9 7.5 11.1 9.6 6.9 10.1 10.7 9.6 8.1 17.7 9.3 5.5 5.7 8.8 9.1 5.7 11.1 9.9 17.6 9.1 10.7 7.2 13.0 14.3 9.8 16.1 8.0 14.7 13.7 9.6 7.0 8.3 9.1 7.6 11.7 11.3 6.9 8.5 11.3 13.2 8.7 17.0 12.4 26.2 21.7 13.9 39.0 22.2 10.6 19.5 12.9 7.3 7.7 7.5 8.4 9.0 8.3 10.3 8.3 6.0 6.5 8.9 6.1 8.3 3.8 4.4 13.5 7.2 8.7 4.3 13.1 11.5 13.3 15.4 14.1 13.6 14.6 13.9 13.1 11.7 11.9 15.6 14.6 18.4 12.0 7.6 4.0 7.6 21.4 11.4 3.5 15.7 11.4 3.3 13.3 21.6 11.3 6.5 0.0 14.3 22.8 9.4 20.3 23.2 7.3 19.4 15.9 16.6 10.4 15.8 5.3 10.3 19.4 1.7 21.6 9.7 6.1 15.3 8.6 10.6 11.0 15.2 19.4 11.2 23.2 8.5 13.4 11.2 15.3 9.0 16.0 HAUS6 "dgt6, FAM29A, FLJ20060, KIAA1574" ENSG00000147874 "HAUS augmin like complex subunit 6" Q7Z4H7 9 19053143-19103119 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 91.7;Spermatocytes: 55.3;Spermatogonia: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020960, HPA020965" Approved Supported "Nuclear speckles,Centriolar satellite,Cytosol" No No "Centriolar satellite, Cytosol" "Nuclear speckles" "HPA020960: AB_1848393, HPA020965: AB_1848394" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (6.04e-3)" "unprognostic (6.51e-3)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.21e-1)" "unprognostic (2.15e-1)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (3.13e-5)" "unprognostic (2.52e-1)" "unprognostic (1.68e-1)" "unprognostic (3.13e-2)" "unprognostic (2.03e-1)" 8.7 9.6 10.9 9.2 13.1 17.5 11.1 10.8 10.3 7.7 7.0 9.9 5.6 4.9 8.9 8.0 7.0 7.4 6.4 7.1 10.5 7.3 5.2 11.0 7.1 12.8 15.0 8.9 11.1 6.3 5.8 8.5 8.4 12.4 7.6 7.9 5.6 7.1 7.4 7.2 9.8 7.2 8.9 13.5 10.0 5.8 27.1 13.6 27.3 6.6 3.8 12.7 7.0 7.1 3.6 2.6 10.9 2.2 7.2 6.1 2.5 11.1 7.6 15.6 12.1 6.0 7.3 8.4 11.9 8.5 11.1 17.0 3.9 5.1 13.0 4.4 6.9 8.5 4.6 14.3 7.0 17.2 11.8 6.8 69.2 13.8 8.9 4.0 9.1 15.8 4.5 7.2 10.5 22.8 5.7 8.0 13.4 9.4 8.6 12.7 3.6 17.8 15.5 16.7 6.3 7.6 13.9 10.6 5.3 5.9 6.4 9.1 12.6 5.3 5.0 7.6 10.4 3.9 11.5 7.9 9.9 6.0 8.5 13.6 3.4 7.5 12.8 9.3 7.8 4.3 10.9 2.2 2.2 4.5 2.2 6.1 3.5 4.3 5.6 2.2 3.6 5.2 4.6 3.5 7.2 2.0 2.6 5.4 2.5 10.9 13.1 10.8 10.3 10.5 7.3 15.0 8.9 12.4 13.6 17.9 12.2 10.4 10.2 8.7 11.6 7.4 5.1 1.4 6.8 8.7 9.8 8.4 0.0 8.9 91.7 7.8 4.2 23.3 5.2 13.1 7.6 7.3 10.5 5.7 7.2 11.1 2.4 4.3 3.2 21.2 10.9 13.1 8.5 3.6 4.4 13.1 7.4 3.5 7.8 3.3 9.3 6.5 5.4 55.3 51.9 7.0 4.1 10.0 7.4 8.8 HAUS7 "UCHL5IP, UIP1" ENSG00000213397 "HAUS augmin like complex subunit 7" Q99871 X 153447666-153495516 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003614 Approved "Nucleoli,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" Nucleoli "HPA003614: AB_1080368" "unprognostic (2.06e-1)" "prognostic favorable (6.12e-4)" "unprognostic (3.81e-2)" "unprognostic (3.21e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-2)" "unprognostic (1.75e-2)" "unprognostic (7.50e-2)" "unprognostic (1.56e-1)" "unprognostic (3.39e-1)" "unprognostic (4.65e-3)" "unprognostic (6.28e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (1.09e-2)" 13.1 9.4 16.1 10.3 16.4 9.4 7.9 9.1 19.3 12.7 9.3 8.9 20.3 7.9 10.8 17.1 7.0 9.9 15.1 11.9 20.3 9.1 13.3 11.9 9.4 12.1 12.0 16.5 9.3 4.3 3.1 6.4 12.6 11.1 11.8 6.2 7.8 8.5 17.4 7.2 46.9 7.4 12.1 8.9 16.4 8.8 6.1 18.4 14.2 10.8 8.8 9.8 7.5 11.8 20.2 22.3 10.1 31.1 16.7 18.5 15.8 13.9 22.4 10.0 19.3 3.5 4.8 13.8 9.7 5.5 11.2 19.9 16.3 7.8 13.3 31.1 6.5 15.5 11.9 14.2 9.7 8.7 16.0 23.5 9.7 20.9 12.2 3.2 16.0 14.0 7.4 2.5 9.9 6.3 4.9 7.9 12.2 12.2 6.8 6.6 26.9 15.0 19.3 6.2 22.3 22.4 14.1 16.4 20.1 3.5 8.8 11.1 8.4 5.2 11.5 3.9 5.0 4.5 7.7 5.1 9.7 19.2 22.5 17.7 10.1 26.5 52.2 5.1 28.8 13.2 4.7 26.2 10.1 17.0 31.1 17.8 20.2 18.5 17.1 22.3 16.6 18.4 16.7 3.4 16.7 27.1 12.6 15.5 15.8 16.1 16.4 9.1 19.3 20.3 9.1 12.0 16.5 11.1 18.4 6.0 7.2 4.5 1.3 6.4 1.9 2.0 2.5 5.3 2.3 0.0 3.9 10.4 5.0 7.9 0.0 5.0 5.8 0.0 7.1 20.6 6.2 1.0 19.6 3.9 10.6 3.2 2.4 11.1 11.1 0.0 5.5 8.1 3.3 14.4 11.6 1.9 6.1 10.5 7.1 11.8 1.3 6.5 6.6 1.6 6.3 4.1 7.8 7.4 13.3 1.1 HBS1L "DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038" ENSG00000112339 "HBS1 like translational GTPase" Q9Y450 6 134960378-135103056 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029728, HPA029729" Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA029728: AB_10611112, HPA029729: AB_10601228" "unprognostic (3.68e-3)" "unprognostic (6.39e-2)" "prognostic favorable (6.77e-4)" "unprognostic (1.26e-1)" "unprognostic (2.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (8.66e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (1.23e-1)" "unprognostic (7.73e-2)" "unprognostic (3.84e-1)" "unprognostic (4.98e-2)" "unprognostic (1.47e-1)" "unprognostic (4.20e-2)" 16.9 18.6 17.5 13.0 27.3 31.8 18.0 23.2 34.7 16.7 14.9 18.2 9.2 10.1 15.6 10.8 20.0 13.8 12.0 22.3 18.4 18.8 17.4 28.4 11.7 16.3 21.1 16.0 15.6 20.4 19.5 25.4 18.7 33.6 14.2 13.5 11.0 17.1 14.1 66.4 14.7 15.3 18.6 25.0 14.4 14.2 14.0 17.1 42.5 17.5 19.9 18.5 16.3 13.6 25.2 28.4 38.4 24.6 32.9 38.4 28.3 15.1 10.2 21.3 30.9 19.6 17.5 16.3 30.7 26.5 29.3 36.3 17.1 11.5 26.3 13.9 27.1 21.2 11.4 29.8 22.6 45.8 26.7 20.4 80.4 28.9 22.9 23.5 49.6 22.0 17.2 17.2 27.7 34.1 22.0 24.2 31.5 42.9 22.2 30.9 14.4 30.5 12.6 13.7 18.2 11.2 28.7 23.8 17.9 18.1 14.5 21.1 14.4 21.0 22.0 21.8 17.6 18.3 30.0 22.8 20.8 21.7 25.7 32.4 50.7 36.5 44.7 31.7 25.8 25.8 38.4 24.6 25.4 23.4 22.1 26.3 25.2 28.1 23.8 28.4 22.6 38.4 31.6 11.2 32.9 21.1 22.6 32.9 28.3 17.5 27.3 23.2 34.7 18.4 18.8 21.1 16.0 33.6 17.1 23.8 21.7 26.8 23.0 24.3 42.7 51.6 22.9 28.1 36.4 10.4 13.7 27.2 21.6 20.9 27.5 18.0 9.8 93.5 17.8 26.9 19.6 19.2 56.8 33.1 12.0 20.6 15.6 17.2 22.1 11.0 17.3 14.9 28.7 27.1 11.4 26.1 16.4 13.9 20.8 19.2 26.4 38.8 24.0 25.9 25.7 16.3 33.9 20.3 14.5 22.5 HBZ "HBZ-T1, HBZ1" ENSG00000130656 "Hemoglobin subunit zeta" P02008 16 152687-154503 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.9;placenta: 5.0;testis: 9.9" "Group enriched" "Detected in some" 4 "Hofbauer cells: 144.1;Late spermatids: 212.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 79 "K-562: 227.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA063268, HPA064073, HPA071726" Approved Approved Nucleoplasm,Cytosol NA NA 160000000 Cytosol Nucleoplasm "HPA063268: , HPA064073: , HPA071726: AB_2732184" "unprognostic (3.56e-1)" "unprognostic (1.32e-1)" 0.8 0.0 0.8 0.1 0.5 8.9 0.6 0.6 0.6 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.6 3.3 0.7 0.3 0.1 1.1 0.6 0.1 1.1 0.1 0.7 0.1 0.0 0.1 5.0 0.1 1.2 0.0 0.1 0.1 0.1 0.9 0.5 0.1 0.1 0.1 0.8 0.1 9.9 0.1 0.1 0.1 0.1 0.1 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 227.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.5 0.6 0.6 0.7 0.3 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 41.3 0.7 0.0 23.3 0.0 16.4 1.4 0.0 0.0 0.0 144.1 0.0 0.0 0.0 0.0 212.4 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.7 6.5 2.0 1.1 0.9 0.1 8.7 0.0 0.0 0.0 HCFC2 HCF-2 ENSG00000111727 "Host cell factor C2" Q9Y5Z7 12 104064457-104106524 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 190.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006227 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA006227: AB_1079042" "unprognostic (4.22e-3)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (7.66e-2)" "unprognostic (3.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.46e-1)" "unprognostic (1.07e-2)" "unprognostic (1.59e-1)" "unprognostic (1.43e-2)" "unprognostic (2.71e-2)" "unprognostic (4.54e-2)" "unprognostic (4.23e-3)" "unprognostic (1.16e-2)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.23e-2)" 11.5 10.0 11.9 4.7 13.2 3.2 12.9 3.8 11.1 11.5 14.4 9.1 8.7 7.2 12.6 7.5 9.1 8.5 8.1 7.7 9.3 5.8 8.5 10.2 9.1 5.9 12.5 8.1 11.8 9.1 10.4 14.3 10.6 10.0 10.8 6.3 6.8 8.0 14.6 17.5 7.4 7.5 19.0 10.2 6.8 9.9 19.2 11.0 9.1 10.1 5.1 5.0 12.8 10.3 1.8 2.2 2.8 5.0 2.5 3.2 1.7 1.9 2.1 2.2 1.9 12.4 12.4 1.6 8.5 3.9 6.6 3.8 1.0 0.9 1.9 3.0 6.6 2.4 2.1 2.7 1.5 7.1 3.2 2.6 1.9 2.0 0.9 8.4 1.6 3.1 7.7 4.2 4.1 3.4 9.5 5.0 3.0 2.2 4.1 11.7 1.7 2.8 3.7 0.4 1.2 4.4 2.3 7.3 1.2 2.9 1.3 3.2 2.4 4.2 3.0 3.2 1.6 4.8 1.7 7.5 10.4 1.4 5.3 2.9 5.2 1.5 1.7 4.9 2.1 4.1 1.3 2.0 2.8 2.6 3.7 3.1 1.6 2.5 3.2 2.2 1.8 3.0 3.2 0.5 2.5 5.0 1.2 2.8 1.7 11.9 13.2 3.8 11.1 9.3 5.8 12.5 8.1 10.0 11.0 11.9 16.0 8.4 6.6 7.1 18.4 9.6 0.0 10.7 11.4 5.2 19.6 4.3 8.3 4.8 190.7 11.3 6.9 0.0 2.9 3.5 9.5 3.2 16.2 9.0 6.3 22.3 8.1 15.4 9.4 44.6 20.1 6.9 6.8 4.6 3.3 13.8 2.7 3.2 26.2 7.0 22.6 12.9 10.3 57.9 10.2 6.4 9.0 9.6 3.3 3.1 HCLS1 "CTTNL, HS1" ENSG00000180353 "Hematopoietic cell-specific Lyn substrate 1" P14317 3 121631399-121660927 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 149.7;lymphoid tissue: 110.1" "Cell type enhanced" "Detected in many" 15 "Kupffer cells: 535.9;Macrophages: 194.3;monocytes: 183.1;T-cells: 152.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 43.1;HMC-1: 61.2;Karpas-707: 39.8;RPMI-8226: 40.9;THP-1: 42.7;U-266/70: 60.6;U-698: 60.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA019143 Enhanced Supported "Plasma membrane,Cytosol" NA NA 200000 "Plasma membrane, Cytosol" "HPA019143: AB_1850532" "unprognostic (2.27e-2)" "unprognostic (1.79e-3)" "unprognostic (5.38e-3)" "unprognostic (6.29e-2)" "unprognostic (1.01e-2)" "unprognostic (4.02e-3)" "unprognostic (2.35e-1)" "unprognostic (4.88e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "unprognostic (6.76e-2)" "unprognostic (2.28e-1)" "unprognostic (1.03e-3)" "unprognostic (2.93e-1)" "unprognostic (3.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" 24.7 10.7 7.8 44.9 14.7 35.5 9.1 1.3 7.4 6.3 10.4 8.5 2.2 5.5 5.6 8.2 4.8 9.1 10.1 7.5 6.7 5.0 10.5 10.1 18.7 59.4 12.9 3.2 4.6 5.1 1.4 6.1 15.4 10.9 6.1 8.6 4.9 7.4 3.1 7.0 4.6 23.0 8.9 15.1 110.1 7.1 3.6 11.6 41.0 6.1 4.4 61.5 12.5 5.6 33.4 59.6 149.7 84.9 24.3 44.1 103.5 0.1 0.0 0.0 0.0 3.6 2.0 0.9 0.6 0.6 0.1 0.2 0.0 0.0 43.1 21.0 0.0 0.0 0.0 1.1 1.6 0.1 19.2 0.0 27.9 0.0 0.0 2.0 30.6 61.2 0.3 0.0 0.0 0.3 0.0 25.4 17.6 5.5 39.8 0.0 0.0 21.7 25.9 0.0 0.0 0.7 22.0 0.0 40.9 0.0 11.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 42.7 33.1 0.0 0.3 0.0 0.1 60.6 18.4 60.6 0.3 29.5 0.0 26.6 64.1 104.2 40.2 80.6 32.9 33.4 33.3 36.8 59.6 29.4 28.5 33.0 149.7 24.3 84.9 18.5 44.1 103.5 7.8 14.7 1.3 7.4 6.7 5.0 12.9 3.2 10.9 11.6 8.9 51.2 119.0 0.8 2.9 0.4 1.7 7.6 18.7 12.5 0.0 0.0 96.0 0.0 0.3 0.8 14.6 0.1 23.3 0.2 50.7 6.0 0.3 70.6 2.1 117.6 0.0 0.0 33.2 535.9 0.9 3.1 194.3 18.6 183.1 0.3 0.6 0.3 0.0 1.1 0.6 0.7 12.9 6.6 0.3 0.6 3.9 121.6 152.2 0.2 1.8 HDAC4 "BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288" ENSG00000068024 "Histone deacetylase 4" P56524 2 239048168-239401654 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Autism spectrum disorder, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 73.9;Late spermatids: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3" "Group enriched" "Detected in many" 8 "granulocytes: 28.3;monocytes: 7.4" "Cell line enhanced" "Detected in many" "JURKAT: 30.4;MOLT-4: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048723, HPA071448" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoplasm, Cytosol" "HPA048723: AB_2680501, HPA071448: " "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.39e-3)" "unprognostic (3.06e-4)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.33e-4)" "prognostic favorable (1.13e-4)" "unprognostic (1.40e-1)" "unprognostic (4.82e-3)" "unprognostic (2.40e-1)" "unprognostic (3.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.04e-2)" 7.9 6.8 6.1 6.8 5.2 17.1 4.6 6.4 12.3 11.3 21.4 4.6 4.3 2.5 10.2 6.4 8.8 9.0 24.6 5.2 5.0 6.0 3.2 3.1 4.2 4.3 6.1 5.4 8.5 5.8 4.9 8.3 2.5 5.2 7.5 4.8 8.3 3.7 7.3 54.6 6.9 6.5 15.8 4.2 5.4 7.0 8.1 4.3 6.5 4.8 13.2 5.6 10.2 4.6 0.5 1.7 28.3 7.4 2.1 1.2 0.4 3.8 3.8 4.9 5.9 2.8 4.7 5.8 4.0 2.7 3.2 3.1 1.7 7.0 1.8 1.6 3.4 4.6 3.8 3.4 1.6 1.6 10.6 1.8 2.8 4.7 5.6 3.7 4.3 2.6 3.2 4.1 5.9 4.7 1.6 3.4 30.4 4.0 4.1 1.5 4.7 28.1 5.9 3.8 4.8 2.0 7.3 9.2 2.8 3.7 4.9 3.9 6.9 5.6 2.5 9.8 2.9 1.3 11.9 5.4 3.7 0.3 6.4 5.4 2.9 2.7 3.5 5.4 6.0 7.4 10.5 7.4 1.1 0.9 2.4 1.1 0.5 0.9 0.8 0.8 0.5 0.5 1.0 28.3 2.1 1.0 1.7 1.2 0.4 6.1 5.2 6.4 7.5 5.0 6.0 6.1 5.4 5.2 4.3 3.0 9.0 3.7 2.2 7.0 11.5 10.1 7.6 0.0 3.4 10.4 2.0 1.2 0.0 2.4 73.9 5.8 4.5 0.0 1.8 1.5 8.0 5.0 2.3 5.8 2.9 15.9 5.8 13.5 22.7 47.3 10.9 5.5 5.0 0.0 5.5 10.1 1.7 0.0 11.7 1.2 7.1 0.0 5.6 2.2 2.1 8.4 1.1 8.7 5.7 2.2 HDAC5 "FLJ90614, KIAA0600, NY-CO-9" ENSG00000108840 "Histone deacetylase 5" Q9UQL6 17 44076746-44123702 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 111.9;Syncytiotrophoblasts: 182.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019400, HPA030991" Approved Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Nuclear speckles" "Golgi apparatus, Cytosol" "CAB019400: AB_2116626, HPA030991: AB_10795286" "unprognostic (1.30e-2)" "prognostic favorable (6.14e-4)" "unprognostic (6.65e-2)" "unprognostic (8.06e-2)" "unprognostic (3.49e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (8.80e-3)" "unprognostic (3.80e-2)" "unprognostic (2.37e-2)" "unprognostic (4.91e-3)" "unprognostic (4.30e-1)" "prognostic favorable (3.30e-5)" "unprognostic (1.51e-2)" "unprognostic (3.11e-1)" "unprognostic (6.00e-2)" "unprognostic (1.76e-2)" 15.6 17.6 24.9 7.9 15.8 13.2 18.1 35.9 25.8 16.5 8.8 19.6 9.5 8.4 15.0 11.9 20.1 16.9 11.3 24.4 22.1 24.2 8.6 6.3 13.6 8.8 24.7 22.1 24.5 16.1 28.2 17.5 23.0 19.3 13.6 5.5 11.7 14.2 11.9 42.6 34.0 9.7 12.4 20.5 13.8 9.3 10.3 18.1 7.6 15.0 9.8 8.2 14.9 20.4 7.6 9.4 17.9 13.6 3.5 4.9 5.0 3.6 2.4 6.5 1.5 12.7 9.8 23.6 9.8 24.4 4.9 8.0 5.2 3.9 5.7 3.9 23.2 7.3 2.9 7.6 4.2 2.1 8.8 12.4 11.1 7.8 12.0 5.4 3.6 15.7 13.9 7.2 5.6 7.0 8.4 4.0 4.6 8.2 11.6 28.3 2.8 5.9 10.9 7.1 2.8 5.6 22.9 18.2 14.7 0.5 1.6 17.0 8.9 2.8 12.0 13.3 10.1 17.1 21.0 2.2 12.3 7.9 2.8 4.9 19.2 16.0 6.8 7.1 4.5 5.8 7.1 7.3 7.7 4.9 11.6 3.5 6.6 3.9 4.9 9.4 7.6 4.1 3.5 17.9 3.5 13.6 8.3 3.5 5.0 24.9 15.8 35.9 25.8 22.1 24.2 24.7 22.1 19.3 18.1 11.9 13.6 10.4 30.2 26.0 84.0 21.0 12.7 5.3 7.9 19.2 111.9 12.7 18.3 13.6 17.9 18.3 11.2 0.0 7.5 47.4 24.1 34.1 11.6 9.0 19.6 77.9 44.2 20.3 12.1 8.7 44.8 13.6 13.5 9.0 13.7 17.3 12.1 15.8 41.1 6.4 58.6 64.7 41.8 2.3 33.8 28.7 182.4 17.5 11.2 18.5 HDAC7 "DKFZP586J0917, HDAC7A" ENSG00000061273 "Histone deacetylase 7" Q8WUI4 12 47782722-47833132 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 85.8" "Cell type enhanced" "Detected in many" 4 "Ito cells: 87.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 10.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004775 Supported Cytosol NA NA Cytosol "HPA004775: AB_1850548" "unprognostic (3.83e-1)" "unprognostic (9.49e-3)" "unprognostic (1.37e-2)" "unprognostic (4.46e-2)" "unprognostic (6.56e-3)" "unprognostic (2.22e-2)" "unprognostic (2.50e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.28e-1)" "unprognostic (2.07e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (6.24e-2)" "unprognostic (4.38e-2)" "unprognostic (9.69e-2)" "prognostic favorable (4.65e-4)" 26.0 21.6 8.2 22.7 10.8 17.3 24.4 8.4 10.7 28.2 20.7 8.7 15.4 8.0 27.9 21.5 19.2 25.2 22.1 16.5 10.3 4.3 17.7 5.1 27.6 21.1 8.2 8.0 25.4 8.9 23.7 11.5 17.5 10.0 20.1 4.1 17.6 16.3 18.9 12.5 19.7 13.9 24.9 10.3 23.1 14.9 9.5 11.5 85.8 20.9 12.9 21.0 24.8 25.0 1.4 0.6 10.5 1.9 1.7 1.5 1.8 14.2 9.7 10.1 16.5 7.9 22.1 9.1 14.0 10.9 10.2 6.7 12.9 13.5 28.6 46.8 12.7 5.0 13.2 2.3 10.9 3.7 13.4 4.8 9.8 9.5 3.0 8.6 3.0 0.4 14.4 3.8 10.1 5.5 18.4 21.0 16.4 10.3 11.7 6.4 6.2 28.1 7.5 14.1 3.1 10.8 21.7 5.4 10.3 4.3 9.3 2.9 6.9 10.7 5.0 5.1 6.8 4.7 4.1 23.8 20.9 22.7 17.0 9.9 26.5 19.2 22.7 8.6 14.5 6.8 0.0 1.9 0.0 1.5 0.8 1.5 1.4 1.3 1.1 0.6 1.1 1.5 1.0 10.5 1.7 0.7 0.5 0.6 1.8 8.2 10.8 8.4 10.7 10.3 4.3 8.2 8.0 10.0 11.5 38.7 36.7 31.8 21.0 12.2 18.0 11.5 30.6 5.3 22.7 34.9 0.0 3.9 1.7 29.4 13.4 71.6 1.1 0.0 19.7 2.5 28.8 40.0 8.1 0.4 13.7 27.0 7.0 87.8 29.5 4.9 50.9 11.5 13.5 12.6 9.7 13.6 47.3 9.7 31.1 2.9 3.2 25.8 20.6 0.9 3.1 18.9 2.4 26.6 7.6 38.2 HDDC3 MGC45386 ENSG00000184508 "HD domain containing 3" Q8N4P3 15 90929964-90935196 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040895 Approved Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA040895: AB_10795494" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (3.75e-2)" "unprognostic (2.53e-1)" "unprognostic (3.57e-1)" "unprognostic (1.28e-1)" "unprognostic (5.93e-3)" "unprognostic (1.08e-1)" "unprognostic (1.91e-2)" "unprognostic (3.43e-2)" "unprognostic (2.26e-1)" "unprognostic (4.86e-2)" "unprognostic (3.15e-1)" "unprognostic (4.65e-1)" 14.3 18.8 16.3 8.9 17.1 10.7 11.3 10.3 17.6 8.2 13.1 9.3 12.6 12.4 5.4 12.8 7.7 12.7 7.1 15.2 12.9 12.3 14.7 18.3 7.8 9.0 14.6 12.5 10.3 30.3 15.1 10.4 10.4 11.0 8.7 11.1 9.7 24.8 14.0 14.2 9.3 17.1 6.1 11.4 13.1 11.2 4.5 8.2 11.8 12.0 10.1 10.7 7.5 7.5 19.9 25.3 5.6 15.6 16.4 21.5 14.3 6.7 8.3 2.9 3.5 6.7 6.8 4.9 4.5 6.2 4.3 6.3 4.1 14.0 12.7 4.8 3.8 3.4 10.5 6.1 10.6 3.6 16.1 12.9 16.0 3.2 9.3 13.7 6.1 7.9 5.9 16.8 7.8 14.0 6.8 9.4 10.6 12.7 11.5 3.8 9.8 8.3 5.3 2.4 25.5 8.5 7.0 1.1 20.3 8.8 7.1 7.4 4.7 3.8 10.7 11.4 6.4 16.2 16.5 5.3 2.7 5.9 4.4 5.8 18.8 21.1 8.8 9.8 12.0 7.9 5.6 11.8 4.7 14.0 15.6 18.4 19.9 18.4 16.2 15.9 17.5 21.5 15.7 2.8 16.4 14.2 25.3 17.4 14.3 16.3 17.1 10.3 17.6 12.9 12.3 14.6 12.5 11.0 8.2 26.8 6.1 27.0 11.4 4.9 12.4 0.8 43.3 20.1 19.4 15.7 3.9 39.0 64.6 34.0 3.9 14.7 23.8 23.3 49.1 27.5 8.7 13.1 6.9 33.8 39.5 14.3 19.1 15.4 12.9 2.4 13.3 18.0 13.5 48.7 31.2 29.5 27.9 30.6 11.0 53.5 35.3 6.5 7.3 16.3 14.0 7.3 20.3 17.5 34.4 10.3 HDLBP "HBP, VGL" ENSG00000115677 "High density lipoprotein binding protein" Q00341 2 241227264-241317061 "Plasma proteins, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 210.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004189, CAB026457" Enhanced Supported Cytosol NA NA Cytosol "CAB026457: , HPA004189: AB_1079044" "unprognostic (2.57e-2)" "unprognostic (1.13e-2)" "unprognostic (2.13e-2)" "unprognostic (1.51e-1)" "unprognostic (4.46e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (1.70e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-2)" "unprognostic (4.39e-3)" "unprognostic (3.92e-2)" "unprognostic (9.48e-3)" "unprognostic (2.47e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (6.39e-5)" "prognostic unfavorable (4.12e-4)" 38.2 38.7 18.1 18.1 27.7 15.9 37.4 18.1 27.0 39.6 30.4 24.7 38.2 22.5 34.8 43.2 35.3 38.7 30.9 37.5 17.9 15.9 33.9 92.0 29.9 20.9 19.8 16.6 40.1 210.4 40.5 40.0 44.4 22.5 35.9 29.4 26.1 105.2 34.3 80.2 27.6 36.1 29.9 18.5 23.0 39.2 39.6 19.3 20.8 39.0 45.7 34.7 31.9 31.0 10.9 22.4 11.6 28.8 10.1 12.3 12.4 34.4 27.7 29.0 46.2 74.2 91.1 41.3 86.0 88.3 39.1 56.0 24.8 35.3 10.5 10.4 124.4 39.5 27.6 43.2 56.3 64.2 16.7 26.7 33.5 35.0 60.5 72.7 23.9 29.2 67.3 45.8 56.8 64.0 61.5 53.3 16.9 31.8 14.1 61.0 35.9 13.7 12.5 28.1 33.9 18.4 12.8 56.4 20.9 31.9 41.1 24.2 27.7 37.5 39.5 33.5 37.7 31.2 23.4 66.9 47.9 30.5 66.1 36.0 16.7 13.7 18.6 60.7 17.8 43.8 11.6 20.0 9.1 9.3 21.9 12.3 10.9 10.6 11.1 22.4 7.4 9.6 8.9 11.5 10.1 28.8 14.7 9.8 12.4 18.1 27.7 18.1 27.0 17.9 15.9 19.8 16.6 22.5 19.3 71.5 78.3 34.3 93.1 62.4 40.0 194.7 68.8 192.7 135.4 71.5 41.2 101.3 114.4 97.3 89.3 67.6 127.8 23.3 105.3 136.3 141.1 173.9 65.9 177.0 82.5 65.2 92.7 87.8 59.9 303.9 137.8 58.4 54.0 82.0 181.5 47.2 115.6 122.0 164.4 96.7 35.3 64.7 111.0 124.2 118.4 67.9 180.2 35.2 119.7 133.4 HDX "CXorf43, FLJ30678" ENSG00000165259 "Highly divergent homeobox" Q7Z353 X 84317874-84502479 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 19.1;Urothelial cells: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047189 Uncertain Approved Cytosol NA NA Cytosol "HPA047189: AB_10965463" "unprognostic (7.26e-2)" "unprognostic (3.53e-2)" "unprognostic (1.64e-2)" "unprognostic (1.51e-5)" "unprognostic (3.23e-4)" "unprognostic (5.52e-2)" "unprognostic (1.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (6.40e-6)" "unprognostic (1.14e-1)" "unprognostic (7.20e-2)" "unprognostic (3.86e-3)" "unprognostic (2.34e-1)" "unprognostic (1.30e-2)" "unprognostic (3.66e-2)" 5.1 7.4 8.3 3.3 7.9 0.6 6.4 23.1 10.2 8.2 4.6 2.6 3.5 1.8 7.4 5.3 4.2 6.3 5.5 4.8 5.5 4.6 4.3 4.5 4.4 2.3 6.5 7.0 8.0 2.2 5.5 16.4 1.4 6.6 6.0 4.5 2.0 4.5 6.2 1.7 1.9 2.9 6.6 5.7 4.2 3.2 4.0 7.1 0.4 5.7 2.7 2.7 5.2 8.3 2.7 6.1 0.0 6.9 1.4 1.4 1.1 0.0 2.2 9.0 0.0 5.4 4.7 0.0 2.9 3.9 6.9 7.8 0.4 1.2 0.0 0.6 3.0 8.8 0.5 0.1 1.1 5.4 0.0 0.6 0.0 1.7 0.0 5.0 0.0 0.0 3.2 0.1 4.4 2.9 3.9 6.9 0.0 0.0 0.0 6.8 0.1 0.0 0.0 6.6 0.0 3.0 0.0 7.6 0.1 3.2 1.5 0.3 5.1 0.0 0.2 0.0 3.8 0.4 0.0 7.3 3.8 2.6 1.2 2.7 0.2 0.0 0.0 1.8 0.0 1.6 0.0 4.3 0.0 1.4 6.9 0.2 2.7 0.4 0.3 6.1 1.0 1.2 0.7 0.0 1.4 5.9 0.6 0.2 1.1 8.3 7.9 23.1 10.2 5.5 4.6 6.5 7.0 6.6 7.1 0.0 2.4 1.3 19.1 2.3 8.5 1.6 2.5 1.4 4.5 5.2 11.8 0.0 0.0 5.2 3.8 7.1 0.7 0.0 1.6 0.0 5.1 11.0 1.1 0.2 0.9 6.4 6.8 1.8 1.6 1.0 3.7 2.6 0.0 3.6 1.3 3.3 2.8 2.0 3.2 1.7 5.0 0.0 3.3 0.5 0.0 1.5 0.1 1.3 0.9 18.0 HEATR3 FLJ20718 ENSG00000155393 "HEAT repeat containing 3" Q7Z4Q2 16 50065941-50106387 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041990, HPA058579" Uncertain Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA041990: AB_10793940, HPA058579: AB_2683762" "unprognostic (7.36e-3)" "unprognostic (2.72e-1)" "unprognostic (2.01e-3)" "unprognostic (1.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "prognostic unfavorable (4.11e-5)" "unprognostic (7.68e-2)" "unprognostic (5.11e-2)" "unprognostic (8.79e-2)" "unprognostic (4.96e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (5.16e-6)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (3.17e-2)" 14.7 13.6 8.8 17.8 16.1 10.1 9.3 19.5 14.0 10.2 11.5 12.4 11.1 10.1 9.2 10.3 13.0 8.5 9.4 9.9 9.4 9.6 10.7 20.7 10.5 14.6 10.9 8.1 7.1 19.2 14.8 13.3 12.1 8.7 8.4 13.8 7.8 12.4 7.8 19.6 13.3 10.9 11.3 10.5 21.6 11.4 15.6 11.1 14.5 6.4 10.7 12.9 9.2 8.0 2.4 4.2 2.2 7.0 2.0 2.9 2.2 10.8 11.1 10.3 16.3 6.4 8.6 11.1 13.2 8.8 13.3 5.3 13.6 8.3 20.5 9.6 12.6 5.0 13.0 12.4 9.9 15.5 5.2 13.3 10.1 7.8 17.2 9.2 17.5 20.6 6.7 6.8 9.4 5.7 5.8 10.7 10.9 12.8 3.6 13.0 6.7 13.4 22.0 12.1 13.2 11.6 14.9 14.0 16.6 7.4 8.9 13.4 7.1 12.8 16.6 8.3 8.3 7.5 12.8 13.9 10.7 7.2 8.2 10.1 8.7 6.9 18.4 10.6 17.7 10.5 1.3 6.2 1.4 2.6 7.0 2.8 1.6 1.6 2.9 4.2 2.4 2.3 2.4 2.2 2.0 6.1 3.7 2.6 2.2 8.8 16.1 19.5 14.0 9.4 9.6 10.9 8.1 8.7 11.1 3.0 4.3 2.7 0.7 2.9 7.2 5.2 5.1 2.7 1.2 1.8 15.7 3.0 6.6 2.2 9.3 3.6 3.8 0.0 2.6 2.9 2.6 1.9 1.1 6.7 8.3 1.6 3.4 2.5 25.3 13.3 3.1 7.0 1.7 3.6 3.3 1.9 2.6 2.9 2.1 3.4 7.3 0.0 2.1 4.8 4.5 1.5 0.8 4.4 4.9 1.4 HEATR5B "DKFZp686P15184, KIAA1414" ENSG00000008869 "HEAT repeat containing 5B" Q9P2D3 2 36968383-37084342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042025, HPA055639" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA042025: AB_10959880, HPA055639: AB_2682870" "unprognostic (3.11e-2)" "unprognostic (1.65e-2)" "unprognostic (4.07e-1)" "unprognostic (6.05e-2)" "unprognostic (3.70e-2)" "unprognostic (7.75e-2)" "unprognostic (5.95e-2)" "unprognostic (3.33e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-2)" "unprognostic (1.66e-1)" "unprognostic (8.07e-2)" "unprognostic (5.80e-3)" "unprognostic (8.69e-2)" "unprognostic (4.18e-1)" "unprognostic (2.72e-1)" "unprognostic (3.95e-1)" 14.7 13.6 13.5 14.1 23.8 21.8 15.0 23.3 22.8 11.1 10.2 15.4 10.1 10.9 16.5 18.0 14.9 9.7 10.9 10.7 11.4 12.1 9.9 12.9 12.5 29.6 13.0 16.6 12.3 23.8 17.9 16.6 10.3 21.6 12.2 14.0 12.4 18.0 9.6 7.1 18.0 14.9 9.4 16.1 18.0 12.8 9.6 14.5 16.0 13.6 8.4 30.0 11.3 12.9 15.2 10.7 15.8 4.9 7.0 9.1 5.0 10.4 5.3 7.9 11.9 8.2 8.2 10.0 6.6 4.9 6.1 6.2 6.0 7.2 22.4 4.8 5.6 8.1 8.9 7.7 5.4 8.0 10.9 8.4 14.6 7.0 8.5 5.1 15.6 19.3 7.4 7.6 8.7 8.4 6.7 10.1 12.1 13.8 19.9 7.3 6.2 13.6 11.2 5.1 10.9 3.7 13.2 8.0 16.8 7.1 9.0 9.7 8.6 6.9 11.2 5.2 8.3 8.0 5.1 11.3 9.3 5.3 6.6 5.1 12.5 10.2 24.7 7.5 9.4 6.1 15.8 4.9 11.3 7.9 2.6 7.2 9.9 8.8 8.8 8.6 15.2 9.1 7.9 5.1 7.0 3.8 10.7 8.9 5.0 13.5 23.8 23.3 22.8 11.4 12.1 13.0 16.6 21.6 14.5 20.8 9.3 11.1 4.0 8.8 13.3 19.3 7.6 8.1 5.7 5.2 9.8 6.2 1.7 3.8 5.6 9.8 9.9 0.0 5.3 5.4 6.6 6.3 6.9 7.3 5.5 15.9 5.2 14.1 16.5 1.9 8.3 10.3 6.8 3.6 9.6 6.3 6.8 5.8 6.0 4.5 15.0 19.4 7.6 2.7 8.5 10.2 4.7 10.0 6.9 4.6 HECA "dJ225E12.1, HDC, HDCL, hHDC" ENSG00000112406 "Hdc homolog, cell cycle regulator" Q9UBI9 6 139135112-139180802 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 111.7;Suprabasal keratinocytes: 124.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012581, HPA042313" Uncertain Approved Cytosol NA NA Cytosol "HPA012581: , HPA042313: AB_10796903" "unprognostic (2.98e-2)" "unprognostic (2.39e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-1)" "unprognostic (7.31e-2)" "unprognostic (3.38e-3)" "unprognostic (4.29e-2)" "unprognostic (3.27e-1)" "unprognostic (7.39e-2)" "unprognostic (2.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.09e-4)" "unprognostic (3.47e-1)" "unprognostic (2.59e-1)" "unprognostic (4.72e-3)" "unprognostic (5.77e-2)" 17.2 8.9 11.7 19.3 12.6 31.5 38.5 10.8 18.7 12.1 17.7 9.2 9.3 15.7 15.5 8.8 21.0 12.0 12.8 26.5 16.6 10.6 7.5 10.3 20.4 34.2 14.1 13.3 19.3 9.6 10.7 8.3 10.4 14.6 10.8 12.3 5.7 16.4 9.7 22.1 24.8 18.8 14.7 14.7 25.2 11.5 9.0 13.3 34.1 11.4 10.8 23.9 16.1 38.3 3.0 1.7 7.5 7.3 2.2 6.9 2.2 3.0 0.6 6.0 6.9 13.9 12.8 4.4 5.5 9.3 2.5 5.8 1.2 3.5 13.2 8.1 11.4 6.0 5.1 3.6 5.0 4.6 20.6 7.7 6.6 3.1 0.2 4.4 11.5 6.0 14.6 12.3 5.5 6.7 6.9 8.4 8.9 2.8 17.9 4.6 3.1 5.6 9.5 1.1 2.6 1.1 8.8 6.1 6.6 2.2 9.7 5.8 1.7 4.5 12.5 3.4 7.0 2.8 15.4 10.5 4.4 4.2 10.0 4.7 10.8 8.0 12.1 1.6 6.8 2.5 6.9 2.0 2.8 4.4 2.6 5.6 2.4 6.9 6.0 1.5 3.0 6.6 6.5 7.5 2.2 7.3 1.7 5.8 2.2 11.7 12.6 10.8 18.7 16.6 10.6 14.1 13.3 14.6 13.3 6.0 15.2 20.0 18.9 111.7 1.4 33.9 7.6 1.4 5.7 10.4 2.0 5.9 0.0 6.7 9.4 34.3 31.1 23.3 8.5 4.8 30.1 27.6 12.7 10.5 16.9 1.6 12.6 37.4 76.3 9.1 14.4 36.1 42.2 3.6 21.1 6.0 12.4 25.2 18.4 2.3 2.5 51.8 34.8 11.1 4.1 124.3 14.5 39.9 15.7 35.1 HECW1 "KIAA0322, NEDL1" ENSG00000002746 "HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1" Q76N89 7 43112599-43566001 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0;kidney: 15.4" "Group enriched" "Detected in some" 4 "Early spermatids: 118.3;Horizontal cells: 42.9;Late spermatids: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 5.5;GAMG: 4.9;U-266/70: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007203, HPA007593, HPA007609" Approved Supported Cytosol NA NA Cytosol "HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518" "unprognostic (1.40e-1)" "unprognostic (2.85e-3)" "unprognostic (2.57e-1)" "unprognostic (4.39e-1)" "unprognostic (2.43e-2)" "unprognostic (2.80e-2)" "unprognostic (8.65e-4)" "unprognostic (6.93e-2)" "unprognostic (7.30e-2)" "unprognostic (7.31e-2)" "unprognostic (3.43e-2)" "unprognostic (2.67e-2)" "unprognostic (1.43e-3)" "unprognostic (1.64e-2)" "unprognostic (5.23e-3)" "unprognostic (1.89e-2)" "unprognostic (2.42e-2)" 0.7 0.5 10.3 0.8 12.1 1.4 0.8 13.6 24.0 0.6 0.8 1.1 0.0 0.4 0.8 1.7 2.6 0.5 4.0 0.4 3.9 4.1 15.4 0.6 0.6 1.3 3.8 15.5 1.0 0.4 1.7 0.4 0.6 10.2 3.2 0.5 0.6 1.0 0.8 1.8 2.1 0.6 0.7 1.4 0.6 1.0 3.7 1.6 0.0 1.5 0.0 0.8 1.2 0.6 2.4 1.6 7.0 1.7 1.6 0.7 0.1 0.1 5.5 0.6 0.8 0.0 0.0 0.0 1.6 2.8 0.1 0.7 0.0 0.0 0.2 3.1 2.7 4.9 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.4 0.2 0.2 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.0 0.0 0.0 0.0 0.0 2.4 0.1 0.9 0.5 0.0 0.0 0.0 0.1 0.2 0.7 0.5 0.1 0.0 0.3 0.4 0.0 0.0 0.8 1.1 1.3 0.4 15.7 0.5 0.0 3.5 0.4 0.0 6.4 1.7 1.1 0.7 1.0 0.5 1.0 0.7 0.3 0.2 2.4 0.6 0.7 7.0 1.6 0.9 1.6 0.2 0.1 10.3 12.1 13.6 24.0 3.9 4.1 3.8 15.5 10.2 1.6 0.0 0.0 0.0 0.3 0.3 13.6 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 118.3 0.3 2.0 0.0 0.0 0.1 0.8 0.5 0.0 0.0 0.0 42.9 0.0 0.6 0.0 44.2 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.6 0.4 15.9 1.8 0.0 0.8 2.1 2.5 0.3 0.0 0.5 0.4 0.3 HERC2 "D15F37S1, jdf2, p528" ENSG00000128731 "HECT and RLD domain containing E3 ubiquitin protein ligase 2" O95714 15 28111040-28322152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017188, HPA048389, HPA074166" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB017188: , HPA048389: AB_2680382, HPA074166: " "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.92e-1)" "unprognostic (6.64e-2)" "unprognostic (6.62e-2)" "unprognostic (5.74e-2)" "unprognostic (9.17e-2)" "unprognostic (2.08e-1)" "unprognostic (1.87e-1)" "unprognostic (4.11e-2)" "unprognostic (9.40e-3)" "unprognostic (3.60e-2)" "prognostic favorable (1.41e-7)" "unprognostic (7.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.34e-2)" "unprognostic (1.71e-1)" 2.5 3.3 3.2 2.2 4.5 3.9 3.1 7.0 5.7 3.2 4.6 2.7 4.4 1.7 2.8 4.1 2.1 4.6 3.5 3.6 3.3 1.6 2.5 2.1 3.8 8.5 3.6 9.2 3.5 2.7 3.0 3.0 2.3 3.3 8.2 3.1 3.1 4.1 4.1 2.3 3.4 3.2 5.6 2.4 3.3 2.3 1.0 1.1 0.5 0.4 0.2 1.1 0.4 5.2 10.3 7.2 3.0 6.0 4.5 2.0 3.8 4.5 4.9 4.7 5.3 0.7 5.2 4.6 6.4 7.4 5.3 7.6 3.7 3.6 3.2 4.9 33.3 12.0 1.7 2.3 7.8 2.7 3.7 2.9 5.8 7.3 3.1 6.4 4.4 12.8 2.2 4.6 2.4 1.7 2.6 2.1 4.0 4.5 6.2 10.3 0.4 1.7 11.3 7.9 4.6 9.1 2.6 3.0 3.9 3.0 9.2 9.6 9.1 5.9 3.5 5.6 1.4 2.0 4.9 4.2 3.7 4.8 0.0 0.4 0.5 1.1 0.1 0.6 0.5 0.2 0.5 1.1 1.0 0.9 0.5 0.0 0.2 0.3 0.9 0.4 0.4 20.8 19.7 23.1 13.0 14.5 100.9 54.0 28.1 17.4 25.0 61.1 139.4 22.6 1.7 24.7 11.1 39.4 24.9 0.0 26.5 13.6 21.3 18.7 3.5 30.6 16.6 116.0 27.0 36.8 21.8 10.6 52.0 17.3 65.8 26.2 29.8 46.8 29.3 31.6 49.1 16.6 140.1 64.7 24.7 57.9 59.4 18.3 14.9 30.2 30.9 10.1 HERC3 KIAA0032 ENSG00000138641 "HECT and RLD domain containing E3 ubiquitin protein ligase 3" Q15034 4 88592423-88708542 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.6;hTERT-HME1: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039170 Approved Approved Cytosol NA NA Cytosol "HPA039170: AB_10673414" "unprognostic (2.21e-2)" "unprognostic (1.65e-2)" "unprognostic (9.28e-3)" "unprognostic (3.24e-1)" "unprognostic (6.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.30e-2)" "unprognostic (1.85e-2)" "unprognostic (9.77e-2)" "unprognostic (6.51e-3)" "unprognostic (3.48e-3)" "unprognostic (2.58e-2)" "prognostic favorable (5.65e-7)" "unprognostic (1.83e-1)" "unprognostic (3.21e-2)" "unprognostic (1.67e-1)" "unprognostic (1.16e-2)" 12.7 13.3 16.9 13.0 27.1 21.0 15.3 37.8 20.1 14.4 12.0 17.9 11.6 11.2 12.0 10.5 16.8 10.7 12.1 22.0 15.2 13.7 15.8 13.0 15.0 15.3 21.9 15.0 12.7 9.7 33.8 16.1 10.0 21.1 22.0 13.4 22.0 14.0 14.0 17.3 19.1 12.8 13.8 16.3 15.7 12.9 3.6 21.5 16.6 15.7 12.6 16.4 13.3 16.7 5.2 7.0 18.2 9.7 3.1 9.0 3.9 7.3 1.1 1.4 2.4 7.9 16.7 4.7 8.3 15.4 8.7 5.8 1.9 8.6 7.8 4.0 27.6 4.0 2.6 2.0 7.6 8.3 3.4 2.3 5.4 3.3 1.2 4.5 13.4 9.8 7.9 9.4 8.3 37.6 4.9 9.6 4.1 3.9 3.4 17.7 2.2 9.2 3.2 0.4 4.8 2.0 10.4 9.7 3.2 5.6 1.4 1.9 1.9 9.6 6.1 3.2 2.4 1.0 6.0 15.0 9.9 5.4 9.3 6.2 6.5 1.6 4.5 6.2 6.1 4.1 5.7 5.7 7.7 4.7 6.2 5.5 5.2 5.5 4.7 7.0 4.9 8.2 5.8 18.2 3.1 9.7 2.4 9.0 3.9 16.9 27.1 37.8 20.1 15.2 13.7 21.9 15.0 21.1 21.5 6.0 5.8 8.8 7.9 31.9 24.1 18.5 7.6 4.0 2.3 8.7 104.1 5.8 1.7 3.6 2.6 9.3 9.2 23.3 7.9 13.2 7.3 12.5 15.1 11.0 8.3 30.2 26.5 8.6 27.9 2.7 7.8 17.3 13.5 2.8 10.1 9.2 7.4 8.6 12.4 5.0 59.1 6.5 11.3 3.0 7.0 44.4 6.2 13.1 5.2 10.4 HERC4 "DKFZP564G092, KIAA1593" ENSG00000148634 "HECT and RLD domain containing E3 ubiquitin protein ligase 4" Q5GLZ8 10 67921899-68075348 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 55.9;fHDF/TERT166: 62.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045453, HPA070301" Uncertain Supported "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA045453: AB_10961917, HPA070301: AB_2686247" "unprognostic (3.66e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-1)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" "unprognostic (1.01e-3)" "unprognostic (3.54e-1)" "unprognostic (8.57e-2)" "unprognostic (4.94e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (3.86e-5)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (3.98e-1)" "unprognostic (2.31e-2)" 25.3 29.4 21.9 28.0 28.4 14.6 22.7 30.5 24.9 24.2 20.5 22.2 26.7 20.0 28.1 24.3 22.2 19.2 20.2 20.5 21.9 22.7 20.6 24.5 20.6 30.2 30.9 14.8 24.5 17.1 25.2 35.6 23.8 26.8 19.4 23.9 17.8 17.7 24.1 19.6 20.9 25.8 23.0 28.7 27.0 17.3 22.2 33.6 23.6 19.5 13.8 28.3 24.7 47.9 7.7 10.4 13.5 9.3 9.9 11.5 6.5 22.8 8.2 5.1 8.6 13.4 18.4 4.6 55.9 34.6 21.0 13.6 4.6 10.8 8.0 4.4 62.8 13.1 12.1 5.7 8.3 28.4 5.2 2.8 3.7 13.5 3.5 7.1 4.5 6.6 9.0 9.7 11.2 10.0 26.4 13.0 4.5 3.9 4.1 32.3 9.8 3.2 5.3 3.0 5.3 14.3 4.3 2.1 2.8 9.5 6.5 2.5 2.8 18.2 7.8 7.9 11.1 4.8 5.7 17.7 11.1 6.2 27.2 9.6 2.8 3.3 5.1 20.3 8.7 3.8 13.5 9.3 11.1 8.2 7.9 11.5 7.7 9.1 9.8 10.4 7.5 8.8 9.0 11.7 9.9 7.6 2.7 10.6 6.5 21.9 28.4 30.5 24.9 21.9 22.7 30.9 14.8 26.8 33.6 44.7 27.7 32.0 24.8 44.8 51.3 21.2 12.7 17.4 15.9 17.4 41.2 23.4 6.6 17.2 55.0 28.7 37.8 0.0 10.6 35.6 22.1 32.9 30.0 21.3 20.3 50.9 21.2 31.3 32.9 34.9 24.7 27.8 16.9 16.2 25.6 23.2 28.7 31.6 18.0 18.2 45.2 6.5 25.8 22.4 10.2 53.2 13.0 27.3 17.7 45.1 HERC6 FLJ20637 ENSG00000138642 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 6" Q8IVU3 4 88378739-88443111 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 47.0;BJ hTERT+ SV40 Large T+ RasG12V: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035846 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035846: AB_10673487" "unprognostic (1.95e-2)" "unprognostic (2.71e-1)" "unprognostic (2.23e-2)" "unprognostic (2.67e-2)" "unprognostic (8.61e-2)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (3.27e-1)" "unprognostic (1.49e-1)" "unprognostic (5.95e-2)" "unprognostic (1.52e-2)" "unprognostic (6.22e-2)" "prognostic favorable (7.14e-5)" "unprognostic (1.80e-1)" "unprognostic (2.59e-1)" "unprognostic (8.43e-3)" "unprognostic (3.77e-2)" 8.0 7.5 7.8 7.2 10.2 7.3 6.3 2.1 14.6 13.6 6.3 5.9 3.4 5.4 13.2 9.6 23.9 10.4 11.2 9.8 7.7 8.4 10.4 5.0 8.3 4.6 7.3 15.8 9.8 6.3 5.2 8.4 7.1 8.5 9.1 6.5 7.2 28.4 5.7 2.9 4.3 7.1 8.5 5.6 8.0 7.3 3.9 5.3 9.0 5.9 7.6 7.8 7.2 13.8 3.6 2.7 4.5 6.4 5.6 13.4 4.2 2.6 1.7 0.1 0.3 0.1 1.6 0.5 0.3 8.8 47.0 35.0 0.1 3.3 0.0 0.6 0.8 7.6 1.0 4.3 2.2 3.1 5.3 0.9 2.4 1.5 0.2 1.5 4.3 1.7 2.1 0.5 3.6 0.1 2.8 1.3 2.0 0.0 0.6 1.0 1.5 2.0 1.3 0.6 2.3 0.9 1.3 0.0 0.1 3.2 3.2 0.1 1.1 3.2 1.1 5.2 2.4 1.9 0.8 0.4 0.6 0.9 0.1 0.8 0.1 0.0 0.0 2.1 1.0 2.1 4.4 3.1 4.5 6.7 3.1 13.4 3.6 9.4 6.5 2.7 2.7 7.5 5.1 1.9 5.6 6.4 0.3 11.8 4.2 7.8 10.2 2.1 14.6 7.7 8.4 7.3 15.8 8.5 5.3 11.9 8.8 2.4 4.4 2.5 11.4 10.6 5.1 16.0 10.3 5.2 15.7 4.9 0.0 6.6 0.9 8.4 5.2 0.0 15.0 1.3 3.7 8.2 5.7 2.1 4.3 1.6 1.7 4.3 3.7 1.3 4.0 2.2 5.0 4.6 2.9 4.3 9.1 3.1 5.3 3.6 1.0 6.5 2.0 0.5 1.1 1.0 2.1 7.7 1.7 6.2 HERPUD1 "HERP, KIAA0025, Mif1, SUP" ENSG00000051108 "Homocysteine inducible ER protein with ubiquitin like domain 1" Q15011 16 56932048-56944863 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Melanocytes: 899.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 78.5;U-266/70: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037041, CAB037104, HPA040754, HPA041219" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (8.64e-2)" "unprognostic (3.93e-3)" "unprognostic (3.39e-1)" "unprognostic (5.00e-3)" "unprognostic (1.17e-1)" "unprognostic (9.69e-3)" "unprognostic (3.33e-1)" "unprognostic (2.56e-1)" "unprognostic (2.84e-1)" "unprognostic (3.50e-1)" "prognostic favorable (1.41e-9)" "unprognostic (1.06e-1)" "unprognostic (3.93e-2)" "unprognostic (2.19e-2)" "unprognostic (2.27e-3)" 22.7 38.8 16.2 35.6 20.7 21.6 39.4 17.7 20.0 30.1 32.1 20.0 48.8 21.4 21.6 51.6 15.0 20.2 32.5 28.8 15.8 15.5 42.9 57.7 30.4 40.0 25.6 12.5 44.8 148.6 37.6 26.7 26.2 25.6 49.5 32.3 35.3 108.6 76.1 34.6 18.3 24.7 17.6 24.2 38.3 37.2 10.6 20.8 9.6 64.2 20.4 53.8 24.4 25.9 50.8 121.9 29.0 39.5 22.4 33.4 46.5 4.5 5.0 4.9 10.2 11.4 15.0 17.6 10.8 17.2 14.0 11.0 6.9 10.4 18.5 13.9 10.5 14.3 7.9 8.3 3.8 13.9 10.7 5.0 1.6 8.3 25.0 62.5 3.3 8.3 18.1 36.5 6.3 20.2 16.9 10.6 20.7 2.5 26.5 39.0 3.8 6.2 6.8 3.1 26.5 11.4 4.3 12.5 78.5 30.0 5.1 5.4 6.3 9.4 46.4 47.9 7.3 5.2 12.5 6.5 5.8 5.8 5.1 4.3 89.5 29.1 28.9 8.3 4.6 7.6 23.9 39.5 18.0 16.1 31.0 17.4 50.8 17.5 21.1 30.6 37.8 11.4 17.4 29.0 22.4 21.5 121.9 33.4 46.5 16.2 20.7 17.7 20.0 15.8 15.5 25.6 12.5 25.6 20.8 65.5 113.2 400.7 628.3 323.4 125.0 136.3 71.4 44.2 47.8 68.0 265.1 118.1 144.2 165.3 52.0 119.9 168.3 70.0 173.1 150.4 186.1 478.3 152.0 140.9 178.2 44.5 416.3 118.4 182.3 185.2 96.4 276.3 899.3 227.2 208.8 76.2 141.3 182.4 89.8 157.6 103.7 97.0 210.0 43.1 8.9 223.2 580.2 183.3 123.2 295.1 HES4 bHLHb42 ENSG00000188290 "Hes family bHLH transcription factor 4" Q9HCC6 1 998962-1000172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 291.1;Glandular cells: 254.1;Paneth cells: 238.4;Smooth muscle cells: 271.9;Urothelial cells: 423.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 12.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.4" "Cell line enriched" "Detected in some" 8 "HEK 293: 66.9" "Low region specificity" "Detected in all" HPA062465 Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA062465: AB_2684771" "unprognostic (6.23e-2)" "unprognostic (3.77e-2)" "unprognostic (7.07e-2)" "prognostic favorable (3.85e-4)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.99e-4)" "unprognostic (6.25e-3)" "unprognostic (2.34e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-1)" "unprognostic (7.76e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (3.97e-1)" "unprognostic (3.87e-2)" "unprognostic (1.86e-1)" "unprognostic (5.08e-3)" 14.8 4.0 8.3 3.9 15.6 2.8 8.7 2.5 16.9 7.6 10.8 2.9 4.8 5.4 7.8 9.0 7.5 6.8 9.6 13.6 5.9 9.4 5.3 3.2 9.1 2.2 7.3 4.0 4.2 14.8 3.1 5.7 6.1 7.2 10.4 2.6 12.8 5.6 9.4 8.0 7.8 4.2 12.1 3.4 8.6 6.1 3.4 3.1 9.0 3.6 8.4 3.3 10.6 5.6 0.0 0.3 12.4 1.4 0.0 0.0 0.0 4.6 0.5 0.5 0.0 0.0 0.0 5.9 2.8 0.3 1.7 1.8 0.7 1.5 0.0 6.7 0.2 0.8 8.2 0.7 0.1 0.0 0.0 66.9 0.0 0.7 0.9 0.6 0.0 0.5 0.0 0.7 0.1 0.1 0.2 0.2 0.8 1.3 0.1 0.0 2.4 3.7 0.2 0.0 1.0 6.5 0.0 0.6 1.4 0.6 0.0 0.4 1.5 1.9 4.7 8.4 0.2 3.5 0.0 0.3 0.5 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 12.4 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.3 15.6 2.5 7.0 5.9 9.4 7.3 4.0 7.2 3.1 0.0 0.0 0.0 291.1 46.2 3.5 11.8 22.9 0.0 2.3 55.8 0.0 0.9 26.6 14.8 0.8 15.3 10.3 0.0 2.5 35.2 22.6 254.1 55.1 0.0 4.4 0.0 10.3 16.0 3.5 0.8 6.9 13.3 109.6 1.0 10.5 119.5 9.0 238.4 14.5 0.6 10.7 161.7 271.9 2.3 28.1 72.3 2.9 0.7 11.0 423.0 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530245 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell type enriched" "Detected in some" 22 "Muller glia cells: 105.2" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.7;HaCaT: 5.1;HAP1: 1.1;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" No NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: AB_2685492, HPA076164: AB_2732303" "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 1.1 0.9 11.1 1.1 12.7 1.4 2.8 3.5 16.7 1.0 1.9 1.2 0.4 1.2 1.9 2.7 1.6 1.1 1.2 2.3 9.7 11.2 1.0 1.0 1.4 1.1 4.1 15.8 1.0 0.9 1.0 2.4 2.2 1.6 1.3 1.4 6.3 1.2 1.1 1.6 6.2 1.2 0.9 0.9 1.0 1.2 2.0 1.9 0.0 1.1 1.9 1.4 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 5.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 12.7 3.5 16.7 9.7 11.2 4.1 15.8 1.6 1.9 0.0 0.0 0.0 0.2 0.1 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 105.2 0.0 3.5 0.0 0.0 4.8 0.0 0.7 0.0 0.0 1.3 0.0 0.0 1.1 0.1 HES6 bHLHb41 ENSG00000144485 "Hes family bHLH transcription factor 6" Q96HZ4 2 238238267-238240662 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 105.3;Mucus-secreting cells: 104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 8.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "NB-4: 51.5;SCLC-21H: 34.1;SK-MEL-30: 49.2;THP-1: 22.8;U-937: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073997 Approved "Nuclear bodies,Cytosol" NA No "Nuclear bodies" Cytosol "HPA073997: " "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (2.40e-3)" "unprognostic (7.46e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.79e-4)" "prognostic favorable (9.18e-5)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-2)" "unprognostic (4.35e-1)" "unprognostic (6.30e-2)" "unprognostic (5.13e-2)" "unprognostic (8.50e-2)" "unprognostic (6.66e-2)" "unprognostic (3.49e-2)" 2.1 5.2 15.4 3.4 10.6 10.5 3.0 7.3 47.4 3.7 12.2 17.1 0.8 18.1 6.3 1.5 1.6 14.3 5.7 1.7 17.5 9.1 1.9 2.5 2.2 3.3 11.4 12.3 1.3 13.9 5.3 23.6 1.7 14.3 2.0 9.6 1.5 3.8 1.7 8.2 1.7 12.9 3.3 18.8 4.6 5.2 9.4 11.7 0.4 5.5 1.7 2.8 1.3 1.0 0.3 1.4 8.0 0.3 0.1 1.0 0.2 1.2 1.5 6.5 7.4 0.4 0.2 4.2 0.4 0.5 0.6 1.0 1.2 0.8 0.0 1.0 0.1 2.7 0.8 6.6 0.5 0.2 2.8 7.9 1.5 1.0 13.4 1.1 10.7 9.0 0.6 4.0 0.9 1.3 0.3 0.4 6.9 13.5 0.1 0.4 3.2 1.6 51.5 10.4 1.2 1.1 7.3 16.5 3.1 0.8 0.6 34.1 14.9 2.0 2.9 49.2 0.8 2.6 22.8 0.6 0.6 1.3 3.6 3.8 3.0 0.5 2.2 2.3 26.2 1.1 0.1 0.3 8.0 1.0 0.2 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.3 1.4 0.7 0.2 15.4 10.6 7.3 39.3 17.5 9.1 11.4 12.3 14.3 11.7 0.0 1.4 8.0 4.1 3.0 8.1 2.8 0.0 9.4 3.4 3.5 21.6 1.0 6.6 9.9 10.9 3.7 18.1 46.7 27.8 3.1 3.8 5.1 0.0 3.8 4.8 3.2 105.3 3.7 1.6 5.6 1.4 5.5 33.7 11.8 104.6 6.1 11.9 16.9 1.4 3.7 4.7 0.0 14.6 24.6 32.4 1.8 0.2 6.2 33.2 1.8 HEXA ENSG00000213614 "Hexosaminidase subunit alpha" P06865 15 72340919-72376476 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 207.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA018082, HPA054583" Supported Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 20000000 Vesicles Cytosol "HPA018082: , HPA054583: AB_2682531" "unprognostic (1.51e-2)" "unprognostic (1.73e-2)" "unprognostic (3.41e-1)" "prognostic favorable (5.63e-8)" "unprognostic (6.58e-2)" "unprognostic (1.32e-2)" "unprognostic (1.34e-2)" "unprognostic (2.82e-2)" "unprognostic (3.75e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (9.98e-2)" "unprognostic (3.98e-1)" "unprognostic (7.05e-3)" "unprognostic (3.02e-2)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" 30.1 37.4 23.1 18.0 22.9 35.5 37.8 23.3 28.1 30.6 20.5 19.4 30.1 18.5 25.9 65.7 11.7 21.8 29.2 33.8 23.4 12.8 34.6 29.5 43.9 31.4 24.9 21.1 20.9 22.2 18.1 22.9 37.9 18.8 18.1 26.0 26.9 24.8 22.0 17.7 17.9 24.6 23.4 21.4 31.5 22.6 18.0 22.9 12.1 31.2 11.1 16.4 26.7 17.1 16.1 37.9 22.4 32.7 17.8 18.1 21.3 7.5 12.8 5.5 10.6 45.5 51.9 7.9 10.6 53.8 23.0 36.8 6.7 55.4 6.3 10.2 21.3 12.0 15.1 14.6 6.7 14.6 5.1 5.8 7.9 12.7 11.6 35.2 18.9 22.7 44.1 20.2 10.0 17.9 42.2 21.0 9.4 12.2 39.2 30.6 6.5 4.1 9.5 3.1 24.7 0.1 4.2 12.0 14.2 25.7 11.9 4.8 5.3 26.5 25.1 59.9 11.7 4.6 23.9 10.6 34.5 14.4 31.7 11.2 20.9 28.2 6.5 12.5 25.3 16.7 8.9 32.7 22.4 18.1 13.7 15.8 16.1 12.0 15.8 37.9 15.6 9.5 14.0 3.1 17.8 4.8 14.4 10.7 21.3 23.1 22.9 23.3 28.1 23.4 12.8 24.9 21.1 18.8 22.9 59.6 55.5 41.1 30.3 19.7 40.2 22.6 35.7 17.4 28.4 62.8 100.1 116.3 51.4 65.3 16.3 43.0 46.2 0.0 33.3 55.3 62.5 30.5 29.9 37.8 207.1 25.4 45.3 44.2 76.0 10.5 68.7 108.5 89.4 50.5 39.4 48.4 43.8 84.5 42.1 55.5 56.1 45.3 20.6 20.4 28.2 13.7 131.8 47.5 44.4 25.0 HEY1 "bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1" ENSG00000164683 "Hes related family bHLH transcription factor with YRPW motif 1" Q9Y5J3 8 79764010-79767863 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.6" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 39.4;Extravillous trophoblasts: 39.7;Intestinal endocrine cells: 35.4;Melanocytes: 32.1" "Cancer enhanced" "Detected in all" "glioma: 43.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.9" "Cell line enhanced" "Detected in many" "HEK 293: 49.4;PC-3: 11.2;SK-MEL-30: 33.8;WM-115: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055599, HPA063472" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Cytosol" "HPA055599: AB_2682858, HPA063472: AB_2685018" "unprognostic (1.15e-1)" "unprognostic (5.06e-2)" "unprognostic (5.13e-3)" "unprognostic (2.12e-1)" "unprognostic (1.86e-3)" "unprognostic (8.47e-2)" "unprognostic (4.21e-3)" "unprognostic (9.56e-2)" "unprognostic (1.72e-1)" "unprognostic (7.22e-2)" "unprognostic (1.25e-2)" "unprognostic (6.71e-3)" "unprognostic (5.92e-3)" "unprognostic (5.77e-2)" "unprognostic (8.53e-2)" "unprognostic (1.74e-2)" "unprognostic (1.00e-1)" 13.3 3.8 13.7 3.6 22.9 1.8 8.8 11.2 60.6 8.9 4.4 10.7 0.0 3.3 3.8 2.4 4.6 3.9 5.7 13.4 11.3 11.6 3.8 2.9 16.4 3.3 11.9 9.3 2.6 4.3 3.0 9.9 20.3 12.5 4.5 3.9 10.3 4.5 3.0 10.3 3.5 3.2 4.4 9.1 2.8 3.6 3.9 10.5 1.3 5.0 3.7 3.7 5.2 2.5 0.0 0.0 9.9 1.7 0.0 0.3 0.1 0.6 0.0 0.4 3.5 0.3 0.3 9.0 0.8 0.8 0.1 0.1 0.1 0.0 1.6 0.9 0.3 0.4 2.2 1.8 0.1 0.2 0.1 49.4 0.0 1.6 0.9 0.5 0.0 0.4 0.5 1.4 0.0 6.2 0.3 1.6 0.0 3.2 1.4 0.5 0.1 0.0 0.2 0.2 0.1 11.2 0.0 1.9 1.4 0.1 1.5 2.0 5.7 0.0 1.0 33.8 8.4 0.0 0.0 1.1 0.2 0.9 0.0 0.6 1.2 0.2 0.0 1.2 0.0 11.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.9 0.0 1.7 0.0 0.0 0.1 13.7 22.9 11.2 12.3 11.3 11.6 11.9 9.3 12.5 10.5 0.0 2.6 0.0 2.2 2.9 5.3 3.2 0.0 8.1 3.4 0.0 0.0 5.4 13.3 2.1 3.3 39.4 0.9 0.0 1.0 39.7 2.7 1.6 10.4 0.5 1.6 20.6 35.4 13.5 0.6 1.6 0.0 2.1 32.1 0.0 1.9 6.0 0.5 5.8 0.4 0.3 11.5 0.0 6.1 0.7 4.1 2.6 19.6 0.0 2.3 1.8 HEYL "bHLHb33, HESR3, HEY3" ENSG00000163909 "Hes related family bHLH transcription factor with YRPW motif-like" Q9NQ87 1 39624153-39639945 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 66.3" "Cell type enhanced" "Detected in many" 13 "Leydig cells: 24.2;Peritubular cells: 53.4;Sertoli cells: 51.8;Smooth muscle cells: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 6.5;LHCN-M2: 17.6;RH-30: 21.7;THP-1: 5.0;U-266/84: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001438, HPA076960" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA001438: AB_1079052, HPA076960: AB_2732326" "unprognostic (1.98e-2)" "unprognostic (7.92e-2)" "unprognostic (4.19e-3)" "unprognostic (3.49e-1)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (7.20e-2)" "unprognostic (5.92e-2)" "unprognostic (1.19e-2)" "unprognostic (2.35e-1)" "unprognostic (8.50e-2)" "prognostic unfavorable (2.26e-6)" "prognostic unfavorable (3.57e-4)" "unprognostic (2.67e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.63e-5)" 10.0 8.3 2.9 4.7 6.2 0.5 6.5 1.8 4.0 14.7 4.4 2.9 5.1 1.9 21.7 13.2 4.0 11.2 13.9 28.2 3.2 4.8 12.3 3.3 12.5 2.0 6.8 2.9 14.4 66.3 1.7 8.2 22.1 7.1 8.1 2.9 10.9 2.3 11.4 8.9 1.9 2.7 18.9 2.4 4.5 3.4 25.4 4.4 0.0 11.0 6.8 1.9 6.0 8.8 1.1 0.5 0.0 0.3 0.0 0.1 0.0 0.0 2.4 4.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.1 1.6 0.2 0.0 1.4 0.4 0.0 0.0 2.2 0.0 0.2 0.0 2.6 4.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 6.5 0.4 0.5 17.6 1.4 0.0 0.0 0.0 0.2 0.1 1.1 21.7 0.1 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.9 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.6 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.2 1.8 4.0 3.2 4.8 6.8 2.9 7.1 4.4 0.0 0.0 0.0 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.6 0.7 0.0 0.0 3.1 0.2 3.8 0.2 0.0 0.0 0.3 1.6 0.0 1.3 0.0 11.8 24.2 1.1 5.0 0.0 0.0 0.2 4.5 0.0 53.4 0.0 3.7 51.8 35.4 0.1 1.7 0.1 0.2 0.0 0.4 0.1 HGH1 "Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236" ENSG00000235173 "HGH1 homolog" Q9BTY7 8 144137769-144140843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042470 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" Nucleoplasm "HPA042470: AB_2678013" "unprognostic (2.13e-2)" "prognostic unfavorable (3.12e-4)" "unprognostic (9.72e-2)" "unprognostic (2.63e-1)" "unprognostic (9.82e-2)" "unprognostic (2.17e-1)" "unprognostic (7.89e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-1)" "unprognostic (1.30e-2)" "unprognostic (4.39e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (4.62e-3)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "unprognostic (1.48e-1)" 13.4 12.3 6.3 7.7 5.5 4.6 7.6 7.3 8.6 5.5 11.8 5.2 4.9 5.0 6.5 3.8 8.7 5.1 5.5 5.1 5.2 3.6 8.2 15.1 5.1 9.5 5.7 7.3 9.7 12.8 6.8 4.4 3.8 6.1 8.6 4.5 5.9 10.5 6.4 13.2 8.9 5.9 5.8 3.8 8.8 15.7 7.9 4.7 11.3 11.0 4.7 8.6 4.9 7.7 2.1 0.9 0.0 0.9 2.2 2.9 0.6 4.8 1.6 1.2 2.2 1.7 1.1 3.0 8.3 0.7 1.8 1.2 2.1 1.3 14.3 11.5 1.5 0.7 5.1 2.3 1.1 0.5 6.8 8.8 5.4 1.4 1.0 1.6 3.0 3.6 0.7 3.6 2.0 1.2 0.6 0.8 3.0 15.4 0.5 1.1 4.1 10.3 2.8 3.3 1.8 28.4 12.9 1.0 2.1 1.0 1.1 2.5 2.7 3.8 2.1 2.8 0.4 1.8 1.1 2.9 1.0 8.8 3.1 9.9 8.6 5.5 3.5 1.0 5.1 1.7 0.0 0.6 0.0 1.5 0.9 0.9 0.5 1.9 2.9 0.9 2.1 1.8 1.3 0.0 2.2 0.7 0.7 0.6 0.6 6.3 5.5 7.3 8.6 5.2 3.6 5.7 7.3 6.1 4.7 0.0 3.7 7.0 2.2 0.0 4.0 2.0 2.5 2.7 1.2 5.2 0.0 9.8 10.0 2.8 9.3 0.4 2.0 0.0 1.6 10.1 0.9 2.8 0.0 8.3 10.9 6.4 4.7 1.3 1.3 15.4 6.9 2.8 0.0 1.0 5.2 8.6 2.5 4.9 3.2 8.4 3.8 6.5 0.3 6.5 15.2 0.0 2.6 4.3 6.8 1.6 HGS "Hrs, Vps27, ZFYVE8" ENSG00000185359 "Hepatocyte growth factor-regulated tyrosine kinase substrate" O14964 17 81683326-81703138 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004872, HPA007728" Uncertain Enhanced Endosomes,Lysosomes,Cytosol NA NA 250000 "Endosomes, Lysosomes" Cytosol "HPA004872: AB_1079053, HPA007728: AB_1850681" "unprognostic (6.52e-2)" "prognostic unfavorable (4.22e-4)" "unprognostic (4.29e-1)" "unprognostic (1.31e-2)" "unprognostic (4.91e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (5.61e-5)" "unprognostic (5.54e-3)" "unprognostic (1.09e-1)" "unprognostic (9.27e-2)" "unprognostic (5.30e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.31e-7)" "unprognostic (3.69e-1)" "unprognostic (2.27e-1)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" 26.8 33.5 34.7 31.9 44.7 66.5 28.9 35.7 45.6 25.4 31.1 35.2 24.5 33.2 27.3 37.2 42.1 32.8 29.1 25.4 32.7 30.4 34.2 31.3 29.4 34.3 39.8 44.2 33.2 39.7 21.8 31.7 32.4 40.7 31.9 31.1 23.6 38.2 27.9 36.3 57.5 32.5 32.6 28.5 38.5 35.6 53.1 38.1 22.2 26.2 25.9 32.5 24.9 34.6 12.2 14.6 28.9 20.2 17.2 18.7 18.8 33.7 27.6 20.8 25.8 18.8 21.2 22.8 25.4 24.6 29.8 23.0 23.2 24.2 9.4 17.4 34.3 33.2 28.7 17.5 27.8 21.0 8.1 29.3 20.3 34.6 29.1 28.3 17.5 26.8 23.7 30.5 33.2 47.3 38.9 37.2 23.2 22.1 17.4 31.3 20.4 19.1 40.4 15.0 28.3 29.2 20.9 16.6 14.9 29.1 25.6 29.8 35.4 19.3 49.1 22.5 25.5 30.1 33.9 30.9 58.0 34.1 28.7 47.2 22.3 7.9 12.0 35.7 22.9 30.5 25.2 17.4 22.3 18.7 20.2 12.4 11.4 13.5 13.0 14.6 12.2 10.1 11.7 28.9 17.2 19.1 12.4 14.9 18.8 34.7 44.7 35.7 45.6 32.7 30.4 39.8 44.2 40.7 38.1 23.8 26.6 16.6 18.4 24.7 29.6 2.2 22.9 13.4 21.6 21.0 33.4 28.4 1.7 42.3 55.8 20.5 45.2 0.0 36.8 31.4 19.8 38.8 22.0 17.4 25.9 22.3 10.9 15.4 21.8 107.7 26.7 24.3 21.9 25.2 29.5 20.6 48.5 29.2 21.5 11.0 33.7 12.9 21.7 39.5 39.2 26.5 42.0 20.8 27.4 34.4 HHIPL2 "FLJ13840, KIAA1822L" ENSG00000143512 "HHIP like 2" Q6UWX4 1 222522258-222548103 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 9.4;testis: 10.4;thyroid gland: 4.6" "Group enriched" "Detected in some" 9 "Early spermatids: 14.1;Late spermatids: 21.2;Spermatocytes: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 16.2;Hep G2: 4.9;RH-30: 18.4;SuSa: 7.1;U-87 MG: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059673 Enhanced Uncertain Mitochondria,Cytosol "Secreted in other tissues" No NA Mitochondria Cytosol "HPA059673: AB_2684100" "unprognostic (1.35e-2)" "unprognostic (4.62e-3)" "unprognostic (2.91e-1)" "unprognostic (9.21e-2)" "unprognostic (3.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.74e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.07e-2)" "unprognostic (3.64e-1)" "unprognostic (2.29e-2)" "unprognostic (2.14e-2)" "unprognostic (0.00e+0)" "unprognostic (6.52e-2)" "unprognostic (4.21e-4)" "unprognostic (2.30e-3)" "unprognostic (8.38e-2)" 0.3 0.7 0.0 0.1 0.6 0.1 0.2 0.1 1.4 0.7 0.0 0.6 0.0 0.0 0.1 0.5 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.9 9.4 0.2 0.3 1.9 3.9 0.0 0.1 0.1 0.0 0.0 0.1 0.1 10.4 0.0 0.0 4.6 0.0 0.3 0.2 0.7 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 16.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.3 0.0 18.4 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.1 0.0 9.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.1 1.4 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.5 0.0 0.0 0.0 0.0 0.0 HID1 "C17orf28, DMC1, HID-1" ENSG00000167861 "HID1 domain containing" Q8IV36 17 74950743-74973166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.3" "Cell type enhanced" "Detected in many" 8 "Mucus-secreting cells: 67.2;Paneth cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 34 "B-cells: 1.5;dendritic cells: 5.8;T-cells: 2.8" "Cell line enhanced" "Detected in many" "MCF7: 34.4;OE19: 29.5;SH-SY5Y: 17.8;SK-BR-3: 52.7;T-47d: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031406 Approved Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA031406: AB_2673866" "unprognostic (7.41e-2)" "unprognostic (1.96e-1)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (4.47e-3)" "unprognostic (6.79e-3)" "unprognostic (4.00e-2)" "unprognostic (1.11e-1)" "unprognostic (2.78e-1)" "unprognostic (3.90e-1)" "unprognostic (1.54e-3)" "unprognostic (1.37e-1)" "prognostic favorable (3.13e-5)" "unprognostic (1.17e-1)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic favorable (1.34e-4)" 5.4 3.8 10.1 3.9 21.2 1.3 8.9 62.3 22.2 12.2 9.2 19.9 21.3 21.9 7.1 17.3 2.4 11.3 16.7 5.4 12.8 13.3 4.7 2.0 7.5 3.0 21.3 12.2 1.3 49.4 9.0 16.9 11.4 15.8 19.7 10.4 4.1 46.7 20.0 2.6 2.9 15.3 4.0 10.5 6.4 31.2 2.6 17.1 0.7 8.5 1.4 3.7 7.4 3.8 1.5 5.8 0.0 0.0 0.0 2.8 1.3 1.5 3.4 0.4 4.8 0.0 0.0 0.8 0.0 0.2 0.3 0.3 3.1 1.7 0.0 0.3 0.0 0.4 1.5 4.4 0.3 0.2 0.0 3.5 0.0 0.1 2.9 0.8 0.0 0.3 0.0 1.8 0.0 0.7 0.1 7.9 1.1 0.2 1.2 0.0 34.4 0.2 0.0 0.1 29.5 2.1 0.0 0.0 6.5 4.5 13.4 6.5 17.8 0.0 52.7 0.0 1.1 31.1 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 1.5 2.3 1.8 0.0 0.4 2.5 2.8 0.0 0.0 0.0 5.8 0.0 1.3 10.1 21.2 62.3 22.2 12.8 13.3 21.3 12.2 15.8 17.1 0.0 5.6 0.0 2.4 1.3 14.1 3.5 5.1 5.3 3.4 0.0 0.0 21.0 3.3 16.2 0.3 14.0 16.0 0.0 23.6 1.0 1.1 25.9 0.0 0.2 2.1 19.1 33.9 18.4 1.0 0.5 0.9 0.5 6.8 1.0 67.2 2.8 20.7 42.1 0.0 0.6 4.6 0.0 1.4 0.0 1.9 0.4 29.3 1.3 7.6 7.9 HIF1AN "DKFZp762F1811, FIH1, FLJ20615, FLJ22027" ENSG00000166135 "Hypoxia inducible factor 1 alpha subunit inhibitor" Q9NWT6 10 100529072-100559998 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048742, HPA065302, CAB069903" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458" "unprognostic (4.07e-2)" "unprognostic (7.75e-2)" "unprognostic (2.35e-2)" "unprognostic (3.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.21e-1)" "unprognostic (8.07e-3)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-3)" "unprognostic (1.54e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-2)" "unprognostic (3.09e-2)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (3.24e-2)" 8.8 12.7 11.6 11.9 10.8 7.6 12.9 9.5 14.1 9.2 10.7 11.5 8.8 9.7 11.6 10.4 11.1 9.6 12.5 16.0 10.2 9.4 10.3 8.8 9.3 12.3 13.0 9.5 14.5 14.3 17.1 10.6 10.2 10.8 10.7 9.3 9.2 10.6 12.1 46.8 13.3 10.6 14.9 9.7 11.1 10.0 17.9 10.3 13.5 8.1 14.8 12.3 10.8 10.8 9.7 8.5 16.9 14.0 10.1 11.3 9.3 9.1 9.7 13.1 13.2 20.4 8.5 11.4 9.8 23.7 14.6 17.2 15.0 7.9 9.9 8.9 14.6 10.8 10.7 11.5 8.8 15.9 10.9 7.0 9.4 8.6 11.4 10.6 11.3 12.6 8.3 8.9 14.1 15.5 20.6 8.2 13.3 4.1 5.6 16.3 9.6 12.1 7.4 4.3 7.8 4.7 8.8 16.3 4.8 10.1 12.3 5.0 8.3 8.4 5.2 9.2 11.5 17.8 6.1 6.8 7.5 9.7 7.3 9.8 7.6 7.7 7.6 12.4 9.3 5.5 13.1 8.8 16.9 9.8 12.4 9.6 9.7 10.1 9.0 8.5 7.5 9.8 9.9 9.3 10.1 14.0 3.1 11.3 9.3 11.6 10.8 9.5 14.1 10.2 9.4 13.0 9.5 10.8 10.3 0.0 6.2 14.3 9.8 9.7 16.8 34.6 12.7 4.0 5.7 10.4 15.7 23.3 8.3 15.7 15.4 9.0 14.8 0.0 12.1 15.1 7.1 8.2 5.8 8.7 13.0 23.8 12.7 7.4 17.7 39.0 10.3 10.4 3.3 16.2 11.3 14.3 15.3 14.0 11.3 14.7 21.9 6.5 12.2 39.9 22.2 10.2 27.3 11.7 11.4 8.4 HIF3A "bHLHe17, IPAS, MOP7, PASD7" ENSG00000124440 "Hypoxia inducible factor 3 alpha subunit" Q9Y2N7 19 46297046-46343433 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation" "Developmental protein, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 39.5;Leydig cells: 126.2;Muller glia cells: 84.5;Peritubular cells: 97.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.3;HHSteC: 16.9;HSkMC: 14.9;TIME: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041141 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041141: AB_10803997" "unprognostic (9.20e-2)" "unprognostic (2.99e-1)" "unprognostic (5.48e-2)" "prognostic unfavorable (6.90e-9)" "unprognostic (4.12e-2)" "unprognostic (2.35e-2)" "unprognostic (3.57e-3)" "unprognostic (1.30e-1)" "unprognostic (3.32e-2)" "unprognostic (1.38e-2)" "unprognostic (3.76e-2)" "unprognostic (7.07e-2)" "unprognostic (3.41e-4)" "unprognostic (1.55e-2)" "unprognostic (1.61e-1)" "unprognostic (4.45e-4)" "unprognostic (5.98e-2)" 15.8 7.7 17.9 4.9 9.8 2.5 8.7 10.6 11.1 15.8 16.1 4.7 6.7 3.1 8.1 10.3 11.6 9.8 9.2 31.2 21.4 6.8 4.5 2.1 13.5 5.2 10.8 8.3 17.7 5.1 2.1 12.1 42.4 9.8 9.7 4.5 10.0 4.3 13.1 12.3 3.6 7.0 26.9 11.2 21.7 14.1 3.3 11.4 0.0 3.2 5.6 2.0 18.8 14.6 1.0 1.3 3.3 1.1 0.5 0.7 0.1 0.0 0.0 1.3 0.3 3.8 8.3 0.4 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 16.9 0.1 0.6 14.9 0.0 0.0 0.0 0.1 2.9 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 2.1 0.0 0.2 13.6 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.7 0.2 0.1 3.3 0.4 0.8 0.4 0.4 0.4 0.5 0.4 0.4 0.2 1.0 0.6 0.7 3.1 0.5 1.1 1.3 0.2 0.1 17.9 9.8 10.6 11.1 21.4 6.8 10.8 8.3 9.8 11.4 3.0 2.6 0.0 2.1 1.0 1.4 39.5 10.2 0.0 1.2 0.0 0.0 0.2 1.7 0.0 1.4 36.8 0.0 0.0 0.0 0.2 7.5 1.3 0.0 0.5 0.5 0.0 1.2 28.8 1.0 2.6 126.2 0.2 3.3 0.0 1.1 84.5 0.1 1.5 97.2 0.0 2.1 6.5 4.2 1.2 3.1 1.9 0.5 0.0 1.4 0.5 HIGD2A "MGC2198, RCF1B" ENSG00000146066 "HIG1 hypoxia inducible domain family member 2A" Q9BW72 5 176388747-176389771 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA042715 Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA042715: AB_2678127" "unprognostic (9.24e-2)" "unprognostic (6.31e-3)" "unprognostic (7.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.94e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (2.39e-1)" "unprognostic (3.19e-1)" "unprognostic (1.98e-2)" "unprognostic (3.11e-3)" "unprognostic (9.56e-2)" "unprognostic (2.39e-2)" "unprognostic (1.45e-1)" "unprognostic (8.09e-2)" "unprognostic (1.78e-1)" "unprognostic (9.65e-2)" 37.2 38.5 31.4 33.5 36.0 34.9 37.5 21.4 33.2 26.8 43.8 22.5 29.7 36.7 25.7 31.1 47.0 31.5 39.4 80.0 28.5 26.6 46.3 56.1 30.1 54.1 30.3 20.0 33.2 42.6 36.6 28.8 26.4 21.0 41.2 30.9 31.2 64.0 32.6 115.9 27.8 38.1 43.3 25.9 37.3 31.6 28.8 15.0 63.1 42.3 53.8 34.3 42.1 28.7 70.4 104.6 25.5 107.7 31.1 67.6 88.9 17.9 31.7 19.0 32.1 19.9 38.1 49.8 11.3 21.6 33.0 41.6 33.1 38.0 32.7 27.6 20.6 40.3 23.2 28.7 50.7 13.2 76.6 45.1 16.1 32.7 45.3 28.0 25.1 43.9 48.3 42.2 18.6 22.6 24.3 27.7 27.5 17.8 65.9 24.2 59.3 28.5 31.9 22.4 34.6 34.9 27.7 14.1 59.1 51.6 29.9 20.0 26.7 12.9 54.6 55.5 20.3 32.6 42.3 17.3 22.5 23.3 20.6 23.5 30.7 36.6 26.6 29.1 45.1 14.1 25.5 84.5 23.8 46.3 106.5 45.8 70.4 64.9 53.5 104.6 52.2 59.6 55.6 14.4 31.1 107.7 68.6 67.6 88.9 31.4 36.0 21.4 33.2 28.5 26.6 30.3 20.0 21.0 15.0 68.5 61.2 245.0 289.8 206.3 55.1 130.4 180.9 116.4 104.6 172.7 11.8 187.5 452.6 160.5 55.4 114.7 272.4 23.3 206.0 150.2 154.5 216.1 128.0 198.8 329.3 62.0 256.0 111.7 344.3 44.7 129.8 304.5 244.6 408.4 365.8 77.7 132.6 412.7 79.9 405.0 38.4 116.4 130.6 108.0 81.6 196.7 234.3 221.4 328.6 443.0 HIGD2B HIGD2BP ENSG00000175202 "HIG1 hypoxia inducible domain family member 2B" Q4VC39 15 72675783-72686149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 11.6" "Group enriched" "Detected in some" 13 "Early spermatids: 11.0;Late spermatids: 7.1;Spermatocytes: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0" "HPA019016, HPA042715" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA019016: AB_1850711, HPA042715: AB_2678127" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.24e-3)" "unprognostic (5.09e-2)" "unprognostic (3.34e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (6.98e-2)" "unprognostic (3.90e-1)" "unprognostic (8.80e-2)" "unprognostic (6.11e-4)" "unprognostic (6.95e-2)" "unprognostic (2.97e-1)" "unprognostic (1.11e-2)" "unprognostic (3.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.6 0.2 0.0 0.7 0.0 1.3 0.7 1.1 0.0 0.0 0.4 0.0 0.6 0.6 0.8 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.2 0.0 0.6 0.0 1.0 0.0 0.5 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.9 0.9 0.7 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 15.1 0.9 0.1 0.1 0.0 0.0 0.1 HINT1 "HINT, PKCI-1, PRKCNH1" ENSG00000169567 "Histidine triad nucleotide binding protein 1" P49773 5 131159027-131171735 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044577 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 Cytosol "Nucleoplasm, Plasma membrane" "HPA044577: AB_10795618" "unprognostic (2.00e-1)" "unprognostic (9.27e-2)" "unprognostic (2.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.35e-1)" "unprognostic (8.30e-3)" "unprognostic (2.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.49e-2)" "unprognostic (6.50e-3)" "unprognostic (4.43e-2)" "unprognostic (4.39e-3)" "unprognostic (2.08e-1)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (3.68e-1)" 28.5 46.5 56.6 46.2 51.6 50.5 64.7 42.9 78.4 29.8 53.3 20.4 49.1 36.5 30.6 43.8 44.3 42.3 36.7 61.4 47.3 43.9 65.4 124.4 38.9 54.7 48.7 50.6 32.2 62.9 43.9 39.6 24.6 40.8 41.3 50.0 22.6 44.4 41.8 84.0 38.3 41.3 37.9 37.5 32.5 32.5 30.5 25.1 29.4 47.5 56.6 39.4 29.1 45.1 26.6 46.5 19.2 25.3 20.9 40.3 52.9 37.7 55.2 43.5 88.9 30.9 33.6 40.1 28.8 26.9 29.1 33.8 53.9 52.9 52.0 57.4 36.8 60.7 23.3 34.6 75.7 26.9 45.4 63.6 20.0 78.3 69.0 64.9 31.2 6.4 44.8 66.9 34.8 58.6 58.2 36.3 80.5 30.4 113.7 37.2 41.6 52.6 78.5 42.1 42.2 44.1 38.1 43.4 94.0 54.6 48.7 53.3 33.4 38.1 26.1 45.4 61.9 31.6 45.6 39.9 38.4 21.8 30.5 58.4 32.7 41.8 45.1 53.8 50.4 35.4 19.2 25.3 9.6 21.7 12.8 29.7 26.6 40.3 28.6 39.2 25.7 32.0 25.3 5.0 20.9 12.9 46.5 27.0 52.9 56.6 51.6 42.9 78.4 47.3 43.9 48.7 50.6 40.8 25.1 262.0 219.1 629.2 1214.3 1155.8 179.6 456.1 1044.6 465.7 406.0 678.7 43.2 639.6 1409.2 899.0 635.9 429.8 1359.9 186.9 676.8 1374.0 368.2 1313.3 104.1 1865.9 757.5 139.8 670.7 421.1 431.2 132.3 363.3 562.9 916.1 1617.7 889.8 207.2 821.7 984.4 393.5 2245.6 149.7 239.3 466.3 357.2 194.1 1001.8 382.0 568.5 1197.2 1396.9 HINT3 FLJ33126 ENSG00000111911 "Histidine triad nucleotide binding protein 3" Q9NQE9 6 125956781-125980244 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 65.8" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 260.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027914 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA "Nucleoli, Mitochondria" Cytosol "HPA027914: AB_10602424" "prognostic unfavorable (4.99e-4)" "unprognostic (4.75e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (1.74e-1)" "unprognostic (4.88e-3)" "unprognostic (3.82e-1)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (1.05e-1)" "prognostic favorable (1.05e-6)" "unprognostic (4.09e-2)" "unprognostic (4.76e-2)" "unprognostic (9.56e-2)" "unprognostic (1.64e-1)" 11.4 16.3 27.4 8.0 23.3 7.2 15.6 19.4 24.3 13.1 13.1 24.8 10.6 10.4 11.5 12.6 15.2 11.4 10.9 19.0 28.1 23.0 15.1 18.5 13.9 7.0 28.7 17.0 10.4 12.8 16.3 13.4 12.1 20.7 20.5 12.1 10.3 16.0 16.2 65.8 11.6 10.5 15.2 40.8 6.8 16.0 21.9 17.0 7.7 15.9 16.8 7.4 16.1 8.8 11.0 11.1 15.0 13.2 7.9 9.9 7.0 7.0 5.6 7.8 16.1 3.1 8.4 9.7 7.6 11.0 5.9 6.1 13.6 3.9 15.3 14.2 5.1 13.1 10.6 9.9 6.4 6.9 14.4 12.8 6.4 8.4 11.4 14.4 10.1 10.9 6.6 14.3 5.9 15.0 15.2 8.8 11.4 19.9 10.3 5.8 10.6 8.0 7.3 2.6 14.4 5.4 6.7 5.3 5.1 12.1 12.9 15.7 9.7 6.9 9.9 35.6 5.9 10.0 15.5 6.2 4.0 5.6 19.2 10.8 15.0 17.2 9.7 11.4 9.6 5.1 14.4 13.2 11.4 7.2 8.4 7.8 11.0 9.2 7.5 11.1 10.4 9.9 8.7 15.0 7.9 10.8 6.9 9.1 7.0 27.4 23.3 19.4 24.3 28.1 23.0 28.7 17.0 20.7 17.0 74.5 57.0 16.0 9.5 16.1 22.3 37.6 10.2 24.1 31.8 15.7 7.9 16.0 28.2 27.0 260.9 11.3 12.3 0.0 17.5 5.7 10.8 19.4 9.2 16.3 23.3 6.4 15.6 6.2 14.5 54.5 9.2 17.0 20.3 9.0 22.7 30.7 20.3 28.1 16.3 21.4 23.9 6.5 13.7 89.1 27.7 15.2 22.1 7.0 19.9 17.1 HIP1R "FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655" ENSG00000130787 "Huntingtin interacting protein 1 related" O75146 12 122834453-122862960 "Cancer-related genes, Predicted intracellular proteins" Endocytosis Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 57.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.5;naive B-cell: 12.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017187, HPA038135, HPA038136" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852" "unprognostic (4.52e-1)" "unprognostic (6.39e-2)" "unprognostic (7.07e-2)" "unprognostic (6.55e-3)" "unprognostic (8.67e-2)" "unprognostic (1.00e-2)" "unprognostic (1.02e-2)" "unprognostic (8.11e-2)" "unprognostic (6.37e-2)" "unprognostic (1.76e-1)" "unprognostic (1.39e-2)" "unprognostic (6.72e-2)" "prognostic favorable (6.50e-7)" "unprognostic (2.18e-2)" "unprognostic (2.84e-1)" "unprognostic (2.54e-3)" "prognostic favorable (7.26e-4)" 9.8 14.5 24.6 13.2 26.5 11.6 8.0 11.5 31.6 4.6 11.6 40.5 19.7 29.2 4.0 9.1 7.0 4.0 7.8 10.8 29.5 21.7 16.2 9.0 6.3 15.3 31.4 20.6 3.2 27.7 7.4 15.6 5.2 18.0 8.6 5.4 2.9 52.0 24.1 5.7 26.5 21.3 3.0 27.4 11.1 30.4 4.0 30.6 8.1 8.1 5.9 12.6 7.4 6.5 12.3 0.0 2.7 0.0 0.6 3.2 1.6 17.5 5.1 3.8 15.8 1.1 3.0 18.9 2.8 4.5 2.8 2.2 7.8 5.3 16.7 9.3 2.0 4.3 15.2 4.6 10.1 0.2 2.6 6.7 0.4 5.8 8.2 3.5 1.3 11.9 1.9 7.2 3.8 6.5 3.9 19.5 7.9 4.3 0.9 1.6 25.2 7.9 4.1 3.5 15.2 6.1 4.1 4.9 5.8 9.5 21.3 3.9 8.7 3.3 8.6 4.5 2.2 17.6 0.7 15.4 1.8 13.6 5.6 2.6 12.0 6.4 9.9 2.9 2.8 1.5 0.0 0.0 2.7 2.9 0.0 1.7 9.5 1.8 2.2 0.0 12.3 3.2 2.0 0.2 0.6 0.0 0.0 0.4 1.6 24.6 26.5 11.5 19.8 29.5 21.7 31.4 20.6 18.0 30.6 0.0 12.0 32.0 12.8 11.7 8.4 4.1 50.9 8.1 7.9 57.6 27.5 3.0 0.0 34.4 2.3 11.7 36.4 0.0 24.6 10.4 2.1 17.0 5.7 20.8 0.6 17.5 7.5 18.4 1.2 2.2 1.4 0.4 10.1 0.0 24.4 12.3 20.4 22.6 1.1 12.5 17.4 0.0 1.9 4.7 9.8 18.3 1.6 6.7 18.0 25.8 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929192-113977869 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 15.1 16.8 21.2 14.7 23.0 90.1 13.6 38.1 20.4 20.4 14.4 20.7 14.5 10.2 15.5 14.2 18.7 27.3 17.5 27.9 22.9 17.2 14.8 13.8 19.3 14.7 15.0 16.4 18.7 16.8 20.7 23.8 13.8 21.3 14.4 15.2 20.7 13.0 14.9 19.7 18.5 13.4 15.1 18.3 15.9 14.8 33.5 21.3 47.2 23.3 13.1 15.5 17.3 26.7 2.3 6.2 9.8 4.2 4.3 6.0 2.3 8.2 6.7 9.3 7.1 10.9 5.7 6.3 5.7 6.9 8.1 7.8 7.7 3.2 11.1 7.8 9.0 3.0 5.6 12.0 6.6 11.8 8.0 6.0 16.1 8.4 8.1 9.1 12.8 20.0 6.2 9.7 10.4 10.6 7.7 12.0 19.7 11.0 12.0 11.6 62.4 16.8 7.3 9.5 6.2 6.0 10.2 27.3 3.9 7.3 7.1 4.1 5.5 10.4 11.2 7.3 10.8 6.5 18.5 11.6 8.0 10.8 13.0 8.6 7.5 5.8 9.6 9.0 10.4 18.2 3.4 4.2 8.2 5.5 3.7 5.2 1.7 4.9 4.9 3.1 2.3 5.0 6.0 9.8 4.3 2.6 6.2 3.6 2.3 21.2 23.0 38.1 20.4 22.9 17.2 15.0 16.4 21.3 21.3 50.6 37.0 12.9 14.8 54.6 47.6 27.1 22.9 64.3 20.5 26.2 66.8 9.7 5.0 12.5 82.7 29.3 18.8 70.0 18.3 7.9 25.0 26.7 45.1 33.6 19.9 69.9 35.7 23.9 54.6 73.8 20.4 35.5 20.3 15.4 24.2 28.9 17.0 17.3 35.0 13.4 60.3 25.8 37.0 35.4 26.0 70.4 11.9 47.3 22.4 23.0 HIPK3 "DYRK6, FIST3, PKY, YAK1" ENSG00000110422 "Homeodomain interacting protein kinase 3" Q9H422 11 33256672-33357023 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 138.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028069 Approved Supported "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA028069: AB_10601815" "unprognostic (2.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.61e-1)" "unprognostic (5.74e-2)" "unprognostic (2.09e-1)" "unprognostic (1.78e-2)" "unprognostic (1.63e-1)" "unprognostic (7.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.78e-1)" "unprognostic (2.18e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-3)" "unprognostic (7.89e-3)" "unprognostic (1.80e-1)" "unprognostic (1.87e-1)" "unprognostic (2.48e-2)" 46.3 13.4 12.7 15.9 15.9 12.7 49.2 11.7 13.7 23.6 24.8 11.9 15.9 9.9 28.3 22.8 22.9 24.1 18.8 69.0 13.4 11.8 23.4 21.1 20.2 20.9 15.5 8.2 23.6 15.4 49.7 21.2 20.5 15.2 23.2 12.8 15.6 18.8 18.1 45.9 18.7 25.0 32.9 15.9 20.1 20.5 14.7 14.2 15.2 37.9 26.0 14.4 33.6 34.6 3.1 11.3 17.6 10.1 3.3 4.4 3.7 9.5 9.1 6.9 7.8 32.1 20.3 6.9 10.1 11.8 8.3 7.0 10.0 7.0 10.4 8.6 12.4 4.2 12.3 5.2 11.3 11.7 15.0 8.1 10.4 10.3 7.6 13.3 11.2 6.6 19.0 22.3 3.2 9.3 8.6 10.0 7.6 3.3 20.8 13.3 5.0 9.2 7.8 1.7 8.6 5.5 12.4 24.5 10.3 13.6 15.0 1.0 5.8 13.7 15.8 9.4 7.8 17.8 20.6 12.9 13.0 8.9 14.9 7.2 11.4 17.9 10.9 6.3 11.8 12.1 6.6 10.1 4.8 3.5 7.6 4.4 2.4 3.2 3.7 11.3 3.1 2.9 3.5 17.6 3.3 8.6 1.4 3.2 3.7 12.7 15.9 11.7 13.7 13.4 11.8 15.5 8.2 15.2 14.2 11.9 40.1 19.6 37.7 59.1 15.0 138.1 28.1 60.2 40.9 31.4 17.7 14.6 5.0 10.7 17.4 81.2 34.9 0.0 21.3 10.5 36.9 34.5 13.9 44.7 26.7 30.2 35.6 49.7 100.8 22.3 39.7 52.2 55.6 6.4 26.9 10.8 18.6 21.6 35.3 28.4 23.7 51.8 63.4 10.0 7.6 65.6 12.9 17.3 20.1 42.6 HIST1H2BB "H2B/f, H2BFF" ENSG00000276410 "Histone cluster 1 H2B family member b" P33778 6 26043277-26043657 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 104.9" "Cell type enhanced" "Detected in some" 10 "Enterocytes: 1.6;Spermatogonia: 1.5" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 3.7;Karpas-707: 3.6;MOLT-4: 4.5;NB-4: 4.9;THP-1: 5.5;U-266/84: 6.1" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.92e-2)" "unprognostic (9.15e-2)" "unprognostic (3.29e-1)" "unprognostic (2.18e-1)" "unprognostic (2.36e-1)" "unprognostic (1.26e-1)" "unprognostic (6.10e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (2.58e-1)" 0.4 0.3 1.0 6.4 0.3 6.6 0.6 0.5 1.0 0.5 1.0 0.0 0.0 1.1 0.4 0.5 4.1 0.6 0.3 1.0 0.2 0.8 0.3 1.7 3.0 0.1 0.4 0.3 0.5 0.3 0.0 0.9 1.0 0.3 0.3 0.2 0.3 0.3 1.3 1.0 0.8 0.3 0.8 5.8 0.5 15.8 0.1 104.9 0.3 4.8 7.4 0.3 0.0 2.1 10.5 4.2 1.1 0.2 3.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.4 1.1 1.6 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.0 0.7 0.3 0.0 1.3 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.6 0.0 0.3 1.4 0.6 3.7 3.6 0.0 0.0 4.5 4.9 2.2 0.7 2.1 2.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.3 5.5 0.0 0.3 0.3 0.3 0.9 0.8 6.1 0.0 0.7 1.8 1.3 4.2 1.1 0.8 1.5 0.1 3.9 2.1 3.9 1.6 3.3 1.6 2.0 0.8 3.6 0.2 0.4 10.5 2.9 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.6 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.3 1.5 0.3 0.1 0.0 0.3 0.0 HIST1H2BC "H2B.1, H2B/l, H2BFL" ENSG00000180596 "Histone cluster 1 H2B family member c" P62807 6 26114873-26123926 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 115.7;lymphoid tissue: 143.2" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 42.1;Glandular cells: 78.6;Urothelial cells: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 20 "neutrophil: 115.7" "Lineage enriched" "Detected in all" 26 "granulocytes: 115.7" "Cell line enhanced" "Detected in many" "K-562: 17.0;SiHa: 33.6;U-2 OS: 23.5;U-266/70: 19.4;U-266/84: 23.8" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (8.30e-3)" "unprognostic (2.60e-2)" "unprognostic (2.37e-2)" "unprognostic (9.26e-2)" "unprognostic (3.20e-2)" "unprognostic (5.08e-2)" "unprognostic (4.72e-1)" "unprognostic (6.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (9.01e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (5.41e-2)" "unprognostic (7.38e-2)" "unprognostic (2.49e-1)" "unprognostic (6.60e-3)" 7.8 5.8 5.5 21.3 7.1 31.3 10.7 2.1 5.9 12.9 11.5 5.9 12.8 5.2 4.1 13.1 20.9 10.8 8.1 5.8 6.5 4.6 8.4 20.2 15.3 11.4 5.4 4.1 5.6 9.6 1.7 9.9 17.5 3.8 31.7 4.1 5.9 12.4 18.6 20.0 10.0 6.0 4.3 10.4 11.7 10.6 9.4 4.5 143.2 6.4 8.7 23.4 12.9 14.3 4.3 2.8 115.7 1.3 1.2 1.8 2.7 3.0 1.8 0.9 0.9 0.9 0.5 1.1 3.0 1.1 2.0 1.7 2.4 1.8 1.1 5.7 1.0 1.5 2.3 1.2 1.2 1.0 2.7 1.0 0.9 2.7 4.1 1.2 1.4 3.8 12.6 0.7 0.8 0.5 1.0 0.8 0.9 17.0 9.5 3.8 3.4 3.2 3.1 1.0 3.2 5.5 1.4 1.3 7.0 3.5 0.7 4.3 1.4 33.6 2.6 1.2 2.6 14.3 1.3 2.4 2.5 23.5 1.5 1.2 19.4 23.8 5.7 1.1 3.7 1.7 4.5 1.1 5.8 1.2 1.3 1.6 2.3 1.8 1.7 0.8 4.3 1.4 1.0 115.7 1.2 1.2 2.8 1.1 2.7 5.5 7.1 2.1 5.9 6.5 4.6 5.4 4.1 3.8 4.5 6.0 2.7 3.0 40.5 0.8 3.0 1.8 5.1 21.4 7.9 3.5 0.0 3.9 1.7 6.8 42.1 2.9 9.5 0.0 8.0 5.4 4.1 78.6 4.6 13.0 5.8 0.0 1.7 1.8 3.7 4.5 1.4 4.6 0.0 1.8 7.4 2.9 25.5 9.9 1.1 3.5 3.9 0.0 1.8 1.8 3.2 1.0 35.8 10.1 4.9 103.5 HIST1H2BD "H2B/b, H2BFB" ENSG00000158373 "Histone cluster 1 H2B family member d" P58876 6 26158146-26171349 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 174.9" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 105.0;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 37.2;U-266/84: 39.2" "Low region specificity" "Detected in some" "HPA042205, HPA043013, HPA048671, CAB062336" Supported Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.39e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.32e-1)" "unprognostic (1.98e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (8.10e-2)" "unprognostic (2.28e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-3)" "unprognostic (2.17e-1)" "unprognostic (4.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" 7.9 6.6 6.0 33.2 9.0 36.4 17.3 14.0 8.9 33.6 17.0 2.9 13.2 8.2 9.5 21.4 18.2 17.4 11.1 17.4 7.5 4.2 19.9 25.3 13.8 32.3 7.7 7.1 33.1 21.7 2.2 11.5 10.1 7.4 43.4 12.9 8.3 13.0 14.7 12.0 14.7 9.5 13.0 18.7 11.0 18.8 7.1 5.6 174.9 9.5 23.9 18.9 13.2 32.7 15.6 12.9 19.3 4.5 6.8 9.6 2.0 5.3 12.2 3.7 2.1 29.3 2.7 1.1 4.7 2.7 6.2 3.9 4.1 4.4 2.4 30.1 5.6 6.9 8.5 2.1 2.0 2.9 11.0 5.2 1.6 9.8 4.3 3.1 2.1 4.6 19.2 3.2 1.7 2.4 2.4 1.5 2.3 16.9 13.5 1.1 19.3 4.8 5.4 3.9 23.1 5.7 1.9 2.4 16.0 5.8 3.9 12.0 5.1 29.9 7.8 4.6 7.6 19.8 0.8 0.9 7.7 20.1 3.1 1.0 37.2 39.2 6.1 1.0 10.0 1.5 19.3 1.5 10.5 5.8 3.4 7.4 8.4 8.9 9.6 3.7 15.6 8.4 5.7 16.6 6.8 4.5 12.9 5.8 2.0 6.0 9.0 14.0 8.9 7.5 4.2 7.7 7.1 7.4 5.6 3.0 5.6 15.9 54.2 1.5 13.9 21.3 12.7 53.5 10.3 21.0 0.0 6.4 19.9 4.3 27.1 2.8 22.0 0.0 3.8 6.2 3.0 105.0 2.3 20.7 3.9 41.3 44.7 1.3 4.0 5.4 6.6 6.9 3.3 3.6 20.2 4.0 12.0 33.1 1.4 75.4 10.4 0.0 1.4 0.9 0.7 2.4 33.0 6.9 14.3 63.6 HIST1H2BE "H2B.h, H2B/h, H2BFH" ENSG00000274290 "Histone cluster 1 H2B family member e" P62807 6 26172059-26184655 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "lymphoid tissue: 165.1" "Cell type enhanced" "Detected in many" 7 "B-cells: 5.6;Glandular cells: 5.8;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 8.2;REH: 8.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-1)" "unprognostic (7.06e-3)" "unprognostic (8.28e-2)" "unprognostic (1.31e-1)" "unprognostic (7.98e-2)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (1.69e-2)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.55e-6)" "unprognostic (3.03e-2)" "unprognostic (4.86e-2)" "unprognostic (2.30e-1)" "unprognostic (3.11e-2)" 0.7 1.1 0.4 12.2 0.8 5.9 1.8 0.6 1.7 2.5 2.9 0.1 1.8 1.1 1.5 2.9 5.5 1.6 1.6 1.9 0.5 1.7 0.3 1.5 6.7 0.0 1.2 2.1 1.2 0.7 0.0 2.4 0.2 5.2 1.5 0.7 4.0 2.2 2.1 1.9 2.0 1.8 1.6 4.5 2.5 5.4 0.0 165.1 1.2 6.4 7.1 1.8 0.0 3.6 3.1 5.5 1.7 1.6 2.9 0.8 0.5 3.7 3.0 0.9 3.0 0.4 0.4 3.1 1.0 0.5 0.3 0.8 2.1 0.7 1.4 0.5 1.7 4.3 0.5 1.1 0.6 1.6 1.0 0.5 1.5 0.2 0.2 0.3 2.5 0.6 0.2 0.6 0.3 1.1 0.3 0.9 2.4 1.8 0.1 1.6 4.6 8.2 2.4 1.6 1.0 8.0 0.2 2.6 1.4 1.8 2.7 3.7 4.0 1.5 0.9 1.6 2.8 1.6 0.8 1.5 2.7 1.1 1.9 2.4 4.5 0.6 0.6 1.4 0.5 5.2 1.7 2.4 2.0 1.3 1.6 2.1 2.0 2.5 0.7 3.6 1.8 1.7 5.5 1.6 1.5 3.1 2.9 0.8 0.0 0.0 5.6 4.5 0.0 4.3 0.3 2.5 2.7 0.0 1.8 3.9 0.7 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.9 0.3 5.8 1.1 1.0 0.8 9.5 1.2 0.6 4.1 0.0 1.4 0.7 0.0 1.0 0.4 1.2 0.2 0.0 0.7 0.4 2.4 0.0 0.0 1.6 0.9 0.0 0.7 0.0 1.6 4.0 HIST1H2BF "H2B/g, H2BFG" ENSG00000277224 "Histone cluster 1 H2B family member f" P62807 6 26199520-26200715 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "lymphoid tissue: 252.2" "Cell type enhanced" "Detected in some" 8 "B-cells: 6.7;Basal glandular cells: 3.6;Bipolar cells: 5.4;Glandular cells: 5.5;Urothelial cells: 5.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "U-266/70: 21.8;U-266/84: 15.3" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (1.12e-1)" "unprognostic (1.38e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (6.80e-3)" "unprognostic (3.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.95e-1)" "unprognostic (7.27e-3)" "unprognostic (4.29e-11)" "unprognostic (4.88e-3)" "unprognostic (4.45e-1)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" 0.4 1.2 0.0 17.3 0.1 3.8 5.7 0.3 0.7 2.7 3.3 0.4 1.0 0.5 1.6 1.3 9.9 1.3 1.2 0.6 0.0 0.5 0.4 2.5 7.0 0.0 0.2 0.8 0.6 0.4 0.0 3.2 0.2 5.4 1.1 0.5 1.4 1.3 0.2 0.4 3.0 0.3 0.9 8.3 1.3 2.2 0.1 252.2 0.4 3.3 14.6 2.4 0.0 3.0 0.7 6.2 0.7 0.4 1.5 1.2 0.4 0.2 0.2 0.4 0.3 0.0 0.2 0.1 0.1 0.6 0.1 0.5 0.0 0.5 0.9 0.0 0.3 0.9 0.4 0.1 0.3 0.7 0.2 0.3 1.4 0.1 0.1 0.1 0.7 0.2 0.0 0.1 0.1 0.0 0.1 0.4 1.7 3.9 0.0 0.1 3.3 1.4 0.5 0.7 0.5 1.2 0.6 2.4 0.1 0.1 2.1 0.3 4.2 0.8 0.0 0.3 3.8 0.2 0.1 0.3 1.9 0.0 0.5 21.8 15.3 1.2 0.1 1.0 0.4 0.0 0.2 1.4 0.7 0.3 1.5 0.7 0.7 0.8 0.4 3.0 0.6 1.2 6.2 0.4 0.7 0.7 0.6 1.2 0.0 0.3 6.7 3.6 0.0 5.4 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.4 0.0 5.5 0.0 0.4 1.0 0.0 0.0 1.3 0.8 0.0 0.0 0.8 0.0 0.0 0.4 1.2 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.0 0.5 2.5 1.0 5.1 HIST1H2BG "H2B.1A, H2B/a, H2BFA" ENSG00000273802 "Histone cluster 1 H2B family member g" P62807 6 26215159-26216692 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 75.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 58.7;Glandular cells: 91.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 8.9;T-47d: 18.1;U-266/70: 16.9" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (4.19e-2)" "unprognostic (1.63e-2)" "unprognostic (8.54e-2)" "unprognostic (6.69e-2)" "unprognostic (1.55e-1)" "unprognostic (2.36e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (1.70e-8)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.97e-2)" 0.4 1.5 0.7 16.5 1.2 8.9 20.2 5.1 3.4 4.3 2.9 0.5 5.1 1.8 2.8 4.0 6.6 2.1 1.8 1.7 0.2 1.2 0.6 2.0 7.2 0.1 2.0 1.3 1.9 0.4 0.5 1.6 0.7 10.3 3.0 1.2 5.0 5.8 0.3 1.6 2.2 2.8 4.7 3.1 2.9 6.7 0.3 75.2 1.0 6.9 8.3 4.3 0.0 5.8 14.6 12.0 1.6 1.3 6.2 2.0 2.5 0.1 1.2 0.0 3.9 0.2 0.3 3.1 0.2 2.0 0.8 0.3 2.2 0.0 3.2 0.3 0.8 2.7 1.1 1.0 1.1 2.2 1.3 0.7 1.2 1.1 0.6 0.3 2.1 1.5 0.5 0.6 0.0 0.1 0.4 0.1 7.8 0.1 0.0 1.8 2.2 1.7 1.2 5.9 1.6 1.5 0.7 4.4 1.2 0.6 7.3 1.1 8.9 3.3 1.0 3.4 18.1 0.8 0.2 0.0 1.0 0.3 0.4 16.9 0.1 0.0 0.3 1.1 0.5 12.0 1.2 2.5 2.0 0.9 6.2 3.7 3.1 3.8 4.4 5.8 1.5 1.3 5.6 1.3 1.6 14.6 2.7 2.0 0.0 12.7 29.3 58.7 0.8 40.1 0.7 5.1 4.0 4.5 5.2 5.9 6.3 0.0 4.8 0.6 0.5 27.1 0.0 0.0 6.6 3.2 91.9 9.3 2.5 17.2 23.8 29.8 2.5 3.5 0.0 2.0 8.0 0.0 1.8 17.9 9.5 1.1 16.4 0.0 1.3 3.0 6.5 0.4 1.4 16.2 0.0 20.1 10.7 14.2 42.2 HIST1H2BH "H2B/j, H2BFJ" ENSG00000275713 "Histone cluster 1 H2B family member h" Q93079 6 26251651-26253710 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 220.5" "Cell type enhanced" "Detected in some" 13 "B-cells: 6.7;Enterocytes: 8.5;Extravillous trophoblasts: 21.0;Paneth cells: 8.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.7" "Cell line enhanced" "Detected in many" "AF22: 7.5;U-266/70: 18.1" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (5.83e-2)" "unprognostic (6.27e-3)" "unprognostic (4.50e-2)" "unprognostic (9.18e-2)" "unprognostic (5.52e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.06e-3)" "unprognostic (3.08e-3)" "unprognostic (1.58e-2)" "unprognostic (2.75e-2)" "unprognostic (1.86e-1)" "unprognostic (3.22e-1)" "unprognostic (2.96e-8)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (1.95e-3)" 0.9 0.6 0.0 25.6 0.0 3.1 2.1 0.0 0.0 0.9 5.5 0.0 0.9 7.8 1.0 2.4 8.4 1.5 4.0 1.8 0.0 0.7 0.0 2.2 11.3 0.0 0.0 0.4 0.1 0.0 0.0 4.9 0.0 1.2 2.2 0.0 1.8 0.1 0.0 0.6 8.1 0.1 0.0 9.6 1.6 3.3 0.0 220.5 0.4 9.5 23.3 1.4 0.0 1.0 0.9 4.7 0.4 1.0 0.7 9.3 1.8 0.1 7.5 0.0 0.0 0.1 1.2 0.9 0.4 1.3 0.6 2.5 1.1 0.0 1.8 0.1 1.9 3.6 0.0 0.6 1.9 0.9 0.1 1.4 5.6 0.4 0.0 0.0 4.3 0.3 0.3 0.5 0.5 0.0 0.3 1.0 2.7 6.6 0.1 2.0 3.8 2.7 1.7 0.0 1.9 4.1 0.0 1.0 0.0 2.8 3.4 3.1 4.4 1.5 0.6 0.3 2.2 3.4 0.0 0.6 0.0 0.8 3.2 18.1 4.5 0.0 0.5 1.5 4.0 3.5 0.4 0.7 0.5 0.0 0.2 1.0 0.3 0.7 0.9 0.6 0.1 0.2 4.7 1.0 0.2 0.4 0.7 9.3 0.0 0.0 6.7 2.8 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 8.5 0.0 0.2 21.0 0.5 1.0 0.0 0.0 6.1 0.0 0.0 0.6 2.2 0.0 0.0 0.5 0.0 0.0 2.7 0.0 0.0 8.6 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.3 3.8 4.9 3.7 3.6 HIST1H2BI "H2B/k, H2BFK" ENSG00000278588 "Histone cluster 1 H2B family member i" P62807 6 26272976-26273356 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 150.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 5.4;MOLT-4: 15.1;THP-1: 6.3" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.59e-1)" "unprognostic (7.10e-2)" "unprognostic (8.53e-2)" "unprognostic (1.52e-1)" "unprognostic (2.80e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (7.22e-3)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.5 0.1 0.0 19.0 0.0 8.9 1.2 0.4 0.1 1.3 3.1 0.0 0.5 0.1 0.7 2.1 6.6 0.4 2.0 1.3 0.0 0.3 0.1 2.0 6.3 0.0 0.0 0.7 0.1 0.1 0.0 2.8 0.0 0.1 0.3 0.0 1.3 0.3 0.1 1.2 1.9 0.1 0.1 11.1 0.4 1.9 0.0 150.8 0.4 8.2 14.5 2.2 0.0 4.7 0.7 0.9 1.3 0.4 4.6 0.2 1.9 0.8 1.2 0.0 0.0 0.0 0.2 0.7 0.7 2.0 5.4 0.8 0.0 0.9 0.5 0.5 0.7 0.9 1.8 0.5 0.8 2.7 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 1.8 2.2 0.0 3.9 0.0 0.8 15.1 2.5 2.9 0.6 0.0 4.1 0.0 5.0 0.0 0.4 0.3 0.9 1.1 1.0 0.0 0.1 0.0 6.3 0.9 0.9 0.0 0.6 3.1 3.2 0.4 0.0 1.1 0.5 2.2 0.2 0.5 0.0 3.4 1.3 2.2 2.2 3.2 4.6 0.7 4.7 1.4 0.8 0.9 0.4 0.1 0.3 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 HIST1H2BJ "H2B/r, H2BFR" ENSG00000124635 "Histone cluster 1 H2B family member j" P06899 6 27125897-27132750 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 124.3" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 63.4;Erythroid cells: 23.3;Glandular cells: 25.8;Spermatocytes: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 13.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.6" "Cell line enhanced" "Detected in many" "K-562: 42.1;Karpas-707: 24.8;SiHa: 37.9;U-2 OS: 42.0;U-266/70: 35.8;U-266/84: 44.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (4.02e-2)" "prognostic favorable (1.51e-4)" "unprognostic (8.58e-2)" "unprognostic (2.34e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.98e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" "unprognostic (1.90e-3)" "unprognostic (2.23e-1)" "unprognostic (3.57e-4)" "unprognostic (8.67e-2)" "unprognostic (5.80e-2)" "unprognostic (1.57e-2)" "unprognostic (6.16e-2)" 4.1 2.2 1.5 30.0 2.4 10.7 11.3 0.9 1.9 12.8 6.2 1.6 3.9 2.1 3.1 5.9 12.8 5.1 2.8 6.0 2.5 1.7 1.9 3.9 7.3 12.0 3.2 0.9 1.3 5.1 0.6 1.2 5.1 2.9 8.0 3.0 0.5 4.0 4.8 5.9 2.9 2.8 2.8 5.9 12.0 5.1 30.5 2.2 124.3 2.7 10.1 22.3 5.2 9.4 2.2 1.0 13.6 0.6 0.7 2.4 14.7 3.8 4.8 1.4 1.3 7.2 0.5 1.9 2.1 1.3 8.5 3.6 4.1 2.2 0.6 6.9 2.3 3.9 2.8 2.1 1.9 4.7 4.5 3.6 1.1 5.5 0.2 0.6 0.5 3.0 3.4 0.2 1.8 0.8 1.2 0.5 1.7 42.1 24.8 2.2 2.0 1.7 2.5 1.7 3.9 4.5 0.9 1.2 3.8 1.0 1.4 9.4 1.1 37.9 2.5 1.1 2.1 0.1 1.5 1.1 2.1 42.0 1.6 0.9 35.8 44.0 10.1 0.5 11.8 1.0 1.8 0.6 0.7 0.5 0.5 0.8 1.6 0.7 0.3 0.4 2.2 0.4 0.5 13.6 0.7 0.2 1.0 2.4 14.7 1.5 2.4 0.9 1.9 2.5 1.7 3.2 0.9 2.9 2.2 0.0 0.0 0.0 10.4 5.5 0.0 2.0 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.4 63.4 0.6 4.0 23.3 0.3 3.2 2.4 25.8 0.0 1.5 3.3 0.0 12.6 4.9 2.6 19.3 1.1 2.4 6.8 4.6 2.6 0.0 2.4 7.0 1.4 0.0 0.0 0.0 3.1 30.9 9.1 4.6 5.1 4.5 2.3 9.5 HIST1H2BK "H2BFAiii, H2BFT" ENSG00000197903 "Histone cluster 1 H2B family member k" O60814 6 27146418-27146798 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 243.8" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 23.8;Basal keratinocytes: 28.0;Melanocytes: 38.8;Suprabasal keratinocytes: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 117.4;U-2 OS: 107.1;U-266/84: 140.9" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.78e-2)" "unprognostic (4.70e-3)" "unprognostic (9.00e-3)" "unprognostic (1.30e-1)" "unprognostic (3.81e-1)" "unprognostic (4.50e-2)" "unprognostic (6.50e-2)" "unprognostic (4.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-3)" "unprognostic (3.46e-3)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (3.93e-2)" "unprognostic (1.49e-1)" "unprognostic (7.59e-2)" "unprognostic (2.37e-2)" 9.4 6.0 3.0 39.8 4.1 7.8 8.6 2.4 3.6 14.9 11.0 2.5 10.5 8.4 8.0 14.6 19.1 13.5 10.5 9.8 4.3 3.7 4.0 19.3 12.7 25.9 3.6 2.3 8.5 17.4 0.6 5.9 18.7 2.0 16.0 5.3 3.5 11.3 10.7 3.7 6.3 10.3 6.9 7.6 28.0 13.7 30.6 1.9 243.8 8.9 32.3 26.4 11.5 16.7 26.5 22.1 60.7 16.2 5.0 11.5 12.5 6.2 16.3 2.6 4.5 11.7 4.4 9.0 10.4 7.5 15.0 9.7 14.7 8.3 2.0 35.1 5.9 10.5 8.2 3.1 3.2 2.2 9.3 15.7 3.5 10.2 0.5 5.1 2.7 21.3 21.0 2.8 2.5 2.8 4.2 3.0 1.3 117.4 23.8 6.7 17.1 5.0 5.0 2.3 22.7 7.0 3.2 1.7 26.5 5.6 2.8 13.2 7.6 61.8 21.2 5.6 2.4 54.8 3.2 3.4 6.7 107.1 6.2 1.8 32.7 140.9 18.6 3.9 28.0 3.8 33.8 9.4 60.7 4.1 8.3 3.9 20.3 4.2 4.1 9.6 26.5 5.0 3.9 60.1 5.0 16.2 22.1 11.5 12.5 3.0 4.1 2.4 3.6 4.3 3.7 3.6 2.3 2.0 1.9 23.8 9.4 4.3 0.6 28.0 0.0 0.4 0.0 13.4 6.8 0.0 0.0 1.2 0.0 1.3 0.1 2.1 2.6 0.0 1.0 2.6 1.9 0.5 4.7 1.7 0.9 0.0 0.0 2.5 2.2 0.0 0.0 4.9 38.8 4.6 1.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 1.5 0.4 3.0 29.2 3.2 9.6 1.2 0.5 HIST1H2BL "dJ97D16.4, H2B/c, H2BFC" ENSG00000185130 "Histone cluster 1 H2B family member l" Q99880 6 27807444-27807931 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "lymphoid tissue: 217.6" "Cell type enhanced" "Detected in single" 13 "Club cells: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 13.2;U-266/84: 13.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (5.32e-3)" "unprognostic (2.46e-2)" "unprognostic (2.22e-1)" "unprognostic (1.02e-3)" "unprognostic (2.32e-3)" "unprognostic (2.66e-1)" "unprognostic (9.22e-2)" "unprognostic (1.87e-2)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (3.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" 1.2 1.0 0.2 13.9 1.0 13.7 1.6 1.4 0.6 1.8 5.1 0.0 0.3 0.6 0.8 0.6 7.4 0.9 0.9 1.3 0.9 0.7 0.3 0.6 1.5 3.5 0.5 0.0 1.3 1.2 1.2 0.2 1.9 0.0 1.2 1.1 0.0 0.7 0.2 0.2 0.9 3.9 0.7 2.8 4.8 0.8 1.5 0.0 217.6 1.2 5.9 15.6 1.1 1.2 1.9 1.2 7.7 0.6 0.4 2.0 0.9 2.4 2.2 0.7 2.3 0.0 0.0 0.1 1.4 0.4 1.3 3.3 1.0 1.7 0.9 0.5 0.3 0.7 1.6 0.0 0.2 0.4 1.1 3.2 1.7 3.1 3.8 0.0 2.8 2.4 1.0 0.0 0.0 0.0 0.2 0.7 2.1 2.2 5.8 0.0 6.1 13.2 4.9 2.2 1.6 3.4 3.1 0.0 1.4 0.0 2.2 3.1 1.1 4.0 1.6 0.2 0.2 1.4 1.0 0.5 0.1 1.7 1.3 1.0 3.3 13.0 4.3 0.4 5.1 0.5 0.6 0.5 4.0 1.1 0.2 1.3 1.9 0.6 1.1 1.2 1.3 0.4 0.6 7.7 0.4 0.6 0.7 2.0 0.9 0.2 1.0 1.4 0.5 0.9 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.2 HIST1H2BM "dJ160A22.3, H2B/e, H2BFE" ENSG00000273703 "Histone cluster 1 H2B family member m" Q99879 6 27815044-27815424 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "lymphoid tissue: 232.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7" "Cell line enhanced" "Detected in many" "Karpas-707: 17.7;NB-4: 11.4;REH: 7.3;U-266/70: 13.7;U-698: 7.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (3.83e-1)" "unprognostic (8.85e-4)" "unprognostic (3.74e-1)" "unprognostic (2.00e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.37e-1)" "unprognostic (9.46e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-1)" "unprognostic (2.65e-1)" 0.1 0.1 0.0 19.9 0.0 11.6 0.1 0.0 0.2 1.6 3.4 0.0 0.0 0.1 0.7 0.9 8.4 0.1 1.4 0.3 0.0 0.1 0.3 1.8 7.3 0.0 0.0 0.3 0.1 0.1 0.0 1.5 0.0 0.5 1.1 0.0 0.3 0.1 0.1 0.8 3.8 0.1 0.5 13.9 0.5 3.5 0.0 232.2 0.1 9.4 27.6 0.1 0.0 2.6 0.4 0.3 0.3 1.5 1.7 0.0 1.5 0.0 0.3 0.0 0.0 0.0 1.2 0.4 0.2 0.5 2.1 0.4 0.3 2.3 0.0 0.0 0.5 1.1 0.0 0.0 0.0 1.2 0.0 0.8 0.2 0.8 0.0 0.0 2.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.2 17.7 0.0 0.5 4.6 11.4 3.4 1.1 0.8 7.3 0.0 0.4 0.0 0.0 0.2 2.0 0.8 1.1 0.0 0.1 1.0 3.4 0.0 0.0 2.0 1.2 0.1 13.7 0.5 7.0 1.1 1.3 0.9 0.0 0.1 0.1 1.5 0.3 1.7 1.9 1.7 1.5 0.4 2.6 0.1 1.2 0.3 1.5 0.0 0.2 0.6 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 HIST1H2BN "H2B/d, H2BFD" ENSG00000233822 "Histone cluster 1 H2B family member n" Q99877 6 27837760-27865798 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 13 "lymphoid tissue: 193.3" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 27.8;Rod photoreceptor cells: 26.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 14.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 8.9;SCLC-21H: 9.8;U-266/84: 9.2" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.33e-1)" "unprognostic (3.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-1)" "unprognostic (4.41e-2)" "unprognostic (2.95e-3)" "unprognostic (2.05e-3)" "unprognostic (1.14e-4)" "unprognostic (9.62e-2)" "unprognostic (3.91e-1)" "unprognostic (9.62e-2)" "unprognostic (2.22e-2)" 2.4 7.2 2.3 14.0 3.3 9.3 3.1 4.9 6.2 3.4 4.5 1.0 4.4 1.8 3.4 3.7 7.6 3.2 3.7 6.4 3.7 2.4 2.3 5.3 5.4 8.0 4.1 4.2 5.0 8.3 4.2 3.8 4.5 1.4 4.0 2.5 1.7 3.3 4.7 4.6 2.3 4.3 2.5 9.4 7.0 2.4 6.8 0.5 193.3 6.1 6.2 10.9 3.6 2.2 6.0 6.2 14.6 2.6 1.0 2.8 1.4 1.4 0.2 1.5 1.5 1.2 2.0 0.9 0.7 1.1 0.7 0.8 0.5 0.9 0.8 3.0 0.7 0.9 2.1 1.3 0.5 0.3 1.5 4.5 0.7 3.7 1.4 1.4 1.0 3.7 1.3 0.4 0.1 1.3 1.1 0.2 1.4 8.9 7.0 0.8 1.8 2.9 4.5 1.4 1.2 1.0 2.1 1.0 5.3 0.4 0.9 9.8 2.0 3.5 1.3 3.0 1.0 2.5 0.8 1.5 2.2 2.1 1.2 0.7 6.1 9.2 3.6 0.7 1.7 0.7 2.3 2.6 1.7 2.6 2.4 1.8 5.8 2.0 1.9 5.0 6.0 1.3 1.2 14.6 1.0 1.8 6.2 2.8 1.4 2.3 3.3 4.9 6.2 3.7 2.4 4.1 4.2 1.4 0.5 0.0 3.2 20.4 5.8 0.9 7.5 2.3 0.0 5.3 2.3 0.0 2.0 9.8 1.7 0.1 3.8 2.7 27.8 0.0 0.7 3.9 3.3 5.0 3.5 1.7 9.0 6.4 4.1 1.8 4.3 0.9 2.8 4.9 6.8 1.0 10.0 15.8 0.8 7.0 1.8 2.0 26.9 0.0 8.3 0.9 2.1 2.0 4.2 20.0 5.2 1.7 HIST1H2BO "H2B.2, H2B/n, H2BFN" ENSG00000274641 "Histone cluster 1 H2B family member o" P23527 6 27893463-27893843 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 164.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 29.4" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (7.22e-2)" "unprognostic (1.77e-3)" "unprognostic (9.47e-2)" "unprognostic (4.43e-2)" "unprognostic (6.67e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.55e-2)" "unprognostic (7.91e-2)" "unprognostic (7.81e-3)" "unprognostic (2.88e-3)" "unprognostic (4.04e-7)" "unprognostic (4.39e-2)" "unprognostic (3.41e-1)" "unprognostic (4.39e-2)" "prognostic favorable (4.89e-4)" 1.9 0.4 0.0 14.9 0.0 8.1 1.5 0.0 0.0 0.9 3.9 0.0 0.0 0.9 0.6 1.6 9.9 0.0 0.7 1.5 0.0 0.3 0.5 2.6 7.4 0.0 0.0 0.0 0.0 0.7 0.0 4.4 0.1 0.3 1.5 0.0 1.2 0.0 0.3 1.5 2.1 0.1 0.5 8.1 0.7 1.4 0.0 164.5 0.0 7.1 15.4 1.1 0.0 2.6 2.2 6.5 0.8 1.3 1.7 5.5 2.2 2.9 1.5 4.4 0.7 0.0 2.7 0.8 0.1 5.5 5.4 1.1 1.3 2.6 1.9 0.2 1.2 2.3 2.5 0.5 0.7 1.8 1.9 1.7 4.5 1.7 0.0 0.2 1.1 0.3 0.0 0.4 0.5 0.1 1.4 2.1 6.5 7.3 0.2 0.5 11.2 9.4 1.7 1.7 2.2 6.5 1.5 4.9 0.9 0.3 6.3 1.3 4.7 1.2 0.7 0.5 2.0 0.2 0.0 1.5 0.3 1.7 2.0 8.1 29.4 7.5 0.9 9.5 0.7 1.3 0.3 3.8 0.8 0.6 1.1 1.4 0.8 1.7 2.2 2.6 0.5 0.5 6.5 1.3 0.8 1.7 1.4 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 HIST2H2BE "H2B, H2B.1, H2B/q, H2BFQ" ENSG00000184678 "Histone cluster 2 H2B family member e" Q16778 1 149884459-149886652 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.1" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 128.7;Syncytiotrophoblasts: 134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 29.9" "Cell line enhanced" "Detected in many" "Karpas-707: 24.3;U-266/70: 40.5;U-266/84: 21.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.63e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (8.28e-2)" "unprognostic (4.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (4.74e-2)" "unprognostic (4.41e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-1)" "unprognostic (2.86e-3)" 14.3 16.2 9.8 22.2 10.0 19.4 16.9 17.2 14.0 31.3 9.0 11.2 10.5 6.4 18.5 24.9 25.5 13.3 9.6 51.1 13.1 10.1 12.5 10.2 27.5 24.5 12.4 8.7 28.0 13.4 5.8 15.4 17.2 8.5 72.8 7.6 19.4 24.1 15.3 43.1 33.5 8.6 18.8 18.2 22.0 17.5 9.3 11.6 198.1 12.1 12.4 25.3 27.2 33.8 2.3 4.5 29.9 5.5 0.7 1.2 5.1 1.1 1.1 1.9 0.4 10.3 2.8 0.9 4.1 2.7 1.7 0.5 0.4 1.8 0.2 1.1 3.6 2.4 4.5 1.5 0.7 0.9 1.4 1.2 0.3 4.6 0.8 3.2 0.3 5.4 9.4 3.4 0.7 2.8 2.1 0.5 1.7 4.9 24.3 2.1 6.9 1.2 2.1 1.2 9.4 2.5 1.5 0.7 5.5 1.6 0.9 13.1 2.1 14.1 1.9 1.0 4.8 10.0 0.9 0.7 1.3 14.7 0.9 0.3 40.5 21.7 1.1 1.7 1.5 0.8 8.4 2.1 3.8 0.7 3.2 1.2 0.8 0.9 1.1 1.6 2.3 1.2 1.1 29.9 0.7 5.5 4.5 1.0 5.1 9.8 10.0 17.2 8.5 13.1 10.1 12.4 8.7 8.5 11.6 8.9 11.7 10.4 57.7 5.4 47.2 56.8 2.5 12.0 5.7 34.9 21.6 22.3 23.2 13.5 1.1 4.5 15.3 23.3 5.9 10.4 14.1 128.7 10.5 5.9 22.3 20.6 53.7 8.6 11.0 0.0 4.6 16.7 18.6 4.6 18.8 12.9 8.3 21.0 0.4 8.8 32.5 0.0 9.8 0.5 6.1 11.8 134.0 22.4 9.0 59.1 HIST2H2BF ENSG00000203814 "Histone cluster 2 H2B family member f" Q5QNW6 1 149782689-149812373 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 117.6" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "neutrophil: 21.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 21.7" "Cell line enhanced" "Detected in many" "U-266/70: 32.1" "Not detected" "Not detected" "CAB007814, HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (9.02e-3)" "unprognostic (7.78e-2)" "unprognostic (5.30e-4)" "unprognostic (3.00e-1)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.08e-2)" "unprognostic (8.33e-2)" "unprognostic (3.46e-2)" "unprognostic (5.36e-2)" "unprognostic (3.87e-5)" "unprognostic (3.72e-2)" "unprognostic (3.54e-7)" "unprognostic (1.84e-1)" "unprognostic (2.59e-2)" "unprognostic (9.42e-3)" "unprognostic (7.62e-2)" 5.6 17.7 3.9 14.9 3.5 3.7 7.1 8.5 5.6 17.4 3.8 3.7 3.2 1.5 5.6 6.2 7.1 7.9 3.6 12.1 3.4 2.4 5.0 4.2 14.6 27.5 3.2 3.8 24.2 6.2 2.6 4.4 5.1 3.2 16.7 2.5 3.5 3.7 5.5 1.2 10.9 3.4 6.0 7.7 12.7 7.9 5.9 3.1 117.6 4.4 6.3 16.7 6.1 21.5 2.0 0.8 21.7 1.1 0.6 0.8 0.2 0.4 0.6 0.6 0.6 4.6 3.1 0.3 7.9 4.1 6.0 5.3 0.3 2.2 0.4 0.6 4.5 5.2 1.3 0.1 0.5 4.7 1.2 0.9 0.4 1.5 0.0 6.7 0.2 1.8 5.5 0.0 7.8 1.9 1.7 3.4 0.3 1.2 2.4 0.8 0.9 3.1 3.8 0.4 4.1 1.0 0.3 1.1 0.7 2.9 0.4 2.7 7.3 4.2 3.5 0.3 0.7 1.3 9.8 1.4 1.5 0.0 11.5 2.0 32.1 1.0 1.3 5.3 0.3 3.4 0.0 1.0 0.2 0.6 0.8 0.7 0.6 0.8 0.3 0.8 2.0 0.4 0.3 21.7 0.6 1.1 0.8 0.2 0.2 3.9 3.5 8.5 5.6 3.4 2.4 3.2 3.8 3.2 3.1 0.0 0.3 2.2 6.9 0.3 6.0 1.7 0.0 4.0 1.2 1.8 2.0 1.5 3.3 1.0 0.9 0.4 5.1 0.0 0.3 1.2 0.9 16.2 0.0 0.6 6.7 4.8 3.4 2.5 4.9 1.4 2.6 2.9 0.0 1.8 2.7 6.6 0.7 2.9 0.0 0.5 0.9 6.5 1.5 0.2 0.4 0.5 4.3 4.9 1.8 5.7 HIST3H2BB ENSG00000196890 "Histone cluster 3 H2B family member b" Q8N257 1 228458107-228460470 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 56.0" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 6.0;Cone photoreceptor cells: 5.9;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 12.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "U-266/70: 18.5" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (5.53e-3)" "unprognostic (2.41e-1)" "unprognostic (3.39e-3)" "unprognostic (5.25e-2)" "unprognostic (8.20e-3)" "unprognostic (8.78e-3)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.34e-2)" "unprognostic (9.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" 2.0 4.7 1.2 12.1 3.1 2.8 1.3 12.8 3.2 8.9 1.3 1.1 0.6 2.1 1.4 2.0 4.1 6.2 1.7 2.2 1.5 2.2 1.3 0.9 2.1 5.4 1.2 1.5 1.6 1.7 1.7 2.0 1.5 4.1 2.2 1.5 3.4 2.0 2.0 1.8 4.8 1.7 1.2 6.2 4.5 2.4 2.1 0.7 56.0 1.7 5.9 11.8 2.0 7.9 1.5 1.1 3.4 1.5 1.1 0.9 0.5 0.2 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.5 1.0 0.1 0.1 0.0 0.0 2.6 0.1 0.1 0.1 0.6 0.6 0.0 0.8 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.2 0.1 0.0 0.4 0.2 0.1 0.0 0.3 0.4 0.1 0.4 0.3 0.2 0.0 0.0 0.8 0.0 0.2 1.5 0.5 1.0 0.4 0.3 0.1 3.7 0.1 0.1 0.0 0.0 0.5 0.1 18.5 4.4 0.0 0.2 0.1 0.1 1.7 1.0 0.5 0.5 0.5 0.7 1.3 0.8 0.9 0.2 1.5 0.9 0.7 3.4 1.1 1.5 1.1 0.7 0.5 1.2 3.1 12.8 3.1 1.5 2.2 1.2 1.5 4.1 0.7 6.0 0.0 0.0 1.2 0.1 3.8 0.8 0.0 4.0 0.0 0.0 5.9 0.2 1.7 0.0 0.0 0.0 0.2 23.3 0.0 0.1 0.0 0.5 0.0 0.0 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.7 2.9 0.0 0.3 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.3 0.8 2.5 0.4 0.5 HIVEP1 "CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A" ENSG00000095951 "Human immunodeficiency virus type I enhancer binding protein 1" P15822 6 12008762-12164999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050724, HPA067457" Approved Supported "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Mitochondria, Cytosol" "HPA050724: AB_2616457, HPA067457: " "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.75e-2)" "unprognostic (5.65e-3)" "unprognostic (4.83e-2)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (1.85e-1)" "unprognostic (5.69e-2)" "unprognostic (1.98e-1)" "unprognostic (4.40e-2)" "unprognostic (3.01e-2)" "unprognostic (2.21e-1)" "unprognostic (4.49e-2)" "unprognostic (2.38e-1)" 22.3 5.5 6.4 20.1 5.6 20.5 13.1 8.0 10.0 11.5 12.6 5.4 13.9 7.0 10.0 10.6 12.9 9.2 10.6 8.8 5.6 7.1 7.3 17.1 13.3 12.4 5.3 6.7 11.6 11.7 23.3 12.2 8.7 7.8 10.5 9.5 7.7 10.9 17.6 8.2 14.1 11.8 12.9 5.9 15.2 7.2 7.3 5.0 23.8 7.7 14.2 16.2 17.3 23.1 5.6 9.6 12.9 4.9 3.6 4.6 0.7 5.2 3.9 5.1 2.8 4.0 5.2 4.9 4.3 3.7 3.6 3.9 2.5 2.8 4.4 9.4 5.2 8.5 5.1 5.0 6.1 4.9 9.5 2.9 2.0 3.7 2.4 3.3 2.3 1.7 3.6 6.2 7.2 11.2 7.5 10.4 3.0 21.1 5.1 7.7 3.9 3.8 2.1 4.3 1.8 2.0 2.1 6.6 6.9 2.1 5.8 4.8 3.5 10.6 8.7 3.0 11.9 5.1 3.1 16.8 9.0 4.0 8.3 4.9 20.5 17.1 7.9 2.7 3.1 3.7 2.4 2.2 2.2 1.4 2.2 1.0 3.4 2.3 0.9 1.3 5.6 4.0 2.3 12.9 3.6 4.9 9.6 4.6 0.7 6.4 5.6 8.0 10.0 5.6 7.1 5.3 6.7 7.8 5.0 26.8 19.2 6.5 21.7 28.6 19.2 7.4 10.2 22.7 26.1 7.0 11.8 2.9 3.3 4.8 2.1 15.5 11.3 0.0 6.3 1.8 12.7 18.9 7.0 11.4 4.9 20.6 10.4 7.4 8.5 1.5 3.4 19.0 18.6 45.9 12.5 13.2 8.5 9.7 4.2 2.7 9.1 0.0 13.4 3.6 3.1 29.2 4.3 7.5 7.1 23.3 HK2 ENSG00000159399 "Hexokinase 2" P52789 2 74833981-74893359 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 87.9;Enterocytes: 116.3;Paneth cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 26.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 54.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028587, HPA061711" Enhanced Supported Vesicles,Centrosome,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "Vesicles, Centrosome" "HPA028587: AB_10602605, HPA061711: " "unprognostic (1.28e-1)" "unprognostic (1.52e-3)" "unprognostic (3.02e-1)" "unprognostic (3.63e-2)" "unprognostic (1.69e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (2.85e-2)" "unprognostic (2.57e-1)" "unprognostic (2.17e-1)" "unprognostic (4.43e-3)" "unprognostic (2.24e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.20e-1)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (7.67e-2)" 27.0 2.2 4.4 9.5 5.0 20.4 10.8 0.7 4.5 5.3 23.2 7.3 5.7 1.3 2.6 40.1 13.6 4.8 9.1 8.3 2.8 2.3 2.1 1.4 16.5 5.0 8.5 1.1 14.9 3.5 1.1 1.7 13.2 5.4 4.0 19.2 9.6 10.3 0.5 29.3 9.7 8.9 1.7 10.9 7.4 8.7 24.8 7.4 4.3 7.1 22.3 9.2 29.0 8.3 0.8 6.2 26.2 7.1 0.0 0.8 2.0 16.5 0.1 3.8 14.0 32.9 3.4 14.3 6.4 9.4 7.3 10.5 13.2 3.0 12.0 6.2 3.0 9.4 5.7 17.5 13.6 21.2 3.4 3.7 16.3 3.8 18.2 10.4 23.8 26.9 5.8 14.8 13.8 24.3 8.2 3.4 6.9 14.2 0.0 2.1 11.8 5.7 24.4 13.9 15.7 11.5 9.3 8.1 9.3 4.4 23.4 2.8 13.7 4.1 20.9 8.2 5.8 1.1 3.8 2.8 23.3 4.1 9.6 11.7 8.3 2.3 6.0 54.3 17.5 6.0 6.6 7.1 26.2 0.1 5.7 0.3 0.6 0.4 0.1 6.2 0.8 0.7 0.7 5.9 0.0 3.7 0.1 0.8 2.0 4.4 5.0 0.7 4.5 2.8 2.3 8.5 1.1 5.4 7.4 14.9 37.6 2.9 5.5 45.8 6.2 6.0 7.6 0.0 6.8 5.2 78.5 0.7 0.0 4.4 87.9 3.6 116.3 0.0 3.8 12.3 8.5 17.2 21.9 0.0 15.7 20.6 37.5 1.3 14.6 32.5 13.6 18.9 21.9 1.0 32.2 4.3 18.4 86.0 7.4 0.0 43.3 12.9 2.3 3.1 4.5 49.8 6.9 2.2 19.9 69.9 HLCS HCS ENSG00000159267 "Holocarboxylase synthetase" P50747 21 36750888-36990236 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ligase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017379 Approved Approved Cytosol NA NA Cytosol "HPA017379: AB_1850768" "prognostic unfavorable (7.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.93e-2)" "unprognostic (2.05e-1)" "unprognostic (2.75e-1)" "unprognostic (1.44e-2)" "unprognostic (5.08e-2)" "unprognostic (2.67e-1)" "unprognostic (1.54e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.44e-2)" "unprognostic (2.43e-1)" "unprognostic (2.55e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-3)" "unprognostic (3.02e-1)" 6.3 9.6 7.1 9.8 10.3 2.9 10.6 12.2 8.5 7.7 7.2 10.3 12.1 5.7 6.4 9.4 7.1 8.1 9.9 5.3 8.4 8.0 9.1 16.4 6.7 5.8 10.2 6.0 5.5 15.6 23.3 23.9 9.9 9.4 12.8 6.4 11.7 9.9 11.6 13.5 4.3 8.1 7.3 10.6 4.5 7.6 7.7 5.1 4.9 14.3 6.1 8.0 9.2 4.9 3.9 5.3 3.2 10.0 8.5 7.8 2.9 18.0 6.7 10.1 7.3 12.1 11.0 9.9 11.0 10.6 5.0 5.6 7.2 8.5 9.8 5.3 15.9 10.4 6.2 5.1 8.4 4.5 19.5 10.5 14.5 6.6 4.6 14.4 7.8 7.5 8.7 13.0 7.6 20.3 9.6 6.3 9.6 15.6 25.1 12.7 10.9 3.5 3.6 15.8 12.4 9.4 6.1 5.8 7.9 7.8 18.2 7.1 7.4 14.5 6.7 11.1 8.3 11.8 8.0 8.5 7.3 2.2 6.6 6.0 24.3 14.9 6.1 10.5 9.8 8.4 3.2 2.1 1.6 7.8 4.0 6.1 2.6 4.5 5.2 2.0 3.9 5.4 5.5 2.7 8.5 10.0 5.3 2.7 2.9 7.1 10.3 12.2 8.5 8.4 8.0 10.2 6.0 9.4 5.1 8.9 12.2 0.5 8.0 3.0 12.5 3.2 15.3 6.7 9.1 12.2 21.6 6.8 6.6 6.7 4.4 2.2 4.0 0.0 6.9 4.9 3.0 9.1 5.7 14.9 3.9 17.5 5.8 4.3 3.1 2.9 4.0 3.4 0.0 3.6 6.5 6.3 7.2 2.9 6.7 5.6 13.6 0.0 6.4 4.4 8.7 3.4 4.2 2.5 5.2 5.4 HLX "HB24, HLX1" ENSG00000136630 "H2.0 like homeobox" Q14774 1 220879400-220885059 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 54.0" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 23.3;Hofbauer cells: 27.0;Ito cells: 38.6;monocytes: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 25.8;neutrophil: 28.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 28.5" "Cell line enhanced" "Detected in many" "SK-MEL-30: 13.5;THP-1: 47.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA005968 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA005968: AB_1079066" "unprognostic (6.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.88e-3)" "unprognostic (2.57e-2)" "unprognostic (9.19e-3)" "unprognostic (1.76e-1)" "unprognostic (1.40e-1)" "unprognostic (5.14e-3)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" "unprognostic (3.19e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.28e-6)" "unprognostic (8.44e-3)" "unprognostic (3.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" 27.7 3.0 2.7 8.8 3.0 54.0 18.4 0.9 2.3 5.7 24.3 2.0 3.8 4.5 7.4 3.6 8.7 5.0 7.5 15.2 3.3 0.9 4.0 11.5 14.3 10.5 6.2 0.3 4.9 4.9 1.8 2.0 14.0 2.5 6.9 2.4 4.2 2.3 3.8 10.4 5.7 11.1 4.2 6.4 10.9 3.1 3.9 3.1 1.4 6.3 3.0 3.2 10.4 12.9 2.2 5.5 28.5 6.3 0.2 0.1 1.8 0.0 1.9 0.0 1.4 4.3 6.9 3.6 5.2 8.6 6.0 5.0 0.4 0.1 0.0 0.1 3.2 1.1 0.0 1.1 0.0 2.5 1.3 3.8 0.0 2.2 0.2 7.6 1.7 0.4 8.0 0.2 6.7 0.4 0.5 2.6 0.0 2.2 0.0 0.8 0.0 0.0 6.2 0.2 0.0 3.6 0.1 4.1 0.0 0.6 0.0 0.0 2.0 0.7 0.1 13.5 0.3 0.0 47.4 0.8 4.0 0.0 0.6 4.1 0.0 0.0 0.0 6.5 5.4 1.6 25.8 6.3 10.7 0.0 1.8 0.0 2.2 0.0 0.0 5.5 1.1 0.0 0.0 28.5 0.2 0.3 3.5 0.1 1.8 2.7 3.0 0.9 2.3 3.3 0.9 6.2 0.3 2.5 3.1 8.9 7.7 1.5 0.1 2.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 11.7 0.0 23.3 0.3 0.6 4.6 0.1 3.5 6.7 27.0 0.0 0.0 38.6 17.7 0.0 2.3 17.3 0.0 67.7 0.0 0.0 0.2 0.0 1.4 0.0 0.0 6.5 9.5 0.1 1.0 2.8 0.3 0.0 0.0 0.1 HMBOX1 "FLJ21616, HNF1LA, HOT1, PBHNF" ENSG00000147421 "Homeobox containing 1" Q6NT76 8 28890394-29064764 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055855, HPA058586, CAB070418" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764" "unprognostic (2.68e-3)" "unprognostic (2.30e-3)" "unprognostic (4.52e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.03e-3)" "unprognostic (1.20e-1)" "unprognostic (2.75e-3)" "unprognostic (1.49e-1)" "unprognostic (4.25e-2)" "unprognostic (1.89e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (3.84e-2)" "unprognostic (2.81e-1)" "unprognostic (1.02e-1)" "unprognostic (1.47e-1)" 10.8 23.1 16.4 10.5 15.5 21.2 10.4 18.6 15.8 9.2 8.4 13.9 8.5 6.7 14.9 8.6 9.6 8.7 9.4 12.7 14.6 8.2 10.1 10.0 15.9 11.0 16.6 10.1 13.9 10.9 13.5 13.6 14.6 15.9 7.6 8.8 9.9 11.7 12.5 9.7 12.1 10.2 11.6 20.0 11.8 9.3 16.8 18.2 13.0 13.7 5.6 12.6 10.4 14.3 6.6 4.8 5.0 9.0 2.2 5.5 2.6 5.1 5.6 6.2 7.1 5.8 6.1 5.2 2.2 2.9 3.5 4.0 2.5 3.3 12.6 5.5 3.8 5.1 4.4 12.1 4.5 4.9 4.6 2.1 13.1 10.5 3.4 4.6 4.4 8.8 2.9 6.5 4.6 8.7 4.3 7.8 7.6 18.5 12.5 4.9 2.9 8.0 2.2 4.3 5.5 1.4 6.6 6.1 2.9 2.5 9.5 2.7 8.0 4.3 3.3 4.7 5.3 3.3 4.0 11.1 3.2 14.9 3.3 3.1 3.8 3.9 4.9 4.3 5.4 4.6 5.0 4.8 2.0 4.0 4.9 5.5 6.6 3.9 3.5 4.8 5.7 5.0 4.8 2.7 2.2 9.0 3.8 1.7 2.6 16.4 15.5 18.6 15.8 14.6 8.2 16.6 10.1 15.9 18.2 14.9 18.6 25.2 14.5 14.8 25.2 15.7 17.8 10.7 7.9 27.9 37.3 10.8 13.3 6.7 69.0 38.3 15.5 0.0 12.5 9.2 16.2 17.3 16.2 11.9 9.1 28.6 16.7 55.9 16.7 24.1 33.1 25.5 15.1 5.4 12.9 28.7 10.4 14.0 29.7 6.9 30.0 19.4 16.5 36.7 13.2 17.2 16.0 21.8 12.1 16.0 HMCN1 "ARMD1, FBLN6, FIBL-6, FIBL6" ENSG00000143341 "Hemicentin 1" Q96RW7 1 185734551-186190949 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell cycle, Cell division, Sensory transduction, Vision" "Age-related macular degeneration, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Endothelial cells: 8.2;Fibroblasts: 12.4;Horizontal cells: 25.4" "Cancer enriched" "Detected in many" 6 "melanoma: 14.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "T-reg: 3.0" "Lineage enriched" "Detected in single" 9 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.5;hTERT-RPE1: 9.8;MCF7: 35.5;SK-MEL-30: 23.4;WM-115: 21.0" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "olfactory region: 22.1" "HPA008220, HPA051677" Uncertain Approved "Golgi apparatus,Cytosol" "Secreted to extracellular matrix" NA NA 2000000 "Golgi apparatus, Cytosol" "HPA008220: , HPA051677: AB_2681572" "unprognostic (1.90e-1)" "unprognostic (2.66e-1)" "unprognostic (8.00e-2)" "unprognostic (1.10e-1)" "unprognostic (7.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (4.36e-2)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.59e-7)" "unprognostic (1.22e-2)" "unprognostic (5.17e-3)" "unprognostic (3.52e-1)" "unprognostic (2.00e-3)" 14.9 1.3 1.0 4.8 2.5 0.0 10.9 0.4 1.7 9.8 8.4 0.8 0.5 0.8 5.9 3.0 12.0 1.9 6.8 13.4 0.9 0.9 2.2 7.9 23.9 2.6 1.3 0.2 4.4 1.1 0.1 6.2 7.7 2.0 8.4 2.9 8.1 7.8 1.3 4.4 4.0 3.7 4.5 1.8 13.1 1.9 2.4 0.4 0.5 3.3 15.8 6.1 3.0 4.3 0.0 0.0 0.3 0.0 0.0 3.0 0.0 0.1 0.0 0.7 0.0 2.3 2.3 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.9 0.1 10.5 0.8 2.4 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.3 0.0 2.7 0.2 9.8 1.3 0.0 0.0 0.0 0.0 35.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 23.4 2.2 0.0 0.0 0.0 6.7 0.6 0.0 2.4 0.1 0.0 0.1 1.3 0.0 21.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.0 2.5 0.4 1.7 0.9 0.9 1.3 0.2 2.0 0.4 3.0 6.5 0.0 0.2 2.9 0.7 2.3 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 6.5 8.2 0.0 0.0 0.0 0.6 12.4 0.1 0.0 1.5 0.1 25.4 0.0 5.5 0.8 1.5 3.4 0.0 5.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 HMGCS1 HMGCS ENSG00000112972 "3-hydroxy-3-methylglutaryl-CoA synthase 1" Q01581 5 43289395-43313512 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 117.0" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 206.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 120.5;GAMG: 80.3;HBEC3-KT: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032907, HPA036913, HPA036914" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 310000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751" "unprognostic (1.31e-1)" "unprognostic (5.12e-3)" "unprognostic (6.82e-3)" "unprognostic (4.59e-2)" "unprognostic (8.39e-2)" "unprognostic (2.49e-2)" "unprognostic (1.03e-1)" "unprognostic (3.14e-2)" "unprognostic (1.27e-2)" "unprognostic (3.13e-1)" "unprognostic (6.40e-3)" "unprognostic (9.15e-2)" "prognostic favorable (3.87e-6)" "unprognostic (1.09e-1)" "unprognostic (9.22e-2)" "unprognostic (3.03e-2)" "unprognostic (2.37e-2)" 6.0 16.5 13.3 8.1 24.4 4.3 12.8 8.4 38.2 16.9 15.5 16.9 9.5 27.8 6.8 11.5 53.0 4.1 7.5 5.1 19.4 18.8 10.5 117.0 26.9 6.2 10.4 20.7 15.4 8.4 10.8 5.0 6.9 59.3 12.9 14.2 13.0 18.5 7.7 5.0 25.2 17.1 6.3 25.8 4.4 13.4 9.8 8.1 3.3 7.5 58.1 23.3 6.1 21.4 9.3 7.8 6.9 7.7 6.7 7.9 3.3 14.9 7.2 120.5 13.8 7.0 27.9 8.1 2.4 9.5 3.4 6.9 12.5 21.6 15.9 5.4 3.4 80.3 11.8 30.0 69.5 3.6 3.4 36.0 5.9 6.6 16.9 11.1 12.8 4.2 15.3 8.4 18.1 7.2 2.1 3.5 14.8 10.5 43.5 2.8 6.9 11.5 15.6 21.6 6.0 3.8 8.3 16.9 17.6 53.4 23.2 10.3 5.0 12.3 6.2 3.6 18.2 9.6 17.0 4.2 2.6 13.0 2.7 2.2 5.9 8.9 21.7 2.3 15.4 2.3 5.5 4.0 3.7 5.6 7.4 5.6 9.3 6.2 7.9 7.8 7.5 5.3 7.3 6.9 6.7 7.7 6.5 5.7 3.3 13.3 24.4 8.4 32.1 19.4 18.8 10.4 20.7 59.3 8.1 62.5 124.5 45.6 35.9 96.3 27.9 7.4 56.0 48.2 36.4 45.4 49.1 20.4 11.6 30.6 5.0 19.7 86.8 0.0 52.0 35.5 35.0 65.2 59.8 78.4 20.7 46.1 88.4 23.4 20.8 1.8 11.8 17.2 25.3 78.5 44.0 19.7 36.3 30.9 13.4 17.7 43.3 0.0 24.9 14.1 7.8 206.6 37.2 20.1 31.2 65.0 HMGN3 TRIP7 ENSG00000118418 "High mobility group nucleosomal binding domain 3" Q15651 6 79201245-79234738 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018370, HPA027971, HPA063572" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703" "unprognostic (1.02e-1)" "unprognostic (2.04e-2)" "unprognostic (5.92e-2)" "unprognostic (5.26e-2)" "unprognostic (3.48e-1)" "unprognostic (3.88e-2)" "unprognostic (5.24e-2)" "prognostic favorable (2.76e-4)" "unprognostic (8.78e-2)" "unprognostic (5.31e-3)" "unprognostic (1.47e-3)" "unprognostic (5.81e-2)" "prognostic unfavorable (1.02e-7)" "unprognostic (1.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.69e-1)" "unprognostic (6.43e-3)" 26.6 57.2 53.6 22.9 52.7 18.8 37.2 73.1 84.6 26.1 28.3 22.6 28.4 27.7 29.9 55.4 29.0 66.8 26.4 68.6 53.3 33.4 52.5 44.6 34.4 35.5 70.8 36.1 34.9 27.8 38.7 66.8 35.4 53.0 27.4 23.5 28.0 47.4 30.6 41.8 24.8 22.3 33.0 53.2 27.7 31.0 24.8 63.5 21.9 36.1 37.9 32.8 26.1 25.6 28.0 52.3 7.7 38.3 32.8 29.4 36.4 14.3 13.1 45.9 19.8 18.5 15.2 10.4 10.0 10.8 11.2 16.5 73.2 12.2 0.1 18.6 8.1 15.0 9.2 29.8 11.3 11.1 42.3 25.0 50.7 41.0 38.1 11.8 41.4 7.7 18.4 12.7 7.4 4.1 10.9 25.0 10.8 29.6 40.6 18.1 13.1 19.0 80.1 33.6 12.5 32.9 32.6 70.1 14.7 77.1 21.0 18.7 25.1 19.1 22.0 14.1 42.2 12.5 70.0 10.9 3.1 13.7 10.8 22.1 35.0 51.6 0.2 1.7 0.1 15.0 7.7 38.3 3.2 29.4 36.2 25.5 28.0 20.6 24.6 44.8 23.2 24.3 29.2 1.8 32.8 33.3 52.3 21.9 36.4 53.6 52.7 73.1 84.6 53.3 33.4 70.8 36.1 53.0 63.5 89.3 143.6 96.0 158.6 151.9 231.2 376.3 186.0 619.7 254.8 230.3 70.7 769.9 510.6 171.3 36.2 149.3 30.7 0.0 172.6 615.0 191.6 116.6 106.3 217.9 268.2 184.3 262.2 186.6 174.4 27.1 173.2 154.2 244.6 542.8 88.7 204.1 113.5 63.1 157.0 607.4 113.5 142.3 169.0 21.1 50.0 131.0 464.4 124.6 105.7 145.7 HMMR "CD168, RHAMM" ENSG00000072571 "Hyaluronan mediated motility receptor" O75330 5 163460203-163491945 "CD markers, FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.5;testis: 16.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 60.3;Erythroid cells: 256.9;Extravillous trophoblasts: 50.4;Spermatocytes: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002433, HPA040025, HPA043926, HPA061524" Enhanced Enhanced Microtubules,Centrosome,Cytosol Yes Yes Microtubules "Centrosome, Cytosol" "CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551" "unprognostic (3.53e-3)" "unprognostic (1.01e-1)" "unprognostic (3.38e-3)" "unprognostic (8.88e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (5.52e-4)" "prognostic unfavorable (1.93e-7)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.68e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.02e-1)" "unprognostic (0.00e+0)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.77e-2)" 1.6 1.4 0.6 13.4 0.6 11.4 2.4 0.4 0.9 1.7 5.0 0.6 0.6 4.5 0.6 2.3 6.4 0.5 0.9 1.6 0.8 0.7 1.4 1.8 2.5 10.9 1.0 0.4 0.6 1.1 0.6 0.5 6.9 1.1 0.7 5.6 0.4 1.6 0.2 1.4 2.3 4.8 1.4 1.9 8.6 2.6 16.7 0.3 54.5 0.7 5.6 10.8 1.8 2.1 1.2 1.8 0.6 0.7 1.5 4.8 0.8 21.1 13.3 27.2 14.5 1.4 2.7 20.3 20.1 9.8 25.2 22.9 27.0 40.9 35.2 19.2 6.2 34.4 24.5 31.4 19.1 43.1 31.9 9.7 21.0 9.5 13.2 0.4 18.6 19.4 0.7 1.1 23.7 18.6 4.2 14.3 24.2 19.9 28.8 26.2 7.7 19.6 10.6 23.4 14.2 14.6 21.4 36.4 17.6 9.8 5.7 22.7 12.6 29.9 9.4 11.4 13.5 27.7 15.0 9.3 18.1 15.4 14.5 26.9 15.5 25.9 28.4 12.0 28.9 17.4 0.5 0.7 0.0 0.5 0.3 0.9 1.2 1.0 0.6 0.9 0.9 0.4 0.7 0.6 1.5 0.0 1.8 4.8 0.8 0.6 0.6 0.4 0.9 0.8 0.7 1.0 0.4 1.1 0.3 0.0 0.6 15.5 0.8 2.3 0.6 1.7 7.6 4.0 4.5 0.0 0.0 5.1 0.0 0.6 60.3 0.1 1.3 256.9 0.2 50.4 2.4 0.8 0.0 1.7 17.7 0.0 1.2 3.1 3.5 44.1 2.0 4.3 0.0 3.6 1.6 0.0 0.1 0.0 0.7 2.4 0.7 6.5 0.0 80.6 18.5 1.3 3.8 1.0 4.2 0.9 HMOX2 HO-2 ENSG00000103415 "Heme oxygenase 2" P30519 16 4474690-4510347 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 438.7;Late spermatids: 1517.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025464, HPA040611" Supported Approved Vesicles,Cytosol NA NA 1200000 "Vesicles, Cytosol" "CAB025464: , HPA040611: AB_10961034" "unprognostic (3.33e-1)" "unprognostic (3.58e-2)" "unprognostic (1.11e-1)" "prognostic favorable (7.91e-4)" "unprognostic (2.74e-1)" "unprognostic (4.27e-2)" "unprognostic (6.23e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (3.60e-1)" "unprognostic (7.74e-3)" "unprognostic (9.87e-2)" "prognostic favorable (8.98e-6)" "unprognostic (3.51e-2)" "unprognostic (4.14e-2)" "unprognostic (1.65e-2)" "unprognostic (2.64e-1)" 19.4 19.2 32.1 15.7 50.7 13.6 16.6 19.7 38.6 13.3 17.9 22.9 12.2 23.5 11.9 18.7 36.6 15.6 19.7 57.2 29.3 22.0 32.2 39.7 15.8 20.8 27.3 35.1 12.5 22.4 20.6 14.7 12.5 36.5 12.1 19.9 8.6 16.0 10.0 20.1 16.6 19.3 16.6 27.2 23.3 29.7 48.1 28.2 8.7 13.8 16.7 25.3 16.5 15.0 14.5 14.5 48.7 8.9 18.7 35.8 25.8 24.9 10.7 6.3 13.8 19.1 9.8 10.6 17.3 8.5 14.7 12.8 13.5 17.0 11.6 19.4 15.8 10.3 15.2 20.0 37.0 16.7 14.8 13.6 8.4 10.3 18.3 12.9 18.2 14.4 15.3 12.4 17.0 12.5 12.3 26.9 14.0 13.6 5.9 13.5 31.0 15.0 14.3 9.7 24.1 10.1 16.0 11.2 24.3 20.4 16.5 10.8 6.3 13.8 29.3 18.6 12.6 18.2 10.2 26.3 8.3 12.3 35.6 8.8 7.3 9.0 25.6 5.3 15.1 10.5 13.7 7.4 48.7 35.2 8.9 29.9 14.5 32.7 35.8 14.5 13.0 31.7 32.7 26.1 18.7 6.5 8.2 30.0 25.8 32.1 50.7 19.7 38.6 29.3 22.0 27.3 35.1 36.5 28.2 32.8 46.9 52.0 27.0 48.7 27.1 59.3 33.1 30.8 38.7 34.9 19.6 64.6 109.5 72.8 438.7 41.7 76.2 0.0 78.6 57.9 43.8 31.4 19.6 78.8 59.5 27.0 30.5 66.3 24.7 1517.1 42.0 39.8 59.1 33.3 27.6 51.0 91.4 52.6 52.6 178.2 20.2 71.1 77.6 151.1 90.1 45.0 32.2 90.0 41.2 25.1 HNF4G NR2A2 ENSG00000164749 "Hepatocyte nuclear factor 4 gamma" Q14541 8 75407914-75566843 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 139.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 53.6;Mucus-secreting cells: 31.7;Paneth cells: 41.9;Undifferentiated cells: 25.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "A549: 4.5;CAPAN-2: 16.8;Karpas-707: 4.7;OE19: 10.3;PC-3: 5.1;THP-1: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005438, HPA010610" Enhanced Enhanced "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA005438: AB_1850822, HPA010610: AB_2668318" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.77e-2)" "unprognostic (9.44e-2)" "unprognostic (5.60e-2)" "unprognostic (4.65e-2)" "unprognostic (5.26e-2)" "unprognostic (1.27e-2)" "unprognostic (3.92e-1)" "unprognostic (8.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.83e-2)" "unprognostic (6.93e-3)" "unprognostic (1.67e-2)" "unprognostic (2.11e-1)" "unprognostic (4.22e-2)" "unprognostic (2.47e-2)" 0.2 0.2 0.5 5.0 0.5 0.0 0.3 0.3 0.3 0.6 56.2 0.1 0.3 35.9 0.4 1.1 0.4 0.3 12.6 0.2 0.3 0.3 6.1 12.1 0.4 0.0 0.4 0.2 0.2 10.9 0.0 0.2 0.0 0.3 0.6 6.9 0.2 0.4 0.6 0.2 0.2 139.6 0.2 0.3 0.2 2.6 0.9 0.1 0.1 0.2 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 4.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.3 16.8 0.0 2.4 0.0 2.0 0.0 2.1 0.0 0.0 0.0 1.9 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.3 10.3 5.1 0.0 0.0 0.3 2.9 0.1 0.3 1.7 0.3 0.1 0.0 0.2 0.3 5.6 0.0 0.3 0.1 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.1 0.0 0.6 0.5 0.6 0.0 0.0 0.2 17.8 9.4 1.2 3.5 0.0 0.0 5.0 2.2 1.7 0.0 53.6 0.0 3.7 0.0 0.0 1.1 0.0 9.0 0.0 0.0 15.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 31.7 0.0 5.6 41.9 0.0 13.6 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 25.9 2.8 HNMT ENSG00000150540 "Histamine N-methyltransferase" P50135 2 137964020-138016364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 259.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 19 "classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6" "Group enriched" "Detected in many" 22 "dendritic cells: 20.9;monocytes: 34.6" "Cell line enhanced" "Detected in many" "Hep G2: 60.9;HSkMC: 24.9;RT4: 31.6;SuSa: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035480, HPA035481, HPA073754" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA 64000 "Nucleoplasm, Cytosol" Centrosome "HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: " "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" "unprognostic (5.44e-2)" "unprognostic (2.09e-2)" "unprognostic (2.81e-1)" "unprognostic (2.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.02e-2)" "unprognostic (5.69e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.41e-4)" "unprognostic (5.24e-2)" "unprognostic (1.34e-2)" "unprognostic (1.76e-2)" "unprognostic (5.34e-2)" "unprognostic (1.21e-1)" "prognostic favorable (4.68e-4)" 41.4 5.8 12.2 12.3 11.1 3.3 28.8 10.7 11.3 27.6 16.3 8.6 13.9 8.7 22.2 21.4 11.6 14.6 21.6 14.7 12.7 7.8 33.4 74.2 21.9 17.0 13.7 9.2 33.1 14.1 24.5 5.5 14.3 11.2 22.3 17.7 8.7 14.1 20.1 4.9 8.1 11.1 13.2 14.8 18.5 11.5 11.7 14.6 1.0 7.3 8.5 6.5 21.3 12.0 0.5 20.9 1.2 34.6 0.1 0.2 9.2 0.2 0.3 1.5 4.1 17.5 18.8 0.1 1.1 1.7 0.1 0.7 7.8 4.4 0.2 13.8 4.5 0.3 0.4 3.2 0.0 0.0 0.2 1.6 0.1 13.0 60.9 7.9 0.0 0.2 24.9 0.0 6.2 0.0 1.4 4.4 0.1 0.2 0.3 13.1 0.9 0.0 0.2 7.8 10.4 1.6 0.1 0.5 0.0 18.8 31.6 0.1 0.4 5.9 7.7 0.0 31.3 0.2 14.3 1.2 1.3 3.4 1.8 4.4 0.1 0.0 0.2 5.9 7.5 0.9 0.8 34.6 0.2 0.2 26.7 0.1 0.5 0.1 0.1 20.9 0.3 0.1 0.2 1.2 0.1 14.6 0.6 0.2 9.2 12.2 11.1 10.7 11.3 12.7 7.8 13.7 9.2 11.2 14.6 26.8 39.0 13.7 77.1 31.6 0.5 1.6 140.1 52.2 86.4 57.6 0.0 45.4 104.5 84.7 1.2 4.9 45.2 0.0 42.0 69.7 45.8 47.7 0.0 146.0 259.0 0.0 15.7 23.4 235.2 1.6 121.7 155.2 54.0 68.5 65.8 22.3 57.9 100.1 99.0 189.5 0.5 77.6 52.5 0.5 0.6 22.6 31.5 5.0 76.2 102.7 HNRNPLL HNRPLL ENSG00000143889 "Heterogeneous nuclear ribonucleoprotein L like" Q8WVV9 2 38561978-38603586 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 114.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046084 Approved Approved Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA046084: AB_10960895" "unprognostic (2.27e-2)" "unprognostic (1.75e-1)" "unprognostic (3.63e-2)" "unprognostic (5.18e-1)" "unprognostic (2.10e-3)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.22e-4)" "unprognostic (1.52e-2)" "unprognostic (1.52e-1)" "unprognostic (1.80e-1)" "unprognostic (4.20e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-2)" 16.6 19.5 14.9 13.3 16.2 47.3 20.0 22.1 17.5 18.2 16.4 10.8 17.0 16.2 21.9 19.4 14.4 17.6 16.5 14.3 17.8 11.8 12.5 11.6 17.6 12.1 13.2 19.2 19.9 16.8 18.8 16.4 13.8 10.9 16.8 13.0 13.5 14.0 22.8 13.1 12.0 13.6 14.2 12.8 12.0 16.3 24.8 12.4 40.0 19.2 11.5 11.5 20.8 26.4 1.0 6.9 5.3 3.6 3.6 21.7 3.5 16.8 7.9 23.2 13.6 11.3 10.7 14.5 15.9 13.1 14.0 11.7 8.9 9.8 0.2 14.3 14.2 14.9 10.8 14.6 11.9 14.4 25.1 12.7 12.3 14.9 22.5 10.7 22.9 12.7 8.4 9.5 11.5 12.9 13.8 14.5 11.3 20.8 38.2 16.3 7.8 24.9 12.5 23.3 16.3 14.5 4.9 16.3 8.2 11.9 22.2 15.9 17.8 14.0 12.3 11.7 13.5 10.4 9.9 15.0 10.5 15.7 11.4 13.0 20.9 20.9 0.1 9.0 5.7 12.7 5.3 3.6 5.1 6.2 1.8 11.0 0.2 15.1 11.6 6.9 1.0 4.6 2.9 2.5 3.6 0.7 0.1 21.7 3.5 14.9 16.2 22.1 17.5 17.8 11.8 13.2 19.2 10.9 12.4 17.9 18.9 4.2 29.5 25.4 12.6 14.4 2.5 10.7 19.4 26.2 7.9 22.8 16.6 20.6 114.5 19.1 12.9 0.0 21.3 24.7 25.6 21.8 9.2 6.4 22.1 6.4 13.8 19.6 15.4 35.0 25.6 26.7 37.1 31.5 16.9 24.6 17.7 17.5 49.1 16.3 10.4 38.8 23.7 68.1 29.6 18.6 18.5 17.5 18.7 17.6 HOMER1 "HOMER-1B, SYN47, Ves-1" ENSG00000152413 "Homer scaffolding protein 1" Q86YM7 5 79372636-79514217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9;skeletal muscle: 28.0" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 87.3;Syncytiotrophoblasts: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004437, HPA036521, HPA036522" Enhanced Supported Approved Cytosol No No Cytosol "CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171" "unprognostic (2.80e-1)" "unprognostic (5.30e-2)" "unprognostic (4.00e-2)" "unprognostic (5.79e-2)" "unprognostic (8.83e-2)" "unprognostic (6.40e-2)" "unprognostic (2.00e-3)" "unprognostic (2.41e-3)" "unprognostic (2.22e-1)" "unprognostic (3.79e-1)" "unprognostic (3.07e-3)" "unprognostic (3.98e-1)" "unprognostic (7.35e-2)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (2.83e-2)" "unprognostic (2.86e-3)" 3.0 1.6 11.3 2.4 19.7 0.6 2.7 8.4 28.9 4.4 1.6 1.2 0.0 1.0 6.8 4.5 4.7 2.5 6.9 19.1 8.5 4.2 5.9 2.0 5.1 1.3 2.9 13.3 4.7 2.4 4.5 3.6 5.3 5.3 2.0 1.3 2.1 1.9 2.1 28.0 2.6 1.2 4.7 2.2 1.1 2.1 5.1 3.5 1.7 14.4 4.8 1.7 5.0 2.2 2.0 0.6 0.2 0.0 0.4 2.3 0.5 8.4 5.9 8.9 14.0 3.4 2.2 20.5 5.4 4.3 5.5 5.9 9.2 6.0 0.1 16.5 4.6 10.0 4.6 10.9 14.6 9.5 1.2 8.6 10.2 2.5 9.1 5.5 4.8 3.3 3.6 9.5 4.9 13.8 2.2 2.5 15.9 12.4 5.6 7.1 11.9 20.0 3.3 14.9 3.0 5.0 13.1 14.5 12.9 5.8 13.2 9.0 5.4 10.2 7.3 5.4 10.3 10.0 4.2 0.4 4.1 10.3 4.9 9.5 2.7 6.1 5.0 11.6 1.9 7.8 0.0 0.0 0.1 2.3 0.0 1.3 2.0 0.9 0.7 0.0 1.6 0.5 1.7 0.2 0.4 0.0 0.6 0.0 0.5 11.3 19.7 8.4 18.8 8.5 4.2 2.9 13.3 5.3 3.5 47.6 11.1 9.8 25.1 57.1 25.5 87.3 10.2 13.4 13.6 15.7 25.5 45.8 10.0 3.7 3.6 4.7 2.6 0.0 3.7 37.8 15.1 20.5 5.7 7.3 10.1 49.3 10.9 3.7 9.0 3.9 5.2 10.5 20.3 1.8 5.0 3.3 4.6 2.9 8.1 5.3 9.1 12.9 15.1 3.3 8.3 47.9 70.6 4.9 2.5 18.0 HOMER2 "CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2" ENSG00000103942 "Homer scaffolding protein 2" Q9NSB8 15 82836946-82986153 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 80.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 186.0;Exocrine glandular cells: 66.4;Glandular cells: 96.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 21.5;Karpas-707: 38.1;SCLC-21H: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040134, CAB079014" Uncertain Supported Supported Cytosol NA NA Cytosol "CAB079014: , HPA040134: AB_10795272" "unprognostic (7.34e-2)" "unprognostic (3.58e-2)" "unprognostic (5.75e-4)" "unprognostic (3.31e-3)" "unprognostic (4.85e-2)" "unprognostic (1.24e-1)" "unprognostic (1.04e-2)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (2.75e-1)" "unprognostic (8.16e-4)" "unprognostic (2.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.26e-1)" "unprognostic (4.45e-3)" 0.7 2.9 3.9 0.5 3.8 1.6 9.9 5.1 6.5 8.9 1.4 4.6 2.7 3.2 3.4 13.0 8.0 9.6 12.9 12.5 5.0 3.1 2.8 19.4 2.5 1.0 2.5 4.2 1.7 80.9 2.7 4.5 0.4 13.2 21.8 0.6 12.7 34.5 2.0 36.0 15.9 0.6 0.7 5.4 2.3 17.8 2.3 2.0 0.2 13.4 14.2 5.0 0.8 4.3 1.4 4.1 1.6 0.6 0.4 1.1 1.0 6.5 2.8 3.0 7.7 0.0 0.0 0.5 0.4 0.0 0.7 0.2 0.5 4.7 0.0 3.6 3.4 3.4 3.7 21.5 10.1 0.5 17.8 13.7 4.2 0.1 3.3 0.3 0.1 13.6 0.7 15.5 0.2 0.9 0.8 0.0 8.4 0.1 38.1 2.8 19.2 1.2 0.4 4.7 0.6 2.1 0.8 4.7 2.2 10.4 8.1 21.1 5.4 7.5 5.8 7.0 2.2 7.0 1.4 0.1 7.2 13.3 0.5 6.0 4.9 2.3 0.7 12.1 0.1 2.6 0.3 0.6 1.5 0.4 0.5 0.3 0.7 0.8 0.2 4.1 1.4 0.6 0.4 1.6 0.4 0.3 1.8 1.1 1.0 3.9 3.8 5.1 6.5 5.0 3.1 2.5 4.2 13.2 2.0 14.9 8.5 2.4 45.7 4.0 9.9 19.3 186.0 1.4 19.4 10.4 17.7 0.8 6.6 25.6 1.4 2.8 0.3 0.0 66.4 0.4 2.5 96.8 0.0 53.3 14.1 19.1 2.9 0.6 2.5 1.8 1.7 5.0 35.4 10.0 0.2 15.8 25.6 0.0 0.7 5.9 4.8 0.0 4.6 4.3 11.4 5.3 0.6 0.9 0.4 25.6 HOMER3 HOMER-3 ENSG00000051128 "Homer scaffolding protein 3" Q9NSC5 19 18929201-18941261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 64.8" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 64.5;Muller glia cells: 59.6;Proximal tubular cells: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 14.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.1;monocytes: 14.7" "Cell line enhanced" "Detected in many" "NB-4: 62.2;THP-1: 74.8;U-266/84: 64.3" "Region enriched" "Detected in many" 6 "cerebellum: 212.2" "Low region specificity" "Detected in all" "CAB032656, HPA040999, CAB079015" Enhanced Supported Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Plasma membrane, Cytoplasmic bodies" "CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242" "unprognostic (3.41e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.24e-5)" "unprognostic (1.19e-1)" "unprognostic (2.06e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (4.93e-5)" "unprognostic (1.07e-1)" "unprognostic (8.88e-2)" "unprognostic (5.78e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-2)" "unprognostic (5.99e-2)" "unprognostic (3.76e-2)" "unprognostic (2.33e-1)" "unprognostic (1.41e-1)" "unprognostic (4.11e-2)" 11.4 8.3 11.1 6.5 16.0 12.4 31.0 42.3 12.2 8.7 6.7 17.6 2.1 4.9 8.2 5.2 7.6 4.8 10.9 11.9 15.8 9.0 21.2 4.1 7.0 5.5 19.4 7.2 8.2 5.3 13.6 2.4 9.7 15.5 8.1 4.5 15.4 8.4 7.0 49.2 10.9 5.5 7.6 24.2 64.8 6.5 3.4 14.6 2.2 19.6 7.8 3.3 12.3 16.8 2.4 1.2 5.1 14.7 0.0 0.7 3.6 19.6 5.1 9.7 8.1 9.1 9.2 4.8 19.5 17.3 19.6 9.9 2.6 7.6 0.1 9.2 21.9 14.1 12.3 3.3 25.3 11.0 0.7 2.0 0.0 1.6 4.8 8.5 3.7 0.3 7.4 16.4 10.9 14.7 21.0 23.8 1.4 0.5 5.2 14.2 5.3 0.3 62.2 5.0 1.0 21.1 9.7 2.9 9.2 7.1 5.0 0.0 8.3 4.8 5.7 13.8 1.9 2.5 74.8 18.9 17.5 7.8 21.0 23.4 50.7 64.3 16.3 27.6 48.1 12.7 0.1 14.7 2.6 0.1 5.1 0.0 2.4 0.7 0.3 1.2 1.7 0.1 0.0 5.1 0.0 1.4 0.2 0.7 3.6 11.1 16.0 42.3 12.2 15.8 9.0 19.4 7.2 15.5 14.6 3.0 0.0 2.4 17.6 10.5 1.9 3.4 2.5 0.0 2.3 12.2 0.0 0.6 10.0 17.4 1.3 13.1 0.0 0.0 11.6 1.4 13.0 10.5 10.3 0.8 64.5 1.6 1.7 20.9 18.2 1.7 12.7 16.1 11.8 1.0 0.9 59.6 32.9 0.0 10.3 70.5 4.1 0.0 6.1 1.0 5.1 12.7 0.9 0.5 0.1 19.7 HOOK2 HK2 ENSG00000095066 "Hook microtubule tethering protein 2" Q96ED9 19 12763003-12872740 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 35.2;RT4: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043519, HPA050351" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043519: AB_2678525, HPA050351: AB_2681102" "unprognostic (4.26e-1)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "unprognostic (1.16e-1)" "unprognostic (4.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.25e-3)" "unprognostic (3.06e-2)" "unprognostic (2.52e-2)" "unprognostic (1.75e-3)" "prognostic unfavorable (7.59e-5)" "prognostic favorable (3.28e-4)" "unprognostic (3.27e-3)" "unprognostic (5.74e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-2)" 18.6 6.6 14.9 5.7 13.5 1.9 15.5 21.9 17.5 8.5 14.5 4.2 32.7 25.5 8.0 24.9 18.5 8.9 16.8 15.5 12.2 6.9 16.0 15.0 8.1 4.1 10.2 8.4 8.7 31.9 28.4 49.1 11.3 12.9 17.3 12.2 6.6 22.9 35.9 29.8 26.4 27.1 5.3 10.8 6.0 18.1 7.4 12.1 3.5 33.5 15.8 11.4 10.1 12.0 3.9 3.7 2.2 2.7 2.6 6.8 2.4 15.6 3.9 4.8 3.2 5.1 4.9 17.0 4.7 2.2 2.6 3.5 13.1 18.7 2.9 8.9 4.7 2.3 20.9 4.9 14.3 2.7 9.0 3.5 3.1 7.2 4.4 2.9 1.6 4.9 5.9 13.7 3.7 5.6 6.2 1.6 6.5 5.1 2.5 5.4 35.2 1.6 3.0 2.2 10.3 4.1 5.2 2.9 7.1 5.6 40.6 12.7 6.1 3.4 10.6 3.2 4.9 15.4 4.1 3.1 6.1 3.6 9.0 1.8 9.9 9.7 1.9 5.7 5.9 4.0 0.8 1.6 0.0 3.4 2.7 2.1 3.9 4.0 1.5 3.7 3.1 6.8 4.4 2.2 2.6 1.6 1.3 1.0 2.4 14.9 13.5 21.9 17.5 12.2 6.9 10.2 8.4 12.9 12.1 17.9 33.1 12.3 94.0 44.9 115.7 31.9 63.7 16.0 21.6 78.5 94.2 60.9 36.5 60.8 8.0 14.2 163.1 0.0 39.8 32.1 17.4 85.4 11.6 20.7 14.2 60.4 60.5 17.8 8.3 6.3 25.0 14.2 27.0 27.9 58.2 33.8 44.8 101.7 25.1 32.2 86.7 12.9 16.7 69.8 14.5 57.2 107.1 16.0 69.7 77.7 HOOK3 HK3 ENSG00000168172 "Hook microtubule tethering protein 3" Q86VS8 8 42896932-43030539 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024756 Approved Supported "Golgi apparatus,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Golgi apparatus, Cytosol" "HPA024756: AB_1850913" "unprognostic (1.84e-2)" "unprognostic (1.61e-1)" "unprognostic (2.73e-1)" "unprognostic (8.61e-3)" "unprognostic (6.05e-2)" "unprognostic (1.77e-3)" "unprognostic (2.36e-1)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.13e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.63e-1)" "unprognostic (3.78e-1)" "unprognostic (2.55e-1)" "unprognostic (7.12e-2)" 15.5 9.3 11.3 10.1 15.1 13.1 16.3 16.0 19.2 13.5 11.3 10.3 14.1 10.2 13.7 12.0 14.8 11.7 20.0 9.5 11.2 11.3 9.9 10.7 14.6 10.3 14.7 11.7 13.4 13.9 13.4 14.4 12.0 13.1 17.7 10.9 6.8 17.1 15.2 24.1 11.0 11.9 19.3 17.5 11.6 12.8 14.5 14.3 7.4 37.5 8.9 10.1 19.2 17.6 1.8 3.8 10.2 3.2 2.0 2.0 1.8 7.4 7.4 18.1 9.8 13.5 12.0 6.9 9.5 8.0 8.0 7.5 9.8 8.7 9.3 9.7 12.7 7.6 4.2 15.0 6.4 13.0 6.3 4.3 17.5 6.1 6.8 7.5 1.8 10.3 9.7 4.7 10.7 9.2 11.1 11.4 6.6 9.6 11.0 9.6 1.8 14.2 3.4 6.5 5.9 2.2 8.3 18.9 2.3 5.9 11.1 4.6 7.4 10.8 4.6 5.0 8.3 8.4 6.3 20.4 12.0 9.3 14.4 6.0 10.8 11.8 12.3 10.1 6.7 17.6 10.2 3.2 3.1 2.0 3.2 0.8 1.6 1.9 1.5 3.8 1.8 1.1 1.5 3.8 2.0 3.1 2.4 1.4 1.8 11.3 15.1 16.0 13.1 11.2 11.3 14.7 11.7 13.1 14.3 86.4 55.8 23.3 27.0 60.8 36.4 44.2 38.2 33.5 45.5 24.4 31.4 32.3 23.2 37.4 88.6 54.3 28.4 23.3 28.8 21.7 50.3 38.0 52.0 28.4 34.2 71.5 62.8 57.7 83.3 26.1 41.4 65.4 52.3 104.6 20.1 29.9 47.3 25.9 50.5 18.0 31.0 64.7 55.1 30.2 18.9 65.4 95.1 27.4 13.5 63.4 HOPX "HOP, LAGY, NECC1, OB1, SMAP31" ENSG00000171476 "HOP homeobox" Q9BPY8 4 56647988-56681899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.8;skin 1: 154.6" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 696.8;Alveolar cells type 2: 414.3;Basal keratinocytes: 368.4;Suprabasal keratinocytes: 329.7;Syncytiotrophoblasts: 269.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 68.6;NK-cell: 90.9" "Group enriched" "Detected in many" 14 "NK-cells: 90.9;T-cells: 68.6" "Cell line enhanced" "Detected in some" "HDLM-2: 13.4;HUVEC TERT2: 29.7;RT4: 22.1;TIME: 33.6;U-266/70: 11.7" "CAB018632, HPA030180" Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "CAB018632: AB_2120833, HPA030180: AB_10603770" "unprognostic (2.32e-1)" "unprognostic (1.81e-2)" "unprognostic (8.03e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (2.88e-1)" "unprognostic (7.79e-2)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-5)" "unprognostic (3.40e-2)" "unprognostic (1.51e-1)" "unprognostic (7.10e-2)" "unprognostic (5.33e-2)" 1.7 5.0 24.1 5.2 13.0 2.0 23.1 4.0 28.2 26.4 3.1 3.6 3.0 3.4 2.5 106.2 90.3 2.3 6.7 5.7 20.0 8.2 2.3 0.7 112.4 3.4 12.1 12.9 1.4 1.1 2.3 1.2 128.8 15.0 4.5 1.6 1.0 19.0 12.9 3.4 154.6 3.4 20.9 11.2 2.3 3.2 9.6 1.9 1.8 65.9 93.2 66.3 6.8 37.8 5.6 0.4 1.5 0.5 90.9 68.6 38.2 0.0 0.0 0.0 0.0 2.3 7.3 2.6 0.0 0.0 0.6 0.4 0.0 0.0 5.4 0.3 0.1 1.0 1.0 0.6 0.0 0.8 13.4 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 5.4 1.6 0.0 1.5 29.7 0.0 0.0 0.2 1.4 0.2 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.1 0.0 22.1 0.4 0.2 0.0 0.0 0.0 2.1 0.0 0.0 33.6 0.0 0.1 0.2 0.0 11.7 0.0 0.0 1.4 0.0 0.0 0.6 0.1 0.2 68.6 0.4 37.4 5.6 17.1 30.1 0.3 4.3 3.1 21.0 1.5 90.9 0.5 0.4 1.0 38.2 24.1 13.0 4.0 28.2 20.0 8.2 12.1 12.9 15.0 1.9 696.8 414.3 13.2 36.1 368.4 1.6 11.3 0.0 20.1 221.8 1.8 0.0 1.7 1.7 0.0 27.8 9.0 0.5 0.0 0.2 4.7 21.3 17.3 9.3 0.8 3.5 0.0 8.1 5.5 16.3 34.5 2.8 8.0 33.7 62.3 1.9 104.0 2.3 0.0 2.8 0.2 4.3 32.3 77.3 2.6 10.4 329.7 269.1 177.7 0.3 25.7 HORMAD2 "CT46.2, MGC26710" ENSG00000176635 "HORMA domain containing 2" Q8N7B1 22 30080174-30177075 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.3" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 115.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.2;U-2197: 3.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA003074, HPA043880" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA003074: AB_1850916, HPA043880: " "unprognostic (1.43e-1)" "unprognostic (6.77e-3)" "unprognostic (2.33e-1)" "unprognostic (1.36e-2)" "unprognostic (8.19e-3)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 115.1 2.7 0.0 0.0 0.0 0.0 0.0 HOXB5 "HOX2, HOX2A" ENSG00000120075 "Homeobox B5" P09067 17 48591257-48593961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 50.6;Distal tubular cells: 21.6;Mucus-secreting cells: 13.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 28.1" "Region enriched" "Detected in single" 33 "pons and medulla: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 21.5;RPTEC TERT1: 16.1" "Region enriched" "Detected in single" 90 "pons and medulla: 24.0" "Region enriched" "Detected in single" 128 "pons and medulla: 14.7" "HPA043851, HPA074454" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA043851: AB_2732509, HPA074454: AB_2686690" "unprognostic (6.50e-2)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.48e-3)" "unprognostic (7.12e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.47e-1)" "unprognostic (1.47e-3)" "unprognostic (5.10e-2)" "unprognostic (9.64e-2)" "unprognostic (7.61e-3)" "unprognostic (8.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "prognostic favorable (8.59e-5)" 3.4 3.1 0.2 2.1 0.2 0.0 5.0 0.2 0.7 5.4 10.5 0.2 25.9 1.5 2.2 18.5 0.6 7.2 0.2 0.7 0.2 0.0 16.0 0.4 5.2 0.8 0.2 0.2 1.9 0.5 0.9 0.2 1.2 25.4 1.3 4.7 0.2 0.6 27.6 0.2 0.5 9.5 1.6 22.5 2.0 4.3 0.7 0.2 0.2 0.7 0.2 0.2 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.8 0.0 2.5 2.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.2 2.7 0.6 0.0 0.2 0.0 0.0 0.0 21.5 0.9 5.6 0.0 4.2 0.0 1.2 1.4 0.0 2.9 0.0 0.8 1.4 0.1 1.6 0.0 3.3 0.0 0.0 0.0 0.0 2.7 1.7 0.0 1.0 0.0 16.1 1.6 0.0 0.0 0.1 0.0 2.3 0.1 0.4 0.0 5.3 0.7 2.1 0.5 0.3 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 25.4 0.2 0.0 0.6 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 50.6 0.0 0.0 21.6 0.0 0.6 2.4 8.9 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.5 0.0 4.1 9.2 5.0 0.0 0.0 0.0 1.7 0.0 13.9 0.0 0.0 3.5 0.4 0.4 0.0 0.0 1.0 7.2 10.8 0.3 0.0 0.0 11.5 0.0 HOXB7 "HOX2, HOX2C" ENSG00000260027 "Homeobox B7" P09629 17 48607227-48633572 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 62.3" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 82.0;Distal tubular cells: 126.0;Enterocytes: 102.1;Mucus-secreting cells: 73.3;Paneth cells: 56.1;Undifferentiated cells: 65.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 30.4;OE19: 26.5;RPTEC TERT1: 24.2;SK-MEL-30: 28.8" "Region enriched" "Detected in single" 45 "pons and medulla: 6.0" "Region enriched" "Detected in single" 14 "pons and medulla: 1.5" HPA049940 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049940: AB_2616461" "unprognostic (6.76e-2)" "unprognostic (6.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-3)" "unprognostic (1.42e-2)" "unprognostic (1.69e-2)" "unprognostic (8.05e-3)" "unprognostic (9.16e-2)" "unprognostic (9.91e-2)" "unprognostic (7.01e-3)" "unprognostic (7.81e-3)" "unprognostic (1.17e-2)" "unprognostic (1.56e-2)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.39e-4)" 8.3 8.3 0.0 7.3 0.3 0.1 17.2 0.1 0.6 10.0 8.1 0.1 24.1 0.5 4.1 62.3 0.8 4.2 0.3 1.1 0.0 0.0 23.7 0.8 1.7 2.4 0.1 0.3 2.3 0.6 0.4 0.5 4.1 4.1 5.2 7.0 0.1 0.1 22.1 2.4 2.2 12.4 3.5 20.1 2.2 4.6 3.0 0.2 0.1 0.5 0.1 0.6 5.8 15.1 2.2 1.8 0.0 0.0 2.0 4.7 0.5 16.9 7.4 0.0 0.1 5.3 8.0 0.0 0.0 0.0 0.1 0.3 11.3 0.3 0.3 30.4 7.1 8.8 2.5 0.0 0.0 0.0 7.8 5.5 2.6 5.8 0.0 4.4 0.0 5.5 5.2 2.3 5.2 0.0 1.3 16.0 5.3 2.8 0.1 16.8 4.4 0.3 0.1 0.0 26.5 0.0 0.0 14.4 1.9 24.2 5.7 0.0 0.0 5.7 0.0 28.8 0.4 1.4 1.6 13.7 0.0 9.3 7.5 13.1 0.9 2.2 0.0 0.1 0.0 21.3 0.0 0.0 0.0 3.8 0.0 1.9 1.9 0.7 2.1 0.0 2.2 0.0 1.4 0.0 2.0 0.0 1.8 4.7 0.5 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.3 4.1 0.2 0.0 0.0 3.7 0.8 4.8 0.0 0.3 0.0 0.0 0.0 82.0 0.0 6.2 126.0 0.0 0.1 2.2 102.1 0.0 1.1 14.9 8.2 0.7 4.7 0.0 8.8 0.0 35.1 1.3 7.8 0.0 0.6 2.8 23.6 2.8 73.3 0.0 0.5 56.1 0.0 27.8 0.0 0.0 8.0 1.4 23.4 1.8 1.5 1.0 65.0 3.1 HOXC11 HOX3H ENSG00000123388 "Homeobox C11" O43248 12 53973126-53977643 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 7.0;skin 1: 9.2" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 6.6;Distal tubular cells: 1.7;Fibroblasts: 2.3;Melanocytes: 3.3;Spermatocytes: 3.8;Suprabasal keratinocytes: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 23.3;BJ hTERT+: 11.7;HaCaT: 10.3;T-47d: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA038291 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038291: AB_10674552" "unprognostic (1.50e-3)" "unprognostic (1.93e-2)" "unprognostic (1.14e-2)" "unprognostic (1.51e-1)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (6.90e-3)" "unprognostic (1.32e-2)" "unprognostic (7.41e-3)" "unprognostic (4.46e-3)" "unprognostic (2.25e-1)" "unprognostic (3.26e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-1)" "unprognostic (1.82e-1)" 4.8 0.0 0.1 0.1 0.1 0.0 1.2 0.1 0.1 2.5 0.1 0.1 0.1 0.8 2.0 1.0 0.1 0.7 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.7 0.1 0.1 0.5 0.1 0.0 0.1 0.6 0.3 0.5 0.0 0.1 0.1 2.0 7.0 9.2 2.7 0.4 0.1 0.1 0.0 1.6 0.1 0.5 0.1 0.1 0.1 1.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.7 0.0 23.3 2.2 3.4 0.0 3.4 11.7 5.0 3.7 0.2 0.9 0.0 0.2 3.2 0.0 10.3 4.4 0.0 2.3 0.6 0.1 0.1 7.6 0.0 0.0 0.1 0.1 0.6 0.9 0.0 0.3 0.0 0.0 0.2 1.0 0.0 3.2 1.4 0.0 0.0 0.0 6.6 0.0 0.0 0.4 0.0 0.4 0.8 0.0 0.1 2.1 5.3 2.0 0.2 18.4 0.0 0.0 0.0 4.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 6.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 3.8 0.2 3.3 0.0 0.0 0.0 0.0 HOXC6 "HOX3, HOX3C" ENSG00000197757 "Homeobox C6" P09630 12 53990624-54030823 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 31.2" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 14.9;Fibroblasts: 27.4;Leydig cells: 20.8;Peritubular cells: 14.2;Spermatocytes: 39.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 17 "pons and medulla: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 38.1;fHDF/TERT166: 19.0;HDLM-2: 31.8" "Region enriched" "Detected in single" 23 "pons and medulla: 1.5" "Not detected" "Not detected" HPA054981 Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA054981: AB_2682662" "unprognostic (3.54e-2)" "unprognostic (9.20e-2)" "unprognostic (1.68e-6)" "unprognostic (3.92e-2)" "unprognostic (1.10e-3)" "unprognostic (5.01e-4)" "unprognostic (5.52e-3)" "unprognostic (3.32e-3)" "unprognostic (2.81e-1)" "unprognostic (6.26e-2)" "unprognostic (8.82e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (3.55e-6)" "unprognostic (8.63e-2)" "unprognostic (5.76e-2)" "unprognostic (1.40e-2)" "unprognostic (4.71e-2)" 10.9 11.2 0.4 1.2 0.4 0.0 16.3 0.4 0.4 0.7 1.9 0.6 0.4 0.0 3.9 14.8 3.1 13.5 0.4 2.0 0.4 0.0 11.3 0.4 0.9 3.0 0.4 0.4 31.2 0.4 0.0 0.4 4.0 7.0 0.8 0.0 0.4 0.4 0.4 11.0 7.6 8.8 6.1 8.1 1.0 0.3 3.3 0.4 0.4 0.6 0.8 0.4 0.7 2.5 0.0 0.0 0.1 0.0 0.0 0.5 0.0 2.5 1.8 0.0 38.1 13.9 13.3 0.4 1.9 1.9 3.1 2.9 1.6 2.9 1.1 2.5 19.0 0.9 4.3 1.5 0.2 2.8 31.8 11.0 2.0 4.9 0.0 1.5 0.2 4.8 12.6 2.0 6.2 2.2 0.0 0.1 0.1 1.3 0.0 11.0 0.6 0.0 1.2 0.0 0.3 1.6 0.0 1.4 0.0 9.6 0.1 0.0 4.7 2.9 2.8 7.8 3.4 6.7 0.5 0.0 4.0 8.6 4.3 2.7 0.3 0.3 0.0 1.4 0.3 8.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 7.0 0.4 0.0 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.3 14.9 0.0 1.1 0.2 0.0 0.0 0.0 2.5 27.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 20.8 0.4 11.8 0.0 0.0 0.2 0.0 0.0 14.2 7.8 1.9 6.5 5.0 39.3 1.1 3.4 0.2 0.0 0.0 0.0 HOXD10 "HOX4, HOX4D" ENSG00000128710 "Homeobox D10" P28358 2 176108790-176119942 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 21.7;endometrium 1: 38.2" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 14.0;Distal tubular cells: 13.3;Intestinal endocrine cells: 23.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 7.3;HEK 293: 26.0;RPTEC TERT1: 18.7;SCLC-21H: 7.3;SiHa: 10.9;U-251 MG: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA065871 Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" No NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA065871: AB_2685573" "unprognostic (4.29e-3)" "unprognostic (2.51e-1)" "unprognostic (2.98e-3)" "unprognostic (1.69e-1)" "unprognostic (1.80e-3)" "unprognostic (6.82e-2)" "unprognostic (1.04e-5)" "unprognostic (1.19e-2)" "unprognostic (1.99e-1)" "unprognostic (2.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.92e-6)" "unprognostic (2.15e-3)" "unprognostic (4.57e-2)" "unprognostic (4.86e-1)" "unprognostic (1.27e-1)" 0.9 0.0 0.1 1.2 0.1 0.0 21.7 0.1 0.1 10.3 9.5 0.1 1.4 0.0 38.2 2.8 1.2 1.6 0.6 0.6 0.1 0.0 16.3 0.1 0.8 0.2 0.1 0.1 2.7 0.1 0.0 0.1 3.0 0.1 9.5 4.3 0.1 0.5 5.1 0.2 1.0 0.1 14.2 0.1 0.1 0.0 3.9 0.1 0.2 0.3 0.4 1.4 2.1 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 7.3 0.0 0.0 0.3 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 18.7 0.0 7.3 1.9 10.9 0.0 0.0 1.4 0.0 0.0 1.6 0.0 1.4 0.6 8.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 4.6 0.8 0.0 0.3 0.0 0.0 0.0 14.0 0.0 0.0 13.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.1 0.0 23.2 0.0 0.0 0.0 1.7 0.0 1.7 0.0 3.9 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 5.2 2.0 HPCAL4 "DKFZp761G122, HLP4" ENSG00000116983 "Hippocalcin like 4" Q9UM19 1 39678648-39691689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 80.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 36.4;Distal tubular cells: 10.0" "Group enriched" "Detected in some" 11 "glioma: 5.4;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 5.6;naive CD4 T-cell: 5.0" "Lineage enriched" "Detected in single" 33 "T-cells: 5.6" "Cell line enhanced" "Detected in some" "Karpas-707: 4.0;SH-SY5Y: 13.4;SK-MEL-30: 4.2;U-2 OS: 2.8;U-266/70: 3.5;U-266/84: 4.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 336.7;basal ganglia: 201.9;cerebral cortex: 348.1;hippocampal formation: 324.0;olfactory region: 266.4" HPA053808 Approved Cytosol NA NA Cytosol "HPA053808: AB_2682270" "unprognostic (2.62e-1)" "unprognostic (2.37e-1)" "unprognostic (2.13e-2)" "unprognostic (8.56e-4)" "unprognostic (4.73e-3)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (4.89e-3)" "unprognostic (1.27e-1)" "unprognostic (3.18e-2)" "unprognostic (4.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.62e-3)" "unprognostic (3.78e-3)" "unprognostic (2.77e-2)" "unprognostic (3.97e-2)" "unprognostic (2.63e-1)" 1.2 10.2 35.8 1.8 46.0 1.5 1.2 31.1 80.4 1.2 1.2 3.7 0.0 1.3 1.2 1.5 5.5 1.2 1.3 1.4 28.3 17.0 3.5 1.2 1.7 1.9 7.5 32.7 3.7 4.7 1.2 0.4 1.2 6.8 1.4 1.3 0.0 1.2 1.3 2.1 1.2 1.3 1.2 4.4 1.4 1.3 4.1 3.0 0.0 1.2 0.0 1.8 1.3 0.0 0.0 0.1 0.0 0.0 0.0 5.6 1.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 2.1 0.3 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.6 0.0 1.2 13.4 0.4 0.0 4.2 0.3 0.0 0.1 0.0 0.0 2.8 0.0 0.0 3.5 4.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.4 0.0 5.6 1.0 0.1 0.0 5.0 1.8 0.0 0.0 0.0 0.0 3.8 1.8 35.8 46.0 31.1 40.4 28.3 17.0 7.5 32.7 6.8 3.0 0.0 0.0 0.0 0.1 0.0 36.4 0.8 0.0 0.0 1.2 1.8 0.0 0.0 10.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 5.0 0.1 0.0 1.4 0.0 1.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 HPF1 "C4orf27, FLJ20534" ENSG00000056050 "Histone PARylation factor 1" Q9NWY4 4 169729465-169757953 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 58.5;Distal tubular cells: 77.9;Extravillous trophoblasts: 50.1;Hofbauer cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043467 Uncertain Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA043467: AB_10793949" "unprognostic (1.09e-1)" "unprognostic (1.15e-2)" "unprognostic (1.72e-2)" "unprognostic (1.47e-1)" "unprognostic (2.70e-1)" "unprognostic (1.09e-1)" "unprognostic (8.68e-3)" "unprognostic (2.74e-2)" "prognostic unfavorable (5.63e-4)" "prognostic favorable (7.47e-4)" "unprognostic (6.34e-2)" "unprognostic (4.55e-1)" "unprognostic (3.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.32e-1)" "unprognostic (5.51e-2)" "unprognostic (1.09e-1)" 16.5 18.6 27.3 14.9 26.3 13.7 20.9 22.9 31.7 17.6 17.5 17.6 10.0 11.5 23.2 25.2 17.2 16.9 12.7 20.9 27.3 24.0 17.5 20.8 13.5 18.0 24.9 22.6 23.1 13.1 13.9 22.9 16.0 33.4 17.4 17.6 15.1 12.2 16.0 17.4 18.6 11.3 24.2 23.8 16.4 14.0 12.9 19.8 20.8 18.5 14.9 19.3 19.0 14.8 13.6 15.6 12.8 14.1 14.9 22.2 13.3 12.6 8.0 28.0 14.7 17.1 21.3 11.9 23.1 22.9 28.8 30.6 5.4 13.7 6.6 6.2 15.0 21.1 5.7 19.2 16.8 30.6 20.7 13.1 21.6 11.8 7.7 12.1 18.2 7.9 13.7 17.1 18.5 5.7 17.5 24.9 22.9 16.2 26.0 25.0 10.2 38.1 15.9 11.4 12.2 10.5 16.8 13.3 7.9 16.4 8.4 6.7 25.0 15.3 6.7 20.8 20.3 13.3 16.4 12.0 9.8 15.6 23.0 20.5 12.4 18.4 19.7 27.2 17.8 15.6 8.9 12.3 12.8 18.5 14.1 21.9 13.6 21.5 22.2 15.6 11.1 21.2 21.7 3.3 14.9 13.1 10.7 22.0 13.3 27.3 26.3 22.9 31.7 27.3 24.0 24.9 22.6 33.4 19.8 41.7 23.7 0.0 0.0 0.0 0.0 0.0 0.0 28.1 31.8 26.2 0.0 58.5 77.9 38.2 0.0 0.0 0.0 0.0 40.0 50.1 0.0 0.0 16.3 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 6.4 0.0 0.0 27.9 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 HPGD SDR36C1 ENSG00000164120 "15-hydroxyprostaglandin dehydrogenase" P15428 4 174490177-174523154 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 193.3" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 52.4" "Region enriched" "Detected in single" 4 "pons and medulla: 3.8" "Group enriched" "Detected in many" 5 "basophil: 37.7;T-reg: 15.1" "Group enriched" "Detected in many" 71 "granulocytes: 37.7;T-cells: 15.1" "Cell line enhanced" "Detected in some" "A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004919, HPA005679" Enhanced Supported Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA004919: AB_1079081, HPA005679: AB_1079080" "unprognostic (1.23e-3)" "unprognostic (1.61e-1)" "unprognostic (5.96e-2)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (2.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.28e-2)" "unprognostic (3.54e-3)" "unprognostic (2.34e-2)" "prognostic favorable (3.20e-4)" "unprognostic (2.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.37e-4)" "unprognostic (2.33e-2)" 5.1 2.6 0.5 7.9 0.6 0.0 24.6 0.4 0.6 23.0 73.3 0.5 2.5 22.9 13.4 7.5 32.0 4.5 10.7 1.2 0.6 0.7 8.5 63.7 22.9 7.9 0.8 0.5 2.3 0.4 0.0 0.9 193.3 3.8 20.1 8.4 4.6 3.0 1.1 1.6 15.3 64.5 9.3 0.5 2.9 36.3 1.9 0.5 5.5 0.4 5.0 7.9 61.2 31.8 0.1 0.2 37.7 0.1 0.3 15.1 1.0 0.0 27.7 0.0 0.0 17.2 1.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 2.5 2.5 0.0 0.0 0.0 0.5 60.6 2.1 0.0 0.0 0.3 0.1 0.9 0.4 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.2 15.8 1.4 2.8 0.0 0.2 5.7 94.3 0.1 0.1 0.0 0.2 0.6 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 37.7 0.1 5.4 3.7 0.0 5.7 0.1 1.9 1.6 0.2 0.0 0.6 1.5 0.4 0.3 0.0 0.0 15.1 1.0 0.5 0.6 0.4 0.6 0.6 0.7 0.8 0.5 3.8 0.5 14.9 46.1 5.2 57.7 15.3 3.1 0.4 43.3 5.3 20.5 21.0 0.0 25.6 18.3 2.4 1.1 0.5 273.6 0.0 86.5 488.8 12.1 51.1 816.1 165.7 20.7 0.0 8.1 18.4 16.1 0.2 18.4 10.6 72.6 1.0 48.2 0.0 26.0 217.5 0.0 68.8 0.6 0.0 6.6 0.4 0.4 19.6 47.4 50.3 31.0 266.0 HPGDS "GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS" ENSG00000163106 "Hematopoietic prostaglandin D synthase" O60760 4 94298535-94342876 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.8" "Group enriched" "Detected in many" 10 "granulocytes: 1000.1;Hofbauer cells: 476.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 15.8" "Lineage enriched" "Detected in single" 25 "granulocytes: 15.8" "Group enriched" "Detected in some" 8 "HEL: 32.4;HMC-1: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA024035 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 170000 "Vesicles, Cytosol" Nucleoplasm "HPA024035: AB_1855743" "unprognostic (5.71e-2)" "unprognostic (5.80e-3)" "unprognostic (1.17e-1)" "unprognostic (5.36e-3)" "unprognostic (2.76e-1)" "unprognostic (2.38e-4)" "unprognostic (1.01e-2)" "unprognostic (4.41e-3)" "unprognostic (1.35e-1)" "unprognostic (7.75e-4)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (5.15e-3)" "unprognostic (4.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" 14.3 2.9 8.0 1.6 12.1 1.6 5.8 2.0 7.7 5.4 6.9 4.4 0.2 7.5 4.7 3.3 4.1 2.5 9.3 3.0 8.4 3.6 2.5 1.3 12.7 0.9 9.6 2.4 1.5 1.8 1.7 1.5 24.8 9.0 6.4 7.5 2.9 3.8 2.2 1.4 5.8 8.6 5.8 14.6 1.4 4.4 1.8 12.1 1.5 1.2 2.8 1.5 4.5 3.5 0.0 0.1 15.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 2.5 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 8.0 12.1 2.0 7.7 8.4 3.6 9.6 2.4 9.0 12.1 11.9 75.3 0.0 0.8 3.7 0.0 0.0 0.0 2.7 6.8 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 4.1 4.0 1000.1 0.0 476.4 0.0 6.8 0.0 3.9 0.0 0.3 14.5 3.3 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.1 4.6 4.6 0.0 0.0 0.1 HPRT1 "HGPRT, HPRT" ENSG00000165704 "Hypoxanthine phosphoribosyltransferase 1" P00492 X 134460153-134520513 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease mutation, FDA approved drug targets, Gout" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 192.3;monocytes: 181.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006360, CAB012200" Enhanced Supported Cytosol NA NA 15000000 Cytosol "CAB012200: AB_297217, HPA006360: AB_1079082" "unprognostic (2.02e-1)" "unprognostic (2.18e-1)" "unprognostic (1.46e-1)" "unprognostic (2.32e-3)" "unprognostic (8.55e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (1.58e-2)" "unprognostic (4.77e-3)" "unprognostic (4.93e-2)" "unprognostic (2.02e-2)" "unprognostic (7.05e-2)" "unprognostic (1.38e-3)" "unprognostic (6.00e-2)" "unprognostic (2.12e-1)" "unprognostic (2.04e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" 7.9 14.9 31.0 12.6 30.2 25.3 11.3 24.2 49.8 7.5 13.7 5.8 9.8 11.0 7.9 36.2 10.3 9.4 8.1 12.8 27.6 37.3 18.4 24.7 7.3 15.9 23.5 28.9 9.8 20.2 9.9 18.6 8.8 34.4 8.8 13.2 9.7 7.1 9.5 10.7 8.0 14.2 9.5 9.8 8.7 17.1 39.7 4.9 13.7 12.3 8.6 15.9 10.8 7.5 13.5 19.7 10.1 18.5 19.9 29.3 12.6 31.4 15.1 4.3 8.8 9.6 13.9 13.0 16.8 16.2 21.5 28.4 13.6 20.2 35.6 38.3 10.9 25.7 19.3 27.7 23.0 37.2 29.5 51.9 19.3 21.5 13.8 9.5 41.5 17.8 10.2 8.7 19.2 30.6 11.9 24.8 21.2 14.8 0.9 16.8 32.1 32.0 36.0 8.8 37.1 40.8 19.2 21.8 36.5 25.9 15.3 27.2 14.8 12.1 9.9 11.4 12.2 8.4 17.4 12.2 14.6 11.0 41.9 41.7 13.6 23.5 0.2 18.0 46.1 8.0 2.2 11.6 10.1 11.6 18.5 16.7 12.3 17.3 15.3 19.7 13.5 14.3 15.1 2.9 19.9 17.2 8.2 29.3 12.6 31.0 30.2 24.2 49.8 27.6 37.3 23.5 28.9 34.4 4.9 17.9 8.0 31.0 44.7 35.1 39.0 20.7 33.1 24.1 15.9 54.1 3.9 12.2 192.3 35.3 6.9 29.4 17.7 0.0 28.2 23.6 24.0 37.5 34.6 18.1 62.7 23.8 26.4 15.4 61.4 18.0 37.7 64.9 52.3 181.3 22.6 23.4 31.4 22.6 25.1 21.6 59.2 51.8 47.2 74.7 143.7 33.9 5.0 61.0 37.4 39.6 HPS5 "AIBP63, BLOC2S2, RU2" ENSG00000110756 "HPS5, biogenesis of lysosomal organelles complex 2 subunit 2" Q9UPZ3 11 18278668-18322198 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Albinism, Disease mutation, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 89.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077851 Approved Supported Cytosol NA NA Cytosol "HPA077851: " "unprognostic (2.25e-2)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "unprognostic (2.59e-1)" "unprognostic (9.85e-3)" "unprognostic (5.89e-1)" "unprognostic (1.47e-2)" "unprognostic (1.55e-1)" "unprognostic (1.61e-1)" "unprognostic (5.20e-2)" "unprognostic (1.51e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.06e-1)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (2.72e-1)" 7.1 9.0 6.7 8.4 7.7 4.5 15.2 6.9 6.1 6.0 8.6 8.0 3.2 8.7 5.5 4.2 7.5 5.5 5.7 6.2 6.5 6.0 8.9 35.7 12.5 11.9 8.1 4.3 7.7 9.9 8.1 18.0 13.5 7.9 5.1 4.8 15.9 20.7 7.1 5.5 6.1 18.6 5.9 11.6 15.1 4.8 17.5 7.8 9.2 7.7 4.3 15.3 6.2 5.5 10.0 14.7 15.7 9.8 4.5 5.0 4.2 6.2 9.3 9.9 10.0 13.4 7.5 10.8 16.5 13.7 10.9 11.6 5.7 2.0 15.2 6.5 14.3 13.8 9.0 11.5 10.9 13.5 12.7 8.4 7.3 7.7 7.0 12.7 16.0 13.7 12.0 11.1 6.7 14.4 11.2 8.7 9.8 9.6 8.9 17.6 5.1 8.4 11.6 5.0 7.2 10.3 12.5 14.2 6.4 10.6 5.7 3.3 6.5 20.8 7.5 24.6 10.3 5.6 9.3 6.5 12.6 6.8 16.3 7.6 3.8 12.4 17.5 7.0 8.3 35.4 15.7 6.2 4.9 4.1 9.6 5.0 10.0 5.0 4.1 14.7 8.6 5.0 4.9 1.8 4.5 9.8 5.7 4.4 4.2 6.7 7.7 6.9 6.1 6.5 6.0 8.1 4.3 7.9 7.8 89.3 10.5 10.0 12.5 13.9 18.0 15.3 15.3 10.7 7.9 7.0 29.5 17.6 5.0 4.5 40.4 9.7 6.7 0.0 7.3 9.4 9.7 13.5 13.9 34.8 16.2 9.5 10.3 9.8 18.6 12.8 7.8 23.5 27.0 37.9 4.6 14.6 5.9 6.0 12.4 5.7 25.2 6.5 9.2 15.0 11.7 13.4 14.5 8.7 5.0 20.3 HRAS HRAS1 ENSG00000174775 "HRas proto-oncogene, GTPase" P01112 11 532242-537287 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002015, HPA049830, HPA070222" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB002015: , HPA049830: AB_2680903, HPA070222: " "unprognostic (3.06e-2)" "unprognostic (2.98e-2)" "unprognostic (7.01e-2)" "unprognostic (3.08e-3)" "unprognostic (3.49e-3)" "unprognostic (3.87e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (1.50e-1)" "unprognostic (2.88e-3)" "unprognostic (9.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.58e-2)" "unprognostic (1.38e-1)" 12.3 11.4 25.2 9.1 34.5 5.0 16.2 16.1 25.3 7.9 9.5 8.1 10.8 8.9 6.2 9.2 22.3 8.3 10.9 28.7 22.2 22.4 8.2 6.5 8.9 8.0 23.2 12.9 7.7 9.7 11.7 10.3 10.1 15.0 10.0 6.2 8.2 10.1 12.7 51.8 32.0 8.2 8.4 17.0 6.5 7.2 6.1 11.0 5.9 8.1 24.5 9.3 9.9 19.8 2.1 1.1 0.7 4.6 0.1 2.0 0.3 22.1 19.7 9.4 8.4 5.8 4.1 12.2 11.0 5.9 17.4 14.8 9.9 8.8 8.6 3.4 15.0 12.3 17.6 10.0 26.8 4.9 7.0 22.4 4.4 7.9 8.6 8.9 3.5 3.4 6.3 30.0 9.4 10.2 3.6 8.6 7.2 8.9 12.5 9.7 18.2 12.9 12.2 9.6 7.7 19.5 10.3 11.9 7.6 9.7 5.5 36.7 14.6 10.3 18.3 7.9 5.9 15.0 6.8 13.7 15.5 12.2 5.7 14.2 4.6 6.2 6.5 14.6 6.4 14.5 0.0 0.6 0.7 1.4 1.2 1.6 0.8 1.4 1.3 0.7 2.1 2.0 0.6 0.0 0.1 4.6 1.1 2.0 0.3 25.2 34.5 16.1 21.1 22.2 22.4 23.2 12.9 15.0 11.0 11.9 12.5 12.6 82.5 116.5 44.6 21.9 15.3 17.4 4.5 33.2 17.7 72.6 63.0 32.7 1.1 22.2 44.1 0.0 32.3 45.3 34.0 46.2 2.3 13.4 33.9 46.1 28.2 19.0 7.6 5.2 15.8 17.6 60.8 16.2 22.1 28.3 35.8 21.0 21.5 42.9 29.1 32.3 38.7 4.7 23.4 127.5 65.3 12.2 21.3 96.6 HRASLS "H-REV107, HRASLS1" ENSG00000127252 "HRAS like suppressor" 3 193241125-193277738 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "skeletal muscle: 40.9;testis: 42.1" "Cell type enriched" "Detected in many" 4 "Early spermatids: 449.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "HAP1: 8.7;NTERA-2: 7.6;PC-3: 16.8;RH-30: 7.4;SCLC-21H: 15.3;U-2 OS: 9.3;U-251 MG: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051179 Uncertain Approved "Focal adhesion sites,Cytosol" No No "Focal adhesion sites" Cytosol "HPA051179: AB_2681375" "unprognostic (3.01e-2)" "unprognostic (4.21e-2)" "unprognostic (7.93e-3)" "unprognostic (4.82e-3)" "unprognostic (2.79e-1)" "unprognostic (1.87e-1)" "unprognostic (9.97e-3)" "unprognostic (9.68e-3)" "unprognostic (1.84e-1)" "unprognostic (3.55e-1)" "unprognostic (1.77e-4)" "unprognostic (5.09e-2)" "unprognostic (1.38e-5)" "unprognostic (1.61e-2)" "prognostic favorable (4.36e-4)" "unprognostic (2.98e-3)" "unprognostic (1.13e-2)" 0.6 1.1 1.8 0.2 3.1 0.1 1.0 0.6 3.3 0.5 0.6 1.7 0.0 0.1 0.6 3.1 2.4 0.5 0.2 4.3 2.0 1.1 0.6 0.6 0.5 0.1 1.5 2.1 0.6 0.8 0.5 0.7 0.1 2.4 0.5 0.1 3.1 6.1 0.5 40.9 1.7 0.6 0.7 0.6 0.6 0.6 42.1 1.7 0.2 3.7 6.2 0.2 0.5 0.6 0.0 0.2 1.7 0.1 0.0 0.0 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.3 0.0 0.1 0.0 0.1 0.0 3.7 0.0 8.7 0.2 0.4 0.0 3.9 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.6 0.2 16.8 0.0 7.4 0.0 2.5 0.0 15.3 2.9 1.0 2.2 0.0 1.4 4.4 0.0 0.1 0.0 9.3 0.0 11.7 0.0 0.0 0.0 4.8 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 6.2 1.8 3.1 0.6 3.3 2.0 1.1 1.5 2.1 2.4 1.7 0.0 0.0 0.0 0.1 0.9 10.8 10.6 2.5 0.0 1.2 0.0 31.4 0.7 0.0 0.7 449.3 0.6 0.0 0.0 0.2 0.8 0.4 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.3 85.3 6.9 0.8 1.7 0.0 0.0 1.6 0.5 0.0 4.6 0.1 5.6 0.0 0.4 112.1 25.2 5.4 0.3 0.0 0.0 0.0 HRH1 ENSG00000196639 "Histamine receptor H1" P35367 3 11137093-11263557 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 41.0;Club cells: 30.7;Enterocytes: 29.3;Suprabasal keratinocytes: 36.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 3.5" "Group enriched" "Detected in many" 7 "granulocytes: 1.2;T-cells: 3.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.5;hTEC/SVTERT24-B: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029740 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA029740: AB_10601578" "unprognostic (4.60e-3)" "unprognostic (3.41e-2)" "unprognostic (6.37e-3)" "unprognostic (9.55e-2)" "unprognostic (3.32e-2)" "unprognostic (1.07e-2)" "unprognostic (9.60e-3)" "unprognostic (4.00e-3)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (1.27e-5)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-2)" "unprognostic (7.19e-2)" "unprognostic (1.20e-1)" 9.1 4.4 7.3 4.6 4.4 0.2 9.6 0.5 10.6 8.0 13.5 1.3 2.4 3.8 6.2 7.2 5.7 10.6 9.9 7.0 5.1 4.0 3.3 1.1 8.2 1.8 2.2 2.1 8.7 2.1 1.7 1.2 5.5 3.2 7.2 7.2 2.0 3.4 6.1 3.0 8.0 10.5 9.2 8.6 1.4 3.3 2.4 2.0 0.1 2.5 7.2 3.1 11.2 16.2 0.1 0.3 1.2 0.2 0.1 3.5 0.1 1.5 3.5 0.0 0.0 1.6 17.5 2.4 2.6 8.8 7.8 5.3 0.6 12.6 0.0 7.8 6.1 8.0 9.9 0.0 3.6 10.7 5.5 0.0 0.8 5.7 0.0 5.3 2.4 1.4 6.1 2.2 17.7 6.2 10.9 10.9 0.1 0.0 0.0 3.5 0.0 0.0 1.1 0.0 1.5 3.2 0.2 0.9 0.3 14.0 2.0 0.1 0.0 3.7 2.7 0.0 0.1 0.0 2.0 16.2 8.8 5.5 9.0 13.1 0.0 0.9 0.0 13.5 2.2 7.6 0.4 0.2 0.0 0.1 0.2 0.0 0.0 1.3 0.5 0.3 0.1 0.1 0.1 1.2 0.1 0.0 0.1 3.5 0.1 7.3 4.4 0.5 8.4 5.1 4.0 2.2 2.1 3.2 2.0 6.0 1.4 0.0 7.7 41.0 0.0 0.4 0.0 2.7 30.7 1.8 0.0 0.2 0.0 0.4 0.3 9.3 29.3 0.0 0.6 1.0 6.7 3.9 2.3 0.0 21.0 0.0 3.4 0.6 6.9 0.0 3.4 5.7 0.0 0.0 8.0 0.0 8.3 11.4 0.0 0.3 0.1 0.0 2.3 2.3 2.8 36.3 0.5 0.0 8.8 18.2 HS1BP3 "FLJ14249, HS1-BP3" ENSG00000118960 "HCLS1 binding protein 3" Q53T59 2 20560448-20651089 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035050 Approved Approved Nucleoli,Cytosol No No 32000 Nucleoli Cytosol "HPA035050: AB_10601816" "unprognostic (4.52e-2)" "unprognostic (5.93e-2)" "unprognostic (2.67e-1)" "unprognostic (4.39e-1)" "unprognostic (4.61e-2)" "unprognostic (1.45e-3)" "prognostic unfavorable (2.97e-5)" "unprognostic (2.06e-3)" "unprognostic (1.88e-2)" "unprognostic (2.16e-1)" "unprognostic (9.53e-2)" "unprognostic (8.00e-2)" "prognostic favorable (2.30e-4)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-1)" 17.9 23.1 10.4 8.8 15.7 10.7 11.8 6.7 17.6 17.6 22.6 21.3 14.3 11.7 17.6 18.6 22.6 13.9 28.4 17.5 11.0 9.1 18.5 47.8 14.2 11.7 16.7 9.4 14.8 13.9 10.6 14.3 22.3 13.5 20.3 11.7 17.0 12.9 17.3 9.6 17.0 16.0 27.3 13.8 14.5 16.4 9.7 14.1 6.6 18.5 8.0 9.9 20.8 17.1 6.0 8.0 14.6 13.3 2.9 5.3 6.1 8.4 9.9 5.0 6.1 26.6 17.9 9.9 3.2 15.0 7.7 10.1 7.7 10.3 5.7 2.6 4.7 35.0 5.3 9.9 10.2 3.7 7.3 8.2 3.0 5.0 25.6 25.0 2.3 13.3 18.9 23.9 8.7 16.2 9.2 14.6 5.1 1.9 12.3 8.7 7.3 1.0 3.9 4.1 12.5 7.2 5.5 10.1 5.5 17.1 10.3 4.7 7.3 2.3 10.1 19.2 10.6 6.3 4.7 9.4 7.7 8.3 11.7 4.9 8.8 9.8 5.2 16.5 10.8 8.1 11.4 11.3 11.0 5.3 11.2 3.7 6.0 3.2 4.0 8.0 4.0 2.7 2.8 14.6 2.9 13.3 3.0 2.9 6.1 10.4 15.7 6.7 17.6 11.0 9.1 16.7 9.4 13.5 14.1 6.0 17.0 9.3 7.5 3.9 3.8 6.1 7.6 10.7 14.8 7.0 0.0 7.7 14.9 17.0 16.8 4.9 13.5 23.3 12.9 14.6 8.0 7.2 2.3 8.2 26.5 14.3 6.4 10.4 16.7 28.4 7.8 10.9 13.5 10.8 6.1 8.6 10.8 7.8 9.9 21.3 4.9 0.0 15.6 11.6 9.6 4.5 14.6 7.5 6.6 4.6 HSCB "DNAJC20, HSC20, Jac1" ENSG00000100209 "HscB mitochondrial iron-sulfur cluster cochaperone" Q8IWL3 22 28742031-28757515 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018447, HPA031518" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA018447: AB_1853867, HPA031518: AB_2673919" "unprognostic (8.19e-3)" "unprognostic (6.48e-2)" "unprognostic (9.62e-3)" "prognostic favorable (3.78e-4)" "unprognostic (3.30e-1)" "unprognostic (7.02e-2)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "unprognostic (5.83e-2)" "unprognostic (7.38e-3)" "unprognostic (4.44e-1)" "unprognostic (2.81e-1)" "unprognostic (1.54e-3)" "unprognostic (2.19e-1)" "unprognostic (3.39e-1)" "unprognostic (2.12e-1)" "prognostic favorable (8.38e-4)" 9.6 18.8 13.1 9.2 13.9 4.9 12.4 13.7 12.9 14.1 11.6 9.1 20.3 13.7 11.5 8.8 11.8 10.4 11.4 9.6 12.3 8.3 12.9 29.5 7.3 15.5 15.8 9.0 16.5 15.2 6.2 16.1 8.7 10.6 15.9 7.7 8.2 28.2 17.5 14.6 9.2 10.0 8.9 12.2 10.9 12.8 6.0 13.2 6.9 14.4 8.1 10.3 15.0 10.5 12.9 11.3 7.7 14.4 9.7 8.5 5.8 9.3 6.0 2.5 3.8 4.6 11.8 4.8 6.9 9.7 10.3 6.3 2.6 3.4 10.6 3.3 3.8 2.5 6.6 4.8 4.5 4.9 10.0 19.5 3.6 4.7 7.4 9.8 6.6 5.4 7.9 9.9 5.7 9.0 5.3 7.8 3.2 5.6 9.3 4.1 13.5 3.0 6.1 6.0 10.3 14.8 6.0 7.8 11.9 11.1 2.7 8.5 7.7 3.8 14.6 18.4 2.1 6.0 4.1 4.1 14.1 7.4 13.3 6.2 13.1 10.7 9.1 9.9 4.9 9.3 7.7 7.9 3.6 6.3 14.4 7.6 12.9 6.4 7.4 11.3 9.9 7.0 8.5 0.4 9.7 11.0 5.9 4.8 5.8 13.1 13.9 13.7 12.9 12.3 8.3 15.8 9.0 10.6 13.2 20.8 15.8 20.1 22.7 10.3 4.8 6.0 22.9 32.1 26.1 19.2 5.9 13.2 24.9 21.9 3.3 15.8 10.3 0.0 24.7 12.0 16.6 18.9 22.0 33.0 23.7 4.8 19.0 17.2 14.9 2.6 17.3 18.5 13.5 19.8 13.1 9.7 21.0 7.0 11.0 37.1 8.1 6.5 15.6 12.2 16.1 13.7 11.1 17.8 19.7 12.8 HSD17B1 "EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1" ENSG00000108786 "Hydroxysteroid 17-beta dehydrogenase 1" P14061 17 42549214-42555213 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 217.6" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 1251.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 8 "BEWO: 89.7" "Low region specificity" "Detected in single" "HPA021032, HPA065296" Enhanced Supported Cytosol NA NA Cytosol "HPA021032: AB_1844345, HPA065296: AB_2685457" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (1.68e-2)" "unprognostic (9.25e-2)" "unprognostic (1.73e-1)" "unprognostic (3.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (9.35e-2)" "unprognostic (6.04e-2)" "unprognostic (2.88e-5)" "unprognostic (2.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.60e-2)" "unprognostic (5.09e-1)" "unprognostic (4.98e-1)" "unprognostic (1.32e-2)" 2.8 1.5 2.0 1.7 2.1 1.1 1.8 2.7 3.1 1.3 1.3 1.3 1.3 1.9 1.5 1.3 4.3 1.4 1.3 1.4 2.4 1.4 1.4 1.3 1.3 1.6 2.4 1.3 5.8 2.6 0.2 1.4 217.6 1.3 1.5 0.2 1.3 2.9 1.3 3.5 4.1 1.9 1.3 1.9 2.1 2.0 2.3 1.3 1.3 1.8 1.3 1.3 1.3 1.8 6.0 5.5 7.5 8.6 6.1 5.4 5.5 1.6 1.8 0.9 4.6 0.6 0.1 89.7 1.2 0.0 0.0 0.0 1.0 0.9 0.0 1.2 0.0 1.0 2.6 0.1 0.7 0.0 2.4 2.8 1.2 1.1 1.5 0.2 1.0 1.4 0.2 2.6 0.1 0.5 1.5 0.0 1.3 1.7 0.4 0.0 1.6 1.3 1.1 0.4 0.6 0.8 1.3 1.1 0.8 0.1 1.4 1.3 1.8 0.7 9.1 1.4 1.0 11.0 0.8 1.4 1.4 1.8 1.0 0.8 2.6 1.5 0.6 0.6 0.9 1.1 3.6 7.6 7.5 4.9 8.6 5.3 5.6 5.4 5.1 5.5 6.0 5.1 4.4 7.2 6.1 5.3 4.3 3.7 5.5 2.0 2.1 2.7 1.5 2.4 1.4 2.4 1.3 1.3 1.3 0.0 2.1 0.5 6.3 2.7 8.7 2.4 2.5 4.0 2.3 5.2 11.8 250.4 19.9 1.5 1.0 4.1 3.2 0.0 4.9 23.6 3.4 13.0 2.3 5.6 26.4 9.5 4.1 4.9 0.8 1.7 1.7 0.5 1.7 1.0 2.4 9.0 2.0 2.5 3.2 10.5 8.2 0.0 2.8 0.7 2.6 6.5 1251.0 1.3 1.9 8.4 HSF1 HSTF1 ENSG00000185122 "Heat shock transcription factor 1" Q00613 8 144291591-144314722 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 199.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004239, HPA008888" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004239: AB_627753, HPA008888: AB_1079088" "unprognostic (7.08e-2)" "unprognostic (1.89e-2)" "unprognostic (6.07e-2)" "prognostic unfavorable (8.93e-4)" "unprognostic (1.55e-1)" "unprognostic (5.63e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (5.69e-3)" "unprognostic (1.05e-1)" "unprognostic (4.35e-2)" "unprognostic (1.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-2)" "unprognostic (2.23e-1)" "unprognostic (2.13e-1)" "unprognostic (1.12e-1)" 24.7 22.9 17.4 21.0 20.9 20.8 30.8 24.4 23.6 21.3 26.9 18.3 17.7 18.9 23.3 16.7 25.5 28.5 22.9 42.8 17.0 17.5 21.2 19.5 20.3 23.6 17.4 15.9 32.4 36.8 25.8 21.8 22.8 17.8 26.7 15.2 20.7 26.4 24.6 55.2 20.3 17.8 35.1 14.4 20.3 23.6 42.6 17.8 23.2 29.9 24.2 19.8 30.3 33.9 16.9 20.3 20.3 24.2 12.9 18.4 14.2 14.9 20.3 8.8 7.5 14.8 13.9 14.6 11.2 10.1 11.1 9.7 13.5 13.1 17.2 16.5 15.5 10.9 10.9 13.4 16.1 7.1 10.9 15.4 21.6 20.8 18.4 23.3 6.2 16.7 13.4 15.1 15.6 28.8 11.9 14.9 15.8 14.3 10.3 11.1 30.3 21.0 9.5 11.3 19.5 58.5 13.7 7.6 21.8 7.9 15.2 13.2 10.7 17.1 13.7 19.8 9.6 15.5 12.8 15.1 11.5 25.8 18.0 18.3 7.2 5.5 14.7 16.3 11.7 10.9 10.6 18.9 20.3 14.5 19.9 15.2 16.9 15.7 18.4 20.3 15.5 15.6 13.9 8.1 12.9 24.2 10.3 18.1 14.2 17.4 20.9 24.4 23.6 17.0 17.5 17.4 15.9 17.8 17.8 6.0 9.1 21.9 60.6 45.6 58.9 41.2 17.8 10.7 19.4 27.9 58.9 60.8 127.6 35.7 199.9 36.5 42.1 116.8 35.5 68.5 39.0 54.5 38.0 51.9 43.8 65.2 39.3 33.7 16.6 84.0 34.5 33.3 32.1 83.0 34.7 20.4 41.5 46.0 40.3 29.1 29.9 58.2 52.3 56.5 53.2 39.6 92.8 41.7 42.2 66.0 HSF2BP ENSG00000160207 "Heat shock transcription factor 2 binding protein" O75031 21 43529192-43659493 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 28.5" "Group enriched" "Detected in many" 6 "Early spermatids: 98.0;Late spermatids: 32.5;Spermatocytes: 127.5;Spermatogonia: 47.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.5;NK-cells: 1.5;T-cells: 2.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 14.6" "Low region specificity" "Detected in some" "HPA031724, HPA075775" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031724: AB_10601022, HPA075775: " "unprognostic (1.91e-2)" "unprognostic (1.19e-1)" "unprognostic (7.27e-3)" "unprognostic (1.54e-4)" "unprognostic (2.62e-1)" "unprognostic (1.78e-2)" "unprognostic (9.36e-4)" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-1)" "unprognostic (3.11e-1)" "unprognostic (1.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.77e-4)" "unprognostic (6.00e-2)" 0.7 0.8 1.3 0.6 3.1 0.5 1.1 1.4 4.1 0.9 0.6 3.5 1.8 0.6 1.1 1.1 0.8 1.2 0.7 0.7 1.3 1.5 0.8 0.6 0.6 0.7 2.3 3.0 1.4 0.6 1.2 2.3 1.6 2.7 0.8 0.6 2.6 1.2 1.4 0.5 0.8 0.7 0.7 2.0 0.5 0.7 28.5 1.6 1.0 1.0 0.0 0.6 0.8 0.8 1.5 0.2 0.0 0.1 1.5 2.8 0.8 5.1 1.1 1.4 0.6 0.2 1.4 1.3 1.8 1.1 1.9 1.6 6.9 5.1 3.9 2.9 1.0 6.6 2.0 0.7 14.6 0.6 1.0 1.3 0.6 2.2 0.4 1.7 1.6 0.4 0.9 9.6 0.8 4.5 8.8 0.5 2.3 1.5 1.2 4.5 0.9 2.2 1.6 4.5 1.2 2.2 3.3 1.4 0.5 2.3 1.0 1.5 1.1 3.8 1.9 2.0 0.6 2.0 1.9 2.9 1.0 3.5 0.2 2.7 1.4 0.9 3.1 1.0 3.4 2.6 0.0 0.1 0.0 0.2 0.0 1.6 1.2 0.5 1.4 0.2 1.5 2.7 2.8 0.0 1.5 0.1 0.2 0.0 0.8 1.3 3.1 1.4 3.6 1.3 1.5 2.3 3.0 2.7 1.6 0.0 0.0 0.0 1.2 0.8 1.0 0.4 0.0 4.0 1.2 0.0 0.0 1.5 0.0 1.0 98.0 0.1 0.0 0.0 0.2 2.3 1.0 0.7 0.0 0.0 0.6 0.0 0.0 0.6 0.0 32.5 1.7 0.3 0.0 0.0 0.0 2.3 1.6 0.0 1.4 0.5 2.5 12.9 1.0 127.5 47.1 0.4 0.7 0.0 0.0 1.0 HSH2D "ALX, FLJ14886, HSH2" ENSG00000196684 "Hematopoietic SH2 domain containing" Q96JZ2 19 16134028-16158575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.4;lymphoid tissue: 33.8" "Cell type enhanced" "Detected in many" 14 "B-cells: 71.7;T-cells: 40.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "basophil: 47.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 13.2;HL-60: 13.7;HMC-1: 18.9;NB-4: 44.6;RPMI-8226: 20.0;U-266/84: 12.9;U-937: 43.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036616 Approved "Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA036616: AB_10671962" "unprognostic (1.69e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (9.46e-6)" "unprognostic (1.06e-1)" "unprognostic (5.50e-3)" "unprognostic (5.21e-3)" "unprognostic (9.35e-2)" "unprognostic (4.78e-2)" "unprognostic (4.21e-3)" "unprognostic (9.96e-2)" "unprognostic (1.57e-2)" "unprognostic (2.22e-2)" "prognostic unfavorable (6.49e-6)" "unprognostic (9.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.21e-2)" "prognostic favorable (3.47e-5)" 1.2 1.1 1.2 31.5 1.1 19.2 1.2 1.1 1.1 1.4 8.9 0.0 5.2 5.5 1.1 6.2 2.0 1.5 10.3 1.2 1.1 1.1 1.3 1.5 6.0 16.7 1.0 0.0 1.1 4.8 0.9 3.7 2.3 0.3 2.2 4.0 1.0 8.8 5.2 1.1 1.1 12.1 0.7 1.1 21.8 5.4 1.1 0.0 8.5 1.7 2.4 33.8 4.7 1.1 14.5 6.0 47.4 8.4 19.0 4.3 3.6 4.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 7.0 13.2 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.7 0.0 0.2 0.1 0.8 0.0 13.7 18.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 12.4 0.0 2.8 0.0 44.6 0.0 1.7 0.0 0.9 0.0 20.0 0.1 1.8 0.0 0.0 0.0 0.4 0.1 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 1.9 12.9 7.3 0.0 43.8 0.0 47.4 3.7 23.0 4.3 5.0 3.9 14.5 1.9 2.8 6.0 8.6 1.8 2.3 43.7 19.0 8.4 1.8 2.9 3.6 1.2 1.1 1.1 1.1 1.1 1.1 1.0 0.0 0.3 0.0 3.0 9.9 71.7 0.7 0.2 0.0 0.6 2.5 4.0 4.5 5.2 0.0 2.1 0.0 5.3 0.0 0.0 13.5 0.0 4.4 3.1 0.4 4.3 5.8 0.0 1.1 0.0 8.1 1.8 1.5 0.0 0.0 2.5 10.1 2.8 14.1 0.0 6.8 10.5 0.0 0.3 0.0 0.0 0.3 0.0 0.5 0.1 2.9 40.6 7.7 3.2 HSP90AA1 "FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA" ENSG00000080824 "Heat shock protein 90 alpha family class A member 1" P07900 14 102080738-102139699 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 519.3" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 6915.7;Urothelial cells: 5558.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002058 Approved Supported Cytosol NA NA 94000000 Cytosol "CAB002058: " "prognostic unfavorable (5.59e-4)" "unprognostic (3.77e-2)" "unprognostic (1.78e-2)" "unprognostic (9.25e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (7.79e-3)" "unprognostic (5.71e-2)" "unprognostic (7.81e-3)" "unprognostic (3.68e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.18e-5)" "unprognostic (1.04e-1)" "unprognostic (2.54e-1)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" 50.8 75.3 96.1 46.7 106.8 64.1 118.6 81.3 113.4 51.0 47.3 50.7 43.0 31.0 40.7 55.5 40.9 94.7 61.0 70.9 99.6 113.3 75.6 62.5 51.7 48.1 134.4 58.6 53.4 40.1 94.9 121.6 67.2 143.6 63.2 53.3 23.4 57.0 57.0 65.2 35.6 38.9 51.0 139.7 35.7 41.3 84.6 132.7 53.5 91.5 34.3 59.5 54.2 519.3 30.7 46.9 31.8 29.9 57.7 63.1 21.9 86.8 118.8 75.9 52.3 46.1 39.0 100.8 96.7 46.5 118.6 66.9 72.1 81.6 106.8 91.1 62.1 77.8 96.5 217.7 94.5 216.3 80.8 71.7 82.4 67.9 92.0 22.8 122.7 63.6 36.6 40.2 75.8 27.9 74.2 65.4 115.4 113.8 54.9 107.3 117.4 131.1 56.4 78.8 160.2 112.4 126.5 103.1 46.1 68.8 112.3 100.0 72.2 122.2 92.0 53.9 132.9 118.3 49.0 46.2 83.0 53.7 123.3 183.5 52.0 162.1 158.0 78.5 75.9 99.9 31.8 19.9 24.0 47.8 29.9 63.1 29.6 40.5 49.0 23.9 30.7 30.1 43.5 13.5 57.7 27.5 46.9 39.2 21.9 96.1 106.8 81.3 102.7 99.6 113.3 134.4 58.6 143.6 132.7 1057.1 642.7 718.4 6915.7 1191.0 1040.4 2043.0 677.7 2973.9 1019.1 486.8 1981.1 1152.8 290.1 998.3 319.6 818.5 645.6 934.5 749.7 1610.0 1217.1 2796.5 903.1 527.2 1188.6 683.3 908.6 338.8 568.8 289.5 677.7 1578.9 1233.2 998.3 507.2 1211.6 739.1 659.3 679.6 610.3 3287.9 608.0 1393.6 3574.3 1881.8 973.5 1714.6 761.4 693.9 5558.4 HSP90AB1 "HSPC2, HSPCB" ENSG00000096384 "Heat shock protein 90 alpha family class B member 1" P08238 6 44246166-44253888 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 3438.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005230, HPA055729, HPA072606, HPA074351" Enhanced Supported Cytosol "Intracellular and membrane" NA Yes 62000000 Cytosol "CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252" "unprognostic (6.12e-3)" "unprognostic (2.96e-3)" "unprognostic (4.72e-2)" "unprognostic (9.24e-2)" "unprognostic (4.20e-1)" "unprognostic (1.15e-3)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "unprognostic (7.97e-2)" "prognostic favorable (4.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (3.02e-1)" "unprognostic (9.53e-2)" "unprognostic (2.63e-1)" "unprognostic (1.06e-1)" 79.9 116.1 88.0 65.9 105.0 74.6 107.8 92.1 118.2 92.3 60.4 61.7 80.9 40.6 113.3 107.6 71.6 138.4 63.8 115.0 89.0 110.5 72.0 70.7 76.2 73.8 109.7 94.4 238.4 113.9 151.6 95.3 83.6 133.7 93.5 76.4 52.7 64.8 100.3 197.1 67.9 49.0 102.1 93.9 57.5 77.3 45.9 100.2 58.3 133.8 89.8 102.5 86.2 223.4 75.9 50.5 7.2 45.7 55.7 82.5 74.9 135.6 87.0 77.3 95.0 53.1 55.6 81.0 61.3 60.1 113.6 80.0 130.1 41.6 173.8 66.5 63.8 115.6 79.1 188.1 91.3 140.6 57.5 76.1 135.2 49.3 170.0 38.5 135.0 93.7 51.4 61.8 89.2 77.1 99.7 108.6 89.9 180.5 64.9 77.2 137.0 112.4 81.4 90.2 251.8 66.7 108.5 79.1 95.4 76.8 82.5 113.3 69.2 47.6 69.1 86.0 109.7 89.8 67.6 68.1 67.8 113.5 55.4 140.0 75.2 117.8 313.9 73.7 99.3 77.2 7.2 30.2 6.8 49.3 45.7 82.5 75.9 55.2 56.4 50.5 63.2 75.2 71.3 3.7 55.7 43.3 31.4 42.6 74.9 88.0 105.0 92.1 118.2 89.0 110.5 109.7 94.4 133.7 100.2 833.7 606.4 539.1 3438.1 940.9 289.3 1217.7 456.0 1493.6 1074.9 347.2 214.0 960.1 618.4 836.0 145.7 761.3 375.2 163.5 596.7 897.4 930.6 1319.6 967.8 307.7 711.8 321.0 544.1 275.6 256.9 156.5 635.1 727.9 698.5 738.6 374.5 296.6 721.4 313.4 574.6 560.9 223.5 342.8 894.3 197.9 740.6 807.2 939.3 460.3 567.6 2341.3 HSPA12A "FLJ13874, KIAA0417" ENSG00000165868 "Heat shock protein family A (Hsp70) member 12A" O43301 10 116671192-116850236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.7" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 58.7;Muller glia cells: 46.8;Peritubular cells: 64.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "basophil: 3.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011273, HPA073244" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA011273: AB_1851190, HPA073244: AB_2686586" "unprognostic (7.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-2)" "unprognostic (1.44e-1)" "unprognostic (7.31e-3)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.62e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (2.85e-2)" "unprognostic (1.66e-1)" "unprognostic (3.75e-1)" "unprognostic (5.55e-4)" 21.2 24.9 15.4 4.0 21.8 1.1 7.5 10.2 47.7 7.6 6.3 6.8 3.3 2.1 9.4 8.0 5.3 9.1 5.9 6.4 17.1 15.5 23.5 1.9 2.8 2.0 17.1 17.8 23.5 3.0 4.0 17.2 4.2 23.3 4.1 4.9 7.4 3.6 9.1 4.9 9.5 2.9 8.6 8.2 3.6 2.8 8.2 8.6 0.0 6.8 1.2 1.6 4.1 6.6 0.0 0.0 3.1 0.0 0.0 0.4 0.0 2.3 9.0 0.9 7.9 9.1 6.6 0.4 4.6 9.1 2.3 1.2 8.3 0.1 0.0 2.4 5.6 3.2 5.9 5.8 0.7 7.5 0.0 3.1 0.0 3.2 8.8 1.2 0.0 0.7 2.7 3.6 6.7 0.6 11.7 0.0 0.1 0.0 0.0 1.2 1.5 0.0 0.0 0.7 0.0 0.0 0.0 2.8 0.1 34.2 0.1 2.0 11.8 2.6 2.2 3.1 2.0 1.7 0.0 0.0 2.1 3.6 12.0 4.4 0.1 0.0 0.0 3.7 0.0 1.5 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 21.8 10.2 32.4 17.1 15.5 17.1 17.8 23.3 8.6 6.0 2.2 0.0 1.3 9.8 28.7 7.4 0.0 18.7 3.4 12.2 21.6 0.0 13.3 3.5 4.2 2.9 0.0 0.0 2.9 0.1 10.4 1.1 0.0 0.2 0.1 28.6 0.0 4.3 0.0 6.5 58.7 1.1 25.3 0.0 0.0 46.8 2.5 0.0 64.3 21.4 8.6 12.9 15.6 0.6 5.9 4.4 0.2 0.0 0.0 0.7 HSPA1A "HSP70-1, HSPA1" ENSG00000204389 "Heat shock protein family A (Hsp70) member 1A" P0DMV8 6 31815464-31817946 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "breast: 216.1;vagina: 741.6" "Cell type enhanced" "Detected in many" 13 "Basal glandular cells: 6419.7;Glandular cells: 2245.3;Urothelial cells: 2114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5" "Cell line enriched" "Detected in some" 10 "HEK 293: 310.1" "CAB017451, CAB032815, HPA052504" Supported Approved Nucleoplasm,Vesicles,Cytosol NA Yes 77000000 "Nucleoplasm, Vesicles" Cytosol "CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854" "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (6.17e-3)" "unprognostic (2.47e-2)" "unprognostic (1.74e-2)" "unprognostic (8.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" "unprognostic (6.48e-2)" "unprognostic (4.12e-2)" "unprognostic (1.51e-1)" 29.1 74.5 35.3 18.4 48.0 3.5 216.1 40.4 36.0 8.8 22.6 27.4 41.1 3.6 33.1 32.3 36.7 14.5 14.6 40.3 37.5 28.8 35.3 49.5 54.7 14.1 89.2 10.8 15.1 31.2 3.5 23.8 22.1 67.4 47.8 11.4 6.1 28.3 52.7 66.7 57.9 17.3 36.4 47.0 35.6 19.3 10.9 85.9 1.3 26.8 16.3 11.8 41.3 741.6 1.0 0.5 8.8 4.7 1.2 4.5 0.5 0.0 31.3 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.7 0.0 0.0 0.0 2.3 0.0 0.2 310.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.4 4.5 1.8 4.7 1.0 1.0 2.5 2.3 0.5 0.4 1.2 1.1 8.8 1.2 2.5 0.5 4.5 0.5 35.3 48.0 40.4 36.0 37.5 28.8 89.2 10.8 67.4 85.9 137.0 84.3 135.2 6419.7 321.9 290.0 857.6 71.4 100.4 76.2 120.4 357.4 38.6 34.9 77.7 73.7 681.4 145.3 0.0 18.8 85.4 940.7 2245.3 456.0 74.4 220.0 193.9 449.0 109.9 284.5 25.8 558.4 1365.8 796.3 117.2 187.3 954.1 43.5 340.1 151.0 60.4 639.2 148.8 1629.0 48.6 175.8 294.0 87.2 208.8 111.9 2114.2 HSPA1B HSP70-2 ENSG00000204388 "Heat shock protein family A (Hsp70) member 1B" P0DMV9 6 31827735-31830255 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 508.1" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 2896.7;Glandular cells: 1002.7;Smooth muscle cells: 978.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A549: 24.5;Karpas-707: 72.8" "CAB008640, HPA052504" Approved Approved Nucleoplasm,Vesicles,Cytosol NA Yes "Vesicles, Cytosol" Nucleoplasm "CAB008640: AB_1617331, HPA052504: AB_2681854" "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (4.23e-3)" "unprognostic (3.23e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.76e-3)" "unprognostic (9.50e-2)" "unprognostic (3.45e-1)" "unprognostic (4.42e-2)" "unprognostic (6.92e-2)" "unprognostic (4.88e-2)" "unprognostic (5.74e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-3)" "unprognostic (4.69e-2)" "unprognostic (5.99e-2)" 21.9 89.9 25.0 20.3 31.1 5.7 129.4 30.8 23.6 8.4 14.6 17.0 36.6 6.2 19.9 40.5 24.4 13.2 12.6 29.2 25.5 22.5 18.6 28.7 30.8 6.3 61.9 8.5 29.3 36.7 35.1 21.6 6.4 53.8 31.1 8.4 5.6 39.7 48.5 102.8 11.3 11.0 27.9 33.4 10.0 20.5 11.8 55.1 0.9 32.1 14.3 9.7 43.4 508.1 1.1 0.6 1.4 1.3 0.4 0.4 0.3 0.2 24.5 0.1 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 7.6 1.3 0.0 1.0 0.0 0.0 0.0 0.5 7.6 0.0 0.2 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 72.8 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.0 0.1 5.1 0.0 0.1 11.9 0.1 0.1 0.0 0.0 0.0 0.5 1.3 1.4 0.1 0.2 0.1 0.2 0.4 0.0 0.6 1.1 0.0 0.0 0.8 0.4 0.7 0.5 0.3 0.3 25.0 31.1 30.8 23.6 25.5 22.5 61.9 8.5 53.8 55.1 104.2 64.8 61.6 2896.7 212.6 40.4 440.6 20.4 54.9 58.0 66.3 123.7 73.9 16.6 33.6 1.7 185.0 221.9 0.0 13.7 87.7 515.0 1002.7 354.9 16.3 116.6 44.5 304.9 19.6 74.0 3.1 204.3 481.3 609.0 26.2 172.9 237.3 22.8 291.0 51.6 32.9 140.4 103.5 978.7 12.8 50.3 194.0 217.2 75.6 121.8 675.8 HSPA4 "HS24/P52, HSPH2" ENSG00000170606 "Heat shock protein family A (Hsp70) member 4" P34932 5 133051962-133106449 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010023, CAB025529" Uncertain Approved Nucleoplasm,Cytosol NA NA 10000000 "Nucleoplasm, Cytosol" "CAB025529: , HPA010023: AB_1851206" "unprognostic (2.54e-2)" "unprognostic (3.59e-1)" "unprognostic (2.91e-2)" "unprognostic (2.62e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-3)" "prognostic unfavorable (4.13e-4)" "unprognostic (2.31e-3)" "unprognostic (2.90e-1)" "unprognostic (2.40e-1)" "unprognostic (1.53e-1)" "unprognostic (2.85e-1)" "unprognostic (4.44e-3)" "unprognostic (2.54e-1)" "unprognostic (1.09e-1)" "unprognostic (4.05e-2)" "unprognostic (1.41e-1)" 20.6 35.0 26.6 25.6 27.6 20.5 39.0 25.9 35.6 19.4 20.5 18.7 19.9 17.4 23.3 20.2 42.0 19.2 18.9 32.9 26.4 31.9 30.3 31.1 17.2 28.9 30.9 24.5 23.2 19.5 37.1 32.8 24.5 34.3 18.9 23.9 16.0 20.3 19.2 48.3 19.6 18.5 23.6 25.9 20.0 20.9 39.8 29.5 27.3 26.8 24.8 38.6 24.5 77.1 27.7 17.9 15.5 23.0 14.1 14.9 11.5 32.4 44.7 31.2 50.9 29.8 25.1 56.8 35.6 26.8 34.6 42.9 83.9 34.1 54.0 37.5 34.2 81.6 29.0 54.2 58.9 50.1 24.9 31.1 39.8 30.0 45.9 23.8 24.7 34.9 24.9 24.9 44.5 29.3 19.8 32.9 26.4 41.6 16.7 37.7 28.6 34.6 18.4 42.8 25.3 20.7 31.8 38.3 28.7 31.2 42.8 24.9 20.5 33.9 17.8 47.3 61.0 26.2 24.2 28.8 31.5 45.3 26.9 42.1 19.3 42.6 41.5 26.9 41.0 31.2 14.8 14.4 15.5 12.6 23.0 14.9 22.6 11.6 13.0 17.9 27.7 12.1 11.2 9.6 14.1 16.4 6.8 11.3 11.5 26.6 27.6 25.9 35.6 26.4 31.9 30.9 24.5 34.3 29.5 59.6 36.4 64.0 74.4 37.2 50.9 98.8 30.6 76.3 54.6 21.0 51.1 57.8 23.2 43.7 30.6 26.4 31.6 23.3 43.2 54.8 30.3 48.9 54.2 27.0 56.2 33.4 45.3 19.0 22.6 20.2 21.6 43.3 28.7 66.7 30.9 56.8 43.7 22.8 24.4 39.4 121.6 25.8 30.7 92.5 94.9 36.5 72.9 27.7 26.5 65.5 HSPA4L "APG-1, HSPH3, Osp94" ENSG00000164070 "Heat shock protein family A (Hsp70) member 4 like" O95757 4 127781821-127840733 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.0;vagina: 32.0" "Group enriched" "Detected in many" 4 "Early spermatids: 393.1;Late spermatids: 711.4;Spermatocytes: 194.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.9" "Cell line enhanced" "Detected in many" "HAP1: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034450, HPA039149, HPA061446" Enhanced Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520" "unprognostic (6.66e-2)" "unprognostic (2.39e-1)" "unprognostic (5.33e-2)" "unprognostic (9.40e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (1.23e-3)" "unprognostic (2.41e-1)" "unprognostic (3.90e-1)" "unprognostic (2.38e-4)" "unprognostic (1.40e-2)" "unprognostic (3.28e-1)" "prognostic favorable (3.80e-9)" "unprognostic (8.53e-2)" "unprognostic (1.56e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (6.78e-4)" 1.6 9.3 7.4 1.4 9.0 2.8 5.5 16.6 11.4 2.9 2.5 1.7 1.6 2.5 1.5 1.7 10.9 5.9 3.5 5.3 6.1 10.1 10.6 5.9 1.9 1.0 6.6 6.6 3.5 3.6 12.2 23.2 2.8 20.1 3.9 3.5 3.5 4.6 4.7 1.5 6.5 1.6 3.8 5.0 1.4 2.1 73.0 5.2 1.0 3.7 4.1 4.0 2.8 32.0 0.7 0.5 3.9 0.4 0.5 0.4 0.1 9.1 12.0 6.5 10.3 4.5 4.6 7.6 4.2 1.7 4.0 4.5 8.8 4.2 0.0 7.7 1.2 3.3 2.1 38.0 15.0 5.6 17.0 11.3 4.9 16.5 10.7 1.7 18.8 8.4 4.2 14.0 2.6 9.6 4.2 5.2 4.3 8.7 5.6 5.0 6.6 6.0 1.6 1.5 9.7 10.0 0.0 0.7 0.9 13.8 4.2 12.0 4.4 7.5 13.1 0.7 4.1 10.0 3.2 1.4 1.4 0.0 1.7 10.0 11.0 12.6 2.9 5.5 12.9 4.3 1.6 0.4 3.9 0.4 0.2 0.2 0.4 0.3 0.3 0.5 0.7 0.4 0.4 1.3 0.5 0.3 0.4 0.3 0.1 7.4 9.0 16.6 11.4 6.1 10.1 6.6 6.6 20.1 5.2 3.0 9.4 0.8 68.9 25.2 54.9 12.6 12.7 56.2 31.8 8.7 98.2 9.5 16.6 6.7 393.1 5.4 0.4 0.0 2.5 1.7 7.0 17.8 15.1 8.3 1.0 38.1 17.6 2.5 1.6 711.4 9.5 7.3 8.5 4.6 2.0 15.2 3.2 0.0 9.2 19.6 62.8 0.0 15.5 194.6 9.3 37.1 14.0 2.9 2.9 72.9 HSPA5 "BiP, GRP78" ENSG00000044574 "Heat shock protein family A (Hsp70) member 5" P11021 9 125234853-125241330 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Basal glandular cells: 1106.3;Syncytiotrophoblasts: 1110.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 200.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005221, HPA038845, HPA038846" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 1000000000 Cytosol "CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478" "unprognostic (3.98e-2)" "unprognostic (2.50e-3)" "unprognostic (6.64e-2)" "unprognostic (9.60e-3)" "unprognostic (1.54e-3)" "unprognostic (6.02e-3)" "unprognostic (9.08e-3)" "unprognostic (9.11e-3)" "unprognostic (4.50e-2)" "unprognostic (7.45e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (7.28e-2)" "unprognostic (3.66e-2)" 44.2 40.3 26.3 40.8 38.4 125.0 58.8 19.5 26.9 37.7 29.3 19.8 47.0 25.5 31.6 75.3 34.1 31.1 25.5 72.7 23.3 28.6 60.4 147.6 43.6 32.7 34.3 14.3 36.2 110.3 41.1 47.6 62.6 43.5 34.3 33.0 16.5 84.9 40.7 23.9 32.3 38.3 33.8 28.2 33.8 35.1 33.0 41.5 23.2 219.3 21.7 29.8 50.4 75.1 33.3 53.8 57.4 55.3 51.9 63.0 90.0 35.5 24.0 31.7 41.8 37.9 43.9 74.7 64.1 50.9 47.7 56.0 37.2 71.1 41.1 40.0 46.7 103.4 45.5 28.3 57.2 51.3 23.8 14.3 24.6 30.1 67.1 200.5 33.5 46.6 27.0 112.4 38.2 167.8 50.6 74.0 8.7 18.2 57.5 34.6 26.3 14.7 23.7 35.8 87.0 24.2 14.0 32.3 66.6 46.2 23.5 16.4 29.2 40.7 43.7 65.3 51.1 45.0 24.5 49.6 29.1 28.3 29.7 29.7 60.2 57.4 34.8 70.6 28.3 43.8 57.4 55.3 44.3 61.9 54.8 63.0 33.3 45.7 57.7 48.6 24.9 37.6 46.6 44.3 51.9 35.5 53.8 31.2 90.0 26.3 38.4 19.5 26.9 23.3 28.6 34.3 14.3 43.5 41.5 172.7 228.8 134.1 1106.3 260.1 93.3 493.6 73.9 190.1 253.6 106.4 331.8 423.2 38.1 330.8 34.2 189.6 316.5 46.7 227.7 576.5 389.6 402.8 329.8 324.2 392.1 60.4 487.5 159.0 114.8 42.9 162.3 280.8 172.1 141.5 125.9 124.7 293.4 101.7 164.1 109.1 122.6 116.4 222.8 360.8 228.7 206.6 1110.2 140.9 109.4 772.3 HSPB1 "CMT2F, Hs.76067, Hsp25, HSP27, HSP28" ENSG00000106211 "Heat shock protein family B (small) member 1" P04792 7 76302544-76304295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 565.5" "Group enriched" "Detected in many" 4 "Basal glandular cells: 13325.7;Exocrine glandular cells: 5786.9;Urothelial cells: 14386.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 165.4;MCF7: 232.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000497, CAB004439, CAB047330, CAB047331, CAB047332" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 57000000 "Plasma membrane, Cytosol" "CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172" "unprognostic (2.55e-1)" "unprognostic (7.25e-3)" "prognostic unfavorable (9.94e-5)" "unprognostic (7.07e-3)" "unprognostic (3.47e-3)" "unprognostic (6.61e-3)" "unprognostic (4.08e-3)" "unprognostic (4.50e-2)" "unprognostic (1.27e-1)" "unprognostic (9.78e-2)" "unprognostic (8.70e-2)" "unprognostic (2.21e-1)" "unprognostic (5.72e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.56e-1)" "unprognostic (3.63e-1)" 67.6 41.7 23.0 42.9 22.8 7.3 186.2 10.1 21.3 127.6 84.9 10.8 89.2 27.1 126.5 65.9 410.5 57.7 52.2 164.8 21.4 22.5 85.4 26.3 43.3 25.1 25.7 14.3 63.4 34.7 16.6 15.5 106.9 32.8 99.6 12.0 31.1 50.5 101.3 439.2 164.4 24.6 139.7 27.3 17.8 37.6 22.0 23.4 31.9 72.9 207.3 126.8 146.2 565.5 27.8 17.8 4.1 27.9 23.2 36.8 14.4 74.1 55.2 6.0 44.0 35.9 31.7 0.3 31.5 16.7 17.1 21.5 4.9 43.5 0.6 24.4 40.9 35.3 68.1 25.8 18.4 5.6 41.4 8.7 3.4 42.6 23.3 19.2 5.0 31.1 39.4 165.4 25.8 3.8 32.5 56.6 12.7 27.0 75.8 19.6 232.3 8.4 34.3 30.2 15.0 48.3 26.2 12.1 60.3 25.5 28.3 0.4 33.8 22.2 90.4 28.2 17.6 106.6 35.5 30.5 51.5 76.9 16.0 79.5 5.3 8.7 0.7 37.7 15.5 37.5 4.1 4.5 2.8 18.6 21.1 9.6 27.5 30.6 20.2 11.1 27.8 36.8 31.5 1.7 23.2 27.9 17.8 19.7 14.4 23.0 22.8 10.1 21.3 21.4 22.5 25.7 14.3 32.8 23.4 253.1 212.2 115.1 13325.7 1643.2 181.1 724.5 257.4 163.3 246.9 1085.2 304.3 116.8 1271.6 1614.7 8.7 728.0 540.2 0.0 5786.9 328.3 1183.3 2785.1 218.6 220.1 1062.0 66.7 404.2 589.9 103.8 18.4 277.3 433.3 1950.2 307.4 101.7 223.5 2381.8 1422.3 502.4 1699.1 24.3 601.5 2360.7 6.2 90.5 1959.6 2034.5 83.1 148.1 14386.7 HSPB11 "C1orf41, HSPCO34, IFT25, PP25" ENSG00000081870 "Heat shock protein family B (small) member 11" Q9Y547 1 53916574-53945929 "Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Stress response, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030140 Uncertain Approved Nucleoplasm,Cytosol NA NA 18000 Nucleoplasm Cytosol "HPA030140: AB_10600713" "unprognostic (5.73e-2)" "unprognostic (6.37e-3)" "unprognostic (8.81e-2)" "unprognostic (2.99e-3)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (9.58e-7)" "unprognostic (5.12e-1)" "unprognostic (6.70e-3)" "unprognostic (8.31e-3)" "unprognostic (2.22e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.84e-2)" "unprognostic (2.74e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-2)" 12.2 19.7 21.5 20.1 19.5 22.6 19.5 13.1 18.6 17.4 15.6 9.5 19.4 11.0 19.1 30.6 19.0 31.9 11.0 12.9 15.4 16.0 16.0 20.0 19.9 24.0 15.0 18.7 20.8 13.4 9.5 31.3 18.2 16.8 15.1 14.6 22.4 13.3 25.1 5.6 16.0 13.1 17.8 17.3 16.0 15.6 19.6 10.0 27.1 40.4 15.0 24.2 23.5 14.3 28.6 35.9 37.5 20.0 31.1 35.0 16.8 20.7 8.9 27.5 6.5 9.5 12.6 11.1 18.6 15.9 25.8 30.5 20.5 11.7 25.1 14.5 12.6 46.9 16.9 11.3 17.7 30.9 20.3 16.3 30.8 19.3 27.5 10.3 15.4 21.6 13.1 13.5 24.4 6.9 17.0 13.5 15.4 18.0 6.0 32.1 4.3 34.3 23.8 11.1 16.4 19.3 23.3 34.9 12.9 20.9 23.1 14.0 11.5 26.3 12.1 16.7 27.5 75.5 22.4 10.0 18.1 22.2 20.2 19.5 10.9 16.2 24.8 28.6 14.5 15.5 35.4 14.8 37.5 28.0 19.0 25.1 28.6 27.8 33.0 16.8 22.9 21.9 28.0 10.3 31.1 20.0 35.9 35.0 16.8 21.5 19.5 13.1 18.6 15.4 16.0 15.0 18.7 16.8 10.0 29.8 26.1 55.8 65.1 94.4 20.9 30.8 43.3 235.5 68.2 48.8 7.9 156.8 99.5 53.0 36.0 40.6 41.8 0.0 57.6 83.4 59.6 60.9 60.0 64.4 99.0 12.7 74.2 30.1 40.7 11.5 57.0 60.6 74.2 95.6 37.1 67.6 70.4 49.1 59.8 97.6 16.4 38.8 75.1 103.5 92.0 72.4 97.7 63.3 38.8 99.6 HSPB6 "FLJ32389, Hsp20, PPP1R91" ENSG00000004776 "Heat shock protein family B (small) member 6" O14558 19 35754569-35758079 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 356.8" "Group enriched" "Detected in many" 5 "Leydig cells: 251.7;Peritubular cells: 207.2;Smooth muscle cells: 65.1" "Cancer enhanced" "Detected in all" "stomach cancer: 93.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 189.0;ASC TERT1: 79.8;HHSteC: 64.1;HSkMC: 74.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB001974, HPA044153, HPA054811" Enhanced Supported "Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 86000 Cytosol "Nucleoli, Golgi apparatus" "CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610" "unprognostic (3.19e-2)" "unprognostic (8.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.21e-3)" "unprognostic (7.02e-2)" "unprognostic (9.67e-2)" "unprognostic (7.57e-2)" "unprognostic (1.18e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.32e-2)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.43e-6)" 95.3 39.5 3.9 18.3 8.1 1.1 40.5 1.1 6.1 49.7 48.4 3.8 18.6 5.7 42.6 57.4 24.6 33.3 80.6 132.0 4.4 2.4 6.2 3.5 8.7 7.2 5.4 2.8 53.4 5.8 1.7 1.2 12.7 8.1 42.1 8.7 18.2 8.6 35.8 356.8 2.5 14.3 128.2 10.2 1.9 32.4 22.6 4.9 0.0 11.0 153.5 16.4 121.6 23.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 189.0 79.8 0.1 8.4 0.1 0.5 0.9 0.1 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 64.1 0.0 0.1 74.6 0.0 1.9 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 1.8 0.0 0.1 0.2 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 8.1 1.1 6.1 4.4 2.4 5.4 2.8 8.1 4.9 3.0 1.1 0.0 0.2 1.5 7.4 26.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 19.2 2.2 0.0 0.0 0.0 2.8 35.4 0.4 0.0 0.0 4.5 0.0 0.0 28.3 0.3 14.1 251.7 2.0 1.7 1.0 0.0 30.6 0.2 0.0 207.2 0.0 2.1 25.8 65.1 2.2 1.2 1.8 4.0 0.0 0.0 0.5 HSPB8 "CMT2L, E2IG1, H11, HSP22, HspB8" ENSG00000152137 "Heat shock protein family B (small) member 8" Q9UJY1 12 119178642-119221131 "Disease related genes, Predicted intracellular proteins" "Stress response" Chaperone "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 152.6" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 553.3;Syncytiotrophoblasts: 1120.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 28.7;HeLa: 21.4;MCF7: 37.7;SuSa: 24.7;U-87 MG: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015876 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear bodies" "HPA015876: AB_1850458" "unprognostic (1.52e-2)" "unprognostic (6.97e-2)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.47e-1)" "unprognostic (4.03e-2)" "unprognostic (7.91e-2)" "unprognostic (6.48e-3)" "unprognostic (1.11e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.36e-2)" "unprognostic (2.17e-2)" 12.2 4.4 19.3 8.2 22.7 0.7 6.8 2.0 18.1 15.3 52.7 34.1 13.1 2.8 18.6 7.2 42.9 9.6 12.0 107.9 17.4 17.6 16.3 1.7 13.4 3.3 27.4 14.7 5.7 7.7 73.3 3.0 64.3 24.5 40.1 11.9 21.7 11.4 79.4 152.6 10.0 7.9 65.5 35.0 13.6 20.6 3.6 19.3 5.4 8.0 42.1 26.7 55.6 18.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.3 4.9 0.2 0.0 5.7 4.5 18.8 10.6 9.4 2.1 0.1 11.8 0.2 0.0 28.7 14.6 16.9 0.7 0.1 0.0 0.3 0.0 0.4 0.0 21.4 1.0 3.9 0.0 0.0 4.9 1.7 7.1 0.6 7.8 4.3 0.0 0.0 0.0 5.2 37.7 0.0 0.1 2.2 0.0 7.0 0.0 7.8 1.0 15.5 2.0 0.1 0.3 4.0 0.5 2.2 24.7 9.7 0.0 6.0 5.2 13.2 6.8 0.5 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 22.7 2.0 16.0 17.4 17.6 27.4 14.7 24.5 19.3 41.7 54.8 0.5 84.4 90.9 0.6 553.3 10.2 4.0 6.8 5.2 7.9 125.9 0.0 51.2 12.3 27.0 0.0 0.0 9.8 10.9 43.0 15.6 1.1 0.0 16.9 1.6 0.0 27.0 1.8 8.5 1.4 3.2 11.8 1.8 0.0 46.4 18.4 0.0 0.4 38.9 2.2 6.5 115.6 0.2 0.0 25.1 1120.5 3.2 0.0 73.8 HSPBP1 "FES1, HspBP1" ENSG00000133265 "HSPA (Hsp70) binding protein 1" Q9NZL4 19 55262231-55280381 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005865, HPA070398, HPA071444" Supported Approved Vesicles,Centrosome,Cytosol NA NA Cytosol "Vesicles, Centrosome" "CAB005865: AB_304116, HPA070398: , HPA071444: AB_2686396" "unprognostic (3.07e-2)" "unprognostic (6.36e-2)" "unprognostic (5.41e-2)" "unprognostic (8.05e-2)" "unprognostic (9.24e-2)" "unprognostic (1.43e-1)" "unprognostic (3.71e-3)" "unprognostic (1.12e-2)" "unprognostic (5.72e-2)" "unprognostic (1.52e-1)" "unprognostic (6.20e-3)" "unprognostic (7.23e-2)" "unprognostic (4.28e-3)" "unprognostic (2.44e-2)" "unprognostic (2.62e-1)" "unprognostic (9.45e-2)" "unprognostic (2.14e-2)" 14.1 13.9 24.5 15.8 42.9 16.4 13.8 13.3 32.5 11.3 17.3 9.1 13.0 18.8 14.8 12.4 14.5 30.3 13.3 19.1 25.3 20.1 15.4 18.0 18.2 17.6 16.2 20.0 17.4 21.1 13.0 10.2 9.8 15.2 12.0 8.3 7.6 19.3 13.6 35.4 15.4 17.2 16.8 15.0 11.6 15.3 21.1 9.3 11.7 12.0 24.4 8.9 10.5 10.5 24.0 23.0 3.0 19.0 18.4 20.5 11.5 22.3 40.2 7.1 10.4 4.2 3.5 21.9 11.8 4.7 11.8 10.1 22.7 15.6 14.8 11.5 6.3 7.2 15.6 8.4 11.4 3.1 12.6 69.2 19.7 12.8 20.8 9.2 18.4 10.4 4.9 10.3 11.7 5.6 5.2 5.9 12.1 15.7 8.4 4.1 21.2 16.6 17.1 25.6 19.1 33.8 16.2 11.3 31.9 8.0 14.7 19.6 29.4 14.5 15.0 11.3 4.0 11.4 14.4 8.1 14.2 15.4 8.0 21.4 13.4 31.0 15.3 15.8 16.0 15.0 0.8 11.5 3.0 18.0 19.0 18.7 21.0 19.8 20.5 23.0 24.0 19.9 19.3 0.8 18.4 16.0 13.1 17.8 11.5 24.5 42.9 13.3 32.5 25.3 20.1 16.2 20.0 15.2 9.3 8.9 8.6 26.9 31.3 23.8 14.1 11.0 25.5 60.2 20.5 33.2 5.9 45.1 61.3 55.5 7.9 15.1 23.6 0.0 40.0 45.3 20.7 24.9 10.4 20.8 34.3 12.7 21.7 7.4 12.3 12.8 18.1 14.0 16.9 35.1 29.8 13.7 36.5 41.9 16.6 45.8 11.0 25.8 20.6 34.2 23.9 25.7 31.4 16.0 46.5 36.6 HSPG2 "perlecan, PRCAN, SJS1" ENSG00000142798 "Heparan sulfate proteoglycan 2" P98160 1 21822245-21937297 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 104.4" "Cell type enriched" "Detected in many" 7 "Ito cells: 621.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 12 "dendritic cells: 3.0" "Cell line enhanced" "Detected in many" "EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009820, HPA018892, CAB020718, HPA072690" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 1700000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: " "unprognostic (1.61e-1)" "unprognostic (1.57e-2)" "unprognostic (4.93e-2)" "unprognostic (9.60e-2)" "unprognostic (2.38e-2)" "unprognostic (8.56e-2)" "unprognostic (4.55e-1)" "unprognostic (1.90e-2)" "unprognostic (9.35e-2)" "unprognostic (2.19e-3)" "unprognostic (5.82e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-3)" "unprognostic (1.17e-2)" "unprognostic (4.86e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (2.82e-4)" 54.8 12.8 1.1 22.9 1.5 0.2 19.8 0.8 1.5 37.3 32.3 2.4 37.2 6.2 62.8 37.6 32.7 20.6 60.0 30.2 1.2 1.2 15.7 8.9 12.5 7.8 2.5 1.2 19.8 9.4 4.6 3.4 24.6 3.8 32.0 2.5 24.6 15.5 22.3 20.8 12.2 13.7 104.4 1.8 16.4 18.9 11.4 0.7 3.4 16.9 20.1 8.5 66.2 28.2 0.2 3.0 0.0 0.0 0.0 0.2 0.0 7.0 6.5 2.2 7.7 22.6 17.2 8.6 10.7 2.7 3.1 2.8 7.9 14.5 0.5 46.8 16.5 0.1 4.4 0.5 5.2 0.7 0.1 0.7 2.4 7.0 5.7 4.7 0.0 0.6 10.4 1.6 3.2 0.9 4.7 103.4 0.0 3.1 0.9 4.2 1.9 0.0 3.2 1.9 3.2 2.9 1.0 9.2 0.9 6.0 0.9 0.2 0.6 8.1 3.4 4.7 2.0 1.3 1.2 82.5 6.1 8.0 4.7 0.3 0.0 1.0 0.4 1.6 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 3.0 0.0 0.0 1.1 1.5 0.8 1.5 1.2 1.2 2.5 1.2 3.8 0.7 65.5 28.7 5.2 10.9 23.5 0.7 4.5 40.8 1.4 12.5 87.2 0.0 9.4 0.0 63.1 1.0 75.0 34.2 0.0 21.9 85.1 58.4 6.6 22.0 2.8 6.1 3.2 2.4 621.2 31.6 2.2 69.6 3.5 57.3 2.8 12.8 1.4 55.1 20.7 65.0 0.5 0.5 32.3 38.8 0.4 4.1 15.6 7.8 6.4 13.9 8.3 HSPH1 "HSP105A, HSP105B, KIAA0201, NY-CO-25" ENSG00000120694 "Heat shock protein family H (Hsp110) member 1" Q92598 13 31134974-31162388 "Cancer-related genes, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "vagina: 286.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 738.6;Urothelial cells: 485.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002060, HPA028675, HPA031569" Uncertain Enhanced Nucleoplasm,Cytosol No Yes 820000 Cytosol Nucleoplasm "CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938" "unprognostic (1.10e-2)" "unprognostic (4.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (1.41e-5)" "unprognostic (5.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (1.53e-1)" "unprognostic (3.13e-1)" "unprognostic (7.45e-3)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (2.04e-1)" "unprognostic (7.89e-2)" 13.7 19.8 36.6 12.2 57.1 9.8 33.7 11.7 44.0 14.7 10.6 9.8 13.0 6.1 13.3 21.7 13.9 31.0 18.1 14.2 34.8 40.3 16.6 14.8 15.9 17.4 36.5 16.3 13.4 10.1 15.1 24.1 19.8 32.7 14.5 14.5 3.6 7.0 17.3 10.5 11.0 6.4 15.7 34.8 9.0 12.2 35.0 34.6 12.1 22.5 7.8 23.8 17.0 286.1 9.0 6.8 2.1 14.6 13.7 12.8 5.5 13.7 26.5 21.8 2.1 21.0 11.9 14.5 23.9 21.3 37.2 17.3 31.1 21.5 35.8 15.0 16.6 52.9 26.8 84.1 21.2 48.1 28.0 10.6 31.0 14.6 27.4 6.9 21.5 24.8 7.5 49.2 24.8 14.3 19.5 21.5 12.6 25.9 5.7 26.1 18.8 30.8 24.6 31.0 67.6 19.8 24.3 17.9 11.8 28.1 16.8 22.6 18.8 21.8 21.4 11.0 34.9 7.2 21.0 13.1 12.8 16.3 18.4 26.4 4.5 14.7 30.7 10.7 26.1 21.4 1.0 3.9 2.1 6.6 9.6 8.1 9.0 8.4 10.0 6.8 7.8 12.8 11.9 0.4 13.7 14.6 5.3 5.3 5.5 36.6 57.1 11.7 44.0 34.8 40.3 36.5 16.3 32.7 34.6 122.1 81.5 33.2 738.6 190.6 38.7 130.6 17.8 302.5 185.4 43.6 392.7 17.7 24.9 44.8 71.1 92.6 26.2 0.0 31.1 55.8 207.2 407.7 251.8 21.5 79.0 28.6 217.9 24.5 27.7 22.4 31.4 113.0 155.3 47.7 22.5 16.6 37.1 45.6 36.7 22.8 57.7 38.8 156.8 128.9 138.0 125.3 35.6 28.0 26.7 485.8 HTATIP2 "CC3, FLJ26963, SDR44U1, TIP30" ENSG00000109854 "HIV-1 Tat interactive protein 2" Q9BUP3 11 20363685-20383783 "Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Differentiation, Host-virus interaction" "Developmental protein, Oxidoreductase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006417, HPA024321" Approved Supported Cytosol NA NA Cytosol "HPA006417: AB_1079091, HPA024321: AB_1851288" "unprognostic (8.05e-3)" "unprognostic (2.13e-1)" "unprognostic (9.31e-2)" "unprognostic (3.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.79e-3)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.20e-3)" "unprognostic (1.05e-1)" "unprognostic (4.93e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (1.75e-1)" "prognostic unfavorable (8.01e-4)" "unprognostic (1.20e-1)" "unprognostic (9.42e-2)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" 16.3 28.1 8.5 11.9 16.3 6.3 26.3 3.2 10.6 9.4 50.4 16.2 10.8 52.2 6.8 13.0 23.1 5.7 17.6 9.5 10.8 9.9 21.5 41.8 19.5 16.2 24.3 8.0 6.8 11.9 17.9 27.4 22.9 12.4 13.9 32.2 3.3 16.5 9.2 19.4 14.8 74.6 12.1 15.0 19.6 29.4 10.6 14.6 6.6 23.9 17.2 12.1 17.8 26.7 16.4 17.4 69.4 30.6 13.5 30.6 23.8 23.1 38.5 0.8 0.0 11.8 9.0 8.6 10.1 10.0 7.8 9.4 22.2 20.4 5.3 20.8 12.6 30.4 32.6 0.0 6.1 7.6 60.3 4.7 6.5 38.0 0.0 28.5 2.4 31.1 12.9 43.5 6.3 9.9 0.0 22.3 0.0 16.0 7.0 14.5 21.7 0.0 1.5 12.5 40.7 19.2 4.9 0.0 19.0 10.6 12.9 10.5 0.1 32.8 13.0 15.4 4.2 27.2 12.2 27.1 5.6 12.3 11.3 0.2 7.5 9.2 0.1 0.0 16.5 24.1 43.7 30.6 37.3 15.5 27.5 17.5 14.9 18.0 16.5 17.4 16.4 15.8 15.5 69.4 13.5 28.3 5.1 30.6 23.8 8.5 16.3 3.2 10.6 10.8 9.9 24.3 8.0 12.4 14.6 23.8 8.1 24.1 49.8 32.3 0.3 9.7 117.2 8.1 10.3 45.4 0.0 50.0 26.6 84.2 36.1 22.9 185.2 0.0 63.6 102.1 14.2 53.7 23.0 69.2 75.1 3.2 23.2 28.8 55.0 45.4 18.4 40.5 42.2 143.3 93.7 9.4 88.6 161.4 8.9 60.3 1.7 12.9 29.5 27.3 17.2 36.8 51.5 35.8 83.1 52.5 HTR7 5-HT7 ENSG00000148680 "5-hydroxytryptamine receptor 7" P34969 10 90740823-90857698 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 30.8;testis: 14.3" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 4.8;Hofbauer cells: 1.3;Kupffer cells: 1.5;Late spermatids: 2.0;Spermatocytes: 1.4" "Group enriched" "Detected in some" 5 "cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "myeloid DC: 4.6" "Lineage enriched" "Detected in single" 12 "dendritic cells: 4.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.2;hTCEpi: 7.5;hTERT-HME1: 25.0;LHCN-M2: 10.0;U-87 MG: 7.7;WM-115: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022708, HPA073617" Approved Supported Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nuclear speckles, Cytosol" "CAB022708: , HPA073617: AB_2732228" "unprognostic (1.17e-1)" "unprognostic (1.24e-2)" "unprognostic (4.72e-2)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (1.71e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (1.15e-1)" "unprognostic (4.58e-3)" "unprognostic (3.32e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-1)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" 1.0 0.5 2.4 1.1 2.5 0.5 0.7 0.3 4.3 0.6 0.8 1.7 1.2 0.8 0.4 0.3 1.0 0.4 1.3 0.6 9.9 5.1 0.3 0.6 0.5 0.7 1.7 1.8 0.4 1.4 30.8 0.2 0.5 3.1 1.0 1.2 0.4 0.6 0.3 1.7 0.9 2.2 3.6 1.5 1.3 1.5 14.3 1.0 0.0 0.3 0.1 0.6 3.5 2.1 0.0 4.6 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.2 0.5 0.8 0.0 0.9 0.0 0.0 0.1 1.5 3.4 0.9 8.2 2.1 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.4 5.9 7.5 2.5 25.0 4.7 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.1 0.9 0.0 1.2 0.7 0.1 0.0 0.0 0.9 0.3 0.0 0.3 0.0 3.9 0.4 0.0 0.2 0.2 4.6 0.0 0.0 6.9 0.0 0.0 0.0 7.7 0.0 9.5 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 4.6 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.1 0.1 2.4 2.5 0.3 4.3 9.9 5.1 1.7 1.8 3.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.6 1.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 0.1 0.1 0.0 0.0 0.2 HTT "HD, IT15" ENSG00000197386 Huntingtin P42858 4 3074681-3243960 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 170.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002756, HPA026114" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB002756: , HPA026114: AB_1851330" "unprognostic (2.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.52e-2)" "unprognostic (8.33e-2)" "unprognostic (8.06e-2)" "unprognostic (2.15e-1)" "unprognostic (1.87e-2)" "unprognostic (6.04e-2)" "prognostic favorable (2.41e-12)" "unprognostic (9.46e-3)" "unprognostic (1.99e-1)" "unprognostic (6.53e-2)" "unprognostic (3.84e-2)" 12.9 13.8 19.4 16.6 18.3 14.1 12.3 24.7 32.3 10.0 13.6 11.6 11.0 10.5 11.5 15.9 16.3 11.6 9.4 8.9 19.7 12.1 11.3 13.1 21.5 18.1 11.8 19.5 13.0 27.0 29.5 13.0 12.0 12.8 10.5 11.4 13.3 10.2 11.4 19.1 25.4 12.8 12.0 10.4 17.4 12.0 14.9 10.4 17.4 13.3 7.3 15.6 11.7 9.6 2.9 3.5 2.8 4.5 2.9 4.3 1.9 12.4 8.7 12.2 7.2 22.4 12.8 12.4 5.8 7.2 8.8 8.3 11.5 8.1 19.1 6.2 14.0 16.1 7.1 14.4 10.6 8.9 5.0 10.6 18.2 12.4 12.2 5.3 12.2 26.7 8.9 6.5 17.2 8.1 6.0 10.2 8.6 11.9 6.9 7.7 12.0 13.0 11.5 14.9 6.3 14.1 11.7 11.7 3.7 9.4 12.9 13.4 9.5 10.4 3.9 10.2 9.7 10.8 7.6 14.1 12.3 7.7 8.4 13.0 5.3 6.2 15.2 9.2 11.3 8.8 0.0 2.6 2.8 3.5 3.4 2.4 2.9 2.7 4.3 3.5 2.4 2.0 2.4 0.4 2.9 4.5 2.6 3.5 1.9 19.4 18.3 24.7 32.3 19.7 12.1 11.8 19.5 12.8 10.4 23.8 15.0 13.9 7.0 12.2 42.6 10.1 20.4 5.3 13.6 14.0 170.8 10.3 5.0 10.2 9.0 10.8 18.4 0.0 14.9 9.2 10.8 13.1 11.5 13.5 23.3 42.9 17.7 23.9 23.5 7.5 15.0 14.5 8.5 13.6 11.4 19.1 18.0 20.1 11.0 9.8 45.2 12.9 7.1 10.4 19.4 17.6 7.0 10.2 16.2 9.9 HUS1B ENSG00000188996 "HUS1 checkpoint clamp component B" Q8NHY5 6 655939-656963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.3" "Cell type enhanced" "Detected in some" 9 "monocytes: 3.6;Sertoli cells: 6.5;Spermatocytes: 7.6;Spermatogonia: 4.7" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 4.4;U-266/84: 5.1;WM-115: 5.5" "Not detected" "Not detected" "HPA034511, HPA063449" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034511: AB_2674203, HPA063449: AB_2685014" "unprognostic (3.56e-4)" "unprognostic (3.68e-2)" "unprognostic (4.81e-2)" "unprognostic (1.95e-1)" "unprognostic (3.45e-2)" "unprognostic (1.36e-1)" "unprognostic (4.95e-2)" "unprognostic (6.53e-2)" "unprognostic (9.44e-2)" "unprognostic (8.46e-2)" "unprognostic (8.76e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-10)" "unprognostic (7.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" 0.5 0.1 0.1 0.5 0.1 3.3 0.6 0.0 0.0 1.4 0.4 1.3 0.9 0.7 0.9 0.2 0.6 0.5 0.2 0.1 0.6 0.8 1.0 0.2 0.3 0.8 0.0 0.0 0.8 1.1 1.4 0.2 0.5 0.1 0.0 0.9 0.3 1.0 0.6 1.0 0.1 4.3 0.7 0.2 0.3 1.2 1.6 1.6 0.0 0.7 0.0 1.9 0.6 0.7 0.0 0.0 1.8 0.0 0.0 1.7 0.2 0.1 0.0 0.1 0.8 0.1 0.3 0.5 0.1 0.4 0.0 0.5 0.0 0.4 1.3 4.4 0.9 0.0 0.0 0.4 0.0 1.5 0.0 0.3 0.4 0.4 0.0 0.1 1.1 1.7 1.0 0.5 0.0 0.5 2.4 2.8 0.0 1.4 0.9 0.8 2.5 0.2 0.6 1.0 0.2 0.3 0.0 0.7 0.5 0.1 0.1 0.4 0.7 0.8 1.5 0.4 2.3 5.1 1.0 0.1 0.6 5.5 0.0 0.7 0.0 0.7 0.3 0.5 1.6 1.1 0.9 0.0 0.8 1.0 1.9 0.0 0.0 0.0 1.6 0.7 0.6 0.0 0.0 0.5 0.6 0.6 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 0.7 0.7 0.0 0.0 0.5 1.0 0.4 0.5 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.9 0.0 0.0 3.6 0.0 0.5 0.9 0.0 1.1 0.0 1.7 6.5 0.5 7.6 4.7 1.5 1.3 1.5 0.2 0.3 HUWE1 "Ib772, KIAA0312, UREB1" ENSG00000086758 "HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase" Q7Z6Z7 X 53532096-53686729 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002548, CAB022718" Approved Enhanced Nucleoplasm,Cytosol NA NA 3400 "Nucleoplasm, Cytosol" "CAB022718: , HPA002548: AB_1080489" "unprognostic (4.73e-2)" "unprognostic (9.06e-2)" "unprognostic (1.31e-1)" "unprognostic (1.59e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (2.21e-1)" "unprognostic (3.56e-1)" "unprognostic (5.51e-2)" "unprognostic (1.33e-1)" "unprognostic (8.89e-2)" "unprognostic (8.10e-3)" "unprognostic (2.17e-1)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" 24.6 28.2 27.7 23.8 43.3 22.4 28.0 37.0 41.1 31.8 25.9 34.3 26.6 17.1 31.9 52.4 27.4 26.5 23.1 27.1 28.0 31.8 30.3 26.2 20.3 23.1 30.0 30.2 43.3 27.8 59.8 34.2 27.2 34.6 27.3 22.7 25.6 26.4 29.6 59.1 50.1 22.1 33.9 23.9 26.6 25.7 28.4 27.7 32.4 27.6 20.7 28.6 27.0 22.9 5.1 7.2 8.2 7.0 6.9 8.9 3.5 50.2 31.0 20.2 14.2 35.4 21.2 24.9 15.1 19.5 16.0 16.7 23.6 16.2 26.4 10.3 27.5 28.8 24.2 45.6 25.3 21.9 38.0 20.2 21.0 27.8 18.3 32.5 31.4 12.9 20.2 19.0 38.3 44.1 15.8 27.6 20.7 20.9 17.1 20.7 31.0 17.0 17.6 27.6 13.8 22.3 15.7 27.8 16.0 26.5 34.9 16.9 12.2 42.7 19.1 13.6 39.5 27.3 15.3 35.1 14.7 21.1 21.0 19.2 15.0 14.8 23.0 15.7 30.8 21.1 4.0 4.7 8.2 7.2 3.8 8.9 5.1 6.9 7.6 6.7 5.1 4.9 4.9 4.2 6.9 7.0 7.2 5.7 3.5 27.7 43.3 37.0 41.1 28.0 31.8 30.0 30.2 34.6 27.7 47.6 43.2 23.8 25.3 26.8 53.1 98.6 45.9 37.5 36.4 38.4 47.1 26.9 1.7 35.4 22.3 29.2 24.7 0.0 30.4 29.3 24.4 33.4 20.9 43.1 21.9 77.9 45.8 31.3 25.6 21.6 26.2 26.1 25.3 40.5 28.4 20.9 40.0 17.3 36.7 12.2 31.9 12.9 33.0 17.1 43.7 36.4 31.7 37.1 29.2 40.4 HYDIN "CILD5, DKFZp434D0513, KIAA1864, PPP1R31" ENSG00000157423 "HYDIN, axonemal central pair apparatus protein" Q4G0P3 16 70807378-71230722 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5;pituitary gland: 23.6;testis: 19.1" "Cell type enhanced" "Detected in many" 22 "Ciliated cells: 180.7;Cone photoreceptor cells: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 3.5;RPTEC TERT1: 5.3;SiHa: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA067155, HPA074129" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA067155: AB_2685792, HPA074129: AB_2686665" "unprognostic (8.90e-2)" "unprognostic (1.04e-2)" "unprognostic (8.65e-2)" "unprognostic (4.88e-4)" "unprognostic (4.25e-3)" "unprognostic (1.81e-1)" "unprognostic (3.87e-2)" "unprognostic (2.45e-1)" "unprognostic (3.95e-1)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (2.52e-5)" "unprognostic (2.13e-3)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (3.97e-2)" 0.8 0.9 6.3 1.2 13.9 1.7 1.5 2.9 4.2 2.1 1.2 13.3 4.4 1.0 2.4 18.4 0.9 14.5 1.9 1.0 6.9 4.3 3.5 1.8 7.1 1.1 2.3 4.1 7.2 1.6 9.0 23.6 0.7 21.5 1.4 0.8 3.9 0.9 1.5 0.8 1.7 1.1 1.0 3.1 1.5 1.1 19.1 3.8 0.0 3.2 0.0 0.6 1.2 0.8 0.9 1.1 3.7 1.3 0.7 1.2 0.2 0.1 0.1 2.1 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.9 0.3 0.2 0.4 0.3 3.5 0.7 0.3 0.2 1.6 0.4 0.5 0.1 0.1 0.2 0.4 0.5 0.2 0.4 0.5 0.0 0.0 0.8 0.0 2.2 0.4 0.1 0.1 0.0 0.7 0.8 1.3 0.1 0.7 0.3 0.2 0.8 5.3 0.7 2.5 0.5 11.0 0.3 0.4 0.4 0.7 0.0 0.3 0.3 0.8 0.1 0.3 1.8 0.1 1.0 0.9 0.2 0.6 1.5 1.0 0.8 1.2 0.9 1.2 0.6 1.0 1.1 0.3 0.9 0.9 0.8 3.7 0.7 1.3 1.1 0.6 0.2 6.3 13.9 2.9 4.2 6.9 4.3 2.3 4.1 21.5 3.8 3.0 1.6 0.0 0.2 0.0 13.2 2.0 0.0 180.7 29.6 8.7 49.1 0.0 1.7 1.7 26.1 0.1 0.0 0.0 0.5 0.0 0.9 0.8 0.0 0.0 0.1 0.0 3.4 0.0 0.0 21.2 2.3 0.0 3.3 0.0 0.0 12.9 0.5 0.0 4.2 1.4 26.6 0.0 0.7 17.1 6.1 0.0 0.0 0.0 0.0 0.1 HYI HT036 ENSG00000178922 "Hydroxypyruvate isomerase (putative)" Q5T013 1 43451003-43453989 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 130.4;seminal vesicle: 80.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 39.2;WM-115: 33.2" "Low region specificity" "Detected in all" HPA040092 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Golgi apparatus" "HPA040092: AB_10795374" "prognostic favorable (9.18e-4)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.68e-2)" "unprognostic (3.86e-1)" "unprognostic (4.40e-2)" "prognostic unfavorable (5.55e-4)" "unprognostic (2.75e-2)" "unprognostic (1.42e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (2.75e-5)" "unprognostic (5.10e-2)" "unprognostic (7.93e-2)" "unprognostic (3.58e-2)" "prognostic favorable (2.72e-5)" 16.5 12.5 11.6 12.1 10.1 5.3 12.8 11.3 9.7 14.6 16.5 13.0 130.4 23.4 15.8 14.8 8.4 15.3 16.7 10.9 9.2 10.0 15.9 25.8 17.8 6.7 10.9 9.3 25.1 34.0 13.8 11.2 10.8 9.0 15.6 7.5 15.0 20.8 80.0 8.8 8.4 22.1 13.4 14.3 7.6 14.1 4.5 11.1 4.9 12.8 9.6 6.4 10.7 11.3 3.2 21.6 6.2 1.2 4.8 5.4 3.0 17.4 2.2 0.7 1.2 3.4 6.4 0.0 15.2 13.7 19.2 12.9 8.9 30.5 0.0 1.1 9.8 7.7 3.2 0.0 16.1 7.9 4.3 6.3 2.8 8.0 0.0 22.7 0.0 0.0 3.8 4.6 21.8 0.0 19.4 39.2 0.1 0.2 0.0 12.9 0.3 2.6 2.9 3.2 1.6 4.5 13.5 0.0 0.1 13.3 0.6 8.3 6.1 17.1 9.6 3.8 2.8 2.5 21.9 18.1 1.2 0.0 3.4 29.7 0.0 0.0 0.0 1.0 4.0 33.2 6.2 1.1 2.4 3.3 0.9 4.1 3.2 5.4 2.6 4.1 2.7 5.1 1.5 0.1 4.8 1.2 21.6 0.5 3.0 11.6 10.1 11.3 9.7 9.2 10.0 10.9 9.3 9.0 11.1 17.9 66.3 11.9 39.0 24.8 15.2 0.3 68.8 10.7 20.5 54.1 9.8 14.0 38.1 94.3 0.9 20.2 81.2 23.3 74.3 97.6 32.9 36.0 43.7 49.7 24.9 7.9 66.7 21.5 7.0 3.1 29.4 17.5 38.8 23.4 57.1 28.8 107.8 112.2 28.7 115.0 14.1 25.8 53.4 0.9 2.1 19.3 10.1 10.0 43.0 29.2 HYLS1 FLJ32915 ENSG00000198331 "HYLS1, centriolar and ciliogenesis associated" Q96M11 11 125883614-125900648 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 72.7;Late spermatids: 40.2;Spermatocytes: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041210 Enhanced Supported "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA041210: AB_10794987" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (3.53e-3)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.28e-1)" "unprognostic (1.04e-3)" "unprognostic (6.56e-3)" "unprognostic (7.63e-2)" "unprognostic (4.81e-3)" "unprognostic (3.00e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" 4.3 4.3 6.5 3.6 8.8 2.8 5.2 12.3 11.6 5.9 5.5 2.7 6.0 7.0 5.3 8.3 5.7 5.0 3.2 5.7 6.7 7.2 8.7 7.2 3.1 6.7 5.0 8.6 5.0 3.4 3.4 5.5 5.1 7.6 6.2 6.0 2.2 3.9 7.6 3.7 5.7 6.7 7.1 3.5 5.6 6.2 28.6 4.3 7.6 5.1 4.6 9.6 5.0 3.8 11.8 14.3 3.2 6.0 4.6 10.3 4.7 4.6 10.2 3.7 2.7 7.4 5.0 6.5 11.8 4.7 11.1 7.5 0.1 7.7 2.0 5.0 10.3 3.7 7.0 5.3 4.1 12.9 11.4 3.7 1.5 1.1 2.1 5.5 5.2 7.9 3.2 4.8 11.0 12.5 2.4 8.0 4.6 2.6 12.7 14.5 7.9 3.8 15.7 8.3 19.6 17.3 8.0 0.0 6.8 11.9 7.8 5.3 3.3 12.5 9.7 4.7 5.0 23.9 11.6 7.2 0.8 9.7 8.8 2.0 4.7 4.6 4.9 2.3 11.5 9.7 3.2 5.5 1.1 8.1 6.0 7.6 11.5 10.2 9.4 6.7 11.8 10.3 7.4 0.9 4.6 4.2 14.3 10.3 4.7 6.5 8.8 12.3 11.6 6.7 7.2 5.0 8.6 7.6 4.3 0.0 0.3 8.0 2.4 3.8 7.9 4.0 2.5 4.0 0.0 1.8 3.9 12.5 10.0 3.9 72.7 3.5 3.3 23.3 3.6 10.5 5.1 2.6 0.0 5.5 6.3 0.0 4.7 4.3 1.9 40.2 7.8 2.2 6.8 14.4 2.1 4.4 3.9 6.0 5.6 10.2 5.6 6.5 5.0 98.2 33.7 3.8 3.7 6.4 5.0 1.4 IARS "IARS1, ILRS" ENSG00000196305 "Isoleucyl-tRNA synthetase" P41252 9 92210207-92293756 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029806 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029806: AB_10601818" "unprognostic (1.32e-3)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (8.23e-2)" "unprognostic (1.33e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (4.98e-7)" "unprognostic (2.00e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-1)" "unprognostic (4.96e-2)" "unprognostic (3.67e-2)" "unprognostic (1.40e-2)" "unprognostic (2.88e-2)" "unprognostic (4.71e-2)" "unprognostic (2.21e-1)" "unprognostic (7.76e-3)" 20.6 31.0 19.1 21.1 28.5 13.8 24.8 24.5 32.1 22.8 23.7 17.5 25.8 13.6 31.9 24.8 29.7 23.8 15.1 26.0 21.4 18.5 24.5 29.9 24.4 24.1 21.6 20.6 28.4 42.8 57.4 29.0 21.1 31.6 23.6 26.7 17.1 25.2 27.7 47.4 25.4 18.8 32.6 20.0 23.1 29.0 18.7 16.9 25.1 52.3 26.7 28.8 22.1 20.5 14.5 15.3 1.9 7.3 18.6 18.6 9.7 35.0 36.3 20.3 32.0 33.5 37.8 32.2 37.2 35.5 29.5 36.1 12.7 22.6 47.6 14.7 57.4 32.5 43.9 62.6 48.4 37.3 29.9 23.3 29.0 31.3 22.6 70.8 39.5 21.5 36.8 54.4 51.4 85.1 19.4 31.0 57.2 51.1 43.3 41.4 25.5 36.5 15.4 32.9 74.5 33.6 25.6 30.9 22.9 24.3 17.6 26.0 21.6 25.2 27.7 35.0 22.9 22.2 24.8 22.8 21.8 27.3 36.0 30.2 31.7 40.5 25.2 51.0 30.5 40.2 1.9 6.7 0.5 14.7 7.3 18.6 14.5 14.5 14.9 15.3 10.7 14.7 15.3 0.8 18.6 6.2 6.2 12.9 9.7 19.1 28.5 24.5 32.1 21.4 18.5 21.6 20.6 31.6 16.9 17.9 25.5 29.7 27.4 60.8 34.2 44.5 40.8 24.1 27.3 17.4 43.2 23.5 13.3 22.2 8.9 20.8 5.4 0.0 25.9 26.2 31.1 25.2 36.9 26.0 15.7 9.5 11.5 16.0 21.6 4.0 26.4 17.7 13.5 11.8 23.8 15.5 26.0 8.6 27.6 29.1 34.6 6.5 32.5 39.2 38.1 59.2 14.5 18.7 26.3 27.4 ICA1 "ICA69, ICAp69" ENSG00000003147 "Islet cell autoantigen 1" Q05084 7 8113184-8262687 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 58.6" "Group enriched" "Detected in many" 8 "Early spermatids: 546.5;Late spermatids: 690.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "T-reg: 20.8" "Lineage enriched" "Detected in many" 8 "T-cells: 20.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.3;MCF7: 15.3;OE19: 17.5;RT4: 17.9;SCLC-21H: 25.1;SH-SY5Y: 41.4;SK-BR-3: 19.6;T-47d: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017646, HPA061452" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA017646: AB_1851382, HPA061452: AB_2684525" "unprognostic (1.39e-1)" "unprognostic (1.37e-1)" "unprognostic (3.74e-1)" "unprognostic (6.83e-3)" "unprognostic (9.49e-2)" "unprognostic (8.57e-3)" "unprognostic (1.37e-2)" "unprognostic (3.54e-1)" "unprognostic (7.61e-2)" "unprognostic (3.42e-1)" "unprognostic (5.84e-2)" "unprognostic (2.62e-1)" "prognostic favorable (4.23e-8)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (4.08e-2)" 8.9 6.1 12.6 4.2 15.3 11.7 13.0 19.4 24.2 10.7 13.2 2.5 8.7 7.7 5.5 8.5 5.8 8.1 10.4 25.7 7.7 7.8 9.1 5.3 9.2 6.9 4.8 12.4 1.6 58.6 13.2 13.5 4.6 10.5 13.7 14.3 2.5 21.2 8.3 2.8 7.0 10.4 3.7 2.8 7.6 17.9 16.0 3.2 0.8 8.1 4.1 5.5 9.6 4.1 0.3 1.7 2.4 1.6 0.7 20.8 1.1 0.0 0.3 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.3 16.3 0.1 1.6 0.0 0.3 0.0 0.3 0.7 0.0 0.0 2.5 3.4 0.3 0.0 0.1 2.8 0.5 0.0 1.1 0.0 0.0 0.1 11.9 3.2 9.6 0.0 0.0 15.3 0.1 0.0 3.7 17.5 0.1 0.0 0.0 7.1 7.0 17.9 25.1 41.4 0.0 19.6 0.2 4.4 15.9 5.2 7.0 0.0 0.3 0.0 0.3 5.2 2.4 0.0 0.0 2.2 3.4 0.5 1.6 0.1 0.2 0.5 0.4 0.2 3.9 0.3 1.7 0.3 0.2 0.1 2.4 0.7 0.2 0.4 20.8 1.1 12.6 15.3 19.4 24.2 7.7 7.8 4.8 12.4 10.5 3.2 26.8 16.6 0.8 11.9 18.2 10.0 32.3 20.4 14.7 17.0 21.0 5.9 2.2 36.5 31.7 546.5 36.1 22.9 0.0 65.8 0.7 3.3 58.9 8.1 0.8 19.0 0.0 74.0 36.2 8.3 690.2 6.9 5.8 13.5 9.0 64.9 0.8 53.9 47.2 2.8 7.3 1.6 6.5 4.7 7.5 6.4 7.9 1.8 8.9 33.8 34.2 ICAM1 "BB2, CD54" ENSG00000090339 "Intercellular adhesion molecule 1" P05362 19 10270835-10286615 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 68.3;lung: 91.3" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 568.7;Alveolar cells type 2: 522.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 31.6;Karpas-707: 90.1;RPMI-8226: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002126, CAB002142, HPA004877" Enhanced Approved "Plasma membrane,Cytosol" NA NA 87900000 3100000000 "Plasma membrane, Cytosol" "CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317" "prognostic favorable (7.09e-4)" "unprognostic (1.88e-1)" "unprognostic (1.94e-1)" "unprognostic (2.63e-2)" "unprognostic (3.25e-3)" "unprognostic (3.05e-1)" "unprognostic (1.45e-2)" "unprognostic (3.48e-1)" "unprognostic (3.18e-2)" "unprognostic (1.09e-2)" "unprognostic (1.49e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.32e-6)" "unprognostic (2.77e-1)" "unprognostic (2.16e-2)" "unprognostic (2.25e-1)" "unprognostic (3.70e-3)" 26.1 8.6 4.0 41.0 4.1 36.5 15.0 1.0 4.5 5.6 10.0 2.7 1.6 6.1 8.5 7.7 7.9 10.7 19.8 16.3 2.6 2.1 10.9 68.3 91.3 32.8 5.4 1.7 12.4 7.2 2.5 4.0 9.3 6.8 10.4 6.6 10.6 7.2 3.6 13.9 6.9 7.9 8.0 7.8 42.2 7.3 6.5 3.6 8.3 11.6 13.7 13.4 14.8 17.1 2.2 13.3 22.2 14.2 7.9 5.6 8.9 8.4 0.1 1.5 0.0 0.4 0.9 2.1 1.7 18.8 4.2 12.7 2.8 9.5 7.7 26.2 0.7 19.3 1.7 0.3 0.0 8.9 23.1 0.0 0.7 0.2 11.5 31.6 0.2 4.5 11.1 0.7 2.6 4.1 0.4 2.1 0.9 2.9 90.1 0.3 0.6 0.1 6.5 0.5 0.1 4.8 0.2 0.0 28.6 7.2 0.0 0.0 0.2 11.6 0.6 18.4 0.7 1.4 0.5 6.5 4.3 0.4 2.4 0.1 27.5 28.3 4.8 7.0 4.9 6.3 2.2 13.9 2.6 3.0 14.2 5.6 2.2 2.4 3.6 13.3 0.9 1.0 2.2 22.2 7.9 7.9 7.5 3.4 8.9 4.0 4.1 1.0 4.5 2.6 2.1 5.4 1.7 6.8 3.6 568.7 522.3 12.0 22.9 75.8 0.0 0.8 20.4 80.3 159.3 3.5 0.0 1.0 0.0 152.6 1.9 139.3 0.5 0.0 84.4 2.5 171.6 19.1 133.1 12.9 75.0 0.0 2.4 56.4 41.3 1.1 4.4 160.6 72.6 168.7 0.3 2.3 107.4 0.0 1.4 9.4 0.3 6.5 95.4 0.5 1.7 60.6 1.0 12.7 0.5 10.0 ICAM2 CD102 ENSG00000108622 "Intercellular adhesion molecule 2" P13598 17 64002594-64020634 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 74.5;lymphoid tissue: 63.9" "Cell type enhanced" "Detected in many" 13 "B-cells: 46.1;Endothelial cells: 80.1;Ito cells: 147.3;Kupffer cells: 54.5;T-cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 167.1;TIME: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071155 Approved "Plasma membrane,Cytosol" NA NA 1200000000 "Plasma membrane" Cytosol "HPA071155: " "unprognostic (9.43e-3)" "unprognostic (3.31e-2)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (1.64e-3)" "unprognostic (1.34e-1)" "unprognostic (3.74e-1)" "unprognostic (8.28e-2)" "unprognostic (2.15e-1)" "unprognostic (4.18e-2)" "unprognostic (1.55e-2)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (3.93e-2)" "unprognostic (6.04e-2)" "unprognostic (2.29e-1)" 36.0 3.6 8.4 13.0 11.5 8.3 34.1 3.5 7.7 9.4 9.7 5.6 2.8 6.4 9.8 5.2 9.5 7.4 8.8 22.8 9.5 8.9 10.5 8.7 27.9 24.0 12.3 3.1 6.3 7.4 3.1 4.5 36.8 9.1 7.9 8.5 8.1 8.8 4.3 17.1 5.5 10.8 13.9 10.5 63.9 8.0 4.0 7.4 14.3 11.6 9.0 18.0 12.8 23.6 49.0 30.9 56.5 74.5 26.0 65.3 67.5 0.0 0.0 0.0 0.0 1.4 1.5 0.4 0.1 0.1 0.0 0.1 0.3 6.9 11.7 2.1 0.0 0.0 0.0 0.1 0.0 0.2 2.6 0.0 10.5 0.6 1.2 0.2 1.7 0.0 0.0 0.0 0.1 0.0 0.0 167.1 9.9 8.6 6.9 0.0 0.0 13.1 1.5 0.0 0.0 0.0 7.9 0.0 16.3 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 42.2 0.0 0.1 0.8 0.0 6.6 2.2 10.5 0.0 2.2 0.0 56.5 30.0 8.9 45.8 66.5 52.8 36.5 60.1 42.8 30.9 49.0 65.3 40.7 3.6 26.0 74.5 10.0 64.5 67.5 8.4 11.5 3.5 7.7 9.5 8.9 12.3 3.1 9.1 7.4 0.0 12.5 46.1 3.4 6.5 0.0 0.3 0.0 6.7 6.8 7.0 0.0 0.4 0.0 0.8 0.5 80.1 0.3 0.0 1.2 0.3 6.9 1.6 11.5 1.0 18.7 0.0 1.2 147.3 54.5 0.0 0.3 23.4 27.0 6.4 1.4 0.4 5.1 5.8 1.8 0.5 0.3 6.5 4.4 0.2 0.2 4.6 0.8 52.4 1.7 2.6 IDH1 ENSG00000138413 "Isocitrate dehydrogenase (NADP(+)) 1, cytosolic" O75874 2 208236227-208266074 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 277.8;Hepatocytes: 306.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 107.6;RT4: 75.1" "Low region specificity" "Detected in all" "CAB033218, HPA035248, HPA057936, CAB062556" Enhanced Approved "Nuclear bodies,Cytosol" NA NA 16000000 "Nuclear bodies, Cytosol" "CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559" "unprognostic (2.79e-1)" "unprognostic (1.00e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-3)" "unprognostic (1.93e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (6.93e-5)" "unprognostic (3.32e-1)" "unprognostic (2.20e-3)" "unprognostic (8.03e-2)" "unprognostic (5.54e-2)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.45e-5)" "unprognostic (2.09e-1)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.69e-2)" 41.3 82.3 6.2 8.8 7.0 1.3 20.9 6.5 8.3 12.6 35.2 8.7 38.0 30.6 8.0 29.9 30.3 8.8 18.7 10.8 6.3 6.2 20.5 91.0 19.8 14.3 8.1 4.7 19.4 21.5 4.8 6.2 24.1 8.7 38.5 23.1 15.4 18.7 39.0 4.7 7.4 54.1 10.1 9.3 21.3 20.4 15.6 8.4 3.5 7.9 11.0 11.9 43.4 12.1 4.9 22.8 6.4 31.6 7.4 6.6 12.0 9.5 16.1 23.0 9.3 41.8 29.9 13.1 4.0 18.3 6.7 16.4 25.4 23.4 1.9 25.4 12.4 28.6 14.8 16.5 19.3 6.5 1.3 6.2 8.2 13.2 107.6 55.7 5.3 8.2 25.7 41.0 15.4 11.2 10.7 18.5 5.6 8.2 6.6 10.3 6.1 3.8 9.2 42.0 68.5 6.6 3.6 8.4 5.4 30.4 75.1 3.9 6.9 15.2 14.7 49.7 25.4 5.6 15.7 12.2 6.9 6.9 9.7 4.3 3.2 5.0 2.5 22.2 32.5 5.5 5.7 31.6 4.8 4.5 14.5 5.1 4.9 4.0 5.3 22.8 4.9 3.3 3.9 6.4 7.4 6.5 8.4 6.6 12.0 6.2 7.0 6.5 8.3 6.3 6.2 8.1 4.7 8.7 8.4 11.9 38.0 25.9 15.5 11.0 19.3 16.8 58.6 14.7 27.3 27.9 23.6 277.8 18.3 23.8 6.9 15.5 112.0 0.0 76.5 152.3 23.7 78.5 13.9 306.5 146.5 11.1 56.1 41.1 109.5 7.7 22.7 46.5 25.3 53.3 85.9 26.7 42.8 52.6 27.6 74.2 45.5 12.9 12.2 7.7 30.8 13.0 80.0 16.0 106.9 38.2 IDNK "bA522I20.2, C9orf103, hGntK" ENSG00000148057 "IDNK, gluconokinase" Q5T6J7 9 83623049-83644130 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 35.9;liver: 39.1" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 68.0;Proximal tubular cells: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020378, HPA058429" Approved Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA020378: AB_1845794, HPA058429: AB_2683716" "unprognostic (1.49e-3)" "unprognostic (7.94e-2)" "unprognostic (3.30e-1)" "prognostic favorable (1.10e-6)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (5.41e-3)" "unprognostic (1.81e-2)" "unprognostic (6.08e-2)" "unprognostic (1.57e-1)" "unprognostic (2.61e-2)" "unprognostic (3.00e-1)" "unprognostic (5.86e-3)" "unprognostic (7.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.55e-1)" "unprognostic (3.11e-2)" 4.3 6.1 9.4 2.9 20.3 2.2 4.5 12.3 8.3 2.3 11.3 7.0 3.1 14.2 2.5 7.4 4.1 6.8 4.5 2.8 7.6 8.6 27.2 39.1 3.7 4.7 7.3 6.3 3.2 6.6 3.6 5.2 1.8 6.2 4.2 4.7 5.2 4.6 5.0 1.2 3.3 20.2 3.5 7.0 4.2 4.3 2.0 6.8 14.5 7.0 1.2 4.3 2.8 2.1 17.5 9.6 35.9 20.5 15.0 23.0 11.4 3.4 8.2 1.1 1.3 3.7 5.4 6.0 2.3 6.9 2.6 2.1 2.1 3.0 4.3 4.0 3.7 2.5 5.7 0.9 1.6 2.8 9.5 1.0 1.6 3.2 9.4 16.4 1.0 2.0 3.7 2.2 5.7 5.4 3.9 5.9 10.3 1.3 4.6 3.8 19.0 2.6 1.0 0.9 13.8 3.7 3.2 3.1 2.5 6.9 4.0 5.3 6.8 5.5 4.3 5.8 1.6 4.3 5.8 6.0 1.1 0.8 10.7 4.4 6.6 7.6 0.6 5.9 1.8 2.1 35.9 6.1 8.6 14.7 10.6 12.3 17.5 12.7 12.1 8.5 11.4 10.2 13.8 1.1 15.0 20.5 9.6 23.0 11.4 9.4 20.3 12.3 8.3 7.6 8.6 7.3 6.3 6.2 6.8 11.9 5.4 5.9 2.6 6.1 7.5 8.7 15.3 22.7 9.1 5.2 0.0 6.3 68.0 10.1 0.3 6.0 10.8 0.0 14.3 3.8 8.4 5.2 19.7 37.2 10.0 9.5 7.0 3.1 9.5 1.1 4.0 7.7 11.8 27.9 10.6 17.7 5.2 11.5 3.9 149.6 3.1 0.0 9.5 1.1 1.5 5.1 2.5 17.5 7.8 2.7 IDO1 "IDO, INDO" ENSG00000131203 "Indoleamine 2,3-dioxygenase 1" P14902 8 39902275-39928444 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;placenta: 33.2" "Cell type enriched" "Detected in some" 552 "monocytes: 4555.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 17 "eosinophil: 77.7" "Lineage enriched" "Detected in many" 17 "granulocytes: 77.7" "Cell line enriched" "Detected in some" 7 "EFO-21: 36.6" "Region enriched" "Detected in single" 13 "basal ganglia: 30.5" "Low region specificity" "Detected in all" "HPA023072, HPA023149, HPA027772, CAB072820" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles, Mitochondria" "CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222" "unprognostic (1.68e-2)" "unprognostic (1.71e-2)" "unprognostic (4.08e-3)" "unprognostic (7.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.09e-2)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "prognostic favorable (5.27e-4)" "prognostic favorable (3.32e-4)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.12e-7)" "unprognostic (4.18e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.97e-2)" 8.7 0.2 0.9 11.2 0.9 0.0 1.4 0.9 0.9 4.0 1.5 0.9 0.9 2.6 2.6 0.9 1.2 0.6 1.3 1.0 0.9 0.0 0.9 0.9 16.8 14.1 0.9 0.9 0.9 0.9 0.0 0.9 33.2 0.9 1.6 2.1 1.9 0.9 0.9 2.5 0.3 5.9 0.9 2.0 6.2 2.2 0.9 0.9 0.9 7.2 0.9 8.9 2.3 0.9 0.0 4.6 77.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 2.6 0.1 0.3 0.0 36.6 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 0.1 0.0 0.1 0.0 4.5 0.1 77.7 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.5 2.6 0.9 0.0 0.0 6.7 0.0 0.2 0.4 0.0 0.0 0.8 0.0 0.0 0.0 8.2 1.3 0.0 6.0 0.0 4555.6 0.0 3.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.4 IDO2 INDOL1 ENSG00000188676 "Indoleamine 2,3-dioxygenase 2" Q6ZQW0 8 39934614-40016391 "Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "liver: 9.7;placenta: 21.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 16.8;Late spermatids: 5.3;monocytes: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;U-266/70: 1.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA054911 Approved Cytosol NA NA Cytosol "HPA054911: " "unprognostic (2.00e-3)" "unprognostic (2.34e-5)" "unprognostic (2.22e-3)" "unprognostic (4.41e-3)" "unprognostic (5.37e-2)" "unprognostic (3.69e-5)" "unprognostic (1.19e-1)" "unprognostic (4.73e-3)" "unprognostic (1.20e-2)" "unprognostic (2.78e-1)" "unprognostic (4.11e-3)" "unprognostic (2.25e-1)" "unprognostic (6.47e-7)" "unprognostic (3.25e-2)" "unprognostic (1.96e-3)" "unprognostic (3.35e-2)" "unprognostic (3.08e-3)" 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 9.7 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 IFI16 "IFNGIP1, PYHIN2" ENSG00000163565 "Interferon gamma inducible protein 16" Q16666 1 158999968-159055155 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA002134, CAB016293" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "CAB016293: AB_627775, HPA002134: AB_1079099" "unprognostic (7.23e-3)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (7.70e-3)" "unprognostic (1.87e-1)" "unprognostic (6.08e-2)" "unprognostic (1.80e-1)" "unprognostic (5.83e-2)" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (5.07e-2)" "unprognostic (4.08e-1)" "unprognostic (7.97e-2)" "unprognostic (1.14e-1)" 64.2 21.0 10.9 42.5 18.0 10.2 34.8 6.7 11.4 28.5 18.6 9.6 7.8 7.5 32.5 21.8 32.8 25.0 33.4 24.8 16.5 7.5 13.3 10.2 32.1 51.0 19.5 6.3 32.6 5.5 3.2 7.0 21.4 18.0 23.0 15.2 10.9 33.6 11.2 14.6 23.7 21.6 29.1 32.2 63.2 11.8 14.2 16.0 81.8 19.1 24.2 41.8 30.9 27.6 28.9 20.8 51.2 21.0 27.9 24.6 16.9 7.0 0.5 2.4 0.1 17.0 56.4 0.0 15.0 40.3 42.3 56.3 0.0 9.1 41.5 12.9 9.2 13.6 20.5 0.3 15.2 16.9 12.8 0.1 10.6 3.1 0.0 31.9 3.6 0.7 53.1 27.3 21.6 30.8 20.3 44.4 36.7 0.2 30.4 23.4 0.0 48.7 3.4 6.5 0.0 5.5 23.0 15.6 47.9 5.9 2.7 1.1 0.0 19.6 0.1 42.6 10.2 0.0 4.3 25.0 10.9 5.1 30.6 6.3 28.4 13.2 39.0 31.3 12.0 26.2 2.5 21.0 0.1 18.9 20.5 16.9 27.6 18.1 19.3 20.8 28.9 11.5 14.6 51.2 27.9 18.5 15.6 24.6 16.9 10.9 18.0 6.7 11.4 16.5 7.5 19.5 6.3 18.0 16.0 35.7 66.1 149.1 95.2 84.3 0.2 6.9 22.9 58.9 119.4 40.1 0.0 3.0 1.7 32.6 4.0 196.0 5.6 0.0 40.2 1.9 91.8 23.0 129.9 2.9 175.9 0.0 11.6 126.4 165.6 4.9 108.7 168.3 79.2 49.5 16.2 31.8 42.0 24.6 49.8 4.4 0.9 84.1 124.0 2.6 1.9 59.6 2.7 201.5 21.7 108.0 IFI27L2 "FAM14A, TLH29" ENSG00000119632 "Interferon alpha inducible protein 27 like 2" Q9H2X8 14 94127779-94130253 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 57.7" "Low region specificity" "Detected in all" HPA049588 Approved Nucleoli,Cytosol "Intracellular and membrane" No No Cytosol Nucleoli "HPA049588: " "unprognostic (9.70e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.45e-1)" "unprognostic (2.80e-2)" "unprognostic (7.46e-3)" "unprognostic (4.76e-2)" "unprognostic (4.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.79e-3)" "unprognostic (3.96e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (3.88e-1)" "unprognostic (5.09e-2)" "unprognostic (3.52e-2)" 11.4 39.9 38.6 18.3 23.8 17.0 18.8 15.2 24.7 19.9 16.0 23.5 8.7 11.6 15.8 9.6 24.5 21.9 20.8 38.9 29.7 32.4 13.2 3.7 16.5 21.5 37.1 22.8 25.9 13.2 11.7 20.6 5.4 27.4 10.6 9.7 20.4 7.2 12.5 4.0 16.0 13.5 15.5 35.7 17.0 15.7 9.1 22.9 13.8 8.5 16.0 22.5 12.0 17.2 31.5 29.6 19.8 38.7 6.0 30.5 31.9 8.4 5.9 1.7 12.1 8.7 22.4 1.1 15.9 16.4 12.0 14.1 1.6 3.9 3.7 17.4 17.1 10.6 10.5 1.3 21.1 4.9 25.3 0.9 5.8 5.9 0.5 14.8 6.8 16.0 20.3 7.8 7.1 4.4 20.5 7.9 14.6 0.5 57.7 12.4 15.9 3.9 4.1 2.1 5.6 6.8 0.1 5.6 4.9 18.2 3.3 3.1 4.7 0.4 0.1 10.2 3.3 19.6 11.4 7.7 8.0 4.9 10.7 4.4 23.6 19.5 1.3 25.6 15.2 5.2 19.8 38.7 7.1 25.6 25.9 16.4 31.5 24.4 28.1 29.6 27.4 17.6 23.0 5.7 6.0 18.8 24.6 30.5 31.9 38.6 23.8 15.2 22.8 29.7 32.4 37.1 22.8 27.4 22.9 35.7 60.1 82.7 48.1 82.4 19.9 126.7 48.4 18.7 11.4 169.3 19.6 1.8 150.9 127.6 5.8 62.7 86.6 0.0 26.4 2.5 85.0 7.4 88.9 2.6 167.2 22.3 95.7 122.2 166.9 22.7 169.5 141.7 224.4 80.2 146.1 108.3 55.0 123.8 108.5 51.2 76.6 122.9 100.0 4.5 24.8 58.5 2.4 89.6 75.5 44.4 IFI30 "GILT, IFI-30, IP-30, IP30, MGC32056" ENSG00000216490 "IFI30, lysosomal thiol reductase" P13284 19 18173162-18178117 "Predicted intracellular proteins, Predicted membrane proteins" Immunity Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 348.5" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 159.4;Kupffer cells: 201.6;Macrophages: 219.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 348.5" "Group enriched" "Detected in all" 8 "dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5" "Cell line enhanced" "Detected in many" "Daudi: 76.0;RPMI-8226: 82.4;SK-BR-3: 55.7;U-266/84: 91.1" "Low region specificity" "Detected in many" HPA026650 Enhanced Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 89000 "Vesicles, Cytosol" "HPA026650: AB_10602237" "unprognostic (4.66e-2)" "unprognostic (1.25e-4)" "unprognostic (2.35e-3)" "unprognostic (7.40e-2)" "unprognostic (1.76e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-3)" "unprognostic (2.40e-1)" "unprognostic (4.01e-2)" "unprognostic (9.19e-3)" "unprognostic (3.04e-1)" "unprognostic (1.19e-1)" "unprognostic (7.29e-11)" "unprognostic (3.50e-1)" "unprognostic (1.62e-2)" "unprognostic (3.39e-2)" "unprognostic (9.59e-3)" 104.2 31.0 5.8 85.5 10.8 28.3 13.9 1.2 5.2 5.3 17.4 6.5 3.2 23.3 5.0 13.7 9.3 15.9 13.1 16.2 5.0 4.0 37.5 60.4 109.7 139.5 12.0 0.8 15.0 14.6 2.0 7.6 123.2 11.0 8.6 18.2 9.2 18.7 4.3 7.2 10.1 28.5 18.9 13.3 140.6 19.4 5.7 7.9 20.6 15.6 9.6 41.2 24.5 8.2 24.3 145.5 95.4 348.5 1.7 1.0 213.4 12.8 6.8 0.0 4.5 1.3 1.8 12.2 1.4 1.9 3.9 10.2 15.3 23.0 76.0 11.7 4.4 20.2 10.1 8.1 3.0 0.4 20.2 5.8 0.9 12.6 21.7 13.0 2.2 5.9 7.9 6.9 6.4 2.3 0.5 0.2 2.3 10.7 47.8 1.9 25.2 1.0 0.2 2.5 44.2 6.8 7.4 0.5 82.4 11.7 0.4 0.6 0.8 23.6 55.7 1.3 0.9 3.8 0.9 0.3 6.8 4.1 13.9 1.4 1.6 91.1 43.3 18.8 15.0 1.0 2.0 228.9 95.4 1.0 348.5 1.0 24.3 0.7 0.8 145.5 16.8 0.5 0.6 52.5 1.7 230.0 4.3 1.0 213.4 5.8 10.8 1.2 5.2 5.0 4.0 12.0 0.8 11.0 7.9 8.9 51.2 68.0 1.9 3.2 0.1 0.6 7.6 13.4 31.8 12.2 0.0 4.4 1.7 1.2 0.2 2.2 3.8 0.0 1.0 12.3 1.9 3.5 12.8 1.5 159.4 0.0 0.0 4.9 201.6 0.0 0.3 219.1 5.0 58.7 4.6 0.6 1.7 2.5 0.0 4.8 0.4 0.0 0.9 0.0 0.7 2.9 10.1 3.8 5.1 1.3 IFI35 IFP35 ENSG00000068079 "Interferon induced protein 35" P80217 17 43006725-43014456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 132.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 50.9;BJ hTERT+ SV40 Large T+ RasG12V: 75.1;GAMG: 27.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045946, HPA075580" Approved Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA 93000 "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA045946: AB_2679509, HPA075580: " "prognostic favorable (1.41e-4)" "unprognostic (1.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.16e-1)" "unprognostic (1.32e-1)" "unprognostic (3.26e-1)" "unprognostic (3.90e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-2)" "unprognostic (9.78e-3)" "unprognostic (6.51e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.03e-5)" "unprognostic (3.55e-1)" "unprognostic (3.62e-2)" "unprognostic (1.34e-2)" "unprognostic (1.49e-1)" 24.9 27.9 9.3 18.1 12.4 14.6 15.1 5.0 9.3 10.7 20.5 9.4 12.8 15.9 13.6 17.4 11.3 14.0 15.5 13.2 7.7 7.0 21.8 26.2 17.7 20.2 9.4 8.1 19.2 11.0 8.3 10.1 15.8 9.5 24.2 13.6 19.5 18.7 10.8 6.4 7.3 33.6 14.1 9.2 31.5 14.9 5.7 9.7 19.5 30.3 8.3 17.8 13.2 10.1 13.2 23.3 22.2 43.2 18.6 17.6 24.9 2.9 7.0 0.0 0.3 6.1 7.4 1.5 2.0 20.7 50.9 75.1 2.5 11.2 0.9 4.0 5.9 27.0 1.7 0.3 3.1 4.1 7.9 1.4 2.2 2.5 9.3 15.1 2.4 4.8 10.2 1.2 7.1 0.9 4.6 4.6 1.9 1.2 15.0 2.0 2.9 5.1 1.9 0.0 2.7 3.1 4.3 0.0 5.5 6.3 2.6 1.3 0.0 3.9 1.5 20.4 0.1 6.5 4.7 2.2 3.7 0.0 1.1 3.1 13.3 4.9 0.2 6.7 1.9 3.6 19.1 35.9 20.5 16.6 43.2 15.2 12.9 12.9 15.4 21.7 13.2 10.4 12.8 22.2 18.6 39.3 23.3 17.6 24.9 9.3 12.4 5.0 9.3 7.7 7.0 9.4 8.1 9.5 9.7 14.9 8.9 23.1 25.1 9.3 0.8 4.8 10.2 6.7 10.3 17.4 2.0 20.6 34.9 37.8 8.8 26.3 85.0 0.0 56.2 27.8 22.8 23.2 7.0 27.6 74.5 1.6 30.4 32.5 38.4 27.5 26.7 42.9 23.6 77.5 32.6 8.6 36.2 132.5 22.3 67.8 0.8 6.5 13.0 0.3 0.1 8.2 8.7 29.8 22.2 28.2 IFIT1 "G10P1, GARG-16, IFI56, IFNAI1" ENSG00000185745 "Interferon induced protein with tetratricopeptide repeats 1" P09914 10 89392546-89406486 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 54.7;Muller glia cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 47.8" "Group enriched" "Detected in all" 7 "granulocytes: 47.8;monocytes: 13.5" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 115.4;BJ hTERT+ SV40 Large T+ RasG12V: 113.9" "CAB045980, HPA053890, HPA055380" Approved Enhanced Cytosol NA NA Cytosol "CAB045980: AB_11125836, HPA053890: , HPA055380: AB_2682800" "unprognostic (1.16e-1)" "unprognostic (2.77e-1)" "unprognostic (1.80e-1)" "unprognostic (7.96e-3)" "unprognostic (1.35e-3)" "unprognostic (2.02e-2)" "unprognostic (6.45e-2)" "unprognostic (3.66e-1)" "unprognostic (3.34e-1)" "unprognostic (8.65e-3)" "unprognostic (1.82e-2)" "unprognostic (7.68e-2)" "unprognostic (2.21e-2)" "unprognostic (2.03e-2)" "unprognostic (5.95e-2)" "unprognostic (9.75e-3)" "unprognostic (6.40e-3)" 17.4 25.1 21.8 4.6 18.4 10.5 8.7 38.8 29.8 9.2 8.1 9.9 3.5 4.1 8.0 13.7 7.6 10.3 17.5 15.6 16.5 24.0 23.7 28.7 16.8 3.4 20.1 22.6 10.3 6.8 19.5 13.5 12.4 28.8 9.6 6.4 10.6 46.4 8.2 18.3 3.3 4.7 10.1 24.9 20.8 4.5 5.2 18.3 5.0 7.9 7.7 2.9 9.6 6.2 2.2 2.7 47.8 13.5 1.3 4.5 5.2 3.2 0.3 0.7 5.6 2.9 6.0 0.0 3.8 24.1 115.4 113.9 0.3 3.4 0.2 1.3 4.9 21.9 2.5 0.3 0.3 5.6 0.1 0.3 0.4 2.7 0.2 3.3 0.4 0.3 4.8 0.0 2.1 0.0 2.1 0.1 0.5 0.0 2.5 1.2 0.0 0.7 2.1 0.0 0.0 2.1 0.9 0.2 0.6 2.7 0.3 0.0 0.1 0.9 0.4 22.5 0.8 0.2 0.4 0.1 0.5 0.6 0.7 0.4 0.2 0.3 0.1 0.7 0.7 0.1 6.8 8.9 10.6 1.2 11.0 2.1 2.2 3.2 2.2 2.7 2.2 4.5 2.7 47.8 1.3 13.5 0.1 3.4 5.2 21.8 18.4 38.8 29.8 16.5 24.0 20.1 22.6 28.8 18.3 32.8 7.2 0.9 3.2 2.6 26.7 16.5 2.5 25.4 6.8 8.7 17.7 2.9 54.7 11.5 0.4 34.0 0.5 0.0 4.5 14.2 8.7 1.0 2.3 9.8 30.9 30.2 0.0 8.6 10.5 2.1 17.8 7.3 1.7 2.8 0.3 73.1 2.3 5.8 41.1 21.7 12.7 38.8 4.2 0.0 0.4 1.5 1.1 1.3 0.1 0.4 IFIT3 "CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G" ENSG00000119917 "Interferon induced protein with tetratricopeptide repeats 3" O14879 10 89327894-89340971 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 80.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 80.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 80.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.1;BJ hTERT+ SV40 Large T+: 82.1;BJ hTERT+ SV40 Large T+ RasG12V: 95.4" "Low region specificity" "Detected in all" HPA059914 Approved Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA059914: AB_2684159" "unprognostic (2.81e-1)" "unprognostic (5.62e-2)" "unprognostic (4.94e-2)" "unprognostic (5.25e-3)" "unprognostic (3.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (5.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.72e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (9.80e-3)" "unprognostic (5.09e-2)" 50.5 15.7 14.9 11.3 17.3 22.1 10.6 6.9 17.0 6.8 9.7 7.6 4.1 14.5 8.8 16.8 6.2 10.9 15.1 8.9 14.2 12.9 19.3 17.0 25.9 10.0 13.5 12.4 11.3 4.3 3.8 5.5 22.9 23.0 9.7 5.4 9.2 19.6 8.1 8.1 5.0 11.3 11.1 18.4 26.0 7.2 5.1 12.1 14.3 14.9 5.5 2.9 11.0 5.9 1.6 2.5 80.0 18.4 0.3 2.6 3.2 6.4 0.4 0.1 1.7 7.5 8.1 0.0 4.1 35.1 82.1 95.4 0.3 9.2 0.5 1.8 6.6 19.1 5.8 0.1 0.8 6.1 0.9 0.0 2.4 1.8 0.2 4.3 0.7 2.1 5.0 0.1 7.1 0.6 3.1 0.5 0.2 0.1 1.4 2.1 0.0 1.5 1.9 0.1 0.0 2.0 1.5 0.5 0.4 2.3 3.0 0.0 0.0 0.7 0.1 16.1 0.2 0.2 0.8 0.6 1.3 0.2 2.2 1.0 2.3 1.8 0.1 1.9 3.0 1.3 15.2 7.5 26.6 0.7 16.0 0.1 1.6 1.1 0.5 2.5 1.4 0.7 0.8 80.0 0.3 18.4 0.5 2.6 3.2 14.9 17.3 6.9 17.0 14.2 12.9 13.5 12.4 23.0 12.1 47.6 8.5 5.9 8.9 2.9 7.9 30.7 12.7 16.0 15.9 8.7 3.9 3.4 18.3 47.8 0.3 46.8 13.4 0.0 31.7 6.8 10.8 7.2 12.8 11.0 32.4 57.2 0.0 15.4 21.3 0.0 28.1 21.7 3.3 10.0 2.5 23.1 19.3 5.1 26.5 8.8 1.8 45.3 10.2 0.9 1.0 1.6 1.6 4.9 2.5 5.5 IFITM1 "9-27, CD225, IFI17" ENSG00000185885 "Interferon induced transmembrane protein 1" P13164 11 313506-315272 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, Osteogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Club cells: 187.7;Leydig cells: 278.5;Sertoli cells: 271.7;T-cells: 358.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "eosinophil: 56.6;gdT-cell: 120.0;MAIT T-cell: 80.7;memory CD4 T-cell: 128.1;memory CD8 T-cell: 121.4;naive CD4 T-cell: 123.5;naive CD8 T-cell: 123.4;neutrophil: 106.8;NK-cell: 164.4;T-reg: 70.4" "Group enriched" "Detected in all" 7 "granulocytes: 106.8;NK-cells: 164.4;T-cells: 128.1" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 122.7;BJ hTERT+ SV40 Large T+ RasG12V: 219.9;HMC-1: 67.9" "HPA004810, CAB017615" Enhanced Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "CAB017615: AB_2264496, HPA004810: AB_1851419" "unprognostic (1.03e-3)" "unprognostic (6.79e-2)" "unprognostic (1.03e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-1)" "unprognostic (9.06e-2)" "unprognostic (7.58e-2)" "unprognostic (3.03e-1)" "unprognostic (6.21e-2)" "unprognostic (5.53e-2)" "unprognostic (6.64e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (5.77e-9)" "unprognostic (7.29e-2)" "unprognostic (6.29e-2)" "unprognostic (3.15e-2)" "unprognostic (3.82e-2)" 81.1 14.2 17.4 36.7 24.5 41.2 57.0 11.9 23.1 71.0 28.2 12.9 20.6 17.2 48.3 152.4 44.4 67.2 31.2 62.6 19.8 13.9 59.8 34.5 44.1 159.7 34.8 14.7 100.2 16.3 22.3 23.3 36.3 27.3 38.7 22.1 49.5 27.4 41.6 38.7 23.6 33.0 46.0 37.9 112.9 20.5 29.4 20.1 42.7 48.3 28.0 50.3 39.3 52.8 13.0 4.3 106.8 18.6 164.4 128.1 147.7 6.4 0.1 53.3 4.3 3.9 13.7 0.3 11.3 53.0 122.7 219.9 0.1 44.5 0.1 8.5 11.9 1.2 15.1 1.7 1.1 2.4 13.5 2.8 6.5 4.1 0.4 35.3 9.5 67.9 25.6 0.0 1.3 0.1 1.3 0.2 2.1 23.2 53.9 0.0 0.9 4.7 18.3 15.2 0.0 1.6 1.2 0.1 1.2 32.8 0.0 0.0 0.0 5.9 0.6 10.9 7.6 2.2 0.8 0.3 0.1 0.1 0.0 0.0 3.8 2.0 0.3 0.1 14.3 0.1 15.6 2.3 56.6 120.0 10.9 80.7 13.0 128.1 121.4 4.3 11.3 123.5 123.4 106.8 164.4 18.6 1.2 70.4 147.7 17.4 24.5 11.9 23.1 19.8 13.9 34.8 14.7 27.3 20.1 32.8 96.7 12.5 9.5 24.7 0.0 4.8 0.0 36.1 187.7 31.4 0.0 1.2 5.0 0.9 1.2 146.9 12.4 0.0 1.2 25.0 131.5 1.8 17.4 17.9 9.3 0.0 1.2 130.1 11.0 0.0 278.5 21.9 74.2 0.0 14.4 0.0 0.9 10.1 117.0 0.3 0.0 271.7 95.7 0.3 1.0 12.5 3.3 358.0 24.3 4.4 IFNLR1 "CRF2/12, IFNLR, IL-28R1, IL28RA" ENSG00000185436 "Interferon lambda receptor 1" Q8IU57 1 24154157-24187959 "Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 13.9;Urothelial cells: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 6.8;dendritic cells: 11.9" "Cell line enhanced" "Detected in many" "U-266/70: 30.2;U-266/84: 10.5;U-698: 22.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA017319 Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA017319: AB_1851708" "prognostic favorable (5.12e-4)" "unprognostic (7.16e-2)" "unprognostic (8.61e-3)" "unprognostic (8.48e-2)" "unprognostic (8.09e-2)" "unprognostic (1.22e-2)" "unprognostic (7.28e-3)" "unprognostic (2.33e-1)" "unprognostic (5.10e-2)" "unprognostic (1.93e-1)" "unprognostic (5.51e-2)" "unprognostic (4.50e-1)" "unprognostic (3.66e-3)" "unprognostic (5.15e-2)" "unprognostic (1.69e-1)" "unprognostic (2.69e-1)" "unprognostic (1.10e-1)" 3.0 3.0 1.1 9.5 1.9 0.4 2.9 10.2 2.1 2.1 9.9 3.8 3.6 6.5 0.8 6.7 4.7 2.0 2.9 6.4 0.9 2.1 4.3 10.1 9.2 8.2 2.0 1.9 1.5 7.8 5.7 8.2 2.5 2.9 4.1 4.6 1.6 9.3 5.7 3.5 8.3 19.2 0.2 5.3 4.4 3.1 1.2 1.1 1.2 5.3 3.1 10.7 2.0 2.7 6.8 11.9 0.0 0.0 0.0 2.0 0.5 3.7 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.7 0.5 6.3 1.1 8.1 8.8 0.0 3.1 2.8 3.8 6.6 0.5 1.6 2.0 0.0 1.3 1.9 0.0 0.0 0.0 0.0 2.2 0.2 2.0 1.4 0.0 1.6 0.1 0.0 0.0 0.8 0.1 0.2 8.1 0.3 2.4 0.0 0.0 0.6 1.5 1.6 1.2 0.7 2.0 1.1 0.8 1.4 1.5 0.0 0.0 0.0 1.6 0.0 0.0 30.2 10.5 22.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 5.1 0.3 1.5 0.0 6.8 0.6 1.6 0.0 0.0 0.0 11.9 0.3 0.5 1.1 1.9 10.2 2.1 0.9 2.1 2.0 1.9 2.9 1.1 0.0 4.5 2.2 6.8 9.8 2.1 2.9 2.5 5.3 1.2 1.8 0.0 0.3 3.3 2.2 2.0 0.2 13.9 0.0 2.1 1.0 0.4 4.3 0.0 7.8 2.4 0.0 0.0 0.0 0.3 3.4 0.3 2.7 0.0 9.0 3.0 3.3 1.7 4.8 0.0 1.8 2.6 0.0 0.5 0.0 0.6 11.0 0.2 1.3 2.9 12.7 IFRD1 "PC4, TIS7" ENSG00000006652 "Interferon related developmental regulator 1" O00458 7 112422968-112481017 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 93.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "eosinophil: 25.6;neutrophil: 44.2" "Lineage enriched" "Detected in all" 12 "granulocytes: 44.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024122, HPA072413" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA024122: AB_1851452, HPA072413: " "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.10e-1)" "unprognostic (9.82e-3)" "unprognostic (1.36e-2)" "unprognostic (2.39e-1)" "unprognostic (5.73e-3)" "unprognostic (1.37e-1)" "unprognostic (2.48e-2)" "prognostic favorable (5.45e-4)" "unprognostic (6.41e-2)" "unprognostic (2.93e-3)" "unprognostic (1.50e-3)" "unprognostic (4.81e-2)" "unprognostic (1.98e-1)" "unprognostic (2.89e-1)" "unprognostic (4.70e-2)" 19.5 18.0 16.7 12.9 19.6 83.1 24.0 14.3 15.7 10.7 18.3 15.6 11.7 18.7 15.7 12.5 12.7 11.4 12.7 16.0 15.2 13.3 11.9 14.1 19.2 7.9 30.9 13.2 16.9 93.0 12.5 23.1 18.7 16.9 14.7 11.7 11.2 14.3 11.0 37.6 12.3 19.0 23.9 28.2 11.7 17.7 17.9 22.0 7.5 16.5 13.5 7.4 14.7 37.5 3.8 2.9 44.2 3.2 3.4 3.7 2.6 15.0 10.1 15.7 14.8 26.9 17.5 14.6 14.9 14.3 19.3 17.4 16.7 12.7 7.3 28.5 7.7 38.4 9.0 10.9 12.6 26.4 12.4 15.5 8.2 18.8 16.0 30.8 11.1 6.5 13.3 27.0 20.4 23.4 15.5 8.0 12.6 25.0 16.5 7.8 13.6 14.1 18.7 35.8 14.0 17.8 12.3 6.3 13.6 5.8 4.2 25.3 13.1 17.0 14.5 48.1 29.7 5.6 12.0 6.9 32.9 7.0 25.6 44.9 14.8 17.5 20.0 8.9 30.9 37.6 5.7 3.2 25.6 3.6 2.8 2.8 3.8 3.5 3.4 2.9 3.0 3.4 3.3 44.2 3.4 2.8 2.1 3.7 2.6 16.7 19.6 14.3 15.7 15.2 13.3 30.9 13.2 16.9 22.0 29.8 31.8 25.5 140.2 175.3 48.0 49.5 22.9 13.4 33.0 17.4 84.4 63.5 14.9 41.7 32.2 54.5 231.2 23.3 49.6 52.8 71.4 123.0 75.8 18.7 104.1 20.6 132.5 47.9 76.5 7.5 33.9 78.9 97.8 73.1 82.8 22.6 50.8 210.5 38.5 11.0 72.9 38.8 197.8 13.7 11.5 110.2 126.9 55.4 87.9 126.0 IFT22 "DKFZp761N0823, FLJ13225, FLJ14117, RABL5" ENSG00000128581 "Intraflagellar transport 22" Q9H7X7 7 101313367-101321823 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.5" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 478.2;Late spermatids: 1059.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 47.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042930 Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA042930: AB_10794537" "unprognostic (1.55e-2)" "unprognostic (7.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (6.70e-3)" "unprognostic (1.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (9.99e-2)" "unprognostic (1.73e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-2)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" 6.6 12.3 18.1 4.4 19.9 2.9 9.3 4.8 17.1 11.2 9.9 10.1 9.5 3.1 13.0 28.8 7.6 39.9 12.0 15.9 14.6 15.8 25.5 6.1 7.9 5.7 12.9 13.9 15.3 13.2 15.6 16.2 3.9 13.5 11.2 4.6 15.5 10.6 12.7 14.7 6.5 3.5 13.8 8.6 2.9 7.7 59.5 6.4 9.2 26.2 6.7 4.6 9.3 5.8 9.9 6.7 1.5 5.1 8.3 7.9 3.0 15.1 19.0 15.4 29.6 9.8 12.5 3.9 8.0 7.1 10.7 8.3 7.3 13.7 2.2 14.8 12.5 24.8 8.1 7.8 9.3 7.5 3.5 7.6 0.7 9.7 6.3 9.2 5.4 3.1 10.0 8.3 16.2 4.4 19.9 8.6 10.8 6.3 1.4 8.9 47.3 11.5 6.2 11.4 9.3 10.0 9.5 9.0 2.4 17.8 8.2 12.9 22.8 18.2 11.4 7.5 16.6 12.1 2.9 7.6 18.5 15.9 42.3 11.1 1.3 7.1 4.7 14.7 1.2 10.7 1.0 1.2 1.5 6.5 2.0 6.7 9.9 7.9 5.9 2.3 9.3 7.0 6.8 1.1 8.3 5.1 6.7 3.1 3.0 18.1 19.9 4.8 17.1 14.6 15.8 12.9 13.9 13.5 6.4 23.8 11.0 19.2 21.0 0.0 26.4 37.5 48.4 188.7 35.2 47.1 51.1 16.8 117.7 62.7 478.2 9.5 2.0 0.0 32.2 14.6 27.1 19.5 9.2 8.9 15.3 30.2 17.7 14.1 2.6 1059.8 35.1 9.9 0.0 4.6 11.8 43.3 28.1 9.3 38.9 121.8 87.3 12.9 21.1 208.9 81.0 0.0 5.5 5.7 8.5 12.1 IFT52 "C20orf9, CGI-53, dJ1028D15.1, NGD2, NGD5" ENSG00000101052 "Intraflagellar transport 52" Q9Y366 20 43590931-43647296 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063367, HPA067423" Enhanced Approved Cytosol NA NA Cytosol "HPA063367: , HPA067423: AB_2685837" "unprognostic (2.88e-1)" "unprognostic (2.44e-2)" "unprognostic (6.82e-2)" "unprognostic (5.18e-3)" "unprognostic (7.39e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.30e-6)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" "unprognostic (2.00e-1)" "unprognostic (2.98e-2)" "unprognostic (2.28e-2)" "unprognostic (3.43e-2)" "unprognostic (7.51e-2)" "prognostic favorable (3.33e-4)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 20.1 13.6 14.2 12.7 13.9 18.6 20.3 14.2 24.9 24.1 12.8 13.4 14.5 7.0 22.2 25.9 11.6 29.8 16.8 16.5 13.1 14.2 16.0 7.1 16.3 20.2 12.1 13.9 31.6 16.2 10.8 15.8 13.1 13.8 14.1 13.9 15.0 11.6 19.4 5.1 13.7 9.5 21.7 13.2 11.3 11.2 36.8 10.8 16.3 24.3 12.1 13.8 14.7 16.8 14.6 23.1 12.8 19.2 13.0 15.9 13.2 15.1 11.6 23.6 16.6 20.1 22.4 11.2 9.5 21.3 25.2 24.5 32.0 15.5 8.5 15.5 19.4 20.5 12.7 9.8 17.1 27.8 7.0 9.2 11.1 8.0 29.6 24.7 14.8 7.7 18.1 18.9 16.3 12.8 18.4 19.7 19.1 9.4 12.2 18.5 15.2 20.4 23.0 13.2 10.0 11.5 21.8 26.9 12.4 19.4 15.0 18.3 21.3 29.2 21.8 22.7 12.5 10.1 20.4 12.3 22.4 16.7 12.3 14.0 11.9 11.8 14.9 26.9 10.9 16.1 6.6 18.0 12.8 15.9 16.4 12.9 14.6 12.9 15.0 23.1 12.2 13.8 14.3 5.2 13.0 19.2 17.5 14.2 13.2 14.2 13.9 14.2 24.9 13.1 14.2 12.1 13.9 13.8 10.8 6.0 13.3 6.0 10.4 11.6 9.9 2.4 5.1 52.2 9.1 7.0 0.0 17.0 16.6 21.9 57.0 17.6 5.6 23.3 19.6 16.8 25.7 6.5 13.9 2.0 16.8 7.9 9.1 19.0 18.3 12.1 26.4 12.2 16.9 15.4 10.7 12.4 14.6 10.5 36.0 14.1 9.7 12.9 18.8 42.1 17.6 13.0 8.0 14.4 10.1 5.8 IFT57 "ESRRBL1, FLJ10147, HIPPI, MHS4R2" ENSG00000114446 "Intraflagellar transport 57" Q9NWB7 3 108160812-108222570 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 14 "Ciliated cells: 679.9;Early spermatids: 1393.1;Late spermatids: 2088.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 22.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035514, HPA035515" Supported Approved "Nuclear speckles,Mitochondria,Cytosol" NA NA "Nuclear speckles" "Mitochondria, Cytosol" "HPA035514: AB_10601757, HPA035515: AB_10696505" "unprognostic (1.35e-2)" "unprognostic (1.37e-2)" "prognostic favorable (6.96e-5)" "unprognostic (2.98e-2)" "unprognostic (5.46e-3)" "unprognostic (1.02e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (3.59e-2)" "prognostic favorable (7.63e-4)" "unprognostic (5.04e-2)" "unprognostic (2.78e-1)" "unprognostic (1.68e-3)" "unprognostic (1.86e-1)" "unprognostic (4.70e-2)" "unprognostic (8.67e-3)" "unprognostic (6.12e-2)" 8.5 13.1 9.4 12.1 11.0 8.8 10.4 5.5 16.4 13.3 10.9 6.3 15.7 5.0 11.8 36.3 11.6 24.8 11.6 12.1 9.2 11.2 19.7 3.7 34.3 12.2 9.1 9.9 21.6 13.4 16.4 30.6 6.2 13.5 21.9 11.6 9.4 8.2 16.0 5.7 7.1 9.4 13.1 6.2 14.3 10.0 38.6 5.6 8.3 31.3 7.4 12.2 14.1 9.1 22.4 5.8 1.8 6.7 3.6 4.7 2.9 18.6 9.7 7.0 12.5 14.7 15.3 3.9 5.7 14.0 8.5 7.6 6.6 3.3 21.1 7.4 9.5 12.2 7.5 6.2 9.6 14.5 3.3 6.7 7.2 4.3 1.7 11.0 14.9 16.7 9.2 8.9 10.9 19.1 13.5 9.5 3.7 3.3 3.8 9.7 10.4 5.0 13.7 7.5 1.4 11.6 3.2 6.3 3.6 17.4 6.8 11.7 8.1 8.6 2.8 5.2 4.1 6.1 4.6 4.0 10.9 5.6 5.7 6.7 4.5 3.2 11.1 15.8 1.5 4.0 0.1 2.1 1.8 2.2 3.6 3.6 22.4 4.7 2.8 5.8 18.6 4.1 2.3 1.1 3.6 6.7 1.2 2.9 2.9 9.4 11.0 5.5 16.4 9.2 11.2 9.1 9.9 13.5 5.6 437.7 206.1 73.5 89.1 36.5 19.9 27.8 48.4 679.9 320.8 48.8 64.8 19.7 99.5 136.8 1393.1 36.5 31.6 23.3 116.3 16.0 63.9 111.6 42.8 4.9 12.7 27.0 54.9 30.7 7.3 2088.2 60.4 26.4 43.9 5.4 28.2 42.9 82.4 31.7 60.5 97.1 66.9 51.8 57.7 146.9 42.2 32.5 12.5 26.6 47.6 75.8 IFT81 "CDV-1R, CDV1, MGC4027" ENSG00000122970 "Intraflagellar transport 81" Q8WYA0 12 110124335-110218797 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Ciliated cells: 199.4;Spermatocytes: 160.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019087, HPA020051" Enhanced Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA019087: AB_1851462, HPA020051: AB_1851465" "unprognostic (2.54e-1)" "unprognostic (1.47e-1)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "unprognostic (9.79e-2)" "unprognostic (1.10e-1)" "unprognostic (7.95e-2)" "unprognostic (3.91e-1)" "unprognostic (3.21e-1)" "unprognostic (1.40e-2)" "unprognostic (1.04e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-2)" "unprognostic (4.23e-2)" "unprognostic (1.88e-1)" "unprognostic (2.45e-1)" 5.3 9.6 8.9 4.6 13.2 1.7 9.2 14.4 11.9 12.6 11.5 6.6 18.8 3.0 14.9 19.6 6.4 18.8 8.9 7.3 8.9 8.5 10.0 4.4 8.5 3.0 5.9 8.4 14.7 5.1 21.8 30.4 5.2 10.7 13.7 6.2 11.8 8.9 15.5 6.4 5.9 4.6 17.7 8.5 4.0 7.4 29.8 8.4 6.2 14.3 5.4 3.1 13.5 10.4 1.8 3.5 3.0 1.3 2.1 1.9 1.3 7.1 13.6 28.1 11.9 5.2 10.7 2.1 4.6 7.1 9.9 8.5 2.6 4.0 2.3 2.5 8.8 7.1 6.4 10.3 5.4 12.9 3.0 5.6 4.9 8.0 4.2 4.4 3.0 2.4 7.6 6.1 9.4 2.4 24.2 6.2 4.7 6.0 1.3 9.1 1.5 6.1 5.1 13.9 4.1 4.5 7.3 7.4 3.1 12.3 4.8 17.5 19.4 12.5 2.6 18.6 8.2 14.1 4.6 4.1 5.6 2.9 4.6 4.2 4.1 4.0 3.2 13.6 3.9 6.3 0.3 1.3 0.6 0.7 0.8 1.9 1.6 1.7 0.8 3.5 1.8 1.5 0.7 3.0 2.1 1.0 3.5 0.7 1.3 8.9 13.2 14.4 11.9 8.9 8.5 5.9 8.4 10.7 8.4 11.9 16.1 2.0 11.5 5.5 16.8 16.5 10.2 199.4 37.5 14.0 39.3 2.2 13.3 8.9 31.3 4.5 0.7 0.0 3.5 1.2 10.0 4.0 3.5 4.0 2.1 23.8 20.7 3.7 1.9 13.2 13.0 1.8 33.7 1.8 4.8 18.2 5.1 1.7 26.2 8.4 36.1 6.5 12.2 160.5 28.1 5.6 0.8 0.0 3.5 3.8 IGDCC4 "LOC57722, NOPE" ENSG00000103742 "Immunoglobulin superfamily DCC subclass member 4" Q8TDY8 15 65381464-65423072 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.1" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 29.5;Fibroblasts: 17.9;Leydig cells: 32.2;Rod photoreceptor cells: 12.0" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.1;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.7;SuSa: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008510, HPA008576" Approved Approved Approved Nucleoplasm,Cytosol NA NA 34000000 "Nucleoplasm, Cytosol" "HPA008510: , HPA008576: AB_1079496" "unprognostic (1.16e-1)" "unprognostic (9.38e-2)" "unprognostic (1.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.77e-2)" "unprognostic (2.75e-3)" "unprognostic (9.94e-2)" "unprognostic (4.18e-2)" "unprognostic (3.65e-2)" "unprognostic (3.29e-2)" "unprognostic (6.36e-2)" "unprognostic (1.83e-8)" "unprognostic (3.30e-2)" "unprognostic (4.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.32e-3)" 1.7 6.2 8.3 3.7 5.0 0.2 1.3 2.0 4.9 6.1 1.4 8.0 0.0 1.0 2.3 7.2 2.6 2.9 6.7 2.2 6.2 4.1 0.6 0.3 0.7 1.1 5.6 3.1 13.3 0.7 0.2 2.4 8.2 6.1 0.9 1.2 1.6 1.5 1.3 14.1 1.5 1.7 3.1 5.0 0.5 1.9 2.5 6.5 0.0 4.6 4.0 1.5 4.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 10.2 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.4 0.6 8.9 0.0 5.1 0.4 0.0 0.0 2.5 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.4 0.0 0.0 5.7 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.8 7.7 0.0 0.0 0.0 2.5 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.5 6.1 0.0 0.0 0.0 4.1 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 5.0 2.0 3.9 6.2 4.1 5.6 3.1 6.1 6.5 0.0 0.0 0.0 0.0 2.1 5.8 2.0 0.0 0.0 0.0 3.5 29.5 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 17.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 32.2 0.4 5.0 0.0 0.0 0.5 0.3 0.0 3.9 0.7 12.0 6.5 0.5 0.4 0.9 1.0 0.7 0.0 0.0 0.0 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2149603 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 330.5" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 871.9;Extravillous trophoblasts: 2792.3;Syncytiotrophoblasts: 1348.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 115.4;Hep G2: 79.2;LHCN-M2: 45.5;RH-30: 56.5;SH-SY5Y: 68.8" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 609000000 1700000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: AB_2667860, HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favorable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 16.6 8.0 1.3 4.5 2.0 0.5 23.3 2.3 1.9 23.4 5.0 3.4 4.7 1.0 9.9 32.0 5.2 17.2 4.5 20.5 1.5 1.6 8.1 39.7 1.9 1.1 3.5 1.6 20.4 5.5 0.7 5.0 330.5 7.6 10.4 1.0 33.2 2.6 6.7 21.9 1.7 2.3 7.5 17.0 2.0 3.2 12.4 0.2 1.8 2.6 14.5 1.8 15.2 14.1 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 15.2 0.1 0.4 0.0 115.4 0.0 0.0 1.1 0.0 0.3 0.0 0.1 0.9 1.1 0.0 0.0 0.0 0.0 79.2 20.3 0.0 0.0 24.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 45.5 0.3 0.0 0.1 0.1 0.0 0.2 0.0 56.5 0.1 0.0 0.1 4.5 68.8 0.0 0.0 0.0 12.0 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 1.3 2.0 2.3 1.4 1.5 1.6 3.5 1.6 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 871.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2792.3 0.0 0.0 0.0 0.0 192.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1348.9 0.0 0.0 0.0 IGF2BP1 IMP-1 ENSG00000159217 "Insulin like growth factor 2 mRNA binding protein 1" Q9NZI8 17 48997412-49055650 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 17.6;testis: 17.8" "Cell type enhanced" "Detected in some" 15 "Extravillous trophoblasts: 31.6;Spermatocytes: 17.9;Spermatogonia: 21.1" "Cancer enriched" "Detected in many" 16 "testis cancer: 28.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 36.1;CACO-2: 56.9;Hep G2: 26.7;K-562: 28.8;NTERA-2: 28.9;REH: 33.0;SuSa: 28.8" "Not detected" "Not detected" "HPA021367, HPA062273" Enhanced Supported Cytosol NA NA Cytosol "HPA021367: AB_1851480, HPA062273: AB_2684733" "unprognostic (6.79e-4)" "unprognostic (2.76e-1)" "unprognostic (4.86e-3)" "unprognostic (2.30e-6)" "unprognostic (1.95e-2)" "unprognostic (9.11e-3)" "unprognostic (1.80e-2)" "unprognostic (1.01e-2)" "unprognostic (9.55e-3)" "unprognostic (2.58e-1)" "unprognostic (2.86e-2)" "unprognostic (5.91e-2)" "unprognostic (2.80e-6)" "unprognostic (2.58e-2)" "unprognostic (1.55e-1)" "unprognostic (2.32e-3)" "unprognostic (1.47e-1)" 0.1 0.1 0.0 0.9 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.1 0.3 0.5 0.1 0.3 0.1 0.1 0.0 0.1 17.6 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 17.8 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 36.1 0.0 1.3 1.9 25.9 2.0 0.0 2.9 5.0 56.9 0.9 2.9 0.2 0.2 0.8 0.0 22.2 0.0 5.2 0.0 13.1 21.6 7.7 26.7 1.7 11.3 5.8 2.6 0.0 0.7 0.0 1.0 6.0 4.0 28.8 0.0 4.0 0.2 0.0 9.5 28.9 0.0 0.0 33.0 11.9 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 28.8 0.0 3.2 0.1 0.0 0.3 3.0 0.0 0.0 0.0 19.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 6.0 0.6 0.0 0.3 0.1 0.0 3.6 0.0 1.4 1.2 0.0 0.0 2.1 0.0 0.0 3.5 0.3 0.0 0.0 0.0 31.6 1.2 0.2 1.1 0.0 5.4 0.0 0.0 0.0 0.0 3.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 17.9 21.1 0.1 2.4 0.0 0.0 0.3 IGF2BP2 IMP-2 ENSG00000073792 "Insulin like growth factor 2 mRNA binding protein 2" Q9Y6M1 3 185643739-185825056 "Plasma proteins, Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 43.0" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 118.2;Rod photoreceptor cells: 160.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 60.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017126, HPA035145" Enhanced Enhanced Cytosol NA NA Cytosol "CAB017126: , HPA035145: AB_2674491" "unprognostic (7.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.12e-5)" "unprognostic (2.46e-3)" "unprognostic (8.25e-3)" "unprognostic (4.17e-1)" "unprognostic (3.45e-2)" "prognostic unfavorable (7.37e-5)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (9.45e-2)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.94e-3)" 7.9 8.9 1.0 6.4 1.9 7.6 4.9 8.6 1.6 6.5 16.4 1.6 1.5 11.3 7.6 4.8 3.7 8.3 8.1 9.9 1.7 1.4 8.0 2.6 14.0 4.0 2.8 0.7 6.7 11.3 7.6 2.9 43.0 4.5 4.9 11.6 16.9 9.0 1.6 3.2 4.3 21.4 3.3 3.7 5.8 9.9 5.1 1.5 2.4 8.6 3.2 3.3 6.2 12.5 0.0 5.5 0.9 3.3 1.3 0.0 1.2 28.3 2.4 27.8 5.2 15.2 24.0 17.0 15.0 21.2 23.3 28.0 20.4 8.0 0.0 22.3 12.6 29.9 12.9 13.0 21.8 37.9 0.0 13.4 8.1 0.1 14.1 32.5 0.2 0.0 17.5 11.6 15.5 60.3 12.2 21.4 2.1 7.9 0.0 17.0 0.2 0.0 6.8 20.3 4.8 10.3 2.9 11.0 8.5 15.1 0.1 1.7 0.2 1.1 0.0 26.7 28.8 2.2 18.9 32.4 8.1 17.7 10.1 17.2 0.1 0.0 0.0 8.0 0.0 11.3 0.9 3.0 0.5 0.0 2.8 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.2 1.3 3.3 1.0 0.0 1.2 1.0 1.9 8.6 1.6 1.7 1.4 2.8 0.7 4.5 1.5 11.9 12.3 0.0 21.8 17.5 3.2 13.6 28.1 48.2 35.2 24.4 15.7 1.7 3.3 33.9 118.2 12.2 59.3 23.3 22.6 14.2 28.3 47.6 2.3 0.0 13.3 1.6 34.2 44.2 10.5 64.7 4.9 7.4 13.5 4.6 42.1 30.6 38.8 84.6 0.4 7.6 160.2 0.0 8.6 2.8 7.0 12.8 5.3 0.0 34.5 53.7 IGF2BP3 "CT98, IMP-3, IMP3" ENSG00000136231 "Insulin like growth factor 2 mRNA binding protein 3" O00425 7 23310209-23470467 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "placenta: 74.0" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 68.4;Extravillous trophoblasts: 72.8;Hofbauer cells: 30.1;Syncytiotrophoblasts: 65.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 49.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA002037, HPA076951" Enhanced Supported Cytosol NA NA Cytosol "HPA002037: AB_1851483, HPA076951: " "unprognostic (5.72e-2)" "unprognostic (3.12e-1)" "unprognostic (7.25e-2)" "unprognostic (3.56e-3)" "unprognostic (1.45e-1)" "unprognostic (3.00e-2)" "unprognostic (2.64e-3)" "unprognostic (3.18e-2)" "unprognostic (2.60e-3)" "unprognostic (3.67e-1)" "unprognostic (1.02e-5)" "unprognostic (8.76e-2)" "unprognostic (0.00e+0)" "unprognostic (1.43e-1)" "unprognostic (7.95e-2)" "unprognostic (2.87e-4)" "unprognostic (7.51e-3)" 0.4 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.3 0.4 0.3 0.4 0.1 0.0 0.2 1.3 4.8 0.7 0.1 0.5 0.3 0.2 0.2 0.3 1.2 3.4 0.2 0.0 0.2 1.5 0.0 0.2 74.0 0.7 0.2 0.0 0.3 0.7 0.1 0.2 0.2 0.3 0.0 1.2 1.0 0.2 6.5 0.0 11.4 0.6 0.2 6.0 0.2 0.6 1.2 0.4 1.5 1.5 0.0 0.2 3.0 13.8 4.1 31.1 9.2 4.9 13.2 19.0 2.3 10.5 5.8 7.3 13.1 11.0 10.4 12.6 6.1 26.0 9.1 13.4 10.2 10.3 1.6 5.3 5.5 11.1 10.9 15.3 10.0 3.9 13.4 7.2 4.4 1.9 34.8 49.8 5.9 25.2 0.0 14.1 0.0 6.1 6.7 24.8 10.6 12.8 9.5 10.4 13.4 11.5 1.2 8.2 17.9 1.4 0.0 11.6 37.1 0.0 1.9 20.0 5.6 0.3 12.1 6.0 0.0 4.4 16.5 22.4 11.2 21.5 0.0 1.5 0.0 0.1 0.8 0.0 1.2 0.0 0.0 0.4 0.9 0.2 0.0 1.5 0.0 0.0 0.0 0.0 3.0 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.0 0.7 0.0 0.0 0.0 1.7 0.6 0.2 0.5 0.3 0.0 4.0 0.0 0.0 0.0 68.4 0.0 1.1 21.3 0.1 0.0 0.0 0.2 72.8 0.5 0.2 3.5 0.0 30.1 1.6 0.0 1.3 0.0 16.9 2.0 1.3 3.3 0.0 0.0 0.3 0.8 0.0 0.0 0.0 1.7 0.0 0.4 1.9 1.5 0.4 65.7 0.0 0.0 0.5 IGFBP3 "BP-53, IBP3" ENSG00000146674 "Insulin like growth factor binding protein 3" P17936 7 45912245-45921874 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 320.7" "Cell type enhanced" "Detected in many" 19 "Basal keratinocytes: 406.6;Extravillous trophoblasts: 1874.7;Urothelial cells: 581.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 28.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 422.0;U-2197: 175.0;U-87 MG: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB010360 Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3250000000 5600000000 Vesicles "Nucleoplasm, Cytosol" "CAB010360: AB_2233528" "unprognostic (4.46e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.30e-1)" "unprognostic (1.15e-1)" "unprognostic (6.54e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (8.14e-3)" "unprognostic (3.31e-2)" "unprognostic (2.03e-1)" "unprognostic (9.67e-3)" "unprognostic (2.80e-1)" "prognostic unfavorable (5.07e-7)" "unprognostic (2.36e-2)" "unprognostic (4.14e-2)" "unprognostic (2.37e-3)" "unprognostic (2.63e-1)" 47.4 1.6 4.4 10.6 2.7 0.0 52.1 2.7 4.1 44.3 21.3 1.7 3.2 6.9 58.4 8.1 11.7 14.9 5.4 41.6 4.4 2.6 11.1 80.4 11.7 12.7 3.7 1.9 49.2 2.2 0.6 19.2 320.7 4.1 22.5 6.1 9.1 6.4 9.3 13.9 23.9 10.2 22.9 3.8 18.7 8.3 12.1 3.1 2.2 5.6 8.6 8.3 32.0 26.3 0.0 28.9 0.0 0.0 0.0 6.0 1.7 9.6 2.9 5.7 0.0 4.3 1.8 0.0 42.1 7.6 3.6 1.9 0.0 7.8 0.0 13.4 422.0 1.8 23.2 0.0 0.1 1.5 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 14.8 0.6 0.7 2.7 5.7 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 3.9 2.6 20.8 0.6 1.6 14.6 0.5 0.7 13.3 0.0 0.0 0.0 41.7 0.0 175.0 2.3 0.6 0.0 0.0 90.6 0.0 14.0 0.0 0.0 0.0 5.2 0.0 4.3 0.0 6.0 5.6 0.0 0.0 2.8 4.7 0.0 0.0 0.0 28.9 0.3 1.7 4.4 2.7 2.7 4.1 4.4 2.6 3.7 1.9 4.1 3.1 3.0 4.6 0.0 95.2 406.6 0.6 9.7 7.6 33.5 117.2 216.3 0.0 45.9 10.0 71.8 0.8 62.6 0.4 0.0 1.7 1874.7 137.7 80.4 1.1 1.7 72.5 0.0 263.4 181.7 8.2 1.9 266.9 3.0 15.1 12.6 1.6 0.4 19.7 2.9 6.3 0.7 0.6 0.0 28.8 0.4 0.4 213.8 129.0 8.2 0.6 581.2 IGFL4 ENSG00000204869 "IGF like family member 4" Q6B9Z1 19 46039748-46077118 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 8.5;skin 1: 13.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 40.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 6.6;HaCaT: 5.9;OE19: 10.3" HPA047655 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA047655: AB_2680113" "unprognostic (1.22e-2)" "unprognostic (3.37e-2)" "unprognostic (2.57e-1)" "unprognostic (7.96e-2)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (2.39e-1)" "unprognostic (8.25e-2)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (1.09e-2)" "unprognostic (3.59e-4)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" 0.1 0.8 4.4 0.3 4.4 0.2 0.3 3.9 8.5 0.2 0.3 0.0 0.0 0.9 1.0 2.9 1.9 0.4 1.1 1.9 2.8 2.8 0.3 0.4 0.7 0.9 1.2 6.0 2.0 0.2 3.3 4.5 0.2 2.1 0.9 0.5 4.6 1.1 0.0 0.5 13.9 0.7 0.1 1.6 0.5 0.7 0.8 0.5 0.0 1.5 0.6 0.2 1.2 0.2 0.3 1.6 1.3 0.7 0.2 0.5 0.1 0.1 6.6 0.2 0.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 1.4 0.3 0.9 0.1 0.1 0.9 5.9 0.0 0.0 0.0 0.7 1.1 0.0 0.8 1.6 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.7 0.0 0.7 0.1 0.5 0.3 10.3 0.3 0.1 2.9 1.4 0.0 0.3 0.4 0.4 0.0 0.1 1.7 0.8 0.4 1.2 0.6 0.8 1.4 0.4 0.4 0.8 0.4 0.2 0.1 0.9 1.8 1.3 0.7 0.7 0.5 0.3 0.3 0.3 0.2 0.1 0.1 0.3 0.1 0.4 0.9 0.2 0.1 1.6 0.4 0.1 4.4 4.4 3.9 8.5 2.8 2.8 1.2 6.0 2.1 0.5 0.0 0.0 0.0 0.0 0.9 5.1 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.4 1.3 1.0 0.0 0.0 0.0 0.0 IGSF1 "IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2" ENSG00000147255 "Immunoglobulin superfamily member 1" Q8N6C5 X 131273506-131578899 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 138.7" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 3.0;Bipolar cells: 11.5;Horizontal cells: 3.2;Melanocytes: 3.3" "Cancer enriched" "Detected in many" 8 "thyroid cancer: 65.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Hep G2: 23.5;SH-SY5Y: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012732, HPA035582" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 430000 Cytosol "HPA012732: AB_2732404, HPA035582: AB_2674687" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (4.11e-1)" "prognostic unfavorable (4.25e-8)" "unprognostic (1.01e-1)" "unprognostic (2.40e-2)" "unprognostic (1.90e-3)" "unprognostic (2.52e-3)" "unprognostic (8.03e-3)" "unprognostic (9.36e-2)" "unprognostic (5.65e-2)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (5.96e-2)" "unprognostic (1.66e-1)" "unprognostic (2.35e-1)" "unprognostic (5.13e-2)" 0.8 11.9 1.4 0.4 5.3 0.0 2.7 0.6 6.2 2.7 0.5 3.3 1.2 0.2 1.1 1.5 1.3 1.6 0.8 5.6 3.3 15.4 0.5 1.5 0.2 0.0 3.8 1.9 1.0 1.7 0.0 138.7 0.6 4.7 3.9 0.2 2.2 2.0 6.4 0.3 0.6 0.4 3.2 2.7 0.2 0.5 11.8 1.9 0.2 5.3 0.8 0.5 0.6 0.5 0.6 0.4 1.5 0.3 0.3 0.3 0.2 0.3 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.2 0.0 0.0 0.0 1.3 0.0 0.0 4.1 0.3 0.0 1.7 23.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.7 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 21.2 0.0 0.2 0.0 3.2 0.4 0.0 0.0 0.3 0.6 0.0 2.4 0.7 0.3 0.0 0.0 0.0 0.0 1.5 0.3 0.2 0.2 0.1 0.2 0.3 0.3 0.3 0.1 0.6 0.3 0.2 1.2 0.3 0.1 0.4 0.3 0.2 1.4 5.3 0.6 2.3 3.3 15.4 3.8 1.9 4.7 1.9 3.0 1.1 0.0 0.2 0.0 11.5 2.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.8 0.2 0.0 0.4 0.0 3.2 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.5 0.0 0.4 0.6 0.5 0.0 0.3 0.0 0.4 0.4 0.2 0.0 0.0 0.1 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 70.7;Early spermatids: 226.0;Late spermatids: 237.3" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;HEL: 4.4;SK-MEL-30: 26.2;U-266/70: 9.1;U-266/84: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 6.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 26.2 1.7 0.5 0.1 0.0 0.0 1.0 0.0 0.0 9.1 10.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 0.0 0.0 0.0 0.1 0.3 5.1 1.1 0.0 0.0 0.0 0.0 70.7 0.1 0.0 0.3 226.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 237.3 3.4 0.2 3.3 0.0 0.0 24.3 0.2 0.0 1.8 5.1 24.8 0.0 0.0 11.7 5.9 0.0 0.1 0.0 0.0 0.2 IGSF3 "EWI-3, MGC117164, V8" ENSG00000143061 "Immunoglobulin superfamily member 3" O75054 1 116574399-116667755 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 62.5;WM-115: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036305, HPA036306" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036305: AB_2675050, HPA036306: AB_10671245" "unprognostic (9.87e-2)" "unprognostic (3.64e-1)" "unprognostic (9.51e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (4.03e-6)" "unprognostic (9.40e-2)" "unprognostic (4.41e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.87e-6)" "unprognostic (5.29e-2)" "unprognostic (4.23e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" 1.4 1.5 1.9 1.2 5.1 0.1 7.7 2.5 8.3 5.8 5.7 1.5 3.0 6.7 2.5 6.5 22.0 1.7 3.5 7.9 1.8 2.8 10.7 0.8 7.4 0.3 1.8 2.8 0.7 4.5 1.4 2.7 42.9 4.1 5.1 5.1 7.8 9.3 5.5 1.1 16.1 12.9 2.4 1.7 0.5 7.3 3.6 0.9 6.2 8.1 9.0 9.3 8.2 9.8 0.0 0.2 0.3 0.6 0.0 0.7 0.2 5.4 9.3 7.2 1.8 1.6 3.5 19.3 0.0 0.2 0.7 0.2 5.3 3.1 0.0 2.9 0.0 4.0 15.2 3.2 7.5 0.3 62.5 2.3 2.9 3.6 0.1 0.0 0.2 5.7 0.4 5.9 0.0 1.3 1.3 0.0 1.0 0.9 0.0 0.1 19.1 0.2 0.1 4.5 3.3 0.2 2.2 8.8 0.0 5.5 6.8 4.2 12.8 2.2 21.5 13.7 14.4 7.2 0.3 0.0 1.2 4.3 0.0 5.6 0.0 0.3 0.0 0.5 0.1 60.3 0.0 0.6 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 1.9 5.1 2.5 8.3 1.8 2.8 1.8 2.8 4.1 0.9 14.9 25.2 0.0 7.0 17.4 1.9 14.4 12.7 8.1 5.7 14.0 0.0 10.1 3.3 13.2 1.8 2.1 14.7 0.0 1.7 24.6 6.6 7.2 1.1 0.0 1.9 6.4 2.9 1.8 1.6 2.1 1.1 0.9 8.5 5.4 5.5 12.8 11.2 8.6 0.0 11.3 0.5 0.0 2.1 0.5 4.3 24.2 11.1 0.0 7.1 9.6 IGSF9B KIAA1030 ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133908564-133956985 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 3.1;Bipolar cells: 2.2;Cardiomyocytes: 2.6;Distal tubular cells: 1.7;Muller glia cells: 2.0;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 39.7" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "OE19: 8.2;SCLC-21H: 17.7;SH-SY5Y: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010744, HPA010802" Uncertain Approved Cytosol NA NA Cytosol "HPA010744: AB_2668357, HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 2.2 2.1 4.9 3.7 6.8 0.7 1.2 39.7 12.4 7.4 6.8 2.4 4.6 1.1 7.7 4.3 5.9 7.6 4.9 13.4 2.9 3.1 1.1 0.5 1.8 1.6 2.1 4.0 2.4 2.1 1.5 6.2 1.3 3.8 4.2 2.4 6.1 2.1 6.4 5.0 2.4 2.4 12.8 1.6 1.8 3.7 5.0 2.3 0.0 4.9 2.6 1.2 5.2 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.3 1.2 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.0 2.6 1.6 0.8 0.5 0.4 3.1 2.6 0.0 0.1 2.8 2.4 0.0 0.0 0.0 0.2 0.7 3.8 0.0 0.0 0.0 0.5 0.2 0.0 3.3 0.0 0.0 0.0 1.8 0.3 0.3 1.9 8.2 0.1 0.0 0.0 0.0 0.3 0.0 17.7 9.0 0.1 0.2 0.0 2.9 1.8 0.0 0.0 1.3 1.4 1.1 0.8 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 4.9 6.8 39.7 9.7 2.9 3.1 2.1 4.0 3.8 2.3 0.0 0.0 0.0 0.1 3.1 2.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.4 0.0 0.7 0.0 1.0 0.0 0.1 4.3 0.0 0.0 0.1 0.0 IKBKB "IKK-beta, IKK2, IKKB, NFKBIKB" ENSG00000104365 "Inhibitor of nuclear factor kappa B kinase subunit beta" O14920 8 42271302-42332653 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 127.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001249, CAB004447" Enhanced Supported Cytosol NA NA Cytosol "CAB004447: AB_627785, HPA001249: AB_1079126" "unprognostic (1.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (1.73e-3)" "unprognostic (1.26e-1)" "unprognostic (1.27e-3)" "unprognostic (1.95e-1)" "unprognostic (1.25e-3)" "unprognostic (1.75e-1)" "unprognostic (1.55e-1)" "unprognostic (3.27e-1)" "unprognostic (1.73e-1)" "unprognostic (1.20e-2)" "unprognostic (1.89e-2)" "unprognostic (9.20e-2)" "unprognostic (3.02e-1)" "prognostic favorable (1.46e-6)" 9.1 10.8 10.9 17.0 16.7 9.3 10.0 26.1 16.9 10.3 10.3 12.4 11.4 4.7 15.3 13.2 17.9 16.4 14.9 7.9 13.1 6.9 12.4 9.9 14.9 12.2 20.3 7.9 9.6 13.3 18.0 13.6 11.2 11.9 14.0 10.9 10.5 11.4 9.7 17.6 22.2 9.8 16.4 10.5 18.7 10.8 8.3 18.6 12.9 14.3 8.4 17.1 18.1 12.8 12.6 14.8 14.1 9.6 11.9 11.2 5.8 3.6 12.9 3.7 6.3 14.3 12.4 4.7 3.2 11.3 9.5 8.4 2.9 6.7 7.1 5.5 8.8 9.0 4.1 5.0 12.7 12.3 6.9 5.7 9.9 6.0 2.3 10.9 1.9 10.4 8.2 9.7 9.1 14.2 18.7 14.0 4.7 8.4 3.5 20.8 4.1 6.9 3.1 3.6 11.8 4.1 7.1 6.3 4.1 10.7 3.3 1.1 2.1 2.0 3.6 5.2 6.9 4.8 8.3 7.2 6.7 3.5 5.2 2.3 2.1 2.1 5.0 7.9 4.7 7.6 14.1 9.6 10.4 10.1 7.6 10.3 9.4 10.5 11.2 8.9 12.6 10.2 10.4 11.4 11.9 9.0 14.8 9.9 5.8 10.9 16.7 26.1 16.9 13.1 6.9 20.3 7.9 11.9 18.6 11.9 24.0 17.7 29.3 21.6 11.3 4.5 15.3 14.7 13.6 15.7 127.6 8.6 1.7 11.4 2.0 27.7 11.8 0.0 11.8 4.6 9.8 23.2 36.9 10.2 15.8 17.5 10.9 15.4 26.9 3.0 15.3 17.7 18.6 13.6 15.1 11.6 13.3 14.4 12.0 4.8 52.3 6.5 6.4 2.6 6.4 25.5 12.7 20.3 13.6 25.7 IKBKE "IKK-i, IKKE, KIAA0151" ENSG00000263528 "Inhibitor of nuclear factor kappa B kinase subunit epsilon" Q14164 1 206470476-206496889 "Enzymes, Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.8;lymphoid tissue: 19.5" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 20.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 25.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015788, CAB025983" Approved Supported Cytosol NA NA Cytosol "CAB025983: , HPA015788: AB_1851566" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (1.48e-1)" "unprognostic (5.76e-2)" "unprognostic (7.78e-3)" "unprognostic (7.37e-3)" "unprognostic (1.99e-3)" "unprognostic (2.82e-1)" "unprognostic (5.09e-3)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.34e-7)" "unprognostic (1.48e-2)" "unprognostic (5.77e-2)" "unprognostic (2.84e-3)" "unprognostic (2.84e-2)" 2.1 0.9 1.0 17.3 3.4 4.3 1.4 1.1 1.7 2.2 4.8 1.5 1.7 3.9 2.0 3.9 6.1 1.2 3.6 1.1 2.9 1.5 0.6 3.7 13.6 2.1 0.7 1.0 1.5 0.0 0.8 2.5 1.9 1.8 4.3 1.5 8.3 2.9 0.1 8.9 4.2 1.0 2.9 12.8 4.0 0.0 2.4 18.8 2.6 4.4 19.5 4.4 0.4 12.9 4.6 4.2 15.9 10.8 24.8 12.3 9.0 7.1 2.0 0.2 3.6 5.2 2.1 3.6 11.5 5.0 5.6 5.6 14.7 17.9 9.9 7.3 6.0 12.2 0.0 9.3 1.0 2.9 1.7 2.5 4.2 3.9 4.7 15.2 8.1 6.6 1.6 4.1 0.8 5.8 7.2 4.9 1.2 5.5 5.2 1.8 9.7 25.6 2.9 2.1 5.5 5.2 2.1 14.2 5.9 15.4 0.0 0.0 1.6 12.3 2.2 2.6 7.3 10.8 14.0 5.0 3.1 3.6 4.1 1.9 0.9 11.6 9.4 12.8 2.0 4.2 15.9 0.3 10.5 11.2 7.5 12.9 16.7 15.2 4.6 7.4 13.3 13.6 1.1 10.8 6.4 1.5 24.8 12.3 0.0 5.0 8.9 3.6 1.6 0.0 0.8 0.0 2.7 0.0 0.0 0.0 3.5 0.0 10.6 2.7 0.6 10.5 0.0 10.9 3.6 2.4 2.6 4.7 0.8 12.5 0.0 3.5 1.3 11.9 5.2 0.9 5.3 6.8 1.8 6.8 0.0 12.0 20.1 0.7 2.0 0.0 0.0 0.5 0.2 0.5 4.3 1.3 14.4 8.0 9.6 IKBKG "FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9" ENSG00000269335 "Inhibitor of nuclear factor kappa B kinase subunit gamma" Q9Y6K9 X 154541199-154565046 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "DNA damage, Host-virus interaction, Transcription, Transcription regulation" "Disease mutation, Ectodermal dysplasia, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 28.8" "Cell type enhanced" "Detected in many" 5 "monocytes: 63.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000426, CAB010373" Uncertain Enhanced Cytosol NA NA Cytosol "CAB010373: AB_2124846, HPA000426: AB_1851572" "unprognostic (7.53e-2)" "unprognostic (2.76e-3)" "unprognostic (1.09e-1)" "unprognostic (3.37e-3)" "unprognostic (9.77e-2)" "unprognostic (3.68e-1)" "unprognostic (9.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (9.87e-2)" "unprognostic (3.57e-2)" "unprognostic (4.41e-2)" "unprognostic (2.78e-1)" "unprognostic (7.07e-2)" "unprognostic (1.36e-2)" 6.5 5.8 5.2 10.2 6.1 15.1 5.0 5.4 9.2 5.2 4.5 9.1 5.9 7.5 5.2 6.2 6.3 4.5 7.7 5.1 4.9 3.9 16.3 6.5 10.4 6.9 5.1 5.1 6.1 3.5 2.0 6.8 6.7 5.0 3.9 5.6 5.7 3.9 4.6 11.4 6.6 8.1 3.7 10.8 7.4 4.2 6.2 6.9 5.0 6.9 9.9 4.9 6.2 11.3 13.7 28.8 21.8 13.8 17.9 13.5 15.6 16.1 3.9 12.8 8.9 7.5 10.8 10.5 13.7 11.2 16.2 11.4 9.4 12.6 26.6 11.8 32.1 14.7 5.7 9.6 4.8 15.0 8.0 10.3 23.3 21.3 13.8 10.1 36.1 8.9 8.1 15.7 6.3 7.5 13.3 12.6 5.7 12.6 9.0 15.2 10.4 16.9 3.6 12.2 26.8 11.5 6.2 13.4 11.1 10.0 7.0 7.0 13.0 12.2 7.5 3.5 7.1 11.3 13.6 10.4 12.1 27.8 25.1 24.7 17.5 23.6 15.5 18.3 15.2 10.5 15.4 28.8 17.9 20.5 12.3 11.3 11.4 13.0 13.7 10.1 9.5 11.3 25.4 13.8 21.8 12.2 13.0 13.5 3.0 11.0 14.9 10.9 11.0 5.1 6.1 15.3 5.3 7.9 12.2 9.8 20.4 1.7 16.8 0.7 11.9 11.2 23.3 14.9 14.8 12.4 9.6 28.8 28.0 25.4 23.8 4.7 9.2 21.2 1.6 13.3 18.6 11.8 63.1 6.7 11.4 17.2 11.5 13.1 6.5 9.8 6.5 12.5 3.4 13.6 9.3 31.8 22.4 7.6 12.2 IKZF1 "hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1" ENSG00000185811 "IKAROS family zinc finger 1" Q13422 7 50304068-50405101 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.7;bone marrow: 55.2;lymphoid tissue: 86.7" "Cell type enhanced" "Detected in many" 11 "B-cells: 46.7;Kupffer cells: 47.2;Macrophages: 43.8;monocytes: 70.3;T-cells: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 26.9;HDLM-2: 45.8;HMC-1: 42.9;JURKAT: 26.3;MOLT-4: 33.5;REH: 36.3;U-698: 68.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009247, HPA035221, HPA035222" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525" "prognostic favorable (4.28e-4)" "prognostic favorable (2.02e-4)" "unprognostic (2.49e-3)" "unprognostic (2.41e-3)" "unprognostic (5.59e-1)" "prognostic favorable (8.63e-4)" "unprognostic (1.45e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-2)" "unprognostic (2.43e-1)" "unprognostic (6.63e-2)" "unprognostic (2.95e-1)" "unprognostic (1.69e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-2)" "unprognostic (6.77e-2)" "unprognostic (4.67e-2)" 3.5 1.5 2.9 25.5 3.8 55.2 2.3 0.7 1.8 1.6 3.6 2.8 0.8 2.4 1.6 2.1 2.2 2.4 2.9 1.6 3.4 1.8 2.5 2.3 8.3 44.4 5.9 1.1 1.1 1.3 0.2 1.2 1.2 3.4 2.2 2.5 1.5 5.2 0.7 0.9 1.9 14.5 1.4 5.1 31.0 3.7 1.1 4.1 86.7 2.4 1.2 26.3 4.5 2.9 24.0 12.6 12.8 23.6 12.8 28.7 12.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.8 0.0 9.2 0.0 0.0 0.0 16.3 42.9 0.0 0.0 0.0 0.0 0.0 0.0 26.3 11.9 3.2 0.0 0.0 33.5 16.2 0.4 0.0 0.0 36.3 0.0 7.6 0.0 0.0 0.3 0.3 0.1 0.2 0.1 0.0 0.0 22.5 0.0 0.0 0.3 0.0 0.0 14.6 7.5 68.8 0.1 17.7 0.1 10.2 7.7 12.8 20.4 23.6 17.0 24.0 21.2 19.9 8.2 21.3 28.7 20.7 11.2 12.8 22.3 12.6 17.1 12.7 2.9 3.8 0.7 1.8 3.4 1.8 5.9 1.1 3.4 4.1 3.0 16.4 46.7 0.1 2.5 0.0 1.1 5.1 2.7 3.4 1.8 0.0 0.3 0.0 0.1 3.0 2.9 0.0 23.3 0.0 0.2 3.4 0.1 22.0 1.0 27.1 0.0 0.0 4.3 47.2 4.5 0.0 43.8 18.6 70.3 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 2.1 0.0 0.7 2.4 0.6 103.3 0.0 0.1 IKZF2 "Helios, ZNFN1A2" ENSG00000030419 "IKAROS family zinc finger 2" Q9UKS7 2 212999691-213152427 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 21.4;T-cells: 23.3;Urothelial cells: 48.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 7.2;T-cells: 7.1" "Cell line enhanced" "Detected in many" "JURKAT: 36.7;MOLT-4: 15.5;RT4: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059142 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA059142: AB_2683923" "unprognostic (2.29e-1)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.87e-2)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (3.03e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.21e-1)" "unprognostic (3.56e-3)" "unprognostic (4.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.93e-3)" "unprognostic (7.09e-2)" 3.4 2.4 6.1 4.1 12.4 5.9 4.0 8.0 8.6 4.9 2.6 5.3 7.6 1.0 2.3 3.9 24.8 3.4 3.6 2.8 6.3 2.6 2.1 2.1 3.7 7.4 11.8 3.4 2.5 3.0 9.7 6.9 3.2 8.6 5.4 2.0 2.3 13.5 9.2 4.3 10.4 2.5 1.2 9.1 5.9 5.2 2.8 13.4 55.8 9.2 5.5 7.5 11.9 11.6 1.5 0.7 5.7 0.0 7.2 7.1 0.3 1.4 0.5 2.8 0.1 9.2 9.4 1.7 1.7 2.0 0.4 0.9 0.7 2.4 1.9 2.3 1.0 0.2 3.4 0.0 0.9 1.4 0.0 0.4 1.0 1.8 0.2 0.1 4.5 0.3 9.1 0.8 0.0 0.2 2.3 0.0 36.7 0.5 1.6 0.8 2.6 15.5 4.5 0.5 1.1 0.4 9.2 1.8 0.0 0.8 14.7 0.8 0.5 0.0 1.9 0.0 2.4 2.5 0.4 4.7 2.6 2.0 1.2 0.3 3.1 0.9 10.6 1.3 0.0 0.5 4.1 0.0 5.7 2.5 0.0 6.5 0.2 0.8 1.9 0.0 1.5 0.4 1.9 0.0 7.2 0.0 0.7 7.1 0.3 6.1 12.4 8.0 8.6 6.3 2.6 11.8 3.4 8.6 13.4 8.9 9.3 3.9 11.1 5.3 4.0 6.2 0.0 21.4 15.9 7.0 3.9 3.0 0.0 1.6 1.0 2.2 1.1 0.0 2.6 1.1 1.5 14.9 3.5 1.7 1.6 0.0 2.9 1.3 1.3 0.0 1.7 1.8 1.7 1.0 2.3 2.4 3.4 0.0 2.1 0.9 7.0 0.0 2.7 0.7 0.4 7.5 3.3 23.3 1.0 48.0 IKZF3 "Aiolos, ZNFN1A3" ENSG00000161405 "IKAROS family zinc finger 3" Q9UKT9 17 39757715-39864188 "Predicted intracellular proteins, Transcription factors" "B-cell activation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7;lymphoid tissue: 55.1" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 27.4;B-cells: 90.1;granulocytes: 44.2;T-cells: 76.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 8.3;T-cells: 17.7" "Group enriched" "Detected in some" 4 "Daudi: 27.2;Karpas-707: 14.3;U-266/70: 17.3;U-266/84: 19.2;U-698: 44.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA024377, HPA073266" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024377: AB_1859477, HPA073266: " "unprognostic (5.43e-3)" "prognostic favorable (6.85e-6)" "unprognostic (6.10e-2)" "unprognostic (1.01e-1)" "unprognostic (2.93e-2)" "prognostic favorable (4.16e-4)" "unprognostic (1.36e-2)" "unprognostic (3.14e-3)" "prognostic favorable (5.42e-4)" "unprognostic (8.03e-3)" "unprognostic (1.65e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (9.13e-2)" "unprognostic (2.20e-1)" "unprognostic (5.51e-2)" "unprognostic (1.05e-3)" 1.7 0.7 0.5 41.7 0.5 3.1 1.0 0.5 0.5 1.1 4.5 0.0 0.6 1.8 1.2 0.6 3.6 1.2 2.4 0.9 0.6 0.6 1.5 1.4 5.3 30.5 0.6 0.0 0.9 0.9 0.0 0.7 0.4 0.1 1.5 1.7 1.2 5.5 1.3 0.6 0.8 11.3 1.2 0.9 41.0 3.3 2.6 0.1 55.1 1.6 1.8 54.1 4.0 1.3 8.3 0.3 0.7 0.1 2.6 17.7 4.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 27.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.1 1.6 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 14.3 0.0 0.1 2.4 0.9 0.1 1.5 0.0 0.1 0.1 4.9 0.0 1.6 0.1 0.1 0.5 0.2 0.0 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.0 17.3 19.2 44.1 0.0 0.1 0.0 0.5 0.1 0.4 16.3 0.1 17.7 8.3 6.7 12.1 0.0 7.7 2.8 7.5 0.7 2.6 0.1 0.3 10.6 4.1 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.0 0.1 0.1 8.9 27.4 90.1 2.1 0.1 1.4 4.0 0.0 1.4 10.3 1.8 0.0 0.1 0.0 0.1 11.6 1.2 0.0 0.0 0.0 0.3 0.2 1.4 44.2 0.6 0.1 0.0 0.0 5.5 6.5 7.4 0.0 0.7 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 1.4 0.0 0.1 4.9 2.0 0.1 0.2 76.1 0.0 1.4 IKZF5 "FLJ22973, Pegasus, ZNFN1A5" ENSG00000095574 "IKAROS family zinc finger 5" Q9H5V7 10 122990806-123008817 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015297, HPA051574" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA015297: AB_1855183, HPA051574: AB_2681538" "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.64e-2)" "unprognostic (2.76e-2)" "unprognostic (1.44e-2)" "unprognostic (1.66e-3)" "unprognostic (2.68e-1)" "unprognostic (9.14e-3)" "unprognostic (5.43e-2)" "unprognostic (2.99e-1)" "unprognostic (6.88e-2)" "unprognostic (1.63e-2)" "unprognostic (3.98e-3)" "unprognostic (4.17e-2)" "unprognostic (6.03e-2)" "unprognostic (6.96e-2)" "unprognostic (3.15e-2)" 11.7 11.7 20.3 9.2 23.5 38.0 16.6 24.9 20.5 12.0 9.2 22.1 7.5 8.8 12.5 13.6 9.4 9.9 8.4 9.4 18.0 14.5 11.8 14.7 10.6 13.4 28.9 13.5 19.3 14.8 14.2 22.9 10.7 21.2 11.6 9.8 11.2 10.6 8.8 12.3 13.7 10.8 9.8 21.8 11.6 9.9 13.4 26.8 14.7 13.6 7.0 12.4 9.4 11.1 7.6 6.7 8.2 8.0 9.7 13.4 6.7 6.0 3.0 6.1 10.3 9.8 9.0 6.7 5.1 10.9 6.8 8.3 4.8 7.1 15.2 3.8 6.2 3.7 8.3 10.7 7.6 10.0 8.4 9.5 9.7 5.0 7.2 6.5 11.7 8.8 7.1 10.5 8.1 17.6 9.4 7.4 10.1 13.3 10.2 7.3 4.4 10.6 12.9 5.6 4.5 4.2 8.7 7.6 8.6 5.6 4.2 6.6 5.9 4.2 5.2 9.8 5.1 4.3 7.5 7.5 4.9 4.1 7.1 8.1 9.5 5.1 14.3 6.3 20.6 2.9 7.5 6.3 8.2 9.4 8.0 10.9 6.2 8.6 9.0 6.7 7.6 11.9 13.4 6.1 9.7 7.7 4.7 10.9 6.7 20.3 23.5 24.9 20.5 18.0 14.5 28.9 13.5 21.2 26.8 11.9 12.5 11.4 9.2 28.6 11.6 12.9 7.6 14.7 14.8 5.2 13.7 5.2 8.3 4.5 3.4 10.1 6.6 0.0 4.5 5.0 9.9 14.8 16.2 13.2 5.6 11.1 17.2 6.7 9.7 2.0 12.4 9.8 15.1 4.6 8.4 7.7 3.6 6.5 9.9 8.9 14.1 12.9 11.3 24.0 22.1 28.2 12.0 15.8 6.0 7.6 IL10RA "CD210, CD210a, CDW210A, HIL-10R, IL10R" ENSG00000110324 "Interleukin 10 receptor subunit alpha" Q13651 11 117986348-118003037 "CD markers, Disease related genes, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 56.2" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 88.9;Kupffer cells: 162.4;Macrophages: 88.5;monocytes: 146.1;T-cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.9;HDLM-2: 37.1;Karpas-707: 13.9;RPMI-8226: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065647, HPA069086" Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA065647: , HPA069086: " "unprognostic (1.01e-2)" "unprognostic (2.07e-3)" "unprognostic (1.58e-2)" "unprognostic (7.08e-2)" "unprognostic (8.27e-2)" "prognostic favorable (4.47e-4)" "unprognostic (5.27e-2)" "unprognostic (4.84e-2)" "unprognostic (7.70e-3)" "unprognostic (5.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.82e-1)" "unprognostic (8.43e-3)" "unprognostic (2.19e-1)" "unprognostic (1.27e-1)" 11.3 6.5 2.9 29.6 3.5 27.2 7.2 1.1 3.0 3.4 7.9 4.7 0.5 3.8 5.5 11.0 4.3 4.9 9.7 7.6 3.0 3.6 5.0 6.4 13.6 49.8 4.7 1.4 3.4 3.6 1.3 3.4 6.9 4.5 5.8 7.5 6.4 7.9 1.9 2.6 3.0 17.6 5.0 8.0 56.2 4.9 3.1 3.5 9.6 3.6 3.9 32.2 9.5 3.4 4.6 15.4 1.2 23.9 23.7 30.7 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.1 0.0 0.3 0.0 0.2 0.0 0.0 37.1 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.7 13.9 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 3.9 0.0 5.6 0.0 1.1 15.8 0.8 19.7 23.9 14.2 4.6 19.0 22.7 15.4 2.3 6.9 12.3 1.2 23.7 18.8 6.0 30.7 22.8 2.9 3.5 1.1 3.0 3.0 3.6 4.7 1.4 4.5 3.5 6.0 26.0 27.4 0.5 5.0 0.0 2.0 0.0 2.7 2.3 0.0 0.0 1.2 0.0 0.1 0.0 1.2 0.0 0.0 0.7 88.9 2.8 0.0 11.6 0.5 54.1 0.0 0.0 4.3 162.4 0.0 0.3 88.5 16.9 146.1 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 1.0 0.1 0.2 3.6 2.7 102.0 0.0 0.4 IL10RB "CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2" ENSG00000243646 "Interleukin 10 receptor subunit beta" Q08334 21 33266358-33310187 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 170.3;Syncytiotrophoblasts: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB020670, HPA047550" Approved Approved Cytosol NA NA 1300000 Cytosol "CAB020670: , HPA047550: AB_2680086" "unprognostic (8.43e-2)" "unprognostic (6.50e-2)" "unprognostic (5.88e-2)" "unprognostic (1.77e-1)" "unprognostic (1.48e-2)" "unprognostic (7.78e-2)" "unprognostic (1.97e-3)" "unprognostic (1.26e-1)" "unprognostic (5.69e-3)" "unprognostic (1.31e-1)" "unprognostic (1.19e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (5.62e-9)" "unprognostic (3.09e-1)" "unprognostic (2.76e-1)" "unprognostic (1.29e-2)" "unprognostic (1.05e-1)" 17.6 11.0 5.4 19.6 7.3 8.9 21.5 3.6 4.4 15.2 29.2 10.3 10.6 19.6 17.5 9.6 22.7 13.2 14.8 12.3 5.6 5.4 11.6 27.5 19.3 36.1 6.6 3.1 18.2 23.2 5.5 9.7 47.4 9.3 17.7 20.8 11.7 26.0 9.7 12.4 13.8 53.6 12.2 8.0 31.7 17.6 8.4 7.3 34.0 14.3 15.3 26.2 15.1 22.6 13.8 19.4 57.9 34.7 14.0 19.5 20.4 10.3 8.0 1.5 6.4 32.4 23.8 11.4 7.9 22.5 8.8 12.6 7.5 12.8 2.9 9.1 13.8 17.9 12.9 4.3 5.4 5.8 9.6 5.9 8.0 6.0 5.7 22.6 10.2 19.5 23.9 10.2 15.3 9.0 13.8 11.6 8.6 7.2 24.2 12.1 10.7 6.8 9.9 1.1 21.0 4.3 6.4 3.6 12.2 7.9 6.1 2.1 2.9 16.3 12.1 13.8 3.6 8.0 38.7 10.5 8.8 8.6 14.9 4.3 12.8 14.3 1.7 15.5 14.7 5.6 22.3 30.1 24.8 8.8 34.4 9.6 13.6 11.1 10.6 17.8 13.8 10.5 10.4 57.9 14.0 34.7 19.4 19.5 20.4 5.4 7.3 3.6 4.4 5.6 5.4 6.6 3.1 9.3 7.3 32.8 21.5 27.9 30.6 12.9 6.2 10.4 22.9 5.3 6.8 3.5 13.7 170.3 0.0 16.0 0.7 24.6 75.7 46.7 26.6 126.8 31.9 37.4 35.7 19.5 105.9 7.9 9.8 35.6 102.1 0.7 29.4 27.9 13.5 55.1 53.6 5.6 21.9 73.7 22.3 0.8 5.5 19.4 14.2 2.2 4.7 12.8 264.0 21.8 41.1 53.1 IL13 "ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600" ENSG00000169194 "Interleukin 13" P35225 5 132656263-132661110 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 20.7" "Group enriched" "Detected in some" 7 "Early spermatids: 74.4;Late spermatids: 141.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 177 "HDLM-2: 30.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA042421 Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 40000 "Plasma membrane, Cytosol" "HPA042421: AB_10795504" "unprognostic (2.17e-1)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (5.21e-3)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (5.20e-1)" "unprognostic (7.10e-2)" "unprognostic (3.61e-3)" "unprognostic (3.34e-1)" "unprognostic (5.97e-4)" "unprognostic (4.70e-2)" "unprognostic (2.05e-1)" "unprognostic (7.39e-2)" "unprognostic (1.38e-1)" 0.3 0.0 0.1 0.8 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 3.0 0.0 0.0 0.1 0.0 0.0 1.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.2 0.2 0.6 0.0 0.0 0.0 0.0 20.7 0.0 2.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 141.6 2.6 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.2 1.2 0.5 0.0 0.0 0.0 0.0 IL16 "FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16" ENSG00000172349 "Interleukin 16" Q14005 15 81159575-81314058 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.7;lymphoid tissue: 97.9" "Cell type enhanced" "Detected in many" 14 "B-cells: 169.7;Erythroid cells: 70.0;Kupffer cells: 59.0;T-cells: 92.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 40.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HEL: 13.2;HMC-1: 23.8;RPMI-8226: 22.5;U-266/70: 28.3;U-698: 11.7;U-937: 15.8" "Group enriched" "Detected in some" 13 "cerebellum: 61.1;hippocampal formation: 29.7" "Region enriched" "Detected in single" 37 "cerebellum: 96.7" "CAB005247, HPA018467, HPA048861" Enhanced Supported "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to blood" Yes NA 208000 14000 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: " "unprognostic (8.23e-3)" "unprognostic (2.70e-3)" "unprognostic (1.97e-2)" "unprognostic (9.61e-4)" "unprognostic (2.01e-1)" "unprognostic (5.26e-4)" "unprognostic (2.63e-2)" "unprognostic (6.72e-3)" "unprognostic (2.25e-1)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (6.21e-2)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" 8.8 2.4 4.1 48.0 5.8 19.5 7.8 40.1 4.3 4.7 4.8 4.6 0.9 3.8 5.4 2.9 3.4 9.7 5.6 5.1 4.9 2.1 2.5 3.9 14.7 58.0 5.8 2.3 3.7 1.7 0.7 1.4 3.0 6.7 3.5 5.9 3.4 13.5 1.5 1.8 6.1 19.2 3.3 7.8 38.2 5.0 2.2 5.5 97.9 3.7 2.4 54.8 8.7 5.4 43.3 37.1 75.7 35.0 49.3 60.5 66.5 0.0 0.0 0.0 0.0 8.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 13.2 0.0 0.0 0.4 9.3 23.8 0.4 0.0 0.0 0.2 0.0 0.2 1.6 1.4 5.0 0.0 0.0 0.7 9.9 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 2.1 0.1 0.1 0.1 0.4 0.0 28.3 2.4 11.7 0.8 15.8 0.7 52.7 27.4 75.7 43.1 35.0 48.6 43.3 45.1 47.1 37.1 39.9 60.5 48.6 69.1 49.3 33.7 28.0 47.0 66.5 4.1 5.8 40.1 4.3 4.9 2.1 5.8 2.3 6.7 5.5 3.0 10.0 169.7 0.1 7.2 0.0 1.2 10.2 8.1 3.4 1.8 0.0 0.2 0.0 0.1 1.3 4.9 0.0 70.0 0.2 0.2 6.6 0.1 25.5 2.4 16.6 0.0 0.0 36.2 59.0 0.7 10.0 30.8 27.0 0.0 0.3 0.4 0.0 0.3 17.0 0.3 0.6 6.5 3.7 2.1 4.7 3.1 0.3 92.0 0.0 0.0 IL17RA "CD217, CDw217, hIL-17R, IL-17RA, IL17R" ENSG00000177663 "Interleukin 17 receptor A" Q96F46 22 17084954-17115694 "CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.0" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 84.8;Macrophages: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 27.6;NB-4: 24.3;THP-1: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB024996 Enhanced Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 20000 "Nucleoplasm, Cytosol" "CAB024996: " "unprognostic (1.92e-1)" "unprognostic (3.15e-1)" "unprognostic (1.65e-2)" "unprognostic (9.83e-2)" "unprognostic (7.66e-2)" "unprognostic (5.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-2)" "unprognostic (1.41e-2)" "unprognostic (8.52e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.96e-2)" "prognostic favorable (8.35e-4)" "unprognostic (2.16e-2)" "unprognostic (1.27e-1)" "unprognostic (6.51e-3)" 17.7 7.6 6.5 13.6 13.8 40.5 24.7 4.0 6.7 8.6 8.1 7.7 4.6 6.2 7.4 9.4 6.8 7.8 7.4 8.8 6.1 4.9 8.3 11.6 16.8 39.2 10.3 2.0 7.7 7.7 6.9 5.4 6.2 8.3 6.9 5.7 5.3 7.0 5.3 5.3 8.6 9.1 8.3 11.2 23.4 7.3 5.3 9.7 50.0 7.9 3.2 11.0 6.3 12.8 0.5 3.6 15.6 6.9 1.4 2.4 2.0 3.6 2.1 1.9 2.5 3.9 2.3 2.5 5.5 3.6 2.6 3.3 2.0 2.4 3.3 2.3 5.5 3.4 6.0 2.7 2.6 1.8 5.4 3.2 0.0 1.2 1.3 4.5 27.6 8.6 3.4 3.8 2.3 1.8 2.5 2.7 2.7 1.4 3.5 2.6 3.1 3.3 24.3 1.1 4.7 2.1 0.7 0.4 0.6 2.4 2.7 1.3 0.0 3.8 3.3 2.7 2.3 2.5 35.0 7.5 2.0 2.9 3.0 2.0 2.8 1.5 1.6 2.9 13.4 2.1 6.7 6.9 6.1 1.1 3.2 0.9 0.4 1.5 1.1 3.6 0.5 2.4 1.8 15.6 1.4 2.9 1.7 0.9 2.0 6.5 13.8 4.0 6.7 6.1 4.9 10.3 2.0 8.3 9.7 11.9 13.1 6.7 5.5 7.8 2.0 4.5 15.3 5.3 3.4 5.2 7.9 5.4 0.0 8.0 2.5 9.3 15.1 0.0 10.8 10.6 8.2 8.5 7.0 9.6 29.2 3.2 12.7 20.9 84.8 1.4 8.3 43.1 8.5 3.6 13.1 3.8 10.5 11.8 4.2 3.1 3.2 12.9 9.0 1.4 14.7 5.9 5.4 20.0 10.6 9.3 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143251-112164117 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9;skin 1: 57.2" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 160.8;Kupffer cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 17.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 26.5;CAPAN-2: 42.1;HaCaT: 38.5;HBEC3-KT: 29.0;hTCEpi: 44.4;PC-3: 25.8;U-2 OS: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA Yes 196000 "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favorable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 9.4 2.6 5.3 12.5 7.9 10.8 5.2 1.3 5.3 18.5 13.1 6.4 2.5 8.6 2.1 3.7 53.9 3.3 11.9 2.1 5.7 3.1 17.5 3.6 15.2 22.6 7.4 1.4 1.4 7.0 0.3 3.3 2.6 8.2 5.5 11.6 2.2 8.3 1.4 3.8 57.2 9.1 4.0 24.7 26.6 5.1 1.7 7.5 3.9 1.8 21.2 26.5 9.1 35.4 0.5 17.1 10.4 6.9 13.8 0.3 1.6 26.5 9.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 5.1 42.1 0.0 6.1 0.0 0.7 38.5 0.0 29.0 0.0 0.0 0.2 4.0 9.5 2.1 0.9 2.1 7.7 0.0 44.4 0.0 10.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 7.3 25.8 0.0 0.0 0.0 19.0 5.7 0.0 0.0 18.3 12.2 0.1 0.2 7.3 5.8 0.0 0.1 50.0 0.3 8.2 0.1 0.0 0.1 0.0 15.4 0.0 3.5 6.0 10.4 0.1 6.9 0.0 0.4 0.0 0.0 17.1 0.5 0.0 0.3 6.7 13.8 3.7 3.8 0.0 1.6 5.3 7.9 1.3 5.3 5.7 3.1 7.4 1.4 8.2 7.5 160.8 35.5 7.5 33.3 109.2 1.7 0.7 22.9 73.6 43.3 8.7 0.0 2.1 68.0 27.4 1.8 2.4 69.7 0.0 126.1 2.6 5.4 10.6 97.2 2.0 69.6 0.0 13.9 6.2 163.5 0.9 0.0 66.1 3.3 30.7 23.3 1.7 111.9 97.0 4.2 13.2 37.2 6.5 2.2 0.6 0.5 97.2 1.5 27.7 45.4 67.4 IL1R1 "CD121A, D2S1473, IL1R, IL1RA" ENSG00000115594 "Interleukin 1 receptor type 1" P14778 2 102064544-102179874 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Club cells: 93.3;Ito cells: 139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 95.6;ASC TERT1: 42.7;HHSteC: 30.0;HSkMC: 117.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001237, HPA005823, CAB007779, HPA029560" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1000000 "Nucleoplasm, Vesicles" "Plasma membrane, Cytosol" "CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094" "unprognostic (6.16e-3)" "unprognostic (3.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (7.10e-2)" "unprognostic (2.01e-1)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-1)" "unprognostic (4.26e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (6.92e-6)" "unprognostic (2.48e-2)" "unprognostic (6.95e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" 48.6 25.2 2.6 18.2 5.2 4.0 92.4 2.4 3.9 47.8 21.0 2.5 34.3 5.2 15.2 30.2 18.2 17.1 25.8 27.0 4.2 2.5 23.7 74.8 40.5 28.0 5.6 1.1 25.1 17.1 16.9 7.3 66.2 10.9 26.0 8.4 8.6 12.7 36.4 15.5 13.5 13.0 15.1 10.0 19.2 15.6 13.4 2.8 3.5 33.6 9.0 9.6 32.0 36.4 0.1 0.1 4.0 0.5 0.8 1.8 0.2 0.2 1.8 0.0 1.5 95.6 42.7 0.6 4.0 18.2 2.8 4.3 0.8 0.5 0.0 2.9 8.0 5.0 0.8 0.0 0.3 2.4 7.9 0.0 0.1 0.4 4.4 30.0 0.0 0.0 117.7 0.3 3.2 0.7 1.2 1.2 0.0 0.5 0.1 4.1 0.8 0.0 0.1 0.1 0.8 0.1 0.0 0.3 0.0 2.7 1.9 0.0 0.0 1.8 1.1 0.0 0.5 1.6 0.1 0.0 8.2 0.5 13.7 0.3 0.0 0.0 0.0 3.2 0.0 0.5 0.6 0.5 0.1 0.0 0.0 0.7 0.1 1.1 0.0 0.1 0.1 0.0 0.1 4.0 0.8 0.0 0.1 1.8 0.2 2.6 5.2 2.4 3.9 4.2 2.5 5.6 1.1 10.9 2.8 23.8 55.6 3.7 27.6 27.6 0.0 3.9 28.1 40.2 93.3 5.2 0.0 5.3 3.3 21.6 6.4 58.3 0.0 0.0 18.7 76.6 77.2 84.5 1.1 43.2 5.1 0.0 1.2 139.3 12.4 9.4 25.9 21.6 18.6 9.0 0.7 7.3 15.4 0.0 1.4 6.2 1.0 6.5 23.1 0.7 0.9 33.8 20.0 2.6 0.9 19.6 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.5;liver: 91.8;placenta: 35.9" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 100.2;Hepatocytes: 172.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "neutrophil: 36.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 36.5" "Cell line enhanced" "Detected in many" "SK-MEL-30: 72.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 260000000 "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.29e-4)" 3.4 1.7 3.7 5.2 4.5 7.8 2.8 0.8 6.0 2.9 1.8 3.4 0.7 1.1 2.6 1.7 9.1 3.2 5.7 3.3 7.4 2.9 1.9 91.8 6.3 12.6 3.5 2.5 2.2 2.0 1.0 1.4 35.9 5.5 2.1 1.4 1.6 4.7 2.0 1.2 5.8 1.5 3.1 6.3 7.1 2.3 1.0 2.9 2.3 2.2 3.8 3.4 3.3 4.4 0.9 1.4 36.5 2.2 0.1 1.3 0.5 3.9 1.0 1.6 0.2 2.9 2.4 3.1 1.7 3.5 4.1 4.0 1.7 8.8 0.7 18.3 4.8 9.5 10.2 0.9 17.1 5.7 0.7 1.0 0.8 1.7 4.2 6.1 5.8 2.8 3.2 7.0 5.9 18.9 8.6 1.8 1.8 0.1 0.0 1.9 1.8 0.5 2.6 2.6 1.7 1.8 2.8 2.5 1.4 1.5 4.2 0.3 0.0 8.0 4.4 72.7 1.6 2.9 4.2 2.4 3.2 3.2 9.7 7.9 1.5 0.0 0.1 5.4 5.3 18.6 3.5 1.5 8.5 0.7 1.7 1.3 0.9 0.8 0.9 1.4 0.9 0.8 0.5 36.5 0.1 2.2 0.2 0.8 0.5 3.7 4.5 0.8 6.0 7.4 2.9 3.5 2.5 5.5 2.9 0.0 14.3 1.4 14.3 39.8 5.4 4.0 43.3 2.7 20.5 3.5 7.9 3.1 0.0 6.5 2.3 7.1 1.3 0.0 6.4 100.2 7.0 5.6 7.0 172.7 6.9 0.0 5.2 8.0 33.0 0.0 4.0 18.3 8.5 1.0 1.3 0.9 14.8 0.0 2.5 0.8 0.6 0.0 3.1 0.0 0.6 32.5 20.3 2.5 1.2 12.8 IL1RL1 "DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1" ENSG00000115602 "Interleukin 1 receptor like 1" Q01638 2 102311502-102352037 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 49.7;lung: 77.2;placenta: 95.0" "Cell type enriched" "Detected in many" 11 "granulocytes: 477.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.9" "Group enriched" "Detected in many" 5 "basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6" "Group enriched" "Detected in some" 59 "basophil: 17.1;eosinophil: 17.0" "Lineage enriched" "Detected in single" 59 "granulocytes: 17.1" "Group enriched" "Detected in some" 6 "HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007406, HPA007917" Uncertain Supported "Plasma membrane,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 19100000 1700000 "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA007406: AB_1079128, HPA007917: AB_1079129" "unprognostic (7.25e-2)" "unprognostic (9.72e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (5.28e-2)" "unprognostic (1.98e-2)" "unprognostic (3.25e-3)" "unprognostic (2.07e-1)" "unprognostic (2.77e-1)" "unprognostic (4.50e-2)" "unprognostic (8.58e-2)" "unprognostic (9.74e-2)" "unprognostic (1.44e-1)" "unprognostic (1.32e-2)" "unprognostic (1.60e-2)" "unprognostic (1.17e-1)" "unprognostic (4.60e-3)" 10.7 7.5 1.4 2.0 11.4 0.9 6.9 0.5 6.6 2.6 3.1 0.1 0.1 1.3 1.7 0.9 2.7 0.8 7.8 16.6 5.6 1.8 49.7 6.2 77.2 1.4 3.8 0.0 0.7 2.8 0.8 1.8 95.0 14.6 1.9 2.3 1.0 0.7 5.7 2.8 1.1 2.0 3.3 5.0 1.0 6.7 0.8 0.3 0.0 5.6 0.7 0.9 6.0 2.6 0.0 0.0 17.1 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 3.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 1.3 0.1 0.0 0.0 9.7 0.1 0.1 55.4 0.4 82.4 1.1 0.3 1.3 8.9 0.1 40.2 0.0 0.2 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.1 17.1 0.0 17.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 11.4 0.5 6.6 5.6 1.8 3.8 0.0 14.6 0.3 8.9 22.8 0.0 15.1 7.6 0.0 1.8 0.0 12.0 13.6 1.8 0.0 0.0 0.0 0.0 0.2 29.2 0.0 0.0 0.4 0.1 4.2 8.9 477.2 0.0 0.0 0.0 0.0 44.2 0.3 0.9 0.9 11.2 3.3 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.2 38.8 5.2 0.0 0.0 4.4 0.0 4.3 0.0 11.1 IL1RN "ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430" ENSG00000136689 "Interleukin 1 receptor antagonist" P18510 2 113107214-113134016 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 163.8;Hofbauer cells: 319.3;Suprabasal keratinocytes: 294.2;Urothelial cells: 333.6" "Cancer enhanced" "Detected in all" "head and neck cancer: 92.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2" "Group enriched" "Detected in many" 332 "dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1" "Cell line enhanced" "Detected in some" "A-431: 21.1;HaCaT: 41.7;RT4: 40.8;THP-1: 11.8" "Not detected" "Not detected" "HPA001482, CAB009633" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Secreted to blood" NA NA 291000 Nucleoplasm "Centrosome, Cytosol" "CAB009633: AB_2125576, HPA001482: AB_1078437" "unprognostic (3.85e-3)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (3.15e-2)" "unprognostic (2.55e-1)" "unprognostic (4.46e-2)" "unprognostic (9.54e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (5.59e-3)" "prognostic unfavorable (2.66e-6)" "unprognostic (2.05e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (4.25e-2)" "unprognostic (1.03e-1)" 17.3 0.2 0.2 7.2 0.3 32.9 1.1 0.2 0.5 27.2 3.8 0.6 1.4 1.1 1.5 0.7 217.8 0.2 4.1 0.5 0.2 0.0 0.5 23.5 2.9 1.9 0.3 0.2 0.4 0.4 0.1 0.3 3.1 0.6 1.6 0.3 0.4 30.9 1.3 0.5 14.4 3.7 0.7 0.2 3.6 5.7 1.4 0.2 1.0 0.7 123.7 194.7 3.3 42.2 0.0 17.1 65.2 17.1 0.0 0.0 4.9 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.4 41.7 0.0 1.2 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.1 7.9 0.0 5.4 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.2 0.0 5.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.1 0.5 0.0 0.3 0.0 0.3 0.0 0.1 4.0 4.7 0.1 0.0 17.1 0.3 0.0 7.6 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 65.2 0.0 3.4 0.1 0.0 4.9 0.2 0.3 0.2 0.5 0.2 0.0 0.3 0.2 0.6 0.2 6.0 10.6 0.5 50.9 163.8 0.0 0.3 12.7 18.7 17.0 3.5 0.0 1.3 0.0 17.2 35.3 2.2 6.5 0.0 25.2 2.5 6.6 30.8 9.3 38.4 319.3 0.0 0.0 3.1 35.8 72.7 0.6 100.5 23.6 1.0 0.6 0.0 89.0 0.0 0.4 0.0 0.0 0.0 6.6 0.7 0.1 294.2 3.8 0.9 2.2 333.6 IL20RA "IL-20R1, ZCYTOR7" ENSG00000016402 "Interleukin 20 receptor subunit alpha" Q9UHF4 6 136999971-137045180 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 28.9" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 33.5;Muller glia cells: 36.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.4;HaCaT: 6.8;OE19: 9.7;RT4: 11.3;SH-SY5Y: 10.9;T-47d: 10.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB024990, HPA042281" Approved Approved Cytosol NA NA Cytosol "CAB024990: , HPA042281: AB_10806235" "unprognostic (3.75e-2)" "unprognostic (8.23e-2)" "unprognostic (1.96e-2)" "prognostic favorable (1.43e-6)" "unprognostic (1.57e-2)" "prognostic favorable (2.29e-5)" "unprognostic (9.87e-3)" "unprognostic (1.64e-1)" "unprognostic (2.43e-1)" "unprognostic (3.78e-1)" "unprognostic (8.03e-3)" "unprognostic (2.18e-1)" "unprognostic (1.85e-6)" "unprognostic (9.38e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-3)" "unprognostic (1.64e-3)" 0.6 7.0 2.0 1.6 5.9 0.1 21.2 4.4 2.8 13.9 3.5 4.3 0.6 2.4 5.5 3.7 6.4 13.6 7.9 5.9 3.6 3.0 0.4 0.8 4.7 0.1 3.7 2.3 5.4 16.3 0.2 1.8 0.4 4.6 7.3 3.7 3.5 11.8 7.8 0.5 28.9 1.3 2.9 5.5 0.0 4.9 2.9 3.3 1.0 2.2 3.7 5.6 5.6 9.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 9.4 0.0 0.1 1.4 0.1 6.8 1.2 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 9.7 1.4 0.0 0.4 0.0 0.0 11.3 0.7 10.9 0.5 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.9 4.4 2.8 3.6 3.0 3.7 2.3 4.6 3.3 3.0 18.4 0.0 11.2 19.5 1.7 3.9 25.5 33.5 14.8 3.5 0.0 2.4 0.0 11.1 0.2 0.6 5.2 0.0 0.6 6.6 2.4 18.3 2.3 0.0 0.4 0.0 7.0 0.6 0.0 0.5 8.1 1.7 13.5 0.0 18.4 36.8 8.0 2.9 14.2 0.6 0.7 0.0 1.2 0.2 3.4 15.7 6.9 0.0 13.3 17.1 IL20RB "DIRS1, FNDC6, IL-20R2, MGC34923" ENSG00000174564 "Interleukin 20 receptor subunit beta" Q6UXL0 3 136946230-137011085 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 64.5;skin 1: 61.2" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 32.6;Early spermatids: 38.8;Late spermatids: 24.0;Suprabasal keratinocytes: 33.2" "Group enriched" "Detected in many" 5 "cervical cancer: 54.5;head and neck cancer: 50.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "hTCEpi: 106.6" "Region enriched" "Detected in single" 9 "cerebellum: 0.6" "Not detected" "Not detected" HPA063914 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA063914: AB_2732709" "unprognostic (1.35e-2)" "unprognostic (1.05e-1)" "unprognostic (7.43e-4)" "unprognostic (2.48e-4)" "unprognostic (2.74e-1)" "unprognostic (3.31e-1)" "unprognostic (7.43e-4)" "unprognostic (4.08e-3)" "unprognostic (7.64e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.57e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.55e-1)" "unprognostic (3.55e-2)" "unprognostic (1.33e-2)" "unprognostic (5.57e-2)" 1.6 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 13.2 0.2 0.0 0.0 0.0 1.3 0.3 64.5 0.1 0.1 0.3 0.0 0.0 0.1 2.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.2 2.8 0.0 1.6 0.3 0.4 4.1 0.2 0.4 61.2 0.1 0.1 0.3 0.0 0.1 0.9 0.0 0.5 0.2 22.6 17.1 0.9 19.2 0.1 0.4 0.0 0.3 0.0 0.6 0.0 4.9 0.0 0.0 0.0 3.0 12.9 0.5 0.1 0.3 0.0 0.2 0.4 0.6 0.0 2.8 1.8 0.1 16.0 0.0 26.4 0.1 0.0 0.0 0.0 3.3 0.0 17.8 0.0 0.0 2.2 106.6 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.5 0.8 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 32.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 38.8 1.0 0.6 0.0 0.2 1.1 0.8 1.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 24.0 0.3 0.8 3.3 2.8 0.7 0.0 0.8 0.0 0.7 0.1 0.0 0.0 2.3 0.6 1.5 33.2 1.4 0.0 0.5 4.8 IL21R CD360 ENSG00000103522 "Interleukin 21 receptor" Q9HBE5 16 27402162-27452042 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 17.9;lymphoid tissue: 47.8" "Cell type enhanced" "Detected in some" 10 "B-cells: 11.8;Early spermatids: 5.2;Hofbauer cells: 7.0;T-cells: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 10.3;HDLM-2: 43.9;Karpas-707: 20.4;RH-30: 15.4;RPMI-8226: 24.5;U-266/70: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042296 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042296: AB_10806236" "unprognostic (2.91e-2)" "unprognostic (2.65e-3)" "unprognostic (6.64e-4)" "unprognostic (1.58e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.29e-4)" "unprognostic (8.33e-2)" "unprognostic (2.06e-1)" "unprognostic (8.50e-6)" "unprognostic (2.26e-2)" "unprognostic (1.13e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-10)" "unprognostic (8.79e-2)" "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.58e-2)" 0.8 0.6 0.6 33.6 3.7 5.7 0.6 0.5 1.6 0.5 0.9 0.3 0.0 0.5 0.5 1.3 1.0 0.8 1.1 1.8 0.6 2.3 1.6 1.3 5.6 20.9 1.3 0.0 0.5 0.5 0.0 0.9 0.9 1.9 0.9 0.9 1.8 3.7 0.3 0.7 0.7 4.0 0.6 1.7 11.2 1.3 1.0 1.4 47.8 1.3 0.8 31.7 2.7 0.8 11.5 1.6 0.7 17.9 6.3 10.3 4.2 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.0 0.0 0.9 0.0 0.0 10.3 0.1 0.8 0.5 0.0 0.0 0.0 0.0 43.9 0.0 2.1 0.0 0.3 1.4 0.0 0.6 1.6 0.0 2.8 0.0 0.3 0.0 0.2 0.1 20.4 1.5 0.0 0.0 0.2 0.3 0.0 0.0 0.1 15.4 24.5 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.5 1.1 0.8 0.3 0.2 0.0 10.3 3.6 2.3 2.1 0.5 0.0 0.2 0.3 0.0 9.8 5.8 3.6 1.0 6.3 10.3 1.6 11.5 6.9 6.7 0.7 6.3 17.9 0.7 7.6 4.2 0.6 3.7 0.5 1.6 0.6 2.3 1.3 0.0 1.9 1.4 0.0 2.2 11.8 0.1 0.3 1.5 2.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.2 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 7.0 0.0 0.0 1.3 4.5 4.0 0.0 2.2 1.7 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.1 0.0 0.6 0.1 8.2 0.0 0.0 IL23A "IL-23, IL-23A, IL23P19, P19, SGRF" ENSG00000110944 "Interleukin 23 subunit alpha" Q9NPF7 12 56334174-56340410 "FDA approved drug targets, Predicted secreted proteins" "Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling" Cytokine "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.0;lymphoid tissue: 15.2;testis: 12.1" "Cell type enhanced" "Detected in many" 10 "Ductal cells: 26.3;monocytes: 58.7;Pancreatic endocrine cells: 46.8;Spermatocytes: 41.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "MAIT T-cell: 8.4;memory B-cell: 10.6;memory CD4 T-cell: 15.5;memory CD8 T-cell: 7.4;naive B-cell: 10.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 10.6;T-reg: 8.4" "Group enriched" "Detected in many" 14 "B-cells: 10.6;T-cells: 17.0" "Cell line enhanced" "Detected in some" "A-431: 9.4;CAPAN-2: 16.5;U-266/70: 27.6;U-266/84: 12.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA001554 Approved Approved Cytosol "Secreted to blood" NA NA 11000 Cytosol "HPA001554: AB_1079135" "unprognostic (2.34e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-1)" "unprognostic (1.06e-1)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (4.40e-1)" "unprognostic (1.43e-3)" "unprognostic (1.30e-1)" "unprognostic (6.79e-2)" "unprognostic (3.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-10)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.83e-1)" "unprognostic (4.50e-3)" 0.7 0.5 0.4 3.9 0.5 3.6 0.4 0.3 0.3 0.5 0.6 0.3 0.3 0.0 1.3 0.8 6.0 0.5 2.0 0.3 0.4 0.5 1.3 1.4 1.2 7.5 0.4 0.3 0.3 1.1 0.0 1.1 0.6 0.3 1.0 0.2 0.3 1.8 0.3 0.3 0.8 2.5 1.0 0.4 2.8 0.7 12.1 0.3 12.9 0.6 10.4 15.2 7.4 0.6 10.6 0.5 0.1 0.2 1.0 17.0 5.9 9.4 0.2 0.3 0.3 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.4 16.5 0.5 4.9 0.0 0.5 0.9 0.0 1.6 0.0 0.6 0.3 0.3 0.1 0.7 0.0 0.2 0.6 0.1 0.0 0.0 0.4 2.1 0.0 2.2 0.4 4.1 0.0 0.4 0.3 0.5 1.4 0.2 0.3 0.2 0.1 0.4 5.7 4.7 0.3 0.4 0.2 0.2 0.8 1.4 0.1 4.4 0.3 0.3 0.3 0.3 1.1 27.6 12.4 1.2 0.3 2.4 0.2 0.0 0.2 0.0 1.7 0.0 8.4 10.6 15.5 7.4 0.5 10.6 17.0 10.6 0.1 1.0 0.0 0.0 8.4 5.9 0.4 0.5 0.3 0.3 0.4 0.5 0.4 0.3 0.3 0.3 3.0 2.1 14.5 10.2 3.2 0.0 0.3 0.0 2.7 5.7 1.8 0.0 0.3 1.7 26.3 4.7 0.6 0.3 0.0 6.4 0.3 1.4 5.0 0.0 0.6 2.4 0.0 0.0 0.0 0.0 3.2 0.3 8.1 8.5 58.7 0.0 0.1 46.8 0.0 0.7 0.5 0.1 0.0 1.9 41.1 5.3 3.4 0.0 10.2 0.0 13.9 IL4I1 FIG1 ENSG00000104951 "Interleukin 4 induced 1" Q96RQ9 19 49889654-49929539 "Enzymes, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.6;testis: 48.8" "Cell type enriched" "Detected in many" 12 "monocytes: 1188.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 38.6" "Group enriched" "Detected in many" 6 "monocytes: 13.0;T-cells: 38.6" "Cell line enhanced" "Detected in some" "EFO-21: 18.0;HDLM-2: 31.2;Karpas-707: 25.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA045598 Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA "Nucleoplasm, Cytosol" "HPA045598: AB_10969138" "unprognostic (6.23e-2)" "unprognostic (1.32e-2)" "unprognostic (8.39e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.61e-2)" "unprognostic (3.74e-3)" "unprognostic (7.03e-2)" "unprognostic (2.52e-2)" "unprognostic (3.84e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.23e-10)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (6.44e-2)" "unprognostic (2.11e-3)" 5.4 3.3 4.0 30.9 4.6 7.1 4.1 5.8 5.6 4.6 4.1 5.5 2.9 8.2 5.9 3.4 4.5 8.2 5.4 4.2 3.9 3.5 11.0 3.5 6.7 15.5 4.0 3.2 6.2 3.7 1.5 5.1 6.8 4.3 5.3 3.8 3.9 4.1 5.0 6.2 3.4 7.4 3.8 7.2 7.6 6.2 48.8 4.4 14.6 4.1 4.4 12.3 6.5 4.9 0.2 4.1 0.1 13.0 0.4 38.6 3.0 0.5 0.6 0.4 0.4 0.0 0.4 0.1 0.3 1.0 0.8 1.1 0.3 1.0 1.8 18.0 0.2 1.5 0.3 0.2 0.0 0.1 31.2 0.1 0.8 0.0 0.2 0.1 0.6 6.4 0.5 0.2 0.3 0.0 0.2 1.4 0.2 0.1 25.3 0.0 0.2 0.4 1.0 0.2 0.4 0.1 0.5 0.5 1.7 1.2 1.6 0.4 0.4 0.2 0.5 0.3 0.1 0.2 1.4 1.5 3.8 0.5 0.0 0.5 2.2 4.7 1.0 0.5 0.2 0.4 0.1 8.0 0.1 2.3 13.0 38.6 0.2 5.0 4.3 4.1 0.1 0.1 0.0 0.1 0.4 1.6 0.4 0.2 3.0 4.0 4.6 5.8 5.6 3.9 3.5 4.0 3.2 4.3 4.4 0.0 0.0 0.0 0.5 8.7 0.0 0.6 0.0 0.0 1.2 3.5 0.0 0.3 0.0 1.9 52.0 3.1 0.0 0.0 3.4 0.6 1.4 1.0 1.1 0.0 102.3 0.0 0.0 1.8 1.8 11.1 0.3 40.3 3.3 1188.5 0.0 0.1 0.5 0.0 0.4 1.6 0.2 0.0 2.1 11.9 2.5 7.2 0.7 5.0 0.1 1.4 IMPAD1 "FLJ20421, gPAPP, IMPA3" ENSG00000104331 "Inositol monophosphatase domain containing 1" Q9NX62 8 56957933-56993844 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009411 Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 560000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA009411: AB_1079138" "unprognostic (1.62e-2)" "unprognostic (7.89e-3)" "unprognostic (6.58e-2)" "unprognostic (6.42e-2)" "unprognostic (2.00e-1)" "unprognostic (8.59e-2)" "unprognostic (1.88e-1)" "unprognostic (1.67e-2)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (4.24e-3)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (1.68e-3)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" 30.6 33.9 17.8 13.9 23.7 9.6 17.6 23.6 33.1 24.7 17.7 30.9 17.8 11.7 23.2 15.2 17.7 15.6 18.0 25.2 19.9 21.6 21.3 32.6 16.5 10.3 23.6 21.1 16.0 25.2 30.4 20.4 23.3 27.2 28.8 16.2 25.2 28.7 22.5 41.4 13.4 12.3 23.0 21.7 13.0 14.7 19.0 19.5 12.0 24.4 18.1 13.0 17.2 14.9 1.9 2.0 6.1 4.6 6.8 2.4 0.6 17.4 14.5 11.2 11.5 34.5 23.7 15.4 26.6 25.9 19.1 16.7 7.2 12.5 10.9 20.4 28.2 13.6 14.3 13.5 17.9 28.4 15.0 9.7 21.3 10.3 12.9 21.5 13.5 15.2 19.0 18.0 17.1 27.8 17.7 25.3 10.3 9.1 19.9 20.9 9.3 16.4 8.1 8.3 20.0 5.4 11.5 10.1 12.3 19.8 10.4 4.3 12.2 14.9 18.4 15.1 12.3 16.4 9.9 21.1 25.9 14.9 25.5 19.0 20.5 17.1 11.7 35.4 11.3 15.8 2.9 1.9 1.1 2.0 1.2 1.6 1.3 1.3 1.2 1.4 1.9 1.5 2.4 6.1 6.8 4.6 2.0 0.9 0.6 17.8 23.7 23.6 33.1 19.9 21.6 23.6 21.1 27.2 19.5 20.8 18.6 9.0 24.5 48.3 29.9 43.1 25.5 8.1 12.5 45.4 15.7 15.1 5.0 17.1 13.5 27.0 19.0 0.0 23.5 68.2 45.0 43.5 9.2 61.6 24.1 38.1 33.4 38.1 25.6 4.2 23.6 23.8 15.1 5.4 33.4 25.1 24.0 17.5 33.6 16.8 27.4 32.3 38.9 34.6 22.2 52.2 28.3 14.9 16.0 33.9 IMPDH1 "LCA11, RP10, sWSS2608" ENSG00000106348 "Inosine monophosphate dehydrogenase 1" P20839 7 128392277-128410252 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" "DNA-binding, Oxidoreductase, RNA-binding" "Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 172.4;Cone photoreceptor cells: 133.5;Horizontal cells: 114.4;Rod photoreceptor cells: 184.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 21.6;eosinophil: 20.2;intermediate monocyte: 26.2;myeloid DC: 15.1;neutrophil: 49.9;non-classical monocyte: 31.0" "Group enriched" "Detected in all" 5 "dendritic cells: 15.1;granulocytes: 49.9;monocytes: 31.0" "Cell line enhanced" "Detected in all" "SK-BR-3: 89.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001400 Approved Supported "Cytosol,Rods & Rings" NA NA Cytosol "Rods & Rings" "HPA001400: AB_1079139" "unprognostic (2.84e-1)" "prognostic unfavorable (3.87e-4)" "unprognostic (2.23e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (7.31e-5)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.12e-7)" "unprognostic (1.24e-1)" "unprognostic (7.45e-3)" "unprognostic (1.03e-2)" "unprognostic (1.79e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (1.78e-12)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.72e-5)" 26.0 7.4 7.5 20.7 8.5 24.5 37.1 7.7 10.2 11.3 10.9 3.6 12.4 5.2 8.5 6.5 14.6 9.1 7.6 12.6 7.6 5.0 7.5 3.5 14.8 31.2 5.1 5.8 10.7 20.3 5.2 12.0 7.2 9.9 12.1 6.3 19.5 20.6 11.4 3.5 11.9 8.8 12.3 6.4 25.1 20.6 7.1 5.6 3.9 5.5 11.2 9.7 14.2 9.9 4.1 15.1 49.9 31.0 2.8 6.4 11.7 25.5 22.0 3.3 24.5 13.9 10.1 9.4 17.5 11.1 15.0 9.8 16.0 8.2 16.3 6.0 26.0 15.6 19.6 18.5 24.6 7.5 5.9 20.7 10.7 16.3 11.3 12.7 14.1 5.1 12.0 11.8 15.2 15.2 7.1 17.7 9.9 10.6 12.3 5.0 17.5 9.9 38.0 18.6 20.3 25.8 11.9 6.1 33.7 6.6 8.2 13.2 13.3 11.3 89.8 15.8 2.1 10.2 27.4 16.2 25.3 9.2 13.2 12.4 9.2 8.5 20.9 12.9 31.3 15.3 2.3 21.6 20.2 5.9 26.2 6.4 4.1 4.7 5.1 15.1 2.4 2.8 3.4 49.9 2.8 31.0 1.5 5.2 11.7 7.5 8.5 7.7 10.2 7.6 5.0 5.1 5.8 9.9 5.6 0.0 12.8 13.7 7.5 7.8 172.4 4.5 0.0 6.7 6.8 5.2 133.5 2.2 5.0 6.6 0.5 14.0 1.7 0.0 15.6 18.1 11.6 17.1 20.7 0.4 41.4 114.4 9.2 12.9 59.2 1.3 4.4 34.4 15.1 56.9 8.9 17.6 11.7 0.0 6.3 1.3 184.8 0.0 13.3 3.1 18.8 6.5 1.9 14.9 11.9 8.5 IMPDH2 ENSG00000178035 "Inosine monophosphate dehydrogenase 2" P12268 3 49024325-49029408 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" "DNA-binding, Oxidoreductase, RNA-binding" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001400, CAB020717" Approved Supported "Cytosol,Rods & Rings" NA NA 19000 Cytosol "Rods & Rings" "CAB020717: , HPA001400: AB_1079139" "unprognostic (2.09e-2)" "unprognostic (2.91e-1)" "unprognostic (5.96e-2)" "unprognostic (1.20e-1)" "unprognostic (7.31e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.30e-1)" "unprognostic (2.65e-1)" "unprognostic (2.17e-1)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.30e-1)" "unprognostic (3.85e-1)" "unprognostic (5.80e-2)" "unprognostic (2.24e-1)" "unprognostic (4.47e-2)" 25.0 21.5 16.1 25.7 15.4 23.9 47.0 9.7 21.1 34.7 24.9 15.1 19.1 18.9 29.5 19.8 40.1 51.9 33.3 29.3 13.0 11.2 21.4 29.4 19.9 52.5 18.1 13.0 89.0 88.8 19.1 16.6 23.2 15.6 33.2 31.7 10.8 22.1 22.2 61.4 40.7 17.8 34.1 15.2 23.7 22.2 15.3 15.4 31.2 29.8 51.3 33.4 30.3 32.1 31.6 18.8 6.2 16.8 21.6 34.8 16.0 40.1 23.2 32.2 33.3 48.2 88.1 31.3 27.9 45.2 67.3 57.4 40.3 36.3 73.4 20.0 33.6 19.1 28.0 66.5 56.6 59.0 19.2 22.2 54.4 34.3 36.9 41.4 57.5 22.4 78.2 62.4 64.3 116.9 51.6 47.2 52.0 32.5 41.6 54.1 32.7 48.7 40.1 41.8 38.4 46.9 21.2 33.9 72.0 38.3 26.0 20.9 20.6 30.3 34.3 50.4 27.9 42.4 25.7 23.7 29.5 54.8 71.6 71.5 40.3 29.1 35.2 34.1 64.3 28.8 6.2 10.1 4.0 17.0 16.8 31.7 31.6 23.3 19.6 18.8 31.1 34.8 28.6 4.4 21.6 13.9 14.5 15.5 16.0 16.1 15.4 9.7 21.1 13.0 11.2 18.1 13.0 15.6 15.4 59.6 51.7 94.7 205.9 180.0 15.2 31.5 58.6 44.2 79.6 34.9 13.7 273.1 68.0 75.3 1.3 60.9 35.9 0.0 160.1 214.5 119.3 96.3 66.7 22.1 86.0 14.3 58.3 51.0 42.7 4.7 114.2 60.0 84.4 76.7 112.2 22.9 107.0 31.6 66.8 71.0 14.2 38.8 124.9 26.3 53.7 171.0 262.6 46.8 265.0 109.1 INA "NEF5, NF-66" ENSG00000148798 "Internexin neuronal intermediate filament protein alpha" Q16352 10 103277163-103290351 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 65.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 51.8;Cone photoreceptor cells: 21.6;Early spermatids: 34.2;Horizontal cells: 42.9;Late spermatids: 14.9;Rod photoreceptor cells: 32.4" "Cancer enhanced" "Detected in many" "testis cancer: 18.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 21.1;SCLC-21H: 41.4;SH-SY5Y: 23.6;SiHa: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002059, HPA007572, HPA008057" Enhanced Supported Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833" "unprognostic (1.77e-1)" "unprognostic (2.50e-2)" "unprognostic (9.54e-2)" "unprognostic (5.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.45e-3)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "unprognostic (8.09e-3)" "unprognostic (3.07e-2)" "unprognostic (1.78e-3)" "unprognostic (1.66e-1)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" 1.5 15.7 16.6 2.6 21.3 1.3 1.3 26.9 65.2 1.3 2.7 2.3 0.0 2.0 1.3 1.4 1.9 1.3 1.5 1.3 13.2 34.0 1.3 1.4 1.5 1.4 27.2 17.7 1.3 3.6 1.3 12.8 1.5 65.4 1.5 2.8 5.5 1.3 1.4 1.3 2.2 2.5 2.2 7.9 1.3 2.6 4.1 3.3 0.0 1.5 0.0 1.5 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 4.7 0.0 0.0 0.0 7.7 5.2 1.3 1.2 0.1 0.0 0.0 0.0 2.2 0.3 0.6 0.7 4.3 0.0 0.3 9.4 1.9 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 5.1 0.0 21.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 41.4 23.6 28.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 21.3 26.9 42.0 13.2 34.0 27.2 17.7 65.4 3.3 0.0 0.0 0.0 0.1 0.2 51.8 0.4 0.0 0.0 0.0 0.0 21.6 0.2 0.0 0.1 34.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.4 42.9 7.5 0.0 0.0 14.9 0.3 0.0 0.0 0.0 0.0 7.6 0.7 0.0 0.4 0.0 32.4 0.0 0.0 4.3 3.8 0.4 0.1 0.0 0.0 0.6 ING1 "p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a" ENSG00000153487 "Inhibitor of growth family member 1" Q9UK53 13 110712736-110723339 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 141.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016136, CAB017773, HPA052591" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016136: AB_628077, CAB017773: , HPA052591: AB_2681876" "unprognostic (1.14e-2)" "unprognostic (3.25e-2)" "unprognostic (3.51e-2)" "prognostic favorable (5.81e-4)" "unprognostic (4.62e-2)" "unprognostic (3.47e-2)" "unprognostic (3.36e-1)" "unprognostic (1.87e-1)" "unprognostic (9.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.36e-3)" "unprognostic (1.35e-1)" "unprognostic (7.05e-3)" "unprognostic (6.78e-2)" "unprognostic (2.40e-3)" 11.8 11.1 8.9 11.7 10.2 24.9 19.8 12.8 12.1 15.7 14.9 6.9 9.5 13.9 16.3 8.3 10.7 13.7 20.0 9.5 9.4 9.0 9.3 16.7 14.1 20.5 11.6 8.0 25.8 11.8 3.8 9.5 13.3 11.7 13.3 6.6 9.5 13.6 10.9 12.2 8.5 13.6 11.1 10.2 17.6 10.0 26.0 12.0 22.0 11.5 8.3 10.6 18.3 14.8 15.5 3.0 21.4 3.7 12.3 11.6 6.1 17.6 7.0 12.7 12.1 6.0 4.1 12.7 9.1 7.7 5.9 7.2 13.3 12.6 11.4 14.9 3.6 9.2 11.2 5.1 4.5 5.0 21.3 9.7 10.0 9.7 9.9 3.4 13.2 9.7 3.7 4.7 5.1 3.1 4.7 4.1 12.4 9.3 9.6 3.8 10.1 22.8 15.3 12.4 11.0 5.9 16.6 6.4 6.4 5.1 9.1 12.5 13.5 9.0 18.1 12.5 4.6 6.1 15.7 6.2 7.3 9.0 7.6 10.2 11.6 11.7 14.5 12.2 10.9 11.9 21.4 2.9 11.1 10.8 3.6 11.1 14.8 9.1 9.7 2.8 15.5 9.4 7.8 4.0 12.3 3.7 3.0 11.6 6.1 8.9 10.2 12.8 12.1 9.4 9.0 11.6 8.0 11.7 12.0 8.9 22.6 17.6 10.5 32.3 15.2 21.4 10.2 21.4 6.8 7.0 13.7 11.0 6.6 9.1 141.8 18.0 28.4 0.0 6.0 70.2 33.8 19.5 2.3 22.9 14.7 3.2 12.0 9.8 17.1 32.8 8.6 12.7 16.9 6.4 20.1 14.5 6.8 19.3 13.8 11.1 20.2 12.9 25.0 17.0 16.6 38.1 12.8 13.1 18.4 17.1 INO80 "hINO80, Ino80, INO80A, INOC1, KIAA1259" ENSG00000128908 "INO80 complex subunit" Q9ULG1 15 40978880-41116354 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Actin-binding, DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041484, HPA048601" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA041484: AB_2677506, HPA048601: " "unprognostic (5.39e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (3.92e-2)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.93e-1)" "unprognostic (6.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.69e-2)" "prognostic favorable (6.30e-4)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.72e-2)" "unprognostic (1.47e-2)" 14.0 10.6 11.8 13.9 13.4 20.7 13.9 29.5 13.0 12.3 13.2 17.4 11.5 11.3 14.9 13.4 15.1 12.6 12.4 10.6 12.8 7.8 12.1 12.9 14.8 13.4 10.2 10.3 15.4 17.8 18.8 13.3 16.4 12.1 12.5 13.9 13.8 11.9 15.7 23.0 16.4 13.2 13.3 9.5 14.5 12.3 13.9 11.6 18.1 13.3 12.6 15.8 13.9 13.3 5.2 2.3 0.9 2.7 5.7 3.4 1.5 9.2 9.2 8.0 7.8 12.6 10.6 9.3 8.6 14.1 13.1 11.4 11.2 7.8 9.9 7.0 13.1 16.3 18.2 14.7 15.0 13.9 11.4 7.5 12.3 12.7 8.4 12.1 12.1 12.1 10.5 13.9 10.5 27.9 8.7 12.5 10.8 13.7 8.5 8.7 7.7 8.8 8.0 8.4 15.8 10.1 13.6 8.5 7.9 9.9 19.4 10.6 7.3 6.3 13.9 5.8 8.3 7.8 14.7 14.3 10.4 9.5 13.2 13.8 9.4 6.4 16.2 12.2 18.0 8.6 0.9 2.7 0.6 2.7 1.7 3.3 3.2 3.4 3.0 2.3 5.2 3.4 3.2 0.9 5.7 1.2 1.8 2.6 1.5 11.8 13.4 29.5 13.0 12.8 7.8 10.2 10.3 12.1 11.6 8.9 25.5 24.6 15.0 7.6 28.4 14.9 12.7 24.1 23.9 15.7 21.6 11.1 6.6 14.7 1.7 13.7 9.7 0.0 11.5 9.4 10.4 13.3 15.1 8.7 8.7 25.4 12.6 11.6 14.9 1.2 13.6 9.5 6.8 18.0 9.2 11.8 12.4 11.0 14.9 9.4 28.8 6.5 11.3 18.4 22.0 11.2 16.0 12.1 11.9 12.8 INPP1 ENSG00000151689 "Inositol polyphosphate-1-phosphatase" P49441 2 190343470-190371665 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 658.4;Late spermatids: 591.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 36.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 36.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036698, HPA036699" Supported Approved "Centriolar satellite,Cytosol" NA NA 15000 "Centriolar satellite" Cytosol "HPA036698: AB_10672226, HPA036699: AB_2675260" "unprognostic (1.08e-3)" "unprognostic (4.50e-3)" "unprognostic (3.87e-2)" "unprognostic (2.70e-1)" "unprognostic (7.85e-2)" "unprognostic (3.67e-3)" "unprognostic (4.44e-2)" "unprognostic (1.17e-1)" "unprognostic (1.75e-1)" "unprognostic (2.96e-2)" "unprognostic (7.28e-2)" "unprognostic (2.41e-1)" "unprognostic (2.54e-1)" "unprognostic (3.74e-1)" "unprognostic (1.55e-1)" "prognostic favorable (1.12e-5)" "prognostic favorable (5.70e-4)" 14.9 25.8 18.3 9.1 26.5 10.3 32.5 17.4 25.1 15.0 19.8 20.4 11.5 27.4 12.0 10.8 42.7 9.8 20.6 17.7 21.2 17.9 11.0 24.8 19.9 8.8 21.0 16.5 10.0 25.6 32.3 17.0 10.4 18.6 10.0 16.8 12.0 9.9 16.0 13.1 28.3 28.0 15.5 23.6 15.7 13.9 31.4 17.1 4.6 12.9 14.0 15.4 19.2 18.8 1.8 3.5 36.6 3.4 6.2 8.0 1.9 10.9 3.1 6.0 0.0 6.5 14.1 0.1 13.2 17.6 12.4 16.3 11.9 7.0 0.0 15.8 12.6 4.0 15.2 2.4 8.5 15.2 13.5 4.6 8.2 9.7 7.1 13.8 6.1 2.6 9.6 13.1 14.1 8.2 8.9 23.1 0.1 19.6 6.9 21.8 0.0 0.4 5.8 1.8 17.5 17.0 0.2 4.9 0.1 9.6 26.1 8.9 3.3 9.1 0.5 12.8 6.5 0.0 8.8 21.3 7.9 5.6 14.2 7.6 1.3 1.4 0.1 2.5 2.4 6.3 8.1 3.4 36.6 3.0 3.1 2.7 1.4 1.9 2.0 3.5 1.8 1.0 1.5 1.6 6.2 1.8 0.1 8.0 1.9 18.3 26.5 17.4 25.1 21.2 17.9 21.0 16.5 18.6 17.1 3.0 5.6 13.4 129.9 76.7 14.5 19.3 28.1 8.1 20.5 10.4 5.9 5.3 6.6 24.1 658.4 50.2 44.8 0.0 75.1 2.7 22.1 67.5 8.1 17.8 8.6 15.9 29.9 60.2 6.9 591.7 24.7 15.4 25.3 5.4 20.3 68.5 42.2 20.4 22.3 14.6 11.6 25.8 20.2 15.3 7.6 85.1 3.3 17.0 22.6 190.1 INPP5A 5PTASE ENSG00000068383 "Inositol polyphosphate-5-phosphatase A" Q14642 10 132537820-132783480 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 8.4" "Lineage enriched" "Detected in single" 21 "granulocytes: 8.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012285 Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA012285: AB_1851802" "prognostic unfavorable (7.47e-4)" "unprognostic (2.38e-1)" "unprognostic (2.54e-1)" "unprognostic (1.68e-3)" "unprognostic (1.43e-1)" "unprognostic (3.25e-2)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (5.65e-2)" "unprognostic (4.35e-1)" "unprognostic (4.70e-2)" "unprognostic (1.70e-2)" "prognostic favorable (3.15e-4)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (8.91e-3)" "unprognostic (8.66e-2)" 13.6 11.8 10.3 11.3 49.8 5.8 10.3 40.7 20.8 17.4 24.0 10.1 11.5 12.9 25.8 13.9 20.3 15.2 13.6 48.8 9.5 8.5 9.4 7.2 13.8 6.0 9.2 10.4 13.1 11.6 8.9 9.4 19.0 9.1 17.1 11.7 17.1 8.5 16.9 43.7 11.5 14.8 27.9 10.6 8.9 14.8 14.9 16.6 4.2 9.5 12.1 7.8 19.4 22.4 0.3 0.1 8.4 0.2 0.0 0.3 0.6 18.7 7.5 12.6 12.1 19.3 13.6 10.3 19.9 15.3 13.0 8.7 17.7 7.7 1.7 7.7 21.1 8.5 10.7 13.6 8.3 15.7 5.7 7.9 2.7 9.4 24.0 14.0 6.8 6.6 9.2 8.3 8.3 15.9 10.5 9.0 3.6 3.9 10.1 6.9 15.2 1.9 21.9 5.7 11.3 13.4 4.0 8.3 3.0 10.8 10.7 3.0 10.3 9.9 14.7 12.0 12.0 9.5 16.5 7.5 8.4 9.7 11.2 11.6 2.0 9.3 5.8 8.1 4.7 3.6 8.4 0.2 1.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.0 1.5 0.0 0.2 0.0 0.3 0.6 10.3 49.8 40.7 20.8 9.5 8.5 9.2 10.4 9.1 16.6 8.9 22.4 1.4 3.6 4.7 10.7 9.0 5.1 2.7 9.1 7.0 0.0 3.3 0.0 5.7 9.4 6.4 18.4 0.0 7.9 3.3 6.2 6.4 8.1 16.0 2.6 7.9 5.8 19.0 6.3 11.2 6.6 3.1 1.7 0.0 9.3 7.8 9.9 11.5 11.0 3.8 4.9 6.5 20.0 5.5 6.6 5.1 2.1 1.9 10.9 5.0 INPP5B ENSG00000204084 "Inositol polyphosphate-5-phosphatase B" P32019 1 37860697-37947057 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028803 Approved Supported Cytosol NA NA Cytosol "HPA028803: AB_10612121" "unprognostic (2.28e-2)" "unprognostic (8.91e-3)" "unprognostic (7.67e-2)" "unprognostic (2.27e-1)" "unprognostic (4.30e-2)" "prognostic favorable (1.11e-4)" "unprognostic (1.67e-2)" "unprognostic (1.52e-2)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "prognostic favorable (5.33e-4)" "unprognostic (8.27e-2)" "prognostic unfavorable (6.11e-5)" "unprognostic (1.03e-1)" "unprognostic (2.00e-1)" "unprognostic (2.51e-1)" "unprognostic (1.28e-1)" 14.5 10.2 11.7 15.9 18.2 22.3 12.8 25.4 16.1 15.3 18.3 21.0 9.4 9.3 19.5 13.7 9.9 15.0 13.7 14.3 12.2 9.0 11.7 16.2 18.7 21.1 23.2 11.4 28.7 11.4 13.1 14.4 14.3 15.9 12.0 13.7 18.9 9.4 16.0 9.7 12.0 13.9 17.5 18.5 19.0 14.7 8.6 21.8 17.4 13.8 4.7 22.3 17.4 13.2 6.7 5.3 19.1 4.7 5.3 9.1 3.8 3.7 2.8 6.7 10.7 8.4 10.8 11.8 4.7 8.3 6.0 8.6 4.4 5.7 14.0 2.2 8.6 3.0 5.2 8.8 3.4 7.8 9.0 3.8 21.3 9.2 2.9 12.2 11.3 31.1 12.6 2.1 6.2 4.0 6.2 7.1 9.4 7.3 18.3 8.1 3.2 9.1 12.0 9.4 5.7 2.2 11.1 13.2 6.6 3.5 3.5 2.6 4.5 5.0 2.4 12.2 9.9 3.0 10.0 7.1 6.0 5.6 5.6 4.3 14.9 7.2 11.3 7.1 10.6 5.1 19.1 2.5 13.2 6.3 2.0 9.1 6.5 4.5 6.1 5.3 6.7 5.8 5.3 3.4 5.3 4.7 4.8 5.6 3.8 11.7 18.2 25.4 16.1 12.2 9.0 23.2 11.4 15.9 21.8 26.8 22.9 10.2 5.0 1.9 15.6 2.4 0.0 5.3 9.1 1.8 23.6 3.4 0.0 1.9 8.1 4.3 3.1 0.0 3.7 12.1 4.3 3.5 8.1 6.4 4.3 22.3 3.4 6.2 6.5 12.4 7.8 6.7 6.8 10.0 4.1 4.5 2.4 3.7 8.5 2.2 20.1 6.5 5.3 4.1 7.5 2.9 3.9 10.7 4.3 3.4 INPP5D "hp51CN, SHIP, SHIP1" ENSG00000168918 "Inositol polyphosphate-5-phosphatase D" Q92835 2 233059967-233207903 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 9 "B-cells: 58.1;Kupffer cells: 48.3;T-cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 15.4;HEL: 31.9;HMC-1: 33.5;hTCEpi: 30.7;NB-4: 29.9;THP-1: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016300, HPA070455" Enhanced Approved Cytosol No No Cytosol "CAB016300: AB_628250, HPA070455: AB_2686267" "unprognostic (5.29e-2)" "unprognostic (2.05e-3)" "unprognostic (1.99e-2)" "unprognostic (6.71e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "unprognostic (2.29e-2)" "unprognostic (3.74e-1)" "unprognostic (2.56e-1)" "unprognostic (1.23e-1)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (6.54e-2)" 7.1 3.1 7.2 33.0 10.7 24.6 4.7 1.7 6.9 3.6 3.7 12.5 0.7 3.5 4.1 2.9 3.3 3.3 6.7 3.2 6.6 9.1 5.1 3.3 8.0 26.1 8.8 2.6 1.9 2.1 1.6 3.4 7.4 7.6 4.5 4.5 3.3 18.8 3.0 1.9 3.4 15.8 3.4 17.6 40.9 4.1 2.4 9.5 16.7 3.1 3.4 32.3 6.2 3.5 14.5 12.0 10.5 18.2 11.9 16.7 14.0 0.0 0.0 0.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.4 6.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 5.1 0.0 31.9 0.0 3.0 0.2 9.6 33.5 0.6 30.7 0.1 3.4 0.1 4.4 0.9 0.1 2.8 0.1 0.0 4.4 29.9 1.0 0.0 0.0 9.3 0.0 2.2 0.0 1.8 0.0 0.0 0.0 0.6 0.0 4.1 0.0 21.4 3.6 0.0 0.5 0.0 0.0 0.0 1.7 9.2 0.0 12.4 0.0 9.8 9.8 10.5 16.7 15.8 11.4 14.5 7.5 12.3 12.0 13.9 6.3 8.8 9.9 11.9 18.2 6.0 10.2 14.0 7.2 10.7 1.7 6.9 6.6 9.1 8.8 2.6 7.6 9.5 3.0 25.7 58.1 1.2 1.4 0.1 3.2 2.5 4.0 4.5 3.5 0.0 0.4 0.0 0.3 12.8 17.5 0.0 0.0 0.4 0.6 1.0 0.4 14.0 1.3 24.6 0.0 0.0 13.5 48.3 10.6 0.0 20.7 0.0 13.6 0.2 0.0 0.2 0.9 1.1 0.3 0.0 0.0 1.2 0.4 0.7 1.0 0.9 51.0 0.4 1.0 INPP5J "INPP5, PIB5PA, PIPP" ENSG00000185133 "Inositol polyphosphate-5-phosphatase J" Q15735 22 31122731-31134696 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 65.2;thyroid gland: 71.2" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 33.2;Enterocytes: 31.9;Muller glia cells: 20.3" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 63.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.4" "Cell line enhanced" "Detected in many" "HL-60: 12.3;SK-BR-3: 26.8;T-47d: 16.9;U-698: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034539 Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA034539: AB_10670974" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-2)" "unprognostic (2.21e-3)" "prognostic favorable (1.47e-5)" "unprognostic (6.81e-2)" "unprognostic (1.86e-2)" "unprognostic (4.29e-4)" "unprognostic (1.47e-1)" "prognostic favorable (1.12e-7)" "unprognostic (2.79e-3)" "unprognostic (3.65e-2)" "unprognostic (2.14e-1)" "unprognostic (1.39e-2)" 0.8 0.9 4.6 0.8 6.3 0.5 3.7 27.4 13.4 1.5 6.4 0.8 16.7 7.9 1.3 0.8 1.0 1.0 1.0 9.5 7.4 2.0 9.5 0.5 1.5 0.7 2.3 4.6 0.8 5.3 65.2 3.7 0.5 5.5 3.5 2.2 5.6 15.5 19.2 1.6 1.7 21.7 1.2 0.9 0.6 3.8 1.6 1.1 0.0 71.2 0.0 0.7 1.1 0.9 0.3 2.4 0.0 0.4 0.0 0.0 0.2 1.3 1.3 0.8 1.5 0.2 0.2 0.7 0.5 0.5 2.7 2.6 0.8 0.8 0.0 0.6 0.2 0.3 1.6 1.6 0.7 1.1 0.0 4.3 0.0 5.6 0.2 0.5 12.3 0.1 0.1 0.8 2.2 0.2 1.8 0.1 0.0 1.1 1.9 0.0 4.1 0.1 0.0 1.5 1.7 0.2 0.0 0.3 2.9 1.1 1.6 6.5 4.9 1.0 26.8 0.3 0.7 16.9 1.0 0.0 0.1 4.9 0.5 0.3 0.0 2.1 11.6 0.4 0.0 2.0 0.0 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.2 4.6 6.3 27.4 13.4 7.4 2.0 2.3 4.6 5.5 1.1 0.0 2.6 0.0 2.3 0.8 7.9 4.8 0.0 0.0 1.2 33.2 0.0 0.0 10.0 1.2 0.3 0.0 31.9 0.0 1.9 0.1 0.2 3.7 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 5.0 20.3 1.0 10.5 0.0 0.6 2.3 0.0 0.3 1.7 0.9 1.1 0.1 0.0 6.8 0.9 INPPL1 SHIP2 ENSG00000165458 "Inositol polyphosphate phosphatase like 1" O15357 11 72223701-72239105 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Immunity" "Actin-binding, Hydrolase" "Cancer-related genes, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037601 Approved Supported "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA037601: AB_10672281" "unprognostic (2.68e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.68e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (2.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.51e-2)" "unprognostic (1.64e-1)" "unprognostic (4.34e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (1.99e-3)" "unprognostic (2.07e-1)" 20.9 23.7 22.2 20.4 19.5 25.1 18.6 11.1 18.9 25.2 32.0 22.7 28.8 19.8 24.7 18.4 17.4 24.3 29.6 29.5 24.1 10.3 23.9 17.1 24.9 19.0 27.6 10.4 30.1 22.7 21.6 26.9 31.9 20.4 28.7 13.5 30.7 27.5 24.2 60.0 17.7 23.0 34.7 27.5 28.3 24.5 11.8 24.3 16.0 29.1 19.3 18.3 25.0 18.1 2.6 5.2 7.0 7.6 4.2 4.5 3.3 6.5 14.0 16.8 11.4 8.3 9.9 30.0 30.2 14.1 18.9 12.1 19.1 16.5 18.6 30.8 23.0 13.5 24.9 13.8 8.5 6.5 24.1 14.3 19.3 70.9 7.0 16.3 12.7 43.3 14.0 9.0 18.3 7.3 23.5 10.1 6.9 13.6 8.0 10.3 17.6 9.4 51.6 17.2 4.6 21.9 44.5 38.2 4.1 22.0 11.0 8.2 11.9 32.4 19.6 42.1 8.9 20.7 24.2 17.2 20.3 23.8 31.1 9.8 23.2 3.8 18.2 5.7 12.1 11.0 5.2 7.6 7.0 4.5 4.4 3.7 2.2 3.7 3.0 5.2 2.6 2.7 3.7 5.2 4.2 7.0 3.9 3.3 3.3 22.2 19.5 11.1 18.9 24.1 10.3 27.6 10.4 20.4 24.3 3.0 13.8 2.4 4.6 6.4 1.2 11.2 5.1 5.3 10.3 12.2 25.5 20.7 1.7 10.7 1.1 6.3 16.0 0.0 10.6 12.5 9.8 6.8 7.0 8.6 18.9 9.5 21.8 10.4 26.9 1.5 9.2 18.1 10.1 3.6 15.4 14.3 13.4 17.5 13.1 12.5 17.2 6.5 9.2 1.2 4.1 4.3 27.1 6.7 17.5 5.2 INTS10 "C8orf35, FLJ10569, INT10" ENSG00000104613 "Integrator complex subunit 10" Q9NVR2 8 19817140-19852083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039129, HPA050570" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA039129: AB_10794424, HPA050570: AB_2681180" "unprognostic (9.11e-2)" "unprognostic (8.41e-3)" "prognostic favorable (4.00e-4)" "prognostic favorable (1.22e-4)" "unprognostic (4.54e-2)" "unprognostic (9.79e-3)" "unprognostic (1.15e-1)" "unprognostic (1.14e-3)" "unprognostic (3.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-2)" "unprognostic (2.62e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (1.33e-1)" 21.9 20.9 31.4 18.9 30.2 22.8 23.5 38.5 28.4 23.7 23.2 23.2 19.9 21.3 18.8 17.4 21.8 31.4 17.0 20.9 31.1 27.1 25.0 42.7 19.2 21.9 28.3 18.4 21.6 39.1 18.1 25.5 18.0 21.2 24.5 22.2 17.3 23.2 26.0 20.7 25.7 19.5 22.0 28.7 21.4 19.4 12.0 24.3 26.9 34.9 21.1 25.0 20.8 23.7 17.8 20.0 8.8 15.0 16.9 21.2 12.6 15.0 22.0 12.1 15.8 18.2 20.4 16.6 11.0 18.7 15.4 14.7 12.2 7.6 42.4 19.4 12.0 16.7 16.2 14.3 14.1 17.3 8.4 16.1 19.6 24.6 23.7 13.5 16.9 13.6 16.2 22.3 11.5 17.9 9.6 14.7 24.5 23.6 34.1 10.4 13.1 30.5 20.2 17.2 33.5 12.0 16.5 14.6 27.5 19.1 23.4 12.4 9.8 15.5 19.4 13.6 11.7 10.1 17.3 12.0 9.8 14.1 23.0 15.3 9.6 12.2 32.1 20.0 23.9 16.1 6.6 15.0 8.8 13.9 13.8 21.2 17.8 17.8 17.5 20.0 15.1 19.9 17.6 5.4 16.9 11.5 17.0 19.9 12.6 31.4 30.2 38.5 28.4 31.1 27.1 28.3 18.4 21.2 24.3 14.9 45.6 29.2 34.7 33.4 56.9 17.3 35.7 92.3 43.3 19.2 49.1 29.7 29.9 37.3 45.1 29.2 27.1 0.0 34.7 39.2 34.7 41.9 34.6 51.9 36.5 66.7 19.5 28.8 32.4 20.0 32.2 27.8 16.9 22.6 31.4 31.4 30.6 24.6 32.9 30.0 84.8 12.9 31.5 8.1 27.2 39.4 18.7 35.8 39.8 27.6 INTS11 "CPSF3L, CPSF73L, FLJ20542, INT11, RC-68" ENSG00000127054 "Integrator complex subunit 11" Q5TA45 1 1311585-1324691 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 66.8;Extravillous trophoblasts: 54.3;monocytes: 63.1;Syncytiotrophoblasts: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028379, HPA029025" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA028379: AB_10599598, HPA029025: AB_10600425" "unprognostic (7.54e-2)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (2.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.97e-1)" "unprognostic (1.71e-1)" "unprognostic (2.75e-2)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.27e-1)" "unprognostic (2.76e-3)" "unprognostic (5.14e-2)" "unprognostic (5.62e-3)" 21.4 22.5 22.8 25.4 24.9 23.2 26.9 50.8 30.4 26.5 31.2 32.1 24.1 29.1 33.1 39.8 25.3 39.1 24.8 29.8 23.7 19.8 23.5 26.7 19.7 25.7 25.9 25.8 34.1 33.5 24.1 26.9 25.8 21.0 29.5 19.9 20.4 33.8 28.0 52.8 28.6 25.4 34.0 20.0 27.3 27.9 57.8 25.9 28.5 23.3 23.5 22.5 27.5 25.7 24.6 37.7 22.0 42.2 28.4 35.2 32.4 21.3 22.1 12.5 23.9 21.5 17.5 13.5 11.8 19.8 27.4 20.3 19.9 27.1 24.0 17.1 24.0 16.6 15.7 18.5 26.4 12.2 22.4 24.2 18.4 30.1 26.7 33.1 14.5 20.3 29.5 14.4 25.0 37.6 15.7 28.7 23.6 21.8 21.8 13.5 19.3 28.7 19.8 15.2 20.6 23.8 22.6 11.8 34.4 19.2 10.9 17.6 16.3 11.9 32.2 33.5 10.1 17.3 21.3 20.5 17.1 15.5 19.4 15.0 34.2 36.6 31.1 23.9 25.9 8.4 22.0 32.3 20.8 31.7 37.2 33.8 24.6 28.1 29.3 37.7 20.3 26.5 24.9 15.3 28.4 42.2 24.5 35.2 32.4 22.8 24.9 50.8 30.4 23.7 19.8 25.9 25.8 21.0 25.9 35.7 28.9 0.0 0.0 0.0 0.0 0.0 0.0 26.8 23.9 17.4 0.0 66.8 26.6 47.9 0.0 0.0 0.0 0.0 46.7 54.3 0.0 0.0 9.3 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 63.1 0.0 0.0 47.3 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 64.4 0.0 0.0 0.0 INTS12 "INT12, PHF22, SBBI22" ENSG00000138785 "Integrator complex subunit 12" Q96CB8 4 105682627-105895986 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035772, HPA041814" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies, Plasma membrane" "HPA035772: AB_10671109, HPA041814: AB_2677687" "unprognostic (5.30e-2)" "unprognostic (4.54e-2)" "unprognostic (1.84e-3)" "unprognostic (1.78e-1)" "unprognostic (3.68e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (2.67e-4)" "unprognostic (3.95e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-3)" "unprognostic (3.00e-2)" "unprognostic (3.48e-2)" "unprognostic (5.93e-3)" "unprognostic (3.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-1)" 16.7 13.5 18.7 12.5 20.7 25.3 20.0 17.3 18.1 14.5 17.0 13.4 11.6 17.0 16.1 17.9 13.6 14.4 12.3 19.3 18.3 15.3 18.2 21.4 15.4 12.1 16.5 11.5 15.0 16.0 17.3 20.7 11.2 17.4 18.1 15.4 10.4 14.8 13.7 28.2 14.1 21.0 16.6 19.3 15.9 14.9 12.6 13.8 22.1 31.1 15.9 15.4 13.8 12.6 20.6 27.6 33.3 17.0 27.1 21.9 14.0 12.7 6.8 15.7 16.2 15.5 18.5 11.4 15.2 15.8 19.2 20.0 9.6 14.6 18.5 8.5 17.1 14.9 7.5 17.2 21.9 23.8 19.3 10.4 13.9 11.1 13.5 25.0 24.4 12.7 17.4 28.5 19.0 28.6 12.5 17.6 15.7 20.6 14.5 20.5 13.5 28.6 15.2 6.8 18.7 10.5 14.7 17.1 14.1 17.8 8.7 17.0 13.6 10.7 17.8 16.7 12.9 14.4 14.4 11.4 12.6 13.0 13.6 16.2 22.5 20.8 27.5 14.0 16.7 24.9 33.3 15.9 24.1 17.9 16.8 20.0 20.6 20.6 20.2 18.0 19.3 21.6 20.2 12.1 27.1 17.0 27.6 21.9 14.0 18.7 20.7 17.3 18.1 18.3 15.3 16.5 11.5 17.4 13.8 11.9 7.3 22.4 10.3 9.7 9.6 17.3 17.8 5.3 5.7 3.5 9.8 14.1 36.5 19.4 33.3 13.5 8.0 0.0 17.7 15.1 9.7 14.5 24.3 8.9 15.5 9.5 5.8 12.9 6.7 20.9 11.2 9.1 6.8 19.0 5.5 11.2 16.6 8.2 7.8 12.9 9.0 0.0 10.3 13.0 12.6 9.2 15.3 10.7 8.3 10.0 INTS5 "INT5, KIAA1698" ENSG00000185085 "Integrator complex subunit 5" Q6P9B9 11 62646848-62653302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046181, HPA056915" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046181: , HPA056915: AB_2683276" "unprognostic (2.87e-1)" "unprognostic (9.51e-2)" "unprognostic (9.11e-2)" "unprognostic (9.70e-2)" "unprognostic (2.71e-1)" "unprognostic (6.41e-2)" "unprognostic (1.97e-2)" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.33e-1)" "unprognostic (5.09e-2)" "prognostic favorable (8.44e-5)" "unprognostic (7.08e-3)" "unprognostic (2.97e-2)" "unprognostic (3.36e-1)" "unprognostic (1.35e-2)" 13.8 13.2 9.1 14.0 8.9 6.5 17.2 9.7 16.5 12.8 11.0 7.0 14.3 10.9 16.0 10.6 16.0 19.1 14.0 14.3 7.4 6.7 12.0 19.9 11.6 22.3 7.8 7.6 15.4 21.3 17.4 9.5 12.1 6.9 12.4 8.5 11.0 16.0 17.4 17.3 15.7 11.2 11.9 5.5 14.8 12.4 9.4 6.6 26.0 16.4 10.8 12.8 12.6 15.7 7.6 7.2 5.1 6.2 10.1 14.3 7.0 11.3 14.0 8.3 7.7 16.4 12.0 7.7 9.4 9.7 12.8 9.2 9.9 12.7 21.7 17.1 11.9 10.6 17.8 16.6 21.9 6.2 13.5 11.5 11.2 11.2 6.6 14.8 12.3 10.8 13.8 17.2 13.6 11.7 9.7 12.6 9.7 17.1 12.8 10.9 23.3 14.0 14.4 12.6 13.5 17.8 14.5 11.2 26.0 9.8 7.5 11.2 9.4 10.6 14.9 14.6 6.1 21.1 8.5 10.4 12.2 9.5 18.7 8.4 18.1 13.8 15.6 14.1 9.3 11.5 5.1 6.2 4.8 8.7 4.6 14.3 5.8 8.2 7.7 7.1 7.6 9.6 8.7 2.6 10.1 5.1 7.2 6.1 7.0 9.1 8.9 9.7 16.5 7.4 6.7 7.8 7.6 6.9 6.6 3.0 5.6 8.0 6.1 1.9 7.0 2.2 5.1 8.1 6.8 3.5 0.0 11.4 10.0 10.5 4.9 4.5 4.9 0.0 9.1 9.3 3.8 5.2 9.2 10.4 7.6 9.5 6.4 8.6 5.1 6.0 6.1 3.3 0.0 13.6 7.3 10.3 9.3 0.0 7.4 7.5 3.6 12.9 4.9 5.2 13.4 3.6 16.6 5.7 6.8 4.7 INTU "KIAA1284, PDZD6, PDZK6" ENSG00000164066 "Inturned planar cell polarity protein" Q9ULD6 4 127623271-127726737 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 112.4;Cone photoreceptor cells: 129.6;Rod photoreceptor cells: 185.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036714, HPA036715, HPA061467" Approved Uncertain Cytosol NA NA Cytosol "HPA036714: AB_10670238, HPA036715: AB_2675267, HPA061467: " "unprognostic (1.09e-1)" "unprognostic (2.89e-1)" "unprognostic (4.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-1)" "unprognostic (2.88e-3)" "unprognostic (4.30e-2)" "unprognostic (2.91e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (1.22e-1)" "unprognostic (9.49e-2)" "unprognostic (3.28e-1)" "unprognostic (2.36e-1)" "unprognostic (5.33e-2)" 4.4 4.8 8.3 3.7 23.0 7.3 8.1 5.6 12.6 7.7 4.0 11.9 5.6 5.9 10.2 14.6 4.0 8.1 4.7 3.2 12.0 8.0 5.7 2.4 4.9 3.4 7.2 8.1 9.9 4.1 4.7 25.8 3.3 12.3 5.2 4.8 9.1 5.2 4.2 3.3 10.6 3.1 4.4 9.1 3.8 6.1 6.9 8.0 0.5 7.9 2.8 2.3 4.6 5.0 1.4 1.5 4.7 0.9 1.0 0.9 0.1 3.3 2.3 12.6 4.7 1.8 4.4 1.0 2.0 1.0 1.3 2.6 1.7 3.1 2.8 3.3 2.0 3.9 2.0 10.0 1.9 3.9 1.2 3.0 3.5 4.0 4.2 1.7 3.1 1.8 1.8 2.1 4.2 1.0 3.9 3.8 1.3 4.2 2.9 1.9 1.6 1.1 1.8 5.9 1.2 2.3 1.2 3.1 0.8 2.6 2.6 5.9 4.2 4.3 2.3 1.5 6.7 2.7 1.9 3.2 3.6 2.9 3.5 2.8 1.9 2.8 0.9 3.0 1.6 2.2 2.8 0.8 0.5 0.9 0.6 0.8 0.7 0.7 0.6 0.4 1.4 0.7 0.8 4.7 1.0 0.9 1.5 0.4 0.1 8.3 23.0 5.6 12.6 12.0 8.0 7.2 8.1 12.3 8.0 20.8 12.5 0.5 9.8 5.4 58.4 12.7 7.6 112.4 25.0 3.5 129.6 6.8 6.6 6.2 9.1 5.6 0.9 0.0 4.4 5.1 5.9 7.3 4.7 2.4 2.6 35.0 11.1 7.4 1.5 8.4 13.0 7.4 6.8 0.0 5.5 15.8 2.9 0.0 11.0 6.2 185.9 0.0 7.6 7.7 20.9 5.4 1.6 2.2 6.3 6.2 INVS NPHP2 ENSG00000119509 Inversin Q9Y283 9 100099256-100301000 "Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Calmodulin-binding, Developmental protein" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 20.2;Late spermatids: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049994 Approved Cytosol NA NA Cytosol "HPA049994: " "unprognostic (3.84e-3)" "unprognostic (3.11e-2)" "unprognostic (1.74e-1)" "unprognostic (2.86e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.53e-3)" "unprognostic (2.93e-3)" "unprognostic (1.99e-1)" "unprognostic (6.46e-2)" "unprognostic (1.15e-1)" "unprognostic (3.56e-2)" "unprognostic (1.34e-3)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (6.37e-2)" "unprognostic (1.83e-1)" 11.9 13.4 9.5 10.7 15.8 7.9 10.1 18.6 15.7 13.4 11.3 14.6 12.4 7.6 16.5 12.3 9.2 10.3 10.4 9.7 10.4 7.1 16.4 17.1 10.2 10.2 15.8 8.5 19.2 9.7 20.9 26.0 11.1 12.1 12.0 9.1 12.8 8.2 10.4 7.2 7.0 9.4 11.9 15.3 10.1 9.1 12.0 15.5 16.9 12.5 4.6 10.7 10.4 15.4 6.0 3.5 3.9 3.8 4.7 5.3 2.6 6.7 12.4 10.3 11.0 13.3 11.0 8.6 7.9 8.6 7.2 5.8 6.5 4.2 15.6 4.7 9.4 13.1 10.5 8.2 10.4 6.0 12.2 5.5 11.8 10.8 6.7 9.8 11.8 9.8 11.1 13.0 7.7 15.3 9.9 12.9 10.8 10.2 9.6 7.5 6.0 9.3 4.7 6.1 12.2 7.5 8.5 18.2 3.7 6.7 6.3 9.6 7.6 9.0 5.6 9.0 8.8 3.9 6.5 9.6 8.4 6.0 8.4 5.9 9.9 11.7 3.2 8.7 5.1 4.4 0.0 2.5 3.9 4.9 1.7 4.3 5.3 4.1 2.6 3.5 6.0 5.3 5.1 0.2 4.7 3.8 3.5 2.6 2.6 9.5 15.8 18.6 15.7 10.4 7.1 15.8 8.5 12.1 15.5 3.0 2.6 0.9 5.7 1.5 4.1 2.5 10.2 0.0 3.4 0.0 7.9 3.2 3.3 2.0 20.2 3.7 1.6 0.0 1.0 3.2 2.2 2.2 1.1 3.2 3.1 6.4 1.2 0.6 3.4 22.0 4.4 1.9 0.0 3.6 1.4 2.5 1.7 2.0 3.2 5.7 5.7 0.0 3.0 8.6 4.3 1.4 2.9 4.3 1.7 3.4 IP6K1 "IHPK1, KIAA0263" ENSG00000176095 "Inositol hexakisphosphate kinase 1" Q92551 3 49724294-49786542 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040825 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA040825: AB_10960426" "unprognostic (6.18e-2)" "unprognostic (1.33e-1)" "unprognostic (3.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.08e-4)" "unprognostic (9.97e-3)" "unprognostic (8.45e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "prognostic favorable (6.85e-4)" "unprognostic (1.29e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.75e-2)" "unprognostic (1.67e-1)" "unprognostic (9.24e-2)" "unprognostic (1.64e-2)" 14.2 17.5 23.5 12.9 26.9 12.1 15.8 38.6 40.4 17.7 16.1 20.7 16.1 13.6 21.4 14.5 19.6 20.0 14.7 13.7 23.8 23.5 16.3 15.9 16.9 16.3 17.9 18.3 30.2 21.9 30.3 16.7 18.3 21.2 14.3 13.2 18.6 18.3 21.1 9.0 18.2 12.7 19.5 16.9 16.9 13.7 27.3 14.8 22.3 17.1 8.4 14.4 16.3 15.6 6.8 4.1 24.0 4.8 6.9 9.7 6.0 12.3 15.0 17.6 20.6 18.4 14.2 14.2 16.5 17.4 27.1 23.8 19.5 12.9 10.8 10.7 18.2 18.4 9.2 24.8 14.9 15.4 21.7 19.8 24.4 23.0 13.1 20.4 14.9 17.1 16.5 18.6 29.2 17.7 15.3 22.6 12.6 16.0 12.7 13.3 11.0 18.1 15.6 18.9 9.8 25.0 11.5 12.5 21.6 17.5 18.9 9.5 19.0 21.0 13.7 18.9 10.6 11.0 22.0 20.2 15.2 15.3 20.8 19.1 15.5 20.8 11.5 13.9 17.3 15.5 2.5 4.8 8.2 8.7 3.9 8.8 4.6 8.0 9.6 4.1 6.8 9.7 9.5 24.0 6.9 4.8 2.9 8.2 6.0 23.5 26.9 38.6 40.4 23.8 23.5 17.9 18.3 21.2 14.8 23.8 10.5 11.8 13.7 13.9 37.4 8.9 15.3 17.4 10.3 12.2 84.4 15.7 5.0 12.1 69.3 16.6 12.9 23.3 11.3 13.2 13.6 16.1 19.6 10.6 10.8 28.6 26.5 17.8 11.8 11.8 19.5 10.7 18.6 14.4 12.2 22.0 16.3 8.6 15.6 10.3 70.3 19.4 11.5 17.9 22.6 16.4 23.0 23.5 11.0 13.3 IP6K3 "IHPK3, INSP6K3" ENSG00000161896 "Inositol hexakisphosphate kinase 3" Q96PC2 6 33721670-33746905 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.5;skeletal muscle: 87.9" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 10.9;Hepatocytes: 5.8;Horizontal cells: 9.5;Proximal tubular cells: 3.6;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 16.2;HSkMC: 5.8;LHCN-M2: 25.7;RH-30: 11.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA053644, HPA062531" Approved Approved Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA053644: AB_2682214, HPA062531: " "unprognostic (3.23e-2)" "unprognostic (2.87e-1)" "unprognostic (2.07e-5)" "unprognostic (1.07e-3)" "unprognostic (2.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "unprognostic (2.47e-2)" "unprognostic (1.24e-2)" "unprognostic (2.94e-3)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.63e-2)" "unprognostic (2.01e-1)" "unprognostic (2.66e-3)" "unprognostic (1.33e-1)" 2.2 1.0 2.1 0.8 13.0 0.5 0.9 0.6 6.2 1.2 2.2 11.8 1.4 0.8 1.6 1.4 5.2 1.3 0.6 10.0 3.2 1.3 4.7 7.7 2.0 0.6 22.5 1.1 0.6 0.7 0.5 0.5 3.8 7.7 2.8 1.0 1.2 1.4 1.8 87.9 0.5 1.1 1.8 9.2 1.4 0.9 0.6 15.2 0.0 9.9 8.1 0.5 1.5 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.1 0.2 0.2 1.9 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 16.2 0.0 0.0 5.8 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.4 4.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 13.0 0.6 6.2 3.2 1.3 22.5 1.1 7.7 15.2 0.0 0.0 0.0 0.0 0.0 2.2 10.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 5.8 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.1 6.5 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 IPO11 RanBP11 ENSG00000086200 "Importin 11" Q9UI26 5 62403972-62628582 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 35.3;Ito cells: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 51.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065346, HPA067097" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA065346: , HPA067097: AB_2685776" "unprognostic (9.29e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.35e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (4.28e-5)" "unprognostic (4.26e-2)" "unprognostic (6.45e-2)" "unprognostic (1.26e-3)" "unprognostic (9.63e-2)" "unprognostic (5.09e-2)" "unprognostic (8.38e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.24e-2)" 25.5 15.3 13.6 14.2 17.1 8.8 22.2 18.4 18.3 19.5 13.7 14.2 17.4 10.4 19.9 13.9 18.6 16.1 16.4 20.0 15.2 13.4 18.5 16.9 12.8 14.2 14.9 13.7 18.6 14.4 23.9 20.9 24.4 17.1 15.9 13.7 13.2 14.8 16.6 19.0 14.0 12.3 17.0 14.4 26.3 13.7 30.9 13.3 18.8 21.7 15.7 15.0 19.8 24.4 4.2 3.6 12.2 5.6 18.0 5.3 3.2 11.9 11.3 10.5 16.1 8.5 11.6 14.2 12.9 9.9 13.6 15.2 12.6 9.4 20.5 10.3 13.1 17.0 9.9 21.6 15.0 21.4 7.7 11.4 9.5 11.6 11.3 6.2 10.8 5.5 8.2 8.7 16.2 17.5 6.8 51.2 10.2 17.9 6.7 13.5 11.3 11.4 14.0 13.4 7.0 6.9 13.9 15.5 18.6 8.4 11.8 11.1 6.5 11.3 8.9 9.2 11.0 11.5 7.5 23.0 8.2 9.0 9.0 11.7 5.3 8.6 14.2 10.1 15.1 9.7 12.2 2.1 1.8 3.5 3.4 4.2 3.1 3.7 3.6 3.6 4.2 5.3 3.8 2.1 18.0 5.6 2.3 2.3 3.2 13.6 17.1 18.4 18.3 15.2 13.4 14.9 13.7 17.1 13.3 8.9 3.0 6.0 3.7 7.6 3.6 10.7 0.0 30.8 4.5 7.0 2.0 6.2 3.3 3.3 35.3 30.0 1.7 23.3 4.6 5.4 5.8 4.2 12.7 5.8 4.4 4.8 2.9 41.7 6.5 18.8 5.2 4.5 3.3 1.8 5.5 3.3 2.5 0.0 3.9 3.4 4.8 6.5 6.6 12.9 16.3 7.8 4.2 4.9 4.6 4.0 IPO4 "FLJ23338, Imp4" ENSG00000196497 "Importin 4" Q8TEX9 14 24180219-24188964 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.5" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 59.5;Late spermatids: 85.2;Spermatocytes: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039043, HPA064572" Uncertain Approved Cytosol NA NA Cytosol "HPA039043: AB_10673233, HPA064572: AB_2685291" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.00e-1)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (9.45e-2)" "unprognostic (2.60e-1)" "unprognostic (5.13e-2)" "unprognostic (6.75e-2)" "unprognostic (9.28e-2)" "prognostic unfavorable (3.20e-4)" "unprognostic (8.59e-4)" "unprognostic (5.45e-2)" "unprognostic (2.18e-1)" "unprognostic (2.15e-2)" 5.3 8.1 1.2 5.2 2.2 6.9 6.1 1.7 3.3 6.5 5.8 2.8 5.5 7.5 5.4 6.5 8.8 6.3 4.4 3.6 2.2 1.6 18.0 29.0 4.4 10.8 1.8 1.2 9.8 27.0 2.2 6.4 4.4 4.1 5.0 2.3 3.0 8.7 7.9 17.2 8.5 4.7 5.3 2.4 8.8 6.9 49.5 1.4 8.8 6.5 11.0 7.4 5.7 4.0 3.5 5.3 0.3 3.0 3.6 5.4 2.2 7.8 10.4 0.9 6.2 0.8 1.2 10.7 4.8 0.2 2.3 0.7 8.9 3.9 11.3 7.8 1.7 2.7 8.8 3.7 6.9 0.3 5.4 15.6 7.0 3.3 20.1 0.8 8.5 5.1 1.6 2.2 2.1 0.7 0.5 2.3 6.2 13.1 0.9 2.4 17.4 5.5 7.6 9.5 5.4 22.9 7.5 4.4 6.1 2.2 5.5 8.1 8.7 8.0 3.8 4.1 0.6 6.9 2.0 4.0 4.8 11.6 5.2 7.0 8.0 12.0 10.0 3.2 4.6 7.9 0.0 1.9 0.3 4.8 2.6 5.4 2.8 4.6 4.4 3.1 3.5 3.6 5.0 0.0 3.6 3.0 5.3 2.2 2.2 1.2 2.2 1.7 2.8 2.2 1.6 1.8 1.2 4.1 1.4 0.0 6.4 4.7 3.4 5.3 0.6 1.8 10.2 9.4 11.4 5.2 3.9 10.1 0.0 11.4 59.5 3.5 0.7 0.0 9.4 8.5 4.2 2.5 0.0 5.1 7.2 1.6 4.1 1.3 1.9 85.2 4.6 1.4 0.0 1.0 5.6 1.3 7.2 0.0 5.3 9.8 2.7 6.5 4.4 44.5 17.3 5.5 4.9 1.3 8.3 2.6 IPO5 "IMB3, KPNB3, MGC2068, Pse1, RANBP5" ENSG00000065150 "Importin 5" O00410 13 97953658-98024297 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 11 "Early spermatids: 1043.3;Late spermatids: 1438.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009110, HPA040983, HPA056548" Approved Supported Nucleoplasm,Cytosol NA NA 92000 "Nucleoplasm, Cytosol" "CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169" "unprognostic (5.20e-2)" "unprognostic (6.94e-2)" "unprognostic (9.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.96e-3)" "unprognostic (2.16e-3)" "unprognostic (2.19e-2)" "unprognostic (5.27e-3)" "unprognostic (6.19e-2)" "unprognostic (2.51e-1)" "unprognostic (1.45e-1)" "unprognostic (1.06e-1)" "unprognostic (9.64e-2)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.66e-1)" "unprognostic (2.73e-1)" 26.3 13.8 16.5 14.5 18.3 13.0 23.5 16.3 20.2 20.2 19.7 15.9 13.5 9.6 21.1 13.4 19.4 18.9 12.4 23.9 15.7 12.7 18.9 23.2 14.1 16.0 20.8 15.9 33.5 60.7 12.5 13.0 14.3 15.3 19.1 16.6 11.0 13.9 20.2 65.0 13.5 11.3 25.5 24.3 14.9 18.9 79.5 19.4 23.3 23.0 24.1 21.1 21.8 23.9 8.0 11.0 1.1 7.3 10.3 12.3 6.1 28.6 19.3 36.3 33.2 24.7 62.9 22.3 42.2 33.3 59.5 42.3 39.6 22.1 82.8 14.8 50.7 13.4 25.0 75.4 28.9 82.3 20.9 23.7 45.1 36.7 31.0 17.7 48.6 16.1 35.3 19.0 48.2 40.6 25.4 33.8 25.6 31.1 11.2 50.7 7.8 36.7 13.2 36.4 43.3 23.2 47.2 41.3 24.5 14.3 18.8 26.9 22.0 21.6 25.3 15.8 46.0 19.2 26.9 23.7 40.2 20.2 20.0 38.3 15.0 18.4 25.8 41.5 30.9 27.5 0.5 4.4 1.1 7.1 7.3 12.3 8.0 8.3 8.8 11.0 7.6 11.6 9.6 0.6 10.3 5.1 5.4 8.5 6.1 16.5 18.3 16.3 20.2 15.7 12.7 20.8 15.9 15.3 19.4 17.9 23.8 15.7 33.9 36.9 31.1 68.2 35.7 18.7 22.7 21.0 5.9 28.6 23.2 26.7 1043.3 35.1 7.8 0.0 36.0 38.4 34.0 35.8 13.9 40.9 21.3 60.4 33.9 28.3 24.1 1438.4 48.9 18.7 25.3 14.4 20.2 40.9 32.7 3.5 41.4 35.7 20.2 25.8 49.1 109.7 53.2 32.2 27.0 19.2 36.5 33.9 IPO7 "Imp7, RANBP7" ENSG00000205339 "Importin 7" O95373 11 9384622-9448126 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019002, HPA056590" Approved Approved Supported Nucleoplasm,Cytosol NA NA 26000 "Nucleoplasm, Cytosol" "HPA019002: AB_1856059, HPA056590: AB_2683180" "unprognostic (1.92e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (9.50e-2)" "unprognostic (1.27e-1)" "unprognostic (3.68e-1)" "unprognostic (1.60e-2)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.19e-2)" "unprognostic (7.60e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.38e-6)" "unprognostic (3.06e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.08e-2)" "unprognostic (2.17e-1)" "unprognostic (3.90e-3)" 23.9 20.6 21.8 18.6 24.4 12.3 36.0 24.1 30.6 24.3 27.4 14.4 19.3 17.0 25.7 19.3 29.0 20.3 20.3 37.7 22.8 23.4 26.5 24.7 22.0 23.2 23.3 17.4 23.4 25.9 33.1 19.1 26.5 24.8 24.4 22.1 12.0 21.4 22.4 88.2 17.1 16.1 53.4 25.7 16.6 21.5 9.7 16.8 20.8 34.3 28.5 20.9 43.7 33.9 3.8 5.8 1.3 6.3 6.9 5.4 1.6 37.7 29.5 34.8 27.6 35.3 45.6 27.9 46.0 29.6 34.0 36.8 25.5 34.8 35.4 16.8 35.3 30.9 29.7 49.3 35.7 56.9 16.8 40.7 29.3 33.5 25.6 22.1 44.7 22.3 29.1 38.7 22.4 52.7 34.8 40.1 12.2 43.9 21.3 44.3 15.3 26.9 21.9 34.2 35.0 34.3 28.4 54.8 16.0 28.1 35.7 13.8 27.2 20.5 40.7 33.1 28.9 18.7 22.5 31.5 41.9 28.9 43.1 49.1 6.2 23.6 24.5 27.5 24.2 22.7 0.1 2.5 0.6 2.7 4.8 5.4 3.8 3.1 3.9 5.8 3.1 3.9 3.2 1.3 6.9 6.3 2.7 2.8 1.6 21.8 24.4 24.1 30.6 22.8 23.4 23.3 17.4 24.8 16.8 62.5 53.8 24.3 76.2 128.0 37.1 127.5 30.6 49.5 67.1 33.2 55.0 44.9 28.2 32.5 3.3 40.5 18.6 0.0 35.7 54.7 55.8 105.1 35.9 39.4 31.6 33.4 29.9 25.2 47.7 3.6 25.9 41.8 37.1 26.2 36.8 30.1 37.3 28.8 33.6 35.8 38.8 12.9 55.6 15.4 22.6 129.4 30.7 22.3 45.0 129.0 IPO9 "FLJ10402, Imp9" ENSG00000198700 "Importin 9" Q96P70 1 201829141-201884294 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059540 Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 30000 Cytosol Vesicles "HPA059540: " "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (7.44e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (4.11e-5)" "unprognostic (8.92e-3)" "unprognostic (2.23e-3)" "unprognostic (2.52e-1)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (5.05e-2)" "unprognostic (2.57e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (5.78e-4)" 16.8 18.0 27.1 14.2 26.5 11.0 15.2 29.1 27.8 14.2 14.3 18.7 11.0 11.5 19.7 24.2 15.2 17.4 12.2 12.0 22.3 17.9 14.9 23.1 16.5 15.7 17.7 22.8 20.9 16.5 24.9 26.0 18.1 21.2 16.3 18.1 24.7 11.2 14.7 15.4 21.9 13.3 21.5 15.0 18.3 13.4 12.8 17.2 21.1 18.4 8.4 20.3 14.4 13.7 10.9 14.6 10.7 15.3 11.0 13.3 8.3 17.8 19.0 26.0 21.1 15.1 10.2 19.5 13.8 14.0 23.1 22.5 30.3 15.6 10.6 7.9 13.2 20.3 16.6 17.5 19.1 20.0 9.7 15.5 7.9 30.8 22.6 11.5 10.3 13.1 11.3 8.8 24.8 20.3 15.5 23.1 14.6 15.7 10.1 16.5 17.9 11.9 13.5 26.1 16.1 6.2 12.7 27.1 10.5 12.5 28.5 22.1 25.2 15.2 24.1 12.2 41.9 17.6 13.1 12.5 21.8 19.5 12.2 25.2 7.5 4.5 12.3 10.8 12.2 16.2 10.7 11.7 9.7 12.2 15.3 10.6 10.9 11.9 13.3 14.6 10.3 9.7 10.4 2.9 11.0 14.9 7.7 10.7 8.3 27.1 26.5 29.1 27.8 22.3 17.9 17.7 22.8 21.2 17.2 20.8 42.9 23.1 13.3 14.1 57.4 22.8 7.6 8.1 26.1 7.0 56.9 22.0 1.7 15.1 6.0 18.8 6.3 23.3 16.1 16.8 22.1 10.7 10.5 17.1 16.6 71.5 10.9 21.5 17.0 6.3 18.7 16.7 13.5 10.0 12.7 40.4 15.2 10.5 26.5 7.9 54.1 38.8 21.7 24.9 32.2 12.4 18.9 13.8 15.0 10.8 IPPK "C9orf12, FLJ13163, INSP5K2, IP5K, IPK1" ENSG00000127080 "Inositol-pentakisphosphate 2-kinase" Q9H8X2 9 92613184-92670265 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020603 Uncertain Approved Cytosol NA NA Cytosol "HPA020603: AB_1851853" "unprognostic (3.51e-2)" "unprognostic (4.66e-2)" "unprognostic (6.26e-2)" "unprognostic (1.26e-1)" "unprognostic (3.63e-2)" "unprognostic (2.08e-1)" "unprognostic (4.88e-2)" "unprognostic (3.13e-2)" "unprognostic (4.40e-2)" "unprognostic (1.10e-1)" "unprognostic (2.68e-1)" "unprognostic (1.98e-1)" "unprognostic (6.26e-9)" "unprognostic (1.28e-2)" "unprognostic (4.23e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.28e-4)" 5.0 7.5 7.6 5.2 12.3 8.3 7.5 13.4 14.1 7.9 4.7 9.7 6.8 3.7 6.0 5.9 29.7 6.4 5.3 8.1 7.9 5.9 5.2 5.8 4.9 6.0 7.1 5.7 6.5 4.2 11.3 11.0 7.1 10.0 5.1 5.3 6.0 10.8 4.3 6.9 31.5 4.6 6.3 6.4 5.8 4.8 12.0 7.7 5.7 5.5 17.8 16.1 4.9 13.7 4.2 3.9 5.8 3.2 1.4 7.5 3.1 11.9 6.4 5.9 5.1 7.3 5.5 19.7 8.6 5.3 8.8 5.0 4.0 4.7 7.5 4.3 11.9 7.8 17.2 10.4 11.9 7.4 9.2 6.7 6.1 13.6 6.1 5.2 10.3 7.2 5.4 11.8 10.5 8.2 8.0 6.5 6.2 8.2 9.1 8.6 16.3 5.9 4.8 10.1 13.2 9.5 5.2 6.4 3.0 5.2 7.3 12.4 7.3 6.9 28.7 5.0 6.1 6.8 2.6 12.6 6.5 7.4 18.3 8.9 8.4 9.7 4.2 8.5 4.7 6.3 0.0 2.3 5.8 6.4 3.1 7.3 4.1 5.6 5.7 3.6 4.2 4.4 4.8 3.6 1.4 3.2 3.9 7.5 3.1 7.6 12.3 13.4 14.1 7.9 5.9 7.1 5.7 10.0 7.7 3.0 4.3 1.5 5.2 22.6 8.3 0.3 0.0 0.0 3.4 1.8 5.9 7.8 5.0 5.2 8.3 5.8 3.3 0.0 6.9 11.0 4.3 5.0 0.0 2.6 4.4 14.3 6.4 10.4 5.9 26.7 2.8 3.9 3.3 1.8 3.4 4.5 6.5 0.0 2.8 3.1 4.1 6.5 2.7 15.7 16.8 25.7 19.1 4.4 3.3 9.0 IQCE KIAA1023 ENSG00000106012 "IQ motif containing E" Q6IPM2 7 2558972-2614734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 360.6;Late spermatids: 290.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019515 Approved Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA019515: AB_1851855" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (3.78e-2)" "prognostic favorable (5.91e-4)" "unprognostic (7.96e-3)" "unprognostic (3.75e-1)" "unprognostic (2.54e-3)" "unprognostic (1.31e-1)" "unprognostic (4.04e-3)" "unprognostic (1.30e-2)" "unprognostic (1.66e-2)" "unprognostic (2.84e-1)" "unprognostic (2.04e-2)" "unprognostic (2.82e-2)" "unprognostic (6.97e-2)" "unprognostic (7.56e-3)" "unprognostic (3.13e-2)" 5.5 7.6 15.1 6.8 17.0 7.0 7.4 11.1 18.7 6.9 10.2 12.8 6.7 13.1 9.6 12.3 6.6 17.1 11.2 7.1 14.3 15.6 7.1 3.6 9.1 4.7 12.0 12.1 9.7 8.4 12.9 15.4 4.1 11.3 8.1 9.9 7.3 9.8 11.2 4.5 8.1 10.9 7.9 11.1 5.1 10.6 35.3 9.6 2.8 11.9 3.0 3.9 6.0 7.4 0.7 4.3 8.3 2.1 0.3 1.3 0.3 20.0 10.5 4.5 13.8 5.6 8.5 7.8 4.2 7.1 5.6 6.1 5.4 11.6 1.4 4.9 9.8 12.2 10.4 3.1 4.9 5.9 3.5 6.5 2.7 12.7 1.7 4.1 7.2 4.0 3.5 8.1 5.4 5.7 6.5 6.0 5.8 8.6 2.6 7.4 20.4 3.2 5.5 3.9 9.0 7.7 3.1 5.2 5.2 6.0 9.4 9.5 11.2 4.7 20.0 4.4 3.3 24.6 9.8 5.9 4.7 9.5 17.8 7.1 2.9 4.9 0.3 9.2 5.2 13.1 1.1 1.4 3.6 1.3 2.1 0.5 0.5 0.7 0.6 0.6 0.7 0.5 1.1 8.3 0.3 0.7 4.3 0.3 0.3 15.1 17.0 11.1 18.7 14.3 15.6 12.0 12.1 11.3 9.6 11.9 11.0 0.0 5.0 4.8 7.8 7.7 22.9 60.2 14.8 12.2 56.9 3.7 14.9 16.6 360.6 3.6 15.8 0.0 17.4 6.9 6.4 7.3 1.1 2.8 8.7 19.1 8.1 7.4 6.4 290.7 13.0 5.9 0.0 10.8 10.7 14.1 17.5 11.8 14.5 8.1 38.1 19.4 3.6 43.3 53.7 3.8 1.6 4.4 10.0 3.3 IQCG "CFAP122, DKFZp434B227, DRC9" ENSG00000114473 "IQ motif containing G" Q9H095 3 197889075-197960142 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 44.9;testis: 34.2" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 433.6;Early spermatids: 224.8;Late spermatids: 337.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042787, HPA051981" Enhanced Approved "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA042787: AB_10797021, HPA051981: AB_2732572" "unprognostic (1.50e-2)" "unprognostic (6.20e-3)" "unprognostic (6.20e-2)" "unprognostic (1.10e-2)" "unprognostic (2.51e-2)" "unprognostic (9.20e-2)" "unprognostic (1.05e-1)" "unprognostic (4.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (7.54e-2)" "unprognostic (1.79e-1)" "unprognostic (2.94e-2)" "unprognostic (9.15e-2)" "unprognostic (1.73e-1)" "unprognostic (2.72e-3)" "unprognostic (7.75e-2)" 6.2 5.0 10.9 3.0 14.6 3.0 5.4 3.6 7.6 5.7 3.0 12.3 4.1 2.5 4.5 11.6 3.9 44.9 4.4 4.2 12.6 12.9 5.9 3.6 8.0 3.9 9.0 5.7 5.0 2.1 4.5 12.0 3.4 20.8 3.9 3.7 5.3 2.5 4.6 2.0 2.8 2.6 4.1 9.2 3.1 3.4 34.2 11.2 1.4 7.4 1.0 3.9 4.5 2.2 8.9 7.3 8.9 8.4 6.6 9.1 5.0 3.9 4.3 5.6 5.4 12.1 12.4 2.2 4.8 5.3 5.7 5.9 0.8 3.8 1.3 5.4 3.9 7.4 3.7 4.0 3.7 9.3 3.0 2.8 2.4 2.3 2.0 2.8 3.1 3.8 6.4 4.7 6.2 2.0 4.7 2.7 6.6 2.5 5.4 4.3 9.0 1.7 1.5 3.4 5.7 5.8 5.0 3.7 1.9 5.5 1.6 4.9 5.9 8.0 3.2 3.3 5.2 24.4 2.1 2.7 3.7 2.5 11.0 4.4 4.7 13.2 2.3 13.6 4.5 5.9 4.6 8.4 8.9 8.2 6.4 5.3 8.9 6.9 5.4 7.3 4.2 6.2 9.1 5.8 6.6 5.7 6.5 6.8 5.0 10.9 14.6 3.6 7.6 12.6 12.9 9.0 5.7 20.8 11.2 6.0 7.7 5.1 2.8 8.2 12.5 9.7 0.0 433.6 42.1 5.2 70.7 5.1 13.3 5.5 224.8 6.9 1.7 0.0 3.7 4.6 6.8 2.4 8.1 3.9 5.8 9.5 4.1 6.7 5.7 337.4 21.0 10.2 13.5 1.0 2.6 13.5 8.6 1.9 22.3 7.8 44.0 6.5 4.6 84.6 32.3 7.9 4.3 11.3 2.3 2.0 IQCH FLJ12476 ENSG00000103599 "IQ motif containing H" Q86VS3 15 67254800-67502260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.5;testis: 20.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 30.8;Early spermatids: 45.3;Late spermatids: 30.4;Spermatocytes: 43.6;Spermatogonia: 18.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.0;dendritic cells: 1.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040845 Uncertain Approved Cytosol NA NA Cytosol "HPA040845: AB_10672898" "unprognostic (2.69e-1)" "unprognostic (2.94e-3)" "unprognostic (3.11e-2)" "unprognostic (5.89e-5)" "unprognostic (2.48e-1)" "unprognostic (9.83e-2)" "unprognostic (2.57e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (3.25e-1)" "unprognostic (5.37e-2)" "unprognostic (1.70e-1)" "unprognostic (1.51e-3)" "unprognostic (2.81e-1)" "unprognostic (3.81e-2)" "unprognostic (6.16e-3)" "unprognostic (6.42e-2)" 0.9 1.8 1.3 0.4 2.9 0.2 2.5 0.9 2.8 1.4 0.8 2.9 4.1 0.3 1.3 6.4 0.9 10.0 2.1 1.3 1.6 2.1 3.3 1.5 2.4 0.5 1.2 1.8 2.7 1.4 6.5 14.5 0.5 2.6 1.2 1.1 3.5 1.0 1.4 0.9 1.0 0.8 0.6 1.4 0.8 1.6 20.9 1.4 0.6 6.1 0.7 0.4 1.3 1.0 1.0 1.2 0.1 0.3 0.2 2.1 0.3 2.8 3.0 1.3 2.2 2.0 4.6 1.0 1.5 1.2 2.4 1.6 0.3 3.1 1.8 1.4 2.5 2.6 4.8 4.4 1.8 4.0 0.3 2.1 0.6 3.0 0.4 3.5 0.9 0.6 3.1 1.8 5.0 4.8 2.1 0.9 5.2 4.2 2.0 1.7 3.0 0.7 0.8 1.6 1.8 1.9 0.6 2.1 2.1 2.7 1.2 4.6 1.2 2.0 2.8 7.9 2.9 7.2 0.5 2.0 2.6 1.3 4.1 1.8 4.1 5.4 0.5 5.3 2.2 2.7 0.0 0.3 0.1 1.2 0.0 2.1 0.4 1.0 1.1 1.1 1.0 0.9 0.8 0.0 0.2 0.1 1.2 0.8 0.3 1.3 2.9 0.9 2.8 1.6 2.1 1.2 1.8 2.6 1.4 3.0 0.6 0.0 0.9 1.1 1.4 0.8 0.0 30.8 3.4 1.8 7.9 0.2 0.0 0.8 45.3 0.7 0.0 0.0 0.7 0.3 0.5 0.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 30.4 0.9 0.0 0.0 1.8 0.5 1.4 0.7 0.0 0.7 1.7 6.0 0.0 0.5 43.6 18.5 0.4 0.2 0.0 0.0 0.9 IQCJ-SCHIP1 ENSG00000283154 "IQCJ-SCHIP1 readthrough" B3KU38 3 158962235-159897366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 6.0;Basal glandular cells: 6.9;Bipolar cells: 12.0;Cone photoreceptor cells: 5.9" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "HPA003243, HPA003445" Approved Approved Cytosol NA NA Cytosol "HPA003243: AB_1079877, HPA003445: AB_1079875" 5.3 2.1 11.1 4.1 12.4 0.5 2.4 1.5 30.0 1.9 3.8 17.8 0.3 1.7 5.6 2.8 7.3 1.4 5.8 16.4 7.7 7.6 6.3 6.8 0.6 18.8 10.6 0.8 0.9 0.2 1.3 10.9 13.1 6.3 3.0 0.4 0.6 10.0 1.8 0.8 1.7 11.8 7.3 1.2 1.0 1.7 15.1 0.0 0.6 0.1 0.4 5.9 0.9 0.0 1.0 0.1 0.0 0.9 0.2 0.2 28.8 5.0 9.9 11.8 2.3 2.2 8.7 24.9 5.9 20.6 14.1 18.6 7.1 1.4 16.1 8.2 7.8 11.7 3.8 8.4 17.0 24.0 9.4 0.0 11.0 0.9 2.7 1.3 0.1 2.3 7.2 9.1 10.9 17.1 15.2 1.6 0.0 0.1 9.4 1.2 0.1 0.0 8.3 2.3 10.9 3.4 20.1 0.0 19.8 1.6 2.0 9.4 13.4 5.7 7.1 11.9 3.3 0.2 12.6 11.9 16.5 7.9 33.7 0.1 0.1 0.1 6.6 4.1 31.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.9 0.0 1.0 0.0 0.2 6.0 0.0 0.0 6.9 1.3 12.0 0.4 0.0 4.0 2.3 1.8 5.9 0.0 0.0 0.6 1.2 0.2 0.0 0.0 0.5 0.0 0.5 0.4 2.3 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.3 0.8 0.0 1.0 0.1 0.4 0.8 0.0 1.1 2.7 0.5 0.0 3.4 0.0 0.4 0.6 0.0 0.0 0.2 1.4 IQCK "FLJ36575, MGC35048" ENSG00000174628 "IQ motif containing K" Q8N0W5 16 19716456-19858467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 107.1;Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 96.8;Spermatocytes: 80.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026792, HPA048786" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA026792: AB_1853889, HPA048786: AB_2680520" "unprognostic (4.21e-2)" "unprognostic (3.19e-1)" "unprognostic (6.29e-3)" "unprognostic (2.04e-2)" "unprognostic (3.70e-1)" "unprognostic (4.07e-2)" "unprognostic (1.69e-1)" "unprognostic (8.51e-2)" "unprognostic (1.58e-1)" "unprognostic (9.68e-3)" "unprognostic (1.17e-1)" "unprognostic (5.13e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" 5.5 4.8 9.3 2.8 11.4 1.1 7.8 3.7 7.1 10.1 3.7 13.9 19.4 5.1 6.3 19.9 2.5 25.2 7.5 4.8 10.4 11.2 11.2 3.0 5.3 2.3 8.3 8.9 8.9 5.7 20.7 14.6 4.4 12.1 5.4 4.2 9.3 8.2 22.4 4.0 3.3 2.7 5.3 8.5 2.6 5.1 27.2 7.9 1.1 21.0 3.2 1.9 5.7 3.5 1.5 1.0 0.0 3.8 0.1 3.0 1.0 2.6 7.2 9.2 6.1 2.8 9.1 0.6 0.0 4.6 4.3 3.4 0.4 5.0 0.3 5.1 2.5 2.7 3.0 2.0 3.5 3.0 1.1 1.9 0.1 1.9 3.5 9.0 1.7 0.1 5.1 3.0 5.5 1.3 4.8 4.6 4.5 2.7 0.8 2.7 8.8 1.6 1.0 2.8 2.8 6.7 5.5 0.7 0.5 10.8 1.9 8.5 3.6 3.7 1.3 5.6 1.8 3.7 0.9 3.1 0.9 1.0 4.9 0.9 0.2 0.5 0.0 5.6 0.2 1.8 0.0 0.7 0.0 1.4 3.8 2.5 1.5 1.6 2.3 0.4 0.6 3.0 1.5 0.0 0.1 3.5 1.0 1.2 1.0 9.3 11.4 3.7 7.1 10.4 11.2 8.3 8.9 12.1 7.9 14.9 3.2 0.8 9.3 5.5 41.5 0.8 20.4 107.1 17.0 43.6 108.0 4.2 39.7 39.8 32.8 16.9 2.7 0.0 25.9 2.1 10.0 6.5 0.0 1.5 4.9 3.2 5.2 9.2 2.7 25.2 16.7 2.6 16.9 1.0 4.3 25.1 23.3 0.0 17.0 27.5 96.8 6.5 9.2 80.7 34.9 4.4 3.4 1.0 5.8 4.3 IQSEC3 "KIAA1110, MGC30156" ENSG00000120645 "IQ motif and Sec7 domain 3" Q9UPP2 12 66765-178460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8" "Group enriched" "Detected in some" 4 "Bipolar cells: 32.6;Horizontal cells: 108.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 9.7;U-266/70: 13.0;U-266/84: 3.1;U-937: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039025 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039025: AB_10672768" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.26e-2)" "unprognostic (4.24e-3)" "unprognostic (4.32e-2)" "unprognostic (1.28e-1)" "unprognostic (4.44e-2)" "unprognostic (5.14e-2)" "unprognostic (3.91e-1)" "unprognostic (8.82e-3)" "unprognostic (2.83e-3)" "unprognostic (7.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-2)" "unprognostic (1.36e-2)" 5.6 1.3 5.6 0.7 4.2 0.8 0.4 19.8 15.5 1.6 0.4 0.5 0.0 0.5 2.0 0.5 0.4 5.2 2.2 1.9 6.5 5.1 2.4 0.2 2.9 0.5 3.7 4.7 2.1 1.2 0.0 2.2 1.3 5.0 1.5 0.2 0.4 0.2 4.5 1.3 0.2 0.7 1.9 1.4 0.3 0.6 1.2 0.8 0.0 0.3 0.0 0.2 1.3 0.6 0.0 2.1 0.0 0.0 0.5 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 13.0 3.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 1.2 0.0 0.5 0.0 2.1 0.0 0.4 5.6 4.2 19.8 12.4 6.5 5.1 3.7 4.7 5.0 0.8 3.0 0.0 0.0 0.0 0.2 32.6 1.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 1.1 0.1 2.3 0.0 1.2 108.1 0.0 1.8 1.0 3.3 0.6 0.0 0.0 0.0 0.0 6.1 0.2 0.0 0.0 4.5 15.7 0.0 0.0 2.2 8.8 0.1 0.0 0.5 0.0 0.0 IQUB FLJ35834 ENSG00000164675 "IQ motif and ubiquitin domain containing" Q8NA54 7 123452400-123535077 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 20.8;testis: 35.5" "Group enriched" "Detected in many" 7 "Ciliated cells: 91.0;Early spermatids: 206.9;Late spermatids: 121.6;Spermatocytes: 83.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.9;RPTEC TERT1: 7.2;T-47d: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049626 Approved "Nuclear speckles,Intermediate filaments,Cytosol" NA NA "Nuclear speckles, Intermediate filaments" Cytosol "HPA049626: AB_2732554" "unprognostic (8.71e-2)" "unprognostic (1.25e-2)" "unprognostic (1.98e-1)" "unprognostic (6.42e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (6.23e-2)" "unprognostic (7.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "unprognostic (3.76e-1)" "unprognostic (5.44e-6)" "unprognostic (2.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.14e-1)" "unprognostic (7.30e-2)" 0.6 1.0 1.3 0.3 2.9 0.3 0.9 3.0 3.5 1.2 0.5 1.8 3.2 0.4 1.4 6.9 1.8 5.7 1.6 0.6 2.6 1.2 8.5 0.4 3.2 0.3 0.7 1.2 2.7 0.7 2.7 20.8 0.5 6.4 0.9 0.4 0.3 0.7 4.3 0.6 0.5 0.5 0.6 1.0 0.4 0.6 35.5 2.8 0.0 5.6 0.0 0.3 0.7 0.6 0.8 0.0 0.0 0.3 0.5 0.7 0.0 0.3 0.0 1.3 0.6 0.6 0.6 0.1 0.0 0.1 0.0 0.3 0.0 0.8 0.8 0.0 0.4 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.7 0.3 0.2 0.3 0.7 0.0 0.2 1.9 0.2 0.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 7.2 1.6 1.1 0.4 0.0 0.0 0.1 1.1 2.5 0.0 0.0 0.5 0.3 0.5 0.2 0.5 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.7 0.3 0.4 0.2 0.2 0.2 0.0 0.8 0.7 0.2 0.0 0.5 0.1 0.0 0.3 0.0 1.3 2.9 3.0 3.5 2.6 1.2 0.7 1.2 6.4 2.8 6.0 0.3 0.0 0.5 0.5 2.7 1.0 0.0 91.0 15.9 17.4 3.9 0.3 1.7 0.9 206.9 0.4 0.0 0.0 0.4 0.2 0.5 0.6 1.1 0.0 0.1 3.2 1.7 0.6 0.0 121.6 2.3 0.1 0.0 0.0 0.0 2.5 0.1 0.0 2.8 4.3 8.8 6.5 0.9 83.1 7.1 0.1 0.6 0.0 0.0 0.3 IRAK1 "IRAK, pelle" ENSG00000184216 "Interleukin 1 receptor associated kinase 1" P51617 X 154010500-154019980 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004461, HPA054476" Supported Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "CAB004461: AB_2249106, HPA054476: AB_2682501" "unprognostic (4.46e-3)" "unprognostic (9.32e-2)" "unprognostic (1.71e-2)" "unprognostic (5.04e-3)" "unprognostic (7.09e-3)" "unprognostic (4.43e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (7.89e-3)" "unprognostic (3.36e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-1)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.06e-4)" "unprognostic (2.76e-3)" "unprognostic (2.36e-1)" "unprognostic (2.21e-3)" "unprognostic (3.04e-1)" 22.3 23.7 12.1 25.0 11.4 48.3 38.5 7.7 14.8 11.1 24.8 10.8 13.4 29.9 13.2 12.4 25.5 12.2 23.1 14.1 9.9 12.3 23.7 46.9 18.5 37.5 12.6 7.9 15.1 34.6 8.1 15.2 14.3 11.9 18.0 11.0 10.1 31.9 15.9 32.6 15.9 34.6 11.5 12.7 34.0 19.3 14.3 9.8 17.0 12.6 20.4 26.7 17.2 15.3 10.0 13.0 6.7 10.6 6.3 6.7 3.4 77.0 30.0 4.3 34.6 8.5 6.8 18.5 11.5 10.9 17.8 16.5 23.7 34.2 32.9 64.8 12.3 27.3 21.1 9.8 18.8 6.9 25.8 29.3 12.0 27.0 14.1 19.5 28.3 20.6 9.4 16.5 16.9 18.7 9.2 10.6 6.7 21.1 38.1 12.4 28.4 11.6 25.3 10.5 24.6 59.8 30.2 21.5 55.2 11.8 14.6 23.8 17.2 13.7 15.3 22.7 1.7 5.9 30.2 14.5 21.6 34.2 49.3 71.3 48.0 30.6 60.3 31.5 34.1 22.3 1.3 8.7 6.7 6.7 10.6 5.9 7.5 5.3 5.3 5.4 10.0 3.1 6.1 5.9 6.3 8.1 13.0 2.5 3.4 12.1 11.4 7.7 14.8 9.9 12.3 12.6 7.9 11.9 9.8 0.0 14.1 25.2 11.0 11.8 8.1 8.2 20.4 6.7 19.4 10.4 5.9 9.6 6.6 45.8 0.6 13.7 36.0 0.0 97.4 17.8 12.1 24.0 12.7 32.6 52.7 15.9 19.7 10.4 45.4 1.8 16.7 26.5 13.5 11.8 24.2 14.0 61.0 24.6 20.1 13.3 5.0 0.0 14.5 1.7 6.3 11.4 10.3 14.0 28.8 23.4 IRAK4 NY-REN-64 ENSG00000198001 "Interleukin 1 receptor associated kinase 4" Q9NWZ3 12 43758944-43789543 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016685, CAB022077" Uncertain Approved Nucleoli,Microtubules,Cytosol NA NA Microtubules "Nucleoli, Cytosol" "CAB016685: AB_1618505, CAB022077: " "unprognostic (2.76e-2)" "unprognostic (5.63e-2)" "unprognostic (1.47e-2)" "prognostic favorable (3.46e-5)" "unprognostic (6.15e-2)" "unprognostic (3.50e-3)" "unprognostic (1.44e-2)" "unprognostic (8.49e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (4.00e-3)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "prognostic favorable (4.42e-5)" 18.0 9.4 5.1 15.0 10.4 10.3 11.3 3.7 6.0 10.3 12.2 9.1 12.5 10.2 13.0 14.1 15.0 9.4 10.8 7.6 6.7 5.2 13.3 11.8 12.0 24.0 13.2 3.9 9.3 20.1 9.1 16.1 14.0 9.8 10.5 10.0 11.9 11.9 15.1 4.1 15.2 15.0 11.8 13.0 25.0 12.3 7.1 11.7 30.3 17.0 7.7 18.9 11.1 10.7 5.1 5.8 16.9 6.0 8.8 7.7 4.7 5.3 4.0 2.8 3.7 10.2 17.2 4.0 7.6 5.4 6.0 5.5 3.4 5.2 9.2 7.5 6.3 4.0 4.4 3.1 4.9 8.7 13.2 2.9 8.8 3.1 2.1 5.8 12.1 10.8 9.1 7.8 7.6 4.5 10.6 8.9 9.0 8.1 6.9 16.6 2.9 10.5 6.8 1.0 0.0 4.7 7.0 3.4 4.8 4.7 5.1 2.0 2.0 3.7 4.7 3.6 4.0 5.9 10.8 7.9 7.4 1.4 9.1 5.2 8.4 10.9 8.0 7.7 32.7 4.1 16.9 4.6 9.4 7.4 5.4 7.7 4.0 6.1 6.3 4.5 5.1 5.5 5.9 9.3 8.8 6.0 5.8 7.5 4.7 5.1 10.4 3.7 6.0 6.7 5.2 13.2 3.9 9.8 11.7 17.9 17.0 15.7 9.4 9.6 5.7 4.1 22.9 6.7 10.3 31.4 19.6 12.5 18.3 10.9 12.6 12.4 13.8 0.0 15.4 7.3 9.3 8.1 20.9 7.3 15.2 7.9 3.5 12.9 29.8 16.3 11.5 22.9 10.1 18.0 9.3 9.1 12.5 5.8 10.6 11.3 25.0 6.5 8.6 27.0 12.6 10.3 23.3 41.5 7.8 11.2 IREB2 IRP2 ENSG00000136381 "Iron responsive element binding protein 2" P48200 15 78437431-78501456 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032885, HPA040371, HPA068982" Uncertain Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064" "unprognostic (1.00e-2)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (3.44e-2)" "unprognostic (3.39e-2)" "unprognostic (2.29e-1)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (7.30e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (6.51e-2)" "unprognostic (3.85e-3)" "unprognostic (4.09e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-2)" "unprognostic (9.40e-2)" 18.9 42.4 12.0 16.2 22.0 22.6 18.3 22.3 24.9 19.0 16.2 14.8 14.3 16.6 20.4 17.9 19.7 17.6 14.4 13.6 10.7 11.8 18.2 21.1 22.4 31.1 10.3 16.7 23.1 17.0 20.3 23.6 23.2 21.7 16.5 19.7 19.2 17.1 15.8 27.3 18.6 25.3 15.5 13.7 25.5 15.7 18.0 12.3 39.6 27.8 14.0 20.3 17.8 18.4 7.1 9.5 7.1 7.8 7.2 8.8 3.4 7.5 13.4 20.8 13.0 18.4 12.1 14.0 12.9 10.0 11.7 10.7 13.2 13.1 27.9 8.8 10.7 8.0 14.7 48.4 13.0 10.4 8.8 16.8 24.1 14.0 9.2 9.6 26.0 26.1 12.7 8.9 9.0 11.0 12.0 13.7 16.5 25.2 10.0 10.0 11.3 15.8 13.3 27.2 9.2 4.9 18.7 20.9 7.9 12.9 20.8 12.5 18.8 17.4 12.4 13.5 24.5 11.6 22.8 11.1 12.1 8.3 6.6 11.1 12.5 27.3 15.9 8.7 24.2 8.6 7.1 5.8 4.4 6.0 7.8 7.7 6.5 6.6 5.9 8.0 7.1 6.5 8.8 6.8 7.2 6.0 9.5 5.3 3.4 12.0 22.0 22.3 24.9 10.7 11.8 10.3 16.7 21.7 12.3 20.8 35.5 37.4 16.1 12.6 53.7 19.9 22.9 14.7 23.9 22.7 62.8 28.6 0.0 17.5 10.0 22.9 41.8 46.7 16.9 20.4 21.6 26.3 17.3 36.2 22.5 74.7 30.7 51.5 44.9 8.1 30.5 32.9 13.5 16.2 28.6 31.2 21.7 38.4 28.7 15.8 44.1 6.5 13.9 30.7 26.0 16.3 25.6 34.5 28.3 19.3 IRF1 MAR ENSG00000125347 "Interferon regulatory factor 1" P10914 5 132481609-132490798 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 103.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011662, HPA063131" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB011662: AB_775784, HPA063131: AB_2684945" "unprognostic (1.30e-3)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (1.21e-1)" "unprognostic (2.27e-1)" "unprognostic (4.48e-2)" "unprognostic (3.67e-1)" "unprognostic (1.64e-1)" "unprognostic (1.52e-2)" "unprognostic (2.24e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.09e-7)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (9.53e-3)" 19.7 8.5 4.1 64.2 9.9 43.8 21.0 3.9 4.6 10.6 27.3 4.0 4.4 31.1 11.4 9.9 12.4 11.8 18.1 11.8 4.2 3.5 14.2 20.9 49.3 41.0 6.8 1.4 11.5 14.5 2.8 8.8 24.7 10.3 18.9 13.6 10.3 13.2 10.3 14.0 8.4 52.1 11.3 8.0 51.7 17.5 5.7 4.9 36.6 26.5 14.7 33.0 14.7 26.7 12.1 16.2 103.0 42.1 21.3 28.5 21.3 9.0 7.4 0.6 2.5 7.2 6.2 14.9 4.3 18.5 13.9 17.4 3.8 27.1 9.0 5.9 6.5 20.8 12.7 2.3 10.5 4.7 19.1 2.5 12.1 3.5 2.7 47.5 5.9 10.4 11.8 2.6 10.3 9.8 8.7 6.5 6.0 2.1 34.8 3.8 5.0 32.0 9.9 0.8 2.8 5.2 37.2 7.8 11.0 7.1 10.2 1.4 1.1 4.6 10.4 4.4 3.4 1.7 8.1 4.1 8.0 2.8 4.6 6.4 27.6 6.9 6.4 9.1 9.4 5.7 23.1 26.2 40.2 28.5 40.0 19.4 12.1 18.7 22.9 16.2 11.5 11.5 16.0 103.0 21.3 42.1 8.2 20.2 21.3 4.1 9.9 3.9 4.6 4.2 3.5 6.8 1.4 10.3 4.9 95.3 109.6 113.9 70.4 78.3 13.4 11.8 35.7 113.8 61.4 21.0 31.4 19.3 16.6 94.9 95.1 107.4 136.0 23.3 99.6 32.8 121.3 247.1 102.7 13.6 47.7 1.6 83.5 49.7 57.7 7.8 25.3 107.0 69.2 266.1 57.5 16.3 73.7 119.3 7.4 13.9 36.6 12.9 178.3 1.1 3.6 72.3 9.4 207.0 53.2 80.6 IRF2 ENSG00000168310 "Interferon regulatory factor 2" P14316 4 184387713-184474580 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 173.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 50.9;Karpas-707: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030813, CAB032306, HPA057327" Supported Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410" "prognostic favorable (6.95e-5)" "unprognostic (1.69e-3)" "unprognostic (5.43e-2)" "unprognostic (1.59e-3)" "unprognostic (2.70e-2)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-3)" "unprognostic (2.90e-2)" "unprognostic (4.00e-2)" "unprognostic (2.35e-1)" "unprognostic (6.87e-3)" "unprognostic (8.55e-3)" "unprognostic (5.25e-2)" "prognostic favorable (8.34e-5)" "unprognostic (1.31e-3)" 27.5 30.6 15.2 31.0 19.3 11.3 21.0 21.5 16.4 21.5 23.7 28.8 16.6 21.2 19.8 16.5 20.5 18.1 17.3 16.1 15.3 12.1 15.3 26.1 24.0 38.7 22.8 9.7 28.0 14.9 12.4 24.5 19.7 17.8 20.5 20.4 16.8 22.1 16.1 21.9 18.1 27.7 21.2 22.4 39.4 21.3 8.4 22.0 36.1 24.0 12.6 34.5 28.8 26.4 22.2 16.2 83.9 27.5 18.1 21.9 17.2 6.1 4.5 5.6 3.7 12.3 12.7 3.3 4.5 14.2 11.1 11.7 1.3 11.9 3.8 2.4 6.7 9.1 5.7 3.8 8.6 7.2 50.9 2.1 10.5 2.5 8.2 12.2 6.4 8.9 13.6 7.9 6.3 16.5 9.6 8.4 4.6 2.0 53.1 4.6 4.3 12.3 7.8 1.2 5.6 3.3 16.2 2.1 16.9 8.5 9.5 2.4 3.7 6.4 5.3 9.3 2.4 4.1 5.8 6.9 3.2 3.5 3.6 3.9 15.2 12.1 3.3 6.7 6.3 5.6 17.7 19.4 34.5 16.4 25.3 16.9 21.2 16.3 17.6 16.2 22.2 17.5 17.3 83.9 18.1 27.5 4.1 21.9 17.2 15.2 19.3 21.5 16.4 15.3 12.1 22.8 9.7 17.8 22.0 35.7 23.2 51.9 43.4 43.6 11.8 19.6 28.1 64.3 26.1 24.4 5.9 27.6 31.5 24.5 0.1 35.9 32.5 23.3 26.4 13.4 30.4 57.1 26.5 32.6 42.8 19.1 29.4 37.4 73.6 1.3 34.5 47.6 18.6 173.1 25.9 25.5 27.3 37.4 49.8 23.7 7.8 38.8 24.7 0.2 1.1 38.9 22.3 58.6 20.9 59.3 IRF3 ENSG00000126456 "Interferon regulatory factor 3" Q14653 19 49659569-49665875 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004895, CAB013018" Approved Supported Cytosol NA NA Cytosol "CAB013018: AB_2533904, HPA004895: AB_1851887" "unprognostic (5.75e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-3)" "unprognostic (1.59e-1)" "unprognostic (9.17e-2)" "unprognostic (9.60e-2)" "unprognostic (7.85e-3)" "unprognostic (7.91e-2)" "unprognostic (6.98e-2)" "unprognostic (5.52e-2)" "unprognostic (5.02e-2)" "unprognostic (3.85e-3)" "prognostic unfavorable (1.56e-7)" "unprognostic (1.61e-2)" "unprognostic (4.98e-1)" "unprognostic (3.47e-2)" "prognostic favorable (3.61e-4)" 14.8 17.0 13.4 33.2 22.1 21.8 17.1 16.9 20.1 23.4 18.9 14.1 30.1 18.3 20.0 16.3 18.7 18.9 22.0 15.9 17.7 11.2 20.5 21.3 19.4 36.3 22.2 10.9 23.5 18.5 13.4 22.3 21.2 18.7 23.1 11.7 18.1 26.3 37.7 8.6 19.9 25.4 20.0 17.4 37.3 21.4 7.6 20.0 23.7 22.6 11.8 31.0 19.0 20.6 17.8 13.4 21.8 14.7 20.3 35.4 17.4 29.3 32.3 11.3 16.8 8.6 13.7 25.6 13.0 19.6 22.5 29.7 22.8 34.7 17.4 14.9 12.0 18.9 24.1 12.0 33.3 10.0 23.5 21.4 16.3 12.5 20.8 9.8 11.9 16.5 13.0 23.9 29.7 9.0 11.6 17.7 22.2 17.9 18.9 11.9 28.7 18.6 34.0 13.3 29.9 30.0 21.5 11.3 30.0 16.4 25.2 6.3 8.0 23.7 25.9 12.8 11.6 11.2 23.5 12.3 13.4 12.6 10.1 16.6 26.0 26.6 16.7 15.2 27.8 13.3 8.8 12.6 21.8 28.5 12.7 25.4 17.8 27.9 26.6 9.8 16.2 24.9 22.5 16.1 20.3 14.7 13.4 35.4 17.4 13.4 22.1 16.9 20.1 17.7 11.2 22.2 10.9 18.7 20.0 23.8 33.4 41.2 30.3 48.1 29.0 4.2 35.7 22.7 48.9 38.4 27.5 71.1 16.6 33.7 3.0 27.5 70.7 46.7 40.8 77.5 30.6 26.3 76.1 23.1 34.6 15.9 43.1 33.2 31.0 6.4 38.0 33.4 28.7 72.1 44.3 38.1 38.6 45.6 33.6 18.9 47.3 32.3 28.3 5.4 10.1 39.9 41.2 70.4 43.2 29.4 IRF4 "LSIRF, MUM1" ENSG00000137265 "Interferon regulatory factor 4" Q15306 6 391739-411447 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 48.7" "Group enriched" "Detected in some" 6 "Melanocytes: 42.2;monocytes: 92.8" "Cancer enriched" "Detected in many" 9 "melanoma: 27.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8" "Group enriched" "Detected in many" 5 "B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8" "Cell line enhanced" "Detected in some" "HDLM-2: 50.2;Karpas-707: 46.7;RPMI-8226: 45.1;U-266/70: 42.2;U-266/84: 31.4;WM-115: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002038, HPA002698, CAB013508" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893" "prognostic favorable (6.44e-4)" "unprognostic (1.88e-3)" "unprognostic (1.00e-3)" "unprognostic (1.72e-4)" "unprognostic (2.74e-1)" "prognostic favorable (1.64e-6)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (1.89e-2)" "unprognostic (5.74e-4)" "unprognostic (8.51e-2)" "unprognostic (1.12e-1)" "unprognostic (9.18e-7)" "unprognostic (2.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.90e-1)" "unprognostic (3.65e-2)" 7.1 0.5 0.4 36.6 0.4 18.4 4.0 0.4 0.4 17.4 13.9 0.1 0.4 5.0 2.2 0.7 6.4 1.2 4.1 1.6 0.4 0.5 1.4 5.6 4.2 31.5 0.5 0.0 1.9 0.7 0.0 0.7 0.5 0.1 1.5 4.8 15.8 21.3 1.9 0.7 4.5 11.1 0.3 0.6 33.8 4.6 1.7 0.1 15.2 1.3 2.4 48.7 8.4 4.2 9.7 10.4 0.0 1.6 0.2 4.8 1.3 0.1 0.0 0.0 0.0 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.9 0.0 45.1 0.0 0.0 0.1 0.0 0.0 0.0 7.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 31.4 13.7 0.0 0.0 25.6 0.0 1.6 0.0 0.6 1.2 0.0 9.5 0.9 0.9 9.0 9.7 1.6 0.7 0.0 0.2 1.2 10.4 4.8 1.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.0 0.1 0.1 0.0 4.0 12.0 0.1 7.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.6 0.2 0.0 0.2 0.2 0.0 0.0 1.8 0.0 0.0 3.1 6.9 42.2 92.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 3.8 0.1 6.2 0.0 0.0 IRF6 "LPS, OFC6, VWS, VWS1" ENSG00000117595 "Interferon regulatory factor 6" O14896 1 209785623-209806175 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 344.0;Suprabasal keratinocytes: 482.8;Urothelial cells: 297.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 8.6;pons and medulla: 4.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 16.4;HaCaT: 59.6;HBEC3-KT: 21.8;hTCEpi: 48.0;hTERT-HME1: 24.0;RT4: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA063121, HPA076162" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA063121: AB_2684942, HPA076162: AB_2686780" "unprognostic (2.59e-1)" "unprognostic (1.79e-3)" "unprognostic (1.74e-1)" "unprognostic (7.80e-2)" "unprognostic (1.33e-2)" "unprognostic (4.94e-3)" "unprognostic (1.46e-1)" "unprognostic (1.36e-1)" "unprognostic (7.82e-2)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (2.03e-1)" "prognostic favorable (0.00e+0)" "unprognostic (2.70e-1)" "unprognostic (2.66e-2)" "unprognostic (2.14e-1)" "unprognostic (4.42e-2)" 1.0 6.3 1.1 4.1 1.0 0.3 13.3 8.6 0.9 11.7 12.9 1.0 38.6 9.2 3.9 31.4 63.7 7.6 17.5 10.3 1.1 0.8 12.9 18.4 8.8 0.3 0.9 0.7 3.9 13.9 10.3 6.8 26.7 4.4 21.8 11.3 1.5 24.8 34.6 0.6 45.6 20.3 3.1 1.1 1.2 9.5 4.3 0.3 13.0 22.1 32.3 33.8 15.0 19.1 0.9 0.5 2.0 1.0 0.6 2.8 0.7 16.4 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.1 0.0 0.0 3.4 5.8 0.0 0.0 0.0 0.0 59.6 0.0 21.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 24.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.3 4.6 0.0 0.0 0.0 0.0 2.1 21.3 5.3 1.7 0.4 9.5 0.5 1.1 6.8 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.2 0.1 2.0 2.8 1.0 1.9 0.6 0.6 0.9 0.5 0.9 2.1 1.1 0.1 0.6 0.1 0.2 0.0 0.7 1.1 1.0 8.6 0.9 1.1 0.8 0.9 0.7 4.4 0.3 14.9 7.2 0.8 177.1 344.0 0.0 23.2 40.8 46.8 50.0 33.2 0.0 79.7 23.2 31.5 0.9 4.3 54.6 0.0 16.8 20.9 7.3 126.3 2.3 30.2 7.1 0.0 57.5 1.3 1.2 0.0 0.6 2.3 33.7 1.8 54.2 5.2 36.6 51.8 0.0 10.3 0.4 0.0 10.3 9.0 3.6 482.8 135.1 0.0 36.4 297.3 IRF7 ENSG00000185507 "Interferon regulatory factor 7" Q92985 11 612553-615999 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 12 "plasmacytoid DC: 81.1" "Lineage enriched" "Detected in all" 12 "dendritic cells: 81.1" "Cell line enhanced" "Detected in some" "EFO-21: 6.1;JURKAT: 2.9;Karpas-707: 10.7;SCLC-21H: 5.3;SK-BR-3: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017694, HPA052757" Approved Supported Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "CAB017694: AB_2280489, HPA052757: AB_2681937" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.08e-3)" "unprognostic (2.45e-1)" "unprognostic (4.52e-2)" "unprognostic (2.73e-1)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-1)" "unprognostic (1.16e-1)" "unprognostic (7.08e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (1.71e-10)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (2.58e-1)" "unprognostic (4.71e-2)" 9.6 4.7 4.5 9.9 6.1 17.2 12.1 2.9 4.9 4.8 4.6 2.5 2.2 2.2 4.2 5.1 6.9 4.9 9.0 5.2 3.7 2.0 8.2 23.3 11.6 12.8 4.6 1.4 4.8 3.6 2.2 3.8 4.8 5.5 5.3 2.9 5.2 5.4 7.4 6.1 4.1 8.4 5.7 4.5 19.0 4.5 4.0 5.2 8.5 9.0 2.4 12.8 7.5 3.9 2.5 81.1 3.7 6.6 2.1 1.5 1.8 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.3 0.0 0.0 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.1 2.9 0.0 10.7 0.9 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.1 5.3 0.0 0.0 3.2 0.0 0.9 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.7 3.7 1.1 6.6 1.1 2.5 1.0 1.2 3.3 2.4 1.1 1.2 1.7 2.1 6.1 81.1 1.5 1.8 4.5 6.1 2.9 4.9 3.7 2.0 4.6 1.4 5.5 5.2 14.9 24.2 54.6 23.1 30.6 0.2 4.4 12.7 16.0 9.1 19.2 0.0 5.2 8.3 25.9 3.8 20.4 38.6 23.3 15.1 33.9 18.3 29.0 31.1 24.9 34.1 0.0 25.2 10.4 19.3 16.9 11.2 41.8 35.4 75.7 24.1 2.9 23.7 31.6 4.6 5.9 4.3 12.9 17.5 0.4 6.1 24.8 20.1 31.9 10.1 30.8 IRF9 ISGF3G ENSG00000213928 "Interferon regulatory factor 9" Q00978 14 24161053-24166565 "Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 34.1;BJ hTERT+ SV40 Large T+ RasG12V: 26.5;GAMG: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001862 Approved Supported Cytosol NA NA Cytosol "HPA001862: AB_1079153" "unprognostic (4.96e-3)" "unprognostic (4.91e-2)" "unprognostic (6.84e-3)" "unprognostic (8.17e-3)" "unprognostic (5.32e-2)" "unprognostic (2.51e-2)" "unprognostic (2.00e-1)" "unprognostic (1.77e-2)" "unprognostic (4.50e-1)" "unprognostic (9.10e-2)" "unprognostic (4.08e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (7.58e-8)" "unprognostic (1.56e-1)" "unprognostic (4.44e-2)" "unprognostic (4.40e-2)" "prognostic favorable (9.92e-4)" 34.4 20.9 23.4 35.0 25.3 21.5 15.8 10.1 19.5 19.1 19.1 22.5 15.1 19.2 23.5 31.3 18.6 22.6 27.4 13.5 17.7 24.6 27.4 26.8 23.8 22.7 22.1 18.4 26.5 13.6 13.9 17.5 25.4 22.1 21.7 11.8 17.8 36.0 16.2 8.1 14.7 20.3 20.4 23.8 37.0 22.4 9.3 20.1 26.4 29.2 12.0 28.3 30.1 21.9 28.4 21.4 57.8 30.9 19.5 29.0 25.4 1.6 1.5 1.5 0.6 7.6 8.0 0.9 3.0 16.4 34.1 26.5 2.8 9.4 2.2 3.4 8.2 22.1 2.9 1.0 0.7 8.6 10.0 0.3 4.7 1.5 2.8 11.6 0.5 6.4 7.6 2.5 4.3 1.0 6.7 3.7 0.6 0.8 12.4 4.4 2.3 1.0 1.8 0.5 1.3 3.0 0.7 1.1 1.2 7.8 1.7 0.4 1.4 2.9 1.9 16.2 2.6 0.7 4.3 6.9 3.5 2.6 2.2 0.9 13.2 10.3 2.1 4.1 0.8 3.2 45.6 24.3 30.8 21.5 30.9 18.4 28.4 22.7 19.3 19.4 25.5 20.1 18.1 57.8 19.5 29.2 21.4 29.0 25.4 23.4 25.3 10.1 18.5 17.7 24.6 22.1 18.4 22.1 20.1 23.8 13.7 11.2 7.5 2.1 5.9 0.2 12.7 49.5 12.5 5.2 7.9 1.0 0.0 4.2 0.1 13.5 7.7 23.3 4.8 21.0 5.8 7.1 23.2 1.7 6.4 7.9 1.7 11.6 4.9 0.2 11.8 15.1 5.0 3.6 2.6 14.7 4.2 5.8 6.3 1.2 4.0 12.9 8.2 1.1 1.5 2.4 1.4 16.0 2.5 9.4 IRS1 HIRS-1 ENSG00000169047 "Insulin receptor substrate 1" P35568 2 226731317-226799759 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.0;naive B-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005261, HPA046433" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005261: AB_649615, HPA046433: AB_2732524" "unprognostic (2.20e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.59e-2)" "unprognostic (3.86e-3)" "unprognostic (1.61e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-3)" "unprognostic (5.47e-2)" "unprognostic (2.24e-2)" "unprognostic (5.48e-3)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.46e-2)" "unprognostic (6.92e-2)" "unprognostic (3.23e-2)" "unprognostic (7.55e-3)" 7.0 9.9 3.1 5.0 2.7 0.6 11.7 9.6 5.4 13.3 14.2 1.4 3.9 4.0 17.2 5.0 3.8 13.9 11.5 6.3 3.9 2.2 5.2 12.0 5.0 2.5 2.3 2.6 21.9 7.1 3.4 2.5 9.1 4.2 9.8 2.9 5.5 3.3 7.5 23.3 5.1 6.5 11.7 2.6 3.3 5.8 2.4 1.7 17.1 23.4 5.6 2.5 14.6 15.8 1.2 0.4 0.0 0.2 0.0 0.3 0.2 3.2 15.0 10.9 0.4 15.1 9.0 0.0 9.0 7.1 12.0 7.8 8.5 8.3 1.3 1.5 6.1 8.3 5.7 0.7 8.6 6.9 3.3 0.6 0.0 1.0 4.0 7.5 0.3 0.0 12.5 4.8 9.5 8.6 7.3 0.0 1.3 1.6 13.3 8.1 12.8 2.7 3.7 4.4 2.0 8.3 0.6 14.2 0.1 5.5 10.8 1.9 0.3 2.9 2.1 4.8 9.2 8.0 0.1 0.7 16.0 14.6 12.2 8.6 6.2 2.5 2.0 15.8 0.3 4.7 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.1 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.3 0.2 3.1 2.7 9.6 5.4 3.9 2.2 2.3 2.6 4.2 1.7 17.9 5.8 0.5 24.9 31.5 18.2 11.5 12.7 4.0 6.8 0.0 0.0 5.2 14.9 12.8 1.3 2.0 11.1 0.0 9.5 0.7 21.2 13.8 0.0 56.3 1.6 19.1 2.4 3.1 1.0 0.0 21.0 0.6 15.1 0.0 7.5 7.6 8.9 10.4 13.8 2.2 1.9 12.9 14.2 1.1 0.7 20.7 15.3 0.0 5.7 21.8 IRS2 ENSG00000185950 "Insulin receptor substrate 2" Q9Y4H2 13 109752698-109786568 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.9" "Cell line enhanced" "Detected in many" "hTERT-HME1: 18.2;LHCN-M2: 17.3;SH-SY5Y: 19.1;THP-1: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016944, HPA054664" Approved Supported Aggresome,Cytosol NA NA Cytosol Aggresome "CAB016944: , HPA054664: AB_2682563" "unprognostic (2.87e-3)" "unprognostic (5.73e-3)" "unprognostic (4.39e-2)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (5.49e-3)" "unprognostic (2.10e-1)" "unprognostic (9.28e-2)" "unprognostic (9.70e-2)" "unprognostic (2.34e-3)" "unprognostic (1.17e-1)" "unprognostic (2.09e-2)" "unprognostic (6.21e-3)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (3.17e-2)" "unprognostic (1.24e-1)" 38.9 24.3 27.6 10.9 25.2 70.1 33.5 19.6 30.6 13.5 10.9 13.0 6.7 8.7 14.4 12.2 7.1 7.7 8.4 13.5 23.6 14.6 7.7 24.6 11.6 5.3 24.2 22.1 27.1 7.9 6.1 23.0 13.6 19.5 20.0 7.5 9.3 11.5 12.2 20.9 15.3 9.7 9.7 25.1 9.0 8.3 6.3 21.3 2.0 10.7 4.7 5.3 8.4 17.8 0.5 0.1 6.9 1.4 0.2 0.5 0.2 2.6 3.0 2.0 0.0 16.7 3.3 1.1 2.9 3.5 1.8 1.5 0.3 3.3 0.0 1.8 2.0 2.6 1.2 1.0 2.6 2.2 1.0 13.8 1.3 4.3 0.0 17.0 4.8 1.6 7.0 14.1 0.5 18.2 11.7 0.6 0.2 0.8 0.0 17.3 1.3 0.0 14.1 2.1 1.5 0.6 5.9 1.8 1.2 5.0 0.7 2.9 19.1 1.5 0.0 11.8 1.7 0.4 28.8 0.0 3.7 0.0 0.2 3.9 0.0 1.4 0.9 2.8 4.7 6.4 2.7 1.4 1.9 0.2 0.3 0.3 0.1 0.4 0.1 0.1 0.5 0.5 0.4 6.9 0.2 0.4 0.1 0.5 0.2 27.6 25.2 19.6 30.6 23.6 14.6 24.2 22.1 19.5 21.3 29.8 35.6 13.7 47.7 101.2 24.8 56.1 71.4 20.1 43.3 29.6 108.0 17.8 5.0 31.2 32.2 11.3 53.1 23.3 2.7 8.4 42.1 75.9 24.3 103.6 21.1 23.8 117.6 11.6 115.0 5.0 34.5 51.6 123.2 5.4 28.3 37.5 20.9 45.6 19.1 3.3 28.3 25.8 34.0 18.6 8.8 110.3 25.6 24.9 31.0 20.7 IRX5 IRX-2a ENSG00000176842 "Iroquois homeobox 5" P78411 16 54930862-54934485 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Vision" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 19.0;heart muscle: 26.5" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 18.7;Ciliated cells: 18.7;Club cells: 21.6;Muller glia cells: 47.9" "Cancer enhanced" "Detected in many" "breast cancer: 20.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 18.1;T-47d: 24.7;THP-1: 13.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "cerebellum: 4.1;hypothalamus: 3.2;midbrain: 7.6;pons and medulla: 5.7;thalamus: 4.7" HPA047130 Approved "Nuclear speckles,Microtubules,Cytosol" No NA "Nuclear speckles" "Microtubules, Cytosol" "HPA047130: AB_10962983" "unprognostic (2.63e-1)" "unprognostic (4.49e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-2)" "unprognostic (1.42e-2)" "unprognostic (3.89e-2)" "unprognostic (5.38e-3)" "prognostic favorable (4.59e-4)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (1.17e-3)" "unprognostic (3.34e-2)" "unprognostic (8.90e-2)" "unprognostic (1.77e-3)" "unprognostic (4.28e-2)" 3.3 0.7 0.2 0.2 1.4 0.2 19.0 5.8 0.3 3.6 0.5 1.7 0.2 0.2 0.4 1.9 7.6 0.3 0.4 26.5 0.9 1.3 4.7 0.2 10.3 0.3 2.6 0.0 0.5 0.3 0.5 0.3 0.2 5.3 4.2 0.2 6.5 13.6 0.5 6.7 13.9 0.2 0.3 4.5 0.2 3.3 0.9 2.2 0.4 0.2 1.0 2.4 0.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 5.8 2.2 2.1 0.4 0.2 2.2 5.5 0.7 0.5 1.3 0.5 0.0 0.5 2.9 0.2 5.6 2.0 2.4 0.4 3.9 2.7 0.6 2.4 0.0 0.0 1.3 2.2 0.6 10.3 3.6 1.6 1.0 0.0 3.2 0.3 0.0 4.2 2.1 6.1 8.0 0.1 0.8 1.6 3.2 3.0 0.3 18.1 0.1 2.0 2.0 0.9 5.0 2.4 0.0 24.7 13.2 0.3 4.1 0.1 2.8 0.8 2.5 1.4 1.9 6.6 2.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 5.8 0.2 0.9 1.3 2.6 0.0 5.3 2.2 8.9 18.7 0.0 8.4 7.3 1.1 9.4 0.0 18.7 21.6 0.0 0.0 0.2 0.0 0.2 0.9 0.7 0.0 0.0 0.5 0.0 2.1 4.4 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.7 0.0 0.0 5.0 0.0 0.5 47.9 1.8 0.0 0.0 0.7 1.9 0.0 1.2 0.2 3.0 6.9 0.0 0.0 0.3 6.1 ISCU "hnifU, IscU, ISU2, NIFUN" ENSG00000136003 "Iron-sulfur cluster assembly enzyme" Q9H1K1 12 108562582-108569384 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 1212.0;Proximal tubular cells: 986.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006329, HPA038602, HPA057592" Approved Supported Cytosol NA NA Cytosol "CAB006329: AB_425907, HPA038602: AB_2676109, HPA057592: AB_2683478" "unprognostic (1.72e-1)" "prognostic favorable (4.90e-7)" "unprognostic (1.53e-1)" "unprognostic (3.53e-1)" "unprognostic (2.43e-1)" "unprognostic (3.15e-2)" "unprognostic (1.33e-1)" "unprognostic (6.69e-3)" "unprognostic (1.14e-1)" "unprognostic (1.84e-1)" "unprognostic (1.28e-3)" "unprognostic (2.49e-2)" "prognostic favorable (2.73e-7)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-3)" "prognostic favorable (6.12e-4)" 37.3 91.2 44.7 25.2 62.2 23.6 44.5 27.4 61.6 37.4 39.7 20.1 32.7 25.2 36.5 44.7 25.2 32.5 34.6 121.6 37.5 56.1 86.7 33.1 29.6 34.1 54.9 58.9 48.5 28.3 41.7 48.5 31.4 65.8 36.6 33.1 34.7 33.9 59.6 87.3 21.4 27.2 50.5 27.4 33.6 32.9 29.9 21.9 30.3 53.2 39.1 37.6 36.3 42.1 86.6 34.7 85.9 34.3 29.6 61.9 53.8 10.0 24.8 17.6 10.4 63.3 48.7 42.9 20.3 33.5 15.6 14.8 18.4 14.5 10.2 17.5 27.8 16.7 14.8 16.7 23.3 14.1 31.3 18.0 11.1 13.5 40.6 36.9 26.3 13.2 47.1 52.3 16.8 33.7 39.8 23.7 22.1 20.6 33.1 32.5 22.0 20.6 48.0 17.0 15.2 36.5 13.7 11.7 43.8 45.3 29.2 15.1 14.0 14.8 8.8 22.2 23.0 22.6 21.4 20.1 15.9 13.3 12.6 10.2 39.4 43.0 31.4 24.7 19.7 15.9 62.3 29.4 84.0 37.2 30.2 44.0 86.6 49.1 48.0 19.9 73.7 61.9 51.7 85.9 29.6 34.3 34.7 49.7 53.8 44.7 62.2 27.4 61.6 37.5 56.1 54.9 58.9 65.8 21.9 71.5 123.4 189.5 128.2 87.1 45.3 660.9 137.6 139.2 104.6 221.6 9.8 370.6 1212.0 123.9 320.9 129.9 119.8 116.8 131.2 128.3 150.8 145.6 112.2 101.8 236.5 42.9 72.1 89.6 118.6 637.7 187.0 156.7 236.2 742.2 114.5 106.7 122.1 101.7 290.0 986.8 36.7 219.9 156.6 289.5 270.8 81.3 397.4 149.5 146.6 136.2 ISOC2 FLJ23469 ENSG00000063241 "Isochorismatase domain containing 2" Q96AB3 19 55452985-55462343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.9" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 256.8;Proximal tubular cells: 330.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 68.8" "Low region specificity" "Detected in all" HPA043142 Enhanced Approved Mitochondria,Cytosol NA NA 230000 Mitochondria Cytosol "HPA043142: AB_10794653" "unprognostic (2.74e-1)" "unprognostic (8.38e-3)" "unprognostic (7.34e-2)" "unprognostic (3.09e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-1)" "unprognostic (3.09e-1)" "unprognostic (5.82e-2)" "unprognostic (8.59e-2)" "unprognostic (9.90e-3)" "unprognostic (2.24e-1)" "unprognostic (2.42e-1)" "unprognostic (9.20e-2)" "unprognostic (2.09e-2)" 12.7 16.4 13.4 12.8 15.0 10.5 28.1 9.0 15.6 10.9 15.9 9.9 17.1 20.6 8.9 13.5 14.7 10.7 19.2 20.9 13.4 12.9 33.2 93.9 11.2 10.2 15.4 11.2 9.1 23.8 12.8 14.2 5.5 14.6 12.0 10.0 7.2 23.3 21.2 47.2 10.0 20.5 12.0 13.9 15.8 12.9 23.3 13.4 5.9 14.9 22.9 11.8 12.8 8.8 11.5 18.1 0.5 20.0 14.1 10.4 9.1 12.7 19.4 5.4 14.4 3.7 7.8 17.2 9.1 9.6 12.1 12.4 9.6 22.8 24.4 17.0 11.1 11.7 12.9 10.4 12.0 4.0 9.3 68.8 13.8 4.7 31.5 14.9 15.4 42.4 11.5 11.6 7.7 5.9 5.5 10.9 10.0 22.5 16.3 7.7 25.3 0.0 18.1 8.3 29.0 55.4 17.5 11.1 31.9 20.0 12.1 6.4 18.1 8.8 20.0 10.3 3.3 16.7 27.6 7.8 8.8 12.6 9.9 10.9 19.8 17.1 19.0 13.9 19.7 15.2 0.4 9.9 0.5 8.3 20.0 8.2 11.5 7.7 10.4 18.1 8.8 7.8 7.8 0.4 14.1 16.1 14.8 9.1 9.1 13.4 15.0 9.0 15.6 13.4 12.9 15.4 11.2 14.6 13.4 6.0 4.6 47.7 58.7 52.9 10.1 19.8 40.8 6.7 4.5 59.3 2.0 32.1 137.6 59.7 16.0 29.2 194.8 0.0 59.2 95.0 50.3 45.4 46.0 256.8 86.3 12.7 68.5 30.1 38.8 34.9 35.9 49.5 59.1 27.9 102.3 53.5 50.1 94.8 29.0 330.6 8.4 25.8 37.6 55.3 11.7 60.0 18.1 24.9 124.1 54.8 ISYNA1 "Ino1, INOS, IPS" ENSG00000105655 "Inositol-3-phosphate synthase 1" Q9NPH2 19 18434388-18438301 "Enzymes, Predicted intracellular proteins" "Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.6" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 829.0;Sertoli cells: 310.4;Syncytiotrophoblasts: 865.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5" "Cell line enriched" "Detected in many" 4 "BEWO: 103.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007931, HPA008232, CAB020720" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018" "unprognostic (1.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.98e-2)" "unprognostic (3.16e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-2)" "unprognostic (2.49e-1)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.28e-2)" "unprognostic (2.73e-2)" "unprognostic (5.08e-2)" "prognostic unfavorable (9.23e-4)" "unprognostic (2.23e-2)" "unprognostic (9.26e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" 7.9 8.4 7.1 3.0 5.7 4.5 7.1 2.7 6.7 9.9 3.5 10.0 44.2 3.4 13.9 12.3 4.5 20.0 6.5 8.0 5.7 7.4 12.7 4.1 4.7 3.8 4.1 4.1 31.6 25.5 7.7 12.6 44.2 16.2 9.5 1.3 19.3 8.8 34.4 8.2 3.4 3.9 3.0 2.3 10.5 3.7 83.6 3.5 3.0 5.6 3.8 3.3 5.9 7.8 4.0 1.9 0.9 0.2 11.9 8.5 4.9 2.8 8.6 20.5 6.1 0.1 0.0 103.8 1.3 0.2 0.1 0.0 4.9 5.2 0.0 7.0 0.6 0.0 7.4 0.6 0.0 0.0 7.7 23.6 10.3 0.5 15.9 2.2 0.1 0.2 1.6 0.1 0.6 0.1 0.0 1.3 0.2 21.1 0.4 0.0 16.6 0.7 0.7 10.7 2.6 6.9 14.2 0.0 4.8 1.7 0.0 6.3 15.8 0.3 1.9 10.5 4.4 14.0 1.1 3.9 0.1 0.2 0.1 0.3 3.3 1.4 0.6 0.6 0.4 3.6 0.9 0.1 0.0 7.6 0.2 5.9 4.0 7.4 6.7 0.7 2.3 6.1 8.5 0.8 11.9 0.1 1.9 5.2 4.9 7.1 5.7 2.7 6.7 5.7 7.4 4.1 4.1 16.2 3.5 3.0 0.6 2.2 67.1 10.6 0.0 4.2 7.6 4.0 4.5 45.4 2.0 829.0 44.7 34.8 81.2 19.7 1.3 0.0 7.5 57.3 25.4 8.5 13.9 0.9 73.6 0.0 62.2 19.0 5.3 178.1 34.5 3.7 21.9 7.2 2.6 7.2 4.6 0.0 47.4 4.7 0.5 310.4 167.1 59.2 21.8 5.0 865.2 9.6 4.6 31.8 ITGA2 CD49b ENSG00000164171 "Integrin subunit alpha 2" P17301 5 52989326-53094779 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 300.3;Glandular cells: 266.4;Pancreatic endocrine cells: 350.7;Urothelial cells: 321.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.9;HaCaT: 30.2;hTERT-RPE1: 28.1;HUVEC TERT2: 27.8;TIME: 23.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017690, HPA060991, HPA063556" Enhanced Approved Nucleoplasm,Cytosol Yes No 46000000 Nucleoplasm Cytosol "CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "unprognostic (3.70e-2)" "unprognostic (2.67e-3)" "unprognostic (2.38e-2)" "unprognostic (1.87e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.27e-1)" "unprognostic (3.88e-2)" "unprognostic (2.87e-2)" "unprognostic (1.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.11e-1)" 1.9 14.0 2.9 4.7 13.4 0.4 7.9 1.8 6.8 7.1 6.5 22.5 12.1 7.6 5.1 10.4 16.7 2.8 9.3 2.5 5.4 3.6 15.1 1.8 17.2 1.4 18.3 4.5 1.8 2.7 16.1 2.5 4.8 10.7 8.5 6.0 0.8 15.8 16.8 1.2 16.9 17.0 2.5 8.4 9.1 7.4 1.3 13.0 1.5 2.5 7.4 10.0 7.5 11.1 0.5 1.5 1.7 0.6 0.2 0.6 0.3 19.4 5.0 0.4 0.2 1.3 2.4 1.5 19.6 29.9 0.7 1.2 9.3 13.7 0.0 3.4 8.3 11.5 30.2 1.6 22.1 2.8 0.0 1.5 1.4 1.2 5.5 4.5 0.2 0.4 0.9 3.8 19.7 3.5 28.1 27.8 1.0 0.0 0.0 0.5 3.6 0.2 0.0 1.2 5.0 10.0 0.0 0.1 0.0 6.3 10.3 0.2 1.1 1.0 1.3 2.0 0.8 3.2 0.0 23.8 3.6 2.1 0.5 3.9 0.0 0.0 0.0 21.6 0.0 15.8 1.7 0.6 0.2 0.6 0.2 0.4 0.4 0.5 0.5 0.1 0.5 0.5 0.6 0.8 0.2 0.1 1.5 0.4 0.3 2.9 13.4 1.8 6.8 5.4 3.6 18.3 4.5 10.7 13.0 53.6 13.6 0.0 300.3 134.2 2.3 1.2 20.4 88.3 161.5 50.6 3.9 0.2 8.3 157.1 0.0 15.8 20.6 0.0 144.3 1.6 1.9 266.4 1.1 0.0 0.3 0.0 13.3 5.5 0.0 0.0 1.1 3.8 11.8 1.8 32.4 18.0 350.7 15.2 0.0 2.9 5.0 0.0 4.2 0.0 0.9 32.5 0.3 1.9 28.1 321.7 ITGAV "CD51, MSK8, VNRA, VTNR" ENSG00000138448 "Integrin subunit alpha V" P06756 2 186590065-186680901 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Group enriched" "Detected in many" 4 "granulocytes: 7.7;monocytes: 2.3" "Cell line enhanced" "Detected in many" "RT4: 71.7;SuSa: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002499, HPA004856" Supported Approved "Focal adhesion sites,Cytosol" NA NA 750000 "Focal adhesion sites, Cytosol" "CAB002499: AB_563594, HPA004856: AB_1846316" "unprognostic (4.03e-2)" "unprognostic (5.17e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.48e-2)" "unprognostic (6.95e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (5.84e-2)" "unprognostic (2.67e-2)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.61e-1)" "unprognostic (9.11e-2)" "unprognostic (8.07e-2)" 23.2 22.1 17.9 18.3 21.8 3.1 25.8 16.7 23.1 22.9 13.6 23.4 11.6 8.4 26.0 11.4 14.2 14.5 25.2 40.7 16.8 12.3 51.5 9.5 20.6 7.6 24.2 11.6 35.4 18.7 65.0 11.0 29.6 22.1 16.5 11.9 83.4 17.9 15.9 13.1 21.5 10.1 29.6 33.0 12.1 17.3 11.2 17.0 7.8 33.1 10.9 11.1 17.6 17.9 0.3 0.9 7.7 2.3 0.4 1.1 0.5 9.3 11.1 7.4 23.7 27.3 18.5 28.3 18.3 14.8 6.5 6.5 9.7 32.2 0.0 36.1 20.6 22.7 11.7 3.8 17.2 9.4 1.8 3.4 2.2 14.6 13.3 10.8 1.5 1.4 13.4 8.2 14.4 12.3 39.0 15.4 1.1 2.1 4.7 17.2 3.7 0.9 1.3 5.6 5.6 5.6 0.0 15.2 1.2 16.8 71.7 1.5 4.6 21.1 6.5 7.7 62.1 5.1 4.3 46.8 40.2 12.6 8.2 15.4 1.1 1.9 1.0 16.2 0.6 19.8 7.7 1.1 1.6 1.0 2.3 0.7 0.3 0.5 0.8 0.9 0.1 0.5 0.5 0.5 0.4 1.2 0.4 1.1 0.5 17.9 21.8 16.7 17.3 16.8 12.3 24.2 11.6 22.1 17.0 26.8 18.5 2.4 54.8 114.0 118.2 124.7 73.9 12.0 20.5 73.3 72.6 46.9 1.7 78.4 0.5 50.4 13.2 0.0 89.0 21.8 61.3 83.9 49.5 15.8 26.1 14.3 7.0 34.4 33.9 1.6 17.8 18.2 43.9 20.8 18.9 82.5 120.4 18.2 24.4 16.5 54.8 32.3 47.2 0.7 1.4 90.7 33.2 6.9 11.4 48.6 ITGB1BP1 "ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B" ENSG00000119185 "Integrin subunit beta 1 binding protein 1" O14713 2 9403475-9423547 "Predicted intracellular proteins" "Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 331.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067348, HPA071538" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA067348: AB_2732765, HPA071538: AB_2686413" "unprognostic (2.21e-1)" "unprognostic (8.31e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (4.39e-2)" "unprognostic (5.88e-3)" "prognostic unfavorable (4.67e-5)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (6.46e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (3.75e-2)" "unprognostic (2.01e-1)" "unprognostic (1.14e-3)" "unprognostic (4.08e-3)" 61.1 15.0 19.0 11.6 29.2 16.1 73.0 17.6 24.0 24.5 16.3 9.9 10.2 7.7 18.0 16.6 13.3 15.0 14.4 23.9 17.1 15.6 23.6 7.7 13.4 12.1 19.7 18.7 14.3 7.6 14.8 9.7 14.1 19.4 11.1 14.8 11.4 7.7 15.1 16.0 16.6 8.6 22.1 19.2 8.6 11.2 5.6 17.0 10.2 11.2 12.1 14.8 12.8 33.6 20.7 29.5 35.2 27.3 24.1 31.3 24.9 16.2 11.7 13.8 15.8 49.4 41.9 7.5 29.9 20.5 27.1 21.1 15.5 10.2 18.0 13.5 41.0 17.7 15.4 21.1 19.6 30.0 48.6 10.6 16.4 13.8 19.4 17.2 12.6 17.9 23.6 16.2 24.8 17.7 23.5 23.6 13.8 9.1 14.9 33.5 14.5 22.3 8.2 11.2 27.0 19.7 12.8 19.0 16.7 27.4 13.4 15.0 14.5 16.6 12.9 20.2 13.4 9.4 9.6 15.0 24.3 17.9 32.3 33.2 15.0 32.2 26.3 33.3 17.4 16.8 35.2 23.0 27.9 30.4 27.3 28.9 20.7 26.5 29.4 29.5 17.5 20.6 26.5 5.0 24.1 20.0 26.6 31.3 24.9 19.0 29.2 17.6 24.0 17.1 15.6 19.7 18.7 19.4 17.0 26.8 17.8 55.0 30.0 54.4 22.1 77.9 25.5 26.8 17.0 36.6 2.0 41.1 331.5 76.9 20.7 75.2 19.2 23.3 63.1 65.6 89.2 30.0 39.4 18.4 81.8 33.4 31.9 48.5 32.7 17.0 50.3 60.8 92.8 103.6 36.3 33.6 74.4 28.1 53.7 63.2 23.3 90.5 99.4 10.4 19.0 55.2 26.3 45.7 35.3 48.0 ITGB1BP2 CHORDC3 ENSG00000147166 "Integrin subunit beta 1 binding protein 2" Q9UKP3 X 71301734-71305371 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 69.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA040721 Approved Cytosol NA NA Cytosol "HPA040721: AB_10805827" "unprognostic (1.87e-1)" "unprognostic (2.65e-2)" "unprognostic (6.91e-5)" "unprognostic (1.95e-2)" "unprognostic (7.92e-2)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (9.02e-2)" "unprognostic (4.69e-2)" "unprognostic (2.15e-2)" "unprognostic (4.85e-2)" "unprognostic (3.17e-1)" "unprognostic (3.08e-11)" "unprognostic (4.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-1)" 0.7 0.3 0.2 1.0 0.3 0.6 0.3 0.6 0.2 2.7 2.8 0.0 2.3 0.4 12.8 3.4 4.0 1.8 4.8 43.0 0.2 0.2 0.4 0.6 0.5 0.5 0.3 0.0 2.4 0.3 0.0 0.3 0.2 0.2 3.2 0.9 3.5 0.7 5.8 21.3 0.3 1.0 18.6 0.3 0.6 1.1 1.6 0.1 0.0 0.4 19.6 0.7 5.6 0.8 0.2 0.2 1.5 0.2 0.0 0.5 0.0 0.7 2.1 3.2 2.8 0.1 0.1 0.7 1.0 1.4 0.7 0.9 1.6 1.6 3.1 0.4 1.6 0.8 1.5 2.9 0.8 1.8 1.0 1.3 1.9 1.9 0.6 0.4 0.7 14.0 1.7 1.3 0.5 0.5 0.7 1.2 3.4 1.4 0.8 1.6 0.9 1.2 3.5 4.7 2.1 1.3 2.1 2.5 1.2 1.6 2.0 1.5 0.5 0.7 0.1 0.8 2.2 0.9 0.4 0.0 1.4 2.8 0.3 0.6 2.9 3.8 4.8 0.4 2.4 0.6 0.0 0.2 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 1.5 69.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.1 0.3 0.9 0.0 1.7 0.3 0.3 0.3 0.0 0.0 0.3 0.0 ITGB7 ENSG00000139626 "Integrin subunit beta 7" P26010 12 53191318-53207307 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.3;lymphoid tissue: 37.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 35.7;granulocytes: 29.9;T-cells: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 99 "Karpas-707: 295.2;RPMI-8226: 230.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042277 Approved "Nucleoplasm,Nuclear membrane,Vesicles,Plasma membrane,Cytosol" NA NA 42000 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA042277: AB_10793877" "unprognostic (5.34e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-3)" "unprognostic (1.40e-2)" "unprognostic (6.57e-4)" "unprognostic (3.51e-5)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.58e-1)" "unprognostic (2.18e-1)" "unprognostic (9.63e-3)" "unprognostic (3.36e-1)" "unprognostic (1.02e-2)" "unprognostic (2.16e-1)" "unprognostic (6.95e-2)" "unprognostic (9.34e-2)" "unprognostic (2.47e-4)" 1.8 1.4 1.4 29.1 1.8 7.5 1.5 0.6 1.2 1.8 8.7 2.9 0.8 6.7 2.3 2.8 6.6 2.0 5.6 1.4 1.5 1.0 5.4 5.1 4.9 26.4 1.9 1.0 1.1 1.3 0.7 1.7 1.8 2.4 2.7 5.6 2.1 10.7 2.2 1.0 6.4 15.1 1.5 2.0 26.7 4.3 0.9 2.0 7.8 3.6 4.4 37.6 4.6 3.0 10.1 15.4 31.3 1.9 7.5 23.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 295.2 0.0 0.0 0.0 0.4 0.0 2.4 0.0 0.1 0.0 230.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.1 0.1 22.6 1.9 31.3 19.3 0.5 14.3 10.1 19.4 23.0 15.4 8.3 16.3 17.1 0.5 7.5 0.1 4.2 22.7 5.2 1.4 1.8 0.6 1.2 1.5 1.0 1.9 1.0 2.4 2.0 3.0 8.5 35.7 0.3 1.9 0.0 0.4 2.5 0.0 0.0 7.0 3.9 0.1 6.6 0.2 0.0 0.1 0.0 0.0 0.5 0.1 1.0 0.1 29.9 1.6 13.8 0.0 0.0 0.6 3.0 0.0 0.0 7.0 6.8 7.2 0.3 6.6 0.6 0.0 0.0 4.4 0.7 0.0 0.4 0.2 1.1 3.1 0.1 27.7 0.9 1.3 ITGB8 ENSG00000105855 "Integrin subunit beta 8" P26012 7 20330702-20415754 "Cancer-related genes, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 99.3;Ciliated cells: 78.9;Glandular cells: 109.9;Urothelial cells: 146.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 105 "basophil: 13.8" "Lineage enriched" "Detected in single" 105 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "AF22: 16.6;EFO-21: 21.4;RPTEC TERT1: 33.2;WM-115: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027796, HPA027797" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027796: AB_10600299, HPA027797: AB_10600879" "unprognostic (8.32e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (5.63e-2)" "unprognostic (3.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (4.36e-2)" "unprognostic (1.75e-2)" "unprognostic (2.49e-3)" "unprognostic (8.47e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.63e-2)" "unprognostic (6.92e-3)" 4.7 4.1 18.0 5.8 20.0 1.2 12.7 7.8 24.3 22.1 4.6 19.4 9.0 4.6 10.5 19.0 8.8 10.4 11.7 3.9 19.4 12.5 28.1 1.7 3.7 1.3 29.3 14.5 7.1 17.5 8.1 7.7 10.7 22.8 9.6 4.4 37.5 16.6 13.1 0.9 8.5 6.0 7.0 23.1 0.8 6.2 8.7 24.0 0.0 3.4 1.3 9.0 6.8 9.9 0.0 0.0 13.8 0.1 0.0 0.1 0.0 10.2 0.4 16.6 2.1 1.4 5.9 0.0 0.0 0.1 0.1 0.6 0.1 2.6 0.0 21.4 0.7 0.6 11.4 0.7 1.6 0.2 0.0 0.2 0.0 8.0 0.0 0.7 0.0 0.0 0.7 4.7 0.2 0.9 10.2 0.8 0.0 0.0 3.1 0.3 0.0 0.0 0.0 1.2 0.1 1.8 0.0 1.4 0.0 33.2 0.9 0.2 0.7 3.2 0.0 8.3 0.3 0.2 0.0 1.1 4.3 2.8 1.2 2.1 3.9 0.0 0.0 1.0 0.0 47.5 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 18.0 20.0 7.8 14.2 19.4 12.5 29.3 14.5 22.8 24.0 11.9 3.7 0.8 99.3 29.5 5.2 3.1 43.3 78.9 30.7 36.6 0.0 12.5 6.6 22.1 2.3 1.9 4.6 0.0 15.3 0.9 3.2 109.9 1.1 0.0 3.1 1.6 32.6 1.3 1.5 3.5 40.9 12.4 3.3 55.1 6.8 26.0 24.5 6.2 42.1 44.6 1.2 0.0 1.4 0.5 0.7 10.8 4.1 0.5 7.3 146.8 ITK "EMT, LYK, PSCTK2" ENSG00000113263 "IL2 inducible T cell kinase" Q08881 5 157142933-157255191 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 28.0;lymphoid tissue: 60.5" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 2: 10.4;granulocytes: 32.2;T-cells: 47.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 28 "gdT-cell: 13.8;MAIT T-cell: 9.1;memory CD4 T-cell: 19.5;memory CD8 T-cell: 18.9;naive CD4 T-cell: 28.0;naive CD8 T-cell: 22.8;NK-cell: 9.2;T-reg: 23.1" "Group enriched" "Detected in many" 29 "NK-cells: 9.2;T-cells: 28.0" "Group enriched" "Detected in some" 9 "JURKAT: 36.5;MOLT-4: 13.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA043670 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043670: " "unprognostic (2.08e-3)" "unprognostic (6.57e-4)" "unprognostic (5.06e-3)" "unprognostic (4.96e-5)" "unprognostic (1.52e-2)" "unprognostic (1.12e-4)" "unprognostic (8.45e-4)" "unprognostic (1.56e-2)" "unprognostic (1.87e-2)" "unprognostic (5.99e-3)" "unprognostic (1.76e-1)" "unprognostic (2.52e-1)" "unprognostic (4.52e-6)" "unprognostic (3.64e-1)" "unprognostic (4.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.26e-2)" 2.3 0.7 0.5 12.2 0.6 2.5 1.3 1.9 0.5 1.4 3.3 0.0 0.0 0.5 1.2 1.1 1.8 1.4 4.3 0.9 0.5 0.5 1.4 1.2 6.6 60.5 0.9 0.0 0.7 0.7 0.0 0.9 0.1 0.3 1.1 1.3 1.5 3.5 1.1 0.5 1.0 8.9 0.4 1.2 10.7 2.3 1.4 0.0 60.3 1.6 2.7 24.3 4.1 1.3 0.0 0.0 0.4 0.6 9.2 28.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 13.8 0.0 9.1 0.0 19.5 18.9 0.0 0.0 28.0 22.8 0.4 9.2 0.6 0.0 23.1 13.6 0.5 0.6 1.9 0.5 0.5 0.5 0.9 0.0 0.3 0.0 0.0 10.4 0.0 0.6 2.4 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 32.2 0.6 0.0 0.0 0.0 1.8 0.6 5.5 0.0 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 3.0 0.1 47.3 0.0 0.4 ITPA "C20orf37, dJ794I6.3, HLC14-06-P" ENSG00000125877 "Inosine triphosphatase" Q9BY32 20 3208868-3223870 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022824, HPA073963" Approved Supported Nucleoplasm,Cytosol NA NA 69000 "Nucleoplasm, Cytosol" "HPA022824: AB_1851960, HPA073963: " "unprognostic (1.58e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-1)" "unprognostic (3.57e-1)" "unprognostic (4.63e-2)" "unprognostic (1.53e-2)" "prognostic unfavorable (2.54e-5)" "unprognostic (1.11e-2)" "unprognostic (1.68e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-1)" "unprognostic (2.28e-1)" "unprognostic (1.94e-2)" "unprognostic (8.34e-2)" "unprognostic (3.63e-1)" "unprognostic (1.24e-1)" "unprognostic (1.84e-1)" 17.7 27.5 18.6 24.7 21.2 20.4 17.7 10.2 22.7 21.3 21.4 18.3 20.6 22.9 18.1 17.3 31.0 26.6 19.6 25.9 18.1 13.5 22.9 20.3 22.7 30.6 20.5 24.1 16.5 43.8 17.6 10.2 17.0 16.2 14.6 16.8 13.2 19.9 21.5 19.5 23.4 19.0 16.3 16.3 20.6 19.3 16.7 19.5 15.2 24.9 29.0 24.1 14.6 17.7 19.3 30.7 11.3 31.0 24.7 24.1 18.2 32.7 25.9 12.8 13.3 8.5 12.6 8.5 14.9 20.7 19.6 17.2 20.7 30.5 14.1 13.6 13.6 19.2 28.5 17.6 22.3 13.7 9.2 26.3 35.3 10.7 31.4 16.1 15.1 12.0 12.0 17.1 18.4 11.5 8.1 14.9 11.4 24.2 9.7 17.5 15.0 17.8 43.9 21.4 37.0 26.2 17.1 17.8 37.0 26.8 10.4 19.4 22.9 11.7 41.1 27.3 5.9 17.1 25.2 10.4 22.0 12.3 14.4 31.4 14.5 18.2 26.7 10.2 28.0 23.9 11.3 25.7 8.8 20.7 31.0 18.0 19.3 18.9 21.8 30.7 17.8 14.2 17.2 1.4 24.7 21.9 28.3 24.1 18.2 18.6 21.2 10.2 22.7 18.1 13.5 20.5 24.1 16.2 19.5 20.8 43.1 32.8 43.8 35.6 18.3 8.0 40.8 26.8 37.5 41.8 13.7 62.7 49.7 88.7 2.3 18.6 41.6 0.0 90.9 108.9 44.0 43.6 41.5 32.1 103.0 4.8 26.4 29.4 43.0 2.3 28.7 50.7 38.8 123.6 48.5 17.1 82.5 52.6 20.8 63.4 20.3 19.4 36.4 14.6 19.4 43.0 47.0 46.3 66.6 52.1 IVL ENSG00000163207 Involucrin P07476 1 152908545-152911886 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 97.1;tongue: 152.1" "Cell type enriched" "Detected in some" 8 "Suprabasal keratinocytes: 62.0" "Group enriched" "Detected in many" 5 "cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "HaCaT: 78.9;RT4: 20.7;SK-BR-3: 23.8" "CAB002243, HPA055211" Enhanced Supported "Nuclear bodies,Centrosome,Cytosol" NA NA 8000000 Cytosol "Nuclear bodies, Centrosome" "CAB002243: AB_563785, HPA055211: AB_2682739" "unprognostic (3.29e-4)" "unprognostic (1.91e-1)" "unprognostic (2.92e-2)" "unprognostic (2.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (4.82e-2)" "unprognostic (3.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.22e-2)" "unprognostic (1.32e-1)" 0.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 39.0 0.1 0.0 0.4 0.1 4.2 11.5 97.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 1.8 0.1 0.0 18.7 0.1 0.2 34.2 0.1 1.0 0.0 0.1 0.1 0.1 0.0 1.9 0.1 152.1 49.1 4.9 43.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 78.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 23.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.0 0.0 0.0 7.4 IVNS1ABP "HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP" ENSG00000116679 "Influenza virus NS1A binding protein" Q9Y6Y0 1 185296388-185317329 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 171.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 72.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003405 Approved Supported Cytosol NA NA Cytosol "HPA003405: AB_1079141" "unprognostic (4.11e-3)" "unprognostic (9.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.77e-1)" "unprognostic (2.03e-2)" "unprognostic (4.42e-2)" "unprognostic (4.31e-3)" "unprognostic (4.18e-1)" "unprognostic (7.04e-2)" "unprognostic (5.13e-2)" "unprognostic (4.28e-1)" "unprognostic (5.42e-3)" "unprognostic (1.85e-3)" "unprognostic (3.73e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-2)" "unprognostic (4.13e-2)" 23.7 8.7 9.9 19.8 35.8 171.2 29.0 9.9 13.8 12.5 17.0 19.2 28.5 16.2 10.2 12.9 17.1 9.0 15.9 19.3 10.9 8.6 38.7 10.2 26.5 29.9 23.0 7.8 12.7 17.1 11.6 11.9 15.8 16.8 12.6 21.5 9.2 36.2 38.8 13.5 19.5 14.3 7.9 19.3 12.8 18.3 9.0 20.8 13.1 17.3 16.0 16.3 11.5 22.5 4.6 9.1 24.5 8.1 7.4 7.9 8.1 6.8 7.6 22.2 8.9 7.9 2.6 21.0 13.5 4.2 8.5 7.8 8.0 11.0 11.0 11.2 6.6 3.8 9.6 8.1 8.9 9.2 8.1 7.8 10.4 11.4 6.4 3.1 7.2 4.1 1.9 10.1 6.5 21.0 19.1 11.0 10.8 6.8 6.2 15.4 5.2 11.9 5.0 14.0 16.6 1.7 7.0 5.9 5.9 72.8 9.2 15.6 13.3 12.0 10.0 8.1 30.6 4.5 3.5 7.5 12.0 7.3 3.0 9.6 8.9 7.1 6.5 8.8 7.4 5.3 5.1 8.1 7.7 7.9 5.9 7.0 4.6 6.0 5.7 9.1 3.3 6.7 6.3 24.5 7.4 7.2 2.5 6.1 8.1 9.9 35.8 9.9 13.8 10.9 8.6 23.0 7.8 16.8 20.8 41.7 67.3 23.9 76.0 167.8 12.2 45.1 25.5 46.8 72.8 122.1 49.1 11.2 139.3 33.5 33.7 62.5 117.0 23.3 36.8 54.3 54.5 48.7 39.4 20.2 32.0 20.6 58.0 23.4 104.1 26.3 5.5 105.9 96.2 13.6 93.0 11.3 26.3 37.4 2.5 68.4 31.5 6.5 42.2 28.1 16.2 158.7 15.3 55.8 81.7 88.9 JAG2 ENSG00000184916 "Jagged 2" Q9Y219 14 105140981-105168824 "Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.0" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 20.7;Cone photoreceptor cells: 23.6;Endothelial cells: 17.9;Horizontal cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 10.7;CAPAN-2: 10.7;HaCaT: 33.0;HBEC3-KT: 11.1;SCLC-21H: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025481, HPA030636, HPA050567" Approved Supported Vesicles,Cytosol NA NA 120000 Vesicles Cytosol "CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178" "unprognostic (6.74e-2)" "unprognostic (4.49e-2)" "unprognostic (4.28e-2)" "unprognostic (6.97e-3)" "unprognostic (3.50e-1)" "unprognostic (2.13e-2)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-2)" "unprognostic (2.62e-1)" "unprognostic (1.67e-2)" "unprognostic (9.19e-2)" "unprognostic (8.47e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.39e-1)" "unprognostic (2.17e-1)" 11.5 2.5 5.4 3.5 6.3 1.3 11.4 6.4 8.4 4.2 3.0 3.5 5.2 3.2 7.5 8.4 8.1 5.0 4.4 9.5 5.6 6.4 3.0 1.5 6.6 2.4 4.5 5.3 2.7 5.8 4.3 15.9 6.8 8.7 7.1 1.7 5.9 12.2 6.9 16.8 36.0 4.3 3.2 2.9 3.7 3.8 4.2 3.0 2.7 4.2 11.0 4.1 5.2 5.6 0.0 0.0 0.0 0.0 0.5 0.3 0.0 8.5 3.5 0.2 0.9 0.0 0.0 10.7 0.1 0.1 0.0 0.0 2.9 10.7 0.0 7.4 0.0 0.0 33.0 2.1 11.1 0.0 1.1 5.1 0.0 9.5 0.0 0.1 0.0 2.1 0.1 5.4 0.0 1.2 0.1 2.7 0.4 2.1 0.0 0.0 3.9 0.0 0.0 1.1 1.0 1.2 2.7 2.1 3.7 0.1 2.3 16.9 0.5 2.9 0.7 0.1 0.2 8.4 1.3 9.1 0.0 0.9 0.0 0.1 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 5.4 6.3 6.4 8.4 5.6 6.4 4.5 5.3 8.7 3.0 6.0 2.7 0.0 7.9 20.7 1.1 5.9 0.0 5.3 7.9 0.0 23.6 1.9 0.0 3.4 0.1 17.9 4.9 0.0 2.2 0.9 1.0 2.7 0.0 0.6 0.6 25.4 0.0 5.5 0.0 0.4 1.4 1.2 6.8 1.8 2.8 0.6 3.6 2.8 0.7 0.1 4.8 0.0 2.1 0.5 13.7 5.9 1.1 2.6 2.9 1.4 JAK3 "JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK" ENSG00000105639 "Janus kinase 3" P52333 19 17824780-17848071 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 68.3" "Cell type enhanced" "Detected in many" 7 "B-cells: 18.2;Ito cells: 14.1;Peritubular cells: 13.8;T-cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 20.6;HEL: 9.2;HMC-1: 9.4;Karpas-707: 24.0;U-266/70: 9.3;U-266/84: 13.8;U-937: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA070314 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA070314: AB_2686251" "unprognostic (5.59e-3)" "prognostic favorable (6.42e-5)" "unprognostic (5.71e-2)" "unprognostic (2.34e-1)" "unprognostic (6.13e-3)" "unprognostic (1.11e-3)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.58e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.89e-14)" "unprognostic (2.28e-1)" "unprognostic (2.21e-2)" "unprognostic (4.43e-2)" "unprognostic (7.61e-2)" 6.8 1.7 4.0 24.5 8.5 12.0 2.7 2.4 3.1 1.9 2.3 1.0 0.0 2.2 1.7 2.0 2.5 3.5 3.6 4.3 2.7 2.8 3.8 2.0 8.4 68.3 7.5 0.0 11.0 2.0 0.4 2.3 4.1 5.3 3.0 2.4 1.6 6.1 1.5 0.7 1.3 9.5 2.5 8.4 36.1 3.2 1.8 5.8 20.9 3.4 1.7 28.8 5.3 2.4 7.4 4.5 16.9 9.6 8.4 15.0 6.8 0.1 0.3 0.3 1.1 0.4 1.5 0.2 0.5 0.0 0.0 0.1 0.0 0.9 0.4 2.0 0.4 0.3 0.1 0.0 0.2 0.0 20.6 0.0 9.2 0.0 0.8 0.7 0.0 9.4 5.1 0.2 0.0 0.0 0.0 0.2 2.1 0.0 24.0 0.0 0.4 3.6 0.0 0.2 0.5 0.7 4.7 0.0 0.4 0.5 0.0 0.0 0.3 0.1 0.2 0.0 0.1 2.0 1.4 0.4 0.0 0.4 0.0 0.0 9.3 13.8 2.5 0.1 14.0 0.2 1.2 4.9 0.2 12.6 9.6 14.5 6.5 15.0 13.1 4.5 7.4 14.9 13.0 16.9 8.4 8.8 3.7 11.8 6.8 4.0 8.5 2.4 3.1 2.7 2.8 7.5 0.0 5.3 5.8 0.0 5.8 18.2 0.5 0.7 0.3 1.4 0.0 0.0 1.2 1.8 0.0 0.9 0.0 0.6 1.0 5.8 0.0 0.0 0.3 0.7 2.3 0.2 4.7 0.0 11.5 0.0 0.0 14.1 10.8 0.9 11.5 3.5 3.3 12.6 0.0 0.8 0.4 0.0 13.8 0.1 0.5 6.5 2.1 0.3 0.7 0.9 1.1 24.5 0.0 0.5 JMJD1C "DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8" ENSG00000171988 "Jumonji domain containing 1C" Q15652 10 63167221-63521850 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056175, HPA066195" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA056175: AB_2683057, HPA066195: AB_2685634" "unprognostic (7.72e-2)" "unprognostic (5.57e-2)" "unprognostic (9.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.87e-2)" "unprognostic (6.91e-2)" "unprognostic (3.85e-1)" "unprognostic (2.54e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (2.22e-3)" "unprognostic (1.27e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-2)" "unprognostic (2.53e-1)" "unprognostic (4.18e-2)" "unprognostic (1.13e-1)" 31.7 10.9 8.7 26.0 10.9 25.9 16.2 43.0 11.1 21.8 16.6 5.4 11.8 12.2 18.1 17.4 16.4 13.1 18.5 11.7 10.8 8.1 14.1 16.7 29.9 20.9 9.6 6.5 19.2 12.6 27.1 18.6 10.3 14.1 14.1 9.2 13.8 15.3 15.6 13.4 11.0 22.2 11.7 17.6 29.1 12.9 10.9 13.3 27.2 15.6 20.1 15.3 21.9 11.8 4.8 4.2 15.2 2.8 1.7 3.1 1.1 11.0 5.6 13.2 10.1 7.0 13.0 4.6 7.7 16.0 7.0 9.6 9.5 11.9 15.0 4.7 7.2 6.3 9.1 3.7 7.4 12.5 4.0 4.7 5.7 5.8 6.9 8.6 12.2 2.1 12.9 7.7 12.3 36.1 15.9 12.5 10.8 10.0 11.4 16.3 3.0 9.3 6.6 14.1 2.5 19.8 16.2 28.7 7.1 7.1 8.0 7.2 11.8 11.6 7.3 11.1 10.1 7.2 22.2 14.9 6.5 9.2 5.6 9.6 10.2 8.1 14.3 7.9 7.3 5.8 0.6 2.8 3.1 2.0 1.9 3.1 4.7 2.2 2.1 2.4 4.8 3.1 2.6 15.2 1.7 1.6 4.2 1.9 1.1 8.7 10.9 43.0 11.1 10.8 8.1 9.6 6.5 14.1 13.3 104.2 81.3 88.7 263.2 135.0 89.5 52.3 45.9 113.8 121.7 52.4 143.3 28.1 11.6 51.6 31.8 129.1 72.6 0.0 41.5 23.6 115.8 122.0 90.2 30.6 51.0 111.2 82.5 89.6 79.2 32.2 96.1 141.3 72.6 41.5 51.6 62.3 60.4 56.1 84.1 23.1 170.7 71.1 102.3 135.2 137.3 117.1 27.8 76.7 33.1 223.6 JMJD7 ENSG00000243789 "Jumonji domain containing 7" P0C870 15 41828085-41837581 "Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Monooxygenase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.9;Ciliated cells: 1.4;Club cells: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 19.5;RT4: 27.5" "Low region specificity" "Detected in all" HPA005726 Approved Approved Cytosol NA NA Cytosol "HPA005726: AB_1852017" "unprognostic (2.92e-1)" "unprognostic (7.99e-2)" "unprognostic (1.47e-2)" "unprognostic (2.30e-2)" "unprognostic (9.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (1.78e-2)" "unprognostic (2.11e-2)" "unprognostic (1.77e-1)" "unprognostic (2.42e-1)" "unprognostic (8.74e-3)" "unprognostic (3.13e-1)" "unprognostic (7.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" 5.8 7.3 9.8 10.7 10.2 9.3 8.1 39.2 10.8 8.9 6.3 12.3 11.2 6.4 5.5 7.4 26.1 8.8 8.6 14.1 10.2 9.6 6.1 7.1 11.2 8.5 10.8 7.8 11.9 19.1 8.0 9.1 4.3 11.2 11.5 4.4 10.9 26.7 15.1 7.1 29.2 6.1 7.6 13.9 6.4 8.5 5.9 10.7 4.9 13.1 11.9 13.9 11.0 13.6 7.9 8.7 8.3 12.6 9.8 17.7 10.0 4.8 4.6 6.0 1.7 1.6 1.1 3.7 1.9 4.2 3.2 2.6 6.5 3.8 0.6 4.1 1.2 3.4 12.3 2.8 9.7 1.0 4.8 2.9 6.5 6.2 3.9 2.7 3.2 7.0 0.7 8.8 2.2 4.7 3.1 3.7 6.3 4.3 4.0 2.3 6.6 3.9 3.0 2.5 19.5 3.1 1.8 4.0 4.8 7.3 27.5 6.4 2.2 1.7 8.7 2.7 1.8 16.8 3.3 3.4 2.4 5.4 5.1 3.8 6.6 2.2 1.9 3.2 7.7 3.6 5.1 12.4 8.3 12.3 12.6 12.9 5.8 13.9 16.2 8.7 7.9 17.7 14.0 3.3 9.8 11.9 5.4 13.3 10.0 9.8 10.2 39.2 10.8 10.2 9.6 10.8 7.8 11.2 10.7 3.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 JMJD7-PLA2G4B ENSG00000168970 "JMJD7-PLA2G4B readthrough" 15 41828095-41848155 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 4.5;Club cells: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 5.6" HPA005726 Approved Approved Cytosol NA NA Cytosol "HPA005726: AB_1852017" "unprognostic (9.87e-3)" "unprognostic (5.65e-2)" "unprognostic (1.27e-2)" "unprognostic (6.86e-3)" "unprognostic (1.04e-1)" "unprognostic (1.84e-3)" "unprognostic (1.47e-1)" "unprognostic (7.21e-3)" "unprognostic (4.52e-2)" "unprognostic (4.92e-2)" "unprognostic (1.53e-2)" "unprognostic (1.02e-3)" "unprognostic (1.02e-3)" "unprognostic (3.98e-1)" "unprognostic (1.33e-1)" "unprognostic (2.15e-1)" "unprognostic (4.75e-3)" 6.6 2.8 4.7 5.2 4.9 6.8 4.5 21.4 5.3 6.0 4.3 6.1 5.5 2.7 4.9 3.5 8.7 6.5 3.8 3.9 4.9 2.2 2.9 3.0 6.7 3.8 5.3 3.6 5.5 5.8 2.7 4.3 1.9 5.5 4.3 2.5 5.3 9.0 7.7 4.9 12.0 4.4 4.2 3.7 3.6 4.0 2.6 5.2 1.9 4.6 5.9 7.0 6.4 6.3 0.7 1.3 0.0 1.5 0.7 4.0 1.0 0.8 0.5 1.2 4.2 1.1 3.1 1.9 0.9 2.2 1.4 2.0 2.0 0.1 0.4 1.8 1.1 0.1 4.3 0.4 3.4 0.3 0.0 0.4 0.6 0.9 0.6 4.7 0.0 2.5 1.6 2.3 0.5 1.1 0.0 0.5 1.7 0.0 0.6 0.4 0.7 0.9 0.1 0.1 1.1 0.2 0.6 0.0 1.5 1.1 5.6 1.5 1.8 3.8 0.0 0.5 0.2 0.9 4.4 0.7 0.7 0.6 4.8 1.7 1.2 0.4 0.0 2.2 0.6 0.4 0.0 1.1 0.0 4.0 1.5 1.9 0.7 0.4 0.6 1.3 0.1 0.7 0.0 0.0 0.7 1.0 0.0 0.1 1.0 4.7 4.9 21.4 5.3 4.9 2.2 5.3 3.6 5.5 5.2 8.9 4.5 0.0 0.1 0.1 0.6 0.4 0.0 1.4 4.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.8 0.0 0.4 0.1 0.2 0.1 1.1 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.9 0.1 0.0 0.9 0.0 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 25.0;Cone photoreceptor cells: 21.6;Early spermatids: 44.0;Horizontal cells: 47.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "MCF7: 6.5;NTERA-2: 5.8;SH-SY5Y: 7.5;SiHa: 4.9;U-2 OS: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA076304: AB_2686793" "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 1.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 6.5 0.0 0.0 5.8 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.5 4.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 0.0 0.0 0.0 0.0 0.0 25.0 2.8 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 44.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.7 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.9 3.4 0.0 0.1 0.0 0.0 0.0 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578800 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.7;seminal vesicle: 37.8" "Group enriched" "Detected in many" 19 "Bipolar cells: 144.6;Horizontal cells: 387.7" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.4;myeloid DC: 5.9" "Group enriched" "Detected in many" 14 "dendritic cells: 5.9;monocytes: 5.4" "Group enriched" "Detected in some" 6 "SCLC-21H: 10.1;SH-SY5Y: 25.2;U-2 OS: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013492 Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013492: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.9 12.3 33.6 2.0 43.8 1.3 1.6 45.3 63.7 3.4 1.9 2.1 8.0 1.8 17.1 6.2 1.5 5.1 1.6 1.3 32.3 16.8 2.7 1.3 3.4 2.0 8.3 27.6 6.2 1.5 3.1 23.2 1.6 9.8 11.6 1.7 0.8 1.2 37.8 1.2 1.6 2.2 13.9 4.2 2.9 1.7 2.2 10.9 0.0 1.3 0.0 1.7 1.7 1.8 0.0 5.9 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.5 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.5 10.1 25.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 33.6 43.8 45.3 42.6 32.3 16.8 8.3 27.6 9.8 10.9 0.0 1.1 0.0 0.1 0.0 144.6 1.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 1.6 387.7 1.7 2.5 1.3 0.0 10.0 1.8 0.0 0.0 0.0 1.5 0.0 0.0 13.8 0.0 7.7 12.9 0.3 0.4 2.7 0.0 0.0 0.0 0.0 0.8 JPT2 "C16orf34, FLJ13092, HN1L, KIAA1426, L11" ENSG00000206053 "Jupiter microtubule associated homolog 2" Q9H910 16 1678256-1702280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 82.6;Ductal cells: 81.9;Extravillous trophoblasts: 170.9;Syncytiotrophoblasts: 141.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041888, HPA041908" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041888: AB_10793937, HPA041908: AB_10794160" "unprognostic (1.49e-2)" "unprognostic (1.76e-1)" "unprognostic (1.30e-3)" "prognostic favorable (7.85e-4)" "unprognostic (3.60e-1)" "unprognostic (2.37e-2)" "prognostic unfavorable (9.14e-4)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (1.50e-2)" "unprognostic (1.12e-3)" "unprognostic (4.27e-2)" "unprognostic (1.01e-2)" "unprognostic (9.22e-3)" "unprognostic (1.65e-1)" "unprognostic (4.14e-2)" "unprognostic (2.78e-2)" 10.6 11.3 6.7 10.4 24.3 4.9 19.9 11.1 12.3 22.5 16.7 24.1 12.6 11.3 11.5 11.1 28.6 34.4 12.4 10.1 10.5 8.7 18.5 37.3 12.0 11.7 33.8 6.2 12.3 31.0 13.2 10.1 33.6 37.7 26.3 16.5 6.8 15.7 12.7 12.8 16.2 12.8 12.4 72.4 8.7 14.8 14.1 17.3 20.3 16.1 15.7 16.8 16.9 16.8 9.7 8.2 4.7 4.6 7.5 10.0 5.4 31.6 32.6 37.8 21.0 5.5 9.2 34.3 31.6 10.0 26.7 22.8 42.4 41.7 20.6 24.4 15.6 26.3 31.3 49.8 42.9 30.7 16.5 30.0 16.9 18.7 24.1 8.4 19.9 10.1 6.4 27.2 26.2 34.1 14.8 16.8 18.8 39.7 8.3 15.4 36.7 24.8 9.9 41.5 35.7 24.8 45.7 35.8 29.7 41.6 18.0 35.3 19.5 47.5 46.1 14.4 38.0 55.8 12.8 19.4 26.0 45.7 12.3 30.7 7.1 28.3 42.9 8.1 15.5 37.8 2.6 4.6 4.7 7.1 4.1 10.0 6.3 7.8 5.6 3.6 9.7 8.5 7.1 0.4 7.5 2.0 8.2 7.0 5.4 6.7 24.3 11.1 12.3 10.5 8.7 33.8 6.2 37.7 17.3 23.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 49.5 22.7 8.7 0.0 82.6 36.5 81.9 0.0 0.0 0.0 0.0 22.2 170.9 0.0 0.0 2.3 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 49.5 0.0 0.0 59.7 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 141.1 0.0 0.0 0.0 KALRN "ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD" ENSG00000160145 "Kalirin RhoGEF kinase" O60229 3 124080023-124726325 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;retina: 31.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 71.2;Early spermatids: 45.5;Ito cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.3" "Lineage enriched" "Detected in single" 5 "T-cells: 4.3" "Cell line enhanced" "Detected in many" "CACO-2: 32.4;HEL: 19.8;OE19: 11.2;SH-SY5Y: 9.3" "Low region specificity" "Detected in many" "HPA011913, CAB026456" Approved Approved Nucleoplasm,Cytosol NA NA 110000 "Nucleoplasm, Cytosol" "CAB026456: , HPA011913: AB_1850494" "unprognostic (2.54e-2)" "unprognostic (3.43e-1)" "unprognostic (2.08e-1)" "unprognostic (3.12e-4)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (3.41e-2)" "unprognostic (8.58e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "unprognostic (2.26e-3)" "unprognostic (5.58e-2)" "unprognostic (2.67e-1)" "unprognostic (3.70e-2)" "unprognostic (2.81e-3)" 5.5 4.3 12.7 2.4 14.1 0.6 4.2 1.8 35.2 4.0 3.8 3.7 0.5 2.7 5.6 2.3 9.6 4.2 3.1 12.1 17.6 3.9 2.6 7.3 2.9 1.1 4.1 15.8 2.3 11.9 2.5 14.4 6.8 9.4 3.1 2.1 31.2 2.2 5.4 23.5 1.5 7.2 6.4 3.6 8.0 11.5 2.2 2.4 0.0 5.3 6.7 3.1 2.9 4.1 0.1 0.0 0.9 0.0 0.1 4.3 1.2 0.3 0.6 3.6 0.7 0.5 0.1 4.7 1.4 0.9 1.4 0.6 32.4 2.5 0.1 0.4 3.6 2.2 0.2 0.8 0.0 1.1 0.0 0.3 19.8 0.3 4.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.5 1.6 0.0 4.5 0.1 0.4 2.4 0.0 0.0 2.0 11.2 3.2 1.0 1.6 0.0 0.1 0.3 1.2 9.3 0.4 0.3 0.3 3.6 0.7 0.1 8.2 4.1 1.6 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.3 0.0 0.0 2.4 0.7 0.9 0.1 0.0 0.0 4.3 1.2 12.7 14.1 1.8 35.2 17.6 3.9 4.1 15.8 9.4 2.4 3.0 3.8 0.0 1.4 1.4 71.2 33.4 17.8 8.1 0.0 15.7 5.9 7.3 1.7 4.7 45.5 26.9 30.6 0.0 7.2 0.7 4.8 2.8 3.5 17.4 0.8 0.0 9.2 50.3 2.6 34.6 3.4 0.7 3.3 0.0 12.2 5.4 3.9 20.4 31.1 2.4 2.7 19.4 14.6 1.9 1.7 1.0 11.9 0.7 10.0 1.4 KANK4 "ANKRD38, KIAA0172" ENSG00000132854 "KN motif and ankyrin repeat domains 4" Q5T7N3 1 62236979-62319414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4" "Cell type enhanced" "Detected in some" 18 "Cytotrophoblasts: 22.8;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 14.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 23.5;Hep G2: 9.8;SuSa: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014030 Uncertain Uncertain Microtubules,Cytosol NA NA Cytosol Microtubules "HPA014030: AB_2128155" "unprognostic (1.66e-2)" "unprognostic (1.90e-3)" "unprognostic (2.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-2)" "unprognostic (6.31e-2)" "unprognostic (1.66e-2)" "unprognostic (3.58e-2)" "unprognostic (1.54e-1)" "unprognostic (3.85e-3)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (9.06e-2)" "unprognostic (1.97e-1)" "unprognostic (3.31e-2)" "unprognostic (7.74e-6)" 10.6 0.7 0.9 1.0 3.1 0.1 3.1 0.5 2.2 0.6 1.2 8.9 1.0 0.4 0.3 1.0 0.4 0.7 0.6 0.6 1.9 2.7 1.7 3.6 2.9 0.1 11.1 0.1 0.4 18.4 20.4 0.4 14.4 23.2 1.8 1.2 2.6 10.4 0.8 0.5 0.8 0.6 0.2 13.4 0.8 2.4 1.0 4.9 0.1 0.7 0.8 0.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 23.5 0.1 0.0 0.1 0.0 3.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 9.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.7 0.4 0.0 21.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 3.1 0.5 2.2 1.9 2.7 11.1 0.1 23.2 4.9 0.0 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.1 0.2 0.0 0.0 0.0 7.3 14.9 0.8 0.0 0.0 0.5 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.3 0.0 3.5 0.2 0.3 0.0 1.7 0.0 0.1 0.0 4.6 0.0 0.6 0.0 KANSL1L "C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2" ENSG00000144445 "KAT8 regulatory NSL complex subunit 1 like" A0AUZ9 2 210021423-210171383 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 178.9" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 44.2;Spermatocytes: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043102, HPA046790" Uncertain Approved Cytosol NA NA Cytosol "HPA043102: AB_2678316, HPA046790: AB_2679808" "unprognostic (3.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-3)" "unprognostic (1.45e-2)" "unprognostic (2.55e-3)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (5.99e-3)" "unprognostic (4.65e-2)" "unprognostic (5.89e-3)" "unprognostic (5.75e-2)" "unprognostic (5.95e-3)" "unprognostic (7.44e-2)" "unprognostic (4.60e-2)" "unprognostic (3.21e-2)" "unprognostic (1.30e-3)" 8.4 5.6 8.3 6.0 12.9 3.8 8.8 12.7 10.9 10.4 6.9 7.5 11.1 4.4 11.3 9.9 5.9 8.9 8.9 7.9 8.8 5.7 12.3 5.8 9.8 4.3 12.1 5.5 16.2 10.0 178.9 14.4 5.3 9.5 14.3 4.7 6.2 7.6 9.9 8.8 7.7 4.9 9.8 13.0 4.5 7.2 12.4 13.6 21.6 14.2 4.4 3.8 11.1 33.0 2.1 2.1 2.7 2.2 3.1 1.7 0.5 2.4 1.3 12.7 5.4 10.3 7.8 3.7 3.6 4.6 2.3 6.5 2.5 9.5 6.7 4.9 2.3 5.7 3.5 2.9 1.2 3.7 2.9 2.4 5.5 4.9 4.3 6.4 6.4 4.0 4.9 5.6 2.3 1.7 10.2 5.2 6.2 4.1 6.2 3.5 2.3 7.1 16.5 7.7 4.2 1.8 5.2 3.6 5.2 14.0 3.7 8.0 7.6 3.3 2.2 2.6 13.3 2.2 13.7 4.5 5.1 4.1 1.7 2.7 4.4 1.9 6.6 6.2 3.2 6.1 1.1 1.4 2.7 1.2 2.2 1.1 0.9 1.0 1.4 2.1 2.1 1.7 1.7 2.4 3.1 0.9 1.4 0.8 0.5 8.3 12.9 12.7 10.9 8.8 5.7 12.1 5.5 9.5 13.6 26.8 15.3 2.0 7.6 6.5 9.3 7.6 7.6 44.2 7.9 29.6 13.7 1.3 3.3 8.2 20.3 7.8 1.8 0.0 4.8 0.8 9.3 6.6 10.4 5.5 2.3 4.8 5.8 5.5 2.6 17.2 13.6 6.0 6.8 1.8 2.8 9.7 7.7 2.5 28.3 10.2 8.9 12.9 9.2 38.9 6.4 9.7 1.6 3.2 2.4 3.0 KANSL2 "C12orf41, FLJ20436, NSL2" ENSG00000139620 "KAT8 regulatory NSL complex subunit 2" Q9H9L4 12 48653401-48682238 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038497, HPA038498" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038497: AB_10674685, HPA038498: AB_2676046" "unprognostic (3.87e-3)" "unprognostic (6.18e-2)" "unprognostic (3.67e-1)" "unprognostic (8.89e-2)" "unprognostic (5.37e-2)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.98e-4)" "unprognostic (5.46e-2)" "unprognostic (1.35e-3)" "unprognostic (6.16e-2)" "unprognostic (6.75e-3)" "unprognostic (4.19e-3)" "unprognostic (8.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "prognostic favorable (4.32e-4)" 11.4 12.3 9.8 9.0 14.0 41.3 14.5 19.7 14.7 12.0 10.7 15.6 8.9 8.9 14.9 14.3 13.7 12.0 9.0 12.8 8.6 8.6 13.8 10.2 11.0 16.8 13.0 11.2 17.4 14.3 10.6 21.0 18.2 11.3 12.5 11.3 14.1 13.2 10.4 36.3 13.1 11.6 13.5 11.2 14.0 10.8 16.5 12.7 20.1 16.4 12.6 16.5 11.8 12.8 23.6 21.3 28.2 18.4 19.8 26.8 18.7 9.5 13.0 11.7 5.6 13.1 11.6 24.6 10.9 8.7 17.8 10.2 22.8 12.4 15.6 19.4 12.9 7.5 9.7 19.0 12.7 14.9 14.0 11.3 18.2 11.6 6.4 14.7 20.1 7.1 12.1 16.1 13.5 23.7 9.8 8.6 13.5 21.1 10.4 12.9 8.9 19.7 15.4 15.1 14.1 13.1 17.0 11.5 17.8 9.6 13.3 13.3 9.2 21.1 15.7 12.9 13.1 20.6 19.7 7.4 13.6 10.0 5.8 9.9 15.8 23.3 22.8 6.7 45.9 6.9 28.2 16.8 19.3 23.0 17.4 22.0 23.6 22.9 23.8 21.3 21.1 26.8 25.5 7.7 19.8 18.4 17.3 25.1 18.7 9.8 14.0 19.7 14.7 8.6 8.6 13.0 11.2 11.3 12.7 3.0 11.0 11.3 11.5 10.5 13.7 8.9 7.6 12.0 14.8 14.0 27.5 18.9 8.3 10.4 20.7 12.1 9.3 0.0 8.7 9.9 12.8 9.0 11.5 8.7 10.5 14.3 8.6 14.7 13.9 11.8 11.5 13.8 15.1 13.6 8.4 6.6 9.4 3.5 9.6 12.2 21.4 25.8 15.9 26.4 33.2 9.8 21.2 22.3 11.4 8.6 KARS "DFNB89, KARS1, KARS2" ENSG00000065427 "Lysyl-tRNA synthetase" Q15046 16 75627474-75648643 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, Transferase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041345, HPA041550" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA041345: AB_10795589, HPA041550: AB_10794520" "unprognostic (1.56e-1)" "unprognostic (7.93e-2)" "unprognostic (3.36e-2)" "unprognostic (1.02e-2)" "unprognostic (5.39e-2)" "prognostic unfavorable (8.84e-6)" "unprognostic (6.24e-3)" "unprognostic (8.97e-3)" "unprognostic (1.18e-1)" "unprognostic (9.11e-3)" "unprognostic (8.71e-3)" "unprognostic (8.46e-2)" "unprognostic (7.86e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (3.07e-2)" "unprognostic (2.13e-1)" 25.4 21.1 19.2 29.2 22.0 24.6 28.0 17.5 19.5 26.3 28.3 15.2 28.1 20.6 23.4 26.7 35.8 24.1 27.5 49.6 16.3 18.6 31.7 47.1 25.8 26.6 18.8 16.2 34.9 62.6 28.5 22.4 30.4 19.6 30.7 29.7 20.1 31.7 23.2 80.0 26.6 32.3 28.4 17.1 37.3 26.3 33.6 14.5 41.3 34.4 43.6 34.7 38.6 33.4 32.8 39.0 35.5 44.2 35.0 62.4 39.5 27.2 31.9 23.3 32.0 25.0 25.3 45.9 23.1 28.4 50.9 38.4 56.3 35.9 49.2 25.6 30.7 24.3 39.3 46.9 42.2 55.7 14.3 24.1 27.0 27.9 58.2 45.9 40.6 30.5 29.7 30.4 45.0 73.3 26.0 41.4 43.5 45.0 11.8 38.4 63.0 41.7 43.5 49.3 40.1 23.5 55.0 20.9 60.0 40.8 23.2 35.1 28.5 58.1 21.2 25.8 26.6 28.7 38.5 22.8 28.2 29.1 21.5 33.0 25.4 29.0 117.4 24.6 34.8 34.3 20.9 31.5 35.5 34.1 44.2 62.4 32.8 42.3 40.2 39.0 27.6 40.1 36.1 7.2 35.0 43.2 24.6 43.5 39.5 19.2 22.0 17.5 19.5 16.3 18.6 18.8 16.2 19.6 14.5 41.7 22.7 66.3 80.5 40.9 19.6 83.2 53.5 42.8 59.1 38.4 33.4 104.3 89.5 100.0 165.6 61.2 50.2 46.7 126.0 122.6 54.5 53.6 38.2 37.5 80.9 11.1 54.8 39.3 59.8 236.5 43.4 52.9 33.7 143.3 61.7 20.0 101.6 42.1 47.7 58.7 38.2 45.3 49.9 89.9 114.1 39.5 92.0 63.4 85.8 94.5 KAT2B "GCN5, GCN5L, P/CAF, PCAF" ENSG00000114166 "Lysine acetyltransferase 2B" Q92831 3 20040023-20154404 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002470, CAB004526, HPA055839, HPA073897" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: " "unprognostic (2.91e-2)" "unprognostic (6.85e-3)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (2.66e-2)" "unprognostic (3.01e-3)" "unprognostic (2.44e-1)" "unprognostic (3.83e-3)" "unprognostic (2.44e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-3)" "unprognostic (7.13e-2)" "unprognostic (7.03e-2)" "unprognostic (2.26e-2)" "unprognostic (1.59e-1)" "unprognostic (5.16e-2)" "unprognostic (4.63e-2)" 10.6 6.6 30.1 9.4 27.5 24.9 6.8 22.0 20.1 10.2 9.4 27.6 7.9 10.9 7.8 5.4 17.3 7.7 8.0 21.9 24.7 18.0 10.8 24.0 10.1 12.7 26.8 15.9 18.2 11.6 38.1 8.7 8.5 24.2 9.5 8.1 10.7 20.9 9.2 33.4 8.9 13.0 8.7 21.4 11.7 9.0 1.8 31.1 8.7 10.0 7.4 12.0 8.7 11.0 2.1 2.7 5.5 1.5 1.1 4.8 0.8 1.5 4.0 2.2 3.6 9.1 8.6 5.2 5.1 7.6 5.4 7.9 1.2 2.6 13.7 2.1 9.6 6.8 1.1 5.5 1.6 4.5 12.4 5.2 12.0 6.3 0.4 4.3 1.8 15.6 3.7 3.0 4.7 3.0 9.5 5.1 3.4 7.7 19.4 7.6 1.9 3.9 3.6 0.9 3.8 3.9 5.1 4.2 2.9 7.3 8.1 1.1 2.4 2.8 4.6 17.3 3.6 4.8 8.1 4.9 9.1 3.7 3.4 5.8 7.4 15.4 3.3 8.3 7.9 19.2 1.3 1.1 2.8 3.6 1.5 3.4 1.0 3.1 2.5 0.9 2.1 1.1 2.1 5.5 1.1 1.1 2.7 4.8 0.8 30.1 27.5 22.0 20.1 24.7 18.0 26.8 15.9 24.2 31.1 29.8 17.3 4.7 10.0 7.6 11.9 56.5 2.5 17.4 14.8 5.2 3.9 5.4 10.0 2.8 2.3 10.5 13.6 23.3 3.8 1.1 9.3 10.0 10.4 26.1 6.5 14.3 11.1 18.4 21.9 1.3 6.1 15.7 16.9 5.4 5.7 12.6 3.7 0.0 4.9 5.3 11.2 6.5 9.9 0.9 0.9 11.3 8.2 13.8 3.1 7.1 KAT6A "MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220" ENSG00000083168 "Lysine acetyltransferase 6A" Q92794 8 41929479-42051990 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017023, HPA063266, HPA065052" Supported Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoli, Cytosol" "CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414" "unprognostic (3.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (3.23e-2)" "unprognostic (2.28e-1)" "unprognostic (9.27e-3)" "unprognostic (3.61e-1)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.50e-1)" "unprognostic (4.45e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" 20.8 10.9 15.3 19.8 20.3 36.8 22.6 29.9 18.7 19.7 14.6 19.4 14.4 10.7 20.6 12.1 16.9 16.5 14.3 13.0 15.5 11.5 12.3 13.6 26.9 28.2 23.2 10.3 27.2 13.1 26.8 22.3 20.9 15.7 14.1 12.0 12.8 15.1 17.0 21.0 25.5 18.0 25.0 22.9 20.4 14.0 14.1 21.7 30.4 17.9 14.3 20.1 16.9 24.2 4.7 1.8 10.9 1.6 3.1 3.9 1.4 13.1 10.8 17.8 11.3 10.0 11.4 6.0 8.8 11.5 10.9 8.5 6.8 6.3 19.5 8.9 8.7 10.6 8.5 13.8 8.4 13.0 10.0 8.1 28.1 6.7 5.1 7.5 14.8 12.9 9.5 9.6 10.1 12.6 8.0 10.5 17.3 23.5 12.4 10.0 5.8 30.0 4.7 6.8 9.9 4.3 24.0 19.9 6.2 5.4 15.1 11.1 9.5 10.3 6.9 7.1 8.4 15.9 6.5 12.2 13.5 9.6 12.0 9.4 10.1 16.4 21.2 7.3 6.7 11.6 3.5 1.6 2.8 3.5 1.2 3.9 2.4 2.6 3.3 1.0 4.7 3.6 2.9 10.9 3.1 1.2 1.8 3.5 1.4 15.3 20.3 29.9 18.7 15.5 11.5 23.2 10.3 15.7 21.7 32.8 30.4 27.2 23.8 44.8 44.6 22.6 25.5 21.4 30.7 12.2 51.1 12.1 3.3 11.8 1.8 50.4 18.7 46.7 10.4 13.1 28.5 21.6 33.6 22.2 14.6 55.6 23.7 43.0 37.4 3.5 26.2 31.3 21.9 8.2 25.7 32.4 13.2 17.5 21.5 9.3 45.4 19.4 33.9 41.9 36.2 53.4 17.6 45.8 18.9 26.1 KAT7 "HBO1, HBOA, MYST2, ZC2HC7" ENSG00000136504 "Lysine acetyltransferase 7" O95251 17 49788555-49835030 "Enzymes, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation" "Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044470, HPA071116" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044470: AB_10965785, HPA071116: " "unprognostic (1.30e-1)" "unprognostic (3.15e-2)" "unprognostic (6.20e-3)" "unprognostic (2.20e-2)" "unprognostic (7.99e-2)" "unprognostic (1.53e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (1.36e-1)" "unprognostic (6.26e-2)" "unprognostic (1.44e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-3)" "unprognostic (2.75e-1)" "unprognostic (5.03e-2)" "unprognostic (6.23e-2)" "unprognostic (7.68e-2)" 15.8 14.3 16.9 16.2 25.9 44.4 17.5 37.0 35.0 19.5 17.3 23.8 17.9 13.1 27.3 18.6 18.8 19.5 14.6 25.3 16.8 21.8 18.7 11.3 13.9 15.3 17.0 23.6 21.9 13.6 44.4 19.8 19.8 21.9 20.4 14.9 20.8 18.9 23.3 31.7 22.7 14.7 21.8 17.9 15.8 15.5 63.7 19.1 25.9 28.6 14.5 20.6 22.7 17.4 13.0 12.7 15.2 11.4 20.6 20.7 14.2 13.0 18.3 17.8 12.4 8.4 11.1 21.5 11.3 13.2 20.4 14.6 28.3 9.3 14.9 18.4 12.0 17.8 11.4 16.9 11.8 24.1 16.2 16.7 17.7 13.3 11.7 12.5 18.1 14.8 10.6 11.9 18.3 22.9 11.8 15.0 16.6 19.6 14.9 19.1 19.8 25.7 13.0 44.1 27.9 16.0 16.2 28.4 12.9 9.5 14.7 19.3 16.4 11.6 6.9 10.6 28.1 25.5 16.0 9.0 25.9 14.0 11.3 14.7 21.8 23.8 17.5 11.7 10.9 16.1 15.2 11.0 15.1 16.9 8.9 20.7 13.0 16.3 17.1 12.7 12.2 20.6 16.2 13.1 20.6 11.4 6.6 14.3 14.2 16.9 25.9 37.0 35.0 16.8 21.8 17.0 23.6 21.9 19.1 23.8 17.6 14.7 9.0 14.9 30.8 23.6 20.4 24.1 20.5 26.2 29.5 18.8 8.3 9.4 17.4 18.6 10.4 0.0 6.5 13.0 11.4 13.2 23.1 9.0 11.5 42.9 24.1 12.3 16.1 11.0 15.5 11.1 13.5 12.6 12.1 15.3 8.2 8.6 17.3 8.7 25.3 38.8 13.9 69.0 33.2 17.6 28.3 20.2 11.4 7.2 KATNAL1 MGC2599 ENSG00000102781 "Katanin catalytic subunit A1 like 1" Q9BW62 13 30202630-30307484 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 107.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 30.6" "Low region specificity" "Detected in all" HPA046205 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046205: AB_10965325" "unprognostic (3.34e-1)" "unprognostic (6.44e-3)" "unprognostic (2.08e-2)" "unprognostic (6.91e-2)" "unprognostic (2.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.57e-2)" "unprognostic (2.84e-2)" "unprognostic (3.43e-1)" "unprognostic (4.68e-3)" "unprognostic (4.54e-2)" "unprognostic (2.17e-2)" "unprognostic (1.84e-3)" "unprognostic (7.41e-2)" "unprognostic (6.42e-2)" "unprognostic (5.12e-2)" "unprognostic (1.83e-3)" 11.0 5.7 12.2 6.4 12.5 7.6 12.0 11.0 14.4 14.1 11.4 10.4 4.6 2.2 12.7 4.2 8.1 6.6 5.4 22.6 8.5 9.8 5.9 5.4 6.7 8.2 10.3 14.9 6.3 2.9 3.2 11.9 4.2 11.9 6.7 5.9 4.1 3.5 8.5 7.1 3.8 4.2 19.7 10.8 4.5 4.7 25.1 7.8 12.0 4.4 3.3 9.1 7.7 7.9 5.2 6.9 3.4 1.0 9.5 7.1 1.4 5.5 4.6 8.1 4.3 6.2 13.2 0.2 23.0 7.4 12.3 9.7 0.9 5.6 8.9 2.7 30.6 15.5 1.5 5.7 5.9 18.8 7.7 2.1 6.4 5.7 2.1 3.3 3.1 4.3 5.1 3.0 13.8 3.4 11.6 12.9 5.0 3.4 3.9 15.0 1.1 7.0 2.9 3.5 0.1 3.0 7.9 9.6 0.9 4.4 0.4 3.4 7.1 6.1 1.2 4.3 7.1 2.0 1.9 11.7 10.9 16.6 5.9 9.2 2.1 3.8 12.3 4.3 3.1 15.6 1.9 0.9 3.4 5.8 0.5 2.9 2.6 4.6 5.8 2.3 5.2 1.1 2.6 0.3 9.5 1.0 6.9 7.1 1.4 12.2 12.5 11.0 14.4 8.5 9.8 10.3 14.9 11.9 7.8 8.9 2.6 1.9 3.5 5.3 9.0 35.3 2.5 16.0 2.3 5.2 25.5 0.2 3.3 5.4 107.1 6.4 0.0 0.0 1.3 0.7 9.4 1.6 9.3 9.0 2.8 20.6 9.8 6.7 2.1 42.6 8.3 3.4 16.9 35.1 0.5 8.5 4.5 0.0 4.9 5.7 17.6 6.5 11.2 41.6 21.5 5.0 0.2 7.5 0.6 1.3 KATNB1 ENSG00000140854 "Katanin regulatory subunit B1" Q9BVA0 16 57735730-57757250 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 86.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041165, HPA041839" Enhanced Supported "Plasma membrane,Microtubules,Cytosol" NA NA "Plasma membrane, Cytosol" Microtubules "HPA041165: AB_10795584, HPA041839: AB_10795598" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "prognostic favorable (9.24e-4)" "unprognostic (2.54e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.42e-1)" "unprognostic (2.92e-1)" "unprognostic (1.75e-1)" "prognostic favorable (8.44e-4)" "unprognostic (2.89e-2)" "unprognostic (1.03e-3)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (6.88e-2)" "unprognostic (1.54e-1)" 6.9 9.1 15.3 9.3 21.4 18.7 6.3 13.2 29.0 7.0 7.4 8.8 6.7 9.4 6.6 5.8 11.0 18.7 5.9 8.5 16.0 14.5 5.8 10.3 8.0 8.8 9.3 14.1 7.0 9.4 9.5 8.0 7.9 10.6 6.3 5.2 6.2 11.9 8.0 7.1 21.4 8.5 6.0 6.9 8.0 9.1 32.7 8.1 10.8 7.2 10.3 8.6 7.4 6.4 5.8 9.8 24.6 11.6 8.4 12.4 10.5 7.4 13.7 7.5 9.7 4.2 3.7 13.3 5.3 7.0 13.9 7.7 11.4 6.7 6.1 10.6 3.4 5.1 10.1 10.1 10.6 6.3 4.1 28.7 8.0 7.6 15.6 4.4 17.3 29.9 3.8 6.5 10.9 6.4 5.8 8.2 22.3 15.6 3.0 5.5 8.0 25.0 22.5 13.2 5.4 23.8 20.1 9.4 22.0 4.2 3.7 38.1 11.4 8.6 10.4 6.2 3.1 3.9 8.9 5.8 9.8 8.6 8.5 11.4 7.0 5.5 7.4 13.6 13.4 6.0 24.1 10.1 24.6 12.4 11.2 12.4 5.6 10.5 9.9 9.8 5.8 10.1 10.0 15.5 8.4 11.6 7.4 10.9 10.5 15.3 21.4 13.2 29.0 16.0 14.5 9.3 14.1 10.6 8.1 3.0 5.6 3.7 6.3 8.0 8.0 1.7 5.1 14.7 4.5 5.2 5.9 14.7 10.0 10.8 86.6 5.3 9.2 0.0 11.9 10.0 8.5 6.7 4.7 3.8 8.6 17.5 4.6 5.5 5.3 24.3 7.2 5.3 6.8 6.4 8.3 8.7 7.8 3.5 4.6 5.9 9.4 6.5 5.0 25.9 8.3 12.0 6.4 11.7 11.9 8.2 KAZN "FLJ43806, KAZRIN, KIAA1026" ENSG00000189337 "Kazrin, periplakin interacting protein" Q674X7 1 13892792-15118043 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 64.9" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 72.8;Suprabasal keratinocytes: 79.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 6.9" "Lineage enriched" "Detected in single" 21 "granulocytes: 6.9" "Cell line enhanced" "Detected in many" "AN3-CA: 40.6;SK-BR-3: 22.0" "HPA032095, HPA032096" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA032095: AB_2674146, HPA032096: AB_10670826" "unprognostic (2.81e-1)" "unprognostic (5.82e-2)" "unprognostic (1.12e-1)" "unprognostic (2.42e-3)" "unprognostic (5.34e-2)" "unprognostic (2.15e-3)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (3.21e-1)" "unprognostic (4.96e-3)" "unprognostic (1.10e-1)" "unprognostic (5.55e-2)" "prognostic favorable (1.20e-6)" "unprognostic (3.61e-2)" "unprognostic (7.93e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-2)" 8.0 11.0 13.4 3.0 17.4 1.2 7.6 41.1 21.9 8.0 3.8 27.5 5.7 4.6 3.1 11.1 18.8 11.0 7.0 4.1 12.4 12.4 13.2 5.2 8.5 1.5 25.1 12.1 10.4 8.0 22.9 2.7 11.0 15.0 4.1 4.0 10.5 16.8 7.2 1.7 14.2 4.9 3.7 25.0 64.9 4.9 4.1 18.9 0.0 6.6 7.0 6.3 7.9 9.4 0.3 0.0 6.9 0.0 0.0 0.0 0.0 8.0 1.4 8.8 40.6 3.8 4.0 3.0 3.8 3.2 7.2 5.2 1.8 4.3 0.0 10.1 8.2 1.3 2.9 2.0 6.3 3.6 0.2 3.9 4.6 4.8 12.0 2.8 0.0 2.4 5.6 8.5 1.6 1.1 3.2 0.0 1.1 1.8 9.4 5.7 5.9 0.0 0.4 2.4 3.6 1.2 2.7 0.2 4.9 12.1 2.5 4.7 3.4 0.7 22.0 15.1 5.3 1.3 3.1 0.0 6.0 5.6 9.4 4.6 1.6 1.3 0.0 5.6 8.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 13.4 17.4 41.1 21.4 12.4 12.4 25.1 12.1 15.0 18.9 3.0 2.6 0.9 12.5 44.8 9.3 3.0 5.1 12.0 6.8 47.1 7.9 1.1 14.9 1.8 4.5 8.1 3.0 0.0 1.4 5.8 10.8 8.1 3.5 0.0 0.7 0.0 6.8 40.5 1.2 5.8 17.5 2.1 43.9 0.0 3.7 72.8 1.4 0.0 16.3 11.4 2.4 6.5 21.7 0.1 4.0 79.0 38.8 2.9 2.8 24.0 KBTBD4 "BKLHD4, FLJ10450, HSPC252" ENSG00000123444 "Kelch repeat and BTB domain containing 4" Q9NVX7 11 47572197-47579015 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037792, HPA037793" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA037792: AB_10671633, HPA037793: AB_2675671" "unprognostic (5.52e-2)" "unprognostic (2.23e-1)" "unprognostic (8.36e-3)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "unprognostic (1.21e-1)" "unprognostic (2.09e-1)" "unprognostic (8.73e-3)" "unprognostic (2.78e-1)" "unprognostic (4.04e-2)" "unprognostic (7.22e-2)" "prognostic favorable (2.70e-7)" "unprognostic (4.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.07e-1)" "unprognostic (4.25e-2)" 8.4 13.4 7.9 6.7 15.9 11.7 9.0 16.2 25.8 9.0 9.7 13.6 13.3 6.5 12.3 13.7 8.0 15.5 7.6 9.5 7.5 8.7 12.0 9.4 8.6 10.7 7.0 7.1 13.2 8.4 23.0 11.9 10.0 11.7 12.1 9.2 13.6 8.6 10.5 19.1 10.8 10.3 10.0 6.2 9.9 9.0 11.6 4.6 13.5 12.4 9.4 14.2 10.9 8.1 12.4 6.6 11.8 5.3 12.3 14.7 10.4 5.1 10.6 11.4 9.6 7.0 9.4 4.0 8.6 10.2 11.2 9.7 4.4 9.5 9.3 4.9 9.8 9.0 8.4 6.3 11.3 9.5 12.1 10.2 6.8 14.7 4.9 5.2 14.1 13.7 8.6 7.9 4.5 6.1 8.6 11.3 6.9 5.4 7.3 8.7 12.7 10.3 4.5 6.2 12.4 7.6 10.3 15.5 5.9 11.9 10.7 15.9 10.5 7.4 9.9 6.5 4.4 16.6 4.5 10.3 8.1 9.0 11.1 8.5 11.3 17.4 12.9 11.2 4.1 8.3 10.7 5.3 11.8 13.7 4.3 14.7 12.4 11.0 12.6 6.6 11.0 11.7 12.5 8.0 12.3 4.1 3.1 12.8 10.4 7.9 15.9 16.2 25.8 7.5 8.7 7.0 7.1 11.7 4.6 6.0 2.2 2.4 5.9 4.2 14.7 0.1 7.6 12.0 6.8 10.4 7.9 10.2 19.9 11.8 9.0 5.2 4.4 23.3 11.9 5.9 6.4 4.0 10.4 7.7 7.1 12.7 6.9 7.4 3.7 13.8 4.6 4.3 1.7 13.6 4.8 22.8 7.7 3.5 8.9 9.1 10.4 12.9 4.2 18.0 16.4 4.0 11.8 11.7 5.0 2.8 KCMF1 "DEBT91, DKFZP434L1021, PCMF, ZZZ1" ENSG00000176407 "Potassium channel modulatory factor 1" Q9P0J7 2 84971093-85059472 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030383, HPA030384" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA030383: AB_10599977, HPA030384: AB_10601230" "unprognostic (8.01e-2)" "unprognostic (1.98e-2)" "unprognostic (9.95e-2)" "unprognostic (7.42e-3)" "unprognostic (1.24e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (5.68e-3)" "unprognostic (1.43e-1)" "unprognostic (9.81e-2)" "prognostic unfavorable (6.10e-5)" "unprognostic (4.98e-2)" "prognostic unfavorable (4.18e-6)" "unprognostic (6.11e-2)" "unprognostic (2.66e-1)" "unprognostic (4.42e-1)" "unprognostic (1.01e-1)" 19.2 13.3 17.9 20.2 16.0 23.6 26.1 13.4 18.6 15.0 20.2 10.7 20.3 15.4 16.3 18.8 28.5 12.8 17.9 30.4 16.5 12.0 14.8 20.7 16.4 18.8 13.7 11.1 17.2 48.6 14.7 18.7 20.5 14.4 17.5 21.4 14.0 19.4 15.7 67.2 17.6 20.6 25.7 10.3 16.7 16.8 29.0 11.5 19.7 18.7 21.8 22.5 23.9 34.0 4.0 4.2 8.1 3.4 2.8 8.8 1.5 27.6 21.7 19.4 14.9 20.5 19.9 33.1 29.6 27.5 28.4 19.0 26.5 29.9 30.1 29.8 40.1 28.4 18.4 15.1 28.6 37.6 22.5 10.5 19.2 16.4 27.0 40.2 21.1 18.3 20.5 45.3 27.8 77.2 25.4 21.4 16.3 19.0 24.0 28.4 25.5 20.3 11.7 21.2 35.2 18.3 14.7 27.3 18.8 25.7 24.3 18.7 14.0 17.2 22.0 28.7 23.3 10.2 13.5 18.2 29.1 28.3 27.1 30.7 27.4 33.8 30.5 21.9 15.6 21.7 5.0 2.6 8.1 4.5 2.2 3.6 3.5 3.2 3.4 2.2 4.0 2.8 3.1 7.5 2.8 3.4 4.2 8.8 1.5 17.9 16.0 13.4 18.6 16.5 12.0 13.7 11.1 14.4 11.5 29.8 28.2 27.9 82.6 63.0 31.1 41.6 20.4 10.7 25.0 12.2 13.7 22.2 21.6 33.1 65.6 24.8 41.1 23.3 45.9 22.3 26.3 94.5 17.3 29.8 18.4 68.3 18.5 25.8 25.1 87.4 23.9 22.8 25.3 23.4 27.6 31.3 46.8 35.9 27.3 28.6 27.5 25.8 36.8 31.0 29.4 69.1 34.1 19.1 28.1 106.5 KCNA10 Kv1.8 ENSG00000143105 "Potassium voltage-gated channel subfamily A member 10" Q16322 1 110517217-110519175 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.4;U-87 MG: 1.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.2" "HPA015061, CAB022564" Uncertain Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "CAB022564: , HPA015061: AB_1855573" "unprognostic (2.96e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 36.6" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: AB_2680109, HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.1 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 0.9 1.1 1.8 0.0 0.3 0.3 2.1 0.6 3.0 0.2 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 1.4 0.0 0.5 0.5 1.2 1.5 0.0 0.0 0.8 7.5 0.9 0.0 0.4 7.1 4.4 0.4 0.5 0.0 0.4 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 1.0 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 0.0 0.0 0.0 0.0 0.0 36.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 7.5 0.0 0.0 8.4 0.3 0.0 0.0 1.0 0.0 1.5 0.2 0.0 0.0 0.1 7.4 0.0 0.4 5.4 4.5 0.0 0.0 0.0 0.0 0.0 KCNC4 "C1orf30, HKSHIIIC, Kv3.4" ENSG00000116396 "Potassium voltage-gated channel subfamily C member 4" Q03721 1 110211343-110283100 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 39.3;Ito cells: 63.3;Rod photoreceptor cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 16.5;U-87 MG: 14.7;WM-115: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014740 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA014740: AB_1855580" "unprognostic (9.16e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-2)" "unprognostic (3.72e-1)" "unprognostic (4.12e-2)" "unprognostic (6.13e-2)" "unprognostic (2.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (2.03e-1)" "unprognostic (4.26e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.25e-2)" 2.3 4.7 12.1 1.6 3.2 0.7 3.3 9.2 12.7 1.9 1.4 1.9 1.1 0.8 4.5 3.1 2.1 3.7 4.8 4.5 9.1 14.2 5.1 1.1 3.0 1.9 6.8 2.0 3.4 4.3 11.2 3.8 2.8 14.3 2.4 1.3 4.7 7.1 3.7 4.5 4.0 2.0 2.6 3.6 3.3 2.8 2.2 1.1 7.2 2.3 7.8 2.3 1.2 1.5 0.8 0.7 0.9 0.4 0.3 1.5 0.1 1.9 1.5 0.4 2.9 1.1 0.3 3.5 8.5 1.5 0.6 0.8 4.8 0.9 3.3 3.4 3.1 2.6 3.2 1.4 0.7 0.4 16.5 1.6 0.1 3.3 0.7 0.5 2.7 0.8 0.3 0.3 1.9 0.2 0.5 4.4 1.8 0.6 1.4 0.0 0.4 1.8 0.6 1.7 0.7 3.9 2.7 0.1 0.5 4.1 0.1 0.6 0.8 0.4 8.3 0.8 2.7 1.1 1.4 1.6 1.1 4.0 0.7 0.3 2.1 1.9 0.6 14.7 2.3 9.5 0.8 0.4 0.2 0.5 0.2 1.5 0.6 0.9 0.4 0.0 0.8 1.3 0.5 0.9 0.3 0.3 0.7 0.4 0.1 12.1 3.2 9.2 12.7 9.1 14.2 6.8 2.0 14.3 1.1 0.0 1.4 0.0 12.5 2.9 1.4 6.7 7.6 4.0 2.3 3.5 39.3 0.3 0.0 5.0 0.3 9.8 2.2 0.0 14.8 0.3 2.4 7.4 1.1 0.5 1.2 3.2 12.7 63.3 3.1 0.4 1.4 0.5 1.7 1.8 5.7 3.7 8.7 6.6 3.9 0.5 44.8 25.8 5.1 0.0 5.7 2.6 0.9 1.3 8.3 10.3 KCNE5 KCNE1L ENSG00000176076 "Potassium voltage-gated channel subfamily E regulatory subunit 5" Q9UJ90 X 109623700-109625172 "Disease related genes, Predicted membrane proteins" "Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5" "Cell type enriched" "Detected in some" 5 "monocytes: 16.2" "Group enriched" "Detected in some" 8 "glioma: 7.9;testis cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 5.6" "Group enriched" "Detected in many" 4 "dendritic cells: 5.6;monocytes: 1.7" "Cell line enhanced" "Detected in some" "HMC-1: 4.2;hTEC/SVTERT24-B: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042316 Uncertain Cytosol NA NA Cytosol "HPA042316: AB_10795397" "unprognostic (5.33e-2)" "unprognostic (2.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-3)" "unprognostic (3.27e-2)" "unprognostic (9.46e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-3)" "unprognostic (7.83e-2)" "unprognostic (5.64e-6)" "unprognostic (5.10e-2)" "unprognostic (9.06e-2)" "unprognostic (1.36e-1)" "unprognostic (5.37e-3)" 4.8 1.1 6.4 1.3 11.3 6.8 1.2 6.0 6.6 1.0 0.6 8.2 0.0 0.7 0.8 1.3 1.2 0.5 2.4 2.2 8.9 8.1 0.7 0.7 0.8 0.8 14.3 1.6 1.7 0.4 0.4 0.2 2.5 29.5 1.9 0.5 0.1 0.6 2.3 3.2 1.1 0.8 0.9 7.3 1.4 0.6 1.2 0.3 8.5 0.6 2.6 0.8 0.8 0.2 0.0 5.6 0.0 1.7 0.1 0.8 0.3 1.0 0.0 0.2 0.4 0.1 0.1 0.1 1.9 0.5 0.7 0.7 0.1 0.4 0.4 0.0 0.4 0.8 0.8 0.0 2.2 0.9 0.2 0.4 2.7 2.6 1.8 0.1 0.0 4.2 0.6 1.5 5.5 1.3 0.5 0.4 0.4 0.0 0.1 0.5 0.0 0.8 3.4 0.0 0.0 0.1 0.2 0.1 0.1 0.8 0.1 0.2 0.4 1.3 0.0 1.1 1.5 0.0 2.5 1.2 1.8 1.0 1.0 2.4 0.5 0.6 0.3 1.2 1.2 0.5 0.0 0.7 0.0 0.8 1.7 0.0 0.0 0.1 0.1 5.6 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.3 6.4 11.3 6.0 6.5 8.9 8.1 14.3 1.6 29.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 1.3 3.0 0.0 1.1 0.2 0.0 16.2 0.0 2.9 0.2 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 KCNH5 "eag2, H-EAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699454-63102037 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 9.2;retina: 5.7" "Cell type enriched" "Detected in some" 15 "Bipolar cells: 64.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.1;RT4: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.9 4.6 1.7 0.5 3.6 0.3 0.4 0.2 9.2 0.3 0.4 0.4 0.0 0.3 0.4 0.5 0.3 0.3 0.3 0.3 1.3 3.0 0.4 0.3 0.3 0.3 1.2 4.2 0.3 0.3 0.3 1.5 1.2 6.5 0.7 0.3 5.7 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 1.7 0.0 0.0 0.3 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 1.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.1 0.0 1.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 0.2 9.2 1.3 3.0 1.2 4.2 6.5 0.0 0.0 0.0 0.0 0.1 0.0 64.7 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.4 0.7 0.0 1.0 0.0 0.0 0.0 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium voltage-gated channel subfamily J member 12" Q14500 17 21376197-21419872 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 39.4;skeletal muscle: 47.8" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 84.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 39.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3" "Low region specificity" "Detected in all" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.2 1.3 1.9 0.9 2.9 0.7 0.9 39.4 5.8 1.2 0.8 1.1 0.5 0.5 0.8 1.4 1.5 2.1 0.7 5.1 0.9 1.4 1.2 0.5 1.3 0.4 1.3 3.4 0.7 0.5 10.6 0.7 0.7 4.0 0.9 0.6 1.7 0.6 0.9 47.8 6.0 0.6 1.0 0.9 1.3 0.9 1.3 0.9 0.0 1.0 7.5 1.1 0.8 1.5 0.0 0.9 0.0 0.5 0.0 0.1 0.0 0.0 1.1 0.4 2.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 3.6 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.1 0.0 1.5 0.0 6.3 0.0 1.0 1.6 0.0 0.0 7.3 0.4 3.7 0.0 1.5 8.0 0.0 0.0 2.8 0.0 0.5 6.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 1.9 2.9 39.4 5.8 0.9 1.4 1.3 3.4 4.0 0.9 0.0 0.0 0.0 0.0 1.3 0.8 12.5 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.4 1.4 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.2 84.2 1.2 5.5 0.0 0.2 6.9 0.0 0.0 0.0 0.4 11.2 0.0 0.0 3.9 0.6 1.4 0.0 0.5 0.5 1.3 1.9 0.1 0.0 0.6 0.0 KCNJ15 "IRKK, Kir1.3, Kir4.2" ENSG00000157551 "Potassium voltage-gated channel subfamily J member 15" Q99712 21 38155549-38307357 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.8;kidney: 99.7" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 153.4;Cholangiocytes: 63.7;Proximal tubular cells: 211.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 21 "neutrophil: 74.8" "Lineage enriched" "Detected in many" 21 "granulocytes: 74.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 26.1;GAMG: 37.4;HBEC3-KT: 25.1;RPTEC TERT1: 25.0;RT4: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA016702 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA016702: AB_1855560" "unprognostic (6.34e-2)" "unprognostic (5.04e-2)" "unprognostic (7.92e-2)" "unprognostic (2.07e-3)" "unprognostic (1.21e-1)" "unprognostic (3.54e-3)" "unprognostic (2.72e-3)" "unprognostic (3.03e-2)" "unprognostic (6.79e-2)" "unprognostic (2.89e-3)" "unprognostic (3.77e-2)" "unprognostic (1.95e-2)" "prognostic favorable (4.09e-10)" "unprognostic (9.46e-3)" "unprognostic (1.82e-1)" "unprognostic (5.27e-2)" "prognostic favorable (1.95e-4)" 6.0 0.3 0.4 5.3 0.3 3.2 1.4 0.2 0.3 3.5 0.4 0.2 27.1 0.2 0.5 12.8 6.0 0.8 17.7 1.0 0.2 0.1 99.7 1.5 34.1 0.8 0.5 0.2 0.6 16.7 0.0 0.3 1.0 0.6 4.0 0.0 0.2 14.4 26.8 1.0 1.7 0.2 0.9 0.4 6.8 10.7 1.1 0.2 0.4 36.8 3.2 1.9 11.3 4.3 0.0 0.2 74.8 3.5 0.0 0.0 0.7 0.6 0.0 0.1 0.2 5.1 26.1 0.2 0.3 1.7 0.0 0.0 0.0 0.2 0.1 0.0 2.7 37.4 8.8 0.0 25.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 7.7 2.5 6.5 1.4 0.5 1.2 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 25.0 29.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 1.3 0.0 0.6 0.1 0.0 2.1 1.5 0.1 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.7 0.4 0.3 0.2 0.3 0.2 0.1 0.5 0.2 0.6 0.2 56.6 153.4 0.8 8.5 2.5 0.0 1.2 63.7 9.4 52.4 29.6 0.0 0.1 14.9 23.3 1.4 1.4 0.0 0.0 7.8 0.4 0.8 0.4 5.8 0.0 0.3 0.0 0.0 1.3 5.1 1.9 0.6 2.6 1.7 0.0 0.0 0.0 26.3 0.0 0.0 211.6 0.0 0.0 1.0 0.9 1.0 1.4 0.1 0.0 0.0 4.1 KCNJ18 "KIR2.6, TTPP2" ENSG00000260458 "Potassium voltage-gated channel subfamily J member 18" B7U540 17 21692523-21704612 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "lymphoid tissue: 3.5;skin 1: 8.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.0;HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.3" "Region enhanced" "Detected in many" "cerebellum: 75.1" HPA027021 Uncertain Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (2.41e-1)" "unprognostic (3.90e-5)" "unprognostic (2.56e-1)" "unprognostic (1.95e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314553 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.1;retina: 20.0" "Group enriched" "Detected in some" 4 "Exocrine glandular cells: 7.3;granulocytes: 5.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 34 "plasmacytoid DC: 29.1" "Lineage enriched" "Detected in single" 34 "dendritic cells: 29.1" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 42.5" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.7 0.4 0.3 0.6 1.1 1.4 3.3 0.3 0.8 0.7 1.3 0.8 1.9 3.0 1.9 0.5 1.0 1.3 6.5 7.9 0.6 0.6 0.3 4.6 10.4 0.9 2.6 0.8 0.4 6.1 0.4 2.7 6.3 1.9 1.1 0.6 20.0 2.9 1.0 0.2 0.1 1.7 1.5 0.6 1.1 5.4 0.6 0.1 3.4 9.3 2.6 2.4 0.9 0.5 0.0 29.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 29.1 0.0 0.1 0.3 1.1 0.3 0.8 0.6 0.6 2.6 0.8 1.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK6 "K2p6.1, TWIK-2" ENSG00000099337 "Potassium two pore domain channel subfamily K member 6" Q9Y257 19 38319844-38332076 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ito cells: 179.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 16.2" "Group enriched" "Detected in many" 5 "dendritic cells: 8.9;granulocytes: 16.2;monocytes: 5.4" "Cell line enhanced" "Detected in many" "HEL: 21.9;HMC-1: 24.6;T-47d: 13.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022637, HPA040184" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "CAB022637: , HPA040184: AB_2676876" "unprognostic (7.98e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.45e-6)" "unprognostic (3.76e-1)" "unprognostic (6.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.08e-2)" "unprognostic (4.31e-1)" "unprognostic (4.91e-1)" "unprognostic (4.10e-3)" "unprognostic (3.15e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (1.07e-2)" "unprognostic (3.46e-1)" "unprognostic (5.88e-2)" "unprognostic (4.59e-3)" 3.0 2.0 2.1 7.4 2.5 2.8 4.9 0.8 2.0 25.3 9.2 1.7 10.6 3.8 20.1 5.2 21.7 8.6 13.1 4.3 2.1 1.0 2.8 2.7 7.1 8.9 2.0 1.3 8.0 21.3 0.2 1.7 11.6 2.3 7.3 8.3 2.3 29.0 13.5 0.9 15.1 10.1 13.4 3.7 12.7 7.0 2.0 2.2 4.2 1.7 17.5 18.8 14.3 12.5 1.2 8.9 16.2 5.4 0.6 1.9 1.5 5.3 2.0 0.3 0.3 3.2 2.1 0.4 4.6 2.3 1.2 1.6 1.5 5.9 0.4 2.2 6.6 1.3 7.0 2.5 10.5 0.8 0.2 0.2 21.9 1.0 0.2 2.9 1.6 24.6 0.5 9.5 1.5 2.9 6.4 3.2 3.6 0.3 1.7 3.4 11.7 1.5 1.4 0.3 11.3 1.3 2.3 0.4 1.6 4.3 0.5 0.3 0.5 0.5 0.5 0.2 1.1 13.8 6.2 3.5 0.4 2.8 2.5 0.2 0.6 0.1 0.6 0.4 7.9 0.2 16.2 5.4 11.7 1.3 4.8 1.1 1.2 1.7 1.6 8.9 1.1 1.5 1.1 4.2 0.6 5.1 2.5 1.9 1.5 2.1 2.5 0.8 2.0 2.1 1.0 2.0 1.3 2.3 2.2 0.0 14.6 13.7 23.5 38.2 2.8 10.2 22.9 6.7 9.1 7.0 5.9 1.3 0.0 19.0 1.1 17.5 33.5 70.0 41.6 3.3 11.7 39.3 21.9 1.0 34.5 0.0 12.1 179.2 66.5 0.5 23.9 52.6 5.0 14.4 56.7 0.9 47.3 39.3 19.1 0.3 5.0 25.8 6.9 9.3 2.7 58.7 2.1 10.1 24.1 88.8 KCNMB4 ENSG00000135643 "Potassium calcium-activated channel subfamily M regulatory beta subunit 4" Q86W47 12 70366276-70434292 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 24.4;brain: 37.7" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 16.9;Collecting duct cells: 22.7;Ito cells: 24.5;Peritubular cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 8.9;RH-30: 9.5;RT4: 10.4;SuSa: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072287 Enhanced Approved Approved Cytosol NA NA Cytosol "HPA072287: AB_2686507" "unprognostic (3.90e-1)" "unprognostic (1.72e-2)" "unprognostic (2.69e-2)" "unprognostic (2.62e-2)" "unprognostic (6.98e-2)" "unprognostic (1.13e-3)" "unprognostic (1.85e-1)" "unprognostic (2.48e-2)" "unprognostic (3.50e-1)" "unprognostic (2.95e-2)" "unprognostic (3.75e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (1.05e-2)" 4.4 24.4 19.8 2.6 24.6 1.3 2.6 13.8 37.7 3.5 5.0 28.4 1.0 2.5 3.2 2.8 2.6 3.3 3.2 5.9 25.9 10.4 5.8 1.8 4.6 2.8 28.6 19.3 5.4 1.5 1.3 1.4 4.9 11.6 2.9 2.9 2.0 3.8 4.5 4.2 4.9 3.0 2.8 15.2 2.8 1.8 3.8 26.0 0.8 3.3 0.0 2.6 2.4 2.1 1.7 0.6 0.3 0.3 0.2 2.8 0.5 0.0 0.3 5.6 3.1 0.3 0.3 0.6 0.6 1.0 0.3 0.9 0.2 2.1 2.7 0.3 0.0 1.2 0.1 6.0 0.9 0.2 1.3 3.5 1.4 1.3 3.2 0.0 0.1 0.1 1.6 0.1 0.0 0.0 0.6 0.2 4.0 0.0 0.0 1.1 0.7 1.9 0.4 8.9 0.1 6.4 2.8 9.5 0.2 0.2 10.4 2.7 3.4 0.8 1.1 0.1 8.9 3.1 0.1 0.1 0.4 1.5 0.1 0.3 2.0 0.0 2.8 0.5 0.0 0.9 0.3 0.3 0.0 0.3 0.3 0.3 0.6 0.6 0.6 0.6 1.7 2.2 2.8 0.3 0.2 0.1 0.2 0.6 0.5 19.8 24.6 13.8 19.1 25.9 10.4 28.6 19.3 11.6 26.0 0.0 1.1 0.0 0.1 2.9 16.9 3.1 0.0 0.0 0.0 22.7 0.0 0.2 0.0 0.0 0.9 6.0 0.0 0.0 0.0 0.2 2.2 0.4 0.0 0.2 1.1 0.0 0.0 24.5 9.5 1.8 6.1 2.0 1.7 0.0 0.0 0.4 0.0 0.0 17.0 7.8 2.7 0.0 1.7 1.5 4.9 4.8 0.2 0.5 0.0 0.0 KCNN1 "hSK1, KCa2.1" ENSG00000105642 "Potassium calcium-activated channel subfamily N member 1" Q92952 19 17951293-18000080 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "brain: 32.5" "Cell type enhanced" "Detected in some" 6 "Melanocytes: 5.0;monocytes: 3.6;Spermatogonia: 4.3" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.3" "Cell line enriched" "Detected in some" 12 "REH: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065938 Approved "Actin filaments,Cytosol" Yes No "Actin filaments, Cytosol" "HPA065938: AB_2685582" "unprognostic (7.55e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-1)" "unprognostic (7.80e-2)" "unprognostic (1.90e-1)" "unprognostic (8.94e-5)" "unprognostic (3.92e-3)" "unprognostic (1.01e-1)" "unprognostic (8.42e-2)" "unprognostic (3.59e-1)" "unprognostic (2.71e-3)" "unprognostic (3.38e-1)" "unprognostic (5.21e-3)" "unprognostic (2.70e-2)" "unprognostic (1.14e-1)" "unprognostic (7.24e-3)" "unprognostic (3.24e-1)" 0.8 0.9 25.8 1.5 11.3 0.9 0.8 3.3 27.0 1.6 1.0 0.5 0.1 1.0 1.7 1.0 1.0 0.9 1.0 1.3 32.5 3.3 0.9 0.8 0.8 1.0 5.0 8.7 2.6 0.9 0.7 0.2 0.8 4.1 1.2 0.8 0.0 1.5 1.3 1.0 0.9 1.2 0.9 1.2 0.9 0.9 2.8 1.6 0.0 0.9 0.0 1.0 0.9 0.0 0.2 0.2 2.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 2.1 0.0 0.1 0.1 0.9 1.9 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.0 25.8 11.3 3.3 22.4 32.5 3.3 5.0 8.7 4.1 1.6 0.0 0.0 0.0 2.5 2.3 2.2 0.8 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.0 2.3 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.9 0.9 5.0 3.6 0.0 1.3 0.2 0.0 1.8 0.0 0.9 0.0 1.9 0.4 4.3 3.3 0.1 0.7 0.0 1.4 KCNS3 Kv9.3 ENSG00000170745 "Potassium voltage-gated channel modifier subfamily S member 3" Q9BQ31 2 17877847-18361616 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 54.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 26.8;Intestinal endocrine cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.6" "Lineage enriched" "Detected in single" 17 "B-cells: 1.6" "Cell line enhanced" "Detected in many" "RH-30: 33.8;RPMI-8226: 13.6;RT4: 23.0;U-266/84: 15.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014864 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA014864: AB_1852155" "unprognostic (5.62e-2)" "unprognostic (4.27e-3)" "unprognostic (6.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.19e-1)" "unprognostic (1.64e-2)" "unprognostic (3.30e-1)" "unprognostic (9.47e-3)" "unprognostic (9.06e-2)" "unprognostic (8.45e-2)" "unprognostic (5.82e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" 2.2 1.1 2.7 5.6 3.2 0.4 14.8 0.5 5.1 6.8 7.9 4.8 1.3 3.1 4.5 2.4 7.2 3.3 5.3 4.6 3.9 3.4 4.2 2.6 17.6 1.2 6.8 1.4 1.1 7.7 1.9 0.8 8.3 15.2 4.4 4.1 9.9 7.6 2.8 54.4 3.7 4.3 9.7 4.7 1.1 7.0 3.9 1.4 0.2 2.4 19.0 3.6 5.0 4.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.7 0.3 0.0 0.8 0.4 1.8 1.3 4.1 0.8 1.0 0.0 8.3 0.0 0.4 1.4 0.9 1.2 10.0 0.0 0.9 0.0 2.6 0.0 0.1 0.0 4.0 0.1 0.3 0.3 6.3 0.0 0.6 7.7 0.2 1.8 0.2 0.0 0.5 1.0 0.0 0.0 5.0 5.4 0.1 1.1 33.8 13.6 0.8 23.0 10.0 0.3 0.0 2.6 2.7 2.4 1.3 0.0 0.1 1.3 0.0 0.1 10.1 0.0 15.7 0.0 7.5 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.2 0.5 5.1 3.9 3.4 6.8 1.4 15.2 1.4 26.8 5.1 0.0 10.1 12.4 0.0 0.4 20.4 0.0 4.5 10.4 0.0 0.5 0.0 16.1 0.2 6.0 3.2 0.0 0.3 2.9 16.6 8.1 1.1 3.2 0.4 0.0 31.2 3.1 0.0 0.2 1.4 0.6 20.3 1.0 3.0 0.1 3.7 3.5 3.5 2.6 0.1 6.5 9.5 0.2 3.1 5.1 0.7 0.0 9.9 5.4 KCTD10 "BTBD28, MSTP028" ENSG00000110906 "Potassium channel tetramerization domain containing 10" Q9H3F6 12 109448656-109477544 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014273 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA014273: AB_1852159" "unprognostic (7.21e-3)" "unprognostic (3.04e-1)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "unprognostic (1.93e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.32e-4)" "unprognostic (1.84e-2)" "unprognostic (1.85e-1)" "unprognostic (7.01e-2)" "unprognostic (9.33e-2)" "unprognostic (3.45e-1)" "unprognostic (7.72e-2)" "unprognostic (5.76e-2)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (1.70e-3)" 29.1 16.2 10.4 16.3 17.1 8.4 21.3 10.6 20.0 25.3 26.9 14.1 15.1 8.5 30.5 15.6 24.4 18.1 23.2 16.1 11.0 16.4 23.2 9.3 20.5 13.9 11.7 8.4 16.7 7.9 14.6 12.7 19.2 16.9 19.8 22.2 29.4 14.4 29.8 9.9 19.3 14.1 36.4 9.6 17.5 19.4 13.5 12.6 12.8 30.8 15.4 17.5 27.8 19.0 6.2 10.4 7.9 14.0 20.8 12.7 11.8 9.2 9.8 28.7 9.5 23.2 33.2 6.4 20.2 26.6 13.4 13.4 9.2 7.6 9.0 11.9 46.1 6.8 7.3 10.2 16.7 12.9 8.7 6.9 10.4 6.3 5.8 14.9 7.6 9.1 31.6 10.3 17.7 9.7 19.6 31.4 8.8 6.9 3.9 23.4 4.8 9.8 10.3 17.0 4.1 12.2 9.7 12.5 7.0 13.5 16.0 10.2 15.3 12.2 12.6 12.7 18.0 15.5 6.2 23.1 14.3 5.5 8.1 11.1 8.8 16.6 12.5 16.1 6.7 21.0 7.9 8.1 5.4 12.7 12.4 9.3 6.2 7.6 9.2 10.4 6.2 8.4 10.5 5.9 20.8 14.0 7.9 8.4 11.8 10.4 17.1 10.6 20.0 11.0 16.4 11.7 8.4 16.9 12.6 14.9 34.6 5.7 16.8 13.1 5.2 10.5 15.3 8.1 9.1 5.2 15.7 7.3 5.0 14.0 8.4 22.7 13.6 0.0 11.3 10.5 16.9 12.3 13.9 4.0 10.5 7.9 11.1 26.4 12.3 7.8 10.6 10.4 15.1 19.0 12.5 2.6 17.7 11.5 17.7 8.4 4.6 25.8 28.8 9.1 5.6 14.4 11.3 10.2 13.3 16.5 KCTD14 MGC2376 ENSG00000151364 "Potassium channel tetramerization domain containing 14" Q9BQ13 11 78015715-78046191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 14.8;Mucus-secreting cells: 15.2;Pancreatic endocrine cells: 12.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 5.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 15.4;Hep G2: 16.8;RPTEC TERT1: 27.3;U-2 OS: 12.4" "HPA041118, HPA042181" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA041118: AB_10963117, HPA042181: AB_10968059" "unprognostic (7.37e-3)" "unprognostic (4.27e-2)" "unprognostic (7.03e-2)" "unprognostic (6.93e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-2)" "unprognostic (2.04e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.96e-5)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (1.05e-4)" "unprognostic (3.19e-1)" "prognostic favorable (6.92e-5)" "unprognostic (2.42e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.93e-4)" "unprognostic (1.63e-1)" 2.6 18.9 1.2 1.5 0.8 0.0 11.6 5.5 0.8 6.5 4.8 1.2 40.8 2.5 2.3 10.8 2.1 6.8 10.3 0.7 1.0 1.3 10.7 14.4 9.6 0.3 0.9 0.5 2.4 42.8 6.2 2.5 5.1 1.3 5.3 6.9 5.8 43.9 47.8 0.7 1.5 6.1 0.9 0.8 0.7 12.1 1.9 0.8 0.7 12.4 2.9 3.6 1.4 1.1 0.4 1.4 0.6 1.1 1.1 1.8 0.4 0.0 2.1 0.3 0.3 0.8 0.5 2.1 1.1 1.0 2.1 5.1 8.0 5.2 0.0 5.7 0.6 0.2 0.6 0.3 15.4 5.4 0.2 7.8 0.0 1.8 16.8 3.1 0.1 0.1 2.4 0.4 8.4 6.6 1.5 0.5 0.1 0.1 0.0 0.8 0.1 0.2 0.4 3.9 0.2 0.3 0.2 0.0 0.0 27.3 2.0 1.4 0.1 0.0 0.1 2.5 0.5 0.8 0.6 0.4 0.1 12.4 0.4 0.2 0.1 0.1 0.1 0.1 0.1 2.2 0.0 0.7 0.6 0.7 0.9 0.5 0.0 0.7 1.8 1.4 0.4 0.8 1.8 0.2 1.1 1.1 1.3 0.0 0.4 1.2 0.8 5.5 0.8 1.0 1.3 0.9 0.5 1.3 0.8 3.0 9.6 0.0 9.5 0.3 0.0 0.0 2.5 0.0 5.7 5.2 0.0 0.6 3.3 2.0 0.1 0.0 2.5 0.0 14.8 1.2 0.8 10.5 1.1 4.0 0.2 0.0 4.6 0.0 0.0 0.0 3.1 0.0 1.7 0.0 15.2 1.7 12.8 7.0 4.9 11.3 0.0 0.0 1.9 0.2 0.2 0.1 0.6 0.0 8.5 5.8 KCTD21 KCASH2 ENSG00000188997 "Potassium channel tetramerization domain containing 21" Q4G0X4 11 78171249-78188822 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041964 Uncertain Approved Cytosol NA NA Cytosol "HPA041964: AB_10795647" "unprognostic (1.17e-1)" "unprognostic (5.45e-2)" "unprognostic (3.74e-3)" "unprognostic (6.40e-3)" "unprognostic (8.06e-2)" "unprognostic (2.48e-2)" "unprognostic (1.52e-1)" "unprognostic (6.82e-2)" "unprognostic (8.85e-2)" "unprognostic (1.37e-3)" "unprognostic (2.49e-1)" "unprognostic (1.31e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "unprognostic (4.70e-1)" "prognostic favorable (9.57e-5)" "unprognostic (3.43e-2)" 8.6 18.1 13.2 7.3 12.5 4.0 15.8 8.4 14.0 7.7 7.7 9.7 7.5 6.2 6.5 11.8 12.1 8.2 9.8 12.4 10.3 12.2 6.8 18.9 8.2 6.1 15.2 9.7 17.9 9.0 11.3 8.4 9.5 10.0 5.9 6.1 6.2 6.7 6.8 9.3 6.0 5.5 11.9 12.3 5.4 5.5 5.6 8.4 7.2 13.8 5.3 7.4 10.1 7.4 2.0 4.3 9.5 7.1 1.9 2.1 2.3 3.7 8.8 4.9 3.7 17.5 12.7 3.1 7.4 7.1 5.2 5.2 8.1 5.7 3.6 7.4 8.0 7.0 7.6 4.6 6.1 5.3 4.9 2.9 2.6 10.1 7.2 9.8 1.7 3.5 12.1 11.1 11.6 6.6 11.1 7.9 4.4 5.6 3.3 7.0 5.1 2.7 5.2 2.3 13.3 6.5 3.7 3.7 2.2 6.1 6.8 3.5 5.2 4.7 3.3 3.4 9.3 8.0 1.9 9.7 8.3 8.3 22.5 2.8 6.4 6.4 3.5 4.4 2.8 4.7 2.1 6.5 8.3 1.2 7.1 1.7 0.8 1.8 2.1 4.3 2.0 1.8 1.3 9.5 1.9 5.6 1.0 1.4 2.3 13.2 12.5 8.4 13.3 10.3 12.2 15.2 9.7 10.0 8.4 0.0 2.4 0.8 1.0 1.5 1.0 3.0 5.1 0.0 1.2 0.0 0.0 1.0 1.7 1.4 0.3 1.7 1.8 0.0 1.8 1.0 2.6 1.6 5.7 6.4 1.9 6.4 0.0 2.5 3.4 0.2 4.0 0.6 1.7 1.0 1.7 1.0 2.0 1.4 8.5 2.2 0.9 0.0 2.3 1.4 1.2 1.3 1.6 1.0 1.5 1.7 KCTD3 NY-REN-45 ENSG00000136636 "Potassium channel tetramerization domain containing 3" Q9Y597 1 215567392-215621807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 70.8" "Low region specificity" "Detected in all" HPA015142 Approved Approved Cytosol NA NA Cytosol "HPA015142: AB_1852174" "unprognostic (1.62e-1)" "unprognostic (2.00e-2)" "unprognostic (5.46e-3)" "unprognostic (3.91e-2)" "unprognostic (3.67e-2)" "unprognostic (6.00e-2)" "unprognostic (3.39e-1)" "unprognostic (1.20e-2)" "unprognostic (5.60e-3)" "unprognostic (9.27e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.49e-1)" "prognostic unfavorable (8.94e-6)" "unprognostic (2.30e-2)" "unprognostic (2.55e-1)" "unprognostic (4.27e-1)" "unprognostic (3.31e-3)" 18.4 47.6 17.3 7.3 16.6 7.7 37.5 23.6 16.9 19.8 35.1 24.1 20.3 25.1 22.6 18.4 25.8 12.1 15.7 10.3 17.4 14.4 16.3 39.6 10.9 4.4 18.7 13.1 13.8 18.2 24.5 12.4 18.1 19.5 22.7 16.4 13.9 24.5 17.9 10.0 10.6 35.1 17.1 26.6 7.5 16.6 13.3 15.0 5.3 15.8 11.0 9.2 18.1 21.9 2.6 2.6 3.3 2.1 2.5 1.3 0.6 15.7 11.4 12.9 7.5 11.0 18.6 17.9 13.0 12.2 11.6 12.2 10.0 26.4 4.4 7.3 13.5 3.5 15.5 13.5 13.3 13.4 2.4 14.1 7.9 22.0 14.0 9.1 8.0 1.5 17.1 9.3 14.8 11.3 14.7 10.5 5.9 15.3 4.3 12.7 13.7 3.4 4.2 21.7 22.9 14.6 5.3 18.3 17.1 13.6 10.7 15.3 17.1 20.2 29.6 11.0 17.0 70.8 10.4 9.4 11.7 11.6 14.3 14.8 3.9 5.3 1.5 9.1 4.2 8.8 1.8 2.1 1.0 1.0 1.1 0.8 1.6 1.1 1.0 2.0 2.6 1.2 1.3 3.3 2.5 1.0 2.6 0.6 0.6 17.3 16.6 23.6 16.2 17.4 14.4 18.7 13.1 19.5 15.0 8.9 12.3 5.1 20.2 16.0 27.6 12.2 20.4 16.0 21.6 10.4 17.7 22.5 19.9 19.6 1.1 12.1 16.9 0.0 18.1 13.1 21.6 24.9 4.7 56.2 6.9 17.5 38.1 19.0 10.5 2.0 25.6 5.8 15.1 4.6 38.5 19.2 13.9 22.0 21.2 23.7 22.3 25.8 16.5 6.7 16.1 15.4 14.6 1.7 24.8 37.9 KCTD9 "BTBD27, FLJ20038" ENSG00000104756 "Potassium channel tetramerization domain containing 9" Q7L273 8 25427847-25458476 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042468, HPA047902" Supported "Nucleoplasm,Intermediate filaments,Cytosol" No No Nucleoplasm "Intermediate filaments, Cytosol" "HPA042468: , HPA047902: AB_2680205" "unprognostic (4.18e-2)" "unprognostic (3.90e-2)" "prognostic favorable (7.88e-4)" "unprognostic (7.04e-2)" "unprognostic (7.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.20e-2)" "unprognostic (6.01e-2)" "unprognostic (4.33e-1)" "unprognostic (2.43e-2)" "unprognostic (4.49e-3)" "unprognostic (2.30e-1)" "unprognostic (1.48e-1)" "unprognostic (6.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.31e-2)" "unprognostic (4.97e-3)" 14.4 5.8 7.4 17.3 7.7 11.5 14.6 17.7 10.1 15.7 14.1 5.4 16.8 12.4 15.6 12.2 18.2 11.3 12.8 48.4 5.9 5.2 9.6 6.6 10.3 6.9 7.4 5.3 12.4 8.3 7.3 11.2 7.4 14.6 11.8 14.8 9.4 14.6 18.4 19.0 15.0 10.9 16.7 10.8 8.6 10.6 11.2 6.6 11.8 8.7 11.7 8.7 19.1 14.8 2.2 3.2 3.7 2.9 0.9 3.8 1.5 18.1 12.9 14.1 4.9 18.4 24.5 11.6 27.6 24.9 18.2 18.5 9.2 13.4 11.9 11.8 27.5 25.7 12.3 12.3 13.0 22.0 6.1 7.3 13.9 12.6 8.5 22.4 4.8 10.4 18.8 15.8 16.5 13.8 11.1 15.3 12.0 14.6 9.4 20.6 4.8 18.7 8.4 6.9 14.1 6.9 7.3 16.4 4.4 18.5 10.4 3.6 4.7 21.2 9.4 14.3 13.3 7.2 5.6 16.9 20.1 11.7 38.5 14.9 2.7 4.9 15.7 14.1 8.6 14.4 2.6 1.7 3.7 3.4 2.5 3.8 2.2 3.6 3.6 1.1 1.2 2.2 3.6 1.8 0.9 2.9 3.2 3.5 1.5 7.4 7.7 17.7 10.1 5.9 5.2 7.4 5.3 14.6 6.6 29.8 11.5 4.5 33.0 66.1 13.0 55.7 5.1 16.0 22.7 26.2 23.6 8.1 11.6 15.4 3.8 15.4 29.0 0.0 23.8 14.2 32.6 43.6 19.7 8.3 8.1 3.2 9.8 12.3 8.1 2.1 28.4 15.1 28.7 7.2 12.4 7.8 24.5 22.1 52.3 8.4 18.3 6.5 26.5 24.6 30.7 47.8 9.4 15.2 16.5 40.5 KDELR1 "ERD2, ERD2.1, HDEL" ENSG00000105438 "KDEL endoplasmic reticulum protein retention receptor 1" P24390 19 48382570-48391553 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 488.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017455 Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "CAB017455: AB_10615208" "unprognostic (3.10e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.49e-4)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.35e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.51e-1)" "unprognostic (7.55e-2)" "unprognostic (4.97e-2)" "unprognostic (3.81e-1)" "unprognostic (2.74e-1)" "unprognostic (3.06e-1)" "unprognostic (1.68e-2)" 46.9 49.3 22.6 23.4 21.5 14.5 60.6 16.1 28.8 51.8 43.3 24.4 64.8 47.7 44.0 45.2 41.3 40.3 56.5 42.8 20.9 20.4 57.3 81.3 38.0 44.6 18.6 20.4 68.9 61.0 63.5 45.7 81.4 20.9 44.8 47.7 39.7 65.8 69.9 31.8 37.4 59.9 39.6 26.0 33.7 42.5 33.2 18.6 26.2 75.5 32.9 42.3 53.2 54.4 10.6 26.5 6.8 23.3 11.6 12.8 9.3 30.2 43.8 25.4 26.9 57.2 67.0 18.6 29.9 52.9 36.5 41.9 28.8 34.6 12.6 19.6 65.3 22.8 27.2 30.6 32.0 34.9 10.2 32.6 10.5 15.6 53.7 49.8 11.7 19.7 63.2 39.5 24.7 26.5 57.6 33.9 10.9 18.2 23.5 48.4 24.4 11.0 120.4 18.4 60.6 17.8 15.8 15.2 19.7 46.3 25.2 25.5 19.9 26.2 23.5 15.6 30.4 18.5 14.5 26.2 25.8 21.4 21.3 25.4 66.6 52.1 8.5 16.4 15.9 26.3 5.9 23.3 6.8 11.2 19.8 12.8 10.6 11.0 12.1 17.7 9.6 9.2 9.9 5.9 11.6 16.5 26.5 11.7 9.3 22.6 21.5 16.1 28.8 20.9 20.4 18.6 20.4 20.9 18.6 32.8 44.6 55.9 109.7 66.9 36.0 25.0 94.3 48.2 69.4 89.0 5.9 200.0 48.0 191.8 3.8 91.1 175.8 46.7 148.2 488.3 138.8 143.5 61.2 66.0 162.8 38.1 139.2 77.3 97.8 10.5 151.3 75.4 87.7 106.4 269.4 89.6 162.2 178.9 124.1 122.0 21.4 84.1 77.3 41.2 38.1 61.4 324.3 45.4 168.0 114.5 KDM1A "AOF2, BHC110, KDM1, KIAA0601, LSD1" ENSG00000004487 "Lysine demethylase 1A" O60341 1 23019443-23083689 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Oxidoreductase, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005884, HPA053660" Supported Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "CAB005884: AB_443964, HPA053660: AB_2682220" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic favorable (6.31e-4)" "unprognostic (1.50e-1)" "unprognostic (6.83e-2)" "unprognostic (3.95e-2)" "prognostic unfavorable (4.47e-12)" "unprognostic (1.80e-2)" "unprognostic (1.99e-2)" "unprognostic (9.41e-2)" "unprognostic (3.34e-3)" "unprognostic (2.13e-1)" "unprognostic (2.61e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (7.74e-2)" "unprognostic (1.39e-1)" 15.1 19.0 19.7 16.8 23.2 24.9 19.3 28.0 26.6 20.0 20.6 15.1 21.0 16.2 28.9 30.6 20.9 22.0 15.7 18.6 16.4 18.9 15.9 14.8 15.1 19.5 13.8 25.4 27.4 21.4 24.6 28.7 19.3 20.3 20.9 21.6 16.4 21.3 19.9 24.8 23.3 16.9 19.1 10.7 16.2 17.1 78.4 12.1 48.1 20.9 19.1 22.1 18.7 21.9 9.1 9.7 5.7 6.9 3.8 7.4 1.9 30.3 15.7 44.9 39.6 11.9 15.2 32.0 12.9 16.3 26.4 23.6 14.7 29.5 22.6 18.6 21.2 13.4 34.1 41.6 24.6 33.6 20.5 25.2 31.7 26.2 35.7 15.2 24.4 14.0 14.1 17.7 28.0 19.8 23.3 32.9 42.0 34.7 10.7 18.7 18.0 53.2 18.7 29.2 16.9 22.9 51.1 29.6 15.3 22.1 19.6 56.2 42.5 58.3 15.4 19.2 32.9 15.4 18.3 26.6 11.8 19.9 21.8 17.6 13.9 10.9 26.3 12.3 29.0 16.7 2.8 3.7 5.7 5.9 5.9 5.2 9.1 5.4 5.7 4.4 3.3 7.1 7.4 0.3 3.8 6.9 9.7 5.8 1.9 19.7 23.2 28.0 26.6 16.4 18.9 13.8 25.4 20.3 12.1 17.9 26.1 9.0 22.9 16.6 27.5 21.6 15.3 26.8 17.0 22.7 25.5 25.8 14.9 30.7 32.2 12.8 14.4 0.0 21.5 47.0 17.4 18.6 11.5 13.9 13.3 14.3 21.9 14.1 13.9 16.3 19.8 15.0 11.8 28.9 20.5 19.3 25.4 14.0 21.5 12.6 20.0 0.0 15.9 100.4 63.4 11.2 13.8 8.7 24.7 17.5 KDM4A "JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A" ENSG00000066135 "Lysine demethylase 4A" O75164 1 43650158-43705515 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA007610 Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA007610: AB_1852006" "unprognostic (7.01e-2)" "unprognostic (1.50e-1)" "unprognostic (3.22e-2)" "unprognostic (6.18e-2)" "unprognostic (3.54e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.39e-5)" "unprognostic (4.88e-3)" "unprognostic (1.13e-1)" "unprognostic (5.47e-1)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.32e-3)" "unprognostic (2.02e-1)" "unprognostic (1.92e-1)" "unprognostic (1.28e-1)" 12.8 29.5 12.7 15.4 19.7 11.2 14.5 23.4 22.3 17.5 18.8 20.7 17.6 29.0 18.2 14.6 19.1 19.7 15.4 10.7 11.9 11.5 13.9 18.5 15.3 14.8 14.8 16.3 22.1 15.1 22.3 22.4 13.8 19.1 15.3 20.0 21.6 17.9 12.9 13.2 23.4 23.3 16.1 13.8 18.6 15.2 6.9 14.1 29.7 18.5 11.3 22.3 17.2 15.5 6.7 5.9 12.8 7.2 6.2 7.7 4.6 10.6 9.9 16.0 28.4 15.8 15.0 11.4 10.1 11.6 15.5 15.4 11.3 9.6 14.0 10.5 10.1 11.8 11.2 19.8 12.0 16.1 9.8 16.3 19.8 14.9 9.1 15.1 14.2 16.0 16.3 19.5 15.2 19.2 11.9 16.1 12.2 9.8 20.1 11.2 8.4 11.1 12.1 26.7 9.2 10.0 14.9 18.8 9.9 11.0 21.4 14.4 13.0 22.1 15.3 27.8 24.9 8.9 48.2 12.3 9.3 15.0 8.3 13.7 9.2 11.0 12.6 9.7 12.0 17.5 11.1 6.8 12.8 6.9 5.6 7.7 6.7 6.7 5.6 5.9 5.1 4.6 4.0 4.5 6.2 7.2 5.3 7.1 4.6 12.7 19.7 23.4 22.3 11.9 11.5 14.8 16.3 19.1 14.1 8.9 21.1 2.2 4.2 8.1 20.8 6.8 7.6 26.8 4.5 1.8 35.3 7.1 5.0 7.9 9.2 7.1 13.8 0.0 5.9 4.7 8.3 4.8 12.7 8.6 7.5 30.2 11.5 9.8 6.4 4.4 11.5 7.7 1.7 10.0 19.3 10.6 8.9 10.5 13.8 5.7 23.4 6.5 6.2 0.7 1.0 4.1 6.8 5.7 14.0 5.0 KDM4B "JMJD2B, KIAA0876, TDRD14B" ENSG00000127663 "Lysine demethylase 4B" O94953 19 4969113-5153595 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 67.3;Cone photoreceptor cells: 92.3;Horizontal cells: 69.9;Rod photoreceptor cells: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 7.1;dendritic cells: 2.5;granulocytes: 6.9" "Cell line enhanced" "Detected in all" "T-47d: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062872 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062872: AB_2684890" "prognostic favorable (7.39e-4)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.74e-4)" "prognostic favorable (4.25e-7)" "unprognostic (5.95e-2)" "unprognostic (7.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.89e-2)" "unprognostic (8.24e-3)" "unprognostic (5.14e-3)" "unprognostic (8.66e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-1)" "unprognostic (4.14e-2)" "unprognostic (5.44e-2)" 13.3 16.0 14.8 15.1 13.4 22.0 20.0 26.1 18.7 19.4 12.6 18.3 24.3 12.1 24.2 18.1 15.9 18.4 12.0 12.6 13.3 9.2 10.4 18.2 11.8 19.2 13.8 12.9 18.5 19.0 12.1 17.9 29.4 11.2 24.8 6.0 18.8 16.5 22.6 38.0 21.1 12.9 16.2 13.3 21.2 12.0 19.9 13.8 14.6 28.9 8.8 13.7 13.3 21.9 7.1 2.5 6.9 0.9 1.3 0.8 0.5 8.9 3.1 7.4 8.9 4.3 4.3 15.0 4.5 3.4 4.0 5.0 5.3 2.5 12.5 4.8 5.1 3.2 5.1 4.5 5.3 2.5 5.6 11.4 4.2 5.4 4.4 8.1 4.2 9.8 6.6 5.7 3.3 2.7 7.2 5.3 7.1 10.3 7.7 3.5 4.6 4.8 6.4 6.5 3.2 7.8 8.2 5.6 10.4 4.0 5.9 13.8 10.6 5.8 6.5 7.1 7.5 35.5 11.1 7.7 6.0 3.4 7.2 4.5 21.3 8.8 9.6 11.7 8.5 3.4 1.6 0.9 2.6 0.5 0.3 0.3 6.1 0.4 0.4 0.4 7.1 0.6 0.8 6.9 1.3 0.4 2.5 0.5 0.5 14.8 13.4 26.1 18.7 13.3 9.2 13.8 12.9 11.2 13.8 6.0 7.2 13.7 11.9 6.5 67.3 12.7 15.3 2.7 5.7 7.0 92.3 21.3 6.6 9.5 13.7 10.5 8.4 0.0 6.6 19.1 10.3 19.8 8.1 23.7 8.0 69.9 8.1 12.3 11.8 8.8 17.0 9.1 10.1 9.0 16.5 20.7 14.6 13.3 21.9 5.2 74.4 6.5 8.1 18.4 7.7 13.4 20.1 10.2 8.4 10.8 KDM5A "JARID1A, RBBP2" ENSG00000073614 "Lysine demethylase 5A" P29375 12 280129-389454 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006201 Supported "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "HPA006201: AB_1079160" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.12e-1)" "unprognostic (4.46e-2)" "unprognostic (1.60e-1)" "unprognostic (3.53e-3)" "unprognostic (1.81e-2)" "unprognostic (5.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.77e-3)" "unprognostic (6.11e-2)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "unprognostic (2.60e-2)" "unprognostic (7.69e-2)" 13.6 14.4 10.6 13.7 13.0 41.6 13.1 21.8 13.2 11.8 10.3 14.8 11.3 7.8 14.2 8.1 13.6 11.2 10.0 10.1 11.5 5.7 9.0 10.7 13.1 14.9 15.1 9.1 15.2 11.5 16.8 13.8 12.4 11.3 10.6 10.9 10.6 12.9 8.6 9.7 20.3 13.0 10.4 10.1 15.5 10.6 21.2 14.8 28.8 11.4 7.1 16.1 13.1 18.8 17.2 16.8 33.7 14.1 18.6 18.1 10.1 7.7 14.0 10.3 7.9 9.3 8.8 11.5 6.9 9.2 10.4 11.3 8.3 9.4 13.0 2.2 11.5 9.1 7.4 10.7 7.8 12.5 20.5 8.9 15.9 14.6 4.9 7.5 20.7 12.6 9.6 7.4 12.8 17.1 10.7 10.5 11.7 9.5 18.3 8.8 5.2 14.8 5.9 16.0 6.7 4.4 13.9 26.9 6.1 5.0 17.9 4.0 11.6 13.6 6.2 7.3 14.9 6.7 13.1 14.3 6.9 9.9 7.6 11.5 6.5 7.1 29.9 8.8 9.1 10.1 30.2 11.3 22.2 17.7 13.1 18.1 14.1 13.8 14.2 11.8 17.2 15.1 12.9 33.7 18.6 14.1 16.8 10.5 10.1 10.6 13.0 21.8 13.2 11.5 5.7 15.1 9.1 11.3 14.8 59.6 53.6 57.8 19.7 29.3 64.2 35.8 35.7 40.2 39.8 33.2 110.0 38.1 3.3 31.6 79.2 46.6 34.3 0.0 27.4 28.3 35.7 25.6 52.1 23.6 26.7 82.6 66.8 42.4 53.2 21.3 44.8 47.2 25.3 60.5 35.6 48.0 31.1 37.9 52.3 10.5 68.8 58.2 30.9 105.6 111.6 41.7 59.5 62.5 36.0 33.9 KDM5B "CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A" ENSG00000117139 "Lysine demethylase 5B" Q9UGL1 1 202724491-202809470 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.0" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 181.0;Spermatocytes: 261.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027179, HPA053723, CAB068193" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241" "unprognostic (1.19e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.67e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (3.49e-3)" "unprognostic (3.02e-2)" "unprognostic (3.23e-2)" "unprognostic (6.12e-2)" "unprognostic (1.61e-2)" "unprognostic (4.79e-2)" "unprognostic (8.25e-3)" "unprognostic (2.56e-2)" "unprognostic (1.61e-1)" "unprognostic (5.56e-2)" "unprognostic (4.13e-1)" 7.7 7.1 5.9 8.2 7.8 14.8 12.3 12.7 9.0 12.9 9.6 5.1 9.7 5.0 13.6 9.4 17.6 8.6 8.4 5.7 6.1 4.5 6.0 4.6 9.0 5.4 3.7 7.3 13.3 9.0 9.8 8.6 23.1 5.0 11.3 9.0 16.0 11.1 8.8 4.3 19.5 7.3 10.1 4.9 6.9 8.2 74.0 5.2 25.8 9.1 6.2 10.4 12.2 12.6 4.1 3.0 16.0 5.2 7.3 4.4 2.6 10.6 4.3 28.9 13.9 13.7 12.4 24.4 7.3 11.3 7.7 8.2 3.6 11.3 0.0 5.0 11.4 5.7 16.4 13.6 12.0 9.9 0.1 5.2 5.8 4.1 5.8 11.7 18.0 7.7 12.9 20.0 11.0 14.5 20.8 17.1 7.2 18.0 0.0 7.7 10.8 5.0 21.5 19.6 7.4 7.6 21.2 0.0 0.0 11.1 18.4 8.8 19.5 15.5 9.5 12.9 39.6 19.5 12.9 12.6 6.8 5.1 0.8 4.2 1.1 0.7 4.5 6.0 6.7 2.8 16.0 2.9 6.4 3.7 3.4 3.1 2.8 3.3 2.7 3.0 4.1 4.2 1.8 9.5 7.3 5.2 2.1 4.4 2.6 5.9 7.8 12.7 9.0 6.1 4.5 3.7 7.3 5.0 5.2 83.4 33.4 5.4 32.8 57.2 30.9 7.3 10.2 54.9 40.9 15.7 58.9 35.8 5.0 41.9 155.3 25.3 16.1 0.0 19.5 25.5 34.2 40.2 25.5 9.6 7.0 14.3 41.9 19.0 17.8 181.0 33.6 10.8 25.3 10.0 31.3 68.3 38.0 17.3 30.8 5.9 133.9 32.3 21.7 261.1 71.6 101.6 68.9 12.5 27.0 45.7 KDM5C "DXS1272E, JARID1C, MRX13, SMCX, XE169" ENSG00000126012 "Lysine demethylase 5C" P41229 X 53191321-53225422 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038244, HPA046147" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038244: AB_2675911, HPA046147: AB_2679555" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (1.56e-2)" "unprognostic (7.10e-2)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.08e-2)" "unprognostic (2.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.45e-2)" "unprognostic (1.58e-2)" "unprognostic (5.05e-3)" "unprognostic (1.96e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.00e-1)" 19.5 22.9 22.4 22.6 24.7 26.3 17.9 43.0 31.7 25.9 19.5 23.4 16.7 22.2 29.2 13.3 26.9 24.8 15.2 17.6 21.6 15.3 17.0 18.8 20.6 25.8 24.6 21.8 33.1 22.5 37.7 31.8 34.0 22.8 18.7 13.5 17.0 25.6 17.1 36.6 28.4 22.2 23.6 16.0 25.0 19.4 10.6 26.2 29.0 22.2 11.3 24.5 21.5 26.4 4.5 4.3 4.8 4.0 2.8 6.1 3.8 16.9 23.1 24.8 19.0 17.2 15.7 17.6 10.6 12.4 14.4 13.4 15.6 11.1 15.8 13.8 13.9 40.6 15.2 28.0 22.7 11.0 11.8 41.4 15.3 24.7 11.0 21.2 18.1 30.6 12.4 16.7 28.1 34.7 20.6 21.2 13.2 29.7 10.5 10.5 21.7 13.2 20.4 21.0 8.8 21.7 15.0 14.8 17.1 9.1 16.3 18.7 24.1 32.2 29.9 12.1 23.8 20.9 16.0 14.5 16.1 13.9 14.4 10.3 15.3 12.4 12.0 20.9 21.5 11.9 3.0 3.8 2.7 6.1 3.6 5.1 4.5 3.7 5.7 3.1 3.2 4.5 2.9 4.8 2.8 4.0 4.3 4.3 3.8 22.4 24.7 43.0 31.7 21.6 15.3 24.6 21.8 22.8 26.2 11.9 12.2 11.9 9.7 10.8 25.0 7.7 17.8 12.0 12.5 7.0 23.6 10.6 3.3 13.4 0.6 14.3 21.7 0.0 18.7 11.4 11.3 12.4 12.7 19.8 12.4 23.8 30.0 18.4 14.6 1.7 13.6 9.4 13.5 10.0 27.8 10.9 20.8 24.6 14.9 4.2 16.1 0.0 10.3 7.0 14.6 13.9 17.4 10.2 15.6 15.9 KDM8 "FLJ13798, JMJD5" ENSG00000155666 "Lysine demethylase 8" Q8N371 16 27203495-27221768 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.9" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026545 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026545: AB_1852015" "unprognostic (1.39e-1)" "unprognostic (1.37e-3)" "unprognostic (2.80e-1)" "unprognostic (2.16e-2)" "unprognostic (3.21e-1)" "unprognostic (1.22e-2)" "unprognostic (2.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.95e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.75e-2)" "unprognostic (5.33e-2)" "unprognostic (2.71e-1)" "unprognostic (2.04e-1)" "unprognostic (3.92e-3)" 1.9 3.2 2.7 3.6 3.5 1.4 2.1 5.9 5.9 2.2 4.2 3.7 3.2 12.0 3.1 2.2 2.1 2.5 2.5 2.0 2.7 3.2 2.3 44.9 2.0 3.3 2.3 5.1 3.0 4.5 2.8 3.3 1.7 3.7 2.9 1.9 2.1 2.6 2.5 4.0 1.9 16.8 1.9 2.2 3.7 2.3 2.2 2.2 5.9 2.9 2.0 3.7 2.8 2.2 5.6 6.5 1.3 3.4 2.2 8.2 3.5 1.6 3.7 6.4 3.3 1.6 1.9 3.4 2.1 2.4 4.8 4.3 3.1 2.9 9.6 3.7 3.5 2.4 1.9 3.7 3.2 2.8 11.0 5.5 6.1 4.1 7.3 3.4 4.3 7.3 2.5 2.6 3.2 2.1 2.8 3.7 4.6 7.7 5.9 2.9 2.8 4.3 7.7 11.1 1.3 2.2 6.3 3.9 8.6 1.8 1.9 6.0 3.8 0.9 3.0 2.3 2.2 3.2 5.7 4.1 5.7 3.0 2.1 2.2 3.7 3.8 7.7 2.3 4.0 0.5 0.4 3.2 1.3 4.2 3.4 3.6 3.2 6.2 6.0 3.0 5.6 6.0 8.2 0.1 2.2 2.9 6.5 3.6 3.5 2.7 3.5 5.9 5.9 2.7 3.2 2.3 5.1 3.7 2.2 0.0 1.7 0.5 0.2 0.2 1.0 1.0 0.0 9.4 2.3 0.0 2.0 1.3 3.3 0.9 0.4 1.0 1.6 0.0 0.6 0.4 0.8 0.4 0.0 46.0 1.6 0.0 5.2 1.3 1.3 0.0 0.3 1.2 0.0 1.0 1.3 1.6 0.7 0.0 1.1 1.2 2.5 0.0 0.8 0.9 2.5 0.0 1.1 0.5 1.1 0.1 KEAP1 "INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454" ENSG00000079999 "Kelch like ECH associated protein 1" Q14145 19 10486120-10503741 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005558, CAB025337" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Centriolar satellite" Cytosol "CAB025337: , HPA005558: AB_1079175" "unprognostic (1.98e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-2)" "unprognostic (2.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (5.22e-3)" "unprognostic (2.04e-1)" "unprognostic (9.99e-2)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.06e-1)" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" 16.0 13.7 13.5 10.4 14.3 9.1 12.4 13.2 15.1 13.1 15.7 15.4 13.8 13.6 11.0 12.7 26.3 15.1 12.7 19.7 13.9 13.7 13.2 22.0 10.8 15.5 16.7 7.4 11.8 14.3 11.1 10.2 11.5 14.3 13.9 8.8 11.8 11.3 13.9 63.9 16.8 13.8 11.6 16.5 11.3 10.6 12.2 13.8 13.1 14.5 29.1 16.1 14.5 11.2 14.6 23.7 21.3 19.8 21.0 30.8 19.6 17.3 31.8 8.8 11.7 18.2 15.5 9.4 14.8 11.0 15.2 13.6 22.6 17.5 24.7 39.0 16.4 11.3 15.6 17.5 11.5 7.5 23.9 19.2 37.3 9.5 26.7 17.6 19.5 20.3 16.0 15.6 17.1 8.0 12.7 14.4 7.4 22.8 45.8 13.2 24.0 14.1 53.6 25.7 16.6 26.8 25.7 11.0 28.9 9.8 20.8 24.3 12.7 20.6 13.8 12.8 8.1 11.9 26.1 17.7 24.5 13.2 27.4 17.9 26.7 33.4 24.2 18.9 23.3 17.9 16.1 19.8 21.3 30.8 17.0 29.3 14.6 21.5 28.3 23.7 5.7 13.5 19.1 10.9 21.0 16.6 16.3 25.4 19.6 13.5 14.3 13.2 12.8 13.9 13.7 16.7 7.4 14.3 13.8 26.8 17.3 19.6 22.6 19.5 21.5 20.3 20.4 13.4 17.0 10.4 7.9 22.5 11.6 29.0 22.3 24.1 31.5 0.0 31.3 21.0 19.7 21.7 11.5 28.8 25.7 25.4 25.8 27.0 14.8 34.6 27.0 14.9 10.1 57.7 20.6 39.6 26.7 21.0 24.4 19.1 11.1 12.9 15.6 19.5 17.3 19.3 22.4 22.4 27.9 21.7 KHDC1 "bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1" ENSG00000135314 "KH domain containing 1" Q4VXA5 6 73241314-73310365 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 19.4;Spermatocytes: 29.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA029032 Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA029032: AB_10602914" "unprognostic (3.46e-1)" "unprognostic (2.20e-2)" "unprognostic (1.74e-1)" "unprognostic (2.73e-4)" "unprognostic (1.95e-1)" "unprognostic (2.18e-1)" "unprognostic (1.20e-1)" "unprognostic (7.54e-2)" "unprognostic (5.76e-2)" "unprognostic (6.27e-2)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" "unprognostic (1.83e-4)" "unprognostic (8.18e-2)" "unprognostic (2.97e-1)" "unprognostic (2.14e-1)" "unprognostic (5.17e-3)" 2.9 2.9 10.3 2.0 12.9 0.9 2.2 8.8 14.6 4.7 1.3 2.6 1.2 0.6 3.9 3.3 2.7 6.2 2.6 3.4 8.5 8.4 1.3 0.4 1.8 3.1 8.6 5.7 7.4 4.4 5.0 9.6 1.5 4.7 4.4 1.4 2.9 1.3 3.6 2.7 1.0 1.1 2.4 6.2 0.9 2.9 8.2 4.1 5.4 5.9 1.7 3.4 2.2 2.1 2.7 2.6 3.8 0.2 2.5 5.2 2.0 2.9 4.2 0.8 2.3 4.0 4.6 2.0 5.7 5.5 8.8 13.1 4.0 2.3 6.2 2.2 2.5 4.5 2.8 5.9 1.2 6.7 5.9 4.2 4.1 3.4 0.0 5.2 2.0 0.1 5.9 2.5 8.7 2.4 3.7 1.9 6.5 3.0 7.5 3.5 6.9 0.4 1.9 3.9 0.5 8.4 0.9 0.0 5.0 1.4 0.1 10.5 2.2 3.2 0.1 0.2 2.9 0.1 6.2 0.1 1.9 4.0 1.1 6.0 12.7 7.6 4.5 0.1 1.7 0.7 3.8 0.2 0.0 4.4 0.0 2.6 2.7 2.8 4.9 0.7 1.9 2.2 3.4 0.0 2.5 0.0 2.6 5.2 2.0 10.3 12.9 8.8 12.4 8.5 8.4 8.6 5.7 4.7 4.1 0.0 1.0 3.0 3.2 0.7 7.8 1.8 0.0 0.0 2.3 3.5 2.0 1.5 1.7 0.8 9.3 0.3 0.0 0.0 3.3 0.3 3.1 1.7 0.0 0.0 0.4 12.7 0.0 0.0 0.0 12.1 2.0 0.0 3.3 1.0 0.5 11.5 2.3 0.0 3.2 0.0 6.8 19.4 1.9 29.8 12.9 0.5 0.1 4.3 0.9 0.4 KHK ENSG00000138030 Ketohexokinase P50053 2 27086747-27100772 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 60.2;kidney: 38.4;liver: 67.0" "Group enriched" "Detected in many" 6 "Hepatocytes: 359.6;Proximal tubular cells: 948.1" "Group enriched" "Detected in all" 7 "liver cancer: 62.2;renal cancer: 32.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 18.6;Hep G2: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007040 Enhanced Approved Cytosol NA NA 320000 Cytosol "HPA007040: AB_1079185" "unprognostic (8.44e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (7.62e-8)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "unprognostic (3.08e-2)" "unprognostic (3.13e-2)" "unprognostic (1.67e-2)" "unprognostic (2.50e-2)" "unprognostic (3.01e-2)" "unprognostic (1.30e-1)" "unprognostic (1.68e-2)" "unprognostic (2.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.44e-1)" "unprognostic (1.02e-2)" 0.9 1.9 2.1 1.2 2.7 0.7 1.9 5.2 3.9 1.1 22.3 1.9 0.2 40.0 1.5 0.9 1.1 1.6 0.6 0.6 2.2 2.2 38.4 67.0 0.7 0.8 3.5 1.9 1.8 4.2 0.6 0.7 0.4 3.0 0.9 0.6 0.6 1.7 0.7 1.4 1.0 60.2 0.9 1.8 0.8 1.0 1.6 3.6 0.0 0.5 1.2 0.6 0.7 0.9 5.1 7.3 0.6 6.6 5.4 8.8 6.0 14.0 10.7 1.7 6.4 1.2 0.3 1.4 1.0 0.6 1.3 0.8 5.1 3.1 2.1 3.4 0.0 1.5 6.2 5.5 1.8 0.4 5.0 10.1 18.6 2.8 27.1 0.6 2.5 2.2 0.1 0.8 1.6 0.1 0.7 1.2 3.0 3.3 3.6 0.1 9.1 3.0 2.0 2.3 12.7 4.2 10.7 0.8 11.8 1.6 1.7 6.0 9.4 2.1 3.6 4.0 0.6 1.6 1.1 1.1 0.4 2.1 0.9 3.7 4.4 7.9 3.6 1.8 6.1 1.0 0.0 6.6 0.4 5.4 3.8 7.4 5.1 8.8 7.8 6.1 5.1 6.4 7.8 0.6 5.4 1.6 7.3 5.5 6.0 2.1 2.7 5.2 3.9 2.2 2.2 3.5 1.9 3.0 3.6 3.0 5.9 9.6 2.3 3.2 3.6 1.9 15.3 0.0 1.2 38.4 2.0 2.6 109.5 3.1 0.8 5.8 12.3 0.0 2.6 3.6 1.9 0.9 4.6 359.6 7.5 6.4 5.8 6.7 13.2 3.6 1.7 5.8 8.5 1.0 5.9 8.5 2.7 1.7 1.4 948.1 5.2 0.0 4.5 0.9 6.8 5.9 7.9 4.6 14.3 1.0 KHNYN KIAA0323 ENSG00000100441 "KH and NYN domain containing" O15037 14 24429286-24441834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003402 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003402: AB_1079190" "unprognostic (2.95e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.03e-1)" "unprognostic (8.03e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (4.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (5.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.47e-1)" "unprognostic (8.43e-2)" "unprognostic (1.41e-1)" "unprognostic (6.08e-2)" "unprognostic (2.73e-1)" 18.3 16.7 8.3 24.2 12.8 21.1 18.1 18.9 9.4 21.6 22.4 14.3 25.2 16.9 18.7 19.5 24.3 18.3 28.8 11.2 8.6 5.9 11.8 12.5 16.8 19.2 12.9 7.2 30.7 23.2 17.6 12.8 31.5 11.3 21.5 16.1 10.8 17.0 20.0 15.1 16.9 21.2 24.5 13.6 22.7 24.6 9.3 12.5 20.1 16.1 16.6 26.0 19.7 30.7 6.6 4.5 7.0 5.8 4.5 5.8 3.7 12.6 15.3 12.7 10.1 14.1 13.9 13.5 12.4 14.4 14.4 11.2 9.5 21.8 17.9 7.2 11.0 11.9 12.0 11.2 19.6 10.3 27.2 5.6 8.0 13.7 17.2 15.1 11.6 17.0 14.1 44.2 15.4 19.2 18.6 16.1 13.0 10.3 15.9 8.3 17.0 4.0 7.0 3.4 22.6 13.3 6.4 0.1 8.8 8.7 18.2 9.4 9.9 10.5 6.6 16.3 13.3 7.7 13.1 16.2 12.6 11.3 14.9 7.0 30.7 16.5 11.9 6.9 6.2 11.7 4.7 4.1 7.0 5.8 5.8 3.4 4.6 4.5 4.9 3.1 6.6 3.5 3.3 5.7 4.5 4.8 4.5 4.4 3.7 8.3 12.8 18.9 9.4 8.6 5.9 12.9 7.2 11.3 12.5 11.9 12.3 7.8 20.6 7.9 2.5 2.9 17.8 1.4 7.9 7.0 2.0 17.5 1.7 15.2 0.3 13.4 27.4 0.0 36.6 11.0 8.5 26.7 13.9 7.6 12.3 0.0 10.4 9.2 10.8 2.0 13.0 9.0 11.8 14.4 22.1 8.3 32.5 14.4 10.6 3.3 7.6 12.9 15.6 1.4 1.5 11.2 22.4 12.5 15.3 26.9 KIAA0100 "BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488" ENSG00000007202 KIAA0100 Q14667 17 28614440-28645454 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042781 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" No No "Nuclear speckles, Cytosol" "HPA042781: AB_10797020" "unprognostic (1.91e-1)" "unprognostic (1.03e-2)" "unprognostic (3.47e-2)" "unprognostic (5.26e-3)" "unprognostic (2.43e-1)" "unprognostic (6.89e-2)" "prognostic unfavorable (3.47e-5)" "unprognostic (4.99e-2)" "unprognostic (3.04e-1)" "unprognostic (3.03e-3)" "unprognostic (2.40e-2)" "unprognostic (2.53e-1)" "unprognostic (4.24e-3)" "unprognostic (7.58e-2)" "unprognostic (5.84e-2)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 27.7 31.2 22.3 21.3 34.7 21.9 26.3 28.1 40.1 20.0 24.0 28.2 20.9 15.5 24.7 21.6 25.4 24.0 20.1 21.4 22.0 22.4 38.1 30.7 24.1 26.3 23.1 19.6 25.6 24.6 48.0 27.0 32.7 35.6 22.7 28.5 22.1 27.0 23.3 40.7 25.0 27.9 28.4 21.4 26.4 22.8 24.8 18.6 26.3 28.6 20.2 26.6 22.7 18.8 2.9 7.2 3.5 3.0 2.0 3.3 1.3 19.6 37.6 19.1 18.1 34.8 20.8 13.9 18.4 24.6 22.6 21.3 25.8 9.0 27.4 22.2 33.6 23.6 26.3 28.0 27.3 27.4 30.3 26.2 21.8 29.8 14.1 15.0 38.0 37.9 21.2 21.2 30.5 23.3 17.6 32.2 19.6 20.5 8.9 20.5 28.2 27.7 18.1 8.3 35.7 13.9 21.3 21.4 17.9 13.6 35.4 18.8 14.5 23.2 63.6 15.5 24.8 38.0 26.6 29.7 17.3 19.1 23.1 34.7 8.4 9.7 17.7 19.7 24.7 20.1 0.8 3.0 3.5 3.0 2.5 3.3 2.9 1.5 2.7 3.3 1.7 1.8 1.8 1.8 2.0 2.7 7.2 1.7 1.3 22.3 34.7 28.1 40.1 22.0 22.4 23.1 19.6 35.6 18.6 14.9 19.1 3.9 6.3 9.2 31.3 27.1 15.3 12.0 12.5 12.2 27.5 10.4 5.0 8.4 12.4 10.5 22.7 23.3 9.4 8.0 8.9 11.1 8.1 28.0 9.4 27.0 11.6 21.5 29.7 18.3 8.6 15.0 10.1 14.4 15.6 12.6 9.2 8.6 6.0 13.8 22.8 0.0 7.8 16.9 20.9 9.7 38.1 8.6 16.1 11.2 KIAA0232 ENSG00000170871 KIAA0232 Q92628 4 6781375-6884170 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 13.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036891, HPA036892, HPA061498" Approved Approved Cytosol NA NA Cytosol "HPA036891: AB_10672272, HPA036892: AB_2675366, HPA061498: AB_2684541" "unprognostic (6.88e-3)" "unprognostic (2.74e-1)" "unprognostic (8.98e-2)" "unprognostic (4.87e-2)" "unprognostic (2.43e-1)" "unprognostic (4.13e-2)" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (1.85e-1)" "unprognostic (3.16e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-1)" "prognostic favorable (3.91e-10)" "unprognostic (1.21e-1)" "unprognostic (8.57e-2)" "unprognostic (2.04e-1)" "unprognostic (3.18e-2)" 12.5 12.7 18.7 8.1 22.2 14.0 13.8 22.8 25.5 13.3 13.8 20.5 12.4 8.5 15.8 13.4 21.1 15.9 12.7 32.2 19.8 18.8 19.5 15.0 12.0 7.0 20.7 17.5 13.9 10.6 25.4 22.2 25.8 25.4 15.5 12.7 11.5 10.6 15.7 32.4 7.7 18.8 13.5 19.8 12.3 11.0 13.5 17.9 10.0 15.5 13.3 8.5 12.1 13.2 1.6 2.4 13.1 2.5 2.1 3.8 0.9 9.0 8.7 18.3 11.4 13.3 14.4 9.7 11.8 12.3 8.3 7.0 5.5 7.6 5.9 4.0 13.2 12.8 4.7 9.3 5.2 10.8 3.3 3.8 17.6 7.5 7.2 7.0 7.6 23.3 9.6 12.3 9.2 5.1 10.7 8.5 6.0 13.3 5.2 10.5 4.4 14.5 7.7 9.7 6.8 9.7 10.4 18.8 2.7 14.0 8.6 14.0 9.0 8.7 7.8 8.1 13.2 9.9 14.0 10.8 7.6 9.1 6.8 10.0 9.0 9.0 4.8 9.4 8.2 20.6 1.9 2.4 6.3 2.8 1.6 3.8 1.6 2.1 3.1 1.6 1.6 2.0 2.0 13.1 2.1 2.5 2.4 1.9 0.9 18.7 22.2 22.8 25.5 19.8 18.8 20.7 17.5 25.4 17.9 29.8 31.7 8.3 22.9 11.3 72.9 121.5 7.6 66.9 34.2 12.2 35.3 11.7 34.9 20.0 36.5 15.7 31.1 46.7 10.2 5.9 11.8 25.5 11.6 36.0 9.6 93.8 24.1 16.0 24.8 44.7 23.0 17.7 6.8 16.2 16.6 51.2 15.7 24.6 31.1 21.7 41.3 25.8 13.1 27.2 17.9 9.7 18.8 12.8 13.7 24.3 KIAA0408 ENSG00000189367 KIAA0408 Q6ZU52 6 127440343-127459391 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.6;smooth muscle: 37.2" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 86.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 12.5;GAMG: 10.9;SCLC-21H: 31.5;SH-SY5Y: 15.6;U-138 MG: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044035, HPA053341" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044035: AB_10964274, HPA053341: AB_2732578" "unprognostic (1.06e-1)" "unprognostic (4.36e-2)" "unprognostic (3.06e-1)" "unprognostic (1.09e-1)" "unprognostic (8.56e-4)" "unprognostic (1.00e-1)" "unprognostic (4.95e-2)" "unprognostic (6.05e-3)" "unprognostic (2.29e-1)" "unprognostic (5.94e-2)" "unprognostic (3.20e-2)" 22.9 3.1 9.1 3.4 6.9 0.0 2.8 12.4 21.0 7.4 12.0 0.6 1.9 1.1 2.6 4.7 16.7 1.1 2.9 2.6 10.2 9.7 0.6 0.7 15.3 0.5 11.5 0.7 3.3 0.5 0.0 6.8 1.1 0.9 20.4 5.0 0.7 1.9 1.7 38.6 0.4 6.7 37.2 13.1 2.0 3.7 3.4 1.2 0.7 1.5 15.4 0.8 25.2 11.3 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 2.9 12.5 0.0 1.1 3.0 0.0 0.3 2.2 1.9 4.5 0.0 0.0 0.0 0.0 0.4 10.9 0.0 1.2 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 0.0 8.1 0.0 1.4 0.0 1.2 0.0 0.3 2.3 0.0 4.3 0.0 4.2 0.0 0.1 0.0 2.1 0.0 0.7 0.0 31.5 15.6 0.0 0.0 0.3 0.0 0.0 0.9 0.0 8.6 1.4 0.0 2.0 0.0 0.0 0.0 5.0 0.2 6.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.1 6.9 12.4 11.8 10.2 9.7 11.5 0.7 0.9 1.2 86.4 19.0 0.0 0.1 0.0 3.3 0.0 0.0 6.7 5.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 7.9 0.0 1.3 0.8 0.0 0.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.2 0.9 0.1 0.0 0.1 0.0 0.0 0.0 KIAA0513 ENSG00000135709 KIAA0513 O60268 16 85027751-85094230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 46.1;Late spermatids: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 15.9;monocytes: 13.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012866, HPA014431" Enhanced Uncertain Nucleoplasm,Cytosol NA NA 8400 "Nucleoplasm, Cytosol" "HPA012866: AB_1852321, HPA014431: AB_1852322" "unprognostic (1.98e-2)" "unprognostic (2.47e-2)" "unprognostic (2.35e-1)" "unprognostic (1.69e-2)" "unprognostic (1.49e-2)" "unprognostic (9.37e-3)" "unprognostic (2.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic favorable (1.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.94e-3)" "unprognostic (7.88e-2)" "unprognostic (4.00e-1)" "unprognostic (2.33e-2)" "unprognostic (2.34e-1)" 5.2 11.0 20.8 8.8 30.8 14.3 2.8 57.6 57.6 6.9 8.1 4.6 1.8 4.7 3.3 3.1 7.6 2.3 4.9 4.5 19.7 14.9 3.0 1.9 6.7 5.2 11.3 27.6 2.9 13.0 4.1 14.8 4.0 17.6 6.2 6.1 2.9 8.3 5.2 5.6 9.9 6.0 5.6 6.9 7.4 10.1 5.7 4.6 0.5 2.8 1.0 6.2 8.3 3.5 0.0 3.6 15.9 13.6 0.7 0.9 3.1 5.7 6.2 4.2 6.1 7.9 5.9 1.0 5.8 9.3 8.4 4.9 2.8 2.7 2.0 2.6 7.0 5.1 5.1 3.9 9.2 5.2 4.3 3.2 3.7 1.9 1.5 3.8 0.4 5.3 10.9 4.9 9.6 1.2 3.6 4.4 4.1 16.2 4.8 7.4 9.0 0.7 1.5 4.1 6.7 5.0 0.7 5.4 1.2 7.8 4.2 12.4 1.9 6.8 11.4 2.8 4.4 9.2 1.2 8.9 5.2 3.9 7.8 2.0 7.6 1.3 4.1 6.8 2.9 5.6 11.0 7.2 10.6 0.9 8.3 0.3 0.0 0.6 0.6 2.6 0.0 0.6 0.6 15.9 0.7 13.6 3.6 0.2 3.1 20.8 30.8 57.6 45.9 19.7 14.9 11.3 27.6 17.6 4.6 6.0 7.2 3.0 6.5 3.5 13.4 5.8 2.5 1.4 2.3 1.8 5.9 0.4 0.0 2.0 38.3 3.2 5.9 0.0 4.1 0.6 3.9 11.1 2.3 2.4 6.7 46.1 10.9 5.5 18.3 149.1 15.0 8.8 3.3 5.4 8.4 2.5 6.6 7.0 25.1 1.3 5.9 0.0 3.1 3.6 4.9 3.9 2.9 4.4 3.5 26.5 KIAA0586 "JBTS23, Talpid3" ENSG00000100578 KIAA0586 Q9BVV6 14 58427385-58551289 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 76.6;Early spermatids: 97.7;Late spermatids: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000846, HPA050249" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000846: AB_2234167, HPA050249: " "unprognostic (1.90e-1)" "unprognostic (7.85e-2)" "unprognostic (2.98e-2)" "unprognostic (6.88e-2)" "unprognostic (4.99e-2)" "unprognostic (1.76e-3)" "unprognostic (4.82e-3)" "unprognostic (1.13e-1)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (2.67e-2)" "unprognostic (5.65e-2)" "prognostic favorable (7.20e-4)" "unprognostic (8.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.41e-1)" "unprognostic (1.13e-1)" 9.5 9.9 10.2 9.2 14.7 9.8 9.9 23.9 13.0 9.9 8.3 7.5 8.0 6.1 9.4 10.7 9.4 7.5 8.3 8.0 12.4 9.6 7.4 11.1 7.9 11.2 15.3 10.7 13.5 8.2 14.6 33.2 6.7 14.5 9.7 11.0 7.0 8.1 8.6 10.4 9.1 8.3 15.8 19.8 9.5 7.6 25.0 14.8 24.5 9.0 7.4 12.7 10.0 8.6 9.1 5.0 13.5 3.6 13.1 10.9 3.1 14.3 10.7 17.8 7.4 12.2 11.0 6.6 13.4 9.5 11.4 10.4 4.3 8.0 17.9 8.5 8.8 5.2 9.2 16.5 8.0 19.6 15.8 6.0 14.6 9.2 12.4 7.2 19.8 10.8 7.0 3.4 9.4 12.4 6.1 13.4 16.4 14.8 9.5 18.4 9.0 10.7 8.5 7.1 9.0 17.4 15.3 20.1 10.8 8.2 6.7 11.1 6.9 13.8 8.3 6.5 9.1 10.6 10.5 12.7 16.9 14.6 9.5 10.6 4.8 8.6 14.3 11.2 14.6 10.5 13.5 2.8 6.1 9.3 2.4 8.6 7.3 9.0 7.1 3.2 9.1 10.9 8.7 3.2 13.1 3.6 5.0 8.5 3.1 10.2 14.7 23.9 13.0 12.4 9.6 15.3 10.7 14.5 14.8 11.9 12.6 13.0 5.3 2.9 27.5 11.3 10.2 29.4 12.5 8.7 76.6 5.9 5.0 5.7 97.7 11.7 3.3 0.0 4.6 6.5 5.6 3.5 19.8 4.3 7.9 30.2 10.3 8.0 7.3 81.1 9.5 6.9 8.5 4.6 6.5 21.5 5.6 2.9 11.3 5.4 50.2 0.0 6.6 51.5 21.3 4.0 4.0 13.8 6.5 3.1 KIAA0753 "MNR, OFIP" ENSG00000198920 KIAA0753 Q2KHM9 17 6578148-6640927 "Disease related genes, Predicted intracellular proteins" Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 41.5;Early spermatids: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023057, HPA023494" Enhanced Enhanced Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA023057: AB_1852338, HPA023494: AB_1852339" "unprognostic (3.72e-2)" "unprognostic (5.91e-2)" "unprognostic (1.60e-2)" "unprognostic (2.93e-2)" "unprognostic (5.17e-2)" "unprognostic (1.47e-1)" "unprognostic (4.19e-3)" "unprognostic (1.47e-1)" "unprognostic (3.01e-3)" "unprognostic (1.82e-1)" "unprognostic (6.10e-3)" "unprognostic (1.47e-2)" "unprognostic (9.57e-2)" "unprognostic (1.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" 6.5 7.0 7.5 11.7 12.8 4.5 9.9 7.4 9.4 10.1 7.7 7.3 20.1 4.4 17.8 15.6 8.5 13.4 10.7 5.0 8.3 7.7 8.7 4.3 8.3 6.6 4.9 7.9 15.4 10.5 26.4 26.0 7.4 8.0 9.6 9.2 9.6 7.0 13.6 5.4 7.4 6.4 11.5 7.2 9.0 7.9 20.1 5.1 13.7 12.1 4.1 6.8 8.4 7.7 2.3 1.8 5.5 2.2 1.1 2.0 0.7 15.9 12.3 16.1 11.2 6.1 10.5 6.1 8.6 8.1 12.3 10.8 9.1 3.7 5.7 5.8 7.9 8.3 14.9 15.1 7.8 19.7 5.7 12.1 3.3 10.7 6.4 9.1 5.6 7.3 6.9 11.0 12.3 10.1 12.6 9.0 7.7 8.0 0.8 9.5 5.6 6.1 4.9 9.8 7.7 6.5 8.9 5.4 1.9 10.9 10.3 6.0 10.8 11.4 3.0 6.6 11.0 5.1 3.6 8.3 11.6 5.3 6.1 12.7 1.4 1.9 2.4 8.1 3.2 7.8 0.0 2.0 1.7 1.8 2.2 2.0 2.3 1.5 1.6 1.3 1.4 1.2 1.1 5.5 1.1 1.1 1.8 1.1 0.7 7.5 12.8 7.4 9.4 8.3 7.7 4.9 7.9 8.0 5.1 6.0 10.5 1.4 2.6 2.9 3.8 3.0 5.1 41.5 11.4 0.0 15.7 1.8 0.0 3.8 63.1 3.6 2.1 0.0 3.4 0.9 2.8 3.6 1.1 1.8 2.2 9.5 6.9 4.3 3.7 9.9 4.0 2.2 0.0 1.0 4.8 2.4 3.4 4.0 3.2 2.9 10.8 0.0 3.3 14.1 7.5 2.0 1.0 0.0 4.0 2.6 KIAA0895 ENSG00000164542 KIAA0895 Q8NCT3 7 36324221-36390125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 69.3;Late spermatids: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021036, HPA061066" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cell Junctions, Cytosol" "HPA021036: AB_2670571, HPA061066: AB_2684423" "unprognostic (4.94e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-1)" "unprognostic (1.39e-1)" "unprognostic (8.85e-2)" "unprognostic (1.15e-3)" "unprognostic (3.79e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (4.71e-3)" "unprognostic (1.46e-1)" "unprognostic (3.49e-1)" "unprognostic (4.51e-2)" "unprognostic (6.68e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-2)" "unprognostic (5.24e-2)" 1.5 9.9 8.1 1.3 11.0 2.8 5.2 28.9 13.5 3.7 3.0 5.8 6.0 3.0 4.6 9.1 3.6 8.6 4.6 2.6 6.2 8.1 13.1 10.4 4.2 0.7 4.2 8.2 12.7 12.4 18.6 14.7 2.0 8.0 4.6 2.1 6.6 4.1 4.7 2.1 7.8 1.7 4.4 4.7 1.2 14.3 27.1 4.9 2.1 5.5 1.5 0.9 2.3 2.7 0.6 0.5 1.3 0.1 0.5 1.5 0.4 7.3 4.5 9.3 9.1 0.2 0.2 2.1 2.0 2.3 4.4 5.4 1.9 3.8 0.0 2.0 0.4 7.7 4.2 12.0 3.9 3.9 0.6 7.6 0.1 7.0 1.7 1.6 1.2 0.2 1.0 7.1 3.9 5.0 5.4 0.1 4.0 2.9 0.1 0.5 2.4 3.6 2.6 0.4 1.9 1.1 1.4 0.4 0.0 10.1 0.8 28.4 9.9 3.6 8.6 2.6 6.6 8.6 1.3 0.0 0.6 2.2 1.3 2.9 4.2 9.4 0.0 1.8 0.3 2.1 0.8 0.1 0.3 0.1 0.1 1.3 0.3 0.9 0.2 0.1 0.6 1.4 0.6 1.3 0.5 0.1 0.5 1.5 0.4 8.1 11.0 28.9 13.5 6.2 8.1 4.2 8.2 8.0 4.9 6.0 2.4 0.0 4.2 8.7 17.4 2.6 5.1 16.0 3.4 3.5 25.5 1.9 5.0 4.7 69.3 1.1 0.4 0.0 2.5 1.3 0.9 3.6 1.1 5.0 0.4 11.1 8.1 0.0 0.0 54.0 2.6 0.2 3.3 0.0 1.0 5.0 3.7 1.4 0.4 9.4 15.7 6.5 1.0 21.6 12.4 7.5 0.6 0.0 1.0 1.4 KIAA1217 "DKFZP761L0424, ETL4, SKT" ENSG00000120549 KIAA1217 Q5T5P2 10 23694746-24547848 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 91.1" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 107.7;Club cells: 95.5;Muller glia cells: 121.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.8" "Lineage enhanced" "Detected in single" "T-cells: 2.8" "Cell line enhanced" "Detected in many" "BEWO: 34.0;Karpas-707: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004941 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA004941: AB_2130659" "unprognostic (3.60e-2)" "unprognostic (7.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.73e-2)" "unprognostic (1.27e-1)" "unprognostic (4.45e-3)" "unprognostic (1.60e-3)" "unprognostic (2.03e-3)" "unprognostic (1.87e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.69e-1)" "unprognostic (1.84e-3)" "unprognostic (5.27e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-1)" "unprognostic (1.22e-1)" 24.9 12.7 3.3 6.6 8.7 0.0 21.6 5.5 16.2 10.2 15.1 2.7 18.0 7.5 7.2 16.5 22.6 10.4 11.9 8.6 5.1 3.7 13.5 10.4 8.6 1.4 4.3 8.1 8.4 10.1 34.1 5.5 12.2 8.8 15.1 8.9 16.9 28.8 26.6 91.1 12.0 13.7 4.1 3.8 5.7 10.1 16.8 1.8 3.3 20.5 20.4 8.8 10.1 13.0 0.0 0.0 0.0 0.0 0.9 2.8 0.0 7.6 3.9 1.5 0.0 1.0 2.8 34.0 1.5 2.4 3.5 7.6 6.6 12.3 0.4 7.7 3.0 7.2 12.8 1.9 14.5 3.9 2.8 1.4 0.1 8.9 7.7 1.7 0.0 0.1 10.7 9.4 7.8 2.1 1.6 0.0 0.7 0.0 30.9 1.8 2.7 4.2 0.2 3.5 7.5 3.5 0.3 9.1 6.3 8.3 10.1 1.0 0.5 3.8 12.9 0.0 16.6 6.2 0.0 8.1 5.4 5.9 21.7 1.9 13.8 11.6 0.0 18.1 0.2 0.2 0.0 0.0 0.0 0.5 0.0 2.8 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.3 8.7 5.5 16.2 5.1 3.7 4.3 8.1 8.8 1.8 35.7 24.2 0.8 63.7 107.7 12.4 33.1 17.8 32.1 95.5 31.4 7.9 43.5 3.3 26.0 24.9 10.8 21.2 0.0 23.1 16.7 14.6 36.0 1.1 21.2 4.6 0.0 23.0 25.8 10.5 7.0 16.4 2.7 1.7 0.0 21.3 121.7 20.1 22.0 31.1 4.5 2.7 12.9 19.6 0.5 0.7 44.5 54.5 0.7 16.6 47.2 KIAA1468 "FLJ33841, HsT3308, HsT885" ENSG00000134444 KIAA1468 Q9P260 18 62187255-62310217 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039708, HPA040038" Approved Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Centriolar satellite, Cytosol" "HPA039708: AB_10794753, HPA040038: AB_10793860" "unprognostic (1.33e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (4.03e-2)" "unprognostic (1.98e-3)" "unprognostic (2.44e-2)" "unprognostic (6.30e-2)" "unprognostic (3.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.36e-1)" "unprognostic (4.84e-3)" "unprognostic (2.47e-2)" "unprognostic (6.86e-2)" "unprognostic (3.54e-1)" "unprognostic (1.71e-2)" 11.7 13.3 14.8 15.7 31.6 18.3 17.8 25.7 25.9 14.3 16.5 14.3 16.6 13.8 13.9 18.3 36.5 11.8 13.9 10.3 12.5 14.4 14.8 11.5 11.8 15.8 13.7 16.0 12.8 12.6 20.2 20.0 11.9 22.8 18.5 21.7 13.5 18.8 14.1 11.8 29.6 15.5 11.1 11.4 17.1 18.0 8.0 16.8 18.3 14.4 16.6 22.0 15.5 21.7 3.7 3.5 6.0 3.5 4.0 4.7 1.9 7.7 7.1 8.7 8.3 9.3 11.0 9.3 14.0 11.7 12.6 14.0 3.7 7.3 5.4 7.3 12.3 8.3 16.3 12.4 8.4 15.5 4.9 7.7 4.5 8.0 8.3 8.3 8.6 6.3 8.0 10.3 10.7 6.6 10.4 8.6 5.2 3.4 5.5 13.2 4.5 5.3 7.4 5.1 5.3 6.1 6.6 11.0 6.3 14.4 15.7 12.4 6.6 8.4 12.4 7.2 11.8 6.4 9.4 10.9 13.5 4.2 5.9 6.9 16.1 3.0 5.3 9.5 9.3 10.7 5.0 3.5 4.1 4.1 3.0 3.3 3.0 3.8 3.9 3.5 3.7 4.1 4.7 6.0 4.0 2.5 2.4 4.4 1.9 14.8 31.6 25.7 25.9 12.5 14.4 13.7 16.0 22.8 16.8 14.9 16.3 7.5 6.2 7.6 23.5 8.1 5.1 8.1 14.8 0.0 9.8 5.5 0.0 5.8 0.4 8.3 12.9 23.3 7.4 3.4 5.4 9.4 7.0 7.8 6.3 20.6 12.1 7.4 15.3 0.0 6.9 14.5 10.1 7.2 16.0 5.2 7.1 5.8 7.4 5.0 13.9 6.5 4.7 9.9 4.9 18.7 5.5 9.5 14.3 9.7 KIAA1551 "C12orf35, FLJ10652, FLJ20696, GET, UTA2-1" ENSG00000174718 KIAA1551 Q9HCM1 12 31959370-31993107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;lymphoid tissue: 56.3" "Cell type enhanced" "Detected in many" 7 "Urothelial cells: 190.4" "Cancer enhanced" "Detected in all" "testis cancer: 65.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 58.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 58.8" "Cell line enhanced" "Detected in all" "SuSa: 44.6" "Low region specificity" "Detected in all" "HPA013816, HPA015622" Approved Supported "Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Intermediate filaments, Cytosol" "HPA013816: AB_1848661, HPA015622: AB_1848663" "unprognostic (7.97e-3)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (8.49e-2)" "unprognostic (3.21e-1)" "unprognostic (3.09e-3)" "unprognostic (2.24e-1)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (5.04e-9)" "unprognostic (3.83e-1)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (7.26e-3)" 12.4 5.8 4.7 28.8 6.1 9.0 10.3 8.7 7.0 15.7 17.5 2.7 7.1 10.7 11.2 10.3 12.3 19.0 8.9 6.2 4.8 3.5 8.1 14.2 17.0 56.3 7.5 4.1 38.3 7.0 3.6 8.0 17.5 5.4 11.6 6.5 3.5 8.6 5.5 5.4 6.7 30.0 8.5 8.1 39.1 8.8 8.7 5.9 48.5 10.0 7.6 27.6 17.3 13.9 9.6 3.3 58.8 4.5 8.0 13.2 5.0 2.7 4.8 8.4 3.2 3.8 4.6 12.6 3.3 3.3 2.4 2.6 18.3 18.0 13.1 8.3 2.7 8.1 3.6 11.5 2.2 3.4 9.6 1.6 18.3 2.4 2.4 7.5 13.2 29.7 2.5 3.4 2.6 4.4 9.6 18.5 9.0 10.4 20.9 2.5 1.3 18.5 5.5 18.0 10.4 2.0 8.6 8.0 5.7 2.3 5.1 3.4 3.0 4.3 2.2 2.3 44.6 7.7 14.6 11.7 2.5 4.0 4.3 3.5 12.7 13.4 16.1 1.3 7.4 2.7 12.5 3.9 3.9 12.5 4.4 11.8 9.6 11.2 11.6 3.3 7.5 13.2 12.6 58.8 8.0 4.5 2.0 10.2 5.0 4.7 6.1 8.7 7.0 4.8 3.5 7.5 4.1 5.4 5.9 32.8 30.1 76.8 35.9 16.7 12.1 16.6 12.7 10.7 22.7 7.0 9.8 10.5 0.0 11.8 4.8 41.3 43.3 0.0 10.4 2.2 15.8 43.7 43.9 40.9 27.9 17.5 8.6 25.8 50.9 5.2 23.9 40.7 10.1 26.2 12.5 8.5 24.6 14.0 22.3 6.7 15.8 77.6 22.7 5.2 36.4 30.5 4.2 83.0 13.0 190.4 KIAA1958 FLJ39294 ENSG00000165185 KIAA1958 Q8N8K9 9 112486847-112669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020625 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA020625: AB_1852451" "unprognostic (3.09e-3)" "unprognostic (1.04e-1)" "unprognostic (1.61e-2)" "unprognostic (1.33e-1)" "unprognostic (7.48e-2)" "unprognostic (2.08e-2)" "unprognostic (2.01e-1)" "unprognostic (4.95e-2)" "unprognostic (1.14e-1)" "unprognostic (1.65e-2)" "unprognostic (2.73e-2)" "unprognostic (7.67e-2)" "unprognostic (5.48e-3)" "unprognostic (3.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.58e-1)" 2.6 14.7 8.6 2.8 14.4 8.7 6.3 21.2 11.7 10.4 3.0 10.8 5.6 3.7 7.0 3.1 3.6 6.3 3.1 2.8 7.8 5.2 11.7 6.9 7.8 2.9 14.0 6.2 19.9 10.8 4.1 8.0 1.9 11.3 3.5 3.4 5.5 5.5 8.0 2.7 4.0 3.9 6.5 10.6 3.2 8.8 11.0 16.5 4.7 5.0 0.4 2.9 3.8 4.8 2.1 2.4 2.6 2.8 2.4 2.7 1.5 2.9 4.2 17.3 5.0 1.2 0.3 8.3 2.2 0.7 2.7 3.0 7.7 2.0 9.5 2.6 7.2 1.8 2.6 12.7 1.2 3.8 2.9 5.1 3.7 5.7 5.4 0.7 5.6 4.7 0.5 1.0 3.5 1.7 2.4 2.1 9.0 8.6 2.4 0.8 3.4 8.7 3.2 9.5 6.9 2.0 7.1 9.9 2.7 3.6 4.1 8.9 9.4 3.7 3.9 2.2 10.0 3.5 5.7 0.4 0.9 5.2 0.6 2.7 4.5 8.1 5.7 1.2 3.9 0.7 1.4 2.8 0.2 2.1 0.9 0.9 0.3 0.8 1.6 0.9 2.1 2.0 2.7 2.6 2.4 0.8 2.4 0.4 1.5 8.6 14.4 21.2 11.7 7.8 5.2 14.0 6.2 11.3 16.5 3.0 13.4 0.0 3.6 4.1 19.3 3.6 2.5 2.7 9.1 1.8 13.7 1.0 6.6 2.5 3.4 0.8 3.6 0.0 5.9 0.9 1.7 5.6 0.0 6.8 0.8 6.4 4.6 0.6 3.5 1.5 6.1 4.1 1.7 0.0 4.4 11.6 3.3 4.3 4.9 9.8 11.0 6.5 2.1 1.1 4.7 4.1 0.7 1.0 5.2 3.5 KIAA2013 "MGC33867, RP5-1077B9.1" ENSG00000116685 KIAA2013 Q8IYS2 1 11919591-11926428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052677, HPA060536" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA052677: AB_2681911, HPA060536: AB_2684313" "unprognostic (3.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.63e-2)" "unprognostic (1.48e-1)" "unprognostic (2.02e-2)" "unprognostic (1.87e-2)" "unprognostic (5.51e-3)" "unprognostic (8.60e-2)" "unprognostic (5.26e-2)" "unprognostic (2.92e-1)" "unprognostic (1.10e-2)" "unprognostic (5.04e-2)" "unprognostic (6.05e-2)" "unprognostic (2.04e-2)" "unprognostic (2.94e-2)" "unprognostic (8.24e-3)" "unprognostic (3.74e-3)" 13.8 13.9 12.0 10.6 16.7 10.9 12.9 11.9 18.7 13.7 32.0 25.2 16.7 42.6 19.1 24.9 15.4 14.7 19.7 18.9 12.5 10.8 17.1 34.4 12.4 12.6 22.8 10.6 12.2 34.0 9.6 17.7 24.6 16.1 15.1 13.5 14.8 26.2 18.6 24.4 18.6 55.1 14.4 16.0 19.2 16.0 21.7 19.0 15.0 19.8 11.2 14.1 17.4 13.1 7.0 10.8 13.8 6.3 4.6 6.3 3.0 23.7 17.7 8.3 16.4 14.2 9.8 13.8 15.2 16.1 18.5 19.2 21.8 24.8 15.7 23.4 14.4 14.4 27.8 11.2 15.0 9.9 18.0 28.8 10.7 16.4 37.2 16.1 22.2 22.2 12.4 16.8 18.0 8.0 20.1 17.6 12.6 16.4 20.9 11.0 18.0 14.1 31.3 10.9 10.6 24.5 18.1 15.3 37.8 11.7 6.5 31.2 17.6 12.3 13.8 29.0 8.7 11.6 20.8 16.8 15.6 20.5 22.9 20.6 25.3 17.8 17.8 18.6 36.2 16.5 4.2 6.3 6.1 6.2 5.3 4.9 6.1 3.4 4.7 4.3 7.0 3.4 4.5 13.8 4.6 4.2 10.8 6.3 3.0 12.0 16.7 11.9 18.7 12.5 10.8 22.8 10.6 16.1 19.0 20.8 11.2 32.1 8.7 19.7 20.2 16.9 25.5 13.4 9.1 24.4 11.8 15.2 3.3 14.9 19.3 18.7 101.7 23.3 16.5 23.6 14.4 15.6 12.7 63.7 23.1 30.2 39.3 30.1 29.1 27.2 21.0 21.6 18.6 9.0 52.1 20.8 20.2 63.3 21.5 21.4 21.4 19.4 12.0 21.8 10.0 24.6 11.1 17.8 48.7 16.6 KIAA2026 FLJ20375 ENSG00000183354 KIAA2026 Q5HYC2 9 5881596-6007901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 22.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002109 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No "Vesicles, Cytosol" Nucleoplasm "HPA002109: AB_1078071" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (8.74e-2)" "unprognostic (6.86e-2)" "unprognostic (9.19e-2)" "unprognostic (8.41e-3)" "unprognostic (6.49e-2)" "unprognostic (1.52e-1)" "prognostic favorable (8.34e-4)" "unprognostic (2.41e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" 7.0 6.3 10.3 13.7 11.1 6.6 6.7 21.4 12.4 10.2 7.5 8.6 5.7 5.5 9.7 7.0 7.2 6.7 7.4 6.2 11.7 9.0 7.5 5.4 6.4 7.0 16.7 7.1 13.0 6.0 13.9 14.5 8.1 9.9 8.0 5.9 5.9 12.8 15.6 15.3 9.4 6.7 7.7 11.2 9.1 7.8 13.3 12.9 11.0 10.3 3.7 7.5 8.0 17.8 7.0 4.1 9.4 5.9 7.0 7.5 1.2 5.9 2.9 6.0 3.9 4.6 7.4 2.9 4.1 5.7 3.7 3.5 1.9 3.3 7.5 1.5 4.9 4.6 3.0 3.5 3.1 5.6 17.2 2.9 22.4 6.5 2.9 3.6 7.9 10.4 4.5 4.2 3.2 5.4 7.0 5.8 4.7 2.4 13.4 4.7 1.7 4.2 13.6 3.4 3.3 2.5 4.7 3.9 3.8 4.0 3.8 8.3 4.9 3.8 3.3 3.1 4.3 3.4 10.1 6.8 7.1 4.3 3.6 4.4 10.4 8.2 7.5 3.6 3.7 2.0 5.2 3.4 9.4 6.4 2.6 7.3 7.0 6.2 5.7 1.3 6.1 6.8 7.5 8.8 7.0 5.9 4.1 3.6 1.2 10.3 11.1 21.4 12.4 11.7 9.0 16.7 7.1 9.9 12.9 41.7 31.3 33.5 27.5 39.6 86.1 47.2 25.5 16.0 17.0 36.6 74.6 12.9 6.6 15.8 25.2 35.7 26.7 23.3 11.7 8.8 23.6 29.1 18.6 14.5 14.8 42.9 37.0 29.4 26.4 11.5 65.3 26.1 21.9 29.7 28.8 49.5 15.0 30.8 71.8 8.6 74.2 45.3 32.0 129.1 110.7 45.8 25.1 37.4 25.6 35.9 KIF11 "Eg5, HKSP, KNSL1, TRIP5" ENSG00000138160 "Kinesin family member 11" P52732 10 92593286-92655395 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 74.2" "Group enriched" "Detected in many" 4 "Early spermatids: 9.6;Erythroid cells: 23.3;Extravillous trophoblasts: 11.2;Hofbauer cells: 6.7;Spermatocytes: 24.7;Spermatogonia: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006916, HPA010093, HPA010568, CAB017617" Enhanced Supported "Mitotic spindle,Cytosol" Yes Yes Cytosol "Mitotic spindle" "CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.35e-2)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (8.19e-7)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-4)" "unprognostic (6.59e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.35e-3)" "unprognostic (7.23e-2)" "unprognostic (9.08e-2)" "unprognostic (2.01e-1)" 2.3 1.6 1.0 20.2 2.6 14.3 1.6 0.7 1.5 2.4 4.6 0.7 0.5 3.7 1.4 1.9 11.5 0.8 2.6 2.0 1.1 1.2 1.1 1.1 2.8 12.1 1.0 1.0 1.1 1.1 0.5 0.7 3.1 1.4 1.0 5.4 0.5 2.7 0.2 0.6 4.2 4.4 1.6 1.8 5.2 2.7 10.5 1.1 74.2 1.2 7.5 13.4 2.2 3.8 2.4 0.9 2.5 1.2 3.5 3.9 1.0 31.0 13.9 31.4 29.2 2.3 3.5 7.8 22.4 19.6 24.9 24.8 12.1 20.6 34.4 11.5 10.4 10.6 22.5 22.4 11.4 29.3 20.5 12.9 21.5 13.3 12.7 0.4 34.6 20.1 1.1 1.0 19.2 18.0 5.8 15.4 14.4 15.2 40.2 18.8 12.4 29.4 19.5 12.5 12.6 9.6 31.7 31.1 12.1 6.5 9.1 9.6 13.8 17.5 7.9 9.1 11.2 21.5 11.1 8.7 11.4 16.4 11.6 29.4 11.2 17.3 35.4 9.2 25.0 15.4 2.5 0.5 0.5 0.4 1.2 1.1 2.4 1.4 1.9 0.9 1.0 0.5 0.7 1.4 3.5 0.4 0.4 3.9 1.0 1.0 2.6 0.7 1.5 1.1 1.2 1.0 1.0 1.4 1.1 0.0 1.3 0.8 0.8 2.6 1.3 1.4 0.0 4.0 3.4 1.8 0.0 1.5 1.7 0.4 9.6 0.3 0.4 23.3 0.6 11.2 1.6 0.8 0.0 0.0 6.7 0.0 0.0 2.5 2.5 3.9 0.9 2.6 0.0 1.0 1.9 0.8 0.3 0.0 0.7 0.5 0.4 0.0 1.2 24.7 25.8 2.9 1.3 3.8 2.9 0.9 KIF14 KIAA0042 ENSG00000118193 "Kinesin family member 14" Q15058 1 200551497-200620734 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease mutation, Meckel syndrome, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 9.0;lymphoid tissue: 34.4" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 20.6;Spermatogonia: 18.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038061, HPA058220" Uncertain Supported "Midbody ring,Cytosol" NA Yes Cytosol "Midbody ring" "HPA038061: AB_10669515, HPA058220: AB_2683642" "unprognostic (1.84e-1)" "unprognostic (7.15e-2)" "unprognostic (2.00e-2)" "unprognostic (1.87e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (8.64e-4)" "unprognostic (8.47e-3)" "unprognostic (1.02e-1)" "unprognostic (2.54e-5)" "unprognostic (2.31e-2)" "unprognostic (0.00e+0)" "unprognostic (6.28e-3)" "unprognostic (3.31e-1)" "unprognostic (8.14e-2)" "unprognostic (7.44e-2)" 0.4 0.6 0.2 2.7 0.4 9.0 2.6 0.3 0.3 0.7 2.0 0.4 0.2 1.8 0.4 0.5 3.8 0.2 0.2 0.5 0.3 0.3 0.4 0.8 1.2 4.7 0.2 0.2 0.3 0.3 0.0 0.2 2.8 0.6 0.6 1.8 0.4 0.9 0.2 0.2 1.4 2.4 0.8 0.6 2.0 1.1 4.5 0.2 34.4 0.3 0.6 4.9 0.8 1.3 0.5 0.1 2.4 0.2 0.7 1.9 0.2 15.6 9.3 14.7 8.2 0.4 1.7 8.2 10.8 6.4 10.3 9.4 5.6 8.2 9.5 3.9 5.1 6.4 12.5 11.7 7.2 14.9 11.6 6.2 15.2 13.2 5.4 0.0 23.8 8.7 0.3 0.3 11.5 9.9 2.2 7.3 14.3 22.8 12.4 12.8 6.4 13.9 7.4 12.4 4.6 8.2 12.8 19.5 12.1 3.5 4.5 7.0 7.8 15.3 5.2 6.2 11.5 7.0 6.1 6.0 8.2 9.7 8.9 18.7 4.5 4.5 13.9 4.8 12.8 16.6 2.4 0.1 0.1 0.1 0.2 0.1 0.5 0.5 0.4 0.0 0.4 0.2 0.1 0.5 0.7 0.1 0.1 1.9 0.2 0.2 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.6 0.2 0.0 0.0 1.5 0.9 2.2 2.0 0.8 0.0 1.4 1.2 0.0 2.0 1.0 0.0 0.2 2.5 0.5 0.0 0.0 0.0 6.3 1.7 0.8 2.3 0.9 4.3 0.0 0.0 1.8 2.6 1.5 0.6 1.0 0.0 0.0 0.8 0.6 0.2 0.0 0.7 0.0 0.7 6.5 0.4 20.6 18.9 0.6 1.1 0.7 1.2 1.4 KIF18B ENSG00000186185 "Kinesin family member 18B" Q86Y91 17 44924709-44947711 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 12.3;lymphoid tissue: 34.7" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 1.6;Extravillous trophoblasts: 3.6;Hofbauer cells: 1.9;Kupffer cells: 1.8;Spermatogonia: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024205 Enhanced Supported "Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol" Yes Yes "Nucleoplasm, Microtubule ends" "Nuclear bodies, Cytosol" "HPA024205: AB_1852472" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (4.61e-2)" "unprognostic (1.13e-2)" "unprognostic (4.17e-1)" "unprognostic (7.27e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (3.34e-3)" "prognostic unfavorable (6.90e-4)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (8.18e-2)" "unprognostic (0.00e+0)" "unprognostic (4.69e-3)" "unprognostic (1.93e-1)" "unprognostic (3.08e-1)" "unprognostic (1.68e-2)" 0.7 0.6 0.5 8.2 0.4 12.3 0.4 0.4 0.5 0.9 1.6 0.3 0.7 2.9 0.5 0.6 3.2 0.3 1.3 1.5 0.5 0.5 0.5 0.7 0.8 5.9 0.6 0.1 0.6 0.4 0.0 0.4 1.9 0.2 0.5 1.5 0.1 0.7 0.1 0.4 2.9 2.5 0.8 0.4 1.7 1.5 3.8 0.1 34.7 0.4 2.7 7.6 0.7 1.1 1.1 0.8 2.0 0.6 1.0 1.4 0.4 14.4 18.8 16.2 15.1 0.4 1.4 13.6 12.4 4.6 15.6 12.3 15.6 12.5 12.8 5.3 4.7 10.0 15.9 11.1 5.0 7.9 26.3 16.6 16.5 21.2 9.6 0.0 13.6 14.5 0.3 0.2 13.5 5.4 2.1 7.9 13.3 12.4 21.8 8.0 11.2 25.3 13.4 11.9 13.1 13.0 19.4 24.7 8.5 2.5 7.9 12.2 11.8 8.3 7.5 4.6 7.8 14.1 9.7 5.2 23.3 23.1 13.7 26.0 7.0 6.9 15.7 7.5 10.4 15.0 1.8 0.6 0.4 0.5 0.3 0.4 0.8 0.7 0.5 0.3 1.1 0.4 0.5 2.0 1.0 0.3 0.8 1.4 0.4 0.5 0.4 0.4 0.4 0.5 0.5 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.4 0.1 0.0 0.0 1.9 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.5 0.4 0.7 0.5 0.6 0.1 KIF1A "ATSV, C2orf20, SPG30, UNC104" ENSG00000130294 "Kinesin family member 1A" Q12756 2 240713764-240820308 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.1" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 383.7;Cone photoreceptor cells: 394.7;Horizontal cells: 506.9;Rod photoreceptor cells: 168.7" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "AN3-CA: 19.2;HAP1: 34.1;K-562: 29.8;SCLC-21H: 91.8;SH-SY5Y: 14.7" "Low region specificity" "Detected in all" HPA005442 Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA005442: AB_1079210" "unprognostic (1.19e-1)" "unprognostic (2.17e-3)" "unprognostic (7.31e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (1.65e-1)" "unprognostic (4.74e-3)" "unprognostic (2.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-2)" "unprognostic (2.06e-2)" "unprognostic (2.60e-1)" "unprognostic (2.54e-1)" "unprognostic (3.83e-2)" "unprognostic (1.96e-1)" "unprognostic (1.74e-3)" "unprognostic (3.90e-2)" 2.1 15.2 47.0 2.9 37.0 2.0 2.0 28.4 144.1 1.9 2.7 35.8 0.0 2.9 2.3 3.1 2.0 2.3 2.1 8.2 40.9 28.4 2.1 2.3 2.1 2.0 35.1 46.8 3.5 31.3 2.0 15.7 2.0 38.7 6.4 2.6 8.6 2.0 2.2 1.9 2.8 2.9 2.3 35.0 2.2 5.0 10.0 30.9 0.0 2.9 0.0 1.9 2.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 1.0 0.0 0.5 0.0 34.1 0.0 0.0 2.6 3.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.1 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.8 14.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 47.0 37.0 28.4 62.2 40.9 28.4 35.1 46.8 38.7 30.9 0.0 0.0 0.0 0.1 0.8 383.7 18.7 0.0 0.0 0.0 0.0 394.7 0.0 0.0 0.3 1.7 0.4 0.0 0.0 21.2 0.0 0.0 9.0 0.0 0.2 0.1 506.9 32.8 0.0 0.0 4.5 0.9 0.0 16.9 0.0 0.0 91.7 23.8 0.0 0.4 0.1 168.7 0.0 1.1 4.7 1.7 0.0 0.0 0.0 0.0 0.4 KIF20B "CT90, KRMP1, MPHOSPH1, MPP1" ENSG00000138182 "Kinesin family member 20B" Q96Q89 10 89701610-89774939 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.2" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 149.9;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050214 Supported Supported "Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol" Yes Yes "Nucleoplasm, Cytokinetic bridge" "Midbody, Cytosol" "HPA050214: AB_2681053" "unprognostic (2.13e-1)" "unprognostic (3.01e-2)" "unprognostic (1.72e-2)" "unprognostic (3.20e-2)" "unprognostic (2.65e-1)" "unprognostic (7.39e-2)" "unprognostic (8.95e-5)" "unprognostic (3.32e-3)" "unprognostic (2.01e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (3.06e-6)" "unprognostic (4.22e-3)" "unprognostic (2.70e-1)" "unprognostic (2.51e-2)" "unprognostic (6.43e-2)" 3.9 2.3 1.3 5.9 6.6 11.1 3.2 12.8 3.0 4.1 3.8 0.7 1.1 4.3 3.4 2.2 7.0 3.3 1.5 2.2 2.1 1.3 2.4 3.2 2.8 9.5 1.6 2.6 4.3 2.0 2.1 3.2 4.0 3.6 2.3 5.1 1.5 3.4 2.0 2.1 4.9 5.5 3.0 3.0 8.0 3.0 10.2 2.6 26.2 2.8 3.9 9.1 2.8 3.8 13.3 4.8 8.3 3.9 2.4 8.6 1.9 36.0 7.4 10.8 9.6 2.1 3.7 9.0 14.8 13.6 15.6 16.4 9.7 16.7 14.0 4.7 7.5 5.8 18.4 12.0 8.3 21.0 16.8 8.2 14.2 12.9 8.4 0.6 24.1 11.8 1.5 1.2 15.0 15.4 5.5 10.0 7.4 13.5 16.2 13.8 6.2 14.1 4.6 11.1 5.9 7.1 9.8 21.3 6.1 4.8 4.8 3.4 6.2 10.6 4.8 5.6 8.1 12.6 7.0 7.8 10.0 10.1 13.0 23.8 4.5 12.2 18.8 9.5 21.5 7.4 8.3 2.3 3.7 5.5 3.9 6.7 11.5 7.4 5.9 1.2 13.3 8.6 8.0 0.1 2.4 3.8 4.8 8.6 1.9 1.3 6.6 12.8 3.0 2.1 1.3 1.6 2.6 3.6 2.6 3.0 15.7 46.6 7.4 15.8 11.8 7.1 2.5 6.7 7.9 0.0 9.8 9.8 3.3 5.1 8.6 7.8 5.9 70.0 4.0 30.5 12.7 3.4 43.8 3.8 17.2 12.7 1.2 8.6 11.6 9.6 7.5 16.4 5.0 9.0 5.4 6.4 2.9 5.7 8.1 2.4 9.1 6.5 15.5 149.9 96.9 12.3 4.3 26.1 13.0 2.2 KIF21A "FEOM1, FLJ20052" ENSG00000139116 "Kinesin family member 21A" Q7Z4S6 12 39293228-39443390 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.5" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 235.9;Ciliated cells: 303.8;Cone photoreceptor cells: 290.6;Rod photoreceptor cells: 184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.4;MAIT T-cell: 4.1;memory CD4 T-cell: 5.2;memory CD8 T-cell: 8.5;naive CD8 T-cell: 5.9;NK-cell: 3.1;T-reg: 2.3" "Group enriched" "Detected in many" 8 "NK-cells: 3.1;T-cells: 8.5" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022079, HPA058432" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB022079: , HPA058432: AB_2683717" "unprognostic (1.08e-3)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (7.67e-2)" "unprognostic (1.13e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-3)" "unprognostic (7.77e-2)" "unprognostic (3.17e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.73e-2)" "prognostic favorable (8.07e-8)" "unprognostic (4.05e-2)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (2.34e-2)" 3.4 10.1 17.7 3.1 18.5 0.8 5.1 22.1 36.7 8.4 9.2 7.7 2.9 7.1 7.7 4.7 16.0 26.8 5.1 13.4 18.0 28.7 20.9 15.6 4.8 2.2 26.4 18.0 3.2 10.1 17.4 12.3 6.4 41.5 9.3 10.6 5.9 16.4 3.5 8.0 8.5 7.9 7.2 29.2 5.0 9.6 9.5 9.6 0.0 7.1 2.5 4.1 3.6 6.0 0.7 0.0 0.1 0.0 3.1 8.5 1.1 5.9 7.6 10.7 4.5 2.0 1.0 8.6 1.5 0.7 2.0 1.4 13.7 7.4 0.0 4.8 0.6 3.2 5.3 6.1 3.7 1.8 11.7 4.9 0.0 13.4 12.5 1.6 9.9 0.0 0.6 8.2 2.5 12.0 4.6 2.6 2.6 11.2 12.3 1.6 3.5 1.2 0.0 14.4 0.0 6.7 0.0 0.0 6.8 7.6 9.9 14.7 63.8 5.8 9.3 3.5 11.4 10.8 1.2 1.8 1.1 4.7 0.3 4.2 5.6 1.9 0.0 2.8 1.4 0.9 0.0 0.0 0.0 8.4 0.0 4.1 0.7 5.2 8.5 0.0 0.0 1.3 5.9 0.1 3.1 0.0 0.0 2.3 1.1 17.7 18.5 22.1 31.6 18.0 28.7 26.4 18.0 41.5 9.6 35.7 17.4 0.8 18.1 16.5 235.9 106.3 17.8 303.8 69.4 12.2 290.6 12.6 8.3 23.9 92.2 5.8 23.8 0.0 35.7 84.3 10.0 29.0 13.8 39.9 3.5 130.3 23.1 8.0 2.4 60.6 2.8 2.1 13.5 12.6 25.5 106.4 33.2 20.1 2.5 41.7 184.9 0.0 9.8 22.7 7.2 26.8 49.4 20.8 23.4 14.6 KIF21B "DKFZP434J212, KIAA0449" ENSG00000116852 "Kinesin family member 21B" O75037 1 200969390-201023700 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.3;brain: 20.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 21.3;Cone photoreceptor cells: 55.0;Late spermatids: 57.7;Muller glia cells: 22.6;Rod photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 15.7;HMC-1: 16.8;JURKAT: 31.6;Karpas-707: 19.8;RPMI-8226: 16.8;U-266/70: 36.2;U-266/84: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027249, HPA027274" Approved Approved "Plasma membrane,Mitotic spindle,Cytosol" Yes No "Plasma membrane" "Mitotic spindle, Cytosol" "HPA027249: AB_10602241, HPA027274: AB_1852483" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (2.15e-1)" "unprognostic (2.28e-1)" "unprognostic (3.92e-3)" "unprognostic (1.32e-2)" "unprognostic (1.80e-1)" "unprognostic (2.18e-1)" "unprognostic (3.03e-1)" "unprognostic (1.54e-3)" "unprognostic (7.14e-2)" "unprognostic (1.41e-4)" "unprognostic (5.98e-3)" "unprognostic (2.64e-1)" "unprognostic (6.81e-2)" "unprognostic (5.81e-4)" 2.2 1.6 19.8 10.0 12.9 34.3 1.5 3.7 20.4 1.5 2.8 6.0 1.0 2.7 1.4 1.0 1.5 1.4 2.9 1.5 15.1 12.5 1.4 1.7 4.3 15.7 8.3 12.7 1.4 1.5 11.3 0.9 1.6 7.1 1.2 2.6 8.6 2.1 1.7 0.9 1.3 6.1 1.5 4.3 11.5 3.2 11.1 4.9 10.8 1.2 0.0 9.1 3.7 1.1 0.9 0.2 8.0 0.5 2.4 1.7 0.6 0.5 0.5 4.7 0.2 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.1 15.7 0.2 0.0 1.4 0.1 0.4 0.1 0.1 0.7 0.1 3.7 0.1 0.0 0.4 11.4 16.8 0.3 1.6 0.1 0.3 0.0 0.6 31.6 1.7 19.8 0.0 0.0 9.1 4.1 2.0 1.5 0.0 3.2 0.0 16.8 0.1 0.0 3.2 0.4 0.2 0.2 0.2 0.8 0.0 3.4 1.1 0.0 1.4 0.0 0.1 36.2 16.7 7.8 1.6 4.9 0.1 8.0 0.1 1.0 1.6 0.4 1.7 0.9 1.2 1.7 0.1 0.7 1.0 1.1 2.0 2.4 0.5 0.2 1.0 0.6 19.8 12.9 3.7 20.0 15.1 12.5 8.3 12.7 7.1 4.9 0.0 6.7 6.1 0.2 0.9 21.3 1.2 0.0 0.0 0.0 1.8 55.0 0.0 0.0 0.6 20.0 1.8 0.0 0.0 1.4 0.1 0.9 0.3 5.8 0.0 1.4 1.6 0.0 0.6 3.8 57.7 0.9 2.5 0.0 2.8 1.1 22.6 1.7 0.0 0.0 0.0 23.6 6.5 1.2 1.4 2.5 0.9 0.0 11.7 0.7 1.8 KIF26A "DKFZP434N178, KIAA1236" ENSG00000066735 "Kinesin family member 26A" Q9ULI4 14 104138723-104180894 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Horizontal cells: 17.5;Intestinal endocrine cells: 7.5;Ito cells: 11.1;Spermatogonia: 7.5" "Group enriched" "Detected in many" 5 "stomach cancer: 3.8;testis cancer: 14.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 17.2;MCF7: 14.6;NTERA-2: 12.8;REH: 11.1;SCLC-21H: 11.9;SH-SY5Y: 24.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046882, HPA060346" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046882: AB_2679856, HPA060346: AB_2684259" "unprognostic (3.01e-1)" "unprognostic (3.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.77e-2)" "unprognostic (2.79e-1)" "unprognostic (1.12e-1)" "unprognostic (5.49e-3)" "unprognostic (1.69e-1)" "unprognostic (1.21e-2)" "unprognostic (3.31e-3)" "unprognostic (5.24e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.78e-4)" "unprognostic (7.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.12e-2)" "unprognostic (4.68e-3)" 12.0 6.8 1.8 4.9 2.1 5.0 15.9 1.3 3.9 8.9 3.3 1.5 4.9 1.7 5.9 3.9 2.1 3.7 4.9 10.1 1.6 2.6 3.4 2.5 8.5 2.5 1.9 2.8 23.5 9.4 1.6 4.4 6.8 2.0 2.5 1.6 6.9 2.5 4.0 9.1 3.9 2.5 2.3 1.0 9.3 2.5 4.1 0.9 1.9 2.3 5.6 0.9 2.6 8.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 2.4 0.0 0.0 4.1 0.2 0.0 0.0 0.0 1.9 0.0 0.0 3.3 0.0 0.4 1.5 1.9 0.0 0.0 0.0 3.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 14.6 0.0 0.0 12.8 0.1 1.2 11.1 4.9 1.2 0.0 0.0 11.9 24.3 2.6 0.4 0.0 1.6 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 1.3 3.5 1.6 2.6 1.9 2.8 2.0 0.9 0.0 0.0 0.0 0.0 1.0 1.2 2.2 0.0 0.0 0.0 1.8 0.0 0.8 1.7 0.8 0.2 5.4 0.0 0.0 0.2 0.8 3.1 0.1 0.0 0.0 1.9 17.5 7.5 11.1 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.1 7.5 1.5 0.3 0.0 3.3 0.0 KIF3A "FLA10, KLP-20" ENSG00000131437 "Kinesin family member 3A" Q9Y496 5 132692628-132737638 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.5" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 131.2;Cone photoreceptor cells: 117.8;Horizontal cells: 174.8;Spermatocytes: 129.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 27.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 27.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037085 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Intermediate filaments, Cytosol" "CAB037085: AB_477147" "unprognostic (8.22e-3)" "unprognostic (2.58e-1)" "unprognostic (2.29e-3)" "unprognostic (3.59e-2)" "unprognostic (2.51e-1)" "unprognostic (3.80e-1)" "unprognostic (8.21e-4)" "unprognostic (1.30e-1)" "unprognostic (4.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" "unprognostic (7.64e-2)" "unprognostic (6.08e-3)" "unprognostic (8.62e-2)" "unprognostic (1.92e-1)" "unprognostic (1.17e-1)" "unprognostic (1.23e-1)" 3.4 9.9 19.6 5.0 21.0 2.5 6.6 23.8 54.5 6.2 3.6 8.1 3.2 3.5 6.5 7.1 4.5 8.7 5.3 7.0 28.0 22.9 7.6 2.5 5.7 4.8 18.7 25.5 6.9 4.0 15.8 18.5 4.3 37.7 6.6 3.8 3.8 3.8 6.6 3.5 5.1 3.0 5.7 15.0 3.8 4.9 23.9 11.1 3.5 6.9 0.1 4.7 5.3 3.5 3.4 0.7 27.1 1.1 2.4 4.3 1.1 7.0 8.8 7.8 14.1 5.2 5.2 6.2 5.9 4.6 5.6 7.9 8.5 5.7 19.3 8.2 6.8 16.8 4.6 6.1 11.7 11.7 5.7 7.1 2.8 4.4 3.2 5.2 3.6 7.6 4.0 6.0 8.1 9.1 7.6 7.0 12.4 2.9 11.2 6.8 5.1 22.7 2.7 3.8 2.6 3.3 6.4 6.2 2.3 5.6 6.0 24.2 7.6 8.9 2.9 8.9 13.2 8.9 1.1 7.3 7.0 12.3 5.1 7.1 8.1 11.8 11.1 8.6 2.9 7.7 27.1 0.4 1.1 3.9 0.8 4.1 3.4 4.0 3.6 0.7 2.1 3.9 4.3 0.3 2.4 1.1 0.7 3.0 1.1 19.6 21.0 23.8 32.3 28.0 22.9 18.7 25.5 37.7 11.1 50.6 33.1 5.4 13.8 12.0 70.6 23.3 7.6 131.2 38.7 36.6 117.8 13.0 24.9 16.7 49.7 8.5 0.9 0.0 11.3 9.8 12.6 8.0 12.8 2.4 5.5 174.8 19.0 9.2 3.3 16.3 15.3 5.0 40.5 6.4 3.4 51.3 11.4 2.3 23.0 7.3 94.7 12.9 10.8 129.4 94.9 13.9 8.2 16.0 1.7 6.0 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57549998-57586632 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 138.6" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 36.9;Horizontal cells: 25.4;Late spermatids: 11.4;Spermatogonia: 9.3" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "HDLM-2: 20.4;K-562: 8.6;NTERA-2: 10.6;SCLC-21H: 21.8;U-87 MG: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" Yes No "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: AB_2686601" "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favorable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 1.8 7.6 85.4 3.0 47.6 1.9 1.9 15.2 138.6 2.1 2.8 4.0 0.0 2.4 3.4 2.1 1.9 2.0 1.9 1.7 52.4 18.3 2.0 1.7 1.8 1.8 12.9 43.6 1.8 2.3 6.0 2.5 1.7 21.6 1.9 2.8 0.6 2.0 2.0 1.7 1.7 3.0 2.8 9.0 1.8 2.1 4.4 12.9 0.0 2.8 0.0 1.8 1.8 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.8 3.3 0.0 0.0 0.1 0.2 0.7 1.3 1.7 0.0 0.0 1.6 0.0 0.7 0.6 0.1 2.0 0.0 1.0 20.4 1.5 0.1 0.1 1.6 0.6 0.0 0.1 0.2 0.1 1.0 0.0 0.0 0.2 1.8 8.6 4.5 0.0 0.0 0.3 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.8 4.9 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.0 2.4 0.0 0.9 2.9 3.5 0.3 8.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.4 0.8 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.3 0.0 85.4 47.6 15.2 112.0 52.4 18.3 12.9 43.6 21.6 12.9 0.0 0.0 0.0 0.1 0.0 36.9 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 25.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 5.8 0.2 0.0 0.4 0.0 8.7 0.0 0.9 2.3 9.3 0.1 0.0 0.0 0.0 0.0 KIF5B "KNS, KNS1" ENSG00000170759 "Kinesin family member 5B" P33176 10 32009010-32056431 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009846, HPA037589, HPA037590" Approved Enhanced "Centriolar satellite,Cytosol" NA Yes 260000 "Centriolar satellite, Cytosol" "CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (4.00e-2)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.70e-1)" "unprognostic (6.37e-3)" "unprognostic (2.03e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-1)" "unprognostic (2.43e-2)" "unprognostic (2.39e-1)" "unprognostic (8.06e-2)" "unprognostic (1.76e-1)" 26.3 19.9 55.7 20.2 55.5 34.1 23.0 22.2 42.4 23.8 34.2 21.7 20.9 23.5 25.7 17.8 28.0 20.3 28.0 48.4 51.5 39.3 21.1 15.3 23.8 16.5 62.9 26.1 18.2 18.9 56.8 22.4 27.7 38.3 31.8 30.0 8.9 20.1 25.6 34.3 17.6 28.6 37.2 80.4 21.1 23.1 27.7 43.7 25.0 23.5 21.5 16.1 33.8 28.1 13.8 27.6 30.0 18.9 13.4 16.5 9.2 30.0 25.6 34.6 24.3 24.8 27.5 14.8 41.5 19.7 32.1 27.5 28.1 33.3 20.6 18.0 49.2 18.3 25.0 31.6 26.5 43.1 17.7 17.2 26.2 23.9 27.3 28.6 18.2 28.9 22.2 37.7 37.0 25.9 25.6 41.0 18.3 31.5 21.8 44.3 18.1 18.9 10.3 5.6 28.9 11.7 24.9 64.6 8.5 24.7 21.1 33.7 24.6 32.1 12.8 30.9 25.2 15.5 26.1 34.1 32.7 30.7 37.8 30.7 6.6 7.5 24.3 31.1 37.7 30.7 20.8 15.2 24.2 11.8 18.9 11.4 13.6 14.9 12.5 14.2 13.8 13.3 13.0 30.0 13.4 18.9 27.6 16.5 9.2 55.7 55.5 22.2 42.4 51.5 39.3 62.9 26.1 38.3 43.7 169.7 163.3 57.7 133.6 189.3 172.7 357.9 96.8 192.7 126.3 99.5 94.2 100.8 38.1 183.2 92.5 169.2 111.4 46.7 153.7 110.6 139.0 208.1 87.9 41.0 117.4 143.0 127.0 87.2 110.1 28.3 54.7 125.3 96.2 194.8 188.9 82.6 173.1 143.2 123.1 50.5 125.5 84.1 199.1 513.7 177.6 206.9 277.6 86.3 159.0 207.4 KIFC2 ENSG00000167702 "Kinesin family member C2" Q96AC6 8 144466043-144474202 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 36.2;skin 1: 48.2" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029264 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA029264: AB_10609999" "unprognostic (2.03e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-3)" "unprognostic (4.12e-3)" "unprognostic (4.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-2)" "unprognostic (2.12e-1)" "unprognostic (9.95e-2)" "unprognostic (2.39e-2)" "unprognostic (4.48e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" "unprognostic (8.13e-2)" "unprognostic (2.71e-2)" 4.2 5.1 18.7 4.2 28.4 4.5 3.4 36.2 35.0 3.1 6.3 2.3 6.6 8.8 2.7 5.2 7.0 2.9 4.4 2.2 13.5 7.2 4.7 2.8 3.8 4.8 4.4 16.8 2.1 7.9 9.8 7.9 2.5 8.3 7.2 4.8 2.2 7.5 6.5 2.3 48.2 7.9 2.1 2.6 8.1 8.7 5.2 6.6 1.6 4.1 1.3 3.5 5.0 4.9 0.8 0.1 0.1 0.1 0.0 0.8 0.1 8.0 6.9 3.3 7.4 4.9 2.9 7.9 4.9 3.5 2.6 2.6 2.7 10.0 8.4 2.8 2.7 4.4 16.5 3.3 4.4 1.1 8.5 2.9 5.1 17.0 3.5 6.3 1.4 15.0 3.8 15.7 2.6 3.4 12.5 1.7 8.3 5.5 8.8 2.0 13.8 6.1 4.3 0.5 8.9 10.3 15.3 0.2 5.0 11.0 12.7 10.6 9.7 3.5 10.7 3.9 2.8 28.4 2.8 4.7 5.2 15.7 5.5 4.9 4.3 2.1 2.3 10.1 7.1 2.8 0.0 0.1 0.0 0.5 0.0 0.8 0.0 0.3 0.6 0.1 0.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.1 18.7 28.4 36.2 35.0 13.5 7.2 4.4 16.8 8.3 6.6 8.9 9.9 2.2 2.6 5.4 8.9 0.8 7.6 2.7 6.8 14.0 5.9 1.6 1.7 3.2 5.2 0.6 17.3 0.0 1.2 1.5 2.6 3.1 8.1 5.4 2.4 14.3 22.4 2.5 6.2 6.9 7.2 4.8 3.3 1.0 9.9 7.2 2.7 14.0 2.8 4.3 3.3 0.0 1.9 5.1 5.5 9.9 2.5 5.7 9.9 2.6 KLC1 "hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A" ENSG00000126214 "Kinesin light chain 1" Q07866 14 103561896-103714249 "Predicted intracellular proteins" "Host-virus interaction" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 117.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB009798, HPA044617, HPA052450" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (6.93e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (7.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-3)" "unprognostic (2.67e-2)" "unprognostic (9.21e-2)" "unprognostic (5.62e-2)" "prognostic favorable (6.75e-4)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.17e-4)" "unprognostic (6.58e-2)" "unprognostic (8.69e-2)" "unprognostic (4.05e-1)" "unprognostic (1.49e-1)" 19.5 20.4 61.3 15.7 45.6 17.6 16.6 103.0 117.9 15.2 14.8 22.4 11.5 10.5 21.1 18.7 19.7 16.0 15.7 27.1 61.0 65.1 8.6 8.9 20.0 15.9 66.2 47.9 19.8 14.8 25.2 17.0 17.9 50.7 16.3 14.1 14.1 16.9 19.7 28.2 22.4 12.8 23.1 56.0 18.3 13.8 14.3 23.2 7.9 13.8 13.0 18.1 15.7 14.9 7.3 10.4 12.4 8.6 4.1 10.9 3.1 16.4 22.1 42.7 23.3 28.9 31.6 19.7 38.8 31.9 36.5 24.9 18.9 18.0 21.8 20.2 41.8 16.2 27.5 26.0 20.5 34.6 26.3 13.1 12.2 26.1 19.1 32.9 23.9 24.3 22.9 33.3 27.5 33.5 38.9 31.3 15.5 18.2 25.1 31.7 27.7 16.0 21.1 13.7 26.3 40.9 15.4 18.0 10.7 22.7 36.5 50.4 28.2 31.5 16.0 25.6 27.6 14.1 11.8 45.5 27.1 13.4 37.1 21.5 20.1 14.0 24.2 31.0 13.8 29.0 7.6 5.8 12.4 10.3 6.0 9.5 6.4 9.3 10.9 6.8 7.3 7.9 7.2 7.0 4.1 8.6 10.4 8.4 3.1 61.3 45.6 103.0 90.3 61.0 65.1 66.2 47.9 50.7 23.2 41.7 27.5 24.9 39.0 23.1 133.1 34.0 22.9 16.0 14.8 19.2 49.1 19.5 8.3 42.1 4.2 42.8 13.0 0.0 26.7 27.4 32.1 34.5 32.4 15.6 26.3 130.3 43.0 31.9 18.1 11.4 35.6 24.1 37.1 46.9 20.2 42.5 49.1 14.4 45.3 3.4 89.3 25.8 40.6 36.8 78.0 15.4 35.2 28.9 14.7 31.8 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.7" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 7.5 12.5 15.9 7.9 20.7 2.9 6.6 51.7 49.4 7.4 7.8 7.5 6.5 8.5 11.3 6.0 8.8 9.0 8.0 15.3 20.0 17.4 6.7 2.4 6.6 7.5 13.8 26.0 11.3 11.2 15.4 15.4 6.4 29.0 13.6 4.4 8.2 8.4 15.5 23.8 9.3 7.7 10.1 8.6 6.6 9.8 17.4 10.0 13.5 6.3 4.5 5.6 8.8 8.5 4.7 4.1 0.8 0.4 2.3 6.2 1.5 20.4 25.1 12.2 7.3 7.4 6.0 9.5 14.5 10.4 14.9 11.5 13.6 6.1 9.3 14.0 10.7 19.2 17.3 12.5 14.0 5.0 14.8 15.8 1.8 19.8 9.2 14.3 4.1 9.9 6.0 18.6 17.4 14.2 9.6 6.9 11.2 9.9 12.5 11.8 28.8 23.2 6.2 12.1 5.9 20.9 8.9 6.3 12.6 11.6 11.5 33.4 16.1 10.6 9.5 17.3 7.1 15.7 2.8 11.3 24.5 21.9 29.6 19.0 13.1 10.9 5.0 17.3 2.8 9.8 0.0 0.4 0.8 4.6 0.1 6.2 3.6 2.2 3.1 0.6 4.7 2.2 2.7 0.7 2.3 0.3 4.1 0.6 1.5 15.9 20.7 51.7 49.4 20.0 17.4 13.8 26.0 29.0 10.0 3.0 1.0 5.6 8.0 7.9 32.1 1.4 0.0 5.3 1.2 12.2 11.8 8.8 11.6 15.0 8.9 4.5 2.9 0.0 7.2 16.4 4.8 12.0 0.0 2.1 2.7 52.4 35.6 4.3 4.6 3.4 8.1 2.8 11.8 10.0 5.8 14.1 13.4 3.6 13.1 9.1 26.5 0.0 16.2 24.4 25.6 8.4 10.6 3.3 3.7 7.1 KLC3 "KLC2L, KLCt, KNS2B" ENSG00000104892 "Kinesin light chain 3" Q6P597 19 45333434-45351520 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 39.5;tongue: 25.3" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 126.0;Ductal cells: 38.6;Suprabasal keratinocytes: 160.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 25.8;HaCaT: 12.0;HBEC3-KT: 7.7;hTCEpi: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052797, HPA056508" Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Actin filaments" "Nucleoplasm, Cytosol" "HPA052797: AB_2681954, HPA056508: AB_2683159" "unprognostic (4.11e-2)" "unprognostic (3.71e-1)" "unprognostic (3.07e-4)" "prognostic unfavorable (1.46e-4)" "unprognostic (3.47e-3)" "unprognostic (1.13e-1)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.53e-1)" "unprognostic (1.75e-2)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (4.79e-3)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (4.14e-1)" "unprognostic (2.37e-1)" 0.1 0.2 0.0 0.2 1.2 1.9 1.9 0.0 0.5 4.0 0.1 0.0 0.0 0.1 0.6 2.9 10.6 0.1 0.2 0.1 0.2 0.0 1.9 0.1 0.7 0.2 0.0 0.0 0.3 4.5 1.5 1.1 0.9 0.5 1.7 0.2 4.0 7.8 2.2 0.6 39.5 0.3 0.0 0.0 0.2 0.2 2.8 0.2 0.3 1.1 25.3 9.2 0.2 7.9 1.5 1.0 3.3 0.9 1.0 1.3 0.6 25.8 0.2 0.1 0.3 0.1 0.1 2.1 0.2 0.0 0.0 0.1 2.6 4.8 0.2 2.1 0.0 2.8 12.0 1.7 7.7 0.1 0.6 3.9 0.1 0.7 0.5 0.0 0.2 1.7 0.0 9.8 0.1 1.9 0.3 0.0 0.4 0.4 0.3 0.1 3.4 0.1 0.4 0.6 0.4 0.8 4.0 0.0 0.2 0.2 0.9 3.4 0.6 0.2 5.5 0.7 0.3 4.8 0.1 0.0 0.3 2.8 0.2 0.3 0.6 0.5 0.2 0.1 0.1 0.3 3.3 0.7 0.6 0.8 0.5 0.7 0.9 1.0 0.9 0.3 1.5 1.0 1.3 2.6 1.0 0.9 1.0 0.8 0.6 0.0 1.2 0.0 0.5 0.2 0.0 0.0 0.0 0.5 0.2 0.0 3.7 0.0 35.4 126.0 0.9 0.4 2.5 2.7 2.3 1.8 0.0 0.2 8.3 38.6 3.0 0.0 0.0 0.0 2.6 0.4 1.2 9.3 0.0 0.0 0.3 1.6 0.0 0.6 0.0 8.5 1.7 1.4 13.5 1.0 0.0 0.8 11.5 0.0 0.4 1.4 1.9 0.0 4.1 0.5 8.3 160.2 0.6 0.0 0.0 19.7 KLC4 "bA387M24.3, KNSL8" ENSG00000137171 "Kinesin light chain 4" Q9NSK0 6 43040777-43075099 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 55.7" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 103.2;Paneth cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030168, HPA030169" Enhanced Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA030168: AB_10599285, HPA030169: AB_10601105" "unprognostic (2.96e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.08e-2)" "unprognostic (3.67e-2)" "unprognostic (5.63e-3)" "unprognostic (6.36e-3)" "unprognostic (1.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.30e-1)" "unprognostic (1.47e-2)" "unprognostic (9.22e-2)" "prognostic favorable (6.99e-6)" "unprognostic (2.08e-1)" "unprognostic (3.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" 6.1 9.7 13.1 8.5 11.5 5.3 6.9 25.0 15.2 7.6 35.0 10.2 8.1 35.1 8.5 12.3 5.6 9.3 15.2 12.2 13.8 10.8 13.6 47.2 8.2 5.8 12.2 13.7 11.2 9.1 17.6 13.3 5.9 12.1 8.6 17.4 9.0 11.4 8.4 9.9 8.7 55.7 7.4 9.2 6.6 16.0 22.6 13.2 6.7 10.9 4.5 5.4 10.2 9.9 5.6 12.2 9.0 3.7 6.1 7.0 3.3 3.5 3.2 8.7 10.4 8.6 8.5 7.7 2.9 4.8 5.3 8.2 5.3 6.3 5.3 10.7 7.0 7.0 6.3 8.7 8.2 4.3 5.3 10.6 6.2 9.2 23.4 8.3 3.0 4.9 11.1 10.3 6.4 6.3 16.8 6.7 11.0 4.2 7.1 4.4 7.2 7.9 6.5 3.4 35.5 4.4 6.4 4.9 10.2 8.1 3.6 14.3 7.0 5.7 5.0 11.1 8.3 9.1 7.6 4.8 6.1 7.2 3.0 3.0 14.1 5.0 12.9 3.3 4.5 2.1 2.6 3.7 4.4 4.0 3.6 5.1 5.6 5.5 3.9 4.2 4.3 7.0 4.8 9.0 6.1 3.6 12.2 6.4 3.3 13.1 11.5 25.0 15.2 13.8 10.8 12.2 13.7 12.1 13.2 14.9 11.8 3.9 8.3 3.3 20.8 10.2 22.9 21.4 5.7 14.0 27.5 9.4 16.6 6.6 6.1 4.4 103.2 0.0 8.7 4.1 5.1 5.1 6.9 51.3 5.8 11.1 21.5 5.5 3.7 6.8 9.5 2.5 3.3 6.4 36.2 15.8 6.6 59.6 6.3 20.0 25.7 12.9 4.4 20.9 15.5 4.0 11.3 4.9 35.1 5.0 KLF11 "MODY7, TIEG2, Tieg3" ENSG00000172059 "Kruppel like factor 11" O14901 2 10042849-10054836 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 120.7;Suprabasal keratinocytes: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058276 Supported "Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Focal adhesion sites, Cytosol" "HPA058276: AB_2683664" "unprognostic (9.66e-3)" "unprognostic (1.87e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-3)" "unprognostic (2.63e-3)" "unprognostic (6.34e-2)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.17e-3)" "unprognostic (3.08e-2)" "unprognostic (2.48e-3)" "unprognostic (8.96e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-2)" "unprognostic (9.24e-2)" 28.7 9.1 2.5 7.0 3.5 11.8 33.1 8.2 4.4 12.9 13.0 5.1 10.8 3.5 12.8 11.7 8.3 11.2 11.6 19.4 2.9 2.3 12.7 27.9 14.6 15.9 5.5 2.4 13.7 38.3 7.3 2.4 9.9 3.4 13.9 4.7 9.2 11.3 10.9 14.0 19.1 7.7 30.4 3.5 16.1 10.2 16.7 2.7 1.5 9.1 8.5 5.6 11.1 42.7 2.9 6.6 1.7 12.7 5.4 2.7 3.8 3.7 1.8 4.4 0.4 3.1 5.5 10.7 4.4 4.5 2.5 2.6 4.3 8.8 0.0 8.0 5.3 10.2 0.9 3.8 3.4 1.7 25.9 2.9 1.9 5.4 0.8 3.0 7.9 12.6 8.6 12.7 4.8 1.3 6.5 2.2 0.7 5.2 17.5 2.5 4.4 0.0 1.4 7.1 3.0 3.8 4.2 0.1 7.3 6.1 4.7 5.7 3.5 6.7 13.9 12.9 7.3 3.2 10.8 6.2 11.1 9.3 8.3 1.4 15.9 18.9 10.2 2.9 2.1 5.9 0.0 6.9 1.7 2.6 11.0 0.8 2.8 1.7 1.8 6.6 2.9 0.5 1.0 0.2 5.4 12.7 0.3 2.7 3.8 2.5 3.5 8.2 4.4 2.9 2.3 5.5 2.4 3.4 2.7 6.0 5.8 3.2 13.5 53.8 5.2 2.8 7.6 5.3 7.9 7.0 5.9 2.4 24.9 7.7 120.7 16.6 3.1 0.0 7.4 3.3 9.7 13.1 8.1 34.1 11.6 3.2 6.8 43.0 29.9 21.5 13.6 21.1 28.7 3.6 6.8 2.3 8.2 0.0 15.6 5.3 4.7 32.3 44.3 14.1 35.0 75.4 6.9 5.7 7.4 9.5 KLF12 "AP-2rep, AP2REP, HSPC122" ENSG00000118922 "Kruppel like factor 12" Q9Y4X4 13 73686089-73995056 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 35.3;Peritubular cells: 26.9;T-cells: 26.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064146, HPA075652" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064146: AB_2685198, HPA075652: " "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (9.22e-2)" "unprognostic (8.59e-2)" "unprognostic (5.19e-2)" "unprognostic (3.70e-2)" "unprognostic (2.60e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-3)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (6.67e-3)" 2.1 0.9 0.4 2.9 0.4 0.9 1.9 0.6 3.4 2.1 1.5 0.1 1.7 7.1 0.7 1.1 1.1 3.2 0.4 0.5 2.9 5.8 2.0 6.1 0.5 2.8 0.6 0.0 3.5 0.0 1.2 1.1 0.9 1.4 1.9 1.4 1.2 1.4 1.3 3.9 1.4 1.5 2.1 5.5 1.7 2.1 1.7 0.9 0.9 0.6 2.6 5.1 1.4 0.0 1.0 10.2 0.0 5.7 12.7 0.1 4.0 2.0 4.5 4.7 0.8 2.5 7.6 1.9 6.0 1.8 2.7 2.7 3.1 12.0 4.9 3.7 0.2 4.5 0.0 1.9 5.0 1.9 11.0 0.8 6.3 5.1 8.6 8.8 5.9 0.0 1.9 13.4 0.8 9.6 0.0 1.4 0.3 2.0 5.3 3.7 0.0 2.5 0.2 2.4 10.5 2.8 1.3 4.6 4.0 0.3 0.8 0.0 8.7 2.7 3.9 1.9 5.3 6.7 2.4 15.4 0.0 4.4 0.9 0.1 0.1 4.2 0.4 5.1 1.7 3.7 4.7 0.5 1.4 2.6 4.0 0.0 2.6 0.6 0.9 1.9 1.4 6.0 2.6 10.8 1.3 3.8 16.4 14.6 5.1 4.0 4.5 3.5 35.3 0.0 3.3 1.8 0.5 3.6 0.9 0.0 0.0 0.1 5.1 2.5 0.0 18.1 0.1 7.9 0.0 2.5 6.0 1.1 19.2 3.5 3.3 5.4 0.7 11.7 0.3 2.9 26.9 6.0 12.5 0.0 10.3 0.4 0.4 5.8 0.1 26.6 4.6 1.0 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Basal glandular cells: 1442.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Supported Nucleoplasm,Nucleoli,Vesicles,Cytosol No No Nucleoplasm "Nucleoli, Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: AB_2686157" "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favorable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 69.8 10.0 8.4 26.3 10.6 80.6 101.1 7.4 10.1 28.6 31.7 10.3 9.7 11.0 24.9 28.8 38.6 28.0 38.6 18.6 7.8 5.1 32.2 32.5 46.0 35.8 13.8 4.2 20.2 23.8 7.5 4.7 26.1 11.2 20.1 21.0 13.2 26.9 16.5 57.8 60.2 44.8 42.8 17.0 20.3 26.7 14.3 10.0 12.5 41.0 28.8 21.5 44.7 30.7 15.6 29.8 77.8 18.7 13.0 30.8 23.2 13.2 3.6 6.9 2.2 40.3 40.4 4.3 22.8 11.7 24.4 16.6 9.3 17.9 3.8 5.3 24.7 19.0 8.1 4.2 21.1 20.5 18.6 2.5 0.5 4.1 8.7 17.3 2.5 13.1 13.3 40.3 17.4 33.2 8.7 24.9 2.5 4.1 29.7 31.0 0.9 4.6 3.8 2.6 7.1 6.5 3.0 7.1 13.4 24.0 13.2 3.0 2.9 5.6 16.3 34.2 19.6 8.0 2.1 32.4 33.1 4.6 19.5 10.4 5.7 18.5 7.0 8.9 3.3 10.2 50.9 17.0 43.7 27.1 14.2 23.9 15.6 30.8 26.8 13.1 12.5 9.6 14.8 77.8 13.0 18.7 29.8 22.2 23.2 8.4 10.6 7.4 10.1 7.8 5.1 13.8 4.2 11.2 10.0 1158.3 540.6 237.0 1442.7 520.2 42.2 53.1 293.0 254.3 251.4 130.9 31.4 113.5 18.3 616.6 54.4 455.0 961.8 70.0 474.3 369.8 410.0 832.0 597.5 234.2 510.8 35.0 381.0 212.4 420.1 42.4 120.8 593.9 458.9 839.6 556.8 32.1 706.5 466.4 125.9 61.9 78.0 135.8 372.0 6.2 13.6 549.2 163.8 409.2 300.8 382.6 KLF7 UKLF ENSG00000118263 "Kruppel like factor 7" O75840 2 207074137-207167267 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003423, HPA030490" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003423: , HPA030490: AB_10601922" "unprognostic (5.93e-2)" "unprognostic (2.49e-3)" "unprognostic (2.98e-1)" "unprognostic (3.99e-3)" "unprognostic (2.56e-1)" "unprognostic (2.85e-3)" "unprognostic (5.44e-2)" "unprognostic (1.24e-2)" "unprognostic (6.75e-2)" "unprognostic (8.78e-2)" "unprognostic (3.67e-2)" "unprognostic (1.47e-1)" "prognostic favorable (4.26e-4)" "unprognostic (3.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (3.47e-2)" 22.2 10.1 10.3 15.1 12.0 40.7 17.3 30.2 12.0 12.2 12.1 14.6 9.3 5.7 19.7 13.4 11.6 10.2 13.8 12.1 10.3 8.0 9.9 8.4 17.1 15.7 12.9 9.1 17.1 6.1 3.0 6.4 7.0 17.4 10.2 6.7 7.0 8.9 9.3 6.2 7.9 11.9 24.2 25.7 11.3 10.7 7.9 14.7 14.4 10.8 8.5 8.3 18.4 18.2 4.5 3.0 24.0 11.7 12.9 9.0 3.5 4.5 3.2 8.7 0.6 3.0 8.0 1.8 5.3 4.2 8.2 3.6 0.0 3.7 0.0 3.4 10.7 14.3 11.3 7.4 24.2 4.4 3.1 0.4 0.1 8.9 1.8 5.3 2.3 3.6 10.6 8.2 5.7 19.0 11.9 9.5 2.4 0.0 4.3 6.3 0.1 2.8 0.8 5.1 0.5 1.6 1.2 2.3 3.2 2.0 3.5 13.5 16.5 4.5 6.4 4.3 7.3 1.0 3.6 18.8 16.4 7.9 6.9 6.2 3.3 2.2 0.0 14.5 2.0 3.2 11.5 5.4 6.8 0.9 6.8 0.4 3.0 5.1 1.0 3.0 4.5 9.0 6.1 24.0 12.9 11.7 1.4 4.1 3.5 10.3 12.0 30.2 12.0 10.3 8.0 12.9 9.1 17.4 14.7 38.7 7.0 15.0 23.7 19.5 5.6 12.5 20.4 8.1 15.9 8.7 11.8 0.4 1.7 20.8 4.5 58.3 0.9 0.0 44.8 0.2 12.4 9.7 11.5 13.5 13.1 11.1 5.8 86.0 44.8 3.3 12.7 20.0 3.3 17.2 0.7 8.2 55.3 0.3 9.6 4.5 8.5 45.3 20.2 0.5 7.5 13.4 0.9 4.9 0.6 7.4 KLF9 BTEB1 ENSG00000119138 "Kruppel like factor 9" Q13886 9 70384597-70414624 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 22.7;ASC TERT1: 31.6;HHSteC: 40.6;HSkMC: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029308 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA029308: AB_10601923" "unprognostic (2.12e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (2.69e-2)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (3.64e-3)" "unprognostic (4.34e-1)" "unprognostic (5.55e-1)" "unprognostic (9.47e-2)" "unprognostic (7.86e-2)" "unprognostic (3.44e-1)" "prognostic favorable (6.59e-6)" "unprognostic (1.43e-3)" "unprognostic (1.75e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" 35.9 15.3 6.8 8.8 25.8 6.1 25.7 42.6 21.4 10.2 20.0 9.7 16.1 6.0 19.6 13.2 17.0 22.2 17.8 18.2 8.4 4.0 26.2 36.7 22.6 5.1 26.3 8.0 22.1 21.3 13.0 8.6 3.9 14.7 12.4 11.0 20.4 31.4 10.7 38.9 12.6 17.6 25.0 12.0 8.6 16.7 5.5 25.2 1.9 24.0 20.3 5.4 15.4 11.9 2.8 1.7 2.8 0.7 0.7 2.8 0.6 0.1 0.2 0.0 2.8 22.7 31.6 0.3 1.4 9.8 0.5 1.1 0.0 1.3 0.0 1.1 2.6 0.7 0.0 4.3 6.6 1.0 0.0 3.4 1.5 4.8 0.8 40.6 0.7 4.0 27.0 6.8 0.4 9.6 13.7 8.7 0.6 2.9 6.0 3.7 0.4 0.1 2.1 0.2 0.4 1.4 0.0 1.3 3.7 1.8 0.0 0.4 1.9 13.4 7.8 15.4 0.9 2.6 2.3 11.8 2.6 1.9 3.0 0.7 4.3 4.6 0.2 2.3 2.3 13.0 2.8 0.5 0.3 1.6 0.3 2.3 2.8 2.1 1.6 1.2 2.5 2.8 1.6 0.0 0.7 0.7 1.7 2.2 0.6 6.8 25.8 42.6 21.4 8.4 4.0 26.3 8.0 14.7 25.2 38.7 21.0 13.2 56.7 42.7 40.6 62.7 48.4 18.7 28.4 14.0 19.6 0.1 26.6 7.4 17.2 139.1 35.5 0.0 11.6 0.2 78.1 86.9 7.0 140.6 3.5 76.3 13.3 97.6 59.8 11.6 84.0 36.1 37.1 4.6 29.3 151.3 10.9 28.5 79.9 29.8 8.8 77.6 214.2 1.0 3.9 29.9 0.0 24.5 27.3 22.8 KLHDC1 MST025 ENSG00000197776 "Kelch domain containing 1" Q8N7A1 14 49693105-49753152 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 8.9;ASC TERT1: 8.5;HSkMC: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020461 Approved Supported Cytosol No No Cytosol "HPA020461: AB_1852556" "unprognostic (2.97e-2)" "unprognostic (6.30e-2)" "unprognostic (8.49e-3)" "unprognostic (1.26e-2)" "unprognostic (5.46e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-1)" "unprognostic (1.95e-2)" "unprognostic (1.01e-1)" "unprognostic (2.53e-1)" "prognostic favorable (1.94e-4)" "unprognostic (3.42e-1)" "unprognostic (5.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" 8.6 9.7 8.5 8.0 14.5 3.3 11.0 13.4 15.2 10.9 8.7 15.4 8.6 4.5 13.3 13.3 5.3 8.9 7.2 9.9 9.2 10.0 7.2 5.9 6.6 7.5 12.0 12.2 18.2 6.7 11.0 13.2 6.0 10.7 10.2 5.6 12.4 7.1 14.2 14.1 11.3 6.5 11.0 12.9 7.9 6.5 11.7 11.7 2.9 12.5 4.4 6.0 7.1 8.5 3.0 3.7 2.5 2.2 1.6 4.8 1.7 1.0 0.5 1.0 0.7 8.9 8.5 0.0 2.4 3.2 0.7 0.6 0.0 2.8 0.5 0.6 0.9 0.8 0.7 0.3 0.0 0.7 2.3 0.8 0.4 0.2 0.0 4.6 0.2 1.0 7.1 0.4 0.3 0.3 4.5 1.8 1.6 0.4 0.0 3.5 0.3 0.7 1.1 0.0 0.3 0.4 0.6 0.7 0.0 1.7 0.2 0.3 2.4 0.4 0.0 0.9 1.1 1.0 1.8 2.6 2.0 2.2 0.7 0.2 0.8 0.1 0.6 2.0 0.3 1.1 1.4 1.0 2.5 2.1 2.2 4.2 3.0 2.8 2.4 1.1 2.1 4.8 4.0 0.1 1.6 1.1 3.7 0.9 1.7 8.5 14.5 13.4 15.2 9.2 10.0 12.0 12.2 10.7 11.7 20.8 6.2 0.8 3.8 3.2 9.9 7.0 5.1 2.7 9.1 0.0 3.9 0.9 8.3 0.7 1.7 5.8 2.2 0.0 0.7 0.6 3.9 1.9 1.1 2.0 2.2 12.7 1.7 5.5 1.3 2.1 16.7 2.6 5.0 1.0 2.2 16.0 0.4 2.9 9.6 1.1 13.1 0.0 6.6 17.9 5.6 2.9 0.2 2.9 1.3 1.3 KLHDC8B MGC35097 ENSG00000185909 "Kelch domain containing 8B" Q8IXV7 3 49171611-49176486 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.4" "Group enriched" "Detected in many" 9 "granulocytes: 19.4;monocytes: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008463, HPA014467" Approved Enhanced Cytosol NA NA Cytosol "HPA008463: AB_1852563, HPA014467: AB_1852565" "unprognostic (1.66e-2)" "unprognostic (1.42e-1)" "unprognostic (5.31e-2)" "unprognostic (8.50e-3)" "unprognostic (2.66e-1)" "unprognostic (5.03e-3)" "unprognostic (1.71e-3)" "prognostic favorable (1.47e-4)" "unprognostic (6.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" "unprognostic (4.30e-2)" "unprognostic (1.02e-3)" "unprognostic (4.78e-2)" "unprognostic (5.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" 15.0 44.0 5.6 4.7 5.8 3.2 12.6 4.5 8.8 12.8 19.3 6.2 10.5 4.6 15.9 12.2 22.6 11.6 13.6 30.5 3.7 8.5 5.6 8.8 6.6 6.3 4.9 5.4 29.6 6.2 5.2 4.2 7.9 5.2 15.2 2.5 21.8 8.4 9.5 15.8 9.8 5.4 18.0 2.4 6.7 6.7 10.0 3.0 2.0 17.1 10.7 6.6 20.0 8.8 0.1 0.6 19.4 5.7 0.0 1.4 1.6 1.5 3.4 14.3 7.2 8.8 5.2 4.4 5.2 3.0 5.2 4.2 2.2 4.6 0.0 3.0 8.7 1.5 0.0 3.5 3.2 1.3 2.8 0.9 9.2 9.3 5.8 16.8 0.0 5.4 8.7 15.3 6.8 0.5 11.8 13.4 3.3 14.3 0.1 3.9 0.4 0.9 10.2 4.7 0.8 8.2 1.4 1.4 0.4 3.9 0.8 0.6 16.2 4.2 0.1 10.4 3.1 4.3 4.5 5.8 4.0 11.3 7.1 1.6 1.3 0.4 0.2 2.9 0.0 1.9 0.0 3.8 19.4 0.8 5.7 0.3 0.0 0.4 0.6 0.3 0.1 1.4 0.8 6.7 0.0 5.0 0.6 0.1 1.6 5.6 5.8 4.5 8.8 3.7 8.5 4.9 5.4 5.2 3.0 8.9 10.4 0.5 10.9 6.8 1.2 36.6 7.6 0.0 5.7 7.0 2.0 6.9 14.9 13.0 6.0 17.8 0.7 0.0 5.2 7.0 14.6 6.8 1.1 5.8 37.1 0.0 6.4 33.7 5.4 5.8 14.1 6.3 11.8 0.0 2.0 19.8 8.8 1.4 13.4 11.3 2.6 97.0 26.4 3.7 4.1 8.5 41.6 2.1 1.5 6.2 KLHL13 "BKLHD2, FLJ10262, KIAA1309" ENSG00000003096 "Kelch like family member 13" Q9P2N7 X 117897813-118117340 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 35.6" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 25.4;Distal tubular cells: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 3.2;eosinophil: 9.3;plasmacytoid DC: 5.6" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;granulocytes: 9.3" "Cell line enhanced" "Detected in many" "HAP1: 12.8;HeLa: 22.7;RH-30: 14.3;RPTEC TERT1: 40.8;SH-SY5Y: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046039, HPA059901" Approved Approved Cytosol NA NA Cytosol "HPA046039: AB_2679514, HPA059901: AB_2684155" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.09e-2)" "unprognostic (1.07e-2)" "unprognostic (9.54e-2)" "unprognostic (7.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.41e-1)" "unprognostic (2.54e-1)" "unprognostic (6.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.09e-3)" "unprognostic (1.24e-2)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (2.31e-1)" 2.4 5.5 3.4 3.9 11.9 0.2 19.0 2.5 3.7 24.9 5.3 3.1 6.6 2.2 35.6 5.6 5.4 8.1 10.1 9.0 2.3 4.0 15.4 3.3 1.4 0.4 4.7 2.1 7.7 3.3 3.5 5.0 1.7 6.6 7.3 3.0 5.6 2.6 9.7 2.3 1.5 4.9 22.2 3.5 1.1 3.5 2.8 4.9 3.6 1.4 3.1 1.2 8.2 5.0 0.0 5.6 9.3 0.1 1.4 0.9 0.4 0.4 0.1 2.6 5.5 0.0 0.0 0.1 0.2 0.0 0.1 0.0 3.4 0.0 0.0 6.3 0.0 0.2 6.3 12.8 2.1 0.0 0.0 4.9 0.1 22.7 0.0 0.3 0.4 0.8 0.7 0.9 0.0 0.2 2.7 9.7 0.0 0.0 0.0 0.0 0.5 2.1 0.5 5.1 0.0 3.6 0.0 14.3 0.0 40.8 1.5 0.0 36.4 0.1 0.4 0.3 1.1 7.9 0.0 0.2 0.9 1.1 0.7 3.2 0.1 0.0 0.0 3.9 0.0 1.5 3.2 0.1 9.3 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.9 0.8 0.0 1.4 0.0 5.6 0.4 0.4 3.4 11.9 2.5 3.5 2.3 4.0 4.7 2.1 6.6 4.9 0.0 0.0 0.0 5.5 0.7 3.9 5.8 0.0 25.4 5.7 1.8 0.0 0.1 24.9 1.1 0.3 0.7 1.6 0.0 2.9 0.1 2.6 1.5 0.0 1.0 0.5 0.0 1.2 4.3 0.0 0.7 5.8 0.0 1.7 0.0 2.0 8.4 1.2 3.5 1.8 8.5 1.1 6.5 3.2 1.2 12.0 0.4 0.0 0.0 2.3 1.7 KLHL14 KIAA1384 ENSG00000197705 "Kelch like family member 14" Q9P2G3 18 32672671-32773062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 14.6;seminal vesicle: 19.3" "Cell type enhanced" "Detected in some" 23 "B-cells: 6.0;Collecting duct cells: 7.0;Muller glia cells: 21.8" "Group enriched" "Detected in many" 10 "endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 97 "memory B-cell: 10.7;naive B-cell: 8.5" "Lineage enriched" "Detected in single" 108 "B-cells: 10.7" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;Hep G2: 16.8;REH: 4.5;RPTEC TERT1: 9.4;SCLC-21H: 3.6;U-698: 4.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "hippocampal formation: 22.7;olfactory region: 20.4" HPA024777 Uncertain Supported "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA024777: AB_1852576" "unprognostic (3.93e-2)" "unprognostic (7.87e-2)" "unprognostic (7.09e-2)" "unprognostic (5.61e-3)" "unprognostic (1.87e-1)" "unprognostic (2.16e-6)" "unprognostic (2.14e-1)" "unprognostic (4.30e-2)" "unprognostic (4.81e-2)" "unprognostic (2.32e-3)" "unprognostic (2.32e-1)" "unprognostic (7.64e-2)" "unprognostic (8.91e-2)" "unprognostic (8.03e-2)" "unprognostic (1.97e-1)" "unprognostic (2.65e-2)" "unprognostic (1.43e-2)" 0.6 0.1 0.4 1.0 0.4 1.5 0.6 0.4 1.0 2.4 0.4 0.4 14.6 0.0 1.5 1.4 0.4 6.3 0.4 0.4 0.4 0.3 4.3 0.4 0.4 5.1 0.4 0.4 1.1 0.4 10.3 1.1 0.4 1.5 1.6 0.0 1.0 0.4 19.3 0.4 0.1 2.3 0.4 0.4 9.5 0.1 2.8 0.4 0.4 11.7 0.4 3.8 0.4 0.7 10.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 16.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 4.5 1.5 0.0 9.4 0.0 3.6 0.4 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.4 1.0 0.4 0.3 0.4 0.4 1.5 0.4 0.0 0.0 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.0 0.0 0.0 3.3 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 1.3 0.3 1.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 KLHL15 KIAA1677 ENSG00000174010 "Kelch like family member 15" Q96M94 X 23983720-24027186 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 25.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065730 Uncertain Approved Aggresome,Cytosol NA NA Cytosol Aggresome "HPA065730: AB_2685547" "unprognostic (5.89e-2)" "unprognostic (6.98e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.13e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (7.37e-3)" "unprognostic (7.42e-2)" "unprognostic (9.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-2)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (8.40e-2)" 2.9 6.1 1.7 1.3 2.3 25.1 1.3 2.8 1.8 1.9 2.0 1.0 2.3 4.0 4.3 3.8 1.9 2.1 1.6 1.9 2.2 6.4 1.6 1.4 1.3 4.6 2.9 4.3 2.6 1.2 2.8 1.2 1.3 1.8 2.6 1.0 1.5 2.2 1.6 1.5 3.4 9.0 2.3 1.2 1.3 1.1 1.4 2.1 2.8 2.6 1.6 2.8 1.3 4.3 4.2 4.7 6.8 7.0 5.0 4.8 7.0 6.1 3.2 3.9 3.8 3.9 11.3 2.5 4.5 5.1 3.3 7.4 3.8 7.9 4.4 15.3 7.2 11.3 2.0 4.4 9.4 5.1 5.2 2.0 5.5 5.5 2.9 2.3 6.8 4.6 16.0 6.0 1.5 8.4 9.2 8.8 2.2 5.2 6.7 8.5 7.0 3.0 3.8 12.4 5.8 9.7 2.4 8.0 6.2 3.2 8.4 2.9 5.0 3.0 9.8 4.5 8.9 8.9 13.1 3.9 6.1 3.9 1.5 1.1 2.8 2.0 2.6 2.8 1.0 1.8 2.3 2.1 1.4 2.4 2.4 1.5 1.6 2.6 1.7 1.8 1.3 6.0 6.4 7.5 3.7 16.0 7.7 9.8 2.5 1.4 6.8 3.5 11.8 0.4 0.0 1.2 1.8 4.4 2.6 0.0 1.2 0.7 6.1 5.3 8.1 11.5 3.2 19.1 8.1 6.2 9.8 1.7 3.1 7.2 11.8 1.8 2.9 11.8 1.7 0.0 3.9 2.1 7.4 0.0 19.6 3.0 13.5 8.7 1.1 5.0 4.0 2.5 KLHL20 "KHLHX, KLEIP" ENSG00000076321 "Kelch like family member 20" Q9Y2M5 1 173714941-173786702 "Predicted intracellular proteins" "Protein transport, Transport, Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025034, HPA053704" Approved Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA025034: AB_1852578, HPA053704: AB_2682234" "unprognostic (2.97e-3)" "unprognostic (3.11e-2)" "unprognostic (8.27e-2)" "unprognostic (6.48e-3)" "unprognostic (1.56e-2)" "unprognostic (1.50e-1)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (1.84e-2)" "unprognostic (2.14e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (8.66e-2)" "unprognostic (3.02e-1)" "unprognostic (1.90e-1)" "unprognostic (2.62e-2)" 18.2 14.5 10.4 12.5 15.1 6.9 15.4 18.8 18.0 17.9 16.1 14.3 17.3 9.1 21.9 13.0 14.4 14.2 13.9 15.2 11.6 10.3 15.1 21.7 13.6 12.0 13.3 10.5 18.0 9.7 12.3 20.6 15.4 16.2 18.8 12.7 11.5 11.3 15.4 17.1 12.9 16.0 18.8 14.8 16.4 11.0 20.7 15.2 20.7 13.3 14.7 13.6 14.3 14.8 6.2 7.1 9.7 5.0 4.7 9.5 3.3 8.3 5.3 8.5 8.8 20.0 18.6 7.0 13.2 12.9 10.2 10.8 3.8 5.8 5.9 11.3 14.1 5.4 8.4 7.5 9.5 12.0 7.2 4.1 5.4 7.3 4.5 12.9 10.0 6.3 15.7 11.0 9.4 12.7 11.9 14.9 6.0 11.9 6.8 18.6 3.0 5.8 5.2 9.0 7.4 24.4 6.3 10.5 6.3 7.8 5.3 3.6 10.1 12.0 8.2 7.8 12.1 7.3 11.8 14.8 9.9 5.9 12.0 10.3 9.1 4.7 9.0 6.4 7.3 10.9 9.7 4.5 6.3 7.3 5.0 6.5 5.9 7.2 8.7 4.3 6.2 9.5 9.1 2.5 4.7 3.5 7.1 8.1 3.3 10.4 15.1 18.8 18.0 11.6 10.3 13.3 10.5 16.2 15.2 14.9 20.4 12.6 7.8 9.8 11.7 8.5 17.8 4.0 9.1 12.2 35.3 11.0 1.7 8.7 93.8 14.9 10.2 0.0 10.5 8.4 16.1 6.1 7.0 13.4 9.6 11.1 9.2 43.6 19.3 24.0 20.8 8.9 3.3 3.6 9.4 15.0 8.8 10.5 26.9 11.3 19.2 0.0 15.5 53.5 31.7 9.3 8.2 13.4 8.1 6.7 KLHL25 "ENC-2, ENC2, FLJ12587" ENSG00000183655 "Kelch like family member 25" Q9H0H3 15 85759323-85795030 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 31.5" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 12.1;Horizontal cells: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 6.1;NK-cells: 5.1;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebral cortex: 36.7;hippocampal formation: 25.8" HPA023450 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023450: AB_1852583" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (8.98e-2)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (4.25e-2)" "unprognostic (5.18e-2)" "unprognostic (2.22e-2)" "unprognostic (3.57e-2)" "unprognostic (1.80e-1)" "unprognostic (2.08e-1)" "unprognostic (2.66e-2)" 10.6 4.2 5.2 6.8 12.1 1.5 12.7 3.9 21.5 4.7 4.8 7.5 7.7 9.9 7.9 7.2 8.2 6.2 5.2 4.2 5.7 5.9 4.3 18.3 4.8 4.0 5.3 5.8 4.4 3.6 4.4 4.6 2.8 5.4 5.7 2.9 3.8 6.2 7.6 7.8 9.7 7.0 6.2 3.0 2.6 7.5 16.3 4.3 3.7 4.7 2.5 3.9 4.1 31.5 0.6 1.2 0.5 6.1 5.1 3.5 1.0 2.3 7.2 10.5 5.1 2.1 1.2 5.4 3.0 1.4 4.3 3.2 9.6 4.0 1.5 1.6 2.5 2.7 5.9 11.3 5.7 0.9 1.4 5.2 0.4 3.0 7.3 2.5 0.4 1.9 2.2 1.9 4.1 1.4 1.9 2.3 5.2 0.6 1.4 1.8 4.4 3.7 2.3 9.5 4.1 3.8 7.6 6.3 2.4 1.6 5.0 14.7 10.2 4.4 5.1 1.9 4.5 9.3 0.6 1.9 4.5 8.2 2.9 5.4 1.5 3.1 1.5 2.0 2.6 2.5 0.0 0.2 0.5 2.0 2.3 1.1 0.1 2.1 1.5 0.5 0.6 3.5 2.2 0.0 5.1 6.1 1.2 1.8 1.0 5.2 12.1 3.9 11.1 5.7 5.9 5.3 5.8 5.4 4.3 0.0 3.4 0.0 4.2 2.4 1.9 2.5 2.5 1.4 1.2 0.0 0.0 0.7 1.7 1.8 12.1 2.1 3.8 0.0 2.3 1.2 1.9 3.4 0.0 9.6 0.7 12.7 10.3 3.1 1.5 3.1 0.9 0.7 6.8 1.0 6.6 2.2 3.8 2.9 1.4 1.7 0.9 6.5 2.3 3.2 3.9 4.1 1.5 1.5 2.8 3.5 KLHL28 "BTBD5, FLJ20081" ENSG00000179454 "Kelch like family member 28" Q9NXS3 14 44924319-45042322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000988 Approved Cytosol NA NA Cytosol "HPA000988: AB_1845480" "unprognostic (8.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "unprognostic (1.37e-1)" "unprognostic (7.84e-3)" "unprognostic (9.20e-2)" "unprognostic (4.36e-3)" "unprognostic (4.92e-2)" "unprognostic (2.66e-1)" "unprognostic (2.14e-1)" "unprognostic (1.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.68e-2)" "unprognostic (7.55e-2)" "unprognostic (4.34e-1)" "unprognostic (1.75e-2)" "unprognostic (6.53e-2)" 10.9 9.0 8.8 11.6 12.7 39.2 10.4 22.9 15.5 12.1 9.9 11.1 10.5 9.1 12.6 9.4 12.8 11.2 9.9 8.9 10.3 10.4 8.6 11.2 10.1 13.5 11.2 9.4 14.4 10.6 9.8 18.1 9.9 16.7 10.2 10.8 12.2 12.6 9.0 13.8 11.5 11.0 10.5 12.8 11.5 8.8 14.2 10.9 27.9 13.6 8.6 12.7 11.3 10.8 10.2 6.0 17.7 7.0 13.0 23.1 4.5 4.5 6.9 9.2 6.0 8.4 7.6 7.0 6.1 6.8 9.1 7.7 3.0 7.2 6.8 6.7 10.6 2.4 8.0 8.2 6.5 10.0 12.6 4.4 5.9 7.1 3.5 7.5 9.4 12.9 5.8 9.1 5.8 9.3 5.2 7.2 10.7 5.2 17.0 5.2 6.6 7.4 4.8 5.7 5.2 6.6 6.5 10.3 3.7 5.2 8.3 10.6 6.5 7.9 5.3 8.4 6.2 10.0 4.0 9.1 8.1 9.5 5.7 3.4 10.1 11.0 9.4 2.8 4.2 4.9 17.7 5.0 11.9 12.4 6.9 23.1 10.2 12.4 13.0 4.4 9.6 14.9 12.6 11.6 13.0 7.0 6.0 9.3 4.5 8.8 12.7 22.9 15.5 10.3 10.4 11.2 9.4 16.7 10.9 14.9 6.5 22.3 14.8 21.8 23.0 10.7 7.6 18.7 11.4 17.4 33.4 6.0 6.6 8.4 28.5 11.7 10.5 23.3 4.9 6.4 12.6 10.9 18.5 10.5 8.1 14.3 13.4 14.7 16.2 34.2 20.1 15.3 21.9 12.6 11.1 27.6 9.0 11.6 16.6 6.3 20.9 12.9 16.0 9.9 4.2 26.3 11.8 25.5 10.0 13.6 KLHL29 "KBTBD9, KIAA1921" ENSG00000119771 "Kelch like family member 29" Q96CT2 2 23385217-23708611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 23.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 13.5;RH-30: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049057, HPA057379" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA049057: AB_2680615, HPA057379: AB_2683422" "unprognostic (8.08e-3)" "unprognostic (2.91e-1)" "unprognostic (7.43e-3)" "unprognostic (2.65e-2)" "unprognostic (9.11e-2)" "unprognostic (1.67e-2)" "unprognostic (3.54e-3)" "unprognostic (1.16e-1)" "unprognostic (4.71e-2)" "unprognostic (2.18e-1)" "prognostic favorable (2.19e-4)" "unprognostic (2.53e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.12e-2)" "unprognostic (9.06e-2)" "unprognostic (7.44e-2)" "unprognostic (5.25e-4)" 9.5 20.8 8.9 6.4 14.5 0.8 7.4 9.0 11.7 6.7 9.4 2.6 5.2 2.6 10.9 3.5 5.4 4.8 10.7 3.3 6.7 7.5 4.7 5.4 6.2 5.7 3.6 9.0 4.0 4.7 5.8 17.7 7.6 6.3 10.8 3.4 11.7 4.2 11.7 12.0 6.9 4.2 7.2 2.7 10.6 5.5 2.5 3.7 0.5 1.9 1.8 4.0 7.5 6.4 0.1 0.4 0.0 0.0 0.9 0.7 0.0 1.0 0.9 6.0 3.0 5.7 3.8 10.3 6.1 4.7 2.5 1.8 0.0 0.3 3.9 2.1 2.3 13.5 0.2 1.4 5.2 1.7 0.0 6.3 0.0 5.1 0.0 2.0 0.0 7.9 2.7 7.1 3.3 9.3 0.8 4.2 0.1 0.0 0.0 1.3 0.5 1.3 0.0 3.0 0.0 1.8 0.3 15.4 0.0 4.6 1.8 9.0 1.8 0.8 0.6 3.5 2.5 0.0 0.0 4.2 2.5 11.7 5.3 2.1 0.1 0.0 0.0 9.5 0.4 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.7 0.7 0.0 0.9 0.0 0.4 0.0 0.0 8.9 14.5 9.0 11.7 6.7 7.5 3.6 9.0 6.3 3.7 6.0 4.0 0.0 9.1 4.1 2.3 2.0 5.1 1.4 1.2 1.8 25.5 0.7 0.0 1.0 1.7 1.4 0.0 0.0 0.2 0.9 1.7 1.7 0.0 0.4 0.2 1.6 4.1 0.6 0.0 0.0 4.6 0.0 1.7 0.0 0.6 1.3 0.4 0.0 3.9 1.3 23.5 6.5 5.1 0.0 1.1 5.1 0.7 0.0 0.2 1.3 KLHL36 "C16orf44, FLJ12543" ENSG00000135686 "Kelch like family member 36" Q8N4N3 16 84648525-84667686 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023423 Approved Approved Cytosol NA NA Cytosol "HPA023423: AB_10962985" "unprognostic (6.50e-2)" "unprognostic (2.41e-2)" "unprognostic (2.35e-1)" "unprognostic (5.84e-2)" "unprognostic (1.49e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (2.90e-1)" "unprognostic (5.25e-2)" "unprognostic (2.59e-2)" "prognostic favorable (9.81e-5)" "unprognostic (3.79e-3)" "prognostic favorable (5.52e-10)" "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (8.47e-2)" "unprognostic (1.67e-3)" 14.6 10.3 13.7 10.8 14.8 26.3 12.2 12.1 11.7 8.9 9.7 7.5 13.0 13.7 11.1 11.1 13.8 10.4 10.1 12.6 10.8 6.0 11.6 16.2 12.7 12.3 10.2 8.6 14.7 21.9 12.7 10.1 9.2 8.7 12.1 5.6 8.8 13.5 12.4 7.8 11.9 14.9 12.0 6.7 16.8 13.1 21.3 10.5 8.4 13.9 7.2 14.0 15.1 22.6 5.9 5.4 8.8 3.7 3.1 10.4 3.2 12.4 13.4 2.5 6.7 2.6 4.8 13.2 8.7 4.8 3.9 2.1 11.8 8.9 8.6 12.8 5.3 3.9 13.3 2.7 7.2 1.8 5.6 5.4 3.0 4.4 6.5 3.5 3.7 8.6 4.6 5.4 5.1 4.0 4.2 4.7 2.6 9.6 1.5 2.8 19.6 0.5 5.3 4.9 4.1 5.9 11.8 3.3 4.2 5.4 11.6 3.8 2.8 11.0 2.8 5.4 3.2 12.0 8.7 10.6 5.0 9.3 5.5 5.8 5.1 6.4 14.8 6.8 4.5 14.9 5.3 3.7 8.8 4.9 2.5 4.1 5.9 8.7 7.1 5.4 5.7 10.4 7.2 4.8 3.1 2.6 4.9 4.0 3.2 13.7 14.8 12.1 11.7 10.8 6.0 10.2 8.6 8.7 10.5 17.9 14.4 23.8 31.2 14.2 21.2 22.4 40.8 10.7 7.9 21.0 33.4 19.3 5.0 22.4 31.8 16.8 29.1 0.0 12.6 9.5 14.3 40.6 6.9 17.9 16.8 25.4 17.9 18.4 15.8 11.8 21.6 15.6 20.3 19.8 20.4 8.6 17.7 24.6 23.7 23.0 22.3 32.3 21.7 14.8 4.7 15.4 16.1 20.8 18.6 36.1 KLHL38 C8ORFK36 ENSG00000175946 "Kelch like family member 38" Q2WGJ6 8 123645527-123652950 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 72.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.5;SK-MEL-30: 1.7;U-2197: 9.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA024770, HPA027115" Uncertain Approved Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA024770: AB_10599286, HPA027115: AB_10599950" "unprognostic (8.62e-3)" "unprognostic (3.86e-3)" "unprognostic (1.02e-2)" "unprognostic (8.94e-2)" "unprognostic (4.68e-1)" "unprognostic (2.09e-2)" "unprognostic (8.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-2)" "unprognostic (5.73e-6)" "unprognostic (8.46e-3)" "unprognostic (3.82e-2)" "unprognostic (6.52e-2)" "unprognostic (2.84e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.5 0.7 0.6 0.1 0.1 16.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.1 72.0 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.8 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.7 0.0 1.0 0.0 0.0 0.0 0.2 9.7 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL41 "KBTBD10, Krp1, SARCOSIN" ENSG00000239474 "Kelch like family member 41" O60662 2 169509702-169526262 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "skeletal muscle: 564.4;tongue: 157.3" "Cell type enriched" "Detected in some" 12 "Cardiomyocytes: 97.4" "Group enriched" "Detected in some" 9 "head and neck cancer: 10.8;prostate cancer: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HSkMC: 12.8;LHCN-M2: 20.3;RH-30: 32.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA021165, HPA021753, HPA021760" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091" "unprognostic (2.44e-2)" "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (2.94e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" "unprognostic (2.05e-1)" "unprognostic (5.46e-3)" "unprognostic (1.88e-1)" "unprognostic (5.38e-2)" "unprognostic (6.65e-4)" "unprognostic (9.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (1.52e-1)" 12.0 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.1 0.1 17.8 9.8 0.2 0.6 10.2 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.5 0.1 0.0 3.9 0.1 0.0 6.6 0.1 564.4 0.2 0.1 2.3 0.2 0.1 0.2 0.5 0.0 0.0 2.0 157.3 5.0 2.1 0.1 0.2 0.5 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 12.8 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 2.2 97.4 0.0 4.0 3.4 0.0 7.9 0.0 0.0 0.4 3.7 0.0 0.0 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.2 0.0 1.2 0.6 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.7 0.7 0.0 1.1 0.2 5.7 0.0 0.6 3.3 0.5 0.0 0.0 0.0 0.0 0.0 KLHL7 "KLHL6, RP42, SBBI26" ENSG00000122550 "Kelch like family member 7" Q8IXQ5 7 23105758-23177914 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 452.0;Late spermatids: 236.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029491, HPA029492" Uncertain Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029491: AB_10599605, HPA029492: AB_10600881" "unprognostic (1.24e-2)" "unprognostic (4.45e-1)" "unprognostic (1.77e-1)" "unprognostic (4.55e-2)" "unprognostic (1.29e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (3.78e-1)" "unprognostic (6.10e-2)" "unprognostic (6.41e-3)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "prognostic favorable (8.98e-5)" "unprognostic (2.46e-2)" "unprognostic (3.55e-3)" "unprognostic (3.23e-2)" "unprognostic (2.27e-2)" 7.5 14.6 9.2 5.6 13.0 8.2 10.3 12.6 15.1 8.8 5.7 7.9 4.7 5.9 9.1 9.9 7.7 7.4 7.6 37.1 8.1 8.7 9.2 7.7 6.4 5.8 8.3 9.7 9.6 5.9 7.1 6.1 6.5 15.9 8.1 6.3 8.6 7.2 6.8 7.4 8.6 5.8 8.1 10.6 5.8 5.2 40.7 6.2 9.6 7.2 5.1 6.7 6.9 7.1 5.5 5.5 32.0 8.7 4.2 8.0 6.0 10.9 9.4 25.9 30.6 12.7 11.1 9.5 9.7 14.4 14.3 16.7 11.4 8.0 10.8 7.9 11.8 23.7 11.9 9.9 6.8 12.1 2.8 7.1 7.1 8.1 14.6 9.5 14.3 5.6 9.8 8.9 16.4 13.5 11.4 18.2 13.4 12.4 11.8 23.3 12.6 11.9 22.8 35.7 7.5 11.2 10.6 14.5 9.8 13.4 9.5 15.6 15.3 21.1 10.5 9.9 16.6 8.7 7.5 7.7 12.1 12.6 26.5 11.5 18.6 15.2 25.7 8.0 15.2 14.4 18.7 7.8 32.0 6.8 8.7 7.1 4.5 7.3 6.4 5.5 5.5 5.5 5.4 7.4 4.2 7.5 4.0 8.0 6.0 9.2 13.0 12.6 15.1 8.1 8.7 8.3 9.7 15.9 6.2 20.8 5.6 13.3 15.2 20.9 19.9 85.8 5.1 16.0 9.1 8.7 27.5 18.6 10.0 15.7 452.0 14.1 4.9 0.0 15.3 24.1 17.0 11.5 20.8 5.9 16.7 35.0 10.4 14.1 15.3 236.4 15.5 14.1 11.8 12.6 7.6 23.5 14.7 0.0 19.4 9.8 15.0 6.5 19.1 94.0 10.6 29.5 19.8 15.2 6.4 22.7 KLHL9 "FLJ13568, KIAA1354" ENSG00000198642 "Kelch like family member 9" Q9P2J3 9 21329671-21335380 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046039, HPA059901" Approved Approved Cytosol NA NA Cytosol "HPA046039: AB_2679514, HPA059901: AB_2684155" "unprognostic (7.82e-2)" "unprognostic (4.36e-1)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (4.89e-1)" "unprognostic (1.87e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-2)" "unprognostic (8.23e-2)" "unprognostic (2.95e-1)" "unprognostic (4.52e-2)" "unprognostic (9.06e-2)" "prognostic favorable (9.43e-10)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (2.91e-1)" "unprognostic (3.33e-3)" 17.8 15.1 16.4 12.4 15.6 9.3 20.8 18.0 19.5 19.7 14.4 19.4 12.7 8.7 19.5 18.7 14.8 16.8 12.6 13.6 15.8 19.9 17.8 15.1 13.6 13.2 16.9 11.9 25.3 20.4 18.1 16.9 22.6 15.7 20.0 15.1 15.3 16.2 14.8 9.3 10.1 15.6 17.6 16.9 17.3 16.1 9.9 13.2 23.0 19.9 11.6 13.5 15.7 16.5 3.4 5.0 16.7 7.2 6.0 8.3 4.5 6.0 7.3 16.7 9.0 21.6 21.5 3.6 11.3 11.5 8.6 9.7 2.7 4.8 2.7 7.3 16.5 8.6 3.3 9.7 11.0 10.7 15.0 7.0 0.0 13.8 7.1 15.1 4.7 3.3 21.1 11.9 6.7 10.9 14.1 13.0 0.0 0.0 3.6 19.6 3.8 9.8 16.6 6.8 6.2 6.3 0.0 7.3 3.2 10.6 7.5 5.3 10.1 6.5 5.9 6.9 16.1 10.7 0.0 15.6 0.0 6.1 4.8 6.5 3.9 5.3 2.9 0.0 5.0 5.8 7.5 6.2 16.7 5.5 6.9 6.2 3.4 6.7 5.0 5.0 2.6 8.3 5.6 2.0 6.0 7.2 3.7 4.6 4.5 16.4 15.6 18.0 19.5 15.8 19.9 16.9 11.9 15.7 13.2 23.8 15.6 6.9 27.6 9.2 23.8 16.3 17.8 16.0 29.6 15.7 17.7 13.6 10.0 13.1 0.6 16.1 14.7 0.0 13.1 6.3 14.6 21.4 11.5 19.5 12.9 17.5 26.5 43.6 22.7 0.9 19.8 10.3 16.9 6.4 23.0 18.7 11.5 17.5 22.6 20.3 16.7 12.9 10.3 12.5 9.5 9.2 8.4 14.9 14.5 18.0 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607886 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 178.9" "Cell type enriched" "Detected in many" 21 "T-cells: 765.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 178.9" "Group enriched" "Detected in many" 133 "NK-cells: 53.0;T-cells: 178.9" "Cell line enhanced" "Detected in some" "HEL: 3.0;Karpas-707: 2.2" "Low region specificity" "Detected in all" HPA039113 Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favorable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favorable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favorable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.61e-4)" "unprognostic (1.17e-2)" 3.8 0.8 0.8 22.8 0.8 18.6 2.1 0.5 0.6 2.9 9.1 0.0 1.3 5.0 1.8 3.7 2.6 1.8 7.3 1.3 0.7 0.8 3.8 4.9 11.8 23.7 1.1 0.2 2.0 1.0 0.0 0.9 2.1 0.8 1.8 3.9 0.9 4.8 1.4 0.9 0.8 20.4 0.6 1.8 25.2 4.4 1.3 0.2 6.2 1.9 2.9 17.7 5.5 2.0 0.1 0.3 0.8 0.2 53.0 178.9 18.5 0.1 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.0 0.9 0.2 1.9 0.0 0.0 0.2 0.0 3.0 0.0 0.4 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.2 2.2 0.0 0.8 0.8 0.6 0.5 0.5 0.0 1.1 0.3 0.9 0.0 0.5 0.4 0.6 0.6 0.7 0.1 1.7 0.3 0.2 0.0 1.6 0.0 0.4 0.7 0.6 0.4 1.5 0.0 1.8 1.0 0.5 0.1 0.0 43.1 0.1 178.9 0.1 25.6 28.1 0.1 0.1 1.5 8.7 0.8 53.0 0.2 0.3 5.7 18.5 0.8 0.8 0.5 0.6 0.7 0.8 1.1 0.2 0.8 0.2 0.0 12.8 14.5 0.6 8.7 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 5.1 1.3 0.0 5.5 0.9 0.0 0.0 35.6 22.5 0.0 0.0 3.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.5 0.0 0.0 7.8 0.8 765.3 0.3 1.3 KMT2A "ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1" ENSG00000118058 "Lysine methyltransferase 2A" Q03164 11 118436490-118526832 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Apoptosis, Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017794, CAB024270, HPA044910" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017794: , CAB024270: , HPA044910: AB_2679141" "unprognostic (6.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.83e-1)" "unprognostic (4.56e-1)" "unprognostic (4.96e-2)" "unprognostic (1.72e-3)" "unprognostic (4.52e-3)" "unprognostic (6.07e-2)" "unprognostic (1.61e-1)" "unprognostic (8.46e-2)" "unprognostic (3.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.91e-3)" "unprognostic (7.90e-2)" "unprognostic (3.73e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" 14.4 11.3 17.7 17.0 19.2 28.6 16.8 43.8 21.2 17.3 14.6 19.8 18.1 8.5 21.8 17.1 10.6 15.7 14.1 10.2 17.3 13.4 13.1 9.3 15.3 19.6 16.6 18.7 35.6 16.8 28.9 21.8 10.2 15.4 15.6 12.4 14.4 14.2 19.2 11.1 16.8 14.2 15.2 12.1 15.7 12.3 7.9 23.4 16.6 16.6 7.8 19.4 18.8 24.6 6.7 3.5 8.3 2.0 6.5 5.3 0.8 12.1 5.6 15.2 11.4 9.3 11.1 4.5 5.5 8.0 5.8 6.7 11.3 8.8 15.0 11.3 8.0 10.3 10.6 16.1 6.1 11.6 16.5 6.2 29.4 5.2 6.1 5.2 17.5 5.7 5.3 6.2 12.7 17.0 7.3 9.0 9.8 19.1 12.8 7.3 9.5 11.6 10.3 9.2 5.0 8.4 8.8 14.6 5.0 8.5 9.2 12.5 8.1 13.8 4.5 2.9 8.3 7.8 5.9 13.2 9.9 9.0 7.2 9.8 3.7 2.9 10.1 3.7 12.9 5.9 8.3 2.0 4.6 5.3 1.3 4.3 6.2 4.8 4.6 0.8 6.7 4.9 4.8 1.3 6.5 1.4 3.5 3.9 0.8 17.7 19.2 43.8 21.2 17.3 13.4 16.6 18.7 15.4 23.4 65.5 59.8 31.5 64.8 77.2 147.8 34.4 38.2 53.5 35.2 36.6 143.3 12.2 3.3 26.8 6.6 70.1 19.7 0.0 22.3 8.1 43.5 71.4 26.7 23.1 14.2 184.3 63.8 45.4 32.6 4.7 61.9 26.1 40.5 33.3 29.3 117.0 23.2 14.4 73.9 6.9 144.6 64.7 59.7 11.1 14.9 70.4 5.0 50.7 27.3 49.9 KMT2B "CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7" ENSG00000272333 "Lysine methyltransferase 2B" Q9UMN6 19 35718019-35738878 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 61.2;Rod photoreceptor cells: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006487 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006487: AB_1080587" "unprognostic (1.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.41e-2)" "unprognostic (7.95e-2)" "unprognostic (9.92e-2)" "unprognostic (3.53e-3)" "unprognostic (2.33e-2)" "unprognostic (4.57e-2)" "unprognostic (7.28e-2)" "unprognostic (2.07e-2)" "unprognostic (3.13e-3)" "unprognostic (2.63e-3)" "unprognostic (9.47e-3)" "unprognostic (2.10e-1)" "unprognostic (2.37e-1)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" 10.2 9.3 11.4 14.2 13.1 18.4 10.4 23.9 11.4 10.0 12.0 14.2 12.9 13.8 13.0 7.1 11.4 11.6 12.6 7.5 11.0 5.3 9.9 8.9 10.6 14.7 14.7 6.8 15.3 19.6 10.8 13.3 9.3 11.2 12.1 5.6 13.8 14.7 10.0 13.3 19.9 12.3 12.2 12.4 15.8 12.1 21.5 14.9 14.1 14.9 7.0 14.2 12.4 14.2 0.4 0.7 3.2 0.7 2.1 0.7 0.2 11.5 19.5 9.0 9.9 4.7 4.6 9.4 5.6 4.1 5.7 4.4 13.0 5.9 10.3 8.8 4.6 6.1 7.6 8.1 4.8 2.5 15.2 9.0 18.5 9.1 6.5 4.6 11.2 21.2 6.2 6.5 5.8 6.4 5.1 5.5 10.7 15.4 12.9 3.7 11.8 9.5 9.7 8.3 10.0 6.9 15.0 5.9 5.6 3.1 10.3 10.2 8.2 8.5 13.8 5.9 5.0 8.4 12.0 7.7 11.4 12.4 7.6 11.8 17.8 10.9 8.2 6.2 10.4 7.9 1.0 0.7 0.6 0.7 0.4 0.4 0.3 0.2 0.3 0.2 0.4 0.3 0.4 3.2 2.1 0.3 0.7 0.2 0.2 11.4 13.1 23.9 11.4 11.0 5.3 14.7 6.8 11.2 14.9 8.9 19.1 13.3 8.5 11.3 61.2 7.7 10.2 4.0 5.7 8.7 49.1 5.2 0.0 5.5 2.1 11.7 14.0 0.0 6.7 4.9 8.1 13.1 4.7 9.7 7.3 33.4 19.4 11.6 8.7 4.1 7.5 6.4 5.0 6.4 10.4 27.2 7.1 11.4 11.7 4.2 74.2 0.0 8.2 28.1 36.4 11.3 7.9 10.2 11.3 12.8 KMT2D "ALR, CAGL114, MLL2, MLL4, TNRC21" ENSG00000167548 "Lysine methyltransferase 2D" O14686 12 49018975-49059774 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035977 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Yes No "Plasma membrane, Cytosol" Nucleoplasm "HPA035977: AB_10670673" "unprognostic (8.33e-2)" "unprognostic (1.49e-1)" "unprognostic (9.14e-2)" "unprognostic (2.52e-1)" "unprognostic (8.07e-2)" "unprognostic (6.91e-3)" "unprognostic (7.35e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (5.14e-2)" "unprognostic (7.23e-2)" "unprognostic (3.07e-1)" "unprognostic (1.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.20e-2)" "unprognostic (7.60e-2)" 12.1 7.6 4.9 6.7 10.8 26.1 6.8 11.7 10.5 9.5 6.5 5.8 13.0 5.5 15.7 7.4 8.8 8.9 5.8 9.1 6.1 3.5 6.2 6.5 22.9 9.6 6.7 3.3 9.7 11.6 13.3 9.2 12.9 13.7 6.7 6.6 9.8 7.6 8.0 16.1 13.6 9.4 7.1 9.1 13.6 8.3 7.3 5.7 6.2 11.0 6.1 7.6 7.0 6.3 2.0 2.2 5.9 0.5 1.5 0.8 0.6 17.1 16.3 16.5 13.3 17.1 11.5 17.7 9.1 9.5 11.8 6.3 28.6 7.3 17.8 11.8 12.7 8.5 11.6 21.7 10.0 9.8 10.4 17.4 22.6 17.1 15.3 11.7 26.8 22.7 9.7 14.4 16.5 17.1 14.1 17.5 18.5 28.3 9.9 13.3 18.9 13.3 25.0 15.6 23.7 14.1 20.0 10.2 6.4 9.9 19.0 13.8 11.7 14.0 13.8 9.5 15.0 13.7 23.5 23.3 9.3 16.6 8.1 15.2 14.1 9.1 17.3 10.7 13.9 6.9 0.6 0.5 3.0 0.8 0.2 0.4 0.3 0.3 0.5 0.3 2.0 0.3 0.8 5.9 1.5 0.1 2.2 0.0 0.6 4.9 10.8 11.7 10.5 6.1 3.5 6.7 3.3 13.7 5.7 8.9 18.4 11.1 6.5 12.5 25.2 4.7 12.7 5.3 9.1 17.4 49.1 6.6 1.7 5.8 2.5 12.6 11.1 0.0 5.2 4.6 8.5 8.3 8.1 12.3 8.3 20.6 12.6 17.2 19.7 1.1 8.9 9.6 10.1 4.6 10.5 5.2 7.2 8.6 10.3 4.3 38.9 6.5 3.3 3.7 3.2 15.4 9.5 10.4 10.1 8.4 KMT5A "PR-Set7, SET07, SET8, SETD8" ENSG00000183955 "Lysine methyltransferase 5A" Q9NQR1 12 123383773-123409358 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064495 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA064495: AB_2685273" "unprognostic (5.62e-2)" "unprognostic (4.45e-2)" "unprognostic (3.90e-1)" "unprognostic (3.04e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.21e-7)" "unprognostic (3.88e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-2)" "unprognostic (6.13e-2)" "unprognostic (3.44e-1)" "unprognostic (4.75e-3)" "unprognostic (4.27e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.06e-1)" 7.6 5.4 8.9 14.0 7.5 20.2 7.9 9.8 14.1 13.9 9.1 9.9 21.4 7.3 15.7 9.5 22.3 12.3 8.3 10.9 8.1 5.5 6.7 7.4 8.7 8.4 7.8 10.6 7.2 13.1 6.8 7.4 9.9 12.8 18.6 9.1 7.9 19.3 12.5 13.6 15.6 9.1 11.0 10.3 13.3 9.0 5.2 8.6 42.2 17.2 8.9 19.7 12.3 14.2 3.5 3.8 7.8 3.8 4.1 5.4 0.6 12.4 7.9 9.5 14.6 6.1 10.9 13.0 18.6 8.9 10.8 9.5 9.0 7.3 28.7 10.8 12.3 4.0 11.6 13.6 6.8 11.6 12.1 14.1 24.1 8.3 4.5 9.1 18.7 6.1 4.6 8.6 11.7 10.9 10.4 8.8 12.3 43.6 13.4 8.8 9.0 18.9 27.9 4.4 11.3 9.0 22.5 8.1 7.8 7.5 15.2 13.0 10.2 18.5 9.4 8.5 8.8 13.1 23.9 11.2 12.2 8.9 14.5 13.3 7.5 7.8 26.3 8.4 9.8 10.2 4.1 2.5 7.8 2.8 3.8 5.4 3.5 3.3 4.3 2.0 2.3 1.8 2.3 3.4 4.1 3.6 3.8 2.7 0.6 8.9 7.5 9.8 14.1 8.1 5.5 7.8 10.6 12.8 8.6 11.9 12.6 0.0 14.2 0.0 19.6 0.0 5.1 21.4 12.5 26.2 5.9 10.7 6.6 8.0 7.4 11.3 8.5 0.0 8.1 13.9 8.7 20.1 2.3 13.4 15.1 3.2 4.7 28.8 17.1 2.1 15.0 10.3 0.0 1.0 28.5 22.4 11.3 10.5 40.3 8.3 16.8 6.5 0.0 8.9 11.7 0.0 11.9 8.2 12.4 19.3 KNDC1 "bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND" ENSG00000171798 "Kinase non-catalytic C-lobe domain containing 1" Q76NI1 10 133160447-133226412 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 7.0;Ciliated cells: 22.7;Club cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 10 "monocytes: 3.1" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;EFO-21: 2.9;MCF7: 2.6;NTERA-2: 3.6;RPMI-8226: 5.0;SuSa: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039624, HPA056143" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Vesicles "HPA039624: AB_10671045, HPA056143: " "unprognostic (2.32e-1)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (1.59e-3)" "unprognostic (1.96e-2)" "unprognostic (2.76e-1)" "unprognostic (5.61e-2)" "unprognostic (2.75e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (6.80e-3)" "unprognostic (2.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.53e-1)" "unprognostic (1.94e-1)" "unprognostic (9.41e-2)" 1.1 11.4 14.7 1.2 13.2 1.0 1.2 23.9 26.2 2.1 1.1 5.4 0.0 1.1 3.9 2.7 1.0 14.6 1.5 1.2 11.3 12.1 1.5 5.5 4.2 1.1 8.3 13.2 10.9 2.1 1.0 13.2 1.9 8.5 2.0 1.1 0.7 2.5 3.2 1.2 1.2 1.2 1.9 3.2 1.7 1.4 2.8 3.5 0.0 2.4 0.0 1.1 1.1 0.3 0.3 0.0 0.0 3.1 0.0 0.0 0.1 0.6 0.9 0.5 4.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 1.5 0.6 0.0 2.9 0.3 1.4 0.6 0.1 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 3.6 0.1 0.0 0.0 0.1 5.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 4.9 0.4 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 14.7 13.2 23.9 25.2 11.3 12.1 8.3 13.2 8.5 3.5 0.0 7.0 0.0 0.0 0.0 0.8 2.0 2.5 22.7 6.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 4.3 0.2 1.6 2.9 0.0 1.0 0.8 3.4 0.4 0.0 0.0 0.0 4.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 KNOP1 "101F10.1, C16orf88, FAM191A, TSG118" ENSG00000103550 "Lysine rich nucleolar protein 1" Q1ED39 16 19701934-19718235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041079, HPA066169" Uncertain Enhanced "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA041079: AB_10962350, HPA066169: AB_2685628" "unprognostic (6.55e-3)" "unprognostic (3.96e-1)" "unprognostic (2.16e-2)" "unprognostic (2.42e-2)" "unprognostic (8.57e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (3.75e-6)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.18e-3)" "unprognostic (5.84e-2)" "unprognostic (2.14e-2)" "unprognostic (7.91e-2)" "unprognostic (3.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" 6.9 7.1 13.9 7.6 34.7 3.9 13.8 11.1 23.7 7.1 9.5 20.9 8.5 8.2 8.5 10.9 10.1 8.1 7.3 6.9 17.0 10.5 6.2 7.6 5.5 9.4 33.1 9.1 12.8 19.6 17.2 6.4 10.3 18.1 8.1 11.1 4.9 13.9 9.8 15.2 15.0 8.2 5.8 21.2 6.4 9.3 10.0 33.2 4.9 7.3 5.8 7.5 8.4 7.7 7.0 5.2 1.6 8.0 4.5 12.8 4.4 12.4 19.2 21.4 16.2 5.3 5.0 11.0 7.7 4.2 7.4 7.5 13.5 10.9 14.9 31.7 4.7 6.5 11.6 16.6 10.6 7.2 10.0 11.6 8.8 10.9 17.7 9.7 13.7 6.9 3.2 15.2 9.7 8.0 6.5 7.8 10.6 26.9 6.7 6.9 16.3 12.1 11.4 41.7 12.4 7.7 26.1 11.5 17.3 7.8 11.9 19.3 16.3 9.6 12.4 12.6 12.8 14.5 9.3 9.0 11.7 12.0 7.1 10.2 9.9 20.5 18.7 6.3 10.5 11.3 0.4 3.5 1.6 4.8 8.0 7.2 6.6 6.9 4.8 4.2 7.0 12.8 7.2 1.0 4.5 7.0 5.2 4.4 4.4 13.9 34.7 11.1 23.7 17.0 10.5 33.1 9.1 18.1 33.2 6.0 16.2 27.4 24.0 10.9 38.4 6.5 40.8 17.4 12.5 36.6 82.5 46.7 39.7 78.4 1.8 39.8 26.2 0.0 57.5 34.0 26.3 21.6 5.8 47.9 31.3 33.4 14.5 23.4 23.1 5.2 56.1 24.0 11.8 27.1 35.8 17.1 64.2 10.5 50.5 25.8 56.7 45.3 37.1 37.0 132.6 14.1 20.6 20.0 51.0 21.1 KNTC1 "KIAA0166, ROD" ENSG00000184445 "Kinetochore associated 1" P50748 12 122527246-122626396 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 23.5;Erythroid cells: 23.3;Spermatocytes: 24.6;Spermatogonia: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025241 Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA025241: AB_1852629" "unprognostic (1.17e-1)" "unprognostic (2.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.53e-2)" "unprognostic (9.34e-2)" "prognostic favorable (8.69e-4)" "prognostic unfavorable (4.79e-6)" "unprognostic (4.04e-2)" "unprognostic (7.20e-3)" "unprognostic (1.59e-2)" "unprognostic (4.78e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.89e-8)" "unprognostic (2.17e-2)" "unprognostic (3.08e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" 5.6 5.6 4.5 15.3 5.4 28.9 5.8 7.5 5.6 5.2 6.4 2.7 3.9 7.0 5.4 5.5 9.6 4.9 2.9 2.9 4.6 1.8 4.9 4.5 5.8 11.8 4.0 3.8 6.7 4.9 3.5 5.9 8.1 3.6 5.3 9.7 3.9 6.1 2.8 1.6 11.7 10.9 7.7 3.1 14.1 5.5 23.2 2.8 39.6 4.0 7.0 15.6 4.4 6.6 4.8 2.1 5.0 2.6 2.2 3.6 0.8 13.1 11.0 31.7 7.3 2.5 4.5 14.3 12.2 7.9 12.1 11.5 10.4 11.1 15.8 6.4 5.9 8.0 18.2 13.7 7.6 16.1 11.2 9.5 19.4 20.5 10.6 0.8 19.0 13.4 2.4 1.7 12.5 8.3 6.3 8.2 20.2 19.3 11.9 9.1 9.7 15.7 44.1 16.0 6.4 13.9 21.6 15.4 17.5 7.2 14.1 9.8 12.7 22.2 4.7 6.5 19.7 17.9 11.0 6.0 13.9 13.3 13.5 14.2 16.1 16.1 24.3 8.3 12.4 15.8 5.0 1.4 4.6 2.0 1.9 1.8 4.8 3.3 3.6 1.3 3.0 2.5 2.9 4.4 2.2 2.6 2.1 1.4 0.8 4.5 5.4 7.5 5.6 4.6 1.8 4.0 3.8 3.6 2.8 0.0 1.6 6.0 1.2 3.8 2.5 1.2 0.0 6.7 2.3 5.2 3.9 5.0 0.0 1.2 23.5 2.1 1.0 23.3 0.3 5.0 2.1 0.8 1.1 0.9 4.0 0.0 0.0 1.3 2.4 13.7 4.4 3.1 1.7 1.8 1.2 0.9 0.7 0.0 2.8 0.3 3.6 6.5 1.4 24.6 35.8 1.9 2.4 3.3 5.2 0.6 KPNA1 "IPOA5, NPI-1, RCH2, SRP1" ENSG00000114030 "Karyopherin subunit alpha 1" P52294 3 122421949-122514945 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.4" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 145.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053627, HPA063426" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053627: AB_2682211, HPA063426: AB_2685013" "unprognostic (6.23e-2)" "unprognostic (3.83e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (4.02e-3)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "unprognostic (6.77e-3)" "unprognostic (7.89e-3)" "unprognostic (5.22e-2)" "unprognostic (9.09e-2)" "unprognostic (5.43e-1)" "unprognostic (4.02e-1)" "unprognostic (4.77e-1)" 15.4 16.9 15.1 14.4 15.5 7.6 17.8 14.6 19.3 11.8 13.6 12.0 9.0 9.9 14.4 12.3 17.2 10.8 9.6 18.7 13.9 11.6 13.1 24.6 12.5 11.2 14.4 16.8 10.8 14.5 19.6 13.8 13.6 16.5 12.3 12.3 8.6 13.2 15.1 89.4 13.1 11.3 17.7 15.8 10.9 12.3 15.2 13.5 12.4 14.1 10.9 15.3 14.5 13.6 11.4 17.3 29.3 18.2 13.5 13.9 10.9 29.9 17.8 30.7 15.5 20.0 22.1 9.7 23.2 19.7 25.5 23.1 21.4 14.7 21.9 21.4 25.5 20.2 15.8 24.0 19.8 37.7 5.9 9.1 26.9 16.0 11.9 11.7 23.8 12.4 15.3 25.8 18.3 25.8 12.5 27.8 11.9 18.8 12.7 23.1 14.0 17.2 5.7 13.3 21.2 19.2 17.7 25.5 14.0 11.1 21.1 21.2 12.8 24.9 13.6 20.2 25.1 18.0 14.1 23.7 16.0 17.6 7.8 17.9 12.2 12.3 40.7 22.4 16.7 16.2 15.7 13.1 12.5 12.6 13.4 13.5 11.4 11.2 13.9 17.3 8.8 11.6 11.8 29.3 13.5 18.2 5.5 11.8 10.9 15.1 15.5 14.6 16.7 13.9 11.6 14.4 16.8 16.5 13.5 14.9 28.5 15.2 21.0 36.9 27.4 26.5 25.5 46.8 42.1 14.0 29.5 18.8 11.6 21.1 89.9 29.2 15.5 46.7 28.8 20.9 21.6 27.0 38.1 43.9 20.5 19.1 15.6 26.4 29.7 145.2 20.8 25.2 16.9 25.2 17.0 23.9 27.4 17.5 23.3 16.7 47.9 12.9 33.5 30.1 16.6 39.6 20.8 27.3 10.7 24.2 KPNA2 "IPOA1, QIP2, RCH1, SRP1alpha" ENSG00000182481 "Karyopherin subunit alpha 2" P52292 17 68035519-68046842 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.9" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 663.6;Spermatocytes: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015460, HPA041270" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes 38000 Nucleoplasm Cytosol "CAB015460: AB_831493, HPA041270: AB_2677385" "unprognostic (2.78e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.83e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (5.16e-3)" "prognostic unfavorable (2.12e-10)" "prognostic unfavorable (5.77e-4)" "unprognostic (3.34e-2)" "unprognostic (7.59e-2)" "unprognostic (3.72e-3)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.26e-13)" "unprognostic (3.07e-2)" "unprognostic (1.78e-1)" "unprognostic (9.50e-2)" "prognostic unfavorable (2.19e-4)" 10.6 8.3 10.2 19.5 12.0 38.6 11.9 6.1 13.2 7.4 11.5 6.6 4.3 10.1 8.3 10.4 21.1 6.3 7.9 8.9 11.6 13.2 10.9 11.8 9.1 25.5 10.3 10.3 5.3 4.7 4.5 8.4 16.4 11.4 4.6 14.5 4.0 8.2 4.7 7.2 8.7 10.2 13.2 8.5 14.8 9.7 103.9 9.0 56.6 5.9 20.3 36.8 10.0 8.3 24.6 28.1 16.4 22.6 20.3 17.7 15.0 62.2 81.9 78.2 31.3 11.6 11.3 49.7 55.0 42.7 88.9 69.4 56.3 29.2 58.5 17.4 31.7 44.3 34.5 86.4 42.9 102.4 23.5 50.9 51.8 39.6 53.7 12.2 44.5 35.7 7.0 8.1 51.1 31.5 12.5 85.5 25.0 41.1 42.3 78.8 58.1 55.5 28.7 52.8 50.8 42.5 30.7 71.4 32.0 35.0 29.2 31.1 34.6 30.9 99.8 32.3 74.7 58.1 22.4 33.3 49.3 61.0 34.7 73.9 35.1 50.2 58.4 24.0 38.3 52.9 16.4 16.1 6.6 14.1 22.6 10.9 24.6 10.3 14.4 28.1 19.7 7.9 12.3 1.2 20.3 18.9 21.4 17.7 15.0 10.2 12.0 6.1 13.2 11.6 13.2 10.3 10.3 11.4 9.0 11.9 32.3 47.6 33.0 97.4 19.1 12.6 7.6 8.1 18.2 17.4 7.9 59.0 13.3 31.3 663.6 49.2 9.8 70.0 22.3 244.0 94.4 18.1 43.8 15.3 104.7 30.2 41.1 16.0 36.5 186.9 17.8 52.4 50.6 104.6 9.7 29.4 18.3 10.5 13.8 26.9 17.8 32.3 72.6 296.7 211.0 77.3 99.4 34.5 15.8 20.4 KPNA3 "hSRP1, IPOA4, SRP1gamma, SRP4" ENSG00000102753 "Karyopherin subunit alpha 3" O00505 13 49699307-49792921 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 71.8" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 254.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046852, HPA077643" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046852: AB_2679840, HPA077643: " "unprognostic (4.20e-2)" "prognostic unfavorable (2.80e-4)" "unprognostic (3.69e-2)" "unprognostic (1.23e-1)" "prognostic favorable (2.03e-4)" "unprognostic (6.27e-3)" "unprognostic (6.79e-2)" "unprognostic (9.40e-3)" "unprognostic (1.56e-2)" "unprognostic (4.57e-3)" "unprognostic (3.93e-3)" "unprognostic (4.66e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (9.78e-2)" "unprognostic (7.83e-2)" "unprognostic (5.68e-3)" "unprognostic (4.60e-3)" 12.4 8.0 15.2 9.1 11.8 14.1 12.4 10.9 14.4 8.5 11.4 7.5 8.1 7.0 9.5 6.8 14.5 7.3 8.4 17.2 12.3 11.4 8.0 13.6 9.6 9.4 11.1 11.4 8.1 6.3 9.1 8.1 8.3 13.0 9.4 9.7 5.9 8.3 11.4 71.8 9.0 8.5 14.3 13.2 8.1 8.3 15.1 11.8 11.4 10.9 14.6 10.8 15.0 16.3 6.0 5.0 7.6 6.8 8.1 12.1 4.1 14.1 9.8 18.9 15.8 19.4 21.3 9.5 25.8 21.4 22.7 16.6 29.8 13.2 30.6 5.3 30.0 15.3 16.7 22.5 20.7 38.0 18.3 15.8 22.4 9.7 34.6 18.9 33.4 14.6 15.6 15.1 19.0 25.1 15.0 28.0 12.9 12.3 8.3 31.2 6.5 17.9 18.2 21.8 19.8 6.9 23.5 18.6 9.3 13.9 11.8 7.9 12.6 9.4 11.8 10.2 16.4 7.0 13.5 25.4 16.8 13.7 15.3 17.1 6.7 9.4 27.0 10.2 15.5 16.6 7.6 4.6 4.3 8.6 5.5 12.1 6.0 8.8 8.4 5.0 4.0 8.8 7.9 2.8 8.1 6.8 2.9 10.1 4.1 15.2 11.8 10.9 14.4 12.3 11.4 11.1 11.4 13.0 11.8 62.5 29.8 19.7 23.8 38.2 22.9 70.2 10.2 37.5 25.0 12.2 31.4 13.2 14.9 42.7 254.1 35.9 17.7 23.3 46.6 15.0 28.3 24.7 32.3 33.4 29.7 49.3 29.2 35.0 34.0 136.0 20.4 32.3 18.6 37.9 17.6 46.9 45.4 10.5 47.0 20.9 62.4 25.8 29.3 52.1 29.9 43.5 8.8 27.7 20.2 28.7 KPNA5 "IPOA6, SRP6" ENSG00000196911 "Karyopherin subunit alpha 5" O15131 6 116681187-116741866 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 211.4;Alveolar cells type 2: 181.5;Ciliated cells: 240.9;Club cells: 211.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026464, HPA054037" Enhanced Supported Cytosol NA NA Cytosol "CAB026464: , HPA054037: AB_2682351" "unprognostic (9.64e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-2)" "unprognostic (3.56e-1)" "unprognostic (6.60e-3)" "unprognostic (6.98e-2)" "unprognostic (1.75e-3)" "unprognostic (5.19e-2)" "unprognostic (1.10e-1)" "unprognostic (6.12e-2)" "unprognostic (1.51e-3)" "unprognostic (3.02e-1)" "unprognostic (6.12e-2)" "unprognostic (8.00e-2)" "unprognostic (4.79e-1)" "unprognostic (7.89e-2)" "unprognostic (1.43e-1)" 5.7 6.5 11.9 5.9 12.8 7.5 7.6 24.1 21.2 8.6 6.0 4.3 3.4 4.0 11.2 5.3 6.1 9.8 6.5 5.8 11.0 8.1 6.6 3.6 7.2 10.7 9.0 13.5 22.3 4.4 9.5 19.7 5.6 14.1 8.4 4.5 5.7 4.7 7.1 14.0 4.7 5.6 8.5 12.0 7.4 4.8 46.6 8.2 10.9 12.2 3.9 7.3 6.4 7.4 18.0 10.5 11.9 4.0 6.3 16.6 2.9 2.5 1.5 11.0 6.8 4.2 7.9 4.5 3.8 10.6 6.7 9.5 7.1 2.6 9.2 5.0 4.1 7.6 4.2 5.8 3.4 8.7 5.8 15.8 8.8 4.6 4.0 5.2 6.8 5.5 7.0 2.1 8.2 4.8 7.9 7.6 9.3 12.9 4.0 7.4 3.4 10.5 4.7 4.9 1.7 4.1 8.7 3.6 2.6 5.1 5.0 11.5 11.0 2.9 2.3 3.6 7.5 4.6 6.7 6.0 2.8 5.7 2.9 6.6 10.4 11.3 10.7 3.1 4.8 5.8 11.9 3.1 3.7 8.8 3.2 10.9 14.9 10.0 10.3 1.6 18.0 16.6 12.1 0.8 6.3 4.0 10.5 7.3 2.9 11.9 12.8 24.1 21.2 11.0 8.1 9.0 13.5 14.1 8.2 211.4 181.5 19.3 7.0 12.0 45.3 13.6 10.2 240.9 211.5 8.7 27.5 3.3 8.3 5.3 34.2 15.8 1.4 0.0 4.7 1.5 10.8 7.1 119.7 4.2 3.8 44.5 32.4 16.0 5.4 5.9 16.4 10.4 10.1 4.6 6.8 34.6 4.2 0.0 15.6 4.2 36.7 12.9 7.2 60.3 9.8 7.9 2.7 12.5 3.5 2.6 KPNA6 "FLJ11249, IPOA7, KPNA7, MGC17918" ENSG00000025800 "Karyopherin subunit alpha 6" O60684 1 32108038-32176568 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 204.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018863 Supported Approved Nucleoplasm,Cytosol NA NA 11000 Cytosol Nucleoplasm "HPA018863: AB_1852632" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.30e-2)" "unprognostic (8.35e-2)" "unprognostic (7.34e-2)" "prognostic unfavorable (9.28e-5)" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.51e-2)" "unprognostic (3.18e-1)" "unprognostic (5.32e-2)" "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.80e-1)" "unprognostic (1.57e-2)" 16.1 18.7 24.6 14.6 19.0 22.9 18.1 23.9 25.2 16.3 18.8 15.7 23.0 11.5 21.3 17.5 21.4 15.9 12.1 23.4 22.7 18.2 18.3 18.0 17.3 13.2 15.4 19.8 16.9 17.1 40.9 18.0 23.5 29.7 17.6 17.3 14.1 16.2 19.8 54.0 20.5 14.2 23.1 29.2 14.8 17.4 22.2 17.6 12.6 17.8 14.5 18.3 17.9 17.8 9.1 9.3 9.5 12.5 5.0 11.2 6.4 17.0 13.5 12.1 15.5 18.6 16.4 14.2 13.8 16.3 20.2 19.6 15.0 18.7 14.3 16.4 24.8 12.2 14.8 18.5 21.1 25.9 14.4 10.2 14.7 20.8 12.1 16.5 16.1 12.1 16.5 20.1 25.0 24.0 17.1 21.0 11.3 14.2 13.2 19.1 9.4 13.0 9.2 28.1 11.1 10.1 13.1 17.4 11.7 17.6 15.7 11.6 9.8 25.1 15.1 13.4 30.9 10.6 8.6 24.4 18.8 13.0 24.4 19.8 9.5 10.8 11.3 20.5 15.1 17.9 4.0 10.2 9.5 11.2 12.5 11.0 7.8 9.7 8.7 8.3 9.1 11.2 10.8 6.0 5.0 12.5 9.3 9.6 6.4 24.6 19.0 23.9 25.2 22.7 18.2 15.4 19.8 29.7 17.6 38.7 37.4 43.4 31.3 56.4 47.6 28.5 33.1 40.2 21.6 27.9 55.0 38.1 14.9 32.5 204.0 37.9 20.6 0.0 27.4 36.4 38.2 41.3 12.8 56.3 26.8 49.3 44.3 35.6 32.3 48.0 31.7 26.8 23.6 28.9 37.1 29.8 38.9 17.5 38.2 28.3 40.5 32.3 29.9 55.9 52.6 74.4 113.5 32.6 29.2 51.1 KPNB1 "IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97" ENSG00000108424 "Karyopherin subunit beta 1" Q14974 17 47649476-47685505 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 28.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029878, CAB034449, HPA050302" Supported Enhanced "Nucleoplasm,Nuclear membrane,Cytosol" Yes No 5500000 "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079" "unprognostic (2.57e-1)" "unprognostic (1.15e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (2.55e-7)" "unprognostic (7.18e-3)" "unprognostic (9.52e-2)" "unprognostic (5.47e-3)" "unprognostic (4.37e-2)" "unprognostic (8.41e-3)" "prognostic unfavorable (8.43e-6)" "unprognostic (1.34e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (3.44e-2)" 38.0 42.1 31.9 46.1 30.7 22.1 33.3 32.9 33.5 37.6 37.9 29.7 39.9 24.5 39.3 35.4 51.2 33.1 35.0 43.5 28.1 30.5 33.8 48.8 35.8 50.5 31.6 35.3 47.2 32.3 42.3 29.4 34.6 34.9 36.1 39.3 23.7 35.2 45.9 74.6 31.7 32.1 40.7 36.6 50.3 35.7 62.4 34.8 47.6 37.0 34.3 62.8 50.8 47.5 5.4 4.0 28.2 3.9 3.7 6.3 2.8 43.7 74.6 47.5 43.1 23.0 40.0 47.7 52.2 46.8 68.5 53.9 130.2 26.1 56.5 35.7 48.7 48.3 31.0 85.7 48.1 104.1 34.7 52.3 62.4 60.2 40.7 23.7 70.6 41.1 32.4 21.2 78.6 77.1 29.2 45.1 31.5 70.5 38.7 52.9 47.6 65.4 21.2 45.2 29.9 47.2 40.6 84.0 32.9 28.1 62.7 41.8 38.8 35.7 19.2 30.2 59.2 41.5 27.3 37.5 74.9 46.5 38.9 63.2 47.4 54.7 81.0 31.9 34.2 54.9 4.3 3.5 7.1 4.9 3.6 6.3 5.4 5.5 5.5 2.1 5.1 5.2 4.9 28.2 3.7 3.9 4.0 4.0 2.8 31.9 30.7 32.9 33.3 28.1 30.5 31.6 35.3 34.9 34.8 119.1 66.6 108.8 81.6 111.6 93.4 119.7 66.2 52.2 73.9 41.8 64.8 98.4 34.9 106.8 32.0 100.4 53.1 46.7 102.8 118.0 87.0 86.2 75.0 80.5 109.7 76.3 118.8 122.8 99.2 31.1 89.8 89.3 57.3 151.5 71.7 76.6 115.8 60.4 114.2 42.9 82.7 97.0 78.3 276.1 166.5 125.5 132.3 92.4 98.1 114.9 KRBA1 KIAA1862 ENSG00000133619 "KRAB-A domain containing 1" A5PL33 7 149714781-149734575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 30.6" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 8.9;Muller glia cells: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021237, HPA050448" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021237: AB_2134145, HPA050448: AB_2681129" "unprognostic (2.19e-2)" "unprognostic (9.01e-2)" "unprognostic (8.06e-2)" "unprognostic (7.48e-3)" "unprognostic (6.75e-3)" "unprognostic (5.59e-2)" "unprognostic (1.01e-5)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (1.42e-1)" "prognostic favorable (2.77e-4)" "unprognostic (2.55e-1)" "unprognostic (6.33e-3)" "unprognostic (9.62e-2)" "unprognostic (4.29e-2)" "unprognostic (1.47e-1)" "unprognostic (9.31e-2)" 3.8 4.6 5.6 6.2 8.1 4.7 5.6 8.7 12.8 5.2 5.2 7.6 11.0 2.2 7.8 4.9 5.5 5.2 5.8 30.6 6.7 5.2 5.3 2.2 4.5 5.7 6.3 9.0 7.9 7.0 9.7 16.9 3.1 7.1 6.0 1.9 9.4 17.2 9.5 7.4 6.4 3.6 8.5 5.1 6.4 5.0 5.7 6.5 2.5 4.3 5.5 4.8 5.0 5.3 4.1 3.7 1.3 3.7 0.3 4.2 1.7 6.2 3.9 7.8 16.2 3.5 3.5 6.8 3.3 4.2 5.4 6.2 0.4 1.7 1.9 7.1 4.2 11.0 6.2 5.8 11.2 2.7 8.7 11.0 3.5 5.0 3.6 4.4 0.0 9.8 7.7 5.3 3.7 2.0 6.4 4.9 10.5 14.1 2.0 2.7 2.4 9.0 5.3 9.3 2.9 3.8 9.5 3.1 1.0 4.1 5.0 6.2 10.4 5.1 14.9 3.5 3.7 2.6 5.4 5.0 6.6 2.9 0.0 4.6 9.6 3.1 8.4 3.9 6.0 6.8 0.0 1.8 0.4 3.8 1.7 2.6 1.8 1.9 2.2 2.6 4.1 3.4 2.9 1.3 0.3 3.7 3.7 4.2 1.7 5.6 8.1 8.7 12.8 6.7 5.2 6.3 9.0 7.1 6.5 0.0 2.7 1.5 2.1 1.5 6.3 8.9 0.0 0.0 0.0 3.5 3.9 0.9 0.0 4.5 0.5 0.9 0.0 0.0 2.3 1.9 2.3 2.2 0.0 0.8 4.2 7.9 0.0 0.6 3.0 0.9 3.7 1.1 0.0 1.0 0.0 11.2 1.2 0.0 3.2 1.5 4.4 6.5 1.7 0.7 3.6 1.6 1.0 1.0 0.0 1.5 KRCC1 FLJ22333 ENSG00000172086 "Lysine rich coiled-coil 1" Q9NPI7 2 88027205-88055729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045618, HPA052666" Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA045618: AB_10960406, HPA052666: AB_2681907" "unprognostic (7.37e-3)" "unprognostic (1.30e-1)" "unprognostic (2.09e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (2.59e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "unprognostic (4.83e-2)" "unprognostic (2.22e-1)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-3)" 22.5 15.0 23.1 30.6 27.3 5.7 25.9 23.5 20.4 23.3 29.9 15.8 19.9 20.7 17.8 29.1 26.4 18.4 16.5 21.4 27.0 15.7 21.5 28.1 23.4 22.3 30.3 15.2 20.3 19.4 24.8 23.8 17.3 23.8 24.0 29.7 12.1 20.8 37.9 23.0 16.7 28.9 24.7 28.2 22.0 17.5 10.0 29.9 20.2 26.9 14.5 20.5 22.1 20.2 18.3 12.7 37.2 11.6 14.8 16.5 8.0 11.5 7.1 11.2 8.2 27.1 32.1 8.3 18.3 20.5 9.8 9.7 0.6 15.6 16.4 6.6 11.6 15.0 6.0 2.5 3.8 11.1 17.2 3.5 3.1 1.9 1.1 19.8 4.7 2.2 16.0 19.1 6.5 14.1 25.7 11.0 13.3 4.4 8.2 21.1 9.8 5.4 6.6 8.5 16.8 4.8 11.1 2.0 1.7 14.8 6.3 8.7 8.8 7.0 9.7 21.3 8.7 6.8 19.6 15.3 11.7 0.8 19.1 5.7 18.7 13.0 13.1 12.5 12.7 27.4 24.7 11.0 37.2 10.1 11.6 11.7 18.3 12.4 12.3 12.7 16.9 14.2 11.2 17.9 14.8 10.0 11.2 16.5 8.0 23.1 27.3 23.5 20.4 27.0 15.7 30.3 15.2 23.8 29.9 32.8 32.4 29.1 30.1 29.3 9.3 36.0 35.7 69.6 47.8 33.2 2.0 40.4 51.4 41.9 2.6 25.4 58.0 0.0 62.9 15.7 37.7 49.3 41.6 47.4 42.5 9.5 40.0 35.6 34.9 3.1 44.3 35.7 27.0 47.7 57.8 33.8 42.5 69.1 40.7 60.7 5.4 19.4 29.2 38.7 19.0 37.3 35.0 34.6 65.3 23.8 KREMEN1 "KREMEN, KRM1" ENSG00000183762 "Kringle containing transmembrane protein 1" Q96MU8 22 29073078-29168333 "Disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "RH-30: 18.3;U-2197: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058513 Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No 400000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA058513: AB_2683739" 5.2 11.8 7.1 6.8 17.8 2.7 5.8 5.0 6.9 9.6 9.6 7.6 25.7 4.9 6.0 13.2 27.8 8.6 5.0 16.8 8.3 3.6 10.5 3.2 8.3 9.1 5.2 4.3 17.4 3.4 16.3 8.0 7.2 4.2 7.1 8.5 21.2 35.4 20.6 18.9 26.5 8.1 4.7 3.0 13.9 6.4 14.5 6.8 19.0 17.1 33.4 20.0 5.9 10.0 0.7 1.2 9.0 0.6 0.8 0.4 0.2 2.6 1.8 6.2 3.2 2.1 6.4 5.3 0.7 6.2 2.0 3.0 8.4 1.2 0.1 2.4 2.9 5.1 12.8 12.8 5.1 2.2 3.1 8.1 0.7 0.9 7.9 2.2 0.1 0.7 6.2 10.4 2.2 1.2 0.9 0.3 5.2 2.7 0.2 2.5 2.2 0.0 0.8 0.3 17.3 1.4 0.4 18.3 0.2 2.2 4.9 12.5 7.0 7.3 2.6 9.6 2.1 9.7 0.4 0.2 8.4 2.6 31.2 0.9 0.6 0.2 0.2 5.3 1.1 9.7 2.1 0.6 0.3 0.3 0.5 0.3 0.3 0.3 0.2 0.1 0.7 0.4 0.4 9.0 0.8 0.4 1.2 0.2 0.2 7.1 17.8 5.0 6.9 8.3 3.6 5.2 4.3 4.2 6.8 14.9 20.2 0.0 11.3 13.6 3.3 19.9 7.6 16.0 26.1 7.0 0.0 11.2 1.7 4.8 2.5 4.1 2.6 0.0 3.6 1.2 9.9 8.7 18.5 2.4 2.3 0.0 0.0 6.7 17.9 7.7 16.4 3.9 0.0 2.8 16.3 29.9 3.3 5.5 9.9 4.4 2.7 12.9 4.2 7.7 6.4 16.9 4.5 2.2 7.3 8.9 KRT18 ENSG00000111057 "Keratin 18" P05783 12 52948871-52952901 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 268.7" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 6515.6;Exocrine glandular cells: 4232.0;Extravillous trophoblasts: 4401.0;Pancreatic endocrine cells: 4358.9;Syncytiotrophoblasts: 6392.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 10.0" "Cell type enriched" "Detected in many" 5 "basophil: 28.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 28.6" "Cell line enhanced" "Detected in many" "A549: 228.6;BEWO: 144.3;CACO-2: 251.4;CAPAN-2: 182.6;MCF7: 334.7;SK-BR-3: 185.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000008, CAB000030, HPA001605" Enhanced Supported Cytosol NA NA 140000000 Cytosol "CAB000008: , CAB000030: , HPA001605: AB_2666381" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.25e-1)" "unprognostic (7.26e-3)" "unprognostic (4.09e-3)" "prognostic unfavorable (5.06e-4)" "unprognostic (8.81e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (3.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.19e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" 23.3 4.8 1.0 31.0 1.1 0.0 24.1 2.9 1.2 28.6 45.4 1.3 66.3 35.0 6.6 55.3 22.4 21.7 147.4 6.8 1.1 2.5 61.9 181.0 39.6 2.8 1.2 1.0 13.7 162.9 8.2 39.8 268.7 10.0 29.3 57.0 14.1 121.1 49.9 1.3 6.5 83.6 3.9 1.4 4.4 36.0 9.5 0.8 4.2 83.4 10.8 20.9 21.5 10.8 4.1 1.0 28.6 0.1 1.0 5.9 1.6 76.6 228.6 0.0 0.3 0.0 0.0 144.3 11.6 14.2 15.1 4.3 251.4 182.6 0.0 32.5 12.6 7.9 18.8 3.2 88.6 9.1 0.0 5.4 0.7 37.4 69.1 39.1 0.0 0.0 0.5 8.3 13.2 18.2 43.2 16.1 0.1 18.5 0.0 0.0 334.7 0.1 1.4 18.6 107.6 17.3 0.1 0.0 8.7 73.6 46.3 2.6 0.1 18.9 185.1 0.7 116.4 97.7 0.2 5.1 0.2 17.6 0.2 2.6 0.0 0.2 0.1 0.0 0.0 1.4 28.6 0.1 1.1 0.2 0.1 1.1 2.1 2.3 0.6 1.0 4.1 5.9 2.1 1.5 1.0 0.0 0.0 0.2 1.6 1.0 1.1 2.9 1.2 1.1 2.5 1.2 1.0 10.0 0.8 801.0 239.7 47.5 1382.6 13.2 0.0 4.9 1332.4 459.0 466.3 591.5 0.0 2872.9 233.8 6515.6 0.9 56.4 1517.2 0.0 4232.0 4401.0 68.2 910.9 48.4 492.5 270.7 1.6 616.3 87.8 9.9 2.3 9.8 37.0 197.4 71.3 2268.9 5.8 4358.9 1644.8 0.0 407.9 0.5 0.0 45.3 1.6 5.9 5.8 6392.2 10.7 1202.1 1262.3 KRT2 "KRT2A, KRTE" ENSG00000172867 "Keratin 2" P35908 12 52644558-52652164 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 289.9" "Cell type enriched" "Detected in some" 15 "Suprabasal keratinocytes: 232.0" "Group enriched" "Detected in some" 35 "head and neck cancer: 4.7;melanoma: 23.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 45 "T-cells: 4.4" "Group enriched" "Detected in some" 4 "HEL: 6.3;HMC-1: 2.7;JURKAT: 2.4;OE19: 2.9" "Group enriched" "Detected in some" 6 "amygdala: 1.8;hippocampal formation: 2.9" "Not detected" "Not detected" "HPA006299, CAB037321" Enhanced Approved "Golgi apparatus,Intermediate filaments,Cytosol" NA NA 14000000000 "Intermediate filaments, Cytosol" "Golgi apparatus" "CAB037321: , HPA006299: AB_1079180" "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (8.47e-3)" "unprognostic (1.69e-2)" "unprognostic (1.84e-1)" "unprognostic (3.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.76e-2)" "unprognostic (3.56e-7)" "unprognostic (6.43e-2)" "unprognostic (5.98e-3)" "unprognostic (6.69e-2)" "unprognostic (3.46e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 9.5 0.1 0.1 18.3 0.1 0.1 0.1 0.0 2.0 0.1 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.4 289.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 6.8 0.1 19.2 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 4.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 4.4 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 15.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.2 0.6 0.8 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.0 0.1 0.0 0.1 0.0 KRT20 "CK20, K20, MGC35423" ENSG00000171431 "Keratin 20" P35900 17 40875941-40885227 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 232.0" "Cell type enhanced" "Detected in some" 29 "Enterocytes: 974.5;Mucus-secreting cells: 369.1;Paneth cells: 1841.1" "Group enriched" "Detected in many" 6 "colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.4;BEWO: 2.7;NB-4: 2.4;RPMI-8226: 2.8;RT4: 7.4;SH-SY5Y: 2.3" "Region enhanced" "Detected in single" "basal ganglia: 0.7" "Not detected" "Not detected" "CAB000032, HPA024309, HPA024684, HPA027236" Enhanced Supported Cytosol NA NA 34000000 Cytosol "CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224" "unprognostic (3.49e-1)" "unprognostic (3.13e-1)" "unprognostic (1.71e-1)" "unprognostic (6.38e-3)" "unprognostic (5.12e-2)" "unprognostic (2.66e-3)" "prognostic unfavorable (7.05e-4)" "unprognostic (2.63e-2)" "unprognostic (4.87e-3)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.71e-2)" "unprognostic (6.30e-2)" "unprognostic (7.27e-2)" 0.2 0.1 0.2 38.0 0.2 0.0 0.2 0.2 0.2 0.2 75.5 0.2 0.2 40.4 0.2 0.2 0.3 0.3 3.9 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.3 45.0 0.2 0.3 0.2 0.2 0.2 232.0 2.7 0.2 0.2 13.6 0.2 0.2 0.2 0.2 0.3 0.2 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.2 0.1 0.0 0.0 2.8 0.0 7.4 0.4 2.3 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 974.5 0.0 0.0 0.0 0.0 1.4 13.8 0.0 0.1 0.0 42.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 369.1 0.0 0.0 1841.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 43.8 1.7 KRT23 "CK23, DKFZP434G032, HAIK1, K23, MGC26158" ENSG00000108244 "Keratin 23" Q9C075 17 40922696-40937634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.3;salivary gland: 99.8;skin 1: 48.2" "Cell type enhanced" "Detected in many" 24 "Basal glandular cells: 835.0;Cytotrophoblasts: 634.9;Glandular cells: 639.4;Syncytiotrophoblasts: 3253.9;Urothelial cells: 1153.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 12 "neutrophil: 30.1" "Lineage enriched" "Detected in single" 70 "granulocytes: 30.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 21.1;Hep G2: 13.1;SuSa: 7.6;T-47d: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA012050, HPA016959, CAB017091" Approved Approved "Intermediate filaments,Cytosol" NA NA 170000 "Intermediate filaments" Cytosol "CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228" "unprognostic (1.62e-1)" "unprognostic (5.29e-2)" "unprognostic (4.35e-2)" "unprognostic (6.18e-3)" "unprognostic (1.45e-2)" "unprognostic (2.83e-1)" "unprognostic (5.22e-2)" "unprognostic (6.84e-3)" "unprognostic (2.74e-1)" "unprognostic (2.15e-2)" "unprognostic (8.96e-2)" "unprognostic (1.56e-1)" "unprognostic (8.22e-2)" "unprognostic (6.78e-2)" "unprognostic (1.40e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (8.26e-4)" 0.3 0.0 0.2 0.5 0.2 0.5 10.0 0.3 0.3 9.8 0.2 0.2 2.1 0.0 1.1 1.2 2.5 1.5 4.5 0.2 0.2 0.0 0.3 0.6 1.1 0.6 0.2 0.2 0.6 1.2 0.0 0.9 128.3 0.2 6.9 0.0 0.3 99.8 2.8 0.3 48.2 0.2 0.3 0.2 1.0 0.0 9.1 0.2 2.0 0.3 11.7 9.5 2.3 3.2 0.0 0.0 30.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.3 0.0 0.0 0.6 0.0 21.1 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 7.6 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 2.2 0.0 835.0 4.0 0.0 0.3 20.4 21.4 10.3 3.5 0.0 634.9 1.7 211.1 47.4 0.7 0.0 0.0 0.7 68.7 0.5 639.4 0.0 0.0 56.0 0.0 6.8 0.0 0.0 5.4 0.6 0.7 5.0 7.2 0.0 11.8 19.4 0.0 0.7 0.0 0.2 0.0 0.4 29.7 0.7 7.0 3253.9 0.0 0.0 1153.1 KRT24 "FLJ20261, MGC138169, MGC138173" ENSG00000167916 "Keratin 24" Q2M2I5 17 40697991-40703750 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 4.0;Extravillous trophoblasts: 1.2;Leydig cells: 2.8;Syncytiotrophoblasts: 3.3" "Cancer enhanced" "Detected in some" "head and neck cancer: 15.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "T-reg: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Cell line enriched" "Detected in single" 14 "SK-BR-3: 12.8" "Region enriched" "Detected in single" 18 "cerebellum: 1.1" "Not detected" "Not detected" HPA022978 Uncertain Approved "Intermediate filaments,Cytosol" No NA "Intermediate filaments, Cytosol" "HPA022978: AB_1852230" "unprognostic (2.74e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (3.75e-1)" "unprognostic (2.74e-1)" "unprognostic (2.95e-1)" "unprognostic (3.37e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 9.2 4.1 0.0 0.0 0.0 0.7 9.3 62.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 48.6 0.0 0.1 3.1 0.0 1.2 0.8 0.1 0.1 0.2 3.4 0.1 0.1 1.1 0.1 0.0 0.0 0.1 1.4 68.9 0.6 3.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 KRT7 "CK7, K2C7, K7, SCL" ENSG00000135480 "Keratin 7" P08729 12 52232520-52252186 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 3055.9;Exocrine glandular cells: 1910.6;Extravillous trophoblasts: 3534.8;Pancreatic endocrine cells: 3941.8;Urothelial cells: 1796.1" "Cancer enhanced" "Detected in many" "urothelial cancer: 560.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 3.8" "Lineage enriched" "Detected in single" 5 "monocytes: 3.8" "Cell line enhanced" "Detected in some" "BEWO: 120.3;HBEC3-KT: 267.7;hTERT-HME1: 108.0;RT4: 319.2;SiHa: 251.7;SK-BR-3: 147.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000028, HPA007272, HPA007315" Enhanced Supported "Intermediate filaments,Cytosol" NA NA 350000000 "Intermediate filaments" Cytosol "CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: " "unprognostic (2.71e-3)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (1.27e-1)" "unprognostic (5.44e-3)" "unprognostic (2.74e-1)" "prognostic unfavorable (9.42e-5)" "prognostic unfavorable (7.78e-5)" "unprognostic (4.54e-2)" "prognostic favorable (2.77e-9)" "unprognostic (2.82e-1)" "unprognostic (1.43e-2)" "unprognostic (3.28e-1)" "unprognostic (3.98e-3)" 3.5 0.2 0.2 0.6 0.2 0.0 43.1 0.2 0.2 7.8 0.5 0.1 18.0 0.0 1.7 9.6 14.4 11.7 27.1 1.2 0.2 0.2 35.0 4.3 63.2 0.0 0.2 0.2 3.3 15.1 1.7 2.1 156.6 0.6 23.1 0.0 0.1 142.6 67.3 0.4 10.7 0.3 4.3 0.3 0.2 2.3 4.3 0.0 0.4 199.7 6.1 16.3 58.2 22.3 0.0 0.8 0.0 3.8 0.0 0.0 0.2 0.1 101.9 0.0 0.0 0.1 0.0 120.3 21.9 0.0 11.5 1.0 0.3 72.7 0.0 0.0 7.5 0.0 80.2 0.0 267.7 0.5 0.1 0.0 0.0 54.7 0.3 2.5 0.0 0.0 0.0 16.7 0.0 108.0 0.0 11.5 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 0.1 0.0 0.2 1.6 66.1 319.2 0.1 0.1 251.7 147.0 0.0 1.2 5.6 0.0 87.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.0 607.4 92.0 0.0 937.0 3.2 0.0 0.8 743.9 127.2 357.2 342.0 0.0 1328.4 114.4 3055.9 12.2 11.7 0.2 0.0 1910.6 3534.8 10.3 851.4 3.5 0.9 166.7 0.0 6.3 7.4 5.2 97.2 3.4 6.2 124.9 61.3 2.1 0.0 3941.8 0.0 0.4 2.8 0.0 0.0 7.2 0.7 0.5 1.9 1206.3 1.8 0.6 1796.1 KRT75 K6HF ENSG00000170454 "Keratin 75" O95678 12 52424070-52434525 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skin 1: 22.9;tongue: 18.8" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 2.5;Ductal cells: 1.2;Early spermatids: 2.0;Late spermatids: 1.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 36.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "PC-3: 22.2;U-2 OS: 29.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019367, HPA076201" Enhanced Approved "Plasma membrane,Cytosol" NA NA 2200000000 Cytosol "Plasma membrane" "HPA019367: AB_1852239, HPA076201: AB_2686786" "unprognostic (2.83e-2)" "unprognostic (2.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (8.85e-3)" "unprognostic (2.67e-1)" "unprognostic (2.17e-2)" "unprognostic (1.72e-1)" "unprognostic (6.60e-2)" "unprognostic (9.20e-2)" "unprognostic (5.19e-2)" "unprognostic (2.45e-1)" "unprognostic (8.98e-2)" "unprognostic (1.94e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.1 0.0 0.4 0.0 3.5 0.0 18.8 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 KRT79 "K6L, KRT6L" ENSG00000185640 "Keratin 79" Q5XKE5 12 52821410-52834295 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 11.3;skin 1: 34.3" "Group enriched" "Detected in some" 5 "granulocytes: 4.6;Melanocytes: 3.3" "Group enriched" "Detected in some" 5 "breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "HMC-1: 99.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA059347 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA 950000000 "Nucleoplasm, Nuclear membrane, Cytosol" "HPA059347: AB_2683986" "unprognostic (5.19e-3)" "unprognostic (1.56e-3)" "unprognostic (5.24e-2)" "unprognostic (2.38e-2)" "unprognostic (6.85e-2)" "unprognostic (6.36e-2)" "unprognostic (3.17e-1)" "unprognostic (7.92e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-2)" "unprognostic (1.32e-1)" "unprognostic (2.72e-1)" "unprognostic (3.99e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 4.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 34.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 11.3 0.1 0.1 0.2 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 99.9 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 KRT86 "Hb6, KRTHB6, MNX" ENSG00000170442 "Keratin 86" O43790 12 52249300-52309163 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 31.5;skin 1: 60.4;testis: 23.0" "Group enriched" "Detected in some" 5 "Early spermatids: 21.8;Late spermatids: 19.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "basophil: 31.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 31.5" "Cell line enhanced" "Detected in some" "A-431: 13.9;A549: 14.7;hTERT-RPE1: 7.5;MCF7: 28.9;RPMI-8226: 18.2;U-251 MG: 8.1" "HPA039798, HPA049778" Supported Approved Cytosol NA NA 240000000 Cytosol "HPA039798: AB_10674986, HPA049778: AB_2680877" "unprognostic (4.52e-2)" "unprognostic (6.83e-2)" "unprognostic (3.16e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (2.61e-2)" "unprognostic (6.49e-2)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.22e-2)" 0.8 0.3 0.2 0.1 0.2 3.5 0.9 0.5 1.1 0.4 0.3 0.1 1.0 0.6 0.6 2.4 0.3 1.1 1.0 0.1 0.2 0.3 3.8 0.2 1.0 0.1 0.3 0.1 0.6 7.9 0.0 0.2 0.6 0.3 0.5 0.0 0.3 6.3 0.4 1.5 60.4 0.2 0.1 0.7 0.1 0.2 23.0 0.1 0.1 7.6 0.1 0.3 1.2 0.2 0.0 0.0 31.5 0.0 3.8 0.0 0.2 13.9 14.7 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.2 0.0 0.1 0.7 0.0 0.6 0.0 0.3 0.9 0.0 2.6 0.0 6.1 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 7.5 0.0 0.0 0.0 1.0 0.0 28.9 0.0 1.6 0.0 0.1 3.5 0.0 0.0 18.2 0.2 1.8 1.7 0.0 2.6 1.1 1.1 0.0 0.8 0.0 0.4 0.0 0.7 0.0 8.1 0.0 0.0 0.0 0.0 3.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.5 0.2 0.3 0.3 0.1 0.3 0.1 0.0 1.1 0.0 3.2 0.6 0.2 0.4 2.5 0.0 1.2 0.0 0.0 0.1 0.0 2.0 21.8 0.0 0.0 0.0 4.2 1.4 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.3 0.0 1.7 0.0 0.0 0.2 2.9 0.0 0.0 0.5 0.1 0.0 0.3 0.7 0.3 0.1 1.0 3.2 0.0 3.1 KRTAP25-1 KAP25.1 ENSG00000232263 "Keratin associated protein 25-1" Q3LHN0 21 30289145-30289514 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031438 Uncertain Approved "Nuclear membrane,Plasma membrane,Cytosol" NA NA "Nuclear membrane" "Plasma membrane, Cytosol" "HPA031438: AB_10610000" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTCAP3 KCP3 ENSG00000157992 "Keratinocyte associated protein 3" Q53RY4 2 27442366-27446481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.8" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 157.5;Undifferentiated cells: 162.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8" "Group enriched" "Detected in many" 19 "B-cells: 5.4;T-cells: 7.0" "Cell line enhanced" "Detected in some" "A-431: 28.1;CAPAN-2: 32.2;HaCaT: 10.3;OE19: 14.3;SCLC-21H: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047136, HPA060203" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA047136: AB_2679949, HPA060203: AB_2684221" "prognostic favorable (2.67e-5)" "unprognostic (5.93e-2)" "unprognostic (5.03e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.04e-1)" "unprognostic (3.73e-3)" "unprognostic (3.79e-2)" "unprognostic (8.21e-2)" "unprognostic (9.42e-3)" 0.9 1.0 0.5 10.0 0.8 0.5 6.3 1.3 1.7 4.6 24.4 0.7 13.3 16.2 1.5 3.2 8.5 9.8 16.5 1.7 0.7 0.3 4.8 6.5 11.8 1.9 0.7 1.4 2.7 28.8 3.3 6.9 1.5 1.5 9.7 6.2 1.9 17.4 22.6 1.0 4.9 34.8 0.9 0.9 1.0 16.7 1.8 0.8 2.3 12.3 6.9 5.4 7.6 4.5 5.4 0.0 0.1 0.0 0.3 7.0 1.8 28.1 0.2 0.7 0.5 0.0 0.0 5.9 0.0 0.0 0.0 0.1 9.0 32.2 0.2 0.2 0.0 0.0 10.3 0.2 7.3 0.0 0.2 0.2 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.1 0.0 0.7 0.3 0.1 0.0 7.5 0.3 1.9 6.1 14.3 0.1 0.1 0.2 0.7 0.0 0.0 15.1 0.5 0.4 9.4 0.6 0.5 0.2 0.2 0.0 0.3 0.7 0.3 0.2 1.6 1.1 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.6 0.0 6.9 5.4 6.2 3.2 0.0 4.6 7.0 3.3 0.0 0.3 0.0 0.0 4.8 1.8 0.5 0.8 1.3 1.7 0.7 0.3 0.7 1.4 1.5 0.8 20.8 18.0 3.7 106.9 20.7 2.6 0.2 86.6 56.2 43.3 40.1 7.9 15.0 5.0 85.6 4.7 0.8 81.3 0.0 157.5 26.3 1.5 101.7 4.6 12.1 1.8 1.6 59.7 1.3 0.6 3.6 0.3 1.8 6.8 4.6 108.5 1.5 121.7 98.2 0.0 4.9 5.9 0.0 1.0 2.7 33.8 13.6 6.6 1.0 162.2 123.8 KXD1 "BORCS4, C19orf50, FLJ25480, KXDL, MGC2749" ENSG00000105700 "KxDL motif containing 1" Q9BQD3 19 18557762-18569387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041507, HPA041599" Approved Approved "Nucleoli fibrillar center,Centrosome,Cytosol" NA NA "Nucleoli fibrillar center, Centrosome, Cytosol" "HPA041507: AB_10795698, HPA041599: AB_10795502" "unprognostic (8.48e-2)" "unprognostic (5.30e-2)" "unprognostic (3.16e-3)" "unprognostic (1.35e-1)" "unprognostic (8.60e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (8.46e-4)" "unprognostic (7.36e-2)" "unprognostic (1.81e-2)" "unprognostic (5.25e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (7.71e-10)" "unprognostic (7.55e-2)" "unprognostic (2.29e-1)" "unprognostic (6.45e-2)" "unprognostic (1.63e-1)" 52.9 42.2 47.2 48.7 44.9 49.1 42.8 28.4 60.9 37.2 44.5 56.7 34.3 43.7 48.9 43.2 45.9 45.6 44.1 43.2 43.3 41.8 39.6 73.3 42.2 56.1 46.7 34.2 52.3 58.9 33.6 48.2 53.7 43.7 46.6 43.2 40.0 60.4 45.4 58.3 46.8 39.9 49.3 56.2 48.3 44.5 75.4 38.9 42.1 47.0 45.5 53.2 57.2 54.0 26.9 37.1 41.3 46.4 29.7 37.6 30.6 33.3 33.8 27.7 31.5 28.8 33.3 45.4 37.0 29.8 27.7 32.2 27.6 40.0 23.1 43.6 32.9 23.1 25.5 42.6 45.3 25.0 27.9 60.1 25.3 26.4 24.9 33.3 39.4 27.8 35.3 32.3 41.6 49.8 30.3 39.2 31.4 39.2 36.5 28.8 38.8 35.4 29.0 34.9 41.9 51.7 34.2 21.8 33.6 28.2 30.6 25.8 33.2 24.2 21.7 31.0 30.3 18.4 27.2 31.8 25.0 22.0 79.8 48.0 43.5 32.4 34.5 43.2 46.4 36.1 15.0 41.0 35.0 29.8 46.4 27.7 26.9 27.6 29.5 37.1 26.4 22.2 24.2 41.3 29.7 43.4 22.1 37.6 30.6 47.2 44.9 28.4 60.9 43.3 41.8 46.7 34.2 43.7 38.9 17.9 34.3 40.9 62.3 30.7 19.6 4.2 28.1 18.7 25.0 15.7 11.8 92.1 68.0 73.5 155.9 50.4 48.5 23.3 98.7 103.8 57.5 68.0 42.7 30.5 108.5 15.9 41.3 44.8 50.9 25.8 31.1 50.7 55.6 151.5 43.0 22.9 81.0 40.7 27.6 42.9 16.0 38.8 55.6 29.3 19.8 36.3 93.3 49.0 44.2 59.1 KYAT1 "CCBL1, GTK, KATI" ENSG00000171097 "Kynurenine aminotransferase 1" Q16773 9 128832942-128882494 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 5.3;Cytotrophoblasts: 3.4;Distal tubular cells: 3.3;Proximal tubular cells: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021176, HPA021177, HPA027736" Approved Supported Cytosol NA NA 21000 Cytosol "HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818" "unprognostic (6.51e-2)" "unprognostic (8.67e-3)" "unprognostic (1.05e-2)" "unprognostic (5.98e-3)" "unprognostic (2.15e-2)" "unprognostic (5.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-2)" "unprognostic (2.47e-1)" "unprognostic (8.60e-3)" "unprognostic (1.43e-1)" "unprognostic (3.65e-2)" "unprognostic (3.10e-2)" "unprognostic (5.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" 4.4 5.2 12.2 5.1 18.9 3.9 7.0 17.8 17.6 4.7 3.8 14.2 5.5 4.1 5.5 5.4 4.6 8.5 4.8 13.5 12.1 9.3 8.1 12.0 4.1 7.3 18.4 12.1 7.1 5.0 8.9 8.1 4.5 12.2 8.9 2.7 5.8 7.0 8.4 17.0 12.2 4.8 5.8 10.2 5.8 4.0 6.9 17.2 3.7 7.5 2.8 7.4 8.1 8.1 12.1 7.6 3.5 5.1 4.6 9.6 4.9 3.8 8.7 8.0 7.9 7.2 9.1 4.1 5.2 6.1 5.2 7.8 4.8 7.1 7.3 2.6 3.9 6.5 12.4 11.8 10.2 6.7 8.2 8.2 4.8 21.2 8.7 6.5 4.6 2.0 4.0 6.5 6.8 6.5 17.5 9.1 18.5 7.3 6.4 6.8 2.5 10.6 3.1 14.0 15.0 6.8 12.7 6.9 13.7 7.1 1.6 8.5 7.3 8.4 2.1 4.8 10.3 5.1 1.7 6.0 3.9 6.8 5.9 4.6 11.9 10.1 9.1 7.5 7.2 3.1 0.1 3.1 3.3 7.8 2.2 6.2 12.1 8.1 8.1 7.6 5.8 8.6 9.6 3.5 4.6 5.1 4.8 8.7 4.9 12.2 18.9 17.8 17.6 12.1 9.3 18.4 12.1 12.2 17.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.2 0.0 0.0 3.4 3.3 1.5 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 KYAT3 "CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3" ENSG00000137944 "Kynurenine aminotransferase 3" Q6YP21 1 88935773-88992953 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 59.0;monocytes: 55.9;Syncytiotrophoblasts: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026538, HPA027168" Enhanced Approved "Nucleoli,Cytokinetic bridge,Cytosol" NA NA Cytosol "Nucleoli, Cytokinetic bridge" "HPA026538: AB_1852076, HPA027168: AB_1852078" "prognostic favorable (3.19e-5)" "unprognostic (3.36e-3)" "unprognostic (1.88e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" "prognostic favorable (1.86e-4)" "unprognostic (2.61e-1)" "unprognostic (3.61e-3)" "unprognostic (2.11e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.04e-1)" "unprognostic (3.17e-1)" "prognostic favorable (5.02e-6)" "unprognostic (1.17e-1)" "unprognostic (1.06e-1)" "unprognostic (2.51e-1)" "unprognostic (2.78e-1)" 22.2 26.8 16.6 13.2 19.3 10.6 27.5 14.9 23.5 23.7 17.5 20.0 13.0 19.4 24.1 21.2 27.2 18.9 17.8 13.2 18.6 14.2 27.3 23.8 17.1 17.6 16.9 22.2 27.4 28.6 27.0 19.5 21.9 23.4 19.0 19.6 19.5 21.0 20.7 10.4 22.0 17.2 22.1 14.8 20.7 23.5 15.6 17.2 15.5 24.5 13.4 20.2 25.2 17.7 9.6 17.0 9.2 12.7 11.5 16.7 8.2 20.8 4.4 21.4 7.1 7.7 21.5 18.6 12.8 24.2 16.5 21.5 6.4 7.3 13.8 9.8 9.5 11.0 5.9 6.0 9.9 25.2 8.1 8.6 12.3 4.2 10.5 25.1 17.2 3.4 18.1 10.0 11.3 20.4 10.5 15.9 16.2 15.9 7.3 15.5 6.9 18.4 8.4 12.7 16.1 3.8 18.8 15.0 7.3 34.6 21.3 15.6 19.1 17.0 22.8 11.1 14.3 12.6 4.2 10.6 6.9 4.6 22.1 9.3 9.9 4.9 9.2 3.4 7.7 5.9 5.6 12.7 7.1 9.1 7.9 12.6 9.6 11.8 10.5 17.0 9.3 12.4 10.4 9.2 11.5 10.2 6.3 16.7 8.2 16.6 19.3 14.9 23.5 18.6 14.2 16.9 22.2 23.4 17.2 11.9 8.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 14.8 12.2 0.0 59.0 21.6 29.8 0.0 0.0 0.0 0.0 33.6 33.1 0.0 0.0 4.7 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 55.9 0.0 0.0 21.3 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.0 0.0 0.0 KYNU ENSG00000115919 Kynureninase Q16719 2 142877498-143055832 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;liver: 41.1;placenta: 34.3" "Cell type enhanced" "Detected in many" 18 "Macrophages: 94.5;monocytes: 360.7;Syncytiotrophoblasts: 87.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9" "Group enriched" "Detected in many" 21 "B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9" "Cell line enhanced" "Detected in some" "A549: 37.9;GAMG: 62.8;HeLa: 42.3;Hep G2: 25.7;hTEC/SVTERT24-B: 22.2;U-87 MG: 66.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA031686 Enhanced Supported Nucleoplasm,Cytosol NA NA 360000 Cytosol Nucleoplasm "HPA031686: AB_2673995" "unprognostic (2.58e-2)" "unprognostic (3.39e-3)" "unprognostic (1.21e-2)" "unprognostic (5.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.36e-3)" "unprognostic (3.58e-3)" "unprognostic (4.88e-2)" "unprognostic (3.35e-2)" "unprognostic (2.87e-3)" "unprognostic (1.51e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-3)" "unprognostic (3.65e-2)" "unprognostic (5.24e-2)" "unprognostic (1.64e-1)" 9.0 3.7 2.2 11.0 3.7 3.9 15.4 0.6 1.7 3.0 1.2 1.3 0.8 0.2 1.1 2.6 5.6 1.5 4.4 3.8 1.4 1.1 8.4 41.1 12.7 13.7 2.9 0.4 1.7 1.0 0.2 1.6 34.3 2.7 1.9 1.2 1.5 3.0 0.8 0.7 1.5 2.7 2.0 6.3 16.0 2.4 7.0 2.6 2.7 2.2 1.7 13.0 12.4 2.6 19.7 28.4 1.3 35.9 0.4 0.1 11.1 0.0 37.9 0.1 0.1 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.6 0.5 2.2 0.1 0.0 62.8 0.1 0.0 0.0 0.0 0.1 0.0 0.8 42.3 25.7 0.5 0.1 0.2 3.6 3.1 22.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 19.3 0.0 2.3 0.1 0.0 0.1 0.0 0.2 0.1 0.6 19.6 0.1 0.0 21.0 3.1 0.2 0.2 10.5 5.4 0.3 1.2 0.1 18.5 0.0 0.1 0.0 0.0 66.4 4.4 0.1 0.1 28.7 0.5 0.1 35.9 0.1 19.7 0.1 0.1 28.4 12.7 0.1 0.0 1.3 0.4 29.2 19.9 0.1 11.1 2.2 3.7 0.6 1.7 1.4 1.1 2.9 0.4 2.7 2.6 3.0 2.4 22.6 0.5 3.5 0.1 1.2 5.1 2.7 10.3 3.5 3.9 2.8 5.0 12.1 34.6 2.9 0.0 0.0 7.8 1.5 3.3 0.8 0.0 44.8 38.5 9.5 0.0 3.1 59.7 39.6 1.7 94.5 1.7 360.7 0.0 0.2 37.4 0.0 0.4 23.0 0.5 6.5 1.3 40.0 8.0 2.8 87.5 0.0 0.0 4.2 LACTB2 CGI-83 ENSG00000147592 "Lactamase beta 2" Q53H82 8 70635318-70669174 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.1;liver: 58.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 194.5;Proximal tubular cells: 262.2;Spermatocytes: 198.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 99.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044391, HPA053040" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 24000 Cytosol "Nucleoplasm, Golgi apparatus" "HPA044391: AB_10965168, HPA053040: AB_2682022" "unprognostic (6.33e-3)" "unprognostic (3.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.23e-2)" "unprognostic (1.82e-1)" "unprognostic (4.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.34e-1)" "unprognostic (8.10e-2)" "unprognostic (3.95e-1)" "unprognostic (7.73e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.60e-4)" "unprognostic (3.70e-1)" "unprognostic (7.49e-2)" "unprognostic (2.93e-1)" "unprognostic (5.93e-2)" 9.3 31.4 6.8 6.7 10.0 1.2 8.9 2.0 7.1 5.5 13.5 9.0 5.3 17.8 5.7 8.3 7.6 5.2 14.6 19.3 7.2 7.2 70.1 58.8 9.7 8.9 11.5 7.5 5.5 10.6 6.2 12.6 6.3 10.1 7.5 10.0 6.2 7.8 8.6 12.0 6.1 19.1 7.2 11.6 8.0 7.7 45.7 11.7 6.0 9.8 10.9 5.9 8.2 7.4 14.0 18.2 13.4 17.3 11.0 13.8 6.4 14.3 15.0 4.7 1.9 8.3 12.7 2.9 8.0 4.7 8.7 6.6 7.1 16.2 0.0 3.3 3.9 17.5 10.3 5.7 8.5 6.9 8.6 6.4 6.7 2.0 3.9 17.4 6.5 5.8 15.3 10.4 4.3 6.5 4.1 2.2 5.3 11.6 13.6 11.4 4.3 3.7 1.2 5.1 19.4 14.2 3.3 2.8 3.0 33.2 7.6 6.8 2.4 17.9 99.3 8.9 6.4 16.6 8.8 3.6 0.6 4.8 15.4 6.5 11.1 8.3 0.0 4.9 11.2 6.4 11.1 15.2 13.4 9.9 17.3 12.5 14.0 10.4 9.7 18.2 13.2 10.1 10.6 6.4 11.0 16.4 12.8 13.8 6.4 6.8 10.0 2.0 7.1 7.2 7.2 11.5 7.5 10.1 11.7 53.6 33.1 13.5 17.8 14.5 13.8 31.9 25.5 20.1 30.7 17.4 7.9 19.6 64.6 43.6 194.5 15.3 25.3 0.0 101.8 11.7 10.3 12.0 9.2 70.0 40.7 7.9 11.6 22.1 31.8 14.1 19.0 23.7 15.1 11.8 21.3 33.2 68.2 19.2 14.2 262.2 14.8 6.5 11.3 198.5 24.5 14.6 16.2 23.0 26.4 8.1 LAMA4 LAMA3 ENSG00000112769 "Laminin subunit alpha 4" Q16363 6 112108760-112254939 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 76.6;Fibroblasts: 77.1;Leydig cells: 154.2;Peritubular cells: 76.4;Smooth muscle cells: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 51.9;ASC TERT1: 79.0;HSkMC: 61.5;hTERT-RPE1: 38.0;HUVEC TERT2: 64.8;TIME: 59.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015693, CAB078156" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 350000 "Plasma membrane, Cytosol" "CAB078156: AB_2665814, HPA015693: AB_1852687" "unprognostic (1.87e-2)" "unprognostic (6.48e-2)" "unprognostic (8.37e-2)" "unprognostic (2.39e-2)" "unprognostic (1.04e-1)" "unprognostic (1.15e-1)" "unprognostic (2.52e-2)" "unprognostic (5.07e-2)" "unprognostic (4.59e-2)" "unprognostic (2.93e-2)" "unprognostic (9.06e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (4.40e-3)" "unprognostic (1.85e-1)" "unprognostic (2.80e-2)" "unprognostic (1.15e-2)" 42.3 3.6 5.8 20.7 5.4 0.0 21.7 3.7 4.6 28.7 28.6 4.7 12.9 6.3 41.0 24.8 29.7 29.6 23.3 13.8 5.1 4.1 4.6 1.8 27.9 8.8 5.5 2.1 19.9 1.6 3.6 5.6 25.4 5.0 21.3 13.2 18.4 22.9 15.7 5.7 6.8 13.1 53.6 3.6 0.4 15.6 9.4 2.5 1.1 9.1 15.2 6.6 35.6 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 51.9 79.0 0.0 13.0 7.8 1.3 0.2 0.0 4.9 0.0 8.6 22.4 3.0 0.0 0.5 0.0 0.2 0.0 6.7 0.0 6.5 0.0 10.6 0.0 0.0 61.5 0.0 9.4 0.0 38.0 64.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 21.2 0.3 0.0 0.3 2.0 0.0 10.0 0.2 0.0 0.0 59.2 21.4 1.1 23.8 4.3 0.0 0.0 0.0 5.3 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.4 3.7 4.6 5.1 4.1 5.5 2.1 5.0 2.5 3.0 5.0 0.0 1.2 20.1 1.0 47.4 0.0 0.0 3.4 3.5 0.0 0.9 3.3 0.4 76.6 56.3 0.0 0.0 0.6 71.2 77.1 1.1 1.1 28.2 2.7 0.0 0.0 19.6 2.2 34.0 154.2 1.7 54.0 1.0 0.0 0.0 0.6 0.0 76.4 0.0 0.2 64.7 100.7 0.7 0.5 16.3 2.5 0.0 0.0 5.2 LAMB2 "LAMS, NPHS5" ENSG00000172037 "Laminin subunit beta 2" P55268 3 49121114-49133118 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 142.0;Leydig cells: 135.4;Peritubular cells: 132.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;myeloid DC: 2.0" "Group enriched" "Detected in many" 9 "dendritic cells: 2.0;monocytes: 2.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 63.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000053, HPA001895, HPA050033, CAB078160" Supported Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA 18000000 Vesicles Cytosol "CAB000053: AB_2313665, CAB078160: AB_2665799, HPA001895: AB_1079227, HPA050033: " "unprognostic (1.12e-2)" "unprognostic (4.40e-2)" "unprognostic (5.14e-3)" "unprognostic (1.10e-1)" "unprognostic (4.08e-1)" "unprognostic (4.01e-1)" "unprognostic (5.59e-2)" "unprognostic (6.80e-2)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (1.26e-1)" "unprognostic (4.96e-2)" "unprognostic (1.21e-3)" "unprognostic (1.78e-1)" "unprognostic (4.38e-2)" "unprognostic (6.20e-2)" "unprognostic (1.24e-2)" 46.1 35.3 7.4 13.0 7.7 0.9 29.0 5.1 8.3 55.0 25.9 10.5 41.3 9.3 43.4 38.6 34.3 27.1 37.7 62.5 9.7 4.1 30.6 29.6 28.2 5.7 8.2 6.1 56.0 12.9 51.7 8.0 41.3 9.9 37.7 7.3 45.1 17.4 39.2 22.7 17.0 23.0 31.5 6.9 16.7 22.7 24.1 8.1 2.1 36.5 21.8 11.4 45.3 38.4 0.0 2.0 0.2 2.4 0.0 0.0 0.4 3.2 8.0 7.4 26.4 43.4 45.0 6.7 28.0 34.7 16.7 16.8 3.8 11.1 0.0 9.7 63.2 8.4 10.5 6.4 10.0 11.5 0.0 2.0 1.4 12.6 6.6 29.3 0.0 0.0 39.1 15.0 13.3 13.6 40.5 16.3 0.0 0.8 0.0 13.5 6.2 0.0 0.0 3.2 4.2 6.7 0.0 3.6 0.1 11.7 4.1 0.0 4.4 16.0 9.3 14.6 13.1 20.2 0.2 27.0 18.1 7.9 6.4 7.3 0.0 0.0 0.0 8.6 0.0 12.2 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 7.4 7.7 5.1 8.3 9.7 4.1 8.2 6.1 9.9 8.1 110.2 52.2 0.0 12.0 27.7 1.3 142.0 43.3 2.7 38.7 52.4 5.9 8.5 5.0 25.4 2.6 76.6 5.9 0.0 8.0 4.8 81.7 11.7 1.1 44.7 9.0 7.9 0.0 93.9 11.6 7.1 135.4 9.2 40.5 3.6 2.2 44.2 14.8 8.6 132.2 36.6 2.1 116.4 74.5 3.5 7.3 21.3 7.9 2.2 4.7 7.1 LAMC2 "BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa" ENSG00000058085 "Laminin subunit gamma 2" Q13753 1 183186238-183244900 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Pancreatic endocrine cells: 902.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 231.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 49.4;CAPAN-2: 44.7;HBEC3-KT: 221.9;hTERT-HME1: 137.0;RPTEC TERT1: 53.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004257, HPA024638, CAB078165" Enhanced Approved Cytosol "Secreted to extracellular matrix" No No Cytosol "CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689" "unprognostic (7.27e-3)" "unprognostic (7.21e-3)" "unprognostic (3.24e-1)" "unprognostic (6.20e-3)" "unprognostic (9.43e-2)" "unprognostic (4.94e-3)" "unprognostic (4.12e-2)" "prognostic unfavorable (4.20e-6)" "unprognostic (1.25e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (7.11e-5)" "unprognostic (2.77e-1)" "unprognostic (7.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" 2.6 0.0 1.0 20.6 4.1 0.0 11.4 3.6 1.2 8.7 8.4 0.9 2.4 0.9 6.6 2.9 6.5 19.0 12.8 1.8 0.7 0.1 10.5 0.8 18.3 3.3 1.6 1.1 1.9 2.9 0.0 7.0 21.2 1.5 3.7 6.8 0.9 11.2 3.2 1.3 12.8 14.3 1.8 0.7 0.7 7.6 1.9 0.9 3.5 9.8 10.0 15.6 3.4 4.8 0.9 0.8 1.7 0.5 0.4 0.6 0.1 49.4 2.2 0.0 0.0 0.4 1.1 3.6 0.3 0.4 0.1 0.0 3.6 44.7 0.0 19.0 0.1 1.4 22.3 0.0 221.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 17.2 0.5 137.0 0.2 2.9 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 18.1 3.1 0.0 0.1 0.0 53.2 12.9 2.7 0.0 1.3 0.0 0.0 1.4 0.1 0.2 0.3 0.2 2.7 1.3 0.6 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.4 0.6 0.4 0.3 0.4 0.5 0.4 0.4 0.1 0.9 0.5 0.6 1.7 0.4 0.5 0.8 0.3 0.1 1.0 4.1 3.6 1.2 0.7 0.1 1.6 1.1 1.5 0.9 202.5 19.1 0.0 163.7 76.6 0.0 1.1 15.3 66.9 51.2 22.7 0.0 26.6 0.0 197.8 16.4 0.5 28.1 0.0 81.6 9.8 7.8 209.4 0.0 0.0 2.2 0.0 8.6 0.0 0.0 8.3 3.1 2.9 8.5 4.6 13.0 0.0 902.6 26.0 0.4 0.0 0.0 0.0 2.3 3.7 1.0 26.0 69.7 0.7 7.1 119.2 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.1;brain: 105.2" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "basal ganglia: 105.2" "Cell type enriched" "Detected in some" 15 "plasmacytoid DC: 42.1" "Lineage enriched" "Detected in many" 30 "dendritic cells: 42.1" "Cell line enhanced" "Detected in some" "Karpas-707: 95.0;SH-SY5Y: 17.4;THP-1: 33.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" NA NA Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: AB_2686309" "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.5 4.1 21.6 1.5 105.2 2.0 1.0 2.3 28.6 9.1 1.3 0.6 1.8 1.3 4.6 6.0 0.6 9.7 2.9 0.6 18.7 4.1 0.9 0.5 1.1 4.8 4.5 7.7 21.2 1.3 0.3 2.0 0.4 23.2 2.3 1.4 2.6 1.4 3.6 0.3 0.5 1.4 3.8 6.7 1.4 1.6 1.1 4.8 0.0 1.1 0.0 4.7 1.2 0.6 1.4 42.1 0.9 0.5 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.1 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.1 0.0 0.0 42.1 0.0 0.7 21.6 105.2 2.3 19.1 18.7 4.1 4.5 7.7 23.2 4.8 0.0 1.4 2.2 0.0 0.1 7.5 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.6 5.8 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 1.1 57.2 0.0 0.0 1.2 5.6 0.6 0.2 3.3 8.2 0.0 4.0 0.2 0.0 0.0 0.0 4.9 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 LAMTOR5 "HBXIP, MGC71071, XIP" ENSG00000134248 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5" O43504 1 110401249-110407942 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Proximal tubular cells: 1943.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006812 Approved Supported Cytosol NA NA 270000 Cytosol "HPA006812: AB_1079040" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (3.54e-3)" "unprognostic (2.75e-1)" "unprognostic (5.29e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (9.97e-2)" "unprognostic (7.58e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.80e-1)" "unprognostic (2.93e-1)" "unprognostic (1.65e-2)" "unprognostic (3.77e-2)" "unprognostic (3.80e-3)" "prognostic favorable (5.52e-4)" "unprognostic (6.66e-2)" 29.0 32.1 38.9 21.0 35.2 60.9 30.1 25.2 35.8 23.6 29.8 24.4 28.9 23.7 21.6 47.3 30.4 26.7 31.0 63.8 33.2 34.8 118.7 54.3 26.7 28.1 41.5 28.5 29.7 34.8 28.9 35.2 46.3 35.8 28.0 31.6 31.0 32.9 29.6 64.0 21.5 34.2 22.9 36.4 30.7 28.6 24.0 29.5 22.6 37.8 56.7 32.3 27.8 24.7 62.0 59.0 86.1 42.6 25.4 32.4 42.1 47.1 39.5 35.9 21.4 60.2 45.9 35.8 40.2 31.7 34.0 32.4 34.4 23.3 37.6 42.9 38.8 41.8 19.2 36.3 33.5 42.0 40.3 40.8 27.5 47.6 69.5 46.0 39.4 34.3 40.0 52.0 35.1 22.4 43.3 40.7 28.1 32.4 35.5 49.3 76.8 35.7 47.7 25.4 26.6 65.8 24.8 64.8 28.5 78.4 53.1 26.5 34.6 35.6 52.1 86.8 32.4 20.1 56.0 38.6 25.8 33.5 64.8 37.6 37.4 41.7 47.9 84.5 39.5 59.2 47.1 42.6 86.1 25.2 41.2 22.1 62.0 29.5 27.0 34.7 54.6 25.9 27.3 65.6 25.4 39.0 59.0 32.4 42.1 38.9 35.2 25.2 35.8 33.2 34.8 41.5 28.5 35.8 29.5 148.9 152.7 204.3 232.1 273.4 108.4 553.2 219.1 164.6 125.1 422.2 23.6 369.9 943.3 353.9 46.9 202.1 225.2 116.8 288.3 319.7 236.7 264.3 143.1 274.5 366.0 84.2 213.4 124.6 149.1 80.3 245.1 172.6 332.3 321.0 240.5 175.3 354.9 273.5 224.9 1943.6 111.9 168.1 174.7 196.9 336.9 281.9 418.5 125.0 192.7 332.5 LANCL2 "GPR69B, TASP" ENSG00000132434 "LanC like 2" Q9NS86 7 55365448-55433742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 38.4;Late spermatids: 42.1" "Cancer enhanced" "Detected in all" "glioma: 52.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 7 "A-431: 58.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019711, HPA029535" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019711: AB_1852699, HPA029535: AB_10602342" "unprognostic (1.11e-1)" "unprognostic (6.89e-2)" "unprognostic (7.28e-2)" "unprognostic (1.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (1.01e-1)" "unprognostic (1.31e-1)" "unprognostic (2.56e-1)" "prognostic favorable (1.89e-4)" "unprognostic (1.35e-3)" "unprognostic (5.58e-2)" "prognostic favorable (1.03e-6)" "unprognostic (4.58e-3)" "unprognostic (1.04e-2)" "unprognostic (3.94e-1)" "unprognostic (1.45e-1)" 3.1 4.9 20.4 2.3 17.0 3.1 5.9 9.9 28.5 6.1 4.6 19.8 1.8 5.0 9.6 5.3 3.5 5.6 3.8 3.9 17.2 11.3 6.0 4.8 3.0 4.0 12.9 21.1 9.6 3.4 10.4 4.2 3.9 10.1 5.9 4.7 2.4 3.3 6.9 5.7 5.3 4.2 7.0 10.8 2.8 3.5 5.7 13.1 3.3 6.6 0.3 2.7 2.8 2.7 2.7 4.7 0.7 4.5 3.6 6.0 2.6 58.4 2.0 4.1 2.7 1.2 2.2 2.3 2.7 3.2 4.1 3.5 2.0 1.7 4.1 2.5 3.8 4.1 2.6 2.2 1.5 2.5 1.8 4.3 1.4 1.6 2.0 2.2 4.5 2.7 3.9 1.6 3.1 1.0 2.1 2.0 1.9 2.5 2.7 3.8 1.7 1.1 2.1 7.9 1.6 2.5 1.7 1.9 2.0 2.7 4.7 7.2 6.8 3.8 5.7 1.5 1.6 2.3 4.8 3.3 2.6 3.5 4.9 5.1 2.6 3.1 4.4 2.0 1.0 4.9 0.4 3.6 0.7 2.6 4.5 4.5 2.7 3.4 3.9 4.7 2.6 3.1 2.7 0.5 3.6 3.0 3.7 6.0 2.6 20.4 17.0 9.9 28.5 17.2 11.3 12.9 21.1 10.1 13.1 3.0 6.2 7.6 5.5 3.5 8.0 7.5 7.6 8.1 4.5 10.4 5.9 10.6 5.0 6.7 38.4 4.8 6.6 23.3 10.4 11.1 9.3 4.3 11.5 7.3 6.6 14.3 12.1 9.2 6.3 42.1 8.3 5.0 0.0 9.0 8.6 10.6 6.7 7.0 7.1 19.5 8.2 0.0 3.1 12.0 10.9 3.3 15.9 4.4 10.3 4.7 LAP3 "LAP, LAPEP, PEPS" ENSG00000002549 "Leucine aminopeptidase 3" P28838 4 17577192-17607972 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029606, HPA029607" Enhanced Supported Nucleoplasm,Midbody,Cytosol Yes No 4100000 Cytosol "Nucleoplasm, Midbody" "HPA029606: AB_10599288, HPA029607: AB_10611381" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (2.87e-1)" "unprognostic (2.16e-1)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.44e-3)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (4.29e-3)" "unprognostic (1.73e-1)" "unprognostic (3.28e-2)" "unprognostic (3.06e-1)" "unprognostic (8.79e-2)" 42.5 29.7 23.2 43.9 38.5 18.1 30.7 8.5 23.5 13.3 21.0 23.5 12.3 27.5 17.2 20.8 19.3 18.7 24.3 25.4 24.4 17.0 71.7 70.3 39.4 54.2 33.7 16.1 13.5 14.7 23.5 13.2 25.0 34.9 15.3 22.7 15.0 23.0 12.1 33.3 20.9 30.6 26.9 35.0 54.9 20.8 19.3 30.7 19.9 29.4 21.7 32.1 24.4 23.7 7.5 45.7 9.5 46.1 11.8 12.9 25.3 10.9 9.6 9.2 8.7 18.3 22.3 0.1 17.3 19.5 62.9 76.5 17.5 20.9 43.2 11.5 13.3 37.5 6.8 34.5 12.2 24.0 16.4 9.9 23.9 10.6 22.8 21.3 21.5 15.4 22.7 7.8 20.6 10.9 7.2 21.8 11.4 23.1 30.9 14.8 11.8 19.1 29.5 19.2 20.6 18.4 29.7 8.8 21.8 16.4 12.9 13.6 11.2 15.8 9.8 33.8 13.3 8.3 8.3 14.1 16.0 10.8 16.8 30.0 28.4 43.4 37.3 21.6 35.9 15.4 8.4 43.4 9.5 8.0 46.1 7.4 7.5 7.5 8.5 45.7 5.2 6.5 6.8 6.2 11.8 31.9 25.9 12.9 25.3 23.2 38.5 8.5 23.5 24.4 17.0 33.7 16.1 34.9 30.7 26.8 44.7 44.2 21.0 19.6 8.0 43.2 10.2 46.8 26.1 26.2 2.0 31.2 99.5 46.8 71.4 104.1 38.5 0.0 96.6 44.5 25.9 23.1 63.4 92.3 227.4 6.4 15.6 68.2 96.6 22.8 21.3 135.7 40.5 251.5 30.0 93.7 42.5 30.2 32.9 217.2 12.6 32.3 24.7 46.4 13.2 19.9 46.6 30.5 39.9 21.7 LAPTM5 ENSG00000162511 "Lysosomal protein transmembrane 5" Q13571 1 30732469-30757820 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5" "Group enriched" "Detected in many" 5 "B-cells: 749.7;granulocytes: 621.6;Hofbauer cells: 1099.3;Kupffer cells: 831.6;Macrophages: 787.9;T-cells: 409.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 47.1;HEL: 89.3;HL-60: 56.6;HMC-1: 211.5;REH: 66.3;U-698: 76.8;U-937: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051293 Approved Approved Cytosol NA NA Cytosol "HPA051293: AB_2681424" "unprognostic (3.12e-2)" "prognostic favorable (3.40e-4)" "unprognostic (6.86e-2)" "unprognostic (4.05e-3)" "unprognostic (1.63e-1)" "unprognostic (8.45e-2)" "unprognostic (1.43e-1)" "unprognostic (3.76e-1)" "unprognostic (1.22e-3)" "unprognostic (2.30e-1)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (9.47e-2)" "unprognostic (8.18e-3)" "unprognostic (5.98e-2)" "unprognostic (3.94e-2)" 56.0 15.5 11.5 59.1 17.8 157.5 15.0 2.2 10.4 8.2 11.2 20.7 1.8 9.5 7.5 6.8 8.3 13.7 19.9 9.2 11.2 12.7 14.0 18.2 60.8 144.5 19.0 3.3 7.7 6.3 2.0 6.8 20.1 14.6 8.2 13.2 7.4 11.7 4.7 4.0 5.5 37.1 12.9 33.8 130.9 9.5 6.7 15.8 75.2 10.1 5.2 91.2 21.4 6.4 98.2 69.1 145.1 109.3 26.0 55.4 166.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.1 4.9 0.1 0.1 0.1 0.0 0.0 0.0 5.2 0.0 89.3 0.0 0.1 0.0 56.6 211.5 0.0 0.1 0.0 0.3 0.0 10.8 6.1 1.1 2.9 0.7 0.0 9.7 11.9 0.0 0.0 0.0 66.3 8.7 32.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 36.0 12.5 0.0 0.2 0.0 0.2 0.2 0.0 76.8 0.2 46.2 0.1 73.5 109.3 115.3 47.7 87.9 55.4 70.2 43.7 44.6 69.1 98.2 44.2 43.1 145.1 26.0 83.9 33.2 53.7 166.6 11.5 17.8 2.2 10.1 11.2 12.7 19.0 3.3 14.6 15.8 23.8 148.6 749.7 1.1 21.2 0.0 5.6 10.2 18.7 25.0 3.5 0.0 5.6 0.0 0.4 1.5 31.3 0.7 0.0 0.6 5.1 16.6 0.8 621.6 4.2 1099.3 0.0 1.2 36.2 831.6 1.7 1.4 787.9 47.2 70.3 0.6 0.2 0.9 0.0 0.4 2.2 1.3 0.0 6.8 0.3 0.3 17.6 7.4 409.7 0.3 1.6 LARP1 "KIAA0731, LARP, MGC19556" ENSG00000155506 "La ribonucleoprotein domain family member 1" Q6PKG0 5 154712902-154817607 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015222, HPA051397, HPA054819" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (7.69e-2)" "unprognostic (1.76e-3)" "unprognostic (3.95e-2)" "unprognostic (3.08e-3)" "unprognostic (2.72e-2)" "unprognostic (3.34e-3)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.20e-1)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" 24.9 30.1 30.5 21.9 31.9 18.9 20.3 25.7 46.5 21.3 20.4 27.3 23.2 21.0 26.5 23.0 29.2 25.4 18.5 28.5 27.8 29.1 25.6 22.6 19.9 23.1 26.8 29.7 28.4 81.2 55.9 23.6 25.1 29.2 18.2 21.3 18.9 38.8 21.4 41.7 24.7 22.3 23.8 22.2 21.5 24.4 27.8 27.4 26.1 33.5 16.4 25.8 22.1 28.7 5.2 6.4 2.8 7.9 10.1 5.8 2.5 26.2 36.7 28.7 32.9 25.0 20.3 31.8 26.7 27.3 31.3 30.6 57.7 31.6 69.3 37.9 33.3 45.8 26.4 52.3 49.1 36.2 22.9 29.5 50.1 38.2 26.6 31.8 67.0 23.3 25.1 28.5 38.9 49.7 17.8 27.5 31.3 41.1 48.1 29.0 25.9 39.6 26.2 30.5 22.8 18.5 44.4 27.3 33.0 19.2 32.7 52.1 28.0 36.2 58.2 32.1 30.8 34.6 31.7 36.4 39.4 24.7 29.7 47.8 43.0 30.9 59.1 26.1 37.1 27.5 2.8 4.0 1.1 4.5 4.9 5.8 4.3 5.4 5.3 4.0 5.2 4.3 4.7 2.4 10.1 7.9 6.4 3.4 2.5 30.5 31.9 25.7 46.5 27.8 29.1 26.8 29.7 29.2 27.4 41.7 26.0 38.9 30.3 69.5 60.5 94.4 40.8 37.5 26.1 38.4 35.3 37.5 24.9 38.5 9.8 50.1 45.7 23.3 70.6 28.5 46.8 41.1 17.3 58.2 49.0 82.6 42.2 50.3 51.5 7.7 64.5 38.5 35.4 31.5 52.6 32.3 54.8 28.1 75.3 40.9 38.4 12.9 41.1 37.6 41.4 73.9 20.0 24.9 61.7 53.6 LARP1B "DKFZp434K245, DKFZp686E0316, FLJ10378, LARP2" ENSG00000138709 "La ribonucleoprotein domain family member 1B" Q659C4 4 128061268-128222931 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 378.6;Late spermatids: 340.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036280 Approved Approved Cytosol NA NA Cytosol "HPA036280: AB_10673126" "unprognostic (1.84e-1)" "unprognostic (7.55e-2)" "unprognostic (9.39e-3)" "unprognostic (4.87e-2)" "unprognostic (2.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.79e-1)" "unprognostic (2.63e-1)" "unprognostic (6.39e-2)" "unprognostic (3.36e-2)" "unprognostic (3.54e-2)" "unprognostic (1.38e-1)" "prognostic favorable (5.13e-5)" "unprognostic (8.46e-2)" "unprognostic (5.94e-2)" "unprognostic (2.08e-1)" "unprognostic (7.50e-2)" 9.3 7.1 8.1 6.5 9.8 10.1 9.8 11.7 11.4 11.2 12.6 6.2 21.4 11.7 8.9 20.3 10.3 8.1 8.2 8.7 7.8 9.0 14.8 39.9 9.1 5.1 8.5 10.3 10.1 37.9 12.3 21.4 17.2 9.4 9.3 13.5 4.8 17.0 17.2 26.2 9.7 13.9 9.6 8.4 6.4 12.1 41.9 7.1 5.3 11.3 8.8 7.4 13.2 9.2 3.1 8.5 2.3 3.9 4.6 6.2 1.5 10.7 3.8 6.9 8.9 7.3 8.4 14.4 9.3 10.3 9.0 5.7 8.6 8.6 13.4 13.0 9.1 6.7 4.3 17.3 10.5 10.7 12.6 10.9 10.6 6.5 21.1 16.0 20.2 4.3 4.4 15.2 7.2 26.3 8.5 10.3 10.0 18.6 22.4 5.0 12.6 17.6 11.7 8.0 16.7 6.3 9.7 10.7 15.1 10.1 8.4 20.9 8.2 8.1 18.9 8.4 9.7 5.5 8.9 8.3 5.7 6.3 9.2 9.2 29.5 11.2 15.5 7.4 15.9 6.0 0.3 3.9 2.3 3.4 2.8 6.2 3.1 3.8 4.3 4.4 3.0 3.1 3.3 1.0 4.6 3.0 8.5 3.0 1.5 8.1 9.8 11.7 11.4 7.8 9.0 8.5 10.3 9.4 7.1 32.8 25.7 18.2 21.4 24.6 34.4 27.1 35.7 42.8 48.9 19.2 49.1 27.6 11.6 20.2 378.6 17.5 36.5 46.7 25.7 20.4 16.4 36.2 19.7 143.6 10.9 22.3 32.6 16.5 12.9 340.9 33.6 15.7 16.9 10.8 61.0 15.5 27.3 34.5 18.7 37.6 67.1 19.4 26.9 140.5 12.9 30.4 43.0 12.8 44.7 23.4 LARP4 PP13296 ENSG00000161813 "La ribonucleoprotein domain family member 4" Q71RC2 12 50392383-50480004 "Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039306, HPA039673" Approved Enhanced "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA039306: AB_10805362, HPA039673: AB_10795110" "unprognostic (4.41e-3)" "unprognostic (4.11e-2)" "unprognostic (2.01e-2)" "unprognostic (8.50e-2)" "unprognostic (3.13e-1)" "unprognostic (1.17e-1)" "unprognostic (1.57e-1)" "unprognostic (1.18e-1)" "unprognostic (6.40e-2)" "unprognostic (9.93e-3)" "unprognostic (9.08e-2)" "unprognostic (8.94e-2)" "unprognostic (8.51e-3)" "unprognostic (1.91e-2)" "unprognostic (3.14e-1)" "unprognostic (9.06e-2)" "unprognostic (3.99e-3)" 15.1 22.5 12.3 13.5 14.4 9.4 15.0 12.2 13.1 12.1 13.8 8.1 17.7 13.0 12.4 11.6 15.1 10.7 10.4 14.7 11.3 10.4 28.5 47.8 13.6 11.3 15.6 9.0 11.5 17.1 18.3 23.1 17.7 14.8 13.1 11.7 13.4 17.3 14.7 31.3 10.2 14.8 15.7 17.9 10.9 13.2 11.2 13.5 14.0 15.9 11.2 11.8 14.0 21.4 11.8 15.6 8.9 14.6 10.9 12.1 8.9 14.9 21.4 14.2 10.4 13.3 11.1 24.2 18.5 11.0 18.3 14.7 41.7 17.5 35.4 22.9 11.5 17.0 14.4 30.9 12.5 24.2 21.9 12.7 28.7 20.1 14.8 12.4 31.8 17.0 10.0 12.1 21.6 23.4 12.1 16.1 13.0 41.2 16.9 17.0 13.4 26.0 10.7 20.5 9.7 18.7 19.2 22.6 20.9 9.9 22.6 16.9 9.9 32.8 17.1 19.1 13.8 14.9 12.9 23.2 12.2 18.1 14.0 17.4 16.6 44.2 31.4 16.9 13.1 10.1 8.9 11.6 7.7 11.4 13.0 10.8 11.7 10.1 6.4 15.6 11.8 12.1 9.6 6.5 10.9 14.6 13.5 9.8 8.9 12.3 14.4 12.2 13.1 11.3 10.4 15.6 9.0 14.8 13.5 44.7 33.6 18.1 22.2 63.1 38.6 40.9 22.9 24.1 25.0 27.9 82.5 21.5 8.3 17.0 7.2 19.1 23.3 70.0 20.6 14.9 30.6 32.6 19.6 105.2 23.1 17.5 23.1 26.4 35.8 21.2 13.8 20.7 25.3 28.9 20.6 20.5 24.0 17.3 18.0 37.0 50.8 6.5 33.0 33.5 42.6 65.0 28.6 15.2 22.3 25.5 LARP4B "KIAA0217, LARP5" ENSG00000107929 "La ribonucleoprotein domain family member 4B" Q92615 10 806914-931705 "Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036566, HPA042738" Approved Enhanced Cytosol NA NA Cytosol "HPA036566: AB_10673624, HPA042738: AB_2678137" "unprognostic (3.02e-3)" "unprognostic (1.43e-1)" "unprognostic (9.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.00e-2)" "unprognostic (3.13e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (8.95e-2)" "unprognostic (2.74e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.65e-1)" "unprognostic (1.40e-1)" "unprognostic (8.10e-3)" "unprognostic (1.62e-1)" "unprognostic (6.47e-2)" "unprognostic (2.54e-2)" 17.5 23.1 16.5 27.7 20.7 17.9 17.3 23.8 23.8 15.0 19.7 21.2 20.9 21.7 19.1 23.6 30.9 17.0 19.4 22.0 15.8 13.0 17.6 17.0 25.4 23.0 16.0 16.7 18.2 21.0 22.3 18.6 27.1 18.3 20.0 18.4 18.9 22.1 28.1 37.1 25.1 21.7 16.0 14.4 25.2 25.3 22.9 15.9 29.5 25.8 16.8 21.8 18.3 20.0 8.3 12.2 13.5 13.6 7.7 9.8 5.2 21.4 18.3 9.5 10.6 8.7 8.9 13.9 14.7 6.8 15.8 15.5 24.7 24.4 26.4 5.8 14.4 4.7 22.9 16.9 12.2 13.9 17.7 12.3 21.6 12.5 14.4 14.2 16.2 19.5 9.7 14.2 16.0 9.3 9.1 10.8 12.4 28.7 17.2 12.8 21.4 23.1 14.3 10.3 21.2 8.5 16.8 8.3 17.7 12.8 16.5 9.4 13.4 14.2 27.5 10.9 9.7 25.8 15.3 15.1 12.2 3.3 38.7 14.5 19.7 23.5 26.1 13.6 13.1 7.7 12.9 12.6 13.5 8.7 13.6 9.0 6.7 9.5 9.8 10.8 8.3 9.2 9.8 12.0 7.7 11.1 12.2 8.6 5.2 16.5 20.7 23.8 23.8 15.8 13.0 16.0 16.7 18.3 15.9 47.6 50.2 9.7 12.4 27.0 18.8 39.5 33.1 28.1 34.2 22.7 25.5 13.9 5.0 14.8 12.1 17.9 31.3 23.3 14.0 11.0 17.2 22.4 7.0 15.6 19.0 22.3 13.2 14.7 29.6 4.7 16.1 24.5 16.9 19.0 36.3 23.2 24.6 23.0 22.6 14.6 23.9 25.8 12.2 23.8 21.2 37.3 38.7 14.1 31.0 33.3 LARP7 "DKFZP564K112, HDCMA18P, PIP7S" ENSG00000174720 "La ribonucleoprotein domain family member 7" Q4G0J3 4 112636964-112657592 "Disease related genes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation" RNA-binding "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026842, HPA027930" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026842: AB_10611116, HPA027930: AB_10601233" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (5.72e-2)" "unprognostic (2.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.82e-2)" "unprognostic (1.12e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 22.9 20.2 26.5 24.2 37.0 23.9 23.9 32.5 33.2 26.8 24.7 15.0 24.5 20.7 26.8 23.3 26.4 21.9 20.0 38.3 34.3 21.3 38.8 26.9 18.1 25.6 33.3 26.5 26.3 14.4 21.4 42.6 23.1 34.7 27.3 23.9 11.5 19.2 19.9 35.5 19.1 35.2 31.1 46.9 32.4 20.0 16.0 41.2 27.5 26.4 21.2 25.2 30.1 20.9 23.8 34.6 30.7 27.8 17.8 19.2 10.4 11.2 11.2 23.6 11.9 16.2 18.9 11.9 14.3 12.0 13.3 12.7 7.7 17.9 27.6 12.7 13.7 12.6 7.6 22.2 12.9 18.0 23.1 15.7 15.8 9.4 12.1 12.0 37.4 23.5 15.1 15.3 11.9 7.0 18.6 12.5 13.4 19.2 14.2 17.2 9.7 30.0 13.9 60.8 19.2 8.4 16.9 18.9 12.0 20.6 12.3 13.0 17.9 9.2 22.8 14.1 41.2 10.0 14.7 12.0 12.6 12.7 12.7 15.2 9.5 15.9 28.0 16.2 14.0 13.3 30.7 15.0 25.3 18.5 20.7 16.5 23.8 18.8 19.2 12.3 22.8 18.4 17.8 18.3 17.8 27.8 34.6 18.1 10.4 26.5 37.0 32.5 33.2 34.3 21.3 33.3 26.5 34.7 41.2 89.3 68.1 68.6 56.9 22.0 61.3 101.6 96.8 136.5 94.4 45.4 27.5 68.0 94.5 57.3 9.9 57.6 66.6 0.0 56.1 62.9 53.2 37.8 100.6 146.5 61.4 55.6 37.3 81.6 89.8 8.5 87.5 66.9 23.6 73.1 66.9 107.4 53.1 75.9 94.0 93.8 47.4 116.4 44.3 77.9 66.8 18.2 84.0 66.0 67.8 40.9 LARS "FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS" ENSG00000133706 "Leucyl-tRNA synthetase" Q9P2J5 5 146113038-146182660 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036424, HPA040881" Supported Approved "Nuclear bodies,Cytosol" NA NA 14000 "Nuclear bodies, Cytosol" "HPA036424: AB_10670102, HPA040881: AB_2677185" "unprognostic (2.20e-2)" "unprognostic (1.87e-1)" "unprognostic (2.38e-3)" "unprognostic (1.92e-1)" "unprognostic (2.69e-1)" "unprognostic (3.39e-1)" "prognostic unfavorable (3.78e-5)" "unprognostic (8.17e-2)" "unprognostic (2.72e-1)" "unprognostic (6.80e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (3.13e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.96e-2)" 32.2 30.1 27.0 25.8 31.2 17.8 38.6 31.8 33.7 25.5 25.3 30.1 23.9 16.8 35.8 31.3 28.5 26.8 16.4 29.0 24.2 22.2 26.5 18.4 20.0 24.8 27.3 26.1 32.0 40.8 35.0 43.0 20.6 31.6 26.3 29.9 19.5 39.9 24.8 55.5 24.1 21.5 32.5 30.9 25.2 24.9 20.5 30.5 25.6 30.8 22.8 28.9 30.9 29.2 21.3 28.0 5.8 18.3 19.0 21.8 11.2 20.5 24.3 28.2 46.2 23.4 30.5 43.9 24.1 17.8 24.4 35.3 25.4 22.5 31.3 14.9 31.6 30.9 17.6 47.6 39.6 42.7 26.9 28.0 35.7 30.8 14.7 32.4 50.7 23.7 23.9 39.9 39.9 69.3 22.0 33.2 46.5 39.7 58.7 26.1 17.0 39.1 31.1 43.7 16.6 27.0 30.3 35.5 31.2 18.6 18.6 27.8 35.1 26.2 28.9 60.8 28.0 32.8 43.8 32.5 28.5 19.0 25.8 36.0 30.5 45.0 51.2 31.0 53.6 33.2 2.5 13.5 5.8 14.8 18.3 19.8 21.1 16.4 13.6 18.6 21.3 21.8 18.0 1.2 19.0 13.6 28.0 14.8 11.2 27.0 31.2 31.8 33.7 24.2 22.2 27.3 26.1 31.6 30.5 26.8 57.1 43.4 48.5 24.6 46.8 120.8 22.9 81.7 77.3 45.4 39.3 32.4 43.1 59.7 27.5 55.0 26.5 0.0 47.0 33.7 27.8 49.5 77.6 28.0 32.9 20.6 30.6 29.4 40.0 22.8 58.1 39.7 21.9 59.5 33.8 40.2 49.7 28.1 56.6 52.5 48.0 32.3 59.7 106.6 46.2 31.0 27.6 32.0 43.8 38.2 LAS1L FLJ12525 ENSG00000001497 "LAS1 like, ribosome biogenesis factor" Q9Y4W2 X 65512582-65534775 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044431, HPA061463" Supported Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA044431: AB_10965695, HPA061463: AB_2684530" "unprognostic (9.71e-2)" "unprognostic (1.62e-3)" "unprognostic (1.57e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-2)" "unprognostic (2.38e-1)" "unprognostic (7.15e-3)" "unprognostic (2.83e-2)" "unprognostic (3.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.14e-1)" "unprognostic (5.06e-2)" "unprognostic (6.00e-3)" "unprognostic (1.26e-1)" "unprognostic (1.17e-3)" "unprognostic (2.00e-3)" "unprognostic (1.53e-1)" 16.4 14.7 22.6 17.8 26.4 27.9 21.4 38.3 26.1 18.0 17.9 30.1 14.1 11.1 21.9 17.4 17.1 23.8 14.2 14.0 24.2 22.0 15.7 24.4 15.5 23.2 26.4 23.4 26.2 19.8 29.0 13.8 16.3 26.0 17.8 17.2 19.7 19.5 22.5 20.4 23.9 13.4 20.4 29.7 17.8 14.6 23.7 25.7 26.7 16.4 15.4 26.7 15.3 16.2 20.7 22.0 12.4 20.8 17.8 22.5 17.3 20.3 33.8 16.1 13.4 7.0 9.0 15.7 12.3 7.9 19.2 17.0 16.5 15.2 31.8 17.7 9.2 14.2 14.5 32.4 21.6 21.7 12.1 26.5 14.3 29.6 16.2 8.5 36.6 13.0 9.2 12.8 19.2 13.7 8.4 12.7 19.8 33.5 33.2 11.3 24.2 27.8 28.1 23.8 24.0 31.3 24.0 22.5 35.2 13.2 9.2 12.8 14.7 19.6 14.4 8.9 14.3 10.8 19.5 9.1 11.9 23.6 36.2 18.5 12.1 14.2 35.0 11.6 38.8 6.3 12.4 15.7 7.8 18.8 20.8 20.8 20.2 17.6 22.3 22.0 20.7 22.5 18.5 1.7 17.8 15.0 16.4 17.6 17.3 22.6 26.4 38.3 26.1 24.2 22.0 26.4 23.4 26.0 25.7 11.9 18.2 15.2 17.8 16.3 32.6 8.3 15.3 32.1 28.4 3.5 27.5 27.9 13.3 18.3 44.1 14.8 7.4 0.0 23.0 25.7 15.1 11.9 17.4 12.9 14.3 42.9 16.0 11.6 7.1 108.3 16.1 12.3 10.1 20.8 7.9 15.2 17.5 7.0 14.5 12.9 33.2 12.9 20.2 20.5 20.0 16.3 14.9 11.8 12.8 14.4 LASP1 "Lasp-1, MLN50" ENSG00000002834 "LIM and SH3 protein 1" Q14847 17 38869859-38921770 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ion transport, Transport" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 124.5" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 467.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012072, CAB022049" Enhanced Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 26000000 "Plasma membrane, Cytosol" "Focal adhesion sites" "CAB022049: , HPA012072: AB_1852714" "unprognostic (1.23e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (4.57e-4)" "unprognostic (1.47e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (2.41e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-1)" "unprognostic (9.60e-2)" "unprognostic (9.87e-3)" "unprognostic (1.01e-1)" "unprognostic (9.65e-3)" "unprognostic (1.29e-3)" "unprognostic (3.95e-2)" "unprognostic (1.60e-3)" "unprognostic (4.53e-2)" 51.2 20.0 23.8 40.3 22.4 45.4 35.5 15.5 25.7 23.6 57.4 16.3 18.7 54.4 23.4 24.1 22.4 20.8 48.3 15.2 18.4 23.3 33.1 47.5 33.3 44.2 20.0 14.3 28.4 30.1 10.1 17.6 40.0 16.1 18.9 38.6 24.2 22.4 24.1 10.7 18.3 124.5 21.3 12.2 43.1 39.5 13.9 12.9 40.5 18.3 18.7 33.7 22.0 28.3 6.4 13.9 34.0 19.9 17.3 16.5 13.1 35.4 73.9 21.6 19.1 31.8 34.5 37.3 44.6 43.6 47.0 34.6 22.0 38.6 16.2 37.3 68.9 26.7 56.5 9.8 33.9 41.2 11.8 5.3 7.7 21.4 38.3 30.2 17.8 23.4 30.6 11.9 39.8 11.3 29.4 31.5 10.0 13.1 5.4 65.4 11.7 21.1 27.5 10.8 31.2 18.5 11.9 11.5 20.4 57.7 31.2 3.2 7.9 26.5 27.9 23.1 41.8 44.0 21.8 55.0 28.2 41.2 33.0 27.0 14.0 18.4 12.6 29.8 16.0 33.9 9.9 14.8 16.8 16.5 17.1 11.3 6.4 8.4 11.0 13.9 6.3 7.2 10.9 34.0 17.3 19.9 10.7 10.7 13.1 23.8 22.4 15.5 25.7 18.4 23.3 20.0 14.3 16.1 12.9 38.7 25.9 38.3 19.5 37.2 55.7 0.8 66.2 32.1 19.4 69.8 9.8 4.3 14.9 58.2 85.5 48.9 225.0 0.0 65.7 33.5 47.6 22.3 51.8 85.9 75.8 25.4 83.1 70.6 116.7 467.6 48.1 58.0 33.7 52.3 91.2 21.1 95.7 106.3 37.4 62.1 22.0 64.7 29.7 2.1 4.1 24.8 5.4 60.9 75.9 23.8 LATS2 ENSG00000150457 "Large tumor suppressor kinase 2" Q9NRM7 13 20973032-21061547 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039191, HPA049037" Approved Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA039191: AB_2676385, HPA049037: AB_2680609" "unprognostic (2.77e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (6.22e-3)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (1.84e-2)" "unprognostic (1.88e-1)" "unprognostic (2.16e-3)" "unprognostic (4.48e-1)" "unprognostic (6.57e-3)" "unprognostic (8.03e-2)" "unprognostic (4.92e-2)" "unprognostic (7.85e-2)" "unprognostic (1.66e-2)" "unprognostic (1.25e-1)" "unprognostic (7.97e-2)" "unprognostic (1.11e-2)" 22.9 13.0 3.0 8.6 5.7 12.8 33.0 7.9 3.7 16.6 14.0 6.8 9.3 2.9 21.2 12.7 15.1 11.0 20.6 14.1 5.4 2.6 12.4 11.0 19.8 10.9 5.2 2.4 17.4 10.2 5.0 3.5 18.3 6.3 13.7 4.5 16.7 8.0 11.1 23.0 9.3 7.4 34.6 7.5 15.2 10.4 27.8 5.2 1.4 17.2 13.8 7.0 20.3 28.0 0.1 1.5 3.3 1.9 1.3 3.1 0.5 3.4 3.8 8.5 5.1 10.0 13.2 7.8 11.4 11.9 12.0 10.3 10.8 5.2 0.0 5.6 17.4 4.7 5.0 5.0 5.2 17.8 1.9 1.3 6.3 4.8 8.1 15.5 1.7 2.2 19.5 9.6 7.9 5.3 6.0 16.7 1.4 1.1 0.2 15.1 5.9 0.2 5.9 2.0 3.5 1.8 1.5 15.1 0.0 8.5 1.6 0.1 0.0 9.0 6.0 11.9 7.7 5.1 3.2 21.0 12.8 8.5 9.3 7.2 1.5 0.8 0.0 3.0 1.9 9.7 0.4 1.9 1.8 1.6 1.5 3.1 0.1 0.2 0.5 1.5 0.0 0.1 0.3 3.3 1.3 0.6 0.1 0.0 0.5 3.0 5.7 7.9 3.7 5.4 2.6 5.2 2.4 6.3 5.2 38.7 6.9 2.4 13.7 29.2 0.0 20.6 15.3 12.0 11.4 5.2 0.0 18.7 3.3 8.7 94.1 30.9 3.2 0.0 6.4 7.9 22.8 18.0 4.7 14.5 9.0 0.0 0.0 43.0 13.7 6.2 23.6 16.6 16.9 0.0 1.6 4.5 14.9 1.7 32.5 6.4 0.7 6.5 25.9 6.7 13.7 22.1 40.2 4.4 1.0 9.4 LAX1 "FLJ20340, LAX" ENSG00000122188 "Lymphocyte transmembrane adaptor 1" Q8IWV1 1 203765176-203776233 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.7" "Group enriched" "Detected in some" 5 "granulocytes: 78.7;T-cells: 27.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0" "Group enriched" "Detected in many" 19 "B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9" "Group enriched" "Detected in some" 4 "Karpas-707: 11.7;U-266/70: 14.4;U-266/84: 32.4;U-698: 12.3" "Low region specificity" "Detected in all" "HPA002461, HPA003887, CAB025358" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240" "unprognostic (2.85e-3)" "unprognostic (3.83e-3)" "unprognostic (3.90e-4)" "unprognostic (3.65e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-5)" "unprognostic (2.99e-2)" "unprognostic (4.91e-2)" "unprognostic (4.36e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (4.36e-1)" "unprognostic (4.23e-4)" "unprognostic (3.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" 1.6 0.6 0.4 19.9 0.4 1.3 1.3 0.4 0.4 1.8 3.4 0.0 0.2 2.1 1.2 1.1 4.5 1.1 3.8 0.6 0.4 0.4 1.0 0.8 6.3 17.4 0.4 0.0 0.7 0.6 0.0 0.5 0.1 0.0 2.2 2.6 1.1 5.7 1.5 0.5 1.0 5.5 1.1 0.5 11.7 3.4 1.0 0.0 22.7 1.1 0.7 26.7 6.3 2.8 6.5 0.0 0.3 0.0 4.6 9.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 11.7 0.0 0.0 3.8 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 32.4 12.3 0.0 0.9 0.0 0.0 0.0 0.3 9.9 0.0 7.4 6.5 5.7 7.3 0.0 1.5 4.5 5.9 0.0 4.6 0.0 0.0 6.0 2.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 3.4 11.5 0.3 1.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 78.7 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.9 10.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 27.9 0.0 0.4 LAYN "FLJ30977, FLJ31092" ENSG00000204381 Layilin Q6UX15 11 111540280-111561745 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 43.8;Endothelial cells: 33.1;Peritubular cells: 51.9;Sertoli cells: 32.3;Urothelial cells: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "myeloid DC: 10.3;T-reg: 11.8" "Group enriched" "Detected in many" 111 "dendritic cells: 10.3;T-cells: 11.8" "Cell line enhanced" "Detected in many" "BJ: 39.7;BJ hTERT+: 43.3;BJ hTERT+ SV40 Large T+ RasG12V: 27.6;fHDF/TERT166: 25.7;HSkMC: 25.5;hTERT-RPE1: 25.7;U-138 MG: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040087 Approved Approved Cytosol NA NA Cytosol "HPA040087: AB_10793927" "unprognostic (2.27e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-3)" "unprognostic (1.96e-1)" "unprognostic (3.90e-2)" "unprognostic (1.83e-2)" "unprognostic (5.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-1)" "unprognostic (7.75e-3)" "unprognostic (4.47e-2)" "unprognostic (1.18e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (1.65e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-2)" 7.7 2.3 9.3 5.9 12.8 1.3 8.0 1.7 12.5 11.3 21.2 28.9 3.0 4.0 15.1 10.5 5.3 12.8 17.0 5.6 12.6 7.5 4.1 1.4 9.6 12.4 20.6 5.9 39.5 2.3 1.6 5.4 13.1 12.3 13.2 3.8 10.9 4.4 17.9 4.8 2.1 8.2 21.7 10.1 7.5 12.1 4.6 13.1 4.6 26.9 4.8 5.0 11.3 10.1 0.0 10.3 0.0 0.0 0.0 11.8 0.4 0.1 1.0 0.2 0.0 7.1 13.7 1.9 39.7 43.3 20.1 27.6 0.0 0.0 0.0 0.3 25.7 5.0 0.8 2.5 0.2 20.8 0.0 0.1 0.2 0.0 0.0 12.1 0.0 0.0 25.5 0.0 8.3 0.0 25.7 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 3.1 0.0 0.1 0.0 1.3 4.8 0.1 0.0 0.1 9.9 0.0 0.1 0.1 29.8 22.0 0.2 19.3 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 10.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 11.8 0.4 9.3 12.8 1.7 12.5 12.6 7.5 20.6 5.9 12.3 13.1 17.9 3.2 0.0 43.8 1.9 0.2 1.4 5.1 18.7 13.6 0.0 0.0 1.1 0.0 5.9 2.2 33.1 0.0 0.0 0.2 1.2 6.5 13.4 1.1 0.0 0.7 0.0 0.0 4.3 1.2 1.3 21.0 1.3 0.0 0.0 0.0 0.2 0.7 0.0 51.9 0.0 0.1 32.3 10.8 0.0 0.7 1.9 0.5 2.2 0.0 40.4 LBHD1 "C11orf48, MGC2477" ENSG00000162194 "LBH domain containing 1" Q9BQE6 11 62662817-62672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 67.7" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 16.0;Club cells: 4.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.1;JURKAT: 33.3" "HPA012127, HPA023592" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012127: AB_1845527, HPA023592: AB_1845528" "unprognostic (4.34e-4)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (7.90e-3)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.18e-8)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-2)" "unprognostic (2.81e-1)" "unprognostic (6.79e-2)" "unprognostic (2.78e-8)" "unprognostic (3.69e-2)" "unprognostic (1.62e-1)" "unprognostic (5.79e-2)" "unprognostic (4.72e-3)" 4.7 14.7 1.7 6.2 3.9 6.9 4.2 3.4 3.6 3.8 4.0 3.9 7.6 4.0 2.3 5.4 4.0 4.1 5.3 67.7 3.4 2.1 4.1 8.3 4.4 8.3 1.8 3.3 3.3 4.1 7.5 4.4 2.3 3.7 4.6 4.1 4.5 4.2 10.0 4.8 2.6 6.0 2.5 3.1 10.4 4.6 6.7 2.3 6.2 4.6 3.0 6.5 4.8 2.6 4.9 7.1 5.7 6.2 8.0 7.0 4.3 1.6 2.8 1.7 1.3 2.7 5.1 3.9 2.2 3.3 3.7 2.9 2.3 19.1 5.7 4.9 2.7 3.8 7.4 1.9 5.2 2.9 7.7 5.9 4.8 7.8 1.6 4.0 4.4 6.3 7.0 0.6 6.5 2.0 4.1 2.0 33.3 4.9 5.2 2.3 2.8 2.8 6.7 2.2 3.9 2.5 6.8 4.3 10.4 4.8 3.3 1.9 2.9 2.5 3.5 7.1 2.5 6.3 6.7 1.5 2.3 1.4 2.3 2.4 8.6 7.4 5.4 2.1 4.5 2.4 2.2 6.2 5.7 6.6 4.5 5.7 4.6 3.7 7.0 5.4 4.9 5.1 4.1 1.8 8.0 3.4 7.1 2.2 4.3 1.7 3.9 3.4 3.6 3.4 2.1 1.8 3.3 3.7 2.3 3.0 2.4 0.0 0.1 0.0 1.9 0.8 0.0 16.0 4.5 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 2.3 0.2 0.2 1.6 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 1.3 0.2 0.0 0.4 0.3 7.3 0.0 0.0 0.6 0.9 0.0 0.2 0.0 0.0 0.3 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 76 "brain: 11.8;skeletal muscle: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 5.0;RH-30: 6.4;SCLC-21H: 13.6" "Group enriched" "Detected in some" 24 "cerebellum: 1.8;pons and medulla: 3.2" "Group enriched" "Detected in some" 21 "cerebellum: 2.9;pons and medulla: 2.8" "HPA002016, HPA002086, CAB079927" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.4 0.0 0.0 0.0 13.6 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCA5L "C21orf13, MGC33295" ENSG00000157578 "LCA5L, lebercilin like" O95447 21 39405844-39445805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 57.2" "Cell type enhanced" "Detected in many" 28 "Early spermatids: 967.3;Late spermatids: 347.9;Spermatocytes: 191.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 6.9;T-47d: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019790, HPA032010" Enhanced Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019790: AB_1845690, HPA032010: AB_2674110" "unprognostic (1.02e-1)" "unprognostic (3.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.54e-3)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (6.34e-2)" "unprognostic (1.27e-2)" "unprognostic (1.85e-2)" "unprognostic (5.50e-2)" "unprognostic (2.37e-1)" "unprognostic (7.53e-3)" "unprognostic (1.40e-1)" "unprognostic (1.04e-2)" "unprognostic (9.68e-3)" "unprognostic (1.95e-1)" 0.4 1.3 1.4 0.3 3.7 0.3 1.2 1.1 1.6 1.2 0.6 2.3 2.7 0.4 0.9 4.6 0.4 4.4 1.0 0.5 1.9 1.2 1.6 1.3 1.0 0.3 0.7 1.2 0.8 1.1 1.7 9.1 0.3 3.1 0.7 0.4 2.2 0.8 1.8 1.7 0.7 0.4 0.5 0.7 0.4 0.6 57.2 1.1 0.3 2.9 0.4 0.3 0.5 0.5 0.3 0.7 0.2 0.5 0.0 1.1 0.0 1.7 1.8 1.0 3.2 1.6 1.4 0.2 0.5 0.8 1.0 0.1 1.0 1.9 1.2 1.5 1.7 0.4 0.5 0.1 1.0 0.6 0.6 1.5 0.9 1.9 0.2 1.3 2.0 0.0 1.2 4.2 3.0 3.4 2.2 0.6 1.9 3.1 1.2 1.1 6.9 0.6 0.7 6.2 1.3 1.9 0.4 0.4 1.2 3.3 0.6 2.1 0.9 3.8 1.6 2.5 0.6 7.4 0.3 0.1 0.6 0.4 1.8 0.5 3.7 1.9 0.4 2.8 0.7 1.2 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.5 0.6 0.2 0.3 0.0 1.1 0.2 0.0 0.5 0.7 0.0 0.0 1.4 3.7 1.1 1.6 1.9 1.2 0.7 1.2 3.1 1.1 3.0 0.3 0.0 0.8 0.5 2.0 1.7 2.5 84.3 27.3 7.0 5.9 0.8 16.6 2.7 967.3 1.0 0.0 0.0 2.0 0.1 1.5 0.5 0.0 1.5 0.5 1.6 4.1 1.8 0.6 347.9 6.1 1.0 1.7 1.0 1.3 3.1 1.7 0.0 7.4 9.1 15.3 19.4 0.9 191.0 27.7 0.5 0.2 0.0 0.8 0.5 LCLAT1 "AGPAT8, ALCAT1, FLJ37965, LYCAT" ENSG00000172954 "Lysocardiolipin acyltransferase 1" Q6UWP7 2 30447226-30644225 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031880, HPA049217" Uncertain Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" Cytosol "HPA031880: AB_10610002, HPA049217: AB_2680678" "unprognostic (6.60e-2)" "unprognostic (2.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.52e-3)" "unprognostic (4.10e-1)" "prognostic unfavorable (9.67e-4)" "prognostic unfavorable (8.72e-4)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (3.88e-2)" "unprognostic (7.11e-3)" "unprognostic (2.85e-2)" "unprognostic (4.14e-2)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (3.93e-3)" "unprognostic (1.10e-1)" 7.7 9.7 7.0 13.7 8.7 12.3 7.1 10.2 10.1 11.6 10.7 5.2 12.6 15.7 18.7 15.0 13.0 9.9 12.6 21.7 7.5 9.2 15.2 13.8 10.0 12.5 6.1 6.0 15.4 16.7 10.8 21.8 5.7 7.0 10.7 10.6 9.7 9.5 16.3 10.9 9.4 25.0 11.3 5.5 8.0 8.4 12.1 4.2 20.7 17.9 11.9 11.7 9.1 10.4 9.6 2.8 10.5 3.9 4.1 12.6 2.8 11.0 14.6 7.9 13.3 1.8 4.2 11.3 8.0 8.0 8.5 7.2 14.7 13.0 7.1 7.4 12.4 10.6 12.5 26.1 10.8 8.5 9.0 8.9 13.1 9.2 14.1 8.4 18.5 10.0 3.2 8.5 9.0 12.6 5.6 5.9 4.1 12.0 6.8 6.5 8.6 10.5 10.9 8.6 9.0 8.4 10.3 15.8 14.5 6.8 16.2 9.2 14.2 17.9 11.9 10.3 5.7 8.6 6.4 6.7 15.5 12.9 8.3 12.5 4.9 10.3 16.0 15.8 13.6 11.8 10.5 2.5 4.8 5.6 3.9 6.6 7.5 8.7 7.1 2.8 9.6 12.6 12.1 7.4 4.1 3.5 2.2 4.0 2.8 7.0 8.7 10.2 10.1 7.5 9.2 6.1 6.0 7.0 4.2 8.9 5.8 4.5 4.6 6.4 12.5 15.1 22.9 13.4 7.9 14.0 25.5 4.3 0.0 7.2 3.1 6.7 11.5 0.0 14.3 4.3 5.5 7.7 3.5 19.0 4.9 14.3 12.6 11.1 5.4 1.2 5.2 2.7 5.0 0.0 15.3 7.3 10.3 7.0 8.5 12.2 16.7 6.5 16.2 8.9 20.5 5.8 1.6 8.7 14.3 4.4 LCMT1 "CGI-68, PPMT1" ENSG00000205629 "Leucine carboxyl methyltransferase 1" Q9UIC8 16 25111729-25178231 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 149.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041559, HPA043530" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041559: AB_2677548, HPA043530: AB_2678532" "unprognostic (9.08e-2)" "prognostic favorable (2.78e-4)" "unprognostic (1.18e-1)" "unprognostic (3.71e-1)" "unprognostic (3.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (1.41e-2)" "unprognostic (7.41e-2)" "unprognostic (4.45e-2)" "unprognostic (4.62e-2)" "unprognostic (1.16e-1)" "prognostic favorable (7.53e-6)" "unprognostic (1.23e-1)" "unprognostic (8.99e-2)" "unprognostic (1.84e-3)" "unprognostic (6.71e-2)" 9.8 18.0 27.9 11.6 30.6 13.9 18.1 27.5 36.4 15.4 17.1 15.5 17.5 13.1 16.2 26.7 13.4 16.8 14.1 25.3 22.8 27.5 17.8 7.5 10.8 11.9 21.7 26.7 23.8 31.4 25.3 20.5 18.9 24.8 15.7 17.2 15.0 14.4 18.3 31.6 16.5 12.7 15.1 18.9 10.1 12.6 29.8 14.4 16.9 15.5 14.3 15.3 11.7 12.1 19.7 17.6 21.6 18.9 15.8 38.9 19.5 17.0 16.1 15.0 20.8 13.5 19.8 15.4 10.7 17.7 15.6 20.6 20.3 15.7 10.4 15.3 16.2 19.9 8.8 15.5 14.7 21.2 10.6 23.7 5.6 16.4 32.9 30.9 13.4 9.3 22.4 16.3 17.8 18.6 23.0 14.2 23.7 8.9 13.7 17.2 43.6 16.0 25.8 22.9 10.8 16.7 19.0 13.8 20.2 17.7 12.1 24.5 15.2 12.8 19.9 24.4 18.4 20.1 6.2 8.4 15.6 10.9 10.1 10.5 17.9 18.1 11.0 19.1 11.8 11.4 12.7 18.9 21.6 20.6 16.7 22.6 19.7 25.6 22.3 17.6 14.3 23.1 21.1 7.4 15.8 17.5 9.1 38.9 19.5 27.9 30.6 27.5 36.4 22.8 27.5 21.7 26.7 24.8 14.4 14.9 13.7 23.2 24.4 21.4 25.3 30.5 15.3 22.7 7.9 31.4 2.0 149.0 41.4 46.1 60.5 21.8 58.0 0.0 58.2 63.7 29.6 28.2 9.2 9.0 41.1 22.3 49.3 17.8 33.7 98.3 24.2 25.1 32.1 33.3 47.4 20.7 45.5 40.3 22.6 69.2 18.9 25.8 18.4 50.2 46.6 27.9 137.0 33.1 48.4 31.3 LCP1 "CP64, L-PLASTIN, LC64P, PLS2" ENSG00000136167 "Lymphocyte cytosolic protein 1" P13796 13 46125920-46211871 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 188.6;lymphoid tissue: 118.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 106.9;B-cells: 102.2;Early spermatids: 108.1;granulocytes: 292.1;Hofbauer cells: 246.0;Kupffer cells: 369.7;Late spermatids: 220.3;Macrophages: 303.2;monocytes: 275.9;T-cells: 260.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 82.8;HDLM-2: 75.7;HL-60: 80.4;HMC-1: 85.3;JURKAT: 76.6;THP-1: 75.0;U-698: 106.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019493, CAB020673" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 2200000000 "Plasma membrane, Cytosol" "Actin filaments" "CAB020673: , HPA019493: AB_1855457" "unprognostic (2.79e-2)" "unprognostic (8.20e-3)" "unprognostic (1.19e-2)" "unprognostic (3.95e-3)" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (2.70e-1)" "unprognostic (4.99e-2)" "unprognostic (6.70e-3)" "unprognostic (2.54e-1)" "unprognostic (5.47e-2)" "unprognostic (3.63e-1)" "unprognostic (3.32e-3)" "unprognostic (2.51e-1)" "unprognostic (1.02e-1)" "unprognostic (7.50e-2)" "unprognostic (2.92e-1)" 57.1 10.0 5.6 44.3 9.4 71.2 8.7 3.9 4.6 3.6 6.2 4.5 5.0 4.5 5.3 43.1 6.2 8.3 8.9 5.5 4.3 3.8 7.2 12.2 33.7 59.1 12.0 1.0 5.7 3.9 0.1 2.8 24.7 7.7 21.5 8.1 5.5 9.5 2.5 3.5 6.8 21.7 6.5 11.9 112.9 6.1 8.2 9.2 118.2 4.5 4.1 68.7 14.0 7.1 25.4 79.3 133.5 127.6 43.2 67.2 188.6 3.3 0.0 0.1 0.0 0.0 0.0 40.2 0.0 0.1 0.3 0.2 22.2 0.1 82.8 17.6 0.0 24.6 0.1 0.0 0.0 0.3 75.7 19.7 17.9 0.0 0.0 0.0 80.4 85.3 0.2 0.0 0.1 0.1 0.0 0.0 76.6 9.3 55.1 0.0 0.1 56.9 55.7 0.0 0.0 0.8 42.4 0.1 59.2 0.0 22.9 0.1 0.7 0.1 8.8 0.6 2.5 0.4 75.0 0.2 2.1 1.3 0.1 2.4 13.2 27.4 106.5 1.6 49.0 0.3 57.1 96.6 54.3 67.2 127.6 60.8 25.4 40.4 55.5 79.3 18.3 25.2 42.3 133.5 43.2 118.1 20.8 40.5 188.6 5.6 9.4 3.9 4.6 4.3 3.8 12.0 1.0 7.7 9.2 29.8 106.9 102.2 0.8 10.6 0.4 3.1 2.5 25.4 33.0 3.5 0.0 8.6 0.0 19.4 108.1 6.6 0.0 23.3 14.4 53.7 6.6 52.4 292.1 26.8 246.0 0.0 1.2 14.1 369.7 220.3 1.1 303.2 21.9 275.9 0.0 19.2 4.7 0.6 1.8 1.4 0.9 0.0 7.9 1.8 1.7 10.3 11.3 260.3 0.1 2.2 LDB3 "CMD1C, KIAA0613, PDLIM6, ZASP" ENSG00000122367 "LIM domain binding 3" O75112 10 86668449-86736068 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3" "Cell type enriched" "Detected in some" 41 "Cardiomyocytes: 1579.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 5.9;hTERT-RPE1: 5.8;SCLC-21H: 9.6;SK-MEL-30: 4.6" "Low region specificity" "Detected in all" HPA048955 Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 450000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA048955: AB_2680568" "unprognostic (1.60e-1)" "unprognostic (9.01e-2)" "unprognostic (4.87e-2)" "unprognostic (6.92e-2)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (2.57e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-2)" "unprognostic (7.61e-2)" "unprognostic (2.54e-3)" "unprognostic (3.55e-2)" "unprognostic (4.72e-4)" "unprognostic (3.07e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-2)" "unprognostic (3.16e-1)" 6.4 0.4 0.9 1.3 1.6 0.2 0.5 0.1 1.3 2.8 2.3 0.0 4.9 0.4 4.2 9.9 9.9 1.3 1.0 213.9 1.7 1.0 0.3 0.2 0.4 0.2 2.6 0.0 1.5 0.3 0.3 0.1 0.5 0.0 4.4 0.8 4.7 7.6 3.1 329.7 0.3 1.2 3.6 6.7 0.2 0.7 0.5 0.0 0.0 2.8 110.3 10.2 1.9 0.9 0.9 0.6 1.8 0.4 0.6 0.6 0.0 0.3 0.2 0.4 3.1 0.4 0.1 0.3 0.4 0.3 0.1 0.2 0.3 0.3 0.2 0.6 0.0 0.7 0.4 0.2 0.0 0.1 0.9 0.7 0.7 0.9 0.1 0.1 0.1 1.6 5.9 0.5 0.1 0.0 5.8 0.0 0.7 0.2 1.8 0.3 1.5 0.4 0.2 0.4 0.4 0.3 0.0 2.0 0.1 0.0 1.1 9.6 1.8 0.3 0.2 4.6 1.4 0.3 0.2 0.0 0.3 0.5 0.4 0.1 0.2 0.6 0.4 0.7 0.3 0.5 1.8 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.9 0.5 0.6 1.4 0.6 0.4 0.6 0.3 0.0 0.9 1.6 0.1 0.6 1.7 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.7 1579.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 18.3 0.7 0.0 0.0 1.0 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.2 10.3 0.4 1.7 0.0 0.0 1.0 0.1 0.0 6.3 0.0 3.4 38.8 33.0 0.6 1.0 0.0 0.0 0.0 0.0 0.1 LDHA ENSG00000134333 "Lactate dehydrogenase A" P00338 11 18394388-18408425 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 249.1" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 1952.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015336, CAB069404" Uncertain Supported Vesicles,Cytosol NA NA 300000000 Cytosol Vesicles "CAB015336: AB_2134947, CAB069404: " "unprognostic (8.83e-2)" "prognostic unfavorable (2.78e-5)" "unprognostic (3.81e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (4.66e-3)" "prognostic unfavorable (3.26e-8)" "prognostic unfavorable (2.27e-6)" "unprognostic (1.08e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.09e-6)" "unprognostic (1.76e-2)" "prognostic unfavorable (9.69e-9)" "unprognostic (4.15e-2)" "unprognostic (1.89e-1)" "unprognostic (3.07e-1)" "unprognostic (1.05e-2)" 84.2 56.4 24.5 52.6 32.5 64.0 56.0 22.3 40.2 38.1 53.5 13.5 9.1 60.5 24.9 36.2 77.7 29.0 31.6 59.4 24.4 33.0 100.1 249.1 37.1 59.4 29.7 25.7 49.7 34.1 10.5 16.4 49.7 44.3 33.3 51.2 45.9 46.3 37.0 199.6 70.2 128.3 50.7 35.5 45.0 31.2 25.9 23.9 45.0 56.4 90.6 60.1 81.9 44.8 27.6 76.5 29.1 61.2 32.8 52.2 72.1 131.7 82.0 3.1 46.2 72.2 49.3 44.0 127.5 135.5 112.0 166.7 36.6 21.7 99.7 41.9 128.8 80.8 106.6 82.0 195.4 242.9 34.0 48.5 34.5 74.9 62.8 17.8 85.1 25.9 49.2 90.1 44.0 44.1 189.0 66.1 31.6 48.6 48.0 131.1 34.9 70.0 53.9 19.8 43.8 102.6 45.4 32.7 83.5 178.0 30.6 24.6 30.4 69.1 57.0 23.6 50.2 26.8 20.3 59.5 140.3 50.9 122.1 1.5 38.2 55.9 95.9 200.8 44.1 47.2 28.9 53.1 29.1 38.1 61.2 42.6 27.6 50.2 40.1 76.5 19.2 32.8 33.3 18.1 32.8 59.5 25.8 52.2 72.1 24.5 32.5 22.3 40.2 24.4 33.0 29.7 25.7 44.3 23.9 68.5 191.6 171.4 331.5 1952.6 415.5 222.7 142.7 85.6 187.7 293.1 137.4 475.1 368.1 1059.9 147.3 475.2 671.1 0.0 1350.8 1780.5 725.6 281.3 256.4 438.3 607.6 486.3 43.8 182.3 215.4 106.3 266.3 427.9 1116.8 1462.6 176.8 316.6 1380.9 487.5 192.7 408.8 354.8 187.5 1239.9 102.9 38.5 1506.3 419.6 213.6 251.8 384.9 LDHB ENSG00000111716 "Lactate dehydrogenase B" P07195 12 21635342-21757857 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 255.8;kidney: 233.1" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 2212.6;Distal tubular cells: 2801.9;Proximal tubular cells: 2766.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "T-cells: 145.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 316.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004641, HPA019007" Enhanced Supported Cytosol No No 780000000 Cytosol "CAB004641: AB_425525, HPA019007: AB_2670008" "unprognostic (2.93e-1)" "unprognostic (9.20e-3)" "unprognostic (6.10e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-3)" "unprognostic (1.36e-3)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (5.34e-2)" "unprognostic (8.40e-2)" "unprognostic (2.91e-1)" "unprognostic (6.41e-2)" "prognostic favorable (2.51e-4)" "unprognostic (1.31e-1)" "unprognostic (1.71e-1)" "unprognostic (2.55e-1)" "unprognostic (9.32e-2)" 70.9 60.2 79.5 33.3 79.6 40.8 33.4 52.4 80.1 24.9 31.8 30.6 13.2 11.8 38.7 27.3 25.6 34.4 32.3 255.8 58.8 69.9 233.1 9.8 27.7 52.3 91.6 62.3 68.0 54.8 41.8 19.4 40.1 84.9 34.9 39.4 26.8 21.8 42.2 29.7 8.6 18.0 42.9 52.9 23.8 47.5 16.4 47.6 59.1 48.5 56.3 58.7 49.7 21.8 28.1 32.9 33.0 15.3 33.7 145.1 93.2 32.6 87.5 77.0 50.6 55.2 61.5 89.5 45.6 45.6 63.8 63.2 138.5 0.1 115.5 29.9 30.7 62.2 16.4 105.9 84.5 81.3 29.6 73.7 118.8 83.7 0.1 52.8 110.9 51.4 70.3 30.3 55.9 76.1 75.5 72.7 83.7 64.9 17.4 70.1 0.1 94.2 134.3 222.1 53.5 38.0 85.1 107.5 93.1 316.6 145.6 24.8 57.4 20.9 32.5 78.6 213.4 0.2 87.0 28.3 43.0 56.4 30.5 85.8 15.4 20.8 151.7 47.6 53.2 51.0 33.0 15.3 1.8 28.5 9.4 47.5 28.1 110.7 59.4 28.3 17.7 145.1 92.2 2.5 33.7 6.7 32.9 105.4 93.2 79.5 79.6 52.4 80.1 58.8 69.9 91.6 62.3 84.9 47.6 131.0 259.8 264.1 356.5 64.9 144.4 2212.6 252.3 329.2 235.4 450.1 64.8 1548.4 2801.9 8.8 8.2 201.1 10.6 163.5 278.5 675.2 313.9 183.2 261.1 6.8 514.5 133.5 88.8 124.0 155.9 19.6 254.3 185.3 170.4 154.1 114.8 173.5 149.2 14.4 390.3 2766.7 85.3 232.8 418.6 17.7 95.7 56.1 1371.1 274.1 316.8 307.0 LDHD ENSG00000166816 "Lactate dehydrogenase D" Q86WU2 16 75111860-75116771 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.3;skeletal muscle: 39.7" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 33.6;Enterocytes: 38.8;Hepatocytes: 81.8;Proximal tubular cells: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 8.9;classical monocyte: 2.7;intermediate monocyte: 4.6;non-classical monocyte: 5.7" "Group enriched" "Detected in many" 31 "granulocytes: 8.9;monocytes: 5.7" "Cell line enhanced" "Detected in many" "Hep G2: 8.7;HMC-1: 12.0;T-47d: 23.5;U-266/70: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041766, HPA048639, HPA066148" Enhanced Approved Cytosol No NA Cytosol "HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626" "unprognostic (8.75e-2)" "unprognostic (3.68e-3)" "unprognostic (1.27e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (1.53e-1)" "prognostic favorable (5.61e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.74e-1)" "unprognostic (4.01e-1)" "prognostic favorable (2.95e-14)" "unprognostic (4.10e-3)" "unprognostic (4.49e-2)" "unprognostic (7.00e-2)" "unprognostic (2.20e-1)" 15.3 5.5 6.8 1.6 6.7 0.8 3.7 4.9 11.7 4.1 12.5 7.6 4.5 6.1 1.5 3.0 3.8 2.1 3.6 25.3 6.6 5.8 21.5 44.3 2.8 0.9 8.1 9.7 7.9 7.7 8.5 4.4 2.1 9.9 4.4 6.8 5.1 14.2 4.5 39.7 1.8 2.5 1.2 4.5 0.7 11.2 1.0 4.0 0.0 4.3 14.4 2.7 1.1 1.2 0.0 0.2 8.9 5.7 0.1 0.1 0.9 0.6 1.6 0.0 0.3 1.3 1.1 5.1 0.1 0.1 0.1 0.2 2.1 2.2 0.0 1.8 0.7 0.8 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.5 8.7 2.1 0.0 12.0 1.6 0.3 0.0 0.0 0.4 0.1 0.3 0.6 1.9 0.0 4.0 0.0 0.6 1.1 2.1 1.0 0.0 0.0 6.0 1.1 0.1 0.0 0.0 0.0 4.1 0.3 0.6 23.5 2.6 0.0 0.0 0.2 0.0 0.0 9.3 0.5 0.0 1.6 0.0 0.0 8.9 2.7 0.8 0.0 4.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 0.9 6.8 6.7 4.9 11.7 6.6 5.8 8.1 9.7 9.9 4.0 0.0 7.9 2.2 2.1 0.6 0.0 33.6 10.2 1.4 1.2 10.4 0.0 1.6 31.5 1.3 0.3 0.6 38.8 0.0 5.5 1.1 0.5 1.6 10.3 81.8 6.2 1.6 2.9 4.3 5.3 0.2 0.0 1.6 5.0 1.0 9.4 11.0 3.7 19.9 0.0 75.5 1.0 0.0 0.4 0.0 0.3 0.3 2.6 1.3 11.0 1.7 LECT2 "chm-II, chm2" ENSG00000145826 "Leukocyte cell derived chemotaxin 2" O14960 5 135922279-135955034 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 100.7" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 116.8;Erythroid cells: 23.3;Hepatocytes: 93.6;Late spermatids: 39.1" "Cancer enriched" "Detected in single" 216 "liver cancer: 35.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043883, HPA058246" Enhanced Supported Vesicles,Cytosol "Secreted to blood" NA NA 26500000 820000 Cytosol Vesicles "HPA043883: AB_2678714, HPA058246: " "prognostic favorable (4.16e-5)" "unprognostic (2.57e-2)" "unprognostic (3.52e-1)" 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 100.7 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.5 2.5 1.2 0.1 0.8 0.3 1.0 1.2 1.5 2.5 0.6 2.2 2.3 0.5 0.2 0.0 0.0 0.9 1.4 2.4 1.9 1.0 1.1 1.5 0.2 0.7 0.2 0.9 3.2 2.4 3.3 4.1 1.0 3.0 0.5 0.8 0.7 1.1 1.1 2.0 1.1 2.6 0.9 2.0 2.0 1.5 1.2 1.3 1.7 0.8 1.9 1.6 1.4 0.7 1.6 2.7 1.0 1.9 0.0 0.6 0.1 3.3 0.3 1.6 2.5 0.9 1.5 1.3 0.4 3.6 1.7 1.0 1.1 2.8 2.4 2.4 1.2 0.4 0.7 0.8 0.5 1.3 0.8 0.8 0.2 1.0 0.7 0.5 2.5 0.1 0.6 0.5 0.7 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.8 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 93.6 0.0 0.0 0.0 3.7 2.2 39.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 6.5 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 LEMD1 "CT50, LEMP-1" ENSG00000186007 "LEM domain containing 1" Q68G75 1 205381378-205457091 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 13.1;testis: 34.8" "Group enriched" "Detected in some" 129 "Early spermatids: 869.0;Late spermatids: 3077.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Group enriched" "Detected in some" 13 "cerebellum: 2.6;pons and medulla: 5.3" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 29.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045425 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA045425: AB_10960538" "unprognostic (1.78e-1)" "unprognostic (2.00e-1)" "unprognostic (1.88e-2)" "unprognostic (4.20e-3)" "unprognostic (7.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.72e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.26e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.31e-1)" "unprognostic (5.66e-6)" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-2)" 0.2 0.2 0.2 0.0 0.3 0.0 0.3 2.6 0.2 0.4 1.4 0.0 3.8 0.6 1.0 13.1 1.0 1.5 0.7 0.2 0.2 0.3 0.9 0.2 0.4 0.0 0.3 0.0 0.6 0.6 0.0 0.6 4.7 5.3 0.3 0.0 0.3 3.2 0.4 0.2 0.3 1.4 0.1 0.2 0.2 0.3 34.8 0.0 0.0 4.8 2.2 2.6 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.7 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 29.9 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.9 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.2 0.3 2.6 0.2 0.2 0.3 0.3 0.0 5.3 0.0 0.0 1.6 0.0 1.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.4 869.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3077.5 11.8 0.0 0.0 0.0 0.0 0.9 4.0 0.0 13.1 1.5 0.7 6.5 0.0 15.3 7.2 0.0 0.3 0.0 0.0 2.2 LENG8 "KIAA1932, MGC40108, pp13842" ENSG00000167615 "Leukocyte receptor cluster member 8" Q96PV6 19 54448887-54462037 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Rod photoreceptor cells: 564.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 102.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042004, HPA042056, HPA061571" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042004: AB_10794642, HPA042056: AB_10795389, HPA061571: AB_2684562" "unprognostic (2.09e-2)" "unprognostic (3.24e-3)" "unprognostic (5.14e-3)" "unprognostic (2.19e-1)" "unprognostic (4.42e-2)" "prognostic favorable (7.59e-4)" "unprognostic (1.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.92e-2)" "unprognostic (4.45e-3)" "unprognostic (5.11e-3)" "unprognostic (8.85e-3)" "prognostic unfavorable (3.30e-7)" "unprognostic (3.64e-2)" "unprognostic (6.92e-2)" "unprognostic (1.71e-1)" "prognostic favorable (2.73e-6)" 58.7 37.3 45.7 53.2 47.3 48.4 30.7 81.5 55.3 37.9 32.9 48.1 54.4 78.1 56.3 66.3 22.9 44.8 39.2 24.1 42.2 21.6 35.0 22.7 36.2 45.8 52.1 30.2 50.3 62.7 13.8 46.4 27.4 38.1 41.9 22.1 48.9 66.7 59.1 36.5 37.2 75.5 35.6 34.3 80.0 53.2 32.6 57.5 24.8 42.2 18.7 33.5 31.5 32.0 4.0 5.6 8.0 1.9 1.7 1.6 0.6 14.5 11.4 14.6 7.4 4.6 7.5 7.8 12.2 1.9 2.3 4.5 9.2 21.1 11.4 5.3 9.9 0.6 19.3 4.7 5.6 1.7 19.2 102.5 17.4 31.4 6.4 5.0 2.6 14.0 16.8 8.7 1.4 5.8 20.0 3.5 8.8 13.2 16.5 2.9 5.0 10.7 13.6 3.4 3.3 2.6 17.3 4.3 16.1 6.0 4.3 11.8 6.1 1.3 9.0 2.8 7.8 8.8 3.8 16.9 10.3 10.7 1.6 12.9 15.6 7.3 4.6 8.4 18.6 6.7 3.9 1.9 2.3 1.6 1.2 1.6 1.4 0.8 1.5 1.0 4.0 1.5 1.1 8.0 1.7 0.9 5.6 1.0 0.6 45.7 47.3 81.5 55.3 42.2 21.6 52.1 30.2 38.1 57.5 17.9 30.7 24.9 18.7 25.5 123.6 1.7 45.9 21.4 29.6 38.4 106.0 15.1 1.7 17.8 25.8 24.8 65.9 23.3 27.1 10.2 22.7 34.5 10.5 37.6 22.3 90.6 100.9 44.2 43.7 9.1 40.3 25.1 23.6 18.0 78.8 36.3 27.0 52.6 34.6 5.3 564.9 19.4 19.6 16.7 13.6 33.6 17.6 19.5 50.5 29.3 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 41.6;Late spermatids: 34.7;Pancreatic endocrine cells: 29.9;Spermatocytes: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.8;hTERT-HME1: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.8 2.5 1.9 1.8 1.5 4.3 1.4 4.7 5.6 6.7 4.1 1.0 5.5 1.7 11.1 1.0 2.0 1.5 3.8 16.8 7.0 0.8 1.6 2.0 1.9 2.5 1.9 0.3 1.9 1.2 4.7 7.1 15.3 3.6 7.0 2.2 1.7 2.7 5.9 2.9 5.0 1.2 0.4 1.0 11.8 1.7 3.1 1.0 11.0 0.6 1.6 1.6 1.6 0.3 0.5 1.3 1.6 0.8 12.1 2.1 14.8 3.8 1.1 1.8 1.0 1.3 3.3 2.2 1.6 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 3.0 5.4 0.5 11.6 0.5 7.0 1.6 5.1 4.0 2.3 5.2 5.9 1.4 1.7 3.5 41.6 2.6 0.2 0.0 17.9 4.8 2.2 2.1 9.2 0.0 1.3 6.4 0.0 1.3 1.5 34.7 2.0 2.5 1.7 1.0 1.4 3.5 29.9 0.0 1.4 2.2 8.2 0.0 2.8 24.4 1.5 0.6 6.8 3.8 1.0 4.4 LGALS1 GBP ENSG00000100097 "Galectin 1" P09382 22 37675608-37679806 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 4031.4;Hofbauer cells: 3788.4;monocytes: 10290.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000646, HPA000687, HPA001130, CAB002157" Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" No No 19000000 Cytosol Nucleoplasm "CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311" "unprognostic (1.65e-1)" "unprognostic (8.13e-2)" "unprognostic (5.13e-2)" "prognostic favorable (2.36e-5)" "unprognostic (6.38e-2)" "unprognostic (2.67e-3)" "prognostic unfavorable (3.06e-4)" "unprognostic (3.22e-3)" "unprognostic (4.91e-3)" "unprognostic (2.51e-1)" "unprognostic (6.16e-3)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.18e-10)" "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.47e-2)" "prognostic unfavorable (5.10e-4)" 167.5 49.3 23.0 56.0 22.9 29.8 213.7 7.6 30.9 158.6 94.5 20.1 44.2 22.0 150.9 80.3 74.0 66.8 78.8 108.6 18.9 29.3 24.0 20.8 55.8 45.4 41.4 28.9 105.1 18.2 5.1 17.5 80.1 53.6 85.9 23.4 35.7 34.9 89.6 117.1 29.2 29.2 145.8 88.3 40.3 40.0 42.4 20.5 16.7 19.6 59.1 20.4 99.8 81.7 29.0 185.2 44.0 149.1 19.6 73.1 180.2 94.5 55.8 1.2 49.5 116.0 227.9 1.1 219.9 258.2 162.9 162.4 6.2 12.5 0.1 22.6 222.0 56.2 10.1 1.9 144.6 57.0 97.1 1.0 8.3 58.6 25.6 75.7 4.8 110.9 141.1 9.9 129.9 55.6 149.1 178.8 0.0 6.0 40.1 126.0 42.2 0.1 67.3 0.4 21.0 132.4 0.1 83.0 25.9 67.0 0.2 0.1 29.4 43.9 7.7 54.9 2.4 40.9 56.9 241.8 217.7 108.9 96.6 112.2 24.6 16.4 0.4 255.8 25.1 86.6 44.0 149.1 5.3 40.8 114.2 6.1 29.0 38.0 39.8 185.2 10.8 6.6 26.8 6.3 19.6 120.0 45.7 73.1 180.2 23.0 22.9 7.6 30.9 18.9 29.3 41.4 28.9 53.6 20.5 154.9 138.0 222.9 146.3 648.8 7.2 914.1 63.7 54.9 94.4 155.3 5.9 84.3 14.9 558.2 21.5 662.6 6.4 23.3 75.7 807.6 4031.4 43.7 528.7 472.3 3788.4 7.9 2.9 939.1 2674.9 59.6 903.3 2724.8 2709.5 10290.5 1.7 156.0 264.8 1.7 1222.7 15.1 31.2 1623.4 2845.4 14.7 12.1 513.9 126.7 373.6 0.9 48.4 LGALS12 GRIP1 ENSG00000133317 "Galectin 12" Q96DT0 11 63506084-63516774 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 45.1;blood: 90.2;breast: 28.6" "Cell type enriched" "Detected in some" 8 "granulocytes: 18.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enriched" "Detected in some" 19 "eosinophil: 90.2" "Lineage enriched" "Detected in many" 19 "granulocytes: 90.2" "Group enriched" "Detected in some" 14 "ASC diff: 11.8;HL-60: 20.4;NB-4: 40.2;U-937: 43.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA021124 Approved Cytosol NA NA Cytosol "HPA021124: " "unprognostic (3.89e-2)" "unprognostic (4.40e-2)" "unprognostic (5.17e-2)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.31e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-3)" "unprognostic (4.69e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (4.60e-7)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (6.22e-2)" "unprognostic (8.60e-2)" 45.1 0.5 0.1 5.8 1.1 10.1 28.6 0.0 0.1 0.1 10.6 0.0 0.0 0.3 0.2 1.1 0.1 0.7 7.7 2.2 0.1 0.1 0.4 0.2 1.4 5.3 0.1 0.0 0.5 0.5 0.0 0.1 0.1 0.2 0.7 0.4 0.1 5.9 1.6 1.6 0.6 1.4 0.6 0.2 0.8 0.4 0.1 0.0 0.1 0.5 2.4 0.2 0.9 0.2 0.0 1.2 90.2 4.7 0.0 0.0 2.8 0.0 0.0 0.0 0.0 11.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 20.4 1.3 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 43.1 0.0 1.8 4.7 90.2 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 2.8 0.1 1.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LGALS3 "GALIG, LGALS2, MAC-2" ENSG00000131981 "Galectin 3" P17931 14 55124110-55145413 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing" "IgE-binding protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 3145.4;Paneth cells: 2942.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9" "Group enriched" "Detected in all" 12 "dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 90.9;CAPAN-2: 72.2;OE19: 119.2;SK-MEL-30: 169.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA003162, CAB005191" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 2300000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005191: AB_2136784, HPA003162: AB_1078937" "unprognostic (1.42e-1)" "unprognostic (9.79e-2)" "unprognostic (1.14e-1)" "unprognostic (3.15e-1)" "unprognostic (2.46e-2)" "unprognostic (3.34e-2)" "unprognostic (1.73e-3)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.08e-3)" "unprognostic (5.97e-2)" "unprognostic (8.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.96e-2)" "unprognostic (2.65e-3)" "unprognostic (7.60e-3)" 95.7 11.0 10.4 50.9 13.6 29.8 53.2 6.5 11.7 54.1 127.1 6.1 42.4 75.7 50.3 30.7 76.1 26.1 83.9 42.3 8.4 5.7 19.9 3.9 65.5 16.6 8.5 9.4 58.9 24.2 0.5 11.0 78.7 5.5 51.7 93.7 25.7 78.3 51.7 31.3 76.1 182.4 48.2 8.7 11.1 36.9 20.4 5.7 5.5 18.0 65.7 41.7 41.1 44.4 1.3 41.7 3.6 67.4 2.5 25.9 37.2 21.7 6.9 0.2 0.1 45.3 90.9 26.5 17.4 36.7 4.8 8.6 15.0 72.2 0.0 9.2 20.3 8.8 21.8 0.4 18.2 2.7 25.7 0.3 0.0 7.7 6.9 34.4 0.0 0.0 28.3 27.8 5.6 11.7 11.0 7.5 0.0 0.0 21.0 10.9 14.7 0.0 5.3 0.3 119.2 19.6 0.0 0.9 1.5 45.3 29.1 0.6 1.7 40.7 0.0 169.5 1.2 17.9 2.4 13.7 23.0 3.2 8.5 0.3 11.7 37.1 0.1 33.0 1.4 2.4 1.7 67.4 3.4 1.8 55.4 11.4 1.3 6.8 5.1 41.7 0.4 0.3 1.0 3.6 2.5 44.2 1.1 25.9 37.2 10.4 13.6 6.5 11.7 8.4 5.7 8.5 9.4 5.5 5.7 670.0 300.6 39.7 543.1 560.7 2.0 183.5 254.8 1263.4 586.9 113.4 0.0 565.8 570.3 541.1 17.4 423.0 3145.4 116.8 951.7 754.6 506.8 590.1 552.4 0.9 1164.5 1.6 166.8 50.3 236.1 23.5 514.6 722.3 804.8 642.0 1587.7 215.8 859.9 2942.3 361.0 42.5 11.3 142.3 241.1 7.7 3.6 697.2 404.6 52.2 1480.8 936.7 LGALS9 LGALS9A ENSG00000168961 "Galectin 9" O00182 17 27629798-27649560 "Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 48.9" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 273.5;Kupffer cells: 189.6;Paneth cells: 182.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 11.4;HMC-1: 29.7;MOLT-4: 14.7;REH: 10.4;THP-1: 26.6;U-937: 22.8" "HPA046876, HPA047218" Approved Approved Cytosol "Secreted to blood" NA NA 448000 Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (2.62e-2)" "prognostic favorable (2.35e-5)" "unprognostic (1.16e-2)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (2.46e-3)" "unprognostic (1.58e-2)" "unprognostic (8.60e-2)" "unprognostic (4.79e-1)" "unprognostic (1.80e-1)" "unprognostic (8.13e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (4.76e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (2.24e-3)" 25.7 3.9 6.4 15.6 11.2 22.2 6.1 2.0 5.3 5.7 26.9 12.6 0.2 8.6 4.3 6.1 6.0 8.5 13.9 4.6 5.6 3.4 5.0 9.0 14.7 29.6 9.7 2.7 5.9 6.0 0.5 2.9 8.5 8.7 4.2 26.0 10.9 5.7 2.1 2.5 3.7 15.0 5.1 13.2 48.9 20.2 2.2 7.9 22.1 3.8 2.0 17.1 14.8 3.6 6.6 28.7 12.0 35.2 4.2 7.0 10.9 0.4 0.3 0.2 0.1 0.0 0.1 0.5 0.2 0.4 3.4 11.4 0.0 2.3 0.4 2.5 0.5 0.3 1.2 0.1 0.0 0.2 3.4 0.4 3.6 0.4 0.0 0.1 7.5 29.7 0.1 0.0 0.2 0.0 0.1 4.0 2.1 0.2 0.2 0.0 0.0 14.7 3.6 0.1 5.3 0.0 10.4 0.0 0.3 1.6 0.3 0.1 0.3 0.0 1.0 0.0 0.2 0.1 26.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 22.8 0.1 5.6 16.4 12.0 1.0 35.2 0.6 4.5 2.6 1.3 28.7 6.6 1.5 0.7 7.2 4.2 31.2 4.5 7.0 10.9 6.4 11.2 2.0 5.3 5.6 3.4 9.7 2.7 8.7 7.9 8.9 7.5 29.3 6.0 2.9 0.1 0.8 25.5 10.7 12.5 7.0 0.0 2.0 3.3 99.7 1.1 23.3 125.2 0.0 111.9 2.5 6.8 2.9 31.1 0.8 273.5 0.0 38.8 18.4 189.6 1.5 4.0 133.7 1.7 127.2 146.3 0.4 119.4 182.0 2.8 0.4 0.5 19.4 3.1 0.1 0.7 1.5 3.1 24.5 106.1 25.8 LGALS9B ENSG00000170298 "Galectin 9B" Q3B8N2 17 20449395-20467539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.4;esophagus: 13.6;stomach 1: 23.2" "Cell type enhanced" "Detected in some" 26 "Enterocytes: 7.8;Mucus-secreting cells: 17.2;Paneth cells: 43.5" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 15 "NK-cell: 13.4" "Lineage enriched" "Detected in single" 15 "NK-cells: 13.4" "Group enriched" "Detected in some" 7 "CAPAN-2: 13.6;U-937: 4.5" "HPA046876, HPA047218" Approved Uncertain Cytosol NA NA Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (4.69e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.05e-1)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (3.93e-3)" "unprognostic (2.72e-1)" "unprognostic (2.26e-2)" "unprognostic (6.85e-2)" "unprognostic (1.32e-2)" "unprognostic (3.20e-1)" "unprognostic (3.79e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (5.27e-2)" "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 1.2 5.7 2.3 0.0 0.0 13.6 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.4 1.8 0.0 0.0 0.3 2.6 0.0 0.0 0.4 23.2 0.0 0.0 1.0 0.0 3.4 0.3 0.4 0.2 0.3 13.4 0.9 1.7 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.2 0.2 0.0 0.4 0.3 0.2 0.4 0.2 13.4 0.3 0.2 0.0 1.7 0.0 1.1 0.0 0.1 2.1 0.0 0.0 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.5 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 5.1 0.1 LGALS9C ENSG00000171916 "Galectin 9C" Q6DKI2 17 18476737-18494945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.9;esophagus: 15.8;intestine: 8.3;lymphoid tissue: 8.5;stomach 1: 15.4" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 16.8;Mucus-secreting cells: 22.5;Paneth cells: 54.7;Undifferentiated cells: 11.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "neutrophil: 3.2;NK-cell: 8.9" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 8.9" "Cell line enhanced" "Detected in some" "A-431: 1.1;CAPAN-2: 2.9;Daudi: 1.0;Karpas-707: 2.8;RPMI-8226: 1.6;U-937: 2.9" "HPA046876, HPA047218" Approved Approved Cytosol NA NA Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (4.47e-2)" "unprognostic (1.43e-3)" "unprognostic (3.17e-2)" "unprognostic (4.30e-2)" "unprognostic (5.92e-1)" "unprognostic (3.02e-2)" "unprognostic (2.52e-1)" "unprognostic (5.16e-2)" "unprognostic (1.63e-1)" "unprognostic (2.56e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.04e-2)" "unprognostic (5.85e-2)" "unprognostic (4.27e-3)" "unprognostic (9.84e-2)" 0.1 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 2.1 8.3 0.2 0.0 1.6 0.0 0.0 15.8 0.0 4.7 1.0 0.0 0.0 0.0 0.8 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.9 0.0 1.6 1.0 0.0 0.2 5.1 0.1 0.0 1.5 15.4 0.0 0.0 0.4 0.0 3.0 7.5 0.0 2.1 0.0 0.4 3.2 1.2 8.9 0.6 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.9 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.5 0.5 0.6 1.2 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.2 3.2 8.9 1.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 7.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.3 54.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 11.0 0.1 LGI3 ENSG00000168481 "Leucine rich repeat LGI family member 3" Q8N145 8 22146825-22157084 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 20.3;Melanocytes: 38.8" "Cancer enhanced" "Detected in many" "melanoma: 14.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.2;GAMG: 2.1;SCLC-21H: 4.6;SK-MEL-30: 4.6;U-2 OS: 2.6;WM-115: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024826 Approved Cytosol "Secreted in brain" NA NA Cytosol "HPA024826: AB_10601131" "unprognostic (4.41e-2)" "unprognostic (1.78e-1)" "unprognostic (3.28e-1)" "unprognostic (8.11e-3)" "unprognostic (1.14e-1)" "unprognostic (7.45e-2)" "unprognostic (3.38e-1)" "unprognostic (2.43e-2)" "unprognostic (9.64e-2)" "unprognostic (1.64e-2)" "unprognostic (6.25e-3)" "unprognostic (1.26e-2)" "unprognostic (5.59e-5)" "unprognostic (1.36e-2)" "unprognostic (9.41e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 1.2 4.8 13.1 1.1 26.4 1.1 1.2 7.7 52.2 2.6 1.2 35.5 0.0 1.4 1.5 1.3 6.1 2.0 1.1 1.5 20.7 15.7 1.1 1.0 17.7 1.0 24.2 10.4 1.1 1.5 0.9 0.7 1.0 24.9 2.3 1.1 4.6 1.2 4.2 1.0 16.3 1.4 1.7 29.8 1.1 1.3 1.4 14.8 0.0 14.9 0.0 1.3 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.0 2.1 1.1 0.8 0.3 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.3 0.4 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.3 0.0 4.6 0.6 0.0 0.0 4.6 0.0 0.5 0.0 0.0 0.0 2.6 0.4 0.0 0.0 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 26.4 7.7 32.1 20.7 15.7 24.2 10.4 24.9 14.8 0.0 20.3 0.0 0.0 2.1 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 38.8 0.0 0.0 1.0 0.1 0.0 6.7 0.0 2.3 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 LHB "CGB4, hLHB, LSH-B" ENSG00000104826 "Luteinizing hormone beta polypeptide" P01229 19 49015980-49017081 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "pituitary gland: 301.4" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 2.3;Late spermatids: 3.3;Pancreatic endocrine cells: 4.8;Syncytiotrophoblasts: 8.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.8;T-reg: 1.3" "Lineage enriched" "Detected in single" 12 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "A549: 6.6;U-266/84: 7.1" "CAB022241, CAB022707, HPA038925" Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "CAB022241: , CAB022707: , HPA038925: AB_2676272" "unprognostic (8.12e-2)" "unprognostic (3.59e-1)" "unprognostic (2.34e-3)" "unprognostic (1.41e-2)" "unprognostic (8.89e-2)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (5.69e-2)" "unprognostic (7.04e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (2.47e-2)" "unprognostic (1.68e-3)" "unprognostic (1.38e-1)" "unprognostic (4.46e-1)" "unprognostic (9.52e-2)" "unprognostic (4.86e-2)" 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.1 23.1 0.0 301.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.5 0.1 0.1 0.1 0.5 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 1.8 0.1 1.3 6.6 0.3 1.3 0.0 0.0 1.8 0.5 0.0 1.0 0.5 5.4 1.9 1.8 0.1 0.0 0.3 0.5 0.0 0.4 0.0 1.7 5.2 0.3 1.7 2.5 0.3 0.4 1.8 0.0 0.0 0.3 0.0 0.0 0.3 1.1 4.8 2.9 0.3 0.4 0.1 0.6 0.7 0.3 0.5 2.8 1.2 1.3 0.0 1.4 3.0 1.2 2.0 0.4 2.2 0.0 2.0 0.0 0.0 2.7 2.8 0.3 3.3 2.5 7.1 1.8 1.4 3.1 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.3 0.0 0.0 0.0 0.7 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.5 0.0 8.6 0.0 0.0 0.1 LHPP HDHD2B ENSG00000107902 "Phospholysine phosphohistidine inorganic pyrophosphate phosphatase" Q9H008 10 124461834-124617888 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 106.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 103.7;Late spermatids: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009163, HPA009269" Enhanced Supported "Nuclear speckles,Cytosol" NA NA 880000 "Nuclear speckles, Cytosol" "HPA009163: AB_1079250, HPA009269: AB_1079249" "unprognostic (3.46e-2)" "unprognostic (1.23e-2)" "unprognostic (4.78e-2)" "unprognostic (3.89e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (5.77e-3)" "unprognostic (2.02e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (6.42e-2)" "unprognostic (5.55e-2)" "unprognostic (1.79e-3)" "unprognostic (2.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" 9.6 14.2 37.3 6.0 34.0 6.9 7.9 11.9 34.2 12.3 13.6 29.7 8.2 17.9 7.5 11.0 12.7 8.1 8.3 9.8 43.0 31.5 18.6 33.8 6.6 8.2 62.7 19.3 5.5 12.2 6.6 5.6 7.2 20.5 6.9 6.7 6.7 13.3 10.6 6.5 8.9 15.7 8.1 106.0 8.2 12.4 14.2 19.5 7.1 20.5 3.6 11.2 8.7 5.7 24.7 20.0 13.3 16.1 3.9 17.2 12.9 14.8 7.4 3.0 7.6 11.7 9.6 8.0 5.5 11.2 3.5 6.4 1.3 13.8 14.7 12.8 8.2 3.8 16.2 0.9 2.9 3.6 3.3 10.6 10.8 2.4 6.8 12.0 2.1 17.5 7.1 12.6 3.4 8.3 10.2 5.5 13.3 5.3 5.9 4.3 14.7 7.1 6.9 5.3 6.3 4.2 7.6 3.3 18.8 7.5 1.9 1.7 9.1 3.8 14.1 5.0 4.3 10.7 0.3 2.6 5.4 8.0 4.5 1.4 4.9 1.5 4.7 4.9 4.2 1.2 4.6 16.1 13.3 9.5 13.5 12.4 23.7 11.1 10.1 20.0 24.7 13.7 9.6 2.7 3.9 14.9 7.5 17.2 12.9 37.3 34.0 11.9 25.0 43.0 31.5 62.7 19.3 20.5 19.5 3.0 15.0 15.6 9.1 6.5 6.2 12.0 15.3 18.7 12.5 7.0 0.0 44.1 28.2 4.0 103.7 1.6 23.3 0.0 2.1 20.7 9.3 7.6 10.4 53.3 22.8 11.1 9.1 7.4 13.2 124.0 5.5 9.2 16.9 14.4 17.3 6.9 3.5 25.9 9.9 58.6 6.4 12.9 5.1 28.8 10.2 4.6 20.3 7.2 19.6 11.1 LHX5 ENSG00000089116 "LIM homeobox 5" Q9H2C1 12 113462034-113472280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0;stomach 1: 2.1;testis: 2.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 5 "cerebellum: 4.8;hypothalamus: 6.7;pons and medulla: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;HMC-1: 4.6;K-562: 1.2;SiHa: 3.3;U-2 OS: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053908 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear bodies" "HPA053908: AB_2682304" "unprognostic (5.20e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.21e-1)" "unprognostic (2.19e-2)" "unprognostic (1.06e-2)" "unprognostic (1.95e-1)" "unprognostic (4.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (5.10e-2)" "unprognostic (7.54e-3)" 0.0 0.1 0.0 0.0 0.3 0.0 0.0 4.8 4.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 2.1 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 6.7 1.2 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Cell type enhanced" "Detected in single" 26 "Spermatogonia: 2.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.8;U-266/70: 8.0" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA071806: AB_2686449" "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 8.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 LIF "CDF, DIA, HILDA" ENSG00000128342 "LIF, interleukin 6 family cytokine" P15018 22 30240447-30246851 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 58.9;granulocytes: 63.7;Smooth muscle cells: 39.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 11.7" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.2" "Cell line enhanced" "Detected in many" "GAMG: 27.0;hTEC/SVTERT24-B: 34.3;hTERT-RPE1: 31.7;U-138 MG: 38.2;U-251 MG: 27.6;U-87 MG: 30.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA018844, CAB025985" Uncertain Supported Cytosol "Secreted in other tissues" NA NA Cytosol "CAB025985: , HPA018844: AB_1852814" "unprognostic (1.28e-2)" "prognostic unfavorable (9.01e-4)" "unprognostic (8.79e-2)" "unprognostic (4.61e-2)" "unprognostic (7.36e-3)" "unprognostic (4.18e-3)" "unprognostic (1.17e-2)" "unprognostic (1.41e-2)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (8.10e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (6.78e-8)" "unprognostic (2.02e-1)" "unprognostic (6.40e-2)" "unprognostic (8.99e-2)" "unprognostic (4.71e-3)" 20.3 1.7 1.4 21.6 3.3 0.6 5.2 0.9 4.3 4.4 3.9 1.8 1.6 3.7 6.9 2.6 2.0 7.3 28.7 14.2 1.2 0.6 5.7 3.4 17.4 3.8 2.2 0.5 7.9 7.5 0.2 7.3 1.3 11.7 8.6 4.7 3.5 3.2 1.2 1.9 6.0 5.2 4.6 4.3 1.6 4.1 2.0 1.8 0.9 3.4 2.2 5.4 20.8 1.7 0.0 0.0 0.0 0.0 1.2 0.2 0.1 8.4 14.2 0.4 3.1 0.0 1.2 5.2 1.2 5.1 1.5 3.7 2.3 13.8 0.0 3.1 0.0 27.0 2.1 0.3 3.8 2.1 2.0 0.6 1.0 4.8 3.1 1.4 0.0 11.1 1.3 0.7 34.3 1.0 31.7 0.0 0.0 0.2 0.0 6.6 6.3 0.1 0.0 0.5 7.7 8.8 0.2 4.8 0.0 12.2 3.2 0.0 0.1 1.4 0.1 2.5 1.6 0.3 0.1 0.1 38.2 14.1 14.4 27.6 0.0 0.0 0.0 30.2 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 1.4 3.3 0.9 4.3 1.2 0.6 2.2 0.5 11.7 1.8 20.8 58.9 0.0 12.0 3.1 0.0 0.2 17.8 4.0 13.6 5.2 0.0 0.1 0.0 27.7 0.1 0.5 3.5 0.0 3.0 0.4 11.3 13.8 63.7 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 2.9 1.2 24.9 0.0 0.0 0.6 0.1 0.0 39.8 0.0 0.2 2.5 0.2 0.5 5.5 18.0 LIMA1 EPLIN ENSG00000050405 "LIM domain and actin binding 1" Q9UHB6 12 50175788-50283546 "Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 458.2;Basal keratinocytes: 492.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 73.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 85.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023871, HPA052645" Enhanced Enhanced "Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol" NA NA 160000 "Plasma membrane, Actin filaments" "Focal adhesion sites, Cytosol" "HPA023871: AB_1852875, HPA052645: AB_2681898" "unprognostic (6.22e-2)" "unprognostic (9.39e-3)" "unprognostic (8.13e-2)" "unprognostic (1.42e-1)" "unprognostic (8.08e-2)" "prognostic unfavorable (1.76e-6)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (1.28e-3)" "unprognostic (6.27e-2)" "prognostic favorable (2.79e-4)" "unprognostic (7.12e-2)" "unprognostic (9.26e-3)" "unprognostic (1.46e-1)" "unprognostic (1.43e-1)" 50.3 19.8 6.6 22.3 6.8 0.9 34.1 73.6 6.6 30.9 49.2 10.4 21.3 35.2 31.1 22.1 25.0 18.0 31.1 12.6 6.6 5.1 29.3 11.1 23.3 11.8 7.2 4.1 21.1 12.4 12.4 18.6 42.0 15.4 28.2 42.8 20.7 27.0 22.1 10.5 16.3 90.5 33.8 10.4 23.6 30.3 11.8 6.0 12.1 17.0 20.7 18.0 41.8 21.4 0.6 4.4 1.3 2.1 5.8 13.6 2.7 24.5 0.7 7.8 11.5 36.2 36.3 29.7 61.7 43.5 49.7 39.8 9.3 36.2 1.1 5.7 85.0 16.7 28.0 7.0 57.0 43.6 15.6 7.4 10.3 2.8 3.2 23.2 3.6 14.6 24.3 16.8 17.4 50.3 15.0 17.4 4.6 7.1 5.0 16.0 4.2 4.5 1.1 4.0 13.0 3.3 4.5 19.2 0.3 11.5 29.3 5.9 12.6 8.4 17.1 26.4 8.7 8.1 2.2 27.1 21.3 16.4 19.7 10.0 2.7 0.3 4.5 23.2 4.1 9.1 0.1 0.2 1.3 6.4 1.0 2.5 0.1 8.1 7.8 4.4 0.6 3.3 5.9 0.1 5.8 2.1 1.1 13.6 2.7 6.6 6.8 73.6 5.6 6.6 5.1 7.2 4.1 15.4 6.0 41.7 69.6 5.7 458.2 492.0 15.2 4.8 91.7 64.3 190.0 113.4 151.2 92.0 13.3 118.0 57.4 79.0 270.8 0.0 268.0 306.1 86.4 160.9 24.3 17.8 31.1 6.4 118.0 121.5 12.4 9.6 69.9 18.4 86.0 15.4 122.6 21.8 175.8 221.0 72.9 21.7 85.9 64.7 111.9 28.1 7.0 254.8 53.5 31.6 178.0 293.9 LIMD2 MGC10986 ENSG00000136490 "LIM domain containing 2" Q9BT23 17 63695902-63701172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 175.1;lymphoid tissue: 98.4" "Cell type enhanced" "Detected in many" 13 "B-cells: 358.9;Hofbauer cells: 123.5;Kupffer cells: 178.4;T-cells: 223.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 54.7;NB-4: 38.1;SH-SY5Y: 38.1;THP-1: 28.6;U-698: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062432, HPA075172" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062432: , HPA075172: " "unprognostic (2.90e-3)" "unprognostic (2.89e-3)" "unprognostic (6.34e-2)" "unprognostic (6.53e-2)" "unprognostic (8.72e-2)" "unprognostic (2.00e-3)" "unprognostic (1.81e-1)" "unprognostic (2.67e-2)" "unprognostic (6.68e-2)" "unprognostic (2.01e-2)" "unprognostic (1.20e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.36e-11)" "unprognostic (1.21e-1)" "unprognostic (2.21e-1)" "unprognostic (2.26e-2)" "unprognostic (6.08e-2)" 3.6 2.0 6.5 54.8 14.8 28.7 2.3 1.2 8.5 2.7 2.9 3.0 1.3 3.9 2.6 3.2 3.0 2.6 5.1 2.7 9.6 3.3 3.7 5.1 8.1 63.5 3.6 3.7 2.8 1.7 0.8 3.5 6.4 2.8 4.1 2.8 5.0 11.3 1.7 1.1 1.8 12.9 2.6 3.0 51.1 5.5 6.1 1.7 98.4 2.5 2.2 79.7 7.4 2.6 81.9 55.1 175.1 65.1 46.6 67.5 73.0 0.1 1.7 21.6 5.3 0.2 0.5 0.5 0.5 0.3 2.2 1.5 0.9 0.4 54.7 4.8 2.6 2.2 0.8 4.7 0.2 0.6 18.8 1.9 16.2 0.3 4.6 4.2 21.0 1.7 5.4 0.2 2.2 0.0 2.5 5.8 3.8 1.4 3.2 2.4 0.2 18.5 38.1 11.6 0.0 1.0 7.7 8.7 9.6 3.0 0.2 26.0 38.1 2.7 0.0 5.0 5.8 0.1 28.6 7.3 3.0 6.6 0.1 0.7 0.6 0.2 57.0 0.3 3.0 5.2 175.1 54.6 122.9 35.7 63.3 35.1 64.6 49.4 41.5 55.1 81.9 67.5 48.1 112.7 46.6 65.1 20.8 58.1 73.0 6.5 14.8 1.2 8.5 9.6 3.3 3.6 3.7 2.8 1.7 0.0 5.8 358.9 7.5 6.6 0.8 0.8 2.5 1.4 3.4 10.4 3.9 1.3 5.0 15.9 14.6 16.3 0.5 0.0 8.0 2.7 7.3 13.6 53.0 1.5 123.5 3.2 21.4 27.0 178.4 36.6 3.1 84.5 35.4 24.4 2.0 5.0 22.0 5.9 4.6 1.7 1.0 6.5 7.3 4.9 6.8 5.3 1.3 223.7 2.1 3.1 LIMK1 LIMK ENSG00000106683 "LIM domain kinase 1" P53667 7 74082933-74122525 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.2" "Cell type enhanced" "Detected in many" 6 "B-cells: 22.9;Hofbauer cells: 25.0;Horizontal cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028516, HPA073571" Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA028516: AB_10601751, HPA073571: " "unprognostic (1.45e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (4.95e-5)" "unprognostic (2.77e-2)" "unprognostic (1.40e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (7.79e-6)" "unprognostic (1.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (6.63e-8)" "unprognostic (4.14e-2)" "unprognostic (7.00e-2)" "unprognostic (3.84e-2)" "unprognostic (5.79e-2)" 8.8 8.6 31.6 18.2 18.6 6.3 7.4 14.3 44.1 11.5 6.6 7.1 6.6 6.9 7.3 5.3 6.4 6.0 10.8 6.3 26.8 32.9 5.2 2.6 12.5 22.0 33.4 22.2 12.1 8.1 4.0 7.2 8.0 45.2 6.1 4.7 4.8 18.1 9.6 10.9 6.8 7.2 7.6 10.8 18.4 7.8 10.4 6.5 4.3 7.5 3.7 18.1 14.1 7.2 4.6 8.6 3.8 7.7 6.9 2.4 3.1 17.0 13.3 10.2 16.9 13.5 18.3 7.4 10.6 10.2 8.6 9.6 7.7 16.9 10.6 4.8 13.0 28.9 10.3 3.8 6.5 3.3 18.3 6.7 7.8 4.5 8.8 15.5 5.9 28.7 18.1 5.9 6.9 3.6 26.0 12.8 7.7 5.2 3.4 10.7 14.9 5.1 10.7 19.3 6.0 8.4 7.4 15.8 6.6 9.6 3.7 4.0 9.3 6.8 16.4 8.5 11.7 5.2 5.4 15.2 13.7 12.8 35.4 17.0 3.8 4.3 19.4 50.9 4.3 9.3 0.1 6.5 3.8 2.4 7.7 1.8 4.6 0.6 1.5 8.6 2.4 0.2 0.7 0.7 6.9 4.7 0.8 0.4 3.1 31.6 18.6 14.3 44.1 26.8 32.9 33.4 22.2 45.2 6.5 3.0 2.4 22.9 4.6 2.6 5.6 2.7 7.6 2.7 3.4 1.8 2.0 2.2 0.0 6.6 0.6 3.0 0.9 0.0 5.6 5.4 7.5 5.1 5.7 1.1 25.0 33.4 2.4 2.5 10.7 1.5 6.6 14.1 3.3 10.0 2.1 3.1 10.2 2.9 5.6 1.5 3.1 0.0 2.1 1.9 12.4 2.8 3.1 10.1 2.5 6.2 LIMK2 ENSG00000182541 "LIM domain kinase 2" P53671 22 31212239-31280080 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 14.7;neutrophil: 37.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 37.2" "Cell line enhanced" "Detected in all" "BEWO: 37.6;hTCEpi: 69.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008183, CAB019313, HPA053882" Approved Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (1.04e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (2.42e-2)" "unprognostic (4.02e-2)" "unprognostic (5.99e-2)" "unprognostic (1.21e-1)" "unprognostic (2.95e-1)" "unprognostic (3.96e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.57e-6)" "unprognostic (4.48e-2)" "unprognostic (1.48e-2)" "unprognostic (5.72e-2)" "unprognostic (1.37e-1)" 9.4 6.6 23.5 23.6 26.2 29.4 17.0 9.9 16.8 11.0 20.9 15.6 10.7 13.1 12.9 8.7 33.7 22.1 28.7 6.0 15.4 10.7 15.4 19.9 21.6 18.1 20.8 7.2 11.4 19.9 20.0 12.8 64.3 23.3 17.1 22.1 10.1 25.7 16.2 9.7 36.7 13.3 10.1 28.3 17.4 18.5 16.8 17.9 12.4 25.8 15.6 15.3 13.1 20.0 1.0 1.6 37.2 1.9 2.4 5.6 1.6 7.0 1.1 4.9 2.7 2.1 2.5 37.6 4.6 2.2 4.7 4.0 6.0 3.3 6.9 8.3 7.0 2.2 14.3 5.7 24.5 2.9 5.0 6.2 5.0 5.5 6.5 3.2 9.2 9.2 4.0 69.7 3.8 11.5 32.0 11.9 5.6 2.7 5.0 6.4 5.5 5.6 3.1 4.6 18.2 1.8 7.4 8.3 3.8 5.4 16.7 6.3 5.6 3.5 22.6 9.3 15.9 18.8 3.7 7.2 4.2 6.6 2.3 4.3 2.8 4.1 6.0 2.6 4.3 1.8 2.1 1.9 14.7 1.3 1.3 2.4 0.8 2.3 1.7 0.7 1.0 2.3 1.8 37.2 2.4 0.5 1.6 5.6 1.6 23.5 26.2 9.9 16.8 15.4 10.7 20.8 7.2 23.3 17.9 29.8 17.0 3.0 42.2 31.9 7.0 19.8 12.7 33.5 28.4 5.2 19.6 59.9 3.3 10.9 1.0 19.3 16.9 0.0 38.9 46.0 10.8 19.1 23.1 6.8 15.7 3.2 12.7 12.9 7.9 1.3 4.0 11.8 3.3 2.8 41.8 15.6 22.5 10.5 4.2 8.1 23.2 19.4 4.1 9.8 10.4 34.3 96.6 8.7 49.0 20.7 LIMS1 "PINCH, PINCH1" ENSG00000169756 "LIM zinc finger domain containing 1" P48059 2 108534355-108687246 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 89.8" "HPA058455, HPA061230" Approved Supported "Focal adhesion sites,Cytosol" NA NA 130000000 Cytosol "Focal adhesion sites" "HPA058455: AB_2683723, HPA061230: AB_2684456" "unprognostic (1.79e-1)" "unprognostic (8.82e-3)" "unprognostic (5.66e-2)" "unprognostic (1.17e-2)" "unprognostic (1.52e-1)" "unprognostic (4.23e-2)" "unprognostic (1.08e-3)" "unprognostic (1.09e-1)" "unprognostic (8.96e-2)" "unprognostic (1.18e-1)" "unprognostic (5.95e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.88e-4)" "unprognostic (7.51e-2)" "unprognostic (8.60e-3)" "unprognostic (1.43e-2)" "unprognostic (2.11e-1)" 39.3 26.3 7.8 18.3 13.3 14.9 21.5 3.9 9.6 18.1 16.9 14.4 38.2 8.3 21.9 21.7 18.4 16.9 16.5 20.2 8.0 7.5 20.8 18.0 26.3 21.2 13.3 4.6 18.3 10.6 6.6 13.6 19.0 10.8 15.8 9.5 11.0 13.8 43.6 54.0 11.2 17.9 18.8 16.7 24.3 13.0 9.3 10.7 20.2 13.1 15.0 25.5 21.1 16.1 4.4 14.2 45.6 34.0 8.8 20.9 29.6 9.4 10.6 4.2 5.0 7.0 10.2 20.3 10.6 12.2 8.2 8.4 18.4 20.5 9.2 32.5 13.6 12.3 6.1 6.3 10.9 11.1 22.6 11.4 48.1 7.5 9.7 16.0 8.9 89.8 9.8 10.1 21.8 18.0 9.9 29.8 8.1 16.9 12.8 25.3 7.8 8.6 6.6 8.3 6.2 10.9 11.0 14.6 7.4 15.7 17.2 7.6 10.3 16.7 7.1 7.4 5.8 3.7 8.5 40.0 37.5 17.1 8.3 21.7 12.5 16.6 13.1 31.3 10.2 9.5 38.3 16.9 45.6 4.3 28.7 7.8 4.4 18.5 5.7 14.2 3.5 5.0 1.8 8.0 8.8 34.0 1.8 20.9 29.6 7.8 13.3 3.9 9.6 8.0 7.5 13.3 4.6 10.8 10.7 92.3 47.6 42.2 53.7 65.8 24.9 55.7 28.1 57.6 58.0 27.9 51.1 39.0 33.2 68.5 16.9 170.7 21.7 0.0 207.4 109.7 78.3 62.8 99.3 29.3 188.7 14.3 113.4 48.5 145.2 7.9 75.4 215.0 42.2 86.6 18.6 60.5 98.7 14.0 82.7 38.3 18.9 64.7 105.6 36.4 43.6 67.2 23.3 45.9 29.9 55.5 LIMS3 ENSG00000256977 "LIM zinc finger domain containing 3" P0CW19 2 109898428-109924868 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 11.9;endometrium 1: 9.7" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 1.7;Club cells: 1.2;Distal tubular cells: 1.7;Exocrine glandular cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 11.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 9.8;HMC-1: 29.8" HPA058455 Uncertain Approved "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA058455: AB_2683723" "unprognostic (2.23e-2)" 1.2 2.8 0.5 2.2 0.5 0.0 1.0 0.8 0.5 1.0 0.7 0.3 4.2 0.2 9.7 2.8 1.2 7.1 0.9 2.6 0.5 0.5 2.6 0.6 0.8 2.8 0.6 0.3 2.2 0.7 0.3 2.4 5.6 0.3 1.0 0.8 0.6 2.2 0.6 3.0 0.8 0.5 1.2 0.6 0.6 0.7 3.7 0.3 0.3 1.0 0.3 0.3 2.6 0.7 0.7 2.5 11.9 5.5 1.1 6.2 8.0 0.0 0.1 1.3 1.5 0.5 0.4 0.0 1.5 0.0 0.2 0.7 1.5 0.0 0.0 4.7 0.3 3.1 0.8 0.0 1.8 1.3 2.4 0.0 9.8 0.5 0.9 1.4 1.7 29.8 2.2 1.1 1.1 1.3 0.0 2.4 0.0 2.0 1.6 3.3 0.1 0.0 0.2 1.6 0.9 0.6 1.8 3.1 1.0 0.8 1.5 0.4 3.6 4.0 0.0 0.8 0.0 0.0 0.5 7.3 6.4 5.9 3.3 0.3 0.0 0.0 1.9 0.8 0.0 1.9 4.7 3.3 11.9 0.9 5.5 1.5 0.7 5.0 1.7 2.5 0.2 0.9 0.3 0.7 1.1 5.2 0.2 6.2 8.0 0.5 0.5 0.8 0.5 0.5 0.5 0.6 0.3 0.3 0.3 0.0 0.3 0.0 0.1 0.1 0.0 1.7 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 LIMS4 LIMS3L ENSG00000256671 "LIM zinc finger domain containing 4" P0CW20 2 110446640-110473075 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 26 "Exocrine glandular cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.7;HHSteC: 2.5;hTEC/SVTERT24-B: 4.9;HUVEC TERT2: 2.8;U-138 MG: 5.3" HPA058455 Uncertain Uncertain "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA058455: AB_2683723" "unprognostic (2.12e-1)" 4.0 4.1 0.0 0.3 0.0 0.6 1.5 0.0 0.3 0.3 0.6 0.3 4.1 0.3 0.3 3.7 0.3 3.5 0.0 0.0 5.5 2.7 0.8 0.3 0.0 1.9 2.2 0.3 0.8 0.6 0.3 0.3 0.3 0.3 5.6 0.4 0.3 0.3 0.0 0.3 0.3 1.3 1.1 0.3 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 2.7 0.2 0.7 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.3 0.2 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LIN28A "CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1" ENSG00000131914 "Lin-28 homolog A" Q9H9Z2 1 26410778-26429722 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 9.8" "Group enriched" "Detected in some" 42 "Early spermatids: 24.2;Late spermatids: 49.8" "Cancer enriched" "Detected in single" 261 "testis cancer: 101.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "NTERA-2: 136.8;SuSa: 50.5" "Not detected" "Not detected" "CAB020785, HPA063074, HPA068814" Enhanced Supported "Nucleoli,Cytosol,Rods & Rings" NA NA Cytosol "Nucleoli, Rods & Rings" "CAB020785: , HPA063074: , HPA068814: " "unprognostic (9.64e-3)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.85e-1)" "unprognostic (2.21e-1)" "unprognostic (2.49e-2)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.5 0.5 0.1 0.1 0.1 0.2 0.3 9.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.6 2.3 0.5 1.0 0.8 0.1 0.0 0.0 13.5 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.7 0.7 0.3 0.4 1.0 0.5 0.6 0.2 1.3 0.8 0.7 2.2 1.0 0.3 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.4 0.1 0.0 0.0 0.0 0.1 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 51.9" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 66.0;Extravillous trophoblasts: 67.8;Syncytiotrophoblasts: 46.7" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 14.1;BEWO: 73.1;Hep G2: 12.2;K-562: 23.6;NTERA-2: 12.9;SuSa: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 1.2 0.0 0.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.0 0.0 1.0 51.9 1.2 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 5.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.7 2.1 0.4 0.2 0.5 0.3 0.0 0.9 14.1 2.8 0.0 0.0 73.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.8 0.0 8.8 0.0 0.0 0.0 6.8 10.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.3 0.0 0.0 1.5 1.7 12.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 1.1 13.5 0.0 2.9 0.3 0.0 1.5 0.0 0.0 4.3 6.0 0.0 0.0 0.0 0.0 1.6 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.1 0.2 2.1 0.2 0.4 0.7 0.2 0.3 1.2 0.8 0.1 1.3 0.9 1.3 0.5 0.8 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 5.9 66.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 67.8 0.0 0.0 0.0 0.0 8.0 1.6 0.0 0.0 0.0 17.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 6.5 0.0 5.8 9.2 0.0 46.7 0.0 0.0 0.0 LIN54 "CXCDC1, DKFZp686L1814, JC8.6, MIP120, TCX1" ENSG00000189308 "Lin-54 DREAM MuvB core complex component" Q6MZP7 4 82909973-83012926 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 27.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 52.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056606 Approved Approved Cytosol NA NA Cytosol "HPA056606: AB_2683187" "unprognostic (2.01e-2)" "unprognostic (1.47e-2)" "unprognostic (2.52e-2)" "unprognostic (7.11e-2)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (3.56e-3)" "unprognostic (6.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.06e-1)" "unprognostic (3.03e-1)" "unprognostic (2.60e-2)" "prognostic favorable (1.06e-4)" "unprognostic (3.02e-2)" "unprognostic (1.51e-1)" "unprognostic (9.17e-2)" "unprognostic (1.81e-2)" 6.9 6.2 9.0 6.7 13.7 16.5 7.1 13.3 12.4 8.4 8.4 12.2 2.0 7.6 6.5 6.1 15.4 5.5 5.6 6.0 10.2 8.6 10.9 11.6 6.1 8.5 15.7 7.5 7.6 4.6 9.8 8.5 8.8 10.5 5.9 10.2 6.7 8.1 6.7 10.6 7.7 6.0 6.5 15.2 7.8 6.4 9.5 12.7 27.2 14.9 8.5 11.9 7.5 8.2 3.4 2.2 8.1 8.8 6.9 7.6 3.6 7.1 4.2 6.7 7.6 3.5 3.4 5.0 11.6 8.1 8.8 8.5 5.0 8.3 7.8 6.4 11.9 5.8 5.6 9.1 3.7 10.8 8.4 4.0 7.1 6.7 5.6 3.1 8.7 52.6 2.9 2.2 9.7 4.7 2.7 5.3 7.4 7.7 15.7 8.5 5.0 18.5 3.6 2.8 8.8 2.8 10.1 7.4 5.5 4.2 6.2 7.0 3.7 7.0 11.3 4.6 4.4 4.9 5.7 4.1 10.6 7.9 9.8 5.2 7.8 5.8 13.3 5.9 5.5 8.3 5.3 3.8 7.7 6.1 3.0 6.9 2.7 6.1 6.6 2.2 3.4 7.6 6.4 8.1 6.9 8.8 1.7 6.8 3.6 9.0 13.7 13.3 12.4 10.2 8.6 15.7 7.5 10.5 12.7 6.0 5.6 7.0 3.2 10.8 8.6 5.1 5.1 4.0 3.4 5.2 2.0 2.9 0.0 2.7 27.1 4.3 4.9 23.3 3.1 4.0 4.3 4.1 2.3 6.2 5.5 4.8 4.1 5.5 4.9 11.6 2.3 5.9 8.5 1.0 3.8 6.3 3.1 2.9 4.6 5.4 8.0 12.9 4.4 2.2 2.8 10.9 2.9 5.1 4.6 6.8 LIPA "CESD, LAL" ENSG00000107798 "Lipase A, lysosomal acid type" P38571 10 89213569-89414557 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.0" "Group enriched" "Detected in many" 7 "Hofbauer cells: 503.3;Kupffer cells: 514.1;Macrophages: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6" "Group enriched" "Detected in all" 5 "dendritic cells: 23.3;monocytes: 68.4" "Cell line enhanced" "Detected in many" "AN3-CA: 61.6;ASC TERT1: 77.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034892, HPA057052" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Intracellular and membrane" NA NA 150000 "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "CAB034892: AB_784329, HPA057052: AB_2683322" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (7.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (4.28e-2)" "unprognostic (1.08e-1)" "unprognostic (7.30e-3)" "unprognostic (1.39e-2)" "unprognostic (1.40e-1)" "unprognostic (4.42e-2)" "unprognostic (3.42e-2)" "unprognostic (5.71e-2)" 139.0 16.3 15.8 14.4 22.7 7.8 19.9 8.8 21.4 13.4 28.1 61.3 3.4 37.4 10.2 5.2 9.5 9.0 19.4 8.7 22.5 13.8 10.8 49.3 38.5 45.7 41.6 13.4 10.4 9.5 17.5 6.3 17.8 28.4 7.4 16.7 5.7 11.0 8.8 4.1 6.8 65.8 11.3 55.1 87.3 7.9 3.1 37.2 7.0 8.3 4.7 10.0 15.1 8.6 7.0 23.3 3.2 68.4 5.5 8.3 25.5 55.0 8.5 5.6 61.6 58.1 77.3 1.6 29.2 34.2 12.2 21.9 3.2 29.7 10.2 5.7 45.7 13.1 55.2 2.4 15.8 9.1 14.3 5.7 4.2 3.6 13.1 15.3 8.1 8.4 34.3 11.4 13.0 7.0 14.8 2.4 7.7 0.0 19.0 9.5 4.6 7.0 5.5 3.6 9.8 9.6 4.6 6.6 9.4 11.3 8.7 1.9 3.9 7.1 9.2 21.5 3.9 10.5 10.5 4.4 10.4 2.7 22.2 7.1 9.9 10.5 4.2 12.4 18.0 13.0 0.8 31.8 3.2 8.2 68.4 8.2 6.5 7.3 7.8 23.3 7.0 7.7 8.3 1.4 5.5 35.6 4.7 7.1 25.5 15.8 22.7 8.8 21.4 22.5 13.8 41.6 13.4 28.4 37.2 38.7 42.2 50.6 22.0 15.8 5.2 8.5 45.9 14.7 13.6 31.4 0.0 28.4 18.3 29.7 4.4 53.1 3.9 23.3 31.7 28.0 34.8 15.2 27.7 46.5 503.3 15.9 20.9 52.8 514.1 1.8 10.6 167.0 45.5 27.9 9.4 29.4 17.5 5.9 20.5 14.6 1.3 6.5 21.8 4.8 10.9 10.9 16.7 33.0 8.7 20.1 LIPE HSL ENSG00000079435 "Lipase E, hormone sensitive type" Q05469 19 42401507-42427426 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism" Hydrolase "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 207.4;breast: 65.1" "Group enriched" "Detected in many" 6 "Early spermatids: 123.5;Late spermatids: 188.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "ASC diff: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA006567, CAB017700" Enhanced Supported Cytosol NA NA Cytosol "CAB017700: AB_2135504, HPA006567: AB_2667618" "unprognostic (4.24e-2)" "unprognostic (2.46e-2)" "unprognostic (8.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.77e-1)" "unprognostic (3.38e-3)" "unprognostic (5.68e-2)" "unprognostic (2.84e-1)" "unprognostic (3.11e-1)" "unprognostic (9.44e-2)" "prognostic favorable (1.15e-4)" "unprognostic (1.52e-1)" "unprognostic (3.63e-10)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (3.76e-2)" "unprognostic (2.34e-3)" 207.4 6.0 3.2 2.9 9.4 2.1 65.1 2.0 6.8 1.2 6.7 19.6 0.8 2.4 1.7 1.3 2.2 1.6 3.6 4.8 6.2 4.2 1.5 1.1 1.4 2.7 18.0 2.3 1.5 2.2 2.2 0.8 1.7 9.9 1.7 1.3 3.7 5.4 1.7 3.7 2.9 3.4 1.7 19.2 3.1 1.6 9.0 10.8 1.7 1.5 1.8 1.9 2.0 3.7 6.1 4.8 10.8 12.1 4.1 5.2 4.0 4.9 3.8 2.5 0.9 57.3 0.5 0.0 2.3 1.3 3.7 3.5 0.9 1.9 8.2 2.6 0.7 1.8 2.2 1.5 4.6 0.4 1.5 2.4 2.3 1.8 0.1 1.1 0.0 5.6 0.5 4.4 0.6 0.8 0.5 1.0 3.4 1.0 5.2 0.5 0.0 5.7 0.2 0.3 3.8 1.1 4.7 0.4 2.7 1.0 5.2 3.5 3.6 2.0 2.3 2.1 0.1 0.6 3.0 1.9 1.0 3.2 0.4 2.1 3.9 3.2 6.1 2.6 0.2 3.5 10.8 12.1 4.7 3.6 6.0 3.3 4.8 4.6 5.2 4.8 6.1 4.1 3.7 2.0 4.1 3.3 3.9 3.9 4.0 3.2 9.4 2.0 6.8 6.2 4.2 18.0 2.3 9.9 10.8 0.0 3.5 1.3 10.1 3.7 8.1 2.2 0.0 0.0 0.0 1.8 9.8 0.0 1.7 6.4 123.5 4.5 3.2 23.3 2.4 0.1 1.7 5.2 0.0 0.0 0.6 7.9 0.0 17.8 1.8 188.1 2.8 1.2 5.0 0.0 1.1 3.3 1.4 0.0 1.4 1.1 12.3 0.0 1.0 26.8 12.4 2.0 0.0 6.9 2.7 9.0 LIX1 "C5orf11, Lft" ENSG00000145721 "Limb and CNS expressed 1" Q8N485 5 97091867-97142872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.9" "Cell type enriched" "Detected in some" 16 "Muller glia cells: 199.8" "Cancer enhanced" "Detected in many" "glioma: 13.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.9" "Lineage enriched" "Detected in single" 9 "B-cells: 5.9" "Group enriched" "Detected in some" 11 "RPTEC TERT1: 24.5;SuSa: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058426 Uncertain Approved "Vesicles,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Vesicles, Cytokinetic bridge" "HPA058426: AB_2683715" "unprognostic (3.18e-1)" "unprognostic (4.53e-2)" "unprognostic (9.46e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (8.96e-2)" "unprognostic (6.60e-2)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (7.63e-2)" "unprognostic (1.58e-2)" "unprognostic (3.52e-1)" "unprognostic (2.01e-1)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" "unprognostic (9.61e-2)" 1.0 1.2 14.9 1.3 16.9 1.4 1.1 6.1 35.9 1.0 1.3 19.2 1.0 1.2 1.2 1.2 1.0 1.2 1.1 1.1 24.6 10.7 4.9 1.0 1.1 1.6 11.7 13.2 1.0 1.0 1.0 1.2 1.4 12.4 3.0 1.4 3.3 1.1 8.3 1.1 1.1 1.2 1.2 10.1 1.2 1.2 1.1 13.0 0.0 6.5 0.0 1.0 1.0 0.2 5.9 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 1.2 0.1 0.0 0.0 5.9 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 14.9 16.9 6.1 11.9 24.6 10.7 11.7 13.2 12.4 13.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 199.8 0.0 0.0 0.0 1.4 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIX1L MGC46719 ENSG00000271601 "Limb and CNS expressed 1 like" Q8IVB5 1 145933423-145958001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 53.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063598 Approved Cytosol NA NA Cytosol "HPA063598: AB_2685055" "unprognostic (5.21e-2)" "unprognostic (4.09e-1)" "unprognostic (6.84e-3)" "unprognostic (2.85e-2)" "unprognostic (3.71e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (9.81e-2)" "unprognostic (3.46e-1)" "unprognostic (3.87e-2)" "unprognostic (1.84e-3)" "unprognostic (3.51e-2)" "prognostic unfavorable (3.19e-5)" "unprognostic (2.10e-3)" "unprognostic (4.95e-1)" "unprognostic (1.25e-2)" "prognostic unfavorable (5.27e-4)" 13.8 8.9 4.6 6.5 4.4 2.1 6.0 4.1 5.9 14.4 8.0 7.1 3.2 2.7 15.9 7.6 5.8 6.3 10.6 10.0 4.3 4.2 5.4 6.4 9.2 5.7 4.0 19.6 1.7 4.4 9.4 7.5 4.0 11.6 4.2 11.4 3.3 10.7 10.5 2.4 4.0 12.7 4.2 9.4 2.6 7.4 5.8 11.1 4.6 4.5 9.5 11.8 8.4 4.3 4.2 5.1 4.4 4.8 11.1 3.1 3.2 4.6 14.2 15.7 29.7 25.2 0.2 7.3 13.3 11.4 8.4 0.3 3.0 8.6 8.1 14.7 4.3 0.1 6.5 6.1 10.8 7.9 2.1 4.8 5.2 4.6 9.8 11.3 11.4 15.4 2.8 9.3 13.5 18.4 22.0 11.6 7.0 13.9 18.0 0.1 14.9 9.5 4.1 0.0 6.0 10.1 7.1 14.2 11.7 0.0 5.1 14.5 15.0 0.0 10.8 6.1 0.5 9.0 16.9 19.4 5.3 12.6 12.2 11.2 7.9 8.9 13.7 9.5 9.3 4.8 2.9 4.6 8.0 2.7 9.7 4.0 9.2 8.0 2.7 4.3 8.6 11.1 5.1 4.8 4.4 4.2 6.7 3.1 0.0 7.2 19.0 10.3 10.1 15.1 14.6 12.7 1.4 3.4 10.4 7.9 1.3 3.3 8.4 5.7 31.4 0.0 23.3 8.5 3.8 21.4 7.3 4.7 17.3 18.5 12.7 12.1 35.6 19.6 3.2 33.1 14.0 27.0 21.6 2.2 22.7 8.5 0.0 53.0 5.7 12.0 25.8 37.6 13.6 3.4 6.8 0.7 21.9 1.8 3.8 LLGL2 "HGL, Hugl-2" ENSG00000073350 "LLGL2, scribble cell polarity complex component" Q6P1M3 17 75525080-75575208 "Predicted intracellular proteins" "Cell cycle, Cell division, Exocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 157.1;Enterocytes: 176.2;Pancreatic endocrine cells: 171.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 6.2" "Group enriched" "Detected in many" 6 "dendritic cells: 2.2;NK-cells: 4.1;T-cells: 6.2" "Cell line enhanced" "Detected in many" "CACO-2: 25.9;CAPAN-2: 38.2;MCF7: 36.7;OE19: 28.3;RT4: 26.1;SK-BR-3: 36.6;T-47d: 27.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA022913 Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA022913: AB_1852930" "unprognostic (1.18e-1)" "unprognostic (4.18e-2)" "unprognostic (2.89e-2)" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "prognostic favorable (9.25e-4)" "unprognostic (2.60e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (3.49e-1)" "prognostic favorable (6.00e-5)" "unprognostic (6.22e-3)" "prognostic favorable (6.14e-9)" "unprognostic (1.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.15e-3)" "unprognostic (1.56e-2)" 1.7 3.9 1.5 17.3 4.2 1.4 4.2 5.1 3.7 7.1 27.5 5.2 23.0 22.9 2.8 17.1 24.3 6.4 45.7 1.7 1.7 1.0 35.6 17.1 16.0 2.1 11.2 1.8 4.6 37.5 5.0 8.3 5.1 3.6 6.6 11.9 6.3 21.4 20.0 0.7 13.9 36.0 1.2 2.5 9.6 27.7 4.3 4.9 1.5 13.4 13.0 13.6 7.0 10.6 0.6 2.2 0.3 0.6 4.1 6.2 0.9 16.5 15.4 0.0 2.9 0.0 0.0 6.5 0.1 0.1 0.3 0.2 25.9 38.2 1.1 3.9 0.0 1.4 20.9 2.9 2.8 0.0 1.4 5.2 1.1 4.3 9.8 0.1 0.1 2.5 0.0 3.9 0.0 0.6 0.3 0.6 1.6 2.1 1.5 0.0 36.7 0.9 1.9 2.1 28.3 6.1 1.9 0.0 4.1 8.2 26.1 6.4 1.2 3.3 36.6 1.1 3.7 27.7 2.6 0.1 0.0 0.1 0.0 0.2 1.8 2.4 0.4 0.1 0.1 0.7 0.0 0.3 0.1 6.2 0.6 1.4 0.6 1.5 4.2 0.3 0.6 0.2 2.5 0.3 4.1 0.2 2.2 1.0 0.9 1.5 4.2 5.1 3.7 1.7 1.0 11.2 1.8 3.6 4.9 83.4 42.2 11.5 27.2 9.4 5.9 2.8 76.5 26.8 35.2 85.5 157.1 2.8 26.6 74.4 0.5 6.7 176.2 0.0 122.1 7.5 2.2 34.1 21.9 22.9 5.2 7.9 91.3 1.8 2.4 0.2 4.4 4.7 3.3 8.2 85.6 35.2 171.3 90.5 3.9 35.9 116.4 6.5 3.9 1.6 19.4 19.1 3.7 12.9 82.9 76.2 LMAN1 "ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60" ENSG00000074695 "Lectin, mannose binding 1" P49257 18 59327823-59359962 "Disease related genes, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 369.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002320, CAB037163" Supported Uncertain Cytosol NA NA 13000000 Cytosol "CAB037163: AB_532237, HPA002320: AB_1079256" "unprognostic (5.64e-2)" "unprognostic (8.96e-3)" "unprognostic (4.20e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (1.65e-1)" "unprognostic (5.40e-3)" "unprognostic (1.16e-1)" "unprognostic (2.03e-1)" "unprognostic (2.40e-2)" "unprognostic (1.06e-1)" "unprognostic (5.79e-2)" "unprognostic (4.28e-2)" "unprognostic (5.37e-3)" "unprognostic (7.05e-2)" "unprognostic (3.71e-3)" 6.2 7.7 2.6 4.5 3.0 1.6 5.7 4.6 1.8 9.8 3.9 5.7 6.7 7.4 6.6 6.5 3.8 8.0 2.7 3.0 9.1 26.2 7.0 2.7 2.8 8.1 15.3 12.7 9.7 7.1 8.2 5.0 8.4 6.1 6.9 3.4 6.1 4.6 3.5 4.8 7.5 2.1 12.3 3.9 4.7 5.6 6.9 8.2 4.0 3.4 9.0 9.8 3.8 18.7 11.1 11.9 9.9 27.9 48.3 24.1 34.0 48.8 23.0 30.9 11.0 18.2 3.3 24.2 40.3 16.5 23.1 16.9 19.2 42.0 12.7 10.8 10.9 14.9 22.8 33.2 37.8 16.8 32.1 23.2 22.2 45.7 43.4 23.1 11.6 18.3 37.4 22.3 5.0 10.9 7.8 8.2 9.5 13.8 12.4 21.7 36.3 12.8 14.2 8.2 8.9 17.1 16.8 19.2 17.5 12.4 14.8 19.0 37.5 13.1 11.9 19.7 28.6 14.2 16.2 39.3 20.2 30.5 4.0 2.3 0.6 7.2 3.4 9.8 6.9 7.9 7.5 3.1 4.7 7.6 7.5 0.3 9.0 1.9 8.2 8.7 3.8 95.3 75.6 40.2 99.5 62.0 36.5 107.3 68.8 120.5 94.4 76.8 100.1 135.4 18.3 109.7 19.1 71.9 34.5 0.0 73.5 233.6 149.7 186.9 32.4 369.6 72.2 55.6 49.5 84.1 33.9 6.3 102.4 44.4 64.1 62.3 110.0 95.5 79.1 59.6 80.2 62.0 60.8 64.7 72.9 37.1 59.8 49.8 193.4 52.2 80.9 90.2 LMBR1 "ACHP, C7orf2, FLJ11665, ZRS" ENSG00000105983 "Limb development membrane protein 1" Q8WVP7 7 156668946-156893230 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016592 Approved Approved Cytosol NA NA Cytosol "HPA016592: AB_1852943" "unprognostic (8.81e-3)" "unprognostic (1.73e-2)" "unprognostic (9.49e-2)" "unprognostic (2.02e-1)" "unprognostic (3.77e-3)" "unprognostic (6.90e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-1)" "unprognostic (1.21e-2)" "unprognostic (1.12e-2)" "unprognostic (1.69e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.44e-6)" "unprognostic (3.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.48e-1)" "unprognostic (7.10e-2)" 15.8 30.5 15.2 12.4 23.7 7.1 12.9 20.4 25.5 16.3 10.1 13.4 12.8 9.1 19.0 19.4 12.1 16.9 12.8 12.9 15.9 17.4 17.5 15.9 11.5 11.3 17.8 11.5 18.9 12.0 38.2 22.7 11.6 24.4 14.1 12.2 11.3 10.6 13.1 14.8 11.2 10.9 15.1 14.4 9.4 12.7 20.3 13.2 14.7 20.9 8.7 12.8 13.9 12.3 2.3 3.6 4.2 2.0 0.9 4.1 1.5 12.5 11.0 12.5 15.4 10.1 12.2 8.5 7.3 9.2 6.6 7.3 7.9 20.5 12.3 14.0 9.4 12.4 10.1 13.1 13.6 14.0 8.8 13.3 9.1 6.1 9.5 7.0 11.2 6.3 9.2 12.3 9.6 12.6 10.5 14.2 10.5 17.4 11.3 13.4 11.8 11.2 9.0 14.5 13.3 9.9 6.1 8.9 15.0 10.4 12.5 13.3 24.8 9.6 13.1 7.0 8.4 9.2 6.2 19.9 11.9 4.6 40.9 9.2 13.7 10.7 12.2 20.2 14.3 7.3 4.2 2.0 2.7 1.7 1.0 4.1 1.3 3.6 2.6 3.6 2.3 4.0 2.5 1.5 0.9 1.7 2.2 2.2 1.5 15.2 23.7 20.4 25.5 15.9 17.4 17.8 11.5 24.4 13.2 3.0 7.2 6.4 11.5 9.3 11.2 15.4 12.7 5.3 4.5 12.2 2.0 12.6 5.0 9.4 6.0 20.0 8.4 0.0 8.9 4.8 11.6 16.2 5.7 18.1 8.5 7.9 7.9 8.6 8.6 8.0 9.8 6.1 6.8 4.6 9.7 6.5 10.3 7.0 8.1 9.4 10.6 0.0 6.0 9.6 27.4 11.2 19.3 5.7 11.0 13.3 LMBRD2 DKFZp434H2226 ENSG00000164187 "LMBR1 domain containing 2" Q68DH5 5 36098412-36151961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 11.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 11.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012165 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA012165: AB_2136131" "unprognostic (9.43e-3)" "unprognostic (3.03e-1)" "unprognostic (1.80e-2)" "unprognostic (7.09e-2)" "unprognostic (1.79e-1)" "unprognostic (9.53e-3)" "unprognostic (6.58e-2)" "unprognostic (8.46e-3)" "unprognostic (6.45e-3)" "unprognostic (2.80e-1)" "unprognostic (8.61e-2)" "unprognostic (6.94e-2)" "unprognostic (2.30e-3)" "unprognostic (7.53e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (5.35e-2)" 6.2 9.7 12.1 6.6 21.4 2.2 8.8 12.8 25.5 7.3 8.7 9.5 7.6 9.6 5.3 7.2 6.8 4.8 5.8 8.2 14.2 11.4 10.5 14.2 5.7 7.6 9.9 15.6 5.0 7.7 16.9 16.9 8.4 14.1 9.7 9.1 4.8 7.6 6.8 11.1 7.7 9.6 5.5 10.5 6.7 10.1 5.2 8.6 8.4 12.8 2.9 7.4 7.6 6.1 1.5 1.2 11.0 1.2 1.0 2.3 0.8 4.9 3.7 4.5 7.4 9.4 8.3 15.9 10.3 5.4 7.6 7.6 4.6 10.8 8.9 5.2 5.4 7.8 6.8 5.9 3.6 12.5 12.7 3.6 6.9 12.6 0.8 6.0 8.3 9.2 4.9 6.4 6.5 6.5 5.7 4.1 6.9 8.1 9.4 9.1 3.3 7.1 5.5 2.5 7.7 4.7 5.4 10.5 5.4 6.5 4.4 8.5 6.6 14.8 8.8 3.6 4.6 10.0 10.1 5.4 9.1 2.4 11.5 5.4 7.7 11.3 7.8 8.6 9.5 6.2 11.0 1.2 2.0 1.6 1.2 1.1 1.5 1.4 1.4 1.0 1.3 1.9 1.9 0.8 1.0 1.2 1.2 2.3 0.8 12.1 21.4 12.8 25.5 14.2 11.4 9.9 15.6 14.1 8.6 8.9 9.8 5.6 4.2 6.2 10.8 22.2 10.2 9.4 2.3 12.2 7.9 8.0 3.3 4.4 1.3 5.8 11.8 0.0 6.6 5.6 6.6 8.8 6.9 25.2 9.7 14.3 6.4 9.8 13.2 1.4 4.4 7.7 6.8 6.4 14.8 11.6 5.6 3.5 6.7 10.2 10.7 12.9 7.9 21.2 8.1 8.8 16.2 6.7 10.4 2.5 LMCD1 ENSG00000071282 "LIM and cysteine rich domains 1" Q9NZU5 3 8501707-8574673 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 189.9" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 99.6;Horizontal cells: 92.2;Smooth muscle cells: 171.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "T-reg: 17.0" "Lineage enriched" "Detected in many" 6 "T-cells: 17.0" "Cell line enhanced" "Detected in many" "HHSteC: 30.4;HSkMC: 42.6;hTEC/SVTERT24-B: 31.3;U-2197: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024059 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane, Cell Junctions" "HPA024059: AB_1852950" "unprognostic (2.46e-1)" "unprognostic (1.79e-1)" "unprognostic (5.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (8.21e-3)" "unprognostic (4.29e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (8.66e-5)" "unprognostic (3.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.01e-3)" "unprognostic (3.68e-3)" 38.6 3.3 1.6 10.1 1.8 0.0 36.4 3.9 1.9 11.7 4.4 3.8 5.2 1.9 22.3 20.8 8.3 11.9 15.4 15.9 2.3 1.7 5.5 2.2 25.9 3.8 2.4 1.7 17.9 8.5 5.8 2.0 14.1 4.5 16.1 1.6 4.6 19.2 7.0 189.9 5.7 3.3 72.9 3.7 14.3 10.6 9.3 1.3 0.8 4.6 34.3 7.1 29.4 15.7 1.8 2.7 0.0 0.3 0.0 17.0 0.2 2.9 16.9 2.8 2.1 21.1 11.9 2.9 12.4 6.4 6.8 16.9 12.5 3.8 0.0 1.4 14.3 2.9 0.2 1.6 3.2 2.8 5.1 1.1 3.7 1.1 2.4 30.4 0.0 0.3 42.6 0.0 31.3 0.2 4.0 3.3 0.0 0.0 0.0 8.8 2.1 0.0 0.0 5.5 3.8 0.7 0.0 9.4 0.0 6.3 1.1 0.1 7.1 2.0 10.3 6.4 8.4 13.4 0.0 1.6 6.9 13.8 27.6 8.3 1.7 1.9 0.8 1.4 0.9 8.8 0.0 0.0 0.0 0.0 0.3 0.1 1.8 2.6 0.5 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.9 17.0 0.2 1.6 1.8 3.9 1.9 2.3 1.7 2.4 1.7 4.5 1.3 8.9 15.4 0.0 47.6 28.0 13.3 13.7 20.4 20.1 15.9 5.2 9.8 2.6 3.3 99.6 0.9 70.2 0.5 0.0 42.3 3.5 58.2 6.1 10.3 11.3 3.1 92.2 11.6 36.2 0.6 1.5 10.6 4.0 50.6 15.4 2.2 34.8 83.3 0.0 30.4 29.2 7.9 0.0 171.0 5.0 7.0 23.7 3.7 2.2 3.3 5.2 LMLN "Gp63, LMNL1, Msp" ENSG00000185621 "Leishmanolysin like peptidase" Q96KR4 3 197960200-198043720 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 32.1;Early spermatids: 29.2;Spermatocytes: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016481, HPA028844" Uncertain Supported "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA016481: AB_1852955, HPA028844: AB_10602347" "unprognostic (2.54e-1)" "unprognostic (3.15e-1)" "unprognostic (7.63e-2)" "prognostic favorable (6.77e-4)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-1)" "unprognostic (6.36e-2)" "unprognostic (2.98e-1)" "unprognostic (4.82e-3)" "unprognostic (8.78e-2)" "unprognostic (7.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" 3.9 4.9 5.2 2.5 11.0 2.3 4.5 6.1 9.1 6.2 3.5 5.8 14.3 2.2 4.8 20.3 3.5 9.3 5.1 5.9 5.7 7.4 6.6 3.7 8.1 3.5 5.6 8.9 6.5 6.1 8.8 15.0 3.9 11.6 4.6 4.1 5.4 4.2 11.7 3.7 6.5 2.3 4.0 5.5 3.0 3.9 27.0 4.4 1.2 7.6 3.0 2.6 3.5 3.7 1.9 1.9 0.8 2.4 1.8 2.4 1.2 6.5 2.5 2.9 3.5 5.8 8.2 2.5 3.4 3.1 6.1 5.1 2.4 2.4 2.1 15.8 2.4 13.3 2.5 2.7 2.7 9.0 0.3 2.0 1.2 2.1 1.8 3.6 3.6 1.8 3.9 6.1 7.6 5.0 3.6 2.6 5.3 6.3 4.0 5.9 4.8 2.2 3.2 3.3 4.7 5.9 2.5 0.7 2.2 6.3 1.7 4.8 1.4 4.7 4.2 3.4 3.5 11.0 2.8 5.7 7.6 1.1 9.1 5.7 7.1 13.7 0.6 10.8 6.4 6.8 0.2 0.6 0.5 1.2 2.4 1.7 1.9 0.8 1.6 1.9 1.1 2.2 2.4 0.8 1.8 0.9 0.5 0.0 1.2 5.2 11.0 6.1 9.1 5.7 7.4 5.6 8.9 11.6 4.4 14.9 11.3 1.9 1.5 1.8 7.7 9.2 2.5 32.1 13.6 8.7 15.7 2.5 0.0 2.5 29.2 2.5 1.0 0.0 2.3 2.1 3.3 1.9 2.3 2.4 4.2 7.9 4.6 4.3 2.8 18.6 4.4 2.0 3.3 0.0 3.1 7.7 1.8 0.0 5.3 3.7 16.3 0.0 3.2 29.2 24.7 1.5 2.4 1.3 2.3 1.3 LMO7 "FBX20, FBXO20, KIAA0858" ENSG00000136153 "LIM domain 7" Q8WWI1 13 75620434-75859870 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.6" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 1563.3;Club cells: 396.9;Urothelial cells: 377.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.1" "Lineage enriched" "Detected in many" 5 "T-cells: 14.1" "Cell line enhanced" "Detected in many" "BJ: 55.4;fHDF/TERT166: 91.4;LHCN-M2: 86.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2" "HPA020923, HPA050184" Enhanced Supported "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA020923: AB_1852963, HPA050184: AB_2681045" "unprognostic (2.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.75e-2)" "unprognostic (1.44e-1)" "unprognostic (1.57e-2)" "unprognostic (1.97e-1)" "unprognostic (1.52e-2)" "unprognostic (3.42e-2)" "prognostic unfavorable (3.51e-4)" "unprognostic (2.14e-1)" "prognostic favorable (7.75e-12)" "unprognostic (2.49e-1)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (8.33e-2)" 2.2 2.2 10.1 6.3 32.6 0.9 2.5 2.7 13.2 6.7 24.3 0.5 2.4 17.5 2.3 7.8 42.5 4.0 16.3 65.6 9.8 2.5 21.7 19.9 57.0 2.6 2.3 8.8 5.5 6.8 6.2 3.1 10.9 1.1 7.6 8.9 2.7 14.3 7.0 44.4 8.6 55.0 2.1 2.0 1.5 16.7 4.7 4.1 16.2 25.7 36.3 23.7 4.6 15.4 2.4 1.1 3.0 0.5 0.5 14.1 2.6 12.2 7.0 0.2 0.2 14.6 10.4 2.4 55.4 27.4 14.1 15.3 17.1 15.9 1.0 4.2 91.4 3.5 11.9 3.0 2.6 16.3 16.5 0.7 7.5 37.2 16.0 4.2 2.4 3.9 7.1 5.2 6.1 7.0 34.6 5.9 2.4 0.2 0.1 86.0 4.8 1.8 1.0 0.3 19.0 10.6 1.1 25.9 0.2 6.0 2.8 0.9 1.9 10.1 1.7 2.2 1.5 2.3 1.8 9.0 34.9 6.5 4.1 13.5 3.7 2.7 4.4 10.2 2.7 15.8 3.0 0.2 2.4 0.7 0.5 0.9 1.1 3.2 1.0 0.4 2.4 14.1 8.5 0.1 0.5 0.3 1.1 1.2 2.6 10.1 32.6 2.7 13.2 9.8 2.5 2.3 8.8 1.1 4.1 1563.3 242.1 2.7 51.2 21.3 5.2 309.1 48.4 234.2 396.9 59.3 2.0 38.6 13.3 56.6 4.7 11.3 219.0 0.0 32.9 6.2 66.8 251.0 19.7 61.7 5.1 6.4 68.3 6.7 3.7 5.6 38.9 4.9 15.1 1.8 69.4 1.7 146.0 64.9 40.0 13.6 10.9 12.9 19.1 8.1 3.2 39.5 14.2 7.0 44.1 377.1 LMOD1 "1D, 64kD, D1" ENSG00000163431 "Leiomodin 1" P29536 1 201896452-201946588 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 199.7;urinary bladder: 165.5" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 127.6;Leydig cells: 116.2;Peritubular cells: 258.9;Rod photoreceptor cells: 66.8;Sertoli cells: 194.1;Smooth muscle cells: 158.8" "Cancer enhanced" "Detected in all" "prostate cancer: 43.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 9.2;BJ: 11.9;BJ hTERT+: 19.3;fHDF/TERT166: 9.6;HSkMC: 8.5;hTERT-RPE1: 31.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028325, HPA028435, HPA030097" Enhanced Approved Cytosol No No Cytosol "HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223" "unprognostic (3.84e-2)" "unprognostic (5.01e-2)" "unprognostic (1.44e-2)" "unprognostic (1.27e-1)" "unprognostic (5.64e-1)" "unprognostic (6.35e-2)" "prognostic favorable (2.52e-5)" "unprognostic (1.27e-1)" "unprognostic (6.10e-2)" "unprognostic (1.73e-2)" "unprognostic (3.51e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.30e-2)" "unprognostic (2.72e-1)" "unprognostic (4.44e-3)" "unprognostic (1.15e-2)" 27.4 12.7 1.9 26.7 6.2 0.0 20.5 2.2 1.9 65.6 83.5 1.8 42.7 6.0 84.9 29.0 94.6 33.2 80.7 8.3 1.6 1.6 5.3 1.0 11.0 5.5 2.3 3.2 38.1 1.6 7.4 1.3 10.2 4.1 77.1 12.0 28.9 6.8 63.8 29.5 7.4 20.9 199.7 1.8 6.3 47.0 23.3 0.7 0.0 7.9 12.3 2.7 165.5 39.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 9.2 1.1 0.7 11.9 19.3 0.7 0.9 0.0 0.1 0.0 0.4 9.6 0.1 0.2 0.3 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 8.5 0.0 0.5 0.0 31.2 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.3 0.2 5.6 0.4 0.0 0.0 0.1 0.4 0.1 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.9 6.2 2.2 1.9 1.6 1.6 2.3 3.2 4.1 0.7 0.0 1.4 0.0 0.7 1.1 4.9 22.4 0.0 1.4 0.0 0.0 127.6 1.1 0.0 0.0 1.9 2.1 0.0 0.0 0.5 0.2 13.9 0.6 0.0 0.0 0.8 3.2 0.0 13.5 0.0 3.6 116.2 0.0 3.3 0.0 0.0 4.5 0.0 0.0 258.9 0.0 66.8 194.1 158.8 1.4 0.2 1.9 1.0 0.0 0.0 0.3 LMOD2 ENSG00000170807 "Leiomodin 2" Q6P5Q4 7 123655807-123664290 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 44 "heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1" "Cell type enriched" "Detected in some" 1164 "Cardiomyocytes: 1233.0" "Group enriched" "Detected in some" 20 "head and neck cancer: 3.5;prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HSkMC: 5.7;SuSa: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046370, HPA051039" Enhanced Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA046370: , HPA051039: AB_2681321" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-3)" "unprognostic (1.18e-1)" "unprognostic (5.50e-1)" "unprognostic (5.69e-2)" "unprognostic (6.98e-2)" "unprognostic (2.13e-2)" "unprognostic (1.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.82e-3)" 3.3 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.2 3.8 0.0 0.0 117.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.0 2.6 0.0 297.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.4 100.1 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.3 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1233.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LMTK2 "AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100" ENSG00000164715 "Lemur tyrosine kinase 2" Q8IWU2 7 98106885-98209633 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010657, HPA041836" Uncertain Approved "Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Nuclear speckles, Centriolar satellite" "Plasma membrane, Cytosol" "HPA010657: AB_1079259, HPA041836: AB_2677698" "unprognostic (7.36e-2)" "unprognostic (3.16e-1)" "unprognostic (1.59e-1)" "unprognostic (2.60e-3)" "unprognostic (2.47e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-2)" "unprognostic (1.23e-1)" "unprognostic (4.96e-1)" "prognostic unfavorable (8.03e-4)" "unprognostic (1.23e-1)" "unprognostic (4.65e-1)" "prognostic favorable (1.12e-7)" "unprognostic (1.88e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (6.38e-3)" 5.1 10.3 13.7 5.6 21.3 17.3 5.6 16.6 34.3 7.3 13.8 6.1 5.6 12.6 6.1 6.3 12.7 6.4 7.9 16.9 11.0 10.1 10.1 8.5 10.0 5.1 7.5 18.9 8.0 21.0 22.2 10.0 4.8 13.2 7.9 11.8 5.4 10.5 6.5 17.5 11.5 13.8 5.7 5.5 6.8 9.4 8.0 6.9 7.2 8.7 5.7 7.4 8.3 8.1 0.6 0.7 4.8 0.9 0.3 1.6 0.5 9.8 11.6 9.0 9.2 4.8 3.9 8.4 4.1 4.5 4.0 4.9 9.1 9.0 5.2 11.8 5.2 15.3 10.8 10.4 6.3 6.3 7.4 7.3 3.5 10.4 9.1 5.9 6.2 6.3 2.6 8.7 8.3 11.3 4.1 6.0 6.0 9.1 10.9 3.6 13.3 6.6 3.7 11.0 13.5 5.7 7.2 6.1 10.2 6.7 17.3 6.5 12.9 8.2 15.0 6.0 9.5 4.1 2.5 7.3 8.4 13.8 16.8 9.3 4.9 8.5 10.3 5.7 4.9 10.0 1.2 0.6 0.5 0.8 0.3 0.5 0.6 0.9 0.9 0.3 0.6 1.1 1.6 4.8 0.3 0.9 0.7 0.8 0.5 13.7 21.3 16.6 34.3 11.0 10.1 7.5 18.9 13.2 6.9 26.8 10.5 0.0 4.2 8.7 14.0 18.7 17.8 10.7 9.1 1.8 13.7 2.3 1.7 5.0 0.8 3.1 26.2 0.0 7.9 1.6 3.5 6.2 2.3 6.8 1.8 6.4 11.5 3.1 2.6 2.1 1.7 2.3 1.7 0.0 13.5 5.8 8.6 13.1 4.2 2.4 9.9 0.0 3.8 6.3 4.7 9.5 2.5 2.9 12.6 13.2 LNP1 NP3 ENSG00000206535 "Leukemia NUP98 fusion partner 1" A1A4G5 3 100401193-100456319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.9" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 107.8;Horizontal cells: 243.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4" HPA047926 Approved "Nuclear speckles,Vesicles,Cytosol" NA NA Vesicles "Nuclear speckles, Cytosol" "HPA047926: " "unprognostic (1.78e-1)" "unprognostic (3.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.40e-3)" "unprognostic (6.33e-3)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (1.66e-3)" "unprognostic (1.81e-1)" "unprognostic (1.75e-2)" "unprognostic (1.58e-2)" "unprognostic (1.74e-2)" "unprognostic (8.28e-3)" "unprognostic (1.43e-1)" "unprognostic (7.98e-2)" "unprognostic (2.11e-1)" "unprognostic (6.08e-2)" 3.1 2.8 6.5 1.7 11.4 0.6 2.7 7.9 9.7 3.4 2.3 1.5 3.4 1.2 4.6 8.4 1.9 4.0 2.7 9.5 5.3 7.2 4.8 7.4 3.8 1.4 5.7 5.6 6.3 4.5 3.0 17.0 3.7 7.4 2.8 2.2 9.0 2.4 3.3 4.3 1.0 1.5 4.5 4.2 1.8 1.9 31.9 3.5 1.6 5.3 0.8 1.7 3.1 1.8 0.9 0.2 0.0 0.4 0.2 2.7 0.8 2.9 1.6 8.5 1.2 5.5 2.4 0.7 2.3 5.6 1.9 2.2 0.6 0.7 2.6 1.0 1.6 3.0 1.9 2.2 2.0 2.2 2.6 2.3 6.2 0.8 2.8 1.7 3.6 0.7 2.6 0.7 1.0 4.8 2.5 0.4 1.3 2.4 9.7 1.7 2.1 5.0 3.6 5.8 1.7 12.8 3.8 4.7 5.1 1.7 0.3 8.8 4.4 1.7 2.5 3.5 2.5 0.6 0.4 0.6 0.9 9.0 0.8 2.0 11.4 12.2 7.5 2.6 3.1 1.6 0.0 0.4 0.0 1.1 0.2 2.5 0.9 1.1 0.6 0.2 0.9 1.0 1.1 0.0 0.2 0.0 0.0 2.7 0.8 6.5 11.4 7.9 9.7 5.3 7.2 5.7 5.6 7.4 3.5 0.0 0.3 4.2 1.2 0.9 32.6 9.6 0.0 5.3 2.3 1.8 47.1 1.2 6.6 0.4 107.8 0.7 0.4 23.3 0.8 1.6 3.1 0.9 0.0 1.6 0.6 243.1 2.4 0.0 0.3 17.2 3.1 0.0 20.3 1.0 1.0 9.4 0.6 0.0 1.1 3.1 35.6 0.0 2.2 31.5 2.7 0.5 0.3 0.0 0.6 0.1 LNX1 "LNX, MPDZ, PDZRN2" ENSG00000072201 "Ligand of numb-protein X 1" Q8TBB1 4 53459301-53701405 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002235, HPA071091" Approved Supported "Cell Junctions,Cytosol" "Intracellular and membrane" NA NA "Cell Junctions" Cytosol "HPA002235: AB_1079261, HPA071091: AB_2686344" "unprognostic (4.95e-2)" "unprognostic (1.74e-2)" "unprognostic (2.00e-2)" "unprognostic (3.16e-2)" "unprognostic (2.79e-1)" "unprognostic (2.31e-1)" "unprognostic (1.31e-1)" "unprognostic (5.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.06e-1)" "unprognostic (5.18e-2)" "unprognostic (8.56e-2)" "prognostic favorable (3.08e-7)" "unprognostic (2.67e-1)" "unprognostic (5.49e-2)" "unprognostic (6.81e-2)" "unprognostic (3.05e-2)" 16.9 2.5 11.8 1.7 24.6 0.8 13.2 4.4 33.3 5.9 7.2 1.5 11.2 8.3 4.5 3.2 21.7 5.6 4.8 6.9 6.1 5.5 10.0 3.7 2.5 1.8 3.8 11.6 2.1 12.9 10.8 5.0 21.6 4.8 5.1 5.6 2.0 22.1 10.0 5.1 10.0 8.2 2.8 1.3 0.9 8.0 4.1 2.0 0.7 15.0 5.7 7.8 5.8 7.7 1.4 1.1 1.5 1.9 3.8 1.6 0.6 1.5 0.5 1.8 0.9 3.3 6.9 8.7 1.4 0.7 0.0 0.0 2.5 7.9 1.9 1.1 3.9 0.5 1.5 0.0 0.2 0.0 0.5 4.4 2.8 1.6 1.5 1.4 2.6 0.8 5.1 0.2 0.4 0.0 2.1 2.7 0.9 1.6 0.9 6.2 4.4 2.2 1.7 4.5 13.4 0.9 1.4 0.7 0.8 6.0 8.3 2.2 2.4 0.7 9.2 1.0 9.8 4.9 1.3 7.6 9.9 2.9 3.2 1.7 3.7 0.5 1.3 9.1 2.2 1.7 1.5 0.5 0.3 1.0 0.5 1.5 1.4 1.5 1.5 0.8 0.9 1.6 1.2 0.4 3.8 1.9 1.1 1.3 0.6 11.8 24.6 4.4 33.3 6.1 5.5 3.8 11.6 4.8 2.0 0.0 3.8 0.8 15.3 7.2 5.9 1.3 7.6 17.4 7.9 7.0 5.9 25.0 16.6 10.0 114.3 7.1 13.2 0.0 10.3 17.0 4.1 9.4 2.3 4.4 2.2 39.7 13.3 2.5 0.3 33.7 4.0 0.6 5.0 0.0 12.2 2.0 9.9 21.0 8.1 2.6 5.0 0.0 1.7 0.9 1.5 10.5 12.5 0.0 12.3 13.6 LNX2 "MGC46315, PDZRN1" ENSG00000139517 "Ligand of numb-protein X 2" Q8N448 13 27545911-27620404 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040698 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA040698: AB_10673138" "unprognostic (4.97e-2)" "unprognostic (1.97e-2)" "unprognostic (3.29e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-2)" "unprognostic (1.12e-1)" "unprognostic (8.38e-2)" "unprognostic (1.16e-1)" "unprognostic (9.27e-3)" "unprognostic (4.21e-2)" "unprognostic (8.79e-2)" "prognostic favorable (7.09e-13)" "unprognostic (4.18e-3)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.84e-2)" 4.6 10.3 2.5 6.7 4.2 2.7 9.8 7.6 4.1 6.0 13.2 2.3 8.3 12.2 4.4 4.3 12.4 4.1 9.7 8.8 2.8 2.9 9.2 24.5 22.1 4.9 3.4 3.1 6.3 24.7 7.6 9.6 10.8 3.7 7.0 9.3 10.2 12.1 9.9 8.0 7.6 19.6 6.5 3.3 4.6 9.0 10.3 2.6 13.4 9.9 4.2 10.0 6.2 8.5 1.6 0.8 5.3 0.9 3.3 2.8 0.6 4.8 2.6 5.1 5.6 5.3 2.4 5.3 4.3 3.7 4.2 3.8 9.5 9.6 7.3 3.7 3.8 7.7 9.1 9.0 11.4 5.6 4.4 3.8 9.2 5.6 6.9 8.4 4.9 5.9 2.0 17.8 2.9 11.6 12.0 7.6 7.6 2.8 2.8 6.1 5.8 7.3 3.2 5.6 21.7 3.0 6.8 9.9 3.7 9.2 8.4 13.0 2.7 5.9 11.8 7.5 6.6 8.3 3.8 9.6 2.4 3.4 2.4 3.5 2.7 4.6 7.6 1.6 4.7 3.4 5.3 0.9 2.4 1.7 0.3 2.3 1.6 1.8 2.1 0.8 1.3 1.9 1.8 1.1 3.3 0.7 0.4 2.8 0.6 2.5 4.2 7.6 4.1 2.8 2.9 3.4 3.1 3.7 2.6 29.8 22.2 3.7 22.5 22.6 3.8 9.2 25.5 16.0 6.8 19.2 2.0 1.2 3.3 8.1 10.5 5.9 18.6 0.0 12.1 6.8 3.1 19.8 1.1 45.5 1.9 4.8 9.8 10.4 5.2 5.3 2.6 5.2 10.1 1.0 14.5 4.5 10.7 23.0 3.2 6.7 16.7 0.0 3.1 16.1 15.8 19.3 2.5 5.2 10.7 16.5 LONRF1 "FLJ23749, RNF191" ENSG00000154359 "LON peptidase N-terminal domain and ring finger 1" Q17RB8 8 12721894-12756073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023584, HPA024814" Uncertain Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA023584: AB_1853233, HPA024814: AB_1853235" "unprognostic (2.59e-1)" "unprognostic (2.17e-3)" "unprognostic (1.35e-2)" "unprognostic (3.56e-1)" "unprognostic (9.09e-2)" "unprognostic (3.96e-3)" "unprognostic (3.13e-1)" "unprognostic (5.78e-2)" "unprognostic (2.74e-3)" "unprognostic (1.18e-1)" "unprognostic (5.83e-2)" "unprognostic (3.39e-1)" "unprognostic (5.46e-3)" "unprognostic (8.97e-2)" "unprognostic (8.90e-2)" "unprognostic (3.08e-3)" "unprognostic (1.15e-1)" 16.5 7.6 7.6 4.9 9.9 4.9 10.4 9.9 8.4 14.0 8.1 6.3 8.8 2.2 11.1 13.0 12.9 11.2 9.4 6.5 8.9 5.3 6.3 9.3 8.1 8.7 6.9 6.9 20.4 10.3 12.6 4.9 9.6 5.5 12.8 4.2 13.9 7.9 10.9 18.4 29.7 5.3 10.0 6.1 9.2 6.9 16.1 4.5 6.2 8.6 7.3 7.3 10.6 19.0 1.1 0.9 2.4 2.1 0.1 1.6 0.2 0.6 1.6 8.6 2.6 9.1 4.4 5.7 2.1 3.6 2.3 3.3 0.5 2.2 13.2 0.5 3.7 7.5 1.0 6.8 2.6 2.6 2.0 3.8 4.3 0.3 3.5 8.5 1.1 1.7 4.1 4.7 1.5 5.2 2.2 3.6 5.4 0.6 32.4 1.5 2.4 5.6 3.8 8.8 2.7 0.5 3.1 5.9 2.4 2.1 5.7 18.0 2.1 1.2 2.9 16.8 6.4 0.6 5.8 1.6 1.3 2.2 5.1 1.6 2.4 11.0 6.9 6.9 4.0 3.9 0.0 0.5 2.4 0.5 1.8 1.6 1.0 1.0 0.6 0.4 1.1 0.0 0.0 1.9 0.1 2.1 0.9 0.0 0.2 7.6 9.9 9.9 8.4 8.9 5.3 6.9 6.9 5.5 4.5 8.9 18.9 3.9 28.3 54.0 22.8 8.7 7.6 13.4 15.9 10.4 15.7 2.8 6.6 5.4 50.1 13.5 3.2 0.0 3.5 6.8 12.7 23.1 5.8 11.9 4.9 7.9 2.4 6.7 7.3 44.0 27.0 10.1 42.2 1.8 5.4 9.2 4.5 5.8 18.7 5.7 12.9 19.4 29.5 7.7 17.7 64.4 6.1 5.0 4.7 22.2 LPIN1 KIAA0188 ENSG00000134324 "Lipin 1" Q14693 2 11677595-11827409 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.4" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1310.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024591, HPA038021" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA024591: , HPA038021: AB_10669514" "unprognostic (1.97e-1)" "unprognostic (2.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (9.17e-2)" "unprognostic (2.69e-2)" "unprognostic (8.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (2.45e-3)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.58e-3)" "unprognostic (1.25e-1)" "unprognostic (9.60e-2)" "unprognostic (4.02e-1)" 18.1 10.1 13.0 10.7 18.3 6.0 22.1 20.0 16.4 10.5 8.6 10.9 7.3 8.9 11.0 15.0 20.0 7.0 10.4 12.8 11.6 11.9 7.6 13.2 8.0 15.4 13.2 11.2 19.3 7.5 17.2 32.0 9.0 17.9 9.6 7.1 9.0 14.4 11.6 88.4 6.5 9.2 11.0 10.3 8.4 7.6 39.0 13.2 8.3 8.1 14.0 19.2 10.4 21.7 6.5 9.6 11.6 2.8 8.0 11.1 3.2 5.5 6.6 5.5 12.3 25.5 28.4 2.8 7.8 13.4 5.0 8.7 2.4 5.5 2.7 1.0 6.6 14.8 6.0 6.2 17.0 4.6 11.4 3.4 6.8 3.7 3.5 9.0 4.7 32.1 25.6 7.7 20.8 7.9 14.7 9.7 6.7 9.4 24.7 3.7 2.1 4.4 4.1 5.7 1.8 6.7 6.1 10.1 17.3 12.7 3.6 15.3 12.1 2.8 6.8 17.5 5.5 1.7 2.6 6.8 8.0 7.2 5.1 6.7 38.8 30.0 5.2 11.3 8.4 5.9 9.5 2.8 11.6 10.3 2.1 11.1 6.5 9.6 9.7 2.5 5.0 8.4 7.1 1.1 8.0 2.1 9.6 10.5 3.2 13.0 18.3 20.0 14.4 11.6 11.9 13.2 11.2 17.9 13.2 20.8 49.1 22.9 38.9 16.9 40.6 49.5 25.5 61.6 63.7 10.4 80.5 7.3 6.6 18.7 314.7 24.6 9.7 0.0 24.2 5.3 24.6 29.2 33.6 21.9 8.1 46.1 34.7 15.4 15.7 1310.7 110.1 27.2 16.9 7.2 23.9 16.4 25.5 11.6 169.0 3.4 47.2 32.3 20.6 18.4 17.8 10.5 10.3 57.5 13.6 26.8 LPIN2 KIAA0249 ENSG00000101577 "Lipin 2" Q92539 18 2916994-3013315 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 83.9" "Cell type enhanced" "Detected in all" 5 "Cholangiocytes: 140.1;Hepatocytes: 111.5;Horizontal cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015223, HPA017857, HPA030550" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" Yes No Cytosol "Plasma membrane, Actin filaments" "CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519" "unprognostic (7.03e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "prognostic favorable (8.01e-4)" "unprognostic (9.85e-3)" "unprognostic (1.89e-2)" "unprognostic (1.03e-2)" "unprognostic (3.44e-3)" "unprognostic (3.19e-1)" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (4.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-2)" 6.8 5.6 13.0 10.5 18.4 9.2 7.7 11.9 16.5 6.6 25.2 10.4 2.4 31.6 6.7 3.9 5.9 6.3 14.3 5.1 11.0 14.5 20.7 83.9 11.8 11.8 11.2 9.8 8.8 9.0 9.7 8.2 16.3 15.3 5.8 7.4 6.8 4.4 5.3 2.2 2.7 43.3 6.1 9.6 10.7 15.6 13.5 9.6 6.3 7.5 1.5 10.0 6.8 6.7 1.2 1.1 20.8 2.0 10.1 9.5 2.1 4.9 6.7 10.6 3.7 18.4 17.1 6.3 12.0 14.6 11.9 11.6 8.7 4.2 3.6 7.3 18.3 18.6 0.2 8.7 3.7 9.4 7.0 1.8 9.2 5.2 9.9 17.2 7.3 10.2 17.2 2.5 11.8 10.3 17.3 14.8 8.8 8.3 1.9 16.7 3.7 9.1 6.3 3.4 7.4 9.6 16.1 9.2 13.4 9.5 11.1 9.0 6.2 11.2 5.3 3.8 6.4 0.0 10.1 20.8 15.4 18.7 19.7 8.8 3.5 5.3 7.8 13.6 7.5 5.4 6.5 2.0 6.1 9.3 1.3 9.5 0.9 7.1 5.3 0.8 1.2 7.3 4.7 20.8 10.1 0.6 1.1 6.3 2.1 13.0 18.4 11.9 16.5 11.0 14.5 11.2 9.8 15.3 9.6 62.5 38.2 16.9 8.2 4.9 31.9 10.4 140.1 21.4 35.2 36.6 13.7 17.4 14.9 9.7 2.1 17.5 52.0 46.7 16.6 9.6 15.9 14.5 11.6 111.5 19.6 109.7 14.3 20.3 21.0 6.9 21.0 19.9 8.5 24.4 30.3 16.0 18.6 10.5 29.4 40.8 14.8 6.5 9.9 28.8 59.6 1.8 41.4 39.9 11.9 3.4 LPIN3 "LIPN3L, SMP2" ENSG00000132793 "Lipin 3" Q9BQK8 20 41340920-41360582 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 49.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 49.9;Late spermatids: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 6.3" "Group enriched" "Detected in many" 4 "granulocytes: 1.8;NK-cells: 6.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA051466, HPA052667, HPA070640" Approved Supported Cytosol NA NA Cytosol "HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288" "unprognostic (2.31e-1)" "unprognostic (4.73e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (9.74e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (6.91e-3)" "unprognostic (4.26e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.74e-4)" "unprognostic (4.29e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (5.60e-3)" "unprognostic (2.02e-1)" "unprognostic (1.35e-1)" "unprognostic (3.37e-3)" 11.6 3.7 3.0 8.1 5.2 0.1 23.4 1.5 3.0 10.9 29.2 2.8 13.5 26.8 12.8 21.6 16.3 7.5 11.2 8.8 3.6 0.7 28.2 14.4 4.5 1.6 2.8 3.7 7.9 7.4 8.1 6.7 4.4 4.2 10.1 8.8 8.7 11.0 15.1 1.8 26.1 49.1 5.5 2.4 2.7 7.4 2.5 1.5 1.2 14.2 10.6 9.0 8.0 12.5 0.9 0.7 1.8 0.9 6.3 0.8 0.2 6.9 6.8 0.4 4.1 11.2 17.5 5.3 4.3 6.0 5.3 7.2 12.7 6.2 0.3 5.4 9.4 5.6 17.7 2.1 11.2 3.3 0.1 4.0 0.3 9.6 6.4 1.8 0.0 4.8 12.6 14.3 8.9 3.5 6.2 1.3 0.1 1.8 0.2 6.6 14.9 0.0 0.1 0.6 4.3 7.1 0.0 0.1 0.5 18.4 8.8 0.5 0.1 5.7 7.4 3.6 3.5 8.6 3.5 0.4 0.3 1.7 5.9 0.0 3.4 1.8 0.0 0.1 0.1 0.3 1.8 0.5 0.7 0.5 0.5 0.8 0.6 0.7 0.4 0.3 0.9 0.7 0.6 1.8 6.3 0.9 0.7 0.5 0.2 3.0 5.2 1.5 3.0 3.6 0.7 2.8 3.7 4.2 1.5 6.0 10.5 0.8 8.2 12.8 0.0 0.6 10.2 1.4 4.5 10.4 0.0 2.3 5.0 7.4 10.4 2.1 49.9 0.0 3.3 2.2 7.7 3.5 1.1 33.7 2.7 0.0 14.3 4.3 1.3 82.8 2.8 1.5 10.1 0.0 16.6 7.5 5.5 21.6 2.5 5.9 0.3 32.3 6.4 0.9 2.1 11.0 2.2 1.3 16.2 3.9 LPP ENSG00000145012 "LIM domain containing preferred translocation partner in lipoma" Q93052 3 188153284-188890671 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 127.8;urinary bladder: 105.1" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 514.4;Late spermatids: 1329.9;Smooth muscle cells: 529.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 18.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 29.5;EFO-21: 36.6;U-698: 61.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011133, HPA017342" Enhanced Enhanced "Focal adhesion sites,Cytosol" NA NA 520000 "Focal adhesion sites, Cytosol" "HPA011133: AB_1853247, HPA017342: AB_1853249" "unprognostic (1.50e-1)" "unprognostic (4.97e-3)" "unprognostic (1.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.86e-1)" "unprognostic (4.05e-1)" "unprognostic (2.43e-3)" "unprognostic (7.97e-2)" "unprognostic (2.17e-1)" "unprognostic (5.56e-2)" "unprognostic (3.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.57e-3)" "unprognostic (2.25e-2)" "unprognostic (6.86e-2)" "unprognostic (2.82e-3)" "unprognostic (1.48e-1)" 19.6 4.2 2.7 29.5 2.8 3.1 12.5 3.0 2.7 42.2 29.9 2.1 19.6 5.0 68.6 14.9 59.7 10.0 37.9 9.3 2.6 2.8 10.9 5.3 11.4 6.0 2.8 1.6 26.1 4.4 4.7 3.2 5.2 3.0 37.7 12.8 8.5 7.0 28.4 11.6 5.9 17.2 127.8 3.2 9.5 12.1 30.7 1.5 5.1 5.4 4.2 7.8 105.1 38.3 5.9 4.9 18.0 4.5 4.3 5.0 1.4 7.7 7.1 5.2 3.5 11.3 11.7 5.6 5.1 6.5 3.7 2.5 12.9 3.7 29.5 36.6 11.4 4.6 3.3 1.5 3.4 9.4 3.2 1.7 1.4 5.5 3.4 4.8 0.6 1.7 8.3 4.8 8.3 7.2 5.4 6.2 1.6 0.0 0.6 6.5 2.4 1.5 0.6 2.1 4.9 2.3 1.9 3.9 0.1 4.1 8.2 0.3 0.0 10.9 3.6 6.1 9.0 2.8 2.4 13.4 8.6 6.6 6.1 12.5 0.0 1.1 61.0 4.3 1.3 7.7 0.8 4.5 1.9 5.0 4.2 3.2 2.9 4.3 3.6 2.4 5.9 2.3 2.9 18.0 4.3 4.0 4.9 1.6 1.4 2.7 2.8 3.0 2.7 2.6 2.8 2.8 1.6 3.0 1.5 83.4 55.0 41.3 72.1 69.3 7.7 101.6 99.3 40.2 83.0 66.3 13.7 35.7 24.9 114.3 514.4 83.0 142.7 23.3 78.6 20.6 102.9 124.2 17.4 84.7 36.8 4.8 74.4 114.2 61.5 1329.9 208.5 76.2 75.9 36.1 86.3 27.1 104.6 158.4 448.3 61.0 7.4 329.8 529.6 8.1 6.6 59.6 15.6 39.5 123.5 109.3 LPXN LDPL ENSG00000110031 Leupaxin O60711 11 58526871-58578220 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 42.0;lymphoid tissue: 75.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 51.8;Kupffer cells: 53.4;Macrophages: 67.3;T-cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 40.0;HMC-1: 67.0;Karpas-707: 57.4;U-2197: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043741, CAB046478, HPA061441" Enhanced Supported "Nuclear speckles,Focal adhesion sites,Cytosol" No No "Focal adhesion sites" "Nuclear speckles, Cytosol" "CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518" "unprognostic (1.61e-3)" "unprognostic (6.91e-2)" "unprognostic (6.54e-2)" "prognostic favorable (8.81e-4)" "unprognostic (5.16e-2)" "unprognostic (2.07e-3)" "unprognostic (2.16e-2)" "unprognostic (8.87e-3)" "unprognostic (5.18e-2)" "unprognostic (3.96e-2)" "unprognostic (2.39e-2)" "unprognostic (3.05e-1)" "unprognostic (3.60e-3)" "unprognostic (1.91e-1)" "unprognostic (5.25e-2)" "unprognostic (2.55e-1)" "unprognostic (2.41e-3)" 16.3 5.6 5.1 34.2 4.7 4.2 5.1 3.5 4.9 4.4 6.7 9.0 4.1 5.1 6.5 5.9 3.8 4.7 7.2 3.9 5.2 5.1 6.3 7.1 19.7 37.2 6.3 2.5 6.6 5.6 3.9 4.8 2.6 5.0 5.7 9.6 6.2 7.6 5.1 2.1 3.7 16.0 4.7 11.4 32.2 5.7 5.9 4.9 75.1 6.8 4.4 52.9 11.2 3.9 19.9 36.5 3.8 19.1 20.1 42.0 20.9 0.3 0.4 0.4 0.7 1.5 1.9 0.2 10.0 40.0 2.5 4.5 0.0 1.0 29.2 0.4 12.1 1.8 0.3 0.3 27.2 10.5 12.7 0.1 1.3 0.2 0.1 2.6 7.9 67.0 1.5 0.6 34.5 4.5 2.4 16.1 17.9 0.3 57.4 20.2 0.2 27.6 9.9 0.3 0.4 9.1 0.4 0.5 25.1 1.6 14.0 0.2 0.3 0.4 0.6 3.9 0.6 0.5 2.3 15.7 6.3 1.8 40.3 8.9 3.7 3.5 28.7 14.6 7.1 14.2 1.7 19.1 3.1 28.2 11.0 42.0 19.9 29.0 32.4 36.5 11.5 22.6 26.8 3.8 20.1 5.6 33.1 38.7 20.9 5.1 4.7 3.5 4.9 5.2 5.1 6.3 2.5 5.0 4.9 0.0 7.0 47.0 4.0 8.7 3.4 1.6 0.0 4.0 2.3 0.0 3.9 2.3 3.3 2.2 22.9 8.0 4.7 0.0 4.9 1.1 4.5 3.3 51.8 6.7 46.1 1.6 5.8 2.5 53.4 6.2 1.7 67.3 18.6 36.9 2.9 4.1 2.8 4.9 3.5 4.2 4.7 6.5 4.1 7.4 4.1 8.4 2.1 74.6 5.2 26.4 LRBA "BGL, CDC4L, LAB300, LBA" ENSG00000198589 "LPS responsive beige-like anchor protein" P50851 4 150264531-151015727 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cone photoreceptor cells: 139.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019366, HPA023597" Approved Approved "Golgi apparatus,Cytosol" NA NA 190000 "Golgi apparatus" Cytosol "HPA019366: AB_2138441, HPA023597: AB_1853256" "unprognostic (2.60e-1)" "unprognostic (4.70e-2)" "unprognostic (1.64e-3)" "unprognostic (4.49e-3)" "unprognostic (4.38e-1)" "unprognostic (8.65e-2)" "unprognostic (5.88e-2)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (6.92e-2)" "unprognostic (2.29e-2)" "unprognostic (5.88e-2)" "prognostic favorable (2.22e-16)" "unprognostic (7.15e-2)" "unprognostic (2.36e-1)" "unprognostic (4.79e-1)" "unprognostic (3.00e-1)" 7.6 15.8 7.1 14.7 10.9 7.2 16.5 14.4 8.3 11.3 12.2 7.3 17.9 9.8 12.9 11.8 21.4 11.9 12.7 10.5 6.4 4.3 18.4 10.2 10.1 14.2 7.4 5.6 10.1 13.8 33.0 32.1 8.8 7.7 14.3 13.0 8.3 18.2 15.1 10.5 20.5 14.7 7.9 8.3 11.3 12.8 10.1 7.8 26.5 15.2 11.0 17.9 14.0 12.4 5.7 2.6 5.9 0.8 3.8 7.9 2.3 15.5 8.0 7.3 6.3 7.8 10.8 9.1 3.3 8.9 6.3 6.2 17.3 19.8 18.0 4.1 5.0 4.6 8.0 12.2 19.5 9.6 13.5 8.8 12.7 12.4 9.3 4.6 17.0 10.2 8.4 11.7 9.3 14.5 14.2 19.0 8.5 13.2 12.8 7.4 10.4 12.4 2.2 6.2 11.6 6.0 10.2 7.6 6.6 20.4 20.6 18.9 7.7 8.9 18.1 4.4 11.3 17.9 3.3 10.0 9.1 6.7 5.0 6.4 12.0 11.6 12.3 14.2 7.0 4.6 5.9 0.7 1.6 7.9 0.3 4.7 5.7 5.3 6.9 1.5 3.5 3.7 5.6 0.2 3.8 0.8 2.6 5.9 2.3 7.1 10.9 14.4 8.3 6.4 4.3 7.4 5.6 7.7 7.8 14.9 9.3 40.2 13.9 15.5 29.4 50.2 20.4 22.7 15.9 48.8 139.4 19.8 8.3 13.5 14.3 11.7 19.3 23.3 11.7 9.5 8.8 23.4 5.8 18.7 5.4 28.6 40.4 11.6 8.5 3.1 8.9 9.2 15.1 5.4 25.0 21.7 13.7 21.8 9.6 13.6 68.2 6.5 6.6 8.1 21.3 20.7 20.3 34.9 29.8 21.2 LRCH1 "CHDC1, KIAA1016" ENSG00000136141 "Leucine rich repeats and calponin homology domain containing 1" Q9Y2L9 13 46553168-46753040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 46.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021536 Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" Nucleoli "HPA021536: AB_1853258" "unprognostic (7.13e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (3.59e-2)" "unprognostic (8.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.37e-1)" "unprognostic (5.16e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (2.16e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.04e-4)" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "unprognostic (1.98e-2)" 17.9 5.0 6.5 20.3 5.9 7.2 15.2 46.4 7.2 17.5 14.6 4.6 11.5 7.0 24.6 9.8 10.6 11.9 14.1 8.0 6.3 5.9 13.8 10.9 14.3 13.5 6.6 4.9 9.5 5.1 5.2 13.1 24.1 8.0 12.8 9.3 8.4 11.3 14.5 5.3 18.1 12.0 20.9 8.5 13.7 14.6 5.0 6.0 31.7 7.8 6.4 13.7 16.6 18.3 6.2 2.3 1.8 2.0 5.1 3.6 1.8 4.3 6.3 5.7 5.9 4.2 8.0 14.7 7.5 9.9 9.4 8.9 14.2 7.5 14.0 2.1 7.1 6.1 6.3 4.3 7.6 13.6 14.4 4.1 12.6 2.5 6.6 5.2 8.1 21.6 5.1 6.0 8.6 10.5 7.7 8.0 9.5 2.4 4.3 6.9 8.5 8.7 10.2 3.2 27.7 3.3 4.8 6.2 3.7 17.5 4.6 9.1 9.1 4.2 4.2 11.2 10.6 3.2 11.0 7.6 5.5 3.7 6.8 7.1 0.8 2.1 6.3 6.4 7.2 6.6 1.5 2.0 1.8 3.6 1.6 2.1 5.3 2.7 2.6 1.9 6.2 2.1 2.1 0.7 5.1 1.2 2.3 1.9 1.8 6.5 5.9 46.4 7.2 6.3 5.9 6.6 4.9 8.0 6.0 6.0 6.7 15.1 9.1 33.3 8.2 6.7 25.5 1.4 6.8 21.0 21.6 11.1 8.3 7.2 1.2 25.9 6.9 0.0 3.5 10.0 10.5 7.9 27.6 7.9 11.4 3.2 1.7 16.5 16.7 1.1 12.0 9.9 28.7 5.4 9.7 6.4 9.5 5.8 15.9 7.3 8.9 12.9 21.7 0.7 3.2 29.1 8.1 10.2 6.5 7.8 LRCH3 MGC4126 ENSG00000186001 "Leucine rich repeats and calponin homology domain containing 3" Q96II8 3 197791226-197888436 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012380, HPA017299" Uncertain Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA012380: AB_1853260, HPA017299: AB_2669576" "unprognostic (1.25e-1)" "unprognostic (4.92e-1)" "unprognostic (1.43e-1)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (8.26e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.29e-1)" "unprognostic (4.13e-1)" "unprognostic (9.85e-2)" "unprognostic (1.64e-1)" "unprognostic (2.06e-2)" "unprognostic (1.79e-3)" "unprognostic (3.29e-2)" "unprognostic (2.67e-1)" "unprognostic (5.59e-2)" "unprognostic (1.32e-1)" 16.4 14.0 19.3 23.4 19.1 11.0 18.0 37.5 19.1 21.9 19.0 28.2 15.6 11.0 24.7 14.8 15.6 18.3 16.7 18.2 15.9 14.5 12.6 14.2 14.8 23.4 19.7 13.1 27.5 12.9 23.7 26.0 15.2 15.4 20.4 16.7 23.6 15.6 22.4 23.0 15.7 15.9 28.3 15.9 18.7 15.0 20.2 20.4 27.0 13.5 9.5 26.0 20.3 18.0 6.9 2.8 22.6 4.8 4.9 6.0 3.3 18.1 6.5 17.5 10.8 21.2 24.1 6.8 13.2 16.0 16.1 18.9 15.3 9.6 9.9 20.7 16.2 22.9 11.9 14.6 12.8 21.7 7.9 9.1 16.5 9.7 13.0 14.5 12.6 13.0 16.5 7.8 15.3 19.6 15.6 19.0 8.8 10.4 16.5 15.2 15.4 9.5 5.5 12.0 9.3 13.6 10.0 10.9 7.1 8.5 10.7 8.7 9.4 16.0 12.1 12.7 16.8 21.2 11.1 18.5 13.4 7.7 16.2 13.2 15.3 13.7 9.0 12.7 18.0 12.6 22.6 3.4 7.0 5.9 4.8 4.5 6.9 4.6 5.0 2.8 5.7 4.3 6.0 2.3 4.9 4.6 2.6 4.4 3.3 19.3 19.1 37.5 19.1 15.9 14.5 19.7 13.1 15.4 20.4 29.8 24.8 15.9 14.0 9.4 55.4 14.2 17.8 16.0 19.4 8.7 53.0 7.0 1.7 10.1 9.5 20.2 6.8 0.0 8.4 5.5 19.9 12.7 10.5 13.0 7.6 36.5 5.8 41.7 13.0 7.1 23.3 15.3 16.9 28.9 8.2 26.6 11.3 7.0 26.9 4.2 44.4 19.4 17.0 16.3 16.6 9.3 5.0 14.0 9.2 13.1 LRCH4 "LRN, LRRN1" ENSG00000077454 "Leucine rich repeats and calponin homology domain containing 4" O75427 7 100574011-100586153 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 153.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 45.7;NB-4: 70.7" "Low region specificity" "Detected in all" "HPA037667, HPA037668" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA037667: AB_10671882, HPA037668: AB_10672910" "unprognostic (2.41e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (8.32e-3)" "unprognostic (2.76e-2)" "unprognostic (3.96e-3)" "unprognostic (8.98e-3)" "unprognostic (3.72e-2)" "unprognostic (2.52e-1)" "unprognostic (5.51e-2)" "unprognostic (2.63e-3)" "unprognostic (7.81e-2)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (7.96e-2)" "unprognostic (1.26e-2)" 11.4 15.2 14.5 32.0 25.7 52.7 13.8 19.7 22.2 12.0 14.0 16.4 11.8 22.0 12.3 9.6 14.4 14.0 15.9 10.2 16.2 9.1 16.1 12.2 20.8 39.1 25.8 13.1 23.7 17.3 8.9 22.8 26.4 19.2 14.6 7.2 18.3 23.5 13.0 15.8 15.0 27.8 8.1 25.7 54.5 14.9 43.3 23.1 31.1 20.0 6.8 25.2 9.9 12.0 5.9 6.2 24.2 8.4 1.4 7.3 2.9 7.9 4.5 4.5 4.0 2.7 2.1 8.6 7.7 3.5 4.5 3.7 7.5 11.7 5.8 8.7 2.3 4.8 6.9 2.2 3.2 1.3 5.7 6.0 6.6 5.3 3.5 8.6 11.4 45.7 3.5 3.5 3.8 2.1 2.9 4.6 15.2 8.2 11.9 3.2 15.0 13.1 70.7 4.7 7.4 5.3 14.6 3.7 7.1 3.5 2.8 5.9 8.8 3.7 11.8 9.0 6.1 7.9 24.9 7.2 6.2 11.3 8.6 4.6 12.1 5.7 5.2 4.8 28.3 10.6 12.6 8.4 11.9 5.2 6.8 4.7 4.7 5.1 5.9 6.2 5.9 7.3 5.9 24.2 1.4 4.7 5.9 5.2 2.9 14.5 25.7 19.7 22.2 16.2 9.1 25.8 13.1 19.2 23.1 8.9 16.7 24.7 13.8 10.6 13.6 0.7 25.5 6.7 6.8 21.0 39.3 33.4 13.3 27.1 153.1 9.5 22.2 0.0 21.3 11.2 9.5 12.1 18.5 11.3 30.3 12.7 5.8 15.4 53.4 19.7 23.0 33.3 13.5 52.3 12.9 15.5 23.1 14.0 9.6 6.2 29.9 19.4 12.2 42.6 28.7 10.0 86.4 42.9 11.0 14.2 LRIG1 "DKFZP586O1624, LIG-1, LIG1" ENSG00000144749 "Leucine rich repeats and immunoglobulin like domains 1" Q96JA1 3 66378797-66501263 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 64.0" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 48.2;Muller glia cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" "Cell line enhanced" "Detected in many" "Daudi: 23.8;hTEC/SVTERT24-B: 18.7;U-698: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011846 Approved Approved Cytosol NA NA 21000 Cytosol "HPA011846: AB_2668545" "unprognostic (6.41e-2)" "unprognostic (4.18e-2)" "unprognostic (4.35e-3)" "unprognostic (4.58e-2)" "unprognostic (2.12e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.01e-5)" "unprognostic (5.12e-1)" "unprognostic (7.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.18e-1)" "unprognostic (2.12e-1)" "unprognostic (8.79e-2)" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.50e-4)" 12.6 1.7 22.3 8.1 21.1 2.4 13.4 9.6 31.8 15.5 24.6 20.3 0.7 8.2 12.7 2.6 6.9 13.3 13.8 16.8 24.6 7.1 2.5 15.8 8.6 4.1 19.8 12.4 8.8 64.0 4.2 6.7 2.8 18.9 12.2 7.6 4.8 9.4 4.3 16.6 6.6 7.5 14.5 10.9 2.4 21.2 6.4 19.8 0.2 8.1 5.0 5.0 5.1 5.4 0.3 0.0 0.7 0.0 0.0 2.7 0.4 0.4 0.4 9.5 0.1 2.6 1.7 0.8 1.5 8.9 1.5 4.8 7.4 0.0 23.8 4.1 0.7 2.1 0.0 1.8 3.2 3.4 0.0 4.9 0.0 1.4 0.6 0.6 0.2 5.4 2.1 1.8 18.7 3.1 6.5 8.2 0.1 0.0 0.0 0.3 1.1 0.0 0.0 7.1 0.7 0.0 4.3 2.8 1.2 1.8 0.0 1.2 0.3 1.4 1.4 0.0 1.7 8.5 2.1 2.5 4.7 2.0 9.2 3.9 1.9 0.9 18.2 8.3 0.0 1.6 0.0 0.0 0.7 0.4 0.0 1.4 0.3 1.1 1.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 2.7 0.4 22.3 21.1 9.6 20.2 24.6 7.1 19.8 12.4 18.9 19.8 35.7 42.0 2.7 7.5 10.1 1.7 28.8 7.6 48.2 30.7 0.0 7.9 0.2 1.7 5.5 1.5 9.8 7.1 0.0 14.9 0.1 9.4 18.3 1.1 17.4 1.5 7.9 25.4 4.3 1.0 1.3 10.6 3.1 10.1 1.8 24.4 47.3 6.2 7.0 16.3 1.0 6.5 0.0 9.2 1.5 18.1 10.0 0.1 9.6 19.5 3.7 LRIG3 "FLJ90440, KIAA3016" ENSG00000139263 "Leucine rich repeats and immunoglobulin like domains 3" Q6UXM1 12 58872149-58920522 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 27.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010773 Approved Approved Cytosol NA NA Cytosol "HPA010773: AB_1853275" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" "unprognostic (1.01e-2)" "unprognostic (3.88e-2)" "unprognostic (2.53e-1)" "unprognostic (3.46e-2)" "unprognostic (1.83e-2)" "unprognostic (1.34e-3)" "unprognostic (1.21e-1)" "unprognostic (1.92e-1)" "unprognostic (3.04e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-3)" "unprognostic (2.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.46e-2)" 15.8 1.7 3.6 11.8 4.1 0.0 16.4 1.0 3.7 18.7 14.8 7.8 12.1 8.4 14.2 13.8 17.1 9.9 17.8 4.7 4.6 1.8 6.5 6.1 9.6 5.0 3.6 2.6 14.7 15.3 4.8 10.3 6.8 5.8 15.5 16.0 13.5 24.9 11.6 5.0 25.9 10.0 21.6 3.0 7.2 13.5 6.4 6.6 5.4 37.6 15.0 12.8 15.7 20.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 2.0 1.9 7.4 0.5 13.6 15.9 1.7 4.9 14.3 4.8 5.1 5.8 2.7 1.9 10.0 5.4 5.8 9.6 2.7 12.6 3.5 14.6 9.6 0.5 3.3 2.8 2.6 0.8 0.2 15.7 27.4 5.1 11.0 9.4 13.1 2.2 0.1 2.4 3.2 0.9 2.3 0.0 7.9 2.4 2.9 0.0 6.3 4.8 3.7 10.6 7.5 0.0 4.3 2.7 4.5 11.0 5.0 0.1 5.6 6.5 4.5 3.9 6.4 1.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 4.1 1.0 3.7 4.6 1.8 3.6 2.6 5.8 6.6 14.9 17.4 0.0 7.5 19.9 2.6 4.1 33.1 13.4 23.9 1.8 0.0 0.7 0.0 9.0 0.3 11.4 10.7 0.0 15.8 0.4 8.2 2.6 0.0 6.8 1.9 3.2 11.1 4.3 0.3 0.0 25.0 0.2 3.3 0.0 11.8 2.8 7.5 14.0 27.3 4.2 0.1 6.5 11.3 0.4 1.5 19.6 0.2 0.0 25.9 2.7 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848202-109872315 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 17.1" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 31.4;Muller glia cells: 15.4;Rod photoreceptor cells: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.6 0.6 0.7 0.6 1.2 0.4 1.7 2.0 1.3 1.2 0.6 0.6 0.6 0.3 0.7 1.8 0.6 1.0 0.6 0.6 0.8 0.7 4.4 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.9 0.5 17.1 0.8 0.6 1.6 3.2 0.6 0.6 0.6 0.8 0.2 1.3 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.1 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.6 0.6 0.0 0.0 0.1 1.3 0.1 0.2 0.3 1.6 0.3 0.4 0.2 0.1 1.3 0.0 0.0 2.0 0.1 0.3 0.2 0.1 1.3 0.3 0.6 0.0 0.0 0.9 1.0 0.2 0.8 0.2 0.6 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.4 0.0 0.3 0.1 1.2 0.0 0.3 0.3 0.6 0.3 0.6 1.0 0.0 0.3 0.9 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.2 2.0 1.3 0.8 0.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 31.4 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LRMDA "C10orf11, CDA017, OCA7" ENSG00000148655 "Leucine rich melanocyte differentiation associated" Q9H2I8 10 75431453-76560167 "Disease related genes, Predicted intracellular proteins" Differentiation Albinism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Distal tubular cells: 28.2;Hofbauer cells: 48.4;Proximal tubular cells: 72.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 23.6;myeloid DC: 27.3" "Group enriched" "Detected in many" 8 "dendritic cells: 27.3;granulocytes: 8.7;monocytes: 23.6" "Cell line enhanced" "Detected in many" "Hep G2: 18.4;HMC-1: 14.3;NB-4: 26.5;SK-MEL-30: 37.3;THP-1: 19.8;U-937: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047446, HPA050419" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047446: AB_2680050, HPA050419: AB_2756316" "unprognostic (1.04e-1)" "unprognostic (8.03e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (8.57e-3)" "unprognostic (5.86e-2)" "unprognostic (6.80e-2)" "unprognostic (8.34e-2)" "unprognostic (1.26e-1)" "unprognostic (7.34e-3)" "unprognostic (7.26e-2)" "unprognostic (6.50e-2)" "unprognostic (4.98e-3)" "unprognostic (3.64e-2)" 12.7 35.3 4.6 4.7 6.4 13.2 6.1 2.6 3.6 7.1 4.6 8.2 12.5 3.1 12.5 34.9 5.3 5.7 8.9 13.2 3.7 5.1 11.5 19.1 13.1 5.6 7.4 3.1 8.6 21.0 6.8 9.7 6.9 6.7 8.3 4.0 19.8 10.7 8.8 2.2 2.3 4.5 5.3 8.1 7.8 8.6 5.8 5.0 0.1 13.2 6.9 3.9 5.5 5.3 0.0 27.3 8.7 23.6 2.6 0.1 6.7 0.1 2.6 0.1 0.0 1.2 1.5 0.0 0.3 0.0 0.1 0.2 3.1 5.5 0.0 10.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.6 1.3 18.4 0.5 3.7 14.3 0.7 0.5 0.3 0.0 2.3 0.5 0.0 0.0 0.6 0.0 0.4 0.0 26.5 0.1 1.6 1.1 0.0 0.1 0.0 0.2 3.4 0.1 0.2 3.3 0.0 37.3 0.1 0.2 19.8 0.3 0.1 1.4 1.0 2.1 0.2 0.0 0.0 9.6 17.7 4.7 2.6 23.6 8.7 0.0 11.2 0.1 0.0 0.0 0.0 27.3 0.0 0.0 0.0 1.3 2.6 6.4 0.2 0.0 6.7 4.6 6.4 2.6 3.6 3.7 5.1 7.4 3.1 6.7 5.0 20.8 17.5 0.0 0.0 0.0 0.0 0.0 0.0 12.0 6.8 12.2 0.0 0.9 28.2 17.1 0.0 0.0 0.0 0.0 13.8 0.8 0.0 0.0 7.0 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 11.8 0.0 0.0 15.2 0.0 0.0 72.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 LRMP JAW1 ENSG00000118308 "Lymphoid restricted membrane protein" Q12912 12 25004342-25108334 "Predicted intracellular proteins, Predicted membrane proteins" "Fertilization, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 69.5" "Cell type enhanced" "Detected in many" 9 "B-cells: 52.5;granulocytes: 24.4;Kupffer cells: 29.4;T-cells: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Daudi: 96.3;REH: 33.5;U-698: 110.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA002967, HPA018505" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA002967: AB_1079161, HPA018505: AB_1851988" "unprognostic (3.78e-2)" "unprognostic (2.59e-3)" "unprognostic (7.54e-2)" "unprognostic (7.08e-3)" "unprognostic (2.36e-1)" "unprognostic (1.48e-3)" "unprognostic (7.98e-2)" "unprognostic (4.08e-2)" "unprognostic (7.32e-2)" "unprognostic (1.15e-1)" "unprognostic (3.59e-2)" "unprognostic (7.97e-2)" "unprognostic (7.25e-3)" "unprognostic (7.72e-2)" "unprognostic (9.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.59e-2)" 5.5 1.4 15.1 51.7 2.9 19.2 4.6 0.4 5.6 1.9 3.6 2.1 0.9 3.2 1.4 1.8 3.9 2.3 3.0 1.7 8.1 1.8 5.5 2.3 5.6 57.8 3.5 4.7 2.3 15.1 0.4 2.1 1.7 7.4 2.8 3.5 1.3 4.1 2.1 0.8 2.7 13.2 1.8 5.3 27.6 3.6 0.7 2.8 67.0 3.6 1.7 69.5 10.4 5.7 17.4 5.7 51.8 12.2 12.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 5.7 0.0 0.0 0.0 7.4 8.5 0.0 0.0 0.1 0.0 0.0 0.0 4.9 1.1 6.4 0.0 0.0 8.1 13.7 0.0 0.0 0.0 33.5 0.0 9.5 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.2 0.0 0.0 6.3 1.1 110.1 0.0 3.3 0.0 17.0 5.4 51.8 6.5 10.5 5.4 17.4 4.1 6.6 5.7 13.3 7.1 6.9 39.3 12.0 12.2 5.4 0.7 4.7 15.1 2.9 0.4 5.6 8.1 1.8 3.5 4.7 7.4 2.8 0.0 7.4 52.5 2.5 0.8 0.2 0.4 0.0 9.4 15.9 0.0 0.0 0.1 0.0 0.2 1.5 2.1 0.0 0.0 7.5 0.1 0.5 0.2 24.4 1.0 11.5 0.0 8.5 4.9 29.4 0.4 0.9 20.0 5.0 1.8 0.0 0.0 1.6 3.5 4.6 13.0 0.2 0.0 0.2 0.2 0.0 4.8 0.1 40.3 0.2 14.4 LRRC1 "dJ523E19.1, FLJ10775, FLJ11834, LANO" ENSG00000137269 "Leucine rich repeat containing 1" Q9BTT6 6 53794497-53924121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 81.7;Syncytiotrophoblasts: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031603, HPA031604" Enhanced Supported Cytosol NA NA Cytosol "HPA031603: AB_10601753, HPA031604: AB_10601224" "unprognostic (2.90e-1)" "unprognostic (8.01e-2)" "unprognostic (9.59e-3)" "unprognostic (2.46e-2)" "unprognostic (7.04e-3)" "unprognostic (1.55e-2)" "unprognostic (2.19e-3)" "unprognostic (6.37e-2)" "unprognostic (7.02e-2)" "unprognostic (7.12e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.97e-1)" "prognostic favorable (2.21e-7)" "unprognostic (1.74e-1)" "unprognostic (2.31e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-3)" 13.1 2.3 8.6 7.6 17.0 2.5 12.4 4.0 13.4 12.1 22.6 17.5 7.3 15.3 5.3 8.9 17.2 7.9 12.0 3.8 9.4 6.1 7.3 1.1 7.0 2.4 21.8 6.1 5.7 8.3 24.8 8.0 26.1 11.2 8.3 23.2 7.8 14.9 7.0 1.9 20.2 20.7 6.1 11.9 1.8 13.2 12.3 20.6 8.3 16.3 8.4 9.3 12.3 16.1 1.8 1.4 0.4 0.2 3.3 1.1 0.1 20.1 2.6 2.8 5.0 0.7 0.4 20.1 2.8 5.7 2.4 3.3 22.4 10.0 2.9 2.3 1.7 4.5 10.0 22.1 8.9 3.1 3.5 6.4 1.7 2.0 15.0 7.3 2.2 1.3 0.7 7.4 0.2 5.4 3.8 4.3 10.6 0.4 2.7 1.3 8.8 14.7 0.3 2.2 15.1 2.0 3.0 4.7 1.5 6.5 26.1 7.4 0.7 3.3 14.7 4.3 7.4 9.6 2.2 2.0 1.8 6.0 0.1 2.5 2.7 2.1 2.0 2.1 3.0 2.2 0.0 0.2 0.4 1.0 0.0 0.4 0.3 0.9 1.1 1.4 1.8 0.8 0.6 0.0 3.3 0.0 1.2 0.1 0.1 8.6 17.0 4.0 13.4 9.4 6.1 21.8 6.1 11.2 20.6 38.7 3.8 2.7 22.4 46.8 33.1 3.3 5.1 9.4 20.5 15.7 3.9 42.9 6.6 17.3 75.0 17.5 33.2 0.0 13.8 43.0 5.2 14.6 5.7 0.0 4.5 7.9 17.2 7.4 0.3 81.7 8.6 1.5 10.1 3.6 22.1 38.2 21.5 36.6 9.6 10.1 2.7 6.5 2.5 6.1 6.9 46.0 89.7 3.8 18.4 26.7 LRRC14 "KIAA0014, LRRC14A" ENSG00000160959 "Leucine rich repeat containing 14" Q15048 8 144517992-144525178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021047 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021047: AB_1853298" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-3)" "unprognostic (1.83e-1)" "unprognostic (7.58e-2)" "unprognostic (6.39e-3)" "unprognostic (1.93e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "prognostic favorable (1.78e-4)" "unprognostic (3.31e-1)" "unprognostic (1.52e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-1)" "unprognostic (6.93e-2)" "unprognostic (1.04e-3)" 9.4 10.3 11.9 15.0 11.9 9.5 26.5 14.3 22.3 10.4 10.5 15.1 5.0 11.0 13.7 8.9 11.5 10.6 11.3 9.7 12.4 8.2 9.4 8.9 10.0 12.2 15.3 16.0 11.2 17.5 16.9 13.5 8.4 12.7 15.6 7.9 9.4 16.8 12.9 9.8 17.6 10.6 12.7 9.2 11.9 11.0 9.6 12.1 9.7 13.8 6.2 9.8 11.9 9.4 10.6 9.8 4.7 8.6 13.1 10.3 8.7 9.6 19.9 5.4 8.7 5.8 4.7 7.7 8.7 3.8 7.0 6.0 8.8 11.8 7.9 9.2 6.4 4.3 10.6 8.4 8.6 3.2 10.5 19.4 11.7 21.2 3.6 5.4 5.0 9.7 5.7 7.4 7.0 3.5 5.8 6.0 9.1 15.4 9.5 6.8 11.9 18.3 6.5 4.4 8.5 28.8 15.7 4.5 11.1 4.2 8.5 14.7 8.2 13.3 10.7 6.2 3.3 16.4 5.5 6.4 12.0 21.3 10.6 12.7 5.3 3.1 9.8 11.3 11.6 7.3 1.9 8.6 1.8 10.3 8.1 10.2 9.0 7.7 9.6 8.4 10.6 8.6 7.0 4.7 13.1 6.7 9.8 7.2 8.7 11.9 11.9 14.3 22.3 12.4 8.2 15.3 16.0 12.7 12.1 6.0 1.9 12.4 4.6 5.7 11.7 3.5 12.7 5.3 5.7 8.7 2.0 5.7 5.0 4.8 1.1 4.5 7.9 0.0 7.0 5.8 3.9 6.7 6.9 9.0 6.6 11.1 5.2 10.4 5.2 2.4 6.9 3.7 1.7 7.2 6.6 8.9 5.7 3.5 7.4 6.0 7.6 6.5 5.2 27.9 24.3 5.1 4.6 6.9 11.4 3.5 LRRC14B ENSG00000185028 "Leucine rich repeat containing 14B" A6NHZ5 5 191511-195353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 4.8" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.8" "Cell line enriched" "Detected in some" 4 "U-266/84: 29.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038046, HPA038047" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038046: AB_10672504, HPA038047: AB_2675806" "unprognostic (7.63e-4)" "unprognostic (4.25e-3)" "unprognostic (8.50e-3)" "unprognostic (7.63e-4)" "unprognostic (4.95e-2)" "unprognostic (3.79e-2)" "unprognostic (6.07e-3)" "unprognostic (9.68e-2)" "unprognostic (6.43e-2)" "unprognostic (6.43e-3)" "unprognostic (2.78e-2)" "unprognostic (6.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.19e-1)" 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 30.6 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.9 0.4 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.2 14.3 0.7 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 3.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 7.1 29.2 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC2 ENSG00000163827 "Leucine rich repeat containing 2" Q9BYS8 3 46515423-46580099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0" "Cell type enriched" "Detected in many" 17 "Cardiomyocytes: 175.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.8;HEL: 6.2;LHCN-M2: 6.2;TIME: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039138, HPA064844" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA039138: AB_10795461, HPA064844: " "unprognostic (1.32e-4)" "unprognostic (3.44e-3)" "unprognostic (2.29e-2)" "unprognostic (3.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.44e-1)" "unprognostic (7.38e-3)" "unprognostic (1.61e-1)" "unprognostic (7.42e-2)" "unprognostic (1.45e-1)" "unprognostic (3.72e-3)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (1.09e-1)" "unprognostic (2.53e-1)" "unprognostic (1.96e-2)" "unprognostic (1.24e-1)" 1.8 0.5 1.9 0.4 1.4 0.4 1.0 1.4 3.0 2.6 1.1 0.2 0.0 0.4 3.9 1.4 1.1 1.1 1.4 53.9 1.3 0.4 2.2 2.5 0.6 0.3 0.5 2.3 2.8 0.7 0.1 2.2 0.5 1.0 1.2 0.8 0.4 1.4 0.2 70.3 1.2 0.6 2.3 0.4 1.3 1.0 0.4 0.0 1.4 10.1 20.0 1.2 1.7 1.8 1.2 0.8 2.6 0.7 1.1 2.5 0.3 0.2 0.1 0.2 0.3 1.0 2.3 0.1 0.8 1.5 0.6 0.8 0.0 0.2 0.3 0.2 10.8 0.1 0.2 3.8 0.0 1.4 0.5 0.1 6.2 0.4 0.2 0.3 0.2 0.1 0.2 0.1 4.3 0.0 3.6 0.2 0.8 0.1 0.4 6.2 0.1 0.8 0.1 1.5 0.5 0.2 0.1 0.1 0.3 0.1 0.3 0.5 1.2 0.8 0.2 1.6 1.3 0.2 0.8 4.9 0.3 0.6 2.5 1.6 0.4 0.3 2.9 0.2 0.1 1.4 2.2 0.7 0.6 0.6 0.4 0.4 0.7 1.6 0.3 0.2 1.2 0.8 0.6 2.6 1.1 0.5 0.8 2.5 0.3 1.9 1.4 1.4 3.0 1.3 0.4 0.5 2.3 1.0 0.0 8.9 0.6 0.0 0.8 1.6 0.0 175.7 2.5 1.4 0.0 1.8 0.0 0.1 8.3 0.2 2.0 1.5 0.0 0.0 0.8 0.0 4.3 0.4 10.3 8.9 1.5 0.0 2.9 5.5 0.0 1.7 0.6 1.1 10.1 0.0 1.5 0.3 1.5 0.0 0.0 0.5 0.1 0.0 3.9 0.6 0.2 2.0 0.1 0.7 1.7 0.4 LRRC20 "FLJ10751, FLJ10844" ENSG00000172731 "Leucine rich repeat containing 20" Q8TCA0 10 70298970-70382650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 111.8" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 28.5;Early spermatids: 20.2;Hepatocytes: 14.5;Late spermatids: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2 OS: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039630 Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA039630: AB_10795467" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-2)" "unprognostic (3.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.50e-3)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" 1.3 2.5 5.6 1.4 7.2 1.6 1.4 5.2 11.2 3.3 3.2 2.5 0.0 1.4 2.7 3.1 7.1 2.4 2.1 15.8 5.0 3.9 1.2 8.3 2.2 1.7 3.7 6.3 2.2 1.3 2.1 3.6 1.1 4.9 2.6 2.0 1.8 1.8 2.4 111.8 1.6 1.4 3.5 2.0 1.4 1.6 3.5 1.9 1.6 2.6 14.3 3.1 2.2 4.8 0.9 2.6 0.0 1.0 1.1 4.1 1.1 14.6 11.3 7.3 15.6 4.1 3.3 0.0 1.9 6.6 5.0 4.7 9.6 15.3 2.9 7.8 1.4 15.6 5.3 7.1 10.6 3.5 8.2 2.3 1.7 2.5 22.0 4.5 4.2 1.4 1.3 3.2 6.9 2.3 4.9 9.7 19.4 2.1 4.7 4.6 2.3 16.0 3.5 2.4 11.0 25.7 13.4 4.2 8.3 6.5 1.5 18.5 8.0 1.2 1.3 5.1 1.9 1.9 4.3 5.9 4.0 34.6 5.3 4.5 7.6 13.4 4.8 6.5 17.4 0.8 0.0 0.9 0.0 1.7 1.0 1.4 0.9 1.3 1.9 2.6 0.0 4.1 1.5 0.0 1.1 0.7 0.4 0.2 1.1 5.6 7.2 5.2 11.2 5.0 3.9 3.7 6.3 4.9 1.9 0.0 5.8 0.0 0.5 1.3 8.0 28.5 2.5 0.0 1.2 0.0 3.9 0.1 0.0 3.5 20.2 2.7 0.4 0.0 4.2 0.1 2.0 0.7 0.0 14.5 0.4 1.6 5.2 1.3 0.3 32.8 2.8 0.0 1.7 1.0 1.3 7.8 4.1 1.7 1.4 1.4 1.7 0.0 1.7 4.3 4.5 0.5 0.0 0.8 1.9 0.6 LRRC37B ENSG00000185158 "Leucine rich repeat containing 37B" Q96QE4 17 32007872-32053504 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 71.2;Spermatocytes: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 2.8;NK-cells: 6.4;T-cells: 4.9" "Low cell line specificity" "Detected in all" HPA015135 Approved Approved Cytosol NA NA Cytosol "HPA015135: AB_1853309" "unprognostic (5.46e-3)" "unprognostic (2.56e-2)" "unprognostic (5.08e-2)" "unprognostic (5.30e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-1)" "unprognostic (3.60e-2)" "unprognostic (9.65e-3)" "unprognostic (5.06e-2)" "unprognostic (3.19e-2)" "unprognostic (1.72e-4)" "unprognostic (6.99e-2)" "unprognostic (5.72e-3)" "unprognostic (6.94e-2)" "unprognostic (3.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.36e-3)" 4.7 5.0 13.7 4.8 15.0 28.5 6.4 35.5 14.4 5.9 5.2 7.2 5.0 4.5 8.3 6.5 4.6 8.2 4.8 2.7 10.7 8.5 3.7 3.0 6.7 5.5 8.6 10.2 12.1 4.3 7.4 13.8 4.6 8.9 5.3 6.4 6.1 6.5 4.2 3.5 11.7 6.3 7.2 8.5 7.6 6.6 24.5 10.3 8.3 4.4 1.8 5.8 5.3 10.2 0.8 1.1 2.8 0.5 6.4 4.9 0.5 2.1 3.9 12.5 7.1 3.2 4.0 3.9 1.9 7.1 5.5 7.1 5.4 2.1 5.6 4.0 4.3 6.9 2.8 7.4 1.5 4.4 1.6 6.3 2.6 5.8 2.0 4.7 10.1 4.8 4.2 4.7 5.0 12.8 5.3 4.6 9.6 6.1 5.4 2.1 1.9 17.6 15.6 3.8 1.9 2.7 12.4 2.9 4.5 3.1 5.2 2.4 4.0 4.8 3.1 6.5 4.3 8.2 16.3 3.9 3.9 2.7 8.6 4.6 5.4 7.7 5.6 2.8 10.2 2.8 0.0 0.4 2.8 1.1 0.5 2.1 0.2 2.2 3.0 0.8 0.8 3.0 0.8 1.1 6.4 0.2 1.1 4.9 0.5 13.7 15.0 35.5 14.4 10.7 8.5 8.6 10.2 8.9 10.3 6.0 7.8 2.7 6.4 3.7 7.8 4.4 10.2 8.1 10.3 1.8 0.0 1.8 8.3 8.5 71.2 5.0 2.9 23.3 9.0 1.9 5.0 8.3 3.5 2.9 8.3 3.2 1.7 7.4 7.9 11.8 6.4 8.3 8.5 7.2 5.5 9.2 8.3 0.0 6.7 6.9 8.7 0.0 9.6 37.1 10.6 4.4 1.8 10.1 5.4 6.5 LRRC45 MGC20806 ENSG00000169683 "Leucine rich repeat containing 45" Q96CN5 17 82023302-82031151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023372, HPA023382, HPA024768" Enhanced Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Nucleoplasm, Plasma membrane" "HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348" "unprognostic (6.69e-2)" "unprognostic (6.10e-2)" "unprognostic (6.86e-2)" "unprognostic (1.38e-2)" "unprognostic (6.92e-2)" "unprognostic (4.41e-3)" "unprognostic (4.70e-3)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (1.78e-3)" "unprognostic (6.17e-3)" "unprognostic (7.46e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" "unprognostic (3.58e-1)" 5.1 4.9 7.1 7.0 9.3 12.0 4.5 20.3 10.8 4.6 7.0 5.7 9.5 11.1 4.4 5.0 8.0 10.5 5.8 3.1 7.7 3.9 5.9 12.9 5.6 6.5 8.3 4.7 3.7 15.5 4.5 4.8 4.9 6.5 6.6 3.6 4.9 13.6 5.0 4.3 10.2 9.4 5.2 3.3 7.6 10.4 3.1 9.9 7.1 9.8 6.8 6.5 5.0 5.1 2.3 3.3 5.0 3.2 2.8 4.6 3.1 9.8 11.2 3.4 7.0 1.4 1.9 13.4 6.9 2.9 4.2 3.5 10.0 6.8 7.4 6.2 1.4 4.3 11.6 3.3 4.1 0.9 4.5 21.3 4.7 20.5 13.5 1.2 5.5 11.8 1.9 1.7 2.5 0.6 1.7 6.1 7.2 3.3 3.3 1.1 16.7 12.3 18.4 3.5 8.0 15.1 10.1 6.7 4.1 2.7 9.2 10.6 10.4 3.1 16.5 5.8 1.8 13.5 6.4 3.5 7.3 9.3 11.6 11.7 6.4 1.6 1.1 3.9 4.8 7.6 5.0 3.2 3.6 3.9 2.4 4.0 1.5 4.5 4.6 2.2 2.3 2.4 3.1 0.2 2.8 1.0 3.3 3.8 3.1 7.1 9.3 20.3 10.8 7.7 3.9 8.3 4.7 6.5 9.9 6.0 2.1 1.9 4.2 3.9 4.5 2.4 10.2 14.7 7.9 3.5 0.0 8.9 5.0 6.8 1.1 3.1 9.1 0.0 4.2 22.5 4.0 3.5 4.6 11.1 7.4 4.8 4.6 8.6 5.9 1.1 6.6 2.5 8.5 2.8 9.8 5.0 5.0 8.6 6.0 6.5 4.0 0.0 3.8 1.4 11.0 2.0 2.5 5.3 10.3 2.0 LRRC46 MGC16309 ENSG00000141294 "Leucine rich repeat containing 46" Q96FV0 17 47831627-47837713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 51.2;testis: 94.4" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 239.6;Early spermatids: 97.9;Late spermatids: 46.8;Spermatocytes: 76.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.4" "Region enriched" "Detected in many" 4 "pons and medulla: 14.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 6.4;T-47d: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021882, HPA074893" Enhanced Approved Cytosol NA NA Cytosol "HPA021882: AB_1853320, HPA074893: AB_2732271" "unprognostic (1.06e-1)" "unprognostic (6.01e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.40e-1)" "unprognostic (2.81e-2)" "unprognostic (4.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-1)" "unprognostic (3.06e-1)" "unprognostic (2.21e-3)" "unprognostic (3.63e-2)" "unprognostic (2.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-1)" 0.3 0.4 1.8 0.3 3.3 0.6 0.5 0.4 0.5 2.3 0.3 5.2 1.6 0.4 1.5 13.8 0.4 51.2 0.5 0.5 2.0 2.4 0.7 0.4 11.8 0.5 0.3 0.1 8.8 0.5 0.3 4.2 0.4 14.0 0.5 0.3 1.8 0.4 1.3 0.3 0.3 0.3 0.3 0.6 0.5 0.3 94.4 1.1 1.2 1.4 0.0 0.4 0.3 0.1 0.6 2.5 4.4 1.6 2.4 1.0 0.5 1.5 6.4 0.8 3.2 0.5 1.4 1.8 0.2 1.7 1.7 3.3 3.0 1.4 0.7 4.1 0.8 1.7 1.4 0.8 1.1 2.6 2.8 2.8 1.3 1.8 1.0 0.3 0.1 1.5 0.0 1.0 3.5 1.3 0.5 0.3 1.1 1.2 0.8 2.3 2.4 2.1 0.3 0.2 0.5 1.3 2.0 0.2 1.3 2.8 1.1 2.7 2.0 0.7 0.0 0.9 0.3 7.6 0.2 0.5 3.5 1.3 0.6 0.4 1.4 1.3 1.3 2.4 0.5 0.3 4.4 1.3 2.0 0.2 1.6 0.0 0.6 0.1 1.0 2.5 0.4 0.7 0.0 1.6 2.4 1.5 1.3 0.2 0.5 1.8 3.3 0.4 0.5 2.0 2.4 0.3 0.1 14.0 1.1 0.0 2.9 0.0 0.3 0.0 0.6 0.3 0.0 239.6 27.3 5.2 2.0 0.1 0.0 0.3 97.9 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 46.8 2.6 0.7 0.0 1.0 0.1 0.9 0.5 0.0 1.8 1.0 5.4 0.0 0.1 76.7 4.0 0.0 0.1 0.0 0.0 0.1 LRRC4C "KIAA1580, NGL-1" ENSG00000148948 "Leucine rich repeat containing 4C" Q9HCJ2 11 40114203-41459773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 31.5" "Group enriched" "Detected in some" 12 "Muller glia cells: 106.3;Rod photoreceptor cells: 97.7" "Cancer enhanced" "Detected in some" "glioma: 3.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "naive B-cell: 1.7" "Lineage enriched" "Detected in single" 18 "B-cells: 1.7" "Group enriched" "Detected in some" 6 "AF22: 17.3;U-2 OS: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054800, HPA075816" Supported Approved Cytosol NA NA Cytosol "HPA054800: AB_2682603, HPA075816: " "unprognostic (4.86e-3)" "unprognostic (3.43e-2)" "unprognostic (7.62e-3)" "unprognostic (4.87e-3)" "unprognostic (6.48e-2)" "unprognostic (1.42e-1)" "unprognostic (2.84e-1)" "unprognostic (4.64e-2)" "unprognostic (1.93e-1)" "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (4.90e-13)" "unprognostic (5.05e-4)" "unprognostic (5.21e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-3)" 1.6 5.7 20.2 1.6 23.7 0.5 2.6 3.6 31.5 5.3 1.9 3.3 0.0 1.1 2.3 1.0 1.2 1.3 1.8 2.6 16.7 8.7 0.9 2.1 1.6 1.4 7.5 10.3 1.6 1.0 4.3 3.2 0.5 8.7 1.5 1.6 1.3 1.4 3.0 0.7 0.7 1.3 2.4 6.0 1.3 0.9 0.9 7.9 0.0 4.0 0.0 1.6 1.1 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 19.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 23.7 3.6 16.4 16.7 8.7 7.5 10.3 8.7 7.9 0.0 2.2 0.0 0.0 0.1 8.7 1.0 0.0 0.0 1.2 0.0 5.9 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.1 7.9 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 0.0 106.3 0.2 0.0 1.4 0.6 97.7 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 LRRC57 FLJ36812 ENSG00000180979 "Leucine rich repeat containing 57" Q8N9N7 15 42537820-42548802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 56.9;Rod photoreceptor cells: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040894 Approved Approved Mitochondria,Cytosol NA NA 230000 "Mitochondria, Cytosol" "HPA040894: AB_10794996" "unprognostic (8.99e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.84e-2)" "unprognostic (4.77e-2)" "unprognostic (4.16e-2)" "unprognostic (4.78e-2)" "unprognostic (2.57e-1)" "unprognostic (1.32e-1)" "unprognostic (3.31e-2)" "unprognostic (3.73e-2)" "prognostic favorable (2.15e-4)" "unprognostic (7.45e-2)" "unprognostic (7.23e-2)" "unprognostic (2.35e-1)" "unprognostic (1.05e-2)" 13.9 14.7 15.8 11.6 13.6 32.7 19.2 12.4 19.1 11.8 16.0 10.6 9.7 12.3 15.7 12.2 18.0 15.3 10.2 15.6 18.0 8.4 14.2 11.1 15.9 11.2 11.8 16.5 17.6 14.5 13.2 12.2 14.4 9.9 12.3 18.9 16.4 15.7 11.6 11.0 16.5 14.5 12.8 10.3 13.0 14.1 12.4 11.3 14.9 15.1 10.0 12.8 13.1 15.6 4.8 6.9 22.1 12.0 11.1 6.7 4.3 10.4 7.9 14.4 10.8 12.0 9.5 7.8 15.0 8.0 10.6 11.2 16.3 8.4 4.9 10.5 11.6 12.0 17.2 9.6 11.7 10.8 10.4 9.0 19.5 17.4 7.3 11.6 12.0 12.6 10.4 15.7 9.6 11.9 7.6 16.9 13.0 15.0 11.8 9.6 4.9 7.0 5.4 3.8 17.7 7.1 11.0 13.9 7.7 7.3 17.1 7.4 8.9 17.3 12.5 8.7 9.9 11.6 14.4 17.2 12.8 9.0 13.1 11.1 10.0 24.8 20.3 7.3 12.1 15.6 22.1 6.5 20.5 5.4 9.4 6.7 4.2 5.2 4.9 6.9 4.8 4.3 5.3 8.5 11.1 12.0 4.0 5.2 4.3 15.8 13.6 12.4 19.1 18.0 8.4 11.8 16.5 9.9 11.3 8.9 13.3 5.4 11.0 5.0 13.4 9.5 10.2 21.4 7.9 8.7 56.9 9.9 11.6 9.6 13.9 12.9 11.6 0.0 8.5 15.7 7.4 12.9 13.9 6.4 12.0 19.1 12.0 18.4 11.9 13.2 8.9 12.9 6.8 22.6 13.5 18.4 11.4 10.2 15.2 6.6 81.1 6.5 8.2 5.0 5.3 4.8 13.3 10.9 11.9 10.1 LRRC58 ENSG00000163428 "Leucine rich repeat containing 58" Q96CX6 3 120324509-120349339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057574 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA057574: AB_2683474" "unprognostic (7.87e-3)" "unprognostic (6.84e-3)" "unprognostic (3.20e-1)" "unprognostic (2.67e-3)" "unprognostic (8.73e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (4.41e-2)" "unprognostic (1.30e-2)" "unprognostic (3.67e-2)" "unprognostic (2.73e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.18e-4)" "unprognostic (1.06e-1)" 15.8 30.1 12.7 10.7 14.3 10.0 15.4 13.9 14.8 15.4 13.3 16.3 11.3 9.6 14.5 11.3 14.6 11.0 9.7 9.6 12.9 9.6 19.2 14.1 10.9 12.7 15.9 10.5 19.7 13.1 21.0 9.8 12.1 14.4 15.1 9.9 13.2 11.6 12.1 9.2 13.8 12.2 15.5 22.9 14.6 10.0 7.9 15.5 27.9 18.3 9.0 11.0 17.2 16.1 5.7 6.4 3.5 5.8 3.7 8.4 3.4 24.8 8.8 6.0 7.7 14.0 13.4 9.6 8.9 7.8 9.6 12.0 8.2 7.7 16.3 11.2 9.6 13.6 10.9 11.1 8.8 18.3 6.3 6.9 17.4 12.0 9.5 9.4 28.1 9.0 9.8 11.3 11.6 15.0 6.2 5.6 10.5 9.8 21.0 10.3 11.3 22.0 9.0 6.1 11.0 16.1 4.9 16.2 10.5 7.3 9.2 7.7 10.3 15.7 10.8 22.3 4.4 11.8 12.8 8.3 16.1 17.9 10.7 11.3 18.1 20.8 34.6 16.2 21.3 13.4 2.4 5.8 2.3 4.4 5.1 6.4 5.4 5.5 5.6 5.5 5.7 8.4 6.2 3.5 3.7 3.9 6.4 5.4 3.4 12.7 14.3 13.9 13.5 12.9 9.6 15.9 10.5 14.4 15.5 68.5 57.6 28.8 17.3 45.2 28.0 15.5 28.1 37.5 38.7 17.4 53.0 14.2 10.0 19.4 6.7 20.4 18.0 23.3 26.5 21.7 39.0 27.8 33.6 31.0 24.2 23.8 16.1 25.2 43.8 4.0 51.8 30.3 32.1 8.2 22.2 43.2 26.4 14.4 68.6 33.1 20.4 25.8 33.5 17.4 24.0 49.8 11.3 27.7 29.0 14.4 LRRC7 "densin-180, KIAA1365" ENSG00000033122 "Leucine rich repeat containing 7" Q96NW7 1 69568398-70151945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 29.1" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 37.9;Early spermatids: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3" "Group enriched" "Detected in many" 14 "granulocytes: 1.4;T-cells: 1.7" "Group enriched" "Detected in some" 6 "HaCaT: 10.5;HEL: 31.3" "Low region specificity" "Detected in many" HPA005625 Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA005625: AB_1853340" "unprognostic (2.81e-2)" "unprognostic (1.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.98e-3)" "unprognostic (2.47e-1)" "unprognostic (1.73e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (4.84e-3)" "unprognostic (2.92e-2)" "unprognostic (1.06e-3)" "unprognostic (1.46e-1)" "unprognostic (5.64e-6)" "unprognostic (1.31e-2)" "unprognostic (1.74e-2)" "unprognostic (5.13e-3)" "unprognostic (2.08e-3)" 1.0 1.3 20.2 1.0 29.1 1.0 0.8 0.5 21.9 1.2 1.9 5.0 0.0 1.0 1.2 1.0 1.3 0.8 3.2 2.8 15.4 5.8 2.8 1.2 0.8 0.9 4.4 17.6 1.0 2.7 0.7 0.4 1.2 2.4 1.5 2.4 0.2 0.9 1.1 2.8 1.1 1.3 1.2 2.5 0.8 0.8 5.8 7.6 0.0 6.7 0.0 0.8 0.9 0.5 0.0 0.1 1.4 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 3.3 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.5 31.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 20.2 29.1 0.5 19.2 15.4 5.8 4.4 17.6 2.4 7.6 0.0 0.0 5.1 0.5 0.7 37.9 5.8 2.5 0.0 0.0 0.0 2.0 0.4 0.0 0.0 20.2 1.4 0.0 0.0 0.0 0.4 2.1 0.7 0.0 5.5 0.3 6.4 0.0 1.8 1.5 4.6 0.6 0.7 5.0 0.0 0.0 0.5 0.0 0.0 2.8 1.3 7.9 0.0 1.4 7.4 2.7 1.1 0.1 2.5 0.0 0.1 LRRC73 "C6orf154, dJ337H4.2" ENSG00000204052 "Leucine rich repeat containing 73" Q5JTD7 6 43506969-43510686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5;testis: 31.6" "Cell type enriched" "Detected in many" 7 "Early spermatids: 299.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "AN3-CA: 5.7;MCF7: 5.7;OE19: 8.0;T-47d: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046698 Enhanced Approved Cytosol NA NA Cytosol "HPA046698: AB_10959526" "unprognostic (3.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (4.42e-3)" "unprognostic (1.04e-2)" "unprognostic (3.52e-1)" "unprognostic (6.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.25e-1)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.81e-1)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-3)" "unprognostic (1.89e-2)" 1.2 6.1 10.4 0.9 19.4 0.8 1.1 2.3 23.5 1.4 1.3 2.3 0.9 2.1 1.4 1.5 1.0 11.3 1.8 1.8 8.9 5.2 3.0 1.2 1.6 0.9 3.1 12.1 2.0 2.8 7.5 4.1 1.2 6.2 1.9 1.1 0.6 1.4 2.1 1.0 1.1 1.2 1.5 1.1 1.2 1.8 31.6 1.8 0.0 1.6 0.0 0.9 1.4 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.8 5.7 0.9 2.9 0.2 0.2 1.6 0.5 0.3 0.0 0.3 0.2 0.1 1.0 0.8 2.2 0.7 0.7 0.0 0.1 0.9 0.0 0.4 0.2 0.9 0.0 0.1 0.5 1.1 1.8 0.3 2.8 0.1 0.3 0.3 0.5 1.0 5.7 0.0 0.0 0.1 8.0 0.7 0.0 0.0 0.1 1.5 0.0 2.1 2.5 0.5 0.4 0.2 0.0 5.8 0.0 0.2 0.4 0.6 2.1 0.2 0.5 0.3 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 19.4 2.3 23.5 8.9 5.2 3.1 12.1 6.2 1.8 0.0 0.0 0.0 2.4 0.3 4.9 0.8 0.0 8.1 2.3 3.5 0.0 0.1 6.6 0.6 299.6 0.1 1.3 0.0 0.7 0.1 0.6 2.3 0.0 0.4 0.1 27.0 5.2 0.0 0.0 27.3 4.0 0.0 1.7 0.0 2.0 8.3 0.2 0.0 3.9 5.1 6.6 6.5 1.1 41.7 9.7 0.0 0.2 0.0 0.6 0.6 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 12.0;HUVEC TERT2: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.2 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.8 2.3 1.1 0.3 0.0 0.8 0.1 0.5 0.4 0.3 0.2 0.1 0.4 0.9 12.0 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 0.4 3.9 1.3 0.5 0.2 0.0 2.0 1.9 0.8 0.2 2.8 0.1 0.7 0.7 0.1 0.6 0.2 2.3 0.6 0.0 0.2 2.8 0.5 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 38.7 51.3 11.9 7.2 0.0 8.7 0.3 7.6 16.0 36.4 1.8 5.9 13.7 16.6 3.8 5.3 6.0 49.1 23.3 6.1 16.9 3.9 6.4 27.8 8.1 10.5 3.2 23.7 9.2 10.7 5.9 15.3 6.7 0.0 1.8 44.8 16.7 5.7 23.0 10.6 15.2 16.4 12.9 2.3 3.8 6.7 0.0 14.0 8.9 47.2 6.2 LRRC75B "C22orf36, FAM211B, MGC131773" ENSG00000178026 "Leucine rich repeat containing 75B" Q2VPJ9 22 24585620-24593208 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 22.2;Muller glia cells: 39.6;Proximal tubular cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 2.7;NK-cell: 2.0" "Group enriched" "Detected in many" 5 "granulocytes: 2.7;NK-cells: 2.0" "Cell line enhanced" "Detected in many" "Hep G2: 8.3;MCF7: 7.4;SH-SY5Y: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002540 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002540: AB_1079263" "unprognostic (1.21e-1)" "unprognostic (2.00e-1)" "unprognostic (2.47e-1)" "unprognostic (2.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.21e-2)" "unprognostic (4.52e-2)" "unprognostic (2.48e-2)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (2.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (7.40e-2)" "unprognostic (9.69e-2)" 4.2 1.9 7.5 1.4 6.0 3.0 2.6 3.8 6.6 3.5 3.8 2.6 11.5 1.4 2.4 5.8 3.4 3.3 9.8 4.3 5.5 9.1 6.0 3.4 1.7 1.7 7.8 4.0 7.3 7.2 1.4 1.5 2.3 4.1 6.9 2.0 4.9 7.5 15.0 10.7 4.3 8.2 6.7 7.0 2.7 2.6 8.3 0.5 0.0 8.6 3.0 2.1 5.5 2.7 0.0 0.3 2.7 0.4 2.0 0.2 0.0 0.1 4.2 0.0 2.3 0.6 1.7 0.4 0.6 0.7 1.5 1.6 3.1 0.0 0.0 1.0 1.2 1.2 4.7 0.4 2.3 0.0 1.3 2.8 0.3 0.6 8.3 4.2 0.0 0.0 0.0 1.8 1.5 0.2 0.9 1.1 0.0 0.4 0.0 0.1 7.4 0.0 1.5 2.1 5.0 1.7 0.0 0.2 0.0 1.9 0.4 2.2 6.6 2.2 0.7 0.6 0.5 0.0 0.7 2.4 2.5 1.6 0.9 0.8 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.3 2.7 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 7.5 6.0 3.8 5.6 5.5 9.1 7.8 4.0 4.1 0.5 11.9 5.1 0.0 2.0 0.0 2.2 3.1 17.8 0.0 0.0 7.0 0.0 1.7 10.0 8.0 1.1 0.8 14.2 0.0 7.9 0.3 1.8 7.4 0.0 22.2 1.0 1.6 1.2 1.3 1.6 5.8 11.8 0.5 0.0 0.0 5.5 39.6 4.2 3.4 9.2 38.2 0.9 0.0 4.1 0.5 0.7 0.0 0.9 0.0 4.5 1.0 LRRFIP1 "FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP" ENSG00000124831 "LRR binding FLII interacting protein 1" Q32MZ4 2 237627576-237813682 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 74.5" HPA006979 Approved Supported Cytosol NA NA 120000 Cytosol "HPA006979: AB_1079282" "unprognostic (2.07e-1)" "unprognostic (2.99e-2)" "unprognostic (4.09e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.09e-1)" "unprognostic (6.50e-2)" "unprognostic (9.68e-3)" "unprognostic (3.08e-2)" "unprognostic (3.99e-3)" "unprognostic (8.90e-2)" "unprognostic (4.70e-2)" "unprognostic (7.29e-2)" "unprognostic (2.69e-2)" "unprognostic (8.07e-2)" "unprognostic (7.64e-2)" 27.2 9.9 11.2 28.6 9.4 28.5 31.3 8.8 14.5 28.0 30.9 5.4 16.4 13.7 36.3 24.1 30.1 18.5 23.3 30.7 11.1 12.0 32.1 27.6 29.9 25.5 7.7 10.0 18.0 10.4 31.3 14.2 16.8 12.2 27.5 16.3 8.2 20.2 14.4 52.7 12.6 19.8 56.8 7.4 27.9 21.5 7.3 5.8 27.6 19.0 23.1 19.4 49.3 39.5 12.8 17.6 71.6 33.1 9.3 19.9 10.6 22.7 11.8 5.6 11.3 8.0 16.0 18.9 17.1 16.5 9.3 9.3 4.5 15.3 1.9 6.9 26.3 20.1 19.1 12.8 23.7 19.9 74.5 8.3 18.1 13.4 12.7 16.2 23.8 17.2 7.2 49.8 21.6 53.1 13.9 18.8 12.8 13.3 18.7 19.9 11.0 13.7 18.2 7.4 17.0 10.9 20.5 33.0 18.5 29.8 33.3 11.5 7.7 7.9 18.3 21.7 10.6 10.3 30.1 32.9 11.3 10.9 12.1 18.0 3.8 3.2 12.7 16.4 24.1 12.3 14.3 22.8 49.4 16.5 19.7 12.4 11.0 19.9 17.1 17.6 12.8 10.6 11.8 71.6 9.3 33.1 15.5 15.3 10.6 11.2 9.4 8.8 14.5 11.1 12.0 7.7 10.0 12.2 5.8 452.6 296.6 160.3 309.8 272.8 47.5 137.7 124.9 346.6 384.5 164.0 35.3 90.2 44.7 209.5 8.0 199.3 165.6 0.0 289.9 289.9 102.6 382.8 229.3 128.8 162.7 20.6 182.9 86.5 247.2 5.6 27.6 484.3 158.6 206.4 114.8 21.5 281.3 91.1 21.9 38.3 5.6 77.6 225.8 8.8 35.9 212.4 21.2 230.4 94.7 523.2 LRRK1 "FLJ23119, KIAA1790, RIPK6, Roco1" ENSG00000154237 "Leucine rich repeat kinase 1" Q38SD2 15 100919215-101078254 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.3" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 30.0;monocytes: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.2;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.5;Karpas-707: 17.3;U-266/84: 15.6;U-698: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010537 Uncertain Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA010537: AB_1079283" "unprognostic (3.74e-2)" "unprognostic (1.41e-1)" "unprognostic (2.82e-1)" "unprognostic (3.72e-1)" "unprognostic (6.68e-2)" "unprognostic (6.35e-2)" "unprognostic (1.94e-1)" "unprognostic (4.75e-2)" "unprognostic (3.43e-2)" "unprognostic (3.34e-2)" "unprognostic (2.95e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-2)" "unprognostic (3.13e-1)" "unprognostic (5.25e-2)" 6.1 1.9 4.5 26.3 3.9 6.5 5.0 2.1 8.1 6.4 8.0 5.9 2.2 2.9 7.9 6.0 5.4 7.1 4.2 3.4 4.0 1.5 2.7 1.0 4.7 15.0 4.5 4.0 6.3 5.3 2.8 2.3 4.4 2.5 7.1 6.5 2.8 7.7 6.8 1.6 7.3 8.5 5.7 3.7 11.1 3.9 5.1 3.4 1.2 3.5 2.1 17.4 7.5 6.7 2.3 3.3 3.2 1.1 0.0 0.0 0.1 0.8 4.8 0.0 0.0 7.4 7.6 0.0 2.9 2.1 2.7 1.9 0.8 2.1 23.5 1.1 7.8 0.0 4.8 0.7 0.5 1.4 0.4 1.1 7.1 1.1 0.0 0.5 3.8 5.5 6.0 1.0 1.7 1.5 0.7 4.7 0.0 1.2 17.3 0.5 0.0 0.0 2.4 0.2 4.3 2.0 1.7 0.4 6.4 0.0 0.0 0.0 1.7 1.8 2.7 5.4 0.0 0.3 4.6 5.4 0.0 0.8 1.0 0.0 8.8 15.6 15.2 0.3 0.5 4.4 0.0 0.7 3.2 0.0 0.3 0.0 2.3 0.0 0.0 0.9 1.5 0.0 0.0 0.8 0.0 1.1 3.3 0.0 0.1 4.5 3.9 2.1 8.1 4.0 1.5 4.5 4.0 2.5 3.4 14.9 12.8 11.9 6.5 2.9 0.6 2.8 2.5 8.1 7.9 0.0 5.9 8.4 0.0 3.6 3.0 5.7 12.0 0.0 2.7 3.1 3.5 6.3 1.1 0.0 9.5 0.0 13.2 12.3 14.3 2.4 30.0 14.0 3.3 32.5 12.8 0.8 6.7 10.5 20.1 0.3 0.4 6.5 2.1 5.2 1.1 3.0 3.0 0.5 10.8 9.3 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.5;brain: 23.8" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 33.5;Leydig cells: 52.0;Peritubular cells: 15.2" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4" "Lineage enriched" "Detected in single" 98 "T-cells: 20.3" "Cell line enhanced" "Detected in some" "AF22: 14.7;BJ: 8.3;BJ hTERT+: 18.2;GAMG: 9.3;SH-SY5Y: 26.4;SuSa: 8.5;T-47d: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043820: AB_2678687, HPA046792: AB_2679810" "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.8 26.5 12.7 1.6 21.2 1.1 2.1 20.0 23.8 3.6 1.4 1.9 0.8 1.0 1.0 3.1 1.9 1.3 1.6 9.0 10.4 10.7 0.9 2.7 8.7 3.6 7.7 13.0 7.9 1.5 0.7 4.9 6.7 9.0 4.7 1.6 0.8 1.9 6.4 4.0 0.8 2.1 1.0 2.9 2.0 0.9 16.4 6.3 8.8 22.3 0.0 4.4 1.6 1.3 0.2 0.0 0.1 0.0 0.0 20.3 4.0 0.0 0.0 14.7 1.8 6.8 2.9 0.0 8.3 18.2 0.8 0.7 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.9 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 26.4 0.0 0.0 0.0 8.5 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.0 20.3 18.4 0.1 0.0 0.0 0.0 0.2 4.0 12.7 21.2 20.0 23.8 10.4 10.7 7.7 13.0 9.0 6.3 0.0 7.0 0.0 0.0 0.0 33.5 12.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.3 9.6 0.0 1.1 0.0 0.7 3.2 1.7 1.3 0.0 3.4 52.0 0.0 1.7 0.0 0.0 10.8 0.0 0.0 15.2 0.0 3.9 0.0 1.2 0.9 0.5 0.1 0.3 3.2 0.0 0.1 LRSAM1 "CMT2P, FLJ31641" ENSG00000148356 "Leucine rich repeat and sterile alpha motif containing 1" Q6UWE0 9 127451486-127503501 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021403, HPA021844, CAB037304" Supported Approved Cytosol NA NA Cytosol "CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368" "unprognostic (8.83e-2)" "unprognostic (3.13e-1)" "unprognostic (7.48e-3)" "unprognostic (4.15e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (1.64e-1)" "unprognostic (5.00e-2)" "unprognostic (1.66e-1)" "unprognostic (2.72e-2)" "prognostic favorable (6.78e-6)" "unprognostic (1.27e-1)" "prognostic favorable (5.72e-4)" "unprognostic (1.94e-2)" "unprognostic (3.26e-1)" "unprognostic (9.07e-2)" "unprognostic (3.33e-2)" 9.5 13.6 15.6 10.1 17.2 15.3 9.2 24.2 22.6 10.7 18.0 15.3 10.9 10.8 12.6 17.6 12.3 11.0 11.9 18.7 13.3 17.3 11.2 15.6 11.7 11.5 13.5 22.7 16.0 9.6 17.6 11.8 9.2 17.9 13.6 8.6 10.2 11.9 13.7 20.4 28.3 11.1 16.0 18.7 12.6 12.2 6.1 13.9 5.5 11.6 9.6 11.5 17.2 12.9 4.1 5.4 17.4 6.6 1.3 4.8 3.2 5.7 8.8 5.3 10.2 9.0 8.9 8.4 5.4 6.8 8.4 6.2 10.1 5.6 9.9 5.6 7.5 4.3 19.1 6.5 11.4 3.3 10.4 4.9 5.4 11.4 8.8 7.2 5.9 11.4 5.1 9.4 5.7 11.0 10.8 9.0 8.2 4.7 10.3 3.7 14.6 4.1 5.1 5.0 13.4 8.9 6.7 4.8 15.4 9.1 5.0 9.8 8.1 3.5 12.1 7.1 5.3 24.9 3.2 10.5 5.6 5.7 7.0 3.7 11.4 8.5 1.6 9.3 5.5 2.9 14.6 4.9 17.4 4.4 6.6 4.8 4.1 3.0 3.7 5.4 3.1 1.5 2.0 5.7 1.3 5.5 4.6 2.4 3.2 15.6 17.2 24.2 22.6 13.3 17.3 13.5 22.7 17.9 13.9 8.9 4.6 2.7 2.8 1.0 5.6 18.3 5.1 6.7 10.3 0.0 5.9 4.1 5.0 5.4 0.6 3.6 5.6 0.0 1.2 1.7 2.4 3.6 9.2 5.9 5.4 11.1 1.2 4.3 6.6 0.2 2.6 4.5 3.3 10.8 5.2 5.7 4.2 4.3 4.9 5.0 4.8 0.0 4.1 4.6 3.0 2.4 5.8 5.0 4.9 3.0 LRTM2 ENSG00000166159 "Leucine rich repeats and transmembrane domains 2" Q8N967 12 1820267-1836752 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "brain: 18.7" "Cell type enhanced" "Detected in some" 29 "Bipolar cells: 3.7;Cone photoreceptor cells: 2.0;Horizontal cells: 11.1;Rod photoreceptor cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 9.2;SCLC-21H: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055094, HPA062745" Uncertain Approved Cytosol NA NA Cytosol "HPA055094: AB_2682693, HPA062745: " "unprognostic (1.84e-3)" "unprognostic (4.83e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (5.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.34e-3)" "unprognostic (2.25e-1)" "unprognostic (1.24e-1)" "unprognostic (6.20e-4)" "unprognostic (2.21e-1)" "unprognostic (8.02e-2)" 0.7 0.7 5.1 0.7 12.3 0.7 0.7 0.8 18.7 0.7 0.7 1.7 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 3.3 5.0 0.7 0.7 0.7 0.7 1.7 10.5 0.7 0.7 0.7 0.1 0.7 4.7 0.7 0.7 0.1 0.7 0.8 0.7 0.7 0.7 0.7 1.7 0.7 0.8 0.9 4.3 0.0 0.7 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.3 0.8 18.7 3.3 5.0 1.7 10.5 4.7 4.3 0.0 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LSAMP "IGLON3, LAMP" ENSG00000185565 "Limbic system-associated membrane protein" Q13449 3 115802363-117139389 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.4" "Cell type enhanced" "Detected in many" 13 "Horizontal cells: 208.2;Leydig cells: 116.8;Muller glia cells: 166.8;Peritubular cells: 86.3" "Cancer enhanced" "Detected in many" "glioma: 13.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.0;SH-SY5Y: 14.2;WM-115: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054051, HPA076122" Enhanced Cytosol NA NA 200000000 Cytosol "HPA054051: AB_2682358, HPA076122: AB_2686779" "unprognostic (4.18e-2)" "unprognostic (2.54e-1)" "unprognostic (9.97e-3)" "unprognostic (6.03e-2)" "unprognostic (9.63e-2)" "unprognostic (4.15e-3)" "unprognostic (6.81e-2)" "unprognostic (2.70e-2)" "unprognostic (5.71e-2)" "unprognostic (6.82e-3)" "unprognostic (1.26e-1)" "unprognostic (6.03e-2)" "unprognostic (1.92e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (5.23e-5)" "unprognostic (1.31e-2)" 2.3 12.7 21.9 4.3 23.7 1.1 1.6 43.4 48.4 17.8 5.5 16.6 0.0 1.9 4.4 2.8 3.4 2.9 11.3 2.1 23.7 18.8 2.5 1.0 8.5 4.0 17.6 21.5 4.8 11.1 0.6 3.1 1.2 18.3 21.1 3.5 1.2 1.7 6.2 0.7 4.6 1.9 3.3 13.1 1.7 3.2 3.9 21.3 0.0 4.2 0.0 5.2 7.3 3.4 1.6 0.4 3.0 0.8 0.3 1.0 0.3 0.2 2.2 7.0 0.2 0.7 2.2 0.7 0.6 0.3 0.2 0.7 0.2 0.4 0.5 0.2 3.6 0.2 0.1 0.1 0.1 0.3 0.5 0.1 0.2 0.8 0.3 0.1 0.5 0.4 1.7 0.0 0.8 0.1 0.2 0.0 0.9 0.3 2.3 0.0 0.2 0.8 0.6 2.7 0.3 0.8 0.2 0.1 0.1 1.7 1.6 1.6 14.2 0.0 0.1 2.2 3.2 0.2 0.8 0.1 1.5 1.3 1.7 0.4 1.5 1.9 0.2 0.5 0.2 34.6 3.0 0.8 1.4 0.9 0.5 1.0 0.7 0.6 0.5 0.2 1.6 1.0 0.7 2.8 0.3 0.6 0.4 0.5 0.3 21.9 23.7 43.4 23.7 23.7 18.8 17.6 21.5 18.3 21.3 0.0 0.6 0.5 0.2 6.8 47.9 18.9 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 15.9 2.5 0.0 0.0 3.0 0.0 16.0 17.5 0.0 0.0 0.3 208.2 0.0 1.8 0.0 18.1 116.8 1.8 54.0 0.0 0.0 166.8 0.6 0.0 86.3 0.0 9.7 0.0 1.3 0.9 0.2 4.4 0.0 0.0 0.0 0.5 LSG1 FLJ11301 ENSG00000041802 "Large 60S subunit nuclear export GTPase 1" Q9H089 3 194640788-194672477 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037704, HPA037705" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies, Cytosol" Nucleoplasm "HPA037704: AB_10672912, HPA037705: AB_2675621" "unprognostic (5.72e-3)" "unprognostic (9.38e-3)" "unprognostic (2.63e-1)" "unprognostic (1.23e-2)" "unprognostic (3.74e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.21e-7)" "unprognostic (4.63e-2)" "unprognostic (1.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.42e-1)" "unprognostic (3.00e-2)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.07e-1)" 20.4 17.8 14.2 17.9 20.7 28.8 21.8 14.5 18.9 17.7 18.5 19.2 16.6 20.4 21.6 24.8 22.5 18.3 15.3 17.8 13.3 15.1 20.4 30.6 18.2 20.2 19.9 13.3 21.9 25.6 20.6 24.4 24.2 23.8 21.0 22.3 15.9 19.8 22.2 30.1 26.0 20.0 18.0 16.3 22.2 18.5 18.6 15.9 25.0 23.5 15.8 28.1 18.7 20.3 13.2 14.0 10.7 10.6 17.0 14.9 8.2 20.3 13.5 8.2 13.8 12.9 7.0 16.7 12.2 11.8 16.8 14.9 17.8 9.4 16.1 36.8 11.2 29.4 14.9 25.9 13.9 20.5 20.8 12.5 17.2 14.0 10.1 9.2 18.9 16.7 6.8 12.1 17.4 16.2 6.2 18.2 11.4 14.3 17.9 13.8 28.3 17.0 11.3 22.4 27.5 24.9 20.7 13.5 18.2 9.0 17.7 15.6 10.8 15.9 14.6 14.9 16.2 34.3 12.4 13.9 12.8 14.6 18.0 25.0 19.7 25.9 38.2 10.3 24.4 19.8 2.8 8.1 10.7 13.5 10.6 14.9 13.2 11.0 11.9 14.0 11.0 12.9 11.5 1.1 17.0 7.1 7.4 12.2 8.2 14.2 20.7 14.5 18.9 13.3 15.1 19.9 13.3 23.8 15.9 17.9 26.4 14.6 12.3 14.3 17.0 13.4 25.5 49.5 39.8 8.7 11.8 20.5 5.0 16.5 8.6 13.5 11.5 23.3 19.4 16.2 10.6 9.4 51.0 12.4 11.2 14.3 7.5 9.8 4.5 6.5 14.4 13.1 11.8 10.8 11.2 18.2 16.1 9.9 13.8 10.2 17.4 19.4 9.8 18.1 33.3 14.1 23.8 13.8 14.5 7.1 LSM1 "CASM, YJL124C" ENSG00000175324 "LSM1 homolog, mRNA degradation associated" O15116 8 38163321-38176730 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024601 Approved "Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Cytosol "HPA024601: AB_1853379" "unprognostic (1.19e-2)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" "unprognostic (9.59e-2)" "unprognostic (7.26e-2)" "unprognostic (1.69e-1)" "unprognostic (2.08e-3)" "unprognostic (2.18e-2)" "unprognostic (1.95e-2)" "unprognostic (2.48e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (3.47e-2)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (2.97e-1)" 21.8 27.6 25.5 20.0 23.5 21.6 34.1 20.8 23.2 19.5 23.4 15.3 21.2 20.6 24.9 27.2 24.9 17.8 21.6 44.2 21.2 23.2 35.3 30.7 16.2 22.5 25.1 18.4 18.0 24.7 14.5 23.2 29.8 22.5 21.3 21.5 18.7 27.7 29.0 26.6 17.7 26.3 31.3 17.1 20.5 22.6 17.6 19.9 18.8 25.7 25.6 22.2 23.5 22.7 21.1 38.2 42.8 26.0 19.9 27.3 26.5 21.7 25.6 15.0 18.4 27.7 23.2 13.9 26.7 27.2 24.7 26.5 17.4 15.0 10.8 23.9 31.6 25.5 11.6 20.3 22.1 26.1 16.4 25.5 34.0 18.3 21.5 24.6 11.5 21.7 24.2 20.3 21.4 17.0 19.0 21.0 22.5 26.9 25.8 30.5 23.2 35.8 22.5 23.6 31.3 26.0 17.5 16.5 12.7 34.1 24.3 28.3 23.5 11.8 17.7 31.4 15.9 14.0 24.7 22.1 22.2 27.2 32.6 21.0 28.5 37.0 21.3 25.5 24.0 22.6 42.8 24.0 32.7 21.8 24.7 23.2 21.1 24.5 23.8 23.2 16.4 22.2 25.5 18.3 19.9 26.0 38.2 27.3 26.5 25.5 23.5 20.8 23.2 21.2 23.2 25.1 18.4 22.5 19.9 11.9 21.1 58.1 39.1 58.8 25.9 4.8 33.1 17.4 23.9 64.6 9.8 87.8 152.5 80.9 5.7 40.5 31.9 0.0 104.6 114.9 46.0 70.8 24.2 49.5 75.1 12.7 44.9 43.6 44.7 7.5 57.0 49.3 45.5 123.6 40.5 32.3 93.7 51.5 53.4 93.6 17.4 51.8 46.2 47.4 123.3 61.5 85.5 56.3 47.0 70.7 LSM12 FLJ30656 ENSG00000161654 "LSM12 homolog" Q3MHD2 17 44034635-44067619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 220.5;Late spermatids: 409.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051934 Approved Approved Cytosol NA NA Cytosol "HPA051934: AB_2681666" "unprognostic (3.42e-2)" "unprognostic (1.01e-2)" "unprognostic (1.64e-1)" "unprognostic (5.98e-2)" "unprognostic (8.04e-2)" "unprognostic (3.87e-3)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.79e-2)" "unprognostic (1.17e-1)" "unprognostic (4.30e-2)" "prognostic unfavorable (7.49e-5)" "unprognostic (3.76e-1)" "prognostic unfavorable (1.18e-7)" "unprognostic (8.91e-3)" "unprognostic (2.79e-2)" "unprognostic (5.04e-2)" "unprognostic (3.18e-2)" 26.7 26.6 26.9 19.8 22.1 30.1 35.1 22.5 30.0 19.5 23.8 23.0 20.7 20.8 22.6 31.5 32.8 18.8 23.8 42.7 24.6 28.9 24.8 44.8 20.4 26.8 25.5 21.2 24.5 36.8 27.4 23.7 30.5 20.4 20.7 30.0 21.7 21.8 26.6 40.8 19.6 19.6 29.2 23.6 23.4 23.4 37.5 18.6 27.7 24.2 17.4 29.1 30.5 19.8 25.4 36.3 16.8 40.1 22.8 29.4 27.0 20.4 22.9 16.1 25.3 21.4 23.3 29.1 23.4 23.0 29.7 30.1 26.3 22.6 34.3 17.0 26.3 23.6 16.9 33.9 30.2 45.2 25.4 35.4 23.8 17.7 31.7 19.7 41.1 25.5 20.7 24.4 27.9 40.6 19.6 25.7 22.4 34.4 25.5 20.2 20.2 39.0 22.5 23.7 20.4 32.4 24.9 31.8 33.1 27.7 30.5 22.6 14.9 18.8 20.5 24.4 35.4 42.6 27.4 22.7 38.0 22.5 20.4 37.8 20.2 20.6 37.5 32.4 29.5 28.6 16.7 32.6 13.6 26.3 40.1 29.4 25.4 29.3 27.9 36.0 23.0 26.3 25.8 16.8 22.8 36.8 36.3 28.7 27.0 26.9 22.1 22.5 30.0 24.6 28.9 25.5 21.2 20.4 18.6 14.9 13.7 22.0 33.6 44.8 40.9 15.7 28.1 14.7 14.8 15.7 82.5 42.0 36.5 47.6 220.5 35.1 29.2 0.0 88.6 80.1 36.6 58.3 7.0 41.9 39.3 33.4 38.2 25.2 29.8 409.2 32.5 34.3 32.1 43.3 44.1 22.7 71.0 35.1 29.7 46.8 61.7 25.8 33.3 54.9 61.7 42.8 70.0 21.8 38.8 70.1 LSM14A "C19orf13, DKFZP434D1335, FAM61A, RAP55, RAP55A" ENSG00000257103 "LSM14A, mRNA processing body assembly factor" Q8ND56 19 34172504-34229515 "Predicted intracellular proteins" "Translation regulation" "Developmental protein, Repressor, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017961 Approved Supported "Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Cytosol "HPA017961: AB_1845610" "unprognostic (2.38e-1)" "unprognostic (3.30e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-2)" "unprognostic (2.45e-3)" "unprognostic (1.88e-1)" "unprognostic (9.62e-3)" "unprognostic (5.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (4.98e-2)" "unprognostic (4.17e-2)" "unprognostic (2.52e-2)" "unprognostic (5.55e-2)" "unprognostic (1.56e-1)" 22.7 22.9 20.8 28.4 23.7 78.7 36.1 33.4 24.9 26.4 26.2 20.3 21.2 13.4 31.5 51.6 22.2 21.0 20.8 22.5 21.3 18.9 33.9 30.7 25.6 32.7 24.6 19.3 30.3 18.2 32.1 18.5 38.1 23.1 27.8 21.8 21.0 20.2 30.2 38.8 38.3 25.9 29.0 25.6 23.2 17.9 20.1 25.7 42.1 37.9 21.5 23.2 26.6 25.3 8.2 10.7 16.4 10.1 10.9 12.0 7.6 1.0 0.4 1.6 1.9 0.7 2.2 0.8 0.7 4.6 0.6 0.9 1.7 1.1 2.1 0.6 1.3 0.0 0.2 7.1 10.3 13.1 1.0 1.2 0.5 2.9 1.8 11.6 1.2 0.9 8.4 6.5 1.2 2.0 1.5 1.5 7.8 0.8 0.0 9.9 3.2 5.9 8.5 10.0 1.1 0.1 1.6 0.4 4.9 8.1 0.1 1.1 3.0 0.6 13.2 8.0 1.7 1.4 28.0 0.5 1.7 1.4 0.0 0.6 0.4 4.2 4.5 10.2 4.4 0.6 11.2 8.2 16.4 10.5 10.0 12.0 7.8 9.1 8.5 10.7 8.2 10.4 9.6 6.1 10.9 10.1 2.8 8.9 7.6 20.8 23.7 33.4 24.9 21.3 18.9 24.6 19.3 23.1 25.7 23.8 36.8 85.4 63.4 110.0 95.0 62.1 43.3 42.8 51.2 55.8 19.6 134.0 58.0 66.2 44.6 70.9 32.8 0.0 47.2 147.3 76.8 75.2 61.1 43.3 59.4 58.8 54.9 51.5 57.3 58.7 116.8 56.2 64.1 58.7 49.5 94.6 53.2 38.6 119.5 64.1 58.7 77.6 80.4 164.6 123.9 114.9 114.9 83.0 49.6 47.7 LSMEM1 "C7orf53, FLJ39575" ENSG00000181016 "Leucine rich single-pass membrane protein 1" Q8N8F7 7 112480853-112491062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "skeletal muscle: 51.3;tongue: 19.2" "Group enriched" "Detected in many" 6 "Early spermatids: 43.6;Late spermatids: 47.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "cerebellum: 3.6" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "HeLa: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA013753, HPA047988" Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA013753: AB_1848926, HPA047988: AB_2680229" "unprognostic (6.87e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-2)" "unprognostic (2.77e-2)" "unprognostic (1.38e-1)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (6.68e-2)" "unprognostic (3.54e-2)" "unprognostic (2.80e-3)" "unprognostic (1.47e-6)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.25e-2)" "unprognostic (3.42e-2)" 1.1 0.7 0.6 0.6 0.6 0.8 0.9 3.6 0.7 0.6 0.6 0.6 0.6 1.3 0.6 1.7 0.7 0.4 0.6 2.1 0.7 0.8 1.4 3.5 1.8 0.6 0.7 0.6 0.6 2.8 0.3 0.9 0.6 0.6 0.9 0.8 0.6 1.9 0.6 51.3 0.8 0.8 0.6 0.6 1.9 0.8 1.1 0.6 0.6 0.9 19.2 1.5 0.6 0.6 0.0 0.1 2.7 0.1 0.0 0.2 2.2 0.8 1.3 0.7 2.8 2.9 3.2 0.1 1.3 0.9 0.6 0.5 2.2 1.9 1.2 1.9 0.3 1.9 0.7 0.8 1.0 1.2 0.6 0.8 0.8 12.5 2.3 1.3 1.2 0.7 2.2 3.8 0.8 0.8 2.7 0.8 1.1 0.9 2.8 0.4 1.1 1.0 3.7 0.6 1.1 0.9 0.4 0.2 0.6 2.4 1.5 2.7 1.4 2.3 1.1 1.5 3.4 0.4 0.5 0.5 2.8 1.0 0.8 1.1 0.9 1.7 1.1 0.8 0.8 0.9 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 2.2 0.6 0.6 3.6 0.7 0.7 0.8 0.7 0.6 0.6 0.6 0.0 3.2 0.8 2.4 4.8 2.2 7.7 5.1 1.4 2.3 1.8 2.0 1.2 0.0 0.6 43.6 2.9 7.1 0.0 0.8 0.7 2.8 7.4 0.0 1.0 3.2 0.0 2.9 1.8 2.7 47.7 0.9 1.3 1.7 2.8 4.0 0.3 1.0 4.3 0.4 0.1 3.4 0.0 6.6 0.5 0.6 4.1 1.6 0.7 3.2 2.2 LSS OSC ENSG00000160285 "Lanosterol synthase" P48449 21 46188141-46228824 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Isomerase "Cataract, Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032060, HPA032062, CAB034116" Supported Approved Cytosol NA NA Cytosol "CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: AB_2674134" "unprognostic (2.78e-3)" "unprognostic (8.53e-3)" "unprognostic (6.95e-2)" "unprognostic (2.07e-1)" "unprognostic (1.74e-2)" "unprognostic (1.06e-1)" "unprognostic (2.74e-2)" "unprognostic (1.33e-2)" "unprognostic (1.72e-1)" "unprognostic (1.58e-2)" "unprognostic (1.68e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-2)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.92e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.07e-4)" 21.1 22.9 17.9 9.9 38.8 5.0 14.7 22.5 33.9 11.2 16.9 37.7 5.8 26.4 16.6 12.5 23.4 11.0 12.1 17.8 19.0 17.3 8.4 33.8 19.7 8.3 49.5 14.9 25.7 15.8 10.4 22.7 10.3 42.7 24.0 10.7 13.2 11.0 13.2 24.5 26.2 10.3 12.2 33.3 7.1 14.1 13.8 46.9 6.0 7.5 9.8 8.3 12.3 11.8 4.8 8.0 5.2 3.3 2.7 8.3 5.0 18.1 5.9 19.2 8.2 26.1 25.1 5.4 7.0 49.9 8.7 17.1 19.4 14.5 3.9 6.0 13.6 63.9 8.6 16.9 29.4 3.5 3.8 9.1 9.7 9.7 12.5 23.8 3.5 6.8 24.7 11.2 16.2 7.0 6.0 7.2 19.3 9.4 23.5 7.4 6.1 7.6 5.0 31.2 2.9 5.3 9.0 5.9 23.7 22.6 10.0 11.2 9.9 8.3 6.4 7.2 8.6 10.2 8.8 10.7 10.3 8.4 9.1 5.4 8.6 7.3 7.9 10.8 15.6 4.4 5.2 3.3 3.5 6.9 3.0 4.7 4.8 5.0 8.3 3.8 3.0 4.2 6.2 0.0 2.7 2.5 8.0 2.3 5.0 17.9 38.8 22.5 33.9 19.0 17.3 49.5 14.9 42.7 46.9 11.9 33.7 11.5 3.8 32.7 12.9 13.4 12.7 8.1 7.9 10.4 3.9 3.4 0.0 9.7 4.2 9.8 5.3 23.3 15.0 5.1 25.7 14.9 3.5 23.8 8.1 22.3 18.9 9.8 7.8 5.3 19.5 5.0 20.3 19.0 10.0 8.7 10.9 0.0 12.7 3.8 15.2 0.0 10.0 13.6 9.4 47.2 5.3 5.0 10.0 4.1 LTA4H ENSG00000111144 "Leukotriene A4 hydrolase" P09960 12 96000828-96043520 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Leukotriene biosynthesis" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 215.6;Kupffer cells: 278.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008399, CAB015221, HPA017017" Supported Approved Nucleoplasm,Cytosol NA NA 85000000 "Nucleoplasm, Cytosol" "CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818" "prognostic favorable (9.79e-4)" "unprognostic (6.62e-2)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (4.25e-3)" "prognostic favorable (8.96e-4)" "unprognostic (1.72e-1)" "unprognostic (1.75e-2)" "unprognostic (3.38e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (1.74e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (1.34e-1)" 27.9 33.2 11.2 21.5 16.7 55.7 19.0 24.1 15.6 27.2 29.1 13.1 16.7 27.6 27.6 14.1 53.4 22.7 14.5 19.2 10.6 12.2 27.2 19.4 68.0 33.4 12.3 11.3 49.9 28.2 21.2 31.8 11.3 13.3 29.6 17.8 20.7 21.1 16.1 20.6 23.6 41.2 21.5 13.3 44.3 22.1 13.7 11.5 29.2 38.8 22.3 43.1 30.1 25.2 20.6 35.3 6.1 84.2 14.2 9.0 54.6 21.0 22.6 31.8 18.9 27.6 30.9 13.9 8.8 26.1 17.4 20.3 16.5 18.2 47.1 11.1 13.1 13.7 27.7 26.0 35.9 23.8 16.1 25.2 17.3 14.5 20.0 16.3 9.1 10.5 29.4 30.3 24.0 29.5 79.5 34.5 27.6 10.5 8.3 25.1 14.4 23.9 28.0 37.0 25.1 30.7 22.4 23.7 27.1 32.0 26.8 16.5 19.5 17.8 20.8 19.1 25.5 25.9 11.2 12.3 7.4 12.5 10.5 9.5 11.2 19.4 21.8 5.2 16.5 5.8 0.4 76.0 2.2 4.5 84.2 8.4 15.1 6.3 5.8 35.3 20.6 9.0 6.7 6.1 14.2 73.2 8.7 6.3 54.6 11.2 16.7 24.1 15.6 10.6 12.2 12.3 11.3 13.3 11.5 35.7 107.1 87.8 57.2 46.0 19.4 23.4 17.8 48.2 91.0 36.6 31.4 27.0 63.0 34.2 44.9 33.1 22.4 0.0 24.3 24.3 27.5 27.6 7.0 18.1 215.6 11.1 20.7 47.3 278.8 8.1 33.9 139.0 20.3 38.7 40.9 32.1 23.4 24.6 38.5 53.1 58.0 6.5 18.5 45.1 12.5 65.5 17.4 34.8 53.6 42.1 LTBP1 ENSG00000049323 "Latent transforming growth factor beta binding protein 1" Q14766 2 32946972-33399509 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 79.5;Fibroblasts: 97.9;Leydig cells: 83.7;Peritubular cells: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.3" "Lineage enriched" "Detected in single" 12 "granulocytes: 4.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 106.2;HSkMC: 34.2;HUVEC TERT2: 34.7;U-87 MG: 46.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005707, CAB025428" Approved Approved Cytosol "Secreted to extracellular matrix" NA NA 200000000 Cytosol "CAB025428: , HPA005707: AB_1853394" "unprognostic (1.02e-2)" "unprognostic (1.12e-1)" "unprognostic (5.29e-2)" "unprognostic (6.23e-2)" "unprognostic (3.11e-3)" "unprognostic (1.83e-1)" "unprognostic (1.06e-3)" "unprognostic (5.67e-2)" "unprognostic (7.48e-2)" "unprognostic (1.14e-1)" "unprognostic (9.96e-3)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.79e-6)" "unprognostic (4.61e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.62e-4)" 10.4 4.9 4.5 16.3 5.4 3.4 9.2 1.3 3.9 66.7 15.6 9.5 10.2 3.6 28.5 22.9 22.9 21.7 64.9 45.6 5.7 2.9 10.6 6.5 15.5 3.4 3.5 4.9 23.4 3.1 0.6 7.0 28.7 11.7 29.6 6.1 10.0 10.6 27.6 8.0 6.6 8.6 38.9 10.9 3.7 22.7 16.2 4.7 2.1 4.4 16.4 10.0 37.4 18.1 0.1 0.3 4.3 0.1 0.0 0.1 8.1 0.0 2.2 5.7 0.0 4.8 106.2 2.4 8.2 17.1 1.1 1.7 4.4 0.8 7.2 0.1 1.0 1.6 0.4 0.1 0.2 4.0 0.1 2.7 23.7 2.8 0.7 22.0 0.0 2.8 34.2 0.8 25.5 1.2 11.2 34.7 1.1 1.5 0.0 9.1 3.4 0.9 0.0 4.0 0.1 7.0 0.8 11.9 0.1 0.0 3.9 1.1 0.6 1.6 13.0 0.1 9.3 5.0 0.0 22.2 1.1 4.8 32.6 6.5 13.6 13.6 10.4 46.7 0.9 1.9 4.3 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 8.1 4.5 5.4 1.3 3.9 5.7 2.9 3.5 4.9 11.7 4.7 0.0 1.1 0.0 4.2 11.9 0.0 79.5 5.1 5.3 1.2 1.8 0.0 38.5 0.0 5.5 5.3 26.2 5.3 23.3 5.7 19.4 97.9 11.5 0.0 9.5 6.8 0.0 1.2 26.4 0.3 4.5 83.7 0.9 18.6 0.0 2.1 0.0 18.1 3.1 151.4 0.0 0.1 58.2 59.0 0.5 7.2 8.5 36.4 0.0 3.4 18.7 LTC4S MGC33147 ENSG00000213316 "Leukotriene C4 synthase" Q16873 5 179793980-179796647 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism" "Lyase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.3" "Cell type enriched" "Detected in many" 6 "granulocytes: 332.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 8.5;eosinophil: 31.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 31.3" "Cell line enriched" "Detected in some" 10 "HMC-1: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044688 Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA Nucleoplasm "Endoplasmic reticulum, Cytosol" "HPA044688: " "unprognostic (8.94e-2)" "unprognostic (2.40e-2)" "unprognostic (9.35e-3)" "unprognostic (3.57e-2)" "unprognostic (1.24e-2)" "unprognostic (9.40e-2)" "unprognostic (4.53e-5)" "unprognostic (2.27e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (2.65e-1)" "unprognostic (1.98e-2)" "unprognostic (4.62e-1)" 9.0 6.7 3.5 2.8 3.5 8.6 4.6 1.7 5.0 6.9 5.0 9.4 5.4 3.6 8.7 10.4 4.2 13.0 15.7 11.3 3.9 3.1 6.2 2.3 28.3 8.0 6.8 4.2 5.8 2.4 2.0 3.2 2.9 4.3 5.6 1.9 3.3 7.4 11.6 2.7 3.5 5.7 4.5 6.3 6.7 5.0 3.3 3.9 0.8 5.3 5.6 3.2 3.6 3.9 0.1 4.5 31.3 0.3 2.2 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 5.3 0.0 0.2 0.2 0.3 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 8.5 0.2 31.3 0.5 0.3 1.7 0.1 1.2 0.8 4.5 0.1 0.2 0.5 0.1 2.2 0.0 0.2 0.1 0.3 3.5 3.5 1.7 5.0 3.9 3.1 6.8 4.2 4.3 3.9 0.0 5.6 2.2 7.5 8.9 0.2 0.0 12.7 4.0 3.4 14.0 0.0 6.9 1.7 4.1 0.3 11.3 0.4 0.0 2.1 1.5 4.7 3.1 332.3 0.8 33.8 0.0 2.9 53.4 8.9 0.0 15.3 23.5 1.7 1.0 1.6 0.0 2.1 0.0 44.6 40.2 0.3 0.0 0.9 0.0 0.7 6.0 2.5 5.0 2.6 5.0 LTN1 "C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294" ENSG00000198862 "Listerin E3 ubiquitin protein ligase 1" O94822 21 28928144-28992956 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 218.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029143, CAB034164, HPA055604" Uncertain Enhanced Cytosol NA NA Cytosol "CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: AB_2682859" "unprognostic (3.67e-2)" "unprognostic (7.07e-2)" "unprognostic (7.78e-2)" "unprognostic (3.99e-1)" "unprognostic (1.42e-2)" "unprognostic (3.66e-3)" "unprognostic (5.38e-2)" "unprognostic (5.40e-2)" "unprognostic (9.98e-2)" "unprognostic (4.45e-2)" "unprognostic (2.85e-2)" "unprognostic (1.13e-1)" "unprognostic (9.87e-2)" "unprognostic (1.72e-1)" "unprognostic (8.22e-2)" "unprognostic (4.57e-2)" "unprognostic (1.52e-1)" 17.9 15.1 10.3 12.4 19.8 21.2 17.9 19.9 23.2 16.6 14.7 17.8 12.1 12.4 16.5 15.4 15.2 14.5 10.8 13.1 12.0 10.6 14.1 19.3 12.0 15.7 19.6 14.2 16.4 23.7 18.4 22.6 29.0 28.7 19.0 15.6 9.7 16.1 12.6 22.5 14.8 17.1 13.4 17.4 16.7 15.4 20.7 15.8 23.0 17.6 14.6 14.9 16.6 14.7 7.8 6.2 12.2 11.9 8.6 8.4 3.3 12.8 5.5 11.5 5.2 9.9 13.6 11.7 10.9 8.9 9.4 13.0 7.7 10.7 8.5 5.3 9.7 8.1 6.6 12.2 8.9 17.1 9.9 8.5 25.3 7.6 6.1 7.4 8.4 9.9 9.4 8.1 13.3 11.1 9.3 9.9 6.2 20.6 20.4 10.7 4.0 5.3 8.1 16.5 10.7 6.6 7.2 23.1 17.7 10.6 11.1 6.3 13.1 12.5 9.6 10.9 11.3 9.7 11.8 13.0 8.3 15.4 11.1 9.1 16.6 15.6 12.0 12.9 18.2 9.8 12.2 6.4 9.5 8.4 9.8 7.0 7.8 5.8 5.6 6.2 7.1 6.2 4.7 11.3 8.6 11.9 3.9 6.1 3.3 10.3 19.8 19.9 23.2 12.0 10.6 19.6 14.2 28.7 15.8 14.9 19.9 19.0 22.3 26.9 24.3 23.8 7.6 21.4 19.4 10.4 31.4 15.4 1.7 12.5 218.4 21.5 16.6 0.0 12.2 16.4 19.2 28.0 26.6 18.4 11.3 39.7 21.8 15.4 24.1 45.8 24.7 18.9 11.8 19.0 17.8 44.4 16.5 17.3 19.8 15.7 29.4 12.9 19.5 36.9 19.0 28.0 24.9 27.3 17.8 29.8 LTV1 "C6orf93, dJ468K18.4, FLJ14909" ENSG00000135521 "LTV1 ribosome biogenesis factor" Q96GA3 6 143843344-143863812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA030159, HPA030160, HPA030161" Approved Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001" "unprognostic (2.26e-2)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (5.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "prognostic unfavorable (4.95e-5)" "unprognostic (7.09e-2)" "unprognostic (2.16e-1)" "unprognostic (1.55e-2)" "unprognostic (1.26e-1)" "unprognostic (4.70e-2)" "prognostic unfavorable (6.01e-13)" "unprognostic (2.94e-1)" "unprognostic (6.83e-2)" "unprognostic (8.62e-3)" "unprognostic (1.41e-1)" 20.0 20.6 15.6 19.5 26.2 39.3 26.7 19.4 26.0 14.6 16.5 11.1 17.9 13.8 21.2 14.7 21.2 18.0 11.3 15.7 25.1 10.9 14.4 29.0 18.9 21.2 21.0 17.1 20.6 20.9 13.3 19.7 17.3 17.4 16.3 18.9 8.0 16.6 18.5 52.0 23.5 17.2 20.7 18.5 20.8 18.3 17.5 18.1 15.0 16.1 26.4 21.8 16.6 25.5 17.3 18.4 4.1 12.9 21.2 16.1 8.3 11.7 11.0 13.1 29.1 9.7 11.9 15.2 18.3 13.5 20.3 16.2 17.8 6.1 24.8 14.8 16.5 22.3 13.3 21.8 17.9 28.4 14.2 21.3 49.0 12.6 27.3 17.2 60.2 28.5 13.3 13.2 22.5 24.8 8.4 14.0 14.5 46.5 16.5 15.6 19.8 20.5 25.7 15.5 13.5 12.2 17.8 24.8 11.1 15.0 16.4 11.6 14.0 18.7 15.5 17.0 12.5 8.7 38.6 12.6 13.0 15.0 28.9 33.5 20.6 25.3 33.7 13.0 31.6 18.2 1.2 10.1 4.1 12.1 12.9 13.1 17.3 12.7 13.0 15.2 14.3 14.1 16.1 0.3 21.2 11.0 18.4 10.9 8.3 15.6 26.2 19.4 26.0 25.1 10.9 21.0 17.1 17.4 18.1 6.0 28.5 25.1 16.5 22.8 9.2 21.2 10.2 29.4 30.7 7.0 2.0 22.4 11.6 22.5 19.1 16.8 7.4 0.0 24.9 25.7 22.1 9.1 24.3 17.3 24.9 11.1 18.9 11.1 11.1 6.2 23.9 21.1 5.0 37.9 11.7 9.9 24.3 8.6 25.8 12.4 8.7 6.5 15.6 50.2 65.1 28.1 13.6 16.6 16.4 15.6 LURAP1 "C1orf190, FLJ25163, LRAP35a" ENSG00000171357 "Leucine rich adaptor protein 1" Q96LR2 1 46203334-46221261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Early spermatids: 111.8;Late spermatids: 227.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 7.8;RPTEC TERT1: 7.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 110.5" "HPA030060, HPA030061" Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA030060: AB_10599997, HPA030061: AB_10601990" "unprognostic (3.88e-2)" "unprognostic (6.21e-2)" "unprognostic (3.22e-3)" "unprognostic (8.82e-2)" "unprognostic (1.91e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.47e-2)" "unprognostic (2.44e-2)" "unprognostic (2.95e-2)" "unprognostic (4.14e-2)" "unprognostic (1.33e-1)" "prognostic favorable (8.81e-8)" "unprognostic (1.32e-2)" "unprognostic (2.80e-1)" "unprognostic (3.11e-2)" "unprognostic (2.39e-2)" 3.0 7.3 7.1 2.2 13.2 3.4 3.9 12.7 12.7 5.8 3.8 15.2 2.2 2.0 5.5 4.9 4.0 4.0 3.7 8.7 6.7 5.8 7.4 1.1 3.2 1.6 18.8 6.0 7.2 1.1 21.5 3.2 2.3 11.2 7.5 2.5 4.7 5.2 9.8 2.5 4.2 1.9 5.6 17.5 3.5 3.7 10.8 13.6 0.0 19.6 0.0 2.1 5.6 5.3 1.0 0.7 6.2 1.1 1.9 0.8 0.3 0.2 0.2 3.0 0.2 4.0 5.5 3.1 2.0 5.3 2.8 3.4 0.1 0.2 0.2 0.1 5.0 1.0 0.3 3.2 6.7 2.4 0.6 1.5 0.2 0.6 0.3 1.2 0.2 0.1 2.8 4.5 5.6 2.6 7.8 4.2 0.8 2.5 0.5 1.6 0.3 0.3 0.3 1.1 0.0 0.5 1.0 1.5 0.0 7.5 0.1 0.4 1.2 0.1 0.2 4.8 1.3 1.5 0.2 0.2 1.8 2.3 1.4 0.4 0.3 0.1 0.3 1.7 0.3 0.4 1.3 1.1 0.4 0.3 0.5 0.8 0.5 0.4 0.3 0.4 1.0 0.8 0.6 6.2 1.9 0.5 0.7 0.1 0.3 7.1 13.2 12.7 12.7 6.7 5.8 18.8 6.0 11.2 13.6 0.0 0.0 0.0 13.1 4.4 0.0 2.2 0.0 0.0 0.0 10.4 0.0 1.9 13.3 0.0 111.8 2.8 0.0 0.0 0.4 1.9 2.3 7.3 0.0 0.0 3.6 0.0 1.2 0.0 0.3 227.3 8.6 1.5 13.5 1.0 0.0 1.6 0.0 0.0 9.2 2.6 0.0 6.5 6.2 8.2 2.0 3.0 6.4 0.0 0.0 4.8 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082631 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.1;brain: 32.7" "Group enriched" "Detected in some" 4 "Early spermatids: 18.8;Paneth cells: 21.8" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 14.2;HAP1: 7.1;HeLa: 2.5;hTERT-RPE1: 6.1" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: AB_2676307, HPA046161: AB_2679564" "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 1.2 11.1 14.5 0.9 10.8 0.9 1.6 2.6 32.7 0.9 2.1 5.9 0.0 0.9 1.0 0.8 0.9 0.8 1.0 1.0 10.3 13.8 1.0 2.3 1.1 0.8 13.7 5.6 0.8 0.8 0.7 1.9 0.8 26.7 4.5 1.7 0.0 1.0 0.9 0.8 0.9 1.1 1.2 30.0 0.9 0.9 1.6 14.5 0.0 0.8 0.9 0.8 1.6 0.3 0.5 0.4 1.9 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.2 7.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.2 0.2 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.5 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.5 0.3 0.2 1.9 0.3 0.2 0.4 0.1 0.0 14.5 10.8 2.6 9.3 10.3 13.8 13.7 5.6 26.7 14.5 0.0 0.0 0.0 0.1 0.6 2.3 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.6 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 1.8 0.2 0.1 21.8 0.0 0.6 0.6 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.9 0.7 LXN ENSG00000079257 Latexin Q9BS40 3 158645822-158672693 "Predicted intracellular proteins" "Inflammatory response" "Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 129.8;granulocytes: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "hTERT-RPE1: 161.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014179, CAB025128" Approved Approved Nucleoplasm,Cytosol No NA 4200000 "Nucleoplasm, Cytosol" "CAB025128: , HPA014179: AB_1853404" "unprognostic (4.46e-2)" "unprognostic (2.59e-1)" "unprognostic (1.80e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" "unprognostic (3.20e-2)" "unprognostic (3.20e-1)" "unprognostic (5.82e-3)" "unprognostic (4.70e-3)" "unprognostic (1.98e-1)" "unprognostic (7.13e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.86e-5)" "unprognostic (8.45e-2)" "unprognostic (3.48e-2)" "unprognostic (3.18e-1)" "unprognostic (8.84e-2)" 32.3 31.5 2.8 13.6 3.3 9.4 35.8 11.7 3.5 11.8 20.9 1.2 12.7 12.4 9.8 17.7 14.0 15.2 17.2 24.4 5.7 3.6 13.6 4.0 16.9 17.8 3.0 2.1 37.1 15.0 7.9 20.6 15.5 4.4 34.0 18.6 11.1 29.3 11.3 7.8 4.8 24.1 22.8 2.6 10.0 7.0 8.5 1.3 12.4 15.8 6.6 7.3 29.3 31.5 5.9 4.5 22.2 3.6 5.2 17.0 4.2 0.0 5.3 0.4 0.0 2.3 8.0 0.4 4.1 10.5 1.0 2.0 0.0 12.0 0.0 3.8 1.1 0.0 1.8 1.0 1.6 1.5 0.0 5.2 2.5 4.6 0.0 2.6 0.6 0.0 17.9 0.3 1.9 0.3 161.2 38.9 0.0 0.0 0.1 0.0 21.2 0.2 0.0 0.4 0.9 1.3 0.7 0.0 5.0 3.6 14.7 0.6 0.0 0.0 5.6 1.3 1.3 0.0 0.0 5.5 0.0 0.0 5.6 0.0 0.1 0.0 0.0 2.0 0.2 0.0 13.8 3.6 5.0 3.7 3.4 3.6 5.9 7.6 5.9 4.3 4.1 8.5 4.7 22.2 5.2 2.1 4.5 17.0 4.2 2.8 3.3 11.7 3.5 5.7 3.6 3.0 2.1 4.4 1.3 14.9 8.6 7.5 61.6 4.9 0.2 3.4 2.5 129.8 31.8 15.7 3.9 11.7 13.3 14.9 2.9 28.6 33.3 23.3 23.6 13.4 20.3 29.5 113.9 0.4 21.7 0.0 33.7 49.1 4.0 7.2 7.8 14.2 18.6 27.9 63.3 8.3 13.1 69.1 2.5 11.5 1.4 12.9 3.7 0.4 8.8 7.2 3.3 7.7 25.5 71.1 LY6G5C "C6orf20, G5c, NG33" ENSG00000204428 "Lymphocyte antigen 6 family member G5C" Q5SRR4 6 31676684-31684040 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 17.4;Spermatocytes: 12.9;Spermatogonia: 13.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HDLM-2: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038690 Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA038690: AB_10673286" "unprognostic (1.51e-2)" "unprognostic (7.26e-2)" "unprognostic (7.19e-2)" "prognostic favorable (1.07e-4)" "unprognostic (4.83e-1)" "unprognostic (6.91e-2)" "unprognostic (1.33e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-2)" "unprognostic (5.63e-2)" "unprognostic (3.74e-5)" "unprognostic (5.84e-2)" "unprognostic (3.78e-4)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.88e-2)" "unprognostic (1.39e-2)" 0.4 0.0 0.5 2.1 2.5 1.1 0.3 4.6 3.8 0.0 0.0 0.2 0.3 0.4 0.0 0.5 2.0 0.8 0.4 0.7 0.0 0.9 0.5 1.2 0.3 0.4 2.5 0.0 1.0 0.4 0.1 0.0 0.2 0.0 1.3 0.3 0.3 0.0 0.4 0.8 1.2 2.1 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.4 2.1 3.1 0.1 0.1 0.1 0.3 0.3 0.8 0.0 2.4 1.5 0.1 0.1 0.0 0.6 0.0 0.0 0.9 2.7 1.4 1.1 0.0 0.5 0.0 0.3 1.2 0.0 0.0 0.7 1.7 0.1 0.0 0.9 0.0 1.5 0.1 0.0 2.3 0.4 0.1 0.1 0.0 1.0 0.4 0.8 0.1 0.5 0.3 0.2 0.9 0.0 0.5 0.0 0.1 1.8 0.0 0.2 1.1 1.8 0.1 0.4 0.5 0.5 2.3 1.5 0.6 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 3.0 1.0 0.0 1.7 1.4 3.1 0.8 2.5 17.4 1.2 1.8 2.0 0.4 3.3 1.5 9.4 4.3 2.9 0.0 4.3 0.1 1.2 2.4 4.7 1.7 5.2 0.0 3.4 7.4 6.5 4.4 1.1 2.2 1.7 1.8 1.7 5.7 3.7 2.5 1.4 3.8 0.9 0.0 1.9 12.9 13.4 0.6 0.2 4.4 2.5 0.9 LYPD5 FLJ30469 ENSG00000159871 "LY6/PLAUR domain containing 5" Q6UWN5 19 43795929-43827206 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "placenta: 39.6;skin 1: 39.8;tongue: 34.7" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 25.8;Late spermatids: 48.7;Melanocytes: 16.9;Syncytiotrophoblasts: 18.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;T-cells: 1.2" "Cell line enhanced" "Detected in some" "A-431: 5.9;BEWO: 9.1;HaCaT: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042511, HPA054670" Approved Approved Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "HPA042511: AB_10794279, HPA054670: AB_2682567" "unprognostic (4.27e-3)" "prognostic favorable (5.84e-4)" "unprognostic (4.63e-2)" "unprognostic (8.42e-3)" "unprognostic (4.80e-2)" "unprognostic (2.91e-3)" "unprognostic (3.96e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-3)" "unprognostic (1.19e-1)" "unprognostic (1.83e-3)" "unprognostic (8.30e-2)" "unprognostic (2.02e-1)" "unprognostic (7.53e-3)" "unprognostic (4.08e-2)" 1.5 1.2 3.4 2.1 7.9 0.7 4.2 2.4 8.8 5.7 1.4 3.5 0.5 1.2 1.3 2.4 7.8 1.6 1.9 1.3 3.9 4.8 0.9 1.0 3.4 1.4 4.5 4.0 0.8 0.9 1.1 1.4 39.6 9.3 1.3 1.5 0.7 2.1 1.5 0.7 39.8 1.1 1.9 3.3 5.9 1.3 7.4 2.7 0.6 1.4 34.7 3.4 2.4 5.4 0.4 0.0 0.5 3.8 0.0 1.2 0.5 5.9 0.0 0.3 0.0 0.1 0.0 9.1 0.5 0.0 0.8 1.0 0.7 2.1 0.3 1.1 0.7 2.3 9.5 0.0 1.1 0.5 1.0 0.0 0.2 0.6 0.0 2.5 0.1 0.1 2.9 2.6 0.4 1.1 0.0 0.3 0.2 0.1 0.3 0.0 0.3 0.2 0.1 0.6 3.1 1.9 0.0 0.1 0.1 0.6 0.9 0.7 0.2 1.2 1.4 0.0 1.9 0.6 0.2 0.8 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 1.2 0.0 0.0 3.8 0.3 0.0 0.8 0.1 0.0 0.4 0.4 1.2 0.5 0.0 1.4 0.0 0.0 0.5 3.4 7.9 2.4 8.8 3.9 4.8 4.5 4.0 9.3 2.7 0.0 0.0 0.0 2.6 3.2 1.5 0.6 0.0 1.4 0.0 0.0 0.0 0.9 3.3 0.4 25.8 1.7 0.0 0.0 0.8 7.4 0.2 1.4 0.0 0.0 2.0 0.0 0.0 0.6 0.0 48.7 0.3 0.7 16.9 0.0 1.8 1.0 0.4 0.2 1.1 0.0 0.6 0.0 0.1 1.1 2.6 2.5 18.1 0.0 0.4 5.1 LYPD6 MGC52057 ENSG00000187123 "LY6/PLAUR domain containing 6" Q86Y78 2 149329985-149474148 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 17.7;placenta: 22.7" "Group enriched" "Detected in many" 33 "Early spermatids: 54.3;Late spermatids: 174.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 18.6;fHDF/TERT166: 23.9;HBF TERT88: 13.1;LHCN-M2: 23.7;RT4: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042805 Enhanced Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA042805: AB_10794159" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (7.23e-3)" "unprognostic (1.64e-2)" "unprognostic (3.25e-1)" "unprognostic (6.49e-3)" "unprognostic (6.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.73e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.14e-3)" "unprognostic (6.75e-2)" "unprognostic (7.33e-4)" "unprognostic (1.39e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.72e-4)" 2.6 1.0 8.7 1.8 7.9 0.4 14.6 3.3 8.2 2.0 4.4 4.3 1.1 2.8 4.0 1.0 1.2 2.9 17.7 1.4 6.2 11.5 3.4 0.8 1.3 0.8 6.2 5.3 1.4 3.2 2.6 0.9 22.7 7.2 2.5 4.1 2.8 0.8 2.6 0.7 1.4 5.6 4.7 5.1 1.3 6.2 4.5 2.6 0.0 0.6 0.0 2.3 4.4 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 18.6 0.0 0.0 0.2 7.6 3.3 9.6 6.1 0.1 1.5 0.0 0.4 23.9 4.7 1.9 2.7 0.0 13.1 0.0 0.9 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 5.8 0.1 0.1 0.0 0.0 0.0 23.7 3.0 0.0 1.7 2.7 1.6 2.2 0.0 10.3 0.0 1.2 19.5 0.7 3.4 5.1 5.8 0.6 6.3 0.7 0.3 0.0 0.2 3.0 0.2 4.1 0.0 0.0 0.0 1.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 8.7 7.9 3.3 8.2 6.2 11.5 6.2 5.3 7.2 2.6 0.0 0.0 0.0 0.5 0.1 1.9 0.3 2.5 1.4 3.4 0.0 0.0 0.0 3.3 2.2 54.3 0.2 1.0 0.0 0.7 0.2 0.4 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 174.5 2.8 0.0 0.0 0.0 2.5 3.5 3.3 0.0 0.4 0.0 3.2 0.0 0.1 0.7 1.1 0.0 0.2 0.0 1.9 1.1 LYPLA1 LPL1 ENSG00000120992 "Lysophospholipase I" O75608 8 54046367-54102017 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 729.6;Late spermatids: 528.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050941, HPA063151" Enhanced Approved Nucleoplasm,Cytosol NA NA 1700000 "Nucleoplasm, Cytosol" "HPA050941: AB_2681284, HPA063151: " "unprognostic (2.62e-2)" "unprognostic (1.28e-2)" "unprognostic (3.25e-3)" "unprognostic (9.42e-2)" "unprognostic (9.48e-2)" "unprognostic (3.56e-1)" "unprognostic (9.58e-2)" "unprognostic (2.05e-2)" "unprognostic (6.52e-3)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.58e-1)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (2.56e-3)" 14.1 17.7 7.2 12.2 8.9 13.4 16.4 10.8 15.2 10.7 14.6 6.9 4.7 15.4 8.0 11.1 30.4 8.0 11.9 27.1 6.8 6.8 31.1 37.3 13.6 23.4 7.3 4.9 12.3 24.3 9.0 7.4 51.1 12.0 15.3 15.2 17.0 23.3 7.1 26.4 22.1 17.6 10.4 6.3 14.0 14.9 64.8 4.1 21.3 13.3 19.3 19.7 24.6 17.3 29.1 37.1 42.7 40.4 27.1 29.2 35.1 30.2 17.1 22.3 20.0 8.1 13.2 28.1 18.1 10.4 16.8 15.8 12.3 29.4 53.0 21.2 11.7 18.5 20.3 31.3 30.1 23.4 19.2 17.1 36.9 10.9 19.8 13.3 22.5 50.1 11.6 26.6 13.0 29.4 14.4 43.3 23.1 37.4 16.1 23.2 8.0 34.3 17.2 33.1 50.7 7.9 20.8 11.8 24.2 25.8 41.0 11.7 20.0 12.7 23.8 27.8 22.1 34.7 20.2 20.8 10.1 14.8 17.5 16.7 22.5 33.8 47.8 13.7 24.0 19.8 31.4 33.1 42.7 19.1 31.1 19.0 29.1 18.2 18.4 37.1 23.9 18.4 17.8 19.5 27.1 40.4 23.8 29.2 35.1 7.2 8.9 10.8 15.2 6.8 6.8 7.3 4.9 12.0 4.1 26.8 44.0 77.0 68.7 54.8 33.9 58.1 45.9 38.8 33.0 59.3 49.1 180.5 257.0 74.6 729.6 72.2 62.9 0.0 77.4 255.5 43.3 142.6 49.5 102.9 105.0 17.5 55.2 78.0 108.6 528.5 26.2 78.4 70.9 59.5 73.4 26.2 94.9 67.1 21.5 145.1 62.5 45.3 42.2 70.4 176.9 70.9 279.5 61.2 78.8 160.0 LYPLA2 APT-2 ENSG00000011009 "Lysophospholipase II" O95372 1 23790970-23795539 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063151 Uncertain Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA063151: " "unprognostic (8.84e-2)" "unprognostic (6.87e-2)" "unprognostic (2.65e-1)" "unprognostic (7.81e-3)" "unprognostic (2.12e-2)" "unprognostic (2.22e-2)" "prognostic unfavorable (5.84e-5)" "unprognostic (3.06e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-2)" "unprognostic (2.52e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.99e-4)" "unprognostic (6.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (1.24e-1)" 12.4 13.6 14.8 13.3 34.8 20.6 13.5 10.7 17.7 9.9 21.2 12.3 5.6 21.3 10.9 17.2 25.4 19.2 21.6 14.4 9.9 9.5 33.2 34.5 14.3 19.0 7.6 12.8 10.3 18.3 32.0 12.0 31.6 35.4 14.8 12.7 11.3 21.1 11.2 14.2 17.7 24.0 9.5 5.4 22.1 19.1 9.9 6.9 27.7 16.5 9.5 16.5 15.3 13.5 29.5 32.3 50.0 40.6 32.0 48.0 42.4 25.5 15.8 19.3 22.3 9.8 11.9 26.6 15.8 15.1 15.0 12.8 21.8 41.6 13.9 22.3 14.9 10.6 24.3 13.9 41.0 6.4 26.0 19.6 17.5 26.0 35.8 15.2 16.4 23.1 14.7 25.4 22.6 8.6 19.3 35.3 15.9 24.4 14.0 16.4 25.3 22.0 26.7 39.3 21.5 22.3 24.4 11.1 25.6 35.3 19.6 28.0 48.6 17.9 28.7 26.8 14.7 23.3 17.3 30.3 15.1 20.0 18.2 13.1 38.0 32.1 19.4 24.9 37.9 19.0 28.9 40.6 50.0 48.0 39.6 38.7 27.6 40.1 41.6 32.3 29.5 35.2 36.0 48.4 32.0 31.2 24.6 35.6 42.4 14.8 34.8 10.7 17.7 9.9 9.5 7.6 12.8 35.4 6.9 8.9 26.4 19.0 29.7 34.6 31.0 13.7 35.7 37.5 20.5 34.9 17.7 93.7 58.0 104.5 13.5 26.9 80.5 23.3 98.3 88.0 17.6 27.9 36.8 28.8 60.5 22.3 42.6 17.8 16.8 9.9 9.8 20.4 18.6 82.0 39.0 26.1 99.3 53.5 6.0 76.2 20.4 25.8 12.4 6.8 19.0 36.3 96.9 32.4 45.1 36.5 LYPLAL1 Q96AV0 ENSG00000143353 "Lysophospholipase like 1" Q5VWZ2 1 219173844-219212865 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 177.4;Proximal tubular cells: 276.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045806 Approved Supported Cytosol NA NA Cytosol "HPA045806: AB_10966647" "unprognostic (1.27e-2)" "unprognostic (1.29e-1)" "unprognostic (3.98e-2)" "unprognostic (8.64e-2)" "unprognostic (2.41e-1)" "unprognostic (1.49e-1)" "unprognostic (2.01e-1)" "unprognostic (3.73e-2)" "unprognostic (4.08e-2)" "unprognostic (2.05e-1)" "unprognostic (1.16e-1)" "unprognostic (2.76e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.68e-1)" "unprognostic (5.87e-2)" "unprognostic (1.73e-1)" "unprognostic (4.65e-2)" 10.7 22.3 19.0 9.4 17.4 2.1 12.4 15.2 13.2 10.6 7.2 14.4 4.4 10.7 19.4 5.9 10.0 7.1 10.5 39.7 17.9 15.4 46.6 29.9 8.9 9.5 19.5 12.3 12.5 12.9 14.6 25.0 9.9 14.9 16.3 7.7 16.1 9.9 8.6 12.0 11.5 9.2 15.6 28.2 6.5 7.7 10.6 17.0 7.3 19.3 9.9 10.3 9.0 12.9 12.8 6.8 8.9 9.6 4.0 7.3 5.3 6.7 6.8 3.0 0.0 6.1 12.2 7.8 3.8 4.4 3.6 4.0 3.1 9.1 7.3 11.4 3.4 3.7 3.6 6.1 8.7 5.2 10.2 7.1 4.1 3.6 6.9 24.7 8.8 3.1 14.2 7.9 3.7 8.9 8.4 10.4 7.2 12.3 7.2 8.0 4.4 4.1 7.5 5.9 6.3 11.0 2.4 7.8 12.2 14.1 5.0 7.3 4.8 4.5 12.0 13.5 10.2 11.3 11.3 6.3 2.9 2.0 5.9 4.7 6.6 3.8 5.3 9.6 7.2 6.4 2.4 8.6 4.7 3.6 6.3 5.7 12.8 4.9 4.2 6.8 7.6 7.3 5.7 8.9 4.0 9.6 6.0 4.8 5.3 19.0 17.4 15.2 12.9 17.9 15.4 19.5 12.3 14.9 17.0 23.8 28.6 20.5 17.9 19.7 28.4 100.7 30.6 32.1 15.9 48.8 7.9 74.1 177.4 41.0 24.6 15.0 13.8 0.0 46.1 29.2 23.4 15.9 16.2 42.9 57.6 17.5 17.9 30.7 27.1 5.9 25.0 31.3 40.5 14.4 18.4 92.9 39.4 14.4 29.0 276.5 27.0 12.9 20.6 24.2 22.3 25.6 52.3 9.2 11.4 10.6 LYRM2 DJ122O8.2 ENSG00000083099 "LYR motif containing 2" Q9NU23 6 89568144-89638753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063932 Uncertain Approved Cytosol NA NA Cytosol "HPA063932: AB_2685155" "unprognostic (3.23e-2)" "unprognostic (1.47e-1)" "unprognostic (8.52e-3)" "unprognostic (8.49e-2)" "unprognostic (4.27e-2)" "unprognostic (6.26e-2)" "prognostic unfavorable (2.58e-8)" "unprognostic (1.46e-1)" "unprognostic (1.18e-1)" "unprognostic (3.29e-3)" "unprognostic (8.07e-3)" "unprognostic (3.63e-2)" "unprognostic (7.98e-2)" "unprognostic (3.70e-1)" "unprognostic (1.45e-1)" "unprognostic (2.23e-2)" "unprognostic (5.64e-2)" 11.2 17.5 21.6 9.8 22.0 12.5 14.5 11.9 22.5 10.3 13.6 15.2 15.1 8.6 13.4 15.4 12.8 14.1 10.7 17.3 19.2 19.6 18.2 13.8 10.2 11.8 22.2 23.0 11.3 10.3 24.9 34.0 16.1 19.0 14.1 16.8 9.0 10.9 10.2 20.9 7.0 10.0 12.5 19.8 9.4 12.9 11.0 22.2 9.8 26.2 13.2 10.8 12.0 8.9 21.9 17.5 9.2 21.0 16.6 20.2 9.6 9.5 5.1 17.5 10.4 8.9 13.5 7.2 16.7 11.9 13.0 13.2 4.5 5.1 13.2 16.1 15.7 19.5 8.8 11.1 15.7 17.0 16.6 19.3 20.7 5.5 3.8 13.3 22.0 16.2 16.5 15.4 14.8 20.0 10.7 10.1 14.4 21.2 17.1 15.0 8.6 5.0 7.8 4.0 7.8 6.4 10.5 21.7 9.8 14.7 9.5 19.5 13.2 9.6 6.1 16.7 8.5 8.5 22.6 16.0 8.2 7.3 14.9 23.0 12.3 17.7 6.8 17.3 15.9 15.5 8.7 14.4 9.2 15.3 16.2 16.3 21.9 17.4 20.2 13.1 20.3 19.8 18.2 4.1 16.6 21.0 17.5 15.7 9.6 21.6 22.0 11.9 22.5 19.2 19.6 22.2 23.0 19.0 22.2 38.7 39.9 36.7 24.6 10.5 26.7 79.5 28.1 89.7 54.6 26.2 15.7 71.6 79.6 33.6 48.2 24.8 26.1 23.3 42.9 26.6 24.6 23.5 31.3 25.1 48.9 23.8 39.0 19.6 27.2 11.4 28.4 37.5 28.7 34.3 38.2 89.1 34.2 35.1 25.5 53.0 48.0 51.8 25.8 46.4 37.1 14.2 60.5 28.7 37.7 23.5 LYSMD3 FLJ13542 ENSG00000176018 "LysM domain containing 3" Q7Z3D4 5 90515611-90529584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018024 Approved Approved Cytosol NA NA Cytosol "HPA018024: AB_2138525" "unprognostic (4.50e-2)" "unprognostic (1.85e-2)" "prognostic favorable (3.83e-4)" "unprognostic (5.59e-2)" "unprognostic (5.61e-2)" "unprognostic (9.80e-3)" "unprognostic (3.99e-2)" "unprognostic (4.66e-2)" "unprognostic (6.23e-2)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (2.02e-1)" "prognostic favorable (9.25e-4)" "unprognostic (1.81e-1)" "unprognostic (8.48e-2)" "unprognostic (4.97e-3)" "unprognostic (9.46e-2)" 12.7 14.0 8.9 11.1 10.5 9.3 11.1 16.0 11.2 15.8 14.1 4.7 16.2 11.8 13.1 9.3 12.0 11.2 12.8 15.7 10.2 8.9 21.1 33.6 15.6 12.9 11.9 6.1 19.1 13.1 24.5 31.1 19.0 12.2 12.9 10.8 7.3 13.3 21.2 16.6 6.4 17.4 10.5 12.1 14.6 9.5 6.6 12.7 18.5 18.8 9.0 11.4 15.4 12.5 6.4 7.3 27.7 9.4 11.9 10.4 7.4 10.3 6.9 8.9 9.4 14.0 14.3 8.8 16.6 18.1 11.6 19.1 5.9 10.7 12.8 7.2 14.5 18.1 5.3 13.7 16.2 22.7 9.4 8.6 9.7 8.6 9.6 14.5 8.1 16.5 10.5 11.4 10.6 17.8 12.4 16.5 8.4 9.3 19.6 12.9 9.1 9.3 4.7 4.4 2.6 11.8 8.8 15.1 18.4 12.7 7.1 2.7 5.5 9.8 7.5 13.5 7.4 8.5 7.7 20.5 7.0 9.9 15.3 11.9 22.4 14.2 10.9 11.9 13.9 10.9 27.7 7.7 11.6 6.5 9.4 10.4 6.4 7.5 7.9 7.3 5.4 10.3 8.8 11.5 11.9 9.3 3.5 8.1 7.4 8.9 10.5 16.0 11.2 10.2 8.9 11.9 6.1 12.2 12.7 32.8 21.9 13.7 9.3 12.7 10.2 22.1 7.6 14.7 21.6 12.2 3.9 8.4 1.7 6.4 0.8 15.5 13.7 23.3 7.0 8.2 18.2 18.7 25.4 28.8 7.7 19.1 20.7 16.0 14.0 1.3 15.5 14.4 6.8 6.4 11.1 18.9 5.9 8.6 12.4 10.1 12.8 19.4 17.8 7.0 4.1 14.4 11.7 15.4 9.0 8.0 LYSMD4 FLJ33008 ENSG00000183060 "LysM domain containing 4" Q5XG99 15 99715697-99733561 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029152, HPA059824" Approved Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA029152: AB_10602033, HPA059824: AB_2684135" "unprognostic (2.43e-3)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (2.81e-1)" "unprognostic (4.07e-3)" "unprognostic (3.80e-2)" "unprognostic (1.53e-3)" "unprognostic (3.75e-1)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (6.35e-3)" "unprognostic (9.77e-2)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (3.30e-1)" 8.8 4.7 5.8 11.6 8.7 4.7 11.1 8.6 14.1 9.5 6.4 7.8 3.6 8.1 9.3 11.4 11.4 5.5 8.3 9.2 7.1 5.6 4.7 6.6 7.0 3.9 4.7 5.7 7.8 6.5 14.9 5.4 5.0 6.7 6.3 5.9 8.3 15.9 7.7 12.3 25.2 6.5 6.9 7.9 4.5 5.6 6.8 6.3 5.4 4.1 11.1 6.3 4.6 8.4 3.1 4.8 8.0 4.0 1.0 6.2 3.4 3.7 3.5 7.2 4.2 8.1 7.4 4.3 4.3 3.0 3.7 5.4 8.8 3.3 4.1 2.5 3.9 6.4 11.0 5.6 6.9 4.3 0.8 10.1 2.7 7.2 6.0 4.6 1.9 5.1 4.2 10.2 3.4 4.0 2.3 4.9 12.0 6.5 5.3 2.4 4.4 5.1 5.4 4.8 10.4 4.1 3.6 5.1 2.0 6.6 9.8 4.2 3.7 7.8 2.4 4.1 9.7 1.7 3.7 6.3 3.0 8.3 4.1 1.8 7.0 9.3 3.3 3.9 4.8 3.2 0.0 2.0 8.0 3.8 3.3 2.9 1.8 5.2 4.5 1.1 3.1 6.2 2.8 0.7 1.0 4.0 4.8 5.0 3.4 5.8 8.7 8.6 14.1 7.1 5.6 4.7 5.7 6.7 6.3 6.0 3.5 0.8 7.0 7.7 8.9 9.7 7.6 2.7 3.4 3.5 9.8 2.0 1.7 3.4 5.6 4.6 4.0 23.3 8.4 2.1 4.5 1.5 0.0 3.6 3.6 9.5 2.9 5.5 2.2 4.3 4.9 4.7 1.7 11.8 4.0 10.8 5.7 2.9 6.3 3.8 10.0 12.9 6.1 10.8 5.5 8.0 1.1 2.5 2.2 3.9 LZIC MGC15436 ENSG00000162441 "Leucine zipper and CTNNBIP1 domain containing" Q8WZA0 1 9922113-9943407 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 240.8;Spermatocytes: 162.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028184, HPA058614" Approved Approved Nucleoplasm,Cytosol NA NA 110000 Nucleoplasm Cytosol "HPA028184: AB_10602706, HPA058614: AB_2683779" "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (1.76e-2)" "unprognostic (1.62e-1)" "unprognostic (6.26e-2)" "unprognostic (8.37e-2)" "prognostic unfavorable (2.47e-5)" "unprognostic (2.89e-1)" "unprognostic (3.79e-3)" "unprognostic (7.84e-2)" "unprognostic (1.70e-3)" "unprognostic (1.23e-1)" "prognostic favorable (3.56e-5)" "unprognostic (1.19e-1)" "unprognostic (3.76e-3)" "unprognostic (1.50e-2)" "unprognostic (1.95e-2)" 13.6 14.2 21.4 12.8 18.0 11.4 17.7 13.6 21.6 18.2 19.2 24.5 15.1 19.5 18.3 13.5 17.6 16.9 14.1 21.0 19.8 16.5 20.0 20.4 11.5 13.6 24.3 10.3 25.5 15.3 26.1 15.9 14.9 20.5 15.8 19.4 13.0 16.6 14.6 21.7 13.9 23.7 21.3 28.2 11.0 12.2 44.3 20.1 20.2 17.2 13.2 15.6 14.9 23.1 13.9 28.1 28.3 22.7 16.8 21.0 12.9 16.1 10.7 20.6 14.6 12.8 21.3 9.2 14.7 12.5 20.8 20.2 13.3 28.4 19.6 16.8 18.5 13.1 12.3 19.4 21.3 31.3 18.1 13.3 28.5 13.9 21.8 12.4 26.0 14.8 13.9 30.6 29.1 27.6 14.9 16.3 26.0 35.3 11.2 19.1 11.4 21.3 12.7 10.4 20.4 17.5 22.8 27.3 15.7 11.2 7.3 10.3 16.3 18.0 7.9 34.6 20.5 13.1 13.4 14.8 14.5 19.8 20.5 15.4 9.2 21.0 33.6 14.8 38.9 19.2 22.0 18.8 28.3 16.0 20.7 14.0 13.9 16.3 15.5 18.1 13.8 16.3 16.9 18.9 16.8 22.7 28.1 21.0 12.9 21.4 18.0 13.6 21.6 19.8 16.5 24.3 10.3 20.5 20.1 6.0 12.9 11.9 18.9 11.3 8.9 52.1 10.2 33.5 11.4 7.0 5.9 24.8 41.4 22.9 240.8 16.9 27.5 0.0 18.4 37.8 16.2 18.9 30.0 19.2 37.4 39.7 8.7 11.6 21.1 51.9 24.5 26.4 13.5 28.9 17.2 47.0 20.3 25.9 25.8 42.9 14.5 19.4 17.6 162.6 67.1 14.6 28.8 17.5 20.6 18.3 LZTFL1 BBS17 ENSG00000163818 "Leucine zipper transcription factor like 1" Q9NQ48 3 45823316-45916042 "Disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.7" "Cell type enhanced" "Detected in all" 11 "Ciliated cells: 188.7;Spermatocytes: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043466, HPA048447" Enhanced Supported Cytosol NA NA Cytosol "HPA043466: AB_2678491, HPA048447: AB_2680398" "unprognostic (1.64e-2)" "unprognostic (1.34e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-2)" "unprognostic (2.65e-2)" "unprognostic (5.42e-2)" "unprognostic (1.15e-2)" "unprognostic (2.26e-2)" "unprognostic (4.20e-2)" "unprognostic (2.94e-2)" "unprognostic (7.83e-2)" "unprognostic (5.32e-2)" "unprognostic (1.30e-3)" "unprognostic (6.27e-3)" "unprognostic (8.31e-2)" "unprognostic (4.27e-3)" "unprognostic (4.19e-1)" 5.8 7.2 12.3 5.0 14.9 4.8 13.6 9.3 21.6 14.5 6.9 4.4 10.4 6.0 14.4 16.6 6.1 20.8 7.3 5.3 10.2 11.6 12.9 10.1 9.7 4.4 6.9 13.4 12.8 8.6 14.6 30.7 6.2 10.1 9.0 6.8 5.6 7.5 10.4 3.6 6.4 6.8 8.7 6.1 5.8 6.3 27.7 5.6 55.7 20.4 4.3 5.7 7.3 6.4 7.2 4.6 1.9 2.5 2.3 4.0 2.7 6.8 3.5 5.5 3.6 5.2 12.7 2.6 3.7 6.1 7.6 9.9 1.0 5.2 2.1 2.2 4.6 9.8 3.2 6.0 6.1 10.6 0.0 4.2 1.3 4.9 2.9 6.9 6.7 2.0 6.8 21.1 9.5 6.2 5.6 4.3 10.8 6.3 4.4 4.1 1.1 18.3 6.4 5.8 4.5 3.0 2.5 0.5 7.2 10.5 2.6 3.8 7.8 4.5 4.1 8.9 6.3 5.0 11.7 6.9 3.2 2.2 8.6 4.7 12.4 6.5 0.0 10.2 7.9 2.6 0.0 1.9 0.7 2.8 2.5 3.9 7.2 2.5 2.4 4.6 3.7 4.0 3.3 1.9 2.3 1.6 4.5 3.5 2.7 12.3 14.9 9.3 21.6 10.2 11.6 6.9 13.4 10.1 5.6 26.8 18.5 8.8 8.3 11.9 7.7 6.9 10.2 188.7 33.0 14.0 13.7 2.5 13.3 10.7 53.9 7.3 2.6 23.3 6.1 4.3 11.0 7.6 8.1 11.6 5.9 22.3 10.9 8.6 3.7 8.6 9.2 5.8 8.5 13.6 11.3 15.2 5.6 3.5 12.7 16.7 14.1 12.9 6.1 140.9 20.0 8.7 1.7 15.3 8.8 4.1 LZTR1 "BTBD29, LZTR-1" ENSG00000099949 "Leucine zipper like transcription regulator 1" Q8N653 22 20982013-20999038 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067852, HPA068772, HPA071248" Approved Approved Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372" "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (9.81e-2)" "unprognostic (3.55e-1)" "unprognostic (3.78e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.16e-3)" "unprognostic (4.29e-2)" "unprognostic (1.65e-1)" "unprognostic (6.25e-2)" "unprognostic (1.25e-2)" 21.2 16.9 17.3 15.6 17.4 10.3 17.9 20.7 24.7 18.5 18.3 25.3 20.6 18.9 24.9 14.0 16.5 18.3 21.2 15.8 15.4 10.9 17.2 13.1 16.2 12.8 19.6 16.5 21.7 16.2 24.9 26.0 18.8 19.0 16.9 12.9 18.9 17.5 18.0 17.2 15.0 15.7 21.9 14.0 19.3 14.5 10.8 19.2 10.8 19.6 12.6 12.5 18.5 16.4 1.6 2.2 0.2 3.4 1.8 3.0 1.5 6.3 5.2 7.8 9.4 17.9 12.4 6.3 13.0 9.1 7.4 10.2 3.0 2.6 6.7 4.8 14.5 6.9 8.6 5.8 10.6 3.0 12.5 13.6 7.2 6.8 4.5 9.6 3.9 9.6 11.4 5.4 9.4 6.8 11.8 14.4 6.3 30.0 11.7 8.4 3.8 6.9 3.7 2.4 7.7 5.7 8.2 11.3 2.6 5.9 8.6 7.7 11.4 7.1 12.3 7.6 4.9 5.7 7.2 12.8 17.4 8.9 7.8 7.0 5.1 4.4 2.0 7.8 3.8 8.4 0.0 2.5 0.2 3.0 3.1 1.6 1.6 1.5 2.8 2.2 1.0 2.1 1.5 0.1 1.8 3.4 1.2 0.5 1.5 17.3 17.4 20.7 24.7 15.4 10.9 19.6 16.5 19.0 19.2 11.9 10.4 9.7 1.4 1.9 8.1 11.2 2.5 6.7 5.7 8.7 5.9 3.6 1.7 6.6 0.8 9.5 7.8 0.0 4.3 3.2 5.4 2.0 5.7 6.2 6.9 3.2 8.7 12.3 11.6 1.3 8.1 4.9 6.8 4.6 9.1 6.6 5.7 5.9 9.2 6.1 9.3 0.0 7.2 2.6 1.7 3.1 3.0 6.9 5.8 0.9 LZTS2 "KIAA1813, LAPSER1" ENSG00000107816 "Leucine zipper tumor suppressor 2" Q9BRK4 10 100996618-101007836 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044956 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA044956: AB_10795989" "unprognostic (1.42e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (8.18e-2)" "unprognostic (4.64e-2)" "unprognostic (1.56e-1)" "unprognostic (5.49e-3)" "unprognostic (3.56e-1)" "unprognostic (7.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.63e-2)" "unprognostic (1.86e-1)" "unprognostic (5.46e-3)" "unprognostic (1.76e-3)" 34.2 25.8 14.6 12.4 21.4 10.9 24.7 15.4 25.0 29.3 30.2 41.0 16.4 15.2 33.7 18.6 28.0 22.6 21.0 20.0 19.0 13.6 18.2 7.4 18.6 9.5 32.8 14.4 30.1 13.9 22.7 16.1 24.5 20.6 32.9 8.2 22.3 34.6 38.4 28.5 24.7 14.9 32.0 29.9 20.1 19.6 18.7 25.6 9.5 29.7 11.8 13.7 38.8 22.7 5.0 2.8 0.5 1.2 4.4 6.1 2.3 11.1 15.0 12.3 21.1 16.4 13.3 25.3 13.5 25.9 11.4 13.0 17.4 9.3 4.5 12.6 18.2 8.2 19.0 7.6 9.8 2.8 4.3 11.2 4.1 14.8 22.5 23.3 2.1 5.4 24.2 7.2 8.9 10.8 24.2 11.6 5.5 13.0 2.6 10.1 10.7 1.9 5.3 13.7 4.3 12.4 25.5 36.1 4.5 8.6 13.6 3.0 22.5 9.2 4.2 34.6 6.9 21.6 17.8 14.7 13.6 15.6 14.4 7.0 5.0 3.4 1.1 23.1 6.1 6.8 0.0 1.2 0.5 4.5 0.5 6.1 3.7 5.4 4.9 1.8 5.0 5.8 4.9 0.5 4.4 0.1 2.8 4.5 2.3 14.6 21.4 15.4 25.0 19.0 13.6 32.8 14.4 20.6 25.6 14.9 10.9 3.2 7.8 11.8 10.0 3.9 10.2 2.7 4.5 5.2 5.9 14.4 6.6 17.8 4.6 17.7 5.6 0.0 10.7 11.4 17.3 13.7 1.1 2.4 18.1 17.5 16.0 22.7 6.1 2.7 23.9 6.5 15.1 6.4 16.1 17.4 13.0 5.8 27.6 6.8 3.6 25.8 21.5 3.1 11.2 10.7 39.4 4.9 13.5 8.0 MACO1 "FLJ10747, TMEM57" ENSG00000204178 "Macoilin 1" Q8N5G2 1 25430858-25500209 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 25.4;Ductal cells: 30.7;Exocrine glandular cells: 53.7;Pancreatic endocrine cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019680 Approved Cytosol NA NA Cytosol "HPA019680: AB_1858125" "unprognostic (2.42e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.83e-2)" "unprognostic (2.16e-1)" "unprognostic (1.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.69e-2)" "unprognostic (6.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (7.02e-2)" "prognostic favorable (7.13e-4)" "unprognostic (2.54e-2)" "unprognostic (4.22e-2)" "unprognostic (5.22e-2)" "unprognostic (5.35e-3)" 9.8 16.5 12.1 6.9 11.3 26.5 8.9 27.8 13.2 9.2 8.9 11.3 12.7 9.5 9.7 11.9 17.2 7.9 8.8 8.8 8.7 9.4 11.9 33.0 9.4 7.8 12.9 11.5 17.2 28.1 11.4 12.8 8.1 11.3 12.9 9.2 10.4 20.7 13.5 31.2 10.7 9.7 8.5 10.1 9.6 11.5 15.6 13.8 17.9 13.2 12.5 11.1 10.5 10.2 2.6 4.0 6.8 2.5 1.5 3.0 0.7 10.2 3.4 10.5 18.9 12.7 9.7 5.6 11.0 11.5 9.9 10.9 3.1 13.7 20.7 12.8 12.1 6.3 10.6 8.9 10.4 10.4 10.7 8.7 25.7 5.8 8.5 9.0 9.1 18.9 9.6 12.8 14.5 9.7 8.9 11.2 12.7 16.9 7.5 9.7 6.2 22.0 11.8 12.4 9.4 5.6 13.5 11.1 16.3 10.9 5.2 17.8 19.3 8.3 21.1 13.2 9.3 7.7 11.2 13.1 11.8 7.6 14.7 7.1 13.4 8.7 12.0 12.9 12.6 9.2 6.8 1.1 6.2 2.1 0.9 3.0 1.6 2.4 2.7 1.4 2.6 2.5 3.0 0.5 1.5 2.5 4.0 1.4 0.7 12.1 11.3 27.8 13.2 8.7 9.4 12.9 11.5 11.3 13.8 17.9 20.5 0.0 0.0 0.0 0.0 0.0 0.0 25.4 20.5 7.0 0.0 11.1 5.0 30.7 0.0 0.0 0.0 0.0 53.7 16.7 0.0 0.0 9.3 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 12.6 0.0 0.0 38.1 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 MAD2L2 "FANCV, MAD2B, POLZ2, REV7" ENSG00000116670 "Mitotic arrest deficient 2 like 2" Q9UI95 1 11674480-11691650 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Late spermatids: 383.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008110, HPA024176, HPA024612" Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: " "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (2.43e-1)" "unprognostic (3.27e-1)" "unprognostic (2.41e-1)" "unprognostic (6.84e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.60e-2)" "unprognostic (1.24e-1)" "unprognostic (9.09e-3)" "unprognostic (1.54e-1)" "unprognostic (9.27e-2)" "unprognostic (8.43e-2)" "unprognostic (2.36e-1)" 12.4 10.1 15.4 15.7 15.6 37.9 13.7 15.5 13.5 10.0 10.5 14.5 11.9 8.6 10.4 11.8 9.8 9.9 10.3 17.3 13.2 11.2 13.2 34.4 12.9 18.3 19.6 9.7 14.6 23.0 5.8 11.1 8.2 12.4 11.8 6.1 8.4 21.0 9.2 23.0 12.0 7.4 11.5 15.0 11.9 12.4 37.0 15.8 42.1 12.0 10.4 19.0 11.9 13.4 19.5 46.9 13.8 31.7 13.2 29.8 27.7 11.7 10.8 18.2 20.5 5.6 11.0 7.3 10.9 12.3 21.5 19.2 14.0 11.4 16.6 13.4 11.4 12.6 5.2 22.5 11.3 12.5 25.0 25.0 7.4 16.7 17.1 9.9 15.0 12.3 7.1 11.6 15.7 13.6 8.4 9.7 22.4 30.5 26.6 10.6 17.4 69.0 70.9 46.8 4.8 17.6 46.9 20.0 20.4 7.8 2.5 33.8 23.7 18.2 7.0 31.6 13.1 10.2 32.6 5.1 17.9 22.7 16.6 15.4 21.4 14.9 43.0 13.2 52.7 13.7 11.9 29.4 13.8 29.8 31.7 23.9 19.5 20.1 23.1 34.0 15.9 13.7 20.3 12.5 13.2 27.2 46.9 22.9 27.7 15.4 15.6 15.5 13.4 13.2 11.2 19.6 9.7 12.4 15.8 0.0 5.3 24.6 22.8 34.3 5.5 13.9 12.7 4.0 5.7 14.0 3.9 14.0 43.1 34.8 122.4 28.4 2.1 70.0 66.1 41.4 31.5 29.1 13.9 52.9 36.0 11.1 32.6 23.9 40.3 383.8 28.7 45.0 45.5 100.0 10.5 7.5 37.7 3.5 15.9 23.1 3.9 38.8 30.9 46.4 40.3 30.4 7.0 38.7 7.5 12.9 MADD "DENN, KIAA0358, RAB3GEP" ENSG00000110514 "MAP kinase activating death domain" Q8WXG6 11 47269161-47330031 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.3" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 72.8;Cone photoreceptor cells: 117.8;Horizontal cells: 125.5;Rod photoreceptor cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038568 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038568: AB_10795030" "unprognostic (3.16e-1)" "unprognostic (1.81e-1)" "unprognostic (8.51e-3)" "prognostic favorable (6.62e-5)" "unprognostic (1.27e-1)" "unprognostic (6.36e-3)" "unprognostic (4.82e-3)" "unprognostic (1.16e-1)" "unprognostic (1.91e-1)" "unprognostic (3.78e-2)" "prognostic favorable (5.69e-5)" "unprognostic (1.53e-1)" "unprognostic (3.55e-1)" "unprognostic (8.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" "prognostic favorable (8.25e-4)" 7.7 18.2 18.3 11.5 27.6 16.9 8.7 66.3 46.5 9.2 10.8 15.5 13.1 8.6 9.4 8.9 6.9 9.4 8.6 13.8 20.2 18.4 9.8 7.7 11.0 13.2 15.5 19.8 14.0 12.2 18.8 26.7 11.2 20.7 12.5 12.0 16.0 10.2 14.0 16.1 14.0 9.8 10.5 11.3 12.3 13.2 19.4 11.0 14.6 8.4 6.0 12.2 11.0 7.8 3.5 4.1 20.8 5.8 4.5 5.7 4.4 6.5 13.6 14.9 13.3 10.2 7.1 3.3 9.2 12.3 11.7 12.7 9.9 6.2 13.8 2.9 10.0 15.2 12.9 12.0 6.4 10.2 15.3 12.3 24.5 25.2 8.4 7.4 16.6 33.8 6.9 6.9 6.2 7.8 8.0 10.7 8.9 15.7 10.2 10.3 9.1 7.8 17.9 8.9 15.3 9.4 10.8 24.0 9.1 6.1 31.1 23.6 15.3 11.8 14.0 8.1 9.2 11.0 12.7 9.1 11.0 7.0 15.6 6.1 12.1 12.5 7.9 10.2 11.8 10.3 20.8 2.6 4.8 4.8 4.6 4.2 3.5 3.4 4.0 4.1 3.3 4.0 3.1 0.7 4.5 5.8 2.2 5.7 4.4 18.3 27.6 66.3 44.6 20.2 18.4 15.5 19.8 20.7 11.0 11.9 8.6 9.0 3.5 9.5 72.8 22.6 10.2 1.4 3.4 7.0 117.8 3.9 0.0 7.0 11.4 9.5 12.1 0.0 4.2 1.9 6.1 7.5 26.5 5.0 10.1 125.5 15.6 17.8 18.3 4.0 6.6 10.6 10.1 9.0 17.0 13.7 8.8 10.5 12.0 4.2 106.1 6.5 6.2 14.6 21.5 7.2 3.7 6.9 11.2 4.8 MAFB KRML ENSG00000204103 "MAF bZIP transcription factor B" Q9Y5Q3 20 40685848-40689240 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.6;parathyroid gland: 154.1" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 322.7;Kupffer cells: 488.8;Macrophages: 252.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 27.4;non-classical monocyte: 36.7" "Lineage enriched" "Detected in many" 14 "monocytes: 36.7" "Cell line enhanced" "Detected in some" "HSkMC: 16.2;hTCEpi: 34.0;SCLC-21H: 9.3;SiHa: 8.4;U-138 MG: 9.2;U-2197: 13.4;U-87 MG: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005653 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Cytosol" "HPA005653: AB_1079293" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.16e-3)" "prognostic unfavorable (5.64e-4)" "unprognostic (9.16e-2)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-1)" "unprognostic (2.57e-2)" "unprognostic (6.09e-2)" "unprognostic (5.45e-3)" "unprognostic (9.92e-2)" "unprognostic (3.95e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-3)" "unprognostic (3.49e-2)" "unprognostic (2.30e-2)" 38.3 7.9 3.2 13.0 4.0 17.0 19.5 1.0 9.7 10.6 6.9 3.0 1.2 3.3 5.6 8.9 16.8 7.0 9.2 12.4 3.6 2.3 10.9 14.0 21.9 28.9 4.7 3.4 7.0 6.1 154.1 2.3 9.4 5.0 7.6 3.3 5.6 10.4 2.7 11.0 41.6 7.6 5.5 7.7 87.6 4.7 7.5 3.8 6.9 18.2 20.5 11.4 8.2 10.9 0.0 2.5 0.7 36.7 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.8 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.1 0.5 0.0 0.1 16.2 34.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 3.9 1.4 3.3 0.0 0.0 0.0 0.0 0.3 0.2 9.3 0.7 8.4 0.8 2.0 3.1 0.8 0.1 0.2 9.2 0.1 13.4 0.0 0.0 0.0 0.0 8.9 0.3 0.0 0.1 7.3 0.0 0.0 27.4 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.7 0.0 36.7 0.0 0.0 2.5 3.2 4.0 1.0 9.7 3.6 2.3 4.7 3.4 5.0 3.8 20.8 32.3 6.7 25.3 60.9 14.6 153.6 7.6 0.0 13.6 48.8 23.6 7.5 1.7 2.0 0.6 19.9 50.9 0.0 3.0 2.1 61.9 37.1 10.4 32.6 322.7 3.2 55.5 34.4 488.8 0.7 27.3 252.1 20.3 0.0 13.7 25.8 5.4 24.6 23.0 0.8 8.2 12.9 44.3 0.5 0.9 77.0 10.4 4.4 8.1 17.7 MAGEA1 "CT1.1, MAGE1, MGC9326" ENSG00000198681 "MAGE family member A1" P43355 X 153179285-153183880 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 13.5" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 29.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 17.8;HMC-1: 31.0;RPMI-8226: 15.3;U-2 OS: 29.6;U-266/70: 44.3;U-266/84: 70.5" CAB002620 Enhanced Supported Cytosol NA NA Cytosol "CAB002620: " "unprognostic (8.65e-2)" "unprognostic (1.33e-1)" "unprognostic (6.40e-3)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (2.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 17.8 3.2 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.1 0.0 0.0 29.6 0.1 0.1 44.3 70.5 0.0 2.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 29.0 0.0 0.0 0.0 0.0 0.0 MAGEA10 "CT1.10, MAGE10, MGC10599" ENSG00000124260 "MAGE family member A10" P43363 X 152133310-152138578 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 48.7" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 4.0;Sertoli cells: 6.5;Spermatocytes: 12.1;Spermatogonia: 8.9;Syncytiotrophoblasts: 9.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "GAMG: 42.1" "HPA003333, HPA070780" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003333: AB_10962837, HPA070780: AB_2686310" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (9.91e-2)" "unprognostic (5.97e-3)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 48.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.9 0.8 2.6 0.8 1.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.9 0.0 0.2 0.0 7.0 2.6 0.8 0.7 0.4 0.7 0.4 0.7 0.5 0.4 0.3 0.9 0.6 0.7 2.6 1.2 0.5 0.8 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 12.1 8.9 0.0 9.4 0.0 0.0 0.0 MAGEA11 "CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511" ENSG00000185247 "MAGE family member A11" P43364 X 149688228-149717266 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 36.5;testis: 9.3" "Cell type enhanced" "Detected in some" 22 "Spermatocytes: 9.3;Spermatogonia: 14.3;Syncytiotrophoblasts: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 23.4" HPA052687 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA052687: AB_2681915" "unprognostic (4.06e-3)" "unprognostic (2.05e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-2)" "unprognostic (9.64e-2)" "unprognostic (1.32e-1)" "unprognostic (6.13e-2)" "unprognostic (1.16e-1)" "unprognostic (6.67e-4)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 36.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 23.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 14.3 0.0 4.9 0.0 0.0 0.0 MAGEA4 "CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336" ENSG00000147381 "MAGE family member A4" P43358 X 151912509-151925170 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "placenta: 12.1;testis: 23.5" "Cell type enriched" "Detected in some" 7 "Spermatogonia: 190.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 62.8;AN3-CA: 39.2;HMC-1: 74.8;U-2 OS: 20.0;U-266/84: 116.4" "HPA021942, CAB040535" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB040535: , HPA021942: AB_1853490" "unprognostic (7.90e-3)" "unprognostic (6.66e-3)" "unprognostic (5.39e-1)" "unprognostic (1.36e-1)" "unprognostic (5.81e-2)" "unprognostic (2.94e-2)" "unprognostic (4.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.8 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 20.0 0.0 0.3 15.9 116.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 23.4 190.5 0.0 27.6 0.0 0.0 0.0 MAGEB2 "CT3.2, DAM6, MAGE-XP-2, MGC26438" ENSG00000099399 "MAGE family member B2" O15479 X 30215560-30220089 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 35.8" "Group enriched" "Detected in some" 11 "Sertoli cells: 12.9;Spermatocytes: 16.1;Spermatogonia: 45.1" "Cancer enriched" "Detected in many" 7 "testis cancer: 33.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 26.1;K-562: 18.8;Karpas-707: 22.8;U-2 OS: 27.2;U-266/70: 44.8;U-266/84: 46.8" "HPA065224, HPA074544, HPA075519" Enhanced Approved Cytosol NA Yes Cytosol "HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294" "unprognostic (4.52e-1)" "unprognostic (2.55e-2)" "unprognostic (6.39e-2)" "unprognostic (5.02e-1)" "unprognostic (6.57e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 27.2 0.0 0.0 44.8 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 16.1 45.1 0.0 0.0 0.0 0.0 0.0 MAGEC1 "CT7, CT7.1, MAGE-C1, MGC39366" ENSG00000155495 "MAGE family member C1" O60732 X 141903894-141909388 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 23.5" "Group enriched" "Detected in some" 7 "Sertoli cells: 6.5;Spermatocytes: 5.9;Spermatogonia: 14.9" "Cancer enhanced" "Detected in many" "melanoma: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 22.9;Karpas-707: 22.9;U-2 OS: 15.4;U-2197: 29.1;U-266/70: 20.9;U-266/84: 18.4" "HPA004622, CAB015452" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB015452: AB_784404, HPA004622: AB_1853495" "unprognostic (5.63e-2)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (4.52e-2)" "unprognostic (9.96e-2)" "unprognostic (3.47e-1)" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 15.4 29.1 0.0 20.9 18.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 5.9 14.9 0.0 0.0 0.0 0.0 0.0 MAGEC2 "CT10, HCA587, MAGE-C2, MAGEE1" ENSG00000046774 "MAGE family member C2" Q9UBF1 X 142202345-142205290 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 319 "testis: 31.8" "Group enriched" "Detected in some" 9 "Spermatocytes: 30.7;Spermatogonia: 86.6" "Cancer enhanced" "Detected in many" "melanoma: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 35.8;U-266/84: 40.4" HPA062230 Enhanced Supported Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA062230: AB_2684718" "unprognostic (1.25e-1)" "unprognostic (5.68e-2)" "unprognostic (3.99e-1)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 1.5 0.0 0.0 0.0 0.1 2.5 0.4 4.9 0.0 0.0 40.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 30.7 86.6 0.0 0.0 0.0 0.0 0.0 MAGED1 "DLXIN-1, NRAGE" ENSG00000179222 "MAGE family member D1" Q9Y5V3 X 51803007-51902357 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 308.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 83.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043645 Approved Cytosol NA NA Cytosol "HPA043645: AB_2678597" "unprognostic (5.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.29e-2)" "unprognostic (1.39e-2)" "unprognostic (3.92e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-3)" "unprognostic (2.04e-2)" "unprognostic (3.92e-1)" "unprognostic (1.77e-1)" "unprognostic (3.15e-3)" "unprognostic (1.42e-1)" "unprognostic (6.10e-3)" "unprognostic (2.14e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.71e-3)" 15.4 57.6 35.3 16.8 52.9 6.9 18.6 34.6 61.8 50.9 18.8 25.9 38.9 15.2 27.6 67.4 13.1 31.6 28.1 32.4 42.2 58.4 22.5 48.6 17.5 13.6 32.2 38.0 30.7 37.2 42.9 69.6 53.5 39.4 35.1 19.3 34.7 38.1 45.5 19.6 12.7 13.4 36.3 25.7 15.9 25.8 33.8 16.1 24.6 35.4 12.5 17.9 23.9 15.8 10.1 28.8 1.5 3.2 7.7 11.6 6.9 3.2 11.9 38.3 33.0 30.3 54.7 20.6 44.2 56.9 24.6 39.0 24.4 11.2 4.6 8.6 83.5 8.8 2.4 34.1 15.7 18.5 4.9 13.2 3.1 0.0 31.6 23.2 11.6 5.8 51.4 5.6 20.7 4.7 43.3 29.3 12.2 4.8 9.2 49.2 29.9 13.2 3.9 30.1 10.7 24.6 13.6 24.8 0.6 25.3 5.9 9.9 55.0 0.0 13.0 6.5 39.2 23.2 2.9 29.1 10.7 27.6 37.6 4.9 6.1 8.9 9.5 41.9 1.0 27.8 0.7 2.2 1.5 11.6 3.2 10.3 9.3 7.6 10.0 6.8 10.1 9.6 11.3 0.7 7.7 2.8 28.8 10.5 6.9 35.3 52.9 34.6 61.8 42.2 58.4 32.2 38.0 39.4 16.1 71.5 28.0 32.1 16.5 10.2 30.8 38.2 40.8 45.5 42.1 33.2 7.9 308.7 24.9 39.2 2.2 19.4 15.3 0.0 43.5 143.1 55.9 27.2 17.3 57.0 89.9 42.9 54.9 52.2 9.4 6.0 40.0 6.3 23.6 4.6 76.3 37.5 33.2 10.5 54.1 29.1 10.5 12.9 17.6 5.6 6.3 7.2 155.3 11.4 21.8 13.6 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 301.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favorable (2.88e-4)" "prognostic favorable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 22.1 38.4 26.9 14.8 26.5 8.2 50.2 24.4 43.0 55.7 27.3 27.8 21.4 16.2 41.1 31.8 21.9 45.9 28.5 40.7 23.8 38.2 42.7 17.3 24.0 13.5 30.3 36.0 79.7 23.5 34.5 57.6 58.6 57.1 63.9 16.4 43.1 32.0 53.7 25.6 16.5 17.6 41.6 24.7 17.5 22.5 21.8 18.3 23.4 45.1 17.3 22.0 31.9 29.2 17.1 11.7 43.1 37.0 28.5 35.5 32.5 5.4 10.0 60.2 18.3 28.7 39.1 11.1 22.5 40.2 17.9 31.8 10.0 13.9 7.6 59.1 45.3 14.7 7.4 17.1 17.0 12.9 13.5 14.2 15.7 11.9 19.5 24.6 4.0 12.1 51.1 7.1 18.1 9.2 36.9 33.9 8.9 3.8 9.3 34.1 15.0 8.9 6.7 22.2 9.5 12.0 5.9 21.6 10.8 24.5 4.1 9.5 24.5 8.9 10.4 52.0 73.5 42.9 6.8 29.2 15.3 23.8 22.7 6.3 6.0 5.0 5.4 22.3 10.6 77.7 43.1 9.1 35.5 35.5 22.4 27.3 16.3 29.4 33.1 11.7 17.1 29.7 34.1 3.4 28.5 37.0 7.2 29.2 32.5 26.9 26.5 24.4 43.0 23.8 38.2 30.3 36.0 57.1 18.3 41.7 33.9 29.8 80.0 37.7 72.3 51.6 53.5 66.9 30.7 73.3 27.5 185.2 208.9 88.2 2.4 76.6 14.7 0.0 47.8 117.1 94.0 95.1 100.4 13.2 60.7 130.3 56.0 66.9 12.9 8.5 216.0 36.3 150.1 64.9 42.6 178.6 48.5 32.3 301.2 111.7 49.9 155.2 150.8 13.5 12.4 30.6 141.5 45.4 24.9 55.9 MAGEE1 "DAMAGE, KIAA1587" ENSG00000198934 "MAGE family member E1" Q9HCI5 X 76427724-76431353 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.9" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 9.4;Horizontal cells: 27.0;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "B-cells: 1.0;NK-cells: 1.5;T-cells: 2.4" "Cell line enhanced" "Detected in many" "GAMG: 9.4" "Low region specificity" "Detected in all" HPA003047 Approved Approved "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA003047: AB_1079298" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-3)" "unprognostic (1.76e-1)" "unprognostic (3.94e-2)" "unprognostic (5.61e-3)" "unprognostic (8.72e-3)" "unprognostic (2.41e-3)" "unprognostic (1.43e-1)" "prognostic favorable (3.95e-4)" "unprognostic (7.91e-2)" "prognostic favorable (6.86e-6)" "unprognostic (4.60e-3)" "unprognostic (2.71e-1)" "unprognostic (6.03e-3)" "unprognostic (5.99e-3)" 2.6 5.8 13.8 3.0 23.5 1.1 3.3 18.7 33.9 4.7 1.9 3.2 0.5 1.5 5.4 3.5 2.3 4.8 2.3 3.9 18.9 20.3 4.1 1.1 2.6 4.1 10.2 22.0 8.4 4.1 15.1 5.1 0.8 19.8 5.9 2.1 2.3 3.4 7.4 2.2 3.3 2.0 4.8 5.4 4.5 2.6 1.3 4.9 1.1 4.0 0.1 3.6 2.4 1.8 1.0 0.0 0.0 0.0 1.5 2.4 0.4 0.2 4.5 4.7 8.9 3.3 1.9 4.1 3.4 3.4 2.9 1.6 1.0 0.7 0.9 1.7 3.0 9.4 3.4 6.9 6.4 2.4 2.2 0.1 0.0 0.0 2.9 0.7 1.8 0.6 1.4 2.9 0.8 0.8 0.1 1.1 4.9 0.3 0.0 4.4 0.6 4.9 0.2 5.6 0.0 6.9 3.9 3.5 0.0 3.7 0.0 0.0 2.4 0.0 0.4 0.6 5.0 2.1 0.1 0.6 4.4 5.6 4.6 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.8 0.8 1.1 2.3 0.0 1.0 1.4 1.3 0.0 1.5 0.0 0.0 0.0 0.4 13.8 23.5 18.7 33.9 18.9 20.3 10.2 22.0 19.8 4.9 3.0 1.6 0.0 0.6 0.5 9.4 1.6 0.0 0.0 1.2 1.8 3.9 0.1 1.7 1.5 0.0 1.0 0.0 0.0 1.3 0.4 0.7 0.2 1.1 0.0 0.1 27.0 0.0 0.6 0.3 0.0 1.4 0.0 0.0 0.0 0.2 4.3 0.8 0.0 4.2 0.9 5.1 19.4 1.4 0.2 0.2 0.1 0.1 4.3 0.0 0.1 MALT1 "MLT, PCASP1" ENSG00000172175 "MALT1 paracaspase" Q9UDY8 18 58671386-58754477 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 80.5;monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 51.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004494, HPA048432" Enhanced Approved "Nucleoli fibrillar center,Cytosol" No No "Nucleoli fibrillar center" Cytosol "CAB004494: AB_627909, HPA048432: AB_2680389" "unprognostic (3.25e-1)" "unprognostic (2.31e-1)" "unprognostic (3.64e-2)" "unprognostic (3.25e-2)" "unprognostic (1.65e-3)" "unprognostic (4.67e-2)" "unprognostic (6.46e-2)" "unprognostic (4.50e-2)" "unprognostic (3.33e-2)" "unprognostic (4.16e-3)" "unprognostic (3.74e-1)" "unprognostic (2.07e-1)" "unprognostic (2.53e-2)" "unprognostic (2.34e-1)" "unprognostic (2.97e-1)" "unprognostic (1.03e-1)" "unprognostic (6.00e-2)" 11.2 3.9 4.1 21.7 5.6 10.2 10.6 9.1 6.8 11.0 10.7 3.9 10.9 5.5 8.1 10.5 16.4 6.6 8.1 8.7 4.0 4.3 14.9 10.5 14.3 29.0 4.1 1.8 8.1 6.2 10.0 9.3 8.8 4.9 18.1 7.9 7.5 10.7 8.4 10.7 12.6 12.2 6.6 6.2 19.9 6.2 11.8 4.8 22.4 7.9 12.4 24.0 9.6 12.3 6.3 3.6 1.2 1.7 1.6 4.8 1.1 7.5 10.8 13.2 3.3 2.6 5.9 6.0 13.6 9.6 11.8 10.1 8.8 9.8 12.0 6.1 16.8 8.5 7.4 5.7 5.6 14.6 8.1 3.1 4.2 7.7 14.1 4.3 8.6 5.8 3.7 11.9 9.3 9.4 6.2 2.5 3.4 7.0 21.0 6.4 2.4 1.9 3.7 3.3 3.1 3.7 6.5 7.8 8.5 51.8 3.1 1.4 3.0 7.5 3.8 5.1 9.8 3.8 5.0 3.5 15.3 6.7 4.5 12.5 18.8 22.2 10.5 6.1 6.5 6.0 0.8 1.5 1.0 2.7 1.7 2.1 3.6 4.8 2.9 2.2 6.3 4.3 2.8 1.2 1.6 1.6 3.6 2.9 1.1 4.1 5.6 9.1 6.8 4.0 4.3 4.1 1.8 4.9 4.8 20.8 19.2 15.7 28.7 29.3 12.4 13.1 10.2 6.7 7.9 10.4 80.5 5.2 3.3 14.7 9.8 21.6 6.8 0.0 7.2 5.0 8.0 52.3 31.1 8.9 10.4 52.4 6.4 9.8 16.4 5.3 9.5 23.0 11.8 107.4 8.2 29.6 11.9 20.1 6.7 17.3 17.2 19.4 12.0 33.4 32.5 21.7 7.6 22.4 9.1 29.1 MAMDC4 "AEGP, DKFZp434M1411" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;liver: 48.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "cerebellum: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 18.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB026377: , HPA059977: AB_2684186" "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favorable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 1.6 1.2 1.9 1.5 1.4 1.2 14.9 1.2 1.2 2.3 1.2 1.2 5.0 1.2 1.2 1.2 1.7 1.2 1.6 1.2 0.4 2.6 48.9 1.2 2.5 1.2 1.2 1.2 3.4 0.5 7.2 1.2 1.2 3.2 0.9 1.2 3.5 1.4 1.7 1.5 6.1 1.2 1.2 5.1 2.3 6.5 1.2 1.2 5.1 1.2 1.2 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 1.6 2.6 1.5 2.9 0.6 0.1 18.9 2.7 0.3 0.3 0.6 2.0 1.6 1.4 0.6 0.7 0.8 2.2 0.3 1.3 0.0 2.1 0.9 0.8 5.3 2.3 1.2 0.2 4.9 0.8 1.7 1.4 0.6 1.4 0.6 2.5 2.7 1.2 0.2 4.2 1.0 3.7 1.4 1.1 0.7 1.6 0.4 2.5 0.9 1.4 1.7 2.1 0.6 1.3 1.1 1.0 4.4 0.9 0.8 7.6 4.8 1.5 0.4 3.1 1.6 0.4 1.7 2.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 14.9 1.2 1.2 0.4 1.2 1.2 1.2 1.2 0.0 4.3 0.0 0.8 0.7 5.4 6.2 12.7 2.7 0.0 1.8 0.0 2.2 1.7 0.8 1.7 1.4 19.8 0.0 4.4 2.8 2.6 1.3 0.0 16.6 2.4 15.9 0.0 2.5 2.4 1.9 1.7 2.2 0.0 1.0 19.5 2.6 0.9 12.5 1.4 2.1 7.4 0.0 1.4 1.2 2.2 0.4 1.9 1.3 10.3 0.7 MAML2 "KIAA1819, MAM3" ENSG00000184384 "Mastermind like transcriptional coactivator 2" Q8IZL2 11 95976598-96343180 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 86.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.9" "Low region specificity" "Detected in all" HPA035223 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA035223: AB_10671101" "unprognostic (8.11e-2)" "unprognostic (2.51e-1)" "unprognostic (7.08e-2)" "unprognostic (9.07e-2)" "unprognostic (3.57e-3)" "unprognostic (3.32e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (8.05e-2)" "prognostic unfavorable (3.89e-4)" "unprognostic (9.11e-2)" "prognostic favorable (1.90e-4)" "unprognostic (9.76e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" 26.3 5.5 10.2 16.1 8.1 4.2 19.7 27.8 13.4 15.8 9.2 10.4 8.4 4.3 11.2 8.5 9.3 11.7 10.8 8.9 10.5 6.9 13.8 3.5 15.0 10.9 6.9 3.4 11.7 8.2 13.3 15.2 18.8 9.3 12.3 8.9 10.8 16.6 12.3 4.4 14.2 8.9 10.2 14.4 16.8 6.5 4.3 10.6 21.2 11.8 4.8 13.6 16.0 15.3 2.1 1.2 4.7 1.1 4.2 6.4 2.0 5.6 1.1 9.8 2.6 10.2 11.8 2.1 6.5 9.8 4.3 4.5 0.7 12.0 1.2 15.5 15.1 2.3 5.2 2.0 6.3 6.0 27.9 0.7 0.7 2.0 2.1 6.0 0.0 0.0 17.2 0.6 7.7 4.5 8.0 2.4 0.1 3.1 1.8 7.6 0.4 0.1 1.5 1.0 2.9 1.8 1.9 1.8 6.5 6.4 8.0 0.1 0.9 2.4 1.0 2.7 3.3 0.9 0.3 10.6 7.6 1.8 2.6 4.1 1.2 0.2 1.8 3.6 1.1 13.9 0.1 1.1 0.0 1.5 0.6 2.6 1.9 3.2 4.1 1.2 2.1 6.4 4.3 4.7 4.2 0.7 0.9 1.2 2.0 10.2 8.1 27.8 7.0 10.5 6.9 6.9 3.4 9.3 10.6 14.9 7.5 12.1 17.3 17.3 40.8 4.1 12.7 18.7 19.4 12.2 86.4 10.3 10.0 14.8 1.1 20.5 18.4 0.0 0.4 20.6 19.5 17.4 1.1 0.2 16.3 0.0 6.4 6.7 12.6 1.4 8.1 15.7 11.8 16.2 6.2 24.7 9.5 14.4 8.1 11.8 21.9 32.3 17.3 0.5 0.6 11.8 10.9 16.0 11.8 13.1 MAOA ENSG00000189221 "Monoamine oxidase A" P21397 X 43654907-43746824 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" Oxidoreductase "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 358.2;Proximal tubular cells: 497.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;MAIT T-cell: 1.3" "Group enriched" "Detected in many" 10 "monocytes: 1.0;T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 40.4;HHSteC: 75.9;HSkMC: 19.1;hTCEpi: 21.4;RT4: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009437, HPA054807, HPA059299" Enhanced Enhanced Mitochondria,Cytosol No No Mitochondria Cytosol "CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970" "unprognostic (9.54e-3)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" "unprognostic (3.07e-1)" "unprognostic (6.75e-2)" "unprognostic (3.32e-1)" "unprognostic (9.51e-2)" "unprognostic (6.89e-3)" "unprognostic (2.21e-1)" "unprognostic (4.29e-2)" "unprognostic (3.94e-1)" "unprognostic (3.54e-1)" "unprognostic (1.45e-3)" "unprognostic (1.16e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-2)" "unprognostic (2.98e-3)" 72.3 11.0 8.2 10.2 7.8 0.3 35.2 3.3 6.1 12.4 85.7 2.8 10.7 53.6 12.5 6.2 36.6 12.0 14.7 37.8 6.7 8.3 77.8 45.9 34.4 5.2 11.1 6.1 14.2 24.4 9.6 1.5 79.8 8.7 26.2 39.9 6.2 49.1 12.9 12.5 11.2 90.1 23.6 3.4 2.1 19.3 5.5 4.7 0.0 68.6 9.7 3.9 35.3 35.1 0.0 0.0 0.1 1.0 0.0 1.3 0.1 0.0 0.8 0.1 2.4 40.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 4.1 1.5 5.4 0.0 0.0 0.6 1.6 0.1 4.3 75.9 0.0 4.1 19.1 21.4 0.0 11.2 0.0 4.8 0.0 0.0 0.1 1.4 0.6 0.0 0.1 0.4 4.9 1.2 0.0 0.0 0.1 5.5 31.3 0.7 1.9 0.0 0.0 0.0 0.1 0.1 0.0 2.1 0.0 2.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.1 8.2 7.8 3.3 6.1 6.7 8.3 11.1 6.1 8.7 4.7 65.5 115.2 10.9 141.7 9.7 4.4 90.1 91.7 34.8 50.0 57.6 21.6 9.7 102.8 29.5 19.6 35.3 358.2 0.0 12.0 17.7 14.2 55.4 5.7 169.3 6.2 3.2 36.6 36.8 14.9 22.5 5.2 4.0 10.1 29.7 119.4 23.2 31.4 140.8 0.0 497.3 21.7 6.5 15.1 1.1 0.4 12.5 173.1 3.1 215.1 89.9 MAP1A MAP1L ENSG00000166963 "Microtubule associated protein 1A" P78559 15 43510958-43531620 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 103.6" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 71.0;Horizontal cells: 282.9;Peritubular cells: 71.8" "Cancer enhanced" "Detected in many" "glioma: 18.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 74 "plasmacytoid DC: 12.3" "Lineage enriched" "Detected in single" 74 "dendritic cells: 12.3" "Cell line enhanced" "Detected in many" "ASC diff: 21.8;BJ hTERT+: 21.4;fHDF/TERT166: 32.0;hTEC/SVTERT24-B: 20.4;U-87 MG: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039063, HPA039064, HPA066488" Enhanced Approved Cytosol No No Cytosol "HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-2)" "unprognostic (5.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.65e-2)" "unprognostic (1.13e-3)" "unprognostic (8.36e-3)" "unprognostic (3.45e-3)" "prognostic unfavorable (6.59e-5)" "unprognostic (5.83e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (1.09e-5)" "prognostic unfavorable (1.66e-5)" 5.2 7.9 43.6 5.4 42.8 2.5 4.3 24.5 103.6 10.5 5.4 18.3 1.0 3.0 5.6 4.3 4.8 9.1 5.9 14.8 40.9 30.2 2.8 1.9 3.4 2.7 34.7 31.3 7.1 2.7 4.1 4.4 4.4 56.2 6.7 5.3 3.1 2.5 9.6 4.5 3.1 3.2 14.5 21.4 2.6 2.7 5.4 12.6 6.5 3.7 0.1 2.7 6.3 2.8 0.0 12.3 0.0 0.0 0.0 0.1 0.2 0.1 0.8 3.9 2.2 21.8 15.0 0.0 12.5 21.4 3.7 3.6 1.5 0.0 0.0 5.4 32.0 1.1 0.1 5.2 0.0 2.1 1.8 0.5 4.8 1.2 0.1 2.1 0.1 2.0 11.2 0.0 20.4 0.1 5.6 2.7 14.2 7.9 0.1 14.8 0.1 8.7 0.2 2.8 0.0 0.3 2.4 11.3 0.0 0.0 0.0 12.2 3.7 0.4 0.0 0.1 5.4 0.8 0.2 0.5 11.9 4.0 3.9 0.1 0.0 0.5 1.7 43.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.1 0.2 43.6 42.8 24.5 63.1 40.9 30.2 34.7 31.3 56.2 12.6 3.0 0.6 0.0 1.1 4.8 35.3 48.5 0.0 71.0 12.5 3.5 23.6 0.3 0.0 0.4 10.6 4.3 0.0 0.0 0.0 0.6 30.1 0.7 6.9 0.0 1.9 282.9 10.9 4.9 0.8 5.2 47.2 1.4 8.5 0.0 0.0 15.3 1.2 0.0 71.8 0.3 20.6 32.3 49.5 9.2 27.3 3.6 0.9 0.7 0.0 0.5 MAP1B "MAP5, PPP1R102" ENSG00000131711 "Microtubule associated protein 1B" P46821 5 72107234-72209570 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 102.5" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 675.4;Horizontal cells: 611.8;Muller glia cells: 420.2;Rod photoreceptor cells: 440.1;Sertoli cells: 756.7;Smooth muscle cells: 465.8" "Cancer enriched" "Detected in all" 5 "glioma: 48.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 64.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009792, HPA022275" Enhanced Supported Enhanced Cytosol NA NA 140000 Cytosol "CAB009792: AB_2137420, HPA022275: AB_1853944" "unprognostic (9.96e-2)" "unprognostic (3.97e-2)" "unprognostic (1.57e-2)" "unprognostic (3.70e-1)" "unprognostic (4.67e-3)" "unprognostic (2.98e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (7.00e-2)" "unprognostic (4.78e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-2)" "unprognostic (1.13e-2)" "unprognostic (1.90e-1)" "unprognostic (1.75e-2)" "prognostic unfavorable (8.22e-5)" 20.3 18.1 27.5 10.2 39.6 1.6 9.3 52.3 101.9 15.3 6.1 21.6 3.5 3.2 9.2 9.8 12.8 7.7 10.7 17.1 37.6 40.7 4.4 3.3 3.7 3.2 42.4 42.5 7.8 4.5 3.0 7.0 9.5 102.5 19.0 6.2 9.4 7.6 24.0 3.6 10.2 3.9 22.9 45.7 2.4 7.2 11.0 11.3 0.0 5.7 0.1 2.6 13.4 5.9 0.2 0.4 0.6 0.0 0.0 0.3 2.1 0.3 12.2 30.7 11.1 19.1 33.5 0.0 6.6 5.1 6.7 8.0 0.1 0.4 0.0 15.8 24.3 20.2 0.1 16.7 0.6 10.1 0.0 2.4 1.3 4.3 4.0 10.2 0.0 1.0 33.6 2.1 26.8 9.9 6.0 20.7 0.0 1.9 0.0 11.3 0.1 0.0 0.0 8.3 0.0 3.9 0.1 3.6 0.0 0.6 0.0 19.9 13.8 6.5 0.0 3.4 26.6 0.0 1.3 64.6 21.2 10.0 15.4 29.6 1.4 0.0 0.0 22.9 0.0 16.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.2 0.6 0.0 0.0 0.4 0.2 2.1 27.5 39.6 52.3 59.1 37.6 40.7 42.4 42.5 102.5 11.3 0.0 1.3 1.7 41.3 28.0 193.6 258.0 2.5 68.3 19.4 8.7 675.4 1.8 0.0 9.0 10.7 79.8 0.0 0.0 2.9 1.2 236.1 19.8 1.1 0.8 5.2 611.8 74.5 53.4 2.2 10.5 286.8 2.8 75.9 0.0 0.2 420.2 9.6 0.0 361.7 0.8 440.1 756.7 465.8 7.7 4.4 44.3 3.3 0.0 0.0 9.8 MAP1S "BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1" ENSG00000130479 "Microtubule associated protein 1S" Q66K74 19 17719242-17734516 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 78.9;Late spermatids: 220.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050934, HPA054637" Approved Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli, Cell Junctions" "HPA050934: AB_2681281, HPA054637: AB_2682552" "unprognostic (8.47e-2)" "unprognostic (2.39e-2)" "unprognostic (1.60e-1)" "unprognostic (2.72e-1)" "unprognostic (3.70e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (5.29e-4)" "unprognostic (2.53e-1)" "unprognostic (6.17e-2)" "unprognostic (4.39e-2)" "prognostic favorable (2.65e-4)" "unprognostic (6.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (8.65e-2)" 14.7 7.1 18.9 14.0 27.0 14.9 13.4 15.4 42.1 12.3 11.5 15.5 4.9 12.5 13.4 9.8 11.6 11.1 13.1 9.3 17.2 12.9 8.3 6.9 17.6 13.2 11.4 18.1 16.8 13.8 8.9 11.9 16.1 14.3 10.0 4.7 8.4 12.6 12.1 21.2 6.0 10.5 8.8 10.3 14.2 16.0 34.1 13.1 13.2 8.5 4.3 8.6 12.6 7.6 13.1 20.7 24.9 17.7 9.4 13.3 12.5 13.0 20.5 6.2 8.1 5.2 7.8 15.7 8.6 4.4 5.5 6.2 27.9 7.5 7.7 15.9 5.5 6.4 7.2 5.0 7.0 2.3 9.6 28.7 6.9 18.2 18.2 11.1 7.6 10.0 8.5 4.0 8.3 5.2 3.9 10.9 5.9 10.7 4.4 2.9 18.3 9.3 19.3 13.6 8.2 24.0 15.1 4.8 7.8 7.1 20.0 11.0 12.1 4.8 7.4 8.6 4.7 4.7 8.4 16.8 10.1 8.7 19.5 12.9 8.3 10.0 7.8 11.6 12.2 11.8 13.3 17.0 19.2 13.3 17.7 12.8 13.1 10.4 13.1 20.7 13.1 8.8 11.7 24.9 9.4 13.1 16.7 9.5 12.5 18.9 27.0 15.4 42.1 17.2 12.9 11.4 18.1 14.3 13.1 3.0 6.9 9.5 12.3 9.2 10.0 4.8 10.2 0.0 4.5 3.5 7.9 17.5 3.3 18.4 78.9 12.8 21.7 0.0 14.9 13.7 10.1 12.1 10.3 3.9 23.4 38.1 19.5 25.8 19.1 220.0 20.8 18.7 1.7 16.2 12.9 7.8 17.9 14.0 29.7 5.2 5.9 12.9 11.4 16.3 26.4 2.9 28.3 10.9 13.1 12.3 MAP2 "MAP2A, MAP2B, MAP2C" ENSG00000078018 "Microtubule associated protein 2" P11137 2 209424058-209734118 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 122.3" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 824.7;Rod photoreceptor cells: 453.2" "Cancer enhanced" "Detected in many" "glioma: 30.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 2.6;naive B-cell: 3.4" "Lineage enriched" "Detected in single" 15 "B-cells: 3.4" "Cell line enhanced" "Detected in some" "AF22: 76.3;NTERA-2: 27.3;SCLC-21H: 38.4;SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001984, HPA008273, HPA012558, HPA012828" Enhanced Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946" "unprognostic (2.47e-2)" "unprognostic (2.81e-1)" "unprognostic (2.58e-2)" "prognostic unfavorable (1.98e-6)" "unprognostic (2.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (6.06e-2)" "unprognostic (1.31e-1)" "unprognostic (9.84e-2)" "unprognostic (1.09e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-1)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (7.28e-2)" "unprognostic (4.10e-5)" 4.6 9.2 62.1 2.1 63.1 1.5 4.9 24.7 122.3 4.4 2.5 3.8 0.0 2.0 2.9 4.0 5.6 2.8 6.3 6.2 73.6 53.8 3.9 3.7 9.3 2.4 31.0 48.8 6.4 8.2 12.5 14.7 1.9 35.4 6.5 2.5 7.6 4.9 4.7 2.2 12.1 2.0 3.2 19.9 2.4 2.6 5.4 11.4 0.0 12.2 0.4 2.9 2.8 1.5 3.4 0.1 0.0 0.0 0.0 0.2 0.3 0.6 0.1 76.3 0.0 1.0 0.5 0.0 0.4 0.5 0.1 0.5 0.0 4.0 0.0 0.4 0.9 3.6 1.0 5.9 0.4 0.2 0.0 0.3 0.2 2.4 0.0 9.7 0.0 0.0 0.8 2.4 0.0 1.5 4.4 2.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 27.3 0.1 0.1 0.0 0.1 0.0 1.0 0.0 38.4 21.5 1.6 0.2 0.9 9.4 2.1 0.0 0.0 0.0 0.4 0.0 1.0 0.5 0.0 0.0 4.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 62.1 63.1 24.7 79.6 73.6 53.8 31.0 48.8 35.4 11.4 89.3 2.7 0.0 3.1 5.3 111.0 3.6 30.6 1.4 4.5 5.2 824.7 0.3 3.3 19.1 16.8 7.1 0.0 0.0 9.4 0.0 1.9 10.4 1.1 0.0 0.5 31.8 31.2 16.0 3.0 7.5 26.4 0.8 18.6 0.0 0.0 125.4 13.7 0.0 14.5 0.4 453.2 32.3 17.6 3.3 19.9 5.6 0.2 0.0 0.0 0.6 MAP2K1 "MAPKK1, MEK1, PRKMK1" ENSG00000169032 "Mitogen-activated protein kinase kinase 1" Q02750 15 66386817-66492312 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003834, HPA026430" Approved Enhanced "Plasma membrane,Cytosol" NA NA 62000 "Plasma membrane, Cytosol" "CAB003834: AB_562310, HPA026430: AB_1853742" "unprognostic (4.05e-2)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (4.92e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.81e-3)" "unprognostic (5.78e-2)" "unprognostic (9.91e-3)" "unprognostic (1.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (9.40e-3)" 28.6 16.9 33.9 19.1 54.1 29.0 23.6 32.5 48.4 12.5 12.1 8.4 10.2 10.0 11.8 16.5 22.0 10.6 14.4 19.1 49.2 26.4 15.3 53.1 16.4 23.3 17.6 31.2 13.5 11.7 23.4 12.0 15.4 17.2 14.4 12.9 9.1 13.2 12.4 39.5 12.3 10.9 16.9 17.4 14.5 10.8 7.8 12.6 12.6 12.3 9.7 27.9 13.6 18.7 4.6 16.2 5.5 8.2 8.4 7.9 2.7 33.6 15.9 31.9 13.3 19.3 14.5 18.5 24.4 20.9 26.5 23.7 23.8 27.7 30.9 30.3 20.1 20.2 30.0 29.8 35.7 31.3 24.9 17.8 9.9 16.6 12.9 15.6 13.0 14.8 11.2 22.1 19.2 28.5 28.3 20.7 15.8 17.5 39.6 38.7 13.0 10.5 17.1 16.3 31.2 13.9 11.9 19.7 27.5 25.7 14.5 19.7 11.0 19.8 15.5 20.5 26.9 14.0 11.2 28.5 34.6 21.2 24.4 36.2 24.5 43.6 19.7 36.5 23.1 16.1 3.2 8.2 5.5 7.4 8.2 6.7 3.0 6.6 6.9 8.3 4.6 7.9 4.9 3.9 8.4 7.3 16.2 4.9 2.7 33.9 54.1 32.5 46.9 49.2 26.4 17.6 31.2 17.2 12.6 26.8 21.9 30.2 40.5 73.6 8.5 16.9 38.2 6.7 13.6 24.4 13.7 40.9 39.7 65.3 10.2 19.0 20.0 46.7 20.4 39.4 31.3 59.4 9.2 116.5 44.9 9.5 20.8 17.2 91.3 18.3 20.8 67.7 50.6 88.4 17.0 33.9 70.1 21.0 20.5 28.5 5.6 6.5 53.6 16.3 44.5 58.8 43.3 40.5 16.8 65.5 MAP2K2 "MEK2, PRKMK2" ENSG00000126934 "Mitogen-activated protein kinase kinase 2" P36507 19 4090321-4124129 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 596.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003835, HPA051993" Supported Supported Cytosol NA NA Cytosol "CAB003835: AB_562312, HPA051993: AB_2681685" "unprognostic (4.39e-1)" "prognostic favorable (3.72e-4)" "unprognostic (4.24e-1)" "unprognostic (1.26e-3)" "unprognostic (2.58e-1)" "prognostic favorable (7.98e-4)" "unprognostic (2.08e-3)" "unprognostic (2.11e-1)" "unprognostic (2.65e-1)" "unprognostic (1.06e-1)" "unprognostic (7.45e-3)" "unprognostic (4.95e-2)" "unprognostic (1.32e-1)" "prognostic favorable (5.43e-5)" "unprognostic (2.91e-2)" "unprognostic (2.25e-1)" "unprognostic (4.90e-2)" 23.9 33.0 35.6 27.6 36.1 46.7 30.2 31.2 43.4 22.6 38.8 24.6 27.0 70.9 21.8 23.2 32.8 21.7 27.9 41.4 33.1 31.0 22.7 42.0 24.1 44.5 34.4 29.2 30.8 46.0 18.9 29.7 21.3 26.1 25.7 24.3 21.7 41.5 24.0 134.9 27.4 56.7 19.0 25.2 25.9 28.3 42.0 20.9 44.1 26.2 42.2 29.1 20.0 26.9 11.4 10.7 28.3 10.6 11.3 12.1 4.5 36.8 40.7 22.3 31.3 30.9 37.3 22.3 24.3 32.6 33.3 30.2 35.2 20.0 31.6 23.0 27.7 26.8 26.6 17.4 26.0 25.8 26.8 21.2 11.5 22.2 38.9 47.3 21.1 24.3 41.1 25.3 23.4 31.2 44.6 29.4 28.8 22.0 62.4 28.0 46.3 41.8 29.7 25.5 27.2 29.6 32.0 14.7 36.1 29.1 23.7 30.3 30.2 22.3 30.9 75.8 26.9 23.8 36.4 25.9 27.3 23.8 69.8 37.4 62.8 38.0 22.1 42.4 38.2 46.8 15.2 9.1 28.3 11.9 10.6 9.7 8.9 9.7 12.1 10.7 11.4 8.9 11.6 14.4 11.3 8.7 6.0 9.2 4.5 35.6 36.1 31.2 43.4 33.1 31.0 34.4 29.2 26.1 20.9 8.9 38.8 57.0 73.8 31.5 79.0 54.9 17.8 10.7 19.4 38.4 39.3 23.7 124.3 17.7 223.1 33.7 242.0 0.0 38.5 28.5 33.0 88.2 19.6 43.1 46.2 114.4 60.6 34.4 35.6 596.7 33.1 29.7 40.5 12.6 77.6 82.3 41.7 90.9 21.5 75.0 82.4 25.8 32.5 25.9 14.5 55.8 29.7 45.4 69.4 97.8 MAP2K3 "MAPKK3, MEK3, MKK3, PRKMK3" ENSG00000034152 "Mitogen-activated protein kinase kinase 3" P46734 17 21284672-21315240 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018548 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB018548: AB_631927" "unprognostic (2.31e-1)" "unprognostic (6.39e-2)" "unprognostic (4.63e-2)" "unprognostic (3.68e-1)" "unprognostic (3.54e-3)" "unprognostic (1.60e-1)" "unprognostic (2.97e-2)" "unprognostic (1.35e-2)" "unprognostic (5.25e-3)" "unprognostic (1.88e-2)" "unprognostic (3.16e-2)" "unprognostic (2.18e-2)" "unprognostic (1.33e-1)" "unprognostic (6.48e-2)" "unprognostic (1.22e-2)" "unprognostic (2.92e-1)" "unprognostic (1.77e-1)" 16.1 12.1 5.5 14.8 7.3 66.9 29.0 12.4 8.9 10.2 12.4 6.3 10.3 18.1 7.6 11.1 24.2 11.6 25.1 26.8 5.6 5.3 15.8 37.1 25.5 34.0 7.4 3.9 10.1 26.3 9.6 15.8 26.7 9.5 12.2 9.3 12.7 18.5 9.2 46.4 20.9 23.8 18.1 7.6 26.7 16.3 5.3 4.1 16.4 11.5 45.0 21.4 16.0 17.3 13.2 17.3 49.2 33.3 5.4 16.2 10.0 21.4 21.7 2.9 13.2 17.6 11.3 11.0 33.2 36.1 26.5 24.4 24.1 13.8 19.4 13.6 52.0 22.4 21.3 9.2 29.5 18.9 20.1 16.8 11.2 12.5 21.8 5.5 14.7 23.1 8.7 8.4 36.1 10.9 8.3 11.8 11.4 2.1 9.7 22.1 21.3 7.4 14.0 8.3 38.6 12.5 15.3 18.7 14.3 15.0 22.6 7.9 2.8 12.3 13.3 23.1 30.1 6.6 5.0 10.8 25.2 20.6 26.9 21.4 12.1 6.1 25.0 24.3 12.7 13.0 14.5 16.0 25.2 14.6 24.0 12.6 13.2 12.1 13.6 17.3 10.6 7.8 10.1 49.2 5.4 33.3 12.7 16.2 10.0 5.5 7.3 12.4 8.9 5.6 5.3 7.4 3.9 9.5 4.1 35.7 59.6 38.8 149.8 229.1 5.9 17.0 45.9 29.4 45.5 21.0 3.9 51.1 63.0 81.6 1.1 21.1 72.0 210.2 69.2 75.4 38.0 143.0 94.4 63.8 45.6 17.5 115.4 21.5 64.9 0.7 11.2 56.1 82.7 15.4 50.2 16.4 93.5 56.1 15.6 27.9 6.9 0.0 70.0 0.9 4.4 190.7 56.1 56.1 31.9 222.1 MAP2K6 "MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3" ENSG00000108984 "Mitogen-activated protein kinase kinase 6" P52564 17 69414698-69553861 "Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.9;skeletal muscle: 55.6" "Cell type enhanced" "Detected in many" 7 "Intestinal endocrine cells: 43.8;Muller glia cells: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9" "Group enriched" "Detected in all" 9 "dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3" "Cell line enhanced" "Detected in many" "A549: 24.4;AN3-CA: 13.3;HUVEC TERT2: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007744, HPA031134" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB007744: AB_562318, HPA031134: AB_10603016" "prognostic favorable (2.27e-6)" "unprognostic (2.24e-1)" "unprognostic (8.46e-2)" "unprognostic (4.10e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.61e-3)" "unprognostic (9.52e-2)" "unprognostic (3.67e-1)" "unprognostic (4.09e-3)" "prognostic favorable (7.52e-4)" "unprognostic (3.61e-2)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (9.43e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-2)" 4.5 2.0 3.2 8.6 5.9 10.1 14.0 13.7 7.5 19.8 21.5 6.2 4.7 7.2 4.7 3.1 3.4 3.3 5.1 2.5 3.9 3.5 4.1 8.6 2.6 10.3 5.4 4.1 2.7 8.5 0.0 3.2 1.1 5.3 2.8 22.8 5.3 4.0 4.6 55.6 2.3 7.3 2.3 6.2 5.9 5.4 2.1 5.4 13.7 2.8 4.8 5.1 3.0 2.5 2.3 31.9 19.3 9.3 1.8 2.1 2.6 0.1 24.4 11.0 13.3 4.7 2.6 1.6 0.1 3.6 1.0 1.5 0.7 1.1 0.6 9.0 0.5 0.8 1.2 3.8 0.5 0.3 0.8 2.0 0.1 6.9 6.8 4.7 1.0 1.0 12.1 0.3 0.3 0.0 1.0 17.5 3.3 0.0 1.7 0.0 0.1 12.7 0.5 7.8 0.5 4.5 4.6 1.1 0.3 4.9 3.4 4.9 7.4 1.0 0.9 2.2 6.1 3.4 1.3 3.1 1.3 1.6 1.1 0.4 1.2 1.3 0.3 1.0 1.5 1.0 0.8 9.3 1.6 1.2 1.1 2.1 1.6 1.4 1.5 2.9 2.3 1.6 1.5 19.3 1.8 0.4 31.9 1.9 2.6 3.2 5.9 13.7 7.5 3.9 3.5 5.4 4.1 5.3 5.4 3.0 7.9 4.7 3.2 2.4 4.9 1.4 2.5 6.7 5.7 0.0 2.0 7.5 19.9 1.2 8.5 2.4 17.0 0.0 3.6 5.4 2.8 1.9 1.1 2.0 5.1 3.2 43.8 4.9 8.9 1.9 4.0 7.0 3.3 0.0 22.4 32.9 1.2 8.6 3.5 1.1 3.8 0.0 3.1 0.0 0.2 3.8 0.7 11.5 23.7 2.3 MAP2K7 "Jnkk2, MKK7, PRKMK7" ENSG00000076984 "Mitogen-activated protein kinase kinase 7" O14733 19 7903843-7914478 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001633, CAB004262, HPA064711" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331" "unprognostic (1.77e-1)" "unprognostic (5.04e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-1)" "unprognostic (4.24e-2)" "prognostic favorable (8.54e-5)" "unprognostic (1.80e-3)" "unprognostic (2.55e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-2)" "unprognostic (1.27e-3)" "unprognostic (1.56e-1)" "unprognostic (3.54e-2)" "unprognostic (3.71e-2)" "unprognostic (6.05e-2)" "unprognostic (1.73e-2)" "prognostic favorable (1.56e-4)" 16.3 14.9 13.5 16.4 16.4 23.8 13.6 28.7 21.5 14.3 15.6 23.2 15.1 19.3 19.1 9.9 13.6 13.1 14.3 15.8 14.6 11.9 12.8 15.9 12.5 15.9 17.2 13.9 18.4 22.3 13.9 17.0 16.4 16.2 14.4 7.9 14.2 23.0 13.4 61.6 21.3 18.7 14.1 12.5 19.4 14.8 21.5 16.5 9.8 13.7 17.3 12.8 15.4 15.2 3.0 2.6 4.8 2.7 3.3 2.5 1.0 12.9 7.4 6.4 10.6 5.2 5.0 12.1 8.5 4.2 5.8 6.0 10.7 7.9 15.4 13.8 4.5 5.7 11.9 5.6 6.5 2.3 12.2 27.8 10.8 9.8 7.9 6.7 10.1 13.8 5.8 8.5 4.6 5.2 7.7 5.2 11.3 15.8 20.3 3.3 6.8 14.3 24.5 11.4 6.9 16.7 14.3 7.0 15.6 5.2 10.8 11.9 11.9 5.8 10.2 11.8 4.0 11.0 11.5 7.8 17.7 10.1 12.4 11.5 29.4 13.6 14.5 8.9 14.9 7.1 0.0 2.7 1.9 2.3 2.5 1.5 2.1 1.9 2.0 1.3 3.0 1.7 2.5 4.8 3.3 1.5 2.6 0.7 1.0 13.5 16.4 28.7 21.5 14.6 11.9 17.2 13.9 16.2 16.5 23.8 21.5 21.9 31.0 34.3 50.6 12.6 22.9 9.4 5.7 19.2 72.6 23.2 11.6 19.1 3.8 18.7 26.2 0.0 16.4 25.3 18.1 32.9 10.4 17.4 16.3 54.0 35.1 19.0 12.4 8.6 26.7 15.7 30.4 16.2 23.6 25.8 19.2 21.0 11.7 14.7 70.3 32.3 26.9 14.2 26.4 37.3 41.2 28.0 24.2 25.2 MAP3K1 "MAPKKK1, MEKK, MEKK1" ENSG00000095015 "Mitogen-activated protein kinase kinase kinase 1" Q13233 5 56815574-56896152 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 27.5;THP-1: 25.7" "Region enriched" "Detected in many" 6 "olfactory region: 22.5" "Low region specificity" "Detected in all" "CAB004500, HPA046509" Approved Approved Cytosol NA NA Cytosol "CAB004500: AB_627926, HPA046509: AB_2679678" "unprognostic (1.77e-1)" "unprognostic (1.71e-2)" "unprognostic (4.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.48e-2)" "unprognostic (5.39e-3)" "unprognostic (5.20e-3)" "unprognostic (2.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (6.73e-2)" "unprognostic (1.97e-3)" "unprognostic (2.18e-2)" "unprognostic (1.58e-1)" "unprognostic (9.92e-3)" "unprognostic (1.11e-1)" 6.7 4.9 5.4 14.6 4.8 15.2 14.9 8.0 4.5 7.6 6.7 5.4 7.3 4.3 7.1 9.4 12.7 7.2 5.9 4.3 3.7 3.2 9.5 4.4 8.8 21.4 6.4 3.1 8.4 9.2 6.3 7.9 8.1 4.5 8.3 4.5 12.6 15.4 9.7 3.5 21.8 11.2 4.0 3.8 21.3 5.5 8.5 5.1 11.7 19.2 6.6 18.2 6.0 11.7 6.6 2.8 6.7 7.2 2.7 5.8 2.3 6.6 4.0 6.3 4.2 1.0 0.8 10.6 1.3 1.7 4.0 5.6 18.7 5.0 5.9 0.4 1.5 3.4 3.4 5.2 2.3 5.6 2.0 2.3 3.3 1.8 8.8 2.5 5.2 9.2 1.0 2.5 1.2 2.0 1.1 1.7 2.0 2.8 10.7 1.0 2.9 3.6 7.1 2.9 3.4 0.5 5.7 4.4 20.3 7.0 6.9 2.6 27.5 3.9 4.9 11.2 5.8 13.4 25.7 5.0 0.4 3.4 1.5 2.4 7.8 4.0 11.3 0.6 3.1 6.8 6.7 4.5 1.0 1.2 6.8 1.2 6.6 3.8 1.8 2.8 5.1 2.5 0.9 2.6 2.7 7.2 1.5 5.8 2.3 5.4 4.8 8.0 4.5 3.7 3.2 6.4 3.1 4.5 5.1 6.0 9.8 47.7 14.5 46.5 15.2 2.7 50.9 4.0 12.5 34.9 45.2 12.9 6.6 14.2 1.6 13.5 6.6 0.0 12.8 7.7 11.3 11.9 7.0 12.1 26.3 27.0 9.8 17.2 81.7 1.9 4.9 40.3 35.4 45.9 10.1 10.6 13.0 7.0 1.8 20.1 34.7 6.5 5.2 10.0 15.0 47.8 5.6 16.6 8.9 10.0 MAP3K10 "MEKK10, MLK2, MST" ENSG00000130758 "Mitogen-activated protein kinase kinase kinase 10" Q02779 19 40191744-40215575 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 13.9;Horizontal cells: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007039 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Actin filaments, Cytosol" "HPA007039: AB_1079357" "unprognostic (2.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-3)" "unprognostic (2.03e-2)" "unprognostic (2.04e-1)" "prognostic favorable (8.69e-4)" "unprognostic (4.50e-3)" "unprognostic (1.80e-1)" "unprognostic (3.94e-2)" "unprognostic (6.13e-2)" "unprognostic (1.34e-3)" "unprognostic (4.62e-3)" "unprognostic (6.88e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-2)" "unprognostic (4.77e-3)" "prognostic favorable (2.13e-4)" 7.7 7.0 29.6 4.7 22.8 3.7 2.2 14.3 32.0 3.3 3.4 5.3 1.8 4.4 4.5 1.8 3.7 3.1 4.0 8.2 28.2 11.2 4.7 2.1 4.2 4.6 11.5 9.4 4.3 8.1 4.7 5.2 3.7 9.0 4.6 2.0 2.4 6.9 4.8 22.9 5.6 5.0 4.0 5.3 6.7 6.2 6.6 7.1 2.3 3.3 2.6 2.4 3.8 5.4 0.8 0.0 0.0 0.2 0.0 0.9 0.0 6.3 7.6 2.4 5.6 2.2 1.3 6.5 4.4 2.2 2.0 2.1 1.7 1.8 5.8 4.6 1.5 5.1 2.1 0.9 2.3 0.3 11.0 7.2 1.5 3.2 1.7 4.2 1.3 3.7 1.2 5.5 2.2 1.5 2.3 1.9 8.2 5.5 9.9 0.6 3.8 4.8 2.3 2.8 2.1 5.0 5.9 2.5 3.4 1.8 4.0 7.9 11.4 5.1 1.9 10.4 1.5 2.5 2.3 3.1 5.4 5.2 7.8 8.5 13.1 7.5 2.6 6.2 2.4 7.8 0.0 0.1 0.0 0.4 0.2 0.0 0.8 0.2 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 29.6 22.8 14.3 28.7 28.2 11.2 11.5 9.4 9.0 7.1 0.0 0.0 2.2 1.5 1.3 13.9 2.4 0.0 0.0 0.0 7.0 7.9 0.6 0.0 2.3 2.6 2.3 2.6 0.0 3.6 0.7 1.9 2.0 0.0 2.6 2.2 22.3 4.1 3.7 2.2 6.5 2.8 1.1 1.7 1.0 1.9 5.2 3.4 1.9 4.6 3.7 7.3 6.5 2.6 2.6 1.7 2.4 1.1 1.9 2.1 1.7 MAP3K11 "MEKK11, MLK3, PTK1, SPRK" ENSG00000173327 "Mitogen-activated protein kinase kinase kinase 11" Q16584 11 65597755-65615382 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 75.8" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 120.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010165 Approved Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "CAB010165: AB_631936" "unprognostic (8.36e-2)" "unprognostic (1.17e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.87e-1)" "unprognostic (7.56e-3)" "unprognostic (3.10e-2)" "unprognostic (4.50e-2)" "unprognostic (4.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.77e-2)" "unprognostic (3.13e-2)" "unprognostic (2.01e-2)" "unprognostic (7.62e-2)" "unprognostic (1.95e-1)" "unprognostic (8.27e-3)" 23.2 10.8 11.4 23.7 21.2 14.2 27.4 7.9 13.8 8.6 15.8 29.8 6.1 31.9 11.0 8.1 14.7 11.6 12.0 11.6 13.3 8.1 16.1 31.2 21.1 14.4 30.9 8.2 8.4 12.5 8.3 10.3 14.7 16.7 13.4 8.2 15.4 13.5 9.5 11.9 13.7 31.9 8.6 17.7 28.8 16.9 8.6 19.0 8.9 13.6 7.6 12.7 8.9 75.8 2.3 7.6 13.8 12.0 1.8 3.5 5.6 16.7 14.8 8.0 8.5 2.6 3.2 8.2 6.5 4.6 7.8 5.3 14.8 16.3 6.3 24.1 5.1 11.4 14.7 4.8 7.0 2.9 13.9 6.1 17.8 10.1 17.7 7.1 10.2 26.9 5.1 6.8 5.8 5.3 8.3 21.8 7.3 7.7 12.7 4.1 20.8 11.9 19.2 8.8 11.2 19.0 19.8 5.2 12.8 7.4 14.6 7.3 8.2 7.7 22.2 38.1 4.2 17.7 16.6 24.4 12.0 13.0 17.5 11.5 8.1 9.2 5.6 14.0 11.8 27.8 4.3 7.7 9.2 2.4 12.0 2.4 2.0 2.6 3.5 7.6 2.3 2.0 1.5 13.8 1.8 11.7 2.3 1.4 5.6 11.4 21.2 7.9 13.8 13.3 8.1 30.9 8.2 16.7 19.0 20.8 19.7 19.7 21.8 18.7 22.9 9.6 17.8 5.3 6.8 10.4 23.6 21.6 16.6 18.8 9.8 69.5 120.7 23.3 23.8 13.7 11.6 23.2 25.4 45.6 44.4 17.5 40.3 49.7 42.7 44.8 8.9 39.8 20.3 37.9 41.8 14.5 24.8 77.2 6.0 21.1 53.6 32.3 11.2 11.4 13.6 26.2 28.7 21.2 36.5 30.8 MAP3K13 "LZK, MEKK13" ENSG00000073803 "Mitogen-activated protein kinase kinase kinase 13" O43283 3 185282941-185489097 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 456.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016497, HPA036691, HPA036692" Uncertain Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845" "unprognostic (8.95e-2)" "unprognostic (6.72e-3)" "unprognostic (9.46e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (5.16e-2)" "unprognostic (2.81e-1)" "unprognostic (2.61e-1)" "unprognostic (1.23e-2)" "unprognostic (9.04e-2)" "prognostic favorable (1.11e-4)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.70e-3)" "unprognostic (1.54e-2)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (6.64e-2)" "unprognostic (9.31e-3)" 9.8 24.8 21.7 8.7 22.2 9.5 15.1 16.4 26.1 12.9 16.9 18.4 10.5 16.8 12.9 42.1 15.2 14.6 13.1 8.1 19.2 18.6 21.9 20.7 15.2 7.4 23.2 17.1 16.5 24.9 20.9 24.5 9.1 21.8 14.5 18.9 18.6 26.2 11.4 3.3 9.8 23.4 12.1 26.4 8.7 16.4 12.9 15.8 4.4 18.6 8.3 10.3 12.5 11.5 23.7 21.5 21.1 13.2 11.5 17.4 7.8 29.1 5.8 11.3 0.3 10.3 12.7 6.7 6.7 4.6 10.9 13.2 11.2 11.0 0.2 23.0 12.2 18.2 16.7 0.3 15.5 19.4 32.5 15.0 0.1 7.9 9.2 11.2 15.3 8.4 11.5 13.6 9.3 11.7 11.3 12.1 0.3 0.3 23.7 9.7 9.1 1.8 7.2 13.0 22.5 13.7 0.2 13.5 16.0 19.2 7.6 18.6 12.4 11.3 17.1 23.2 12.9 25.8 8.6 8.0 9.0 11.7 16.2 14.5 12.1 15.6 9.6 13.2 7.8 14.7 6.4 13.2 5.1 10.3 12.2 15.8 23.7 12.4 12.8 21.5 19.0 17.4 16.8 21.1 11.5 8.6 9.4 4.8 7.8 21.7 22.2 16.4 26.1 19.2 18.6 23.2 17.1 21.8 15.8 50.6 76.2 44.7 172.9 125.7 111.5 22.1 104.4 64.3 84.2 75.0 86.4 120.9 243.7 92.5 109.7 52.6 82.0 0.0 111.2 29.4 48.3 249.1 28.9 83.1 55.4 42.9 102.2 83.4 50.4 168.4 40.0 59.4 81.0 456.3 109.9 93.7 112.0 96.2 50.9 224.8 81.3 45.3 74.0 119.3 28.8 127.2 170.1 31.2 98.7 249.0 MAP3K14 "FTDCR1B, HS, HSNIK, NIK" ENSG00000006062 "Mitogen-activated protein kinase kinase kinase 14" Q99558 17 45263121-45317040 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 49.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 22.4;HDLM-2: 23.0;U-251 MG: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027269, HPA027270" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "HPA027269: AB_2732436, HPA027270: AB_2732437" "unprognostic (1.05e-2)" "prognostic favorable (5.27e-5)" "unprognostic (2.71e-2)" "unprognostic (9.42e-2)" "unprognostic (5.31e-2)" "unprognostic (2.61e-3)" "unprognostic (2.70e-2)" "unprognostic (1.72e-1)" "unprognostic (3.40e-1)" "unprognostic (3.45e-1)" "unprognostic (1.07e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (8.82e-2)" "unprognostic (3.49e-2)" "unprognostic (1.03e-2)" "unprognostic (2.28e-1)" 3.7 3.4 3.0 14.7 4.0 3.4 2.7 4.9 3.6 5.0 7.3 4.5 3.5 6.0 5.5 3.3 6.8 4.2 6.2 4.5 3.0 4.4 5.1 4.9 12.0 3.0 0.6 3.5 5.7 3.5 7.7 1.5 4.6 5.2 3.5 4.3 7.5 4.8 14.5 6.1 9.6 5.2 4.1 8.4 4.0 4.5 4.5 7.1 2.2 6.9 18.0 4.9 2.8 9.5 4.8 7.7 3.6 5.6 5.2 2.3 9.5 22.4 2.3 4.0 1.6 3.8 5.7 2.6 1.8 8.5 5.2 3.4 11.9 4.2 13.6 2.8 8.5 6.8 1.0 3.6 4.4 23.0 1.7 0.9 6.1 1.5 4.1 0.7 4.5 5.9 2.3 4.2 2.2 9.0 1.6 2.0 1.8 18.3 4.3 3.5 4.0 1.5 1.2 5.9 3.1 5.2 6.9 9.6 6.2 1.9 2.4 1.9 4.1 2.7 2.9 3.4 1.7 0.4 3.6 3.9 6.0 3.3 22.5 17.5 6.5 2.2 2.2 2.5 5.2 1.5 3.4 1.6 3.5 3.6 2.0 7.6 2.4 2.5 2.3 9.5 2.6 2.5 7.7 5.6 2.2 4.8 5.2 2.3 3.0 13.8 9.7 13.7 0.0 3.6 2.0 15.3 9.4 4.5 0.0 3.9 0.7 0.0 4.2 3.7 1.6 11.2 0.0 2.3 1.2 1.8 6.5 1.1 8.1 4.4 1.6 12.6 4.9 7.8 4.5 4.4 6.2 0.0 49.5 6.4 2.2 3.3 7.8 1.1 2.5 2.7 0.0 0.6 4.5 2.4 0.0 0.0 5.1 6.7 5.0 MAP3K19 "FLJ23074, RCK, YSK4" ENSG00000176601 "Mitogen-activated protein kinase kinase kinase 19" Q56UN5 2 134964491-135047468 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.3;fallopian tube: 23.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 151.3;Early spermatids: 55.2;Late spermatids: 74.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8" "Region enhanced" "Detected in many" "pons and medulla: 18.3" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.5" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.1;U-266/70: 2.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 20.2" HPA011388 Uncertain Cytosol NA NA Cytosol "HPA011388: AB_1848822" "unprognostic (7.12e-3)" "unprognostic (6.55e-3)" "unprognostic (6.96e-2)" "unprognostic (3.90e-3)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (1.96e-1)" "unprognostic (9.38e-2)" "unprognostic (1.09e-1)" "unprognostic (4.33e-1)" "unprognostic (2.02e-2)" "unprognostic (1.32e-1)" "unprognostic (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (2.83e-4)" 0.1 0.2 1.7 0.2 6.2 0.1 0.1 0.0 0.5 1.1 0.2 7.3 0.0 0.2 1.0 6.7 0.2 23.9 0.1 0.1 2.9 3.8 0.2 0.2 5.6 0.2 0.5 1.5 7.3 0.1 0.1 1.0 0.1 18.3 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.2 7.6 3.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 4.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.7 6.2 0.0 0.5 2.9 3.8 0.5 1.5 18.3 3.1 0.0 0.6 0.0 0.0 0.0 0.2 0.4 0.0 151.3 17.0 0.0 9.8 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 74.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.1 0.0 0.0 0.0 0.0 0.1 MAP3K2 "MEKK2, MEKK2B" ENSG00000169967 "Mitogen-activated protein kinase kinase kinase 2" Q9Y2U5 2 127298730-127388465 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 13.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021540 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021540: AB_2670742" "unprognostic (5.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.58e-1)" "unprognostic (9.46e-2)" "unprognostic (1.02e-1)" "unprognostic (5.76e-2)" "unprognostic (7.19e-2)" "unprognostic (4.50e-1)" "unprognostic (1.27e-1)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.97e-3)" "unprognostic (7.56e-2)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (2.11e-1)" 18.5 14.5 13.7 20.1 14.5 41.0 22.6 20.1 16.3 16.6 19.6 12.7 18.9 18.8 19.8 18.0 13.4 15.9 18.6 13.3 12.5 10.2 15.5 27.6 20.0 28.5 17.9 13.0 20.3 15.4 23.8 21.2 13.9 12.3 13.6 13.1 12.2 18.1 25.5 24.5 19.4 22.5 18.1 14.9 17.0 18.0 14.9 14.3 25.8 22.5 13.7 16.8 17.1 20.3 3.1 5.1 13.6 2.9 2.3 2.1 1.1 16.4 7.0 5.6 5.7 7.9 10.5 9.4 10.3 11.2 10.2 8.3 8.4 7.3 10.9 17.8 14.7 9.4 14.0 9.0 6.9 11.5 27.3 7.0 10.1 12.8 7.3 9.2 10.1 21.9 9.4 7.6 12.3 15.2 9.0 4.7 8.2 4.7 21.8 10.0 6.0 11.9 7.2 5.8 4.6 9.2 7.8 10.6 8.1 4.1 15.5 11.2 6.0 15.0 9.2 9.3 4.8 6.0 7.8 10.7 20.0 18.8 9.2 13.9 22.7 16.3 11.2 9.6 6.7 8.6 4.0 2.9 2.0 1.7 1.8 2.1 3.1 1.6 1.7 2.4 2.6 1.9 2.0 13.6 2.3 2.2 5.1 1.4 1.1 13.7 14.5 20.1 16.3 12.5 10.2 17.9 13.0 12.3 14.3 77.4 39.5 24.5 32.1 64.0 51.3 27.5 38.2 57.6 46.6 27.9 100.1 16.2 11.6 17.3 3.2 38.8 49.0 23.3 29.5 16.3 51.8 41.5 60.0 61.1 46.1 68.3 43.6 22.1 61.3 3.8 39.1 76.0 54.0 23.4 36.2 25.5 35.7 24.6 48.8 27.2 56.9 19.4 48.6 31.4 55.2 68.6 22.0 30.5 24.4 35.7 MAP3K20 "MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK" ENSG00000091436 "Mitogen-activated protein kinase kinase kinase 20" Q9NYL2 2 173075435-173268010 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 96.1" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 35.7;Alveolar cells type 2: 51.9;Cytotrophoblasts: 48.5;Ductal cells: 34.2;Pancreatic endocrine cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 13.7" "Group enriched" "Detected in many" 5 "dendritic cells: 13.7;monocytes: 8.0" "Cell line enhanced" "Detected in many" "hTERT-HME1: 44.9;U-138 MG: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017205 Approved Supported Cytosol NA NA Cytosol "HPA017205: AB_1858933" "unprognostic (2.90e-2)" "unprognostic (9.99e-3)" "unprognostic (4.63e-3)" "unprognostic (1.98e-1)" "unprognostic (7.63e-2)" "unprognostic (5.02e-2)" "unprognostic (2.34e-2)" "unprognostic (3.89e-3)" "unprognostic (2.83e-2)" "unprognostic (9.27e-2)" "unprognostic (4.54e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.41e-6)" "unprognostic (2.34e-1)" "unprognostic (1.86e-1)" "unprognostic (2.23e-1)" "unprognostic (1.19e-2)" 21.7 5.0 2.9 7.4 3.3 0.8 9.2 2.8 3.1 25.7 24.8 2.1 10.7 3.1 30.2 15.4 26.2 13.1 14.9 52.5 3.5 3.0 2.4 8.5 7.5 2.5 4.5 3.0 21.7 4.4 22.6 3.1 6.9 4.2 25.6 5.4 11.5 6.7 15.8 96.1 5.8 8.0 68.4 4.7 3.7 15.8 6.6 3.5 2.8 6.7 38.0 4.9 46.7 24.0 2.1 13.7 2.3 8.0 0.4 1.6 2.7 8.9 7.5 5.9 7.8 17.3 25.8 3.7 32.3 25.3 15.1 16.3 5.1 5.9 6.9 8.5 32.3 13.3 6.1 8.8 17.1 34.1 13.4 5.9 11.2 8.5 1.0 6.9 10.0 11.9 20.7 7.4 28.4 44.9 12.6 10.0 7.6 5.0 1.3 9.9 3.8 6.3 5.0 3.3 7.5 4.3 9.3 12.1 0.0 3.7 5.1 3.5 3.4 12.4 3.0 5.3 10.1 3.4 5.4 10.0 48.3 19.8 14.3 7.3 0.0 0.0 1.4 34.7 2.7 5.0 0.1 8.0 0.0 0.9 7.5 0.9 1.5 0.8 1.6 13.7 2.1 0.0 0.8 2.3 0.4 6.6 0.3 0.7 2.7 2.9 3.3 2.8 3.1 3.5 3.0 4.5 3.0 4.2 3.5 35.7 51.9 0.0 0.0 0.0 0.0 0.0 0.0 24.1 13.6 10.4 0.0 48.5 1.7 34.2 0.0 0.0 0.0 0.0 23.2 22.4 0.0 0.0 4.7 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 27.1 0.0 0.0 31.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 MAP3K21 "KIAA1804, MLK4" ENSG00000143674 "Mitogen-activated protein kinase kinase kinase 21" Q5TCX8 1 233327768-233385148 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 28.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 7.7;Collecting duct cells: 14.0;Ductal cells: 9.7;Exocrine glandular cells: 8.4;Pancreatic endocrine cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.0" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.0" "Cell line enhanced" "Detected in many" "HEK 293: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007636 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007636: AB_1079392" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.42e-3)" "unprognostic (4.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.82e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (8.21e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (1.71e-1)" "unprognostic (9.22e-2)" "unprognostic (4.84e-2)" 0.6 3.2 2.0 3.4 2.2 1.3 2.2 10.0 3.3 1.5 11.4 0.6 9.1 9.9 0.8 5.2 2.4 3.9 3.9 0.7 1.3 2.1 12.5 13.3 5.6 0.5 0.9 1.7 0.8 28.9 4.4 2.6 1.0 1.2 1.3 6.0 1.0 3.7 2.5 0.4 2.7 17.2 0.3 0.9 0.7 10.1 12.4 0.6 0.5 2.4 0.8 1.3 1.1 1.6 0.5 0.8 0.1 0.3 5.0 0.2 0.1 7.4 12.7 0.2 0.0 0.0 0.0 6.4 0.2 0.0 0.3 0.5 7.0 6.5 0.7 5.2 0.1 2.4 4.0 9.5 3.9 0.8 13.8 18.3 0.1 7.1 0.0 0.5 12.1 2.9 0.1 5.2 0.2 7.4 1.4 0.4 5.8 0.1 2.4 0.0 1.6 3.8 4.3 9.1 8.7 5.6 0.0 0.0 13.3 8.8 3.1 9.4 2.5 4.3 0.2 0.0 1.0 3.7 3.9 0.0 0.0 1.2 0.0 7.4 2.3 2.9 0.0 1.2 3.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.8 0.5 0.0 0.0 0.1 5.0 0.0 0.2 0.2 0.1 2.0 2.2 10.0 3.3 1.3 2.1 0.9 1.7 1.2 0.6 32.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 14.0 0.0 0.0 3.3 9.7 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 7.8 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MAP3K4 "KIAA0213, MAPKKK4, MEKK4, MTK1" ENSG00000085511 "Mitogen-activated protein kinase kinase kinase 4" Q9Y6R4 6 160991727-161117385 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007625 Uncertain Approved Cytosol NA NA Cytosol "HPA007625: AB_1853770" "unprognostic (3.05e-3)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (2.06e-1)" "unprognostic (7.65e-2)" "unprognostic (1.35e-3)" "unprognostic (6.38e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-3)" "unprognostic (2.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.16e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.93e-1)" "unprognostic (6.84e-2)" 12.0 8.0 13.1 17.7 12.6 9.1 14.6 23.1 14.0 16.4 13.9 9.3 12.2 9.5 22.2 11.9 21.4 14.1 11.4 12.4 11.9 7.8 9.4 8.2 15.9 14.4 12.8 8.9 17.4 12.1 15.8 16.2 12.4 9.2 14.2 9.8 9.4 15.0 15.4 24.4 15.1 13.3 13.9 7.7 10.6 11.1 13.5 12.4 16.2 10.6 13.0 16.8 15.8 23.9 8.8 5.4 17.5 3.8 3.5 8.9 2.2 4.7 5.4 10.3 8.8 6.4 7.5 6.7 5.4 4.8 6.2 6.6 7.7 3.5 9.8 3.9 13.7 8.9 11.9 10.5 10.8 7.6 7.1 8.6 12.8 5.0 7.5 4.9 13.2 6.2 4.7 12.6 6.5 5.9 9.7 8.1 7.4 32.2 11.3 6.6 4.9 8.9 6.7 6.3 3.4 8.3 9.8 9.5 7.8 5.7 3.5 5.9 5.3 10.1 10.8 0.9 9.4 4.4 16.2 7.5 7.6 9.8 7.1 25.5 6.6 5.3 9.0 9.0 13.7 8.0 17.5 3.8 2.3 5.0 3.0 8.9 6.2 7.1 4.5 4.3 8.8 5.0 4.9 0.2 3.5 1.7 5.4 4.8 2.2 13.1 12.6 23.1 14.0 11.9 7.8 12.8 8.9 9.2 12.4 17.9 12.6 14.2 8.2 8.8 15.7 17.9 10.2 8.1 19.4 14.0 21.6 16.7 3.3 8.0 2.6 11.3 5.9 0.0 6.5 9.4 7.8 10.8 3.5 7.3 6.4 22.3 14.8 4.3 7.0 2.5 10.6 9.0 0.0 18.0 9.4 18.9 9.7 7.0 11.7 5.9 28.6 6.5 8.0 13.5 29.6 10.3 27.7 12.1 10.9 12.9 MAP3K5 "ASK1, MAPKKK5, MEKK5" ENSG00000197442 "Mitogen-activated protein kinase kinase kinase 5" Q99683 6 136557047-136792518 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 55.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007824, HPA063245" Supported Supported Cytosol NA NA Cytosol "CAB007824: AB_598175, HPA063245: AB_2684969" "unprognostic (1.37e-1)" "unprognostic (3.21e-2)" "unprognostic (2.85e-2)" "unprognostic (1.38e-1)" "unprognostic (3.19e-1)" "prognostic favorable (6.08e-4)" "unprognostic (8.76e-2)" "unprognostic (1.41e-2)" "unprognostic (2.84e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.91e-4)" "unprognostic (3.97e-1)" "unprognostic (3.75e-2)" "unprognostic (1.37e-1)" "unprognostic (2.72e-1)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 7.7 55.6 13.0 7.5 17.6 7.6 5.5 12.9 12.7 4.0 5.4 6.9 3.6 4.6 7.2 5.1 6.4 6.1 4.9 7.3 11.8 6.8 6.8 5.5 7.7 8.8 8.2 6.4 32.4 28.2 1.5 9.9 3.4 7.9 11.6 6.2 5.8 4.2 4.9 3.7 5.0 4.6 4.3 7.5 9.8 8.7 7.3 8.6 2.0 10.0 3.4 9.0 10.8 18.9 2.5 2.5 8.5 3.0 4.1 7.0 1.4 2.9 1.8 0.0 0.0 4.2 11.3 1.0 4.2 22.7 2.2 2.1 0.1 3.0 1.7 6.2 5.8 1.6 4.0 7.2 2.1 5.7 2.3 5.7 15.0 4.0 0.0 20.1 6.9 0.0 14.8 2.8 3.4 9.8 8.4 7.3 2.1 3.7 16.8 15.3 5.6 0.1 5.9 0.7 5.7 2.4 3.9 4.8 6.8 8.8 18.6 5.3 3.5 3.5 3.4 0.9 0.8 0.7 6.2 6.3 3.6 1.1 0.2 3.9 13.7 9.1 0.0 2.8 9.8 3.2 5.7 3.0 3.3 2.7 2.3 4.9 2.0 4.3 3.7 2.5 2.5 0.4 1.4 8.5 4.1 2.1 2.4 7.0 1.4 13.0 17.6 12.9 9.4 11.8 6.8 8.2 6.4 7.9 8.6 6.0 22.4 10.4 17.9 4.4 17.5 21.8 2.5 16.0 34.2 10.4 5.9 0.7 3.3 2.1 4.9 3.8 7.7 0.0 19.7 0.9 5.1 22.3 5.7 9.6 7.1 0.0 33.5 9.8 22.1 2.3 21.9 18.4 0.0 1.0 12.1 42.4 18.9 5.8 13.4 6.8 2.5 12.9 8.0 1.4 15.0 8.8 2.3 6.9 10.0 19.3 MAP3K6 "ASK2, MAPKKK6, MEKK6" ENSG00000142733 "Mitogen-activated protein kinase kinase kinase 6" O95382 1 27355184-27366892 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 63.9" "Cell type enhanced" "Detected in many" 4 "Ito cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA051192 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA051192: AB_2681380" "unprognostic (1.19e-2)" "unprognostic (2.77e-3)" "unprognostic (2.62e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.13e-4)" "prognostic favorable (7.26e-4)" "prognostic unfavorable (8.76e-4)" "unprognostic (9.10e-2)" "unprognostic (2.79e-1)" "unprognostic (6.91e-2)" "unprognostic (6.56e-2)" "unprognostic (1.25e-1)" "unprognostic (4.65e-3)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (7.07e-3)" "unprognostic (1.50e-1)" 37.5 6.3 7.4 6.9 8.6 1.3 22.1 12.6 8.3 19.9 9.0 2.7 8.9 3.3 13.1 10.3 25.7 12.8 12.4 14.9 6.2 2.6 13.6 5.0 21.7 5.5 11.4 1.9 11.7 8.3 8.2 15.8 7.3 9.8 13.9 5.9 15.7 11.5 9.7 6.3 63.9 6.2 16.0 11.7 8.7 9.0 6.7 7.0 0.6 12.0 16.1 14.3 14.3 18.3 2.7 3.3 5.1 6.9 1.1 7.6 2.4 7.5 7.0 6.3 7.0 8.8 15.4 1.6 9.4 5.4 7.1 5.4 2.1 10.2 0.1 8.4 14.2 2.8 11.9 2.1 6.5 3.6 6.2 5.2 0.5 16.2 3.1 2.7 0.5 0.6 12.4 16.1 7.4 2.6 7.9 4.8 0.5 2.3 4.1 11.3 18.7 0.3 8.6 2.0 7.5 5.8 2.7 4.2 1.7 10.6 7.9 2.3 3.5 9.9 8.7 7.4 2.7 4.6 6.4 9.9 17.9 7.5 19.9 4.9 3.4 4.2 0.1 15.8 6.1 5.2 1.8 1.5 5.1 5.3 3.3 7.6 2.7 5.5 5.9 3.3 2.3 4.4 3.6 2.4 1.1 6.9 0.0 5.6 2.4 7.4 8.6 12.6 8.3 6.2 2.6 11.4 1.9 9.8 7.0 17.9 16.2 4.7 10.4 11.1 0.5 8.9 10.2 1.4 11.4 3.5 0.0 0.9 3.3 2.3 0.4 15.8 1.7 0.0 3.8 1.7 7.7 7.3 2.3 0.8 2.5 4.8 0.0 28.8 12.5 1.1 15.0 5.1 5.0 13.6 4.9 5.2 8.9 0.0 14.2 1.5 0.4 6.5 10.5 8.7 2.1 12.9 0.1 10.2 4.3 14.4 MAP3K7 "MEKK7, TAK1" ENSG00000135341 "Mitogen-activated protein kinase kinase kinase 7" O43318 6 90513573-90587045 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007633, HPA075335" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA Cytosol "Nuclear speckles, Plasma membrane" "HPA007633: AB_1079359, HPA075335: " "unprognostic (1.48e-1)" "unprognostic (3.45e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (9.77e-2)" "unprognostic (6.51e-2)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.79e-1)" "unprognostic (2.56e-3)" "unprognostic (4.76e-2)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (1.17e-1)" 15.5 17.6 19.6 17.3 26.3 10.3 21.6 27.5 27.3 21.1 16.4 15.7 15.8 12.5 23.1 23.6 15.2 15.5 17.6 22.2 20.5 17.5 15.9 15.5 20.0 22.2 22.9 16.4 25.0 13.5 25.8 25.6 23.6 20.7 21.2 15.3 12.4 17.0 23.3 24.3 18.7 14.7 19.4 23.0 23.3 14.7 13.8 21.7 28.2 20.3 10.8 21.9 17.2 18.9 14.2 15.9 19.4 17.7 18.2 22.1 13.6 7.9 7.0 20.5 17.6 15.0 20.1 14.5 16.0 18.5 14.4 18.2 9.0 7.6 17.7 10.2 17.2 12.8 8.5 12.9 12.4 24.6 9.0 13.7 15.8 9.7 11.9 15.8 17.5 12.2 16.6 15.3 14.0 17.2 16.6 13.5 15.6 31.5 14.5 20.6 9.7 8.1 14.8 16.8 12.4 8.9 14.0 36.9 8.6 12.1 8.9 10.4 14.8 11.1 7.7 12.0 16.8 7.7 31.1 12.9 11.7 7.4 10.7 14.8 12.9 11.5 7.7 18.0 19.2 17.2 15.5 12.7 19.4 15.1 17.4 16.8 14.2 14.5 14.4 15.9 10.5 16.5 16.0 12.5 18.2 17.7 9.8 22.1 13.6 19.6 26.3 27.5 27.3 20.5 17.5 22.9 16.4 20.7 21.7 14.9 24.0 20.7 17.4 32.3 22.8 28.8 12.7 16.0 10.3 15.7 25.5 27.6 6.6 16.6 2.6 20.3 9.3 0.0 18.3 26.6 23.5 24.4 12.8 17.9 21.1 27.0 11.6 30.7 26.3 2.2 24.7 25.3 20.3 27.9 15.6 18.9 15.5 7.0 38.5 13.1 21.1 19.4 19.1 24.6 24.0 32.5 40.5 25.5 15.1 23.0 MAP3K8 "c-COT, COT, EST, ESTF, MEKK8, Tpl-2" ENSG00000107968 "Mitogen-activated protein kinase kinase kinase 8" P41279 10 30433937-30461833 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 104.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 133.3;Urothelial cells: 168.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005120, HPA017962" Supported Supported Cytosol NA NA Cytosol "CAB005120: AB_2140669, HPA017962: AB_1853776" "unprognostic (1.91e-2)" "unprognostic (2.94e-1)" "unprognostic (3.07e-1)" "unprognostic (9.29e-2)" "unprognostic (6.73e-2)" "unprognostic (1.00e-2)" "unprognostic (1.44e-1)" "unprognostic (3.36e-2)" "unprognostic (1.41e-2)" "unprognostic (8.04e-3)" "unprognostic (8.23e-2)" "unprognostic (2.96e-1)" "prognostic unfavorable (8.76e-7)" "unprognostic (1.88e-1)" "unprognostic (1.49e-1)" "unprognostic (1.63e-2)" "unprognostic (5.98e-3)" 28.0 7.6 3.6 15.6 4.1 104.6 26.1 1.5 2.6 8.2 8.4 2.7 11.3 3.4 11.5 16.5 13.8 19.5 15.3 20.1 4.3 2.9 6.3 7.6 29.0 33.7 4.3 2.0 9.8 3.6 2.8 4.1 27.5 8.3 7.9 6.8 9.4 6.1 18.4 8.6 15.3 9.6 23.4 9.7 25.6 10.7 6.7 3.6 2.4 7.0 13.2 17.2 13.2 15.6 19.6 13.8 23.7 16.8 12.4 7.8 4.0 8.0 7.2 2.0 4.2 10.5 8.8 9.3 2.0 12.1 4.5 5.4 5.0 18.8 5.3 5.2 4.3 4.4 15.2 4.5 1.9 1.6 12.3 2.3 9.9 12.3 16.0 8.9 3.1 24.4 11.0 1.1 4.5 0.9 4.5 2.0 0.1 4.4 8.0 0.7 4.6 0.1 11.8 0.7 4.3 2.6 0.6 1.6 3.0 4.4 16.4 0.2 0.8 7.2 6.2 0.9 5.7 2.1 6.6 0.1 2.8 2.4 9.9 0.3 12.1 11.3 1.6 4.0 13.4 0.1 17.9 7.0 23.7 7.8 12.0 4.3 9.6 1.7 4.9 6.6 19.6 0.1 3.0 16.7 12.4 16.8 13.8 0.4 4.0 3.6 4.1 1.5 2.6 4.3 2.9 4.3 2.0 8.3 3.6 35.7 41.7 14.7 46.9 103.8 13.9 7.1 5.1 25.4 13.6 3.5 0.0 23.9 1.7 25.2 0.4 36.9 5.2 0.0 9.8 71.1 77.1 32.5 71.4 3.0 109.0 0.0 11.5 14.1 86.6 0.0 7.8 94.5 40.5 78.5 5.3 5.0 17.6 17.5 3.9 2.4 1.1 6.5 75.4 0.0 0.7 74.2 133.3 52.3 5.8 168.4 MAP4 ENSG00000047849 "Microtubule associated protein 4" P27816 3 47850690-48089272 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 131.5;skeletal muscle: 197.9" "Group enriched" "Detected in many" 6 "Bipolar cells: 398.9;Cardiomyocytes: 855.4;Cone photoreceptor cells: 589.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038149, HPA038150" Enhanced Enhanced "Plasma membrane,Microtubules,Cytosol" NA NA 120000 "Plasma membrane, Microtubules, Cytosol" "HPA038149: AB_10672471, HPA038150: AB_10672505" "unprognostic (2.51e-1)" "unprognostic (4.48e-1)" "unprognostic (2.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.36e-1)" "unprognostic (4.57e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.82e-2)" "unprognostic (1.46e-2)" "unprognostic (5.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.30e-2)" "unprognostic (2.25e-2)" "unprognostic (8.89e-2)" "unprognostic (6.45e-2)" "unprognostic (1.88e-1)" "unprognostic (1.21e-3)" 39.3 14.8 60.5 18.2 50.9 6.3 16.4 29.3 56.0 26.9 26.4 80.8 15.8 13.6 25.8 27.4 27.0 24.6 20.1 110.2 63.7 57.5 20.8 13.8 22.7 12.4 86.8 26.1 26.8 18.9 14.6 9.3 24.0 59.5 21.8 18.8 25.2 14.0 34.9 197.9 25.1 15.2 35.0 131.5 18.3 16.2 21.2 41.8 7.3 15.4 31.3 14.2 24.3 18.1 9.9 8.9 6.3 19.7 10.7 13.4 6.7 22.2 17.9 22.4 17.0 33.1 59.1 9.5 41.8 45.7 35.4 39.8 15.0 14.0 18.9 9.8 63.0 33.3 14.9 28.6 37.9 39.8 27.2 12.1 12.7 20.0 19.4 45.0 8.8 10.4 49.4 47.4 43.0 52.7 32.3 46.4 13.3 16.4 22.0 27.8 12.6 12.5 10.8 13.5 11.0 37.0 6.7 21.1 23.4 22.7 18.7 8.9 13.9 32.1 13.0 22.1 32.8 9.5 8.2 62.6 33.5 25.9 35.0 26.7 15.4 11.9 8.9 43.1 10.9 31.6 6.3 5.3 2.8 13.4 9.0 6.5 9.9 9.0 10.9 5.7 9.4 4.3 6.7 2.2 10.7 19.7 8.9 10.2 6.7 60.5 50.9 29.3 51.8 63.7 57.5 86.8 26.1 59.5 41.8 65.5 44.5 28.6 38.3 66.4 398.9 855.4 48.4 45.5 70.5 76.8 589.0 27.7 23.2 85.7 90.1 78.7 34.2 0.0 56.1 64.5 84.5 58.1 26.6 49.9 34.2 44.5 27.6 41.1 23.5 28.8 71.4 40.8 74.2 101.8 29.5 77.6 76.7 23.0 96.9 27.0 86.7 71.1 108.8 53.1 49.0 60.9 18.8 48.4 33.0 40.0 MAP4K5 "GCKR, KHS, KHS1" ENSG00000012983 "Mitogen-activated protein kinase kinase kinase kinase 5" 14 50418501-50561126 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 26.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 26.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036696, HPA078030" Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA036696: AB_10672362, HPA078030: " "unprognostic (1.39e-1)" "unprognostic (1.00e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-1)" "unprognostic (8.58e-3)" "unprognostic (4.13e-2)" "unprognostic (6.31e-2)" "unprognostic (2.24e-2)" "unprognostic (1.53e-3)" "unprognostic (7.34e-2)" "unprognostic (1.78e-2)" "unprognostic (3.71e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (2.02e-2)" 17.4 11.8 23.4 12.1 44.4 16.5 19.7 24.6 32.3 25.8 17.1 43.5 13.4 11.3 29.9 12.1 18.7 17.4 19.3 10.3 24.4 14.0 10.9 8.7 15.2 9.9 48.8 17.1 29.9 13.3 16.7 17.5 17.3 26.0 16.6 15.1 9.1 16.9 19.9 10.7 24.8 12.7 22.3 30.7 13.0 14.4 6.8 51.1 8.4 15.3 8.7 11.2 19.3 21.2 5.0 2.7 26.1 1.8 5.4 3.9 1.0 22.9 6.9 17.0 14.6 15.7 16.6 16.6 27.1 24.5 18.5 16.5 8.7 16.1 15.9 16.2 24.8 9.8 16.5 15.8 14.6 28.2 13.1 11.5 9.7 12.2 7.8 13.3 8.7 15.4 12.0 12.0 16.2 17.0 29.6 24.2 14.5 9.2 10.4 27.0 8.7 11.7 8.3 8.3 7.4 13.6 14.2 25.8 6.0 18.3 17.9 5.5 12.5 15.3 10.7 10.5 14.3 11.9 6.6 24.6 24.1 16.8 16.4 12.7 7.6 7.7 10.6 9.0 6.1 17.1 26.1 1.5 13.5 3.9 1.8 2.2 3.2 2.4 3.3 1.6 5.0 2.6 2.7 0.6 5.4 1.1 2.7 0.5 1.0 23.4 44.4 24.6 32.3 24.4 14.0 48.8 17.1 26.0 51.1 38.7 17.3 14.6 29.9 62.2 51.9 7.3 20.4 26.8 27.3 26.2 45.2 9.4 16.6 24.0 2.8 33.1 15.9 23.3 18.3 16.7 46.1 53.8 28.9 7.8 7.5 31.8 22.5 35.6 13.9 2.2 39.4 20.9 21.9 17.2 14.2 18.2 23.1 15.0 48.1 9.9 33.6 12.9 40.4 11.2 13.6 75.3 5.5 21.8 16.2 55.0 MAP6D1 "FLJ12748, SL21" ENSG00000180834 "MAP6 domain containing 1" Q9H9H5 3 183815876-183825594 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 48.1;skeletal muscle: 33.5" "Cell type enhanced" "Detected in some" 5 "Early spermatids: 2.4;Glandular cells: 2.6;Intestinal endocrine cells: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 5 "T-cells: 2.7" "Cell line enriched" "Detected in many" 5 "T-47d: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037991 Enhanced Supported Approved Cytosol NA NA Cytosol "HPA037991: AB_10672503" "unprognostic (9.23e-3)" "unprognostic (2.70e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-1)" "unprognostic (1.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (8.81e-12)" "unprognostic (1.08e-1)" "unprognostic (2.96e-3)" "unprognostic (1.86e-1)" "unprognostic (5.72e-2)" 1.1 1.2 11.8 1.5 16.0 1.1 2.0 30.9 32.1 1.5 1.4 48.1 0.0 1.9 1.4 2.0 1.1 1.5 1.3 1.9 18.8 9.2 1.2 1.3 1.4 1.7 24.7 8.7 1.7 6.0 1.8 0.5 1.3 18.4 2.7 1.4 0.0 1.6 2.0 33.5 4.6 1.5 1.4 37.7 1.5 1.2 1.3 20.4 2.2 1.1 0.0 1.4 1.1 0.2 0.5 0.3 0.2 0.2 0.0 2.7 0.3 1.9 1.4 2.2 0.4 0.5 0.7 1.7 2.4 0.4 4.6 3.1 1.8 0.1 0.2 3.1 3.6 2.3 1.4 4.5 1.2 3.1 1.3 6.8 0.2 0.0 0.0 1.3 2.4 0.8 0.3 0.3 1.1 0.4 0.6 0.9 3.6 0.3 0.0 0.6 8.4 5.9 3.4 2.0 1.1 3.9 2.9 3.4 0.0 0.2 0.0 7.2 1.3 1.8 1.3 2.5 1.6 39.9 2.4 0.4 1.1 1.6 1.6 3.5 1.5 0.9 1.1 0.3 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.5 2.7 0.3 0.0 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.3 11.8 16.0 30.9 19.9 18.8 9.2 24.7 8.7 18.4 20.4 0.0 0.0 0.0 0.5 1.0 2.2 1.3 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.4 0.5 2.6 0.0 0.0 0.8 1.6 2.4 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.4 1.7 1.3 0.6 0.0 0.3 0.6 MAP7 E-MAP-115 ENSG00000135525 "Microtubule associated protein 7" Q14244 6 136342281-136550819 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.4" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 301.8;Early spermatids: 212.6;Horizontal cells: 287.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 21.8;HeLa: 26.0;MCF7: 32.0;OE19: 20.1;RT4: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029712, HPA029713" Enhanced Supported Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA029712: AB_10600303, HPA029713: AB_10601339" "unprognostic (8.68e-3)" "prognostic unfavorable (9.70e-5)" "unprognostic (2.33e-3)" "unprognostic (4.35e-3)" "unprognostic (6.95e-2)" "unprognostic (3.35e-1)" "prognostic favorable (9.22e-4)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.72e-1)" "unprognostic (4.61e-2)" "unprognostic (3.33e-1)" "prognostic favorable (5.07e-7)" "unprognostic (1.62e-3)" "unprognostic (7.84e-2)" "unprognostic (3.62e-1)" "unprognostic (6.51e-2)" 2.2 6.8 24.1 3.6 41.3 3.4 10.4 36.9 29.3 5.2 18.5 49.8 6.0 21.8 2.1 15.7 11.9 7.9 6.5 1.5 30.7 18.3 25.3 13.3 5.5 1.3 47.6 16.5 1.5 19.0 18.9 13.8 5.3 26.2 15.8 18.0 6.6 14.0 8.2 1.1 13.0 19.7 2.1 55.4 1.5 14.4 17.1 52.7 0.4 12.6 4.3 3.9 6.3 6.0 1.6 5.9 13.0 2.8 0.7 0.6 0.7 9.2 14.4 0.1 0.0 0.1 0.1 15.3 0.2 0.4 0.1 0.2 21.8 9.8 0.0 2.0 0.3 2.5 14.1 4.1 12.8 0.2 0.0 9.1 9.6 26.0 0.1 0.1 9.3 1.1 0.0 11.9 0.0 0.9 0.3 0.1 0.7 6.5 0.2 0.0 32.0 0.1 0.9 1.9 20.1 2.1 0.0 0.3 1.7 8.9 25.1 9.2 1.9 10.1 19.4 0.2 3.6 7.7 0.9 0.2 0.0 0.7 0.1 0.6 1.7 2.2 0.0 0.2 3.7 0.2 3.0 2.6 0.0 0.0 1.7 0.3 1.6 0.6 0.0 5.9 1.2 0.1 0.0 13.0 0.7 2.8 0.0 0.2 0.7 24.1 41.3 36.9 29.3 30.7 18.3 47.6 16.5 26.2 52.7 53.6 37.7 2.9 34.7 25.0 301.8 2.2 22.9 77.6 53.4 17.4 137.4 27.7 26.6 30.3 212.6 2.8 55.1 0.0 42.3 19.5 2.8 61.3 0.0 30.9 12.9 287.6 112.9 1.3 3.2 27.4 6.4 5.9 16.9 1.8 75.1 52.0 32.2 46.0 3.2 70.8 107.3 19.4 5.2 36.1 19.0 26.6 63.7 2.1 55.9 54.6 MAP7D1 "FLJ10350, FLJ39022, PARCC1, RPRC1" ENSG00000116871 "MAP7 domain containing 1" Q3KQU3 1 36155579-36180849 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 144.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028075 Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA028075: AB_10603778" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (5.22e-2)" "unprognostic (9.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.49e-6)" "unprognostic (6.00e-3)" "unprognostic (2.05e-1)" "unprognostic (3.57e-2)" "unprognostic (1.88e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (8.56e-6)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (2.26e-1)" "unprognostic (9.32e-3)" 39.4 12.8 25.4 24.4 27.8 19.4 17.4 26.4 44.7 11.2 24.0 32.4 4.6 12.4 16.6 5.5 25.9 10.6 18.4 51.7 25.1 22.5 7.4 4.9 21.3 14.7 31.2 24.1 10.2 10.0 8.3 12.2 15.4 30.8 18.4 7.1 10.2 11.0 19.5 144.7 20.9 10.9 21.1 40.7 17.8 14.2 6.7 22.8 14.9 10.5 18.6 11.5 22.8 12.4 0.4 0.8 4.7 1.4 0.4 1.9 0.2 29.2 17.2 27.1 17.1 16.6 12.6 20.0 29.4 29.9 31.0 27.4 9.6 30.2 12.3 25.3 26.6 17.0 32.2 11.1 39.9 10.2 20.9 9.9 8.3 12.9 3.6 26.2 12.3 21.5 22.0 11.4 41.8 26.0 24.1 21.1 17.3 8.0 19.0 17.1 5.9 22.6 10.4 24.7 4.1 9.7 23.5 20.0 11.6 15.7 10.1 10.5 20.2 16.9 9.4 22.8 15.3 6.2 8.7 39.6 36.6 27.9 30.9 39.7 18.9 5.6 14.3 31.4 8.4 21.9 0.5 1.4 1.4 1.1 0.7 1.5 0.1 1.0 0.8 0.6 0.4 1.9 0.6 4.7 0.4 0.5 0.8 0.3 0.2 25.4 27.8 26.4 43.8 25.1 22.5 31.2 24.1 30.8 22.8 41.7 15.6 16.1 127.0 127.2 31.7 140.8 17.8 0.0 13.6 22.7 9.8 41.0 14.9 35.7 29.9 48.9 40.4 0.0 23.7 93.6 61.5 85.8 12.7 8.6 62.7 46.1 9.7 27.0 38.3 58.1 28.4 52.1 30.4 27.9 12.4 29.4 46.9 17.5 44.9 9.2 38.5 19.4 64.5 7.6 15.3 124.0 108.9 52.3 17.2 165.9 MAP7D2 FLJ14503 ENSG00000184368 "MAP7 domain containing 2" Q96T17 X 20006713-20116917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;epididymis: 38.7" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 80.1;Spermatocytes: 34.1;Spermatogonia: 117.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "basophil: 5.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 8.8;CACO-2: 12.7;HEK 293: 17.4;HeLa: 15.1;Hep G2: 7.5;SCLC-21H: 20.0;SiHa: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051508, HPA059537" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051508: AB_2681513, HPA059537: AB_2684054" "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (3.76e-1)" "unprognostic (1.45e-5)" "unprognostic (5.65e-2)" "unprognostic (9.77e-3)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (7.77e-3)" "unprognostic (3.58e-4)" "unprognostic (2.21e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (9.12e-3)" "unprognostic (3.60e-2)" "unprognostic (2.54e-3)" "unprognostic (3.19e-1)" 0.7 3.6 11.1 0.9 18.5 1.3 1.0 12.9 30.8 0.7 1.3 0.8 0.7 1.3 1.2 38.7 0.9 3.0 1.1 0.9 16.5 10.3 4.1 0.7 0.9 0.8 10.4 15.0 0.8 1.7 0.7 3.0 8.1 24.2 1.5 1.5 0.8 0.8 2.8 1.0 1.5 1.8 1.0 7.1 0.7 8.9 9.7 2.1 0.0 0.6 0.0 0.9 0.7 0.5 0.0 0.8 5.5 0.1 0.0 0.3 0.0 0.0 8.8 0.8 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.1 12.7 0.3 1.5 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 17.4 0.0 15.1 7.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.6 0.0 0.2 0.0 0.0 1.0 0.0 20.0 3.4 8.5 3.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 1.0 0.0 0.9 5.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 11.1 18.5 12.9 21.7 16.5 10.3 10.4 15.0 24.2 2.1 3.0 0.0 0.0 0.4 1.5 29.4 1.1 0.0 9.4 1.2 0.0 2.0 80.1 3.3 1.1 10.2 0.5 2.0 0.0 0.7 5.5 1.0 0.6 0.0 0.0 5.1 17.5 9.2 0.0 0.0 16.3 0.6 0.7 0.0 0.0 0.3 1.9 0.6 3.2 1.8 13.3 7.3 0.0 0.1 34.1 117.0 1.4 25.6 0.0 1.4 0.4 MAPK12 "ERK6, p38gamma, PRKM12, SAPK-3, SAPK3" ENSG00000188130 "Mitogen-activated protein kinase 12" P53778 22 50245450-50261825 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "skeletal muscle: 104.2" "Cell type enhanced" "Detected in many" 8 "Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "NK-cell: 3.0" "Lineage enriched" "Detected in single" 31 "NK-cells: 3.0" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 35.4" "Low region specificity" "Detected in all" "CAB025483, HPA054562" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB025483: , HPA054562: AB_2682524" "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (4.53e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (6.35e-3)" "unprognostic (3.90e-3)" "unprognostic (3.16e-2)" "unprognostic (6.02e-2)" "unprognostic (5.70e-2)" "unprognostic (3.48e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.00e-6)" "unprognostic (2.57e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-2)" "unprognostic (4.28e-3)" 3.0 1.6 4.5 2.1 4.5 1.0 1.8 9.0 7.0 2.1 1.4 2.1 1.6 2.0 5.4 5.1 3.3 2.9 2.4 5.1 3.9 3.6 2.5 1.0 2.1 2.0 3.5 5.7 3.0 1.4 1.2 7.0 2.3 2.6 2.9 1.1 2.2 1.4 3.7 104.2 0.9 1.5 4.2 2.6 1.6 1.5 1.6 2.4 0.0 1.3 10.8 1.1 2.4 1.9 0.0 0.0 0.0 0.0 3.0 0.0 0.0 10.4 6.4 2.5 7.5 5.7 6.3 3.5 8.0 6.9 13.4 8.5 9.3 3.3 19.6 10.9 8.8 8.0 7.0 11.1 1.6 2.6 5.6 15.6 12.8 19.5 11.5 18.1 12.0 25.4 13.5 2.9 3.0 0.0 7.3 15.2 1.8 11.3 18.2 6.2 5.7 0.0 16.0 7.5 3.5 10.5 18.3 6.7 19.9 7.9 1.4 8.6 2.9 6.2 0.2 9.9 1.9 3.4 14.0 7.9 13.9 12.5 3.0 5.0 4.2 3.2 10.5 3.5 11.3 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 4.5 4.5 9.0 7.0 3.9 3.6 3.5 5.7 2.6 2.4 0.0 5.6 1.3 0.4 0.7 5.1 7.8 2.5 1.4 0.0 0.0 0.0 0.3 1.7 0.4 0.3 9.5 0.0 0.0 0.0 1.8 2.8 3.0 10.4 1.0 4.9 1.6 1.7 22.1 2.8 1.3 6.1 0.8 0.0 1.0 0.0 5.1 0.6 0.0 3.5 6.5 1.7 6.5 2.4 0.2 9.7 0.5 0.3 1.0 0.2 0.0 MAPK13 "p38delta, PRKM13, SAPK4" ENSG00000156711 "Mitogen-activated protein kinase 13" O15264 6 36127809-36144524 "Enzymes, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 143.1;Late spermatids: 214.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 16.5;T-cells: 27.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 46.2;RPMI-8226: 27.9;RT4: 28.9" "Region enhanced" "Detected in some" "cerebellum: 6.5" "Region enriched" "Detected in some" 15 "cerebellum: 59.9" "HPA007667, CAB025854" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol" "CAB025854: , HPA007667: AB_1079867" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" "unprognostic (2.93e-1)" "unprognostic (6.64e-3)" "unprognostic (1.13e-2)" "unprognostic (4.80e-2)" "unprognostic (4.30e-3)" "unprognostic (5.28e-2)" "unprognostic (1.77e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-1)" "unprognostic (7.21e-2)" "prognostic favorable (9.00e-4)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.41e-1)" 6.5 22.0 2.2 5.4 4.0 2.9 6.8 2.8 7.3 6.8 18.9 0.5 36.8 18.8 1.9 10.3 41.1 2.4 12.0 1.2 1.7 1.8 6.5 2.8 9.6 11.2 0.8 3.8 3.9 24.6 18.8 12.4 10.5 2.5 6.8 16.0 2.4 20.7 26.3 0.9 28.6 37.7 2.1 0.8 5.9 12.2 23.7 1.1 5.0 13.8 16.0 18.5 7.3 13.9 16.5 0.1 5.2 0.3 2.8 27.8 6.7 19.6 0.1 0.3 0.2 1.2 5.7 2.7 1.6 0.2 0.2 0.5 16.3 19.4 4.7 1.2 1.5 2.8 15.2 0.0 46.2 0.4 12.0 5.2 0.1 0.5 16.2 2.0 0.1 1.2 4.9 16.4 3.0 0.6 2.3 3.0 0.5 0.3 5.3 0.5 10.3 0.1 1.2 0.1 19.4 0.3 11.6 0.2 27.9 9.0 28.9 19.6 0.3 1.7 0.3 0.1 0.6 22.0 2.5 4.1 1.4 0.2 0.5 0.3 0.3 7.0 1.4 0.0 0.5 0.1 5.2 0.3 4.5 16.2 0.0 10.5 10.8 11.6 13.0 0.1 16.5 10.6 11.9 3.9 2.8 0.0 0.0 27.8 6.7 2.2 4.0 2.8 7.3 1.7 1.8 0.8 3.8 2.5 1.1 26.8 24.1 11.5 34.8 24.3 0.8 1.6 22.9 1.4 22.7 27.9 5.9 41.4 13.3 48.4 89.5 2.3 143.1 0.0 102.6 8.3 3.2 28.0 2.3 1.6 35.8 0.0 63.0 0.6 6.1 214.3 6.6 6.4 16.9 22.6 80.8 1.5 76.0 89.2 9.2 7.9 2.2 0.0 1.0 6.1 1.5 46.5 27.0 20.2 93.7 47.8 MAPK14 "CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15" ENSG00000112062 "Mitogen-activated protein kinase 14" Q16539 6 36027677-36111236 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 32.1;neutrophil: 12.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 32.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010285, CAB040578, HPA051825" Approved Supported "Nuclear speckles,Cytosol" NA NA 7100000 "Nuclear speckles" Cytosol "CAB010285: AB_632140, CAB040578: , HPA051825: " "unprognostic (6.76e-3)" "unprognostic (6.28e-2)" "unprognostic (6.30e-3)" "unprognostic (3.30e-3)" "unprognostic (6.98e-2)" "unprognostic (4.04e-2)" "unprognostic (8.10e-2)" "unprognostic (1.93e-1)" "unprognostic (2.20e-3)" "unprognostic (8.39e-2)" "unprognostic (6.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.47e-2)" "unprognostic (3.66e-3)" "unprognostic (6.66e-2)" "unprognostic (3.25e-1)" "unprognostic (1.58e-1)" 21.5 20.6 11.7 18.4 15.5 49.9 20.7 26.5 18.1 22.0 20.5 12.5 11.9 16.9 38.8 12.1 24.0 18.9 16.0 16.4 9.3 9.5 16.0 29.8 21.5 29.0 12.0 11.3 17.7 18.5 15.0 27.2 27.3 10.2 23.4 18.3 17.0 16.7 16.5 21.2 25.6 22.5 26.0 10.6 35.5 18.2 11.1 10.3 34.1 20.9 17.6 20.8 25.0 30.0 2.3 4.0 32.1 4.9 3.0 2.8 2.1 18.5 10.2 11.0 17.7 25.1 25.0 24.2 19.4 25.3 23.0 24.0 24.9 9.6 15.0 19.3 21.3 11.0 13.3 18.1 16.8 24.1 16.9 14.5 34.7 14.5 20.8 13.8 21.9 21.0 17.6 16.4 16.6 16.5 19.2 26.1 26.0 19.2 18.9 15.7 8.8 22.4 26.3 6.7 11.4 10.2 26.7 17.9 13.9 16.2 25.6 8.3 7.0 17.5 13.1 20.3 14.1 15.4 40.9 18.3 20.7 12.0 13.0 17.7 9.3 21.2 15.1 9.4 43.2 16.9 32.1 4.9 3.0 2.4 3.5 2.8 1.5 2.2 2.6 4.0 2.3 2.5 2.4 12.3 3.0 4.7 1.9 2.6 2.1 11.7 15.5 26.5 18.1 9.3 9.5 12.0 11.3 10.2 10.3 29.8 11.5 18.2 10.6 14.2 19.3 23.5 7.6 16.0 19.4 17.4 29.5 38.2 1.7 12.1 2.6 20.2 25.7 0.0 9.9 14.8 20.9 9.0 20.7 39.4 22.3 11.1 16.1 21.5 58.1 3.7 22.7 30.0 10.1 19.8 22.5 12.2 17.6 20.3 25.1 14.0 24.3 12.9 11.5 6.3 7.7 16.7 20.0 23.5 15.6 8.8 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716259-143722458 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;epididymis: 27.6;fallopian tube: 29.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 85.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 0.6 0.1 3.6 0.3 8.1 0.1 1.1 0.2 2.1 4.5 0.4 8.7 5.2 0.5 2.2 27.6 1.3 29.5 0.4 1.1 5.4 4.6 3.9 0.2 7.4 0.5 0.2 1.5 4.7 2.0 9.1 4.2 0.6 26.9 0.9 0.4 1.6 3.0 2.4 0.2 4.9 0.7 0.5 0.4 0.5 0.9 7.3 2.4 0.1 8.4 0.5 0.4 0.5 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.7 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 7.2 0.0 1.3 0.0 0.0 5.4 0.1 0.2 0.0 1.1 1.6 0.0 14.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.3 2.7 0.0 0.0 13.9 0.0 0.0 2.0 1.2 1.1 0.0 3.0 0.4 0.9 1.3 4.0 4.0 0.0 2.8 0.0 0.2 12.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.1 0.2 2.1 5.4 4.6 0.2 1.5 26.9 2.4 0.0 8.3 0.0 0.2 0.3 0.0 0.8 0.0 85.6 13.6 0.0 0.0 0.0 0.0 0.6 12.6 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.7 0.3 0.1 0.0 0.1 0.0 MAPK1IP1L C14orf32 ENSG00000168175 "Mitogen-activated protein kinase 1 interacting protein 1 like" Q8NDC0 14 55051631-55070192 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034506 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034506: AB_10669784" "unprognostic (3.27e-2)" "unprognostic (1.30e-1)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (1.28e-1)" "unprognostic (6.86e-3)" "unprognostic (8.17e-3)" "unprognostic (3.32e-1)" "unprognostic (2.91e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "prognostic favorable (4.82e-5)" "unprognostic (7.96e-2)" "unprognostic (1.71e-1)" "unprognostic (2.45e-1)" "unprognostic (5.40e-2)" 37.7 27.1 22.9 23.9 23.7 65.9 27.9 25.7 29.3 26.3 24.7 24.2 20.0 17.3 32.1 28.6 28.6 31.5 24.9 32.6 20.1 25.8 41.9 32.6 27.6 33.6 21.3 18.0 41.1 21.2 25.7 32.8 36.4 22.8 23.9 23.6 28.5 33.8 30.6 38.5 26.7 29.5 32.8 19.9 33.3 26.7 30.8 17.4 37.7 25.9 26.6 39.1 32.9 24.2 27.5 30.8 28.8 30.4 21.4 30.7 19.6 19.6 17.4 30.7 19.5 24.9 24.6 23.9 22.1 23.6 27.6 32.1 13.9 17.5 22.8 18.9 29.5 16.6 21.8 33.0 33.6 38.8 20.6 21.1 22.0 17.0 20.9 27.3 26.8 24.3 31.7 25.3 23.0 36.7 20.2 36.5 14.7 20.3 20.4 39.8 23.7 22.5 20.8 22.3 18.7 29.4 19.4 33.9 13.7 37.8 22.2 20.1 23.3 21.4 15.4 20.0 28.8 27.4 15.6 27.5 28.4 37.3 17.5 19.7 12.6 18.1 30.2 22.7 14.1 20.3 28.8 22.2 25.7 21.4 30.4 28.2 27.5 25.5 23.1 23.9 23.6 23.8 23.4 16.5 21.4 28.1 30.8 30.7 19.6 22.9 23.7 25.7 29.3 20.1 25.8 21.3 18.0 22.8 17.4 65.5 67.1 61.8 149.4 63.8 21.0 62.4 25.5 29.4 52.4 45.4 35.3 104.9 59.7 58.1 17.0 57.5 43.4 46.7 60.7 94.2 53.6 91.3 81.9 48.3 65.8 36.5 55.6 41.7 57.7 6.7 47.5 53.4 47.2 65.9 50.1 56.2 70.4 41.2 50.9 82.4 22.3 32.3 53.6 84.9 56.9 62.6 126.5 57.4 37.9 127.6 MAPK6 "ERK3, HsT17250, p97MAPK, PRKM6" ENSG00000069956 "Mitogen-activated protein kinase 6" Q16659 15 51952106-52067372 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005184, HPA030262, HPA047825" Approved Supported Supported Cytosol NA NA Cytosol "CAB005184: AB_2140298, HPA030262: AB_10601868, HPA047825: " "unprognostic (6.61e-2)" "unprognostic (1.75e-2)" "unprognostic (5.05e-2)" "unprognostic (3.40e-3)" "unprognostic (2.72e-1)" "unprognostic (5.52e-2)" "unprognostic (6.13e-2)" "unprognostic (2.32e-3)" "unprognostic (3.99e-2)" "unprognostic (8.54e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-2)" "unprognostic (3.27e-3)" "unprognostic (2.03e-1)" "unprognostic (1.72e-1)" "unprognostic (3.07e-2)" "unprognostic (2.31e-2)" 11.8 7.4 14.4 10.9 23.2 25.6 13.7 33.0 24.5 16.3 18.7 12.5 9.3 16.3 15.9 13.3 32.3 8.2 17.0 9.1 13.3 15.9 14.4 32.6 12.6 9.4 13.1 16.8 11.5 8.5 12.2 15.3 13.9 23.8 10.5 18.1 9.5 17.9 11.4 27.1 24.0 26.2 17.8 14.2 9.2 15.7 25.7 13.0 11.7 13.4 22.7 12.4 18.9 22.4 4.9 4.2 3.0 4.5 6.5 7.9 3.6 8.7 11.8 23.3 8.9 7.2 11.9 17.1 12.6 12.7 11.6 13.7 14.1 5.3 12.6 8.8 16.1 17.0 12.4 17.9 23.9 15.9 7.7 5.6 18.8 7.0 22.4 17.5 14.0 40.2 12.7 44.0 14.0 36.5 12.4 10.9 8.7 24.3 21.6 14.8 19.8 9.8 11.1 8.3 10.9 5.7 8.6 15.0 20.3 11.1 36.9 11.5 10.8 10.1 8.3 18.3 33.7 7.5 20.9 10.8 13.9 15.0 9.0 16.7 11.2 32.9 15.7 17.2 20.6 17.0 3.0 4.5 1.2 3.8 4.3 4.7 4.9 5.6 4.3 4.2 2.6 5.4 3.8 0.6 6.5 2.8 1.9 7.9 3.6 14.4 23.2 33.0 24.3 13.3 15.9 13.1 16.8 23.8 13.0 26.8 29.8 23.8 84.4 99.5 34.6 20.2 22.9 24.1 29.6 15.7 15.7 14.3 14.9 31.8 133.3 22.8 95.4 0.0 43.1 33.7 40.4 80.6 139.2 47.8 25.7 31.8 29.7 16.5 30.7 167.7 21.0 26.7 28.7 11.8 32.2 25.1 52.1 31.6 22.3 30.5 21.1 19.4 21.7 56.4 75.8 96.7 27.7 17.0 19.8 153.6 MAPK7 "BMK1, ERK5, PRKM7" ENSG00000166484 "Mitogen-activated protein kinase 7" Q13164 17 19377721-19383544 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 25.8;Spermatocytes: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 24.1;SuSa: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018561, HPA031031" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB018561: AB_2140544, HPA031031: AB_2673706" "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.72e-1)" "unprognostic (2.90e-2)" "unprognostic (4.38e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (5.67e-3)" "unprognostic (1.62e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-2)" "unprognostic (4.75e-2)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (5.71e-1)" "unprognostic (1.55e-1)" "unprognostic (3.78e-2)" 11.5 15.0 6.4 7.3 7.6 9.2 11.8 12.5 7.9 13.4 15.3 7.2 6.0 9.2 13.1 14.1 17.3 9.4 11.8 8.2 5.9 4.7 10.8 4.8 9.9 9.2 8.2 5.2 25.4 5.7 7.3 7.5 12.5 6.7 14.0 6.9 10.5 7.8 12.3 7.5 13.1 11.2 13.8 7.1 13.2 8.0 13.3 7.5 4.5 8.6 11.3 10.6 12.7 15.9 2.2 2.6 11.5 7.4 5.5 4.7 3.0 3.6 5.8 4.8 3.7 24.1 10.1 5.6 5.0 4.6 6.9 6.4 6.7 0.6 2.2 4.0 8.6 5.1 4.1 5.6 4.6 4.3 3.8 4.3 1.0 4.1 2.9 10.4 0.9 3.7 10.6 3.2 10.5 3.7 6.0 5.1 4.3 1.9 0.8 6.9 2.4 7.4 3.9 5.5 3.7 3.8 4.0 7.0 1.5 2.3 2.0 2.2 6.4 5.1 0.5 2.5 29.6 3.1 1.2 2.8 7.4 5.5 8.2 3.4 1.4 2.1 0.6 8.6 0.9 4.5 1.0 3.6 11.5 4.7 7.4 2.5 2.2 2.2 4.1 2.6 1.4 2.1 2.6 1.3 5.5 6.5 1.7 1.0 3.0 6.4 7.6 12.5 7.9 5.9 4.7 8.2 5.2 6.7 7.5 6.0 3.5 6.2 5.5 4.8 2.0 1.7 0.0 1.4 2.3 5.2 2.0 4.8 5.0 7.1 6.3 7.1 9.0 0.0 5.3 6.9 8.3 5.5 2.3 1.3 6.7 0.0 10.3 6.7 6.7 5.9 10.6 6.3 3.3 2.8 5.7 14.5 6.2 13.5 11.0 3.0 2.0 25.8 8.6 31.4 10.6 3.8 4.2 4.4 6.1 5.2 MAPKAP1 "MGC2745, MIP1, SIN1" ENSG00000119487 "Mitogen-activated protein kinase associated protein 1" Q9BPZ7 9 125437393-125707234 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029091, HPA029092" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029091: AB_10599732, HPA029092: AB_10601568" "unprognostic (6.65e-2)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (5.11e-2)" "unprognostic (2.57e-2)" "unprognostic (1.68e-1)" "unprognostic (8.94e-2)" "unprognostic (2.59e-1)" "unprognostic (8.08e-2)" "prognostic favorable (7.23e-6)" "unprognostic (1.66e-1)" "unprognostic (2.04e-1)" "unprognostic (2.98e-1)" "unprognostic (4.27e-2)" 27.2 33.9 35.0 24.4 41.4 20.4 22.6 20.3 30.4 27.0 30.1 21.0 20.6 20.1 26.4 25.6 30.3 20.5 21.3 44.9 29.5 24.9 37.5 37.5 20.1 21.3 28.3 20.4 29.1 24.8 29.8 24.1 31.3 27.1 21.7 26.7 22.8 29.7 26.2 60.7 18.2 23.3 33.2 28.5 27.0 25.1 24.9 22.1 24.1 32.7 23.2 24.7 27.2 25.7 7.6 7.1 18.8 6.1 5.4 7.5 2.5 23.7 27.0 18.2 19.3 25.2 24.1 30.4 30.1 30.9 23.4 16.5 27.3 26.8 24.4 18.5 42.0 25.7 33.2 28.2 35.4 31.9 27.6 11.5 17.5 32.6 25.8 28.4 31.3 20.5 23.6 32.7 33.4 35.1 26.2 34.5 24.1 27.8 19.3 49.6 49.6 23.1 12.6 29.0 56.1 33.9 19.6 43.2 32.4 25.7 17.3 22.2 21.8 30.2 28.5 18.9 25.9 33.0 18.4 22.2 33.3 22.0 39.9 50.0 24.2 59.4 24.9 47.5 14.5 35.9 3.6 6.1 5.3 4.6 5.8 6.2 7.5 5.0 5.0 4.8 7.6 4.4 7.5 18.8 5.4 5.2 7.1 5.4 2.5 35.0 41.4 20.3 30.4 29.5 24.9 28.3 20.4 27.1 22.1 11.9 14.2 27.4 23.3 14.1 24.1 59.7 30.6 14.7 36.4 14.0 39.3 28.8 46.4 43.0 56.5 22.7 24.3 23.3 57.0 40.4 18.6 34.5 17.3 28.8 47.0 30.2 9.2 14.1 24.3 91.3 17.5 38.5 21.9 66.7 20.1 28.1 47.7 20.1 16.6 60.6 25.2 6.5 23.4 54.5 81.3 16.9 42.6 24.5 23.4 26.9 MAPKAPK5 PRAK ENSG00000089022 "Mitogen-activated protein kinase-activated protein kinase 5" Q8IW41 12 111841978-111902238 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004546, HPA015515" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004546: AB_627910, HPA015515: AB_1853569" "unprognostic (6.45e-2)" "unprognostic (7.29e-2)" "unprognostic (1.27e-3)" "unprognostic (1.09e-2)" "unprognostic (5.52e-2)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.98e-8)" "unprognostic (1.88e-1)" "unprognostic (3.09e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (3.20e-1)" "unprognostic (6.03e-2)" "unprognostic (3.39e-2)" "unprognostic (9.41e-2)" "unprognostic (3.25e-2)" 20.7 26.2 21.4 17.5 26.4 24.1 21.7 23.7 28.3 17.3 28.8 26.1 21.9 26.3 25.8 22.8 20.8 17.5 22.7 20.7 17.7 15.2 21.7 21.5 18.9 19.4 22.3 20.4 21.3 24.5 19.8 20.4 21.0 17.3 18.7 32.9 23.6 23.3 20.5 33.2 23.0 28.4 21.1 18.0 18.4 19.8 16.7 22.0 19.3 20.5 15.1 19.3 19.9 16.5 4.9 4.1 3.2 11.4 3.9 6.8 2.5 14.9 19.8 19.2 16.1 13.9 14.1 29.3 15.0 18.1 23.0 16.0 25.6 12.3 22.6 11.1 17.6 13.7 14.9 25.2 15.7 21.6 15.0 13.8 20.1 13.8 20.5 16.8 25.2 14.2 14.8 22.6 22.0 26.2 17.5 16.9 20.6 27.7 8.9 16.8 16.8 25.0 39.9 27.3 36.8 14.0 24.8 14.0 21.7 18.3 21.7 23.7 20.1 17.0 29.0 20.8 18.3 23.5 28.9 14.7 13.1 13.2 13.4 18.7 18.3 22.4 26.7 15.9 18.4 18.5 1.3 4.8 3.2 6.5 3.5 3.5 4.9 4.3 4.7 3.3 4.0 6.8 5.1 2.5 3.9 11.4 4.1 6.6 2.5 21.4 26.4 23.7 28.3 17.7 15.2 22.3 20.4 17.3 22.0 3.0 17.2 13.8 19.4 18.2 45.9 15.7 22.9 9.4 15.9 3.5 39.3 26.2 11.6 25.6 11.1 15.5 36.7 0.0 25.7 28.0 17.4 20.5 2.3 11.1 17.5 22.3 35.2 16.5 15.8 5.6 14.4 16.6 8.5 24.4 39.9 19.2 27.7 28.8 16.6 16.8 34.7 19.4 17.9 18.0 36.8 18.6 25.2 22.3 30.8 24.3 MAPRE1 EB1 ENSG00000101367 "Microtubule associated protein RP/EB family member 1" Q15691 20 32819893-32850405 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003600, CAB009337, CAB019391" Supported Enhanced "Centriolar satellite,Cytosol" NA NA 17000000 "Centriolar satellite, Cytosol" "CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309" "unprognostic (3.74e-1)" "unprognostic (1.89e-1)" "unprognostic (2.68e-1)" "unprognostic (4.48e-3)" "unprognostic (2.98e-3)" "unprognostic (1.10e-2)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.25e-2)" "unprognostic (1.17e-1)" "unprognostic (7.24e-2)" "unprognostic (5.99e-2)" "unprognostic (6.05e-2)" "unprognostic (3.76e-2)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (5.42e-2)" "unprognostic (4.59e-3)" 35.4 23.4 30.9 30.9 28.7 77.5 27.2 12.3 25.3 26.1 39.3 34.0 25.9 18.3 40.0 29.8 30.0 28.4 27.4 31.7 26.9 25.0 33.6 14.2 30.3 31.9 36.6 17.5 29.5 22.1 19.7 20.0 35.2 27.9 29.1 28.1 24.7 22.0 35.3 20.4 19.3 25.8 42.5 37.1 38.5 29.1 31.7 24.1 48.4 35.2 26.1 31.0 39.1 30.0 19.7 25.7 66.8 41.4 27.3 30.3 42.1 31.0 28.6 32.0 18.3 17.3 15.8 45.6 30.5 19.0 47.5 35.1 82.5 28.9 47.4 30.6 27.3 48.5 28.5 38.1 34.0 52.1 16.0 14.9 91.3 19.9 44.0 18.4 32.8 40.6 17.0 17.1 38.8 26.0 16.3 29.5 27.0 41.0 27.1 41.7 19.2 44.9 28.7 23.0 31.9 26.5 30.3 56.8 25.4 25.9 21.5 20.0 21.0 54.6 24.2 31.3 30.6 35.0 24.5 26.1 53.6 28.9 26.7 39.2 23.9 32.9 51.0 28.4 75.2 29.7 55.1 33.6 66.8 28.1 39.3 29.1 19.7 26.9 25.9 25.7 18.9 27.3 30.3 36.8 27.3 41.4 23.6 27.0 42.1 30.9 28.7 12.3 25.3 26.9 25.0 36.6 17.5 27.9 24.1 17.9 34.2 60.4 129.6 117.9 10.3 33.9 28.1 30.8 33.0 52.4 7.9 94.3 71.3 67.9 73.1 54.9 44.5 23.3 67.9 106.9 60.2 92.7 113.1 12.3 96.7 9.5 68.5 33.7 89.3 54.6 33.1 84.1 67.4 151.5 35.2 27.8 62.8 37.1 60.5 57.4 11.1 64.7 114.0 59.6 50.9 96.9 141.5 79.8 37.3 118.6 MARCH10 "FLJ35757, MARCH-X, RNF190" ENSG00000173838 "Membrane associated ring-CH-type finger 10" Q8NA82 17 62701314-62808344 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 80.2" "Group enriched" "Detected in some" 7 "Early spermatids: 371.3;Late spermatids: 1043.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 3.4" "Lineage enriched" "Detected in single" 5 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "BEWO: 3.9;EFO-21: 7.3;HSkMC: 3.2;SCLC-21H: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA023322 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023322: AB_1856351" "unprognostic (2.79e-2)" "unprognostic (2.32e-1)" "unprognostic (9.60e-3)" "unprognostic (6.95e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-2)" "unprognostic (1.67e-1)" "unprognostic (1.39e-1)" "unprognostic (7.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (9.37e-3)" "unprognostic (2.66e-1)" 0.2 0.1 0.7 0.2 1.6 0.0 0.1 0.1 0.3 0.5 0.1 1.9 0.6 0.0 0.3 4.8 0.1 7.9 0.1 0.1 1.0 1.0 0.6 0.1 1.4 0.1 0.2 0.5 1.0 0.1 0.3 4.5 0.1 1.8 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 80.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.6 3.4 0.3 0.1 0.0 0.2 0.0 0.0 0.2 3.9 1.7 0.2 1.2 0.3 0.0 0.1 0.0 7.3 0.5 0.1 0.0 0.0 0.4 1.4 0.0 0.0 1.3 0.7 0.0 1.5 0.0 0.0 3.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.5 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.2 1.1 0.0 12.7 0.0 0.0 0.7 0.1 0.5 0.2 0.0 0.0 0.0 0.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 3.4 0.0 1.5 0.0 0.7 0.3 0.7 0.1 0.6 1.8 0.0 0.6 0.0 0.0 0.7 0.3 0.7 1.6 0.1 0.3 1.0 1.0 0.2 0.5 1.8 0.3 3.0 1.0 0.0 0.0 0.1 0.0 0.3 0.0 105.7 15.9 3.5 0.0 0.1 44.7 0.0 371.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 1043.9 4.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.5 0.0 42.4 10.6 0.0 0.1 0.5 0.0 0.0 MARCH2 "HSPC240, MARCH-II, RNF172" ENSG00000099785 "Membrane associated ring-CH-type finger 2" Q9P0N8 19 8413270-8439017 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014063 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" Cytosol "HPA014063: AB_1853576" "unprognostic (1.15e-2)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.48e-4)" "prognostic favorable (1.05e-5)" "unprognostic (3.00e-1)" "prognostic favorable (8.29e-4)" "unprognostic (3.43e-2)" "unprognostic (6.95e-2)" "unprognostic (3.06e-3)" "unprognostic (2.32e-1)" "prognostic favorable (6.21e-4)" "unprognostic (2.01e-1)" "unprognostic (3.52e-1)" "unprognostic (1.01e-1)" "unprognostic (3.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.80e-2)" 37.7 12.4 30.7 13.5 28.3 17.5 23.9 8.6 39.1 9.8 29.8 20.7 9.7 11.2 12.5 39.0 19.3 10.0 11.4 38.9 23.5 21.9 11.0 17.9 18.2 15.0 30.8 19.8 8.2 10.0 10.5 11.3 13.9 20.2 16.0 10.3 12.7 13.4 21.8 46.9 12.7 11.7 28.5 27.8 18.9 13.3 8.6 13.3 8.4 21.3 14.1 10.0 20.4 9.7 3.6 26.5 20.4 14.6 3.7 7.3 10.1 5.6 7.2 3.2 15.1 19.9 6.5 5.5 6.1 7.5 4.9 5.1 3.5 2.6 2.2 18.0 13.1 6.5 4.0 4.2 8.6 3.8 11.1 9.9 17.0 3.3 7.8 10.8 2.5 25.7 7.8 9.9 4.7 4.2 7.1 19.2 9.0 2.4 12.5 3.8 10.7 3.4 8.1 6.8 6.8 17.4 5.4 1.0 5.6 11.3 6.7 1.6 9.1 0.4 6.6 11.5 11.6 5.0 5.4 19.3 6.9 4.2 22.8 5.1 11.2 13.3 2.5 11.2 5.1 5.2 20.4 10.0 15.4 5.7 14.6 5.9 3.6 5.9 4.6 6.7 3.5 4.0 5.4 12.5 3.7 12.8 26.5 7.3 10.1 30.7 28.3 8.6 39.1 23.5 21.9 30.8 19.8 20.2 13.3 3.0 10.9 4.5 0.0 6.6 10.7 38.1 7.6 2.7 3.4 19.2 2.0 6.6 33.2 0.0 8.1 27.0 13.6 23.3 0.0 9.3 10.5 0.0 12.7 24.6 57.4 22.3 11.6 47.9 48.6 36.4 8.6 19.4 23.6 0.0 5.5 17.5 0.0 7.4 11.0 43.4 7.7 12.9 20.6 5.4 8.5 11.3 4.8 18.1 4.6 0.0 MARCH7 "AXOT, MARCH-VII, RNF177" ENSG00000136536 "Membrane associated ring-CH-type finger 7" Q9H992 2 159712457-159771027 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 208.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014275, HPA022152" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014275: AB_10599820, HPA022152: AB_10601107" "unprognostic (2.42e-1)" "unprognostic (2.24e-1)" "unprognostic (1.02e-2)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.41e-4)" "unprognostic (2.46e-2)" "unprognostic (6.42e-2)" "unprognostic (3.44e-1)" "unprognostic (3.17e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.84e-4)" "unprognostic (1.41e-3)" "unprognostic (1.38e-1)" "unprognostic (2.57e-1)" "unprognostic (1.61e-1)" 31.6 21.1 18.3 27.4 29.0 22.6 28.9 33.1 23.0 33.4 25.3 17.0 22.0 17.1 32.3 24.1 47.6 22.7 22.4 28.1 16.9 14.4 21.8 30.9 29.5 32.9 21.6 17.8 31.6 15.4 25.3 31.5 41.3 21.5 28.8 22.3 24.8 25.7 22.6 48.0 24.2 25.2 33.8 20.4 28.9 20.0 34.1 21.8 60.4 28.5 25.5 32.9 30.0 35.1 10.0 10.1 46.1 14.5 14.0 14.6 10.5 18.4 12.7 34.2 15.3 24.9 32.9 33.1 31.0 31.3 31.9 29.3 26.2 22.2 26.2 14.1 32.2 18.1 23.3 21.0 28.6 40.9 26.8 15.5 35.6 18.4 19.8 24.2 29.1 27.8 29.2 32.7 38.9 33.8 36.4 38.2 19.2 27.0 25.4 32.2 15.1 18.6 27.9 32.3 20.3 18.2 27.7 25.3 21.7 29.3 38.5 20.4 19.1 25.3 18.6 24.8 38.8 21.6 35.4 34.4 34.2 20.6 20.9 17.5 20.2 21.3 35.8 21.2 17.6 31.8 24.8 10.3 20.6 11.1 10.6 13.3 10.0 12.1 12.6 10.1 9.7 14.6 14.1 46.1 14.0 14.5 7.9 12.5 10.5 18.3 29.0 33.1 23.0 16.9 14.4 21.6 17.8 21.5 21.8 68.5 35.6 53.7 0.0 76.4 37.4 78.7 10.2 57.6 44.3 34.9 25.5 31.0 16.6 0.0 208.1 38.3 17.5 23.3 0.0 29.9 37.4 0.0 53.3 28.0 29.4 46.1 27.6 52.2 38.4 46.0 45.8 42.0 21.9 0.0 24.9 38.9 0.0 17.5 38.5 32.1 34.2 58.2 45.3 77.0 31.7 79.3 37.0 41.5 21.9 0.0 MARCKS "80K-L, MACS, PKCSL" ENSG00000277443 "Myristoylated alanine rich protein kinase C substrate" P29966 6 113857362-113863471 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "monocytes: 652.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 10.1;neutrophil: 15.0" "Group enriched" "Detected in many" 10 "B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1" "Cell line enhanced" "Detected in many" "AF22: 74.7;TIME: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022062, HPA054820, HPA067595, HPA069443" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA 17000000 "Plasma membrane" "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133" "unprognostic (4.71e-1)" "unprognostic (1.91e-2)" "unprognostic (2.46e-1)" "unprognostic (5.51e-3)" "unprognostic (8.22e-3)" "unprognostic (2.38e-2)" "prognostic unfavorable (2.78e-8)" "unprognostic (7.82e-2)" "unprognostic (2.57e-1)" "unprognostic (6.92e-2)" "unprognostic (2.27e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (4.85e-4)" "unprognostic (1.36e-3)" "unprognostic (2.77e-2)" "unprognostic (8.07e-2)" "unprognostic (2.70e-2)" 13.0 5.0 11.2 17.0 12.9 26.9 16.0 18.5 43.3 12.1 23.2 17.9 0.9 11.6 9.7 4.0 17.0 8.4 10.9 9.7 10.5 5.3 8.7 12.9 13.3 8.8 15.9 12.6 11.2 1.2 6.5 39.5 13.8 14.1 21.6 11.4 8.2 5.6 5.0 9.5 12.9 9.1 42.3 20.9 18.8 5.2 8.5 30.0 4.9 7.9 13.6 23.5 7.8 3.9 0.9 15.0 10.1 0.0 0.0 0.4 6.8 4.0 74.7 4.0 25.3 16.5 0.4 22.2 31.2 15.7 26.2 7.2 9.8 0.0 4.7 40.9 12.4 21.3 12.3 6.4 20.5 0.0 7.3 0.0 4.3 9.4 16.9 1.8 0.1 17.0 12.7 15.1 14.4 43.1 44.2 0.0 0.8 19.7 22.2 0.0 0.2 0.0 9.6 7.7 5.3 0.0 7.5 0.7 4.9 13.2 10.4 30.3 14.2 7.2 15.2 18.4 0.3 2.0 58.7 14.6 0.1 23.9 37.8 53.3 3.8 2.0 11.2 9.9 27.9 0.0 3.4 0.0 0.0 10.1 0.0 3.9 0.0 0.0 0.9 1.6 0.0 0.0 15.0 0.0 5.5 0.0 0.0 0.4 8.9 19.9 84.3 477.4 447.8 131.4 10.5 56.0 99.0 62.6 36.6 27.5 5.0 31.5 120.8 46.4 214.9 254.5 0.0 195.2 5.5 224.2 281.9 2.3 4.3 324.8 79.4 322.8 234.5 223.1 24.8 111.7 249.4 259.8 652.8 331.8 330.7 220.9 241.8 62.9 3.4 33.7 38.8 128.7 20.0 15.6 558.1 24.6 7.5 259.9 481.3 MARCKSL1 "F52, MacMARCKS, MLP, MLP1" ENSG00000175130 "MARCKS like 1" P49006 1 32333832-32336379 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 166.5" "Cell type enhanced" "Detected in many" 9 "monocytes: 1596.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "eosinophil: 54.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 54.9" "Cell line enhanced" "Detected in many" "AF22: 108.3;NTERA-2: 104.4" "Low region specificity" "Detected in all" "CAB020787, HPA030528" Enhanced Supported "Nucleoplasm,Actin filaments,Cytosol" NA Yes 120000 Cytosol "Nucleoplasm, Actin filaments" "CAB020787: , HPA030528: AB_2673514" "unprognostic (8.08e-2)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (3.16e-3)" "prognostic unfavorable (1.78e-6)" "unprognostic (3.65e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.50e-1)" "unprognostic (8.16e-3)" "unprognostic (1.08e-1)" "unprognostic (3.22e-2)" 9.9 12.7 59.9 22.1 45.4 10.9 27.7 22.0 58.0 22.3 27.5 126.3 5.3 15.9 25.8 42.3 3.6 15.9 24.9 10.7 64.2 47.2 6.4 9.7 9.0 41.5 83.6 35.4 74.1 4.8 1.3 4.9 11.0 56.6 22.5 30.7 5.2 19.9 14.2 2.0 5.3 13.9 11.3 166.5 12.5 34.8 30.3 52.3 41.4 29.0 2.2 49.2 17.0 5.5 6.4 2.2 54.9 6.7 0.2 3.9 1.2 8.4 7.6 108.3 44.2 2.4 0.9 19.2 3.5 2.2 10.6 7.0 18.0 6.2 19.0 13.3 2.4 0.0 4.5 34.9 0.4 7.8 0.4 25.8 1.0 2.9 39.7 7.5 4.9 0.1 12.4 1.4 7.9 0.2 16.5 30.9 32.8 29.1 0.2 14.2 20.0 61.7 20.9 104.4 27.4 17.6 77.1 11.6 9.0 15.9 16.8 67.2 63.9 18.6 20.6 58.5 46.0 14.3 8.8 9.1 4.5 26.3 0.4 6.7 2.9 0.2 49.9 0.5 7.5 23.7 0.7 1.0 54.9 0.9 5.4 0.3 4.6 1.9 1.2 1.5 6.4 3.9 1.6 4.4 0.2 6.7 2.2 1.0 1.2 59.9 45.4 22.0 54.9 64.2 47.2 83.6 35.4 56.6 52.3 0.0 2.2 147.6 95.4 83.2 17.7 7.3 163.1 2.7 4.5 57.6 5.9 9.9 69.6 353.9 21.7 181.6 54.0 0.0 269.1 98.8 68.7 341.5 23.0 3.8 20.1 9.5 716.9 486.2 57.0 35.8 567.8 77.4 285.1 1596.0 443.0 406.9 517.8 228.0 602.9 1.2 12.4 129.4 72.9 6.2 129.4 72.6 11.2 47.2 387.2 506.2 MARK4 "FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D" ENSG00000007047 "Microtubule affinity regulating kinase 4" Q96L34 19 45079288-45305283 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039186 Approved Supported Cytosol NA NA Cytosol "HPA039186: AB_10796223" "unprognostic (1.64e-1)" "unprognostic (1.95e-1)" "unprognostic (1.57e-3)" "prognostic unfavorable (8.31e-8)" "unprognostic (2.02e-1)" "prognostic unfavorable (3.05e-5)" "unprognostic (1.90e-1)" "unprognostic (2.16e-2)" "unprognostic (6.26e-2)" "unprognostic (5.64e-3)" "unprognostic (1.24e-3)" "unprognostic (7.50e-2)" "unprognostic (3.80e-2)" "unprognostic (6.89e-2)" "unprognostic (7.23e-2)" "unprognostic (4.65e-2)" "unprognostic (3.02e-2)" 11.8 13.0 19.4 10.3 26.0 8.4 15.2 21.9 28.6 11.4 10.2 9.0 12.9 6.6 14.0 17.5 13.5 12.9 13.4 14.7 22.2 15.7 8.7 13.5 11.7 10.5 14.3 21.6 21.0 16.8 13.7 12.9 12.1 15.0 12.2 6.3 14.1 12.1 14.2 40.7 20.6 7.5 14.1 10.8 12.4 10.3 32.1 12.3 11.2 10.5 11.5 9.4 13.7 17.9 1.0 2.8 3.5 2.9 1.8 4.3 1.2 8.9 3.8 15.1 11.0 10.8 17.2 4.2 6.6 10.4 9.9 9.3 2.3 5.1 4.3 5.7 12.1 8.2 6.1 10.7 9.7 5.6 7.9 8.8 8.6 4.7 8.2 19.9 2.1 7.5 21.4 13.8 8.3 9.6 17.5 13.2 9.6 10.9 10.8 10.7 7.5 7.6 6.7 6.5 7.4 3.3 29.6 4.9 2.8 9.3 7.2 28.4 12.5 9.8 8.7 5.1 15.3 4.1 12.5 10.7 8.9 6.8 6.0 4.3 12.1 9.6 4.9 9.5 4.0 7.1 3.5 2.9 0.7 3.4 2.2 0.7 0.9 1.2 4.3 0.8 1.0 2.3 2.6 2.9 1.8 2.0 2.8 2.4 1.2 19.4 26.0 21.9 22.7 22.2 15.7 14.3 21.6 15.0 12.3 11.9 1.9 3.0 9.5 22.1 20.9 7.3 10.2 0.0 2.3 8.7 23.6 3.3 10.0 7.8 2.1 10.5 3.3 0.0 5.3 1.1 7.5 8.5 2.3 10.9 5.8 112.8 5.8 18.4 8.4 4.1 15.0 6.1 3.3 2.8 6.0 13.2 7.3 3.2 13.1 5.6 14.6 0.0 7.3 0.5 6.1 21.1 9.6 6.9 3.4 14.0 MARS "CMT2U, MetRS, SPG70" ENSG00000166986 "Methionyl-tRNA synthetase" P56192 12 57475445-57517569 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 118.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004125, CAB017097" Supported Approved Enhanced Cytosol NA NA 21000 Cytosol "CAB017097: , HPA004125: AB_1079312" "prognostic unfavorable (1.73e-4)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.57e-2)" "unprognostic (4.90e-3)" "prognostic unfavorable (4.55e-7)" "unprognostic (8.47e-2)" "unprognostic (1.73e-1)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.13e-2)" "unprognostic (1.96e-1)" "unprognostic (1.13e-1)" "unprognostic (2.06e-2)" 23.8 26.7 35.1 27.3 29.1 23.0 19.8 25.1 36.0 17.4 23.9 23.1 23.9 17.3 23.3 36.3 29.5 17.9 16.1 25.0 28.0 29.5 20.5 45.9 24.3 25.1 40.1 25.5 25.8 48.3 35.7 34.0 22.2 30.9 25.6 24.7 19.8 26.0 30.0 24.5 18.4 20.1 33.7 30.7 30.7 31.3 29.6 30.9 21.4 26.9 22.3 34.3 24.3 27.9 12.9 29.3 19.0 27.0 14.1 18.9 15.5 16.8 23.4 15.7 27.1 17.6 10.7 28.9 24.1 28.2 25.5 27.3 25.1 18.7 29.6 16.0 29.2 15.9 19.2 35.7 31.1 26.8 25.6 15.5 20.9 8.7 14.1 39.2 31.4 24.0 15.5 48.4 29.2 75.7 12.2 18.2 37.8 32.3 63.4 17.7 23.3 28.1 23.7 29.6 27.0 25.8 24.4 118.3 30.6 19.2 13.2 20.9 21.3 12.5 19.3 33.4 18.4 25.4 41.2 13.5 9.2 27.3 13.3 14.3 58.2 58.8 35.7 22.7 23.9 31.5 12.1 14.6 19.0 18.9 27.0 17.2 12.9 12.9 17.1 29.3 7.7 11.1 15.2 7.2 14.1 21.8 28.4 13.1 15.5 35.1 29.1 25.1 36.0 28.0 29.5 40.1 25.5 30.9 30.9 35.7 22.7 29.8 15.6 16.6 14.8 10.1 12.7 28.1 29.6 17.4 31.4 24.6 5.0 32.2 19.0 13.7 11.1 0.0 39.9 18.6 15.5 18.1 26.7 11.3 17.0 6.4 14.5 8.0 12.0 6.6 12.0 22.6 3.3 32.5 10.3 11.5 33.5 14.0 14.2 9.8 28.8 12.9 17.9 33.4 34.1 14.1 31.8 20.3 9.7 23.1 MAS1L "dJ994E9.2, MAS-L, MRG" ENSG00000204687 "MAS1 proto-oncogene like, G protein-coupled receptor" P35410 6 29486697-29487956 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 7.5;epididymis: 4.0" "Cell type enriched" "Detected in single" 58 "granulocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 40 "HEL: 3.9" HPA017983 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA017983: AB_1849332" "unprognostic (3.66e-2)" "unprognostic (2.51e-1)" "unprognostic (2.30e-2)" "unprognostic (5.22e-2)" "unprognostic (1.65e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 7.5 1.3 0.4 1.2 4.0 2.1 0.2 1.2 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.5 0.3 0.2 1.7 1.5 1.1 0.0 0.0 0.5 0.3 0.0 0.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MASP1 "CRARF, MASP, PRSS5" ENSG00000127241 "Mannan binding lectin serine peptidase 1" P48740 3 187217285-187292022 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 43.4;liver: 80.1" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 32.5;Cholangiocytes: 28.1;Hepatocytes: 57.1;Ito cells: 30.7" "Group enriched" "Detected in some" 9 "glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BJ: 27.1;BJ hTERT+: 103.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001617, HPA009641" Supported Enhanced Nucleoplasm,Cytosol "Secreted to blood" No NA 8670000000 1800000000 "Nucleoplasm, Cytosol" "HPA001617: AB_1079314, HPA009641: AB_1079313" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (1.99e-1)" "unprognostic (5.20e-2)" "unprognostic (1.02e-2)" "unprognostic (1.25e-6)" "prognostic favorable (2.20e-4)" "unprognostic (9.92e-2)" "unprognostic (3.22e-1)" "unprognostic (2.29e-1)" "unprognostic (4.18e-1)" "unprognostic (1.29e-1)" "unprognostic (2.82e-3)" "unprognostic (3.56e-3)" "unprognostic (1.97e-1)" "unprognostic (7.85e-2)" "unprognostic (4.29e-1)" 2.1 1.4 3.6 1.2 3.8 0.1 1.2 1.9 10.2 43.4 19.1 14.8 2.4 0.8 34.9 7.1 4.1 6.7 3.3 39.6 6.1 2.5 1.6 80.1 2.2 0.4 6.4 3.0 1.7 0.2 0.2 0.5 3.2 13.0 17.4 2.1 0.1 0.9 19.4 12.2 2.5 2.6 17.1 21.8 0.4 0.6 1.5 6.7 0.0 1.3 6.3 3.5 4.4 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.7 0.0 27.1 103.4 0.4 0.1 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.8 1.9 3.5 6.1 2.5 6.4 3.0 13.0 6.7 0.0 2.6 0.0 0.1 2.6 0.0 32.5 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.2 11.0 0.0 0.0 57.1 0.4 0.0 0.0 30.7 2.4 3.8 2.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 5.9 0.0 0.0 1.5 0.1 0.5 0.0 0.1 MAST1 "KIAA0973, SAST" ENSG00000105613 "Microtubule associated serine/threonine kinase 1" Q9Y2H9 19 12833951-12874951 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 51.0" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 22.6;Cone photoreceptor cells: 41.2;Early spermatids: 13.0;Horizontal cells: 14.3;Rod photoreceptor cells: 18.7" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 3.6;T-reg: 2.0" "Lineage enriched" "Detected in single" 8 "T-cells: 3.6" "Cell line enhanced" "Detected in many" "AN3-CA: 15.0;SCLC-21H: 26.5;SH-SY5Y: 13.2;U-266/70: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028181, HPA073106" Enhanced Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA028181: AB_10603872, HPA073106: AB_2732218" "unprognostic (6.32e-2)" "unprognostic (3.66e-2)" "unprognostic (3.93e-2)" "unprognostic (2.83e-5)" "unprognostic (1.72e-1)" "unprognostic (4.19e-2)" "unprognostic (2.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "unprognostic (8.89e-3)" "unprognostic (3.43e-2)" "unprognostic (3.84e-3)" "unprognostic (1.19e-1)" "unprognostic (7.04e-2)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" 1.2 5.2 20.4 1.7 13.6 1.6 1.5 51.0 40.1 1.1 1.5 1.4 0.0 1.7 1.3 1.2 1.3 1.2 1.6 1.3 16.1 16.3 1.2 1.3 1.2 1.3 8.8 19.5 1.5 1.6 1.2 10.4 1.2 19.9 1.2 1.3 1.6 1.3 1.2 1.2 4.1 1.6 1.3 4.2 1.2 1.5 3.9 2.7 0.0 1.2 0.0 1.3 1.2 0.2 0.4 0.0 0.0 0.2 0.0 3.6 0.1 2.2 1.0 1.0 15.0 0.0 0.0 1.2 0.1 0.1 0.2 0.6 0.5 0.9 3.6 1.7 0.0 2.5 0.0 4.4 0.0 0.0 2.5 2.9 0.3 3.6 1.6 0.0 0.8 0.8 0.3 0.0 0.5 0.5 0.8 0.0 9.8 3.1 1.9 0.0 0.5 1.5 0.4 4.5 0.4 4.6 9.9 3.0 5.1 0.2 0.1 26.5 13.2 0.5 0.9 2.7 0.8 2.4 1.3 0.0 1.8 2.8 2.0 0.5 10.8 8.6 2.1 3.3 2.0 0.1 0.0 0.2 0.0 0.0 0.2 3.6 0.1 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 2.0 0.1 20.4 13.6 51.0 34.3 16.1 16.3 8.8 19.5 19.9 2.7 0.0 3.7 0.0 1.9 0.8 22.6 0.8 0.0 1.4 0.0 0.0 41.2 0.4 0.0 0.1 13.0 1.0 0.7 0.0 0.4 0.4 0.7 0.9 1.1 0.8 0.2 14.3 0.0 0.6 1.2 6.5 0.6 1.0 5.0 0.0 0.0 3.6 0.3 2.9 1.1 0.1 18.7 0.0 0.8 2.8 4.1 1.3 0.2 1.0 0.4 0.6 MAST2 "KIAA0807, MAST205" ENSG00000086015 "Microtubule associated serine/threonine kinase 2" Q6P0Q8 1 45786987-46036124 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.3" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 43.3;Cone photoreceptor cells: 51.1;Enterocytes: 45.1;Late spermatids: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039722, HPA040155" Approved Approved Cytosol NA NA Cytosol "HPA039722: AB_10795294, HPA040155: AB_10793957" "unprognostic (7.80e-2)" "unprognostic (3.02e-2)" "unprognostic (5.77e-2)" "unprognostic (1.52e-1)" "unprognostic (3.82e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (4.31e-8)" "unprognostic (8.86e-2)" "unprognostic (2.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (6.85e-13)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (9.73e-2)" "unprognostic (4.90e-1)" 8.9 4.3 7.0 9.9 8.1 3.7 7.1 7.1 11.8 13.6 15.2 8.4 6.6 11.2 16.7 7.7 8.8 9.5 9.9 25.5 5.0 7.6 4.8 6.1 5.9 4.4 8.9 7.3 19.8 3.6 9.1 10.5 5.5 10.1 13.9 13.9 7.2 8.3 8.6 83.3 5.5 21.3 14.9 5.8 2.5 9.0 24.8 4.8 3.5 5.7 27.4 7.5 16.3 10.6 0.5 1.9 1.4 4.3 1.4 1.4 0.5 14.9 12.1 12.3 9.4 16.1 23.1 13.6 16.0 11.6 14.8 16.5 13.9 4.9 23.4 7.5 19.5 30.0 7.4 14.8 9.1 15.7 11.2 8.0 10.6 13.7 12.7 14.0 5.6 13.6 17.7 11.8 24.8 19.8 18.6 13.8 6.1 8.1 7.2 17.6 10.2 8.2 5.8 10.1 10.1 13.9 12.2 20.6 4.4 7.7 8.1 17.1 10.1 18.8 24.6 8.0 14.1 11.2 5.6 13.4 28.7 18.5 14.9 15.8 9.7 8.7 8.5 19.1 7.7 11.8 0.0 1.1 1.4 1.4 0.6 1.4 0.2 0.7 1.4 1.9 0.5 0.5 1.0 0.0 1.4 4.3 0.1 0.0 0.5 7.0 8.1 7.1 11.8 5.0 7.6 8.9 7.3 10.1 4.8 0.0 1.3 0.0 4.2 3.8 14.9 43.3 2.5 1.4 7.9 3.5 51.1 4.4 1.7 4.2 27.6 5.3 45.1 0.0 5.4 4.0 6.6 7.8 0.0 5.6 5.5 4.8 11.6 3.1 1.6 44.9 8.3 6.4 6.8 1.0 18.3 3.0 6.7 26.6 9.6 4.2 12.7 6.5 6.1 28.4 11.7 2.4 4.6 1.9 18.1 6.0 MAST4 KIAA0303 ENSG00000069020 "Microtubule associated serine/threonine kinase family member 4" O15021 5 66596361-67169595 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 428.6;Basal keratinocytes: 327.4;Glandular cells: 324.3;Suprabasal keratinocytes: 348.9;Urothelial cells: 641.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 17.8;HDLM-2: 22.6;HEL: 18.7;RT4: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000544 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000544: AB_1079315" "unprognostic (1.77e-2)" "unprognostic (6.24e-2)" "unprognostic (1.80e-1)" "unprognostic (4.99e-3)" "unprognostic (2.83e-2)" "prognostic favorable (5.18e-5)" "unprognostic (9.01e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-2)" "unprognostic (9.47e-2)" "unprognostic (5.03e-2)" "unprognostic (3.01e-2)" "unprognostic (1.01e-2)" "unprognostic (1.37e-2)" "unprognostic (2.63e-1)" "unprognostic (2.63e-1)" "unprognostic (3.08e-2)" 16.2 12.9 10.2 6.9 11.8 2.5 12.6 6.2 19.4 13.9 6.9 6.3 6.3 6.3 14.4 8.9 31.2 11.6 9.7 24.5 9.9 8.1 14.2 9.5 13.1 5.0 6.5 9.2 20.2 5.9 35.6 16.7 18.4 11.1 10.1 5.3 5.7 13.7 8.7 12.7 16.9 6.8 11.4 5.6 6.0 8.2 10.7 5.0 37.5 8.1 21.8 20.6 13.6 22.3 3.4 1.1 12.1 0.9 2.4 7.5 1.4 7.6 4.2 2.1 0.1 6.9 6.2 5.0 1.7 2.6 0.6 0.5 3.8 2.1 0.5 3.6 1.4 1.6 6.9 6.4 17.8 0.7 22.6 2.1 18.7 2.4 1.6 0.5 0.0 6.6 10.3 9.8 3.9 7.9 7.3 14.1 1.7 1.8 2.1 4.8 6.6 2.7 0.1 1.4 0.6 3.4 0.6 1.8 0.4 1.7 22.9 3.0 2.4 2.3 0.9 0.1 1.5 1.5 0.1 13.5 1.6 2.3 2.5 2.9 5.5 2.4 0.1 4.3 0.0 1.3 12.1 0.4 0.8 1.2 0.5 2.9 3.4 4.7 1.2 0.4 2.1 5.0 2.1 4.1 2.4 0.9 1.1 7.5 1.4 10.2 11.8 6.2 19.4 9.9 8.1 6.5 9.2 11.1 5.0 29.8 44.7 9.0 428.6 327.4 18.2 114.6 17.8 29.4 59.1 17.4 2.0 33.2 31.5 46.4 104.5 72.0 17.3 0.0 103.5 42.2 34.0 324.3 92.3 37.2 4.6 7.9 30.9 60.2 6.0 92.7 38.3 9.8 45.5 2.8 14.9 56.5 55.6 15.6 30.8 73.9 3.5 38.8 35.8 11.4 8.5 348.9 114.8 15.2 15.0 641.7 MAT2A "MATA2, MATII, SAMS2" ENSG00000168906 "Methionine adenosyltransferase 2A" P31153 2 85539165-85545280 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 205.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009968, HPA043028" Approved Approved Nucleoplasm,Cytosol NA NA 950000 Nucleoplasm Cytosol "CAB009968: AB_675710, HPA043028: AB_10960707" "unprognostic (1.38e-3)" "unprognostic (2.58e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (5.29e-5)" "unprognostic (9.89e-3)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.87e-4)" "prognostic favorable (8.94e-4)" "prognostic unfavorable (5.94e-5)" "unprognostic (4.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.59e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (1.77e-2)" 55.9 68.9 37.4 35.3 54.1 20.4 30.3 37.5 50.0 28.6 35.3 74.5 39.7 33.6 35.8 59.8 33.5 44.9 51.6 35.0 41.7 28.5 52.3 26.4 32.9 27.0 74.8 37.6 44.2 205.8 38.8 60.5 29.3 48.9 40.6 36.8 35.0 28.2 31.3 51.4 33.7 35.8 47.6 57.7 24.7 44.6 34.9 69.4 22.7 94.0 34.1 30.8 46.9 33.4 13.8 15.3 4.9 17.2 16.9 22.8 14.9 30.0 44.6 52.4 32.5 36.1 44.1 31.0 37.8 34.9 39.8 42.5 36.4 101.4 70.5 24.9 45.9 32.5 46.9 65.9 56.4 51.2 35.7 48.4 42.1 64.6 31.5 66.0 62.4 47.1 39.9 57.2 42.9 30.0 50.7 37.7 41.0 47.3 55.5 90.3 25.8 56.9 68.8 34.8 25.9 57.5 60.6 49.6 45.7 60.1 47.7 41.3 38.1 34.2 33.0 60.9 27.7 27.9 33.5 36.6 48.9 29.5 26.9 45.1 34.3 27.2 51.0 31.9 78.4 25.6 4.8 15.2 4.9 15.4 17.2 22.8 13.8 17.5 16.2 15.3 12.2 16.4 14.3 1.6 16.9 13.7 10.9 15.3 14.9 37.4 54.1 37.5 50.0 41.7 28.5 74.8 37.6 48.9 69.4 44.7 76.0 36.8 172.0 127.5 81.9 4.5 86.6 34.8 63.7 68.0 64.8 30.7 16.6 50.4 46.3 49.1 61.0 23.3 49.9 34.3 63.9 55.3 83.1 40.6 57.5 25.4 79.9 36.2 106.8 20.7 66.7 92.6 64.1 35.1 55.5 59.7 55.5 42.1 78.8 119.6 80.9 109.9 101.9 51.4 57.7 103.4 31.9 36.2 51.7 86.6 MATK "CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101" ENSG00000007264 "Megakaryocyte-associated tyrosine kinase" P42679 19 3777970-3802129 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.3;bone marrow: 19.1;brain: 27.4" "Group enriched" "Detected in many" 6 "granulocytes: 44.9;Hofbauer cells: 58.6;T-cells: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 19.4;NK-cell: 29.3" "Group enriched" "Detected in many" 54 "NK-cells: 29.3;T-cells: 19.4" "Cell line enhanced" "Detected in some" "HL-60: 41.6;HMC-1: 12.8;K-562: 18.5;MCF7: 13.5;NB-4: 29.0;SCLC-21H: 12.7;THP-1: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004847, HPA066547" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol" "HPA004847: AB_1079316, HPA066547: " "prognostic favorable (5.27e-4)" "unprognostic (1.28e-2)" "unprognostic (1.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.36e-1)" "unprognostic (3.39e-2)" "unprognostic (9.50e-2)" "unprognostic (1.23e-1)" "unprognostic (7.91e-2)" "unprognostic (3.19e-3)" "unprognostic (2.07e-2)" "unprognostic (4.51e-2)" "unprognostic (1.16e-2)" "unprognostic (7.59e-2)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (2.33e-2)" 11.2 1.6 22.1 6.8 18.1 19.1 2.2 1.5 27.4 1.5 2.3 1.7 0.0 7.0 1.2 0.4 1.1 4.7 5.1 1.7 25.1 10.0 1.1 2.8 7.3 9.6 7.0 11.0 1.0 1.6 0.1 1.4 1.4 6.1 1.2 1.4 0.6 3.8 1.0 0.8 1.6 6.7 1.1 2.8 14.8 4.1 2.1 1.3 3.5 0.9 0.0 4.5 2.4 0.7 0.4 0.3 0.4 0.0 29.3 19.4 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.4 4.2 5.5 0.1 0.0 0.0 7.2 4.6 0.5 1.1 0.0 41.6 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.5 0.0 0.0 13.5 0.1 29.0 3.4 3.5 0.1 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.4 0.0 10.9 1.3 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 13.2 0.0 2.5 12.2 0.3 0.4 1.2 7.1 0.4 29.3 0.0 0.1 0.1 2.7 22.1 18.1 1.5 27.4 25.1 10.0 7.0 11.0 6.1 1.3 0.0 1.4 2.4 0.0 0.3 1.7 1.1 0.0 1.4 0.0 0.0 11.8 0.2 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.3 0.5 0.1 44.9 0.8 58.6 0.0 6.8 11.6 3.5 4.0 0.0 7.2 1.7 1.0 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.3 2.7 1.0 0.2 105.8 0.1 0.0 MB21D2 C3orf59 ENSG00000180611 "Mab-21 domain containing 2" Q8IYB1 3 192796815-192918161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 34.9" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 55.7;Syncytiotrophoblasts: 92.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 6.6;T-reg: 5.5" "Lineage enriched" "Detected in single" 10 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "HDLM-2: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044026 Approved Approved Cytosol NA NA Cytosol "HPA044026: AB_10962840" "unprognostic (3.52e-2)" "unprognostic (1.02e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (3.74e-5)" "unprognostic (2.42e-2)" "prognostic unfavorable (9.94e-4)" "unprognostic (2.76e-2)" "unprognostic (3.50e-2)" "unprognostic (1.53e-1)" "unprognostic (2.46e-1)" "unprognostic (2.84e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-3)" "unprognostic (5.94e-3)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (3.28e-2)" 5.7 6.0 4.4 4.4 6.9 1.6 5.1 11.1 10.9 5.8 6.9 5.6 2.7 12.0 7.3 2.9 3.2 5.3 10.1 7.6 3.9 5.0 5.8 2.3 5.9 3.1 4.4 3.5 6.5 2.8 5.6 8.6 34.9 4.6 4.9 4.3 4.0 3.1 3.9 4.9 8.6 15.7 7.8 3.5 3.0 5.1 11.4 3.3 1.2 3.3 2.5 2.5 8.7 5.0 0.3 0.6 0.0 0.6 0.0 6.6 1.8 9.9 1.4 2.4 7.3 1.5 2.3 4.4 7.2 6.7 13.0 7.8 6.4 1.6 0.0 4.3 17.6 5.4 4.4 5.6 1.8 14.2 43.0 3.1 1.2 0.7 0.7 2.9 0.1 0.6 3.0 2.8 3.6 2.2 1.0 2.5 1.2 0.0 0.6 2.2 7.3 0.1 0.0 5.1 5.4 17.8 0.2 4.0 2.0 3.0 5.7 3.8 1.9 1.5 4.9 0.7 5.2 7.7 0.1 0.8 2.4 7.3 4.3 13.7 19.1 15.1 0.0 1.7 1.5 3.3 0.0 0.3 0.0 0.3 0.6 2.9 0.3 6.6 1.7 0.6 0.0 4.2 1.2 0.0 0.0 0.0 0.0 5.5 1.8 4.4 6.9 11.1 10.9 3.9 5.0 4.4 3.5 4.6 3.3 6.0 0.3 0.9 0.8 8.1 10.6 1.0 0.0 1.4 1.2 0.0 2.0 55.7 0.0 5.2 0.1 4.8 2.9 0.0 0.2 7.2 7.6 0.7 0.0 0.0 5.0 7.9 9.8 9.8 4.3 1.3 2.8 10.7 13.5 22.6 2.4 1.0 1.6 5.8 5.6 8.4 0.7 12.9 4.7 2.1 19.4 7.5 92.3 1.3 2.5 0.9 MBD2 ENSG00000134046 "Methyl-CpG binding domain protein 2" Q9UBB5 18 54151601-54224788 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Kupffer cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 8.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037282, HPA067582, HPA067615" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872" "unprognostic (4.86e-2)" "unprognostic (7.21e-2)" "prognostic favorable (6.49e-4)" "unprognostic (1.19e-1)" "unprognostic (3.36e-2)" "unprognostic (2.47e-1)" "unprognostic (2.38e-3)" "unprognostic (2.35e-2)" "unprognostic (2.71e-2)" "unprognostic (2.36e-3)" "unprognostic (8.04e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-3)" "unprognostic (5.19e-2)" 29.8 11.9 8.5 27.9 9.8 15.3 24.0 9.9 9.0 17.5 22.5 7.4 20.1 10.5 12.5 14.8 33.1 11.3 18.7 17.9 7.9 8.1 23.3 23.2 21.3 33.7 10.0 5.3 15.3 19.3 13.1 12.5 38.1 8.6 18.3 15.0 12.1 23.3 17.3 13.9 24.1 26.7 15.7 11.7 36.9 12.5 26.1 9.4 31.0 31.0 25.4 32.2 22.8 27.1 2.0 1.5 2.2 8.2 0.4 2.6 0.8 12.7 5.8 10.8 5.3 12.7 10.8 10.6 12.1 15.2 14.0 12.3 3.7 7.1 30.2 6.2 18.6 6.2 20.5 9.1 16.3 15.4 22.5 5.0 4.4 9.1 8.0 13.2 14.1 8.2 9.4 18.4 10.7 15.7 9.3 16.1 9.3 3.4 28.1 12.6 6.1 14.2 7.9 11.3 5.0 7.8 9.6 6.3 12.2 20.1 13.2 11.8 5.0 9.4 9.5 6.3 14.9 4.9 7.2 13.9 14.3 6.6 4.9 10.7 30.5 16.6 23.3 12.6 12.0 8.5 0.1 2.6 1.2 1.2 4.6 1.6 1.4 1.3 1.9 1.5 2.0 0.7 1.2 2.2 0.4 8.2 1.2 2.6 0.8 8.5 9.8 9.9 9.0 7.9 8.1 10.0 5.3 8.6 9.4 26.8 16.0 24.2 25.1 43.8 17.7 28.8 20.4 24.1 20.5 31.4 15.7 11.3 6.6 23.6 1.7 25.3 29.7 23.3 49.8 45.1 20.5 42.9 8.1 17.9 28.1 20.6 15.6 24.5 111.1 3.3 23.3 44.3 25.3 33.3 38.0 36.6 44.0 20.1 24.8 19.0 23.2 25.8 18.1 5.2 4.3 54.6 15.3 17.5 33.1 78.0 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298558-36320676 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.2" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 218.5;Club cells: 169.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favorable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 10.4 11.7 11.4 5.7 17.0 15.4 12.9 16.4 14.9 15.4 12.2 11.5 3.6 8.6 14.0 11.3 14.0 9.1 8.6 7.2 10.7 13.0 19.5 15.0 46.2 8.1 9.9 8.9 20.0 9.0 10.4 25.1 9.8 13.3 13.8 11.7 10.1 7.7 8.9 6.0 14.3 13.2 11.0 13.6 9.8 19.0 8.8 11.8 14.4 61.2 4.0 7.9 12.4 9.3 12.0 10.4 5.1 9.3 8.3 17.9 9.6 16.6 8.7 18.7 18.8 18.8 18.2 14.1 14.3 17.8 19.0 20.0 17.8 16.8 15.8 21.9 18.4 10.0 12.8 19.6 13.2 23.4 22.8 14.7 9.2 8.7 30.3 20.5 18.8 10.3 18.6 20.4 12.4 16.1 19.7 11.8 22.2 15.8 19.8 14.0 16.0 18.0 15.3 15.8 14.3 26.0 8.7 16.3 11.0 21.4 12.9 28.0 11.1 11.8 11.4 18.9 16.7 18.6 12.3 9.2 21.2 13.8 15.5 14.7 16.4 18.9 24.8 8.1 9.7 14.6 1.4 9.3 2.0 11.2 6.8 14.1 12.0 13.7 13.8 9.2 8.7 17.9 14.5 5.1 8.3 5.3 10.4 16.1 9.6 11.4 17.0 16.4 14.9 10.7 13.0 9.9 8.9 13.3 11.8 202.5 218.5 10.4 31.7 80.1 24.3 9.4 2.5 50.9 169.5 24.4 2.0 20.7 49.7 17.7 2.7 17.7 14.6 0.0 16.6 17.7 24.9 20.7 12.7 21.2 15.9 87.4 30.2 15.4 9.9 2.5 29.7 14.5 20.3 9.0 12.1 23.6 16.8 17.5 25.5 38.3 22.5 12.9 21.2 42.9 36.4 57.2 16.6 14.9 17.7 12.9 MBNL1 "EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL" ENSG00000152601 "Muscleblind like splicing regulator 1" Q9NR56 3 152243828-152465780 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016398, HPA035098" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016398: AB_784435, HPA035098: AB_2674461" "unprognostic (5.46e-3)" "unprognostic (6.01e-3)" "unprognostic (1.94e-3)" "unprognostic (1.99e-1)" "unprognostic (3.44e-2)" "unprognostic (5.82e-3)" "unprognostic (2.75e-2)" "unprognostic (9.49e-3)" "unprognostic (5.18e-2)" "unprognostic (1.70e-2)" "unprognostic (2.78e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.90e-7)" "unprognostic (7.53e-3)" "unprognostic (6.15e-2)" "unprognostic (1.77e-1)" "unprognostic (2.98e-1)" 55.9 17.5 14.5 50.8 17.0 28.5 43.8 11.8 14.5 46.4 44.0 10.8 18.0 15.2 41.1 23.6 33.3 22.3 27.5 29.9 14.3 12.9 18.6 16.5 39.6 45.6 18.0 9.1 30.5 12.5 12.5 16.0 10.4 12.6 30.5 26.0 12.7 18.3 25.1 87.6 22.8 29.5 59.8 22.1 39.6 23.1 14.6 17.4 71.9 18.5 34.5 46.0 64.4 29.3 25.0 30.7 38.2 27.4 33.6 39.9 40.2 27.8 23.0 3.7 8.4 29.6 30.6 2.8 35.0 28.4 23.1 19.4 10.1 16.4 28.7 17.9 49.0 7.2 12.8 6.9 20.2 34.3 22.3 9.4 31.3 11.7 4.7 16.5 37.4 22.9 14.2 11.0 26.6 20.8 17.8 47.4 11.6 15.9 39.2 22.4 9.6 34.8 13.7 1.5 8.2 18.4 35.7 11.6 35.9 11.7 14.1 3.0 3.4 15.2 8.3 14.8 1.4 11.5 57.1 39.8 31.7 12.2 21.0 30.1 41.0 23.4 33.0 18.5 46.8 17.0 32.6 22.7 38.2 37.2 27.4 39.9 25.0 30.5 30.9 30.7 24.1 38.9 33.3 35.4 33.6 22.8 11.1 27.0 40.2 14.5 17.0 11.8 14.5 14.3 12.9 18.0 9.1 12.6 17.4 140.0 156.6 98.0 41.0 189.8 25.7 160.6 45.9 78.9 139.9 36.6 60.9 20.0 18.3 32.5 2.1 146.2 138.0 70.0 54.4 8.3 91.5 50.3 155.2 83.5 55.2 30.2 45.4 75.5 193.7 5.9 82.8 171.1 97.8 129.0 61.7 16.0 47.0 71.9 67.1 29.9 84.3 97.0 113.3 4.9 10.9 213.0 12.4 228.4 54.7 46.0 MBOAT7 "BB1, hMBOA-7, LENG4, LPIAT" ENSG00000125505 "Membrane bound O-acyltransferase domain containing 7" Q96N66 19 54173412-54189882 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0" "Lineage enriched" "Detected in many" 10 "granulocytes: 30.6" "Cell line enhanced" "Detected in many" "HMC-1: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055967 Approved Approved Cytosol NA NA Cytosol "HPA055967: AB_2682990" "unprognostic (1.89e-2)" "unprognostic (2.60e-2)" "unprognostic (2.60e-1)" "unprognostic (3.31e-1)" "unprognostic (3.54e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (5.55e-6)" "prognostic unfavorable (5.13e-4)" "unprognostic (5.36e-2)" "unprognostic (2.31e-2)" "unprognostic (1.08e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (6.62e-5)" "unprognostic (1.31e-1)" "unprognostic (4.75e-2)" "unprognostic (3.95e-1)" "prognostic favorable (4.31e-4)" 10.7 63.1 16.8 14.8 24.2 15.9 7.9 11.3 37.8 10.3 17.7 9.2 15.6 30.3 10.5 8.0 10.5 11.5 14.3 6.9 18.5 23.4 10.5 11.6 11.5 14.7 10.0 18.8 15.1 24.4 23.8 12.4 11.9 21.6 11.4 6.1 8.1 10.8 28.8 7.9 10.0 28.5 6.5 9.2 14.4 16.4 30.8 6.8 7.6 12.7 5.0 6.3 22.6 17.5 0.3 2.9 30.6 2.1 0.9 0.5 0.8 14.2 8.5 1.3 14.0 4.6 3.6 12.3 25.0 8.9 5.8 11.5 4.8 16.2 3.7 11.2 5.4 2.5 29.2 0.0 5.1 1.1 5.1 16.6 3.9 9.2 3.1 4.5 9.0 57.3 6.7 3.4 2.8 2.0 4.6 10.4 2.7 14.7 11.8 2.0 8.6 2.6 3.2 5.9 2.5 18.2 8.4 2.4 7.5 5.8 17.3 0.5 3.7 16.7 10.2 5.1 0.1 10.3 0.8 20.7 12.3 4.4 3.6 9.9 5.4 9.3 1.5 17.7 6.4 8.1 15.7 2.1 30.6 0.2 1.5 0.5 0.2 0.2 0.2 2.9 0.3 0.1 0.2 30.0 0.9 0.8 0.8 0.2 0.8 16.8 24.2 11.3 37.8 18.5 23.4 10.0 18.8 21.6 6.8 11.9 26.6 12.2 44.1 12.4 15.8 6.5 30.6 13.4 14.8 41.8 5.9 38.6 5.0 45.1 1.1 16.6 88.9 0.0 28.7 43.8 12.7 39.8 76.1 13.9 28.4 28.6 40.8 14.7 36.9 1.9 17.8 32.1 8.5 19.8 45.8 22.4 34.4 40.3 14.5 12.2 6.8 38.8 23.4 3.9 14.5 18.9 43.1 11.4 38.5 48.0 MBTD1 "FLJ20055, SA49P01" ENSG00000011258 "Mbt domain containing 1" Q05BQ5 17 51177425-51260163 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021876 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021876: AB_2140367" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" "unprognostic (6.91e-3)" "unprognostic (3.39e-2)" "unprognostic (1.81e-2)" "unprognostic (2.52e-3)" "unprognostic (1.48e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-2)" "unprognostic (5.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.61e-2)" "unprognostic (7.90e-3)" "unprognostic (1.50e-2)" "unprognostic (3.03e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-3)" 9.0 6.8 8.8 10.6 14.2 11.0 13.5 21.2 12.0 10.7 8.8 13.2 8.6 9.2 14.3 9.6 9.3 8.3 7.1 5.8 9.9 5.8 7.4 11.2 7.2 9.3 12.6 8.1 15.4 11.0 8.8 9.6 10.0 8.8 8.9 9.3 8.3 9.0 8.8 7.9 16.7 9.8 11.9 7.7 11.7 9.5 27.9 11.7 32.4 10.1 4.8 9.0 9.5 10.5 0.9 1.1 5.1 0.4 0.4 0.9 0.1 3.7 3.5 19.0 7.6 4.6 5.3 10.0 2.9 3.6 3.1 3.9 4.2 4.9 14.8 6.9 2.1 2.2 3.7 8.6 2.1 5.9 4.1 7.9 15.3 4.0 6.4 3.1 10.2 4.6 4.6 4.1 2.3 4.3 6.2 5.5 13.1 11.8 3.7 2.4 3.8 13.9 10.7 10.8 8.1 3.2 16.1 11.5 7.3 4.8 7.2 12.1 18.4 2.6 5.1 6.1 16.7 7.3 20.2 3.3 3.4 3.4 2.5 3.1 9.2 5.8 13.3 2.0 6.8 1.9 5.1 0.4 1.9 0.7 0.3 0.2 0.9 0.7 0.5 0.7 0.6 0.4 0.9 0.9 0.4 0.4 1.1 0.8 0.1 8.8 14.2 21.2 12.0 9.9 5.8 12.6 8.1 8.8 11.7 14.9 12.9 8.2 5.9 15.2 7.9 6.2 15.3 5.3 6.8 7.0 15.7 6.4 1.7 4.3 44.2 8.9 7.3 0.0 4.5 4.2 7.6 8.0 4.7 10.0 5.0 9.5 13.2 9.8 13.1 11.1 13.6 8.4 10.1 7.2 14.7 5.6 5.7 10.5 9.9 3.9 11.4 0.0 8.0 28.1 14.5 19.3 7.2 8.2 11.6 6.8 MBTPS2 "KFSD, S2P" ENSG00000012174 "Membrane bound transcription factor peptidase, site 2" O43462 X 21839636-21885424 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005494, CAB009486" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009486: AB_2140370, HPA005494: AB_1079329" "unprognostic (7.97e-3)" "unprognostic (9.12e-2)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (7.22e-2)" "unprognostic (3.32e-1)" "unprognostic (9.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (8.38e-2)" "unprognostic (7.76e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (3.05e-2)" 12.0 17.4 9.3 7.2 13.9 2.5 12.7 20.8 18.5 11.8 9.3 13.4 6.9 7.6 14.7 9.1 9.3 10.9 10.1 11.6 9.9 10.7 13.9 26.0 8.6 6.6 10.6 13.0 18.7 12.2 17.9 15.6 22.3 17.4 15.7 9.1 12.4 14.1 13.1 14.5 8.2 8.1 14.6 14.6 7.5 9.1 6.9 7.0 7.1 13.1 7.4 6.7 11.4 9.1 3.9 6.9 1.5 4.8 4.6 5.9 3.3 8.9 18.6 8.9 9.1 11.3 14.0 4.3 13.3 13.6 12.7 11.1 7.4 12.3 7.8 6.9 14.2 24.8 8.4 12.3 7.6 15.7 5.8 9.8 3.8 11.8 6.1 15.5 8.2 3.8 13.2 8.3 19.1 14.1 12.9 9.7 4.6 10.6 8.7 14.4 5.6 3.3 4.3 8.3 4.7 13.8 4.2 16.6 8.7 8.8 4.6 2.2 18.3 18.7 11.9 16.4 12.4 15.9 7.1 11.5 16.0 3.7 23.2 9.9 10.7 13.5 3.8 17.8 3.4 15.3 0.1 4.3 1.5 4.5 4.8 4.2 3.9 3.5 4.1 6.9 3.8 4.7 5.6 0.5 4.6 4.8 4.8 5.9 3.3 9.3 13.9 20.8 18.5 9.9 10.7 10.6 13.0 17.4 7.0 8.9 7.8 3.0 3.4 4.8 11.7 12.0 7.6 10.7 6.8 7.0 17.7 5.6 0.0 5.1 0.3 4.6 3.3 0.0 7.7 5.4 8.9 6.6 10.4 16.1 8.0 28.6 2.4 10.4 9.5 0.9 9.8 4.4 10.1 3.6 3.3 7.7 5.3 3.1 12.4 7.5 14.0 0.0 6.9 2.8 1.7 2.4 4.0 4.3 4.2 4.1 MCC ENSG00000171444 "Mutated in colorectal cancers" P23508 5 113022099-113488830 "Predicted intracellular proteins" "Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 49.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 97.8;Cone photoreceptor cells: 53.0;Hepatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.2;hTCEpi: 19.0;RT4: 17.6" "Low region specificity" "Detected in all" "HPA037390, HPA037391" Approved Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytosol" "Cytoplasmic bodies" "HPA037390: AB_2675451, HPA037391: AB_10671248" "unprognostic (6.60e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (8.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (5.21e-2)" "unprognostic (9.59e-2)" "unprognostic (8.02e-3)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (6.19e-4)" "unprognostic (1.70e-3)" "unprognostic (3.34e-1)" "unprognostic (2.47e-2)" "unprognostic (2.90e-1)" 7.1 2.3 6.9 3.2 6.1 0.5 7.8 11.4 8.1 11.8 3.2 3.4 5.9 1.7 12.5 4.7 9.1 7.4 4.4 8.4 9.2 5.0 3.9 12.7 4.6 3.0 7.6 5.1 49.4 4.5 28.9 5.2 7.1 7.8 7.7 2.4 15.1 6.7 9.5 5.0 13.9 2.6 9.1 5.8 3.4 3.6 6.5 5.2 1.3 3.2 6.1 4.3 9.3 11.8 0.2 6.3 1.3 0.2 0.1 1.6 0.1 0.4 0.1 7.2 0.7 6.2 5.8 7.9 1.2 3.2 1.3 1.6 0.2 6.5 0.0 7.6 0.5 3.6 8.7 4.3 28.2 0.6 2.3 2.7 0.0 2.5 1.9 1.8 0.3 0.1 7.7 19.0 3.5 13.4 7.2 8.4 0.9 0.0 10.7 2.9 0.6 0.1 0.1 3.9 0.0 0.5 0.1 6.3 1.9 0.1 17.6 3.1 6.8 5.8 0.0 15.4 2.6 2.3 0.0 10.0 4.9 4.6 7.6 2.2 3.1 0.0 0.0 13.1 0.0 5.1 0.0 0.2 0.1 0.5 0.2 1.6 0.2 0.5 0.6 0.0 0.2 0.4 0.5 1.3 0.1 0.1 6.3 1.5 0.1 6.9 6.1 11.4 8.1 9.2 5.0 7.6 5.1 7.8 5.2 0.0 0.6 0.5 24.4 33.4 97.8 13.9 7.6 0.0 3.4 3.5 53.0 0.7 0.0 2.9 10.6 23.9 0.0 0.0 1.2 1.7 27.7 5.4 0.0 50.6 2.0 35.0 4.6 25.2 4.0 24.2 19.5 0.5 15.1 5.4 0.2 7.4 3.0 0.2 25.5 1.4 8.2 0.0 10.3 8.2 8.5 41.3 1.0 2.9 0.0 14.9 MCF2L2 "ARHGEF22, KIAA0861" ENSG00000053524 "MCF.2 cell line derived transforming sequence-like 2" Q86YR7 3 183178043-183428778 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.4;brain: 23.7" "Group enriched" "Detected in many" 11 "Bipolar cells: 64.6;Cone photoreceptor cells: 208.1;Early spermatids: 86.7;Rod photoreceptor cells: 135.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "T-reg: 4.6" "Lineage enriched" "Detected in single" 8 "T-cells: 4.6" "Cell line enhanced" "Detected in many" "HDLM-2: 9.4;Karpas-707: 8.2;REH: 5.4" "Low region specificity" "Detected in all" "HPA038946, HPA038947" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038946: AB_10670914, HPA038947: AB_10672655" "unprognostic (2.17e-2)" "unprognostic (4.42e-1)" "unprognostic (3.08e-1)" "unprognostic (1.95e-3)" "unprognostic (1.98e-1)" "unprognostic (2.87e-2)" "unprognostic (3.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (5.08e-2)" "unprognostic (4.80e-4)" "unprognostic (1.32e-1)" "unprognostic (8.75e-6)" "unprognostic (1.09e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" 0.9 16.4 12.8 1.4 14.9 1.1 1.1 11.3 23.7 1.3 1.4 3.6 0.0 0.9 1.3 1.3 1.3 1.0 1.5 1.1 12.2 7.6 1.4 0.8 1.2 1.7 5.6 13.0 1.2 1.2 10.5 8.9 0.8 7.3 2.1 1.4 7.5 0.8 1.6 1.4 1.0 1.2 1.4 4.5 5.3 1.2 5.5 4.3 0.0 0.9 0.0 2.1 1.6 0.4 0.1 0.0 0.6 0.0 0.1 4.6 0.2 0.1 0.6 0.2 1.8 0.1 0.2 0.4 0.0 0.1 0.3 0.0 1.2 0.2 1.5 0.2 0.1 1.9 0.0 0.3 0.2 0.1 9.4 1.4 4.0 0.3 0.0 0.3 1.2 0.8 0.3 0.0 0.0 0.7 0.0 0.7 2.5 1.2 8.2 0.5 1.2 1.2 0.9 1.3 0.0 1.6 5.4 0.0 1.5 0.4 0.2 2.6 0.9 1.0 0.0 2.1 0.6 0.5 0.9 0.6 0.0 0.9 0.1 0.1 3.3 3.5 1.7 0.8 1.4 0.1 0.1 0.0 0.1 0.4 0.0 1.0 0.0 1.0 0.6 0.0 0.1 0.0 0.9 0.6 0.1 0.0 0.0 4.6 0.2 12.8 14.9 11.3 23.7 12.2 7.6 5.6 13.0 7.3 4.3 0.0 2.1 0.0 0.4 0.3 64.6 1.2 0.0 4.0 0.0 5.2 208.1 0.2 0.0 0.1 86.7 0.7 0.3 0.0 0.2 0.1 0.7 0.2 1.1 0.0 0.4 7.9 0.0 3.1 0.6 11.7 0.9 1.0 1.7 2.8 0.0 3.0 0.2 0.0 0.4 0.0 135.4 0.0 0.4 0.7 3.4 0.4 1.1 2.1 0.0 0.6 MCM3AP "GANP, KIAA0572, Map80, SAC3" ENSG00000160294 "Minichromosome maintenance complex component 3 associated protein" O60318 21 46235126-46286297 "Predicted intracellular proteins, Transporters" "Immunity, mRNA transport, Protein transport, Translocation, Transport" "Acyltransferase, Transferase" "Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021527, HPA032103" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" Nucleoplasm "HPA021527: AB_1853626, HPA032103: AB_2674152" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (6.31e-3)" "unprognostic (1.48e-2)" "unprognostic (2.06e-1)" "unprognostic (4.17e-2)" "unprognostic (4.76e-3)" "prognostic favorable (2.05e-4)" "unprognostic (1.96e-1)" "unprognostic (2.81e-3)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (2.28e-1)" 19.4 16.7 14.2 21.5 25.3 19.5 19.0 26.6 29.2 18.3 17.2 27.7 19.3 15.4 24.8 18.0 18.1 21.1 16.3 17.9 14.4 13.2 15.5 13.3 18.2 21.9 16.5 14.6 23.7 17.5 25.7 20.6 18.2 18.2 17.7 17.6 21.3 22.1 21.4 52.9 18.2 19.9 19.5 15.1 20.7 18.7 15.7 15.7 31.8 19.6 15.7 26.0 21.1 16.4 4.8 4.8 3.8 4.9 3.0 6.9 4.1 16.0 15.8 18.6 20.0 15.2 19.0 16.9 17.7 21.7 16.8 13.7 14.4 9.6 22.9 14.6 18.7 18.1 9.6 24.5 14.9 14.8 23.5 22.2 37.5 15.1 11.2 13.7 17.0 21.2 14.8 13.0 22.9 15.9 11.5 17.8 13.9 44.7 17.5 19.3 9.2 18.2 11.5 31.9 17.5 13.2 23.8 11.7 20.7 8.2 14.9 15.7 16.7 22.6 15.0 17.3 14.7 20.4 17.8 22.5 17.6 13.4 14.6 13.2 31.9 35.3 14.2 15.9 16.5 22.8 1.5 4.7 3.8 6.1 4.9 6.5 2.9 3.7 6.9 4.8 4.8 3.3 3.4 2.9 3.0 2.7 4.2 4.4 4.1 14.2 25.3 26.6 29.2 14.4 13.2 16.5 14.6 18.2 15.7 8.9 17.6 16.7 6.1 6.3 21.7 3.6 15.3 10.7 12.5 10.4 19.6 9.8 1.7 9.7 2.5 7.8 12.3 0.0 12.4 9.8 8.9 11.6 8.1 15.3 13.5 15.9 11.5 13.5 20.6 3.6 17.0 12.4 10.1 21.6 18.4 8.9 12.8 7.0 13.4 5.2 21.0 19.4 6.6 18.9 13.4 9.2 7.8 8.5 14.5 5.5 MCMBP "C10orf119, FLJ13081, MCM-BP" ENSG00000197771 "Minichromosome maintenance complex binding protein" Q9BTE3 10 119829404-119892556 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013792, HPA038481" Uncertain Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB013792: , HPA038481: AB_10794620" "unprognostic (1.26e-1)" "unprognostic (7.92e-2)" "unprognostic (4.62e-2)" "unprognostic (2.31e-2)" "unprognostic (1.72e-2)" "unprognostic (4.64e-2)" "unprognostic (1.31e-3)" "unprognostic (5.61e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (7.32e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.23e-2)" "unprognostic (8.24e-2)" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" 33.6 15.3 11.7 23.2 13.8 14.6 35.5 17.2 13.8 27.0 26.3 16.9 11.4 15.5 28.0 14.9 26.4 23.0 18.7 26.3 12.0 10.2 18.7 23.7 28.5 38.6 17.4 8.5 29.2 18.2 23.2 17.6 35.4 14.2 22.5 21.4 15.7 21.0 17.4 30.1 23.8 20.7 26.0 16.8 26.0 20.7 15.4 15.5 38.0 24.5 28.2 24.7 32.5 28.6 4.5 6.9 12.1 9.7 4.1 5.1 2.4 31.0 22.1 31.0 21.4 15.7 19.3 18.2 28.8 31.6 36.7 38.0 28.8 25.5 36.2 13.3 23.0 16.7 29.0 37.0 29.0 43.0 26.5 27.3 18.6 17.6 22.0 24.4 34.3 45.0 15.8 16.4 33.2 43.8 20.2 25.1 23.7 17.1 27.3 24.0 23.0 43.0 20.7 15.6 23.1 16.0 27.2 60.0 18.4 15.7 21.4 13.4 17.2 21.0 17.5 24.0 24.3 11.9 24.5 19.4 18.1 17.8 18.3 34.3 19.7 21.9 40.1 21.6 23.1 11.1 12.1 5.3 3.6 4.2 9.7 5.1 4.5 3.9 4.4 6.9 1.8 4.2 3.8 6.4 4.1 6.1 3.5 3.9 2.4 11.7 13.8 17.2 13.8 12.0 10.2 17.4 8.5 14.2 15.5 14.9 13.9 20.1 27.2 38.0 10.0 16.2 12.7 10.7 18.2 19.2 3.9 30.7 11.6 9.6 3.3 32.4 15.1 0.0 11.5 42.5 26.3 18.7 17.4 23.1 33.4 30.2 10.4 30.1 35.7 4.9 27.9 31.3 21.9 8.2 18.5 16.9 12.8 7.0 21.2 17.5 17.1 19.4 29.9 27.6 61.5 37.4 33.2 27.4 26.9 24.5 MCOLN3 "FLJ11006, TRP-ML3, TRPML3" ENSG00000055732 "Mucolipin 3" Q8TDD5 1 85018082-85048499 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.2;pituitary gland: 38.3" "Group enriched" "Detected in many" 8 "Intestinal endocrine cells: 109.0;Melanocytes: 143.4" "Cancer enriched" "Detected in many" 6 "melanoma: 8.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 10.1;HAP1: 10.0;RH-30: 12.2;SK-MEL-30: 21.6" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 1.7" "HPA018106, HPA062137" Enhanced Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA018106: AB_1853647, HPA062137: AB_2684695" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (1.49e-2)" "unprognostic (3.21e-5)" "unprognostic (2.25e-1)" "unprognostic (8.80e-3)" "unprognostic (3.97e-3)" "unprognostic (1.13e-1)" "unprognostic (2.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.45e-3)" "unprognostic (3.09e-2)" "unprognostic (7.32e-5)" "unprognostic (6.36e-3)" "unprognostic (2.61e-1)" "unprognostic (6.11e-2)" "unprognostic (6.43e-2)" 4.7 29.2 1.5 0.8 0.8 0.0 3.0 0.2 0.4 6.1 2.8 0.9 2.1 3.2 5.4 15.6 0.8 1.1 0.6 5.1 3.4 0.3 4.5 0.2 4.1 0.0 0.5 0.0 2.2 6.5 17.9 38.3 1.8 2.7 0.5 0.5 4.5 8.1 0.4 1.9 2.5 1.9 1.1 0.3 0.9 1.6 0.4 0.3 2.6 1.5 0.9 0.4 0.7 2.8 0.0 0.0 0.0 0.0 0.0 2.9 0.7 6.5 1.5 0.0 0.0 5.3 4.8 1.7 0.1 10.1 2.5 7.0 0.5 1.2 0.0 0.7 0.1 2.3 0.0 10.0 3.2 1.6 2.6 5.9 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.2 2.1 1.2 2.6 0.0 0.0 0.0 0.0 4.9 0.6 0.0 0.0 0.7 0.0 0.6 0.0 12.2 0.0 0.3 0.0 0.4 0.0 0.3 0.0 21.6 0.8 4.1 5.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.8 0.2 0.4 3.4 0.3 0.5 0.0 2.7 0.3 14.9 1.7 0.0 3.6 7.7 0.0 6.9 10.2 0.0 1.2 3.5 0.0 6.4 0.0 1.9 0.3 0.5 1.3 0.0 8.4 0.1 5.1 1.1 0.0 0.0 3.4 0.0 109.0 0.0 0.0 0.0 1.7 0.8 143.4 2.8 0.6 0.0 4.9 7.8 0.0 2.2 0.0 6.5 1.2 0.9 1.6 3.0 2.2 0.0 0.6 0.3 MCRIP1 "FAM195B, GRAN2, MCRIP" ENSG00000225663 "MAPK regulated corepressor interacting protein 1" C9JLW8 17 81822361-81833302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 209.6;Extravillous trophoblasts: 120.1;Hofbauer cells: 139.9;Pancreatic endocrine cells: 110.1;Proximal tubular cells: 118.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045542 Approved Approved Cytosol NA NA Cytosol "HPA045542: AB_2679363" "unprognostic (3.11e-3)" "unprognostic (3.82e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-3)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" "unprognostic (3.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (9.08e-3)" "prognostic favorable (2.26e-4)" "unprognostic (2.53e-2)" "unprognostic (3.65e-2)" "unprognostic (4.84e-2)" "unprognostic (1.64e-1)" "unprognostic (2.87e-1)" "unprognostic (1.86e-1)" 34.8 29.8 43.1 23.9 29.9 32.2 19.7 27.4 47.8 20.9 29.4 23.3 13.9 12.9 26.3 19.6 20.2 28.2 25.9 46.0 36.4 32.8 21.9 17.9 21.3 28.6 37.0 34.6 28.5 36.3 11.9 22.8 25.4 34.3 24.1 5.6 18.3 33.6 24.7 25.4 11.1 14.2 22.5 32.4 24.3 16.8 35.9 27.4 33.3 29.0 14.2 11.2 28.0 19.9 33.2 37.4 49.8 40.7 23.6 38.2 33.7 13.1 20.7 23.1 24.3 15.0 17.5 18.2 15.7 11.4 19.3 21.2 5.4 13.2 8.2 9.2 13.2 7.1 3.0 2.7 9.4 4.6 8.8 29.4 14.4 3.5 20.8 15.2 9.4 13.4 19.0 9.4 10.9 4.7 10.4 34.3 19.1 11.5 7.1 12.8 8.7 30.3 22.7 14.3 5.4 12.0 12.0 14.8 3.7 6.5 11.9 19.7 61.6 7.7 10.2 47.7 9.4 9.1 13.0 20.8 27.4 29.2 29.9 28.4 3.7 1.1 5.3 25.5 8.7 21.6 49.8 30.5 40.1 38.2 39.1 29.0 23.3 29.9 33.9 27.4 33.2 24.5 28.0 23.5 23.6 40.7 37.4 35.0 33.7 43.1 29.9 27.4 47.8 36.4 32.8 37.0 34.6 34.3 27.4 17.9 37.8 0.0 0.0 0.0 0.0 0.0 0.0 25.4 20.5 36.6 0.0 100.3 63.0 86.4 0.0 0.0 0.0 0.0 209.6 120.1 0.0 0.0 18.6 0.0 139.9 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 85.6 0.0 0.0 110.1 0.0 0.0 118.3 0.0 0.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 MCTP1 FLJ22344 ENSG00000175471 "Multiple C2 and transmembrane domain containing 1" Q6DN14 5 94703741-95284575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 49.2;brain: 42.4" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 29.9;granulocytes: 61.2;Kupffer cells: 33.5;Macrophages: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 41 "basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 52 "dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2" "Cell line enhanced" "Detected in many" "Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019018 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019018: AB_1853665" "unprognostic (1.20e-2)" "unprognostic (6.70e-4)" "unprognostic (1.77e-2)" "unprognostic (1.03e-2)" "unprognostic (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" "unprognostic (1.86e-1)" "unprognostic (6.99e-2)" "unprognostic (5.31e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-6)" "unprognostic (5.38e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (4.43e-2)" 49.2 2.7 6.5 11.4 42.4 36.9 18.3 18.3 16.5 6.9 7.2 0.3 4.4 5.0 11.1 9.2 6.5 4.1 16.7 4.6 8.5 7.4 3.0 3.8 11.3 5.5 4.1 3.8 3.3 3.4 3.1 5.2 7.1 3.9 5.9 7.3 1.0 4.3 2.7 5.1 4.5 4.8 10.9 5.7 8.2 5.3 4.0 8.1 5.5 5.0 21.2 4.3 17.3 12.6 0.3 10.1 18.7 19.2 0.2 0.2 3.3 0.1 2.0 1.3 0.0 20.0 8.0 0.0 0.1 9.8 0.9 3.2 0.0 5.2 7.2 7.7 0.0 20.5 0.0 0.1 0.1 1.1 0.0 1.4 4.3 4.9 0.0 2.6 8.9 5.8 2.9 0.0 3.6 13.1 8.5 20.7 3.0 0.1 28.3 7.4 0.2 0.5 6.8 1.6 0.1 8.2 0.3 0.0 28.0 21.3 11.3 4.0 0.2 0.6 0.0 14.6 0.6 0.0 8.4 0.1 3.6 5.6 0.1 1.6 2.0 0.0 0.0 16.9 14.9 3.6 11.5 12.9 5.8 0.0 19.2 0.0 0.3 0.0 0.1 10.1 0.1 0.2 0.0 18.7 0.2 17.6 5.3 0.0 3.3 6.5 42.4 18.3 12.2 8.5 7.4 4.1 3.8 3.9 8.1 3.0 9.6 0.0 0.1 16.1 2.0 2.5 0.0 4.0 6.8 3.5 0.0 0.3 0.0 0.0 20.6 29.9 0.0 0.0 0.2 0.1 3.0 0.6 61.2 0.5 10.7 3.2 0.0 1.8 33.5 12.2 0.6 35.3 11.8 0.0 0.0 3.6 0.8 0.0 0.0 0.0 3.7 0.0 2.2 1.4 1.4 11.7 0.2 2.2 0.0 0.4 MCTP2 "FLJ11175, FLJ33303" ENSG00000140563 "Multiple C2 and transmembrane domain containing 2" Q6DN12 15 94231538-94483952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.6" "Cell type enhanced" "Detected in many" 5 "granulocytes: 35.7;Mucus-secreting cells: 42.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 14.5;HMC-1: 12.0;U-698: 15.9;U-87 MG: 18.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA051176, HPA070541" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051176: AB_2681373, HPA070541: AB_2686277" "unprognostic (1.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.63e-2)" "unprognostic (7.15e-4)" "unprognostic (3.57e-2)" "unprognostic (2.66e-3)" "unprognostic (3.45e-2)" "unprognostic (3.68e-3)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.18e-5)" "unprognostic (5.87e-2)" "unprognostic (4.36e-1)" "unprognostic (1.76e-3)" "unprognostic (9.41e-2)" 5.3 4.1 0.8 19.7 1.7 12.6 2.7 0.7 1.5 5.4 12.3 0.0 6.9 5.6 4.0 9.5 5.7 4.5 10.3 4.6 1.0 2.2 3.6 2.3 12.4 18.4 2.5 0.8 3.8 10.0 5.3 24.4 17.1 0.6 6.8 10.2 2.5 16.8 9.6 0.8 4.0 10.9 4.0 0.9 41.6 3.7 1.7 0.4 3.0 8.7 4.1 12.9 6.2 14.8 2.7 0.1 21.2 0.5 6.8 4.4 1.1 2.5 0.0 0.0 0.0 0.0 0.0 1.8 1.3 0.8 0.2 0.1 1.7 3.1 7.3 0.3 0.0 0.0 5.7 0.1 4.7 0.0 1.4 0.5 14.5 2.0 0.8 1.0 3.0 12.0 0.8 5.8 0.1 6.0 0.0 0.0 2.5 0.5 4.1 0.0 0.0 1.4 8.0 0.6 2.4 2.6 3.3 0.1 2.7 0.3 7.6 1.4 0.3 0.1 2.4 0.9 0.5 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.7 0.1 15.9 18.0 7.9 0.9 3.2 0.5 7.7 4.4 0.1 2.1 2.2 1.2 1.9 0.0 2.7 0.5 1.9 21.2 6.8 0.5 0.1 0.0 1.1 0.8 1.7 0.7 1.5 1.0 2.2 2.5 0.8 0.6 0.4 3.0 24.7 20.4 10.8 3.8 0.8 0.8 5.1 5.3 15.9 3.5 0.0 13.2 0.0 2.7 3.2 2.1 18.6 0.0 4.1 5.9 7.2 13.7 35.7 1.3 7.5 0.0 15.0 1.3 12.7 3.9 0.3 2.1 1.7 0.0 42.4 0.2 4.0 21.0 0.0 1.7 0.5 0.0 0.8 0.1 2.0 1.9 20.5 19.7 18.7 14.9 MCTS1 MCT-1 ENSG00000232119 "MCTS1, re-initiation and release factor" Q9ULC4 X 120594010-120621074 "Predicted intracellular proteins" "Cell cycle, DNA damage, Growth regulation, Protein biosynthesis, Transcription, Transcription regulation" "Initiation factor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001045 Supported "Plasma membrane,Cytosol" NA NA 52000 Cytosol "Plasma membrane" "HPA001045: " "prognostic unfavorable (1.38e-4)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (9.37e-3)" "unprognostic (7.29e-2)" "prognostic unfavorable (3.27e-5)" "unprognostic (2.94e-3)" "unprognostic (9.59e-2)" "unprognostic (8.28e-2)" "unprognostic (4.89e-2)" "unprognostic (7.42e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (4.35e-5)" "unprognostic (1.95e-1)" "unprognostic (7.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" 20.2 26.8 23.7 22.5 29.3 16.9 27.4 16.8 33.8 20.7 24.0 14.3 26.6 23.2 17.4 30.7 31.7 16.6 16.8 24.6 25.2 22.4 22.7 37.9 17.2 31.1 22.6 25.0 14.7 42.0 21.1 38.2 20.7 22.3 16.6 29.7 13.4 31.0 27.3 20.9 18.1 21.2 19.2 20.8 24.1 22.9 13.1 19.0 28.5 23.1 32.1 36.1 20.5 19.1 28.2 32.0 13.7 24.4 17.7 24.5 15.5 31.3 22.1 18.0 18.0 23.0 33.5 24.5 23.6 21.7 29.8 28.6 19.2 31.1 33.8 34.0 29.1 53.9 20.9 31.6 30.1 43.2 21.3 21.0 10.9 24.5 15.1 26.2 27.4 21.0 23.0 26.6 25.9 28.3 25.3 35.9 24.3 29.7 22.6 36.6 36.1 26.2 36.6 20.1 58.6 43.8 20.2 16.6 40.9 31.8 15.7 22.8 21.2 16.5 26.9 21.3 23.2 19.8 25.3 24.5 24.2 14.8 26.1 43.3 17.1 23.1 46.0 28.1 40.4 26.3 11.9 20.1 13.7 15.1 24.4 24.5 28.2 19.8 19.3 24.8 20.7 18.3 18.5 9.9 17.7 22.4 32.0 22.9 15.5 23.7 29.3 16.8 33.8 25.2 22.4 22.6 25.0 22.3 19.0 17.9 22.2 67.0 49.4 28.6 12.4 74.2 43.3 28.1 29.6 43.6 7.9 83.5 109.5 76.8 43.6 38.3 78.6 0.0 76.9 150.4 40.7 48.4 51.8 84.7 116.3 14.3 53.5 53.4 77.2 73.5 38.9 64.4 59.1 54.1 77.4 19.3 85.0 71.9 26.2 116.5 16.5 38.8 36.0 9.3 15.1 30.2 94.4 51.1 64.3 66.0 MDH1 ENSG00000014641 "Malate dehydrogenase 1" P40925 2 63588609-63607197 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 155.8" "Cell type enhanced" "Detected in all" 12 "Cardiomyocytes: 1859.7;Proximal tubular cells: 683.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027296, CAB047333, HPA054276" Uncertain Supported Centrosome,Cytosol NA NA 63000000 "Centrosome, Cytosol" "CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434" "unprognostic (1.01e-1)" "unprognostic (6.52e-3)" "unprognostic (1.61e-2)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.83e-1)" "unprognostic (8.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.79e-2)" "unprognostic (9.52e-2)" "unprognostic (2.05e-1)" "unprognostic (3.26e-1)" "unprognostic (8.80e-2)" "prognostic favorable (9.95e-4)" "unprognostic (6.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.97e-2)" "unprognostic (3.05e-1)" 32.0 28.6 28.0 10.5 58.1 9.2 18.4 38.0 69.5 12.4 21.4 12.5 9.0 19.3 13.4 22.6 16.7 14.7 11.5 155.8 33.6 37.5 47.6 33.2 11.2 14.7 33.4 40.1 10.9 8.9 26.0 18.3 11.4 65.9 16.1 24.9 13.8 15.4 19.9 91.1 11.1 17.1 21.5 18.6 9.4 22.4 8.6 12.2 14.1 15.6 47.1 20.2 15.6 10.2 61.7 57.1 50.7 61.5 46.7 74.5 67.8 44.2 36.3 49.1 32.1 69.7 51.7 50.8 34.9 51.6 53.1 53.9 42.9 39.4 55.8 20.7 45.7 66.4 39.0 55.2 64.6 76.3 33.7 42.6 52.3 33.9 68.2 38.3 60.2 41.5 51.2 44.2 49.8 29.4 43.3 40.5 56.8 28.9 40.6 69.9 26.6 52.7 60.8 28.7 66.4 45.2 42.1 57.8 54.7 88.0 42.0 45.5 27.1 29.2 47.2 66.8 39.1 34.4 62.9 23.6 40.8 40.0 33.9 43.8 50.7 44.4 68.3 50.4 54.5 33.7 50.7 45.8 45.8 52.7 61.5 55.0 61.7 61.3 57.6 57.1 56.4 60.5 57.5 7.0 46.7 55.7 43.3 74.5 67.8 28.0 58.1 38.0 69.5 33.6 37.5 33.4 40.1 65.9 12.2 56.6 41.7 76.8 91.9 72.5 153.0 1859.7 86.6 136.5 79.6 127.4 66.8 222.4 533.9 152.0 8.3 50.1 143.7 70.0 94.8 211.6 90.4 54.0 78.5 143.3 336.7 116.0 60.3 41.1 68.1 11.1 92.6 78.1 168.7 212.0 97.2 112.7 85.3 103.5 102.6 683.5 120.0 58.2 87.6 48.3 49.0 73.4 125.1 76.2 138.8 88.5 MDM1 ENSG00000111554 "Mdm1 nuclear protein" Q8TC05 12 68272443-68332381 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 49.5;Spermatocytes: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA040411, HPA041594" Uncertain Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA040411: AB_10805711, HPA041594: AB_10793968" "unprognostic (7.41e-2)" "prognostic favorable (6.01e-4)" "unprognostic (8.58e-2)" "unprognostic (2.62e-3)" "unprognostic (1.21e-1)" "unprognostic (3.50e-3)" "unprognostic (4.24e-3)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" "unprognostic (2.92e-1)" "unprognostic (2.56e-3)" "unprognostic (3.13e-2)" "unprognostic (4.29e-3)" "unprognostic (1.29e-1)" "unprognostic (2.84e-1)" "unprognostic (4.63e-2)" "unprognostic (5.23e-3)" 7.0 6.7 11.5 11.9 11.4 15.4 10.0 8.2 12.7 11.9 28.7 9.6 12.4 5.1 15.2 12.7 5.4 20.3 6.5 6.7 12.3 10.0 8.8 4.9 6.8 12.8 11.4 10.5 10.9 11.3 8.8 22.8 6.0 14.9 12.3 11.1 9.0 6.8 15.9 3.8 4.2 9.0 18.8 11.4 9.5 9.8 20.7 12.4 14.6 11.0 5.3 13.4 17.0 8.9 7.1 4.0 13.3 17.2 6.0 8.1 5.4 5.0 4.2 8.1 7.8 4.0 5.5 6.2 6.7 3.7 10.7 9.9 5.0 2.3 11.6 4.4 3.0 5.3 5.2 5.5 3.6 12.2 15.1 5.3 25.4 5.4 3.4 6.2 14.0 10.1 2.5 4.7 7.2 7.0 5.8 6.0 13.4 4.8 13.0 6.2 3.6 19.8 9.9 4.3 5.0 5.1 19.5 7.2 3.4 5.1 4.4 7.4 3.9 6.5 3.9 6.6 6.7 9.3 10.1 3.2 8.6 3.8 5.4 6.1 6.8 19.8 7.8 4.5 9.2 5.5 6.0 4.7 13.3 5.0 11.1 8.1 6.8 6.4 5.2 4.0 7.1 7.7 6.2 3.1 6.0 17.2 2.3 5.9 5.4 11.5 11.4 8.2 12.7 12.3 10.0 11.4 10.5 14.9 12.4 3.0 5.8 13.3 3.9 4.2 12.7 8.1 0.0 49.5 7.9 7.0 0.0 3.7 8.3 4.3 22.5 6.3 1.6 23.3 3.1 3.8 5.8 2.3 6.9 4.2 5.4 7.9 2.4 3.7 2.4 9.0 8.3 7.6 15.1 3.6 2.6 24.9 2.7 3.6 12.7 8.4 32.9 6.5 7.2 38.1 17.8 3.6 0.2 13.6 4.1 1.3 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642499-89819723 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 27.1;NTERA-2: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 10.0 8.8 8.6 10.1 18.2 16.1 14.9 19.2 18.7 9.1 7.5 14.8 8.6 5.9 14.1 10.0 9.2 10.2 6.4 8.6 9.4 9.6 9.4 15.1 7.3 10.9 13.1 12.4 22.3 10.7 19.0 10.9 5.9 15.9 8.1 8.6 9.4 9.3 8.3 16.2 19.6 8.8 9.2 12.7 9.0 8.2 14.0 13.7 8.4 12.8 8.2 12.7 7.5 7.8 3.8 8.9 6.7 1.0 3.3 4.2 0.3 4.6 4.6 4.8 4.5 7.9 7.5 4.8 3.2 2.4 3.6 4.5 10.6 1.7 14.0 3.7 3.3 3.9 4.1 12.4 4.3 6.5 5.5 8.2 15.2 5.9 6.9 3.0 19.6 3.8 4.6 3.7 9.7 9.0 2.2 6.4 6.4 27.1 3.4 3.5 5.6 3.0 7.4 26.4 3.9 4.0 6.1 9.1 3.5 3.2 6.6 8.7 3.9 4.5 2.7 2.9 6.6 1.9 8.7 8.2 2.4 4.5 3.2 7.4 3.9 4.3 6.9 3.3 11.2 4.2 6.7 1.0 1.9 2.4 0.8 2.1 3.0 3.3 2.6 0.6 3.8 4.2 3.3 0.2 3.3 1.0 8.9 1.3 0.3 8.6 18.2 19.2 18.7 9.4 9.6 13.1 12.4 15.9 13.7 26.8 15.5 8.5 5.2 26.1 24.4 30.7 7.6 13.4 25.0 14.0 23.6 4.9 0.0 5.9 6.0 13.3 4.6 23.3 6.9 5.7 10.0 7.3 5.8 41.4 5.9 17.5 7.5 9.2 3.3 2.5 6.6 6.6 11.8 2.8 6.9 7.8 5.6 3.5 8.1 1.8 19.5 0.0 9.5 21.7 50.0 26.3 2.9 9.6 9.3 8.7 ME1 ENSG00000065833 "Malic enzyme 1" P48163 6 83210389-83431071 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Kupffer cells: 57.7;Muller glia cells: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 15.6" "Lineage enriched" "Detected in many" 11 "T-cells: 15.6" "Cell line enhanced" "Detected in many" "CACO-2: 42.9;OE19: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006493 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3800000 "Nucleoplasm, Plasma membrane" Cytosol "HPA006493: AB_1078272" "unprognostic (7.21e-2)" "unprognostic (3.99e-2)" "unprognostic (2.24e-1)" "unprognostic (3.12e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (7.98e-3)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.24e-1)" "unprognostic (4.44e-3)" "unprognostic (1.41e-3)" "unprognostic (7.10e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.81e-7)" "unprognostic (4.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.85e-2)" "unprognostic (4.51e-2)" 30.7 35.3 16.3 4.6 17.7 0.8 27.1 5.5 13.1 5.9 6.7 5.4 39.2 18.1 3.8 7.4 24.5 4.2 13.5 21.3 10.5 14.0 3.6 12.4 7.7 6.0 16.8 11.8 10.0 3.3 30.0 11.1 2.9 16.3 7.9 10.1 9.3 7.8 30.2 25.7 10.1 8.7 18.7 17.2 6.3 20.0 13.4 7.2 1.4 6.3 20.9 4.5 13.7 14.9 0.0 0.0 0.0 1.4 0.0 15.6 0.5 8.8 18.3 0.4 0.0 15.6 14.6 0.0 5.7 14.7 6.1 11.9 42.9 7.8 0.0 15.0 13.4 12.2 9.3 13.6 5.1 6.7 0.0 7.6 0.0 11.7 0.0 20.0 4.3 16.1 15.9 10.3 12.3 8.4 10.3 9.5 0.0 6.1 0.0 8.3 9.9 0.0 4.9 0.0 48.5 7.2 0.0 15.4 8.5 18.1 4.2 1.8 4.7 9.7 14.4 0.3 8.3 0.0 10.6 10.0 3.8 4.6 1.2 0.0 3.4 3.9 0.0 0.0 0.0 11.2 0.0 1.4 0.0 0.8 0.3 15.6 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 16.3 17.7 5.5 13.1 10.5 14.0 16.8 11.8 16.3 7.2 17.9 8.9 0.0 4.2 1.6 16.7 35.8 5.1 1.4 6.8 5.2 2.0 0.5 1.7 10.0 4.4 1.9 8.0 0.0 8.4 0.6 7.1 5.6 0.0 12.4 6.8 12.7 0.0 4.9 57.7 4.2 23.9 9.5 0.0 5.4 4.0 93.9 12.7 5.8 35.0 2.6 6.4 0.0 3.3 4.9 1.5 3.0 0.7 0.9 5.5 1.8 MEA1 MEA ENSG00000124733 "Male-enhanced antigen 1" Q16626 6 43011143-43016868 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 109.4" "Group enriched" "Detected in many" 5 "Early spermatids: 615.5;Late spermatids: 1508.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017921, HPA073087" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017921: AB_1853708, HPA073087: " "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (1.42e-1)" "unprognostic (2.15e-1)" "unprognostic (2.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.74e-2)" "prognostic favorable (3.37e-4)" "unprognostic (8.56e-2)" "unprognostic (2.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (2.07e-1)" "unprognostic (8.62e-2)" "unprognostic (1.89e-2)" "unprognostic (5.58e-2)" 16.8 17.4 26.6 13.9 23.4 11.8 17.4 13.1 29.9 16.2 14.3 17.2 14.0 12.7 20.1 25.2 16.8 20.5 17.2 12.5 20.9 25.4 16.5 18.7 15.2 14.2 21.9 20.8 22.7 26.7 13.2 17.7 17.3 17.5 20.9 17.0 19.6 16.6 20.3 14.6 15.2 13.1 19.5 15.7 12.8 13.0 109.4 8.7 19.1 15.8 13.4 21.2 21.5 14.1 61.2 40.9 70.6 51.0 46.6 51.7 59.9 38.7 22.4 33.6 26.6 30.8 20.6 13.4 26.0 27.7 32.5 35.7 33.3 10.2 20.3 27.3 31.7 47.5 19.7 25.9 35.3 30.6 23.2 35.1 37.7 24.5 35.9 15.9 27.4 19.8 16.4 17.6 43.1 28.2 33.1 19.5 33.3 25.4 22.8 35.5 74.3 36.7 31.8 15.8 110.3 19.8 18.0 20.0 20.2 22.4 36.8 32.5 22.8 20.0 17.2 29.5 28.3 26.2 30.0 14.4 35.9 28.9 23.2 44.8 26.0 21.5 33.9 18.0 20.6 29.1 64.5 39.2 70.6 46.7 44.5 42.9 61.2 42.9 45.6 40.9 56.8 43.2 45.8 35.9 46.6 51.0 40.0 51.7 59.9 26.6 23.4 13.1 29.9 20.9 25.4 21.9 20.8 17.5 8.7 23.8 11.8 43.2 62.1 58.8 20.2 24.9 43.3 58.9 39.8 52.4 3.9 94.6 142.6 74.9 615.5 56.2 55.4 0.0 80.2 87.3 55.2 61.8 46.1 39.4 95.1 15.9 28.7 41.7 31.9 1508.8 58.7 50.6 64.1 93.8 42.8 52.2 71.4 49.1 56.3 121.5 14.8 116.4 68.9 194.8 94.1 60.9 71.1 58.2 45.3 74.3 MED17 "CRSP6, CRSP77, DRIP80, SRB4, TRAP80" ENSG00000042429 "Mediator complex subunit 17" Q9NVC6 11 93784227-93814963 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046619 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA046619: " "prognostic unfavorable (4.94e-4)" "unprognostic (2.92e-1)" "unprognostic (2.72e-3)" "unprognostic (1.38e-1)" "unprognostic (6.71e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.48e-3)" "unprognostic (7.73e-2)" "unprognostic (1.41e-1)" "unprognostic (4.59e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-1)" "unprognostic (2.22e-1)" "unprognostic (5.56e-3)" "unprognostic (1.48e-1)" 9.0 7.4 5.8 9.9 8.0 9.5 9.2 13.9 10.7 10.7 10.2 9.0 9.4 4.3 12.1 7.5 7.9 10.4 7.3 11.5 6.3 5.4 6.4 4.6 8.2 8.1 9.5 7.3 13.8 9.9 5.4 13.1 9.5 6.1 8.2 4.9 8.0 9.4 6.6 9.3 10.2 14.0 7.7 7.7 13.9 12.1 7.9 8.8 20.7 7.8 5.5 9.8 11.2 11.6 10.5 6.8 10.8 5.7 10.2 8.5 5.1 3.0 1.0 2.6 5.5 3.2 0.4 5.1 6.7 2.3 4.5 2.8 5.3 6.3 5.0 11.3 0.6 1.3 9.4 2.4 1.4 1.2 6.0 2.7 5.6 3.4 1.5 1.7 9.3 9.5 1.3 3.3 3.3 2.2 1.1 1.8 1.3 4.9 3.0 2.7 0.8 11.2 2.7 4.8 0.7 0.8 8.6 7.6 4.1 2.7 2.1 9.1 11.7 5.6 4.6 2.8 0.7 7.0 2.3 6.0 7.0 5.6 9.3 5.8 4.6 9.1 3.6 1.8 6.6 7.9 4.9 4.6 10.8 6.4 5.7 7.6 10.5 8.2 8.0 6.0 9.0 8.5 4.8 4.7 10.2 3.3 6.8 8.1 5.1 5.8 8.0 13.9 7.9 6.3 5.4 9.5 7.3 6.1 8.8 6.0 9.4 35.0 34.7 26.8 21.7 12.1 12.7 18.7 14.8 7.0 15.7 32.8 1.7 12.8 0.7 13.4 11.5 0.0 8.5 22.7 17.1 21.5 10.4 6.8 12.9 14.3 25.7 13.5 13.7 2.2 14.7 12.1 13.5 11.8 11.2 17.1 9.7 14.1 20.1 1.5 35.0 64.7 19.8 24.7 15.4 22.5 28.5 20.3 13.8 32.7 MED21 "SRB7, SURB7" ENSG00000152944 "Mediator complex subunit 21" Q13503 12 27022546-27066343 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017177 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA017177: AB_1857665" "unprognostic (3.02e-1)" "unprognostic (7.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (7.18e-3)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" "unprognostic (7.32e-2)" "unprognostic (1.03e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.74e-8)" "unprognostic (3.18e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-2)" 20.7 31.5 20.7 13.3 32.4 31.9 23.9 25.9 31.9 24.8 21.9 18.0 18.8 14.9 25.9 21.7 30.4 20.8 19.6 31.3 19.5 21.9 34.1 18.8 20.8 15.7 21.1 26.2 30.8 17.1 30.3 26.0 19.8 23.6 27.6 20.6 18.3 25.3 24.5 30.7 19.3 17.4 27.3 20.2 16.0 19.6 28.9 22.1 22.1 28.2 28.7 19.9 31.6 27.2 20.1 15.8 35.5 18.6 12.8 28.0 19.1 16.6 17.6 9.3 14.8 20.8 21.0 15.4 19.0 14.3 16.1 21.0 18.4 19.0 11.0 12.1 14.5 23.4 13.8 19.8 17.6 27.8 9.6 17.7 15.8 18.2 11.3 11.6 19.3 11.4 14.8 25.8 19.9 23.9 26.1 23.3 14.9 12.8 14.7 18.1 12.5 16.9 35.6 28.5 21.2 23.3 14.6 59.7 12.4 16.7 19.1 7.1 10.4 23.2 10.0 15.0 37.3 17.7 12.9 16.8 18.0 14.0 22.3 19.2 4.5 9.3 18.1 17.1 21.6 12.1 35.5 17.5 23.9 20.4 18.6 20.8 20.1 24.6 23.9 15.8 16.6 28.0 25.3 14.0 12.8 16.5 12.9 23.8 19.1 20.7 32.4 25.9 31.9 19.5 21.9 21.1 26.2 23.6 22.1 14.9 16.5 22.6 105.7 87.8 9.2 30.8 7.6 12.0 29.6 50.6 0.0 52.6 79.6 36.3 190.1 33.7 16.5 23.3 33.3 49.3 57.0 71.3 18.4 20.0 27.5 12.7 17.1 22.1 17.5 59.3 44.8 27.0 67.4 36.9 17.6 15.1 29.2 17.3 44.6 72.5 13.1 19.4 58.7 92.2 54.3 88.5 51.0 27.7 17.2 125.9 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 45.5;Late spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No Nucleoplasm "Vesicles, Cytosol" "HPA057997: AB_2732618, HPA071835: AB_2686455" "unprognostic (2.02e-2)" "prognostic favorable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 5.5 4.6 5.9 8.3 6.2 14.0 7.3 8.7 6.2 6.0 5.1 4.2 5.2 4.0 5.7 6.0 6.2 4.3 4.4 4.0 5.1 4.5 3.7 5.9 9.0 7.6 4.8 4.5 6.2 6.8 6.8 5.4 7.9 4.9 5.4 3.3 3.8 7.2 7.9 9.9 7.1 4.8 4.2 4.5 6.8 5.1 34.7 4.6 8.5 5.0 6.0 6.9 4.8 5.7 2.6 4.4 2.3 1.0 1.2 2.3 0.4 9.1 3.6 3.3 7.1 4.3 3.4 9.7 5.4 3.8 5.8 5.3 5.3 5.5 14.7 5.7 3.4 1.9 6.9 5.1 5.4 4.0 10.8 10.5 5.8 3.3 4.2 4.2 6.5 5.5 4.1 5.3 4.9 5.2 3.5 3.1 7.8 9.4 17.8 3.6 9.1 6.9 6.2 7.8 4.4 11.5 7.2 5.0 16.0 3.4 3.6 8.8 4.6 4.7 4.6 5.3 2.4 3.4 8.6 3.7 7.4 5.9 9.0 7.1 12.4 10.0 11.8 5.2 8.7 4.3 2.3 0.4 0.4 1.6 1.0 0.3 1.4 0.2 0.7 0.8 2.6 1.0 0.2 1.2 1.2 0.4 4.4 2.3 0.4 5.9 6.2 8.7 6.2 5.1 4.5 4.8 4.5 4.9 4.6 3.0 10.1 12.7 3.9 12.6 3.9 0.7 2.5 1.4 1.2 5.2 9.8 5.8 3.3 3.7 45.5 4.7 4.3 0.0 3.4 8.8 6.2 4.9 1.1 4.0 4.3 4.8 2.4 3.7 9.4 52.0 6.1 4.7 1.7 2.8 4.3 5.2 5.1 3.5 3.5 1.9 5.7 0.0 6.4 21.0 16.9 9.4 14.1 4.9 5.0 7.6 MED27 "CRSP34, CRSP8, MED3, TRAP37" ENSG00000160563 "Mediator complex subunit 27" Q6P2C8 9 131860107-132079908 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007002 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA007002: AB_1078574" "unprognostic (8.81e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" "unprognostic (9.57e-2)" "unprognostic (1.32e-2)" "unprognostic (1.55e-2)" "unprognostic (6.07e-2)" "unprognostic (6.63e-3)" "unprognostic (1.63e-1)" "unprognostic (8.59e-3)" "unprognostic (5.93e-2)" "unprognostic (7.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.60e-2)" 11.1 12.1 18.0 9.5 18.1 15.5 11.5 14.0 21.4 10.9 11.7 19.5 10.1 7.8 18.6 23.5 15.5 13.9 9.5 17.5 17.5 11.2 10.4 7.5 10.9 13.5 18.6 19.1 12.7 7.9 10.6 17.8 12.7 17.4 12.7 10.7 16.0 17.7 14.4 15.2 15.7 8.6 16.3 16.1 11.7 10.2 14.7 14.0 17.9 13.2 9.6 15.8 12.3 10.5 12.9 19.8 13.4 18.6 18.0 19.7 11.8 16.1 15.9 18.4 14.6 13.2 12.2 15.5 16.8 22.4 33.8 26.5 23.8 13.1 16.0 11.4 17.5 22.6 29.4 25.4 23.9 22.2 17.2 15.0 12.0 16.7 14.1 19.8 21.5 15.2 13.4 16.5 26.6 27.3 10.7 17.6 23.5 17.5 13.4 24.6 25.7 23.1 12.5 18.7 15.9 27.1 20.4 26.0 19.6 13.6 9.0 34.4 13.9 21.7 11.2 11.2 12.3 17.8 10.1 14.7 34.4 15.1 25.4 25.3 5.4 16.6 28.4 19.1 15.0 23.4 3.5 12.2 13.4 18.9 18.6 15.3 11.6 14.8 18.5 19.2 12.9 12.7 15.5 4.8 18.0 16.0 19.8 19.7 11.8 18.0 18.1 14.0 21.4 17.5 11.2 18.6 19.1 17.4 14.0 14.9 8.5 3.0 11.2 5.4 24.5 5.9 5.1 6.7 10.3 12.2 17.7 28.2 11.6 13.9 12.9 10.6 2.1 0.0 14.5 17.3 8.9 5.1 10.4 4.9 15.2 20.6 5.1 5.5 3.7 5.4 13.3 8.8 6.8 11.8 4.2 23.3 12.9 0.0 15.9 6.0 17.8 6.5 8.3 20.7 22.2 4.4 45.8 10.2 4.7 10.7 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145568-19170289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "lymphoid tissue: 81.2" "Cell type enriched" "Detected in single" 16 "Sertoli cells: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "Daudi: 50.9;U-266/70: 51.2;U-698: 67.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 2.0 1.0 0.8 81.2 1.2 1.4 1.9 0.6 1.4 2.7 3.0 0.9 0.6 1.5 2.2 1.1 1.5 2.3 2.2 1.9 1.0 0.6 1.8 2.9 2.0 32.3 1.1 0.9 3.7 0.8 0.8 2.1 0.8 1.0 3.7 1.0 1.8 3.5 1.1 1.4 2.3 3.1 1.1 1.2 6.7 1.7 1.7 0.8 1.6 3.0 3.5 58.7 1.9 2.9 0.1 0.2 1.1 0.9 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 50.9 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.1 0.5 0.0 0.2 0.3 0.3 0.0 0.0 0.9 0.4 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.5 0.1 51.2 4.7 67.3 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.6 1.4 1.0 0.6 1.1 0.9 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MEFV "FMF, MEF, TRIM20" ENSG00000103313 "MEFV, pyrin innate immunity regulator" O15553 16 3242028-3256627 "Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" Actin-binding "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.3" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 7.0;Kupffer cells: 14.8;Macrophages: 7.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "THP-1: 12.1" HPA077497 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA077497: " "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (4.96e-2)" "unprognostic (2.01e-1)" "unprognostic (2.49e-2)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "unprognostic (3.35e-2)" "unprognostic (2.97e-2)" "unprognostic (1.09e-1)" "unprognostic (8.89e-2)" "unprognostic (3.27e-1)" "unprognostic (7.58e-7)" "unprognostic (1.08e-1)" "unprognostic (7.16e-4)" "unprognostic (1.73e-3)" "unprognostic (1.48e-1)" 4.2 1.2 0.5 9.8 1.0 9.7 0.9 0.4 0.9 1.1 1.4 0.3 0.0 1.0 0.6 2.7 1.2 1.6 1.8 4.2 0.5 0.5 1.3 1.5 11.4 14.8 2.8 0.1 1.2 1.8 0.2 0.7 1.8 0.8 0.9 0.6 1.7 0.8 0.7 1.7 0.6 1.3 1.6 2.2 23.3 1.0 2.2 1.3 1.2 1.7 0.2 1.4 2.7 4.1 0.4 2.1 10.0 6.5 0.5 0.3 1.3 0.1 0.1 0.1 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.2 1.1 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.1 12.1 0.1 0.3 0.1 0.1 0.1 0.5 0.4 0.2 0.4 2.1 0.0 2.5 3.8 0.2 0.1 4.2 0.1 0.2 0.2 0.1 2.1 0.4 0.1 0.3 10.0 0.5 6.5 0.3 0.1 1.3 0.5 1.0 0.4 0.9 0.5 0.5 2.8 0.1 0.8 1.3 0.0 2.2 0.0 0.0 0.2 0.0 7.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.9 0.0 0.0 0.6 14.8 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 MEGF9 EGFL5 ENSG00000106780 "Multiple EGF like domains 9" Q9H1U4 9 120600813-120714470 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 80.4;Cone photoreceptor cells: 200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.1" "Group enriched" "Detected in many" 5 "granulocytes: 19.1;monocytes: 5.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014319, HPA050238" Approved Approved Nucleoplasm,Cytosol NA NA 32000000 Nucleoplasm Cytosol "HPA014319: AB_1848035, HPA050238: AB_2681060" "unprognostic (1.18e-1)" "unprognostic (5.33e-2)" "unprognostic (1.84e-1)" "unprognostic (1.75e-2)" "unprognostic (3.30e-1)" "unprognostic (3.68e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-2)" "unprognostic (3.63e-2)" "unprognostic (1.13e-2)" "unprognostic (5.92e-2)" "unprognostic (4.97e-2)" "prognostic favorable (5.48e-11)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" 15.0 9.6 22.4 9.9 21.7 15.4 12.8 27.9 26.2 11.7 6.7 29.3 2.1 6.4 6.1 5.5 12.8 12.8 7.9 6.1 24.6 16.4 12.5 33.8 17.9 7.0 28.6 16.0 9.3 5.4 15.6 6.8 4.8 22.6 8.4 5.8 21.4 7.8 6.6 6.0 19.0 6.5 8.1 21.1 12.9 7.2 3.1 25.8 3.2 25.5 4.6 5.6 11.3 9.6 0.3 2.2 19.1 5.7 0.3 0.6 1.3 2.7 10.7 9.4 2.9 13.1 8.1 3.0 2.8 2.4 0.7 1.0 0.6 1.6 10.1 4.2 2.6 3.4 11.8 13.5 4.8 2.0 8.2 3.9 1.4 20.1 4.4 5.6 4.0 8.7 3.8 14.8 4.6 3.7 26.3 6.6 5.5 3.2 4.8 7.8 7.8 7.9 1.4 0.4 6.0 2.9 6.0 10.5 4.3 19.3 8.9 9.3 7.9 3.3 2.7 7.9 1.6 8.1 4.1 7.7 2.8 1.6 10.4 4.2 8.8 10.3 3.3 4.0 4.8 16.1 0.4 5.7 3.6 0.6 1.9 0.2 0.3 0.6 0.5 2.2 0.3 0.5 0.4 19.1 0.3 3.0 0.2 0.5 1.3 22.4 21.7 27.9 21.5 24.6 16.4 28.6 16.0 22.6 25.8 80.4 47.6 4.9 4.8 24.4 27.8 23.0 15.3 6.7 21.6 22.7 200.3 0.3 0.0 3.9 0.6 7.3 6.5 23.3 4.7 1.1 6.1 8.8 6.9 41.0 5.9 12.7 6.3 10.4 54.2 0.9 10.6 18.5 25.3 2.8 3.3 28.2 11.0 6.8 11.0 5.0 70.5 12.9 9.9 8.4 6.1 38.3 1.0 9.6 6.0 5.7 MEIS2 "HsT18361, MRG1" ENSG00000134138 "Meis homeobox 2" O14770 15 36889204-37101299 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 108.0;Cone photoreceptor cells: 239.5;Ito cells: 148.5;Rod photoreceptor cells: 121.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 49 "basophil: 4.8;eosinophil: 4.9" "Lineage enriched" "Detected in single" 49 "granulocytes: 4.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 41.7;SH-SY5Y: 39.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 83.2;olfactory region: 364.7" "HPA003256, CAB004999" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004999: AB_425545, HPA003256: AB_1079356" "unprognostic (4.33e-2)" "unprognostic (1.94e-2)" "unprognostic (6.71e-4)" "unprognostic (2.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.24e-1)" "unprognostic (5.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-1)" "unprognostic (4.73e-2)" "unprognostic (7.97e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.64e-7)" "unprognostic (6.47e-2)" "unprognostic (8.15e-2)" "unprognostic (8.79e-5)" "unprognostic (1.15e-1)" 6.3 16.5 9.6 6.5 36.8 0.4 7.7 7.4 12.4 26.4 17.0 4.3 12.0 15.1 35.6 6.3 10.6 17.8 16.9 11.3 6.7 3.9 7.3 5.9 7.5 5.2 3.9 6.9 16.4 10.0 2.8 19.8 6.4 10.7 28.8 5.2 6.4 39.0 16.7 1.0 2.9 5.2 34.6 6.2 5.6 11.3 2.6 8.6 2.2 3.5 4.6 3.2 19.5 16.9 0.0 0.0 4.9 0.0 0.0 0.0 0.0 4.7 4.4 5.7 16.2 6.5 8.0 1.3 10.3 5.8 12.3 6.9 6.2 3.9 2.7 0.2 41.7 7.9 8.3 10.0 2.6 6.9 3.9 6.4 21.0 5.9 5.1 11.0 6.2 21.5 10.6 2.3 8.3 2.5 16.4 7.0 1.0 7.0 0.0 2.5 5.0 0.0 2.4 0.0 5.7 1.4 0.0 4.2 1.5 0.0 9.3 4.4 39.4 3.9 2.7 3.0 6.6 1.2 4.9 9.9 14.2 1.7 3.7 4.4 2.8 2.8 5.3 16.8 3.5 3.5 4.8 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 36.8 7.4 8.0 6.7 3.9 3.9 6.9 10.7 8.6 0.0 8.2 2.9 108.0 15.5 14.5 21.8 66.2 25.4 6.8 1.8 239.5 21.3 0.0 42.0 11.8 23.5 0.9 0.0 24.0 5.7 46.8 24.7 61.2 7.9 2.8 3.2 1.7 148.5 6.6 4.4 44.3 1.7 8.5 1.0 0.0 11.8 22.0 0.0 38.9 0.0 121.2 32.3 43.2 1.8 2.7 5.4 3.8 1.9 0.6 43.1 MEN1 ENSG00000133895 "Menin 1" O00255 11 64803510-64811294 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030342 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030342: AB_10610138" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.66e-1)" "unprognostic (2.59e-1)" "unprognostic (1.42e-2)" "unprognostic (4.96e-2)" "unprognostic (1.36e-1)" "unprognostic (7.39e-2)" "prognostic favorable (6.31e-5)" "unprognostic (1.40e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" 12.1 20.6 13.2 15.6 17.7 11.8 12.5 25.8 26.9 15.5 14.9 16.4 22.2 16.9 14.8 18.4 18.9 17.6 14.7 9.0 12.4 11.5 15.9 23.0 12.8 22.1 12.5 15.6 19.7 25.9 16.8 18.0 16.1 16.0 15.9 11.6 16.6 23.3 19.9 8.4 21.6 15.8 11.0 9.8 20.6 15.3 21.2 12.3 33.2 23.9 6.2 20.3 13.7 15.5 5.2 2.9 3.4 1.5 1.8 4.8 1.0 16.3 22.0 14.1 22.1 15.8 10.2 16.6 11.8 11.7 18.4 12.4 12.7 16.2 23.3 19.3 9.1 15.4 23.4 19.1 16.3 11.1 19.9 28.2 19.3 17.7 16.9 14.0 12.4 13.1 11.7 12.3 15.5 12.8 11.1 17.0 30.0 28.0 8.9 10.2 30.6 31.3 25.1 18.4 13.8 33.1 24.3 16.0 22.3 11.9 15.2 19.9 17.5 13.9 19.7 14.3 10.5 29.3 13.8 10.7 17.4 16.7 20.8 9.9 14.0 16.2 11.8 13.8 9.7 11.0 0.9 1.3 3.4 3.7 1.5 4.8 3.7 2.6 4.6 1.3 5.2 4.5 2.6 0.2 1.8 0.5 2.9 1.9 1.0 13.2 17.7 25.8 26.9 12.4 11.5 12.5 15.6 16.0 12.3 3.0 4.8 19.3 3.8 5.0 8.3 3.7 2.5 1.4 1.2 3.5 5.9 15.7 3.3 7.3 0.9 4.4 8.4 0.0 6.2 18.5 4.6 4.9 1.1 9.4 7.9 3.2 4.1 8.0 0.3 0.6 11.2 2.6 8.5 6.4 8.7 8.4 7.1 10.1 3.5 6.2 5.7 12.9 2.7 16.6 15.5 6.0 13.6 6.7 9.5 3.0 MEOX1 MOX1 ENSG00000005102 "Mesenchyme homeobox 1" P50221 17 43640388-43661954 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 25 "Basal keratinocytes: 3.7;Endothelial cells: 15.5;Melanocytes: 5.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 17.9" "Lineage enriched" "Detected in single" 66 "T-cells: 17.9" "Cell line enriched" "Detected in some" 13 "HeLa: 24.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA045214, HPA063788" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA045214: AB_10959299, HPA063788: " "unprognostic (1.36e-3)" "unprognostic (2.15e-4)" "unprognostic (1.25e-1)" "unprognostic (2.58e-3)" "unprognostic (2.01e-2)" "unprognostic (5.65e-3)" "unprognostic (1.25e-1)" "unprognostic (4.55e-3)" "unprognostic (6.71e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-1)" "unprognostic (9.36e-2)" "unprognostic (3.44e-6)" "unprognostic (2.40e-2)" "unprognostic (2.66e-1)" "unprognostic (1.82e-1)" "unprognostic (7.47e-3)" 24.3 0.3 0.1 7.4 0.1 0.0 17.3 0.1 0.1 12.4 3.2 0.1 2.3 1.2 11.6 5.7 10.9 6.7 6.5 17.8 0.1 0.1 0.2 0.3 1.2 5.4 0.1 0.1 4.8 1.2 1.5 0.5 0.3 0.1 8.2 1.9 0.8 5.8 2.0 19.8 4.6 3.5 8.6 0.1 8.9 2.4 3.5 0.1 3.2 1.7 15.4 7.1 6.1 16.7 0.0 0.0 0.0 0.0 0.2 17.9 0.9 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 1.7 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.1 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.6 3.0 0.0 0.0 1.8 0.5 0.0 0.2 0.0 0.0 17.9 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 1.6 0.1 0.0 0.0 0.0 MERTK "c-Eyk, mer, RP38, Tyro12" ENSG00000153208 "MER proto-oncogene, tyrosine kinase" Q12866 2 111898479-112029561 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation, Proto-oncogene, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Ito cells: 36.8;Kupffer cells: 92.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "intermediate monocyte: 10.3;non-classical monocyte: 6.4" "Lineage enriched" "Detected in single" 48 "monocytes: 10.3" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;Hep G2: 22.1;HUVEC TERT2: 22.0;RT4: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036196, HPA075622" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol" NA NA 29000000 "Plasma membrane" "Endoplasmic reticulum, Midbody, Cytosol" "HPA036196: AB_10670676, HPA075622: AB_2686759" "unprognostic (2.17e-2)" "unprognostic (8.10e-2)" "unprognostic (4.85e-2)" "unprognostic (2.68e-1)" "unprognostic (2.44e-1)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.74e-4)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (6.22e-2)" "unprognostic (3.72e-1)" "prognostic favorable (4.43e-5)" "unprognostic (5.13e-2)" "unprognostic (2.11e-1)" "unprognostic (5.86e-2)" "unprognostic (2.05e-2)" 20.1 55.1 13.1 12.5 17.8 1.9 31.8 6.2 13.8 10.8 13.8 6.8 27.7 11.5 11.3 25.4 8.4 12.8 11.7 7.1 16.5 6.3 14.2 18.9 12.7 30.3 8.1 10.1 12.9 9.0 23.9 14.3 18.4 18.6 14.1 7.9 20.4 6.8 24.9 6.4 6.4 12.8 13.6 12.2 38.4 12.3 17.3 9.8 1.7 9.9 2.0 8.4 14.1 26.6 0.0 0.2 0.1 10.3 0.0 0.0 0.3 0.5 0.9 4.4 10.0 0.2 0.1 7.1 0.0 0.1 0.5 1.0 21.3 1.3 0.1 4.7 0.0 4.6 0.1 5.8 0.0 0.8 0.8 3.1 3.8 0.0 22.1 0.1 0.1 0.9 0.2 0.0 5.1 0.3 2.3 22.0 0.8 1.2 2.0 1.7 1.0 0.0 5.0 2.7 0.6 3.4 1.4 1.2 1.7 11.2 13.1 0.1 4.2 0.1 0.3 1.7 1.6 0.0 0.2 3.3 0.6 2.0 0.0 0.0 1.7 2.5 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 6.4 0.1 0.0 0.3 13.1 17.8 6.2 13.8 16.5 6.3 8.1 10.1 18.6 9.8 3.0 20.1 0.8 2.9 1.4 0.6 2.1 5.1 1.4 11.4 0.0 2.0 2.6 1.7 0.8 1.6 7.1 1.6 0.0 0.8 1.0 4.1 2.0 0.0 8.9 23.6 0.0 0.0 36.8 92.6 1.5 4.6 11.0 0.0 0.0 2.3 8.6 1.7 1.9 6.3 1.9 9.2 6.5 11.3 0.5 1.5 1.1 15.8 0.8 1.8 1.4 MESD "BOCA, KIAA0081, MESDC2" ENSG00000117899 "Mesoderm development LRP chaperone" Q14696 15 80946289-80989878 "Predicted intracellular proteins" "Wnt signaling pathway" Chaperone "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 294.4;Extravillous trophoblasts: 237.4;monocytes: 150.5;Syncytiotrophoblasts: 364.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039414, HPA041721" Approved Supported "Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 690000 "Endoplasmic reticulum" "Nuclear bodies, Cytosol" "HPA039414: AB_10674981, HPA041721: AB_2756310" "unprognostic (9.21e-2)" "unprognostic (4.50e-2)" "unprognostic (8.02e-2)" "prognostic favorable (2.31e-4)" "unprognostic (4.93e-3)" "unprognostic (2.32e-3)" "unprognostic (3.47e-2)" "unprognostic (3.09e-3)" "unprognostic (4.04e-1)" "prognostic favorable (1.12e-4)" "unprognostic (7.93e-2)" "unprognostic (3.05e-2)" "unprognostic (3.42e-2)" "unprognostic (1.68e-1)" "unprognostic (4.32e-2)" "unprognostic (3.83e-1)" "unprognostic (1.88e-1)" 15.5 19.5 15.5 19.7 17.6 5.7 23.5 15.6 14.4 21.1 15.8 15.3 31.3 14.0 14.5 48.3 17.1 14.3 16.2 15.5 14.0 17.6 16.4 28.2 17.6 23.8 20.9 13.4 22.2 34.7 12.8 23.4 32.1 17.0 20.8 16.4 15.0 20.4 37.6 14.2 12.3 13.7 13.9 22.4 16.2 16.5 13.6 17.8 13.0 37.1 12.7 14.3 13.7 17.1 19.0 25.6 17.7 15.0 24.7 25.1 16.0 12.3 18.7 16.7 10.7 28.3 16.1 25.9 18.9 22.6 20.7 25.3 16.7 34.7 10.4 21.9 15.2 22.0 20.8 25.8 19.4 19.7 22.9 16.5 13.1 16.2 28.4 21.7 15.5 14.5 16.7 22.5 17.4 20.8 17.4 19.6 12.8 15.7 26.7 17.5 15.5 9.5 13.0 20.1 18.3 7.7 14.7 10.3 27.7 17.1 17.0 14.5 8.5 20.7 14.1 30.9 31.7 16.3 12.4 15.2 20.0 19.0 10.7 24.2 16.9 21.5 14.3 18.8 27.8 20.8 17.7 15.0 10.3 21.6 13.8 25.1 19.0 22.8 21.1 15.3 18.1 21.5 21.6 4.5 24.7 11.6 25.6 22.8 16.0 15.5 17.6 15.6 14.4 14.0 17.6 20.9 13.4 17.0 17.8 74.5 55.2 0.0 0.0 0.0 0.0 0.0 0.0 78.9 51.2 55.8 0.0 294.4 11.6 87.8 0.0 0.0 0.0 0.0 97.3 237.4 0.0 0.0 33.7 0.0 108.4 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 150.5 0.0 0.0 77.9 0.0 0.0 41.5 0.0 0.0 0.0 0.0 0.0 0.0 364.7 0.0 0.0 0.0 MEST PEG1 ENSG00000106484 "Mesoderm specific transcript" Q5EB52 7 130486171-130506465 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.8;placenta: 193.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 680.5;Syncytiotrophoblasts: 836.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 18.8" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "AN3-CA: 525.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005623 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "HPA005623: AB_1079364" "unprognostic (6.14e-2)" "unprognostic (5.06e-3)" "unprognostic (9.82e-2)" "unprognostic (1.64e-3)" "unprognostic (3.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.36e-3)" "unprognostic (1.12e-1)" "unprognostic (7.81e-2)" "unprognostic (6.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (6.20e-5)" "unprognostic (7.09e-2)" "unprognostic (1.05e-1)" "unprognostic (2.30e-1)" "unprognostic (1.67e-2)" 44.9 26.0 7.8 4.7 12.9 3.4 63.8 2.6 22.7 2.4 7.5 3.4 1.1 7.9 7.3 4.6 2.6 5.2 6.6 3.7 7.9 8.0 6.7 13.7 18.8 4.1 3.3 9.0 7.8 13.0 2.5 15.4 193.5 15.5 4.1 6.1 8.4 7.0 2.5 2.2 2.1 7.2 5.3 3.2 22.4 3.0 10.1 3.3 2.0 4.3 2.5 1.9 4.5 3.7 3.1 6.7 8.6 2.0 2.7 18.8 5.3 3.2 1.7 8.5 525.5 0.1 0.0 0.0 3.5 1.6 3.7 1.7 10.1 4.9 1.6 1.2 0.1 3.2 0.4 0.1 0.0 1.4 0.0 0.0 2.8 2.7 1.6 14.5 0.1 0.0 0.2 0.1 2.7 0.0 18.9 1.4 0.0 3.1 0.0 7.1 4.5 0.3 3.5 5.3 4.8 0.8 0.0 94.6 1.0 4.0 3.0 30.0 0.0 3.1 10.2 0.0 9.0 0.3 2.4 1.4 1.2 0.0 11.7 0.2 0.1 0.3 0.0 4.5 0.0 0.4 8.6 1.9 6.2 0.7 2.0 1.7 3.1 2.0 1.4 6.7 2.8 7.6 18.8 1.1 2.7 1.2 0.3 0.1 5.3 7.8 12.9 2.6 22.7 7.9 8.0 3.3 9.0 15.5 3.3 6.0 3.8 2.4 36.0 3.9 9.1 0.6 17.8 4.0 5.7 15.7 3.9 680.5 10.0 19.8 53.5 3.4 10.9 0.0 35.4 99.2 31.1 18.0 0.0 15.8 79.5 1.6 28.4 35.6 7.7 27.3 78.6 1.9 1.7 1.0 19.5 40.4 28.9 28.1 12.7 9.2 19.9 19.4 5.2 33.9 38.5 0.5 836.0 0.0 33.2 16.5 MET "DFNB97, HGFR, RCCP2" ENSG00000105976 "MET proto-oncogene, receptor tyrosine kinase" P08581 7 116672390-116798386 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 45.3;CAPAN-2: 49.5" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1" "Low region specificity" "Detected in many" "CAB005282, CAB018577, HPA055607" Approved Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 179000000 70000000 "Plasma membrane, Cytosol" "CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860" "unprognostic (1.60e-2)" "unprognostic (7.71e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.75e-4)" "unprognostic (1.68e-1)" "unprognostic (3.22e-2)" "unprognostic (3.81e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.21e-7)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.88e-2)" "unprognostic (2.01e-2)" "unprognostic (2.20e-1)" 16.2 1.1 1.8 4.5 2.3 4.3 11.2 0.9 15.2 9.9 6.5 2.4 2.4 4.4 7.5 5.2 5.1 4.6 12.3 5.4 5.7 1.8 20.1 30.2 15.6 1.4 3.6 2.1 2.0 9.3 0.7 8.1 24.4 2.6 8.0 6.6 34.1 12.2 8.4 12.8 7.2 8.6 4.0 2.3 5.7 10.6 2.7 2.4 0.5 21.4 7.0 2.1 10.1 15.0 0.2 0.3 1.2 0.2 0.3 0.4 0.0 45.3 26.1 0.0 0.1 2.0 2.0 1.8 25.9 10.5 14.0 11.8 5.4 49.5 2.0 43.2 16.2 37.7 12.0 4.4 24.7 28.6 0.1 5.6 0.0 27.1 4.7 0.3 0.0 0.0 2.6 9.8 9.1 30.0 25.3 9.6 0.0 0.9 0.2 25.9 1.0 0.0 0.0 3.9 7.2 26.6 0.0 22.0 0.0 24.5 5.2 3.8 0.0 10.6 3.4 10.1 4.7 0.0 0.2 17.6 20.9 7.4 11.0 20.0 0.5 4.0 0.2 22.9 0.0 2.9 1.1 0.2 0.4 0.4 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.2 0.3 0.1 0.3 0.1 0.0 1.8 2.3 0.9 15.2 5.7 1.8 3.6 2.1 2.6 2.4 26.8 78.1 2.4 56.1 34.7 0.9 10.0 15.3 22.7 116.0 29.6 0.0 57.9 0.0 28.0 0.0 11.7 11.2 0.0 39.8 5.0 4.0 55.8 0.0 26.0 6.1 0.0 6.9 1.3 1.0 0.0 0.6 2.0 3.3 1.8 19.7 7.4 69.4 7.0 0.0 13.5 0.3 0.0 2.3 0.0 0.6 15.6 18.2 0.0 12.7 88.5 METAP1 "KIAA0094, MAP1A, MetAP1A" ENSG00000164024 "Methionyl aminopeptidase 1" P53582 4 98995620-99062813 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 345.0;Late spermatids: 1171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025485, HPA037997, HPA037998" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 11000 Cytosol "Nucleoplasm, Plasma membrane" "CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778" "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "prognostic favorable (7.22e-4)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (1.09e-1)" "unprognostic (1.51e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.28e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.72e-4)" "unprognostic (5.50e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-3)" "prognostic favorable (9.31e-4)" 12.1 8.3 10.0 16.0 10.1 11.8 18.6 9.2 13.8 16.0 17.9 7.0 22.9 13.4 24.1 25.9 37.2 14.0 12.3 27.9 9.5 7.1 14.3 13.7 10.7 12.6 7.9 9.8 11.3 13.0 7.8 14.4 9.2 9.9 19.1 19.3 7.5 19.0 21.5 27.2 16.4 15.2 27.8 10.1 13.9 11.6 46.8 8.1 27.0 10.8 21.8 19.1 36.6 22.6 12.7 11.7 10.4 11.1 12.5 19.2 10.8 21.7 21.5 18.9 20.3 15.0 24.1 21.0 31.2 20.1 26.7 25.5 24.1 32.5 32.3 12.5 25.2 16.0 21.9 33.1 31.2 37.1 22.5 15.8 28.8 15.7 25.9 16.3 38.9 24.2 17.3 22.8 22.7 24.1 20.8 21.9 18.3 22.5 19.5 28.5 16.6 34.1 18.6 23.2 37.1 17.5 22.4 29.5 17.2 42.9 28.2 25.9 15.3 10.4 32.4 12.3 22.1 12.4 14.9 17.8 21.6 27.5 19.8 27.2 14.2 19.9 25.5 18.6 20.0 21.4 10.4 9.4 4.2 14.9 11.1 19.2 12.7 15.4 14.5 11.7 10.1 15.1 13.5 2.3 12.5 10.7 5.8 13.4 10.8 10.0 10.1 9.2 13.8 9.5 7.1 7.9 9.8 9.9 8.1 38.7 10.5 13.7 44.1 37.7 4.6 49.8 20.4 18.7 17.0 14.0 2.0 22.0 11.6 26.9 345.0 13.5 29.0 0.0 25.4 55.9 12.3 21.8 3.5 16.4 15.6 3.2 7.5 16.5 19.6 1171.9 17.8 14.6 15.1 6.4 25.2 8.3 22.3 34.2 21.2 22.9 3.5 25.8 22.1 15.1 46.4 33.9 6.4 15.2 32.6 39.6 METAP2 "MAP2, MNPEP, p67" ENSG00000111142 "Methionyl aminopeptidase 2" P50579 12 95473520-95515839 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013025, HPA019095" Enhanced Supported "Plasma membrane,Cytosol" NA NA 22000 "Plasma membrane, Cytosol" "CAB013025: AB_2533993, HPA019095: AB_1853823" "unprognostic (1.91e-1)" "unprognostic (1.02e-1)" "unprognostic (5.92e-2)" "unprognostic (2.44e-1)" "unprognostic (3.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (4.51e-6)" "unprognostic (1.25e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-2)" "unprognostic (8.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-1)" "unprognostic (1.07e-1)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" 24.2 36.4 25.8 49.9 33.7 39.1 25.1 25.9 32.3 23.9 26.2 16.3 102.5 16.6 28.7 25.4 30.1 22.5 21.7 30.7 29.6 24.0 26.0 46.8 22.1 32.6 29.1 23.4 29.4 31.9 21.0 36.1 25.1 42.9 24.2 24.0 10.1 22.1 140.7 94.4 28.7 19.7 26.1 48.2 25.2 22.2 26.3 27.7 32.1 24.1 29.0 55.2 33.4 37.3 39.4 31.8 21.3 27.1 25.7 32.0 16.2 33.9 28.6 30.6 23.8 18.7 30.0 23.6 33.5 23.4 33.0 23.5 41.5 16.3 98.8 21.1 23.9 19.2 21.9 34.4 25.6 38.0 23.5 29.7 44.2 21.8 29.2 19.9 54.7 21.7 25.9 27.4 31.2 30.6 39.6 35.1 34.1 57.2 11.2 24.4 22.3 40.5 37.4 37.5 19.6 42.8 31.9 26.5 32.4 22.6 36.0 23.8 31.3 29.7 24.3 29.3 27.6 29.3 26.0 30.1 19.0 18.4 21.2 35.3 16.2 42.1 105.9 10.8 30.9 23.8 21.3 27.1 11.1 23.8 19.1 29.2 39.4 26.7 26.6 24.4 37.6 32.0 29.7 1.2 25.7 22.3 31.8 25.3 16.2 25.8 33.7 25.9 32.3 29.6 24.0 29.1 23.4 42.9 27.7 262.0 228.6 96.8 102.9 207.2 62.7 117.4 91.7 104.4 160.3 275.7 62.8 125.5 139.3 94.7 135.8 104.6 80.2 256.9 126.2 136.4 102.7 68.6 119.0 278.9 86.9 71.5 88.0 102.5 122.4 83.3 92.9 93.2 87.7 80.2 109.6 67.6 105.7 83.4 100.4 81.6 68.7 97.0 97.6 340.7 217.0 187.9 143.8 93.5 118.5 90.7 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715115-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.9" "Cell type enriched" "Detected in many" 8 "Muller glia cells: 554.6" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 53.4;PC-3: 41.3" "Region enriched" "Detected in all" 5 "cerebellum: 549.1" "Low region specificity" "Detected in all" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: AB_2681369" "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 7.7 14.9 44.7 5.1 58.9 2.6 4.6 14.2 45.4 4.1 7.0 24.1 19.8 5.6 5.3 7.8 3.1 27.4 6.4 12.4 39.6 31.6 10.5 8.5 6.0 4.2 45.7 15.1 2.7 43.1 5.2 15.1 5.3 15.3 7.4 2.5 9.2 27.3 16.8 21.5 3.9 5.9 4.4 39.5 5.4 8.3 4.6 19.0 2.5 6.6 3.4 3.0 3.9 5.0 3.2 0.9 0.8 1.0 1.7 2.9 0.5 2.6 22.5 4.4 22.5 7.9 4.4 7.2 5.3 2.7 2.1 1.4 3.3 6.6 0.4 12.5 3.7 8.2 9.9 0.6 5.2 0.3 1.4 9.9 0.9 4.1 17.0 4.8 1.9 2.9 10.7 5.7 0.6 1.3 6.7 0.7 6.3 1.5 0.5 1.6 53.4 0.7 6.5 1.6 2.9 41.3 7.3 5.1 7.3 5.5 0.7 7.0 8.9 2.1 5.9 27.4 0.5 8.9 3.8 2.4 6.1 11.7 7.1 4.6 3.4 0.9 0.4 9.6 1.4 14.4 0.0 0.3 0.8 2.9 1.0 1.7 3.2 1.5 2.7 0.2 0.5 0.9 1.9 0.0 1.7 1.0 0.9 2.8 0.5 44.7 58.9 14.2 27.4 39.6 31.6 45.7 15.1 15.3 19.0 0.0 2.1 4.2 14.7 3.4 38.6 14.0 50.9 2.7 0.0 15.7 13.7 0.6 43.1 6.3 6.5 12.6 15.0 0.0 4.2 1.8 8.7 28.3 0.0 27.2 5.2 66.7 26.2 19.0 5.1 14.5 10.3 4.8 10.1 0.0 8.1 554.6 5.4 14.7 8.9 43.5 29.1 25.8 15.3 3.9 11.3 2.6 0.3 6.4 8.6 14.2 METTL13 "CGI-01, KIAA0859" ENSG00000010165 "Methyltransferase like 13" Q8N6R0 1 171781664-171814023 "Predicted intracellular proteins" "Methyltransferase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044498, HPA053705" Approved Approved Cytosol NA NA Cytosol "HPA044498: AB_10960884, HPA053705: AB_2682235" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" "unprognostic (8.30e-2)" "unprognostic (2.76e-1)" "unprognostic (3.78e-1)" "unprognostic (4.40e-1)" "prognostic unfavorable (5.68e-4)" "unprognostic (1.86e-1)" "unprognostic (3.12e-1)" "unprognostic (8.83e-2)" "unprognostic (1.16e-1)" "unprognostic (3.65e-1)" "unprognostic (4.12e-1)" "unprognostic (6.86e-3)" "unprognostic (7.49e-2)" "unprognostic (3.01e-1)" "unprognostic (1.13e-1)" 13.0 20.7 18.3 13.3 17.8 9.0 14.7 19.0 21.8 14.6 13.6 14.7 13.6 15.1 16.5 24.8 14.9 16.2 11.2 11.7 14.1 10.9 13.2 16.9 15.1 15.9 16.3 17.9 15.3 16.0 14.0 11.0 11.4 14.7 12.6 15.1 11.7 19.2 14.5 18.4 14.2 14.0 15.4 11.4 16.8 14.7 18.9 16.2 16.3 13.1 9.4 17.7 13.7 12.6 10.2 10.0 3.2 8.7 11.5 12.0 7.8 11.8 28.2 7.4 7.8 10.8 9.9 20.5 15.0 11.8 18.2 14.2 21.2 12.3 21.9 18.0 10.4 11.9 12.2 23.1 12.0 14.3 14.0 13.2 15.1 14.6 9.3 8.0 19.8 15.4 8.6 11.2 18.9 8.3 8.3 10.8 11.9 30.2 7.5 13.8 9.0 15.8 13.6 29.0 23.9 38.2 14.6 10.0 20.0 10.5 12.2 12.5 17.1 11.1 25.8 13.7 19.5 18.8 17.6 8.9 12.3 11.3 12.4 17.6 19.5 21.8 25.2 9.3 13.8 10.9 1.8 8.7 3.2 9.9 8.5 11.5 10.2 9.9 8.4 8.6 8.0 9.1 12.0 2.6 11.5 7.4 10.0 7.4 7.8 18.3 17.8 19.0 21.8 14.1 10.9 16.3 17.9 14.7 16.2 8.9 3.2 7.7 6.4 7.6 7.2 7.5 20.4 6.7 5.7 3.5 5.9 14.0 10.0 17.2 33.4 10.5 9.8 0.0 13.4 20.0 7.6 8.6 9.2 11.6 15.1 4.8 10.4 11.6 14.9 8.4 9.2 8.5 3.3 12.6 11.5 8.1 16.0 7.0 7.4 10.9 6.9 12.9 7.2 4.7 14.5 7.9 8.0 7.2 11.1 7.5 METTL16 "METT10D, MGC3329" ENSG00000127804 "Methyltransferase like 16" Q86W50 17 2405562-2511891 "Enzymes, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020352, HPA059798" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020352: AB_1853828, HPA059798: AB_2684128" "unprognostic (4.94e-3)" "unprognostic (2.86e-2)" "unprognostic (2.29e-2)" "unprognostic (5.66e-3)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (3.35e-2)" "unprognostic (1.88e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-1)" "prognostic favorable (3.06e-4)" "unprognostic (5.35e-2)" "unprognostic (4.85e-3)" "unprognostic (2.91e-2)" "unprognostic (2.32e-1)" "unprognostic (1.61e-1)" "unprognostic (2.68e-2)" 12.7 14.0 13.1 11.0 15.2 13.1 14.1 22.5 14.4 14.9 13.1 19.8 11.2 8.6 21.6 10.6 11.0 16.5 9.6 12.4 12.6 9.7 11.5 6.9 12.2 13.1 18.3 9.7 22.5 13.5 19.7 22.8 7.5 13.6 13.5 10.4 18.3 12.1 13.1 14.2 14.7 10.4 16.5 14.6 11.1 11.2 11.0 17.5 15.7 16.5 8.8 17.5 15.3 12.7 5.7 3.1 2.3 3.2 2.0 8.1 2.0 6.1 16.4 9.3 8.9 7.0 8.9 8.7 7.8 6.8 8.9 7.4 21.8 4.0 19.3 8.5 7.1 9.5 8.9 21.4 10.7 12.2 7.3 13.6 9.9 13.5 9.9 7.6 9.1 8.0 7.5 10.2 12.3 18.2 6.1 9.2 11.3 12.9 10.4 6.0 6.7 13.0 5.4 10.6 7.6 6.9 21.7 9.8 8.7 6.5 5.6 4.9 7.7 11.7 6.4 6.9 10.0 8.1 5.8 6.7 8.2 5.3 11.6 11.3 6.1 7.5 13.8 11.1 7.6 11.1 2.3 3.2 1.2 5.7 2.1 7.2 5.7 5.6 5.5 2.2 5.0 8.1 5.9 0.1 2.0 1.5 3.1 3.5 2.0 13.1 15.2 22.5 14.4 12.6 9.7 18.3 9.7 13.6 17.5 11.9 31.0 7.0 19.7 10.2 26.4 14.0 15.3 34.8 36.4 7.0 43.2 7.3 11.6 8.4 12.4 12.9 15.8 0.0 9.2 7.9 8.9 15.5 24.3 7.3 8.9 25.4 19.5 19.6 9.2 5.4 13.8 8.2 8.5 9.0 12.7 25.1 8.0 3.5 12.0 7.0 38.8 6.5 13.2 11.4 17.4 11.2 5.0 20.8 14.0 13.5 METTL18 "AsTP2, C1orf156, HPM1, MGC9084" ENSG00000171806 "Methyltransferase like 18" O95568 1 169792529-169794966 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035314 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035314: AB_10601146" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" "unprognostic (3.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (5.67e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (3.65e-1)" "unprognostic (3.06e-2)" "unprognostic (3.03e-2)" "prognostic favorable (3.28e-4)" 8.7 7.3 12.1 9.9 9.0 3.8 11.5 13.5 11.8 6.5 6.8 3.5 8.4 5.6 7.7 9.8 7.8 8.2 5.2 10.2 8.5 6.8 8.6 8.5 5.9 16.5 11.1 10.1 10.4 9.4 31.9 9.4 6.3 9.2 11.2 6.8 3.4 8.4 7.5 5.0 6.5 9.2 6.3 12.7 14.3 8.2 6.7 11.2 9.8 10.0 8.0 11.8 7.8 8.9 13.4 5.4 12.2 5.8 12.4 19.3 9.8 9.0 5.2 8.5 5.8 5.0 9.3 5.9 4.2 4.9 5.4 4.7 6.6 14.7 15.4 11.8 5.6 7.9 10.4 8.5 9.6 7.3 9.2 6.8 11.0 4.7 5.4 10.3 11.6 5.1 4.2 10.1 5.5 6.0 5.5 10.3 11.9 11.6 7.3 7.2 4.4 12.2 7.9 10.7 19.5 13.1 9.1 8.4 11.6 8.7 9.1 6.3 9.7 9.0 10.2 12.4 13.2 13.5 12.8 4.6 6.8 6.5 6.8 9.8 14.3 18.6 20.8 5.0 9.3 6.8 9.3 5.2 12.2 14.6 5.8 18.5 12.1 16.3 17.0 5.4 13.4 19.3 18.3 3.0 12.4 3.4 4.2 18.4 9.8 12.1 9.0 13.5 11.8 8.5 6.8 11.1 10.1 9.2 11.2 3.0 5.8 1.5 5.6 1.3 7.5 5.3 5.1 13.4 5.7 5.2 0.0 11.5 21.6 9.3 13.7 7.8 3.9 0.0 6.9 4.9 5.6 3.4 6.9 2.6 6.5 6.4 2.9 2.5 4.7 3.6 5.8 2.8 5.0 1.0 4.9 8.5 5.3 5.8 4.9 7.0 6.1 0.0 2.8 14.4 9.4 0.6 9.6 10.0 4.9 2.1 METTL21A "FAM119A, HCA557b, HSPA-KMT, LOC151194" ENSG00000144401 "Methyltransferase like 21A" Q8WXB1 2 207580631-207625928 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034712 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034712: AB_10670160" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (4.56e-2)" "unprognostic (2.09e-3)" "unprognostic (2.00e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (1.87e-5)" "unprognostic (4.80e-2)" "unprognostic (2.30e-2)" "unprognostic (2.47e-3)" "unprognostic (6.65e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (5.43e-4)" "unprognostic (5.01e-2)" "unprognostic (3.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" 10.4 9.1 16.5 13.8 18.2 20.2 14.6 14.0 16.9 9.0 9.3 8.7 3.8 8.1 10.0 8.4 6.7 8.3 7.1 13.2 16.3 15.4 11.1 20.9 8.9 15.4 25.8 10.6 12.0 10.6 11.6 10.1 12.7 20.2 8.8 9.2 8.8 8.4 7.1 19.5 9.0 8.3 8.3 19.2 15.4 12.3 7.1 18.8 18.5 15.2 6.2 14.8 10.1 24.3 25.2 14.8 25.9 20.6 7.5 14.4 8.3 8.0 7.6 12.6 9.5 5.6 5.9 24.5 4.5 5.6 7.3 7.4 14.4 13.0 11.7 10.0 3.5 12.9 4.7 18.0 5.9 6.1 6.8 12.4 13.6 12.2 23.7 9.9 17.8 13.8 5.2 7.9 3.6 6.1 9.1 8.2 19.6 19.6 6.9 4.8 13.1 17.9 30.5 20.9 11.0 5.4 13.2 5.3 16.9 10.5 6.8 14.9 12.3 9.7 3.4 9.4 18.3 4.7 26.4 4.2 6.4 14.0 5.9 7.9 10.2 12.8 24.1 10.5 14.0 9.5 13.8 14.4 25.9 5.0 13.9 8.3 25.2 7.6 7.1 11.8 21.6 14.4 9.2 5.0 7.5 20.6 14.8 5.9 8.3 16.5 18.2 14.0 16.9 16.3 15.4 25.8 10.6 20.2 18.8 14.9 22.3 43.0 29.8 14.2 19.9 23.8 15.3 25.4 21.6 10.4 7.9 32.6 24.9 21.2 24.4 14.8 9.7 0.0 22.0 25.1 20.5 35.0 46.1 10.9 26.1 17.5 5.2 12.3 20.6 28.4 9.2 39.1 42.2 19.0 14.2 15.6 18.5 61.9 7.1 19.3 19.9 12.9 12.5 9.8 17.2 11.0 8.8 18.3 16.6 16.6 METTL25 "C12orf26, FLJ22789" ENSG00000127720 "Methyltransferase like 25" Q8N6Q8 12 82358497-82479236 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039534, HPA041207" Uncertain Uncertain "Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane, Mitochondria, Cytosol" "HPA039534: AB_10794749, HPA041207: AB_10794406" "unprognostic (1.60e-2)" "unprognostic (3.36e-3)" "unprognostic (2.06e-2)" "unprognostic (4.15e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-1)" "unprognostic (5.73e-3)" "unprognostic (1.21e-2)" "unprognostic (5.20e-2)" "unprognostic (6.66e-2)" "unprognostic (7.00e-3)" "unprognostic (2.15e-2)" "unprognostic (2.59e-3)" "unprognostic (1.48e-1)" "unprognostic (1.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.44e-2)" 8.3 9.2 8.7 8.5 8.1 5.0 11.1 23.6 8.3 8.2 7.7 8.1 9.0 7.5 8.2 9.1 10.0 8.0 5.8 8.7 9.1 3.1 8.8 6.3 6.5 8.1 7.6 5.7 10.8 6.5 7.8 25.9 6.8 7.6 8.0 9.2 5.8 10.5 6.0 10.7 9.7 8.2 7.5 5.8 8.6 6.7 11.0 13.0 9.9 10.2 8.7 7.4 8.8 8.5 7.9 13.2 14.4 7.6 9.8 7.6 3.8 1.4 3.3 4.5 0.9 5.1 6.0 4.6 7.0 4.0 3.7 2.7 4.3 3.9 8.6 1.5 5.1 0.9 1.5 8.9 1.1 2.4 8.2 7.5 4.1 1.8 4.1 3.1 7.2 5.0 4.4 4.2 1.2 0.0 7.3 7.6 3.1 3.1 3.9 3.8 4.9 3.1 6.3 6.8 3.9 1.0 1.7 2.7 4.4 11.5 5.2 3.4 2.6 2.5 4.2 4.4 3.9 3.7 6.8 2.8 1.7 1.6 2.8 3.9 4.9 3.0 3.2 2.8 4.4 3.9 14.4 7.6 4.4 4.9 6.4 7.3 6.4 5.3 4.0 6.0 7.9 7.6 5.4 13.6 9.8 5.7 13.2 4.5 3.8 8.7 8.1 23.6 8.3 9.1 3.1 7.6 5.7 7.6 13.0 8.9 8.1 3.7 6.4 4.0 6.1 10.1 7.6 16.0 3.4 3.5 5.9 10.0 6.6 4.2 2.8 6.2 4.5 0.0 2.7 4.4 6.1 4.2 3.5 3.9 5.0 3.2 7.0 6.7 3.1 1.1 4.4 5.4 5.0 15.4 4.2 3.5 4.1 5.5 9.9 6.8 9.7 0.0 5.1 11.8 6.4 5.4 6.5 4.9 5.5 3.1 METTL27 WBSCR27 ENSG00000165171 "Methyltransferase like 27" Q8N6F8 7 73834590-73842535 "Disease related genes, Predicted intracellular proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 56.2;Collecting duct cells: 19.2;Distal tubular cells: 24.9;Proximal tubular cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 9.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.6;RPMI-8226: 40.8;T-47d: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA022420, HPA074662" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA022420: AB_2304370, HPA074662: " "unprognostic (6.70e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.38e-2)" "unprognostic (2.66e-2)" "unprognostic (4.39e-2)" "unprognostic (4.81e-3)" "unprognostic (1.20e-1)" "unprognostic (3.23e-1)" "unprognostic (2.27e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-1)" "prognostic favorable (1.10e-6)" "unprognostic (1.86e-1)" "unprognostic (2.15e-2)" "unprognostic (6.49e-2)" "unprognostic (1.24e-2)" 5.7 2.7 1.5 1.4 2.6 0.3 5.2 4.2 3.9 10.2 3.6 3.8 14.5 3.3 5.3 4.4 5.8 9.3 12.4 0.9 1.4 1.3 9.2 2.7 4.7 6.0 1.2 6.0 5.2 11.1 10.0 4.0 8.7 2.8 8.0 1.3 2.4 20.3 12.4 2.3 2.0 4.5 1.3 1.3 5.1 1.7 10.6 0.8 3.0 6.6 0.9 3.1 4.3 3.6 2.4 1.4 2.0 3.4 0.0 9.2 0.3 6.4 7.9 0.0 0.6 1.2 3.5 1.3 0.0 0.1 0.2 0.2 0.4 9.6 1.5 1.5 1.3 5.6 0.6 0.0 2.5 0.1 1.0 0.1 0.0 2.3 2.4 1.4 0.0 0.0 1.4 0.6 4.1 2.0 0.4 1.5 0.5 0.1 1.3 0.9 1.8 0.0 0.0 0.1 5.1 2.0 0.4 1.8 40.8 2.1 1.2 0.7 0.2 0.9 0.7 0.7 1.9 11.9 0.4 1.7 2.5 0.6 4.9 2.5 1.8 0.6 0.0 0.5 0.0 0.8 0.0 1.0 2.0 0.1 3.4 0.0 2.4 0.6 0.0 1.4 1.0 1.2 0.8 1.0 0.0 0.8 1.0 9.2 0.3 1.5 2.6 4.2 3.9 1.4 1.3 1.2 6.0 2.8 0.8 6.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 56.2 4.5 19.2 0.0 3.4 24.9 12.8 0.0 0.0 0.0 0.0 1.9 1.5 0.0 0.0 2.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 7.4 0.0 0.0 40.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 METTL5 HSPC133 ENSG00000138382 "Methyltransferase like 5" Q9NRN9 2 169810081-169824931 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038223 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA038223: AB_10672509" "unprognostic (2.55e-2)" "unprognostic (8.41e-2)" "unprognostic (4.73e-1)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (6.64e-5)" "unprognostic (2.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.24e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (3.06e-8)" "unprognostic (8.53e-2)" "unprognostic (1.70e-1)" "unprognostic (1.95e-2)" "unprognostic (6.87e-3)" 28.9 25.2 30.1 15.8 29.3 17.6 31.2 18.1 30.2 19.8 28.6 14.2 14.9 17.7 18.8 40.4 29.0 17.9 17.3 38.2 25.6 28.5 27.8 29.2 15.8 19.4 25.6 20.8 16.6 32.5 18.0 24.2 22.3 30.2 25.3 26.5 11.9 27.9 20.9 50.1 19.6 24.9 38.4 26.5 17.8 25.1 14.1 23.9 18.1 26.1 33.9 22.3 31.6 26.5 28.6 21.9 15.0 14.1 18.8 29.1 15.1 24.3 13.5 19.6 21.7 18.0 27.1 32.3 20.7 19.4 25.2 20.3 42.0 28.9 31.2 25.2 16.9 33.6 25.5 26.7 43.3 35.5 24.0 19.2 47.0 11.0 45.7 24.6 58.9 23.2 19.8 58.1 31.9 39.3 26.4 23.3 42.9 43.6 26.2 32.0 23.6 28.2 47.9 26.5 31.9 25.6 28.6 18.4 48.2 43.2 22.4 23.9 17.9 13.3 21.0 35.9 23.3 19.8 26.6 16.0 27.6 22.4 17.2 26.4 25.6 38.6 51.7 23.0 28.9 24.7 15.0 11.7 9.0 19.0 14.1 29.1 28.6 26.3 25.2 14.2 24.1 27.5 24.9 3.5 18.8 12.9 21.9 24.9 15.1 30.1 29.3 18.1 30.2 25.6 28.5 25.6 20.8 30.2 23.9 11.9 24.5 38.7 74.0 34.3 24.2 70.2 53.5 52.2 44.3 41.8 15.7 76.3 94.5 98.0 3.3 34.7 33.8 0.0 128.2 98.7 39.5 65.1 45.1 44.3 68.6 22.3 58.3 36.8 31.3 6.8 46.6 34.4 52.3 48.7 58.4 27.4 118.7 49.1 56.6 81.1 18.3 51.8 54.3 46.4 73.5 35.8 32.7 42.8 68.9 70.1 METTL8 "FLJ13984, TIP" ENSG00000123600 "Methyltransferase like 8" Q9H825 2 171317405-171434802 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035421 Uncertain Approved Cytosol NA NA Cytosol "HPA035421: AB_10670116" "unprognostic (3.13e-1)" "unprognostic (2.72e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.76e-1)" "unprognostic (3.76e-1)" "unprognostic (1.43e-4)" "unprognostic (2.94e-3)" "unprognostic (7.29e-2)" "unprognostic (6.52e-3)" "unprognostic (4.83e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (6.75e-4)" "unprognostic (1.45e-1)" "unprognostic (2.04e-1)" "unprognostic (2.10e-3)" "unprognostic (2.59e-3)" 10.8 8.0 7.4 8.4 9.6 6.8 8.8 6.2 8.5 9.4 12.6 10.4 9.2 4.6 8.4 6.3 21.0 5.9 7.2 6.7 8.7 6.4 8.6 8.6 5.5 6.0 13.2 4.5 6.4 8.1 6.1 5.0 7.8 10.9 10.9 14.1 5.2 6.2 11.6 6.9 15.1 8.2 20.5 12.5 7.8 6.3 11.2 10.1 4.0 4.7 13.5 8.9 13.7 10.3 6.6 10.1 1.2 4.4 7.0 7.5 3.6 8.4 6.4 3.1 9.5 10.4 12.4 17.2 10.5 8.0 9.9 12.4 14.0 11.8 17.5 8.4 5.0 8.5 8.6 11.2 17.1 12.5 9.2 5.8 9.7 5.7 19.7 8.4 14.8 7.5 12.2 18.9 15.7 24.7 2.5 19.5 9.3 17.9 4.0 13.5 9.2 10.4 3.6 13.1 7.4 5.8 5.5 12.2 19.0 7.4 8.3 11.5 4.5 11.1 8.5 7.7 5.4 6.1 5.6 9.6 8.7 6.8 6.1 5.8 2.1 9.3 10.6 6.9 10.5 9.0 0.8 3.0 0.9 5.4 4.4 7.5 4.3 6.3 5.0 4.0 6.6 2.9 3.3 1.2 7.0 2.1 10.1 6.3 3.6 7.4 9.6 6.2 8.5 8.7 6.4 13.2 4.5 10.9 10.1 6.0 6.7 33.5 8.2 22.7 7.5 7.5 17.8 8.1 17.0 3.5 2.0 14.4 10.0 7.3 11.1 8.1 7.4 23.3 5.3 17.3 10.8 7.0 5.8 8.6 10.6 11.1 6.4 5.5 9.4 2.9 13.0 11.6 10.1 7.2 4.2 7.7 7.5 2.9 15.2 14.4 9.6 6.5 10.5 6.1 18.1 23.3 10.8 12.5 12.5 8.1 METTL9 DREV1 ENSG00000197006 "Methyltransferase like 9" Q9H1A3 16 21597218-21657473 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 326.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053588, HPA056347" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA053588: AB_2682203, HPA056347: " "unprognostic (1.55e-1)" "unprognostic (2.18e-2)" "unprognostic (1.98e-3)" "unprognostic (5.43e-2)" "unprognostic (5.81e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (8.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.11e-2)" "unprognostic (7.57e-3)" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.49e-3)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (5.17e-2)" "unprognostic (1.65e-1)" 24.0 45.5 29.6 18.8 34.9 50.0 45.1 12.2 31.9 34.2 19.1 18.7 15.5 14.9 23.4 35.6 30.2 23.8 19.4 32.0 22.2 20.0 61.0 8.7 24.0 38.8 26.8 8.4 22.8 28.8 37.2 25.0 25.4 17.7 23.8 20.3 32.5 22.1 19.3 30.6 21.5 20.6 21.1 25.0 29.6 18.8 10.8 18.1 39.8 37.8 20.0 25.9 24.9 24.6 4.9 14.1 30.5 24.5 5.6 7.3 7.6 13.6 10.4 26.4 22.8 27.3 49.5 9.5 21.9 31.4 17.3 21.0 7.5 24.9 24.0 18.7 38.3 16.7 8.6 17.5 19.6 23.7 18.2 14.3 10.4 10.5 27.9 19.6 8.1 21.6 29.1 20.9 17.9 23.4 32.6 33.1 26.9 15.3 19.8 34.2 15.1 21.1 13.6 23.7 17.0 10.8 30.8 20.5 21.8 28.5 13.4 15.3 27.6 18.6 12.9 46.7 20.7 13.1 4.2 18.7 28.8 12.6 17.6 13.4 16.8 27.0 19.3 28.3 20.2 20.3 30.5 24.5 10.7 4.0 4.5 4.8 4.6 6.8 7.3 14.1 4.9 7.3 5.4 12.5 5.6 3.9 4.4 5.4 7.6 29.6 34.9 12.2 31.9 22.2 20.0 26.8 8.4 17.7 18.1 17.9 25.0 67.7 73.4 63.7 38.7 50.8 28.1 17.4 25.0 82.0 43.2 62.9 238.8 101.7 6.4 91.1 45.1 0.0 107.0 99.3 82.6 115.4 48.3 10.4 80.8 42.9 81.5 80.4 211.5 4.5 58.7 86.5 99.5 101.8 76.5 49.9 98.9 45.6 61.2 326.8 37.5 64.7 68.4 13.2 20.0 67.2 116.4 146.0 75.0 107.4 MEX3A "RKHD4, RNF162" ENSG00000254726 "Mex-3 RNA binding family member A" A1L020 1 156072013-156081998 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 7.2;ovary: 10.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8;Ductal cells: 9.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 13 "B-cells: 1.4" "Cell line enhanced" "Detected in many" "AF22: 25.4;NTERA-2: 23.1;SCLC-21H: 24.1;SH-SY5Y: 43.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062703 Supported Cytosol NA NA Cytosol "HPA062703: AB_2684840" "unprognostic (8.63e-2)" "unprognostic (2.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.55e-3)" "unprognostic (6.18e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.23e-8)" "unprognostic (4.25e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.96e-1)" "unprognostic (1.08e-3)" "unprognostic (4.73e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" "unprognostic (4.96e-2)" 0.4 0.2 1.8 1.0 1.8 0.8 2.5 3.3 5.1 2.5 1.3 1.4 0.2 0.7 7.2 0.7 1.4 1.7 1.1 0.2 3.5 1.0 1.1 1.8 0.6 3.4 1.9 2.1 10.1 0.6 0.4 0.4 0.8 2.2 1.7 1.0 1.0 2.0 0.6 0.2 0.7 0.6 1.7 1.0 1.4 0.5 3.1 2.0 3.6 1.5 0.2 1.1 1.9 1.4 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 25.4 6.3 0.3 0.4 3.0 0.6 0.1 1.0 0.9 1.4 0.3 0.8 3.0 0.3 0.6 0.5 11.0 0.4 1.2 1.2 3.0 0.6 1.1 2.5 0.5 0.3 0.5 0.7 0.8 0.5 0.4 2.6 4.8 5.8 5.7 0.0 1.4 1.6 2.9 0.4 23.1 1.0 3.3 9.3 2.0 0.1 0.8 1.1 24.1 43.9 0.7 2.8 1.5 11.1 4.9 1.9 1.6 1.6 3.9 0.4 1.4 0.6 0.4 1.3 0.1 0.7 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.8 3.3 2.0 3.5 1.0 1.9 2.1 2.2 2.0 0.0 0.3 0.0 2.6 3.5 1.6 0.8 0.0 2.7 0.0 0.0 9.8 0.6 1.7 9.9 0.1 6.0 0.0 0.0 1.3 1.8 2.8 2.1 0.0 5.6 1.7 3.2 5.8 7.4 1.5 0.0 4.6 0.0 5.0 0.0 0.5 1.4 4.2 0.0 1.1 7.5 2.7 0.0 2.7 0.0 2.7 3.0 0.2 0.0 2.2 1.1 MEX3B "DKFZp434J0617, RKHD3, RNF195" ENSG00000183496 "Mex-3 RNA binding family member B" Q6ZN04 15 82041778-82046141 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 15.6;testis: 33.3" "Group enriched" "Detected in many" 21 "Early spermatids: 185.8;Late spermatids: 144.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 33.5;HEL: 24.6;SH-SY5Y: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041093 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041093: AB_10793868" "unprognostic (2.42e-1)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (6.84e-2)" "unprognostic (1.43e-1)" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (7.56e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.31e-1)" "unprognostic (9.31e-3)" "unprognostic (5.93e-8)" "unprognostic (1.24e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.51e-2)" 2.0 0.6 1.5 1.8 1.6 2.0 1.6 3.8 4.5 15.6 2.8 1.6 2.5 0.8 7.9 0.6 1.1 1.2 2.8 2.0 2.0 1.4 1.0 1.0 1.4 2.8 2.2 3.3 6.8 0.7 0.2 0.9 3.3 1.0 3.7 0.9 1.2 3.0 3.8 1.6 1.1 1.1 4.0 1.0 1.2 1.0 33.3 0.7 8.4 1.0 1.8 1.2 3.1 4.2 0.0 1.3 0.0 0.1 0.4 0.1 0.0 0.1 1.2 8.8 33.5 0.7 1.0 2.5 1.0 0.5 1.8 1.6 0.2 0.2 1.5 0.6 1.9 0.5 0.2 4.1 0.1 1.3 0.3 2.7 24.6 1.4 1.1 1.4 0.3 7.8 0.5 0.7 1.0 2.0 4.3 3.8 3.1 1.2 0.0 3.1 0.8 4.0 2.1 11.4 0.0 0.3 5.6 5.4 0.8 0.0 0.0 7.0 13.7 1.7 0.3 1.1 2.6 0.1 0.4 3.5 4.6 5.4 2.5 1.5 3.2 1.6 1.8 1.5 2.4 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 1.6 3.8 4.5 2.0 1.4 2.2 3.3 1.0 0.7 0.0 1.1 0.0 0.4 2.5 3.3 3.7 0.0 0.0 0.0 0.0 2.0 7.7 0.0 0.8 185.8 1.9 0.0 0.0 0.2 7.2 4.3 0.9 1.1 0.0 1.5 0.0 1.2 3.7 1.0 144.1 6.1 3.6 6.8 0.0 1.6 5.7 0.6 0.0 4.2 0.0 2.8 6.5 4.0 2.6 4.3 1.8 2.1 0.0 1.1 0.3 MFGE8 "BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10" ENSG00000140545 "Milk fat globule-EGF factor 8 protein" Q08431 15 88898683-88913411 "Cancer-related genes, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Fertilization" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 363.2;Rod photoreceptor cells: 972.8;Sertoli cells: 1067.2;Smooth muscle cells: 475.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 13.3" "Group enriched" "Detected in many" 6 "granulocytes: 3.6;NK-cells: 6.3;T-cells: 13.3" "Cell line enhanced" "Detected in many" "ASC diff: 181.9;ASC TERT1: 94.5;fHDF/TERT166: 64.0;HSkMC: 95.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002753, HPA002807" Enhanced Approved Cytosol "Secreted to blood" NA NA 2830000 1100000 Cytosol "CAB002753: , HPA002807: AB_1078072" "unprognostic (1.28e-1)" "unprognostic (1.23e-1)" "unprognostic (1.63e-2)" "unprognostic (7.68e-2)" "unprognostic (2.75e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.11e-3)" "unprognostic (6.27e-2)" "unprognostic (8.49e-2)" "unprognostic (3.99e-1)" "prognostic unfavorable (6.06e-9)" "prognostic unfavorable (3.08e-4)" "unprognostic (4.85e-2)" "unprognostic (7.36e-3)" "unprognostic (2.41e-3)" 34.2 23.2 5.4 14.5 11.2 0.9 73.4 5.7 14.8 43.4 15.8 9.6 11.3 5.2 73.2 38.6 32.8 56.2 30.2 115.4 5.6 4.1 12.4 3.9 20.8 14.9 6.0 8.3 49.8 6.6 2.9 8.1 23.1 10.8 29.5 7.3 59.5 15.6 50.7 57.8 18.3 15.4 39.6 8.8 6.5 22.2 23.6 4.4 8.5 21.7 21.1 12.6 32.8 68.3 1.2 0.0 3.6 0.2 6.3 13.3 2.0 1.8 7.1 7.8 9.5 181.9 94.5 0.6 46.9 14.0 9.4 11.2 6.2 2.2 0.0 14.5 64.0 14.1 0.9 2.7 9.3 3.1 7.5 4.7 13.6 0.4 0.6 47.9 0.0 4.8 95.7 25.0 7.4 12.4 20.5 3.6 3.4 2.1 4.1 18.2 0.1 2.1 0.3 39.9 0.7 2.5 2.1 7.4 2.4 3.3 0.6 0.8 4.1 2.5 0.2 21.2 17.1 0.2 1.0 3.9 23.4 12.6 6.0 3.4 14.4 2.8 1.4 3.1 1.1 9.0 3.6 0.2 0.4 1.2 0.0 4.2 1.2 4.2 3.0 0.0 0.8 4.4 3.1 0.0 6.3 0.1 0.0 13.3 2.0 5.4 11.2 5.7 14.8 5.6 4.1 6.0 8.3 10.8 4.4 11.9 4.8 1.9 27.2 43.3 16.8 80.8 12.7 0.0 2.3 3.5 363.2 4.3 0.0 12.8 9.7 36.0 0.8 0.0 3.6 16.7 111.8 11.6 4.7 7.4 7.1 15.9 42.9 28.3 35.4 22.8 173.2 16.6 113.1 2.8 5.4 69.0 18.8 0.0 102.6 0.0 972.8 1067.2 475.7 2.7 8.6 31.5 4.5 12.2 1.2 7.4 MFHAS1 "LRRC65, MASL1, ROCO4" ENSG00000147324 "Malignant fibrous histiocytoma amplified sequence 1" Q9Y4C4 8 8783354-8893645 "Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Signal transduction inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.5;MAIT T-cell: 2.1;memory B-cell: 1.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive B-cell: 1.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.7;T-reg: 3.1" "Group enriched" "Detected in many" 5 "B-cells: 1.1;T-cells: 3.9" "Cell line enhanced" "Detected in many" "MOLT-4: 51.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051213, HPA054471" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051213: AB_2681391, HPA054471: AB_2682498" "unprognostic (1.33e-1)" "unprognostic (4.46e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-1)" "unprognostic (1.95e-1)" "unprognostic (8.91e-3)" "unprognostic (2.70e-2)" "unprognostic (2.68e-3)" "unprognostic (9.23e-3)" "unprognostic (7.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.81e-1)" "unprognostic (2.01e-3)" "unprognostic (5.93e-2)" "unprognostic (4.91e-1)" "unprognostic (1.82e-1)" "unprognostic (1.81e-1)" 8.0 2.7 10.1 14.9 10.2 12.5 5.8 10.3 10.0 8.7 16.6 5.0 5.0 7.6 7.7 4.8 7.6 9.9 10.7 7.6 10.0 6.5 15.8 10.5 12.5 12.1 6.2 4.7 6.8 6.3 6.2 3.3 11.1 7.4 8.9 14.9 5.4 7.6 6.1 4.4 8.5 9.5 10.4 3.6 13.5 9.0 7.6 5.2 24.9 10.8 3.6 10.6 9.3 15.0 1.1 0.5 0.0 0.3 0.4 3.9 0.9 7.9 6.0 3.6 2.7 3.4 4.4 12.0 3.3 7.1 2.4 3.2 9.5 1.5 11.6 4.1 3.1 6.9 2.7 3.8 3.0 2.1 15.0 3.4 0.8 2.2 6.1 4.1 3.3 1.2 2.4 6.4 3.2 3.2 2.6 5.2 14.5 5.3 0.0 1.9 2.8 51.2 2.9 7.1 10.5 2.5 7.0 5.6 1.8 16.7 8.3 5.8 4.7 1.9 3.0 5.2 6.5 2.0 4.5 2.2 2.9 4.3 11.5 6.3 0.6 2.7 9.1 5.4 4.4 1.7 0.0 0.3 0.0 2.5 0.1 2.1 1.1 3.9 2.2 0.5 1.0 1.9 1.7 0.0 0.4 0.0 0.1 3.1 0.9 10.1 10.2 10.3 10.0 10.0 6.5 6.2 4.7 7.4 5.2 50.6 44.0 7.4 22.5 33.3 17.4 14.0 22.9 5.3 25.0 29.6 3.9 2.5 11.6 10.6 1.9 16.1 8.6 23.3 13.2 2.5 21.6 32.3 21.9 15.3 25.5 3.2 18.1 27.0 25.7 1.9 10.6 10.6 10.1 2.8 28.4 21.8 21.5 5.8 7.8 14.6 8.1 0.0 42.2 1.9 20.2 43.7 1.9 20.8 24.0 15.4 MFSD1 "FLJ14153, UG0581B09" ENSG00000118855 "Major facilitator superfamily domain containing 1" Q9H3U5 3 158732198-158829719 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Hofbauer cells: 192.2;Kupffer cells: 259.8;Macrophages: 135.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065858 Approved Approved "Plasma membrane,Cytosol" NA NA 14000 "Plasma membrane" Cytosol "HPA065858: AB_2685569" "unprognostic (9.94e-2)" "unprognostic (3.12e-3)" "unprognostic (3.54e-2)" "unprognostic (1.00e-1)" "unprognostic (2.16e-2)" "unprognostic (7.37e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (2.52e-1)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (2.92e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (4.66e-2)" "unprognostic (2.57e-1)" 26.2 29.5 11.4 22.0 11.8 17.2 24.2 9.1 14.0 18.7 15.7 13.4 18.9 13.2 18.3 20.6 37.0 18.4 17.5 17.7 10.8 10.3 20.7 24.8 24.9 39.8 15.7 11.7 15.3 16.8 16.5 16.8 18.3 13.6 14.7 11.5 14.5 34.5 17.9 9.2 18.6 16.8 15.0 14.5 29.1 19.9 15.0 14.3 11.3 18.7 16.3 16.7 23.8 24.1 10.5 45.3 42.6 49.6 5.4 7.3 35.3 14.9 6.4 1.6 5.0 8.7 8.2 10.3 23.4 10.5 8.3 8.2 2.6 14.8 4.2 17.2 14.9 5.0 7.8 4.0 5.1 7.8 16.6 10.9 11.2 4.9 1.1 9.4 41.3 28.1 12.2 6.7 7.5 2.1 3.3 6.5 2.8 8.7 8.6 14.7 3.4 2.5 12.2 1.6 6.3 16.4 5.6 2.4 36.6 3.0 3.9 4.8 7.2 17.2 13.3 4.1 2.0 10.5 16.2 21.3 11.9 4.6 17.6 11.5 27.4 19.2 2.3 15.0 30.0 8.3 14.0 49.6 42.6 7.3 38.5 6.6 10.5 5.8 6.5 45.3 8.5 6.4 7.0 17.6 5.4 31.6 14.7 6.8 35.3 11.4 11.8 9.1 14.0 10.8 10.3 15.7 11.7 13.6 14.3 17.9 31.3 39.5 33.3 19.1 11.9 17.1 12.7 40.2 29.6 21.0 5.9 23.7 16.6 28.2 3.5 25.1 25.5 23.3 24.8 27.2 23.6 39.9 47.4 30.1 192.2 17.5 21.9 39.3 259.8 5.3 11.2 135.3 30.4 15.4 26.6 23.4 26.7 20.1 10.6 25.9 10.0 12.9 15.5 8.8 7.0 22.7 46.8 15.4 24.0 47.5 MFSD13A "bA18I14.8, C10orf77, FLJ22529, TMEM180" ENSG00000138111 "Major facilitator superfamily domain containing 13A" Q14CX5 10 102461395-102477045 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Horizontal cells: 20.6;Syncytiotrophoblasts: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018031 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA018031: AB_2204891" "unprognostic (2.24e-2)" "prognostic favorable (8.29e-4)" "unprognostic (7.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.79e-1)" "unprognostic (2.11e-1)" "unprognostic (9.16e-3)" "unprognostic (4.70e-2)" "unprognostic (4.03e-2)" "unprognostic (8.10e-2)" "unprognostic (2.04e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.66e-3)" "unprognostic (2.44e-1)" "unprognostic (2.74e-1)" "unprognostic (4.02e-2)" 3.8 3.3 8.8 5.9 15.7 9.0 2.6 18.0 18.7 2.4 7.0 8.5 0.4 10.2 4.3 1.8 3.0 2.4 4.7 5.2 9.0 6.5 3.3 5.7 14.1 5.6 7.9 8.7 2.3 5.1 2.8 4.4 7.2 8.2 3.1 6.4 3.9 3.0 2.3 3.9 17.4 7.5 4.9 5.2 6.9 7.1 5.8 8.6 2.3 5.7 1.8 6.7 3.1 2.5 5.0 7.5 5.5 7.2 2.2 5.8 3.4 9.3 4.3 3.3 7.9 0.3 0.3 5.1 1.9 4.9 3.7 8.7 8.5 12.9 8.4 9.8 0.7 3.6 11.7 6.2 5.0 1.4 10.6 5.5 10.3 6.1 4.4 8.5 5.2 10.1 4.3 2.1 2.1 3.8 3.1 4.3 11.4 2.3 4.6 0.3 1.9 8.7 3.4 5.6 8.2 4.2 10.6 0.5 1.4 1.7 2.5 8.2 7.8 1.8 1.0 4.2 1.2 4.8 3.5 1.3 1.7 2.1 2.1 2.6 1.6 4.1 10.9 9.6 8.6 2.4 0.7 7.2 5.5 5.2 5.3 5.2 5.0 5.0 4.1 7.5 2.8 5.2 5.8 4.4 2.2 3.0 0.8 1.4 3.4 8.8 15.7 18.0 18.7 9.0 6.5 7.9 8.7 8.2 8.6 17.9 9.6 0.0 1.2 0.0 6.8 0.0 2.5 1.4 1.2 1.8 3.9 1.5 0.0 2.4 1.1 2.3 2.9 0.0 3.2 2.5 0.7 1.4 1.1 4.9 15.8 20.6 2.4 4.9 3.5 0.4 0.9 7.8 0.0 4.6 3.9 3.0 2.8 5.7 2.1 1.2 13.5 0.0 0.0 3.4 2.9 0.0 23.8 1.5 6.0 0.9 MFSD14B "FLJ14753, HIATL1" ENSG00000148110 "Major facilitator superfamily domain containing 14B" Q5SR56 9 94374551-94461042 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.0" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017978 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017978: AB_2116836" "unprognostic (3.03e-2)" "unprognostic (2.28e-1)" "unprognostic (3.96e-3)" "unprognostic (5.95e-3)" "unprognostic (1.39e-1)" "unprognostic (3.29e-2)" "unprognostic (4.13e-3)" "unprognostic (3.27e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-2)" "unprognostic (1.16e-2)" "unprognostic (3.11e-3)" "unprognostic (1.15e-1)" "unprognostic (9.12e-2)" "unprognostic (6.63e-2)" "unprognostic (1.93e-1)" "unprognostic (9.01e-2)" 15.1 18.9 13.3 14.3 14.7 9.0 20.2 11.6 12.8 14.9 14.2 19.7 15.5 9.9 18.6 16.1 28.1 14.4 12.5 13.4 13.3 12.4 14.7 9.0 25.7 21.5 14.6 7.8 15.9 21.5 86.0 9.2 24.2 28.3 14.5 15.4 21.6 15.9 14.2 7.3 21.8 16.0 12.8 19.1 19.3 13.0 9.2 13.2 24.0 16.7 14.2 23.9 14.1 18.8 4.6 7.8 10.4 11.4 3.6 7.1 3.6 25.9 16.7 13.1 10.2 28.8 20.7 20.9 25.3 22.0 22.5 22.1 8.4 31.1 31.3 15.1 21.7 26.1 57.4 15.6 16.1 22.0 22.3 8.4 10.7 16.1 12.6 20.5 33.8 20.0 18.9 24.4 23.8 18.3 12.6 19.2 17.2 20.3 18.6 29.9 19.7 24.7 19.4 19.2 38.0 13.5 12.4 30.1 10.1 24.0 20.0 12.6 16.6 21.5 25.5 26.7 16.4 11.6 20.0 20.6 23.6 16.7 36.2 23.3 20.6 25.5 8.6 21.0 16.6 21.1 0.6 7.9 5.9 5.6 11.4 5.1 4.6 5.1 5.6 7.8 2.9 5.1 7.1 10.4 3.6 7.7 7.7 5.1 3.6 13.3 14.7 11.6 12.8 13.3 12.4 14.6 7.8 28.3 13.2 6.0 21.9 13.7 20.2 0.0 11.2 0.0 17.8 13.4 12.5 41.8 3.9 12.4 6.6 15.2 2.6 11.3 7.1 0.0 16.4 22.4 13.2 30.5 3.5 10.4 25.8 4.8 7.0 27.0 63.5 2.1 15.5 18.5 0.0 10.8 26.6 18.1 22.0 15.8 15.2 5.7 9.1 12.9 0.0 10.4 17.5 0.0 16.0 13.8 14.9 41.4 MFSD2A "FLJ14490, MFSD2" ENSG00000168389 "Major facilitator superfamily domain containing 2A" Q8NA29 1 39955112-39969968 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Symport, Transport" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 112.2;Enterocytes: 112.9;Hepatocytes: 268.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7" "Group enriched" "Detected in many" 11 "dendritic cells: 16.7;monocytes: 9.3" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.9;THP-1: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043107 Uncertain Approved "Plasma membrane,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Plasma membrane, Cytoplasmic bodies" "HPA043107: AB_10794387" "unprognostic (2.20e-1)" "unprognostic (1.15e-1)" "unprognostic (5.23e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (6.92e-2)" "unprognostic (2.61e-2)" "unprognostic (2.45e-2)" "unprognostic (1.60e-1)" "unprognostic (4.33e-1)" "unprognostic (2.85e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.22e-6)" "unprognostic (9.26e-2)" "unprognostic (4.11e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.33e-4)" 2.0 0.9 6.0 1.6 7.2 3.3 6.2 2.4 6.5 1.6 5.6 4.3 96.9 6.4 4.3 45.0 5.0 1.5 1.2 0.7 7.6 6.1 7.2 87.9 15.8 1.1 7.5 2.6 0.8 0.5 0.3 3.0 111.3 7.8 1.0 2.5 2.0 1.7 121.2 0.3 27.0 20.4 1.8 7.3 0.8 1.0 17.7 2.3 0.2 2.9 4.7 1.7 2.6 4.6 1.1 16.7 0.9 9.3 0.1 0.1 2.3 2.1 0.9 4.5 6.8 3.2 0.6 0.0 2.0 4.0 4.6 5.5 0.2 1.2 13.3 1.2 1.0 3.2 5.3 4.4 7.7 3.6 1.7 2.1 1.6 0.0 0.0 10.7 2.3 7.9 3.6 4.8 18.9 7.8 0.8 1.1 4.1 0.0 3.4 2.0 0.2 3.6 3.6 3.6 7.4 1.6 2.5 6.6 3.0 0.7 6.3 1.6 2.4 1.6 11.4 1.1 0.4 0.5 59.5 0.7 1.0 2.0 3.4 8.7 0.6 1.2 2.9 10.6 9.0 3.3 0.0 9.3 0.9 0.1 4.6 0.1 1.1 0.0 0.1 10.3 0.2 0.0 0.0 0.5 0.1 0.8 16.7 0.0 2.3 6.0 7.2 2.4 6.5 7.6 6.1 7.5 2.6 7.8 2.3 17.9 112.2 11.5 13.4 46.9 1.9 0.6 12.7 12.0 31.8 15.7 0.0 0.3 0.0 3.2 0.6 6.7 112.9 0.0 22.5 6.5 9.7 5.7 17.3 268.3 6.4 0.0 1.2 10.4 12.4 0.9 0.6 11.4 0.0 2.8 16.4 41.8 16.3 3.5 0.4 3.7 1.8 0.0 3.4 1.1 1.0 47.9 43.9 2.2 10.0 23.0 MFSD6 FLJ20160 ENSG00000151690 "Major facilitator superfamily domain containing 6" Q6ZSS7 2 190408355-190509205 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022274 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA022274: AB_2142776" "unprognostic (9.47e-2)" "unprognostic (7.01e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-2)" "unprognostic (2.49e-1)" "unprognostic (4.13e-3)" "unprognostic (1.78e-2)" "unprognostic (3.08e-2)" "unprognostic (3.92e-1)" "unprognostic (3.77e-1)" "unprognostic (9.54e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.05e-4)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" "unprognostic (9.14e-2)" "unprognostic (9.18e-2)" 12.3 26.9 20.8 9.3 23.3 4.2 13.8 19.4 33.1 15.3 20.0 29.0 29.0 12.6 7.1 22.3 26.6 13.0 10.3 11.1 25.4 26.5 7.4 2.0 16.9 8.7 36.2 22.9 3.5 10.9 28.2 35.7 5.6 43.1 15.7 19.0 12.2 19.2 29.6 3.8 18.9 15.4 9.5 36.7 12.7 20.2 4.9 18.3 13.0 25.5 10.8 12.7 13.3 13.6 2.4 2.6 8.1 2.0 3.3 5.6 1.2 10.6 6.6 0.2 2.3 4.8 6.2 9.1 5.5 11.1 3.7 4.7 2.4 13.6 16.7 2.6 11.4 7.0 18.2 3.2 9.6 4.2 33.9 5.0 8.9 6.5 1.2 1.9 3.5 2.8 0.9 17.5 5.5 3.6 12.2 1.3 13.3 2.2 18.6 0.9 4.1 16.3 0.7 1.5 11.6 7.1 3.6 0.5 14.3 7.1 19.5 21.2 5.4 7.8 18.4 10.6 0.7 6.0 4.1 5.5 0.6 1.3 7.3 8.4 8.6 3.5 6.0 6.1 7.3 3.0 8.1 2.0 0.6 2.6 0.6 2.7 2.4 3.5 3.6 2.6 1.3 1.6 3.6 0.1 3.3 0.9 1.3 5.6 1.2 20.8 23.3 19.4 33.1 25.4 26.5 36.2 22.9 43.1 18.3 29.8 21.2 3.9 9.9 5.7 8.3 17.9 5.1 108.4 37.5 22.7 7.9 0.1 0.0 12.6 37.9 12.8 13.4 0.0 17.7 0.1 2.3 15.4 22.1 0.6 4.2 27.0 34.0 11.1 2.1 9.9 5.2 9.2 8.5 4.6 38.6 7.1 20.1 17.5 4.9 1.3 7.7 0.0 3.1 0.9 1.1 15.9 0.0 10.2 14.4 19.0 MGA "FLJ12634, KIAA0518, MAD5, MXD5" ENSG00000174197 "MGA, MAX dimerization protein" Q8IWI9 15 41621224-41773081 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042278, HPA058183" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA042278: AB_10794647, HPA058183: AB_2683632" "unprognostic (5.78e-2)" "unprognostic (7.97e-2)" "unprognostic (2.97e-1)" "unprognostic (7.20e-2)" "unprognostic (6.26e-3)" "unprognostic (5.82e-3)" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (1.90e-2)" "unprognostic (3.96e-3)" "unprognostic (3.71e-1)" "unprognostic (3.80e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-1)" "unprognostic (3.93e-1)" "unprognostic (2.50e-1)" "unprognostic (3.89e-1)" 9.3 11.3 13.8 13.6 15.3 14.3 13.0 28.2 16.9 14.5 10.1 13.3 12.2 6.8 14.2 11.5 9.8 11.3 7.8 10.1 11.2 7.7 10.1 8.5 8.5 12.7 18.7 10.5 22.7 12.0 18.0 27.6 12.4 13.7 11.0 9.7 7.2 10.3 10.8 11.8 11.2 10.6 11.8 16.1 12.5 9.8 16.4 14.7 22.4 13.9 5.3 13.4 11.6 11.5 5.0 4.1 4.9 4.9 9.8 5.0 1.5 1.4 8.5 10.7 7.0 8.4 6.7 8.6 4.2 4.3 5.1 5.0 9.0 5.0 10.0 7.7 4.9 9.2 5.9 16.5 3.7 7.0 4.7 5.4 21.3 14.0 8.0 7.5 19.5 10.6 5.1 4.6 7.0 7.0 2.1 6.5 9.8 24.7 4.6 4.5 4.1 11.8 7.6 6.6 4.3 4.4 13.4 10.9 5.2 2.7 6.1 10.2 9.9 15.1 5.3 2.7 8.2 4.3 12.5 6.9 6.1 8.7 6.3 5.0 6.3 9.4 9.8 3.9 7.5 3.0 4.9 2.3 2.5 4.7 1.8 4.6 4.8 3.7 5.0 2.4 5.0 3.9 4.3 1.2 9.8 4.9 4.1 1.8 1.5 13.8 15.3 28.2 16.9 11.2 7.7 18.7 10.5 13.7 14.7 20.8 17.5 20.6 9.5 7.0 24.2 25.5 5.1 20.1 21.6 12.2 31.4 14.6 6.6 10.4 11.7 15.0 7.0 23.3 4.6 10.4 12.5 11.4 13.9 8.1 10.1 12.7 7.5 15.4 11.0 4.6 19.2 11.8 8.5 2.8 9.2 13.5 7.3 11.5 19.4 4.2 21.2 38.8 13.4 27.3 40.0 9.8 21.7 17.5 10.5 8.7 MGAM2 ENSG00000257743 "Maltase-glucoamylase 2 (putative)" Q2M2H8 7 142111749-142222324 "Enzymes, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 61.2;pancreas: 15.6;salivary gland: 35.4" "Group enriched" "Detected in some" 10 "Early spermatids: 21.0;Late spermatids: 12.0" "Group enriched" "Detected in some" 11 "colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Group enriched" "Detected in some" 8 "OE19: 5.5;RH-30: 4.0" "Low region specificity" "Detected in many" HPA055697 Enhanced Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA055697: AB_2682890" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-3)" "unprognostic (5.65e-2)" "unprognostic (2.19e-2)" "unprognostic (1.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-2)" "unprognostic (5.93e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-1)" "unprognostic (5.50e-4)" "unprognostic (7.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.71e-2)" "unprognostic (9.33e-2)" 0.2 0.1 0.1 2.5 0.1 0.2 1.3 0.1 0.1 0.1 28.8 0.0 0.0 15.0 0.1 0.4 0.1 0.3 7.0 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.4 0.0 0.1 15.6 0.0 0.1 0.0 0.1 0.1 1.4 0.7 35.4 0.0 0.1 0.2 61.2 0.0 0.5 1.5 0.7 1.0 0.0 0.0 0.1 1.7 0.8 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 4.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MGAT4B GnT-Ivb ENSG00000161013 "Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B" Q9UQ53 5 179797597-179806952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 125.6;liver: 100.0" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 212.8;Paneth cells: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "eosinophil: 8.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 8.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012804, HPA052134" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus, Vesicles, Cytosol" "HPA012804: , HPA052134: AB_2681741" "unprognostic (2.01e-2)" "unprognostic (8.68e-3)" "unprognostic (1.40e-1)" "unprognostic (3.83e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (3.61e-3)" "unprognostic (7.57e-3)" "unprognostic (1.22e-2)" "unprognostic (2.02e-1)" "unprognostic (5.13e-2)" "unprognostic (2.26e-2)" "unprognostic (2.27e-2)" "prognostic favorable (5.78e-4)" "unprognostic (1.52e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-2)" "unprognostic (1.42e-1)" 13.2 22.8 9.1 19.5 8.2 9.5 18.7 15.3 13.5 8.7 77.3 5.9 10.1 61.7 9.2 10.4 16.8 10.7 26.0 20.6 9.5 5.4 31.9 100.0 17.1 15.6 6.3 5.2 9.1 13.4 10.3 8.3 14.4 6.3 8.8 30.9 10.1 19.2 8.2 8.4 12.1 125.6 7.5 4.9 12.5 22.3 11.2 5.6 7.0 16.6 14.6 10.0 9.5 13.7 0.9 0.6 8.5 0.7 0.0 0.6 0.2 20.8 21.1 10.4 24.1 32.0 17.2 18.1 12.4 24.9 11.3 8.9 23.1 58.2 3.5 31.9 28.6 50.4 15.8 15.2 27.9 8.6 29.2 8.1 10.7 19.2 20.1 22.6 13.5 3.3 18.6 19.6 11.5 14.3 44.4 23.2 4.2 6.9 9.6 19.0 23.3 2.0 11.2 6.4 31.9 8.5 5.2 8.3 9.9 33.9 40.6 17.2 10.1 18.6 19.3 33.4 9.2 13.2 13.7 28.3 28.6 12.7 16.0 19.8 8.2 9.4 8.8 34.3 17.0 20.6 0.0 0.7 8.5 0.3 0.1 0.1 0.0 0.5 0.2 0.6 0.9 0.4 0.6 0.3 0.0 0.5 0.5 0.0 0.2 9.1 8.2 15.3 13.5 9.5 5.4 6.3 5.2 6.3 5.6 11.9 8.6 8.5 16.0 11.1 15.5 21.6 25.5 0.0 5.7 26.2 3.9 6.8 3.3 60.0 0.5 14.3 212.8 0.0 46.0 9.9 10.4 29.2 4.7 75.0 15.1 28.6 22.0 31.9 17.0 1.6 14.1 11.7 10.1 18.0 64.6 23.5 79.0 114.3 15.9 20.7 10.4 12.9 8.6 1.6 4.8 10.5 11.7 5.0 102.6 39.7 MGEA5 "MEA5, NCOAT, OGA" ENSG00000198408 "Meningioma expressed antigen 5 (hyaluronidase)" O60502 10 101784443-101818465 "Enzymes, Predicted intracellular proteins" "Host-virus interaction" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 265.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036141, HPA076501" Approved Supported Cytosol NA NA Cytosol "HPA036141: AB_10672079, HPA076501: AB_2686802" "unprognostic (4.34e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (8.69e-5)" "unprognostic (4.63e-1)" "unprognostic (2.06e-1)" "unprognostic (2.57e-2)" "unprognostic (2.65e-1)" "unprognostic (1.79e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-3)" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "unprognostic (1.68e-1)" "unprognostic (3.01e-1)" "unprognostic (3.21e-2)" "unprognostic (1.90e-1)" "unprognostic (9.23e-3)" 29.5 17.5 51.9 27.4 54.4 49.3 35.5 58.9 51.4 24.5 27.0 29.0 20.9 17.6 29.9 36.8 26.0 23.3 19.1 27.4 46.0 29.8 27.7 28.6 24.0 40.1 30.7 43.6 33.8 20.9 53.3 22.1 25.5 42.6 31.6 26.5 30.7 24.4 26.3 25.4 36.6 28.5 37.4 29.5 35.2 23.9 21.9 35.4 32.9 25.9 11.8 39.5 34.3 26.7 8.1 3.3 14.7 5.6 6.8 7.1 1.4 30.8 15.7 23.0 44.6 14.8 36.0 16.0 21.7 22.0 10.1 17.5 11.5 19.8 20.7 15.9 25.9 17.5 22.3 21.5 27.4 21.6 30.2 14.7 20.6 21.9 9.0 16.0 15.2 11.7 34.7 30.8 17.4 41.5 29.1 18.8 18.9 14.5 38.4 17.2 15.7 16.0 15.9 12.7 6.7 16.0 22.3 25.4 15.1 17.0 28.0 10.0 17.7 19.5 10.5 27.1 22.0 27.8 16.6 28.4 15.7 15.2 22.7 24.8 19.2 30.5 16.5 19.7 26.2 8.5 10.5 2.1 6.8 7.1 2.0 5.6 6.4 4.9 6.1 1.3 8.1 6.8 5.7 14.7 6.8 5.6 3.3 4.5 1.4 51.9 54.4 58.9 51.4 46.0 29.8 30.7 43.6 42.6 35.4 107.2 86.7 52.8 42.9 64.5 144.1 0.0 63.7 61.6 70.5 0.0 265.1 31.5 0.0 0.0 86.9 51.4 61.9 23.3 0.0 23.6 49.2 69.4 73.0 70.0 33.8 74.7 86.1 95.8 62.6 94.2 73.4 62.1 62.4 0.0 53.3 63.6 0.0 48.9 59.4 0.0 132.6 25.8 55.6 20.2 36.6 81.8 42.6 117.6 48.7 51.0 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" "O94851, Q6ZW33" 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 138.4" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 73.9;Late spermatids: 128.9;Peritubular cells: 106.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebellum: 138.4;cerebral cortex: 39.8" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.1 3.3 15.4 7.3 15.1 6.8 2.9 138.4 39.8 6.6 14.7 2.7 2.9 7.2 14.7 7.7 11.5 5.4 11.1 24.8 22.0 6.9 2.9 3.9 12.8 2.3 5.6 17.9 3.9 4.4 0.7 2.4 5.0 5.5 3.3 15.1 2.8 2.9 8.4 14.6 9.3 10.8 22.7 7.6 2.6 5.9 24.6 0.6 0.0 4.5 1.9 2.2 7.8 3.2 0.2 5.5 12.2 6.7 3.7 3.5 2.1 11.8 6.3 0.3 1.4 1.6 3.0 7.5 18.9 21.4 7.4 11.6 13.2 8.5 0.3 4.1 13.2 21.2 8.4 2.3 30.4 18.4 13.7 1.5 11.2 1.2 0.9 14.2 2.1 1.4 5.3 5.4 32.6 31.9 13.8 16.9 0.8 19.5 0.5 11.9 0.7 0.1 1.0 0.4 8.4 5.9 0.1 7.5 7.9 1.5 14.9 6.1 0.5 6.2 17.3 1.2 4.7 1.7 0.6 30.1 40.3 15.2 6.6 16.4 0.4 0.9 0.4 24.5 3.0 0.8 0.1 6.7 0.5 2.8 1.7 3.5 0.2 1.7 1.7 5.5 0.2 0.2 0.9 12.2 3.7 0.5 1.0 2.1 2.1 15.4 15.1 138.4 39.8 22.0 6.9 5.6 17.9 5.5 0.6 38.7 29.6 4.2 6.7 9.0 2.8 28.1 7.6 5.3 11.4 3.5 0.0 2.1 0.0 9.6 73.9 7.1 31.5 23.3 12.4 9.5 4.5 7.0 1.1 17.8 3.0 0.0 21.7 11.1 11.1 128.9 19.5 8.9 5.0 8.2 10.0 0.2 29.0 14.1 106.1 0.6 1.6 12.9 27.6 0.9 0.9 8.3 1.9 9.2 9.9 9.7 MICAL3 KIAA0819 ENSG00000243156 "Microtubule associated monooxygenase, calponin and LIM domain containing 3" Q7RTP6 22 17787649-18024559 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Exocytosis" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2" "Group enriched" "Detected in many" 6 "B-cells: 5.2;granulocytes: 10.0" "Cell line enhanced" "Detected in many" "WM-115: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000639, HPA003421, HPA034882" Approved Supported "Nucleoplasm,Plasma membrane,Midbody ring,Cytosol" Yes No "Nucleoplasm, Midbody ring" "Plasma membrane, Cytosol" "HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371" "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-2)" "unprognostic (2.00e-2)" "unprognostic (7.68e-2)" "unprognostic (2.06e-1)" "unprognostic (4.71e-2)" "unprognostic (3.07e-3)" "unprognostic (3.41e-1)" "unprognostic (1.01e-1)" "unprognostic (4.58e-1)" "unprognostic (3.82e-1)" "unprognostic (8.86e-3)" "unprognostic (1.36e-2)" "unprognostic (1.23e-1)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" 10.1 9.0 15.4 20.7 19.2 10.2 9.6 62.2 25.0 12.8 22.4 30.0 8.8 8.3 30.3 14.0 13.8 28.6 9.5 23.7 15.4 13.8 8.7 16.8 6.1 15.2 21.6 15.6 20.2 10.2 30.4 11.0 11.9 19.4 11.8 16.5 14.2 8.0 14.8 28.0 14.7 13.2 26.1 20.9 12.2 11.1 15.7 22.6 3.0 10.4 7.8 20.8 14.7 15.1 5.2 0.3 10.0 0.1 1.3 1.1 0.2 13.9 15.4 8.2 13.2 6.1 7.9 9.8 12.3 13.4 17.5 13.8 14.6 2.0 15.6 6.3 16.8 20.1 16.2 12.0 14.2 17.0 15.1 11.4 16.2 16.3 6.1 4.1 7.2 8.7 6.3 11.4 18.3 19.5 11.1 10.1 4.5 17.8 10.1 6.4 12.5 6.8 4.5 5.5 10.3 10.0 9.5 12.2 0.7 14.0 9.9 21.5 8.4 17.4 11.0 26.2 13.0 4.4 3.1 17.8 18.0 11.6 12.3 25.6 6.6 11.7 20.9 15.6 3.2 51.4 10.0 0.0 0.1 0.5 0.1 0.8 3.3 0.6 0.5 0.1 5.2 0.3 0.2 0.2 1.3 0.0 0.3 1.1 0.2 15.4 19.2 62.2 25.0 15.4 13.8 21.6 15.6 19.4 22.6 3.0 15.1 14.3 10.9 10.0 13.4 13.4 12.7 20.1 15.9 12.2 49.1 11.8 0.0 19.8 9.4 14.0 21.9 23.3 8.4 29.4 9.6 10.5 18.5 33.0 2.7 1.6 9.8 6.2 2.7 10.5 3.7 3.7 8.5 8.2 18.5 59.7 22.3 20.1 6.0 3.9 11.6 0.0 9.2 19.3 12.6 10.3 9.4 7.7 15.7 6.7 MICALL1 "KIAA1668, MICAL-L1, MIRAB13" ENSG00000100139 "MICAL like 1" Q8N3F8 22 37905657-37942822 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 26.6;Syncytiotrophoblasts: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043480, HPA051956" Approved Supported "Cell Junctions,Centriolar satellite,Cytosol" NA NA "Cell Junctions, Centriolar satellite, Cytosol" "HPA043480: AB_10793950, HPA051956: AB_2681671" "unprognostic (2.13e-1)" "unprognostic (1.13e-1)" "unprognostic (4.94e-2)" "unprognostic (4.90e-1)" "unprognostic (1.57e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (3.08e-6)" "unprognostic (3.46e-2)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.42e-3)" "unprognostic (1.57e-2)" "unprognostic (6.96e-3)" "unprognostic (6.61e-2)" "unprognostic (8.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.92e-2)" 8.0 4.8 5.3 10.1 10.3 6.3 12.6 5.9 7.3 19.1 25.2 21.4 17.6 6.1 21.3 11.0 32.3 11.1 14.4 6.0 7.5 5.5 6.4 5.7 11.8 9.2 17.4 5.1 6.8 14.2 19.2 4.3 29.6 12.5 15.3 7.5 8.7 13.4 25.2 8.5 24.4 9.2 43.5 18.7 5.9 28.5 7.4 11.1 5.3 9.4 15.5 13.5 21.4 17.5 2.8 3.3 2.3 1.6 4.1 2.6 1.6 10.9 6.1 6.6 7.1 6.7 5.7 26.5 15.6 8.9 15.3 11.5 8.3 5.9 4.7 4.8 10.3 10.8 28.5 5.1 30.4 11.1 8.1 13.4 1.9 6.5 8.2 10.9 5.4 5.5 4.8 47.6 18.2 37.9 5.6 10.5 1.8 3.4 4.6 13.3 5.2 1.3 2.4 2.3 6.4 4.6 7.3 12.6 2.6 4.0 30.4 4.6 8.2 9.7 8.5 8.3 8.5 5.1 5.2 14.5 25.6 21.2 17.0 12.7 4.7 1.6 3.0 23.3 2.5 12.4 0.4 1.1 0.6 1.8 1.6 2.3 2.5 1.4 2.2 1.7 2.8 2.6 1.3 2.3 4.1 0.6 3.3 0.9 1.6 5.3 10.3 5.9 7.3 7.5 5.5 17.4 5.1 12.5 11.1 0.0 5.6 1.5 8.1 6.6 0.9 9.0 7.6 5.3 9.1 5.2 0.0 26.6 1.7 8.5 12.7 6.0 4.2 0.0 8.9 24.3 3.8 4.6 1.1 3.9 7.9 4.8 3.4 4.3 1.8 17.7 1.7 3.7 1.7 9.0 3.4 0.8 10.8 2.6 3.9 2.2 0.6 0.0 4.2 2.8 2.1 8.0 33.0 2.5 3.3 12.7 MIEN1 "C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4" ENSG00000141741 "Migration and invasion enhancer 1" Q9BRT3 17 39728496-39730787 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 14 "OE19: 214.8;SK-BR-3: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056650, HPA061344" Approved Supported "Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Centriolar satellite, Cytosol" "HPA056650: , HPA061344: AB_2684484" "unprognostic (2.48e-1)" "unprognostic (3.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.13e-2)" "unprognostic (3.04e-1)" "unprognostic (1.17e-1)" "unprognostic (4.47e-2)" "unprognostic (8.37e-2)" "unprognostic (6.72e-2)" "unprognostic (2.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.17e-1)" "unprognostic (2.99e-2)" "unprognostic (3.70e-1)" "unprognostic (2.00e-1)" "unprognostic (3.88e-3)" "unprognostic (2.22e-3)" 16.9 18.6 27.0 16.7 38.6 23.2 19.8 14.9 26.1 12.4 25.2 18.0 37.5 30.2 13.6 19.1 26.3 17.2 19.4 37.2 25.8 21.8 32.2 40.6 16.1 19.7 27.1 17.5 11.7 26.3 14.1 18.9 27.0 18.3 23.5 13.9 12.5 45.6 30.1 24.5 16.0 26.8 11.5 27.2 17.3 32.8 18.6 20.9 21.4 34.5 17.5 14.9 15.6 19.6 41.2 37.8 59.2 45.4 23.7 40.4 48.1 4.6 9.1 1.9 4.4 3.2 2.1 2.1 4.9 3.7 4.5 4.2 2.4 3.6 3.5 6.8 2.6 5.0 5.9 2.1 2.5 1.0 6.8 10.0 3.1 4.3 5.4 5.9 4.2 5.0 2.4 4.5 2.0 1.7 2.5 3.0 8.0 4.7 6.3 2.4 3.7 9.1 4.9 1.5 214.8 4.4 3.9 3.0 7.2 2.0 3.1 5.8 5.4 5.1 64.0 8.7 1.4 8.3 5.5 5.1 2.0 5.2 9.8 5.5 7.8 7.1 6.7 9.0 5.2 4.0 51.7 37.3 47.1 38.0 43.9 21.6 41.2 27.0 33.8 25.9 35.7 20.5 30.2 59.2 23.7 45.4 37.8 40.4 48.1 27.0 38.6 14.9 26.1 25.8 21.8 27.1 17.5 18.3 20.9 41.7 48.6 67.4 114.7 53.3 25.2 45.2 58.6 85.6 33.0 94.2 3.9 131.8 257.0 122.9 87.4 56.2 154.8 46.7 153.4 61.5 51.5 183.7 80.7 101.9 128.4 33.4 181.2 58.3 96.9 55.5 39.1 66.0 131.6 84.8 136.7 78.2 163.9 235.0 46.7 153.1 13.5 45.3 67.4 80.7 70.9 61.5 222.5 83.1 110.2 164.5 MIER2 KIAA1193 ENSG00000105556 "MIER family member 2" Q8N344 19 301444-344815 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041439 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041439: AB_2677481" "unprognostic (1.48e-1)" "unprognostic (1.45e-3)" "prognostic unfavorable (2.89e-4)" "prognostic favorable (1.72e-5)" "unprognostic (6.71e-2)" "unprognostic (2.96e-1)" "unprognostic (6.95e-3)" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (4.24e-1)" "unprognostic (1.18e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (7.22e-6)" "unprognostic (8.05e-2)" "unprognostic (4.28e-2)" "unprognostic (4.94e-3)" "unprognostic (1.68e-2)" 15.5 6.8 9.1 9.3 11.8 4.3 9.7 14.4 12.5 8.6 7.5 10.0 6.6 9.8 12.0 7.8 9.4 7.9 8.5 9.1 9.8 6.7 6.4 3.4 12.5 8.5 9.1 7.8 8.5 11.6 3.7 9.8 13.5 9.1 10.9 3.3 8.3 12.9 10.9 17.0 18.4 9.3 6.4 6.4 17.2 10.3 31.5 12.1 4.6 8.3 7.1 6.6 9.1 16.5 2.2 6.6 6.4 5.8 1.6 3.3 3.0 8.9 5.7 5.1 5.9 1.9 2.8 11.1 7.4 3.5 5.6 5.9 8.8 2.9 4.7 4.0 3.8 2.2 7.7 3.3 4.3 1.7 11.2 15.8 2.8 4.5 6.6 5.6 0.0 22.2 3.6 3.3 4.5 1.6 3.7 6.3 6.4 7.8 0.0 3.1 9.5 7.3 10.0 13.2 2.7 0.0 6.4 1.7 1.2 2.7 5.1 8.2 7.4 4.3 3.2 7.3 3.2 3.7 5.0 6.6 7.6 5.3 11.6 8.2 13.6 6.7 3.8 7.2 4.0 7.5 6.4 5.8 4.2 2.0 5.2 1.8 0.9 2.7 3.0 6.6 2.2 3.3 2.2 0.5 1.6 5.8 3.7 1.1 3.0 9.1 11.8 14.4 12.5 9.8 6.7 9.1 7.8 9.1 12.1 0.0 4.8 6.0 10.5 10.0 6.4 1.1 7.6 2.7 3.4 3.5 15.7 19.2 1.7 7.9 4.7 8.7 3.5 0.0 4.8 14.6 4.7 8.4 0.0 1.6 9.0 3.2 10.3 9.8 7.0 13.3 5.8 6.5 5.0 4.6 4.2 6.6 6.4 6.2 5.3 1.0 11.5 6.5 4.2 17.7 25.6 9.4 24.6 5.2 4.9 11.3 MIF "GIF, GLIF" ENSG00000240972 "Macrophage migration inhibitory factor" P14174 22 23894004-23895227 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Isomerase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 1397.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 129.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003868, CAB005284" Approved Supported Nucleoplasm,Cytosol "Secreted to blood" No No 13800000 14000000 Cytosol Nucleoplasm "CAB005284: AB_648587, HPA003868: AB_1079290" "unprognostic (1.68e-1)" "unprognostic (7.79e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-1)" "unprognostic (1.36e-2)" "unprognostic (9.48e-2)" "unprognostic (1.22e-3)" "unprognostic (2.17e-2)" "unprognostic (1.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-2)" "unprognostic (2.19e-2)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" 30.6 49.8 43.9 42.0 39.9 46.0 71.6 19.0 66.1 23.0 42.7 10.4 55.6 39.9 22.5 113.3 51.9 23.3 42.5 60.7 42.8 40.3 71.8 58.8 46.2 113.9 33.5 43.7 24.5 80.2 16.2 41.1 30.5 45.2 54.8 11.6 15.0 57.3 101.2 36.0 63.3 50.6 26.7 78.3 42.5 56.2 24.9 19.2 19.0 28.9 43.7 16.7 21.4 44.6 56.8 42.5 17.6 23.8 38.3 52.7 66.0 49.8 11.0 2.4 11.2 0.9 2.3 18.7 18.8 3.1 6.1 7.8 8.3 8.2 23.7 14.9 1.3 2.8 22.2 2.6 11.4 0.7 19.9 129.4 8.9 10.1 17.2 4.9 34.6 21.1 4.7 6.8 3.6 1.7 4.5 4.8 17.8 13.8 12.1 2.0 25.1 23.5 64.2 14.3 9.8 60.3 30.2 4.1 66.5 4.7 3.4 32.5 37.8 12.0 12.7 31.0 0.6 16.4 10.4 13.7 5.3 35.6 3.2 0.4 52.3 18.4 24.4 21.5 12.9 10.8 16.3 23.8 17.6 37.4 22.3 52.7 56.8 51.8 40.4 31.6 49.1 46.1 38.0 7.1 38.3 14.6 42.5 48.3 66.0 43.9 39.9 19.0 66.1 42.8 40.3 33.5 43.7 45.2 19.2 145.9 147.8 297.7 257.6 597.1 25.5 0.3 433.1 384.1 354.8 657.8 2.0 427.6 1397.6 643.7 166.1 220.2 275.4 0.0 324.9 742.0 370.2 224.8 172.4 900.8 252.9 20.6 335.5 293.4 221.5 97.3 311.3 223.0 733.9 288.6 378.1 30.6 687.0 340.1 284.6 1307.4 25.0 135.8 432.6 7.9 117.5 663.2 573.7 251.6 418.6 198.5 MIF4GD "AD023, MGC45027, MIFD, SLIP1" ENSG00000125457 "MIF4G domain containing" A9UHW6 17 75266228-75271227 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 67.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051222 Approved Supported "Nucleoli,Golgi apparatus,Cytosol" NA NA Nucleoli "Golgi apparatus, Cytosol" "HPA051222: AB_2681393" "unprognostic (1.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.94e-2)" "unprognostic (3.82e-3)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-1)" "unprognostic (8.15e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (9.88e-2)" "unprognostic (2.29e-1)" "unprognostic (7.12e-2)" "unprognostic (7.31e-2)" 19.0 13.9 10.4 14.5 11.1 30.5 13.3 7.4 14.6 11.9 12.9 20.8 14.2 10.3 16.8 12.8 18.3 13.9 20.4 20.4 10.2 8.2 16.0 15.1 15.1 30.4 12.0 9.9 12.2 16.2 18.2 7.4 15.9 12.0 12.0 11.7 15.5 15.4 11.5 34.4 18.6 14.1 20.4 15.4 22.0 11.7 12.6 10.9 21.8 15.0 20.7 20.9 16.6 12.2 14.1 67.0 11.3 21.5 14.5 17.5 14.4 12.0 21.3 4.7 11.0 7.7 2.3 6.8 3.1 8.8 6.2 4.2 7.5 13.6 18.8 5.6 4.9 7.3 9.6 5.7 10.8 4.7 9.3 14.6 9.3 9.3 6.6 8.5 8.1 10.8 2.2 16.9 4.3 17.7 8.5 12.8 21.2 12.2 23.0 1.6 23.5 25.8 19.4 2.1 13.9 10.4 16.9 6.0 25.6 12.5 6.5 7.1 10.4 6.3 16.6 15.4 11.4 30.8 19.0 4.9 3.2 7.7 4.0 6.1 33.5 8.7 15.8 5.9 14.4 4.2 5.7 21.5 11.3 15.4 11.0 16.2 14.1 12.5 13.7 25.4 13.0 11.4 12.0 3.8 14.5 13.1 67.0 17.5 14.4 10.4 11.1 7.4 14.6 10.2 8.2 12.0 9.9 12.0 10.9 0.0 11.2 26.7 11.3 10.2 3.8 4.0 25.5 13.4 10.3 12.2 0.0 12.2 18.3 40.4 24.1 17.9 11.2 0.0 38.2 7.9 11.3 11.9 32.2 7.2 42.0 1.6 15.0 11.1 45.6 9.9 8.6 38.5 15.1 48.7 15.0 22.4 20.7 21.6 14.9 22.6 5.3 19.4 24.2 20.0 17.4 16.6 7.8 34.5 16.9 11.4 MIGA2 "C9orf54, FAM73B, FLJ00199, FLJ14596" ENSG00000148343 "Mitoguardin 2" Q7L4E1 9 129036621-129072082 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 9.0;Club cells: 5.7;Collecting duct cells: 7.0;monocytes: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041363 Approved Approved "Cell Junctions,Cytosol" NA NA Cytosol "Cell Junctions" "HPA041363: AB_10794664" "unprognostic (2.10e-1)" "unprognostic (4.82e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (1.01e-1)" "unprognostic (3.93e-2)" "unprognostic (3.07e-3)" "unprognostic (2.90e-2)" "prognostic favorable (3.04e-6)" "unprognostic (1.12e-2)" "unprognostic (1.44e-3)" "unprognostic (8.57e-3)" "unprognostic (1.25e-1)" "unprognostic (4.63e-2)" "unprognostic (4.15e-3)" 10.1 14.3 7.7 11.5 10.2 17.3 6.8 17.6 16.0 5.6 17.2 8.9 14.6 23.7 7.6 8.7 11.5 7.1 13.3 24.4 7.9 11.6 7.6 7.4 5.2 7.5 9.0 10.9 8.4 6.8 7.5 8.5 3.1 9.4 9.3 5.5 8.7 11.1 12.3 13.0 9.8 21.6 9.0 7.6 7.1 9.9 7.0 7.2 8.0 9.6 5.3 10.8 10.0 9.8 2.8 3.9 8.5 3.1 1.2 6.5 2.2 4.0 8.3 2.6 13.0 7.1 3.7 5.8 7.3 5.5 8.4 5.3 7.2 8.5 6.1 3.3 5.6 7.3 19.3 3.5 5.4 1.3 5.6 5.1 4.4 16.2 5.3 7.9 5.0 10.1 5.2 4.3 7.6 3.9 2.7 5.8 5.8 6.4 2.6 4.5 10.6 5.0 10.3 6.0 9.7 12.1 10.3 7.6 10.1 4.4 7.8 8.2 5.8 8.1 12.9 4.5 1.6 9.3 5.4 5.7 5.5 6.3 9.1 5.5 3.5 5.1 5.7 7.8 4.0 6.4 8.5 2.6 2.4 3.0 3.1 6.5 2.3 2.2 3.9 2.9 2.8 2.2 1.3 4.8 1.2 1.7 3.9 1.9 2.2 7.7 10.2 17.6 16.0 7.9 11.6 9.0 10.9 9.4 7.2 3.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.7 7.0 0.0 2.5 1.7 4.7 0.0 0.0 0.0 0.0 4.0 1.9 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 6.4 0.0 0.0 4.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 MIIP "FLJ12438, IIp45" ENSG00000116691 "Migration and invasion inhibitory protein" Q5JXC2 1 12019466-12032045 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "HDLM-2: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044948 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044948: AB_10795887" "unprognostic (1.36e-2)" "unprognostic (1.95e-2)" "unprognostic (5.02e-3)" "unprognostic (3.59e-2)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.65e-3)" "unprognostic (7.16e-2)" "unprognostic (2.97e-1)" "unprognostic (4.03e-2)" "unprognostic (3.73e-3)" "unprognostic (6.56e-2)" "prognostic unfavorable (8.26e-7)" "unprognostic (8.02e-3)" "unprognostic (5.09e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-2)" 13.2 9.4 12.2 17.0 17.3 53.4 10.8 13.7 15.3 11.1 11.4 11.9 11.6 11.0 16.5 8.8 11.1 13.0 8.9 13.3 12.9 10.1 9.2 11.7 13.3 18.3 15.9 10.6 20.4 13.5 5.8 7.1 14.6 17.0 11.3 4.5 8.5 18.1 14.2 26.3 14.8 12.7 12.3 11.0 20.4 10.0 18.2 15.2 10.5 22.5 9.7 12.5 12.3 11.9 14.8 45.0 18.3 27.1 10.6 19.0 12.5 5.0 3.4 2.7 5.2 1.4 1.6 9.4 2.7 1.4 5.4 4.1 6.6 8.1 6.4 6.6 1.4 3.8 5.3 2.0 3.1 0.7 90.6 7.5 4.0 5.4 7.0 3.1 6.1 12.4 2.2 4.0 4.7 2.1 0.9 3.0 8.8 11.9 5.9 1.6 5.1 6.0 9.1 4.8 3.7 5.1 8.6 3.4 9.8 2.3 1.5 5.0 5.3 4.0 5.1 9.8 1.5 3.4 10.6 3.2 5.0 5.3 9.9 4.2 5.0 6.3 8.6 3.2 10.7 5.0 4.9 23.2 7.1 9.0 25.9 8.4 14.8 9.3 7.8 14.2 13.0 5.8 4.5 18.3 10.6 27.1 45.0 19.0 12.5 12.2 17.3 13.7 15.3 12.9 10.1 15.9 10.6 17.0 15.2 11.9 7.7 14.7 6.9 11.6 14.2 5.0 2.5 6.7 2.3 8.7 7.9 31.4 21.6 13.8 26.0 9.8 14.7 23.3 15.9 82.3 17.4 10.1 17.3 12.5 36.1 7.9 16.0 9.2 17.8 38.7 7.8 20.3 15.1 64.1 9.7 14.2 13.7 14.4 6.3 10.1 14.5 12.9 14.7 14.7 41.9 15.1 27.7 20.8 13.4 5.9 MINDY4 "C7orf67, FAM188B, FLJ22374" ENSG00000106125 "MINDY lysine 48 deubiquitinase 4" Q4G0A6 7 30771417-30892387 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 8.9;Ciliated cells: 33.5;Collecting duct cells: 12.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.1;T-cells: 2.7" "Cell line enhanced" "Detected in many" "K-562: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA019475, HPA030129, HPA030130" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565" "unprognostic (2.96e-1)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.07e-1)" "unprognostic (6.01e-3)" "unprognostic (3.81e-2)" "unprognostic (5.25e-3)" "unprognostic (1.97e-1)" "unprognostic (5.59e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-1)" "unprognostic (9.55e-2)" "unprognostic (1.12e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" 9.3 6.7 9.3 2.6 15.2 4.1 7.0 3.4 15.1 10.8 6.6 5.4 16.6 2.9 15.6 16.2 5.7 20.7 10.0 7.5 8.4 5.1 9.4 3.8 14.2 2.4 4.3 9.5 14.8 5.6 9.6 16.1 6.2 9.0 9.4 4.3 7.8 5.3 15.9 3.7 5.1 3.7 10.8 3.6 2.3 5.8 20.1 5.0 1.5 12.5 3.6 2.2 6.4 6.3 0.0 1.1 0.0 0.3 0.0 2.7 0.7 2.1 5.3 2.8 8.5 2.5 9.6 4.1 3.1 5.4 2.4 2.0 0.0 4.0 0.0 3.6 2.0 3.3 2.3 1.9 1.7 2.3 0.0 3.1 1.7 2.8 0.0 3.1 2.3 1.2 4.9 2.8 7.0 1.4 0.2 3.4 1.6 16.4 1.0 2.0 0.0 1.3 0.7 8.0 7.4 1.2 0.4 0.0 0.5 6.4 1.0 5.2 7.1 2.1 11.3 1.2 3.4 5.7 1.7 2.0 0.1 1.3 2.4 1.3 2.3 3.0 0.0 4.5 0.1 10.0 0.0 0.1 0.0 0.6 0.0 2.7 0.0 0.8 0.2 1.1 0.0 0.3 0.5 0.0 0.0 0.3 0.0 0.5 0.7 9.3 15.2 3.4 15.1 8.4 5.1 4.3 9.5 9.0 5.0 8.9 3.8 0.0 0.0 0.0 0.0 0.0 0.0 33.5 3.4 12.2 0.0 2.1 3.3 2.3 0.0 0.0 0.0 0.0 1.2 3.5 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 MIOS "FLJ20323, MIO, Sea4" ENSG00000164654 "Meiosis regulator for oocyte development" Q9NXC5 7 7566872-7608929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042928, HPA052223" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042928: AB_10795610, HPA052223: AB_2681768" "unprognostic (8.09e-3)" "unprognostic (1.25e-2)" "unprognostic (6.93e-2)" "prognostic favorable (6.51e-4)" "unprognostic (3.42e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (1.44e-2)" "unprognostic (2.27e-1)" "unprognostic (2.09e-1)" "prognostic favorable (3.28e-6)" "unprognostic (1.03e-1)" "unprognostic (1.10e-2)" "unprognostic (7.67e-3)" "unprognostic (2.72e-1)" 9.9 7.8 6.7 14.4 9.5 10.3 9.6 11.7 10.3 9.9 7.0 7.3 10.3 5.5 8.8 8.7 17.1 8.1 6.4 8.0 7.3 5.6 12.0 11.2 7.4 13.9 5.7 7.2 9.0 16.2 24.6 14.9 11.0 16.8 14.7 8.7 10.9 12.3 14.3 67.7 15.3 8.9 8.0 8.8 15.2 10.6 11.9 7.8 14.0 6.8 14.6 19.0 9.3 12.2 10.5 8.3 8.9 11.0 6.4 7.5 4.2 18.9 8.5 10.3 12.3 8.1 17.5 8.6 14.9 11.9 9.5 9.6 10.5 7.5 16.8 4.7 8.8 25.6 17.2 10.4 10.9 12.7 6.8 9.1 4.1 10.2 7.0 11.4 18.0 4.7 14.5 13.7 8.5 21.4 9.4 8.5 5.7 20.9 13.8 40.2 13.2 4.0 8.2 20.8 9.6 9.1 12.5 15.7 16.1 8.6 9.7 10.8 17.5 7.9 22.7 8.8 19.8 12.3 16.2 7.4 14.9 16.0 8.2 12.6 12.3 13.5 15.0 13.0 10.5 17.3 0.0 5.9 8.9 5.1 11.0 4.3 10.5 5.5 4.7 8.3 9.5 7.5 5.8 0.6 6.4 5.3 5.0 5.4 4.2 6.7 9.5 11.7 10.3 7.3 5.6 5.7 7.2 16.8 7.8 8.9 11.0 15.3 12.4 10.8 7.9 16.5 10.2 12.0 9.1 7.0 11.8 14.7 14.9 11.0 29.5 6.4 6.3 0.0 15.2 7.3 5.7 25.8 9.2 15.1 13.8 11.1 4.1 6.7 20.9 40.8 5.5 13.5 6.8 5.4 8.1 7.8 11.3 9.0 7.1 8.4 15.6 12.9 6.6 24.4 28.0 16.6 17.7 12.5 9.3 16.5 MIPOL1 CCDC193 ENSG00000151338 "Mirror-image polydactyly 1" Q8TD10 14 37197913-37552361 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 99.0;Club cells: 96.7;Early spermatids: 128.1;Late spermatids: 106.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.2" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002893, HPA050179" Enhanced Approved Cytosol NA NA Cytosol "HPA002893: AB_1079386, HPA050179: AB_2681043" "unprognostic (3.24e-1)" "unprognostic (1.33e-1)" "unprognostic (2.26e-1)" "unprognostic (4.30e-2)" "unprognostic (1.08e-1)" "unprognostic (6.29e-2)" "unprognostic (4.61e-4)" "unprognostic (2.37e-2)" "unprognostic (2.84e-2)" "unprognostic (2.39e-2)" "unprognostic (3.54e-2)" "unprognostic (8.73e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-1)" "unprognostic (9.78e-3)" "unprognostic (3.41e-3)" "unprognostic (1.85e-2)" 5.8 6.1 8.8 4.5 8.4 1.5 8.6 2.1 11.1 14.0 5.7 1.4 7.8 3.0 9.3 5.1 7.4 7.6 7.0 7.0 8.1 3.9 8.9 4.2 5.3 1.1 4.6 8.4 13.2 8.7 12.6 24.4 3.2 6.6 13.7 4.7 4.6 8.0 9.1 10.1 4.2 3.2 13.7 7.6 2.7 7.5 14.7 8.0 0.0 11.2 5.4 1.7 8.7 15.8 0.8 0.8 4.2 0.3 0.5 0.5 0.3 3.9 1.7 0.6 5.7 4.2 7.0 0.0 3.7 2.4 3.2 4.7 2.2 2.4 0.0 3.6 3.1 1.3 4.7 0.0 5.0 4.3 0.0 6.0 0.0 2.9 9.7 2.7 0.0 0.1 4.5 5.3 0.8 10.2 3.9 19.6 0.0 7.7 0.1 4.7 4.0 0.0 0.0 2.4 2.6 12.7 0.0 0.6 0.0 4.6 4.5 4.9 0.0 4.7 4.1 4.3 4.4 5.1 0.0 10.2 0.0 3.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 7.3 1.1 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.2 0.1 0.8 0.4 0.3 4.2 0.5 0.3 0.8 0.4 0.3 8.8 8.4 2.1 11.1 8.1 3.9 4.6 8.4 6.6 8.0 71.5 49.9 0.9 13.5 3.8 14.5 12.3 12.7 99.0 96.7 8.7 49.1 0.0 8.3 3.6 128.1 5.3 0.9 0.0 6.1 0.1 5.3 14.0 43.0 2.1 0.1 11.1 8.7 4.3 1.0 106.6 7.8 1.8 6.8 0.0 2.1 5.8 9.4 0.0 8.5 3.6 25.3 0.0 5.2 29.2 13.6 5.5 0.0 2.2 2.7 7.6 MIS18A "B28, C21orf45, C21orf46, FASP1, hMis18alpha" ENSG00000159055 "MIS18 kinetochore protein A" Q9NYP9 21 32268219-32279069 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 118.1;Spermatogonia: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA018286, HPA020585" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA018286: AB_1845693, HPA020585: AB_1845694" "unprognostic (1.19e-1)" "unprognostic (1.55e-2)" "unprognostic (4.44e-2)" "unprognostic (1.98e-3)" "unprognostic (3.45e-2)" "unprognostic (2.29e-2)" "unprognostic (1.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.19e-2)" "unprognostic (4.39e-3)" "unprognostic (1.01e-2)" "unprognostic (1.52e-1)" "unprognostic (3.34e-2)" "unprognostic (1.85e-2)" "unprognostic (1.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.28e-1)" 5.5 7.5 7.8 6.6 10.7 13.8 7.4 16.4 8.3 6.1 8.9 5.4 1.9 7.9 6.6 6.3 11.4 5.6 5.3 3.9 6.8 4.7 6.7 5.7 3.7 9.7 6.8 9.3 9.8 5.8 3.3 4.3 7.1 6.6 5.5 10.6 4.4 6.0 4.1 4.0 7.8 8.5 7.7 6.2 7.3 6.1 26.6 5.4 19.3 3.9 6.8 11.3 5.3 6.5 18.5 13.2 8.2 11.7 10.4 15.5 6.4 21.1 5.3 15.3 14.6 2.3 4.0 23.5 11.2 5.8 11.0 9.6 10.5 11.8 23.2 8.3 4.2 13.3 7.2 15.0 8.5 13.3 13.2 16.6 26.6 5.6 13.5 1.5 22.7 9.0 1.7 3.7 9.2 6.7 3.6 7.7 23.7 30.9 19.6 10.7 14.5 26.0 20.7 31.6 14.7 15.5 22.8 22.9 21.7 7.6 7.3 18.4 9.1 17.1 14.6 10.5 11.5 17.6 13.9 4.5 13.9 25.7 10.8 11.5 10.6 16.8 29.3 8.9 36.6 12.5 2.4 5.3 8.2 10.2 6.8 10.2 18.2 11.2 11.7 4.9 18.5 15.5 11.5 1.7 10.4 11.7 13.2 14.6 6.4 7.8 10.7 16.4 8.3 6.8 4.7 6.8 9.3 6.6 5.4 17.9 6.2 11.5 6.8 13.9 10.1 5.2 5.1 10.7 5.7 10.4 3.9 29.4 11.6 9.4 4.3 6.8 2.0 0.0 10.7 41.8 12.1 4.6 3.5 7.3 14.5 7.9 5.8 14.1 5.4 5.3 9.8 6.3 5.0 6.4 17.5 9.7 8.2 7.8 9.6 13.7 7.4 19.4 6.6 118.1 79.0 12.9 12.2 8.9 15.3 3.5 MIS18BP1 "C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1" ENSG00000129534 "MIS18 binding protein 1" Q6P0N0 14 45203190-45253540 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006504 Approved Approved Nucleoli,Cytosol NA Yes Nucleoli Cytosol "HPA006504: AB_1078317" "unprognostic (2.12e-1)" "unprognostic (1.06e-1)" "unprognostic (2.58e-2)" "unprognostic (1.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (4.18e-1)" "unprognostic (1.36e-2)" "unprognostic (3.33e-1)" "unprognostic (3.32e-2)" "unprognostic (2.32e-3)" "unprognostic (3.31e-2)" "unprognostic (5.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.97e-1)" "unprognostic (2.21e-1)" 10.3 5.2 5.1 22.5 5.7 26.3 14.1 1.8 5.7 9.0 11.8 2.3 7.6 6.0 9.8 9.5 10.2 8.6 5.7 5.3 5.1 2.8 5.0 4.3 14.3 23.9 4.5 4.1 12.5 7.1 1.8 5.2 9.5 6.7 7.9 7.6 1.9 12.5 10.2 3.0 8.4 10.7 7.3 10.2 22.5 6.9 9.5 3.1 38.4 7.1 8.2 15.5 8.2 7.7 13.1 14.7 23.6 22.6 4.5 4.8 4.0 21.0 7.9 16.5 7.2 5.1 7.3 12.2 14.6 7.7 12.2 15.2 4.2 20.4 29.1 6.4 7.2 5.2 14.8 9.7 7.4 23.0 15.3 6.1 17.4 9.8 5.4 3.4 40.1 16.3 5.2 3.0 7.2 6.8 7.9 14.8 5.6 7.6 6.9 11.8 7.7 16.7 17.7 12.5 10.4 9.9 20.0 6.7 11.2 6.2 8.8 11.6 5.1 5.9 10.0 5.3 10.3 11.9 23.0 8.1 6.5 19.8 7.9 6.4 6.2 8.2 13.6 3.6 16.8 9.1 23.6 14.2 16.2 3.9 13.2 4.1 13.1 3.6 3.2 9.6 12.9 2.4 2.5 8.5 4.5 22.6 14.7 4.8 4.0 5.1 5.7 1.8 5.7 5.1 2.8 4.5 4.1 6.7 3.1 23.8 23.8 43.1 9.7 17.9 7.9 11.8 10.2 20.1 35.2 8.7 15.7 30.2 5.0 11.5 2.9 28.7 11.1 23.3 9.7 38.0 14.2 17.4 41.7 6.7 32.5 0.0 26.5 30.1 69.4 3.6 51.2 58.2 5.0 70.3 23.5 4.8 11.1 34.8 57.0 3.6 8.2 0.0 14.2 67.2 107.7 23.1 16.2 47.3 24.4 11.0 MKL1 "BSAC, KIAA1438, MAL, MKL, MRTF-A" ENSG00000196588 "Megakaryoblastic leukemia (translocation) 1" Q969V6 22 40410281-40636702 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Actin-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 87.5;Late spermatids: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 50.9" "Group enriched" "Detected in all" 5 "dendritic cells: 26.4;granulocytes: 50.9;monocytes: 15.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030782 Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA030782: AB_10600930" "unprognostic (7.90e-3)" "unprognostic (4.51e-2)" "unprognostic (2.99e-1)" "unprognostic (1.29e-1)" "unprognostic (9.04e-2)" "unprognostic (9.37e-2)" "unprognostic (4.38e-3)" "unprognostic (1.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-2)" "prognostic unfavorable (1.58e-7)" "unprognostic (9.05e-2)" "unprognostic (8.15e-2)" "unprognostic (1.30e-2)" "unprognostic (3.98e-1)" 18.1 11.1 15.4 25.4 19.1 69.2 15.8 16.2 26.1 17.6 14.2 13.5 10.1 11.3 27.6 12.9 12.3 17.5 13.2 16.3 14.2 11.1 11.3 8.9 17.4 25.6 11.8 16.6 16.9 14.5 10.2 10.5 18.9 12.6 14.2 9.4 13.3 16.9 15.7 14.3 18.0 13.6 15.7 11.0 23.9 14.3 25.4 10.8 28.2 17.3 9.0 25.5 15.5 14.6 4.9 26.4 50.9 15.0 3.8 5.6 7.5 10.9 14.8 6.5 7.7 8.2 6.2 12.7 10.7 7.0 9.9 9.6 7.0 3.3 11.7 4.4 11.3 8.5 14.4 5.4 13.2 6.4 13.0 9.5 19.4 16.6 10.3 8.1 22.4 38.2 6.7 15.9 9.5 6.6 7.3 7.2 6.9 5.4 5.3 4.6 10.7 8.7 25.2 5.1 5.6 5.2 14.2 7.2 5.9 7.8 8.2 3.6 3.8 17.5 8.9 6.5 8.7 6.0 25.4 11.8 6.7 18.1 8.9 9.2 7.1 6.3 16.9 5.5 11.4 13.0 12.0 15.0 50.9 4.4 11.6 4.1 3.2 4.0 3.4 17.8 4.9 5.6 4.7 14.5 3.8 15.0 26.4 5.2 7.5 15.4 19.1 16.2 26.1 14.2 11.1 11.8 16.6 12.6 10.8 6.0 8.3 7.8 6.0 13.9 11.5 7.3 2.5 8.1 2.3 8.7 21.6 7.0 3.3 9.5 87.5 7.1 7.4 0.0 12.0 6.9 9.1 8.9 16.1 3.9 10.9 3.2 6.4 6.7 17.0 76.0 10.3 13.9 6.8 16.2 6.5 3.7 14.1 2.9 7.4 2.6 12.0 25.8 12.1 9.2 9.5 11.2 6.5 10.1 3.7 8.0 MKLN1 TWA2 ENSG00000128585 "Muskelin 1" Q9UL63 7 131110096-131496636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022817, HPA041810" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA022817: AB_1853974, HPA041810: AB_2677686" "unprognostic (1.97e-1)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.03e-1)" "unprognostic (4.20e-2)" "unprognostic (1.44e-3)" "unprognostic (4.58e-2)" "unprognostic (1.94e-2)" "unprognostic (1.97e-1)" "unprognostic (2.43e-3)" "unprognostic (1.55e-1)" "unprognostic (9.18e-3)" "unprognostic (1.70e-1)" "unprognostic (4.13e-1)" "unprognostic (1.13e-2)" "unprognostic (2.32e-1)" 22.7 21.1 22.1 15.7 27.6 12.8 34.4 27.5 25.8 18.8 15.0 11.7 26.6 14.2 19.3 19.8 11.8 19.6 11.6 16.7 21.9 14.4 23.0 22.8 19.3 18.7 26.6 17.5 23.2 12.6 20.9 28.8 18.2 25.0 26.4 12.2 10.0 18.1 28.9 28.6 15.4 13.5 20.8 30.3 13.1 14.4 16.9 24.0 14.7 18.0 9.9 12.0 17.8 21.5 2.3 1.6 12.4 1.6 0.9 2.3 0.5 8.3 9.7 8.4 8.5 20.9 18.8 5.1 8.1 18.9 9.3 11.9 4.4 7.2 8.7 5.5 10.1 18.3 5.8 8.8 7.7 15.2 8.4 4.3 3.7 7.5 5.1 10.0 6.1 5.4 11.3 5.5 12.5 6.3 10.0 8.4 5.4 13.6 6.3 11.4 3.1 7.2 6.6 9.6 6.8 5.1 4.5 10.0 6.0 10.3 4.9 4.4 9.4 15.9 15.9 7.3 9.2 3.1 7.7 8.6 7.3 4.1 13.1 6.6 15.4 5.7 14.9 25.0 7.4 10.6 1.2 1.0 1.7 1.6 1.1 1.2 1.2 1.5 1.3 1.0 2.3 2.3 1.9 12.4 0.9 1.6 1.6 0.9 0.5 22.1 27.6 27.5 25.8 21.9 14.4 26.6 17.5 25.0 24.0 47.6 36.6 23.7 26.7 39.2 45.2 21.2 38.2 10.7 22.7 43.6 66.8 14.7 6.6 17.8 2.6 48.1 26.9 0.0 20.5 13.9 40.1 45.0 33.5 67.6 18.7 50.9 35.6 60.2 36.9 3.6 63.0 28.4 33.7 24.4 27.8 54.4 22.4 31.9 79.2 25.0 67.1 84.1 41.9 34.6 26.5 40.1 12.4 26.1 25.0 33.3 MKRN1 RNF61 ENSG00000133606 "Makorin ring finger protein 1" Q9UHC7 7 140453040-140479569 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000567 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000567: AB_1079299" "unprognostic (9.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.65e-2)" "unprognostic (2.41e-1)" "unprognostic (4.87e-3)" "unprognostic (1.24e-2)" "unprognostic (8.02e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.35e-1)" "unprognostic (2.89e-3)" "unprognostic (5.76e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (1.22e-2)" 16.8 17.6 26.8 20.8 28.8 69.9 20.1 37.2 32.6 20.4 39.6 16.1 19.7 28.4 20.1 18.6 23.3 22.2 22.4 38.5 24.9 29.8 20.6 17.5 23.6 18.3 25.7 23.3 24.9 27.3 28.2 21.5 31.7 29.4 21.0 33.7 19.4 24.8 23.1 38.5 24.4 26.6 26.3 20.5 22.5 21.7 95.4 20.2 21.0 23.6 18.8 22.3 25.3 36.4 13.1 7.5 39.3 10.5 12.8 17.8 6.4 28.4 22.0 17.2 25.5 27.3 23.9 24.3 19.6 25.5 15.5 17.9 9.0 30.0 20.7 30.8 19.1 31.0 13.9 19.3 21.6 19.7 40.9 16.7 21.5 13.2 16.6 22.0 18.4 33.2 23.8 32.6 17.4 16.5 25.6 15.4 14.3 16.9 26.1 14.8 24.5 21.5 32.9 44.2 24.0 16.3 15.6 14.7 31.6 24.8 33.0 23.8 24.6 24.6 33.4 35.1 26.5 16.4 16.0 21.8 10.9 8.7 26.5 17.9 62.3 45.6 18.1 31.2 28.9 22.4 19.4 9.2 39.3 6.7 8.7 8.0 13.1 13.0 10.1 7.5 10.9 17.8 11.3 18.1 12.8 10.5 2.5 14.0 6.4 26.8 28.8 37.2 32.6 24.9 29.8 25.7 23.3 29.4 20.2 47.6 30.4 57.3 58.0 72.9 58.8 51.3 63.7 33.5 43.3 40.1 33.4 63.4 87.9 55.8 227.6 33.8 112.4 256.9 59.7 76.6 47.0 74.5 36.9 38.9 53.2 112.8 93.6 40.5 91.7 263.0 61.5 68.3 65.8 87.4 100.7 52.1 52.9 123.8 58.7 39.1 43.2 45.3 49.5 153.2 47.1 83.4 115.4 66.0 96.2 100.8 MKRN2 "HSPC070, RNF62" ENSG00000075975 "Makorin ring finger protein 2" Q9H000 3 12557014-12583713 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Early spermatids: 562.3;Late spermatids: 587.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037559, HPA037560" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037559: AB_10672460, HPA037560: AB_10696936" "unprognostic (4.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-2)" "unprognostic (5.99e-2)" "unprognostic (3.89e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (4.38e-1)" "unprognostic (8.49e-2)" "unprognostic (2.86e-1)" "unprognostic (1.42e-1)" "unprognostic (2.56e-3)" "prognostic favorable (6.04e-4)" "unprognostic (3.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.33e-2)" "unprognostic (3.32e-2)" 13.7 10.4 15.1 11.1 18.3 16.4 11.6 29.3 19.5 13.7 12.7 12.4 16.1 12.5 15.2 12.3 16.2 13.1 10.9 26.3 14.0 15.1 13.7 12.5 12.1 12.6 15.2 14.8 20.8 26.6 17.3 11.9 14.4 16.0 11.3 11.5 13.2 12.8 13.1 24.5 12.8 10.9 15.9 16.2 10.1 11.7 46.1 14.7 15.4 18.2 17.0 13.7 13.0 12.6 21.3 19.0 30.0 20.3 25.3 26.2 18.7 10.7 12.5 14.9 11.2 23.3 22.7 28.8 16.7 17.9 21.3 17.9 12.0 10.7 15.3 9.6 18.4 9.8 6.6 19.3 16.4 19.0 17.3 16.3 21.8 14.3 16.1 26.9 21.4 9.9 25.2 15.3 24.8 15.6 19.1 17.4 21.3 20.3 21.7 18.3 15.2 26.2 11.1 9.9 10.5 22.0 25.3 14.4 17.2 14.9 14.3 8.7 14.8 14.5 7.4 14.8 11.0 16.8 19.0 17.6 14.6 14.3 17.3 22.6 16.5 33.7 32.8 15.8 25.7 21.9 18.9 17.2 30.0 21.5 15.6 26.2 21.3 22.1 22.0 19.0 16.4 23.9 22.3 15.0 25.3 20.3 15.1 23.4 18.7 15.1 18.3 29.3 19.2 14.0 15.1 15.2 14.8 16.0 14.7 17.9 8.1 9.3 8.8 8.5 14.5 12.1 2.5 17.4 11.4 5.2 3.9 16.1 16.6 13.6 562.3 11.6 7.3 0.0 14.7 16.7 10.4 6.8 18.5 5.4 13.3 11.1 2.4 6.7 9.8 587.8 19.0 7.9 15.1 24.4 11.9 18.1 12.7 12.9 19.4 8.1 12.4 12.9 14.7 60.0 42.8 8.2 13.5 9.6 11.4 7.9 MKRN3 "D15S9, MGC88288, RNF63, ZFP127, ZNF127" ENSG00000179455 "Makorin ring finger protein 3" Q13064 15 23565678-23630075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 12.6;Cone photoreceptor cells: 23.6;Horizontal cells: 6.4;Rod photoreceptor cells: 6.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 4 "T-cells: 5.7" "Cell line enhanced" "Detected in many" "JURKAT: 16.0;K-562: 17.1" "Low region specificity" "Detected in many" HPA029494 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA029494: AB_10603873" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (4.26e-1)" "unprognostic (1.86e-3)" "unprognostic (1.04e-3)" "unprognostic (1.15e-2)" "unprognostic (6.27e-4)" "unprognostic (1.51e-1)" "unprognostic (8.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.97e-3)" "unprognostic (2.86e-1)" "unprognostic (1.05e-4)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (8.91e-2)" "unprognostic (9.78e-2)" 1.0 0.7 5.1 1.2 10.4 4.0 1.2 1.0 11.1 0.5 1.1 8.4 0.0 1.3 1.3 3.2 5.6 0.9 0.8 0.8 6.4 3.4 1.1 0.7 1.0 1.9 14.4 3.0 1.2 1.7 0.5 3.8 8.5 5.1 1.2 0.8 3.1 5.2 1.0 1.4 1.2 1.9 0.8 8.2 1.5 0.9 5.7 13.3 5.0 0.9 1.1 1.7 0.7 0.6 1.0 0.9 1.3 0.5 0.4 5.7 0.7 4.6 3.3 3.0 3.1 0.0 0.0 7.0 0.3 0.0 2.8 1.9 8.3 0.0 0.2 0.1 0.0 6.2 8.0 1.3 0.0 0.7 0.0 0.3 6.7 8.9 0.3 0.1 7.8 6.0 0.1 0.0 5.8 0.0 1.2 0.0 16.0 17.1 7.3 0.8 0.0 8.2 3.4 0.0 4.4 10.1 5.9 1.1 4.1 0.0 0.1 0.7 2.4 0.0 3.4 0.0 0.2 2.6 2.3 0.0 7.8 6.6 0.4 5.5 9.2 11.3 5.5 4.5 0.1 0.1 1.3 0.5 0.4 1.8 0.2 1.0 1.0 0.6 1.4 0.2 0.9 2.0 5.7 1.3 0.4 0.3 0.9 0.4 0.7 5.1 10.4 1.0 6.8 6.4 3.4 14.4 3.0 5.1 13.3 0.0 0.0 0.0 1.1 0.5 12.6 0.4 0.0 0.0 0.0 0.0 23.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 3.4 0.0 0.0 0.4 0.0 6.4 0.0 1.2 2.4 1.0 0.0 0.5 0.0 0.0 0.4 MLC1 "KIAA0027, LVM, MLC, VL" ENSG00000100427 "Megalencephalic leukoencephalopathy with subcortical cysts 1" Q15049 22 50059391-50085902 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.0;brain: 95.3" "Cell type enhanced" "Detected in some" 23 "Hofbauer cells: 2.6;Muller glia cells: 12.6;T-cells: 4.5" "Cancer enriched" "Detected in some" 69 "glioma: 122.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 46.8;NB-4: 43.3;THP-1: 82.0;U-266/70: 28.7;U-266/84: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003040 Enhanced Supported Cytosol NA NA Cytosol "HPA003040: AB_1079387" "unprognostic (2.68e-2)" "unprognostic (5.46e-6)" "unprognostic (5.41e-3)" "unprognostic (1.51e-1)" "unprognostic (1.47e-1)" "unprognostic (2.42e-3)" "unprognostic (9.54e-3)" "unprognostic (7.21e-2)" "unprognostic (2.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.31e-1)" "unprognostic (1.51e-3)" "unprognostic (8.39e-4)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (3.66e-2)" "unprognostic (2.92e-1)" 1.6 1.4 42.3 1.9 45.4 27.0 1.4 17.6 95.3 2.5 1.5 25.9 0.0 1.8 1.5 2.3 1.4 2.8 2.1 1.6 30.9 19.6 1.4 1.6 2.3 1.6 22.5 28.9 1.4 1.4 1.4 0.1 3.2 18.4 2.9 1.4 0.0 1.5 2.6 1.4 2.2 1.5 1.6 18.9 2.8 1.5 2.8 17.3 0.0 1.4 0.0 1.8 1.8 2.6 0.1 0.7 0.1 7.1 15.8 3.3 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 46.8 15.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 43.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 82.0 0.0 0.0 0.0 0.0 0.0 28.7 24.5 0.0 0.0 7.2 0.4 0.0 0.7 0.0 3.3 5.7 0.1 0.1 0.2 1.4 0.7 0.0 0.1 1.6 0.1 15.8 7.1 0.1 0.1 2.7 42.3 45.4 17.6 29.8 30.9 19.6 22.5 28.9 18.4 17.3 0.0 0.3 0.0 0.0 0.2 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 2.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.2 4.5 0.0 0.0 MLF1 ENSG00000178053 "Myeloid leukemia factor 1" P58340 3 158571163-158607252 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Differentiation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1" "Group enriched" "Detected in many" 15 "Early spermatids: 4250.8;Late spermatids: 9284.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in single" 12 "T-cells: 10.4" "Cell line enhanced" "Detected in many" "A-431: 33.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA069479, HPA079339" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA069479: AB_2686140, HPA079339: " "unprognostic (6.49e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.72e-2)" "unprognostic (2.65e-2)" "unprognostic (8.55e-2)" "unprognostic (4.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.21e-2)" "unprognostic (1.07e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (5.54e-4)" "unprognostic (9.34e-3)" "unprognostic (2.47e-3)" "unprognostic (3.36e-2)" 3.5 2.6 6.0 1.8 11.9 0.9 5.3 3.4 7.1 3.1 2.7 6.5 0.5 0.8 4.9 5.6 3.5 18.3 4.9 41.4 6.3 6.3 5.7 1.2 5.2 1.0 4.9 6.3 6.2 3.1 5.2 10.4 1.0 20.1 2.0 1.7 2.8 2.2 1.6 53.6 1.8 1.3 4.5 4.7 1.2 1.9 101.1 5.7 0.0 5.3 18.9 1.4 4.2 1.5 0.6 0.3 0.4 0.3 0.8 10.4 2.3 33.7 4.4 11.4 0.0 6.0 7.1 3.4 3.5 3.3 12.8 11.7 0.0 19.2 0.0 13.4 6.0 18.7 6.6 0.1 5.9 17.1 0.0 7.4 2.0 3.3 0.3 4.1 0.0 2.5 4.4 8.7 6.1 3.4 13.4 3.0 0.0 2.5 0.0 8.4 4.9 0.0 0.1 2.7 18.0 9.9 0.0 6.4 0.4 9.8 2.4 14.7 8.7 15.9 5.6 16.7 11.7 16.2 3.4 1.1 12.0 12.2 14.1 13.6 6.1 3.8 0.0 8.7 0.0 8.6 0.0 0.0 0.0 3.6 0.0 1.6 0.6 8.3 8.7 0.3 0.3 2.1 4.4 0.4 0.8 0.3 0.2 10.4 2.3 6.0 11.9 3.4 7.1 6.3 6.3 4.9 6.3 20.1 5.7 23.8 26.2 2.2 109.9 39.8 12.6 168.2 0.0 238.3 60.3 19.2 31.4 0.6 61.3 22.4 4250.8 23.3 4.2 0.0 6.9 3.5 36.8 26.1 43.8 0.0 6.4 9.5 32.5 8.0 2.7 9284.2 64.7 13.2 21.9 1.8 14.3 25.9 7.6 14.4 47.4 27.5 58.5 19.4 36.9 440.7 150.0 29.9 1.4 8.9 10.3 65.9 MLF2 NTN4 ENSG00000089693 "Myeloid leukemia factor 2" Q15773 12 6747996-6767475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010811, HPA010859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA010811: AB_1079389, HPA010859: AB_1079388" "unprognostic (1.65e-1)" "unprognostic (6.55e-2)" "unprognostic (4.42e-1)" "unprognostic (9.88e-3)" "unprognostic (1.76e-1)" "unprognostic (4.19e-2)" "unprognostic (1.52e-1)" "unprognostic (4.15e-2)" "unprognostic (1.31e-1)" "unprognostic (9.11e-2)" "unprognostic (3.37e-1)" "unprognostic (6.23e-2)" "unprognostic (1.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.72e-1)" "unprognostic (8.44e-2)" "unprognostic (3.63e-1)" 31.4 45.6 55.8 23.3 65.4 36.9 24.9 50.5 100.5 28.6 30.9 44.0 23.9 36.5 32.1 30.5 39.3 31.7 28.6 44.1 54.4 47.2 37.9 77.4 24.8 21.5 40.2 42.5 28.3 33.4 43.3 31.1 32.5 44.8 38.4 27.6 28.2 43.1 36.7 45.3 33.6 35.1 35.9 33.7 21.8 27.7 21.0 30.7 26.0 36.3 28.9 29.4 29.3 23.6 17.0 38.9 86.7 20.1 11.8 14.8 16.9 39.1 64.9 33.4 58.7 31.3 31.9 51.3 38.6 46.4 66.4 58.3 62.7 38.9 28.3 10.2 50.2 43.4 32.9 41.0 55.8 41.3 44.5 38.0 20.0 34.4 35.9 34.6 21.2 27.6 29.8 45.6 51.3 39.3 48.8 27.0 27.0 25.1 11.8 46.2 55.6 29.1 32.8 107.8 42.5 22.4 18.6 30.7 25.1 55.4 49.5 21.3 42.2 34.8 61.6 37.3 73.7 17.9 35.1 26.6 39.6 52.8 41.8 56.3 14.4 16.3 37.6 52.9 18.5 46.6 35.4 20.1 73.9 14.8 18.0 14.3 15.3 11.5 13.9 22.6 17.0 12.2 13.5 86.7 11.8 19.5 38.9 11.2 16.9 55.8 65.4 50.5 100.5 54.4 47.2 40.2 42.5 44.8 30.7 35.7 25.7 57.9 127.1 121.2 102.4 55.8 104.4 45.5 36.4 104.7 39.3 229.6 237.1 156.1 7.9 68.0 134.5 0.0 110.6 175.2 95.0 155.3 83.1 146.5 129.4 76.3 96.6 62.0 41.9 7.0 105.6 62.0 97.8 201.0 116.3 120.9 125.1 111.0 100.8 262.4 48.7 51.8 117.9 51.9 90.7 109.8 357.4 59.8 120.9 152.3 MLKL FLJ34389 ENSG00000168404 "Mixed lineage kinase domain like pseudokinase" Q8NB16 16 74671855-74700960 "Enzymes, Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 50.4" "Cell type enhanced" "Detected in many" 6 "granulocytes: 27.8;Macrophages: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA078638 Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane" "Cell Junctions, Cytosol" "HPA078638: " "unprognostic (7.53e-2)" "unprognostic (1.74e-2)" "unprognostic (2.57e-1)" "prognostic favorable (2.16e-4)" "unprognostic (1.23e-1)" "unprognostic (3.07e-1)" "unprognostic (5.69e-2)" "unprognostic (3.67e-3)" "unprognostic (1.90e-1)" "unprognostic (6.64e-3)" "unprognostic (1.37e-1)" "unprognostic (2.74e-1)" "unprognostic (1.60e-3)" "unprognostic (5.30e-2)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.53e-3)" 18.5 4.7 5.2 15.1 8.9 21.6 13.2 2.9 7.9 6.4 8.0 3.2 5.3 8.5 7.5 3.8 11.5 5.2 9.1 6.8 6.4 3.5 7.4 6.7 17.3 14.8 10.5 1.8 2.8 8.2 1.6 3.0 7.1 8.1 6.3 9.2 6.5 12.6 4.3 2.3 3.6 10.0 6.0 11.2 26.2 8.2 1.9 8.4 4.3 6.5 4.9 10.4 9.2 50.4 4.2 9.2 25.2 17.7 1.7 8.1 7.1 6.5 12.2 0.1 0.1 3.2 6.7 0.1 8.5 7.4 8.0 11.9 7.0 13.2 0.1 9.8 7.2 6.9 10.5 2.2 12.2 3.0 4.1 0.3 9.2 9.1 8.0 2.3 6.0 9.6 4.5 1.2 8.5 3.0 4.7 19.3 10.7 1.3 1.3 6.2 10.9 3.4 12.0 1.1 14.3 15.0 6.7 0.9 11.7 11.4 4.8 0.5 0.4 6.7 4.5 3.7 0.0 3.2 6.3 21.0 4.0 2.4 3.6 5.8 5.7 19.2 1.6 7.3 21.2 1.9 8.3 17.7 21.7 5.8 10.6 7.9 4.2 6.5 6.0 9.2 2.8 3.6 5.5 25.2 1.7 10.2 0.5 8.1 7.1 5.2 8.9 2.9 7.9 6.4 3.5 10.5 1.8 8.1 8.4 3.0 15.4 8.1 4.8 3.1 0.0 1.6 2.5 2.7 7.9 1.8 0.0 0.2 1.7 4.0 2.6 17.9 5.8 0.0 4.6 0.5 3.8 2.0 27.8 0.9 14.2 1.6 1.2 14.7 15.5 3.8 0.9 24.1 6.8 1.0 5.6 0.0 4.1 9.1 0.4 0.3 0.4 0.0 3.3 0.0 0.2 2.5 0.2 10.0 6.4 5.1 MLLT11 AF1Q ENSG00000213190 "MLLT11, transcription factor 7 cofactor" Q13015 1 151057758-151068497 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.1" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 72.1;Late spermatids: 161.6;monocytes: 56.9" "Cancer enhanced" "Detected in all" "glioma: 29.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 38.6;EFO-21: 29.3;SH-SY5Y: 42.4;U-698: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000540 Uncertain Supported Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA000540: AB_2666024" "unprognostic (2.96e-2)" "unprognostic (1.98e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (4.26e-5)" "unprognostic (1.69e-1)" "unprognostic (1.96e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.25e-12)" "unprognostic (5.66e-3)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (3.94e-3)" 1.9 7.5 13.6 3.4 9.1 1.1 1.2 16.3 42.1 1.9 2.1 5.1 1.2 0.8 3.7 1.2 1.3 0.8 11.1 11.8 11.3 16.4 1.2 1.2 5.3 2.3 10.3 1.2 4.2 1.3 8.4 1.8 1.2 3.2 1.3 1.1 1.2 1.5 1.2 2.6 1.0 2.0 4.2 5.8 2.1 0.9 1.2 1.2 2.0 1.2 1.2 2.6 3.2 1.2 2.4 1.0 6.5 1.0 4.2 9.2 2.8 1.2 5.3 38.6 6.1 0.6 1.0 0.6 2.4 2.6 2.3 4.2 0.5 2.5 1.9 29.3 1.8 6.5 1.5 9.3 2.2 1.3 11.3 2.6 5.0 3.8 0.1 1.2 0.3 0.8 1.7 0.3 12.7 0.5 8.0 17.0 7.6 5.3 0.9 7.4 0.4 17.7 3.3 16.8 0.1 0.8 16.9 5.1 0.1 4.4 1.1 23.3 42.4 0.2 0.4 1.2 26.5 1.4 0.6 11.8 5.0 5.5 1.8 4.4 0.9 0.8 36.0 12.5 0.3 9.4 1.6 0.6 1.6 5.9 0.7 2.7 2.4 3.9 6.0 0.8 2.1 5.3 9.2 6.5 4.2 1.0 1.0 3.6 2.8 13.6 9.1 16.3 21.0 11.3 16.4 10.3 1.2 3.2 1.2 0.0 0.6 1.5 4.0 3.2 38.5 10.1 0.0 0.0 0.0 3.5 7.9 2.0 14.9 2.6 72.1 3.6 0.0 0.0 1.1 2.1 12.7 1.7 4.6 0.0 5.6 35.0 10.3 5.5 4.8 161.6 2.0 7.6 5.0 56.9 0.0 12.4 2.9 0.0 3.5 1.1 18.5 0.0 35.9 4.7 8.8 3.0 6.2 7.5 0.1 4.1 MLLT3 "AF-9, AF9, YEATS3" ENSG00000171843 "MLLT3, super elongation complex subunit" P42568 9 20341665-20622543 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Mucus-secreting cells: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.4" "Group enriched" "Detected in many" 5 "NK-cells: 3.8;T-cells: 14.4" "Cell line enhanced" "Detected in many" "HEL: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001824 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001824: AB_1079394" "unprognostic (3.31e-1)" "unprognostic (2.22e-1)" "unprognostic (1.23e-3)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.01e-3)" "unprognostic (2.12e-1)" "unprognostic (3.92e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-2)" "prognostic favorable (1.84e-4)" "unprognostic (1.85e-1)" "unprognostic (4.81e-2)" "unprognostic (1.40e-2)" "unprognostic (1.68e-1)" 8.6 17.3 18.0 10.4 25.8 19.7 11.4 34.6 20.3 12.3 20.9 7.2 10.6 7.2 13.6 7.9 10.2 11.5 12.7 8.6 18.0 12.8 10.1 2.1 10.7 9.1 14.8 13.8 10.5 4.6 18.3 24.7 10.3 13.2 11.7 22.8 7.4 21.3 12.1 9.1 7.9 12.3 13.5 12.0 5.9 15.3 3.6 21.4 22.1 22.5 6.1 6.5 12.9 10.4 1.4 0.7 1.6 0.3 3.8 14.4 2.8 2.6 7.2 2.6 2.9 6.0 3.7 1.6 6.8 11.5 3.1 3.5 7.0 2.5 10.0 3.7 3.2 0.9 1.3 2.4 11.8 2.8 20.6 6.3 73.6 22.3 3.3 4.3 1.3 6.2 2.8 4.5 1.1 7.4 10.4 3.0 4.2 0.0 12.9 6.4 2.0 7.2 4.3 1.6 14.4 2.1 0.0 4.7 2.7 14.1 3.9 8.3 2.9 5.5 2.8 3.0 2.6 2.9 1.9 2.0 0.0 1.7 1.7 2.4 5.8 5.3 4.1 0.0 3.2 1.4 1.6 0.3 0.5 3.9 0.2 3.6 0.5 7.0 5.3 0.7 1.4 14.4 8.3 0.1 3.8 0.3 0.4 7.3 2.8 18.0 25.8 34.6 20.3 18.0 12.8 14.8 13.8 13.2 21.4 26.8 23.0 7.3 15.3 7.3 5.5 12.1 7.6 9.4 38.7 21.0 31.4 0.9 11.6 23.0 2.7 8.6 13.6 0.0 7.3 5.3 16.7 15.6 11.5 1.7 2.0 4.8 31.7 6.7 2.6 4.2 12.7 3.2 21.9 1.0 101.9 37.2 18.7 17.3 8.9 7.0 1.0 0.0 16.5 0.1 5.6 7.3 1.4 25.4 28.6 13.2 MLX "bHLHd13, MAD7, MXD7, TCFL4" ENSG00000108788 "MLX, MAX dimerization protein" Q9UH92 17 42567068-42573239 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025329, HPA052766, HPA064438" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "CAB025329: , HPA052766: AB_2681940, HPA064438: AB_2685265" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.21e-3)" "unprognostic (3.88e-1)" "unprognostic (2.46e-2)" "unprognostic (8.55e-3)" "unprognostic (2.49e-1)" "unprognostic (4.87e-2)" "unprognostic (8.66e-2)" "unprognostic (9.66e-2)" "unprognostic (2.89e-1)" "unprognostic (1.61e-2)" "unprognostic (7.43e-2)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (3.25e-1)" 21.3 19.2 10.4 12.6 11.9 8.3 22.5 10.3 14.3 12.3 32.2 10.8 15.4 27.5 11.0 15.1 18.8 10.5 19.2 38.1 9.8 9.8 23.5 34.7 19.0 18.6 11.3 6.6 10.4 36.8 8.5 13.0 13.7 9.4 13.4 23.1 11.6 18.5 14.8 43.3 15.6 42.5 12.1 10.2 18.7 20.6 7.4 8.9 20.3 23.5 24.9 19.7 16.5 13.1 14.6 26.3 34.7 33.5 12.8 18.2 23.0 15.8 18.3 14.4 14.6 22.0 25.4 10.0 23.8 21.1 25.7 23.3 16.5 16.5 19.1 16.8 20.2 23.4 24.0 26.2 15.4 22.6 15.1 24.6 19.7 13.2 18.3 25.9 26.4 28.5 22.0 17.2 20.6 18.9 17.4 18.9 23.1 21.5 17.1 29.3 21.0 37.0 13.0 10.2 39.3 16.6 16.8 29.9 20.4 20.8 19.6 22.5 11.2 10.6 13.7 26.7 20.0 28.1 31.3 13.4 22.9 14.8 25.0 35.1 17.4 19.7 18.0 25.7 16.9 26.9 14.2 25.0 34.7 14.3 30.8 15.8 14.6 14.8 14.3 26.3 11.8 13.1 13.1 32.3 12.8 33.5 14.1 18.2 23.0 10.4 11.9 10.3 14.3 9.8 9.8 11.3 6.6 9.4 8.9 62.5 76.9 37.4 23.4 37.3 27.5 22.9 40.8 30.8 50.0 26.2 23.6 33.1 51.4 35.7 17.8 23.2 101.9 0.0 60.3 38.8 28.7 21.1 44.1 46.0 60.8 23.8 24.8 23.4 50.2 21.2 32.5 61.4 30.4 50.5 40.2 12.3 61.7 61.4 29.4 44.4 24.5 51.8 33.9 8.4 38.4 43.5 36.8 35.8 48.8 32.5 MMAA cblA ENSG00000151611 "Methylmalonic aciduria (cobalamin deficiency) cblA type" Q8IVH4 4 145618263-145660035 "Disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 14.7" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 28.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037361, HPA058187" Supported Approved Cytosol No No Cytosol "HPA037361: AB_10672107, HPA058187: " "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "prognostic favorable (3.38e-4)" "unprognostic (1.97e-3)" "unprognostic (1.44e-1)" "unprognostic (4.83e-3)" "unprognostic (1.31e-3)" "unprognostic (3.98e-1)" "unprognostic (7.03e-2)" "unprognostic (7.26e-2)" "unprognostic (3.19e-3)" "unprognostic (1.46e-1)" "prognostic favorable (2.23e-5)" "unprognostic (3.40e-2)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.21e-4)" 1.7 3.3 1.4 1.4 1.7 0.5 2.6 2.3 1.5 1.5 3.1 4.2 1.4 2.6 2.3 1.5 2.0 1.8 1.2 1.5 4.3 14.7 1.7 1.3 1.4 1.3 2.5 1.4 0.9 1.1 1.3 3.5 2.0 1.3 5.2 2.3 3.4 1.2 1.2 1.6 1.9 2.0 2.2 1.7 1.6 1.6 4.2 4.2 4.1 10.0 5.8 7.8 2.9 2.3 1.3 4.3 2.2 10.4 10.4 0.9 5.9 4.7 2.4 1.4 1.8 4.7 7.9 2.0 3.9 1.2 1.9 2.1 4.5 1.6 5.5 1.0 3.5 0.9 1.4 7.5 4.2 3.2 6.5 6.4 2.5 6.6 4.1 7.4 9.5 1.0 5.4 5.1 2.9 7.6 1.6 1.6 6.1 2.2 3.6 1.5 1.5 14.1 1.8 2.1 1.7 3.4 7.2 3.2 2.2 3.7 2.0 6.1 3.8 1.6 4.6 1.5 3.0 1.9 3.6 4.0 4.2 3.4 4.1 3.8 3.2 6.3 8.4 5.8 4.2 7.8 6.4 3.6 3.3 5.9 7.8 0.0 5.8 10.0 4.2 6.1 2.9 11.9 3.5 2.2 7.3 2.6 2.9 7.0 12.7 4.0 15.9 10.4 2.0 6.9 13.3 8.5 7.0 3.3 8.8 0.0 10.8 2.8 3.8 5.2 8.1 28.6 4.5 0.0 2.4 7.4 2.7 4.7 4.4 2.6 1.7 3.6 4.9 2.2 7.8 7.0 2.8 15.3 1.5 0.0 3.1 6.7 4.9 1.0 6.4 1.7 5.9 9.5 MMACHC "cblC, DKFZP564I122" ENSG00000132763 "Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria" Q9Y4U1 1 45500053-45513382 "Disease related genes, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.1" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027394, HPA027399, HPA027402" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255" "unprognostic (3.34e-1)" "unprognostic (1.63e-1)" "unprognostic (7.03e-3)" "unprognostic (3.14e-2)" "unprognostic (4.05e-1)" "unprognostic (1.16e-2)" "unprognostic (9.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.90e-1)" "unprognostic (1.05e-2)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.61e-3)" "unprognostic (2.08e-3)" "unprognostic (8.83e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" 3.5 7.4 5.8 3.3 10.2 2.2 6.1 3.6 12.2 5.4 6.3 11.8 3.2 5.6 4.1 5.6 4.0 6.2 2.9 11.1 6.2 5.1 7.6 30.1 2.7 3.1 7.3 6.9 6.4 9.8 9.5 5.4 2.9 8.5 3.9 7.6 4.0 11.9 7.5 14.7 3.8 4.1 4.2 6.7 3.6 4.5 7.3 5.7 4.1 4.4 3.7 3.6 3.9 3.1 2.1 3.6 5.0 6.1 2.6 3.9 1.1 6.8 3.5 6.1 9.2 5.8 3.5 7.6 5.3 3.5 9.7 8.8 7.3 4.2 10.7 6.9 4.4 1.8 5.7 11.2 12.7 8.9 2.9 10.2 8.3 5.9 8.2 5.5 11.8 3.0 5.0 7.2 10.7 11.8 3.5 4.6 11.3 9.4 6.1 7.4 7.3 7.9 3.8 10.0 7.8 8.3 9.8 2.5 11.9 5.6 5.4 9.8 5.0 8.0 13.3 17.3 4.8 7.6 4.3 2.1 6.8 9.3 7.6 2.8 9.2 7.4 6.2 4.9 5.7 6.3 5.0 1.6 1.6 1.7 2.4 2.8 2.0 2.0 1.4 1.7 2.1 3.9 2.0 3.5 2.6 6.1 3.6 1.4 1.1 5.8 10.2 3.6 12.2 6.2 5.1 7.3 6.9 8.5 5.7 3.0 5.6 1.5 1.7 0.1 0.9 8.7 2.5 1.4 3.4 1.8 0.0 3.1 5.0 1.1 0.6 0.7 1.6 0.0 1.2 3.7 1.8 1.3 2.3 21.9 2.9 3.2 4.1 2.5 3.1 0.0 1.7 0.9 0.0 0.0 2.6 1.0 1.8 0.0 1.4 3.2 4.4 0.0 1.7 8.1 2.0 0.1 2.3 1.3 6.0 1.6 MMP10 STMY2 ENSG00000166670 "Matrix metallopeptidase 10" P09238 11 102770503-102780628 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "endometrium 1: 89.4" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 38.9;Club cells: 70.5;Collecting duct cells: 27.9;Pancreatic endocrine cells: 62.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 102.2" "Region enriched" "Detected in single" 9 "pons and medulla: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 12.6;HUVEC TERT2: 16.2;SCLC-21H: 5.2" "Not detected" "Not detected" CAB002159 Uncertain Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 765000 Cytosol "Plasma membrane" "CAB002159: AB_564103" "unprognostic (8.76e-2)" "unprognostic (3.38e-1)" "unprognostic (1.98e-3)" "unprognostic (2.72e-3)" "unprognostic (7.17e-3)" "unprognostic (1.52e-2)" "unprognostic (5.67e-8)" "unprognostic (2.08e-3)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" "unprognostic (6.99e-5)" "unprognostic (2.66e-2)" "unprognostic (7.98e-2)" "unprognostic (5.46e-2)" "prognostic favorable (7.12e-4)" 0.1 0.1 0.0 2.6 0.2 0.1 0.1 0.0 0.3 1.7 0.5 0.0 0.0 0.4 89.4 0.1 0.2 0.1 0.5 0.1 0.0 0.1 0.1 3.6 11.0 0.1 0.0 0.0 0.5 0.3 0.1 0.9 19.8 2.8 3.2 0.2 0.0 2.9 0.1 0.1 0.1 0.7 0.1 0.0 0.2 3.3 0.5 0.0 1.2 0.1 0.0 1.9 0.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.2 12.6 0.7 0.1 0.1 0.3 0.0 0.0 3.7 1.9 0.2 2.9 0.0 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.6 0.0 16.2 0.0 0.7 0.0 0.0 0.0 0.0 0.3 3.0 0.5 1.7 0.0 0.0 0.0 0.0 0.7 5.2 0.0 2.5 0.0 0.0 0.9 0.0 0.0 2.0 3.9 1.3 0.4 0.5 0.0 0.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 38.9 0.7 0.0 0.0 0.0 5.3 70.5 27.9 0.0 0.0 0.0 9.8 5.0 0.0 0.0 0.0 12.9 0.0 0.2 5.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 2.8 0.0 0.0 62.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 7.4 MMP14 MT1-MMP ENSG00000157227 "Matrix metallopeptidase 14" P50281 14 22836557-22849027 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 216.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 96.4;HHSteC: 91.2;HSkMC: 92.7;hTERT-RPE1: 91.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009918, HPA051432" Approved Approved "Intermediate filaments,Cytosol" No No 570000 Cytosol "Intermediate filaments" "CAB009918: AB_2250767, HPA051432: AB_2681484" "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (4.28e-2)" "unprognostic (1.12e-2)" "unprognostic (3.05e-3)" "unprognostic (5.91e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (3.82e-3)" "unprognostic (7.31e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (5.02e-2)" "unprognostic (6.69e-2)" "unprognostic (1.00e-2)" "unprognostic (3.41e-3)" 60.9 10.5 2.4 16.6 4.7 0.2 64.2 2.2 3.2 56.3 35.0 8.2 12.7 12.0 53.1 24.1 47.0 21.9 39.6 17.5 3.4 1.8 16.8 9.0 29.8 16.9 5.8 2.9 39.3 11.2 34.4 4.7 73.5 16.4 39.1 11.3 27.1 24.4 16.7 20.4 37.0 22.9 28.5 20.7 22.5 18.2 26.3 4.6 5.4 22.3 14.6 16.7 52.5 53.9 0.1 0.7 0.0 0.7 0.0 0.0 0.1 7.8 0.1 2.4 0.1 96.4 61.3 44.3 24.7 49.8 7.5 13.4 2.3 29.4 0.1 13.8 26.0 2.3 20.0 0.0 25.7 9.6 0.1 0.1 3.6 0.1 0.5 91.2 0.0 0.1 92.7 15.5 31.2 26.8 91.6 45.3 0.1 0.0 0.2 17.6 0.1 0.0 8.8 1.4 1.7 4.3 0.3 8.5 0.0 6.8 13.5 0.0 0.0 16.1 0.0 53.5 10.8 0.1 7.9 40.0 60.9 5.2 17.7 28.1 0.1 0.1 0.1 37.1 0.0 35.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 4.7 2.2 3.2 3.4 1.8 5.8 2.9 16.4 4.6 11.9 4.8 3.7 19.4 30.2 0.0 3.6 53.5 2.7 3.4 7.0 0.0 83.6 10.0 61.2 0.4 13.5 16.8 0.0 24.9 216.8 65.7 13.9 3.5 2.9 79.3 0.0 7.5 41.1 18.3 0.7 66.7 26.5 35.4 34.3 32.5 17.1 102.2 28.5 51.6 13.0 0.8 38.8 34.8 0.9 0.7 29.9 102.6 1.0 17.1 28.7 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025566-58046901 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 56.0;Enterocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 30 "dendritic cells: 2.9" "Cell line enhanced" "Detected in many" "BEWO: 37.1;Hep G2: 19.3;SK-BR-3: 18.6;WM-115: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: AB_2676956" "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favorable (3.08e-4)" 5.9 2.3 2.0 5.5 3.0 0.1 7.7 3.7 7.2 3.3 19.5 4.2 16.3 22.6 2.9 1.7 2.5 3.6 15.9 17.6 2.3 3.7 8.4 26.4 6.1 2.0 2.5 2.2 2.1 10.3 7.3 5.2 28.5 10.4 3.6 8.2 9.5 4.7 14.7 3.4 2.3 43.2 3.4 3.4 5.2 14.7 28.0 2.1 1.1 26.8 2.5 2.2 3.3 4.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 5.7 4.4 2.3 11.9 2.4 0.1 37.1 0.5 0.3 2.1 0.5 3.5 14.9 0.0 7.0 0.6 1.6 8.1 2.0 1.7 0.6 0.0 3.9 0.0 1.9 19.3 3.1 0.1 7.7 1.2 3.1 0.3 0.9 3.3 1.4 3.3 4.8 0.0 0.7 2.9 0.2 0.9 6.8 17.0 1.2 2.9 0.3 3.1 6.5 2.1 0.6 4.1 7.7 18.6 3.5 5.5 2.0 3.1 1.3 0.1 3.7 1.4 0.5 0.0 0.0 0.1 0.7 0.9 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 3.0 3.7 7.2 2.3 3.7 2.5 2.2 10.4 2.1 17.9 11.8 0.9 1.0 2.3 1.9 19.3 56.0 5.3 9.1 17.4 15.7 33.4 1.7 33.5 2.2 6.0 81.1 0.0 10.5 19.6 2.8 1.6 0.0 29.0 10.2 1.6 10.9 19.6 3.5 4.8 0.9 0.1 1.7 0.0 31.8 1.7 13.5 40.7 3.2 5.4 1.4 0.0 0.8 0.9 4.9 1.9 40.5 1.5 28.3 1.4 MMP16 "C8orf57, DKFZp761D112, MT3-MMP" ENSG00000156103 "Matrix metallopeptidase 16" P51512 8 88032009-88328025 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 3.9;Early spermatids: 4.9;Fibroblasts: 9.9;Late spermatids: 4.7" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;HUVEC TERT2: 8.8;SH-SY5Y: 11.4;U-138 MG: 9.7;WM-115: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023693 Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA Cytosol Vesicles "HPA023693: AB_1854025" "unprognostic (2.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.31e-2)" "unprognostic (2.39e-3)" "unprognostic (1.45e-3)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "unprognostic (9.42e-2)" "unprognostic (2.92e-1)" "unprognostic (2.09e-8)" "unprognostic (6.90e-3)" "unprognostic (1.16e-1)" "unprognostic (3.62e-1)" "unprognostic (2.19e-3)" 2.4 1.3 11.0 1.4 6.8 0.5 4.9 8.3 15.9 5.3 2.2 2.9 0.7 0.8 4.9 2.1 1.7 2.1 7.3 2.7 8.7 6.9 0.8 0.9 1.0 1.0 5.5 9.1 3.3 2.1 1.5 1.7 3.0 6.3 3.2 1.7 0.6 1.2 2.4 0.7 1.1 1.3 4.0 4.6 1.5 1.4 1.5 5.5 0.0 3.2 0.7 1.0 2.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.5 20.4 0.7 1.4 0.0 7.5 1.1 2.1 1.3 0.0 0.0 0.0 0.0 3.3 1.2 0.0 4.0 0.0 2.6 0.0 2.4 0.0 0.0 0.0 1.7 0.0 0.3 1.0 0.0 3.1 0.9 3.8 8.8 0.0 0.0 0.7 1.1 0.0 0.0 0.0 1.2 0.0 2.0 0.2 0.4 0.0 0.4 0.0 0.1 11.4 0.0 0.0 0.1 1.6 0.8 0.0 4.9 9.7 5.5 0.1 2.8 0.0 0.0 0.0 3.9 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 6.8 8.3 14.1 8.7 6.9 5.5 9.1 6.3 5.5 0.0 0.0 0.0 0.0 1.0 3.9 0.6 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 4.9 2.9 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.3 1.6 0.0 0.6 0.0 4.7 0.9 0.6 1.7 0.0 0.0 3.2 0.2 0.0 1.1 0.0 0.3 0.0 1.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 MMP9 CLG4B ENSG00000100985 "Matrix metallopeptidase 9" P14780 20 46008908-46016561 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1" "Cell type enhanced" "Detected in many" 25 "Hofbauer cells: 273.8;Macrophages: 115.1;Melanocytes: 54.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 141 "neutrophil: 63.2" "Lineage enriched" "Detected in single" 339 "granulocytes: 63.2" "Cell line enriched" "Detected in some" 12 "NB-4: 89.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201" Enhanced Approved Cytosol "Secreted to blood" NA NA 43300000 57000000 Cytosol "CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150" "unprognostic (4.62e-2)" "unprognostic (1.64e-1)" "unprognostic (2.85e-2)" "prognostic favorable (2.55e-4)" "unprognostic (6.65e-3)" "unprognostic (2.82e-1)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.54e-1)" "unprognostic (8.57e-2)" "unprognostic (3.21e-2)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.05e-5)" "unprognostic (4.65e-1)" "unprognostic (9.85e-3)" "unprognostic (2.48e-2)" "unprognostic (2.17e-3)" 64.0 0.5 0.6 38.6 0.7 89.4 4.3 0.4 0.6 0.8 1.2 0.1 0.0 2.8 0.6 0.2 0.9 1.5 0.6 4.0 0.5 0.6 1.4 2.0 13.3 80.1 0.6 0.0 2.7 1.4 0.0 0.8 2.6 0.5 0.6 0.8 0.5 12.5 0.0 1.3 1.3 4.2 0.3 0.5 53.7 2.5 2.7 0.0 23.6 1.3 2.3 44.5 4.5 2.9 0.0 0.0 63.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 7.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 89.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 1.0 0.0 0.3 0.0 2.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.2 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.4 0.6 0.5 0.6 0.6 0.0 0.5 0.0 0.0 8.5 0.0 0.0 30.5 1.6 0.4 0.0 0.0 0.0 0.0 7.9 0.9 0.0 0.8 0.6 0.5 0.0 0.0 1.5 2.0 1.7 0.1 1.1 0.0 273.8 3.2 0.0 0.0 1.9 0.0 0.0 115.1 54.0 3.6 0.0 0.5 1.6 0.0 0.0 0.3 4.3 0.0 12.3 5.4 5.5 24.6 1.6 0.0 0.0 0.0 MNDA PYHIN3 ENSG00000163563 "Myeloid cell nuclear differentiation antigen" P41218 1 158831317-158849506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 289.8;bone marrow: 83.3" "Group enriched" "Detected in many" 4 "Hofbauer cells: 203.8;Kupffer cells: 493.3;Macrophages: 520.9;Muller glia cells: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 289.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 289.8" "Group enriched" "Detected in some" 15 "NB-4: 36.7;THP-1: 69.4;U-937: 45.4" "Low region specificity" "Detected in all" "HPA034532, HPA073215" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol" NA NA 110000 Nucleoplasm "Nucleoli, Nucleoli rim, Vesicles, Cytosol" "HPA034532: AB_10669677, HPA073215: AB_2686582" "unprognostic (1.53e-2)" "unprognostic (7.84e-3)" "unprognostic (2.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.41e-2)" "unprognostic (2.02e-2)" "unprognostic (7.99e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (9.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" 17.6 6.3 5.4 24.4 7.9 83.3 3.0 1.4 5.8 2.1 2.1 3.2 0.2 1.1 1.7 3.4 2.3 4.7 8.4 6.3 4.9 3.2 3.9 4.2 31.3 32.2 10.7 2.6 3.4 2.4 1.1 2.2 9.9 6.8 2.6 2.5 5.0 3.6 1.2 2.0 1.9 3.6 6.2 18.6 57.3 2.6 4.0 6.3 5.5 2.1 1.4 4.2 9.1 4.9 1.6 29.7 289.8 60.9 0.1 0.1 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 0.0 7.1 60.9 11.1 0.1 25.4 0.1 1.6 0.0 0.1 29.7 0.6 0.0 0.0 289.8 0.1 12.0 0.4 0.0 40.2 5.4 7.9 1.4 5.8 4.9 3.2 10.7 2.6 6.8 6.3 32.8 82.3 20.5 0.0 2.2 0.6 0.7 10.2 14.7 17.0 0.0 0.0 0.8 0.0 0.0 0.2 2.1 0.0 0.0 0.3 0.9 2.3 0.0 40.7 1.3 203.8 0.0 0.0 6.2 493.3 0.9 1.1 520.9 1.7 25.2 0.0 130.5 0.0 0.0 0.0 1.1 4.7 12.9 9.2 0.3 0.2 1.9 0.8 1.0 0.0 0.0 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010651 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 43.3" "Cell type enhanced" "Detected in some" 15 "Intestinal endocrine cells: 24.1;Mucus-secreting cells: 18.0;Paneth cells: 9.0;Undifferentiated cells: 12.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 11.8;BEWO: 8.8;EFO-21: 11.3;HEK 293: 9.0;RPMI-8226: 24.7;SCLC-21H: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol No NA Nucleoplasm "Nucleoli, Cytosol" "HPA071717: AB_2686437" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.1 6.0 0.2 0.1 9.0 0.1 0.1 0.3 0.0 7.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 43.3 0.0 3.2 0.1 0.2 0.8 3.7 0.1 1.9 0.1 0.1 0.1 7.3 0.1 0.2 0.1 2.7 1.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 3.9 0.0 11.8 0.0 0.0 8.8 0.0 0.0 0.1 0.0 5.1 1.7 0.9 11.3 0.0 0.3 0.2 2.0 1.6 0.9 1.4 9.0 0.0 0.8 2.3 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 4.1 3.7 1.9 0.0 6.6 0.6 0.1 0.0 1.1 0.7 0.0 1.7 24.7 4.4 0.4 13.3 0.0 1.7 1.5 0.2 0.1 3.7 2.9 0.0 0.0 0.0 0.0 0.0 3.7 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.7 0.0 4.3 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 24.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 18.0 0.0 2.5 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.4 0.0 MOB1A "C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B" ENSG00000114978 "MOB kinase activator 1A" Q9H8S9 2 74152528-74178898 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 381.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (5.32e-2)" "unprognostic (2.45e-1)" "unprognostic (5.38e-2)" "unprognostic (2.62e-1)" "unprognostic (2.19e-1)" "unprognostic (8.19e-2)" "prognostic unfavorable (3.34e-4)" "unprognostic (9.36e-2)" "unprognostic (3.91e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-3)" "unprognostic (1.04e-1)" "unprognostic (2.20e-3)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.11e-3)" 32.2 18.0 12.2 41.5 16.3 36.6 36.2 10.8 11.3 24.5 21.5 12.6 16.1 19.7 27.1 19.8 28.9 22.0 19.9 20.9 11.0 10.4 34.7 21.4 28.4 65.1 14.7 6.9 28.4 12.6 13.8 11.5 20.9 15.9 21.0 20.7 14.3 18.1 18.8 12.8 22.9 30.2 31.6 21.8 51.1 18.7 17.9 12.8 57.0 25.4 16.9 42.4 29.2 24.6 22.3 22.2 32.3 42.8 20.6 15.9 25.2 21.0 12.1 15.2 16.4 25.1 27.5 18.0 17.0 22.9 22.2 21.9 16.5 15.4 43.3 14.6 21.3 16.5 17.7 19.4 19.4 33.7 30.4 11.6 39.1 8.4 17.4 20.1 33.8 63.2 23.2 19.0 17.7 15.0 16.7 23.2 16.8 16.7 16.1 21.5 11.4 42.4 28.8 14.1 18.1 9.9 29.3 52.4 23.0 19.1 26.4 7.7 10.1 24.1 17.9 15.5 12.0 14.3 16.1 22.0 28.9 15.2 20.2 26.9 12.0 10.6 33.3 19.4 28.9 15.4 30.8 24.0 32.3 14.8 39.0 15.9 22.3 13.3 15.7 22.2 17.2 12.3 14.6 24.0 20.6 42.8 15.5 13.4 25.2 12.2 16.3 10.8 11.3 11.0 10.4 14.7 6.9 15.9 12.8 47.6 54.3 138.1 70.9 121.6 12.3 37.0 43.3 80.3 58.0 78.5 5.9 57.5 77.9 53.0 5.0 60.8 83.6 46.7 46.0 83.4 58.3 90.4 109.5 38.0 153.8 25.4 36.1 63.3 177.0 8.5 57.8 185.9 64.1 381.5 63.9 22.4 63.0 74.8 64.3 137.3 13.0 71.1 74.1 87.4 46.2 115.4 55.5 96.5 62.4 139.8 MOB1B "MOB4A, MOBKL1A" ENSG00000173542 "MOB kinase activator 1B" Q7L9L4 4 70902326-71022449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;monocytes: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 34.3" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (1.05e-1)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.94e-1)" "unprognostic (1.36e-1)" "unprognostic (3.45e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.09e-3)" "unprognostic (2.70e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-3)" 9.8 10.1 15.7 17.8 13.0 30.9 11.1 10.4 20.0 10.5 9.7 17.3 4.8 6.1 13.9 8.6 9.9 11.8 9.1 11.1 19.8 10.6 29.3 8.3 20.6 13.4 15.5 18.6 13.8 11.0 18.0 10.9 11.2 12.8 12.7 8.5 8.0 11.1 8.6 10.8 11.2 8.4 14.1 17.4 10.6 10.1 7.6 15.4 52.3 14.4 8.2 12.8 10.8 9.8 0.6 5.3 2.5 3.1 0.7 1.4 1.2 3.9 3.2 12.2 9.9 6.6 8.4 10.0 11.9 6.5 6.7 5.9 4.2 7.6 22.0 5.7 10.5 4.5 2.8 7.5 10.0 16.2 11.6 2.6 34.3 3.6 3.3 6.6 7.5 6.9 6.9 5.5 7.5 6.1 7.5 7.9 11.4 21.0 7.2 10.5 4.2 23.2 4.6 4.0 2.6 4.2 7.5 11.8 3.0 11.1 6.9 4.2 8.1 5.1 2.3 15.9 6.8 5.4 4.8 9.4 18.6 9.5 8.4 4.8 4.6 1.5 9.4 6.5 5.5 8.5 0.8 3.1 2.5 1.3 1.6 1.1 0.5 0.6 0.6 4.0 0.6 0.8 0.7 0.4 0.7 0.9 5.3 1.4 1.2 15.7 13.0 10.4 20.0 19.8 10.6 15.5 18.6 12.8 15.4 23.8 15.5 2.2 5.2 15.9 2.0 14.7 7.6 21.4 12.5 41.8 17.7 4.6 8.3 4.9 0.4 9.5 0.9 70.0 4.0 4.9 11.2 9.8 10.4 6.4 9.9 6.4 36.4 9.8 34.3 1.4 4.0 21.6 10.1 52.3 8.4 6.0 8.0 0.0 8.1 15.9 4.3 25.8 21.7 7.2 9.8 14.9 4.8 5.4 5.6 8.4 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 57.3;urinary bladder: 51.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favorable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 9.2 4.2 2.4 17.0 2.5 3.0 12.1 2.5 3.2 14.9 30.9 1.8 6.7 2.5 12.5 8.7 17.3 13.8 26.8 8.1 2.8 1.9 3.2 3.0 4.1 8.2 2.1 2.1 8.6 5.8 6.8 1.8 4.2 2.9 21.2 6.7 4.3 12.9 20.1 7.1 9.4 10.6 57.3 2.5 3.7 9.9 4.2 2.0 2.0 4.3 3.2 4.4 51.8 21.2 10.6 10.8 11.2 12.5 11.6 17.3 9.0 13.9 15.2 9.4 7.6 23.5 16.6 8.7 11.0 16.1 21.2 16.8 9.7 19.2 10.3 8.5 25.9 13.2 17.1 14.5 24.7 13.0 13.8 21.7 7.8 5.5 12.3 15.9 10.2 12.3 13.4 29.8 11.3 13.3 17.1 22.5 13.4 12.6 10.7 10.7 9.9 13.2 17.4 11.6 26.7 14.2 9.6 9.6 10.7 17.7 13.3 17.6 18.7 13.7 17.1 13.2 12.5 7.9 10.2 18.5 13.0 6.6 4.2 6.9 10.6 10.3 10.7 9.0 9.9 9.9 8.2 8.6 11.2 17.3 8.7 14.6 8.2 14.9 13.8 10.8 10.6 12.5 10.5 7.1 11.6 12.5 6.9 12.8 9.0 2.4 2.5 2.5 2.5 2.8 1.9 2.1 2.1 2.9 2.0 6.0 7.7 13.7 25.1 73.0 17.7 11.3 12.7 6.7 5.7 7.0 11.8 26.7 23.2 29.5 22.2 55.0 43.9 70.0 33.6 25.8 27.0 36.5 25.3 7.4 23.5 41.3 20.1 25.8 15.2 9.0 22.2 20.7 54.0 32.5 29.1 18.0 31.2 63.1 48.1 18.3 17.2 84.1 54.6 22.2 39.4 71.6 49.7 45.0 24.3 28.6 MOB3A "MOB-LAK, MOB1C, MOBKL2A, moblak" ENSG00000172081 "MOB kinase activator 3A" Q96BX8 19 2071038-2096673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 69.3" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 40.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (2.05e-2)" "unprognostic (3.58e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.33e-6)" "unprognostic (3.40e-2)" "unprognostic (3.53e-3)" "unprognostic (3.12e-3)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (2.16e-2)" "unprognostic (7.74e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (5.90e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-1)" 19.6 9.5 9.8 31.9 10.0 27.4 11.9 11.1 9.2 15.5 19.2 12.7 7.7 7.7 19.9 9.2 14.3 16.7 14.1 10.6 10.0 6.9 10.7 5.7 14.9 39.6 9.4 6.4 15.6 8.2 6.7 7.0 15.9 8.8 15.3 9.2 13.4 11.6 13.1 7.9 12.0 18.2 17.0 7.6 37.3 12.5 8.3 10.0 39.3 11.7 6.7 42.2 17.1 13.1 11.6 14.5 69.3 22.0 13.0 16.5 17.1 14.1 5.8 6.9 6.6 16.5 18.2 5.4 8.9 5.6 6.1 4.9 2.3 5.1 36.3 3.2 15.3 4.9 6.0 3.8 19.7 4.9 12.7 1.9 7.9 4.1 3.1 16.3 12.3 40.9 10.7 13.1 16.6 7.1 7.0 11.3 7.0 4.0 36.5 8.8 5.6 6.4 12.5 2.1 1.7 4.2 3.9 2.0 28.2 7.5 3.5 4.4 5.9 4.5 4.8 4.9 5.4 5.1 20.1 19.2 7.4 4.1 13.7 5.2 7.2 25.6 28.7 19.9 8.3 8.8 18.0 20.6 23.9 16.5 20.8 14.2 11.6 12.3 13.6 14.5 10.7 9.4 11.8 69.3 13.0 22.0 8.3 14.7 17.1 9.8 10.0 11.1 9.2 10.0 6.9 9.4 6.4 8.8 10.0 3.0 5.0 50.6 9.8 13.4 3.1 3.2 2.5 8.1 7.9 10.4 19.6 7.9 3.3 9.5 1.2 10.7 14.2 0.0 8.2 48.6 12.6 10.3 27.6 4.0 28.8 1.6 14.3 14.7 70.3 4.0 17.0 36.1 15.1 49.5 10.5 6.2 9.2 8.6 15.9 6.8 6.6 6.5 12.0 6.6 6.4 13.9 23.0 40.6 7.6 10.1 MOB3B "C9orf35, FLJ13204, MOB1D, MOBKL2B" ENSG00000120162 "MOB kinase activator 3B" Q86TA1 9 27325209-27529781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2;ovary: 29.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 47.8;Muller glia cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.8;myeloid DC: 4.6;naive B-cell: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.1;HAP1: 10.4;K-562: 29.7;SK-BR-3: 12.5" "Low region specificity" "Detected in many" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (6.96e-3)" "unprognostic (9.60e-2)" "unprognostic (5.10e-3)" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.87e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (7.57e-3)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "prognostic favorable (2.33e-10)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.99e-2)" 6.0 2.3 6.2 4.2 18.0 1.0 7.0 5.0 13.9 7.8 13.2 32.6 2.8 19.0 10.9 6.1 4.3 9.4 5.8 2.0 9.8 6.4 8.6 1.9 7.5 4.2 19.7 6.2 29.9 4.5 0.9 1.8 5.3 17.2 2.8 14.9 5.7 3.9 3.8 8.5 7.1 16.6 7.5 33.2 8.6 6.2 3.7 17.5 0.6 7.0 2.9 6.2 4.0 5.2 5.9 4.6 0.0 1.4 0.0 0.1 0.5 2.0 1.5 4.8 0.0 1.2 0.1 10.1 0.0 0.1 0.1 0.1 1.1 0.0 0.0 2.1 0.0 0.0 6.8 10.4 8.2 0.0 4.6 1.6 3.0 6.3 0.0 0.0 0.0 0.6 2.2 8.7 0.0 1.6 0.0 0.0 0.0 29.7 0.1 0.0 0.0 0.0 0.0 6.1 3.8 0.5 2.0 0.5 0.0 2.9 3.9 0.0 1.5 1.7 12.5 2.9 6.6 0.8 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.9 0.0 0.0 1.4 0.0 4.8 0.0 0.0 4.6 5.9 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.5 6.2 18.0 5.0 12.0 9.8 6.4 19.7 6.2 17.2 17.5 3.0 5.5 18.6 6.8 20.1 1.2 1.2 30.6 1.4 4.5 10.4 0.0 18.9 8.3 13.5 0.7 4.3 47.8 0.0 18.5 45.9 11.2 4.0 1.1 2.6 4.6 1.6 2.4 6.2 11.6 1.7 14.7 22.9 15.1 8.2 27.2 68.7 10.1 17.5 15.2 9.1 1.3 0.0 12.2 1.4 1.7 8.3 9.8 1.0 31.1 6.2 MOB3C "MOB1E, MOBKL2C" ENSG00000142961 "MOB kinase activator 3C" Q70IA8 1 46607715-46616891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (1.76e-3)" "prognostic favorable (3.16e-5)" "unprognostic (1.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (6.26e-3)" "unprognostic (1.56e-1)" "unprognostic (1.76e-1)" "unprognostic (9.97e-2)" "unprognostic (3.85e-2)" "unprognostic (1.20e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (2.35e-2)" "unprognostic (4.61e-3)" 16.9 9.0 8.8 8.0 14.7 4.1 12.1 19.7 7.5 10.7 11.2 9.3 11.8 8.8 8.4 12.9 12.6 9.6 10.8 12.3 10.1 5.6 9.1 8.8 13.3 7.8 13.2 6.8 12.6 29.8 10.4 10.9 12.8 12.5 12.2 9.3 9.5 16.8 12.5 20.2 6.0 12.5 9.8 5.5 14.7 10.9 4.2 9.4 3.1 11.1 19.1 11.4 10.8 16.0 9.3 7.1 15.1 9.0 16.1 21.5 11.4 7.4 3.0 1.5 4.5 14.9 11.7 0.6 4.2 10.7 7.7 7.5 0.9 5.3 0.6 4.6 7.2 11.1 10.8 1.6 5.4 4.1 11.1 0.2 17.5 4.0 1.1 7.8 1.5 6.6 9.5 8.4 7.3 2.0 10.2 5.0 1.9 2.6 4.4 3.2 3.1 0.7 2.3 0.5 4.7 9.0 1.9 5.0 3.2 4.3 13.5 0.6 1.8 6.5 4.6 5.2 1.8 2.8 5.9 3.7 3.9 2.7 6.4 3.7 4.1 0.9 0.5 5.8 2.6 3.2 2.1 8.4 15.1 12.2 9.0 21.5 6.9 12.0 12.3 5.8 9.3 10.7 10.8 6.0 16.1 5.7 7.1 8.1 11.4 8.8 14.7 19.7 7.5 10.1 5.6 13.2 6.8 12.5 9.4 6.0 5.8 3.7 9.1 9.8 2.1 3.9 2.5 5.3 4.5 7.0 0.0 1.6 5.0 2.4 7.1 5.1 6.0 0.0 5.5 0.8 8.0 8.1 5.7 2.6 10.5 4.8 8.1 7.4 8.5 0.4 5.8 10.4 3.3 4.6 7.9 1.5 4.0 2.9 6.3 2.6 0.6 6.5 9.8 0.0 0.2 5.6 1.1 7.9 5.2 13.3 MOCOS "FLJ20733, HMCS, MOS" ENSG00000075643 "Molybdenum cofactor sulfurase" Q96EN8 18 36187519-36272157 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.0;liver: 36.6" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 30.1;monocytes: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 20.8;hTERT-HME1: 25.6;SiHa: 27.4;SK-MEL-30: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039412, HPA047958" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039412: AB_2676496, HPA047958: AB_2680225" "unprognostic (3.07e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (3.18e-3)" "unprognostic (2.55e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.84e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.91e-2)" "prognostic unfavorable (3.03e-12)" "unprognostic (8.98e-2)" "unprognostic (2.37e-1)" "unprognostic (4.09e-1)" "unprognostic (6.35e-2)" 3.7 12.7 0.6 1.6 0.5 0.2 6.4 0.4 0.4 1.4 10.4 0.7 8.0 6.7 1.3 4.6 4.8 1.9 5.8 1.3 0.4 0.5 1.7 36.6 1.8 0.2 0.4 0.1 17.2 3.2 1.1 9.4 11.2 2.2 2.8 1.8 2.1 2.5 7.2 1.3 2.6 33.0 1.0 0.4 0.7 1.7 1.3 0.2 0.0 1.2 2.9 3.5 2.6 1.7 0.4 0.3 1.9 0.3 1.1 0.3 0.1 6.9 2.4 0.1 0.0 2.2 2.9 1.5 4.1 2.3 2.0 5.1 1.5 2.2 0.0 1.3 6.6 0.5 4.3 1.5 6.5 2.8 1.2 1.2 0.1 6.9 5.7 7.6 0.0 2.0 4.5 20.8 7.7 25.6 0.2 0.3 0.0 2.3 0.0 3.2 1.8 0.0 0.0 0.4 1.6 2.0 0.0 0.0 0.0 2.8 9.1 0.0 0.6 27.4 1.7 19.1 0.4 1.3 0.1 1.3 1.6 1.9 3.4 0.7 0.0 0.0 0.0 4.0 0.0 0.7 1.7 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.3 0.1 0.4 0.2 0.3 1.9 1.1 0.2 0.3 0.1 0.1 0.6 0.5 0.4 0.4 0.4 0.5 0.4 0.1 2.2 0.2 11.9 5.3 3.4 1.2 0.6 0.2 0.4 0.0 2.7 6.8 0.0 2.0 0.4 0.0 2.7 5.7 0.9 2.6 0.0 10.9 3.3 1.5 1.2 0.0 30.1 0.5 0.0 2.9 0.0 0.6 1.7 1.7 1.4 3.3 20.8 2.3 7.6 4.3 2.8 8.5 0.0 0.3 0.0 0.5 0.1 0.2 1.1 1.9 0.0 2.8 2.2 MOCS1 MOCOD ENSG00000124615 "Molybdenum cofactor synthesis 1" Q9NZB8 6 39899578-39934551 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 23.5;Hepatocytes: 33.6;Sertoli cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.5" "Group enriched" "Detected in many" 9 "NK-cells: 1.5;T-cells: 2.9" "Cell line enhanced" "Detected in many" "CACO-2: 23.6;JURKAT: 30.1" "Low region specificity" "Detected in all" "HPA045783, HPA058177, HPA075505" Uncertain Enhanced Cytosol NA NA Cytosol "HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751" "unprognostic (1.22e-1)" "prognostic unfavorable (1.07e-5)" "unprognostic (3.26e-2)" "unprognostic (1.44e-1)" "unprognostic (9.03e-2)" "unprognostic (1.99e-1)" "unprognostic (2.61e-2)" "unprognostic (4.85e-2)" "unprognostic (3.14e-2)" "unprognostic (1.08e-1)" "prognostic favorable (6.07e-5)" "unprognostic (5.34e-3)" "unprognostic (1.21e-1)" "unprognostic (3.97e-3)" "unprognostic (2.78e-1)" "unprognostic (2.93e-1)" "unprognostic (6.21e-2)" 26.6 9.6 4.6 5.3 7.9 0.2 27.1 5.9 8.7 6.4 17.5 10.5 5.0 15.4 10.1 8.7 6.9 7.9 8.0 18.0 6.2 2.3 17.5 34.9 19.6 9.2 9.5 6.2 9.0 10.9 4.5 6.3 30.2 7.0 6.7 5.2 11.2 5.9 7.6 19.9 7.1 13.1 8.9 7.1 3.5 6.5 4.0 7.6 0.2 15.4 5.9 3.1 9.7 7.7 0.0 0.1 0.0 0.2 1.5 2.9 0.8 0.0 1.2 4.4 7.1 12.1 4.6 9.0 4.9 8.9 7.0 6.4 23.6 0.1 0.0 5.1 4.8 4.5 0.3 5.3 5.9 5.4 0.0 4.9 0.0 0.0 7.5 7.7 0.0 1.9 8.1 2.2 4.9 2.6 4.3 6.0 30.1 4.8 0.4 7.1 3.0 9.2 0.0 4.1 0.0 2.6 0.0 3.4 0.7 4.3 4.6 3.6 4.7 0.0 2.9 4.1 3.7 3.1 0.8 9.3 7.0 6.1 4.6 2.5 0.0 0.9 0.0 0.8 0.0 2.5 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.6 0.5 0.1 0.0 2.9 2.5 0.0 1.5 0.2 0.0 0.0 0.8 4.6 7.9 5.9 8.7 6.2 2.3 9.5 6.2 7.0 7.6 6.0 1.0 0.0 0.5 0.6 0.8 10.1 7.6 0.0 0.0 8.7 11.8 23.5 5.0 3.4 0.6 2.8 6.4 0.0 3.7 1.2 2.9 0.2 1.1 33.6 2.5 3.2 0.0 2.5 2.8 0.6 3.4 0.0 1.7 0.0 2.9 4.2 1.1 4.8 2.8 12.2 2.2 77.6 15.6 1.4 1.5 1.0 5.1 0.0 4.1 0.3 MOCS2 MOCO1 ENSG00000164172 "Molybdenum cofactor synthesis 2" "O96007, O96033" 5 53095679-53110063 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 485.7;Proximal tubular cells: 194.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037679, HPA037680" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear speckles" "HPA037679: AB_2675604, HPA037680: AB_10673635" "unprognostic (3.27e-1)" "unprognostic (3.11e-2)" "unprognostic (2.82e-1)" "unprognostic (8.37e-3)" "unprognostic (2.12e-1)" "unprognostic (3.48e-2)" "unprognostic (1.60e-2)" "unprognostic (1.33e-1)" "unprognostic (6.66e-2)" "unprognostic (7.59e-2)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" "prognostic favorable (3.68e-6)" "unprognostic (1.04e-1)" "unprognostic (1.04e-2)" "unprognostic (2.04e-1)" "unprognostic (5.86e-2)" 18.1 34.6 41.5 9.8 38.0 4.0 19.6 21.7 41.8 16.0 17.1 20.7 10.4 17.6 14.8 28.2 17.0 12.9 15.9 39.9 36.7 32.1 49.7 52.0 13.1 11.4 30.0 22.4 21.2 18.4 30.4 23.3 16.2 28.7 18.6 14.9 17.2 21.2 20.8 38.3 8.9 17.6 16.1 27.1 10.7 16.6 11.0 20.0 8.2 31.5 19.4 11.2 16.9 15.4 16.9 12.5 6.3 10.9 17.3 25.8 12.9 20.2 16.6 12.0 28.7 24.6 22.7 15.2 24.9 26.2 22.2 26.4 22.6 15.2 20.7 37.5 19.6 34.4 12.3 24.0 25.5 35.0 5.2 23.4 15.9 16.3 20.4 25.3 17.2 12.0 18.1 12.8 25.2 22.5 22.0 23.8 26.7 15.4 11.3 37.0 30.0 18.5 9.8 10.6 8.7 34.6 9.4 25.8 18.8 38.4 15.4 8.9 10.3 18.1 14.8 18.6 15.9 28.6 4.4 15.2 21.3 22.1 18.9 32.0 13.3 19.7 23.4 30.5 4.9 32.9 5.2 9.2 6.3 16.9 10.9 20.2 16.5 19.0 19.2 12.5 16.9 25.8 22.2 1.7 17.3 9.8 11.4 18.3 12.9 41.5 38.0 21.7 41.8 36.7 32.1 30.0 22.4 28.7 20.0 50.6 20.6 25.2 32.7 11.8 27.0 111.0 66.2 36.1 19.4 66.3 25.5 82.4 485.7 34.6 5.6 32.8 17.8 0.0 38.2 28.9 48.8 44.5 9.3 99.9 36.5 6.4 25.3 19.0 25.0 10.1 46.9 27.4 21.9 7.2 17.9 36.8 23.4 19.3 64.7 194.9 18.1 32.3 50.3 40.7 54.7 13.7 27.0 26.1 22.9 30.2 MON1A "MGC13272, SAND1" ENSG00000164077 "MON1 homolog A, secretory trafficking associated" Q86VX9 3 49907160-49930173 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3;Late spermatids: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053752, HPA058032" Uncertain Approved Cytosol NA NA Cytosol "HPA053752: AB_2682250, HPA058032: AB_2683584" "unprognostic (1.81e-2)" "unprognostic (6.34e-2)" "unprognostic (1.48e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-2)" "unprognostic (3.51e-2)" "unprognostic (3.29e-2)" "unprognostic (2.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-2)" "prognostic favorable (3.30e-4)" "unprognostic (5.23e-2)" "unprognostic (2.07e-1)" "unprognostic (1.46e-1)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" "unprognostic (1.55e-1)" 7.1 6.5 11.7 6.1 10.4 4.1 4.6 5.2 17.8 5.9 9.3 7.6 3.8 27.9 5.6 3.2 5.6 5.1 6.3 5.4 10.8 10.3 6.0 11.0 4.9 5.2 10.3 8.8 4.7 10.9 5.8 7.4 4.9 8.9 5.0 4.0 5.6 6.0 6.7 15.2 6.9 17.6 5.9 9.7 4.6 5.8 12.6 6.6 6.6 6.3 4.1 4.5 4.6 4.4 8.8 7.8 3.3 6.4 13.6 13.5 7.8 4.6 3.9 2.4 7.5 7.7 4.6 3.4 6.7 3.3 6.5 7.3 5.8 3.1 14.2 6.1 6.2 5.6 5.9 5.2 8.4 2.7 11.8 13.1 6.2 4.6 7.4 9.7 7.2 9.0 6.3 9.1 12.6 4.4 3.3 9.4 6.1 9.6 5.0 4.9 7.7 8.2 10.6 5.4 10.1 20.1 5.1 2.7 10.9 4.6 3.4 7.0 4.2 2.8 5.6 6.7 1.7 4.3 4.9 7.4 4.3 5.1 11.9 10.6 10.5 10.3 8.8 6.6 11.2 6.4 0.1 6.4 3.3 11.9 4.9 13.5 8.8 10.0 11.9 7.8 4.8 12.4 10.0 1.9 13.6 3.9 3.9 10.1 7.8 11.7 10.4 5.2 17.8 10.8 10.3 10.3 8.8 8.9 6.6 3.0 4.8 4.3 1.7 13.3 2.8 5.3 0.0 4.0 3.4 1.8 3.9 3.7 1.7 4.2 11.9 3.8 9.3 23.3 5.8 2.6 3.5 3.7 4.6 12.9 4.7 0.0 6.4 4.3 3.8 25.2 3.1 2.5 5.0 1.8 4.0 4.6 9.6 5.8 5.3 10.5 2.2 0.0 6.2 14.0 5.7 8.0 3.3 4.9 4.9 1.8 MON1B "HSRG1, KIAA0872, SAND2" ENSG00000103111 "MON1 homolog B, secretory trafficking associated" Q7L1V2 16 77190835-77202405 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046285 Approved Approved Cytosol NA NA Cytosol "HPA046285: AB_10959467" "unprognostic (1.73e-2)" "unprognostic (9.99e-2)" "unprognostic (9.97e-2)" "prognostic favorable (6.90e-4)" "unprognostic (1.94e-1)" "unprognostic (7.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-2)" "unprognostic (9.78e-2)" "unprognostic (2.42e-2)" "unprognostic (1.76e-1)" "unprognostic (1.19e-1)" "prognostic favorable (9.42e-5)" "unprognostic (2.21e-2)" "unprognostic (3.62e-2)" "unprognostic (8.34e-3)" "unprognostic (1.75e-1)" 15.7 12.3 21.8 19.1 22.5 16.5 12.4 17.5 22.9 14.7 19.1 25.3 18.5 17.1 14.6 14.4 16.7 13.6 16.1 12.5 21.7 19.4 17.4 26.9 14.9 19.3 26.8 17.9 11.5 17.7 25.1 13.0 11.8 19.9 23.7 15.7 15.2 22.9 13.3 11.5 15.9 23.1 11.6 28.0 18.0 16.9 10.8 24.0 23.5 23.2 11.2 17.7 15.1 12.0 5.7 7.2 19.8 14.5 9.2 8.6 6.7 8.2 19.7 7.5 8.4 8.3 8.2 10.6 7.0 9.1 7.2 7.1 11.2 12.6 13.3 13.9 5.5 12.1 15.2 7.8 7.5 5.9 10.5 8.0 9.3 6.9 11.0 11.5 9.8 28.7 8.6 14.5 10.4 8.7 7.0 12.9 12.8 13.2 4.7 5.8 15.5 14.9 11.8 7.9 9.5 4.9 18.6 5.2 14.2 7.4 5.8 11.6 9.6 13.5 5.2 8.9 5.6 13.3 14.9 13.3 8.6 10.4 10.3 7.1 17.0 10.8 37.7 14.3 10.9 11.0 10.4 8.3 14.1 8.6 14.5 8.6 5.7 6.8 8.4 7.2 5.4 5.2 6.6 19.8 9.2 8.7 3.9 8.4 6.7 21.8 22.5 17.5 22.1 21.7 19.4 26.8 17.9 19.9 24.0 35.7 33.3 8.0 9.8 6.6 14.8 9.6 10.2 9.4 20.5 14.0 17.7 8.8 3.3 11.7 15.0 19.4 25.6 0.0 17.0 10.5 7.8 20.2 12.7 25.2 11.7 7.9 23.1 20.9 26.4 11.3 8.3 13.6 8.5 16.2 23.9 20.3 15.9 17.5 9.6 9.9 21.2 19.4 7.2 10.4 4.9 8.3 14.1 20.2 19.5 16.9 MORC2 "AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1" ENSG00000133422 "MORC family CW-type zinc finger 2" Q9Y6X9 22 30925130-30968298 "Disease related genes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 10.3;MAIT T-cell: 9.1;memory CD4 T-cell: 14.3;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 8.9;T-reg: 17.7" "Lineage enriched" "Detected in many" 8 "T-cells: 17.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000436 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000436: AB_1079404" "unprognostic (3.43e-2)" "unprognostic (1.71e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-2)" "unprognostic (6.15e-2)" "unprognostic (3.56e-3)" "unprognostic (2.89e-3)" "unprognostic (4.63e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-1)" "unprognostic (5.46e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.54e-8)" "unprognostic (5.64e-2)" "unprognostic (2.38e-1)" "unprognostic (1.02e-2)" "unprognostic (6.66e-3)" 6.7 5.3 4.6 6.0 7.0 5.2 16.9 6.4 7.5 6.8 7.1 6.5 14.8 4.7 7.4 5.9 6.1 6.3 4.7 7.7 4.7 5.0 5.3 9.6 6.3 8.8 4.8 4.1 8.1 7.5 9.4 8.1 7.7 7.7 8.0 4.5 7.7 11.0 7.9 9.8 10.4 5.6 6.7 5.3 7.3 5.9 50.5 5.0 5.5 6.6 6.1 6.6 6.8 9.7 1.7 2.2 0.8 2.0 1.2 17.7 3.9 18.6 17.0 20.2 22.3 21.1 15.7 15.3 13.8 10.8 14.2 14.6 22.2 9.0 16.7 12.4 12.0 10.0 16.0 18.1 8.6 11.8 13.1 21.9 17.4 13.6 26.0 18.2 14.2 18.0 14.9 12.6 14.9 19.3 11.8 14.2 9.8 22.8 17.3 14.8 30.3 15.1 29.0 18.7 22.0 12.6 29.0 11.8 21.5 13.7 17.0 18.0 14.2 14.6 23.9 10.5 16.9 12.8 24.2 14.2 17.2 17.0 12.1 12.2 15.5 19.1 18.8 12.6 10.1 12.2 0.5 1.1 0.8 10.3 1.9 9.1 1.5 14.3 8.3 1.2 1.7 14.7 8.9 0.3 1.2 2.0 2.2 17.7 3.9 4.6 7.0 6.4 7.5 4.7 5.0 4.8 4.1 7.7 5.0 0.0 2.9 5.2 6.2 6.5 7.0 4.5 2.5 2.7 6.8 10.4 9.8 7.0 3.3 6.4 23.5 7.1 4.0 0.0 7.0 9.6 6.6 7.4 1.1 7.8 4.5 12.7 8.6 4.9 4.0 7.4 7.2 3.7 6.8 2.8 5.8 3.5 9.1 3.5 9.6 2.8 9.9 19.4 6.2 20.9 18.8 8.2 5.3 4.4 6.4 4.9 MOSPD3 "CDS3, NET30" ENSG00000106330 "Motile sperm domain containing 3" O75425 7 100612102-100615384 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1149.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041137, HPA048240" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA041137: AB_10803996, HPA048240: AB_2680325" "unprognostic (1.24e-1)" "unprognostic (8.98e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.25e-2)" "unprognostic (1.80e-2)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (9.88e-2)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (8.65e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" 13.8 22.3 13.0 7.7 12.8 17.4 9.8 9.0 16.9 14.7 9.1 14.5 13.9 9.9 12.0 12.9 22.5 12.0 14.9 10.2 11.2 10.8 19.3 29.8 11.1 18.5 10.6 11.6 13.1 17.1 6.7 9.8 7.8 12.0 12.9 4.8 14.9 19.1 11.3 11.3 24.4 10.6 10.3 9.5 11.8 14.7 37.0 9.9 16.6 12.2 13.6 16.8 12.4 13.4 11.6 17.9 22.2 16.7 20.9 29.7 8.0 6.0 8.2 6.6 11.4 3.5 2.6 4.7 4.6 5.5 4.8 4.9 7.6 8.1 3.8 10.2 4.2 6.8 4.7 3.8 6.6 0.9 9.8 5.1 3.9 6.1 11.4 4.5 3.0 15.1 7.4 5.7 4.1 2.4 4.2 8.2 6.4 9.1 7.8 4.9 17.9 8.4 23.0 6.0 7.9 12.4 7.9 6.9 9.1 7.6 9.1 3.6 21.7 8.6 13.4 4.6 2.8 8.1 8.9 9.2 9.3 14.7 19.3 4.4 6.2 5.8 2.6 9.3 33.7 11.4 18.5 16.7 22.2 18.8 12.4 22.2 11.6 21.8 21.8 17.9 11.3 13.0 13.5 12.3 20.9 8.5 12.0 29.7 8.0 13.0 12.8 9.0 16.9 11.2 10.8 10.6 11.6 12.0 9.9 8.9 6.5 11.9 14.9 10.8 6.6 3.2 17.8 9.4 4.5 19.2 5.9 6.0 36.5 33.9 271.2 15.7 8.7 0.0 37.6 23.2 22.0 20.1 3.5 26.2 25.2 6.4 20.7 19.0 23.0 1149.7 25.6 15.1 25.3 14.4 14.9 11.4 39.0 17.5 20.5 35.7 3.4 12.9 20.0 17.7 21.5 17.1 5.1 29.3 16.9 17.8 MOV10 "fSAP113, gb110, MGC2948" ENSG00000155363 "Mov10 RISC complex RNA helicase" Q9HCE1 1 112673141-112700746 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031627 Approved Cytosol NA NA Cytosol "HPA031627: AB_2673966" "unprognostic (1.44e-2)" "unprognostic (1.83e-2)" "unprognostic (1.53e-1)" "unprognostic (6.82e-3)" "unprognostic (1.91e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (3.44e-4)" "unprognostic (9.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.58e-3)" "unprognostic (2.85e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.48e-11)" "unprognostic (4.01e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-3)" "unprognostic (1.21e-3)" 12.5 17.0 6.2 12.6 6.9 3.5 15.0 1.9 6.3 11.4 23.1 9.3 12.3 18.8 16.4 12.6 15.8 12.2 15.3 5.8 8.6 5.1 13.3 19.4 9.7 7.7 5.9 5.1 14.5 12.9 13.1 14.1 20.2 8.2 14.0 9.3 13.8 13.5 16.5 3.1 23.2 33.8 9.4 6.3 12.9 10.4 17.7 6.0 14.5 12.1 6.9 10.9 11.0 12.5 1.9 5.6 0.9 9.5 9.9 10.8 5.9 12.0 7.4 4.4 17.0 3.6 10.4 16.8 8.3 19.7 24.4 35.0 13.7 13.3 0.0 5.7 11.4 9.1 12.8 16.8 19.9 8.5 13.2 10.2 8.3 10.8 15.4 15.5 3.4 8.3 17.5 6.1 14.8 4.7 16.1 20.7 17.2 11.0 4.2 7.5 22.3 13.1 2.7 9.9 5.0 7.6 23.7 11.2 0.5 11.3 13.2 1.9 6.4 17.1 11.6 13.4 9.1 9.0 8.0 12.3 7.6 13.7 5.3 7.3 4.8 1.3 0.0 15.1 7.2 21.7 0.7 2.8 0.5 10.7 8.4 10.8 1.9 9.7 9.7 5.6 1.4 9.4 7.1 0.9 9.9 9.5 0.9 8.2 5.9 6.2 6.9 1.9 6.3 8.6 5.1 5.9 5.1 8.2 6.0 8.9 10.9 5.4 9.8 7.8 2.1 2.5 7.6 6.7 10.3 15.7 0.0 42.2 3.3 13.7 4.2 14.7 31.4 0.0 13.3 16.6 5.1 9.2 1.1 14.0 13.8 4.8 14.5 17.8 9.4 4.9 8.6 7.1 3.3 18.0 15.3 20.4 13.7 28.1 7.1 11.2 0.8 12.9 6.2 2.6 2.6 6.0 31.9 5.7 11.5 9.5 MOXD1 "dJ248E1.1, DKFZP564G202, MOX" ENSG00000079931 "Monooxygenase DBH like 1" Q6UVY6 6 132296055-132401545 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 57.2;smooth muscle: 41.1" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 24.8;Early spermatids: 36.8;Muller glia cells: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 47 "memory B-cell: 4.9;naive B-cell: 2.8;plasmacytoid DC: 7.8" "Group enriched" "Detected in many" 58 "B-cells: 4.9;dendritic cells: 7.8" "Cell line enhanced" "Detected in many" "ASC diff: 38.5;ASC TERT1: 31.0;BJ: 23.4;fHDF/TERT166: 43.5;HBF TERT88: 28.1;U-2197: 69.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035740 Approved Approved Cytosol NA NA Cytosol "HPA035740: AB_10610141" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (8.05e-2)" "unprognostic (9.87e-3)" "unprognostic (5.62e-2)" "prognostic favorable (7.09e-5)" "unprognostic (5.77e-2)" "unprognostic (2.48e-1)" "unprognostic (6.55e-2)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" "unprognostic (9.54e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (3.72e-4)" "unprognostic (2.92e-2)" "unprognostic (6.24e-2)" "unprognostic (1.73e-2)" 1.9 19.5 13.4 3.8 12.5 0.2 1.4 0.3 16.0 17.2 7.7 6.7 7.3 2.7 57.2 7.8 17.4 1.9 15.1 3.2 9.8 1.1 21.4 1.2 15.3 2.9 1.0 6.4 2.4 1.7 0.1 4.3 3.3 0.2 17.6 4.9 0.9 10.6 21.5 0.4 7.4 4.5 41.1 0.8 3.2 3.1 3.1 4.6 0.8 1.5 7.7 7.7 9.4 8.6 4.9 7.8 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.9 0.0 38.5 31.0 0.0 23.4 15.9 8.6 15.1 0.0 0.2 0.1 0.0 43.5 7.1 0.0 0.3 0.1 28.1 0.0 4.3 0.0 0.0 0.0 0.3 0.0 0.0 7.3 0.0 17.3 0.5 10.7 0.0 0.0 0.0 1.7 5.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.1 0.0 10.5 0.0 0.6 0.0 0.0 0.1 0.5 2.3 0.0 1.3 0.1 3.9 3.7 69.7 12.2 0.9 0.0 0.0 10.0 0.0 11.5 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.3 13.4 12.5 0.3 16.0 9.8 1.1 1.0 6.4 0.2 4.6 0.0 2.2 3.4 0.4 24.8 0.2 0.6 0.0 0.0 4.5 1.8 0.0 0.6 0.0 0.4 36.8 0.0 0.0 0.0 0.0 1.0 9.6 0.2 3.5 0.0 0.4 0.0 0.0 0.0 0.0 6.8 0.3 0.6 6.8 0.0 0.0 14.0 0.4 0.0 0.4 0.0 0.8 0.0 0.4 0.5 0.4 5.9 0.0 0.0 0.0 0.0 MPG MDG ENSG00000103152 "N-methylpurine DNA glycosylase" P29372 16 77007-85853 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006531 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006531: AB_1854075" "unprognostic (1.78e-2)" "unprognostic (8.48e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.82e-5)" "unprognostic (8.54e-2)" "unprognostic (3.27e-1)" "unprognostic (2.75e-2)" "unprognostic (1.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-2)" "unprognostic (1.83e-2)" "unprognostic (1.39e-2)" "unprognostic (1.86e-3)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 20.8 32.1 18.4 21.1 18.4 25.3 33.2 18.3 32.1 19.5 20.4 12.6 24.6 21.0 22.6 30.5 21.5 18.5 28.5 37.4 16.7 15.1 16.1 32.0 20.1 39.7 15.8 18.2 23.8 36.5 8.0 21.7 19.0 16.5 23.2 7.2 15.2 47.1 24.2 33.6 19.0 19.4 19.2 13.6 25.6 27.3 10.9 11.2 18.3 29.2 22.4 22.8 27.2 25.2 33.5 38.8 27.2 27.4 41.2 31.1 22.4 14.0 20.5 5.6 17.1 10.3 23.5 14.0 20.1 27.8 13.1 14.4 12.9 18.9 10.0 17.6 11.4 6.5 18.0 3.9 8.8 2.0 17.1 14.9 6.5 10.4 19.2 29.8 6.7 40.2 22.6 12.2 14.7 6.1 17.5 22.8 11.3 14.2 18.0 17.0 48.4 11.7 31.1 10.1 8.1 22.4 22.3 6.7 38.0 10.9 5.1 4.6 11.7 10.6 11.5 25.3 2.7 16.4 34.9 19.9 10.7 13.6 14.5 9.9 17.6 5.9 12.7 19.8 19.5 38.1 14.2 27.4 27.2 22.7 19.2 20.6 33.5 21.8 22.6 28.5 30.6 16.8 17.2 14.0 41.2 15.7 38.8 31.1 22.4 18.4 18.4 18.3 32.1 16.7 15.1 15.8 18.2 16.5 11.2 3.0 24.6 65.6 62.0 31.8 13.4 1.1 30.6 20.1 22.7 38.4 3.9 68.9 28.2 68.7 6.3 43.1 60.4 0.0 99.2 74.2 79.8 90.4 54.4 44.9 80.7 9.5 47.8 47.3 65.5 3.6 60.9 47.4 54.0 72.1 66.3 38.4 109.6 66.2 54.5 52.3 9.1 84.1 64.9 18.8 43.7 35.9 51.7 62.9 63.6 97.9 MPHOSPH8 "HSMPP8, mpp8" ENSG00000196199 "M-phase phosphoprotein 8" Q99549 13 19633681-19673459 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039701, HPA040035" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA039701: AB_10805484, HPA040035: AB_10794207" "unprognostic (4.22e-1)" "unprognostic (5.58e-2)" "unprognostic (2.66e-1)" "unprognostic (4.01e-3)" "unprognostic (3.05e-2)" "unprognostic (1.86e-1)" "unprognostic (2.81e-3)" "unprognostic (4.90e-2)" "unprognostic (4.55e-2)" "unprognostic (1.59e-1)" "unprognostic (3.52e-3)" "unprognostic (3.40e-2)" "unprognostic (6.49e-2)" "unprognostic (3.86e-2)" "unprognostic (4.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.02e-1)" 20.6 27.1 37.7 33.4 37.1 19.2 21.4 48.9 45.0 32.0 26.6 13.2 31.7 17.8 29.4 26.7 19.1 22.3 18.8 27.9 31.0 27.2 18.9 16.5 22.9 28.4 28.8 32.8 43.6 22.0 20.9 44.3 20.0 28.4 26.1 20.1 11.9 24.5 38.8 25.7 26.6 23.9 31.3 37.1 30.0 22.5 16.6 33.5 16.5 26.8 11.7 20.4 31.3 37.9 21.7 13.8 39.4 9.9 11.5 17.6 3.6 12.9 8.3 12.5 20.2 16.2 20.6 22.1 19.5 14.2 12.3 10.6 12.7 22.9 20.5 15.6 11.8 19.2 21.7 22.9 13.6 15.9 25.5 11.7 33.0 13.7 15.4 14.4 23.7 26.9 12.1 17.7 9.7 13.7 18.8 16.2 16.7 15.9 13.2 11.4 12.6 18.1 19.9 12.2 24.1 9.3 14.6 28.8 16.2 21.4 10.1 17.1 10.5 18.2 16.8 17.7 21.8 10.2 19.7 19.0 9.6 8.6 18.1 9.8 9.0 9.3 20.4 7.3 22.0 14.8 39.4 9.5 15.4 13.0 6.9 11.5 21.5 14.6 12.5 4.3 21.7 17.6 14.4 27.5 11.5 9.9 13.8 11.3 3.6 37.7 37.1 48.9 45.0 31.0 27.2 28.8 32.8 28.4 33.5 86.4 100.8 102.7 102.3 61.2 189.0 78.6 81.5 60.2 84.2 97.7 78.5 107.7 41.4 45.8 58.1 101.2 89.2 23.3 47.7 70.1 98.0 73.8 137.8 68.9 64.6 198.6 56.6 106.2 53.3 25.9 166.0 79.7 64.1 91.0 71.4 105.7 42.2 94.7 147.8 48.2 208.1 174.6 116.5 181.6 204.0 64.6 49.1 124.6 63.9 55.3 MPHOSPH9 MPP9 ENSG00000051825 "M-phase phosphoprotein 9" Q99550 12 123152320-123244014 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 48.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037485 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA037485: AB_10672792" "unprognostic (2.98e-2)" "unprognostic (5.00e-1)" "unprognostic (4.36e-3)" "unprognostic (1.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.81e-1)" "unprognostic (5.81e-3)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.53e-3)" "unprognostic (1.31e-2)" "unprognostic (2.75e-1)" "unprognostic (5.14e-3)" "unprognostic (1.17e-1)" 5.3 9.8 11.0 10.5 14.6 24.8 5.6 21.6 14.9 5.5 6.7 7.7 4.9 7.9 6.4 12.8 5.9 6.1 4.0 8.8 8.8 6.0 7.1 12.7 6.1 12.0 7.1 8.0 6.9 6.3 9.9 20.4 5.7 9.9 5.8 7.6 7.7 5.9 5.2 7.2 5.4 8.0 5.9 9.1 10.2 5.9 14.4 11.0 48.9 6.2 3.2 10.8 5.5 5.0 6.2 4.9 8.3 3.7 8.5 12.1 3.0 8.5 9.1 14.6 16.4 6.5 6.1 5.5 8.8 4.5 11.1 8.9 8.6 4.2 16.8 6.5 5.8 10.6 6.1 18.8 7.2 15.5 10.7 12.2 17.1 10.1 8.4 5.0 15.9 14.9 6.6 2.7 10.5 10.5 9.8 11.3 25.6 11.8 7.4 10.1 7.2 18.1 25.2 10.0 5.6 9.9 16.2 14.7 10.9 8.6 8.4 18.7 8.8 13.7 5.5 8.6 15.3 10.3 12.0 6.4 9.1 13.1 10.5 12.5 11.6 18.7 14.0 7.3 15.3 18.8 8.3 3.7 5.1 10.9 3.6 7.7 5.6 8.6 9.8 3.5 6.2 12.1 11.8 0.7 8.5 3.1 4.9 7.4 3.0 11.0 14.6 21.6 14.9 8.8 6.0 7.1 8.0 9.9 11.0 8.9 7.4 13.8 3.9 3.9 36.9 12.6 10.2 14.7 9.1 7.0 108.0 8.9 5.0 4.1 46.8 4.5 3.3 0.0 1.6 5.6 8.1 2.8 2.3 27.6 7.3 50.9 13.7 5.5 12.0 48.4 6.6 7.2 3.3 14.4 5.1 17.7 1.6 0.0 10.6 7.1 64.2 0.0 4.1 30.0 19.6 1.9 1.4 22.3 7.5 2.4 MPI ENSG00000178802 "Mannose phosphate isomerase" P34949 15 74890005-74902219 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007200 Approved Approved "Plasma membrane,Cytosol" NA NA 170000 Cytosol "Plasma membrane" "HPA007200: AB_1854079" "unprognostic (1.38e-1)" "unprognostic (7.18e-2)" "unprognostic (1.63e-1)" "unprognostic (1.65e-3)" "unprognostic (7.34e-2)" "prognostic unfavorable (2.39e-4)" "unprognostic (1.79e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (3.34e-2)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.09e-1)" "unprognostic (6.58e-2)" 13.6 33.3 24.2 11.2 26.2 7.4 14.7 19.2 33.7 16.7 22.6 26.1 15.3 32.6 15.7 26.8 17.1 20.7 13.4 28.8 22.7 22.2 22.5 30.2 10.6 16.2 28.1 28.3 23.2 34.2 24.7 15.0 11.4 37.4 20.6 23.1 18.3 18.6 17.9 33.3 11.7 27.4 16.4 21.7 14.7 14.3 23.5 17.7 16.4 17.1 15.0 16.6 15.6 11.7 12.8 10.2 2.4 7.4 17.7 27.1 12.9 10.6 14.7 12.2 13.8 28.0 13.6 10.7 9.2 15.0 15.8 22.1 14.5 14.1 15.1 20.0 13.4 12.6 26.6 24.2 26.7 15.0 11.5 30.3 27.1 14.0 15.6 19.9 12.5 8.0 18.1 6.9 14.8 26.7 24.0 21.4 18.2 9.0 12.4 20.3 9.1 13.3 5.5 6.7 16.1 12.6 13.7 11.5 37.0 18.5 12.1 22.9 10.0 10.7 19.4 11.5 18.7 26.5 8.6 9.6 9.5 8.1 7.0 8.9 30.8 18.2 9.9 19.8 18.1 6.9 0.7 7.2 2.4 13.5 7.4 17.5 12.8 18.3 15.4 10.2 12.5 27.1 19.7 1.1 17.7 6.3 8.5 22.7 12.9 24.2 26.2 19.2 33.7 22.7 22.2 28.1 28.3 37.4 17.7 6.0 15.9 13.7 6.7 1.6 21.7 47.5 10.2 5.3 7.9 14.0 3.9 26.1 13.3 15.5 13.7 8.7 34.2 0.0 7.5 9.1 12.2 5.4 15.0 15.8 20.6 33.4 10.4 6.2 5.3 24.3 10.3 5.6 3.3 11.8 18.1 18.3 14.3 17.3 8.1 25.8 16.8 6.5 6.6 23.8 10.1 2.4 13.6 6.9 11.8 4.7 MPIG6B "C6orf25, G6b, G6b-B, NG31" ENSG00000204420 "Megakaryocyte and platelet inhibitory receptor G6b" O95866 6 31718594-31726714 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.2" "Cell type enriched" "Detected in single" 30 "granulocytes: 9.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NK-cell: 3.0;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.8;NK-cells: 3.0" "Cell line enriched" "Detected in single" 17 "HEL: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA054404, HPA073017" Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 7400000 "Golgi apparatus" "Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA054404: , HPA073017: AB_2686566" "unprognostic (1.45e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (6.53e-2)" "unprognostic (3.53e-2)" "unprognostic (2.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (1.82e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-2)" "unprognostic (1.71e-2)" 0.8 0.2 0.0 1.2 0.5 5.3 0.7 0.1 0.4 1.0 0.9 0.0 0.0 0.9 1.0 0.8 2.0 0.7 1.5 7.4 0.2 0.0 0.4 0.5 7.6 2.8 1.0 0.0 2.7 0.2 0.2 0.2 1.4 0.7 0.9 0.2 1.1 1.8 0.3 1.2 10.5 0.8 1.9 0.6 33.2 0.4 2.7 0.1 1.2 1.0 1.4 0.8 1.6 1.6 0.2 1.8 0.5 0.1 3.0 0.1 5.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.5 3.0 0.1 1.8 0.0 5.7 0.0 0.5 0.1 0.4 0.2 0.0 1.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MPP2 "DKFZp761D0712, DLG2" ENSG00000108852 "Membrane palmitoylated protein 2" Q14168 17 43875357-43909711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.3;epididymis: 31.0;parathyroid gland: 31.1" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 89.3;Early spermatids: 63.3;Horizontal cells: 33.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 14 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "T-47d: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026486, HPA073483" Enhanced Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA026486: AB_1854085, HPA073483: " "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (1.30e-5)" "prognostic unfavorable (1.87e-4)" "unprognostic (4.37e-2)" "unprognostic (2.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.34e-1)" "unprognostic (1.25e-1)" "unprognostic (3.69e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.72e-2)" "unprognostic (4.93e-2)" "unprognostic (1.85e-1)" "unprognostic (7.23e-2)" "unprognostic (6.89e-4)" 2.1 5.0 12.1 2.1 11.8 1.1 3.1 19.5 26.3 3.5 5.1 19.8 2.7 1.9 4.6 31.0 4.1 3.3 3.0 9.0 13.8 14.2 2.0 0.9 2.0 1.2 15.3 14.4 2.8 4.4 31.1 8.4 3.4 11.5 7.1 2.0 6.5 2.3 10.7 1.7 2.0 2.0 6.5 20.3 1.3 2.5 13.8 12.3 0.0 4.5 0.0 1.4 3.6 2.8 0.1 0.0 0.0 0.1 0.0 1.9 0.7 4.9 7.2 7.8 11.3 1.1 0.7 4.3 1.7 0.2 6.8 6.4 2.5 3.3 7.1 4.0 1.7 8.7 2.0 10.5 4.1 5.3 0.0 8.0 0.6 6.7 0.1 0.2 0.0 2.1 1.1 0.3 4.9 0.0 3.8 0.4 11.6 2.6 0.0 2.0 1.9 1.0 0.5 14.0 0.6 4.5 5.0 11.2 0.5 0.1 0.1 8.4 7.8 2.1 0.7 2.9 7.3 17.2 3.4 0.1 7.5 9.6 2.9 3.1 2.4 4.9 0.0 11.4 4.8 1.4 0.0 0.1 0.0 1.4 0.0 0.2 0.0 0.5 1.2 0.0 0.1 1.6 1.9 0.0 0.0 0.0 0.0 0.1 0.7 12.1 11.8 19.5 22.5 13.8 14.2 15.3 14.4 11.5 12.3 0.0 0.0 0.0 1.5 0.3 89.3 8.5 0.0 0.0 0.0 0.0 2.0 4.5 0.0 0.5 63.3 0.5 0.0 0.0 0.3 0.3 2.4 0.0 0.0 0.0 0.6 33.4 0.0 0.0 0.0 16.0 3.4 0.0 0.0 0.0 0.0 15.3 0.8 0.0 5.3 0.0 6.4 0.0 2.8 18.2 18.0 0.1 2.3 0.0 0.0 0.0 MPP3 DLG3 ENSG00000161647 "Membrane palmitoylated protein 3" Q13368 17 43800799-43833170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 24.5;Early spermatids: 39.4;Late spermatids: 56.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 46.7;pons and medulla: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.6;SCLC-21H: 13.3;T-47d: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021818, HPA024742" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021818: AB_1854086, HPA024742: AB_1854087" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (2.30e-2)" "unprognostic (2.23e-5)" "unprognostic (4.59e-3)" "unprognostic (5.63e-2)" "unprognostic (5.07e-6)" "unprognostic (2.01e-1)" "unprognostic (1.03e-2)" "unprognostic (3.43e-2)" "unprognostic (1.77e-1)" "unprognostic (1.84e-3)" "unprognostic (8.02e-11)" "unprognostic (9.98e-3)" "unprognostic (1.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.75e-2)" 5.1 2.0 4.8 2.1 2.9 0.6 5.1 46.7 5.2 3.3 1.7 2.2 4.5 1.4 3.5 4.0 3.0 2.7 5.4 12.3 2.7 5.0 2.1 1.2 7.4 1.3 3.0 1.5 1.7 5.9 3.0 2.6 2.1 13.0 3.0 1.1 1.7 1.6 4.3 1.5 2.4 1.3 3.5 2.5 2.2 4.3 3.7 1.1 0.0 1.7 0.9 1.4 1.6 4.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.6 3.1 0.8 0.8 1.8 1.4 0.0 1.6 0.6 1.2 0.7 1.2 1.9 0.0 0.6 1.3 0.8 1.5 1.2 2.3 1.8 0.0 1.6 1.5 3.7 0.7 0.1 0.0 0.1 0.9 3.1 2.1 6.6 3.7 1.6 0.3 0.9 0.0 0.6 0.9 0.0 0.0 0.8 0.7 1.2 0.0 1.0 0.4 4.4 0.6 13.3 3.5 0.8 2.8 0.5 1.1 7.1 1.6 1.4 3.5 3.3 0.9 3.0 0.9 0.4 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.8 2.9 46.7 3.3 2.7 5.0 3.0 1.5 13.0 1.1 11.9 2.6 0.0 5.5 3.5 1.9 24.5 7.6 0.0 6.8 1.8 0.0 0.1 0.0 3.4 39.4 2.7 0.7 0.0 1.2 0.5 2.6 4.8 1.1 0.9 0.9 9.5 1.2 1.3 0.0 56.6 3.4 2.8 1.7 2.8 0.9 0.8 2.2 3.1 2.5 0.3 1.9 6.5 4.1 0.7 1.9 2.4 0.1 0.0 1.7 2.5 MPP4 DLG6 ENSG00000082126 "Membrane palmitoylated protein 4" Q96JB8 2 201644870-201698694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 78.2" "Group enriched" "Detected in many" 41 "Cone photoreceptor cells: 1494.2;Rod photoreceptor cells: 807.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBF TERT88: 11.2;hTEC/SVTERT24-B: 10.5;LHCN-M2: 42.4;TIME: 8.4;U-87 MG: 11.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 8.1" HPA057393 Supported "Actin filaments,Cytosol" No No Cytosol "Actin filaments" "HPA057393: AB_2732612" "unprognostic (1.42e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-1)" "unprognostic (2.50e-2)" "unprognostic (2.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.09e-2)" "unprognostic (9.42e-2)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (1.19e-1)" "unprognostic (9.20e-2)" "unprognostic (3.33e-16)" "unprognostic (1.82e-2)" "unprognostic (8.23e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" 0.4 1.7 0.3 0.5 0.6 0.0 0.3 4.9 1.1 1.2 0.2 0.2 0.2 0.0 0.8 0.4 0.3 0.1 0.4 0.2 0.5 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.2 0.0 0.7 0.7 0.3 0.3 0.3 78.2 0.2 0.5 0.6 4.1 0.2 0.3 0.2 3.8 0.1 2.2 0.2 0.2 0.6 0.6 0.2 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 5.5 1.3 3.4 3.3 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.4 11.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 10.5 0.0 1.6 6.2 0.0 0.0 0.0 42.4 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.4 4.3 1.3 0.9 3.8 0.0 0.0 0.0 11.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 4.9 0.6 0.5 0.4 0.2 0.2 0.3 0.2 3.0 10.4 0.0 0.0 0.3 13.4 0.3 2.5 12.0 11.4 1.8 1494.2 0.1 0.0 0.2 2.9 0.1 0.0 0.0 0.2 0.0 0.3 0.0 3.5 0.0 0.1 17.5 0.0 0.0 0.3 2.1 0.0 0.3 1.7 0.0 0.0 28.2 0.1 0.0 0.0 0.0 807.6 0.0 1.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 MPP5 "FLJ12615, PALS1" ENSG00000072415 "Membrane palmitoylated protein 5" Q8N3R9 14 67241109-67335819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000993, HPA063890" Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000993: AB_1079407, HPA063890: AB_2732707" "unprognostic (3.65e-1)" "unprognostic (3.82e-3)" "unprognostic (4.56e-2)" "unprognostic (9.20e-2)" "unprognostic (9.86e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.93e-3)" "unprognostic (9.89e-3)" "prognostic favorable (1.71e-12)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (6.90e-2)" "unprognostic (6.87e-2)" 7.1 9.2 14.8 6.8 29.2 7.0 10.1 9.4 18.0 9.0 12.5 15.9 13.7 18.5 6.9 20.8 14.4 7.2 9.0 7.3 16.4 17.0 28.8 17.2 11.5 4.5 30.6 10.2 6.4 8.6 22.9 11.4 27.9 20.5 15.8 11.6 7.6 15.9 18.6 14.6 8.6 18.7 11.9 23.3 6.2 9.7 8.2 25.4 6.8 24.1 6.9 5.8 9.1 9.1 3.6 2.4 3.7 2.8 6.7 4.4 1.2 54.9 8.8 8.9 7.2 5.2 4.7 7.9 16.8 8.8 12.3 8.3 8.7 16.9 4.7 8.0 13.6 4.3 11.5 5.1 9.7 18.9 2.2 3.5 4.3 9.3 6.0 6.0 1.6 3.3 5.0 3.7 7.1 9.1 8.9 6.8 5.4 4.5 2.1 19.6 7.4 5.2 2.0 3.0 8.0 6.0 4.7 14.2 5.6 11.2 13.7 5.0 3.6 10.4 10.2 5.8 8.2 10.5 3.3 10.6 15.7 33.4 5.5 7.3 3.2 2.9 7.2 10.5 3.7 5.4 0.4 2.2 3.7 1.7 2.8 1.4 3.6 2.0 1.9 2.4 1.9 4.4 2.4 0.8 6.7 2.3 2.4 1.1 1.2 14.8 29.2 9.4 18.0 16.4 17.0 30.6 10.2 20.5 25.4 59.6 21.6 6.0 21.7 18.7 9.4 22.4 12.7 9.4 17.0 21.0 41.2 18.5 11.6 19.2 4.4 14.3 41.0 0.0 23.5 8.9 16.6 25.6 4.7 16.8 14.2 3.2 5.2 16.5 9.6 3.9 7.5 7.2 3.3 7.2 18.4 24.1 20.2 31.6 10.6 28.4 34.5 6.5 19.6 8.3 33.8 15.2 14.6 4.4 19.5 31.5 MPRIP "M-RIP, p116Rip, RHOIP3" ENSG00000133030 "Myosin phosphatase Rho interacting protein" Q6WCQ1 17 17042545-17217679 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 27.5" "Lineage enriched" "Detected in all" 6 "T-cells: 27.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022034, HPA022901" Enhanced Supported "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA022034: AB_1854093, HPA022901: AB_2297761" "unprognostic (1.92e-2)" "unprognostic (1.53e-3)" "unprognostic (5.81e-3)" "unprognostic (9.92e-3)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (4.19e-1)" "unprognostic (3.55e-2)" "unprognostic (5.18e-2)" "unprognostic (9.01e-3)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (6.56e-2)" "unprognostic (2.38e-1)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (5.04e-2)" 46.5 38.7 46.7 33.7 58.8 27.7 47.4 47.7 62.0 48.4 35.3 45.8 31.9 36.1 54.9 40.9 51.6 32.9 38.2 63.7 46.9 39.7 30.2 31.3 40.2 34.5 46.8 44.9 33.5 46.6 55.0 35.8 37.4 36.5 33.4 29.0 41.0 34.0 46.8 66.7 35.1 32.9 63.0 38.2 35.3 45.9 31.4 47.7 19.9 38.4 30.1 35.4 39.8 55.3 4.4 4.8 1.5 1.2 1.9 27.5 5.0 59.7 43.8 18.8 15.4 20.0 15.0 28.3 30.9 21.3 24.4 18.3 33.9 44.0 23.5 31.8 45.2 20.0 57.4 23.8 41.0 25.7 24.2 12.6 12.8 37.6 11.9 13.5 6.7 10.2 14.3 24.8 27.3 21.1 34.9 25.1 17.6 7.9 13.3 39.0 19.7 27.4 23.0 9.1 56.9 50.5 24.4 30.6 8.7 18.6 27.5 10.8 17.6 32.8 26.9 14.7 80.2 12.6 10.6 24.3 22.8 25.8 60.4 52.7 10.4 8.2 10.9 41.2 12.2 54.3 1.1 1.2 1.5 4.5 0.8 9.2 4.4 17.5 7.3 1.1 3.8 12.6 6.0 0.5 1.9 0.8 4.8 27.5 5.0 46.7 58.8 47.7 62.0 46.9 39.7 46.8 44.9 36.5 47.7 29.8 40.0 22.0 18.6 24.0 107.8 52.3 38.2 24.1 31.8 24.4 76.6 22.0 3.3 28.6 25.8 47.2 27.1 23.3 24.7 31.0 37.5 32.3 16.1 17.5 10.5 92.2 21.8 33.7 9.4 22.6 27.0 15.1 30.4 1.8 17.1 26.6 59.6 23.0 40.7 7.3 45.9 77.6 90.5 19.2 26.5 24.0 26.5 24.9 25.9 105.7 MPST "MST, TST2, TUM1" ENSG00000128309 "Mercaptopyruvate sulfurtransferase" P25325 22 37019635-37029822 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 106.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 780.2;Hepatocytes: 473.7;Paneth cells: 550.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001240 Enhanced Approved Mitochondria,Cytosol NA NA 2800000 Mitochondria Cytosol "HPA001240: AB_1079408" "unprognostic (7.18e-3)" "unprognostic (4.45e-1)" "unprognostic (1.80e-1)" "unprognostic (1.30e-3)" "unprognostic (1.73e-3)" "unprognostic (1.43e-1)" "unprognostic (7.07e-2)" "unprognostic (2.15e-1)" "unprognostic (2.22e-1)" "unprognostic (1.35e-1)" "unprognostic (2.25e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-3)" "unprognostic (3.98e-2)" "unprognostic (3.51e-1)" "unprognostic (2.52e-1)" "prognostic favorable (5.89e-4)" 8.7 7.2 4.5 6.8 6.4 10.5 22.7 2.6 5.4 8.8 39.1 8.0 2.8 36.8 6.1 3.0 19.8 4.3 15.3 14.1 4.6 2.3 14.1 106.2 10.3 5.4 8.8 3.8 12.6 20.7 0.7 2.7 4.2 5.6 6.6 5.7 3.8 13.4 3.9 11.5 15.9 33.7 4.8 4.8 4.1 12.8 24.9 7.1 2.1 6.3 6.2 5.1 8.7 11.6 9.6 37.1 18.5 26.5 28.8 16.1 12.5 14.3 17.0 8.3 17.1 9.8 6.1 13.2 7.8 7.1 8.6 11.5 16.2 6.4 22.6 11.4 5.6 5.7 10.1 7.2 11.4 1.2 13.6 40.3 8.7 7.4 38.0 31.0 9.4 12.2 10.6 22.2 5.6 5.2 7.9 17.3 11.2 15.5 6.6 2.3 11.1 0.8 32.0 15.7 18.8 17.7 24.3 9.9 16.8 8.6 4.7 4.2 32.0 5.2 8.3 14.9 4.4 8.9 15.2 13.3 7.4 21.0 8.1 5.3 11.6 5.3 6.8 2.6 11.5 3.7 15.3 26.5 18.5 11.8 9.4 16.1 9.6 7.7 9.9 37.1 9.6 1.1 4.1 7.9 28.8 4.3 6.0 15.2 12.5 4.5 6.4 2.6 5.4 4.6 2.3 8.8 3.8 5.6 7.1 32.8 55.2 24.6 70.3 72.5 4.6 26.6 188.5 1.4 19.4 57.6 0.0 50.1 112.7 124.1 138.8 35.9 780.2 116.8 129.7 102.0 53.0 67.5 17.3 473.7 65.5 3.2 104.3 84.7 67.1 60.3 84.3 59.9 55.6 57.7 299.4 16.4 119.7 550.6 79.5 318.0 2.6 45.3 28.3 7.9 12.0 133.6 41.9 42.6 311.7 103.6 MRAS "M-RAs, R-RAS3, RRAS3" ENSG00000158186 "Muscle RAS oncogene homolog" O14807 3 138347648-138405534 "Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 69.1" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 103.5;Distal tubular cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 18.9" "Lineage enriched" "Detected in many" 9 "monocytes: 18.9" "Cell line enhanced" "Detected in many" "ASC diff: 29.2;BJ: 31.3;EFO-21: 39.0;fHDF/TERT166: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042728 Approved Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA042728: AB_10796582" "unprognostic (1.96e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.69e-1)" "unprognostic (5.32e-2)" "unprognostic (8.96e-2)" "unprognostic (3.85e-3)" "unprognostic (1.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (3.18e-3)" "unprognostic (1.78e-2)" "unprognostic (6.25e-2)" "unprognostic (2.21e-1)" "unprognostic (4.23e-2)" 49.3 32.6 32.0 6.4 37.6 1.3 17.7 12.3 37.3 6.4 5.4 9.4 1.7 2.3 11.9 5.2 5.1 6.8 8.6 69.1 29.0 23.9 8.9 3.7 8.9 3.3 31.3 18.0 17.2 3.4 7.6 4.7 6.9 25.2 7.6 3.4 8.2 8.0 12.0 22.5 2.7 2.7 16.9 21.5 7.3 3.4 5.9 19.3 0.0 12.1 2.4 2.8 10.0 6.4 0.0 2.1 0.3 18.9 0.6 0.0 0.5 0.2 2.5 6.7 8.8 29.2 13.4 13.9 31.3 7.9 3.2 3.9 1.1 1.0 0.1 39.0 30.6 8.3 0.0 3.3 0.7 2.5 2.7 1.0 0.1 1.6 6.4 7.4 0.0 0.6 19.2 3.0 0.2 0.5 5.9 0.5 0.0 3.5 0.2 14.4 1.1 0.0 7.6 7.3 0.0 0.9 0.3 12.2 0.0 14.1 0.6 7.0 15.5 20.5 0.2 16.4 5.0 6.0 15.2 0.1 8.2 9.3 8.9 0.8 0.0 0.3 0.3 8.3 0.0 4.5 0.1 1.6 0.0 0.0 3.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.6 18.9 0.1 0.0 0.5 32.0 37.6 12.3 28.9 29.0 23.9 31.3 18.0 25.2 19.3 8.9 1.0 0.5 2.6 1.9 4.1 103.5 5.1 1.4 4.5 8.7 9.8 16.8 49.7 8.5 9.6 16.3 0.0 0.0 2.7 2.0 11.9 1.9 5.8 1.5 26.7 27.0 1.7 8.6 13.8 26.2 21.6 13.8 27.0 15.4 0.0 15.8 4.3 0.0 32.2 23.1 10.4 6.5 19.8 4.6 11.9 0.9 12.0 0.0 0.0 0.5 MRI1 "MGC3207, MRDI, mtnA, Ypr118w" ENSG00000037757 "Methylthioribose-1-phosphate isomerase 1" Q9BV20 19 13764532-13774282 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042744, CAB045988" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No 2600000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "CAB045988: AB_2145566, HPA042744: AB_2678141" "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-3)" "unprognostic (1.61e-1)" "unprognostic (8.98e-2)" "unprognostic (1.50e-3)" "unprognostic (1.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.77e-1)" "unprognostic (1.28e-1)" 14.5 18.5 12.5 21.8 18.3 16.6 16.8 24.5 21.8 21.5 17.2 23.6 23.5 19.0 24.2 21.3 20.7 19.9 17.6 13.5 14.6 12.1 24.4 20.1 15.4 19.5 16.5 14.3 24.0 20.5 21.3 17.3 24.2 17.2 17.8 13.4 18.5 23.4 21.6 13.0 28.6 18.5 13.3 16.6 22.0 19.8 5.0 16.7 20.0 21.8 10.5 18.2 18.1 20.6 5.7 8.9 6.9 5.8 5.0 6.6 3.6 10.7 8.0 4.0 9.6 4.4 8.2 9.8 12.8 7.4 11.6 10.6 8.4 8.6 5.8 5.1 4.7 5.5 18.1 18.6 13.2 7.1 10.1 32.2 4.6 12.7 9.0 3.9 13.9 10.8 8.2 7.3 5.9 4.7 10.5 10.7 5.7 8.8 0.3 5.0 15.8 15.4 8.9 6.6 3.9 22.9 14.5 5.4 13.1 5.9 8.4 8.0 7.2 4.6 10.5 10.0 5.6 8.2 5.1 6.5 6.0 5.5 21.2 6.2 7.9 8.3 1.7 5.1 16.1 7.1 6.9 5.5 1.9 6.2 5.8 6.0 5.0 5.3 6.6 4.7 5.7 4.3 3.3 4.1 5.0 3.2 8.9 4.8 3.6 12.5 18.3 24.5 21.8 14.6 12.1 16.5 14.3 17.2 16.7 8.9 16.6 10.8 9.0 9.8 3.1 0.8 5.1 20.1 14.8 15.7 7.9 10.1 5.0 8.2 0.6 6.0 9.1 0.0 11.0 7.7 8.5 6.0 12.7 9.0 6.3 1.6 8.7 12.3 8.9 1.4 16.1 8.5 1.7 6.4 9.4 3.3 5.8 11.0 14.2 8.1 6.3 25.8 5.5 0.4 3.9 9.9 4.5 14.4 9.1 8.0 MRNIP "C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537" ENSG00000161010 "MRN complex interacting protein" Q6NTE8 5 179835133-179862173 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 54.9;Club cells: 21.6;Distal tubular cells: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043975 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043975: AB_2678754" "unprognostic (4.97e-2)" "unprognostic (2.79e-1)" "unprognostic (7.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (5.15e-3)" "unprognostic (1.68e-3)" "unprognostic (2.51e-2)" "unprognostic (1.10e-1)" "unprognostic (6.11e-2)" "unprognostic (3.63e-3)" "unprognostic (2.05e-2)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (7.00e-2)" "unprognostic (1.43e-3)" 6.6 6.3 11.8 10.7 12.2 4.6 10.8 30.0 16.1 14.8 8.5 14.2 14.3 7.8 13.7 16.1 4.8 23.5 7.7 7.8 12.6 11.8 8.8 6.0 8.8 14.1 16.0 13.4 21.1 9.7 11.2 22.7 5.0 12.1 11.1 8.4 12.9 9.1 19.8 5.8 12.0 11.0 11.7 10.1 13.3 7.1 8.0 14.7 2.7 11.6 3.5 14.0 8.6 10.5 10.7 5.5 2.9 1.0 4.0 8.1 2.8 1.3 2.8 4.5 10.9 9.1 8.2 5.4 3.2 2.8 4.0 5.8 4.6 4.2 5.2 3.8 1.5 1.9 3.5 5.0 10.3 3.1 4.9 5.0 1.7 4.9 3.2 5.6 2.2 2.1 6.1 8.3 4.6 3.6 3.2 4.4 5.4 2.5 2.5 4.1 5.3 3.4 2.2 2.2 1.6 2.5 4.1 1.7 3.8 7.1 1.0 8.5 2.7 1.5 4.4 3.7 3.7 5.5 1.8 1.0 2.5 2.0 1.9 2.2 3.0 1.8 3.6 2.4 3.6 1.7 1.3 0.7 2.9 3.4 0.7 4.5 10.7 5.1 4.2 0.9 10.3 8.1 5.9 1.1 4.0 1.0 5.5 2.9 2.8 11.8 12.2 30.0 16.1 12.6 11.8 16.0 13.4 12.1 14.7 14.9 14.1 0.0 0.0 0.0 0.0 0.0 0.0 54.9 21.6 17.4 0.0 8.6 39.7 3.6 0.0 0.0 0.0 0.0 2.0 5.9 0.0 0.0 10.5 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 3.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 MROH1 "HEATR7A, KIAA1833" ENSG00000179832 "Maestro heat like repeat family member 1" Q8NDA8 8 144148016-144261940 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024287, HPA044465" Approved Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024287: , HPA044465: AB_10960985" "unprognostic (1.25e-1)" "unprognostic (4.85e-2)" "unprognostic (1.38e-1)" "prognostic favorable (6.74e-4)" "unprognostic (2.97e-2)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (4.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.48e-2)" "unprognostic (6.64e-2)" "unprognostic (1.92e-1)" "prognostic favorable (3.65e-6)" "unprognostic (1.61e-3)" "unprognostic (1.97e-1)" "unprognostic (1.68e-1)" "unprognostic (1.48e-2)" 5.7 7.5 11.9 7.6 10.0 19.7 6.1 17.8 16.0 6.0 8.5 4.5 13.0 16.7 5.4 7.3 9.2 6.8 7.0 5.4 7.0 6.0 8.3 5.8 9.4 8.1 5.2 11.7 5.1 17.3 5.4 11.1 8.3 10.3 9.0 4.5 6.9 14.3 9.8 5.2 13.4 14.3 6.5 3.9 11.5 14.0 7.5 5.0 5.2 33.3 3.9 7.5 8.5 6.6 1.9 5.5 4.4 9.5 1.1 5.6 2.8 9.8 4.1 0.5 4.0 1.9 2.1 18.0 4.4 3.1 2.4 3.4 6.9 17.9 5.3 6.4 2.5 6.0 9.5 0.6 6.7 1.1 3.0 5.8 6.3 12.0 6.2 4.9 2.8 6.7 3.8 7.0 3.9 5.7 2.9 3.5 4.3 2.6 2.4 2.7 21.2 4.8 5.9 1.5 6.8 19.4 6.3 1.3 5.4 3.6 19.7 4.5 3.9 11.0 10.6 3.3 1.6 7.8 3.9 8.7 5.0 9.5 10.1 3.6 4.2 2.0 5.6 9.8 8.5 2.9 4.4 7.4 1.9 2.4 9.5 1.9 1.1 2.1 2.5 5.5 1.9 2.0 1.4 1.5 1.1 7.9 1.7 5.6 2.8 11.9 10.0 17.8 16.0 7.0 6.0 5.2 11.7 10.3 5.0 8.9 29.5 3.9 7.0 5.6 34.8 9.5 2.5 9.4 15.9 5.2 11.8 23.8 3.3 10.4 3.8 5.8 32.2 0.0 14.2 16.8 5.9 13.3 13.9 7.6 17.4 35.0 22.5 3.1 11.3 9.9 2.8 12.0 1.7 8.2 20.3 6.7 14.9 14.4 2.5 4.9 3.5 6.5 5.8 9.3 14.5 5.1 41.9 5.7 18.1 10.6 MROH2A HEATR7B1 ENSG00000185038 "Maestro heat like repeat family member 2A" A6NES4 2 233775679-233833423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 1.8;testis: 5.0;thyroid gland: 5.1" "Cell type enhanced" "Detected in single" 13 "Spermatocytes: 1.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RT4: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA052107 Uncertain Uncertain Cytosol NA NA Cytosol "HPA052107: AB_2681729" "unprognostic (7.00e-2)" "unprognostic (3.37e-3)" "unprognostic (4.77e-1)" "unprognostic (1.65e-2)" "unprognostic (4.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.87e-1)" "unprognostic (4.41e-2)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (4.32e-2)" "unprognostic (5.05e-2)" "unprognostic (4.06e-9)" "unprognostic (5.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 5.0 5.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 11.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.0 0.0 0.0 0.1 MRPS16 CGI-132 ENSG00000182180 "Mitochondrial ribosomal protein S16" Q9Y3D3 10 73248843-73252693 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050081, HPA054538" Supported Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA050081: AB_2681007, HPA054538: AB_2682519" "unprognostic (9.19e-2)" "unprognostic (5.19e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.23e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (1.68e-2)" "unprognostic (6.44e-2)" "unprognostic (2.98e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.20e-1)" "unprognostic (5.84e-2)" 16.6 28.4 16.4 16.9 15.8 15.8 28.6 12.6 26.6 13.3 22.1 12.4 18.0 20.8 16.3 16.8 22.7 16.5 20.8 42.2 17.6 15.7 23.4 35.1 17.7 30.0 16.2 16.0 16.5 37.0 15.7 15.5 17.0 15.9 15.4 21.1 14.4 18.4 19.0 53.2 16.8 18.4 18.0 14.7 18.4 18.3 13.7 9.8 32.7 16.9 26.1 20.1 15.5 13.9 30.0 28.3 17.0 24.2 17.7 22.3 24.3 22.8 33.1 12.8 16.9 10.3 8.4 18.8 10.6 18.5 14.8 15.4 39.2 22.5 27.7 11.8 11.1 13.4 21.4 14.7 21.1 9.3 15.6 14.4 17.4 17.9 29.6 17.4 22.5 15.6 12.7 16.1 15.1 36.3 12.9 16.1 24.5 25.5 15.6 15.3 25.4 24.2 20.8 15.5 15.1 62.2 22.0 17.2 20.0 15.5 13.7 8.6 15.9 12.1 50.0 23.2 8.2 35.2 12.0 12.7 14.1 24.6 15.2 20.5 23.4 24.8 21.6 15.4 26.2 9.5 16.7 22.7 17.0 19.0 24.2 20.5 28.7 20.8 17.8 18.5 30.0 22.3 19.6 10.4 17.7 19.1 28.3 20.6 24.3 16.4 15.8 12.6 26.6 17.6 15.7 16.2 16.0 15.9 9.8 6.0 25.9 52.8 58.4 31.1 26.8 89.2 63.7 37.5 47.8 45.4 29.5 103.9 210.5 89.2 46.6 48.4 69.2 23.3 103.5 134.8 44.9 77.2 30.0 123.8 134.2 19.1 52.3 41.7 57.2 29.0 57.5 59.6 62.4 83.0 89.7 45.0 115.2 38.6 39.3 179.3 33.2 0.0 45.3 128.1 75.4 38.6 89.4 44.9 103.6 86.7 MRPS35 "MDS023, MRPS28" ENSG00000061794 "Mitochondrial ribosomal protein S35" P82673 12 27710773-27756295 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 205.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038513 Supported Approved Mitochondria,Cytosol No No Mitochondria Cytosol "HPA038513: AB_10794084" "prognostic unfavorable (9.41e-4)" "unprognostic (8.35e-2)" "prognostic favorable (5.01e-4)" "unprognostic (2.59e-2)" "unprognostic (5.31e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (7.32e-2)" "unprognostic (2.12e-3)" "unprognostic (2.05e-1)" "unprognostic (3.24e-2)" "unprognostic (7.19e-2)" "prognostic favorable (1.51e-5)" "unprognostic (4.63e-2)" "unprognostic (2.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.25e-1)" 18.3 32.3 21.0 19.4 22.4 14.2 23.2 21.2 25.7 14.0 31.0 16.3 18.5 27.7 17.1 17.6 25.0 16.1 20.5 31.9 19.5 20.6 42.2 52.1 15.9 20.2 20.1 19.4 17.3 18.4 18.2 11.9 18.8 24.4 17.5 33.2 11.9 17.6 14.8 46.3 15.1 24.5 19.9 18.1 17.3 23.1 13.5 13.5 19.3 28.9 27.6 18.5 17.8 14.3 12.4 17.4 4.2 24.8 14.2 14.7 12.6 23.6 26.0 10.9 16.7 15.7 19.2 40.8 15.8 13.5 22.1 20.2 31.9 33.9 22.1 23.3 16.0 17.2 17.9 22.6 19.9 26.0 18.8 22.3 25.0 11.0 25.8 15.6 34.0 13.4 16.3 24.8 18.6 37.6 20.3 17.8 18.8 27.3 15.2 20.0 14.4 23.9 56.5 41.3 58.3 39.1 25.4 28.5 36.3 33.9 19.5 6.3 12.7 21.7 33.9 26.3 25.6 34.6 27.1 13.9 13.5 14.6 30.6 28.0 6.0 9.0 47.7 18.0 26.3 17.6 4.2 12.2 4.1 9.3 21.4 14.5 12.4 11.7 11.3 17.4 11.9 13.9 12.4 0.7 14.2 24.8 8.1 14.7 12.6 21.0 22.4 21.2 25.7 19.5 20.6 20.1 19.4 24.4 13.5 68.5 32.3 38.3 32.8 42.0 19.5 84.0 50.9 89.7 45.5 48.8 3.9 92.7 205.6 67.5 9.7 23.4 54.6 0.0 51.8 95.3 26.6 44.8 53.1 52.9 64.9 17.5 57.9 16.5 31.2 5.0 23.6 48.6 40.5 65.9 65.4 26.2 51.0 42.1 23.0 153.4 13.6 25.8 33.1 24.4 24.8 45.7 51.6 29.9 92.5 38.4 MRVI1 "IRAG, JAW1L" ENSG00000072952 "Murine retrovirus integration site 1 homolog" Q9Y6F6 11 10573091-10693988 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Peritubular cells: 82.0;Sertoli cells: 51.8;Smooth muscle cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 18.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 18.5" "Cell line enhanced" "Detected in some" "ASC diff: 18.0;BJ: 12.7;BJ hTERT+: 14.7;fHDF/TERT166: 5.7;REH: 5.5" "Region enriched" "Detected in many" 5 "thalamus: 8.3" "Low region specificity" "Detected in many" HPA008704 Uncertain Approved "Nuclear bodies,Cytosol" NA NA 280000 Cytosol "Nuclear bodies" "HPA008704: AB_1079413" "unprognostic (2.18e-1)" "unprognostic (3.40e-2)" "unprognostic (2.86e-3)" "prognostic favorable (5.78e-4)" "unprognostic (5.30e-1)" "unprognostic (3.37e-3)" "unprognostic (1.04e-2)" "unprognostic (1.87e-1)" "unprognostic (5.63e-3)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (3.72e-2)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-3)" 15.7 6.3 19.4 12.4 22.0 1.5 6.6 4.4 13.7 31.6 26.7 15.5 10.7 6.3 42.1 17.1 27.1 19.6 23.2 6.3 13.8 12.0 5.3 1.7 5.5 2.9 21.3 10.6 16.4 1.9 2.8 1.8 8.7 18.2 24.8 12.9 37.6 3.3 29.0 4.1 4.0 9.4 47.3 12.1 3.5 16.4 8.3 10.3 0.0 4.5 2.3 1.8 27.3 10.4 0.7 0.4 18.5 4.1 0.0 0.0 0.5 0.1 0.0 3.6 0.0 18.0 3.5 0.1 12.7 14.7 0.0 0.0 0.3 1.4 0.0 0.1 5.7 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.6 0.0 0.1 0.2 0.0 0.2 4.1 0.3 0.0 0.1 0.0 1.0 0.0 0.5 0.1 0.2 0.0 0.1 0.3 0.4 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 2.6 0.0 2.2 0.0 3.9 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.9 0.0 0.6 1.7 1.2 0.0 2.9 0.0 0.5 0.0 0.0 0.4 0.7 0.0 0.0 18.5 0.0 4.1 0.1 0.0 0.5 19.4 22.0 4.4 13.2 13.8 12.0 21.3 10.6 18.2 10.3 0.0 4.5 0.5 0.3 1.8 6.8 6.1 0.0 0.0 2.3 0.0 3.9 0.3 1.7 0.0 25.8 1.6 0.0 0.0 0.0 0.1 3.1 0.3 1.1 0.0 8.4 7.9 0.0 3.1 12.0 23.3 19.8 2.1 1.7 0.0 0.0 2.1 0.0 0.0 82.0 0.0 1.0 51.8 82.4 1.7 2.2 1.6 1.4 0.0 0.0 0.6 MS4A12 "FLJ20217, Ms4a10" ENSG00000071203 "Membrane spanning 4-domains A12" Q9NXJ0 11 60492778-60507430 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "intestine: 64.7;lymphoid tissue: 28.6" "Group enriched" "Detected in some" 6 "Enterocytes: 108.9;Paneth cells: 59.6" "Cancer enriched" "Detected in some" 8 "colorectal cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.6;LHCN-M2: 2.2;NTERA-2: 3.1;RH-30: 4.3;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048616, HPA057657" Enhanced Approved "Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli, Endoplasmic reticulum, Golgi apparatus" "HPA048616: , HPA057657: AB_2683491" "unprognostic (2.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.49e-1)" "unprognostic (3.26e-1)" "unprognostic (2.83e-1)" "unprognostic (9.20e-3)" 0.1 0.0 0.1 28.6 0.1 0.0 0.1 0.1 0.1 0.1 57.7 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 64.7 0.1 0.1 0.1 0.1 0.0 0.2 1.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.1 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 1.8 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 108.9 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 59.6 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 13.2 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756953-60776732 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 9.9;lung: 32.4" "Cell type enriched" "Detected in some" 8 "Alveolar cells type 1: 89.3" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 9.9" "Lineage enriched" "Detected in single" 15 "T-cells: 9.9" "Cell line enhanced" "Detected in some" "HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7" "Region enriched" "Detected in single" 28 "olfactory region: 205.0" "Region enriched" "Detected in single" 30 "olfactory region: 39.1" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.3 0.3 0.3 0.0 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 1.8 0.3 0.4 1.0 0.3 0.3 0.3 0.2 0.3 0.3 32.4 0.3 0.3 0.3 2.4 0.3 0.0 0.3 1.1 0.3 0.3 0.5 0.3 0.3 1.9 0.3 0.2 1.4 1.7 0.3 0.3 0.2 0.6 0.3 0.3 0.3 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 9.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.4 1.6 3.8 0.0 0.0 4.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.0 13.5 5.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.9 0.5 0.0 0.0 1.8 0.7 0.0 0.6 0.0 0.0 9.9 0.7 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 89.3 4.8 0.0 0.0 0.0 0.0 0.2 0.0 2.7 11.4 0.0 0.0 0.7 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.0 0.0 0.0 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071128 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 196.2;bone marrow: 105.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.6" "Cell type enriched" "Detected in single" 1061 "basophil: 196.2" "Lineage enriched" "Detected in single" 1963 "granulocytes: 196.2" "Group enriched" "Detected in some" 4 "HEL: 37.1;K-562: 31.7;NB-4: 25.7;THP-1: 75.0;U-937: 29.6" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.2 0.0 0.1 0.1 0.3 105.4 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 14.7 0.1 0.1 0.1 0.5 6.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.1 8.6 0.0 1.0 0.0 7.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 196.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 9.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.6 0.0 196.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MSI1 ENSG00000135097 "Musashi RNA binding protein 1" O43347 12 120341330-120369180 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 27.3;skeletal muscle: 23.2" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 51.1;Early spermatids: 46.0;Late spermatids: 40.7;Muller glia cells: 68.3;Rod photoreceptor cells: 92.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 43.8;HAP1: 20.0;NTERA-2: 22.8;SCLC-21H: 32.5;SH-SY5Y: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074923, HPA075573" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074923: , HPA075573: " "unprognostic (1.21e-1)" "unprognostic (3.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (3.89e-1)" "unprognostic (3.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.75e-2)" "prognostic favorable (5.99e-4)" "unprognostic (3.66e-1)" "unprognostic (1.46e-3)" "unprognostic (7.61e-2)" "unprognostic (7.35e-2)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" 0.8 6.8 8.7 0.6 7.4 0.4 1.2 3.9 14.2 1.9 1.5 8.6 2.2 7.8 4.3 2.7 1.5 3.1 1.4 4.0 11.3 5.9 0.7 1.0 1.0 0.6 4.7 6.1 2.9 7.3 1.3 12.8 1.4 4.6 4.5 1.5 27.3 1.3 2.5 23.2 0.5 5.2 2.2 4.7 0.7 3.1 12.5 5.4 0.0 1.3 0.0 0.4 0.9 0.9 0.1 0.4 0.6 0.2 0.2 0.3 0.0 0.0 0.5 43.8 11.1 0.0 0.0 5.6 0.0 0.0 0.3 0.5 7.7 0.2 0.0 0.6 0.0 0.2 0.1 20.0 0.0 0.1 0.2 4.5 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.1 22.8 0.2 0.2 0.1 0.0 0.1 0.0 0.0 32.5 15.8 0.0 0.3 0.3 4.4 6.7 0.0 0.0 0.1 6.0 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.6 0.2 0.2 0.4 0.1 0.0 8.7 7.4 3.9 7.2 11.3 5.9 4.7 6.1 4.6 5.4 0.0 0.0 0.0 1.0 0.9 20.9 2.6 0.0 0.0 0.0 0.0 51.1 0.0 1.7 1.0 46.0 0.3 0.5 0.0 4.5 0.5 0.5 5.5 0.0 0.0 0.1 3.2 9.7 0.0 0.0 40.7 0.3 0.0 0.0 1.0 0.7 68.3 2.0 5.5 0.4 0.0 92.6 12.9 2.1 7.0 1.3 0.0 0.3 0.0 2.5 0.3 MSI2 ENSG00000153944 "Musashi RNA binding protein 2" Q96DH6 17 57255851-57684685 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Cone photoreceptor cells: 710.8;Rod photoreceptor cells: 517.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022300, HPA068990" Approved Supported Cytosol NA NA Cytosol "CAB022300: , HPA068990: " "unprognostic (4.73e-2)" "unprognostic (2.28e-1)" "unprognostic (3.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.12e-1)" "unprognostic (1.08e-1)" "unprognostic (4.20e-2)" "unprognostic (2.20e-2)" "unprognostic (4.89e-2)" "unprognostic (2.96e-1)" "unprognostic (4.17e-2)" "unprognostic (1.18e-1)" "prognostic favorable (9.22e-8)" "prognostic favorable (2.00e-4)" "unprognostic (4.87e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-3)" 3.4 34.7 20.0 22.4 21.5 8.4 8.8 18.0 25.3 9.7 14.4 7.7 14.2 5.0 6.7 36.3 4.6 11.1 23.5 28.5 13.9 16.9 18.0 3.6 6.9 9.6 21.0 6.4 22.8 6.1 41.4 23.1 10.7 19.7 10.5 7.4 14.6 9.8 48.5 25.6 3.6 5.4 4.6 14.8 8.7 7.7 7.5 9.5 23.7 12.4 8.4 8.6 11.6 5.0 1.9 3.0 4.8 1.5 1.9 4.1 0.5 3.4 5.9 20.4 7.9 2.3 2.2 16.1 3.9 4.5 5.1 3.1 7.0 5.9 16.1 13.7 2.4 4.1 3.4 13.0 5.2 9.5 22.4 9.1 7.0 13.1 16.1 5.1 7.7 7.2 2.8 6.8 0.6 8.3 6.4 5.2 12.9 15.3 12.1 17.9 8.1 34.8 2.1 7.4 17.5 9.5 48.9 30.6 12.7 12.4 22.6 22.7 42.3 6.3 6.0 18.1 9.8 10.8 6.0 6.6 3.2 8.5 2.8 6.6 16.9 14.2 19.6 8.5 4.7 19.6 4.4 0.4 4.8 2.0 0.3 1.5 1.9 1.9 1.8 0.6 1.1 1.8 1.7 0.4 1.9 1.5 3.0 4.1 0.5 20.0 21.5 18.0 25.3 13.9 16.9 21.0 6.4 19.7 9.5 6.0 26.6 60.1 59.4 21.3 190.2 86.4 56.0 93.7 29.6 71.5 710.8 98.4 104.5 41.8 12.8 24.4 15.3 23.3 12.7 17.2 28.6 73.1 40.5 25.1 17.3 278.1 94.3 28.8 11.1 19.3 59.8 13.2 37.1 1.8 48.0 265.7 11.1 17.5 72.9 43.4 517.0 12.9 27.8 3.9 4.5 14.1 124.8 44.8 33.3 79.0 MSL2 "FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184" ENSG00000174579 "MSL complex subunit 2" Q9HCI7 3 136148922-136197241 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003413 Uncertain Approved Nucleoplasm,Cytosol NA No "Nucleoplasm, Cytosol" "HPA003413: AB_1848659" "unprognostic (9.86e-2)" "prognostic favorable (4.80e-4)" "unprognostic (1.30e-1)" "unprognostic (2.32e-1)" "unprognostic (4.41e-2)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (4.62e-2)" "unprognostic (7.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.71e-1)" "unprognostic (2.54e-2)" "unprognostic (2.23e-1)" "unprognostic (5.79e-3)" "unprognostic (4.54e-2)" "unprognostic (3.52e-2)" "unprognostic (1.76e-3)" 13.1 10.1 13.3 16.2 15.6 40.2 13.5 31.0 15.8 13.7 11.3 14.8 9.9 11.1 15.5 8.2 12.2 14.1 10.0 9.8 12.4 9.0 10.0 14.1 13.4 23.7 12.6 11.2 18.3 12.7 19.9 19.8 15.9 12.0 13.0 10.1 10.6 13.2 9.8 14.9 14.1 18.2 9.6 14.2 24.2 12.3 13.6 15.6 59.3 13.8 7.4 23.9 13.4 12.9 7.6 3.8 8.7 3.9 6.6 13.3 5.4 12.6 4.2 8.7 9.9 6.0 6.8 15.9 7.7 6.5 6.1 6.2 8.4 6.7 23.7 10.6 5.7 7.5 9.1 10.0 6.6 9.7 12.5 7.7 25.8 8.4 4.7 6.2 21.2 13.5 5.3 7.3 5.0 14.2 6.0 6.1 20.8 9.2 20.6 5.1 7.7 38.3 12.4 11.6 6.0 7.4 17.9 14.8 15.1 3.1 9.0 11.3 8.1 17.5 7.2 11.6 7.0 6.4 13.9 9.6 8.3 7.3 7.7 7.1 24.5 12.7 35.5 7.1 9.0 5.5 5.2 3.7 5.0 7.0 3.9 8.8 4.5 6.6 8.2 3.8 7.6 13.3 8.9 8.7 6.6 2.8 2.5 5.0 5.4 13.3 15.6 31.0 15.8 12.4 9.0 12.6 11.2 12.0 15.6 17.9 9.1 20.4 14.9 24.8 12.8 13.4 10.2 4.0 6.8 12.2 3.9 7.2 3.3 4.6 2.3 10.7 6.9 0.0 4.7 5.4 8.2 10.7 6.9 17.8 7.6 15.9 17.2 19.0 22.8 1.6 8.6 10.5 20.3 9.0 14.4 7.2 5.5 3.5 8.1 5.6 10.1 6.5 12.3 12.6 10.5 23.3 4.0 25.4 10.9 11.2 MSMP "PC-3, PSMP" ENSG00000215183 "Microseminoprotein, prostate associated" Q1L6U9 9 35752990-35756613 "Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;pituitary gland: 6.0;placenta: 5.7" "Group enriched" "Detected in some" 67 "Early spermatids: 95.5;Late spermatids: 142.6" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.9" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 35.1;PC-3: 44.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055174 Uncertain Supported Vesicles,Cytosol "Secreted in male reproductive system" No No Vesicles Cytosol "HPA055174: AB_2682726" 0.5 0.0 1.2 1.1 0.6 0.0 0.8 0.0 0.7 0.2 0.8 0.6 0.0 0.0 0.1 0.0 0.0 0.5 1.9 0.0 0.1 0.1 0.4 0.0 0.4 0.9 3.9 0.0 0.0 0.0 0.0 6.0 5.7 0.8 0.7 0.5 0.0 0.0 0.3 1.3 0.5 1.5 0.3 2.2 0.0 0.1 0.6 0.0 0.0 1.3 0.0 0.2 0.1 0.1 0.0 0.1 3.2 0.3 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.2 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.7 1.1 0.0 1.2 0.3 0.1 0.3 0.4 1.2 0.6 0.0 0.6 0.1 0.1 3.9 0.0 0.8 0.0 0.0 0.6 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 95.5 0.3 0.0 0.0 1.8 0.1 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 142.6 0.3 0.0 1.7 0.0 0.0 0.8 1.3 0.0 0.7 0.2 0.6 0.0 0.0 0.7 0.4 0.1 0.2 0.0 0.0 1.1 MSRA ENSG00000175806 "Methionine sulfoxide reductase A" Q9UJ68 8 10054268-10428891 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 597.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 78.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Group enriched" "Detected in many" 4 "dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2" "Cell line enhanced" "Detected in many" "HMC-1: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023804, HPA075766" Approved Supported "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" No No 25000 "Nucleoplasm, Plasma membrane, Cytosol" "Actin filaments" "HPA023804: AB_1853826, HPA075766: " "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.45e-3)" "unprognostic (1.00e-2)" "unprognostic (4.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.49e-2)" "unprognostic (6.40e-2)" "unprognostic (9.69e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.07e-3)" "unprognostic (6.43e-3)" "unprognostic (4.02e-1)" "unprognostic (6.36e-3)" "unprognostic (3.07e-1)" 7.0 8.1 8.0 5.2 7.5 36.1 5.9 78.4 13.7 3.6 5.9 4.3 2.2 5.9 4.8 3.7 5.5 4.2 4.4 8.5 8.9 5.5 32.4 22.9 5.7 6.8 6.8 9.5 4.2 10.2 2.9 3.4 4.6 8.1 3.4 4.0 3.9 6.0 5.0 4.7 3.8 12.7 4.9 6.7 7.2 4.9 8.5 5.5 3.5 4.4 2.6 3.8 3.9 2.7 1.1 2.3 9.0 3.2 1.1 0.8 0.3 0.1 1.1 1.8 5.4 1.6 1.8 0.6 3.3 0.7 0.5 2.2 0.7 2.7 0.0 0.8 3.0 7.2 2.9 0.5 0.2 1.7 0.4 0.0 0.5 1.7 2.5 5.3 1.0 15.2 0.5 3.9 0.4 0.0 1.8 0.9 0.3 0.5 0.3 5.9 0.2 0.0 0.3 0.8 3.9 1.0 1.8 1.7 2.3 1.3 1.3 3.1 2.0 5.4 0.2 0.7 0.6 2.8 3.3 3.2 2.2 2.6 0.5 1.6 0.2 0.1 0.9 5.9 1.0 4.1 0.8 3.2 9.0 0.7 2.2 0.6 1.1 0.8 0.5 2.3 0.4 0.6 0.5 3.8 1.1 1.6 0.3 0.5 0.3 8.0 7.5 78.4 13.7 8.9 5.5 6.8 9.5 8.1 5.5 0.0 9.0 10.0 24.1 14.5 10.7 18.1 17.8 5.3 4.5 24.4 29.5 5.8 77.9 27.0 64.1 26.4 29.0 0.0 41.4 4.5 11.3 16.9 81.6 82.9 42.3 15.9 9.2 16.5 31.0 107.2 8.6 33.1 28.7 14.4 19.7 13.4 40.7 28.8 9.2 597.4 5.8 12.9 17.6 27.7 18.8 12.3 7.0 15.3 17.4 28.6 MSS51 "FLJ39565, ZMYND17" ENSG00000166343 "MSS51 mitochondrial translational activator" Q4VC12 10 73423579-73433561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "parathyroid gland: 34.4;skeletal muscle: 66.9" "Cell type enhanced" "Detected in some" 7 "Cardiomyocytes: 3.9;granulocytes: 4.7;Leydig cells: 2.8;Paneth cells: 2.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "cerebellum: 2.7" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA038564 Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA038564: AB_10674687" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.40e-3)" "unprognostic (2.06e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-3)" "unprognostic (3.05e-3)" "unprognostic (7.88e-3)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (1.50e-4)" "unprognostic (1.22e-1)" "unprognostic (1.78e-7)" "unprognostic (1.51e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-2)" 2.8 0.3 0.4 0.4 0.4 0.3 0.4 2.7 0.4 0.5 0.5 0.4 0.4 0.2 0.6 0.4 0.9 0.6 0.4 3.9 0.4 0.1 0.4 0.4 0.6 0.4 0.4 0.4 1.1 0.5 34.4 0.7 0.4 0.4 0.8 0.3 0.4 2.3 0.4 66.9 0.8 0.8 0.4 0.4 1.4 0.4 0.4 0.4 0.6 0.4 1.2 0.4 0.5 0.6 0.1 0.0 0.0 0.5 0.0 1.7 0.4 1.2 1.3 3.0 4.7 4.2 6.0 2.6 1.5 1.1 0.6 1.3 0.7 1.5 3.8 0.5 1.5 0.2 2.3 1.9 0.4 1.7 1.8 1.5 3.3 2.0 1.1 1.5 2.2 3.1 4.7 1.5 1.3 3.5 4.3 0.6 1.5 1.1 2.0 2.5 0.5 1.9 3.0 0.9 1.0 1.6 1.1 7.8 0.2 1.8 1.9 0.6 1.2 1.0 2.2 1.7 3.2 1.9 1.8 2.7 2.3 1.4 0.9 3.0 1.2 3.4 2.0 1.0 3.8 0.6 0.0 0.4 0.0 1.7 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.3 1.2 0.0 0.0 0.5 0.0 0.0 0.4 0.4 0.4 2.7 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 2.2 2.2 0.0 0.5 1.4 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.7 0.4 0.0 0.3 0.1 0.5 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.6 0.0 2.8 0.1 0.0 0.0 0.6 0.9 0.1 2.9 1.4 0.0 1.2 0.0 0.4 0.5 0.2 0.0 0.1 0.7 0.6 0.1 MST1R "CD136, CDw136, PTK8, RON" ENSG00000164078 "Macrophage stimulating 1 receptor" Q04912 3 49887002-49903873 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;intestine: 34.3;skin 1: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 23.8;Enterocytes: 29.1;Mucus-secreting cells: 21.5;Pancreatic endocrine cells: 19.7;Paneth cells: 20.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 35.9;HaCaT: 19.8;HBEC3-KT: 21.6;hTCEpi: 30.3;RT4: 23.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007657, HPA008180, CAB008972" Enhanced Approved Cytosol NA NA Cytosol "CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291" "unprognostic (3.84e-3)" "unprognostic (3.86e-1)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.82e-2)" "unprognostic (2.32e-1)" "unprognostic (8.07e-3)" "unprognostic (1.54e-2)" "unprognostic (4.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.24e-3)" "unprognostic (2.28e-1)" "unprognostic (8.08e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-1)" "unprognostic (8.00e-3)" "prognostic favorable (2.33e-5)" 1.7 0.1 0.4 7.5 0.6 0.0 2.4 0.5 0.7 1.8 20.5 0.7 2.0 11.2 1.2 1.3 6.1 0.6 27.7 0.9 0.5 0.1 1.4 0.4 5.0 1.1 0.4 0.6 0.5 4.1 0.0 1.3 0.8 0.9 1.7 9.7 2.5 2.1 0.4 0.5 28.7 34.3 0.7 0.4 0.6 19.1 1.9 0.4 7.7 1.3 6.0 4.5 4.3 3.5 0.2 0.0 0.0 0.0 0.6 2.1 0.0 12.9 5.0 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.2 35.9 0.5 3.1 0.2 0.0 19.8 0.0 21.6 0.0 0.3 0.3 0.0 8.5 0.3 0.3 0.0 0.4 0.1 30.3 0.1 4.3 0.1 0.0 0.0 0.2 0.1 0.0 1.8 0.0 0.0 0.1 11.6 10.5 0.9 0.0 0.3 13.3 23.1 0.3 0.0 3.6 8.4 0.0 0.0 6.6 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.4 0.6 0.5 0.7 0.5 0.1 0.4 0.6 0.9 0.4 23.8 10.1 0.0 2.2 7.8 0.0 1.2 0.0 2.7 9.1 0.0 0.0 0.1 0.0 5.2 13.7 0.0 29.1 0.0 8.7 0.4 0.4 1.7 0.0 0.0 0.1 0.0 4.1 0.0 0.0 7.9 0.3 0.0 0.0 1.0 21.5 0.0 19.7 20.4 0.0 0.0 0.0 0.0 0.4 1.6 0.8 4.1 0.0 0.0 12.4 4.6 MSTO1 "FLJ10504, LST005, misato, MST" ENSG00000125459 "Misato 1, mitochondrial distribution and morphology regulator" Q9BUK6 1 155610205-155614967 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 30 "Early spermatids: 324.7;Late spermatids: 974.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005899, HPA005914" Approved Supported Cytosol NA NA Cytosol "HPA005899: AB_2667460, HPA005914: AB_2667466" "unprognostic (1.80e-2)" "unprognostic (3.43e-1)" "unprognostic (6.49e-2)" "unprognostic (2.65e-1)" "unprognostic (1.15e-1)" "unprognostic (4.46e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.63e-2)" "unprognostic (1.26e-1)" "unprognostic (5.28e-2)" "unprognostic (3.73e-2)" "unprognostic (3.67e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (5.35e-2)" "unprognostic (1.28e-1)" 9.5 5.8 3.5 5.0 3.8 3.0 6.9 5.3 4.2 5.1 3.9 4.6 6.8 10.6 4.8 6.3 3.5 4.6 4.4 4.3 5.7 11.5 4.6 5.6 4.3 6.9 8.3 9.6 8.9 4.3 7.4 4.8 4.8 9.3 1.6 4.5 4.9 6.6 2.9 7.5 4.6 7.1 7.9 5.2 3.8 4.0 7.6 8.3 3.1 8.0 8.8 10.9 6.3 12.2 15.8 15.0 22.8 12.9 10.1 17.6 15.0 13.4 19.3 15.2 16.7 7.9 20.3 14.9 13.6 11.9 13.6 21.5 20.7 13.7 8.3 18.2 18.4 15.2 9.7 20.2 19.6 15.3 10.8 11.0 21.5 31.9 9.0 16.1 15.4 14.6 9.7 16.0 20.0 12.4 13.7 19.1 20.6 21.9 11.5 13.7 19.2 16.2 12.4 12.5 15.0 11.3 33.1 14.0 17.7 18.8 25.7 10.7 12.9 13.7 13.2 23.5 20.8 17.0 15.5 14.2 18.6 16.2 3.1 5.7 0.2 10.4 8.0 10.9 7.6 9.7 9.7 8.0 5.5 10.6 6.3 0.5 8.8 5.0 8.3 6.8 6.3 6.0 5.9 7.5 4.2 2.4 9.1 8.7 5.1 13.4 5.7 7.0 21.6 6.7 3.3 7.9 324.7 6.4 2.1 0.0 11.6 19.0 5.5 4.0 13.9 6.2 7.6 11.1 5.2 1.8 2.7 974.9 8.3 6.0 3.3 10.0 3.4 3.7 6.8 0.0 10.6 6.9 9.8 0.0 4.7 18.6 13.2 1.3 5.5 5.0 3.7 2.5 MT-ND3 "MTND3, NAD3, ND3" ENSG00000198840 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3" P03897 MT 10059-10404 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 357.8" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 33020.6;Erythroid cells: 20674.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 644.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063296 Enhanced Uncertain Cytosol NA NA Cytosol "HPA063296: AB_2684978" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (8.10e-2)" "unprognostic (3.07e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "prognostic favorable (4.63e-5)" "unprognostic (2.45e-2)" "unprognostic (7.13e-2)" "unprognostic (8.85e-2)" "unprognostic (1.76e-3)" "unprognostic (1.74e-1)" "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-1)" "unprognostic (5.65e-3)" 102.1 73.9 117.3 17.6 137.2 17.9 59.3 33.7 70.5 31.2 76.3 64.0 25.9 49.2 21.7 24.7 19.7 256.8 110.3 81.7 138.1 145.8 19.7 17.4 92.0 27.5 77.8 14.6 22.2 34.6 39.1 59.1 67.6 50.7 357.8 42.2 48.9 28.4 66.8 19.1 60.6 21.0 25.0 20.3 24.2 15.9 84.8 32.6 159.6 48.5 48.6 75.3 24.4 85.5 139.7 93.3 91.5 644.7 129.2 77.7 72.1 42.4 39.1 44.3 210.2 133.3 89.1 111.9 92.5 70.8 178.3 40.1 157.5 67.3 127.7 192.1 87.6 465.1 346.0 100.6 129.0 132.7 223.4 292.0 65.5 73.9 233.9 60.8 102.4 69.0 104.2 73.7 279.5 67.7 172.2 47.9 245.4 129.3 58.7 91.7 82.0 237.9 236.2 38.5 83.7 34.8 69.8 142.5 254.3 161.5 208.4 103.2 60.5 91.9 105.1 77.0 40.5 53.1 192.1 49.1 78.4 34.2 159.6 48.5 36.6 36.7 36.4 49.8 73.1 42.6 44.8 32.6 84.8 63.1 75.3 100.7 48.6 32.7 32.3 27.6 24.4 652.1 738.1 6543.7 1904.3 1765.5 0.0 33020.6 8848.3 2785.1 1856.3 4782.3 0.0 0.0 986.5 1173.3 880.9 872.1 11850.5 20674.5 2500.6 0.0 790.1 1401.0 1375.6 14769.6 0.0 0.0 2746.0 8921.3 11655.5 4356.4 8457.2 1642.1 1763.0 2463.5 12873.7 0.0 1918.1 9893.1 4573.5 7467.5 0.0 6887.9 1962.1 6063.0 3539.9 1651.0 0.0 4305.8 10869.3 1952.0 MTA1 ENSG00000182979 "Metastasis associated 1" Q13330 14 105419820-105470729 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004508, HPA005544" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004508: AB_627969, HPA005544: AB_1079420" "unprognostic (6.79e-3)" "unprognostic (4.22e-2)" "unprognostic (1.06e-1)" "unprognostic (6.36e-2)" "unprognostic (2.91e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (6.59e-2)" "unprognostic (1.47e-1)" "unprognostic (6.72e-3)" "prognostic favorable (9.48e-5)" "unprognostic (4.57e-3)" "unprognostic (1.39e-2)" "unprognostic (2.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-1)" 23.4 20.1 22.4 24.7 24.3 22.0 22.9 33.8 23.4 17.9 18.9 21.9 22.5 22.3 22.1 21.3 14.9 22.5 20.0 27.7 22.1 17.3 14.8 15.1 20.1 22.3 22.8 18.4 31.4 31.1 15.7 26.5 16.1 19.4 21.9 10.6 22.2 28.7 24.8 29.1 20.0 19.8 27.1 15.0 23.6 18.9 31.4 24.1 27.3 21.1 16.1 16.3 19.3 20.5 1.8 3.7 2.8 0.9 1.8 1.8 0.6 13.3 10.7 19.9 19.8 7.6 13.0 17.6 10.7 8.1 10.6 10.2 13.8 18.1 26.2 11.1 7.8 7.5 18.4 14.4 10.2 7.2 17.1 24.2 13.6 9.7 14.1 16.9 17.1 10.5 14.6 12.9 7.5 17.3 14.8 15.0 19.6 15.4 11.4 5.5 24.0 30.8 33.9 28.7 19.1 22.7 29.1 12.1 8.5 8.4 10.5 32.2 33.5 14.4 16.7 15.3 10.6 15.1 16.3 10.8 8.6 9.1 14.1 11.1 23.4 11.2 16.6 10.7 11.6 14.9 0.5 0.9 2.8 1.4 0.9 1.2 1.5 1.2 1.1 1.1 1.8 1.5 1.8 0.2 1.8 0.5 3.7 0.9 0.6 22.4 24.3 33.8 23.4 22.1 17.3 22.8 18.4 19.4 24.1 3.0 13.6 15.6 26.8 13.9 0.0 8.1 15.3 2.7 7.9 33.2 0.0 10.1 14.9 11.4 24.8 18.0 14.8 23.3 17.3 6.9 18.4 25.2 5.7 11.5 9.4 0.0 17.9 12.9 12.5 9.1 33.4 11.0 11.8 8.2 18.6 0.0 14.9 7.0 30.1 7.7 0.0 19.4 23.4 21.9 11.6 16.7 7.8 15.7 21.8 39.4 MTAP "c86fus, MSAP" ENSG00000099810 "Methylthioadenosine phosphorylase" Q13126 9 21802543-21937651 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046915 Supported Nucleoplasm,Cytosol NA NA 3100000 Cytosol Nucleoplasm "HPA046915: AB_2679862" "unprognostic (1.40e-2)" "unprognostic (1.83e-1)" "unprognostic (2.21e-1)" "unprognostic (2.58e-3)" "unprognostic (2.78e-1)" "unprognostic (6.16e-2)" "prognostic unfavorable (4.68e-4)" "unprognostic (9.47e-2)" "unprognostic (2.03e-1)" "unprognostic (8.63e-2)" "unprognostic (4.76e-3)" "unprognostic (4.27e-2)" "unprognostic (6.28e-3)" "unprognostic (2.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" 17.0 12.6 7.8 12.6 10.4 8.4 13.9 4.6 10.2 17.3 14.5 12.8 13.4 8.0 21.2 11.6 19.6 12.2 16.9 11.4 7.9 7.7 13.0 17.5 11.4 13.0 12.0 6.2 20.5 17.2 17.6 14.4 17.5 12.3 17.0 13.1 14.3 14.6 15.9 10.8 11.8 10.3 19.9 14.3 17.9 11.7 7.9 10.1 19.1 11.7 14.3 16.2 19.7 17.2 9.3 8.4 1.4 6.9 8.5 8.2 3.5 14.4 2.2 11.7 9.9 9.7 10.0 13.2 21.2 10.4 10.7 12.4 9.9 6.8 7.2 6.6 10.0 8.8 6.7 12.0 29.9 18.3 0.1 9.8 0.1 27.4 13.1 9.4 11.5 12.9 12.0 0.0 19.8 21.7 12.4 11.1 0.2 0.1 9.7 11.2 2.0 13.2 0.3 13.7 6.7 17.7 0.2 8.9 12.7 9.3 0.1 6.7 7.6 6.9 8.1 10.5 8.9 5.2 0.2 12.1 0.1 7.6 0.1 16.8 6.5 11.4 15.1 0.1 11.5 6.2 1.4 6.9 0.3 5.0 5.4 8.2 7.7 7.2 5.6 8.4 9.3 6.5 5.9 1.0 8.5 3.4 8.0 4.1 3.5 7.8 10.4 4.6 10.2 7.9 7.7 12.0 6.2 12.3 10.1 20.8 16.6 17.1 39.8 12.6 0.0 21.0 25.5 16.0 28.4 14.0 0.0 42.6 13.3 34.0 42.8 11.2 6.9 0.0 24.4 68.9 13.3 17.2 10.4 19.8 23.3 0.0 9.2 16.5 21.0 8.8 13.8 17.0 10.1 12.6 13.2 0.0 37.3 0.0 13.8 15.3 0.0 12.9 13.2 0.9 16.0 11.4 18.9 13.4 18.8 44.6 MTERF3 "CGI-12, FLJ10939, MTERFD1" ENSG00000156469 "Mitochondrial transcription termination factor 3" Q96E29 8 96239398-96261610 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007355 Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA007355: " "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (4.68e-2)" "unprognostic (2.31e-2)" "unprognostic (3.86e-2)" "unprognostic (6.66e-2)" "unprognostic (2.75e-3)" "unprognostic (3.11e-3)" "unprognostic (6.43e-2)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (8.56e-2)" "prognostic unfavorable (5.88e-5)" "unprognostic (8.67e-3)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (1.74e-3)" 13.8 16.4 14.2 15.9 20.1 9.9 22.9 17.8 18.0 14.8 13.8 12.3 17.4 11.9 15.4 23.8 12.6 13.2 12.9 21.9 17.3 15.3 15.9 22.2 18.5 18.3 18.1 16.0 13.7 14.8 18.9 14.1 16.1 23.7 15.5 14.5 9.8 12.1 17.9 28.8 16.1 11.6 21.9 13.2 16.9 12.8 10.9 13.5 16.0 15.0 14.1 18.1 13.9 12.3 15.3 18.0 18.6 11.6 16.7 17.8 7.8 18.9 12.2 18.4 14.5 13.1 13.6 8.4 14.6 12.0 21.5 21.7 8.7 14.1 17.1 30.9 8.5 10.9 10.7 19.0 11.4 26.2 16.4 13.9 24.4 9.4 10.5 18.5 8.2 10.0 13.6 17.1 17.4 16.4 11.1 17.5 18.4 20.5 9.0 21.5 12.3 34.9 24.3 9.6 33.5 19.1 21.2 15.1 13.3 15.7 10.1 12.6 9.9 10.9 3.2 15.5 12.4 16.5 11.6 7.8 15.1 10.2 17.4 12.9 10.3 12.9 19.9 16.4 22.1 19.7 18.6 10.3 4.3 12.4 11.6 17.8 15.3 14.1 14.0 14.8 13.2 16.1 16.1 1.8 16.7 11.0 18.0 13.3 7.8 14.2 20.1 17.8 18.0 17.3 15.3 18.1 16.0 23.7 13.5 3.0 5.8 10.9 13.1 0.0 0.0 27.8 10.2 9.4 10.3 5.2 0.0 26.6 11.6 10.9 4.4 8.2 0.8 23.3 8.6 17.4 15.8 7.5 5.8 7.3 14.3 0.0 0.0 6.2 4.9 3.1 12.7 6.3 0.0 21.6 3.8 0.0 7.5 3.5 13.1 8.7 0.0 12.9 10.0 24.4 18.8 0.0 14.5 4.4 6.2 9.1 MTERF4 "MGC61716, MTERFD2" ENSG00000122085 "Mitochondrial transcription termination factor 4" Q7Z6M4 2 241072169-241102332 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027097 Uncertain Supported Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" "HPA027097: AB_10603879" "unprognostic (4.58e-2)" "unprognostic (3.66e-1)" "unprognostic (2.82e-1)" "unprognostic (5.95e-2)" "unprognostic (1.50e-1)" "unprognostic (6.70e-2)" "unprognostic (1.17e-3)" "unprognostic (2.99e-2)" "unprognostic (2.68e-2)" "unprognostic (1.20e-2)" "prognostic favorable (3.48e-4)" "unprognostic (2.28e-2)" "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-1)" 14.2 15.5 14.4 17.6 22.1 17.2 18.6 42.2 21.7 16.2 14.6 25.3 12.5 13.4 23.2 14.1 17.6 17.7 12.1 13.4 14.4 12.1 13.4 16.5 14.2 29.8 19.2 19.4 25.7 20.9 11.7 25.7 11.6 20.4 28.9 17.2 16.3 19.5 18.1 38.8 15.5 19.6 17.3 17.8 20.3 14.7 12.7 22.3 23.7 29.4 20.5 29.7 14.3 15.2 16.6 6.2 11.4 5.4 8.0 24.9 10.2 8.7 8.3 16.5 9.5 22.5 10.1 12.3 14.9 16.6 14.5 20.7 5.7 13.2 13.6 5.4 17.3 16.5 9.9 22.5 21.3 19.7 18.4 16.3 17.4 15.9 25.1 14.8 20.7 13.3 17.2 20.9 17.0 19.7 18.9 16.5 18.6 15.5 6.0 17.4 12.4 15.1 14.3 18.9 18.1 14.3 14.8 18.8 7.7 13.8 17.6 15.2 13.2 12.2 15.2 11.3 11.7 11.2 10.7 22.8 13.4 13.1 15.7 13.3 16.1 4.1 33.2 11.3 13.2 12.3 4.2 5.4 11.4 10.0 5.2 12.5 16.6 15.5 13.7 6.2 15.4 24.9 19.5 1.9 8.0 4.4 4.7 15.8 10.2 14.4 22.1 42.2 21.7 14.4 12.1 19.2 19.4 20.4 22.3 11.9 23.0 29.4 17.6 0.0 0.0 17.5 25.5 32.1 23.9 19.2 0.0 24.9 34.9 21.1 40.5 13.6 19.2 23.3 21.3 22.9 13.5 15.6 10.5 27.2 22.0 0.0 10.5 14.7 21.8 48.5 21.6 18.0 0.0 19.8 26.7 0.0 20.5 25.8 24.8 32.1 0.0 38.8 15.9 42.6 38.1 0.0 19.8 30.5 22.5 14.8 MTFMT FMT1 ENSG00000103707 "Mitochondrial methionyl-tRNA formyltransferase" Q96DP5 15 65001512-65029639 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040710 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040710: AB_10794879" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (9.28e-3)" "unprognostic (4.35e-2)" "unprognostic (1.28e-1)" "unprognostic (1.42e-2)" "unprognostic (6.63e-2)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (2.18e-2)" "unprognostic (2.41e-2)" "unprognostic (1.78e-1)" "prognostic favorable (3.31e-8)" "unprognostic (2.75e-2)" "unprognostic (4.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.85e-2)" 8.7 10.2 7.9 10.0 11.5 11.6 7.5 13.5 12.7 9.5 12.7 6.8 8.0 9.7 11.8 10.6 9.5 10.9 9.7 13.8 8.0 7.8 12.8 13.4 8.4 8.6 6.8 9.4 14.0 5.9 7.3 9.3 7.5 10.3 10.8 10.8 12.2 8.7 9.8 13.3 11.6 13.9 12.0 5.7 9.2 8.7 7.2 5.2 9.2 11.7 4.6 8.8 12.0 9.1 5.0 9.6 16.9 3.6 4.6 5.9 1.9 2.5 3.5 3.4 6.0 4.9 3.4 3.0 2.4 4.2 3.1 3.0 2.2 3.0 9.0 3.2 4.3 5.1 7.6 6.4 4.2 3.0 3.4 4.7 3.8 3.4 2.5 5.7 5.2 1.2 4.9 5.3 1.7 3.7 4.4 2.8 8.0 4.0 4.3 4.7 3.5 4.1 5.5 4.7 7.3 6.1 3.8 5.0 4.1 5.1 3.0 3.5 3.6 5.7 5.3 4.3 4.7 3.3 3.7 5.2 3.7 3.8 4.3 4.7 3.7 5.3 3.5 3.3 8.4 3.8 3.1 3.6 2.4 4.9 2.9 4.9 4.7 4.9 5.2 5.6 5.0 5.5 5.9 16.9 4.6 2.0 9.6 4.9 1.9 7.9 11.5 13.5 12.7 8.0 7.8 6.8 9.4 10.3 5.2 3.0 8.9 11.5 12.6 3.0 0.0 15.0 7.6 5.3 9.1 3.5 0.0 9.0 21.6 10.4 1.6 6.5 11.9 0.0 8.5 10.3 10.0 11.7 8.1 9.5 14.2 0.0 7.5 10.4 10.8 1.4 14.4 11.1 8.5 2.8 9.0 0.0 9.2 16.4 14.5 15.3 0.0 0.0 10.3 10.9 21.6 4.0 7.4 9.6 15.3 13.2 MTFR1 "CHPPR, FAM54A2, KIAA0009" ENSG00000066855 "Mitochondrial fission regulator 1" Q15390 8 65644734-65771261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 350.9;Late spermatids: 606.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "hTERT-HME1: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023152, HPA056120" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA023152: AB_1854176, HPA056120: AB_2683043" "prognostic unfavorable (4.06e-4)" "unprognostic (4.58e-2)" "unprognostic (4.01e-2)" "unprognostic (4.57e-2)" "unprognostic (6.56e-3)" "unprognostic (3.93e-2)" "unprognostic (1.66e-1)" "unprognostic (3.28e-2)" "unprognostic (1.50e-1)" "unprognostic (3.53e-1)" "unprognostic (5.69e-3)" "unprognostic (5.44e-2)" "unprognostic (6.63e-3)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.21e-4)" "unprognostic (8.25e-2)" 10.7 17.7 6.6 5.5 11.7 3.9 9.5 10.1 8.8 9.7 10.7 10.8 14.2 11.1 9.9 11.9 12.3 7.2 6.2 8.7 6.8 5.5 28.4 37.7 7.1 3.9 10.3 5.4 7.9 19.1 8.0 15.0 16.2 9.7 8.1 11.2 14.8 11.0 11.5 11.7 8.3 16.2 8.8 11.3 6.5 13.2 16.8 11.7 5.4 13.0 11.2 9.3 10.5 9.7 1.7 3.1 4.3 2.8 0.8 2.9 1.7 14.1 10.6 8.4 9.8 11.7 11.5 6.8 9.3 8.6 11.6 12.3 9.0 14.8 7.9 3.0 9.0 11.3 9.3 19.1 12.7 15.7 2.8 10.3 9.8 7.8 18.1 14.6 2.5 4.8 7.8 13.7 14.9 47.7 6.6 14.1 5.8 13.3 8.2 13.4 12.7 8.6 6.0 8.9 31.3 9.5 4.4 11.6 6.6 14.3 12.8 3.8 5.6 9.3 15.9 12.4 9.0 17.6 5.6 10.6 7.1 9.8 16.7 8.1 8.0 5.2 5.8 8.6 10.4 9.3 4.3 2.8 1.2 2.0 2.5 2.9 1.7 2.6 2.2 3.1 1.4 2.6 2.9 0.7 0.8 1.2 1.9 2.5 1.7 6.6 11.7 10.1 8.8 6.8 5.5 10.3 5.4 9.7 11.7 17.9 6.0 12.0 9.6 14.9 0.0 6.4 12.7 10.7 3.4 10.4 0.0 20.7 48.0 16.4 350.9 6.4 10.7 23.3 21.3 22.9 9.7 11.6 4.7 33.1 8.6 0.0 4.6 8.6 5.4 606.6 15.5 6.1 13.5 2.8 11.8 0.0 17.5 7.0 11.3 91.0 0.0 6.5 16.5 66.0 16.8 16.9 32.7 5.0 14.1 15.2 MTHFD1 "MTHFC, MTHFD" ENSG00000100714 "Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1" P11586 14 64388031-64463457 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis" "Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 121.6" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000704, HPA001290, HPA015006, HPA050052" Approved Enhanced Cytosol NA Yes 250000 Cytosol "HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998" "unprognostic (3.58e-2)" "unprognostic (5.50e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.37e-1)" "unprognostic (7.01e-2)" "unprognostic (8.85e-3)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.84e-1)" "prognostic favorable (5.93e-5)" "unprognostic (2.45e-2)" "unprognostic (1.75e-1)" "unprognostic (7.30e-2)" "unprognostic (2.29e-2)" 18.9 9.0 8.1 8.4 18.1 9.7 12.2 5.7 15.9 7.1 9.3 9.0 4.0 7.5 8.5 6.9 12.0 6.7 6.4 10.6 8.4 6.5 20.5 121.6 6.8 9.2 8.0 10.4 10.1 13.4 13.1 5.6 5.6 10.0 5.5 11.4 9.3 11.6 5.6 26.5 7.6 7.3 8.8 6.9 8.3 7.9 2.3 7.4 15.6 8.6 14.0 12.5 8.7 7.3 21.1 12.8 0.5 13.2 12.8 14.9 8.4 72.5 41.3 15.7 34.2 16.9 13.8 25.5 28.5 19.6 37.0 36.7 40.1 33.4 30.5 13.5 16.9 18.6 35.7 48.4 28.3 43.3 30.3 31.9 37.8 41.4 30.4 12.5 29.0 20.6 10.7 9.2 33.0 17.9 15.3 23.0 30.9 28.1 25.1 28.0 60.2 46.7 17.0 28.7 46.2 43.8 37.3 54.6 27.6 27.8 42.5 34.0 13.2 47.6 25.9 14.3 15.3 40.3 14.7 14.1 27.9 48.4 25.7 34.1 16.8 20.6 53.8 25.6 33.5 31.6 0.2 8.2 0.1 8.1 13.2 10.9 21.1 9.0 9.9 12.8 11.6 7.6 10.1 0.5 12.8 10.3 3.2 14.9 8.4 8.1 18.1 5.7 15.9 8.4 6.5 8.0 10.4 10.0 7.4 17.9 26.3 11.5 9.9 12.2 0.0 38.1 17.8 12.0 20.5 15.7 0.0 20.0 34.9 15.4 0.9 9.9 5.2 0.0 9.0 24.2 10.6 8.3 49.7 125.3 21.6 0.0 2.9 7.4 11.3 0.9 12.0 10.9 13.5 14.4 11.9 0.0 10.8 2.9 12.4 49.9 0.0 19.4 18.6 0.9 7.5 9.4 8.2 20.0 21.3 9.9 MTHFS HsT19268 ENSG00000136371 "Methenyltetrahydrofolate synthetase" P49914 15 79833585-79897379 "Enzymes, Predicted intracellular proteins" Ligase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.7;liver: 120.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 163.6;monocytes: 231.8;Proximal tubular cells: 140.3;Syncytiotrophoblasts: 212.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 88.7" "Group enriched" "Detected in all" 5 "granulocytes: 88.7;monocytes: 25.4" "Low cell line specificity" "Detected in many" "HPA008067, HPA054177" Approved Supported Cytosol NA NA Cytosol "HPA008067: AB_1078882, HPA054177: AB_2682405" "unprognostic (4.57e-2)" "unprognostic (9.76e-2)" "unprognostic (6.11e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (8.52e-4)" "unprognostic (9.13e-3)" "prognostic favorable (1.29e-6)" "unprognostic (1.34e-2)" "unprognostic (1.03e-1)" "unprognostic (6.18e-3)" "unprognostic (2.91e-2)" "unprognostic (2.76e-1)" "prognostic favorable (2.04e-4)" "unprognostic (1.36e-1)" "unprognostic (2.85e-1)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" 10.0 6.6 4.5 7.6 4.4 2.5 5.7 3.9 2.8 4.4 12.4 3.7 6.8 8.3 4.3 6.2 4.5 4.0 7.9 5.2 4.1 5.0 27.9 120.9 6.4 5.4 5.5 1.7 3.3 18.8 11.4 9.4 13.9 3.9 8.6 3.7 6.5 10.6 7.6 6.0 1.9 18.3 4.4 6.1 7.6 6.3 5.9 3.3 5.3 12.0 3.1 5.7 4.0 9.9 9.7 9.3 88.7 25.4 12.4 12.6 13.8 10.9 27.7 2.5 1.4 9.8 8.3 11.2 7.7 10.1 13.5 10.3 21.5 21.6 13.8 23.4 9.5 12.1 17.7 23.6 7.5 10.3 14.3 15.7 11.8 16.1 25.5 17.0 5.5 0.4 12.5 22.1 5.6 14.1 12.6 5.0 12.2 26.1 11.3 10.7 23.6 8.5 23.0 11.8 34.2 10.4 9.3 13.6 20.9 24.6 20.6 6.8 3.2 21.4 12.8 28.2 12.5 16.4 10.2 3.3 5.2 11.0 2.4 5.1 5.7 18.4 13.9 2.6 21.8 4.0 9.8 16.6 43.5 7.7 19.0 9.9 9.7 10.8 9.0 9.3 8.7 12.6 9.7 88.7 12.4 25.4 7.0 11.2 13.8 4.5 4.4 3.9 2.8 4.1 5.0 5.5 1.7 3.9 3.3 17.9 35.3 18.8 8.6 9.5 0.0 0.6 40.8 25.4 18.2 21.0 0.0 57.2 54.7 50.9 1.1 8.4 11.9 0.0 65.9 31.6 13.1 11.4 8.1 163.6 41.2 0.0 16.9 16.5 21.5 1.7 12.7 29.7 20.3 231.8 22.7 0.0 65.8 29.8 14.9 140.3 0.0 12.9 5.1 7.5 7.3 7.0 212.2 35.2 30.5 7.4 MTMR10 FLJ20313 ENSG00000166912 "Myotubularin related protein 10" Q9NXD2 15 30938941-30991607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006081 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nucleoplasm, Nuclear bodies" Cytosol "HPA006081: AB_2667508" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (7.36e-2)" "unprognostic (4.43e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" "unprognostic (6.43e-2)" "unprognostic (2.54e-1)" "prognostic favorable (7.77e-12)" "unprognostic (9.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-1)" 13.9 7.3 19.9 7.8 22.8 12.0 16.3 8.4 19.3 10.0 8.4 32.9 4.2 9.6 7.4 8.1 17.1 6.4 7.5 10.2 22.5 13.3 25.9 19.2 10.6 9.6 30.9 11.9 9.5 9.8 14.8 4.3 32.7 29.4 9.2 8.5 9.5 11.1 10.0 24.3 7.6 8.9 8.3 84.0 10.7 10.0 6.6 24.9 8.9 11.7 6.0 8.3 9.5 7.2 3.4 3.8 14.1 6.9 1.4 1.6 1.6 5.5 6.3 5.8 3.1 12.9 7.0 4.2 8.0 16.8 6.8 6.7 4.0 1.9 2.3 11.0 10.7 6.7 8.2 4.5 4.8 6.4 8.3 1.2 2.9 4.1 5.9 7.5 5.5 5.9 9.4 3.8 4.3 4.8 8.0 16.7 6.8 3.1 6.5 6.1 1.6 5.8 1.6 2.9 6.9 2.6 4.4 5.0 13.1 25.3 8.8 2.1 5.4 3.8 4.6 1.6 8.4 2.9 10.4 7.9 7.9 5.0 4.1 4.9 5.9 5.0 6.0 4.6 2.0 8.8 3.3 3.2 3.0 0.8 4.2 0.8 2.1 0.9 0.6 3.2 3.4 1.6 1.3 14.1 1.4 6.9 3.8 1.3 1.6 19.9 22.8 8.4 19.3 22.5 13.3 30.9 11.9 29.4 24.9 23.8 14.6 5.9 3.7 7.9 0.0 20.2 5.1 4.0 7.9 31.4 0.0 14.7 1.7 2.9 11.5 11.7 10.0 0.0 3.2 2.6 7.6 7.4 16.2 28.7 10.3 0.0 5.8 10.4 21.9 17.8 9.8 17.2 8.5 2.8 9.0 0.0 4.2 8.6 7.1 13.3 0.0 0.0 5.3 12.1 6.6 9.7 32.2 5.7 6.8 5.2 MTMR3 "FYVE-DSP1, KIAA0371, ZFYVE10" ENSG00000100330 "Myotubularin related protein 3" Q13615 22 29883155-30030866 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034515, HPA034516, HPA061399" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: " "unprognostic (4.39e-3)" "unprognostic (7.84e-2)" "unprognostic (2.46e-2)" "unprognostic (1.76e-2)" "unprognostic (5.61e-2)" "unprognostic (4.51e-3)" "unprognostic (2.25e-2)" "unprognostic (3.20e-2)" "unprognostic (3.42e-1)" "unprognostic (4.39e-1)" "unprognostic (8.33e-4)" "unprognostic (1.28e-1)" "unprognostic (5.35e-4)" "unprognostic (7.96e-2)" "unprognostic (7.64e-2)" "unprognostic (2.49e-1)" "unprognostic (8.38e-2)" 15.8 17.2 15.7 12.6 20.6 66.7 16.0 24.2 18.0 13.7 12.6 18.9 14.8 10.6 18.8 13.5 20.1 16.7 13.0 14.4 13.0 11.7 12.4 9.9 18.3 12.6 14.7 11.4 20.3 15.8 22.1 20.6 20.6 15.8 15.1 12.9 18.1 15.9 14.7 30.7 22.5 13.1 16.0 17.0 20.7 14.1 23.7 14.6 14.0 16.6 11.9 14.9 14.0 19.3 2.6 3.9 16.5 6.6 3.9 4.1 3.5 8.5 6.7 11.7 12.4 11.8 8.6 8.6 7.6 11.6 10.5 12.2 6.3 5.2 6.5 5.1 14.7 8.4 10.6 12.3 9.7 10.6 12.9 10.2 11.8 6.8 6.7 10.9 10.0 30.2 9.1 16.1 10.2 18.6 10.3 10.5 7.1 7.3 11.8 6.5 10.7 6.7 7.3 4.3 9.2 5.0 8.0 15.8 6.6 9.9 16.0 12.9 8.9 14.7 13.3 7.9 10.3 7.4 10.1 11.1 17.2 11.7 3.5 5.4 10.2 6.9 6.1 7.5 5.0 7.9 6.4 6.6 10.0 3.1 4.6 4.1 2.2 2.5 3.4 3.9 2.6 3.1 2.7 16.5 3.9 4.7 1.5 2.7 3.5 15.7 20.6 24.2 18.0 13.0 11.7 14.7 11.4 15.8 14.6 3.0 11.3 4.3 8.7 14.8 0.0 2.8 10.2 6.7 14.8 12.2 0.0 10.4 1.7 9.3 11.6 8.9 12.4 0.0 7.6 5.5 9.4 14.8 7.0 8.5 9.8 0.0 12.0 13.5 24.0 12.1 12.7 12.9 13.5 2.8 11.1 0.0 9.9 8.6 10.6 5.7 0.0 6.5 5.0 20.9 24.0 12.0 11.4 7.0 9.3 11.6 MTMR7 ENSG00000003987 "Myotubularin related protein 7" Q9Y216 8 17298030-17413528 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;parathyroid gland: 17.9" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 9.5;Intestinal endocrine cells: 3.5;Late spermatids: 3.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 5.4;SCLC-21H: 14.3;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" HPA075682 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA075682: " "unprognostic (1.01e-1)" "unprognostic (6.10e-2)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (4.15e-2)" "unprognostic (1.41e-2)" "unprognostic (1.92e-1)" "unprognostic (2.45e-1)" "unprognostic (2.07e-4)" "unprognostic (1.46e-2)" "unprognostic (1.97e-7)" "unprognostic (1.12e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (2.66e-3)" 1.4 4.9 10.9 1.9 16.7 3.4 0.9 16.2 25.8 1.2 1.3 16.0 0.0 2.0 1.8 0.8 1.5 1.5 1.6 1.7 7.5 7.8 2.4 2.2 1.4 1.7 9.2 9.5 3.5 2.6 17.9 10.3 1.8 19.5 1.2 1.3 4.7 1.4 1.1 2.1 2.6 1.9 1.1 11.2 1.4 1.8 2.9 9.4 0.0 6.5 0.0 0.8 1.4 0.7 0.7 0.2 0.8 0.2 0.3 1.4 0.1 0.8 0.7 1.2 1.0 0.0 0.0 0.9 1.8 0.0 0.0 0.0 0.9 0.2 0.9 0.5 0.0 0.8 0.4 4.1 0.1 0.0 0.1 3.0 1.2 1.6 0.5 1.0 0.7 0.9 0.2 0.0 0.1 0.0 0.8 0.2 0.4 0.6 0.7 0.0 0.6 1.3 1.7 5.4 0.7 0.6 0.4 1.8 0.5 0.0 3.4 14.3 8.3 0.6 0.8 0.9 2.0 0.4 0.9 1.5 0.9 0.5 2.0 1.1 0.4 0.4 0.7 2.6 1.3 0.7 0.0 0.1 0.7 0.2 0.2 0.1 0.7 0.1 0.2 0.1 0.0 0.5 0.3 0.8 0.3 0.2 0.2 1.4 0.1 10.9 16.7 16.2 15.2 7.5 7.8 9.2 9.5 19.5 9.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 9.5 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.5 0.6 1.6 0.1 1.1 0.0 0.0 0.0 MTO1 ENSG00000135297 "Mitochondrial tRNA translation optimization 1" Q9Y2Z2 6 73461578-73509236 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030230, HPA030232" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030230: AB_10598910, HPA030232: AB_10600891" "unprognostic (2.17e-2)" "unprognostic (5.29e-2)" "unprognostic (1.05e-2)" "unprognostic (3.22e-2)" "unprognostic (6.47e-2)" "unprognostic (8.58e-2)" "unprognostic (6.28e-2)" "unprognostic (5.48e-2)" "unprognostic (2.97e-1)" "unprognostic (2.12e-3)" "unprognostic (9.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.67e-1)" "unprognostic (8.08e-3)" "unprognostic (1.64e-1)" 10.4 11.0 11.1 13.5 13.7 14.7 11.5 21.8 13.6 14.0 14.0 11.3 12.4 12.7 12.6 11.2 12.1 10.0 8.1 13.3 10.0 10.9 19.7 28.4 9.8 15.8 19.3 10.0 14.5 12.1 24.6 15.6 8.7 13.9 12.2 12.7 10.1 10.7 12.3 15.8 9.8 13.6 11.9 12.1 18.6 11.9 20.5 15.0 13.0 14.0 11.0 16.6 12.1 15.0 10.4 7.4 5.3 7.8 10.5 14.0 8.7 5.1 4.7 6.5 5.3 9.4 11.0 5.9 10.7 9.8 10.5 12.8 9.7 3.9 13.5 8.4 10.0 8.2 8.8 11.9 8.6 16.1 7.8 7.8 10.3 11.4 10.5 12.4 18.5 7.0 9.5 13.6 11.3 12.7 7.4 7.9 12.0 17.6 13.0 10.9 8.9 5.1 16.0 4.8 7.7 4.8 8.5 18.7 22.4 8.4 8.1 5.5 3.3 5.5 9.3 9.6 6.2 6.1 19.6 5.0 6.2 6.1 3.5 10.1 8.5 13.1 5.4 3.2 13.8 8.2 1.7 6.4 5.3 9.7 7.2 11.9 10.4 11.7 9.8 7.4 7.9 12.9 10.5 1.8 10.5 7.8 5.5 14.0 8.7 11.1 13.7 21.8 13.6 10.0 10.9 19.3 10.0 13.9 15.0 14.9 17.0 14.3 13.5 6.9 0.0 12.9 7.6 6.7 11.4 10.4 0.0 10.2 18.3 6.5 108.3 9.0 9.0 0.0 6.4 6.5 6.9 10.3 5.8 18.4 7.8 0.0 8.1 9.2 5.9 11.0 10.3 10.8 0.0 8.2 8.1 0.0 6.1 7.0 9.2 12.6 0.0 6.5 10.2 21.7 10.2 8.8 8.6 24.2 9.8 9.7 MTOR "FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1" ENSG00000198793 "Mechanistic target of rapamycin kinase" P42345 1 11106535-11262507 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 38.8;Spermatocytes: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB069425, HPA071227" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB069425: , HPA071227: AB_2686367" "unprognostic (3.18e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (2.45e-3)" "unprognostic (5.50e-2)" "unprognostic (2.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (8.24e-3)" "unprognostic (3.48e-2)" "unprognostic (1.88e-1)" "prognostic favorable (1.49e-5)" "unprognostic (1.27e-1)" "unprognostic (2.45e-1)" "unprognostic (6.60e-2)" "unprognostic (7.55e-2)" 11.3 13.9 18.7 13.0 22.5 12.3 14.9 25.2 25.2 11.3 14.5 18.2 10.4 11.2 13.8 23.6 13.1 10.5 15.7 14.2 14.5 13.6 15.8 19.4 10.8 14.3 14.0 14.4 10.7 16.6 26.5 16.0 12.5 15.5 15.2 17.1 14.4 14.2 15.2 24.6 16.5 13.6 15.2 10.4 15.4 13.1 38.6 13.1 16.6 13.2 9.9 15.7 11.7 10.2 3.9 4.0 3.0 6.4 2.6 5.6 2.3 15.2 13.9 18.7 14.2 22.7 10.8 9.4 12.9 12.4 17.3 17.0 14.2 14.1 17.0 11.1 15.2 10.7 18.2 25.3 19.8 22.4 13.5 18.5 22.6 28.7 17.9 14.2 21.9 16.8 13.8 15.1 24.7 25.1 8.2 21.8 16.4 25.2 14.6 12.0 17.4 15.1 16.8 14.2 16.0 13.1 15.2 22.1 11.4 15.3 13.9 18.9 13.9 27.6 15.0 16.9 21.5 12.2 13.0 23.3 15.1 13.7 11.5 17.3 14.4 13.4 33.4 10.9 23.8 15.9 0.7 2.9 3.0 5.2 6.4 4.3 3.9 3.0 2.7 4.0 3.4 3.6 3.1 2.0 2.6 3.3 3.1 5.6 2.3 18.7 22.5 25.2 25.2 14.5 13.6 14.0 14.4 15.5 13.1 14.9 10.2 5.2 4.5 3.1 0.0 25.7 2.5 2.7 10.3 8.7 0.0 6.5 1.7 6.3 31.2 7.8 7.9 0.0 5.4 5.9 5.1 7.5 12.7 13.0 6.1 0.0 9.9 5.5 7.3 29.3 7.2 6.0 8.5 5.4 6.8 0.0 8.6 3.5 7.8 4.3 0.0 38.8 6.9 48.4 31.3 5.0 8.2 6.5 9.5 5.5 MTPN "GCDP, MYOTROPHIN, V-1" ENSG00000105887 Myotrophin P58546 7 135926761-135977353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019735 Approved Approved "Plasma membrane,Cytosol" NA NA 48000000 "Plasma membrane, Cytosol" "HPA019735: AB_1858710" "unprognostic (5.97e-2)" "unprognostic (2.53e-2)" "unprognostic (8.52e-2)" "unprognostic (3.62e-3)" "unprognostic (2.20e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.19e-4)" "unprognostic (2.06e-3)" "unprognostic (3.30e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (4.50e-2)" "unprognostic (1.83e-2)" "unprognostic (2.60e-2)" "unprognostic (2.43e-1)" "unprognostic (9.00e-3)" "unprognostic (4.86e-3)" 31.0 22.1 40.2 28.5 53.2 55.1 39.6 34.4 50.0 30.9 21.4 20.4 16.0 17.2 29.5 21.9 62.1 27.0 23.7 31.6 38.0 31.6 25.1 20.5 31.6 49.3 24.2 32.4 22.0 10.7 29.2 22.5 26.3 22.9 23.4 23.6 21.5 22.2 24.0 27.4 19.1 23.1 27.9 23.3 42.4 17.6 23.4 19.9 36.4 36.9 24.9 42.8 26.1 30.5 37.9 24.6 50.6 43.5 12.8 16.7 17.0 27.7 22.0 24.3 36.3 34.9 41.5 12.7 44.0 44.7 28.2 30.9 25.0 30.0 49.0 32.6 54.0 43.2 17.7 22.7 34.5 52.4 36.2 22.4 33.4 23.8 16.3 28.7 44.8 48.2 30.3 34.2 33.5 31.5 39.1 43.9 39.3 39.6 29.6 53.1 21.2 45.1 33.2 34.4 25.6 31.3 26.3 18.6 39.8 30.6 23.0 31.3 57.2 35.8 22.3 33.8 23.0 16.4 27.4 47.0 42.7 19.6 42.4 41.4 24.7 36.3 72.3 68.3 39.4 90.8 25.4 21.4 22.6 16.7 28.9 14.3 30.9 10.4 12.5 24.6 37.9 6.9 9.9 50.6 12.8 43.5 24.2 9.0 17.0 40.2 53.2 34.4 50.0 38.0 31.6 24.2 32.4 22.9 19.9 44.7 37.6 120.5 45.1 105.9 0.0 68.2 66.2 34.8 50.0 66.3 0.0 53.8 76.3 60.3 68.1 93.1 49.6 70.0 44.7 56.8 87.2 72.5 93.8 50.8 91.4 0.0 31.8 97.0 229.9 24.5 80.0 156.1 96.2 119.0 41.0 0.0 73.4 59.1 116.3 67.4 0.0 90.5 53.6 60.7 100.9 130.2 57.6 66.6 47.3 89.4 MTR cblG ENSG00000116984 "5-methyltetrahydrofolate-homocysteine methyltransferase" Q99707 1 236795281-236903981 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Methyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 84.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044474, HPA054915" Approved Supported Cytosol NA NA Cytosol "HPA044474: AB_10966696, HPA054915: AB_2732589" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (6.96e-2)" "unprognostic (1.99e-1)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (4.87e-1)" "unprognostic (1.02e-1)" "unprognostic (2.48e-2)" "unprognostic (3.34e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-1)" "unprognostic (1.67e-2)" "unprognostic (8.84e-3)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (8.10e-2)" 14.5 11.4 9.9 13.2 13.5 7.6 13.6 14.8 14.4 16.9 16.4 16.2 16.0 7.5 18.1 27.3 10.4 18.4 16.3 21.9 9.4 9.8 21.2 9.5 11.7 14.3 12.6 12.8 24.7 20.8 27.4 12.4 17.5 13.0 14.0 8.9 17.7 11.1 17.3 27.0 15.4 11.7 23.3 12.1 13.9 14.9 20.1 12.1 20.8 22.4 11.1 13.2 18.4 14.4 3.3 1.6 3.0 2.0 2.3 5.8 2.1 9.9 6.7 8.3 6.8 15.4 14.2 9.8 8.8 7.8 9.7 10.1 6.4 7.7 22.3 8.1 9.8 5.2 6.9 10.7 7.8 11.6 10.3 9.2 13.1 9.0 11.7 10.3 20.7 8.2 20.2 4.9 12.8 12.3 7.6 12.8 12.1 18.8 10.5 8.1 6.9 10.8 6.7 11.1 8.2 3.6 11.8 14.7 14.3 7.0 11.6 6.8 18.9 9.9 7.2 8.8 6.1 10.3 8.5 16.6 16.0 6.1 12.2 11.3 22.7 7.0 13.0 10.4 13.1 15.8 2.7 1.6 3.0 3.2 2.0 5.8 2.7 4.2 4.5 1.5 3.3 5.0 4.0 0.1 2.3 1.5 1.6 2.9 2.1 9.9 13.5 14.8 14.4 9.4 9.8 12.6 12.8 13.0 12.1 53.6 31.2 20.1 6.8 7.2 0.0 84.0 20.4 20.1 13.6 38.4 0.0 19.3 1.7 11.9 5.3 12.8 6.3 0.0 12.8 7.8 17.5 8.3 29.0 9.6 12.6 0.0 8.1 15.4 16.5 4.2 22.2 10.4 10.1 10.8 7.3 0.0 11.7 10.5 31.1 5.7 0.0 6.5 15.5 14.9 19.7 4.4 18.9 11.7 12.1 4.8 MTRR cblE ENSG00000124275 "5-methyltetrahydrofolate-homocysteine methyltransferase reductase" Q9UBK8 5 7851186-7906025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 57.4;Late spermatids: 61.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038113 Supported Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA038113: AB_10671520" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (5.32e-2)" "unprognostic (1.17e-2)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.60e-4)" "unprognostic (2.56e-2)" "unprognostic (5.82e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (9.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" 12.2 12.3 11.2 10.5 13.8 5.4 9.7 15.6 14.3 10.8 10.4 24.1 11.5 10.3 17.3 15.9 10.5 11.3 13.3 15.8 14.2 12.9 22.0 23.9 14.9 11.4 18.1 9.6 13.6 13.6 9.4 13.1 11.6 16.6 10.8 11.9 13.6 11.3 7.4 34.6 10.5 11.5 14.2 22.1 9.3 9.2 8.4 12.5 8.1 14.7 9.9 13.5 13.6 8.8 4.6 4.8 4.6 6.8 3.4 11.4 4.2 9.4 8.9 4.7 10.5 18.2 5.9 13.5 14.7 8.7 7.3 8.4 13.4 7.6 15.9 14.1 11.8 14.0 6.1 7.3 7.2 13.9 10.1 8.2 7.6 31.0 7.1 11.1 11.6 3.3 9.5 6.6 12.4 9.1 10.4 4.7 4.1 9.9 12.1 4.3 1.8 7.4 5.9 3.6 14.0 9.9 6.1 5.1 6.7 7.9 7.4 7.4 1.0 25.8 18.8 16.2 9.7 5.8 9.0 7.3 17.1 10.8 13.1 11.5 18.0 5.9 13.1 12.4 25.6 9.1 4.6 5.1 4.1 5.5 6.8 9.5 4.6 9.2 7.9 4.8 4.1 5.4 5.1 0.1 3.4 5.4 2.7 11.4 4.2 11.2 13.8 15.6 14.3 14.2 12.9 18.1 9.6 16.6 12.5 14.9 57.4 8.2 7.5 14.4 0.0 10.1 2.5 9.4 11.4 8.7 0.0 8.3 18.3 8.0 40.0 7.0 8.5 0.0 4.9 7.5 10.2 9.9 10.3 16.6 6.7 0.0 9.2 10.4 12.5 61.7 9.8 8.7 1.7 5.4 9.6 0.0 5.8 7.0 11.0 23.3 0.0 6.5 13.3 16.9 11.9 18.1 9.4 12.9 8.9 7.0 MTSS1 "KIAA0429, MIM, MIMA, MIMB" ENSG00000170873 "MTSS1, I-BAR domain containing" O43312 8 124550790-124728429 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 152.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 44.8" "Group enriched" "Detected in many" 4 "B-cells: 16.1;monocytes: 44.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.1;HDLM-2: 24.2;HEL: 83.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019613, HPA064003, HPA075540" Approved Supported Approved "Plasma membrane,Cytosol" NA NA 10000 "Plasma membrane, Cytosol" "HPA019613: , HPA064003: , HPA075540: AB_2686756" "unprognostic (1.70e-1)" "unprognostic (4.13e-2)" "unprognostic (9.50e-2)" "unprognostic (1.38e-1)" "unprognostic (3.87e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-1)" "unprognostic (2.50e-1)" "unprognostic (8.12e-2)" "unprognostic (1.48e-1)" "prognostic favorable (2.11e-7)" "unprognostic (6.74e-2)" "unprognostic (1.04e-1)" "unprognostic (2.41e-1)" "unprognostic (8.92e-3)" 18.7 27.3 14.0 9.2 16.3 8.5 12.4 36.0 19.1 8.1 8.2 32.1 1.7 5.0 5.6 15.8 32.4 8.9 7.0 13.4 13.5 13.6 18.2 51.5 12.0 12.1 18.1 10.3 8.2 21.0 2.6 10.5 25.3 16.9 7.9 7.0 19.8 10.2 5.3 16.5 21.3 5.0 7.2 20.9 23.9 9.0 15.8 20.0 8.2 4.1 12.1 12.2 9.7 13.7 16.1 3.3 0.6 44.8 0.6 6.9 6.8 0.9 0.2 13.2 0.3 21.1 10.9 0.0 0.5 3.5 0.2 0.1 1.2 0.1 0.4 1.3 0.0 0.1 0.2 0.1 7.3 0.2 24.2 0.4 83.0 0.2 6.6 4.8 0.0 8.9 17.3 16.8 4.0 10.5 0.5 7.9 0.1 0.1 0.1 1.4 0.7 0.2 1.0 0.5 13.5 0.1 0.1 0.0 0.1 2.9 2.8 9.5 0.8 2.0 2.0 6.7 0.7 0.3 0.2 4.1 0.7 0.4 0.0 0.2 0.2 0.2 1.4 7.6 0.2 2.7 0.6 3.9 0.0 6.9 25.6 0.8 13.2 1.5 2.6 3.3 16.1 0.7 2.1 0.6 0.6 44.8 0.0 0.1 6.8 14.0 16.3 36.0 16.7 13.5 13.6 18.1 10.3 16.9 20.0 0.0 21.1 45.6 48.9 31.8 0.0 27.4 30.6 33.5 18.2 62.8 0.0 25.3 18.3 13.8 44.0 23.2 2.5 0.0 4.6 1.9 16.6 37.6 45.1 69.1 57.6 0.0 42.4 74.3 152.0 42.3 3.4 94.8 25.3 120.0 19.1 0.0 21.1 14.0 4.2 16.2 0.0 38.8 12.2 2.8 11.5 55.5 78.9 13.4 15.0 51.5 MTTP "ABL, MTP" ENSG00000138823 "Microsomal triglyceride transfer protein" P55157 4 99563761-99623999 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Lipid transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 49 "intestine: 211.4;liver: 60.8" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 201.1" "Cancer enriched" "Detected in many" 13 "liver cancer: 28.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" "Group enriched" "Detected in some" 6 "AF22: 12.8;Hep G2: 14.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA051170, HPA054862" Uncertain Uncertain Cytosol "Intracellular and membrane" NA NA 450000 Cytosol "HPA051170: , HPA054862: AB_2682628" "unprognostic (1.66e-2)" "unprognostic (1.14e-1)" "unprognostic (5.64e-2)" "unprognostic (5.33e-2)" "unprognostic (3.49e-3)" "unprognostic (7.38e-2)" "unprognostic (1.05e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (3.66e-2)" "unprognostic (1.00e-2)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (2.02e-2)" "unprognostic (3.64e-1)" "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" 0.1 0.1 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.0 53.2 0.2 0.1 53.4 0.0 0.0 0.2 0.2 0.4 0.4 0.3 0.4 2.7 60.8 0.1 0.0 0.4 0.1 1.1 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 211.4 0.7 0.4 0.1 0.2 1.8 0.2 0.1 0.1 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.8 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.3 0.5 0.0 0.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.2 0.3 0.1 14.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.7 0.6 0.0 0.3 0.3 0.2 1.3 0.0 0.0 0.8 1.0 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.3 0.4 0.4 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.6 0.0 0.0 1.8 0.0 0.1 0.0 0.0 25.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 201.1 0.1 0.0 0.0 5.5 3.3 7.9 0.9 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.4 18.6 0.0 6.5 0.0 21.9 1.5 0.0 0.0 0.0 0.0 0.0 MTURN "C7orf41, Ells1, FLJ25903" ENSG00000180354 "Maturin, neural progenitor differentiation regulator homolog" Q8N3F0 7 30134810-30162762 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 189.2" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 9.9" "Group enriched" "Detected in many" 4 "granulocytes: 9.9;NK-cells: 3.0" "Cell line enhanced" "Detected in many" "ASC diff: 23.1;HEL: 40.2;SCLC-21H: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029507 Enhanced Approved Cytosol NA NA Cytosol "HPA029507: AB_10601149" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (3.70e-1)" "unprognostic (7.14e-2)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-3)" "unprognostic (9.80e-2)" "unprognostic (1.94e-1)" "unprognostic (1.11e-3)" "unprognostic (8.11e-3)" "prognostic favorable (7.64e-13)" "unprognostic (9.50e-2)" "unprognostic (7.64e-2)" "unprognostic (4.64e-1)" "unprognostic (3.26e-1)" 35.9 5.7 113.5 4.8 86.7 9.3 14.2 21.7 100.8 12.9 5.2 97.0 3.3 3.0 7.9 45.6 9.6 8.2 5.3 11.2 122.8 79.5 24.7 2.3 10.1 2.8 162.4 26.2 16.5 6.2 9.7 2.7 4.0 54.2 9.2 5.3 2.9 14.9 12.0 14.3 7.8 3.4 8.5 189.2 4.1 10.0 4.5 49.4 0.0 6.7 2.4 3.0 6.0 6.5 0.7 1.4 9.9 0.4 3.0 0.8 2.4 5.1 0.9 3.0 3.2 23.1 15.8 2.7 2.5 2.9 0.8 1.2 0.4 2.1 0.3 2.1 5.5 4.8 1.0 6.8 9.8 2.8 2.2 5.5 40.2 6.4 2.8 1.8 2.0 13.3 7.8 4.6 2.6 4.7 3.7 1.3 5.5 2.5 2.1 5.8 1.9 2.3 0.9 2.1 4.8 3.2 0.2 7.1 8.6 10.3 2.1 29.7 7.9 1.6 8.1 8.1 3.0 5.7 3.0 6.5 3.4 3.7 7.1 3.5 3.6 5.1 0.4 4.5 4.3 1.7 9.9 0.4 4.8 0.5 0.2 0.1 0.7 0.3 0.2 0.6 0.5 0.2 0.5 3.1 3.0 0.0 1.4 0.8 2.4 113.5 86.7 21.7 51.7 122.8 79.5 162.4 26.2 54.2 49.4 14.9 18.3 2.9 13.7 33.3 0.0 22.0 17.8 22.7 9.1 41.8 0.0 1.8 132.6 7.5 10.1 17.9 0.4 0.0 7.6 5.5 12.8 24.6 5.8 4.4 4.8 0.0 52.0 18.4 18.2 26.7 15.8 6.5 52.3 10.8 9.2 0.0 8.6 5.7 11.7 9.1 0.0 6.5 31.2 1.4 3.4 32.1 1.8 6.9 3.0 16.5 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720882-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 50.6" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 60.2;Urothelial cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 25.3" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 11000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 1.7 1.2 1.1 3.4 2.1 1.2 1.8 2.5 1.2 6.3 15.2 1.1 4.7 3.2 1.5 5.2 15.9 5.7 8.7 1.1 1.1 0.7 50.6 4.8 6.4 1.1 1.1 1.1 4.6 7.6 1.0 4.6 13.3 1.1 4.9 7.6 1.2 10.6 1.8 2.5 2.1 4.1 2.0 1.1 1.6 2.3 1.8 1.1 3.0 3.9 1.9 14.9 10.6 26.6 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 3.0 0.1 0.5 0.0 0.2 1.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.5 3.4 0.1 0.8 0.1 0.8 0.0 1.9 1.0 0.3 0.0 25.3 0.2 0.4 0.1 0.0 0.0 0.2 0.7 0.9 0.1 1.1 1.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 2.5 1.2 1.1 0.7 1.1 1.1 1.1 1.1 32.8 14.7 0.0 8.8 1.5 20.2 0.5 10.2 60.2 37.5 21.0 33.4 0.0 1.7 32.3 0.0 1.3 15.6 0.0 8.7 0.1 1.5 12.8 1.1 6.4 0.4 11.1 13.3 1.8 0.6 0.0 4.9 0.9 3.3 0.0 7.2 5.6 13.7 18.6 6.0 1.4 22.0 0.0 1.6 1.1 0.7 1.6 0.0 0.5 13.5 102.7 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508161 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favorable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 13.3 15.9 10.3 12.9 12.3 20.6 20.4 9.2 22.2 13.1 15.8 19.0 8.0 11.6 18.2 10.7 17.2 17.0 18.5 26.2 11.7 12.5 20.5 20.1 16.3 12.1 16.8 9.5 17.5 26.8 21.9 13.0 21.6 17.6 13.9 13.3 14.3 15.3 18.1 26.7 17.4 19.5 17.0 11.7 13.6 15.2 14.1 11.6 18.5 15.1 14.6 14.0 16.3 13.6 23.2 26.0 31.9 30.4 25.2 32.1 27.5 17.1 16.6 9.6 19.8 20.8 11.7 10.4 17.0 20.4 21.2 20.5 10.2 28.5 12.9 19.1 24.0 16.1 26.1 17.2 24.6 15.5 12.8 13.6 9.9 11.2 14.8 24.5 13.5 17.0 19.1 32.5 21.7 22.6 12.5 13.8 11.7 12.9 15.8 23.0 8.7 8.1 9.1 9.8 14.3 15.9 8.0 12.1 16.7 25.0 9.6 9.8 14.5 15.3 16.4 20.9 8.1 11.5 13.0 15.6 20.7 11.9 18.0 15.2 18.5 16.1 13.9 16.2 18.4 19.1 26.3 26.5 31.9 30.9 30.4 32.1 23.2 23.6 31.4 26.0 21.5 27.1 26.3 24.0 25.2 25.4 20.1 32.1 27.5 10.3 12.3 9.2 22.2 11.7 12.5 16.8 9.5 17.6 11.6 20.8 9.3 11.7 7.8 4.6 12.5 14.6 12.7 9.4 6.8 17.4 5.9 33.7 10.0 21.4 1.6 9.7 12.0 0.0 20.3 20.8 12.1 8.1 3.5 11.9 19.7 12.7 8.2 10.4 11.4 2.8 12.0 7.7 18.6 21.6 11.8 15.6 19.7 11.5 14.5 8.7 10.5 19.4 8.5 10.6 13.4 6.1 31.5 10.8 10.1 9.0 MUM1 "EXPAND1, MUM-1" ENSG00000160953 "Melanoma associated antigen (mutated) 1" Q2TAK8 19 1354711-1378431 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 192.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048063 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA048063: AB_2680243" "unprognostic (2.50e-2)" "unprognostic (4.67e-1)" "unprognostic (1.72e-1)" "prognostic favorable (4.82e-4)" "unprognostic (1.14e-1)" "unprognostic (4.21e-3)" "unprognostic (4.84e-2)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.25e-6)" "unprognostic (1.60e-1)" "unprognostic (6.05e-3)" "unprognostic (5.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (7.29e-3)" 6.7 5.3 14.4 3.6 20.9 2.1 5.6 21.9 19.2 7.0 5.8 13.6 4.5 3.7 10.4 5.6 4.3 13.0 5.4 5.3 13.6 9.1 4.9 8.3 6.8 3.6 14.2 11.5 18.4 4.0 7.7 7.5 6.0 11.5 6.7 4.8 5.8 6.7 8.7 5.5 8.1 4.8 11.5 10.5 6.0 4.8 19.9 13.1 1.9 6.0 0.9 4.5 5.6 11.5 4.3 3.9 11.8 2.6 3.8 4.5 1.3 7.2 9.3 13.0 13.8 10.6 14.1 15.9 12.6 7.9 11.6 8.6 6.4 4.8 14.7 5.9 16.2 4.1 8.2 13.1 8.2 8.8 15.8 8.3 7.9 9.5 9.6 10.2 6.1 17.8 9.2 5.1 6.5 4.7 14.9 11.8 9.9 12.2 7.4 11.0 8.1 10.4 6.5 14.7 8.1 5.3 16.8 10.9 6.1 7.7 10.5 9.4 21.5 11.1 13.1 8.4 11.8 6.4 14.0 11.3 10.5 14.6 8.5 11.6 15.0 12.6 6.7 14.0 9.9 14.2 11.8 1.1 6.8 4.5 2.6 3.8 3.9 2.5 3.3 2.1 4.3 3.7 4.0 2.2 3.8 2.2 3.9 1.6 1.3 14.4 20.9 21.9 19.2 13.6 9.1 14.2 11.5 11.5 13.1 32.8 18.3 29.6 30.8 15.0 192.5 23.6 48.4 30.8 14.8 17.4 133.5 16.7 10.0 30.8 84.4 21.8 35.5 0.0 19.1 20.1 33.2 18.7 32.4 72.0 15.3 151.0 36.8 28.8 14.8 101.3 53.8 14.7 28.7 20.8 26.2 51.9 24.8 28.3 53.0 11.0 82.1 116.4 31.5 168.6 74.1 12.9 11.9 20.8 29.5 16.6 MUT ENSG00000146085 "Methylmalonyl-CoA mutase" P22033 6 49430360-49463191 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Isomerase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.5" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035971, HPA035972" Enhanced Approved Mitochondria,Cytosol NA NA 110000 Cytosol Mitochondria "HPA035971: AB_10696648, HPA035972: AB_2674895" "unprognostic (1.34e-2)" "unprognostic (1.12e-1)" "unprognostic (1.17e-2)" "unprognostic (3.72e-2)" "unprognostic (3.18e-3)" "unprognostic (1.20e-1)" "unprognostic (1.16e-2)" "unprognostic (1.16e-2)" "unprognostic (3.62e-2)" "unprognostic (1.89e-2)" "unprognostic (6.57e-2)" "unprognostic (9.89e-2)" "prognostic favorable (8.71e-13)" "unprognostic (5.38e-2)" "unprognostic (3.78e-1)" "unprognostic (6.01e-3)" "unprognostic (1.91e-1)" 10.7 14.3 10.9 5.7 13.4 4.1 9.7 10.0 12.1 8.9 12.7 8.6 9.0 13.6 8.7 8.6 13.2 8.4 7.5 16.6 10.1 10.0 25.5 96.5 7.8 5.7 11.8 9.5 13.1 15.7 15.8 13.5 7.5 12.0 11.2 11.2 8.0 9.3 9.2 13.7 9.0 14.7 11.8 9.7 6.4 10.9 9.1 9.9 8.2 11.2 9.1 5.8 12.8 8.1 9.4 8.9 14.0 15.2 14.2 12.0 6.7 13.4 4.8 14.5 16.9 28.9 27.5 8.0 12.1 16.0 12.8 19.0 5.5 7.0 12.5 9.7 12.9 19.4 7.7 16.1 8.6 18.1 10.6 11.7 6.6 11.0 14.4 21.1 8.5 6.4 16.6 12.8 13.0 15.2 11.5 12.3 13.6 12.0 15.0 15.0 8.4 9.9 8.4 6.2 14.2 3.5 8.9 18.2 17.2 14.8 12.9 13.5 9.4 13.3 9.6 20.0 15.9 8.3 13.6 8.8 11.9 8.8 16.1 16.3 5.9 6.7 10.7 16.8 10.0 10.4 14.0 7.5 12.5 7.9 9.9 9.9 9.4 9.5 9.9 8.9 8.3 12.0 9.0 4.3 14.2 15.2 6.3 11.9 6.7 10.9 13.4 10.0 12.1 10.1 10.0 11.8 9.5 12.0 9.9 17.9 17.4 10.4 16.2 17.7 16.5 60.2 22.9 18.7 21.6 31.4 2.0 21.2 24.9 14.4 5.7 10.0 27.4 0.0 12.8 11.2 13.8 13.3 10.4 117.7 10.8 19.1 50.0 14.1 10.0 2.1 22.2 9.4 8.5 2.8 23.1 28.2 10.5 23.0 26.2 34.2 15.2 32.3 12.2 18.6 14.3 17.6 27.9 7.9 21.2 11.5 MVD MPD ENSG00000167508 "Mevalonate diphosphate decarboxylase" P53602 16 88651935-88663161 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041404, HPA048250" Uncertain Approved "Cell Junctions,Cytosol" NA NA 30000 Cytosol "Cell Junctions" "HPA041404: AB_2677457, HPA048250: AB_2680329" "unprognostic (1.67e-1)" "unprognostic (3.05e-1)" "unprognostic (2.42e-1)" "prognostic favorable (2.17e-4)" "unprognostic (1.89e-1)" "unprognostic (9.56e-2)" "unprognostic (9.26e-3)" "unprognostic (8.33e-2)" "unprognostic (6.68e-2)" "unprognostic (5.47e-2)" "unprognostic (2.51e-1)" "unprognostic (6.22e-2)" "unprognostic (1.19e-3)" "unprognostic (4.12e-2)" "unprognostic (1.69e-1)" "unprognostic (2.11e-1)" "unprognostic (5.00e-2)" 11.9 18.5 15.8 16.9 19.7 7.6 12.5 21.7 27.9 10.8 19.4 17.1 10.8 39.6 8.4 7.3 30.0 7.4 8.7 11.9 17.2 18.2 9.2 25.9 14.6 12.6 14.6 17.3 11.1 19.0 11.0 7.8 7.6 24.5 13.7 5.1 10.8 16.1 8.7 27.8 18.3 20.7 6.6 23.8 11.1 21.2 23.0 14.6 4.3 9.2 18.6 12.2 7.3 13.8 15.0 17.6 2.5 8.9 18.1 18.1 9.4 14.7 9.5 15.9 10.3 5.4 11.9 9.0 7.3 7.7 5.0 4.3 25.1 37.5 7.1 11.9 4.3 18.6 22.0 7.1 39.0 1.4 4.5 12.1 5.2 5.2 38.1 10.9 3.3 3.7 9.4 7.5 13.3 4.2 2.5 5.3 17.5 14.6 3.9 2.7 34.5 11.3 17.0 19.1 5.1 9.3 11.8 4.6 18.5 14.8 9.3 16.1 5.4 18.3 4.2 5.3 3.4 20.8 15.0 11.5 4.7 9.5 8.3 4.1 11.0 4.8 24.4 5.6 16.4 7.7 2.5 8.2 1.5 18.1 8.6 13.5 10.3 12.1 11.9 9.5 15.0 9.4 11.5 1.1 18.1 8.9 17.6 12.6 9.4 15.8 19.7 21.7 27.9 17.2 18.2 14.6 17.3 24.5 14.6 23.8 45.3 22.0 10.8 13.5 19.2 11.9 28.1 10.7 15.9 19.2 5.9 20.1 21.6 27.8 48.8 12.0 73.8 0.0 53.8 25.2 18.8 15.9 16.1 17.8 31.6 22.3 31.6 23.9 28.8 70.6 7.5 16.4 20.3 45.9 40.3 14.8 24.2 38.6 8.5 16.5 16.5 6.5 14.2 32.0 13.5 18.9 40.8 32.0 29.4 16.7 MVK "LRBP, MK" ENSG00000110921 "Mevalonate kinase" Q03426 12 109573255-109598117 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Kinase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 59.6;Horizontal cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016961, HPA044110" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA016961: AB_1854220, HPA044110: " "unprognostic (3.10e-1)" "unprognostic (2.27e-2)" "unprognostic (1.85e-1)" "unprognostic (4.43e-2)" "unprognostic (3.66e-2)" "unprognostic (2.08e-2)" "unprognostic (4.30e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (8.23e-2)" "unprognostic (1.30e-1)" "unprognostic (6.43e-2)" "unprognostic (2.09e-1)" "unprognostic (1.58e-1)" "unprognostic (3.88e-1)" "unprognostic (3.28e-1)" 4.7 14.3 6.8 5.9 11.7 6.8 11.2 6.3 13.1 7.1 7.8 16.7 5.1 11.5 4.2 9.5 23.0 5.1 5.3 6.7 7.8 9.0 16.5 33.1 8.7 4.9 12.5 8.3 8.5 9.3 7.0 6.5 5.5 22.5 9.0 6.3 6.4 8.1 5.8 6.3 19.5 6.9 3.7 18.0 3.8 6.1 17.5 10.5 2.8 11.9 8.5 8.8 5.5 9.9 11.5 7.4 3.4 5.9 8.3 12.2 5.4 12.4 10.5 12.8 6.3 4.1 10.1 6.8 4.5 8.4 11.9 13.0 15.0 15.1 8.7 3.5 4.5 19.3 15.1 13.5 21.3 5.8 8.6 9.6 4.7 7.1 22.5 12.7 4.9 6.0 11.0 18.0 21.5 5.8 5.1 8.0 8.5 8.0 8.3 5.3 15.7 5.1 15.8 10.7 5.8 16.2 4.6 9.8 17.1 27.4 18.4 11.8 10.3 8.9 25.2 6.3 5.3 23.2 8.7 7.1 5.5 7.1 5.2 5.8 7.0 9.2 12.9 6.5 12.8 7.4 0.7 5.9 3.4 12.2 5.8 9.9 8.4 7.4 11.6 7.4 11.5 11.7 8.3 1.7 8.3 3.7 6.2 6.2 5.4 6.8 11.7 6.3 13.1 7.8 9.0 12.5 8.3 22.5 10.5 11.9 11.3 13.4 4.5 4.1 10.2 4.4 15.3 9.4 10.3 14.0 17.7 28.9 18.3 11.3 59.6 5.6 12.5 0.0 15.7 10.9 4.7 4.6 1.1 18.5 13.2 58.8 8.6 6.2 4.1 29.2 7.5 3.3 6.8 17.2 7.2 10.0 9.4 2.9 6.7 32.6 11.5 6.5 4.7 19.9 19.0 7.4 40.0 7.5 9.8 4.5 MVP "LRP, VAULT1" ENSG00000013364 "Major vault protein" Q14764 16 29820394-29848039 "Cancer-related genes, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" Ribonucleoprotein "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Enterocytes: 450.3;monocytes: 338.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 69.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002321, CAB002752, CAB022717, HPA064740" Enhanced Supported Cytosol NA NA 38000 Cytosol "CAB002752: , CAB022717: , HPA002321: AB_1079277, HPA064740: AB_2685342" "prognostic favorable (4.51e-4)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "unprognostic (1.80e-1)" "unprognostic (8.17e-2)" "unprognostic (3.03e-2)" "unprognostic (1.11e-2)" "unprognostic (2.22e-2)" "unprognostic (6.03e-3)" "unprognostic (2.19e-1)" "unprognostic (6.85e-3)" "unprognostic (2.86e-1)" "prognostic favorable (5.49e-5)" "unprognostic (2.22e-1)" "unprognostic (5.19e-2)" "unprognostic (5.69e-3)" "unprognostic (2.65e-2)" 32.4 55.4 6.8 37.8 17.9 13.9 20.7 5.4 11.4 20.5 49.5 12.0 11.7 48.7 29.5 29.0 28.6 21.0 46.6 27.8 6.6 6.0 58.9 43.6 57.9 59.4 20.4 4.9 42.7 37.2 8.9 14.6 22.8 13.2 18.3 32.6 14.5 23.3 14.8 16.9 17.6 81.5 24.4 14.6 38.8 34.2 27.4 13.5 17.4 27.1 23.5 23.3 25.4 21.6 10.1 28.7 41.1 53.1 17.6 22.4 33.3 10.6 31.5 0.9 1.0 37.5 49.2 4.6 27.0 44.5 16.5 21.4 4.7 36.1 2.0 22.0 39.5 19.2 13.7 1.5 23.6 8.0 25.7 1.6 0.6 13.6 14.1 33.9 1.0 11.5 64.2 18.6 36.6 10.8 30.6 47.8 2.6 0.7 15.4 29.1 5.3 0.5 2.7 1.0 15.8 3.9 2.4 1.6 6.7 39.7 18.2 3.7 2.1 7.7 10.0 5.6 2.0 2.3 3.8 69.8 21.5 10.7 20.6 10.8 12.1 8.6 1.1 50.1 1.9 4.5 9.7 33.8 13.4 19.3 53.1 15.1 10.1 21.8 19.8 28.7 7.1 16.8 14.9 41.1 17.6 47.5 17.5 22.4 33.3 6.8 17.9 5.4 11.4 6.6 6.0 20.4 4.9 13.2 13.5 44.7 98.7 34.8 31.6 17.4 4.2 10.1 86.6 40.2 47.8 66.3 2.0 102.0 38.1 233.0 4.4 35.9 450.3 23.3 272.7 63.2 42.2 19.8 33.4 21.2 72.1 7.9 54.3 39.9 45.7 14.1 53.2 49.6 30.4 338.2 134.2 3.3 221.7 280.5 44.9 146.5 4.3 19.4 32.8 1.7 1.3 19.2 221.2 37.1 139.8 52.1 MX1 "IFI-78K, MxA" ENSG00000157601 "MX dynamin like GTPase 1" P20591 21 41420304-41459214 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 59.4;Extravillous trophoblasts: 73.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 120.2;BJ hTERT+ SV40 Large T+ RasG12V: 108.2;Karpas-707: 27.8;SK-MEL-30: 36.3" "Low region specificity" "Detected in all" "HPA030917, HPA030918, HPA049724" Approved Approved Supported "Nuclear membrane,Cytosol" No NA "Nuclear membrane, Cytosol" "HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862" "unprognostic (3.62e-1)" "unprognostic (6.84e-2)" "unprognostic (3.41e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (2.27e-1)" "unprognostic (1.35e-3)" "unprognostic (5.86e-2)" "unprognostic (1.77e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (6.88e-2)" "prognostic unfavorable (1.57e-4)" "unprognostic (9.95e-2)" "unprognostic (8.10e-2)" "unprognostic (3.24e-1)" "unprognostic (1.81e-1)" 19.3 7.5 8.6 19.8 22.5 25.7 11.6 3.1 15.5 14.4 12.8 9.4 4.7 14.7 13.2 19.3 19.2 12.4 19.0 8.1 12.4 16.2 20.8 11.9 28.4 17.3 14.3 11.4 16.3 7.2 7.5 16.2 9.7 20.5 7.2 5.4 15.9 54.0 8.4 3.7 5.7 15.4 11.3 13.1 34.5 16.2 5.2 4.8 33.7 16.9 14.5 20.7 15.6 11.5 22.8 25.0 36.5 27.0 9.2 29.5 17.0 2.4 0.0 0.1 0.2 0.1 1.0 0.0 0.1 3.7 120.2 108.2 0.8 5.0 0.0 1.0 0.4 1.2 0.3 0.1 0.1 2.3 0.7 0.1 0.2 0.4 0.3 1.2 0.1 0.1 1.1 0.3 7.2 0.2 0.0 0.4 0.5 0.0 27.8 0.0 0.2 2.0 0.4 0.4 0.0 1.2 2.0 0.1 3.8 0.5 1.5 0.2 0.1 0.1 0.2 36.3 0.0 1.6 0.9 0.2 0.1 0.1 0.0 0.1 6.1 5.7 0.2 0.1 0.4 0.3 13.7 24.0 14.0 10.9 27.0 14.6 22.8 16.0 12.7 16.9 20.1 14.5 10.7 36.5 9.2 22.0 25.0 29.5 17.0 8.6 22.5 3.1 15.5 12.4 16.2 14.3 11.4 20.5 4.8 29.8 25.9 23.1 15.8 5.7 3.4 3.6 12.7 26.8 20.5 22.7 0.0 1.9 16.6 32.5 0.6 59.4 10.1 0.0 48.6 73.8 14.8 6.8 1.1 5.4 46.7 1.6 0.0 16.5 13.3 1.0 10.0 24.5 18.6 17.2 6.7 6.8 30.1 1.5 15.6 3.8 2.2 0.0 18.2 0.3 0.7 3.0 3.4 19.1 2.9 30.8 MXD1 "bHLHc58, MAD, MAD1" ENSG00000059728 "MAX dimerization protein 1" Q05195 2 69897688-69942945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;bone marrow: 72.8;esophagus: 64.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 81.1" "Lineage enriched" "Detected in many" 49 "granulocytes: 81.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001599 Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA001599: AB_1079434" "unprognostic (1.59e-1)" "unprognostic (5.11e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (8.14e-6)" "unprognostic (1.49e-1)" "unprognostic (1.76e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-3)" "unprognostic (3.39e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.50e-4)" "unprognostic (8.72e-2)" "unprognostic (3.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.56e-3)" "unprognostic (1.77e-2)" 6.9 2.2 2.7 18.7 3.8 72.8 3.7 5.7 4.1 15.8 19.6 4.7 0.9 13.6 2.9 2.6 64.8 3.8 4.9 10.8 3.0 2.9 3.0 5.5 17.0 14.3 5.9 2.4 3.3 2.5 3.6 4.0 15.8 3.1 3.3 14.0 5.1 8.8 1.4 3.1 5.9 50.2 4.6 4.3 15.8 8.2 3.6 3.7 9.4 4.0 20.8 34.0 6.3 21.6 0.2 0.8 81.1 1.6 0.4 0.4 0.6 3.5 1.5 2.2 1.6 5.0 2.5 8.4 3.9 2.2 1.9 1.3 4.9 2.8 2.0 2.0 1.5 1.9 12.6 4.2 7.8 2.0 1.1 5.1 4.2 4.5 4.9 16.8 5.0 4.2 2.8 13.3 4.4 20.4 2.4 2.4 2.1 7.3 8.1 1.2 2.8 2.4 10.1 0.6 5.2 2.5 1.1 2.3 5.0 2.5 4.2 7.3 3.1 5.2 7.0 2.7 2.7 1.0 3.0 9.6 2.8 0.8 3.0 3.7 5.5 9.3 0.8 2.9 8.9 1.0 17.0 1.6 16.8 0.3 1.0 0.4 0.1 0.2 0.2 0.8 0.2 0.2 0.3 81.1 0.4 0.8 0.2 0.2 0.6 2.7 3.8 5.7 4.1 3.0 2.9 5.9 2.4 3.1 3.7 35.7 30.8 18.2 23.9 22.9 27.8 4.8 7.6 10.7 11.4 1.8 51.1 7.9 6.6 10.8 12.4 9.0 212.1 0.0 14.8 5.1 13.6 61.3 26.5 6.7 26.9 9.5 93.4 6.2 48.3 15.3 4.4 71.5 15.1 20.8 115.5 40.4 44.4 91.2 2.5 5.1 17.8 0.0 28.7 8.1 2.0 49.3 88.6 20.8 26.6 110.0 MXD4 "bHLHc12, MAD4, MST149, MSTP149" ENSG00000123933 "MAX dimerization protein 4" Q14582 4 2247432-2262294 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053363 Supported Cytosol NA NA Cytosol "HPA053363: AB_2682128" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-2)" "unprognostic (2.84e-2)" "unprognostic (3.54e-2)" "prognostic favorable (2.21e-5)" "unprognostic (1.64e-1)" "unprognostic (5.94e-2)" "unprognostic (8.37e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.39e-5)" "unprognostic (5.65e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (2.64e-2)" "unprognostic (4.12e-2)" 31.9 21.6 20.1 11.8 17.1 23.3 26.2 63.2 23.3 16.5 17.6 15.1 29.8 17.4 19.7 19.7 13.6 24.4 19.2 19.8 16.0 13.1 23.3 12.1 20.0 19.9 13.5 12.4 12.6 18.7 11.4 32.7 24.5 14.4 17.6 7.3 18.3 32.7 26.3 19.3 24.3 16.8 13.8 11.4 29.8 15.1 11.8 11.3 34.8 17.6 8.0 16.1 16.2 21.3 3.5 10.6 8.1 4.3 2.7 5.6 1.9 1.0 3.6 5.7 6.8 20.2 15.0 1.3 7.2 7.4 5.4 5.5 0.8 3.1 3.0 16.2 10.8 2.8 4.9 1.6 5.7 1.4 2.7 17.4 0.5 12.2 10.0 14.9 2.3 6.5 23.4 10.2 1.7 2.7 11.9 12.8 4.5 4.1 5.1 5.0 6.9 5.3 13.4 2.3 4.1 16.1 3.6 1.9 6.3 6.3 5.6 9.3 17.4 6.7 3.3 5.1 7.4 15.6 14.9 30.0 6.0 2.4 4.4 1.6 7.8 5.5 1.1 8.2 2.1 1.7 8.1 4.2 4.8 5.3 4.3 4.3 3.4 4.7 5.0 3.6 3.5 2.4 2.5 1.7 2.7 4.1 10.6 5.6 1.9 20.1 17.1 63.2 23.3 16.0 13.1 13.5 12.4 14.4 11.3 17.9 14.5 26.4 14.2 16.9 79.3 15.7 15.3 5.3 14.8 57.6 82.5 34.2 13.3 14.4 8.0 36.0 42.9 23.3 15.5 42.1 33.4 28.8 24.2 29.8 42.0 62.0 32.2 108.1 54.1 22.1 30.8 25.9 21.9 4.6 47.2 66.8 16.1 28.8 53.0 18.4 95.5 25.8 30.2 4.9 21.1 23.1 27.3 29.9 29.8 10.8 MXI1 "bHLHc11, MAD2, MXD2, MXI" ENSG00000119950 "MAX interactor 1, dimerization protein" P50539 10 110207605-110287365 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 32.0;SK-MEL-30: 52.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035319, HPA035320, HPA056762" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" Yes No Nucleoplasm "Nucleoli, Nucleoli rim, Cytosol" "HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229" "unprognostic (1.77e-2)" "unprognostic (2.02e-1)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.26e-3)" "prognostic unfavorable (9.17e-4)" "prognostic unfavorable (1.02e-5)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-1)" 16.9 19.4 37.2 7.5 34.9 32.7 26.5 56.4 36.9 20.3 26.4 33.9 20.1 12.0 26.0 23.8 39.5 19.1 17.4 36.0 35.1 26.6 23.9 30.5 16.5 7.1 37.0 25.9 46.4 23.1 25.6 12.1 14.4 26.2 24.5 22.1 15.8 41.2 32.7 22.8 25.4 22.5 18.2 44.7 7.8 14.7 13.5 38.1 7.0 29.2 13.4 9.8 32.8 33.9 4.5 2.2 11.0 4.7 1.4 8.6 2.3 5.4 2.2 5.6 11.2 8.8 6.7 2.4 3.2 10.8 2.1 6.6 0.9 9.8 7.2 5.2 5.5 3.5 7.1 6.7 7.6 5.6 3.6 9.0 1.9 4.4 4.1 5.8 3.8 4.3 7.1 29.0 3.7 14.8 32.0 2.0 5.7 7.1 15.6 3.5 3.5 2.5 7.8 2.4 8.9 6.7 1.6 7.3 11.4 7.3 0.5 9.5 15.7 3.1 2.3 52.2 7.3 2.6 12.5 2.0 3.7 6.4 4.0 1.6 12.9 6.8 2.6 10.0 14.2 3.9 2.2 3.1 11.0 3.1 2.5 5.8 3.9 6.7 3.6 1.7 4.5 8.6 2.2 7.8 1.4 4.7 2.2 5.0 2.3 37.2 34.9 56.4 36.9 35.1 26.6 37.0 25.9 26.2 38.1 14.9 15.6 8.3 48.3 51.5 37.3 78.1 28.1 21.4 31.8 31.4 45.2 3.4 39.7 15.1 4.1 38.3 50.6 116.8 12.7 13.2 31.9 46.8 3.5 46.4 10.1 49.3 16.3 19.6 18.4 7.0 41.7 19.0 99.5 18.0 20.8 127.5 14.4 35.1 52.3 53.0 43.0 45.3 88.6 8.6 26.0 58.8 8.1 21.3 15.6 33.1 MYB c-myb ENSG00000118513 "MYB proto-oncogene, transcription factor" P10242 6 135181315-135219173 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 104.9" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 44.2;granulocytes: 25.4;Intestinal endocrine cells: 16.9;Mucus-secreting cells: 26.5;Undifferentiated cells: 37.5" "Cancer enhanced" "Detected in many" "breast cancer: 17.7" "Region enhanced" "Detected in some" "basal ganglia: 4.7" "Group enriched" "Detected in some" 4 "basophil: 5.6;eosinophil: 10.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.0" "Cell line enhanced" "Detected in many" "HL-60: 39.5;MOLT-4: 72.0;NB-4: 37.5;REH: 44.5;THP-1: 62.8;U-937: 34.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB017704, HPA071605" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017704: , HPA071605: " "unprognostic (1.69e-1)" "unprognostic (5.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.37e-2)" "unprognostic (4.06e-1)" "unprognostic (8.35e-3)" "unprognostic (1.13e-3)" "unprognostic (2.48e-2)" "unprognostic (6.44e-2)" "unprognostic (1.00e-1)" "unprognostic (3.71e-2)" "prognostic favorable (9.65e-4)" "unprognostic (2.41e-11)" "prognostic favorable (9.87e-4)" "unprognostic (8.35e-2)" "unprognostic (3.04e-2)" "unprognostic (9.40e-2)" 0.5 0.7 1.3 9.1 4.7 18.9 13.2 0.3 0.6 1.4 15.4 0.5 0.3 6.5 0.9 1.0 3.7 5.0 1.7 0.6 0.7 0.7 0.4 0.5 1.8 3.3 0.3 0.5 1.0 0.3 0.4 0.3 0.6 0.5 1.6 16.7 0.5 0.8 1.5 1.0 3.5 5.9 0.7 0.4 1.4 0.9 2.0 0.6 104.9 0.4 2.0 4.7 0.7 1.5 0.1 1.7 10.0 0.8 0.0 0.5 0.1 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.1 3.1 0.4 25.2 0.1 0.0 0.0 39.5 20.0 0.0 0.0 0.1 0.0 0.0 0.0 24.8 20.4 3.8 0.2 2.0 72.0 37.5 0.2 3.5 0.3 44.5 1.0 6.1 0.0 0.2 1.9 1.2 0.0 2.0 0.0 0.1 1.5 62.8 0.0 0.0 0.3 1.5 0.4 4.8 1.2 12.2 0.0 34.2 0.4 5.6 0.8 10.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 1.7 0.5 0.1 1.3 4.7 0.3 0.6 0.7 0.7 0.3 0.5 0.5 0.6 0.0 2.2 2.9 1.1 2.4 0.6 0.4 2.5 44.2 10.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 2.9 0.0 0.7 0.6 0.4 2.7 25.4 0.0 0.9 0.0 16.9 0.0 1.2 0.0 0.0 1.5 8.5 0.0 26.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 6.0 0.2 1.9 37.5 2.0 MYBL2 "B-MYB, BMYB" ENSG00000101057 "MYB proto-oncogene like 2" P10244 20 43667019-43716496 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 93.5;Extravillous trophoblasts: 28.3;Spermatogonia: 25.7" "Cancer enriched" "Detected in all" 5 "testis cancer: 295.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 30 "plasmacytoid DC: 35.9" "Lineage enriched" "Detected in many" 30 "dendritic cells: 35.9" "Cell line enhanced" "Detected in many" "MCF7: 103.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017114, HPA030530, HPA055416" Uncertain Supported Nucleoplasm,Cytosol Yes Yes Nucleoplasm Cytosol "CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811" "unprognostic (9.75e-3)" "unprognostic (1.29e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (2.35e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.66e-3)" "unprognostic (9.23e-3)" "unprognostic (1.78e-1)" "unprognostic (2.38e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-1)" "unprognostic (2.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" 1.7 0.7 0.2 48.3 0.2 33.0 1.0 0.2 0.2 1.0 4.4 0.2 0.1 2.7 1.1 1.1 8.4 0.3 1.7 0.9 0.2 0.2 1.0 1.2 1.8 22.3 0.3 0.1 0.8 9.4 0.0 0.4 4.0 0.2 0.7 2.7 0.3 2.9 0.1 0.3 1.8 6.4 0.6 0.3 43.9 2.9 12.6 0.1 49.2 0.6 6.4 33.8 1.9 2.1 1.1 35.9 0.0 0.0 0.0 0.4 0.3 26.3 16.8 14.9 15.4 0.1 0.5 19.3 11.9 4.0 37.8 27.9 82.4 16.6 53.3 6.9 5.2 7.9 16.1 26.9 8.2 14.2 9.9 17.2 24.9 16.8 22.2 0.0 22.7 17.3 0.3 0.7 14.4 3.2 0.8 10.1 26.5 24.8 66.3 3.3 103.7 46.1 32.0 17.1 21.2 14.7 32.1 30.6 30.5 7.0 5.4 13.7 20.0 35.5 35.7 3.6 16.4 23.5 24.9 4.7 2.3 38.0 16.7 20.5 23.0 47.4 83.8 4.9 19.5 14.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 35.9 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.0 13.4 0.2 3.8 0.0 1.7 2.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.3 0.0 0.5 93.5 0.8 28.3 0.4 0.1 0.0 0.0 11.2 0.0 0.0 1.3 1.6 10.0 0.0 0.5 1.7 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 3.4 25.7 2.0 3.1 2.1 2.2 0.9 MYD88 ENSG00000172936 "Myeloid differentiation primary response 88" Q99836 3 38138478-38143022 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.0" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 75.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009104 Approved Supported Vesicles,Mitochondria,Cytosol NA NA Cytosol "Vesicles, Mitochondria" "CAB009104: AB_2146724" "prognostic favorable (8.45e-4)" "unprognostic (1.19e-1)" "unprognostic (4.31e-2)" "unprognostic (2.51e-2)" "unprognostic (4.77e-2)" "unprognostic (4.38e-3)" "unprognostic (4.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" "unprognostic (1.01e-2)" "unprognostic (7.30e-2)" "unprognostic (2.11e-2)" "unprognostic (4.41e-1)" "unprognostic (4.17e-2)" "unprognostic (1.65e-1)" "unprognostic (2.08e-2)" 25.0 11.3 5.9 19.5 6.9 18.1 14.7 5.2 4.6 10.0 13.4 5.8 5.0 15.1 9.5 12.3 25.5 9.8 12.4 10.4 5.3 3.2 15.1 47.9 25.6 40.1 6.2 3.5 13.3 10.3 5.4 10.4 17.8 6.7 11.3 14.3 8.8 13.9 5.4 3.9 12.5 30.4 10.7 7.0 39.0 12.5 5.8 5.1 28.5 10.4 17.5 30.8 13.9 13.7 7.8 34.7 49.0 68.0 8.3 14.3 34.6 8.1 12.2 1.8 10.8 8.6 11.2 3.8 8.1 13.2 22.8 24.3 7.6 10.0 17.6 4.8 14.5 5.2 10.3 14.4 8.1 7.6 13.6 3.0 9.5 6.2 11.5 7.1 12.1 24.8 12.9 8.6 12.9 4.8 4.3 13.0 13.5 4.1 7.2 12.0 8.3 19.8 3.9 7.7 17.2 12.1 8.5 2.3 7.5 11.7 19.3 0.8 4.0 11.5 55.1 7.1 1.5 8.6 13.7 12.0 4.5 2.7 20.7 7.7 10.7 11.8 13.1 8.7 21.1 9.7 38.3 37.6 48.1 12.2 56.5 10.4 7.8 11.0 12.2 34.7 6.7 7.7 10.9 49.0 8.3 68.0 16.6 14.3 34.6 5.9 6.9 5.2 4.6 5.3 3.2 6.2 3.5 6.7 5.1 6.0 14.6 17.4 10.4 12.8 0.9 1.5 7.6 10.7 11.4 5.2 0.0 12.2 6.6 22.7 0.7 10.5 25.9 0.0 24.0 20.1 9.1 11.9 24.2 27.6 30.3 0.0 9.2 9.8 75.0 0.6 12.7 48.3 3.3 18.0 16.3 3.5 43.6 34.5 9.9 9.2 0.0 12.9 7.0 2.1 0.4 15.1 10.1 20.3 13.1 37.7 MYH10 NMMHCB ENSG00000133026 "Myosin heavy chain 10" P35580 17 8474205-8630761 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 96.0;Cytotrophoblasts: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 56.0" "Low region specificity" "Detected in all" "CAB017180, HPA047541, HPA057198" Enhanced Supported "Actin filaments,Mitochondria,Cytosol" NA NA 130000000 "Actin filaments" "Mitochondria, Cytosol" "CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364" "unprognostic (4.67e-2)" "unprognostic (9.64e-3)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (2.40e-1)" "unprognostic (2.33e-2)" "unprognostic (2.75e-1)" "unprognostic (6.45e-2)" "unprognostic (4.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-3)" "unprognostic (1.69e-2)" "prognostic favorable (1.38e-4)" "unprognostic (2.02e-2)" "unprognostic (2.73e-1)" "unprognostic (5.58e-2)" "prognostic unfavorable (6.42e-4)" 18.3 12.3 12.6 5.4 24.7 7.9 9.6 15.6 30.8 16.9 7.3 5.4 5.3 1.9 19.9 12.4 5.0 18.0 18.2 25.7 15.1 12.9 23.7 13.0 40.0 4.2 9.5 16.7 21.8 6.9 14.7 18.4 35.9 19.2 12.9 3.1 8.6 4.7 19.6 3.3 5.1 3.9 15.7 4.9 3.3 7.1 5.3 5.9 2.7 9.7 2.6 3.0 9.8 7.4 0.5 0.2 2.8 0.1 0.0 1.1 0.2 13.3 8.8 56.0 18.7 7.3 8.8 25.2 11.2 10.1 13.6 14.6 23.7 2.0 0.1 7.4 11.0 7.4 1.3 27.8 13.4 15.2 0.3 22.6 15.5 5.7 20.6 17.2 1.3 1.0 12.5 4.9 17.5 6.8 8.4 21.8 18.1 21.5 0.0 8.4 5.3 16.4 0.4 26.3 0.9 1.9 26.3 16.6 0.0 15.4 5.6 4.6 25.2 17.5 0.8 17.9 44.9 4.7 0.9 0.7 12.8 9.4 0.0 9.6 2.1 2.6 3.4 0.0 1.2 28.6 0.0 0.1 0.1 0.3 0.0 0.3 0.5 0.3 0.6 0.0 0.2 1.1 0.5 2.8 0.0 0.0 0.2 0.3 0.2 12.6 24.7 15.6 30.8 15.1 12.9 9.5 16.7 19.2 5.9 20.8 13.1 0.5 8.0 4.1 35.4 26.9 7.6 26.8 14.8 96.0 47.1 123.2 14.9 10.8 44.7 37.5 0.0 23.3 1.6 73.0 63.0 8.6 1.1 13.1 13.8 33.4 2.4 60.2 3.8 18.2 3.4 1.4 1.7 1.0 1.4 23.8 2.7 0.0 37.4 12.9 34.3 0.0 10.8 8.2 29.6 3.4 64.0 2.2 1.7 3.1 MYH11 "SMHC, SMMHC" ENSG00000133392 "Myosin heavy chain 11" P35749 16 15703172-15857033 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Aortic aneurysm, Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 507.4;urinary bladder: 394.5" "Group enriched" "Detected in many" 29 "Peritubular cells: 1569.5;Sertoli cells: 614.4;Smooth muscle cells: 1327.8" "Cancer enhanced" "Detected in many" "prostate cancer: 173.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 3.6;NB-4: 3.9;U-698: 9.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 54.5" "CAB002302, HPA014539, HPA015310" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 130000000 "Plasma membrane, Cytosol" "CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261" "unprognostic (7.99e-2)" "unprognostic (3.07e-2)" "unprognostic (4.18e-2)" "unprognostic (9.21e-3)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "prognostic favorable (1.10e-5)" "unprognostic (1.41e-2)" "unprognostic (1.87e-1)" "unprognostic (3.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-3)" "unprognostic (4.06e-2)" "unprognostic (9.53e-2)" "unprognostic (5.00e-2)" "unprognostic (5.45e-3)" 13.2 3.0 0.6 31.5 1.2 0.0 5.9 0.5 1.7 90.3 227.5 1.3 100.0 11.6 102.0 38.4 233.0 43.8 94.3 6.2 0.6 0.7 4.7 0.7 8.5 1.5 1.4 2.6 45.5 1.3 0.0 1.0 5.3 3.6 164.7 22.2 37.0 8.8 127.2 6.4 5.0 50.6 507.4 1.4 3.7 77.7 22.3 0.2 0.1 3.7 6.2 3.0 394.5 57.5 1.5 0.9 6.0 0.9 1.1 1.5 0.4 0.1 0.4 0.2 0.1 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.4 0.2 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 1.5 0.0 0.3 0.3 3.9 0.4 0.1 0.1 0.4 0.2 1.9 0.0 0.2 0.7 1.4 0.2 0.5 1.2 0.2 0.5 0.0 0.3 0.1 0.3 2.0 0.1 0.5 0.4 9.9 0.4 0.4 0.4 3.1 0.9 2.7 1.2 0.6 1.2 1.5 1.5 1.4 0.5 1.2 1.4 1.4 6.0 1.1 0.6 0.9 1.4 0.4 0.6 1.2 0.5 1.7 0.6 0.7 1.4 2.6 3.6 0.2 0.0 2.6 4.5 1.6 11.7 1.5 38.7 0.0 1.4 2.3 0.0 7.9 0.2 0.0 0.0 36.6 5.7 0.0 0.0 0.3 0.2 8.0 5.1 0.0 0.0 1.1 0.0 1.2 4.3 0.0 30.8 39.7 3.8 11.8 2.8 0.3 0.3 0.2 0.0 1569.5 0.0 1.6 614.4 1327.8 3.2 7.5 16.3 0.0 4.9 0.4 2.5 MYH15 KIAA1000 ENSG00000144821 "Myosin heavy chain 15" Q9Y2K3 3 108380369-108529322 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell type enhanced" "Detected in some" 13 "Muller glia cells: 7.0;Rod photoreceptor cells: 5.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.4;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 13 "B-cells: 1.4;dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "GAMG: 7.9;Karpas-707: 4.1;PC-3: 8.9;SH-SY5Y: 3.2;U-87 MG: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034871, HPA057915" Uncertain Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA034871: AB_10669996, HPA057915: " "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.31e-3)" "unprognostic (2.62e-1)" "unprognostic (1.70e-1)" "unprognostic (2.96e-1)" "unprognostic (7.84e-3)" "unprognostic (7.32e-2)" "unprognostic (1.89e-2)" "unprognostic (5.67e-2)" "unprognostic (6.67e-2)" "unprognostic (4.42e-2)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (8.41e-2)" "unprognostic (3.57e-2)" 0.1 0.9 2.9 0.3 2.4 0.1 0.1 1.1 4.6 0.3 1.4 1.5 0.0 1.1 0.0 0.5 0.8 1.3 2.8 2.3 0.0 0.0 1.1 0.2 3.3 0.0 0.1 0.0 1.5 0.0 0.7 1.0 0.0 0.0 0.7 1.2 2.3 0.0 3.3 0.6 0.5 1.4 0.3 0.1 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.8 1.7 0.2 0.4 0.1 0.7 0.0 0.2 0.0 7.9 0.1 0.2 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.3 2.3 0.0 0.1 0.0 0.5 0.3 0.4 0.5 0.3 0.0 4.1 2.1 0.0 0.0 0.0 0.1 0.0 8.9 0.2 0.1 0.0 0.0 0.0 0.5 3.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.8 0.9 0.0 0.9 2.2 0.3 0.0 3.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.3 1.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 7.0 0.3 0.0 0.0 0.0 5.3 0.0 0.0 1.2 0.2 0.1 0.0 0.0 1.0 0.0 MYH9 "DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA" ENSG00000100345 "Myosin heavy chain 9" P35579 22 36281277-36388067 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001644, CAB015386, HPA064783" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" No No 3100000000 "Plasma membrane, Actin filaments" Cytosol "CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721" "unprognostic (1.38e-1)" "unprognostic (9.12e-2)" "unprognostic (4.21e-2)" "unprognostic (6.34e-2)" "unprognostic (1.49e-1)" "unprognostic (3.90e-2)" "unprognostic (9.56e-2)" "unprognostic (8.28e-2)" "unprognostic (5.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-1)" "unprognostic (7.98e-2)" "unprognostic (9.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.62e-1)" "unprognostic (2.59e-2)" 115.5 26.1 11.9 43.7 12.9 55.6 59.0 9.3 16.8 67.1 44.6 18.0 26.4 26.9 120.8 39.7 48.3 45.6 66.9 39.2 11.0 8.1 45.0 42.8 74.4 57.7 15.1 9.2 56.4 43.9 19.0 15.4 65.7 17.9 47.6 23.6 32.4 66.2 27.2 36.9 40.3 49.8 46.7 13.5 91.5 37.1 25.8 11.9 76.0 42.5 38.4 65.0 56.0 53.7 6.9 8.2 28.5 11.5 4.2 16.6 19.3 61.6 28.6 9.1 7.8 17.0 21.4 46.4 41.4 53.6 59.1 44.4 30.9 17.7 16.0 24.6 69.2 28.2 42.8 13.3 80.9 60.9 36.0 12.6 30.8 30.7 26.3 52.3 34.9 49.4 25.3 24.9 79.9 67.9 58.0 48.7 11.8 6.7 21.7 47.2 16.4 12.4 20.6 5.4 17.4 17.7 23.6 28.3 14.8 33.4 60.0 13.8 5.6 58.1 22.9 26.7 24.6 17.0 18.1 139.1 131.2 39.8 25.1 74.7 14.3 11.3 13.5 49.6 17.7 38.0 26.8 10.4 28.5 16.6 9.6 14.7 6.9 12.0 13.2 8.2 6.4 9.6 10.1 19.7 4.2 11.5 3.8 12.6 19.3 11.9 12.9 9.3 16.8 11.0 8.1 15.1 9.2 17.9 11.9 110.2 86.9 60.5 130.0 128.0 2.3 53.2 81.5 28.1 77.3 87.2 2.0 72.9 6.6 289.4 34.4 187.8 163.7 0.0 209.5 151.1 61.7 129.5 90.2 89.4 89.7 77.9 70.9 122.8 115.2 27.9 63.0 105.6 81.0 160.5 123.0 11.0 299.7 150.8 198.7 19.2 4.7 200.5 251.3 3.0 6.8 118.2 38.8 112.2 120.6 111.1 MYMX MINION ENSG00000262179 "Myomixer, myoblast fusion factor" A0A1B0GTQ4 6 44216939-44218236 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "adipose tissue: 27.4;blood: 12.2;pancreas: 9.0" "Cell type enhanced" "Detected in some" 24 "Distal tubular cells: 3.3;Exocrine glandular cells: 2.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 121 "dendritic cells: 12.2" "Cell line enriched" "Detected in some" 31 "RH-30: 56.5" "Not detected" "Not detected" HPA051451 Supported Approved Vesicles,Mitochondria,Cytosol NA NA Vesicles "Mitochondria, Cytosol" "HPA051451: " "unprognostic (1.24e-1)" "unprognostic (8.55e-2)" "unprognostic (6.86e-2)" "unprognostic (6.51e-3)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-2)" "unprognostic (2.10e-3)" "unprognostic (4.32e-1)" "unprognostic (1.77e-1)" "unprognostic (8.71e-2)" "unprognostic (2.70e-2)" "unprognostic (2.01e-4)" "unprognostic (1.63e-2)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "unprognostic (2.67e-1)" 27.4 0.0 0.0 1.0 0.0 0.0 2.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.8 0.0 1.1 0.0 0.5 1.4 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.7 0.0 2.2 0.0 0.1 0.0 0.0 1.8 3.2 0.6 0.0 2.8 0.4 0.0 0.4 0.5 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 56.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 12.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYO10 KIAA0799 ENSG00000145555 "Myosin X" Q9HD67 5 16661914-16936276 "Plasma proteins, Predicted intracellular proteins" Transport "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Muller glia cells: 290.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.0" "Lineage enriched" "Detected in many" 5 "monocytes: 6.0" "Cell line enhanced" "Detected in many" "HAP1: 39.5;SK-MEL-30: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015224, HPA024223" Enhanced Supported "Nucleoli rim,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli rim" "CAB015224: , HPA024223: AB_1854248" "unprognostic (1.13e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (7.63e-2)" "unprognostic (1.04e-1)" "unprognostic (4.43e-2)" "unprognostic (2.96e-2)" "unprognostic (4.40e-2)" "unprognostic (8.34e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-2)" "unprognostic (8.42e-2)" "unprognostic (1.85e-1)" "prognostic favorable (2.75e-4)" "unprognostic (8.93e-2)" "unprognostic (9.86e-2)" "unprognostic (4.56e-2)" "unprognostic (1.84e-1)" 10.5 3.4 28.1 5.1 30.1 3.0 8.0 8.9 39.7 6.3 15.3 17.3 6.6 19.5 5.7 4.3 7.7 3.8 7.7 3.7 26.2 10.9 13.3 7.1 14.5 1.6 14.6 15.3 12.1 22.0 10.4 16.2 22.0 10.6 5.4 15.8 19.7 9.8 7.4 6.6 13.4 14.6 4.3 11.1 10.9 24.2 12.4 18.5 0.5 28.6 3.3 2.3 6.6 7.1 0.9 0.5 1.1 6.0 0.5 0.6 0.3 13.4 21.3 8.9 4.2 6.6 3.6 8.2 24.1 17.0 6.7 5.5 13.5 2.2 0.4 16.5 10.9 9.0 7.1 39.5 15.8 12.5 0.0 3.9 0.0 35.6 3.7 24.0 0.1 0.4 7.3 6.9 16.2 19.4 13.0 22.4 0.0 0.0 1.3 6.5 2.6 0.1 0.1 22.9 14.0 7.7 5.4 2.2 14.2 6.8 10.4 1.2 0.6 5.2 2.7 46.2 14.0 1.7 2.2 27.1 16.3 6.0 0.2 13.2 0.2 0.1 0.1 8.0 2.5 16.2 1.0 0.6 0.5 0.3 1.5 0.4 0.3 0.4 0.3 0.5 0.9 0.6 0.6 1.1 0.5 6.0 0.4 0.3 0.3 28.1 30.1 8.9 20.7 26.2 10.9 14.6 15.3 10.6 18.5 32.8 31.7 1.4 29.1 36.4 7.9 2.8 30.6 21.4 28.4 29.6 17.7 18.9 14.9 93.1 19.9 41.2 28.6 0.0 35.5 49.8 11.5 32.7 26.6 0.8 4.8 77.9 71.0 93.3 9.4 6.5 11.8 4.4 64.1 5.4 48.0 290.6 80.7 37.4 18.0 3.6 6.4 64.7 26.7 1.4 6.4 27.9 123.6 2.5 57.5 32.3 MYO15B MYO15BP ENSG00000266714 "Myosin XVB" 17 75588058-75626501 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 10 "intestine: 155.3" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 148.8;Paneth cells: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 26.0;HEL: 10.9;HMC-1: 14.9;THP-1: 21.5" "Not detected" "Not detected" "HPA022857, HPA023105" Approved Cytosol No No Cytosol "HPA022857: AB_1848813, HPA023105: AB_1859526" "prognostic favorable (9.34e-4)" "unprognostic (7.55e-2)" "unprognostic (6.99e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (5.59e-4)" "unprognostic (7.29e-3)" "unprognostic (1.48e-1)" "unprognostic (4.97e-2)" "unprognostic (2.28e-1)" "unprognostic (8.54e-3)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (6.39e-2)" "unprognostic (1.68e-1)" "unprognostic (3.35e-1)" "prognostic favorable (6.90e-5)" 7.5 2.8 4.2 7.3 5.3 13.8 8.9 1.6 4.3 8.0 58.9 8.1 5.4 48.9 13.6 4.5 2.8 10.8 13.5 5.8 4.5 1.7 13.0 2.0 10.7 5.0 6.5 5.5 14.9 3.6 1.8 3.7 4.0 5.1 7.1 5.9 6.5 5.2 4.5 3.1 3.9 155.3 5.9 4.0 13.2 4.8 3.1 5.9 5.5 14.0 2.3 4.0 4.9 7.2 2.8 2.0 6.2 1.5 1.9 1.4 1.1 0.3 26.0 0.3 1.0 0.2 0.4 0.4 0.1 0.0 0.0 0.0 3.4 7.4 0.4 1.0 0.0 0.3 0.4 0.0 0.0 0.0 0.3 2.0 10.9 5.0 6.4 0.7 0.0 14.9 0.7 0.5 0.0 0.0 0.5 0.1 4.6 0.6 2.9 0.0 3.5 0.2 4.3 0.5 7.2 6.5 6.8 0.2 1.1 0.1 0.5 1.0 2.0 0.2 0.4 0.8 0.9 2.3 21.5 0.5 0.1 1.1 0.1 0.1 1.4 0.8 0.1 0.6 5.3 0.4 2.4 1.5 1.2 1.4 1.4 0.9 1.5 0.7 0.5 0.8 2.8 0.5 1.0 6.2 1.9 1.5 2.0 0.2 1.1 4.2 5.3 1.6 4.3 4.5 1.7 6.5 5.5 5.1 5.9 0.0 3.5 8.0 2.1 2.2 3.8 5.6 10.2 6.7 2.3 8.7 15.7 0.1 1.7 1.5 0.5 9.8 148.8 0.0 1.4 0.1 5.1 1.7 13.9 1.6 4.7 1.6 30.4 25.2 9.1 0.4 5.2 10.2 3.3 1.8 31.9 6.1 5.2 56.1 4.6 12.7 14.2 6.5 3.8 3.5 3.6 2.6 0.1 4.3 11.1 1.6 MYO19 "FLJ22865, MYOHD1" ENSG00000278259 "Myosin XIX" Q96H55 17 36495633-36543435 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 50.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021415, HPA059715" Approved Enhanced Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA021415: AB_2266815, HPA059715: AB_2684111" "unprognostic (3.12e-1)" "unprognostic (2.38e-1)" "unprognostic (8.44e-3)" "unprognostic (1.46e-1)" "unprognostic (2.02e-1)" "unprognostic (4.89e-3)" "prognostic unfavorable (8.33e-6)" "unprognostic (1.07e-3)" "unprognostic (1.39e-2)" "unprognostic (2.41e-1)" "unprognostic (1.67e-1)" "unprognostic (3.70e-3)" "unprognostic (1.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.57e-1)" "unprognostic (1.89e-1)" "unprognostic (4.17e-2)" 5.2 1.9 3.1 5.4 6.2 7.8 4.7 2.7 6.5 4.7 7.7 7.0 6.8 7.5 4.3 4.1 9.8 3.4 4.1 1.4 4.7 5.7 7.0 3.8 5.2 6.1 3.1 2.9 5.8 9.8 7.2 8.1 5.0 2.8 11.2 4.8 9.5 9.3 6.3 13.1 7.9 5.2 5.4 3.0 8.3 8.0 5.7 5.8 4.2 5.6 7.2 3.3 2.8 2.2 3.4 1.7 1.7 3.7 3.9 1.4 14.0 17.2 8.2 9.4 4.5 4.5 10.0 14.0 11.2 22.3 22.8 17.0 14.7 8.8 5.5 9.5 7.6 21.2 19.4 14.6 15.9 6.3 13.2 14.1 18.8 10.7 3.0 13.6 15.3 4.3 7.3 15.9 17.4 5.3 9.9 10.7 16.5 9.3 11.3 10.6 9.5 11.1 9.1 15.2 10.2 11.1 13.2 10.5 10.4 11.4 14.1 8.8 18.6 11.4 5.9 12.4 18.7 5.6 6.4 12.5 14.2 17.0 24.6 7.2 14.1 8.1 7.8 8.4 14.6 1.7 1.7 1.7 3.8 1.2 2.8 2.2 2.4 2.6 3.4 1.7 1.7 3.9 0.1 3.7 0.5 1.9 2.0 1.4 8.9 8.1 14.1 10.0 26.3 17.4 3.6 15.3 2.7 5.7 5.2 33.4 7.0 1.7 8.7 50.4 9.5 18.8 0.0 11.4 18.5 7.3 9.0 2.3 7.8 9.6 3.2 10.4 6.2 3.9 17.2 11.5 7.5 3.3 10.0 20.3 5.6 12.4 10.5 9.2 3.6 25.6 0.0 8.2 19.0 17.7 20.6 6.1 12.7 27.7 11.1 MYO1D "KIAA0727, myr4, PPP1R108" ENSG00000176658 "Myosin ID" O94832 17 32492522-32877177 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 110.8;Enterocytes: 119.8;Mucus-secreting cells: 86.3;Paneth cells: 95.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 2.6" "Group enriched" "Detected in many" 5 "B-cells: 1.7;T-cells: 2.6" "Cell line enhanced" "Detected in many" "ASC diff: 34.4;CACO-2: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054744 Uncertain Approved Cytosol NA NA Cytosol "HPA054744: AB_2682589" "unprognostic (3.83e-3)" "unprognostic (1.53e-1)" "unprognostic (9.70e-3)" "unprognostic (3.95e-2)" "unprognostic (6.68e-2)" "unprognostic (1.89e-1)" "unprognostic (1.84e-1)" "unprognostic (2.04e-1)" "unprognostic (8.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" "prognostic favorable (5.01e-6)" "unprognostic (1.73e-1)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.53e-6)" 20.3 16.9 4.4 21.6 14.4 1.8 13.9 8.8 9.7 12.8 53.1 26.2 4.8 40.5 12.5 11.8 19.8 9.2 26.9 7.4 6.4 3.7 15.7 8.1 17.7 6.9 18.4 6.8 14.7 15.2 19.6 7.4 8.4 11.6 11.3 45.6 10.2 18.7 7.1 3.8 22.0 46.5 9.4 20.9 5.9 13.1 6.4 15.7 2.5 21.9 10.6 13.4 12.7 13.9 1.7 0.2 0.3 0.0 0.4 2.6 0.5 9.7 0.4 0.3 0.1 34.4 19.9 0.4 5.8 11.5 1.1 6.8 45.7 15.7 5.5 1.2 26.0 0.2 9.2 1.2 14.7 1.7 0.7 11.8 5.0 0.0 3.2 2.2 0.0 2.7 5.7 9.3 8.5 7.8 0.1 14.4 3.0 8.3 9.2 5.2 11.8 0.0 0.1 1.8 11.1 8.8 0.0 6.7 6.3 4.7 19.3 11.5 1.9 1.9 3.6 29.1 3.0 15.9 0.0 17.8 5.2 2.6 0.2 0.1 11.1 12.7 0.0 7.0 0.0 1.5 0.0 0.0 0.0 1.1 0.0 2.6 1.7 1.2 1.4 0.2 0.3 0.3 0.4 0.3 0.4 0.0 0.0 1.1 0.5 4.4 14.4 8.8 9.7 6.4 3.7 18.4 6.8 11.6 15.7 20.8 12.5 9.3 7.7 7.1 0.6 3.4 25.5 14.7 9.1 22.7 17.7 15.0 5.0 18.0 110.8 9.4 119.8 0.0 20.4 3.3 8.0 13.6 1.1 10.5 7.3 0.0 25.5 4.9 1.0 24.7 5.5 2.8 15.1 0.0 86.3 0.9 36.4 95.1 17.3 1.8 0.8 6.5 15.5 14.6 6.8 9.8 10.4 1.9 66.0 16.9 MYO1E "HuncM-IC, MGC104638, MYO1C" ENSG00000157483 "Myosin IE" Q12965 15 59132434-59372900 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 16.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 51.5;HaCaT: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003003, HPA023886" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA003003: , HPA023886: AB_1854253" "unprognostic (7.90e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.49e-1)" "unprognostic (3.59e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (1.89e-1)" "unprognostic (5.38e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (2.41e-1)" "unprognostic (7.92e-2)" "unprognostic (7.31e-2)" "unprognostic (9.71e-2)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" 25.9 4.6 7.9 18.4 19.0 0.7 13.3 2.3 12.6 13.6 28.5 40.6 26.5 13.6 18.1 17.0 22.1 10.0 21.5 6.8 12.6 7.6 22.4 33.4 11.6 18.9 27.2 7.6 6.8 8.8 23.7 6.6 18.7 17.2 15.6 19.4 13.0 12.4 43.5 7.2 28.8 25.9 12.3 25.5 11.4 17.1 4.7 22.4 2.6 9.9 10.6 21.7 15.6 16.2 7.0 16.9 0.4 3.4 2.5 0.4 1.6 29.6 51.5 2.8 1.9 22.1 18.1 14.6 12.1 5.9 6.7 7.9 12.7 11.6 11.8 8.7 9.4 27.7 47.8 4.3 18.7 9.0 5.4 2.4 0.1 43.0 11.2 20.5 0.0 1.6 24.7 11.5 8.6 25.4 21.4 11.0 0.2 0.0 0.1 11.4 2.7 0.1 0.2 6.8 4.8 11.5 0.0 12.5 7.2 36.4 14.0 1.5 5.1 26.9 5.6 10.4 8.9 3.7 1.3 13.3 13.6 3.9 41.3 11.8 0.0 0.7 0.2 24.9 0.1 12.2 0.0 3.1 0.0 0.1 3.4 0.0 6.6 0.0 0.0 11.0 7.0 0.0 0.0 0.4 2.5 1.2 16.9 0.4 1.6 7.9 19.0 2.3 12.6 12.6 7.6 27.2 7.6 17.2 22.4 6.0 7.7 0.0 21.2 22.0 0.0 3.2 20.4 34.8 6.8 24.4 0.0 3.3 3.3 39.7 3.4 16.1 46.1 0.0 15.8 17.7 9.9 27.4 4.6 9.4 29.8 0.0 18.9 4.3 3.3 5.2 8.6 16.2 18.6 7.2 21.7 11.7 42.3 31.6 11.3 3.0 0.9 12.9 23.0 1.0 3.8 21.0 10.8 1.0 19.6 34.4 MYO1F ENSG00000142347 "Myosin IF" O00160 19 8520790-8577577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 64.9;bone marrow: 50.6;lung: 17.1;lymphoid tissue: 56.1" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 69.4;Kupffer cells: 191.9;Macrophages: 117.9;T-cells: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 15.5;HL-60: 15.3;HMC-1: 27.2;NB-4: 60.4;THP-1: 45.0;U-937: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055242, HPA056036" Enhanced Enhanced Cytosol NA NA 8800 Cytosol "HPA055242: AB_2682754, HPA056036: " "unprognostic (4.86e-2)" "unprognostic (5.86e-3)" "unprognostic (1.39e-2)" "unprognostic (1.04e-3)" "unprognostic (1.76e-2)" "unprognostic (2.12e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (7.47e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.57e-1)" "unprognostic (9.35e-2)" 7.6 3.7 4.8 22.9 9.1 50.6 3.6 1.0 4.6 2.2 4.3 7.5 0.4 4.6 2.1 4.7 2.7 5.4 6.5 4.0 5.2 3.1 3.7 6.2 17.1 24.8 9.0 1.7 2.5 2.3 0.6 2.3 4.8 6.9 3.3 2.3 3.5 3.3 1.3 1.2 1.8 8.5 3.9 9.9 56.1 3.9 1.3 7.0 4.2 2.7 1.8 11.1 6.8 2.5 1.5 15.4 64.9 23.7 7.5 14.9 18.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 15.5 0.0 11.2 0.0 0.0 0.0 15.3 27.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 60.4 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 45.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 24.8 0.0 14.4 23.7 24.5 14.9 19.6 11.6 1.5 5.9 10.2 15.4 0.7 0.4 4.6 64.9 7.5 22.4 1.9 8.1 18.6 4.8 9.1 1.0 4.6 5.2 3.1 9.0 1.7 6.9 7.0 3.0 20.1 25.2 1.9 3.0 0.7 2.1 7.6 0.0 4.5 1.8 2.0 4.1 1.7 1.2 5.2 2.7 2.1 23.3 0.8 6.0 3.1 1.2 30.1 5.6 69.4 6.4 1.2 14.1 191.9 3.6 2.3 117.9 6.8 53.3 1.7 1.4 1.7 1.9 1.1 2.1 0.3 0.0 2.8 2.7 2.1 4.6 4.2 142.2 2.4 1.4 MYO5C MGC74969 ENSG00000128833 "Myosin VC" Q9NQX4 15 52192322-52295798 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 122.1;Alveolar cells type 2: 62.6;Ciliated cells: 60.2;Club cells: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 12.8;MCF7: 22.9;OE19: 20.7;RT4: 13.3;SK-BR-3: 17.5;T-47d: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB020790, HPA032115, HPA032116" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB020790: , HPA032115: AB_2674158, HPA032116: AB_2674159" "unprognostic (1.85e-1)" "unprognostic (1.29e-1)" "unprognostic (3.49e-2)" "prognostic favorable (5.18e-5)" "unprognostic (2.94e-1)" "unprognostic (4.01e-2)" "unprognostic (2.07e-1)" "unprognostic (1.53e-1)" "unprognostic (4.53e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-3)" "unprognostic (4.82e-2)" "prognostic favorable (2.47e-5)" "prognostic favorable (5.82e-4)" "unprognostic (9.15e-2)" "unprognostic (2.34e-1)" "unprognostic (2.32e-1)" 11.2 1.5 2.7 4.0 4.0 0.4 10.7 14.7 3.4 11.1 10.0 3.4 9.5 3.7 3.7 9.8 6.6 8.6 12.2 1.7 2.5 1.7 6.4 2.7 11.4 1.2 2.6 3.0 2.6 33.9 18.5 7.8 2.1 7.5 7.8 13.2 6.5 22.6 12.8 2.1 4.3 4.1 4.2 4.3 2.7 14.2 4.7 3.4 0.5 15.1 3.7 3.8 4.5 18.4 1.2 1.6 1.5 0.0 0.0 2.9 0.1 10.6 12.8 1.8 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 1.9 4.5 0.6 2.7 0.0 0.1 1.7 2.7 3.7 0.0 0.5 4.3 0.0 9.1 7.8 0.0 0.0 0.1 0.0 3.7 0.0 3.6 1.9 2.8 0.4 0.0 0.2 0.0 22.9 0.6 0.1 0.7 20.7 6.1 8.7 1.1 5.3 10.2 13.3 1.8 2.0 0.8 17.5 0.0 2.9 21.1 0.0 0.0 0.0 0.1 0.0 1.6 0.3 0.3 1.0 0.1 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.2 0.2 1.0 0.4 0.4 0.3 1.5 0.0 0.0 1.6 2.9 0.1 2.7 4.0 14.7 3.4 2.5 1.7 2.6 3.0 7.5 3.4 122.1 62.6 0.5 13.4 0.6 0.0 5.8 15.3 60.2 64.8 21.0 0.0 2.2 3.3 17.6 2.0 14.0 14.6 0.0 25.7 1.2 0.6 32.8 3.5 4.2 0.7 0.0 5.2 0.0 0.3 1.8 1.7 0.7 6.8 0.0 44.0 4.9 30.1 23.0 0.4 0.8 0.4 0.0 1.0 6.5 4.7 1.3 0.6 0.0 22.4 35.7 MYO7A "DFNA11, DFNB2, NSRD2, USH1B" ENSG00000137474 "Myosin VIIA" Q13402 11 77128264-77215241 "Disease related genes, Predicted intracellular proteins" Hearing "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.3;retina: 30.9" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 45.2;Cytotrophoblasts: 34.1;Hofbauer cells: 24.3;Ito cells: 21.5;Kupffer cells: 20.9;Rod photoreceptor cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 5.6;intermediate monocyte: 4.0;NK-cell: 1.4" "Group enriched" "Detected in many" 10 "monocytes: 5.6;NK-cells: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 11.6;CACO-2: 7.1;RH-30: 15.9;RPMI-8226: 10.4;SK-BR-3: 8.7;U-937: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA028918, CAB034059" Uncertain Approved Cytosol NA NA Cytosol "CAB034059: AB_2148626, HPA028918: AB_10603022" "unprognostic (1.14e-3)" "unprognostic (2.58e-2)" "unprognostic (2.94e-2)" "unprognostic (1.61e-1)" "unprognostic (9.66e-2)" "unprognostic (4.02e-3)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (3.65e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (3.03e-2)" 5.8 26.3 3.6 3.7 5.6 1.1 5.0 0.7 3.0 1.3 1.7 3.5 0.9 2.2 1.3 2.9 1.2 2.3 2.8 1.7 4.0 3.8 5.3 14.8 1.6 4.5 5.2 1.7 4.4 3.8 1.2 25.1 16.9 7.2 13.6 1.4 30.9 1.1 0.9 1.0 0.6 2.4 2.4 3.9 11.2 2.0 22.9 4.7 0.5 1.5 0.3 1.1 1.9 4.4 0.0 0.3 0.0 5.6 1.4 0.1 1.8 0.0 1.1 0.1 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 7.1 2.0 0.0 1.6 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.7 0.0 0.3 4.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 3.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.3 0.0 15.9 10.4 0.0 0.2 2.5 0.8 0.1 8.7 0.1 1.9 1.2 1.1 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 5.6 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 1.8 3.6 5.6 0.7 3.0 4.0 3.8 5.2 1.7 7.2 4.7 0.0 0.0 0.0 0.2 0.2 7.3 3.6 7.6 0.0 0.0 0.0 45.2 34.1 0.0 0.6 1.5 0.7 0.0 0.0 1.5 7.0 0.8 0.1 0.0 12.4 24.3 0.0 1.2 21.5 20.9 3.7 2.8 1.1 0.0 0.0 0.5 15.1 1.0 0.0 0.4 2.2 31.8 0.0 0.3 0.3 0.4 0.3 13.5 0.0 0.4 0.1 MYO9B CELIAC4 ENSG00000099331 "Myosin IXB" Q13459 19 17075781-17214537 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, GTPase activation, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 192.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037190, HPA042043" Approved Supported Cytosol NA NA Cytosol "CAB037190: AB_477214, HPA042043: AB_10796897" "unprognostic (1.92e-1)" "unprognostic (1.79e-3)" "unprognostic (4.35e-2)" "unprognostic (6.63e-2)" "unprognostic (1.70e-1)" "unprognostic (1.18e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (2.61e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (5.66e-6)" "unprognostic (1.97e-1)" "unprognostic (1.50e-1)" "unprognostic (2.36e-2)" "unprognostic (5.53e-2)" 17.4 14.3 14.3 34.7 30.2 59.3 16.0 16.2 25.0 12.7 15.3 40.1 10.6 12.5 16.2 12.8 11.0 10.0 14.9 11.2 16.0 11.8 9.4 12.9 25.0 37.4 38.8 10.7 8.2 9.0 6.7 9.2 15.2 18.8 15.6 11.1 14.7 12.3 10.7 4.8 13.5 20.3 17.2 27.8 55.9 15.2 21.8 28.2 17.4 9.2 5.4 24.8 17.2 16.2 3.3 4.4 14.4 4.7 2.9 3.9 1.9 19.1 8.9 11.9 13.9 8.7 9.2 34.6 18.2 9.4 11.5 10.1 7.1 9.8 17.9 10.2 15.9 10.3 12.0 5.1 8.9 8.7 31.9 10.5 21.5 10.5 6.8 11.2 16.8 34.8 8.4 4.7 15.9 6.2 7.1 12.0 8.0 8.8 12.2 7.9 8.0 22.8 31.3 9.0 6.2 19.8 25.0 8.9 5.1 4.5 16.3 4.1 9.1 11.3 9.0 23.5 6.7 8.9 17.7 23.2 21.5 9.6 33.1 15.3 17.6 11.1 11.5 21.2 22.1 26.7 4.2 3.8 6.6 3.4 4.7 2.1 3.3 2.5 2.7 2.2 3.0 1.6 2.4 14.4 2.9 2.8 4.4 3.9 1.9 14.3 30.2 16.2 25.0 16.0 11.8 38.8 10.7 18.8 28.2 8.9 32.6 32.1 45.6 17.4 8.0 8.7 12.7 6.7 11.4 5.2 192.4 14.3 1.7 7.0 4.2 25.9 19.2 0.0 6.6 21.0 16.9 41.3 20.9 13.5 66.4 7.9 6.9 26.4 56.8 7.6 11.5 84.1 42.2 45.1 12.6 9.3 9.7 12.7 15.9 2.2 97.0 6.5 29.9 8.0 13.2 15.7 12.0 35.7 13.3 33.8 MYOZ2 "C4orf5, CS-1" ENSG00000172399 "Myozenin 2" Q9NPC6 4 119135784-119187789 "Disease related genes, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 219.1;skeletal muscle: 188.6" "Cell type enriched" "Detected in some" 343 "Cardiomyocytes: 2214.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.3;HSkMC: 3.7;SK-MEL-30: 9.5;U-87 MG: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035763, HPA035764" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035763: AB_2674770, HPA035764: AB_10696509" "unprognostic (2.53e-1)" "unprognostic (9.20e-2)" "unprognostic (6.94e-2)" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.34e-2)" "unprognostic (5.71e-1)" "unprognostic (2.18e-1)" "unprognostic (4.77e-2)" "unprognostic (4.04e-1)" "unprognostic (8.25e-2)" "unprognostic (5.07e-2)" "unprognostic (6.19e-7)" "unprognostic (6.66e-4)" "unprognostic (2.43e-1)" "unprognostic (3.06e-1)" "unprognostic (2.83e-2)" 3.7 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.4 2.4 2.6 0.2 0.1 219.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 1.9 0.1 188.6 0.0 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.0 2.0 13.9 3.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.7 0.0 0.6 0.0 0.1 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.5 1.7 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 10.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2214.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.9 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.7 0.7 0.0 6.5 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 MYPN MYOP ENSG00000138347 Myopalladin Q86TC9 10 68106117-68212017 "Disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 94.6" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "BJ: 16.6;fHDF/TERT166: 46.6;GAMG: 9.2;HBF TERT88: 11.0;LHCN-M2: 20.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA036299, HPA061494" Enhanced Approved Nucleoplasm,Vesicles,Cytosol No No "Nucleoplasm, Vesicles" Cytosol "HPA036299: , HPA061494: AB_2684539" "unprognostic (4.75e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "unprognostic (8.62e-3)" "unprognostic (3.91e-1)" "unprognostic (3.36e-3)" "unprognostic (4.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "unprognostic (2.26e-3)" "unprognostic (3.94e-3)" "unprognostic (3.10e-1)" "unprognostic (2.88e-8)" "unprognostic (4.63e-5)" "unprognostic (9.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.47e-1)" 4.5 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.1 0.0 0.0 23.6 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.1 2.1 0.0 114.9 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.9 46.3 3.4 0.0 0.0 0.3 0.1 3.8 0.1 0.2 0.1 0.0 1.2 0.5 0.0 0.0 0.3 1.8 0.0 16.6 8.3 6.3 2.3 0.0 0.0 0.0 0.0 46.6 9.2 0.3 0.0 0.1 11.0 0.1 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.8 0.0 3.3 0.4 1.5 0.1 0.0 0.0 0.1 20.1 3.5 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.0 0.0 0.0 2.0 0.0 1.8 3.8 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 94.6 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MYRF "C11orf9, MRF, Ndt80, pqn-47" ENSG00000124920 "Myelin regulatory factor" Q9Y2G1 11 61752642-61788518 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.7;stomach 1: 57.2" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 44.7;Cholangiocytes: 58.6;Ductal cells: 29.2;Exocrine glandular cells: 31.5;Pancreatic endocrine cells: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 17.5;CACO-2: 29.3;CAPAN-2: 16.9;EFO-21: 22.9;Hep G2: 12.4;HHSteC: 13.1;OE19: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018310 Approved Nucleoplasm,Cytosol NA NA 550000 Nucleoplasm Cytosol "HPA018310: AB_1845534" "unprognostic (3.51e-2)" "unprognostic (3.34e-1)" "unprognostic (1.56e-1)" "unprognostic (5.39e-2)" "unprognostic (1.54e-1)" "unprognostic (3.65e-2)" "unprognostic (1.34e-1)" "unprognostic (9.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (8.91e-3)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" 4.6 1.3 16.4 2.1 42.9 1.4 1.5 3.3 38.5 3.7 4.3 96.7 0.0 12.8 6.9 1.6 2.0 8.0 22.4 1.5 29.2 13.9 4.5 5.8 15.8 1.2 54.3 19.9 5.8 19.7 1.2 0.2 2.6 35.7 1.2 4.0 11.6 1.7 1.6 1.0 1.4 11.4 5.4 53.8 1.3 57.2 3.0 51.4 0.0 1.2 0.0 1.2 1.3 0.3 0.0 0.0 0.2 0.3 0.5 2.1 0.5 1.3 17.5 3.1 1.0 0.0 0.0 0.1 0.1 0.0 0.6 0.7 29.3 16.9 0.6 22.9 0.0 0.8 0.7 1.0 0.1 1.2 0.0 0.3 0.1 0.3 12.4 13.1 0.0 0.3 0.3 0.1 0.4 0.0 7.7 0.1 0.9 5.4 0.2 0.1 0.3 0.0 0.6 0.8 25.8 2.3 0.0 0.1 1.1 7.8 0.1 0.1 0.6 0.1 1.2 0.3 10.9 0.3 0.1 0.6 0.2 10.2 0.2 0.3 0.3 0.1 0.1 0.1 1.2 0.2 0.0 0.0 0.2 2.1 0.3 1.2 0.0 0.7 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.5 16.4 42.9 3.3 29.3 29.2 13.9 54.3 19.9 35.7 51.4 44.7 6.1 0.0 0.0 0.1 0.1 0.8 58.6 0.0 2.3 3.5 0.0 0.2 0.0 29.2 0.3 0.0 8.4 0.0 31.5 0.2 4.9 0.2 0.0 5.3 0.8 0.0 1.2 0.6 0.0 0.2 5.5 0.6 3.3 1.8 3.2 3.7 47.6 11.5 3.5 1.0 0.0 0.0 0.3 1.0 3.2 0.0 0.7 0.0 5.2 0.7 MYT1 "MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A" ENSG00000196132 "Myelin transcription factor 1" Q01538 20 64102394-64242253 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 69.5" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 28.8;Cone photoreceptor cells: 56.9;Horizontal cells: 25.4;Rod photoreceptor cells: 27.0" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 13 "cerebellum: 69.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.8;REH: 13.3;SCLC-21H: 16.6;SH-SY5Y: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006303 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006303: AB_1079446" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.05e-7)" "unprognostic (1.28e-1)" "unprognostic (8.34e-2)" "unprognostic (1.20e-1)" "unprognostic (7.10e-2)" "unprognostic (9.33e-3)" "unprognostic (2.28e-2)" "unprognostic (8.45e-4)" "unprognostic (9.73e-2)" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (9.68e-2)" "unprognostic (2.91e-3)" "unprognostic (1.23e-1)" 0.4 7.4 4.3 0.5 5.0 2.4 0.4 69.5 11.0 0.3 0.7 2.7 0.0 0.9 0.4 0.5 0.3 0.6 0.5 0.8 4.2 5.3 0.6 0.4 0.4 0.4 3.7 2.2 0.4 4.7 0.4 3.7 0.4 5.1 0.6 0.6 3.7 0.3 0.4 0.3 0.4 0.6 0.4 2.0 0.5 1.0 2.1 4.8 0.0 1.4 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.6 0.0 0.5 0.0 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 1.0 0.0 0.0 1.4 0.0 0.7 0.0 0.3 13.3 0.0 0.0 0.0 0.0 16.6 4.3 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.9 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.3 5.0 69.5 3.1 4.2 5.3 3.7 2.2 5.1 4.8 0.0 0.0 0.0 0.2 0.0 28.8 1.1 5.1 0.0 0.0 0.0 56.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 25.4 2.4 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.5 9.8 0.0 0.0 0.0 0.0 0.0 MZT2A "FAM128A, MOZART2A" ENSG00000173272 "Mitotic spindle organizing protein 2A" Q6P582 2 131464900-131492743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 31.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 70.8" "HPA051758, HPA052623" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA051758: , HPA052623: AB_2681888" "prognostic favorable (3.04e-4)" "unprognostic (3.82e-2)" "unprognostic (7.14e-2)" "unprognostic (1.78e-1)" "unprognostic (5.39e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-2)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (3.55e-2)" "unprognostic (2.16e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (3.04e-11)" "unprognostic (1.51e-2)" "unprognostic (5.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.66e-1)" 17.7 17.1 34.7 22.1 22.6 31.3 17.1 9.6 25.1 17.5 20.3 7.6 23.0 30.0 11.9 22.3 23.5 14.0 17.5 57.5 28.0 20.7 14.4 15.9 7.5 15.6 18.9 16.4 20.8 55.4 5.6 7.2 5.3 8.8 16.4 3.4 9.3 48.5 19.7 40.7 12.6 22.8 17.3 12.0 15.5 24.0 11.1 5.5 28.3 17.8 23.8 17.0 16.2 12.8 11.9 5.4 31.9 1.0 2.6 9.3 2.2 36.0 19.5 0.4 7.5 0.5 1.3 7.8 12.2 2.9 4.7 4.6 47.7 12.5 23.4 15.9 0.5 0.5 16.3 1.2 8.2 0.1 9.2 59.4 9.6 21.8 56.4 2.9 16.8 3.6 3.7 4.5 3.0 1.4 1.0 3.8 20.6 18.9 24.6 1.1 32.6 23.2 70.8 12.6 4.6 44.6 19.8 6.7 52.3 2.9 16.7 28.3 3.5 12.4 8.5 22.3 0.3 13.3 30.4 10.7 12.4 30.2 5.2 11.9 23.1 17.1 18.8 17.4 10.9 7.3 6.9 1.0 31.9 3.8 0.6 4.2 11.9 8.5 4.9 3.4 6.2 9.3 4.5 0.4 2.6 0.3 5.4 8.4 2.2 34.7 22.6 9.6 23.1 28.0 20.7 18.9 16.4 8.8 5.5 14.9 14.4 124.6 117.1 131.5 40.9 255.9 112.1 8.1 19.4 68.0 19.6 68.5 144.2 181.3 20.5 65.2 170.0 23.3 144.3 204.7 90.3 143.8 24.1 118.5 108.3 25.4 104.6 85.3 77.6 66.4 141.5 90.6 97.8 130.8 207.2 54.1 253.1 157.8 193.0 188.7 35.9 90.5 69.3 35.8 155.3 125.0 35.5 160.8 232.9 112.8 MZT2B "FAM128B, FLJ14346, MOZART2B" ENSG00000152082 "Mitotic spindle organizing protein 2B" Q6NZ67 2 130181737-130190729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 93.9" "HPA051758, HPA052623" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA051758: , HPA052623: AB_2681888" "unprognostic (8.09e-3)" "unprognostic (5.38e-2)" "unprognostic (2.40e-2)" "unprognostic (1.31e-2)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (1.06e-1)" "unprognostic (1.14e-1)" "unprognostic (2.28e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (9.37e-8)" "unprognostic (1.67e-1)" "unprognostic (2.04e-1)" "unprognostic (3.04e-1)" "unprognostic (2.09e-1)" 28.9 39.1 50.8 23.9 33.5 63.4 23.8 19.5 35.1 24.3 31.3 14.4 27.7 34.2 24.7 24.0 30.6 19.4 26.7 56.6 33.7 29.3 22.5 31.1 14.4 27.8 32.8 33.3 31.0 104.2 10.9 17.1 16.2 19.7 28.4 11.6 18.6 63.6 24.9 87.5 20.9 32.1 31.8 21.7 26.8 33.8 26.1 15.4 35.3 36.0 27.1 22.2 24.4 34.9 15.3 21.7 31.7 9.3 12.1 13.3 4.9 41.2 17.4 4.4 21.2 1.7 6.4 20.5 19.8 7.3 7.6 5.6 35.6 21.5 22.7 30.9 4.5 5.1 23.4 2.3 6.5 1.2 33.6 53.9 12.3 25.5 38.9 7.6 16.1 12.2 7.0 9.1 5.1 2.6 5.7 8.4 30.0 16.1 34.0 5.5 47.8 36.1 93.9 14.1 8.7 32.0 42.2 11.1 71.2 4.5 13.7 30.7 37.6 11.9 21.6 32.1 2.0 25.5 47.8 15.0 22.1 35.8 17.6 18.7 41.4 25.9 28.0 33.3 23.9 15.9 0.1 9.3 31.7 7.7 9.1 6.2 15.3 11.3 10.7 11.2 14.8 13.3 10.7 4.6 12.1 8.4 21.7 8.7 4.9 50.8 33.5 19.5 35.1 33.7 29.3 32.8 33.3 19.7 15.4 38.7 21.9 238.2 264.1 264.0 158.4 293.3 170.7 40.2 50.0 230.3 41.2 229.1 396.3 323.5 266.4 198.6 241.8 140.2 511.3 411.3 250.4 326.9 50.7 320.9 295.2 123.9 166.1 171.9 146.8 852.0 231.3 260.0 254.8 212.0 316.3 142.6 514.2 241.6 135.1 586.2 76.3 161.7 241.9 132.8 161.7 329.7 138.1 211.9 294.6 315.0 N4BP2 B3BP ENSG00000078177 "NEDD4 binding protein 2" Q86UW6 4 40056826-40158252 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036770, HPA042607, HPA072549" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: " "unprognostic (5.03e-2)" "unprognostic (3.42e-1)" "unprognostic (7.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-3)" "unprognostic (2.88e-1)" "unprognostic (1.01e-1)" "unprognostic (3.66e-2)" "unprognostic (2.65e-2)" "unprognostic (9.55e-3)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (6.85e-3)" "unprognostic (1.45e-1)" 3.5 3.1 3.4 7.4 5.1 7.0 5.8 6.1 3.2 5.5 4.3 1.2 7.1 4.7 7.0 6.6 5.2 4.8 3.8 3.5 2.5 3.6 3.2 11.3 7.5 9.2 1.9 1.6 7.0 13.1 2.5 14.3 11.9 2.8 4.9 4.5 4.3 10.7 11.0 2.9 5.4 5.3 3.2 3.1 4.3 3.8 3.5 2.1 35.6 7.2 3.5 7.8 5.6 5.2 2.4 8.1 5.7 1.2 10.6 4.5 1.2 1.5 1.6 9.4 1.5 0.6 3.1 7.7 1.8 1.9 1.0 2.2 3.0 3.1 8.3 3.5 1.7 1.7 1.2 6.0 1.9 2.5 2.6 1.9 3.7 1.4 1.4 1.6 10.0 8.9 3.5 2.7 1.7 3.7 0.3 2.7 7.9 8.2 3.6 2.0 1.5 20.2 4.3 4.7 1.2 1.3 11.8 11.1 1.9 0.8 3.7 3.8 6.7 1.6 1.3 1.5 6.3 1.1 2.7 3.7 1.1 5.9 0.7 1.3 5.9 6.0 5.7 1.2 3.6 2.3 5.7 1.1 0.5 2.3 1.2 2.4 1.7 3.0 1.7 1.7 2.4 4.5 2.5 0.3 10.6 1.0 8.1 1.3 1.2 3.4 5.1 6.1 3.2 2.5 3.6 1.9 1.6 2.8 2.1 20.8 19.5 2.9 12.0 10.6 30.6 12.3 12.7 6.7 18.2 21.0 25.5 34.4 0.0 5.4 2.6 6.6 6.0 23.3 10.7 11.4 12.3 12.2 4.7 15.5 10.4 68.3 18.6 4.9 16.3 2.7 9.2 17.8 6.8 9.0 15.0 11.8 9.7 8.6 3.5 3.1 20.2 12.9 5.7 13.6 27.0 11.4 22.5 13.8 8.0 8.4 N4BP2L1 CG018 ENSG00000139597 "NEDD4 binding protein 2 like 1" Q5TBK1 13 32400723-32428311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 143.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 13.1;JURKAT: 12.5;NB-4: 33.0" "Low region specificity" "Detected in all" HPA038971 Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038971: AB_10673408" "unprognostic (2.66e-3)" "unprognostic (2.38e-3)" "unprognostic (3.63e-2)" "unprognostic (5.32e-2)" "unprognostic (5.09e-2)" "unprognostic (3.40e-2)" "prognostic favorable (3.11e-4)" "unprognostic (6.91e-3)" "unprognostic (2.30e-1)" "unprognostic (9.37e-2)" "unprognostic (2.30e-2)" "unprognostic (1.20e-3)" "unprognostic (4.56e-2)" "unprognostic (1.04e-1)" "unprognostic (2.30e-1)" "unprognostic (3.29e-2)" "unprognostic (2.57e-3)" 12.1 9.4 19.6 10.5 22.2 29.5 22.1 24.5 21.8 12.3 11.0 9.4 4.2 11.6 14.6 12.8 8.3 14.0 9.6 6.3 15.0 16.6 7.4 57.8 17.3 17.6 12.1 18.8 30.1 11.0 7.3 21.2 10.0 11.0 11.3 11.3 7.3 7.6 9.5 11.0 17.5 13.4 11.3 10.6 19.2 7.2 3.6 15.5 14.2 10.4 5.1 12.9 13.5 16.5 15.9 28.0 24.2 25.5 15.2 13.5 17.4 0.5 0.1 0.7 0.2 2.9 2.3 0.2 0.3 1.2 0.7 1.2 2.1 2.9 5.6 0.8 0.6 2.1 0.0 2.1 0.2 0.9 8.5 1.3 13.1 0.6 6.2 4.6 4.9 0.8 1.6 0.5 0.5 0.6 5.2 0.4 12.5 0.0 10.5 0.5 0.4 10.0 33.0 1.1 0.0 0.3 9.6 0.3 4.7 2.8 1.0 2.0 2.4 2.1 0.0 0.9 1.5 0.3 9.3 0.2 0.2 0.1 0.1 0.1 5.9 3.5 0.3 0.3 1.8 0.4 24.2 25.5 6.6 9.8 23.1 8.5 14.0 9.5 11.9 21.9 15.9 13.1 11.3 6.2 15.2 15.8 28.0 13.5 17.4 19.6 22.2 24.5 21.8 15.0 16.6 12.1 18.8 11.0 15.5 41.7 25.1 28.7 27.2 26.8 7.4 3.4 10.2 5.3 22.7 5.2 0.0 17.0 8.3 8.8 17.8 35.7 4.5 0.0 7.4 0.9 15.9 22.7 8.1 57.2 20.1 0.0 36.5 11.6 41.3 15.5 25.3 44.8 28.7 143.3 11.5 10.0 6.2 10.7 20.8 8.4 1.6 77.6 56.7 0.7 0.2 30.9 8.7 43.1 13.3 12.8 NAA10 "ARD1, ARD1A, DXS707, TE2" ENSG00000102030 "N(alpha)-acetyltransferase 10, NatA catalytic subunit" P41227 X 153929242-153935223 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006269, HPA030711" Supported Supported Nucleoli,Cytosol No No Cytosol Nucleoli "CAB006269: AB_425759, HPA030711: AB_2673579" "unprognostic (7.57e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (1.94e-2)" "unprognostic (4.52e-3)" "unprognostic (1.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.04e-1)" "unprognostic (9.01e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (3.29e-8)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.29e-2)" "unprognostic (7.48e-3)" 18.9 21.2 17.7 20.3 14.0 12.5 31.8 15.5 20.8 12.4 15.3 8.1 19.2 16.7 17.2 17.6 19.7 16.5 17.6 26.4 15.0 14.2 16.3 18.6 20.7 30.0 15.0 18.0 14.1 33.3 12.3 12.0 13.7 17.5 13.6 11.7 9.3 19.0 17.9 57.8 14.1 14.7 21.7 14.7 14.9 17.7 7.1 11.8 11.4 12.2 25.3 16.3 17.1 22.1 33.7 34.8 35.0 31.9 27.6 44.8 29.0 32.1 33.9 6.4 20.8 9.1 9.6 18.1 11.3 6.6 15.5 13.6 22.0 10.2 24.5 37.7 9.3 20.1 15.4 13.4 13.6 6.0 10.2 62.5 8.8 23.7 22.1 12.5 17.1 19.5 7.3 15.3 14.4 15.0 7.8 17.5 9.6 17.6 10.4 10.2 42.2 27.3 25.5 10.7 30.4 47.1 21.7 16.5 26.8 11.3 14.8 13.7 16.5 4.4 17.9 26.7 6.3 9.6 14.2 10.1 6.5 22.3 22.5 34.3 22.0 24.5 46.0 8.8 22.1 18.9 12.0 24.2 35.0 29.0 28.0 38.0 33.7 31.2 31.7 31.6 32.6 18.7 28.0 22.6 27.6 31.9 34.8 44.8 29.0 17.7 14.0 15.5 20.8 15.0 14.2 15.0 18.0 17.5 11.8 8.9 27.5 83.3 53.7 62.3 28.9 38.0 53.5 29.4 26.1 36.6 11.8 113.1 81.2 114.3 2.1 90.5 71.7 46.7 129.7 161.7 59.9 66.0 66.9 63.8 109.5 35.0 55.8 64.4 62.9 8.3 43.1 71.4 113.1 75.7 61.8 26.2 121.2 58.3 43.9 155.0 22.4 64.7 78.5 5.8 39.4 79.2 91.0 68.3 80.9 64.7 NAA11 "ARD1B, ARD2, hARD2" ENSG00000156269 "N(alpha)-acetyltransferase 11, NatA catalytic subunit" Q9BSU3 4 79225694-79326050 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 166 "placenta: 32.1;testis: 30.5" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 16.7;Early spermatids: 21.1;Extravillous trophoblasts: 13.6;Late spermatids: 20.7;Spermatocytes: 14.4;Spermatogonia: 15.0;Syncytiotrophoblasts: 11.1" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "GAMG: 14.7;K-562: 8.8;U-266/70: 25.1;U-266/84: 8.0" "Not detected" "Not detected" HPA035922 Approved Supported "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA035922: AB_10673490" "unprognostic (7.37e-2)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 32.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 30.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 25.1 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 21.1 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 20.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 14.4 15.0 0.0 11.1 0.0 0.0 0.0 NAA15 "FLJ13340, NARG1, NATH, TBDN100" ENSG00000164134 "N(alpha)-acetyltransferase 15, NatA auxiliary subunit" Q9BXJ9 4 139301455-139420033 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023589, HPA050661" Approved Supported "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA023589: AB_1854311, HPA050661: AB_2681208" "unprognostic (6.25e-3)" "unprognostic (5.95e-2)" "unprognostic (7.80e-3)" "unprognostic (8.45e-2)" "unprognostic (2.88e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.16e-2)" "unprognostic (9.20e-3)" "unprognostic (1.07e-2)" "unprognostic (5.21e-3)" "unprognostic (1.99e-2)" "unprognostic (8.65e-2)" "unprognostic (7.37e-3)" "unprognostic (2.12e-1)" "unprognostic (8.28e-3)" "unprognostic (1.58e-1)" 13.7 12.9 13.7 17.8 14.2 18.6 15.2 21.0 18.9 10.8 12.3 7.8 9.0 10.1 13.4 9.8 20.5 11.4 9.7 14.8 16.6 10.1 10.3 14.5 13.3 17.7 15.6 10.7 13.1 11.4 16.8 20.3 14.0 13.8 11.6 12.6 6.7 13.8 10.4 54.4 13.8 10.3 19.3 22.2 12.2 11.4 17.6 15.9 18.0 12.2 22.3 19.9 15.3 15.1 8.7 7.1 4.1 5.6 6.8 9.4 3.1 16.8 12.4 12.0 19.3 8.8 10.8 14.8 16.4 10.8 15.9 12.3 17.4 14.9 34.8 10.1 13.5 13.8 11.0 31.4 20.1 22.9 16.2 11.6 18.7 12.0 11.3 9.3 34.0 12.1 7.6 12.3 20.0 15.7 8.4 15.8 13.7 34.5 15.2 16.8 13.5 32.4 10.1 20.0 31.9 9.8 20.2 16.2 17.9 12.6 14.3 15.7 12.3 10.9 18.0 10.9 12.7 10.9 13.4 13.5 15.4 10.8 14.5 18.6 18.5 33.0 34.6 13.2 24.9 14.6 4.1 5.4 1.7 8.0 5.6 9.3 7.4 8.4 9.4 7.1 8.7 8.3 9.3 4.1 6.8 5.3 6.0 8.0 3.1 13.7 14.2 21.0 18.9 16.6 10.1 15.6 10.7 13.8 15.9 44.7 29.8 38.0 57.7 83.0 32.8 40.0 33.1 40.2 39.8 19.2 19.6 34.9 13.3 24.8 5.1 26.3 10.0 23.3 16.8 38.0 39.1 29.9 33.5 22.9 28.5 38.1 15.0 11.1 25.3 8.2 23.6 28.7 27.0 26.2 18.1 25.1 20.6 17.5 27.3 13.6 35.4 32.3 30.9 81.6 51.1 86.8 34.9 28.8 24.7 61.8 NAA16 "FLJ22054, MGC40612, NARG1L, PRO2435" ENSG00000172766 "N(alpha)-acetyltransferase 16, NatA auxiliary subunit" Q6N069 13 41311205-41377030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039761, HPA040157" Approved Enhanced Cytosol NA NA Cytosol "HPA039761: AB_10795112, HPA040157: AB_10793917" "unprognostic (2.09e-2)" "unprognostic (2.86e-2)" "unprognostic (2.95e-1)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "unprognostic (4.45e-2)" "unprognostic (1.60e-1)" "unprognostic (4.47e-3)" "unprognostic (1.09e-2)" "unprognostic (2.90e-1)" "unprognostic (3.04e-2)" "unprognostic (3.50e-2)" "unprognostic (1.36e-2)" "unprognostic (7.94e-2)" "unprognostic (5.81e-2)" "unprognostic (1.58e-1)" "unprognostic (3.34e-2)" 7.2 6.3 8.4 6.1 9.6 25.5 6.7 20.0 13.2 7.7 6.0 5.1 5.3 5.6 10.0 4.3 7.9 9.0 5.0 5.3 7.5 3.7 4.4 4.0 6.3 9.0 8.5 5.8 8.0 25.7 5.1 9.6 5.0 6.6 6.5 4.4 4.5 7.0 8.3 8.3 7.9 6.5 10.0 7.9 5.5 6.7 9.2 9.7 8.3 5.7 4.0 5.1 8.7 21.1 3.0 2.7 4.8 2.4 5.4 8.2 2.2 6.5 5.4 13.6 10.0 4.8 6.2 5.3 8.1 6.8 8.1 7.1 6.5 5.2 11.0 3.9 6.4 3.3 9.2 7.0 5.2 9.9 6.7 14.3 13.4 5.3 6.4 5.2 15.0 9.1 4.3 3.8 3.3 6.3 5.3 7.9 10.8 6.0 6.1 5.1 5.3 15.5 4.2 11.7 9.1 7.5 11.5 5.7 9.0 6.3 6.0 4.7 10.8 7.3 7.2 2.8 8.3 4.4 8.2 5.8 5.6 4.6 8.8 6.2 4.3 4.8 12.8 7.1 6.4 6.5 4.3 2.4 4.8 3.9 1.3 3.8 1.6 4.5 4.1 1.3 3.0 8.2 8.2 1.3 5.4 1.8 2.7 3.3 2.2 8.4 9.6 20.0 13.2 7.5 3.7 8.5 5.8 6.6 9.7 8.9 11.8 13.7 18.6 15.8 26.3 8.9 7.6 21.4 14.8 8.7 13.7 7.0 1.7 10.1 15.7 15.9 5.1 0.0 17.9 6.4 12.5 16.7 3.5 8.3 15.8 36.5 7.5 13.5 8.7 15.8 27.9 12.3 13.5 5.4 4.4 14.0 13.0 5.8 18.7 6.3 35.1 19.4 13.2 29.7 27.4 12.8 2.4 20.3 8.7 16.6 NAA20 "dJ1002M8.1, NAT3, NAT5" ENSG00000173418 "N(alpha)-acetyltransferase 20, NatB catalytic subunit" P61599 20 20017116-20033655 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063344 Supported Cytosol NA NA Cytosol "HPA063344: AB_2684991" "unprognostic (2.94e-2)" "unprognostic (1.14e-1)" "unprognostic (7.14e-2)" "unprognostic (2.59e-1)" "unprognostic (1.89e-1)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.00e-2)" "unprognostic (1.11e-2)" "unprognostic (2.40e-1)" "unprognostic (6.18e-2)" "unprognostic (9.30e-2)" "unprognostic (3.85e-1)" "unprognostic (2.93e-1)" "unprognostic (1.72e-1)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.32e-1)" 15.9 20.0 14.2 10.0 21.4 17.4 23.2 15.5 34.1 17.3 12.7 12.0 22.7 9.7 20.5 17.7 58.4 15.8 12.3 24.1 14.7 14.1 24.6 25.0 15.7 19.0 13.1 18.3 12.9 43.2 24.8 20.0 18.5 19.4 14.4 12.2 11.2 22.0 20.6 35.2 15.6 11.0 17.3 13.1 11.0 14.5 43.7 10.2 9.5 23.6 37.5 22.1 14.0 23.7 18.6 28.3 20.4 27.5 17.7 25.8 26.4 40.5 24.6 8.9 13.9 18.8 19.8 13.4 30.0 20.5 27.0 25.3 12.6 29.4 22.0 16.3 20.2 21.8 32.2 15.2 48.1 22.0 9.9 16.5 16.5 6.5 18.8 27.0 17.4 12.2 22.5 31.7 27.4 27.7 15.6 23.2 15.8 26.7 22.8 23.5 31.7 24.5 18.2 6.9 28.1 40.3 13.5 35.1 29.2 26.6 9.4 16.9 11.5 18.1 51.2 25.0 6.1 31.6 28.1 25.2 22.5 13.2 27.0 27.5 24.8 30.9 23.8 13.6 15.3 16.0 8.0 27.5 20.4 17.6 27.5 25.8 18.6 20.5 20.2 28.3 16.5 19.9 22.0 3.6 17.7 23.2 22.9 20.8 26.4 14.2 21.4 15.5 34.1 14.7 14.1 13.1 18.3 19.4 10.2 62.5 35.6 41.7 83.1 96.6 54.1 70.6 71.4 99.0 55.7 99.5 23.6 98.0 195.6 180.5 209.7 76.7 31.4 0.0 145.5 94.1 66.4 74.5 49.7 69.9 213.0 65.2 39.6 52.2 51.1 27.3 64.7 64.9 67.4 121.8 44.4 78.6 191.0 35.1 70.4 177.4 48.7 38.8 66.9 234.3 53.9 103.8 71.5 45.7 56.2 118.5 NAA25 "C12orf30, FLJ13089" ENSG00000111300 "N(alpha)-acetyltransferase 25, NatB auxiliary subunit" Q14CX7 12 112026689-112109022 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 137.4;monocytes: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039322 Approved Supported "Golgi apparatus,Cytosol" No No "Golgi apparatus, Cytosol" "HPA039322: AB_10697548" "unprognostic (1.26e-1)" "unprognostic (1.31e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.91e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (9.09e-3)" "unprognostic (3.24e-2)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (8.34e-2)" "prognostic unfavorable (1.32e-8)" "unprognostic (2.44e-2)" "unprognostic (2.01e-1)" "unprognostic (9.34e-2)" "unprognostic (9.18e-2)" 12.8 11.4 12.7 12.3 19.3 18.4 14.9 21.0 17.0 10.4 11.7 17.9 11.2 8.3 18.1 10.3 14.7 11.3 8.5 10.7 11.6 10.7 8.0 10.2 9.0 12.9 21.7 12.4 15.8 15.1 14.3 13.5 11.4 16.3 11.7 9.4 15.6 9.5 10.5 25.9 15.7 8.8 11.9 16.7 10.3 9.2 10.8 17.9 8.7 12.5 10.8 14.2 10.2 12.1 4.7 5.5 0.5 3.6 2.3 7.0 2.5 10.3 10.3 9.7 7.4 5.4 9.4 11.7 9.8 7.9 12.4 8.3 10.8 5.4 18.1 9.8 7.8 6.9 12.4 21.6 8.1 16.5 10.2 14.8 14.7 10.5 9.5 9.0 20.7 9.2 8.2 10.3 14.0 14.2 10.2 10.5 8.0 21.5 2.2 10.9 8.5 12.2 15.7 15.0 22.0 12.3 13.4 9.9 12.5 9.3 17.3 12.3 6.8 11.3 12.8 9.3 9.9 12.6 8.5 8.4 10.0 9.1 11.1 13.5 9.6 18.4 21.3 13.2 9.2 9.8 0.0 2.7 0.5 4.0 3.1 6.1 4.1 4.7 3.6 5.4 4.7 7.0 6.5 0.1 2.3 3.6 5.5 3.6 2.5 12.7 19.3 21.0 17.0 11.6 10.7 21.7 12.4 16.3 17.9 8.9 14.4 17.2 29.4 59.2 38.1 20.9 17.8 25.4 30.7 7.0 137.4 21.0 3.3 13.4 16.8 15.8 6.7 0.0 16.6 19.0 17.4 38.4 19.7 15.8 12.5 22.3 15.5 16.5 15.1 4.5 16.1 18.0 15.1 128.0 10.9 11.8 15.0 7.0 12.0 3.7 67.7 6.5 18.9 28.1 31.3 61.4 18.9 13.8 13.4 35.7 NAA30 "C14orf35, FLJ35355, MAK3, Mak3p, NAT12" ENSG00000139977 "N(alpha)-acetyltransferase 30, NatC catalytic subunit" Q147X3 14 57390544-57415917 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057824 Uncertain Supported Cytosol NA NA Cytosol "HPA057824: AB_2683539" "unprognostic (5.13e-2)" "unprognostic (7.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.52e-2)" "unprognostic (5.22e-2)" "unprognostic (6.31e-2)" "unprognostic (1.84e-2)" "unprognostic (5.44e-2)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.25e-8)" "unprognostic (1.77e-1)" "unprognostic (1.67e-1)" "unprognostic (5.75e-3)" "unprognostic (1.63e-1)" 10.7 10.3 15.8 10.7 18.3 15.0 16.4 18.1 18.9 9.9 15.0 9.2 8.6 11.4 12.1 8.8 13.5 9.1 12.5 18.8 13.9 15.6 14.7 19.1 8.2 9.6 12.9 16.4 18.1 10.5 16.2 13.4 15.4 12.0 12.3 9.6 9.6 10.8 12.8 34.9 10.5 13.5 13.0 9.9 9.8 8.6 21.4 10.1 15.0 12.6 13.6 10.3 12.8 13.7 2.6 1.5 1.7 5.3 5.5 4.2 0.8 14.1 13.6 7.8 12.7 13.2 17.3 13.2 16.6 16.1 12.7 11.6 12.2 10.5 10.4 14.7 13.7 9.7 15.0 14.0 10.7 21.3 18.0 7.2 8.4 7.8 10.6 13.8 16.8 9.8 11.7 16.0 11.5 19.3 14.2 19.5 13.0 8.2 10.4 16.8 16.3 14.0 9.8 8.3 13.1 15.2 11.2 22.5 8.1 13.1 12.9 16.8 8.8 14.0 13.9 16.8 14.6 17.8 8.8 17.0 20.0 21.0 10.9 10.5 7.7 9.3 12.7 13.2 8.5 14.1 1.7 0.9 0.5 2.9 2.1 3.0 2.3 2.8 4.2 0.8 2.6 3.0 2.8 0.4 5.5 5.3 1.5 3.7 0.8 15.8 18.3 18.1 18.9 13.9 15.6 12.9 16.4 12.0 10.1 8.9 7.5 12.0 10.0 36.5 12.8 36.4 15.3 6.7 5.7 3.5 17.7 14.5 8.3 11.2 72.4 16.1 8.5 0.0 10.2 13.2 13.2 14.3 6.9 21.2 8.7 9.5 20.2 11.6 10.7 23.6 12.7 6.9 21.9 8.2 14.6 12.3 11.8 11.9 12.7 13.7 13.4 19.4 12.3 44.7 16.9 36.0 18.5 14.6 10.9 12.4 NAA35 "bA379P1.1, FLJ21613, FLJ22643, MAK10" ENSG00000135040 "N(alpha)-acetyltransferase 35, NatC auxiliary subunit" Q5VZE5 9 85941146-86022298 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021547 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA021547: AB_1853505" "unprognostic (5.87e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-3)" "unprognostic (9.25e-3)" "unprognostic (2.37e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.16e-7)" "unprognostic (1.86e-1)" "unprognostic (5.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.30e-2)" "unprognostic (1.09e-1)" "unprognostic (2.36e-3)" "unprognostic (1.88e-1)" "unprognostic (4.34e-2)" "unprognostic (9.18e-2)" "unprognostic (1.07e-2)" 11.3 19.5 15.2 16.4 14.6 9.7 17.1 20.1 17.6 13.4 16.5 12.5 22.9 14.9 20.5 21.0 16.8 13.5 14.4 14.2 16.6 14.0 16.0 14.3 10.8 10.2 14.6 16.2 16.2 16.4 19.1 25.5 16.9 14.4 17.4 19.5 13.0 16.3 20.0 28.7 13.4 17.4 16.4 14.1 10.3 13.4 25.7 15.1 10.0 19.8 15.8 12.7 14.4 13.5 12.2 5.8 8.9 4.7 5.9 9.6 4.4 22.9 16.0 16.0 12.5 9.4 11.3 25.1 14.5 14.2 16.3 13.8 11.0 15.9 7.8 8.5 14.7 13.7 32.2 14.6 17.0 17.5 19.5 10.5 17.2 17.4 15.0 17.5 26.3 15.6 11.7 14.8 17.4 25.8 11.4 15.3 16.2 21.0 15.3 15.4 15.8 14.7 15.3 16.1 27.7 16.4 12.6 22.7 12.1 17.8 20.9 14.6 13.0 16.5 14.6 12.8 17.3 11.7 11.1 12.1 10.5 13.2 17.5 13.4 20.5 25.1 5.3 13.4 11.4 10.7 2.0 4.6 8.9 7.0 4.7 9.3 12.2 7.7 6.5 5.8 12.2 9.6 7.7 2.1 5.9 3.2 3.8 6.4 4.4 15.2 14.6 20.1 17.6 16.6 14.0 14.6 16.2 14.4 15.1 3.0 13.1 12.0 17.1 14.4 24.0 19.6 10.2 32.1 21.6 10.4 21.6 18.4 1.7 16.5 5.9 11.9 11.1 0.0 22.5 15.1 13.4 18.4 11.5 8.9 10.6 20.6 20.1 8.6 9.5 3.6 8.6 12.9 13.5 11.8 15.0 22.0 15.4 14.0 11.0 7.1 32.7 12.9 16.5 58.6 33.7 14.4 26.0 12.8 14.6 17.4 NAA40 "FLJ13848, NAT11" ENSG00000110583 "N(alpha)-acetyltransferase 40, NatD catalytic subunit" Q86UY6 11 63938959-63957328 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 96.9;Late spermatids: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037816, HPA056142" Uncertain Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA037816: AB_10672289, HPA056142: " "unprognostic (3.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-1)" "unprognostic (6.88e-3)" "unprognostic (1.50e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (1.43e-7)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (1.58e-1)" "unprognostic (7.01e-3)" "unprognostic (6.29e-3)" "unprognostic (3.42e-2)" "unprognostic (6.43e-3)" "unprognostic (2.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.25e-2)" 4.9 12.4 9.8 10.0 11.6 4.1 7.6 16.7 13.5 7.1 7.3 12.2 10.8 9.2 5.0 7.7 9.2 11.2 7.6 13.8 9.8 10.0 10.0 5.1 6.1 10.7 8.3 8.6 4.2 8.9 28.0 22.7 10.5 8.9 6.0 7.9 12.2 9.7 11.3 7.5 4.5 9.8 5.4 7.6 12.5 6.3 19.2 8.9 10.1 10.1 4.1 11.7 8.1 4.9 4.1 5.0 3.5 0.8 6.7 10.1 2.8 10.7 12.6 15.7 8.4 4.4 4.3 10.0 8.0 8.6 19.9 14.0 10.4 13.7 6.6 10.0 7.2 13.9 9.7 13.1 5.8 14.8 8.7 8.1 9.1 8.0 11.7 5.9 14.3 7.8 4.5 5.3 12.3 3.4 7.8 12.8 11.6 15.3 5.0 9.2 8.1 15.2 11.3 14.6 10.0 8.5 15.1 14.2 8.4 13.3 8.3 20.9 11.1 12.5 11.0 6.5 11.9 18.0 6.4 8.2 11.1 13.5 6.4 6.5 6.0 3.8 11.7 6.6 6.2 8.5 3.3 0.8 3.5 10.1 0.6 3.6 4.1 2.7 4.8 3.6 3.9 1.7 4.1 0.3 6.7 0.3 5.0 0.8 2.8 9.8 11.6 16.7 13.5 9.8 10.0 8.3 8.6 8.9 8.9 3.0 3.7 5.1 1.9 2.5 27.2 12.8 7.6 22.7 12.5 17.4 31.4 8.4 0.0 5.2 38.5 7.1 10.5 0.0 4.7 10.2 4.6 1.9 1.1 4.5 7.8 96.9 16.8 10.4 9.4 100.4 4.4 8.4 1.7 3.6 6.5 9.4 4.8 3.5 6.7 3.0 24.2 0.0 3.1 19.1 16.8 2.5 3.4 8.2 6.8 1.0 NAA60 "FLJ14154, NAT15" ENSG00000122390 "N(alpha)-acetyltransferase 60, NatF catalytic subunit" Q9H7X0 16 3443611-3486963 "Enzymes, Predicted intracellular proteins" "Chromosome partition" "Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040916 Approved Uncertain "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA040916: AB_10794428" "unprognostic (8.59e-2)" "unprognostic (2.16e-3)" "unprognostic (3.39e-1)" "prognostic favorable (3.14e-4)" "unprognostic (1.81e-1)" "unprognostic (5.90e-2)" "unprognostic (2.88e-2)" "unprognostic (1.53e-2)" "unprognostic (5.23e-2)" "unprognostic (5.12e-2)" "prognostic favorable (4.30e-4)" "unprognostic (9.54e-2)" "unprognostic (1.64e-1)" "unprognostic (1.60e-2)" "unprognostic (8.96e-2)" "unprognostic (3.59e-1)" "unprognostic (6.74e-3)" 18.5 28.7 24.2 17.9 30.8 26.6 16.2 38.1 40.2 17.1 29.4 29.1 34.0 36.8 24.3 18.6 21.3 21.7 23.7 26.2 25.6 21.3 35.8 40.3 23.6 19.4 21.6 17.7 21.2 41.8 46.4 29.0 27.0 24.4 23.7 21.4 29.1 20.7 31.6 38.9 16.9 42.2 19.9 25.7 28.1 34.8 25.3 19.0 22.8 21.8 21.8 24.1 21.7 22.1 8.5 11.2 34.8 13.2 11.6 13.4 10.0 8.2 32.5 23.0 24.2 18.4 12.6 20.6 15.8 16.9 16.4 14.8 22.2 17.8 17.2 16.1 18.0 11.7 19.3 22.7 18.4 16.0 25.8 15.3 20.9 20.5 26.0 19.9 26.7 27.7 15.4 14.3 11.2 21.7 20.2 26.2 15.4 22.0 24.5 11.5 37.8 16.8 19.7 28.0 21.9 9.5 21.1 17.4 26.0 16.9 17.4 12.2 26.4 23.5 26.2 12.5 23.0 23.4 18.9 19.3 21.1 18.1 6.8 14.6 20.5 19.0 16.7 6.7 16.6 16.1 19.8 10.5 34.8 11.8 12.3 12.5 8.0 10.8 11.5 11.2 8.5 9.3 10.8 13.2 11.6 13.2 7.8 13.4 10.0 24.2 30.8 38.1 40.2 25.6 21.3 21.6 17.7 24.4 19.0 8.9 16.5 13.7 11.2 0.1 21.2 12.6 35.7 6.7 10.3 12.2 5.9 22.8 36.5 27.5 41.1 18.6 61.4 0.0 36.4 33.1 15.4 16.7 30.0 42.3 27.8 11.1 25.9 27.6 28.5 44.0 10.6 14.5 0.0 26.2 34.4 20.8 29.9 45.6 14.9 32.7 14.2 25.8 11.2 14.9 20.2 0.3 27.6 21.0 31.9 22.0 NAALADL1 ENSG00000168060 "N-acetylated alpha-linked acidic dipeptidase like 1" Q9UQQ1 11 65044818-65058549 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "blood: 49.5;intestine: 123.4" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 39.3;monocytes: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 49.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.4;fHDF/TERT166: 6.8;HHSteC: 19.0;HSkMC: 12.5;SCLC-21H: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047123 Enhanced Uncertain Cytosol NA NA Cytosol "HPA047123: AB_2679942" "unprognostic (2.98e-2)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "unprognostic (8.76e-2)" "unprognostic (1.70e-1)" "unprognostic (1.28e-3)" "unprognostic (1.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.75e-4)" "unprognostic (2.10e-3)" "unprognostic (3.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.80e-2)" 4.1 0.9 1.4 3.3 1.6 7.0 4.1 1.9 1.4 6.0 54.3 1.2 2.6 7.8 7.2 1.8 2.7 4.4 3.4 3.5 1.3 0.6 2.3 1.2 3.4 5.2 1.5 1.5 6.2 1.0 0.9 2.0 1.5 1.6 4.6 2.6 3.1 2.3 4.8 2.0 1.6 123.4 4.3 1.4 5.0 2.8 1.8 1.2 1.8 1.8 2.3 2.9 3.1 5.4 8.8 4.9 49.5 6.3 22.2 12.9 7.0 0.0 0.0 0.1 0.2 0.5 5.4 0.9 2.0 0.0 2.5 1.1 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.0 0.1 3.1 19.0 0.0 0.0 12.5 0.0 2.5 0.0 0.0 3.2 0.1 0.0 0.2 0.0 0.2 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.0 9.8 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.7 0.0 0.1 0.1 49.5 6.3 10.3 9.5 4.3 4.9 8.0 7.6 4.8 4.9 8.8 8.8 4.9 1.1 22.2 2.5 0.2 12.9 7.0 1.4 1.6 1.9 1.4 1.3 0.6 1.5 1.5 1.6 1.2 0.0 0.0 8.2 3.2 3.2 1.1 1.1 2.5 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.6 9.0 39.3 0.0 0.7 0.2 5.7 0.5 19.6 0.0 2.8 9.5 1.2 16.5 7.6 1.7 10.9 6.4 15.1 22.6 0.7 10.8 0.3 14.4 17.0 0.0 0.9 0.0 13.7 1.6 2.6 2.9 0.3 11.7 0.4 0.3 NAB2 MADER ENSG00000166886 "NGFI-A binding protein 2" Q15742 12 57088894-57095476 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004510, HPA027464" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004510: AB_627982, HPA027464: AB_10601138" "prognostic favorable (7.41e-4)" "unprognostic (4.04e-2)" "unprognostic (2.20e-3)" "unprognostic (2.43e-2)" "unprognostic (4.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.88e-3)" "unprognostic (1.80e-1)" "unprognostic (5.85e-2)" "unprognostic (1.19e-1)" "unprognostic (2.13e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (5.67e-3)" "unprognostic (6.19e-3)" 9.5 12.6 11.7 9.9 14.2 4.8 7.9 33.3 20.4 18.7 13.7 5.3 9.6 8.2 22.8 18.9 10.5 15.6 14.5 9.6 8.6 6.8 8.4 18.7 12.8 9.1 4.4 14.6 29.2 8.5 14.5 17.0 13.4 6.8 15.0 4.4 8.5 5.6 14.5 7.1 18.6 7.1 14.5 4.1 8.0 8.2 11.8 7.0 12.4 9.8 7.7 8.6 14.5 26.5 4.2 1.2 0.9 5.4 0.9 2.5 1.2 5.5 3.6 18.9 17.3 17.0 22.3 2.0 16.8 15.2 10.6 8.9 5.8 3.3 3.5 6.9 16.5 3.2 10.1 6.5 12.4 5.7 1.5 1.7 4.2 2.8 5.9 12.9 3.4 10.1 24.7 13.7 12.6 4.3 16.9 2.8 2.6 9.5 3.7 12.3 26.0 5.1 16.3 3.8 4.8 6.3 3.8 24.9 1.8 4.5 2.2 2.1 5.0 8.1 4.7 35.2 5.1 10.6 7.4 3.2 15.7 13.1 11.1 4.9 8.7 2.1 1.8 15.3 2.2 9.4 0.0 2.3 0.3 1.2 5.3 1.4 2.1 2.0 1.5 1.2 4.2 2.5 2.5 0.9 0.9 5.4 0.0 1.9 1.2 11.7 14.2 33.3 20.4 8.6 6.8 4.4 14.6 6.8 7.0 11.9 15.4 9.0 20.1 26.3 18.7 2.4 0.0 1.4 13.6 8.7 2.0 2.7 6.6 7.2 0.4 10.5 2.6 0.0 1.2 8.8 23.4 12.6 16.2 13.0 10.6 9.5 6.3 16.5 13.7 2.1 18.1 18.0 20.3 0.0 0.5 7.5 3.3 0.0 17.7 4.4 3.8 19.4 16.0 1.6 15.0 28.4 47.0 5.1 1.3 8.4 NABP1 "DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2" ENSG00000173559 "Nucleic acid binding protein 1" Q96AH0 2 191678068-191696659 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 620.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054978, HPA067802" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054978: AB_2682660, HPA067802: AB_2685899" "unprognostic (5.43e-2)" "unprognostic (5.33e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.48e-1)" "unprognostic (6.89e-2)" "unprognostic (8.07e-4)" "unprognostic (1.33e-1)" "unprognostic (2.89e-2)" "unprognostic (2.99e-1)" "unprognostic (2.82e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (8.20e-7)" "unprognostic (5.64e-2)" "unprognostic (7.50e-2)" "unprognostic (1.48e-1)" "unprognostic (6.02e-2)" 20.8 4.9 2.4 26.0 2.3 4.2 22.2 1.1 2.1 4.4 14.1 1.9 1.6 13.3 6.7 9.2 12.1 4.9 8.1 6.9 4.7 2.0 8.8 8.7 18.6 39.6 3.9 1.3 4.9 6.3 0.8 4.4 28.0 6.1 4.7 5.2 2.6 6.2 3.9 3.1 4.3 30.6 4.7 5.3 40.0 4.6 18.4 1.5 7.4 3.6 12.1 23.0 8.7 8.8 3.8 2.2 18.6 7.7 1.6 14.2 1.9 14.8 2.3 0.3 0.4 11.3 13.7 3.9 23.2 19.0 14.4 8.7 12.3 8.4 0.8 18.4 14.0 11.7 4.2 2.1 9.9 16.0 7.7 1.9 7.4 4.7 3.1 8.2 3.4 8.4 18.0 12.5 20.7 14.9 17.2 5.4 2.2 10.4 32.9 22.5 1.2 1.1 4.0 1.3 3.1 11.7 2.5 2.6 7.0 21.6 11.0 0.5 0.1 8.0 2.8 6.5 14.1 0.7 2.2 13.8 12.1 10.2 6.3 14.5 10.9 4.5 3.1 10.0 4.1 2.1 2.5 4.0 1.9 6.4 6.7 8.7 3.8 8.6 6.6 2.2 0.6 2.2 3.8 18.6 1.6 7.7 1.4 14.2 1.9 2.4 2.3 1.1 1.9 4.7 2.0 3.9 1.3 6.1 1.5 199.5 620.7 29.6 104.4 47.2 3.0 6.7 12.7 85.6 168.4 10.4 2.0 20.0 3.3 17.5 161.5 9.3 94.3 0.0 4.6 34.8 18.6 41.1 131.1 6.7 49.8 3.2 4.1 11.6 96.8 54.0 9.5 125.6 38.8 147.9 15.3 1.1 20.2 31.6 3.5 17.7 3.8 6.5 28.6 21.1 18.0 39.5 122.3 52.2 21.7 106.4 NACA NACA1 ENSG00000196531 "Nascent polypeptide-associated complex alpha subunit" "E9PAV3, Q13765" 12 56712428-56731628 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Activator, Chaperone, DNA-binding" Allergen "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA073152, HPA073648" Approved Cytosol NA Yes Cytosol "HPA073152: AB_2686575, HPA073648: AB_2686621" "unprognostic (3.35e-2)" "unprognostic (9.98e-3)" "unprognostic (1.56e-1)" "unprognostic (2.30e-3)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.24e-3)" "unprognostic (1.55e-1)" "unprognostic (3.92e-2)" "unprognostic (2.95e-2)" "unprognostic (5.64e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (4.58e-11)" "unprognostic (9.47e-2)" "unprognostic (6.28e-2)" "unprognostic (7.00e-2)" "unprognostic (9.79e-2)" 106.9 85.3 72.2 77.6 63.0 120.7 149.8 71.7 65.5 115.5 89.1 40.5 76.7 57.3 83.3 107.7 142.6 95.2 69.2 111.5 58.9 52.7 79.8 130.1 68.5 148.3 63.7 51.3 213.8 119.9 58.1 61.3 80.8 63.7 112.3 79.7 45.9 95.5 72.9 241.6 124.5 71.2 115.1 74.1 81.9 72.3 53.2 53.8 97.8 109.0 149.1 125.1 144.8 139.1 91.8 101.6 45.4 160.0 66.3 97.4 146.6 78.5 91.5 109.0 86.1 130.5 223.6 108.3 78.8 113.8 107.4 74.8 110.2 87.3 141.4 88.3 73.9 44.3 69.2 96.5 126.6 114.5 69.2 150.1 102.6 64.1 109.6 122.4 144.6 66.2 176.7 162.8 87.2 178.1 193.1 118.5 83.8 127.1 184.9 104.9 76.4 93.4 178.8 111.2 76.1 102.2 106.3 91.9 150.0 149.2 79.8 80.9 87.4 58.5 139.6 121.0 79.5 152.0 166.3 76.7 56.8 69.7 60.3 79.1 88.6 98.6 125.9 83.3 99.2 72.2 33.2 88.1 45.4 58.5 124.6 85.6 91.8 83.4 72.5 94.4 74.6 97.4 83.9 33.2 66.3 160.0 101.6 85.9 146.6 72.2 63.0 71.7 65.5 58.9 52.7 63.7 51.3 63.7 53.8 413.9 563.5 1474.2 1870.1 1800.9 294.5 578.3 937.6 440.3 720.0 375.1 62.8 1562.4 1507.1 1062.8 561.3 1209.8 673.8 420.4 1761.3 2399.9 1079.6 1341.5 713.0 646.1 1391.2 173.2 622.3 710.2 1196.9 484.6 2231.3 1465.0 1175.9 1424.7 1175.0 458.5 1465.8 1052.1 1345.3 1857.7 337.7 789.0 1297.8 499.0 489.8 1950.7 1943.0 1208.8 1657.0 2037.8 NACA2 "MGC71999, NACAL" ENSG00000253506 "Nascent polypeptide associated complex alpha subunit 2" Q9H009 17 61590426-61591202 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 76.7" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 120.7;Early spermatids: 304.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 7.7;SK-MEL-30: 4.4" "HPA073152, HPA073648" Approved Cytosol NA NA Cytosol "HPA073152: AB_2686575, HPA073648: AB_2686621" "unprognostic (2.37e-1)" "unprognostic (1.50e-2)" "unprognostic (9.59e-2)" "unprognostic (5.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.45e-1)" "unprognostic (8.14e-3)" "unprognostic (4.91e-2)" "unprognostic (3.51e-2)" "unprognostic (1.18e-2)" "unprognostic (7.80e-2)" "unprognostic (2.08e-1)" "unprognostic (1.80e-2)" "unprognostic (6.88e-2)" "unprognostic (7.53e-3)" "unprognostic (5.45e-3)" "unprognostic (3.09e-3)" 2.5 2.5 2.4 2.7 2.8 2.2 5.6 2.2 2.8 6.6 2.4 1.0 0.8 2.2 2.1 2.6 5.0 2.2 1.9 3.7 2.2 2.0 4.7 5.5 3.3 6.5 2.2 2.1 9.5 14.3 2.3 2.1 3.6 1.3 3.3 2.1 1.3 2.2 2.0 7.2 2.8 4.1 5.4 2.9 4.2 2.2 76.7 2.8 4.8 4.1 3.2 2.7 6.3 2.4 2.1 1.9 0.7 3.2 1.7 2.0 2.9 0.8 0.0 0.8 0.8 0.3 0.6 2.3 0.2 0.8 0.3 0.5 0.7 0.4 0.0 1.3 0.0 0.3 0.2 0.2 0.2 0.6 0.6 0.2 0.2 0.8 0.8 0.2 0.3 0.8 0.0 0.9 0.0 0.0 0.3 0.4 0.1 0.2 2.6 0.2 0.2 1.1 7.7 1.9 0.1 0.2 1.0 0.5 2.5 0.3 0.1 1.0 1.9 0.5 1.2 4.4 0.0 2.0 2.8 0.0 0.4 1.0 1.5 0.8 0.9 0.7 0.8 1.0 0.5 0.7 0.4 1.4 0.7 1.2 3.2 1.4 2.1 1.6 1.6 1.9 1.8 2.0 1.8 0.4 1.7 3.0 1.8 1.9 2.9 2.4 2.8 2.2 2.8 2.2 2.0 2.2 2.1 1.3 2.8 0.0 0.0 26.2 34.9 61.6 0.7 120.7 33.1 0.0 0.0 1.8 0.0 16.5 72.9 0.3 304.8 29.2 2.8 0.0 0.7 19.1 22.7 38.5 0.0 16.2 12.6 0.0 3.5 22.7 59.5 103.0 31.4 21.0 43.9 0.0 6.5 1.2 0.5 10.5 10.6 5.1 0.8 12.9 44.3 61.4 10.7 69.4 20.1 27.7 11.9 38.7 NACAD KIAA0363 ENSG00000136274 "NAC alpha domain containing" O15069 7 45080438-45088914 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.0" "Cell type enhanced" "Detected in many" 16 "Horizontal cells: 30.2;Peritubular cells: 11.3" "Group enriched" "Detected in many" 7 "glioma: 12.1;testis cancer: 16.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 12 "monocytes: 1.8;T-cells: 1.4" "Cell line enhanced" "Detected in many" "GAMG: 24.1;SCLC-21H: 18.5;SH-SY5Y: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020981, HPA079208" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020981: AB_2670549, HPA079208: " "unprognostic (5.54e-6)" "unprognostic (1.89e-1)" "unprognostic (8.55e-4)" "unprognostic (7.06e-3)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.61e-1)" "unprognostic (6.91e-2)" "unprognostic (1.16e-1)" "unprognostic (4.17e-2)" "unprognostic (3.17e-2)" "unprognostic (8.17e-3)" "unprognostic (2.76e-2)" "unprognostic (7.72e-3)" "unprognostic (2.72e-3)" "unprognostic (9.22e-2)" "unprognostic (1.54e-1)" "unprognostic (2.87e-2)" 4.7 8.9 11.5 2.7 19.4 1.1 2.1 16.7 45.0 4.8 3.5 43.1 0.1 2.1 6.9 2.3 3.9 4.8 3.7 5.1 16.7 15.9 2.2 1.2 3.0 1.9 30.2 12.9 10.4 2.4 3.2 11.7 3.8 26.7 4.7 2.3 1.1 3.2 5.7 2.0 2.1 2.7 7.4 30.8 2.7 2.5 4.5 21.5 0.0 1.4 0.0 1.5 3.2 2.3 0.1 0.0 0.0 1.8 0.0 1.4 0.1 0.0 0.0 1.8 0.0 1.1 0.5 0.0 2.0 2.5 5.6 3.5 0.1 0.1 0.0 1.6 3.6 24.1 0.1 1.6 1.3 2.0 0.0 0.5 0.0 1.2 0.0 1.3 0.0 0.0 1.2 0.0 2.4 0.2 2.9 1.7 0.0 0.0 2.5 1.4 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.7 0.0 0.2 0.0 18.5 12.8 0.0 0.0 0.1 5.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 1.3 0.7 0.0 1.1 0.0 3.7 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.1 11.5 19.4 16.7 24.1 16.7 15.9 30.2 12.9 26.7 21.5 0.0 0.0 0.0 2.7 0.6 5.1 4.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.4 2.0 1.0 0.0 0.0 0.2 0.0 3.8 1.7 1.1 0.0 0.1 30.2 1.2 0.6 0.0 3.6 6.4 0.0 1.7 1.8 0.0 1.9 0.1 0.0 11.3 0.0 1.4 6.5 2.2 1.5 0.6 0.1 0.1 0.0 0.0 0.6 NADSYN1 FLJ10631 ENSG00000172890 "NAD synthetase 1" Q6IA69 11 71453109-71524107 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017798, HPA038523, HPA038524" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA Vesicles "Golgi apparatus, Cytosol" "CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061" "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" "unprognostic (7.30e-2)" "unprognostic (2.63e-3)" "unprognostic (1.75e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.17e-6)" "unprognostic (1.19e-2)" "unprognostic (4.38e-2)" "unprognostic (1.41e-1)" "unprognostic (9.41e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (4.12e-3)" "unprognostic (1.38e-1)" "unprognostic (1.54e-2)" "prognostic favorable (5.10e-4)" 14.5 16.9 10.8 23.2 21.2 39.6 14.0 12.2 18.5 12.4 30.6 21.9 24.1 26.3 15.0 17.5 29.1 16.4 33.1 10.6 10.4 9.5 16.5 24.8 18.1 20.5 22.7 9.2 15.6 20.6 13.5 20.2 17.1 15.6 23.9 25.3 12.9 18.0 17.2 9.8 15.0 36.8 13.6 14.6 30.7 19.2 17.4 20.0 26.4 17.3 21.7 29.8 26.1 17.1 9.5 22.3 12.8 19.7 11.9 12.6 13.1 6.1 14.9 4.8 8.8 14.6 21.4 13.3 12.0 10.9 6.3 6.9 12.7 10.5 5.4 13.7 14.1 8.4 22.1 6.3 17.2 3.3 10.9 5.1 8.8 10.0 14.1 18.3 17.6 17.0 30.3 27.1 8.1 7.4 14.4 22.1 9.8 4.5 7.6 8.9 19.3 8.6 11.5 2.9 27.5 8.7 10.8 15.3 5.3 15.5 28.6 3.6 5.2 8.6 11.3 22.0 7.6 10.0 9.6 26.6 7.0 6.0 12.7 4.6 9.8 4.2 4.6 12.3 10.1 4.8 4.5 19.7 11.8 11.7 17.4 9.9 9.5 10.5 10.6 22.3 7.4 7.0 8.8 12.8 11.9 15.1 16.7 12.6 13.1 10.8 21.2 12.2 18.5 10.4 9.5 22.7 9.2 15.6 20.0 20.8 35.4 18.2 14.5 5.6 6.5 6.9 15.3 14.7 18.2 10.4 3.9 14.5 3.3 15.1 16.8 15.8 63.6 23.3 14.9 11.8 10.8 15.4 20.9 14.4 17.4 12.7 22.5 9.2 22.1 49.9 8.6 20.8 8.5 20.8 28.6 6.9 16.9 54.7 9.6 13.9 7.7 12.9 7.8 16.4 4.3 11.2 14.4 21.3 38.6 20.2 NAF1 ENSG00000145414 "Nuclear assembly factor 1 ribonucleoprotein" Q96HR8 4 163110073-163166921 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036241, HPA036242, HPA066090" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614" "unprognostic (6.24e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-2)" "unprognostic (2.58e-1)" "unprognostic (8.99e-2)" "unprognostic (2.00e-2)" "unprognostic (1.18e-2)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.64e-3)" "unprognostic (1.45e-1)" "unprognostic (8.73e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.17e-2)" "unprognostic (3.05e-1)" 13.3 12.3 8.6 9.6 19.8 8.7 11.9 10.7 18.9 12.9 10.6 14.7 6.4 6.2 18.8 8.6 11.0 17.3 10.9 11.7 10.5 7.8 9.5 10.5 10.9 10.7 7.2 9.1 20.1 11.1 15.7 18.7 8.8 10.1 12.0 11.4 13.4 10.4 12.5 36.4 14.3 8.3 12.7 7.4 10.0 11.3 17.2 7.5 12.3 14.0 12.2 12.2 12.5 10.4 2.5 2.4 0.1 1.6 1.2 3.5 1.4 9.1 7.7 10.0 10.2 5.9 9.4 11.7 10.8 7.2 9.5 9.5 8.7 10.9 23.7 3.1 6.6 7.6 7.7 20.2 11.6 12.5 10.4 12.5 25.1 6.9 7.4 10.3 16.2 9.0 8.9 10.4 11.5 9.4 9.9 8.4 7.7 28.1 12.6 12.6 8.9 18.7 9.2 13.0 6.9 7.7 15.6 7.4 12.4 9.4 4.2 10.9 8.2 7.1 13.0 7.7 9.2 7.0 7.1 8.8 11.4 9.8 8.8 12.1 7.9 11.0 18.3 10.8 9.4 11.2 0.0 1.5 0.1 2.2 1.6 0.9 1.9 2.5 3.3 2.4 2.5 3.5 2.3 0.0 1.2 1.5 2.4 0.7 1.4 8.6 19.8 10.7 18.9 10.5 7.8 7.2 9.1 10.1 7.5 6.0 14.7 11.5 15.4 28.7 11.4 3.1 10.2 36.1 7.9 8.7 17.7 12.3 3.3 7.0 37.3 8.5 2.7 0.0 5.9 13.9 10.6 10.3 10.4 4.4 10.8 7.9 18.4 14.1 15.7 16.6 6.4 9.3 8.5 6.4 5.3 9.3 6.7 3.5 4.9 6.9 13.7 32.3 14.4 17.6 14.3 35.9 17.8 10.0 8.4 10.5 NAGK GNK ENSG00000124357 "N-acetylglucosamine kinase" Q9UJ70 2 71064344-71079805 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 191.3;Syncytiotrophoblasts: 266.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035206, HPA035207" Enhanced Approved Nucleoplasm,Cytosol NA NA 690000 Cytosol Nucleoplasm "HPA035206: AB_2674517, HPA035207: AB_10602031" "unprognostic (6.15e-2)" "unprognostic (4.23e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.44e-1)" "prognostic favorable (5.87e-4)" "unprognostic (4.65e-3)" "unprognostic (2.18e-2)" "unprognostic (2.31e-1)" "unprognostic (9.99e-2)" "unprognostic (4.32e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (4.35e-4)" "unprognostic (8.60e-2)" "unprognostic (1.45e-2)" "unprognostic (5.50e-3)" "unprognostic (2.13e-2)" 20.0 17.6 21.8 30.9 24.5 9.8 15.7 13.9 18.8 23.6 15.5 23.7 17.4 11.4 16.4 19.7 67.0 13.7 20.0 14.0 17.6 20.4 16.9 20.2 18.3 30.6 31.1 20.3 15.0 25.8 27.5 21.8 43.9 26.2 15.8 15.8 14.7 49.0 17.8 11.3 29.5 14.6 22.8 21.6 43.4 15.5 24.8 26.7 20.2 13.0 27.2 39.9 24.5 26.1 14.3 53.0 37.4 79.3 8.5 7.1 52.2 19.0 15.5 8.7 8.9 34.8 21.3 34.3 42.5 18.4 28.5 25.9 18.1 10.0 10.6 10.1 29.4 33.6 9.2 6.6 12.6 17.7 15.1 5.2 6.0 5.1 11.2 26.1 3.7 15.2 19.0 13.2 30.6 4.8 20.6 29.9 9.3 2.7 12.0 39.4 17.4 9.4 13.3 9.3 15.2 12.0 7.4 24.4 5.4 17.2 34.1 9.0 5.0 12.8 20.2 13.3 15.6 10.5 4.8 26.2 34.0 13.2 13.1 14.8 8.4 7.3 6.2 23.2 10.2 18.6 10.3 79.3 31.5 5.4 69.8 5.5 14.3 6.4 5.2 53.0 13.3 5.5 4.5 37.4 8.5 46.6 42.4 7.1 52.2 21.8 24.5 13.9 18.8 17.6 20.4 31.1 20.3 26.2 26.7 35.7 38.8 52.2 25.0 23.9 42.8 14.8 22.9 24.1 28.4 36.6 21.6 111.0 34.9 60.8 114.8 28.1 13.8 0.0 39.8 106.9 36.8 15.4 49.8 12.1 191.3 44.5 22.4 30.7 107.2 16.6 27.9 97.6 37.1 45.1 18.1 42.9 52.7 22.6 35.3 46.9 53.5 19.4 33.0 33.7 22.6 36.4 266.6 23.8 13.8 37.2 NAIF1 "bA379C10.2, C9orf90, DKFZp762G199" ENSG00000171169 "Nuclear apoptosis inducing factor 1" Q69YI7 9 128061233-128068206 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054898, HPA064931" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA054898: AB_2682633, HPA064931: AB_2732725" "unprognostic (7.09e-2)" "unprognostic (5.92e-2)" "unprognostic (1.20e-2)" "unprognostic (5.56e-3)" "unprognostic (1.58e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (6.15e-2)" "unprognostic (9.41e-2)" "prognostic favorable (1.02e-5)" "unprognostic (3.08e-1)" "prognostic favorable (8.30e-5)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (3.92e-2)" 7.1 7.2 4.5 5.1 4.5 11.3 10.3 5.6 5.5 6.0 4.5 2.4 10.9 6.0 6.3 5.1 7.1 5.4 6.6 7.4 5.5 3.4 5.2 8.3 9.3 8.3 3.8 4.2 5.4 7.3 3.4 4.5 7.3 5.3 6.0 3.7 5.5 6.5 9.5 7.1 5.5 6.2 5.2 4.8 9.0 5.5 15.6 2.9 12.5 6.2 6.1 7.8 5.5 16.3 3.4 2.2 4.5 3.0 1.6 3.4 1.5 4.8 4.2 2.7 6.9 2.5 2.3 6.1 3.7 2.2 3.2 2.6 3.3 3.9 5.9 3.3 2.3 4.5 3.6 2.8 2.8 2.6 18.0 3.7 4.4 5.0 1.9 4.2 6.0 12.4 2.1 3.4 2.4 4.0 2.5 2.9 6.7 10.3 3.8 2.9 5.6 5.8 7.3 2.9 6.6 7.2 5.6 4.3 5.3 2.4 3.0 3.9 4.5 3.6 5.1 3.8 2.0 3.9 6.0 1.9 3.8 11.9 3.1 4.2 6.2 12.9 3.9 3.6 3.9 5.0 0.0 2.2 3.3 1.7 2.0 1.4 1.1 3.4 2.5 2.2 3.4 2.6 2.2 4.5 1.6 3.0 1.7 0.9 1.5 4.5 4.5 5.6 5.5 5.5 3.4 3.8 4.2 5.3 2.9 0.0 4.0 8.8 4.0 4.2 3.3 3.9 5.1 0.0 2.3 5.2 0.0 5.0 3.3 3.1 5.9 4.7 5.1 0.0 5.8 5.0 3.3 3.0 8.1 2.4 4.8 9.5 5.2 5.5 4.7 9.2 5.8 4.4 0.0 4.6 2.5 4.1 3.4 4.0 2.8 3.4 5.0 0.0 3.3 10.8 7.6 3.3 3.9 7.2 3.1 2.0 NANOS1 "NOS1, ZC2HC12A" ENSG00000188613 "Nanos C2HC-type zinc finger 1" Q8WY41 10 119029716-119033732 "Disease related genes, Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 40.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 10.9;Cone photoreceptor cells: 9.8;Muller glia cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 39.6;SK-BR-3: 22.7;SK-MEL-30: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012219 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB012219: " "prognostic unfavorable (1.52e-4)" "unprognostic (1.17e-1)" "unprognostic (1.50e-3)" "unprognostic (1.59e-3)" "unprognostic (7.07e-3)" "unprognostic (2.01e-1)" "unprognostic (2.19e-2)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (2.70e-1)" "unprognostic (8.22e-3)" "unprognostic (8.79e-2)" "unprognostic (2.64e-4)" "unprognostic (7.89e-2)" "unprognostic (6.99e-2)" "unprognostic (2.78e-2)" "unprognostic (2.52e-3)" 8.5 10.5 8.1 1.0 7.1 1.0 6.4 6.5 4.8 4.9 2.1 4.5 1.3 1.2 2.1 4.4 2.1 1.5 1.0 16.7 5.0 6.7 3.5 1.0 1.3 1.1 3.4 2.4 0.9 3.3 0.9 2.2 8.2 6.0 3.5 1.2 8.8 1.5 2.5 40.7 1.7 1.4 3.4 6.7 0.9 3.1 2.9 3.0 0.1 9.3 0.3 1.0 3.3 9.8 0.6 0.5 3.2 0.3 0.6 0.3 0.1 7.6 0.6 1.1 0.2 3.7 0.5 4.7 0.1 0.2 0.2 0.1 0.9 2.7 4.1 1.0 0.0 0.0 2.8 1.3 1.3 0.3 1.2 3.2 0.1 1.9 0.8 1.7 0.4 0.0 0.7 5.7 0.0 0.8 1.2 0.2 1.4 0.7 0.5 0.2 1.1 1.0 1.3 3.5 1.6 0.6 0.0 1.3 2.7 1.5 0.6 3.0 39.6 2.2 22.7 17.2 6.2 3.6 2.2 0.2 0.0 1.7 0.0 0.3 1.2 3.9 1.4 0.3 1.0 0.0 3.2 0.3 0.4 0.2 0.1 0.1 0.2 0.2 0.2 0.0 0.6 0.3 0.2 1.3 0.6 0.2 0.5 0.1 0.1 8.1 7.1 6.5 4.8 5.0 6.7 3.4 2.4 6.0 3.0 6.0 0.6 0.0 3.5 0.7 3.3 10.9 0.0 0.0 1.2 1.8 9.8 5.3 0.0 0.5 0.1 0.6 0.4 0.0 0.2 0.2 4.1 3.2 0.0 0.0 0.5 1.6 2.9 0.6 0.0 0.0 1.7 0.0 0.0 0.0 1.0 8.5 0.2 0.0 0.7 0.2 1.7 0.0 0.5 0.2 0.7 1.1 0.8 0.0 0.6 0.9 NAP1L2 "BPX, MGC26243" ENSG00000186462 "Nucleosome assembly protein 1 like 2" Q9ULW6 X 73212299-73214848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 49.8" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 24.8;Horizontal cells: 17.5;Muller glia cells: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 12.1;Karpas-707: 10.2;NTERA-2: 13.0;U-2197: 10.5;U-266/84: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054050, HPA057065" Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA054050: AB_2682357, HPA057065: AB_2797258" "unprognostic (1.12e-1)" "unprognostic (6.64e-5)" "unprognostic (4.22e-2)" "unprognostic (9.64e-4)" "unprognostic (1.78e-1)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (8.51e-3)" "unprognostic (1.76e-2)" "unprognostic (2.66e-1)" "prognostic favorable (5.41e-4)" "unprognostic (1.53e-2)" "unprognostic (1.54e-2)" "unprognostic (6.95e-4)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.45e-2)" 2.3 5.8 15.7 2.2 20.0 0.9 3.2 37.5 49.8 4.5 2.8 2.0 0.2 1.3 4.9 8.0 2.8 4.2 2.5 7.2 21.0 22.8 8.0 1.3 2.5 2.9 15.7 28.7 8.6 2.6 10.5 10.2 0.5 20.5 10.4 3.1 2.6 3.1 5.9 1.1 4.9 1.7 4.6 8.3 3.9 2.0 2.2 4.9 0.0 8.0 0.0 1.8 2.6 2.5 0.9 0.0 0.0 0.0 1.2 3.6 1.4 0.0 3.4 0.1 6.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 12.1 0.0 6.5 0.7 2.4 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.9 0.1 1.8 0.0 0.2 4.7 0.2 10.2 0.0 1.2 4.0 0.0 13.0 0.0 6.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.8 0.0 2.7 1.2 0.0 0.1 0.0 7.6 10.5 0.8 4.8 21.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 0.9 3.4 2.3 0.0 0.1 1.6 3.6 0.0 1.2 0.0 0.0 2.6 1.4 15.7 20.0 37.5 42.1 21.0 22.8 15.7 28.7 20.5 4.9 0.0 4.0 0.0 4.6 5.7 24.8 10.9 5.1 0.0 1.2 12.2 0.0 0.0 11.6 0.8 0.0 2.2 0.0 0.0 0.2 0.0 0.5 2.4 4.6 0.8 0.1 17.5 6.9 2.5 0.8 0.0 0.3 0.0 0.0 0.0 0.2 12.4 1.1 0.0 0.4 3.1 8.7 0.0 3.3 0.2 0.0 2.6 0.0 3.2 0.2 0.8 NAP1L5 DRLM ENSG00000177432 "Nucleosome assembly protein 1 like 5" Q96NT1 4 88695915-88697829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.4" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 32.4;granulocytes: 31.1;Muller glia cells: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.5" "Low region specificity" "Detected in all" HPA058227 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058227: AB_2683644" "unprognostic (1.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (8.54e-3)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-2)" "unprognostic (1.39e-1)" 7.3 21.8 24.5 3.6 23.3 4.9 4.9 25.8 53.4 6.2 3.1 4.2 2.1 1.9 6.4 10.5 4.1 4.9 5.4 5.6 23.9 52.8 6.1 5.0 3.1 3.0 28.4 33.6 8.2 2.8 7.9 12.9 4.7 35.6 6.7 3.1 3.6 2.5 8.7 1.8 1.7 2.4 6.4 11.5 3.5 2.8 4.9 5.4 0.5 9.3 1.3 2.4 5.2 2.0 0.7 0.9 0.6 0.8 1.5 3.9 1.0 0.0 1.1 7.3 4.4 10.7 6.9 0.0 7.8 4.8 4.0 6.3 0.0 0.9 0.0 3.2 4.5 1.7 1.5 12.9 3.1 7.3 2.4 0.0 13.5 4.7 1.1 9.3 6.9 8.9 10.8 1.0 4.7 0.7 5.2 7.1 7.6 3.8 0.0 11.8 0.1 8.5 0.5 3.0 3.7 0.0 4.6 2.1 0.8 2.7 3.3 9.7 29.5 0.0 1.4 5.7 8.2 0.0 2.0 5.1 4.6 1.1 2.9 3.9 2.0 0.0 0.0 9.8 0.0 3.5 0.0 0.2 0.4 3.9 0.4 2.6 0.0 1.9 3.0 0.9 0.7 3.5 3.3 0.6 1.5 0.8 0.7 1.7 1.0 24.5 23.3 25.8 41.9 23.9 52.8 28.4 33.6 35.6 5.4 3.0 7.0 2.4 3.4 1.5 32.4 4.8 0.0 1.4 6.8 5.2 13.7 12.6 13.3 1.7 0.6 5.4 0.0 0.0 2.2 1.6 8.5 2.9 31.1 2.9 4.8 14.3 16.6 10.4 0.0 0.4 10.0 1.2 5.0 2.8 1.4 32.8 1.0 0.2 17.0 3.4 17.3 19.4 9.8 5.6 2.1 1.3 18.5 7.9 0.9 1.7 NAPA ENSG00000105402 "NSF attachment protein alpha" P54920 19 47487637-47515240 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010100, HPA046149, HPA050196" Approved Uncertain Cytosol NA NA 5400000 Cytosol "CAB010100: AB_628263, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (9.83e-2)" "unprognostic (9.43e-3)" "unprognostic (1.12e-2)" "unprognostic (1.76e-3)" "unprognostic (9.72e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (5.61e-2)" "unprognostic (2.42e-3)" "unprognostic (1.09e-3)" "prognostic favorable (4.26e-9)" "unprognostic (4.04e-2)" "unprognostic (4.17e-2)" "unprognostic (8.55e-2)" "unprognostic (2.90e-2)" 28.1 52.4 35.5 24.5 49.1 43.6 29.3 70.2 86.9 30.9 29.9 34.8 31.0 26.5 37.6 29.0 56.0 29.1 33.4 47.3 41.8 29.6 35.8 73.8 30.3 24.6 28.1 39.4 28.8 41.2 40.4 35.4 30.3 52.6 49.0 21.7 35.5 52.3 45.5 56.9 45.6 27.4 31.8 25.1 24.8 28.8 38.5 20.8 44.8 36.4 39.0 28.4 31.4 29.1 15.7 44.5 68.2 41.1 24.1 23.5 40.6 17.3 22.9 11.2 19.3 23.5 20.2 8.2 19.7 23.8 43.9 55.4 17.2 10.0 13.1 10.3 25.7 29.1 13.0 18.1 22.9 17.5 21.2 19.6 16.9 22.7 21.0 61.8 19.1 30.0 30.1 15.8 18.3 11.4 9.2 21.3 17.3 14.0 34.8 28.9 14.5 26.1 51.2 9.3 25.9 17.6 17.2 10.6 18.4 34.1 33.4 40.6 15.4 25.1 29.5 17.3 11.2 24.2 30.1 22.8 22.5 11.9 19.1 21.1 22.3 32.4 18.7 42.3 20.1 23.2 35.6 35.6 68.2 22.7 41.1 18.8 15.7 19.3 22.0 30.1 15.2 20.5 20.0 39.6 24.1 41.0 44.5 23.5 40.6 35.5 49.1 70.2 86.9 41.8 29.6 28.1 39.4 52.6 20.8 11.9 40.4 29.8 78.5 56.2 53.9 2.8 68.8 9.4 20.5 48.8 25.5 90.7 150.9 96.2 24.5 35.3 77.2 46.7 87.3 57.2 49.8 66.0 64.5 77.8 115.3 33.4 80.2 40.5 54.8 27.9 39.7 56.4 92.8 101.0 48.5 71.6 84.3 49.1 43.5 81.6 37.2 90.5 59.0 82.1 70.7 60.0 191.4 49.8 39.9 62.1 NAPB "SNAP-BETA, SNAPB" ENSG00000125814 "NSF attachment protein beta" Q9H115 20 23374519-23421519 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 110.9" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 176.7;Cone photoreceptor cells: 62.8;Horizontal cells: 63.5;Rod photoreceptor cells: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 24.5;U-937: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037225, CAB037227, HPA046149, HPA050196" Supported Uncertain Cytosol NA NA Cytosol "CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (3.89e-1)" "unprognostic (2.71e-1)" "unprognostic (5.95e-2)" "unprognostic (1.05e-1)" "unprognostic (2.54e-2)" "unprognostic (3.92e-2)" "unprognostic (1.32e-3)" "unprognostic (1.25e-1)" "unprognostic (4.71e-2)" "unprognostic (6.37e-2)" "unprognostic (4.46e-3)" "unprognostic (7.52e-3)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" 3.2 15.5 32.7 3.8 32.7 6.0 4.4 46.0 110.9 4.0 4.0 4.4 2.6 3.8 4.7 6.3 3.7 4.6 3.8 3.7 30.5 32.0 4.4 3.8 3.9 4.0 26.1 40.1 6.4 3.4 6.1 4.6 5.9 50.2 4.0 5.0 6.1 4.0 4.6 3.4 5.0 5.5 4.5 9.7 4.5 4.3 5.3 4.0 0.7 5.1 0.1 3.4 3.6 2.3 2.4 1.9 6.0 2.1 1.5 5.1 2.1 4.3 2.8 4.6 4.8 5.2 4.8 6.5 5.6 3.0 4.5 4.0 3.3 3.8 6.3 6.7 3.3 3.3 5.5 5.9 3.8 5.5 2.0 4.4 6.9 3.7 7.7 6.1 5.1 4.1 4.8 5.0 3.2 4.0 4.1 3.3 6.5 5.8 8.4 7.2 2.9 5.2 4.7 2.0 3.5 5.1 3.5 3.7 4.7 5.9 4.7 24.5 7.8 3.2 3.1 5.2 7.0 3.2 3.2 3.9 4.3 3.2 4.8 3.9 6.2 4.8 2.9 2.2 24.4 4.3 6.0 1.2 0.0 5.1 1.3 1.5 1.7 2.0 2.4 1.9 2.4 2.0 3.3 1.5 1.5 2.1 1.5 2.5 2.1 32.7 32.7 46.0 57.7 30.5 32.0 26.1 40.1 50.2 4.0 11.9 6.2 5.1 4.4 7.7 176.7 4.9 7.6 2.7 6.8 14.0 62.8 5.6 0.0 2.9 39.1 7.7 3.5 0.0 1.2 4.4 8.4 3.3 10.5 4.9 4.4 63.5 9.8 10.4 7.2 45.5 8.3 3.6 10.1 4.6 2.3 15.7 2.7 0.0 8.5 2.2 78.5 6.5 6.2 9.7 9.8 7.3 5.1 5.7 4.5 3.3 NAPEPLD "C7orf18, FMP30, NAPE-PLD" ENSG00000161048 "N-acyl phosphatidylethanolamine phospholipase D" Q6IQ20 7 103099776-103149560 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 74.1;Early spermatids: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019832, HPA024338" Approved Approved Cytosol NA NA Cytosol "HPA019832: AB_1844422, HPA024338: AB_2671533" "unprognostic (3.62e-1)" "unprognostic (1.86e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-1)" "unprognostic (7.58e-2)" "unprognostic (1.05e-3)" "unprognostic (1.02e-2)" "unprognostic (6.39e-3)" "unprognostic (2.70e-2)" "unprognostic (1.20e-1)" "unprognostic (2.81e-2)" "unprognostic (3.21e-1)" "prognostic favorable (7.32e-6)" "unprognostic (8.83e-2)" "unprognostic (1.19e-1)" "unprognostic (1.42e-1)" "unprognostic (2.41e-2)" 3.8 5.3 8.6 3.8 14.0 3.1 3.9 13.9 18.5 5.1 8.8 17.2 3.7 15.9 4.9 3.5 2.6 6.5 6.1 4.2 6.4 5.5 15.1 7.4 4.3 3.8 15.0 11.6 9.7 4.1 8.5 6.2 2.9 10.3 5.4 10.1 5.0 4.2 4.1 5.0 5.7 10.8 4.5 9.7 6.6 11.2 11.1 16.7 5.3 8.8 0.9 3.8 6.9 4.6 7.9 3.7 5.7 4.6 2.9 7.6 2.5 4.6 6.2 4.0 3.6 3.6 3.9 0.6 3.0 2.8 2.1 3.4 2.7 6.2 4.2 5.1 2.3 4.7 4.3 2.8 1.0 2.5 6.5 3.9 1.7 3.7 1.2 0.9 3.7 1.8 2.2 1.2 1.9 0.0 7.8 3.4 3.0 2.0 4.5 4.0 1.7 4.4 2.0 3.7 7.3 7.3 2.8 1.8 2.2 7.6 2.1 2.9 3.9 8.2 2.6 1.8 2.2 1.7 2.1 3.0 5.9 4.2 12.0 3.7 5.6 6.1 3.6 4.2 2.7 11.3 0.2 3.1 5.7 4.9 4.6 4.4 7.4 5.3 5.8 3.7 7.9 7.6 5.6 0.3 2.9 3.0 2.7 4.7 2.5 8.6 14.0 13.9 18.5 6.4 5.5 15.0 11.6 10.3 16.7 17.9 7.7 9.8 4.8 6.0 74.1 10.2 20.4 1.4 6.8 50.6 49.1 7.3 8.3 4.4 112.3 2.9 30.7 0.0 2.3 3.1 4.6 8.5 4.6 18.4 3.5 47.7 13.3 4.9 3.5 31.4 29.4 2.7 13.5 4.6 26.3 21.0 3.7 28.6 31.5 26.7 34.0 6.5 2.3 14.6 10.9 2.5 2.4 4.3 23.0 5.5 NAPG ENSG00000134265 "NSF attachment protein gamma" Q99747 18 10525905-10552761 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008208, HPA011389" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA008208: AB_1854305, HPA011389: AB_1854306" "unprognostic (1.23e-1)" "unprognostic (7.64e-3)" "unprognostic (6.96e-2)" "unprognostic (1.53e-1)" "unprognostic (9.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.28e-1)" "unprognostic (4.59e-2)" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (1.46e-3)" "unprognostic (5.85e-2)" "prognostic favorable (8.14e-4)" "unprognostic (3.81e-2)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (6.96e-2)" 11.0 14.0 20.5 9.1 31.2 6.1 12.1 24.0 40.2 11.6 11.6 17.8 4.9 9.3 11.0 12.7 12.3 11.3 13.5 19.3 26.3 20.8 16.9 13.3 9.6 8.7 24.1 21.4 7.6 12.4 12.8 10.5 13.7 54.1 14.3 14.1 10.1 10.7 11.6 9.0 8.8 10.3 12.5 25.2 8.5 13.4 7.1 11.9 6.9 14.8 8.2 10.6 12.6 8.7 8.4 4.7 15.2 7.1 6.6 7.1 3.6 5.0 3.0 5.3 4.6 15.2 10.5 7.7 10.7 15.4 10.5 13.4 6.6 7.6 6.7 8.6 14.6 9.6 4.9 7.0 9.7 15.1 5.7 4.3 4.9 5.3 6.8 14.6 13.5 9.2 11.0 11.2 12.0 9.0 6.9 9.8 8.7 7.9 16.0 15.3 7.0 10.4 5.8 4.1 38.5 4.5 4.6 8.8 11.2 12.3 11.9 21.2 5.6 8.7 9.3 12.3 9.0 4.2 9.0 11.0 16.6 8.0 15.2 11.3 10.3 10.5 7.4 11.1 9.5 7.6 11.3 5.7 15.2 6.5 7.1 5.8 8.4 5.2 6.3 4.2 4.1 7.1 6.1 9.7 6.6 6.9 4.7 5.1 3.6 20.5 31.2 24.0 40.2 26.3 20.8 24.1 21.4 54.1 11.9 26.8 26.7 24.1 23.8 21.6 62.1 30.5 22.9 17.4 22.7 26.2 11.8 20.2 34.9 43.8 12.0 21.5 22.5 0.0 37.3 25.1 18.2 29.7 43.9 18.8 22.3 42.9 22.5 17.2 23.1 2.1 7.2 19.7 25.3 19.8 17.1 28.2 53.8 34.5 19.8 31.9 31.3 25.8 21.7 12.7 37.9 18.4 37.8 20.1 14.3 46.1 NAPRT "NAPRT1, PP3856" ENSG00000147813 "Nicotinate phosphoribosyltransferase" Q6XQN6 8 143574785-143578649 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Ligase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 22.3;SK-BR-3: 23.9;U-937: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023739, HPA024017, CAB068206, CAB068207" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 2000000 "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309" "unprognostic (7.08e-2)" "unprognostic (1.55e-1)" "unprognostic (5.76e-3)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.30e-1)" "unprognostic (7.65e-2)" "unprognostic (2.19e-1)" "unprognostic (2.84e-1)" "unprognostic (1.08e-2)" "unprognostic (1.75e-1)" "unprognostic (4.13e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.02e-2)" "unprognostic (3.97e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-2)" 9.7 6.4 4.9 9.7 6.2 21.1 13.2 10.7 5.4 6.7 25.2 2.3 9.9 33.0 4.7 4.7 16.4 4.8 15.5 4.9 3.9 2.1 10.7 28.3 8.3 12.1 3.7 0.1 5.9 6.5 2.4 2.8 8.6 4.1 6.9 3.8 5.2 12.8 3.8 7.1 12.4 34.4 5.2 2.2 9.8 11.8 5.5 4.0 3.0 6.8 8.9 9.5 7.6 8.1 0.8 4.7 4.6 8.4 0.5 1.6 2.4 3.4 4.0 0.4 0.8 0.3 1.2 2.6 0.8 0.4 1.3 0.8 3.3 22.3 0.9 6.3 0.2 0.0 7.7 0.2 6.3 0.0 4.1 6.4 5.3 10.5 0.9 2.8 1.3 2.8 0.1 2.2 0.1 0.0 0.0 1.4 4.4 4.9 4.1 0.1 4.3 2.6 2.7 1.0 4.7 2.5 4.6 0.1 11.0 0.9 1.3 1.8 0.4 10.0 23.9 3.0 0.1 0.9 3.1 4.2 0.7 6.4 4.7 1.7 0.5 0.2 1.1 1.1 18.5 3.3 0.0 4.4 4.6 1.6 8.4 0.5 0.8 0.7 1.5 4.7 0.2 0.8 0.7 2.7 0.5 8.4 1.5 0.2 2.4 4.9 6.2 10.7 5.4 3.9 2.1 3.7 0.1 4.1 4.0 32.8 29.7 8.2 53.6 0.0 11.6 7.8 50.9 2.7 17.0 71.5 17.7 41.1 58.0 56.8 30.9 28.6 149.9 23.3 48.4 46.0 12.4 35.0 7.0 99.2 70.9 15.9 10.5 37.4 86.2 46.4 29.7 44.6 0.0 92.0 73.3 27.1 82.3 117.4 20.5 160.6 12.5 12.9 11.5 15.6 17.6 0.0 47.0 17.5 111.6 67.7 NARFL "FLJ21988, HPRN, IOP1, NAR1, PRN" ENSG00000103245 "Nuclear prelamin A recognition factor like" Q9H6Q4 16 729753-741329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040851 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA040851: AB_10794427" "unprognostic (6.31e-2)" "prognostic favorable (1.32e-5)" "unprognostic (7.61e-2)" "unprognostic (8.25e-2)" "unprognostic (1.01e-1)" "unprognostic (1.27e-3)" "unprognostic (8.85e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (8.39e-2)" "unprognostic (4.45e-3)" "unprognostic (3.02e-1)" "prognostic favorable (9.83e-5)" "unprognostic (2.49e-2)" "unprognostic (8.15e-2)" "unprognostic (2.62e-1)" "unprognostic (8.33e-3)" 10.2 11.9 16.4 15.3 19.7 15.0 10.3 21.8 28.8 10.0 12.6 21.6 21.1 20.9 11.1 19.2 15.2 13.7 10.6 20.9 18.1 14.2 16.1 17.6 9.1 16.2 15.1 9.8 11.3 18.4 18.5 13.1 11.1 16.7 15.7 8.1 14.3 25.4 17.5 24.1 14.9 15.5 8.7 14.1 15.0 14.5 8.7 13.1 18.4 12.6 13.7 18.9 11.7 11.3 16.0 11.8 8.3 10.9 13.9 12.9 9.4 3.5 10.5 4.2 6.0 4.4 3.1 10.1 5.1 3.8 7.2 6.2 7.4 8.9 5.1 7.9 3.2 5.2 8.1 4.1 6.2 2.6 9.4 9.3 4.3 6.0 6.0 5.6 7.6 6.2 3.8 7.8 4.2 3.5 4.7 5.2 20.5 7.9 4.9 3.5 13.2 6.8 3.5 3.4 7.3 6.7 56.0 6.3 9.2 4.3 3.6 4.8 6.6 6.1 14.7 5.2 2.6 13.4 7.7 5.6 6.0 5.6 6.6 4.5 6.4 4.5 14.1 4.1 4.3 7.7 2.7 10.9 8.3 11.5 9.9 8.9 16.0 11.7 9.5 11.8 10.5 9.5 12.9 2.3 13.9 10.6 9.5 11.1 9.4 16.4 19.7 21.8 28.8 18.1 14.2 15.1 9.8 16.7 13.1 6.0 6.4 14.5 7.7 4.9 20.9 9.7 7.6 5.3 5.7 14.0 13.7 17.8 6.6 15.0 1.0 7.2 23.1 0.0 13.6 10.0 4.7 8.1 15.0 5.9 13.5 36.5 7.5 4.9 9.5 1.9 9.5 7.2 10.1 29.7 16.3 14.6 10.4 15.0 9.9 11.3 16.3 12.9 4.7 11.3 8.9 5.3 11.9 8.7 15.0 7.0 NARS NARS1 ENSG00000134440 "Asparaginyl-tRNA synthetase" O43776 18 57600656-57622213 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034257, HPA040017" Enhanced Supported Cytosol NA NA Cytosol "CAB034257: AB_2151043, HPA040017: AB_2676801" "unprognostic (9.85e-2)" "unprognostic (1.88e-1)" "unprognostic (3.86e-3)" "unprognostic (1.68e-1)" "unprognostic (2.61e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.23e-7)" "unprognostic (1.78e-1)" "unprognostic (1.48e-1)" "unprognostic (1.62e-2)" "unprognostic (1.98e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.73e-7)" "unprognostic (1.24e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-1)" "unprognostic (1.51e-1)" 30.9 36.9 35.0 28.8 42.6 19.5 31.6 47.1 51.4 28.1 49.7 24.8 31.1 42.5 30.8 31.6 40.2 27.4 26.8 40.6 40.5 36.5 66.0 41.9 26.0 23.0 39.5 39.2 29.4 29.4 52.0 35.7 25.6 49.5 33.1 46.1 18.5 33.7 30.9 76.6 26.9 35.2 29.9 40.6 25.7 36.0 14.9 36.3 25.0 44.5 31.9 29.2 34.6 35.3 20.0 26.6 15.6 40.8 15.8 23.4 23.7 36.6 24.2 22.8 33.3 29.3 22.5 35.6 51.3 26.8 30.3 37.5 17.4 17.2 46.2 24.6 35.5 30.5 41.8 35.8 31.7 44.4 22.4 12.4 35.3 18.6 27.4 49.6 73.2 36.5 23.9 55.5 41.5 39.7 23.8 25.1 28.4 43.3 34.5 34.0 13.6 28.3 17.8 33.5 23.3 19.5 22.5 26.9 39.0 56.6 41.3 25.1 27.5 24.9 32.1 53.8 25.1 17.9 40.7 27.4 33.8 22.6 14.2 37.9 77.5 95.9 44.9 31.1 48.1 39.3 15.6 40.8 14.2 16.4 35.1 20.2 20.0 17.3 17.4 26.6 18.8 23.4 21.2 12.7 15.8 26.6 25.1 17.2 23.7 35.0 42.6 47.1 51.4 40.5 36.5 39.5 39.2 49.5 36.3 71.5 60.9 52.8 56.5 68.6 83.3 195.9 79.0 170.0 72.8 66.3 33.4 91.5 286.8 103.2 11.5 56.6 105.3 93.5 78.8 68.1 57.5 71.7 91.6 94.8 102.8 90.6 60.9 38.1 67.5 12.5 65.3 70.5 74.2 75.7 75.6 85.4 101.4 49.1 73.2 181.5 68.2 71.1 59.4 41.1 41.9 66.1 132.6 49.0 92.8 67.0 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435961-78574874 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol No No "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favorable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 10.9 16.0 11.8 9.3 11.2 6.4 13.4 19.4 11.8 11.6 13.0 13.1 13.5 12.0 17.6 13.9 10.8 12.0 9.9 12.7 11.3 12.2 22.3 26.8 9.0 10.2 13.4 8.4 15.9 20.0 14.0 17.3 9.4 13.8 13.3 13.3 23.2 12.7 13.2 24.4 9.1 11.1 10.6 10.8 12.6 11.3 11.8 10.3 17.3 16.0 7.7 14.1 9.7 10.7 14.6 13.5 6.7 9.4 16.2 16.6 8.7 7.3 10.3 10.8 7.1 7.6 6.4 9.0 6.1 6.0 9.5 7.9 17.7 7.9 18.2 15.9 3.9 9.2 9.7 18.2 11.9 13.3 11.9 9.8 12.8 8.0 15.0 6.3 13.7 4.8 4.5 7.7 8.4 15.0 8.6 8.1 15.4 19.3 5.0 10.6 8.6 14.2 22.2 11.8 30.0 12.5 14.9 17.7 24.6 12.7 10.4 12.9 8.1 9.1 11.7 15.7 12.2 11.0 5.5 4.9 13.0 15.3 14.8 10.3 8.4 14.1 40.1 2.5 12.4 8.8 6.7 7.9 3.5 9.8 8.3 12.0 14.6 11.3 10.8 13.5 12.6 16.6 14.8 1.7 16.2 9.4 10.3 8.2 8.7 11.8 11.2 19.4 11.8 11.3 12.2 13.4 8.4 13.8 10.3 17.9 17.1 9.0 12.7 11.9 5.3 8.3 2.5 10.7 7.9 5.2 2.0 17.3 24.9 8.2 11.0 6.3 5.0 0.0 6.5 20.2 10.4 14.0 8.1 16.3 10.6 0.0 11.5 2.5 6.5 3.9 7.2 6.1 16.9 1.0 7.7 5.7 6.1 13.3 4.6 22.1 8.7 6.5 8.3 7.4 18.1 12.0 12.8 5.1 13.7 7.5 NAV3 "KIAA0938, POMFIL1" ENSG00000067798 "Neuron navigator 3" Q8IVL0 12 77324641-78213008 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2;ovary: 29.6" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 47.7;Leydig cells: 22.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 23.8;THP-1: 20.9;U-138 MG: 16.0;WM-115: 19.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032111, HPA061392" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA032111: AB_10603881, HPA061392: " "unprognostic (3.51e-1)" "unprognostic (6.72e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (2.14e-1)" "unprognostic (2.78e-1)" "unprognostic (3.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-2)" "unprognostic (2.99e-1)" "unprognostic (1.90e-1)" "unprognostic (5.68e-7)" "unprognostic (6.86e-3)" "unprognostic (1.23e-1)" "unprognostic (1.58e-2)" "unprognostic (2.29e-3)" 6.2 8.5 17.8 2.4 14.2 1.5 7.1 14.7 25.2 2.8 2.1 9.7 2.6 1.2 4.1 5.8 3.8 3.6 8.6 3.7 14.2 7.5 1.4 2.3 3.8 1.6 7.8 13.0 29.6 1.4 2.2 9.3 4.3 7.1 4.5 2.0 12.3 2.2 5.1 2.6 4.1 1.3 4.6 10.6 12.7 1.6 5.0 8.3 0.0 1.7 0.0 1.4 3.9 2.3 0.3 0.1 3.8 0.2 0.1 0.0 0.0 1.8 4.4 0.3 0.1 4.6 9.5 0.1 13.4 10.5 5.5 2.9 1.2 0.3 0.1 1.0 10.7 3.8 1.4 3.9 2.0 9.8 0.0 0.0 0.0 1.8 0.1 3.6 0.0 0.1 3.5 0.0 23.8 6.0 4.9 8.2 0.0 0.0 0.0 13.5 0.1 0.1 6.0 1.5 0.1 1.2 0.6 1.1 0.0 0.9 0.0 0.4 0.0 0.9 0.1 1.9 0.5 0.0 20.9 7.1 16.0 4.5 6.8 9.1 0.7 0.0 0.4 4.8 0.2 19.8 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.8 0.1 0.2 0.1 0.0 0.0 17.8 14.2 14.7 20.5 14.2 7.5 7.8 13.0 7.1 8.3 17.9 7.7 0.0 7.4 3.2 3.1 2.1 0.0 16.0 13.6 0.0 0.0 0.1 0.0 1.7 7.6 3.5 0.0 0.0 1.3 0.1 8.7 1.8 10.5 0.0 5.4 47.7 15.7 2.5 0.0 3.6 22.2 1.3 11.8 0.0 0.0 19.9 11.8 0.0 7.1 0.0 2.1 0.0 2.8 0.2 0.5 1.3 0.2 0.0 0.0 2.8 NAXE "AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1" ENSG00000163382 "NAD(P)HX epimerase" Q8NCW5 1 156591762-156594299 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Lipid transport, Transport" Isomerase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 120.4;Distal tubular cells: 170.8;Proximal tubular cells: 189.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043766, HPA048164" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3300000 Nucleoplasm "Vesicles, Cytosol" "HPA043766: AB_2678660, HPA048164: AB_2680294" "unprognostic (1.27e-1)" "unprognostic (2.34e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.38e-2)" "unprognostic (5.32e-2)" "unprognostic (2.46e-3)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.08e-3)" "unprognostic (3.23e-2)" "unprognostic (3.14e-2)" "unprognostic (2.15e-2)" "unprognostic (8.05e-2)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-1)" 19.1 29.9 31.6 14.4 28.5 12.1 22.6 17.6 42.5 23.0 30.0 31.0 17.4 28.4 28.5 57.9 23.4 29.4 25.8 46.3 28.5 25.0 41.6 41.0 17.2 16.9 33.2 29.3 29.3 37.3 36.3 29.0 21.8 28.8 27.9 26.6 23.0 29.5 36.3 30.9 20.2 25.9 25.0 29.1 17.4 25.0 29.5 22.2 17.7 32.4 19.5 20.4 20.8 18.3 52.4 53.8 12.4 26.5 31.6 32.5 40.6 31.6 42.0 13.4 24.0 17.9 12.3 16.0 10.9 16.7 18.7 19.8 34.9 21.3 21.5 33.2 13.9 16.2 30.9 13.4 26.1 13.3 22.7 29.3 17.8 24.0 23.1 20.5 22.3 18.3 12.3 33.8 23.8 22.2 15.0 25.4 29.0 18.1 19.6 19.1 56.3 24.5 27.2 16.6 43.8 32.8 24.7 12.6 56.8 25.3 26.3 32.5 31.0 26.2 50.1 38.5 19.8 48.6 32.9 14.8 13.5 21.1 19.1 23.8 50.8 30.7 20.5 18.6 13.3 20.8 4.9 24.1 12.4 31.6 26.5 31.3 52.4 29.2 32.2 21.7 41.7 32.5 30.9 2.9 31.6 20.6 53.8 25.5 40.6 31.6 28.5 17.6 42.5 28.5 25.0 33.2 29.3 28.8 22.2 38.7 23.3 0.0 0.0 0.0 0.0 0.0 0.0 21.4 43.3 64.6 0.0 120.4 170.8 89.3 0.0 0.0 0.0 0.0 87.1 28.1 0.0 0.0 4.7 0.0 80.7 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 71.3 0.0 0.0 83.0 0.0 0.0 189.4 0.0 0.0 0.0 0.0 0.0 0.0 68.0 0.0 0.0 0.0 NBEA "BCL8B, FLJ10197, KIAA1544, LYST2" ENSG00000172915 Neurobeachin Q8NFP9 13 34942287-35673022 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 130.3;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 84.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 16.5;SH-SY5Y: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039730, HPA040385" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA039730: AB_10794202, HPA040385: AB_10795523" "unprognostic (1.80e-2)" "unprognostic (2.90e-1)" "unprognostic (4.99e-2)" "unprognostic (3.89e-4)" "unprognostic (3.59e-1)" "unprognostic (2.04e-1)" "unprognostic (8.75e-2)" "unprognostic (6.95e-3)" "unprognostic (5.01e-1)" "unprognostic (7.43e-2)" "unprognostic (1.03e-3)" "unprognostic (2.45e-1)" "prognostic favorable (7.86e-8)" "unprognostic (2.28e-2)" "unprognostic (9.35e-2)" "unprognostic (1.17e-1)" "unprognostic (6.46e-2)" 3.9 11.9 12.2 2.7 20.6 1.0 8.2 32.6 28.5 7.4 9.8 3.9 10.9 2.7 10.3 6.2 6.2 9.4 5.4 11.7 13.5 10.6 6.6 1.7 3.6 2.6 6.9 22.2 10.4 5.7 9.3 25.0 1.5 14.2 11.9 4.8 13.3 7.0 14.2 8.5 2.0 3.8 11.4 4.7 5.1 4.8 7.7 6.0 6.1 9.6 0.7 2.4 7.1 6.4 1.1 1.3 0.0 0.5 0.4 1.4 0.1 0.0 2.3 5.3 3.0 0.4 0.0 0.1 3.4 5.2 4.0 3.3 0.0 0.5 1.4 0.0 5.8 2.2 0.1 1.8 0.7 8.4 0.6 1.8 0.0 1.6 0.5 0.3 0.9 2.2 0.9 0.6 0.0 0.4 16.5 0.7 0.6 0.0 9.7 0.5 1.0 0.5 0.0 2.3 2.9 0.9 0.6 2.3 0.4 4.6 1.0 3.1 41.0 2.5 0.0 1.7 4.3 0.9 0.2 0.0 1.0 0.6 0.0 0.7 0.9 0.2 0.7 2.5 0.3 2.1 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.1 0.2 0.0 1.1 1.4 1.3 0.0 0.4 0.0 1.3 0.0 0.1 12.2 20.6 32.6 18.4 13.5 10.6 6.9 22.2 14.2 6.0 26.8 8.6 0.5 5.0 0.9 130.3 43.7 12.7 61.6 14.8 8.7 137.4 0.1 1.7 7.3 14.9 6.3 0.0 0.0 1.5 0.1 8.3 8.7 23.3 0.0 0.7 44.5 22.0 9.2 2.4 11.0 16.4 2.9 6.8 1.0 1.4 66.5 2.3 0.0 18.0 7.1 84.5 6.5 12.2 4.9 5.9 0.6 0.0 0.0 0.8 13.1 NBEAL1 "ALS2CR16, ALS2CR17, MGC164581" ENSG00000144426 "Neurobeachin like 1" Q6ZS30 2 203014879-203226378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 915.3;Suprabasal keratinocytes: 1140.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049189, HPA049447" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049189: AB_2680669, HPA049447: AB_2680771" "unprognostic (3.66e-2)" "unprognostic (5.26e-2)" "unprognostic (2.86e-2)" "unprognostic (1.11e-1)" "unprognostic (4.52e-4)" "unprognostic (1.16e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-3)" "unprognostic (2.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (2.22e-1)" "unprognostic (7.98e-3)" "unprognostic (7.59e-2)" 11.2 7.8 5.2 7.3 7.9 2.7 13.4 7.5 6.0 9.2 14.5 6.5 8.4 9.9 19.1 7.0 8.7 7.9 8.9 8.2 4.8 2.9 14.4 12.3 14.7 3.3 5.1 2.7 8.8 8.5 9.2 13.6 10.2 7.0 6.7 14.4 9.7 8.1 10.6 6.9 6.6 11.7 11.9 7.3 5.0 14.7 9.9 6.2 2.8 10.1 6.4 5.3 9.8 9.5 0.9 0.7 0.9 0.6 0.6 3.0 0.2 4.9 4.7 2.0 1.7 12.2 9.5 2.8 4.8 3.5 2.6 3.9 5.2 2.6 1.1 4.0 8.1 5.0 4.1 3.9 5.6 6.0 2.2 1.7 1.9 7.0 2.9 2.9 1.7 2.3 3.6 3.7 4.2 5.3 6.2 4.0 2.0 3.3 1.8 5.8 3.5 0.7 0.9 1.0 2.1 4.3 0.8 3.2 1.1 7.2 9.4 1.3 1.0 4.1 3.1 3.1 5.1 3.6 1.7 6.8 6.8 5.8 3.2 2.2 2.9 2.2 1.5 4.1 0.8 2.3 0.0 0.5 0.9 0.8 0.4 1.0 0.4 0.9 0.5 0.4 0.9 0.7 0.5 0.3 0.6 0.6 0.7 3.0 0.2 5.2 7.9 7.5 6.0 4.8 2.9 5.1 2.7 7.0 6.2 35.7 64.5 271.2 252.7 915.3 18.0 15.9 229.3 49.5 45.5 36.6 25.5 175.9 71.3 47.8 23.3 102.0 184.3 0.0 85.7 226.2 143.2 257.6 106.1 170.8 139.2 77.9 282.5 298.9 603.4 33.7 254.0 131.4 597.2 39.7 387.3 18.1 70.0 210.5 121.6 72.5 26.3 116.4 186.6 37.7 34.6 1140.0 191.8 258.9 547.2 252.4 NBPF4 FLJ32833 ENSG00000196427 "NBPF member 4" Q96M43 1 108223341-108244081 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 3.1;testis: 8.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 8.2;K-562: 11.8;Karpas-707: 3.5;MCF7: 13.9;THP-1: 4.2" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (6.33e-2)" "unprognostic (2.08e-1)" "unprognostic (2.18e-2)" "unprognostic (8.29e-2)" "unprognostic (2.90e-1)" "unprognostic (8.73e-2)" 0.0 0.0 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.0 0.8 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 3.5 0.0 13.9 0.0 0.0 0.7 0.0 0.0 0.0 2.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 1.7 0.0 0.2 4.2 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF6 ENSG00000186086 "NBPF member 6" Q5VWK0 1 108450282-108471002 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.9;testis: 7.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.9;K-562: 14.0;SK-BR-3: 3.3;SK-MEL-30: 2.5" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (4.36e-2)" "unprognostic (5.87e-2)" "unprognostic (4.62e-2)" "unprognostic (2.39e-1)" "unprognostic (2.61e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.4 0.0 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 1.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.3 2.5 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 110.6;heart muscle: 67.7" "Group enriched" "Detected in many" 4 "Bipolar cells: 108.7;Cardiomyocytes: 109.4;Horizontal cells: 165.3;Muller glia cells: 263.9;Rod photoreceptor cells: 95.4" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "NK-cell: 27.2" "Lineage enriched" "Detected in many" 14 "NK-cells: 27.2" "Cell line enhanced" "Detected in some" "HEL: 19.5;RH-30: 44.0;SCLC-21H: 35.8;SH-SY5Y: 17.6;U-138 MG: 24.5;WM-115: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1200000 2800000000 "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705" "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favorable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 3.5 36.4 22.7 3.0 35.7 1.8 2.1 20.2 110.6 13.3 9.0 55.8 0.3 3.4 24.7 3.0 4.8 8.3 3.6 67.7 22.5 19.2 2.3 2.6 2.0 1.7 45.0 27.1 21.9 2.3 1.1 9.1 1.4 38.8 8.4 4.6 5.5 2.5 10.9 14.6 1.8 5.3 25.6 27.6 3.4 6.7 2.9 39.2 0.0 16.9 0.7 1.7 7.0 6.5 0.0 0.0 0.4 0.1 27.2 2.0 0.9 0.0 0.0 6.9 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.1 0.1 1.0 6.1 6.5 0.2 0.1 0.0 0.0 0.0 0.1 3.9 19.5 0.0 0.0 0.7 0.0 3.1 4.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 6.8 0.0 0.0 1.6 0.6 0.0 0.1 0.0 44.0 3.1 0.0 0.0 35.8 17.6 0.0 0.1 0.0 0.7 0.0 0.2 0.0 24.5 11.4 0.1 10.2 0.0 0.1 0.0 2.7 9.2 25.9 0.0 0.1 0.0 2.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.4 27.2 0.0 0.0 0.1 0.9 22.7 35.7 20.2 41.6 22.5 19.2 45.0 27.1 38.8 39.2 0.0 0.0 0.0 0.4 1.4 108.7 109.4 0.0 1.4 0.0 0.0 35.3 0.5 1.7 14.4 4.5 0.3 0.0 0.0 0.0 0.2 7.6 0.3 1.1 0.5 0.4 165.3 5.2 6.7 5.1 3.9 14.1 1.7 0.0 0.0 0.0 263.9 1.7 0.0 9.6 0.0 95.4 0.0 3.8 0.5 2.3 1.5 0.1 11.4 0.0 0.1 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 84.1" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavorable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 6.8 8.8 6.5 24.6 12.7 16.7 7.7 7.7 9.0 8.0 11.3 16.2 7.0 10.6 11.5 8.8 17.7 8.1 6.5 6.2 7.5 5.4 7.0 5.1 7.7 20.4 16.5 6.2 7.7 7.2 9.6 6.3 13.9 8.7 8.2 12.4 8.1 10.5 8.3 7.0 14.8 13.0 8.2 12.7 16.4 9.9 17.2 11.4 84.1 11.4 12.4 24.3 10.9 9.5 5.0 4.8 7.2 2.8 7.8 7.4 3.2 22.1 20.5 22.1 16.0 5.8 6.0 25.8 15.3 12.3 24.8 20.1 18.5 23.6 23.3 4.6 10.0 21.0 19.6 36.4 17.9 47.4 42.2 20.4 21.3 23.5 10.5 2.4 26.4 15.4 3.8 6.7 19.3 19.8 11.4 16.3 15.0 13.5 9.5 21.9 11.0 29.9 17.4 34.5 20.9 16.0 25.6 50.3 12.4 8.3 12.4 9.1 9.6 22.8 10.8 8.1 36.0 4.7 16.6 10.2 16.3 26.8 11.0 29.7 7.4 10.0 33.2 9.6 15.3 20.2 7.2 2.0 3.6 6.3 2.8 5.6 5.0 6.2 7.3 3.0 3.8 7.4 7.2 1.9 7.8 1.9 4.8 7.2 3.2 6.5 12.7 7.7 9.0 7.5 5.4 16.5 6.2 8.7 11.4 6.0 6.1 13.0 3.2 3.2 3.6 2.9 7.6 5.3 3.4 1.8 7.9 6.8 0.0 4.1 14.9 2.6 5.2 46.7 3.3 16.2 3.1 2.8 3.5 2.6 8.6 4.8 1.2 9.2 10.8 20.4 5.5 5.4 0.0 5.4 6.3 10.0 4.5 5.7 5.6 2.0 7.6 0.0 3.6 17.7 10.0 3.0 5.3 6.9 8.0 3.0 NCAPH "BRRN1, CAP-H, hCAP-H" ENSG00000121152 "Non-SMC condensin I complex subunit H" Q15003 2 96335787-96373845 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4" "Cell type enhanced" "Detected in many" 22 "Spermatocytes: 77.0;Spermatogonia: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 5.6;T-reg: 8.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.6;T-cells: 8.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA002647, HPA003008" Enhanced Supported Nucleoplasm,Cytosol Yes Yes Cytosol Nucleoplasm "HPA002647: AB_1078300, HPA003008: AB_1078301" "unprognostic (5.52e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-2)" "unprognostic (2.85e-3)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "prognostic unfavorable (9.53e-6)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.50e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-2)" "unprognostic (0.00e+0)" "unprognostic (3.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.14e-1)" "unprognostic (2.30e-2)" 1.3 1.1 0.8 13.2 0.9 17.2 1.7 0.7 1.2 1.5 3.9 0.7 0.4 2.9 0.7 1.1 7.4 0.4 1.0 0.8 0.8 0.7 0.9 0.9 1.5 10.6 1.0 0.6 0.8 0.6 0.1 0.5 3.4 1.0 0.7 5.1 0.6 1.9 0.4 0.6 2.7 3.5 1.4 1.2 6.7 2.1 60.4 0.8 41.3 0.6 6.4 12.2 1.7 2.2 1.3 0.5 5.6 1.0 0.1 8.7 0.8 31.2 11.9 30.2 15.6 1.1 1.6 20.0 14.8 10.4 28.7 30.3 21.9 17.5 29.2 10.5 6.5 26.2 14.1 25.8 10.1 30.8 25.6 17.1 30.1 12.4 19.8 0.2 27.8 25.7 0.5 1.1 22.2 9.4 2.7 11.3 23.4 20.8 21.6 13.6 14.7 40.7 29.0 21.6 13.8 15.1 31.7 27.5 23.7 5.7 12.1 17.9 13.7 8.6 12.1 5.2 11.9 8.9 20.6 6.5 21.2 32.4 19.8 23.9 11.6 16.5 31.0 9.1 27.9 23.9 5.6 0.0 0.3 1.3 1.0 0.2 1.3 1.9 1.5 0.5 0.9 0.0 0.7 0.3 0.1 0.0 0.0 8.7 0.8 0.8 0.9 0.7 1.2 0.8 0.7 1.0 0.6 1.0 0.8 0.0 0.0 0.8 0.2 0.6 0.4 0.4 0.0 2.7 2.3 0.0 7.9 1.1 0.0 0.4 3.9 0.5 0.0 0.0 0.0 14.1 0.4 0.5 1.1 0.5 6.8 0.0 0.0 0.6 3.2 4.0 0.9 3.0 1.7 0.0 1.0 4.7 0.2 0.0 0.4 0.0 2.3 0.0 0.9 77.0 26.2 0.6 1.6 5.4 1.2 0.6 NCBP1 "CBP80, NCBP, Sto1" ENSG00000136937 "Nuclear cap binding protein subunit 1" Q09161 9 97633626-97673748 "Predicted intracellular proteins, Transporters" "mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042411, HPA049031" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA042411: AB_2677985, HPA049031: AB_2680606" "unprognostic (4.76e-3)" "unprognostic (2.16e-1)" "prognostic favorable (5.28e-4)" "unprognostic (4.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (3.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (4.11e-2)" "unprognostic (3.84e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-2)" 18.5 17.2 19.8 27.4 26.2 37.2 23.6 25.5 27.1 17.0 21.9 18.7 19.8 18.0 19.2 15.3 21.7 15.9 16.3 20.4 23.7 17.8 17.9 22.7 17.3 25.9 16.6 23.8 22.8 22.0 17.1 26.9 20.3 22.6 18.4 25.7 18.1 18.3 17.7 25.5 22.4 19.3 16.3 18.7 20.5 19.4 26.8 17.8 36.1 22.5 15.1 25.0 18.5 19.4 7.6 13.7 12.9 14.6 14.9 10.0 7.7 24.3 16.8 18.9 17.6 13.3 13.4 18.4 18.7 10.9 17.1 16.1 22.4 12.8 21.0 8.1 16.8 16.3 27.6 30.0 21.3 24.6 14.0 9.7 19.4 25.3 14.0 13.0 25.8 20.2 10.1 10.7 19.9 15.4 12.3 17.7 16.1 28.6 11.8 28.6 17.6 18.7 13.7 20.4 34.8 18.2 18.0 43.8 8.4 13.9 18.2 24.1 16.2 18.7 16.4 9.7 16.8 10.2 15.8 14.8 13.4 12.5 26.6 19.2 11.5 14.0 10.9 12.3 20.1 17.6 12.9 11.4 11.0 8.7 14.6 9.9 6.5 9.9 9.1 13.7 7.6 8.7 10.0 3.5 14.9 14.3 5.9 8.6 7.7 19.8 26.2 25.5 27.1 23.7 17.8 16.6 23.8 22.6 17.8 6.0 12.0 5.8 5.1 12.0 20.2 21.7 2.5 14.7 14.8 8.7 19.6 11.5 3.3 7.8 12.7 8.7 10.7 0.0 6.0 12.8 9.3 6.9 8.1 14.8 10.5 20.6 8.7 8.0 13.7 6.8 6.1 9.5 5.0 14.4 11.4 10.1 8.6 8.6 7.1 4.5 23.7 6.5 9.2 16.8 15.2 6.5 12.0 8.5 8.9 7.4 NCDN "NCDN-1, NCDN-2" ENSG00000020129 Neurochondrin Q9UBB6 1 35557473-35567274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 144.3" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 21.4;Club cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023676 Enhanced Supported Supported Cytosol NA NA Cytosol "HPA023676: AB_1854325" "unprognostic (1.15e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (4.66e-2)" "unprognostic (1.41e-1)" "unprognostic (4.36e-2)" "prognostic favorable (3.73e-4)" "unprognostic (5.91e-3)" "unprognostic (5.34e-3)" "unprognostic (5.88e-3)" "unprognostic (2.87e-1)" "unprognostic (3.24e-2)" "unprognostic (2.23e-2)" 5.2 11.3 33.4 6.0 144.3 3.4 3.6 28.7 104.9 9.9 3.5 8.7 1.2 3.9 6.2 4.8 4.5 8.1 6.5 12.0 45.4 25.0 4.0 2.5 4.5 5.9 15.8 32.3 9.2 6.1 6.2 5.5 4.7 26.4 7.1 2.9 3.6 6.7 8.0 5.3 5.6 3.2 6.5 10.7 5.0 4.7 5.8 15.6 0.8 6.5 0.6 4.6 6.0 2.4 5.9 2.7 0.8 4.5 3.0 6.5 5.5 8.8 10.7 9.0 14.1 13.1 16.2 6.2 11.7 12.2 12.3 9.9 10.7 13.1 10.1 11.4 10.8 8.9 13.6 8.8 14.2 4.5 9.8 18.2 12.5 15.7 5.5 18.1 11.3 14.5 15.5 12.0 21.8 8.8 10.2 6.5 6.1 13.5 16.2 10.0 15.9 10.3 7.3 40.3 9.8 18.9 8.5 5.0 13.0 8.3 9.9 11.2 16.1 13.3 12.3 16.5 7.5 11.8 7.4 8.9 15.8 11.3 11.5 16.0 22.8 16.1 7.5 19.6 18.2 14.3 0.0 4.5 0.8 3.1 2.6 3.8 5.9 4.8 4.8 2.7 2.7 6.5 5.3 0.7 3.0 4.2 1.6 2.7 5.5 33.4 144.3 28.7 61.4 45.4 25.0 15.8 32.3 26.4 15.6 3.0 11.8 0.8 0.5 3.1 3.4 12.0 5.1 21.4 15.9 7.0 0.0 5.0 1.7 3.2 2.2 2.8 1.0 0.0 3.7 2.2 5.0 0.4 3.5 3.6 3.3 6.4 3.5 3.1 7.0 0.7 6.1 1.9 5.0 1.0 2.8 1.6 3.5 2.8 3.9 3.0 2.4 0.0 4.1 3.2 2.2 2.6 4.7 3.2 2.1 0.4 NCF2 "NOXA2, p67phox" ENSG00000116701 "Neutrophil cytosolic factor 2" P19878 1 183555563-183590876 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4" "Group enriched" "Detected in many" 6 "Ductal cells: 59.6;Hofbauer cells: 199.3;Kupffer cells: 138.6;Macrophages: 192.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 125.2;neutrophil: 80.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 13.4;HMC-1: 11.7;hTERT-HME1: 28.0;U-2 OS: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002327, HPA006040, CAB022160" Enhanced Supported Cytosol NA NA Cytosol "CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906" "unprognostic (4.97e-2)" "unprognostic (3.48e-2)" "unprognostic (2.40e-2)" "unprognostic (1.22e-3)" "unprognostic (5.83e-3)" "unprognostic (4.04e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (1.29e-1)" "unprognostic (2.45e-1)" "unprognostic (2.33e-1)" "unprognostic (5.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-2)" "unprognostic (8.24e-2)" "unprognostic (2.36e-2)" 15.3 3.1 2.0 23.0 4.5 53.0 3.9 0.7 2.8 2.9 2.8 3.7 0.2 2.3 1.8 6.1 4.1 5.2 7.2 6.4 2.0 1.8 2.9 5.4 39.5 42.7 6.8 0.4 3.5 4.2 0.6 1.9 11.5 3.8 3.4 3.7 4.2 4.4 0.8 3.5 7.1 3.8 5.8 5.5 45.4 2.6 3.9 3.2 4.2 2.0 5.6 5.5 7.3 3.5 1.4 24.3 125.2 45.7 0.2 1.0 22.7 13.4 0.4 0.0 0.0 0.0 0.0 0.1 1.0 1.2 1.8 0.8 0.1 0.4 1.6 2.3 0.4 0.3 7.6 0.0 9.9 1.6 8.4 0.0 0.0 3.4 3.1 0.0 1.0 11.7 0.0 2.2 1.8 28.0 1.1 0.0 0.0 0.0 3.0 3.1 0.1 0.1 0.5 0.2 0.8 0.8 3.6 1.2 10.1 0.4 0.1 0.0 0.0 0.1 0.0 0.4 1.0 1.5 4.7 0.6 0.0 27.2 0.0 2.5 0.5 0.7 0.3 0.2 5.4 0.0 15.5 45.7 125.2 0.1 34.4 0.1 1.4 0.4 0.1 24.3 0.8 0.2 0.1 80.6 0.2 29.7 1.3 1.0 22.7 2.0 4.5 0.7 2.8 2.0 1.8 6.8 0.4 3.8 3.2 8.9 17.8 4.8 0.1 4.8 0.4 1.1 10.2 26.8 13.6 0.0 0.0 0.8 3.3 59.6 1.0 0.7 0.0 0.0 3.3 0.8 2.1 0.3 7.0 0.4 199.3 0.0 0.0 4.3 138.6 2.1 0.6 192.4 6.8 20.8 0.0 0.0 18.4 1.1 0.0 0.1 0.6 12.9 3.4 0.0 0.2 3.8 1.6 1.3 0.0 0.8 NCF4 "p40phox, SH3PXD4" ENSG00000100365 "Neutrophil cytosolic factor 4" Q15080 22 36860988-36878015 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0" "Cell type enhanced" "Detected in many" 14 "B-cells: 49.2;granulocytes: 71.7;Hofbauer cells: 162.7;Kupffer cells: 83.9;Macrophages: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 130.3" "Cell line enhanced" "Detected in some" "HEL: 18.6;HMC-1: 88.9;NB-4: 31.5;REH: 16.2;RPMI-8226: 31.3;THP-1: 29.6;U-937: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010146, HPA036156, HPA057975" Enhanced Enhanced Cytosol NA NA Cytosol "CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568" "unprognostic (3.27e-2)" "unprognostic (1.55e-2)" "unprognostic (2.68e-2)" "unprognostic (1.36e-3)" "unprognostic (1.35e-1)" "unprognostic (2.78e-3)" "unprognostic (4.20e-2)" "unprognostic (3.69e-2)" "unprognostic (4.03e-2)" "unprognostic (2.70e-1)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "prognostic unfavorable (7.06e-8)" "unprognostic (3.60e-1)" "unprognostic (2.23e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-1)" 10.4 5.8 4.4 24.8 5.6 69.0 5.6 0.7 2.8 3.4 7.4 2.5 1.2 5.0 2.2 8.1 4.4 5.9 7.2 8.0 3.9 2.2 4.4 4.2 17.5 21.2 8.0 1.0 3.3 2.1 0.6 2.6 10.3 4.6 5.1 5.3 4.2 6.5 2.2 2.6 2.3 16.0 4.3 7.7 66.0 3.9 3.0 5.4 5.0 3.5 2.8 22.2 9.0 7.1 12.6 10.0 130.3 19.5 0.4 10.8 10.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 18.6 0.0 0.0 0.0 2.7 88.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 31.5 0.0 0.0 0.0 16.2 0.0 31.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 16.5 0.0 58.0 19.5 76.4 0.2 9.6 1.1 12.6 3.9 0.8 9.1 8.9 0.2 0.2 130.3 0.4 6.4 10.0 10.8 10.2 4.4 5.6 0.7 2.8 3.9 2.2 8.0 1.0 4.6 5.4 3.0 28.4 49.2 2.2 2.5 0.0 0.8 0.0 1.4 9.1 1.8 0.0 2.5 0.0 0.6 0.3 1.4 0.4 0.0 2.7 14.2 2.5 0.3 71.7 0.6 162.7 0.0 0.0 0.6 83.9 1.0 0.6 82.4 13.5 17.2 0.3 0.0 1.2 17.3 0.0 0.2 0.2 0.0 0.4 0.0 0.2 1.9 10.9 17.0 1.2 3.8 NCK1 "NCK, NCKalpha" ENSG00000158092 "NCK adaptor protein 1" P16333 3 136862208-136949823 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005063, HPA030766" Supported Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB005063: AB_562169, HPA030766: AB_2673602" "unprognostic (7.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.98e-2)" "unprognostic (3.03e-2)" "unprognostic (1.06e-2)" "unprognostic (8.77e-3)" "unprognostic (4.24e-3)" "unprognostic (8.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.14e-5)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.64e-1)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (4.17e-2)" 44.5 15.7 11.5 24.5 13.4 19.3 38.9 22.6 11.6 23.7 18.3 8.4 16.5 10.2 20.8 19.2 35.9 14.6 13.9 16.8 11.8 11.1 14.0 20.9 22.4 33.0 13.9 12.1 19.6 14.3 17.9 17.7 22.7 13.5 26.3 19.5 10.8 24.0 15.8 29.0 27.3 14.3 24.0 13.5 18.7 12.8 14.7 12.7 41.1 23.8 23.5 29.0 27.3 43.3 8.5 13.3 26.8 27.1 11.2 20.2 11.9 20.0 8.9 11.8 9.7 27.4 26.6 13.2 14.9 26.8 17.3 18.1 12.9 20.0 19.7 30.9 17.4 22.4 15.5 16.6 15.1 23.1 14.2 6.8 17.1 12.6 10.1 44.6 12.3 11.8 24.1 19.9 16.8 33.5 17.7 26.5 18.7 10.2 17.6 18.1 10.9 27.9 10.0 11.2 18.1 11.3 15.3 11.0 18.9 16.1 13.8 8.4 8.1 26.8 12.0 23.9 15.0 17.3 13.6 13.1 11.3 7.3 16.0 8.4 17.7 13.8 24.4 11.9 11.1 12.0 26.8 12.4 13.2 19.7 27.1 20.2 8.1 15.6 19.8 13.3 8.5 12.6 15.0 7.2 11.2 13.4 5.2 15.0 11.9 11.5 13.4 22.6 11.6 11.8 11.1 13.9 12.1 13.5 12.7 8.9 15.7 26.5 64.7 66.4 18.9 9.4 15.3 10.7 23.9 8.7 5.9 42.1 13.3 38.5 9.2 68.0 17.2 0.0 24.2 41.6 41.4 45.8 9.2 33.7 45.3 23.8 13.3 25.2 28.8 7.3 40.9 45.6 40.5 48.7 17.1 19.3 29.4 23.0 25.1 18.7 12.7 12.9 33.0 44.9 32.9 72.8 51.0 68.2 15.6 120.8 NCKAP1 "HEM2, Nap1, NAP125" ENSG00000061676 "NCK associated protein 1" Q9Y2A7 2 182909115-183038858 "Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020449 Enhanced Approved Cytosol NA NA 210000 Cytosol "HPA020449: AB_1854327" "unprognostic (7.92e-3)" "unprognostic (1.24e-2)" "unprognostic (3.35e-2)" "unprognostic (8.10e-2)" "unprognostic (1.31e-1)" "unprognostic (1.24e-1)" "unprognostic (2.12e-3)" "prognostic unfavorable (9.71e-4)" "unprognostic (5.06e-2)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (3.48e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-2)" "unprognostic (2.41e-1)" "unprognostic (1.36e-1)" "unprognostic (3.61e-2)" 25.2 23.7 35.8 12.6 49.7 0.6 25.5 32.9 47.2 30.8 29.1 12.9 17.8 28.2 27.9 28.6 42.6 22.6 22.0 46.1 34.0 26.8 37.0 20.8 20.5 4.9 25.8 36.4 24.5 21.9 47.9 26.2 29.4 25.5 30.0 25.6 16.9 24.2 35.9 45.4 26.2 28.5 38.2 20.0 10.2 28.4 16.0 20.4 4.3 44.3 21.0 12.2 33.3 40.9 0.2 0.2 2.8 0.2 0.5 0.9 0.3 23.3 14.7 22.6 14.4 32.0 31.2 25.2 30.6 27.8 20.8 26.3 22.7 20.1 0.1 20.6 36.3 31.3 22.3 19.1 28.8 34.8 5.6 14.9 5.2 16.6 18.8 33.0 0.0 4.5 23.3 35.7 30.1 49.5 28.5 33.0 1.4 12.6 0.0 39.2 15.0 0.4 0.1 23.2 18.9 25.5 1.5 24.7 0.1 29.3 31.6 16.7 15.9 27.7 22.1 28.6 37.5 11.8 0.1 35.7 35.5 20.0 19.9 18.7 3.0 5.6 0.1 27.4 0.0 17.9 2.1 0.2 2.8 0.8 0.1 0.7 0.1 0.6 0.6 0.2 0.2 0.2 0.8 0.9 0.5 0.2 0.2 0.9 0.3 35.8 49.7 32.9 42.3 34.0 26.8 25.8 36.4 25.5 20.4 44.7 40.1 0.9 54.6 77.4 82.1 92.1 56.0 17.4 39.8 76.8 66.8 26.6 23.2 49.3 3.9 76.4 44.4 0.0 53.6 42.5 61.5 90.7 13.9 36.6 4.6 116.0 48.5 68.7 7.0 6.0 72.8 6.1 52.3 1.0 58.2 92.2 72.3 65.1 99.0 50.0 60.1 58.2 79.6 45.9 29.8 98.2 43.6 7.5 47.8 94.9 NCKAP1L HEM1 ENSG00000123338 "NCK associated protein 1 like" P55160 12 54497711-54548238 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.1;lymphoid tissue: 56.7" "Group enriched" "Detected in many" 5 "B-cells: 52.5;granulocytes: 53.3;Hofbauer cells: 98.9;Kupffer cells: 144.7;Macrophages: 81.9;monocytes: 90.2;T-cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 33.5;HMC-1: 35.4;NB-4: 24.7;REH: 17.7;THP-1: 36.7;U-937: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039490, HPA040772" Approved Uncertain "Plasma membrane,Cytosol" NA NA 52000 Cytosol "Plasma membrane" "HPA039490: AB_2676540, HPA040772: AB_2677129" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (1.61e-2)" "unprognostic (1.22e-3)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (3.69e-1)" "unprognostic (2.95e-2)" "unprognostic (6.53e-3)" "unprognostic (4.80e-1)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (1.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.76e-2)" "unprognostic (3.63e-2)" "unprognostic (4.74e-2)" 18.1 5.0 5.9 22.0 10.5 16.9 7.2 1.2 5.8 3.1 15.0 8.1 0.6 4.0 3.1 4.3 4.8 4.0 5.1 6.5 4.1 3.5 3.9 6.5 19.7 56.7 9.3 2.5 2.2 2.4 4.4 2.3 7.3 6.6 4.8 6.9 3.0 4.3 4.0 1.5 2.8 15.4 7.0 13.9 44.7 4.7 1.7 7.9 47.2 2.8 1.8 30.0 22.2 3.3 11.2 25.4 18.4 39.1 12.3 15.2 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.1 14.4 0.0 0.0 0.0 33.5 35.4 0.0 0.0 0.0 0.0 0.0 0.2 12.4 2.3 13.6 0.0 0.0 14.1 24.7 0.0 0.0 0.0 17.7 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 11.8 0.0 21.5 0.0 8.6 23.3 18.4 11.9 36.4 9.8 11.2 10.7 12.1 25.4 11.0 6.9 10.0 5.9 12.3 39.1 14.4 15.2 19.2 5.9 10.5 1.2 5.8 4.1 3.5 9.3 2.5 6.6 7.9 0.0 15.2 52.5 0.4 1.1 0.9 1.3 7.6 1.4 3.4 0.0 0.0 0.6 0.0 0.0 0.6 2.0 0.0 0.0 0.3 0.7 1.7 0.1 53.3 0.9 98.9 0.0 0.0 9.2 144.7 1.5 1.1 81.9 5.0 90.2 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 1.4 0.5 1.0 0.5 1.1 53.6 0.0 0.3 NCKAP5 "ERIH1, ERIH2, NAP5" ENSG00000176771 "NCK associated protein 5" O14513 2 132671799-133568463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.3;lung: 19.2" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 244.2;Bipolar cells: 119.6;Muller glia cells: 83.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "basophil: 3.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.1" "Cell line enriched" "Detected in some" 6 "AF22: 32.3" "Low region specificity" "Detected in all" "HPA034639, HPA044859" Uncertain Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoli "Golgi apparatus, Plasma membrane, Cytosol" "HPA034639: AB_10669678, HPA044859: AB_2679114" "unprognostic (2.54e-1)" "unprognostic (1.95e-2)" "unprognostic (2.30e-2)" "unprognostic (2.58e-2)" "unprognostic (2.49e-2)" "unprognostic (3.13e-1)" "unprognostic (7.07e-2)" "unprognostic (1.90e-1)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.46e-1)" "unprognostic (2.93e-1)" "unprognostic (1.06e-11)" "unprognostic (4.56e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.03e-1)" 3.6 2.0 6.6 1.5 6.3 0.2 5.4 5.2 5.6 3.1 5.8 6.2 0.9 3.8 3.6 6.2 6.9 1.0 1.5 4.6 6.0 3.9 16.3 6.7 19.2 2.2 6.6 4.7 4.5 1.8 2.2 1.3 4.6 4.2 1.6 1.9 7.5 7.8 1.0 1.1 3.7 18.3 1.0 6.3 2.9 3.0 2.1 6.6 0.3 2.1 5.4 2.3 1.3 3.1 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 1.5 32.3 0.0 0.0 0.3 0.1 0.5 5.7 0.5 0.6 0.0 0.0 2.4 0.0 0.3 0.3 0.1 0.2 0.4 1.8 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.3 2.7 3.1 0.4 5.3 0.5 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.7 0.2 1.0 0.3 0.0 1.3 0.7 0.7 0.1 1.0 0.0 1.2 1.6 0.3 0.5 0.0 1.6 0.2 0.2 4.7 0.0 0.1 0.0 0.9 0.3 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 6.3 5.2 5.6 6.0 3.9 6.6 4.7 4.2 6.6 244.2 14.1 0.0 0.4 7.9 119.6 16.1 0.0 1.4 51.2 1.8 39.3 0.0 3.3 0.4 5.4 0.8 11.0 0.0 0.2 0.1 5.2 0.9 1.1 5.3 0.5 31.8 3.5 0.6 5.1 2.7 24.5 6.8 1.7 6.4 3.3 83.1 0.9 4.9 7.1 9.0 5.6 6.5 8.1 0.1 0.7 2.5 0.0 0.0 0.9 1.6 NCOA1 "bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1" ENSG00000084676 "Nuclear receptor coactivator 1" Q15788 2 24491914-24770702 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019402, HPA070213, HPA070520" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276" "unprognostic (2.73e-1)" "unprognostic (5.82e-2)" "unprognostic (2.46e-2)" "unprognostic (9.89e-3)" "unprognostic (7.60e-2)" "unprognostic (2.36e-2)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (1.72e-1)" "unprognostic (2.93e-3)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.15e-2)" "unprognostic (3.08e-1)" "unprognostic (1.29e-1)" "unprognostic (2.92e-2)" 9.8 10.0 15.3 7.3 18.0 8.9 10.5 15.9 17.1 13.7 8.9 13.5 4.9 12.5 13.0 11.5 10.8 10.0 8.3 8.8 20.8 12.2 11.9 8.8 9.4 8.2 10.8 9.9 17.2 10.3 23.9 16.0 10.1 14.2 9.6 10.1 19.9 10.6 13.0 42.5 9.3 10.9 11.6 9.7 9.6 7.6 11.4 10.7 8.5 7.0 12.2 9.3 9.7 10.8 2.5 5.5 14.2 3.5 3.4 4.1 1.8 6.7 5.0 8.9 4.6 9.8 9.0 13.6 3.6 7.3 4.6 4.1 4.7 2.9 4.9 1.5 6.6 8.8 1.6 5.3 3.1 5.0 23.3 7.7 17.6 2.0 1.9 6.2 8.0 14.7 14.3 4.7 4.4 3.6 5.7 4.6 6.4 10.7 8.2 6.9 4.5 7.1 2.9 4.2 4.0 3.4 5.7 41.0 2.5 5.0 9.2 8.1 6.4 8.4 5.1 3.7 4.9 6.1 4.1 5.0 7.7 6.1 5.2 3.6 9.5 8.2 8.6 4.4 5.1 3.8 11.0 3.5 6.9 3.8 2.7 4.1 1.8 3.4 4.1 2.6 2.5 3.3 4.0 14.2 3.4 2.8 5.5 3.7 1.8 15.3 18.0 15.9 17.1 20.8 12.2 10.8 9.9 14.2 10.7 35.7 29.8 13.6 10.7 27.1 97.2 33.1 15.3 20.1 31.8 14.0 49.1 11.2 6.6 12.0 13.1 29.2 24.6 23.3 23.0 14.9 31.2 14.1 18.6 20.3 15.3 58.8 24.2 33.2 25.2 3.8 43.7 26.2 18.6 10.0 22.7 63.8 17.7 35.1 40.7 11.4 67.4 38.8 35.4 32.1 36.8 27.0 4.5 25.4 23.0 14.6 NCOA3 "ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1" ENSG00000124151 "Nuclear receptor coactivator 3" Q9Y6Q9 20 47501902-47656877 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 38.1;MCF7: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009800, HPA024210" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009800: AB_2251314, HPA024210: AB_10602011" "unprognostic (7.26e-3)" "unprognostic (1.00e-1)" "unprognostic (2.69e-1)" "unprognostic (3.23e-2)" "unprognostic (5.78e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (8.09e-4)" "unprognostic (2.83e-2)" "unprognostic (1.47e-1)" "unprognostic (5.22e-3)" "unprognostic (2.09e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.95e-1)" "unprognostic (2.04e-2)" "unprognostic (4.18e-1)" "unprognostic (1.63e-1)" 20.1 8.9 6.6 34.0 7.4 11.1 15.7 11.9 9.9 12.3 10.1 8.1 9.0 6.7 15.5 8.8 16.7 12.0 8.6 11.5 6.7 4.8 9.1 9.3 17.4 25.8 7.9 4.7 13.3 10.7 13.5 13.5 54.7 7.9 9.7 9.0 10.8 13.5 10.0 32.5 15.0 17.1 11.3 9.5 30.8 11.4 9.2 7.2 17.6 13.5 10.5 33.3 15.1 17.7 13.0 6.7 6.0 7.3 2.7 4.0 3.5 5.9 19.2 5.4 7.3 12.8 15.0 38.1 5.7 8.6 9.8 5.2 9.2 6.5 20.5 3.8 9.8 13.8 14.4 4.2 7.0 7.5 10.8 2.2 2.8 5.4 12.7 7.6 2.2 15.3 6.8 20.2 9.3 10.8 7.9 6.9 3.4 6.3 4.8 5.4 63.9 3.2 3.8 1.9 4.5 7.4 6.1 3.8 8.8 5.4 13.8 1.0 1.9 14.4 17.9 6.1 6.5 8.3 5.6 12.0 5.8 5.1 7.0 2.5 13.2 12.0 21.1 6.8 2.2 3.9 3.4 5.2 4.0 3.5 7.3 3.2 13.0 3.2 3.1 6.7 10.0 3.7 4.0 6.0 2.7 7.0 5.5 4.0 3.5 6.6 7.4 11.9 9.9 6.7 4.8 7.9 4.7 7.9 7.2 11.9 21.3 77.0 14.2 30.7 16.1 22.0 20.4 22.7 17.0 14.0 7.9 56.2 5.0 11.0 9.0 39.0 7.8 0.0 16.8 23.2 22.6 21.3 8.1 18.4 20.1 12.7 14.3 66.9 49.4 3.6 23.0 45.5 32.1 22.6 11.4 9.7 15.9 14.0 25.8 5.1 22.4 19.4 26.8 22.7 17.8 45.2 74.6 22.4 11.7 56.9 NCOA4 "ARA70, DKFZp762E1112, ELE1, PTC3, RFG" ENSG00000266412 "Nuclear receptor coactivator 4" Q13772 10 46005088-46030714 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 30.2;granulocytes: 100.1;monocytes: 40.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051260, HPA065208" Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA Nucleoli "Golgi apparatus, Cytosol" "HPA051260: AB_2681412, HPA065208: AB_2685432" "unprognostic (4.23e-2)" "unprognostic (1.50e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.34e-1)" "unprognostic (1.80e-1)" "unprognostic (9.34e-2)" "unprognostic (4.67e-2)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.04e-2)" "prognostic favorable (8.04e-6)" "unprognostic (1.35e-1)" "unprognostic (4.71e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" 18.5 6.9 5.5 9.5 10.0 17.4 10.0 5.5 11.3 10.8 22.5 13.6 5.9 27.0 9.9 9.4 17.0 6.3 9.0 16.6 5.7 20.8 40.9 11.6 11.6 8.7 7.1 11.0 9.1 9.3 9.6 28.4 13.5 14.7 12.4 9.9 12.6 8.5 15.5 6.8 36.4 11.2 9.7 23.8 8.9 6.4 8.1 26.8 13.2 13.9 16.3 13.0 6.4 7.3 30.2 100.1 40.4 13.4 10.9 53.9 31.8 13.5 15.9 16.3 42.1 38.2 39.8 29.3 47.4 28.9 28.4 20.8 23.6 36.0 35.3 47.8 16.2 32.6 16.6 32.3 32.3 25.4 17.1 24.3 18.6 59.4 29.5 61.8 54.3 37.1 32.4 24.6 41.4 30.9 42.5 18.2 26.4 21.7 39.4 14.2 30.0 23.2 9.6 24.6 8.0 17.8 23.1 21.5 34.6 27.1 16.0 10.8 29.6 33.8 29.3 32.9 24.4 30.4 39.1 17.9 21.5 18.9 19.7 16.2 17.3 35.8 22.4 52.1 9.5 69.1 40.4 70.7 10.0 26.8 10.9 7.3 9.4 9.5 30.2 6.6 10.2 8.6 100.1 13.4 30.4 9.3 10.8 53.9 47.6 78.0 32.8 33.2 44.0 13.3 136.0 38.2 50.9 59.1 41.8 27.5 85.3 68.0 41.7 72.4 47.2 113.4 186.9 45.2 92.9 44.2 51.5 191.6 148.1 148.2 19.1 25.8 53.4 209.6 51.8 34.5 96.2 49.0 73.1 41.3 37.9 41.1 57.5 44.6 100.4 11.3 12.9 47.2 22.7 15.1 49.4 132.3 41.5 50.4 45.0 NCOR1 "hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1" ENSG00000141027 "Nuclear receptor corepressor 1" O75376 17 16029157-16218185 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043246, HPA050288, HPA051168, CAB072830" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370" "unprognostic (1.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.10e-1)" "unprognostic (7.38e-2)" "unprognostic (3.59e-2)" "unprognostic (2.55e-2)" "unprognostic (4.27e-2)" "unprognostic (4.87e-2)" "unprognostic (4.06e-2)" "unprognostic (7.07e-2)" "unprognostic (1.52e-2)" "prognostic favorable (7.92e-5)" "unprognostic (4.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-1)" "unprognostic (5.42e-2)" 19.6 21.2 25.4 24.0 30.8 27.0 25.0 41.8 31.5 24.0 30.6 19.6 18.6 33.2 29.0 19.5 25.0 20.5 21.9 17.8 22.4 17.8 25.6 33.8 20.1 19.5 25.1 19.1 25.9 24.3 39.9 39.8 19.8 21.6 20.8 29.7 17.1 20.9 29.1 43.0 23.8 36.9 29.7 26.4 23.7 29.8 22.1 26.4 38.8 25.3 15.7 23.8 29.6 27.0 43.4 29.9 78.2 24.8 30.4 35.5 19.7 20.4 34.2 24.4 20.3 20.1 15.3 12.2 15.1 17.1 16.6 15.1 18.3 9.4 21.5 10.7 26.3 12.4 15.6 30.0 18.3 24.7 28.6 22.2 21.4 29.6 21.4 19.7 13.4 25.6 15.7 19.2 25.7 30.1 14.2 23.0 30.4 18.6 8.9 16.3 13.3 23.6 8.6 12.1 36.0 9.3 23.6 24.8 10.0 17.2 23.2 8.3 13.9 24.9 10.9 11.8 65.5 10.5 15.3 20.0 17.1 10.1 12.5 20.8 6.1 7.1 12.5 16.3 16.0 14.6 78.2 24.8 52.2 31.3 19.5 25.9 40.7 35.5 34.1 17.5 43.4 34.7 34.8 48.5 30.4 24.0 29.9 31.7 19.7 25.4 30.8 41.8 31.5 22.4 17.8 25.1 19.1 21.6 26.4 74.5 98.7 86.4 91.4 60.2 144.1 78.9 66.2 61.6 72.8 50.6 149.2 79.2 29.9 80.2 53.7 68.9 164.0 93.5 85.1 85.7 74.0 70.9 83.3 105.0 67.5 122.3 84.4 59.5 70.8 35.4 94.0 84.8 35.4 184.0 101.0 81.4 89.5 133.5 114.2 37.3 152.7 90.5 89.5 82.3 75.1 59.6 73.2 110.7 125.6 110.0 NCSTN "APH2, KIAA0253" ENSG00000162736 Nicastrin Q92542 1 160343272-160358952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021982, HPA054846, HPA070642" Approved Approved Cytosol NA NA 120000 Cytosol "CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289" "unprognostic (1.08e-1)" "unprognostic (5.22e-3)" "unprognostic (1.51e-1)" "unprognostic (2.89e-2)" "unprognostic (1.19e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-3)" "unprognostic (2.89e-1)" "unprognostic (3.30e-2)" "unprognostic (3.62e-2)" "unprognostic (8.21e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.75e-9)" "unprognostic (1.36e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-2)" "unprognostic (4.89e-2)" 25.6 23.8 12.7 15.3 20.9 12.8 23.3 15.8 24.3 21.8 24.1 39.0 16.5 31.7 24.1 23.3 23.3 19.9 19.5 23.7 13.8 13.9 25.3 37.8 24.7 19.8 28.2 14.2 29.5 41.3 38.9 21.8 63.3 21.5 18.5 24.6 25.1 49.2 19.6 24.2 20.2 38.5 20.7 25.4 25.8 21.4 22.4 22.8 20.3 25.9 13.6 20.6 26.1 20.1 12.5 28.8 27.0 30.5 13.1 11.1 16.8 10.4 12.9 22.2 18.1 68.0 34.4 24.5 21.5 39.4 20.9 24.6 10.0 30.8 7.7 44.8 44.0 14.5 17.8 10.0 20.5 17.7 12.3 8.8 7.3 16.0 15.0 27.0 15.8 33.7 35.0 20.4 19.9 20.8 45.9 30.6 11.9 13.6 22.2 29.8 7.3 5.6 8.3 18.1 27.3 7.2 7.7 13.7 21.7 29.2 14.6 7.4 16.7 23.2 26.5 15.7 37.0 23.7 39.5 24.6 15.7 10.3 10.9 16.3 28.8 40.7 7.7 24.5 10.0 28.6 17.8 29.9 25.0 11.1 30.5 10.4 12.5 9.5 9.5 28.8 11.2 9.9 9.4 27.0 13.1 27.9 16.9 10.0 16.8 12.7 20.9 15.8 24.3 13.8 13.9 28.2 14.2 21.5 22.8 6.0 9.4 20.1 21.7 9.3 17.2 15.2 35.7 12.0 12.5 50.6 49.1 93.6 6.6 34.8 2.1 17.5 49.8 0.0 23.7 84.3 24.4 16.5 12.7 26.8 52.0 17.5 19.4 28.3 43.7 3.1 25.0 26.3 16.9 14.4 31.1 35.8 29.7 28.1 19.8 21.9 19.7 25.8 15.0 43.2 41.7 9.9 123.2 16.0 27.7 17.4 NDN "HsT16328, PWCR" ENSG00000182636 "Necdin, MAGE family member" Q99608 15 23685400-23687330 "Plasma proteins, Predicted membrane proteins" "Growth regulation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 218.9;Peritubular cells: 195.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.5;plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.3" "Cell line enhanced" "Detected in many" "AF22: 20.6;ASC diff: 20.3;HSkMC: 27.3;NTERA-2: 16.4;SuSa: 22.6;U-2 OS: 30.6;U-266/70: 19.4;U-266/84: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074457 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA074457: AB_2686691" "unprognostic (3.49e-1)" "unprognostic (1.65e-1)" "unprognostic (4.20e-1)" "unprognostic (2.19e-2)" "unprognostic (2.71e-1)" "unprognostic (9.04e-2)" "unprognostic (6.79e-2)" "unprognostic (3.51e-1)" "unprognostic (3.11e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (1.89e-2)" "unprognostic (8.10e-2)" "unprognostic (1.96e-1)" "unprognostic (6.81e-2)" 29.9 35.5 19.2 7.7 39.1 1.3 25.0 2.6 28.2 32.7 12.9 12.9 8.1 8.0 29.9 17.7 12.3 21.4 19.1 20.3 18.1 40.3 6.9 3.0 10.3 8.9 14.8 17.6 50.7 7.1 2.1 23.2 22.4 19.0 18.8 8.1 16.5 9.2 29.3 9.2 4.7 8.4 23.5 11.8 11.8 8.6 16.4 7.3 7.1 8.4 8.7 4.9 13.1 17.3 0.0 4.3 0.0 0.8 0.4 0.0 0.0 0.0 0.0 20.6 0.0 20.3 7.8 0.0 13.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 3.9 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 12.0 27.3 0.0 3.8 0.0 0.0 0.0 8.0 0.4 0.0 6.7 0.0 9.7 0.0 16.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 22.6 3.5 0.0 0.0 0.9 30.6 0.0 0.0 19.4 18.0 0.0 2.1 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.6 4.3 0.0 0.0 19.2 39.1 2.6 28.2 18.1 40.3 14.8 17.6 19.0 7.3 23.8 8.3 0.0 15.5 11.6 59.9 32.5 12.7 6.7 2.3 12.2 19.6 1.7 19.9 16.4 1.9 15.7 4.6 0.0 9.4 1.1 70.8 4.8 0.0 0.2 6.3 47.7 6.4 30.1 7.8 3.8 218.9 3.2 37.1 0.0 4.5 81.6 7.3 0.0 195.2 0.5 41.1 97.0 76.9 10.9 21.7 7.2 2.1 0.7 6.9 3.1 NDOR1 "bA350O14.9, NR1" ENSG00000188566 "NADPH dependent diflavin oxidoreductase 1" Q9UHB4 9 137205685-137217009 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024504 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA024504: AB_1854338" "unprognostic (1.67e-1)" "unprognostic (1.44e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (5.89e-3)" "unprognostic (5.99e-2)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (2.61e-3)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (4.69e-3)" "unprognostic (2.05e-1)" "unprognostic (4.30e-2)" "unprognostic (6.74e-3)" 9.6 11.4 10.6 18.4 17.4 29.2 10.0 15.0 16.2 9.4 10.4 18.7 7.4 19.1 11.4 10.5 11.2 11.0 10.4 7.4 11.6 7.7 12.1 9.4 11.6 20.5 18.6 8.6 10.2 14.7 9.7 12.2 9.2 13.5 13.0 6.8 12.5 17.3 16.1 6.5 18.5 16.5 8.7 14.2 19.9 13.9 22.2 14.2 20.6 14.4 4.9 15.8 9.7 9.4 2.7 3.7 6.6 4.8 1.6 4.0 3.0 7.2 10.9 7.5 11.4 3.2 3.2 22.5 10.6 4.9 10.4 7.2 10.9 8.6 10.1 8.4 4.1 8.3 27.1 5.4 7.5 2.1 13.0 8.4 9.0 26.2 5.8 5.3 10.1 19.3 4.3 5.3 11.6 4.3 2.8 4.8 13.7 14.5 10.8 3.7 13.0 10.4 17.9 11.9 6.7 13.6 19.2 8.8 14.4 3.3 6.3 9.4 9.3 8.8 8.9 5.5 3.4 14.4 11.7 6.2 19.1 12.5 22.0 11.8 6.7 13.2 10.5 8.3 9.2 10.8 1.7 4.4 6.3 3.2 4.8 2.7 1.3 2.8 2.7 3.7 2.7 1.6 1.4 6.6 1.6 3.8 2.4 4.0 3.0 10.6 17.4 15.0 16.2 11.6 7.7 18.6 8.6 13.5 14.2 0.0 1.6 0.8 0.6 0.5 0.2 1.1 0.0 0.0 2.3 3.5 0.0 4.2 1.7 0.9 0.6 1.5 2.2 0.0 1.0 2.8 0.6 0.5 1.1 0.6 2.3 0.0 2.4 1.8 3.7 0.8 0.6 1.6 1.7 4.6 1.4 0.1 1.5 0.8 0.4 1.1 1.0 0.0 0.8 1.9 1.1 0.3 3.1 0.0 1.7 0.7 NDRG1 "CAP43, DRG1, NDR1, RTP, TDD5" ENSG00000104419 "N-myc downstream regulated 1" Q92597 8 133237171-133302022 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 508.1;Horizontal cells: 556.2;Suprabasal keratinocytes: 583.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 70.6;hTERT-HME1: 142.3;U-87 MG: 95.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006881 Approved Supported Microtubules,Cytosol NA NA Cytosol Microtubules "HPA006881: AB_1078392" "unprognostic (6.96e-3)" "unprognostic (3.31e-3)" "unprognostic (8.53e-2)" "unprognostic (1.41e-3)" "unprognostic (1.54e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.47e-4)" "unprognostic (3.04e-3)" "unprognostic (5.33e-2)" "unprognostic (4.29e-2)" "unprognostic (9.09e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (4.13e-4)" "unprognostic (7.27e-2)" "unprognostic (1.91e-1)" "unprognostic (2.47e-3)" "unprognostic (4.28e-2)" 43.9 23.6 42.0 17.0 80.9 18.0 29.8 6.4 36.2 33.1 47.7 73.2 24.2 74.2 20.9 20.6 83.0 24.7 26.8 22.2 48.7 32.9 62.6 12.1 31.0 11.4 96.3 19.8 37.5 16.7 17.8 18.6 32.5 50.0 115.0 22.4 16.2 29.0 26.4 13.2 56.9 78.2 19.2 102.0 11.5 45.7 15.0 74.3 10.3 21.4 40.0 34.9 58.7 64.9 1.9 12.2 8.9 4.1 1.3 9.3 2.9 22.0 2.7 0.2 0.1 14.0 9.8 3.0 1.6 12.1 1.1 6.2 1.4 3.1 0.1 15.8 6.6 2.6 7.1 0.2 34.8 2.4 1.4 26.1 0.2 5.6 1.6 5.3 0.7 0.5 9.1 70.6 5.9 142.3 13.4 5.2 2.9 0.2 15.4 2.0 1.3 2.0 2.1 0.4 8.1 18.3 0.2 2.4 10.2 3.6 3.2 1.6 1.6 3.4 36.5 8.8 6.1 0.1 2.4 6.8 9.9 5.1 4.3 1.2 11.5 30.3 0.1 95.8 8.3 19.5 8.9 4.1 0.0 6.3 3.7 9.3 1.7 5.9 7.5 6.1 1.9 4.6 3.1 4.2 1.3 4.0 12.2 8.0 2.9 42.0 80.9 6.4 36.2 48.7 32.9 96.3 19.8 50.0 74.3 134.0 42.5 17.1 123.5 508.1 21.1 16.5 73.9 9.4 26.1 177.9 2.0 8.9 28.2 21.1 5.4 137.1 330.3 0.0 11.8 79.9 76.6 236.9 21.9 52.2 15.9 556.2 21.2 77.3 31.9 4.3 45.5 36.0 96.2 19.0 134.0 72.1 84.1 91.2 41.4 59.7 33.2 45.3 59.4 0.9 6.4 583.4 36.3 25.4 80.8 209.3 NDRG2 "KIAA1248, SYLD" ENSG00000165795 "NDRG family member 2" Q9UN36 14 21016763-21070872 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 310.5;skeletal muscle: 253.0" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 411.1;Leydig cells: 322.7;Muller glia cells: 402.9;Sertoli cells: 588.6" "Cancer enhanced" "Detected in all" "glioma: 78.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "myeloid DC: 54.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 54.5" "Cell line enhanced" "Detected in many" "Hep G2: 27.9;HMC-1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002896, HPA003590, CAB017491" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 150000 "Centriolar satellite" "Nucleoplasm, Cytosol" "CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458" "unprognostic (9.27e-3)" "unprognostic (2.97e-3)" "unprognostic (1.26e-2)" "unprognostic (5.09e-3)" "unprognostic (2.00e-2)" "unprognostic (2.92e-2)" "prognostic favorable (6.71e-4)" "unprognostic (1.85e-3)" "unprognostic (5.57e-2)" "unprognostic (3.46e-2)" "unprognostic (1.69e-1)" "unprognostic (5.10e-2)" "prognostic favorable (1.43e-12)" "unprognostic (1.46e-1)" "unprognostic (5.56e-2)" "unprognostic (6.11e-2)" "unprognostic (4.19e-2)" 19.3 45.3 140.2 4.8 135.1 1.4 50.3 93.5 110.0 35.5 21.0 89.6 23.8 12.2 30.7 44.4 37.3 29.5 21.5 45.2 103.6 86.1 24.3 84.8 13.7 7.7 128.9 73.5 79.7 15.5 35.6 6.0 8.1 95.4 23.7 18.8 8.9 310.5 37.3 253.0 18.9 12.0 22.0 73.0 21.1 11.2 5.2 71.2 0.4 13.6 53.4 16.1 13.9 19.3 1.8 54.5 0.4 1.8 0.7 5.4 4.0 5.3 1.1 3.4 6.4 0.5 0.0 0.5 0.1 2.2 2.0 1.1 7.4 10.0 0.3 2.0 0.1 3.2 8.8 15.3 3.1 2.7 0.0 5.5 6.9 1.2 27.9 0.7 0.6 20.0 6.1 6.7 0.4 0.9 3.2 0.0 6.3 13.9 0.6 0.3 4.5 2.4 1.9 9.1 17.3 0.4 7.1 0.3 1.6 3.8 13.6 0.0 9.9 1.5 1.7 7.0 9.3 13.5 4.0 0.0 0.6 10.9 0.2 0.2 3.1 2.2 0.1 0.9 0.1 2.3 0.0 1.8 0.2 2.4 0.4 3.2 1.8 3.6 3.3 54.5 1.3 5.4 4.0 0.4 0.7 0.0 1.9 2.4 4.0 140.2 135.1 93.5 110.0 103.6 86.1 128.9 73.5 95.4 71.2 0.0 14.8 8.5 70.8 25.4 6.7 160.9 140.1 20.1 13.6 38.4 9.8 8.0 411.1 69.3 4.7 52.6 25.5 0.0 18.9 0.6 20.1 71.2 47.4 183.0 19.8 3.2 32.1 116.6 25.7 5.9 322.7 43.4 305.4 6.4 71.2 402.9 14.6 28.8 156.3 32.0 12.8 588.6 188.5 1.1 3.4 26.6 18.1 10.1 86.6 132.0 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 389.7;Horizontal cells: 487.8" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 18.4;GAMG: 16.2;hTERT-RPE1: 15.2;SCLC-21H: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 3.6 59.2 28.7 2.9 49.4 1.6 2.3 65.4 134.1 3.8 3.5 11.0 15.6 3.4 10.2 5.1 10.0 3.9 3.4 112.6 30.5 32.0 2.3 1.9 6.5 3.4 33.7 35.4 2.1 2.6 10.8 11.6 2.6 81.2 2.1 3.2 8.7 2.9 18.2 5.3 3.9 3.2 8.7 11.7 11.7 2.6 19.9 7.4 0.0 2.6 0.3 3.5 2.7 8.0 1.5 0.1 0.2 0.0 0.1 0.9 0.2 0.1 9.3 8.9 1.7 0.2 1.7 0.7 2.9 4.5 1.4 0.9 3.5 2.4 0.2 18.4 2.2 16.2 0.8 0.7 0.5 1.2 0.0 1.8 0.4 1.5 2.5 2.5 0.1 0.1 2.1 0.2 0.9 0.0 15.2 11.7 0.0 0.1 0.1 1.3 2.3 0.9 0.1 0.8 0.3 6.8 0.2 2.5 0.2 0.4 5.8 27.8 10.4 0.3 0.8 0.1 1.1 0.3 0.1 4.2 1.2 3.5 0.3 0.4 0.5 0.2 3.0 6.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.2 28.7 49.4 65.4 63.4 30.5 32.0 33.7 35.4 81.2 7.4 0.0 3.4 0.0 4.0 1.8 38.9 389.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 3.6 4.6 13.5 0.0 0.0 0.2 0.1 1.5 1.4 0.0 0.2 0.0 487.8 1.7 23.9 1.0 6.2 4.0 0.7 6.8 0.0 0.0 74.2 3.2 0.0 2.5 0.0 22.6 6.5 5.7 3.9 3.6 5.1 0.0 0.0 0.0 7.5 NDST2 "HSST2, NST2" ENSG00000166507 "N-deacetylase and N-sulfotransferase 2" P52849 10 73801911-73811798 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 50.8" HPA051515 Approved Approved Cytosol NA NA 72000 Cytosol "HPA051515: AB_2681517" "unprognostic (8.84e-2)" "unprognostic (7.57e-2)" "unprognostic (2.53e-2)" "unprognostic (9.43e-3)" "unprognostic (5.69e-1)" "unprognostic (1.07e-2)" "unprognostic (5.83e-3)" "unprognostic (2.16e-2)" "unprognostic (8.19e-2)" "unprognostic (1.61e-2)" "unprognostic (2.23e-5)" "unprognostic (1.49e-2)" "unprognostic (4.08e-7)" "unprognostic (3.71e-2)" "unprognostic (3.69e-2)" "unprognostic (5.93e-2)" "unprognostic (9.06e-2)" 12.6 14.6 7.9 19.2 11.3 37.5 11.8 30.2 12.2 16.6 10.7 13.8 13.4 8.9 18.4 14.8 14.4 12.8 15.5 9.3 9.6 8.4 11.0 9.4 14.7 21.9 7.3 8.8 15.1 12.3 17.3 26.5 14.1 9.2 13.6 10.5 14.7 20.1 17.2 16.4 15.1 14.4 13.4 7.5 31.8 11.8 13.5 9.2 35.3 12.2 8.2 19.3 12.3 13.3 3.1 6.8 5.8 5.3 2.2 7.1 3.2 4.3 3.6 7.5 11.5 9.3 10.8 3.9 5.1 10.9 5.9 6.1 1.9 5.3 3.9 3.1 9.7 6.0 5.0 3.7 5.4 4.8 10.4 3.6 3.9 2.7 3.0 16.4 5.0 50.8 10.2 6.6 10.2 10.5 18.4 7.7 7.9 3.7 15.1 7.4 3.3 5.8 5.5 2.1 2.7 15.3 3.6 3.7 2.4 5.0 3.0 2.5 4.2 4.5 10.7 3.5 5.2 8.2 7.7 12.3 3.0 3.5 3.9 3.6 7.5 3.3 5.2 3.5 7.7 2.3 1.4 5.3 2.1 5.5 3.7 6.5 2.5 4.7 4.8 4.0 3.1 5.6 7.1 5.8 2.2 3.5 6.8 3.1 3.2 7.9 11.3 30.2 12.2 9.6 8.4 7.3 8.8 9.2 9.2 0.0 4.8 3.7 0.3 1.1 0.6 1.4 0.0 4.0 2.3 0.0 0.0 1.2 0.0 4.4 5.7 0.5 3.5 0.0 8.4 1.4 1.0 1.5 13.9 3.8 4.5 1.6 2.4 0.0 6.7 6.8 0.0 3.5 1.7 4.6 2.3 0.7 5.5 2.6 0.0 5.6 0.7 0.0 1.0 2.4 1.4 1.4 5.1 3.2 1.7 2.1 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871487-119876662 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 144.8;skeletal muscle: 138.8" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3052.5;Distal tubular cells: 1856.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA029768: AB_2673192, HPA054359: AB_2682461" "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favorable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 24.5 30.1 37.9 20.1 42.5 25.2 23.8 27.9 37.8 19.7 38.4 8.7 27.3 41.0 13.5 25.8 21.6 15.9 24.8 144.8 30.1 28.5 46.0 40.2 21.1 22.2 34.6 32.8 14.6 40.4 22.7 21.7 15.4 29.5 17.9 31.1 15.5 38.4 29.6 138.8 12.1 34.6 19.3 31.5 17.1 28.1 7.7 21.1 9.2 16.2 67.4 16.7 14.0 14.9 66.3 90.5 96.3 85.7 49.8 75.5 73.8 33.6 36.4 26.0 27.7 31.4 19.9 32.6 26.6 24.3 18.7 23.4 20.3 28.2 27.5 41.1 27.8 40.0 32.5 36.5 25.6 21.5 37.9 50.4 28.5 66.4 45.5 24.4 43.5 31.7 32.4 34.8 19.9 15.5 30.6 23.2 28.1 15.5 42.7 25.7 59.6 30.9 41.2 38.4 87.9 65.0 31.3 24.8 82.5 56.4 48.0 19.0 25.1 54.7 67.9 36.5 36.6 17.2 51.3 29.9 16.0 16.2 33.2 51.9 39.4 48.8 35.9 29.0 51.7 19.7 96.3 79.0 91.6 60.2 80.4 57.1 66.3 67.1 62.8 84.0 52.7 56.1 65.7 94.6 49.8 85.7 90.5 75.5 73.8 37.9 42.5 27.9 37.8 30.1 28.5 34.6 32.8 29.5 21.1 148.9 173.3 221.0 195.7 189.9 139.0 3052.5 636.9 330.6 205.9 533.9 74.6 331.6 1856.9 408.0 28.1 249.5 1244.9 256.9 444.8 351.6 251.4 215.4 204.5 881.4 567.3 77.9 441.2 254.8 408.9 27.3 272.7 346.6 541.6 587.1 745.3 168.3 446.0 706.9 268.0 1089.7 161.0 213.4 269.6 46.1 78.8 217.9 318.3 243.7 663.1 282.7 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003770 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Group enriched" "Detected in all" 5 "Cardiomyocytes: 2083.1;Distal tubular cells: 525.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 24.0 24.8 36.0 17.9 36.8 19.7 19.7 27.2 36.5 17.9 35.5 12.5 20.0 27.4 17.0 21.9 23.3 19.4 14.4 82.8 31.2 32.0 33.2 34.6 18.1 20.1 37.0 29.9 17.0 18.4 22.3 22.4 21.1 31.3 19.1 35.7 13.1 18.7 20.7 129.0 17.4 26.7 24.0 24.2 23.9 20.9 14.2 23.5 21.0 27.9 40.0 28.1 21.9 21.4 60.8 78.4 69.7 67.9 59.1 93.8 100.6 41.6 45.3 37.9 26.9 31.1 29.0 28.2 19.9 29.3 43.5 39.5 55.9 21.5 47.9 11.8 30.4 24.1 31.5 38.9 45.9 49.4 41.3 46.7 40.1 37.8 56.3 32.0 56.8 49.0 31.1 58.0 36.4 44.7 45.5 35.6 41.7 37.4 22.3 42.1 60.4 39.3 87.8 28.7 51.2 78.9 30.1 32.8 54.6 42.6 62.6 36.1 21.9 33.7 49.2 25.8 34.2 48.6 37.4 40.6 23.1 23.5 33.5 33.8 36.4 54.0 73.1 13.9 47.6 35.2 69.7 59.5 29.8 52.1 67.9 48.2 60.8 71.6 62.5 78.4 50.7 93.8 68.6 8.6 59.1 63.3 48.0 74.8 100.6 36.0 36.8 27.2 36.5 31.2 32.0 37.0 29.9 31.3 23.5 68.5 58.6 79.6 121.2 96.5 65.8 2083.1 160.5 77.6 45.5 102.9 60.9 215.5 525.6 141.2 192.8 157.8 177.2 46.7 143.2 214.5 94.4 120.9 56.6 123.1 168.7 35.0 81.9 98.8 95.5 70.6 90.3 125.9 151.8 218.2 146.8 79.4 169.8 188.7 125.5 242.6 113.4 103.5 149.9 130.8 119.2 111.7 175.3 96.5 189.4 182.6 NDUFAF1 "CGI-65, CIA30" ENSG00000137806 "NADH:ubiquinone oxidoreductase complex assembly factor 1" Q9Y375 15 41387349-41402519 "Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039933, HPA040064" Supported Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA039933: AB_10795265, HPA040064: AB_10795687" "unprognostic (2.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.72e-1)" "unprognostic (2.10e-3)" "unprognostic (2.38e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.88e-5)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "prognostic favorable (3.34e-6)" "unprognostic (1.68e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-2)" "unprognostic (2.05e-1)" 11.1 22.0 15.0 6.4 14.0 3.0 9.8 13.3 17.8 7.8 7.7 12.4 5.3 8.4 8.3 10.7 9.6 7.9 7.1 29.7 13.2 13.4 21.9 27.5 7.0 8.5 14.7 14.4 7.0 7.7 11.9 9.7 7.0 13.1 8.5 8.1 8.4 8.5 9.8 38.6 6.2 7.7 10.3 13.5 7.5 8.5 14.1 12.0 6.5 9.6 15.8 9.1 8.8 5.8 14.5 19.1 25.2 16.2 13.9 15.9 8.7 9.2 6.6 8.7 9.0 20.0 20.4 9.6 17.7 14.5 15.6 13.0 12.2 5.1 10.6 24.6 15.5 11.0 15.3 11.8 11.9 14.1 19.9 13.7 15.0 13.9 7.2 17.1 16.0 10.6 22.7 11.4 12.9 13.0 13.6 11.1 19.2 22.8 11.5 22.8 8.5 12.8 13.3 7.0 16.1 11.1 10.0 11.7 21.9 23.8 15.0 10.5 8.3 9.0 20.1 6.7 11.6 16.5 30.9 11.5 12.7 5.9 19.0 14.6 9.4 20.3 16.0 14.2 25.4 12.1 25.2 13.7 16.4 9.6 16.2 9.9 14.5 11.5 12.3 12.1 12.6 13.0 10.3 12.8 13.9 12.4 19.1 15.9 8.7 15.0 14.0 13.3 17.8 13.2 13.4 14.7 14.4 13.1 12.0 11.9 8.5 15.6 13.8 4.1 14.0 56.8 12.7 16.0 5.7 21.0 11.8 32.1 54.7 26.4 36.4 11.3 11.9 0.0 27.1 30.5 15.5 11.6 6.9 25.2 26.1 6.4 6.4 6.7 14.8 5.4 15.3 14.8 10.1 26.2 6.8 19.5 18.8 2.9 15.2 56.4 17.6 25.8 9.9 67.2 17.8 6.8 42.1 10.2 8.1 13.6 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67606852-67612535 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 150.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Enhanced Supported Mitochondria,Cytosol No No Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: AB_2686732" "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favorable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 23.3 28.9 27.3 20.7 33.9 20.3 18.9 32.9 48.8 18.5 33.0 23.1 19.2 40.6 19.4 21.5 25.5 22.5 23.4 93.0 26.5 24.1 39.0 41.5 15.9 20.6 31.5 40.5 24.6 38.3 49.2 18.8 15.7 34.8 16.1 25.1 17.6 27.3 27.0 150.8 28.4 30.3 22.7 23.1 21.5 28.2 30.2 24.3 18.3 23.4 67.9 20.3 18.7 18.6 23.8 41.2 13.5 30.7 36.2 28.2 24.3 25.9 27.9 14.2 28.5 17.8 17.9 26.6 16.2 15.6 25.4 17.0 52.8 31.5 48.0 34.2 13.9 20.7 35.0 30.0 25.3 8.0 24.4 23.7 19.6 37.9 26.0 25.2 26.7 22.0 26.5 24.6 20.6 18.5 16.1 22.5 35.2 35.7 39.3 15.4 39.0 31.2 52.9 13.9 59.1 35.2 36.3 27.6 77.9 20.6 19.5 22.7 21.4 20.5 71.8 54.1 9.9 36.4 27.2 17.8 24.7 18.4 35.1 17.0 38.4 21.8 23.9 28.7 28.3 23.7 12.6 26.7 13.5 25.9 30.7 28.2 23.2 21.7 24.5 41.2 23.8 20.2 25.1 4.8 36.2 17.4 26.5 27.8 24.3 27.3 33.9 32.9 48.8 26.5 24.1 31.5 40.5 34.8 24.3 56.6 80.9 64.0 70.8 71.3 67.0 408.9 66.2 72.3 67.1 82.0 47.1 180.6 336.5 96.7 57.0 53.7 205.0 23.3 97.8 127.6 79.5 47.7 59.0 122.2 121.6 60.4 94.7 53.4 67.1 159.3 60.7 67.5 108.0 83.8 141.7 63.1 68.4 126.7 55.5 398.9 60.4 45.3 98.9 77.2 78.1 70.4 158.1 71.2 225.4 78.9 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "HPA003404: AB_1079466, HPA077896: AB_2686866" "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 20.0 34.5 25.2 18.0 23.7 31.1 25.6 20.6 37.3 15.6 26.1 13.1 20.3 23.1 14.7 21.5 27.5 13.9 17.6 82.6 22.7 23.8 40.7 89.1 17.2 29.9 26.7 19.4 11.2 36.3 14.9 14.9 21.6 26.2 20.8 27.8 17.8 20.1 20.2 122.6 17.4 24.4 23.5 20.8 19.3 25.2 19.0 12.7 20.5 20.5 59.5 22.7 20.4 14.1 55.6 74.7 49.3 45.1 27.0 53.5 48.1 18.6 19.6 22.7 21.1 16.8 24.0 19.2 23.5 37.4 31.1 29.6 36.6 15.4 28.8 21.6 22.0 28.7 9.5 22.0 24.4 29.8 14.5 19.4 18.4 20.2 49.3 19.4 51.2 22.9 20.1 20.5 19.2 20.8 22.5 33.5 26.0 29.3 91.0 28.5 23.4 35.7 44.9 18.9 103.3 24.4 17.0 16.8 109.2 49.6 30.3 23.8 17.7 23.2 26.5 29.5 16.9 24.8 39.0 20.5 39.7 28.2 28.4 30.5 26.3 39.0 32.2 28.3 22.7 25.6 49.3 39.9 44.1 30.2 45.1 37.6 55.6 45.5 35.7 56.6 43.6 40.0 36.9 18.0 27.0 41.6 74.7 53.5 48.1 25.2 23.7 20.6 37.3 22.7 23.8 26.7 19.4 26.2 12.7 74.5 120.4 122.8 254.8 131.4 96.8 61.3 175.8 207.5 127.4 143.1 82.5 309.8 742.8 337.2 214.8 108.5 232.3 46.7 461.4 265.4 107.6 372.3 115.7 324.6 267.7 89.0 102.4 92.7 98.1 135.7 113.1 187.8 219.4 393.1 177.0 104.6 465.3 175.4 95.8 576.3 143.4 103.5 138.2 182.6 170.4 129.0 242.0 118.9 207.0 348.6 NECAB1 EFCBP1 ENSG00000123119 "N-terminal EF-hand calcium binding protein 1" Q8N987 8 90791550-90959408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 56.4" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 54.2;Cardiomyocytes: 55.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 6.1;hTERT-RPE1: 6.4;MOLT-4: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210" Enhanced Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815" "unprognostic (8.09e-3)" "unprognostic (3.78e-1)" "unprognostic (8.17e-3)" "unprognostic (5.96e-5)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-3)" "unprognostic (8.38e-2)" "unprognostic (1.78e-3)" "unprognostic (2.60e-1)" "unprognostic (2.25e-2)" "unprognostic (2.57e-2)" "unprognostic (2.19e-3)" "unprognostic (4.45e-3)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (5.39e-3)" 2.7 4.9 19.7 2.0 27.3 3.2 1.5 0.5 56.4 1.4 3.7 12.1 0.3 1.7 4.1 4.4 3.6 1.6 3.1 10.9 19.5 9.8 3.4 1.1 6.8 1.4 16.0 30.7 3.8 1.3 1.9 1.9 2.8 10.8 2.6 1.1 4.1 2.5 2.0 1.3 1.9 1.8 1.3 18.7 2.4 2.1 5.2 17.4 0.0 2.9 0.0 1.0 4.2 1.2 0.5 1.8 0.3 0.0 0.7 0.9 0.2 0.1 0.1 2.3 0.4 0.0 0.1 0.1 2.5 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 2.3 0.0 1.0 0.0 0.1 0.0 4.6 6.1 2.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 6.4 0.0 1.7 4.0 4.4 0.0 4.9 6.3 3.1 0.8 0.0 0.1 0.0 3.9 0.0 0.0 0.0 4.1 4.3 0.1 0.0 2.1 2.9 0.0 0.2 1.5 3.8 3.8 0.0 1.6 6.0 3.6 3.1 3.8 0.0 1.8 0.0 0.0 0.1 0.6 0.0 0.4 0.2 0.4 0.6 0.1 0.5 0.6 0.9 0.3 0.7 0.0 1.8 0.9 0.2 19.7 27.3 0.5 37.1 19.5 9.8 16.0 30.7 10.8 17.4 17.9 54.2 0.0 0.2 0.5 3.9 55.7 0.0 0.0 4.5 12.2 0.0 0.0 0.0 0.0 3.5 0.7 0.0 0.0 0.2 0.0 1.3 0.1 1.1 0.0 0.1 0.0 0.0 0.6 0.0 1.0 2.3 0.7 3.3 0.0 0.0 0.3 0.1 0.0 2.1 5.6 0.5 6.5 2.7 4.3 1.7 0.6 0.0 0.0 0.0 0.0 NECAP1 DKFZP566B183 ENSG00000089818 "NECAP endocytosis associated 1" Q8NC96 12 8076939-8097859 "Disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053980, HPA063300" Uncertain Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA053980: AB_2682331, HPA063300: AB_2684981" "unprognostic (1.73e-2)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-3)" "unprognostic (1.03e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (5.79e-3)" "unprognostic (5.72e-3)" "unprognostic (1.03e-1)" "unprognostic (1.72e-2)" "unprognostic (1.89e-2)" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (5.94e-2)" 7.5 19.1 25.5 9.2 34.1 6.5 10.5 45.9 53.2 11.9 13.1 9.6 5.1 12.1 8.4 8.1 9.3 12.0 7.8 9.4 27.6 36.8 12.5 11.1 8.5 6.0 19.2 22.1 13.1 17.4 16.3 17.9 11.6 32.5 12.7 13.3 11.1 10.9 10.1 5.0 5.9 11.8 9.0 9.6 7.0 12.0 10.0 7.5 5.3 9.6 4.4 8.0 8.9 5.8 7.0 8.9 25.4 14.3 6.8 12.0 8.5 10.3 9.4 6.8 9.4 15.8 12.0 15.3 22.4 13.6 18.8 18.9 20.4 11.9 5.3 3.9 10.6 14.1 7.2 18.2 11.7 16.1 14.2 14.3 5.8 12.1 10.2 14.4 5.4 17.1 15.3 14.2 20.6 25.8 14.4 13.5 7.9 13.4 7.9 19.9 12.7 9.1 1.8 18.6 29.1 8.7 3.6 16.5 4.9 13.0 15.7 11.0 8.5 11.1 15.8 8.8 22.4 5.3 4.7 13.2 9.1 18.4 10.7 15.4 5.2 9.2 10.8 15.9 6.0 13.2 18.5 11.5 25.4 8.4 11.5 9.4 6.6 7.9 8.6 8.9 7.0 9.5 8.8 18.8 6.8 14.3 4.8 12.0 8.5 25.5 34.1 45.9 47.0 27.6 36.8 19.2 22.1 32.5 7.5 35.7 20.0 25.7 18.8 22.7 49.9 10.1 7.6 12.0 15.9 22.7 25.5 13.2 21.6 14.6 19.8 16.3 20.6 0.0 14.6 12.1 18.7 18.9 28.8 12.1 12.4 27.0 15.5 12.9 12.3 10.2 21.6 22.0 27.0 6.4 14.2 29.7 14.4 14.7 13.8 16.1 43.1 6.5 22.7 14.7 23.0 18.6 18.8 28.0 11.7 17.3 NECTIN3 "CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3" ENSG00000177707 "Nectin cell adhesion molecule 3" Q9NQS3 3 111070071-111275563 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 94.2" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "AF22: 33.5;TIME: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009869, HPA011038" Approved Approved "Cell Junctions,Cytosol" NA NA 20000000 Cytosol "Cell Junctions" "CAB009869: AB_2284699, HPA011038: AB_1079719" "unprognostic (3.76e-2)" "unprognostic (3.81e-3)" "unprognostic (1.74e-1)" "unprognostic (1.97e-2)" "unprognostic (1.02e-1)" "unprognostic (9.77e-2)" "unprognostic (3.26e-3)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (3.94e-2)" "unprognostic (5.33e-2)" "unprognostic (7.04e-2)" "prognostic favorable (9.82e-7)" "unprognostic (2.01e-1)" "unprognostic (1.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.05e-1)" 5.6 4.0 5.4 4.4 6.0 0.0 4.5 1.3 8.9 4.6 12.6 6.5 2.8 17.8 5.0 2.2 3.5 5.4 4.4 4.8 6.3 5.0 6.9 16.4 5.6 1.9 6.0 4.1 9.2 4.7 1.9 1.9 94.2 5.5 6.9 12.6 10.7 3.4 4.8 2.3 1.8 18.9 7.2 8.9 1.8 13.2 27.6 4.5 0.4 24.1 2.0 1.4 5.4 7.7 0.1 0.0 0.3 0.0 0.2 1.7 0.7 0.0 10.1 33.5 2.2 13.6 25.2 2.0 22.0 23.3 13.7 11.7 9.3 4.7 0.0 7.3 31.3 7.6 0.1 9.3 3.2 25.2 0.2 2.5 0.0 3.6 0.7 23.0 1.6 0.3 12.7 1.4 9.0 8.7 12.3 11.5 0.4 0.0 8.8 29.5 0.0 2.2 0.0 9.4 3.1 3.6 0.0 16.6 0.0 8.5 5.3 0.8 6.1 0.4 0.0 4.6 11.7 0.3 0.1 47.5 17.4 7.2 3.1 13.1 4.9 0.0 0.0 11.0 0.0 16.0 0.0 0.0 0.3 0.1 0.0 1.2 0.0 1.7 1.0 0.0 0.1 0.3 0.4 0.0 0.2 0.0 0.0 0.1 0.7 5.4 6.0 1.3 8.9 6.3 5.0 6.0 4.1 5.5 4.5 23.8 7.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.7 12.2 0.0 3.3 0.0 3.9 0.0 0.0 0.0 0.0 16.4 7.6 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 13.3 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 98.1 0.0 0.0 0.0 NEDD4 "KIAA0093, MGC176705, NEDD4-1, RPF1" ENSG00000069869 "Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase" P46934 15 55826922-55993746 "Enzymes, Predicted intracellular proteins, Transporters" "Host-virus interaction, Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 57.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 86.4;Alveolar cells type 2: 87.7;Ciliated cells: 135.1;Club cells: 79.6;granulocytes: 67.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001991, HPA039883, CAB072833" Approved Approved Cytosol NA NA Cytosol "CAB001991: , CAB072833: , HPA039883: AB_10795683" "unprognostic (1.18e-1)" "unprognostic (2.10e-2)" "unprognostic (5.66e-3)" "unprognostic (1.15e-1)" "unprognostic (6.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.18e-3)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.36e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (6.38e-3)" "unprognostic (2.98e-1)" "unprognostic (2.22e-1)" "unprognostic (2.35e-2)" 14.1 4.1 2.5 3.1 3.3 4.5 8.7 1.5 2.7 9.9 9.4 2.8 3.4 3.4 10.1 4.1 8.2 3.8 4.5 4.1 2.9 2.4 8.6 21.5 7.2 2.1 3.5 1.3 6.6 2.8 6.5 6.7 20.1 3.5 8.4 3.4 5.4 4.0 6.4 57.7 7.1 15.2 10.9 6.0 5.9 4.4 2.6 3.1 9.4 5.7 9.0 3.3 11.9 8.9 0.1 1.6 1.2 2.8 1.2 2.9 0.9 7.3 11.5 3.1 3.0 4.1 6.8 5.1 14.1 22.3 10.5 10.5 5.1 2.2 1.8 3.7 5.4 25.5 12.2 3.4 9.3 17.2 4.1 2.1 9.1 2.7 2.6 21.9 4.0 0.9 11.6 23.1 12.5 21.1 5.1 8.6 5.4 3.9 0.0 30.6 3.8 5.3 0.0 0.8 3.9 1.7 3.9 24.8 1.0 4.3 14.6 0.3 2.0 6.3 4.5 5.6 5.9 5.6 3.0 29.6 23.3 7.7 4.9 22.9 1.2 2.7 4.8 15.7 8.6 5.5 0.6 1.0 0.0 1.3 2.8 2.9 0.1 1.5 1.2 0.8 0.0 1.4 1.6 1.2 1.2 1.9 1.6 1.3 0.9 2.5 3.3 1.5 2.7 2.9 2.4 3.5 1.3 3.5 3.1 86.4 87.7 2.0 3.3 10.8 0.3 4.8 7.6 135.1 79.6 0.0 21.6 16.5 1.7 3.2 1.3 16.8 6.9 0.0 4.8 6.4 6.3 3.4 67.4 17.9 4.0 0.0 0.0 15.4 1.8 1.0 5.2 3.8 1.7 0.0 4.2 8.4 3.3 0.0 6.7 10.8 6.0 0.0 8.2 1.2 5.9 9.2 11.6 2.2 2.9 1.6 NEDD8 Nedd-8 ENSG00000129559 "Neural precursor cell expressed, developmentally down-regulated 8" Q15843 14 24216852-24232454 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004082, HPA027583, HPA060254" Uncertain Enhanced Nucleoplasm,Cytosol NA NA 5700000 Nucleoplasm Cytosol "CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644" "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.34e-3)" "unprognostic (1.83e-3)" "unprognostic (9.19e-2)" "unprognostic (4.66e-1)" "unprognostic (1.35e-2)" "unprognostic (2.66e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-3)" "unprognostic (2.76e-2)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (5.25e-3)" 38.2 48.1 55.5 30.7 58.1 34.6 42.2 34.1 62.4 41.0 36.3 26.8 32.6 25.0 32.2 59.9 40.3 34.3 31.3 50.7 47.1 49.5 46.5 48.4 30.5 31.5 49.4 54.6 34.3 33.4 101.1 31.3 39.7 45.5 31.6 40.0 27.4 37.2 40.7 70.7 36.5 28.4 43.0 36.0 34.9 29.9 25.7 34.3 26.9 37.5 44.7 46.8 30.7 32.0 60.2 76.1 90.2 60.1 43.2 64.1 89.9 26.0 45.7 37.1 26.2 42.2 36.9 27.0 35.6 37.8 42.0 38.8 31.5 31.9 22.5 20.9 50.1 35.4 27.5 37.0 55.6 59.1 31.7 22.4 24.0 42.1 107.3 36.6 39.7 25.2 39.2 37.0 35.3 27.8 39.6 50.1 26.4 21.4 26.4 64.7 57.9 31.6 37.7 27.4 48.1 53.5 22.5 29.4 22.9 48.4 49.6 15.7 36.6 30.8 31.4 25.6 39.6 19.0 31.6 37.5 23.9 24.0 30.5 31.5 31.4 47.3 32.6 17.2 22.9 22.6 73.5 57.9 90.2 46.8 60.1 50.7 60.2 54.4 51.9 56.9 51.1 51.2 52.0 62.2 43.2 59.0 76.1 64.1 89.9 55.5 58.1 34.1 62.4 47.1 49.5 49.4 54.6 45.5 34.3 134.0 147.7 239.7 188.0 246.8 91.4 436.0 229.3 136.5 126.3 294.8 45.2 457.7 504.0 309.5 46.7 283.5 261.3 163.5 353.5 526.2 324.5 205.0 213.6 344.7 501.8 100.1 204.1 216.7 303.8 60.6 252.0 280.5 254.8 432.0 208.2 154.8 360.0 256.1 259.2 606.3 68.0 207.0 308.8 113.9 219.0 337.9 350.8 243.7 228.6 222.9 NEDD9 "CAS-L, CASS2, HEF1" ENSG00000111859 "Neural precursor cell expressed, developmentally down-regulated 9" Q14511 6 11183298-11382348 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 72.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 437.7;Basal glandular cells: 247.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 49.8;HSkMC: 24.9" "Low region specificity" "Detected in all" "HPA009689, CAB009720, HPA038768, HPA039270, HPA072955" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: " "unprognostic (2.83e-3)" "unprognostic (2.33e-2)" "unprognostic (1.08e-2)" "unprognostic (6.93e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "unprognostic (3.05e-2)" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.64e-1)" "unprognostic (5.59e-3)" "unprognostic (2.25e-2)" "unprognostic (2.37e-1)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" 72.8 4.7 4.5 14.9 5.6 3.3 35.7 2.2 5.9 14.0 16.6 5.1 14.2 7.1 17.3 21.7 10.3 11.5 15.3 17.3 4.6 4.1 34.6 9.5 58.4 15.0 4.9 3.9 11.1 7.9 4.2 6.1 32.6 6.6 13.4 14.7 12.8 15.4 15.4 22.4 12.3 17.9 12.4 5.3 25.7 10.9 12.2 4.3 18.8 15.8 6.8 18.6 17.6 9.9 5.8 6.0 34.8 19.8 5.1 8.3 6.3 1.5 10.2 9.5 0.1 6.5 0.8 10.0 2.3 2.9 4.4 8.1 3.2 0.6 3.2 49.8 5.1 0.5 4.4 12.7 4.7 5.7 1.4 0.3 0.3 1.5 21.4 3.0 3.4 0.2 24.9 1.4 2.8 0.5 1.6 7.4 0.2 0.0 2.7 9.8 0.4 1.9 1.3 1.4 11.9 1.0 0.5 0.2 1.8 2.2 13.9 0.2 1.7 0.4 11.2 19.3 11.0 0.8 2.6 18.8 3.0 5.3 0.3 5.7 2.8 11.5 3.9 0.0 2.7 12.9 9.1 5.5 15.4 8.3 12.2 6.8 5.0 5.6 8.0 6.0 5.8 3.0 4.7 34.8 5.1 19.8 3.7 5.0 6.3 4.5 5.6 2.2 5.9 4.6 4.1 4.9 3.9 6.6 4.3 437.7 110.8 20.8 247.6 53.8 4.8 7.3 53.5 97.7 139.9 41.8 23.6 41.8 8.3 54.6 6.0 101.8 77.5 0.0 17.3 34.2 31.7 54.5 61.4 16.3 13.3 9.5 103.9 91.4 24.8 2.9 6.9 22.9 23.6 1.8 90.0 104.5 46.5 35.1 27.3 20.3 12.2 25.8 25.0 1.1 0.5 18.1 35.8 41.5 37.6 69.7 NEGR1 "IGLON4, KILON, MGC46680, Ntra" ENSG00000172260 "Neuronal growth regulator 1" Q7Z3B1 1 71395940-72282734 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.5" "Cell type enhanced" "Detected in many" 20 "Bipolar cells: 41.5;Leydig cells: 194.8;Peritubular cells: 42.1;Rod photoreceptor cells: 57.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 16.0;TIME: 16.3;U-2 OS: 13.6;U-251 MG: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011894 Uncertain Approved "Vesicles,Actin filaments,Cytosol" NA NA 390000000 "Vesicles, Actin filaments, Cytosol" "HPA011894: AB_1854363" "unprognostic (2.60e-1)" "unprognostic (1.89e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (7.99e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.94e-2)" "unprognostic (8.15e-2)" "unprognostic (8.73e-2)" "unprognostic (3.38e-2)" "unprognostic (1.36e-1)" "unprognostic (3.31e-5)" "unprognostic (5.89e-3)" "unprognostic (1.31e-1)" "unprognostic (1.43e-3)" "unprognostic (2.11e-4)" 17.5 7.8 18.1 7.6 16.3 2.2 7.3 24.1 41.5 8.0 14.7 2.6 2.4 3.8 7.1 5.9 13.6 5.9 13.5 10.7 11.2 14.8 8.8 1.1 5.4 2.4 8.7 26.3 8.4 6.0 1.5 4.6 4.1 5.9 9.9 10.3 3.2 3.6 7.6 5.9 5.5 6.3 25.5 10.2 1.5 7.6 4.4 3.0 0.3 3.8 1.5 1.6 20.1 9.1 0.5 3.3 1.1 0.4 0.4 0.4 0.1 0.2 0.1 0.5 0.2 16.0 12.7 0.1 11.1 4.2 6.1 7.5 0.1 0.1 0.2 0.1 12.2 0.2 0.3 0.0 0.0 13.3 0.2 0.1 0.1 2.2 0.1 1.3 0.2 0.3 6.1 0.0 5.2 0.9 9.1 7.2 0.2 0.1 0.5 11.3 0.1 0.1 0.2 1.8 0.2 6.4 7.7 11.9 0.2 1.0 0.2 0.9 1.0 3.9 0.1 0.1 0.3 0.1 0.2 16.3 1.4 13.6 0.6 13.8 0.3 0.2 0.1 3.1 7.4 4.8 1.1 0.4 0.3 0.4 0.2 0.3 0.3 0.3 0.3 3.1 0.5 0.3 0.3 0.8 0.4 0.4 3.3 0.2 0.1 18.1 16.3 24.1 31.8 11.2 14.8 8.7 26.3 5.9 3.0 0.0 0.3 0.0 0.5 4.4 41.5 4.0 0.0 12.0 4.5 0.0 25.5 0.0 0.0 1.5 4.9 2.9 0.0 0.0 0.0 0.0 29.4 1.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 7.1 194.8 2.2 8.5 0.0 0.0 10.8 0.6 0.0 42.1 1.4 57.5 32.3 6.6 0.7 1.5 3.0 0.0 0.0 0.0 0.7 NEK1 "KIAA1901, NY-REN-55" ENSG00000137601 "NIMA related kinase 1" Q96PY6 4 169392857-169612629 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 85.6;Early spermatids: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020873, HPA040413" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Cytosol "Nucleoplasm, Centriolar satellite" "HPA020873: AB_10671583, HPA040413: AB_10671169" "unprognostic (4.10e-2)" "unprognostic (2.97e-1)" "unprognostic (1.59e-2)" "unprognostic (1.97e-1)" "unprognostic (6.98e-2)" "unprognostic (3.10e-1)" "unprognostic (3.95e-1)" "unprognostic (3.29e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (4.06e-3)" "unprognostic (2.21e-1)" "prognostic favorable (1.42e-4)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.10e-2)" "unprognostic (3.46e-1)" 9.6 10.5 13.5 9.2 15.8 6.0 8.7 20.7 14.5 13.6 8.4 12.5 7.1 5.4 12.4 9.1 7.9 15.7 10.2 11.4 13.7 13.2 10.2 6.9 7.7 8.0 15.9 11.3 16.3 6.6 15.3 16.5 7.2 16.0 11.6 7.7 8.9 6.4 10.6 7.1 4.7 5.7 11.1 18.2 8.0 8.1 18.3 14.8 14.7 13.3 6.4 7.4 10.0 8.2 4.5 3.3 6.7 3.3 2.2 5.3 1.3 4.2 1.8 7.8 8.4 12.1 13.5 2.5 8.9 8.0 7.2 6.8 2.4 5.0 11.3 1.7 7.8 6.9 1.4 7.3 7.6 8.2 12.4 5.0 7.6 7.7 2.9 7.1 7.6 6.1 10.8 4.3 7.3 12.8 14.7 7.0 10.9 13.4 21.5 9.2 2.7 9.8 3.4 2.5 2.7 4.5 6.1 5.1 3.6 7.6 5.0 8.5 9.7 6.5 3.2 6.0 6.2 4.0 3.4 8.4 4.6 4.2 4.7 6.0 8.7 13.3 8.6 7.6 3.8 8.0 6.7 2.1 1.8 4.4 3.3 4.8 4.4 3.4 2.7 1.5 4.5 5.1 5.3 1.1 2.2 1.6 3.3 3.2 1.3 13.5 15.8 20.7 12.9 13.7 13.2 15.9 11.3 16.0 14.8 11.9 13.1 13.3 12.5 8.5 20.5 31.9 0.0 85.6 22.7 17.4 27.5 17.5 14.9 8.5 83.6 9.0 5.4 23.3 5.5 6.7 16.2 7.0 17.4 6.6 9.1 17.5 6.9 8.6 6.9 39.7 21.9 8.9 5.0 2.8 5.0 23.4 6.9 4.2 29.7 8.1 24.4 12.9 18.6 59.1 27.4 5.5 24.7 8.6 6.8 9.5 NEK4 "NRK2, pp12301, STK2" ENSG00000114904 "NIMA related kinase 4" P51957 3 52708449-52770949 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 47.7" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 58.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015750, HPA058543" Enhanced Supported Cytosol NA NA Cytosol "HPA015750: AB_1854367, HPA058543: AB_2732623" "unprognostic (1.32e-1)" "unprognostic (1.57e-1)" "prognostic favorable (2.69e-5)" "unprognostic (9.65e-3)" "unprognostic (3.42e-1)" "unprognostic (6.64e-2)" "unprognostic (8.75e-3)" "unprognostic (2.27e-1)" "unprognostic (7.85e-2)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.74e-3)" "unprognostic (5.11e-2)" "unprognostic (2.85e-1)" "unprognostic (1.51e-2)" "unprognostic (8.39e-2)" 7.2 10.7 15.5 9.1 15.7 7.3 11.0 20.2 16.1 10.6 8.4 10.6 9.6 7.6 10.3 10.7 8.1 15.8 7.5 7.4 12.5 14.2 11.6 12.4 7.7 8.8 12.7 8.6 15.8 10.2 13.4 17.6 8.7 11.9 9.4 9.7 9.1 8.5 11.3 10.8 5.3 6.6 9.5 10.7 7.9 11.0 47.7 12.4 11.1 15.5 5.0 10.4 9.3 10.7 5.1 6.4 12.4 11.8 4.6 5.2 5.5 12.9 10.1 13.9 10.9 12.7 9.2 15.1 9.2 12.5 17.3 17.5 8.8 9.7 13.3 4.3 9.0 19.1 6.1 16.9 10.9 23.2 13.3 7.1 10.4 12.3 11.2 7.9 25.4 10.5 5.6 10.1 22.1 14.8 9.2 6.4 11.7 12.9 10.9 10.9 11.1 13.7 9.3 12.0 13.7 10.0 12.0 12.1 9.8 9.8 18.7 10.3 6.1 19.4 11.9 9.1 11.2 11.1 15.3 5.9 11.6 11.8 18.5 17.0 12.2 17.7 13.1 13.3 12.0 12.5 12.4 11.8 5.8 4.6 7.3 5.2 3.6 4.0 4.8 6.4 5.1 4.9 4.2 1.8 4.6 4.8 3.2 3.1 5.5 15.5 15.7 20.2 16.1 12.5 14.2 12.7 8.6 11.9 12.4 11.9 5.1 9.5 4.6 3.7 12.7 3.5 0.0 21.4 15.9 5.2 11.8 6.1 8.3 6.4 16.2 5.3 5.1 0.0 8.4 6.8 4.6 6.5 7.0 13.4 7.2 6.4 4.6 4.9 14.9 16.1 13.6 7.0 1.7 5.4 9.6 16.2 7.8 0.0 11.7 14.6 17.4 6.5 5.9 58.3 31.9 3.6 5.6 5.3 8.2 4.1 NEK6 SID6-1512 ENSG00000119408 "NIMA related kinase 6" Q9HC98 9 124257606-124353307 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 103.8;Hofbauer cells: 99.7;monocytes: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045993, HPA056828" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Cytosol" "Centriolar satellite" "CAB045993: AB_2150651, HPA056828: AB_2683250" "unprognostic (6.27e-2)" "unprognostic (1.02e-2)" "unprognostic (4.15e-2)" "unprognostic (1.65e-2)" "unprognostic (5.22e-2)" "unprognostic (2.47e-2)" "unprognostic (3.13e-3)" "unprognostic (2.13e-2)" "unprognostic (2.38e-1)" "unprognostic (3.30e-2)" "unprognostic (1.38e-3)" "unprognostic (6.53e-2)" "unprognostic (5.03e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (7.66e-4)" "unprognostic (5.27e-2)" "unprognostic (4.77e-3)" 14.8 5.3 26.1 22.2 29.1 12.8 18.8 7.2 21.2 20.5 15.6 13.4 4.3 12.5 9.2 7.5 6.8 8.5 18.4 7.0 17.1 16.6 12.9 51.9 17.0 18.1 19.4 13.3 11.2 20.5 1.6 6.4 21.4 14.7 14.8 16.6 18.5 16.9 13.2 5.5 5.1 18.2 23.4 13.0 11.3 19.0 5.8 12.9 4.0 6.3 1.9 22.0 17.7 10.1 21.9 11.5 29.0 18.8 8.3 3.8 7.6 7.4 12.3 11.9 4.6 22.5 29.4 14.8 9.4 15.1 14.6 12.2 11.6 14.0 9.1 15.1 18.1 33.4 1.4 6.1 27.3 9.9 10.0 5.4 24.9 10.4 20.4 26.9 4.5 62.6 39.1 4.4 13.8 14.3 38.4 15.9 4.3 4.4 0.4 26.0 7.8 0.2 4.9 3.0 39.4 11.2 9.6 8.9 4.6 15.6 2.7 5.3 1.8 3.0 5.8 13.3 12.6 12.7 18.4 31.0 10.7 10.8 7.3 6.4 2.0 2.5 5.2 13.4 10.2 14.1 10.2 18.8 29.0 3.8 12.3 2.4 21.9 2.3 3.2 11.5 9.0 0.4 1.6 23.4 8.3 14.7 10.6 2.8 7.6 26.1 29.1 7.2 21.2 17.1 16.6 19.4 13.3 14.7 12.9 8.9 6.6 9.8 11.0 2.2 0.7 2.5 17.8 1.4 4.5 3.5 0.0 33.9 1.7 35.3 14.7 5.5 12.9 23.3 20.0 103.8 9.9 17.8 21.9 33.3 99.7 0.0 5.8 4.3 10.7 12.3 4.6 30.4 6.8 90.2 15.5 28.1 24.3 15.2 3.5 29.9 1.8 0.0 5.3 1.2 10.6 1.0 30.2 0.0 18.6 8.9 NELFCD "HSPC130, NELF-C, NELF-D, TH1, TH1L" ENSG00000101158 "Negative elongation factor complex member C/D" 20 58981208-58995133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050641, HPA066262, HPA074936" Enhanced Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Vesicles, Cytosol" "HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: " "unprognostic (1.70e-2)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.98e-5)" "unprognostic (6.20e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.47e-1)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.07e-3)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (9.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" 9.1 11.1 10.2 9.4 13.0 8.8 12.7 18.1 13.7 10.2 10.8 15.2 9.2 8.4 11.2 8.2 14.6 12.5 8.6 9.2 10.9 8.2 16.4 15.9 7.9 11.2 16.7 13.4 15.4 10.3 19.1 18.1 12.1 12.5 10.2 8.9 9.4 14.7 9.1 12.0 11.9 8.8 8.1 11.8 9.2 8.9 26.1 12.4 17.4 14.4 10.0 13.6 9.8 11.3 22.7 29.6 9.4 27.7 19.4 24.6 20.5 12.5 14.5 17.4 18.6 6.0 10.7 11.2 10.2 10.0 31.0 18.0 48.0 18.1 16.5 16.1 10.2 16.1 22.0 23.4 25.8 25.1 5.1 16.6 21.8 18.1 37.5 7.2 15.6 15.0 11.3 8.3 11.3 7.9 8.1 17.8 13.4 29.0 12.7 14.1 49.9 33.7 23.6 10.1 39.1 32.2 18.9 14.5 30.7 13.0 19.5 19.2 28.7 31.9 38.5 21.2 10.4 41.5 18.3 7.1 23.9 22.7 9.2 16.9 10.0 18.6 16.9 14.2 13.9 20.6 7.2 20.4 9.4 20.3 22.8 23.9 22.7 19.3 24.6 29.6 20.0 18.9 19.9 2.2 19.4 27.7 15.0 17.6 20.5 10.2 13.0 18.1 13.7 10.9 8.2 16.7 13.4 12.5 12.4 8.9 25.1 37.2 47.8 26.9 66.4 9.8 22.9 12.0 13.6 21.0 39.3 113.3 43.1 46.4 10.6 25.5 19.3 23.3 27.3 56.4 21.7 32.6 16.1 21.3 33.3 52.4 22.4 17.8 14.5 18.1 34.2 21.7 25.3 58.7 19.2 42.7 32.2 14.0 24.8 35.6 57.2 38.8 32.5 57.5 97.9 27.5 86.2 40.8 33.2 48.7 NEMF "FLJ10051, NY-CO-1, SDCCAG1" ENSG00000165525 "Nuclear export mediator factor" O60524 14 49782083-49853203 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004160 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA004160: AB_1079884" "unprognostic (9.92e-2)" "unprognostic (6.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.65e-1)" "unprognostic (9.15e-3)" "unprognostic (7.62e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.50e-1)" "unprognostic (1.12e-1)" "prognostic favorable (2.85e-4)" "unprognostic (3.61e-1)" "unprognostic (2.36e-1)" "unprognostic (8.98e-2)" "unprognostic (1.81e-2)" 13.6 12.2 15.0 14.8 20.9 30.9 12.5 28.0 22.1 15.0 14.4 14.6 14.4 8.1 14.3 12.2 18.2 11.6 11.2 15.0 16.9 15.0 14.6 11.2 11.6 13.4 21.1 17.2 15.2 13.1 26.4 30.9 15.5 27.9 13.9 12.4 10.7 14.8 14.8 17.4 11.5 15.1 13.9 24.8 14.7 13.7 8.4 23.2 17.0 15.7 9.8 14.5 13.5 13.4 36.1 33.0 28.4 21.9 20.3 26.8 7.8 18.8 21.1 20.2 13.4 22.9 18.5 18.1 23.8 15.8 15.7 15.5 10.8 20.3 5.2 18.3 19.6 12.3 27.0 19.0 14.9 25.4 21.0 10.9 20.9 20.1 16.3 13.4 27.3 19.2 16.4 11.0 16.6 15.5 21.3 22.4 12.1 25.8 19.8 21.5 17.3 16.2 9.0 12.1 15.1 21.3 16.8 20.0 11.9 18.6 25.0 13.4 12.5 22.1 23.8 22.1 22.8 20.5 17.8 26.4 23.1 20.3 15.0 16.3 14.1 25.1 22.4 8.6 12.9 20.6 27.6 18.2 20.1 20.5 16.3 19.5 32.8 21.0 19.2 15.2 36.1 24.8 26.8 28.4 20.3 21.9 33.0 17.9 7.8 15.0 20.9 28.0 22.1 16.9 15.0 21.1 17.2 27.9 23.2 38.7 66.5 52.5 59.9 30.6 90.1 88.4 30.6 92.3 58.0 41.8 94.2 66.4 31.5 48.3 7.7 60.9 51.0 23.3 34.1 50.5 56.0 46.7 86.6 27.6 51.0 123.9 51.9 44.2 43.5 8.9 60.9 57.0 23.6 64.1 43.0 55.4 40.2 57.5 63.3 24.8 92.1 71.1 53.6 79.2 54.9 29.7 90.6 62.3 45.2 79.7 NEURL1B "DKFZP761M1511, Neur2, RNF67B" ENSG00000214357 "Neuralized E3 ubiquitin protein ligase 1B" A8MQ27 5 172641266-172691540 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Endothelial cells: 32.6;Enterocytes: 45.0;Ito cells: 36.2;Leydig cells: 50.6;Paneth cells: 33.1;Smooth muscle cells: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 27.6;T-47d: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037612 Approved Supported "Actin filaments,Cytosol" NA Yes Cytosol "Actin filaments" "HPA037612: AB_10795573" "unprognostic (3.56e-2)" "unprognostic (8.46e-2)" "unprognostic (6.72e-3)" "unprognostic (2.70e-1)" "unprognostic (1.64e-1)" "unprognostic (1.55e-1)" "unprognostic (6.58e-2)" "unprognostic (2.95e-1)" "unprognostic (2.86e-1)" "unprognostic (1.09e-1)" "unprognostic (7.13e-3)" "unprognostic (6.81e-2)" "prognostic unfavorable (3.00e-6)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (4.67e-2)" "unprognostic (3.22e-3)" 26.6 11.8 7.5 10.3 3.2 1.5 23.9 0.6 7.0 21.4 17.5 5.6 31.2 5.7 26.7 24.7 14.0 15.8 23.0 19.2 10.7 4.2 7.6 4.4 10.5 7.8 3.1 3.2 20.9 4.8 4.1 6.0 5.1 2.7 20.7 11.6 6.1 4.9 28.4 12.3 14.7 12.1 29.1 1.5 0.6 5.9 6.6 2.8 3.6 7.2 13.9 5.4 16.0 30.8 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.5 2.4 1.3 5.8 0.4 0.2 0.1 5.1 2.3 2.7 4.0 8.7 2.1 0.0 1.4 3.3 3.3 1.3 0.5 2.3 1.8 8.3 0.3 6.2 8.3 0.0 0.4 0.0 1.9 0.0 9.9 0.6 2.7 0.8 0.4 0.9 0.0 2.0 5.8 5.0 1.4 0.1 0.8 2.0 0.2 27.6 6.1 0.9 0.1 1.0 1.0 5.9 4.9 7.8 0.2 2.4 13.0 0.9 0.8 2.0 12.2 1.4 3.2 0.8 0.2 0.0 5.9 0.1 1.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.5 3.2 0.6 7.0 10.7 4.2 3.1 3.2 2.7 2.8 0.0 3.4 0.0 0.6 4.2 0.1 7.8 0.0 8.1 4.5 0.0 0.0 0.2 0.0 0.3 1.9 32.6 45.0 0.0 0.6 0.2 3.5 1.8 0.0 0.5 0.2 0.0 13.4 36.2 2.4 4.1 50.6 1.8 6.8 1.0 12.5 0.7 3.5 33.1 11.7 0.8 0.3 25.8 30.8 2.1 1.5 4.6 0.1 0.0 15.7 0.9 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925485 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;parathyroid gland: 9.0" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 2.2;Ciliated cells: 5.3;Club cells: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 6.7;Karpas-707: 10.8;SiHa: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Yes NA Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: AB_2665984" "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.6 3.0 5.4 0.7 6.2 0.4 1.3 10.2 9.4 1.7 1.9 0.7 1.0 0.6 1.7 0.9 1.8 1.3 0.5 0.3 5.0 6.2 2.4 0.2 0.9 0.5 1.8 5.0 1.7 4.4 9.0 7.5 0.5 1.9 3.2 1.1 1.1 2.5 2.5 0.4 1.8 1.1 2.6 1.2 0.6 1.6 0.9 1.5 0.0 1.5 0.0 0.5 0.7 2.8 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.8 0.0 0.2 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 9.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 6.2 10.2 6.8 5.0 6.2 1.8 5.0 1.9 1.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NF2 "ACN, BANF, merlin, SCH" ENSG00000186575 "Neurofibromin 2" P35240 22 29603556-29698598 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 61.9;Late spermatids: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003097, CAB005385" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB005385: AB_2298548, HPA003097: AB_1079473" "unprognostic (3.27e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.61e-1)" "unprognostic (3.67e-2)" "unprognostic (2.16e-2)" "unprognostic (2.01e-3)" "unprognostic (4.66e-1)" "prognostic favorable (2.89e-5)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (9.62e-2)" 11.8 12.4 23.6 11.1 20.1 10.0 15.4 20.8 28.1 10.8 9.7 9.0 11.8 7.8 10.5 11.3 14.2 11.3 8.0 19.7 26.6 16.4 13.5 11.1 11.9 24.1 18.0 13.5 11.0 12.9 46.8 8.6 6.9 11.4 10.2 8.7 9.5 9.3 15.4 25.7 12.1 8.5 11.9 10.7 10.4 8.8 21.6 10.1 14.9 15.6 11.5 9.9 10.6 10.2 8.5 13.6 6.6 17.3 11.6 15.0 9.8 26.6 10.8 3.8 24.6 7.4 7.4 3.6 21.7 12.2 23.8 20.6 10.6 6.6 7.1 18.0 22.3 16.5 9.5 7.8 12.6 21.3 10.3 6.1 8.4 8.1 7.6 7.9 12.0 10.0 6.8 5.7 16.9 20.6 8.1 16.7 4.6 4.1 6.6 23.1 11.2 7.3 4.8 2.8 6.3 10.2 7.6 20.3 6.8 24.2 12.5 5.8 4.0 12.4 8.4 4.9 4.0 5.4 4.8 31.0 35.5 40.5 15.4 36.6 10.3 8.2 8.5 9.4 4.7 22.6 6.6 9.5 3.6 15.0 13.5 12.8 8.2 11.3 10.1 13.6 8.5 9.8 9.2 2.3 11.6 17.3 9.3 9.4 9.8 23.6 20.1 20.8 28.1 26.6 16.4 18.0 13.5 11.4 10.1 6.0 16.1 9.0 9.6 12.6 16.5 19.9 17.8 6.7 7.9 14.0 9.8 9.9 18.3 42.9 61.9 9.8 8.4 0.0 21.5 6.3 12.6 9.5 23.0 12.5 12.4 28.6 12.6 10.4 10.0 86.8 6.6 7.2 8.5 6.4 7.5 17.3 28.7 15.6 11.7 16.2 8.5 6.5 14.9 21.4 7.2 12.5 3.2 10.9 9.8 8.6 NFAT5 "KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP" ENSG00000102908 "Nuclear factor of activated T cells 5" O94916 16 69565094-69704666 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057304, HPA069711" Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA057304: AB_2683407, HPA069711: AB_2686180" "unprognostic (2.71e-1)" "unprognostic (1.50e-2)" "unprognostic (1.77e-1)" "unprognostic (3.57e-2)" "unprognostic (5.65e-3)" "unprognostic (2.08e-1)" "unprognostic (2.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" "unprognostic (3.56e-2)" "unprognostic (4.05e-3)" "unprognostic (1.87e-1)" "prognostic favorable (1.08e-4)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (6.32e-2)" "unprognostic (9.42e-2)" 15.4 19.1 19.0 17.0 17.1 25.1 15.8 22.4 18.0 19.3 11.9 11.9 12.5 7.7 18.7 19.5 15.7 15.0 11.7 11.6 15.6 8.2 15.7 10.2 15.6 10.5 13.0 12.7 15.6 13.8 35.6 24.2 30.8 13.1 14.7 12.8 13.9 20.1 15.6 12.1 26.5 14.0 12.5 10.5 11.6 12.0 10.1 14.4 10.3 21.9 7.7 10.8 19.6 30.4 2.1 2.9 5.5 4.6 1.1 2.6 0.5 11.1 14.6 7.2 8.9 10.8 13.1 7.9 11.6 13.9 12.3 9.0 11.0 9.2 5.1 6.9 14.0 4.9 9.7 6.4 6.6 13.0 2.9 2.5 4.0 5.3 13.5 8.8 3.9 7.6 9.1 4.5 9.3 11.4 10.2 12.0 3.0 7.8 2.7 11.4 4.9 3.0 5.7 4.2 2.3 1.7 5.3 3.2 2.8 11.8 19.2 3.9 2.4 25.0 2.7 6.9 9.2 5.5 3.1 14.9 10.8 6.6 5.8 3.9 5.9 4.5 8.9 7.2 3.4 6.4 3.5 1.3 1.4 2.2 0.8 1.6 2.1 1.1 2.6 0.6 1.9 0.9 0.8 5.5 1.1 4.6 2.9 1.6 0.5 19.0 17.1 22.4 18.0 15.6 8.2 13.0 12.7 13.1 14.4 44.7 38.8 29.6 89.1 131.5 50.5 7.8 35.7 17.4 37.5 137.9 80.5 49.6 5.0 15.7 6.5 62.4 23.8 0.0 11.1 13.9 39.1 74.1 19.6 23.1 15.6 57.2 23.5 47.3 21.8 4.7 55.0 41.6 55.6 38.7 30.3 54.8 18.7 24.6 51.6 7.0 64.7 25.8 65.5 64.9 26.2 122.5 42.6 32.0 18.1 90.9 NFATC2 "NF-ATP, NFAT1, NFATp" ENSG00000101096 "Nuclear factor of activated T cells 2" Q13469 20 51386957-51562831 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.6" "Cell type enhanced" "Detected in many" 8 "Melanocytes: 59.1;T-cells: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 14.4;HMC-1: 16.6;WM-115: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA008789, CAB018567, HPA024369" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413" "unprognostic (2.69e-3)" "unprognostic (2.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.15e-1)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (4.05e-2)" "unprognostic (9.26e-2)" "unprognostic (3.74e-3)" "unprognostic (2.17e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.57e-4)" "unprognostic (9.25e-2)" "unprognostic (1.02e-1)" "unprognostic (1.05e-2)" "unprognostic (6.59e-2)" 8.6 2.4 4.1 44.6 8.2 4.4 9.8 1.1 5.1 8.4 7.8 6.8 3.9 8.4 7.0 7.6 4.0 5.6 19.4 8.5 4.1 3.3 3.4 6.7 6.1 25.2 8.4 0.7 5.0 8.7 3.9 3.7 8.1 10.4 5.4 4.1 6.2 7.9 7.2 5.4 7.0 11.7 5.9 6.5 16.0 11.0 4.5 6.5 8.6 7.0 13.2 18.7 4.5 4.9 1.6 1.7 3.8 0.7 7.6 7.7 1.6 1.6 1.7 0.0 2.2 0.0 0.0 4.6 0.2 1.1 0.7 0.3 8.3 1.5 11.1 1.3 0.5 1.6 0.0 0.5 0.0 0.6 14.4 0.2 4.7 1.2 2.1 0.0 1.3 16.6 0.0 0.0 0.6 0.0 0.1 5.1 3.9 4.6 7.4 0.0 1.8 1.9 7.8 0.1 1.0 4.0 0.8 0.0 4.9 0.3 0.0 0.1 0.0 5.2 1.3 12.1 1.1 2.0 3.1 0.5 1.0 1.9 2.5 0.1 6.3 4.1 11.5 1.1 5.2 25.0 0.3 0.0 3.8 7.7 0.7 3.2 1.6 4.3 6.1 1.7 1.6 2.4 4.4 0.2 7.6 0.2 0.6 2.3 1.6 4.1 8.2 1.1 5.1 4.1 3.3 8.4 0.7 10.4 6.5 6.0 4.8 3.9 10.4 12.8 0.0 2.8 5.1 10.7 9.1 0.0 0.0 2.4 1.7 3.6 1.5 16.9 1.1 0.0 4.9 0.5 28.2 7.4 15.0 6.0 28.1 0.0 7.5 9.2 21.2 0.4 2.0 16.7 59.1 3.6 6.2 0.0 8.0 0.0 0.4 0.2 0.0 0.0 12.2 0.5 0.9 11.3 0.8 40.6 7.1 5.6 NFATC3 "NFAT4, NFATX" ENSG00000072736 "Nuclear factor of activated T cells 3" Q12968 16 68084751-68229259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 129.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050665 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA050665: AB_2681210" "unprognostic (1.19e-1)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.25e-3)" "unprognostic (6.41e-2)" "unprognostic (1.28e-2)" "unprognostic (7.28e-3)" "unprognostic (2.97e-1)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.93e-2)" "unprognostic (9.07e-3)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (4.04e-2)" "unprognostic (1.30e-1)" 9.6 6.8 4.3 16.0 6.6 12.0 7.8 7.5 5.8 9.8 11.0 9.7 7.6 7.1 12.2 6.5 7.7 8.3 7.6 7.0 4.7 4.0 8.2 12.1 11.3 14.2 8.7 3.5 10.0 7.0 18.7 6.8 6.6 5.1 10.5 6.1 11.1 7.9 7.6 27.1 14.0 12.0 9.0 6.7 12.3 6.2 25.9 5.8 129.5 11.0 8.1 16.0 10.2 14.1 6.7 3.1 12.0 7.1 13.4 15.6 9.0 4.9 5.9 9.5 10.5 8.6 5.5 8.8 3.3 4.1 9.2 8.1 8.6 4.4 16.8 5.0 5.4 3.0 7.5 11.9 5.6 9.1 3.4 7.7 16.5 6.2 19.2 5.7 14.7 43.4 4.1 7.2 9.3 5.1 4.8 7.8 13.8 21.2 4.8 6.8 10.1 22.7 20.1 6.2 7.7 3.2 12.9 9.2 17.3 4.0 5.8 7.2 7.8 24.5 6.2 3.1 6.1 8.5 11.2 4.9 4.7 5.1 5.5 4.8 6.6 11.4 30.5 3.7 13.7 6.6 12.0 2.4 5.3 15.6 3.7 14.8 5.2 8.9 15.2 2.9 6.7 9.1 14.0 3.3 13.4 7.1 3.1 6.0 9.0 4.3 6.6 7.5 5.8 4.7 4.0 8.7 3.5 5.1 5.8 32.8 43.8 26.5 36.2 69.6 25.5 1.2 58.6 28.1 20.5 55.8 31.4 42.2 19.9 24.1 115.7 21.0 23.8 23.3 19.3 12.6 19.4 42.3 47.4 89.3 20.8 35.0 25.0 35.6 50.9 81.4 20.1 25.0 21.9 16.2 39.9 8.2 24.8 38.6 25.1 33.5 23.7 19.4 17.8 57.1 69.8 125.2 71.1 59.3 49.1 48.0 NFATC4 NFAT3 ENSG00000100968 "Nuclear factor of activated T cells 4" Q14934 14 24365673-24379604 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 22.4;Leydig cells: 16.1;Sertoli cells: 25.8;Smooth muscle cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 19.3;BJ hTERT+: 24.9;hTERT-RPE1: 21.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA031641, CAB032859, HPA076526" Uncertain Supported "Nuclear speckles,Cytosol" No No "Nuclear speckles, Cytosol" "CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: AB_2686805" "unprognostic (3.51e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (8.08e-2)" "unprognostic (1.67e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (1.81e-6)" "unprognostic (1.47e-2)" "unprognostic (1.07e-1)" "unprognostic (1.35e-1)" "unprognostic (4.19e-2)" 9.0 11.3 4.3 5.5 6.7 0.4 10.9 4.2 5.1 28.2 14.0 3.3 8.9 3.4 19.0 11.4 9.1 13.8 21.6 7.8 4.9 1.3 6.4 0.9 5.6 3.3 8.0 4.1 33.1 2.7 8.4 8.6 14.0 6.3 14.8 3.9 9.3 4.0 13.5 4.6 6.9 5.9 20.9 2.8 4.2 7.7 9.6 3.1 1.5 11.0 5.9 5.8 22.3 14.7 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 13.2 19.3 0.0 8.6 24.9 11.7 10.3 0.0 7.2 7.3 0.2 12.4 0.8 0.0 3.5 0.1 7.1 0.0 0.3 5.6 9.0 0.0 6.4 0.0 0.0 13.9 0.1 7.1 0.0 21.8 9.1 2.3 1.8 0.0 2.2 0.4 0.0 0.8 1.1 0.5 0.0 0.5 0.8 0.9 0.0 0.1 1.5 6.1 0.0 1.7 2.8 4.6 5.2 2.2 5.2 10.9 2.3 10.2 0.0 5.3 0.7 5.1 2.2 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 6.7 4.2 5.1 4.9 1.3 8.0 4.1 6.3 3.1 3.0 7.2 0.8 1.0 3.9 0.4 5.2 0.0 0.0 5.7 0.0 0.0 0.4 0.0 1.8 2.4 3.8 0.4 0.0 0.2 0.5 22.4 0.6 0.0 0.0 0.6 0.0 7.5 1.8 0.0 4.0 16.1 0.0 6.8 0.0 4.7 11.3 0.8 0.0 7.1 0.0 1.6 25.8 25.5 13.4 2.2 3.0 0.5 0.0 1.3 2.1 NFE2L1 "FLJ00380, LCR-F1, NRF1, TCF11" ENSG00000082641 "Nuclear factor, erythroid 2 like 1" Q14494 17 48048329-48061487 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 194.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 262.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063384, HPA065424" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA063384: AB_2684998, HPA065424: AB_2685488" "unprognostic (3.19e-1)" "unprognostic (2.41e-1)" "unprognostic (5.44e-2)" "prognostic favorable (8.20e-5)" "unprognostic (5.25e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (5.20e-2)" "unprognostic (5.58e-2)" "unprognostic (9.30e-2)" "unprognostic (2.61e-1)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic favorable (5.79e-6)" "unprognostic (2.20e-1)" "unprognostic (4.09e-2)" "unprognostic (6.19e-3)" "unprognostic (2.01e-2)" 24.2 25.7 15.5 13.1 15.5 4.6 50.3 9.1 19.8 18.8 17.5 17.4 32.3 17.4 31.4 30.5 21.4 22.7 16.3 85.5 18.2 19.2 27.9 18.4 13.9 12.6 21.7 21.2 26.2 11.1 16.6 16.3 16.6 25.0 16.5 13.6 22.6 17.7 26.1 194.7 19.9 18.3 24.3 27.5 17.7 13.9 18.8 16.5 5.8 22.4 58.9 10.7 17.3 24.2 4.1 9.4 19.7 9.4 2.1 2.6 0.9 19.2 43.0 28.2 23.8 59.2 28.9 21.2 31.5 43.8 22.4 25.0 52.4 22.3 22.2 64.0 39.7 29.1 40.1 19.9 25.1 24.1 38.0 16.6 12.5 29.1 17.5 70.3 27.8 20.2 39.4 62.8 40.7 45.8 37.5 34.9 15.0 22.1 61.6 27.5 16.5 17.6 8.7 18.2 17.4 16.4 12.5 39.9 21.1 24.7 28.9 17.4 26.3 21.5 14.5 44.4 38.3 28.6 19.1 46.7 54.9 23.8 18.5 31.5 103.1 69.0 20.8 52.1 11.8 31.1 7.9 9.4 2.7 2.6 4.8 1.5 3.8 2.5 2.6 1.9 4.1 1.9 2.1 19.7 2.1 5.6 9.4 0.9 0.9 15.5 15.5 9.1 19.8 18.2 19.2 21.7 21.2 25.0 16.5 53.6 49.6 9.7 17.8 49.5 67.0 262.2 61.1 40.2 31.8 73.3 33.4 18.6 21.6 36.9 6.0 55.4 91.6 0.0 31.5 17.7 25.0 31.4 26.7 111.7 30.3 68.3 28.9 55.9 33.7 7.9 94.6 19.5 20.3 41.5 46.8 24.4 46.3 54.1 78.8 38.4 33.8 58.2 41.2 22.3 20.4 42.3 18.7 14.4 38.2 19.7 NFE2L2 NRF2 ENSG00000116044 "Nuclear factor, erythroid 2 like 2" Q16236 2 177227595-177392697 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002990, CAB020317, HPA043438" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB020317: , HPA002990: AB_1079476, HPA043438: AB_2678482" "unprognostic (2.11e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.41e-1)" "unprognostic (5.95e-2)" "unprognostic (3.90e-1)" "unprognostic (5.27e-2)" "unprognostic (9.58e-2)" "unprognostic (3.48e-2)" "unprognostic (9.86e-2)" "unprognostic (4.86e-2)" "unprognostic (1.83e-1)" "prognostic favorable (2.26e-4)" "unprognostic (1.97e-2)" "unprognostic (1.61e-1)" "unprognostic (1.26e-1)" "unprognostic (9.77e-3)" 30.9 24.4 25.4 19.3 34.7 15.0 24.6 36.4 29.7 31.7 28.3 25.8 22.2 28.1 27.7 30.9 82.5 27.0 28.9 32.3 28.0 16.9 44.8 49.3 29.0 19.7 49.0 18.7 53.1 16.3 21.7 52.5 29.4 33.5 39.0 25.4 21.7 34.7 28.1 25.9 48.1 29.2 42.1 42.7 26.8 45.9 21.9 41.6 21.1 49.5 35.8 25.5 43.7 47.1 23.5 41.1 42.4 35.6 25.8 43.2 22.6 10.6 12.3 11.2 12.0 37.8 40.8 12.8 18.2 25.3 16.6 18.8 16.2 20.4 10.5 19.8 20.6 31.6 19.8 13.1 27.7 23.3 8.1 8.0 13.5 21.6 31.6 48.4 8.0 12.8 28.1 65.2 23.6 35.1 39.4 16.4 8.3 14.0 20.6 22.8 10.6 8.1 21.1 12.2 55.2 11.6 6.7 9.8 10.6 25.4 40.1 14.6 9.5 41.2 13.3 43.1 33.7 10.3 21.6 24.7 17.2 11.5 19.1 11.1 14.5 8.7 8.8 17.2 8.9 33.0 42.4 35.6 21.4 23.0 34.1 26.6 23.5 26.9 23.6 41.1 19.9 43.2 28.2 39.9 25.8 31.9 15.5 25.0 22.6 25.4 34.7 36.4 29.7 28.0 16.9 49.0 18.7 33.5 41.6 145.9 85.8 49.5 216.1 262.7 59.6 57.4 96.8 143.2 127.4 146.5 15.7 88.4 333.2 126.2 58.6 116.1 96.6 0.0 147.7 27.7 204.6 118.5 212.0 76.9 78.0 54.0 72.6 97.6 100.1 19.8 266.3 164.9 91.1 213.8 57.7 176.6 122.9 89.2 201.2 56.4 47.1 38.8 169.0 50.5 33.8 275.8 155.7 62.3 90.2 201.5 NFKB1 "KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50" ENSG00000109320 "Nuclear factor kappa B subunit 1" P19838 4 102501329-102617302 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "monocytes: 303.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004031, HPA027305" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004031: AB_330564, HPA027305: AB_1854429" "unprognostic (1.06e-1)" "unprognostic (1.61e-2)" "unprognostic (4.37e-2)" "unprognostic (2.38e-2)" "unprognostic (1.60e-1)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (8.98e-2)" "unprognostic (1.96e-1)" "unprognostic (9.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.71e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.84e-2)" "unprognostic (6.75e-3)" "unprognostic (1.74e-1)" "unprognostic (6.92e-3)" 19.8 14.7 8.2 37.7 12.0 44.5 26.6 12.4 10.3 18.2 17.1 10.4 10.4 10.7 17.5 11.2 20.5 16.4 20.3 14.5 7.5 5.1 13.2 15.8 26.9 46.0 11.4 4.8 17.5 14.3 10.2 8.7 13.7 10.0 18.8 14.6 10.8 17.7 13.5 17.1 19.6 16.7 16.0 10.1 30.0 14.6 9.3 12.5 37.5 14.7 16.3 26.7 18.4 22.7 5.8 10.4 5.5 7.1 14.3 10.6 3.5 17.1 9.7 5.2 7.9 16.2 14.6 6.4 9.9 29.1 12.3 12.5 10.7 24.6 28.1 8.9 15.5 17.8 13.7 10.3 17.2 16.9 25.3 6.1 11.9 7.8 11.5 15.1 21.2 25.4 12.0 12.1 11.9 16.6 8.9 15.4 9.4 11.6 20.6 8.8 12.1 1.8 11.7 3.1 12.7 8.9 15.0 12.4 12.7 11.5 24.2 3.6 5.9 18.1 25.3 9.9 5.2 5.1 15.9 19.7 16.7 8.7 9.0 13.8 9.1 6.3 27.3 10.7 10.9 23.6 5.2 5.4 4.9 3.4 7.1 6.0 5.6 8.4 5.6 10.4 5.8 10.6 8.9 5.5 14.3 5.9 7.4 4.5 3.5 8.2 12.0 12.4 10.3 7.5 5.1 11.4 4.8 10.0 12.5 38.7 46.7 27.4 82.1 147.0 6.7 16.5 12.7 24.1 36.4 19.2 5.9 12.5 3.3 25.5 3.8 30.8 32.3 0.0 31.9 14.4 46.3 57.3 111.6 20.3 23.2 19.1 32.2 22.7 57.1 0.9 22.2 56.9 52.3 303.0 36.5 10.3 40.0 26.9 32.5 21.4 6.5 0.0 61.7 2.1 6.6 131.4 11.9 22.4 32.1 74.8 NFKB2 "LYT-10, NF-kB2, p105, p49/p100, p52" ENSG00000077150 "Nuclear factor kappa B subunit 2" Q00653 10 102394110-102402529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5;Karpas-707: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008422, CAB022098, HPA023900" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435" "unprognostic (1.10e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.86e-4)" "unprognostic (1.53e-2)" "unprognostic (8.08e-3)" "unprognostic (2.15e-1)" "unprognostic (2.38e-3)" "unprognostic (3.98e-2)" "prognostic favorable (8.45e-5)" "unprognostic (4.04e-1)" "unprognostic (8.34e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (6.69e-12)" "unprognostic (2.37e-3)" "unprognostic (1.63e-1)" "unprognostic (4.90e-2)" "unprognostic (1.56e-1)" 14.9 10.8 5.6 43.6 7.1 40.6 18.7 2.0 4.9 12.5 20.1 4.2 9.4 11.3 18.8 11.0 12.9 10.8 20.4 10.9 4.6 2.5 15.5 14.5 20.6 34.2 6.6 2.5 15.1 17.4 5.2 6.3 12.8 7.9 19.6 5.2 7.3 16.7 15.1 13.6 10.4 14.1 24.0 7.7 28.0 13.1 6.6 5.8 19.5 11.5 14.8 39.2 21.9 24.4 5.2 1.4 7.5 3.4 1.3 2.0 0.9 21.4 13.4 2.7 10.7 3.3 5.1 6.4 6.1 19.6 6.2 9.0 8.0 17.6 9.9 15.3 3.7 15.5 13.0 6.1 8.4 2.5 50.5 3.6 2.5 3.2 4.6 9.4 1.6 14.4 7.0 4.1 10.4 10.3 8.6 2.2 5.2 2.3 55.2 2.4 7.3 2.5 6.7 3.4 4.7 4.8 5.4 7.4 7.8 10.5 6.3 0.5 3.0 5.0 12.2 8.6 2.9 9.4 4.8 6.4 6.5 9.5 9.1 16.3 36.5 33.8 10.4 10.6 4.2 3.4 0.3 2.4 0.1 1.4 1.5 1.4 5.2 1.7 1.5 1.4 4.5 1.8 1.5 7.5 1.3 3.4 0.9 2.0 0.9 5.6 7.1 2.0 4.9 4.6 2.5 6.6 2.5 7.9 5.8 8.9 9.1 51.9 51.4 38.6 1.9 2.2 17.8 1.4 18.2 17.4 15.7 4.7 5.0 29.4 1.1 15.8 40.4 0.0 18.1 14.3 9.4 46.1 72.5 3.4 19.0 0.0 15.6 9.8 13.8 0.9 6.9 24.3 28.7 115.4 13.1 4.9 35.6 14.0 4.6 9.2 5.1 0.0 25.6 1.7 10.2 39.0 19.3 24.9 10.6 38.3 NFKBIA "IkappaBalpha, IKBA, MAD-3, NFKBI" ENSG00000100906 "NFKB inhibitor alpha" P25963 14 35401511-35404749 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 209.1" "Cell type enhanced" "Detected in all" 8 "Basal keratinocytes: 3603.5;Suprabasal keratinocytes: 2990.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003815, HPA029207" Approved Enhanced Cytosol NA NA Cytosol "CAB003815: AB_344886, HPA029207: AB_10603122" "prognostic favorable (1.33e-5)" "unprognostic (3.39e-1)" "unprognostic (7.29e-2)" "unprognostic (7.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.46e-1)" "unprognostic (2.39e-1)" "unprognostic (2.46e-1)" "unprognostic (2.46e-1)" "unprognostic (7.19e-2)" "unprognostic (2.32e-2)" "unprognostic (3.69e-1)" "unprognostic (4.44e-2)" "unprognostic (9.74e-2)" "unprognostic (3.80e-2)" 49.0 38.5 14.9 63.7 25.7 209.1 60.8 16.1 27.8 33.8 32.8 10.3 36.7 13.5 21.3 15.6 50.4 30.5 34.3 30.9 18.8 10.5 30.6 45.1 73.0 47.7 29.7 7.8 57.4 22.1 6.5 25.3 25.5 21.8 28.7 18.6 19.5 44.2 64.6 33.1 48.2 42.3 24.9 23.0 47.4 26.1 19.6 23.9 35.0 27.8 46.2 38.1 41.8 45.2 45.3 55.0 118.2 58.3 33.2 37.3 51.7 13.1 11.7 4.4 4.0 26.1 17.4 15.8 5.5 52.8 11.9 10.6 3.6 8.0 8.0 14.7 8.7 28.0 17.4 8.4 22.8 17.1 48.5 3.2 3.9 8.4 21.5 15.6 6.2 3.3 18.9 23.0 8.1 20.7 7.9 10.7 4.0 3.3 12.9 8.4 15.5 8.2 15.0 4.1 12.8 7.2 18.6 5.1 6.6 20.4 84.8 4.0 6.9 14.6 25.7 6.1 9.6 14.6 13.3 19.9 16.4 5.9 4.7 8.8 15.8 16.0 13.6 13.7 4.7 3.3 35.8 58.3 36.6 24.2 33.4 37.3 34.0 29.3 25.4 55.0 45.3 25.6 21.7 118.2 33.2 22.1 29.7 19.5 51.7 14.9 25.7 16.1 27.8 18.8 10.5 29.7 7.8 21.8 23.9 497.3 711.4 171.6 1047.5 3603.5 25.1 132.1 298.1 131.2 346.9 59.3 11.8 146.4 165.8 692.3 3.4 543.9 448.5 23.3 344.2 134.5 404.0 1015.6 876.2 131.0 760.7 46.1 195.3 279.9 370.8 7.2 141.8 871.3 1029.1 602.3 143.8 87.6 391.8 259.6 109.3 89.7 34.8 200.5 1642.1 2.8 10.7 2990.0 552.0 370.7 198.2 907.4 NFKBIB "IKBB, TRIP9" ENSG00000104825 "NFKB inhibitor beta" Q15653 19 38899700-38908893 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.2" "Group enriched" "Detected in all" 13 "Early spermatids: 932.5;Late spermatids: 859.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063734 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA063734: AB_2685107" "unprognostic (2.73e-1)" "unprognostic (3.24e-1)" "unprognostic (2.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.42e-1)" "unprognostic (4.35e-2)" "unprognostic (1.72e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-1)" "unprognostic (8.84e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.19e-2)" "unprognostic (4.35e-1)" "unprognostic (2.08e-1)" "unprognostic (3.50e-3)" 7.9 7.1 7.0 12.5 9.8 22.0 6.8 2.9 7.3 3.9 7.6 8.1 7.6 10.8 5.8 5.7 8.6 5.1 7.6 7.1 7.3 5.8 7.9 14.6 6.7 8.7 11.2 5.2 4.3 9.7 4.0 3.9 7.2 7.2 5.0 3.6 5.1 8.6 6.6 13.9 8.0 11.7 5.1 9.9 9.2 12.4 80.2 9.3 6.0 6.6 8.7 8.7 6.6 5.1 3.8 5.4 12.4 5.8 8.7 7.2 2.9 8.1 10.2 1.5 3.6 1.5 0.9 4.8 5.5 2.2 3.0 3.4 7.2 4.4 9.0 6.2 1.2 2.8 4.5 3.8 2.7 0.9 27.5 4.9 6.0 1.9 4.1 5.3 6.9 12.8 1.2 3.0 3.3 4.2 0.8 1.6 6.7 7.0 8.3 1.1 5.3 8.5 6.8 5.1 6.9 4.2 12.0 6.3 8.2 1.4 3.2 8.9 5.3 3.5 5.1 3.9 0.9 3.0 5.9 3.9 5.1 6.5 8.7 8.4 17.3 15.3 19.2 3.3 7.2 6.2 1.5 4.3 12.4 5.3 5.8 4.1 3.6 3.1 4.5 3.8 3.8 2.3 3.4 9.0 8.7 4.7 5.4 7.2 2.9 7.0 9.8 2.9 7.3 7.3 5.8 11.2 5.2 7.2 9.3 8.9 22.4 22.8 35.7 28.0 10.9 6.5 10.2 4.0 11.4 12.2 3.9 24.4 6.6 26.6 932.5 20.4 53.1 23.3 27.0 21.6 13.5 31.8 66.8 18.7 21.9 23.8 21.2 8.0 14.6 859.8 12.7 18.6 16.9 37.9 17.0 13.0 38.2 17.5 14.2 19.2 11.5 19.4 18.9 20.1 14.9 21.1 49.4 29.9 18.2 31.5 NFKBID "IkappaBNS, TA-NFKBH" ENSG00000167604 "NFKB inhibitor delta" Q8NI38 19 35887653-35902303 "Predicted intracellular proteins, Transcription factors" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.0" "Cell type enhanced" "Detected in many" 9 "granulocytes: 91.9;Macrophages: 54.1;monocytes: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054778 Uncertain "Nuclear bodies,Plasma membrane,Cytosol" NA NA Cytosol "Nuclear bodies, Plasma membrane" "HPA054778: " "prognostic favorable (6.01e-4)" "unprognostic (9.60e-2)" "unprognostic (1.00e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-2)" "prognostic favorable (5.43e-4)" "unprognostic (4.21e-2)" "unprognostic (7.68e-2)" "unprognostic (3.83e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (5.64e-2)" "unprognostic (6.83e-2)" "unprognostic (1.04e-1)" "unprognostic (5.21e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.34e-6)" 4.1 2.8 0.9 13.5 2.5 21.0 7.0 4.5 2.4 1.9 2.1 4.4 0.9 1.9 2.3 2.7 3.0 3.7 6.9 2.1 0.7 1.1 3.4 1.8 11.4 9.1 2.3 0.4 4.3 3.5 1.9 5.5 1.6 2.0 2.6 1.5 2.7 2.3 3.4 0.9 3.6 4.8 5.1 2.4 6.8 2.8 1.5 1.1 14.4 5.1 1.0 14.7 2.8 7.4 9.4 1.9 4.8 1.6 2.0 2.3 0.6 4.7 4.4 0.9 3.0 0.6 0.7 2.1 3.0 3.5 3.2 2.3 1.0 3.9 5.8 2.3 3.1 2.8 2.5 3.1 2.3 1.3 3.3 0.6 3.5 6.2 1.1 0.8 3.0 10.5 1.0 1.6 5.9 1.5 0.8 1.1 2.7 0.7 3.6 0.7 3.7 2.5 3.6 1.3 0.9 0.9 1.3 0.7 1.2 2.8 2.0 1.6 1.2 4.0 3.1 0.3 0.8 1.4 3.0 1.2 5.0 4.5 2.2 2.0 2.5 0.9 6.8 2.7 7.1 0.7 0.0 1.4 2.5 2.3 0.9 1.7 5.4 1.0 1.8 1.4 9.4 1.7 1.0 4.8 2.0 1.6 1.9 2.2 0.6 0.9 2.5 4.5 2.4 0.7 1.1 2.3 0.4 2.0 1.1 0.0 13.7 34.0 7.1 26.4 8.1 0.8 5.1 4.0 2.3 1.8 19.6 1.1 0.0 2.3 0.0 8.7 2.9 0.0 0.9 2.2 15.4 12.3 91.9 0.0 32.9 0.0 2.9 2.5 30.8 0.0 1.1 54.1 18.6 51.3 2.6 1.1 2.7 2.5 1.8 0.9 9.7 0.0 9.5 0.5 0.5 29.2 0.8 15.2 4.8 7.9 NFKBIE IKBE ENSG00000146232 "NFKB inhibitor epsilon" O00221 6 44258166-44265788 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 85.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002692, HPA005941, CAB010272" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478" "prognostic favorable (1.72e-5)" "unprognostic (1.43e-1)" "unprognostic (1.39e-2)" "unprognostic (2.37e-2)" "unprognostic (6.32e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (4.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-2)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (1.37e-6)" "unprognostic (2.61e-2)" "unprognostic (8.83e-2)" "unprognostic (1.37e-2)" "prognostic favorable (8.07e-4)" 5.8 5.2 7.6 24.6 5.4 24.0 5.2 9.4 7.8 3.7 8.0 4.2 3.2 6.7 4.7 5.5 6.9 3.0 9.8 4.6 7.9 5.5 11.5 8.7 15.9 17.1 6.0 4.1 6.1 7.1 3.5 4.1 6.0 4.8 7.1 5.9 3.6 7.7 4.1 3.7 7.4 9.5 3.6 5.0 29.6 6.3 7.9 3.7 14.5 5.5 4.6 22.7 6.7 6.7 8.1 8.2 7.1 10.2 0.8 3.5 1.6 13.9 3.5 4.9 7.7 1.9 1.4 2.6 2.5 12.2 7.7 8.1 7.5 6.6 7.5 8.9 2.5 20.7 3.0 5.2 7.8 8.7 12.9 2.9 3.9 1.5 8.4 6.0 12.8 11.8 3.7 3.4 7.1 4.4 6.5 5.2 3.6 3.6 20.2 1.9 7.1 2.5 26.1 2.6 22.0 1.9 4.7 4.4 6.9 17.7 15.2 3.1 4.0 1.7 6.4 10.1 4.3 4.4 15.0 9.1 4.4 5.1 2.7 7.7 12.9 5.4 13.9 3.9 14.2 8.2 7.1 8.1 3.8 1.8 9.4 3.5 8.1 2.4 1.6 6.8 7.3 1.1 1.7 3.2 0.8 10.2 8.2 3.0 1.6 7.6 5.4 9.4 7.8 7.9 5.5 6.0 4.1 4.8 3.7 0.0 11.9 25.1 19.3 34.0 3.3 3.4 15.3 0.0 3.4 3.5 2.0 4.3 14.9 42.8 13.7 8.7 11.0 0.0 18.4 6.2 6.8 25.5 33.3 1.6 52.3 3.2 14.3 4.9 17.8 25.0 1.7 66.3 45.5 85.6 7.0 2.6 39.6 24.6 2.5 10.3 4.0 6.5 16.9 21.4 8.7 34.4 4.5 9.6 6.6 32.1 NFS1 "IscS, NifS" ENSG00000244005 "NFS1, cysteine desulfurase" Q9Y697 20 35668055-35699359 "Enzymes, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB034314, HPA051801, HPA054755" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594" "unprognostic (1.72e-1)" "unprognostic (2.96e-1)" "unprognostic (1.27e-2)" "unprognostic (5.88e-3)" "unprognostic (1.05e-1)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (2.02e-1)" "unprognostic (9.00e-2)" "unprognostic (1.73e-1)" "unprognostic (6.52e-3)" "unprognostic (3.93e-2)" "prognostic favorable (4.72e-6)" "unprognostic (2.33e-2)" "unprognostic (1.97e-1)" "unprognostic (1.64e-2)" "unprognostic (5.54e-2)" 10.2 28.0 16.9 6.7 19.3 3.7 9.7 15.3 20.8 11.2 11.7 12.0 10.0 11.0 8.4 9.9 10.1 11.7 9.9 19.2 14.6 14.0 36.9 33.0 7.8 7.0 16.5 15.5 12.5 14.0 20.7 14.8 7.8 14.3 9.5 13.0 12.2 12.6 12.2 19.7 9.5 9.6 10.1 12.4 6.6 10.3 25.3 15.8 4.9 10.2 8.4 10.4 8.1 7.7 10.4 11.2 7.4 8.1 12.8 11.4 6.1 13.2 16.5 5.8 6.1 15.8 14.5 11.7 10.1 10.8 15.4 10.0 29.8 7.6 11.3 20.0 9.4 15.7 16.8 19.7 20.5 13.9 5.0 9.3 24.2 17.7 23.1 13.2 10.2 4.7 11.6 19.6 12.0 13.2 11.4 11.4 13.4 17.2 7.6 10.7 20.3 11.4 10.7 6.6 30.4 24.9 4.5 18.8 19.0 15.6 9.0 7.3 6.6 25.3 24.6 16.5 14.2 21.9 9.1 8.3 17.4 8.3 10.1 9.9 11.0 15.1 10.4 14.7 11.1 8.5 2.5 8.1 7.4 7.6 7.7 9.7 10.4 8.8 11.2 11.2 7.6 10.3 9.3 3.4 12.8 6.0 5.6 11.4 6.1 16.9 19.3 15.3 20.8 14.6 14.0 16.5 15.5 14.3 15.8 6.0 16.7 9.7 7.5 5.5 12.2 19.3 20.4 2.7 6.8 17.4 9.8 28.1 28.2 13.8 4.2 5.7 12.1 0.0 9.8 17.9 7.5 4.8 6.9 24.1 14.2 14.3 6.4 8.0 8.9 3.4 5.2 8.5 10.1 15.4 7.8 14.5 9.3 9.9 9.9 41.3 11.8 12.9 8.7 36.8 17.8 5.0 17.6 9.6 13.4 5.0 NFU1 "CGI-33, HIRIP5, NifU, NIFUC" ENSG00000169599 "NFU1 iron-sulfur cluster scaffold" Q9UMS0 2 69395750-69437628 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035826 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035826: AB_2674803" "unprognostic (4.49e-3)" "unprognostic (5.62e-2)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (2.81e-1)" "unprognostic (2.16e-3)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.31e-1)" "unprognostic (2.12e-1)" "unprognostic (2.21e-3)" "unprognostic (2.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.87e-1)" 32.3 26.0 24.9 14.7 23.5 14.9 59.9 19.7 40.4 14.7 20.0 12.1 16.0 15.9 17.1 31.8 13.9 17.6 15.9 83.2 21.4 23.6 32.8 20.0 23.0 20.8 24.1 29.7 18.5 21.7 22.9 23.0 19.1 23.7 17.5 20.8 12.2 19.1 19.8 69.3 9.7 16.3 28.9 24.8 13.9 18.7 16.5 16.8 7.8 21.4 28.3 14.4 19.0 19.4 18.2 17.7 16.0 17.5 12.9 18.2 8.0 20.3 18.8 19.7 19.7 25.1 23.8 21.5 22.0 19.4 19.3 14.5 40.9 17.9 12.3 11.5 18.1 30.6 9.2 20.2 20.6 27.0 25.9 19.8 13.8 16.1 37.2 25.7 25.1 21.0 19.9 12.1 20.8 14.3 22.0 24.6 14.5 23.7 15.1 34.7 4.3 13.2 43.1 18.0 21.8 21.3 14.6 30.9 5.0 29.5 21.5 15.9 12.6 12.0 11.0 34.2 21.8 13.3 17.6 24.2 24.6 17.6 19.1 29.4 19.9 16.8 8.1 18.5 25.5 18.9 13.5 8.5 16.0 12.1 12.4 11.8 15.9 12.3 14.4 8.6 18.2 12.8 14.4 2.8 12.9 17.5 17.7 18.2 8.0 24.9 23.5 19.7 40.4 21.4 23.6 24.1 29.7 23.7 16.8 29.8 16.1 41.2 30.6 14.3 22.2 90.1 35.7 50.9 15.9 36.6 11.8 101.7 160.8 46.6 83.4 32.3 30.2 23.3 53.3 58.8 29.6 33.8 57.7 33.6 71.3 17.5 51.2 28.3 33.0 20.9 32.2 38.6 37.1 88.4 43.8 34.7 48.9 45.6 34.6 134.1 25.7 45.3 49.1 77.4 52.4 13.0 51.3 35.0 49.8 27.4 NFX1 "MGC20369, NFX2, TEG-42, Tex42" ENSG00000086102 "Nuclear transcription factor, X-box binding 1" Q12986 9 33290511-33371157 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056310, HPA061382, HPA073519" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614" "unprognostic (3.90e-2)" "unprognostic (6.01e-2)" "unprognostic (1.19e-2)" "unprognostic (1.40e-1)" "unprognostic (3.07e-2)" "unprognostic (2.02e-2)" "unprognostic (9.11e-2)" "unprognostic (1.81e-2)" "unprognostic (8.71e-2)" "prognostic favorable (3.75e-4)" "unprognostic (3.40e-2)" "unprognostic (1.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.36e-2)" "unprognostic (1.14e-2)" "unprognostic (9.62e-2)" "unprognostic (3.20e-2)" 23.7 19.8 17.6 17.8 26.3 22.5 24.1 33.0 26.7 19.2 24.4 24.7 18.0 19.2 26.3 19.2 22.3 18.6 14.4 26.4 16.2 16.0 17.4 31.3 19.6 23.1 17.8 19.5 26.5 20.9 28.3 30.9 17.7 25.2 20.4 22.4 19.3 22.9 23.6 44.8 31.2 23.0 21.5 18.1 21.0 19.3 14.4 22.0 35.1 26.7 19.1 32.8 24.7 19.8 10.7 12.3 22.9 7.1 6.8 10.1 5.0 15.3 12.5 11.5 10.9 17.2 19.4 11.6 14.5 14.5 16.5 16.5 11.4 6.3 23.8 9.3 16.7 11.1 8.7 20.5 15.7 15.5 17.4 10.3 12.5 30.6 12.7 21.0 22.2 13.9 18.1 26.3 14.0 35.5 14.8 10.0 13.6 19.0 20.8 17.2 10.8 14.3 20.9 18.7 11.3 14.2 15.4 12.6 13.0 11.1 14.7 16.0 11.2 14.5 15.7 8.3 14.2 9.1 22.2 12.5 13.5 11.3 9.7 15.7 11.2 10.1 23.7 14.8 11.3 7.7 22.9 4.2 7.9 8.4 7.1 8.9 10.7 9.0 9.0 7.1 9.1 10.1 9.9 3.0 6.8 5.5 12.3 6.1 5.0 17.6 26.3 33.0 26.7 16.2 16.0 17.8 19.5 25.2 22.0 56.6 43.9 35.8 19.9 7.4 27.8 34.3 28.1 53.5 48.9 26.2 51.1 10.2 6.6 13.9 65.8 11.3 19.0 23.3 11.5 10.2 12.0 21.1 17.4 26.0 12.8 20.6 8.7 16.5 16.7 13.3 17.0 11.5 3.3 13.6 22.8 15.1 11.3 17.6 21.5 6.4 32.6 12.9 11.2 12.1 13.1 9.8 15.1 13.1 16.7 16.1 NGEF ARHGEF27 ENSG00000066248 "Neuronal guanine nucleotide exchange factor" Q8N5V2 2 232878686-233013272 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.1;brain: 55.6;intestine: 23.2" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 44.3;Hepatocytes: 17.7;Paneth cells: 20.1;Undifferentiated cells: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 25.6;HDLM-2: 21.6;HeLa: 10.4;PC-3: 28.1;T-47d: 15.9" "Group enriched" "Detected in many" 4 "amygdala: 177.2;basal ganglia: 332.1;cerebral cortex: 231.3;hippocampal formation: 147.2" "Low region specificity" "Detected in many" HPA008160 Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008160: AB_1854450" "unprognostic (3.92e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-3)" "unprognostic (1.66e-1)" "unprognostic (5.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.15e-1)" "unprognostic (2.39e-3)" "unprognostic (5.41e-3)" "unprognostic (2.58e-1)" "unprognostic (6.94e-3)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.80e-2)" "unprognostic (2.74e-1)" 0.8 29.1 15.8 1.4 55.6 0.3 1.4 0.8 53.8 1.4 7.9 1.6 0.0 23.2 2.8 2.6 5.3 3.1 2.0 0.9 7.0 5.1 4.2 9.7 0.6 0.3 3.2 26.7 1.5 1.8 7.9 0.9 0.4 5.4 1.3 6.1 0.0 0.8 0.7 0.7 16.5 16.6 4.0 1.4 0.5 6.2 2.3 12.0 0.0 0.8 1.0 0.4 0.9 1.6 0.0 0.5 0.5 0.3 0.0 0.0 0.0 25.6 7.5 0.3 0.1 0.1 4.2 0.4 0.4 0.0 0.2 0.0 0.3 2.5 0.0 7.6 5.3 2.7 3.3 5.7 1.4 0.2 21.6 1.8 0.0 10.4 8.0 0.1 0.0 0.1 0.0 0.1 1.7 0.3 0.1 0.9 0.1 0.1 0.1 0.2 1.9 0.0 0.0 0.6 0.1 28.1 0.0 0.0 0.0 0.5 0.7 0.9 0.2 3.2 1.6 0.0 1.0 15.9 0.2 0.0 0.2 2.3 0.1 0.5 0.2 0.1 0.0 1.9 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 15.8 55.6 0.8 53.8 7.0 5.1 3.2 26.7 5.4 12.0 0.0 0.0 0.0 1.0 8.9 0.2 2.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.6 0.4 44.3 0.0 9.2 0.2 0.3 0.6 0.0 17.7 0.1 1.6 4.7 0.0 0.3 1.3 0.0 0.2 1.7 0.0 13.6 5.2 7.7 20.1 1.1 6.3 0.0 0.0 0.7 1.1 0.4 6.6 0.0 0.0 17.8 0.3 NHP2 "FLJ20479, NOLA2" ENSG00000145912 "NHP2 ribonucleoprotein" Q9NX24 5 178149460-178153967 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044171, HPA050400" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044171: AB_2678844, HPA050400: AB_2681113" "unprognostic (1.19e-1)" "unprognostic (1.59e-1)" "unprognostic (3.71e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (4.05e-1)" "unprognostic (3.97e-2)" "prognostic unfavorable (5.24e-4)" "unprognostic (8.87e-2)" "unprognostic (9.12e-2)" "unprognostic (1.78e-2)" "unprognostic (4.20e-2)" "unprognostic (6.72e-2)" "unprognostic (1.67e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (4.04e-2)" "unprognostic (8.63e-2)" 35.4 41.0 42.5 37.5 46.4 44.2 37.9 26.2 54.2 27.1 37.3 23.7 26.2 29.0 31.9 34.4 59.4 37.6 33.6 52.3 37.7 33.6 31.3 57.1 24.9 60.3 37.1 29.3 38.2 62.1 15.1 25.3 25.0 26.7 28.0 22.4 18.6 40.0 35.5 50.9 39.1 26.7 34.2 34.1 29.9 30.4 26.9 25.6 40.6 34.5 61.9 32.9 26.8 33.4 50.8 78.2 7.1 38.9 37.9 43.8 51.2 32.7 49.5 16.0 46.4 11.0 14.5 55.9 25.6 12.4 27.4 23.8 29.0 28.0 47.0 47.4 14.1 25.5 20.5 24.0 52.9 14.6 89.3 80.8 24.8 38.6 32.5 18.7 42.3 26.8 17.5 25.1 21.5 19.4 10.8 25.6 31.2 25.0 30.3 15.3 142.0 58.6 29.4 24.7 28.3 76.7 39.7 22.0 70.1 20.5 20.9 41.4 48.0 19.2 51.8 44.5 10.3 26.6 29.9 25.9 28.8 32.3 24.3 57.3 38.2 77.0 55.9 29.9 56.0 31.5 7.1 35.3 4.8 31.6 38.9 43.8 50.8 39.2 36.3 48.7 50.0 40.8 42.0 2.7 37.9 27.0 78.2 36.3 51.2 42.5 46.4 26.2 54.2 37.7 33.6 37.1 29.3 26.7 25.6 56.6 57.1 131.8 167.2 171.7 49.1 10.9 119.8 60.2 96.7 120.4 17.7 208.0 303.4 170.3 42.0 112.3 43.9 23.3 260.6 296.0 121.9 161.1 78.4 142.5 155.5 28.6 121.6 77.3 74.8 92.9 124.8 98.1 138.3 123.6 126.5 46.8 190.5 31.6 91.6 215.9 23.6 58.2 119.3 92.2 127.8 212.3 139.6 90.9 179.9 243.4 NIM1K "MGC42105, NIM1" ENSG00000177453 "NIM1 serine/threonine protein kinase" Q8IY84 5 43192071-43280850 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 23.7;pituitary gland: 9.7" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 7.1;Cone photoreceptor cells: 5.9;Horizontal cells: 17.5;Muller glia cells: 8.2;Rod photoreceptor cells: 6.1" "Cancer enriched" "Detected in some" 11 "glioma: 6.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 10 "dendritic cells: 1.2;T-cells: 3.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 4.5;HDLM-2: 4.9;PC-3: 5.6;U-87 MG: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007695 Uncertain Approved Cytosol NA NA Cytosol "HPA007695: AB_2667897" "unprognostic (7.97e-2)" "unprognostic (9.79e-2)" "unprognostic (8.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (4.35e-2)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (8.84e-4)" "unprognostic (1.25e-1)" "unprognostic (1.55e-5)" "unprognostic (2.18e-1)" "unprognostic (2.66e-1)" "unprognostic (6.46e-3)" "unprognostic (4.98e-3)" 1.4 3.5 9.4 1.6 10.9 0.9 1.3 4.9 23.7 1.6 1.4 6.3 0.0 1.1 1.2 1.6 1.6 1.4 1.5 1.8 8.7 7.7 1.4 1.2 3.6 1.2 5.6 5.8 1.2 1.5 1.2 9.7 1.8 6.4 1.4 1.7 1.7 2.3 2.4 2.0 1.8 1.2 1.3 4.9 1.0 3.0 1.4 8.1 0.0 2.7 0.0 1.0 1.1 0.8 0.1 1.2 0.0 0.0 0.2 3.2 0.0 0.2 0.6 0.1 0.1 0.9 0.6 0.0 1.0 3.2 1.2 4.5 0.1 0.0 0.5 0.6 0.8 1.6 0.3 0.6 0.0 2.8 4.9 0.3 0.1 0.6 0.2 1.6 0.2 0.7 1.9 0.1 0.5 0.0 1.7 0.0 0.1 0.2 0.3 0.9 0.2 0.3 0.2 0.0 0.0 5.6 0.2 0.3 0.5 0.1 0.7 0.9 0.1 1.8 0.5 0.3 0.2 0.4 1.5 0.0 0.9 0.8 0.8 0.7 1.6 0.4 0.3 6.1 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 1.2 3.2 0.0 9.4 10.9 4.9 11.6 8.7 7.7 5.6 5.8 6.4 8.1 0.0 4.1 0.0 0.1 0.5 7.1 0.3 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.3 0.1 0.0 0.0 0.1 17.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 8.2 0.2 0.0 0.7 0.0 6.1 0.0 0.4 0.4 0.5 0.4 0.0 0.0 0.0 0.0 NINJ2 ENSG00000171840 "Ninjurin 2" Q9NZG7 12 564296-663779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.7;brain: 43.6" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 32.8;Hofbauer cells: 25.9;Kupffer cells: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 41.4;MOLT-4: 70.0;THP-1: 14.8;U-698: 13.3" "Low region specificity" "Detected in many" "HPA058980, HPA067226" Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol" "HPA058980: AB_2683869, HPA067226: " "unprognostic (1.16e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.37e-1)" "prognostic favorable (5.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.90e-3)" "unprognostic (4.60e-2)" "unprognostic (4.98e-3)" "unprognostic (5.88e-2)" "unprognostic (5.12e-2)" "unprognostic (2.68e-2)" "unprognostic (9.05e-2)" "unprognostic (1.03e-2)" "unprognostic (3.51e-3)" "unprognostic (1.23e-1)" 11.8 1.4 9.8 9.2 14.1 27.8 9.2 2.4 18.5 7.3 5.0 43.6 1.6 4.6 2.9 3.3 8.4 3.8 4.7 7.9 16.4 8.7 1.4 13.8 31.3 10.8 21.8 10.2 0.8 1.8 0.9 1.1 3.9 17.2 2.7 4.5 2.9 4.5 2.8 20.1 6.7 3.9 4.8 26.4 8.8 3.6 3.9 21.1 3.6 2.6 2.2 9.2 9.0 3.9 5.6 14.9 34.2 17.7 5.7 44.7 9.1 0.4 0.1 0.0 0.4 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.8 3.2 0.0 0.1 1.6 0.4 0.0 0.0 0.0 0.0 2.3 0.0 41.4 9.9 0.5 0.0 1.1 1.7 0.6 0.0 0.0 0.0 0.0 0.8 0.8 2.4 7.1 0.0 0.0 70.0 2.2 0.7 0.0 0.0 1.8 0.0 0.2 0.7 0.0 0.0 0.0 7.8 0.0 0.0 0.1 0.0 14.8 0.2 0.0 0.4 2.7 0.0 0.0 1.1 13.3 0.1 7.7 0.0 2.0 17.7 14.1 10.5 13.7 3.1 5.6 11.8 11.1 14.9 4.5 2.6 5.5 34.2 5.7 11.2 7.8 44.7 9.1 9.8 14.1 2.4 18.5 16.4 8.7 21.8 10.2 17.2 21.1 20.8 32.8 6.5 0.2 5.0 0.0 1.2 0.0 6.7 14.8 0.0 0.0 2.3 1.7 0.0 2.1 5.4 1.6 0.0 0.0 3.2 5.6 0.2 2.3 10.6 25.9 0.0 4.1 5.5 33.3 1.9 7.5 17.3 6.8 6.4 3.2 0.3 0.5 3.5 3.9 0.0 0.0 0.0 1.0 3.2 2.5 4.8 0.7 14.4 3.3 0.0 NINL "KIAA0980, NLP" ENSG00000101004 "Ninein like" Q9Y2I6 20 25452705-25585517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 20.1;Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 10 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "AF22: 14.6;Hep G2: 22.9" "Low region specificity" "Detected in many" HPA000686 Uncertain Uncertain "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Microtubules, Cytokinetic bridge, Cytosol" "HPA000686: AB_1079193" "unprognostic (7.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (8.56e-2)" "unprognostic (2.50e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (3.39e-1)" "prognostic favorable (1.03e-5)" "unprognostic (3.95e-2)" "unprognostic (2.72e-1)" "unprognostic (1.51e-1)" "unprognostic (6.26e-2)" 3.8 7.5 5.9 7.6 10.7 0.8 4.2 17.2 4.2 10.3 6.7 5.5 3.9 4.1 13.0 9.7 4.7 4.1 7.5 4.0 5.8 6.3 17.1 5.9 5.3 2.7 4.5 4.2 18.5 5.0 14.8 12.1 2.0 7.5 8.8 2.8 13.8 4.7 5.2 5.2 2.7 3.6 9.7 5.5 5.3 6.5 10.5 2.0 17.2 8.2 2.6 3.9 2.8 6.6 0.2 0.0 0.0 0.0 0.0 2.2 0.2 0.6 6.7 14.6 9.6 1.6 4.9 4.5 2.2 1.9 2.0 2.8 1.7 4.7 0.3 3.2 3.5 4.8 0.5 2.1 0.4 1.7 0.3 3.0 1.0 3.0 22.9 3.5 0.3 0.0 6.0 0.4 2.3 0.0 5.6 4.2 11.2 1.1 0.1 2.4 5.9 13.0 0.4 4.1 0.1 0.7 0.3 11.4 0.5 1.0 0.8 14.5 10.3 5.1 1.9 5.5 12.3 3.1 3.9 0.2 0.1 5.6 0.0 0.1 1.5 2.6 0.0 0.1 0.3 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.8 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.2 5.9 10.7 17.2 4.2 5.8 6.3 4.5 4.2 7.5 2.0 0.0 10.5 0.0 3.6 1.8 2.4 4.5 15.3 20.1 5.7 7.0 23.6 2.5 0.0 4.7 0.4 1.8 0.3 0.0 1.1 1.1 6.2 3.9 0.0 6.0 1.8 7.9 5.8 6.7 0.8 1.8 12.0 0.7 0.0 0.0 1.6 2.4 2.5 0.8 11.7 6.9 1.9 6.5 2.1 2.4 4.1 0.6 1.3 0.0 1.5 1.6 NIPBL "DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2" ENSG00000164190 "NIPBL, cohesin loading factor" Q6KC79 5 36876759-37066413 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040834, HPA058239" Approved Supported Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA040834: AB_10796562, HPA058239: AB_2683650" "unprognostic (4.92e-2)" "unprognostic (9.77e-2)" "unprognostic (5.28e-2)" "unprognostic (8.10e-2)" "unprognostic (9.38e-2)" "unprognostic (6.02e-2)" "unprognostic (7.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.85e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (1.04e-1)" "unprognostic (3.40e-2)" 16.8 13.9 13.3 21.9 15.7 22.7 15.8 22.9 15.9 17.3 19.2 10.8 20.1 10.4 18.7 16.5 16.6 14.3 15.9 12.4 13.5 7.1 12.6 13.2 16.0 16.0 17.2 11.1 21.2 14.6 30.0 20.9 17.4 13.5 15.1 13.2 8.5 17.1 24.7 18.9 18.2 18.4 13.2 11.9 18.5 14.7 14.1 19.0 42.5 18.1 14.0 16.9 17.6 29.2 4.8 4.6 11.1 4.3 3.8 4.9 1.9 10.3 6.1 16.0 7.5 10.2 11.2 11.8 8.3 9.3 9.2 7.7 8.6 10.7 15.7 5.4 10.3 10.6 9.1 13.6 7.7 13.3 12.9 7.1 19.1 27.2 6.3 7.0 22.3 12.8 8.2 9.5 10.3 13.6 8.8 11.5 9.9 18.1 11.8 8.6 5.0 15.2 8.5 7.6 6.1 5.3 13.0 25.2 6.0 6.5 14.8 11.9 8.4 40.3 10.8 8.5 13.2 11.0 13.0 12.5 12.2 13.3 10.3 6.2 8.6 11.4 18.6 6.7 15.3 9.1 10.0 4.1 5.7 4.8 3.2 4.4 4.0 3.9 4.2 3.3 4.8 4.3 4.9 11.1 3.8 4.3 4.6 2.9 1.9 13.3 15.7 22.9 15.9 13.5 7.1 17.2 11.1 13.5 19.0 122.1 90.0 21.9 65.0 42.9 59.8 76.5 43.3 84.3 83.0 31.4 72.6 34.3 5.0 46.3 10.9 63.8 39.1 70.0 40.4 27.0 34.9 58.3 78.9 22.9 32.7 38.1 39.9 33.7 44.3 10.2 61.5 61.2 23.6 64.9 38.5 49.5 45.0 45.6 53.0 10.2 67.9 51.8 44.3 162.2 75.4 41.0 63.5 61.8 38.0 88.6 NISCH "I-1, IRAS, KIAA0975" ENSG00000010322 Nischarin Q9Y2I1 3 52455118-52493071 "FDA approved drug targets, Predicted intracellular proteins" Apoptosis Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Intestinal endocrine cells: 162.6;Peritubular cells: 231.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023189 Approved Approved "Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cytosol" "Vesicles, Microtubules, Cytokinetic bridge" "HPA023189: AB_1854495" "unprognostic (6.66e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (4.11e-3)" "unprognostic (1.64e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-2)" "unprognostic (6.56e-3)" "unprognostic (4.96e-2)" "unprognostic (8.33e-3)" "prognostic favorable (1.91e-4)" "unprognostic (1.40e-2)" "unprognostic (5.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.94e-2)" "unprognostic (1.47e-1)" "unprognostic (7.05e-3)" 16.5 24.9 29.7 14.3 36.1 18.1 16.7 84.5 47.5 24.1 16.4 21.4 22.1 12.9 24.4 19.5 14.1 20.9 16.4 14.1 24.7 18.8 14.9 11.8 17.1 15.9 13.2 35.6 30.7 21.8 23.3 55.3 21.0 20.8 29.8 11.4 27.0 26.5 30.2 12.2 42.5 14.8 20.9 13.3 16.8 14.8 27.3 13.9 16.3 17.1 7.8 12.6 21.9 19.5 5.8 6.6 6.5 8.3 6.1 8.1 6.4 7.4 7.9 24.6 20.0 18.4 20.4 20.2 16.2 10.7 13.0 13.3 11.8 11.3 10.5 4.5 22.4 10.7 10.1 13.0 17.6 7.7 10.6 14.0 18.9 27.5 11.4 16.8 11.1 17.0 32.0 14.2 14.0 12.0 27.5 20.9 21.1 10.0 11.7 12.1 10.7 19.8 24.6 15.0 9.6 13.5 11.8 6.7 12.2 14.8 15.0 10.4 18.2 17.5 4.6 11.2 22.4 14.5 18.7 22.8 18.3 17.6 18.5 11.5 19.5 11.1 13.3 12.6 18.1 11.1 6.3 8.3 6.5 6.4 7.6 6.3 4.7 5.4 8.1 4.5 5.8 6.5 6.5 2.9 6.1 1.1 6.6 5.8 6.4 29.7 36.1 84.5 47.5 24.7 18.8 13.2 35.6 20.8 13.9 23.8 28.8 12.0 14.1 24.5 39.6 18.2 7.6 10.7 18.2 14.0 7.9 26.9 8.3 11.4 7.2 20.2 15.8 0.0 8.2 11.6 19.3 13.0 24.3 12.4 25.4 27.0 162.6 52.2 62.2 16.8 81.7 22.2 18.6 5.4 16.3 10.6 9.2 13.9 231.3 11.0 23.3 25.8 23.1 31.1 15.6 19.4 20.3 13.8 15.0 10.8 NIT2 ENSG00000114021 "Nitrilase family member 2" Q9NQR4 3 100334701-100361635 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 41.1" "Cell type enhanced" "Detected in many" 10 "Proximal tubular cells: 436.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036999, HPA041289" Approved Supported Centrosome,Cytosol NA NA 960000 Cytosol Centrosome "HPA036999: AB_10672105, HPA041289: " "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.06e-3)" "prognostic unfavorable (4.62e-4)" "unprognostic (6.28e-2)" "unprognostic (2.10e-1)" "unprognostic (4.56e-1)" "unprognostic (1.12e-1)" "unprognostic (6.60e-3)" "unprognostic (2.21e-1)" "unprognostic (6.68e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (8.26e-2)" "unprognostic (1.47e-3)" 9.9 7.4 6.7 5.4 9.9 5.9 12.4 3.7 10.5 6.4 7.2 6.1 10.6 5.5 6.6 13.3 9.2 7.9 7.1 7.4 5.8 6.3 29.8 41.1 5.6 8.9 5.9 8.0 7.2 8.5 4.7 7.6 4.9 7.7 7.2 6.8 11.3 8.2 10.2 14.7 7.7 5.3 7.0 5.4 5.7 6.8 3.3 3.3 4.4 10.8 14.5 10.5 8.2 5.6 4.2 5.9 1.5 2.4 3.0 4.3 1.3 9.9 9.9 1.2 5.2 8.9 12.1 6.2 4.1 6.1 9.7 9.3 8.4 11.2 10.0 6.2 5.9 4.2 7.5 4.5 11.0 11.6 3.1 2.3 7.2 3.2 4.3 10.9 4.7 4.9 7.6 16.8 5.2 8.5 5.1 6.2 5.7 3.3 8.1 11.8 9.5 3.1 4.3 4.4 12.5 15.1 3.5 4.2 9.8 16.0 6.3 6.9 3.2 5.6 9.6 6.1 3.3 7.1 4.5 4.5 6.1 2.5 2.9 3.5 5.0 5.5 8.5 9.6 8.0 7.7 0.4 2.4 1.1 3.3 2.1 4.3 4.2 3.1 2.5 5.9 3.7 3.6 3.5 1.5 3.0 1.6 1.8 3.1 1.3 6.7 9.9 3.7 10.5 5.8 6.3 5.9 8.0 7.7 3.3 11.9 12.1 26.5 41.3 29.0 11.3 49.4 30.6 38.8 26.1 55.8 15.7 80.0 159.2 63.8 2.3 15.5 14.9 0.0 46.2 64.1 34.7 40.0 20.7 147.3 56.1 12.7 23.1 16.0 18.8 2.4 40.9 33.3 47.2 136.1 20.8 11.7 55.0 25.7 35.3 436.2 23.6 38.8 46.4 1.5 14.5 36.4 49.5 26.2 34.7 40.6 NKAIN2 "FAM77B, TCBA1" ENSG00000188580 "Sodium/potassium transporting ATPase interacting 2" Q5VXU1 6 123804141-124825657 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 43.2" "Group enriched" "Detected in some" 16 "Horizontal cells: 44.5;Muller glia cells: 20.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.9;HEK 293: 6.5;HEL: 8.2;Karpas-707: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045860 Approved Cytosol NA NA Cytosol "HPA045860: AB_10983192" "unprognostic (3.09e-2)" "unprognostic (1.06e-2)" "unprognostic (2.33e-2)" "unprognostic (4.53e-3)" "unprognostic (5.67e-2)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-1)" "unprognostic (5.41e-3)" "unprognostic (2.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.95e-3)" "unprognostic (3.63e-3)" "unprognostic (1.77e-1)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" 2.2 1.6 12.9 1.1 12.1 1.9 1.3 17.3 43.2 1.4 1.7 24.9 0.0 1.1 1.2 1.6 1.4 1.4 1.3 2.6 17.5 8.8 1.3 1.2 1.3 1.3 18.1 10.9 1.2 1.0 1.0 1.1 1.2 18.0 1.4 1.3 0.5 1.1 1.3 4.8 1.1 1.5 1.5 42.9 1.1 1.0 1.6 16.1 0.0 1.2 0.5 1.3 1.5 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.2 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.5 0.1 0.0 0.0 0.0 13.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.1 17.3 15.3 17.5 8.8 18.1 10.9 18.0 16.1 0.0 0.0 0.0 0.0 0.1 2.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 44.5 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NKAP FLJ22626 ENSG00000101882 "NFKB activating protein" Q8N5F7 X 119920672-119943772 "Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000916 Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000916: AB_1079486" "prognostic unfavorable (4.20e-4)" "unprognostic (4.28e-3)" "unprognostic (9.14e-2)" "unprognostic (1.33e-3)" "unprognostic (2.66e-1)" "unprognostic (3.42e-2)" "unprognostic (3.49e-3)" "unprognostic (4.18e-3)" "unprognostic (3.70e-2)" "unprognostic (1.05e-2)" "unprognostic (1.05e-2)" "unprognostic (1.03e-1)" "unprognostic (4.14e-3)" "unprognostic (1.72e-1)" "unprognostic (1.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.49e-2)" 13.9 17.5 12.2 11.2 16.8 15.9 14.0 11.6 16.9 13.0 13.2 15.6 9.9 10.1 16.2 12.4 12.0 15.2 14.0 15.5 12.9 14.0 14.8 19.5 12.6 14.1 14.5 9.7 23.9 13.5 14.1 21.7 18.1 16.6 16.0 8.5 10.3 13.9 15.0 23.9 13.5 13.7 12.0 19.5 15.8 12.3 11.8 16.7 20.1 16.4 11.6 12.2 17.9 15.3 11.8 9.7 16.5 8.0 7.0 8.1 4.4 6.3 7.6 6.1 5.5 4.9 8.3 8.3 4.9 4.6 6.2 4.7 4.6 4.9 6.5 7.8 4.4 7.8 4.6 11.4 4.6 5.4 8.9 10.9 3.1 5.3 4.0 6.5 7.3 6.3 5.7 8.0 5.8 5.0 6.4 4.3 7.8 7.5 6.3 4.8 7.8 8.0 10.4 6.0 5.0 9.9 8.3 6.7 8.4 3.4 2.4 6.9 8.4 9.7 4.7 10.0 3.7 4.2 6.6 6.5 4.4 2.2 10.4 6.3 8.0 6.4 7.4 6.1 6.9 6.4 11.3 8.0 10.8 6.9 5.9 6.8 9.7 8.1 6.5 6.0 11.8 8.1 7.5 16.5 7.0 6.6 9.7 7.5 4.4 12.2 16.8 11.6 14.6 12.9 14.0 14.5 9.7 16.6 16.7 20.8 36.8 31.3 29.8 23.0 31.8 24.6 17.8 53.5 42.1 19.2 23.6 52.3 31.5 32.4 6.3 40.4 20.0 23.3 38.4 96.9 34.2 30.7 45.2 40.3 46.7 52.4 21.9 35.6 26.7 5.0 41.7 39.0 33.7 35.1 23.0 50.3 32.5 24.1 51.9 32.9 36.1 12.9 39.1 33.7 68.2 25.1 61.0 34.9 24.1 27.3 NKAPD1 "C11orf57, FLJ10726" ENSG00000150776 "NKAP domain containing 1" Q6ZUT1 11 112074086-112085150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 29.8;Ciliated cells: 32.1;Club cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039493, HPA039892" Approved Approved Cytosol NA NA Cytosol "HPA039493: AB_10795036, HPA039892: AB_10795372" "unprognostic (5.93e-2)" "unprognostic (3.24e-1)" "unprognostic (6.45e-3)" "unprognostic (1.80e-1)" "unprognostic (1.45e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.17e-1)" "unprognostic (1.45e-2)" "unprognostic (8.61e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (7.05e-3)" "unprognostic (1.15e-2)" "unprognostic (2.86e-1)" "unprognostic (8.24e-2)" "unprognostic (1.41e-1)" 20.6 16.2 20.6 14.1 19.1 13.5 20.6 34.8 21.6 21.5 16.0 13.9 13.1 13.4 19.3 15.7 18.1 17.6 15.6 14.7 19.6 21.1 21.7 14.5 13.4 17.6 20.7 14.7 26.0 17.9 17.4 15.8 24.0 20.7 18.9 14.6 13.2 18.0 14.8 28.2 14.6 16.2 23.3 19.6 19.6 13.9 18.8 15.9 29.7 26.7 15.6 16.4 21.6 19.4 9.1 19.4 7.5 7.7 12.2 11.2 4.3 8.0 5.4 11.5 18.5 11.9 13.9 8.5 11.9 10.2 10.0 11.5 16.7 14.6 22.7 18.3 10.7 11.4 11.7 13.7 12.8 13.1 16.2 9.6 17.3 5.4 8.0 11.0 26.1 11.4 14.1 17.6 12.1 28.0 15.3 8.9 18.7 25.5 14.0 10.0 4.9 23.3 16.2 11.5 13.7 12.0 18.1 14.2 18.5 11.6 7.2 9.7 17.7 12.3 15.3 11.1 10.7 19.1 10.9 9.0 13.5 15.2 8.2 10.2 10.6 23.2 46.6 5.7 24.8 13.6 7.5 7.2 4.3 9.9 7.1 10.1 8.3 10.5 6.7 7.6 9.1 11.2 9.5 3.8 12.2 7.7 19.4 8.1 4.3 20.6 19.1 34.8 21.6 19.6 21.1 20.7 14.7 20.7 15.9 29.8 20.2 0.0 0.0 0.0 0.0 0.0 0.0 32.1 31.8 15.7 0.0 16.4 11.6 17.6 0.0 0.0 0.0 0.0 18.5 14.6 0.0 0.0 8.1 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 24.4 0.0 0.0 18.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 NKIRAS1 "kappaB-Ras1, KBRAS1" ENSG00000197885 "NFKB inhibitor interacting Ras like 1" Q9NYS0 3 23891660-23946591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 54.6;Spermatocytes: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077387 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA077387: " "unprognostic (1.36e-2)" "unprognostic (1.88e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.31e-4)" "unprognostic (1.08e-2)" "unprognostic (4.25e-2)" "unprognostic (5.30e-2)" "prognostic favorable (3.69e-4)" "unprognostic (3.69e-3)" "unprognostic (8.07e-3)" "unprognostic (1.19e-2)" "unprognostic (3.37e-2)" "prognostic favorable (7.71e-13)" "unprognostic (1.98e-1)" "unprognostic (4.90e-2)" "unprognostic (1.18e-1)" "unprognostic (2.63e-3)" 8.1 12.2 20.2 4.2 20.8 2.3 8.1 21.8 30.3 8.7 5.8 7.4 6.3 3.3 7.8 8.5 7.6 7.2 5.7 13.3 18.3 25.0 14.2 21.6 5.7 4.0 18.1 15.5 10.8 5.1 19.2 16.2 5.7 23.7 8.8 3.9 8.5 5.9 12.3 24.0 4.4 3.5 8.0 11.2 5.3 4.4 18.4 8.2 0.5 9.0 2.5 4.0 7.1 9.2 8.8 5.1 9.4 5.3 4.0 10.7 4.7 6.5 5.5 6.0 6.1 16.6 8.1 5.2 15.6 9.5 11.3 9.7 5.6 1.9 3.4 6.8 8.8 6.8 3.2 10.0 6.8 10.2 12.6 6.9 1.9 5.4 5.4 8.5 3.4 1.8 6.3 9.7 13.9 7.1 11.7 3.2 3.3 3.2 12.9 12.5 3.4 2.3 3.0 7.5 4.1 7.3 3.5 8.7 3.3 8.4 2.8 2.2 10.8 4.8 7.8 10.8 6.6 5.6 4.9 5.9 5.5 6.0 13.6 12.6 28.6 28.0 2.2 7.1 5.1 4.9 9.4 5.3 6.8 9.5 3.8 10.6 6.5 6.9 9.1 5.1 8.8 10.7 8.9 2.7 4.0 4.1 3.6 5.2 4.7 20.2 20.8 21.8 30.3 18.3 25.0 18.1 15.5 23.7 8.2 6.0 8.0 2.2 9.5 10.0 31.6 17.4 0.0 16.0 10.3 5.2 60.9 10.1 13.3 6.4 10.5 5.8 3.6 0.0 4.0 8.6 9.7 6.7 6.9 13.9 6.4 12.7 1.2 6.7 3.1 4.5 6.9 8.8 10.1 6.4 2.0 42.9 4.5 3.1 8.5 19.1 54.6 12.9 12.3 67.0 40.9 8.7 8.7 5.0 2.2 6.7 NKTR p104 ENSG00000114857 "Natural killer cell triggering receptor" P30414 3 42600614-42648741 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022120, HPA051576" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Plasma membrane, Cytosol" "HPA022120: AB_1854513, HPA051576: AB_2681540" "unprognostic (2.73e-3)" "unprognostic (3.11e-1)" "unprognostic (2.33e-1)" "unprognostic (2.06e-1)" "unprognostic (5.27e-3)" "prognostic favorable (1.26e-4)" "unprognostic (4.62e-2)" "unprognostic (5.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (6.01e-4)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.82e-1)" "unprognostic (4.57e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.05e-5)" 12.9 14.4 9.8 18.8 22.2 16.3 15.9 42.0 12.3 18.8 10.4 18.5 15.4 11.8 27.2 17.4 11.0 12.0 13.1 11.2 10.9 10.5 9.5 9.7 14.6 15.5 14.5 11.3 22.7 18.4 19.2 26.9 11.1 14.1 12.9 11.1 20.4 13.2 19.5 12.0 20.0 13.3 19.4 15.0 18.5 10.1 17.8 13.8 20.6 14.9 10.9 19.4 12.9 13.9 9.3 8.5 11.7 10.0 11.1 10.2 3.6 8.9 5.2 17.2 7.0 10.3 12.6 9.7 14.6 3.7 6.1 8.3 9.0 7.2 14.2 7.0 4.4 6.0 7.9 10.1 3.7 12.5 7.1 8.5 18.2 16.3 14.6 4.4 14.0 12.0 5.1 7.2 12.0 4.6 11.1 10.7 3.4 18.3 11.0 11.5 3.7 9.5 13.7 14.8 4.8 7.6 10.1 7.7 5.8 8.5 6.9 6.1 3.6 15.7 6.5 2.4 8.0 9.6 10.2 17.1 10.9 8.0 11.9 14.0 9.5 13.3 9.9 5.8 17.2 6.7 9.2 6.2 11.7 10.2 7.7 9.4 8.9 9.8 8.5 4.7 9.3 10.0 8.7 9.1 11.1 10.0 8.5 8.3 3.6 9.8 22.2 42.0 12.3 10.9 10.5 14.5 11.3 14.1 13.8 101.3 122.0 67.1 53.1 52.4 190.3 63.1 50.9 45.5 75.1 83.7 231.7 56.8 14.9 39.7 13.6 120.9 75.7 23.3 34.0 42.2 62.5 58.7 92.6 44.7 39.4 125.5 69.0 103.2 49.9 13.7 155.3 72.2 49.0 62.3 51.5 160.2 38.7 44.6 126.2 9.7 283.7 90.5 58.5 210.1 183.7 50.1 26.2 126.8 54.0 42.1 NKX1-1 "HSPX153, SAX2" ENSG00000235608 "NK1 homeobox 1" Q15270 4 1402932-1406331 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "pituitary gland: 1.0;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "pons and medulla: 0.2" HPA029367 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX1-2 "bB238F13.2, C10orf121" ENSG00000229544 "NK1 homeobox 2" Q9UD57 10 124445239-124450184 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7;intestine: 2.9;skin 1: 2.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 3.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.0;hTCEpi: 5.9;NTERA-2: 11.6;SCLC-21H: 5.1;SuSa: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029367 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" "unprognostic (2.43e-1)" "unprognostic (7.85e-3)" "unprognostic (6.81e-5)" "unprognostic (1.55e-2)" "unprognostic (3.61e-2)" "unprognostic (5.40e-2)" "unprognostic (7.28e-2)" "unprognostic (2.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.7 0.0 2.0 0.0 0.9 0.2 2.9 0.4 0.0 1.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.4 0.0 0.7 3.7 0.3 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 1.2 0.0 0.0 2.2 2.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 6.0 0.5 0.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.1 14.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.0 0.2 2.9 0.6 0.3 0.7 3.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-3 "CSX3, NKX2.3, NKX2C, NKX4-3" ENSG00000119919 "NK2 homeobox 3" Q8TAU0 10 99532933-99536524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HAP1: 2.1;NB-4: 4.8;REH: 6.2;THP-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA047561 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047561: AB_2680088" "unprognostic (5.70e-2)" "unprognostic (2.95e-1)" "unprognostic (2.70e-4)" "unprognostic (6.34e-3)" "unprognostic (3.92e-2)" "unprognostic (7.40e-2)" "unprognostic (1.20e-1)" "unprognostic (4.91e-2)" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" 0.8 0.0 0.1 17.2 0.1 0.0 0.1 0.1 0.1 0.3 21.6 0.1 0.1 10.4 0.2 0.1 0.5 0.0 12.5 0.1 0.1 0.0 0.1 0.2 0.1 1.1 0.1 0.1 0.1 6.4 0.0 0.1 0.1 0.1 0.1 4.6 0.1 9.0 0.5 0.1 0.0 19.1 3.1 0.1 36.8 1.8 0.1 0.1 0.2 1.0 0.7 3.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 6.2 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.4 0.0 1.6 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NKX2-5 "CSX, CSX1, NKX2.5, NKX2E, NKX4-1" ENSG00000183072 "NK2 homeobox 5" P52952 5 173232109-173235357 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Atrial septal defect, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 95.6" "Cell type enriched" "Detected in some" 32 "Cardiomyocytes: 56.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 21.0;NTERA-2: 7.6;SK-MEL-30: 9.3;U-2 OS: 17.3;U-251 MG: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA065034 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA065034: AB_2685409" "unprognostic (3.81e-1)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (9.57e-3)" "unprognostic (3.22e-3)" "unprognostic (6.63e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-1)" "unprognostic (2.31e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.77e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 95.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.1 0.0 0.0 0.2 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.0 1.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 4.9 21.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.3 4.2 0.0 9.3 2.9 0.0 0.0 0.0 4.0 17.3 5.3 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.1 0.1 0.0 0.0 0.0 NKX3-1 "BAPX2, NKX3.1, NKX3A" ENSG00000167034 "NK3 homeobox 1" Q99801 8 23678693-23682927 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "prostate: 95.3" "Group enriched" "Detected in many" 6 "Basal glandular cells: 52.8;Glandular cells: 96.8" "Cancer enriched" "Detected in many" 65 "prostate cancer: 392.7" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 7 "eosinophil: 23.5;neutrophil: 23.4" "Lineage enriched" "Detected in many" 19 "granulocytes: 23.5" "Cell line enhanced" "Detected in many" "GAMG: 16.9;SiHa: 16.7;U-138 MG: 17.0;U-251 MG: 14.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA025693, HPA078571" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA025693: AB_1854522, HPA078571: AB_2732384" "unprognostic (1.47e-2)" "unprognostic (4.03e-2)" "unprognostic (2.67e-1)" "unprognostic (5.87e-2)" "unprognostic (2.56e-6)" "unprognostic (6.90e-3)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (9.42e-2)" "unprognostic (1.41e-1)" "unprognostic (3.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.37e-2)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.09e-2)" "unprognostic (1.69e-1)" 0.6 1.3 0.3 0.6 0.9 0.6 1.5 0.1 0.8 1.1 0.6 0.2 0.5 0.5 0.7 0.5 1.2 0.7 0.8 2.4 0.8 0.3 0.4 1.6 0.8 0.7 0.6 0.2 1.6 0.6 0.5 0.4 0.3 1.2 95.3 0.2 0.5 17.9 0.7 2.0 0.2 0.4 0.7 0.6 0.3 0.5 12.3 0.7 0.0 0.6 3.2 20.5 0.7 2.5 1.0 0.0 23.5 0.0 0.2 1.2 0.1 3.0 2.3 0.0 5.6 2.1 0.5 4.6 4.2 2.7 9.0 10.7 1.3 3.5 0.0 0.6 3.1 16.9 0.8 2.2 4.8 7.1 0.0 1.1 2.1 1.7 3.4 4.0 0.0 0.8 0.8 1.3 9.1 0.5 5.6 0.5 12.9 0.1 0.0 3.5 1.0 7.3 0.6 1.3 0.0 1.6 0.0 3.6 0.3 0.5 3.6 1.1 0.3 16.7 3.1 0.3 6.8 2.2 0.3 0.6 17.0 6.0 1.3 14.5 0.0 0.0 0.0 8.3 1.6 2.0 3.4 0.0 23.5 0.5 0.0 0.1 1.0 0.2 0.5 0.0 0.9 0.7 1.2 23.4 0.2 0.0 0.0 0.0 0.1 0.3 0.9 0.1 0.8 0.8 0.3 0.6 0.2 1.2 0.7 3.0 4.0 0.5 52.8 4.9 1.7 7.0 0.0 1.4 5.7 0.0 7.9 0.3 0.0 2.4 2.0 6.8 0.4 0.0 6.1 1.2 4.1 96.8 0.0 3.8 0.2 3.2 6.3 4.9 0.3 4.5 2.0 2.9 1.7 1.0 0.4 4.3 4.7 0.0 6.0 0.5 4.5 0.0 13.3 0.7 1.4 1.8 0.2 0.5 0.5 9.3 NLRC3 "CLR16.2, FLJ00348, NOD3" ENSG00000167984 "NLR family CARD domain containing 3" Q7RTR2 16 3539033-3577400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.0" "Cell type enhanced" "Detected in some" 14 "Ito cells: 6.2;T-cells: 15.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 6.3;HL-60: 13.1;HMC-1: 6.6;JURKAT: 6.5;NB-4: 14.0;U-698: 20.2;U-937: 9.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA048062 Supported "Vesicles,Centriolar satellite,Cytosol" NA NA Cytosol "Vesicles, Centriolar satellite" "HPA048062: AB_2680242" "unprognostic (4.93e-3)" "unprognostic (3.84e-4)" "unprognostic (7.61e-4)" "unprognostic (4.94e-7)" "unprognostic (9.56e-2)" "unprognostic (3.76e-5)" "unprognostic (1.86e-3)" "unprognostic (6.70e-3)" "unprognostic (2.66e-2)" "unprognostic (7.02e-2)" "unprognostic (3.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.40e-2)" "unprognostic (5.13e-2)" "unprognostic (7.15e-3)" "unprognostic (4.54e-2)" "unprognostic (2.08e-2)" 0.2 0.4 0.0 20.1 0.1 2.8 0.0 0.0 0.2 0.4 1.3 0.0 0.2 1.2 1.0 0.1 1.0 0.0 1.8 0.8 0.0 0.6 0.5 6.0 11.2 0.2 0.0 0.1 1.5 0.0 0.0 0.6 0.2 0.9 0.7 0.9 2.7 0.2 0.5 0.0 2.4 0.1 0.0 10.5 1.4 0.0 0.0 27.0 0.4 1.1 18.1 1.6 1.0 1.0 0.0 2.6 0.0 4.7 4.1 3.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 5.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 6.3 0.1 0.0 0.0 13.1 6.6 0.0 0.0 0.0 0.0 0.3 0.2 6.5 0.1 0.0 0.0 0.3 5.4 14.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 3.3 0.4 0.2 0.0 0.2 0.1 0.3 0.0 20.2 0.1 9.8 0.0 2.6 0.0 0.0 3.7 0.0 4.1 1.0 2.7 3.8 0.0 0.8 2.1 2.0 0.0 4.7 0.0 0.0 3.1 3.3 3.0 0.0 4.2 0.2 0.0 1.6 3.7 0.0 1.4 1.2 1.8 3.9 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 6.2 0.6 0.7 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.5 0.2 0.0 0.0 15.2 0.0 0.1 NLRC5 "CLR16.1, FLJ21709, NOD27" ENSG00000140853 "NLR family CARD domain containing 5" Q86WI3 16 56989485-57083531 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "B-cells: 22.9;T-cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 41.5;NB-4: 22.8;U-2197: 15.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA060405, HPA074724" Supported Centrosome,Cytosol NA NA Cytosol Centrosome "HPA060405: AB_2684277, HPA074724: " "unprognostic (9.66e-2)" "prognostic favorable (9.69e-4)" "unprognostic (1.64e-2)" "unprognostic (1.23e-2)" "unprognostic (3.12e-1)" "unprognostic (9.27e-3)" "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "unprognostic (2.24e-2)" "prognostic favorable (2.30e-4)" "unprognostic (2.69e-1)" "unprognostic (3.46e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (2.99e-2)" "unprognostic (3.91e-2)" "unprognostic (5.06e-2)" "unprognostic (2.75e-3)" 10.0 5.7 3.4 26.4 7.0 24.9 6.0 1.6 6.2 5.4 7.0 4.2 2.9 4.9 10.8 4.4 6.4 4.9 8.9 3.7 4.3 2.4 5.5 5.5 12.8 21.3 7.0 2.0 3.9 3.6 2.1 20.2 2.3 6.0 5.2 5.6 4.7 8.9 3.0 3.5 10.9 16.1 5.8 7.8 24.6 7.2 1.3 6.3 9.4 5.9 6.6 29.7 7.3 7.0 5.4 1.7 13.2 4.0 2.7 7.0 2.7 4.9 0.9 0.1 0.3 0.3 1.7 0.0 2.7 4.3 8.8 8.6 0.0 8.6 10.1 2.1 4.5 3.5 3.3 1.1 0.3 1.0 0.4 0.3 41.5 8.8 1.0 3.1 1.4 2.5 3.3 0.1 7.1 0.8 2.8 3.4 1.4 0.0 2.0 1.8 0.1 2.2 22.8 0.0 0.1 0.9 10.8 3.1 4.2 1.0 0.4 0.3 0.3 5.6 0.5 1.2 0.0 0.6 5.5 4.3 4.2 1.5 15.4 2.2 4.1 2.1 10.3 7.5 3.1 0.8 6.4 4.0 13.2 7.0 2.2 4.2 5.4 4.0 6.6 1.7 3.1 2.6 2.7 9.8 2.7 2.5 1.3 4.6 2.7 3.4 7.0 1.6 6.2 4.3 2.4 7.0 2.0 6.0 6.3 0.0 15.7 22.9 0.8 6.1 0.4 3.1 0.0 2.7 5.7 5.2 0.0 0.0 0.0 5.5 0.4 10.5 19.1 0.0 7.2 0.1 2.8 1.7 9.2 3.9 4.4 0.0 8.1 9.8 17.0 0.0 0.9 7.3 0.0 6.4 10.5 0.3 6.9 10.5 0.4 0.6 1.3 0.0 5.7 0.0 0.0 8.7 0.1 30.5 9.0 3.8 NLRP1 "CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1" ENSG00000091592 "NLR family pyrin domain containing 1" Q9C000 17 5499427-5619424 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 371.4;Muller glia cells: 111.8" "Cancer enhanced" "Detected in all" "glioma: 20.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.7;Karpas-707: 42.0;U-266/70: 21.0" "CAB009189, HPA064431" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009189: , HPA064431: AB_2685262" "unprognostic (4.40e-2)" "unprognostic (1.02e-1)" "unprognostic (3.16e-2)" "unprognostic (3.65e-2)" "unprognostic (4.00e-2)" "unprognostic (1.23e-3)" "unprognostic (4.13e-2)" "unprognostic (1.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "prognostic favorable (7.57e-4)" "unprognostic (2.99e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (6.69e-2)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "unprognostic (1.34e-2)" 19.5 2.5 2.4 39.9 3.1 15.1 16.4 0.9 2.8 19.1 6.1 5.3 5.6 4.0 16.2 10.2 12.4 7.6 15.5 8.6 4.9 1.8 6.3 3.4 19.1 31.2 4.2 1.9 4.5 2.3 2.2 2.9 8.3 5.2 10.2 5.7 6.3 8.1 11.3 17.8 35.2 18.3 13.1 6.8 34.4 4.4 6.9 3.2 15.9 13.7 11.9 30.8 17.5 16.8 5.3 4.6 16.8 7.5 3.8 7.0 3.7 6.3 0.0 0.0 0.0 3.4 4.7 0.7 2.6 2.5 1.0 2.2 0.1 2.4 2.2 9.9 2.5 0.3 2.8 0.0 10.3 1.6 23.7 0.0 0.6 2.0 0.2 3.1 0.0 0.7 2.8 6.6 8.7 6.4 3.5 11.1 0.4 5.5 42.0 5.1 0.0 0.0 1.8 0.0 0.0 0.1 2.4 1.6 9.9 0.0 2.0 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.2 10.8 2.2 1.3 1.3 0.4 21.0 6.7 1.7 3.6 0.3 0.1 13.8 6.3 4.4 6.0 4.5 6.6 4.4 4.9 6.1 4.6 5.3 5.5 5.0 16.8 3.8 7.5 0.4 7.0 3.7 2.4 3.1 0.9 2.8 4.9 1.8 4.2 1.9 5.2 3.2 0.0 8.5 24.6 6.0 15.8 56.5 3.9 2.5 10.7 15.9 7.0 3.9 0.6 3.3 0.4 371.4 16.8 0.0 0.0 0.0 0.8 24.2 1.2 3.5 0.2 6.0 81.0 74.8 31.9 19.2 46.3 23.6 25.8 6.8 1.0 0.0 111.8 5.1 0.0 26.5 0.4 10.1 6.5 13.3 14.2 10.0 21.8 1.3 35.5 0.0 7.6 NLRP11 "CLR19.6, NALP11, NOD17, PAN10, PYPAF6" ENSG00000179873 "NLR family pyrin domain containing 11" P59045 19 55785397-55836800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.0;liver: 3.3;lymphoid tissue: 4.5;testis: 3.6" "Cell type enhanced" "Detected in some" 26 "Collecting duct cells: 1.8;Early spermatids: 10.0;Late spermatids: 2.7;Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 39.1;RPMI-8226: 22.0;U-266/70: 38.9;U-266/84: 16.8;U-698: 28.3" "Not detected" "Not detected" "HPA046402, HPA078027" Uncertain Supported Cytosol NA NA Cytosol "HPA046402: AB_10962951, HPA078027: AB_2732369" "unprognostic (2.36e-2)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (4.36e-3)" "unprognostic (3.31e-2)" "unprognostic (7.88e-2)" "unprognostic (9.95e-3)" "unprognostic (8.04e-2)" "unprognostic (1.94e-1)" "unprognostic (2.52e-1)" "unprognostic (3.75e-2)" "unprognostic (3.14e-2)" "unprognostic (1.10e-2)" "unprognostic (2.06e-1)" "unprognostic (2.89e-2)" "unprognostic (1.76e-2)" "unprognostic (7.61e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 4.0 0.1 0.3 0.2 0.1 0.1 0.0 0.7 3.3 0.1 0.6 0.1 0.1 0.9 0.4 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 1.2 0.1 0.1 0.3 0.5 3.6 0.1 0.1 0.1 0.1 4.5 0.1 0.1 1.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 39.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.7 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.7 0.0 0.0 38.9 16.8 28.3 0.7 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 2.7 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 NLRP14 "CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8" ENSG00000158077 "NLR family pyrin domain containing 14" Q86W24 11 7020446-7071308 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 2.5;testis: 3.4" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 1.7;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7;Early spermatids: 1.5;Rod photoreceptor cells: 2.9;Spermatocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HEK 293: 1.7;HL-60: 1.2;HUVEC TERT2: 4.1;U-698: 2.2" "Not detected" "Not detected" HPA039477 Approved Uncertain Cytosol NA NA Cytosol "HPA039477: AB_10794748" "unprognostic (6.46e-3)" "unprognostic (5.76e-3)" "unprognostic (1.44e-4)" "unprognostic (7.20e-4)" "unprognostic (5.57e-2)" "unprognostic (8.02e-3)" "unprognostic (6.57e-2)" "unprognostic (2.65e-1)" "unprognostic (2.68e-1)" "unprognostic (1.44e-1)" "unprognostic (2.68e-1)" "unprognostic (2.65e-2)" "unprognostic (3.17e-3)" "unprognostic (6.69e-2)" "unprognostic (3.22e-1)" "unprognostic (3.85e-2)" "unprognostic (1.25e-1)" 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.3 0.3 1.6 2.5 0.4 0.2 0.4 1.3 0.0 1.7 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.0 1.2 0.3 0.0 3.4 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.2 0.9 0.5 0.7 0.0 0.4 1.6 0.0 0.1 0.4 0.0 0.0 0.1 0.7 0.0 1.7 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 4.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 2.2 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.3 2.9 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.0 0.0 NLRP2 "CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2" ENSG00000022556 "NLR family pyrin domain containing 2" Q9NX02 19 54953130-55001142 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.3" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 180.1;Syncytiotrophoblasts: 81.4" "Cancer enriched" "Detected in many" 7 "testis cancer: 78.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 25.0;K-562: 10.4;SuSa: 11.1;U-266/84: 11.3" HPA021183 Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles, Cytosol" "HPA021183: AB_2670615" "unprognostic (1.66e-2)" "unprognostic (9.28e-2)" "unprognostic (6.60e-2)" "unprognostic (6.50e-3)" "unprognostic (1.09e-2)" "unprognostic (4.57e-3)" "unprognostic (4.27e-1)" "unprognostic (1.79e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (3.63e-1)" "unprognostic (2.34e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.86e-2)" "unprognostic (7.57e-2)" 0.6 0.9 1.1 5.0 3.8 1.7 1.4 0.6 2.7 2.6 2.6 0.9 0.2 2.5 2.1 3.7 10.8 1.0 3.7 0.7 2.0 1.8 4.7 0.9 2.2 5.0 0.8 0.8 1.0 6.1 0.3 1.7 8.1 2.9 2.1 1.2 2.4 4.1 1.6 1.4 3.5 2.9 1.1 1.0 3.0 3.1 14.3 0.9 4.2 3.1 0.2 3.5 4.7 5.6 3.8 1.8 0.6 0.9 3.4 2.6 0.8 2.3 3.9 1.9 0.4 0.1 0.1 25.0 0.1 0.0 0.2 0.1 5.0 0.5 2.6 0.2 0.1 0.1 4.1 0.0 4.2 0.2 2.5 0.2 2.5 0.3 0.0 0.3 0.1 0.3 0.1 0.2 0.0 0.1 0.1 0.0 0.0 10.4 0.3 0.0 0.3 0.2 1.0 3.0 4.4 0.0 2.8 0.0 1.4 2.3 0.9 2.4 0.6 0.1 1.1 0.0 11.1 3.4 0.8 0.0 0.2 0.5 0.3 0.3 2.7 11.3 0.9 0.3 0.7 0.1 0.6 0.7 0.3 2.6 0.9 1.5 3.8 1.1 1.0 0.6 2.6 0.8 1.5 0.5 3.4 0.5 1.8 1.2 0.8 1.1 3.8 0.6 2.7 2.0 1.8 0.8 0.8 2.9 0.9 8.9 5.3 0.5 1.3 0.5 2.1 0.6 2.5 6.7 7.9 1.8 3.9 28.7 0.0 4.2 18.8 0.2 1.3 0.0 1.8 180.1 0.4 2.2 4.6 0.0 10.4 0.0 2.4 0.0 0.0 4.9 0.9 0.5 0.0 4.6 2.8 1.1 4.4 0.0 0.0 0.3 2.2 0.0 0.3 13.5 11.4 1.1 81.4 0.5 2.3 3.1 NMBR "BB1, BB1R" ENSG00000135577 "Neuromedin B receptor" P28336 6 142058330-142088799 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.5;fallopian tube: 3.3;testis: 5.1" "Cell type enhanced" "Detected in some" 35 "Early spermatids: 5.9;Late spermatids: 1.6;Spermatocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;RPTEC TERT1: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026665 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA026665: AB_1854527" "unprognostic (6.24e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (7.88e-2)" "unprognostic (3.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (3.95e-1)" "unprognostic (7.94e-3)" "unprognostic (3.44e-1)" "unprognostic (2.11e-1)" "unprognostic (8.45e-2)" 0.1 0.0 0.6 0.0 2.5 0.0 0.4 0.0 0.8 0.5 0.0 0.0 0.2 0.3 0.6 3.3 0.0 0.0 0.5 1.6 0.2 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.8 0.1 0.2 5.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.9 0.9 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.9 0.0 0.6 0.1 0.0 0.3 0.5 0.0 0.0 0.5 0.2 0.0 0.4 0.0 0.2 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 NME1 "NDPKA, NM23, NM23-H1" ENSG00000239672 "NME/NM23 nucleoside diphosphate kinase 1" P15531 17 51153536-51162428 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008467, CAB040571, HPA041113" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 28000000 Cytosol "Nucleoplasm, Plasma membrane" "CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305" "unprognostic (2.24e-1)" "unprognostic (2.01e-1)" "unprognostic (3.48e-3)" "unprognostic (5.96e-2)" "unprognostic (9.71e-2)" "unprognostic (2.33e-3)" "prognostic unfavorable (2.60e-5)" "unprognostic (4.54e-2)" "unprognostic (3.35e-1)" "unprognostic (2.33e-3)" "unprognostic (2.90e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.07e-9)" "unprognostic (9.01e-2)" "unprognostic (1.51e-1)" "unprognostic (1.83e-1)" "unprognostic (9.46e-2)" 25.0 29.5 38.0 28.1 30.1 27.9 29.0 19.6 41.9 16.4 25.4 13.1 10.1 15.1 17.3 22.5 30.1 22.2 13.4 14.1 41.7 39.4 19.6 56.0 14.2 28.5 34.2 34.2 15.6 43.6 13.7 17.3 16.9 38.9 14.5 36.8 14.9 34.3 14.7 14.8 22.4 12.4 29.6 20.5 22.4 13.4 11.6 11.3 19.0 18.8 32.7 41.4 22.8 15.2 24.9 36.2 0.6 19.5 17.2 20.3 18.4 46.6 93.2 32.2 44.9 13.5 21.6 54.1 36.4 25.3 75.5 57.3 73.3 28.3 82.1 38.0 33.6 30.0 25.1 61.5 61.9 64.6 39.8 82.8 53.8 72.4 101.8 27.4 59.0 24.7 20.5 39.0 56.8 53.2 13.3 45.5 26.4 79.4 27.3 44.7 79.0 70.1 67.8 38.6 103.3 85.0 43.0 63.6 75.6 57.9 32.6 44.7 51.5 19.1 52.3 33.9 28.8 54.4 39.9 28.6 48.7 44.2 30.3 74.7 35.2 81.2 96.7 29.5 50.1 37.0 0.2 15.2 0.6 13.4 19.5 20.3 24.9 14.4 14.6 36.2 17.3 16.4 17.8 0.4 17.2 11.5 20.7 12.1 18.4 38.0 30.1 19.6 41.9 41.7 39.4 34.2 34.2 38.9 11.3 29.8 22.5 33.5 67.6 117.7 287.4 27.7 63.7 36.1 59.1 68.0 269.0 166.3 127.6 180.3 23.8 58.6 14.6 46.7 172.7 210.0 82.7 60.4 46.0 102.6 183.6 38.1 86.1 27.0 26.9 65.0 56.7 62.9 123.2 55.9 70.8 61.6 165.1 38.6 55.2 140.8 268.7 12.9 66.0 19.8 83.3 116.3 74.0 40.6 110.8 81.0 NME1-NME2 "NM23-LV, NMELV" ENSG00000011052 "NME1-NME2 readthrough" 17 51153590-51171744 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 41.6;Basal keratinocytes: 34.1;Ciliated cells: 25.4;Club cells: 45.5;granulocytes: 20.9;Melanocytes: 21.9;Suprabasal keratinocytes: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB002169, HPA008467, HPA041113, CAB076057" Approved Approved Cytosol NA NA Cytosol "CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: AB_2677305" "unprognostic (2.39e-1)" "unprognostic (5.29e-2)" "unprognostic (9.70e-2)" "unprognostic (5.13e-2)" "prognostic favorable (6.66e-4)" "unprognostic (2.46e-2)" "unprognostic (4.82e-3)" "unprognostic (8.39e-2)" "unprognostic (2.30e-2)" "unprognostic (1.53e-1)" "unprognostic (4.58e-6)" "unprognostic (1.03e-1)" "unprognostic (2.74e-6)" "unprognostic (1.84e-1)" "unprognostic (9.72e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-3)" 12.8 29.3 19.7 35.5 16.7 20.6 8.5 13.9 31.2 5.4 7.2 6.7 4.9 14.7 10.6 6.2 10.6 7.4 6.8 8.0 23.0 17.0 10.4 31.3 7.8 18.3 16.9 18.7 8.1 24.1 6.5 11.4 13.6 21.5 6.7 5.7 7.7 23.5 4.7 10.1 8.2 10.7 11.7 11.0 11.9 14.8 5.8 5.6 10.0 8.6 17.9 12.7 9.5 7.6 19.6 37.6 1.0 21.1 14.6 21.9 16.2 29.0 2.0 9.4 34.6 8.8 4.5 7.4 23.0 7.5 6.1 3.8 3.8 19.6 17.0 24.1 11.8 15.3 18.1 9.2 14.8 4.0 25.6 13.8 14.1 3.5 7.3 10.7 23.8 23.5 8.1 11.1 7.7 11.0 14.3 9.7 17.0 11.1 22.0 3.8 4.8 58.2 16.4 28.2 34.6 2.9 34.5 23.1 50.3 7.1 3.8 30.4 17.8 12.1 52.6 26.4 14.4 53.8 40.4 19.4 38.8 28.3 37.6 47.0 37.7 40.7 33.1 22.3 17.2 33.3 0.2 15.1 0.3 15.0 21.1 21.9 19.6 14.7 16.1 37.6 18.4 13.7 16.8 1.0 14.6 11.6 25.7 13.7 16.2 19.7 16.7 13.9 26.4 23.0 17.0 16.9 18.7 21.5 5.6 14.9 41.6 0.0 0.0 34.1 0.0 1.7 0.0 25.4 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 20.9 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.3 8.1 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 45.4 0.0 0.0 0.0 0.0 NME2 "NDPKB, NM23-H2" ENSG00000243678 "NME/NM23 nucleoside diphosphate kinase 2" P22392 17 51165435-51171747 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Nucleotide metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 115.1;Club cells: 150.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB036213, CAB036214, CAB036215, HPA041113" Approved Supported "Plasma membrane,Midbody ring,Cytosol" NA NA Cytosol "Plasma membrane, Midbody ring" "CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305" "unprognostic (7.21e-3)" "prognostic unfavorable (4.74e-4)" "unprognostic (4.85e-2)" "unprognostic (1.15e-2)" "unprognostic (8.86e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (6.62e-3)" "unprognostic (5.68e-2)" "unprognostic (2.31e-1)" "unprognostic (1.38e-1)" "unprognostic (6.41e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (2.82e-1)" "unprognostic (9.09e-2)" "unprognostic (8.87e-2)" "unprognostic (3.19e-2)" 62.1 54.6 42.3 58.2 44.1 44.2 188.9 20.1 43.7 58.9 74.0 16.3 67.7 52.5 65.0 52.0 104.3 56.8 65.3 115.1 38.2 32.1 77.3 115.7 59.0 174.7 45.0 23.7 90.7 234.3 17.5 30.4 37.9 34.0 64.0 62.7 29.9 109.4 65.8 105.3 63.3 45.1 88.3 34.6 69.4 50.2 32.3 24.4 42.5 66.9 102.0 56.6 81.3 140.8 49.3 71.3 8.3 43.7 32.6 34.5 38.2 89.1 131.0 31.4 54.7 70.2 102.4 86.6 61.8 64.3 94.6 72.1 105.7 47.5 75.0 100.2 63.3 48.6 57.1 65.8 84.3 78.0 90.4 194.5 63.0 91.4 153.0 76.6 99.5 44.2 92.6 98.5 61.0 107.4 67.1 56.3 53.7 86.3 50.6 68.1 158.5 49.8 124.4 46.7 205.0 201.3 47.8 104.0 119.7 102.4 112.7 71.5 44.3 38.0 95.6 92.8 61.7 65.9 76.3 57.1 91.3 66.0 64.8 98.2 88.4 114.8 85.9 49.3 50.7 45.7 8.3 35.1 2.0 24.7 43.7 34.5 49.3 33.0 26.9 61.5 36.2 23.8 25.6 2.1 32.6 38.0 71.3 29.9 38.2 42.3 44.1 20.1 43.7 38.2 32.1 45.0 23.7 34.0 24.4 26.8 56.3 13.7 6.1 12.9 0.9 0.0 22.9 115.1 150.2 5.2 0.0 10.6 31.5 37.0 0.4 14.4 5.6 23.3 30.1 24.4 10.8 3.7 39.5 37.1 14.9 0.0 14.0 31.9 41.2 1.1 23.9 13.6 10.1 88.4 24.3 0.2 47.4 14.0 12.0 26.2 0.8 6.5 5.7 0.5 5.0 13.0 7.3 18.1 29.3 6.8 NME3 "DR-nm23, NDPKC, NM23-H3" ENSG00000103024 "NME/NM23 nucleoside diphosphate kinase 3" Q13232 16 1770286-1771730 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041113, HPA052733" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 7900000 Nucleoplasm Cytosol "HPA041113: AB_2677305, HPA052733: AB_2681930" "prognostic favorable (6.81e-5)" "unprognostic (1.41e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.22e-3)" "unprognostic (4.40e-2)" "unprognostic (4.43e-2)" "unprognostic (7.09e-3)" "unprognostic (1.79e-1)" "unprognostic (3.84e-1)" "unprognostic (3.64e-1)" "unprognostic (6.11e-3)" 20.6 45.6 18.0 12.9 19.8 6.6 20.0 21.9 18.2 16.6 18.0 11.0 31.6 25.7 14.4 19.1 12.9 14.3 21.5 11.8 17.5 16.1 17.7 11.2 17.3 11.3 18.4 15.9 22.1 26.8 15.1 24.1 9.7 14.4 26.9 6.4 13.8 34.3 41.4 15.2 9.2 24.6 14.6 14.1 20.4 17.5 7.2 14.6 5.1 24.1 11.7 8.8 11.5 17.9 19.3 34.1 15.5 25.6 20.1 24.4 20.0 0.7 11.7 0.2 9.6 2.7 1.4 1.1 6.8 2.0 1.2 0.9 0.0 14.0 0.1 19.2 0.9 1.2 10.0 0.6 3.8 0.1 13.7 31.3 0.0 5.5 5.5 5.2 2.3 4.4 6.4 3.5 1.2 0.7 2.3 2.5 0.1 4.7 1.9 1.2 17.0 0.2 4.6 12.5 2.3 9.5 6.5 0.1 18.3 2.0 0.5 13.7 10.6 20.7 15.6 1.7 0.5 14.9 5.6 8.7 2.6 9.7 8.3 4.6 5.0 1.5 1.0 3.5 0.4 5.8 4.9 25.6 15.5 17.5 22.9 17.1 19.3 24.4 16.4 22.0 16.3 21.4 16.8 5.3 20.1 24.5 34.1 21.8 20.0 18.0 19.8 21.9 18.2 17.5 16.1 18.4 15.9 14.4 14.6 32.8 63.8 51.1 124.1 64.5 115.4 25.8 76.5 58.9 55.7 120.4 56.9 65.8 51.4 53.1 16.8 69.7 85.0 0.0 33.3 35.7 82.8 109.1 50.7 52.9 65.1 62.0 130.1 72.4 57.8 13.2 138.4 78.5 77.6 175.9 94.2 102.4 38.5 89.7 119.9 123.2 117.3 116.4 86.4 1.4 41.7 57.3 38.6 61.8 96.6 69.8 NME8 "CILD6, NM23-H8, SPTRX2, TXNDC3" ENSG00000086288 "NME/NM23 family member 8" Q8N427 7 37848597-37900401 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 7.9;bone marrow: 13.4;testis: 11.3" "Group enriched" "Detected in some" 5 "Early spermatids: 33.4;Late spermatids: 14.1" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 1.7;HMC-1: 2.5;NB-4: 3.7;NTERA-2: 3.5;THP-1: 3.2;U-937: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016416, HPA019259, HPA029572" Enhanced Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "CAB016416: , HPA019259: AB_1858475, HPA029572: " "unprognostic (7.44e-3)" "unprognostic (2.32e-2)" "unprognostic (9.11e-2)" "unprognostic (2.97e-2)" "unprognostic (6.05e-2)" "unprognostic (1.20e-2)" "unprognostic (6.56e-2)" "unprognostic (4.22e-2)" "unprognostic (7.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (2.34e-2)" "unprognostic (8.13e-8)" "unprognostic (5.90e-2)" "unprognostic (3.36e-1)" "unprognostic (1.49e-1)" "unprognostic (1.86e-1)" 0.1 0.0 0.1 0.5 0.1 13.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.2 0.2 0.1 0.1 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.8 1.9 0.1 11.3 0.0 0.2 0.0 0.0 0.0 7.9 3.8 1.9 0.2 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 1.9 1.5 0.7 0.4 0.0 0.0 0.1 1.3 1.5 0.0 0.0 0.7 3.8 0.2 0.0 7.9 0.0 0.8 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.8 0.0 0.0 0.0 3.0 14.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 3.8 0.0 0.0 NME9 "NM23-H9, TXL-2, TXNDC6" ENSG00000181322 "NME/NM23 family member 9" Q86XW9 3 138261437-138329886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 30.4" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 64.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.2" "Lineage enriched" "Detected in single" 4 "T-cells: 4.2" "Cell line enhanced" "Detected in many" "HMC-1: 4.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020943, HPA040000, HPA043881" Enhanced Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712" "unprognostic (2.71e-5)" "unprognostic (1.68e-1)" "unprognostic (5.09e-2)" "unprognostic (3.01e-3)" "unprognostic (3.67e-1)" "unprognostic (1.69e-3)" "unprognostic (4.58e-2)" "unprognostic (5.19e-2)" "unprognostic (1.66e-1)" "unprognostic (1.12e-2)" "unprognostic (1.03e-2)" "unprognostic (1.72e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (9.14e-2)" "unprognostic (4.89e-2)" "unprognostic (7.17e-3)" 1.0 1.7 5.3 1.3 11.3 4.4 1.0 6.2 8.3 1.5 0.8 4.1 3.5 1.1 1.6 3.6 0.8 30.4 1.3 0.9 5.6 8.2 1.7 0.8 4.0 1.1 3.6 3.1 2.5 3.3 1.8 7.5 1.1 10.3 1.7 0.8 0.9 3.4 1.9 4.3 1.8 1.1 1.0 3.6 1.2 1.5 6.0 3.9 0.9 2.3 0.0 1.0 0.8 0.5 0.6 0.6 0.3 0.9 0.3 4.2 0.5 1.1 1.6 1.1 0.5 0.0 0.0 1.7 0.7 0.0 0.2 0.1 0.9 1.9 2.5 1.2 0.0 1.3 1.3 0.2 0.0 0.0 0.5 1.8 2.1 1.6 0.6 0.0 2.7 4.9 0.9 0.0 0.1 0.0 2.9 0.1 3.2 0.6 1.4 0.2 0.4 0.6 2.5 0.7 0.5 1.2 1.0 0.0 0.7 1.7 2.6 3.7 1.0 1.6 0.6 0.4 0.9 0.9 0.1 3.0 0.5 0.8 0.8 0.6 0.9 1.2 1.1 1.0 1.1 0.5 0.1 0.9 0.0 0.5 0.0 4.2 0.2 1.7 0.4 0.3 0.6 2.8 1.2 0.3 0.3 0.2 0.6 0.7 0.5 5.3 11.3 6.2 8.3 5.6 8.2 3.6 3.1 10.3 3.9 0.0 0.3 0.0 0.2 0.0 1.3 1.1 2.5 64.3 3.4 1.8 0.0 0.1 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 2.3 0.0 0.0 5.5 0.5 0.0 0.2 0.0 0.0 0.0 NMI ENSG00000123609 "N-myc and STAT interactor" Q13287 2 151270465-151290057 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 75.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008588 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008588: AB_1079493" "unprognostic (5.28e-2)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.42e-2)" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "prognostic unfavorable (3.54e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.57e-7)" "unprognostic (1.91e-1)" "unprognostic (4.69e-2)" "unprognostic (1.52e-2)" "unprognostic (4.57e-2)" 12.0 14.2 5.0 18.6 7.1 26.4 14.0 1.3 5.8 8.9 15.0 3.4 11.1 13.2 8.6 10.4 16.1 9.8 14.7 8.7 5.9 3.8 13.0 20.4 18.5 26.9 5.1 2.7 14.8 8.4 2.9 6.5 24.6 6.9 13.6 10.5 5.0 9.8 7.9 5.1 7.3 26.0 13.1 7.7 30.2 10.2 5.3 6.4 36.7 14.9 10.2 14.2 10.4 10.3 10.8 17.0 75.1 26.9 14.3 12.5 14.9 10.9 5.4 0.3 0.0 3.1 8.5 10.7 3.2 7.5 15.4 23.5 1.1 25.0 10.7 11.9 4.8 5.1 6.3 1.1 2.8 3.9 22.7 0.6 30.1 5.6 0.6 13.2 28.5 8.7 5.5 3.8 9.2 2.1 6.8 19.0 11.9 14.9 2.6 2.9 8.4 23.9 42.6 6.3 2.2 8.1 25.8 0.6 9.2 12.7 9.5 1.5 0.0 6.7 7.3 4.1 1.1 1.2 32.5 10.3 2.2 5.0 7.2 4.6 0.4 0.4 0.6 5.3 34.3 2.4 31.6 19.7 21.6 10.8 26.9 12.5 10.8 11.3 10.7 17.0 9.1 9.2 9.4 75.1 14.3 24.4 6.9 9.7 14.9 5.0 7.1 1.3 5.8 5.9 3.8 5.1 2.7 6.9 6.4 23.8 19.8 16.0 18.1 14.8 0.2 3.1 15.3 38.8 27.3 12.2 0.0 62.5 13.3 54.5 2.6 35.8 24.2 0.0 36.0 53.3 19.2 13.1 34.7 16.0 71.3 0.0 17.3 17.2 39.1 0.0 18.1 53.0 1.7 45.9 20.9 5.8 34.1 23.0 13.1 20.9 0.0 6.5 14.7 3.3 1.7 15.6 45.5 40.7 19.5 19.2 NMNAT2 "C1orf15, KIAA0479, PNAT2" ENSG00000157064 "Nicotinamide nucleotide adenylyltransferase 2" Q9BZQ4 1 183248237-183418602 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.9" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 30.1;Early spermatids: 50.3;Horizontal cells: 19.1;Late spermatids: 19.5;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 12.9;SCLC-21H: 37.5;SuSa: 12.3;U-2197: 21.9;U-87 MG: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015708, HPA061714" Enhanced Approved Cytosol NA NA Cytosol "HPA015708: , HPA061714: AB_2732669" "unprognostic (3.70e-1)" "unprognostic (7.98e-3)" "unprognostic (8.83e-2)" "unprognostic (4.16e-2)" "unprognostic (8.95e-2)" "unprognostic (9.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.35e-1)" "unprognostic (7.92e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.73e-3)" "unprognostic (2.90e-3)" "unprognostic (1.87e-1)" "unprognostic (7.51e-2)" "unprognostic (1.02e-1)" 9.6 7.7 26.2 1.9 34.5 1.0 2.9 53.9 53.5 3.6 2.2 2.0 0.0 1.5 2.5 2.7 1.9 3.8 4.1 19.6 20.6 15.1 1.5 1.1 1.8 1.7 8.6 28.3 1.5 2.9 1.3 17.4 2.0 15.6 1.3 2.1 0.5 1.5 4.1 1.3 1.7 2.0 2.7 4.1 1.2 2.1 8.7 6.3 0.0 7.2 0.0 1.7 1.9 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.2 2.5 0.0 1.5 6.2 2.2 1.6 4.1 0.8 0.2 1.2 2.4 0.0 6.8 0.4 0.7 1.0 0.1 0.0 1.6 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 12.9 0.5 1.0 0.2 5.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.2 4.4 0.0 2.4 0.0 0.1 0.0 2.8 2.0 37.5 2.9 0.3 0.1 0.0 12.3 0.3 0.6 1.4 1.2 0.4 21.9 1.5 0.3 0.0 0.0 17.1 0.1 0.1 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 26.2 34.5 53.9 34.7 20.6 15.1 8.6 28.3 15.6 6.3 0.0 1.0 0.0 0.2 0.7 10.7 30.1 0.0 2.7 3.4 0.0 0.0 0.6 0.0 0.1 50.3 2.9 0.0 0.0 0.0 9.6 0.4 0.1 0.0 0.0 0.5 19.1 0.0 0.0 0.6 19.5 0.0 0.5 1.7 0.0 0.0 0.3 0.5 0.0 0.0 0.0 1.6 19.4 5.0 0.5 0.2 0.3 1.1 0.0 0.0 0.0 NMRK1 "bA235O14.2, C9orf95, FLJ20559, NRK1" ENSG00000106733 "Nicotinamide riboside kinase 1" Q9NWW6 9 75060573-75088217 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 102.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 29.9;Karpas-707: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049795 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA049795: AB_2680886" "unprognostic (1.12e-1)" "unprognostic (4.13e-2)" "unprognostic (3.58e-2)" "prognostic favorable (3.70e-6)" "unprognostic (3.56e-2)" "unprognostic (2.35e-1)" "unprognostic (5.20e-3)" "unprognostic (2.21e-2)" "unprognostic (3.27e-2)" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (1.78e-1)" "prognostic favorable (5.60e-4)" "unprognostic (9.25e-2)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "unprognostic (5.64e-2)" 15.5 7.7 11.1 15.9 10.7 6.9 14.3 21.5 14.6 13.2 15.2 5.8 20.1 12.2 8.1 15.6 24.6 9.4 10.9 9.4 10.2 9.7 22.1 40.3 15.4 19.9 10.8 9.7 15.2 30.6 45.8 18.1 19.7 10.2 15.9 10.3 10.9 29.5 17.7 15.0 15.6 26.6 8.3 8.7 18.8 13.6 6.7 8.9 14.4 31.6 11.2 22.0 12.6 14.8 6.7 8.8 7.3 6.7 8.2 24.2 10.1 5.1 1.1 1.5 3.5 12.2 16.5 8.3 7.5 11.8 1.9 3.1 0.0 13.6 3.0 4.5 7.2 3.6 9.0 1.7 5.0 6.0 29.9 1.8 2.1 2.4 2.6 10.9 2.0 0.4 11.4 12.9 3.1 6.4 11.4 13.0 5.2 0.2 36.8 13.2 3.8 1.9 1.8 1.9 19.4 4.7 0.6 13.5 19.3 15.3 9.2 1.0 0.2 3.2 3.3 4.2 10.3 8.5 2.2 8.9 6.5 1.2 5.9 2.0 16.3 13.0 1.8 10.6 2.2 6.6 7.3 2.7 4.5 13.9 2.5 16.7 6.7 24.2 16.0 3.1 3.9 22.1 16.7 5.2 8.2 6.7 8.8 15.4 10.1 11.1 10.7 21.5 14.6 10.2 9.7 10.8 9.7 10.2 8.9 35.7 17.1 17.1 33.3 18.7 8.5 15.1 15.3 20.1 22.7 22.7 7.9 52.7 44.7 25.5 14.0 20.7 33.3 0.0 31.3 65.3 17.5 21.3 1.1 34.4 51.6 11.1 4.1 39.3 19.7 24.5 21.9 10.5 25.3 102.8 28.0 9.6 23.2 24.6 11.7 75.6 7.6 12.9 15.2 6.6 3.8 23.6 38.1 29.9 22.4 26.0 NMT1 NMT ENSG00000136448 "N-myristoyltransferase 1" P30419 17 45051610-45109016 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 304.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022949, HPA022963" Supported Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA022949: AB_1854534, HPA022963: AB_1854535" "unprognostic (1.40e-1)" "unprognostic (2.87e-1)" "unprognostic (1.30e-2)" "unprognostic (6.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (4.96e-3)" "unprognostic (3.86e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (3.77e-3)" "unprognostic (1.01e-2)" "unprognostic (4.89e-2)" "unprognostic (4.17e-3)" "unprognostic (9.45e-2)" 28.8 32.6 44.9 28.2 37.3 12.0 26.1 34.5 64.3 23.7 24.4 17.2 22.9 23.4 27.3 29.3 26.6 30.9 17.3 26.8 37.7 29.6 28.8 36.6 26.7 27.2 27.7 43.6 29.3 21.8 41.6 23.7 32.7 38.1 23.7 23.1 18.1 34.9 30.1 75.5 28.8 24.8 30.1 36.6 28.2 23.4 26.1 34.0 20.7 29.4 18.6 30.9 25.1 43.3 10.2 18.2 7.6 9.3 7.4 10.0 3.3 17.0 22.6 19.5 17.2 35.3 22.8 20.5 19.0 25.2 37.1 30.6 25.2 14.7 20.5 27.6 26.1 26.6 16.1 33.5 26.6 34.4 52.1 23.4 20.4 15.1 24.8 23.2 26.3 24.6 28.7 24.2 27.5 21.9 19.9 24.8 21.0 32.3 10.4 20.6 14.6 31.9 17.9 18.2 31.4 23.6 21.9 29.1 15.6 29.3 15.8 16.3 14.7 12.0 11.0 17.2 34.8 23.7 20.9 19.9 22.7 17.4 18.2 25.3 16.2 23.0 20.5 24.3 14.8 23.9 6.5 8.1 7.6 7.9 9.3 7.2 10.2 7.8 9.3 6.6 7.6 10.0 7.6 5.3 7.4 6.9 18.2 7.5 3.3 44.9 37.3 34.5 64.3 37.7 29.6 27.7 43.6 38.1 34.0 35.7 35.1 55.6 14.2 12.4 85.1 38.9 94.3 16.0 27.3 66.3 110.0 63.6 66.3 62.0 17.1 41.3 50.2 116.8 61.6 49.6 39.9 11.1 22.0 304.8 40.7 122.3 48.9 77.3 77.9 6.8 50.9 41.1 10.1 108.2 32.8 38.5 58.3 45.6 48.1 45.3 119.2 58.2 14.4 60.6 32.8 12.3 68.4 41.5 52.5 15.0 NMT2 ENSG00000152465 "N-myristoyltransferase 2" O60551 10 15102584-15168693 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 89.2;Hepatocytes: 122.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 8.7;eosinophil: 7.9;gdT-cell: 7.2;MAIT T-cell: 12.9;memory CD4 T-cell: 11.5;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 9.3;NK-cell: 12.9;T-reg: 17.5" "Group enriched" "Detected in many" 7 "granulocytes: 8.7;NK-cells: 12.9;T-cells: 17.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 33.8;TIME: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001303 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA001303: AB_1079494" "unprognostic (1.08e-1)" "unprognostic (7.65e-2)" "unprognostic (8.78e-2)" "unprognostic (1.15e-3)" "unprognostic (6.97e-2)" "unprognostic (2.24e-1)" "unprognostic (7.11e-2)" "unprognostic (5.13e-2)" "unprognostic (3.20e-1)" "unprognostic (4.01e-3)" "unprognostic (3.31e-1)" "unprognostic (2.00e-1)" "unprognostic (7.06e-2)" "unprognostic (3.79e-3)" "unprognostic (2.00e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" 29.3 5.4 18.9 6.5 17.3 3.8 19.2 35.6 25.3 12.0 9.9 6.0 4.7 7.4 14.5 5.0 8.2 8.9 8.1 9.6 12.8 9.2 10.8 18.5 7.2 9.0 8.8 15.0 18.2 7.1 28.5 7.9 5.1 10.3 10.7 10.7 8.3 5.8 9.4 18.8 11.5 11.9 12.5 10.3 10.1 8.8 14.5 9.9 23.7 6.9 4.5 8.9 10.1 20.1 1.9 0.3 8.7 0.5 12.9 17.5 3.9 2.8 3.6 4.2 3.1 11.5 12.4 0.8 6.2 5.0 5.7 7.8 3.5 12.7 0.1 4.3 33.8 15.7 3.5 3.7 3.5 9.6 3.7 4.8 7.6 1.8 4.8 7.7 0.5 28.3 11.0 3.6 8.1 2.4 20.9 22.0 5.3 3.6 0.5 21.2 3.5 5.8 1.4 3.1 3.2 3.5 4.3 6.2 0.5 4.2 0.6 1.2 4.8 7.5 1.2 2.0 3.7 3.8 2.3 49.0 5.7 8.4 25.0 4.4 4.3 4.5 0.3 7.0 2.0 4.1 8.7 0.3 7.9 7.2 0.4 12.9 1.4 11.5 8.3 0.3 1.9 14.7 9.3 1.2 12.9 0.5 0.2 17.5 3.9 18.9 17.3 35.6 25.3 12.8 9.2 8.8 15.0 10.3 9.9 8.9 9.1 18.2 17.3 14.7 21.8 11.1 76.5 5.3 14.8 26.2 3.9 0.8 8.3 23.8 6.4 20.4 30.1 46.7 16.8 2.1 11.6 13.9 89.2 122.4 2.4 19.1 17.2 24.5 6.9 9.6 20.1 6.5 11.8 13.6 9.9 12.0 21.3 12.2 19.4 44.1 14.9 0.0 15.3 7.4 50.5 12.9 2.2 38.3 16.9 13.4 NNMT ENSG00000166741 "Nicotinamide N-methyltransferase" P40261 11 114257787-114313285 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 97.7" "Cell type enriched" "Detected in many" 9 "Hepatocytes: 3284.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 68.8;LHCN-M2: 40.9;RPTEC TERT1: 105.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059180 Approved Approved "Golgi apparatus,Cytosol" NA NA 15000 "Golgi apparatus" Cytosol "HPA059180: AB_2683940" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" "unprognostic (1.61e-2)" "unprognostic (6.14e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (2.07e-4)" "unprognostic (1.76e-1)" "unprognostic (5.84e-2)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-6)" "prognostic unfavorable (1.75e-4)" "unprognostic (1.11e-1)" "unprognostic (3.37e-3)" "unprognostic (2.77e-2)" 23.7 1.4 0.6 8.8 0.9 0.1 14.6 0.6 1.7 13.1 8.5 0.7 4.9 0.5 15.8 8.7 12.0 8.3 15.3 8.2 1.6 0.0 4.7 97.7 10.0 3.4 1.1 0.6 11.2 2.0 0.6 2.6 8.6 3.3 9.6 3.3 1.6 3.6 6.7 18.3 8.2 4.3 12.4 1.5 5.8 5.1 7.3 0.6 1.3 5.3 2.2 3.1 10.9 35.3 0.6 0.1 0.7 0.2 0.0 0.9 0.0 0.0 4.8 0.0 4.3 24.8 32.2 0.0 6.1 16.3 9.8 19.5 0.0 6.6 0.0 21.8 12.5 1.3 0.0 0.0 2.2 9.9 0.0 0.0 0.0 7.6 0.0 33.8 0.0 0.0 68.8 23.8 6.9 10.3 8.2 13.5 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 27.4 0.0 105.9 0.0 0.0 0.0 30.7 0.0 0.0 1.5 0.0 0.0 9.5 5.6 22.6 8.7 1.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.2 0.0 0.2 0.1 0.9 0.2 0.0 0.2 0.1 0.6 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.6 0.9 0.6 1.7 1.6 0.0 1.1 0.6 3.3 0.6 41.7 380.8 30.2 10.6 92.0 0.5 4.0 76.5 18.7 20.5 76.8 0.0 0.9 8.3 207.6 0.2 191.1 0.0 163.5 133.3 1.9 375.3 11.6 12.8 3284.1 21.8 0.0 5.1 176.1 103.2 1.0 68.7 12.7 91.1 10.0 0.0 0.0 366.0 0.0 12.4 27.9 0.1 0.0 113.1 0.3 0.4 80.5 1.8 46.0 0.0 2.4 NNT ENSG00000112992 "Nicotinamide nucleotide transhydrogenase" Q13423 5 43602692-43707405 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Translocase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.0" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 303.5;Hepatocytes: 274.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004829, CAB004975" Enhanced Approved Mitochondria,Cytosol NA NA 1100000 Mitochondria Cytosol "CAB004975: AB_425908, HPA004829: AB_1079495" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (4.81e-2)" "unprognostic (5.02e-2)" "unprognostic (1.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.96e-3)" "unprognostic (2.20e-2)" "unprognostic (3.98e-2)" "unprognostic (1.65e-1)" "unprognostic (8.33e-2)" "prognostic favorable (1.22e-15)" "unprognostic (8.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (2.58e-1)" 10.8 10.5 11.7 8.3 14.0 7.3 9.1 8.3 19.0 7.6 11.2 7.3 8.8 9.2 7.1 8.8 7.9 5.4 7.1 62.1 10.8 8.2 26.0 48.5 7.2 9.6 9.2 10.3 5.8 12.2 15.6 6.2 5.8 10.0 8.5 12.1 6.7 14.4 7.8 100.0 6.0 8.9 14.7 6.1 6.5 13.6 4.2 6.1 14.0 14.0 32.6 8.7 10.9 6.2 11.4 25.5 13.1 18.5 18.2 19.1 13.5 8.3 6.2 14.3 26.6 16.7 18.6 4.5 8.4 14.4 10.4 9.4 7.1 13.9 8.6 10.5 16.0 11.0 8.0 56.7 2.0 11.0 13.6 15.3 12.4 33.3 8.7 9.6 20.7 18.5 16.0 6.3 5.9 8.5 18.2 20.5 12.5 8.9 34.4 24.7 5.7 22.3 11.2 2.8 0.0 5.6 25.1 33.8 30.8 19.7 7.4 21.1 17.6 30.9 0.4 19.1 3.1 21.6 20.9 11.2 15.2 14.8 6.3 4.1 18.5 19.0 13.2 3.1 27.7 9.8 9.3 14.2 13.1 14.4 18.4 14.8 11.4 15.6 14.5 25.5 10.3 14.6 13.3 2.4 18.2 18.5 9.2 19.1 13.5 11.7 14.0 8.3 19.0 10.8 8.2 9.2 10.3 10.0 6.1 50.6 27.8 20.7 7.7 10.2 17.5 303.5 28.1 24.1 31.8 26.2 33.4 7.2 23.2 10.7 12.2 12.6 17.2 23.3 9.3 2.1 17.9 10.5 23.3 274.2 21.7 6.4 19.1 20.3 31.4 3.4 13.8 18.2 13.5 10.8 24.6 13.2 9.5 11.5 18.0 21.1 11.9 0.0 15.1 2.1 1.2 7.0 1.7 27.7 25.8 7.6 NOB1 "ART-4, MST158, NOB1P, PSMD8BP1" ENSG00000141101 "NIN1/PSMD8 binding protein 1 homolog" Q9ULX3 16 69741867-69754940 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041522, HPA049430, HPA067411" Approved Approved "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA041522: , HPA049430: AB_2680764, HPA067411: " "unprognostic (5.11e-2)" "unprognostic (4.49e-2)" "unprognostic (3.15e-1)" "unprognostic (8.61e-3)" "unprognostic (9.45e-2)" "prognostic unfavorable (4.21e-5)" "prognostic unfavorable (8.16e-4)" "unprognostic (3.26e-2)" "unprognostic (3.04e-1)" "unprognostic (7.51e-2)" "unprognostic (1.04e-2)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (1.16e-1)" 18.2 31.6 9.9 14.5 18.0 17.4 18.9 13.4 16.2 18.8 19.4 12.5 12.4 20.3 21.3 15.5 25.4 29.2 19.0 13.3 9.6 9.7 18.4 23.4 13.3 21.3 12.9 7.5 37.5 68.5 13.9 10.1 13.1 13.5 21.5 12.7 13.0 20.4 14.8 26.3 25.1 15.5 18.0 10.1 21.5 20.5 11.6 15.4 23.7 28.9 25.8 29.0 25.6 18.4 21.0 20.3 2.0 15.0 24.5 26.1 17.3 14.8 32.6 7.7 21.8 17.1 27.1 15.3 11.9 16.7 22.4 20.4 36.9 24.5 33.2 18.7 13.2 11.8 22.1 21.1 26.7 13.3 8.3 24.6 12.9 15.4 47.3 30.4 23.8 10.9 34.2 22.8 25.8 33.0 20.9 18.9 20.2 29.4 10.3 11.1 38.9 29.9 47.7 23.6 16.6 19.4 33.2 7.9 41.9 16.6 14.5 20.0 9.9 37.6 13.2 18.6 7.1 14.3 21.6 14.3 15.3 13.9 13.9 19.4 17.0 12.9 58.5 15.3 21.8 16.8 0.1 15.0 2.0 17.6 12.7 24.6 19.4 21.4 16.1 20.3 21.0 23.1 21.0 0.7 24.5 9.5 10.5 26.1 17.3 9.9 18.0 13.4 16.2 9.6 9.7 12.9 7.5 13.5 15.4 3.0 13.1 37.1 60.4 53.2 9.7 4.8 15.3 18.7 46.6 19.2 0.0 58.6 34.9 34.6 8.8 42.1 15.8 23.3 74.6 74.1 39.0 28.3 16.1 13.2 32.4 4.8 9.8 18.4 20.2 5.9 33.9 23.1 20.3 37.9 33.2 10.5 44.9 17.5 40.0 27.6 4.6 25.8 39.2 17.4 28.1 52.1 39.7 37.4 50.6 54.8 NOCT "Ccr4c, CCR4L, CCRN4L, NOC" ENSG00000151014 Nocturnin Q9UK39 4 139015789-139045939 "Enzymes, Predicted intracellular proteins" "Biological rhythms" "Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Cone photoreceptor cells: 13.7;Extravillous trophoblasts: 7.7;Syncytiotrophoblasts: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012287, HPA053714" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA012287: AB_2668640, HPA053714: AB_2682238" "unprognostic (2.16e-1)" "unprognostic (2.16e-3)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-3)" "unprognostic (2.00e-3)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.86e-1)" "unprognostic (5.64e-3)" "unprognostic (4.63e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (3.52e-4)" "prognostic unfavorable (6.23e-4)" 17.5 3.9 3.3 4.9 8.0 38.7 7.4 3.2 7.3 2.7 3.1 2.7 0.0 2.2 2.8 1.5 4.0 2.5 7.9 5.4 4.9 3.7 6.9 25.8 5.1 3.1 3.0 3.1 1.7 4.4 4.0 4.7 9.3 3.7 2.0 2.8 1.8 10.8 1.4 12.0 3.9 10.5 4.5 2.3 3.2 3.0 4.9 2.6 3.7 2.9 11.8 3.9 3.7 4.6 1.9 1.5 6.3 3.1 1.4 2.4 0.2 4.7 5.5 2.2 4.1 5.0 2.1 13.5 7.1 5.1 10.1 7.3 7.3 2.0 15.8 5.7 5.3 14.3 3.4 11.4 6.2 9.6 7.0 4.6 7.3 3.3 6.4 4.5 10.7 4.3 2.4 3.1 11.2 7.6 2.0 4.4 3.2 13.1 5.2 4.5 5.4 7.3 5.6 7.0 2.1 5.9 6.0 6.4 5.6 6.8 3.1 8.2 5.5 4.5 5.1 4.0 8.9 3.7 8.3 6.6 5.5 7.1 5.2 8.4 4.3 4.0 10.0 5.1 21.2 6.9 1.5 1.4 0.8 2.4 1.5 1.4 1.1 1.1 1.3 0.6 1.9 0.8 1.6 6.3 1.4 3.1 1.5 0.7 0.2 3.3 8.0 3.2 7.3 4.9 3.7 3.0 3.1 3.7 2.6 8.9 0.6 0.0 2.6 0.0 4.7 0.0 2.5 1.4 1.2 0.0 13.7 4.3 1.7 1.9 0.6 0.0 0.3 0.0 0.2 7.7 0.5 2.0 2.3 1.5 1.4 1.6 0.0 0.6 2.2 0.0 0.9 0.7 0.0 0.0 0.1 0.3 1.8 0.0 0.0 3.1 4.6 0.0 0.0 0.9 3.2 0.0 10.1 0.0 0.0 1.7 NOD2 "BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1" ENSG00000167207 "Nucleotide binding oligomerization domain containing 2" Q9HC29 16 50693588-50734041 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 5.9;Basal keratinocytes: 5.3;Kupffer cells: 9.7;Macrophages: 13.7;Suprabasal keratinocytes: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 15.3;eosinophil: 3.9;intermediate monocyte: 9.1;myeloid DC: 15.5;neutrophil: 6.3;non-classical monocyte: 5.8" "Group enriched" "Detected in many" 6 "dendritic cells: 15.5;granulocytes: 6.3;monocytes: 15.3" "Cell line enhanced" "Detected in some" "HMC-1: 11.9;T-47d: 5.7;THP-1: 6.8;U-266/70: 15.7;U-266/84: 6.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041985, HPA054494" Enhanced Approved "Golgi apparatus,Cytosol" No NA "Golgi apparatus, Cytosol" "HPA041985: AB_2677780, HPA054494: AB_2682505" "unprognostic (1.01e-1)" "unprognostic (4.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.02e-3)" "unprognostic (9.91e-3)" "unprognostic (5.84e-2)" "unprognostic (5.90e-3)" "unprognostic (1.23e-1)" "unprognostic (4.17e-1)" "unprognostic (3.88e-2)" "unprognostic (6.94e-3)" "unprognostic (1.48e-2)" "unprognostic (2.31e-9)" "unprognostic (4.38e-2)" "unprognostic (1.08e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" 2.6 0.6 0.9 6.2 0.5 13.2 1.7 0.5 1.5 5.7 1.0 0.7 0.9 1.5 1.8 2.6 12.6 1.1 3.7 3.2 1.2 0.5 0.8 1.9 7.6 8.0 1.6 0.0 1.4 0.4 0.0 1.0 2.6 1.4 1.8 1.0 1.2 5.5 0.4 1.4 14.2 1.3 1.9 3.2 4.7 1.4 2.2 0.9 1.0 0.9 12.1 8.3 4.0 10.6 0.0 15.5 6.3 15.3 1.9 1.0 6.8 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 11.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.1 0.0 1.4 0.0 0.0 5.7 6.8 0.0 0.0 0.0 0.0 0.0 15.7 6.7 0.0 0.2 0.1 0.0 2.0 15.3 3.9 0.2 9.1 0.5 0.0 1.0 0.9 15.5 0.0 0.1 0.3 6.3 1.9 5.8 0.6 0.6 6.8 0.9 0.5 0.5 1.5 1.2 0.5 1.6 0.0 1.4 0.9 0.0 5.9 0.0 0.3 5.3 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 1.1 0.0 2.4 0.0 1.2 0.0 9.7 0.0 0.0 13.7 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.2 0.7 0.0 0.3 NOL3 "ARC, CARD2, MYP, NOP30" ENSG00000140939 "Nucleolar protein 3" O60936 16 67170154-67175735 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009208 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009208: AB_634091" "unprognostic (2.83e-2)" "unprognostic (1.63e-2)" "unprognostic (3.34e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-3)" "unprognostic (2.83e-1)" "prognostic unfavorable (6.43e-5)" "unprognostic (5.74e-2)" "unprognostic (4.07e-2)" "unprognostic (1.83e-1)" "unprognostic (2.15e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (2.41e-4)" "unprognostic (1.39e-2)" "unprognostic (3.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.48e-2)" 16.3 22.6 13.0 3.2 19.6 1.3 9.4 7.3 14.1 8.4 7.1 10.8 19.7 5.3 7.5 10.5 15.4 7.8 15.7 29.1 11.1 8.3 10.1 12.8 10.1 2.6 15.9 12.3 6.8 12.3 22.8 14.8 8.6 12.7 19.8 6.1 13.8 18.0 13.3 76.1 39.7 5.2 10.6 11.6 3.7 11.1 2.7 15.8 0.6 9.6 27.7 6.3 9.4 9.2 0.0 2.1 1.5 6.8 0.7 3.4 2.5 6.2 10.2 1.7 9.6 8.6 6.5 9.6 5.0 5.4 5.5 3.3 2.2 16.5 0.1 16.8 5.9 1.4 10.5 2.3 7.8 1.3 5.6 3.6 0.2 8.1 3.2 5.4 0.5 1.3 4.0 14.5 4.3 3.1 15.8 2.3 2.2 2.2 6.6 10.3 16.2 0.1 0.8 1.6 5.7 25.2 5.6 3.6 12.4 9.3 1.9 13.6 7.3 21.2 15.4 2.2 2.3 32.8 1.7 5.3 7.3 6.2 7.1 4.3 9.7 3.0 1.7 20.6 1.6 2.4 0.0 6.8 0.0 0.3 0.6 0.1 0.0 3.4 0.3 2.1 0.0 0.0 0.5 1.5 0.7 0.2 2.1 0.0 2.5 13.0 19.6 7.3 14.1 11.1 8.3 15.9 12.3 12.7 15.8 26.8 25.2 2.2 26.4 12.2 16.6 45.2 33.1 8.1 13.6 3.5 15.7 7.0 13.3 54.2 0.9 10.5 15.3 0.0 30.2 9.9 15.1 25.5 2.3 27.7 9.5 52.4 21.5 8.0 5.1 0.4 23.3 3.1 20.3 20.8 17.6 28.3 36.8 10.5 28.3 17.3 46.0 12.9 36.2 0.2 1.1 17.2 9.3 2.2 13.7 21.4 NOP9 C14orf21 ENSG00000196943 "NOP9 nucleolar protein" Q86U38 14 24299862-24309124 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000850 Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA000850: AB_1078287" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (4.57e-3)" "unprognostic (1.85e-1)" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.69e-2)" "unprognostic (9.37e-2)" "unprognostic (7.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "prognostic favorable (9.39e-6)" "unprognostic (7.03e-3)" "unprognostic (3.80e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" 12.0 12.9 11.3 11.4 11.4 14.4 10.0 13.3 17.5 11.3 14.4 16.8 9.6 16.5 11.1 10.1 16.6 10.3 13.8 19.4 10.9 10.6 9.7 14.2 9.5 15.1 13.7 10.0 13.3 13.3 20.1 8.9 11.6 10.9 10.8 12.3 13.0 12.5 11.5 29.7 13.5 12.4 12.3 12.3 18.8 10.9 13.0 10.7 11.8 11.2 18.3 14.9 12.1 9.4 1.6 2.1 1.8 5.2 0.4 1.6 1.4 5.0 10.1 8.2 10.3 7.2 6.1 8.2 9.1 6.8 10.7 8.4 7.6 9.0 13.0 5.1 8.2 8.7 13.2 16.3 11.3 11.2 8.2 6.2 9.5 14.0 17.3 5.8 21.8 11.0 6.1 8.8 7.9 7.4 5.8 9.9 7.6 8.1 6.5 7.4 8.7 10.1 8.3 3.7 17.8 13.0 12.7 5.0 8.3 6.6 11.6 8.3 6.4 12.7 14.9 2.8 6.2 6.3 5.8 10.1 7.3 6.0 5.9 8.5 9.1 8.0 9.8 3.9 10.0 5.7 1.4 2.3 1.8 1.5 2.4 1.6 1.2 1.4 0.7 2.1 1.6 1.0 1.0 0.5 0.4 5.2 1.1 1.2 1.4 11.3 11.4 13.3 17.5 10.9 10.6 13.7 10.0 10.9 10.7 3.0 3.5 3.7 3.0 11.1 8.2 0.8 5.1 5.3 9.1 8.7 7.9 5.4 0.0 6.6 2.4 4.1 11.3 23.3 8.7 4.6 4.7 4.7 1.1 16.3 6.5 6.4 10.3 3.7 9.7 0.5 6.1 4.7 0.0 2.8 8.1 3.9 9.7 9.9 4.2 6.5 7.4 6.5 3.1 3.5 6.0 11.8 5.4 3.2 12.1 3.9 NOSTRIN MGC20702 ENSG00000163072 "Nitric oxide synthase trafficking" Q8IVI9 2 168786539-168865514 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 51.2" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 61.2;Ito cells: 157.8;Sertoli cells: 71.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.8;HEL: 25.9;K-562: 19.5;OE19: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044384, HPA076885" Approved Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA044384: AB_2678922, HPA076885: " "unprognostic (4.74e-2)" "unprognostic (2.42e-1)" "unprognostic (8.73e-2)" "unprognostic (2.27e-1)" "unprognostic (3.15e-3)" "unprognostic (3.02e-6)" "unprognostic (4.89e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-4)" "unprognostic (5.47e-3)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" "unprognostic (1.63e-1)" "unprognostic (1.75e-1)" "unprognostic (2.33e-1)" "unprognostic (6.47e-2)" "unprognostic (4.98e-2)" 27.1 11.6 4.4 7.6 5.6 0.2 17.4 2.7 6.0 20.5 11.0 2.3 10.3 10.4 11.9 12.1 7.8 9.0 20.5 9.8 4.8 4.1 27.9 7.8 19.6 3.5 5.8 3.7 11.2 14.8 2.3 4.2 18.5 7.9 9.4 12.5 2.8 51.2 13.6 7.6 4.2 22.3 9.7 5.1 5.6 16.5 11.2 3.9 0.7 8.5 8.6 2.6 7.6 12.8 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.5 0.0 0.0 0.0 6.8 0.2 0.0 0.0 0.0 4.0 4.3 0.0 2.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 25.9 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.1 0.1 0.7 0.0 2.2 0.9 0.0 0.1 0.1 1.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 4.4 5.6 2.7 6.0 4.8 4.1 5.8 3.7 7.9 3.9 8.9 10.1 6.5 0.6 0.9 0.0 3.9 15.3 2.7 5.7 3.5 0.0 14.5 11.6 7.5 21.4 61.2 43.4 0.0 18.9 6.3 2.1 3.0 0.0 0.6 1.3 0.0 10.9 157.8 7.0 42.2 8.1 0.9 23.6 1.0 34.1 2.0 16.3 18.2 5.3 37.6 0.2 71.1 2.2 11.4 1.6 0.4 22.0 0.5 13.9 1.1 NOTCH3 "CADASIL, CASIL" ENSG00000074181 "Notch 3" Q9UM47 19 15159038-15200981 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Sertoli cells: 407.4;Smooth muscle cells: 286.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;granulocytes: 1.0" "Cell line enhanced" "Detected in many" "AF22: 28.4;MCF7: 28.0;U-87 MG: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005393, HPA044392" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA 18000000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB005393: AB_2151246, HPA044392: AB_2678926" "unprognostic (4.97e-2)" "unprognostic (3.89e-2)" "unprognostic (7.06e-3)" "prognostic unfavorable (5.92e-4)" "unprognostic (9.20e-2)" "unprognostic (1.73e-2)" "unprognostic (2.72e-1)" "unprognostic (9.04e-2)" "unprognostic (3.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (3.13e-1)" "prognostic unfavorable (2.53e-7)" "unprognostic (3.35e-2)" "unprognostic (8.34e-3)" "unprognostic (4.40e-2)" "unprognostic (2.00e-3)" 35.9 3.7 4.7 6.4 6.4 0.5 53.7 2.7 7.5 25.9 7.3 6.2 9.2 3.7 22.9 23.1 33.8 14.6 22.7 25.0 4.6 3.6 9.2 1.6 16.2 11.7 5.0 6.4 14.1 6.9 10.1 4.9 37.3 6.4 13.4 3.0 8.3 11.4 11.4 16.6 48.3 6.2 11.0 2.8 11.8 5.5 10.1 3.9 44.4 14.9 36.7 10.3 14.9 24.6 0.1 2.4 1.0 0.1 0.1 0.1 0.0 5.3 3.4 28.4 12.9 4.0 3.2 12.8 4.3 0.2 0.2 0.1 6.5 5.6 0.1 3.3 7.9 0.1 6.4 5.1 0.1 0.2 0.0 1.3 0.1 5.3 1.4 2.0 0.0 0.5 3.7 3.1 6.6 0.7 0.2 0.3 1.9 0.2 0.2 0.5 28.0 6.4 0.0 16.6 4.6 0.0 0.0 1.6 0.1 0.0 17.2 0.8 9.2 0.0 16.2 0.0 8.8 17.2 0.0 0.0 0.8 9.3 0.1 0.1 0.0 0.3 0.0 19.9 0.1 0.4 1.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 2.4 0.0 0.0 4.7 6.4 2.7 7.5 4.6 3.6 5.0 6.4 6.4 3.9 8.9 1.0 0.0 6.5 21.4 0.3 21.8 0.0 0.0 9.1 15.7 0.0 16.8 5.0 12.3 0.3 7.4 0.0 0.0 0.0 3.2 12.6 12.2 0.0 0.0 2.5 0.0 0.0 3.1 9.7 0.0 8.3 3.7 16.9 1.0 0.3 0.5 1.2 0.0 11.0 0.0 0.6 407.4 286.6 0.7 1.1 63.1 26.3 0.0 0.0 30.2 NOTO ENSG00000214513 "Notochord homeobox" A8MTQ0 2 73202258-73212513 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034660, HPA063906" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034660: AB_10601974, HPA063906: " "unprognostic (6.09e-2)" "unprognostic (9.77e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.68e-2)" 0.2 0.8 0.3 0.6 0.4 2.3 0.3 1.4 0.2 0.1 0.5 0.1 0.1 0.8 0.1 0.6 0.1 0.1 0.4 0.2 0.2 0.6 0.1 0.2 0.3 0.5 0.3 0.1 0.2 0.1 0.0 0.4 0.1 2.4 1.3 0.3 0.6 0.2 0.1 0.5 2.2 2.7 0.1 0.5 0.5 0.5 5.7 0.1 0.7 0.1 0.1 0.1 0.4 0.1 0.8 0.8 2.6 0.8 1.4 1.0 0.3 0.2 0.2 0.4 0.5 0.2 0.3 0.7 0.3 0.0 0.1 0.2 1.1 0.8 0.3 0.2 0.3 0.3 1.1 0.1 0.4 0.5 0.8 0.4 0.5 1.8 0.7 0.0 0.6 1.4 0.2 0.4 0.1 0.0 0.3 0.0 0.5 0.1 1.0 0.0 0.6 0.1 0.4 0.7 0.0 0.5 0.7 0.2 0.3 0.1 0.8 0.9 0.6 1.1 0.8 0.0 0.6 0.7 0.6 1.3 0.8 0.4 0.2 0.7 0.7 0.2 0.8 0.3 1.0 0.2 1.9 0.8 0.3 0.6 0.3 0.9 0.6 0.8 0.5 0.3 0.8 0.8 1.0 2.6 1.4 0.5 0.8 0.5 0.3 0.3 0.4 1.4 0.2 0.2 0.6 0.3 0.1 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NPDC1 "CAB-, CAB1, DKFZp586J0523" ENSG00000107281 "Neural proliferation, differentiation and control 1" Q9NQX5 9 137039470-137046203 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Glandular cells: 329.4;Intestinal endocrine cells: 270.4;Ito cells: 337.0;Mucus-secreting cells: 535.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4" "Lineage enriched" "Detected in many" 7 "T-cells: 13.6" "Cell line enhanced" "Detected in many" "T-47d: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008189 Approved Approved Nucleoplasm,Cytosol NA NA 180000 Nucleoplasm Cytosol "HPA008189: AB_1854584" "unprognostic (6.94e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.01e-5)" "prognostic favorable (6.19e-5)" "unprognostic (2.06e-1)" "unprognostic (4.83e-3)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (8.65e-2)" "unprognostic (1.53e-1)" "prognostic favorable (3.18e-4)" "unprognostic (2.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.23e-2)" "unprognostic (2.35e-1)" "unprognostic (4.20e-2)" "unprognostic (8.84e-2)" 35.4 21.7 33.1 11.9 35.5 4.1 21.6 59.7 65.6 27.8 27.1 18.4 23.8 22.2 26.7 10.8 11.6 25.4 32.3 20.4 34.5 35.3 12.7 5.9 18.9 11.5 25.1 49.0 12.0 28.6 17.2 47.7 20.1 29.5 73.1 13.3 10.6 58.0 35.5 19.0 17.7 23.0 16.4 30.3 32.4 59.6 10.4 14.5 0.8 11.5 8.6 7.2 12.8 20.2 0.1 2.0 0.5 0.4 0.1 13.6 2.6 9.4 11.4 2.8 18.4 6.6 6.8 0.7 20.4 6.4 4.6 1.8 4.6 5.2 9.4 15.5 7.8 1.4 35.7 2.4 5.5 0.5 7.6 11.6 3.8 29.2 3.3 9.5 3.3 0.0 4.7 8.6 2.5 5.0 12.0 11.8 3.8 0.2 0.2 0.9 35.9 0.2 0.3 6.1 30.0 19.0 5.6 0.0 36.0 7.8 6.1 22.7 15.7 5.4 18.2 12.2 1.1 39.3 4.7 20.3 3.4 6.2 24.3 6.2 0.0 0.1 0.3 5.0 0.3 2.9 0.0 0.4 0.5 8.4 0.0 10.7 0.1 13.2 13.6 0.7 0.0 0.3 2.3 0.0 0.1 0.0 2.0 10.4 2.6 33.1 35.5 59.7 65.6 34.5 35.3 25.1 49.0 29.5 14.5 0.0 10.6 4.2 65.4 20.9 88.5 13.4 79.0 2.7 4.5 27.9 15.7 1.0 0.0 43.0 1.0 147.8 41.7 23.3 59.4 1.0 34.3 329.4 0.0 0.8 17.1 58.8 270.4 337.0 25.4 2.5 149.3 6.8 28.7 2.8 535.1 32.8 34.0 79.7 136.9 0.3 54.6 38.8 34.0 2.9 19.1 20.7 1.5 7.7 84.8 89.4 NPEPPS "MP100, PSA" ENSG00000141279 "Aminopeptidase puromycin sensitive" P55786 17 47522942-47623276 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 253.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021453, HPA045649" Uncertain Supported Cytosol No No 2100000 Cytosol "HPA021453: AB_2670709, HPA045649: AB_2679406" "unprognostic (1.63e-1)" "unprognostic (3.15e-2)" "prognostic favorable (3.39e-5)" "unprognostic (2.66e-2)" "unprognostic (1.53e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (3.67e-5)" "unprognostic (3.84e-2)" "unprognostic (1.22e-1)" "unprognostic (1.77e-1)" "unprognostic (3.85e-2)" "unprognostic (3.63e-2)" "unprognostic (1.93e-1)" "unprognostic (8.55e-2)" "unprognostic (1.52e-1)" "unprognostic (1.23e-2)" "unprognostic (1.07e-1)" 16.0 26.0 27.2 15.9 27.7 11.1 56.1 36.5 33.8 17.1 17.7 9.8 14.6 14.6 16.9 17.1 47.7 17.2 16.3 22.2 24.0 15.6 18.8 11.1 30.3 24.1 16.0 29.7 20.8 16.8 21.2 15.3 17.6 27.2 18.6 20.0 13.3 21.8 16.5 52.3 29.6 17.3 20.4 22.8 15.7 16.2 15.3 16.1 7.0 14.5 14.8 18.1 19.0 30.5 6.9 9.0 23.2 8.6 9.3 9.2 5.4 32.7 21.6 21.8 15.3 25.1 25.4 45.9 14.5 18.8 21.9 21.4 13.9 37.7 19.6 22.4 21.1 19.9 20.0 23.9 13.3 34.2 8.7 20.6 23.5 22.3 16.1 14.5 13.3 15.3 19.4 13.2 15.9 8.4 32.0 22.5 6.8 19.8 11.4 31.1 8.8 17.6 11.9 13.3 18.5 19.6 14.3 30.6 17.3 27.4 24.0 17.4 15.0 18.6 10.9 12.9 38.4 81.1 9.3 28.8 14.7 10.6 21.8 10.1 23.4 22.5 11.9 20.7 7.0 9.6 10.2 8.6 10.7 9.1 6.6 9.2 6.8 7.3 8.5 8.7 6.9 6.5 7.6 23.2 9.3 6.8 9.0 8.4 5.4 27.2 27.7 36.5 33.8 24.0 15.6 16.0 29.7 27.2 16.1 77.4 58.6 28.2 59.7 69.1 136.0 50.0 50.9 29.4 39.8 40.1 253.3 68.9 23.2 54.3 25.4 43.7 53.1 0.0 47.2 63.0 58.6 89.0 39.4 26.9 35.7 106.5 42.6 39.3 44.0 43.4 48.9 38.9 55.6 26.2 41.6 39.6 80.1 54.0 47.0 38.3 167.1 77.6 44.8 47.1 27.9 89.6 87.5 32.0 44.8 147.8 NPHP4 "KIAA0673, POC10, SLSN4" ENSG00000131697 "Nephrocystin 4" O75161 1 5862811-5992473 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063852, HPA065526" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies, Vesicles" "HPA063852: , HPA065526: AB_2685505" "unprognostic (1.82e-1)" "unprognostic (1.57e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (5.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.08e-2)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (1.23e-2)" "unprognostic (7.49e-3)" "unprognostic (9.00e-2)" "unprognostic (1.75e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" 5.6 4.7 7.3 4.7 11.2 7.2 4.9 6.3 12.0 5.4 3.5 4.9 8.9 4.4 5.2 11.9 3.7 17.4 5.7 3.7 6.6 3.9 4.5 2.5 6.7 4.6 2.8 6.4 7.0 4.9 7.1 17.8 3.7 5.4 4.5 2.9 8.3 4.1 5.7 3.7 9.6 4.5 5.3 3.5 4.6 4.3 11.4 3.7 5.8 14.9 3.7 2.6 4.3 4.5 0.5 0.4 2.6 1.0 0.5 0.8 0.4 7.6 4.2 5.7 4.4 5.1 7.4 4.4 4.0 4.1 5.6 4.4 4.0 6.7 4.0 10.1 4.5 3.8 7.2 2.8 6.8 2.8 4.9 6.5 3.4 7.7 3.6 3.5 6.6 5.2 6.0 3.4 6.6 4.2 3.4 3.9 9.7 6.1 4.3 2.5 5.6 8.0 6.6 1.0 4.0 4.5 6.9 3.6 6.5 2.5 1.0 18.0 5.5 6.3 4.6 6.6 2.6 6.1 7.2 3.5 8.1 3.4 13.4 4.9 5.2 6.9 4.0 3.4 8.4 2.1 2.6 1.0 0.0 0.5 0.2 0.8 0.3 0.5 0.0 0.4 0.5 0.4 0.0 1.4 0.5 0.8 0.3 0.2 0.4 7.3 11.2 6.3 12.0 6.6 3.9 2.8 6.4 5.4 3.7 0.0 0.6 0.0 1.0 3.5 6.4 2.5 5.1 5.3 5.7 3.5 31.4 0.5 1.7 0.8 1.5 2.2 1.6 0.0 1.6 0.4 1.8 1.5 0.0 1.5 1.7 4.8 3.5 1.3 4.3 1.0 3.7 2.6 10.1 1.0 2.3 5.4 1.9 2.6 2.1 1.4 19.4 6.5 2.1 11.2 6.0 4.5 0.9 0.7 1.2 0.9 NPLOC4 "FLJ20657, KIAA1499, NPL4" ENSG00000182446 "NPL4 homolog, ubiquitin recognition factor" Q8TAT6 17 81556887-81648465 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021560, HPA023295" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021560: AB_1854586, HPA023295: AB_1854587" "unprognostic (3.17e-1)" "unprognostic (2.98e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-3)" "unprognostic (8.72e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.16e-5)" "unprognostic (1.06e-2)" "unprognostic (4.42e-1)" "unprognostic (2.97e-1)" "unprognostic (4.15e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.95e-7)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.72e-1)" 21.7 23.0 15.3 18.7 16.1 22.0 15.4 14.7 24.1 13.2 15.9 18.6 14.2 14.7 18.9 16.3 25.1 14.7 14.4 35.4 16.2 13.5 20.2 28.2 18.4 18.3 16.4 15.5 13.9 18.2 17.8 17.1 25.6 17.2 16.7 13.3 21.0 16.4 14.9 89.8 24.2 16.4 19.4 14.9 22.0 17.6 31.0 13.4 19.7 14.7 17.1 20.6 15.7 16.6 4.6 5.9 5.7 18.1 2.5 4.6 7.8 29.0 38.3 15.3 23.8 18.9 15.7 19.0 24.1 26.9 40.1 37.2 29.0 26.3 21.6 19.4 28.1 29.4 23.6 15.0 20.2 34.9 13.5 19.8 25.0 31.0 25.7 18.1 26.3 31.9 15.5 19.6 37.4 13.4 19.4 40.9 20.2 26.3 32.9 24.2 18.8 35.4 14.3 17.9 14.5 24.2 23.4 24.6 17.6 14.4 28.1 20.5 23.7 30.3 42.3 27.3 30.5 33.1 19.4 29.2 52.7 36.6 28.6 38.6 25.1 17.7 26.6 42.0 17.7 33.8 3.0 18.1 3.9 4.6 4.6 2.8 4.6 3.2 3.6 5.9 3.7 2.9 3.8 5.7 2.5 2.8 4.6 3.0 7.8 15.3 16.1 14.7 24.1 16.2 13.5 16.4 15.5 17.2 13.4 11.9 17.8 16.0 14.4 15.7 22.7 39.6 12.7 8.1 18.2 19.2 27.5 16.5 1.7 17.6 91.1 20.1 26.2 46.7 32.2 17.3 15.5 19.7 3.5 46.4 16.9 19.1 29.2 29.4 24.0 71.7 16.4 19.3 11.8 19.8 15.0 18.4 36.6 20.1 12.0 20.4 35.3 19.4 16.4 22.3 23.3 21.1 31.0 15.0 15.3 23.7 NPM3 ENSG00000107833 "Nucleophosmin/nucleoplasmin 3" O75607 10 101781325-101783413 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036295, HPA036296" Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Nucleoli, Actin filaments, Cytosol" "HPA036295: AB_10671244, HPA036296: AB_10672083" "unprognostic (3.41e-2)" "unprognostic (3.70e-2)" "unprognostic (4.33e-2)" "unprognostic (1.75e-1)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.00e-2)" "unprognostic (1.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.75e-1)" "unprognostic (2.45e-2)" "unprognostic (1.35e-2)" "unprognostic (2.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (5.69e-2)" "unprognostic (9.58e-2)" 9.8 17.0 14.3 20.9 8.5 17.2 14.3 1.5 16.8 13.3 12.3 2.4 6.2 6.0 15.7 15.0 22.7 11.7 12.4 8.9 9.9 7.3 13.6 13.7 8.8 26.3 7.3 11.4 17.7 39.0 11.3 11.1 12.0 9.1 11.5 15.1 3.7 13.2 7.1 11.7 14.0 8.7 15.0 4.8 14.7 11.0 16.4 7.7 18.5 9.8 23.7 18.8 13.0 13.9 4.5 8.3 0.1 3.7 7.0 10.4 5.7 17.3 22.1 6.6 43.2 15.1 15.9 6.9 9.4 14.4 14.7 12.5 23.6 22.2 28.8 17.6 10.5 8.0 18.7 36.6 40.0 11.6 12.2 38.0 23.1 10.3 37.9 17.0 52.5 16.9 13.7 19.4 20.3 81.4 7.6 19.2 35.5 28.5 16.0 12.0 32.1 21.9 68.4 11.6 24.3 17.0 17.2 34.6 29.2 14.3 8.6 13.5 8.7 5.9 13.8 26.3 8.4 18.0 10.9 7.5 5.8 18.6 8.6 17.4 6.9 7.1 33.1 8.1 48.9 6.0 0.0 2.7 0.0 3.8 3.7 7.0 4.3 6.3 7.2 6.3 4.5 10.4 10.4 0.1 7.0 0.8 8.3 2.6 5.7 14.3 8.5 1.5 16.8 9.9 7.3 7.3 11.4 9.1 7.7 3.0 5.3 14.5 57.6 55.6 1.3 2.9 20.4 4.0 9.1 34.9 0.0 79.7 66.3 48.2 5.3 26.4 2.6 0.0 35.4 70.4 52.3 31.9 16.1 16.1 61.3 0.0 23.3 13.5 17.1 8.8 25.9 36.7 28.7 12.6 30.0 2.2 35.2 3.5 22.3 41.9 1.9 6.5 31.6 40.9 83.0 43.5 50.8 26.6 45.2 53.9 NPNT "EGFL6L, POEM" ENSG00000168743 Nephronectin Q6UXI9 4 105894775-106004027 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 125.3" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 172.7;Alveolar cells type 2: 69.4;Club cells: 97.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 104.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 15.2;CAPAN-2: 9.9;HeLa: 17.2;Hep G2: 13.7;MCF7: 12.2;RPTEC TERT1: 20.0;T-47d: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003711, HPA050203" Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cell Junctions, Cytosol" "HPA003711: AB_1854591, HPA050203: AB_2681050" "unprognostic (1.24e-1)" "unprognostic (7.93e-2)" "unprognostic (1.59e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-1)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (7.85e-3)" "unprognostic (4.78e-4)" "unprognostic (1.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "prognostic favorable (8.28e-8)" "unprognostic (4.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (2.31e-2)" 5.4 1.6 3.4 2.4 4.4 0.0 8.3 0.7 2.5 13.3 11.0 1.9 4.2 16.4 8.7 11.4 5.7 5.9 19.0 2.5 2.5 2.7 22.7 1.3 34.9 0.9 7.5 2.4 4.1 11.6 0.0 14.6 3.0 2.2 26.3 7.6 16.9 2.8 5.7 2.6 2.1 37.7 4.0 0.9 4.4 4.0 3.0 2.8 3.4 125.3 3.7 2.3 3.7 6.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 15.2 0.1 0.0 0.0 0.0 7.6 9.9 0.1 0.4 0.1 0.0 0.9 3.8 0.0 0.0 0.0 3.9 0.4 17.2 13.7 0.0 0.0 0.1 1.7 1.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 12.2 0.2 0.7 0.1 0.0 6.2 0.0 0.0 0.1 20.0 0.8 0.9 0.3 0.9 7.4 0.0 2.3 26.8 0.6 0.0 0.3 0.2 0.2 0.6 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 0.7 2.5 2.5 2.7 7.5 2.4 2.2 2.8 172.7 69.4 0.0 4.6 1.6 0.2 2.0 33.1 10.7 97.8 31.4 0.0 2.2 1.7 19.0 11.6 8.0 8.0 0.0 2.1 0.1 0.9 29.6 0.0 0.0 0.3 0.0 15.0 3.1 0.0 11.8 2.3 1.3 5.0 0.0 9.2 0.0 6.3 3.1 0.0 3.0 0.1 0.0 33.5 0.5 1.5 1.0 1.3 0.0 6.9 2.8 NPR3 "ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC" ENSG00000113389 "Natriuretic peptide receptor 3" P17342 5 32689070-32791724 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.2" "Group enriched" "Detected in many" 4 "Distal tubular cells: 44.7;Proximal tubular cells: 133.6" "Cancer enhanced" "Detected in many" "renal cancer: 19.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.3;fHDF/TERT166: 10.5;HeLa: 37.5;HSkMC: 24.4;U-138 MG: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052702 Supported Approved Cytosol NA NA Cytosol "HPA052702: AB_2681922" "unprognostic (8.56e-3)" "unprognostic (1.54e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (7.64e-3)" "unprognostic (2.66e-3)" "unprognostic (1.68e-2)" "unprognostic (9.28e-2)" "unprognostic (6.78e-3)" "unprognostic (1.76e-1)" "unprognostic (6.07e-2)" "unprognostic (3.46e-3)" "prognostic favorable (5.43e-6)" "unprognostic (6.00e-4)" "unprognostic (5.74e-2)" "unprognostic (2.80e-2)" "unprognostic (3.38e-2)" 26.9 3.5 0.4 0.4 1.5 1.9 2.7 0.2 0.8 4.5 5.3 0.3 1.4 0.3 4.2 3.3 6.8 2.5 3.9 16.4 0.4 0.5 54.2 7.6 24.2 0.5 0.2 0.8 1.9 0.7 0.3 0.7 5.3 3.1 8.8 0.5 7.3 1.2 18.1 9.5 3.7 1.4 1.8 0.3 4.5 1.0 1.5 0.0 1.1 11.0 13.4 1.4 5.5 4.5 1.4 0.9 7.3 0.6 1.1 1.1 0.2 0.1 1.9 0.1 0.2 1.1 17.3 0.0 4.6 0.9 0.2 0.2 0.0 0.1 0.0 0.1 10.5 0.3 0.0 2.3 0.0 0.5 0.0 0.0 0.2 37.5 0.0 3.4 0.0 0.1 24.4 0.3 1.2 3.3 1.1 0.1 0.0 0.0 0.3 1.5 0.3 0.0 0.2 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 6.3 0.0 0.1 0.1 0.0 0.1 10.3 0.1 0.8 0.1 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.6 0.4 0.8 0.3 0.5 0.9 0.7 0.5 0.0 1.4 0.9 1.1 7.3 1.1 0.1 0.9 0.4 0.2 0.4 1.5 0.2 0.8 0.4 0.5 0.2 0.8 3.1 0.0 14.9 8.2 0.9 0.0 4.7 3.3 20.6 0.0 6.7 2.3 8.7 0.0 0.0 44.7 0.0 1.1 3.3 0.0 0.0 0.0 0.1 1.5 2.5 3.5 1.5 0.1 3.2 0.0 4.9 0.0 2.2 10.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 12.0 133.6 1.2 6.5 2.7 0.1 0.9 1.1 0.1 0.0 0.0 0.1 NPRL3 "C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11" ENSG00000103148 "NPR3 like, GATOR1 complex subunit" Q12980 16 84271-138860 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011741 Uncertain Approved Cytosol NA NA Cytosol "HPA011741: AB_1845577" "unprognostic (1.34e-1)" "unprognostic (1.32e-1)" "unprognostic (3.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.24e-2)" "unprognostic (4.87e-2)" "unprognostic (6.18e-3)" "unprognostic (9.50e-2)" "unprognostic (7.28e-2)" "unprognostic (4.85e-2)" "unprognostic (9.07e-3)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (8.69e-2)" "unprognostic (1.65e-1)" "unprognostic (3.11e-1)" "unprognostic (2.73e-1)" 11.0 16.8 17.1 10.0 17.1 16.5 9.6 20.5 18.9 11.4 7.4 11.8 9.2 6.9 12.3 6.8 10.0 15.1 6.7 9.8 15.9 6.8 8.4 10.3 8.1 7.9 12.6 20.2 16.1 11.9 21.7 14.9 6.8 13.0 7.5 5.9 8.6 11.3 9.8 22.6 8.2 8.3 8.9 10.4 9.5 9.4 15.7 13.7 5.7 13.2 6.5 7.6 12.5 9.1 4.8 5.5 1.4 5.5 3.4 6.5 3.2 7.0 14.5 6.9 14.0 19.2 10.3 10.9 7.6 9.7 12.6 9.5 22.4 13.0 14.2 12.1 14.2 6.5 7.9 11.8 17.0 7.5 13.7 7.5 19.8 7.9 16.8 18.9 8.1 10.8 12.5 13.2 16.4 14.9 7.5 11.7 10.9 20.3 13.3 11.3 24.5 8.4 4.6 5.0 5.0 9.9 13.2 5.6 20.2 12.2 6.4 15.1 8.1 11.8 13.9 6.7 3.7 11.1 3.6 9.1 15.9 9.0 9.6 6.2 14.8 7.5 19.8 0.5 8.2 7.2 0.1 4.1 1.4 6.0 3.6 6.5 4.2 4.9 4.9 5.3 4.8 5.6 6.4 1.2 3.4 5.5 5.5 5.1 3.2 17.1 17.1 20.5 18.9 15.9 6.8 12.6 20.2 13.0 13.7 11.9 9.4 19.1 15.2 8.4 58.2 7.6 2.5 8.1 5.7 10.4 62.8 19.7 19.9 13.2 26.4 10.8 6.6 93.5 7.9 28.0 13.0 11.6 3.5 9.6 17.4 52.4 9.2 12.3 13.2 60.2 21.0 9.3 11.8 19.0 10.2 23.2 10.7 3.5 18.4 17.0 53.4 6.5 14.6 43.6 33.7 4.8 12.8 16.6 12.8 9.0 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38843982 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.6" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "GAMG: 11.4;SCLC-21H: 15.0;SiHa: 11.2;U-87 MG: 43.1" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 280000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favorable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.3 3.8 39.1 1.8 17.5 0.8 1.9 16.2 73.6 5.8 2.6 4.3 0.5 1.5 5.6 3.3 2.7 6.1 2.0 10.5 57.4 15.2 1.3 0.8 1.7 1.6 5.6 20.7 6.2 3.6 5.9 2.0 0.9 4.5 6.2 1.7 1.0 3.2 5.6 0.9 1.2 1.4 5.7 3.3 2.1 2.0 1.6 4.0 0.0 2.5 0.0 1.6 2.5 1.9 0.3 0.2 0.6 0.2 0.6 2.3 0.4 0.4 2.9 0.1 0.8 6.0 0.6 0.0 1.9 0.4 3.8 1.3 2.9 0.6 0.0 3.5 0.5 11.4 0.4 0.8 0.1 1.3 0.2 1.0 0.0 0.1 4.5 0.6 0.0 0.1 1.9 0.1 3.5 0.0 5.6 0.1 0.0 3.6 0.1 0.1 4.5 0.0 0.2 3.5 1.4 1.0 0.7 0.0 7.0 1.0 8.1 15.0 0.9 11.2 0.0 0.3 0.8 4.8 1.1 0.2 6.9 4.2 0.0 0.3 1.0 0.0 0.0 43.1 8.7 3.5 0.5 0.2 0.1 1.8 0.0 1.3 0.1 1.0 2.3 0.0 0.3 1.5 1.2 0.6 0.6 0.1 0.2 0.0 0.4 39.1 17.5 16.2 49.0 57.4 15.2 5.6 20.7 4.5 4.0 0.0 0.0 0.0 1.9 1.0 5.4 14.2 5.1 2.7 3.4 3.5 2.0 0.0 0.0 5.7 1.6 4.2 0.0 0.0 3.3 0.0 0.8 4.6 0.0 0.2 0.2 0.0 1.7 5.5 0.3 0.4 1.7 0.3 1.7 0.0 0.0 6.5 3.1 0.0 2.1 0.5 3.1 0.0 2.6 0.0 0.8 0.9 0.0 0.0 0.0 3.3 NQO1 "DHQU, DIA4, DTD, NMOR1, QR1" ENSG00000181019 "NAD(P)H quinone dehydrogenase 1" P15559 16 69706996-69726951 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 142.1" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 203.8;Ciliated cells: 259.6;monocytes: 222.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 149.4;OE19: 264.4;SiHa: 169.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007308, CAB012421" Enhanced Supported Cytosol NA NA 310000 Cytosol "CAB012421: , HPA007308: AB_1079501" "unprognostic (1.04e-2)" "unprognostic (1.95e-3)" "unprognostic (3.14e-1)" "unprognostic (3.76e-3)" "unprognostic (9.03e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.05e-3)" "unprognostic (1.97e-1)" "unprognostic (5.07e-2)" "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (2.25e-1)" "unprognostic (2.41e-2)" "unprognostic (6.36e-2)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.27e-1)" 31.3 24.2 12.8 6.4 20.7 0.6 77.1 2.7 9.1 7.6 23.2 7.8 5.7 29.5 3.9 8.6 36.3 8.2 77.2 9.3 9.9 7.5 44.7 1.2 17.2 6.9 11.3 6.0 3.7 2.5 7.0 3.7 3.5 25.5 9.8 20.8 20.2 10.5 7.6 7.6 2.3 17.7 22.7 10.4 6.0 142.1 3.8 4.9 0.1 25.7 69.7 16.2 21.2 18.9 5.2 3.2 0.9 3.2 15.1 12.3 4.4 13.1 149.4 12.5 55.9 31.2 45.3 4.7 22.3 40.0 23.0 35.6 18.1 85.3 0.4 26.5 115.2 40.2 13.8 4.8 25.1 11.8 5.3 0.2 0.6 37.0 131.8 41.5 3.1 10.7 10.6 15.9 39.9 4.6 34.6 57.0 1.0 5.4 0.9 122.9 42.6 0.6 5.7 6.6 264.4 14.5 1.0 2.6 6.1 45.9 47.9 4.5 1.0 169.7 24.1 99.3 14.9 39.0 10.5 38.6 23.2 9.6 8.7 17.5 0.7 2.9 0.6 29.7 1.7 114.7 0.6 3.2 0.2 5.7 0.3 2.9 5.2 6.6 7.2 3.2 2.1 2.1 4.7 0.9 15.1 0.3 1.2 12.3 4.4 12.8 20.7 2.7 9.1 9.9 7.5 11.3 6.0 25.5 4.9 23.8 13.4 1.4 19.5 4.6 4.0 4.5 203.8 259.6 28.4 40.1 3.9 2.1 124.3 22.1 0.3 55.5 72.0 0.0 134.0 3.1 13.1 25.1 19.6 3.2 12.5 3.2 19.5 31.9 3.3 0.9 23.3 8.2 16.9 222.8 60.8 7.6 63.7 49.1 11.3 24.5 10.7 6.5 17.6 0.2 1.5 4.0 1.6 4.4 33.4 25.4 NQO2 "DHQV, DIA6, NMOR2, QR2" ENSG00000124588 "N-ribosyldihydronicotinamide:quinone reductase 2" P16083 6 2987987-3028869 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 14 "monocytes: 212.8;Proximal tubular cells: 716.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 62.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021283, HPA021332" Enhanced Supported Nucleoplasm,Cytosol NA NA 6500000 Cytosol Nucleoplasm "HPA021283: AB_1854600, HPA021332: AB_1854601" "unprognostic (7.11e-3)" "unprognostic (1.43e-3)" "unprognostic (2.41e-1)" "unprognostic (3.01e-2)" "unprognostic (1.00e-2)" "unprognostic (3.58e-1)" "prognostic unfavorable (8.40e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (4.90e-2)" "unprognostic (6.59e-2)" "unprognostic (3.60e-2)" "unprognostic (8.28e-2)" "unprognostic (2.03e-1)" "unprognostic (3.32e-2)" "unprognostic (3.96e-1)" "unprognostic (2.02e-1)" 24.7 45.6 18.2 11.0 17.6 27.2 21.9 44.3 28.1 12.9 11.5 8.9 8.8 15.6 10.4 15.4 12.1 11.2 12.8 38.2 16.0 13.3 82.9 47.0 11.7 17.5 17.0 23.5 13.5 18.4 12.1 9.3 12.1 24.5 12.7 9.0 18.0 24.5 13.5 41.3 20.2 15.5 10.7 11.8 15.3 12.8 7.7 12.5 7.0 11.9 13.9 7.9 10.4 11.0 3.2 16.6 62.1 25.2 7.3 9.3 13.1 12.7 21.6 13.2 29.0 23.3 13.8 14.2 12.4 15.9 11.5 12.9 22.7 4.9 11.2 45.3 21.3 26.9 9.8 13.5 8.6 9.0 26.1 11.5 6.9 26.5 22.7 19.0 6.9 22.1 8.5 10.3 13.9 13.0 16.5 11.1 14.6 39.2 6.7 9.5 28.4 7.9 12.8 17.9 26.9 18.0 14.7 15.7 32.7 17.3 6.8 2.8 5.1 18.8 8.0 39.4 24.7 11.0 4.8 19.1 10.8 4.2 14.4 5.4 14.6 33.1 3.4 12.7 21.0 21.3 5.6 25.2 13.5 9.2 15.7 6.6 3.2 8.3 8.3 16.6 2.1 5.0 5.7 62.1 7.3 13.9 1.7 9.3 13.1 18.2 17.6 44.3 28.1 16.0 13.3 17.0 23.5 24.5 12.5 8.9 17.3 8.1 35.0 31.3 32.4 60.5 50.9 22.7 10.3 24.4 9.8 36.3 137.6 19.8 39.2 32.9 25.6 23.3 55.3 41.3 45.4 32.3 12.8 167.7 66.5 39.7 4.6 20.3 34.6 38.3 33.1 71.3 64.1 212.8 19.0 47.3 40.8 17.3 38.5 716.7 18.8 25.8 46.2 7.0 10.1 36.0 26.1 17.3 20.9 42.3 NR1H3 "LXR-a, RLD-1" ENSG00000025434 "Nuclear receptor subfamily 1 group H member 3" Q13133 11 47248300-47269032 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 74.2" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 54.2;Hofbauer cells: 54.7;Kupffer cells: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 14.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 22.9;HSkMC: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036443, CAB037109" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB037109: AB_1840991, HPA036443: AB_10966142" "unprognostic (2.95e-3)" "unprognostic (5.31e-3)" "unprognostic (5.19e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.19e-1)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "unprognostic (7.73e-2)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.40e-5)" "unprognostic (3.56e-1)" "unprognostic (4.42e-2)" "unprognostic (2.84e-1)" "prognostic favorable (3.40e-4)" 74.2 9.4 4.8 12.7 6.9 1.2 22.8 7.0 5.5 10.2 17.9 4.4 7.2 23.1 6.7 10.0 6.6 8.1 9.2 8.5 4.0 2.9 10.3 35.7 13.7 29.4 6.8 5.6 7.5 7.8 4.3 3.5 16.1 4.3 10.1 5.9 6.4 7.1 9.0 6.1 5.1 19.0 7.1 3.4 40.2 7.6 13.7 4.1 6.3 9.7 2.6 10.7 10.8 12.9 1.1 4.5 6.5 14.6 6.1 3.8 2.1 1.6 6.8 3.1 3.0 20.9 22.9 14.7 1.7 8.6 2.8 4.4 8.3 21.5 2.9 3.3 1.4 1.0 4.5 3.7 2.9 1.9 2.7 3.0 3.9 9.0 12.4 8.6 1.4 0.5 29.9 1.8 4.4 2.6 4.9 2.4 4.6 4.8 1.2 1.9 7.1 2.7 7.9 3.4 9.1 2.3 4.0 4.2 1.9 2.5 15.3 3.0 1.0 6.1 4.0 5.1 3.2 9.7 3.7 0.6 2.3 3.1 4.5 1.0 6.0 8.7 3.5 4.2 1.8 1.1 6.5 2.9 2.4 1.5 14.6 2.1 1.1 1.7 1.4 4.5 0.9 1.8 1.5 1.5 6.1 4.5 0.8 3.8 2.1 4.8 6.9 7.0 5.5 4.0 2.9 6.8 5.6 4.3 4.1 0.0 9.9 6.1 6.3 3.0 2.1 4.5 22.9 1.4 5.7 5.2 2.0 9.7 10.0 4.4 23.5 12.0 39.9 0.0 7.5 11.4 9.9 3.2 12.7 54.2 54.7 1.6 1.7 21.5 70.5 33.3 8.3 7.9 3.3 6.4 9.7 4.8 4.0 10.5 5.6 19.2 0.9 19.4 6.4 27.2 16.3 2.0 5.5 2.9 12.1 4.1 NR2C1 "TR2, TR2-11" ENSG00000120798 "Nuclear receptor subfamily 2 group C member 1" P13056 12 95020229-95073703 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035040, HPA035041, HPA067767" Supported Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898" "unprognostic (2.44e-1)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.51e-1)" "unprognostic (3.56e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (5.18e-5)" "unprognostic (1.30e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-1)" "unprognostic (3.83e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (2.31e-1)" "unprognostic (1.42e-1)" "unprognostic (2.16e-1)" "prognostic favorable (5.62e-5)" 11.6 15.8 15.9 11.8 14.7 15.5 12.4 38.3 23.9 12.5 11.2 12.5 12.9 11.2 17.6 20.2 8.3 15.5 11.1 14.8 14.6 9.3 10.3 14.0 14.2 9.9 11.7 15.2 16.3 12.5 16.4 15.4 11.2 13.7 10.7 12.7 14.6 8.0 17.4 19.6 11.0 11.2 15.7 14.2 14.3 10.5 22.2 14.9 12.3 18.0 9.0 10.2 12.3 10.7 4.5 6.2 3.5 4.2 3.5 9.0 3.9 8.1 10.1 16.1 7.6 3.7 6.7 22.9 8.0 5.8 8.0 7.5 8.9 4.6 9.9 2.9 5.3 5.1 8.7 7.9 6.2 6.1 4.3 16.8 12.0 8.2 10.6 8.5 8.0 5.2 7.7 5.1 5.5 6.8 8.9 8.5 12.4 9.1 3.9 9.3 5.4 8.7 18.6 10.9 6.6 17.8 8.4 11.3 5.9 9.0 9.4 8.3 6.6 12.8 5.5 5.9 9.3 9.6 5.1 8.0 6.5 6.4 7.9 4.5 5.7 9.3 9.5 1.6 9.4 3.0 0.5 4.1 3.5 7.1 4.2 9.0 3.7 5.7 6.0 6.2 4.5 7.2 5.0 2.6 3.5 3.7 6.2 3.7 3.9 15.9 14.7 38.3 23.9 14.6 9.3 11.7 15.2 13.7 14.9 32.8 12.5 7.0 12.2 7.3 39.9 16.1 10.2 22.7 1.2 10.4 17.7 12.6 3.3 10.1 14.3 14.6 8.5 0.0 8.2 10.9 11.3 8.0 9.3 10.6 8.3 23.8 6.9 12.9 10.5 3.8 40.6 10.2 13.5 10.8 10.9 14.6 14.3 11.5 28.3 6.8 50.7 6.5 9.8 54.9 23.8 6.5 6.5 10.9 10.9 17.1 NR2F1 "COUP-TFI, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1" ENSG00000175745 "Nuclear receptor subfamily 2 group F member 1" P10589 5 93583224-93594615 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Ito cells: 216.7;Leydig cells: 86.6;Muller glia cells: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 57.1;HHSteC: 43.9;hTERT-RPE1: 38.5;PC-3: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019281, HPA058974" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB019281: , HPA058974: AB_2732629" "unprognostic (8.07e-2)" "unprognostic (1.06e-2)" "unprognostic (3.86e-2)" "unprognostic (2.26e-1)" "unprognostic (4.75e-1)" "unprognostic (7.68e-3)" "unprognostic (3.18e-3)" "unprognostic (3.07e-2)" "unprognostic (2.21e-1)" "unprognostic (2.71e-3)" "unprognostic (5.24e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.28e-2)" "prognostic unfavorable (1.47e-4)" 15.8 22.9 22.5 5.0 13.7 1.2 9.1 27.4 25.1 31.7 4.6 12.9 10.8 3.3 20.6 24.1 9.4 32.3 30.7 7.2 20.9 13.7 16.4 10.6 18.0 12.7 13.4 23.0 40.4 4.4 1.8 10.3 46.0 14.6 20.5 3.8 44.4 7.2 38.9 1.2 1.6 4.4 14.2 26.7 6.7 12.9 5.9 11.4 0.0 7.5 4.8 4.2 20.9 18.0 0.0 0.0 0.5 0.1 0.2 0.0 0.0 4.7 2.3 57.1 22.6 12.1 3.7 2.7 2.8 1.1 1.7 1.7 0.3 0.8 0.0 0.1 1.1 0.7 1.2 1.4 0.0 0.7 5.8 10.9 2.1 13.8 3.5 43.9 0.4 0.2 17.5 0.0 0.8 0.3 38.5 6.4 0.0 0.0 0.0 5.2 0.0 0.0 0.6 0.0 0.3 47.2 0.6 0.4 0.0 0.3 0.2 5.9 11.9 1.2 0.0 0.1 1.0 0.4 0.8 6.4 9.7 0.4 5.0 6.9 0.0 0.0 0.0 15.9 0.2 4.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 22.5 13.7 27.4 19.8 20.9 13.7 13.4 23.0 14.6 11.4 0.0 1.7 2.2 0.1 1.1 31.9 15.8 2.5 16.0 5.7 14.0 51.1 0.6 6.6 0.9 1.2 13.7 0.0 0.0 1.4 0.4 39.1 0.4 0.0 3.0 1.0 0.0 0.0 216.7 20.5 2.3 86.6 0.5 0.0 0.0 0.0 68.8 3.2 0.0 9.9 27.4 2.5 12.9 31.6 3.7 2.2 0.5 0.9 0.0 0.0 0.6 NR2F2 "ARP1, COUP-TFII, COUPTFB, NF-E3, SVP40, TFCOUP2" ENSG00000185551 "Nuclear receptor subfamily 2 group F member 2" P24468 15 96325938-96340263 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Ito cells: 273.8;Leydig cells: 472.6;Peritubular cells: 573.9;Sertoli cells: 478.6;Smooth muscle cells: 322.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058974 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058974: AB_2732629" "unprognostic (9.28e-2)" "unprognostic (2.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.42e-2)" "unprognostic (8.96e-2)" "unprognostic (5.44e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.89e-1)" "unprognostic (9.19e-2)" "unprognostic (5.14e-2)" "unprognostic (5.96e-2)" "unprognostic (1.72e-2)" "unprognostic (7.47e-2)" "unprognostic (1.28e-2)" 30.8 15.0 19.6 13.8 5.3 0.2 81.2 3.7 6.2 85.7 21.9 2.9 22.3 7.0 70.0 32.6 27.7 32.4 50.8 30.1 12.5 8.4 39.8 15.0 25.0 35.4 7.8 3.4 105.1 7.3 12.3 9.6 24.0 7.1 28.6 9.0 30.5 7.7 43.5 18.4 8.3 10.8 27.2 9.8 63.4 26.9 32.5 4.8 1.1 18.5 16.2 7.0 32.6 34.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 31.6 8.2 26.9 16.6 54.6 18.9 9.0 22.9 17.7 23.9 20.5 28.1 32.4 0.0 18.7 11.5 9.5 19.0 4.7 16.4 30.1 0.1 18.3 10.2 10.5 5.0 15.3 7.8 3.8 13.4 5.7 19.8 4.3 28.2 43.8 0.0 27.3 0.0 15.1 21.8 0.0 5.6 0.2 12.3 11.1 0.0 6.6 0.0 52.1 34.6 3.4 0.0 2.5 0.8 3.4 12.4 13.0 0.5 45.1 26.0 8.6 6.0 8.0 0.0 0.0 0.0 14.5 3.9 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 5.3 3.7 6.2 12.5 8.4 7.8 3.4 7.1 4.8 26.8 17.8 0.0 24.0 12.8 5.0 27.9 168.2 26.8 26.1 59.3 23.6 98.0 39.7 17.6 2.2 116.4 17.6 0.0 9.4 41.1 54.4 18.3 0.0 43.3 8.9 3.2 25.3 273.8 17.3 5.8 472.6 7.1 25.3 1.0 36.2 33.9 13.5 17.5 573.9 53.6 13.0 478.6 322.1 4.1 3.6 9.2 29.5 2.9 25.5 16.9 NR2F6 "EAR-2, ERBAL2" ENSG00000160113 "Nuclear receptor subfamily 2 group F member 6" P10588 19 17231883-17245940 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 123.8;Hepatocytes: 131.0;Horizontal cells: 143.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 59.1;EFO-21: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079917 Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "CAB079917: AB_2635238" "unprognostic (1.48e-1)" "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.07e-1)" "unprognostic (3.67e-1)" "unprognostic (7.20e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (6.62e-2)" "unprognostic (9.68e-2)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (7.28e-3)" "unprognostic (1.37e-3)" 10.0 8.0 5.4 9.3 5.6 1.1 15.2 6.9 7.4 9.0 23.4 4.7 10.9 26.0 7.9 26.3 16.8 7.7 11.3 14.8 4.6 5.9 17.7 49.3 10.0 2.8 4.8 4.7 9.8 23.5 7.0 8.6 26.5 4.0 10.5 8.2 8.0 13.4 10.3 20.2 9.4 36.2 6.6 2.4 5.0 26.8 9.7 4.5 1.7 13.8 9.3 6.7 10.7 11.5 2.7 1.8 1.6 1.1 7.4 6.5 1.3 19.4 11.7 6.4 11.6 2.5 2.8 59.1 11.0 4.0 4.8 4.1 7.9 17.2 4.6 34.6 4.9 2.8 9.7 4.8 6.3 2.1 6.1 28.0 4.2 7.5 14.2 5.6 2.0 5.9 3.7 7.3 2.2 3.6 5.0 2.9 2.1 9.9 1.1 2.0 10.4 1.7 7.4 17.6 14.6 18.2 3.5 4.0 3.9 6.6 12.7 5.1 14.8 6.1 21.5 12.4 6.5 11.9 6.4 4.8 3.4 8.3 6.5 8.7 6.6 2.3 3.3 4.2 3.0 4.1 0.0 1.1 1.6 2.7 0.0 2.4 0.5 3.9 2.5 1.8 2.7 6.5 2.2 0.2 7.4 0.1 0.8 3.5 1.3 5.4 5.6 6.9 7.4 4.6 5.9 4.8 4.7 4.0 4.5 8.9 18.5 4.7 14.9 9.4 63.1 33.0 33.1 10.7 11.4 24.4 72.6 54.8 24.9 20.6 7.8 12.6 123.8 0.0 41.6 54.2 11.1 17.2 1.1 131.0 13.7 143.0 44.1 17.8 2.9 4.1 16.4 3.3 10.1 1.8 71.7 40.3 40.0 73.0 17.7 29.4 53.0 6.5 15.5 1.0 7.7 9.3 66.7 2.9 56.2 14.1 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 27.7 8.6 13.5 26.1 14.9 29.6 23.5 30.1 19.2 14.9 14.2 17.0 10.5 13.0 14.7 12.9 18.2 13.7 14.7 17.4 13.4 14.1 13.5 27.3 22.0 16.1 18.3 12.8 15.5 12.5 21.9 18.9 31.9 13.6 14.3 10.3 14.2 12.0 15.2 40.4 18.3 14.8 16.8 17.2 17.5 13.4 7.3 18.2 37.1 18.0 15.1 18.2 14.8 32.2 11.1 13.6 33.7 11.8 10.9 9.6 7.3 10.1 20.7 1.5 0.0 13.6 15.2 1.8 15.9 19.1 13.8 15.9 1.5 13.6 9.0 7.3 23.3 16.1 9.6 0.1 12.5 17.1 5.0 7.1 2.3 28.0 4.5 12.8 9.3 7.2 11.0 16.2 22.6 22.1 17.2 5.1 4.1 3.3 34.3 12.1 3.6 5.4 6.6 4.1 1.7 4.4 1.9 14.4 19.1 4.0 0.7 2.7 2.1 27.8 4.0 6.6 1.8 1.8 13.4 12.2 33.4 6.6 15.9 12.0 6.9 6.3 14.1 17.5 9.6 11.6 25.4 9.8 17.9 9.3 11.8 7.7 7.6 9.6 8.9 13.6 11.1 9.2 8.9 33.7 10.9 10.5 12.4 5.8 7.3 13.5 14.9 30.1 19.2 13.4 14.1 18.3 12.8 13.6 18.2 62.5 66.3 52.2 35.5 52.2 11.3 38.3 43.3 45.5 46.6 24.4 15.7 34.4 14.9 27.4 129.9 67.3 15.8 0.0 28.6 30.5 63.9 36.5 86.6 160.0 47.2 35.0 27.0 55.3 56.4 113.7 58.4 78.4 50.6 53.3 2.3 41.2 29.3 21.0 67.1 50.1 55.0 148.8 81.5 18.0 35.6 49.2 30.6 85.5 12.0 12.3 NR4A1 "GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3" ENSG00000123358 "Nuclear receptor subfamily 4 group A member 1" P22736 12 52022832-52059507 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 1121.0;granulocytes: 643.7;Smooth muscle cells: 682.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "intermediate monocyte: 18.2;non-classical monocyte: 24.4" "Lineage enriched" "Detected in many" 13 "monocytes: 24.4" "Cell line enhanced" "Detected in many" "HeLa: 25.8;MCF7: 29.4;SK-BR-3: 28.0;SK-MEL-30: 48.6" "Group enriched" "Detected in many" 5 "amygdala: 35.3;basal ganglia: 43.1;cerebral cortex: 77.4;hippocampal formation: 65.3;olfactory region: 79.3" "Low region specificity" "Detected in all" "HPA059742, HPA070142" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA059742: AB_2684119, HPA070142: AB_2732149" "unprognostic (2.40e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (1.74e-1)" "unprognostic (1.65e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-2)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (1.16e-1)" "prognostic favorable (6.99e-4)" "unprognostic (3.41e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-2)" "unprognostic (8.89e-3)" 69.1 111.3 4.0 58.1 12.9 5.7 25.0 5.4 10.9 32.3 23.3 21.1 46.0 5.6 49.8 33.9 28.1 63.3 99.9 76.7 4.8 5.0 17.9 12.1 50.1 8.3 7.5 5.9 177.3 16.1 28.9 51.8 7.6 13.1 88.3 13.8 43.7 66.8 203.2 32.3 23.4 24.3 98.4 6.8 5.1 32.8 11.8 6.4 11.9 34.7 35.8 14.9 71.4 54.5 0.4 1.8 0.2 24.4 0.1 0.2 0.7 1.9 9.7 1.9 3.4 1.4 0.4 7.4 1.8 3.6 1.5 2.1 9.5 1.8 2.0 0.8 3.2 1.4 1.0 5.8 0.8 0.8 0.1 2.0 2.7 25.8 2.6 1.4 1.0 9.1 0.3 1.1 1.4 0.1 1.0 0.4 2.1 2.6 0.5 0.1 29.4 0.7 2.8 5.3 3.0 1.0 0.9 0.3 4.8 0.0 0.7 1.6 4.8 6.0 28.0 48.6 1.3 1.7 3.0 0.0 1.4 4.7 0.9 1.5 16.5 7.8 4.2 1.0 0.8 8.1 0.1 0.6 0.0 0.1 18.2 0.1 0.4 0.0 0.0 1.8 0.4 0.2 0.0 0.2 0.1 24.4 0.1 0.1 0.7 4.0 12.9 5.4 10.9 4.8 5.0 7.5 5.9 13.1 6.4 223.4 1121.0 24.4 132.4 396.0 36.6 7.8 15.3 111.1 143.3 82.0 117.8 62.1 5.0 12.1 16.2 91.9 82.8 0.0 11.1 32.1 293.0 212.1 643.7 7.4 47.6 15.9 331.5 135.7 50.1 4.5 28.1 257.6 352.6 8.2 251.3 24.1 5.1 265.7 22.3 0.7 70.9 122.9 682.6 1.5 12.4 413.3 92.5 20.2 184.5 44.7 NR5A1 "AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1" ENSG00000136931 "Nuclear receptor subfamily 5 group A member 1" Q13285 9 124481236-124507430 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 47.7;lymphoid tissue: 50.8" "Group enriched" "Detected in some" 10 "Leydig cells: 10.9;Peritubular cells: 7.1;Sertoli cells: 12.9" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "HEL: 39.1;Hep G2: 25.3;K-562: 9.3" "Region enriched" "Detected in single" 20 "hypothalamus: 6.1" "Not detected" "Not detected" HPA079181 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA079181: " "unprognostic (1.66e-1)" "unprognostic (3.08e-1)" "unprognostic (6.13e-5)" "unprognostic (2.32e-7)" "unprognostic (3.95e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (1.60e-2)" "unprognostic (9.74e-2)" "unprognostic (4.14e-2)" "unprognostic (4.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" 0.2 47.7 0.2 0.2 0.5 0.0 0.2 0.2 0.4 0.2 0.2 1.3 0.2 0.0 0.2 0.4 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 13.1 0.2 0.0 5.8 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 50.8 0.0 9.4 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 25.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.5 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 12.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NR6A1 "CT150, GCNF, GCNF1, RTR" ENSG00000148200 "Nuclear receptor subfamily 6 group A member 1" Q15406 9 124517275-124771310 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.2" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 112.0;Spermatocytes: 68.9;Spermatogonia: 111.8" "Cancer enriched" "Detected in many" 16 "testis cancer: 27.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.6" "Cell line enhanced" "Detected in many" "BEWO: 47.8;CACO-2: 11.0;Hep G2: 10.7;K-562: 14.1;NTERA-2: 17.0;U-266/84: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031461, HPA045145" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031461: AB_2673894, HPA045145: AB_2679233" "unprognostic (1.73e-1)" "unprognostic (6.66e-2)" "unprognostic (4.53e-1)" "unprognostic (1.34e-6)" "unprognostic (4.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.52e-5)" "unprognostic (6.31e-2)" "unprognostic (8.01e-3)" "unprognostic (2.71e-2)" "unprognostic (1.58e-2)" "unprognostic (1.63e-1)" "unprognostic (7.26e-2)" "unprognostic (7.20e-3)" "unprognostic (1.71e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-1)" 0.6 1.0 2.9 1.4 3.4 5.5 1.8 5.8 3.5 0.8 7.9 1.2 1.3 2.5 0.9 1.4 2.2 1.0 0.9 1.0 3.3 1.3 1.9 2.8 1.8 0.7 2.1 2.4 0.6 3.3 1.5 2.2 4.2 2.2 1.7 2.3 1.7 1.5 1.4 1.9 2.6 5.3 0.8 2.3 1.1 0.7 28.2 2.8 0.0 7.3 0.8 1.1 1.3 1.4 0.3 1.0 8.6 1.2 0.1 0.0 0.1 0.5 1.2 6.3 0.8 0.1 0.1 47.8 0.1 0.4 0.3 0.5 11.0 1.2 2.1 0.4 0.0 1.6 1.1 0.6 0.5 0.7 0.5 2.0 1.7 1.8 10.7 0.0 1.0 3.1 0.0 0.6 0.5 0.7 0.1 0.1 0.5 14.1 0.3 0.2 0.2 0.0 1.3 17.0 0.5 0.5 0.5 0.6 0.9 0.2 0.8 0.9 0.3 0.0 0.3 0.4 9.8 1.1 0.5 0.0 0.6 1.3 0.4 0.3 1.4 10.3 1.9 0.3 1.0 0.3 0.1 1.2 2.0 0.0 0.9 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 8.6 0.1 0.6 0.2 0.0 0.1 2.9 3.4 5.8 3.5 3.3 1.3 2.1 2.4 2.2 2.8 0.0 7.7 0.0 15.1 33.2 2.8 1.4 10.2 4.0 4.5 5.2 27.5 30.8 1.7 7.9 43.0 2.7 13.2 0.0 3.1 112.0 3.0 14.2 1.1 5.5 7.1 1.6 4.6 1.3 1.8 22.4 1.1 4.6 8.5 5.4 6.7 8.0 2.3 7.0 1.8 1.9 10.5 0.0 2.1 68.9 111.8 34.8 25.6 0.0 13.0 11.9 NRARP MGC61598 ENSG00000198435 "NOTCH regulated ankyrin repeat protein" Q7Z6K4 9 137300482-137302251 "Predicted intracellular proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 41.7" "Group enriched" "Detected in many" 7 "Basal keratinocytes: 86.2;Suprabasal keratinocytes: 333.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 23.4;HEK 293: 11.8;NTERA-2: 17.2;OE19: 11.5;T-47d: 11.9;TIME: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025729 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA025729: AB_1854633" "unprognostic (9.92e-2)" "unprognostic (1.75e-2)" "unprognostic (1.56e-1)" "unprognostic (7.17e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-1)" "unprognostic (3.42e-2)" "unprognostic (1.89e-2)" "unprognostic (1.00e-2)" "unprognostic (6.42e-2)" "unprognostic (4.73e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (6.73e-6)" "unprognostic (2.85e-3)" "unprognostic (1.34e-1)" "unprognostic (4.90e-2)" "unprognostic (3.28e-3)" 7.9 1.6 6.5 8.4 7.8 1.7 13.8 3.9 11.7 5.6 41.7 6.1 1.1 17.1 5.2 1.9 17.4 3.2 26.0 7.1 5.0 6.5 3.2 2.9 7.0 1.8 6.0 3.0 5.6 14.2 3.1 7.1 8.9 7.4 11.8 22.8 5.6 1.9 2.8 4.4 19.7 15.7 4.5 3.2 7.7 8.7 6.0 3.4 2.3 4.2 14.0 14.4 7.6 10.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.5 3.5 4.2 0.0 0.0 1.6 0.1 0.1 0.0 0.0 2.8 1.4 0.0 6.4 0.0 0.1 23.4 6.4 0.2 0.1 0.2 11.8 0.7 1.0 2.6 0.4 0.9 2.3 0.0 1.1 0.0 0.2 0.0 5.3 0.1 6.9 0.1 0.0 7.7 0.1 2.7 17.2 11.5 3.5 4.6 0.7 8.4 0.6 0.2 2.4 4.4 0.7 1.2 0.0 0.7 11.9 1.9 17.1 0.0 0.0 0.1 1.0 0.1 0.1 1.4 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 6.5 7.8 3.9 6.8 5.0 6.5 6.0 3.0 7.4 3.4 0.0 0.0 0.5 2.8 86.2 0.3 2.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.7 6.0 10.7 0.0 1.0 0.0 0.6 6.0 0.0 0.0 0.4 0.0 9.8 5.5 0.8 2.9 0.0 0.0 16.9 0.0 15.3 9.4 0.6 31.1 0.4 0.0 2.5 6.5 23.4 0.0 0.8 333.1 0.0 0.0 19.6 5.5 NRBF2 "COPR1, COPR2, DKFZp564C1664, FLJ30395" ENSG00000148572 "Nuclear receptor binding factor 2" Q96F24 10 63133247-63155031 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.9" "Cell type enhanced" "Detected in many" 8 "Syncytiotrophoblasts: 238.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 100.9" "Lineage enriched" "Detected in all" 8 "granulocytes: 100.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021670, HPA059477" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021670: AB_2670803, HPA059477: AB_2684032" "unprognostic (7.71e-2)" "unprognostic (2.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.05e-2)" "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-2)" "unprognostic (2.42e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (2.36e-4)" "unprognostic (2.38e-1)" "unprognostic (3.21e-2)" "unprognostic (2.44e-2)" "unprognostic (1.59e-2)" 15.1 10.0 10.7 16.1 10.2 22.1 21.6 10.9 13.9 12.3 12.3 7.0 9.0 12.4 13.9 9.9 13.9 10.0 13.2 13.6 10.9 9.5 10.6 50.2 19.1 29.4 13.1 8.9 9.2 10.3 6.9 11.5 21.3 11.7 8.7 12.8 6.0 14.8 11.0 46.2 14.6 15.0 10.8 11.7 22.9 10.5 10.0 8.9 16.4 14.2 13.9 14.6 14.6 13.5 7.0 10.0 100.9 13.3 4.3 5.7 7.2 8.9 8.1 8.1 7.4 19.5 30.1 8.1 12.8 21.9 10.3 14.6 17.2 9.6 11.6 6.3 14.3 10.3 7.0 7.9 10.8 14.1 10.4 7.9 8.6 4.2 13.7 25.0 11.3 10.0 27.9 23.2 16.7 41.0 19.3 10.5 7.6 8.7 13.5 13.0 6.6 9.5 20.1 9.4 7.3 33.9 9.3 7.3 6.8 11.8 5.1 4.6 8.0 7.6 14.9 22.2 13.9 9.2 11.3 10.7 7.1 10.5 11.1 13.6 17.0 13.0 14.1 19.9 18.2 5.7 13.8 11.8 22.8 4.5 13.3 4.7 7.0 4.6 4.9 10.0 5.9 5.7 5.3 100.9 4.3 12.5 4.9 5.1 7.2 10.7 10.2 10.9 13.9 10.9 9.5 13.1 8.9 11.7 8.9 3.0 27.1 28.8 40.1 25.5 11.4 6.2 10.2 25.4 19.4 12.2 3.9 45.0 19.9 27.6 5.4 22.2 25.7 0.0 30.6 61.0 36.0 34.9 13.9 47.4 43.7 19.1 15.0 14.7 52.1 5.3 21.6 53.4 43.9 52.3 26.6 14.8 33.1 28.5 20.1 23.0 7.6 19.4 24.5 21.3 67.9 27.9 238.6 37.4 22.2 49.9 NRBP1 "BCON3, MADM, MUDPNP, NRBP" ENSG00000115216 "Nuclear receptor binding protein 1" Q9UHY1 2 27427790-27442259 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029527, CAB033078" Supported Supported Cytosol NA NA 38000 Cytosol "CAB033078: AB_2154375, HPA029527: AB_10601379" "unprognostic (4.95e-3)" "unprognostic (1.29e-1)" "unprognostic (1.09e-1)" "unprognostic (1.38e-1)" "unprognostic (3.62e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.22e-5)" "unprognostic (7.36e-2)" "unprognostic (1.44e-1)" "unprognostic (6.11e-2)" "unprognostic (3.13e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (5.84e-5)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.75e-2)" "unprognostic (3.48e-3)" 30.8 27.6 20.9 30.8 25.9 49.8 29.1 31.6 38.4 36.3 35.2 21.3 27.5 27.3 40.6 34.2 52.2 28.7 29.9 27.7 18.0 26.0 24.6 38.8 27.1 25.6 21.5 26.2 36.6 28.2 23.0 27.0 58.7 33.9 30.3 25.4 30.6 31.6 34.7 62.2 36.6 31.5 40.7 18.3 29.1 28.9 46.9 20.6 24.4 25.4 39.4 37.6 34.2 37.7 20.6 29.1 57.9 37.2 27.5 33.7 32.9 30.2 30.4 25.2 33.4 39.1 39.0 30.6 28.9 36.4 41.3 32.2 30.7 12.4 8.8 21.7 45.8 41.1 20.9 25.0 26.0 26.7 17.2 15.6 17.4 12.4 40.3 32.8 9.7 23.5 31.8 32.8 42.2 28.3 27.0 45.4 9.8 9.8 14.0 36.2 45.6 12.8 23.5 31.7 26.9 19.2 9.9 53.8 9.8 29.3 21.1 6.8 19.2 34.2 24.7 18.0 29.4 13.6 10.9 35.8 36.5 36.3 21.8 23.3 29.4 29.3 10.5 28.6 17.0 18.2 53.6 28.5 57.9 33.2 37.2 29.2 20.6 28.6 29.9 29.1 18.1 26.3 27.0 38.2 27.5 33.3 18.6 33.7 32.9 20.9 25.9 31.6 38.4 18.0 26.0 21.5 26.2 33.9 20.6 6.0 18.4 41.7 48.8 50.8 34.3 23.0 17.8 34.8 28.4 33.2 33.4 135.2 26.6 78.8 200.9 40.3 55.7 0.0 84.0 190.6 54.2 36.0 19.7 33.7 70.8 27.0 26.9 44.8 33.9 22.9 42.6 38.2 28.7 87.4 34.7 43.5 81.5 38.6 57.0 40.7 51.1 32.3 51.5 50.5 89.7 45.8 169.9 34.6 27.6 51.7 NRBP2 DKFZp434P086 ENSG00000185189 "Nuclear receptor binding protein 2" Q9NSY0 8 143833594-143840974 "Enzymes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.1" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020944, HPA029051, HPA029052" Approved Approved Cytosol NA NA Cytosol "CAB020944: , HPA029051: AB_2672886, HPA029052: AB_10602714" "unprognostic (1.84e-1)" "unprognostic (4.66e-2)" "unprognostic (2.54e-2)" "unprognostic (1.53e-3)" "unprognostic (1.01e-1)" "unprognostic (2.00e-2)" "unprognostic (4.03e-1)" "unprognostic (2.86e-1)" "unprognostic (3.97e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (2.01e-5)" "unprognostic (3.86e-2)" "unprognostic (3.98e-1)" "unprognostic (4.56e-2)" "unprognostic (2.04e-1)" 18.5 10.7 21.6 6.8 21.1 1.9 10.0 17.5 32.6 7.6 13.3 47.5 8.7 8.8 11.2 10.0 9.9 14.6 11.3 15.2 23.5 14.9 14.0 18.9 14.9 4.9 30.9 23.6 10.7 10.4 8.4 8.8 6.1 30.2 17.8 6.9 10.1 22.1 15.5 7.6 23.0 9.3 12.3 54.1 7.5 10.1 6.1 27.5 1.0 9.0 3.6 3.8 8.2 7.8 0.5 0.0 0.0 0.4 0.0 1.5 0.3 5.9 7.4 6.7 8.3 10.5 16.2 1.5 12.1 5.3 4.4 6.4 1.7 5.5 0.6 3.2 14.4 3.3 9.5 3.9 4.2 1.7 7.1 2.9 1.1 19.6 3.0 10.8 0.0 2.8 20.7 10.0 2.3 2.2 14.9 6.1 2.1 3.7 7.8 9.3 2.5 0.5 0.3 2.5 6.0 4.1 2.0 6.2 2.7 6.0 2.0 2.4 4.9 15.5 7.9 6.0 4.5 11.3 0.4 14.0 2.6 8.0 12.5 3.9 4.3 0.2 0.1 13.9 2.4 3.5 0.0 0.4 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 21.6 21.1 17.5 21.4 23.5 14.9 30.9 23.6 30.2 27.5 41.7 10.7 0.8 6.0 8.1 14.2 8.1 28.1 5.3 13.6 10.4 13.7 0.7 0.0 4.0 0.3 7.1 5.1 0.0 3.6 0.9 5.8 9.0 0.0 32.1 2.4 15.9 8.6 7.4 4.1 0.0 26.7 3.2 10.1 4.6 8.4 23.2 4.7 3.5 20.1 2.8 10.6 12.9 10.3 1.1 2.3 8.0 0.7 2.9 4.5 3.7 NRF1 "ALPHA-PAL, EWG" ENSG00000106459 "Nuclear respiratory factor 1" Q16656 7 129611714-129757082 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029329 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029329: AB_10601240" "unprognostic (2.80e-2)" "unprognostic (2.20e-3)" "unprognostic (4.51e-1)" "unprognostic (4.04e-2)" "unprognostic (2.01e-1)" "unprognostic (4.20e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.09e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-3)" "unprognostic (1.83e-2)" "unprognostic (2.06e-1)" "unprognostic (6.52e-2)" "unprognostic (4.20e-1)" "unprognostic (2.06e-3)" 14.8 7.3 10.9 18.9 13.0 20.3 18.2 22.2 11.1 15.4 10.3 12.6 16.0 9.0 15.7 10.4 10.1 18.7 10.0 12.3 11.5 11.1 10.0 7.8 11.2 18.7 12.1 7.7 24.4 15.2 13.5 10.9 12.5 11.5 11.5 9.9 11.7 13.8 13.9 19.3 12.2 10.7 14.0 9.6 14.2 8.7 17.2 15.2 29.2 13.8 11.4 16.1 12.8 19.2 8.8 7.0 13.1 7.0 5.8 13.3 6.2 11.8 9.7 14.1 12.4 8.5 6.8 11.2 8.3 8.6 12.7 9.9 11.7 7.9 13.6 6.1 9.3 8.0 9.1 15.1 8.4 13.0 13.0 10.8 11.3 8.2 7.9 6.2 13.8 11.3 5.8 7.9 12.5 12.1 7.3 9.3 13.3 13.6 10.5 7.7 10.8 27.0 13.0 13.1 10.9 8.7 17.2 11.4 12.1 7.2 8.7 12.2 13.3 12.5 13.0 8.4 12.0 8.1 13.2 7.2 7.2 10.0 8.4 15.2 11.5 11.4 24.2 7.6 12.8 13.9 6.1 5.5 13.1 11.4 6.9 13.3 7.7 8.7 10.5 7.0 8.8 9.6 8.2 11.4 5.8 7.0 4.7 9.1 6.2 10.9 13.0 22.2 11.1 11.5 11.1 12.1 7.7 11.5 15.2 3.0 6.2 3.7 2.8 6.0 10.2 5.1 5.1 13.4 5.7 3.5 9.8 2.1 0.0 2.1 0.3 6.7 3.2 0.0 3.1 3.5 3.7 4.4 4.7 4.7 2.6 9.5 6.4 8.0 5.6 1.4 4.9 5.8 5.0 2.8 5.0 5.6 2.4 5.8 4.2 2.2 10.4 6.5 3.6 6.7 6.0 6.8 2.9 9.2 3.9 2.6 NRIP1 RIP140 ENSG00000180530 "Nuclear receptor interacting protein 1" P48552 21 14961235-15065936 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029785, HPA046571, HPA060036" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193" "unprognostic (5.60e-2)" "unprognostic (1.87e-1)" "unprognostic (5.20e-3)" "unprognostic (4.64e-3)" "unprognostic (7.98e-2)" "unprognostic (2.59e-2)" "unprognostic (2.74e-1)" "unprognostic (2.75e-3)" "unprognostic (8.94e-3)" "unprognostic (1.55e-1)" "unprognostic (2.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-2)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (2.72e-1)" "unprognostic (2.80e-1)" 29.0 15.0 10.8 12.6 7.5 19.6 18.4 20.8 10.5 23.1 21.2 6.7 8.5 14.5 16.6 13.4 13.1 18.8 9.0 11.8 9.3 5.8 16.0 22.7 9.3 8.9 5.9 7.3 14.4 15.8 8.3 11.2 16.8 7.2 13.9 15.8 12.7 10.3 7.7 36.5 7.6 30.3 17.3 12.9 17.0 8.4 6.8 7.7 22.1 7.3 12.4 5.9 13.0 14.9 2.6 1.7 0.5 1.4 1.2 5.6 0.7 9.7 20.7 16.3 0.0 8.2 5.3 5.8 11.6 5.2 7.8 5.9 3.8 7.7 0.0 6.6 11.0 3.6 5.1 1.0 6.9 15.7 0.0 4.5 14.7 7.2 11.9 4.9 7.4 3.2 6.5 9.7 8.0 9.4 8.1 5.7 2.2 10.4 8.1 5.1 5.5 3.4 0.0 6.6 3.9 6.2 41.5 12.8 0.3 4.5 16.9 1.4 0.0 9.6 5.1 3.9 13.3 12.4 5.6 9.8 6.3 4.2 9.8 4.7 3.9 0.0 0.0 13.8 0.0 3.2 0.0 1.4 0.5 1.0 0.8 5.6 0.9 1.0 1.1 1.7 2.6 1.7 0.6 0.3 1.2 1.4 1.7 0.5 0.7 10.8 7.5 20.8 10.5 9.3 5.8 5.9 7.3 7.2 7.7 44.7 32.8 11.5 54.8 16.6 33.5 15.3 17.8 18.7 61.4 27.9 47.1 13.0 8.3 20.2 11.9 25.5 34.2 0.0 23.8 109.4 21.7 35.8 29.1 42.3 36.7 20.6 36.1 28.3 37.6 14.4 34.8 26.2 8.5 33.3 38.8 58.9 25.8 40.3 25.5 33.6 60.2 32.3 17.0 9.3 2.3 16.4 11.8 7.7 42.0 78.2 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 48.5" "Cell type enhanced" "Detected in some" 16 "Rod photoreceptor cells: 9.2;Sertoli cells: 25.8;Smooth muscle cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favorable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 5.1 5.8 3.9 20.1 4.3 3.9 48.5 20.9 6.0 4.2 13.5 1.1 2.9 9.8 9.9 3.0 5.9 7.4 6.2 9.7 7.3 9.2 1.6 2.0 4.6 27.6 5.6 11.7 2.5 0.5 2.6 3.3 11.9 3.2 3.8 4.6 4.3 6.6 5.4 3.2 4.1 6.4 7.2 8.0 3.3 2.6 27.7 0.7 5.9 3.0 3.0 3.8 6.3 2.1 0.8 5.9 1.1 1.1 2.3 0.3 0.8 1.7 2.9 1.7 0.0 0.0 3.6 2.1 0.0 0.0 0.0 4.3 2.1 2.3 0.6 0.0 0.7 1.6 0.0 0.0 0.0 1.6 2.5 3.6 4.5 0.5 0.0 4.4 2.7 0.1 0.0 0.0 0.0 4.4 0.0 2.5 2.0 5.3 0.0 1.8 2.7 2.3 2.9 1.7 0.8 1.7 3.1 1.4 0.0 2.9 2.3 3.3 1.6 2.4 0.5 5.4 1.6 0.8 2.3 1.2 1.5 1.7 3.0 0.9 0.2 3.4 2.9 2.1 1.5 5.9 1.1 0.4 1.7 0.7 0.9 2.1 1.3 1.5 0.7 2.0 2.3 1.0 0.5 1.1 0.4 0.8 0.5 0.3 5.8 20.1 48.5 20.9 9.7 7.3 27.6 5.6 11.9 27.7 0.0 0.6 0.0 0.5 0.1 4.0 1.4 0.0 0.0 0.0 1.8 5.9 0.2 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 4.9 0.0 9.2 25.8 17.6 0.1 0.2 0.1 0.0 0.0 0.0 0.0 NRIP3 C11orf14 ENSG00000175352 "Nuclear receptor interacting protein 3" Q9NQ35 11 8980576-9004049 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 11.5;blood: 13.8;bone marrow: 12.7;brain: 28.4;testis: 30.3" "Group enriched" "Detected in many" 7 "Early spermatids: 432.1;Horizontal cells: 228.8;Late spermatids: 344.8;Spermatocytes: 110.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "basophil: 13.8" "Lineage enriched" "Detected in many" 13 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "HBF TERT88: 14.4;HMC-1: 26.2;SiHa: 17.0;U-87 MG: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058827, HPA072961" Approved Approved Cytosol NA NA Cytosol "HPA058827: AB_2683829, HPA072961: " "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (8.84e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-1)" "unprognostic (2.68e-1)" "unprognostic (2.03e-4)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (3.63e-2)" "unprognostic (1.04e-2)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.13e-1)" "unprognostic (1.41e-1)" "unprognostic (5.88e-3)" "unprognostic (1.30e-1)" 2.9 11.5 10.0 2.0 19.7 12.7 4.8 27.6 24.7 1.9 1.0 3.1 0.0 1.0 3.9 3.8 1.4 2.1 2.2 1.4 28.4 9.6 1.2 0.7 1.3 1.3 10.5 6.8 0.8 0.8 2.4 0.7 1.3 11.0 1.2 1.2 3.3 1.1 1.4 0.6 0.9 1.0 2.8 4.5 1.0 1.6 30.3 0.8 0.0 1.4 0.0 1.1 1.0 0.3 0.1 0.2 13.8 0.3 0.1 1.0 0.2 0.0 0.4 0.9 0.1 0.4 1.4 0.0 10.2 4.0 8.2 8.7 1.5 0.9 0.0 1.5 2.9 4.9 0.1 2.7 0.2 14.4 0.7 4.0 1.1 0.5 0.1 0.6 12.7 26.2 1.9 0.1 8.5 0.1 8.7 6.6 2.2 2.0 0.1 7.5 0.0 0.6 4.1 3.3 0.0 0.0 0.0 1.4 0.0 0.1 0.6 2.7 0.8 17.0 0.5 2.6 0.7 1.7 1.2 8.3 12.7 6.0 0.7 0.0 0.0 0.0 0.0 24.5 1.5 6.1 13.8 0.1 2.0 0.1 0.3 0.2 0.1 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 1.0 0.2 10.0 19.7 27.6 19.6 28.4 9.6 10.5 6.8 11.0 0.8 0.0 2.2 0.0 4.8 1.9 6.7 1.2 0.0 0.0 0.0 0.0 9.8 0.4 5.0 0.4 432.1 1.4 0.0 0.0 1.0 0.4 1.2 2.6 15.1 0.0 12.7 228.8 5.1 0.0 1.5 344.8 6.4 5.2 3.3 1.0 0.0 4.1 4.8 0.0 5.3 0.0 9.8 0.0 2.1 110.3 37.3 0.9 0.8 0.0 0.0 3.4 NRK DKFZp686A17109 ENSG00000123572 "Nik related kinase" Q7Z2Y5 X 105822543-105958610 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 42.2;placenta: 64.8" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 56.0;Leydig cells: 105.0;Syncytiotrophoblasts: 56.8" "Cancer enriched" "Detected in some" 8 "testis cancer: 6.1" "Region enriched" "Detected in single" 10 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 30.7;HSkMC: 5.9;RH-30: 7.0;RPTEC TERT1: 18.9;SuSa: 23.1" "Region enriched" "Detected in single" 28 "cerebellum: 16.0" "Low region specificity" "Detected in many" HPA017238 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017238: AB_1854645" "unprognostic (2.64e-4)" "unprognostic (9.82e-2)" "unprognostic (5.98e-3)" "unprognostic (5.52e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (1.35e-2)" "unprognostic (6.08e-2)" "unprognostic (3.24e-2)" "unprognostic (5.28e-3)" "unprognostic (1.47e-3)" "unprognostic (1.14e-1)" "unprognostic (4.28e-2)" "unprognostic (6.80e-3)" 2.6 12.7 0.4 2.7 0.4 0.0 0.8 4.3 0.3 3.5 1.5 0.1 4.6 0.0 4.3 15.6 1.6 1.3 7.5 2.9 0.4 0.4 9.9 0.4 0.5 0.0 0.3 0.0 42.2 0.5 0.0 2.9 64.8 0.2 22.0 0.1 0.0 2.1 1.6 0.4 0.4 0.5 2.8 0.4 0.3 0.9 10.6 0.0 0.0 0.5 3.1 0.3 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.9 0.0 0.0 0.0 1.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.0 0.0 18.9 0.3 0.0 0.1 0.0 1.0 0.0 23.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 4.3 0.3 0.4 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 56.0 16.6 0.2 0.9 0.3 0.0 0.0 0.0 7.2 0.5 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 1.1 105.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.6 1.4 0.0 56.8 0.0 0.0 0.1 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24080107-24115014 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "retina: 124.5" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 2618.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB026066: , HPA064599: AB_2685295" "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 1.5 2.7 4.4 2.3 4.1 1.0 1.8 2.1 2.8 1.9 1.3 1.7 1.7 3.2 1.4 7.9 1.3 1.4 1.2 2.7 3.8 3.1 3.5 3.9 1.7 1.9 3.9 1.4 1.8 3.4 5.4 2.8 1.8 2.1 1.8 1.0 124.5 1.6 2.4 4.1 0.9 1.9 1.0 4.4 2.6 1.3 4.3 1.2 3.3 4.3 1.8 1.6 1.5 2.2 3.8 1.4 4.1 1.3 2.0 2.7 1.2 0.8 1.7 0.5 1.8 0.5 0.5 1.6 0.4 0.4 2.2 1.0 1.1 0.8 2.5 0.8 1.0 1.6 1.0 1.0 1.2 0.3 1.8 1.5 0.7 0.5 3.7 1.2 1.9 3.3 0.7 1.0 0.6 1.2 0.4 1.1 3.1 1.6 3.0 0.8 2.6 2.2 1.8 0.6 3.4 1.8 2.2 2.1 0.7 1.2 1.7 2.0 2.0 1.3 1.5 1.6 0.7 1.1 2.6 0.4 1.4 0.8 0.6 1.2 7.6 3.2 2.7 0.2 1.6 1.5 0.0 1.1 4.1 1.1 1.2 0.7 3.8 1.1 1.6 1.3 2.4 2.7 2.3 0.2 2.0 1.3 1.4 1.0 1.2 4.4 4.1 2.1 2.8 3.8 3.1 3.9 1.4 2.1 1.2 0.0 0.3 4.4 1.7 0.7 340.0 1.6 0.0 0.0 1.2 7.0 406.4 1.0 11.6 0.5 1.7 0.6 2.1 23.3 1.0 0.8 0.5 2.4 0.0 2.6 1.7 236.8 1.7 0.0 0.6 2.8 1.1 0.2 1.7 1.0 1.8 381.3 0.4 0.9 1.8 6.8 2618.0 0.0 0.5 8.2 3.4 0.4 2.1 1.5 0.9 1.6 NRSN1 "p24, VMP" ENSG00000152954 "Neurensin 1" Q8IZ57 6 24126122-24154900 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 67.2" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 114.4" "Cancer enriched" "Detected in single" 17 "glioma: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019681, HPA061006" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019681: , HPA061006: AB_2684413" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (8.00e-3)" "unprognostic (8.01e-3)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (7.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.40e-3)" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" 1.3 6.9 21.5 1.7 27.7 1.7 1.3 5.3 67.2 1.3 1.7 2.1 0.0 1.7 1.5 1.4 1.4 1.3 1.5 1.4 15.3 25.0 1.5 1.4 1.4 1.5 12.4 25.4 1.3 2.6 1.4 12.9 1.3 27.4 1.4 1.7 0.3 1.5 1.3 3.3 1.5 1.6 1.6 6.7 1.5 1.9 1.6 5.0 0.0 1.4 0.0 1.3 1.3 0.1 0.5 0.2 1.8 0.2 0.1 0.3 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.7 0.1 1.7 0.0 0.0 0.3 0.1 0.0 0.1 1.7 0.6 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.3 2.0 1.3 0.1 0.2 0.3 0.9 0.7 0.2 2.5 0.5 0.2 0.5 0.0 0.0 14.6 11.7 0.0 0.1 0.9 0.2 1.7 3.5 0.2 0.5 0.6 0.1 0.4 0.8 2.3 0.9 0.7 0.0 1.3 1.8 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.3 1.0 0.1 0.2 0.2 0.0 0.0 21.5 27.7 5.3 34.1 15.3 25.0 12.4 25.4 27.4 5.0 0.0 0.0 0.0 0.0 0.0 24.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favorable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.9 23.0 13.9 13.1 18.4 20.6 5.4 12.6 24.3 22.9 23.0 12.6 0.4 0.0 4.4 23.3 16.8 8.3 11.2 1.9 14.6 0.1 11.3 6.8 11.0 24.0 18.6 0.2 1.1 23.3 1.5 16.3 2.7 18.7 15.7 0.1 13.5 12.3 20.0 3.3 0.3 5.8 10.7 0.2 11.9 10.8 7.8 0.9 22.8 0.1 28.4 20.4 15.0 4.4 21.5 9.5 18.4 7.1 10.4 24.5 13.0 0.9 15.3 2.3 0.4 5.1 3.2 0.2 12.9 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 0.0 1.9 0.0 3.1 2.9 24.5 4.0 0.0 2.7 7.9 12.2 2.0 6.1 1.7 11.0 5.5 4.5 1.3 0.0 1.4 5.3 10.8 2.5 4.7 0.4 2.7 15.9 28.3 4.3 1.2 10.0 12.0 1.2 3.3 3.6 2.7 12.3 3.8 1.9 9.9 5.7 12.7 19.4 9.2 21.3 6.6 1.9 3.7 1.0 2.0 2.7 NSF "SEC18, SKD2" ENSG00000073969 "N-ethylmaleimide sensitive factor, vesicle fusing ATPase" P46459 17 46590669-46757464 "Enzymes, Predicted intracellular proteins, Transporters" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.4" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 95.1;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 82.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003154, CAB009324, HPA071089" Enhanced Supported "Golgi apparatus,Cytosol" NA NA 6900 Cytosol "Golgi apparatus" "CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343" "unprognostic (5.70e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-3)" "unprognostic (1.98e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.95e-2)" "unprognostic (5.48e-2)" "unprognostic (2.37e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (3.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.74e-1)" 1.9 3.6 11.2 2.7 19.1 1.6 2.6 14.1 35.4 2.5 4.0 1.4 1.9 2.7 3.9 2.2 2.8 1.5 13.9 14.4 3.4 2.5 2.2 3.1 12.6 1.3 3.5 6.5 5.5 2.6 2.8 5.5 2.4 2.1 4.3 2.4 3.2 2.2 3.1 1.6 3.0 3.1 3.6 3.4 3.3 1.0 7.2 15.5 10.4 13.3 6.7 11.1 8.8 6.1 13.6 9.1 0.6 5.4 7.6 7.4 8.4 9.9 8.1 7.9 9.3 0.0 15.0 15.1 18.6 8.4 1.1 10.2 3.1 13.3 5.3 13.4 0.5 9.8 12.8 8.0 0.4 3.3 6.9 4.3 16.4 6.9 4.3 12.7 3.8 10.0 8.2 17.9 12.0 10.0 3.9 5.1 19.1 16.2 7.2 8.8 14.0 9.3 12.8 8.4 9.5 12.4 0.0 5.9 10.1 15.6 18.7 10.3 22.9 8.1 12.1 12.6 17.7 10.1 8.9 6.4 8.1 16.1 10.4 13.3 7.8 8.2 12.1 8.9 6.8 8.2 10.5 15.5 7.2 6.9 8.1 6.0 6.7 12.1 6.2 11.1 8.8 8.9 9.9 12.6 3.2 3.5 95.1 6.2 10.2 4.0 7.9 21.0 82.5 10.9 10.0 10.3 26.6 10.6 25.1 0.0 14.0 12.0 9.3 10.6 9.2 18.7 16.9 41.3 29.3 11.6 27.2 34.0 5.5 15.5 10.1 28.9 27.8 21.3 11.7 14.4 8.1 12.2 82.9 0.0 11.7 28.9 31.3 5.0 15.4 10.9 16.1 7.8 NSFL1C "dJ776F14.1, p47, UBX1, UBXD10, UBXN2C" ENSG00000088833 "NSFL1 cofactor" Q9UNZ2 20 1442162-1473842 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047108, HPA050628" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No 920000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA047108: AB_2679935, HPA050628: AB_2681194" "unprognostic (7.55e-2)" "unprognostic (5.26e-2)" "unprognostic (2.51e-2)" "unprognostic (2.47e-1)" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.10e-2)" "unprognostic (1.59e-1)" "unprognostic (4.67e-2)" "unprognostic (2.58e-1)" "unprognostic (4.97e-2)" "unprognostic (6.90e-2)" "unprognostic (5.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.44e-2)" "unprognostic (7.50e-3)" 15.7 22.7 20.2 10.2 23.5 15.8 15.3 18.2 26.5 16.6 14.7 17.1 9.3 11.1 17.4 21.2 19.8 19.9 12.2 21.9 16.7 18.2 14.8 19.8 12.7 9.6 17.1 22.4 22.7 10.8 12.4 9.9 21.5 24.2 16.8 13.9 20.1 13.6 21.8 49.7 25.6 12.4 18.9 15.8 12.2 12.6 11.1 15.3 12.8 13.1 14.8 12.4 15.9 13.7 14.5 12.0 32.4 10.9 5.9 11.0 9.4 21.3 24.8 15.9 15.1 14.4 13.4 11.8 10.0 18.0 24.5 18.2 20.9 17.4 11.9 8.1 18.1 23.3 20.3 9.7 26.2 18.9 4.4 10.6 12.0 4.4 24.0 15.2 11.6 7.3 11.4 9.6 25.5 8.5 14.2 17.4 8.6 15.5 10.7 17.1 10.2 12.1 22.2 17.1 16.5 27.5 5.8 19.8 11.6 28.5 15.0 9.2 11.3 12.1 24.1 10.9 9.7 14.7 8.0 16.1 19.0 14.0 11.0 16.3 8.6 15.3 9.9 14.1 16.3 13.4 10.7 8.9 32.4 8.5 10.6 8.5 13.9 9.2 8.3 12.0 14.5 10.5 9.2 29.1 5.9 10.9 9.5 11.0 9.4 20.2 23.5 18.2 26.5 16.7 18.2 17.1 22.4 24.2 15.3 20.8 21.0 25.3 52.2 79.2 58.7 30.5 20.4 25.4 30.7 29.6 21.6 128.5 48.0 77.9 14.8 36.0 52.0 0.0 82.5 121.5 43.5 44.6 39.3 35.8 71.3 66.7 41.9 25.2 37.6 26.4 36.2 39.7 40.5 47.7 29.3 44.2 95.4 52.6 43.5 54.7 37.5 77.6 53.6 80.7 105.4 66.1 126.8 34.5 37.5 81.7 NT5C "cdN, DNT-1, DNT1, PN-I, UMPH2" ENSG00000125458 "5', 3'-nucleotidase, cytosolic" Q8TCD5 17 75130225-75131795 "Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021581, HPA023632" Approved Supported Cytosol NA NA 600000 Cytosol "HPA021581: AB_1854663, HPA023632: AB_1854662" "unprognostic (3.83e-2)" "unprognostic (4.45e-2)" "unprognostic (2.39e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (9.21e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.26e-1)" "unprognostic (7.25e-2)" "unprognostic (8.26e-3)" "unprognostic (7.15e-2)" "unprognostic (2.22e-1)" "unprognostic (6.57e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "prognostic favorable (7.66e-4)" 14.5 16.7 10.7 32.5 10.5 14.4 15.2 16.0 13.8 16.3 27.3 18.5 16.2 25.1 18.0 18.7 21.6 15.9 21.0 16.7 9.6 11.0 21.0 13.5 19.9 30.1 12.3 11.0 19.7 28.0 10.4 9.7 11.6 10.9 17.5 14.2 18.0 17.9 17.7 27.1 16.0 30.1 16.7 13.7 20.5 24.5 11.4 12.0 17.2 22.0 30.4 24.5 20.5 17.1 30.7 16.8 46.7 15.8 22.7 14.3 9.7 21.0 33.1 10.9 11.4 3.3 6.9 15.0 12.6 11.0 12.7 8.1 12.3 24.9 14.7 9.2 8.8 2.3 14.8 7.6 15.7 7.3 6.9 23.9 16.1 25.7 20.6 16.5 15.6 7.4 10.0 7.5 9.1 25.5 5.2 14.1 11.7 15.7 7.2 13.0 21.2 11.4 15.9 11.2 18.3 22.0 10.4 14.3 20.4 16.5 11.4 12.9 26.5 12.1 15.0 17.4 6.5 21.0 11.5 8.1 11.1 27.5 4.2 16.6 14.3 2.1 16.3 10.3 9.6 17.2 46.7 10.2 15.2 13.8 15.8 9.7 30.7 9.0 11.6 12.7 29.1 7.9 11.9 4.6 22.7 15.5 16.8 14.3 9.7 10.7 10.5 16.0 13.8 9.6 11.0 12.3 11.0 10.9 12.0 29.8 21.6 121.5 83.2 42.1 67.1 15.5 94.3 9.4 11.4 55.8 19.6 58.2 66.3 80.9 1.6 21.2 215.1 0.0 106.1 86.7 57.7 61.8 46.1 34.2 66.0 39.7 61.5 16.5 50.0 3.3 55.0 59.6 55.6 144.3 82.5 46.3 97.1 133.3 44.6 119.5 63.7 32.3 67.0 20.7 54.1 38.8 26.1 67.1 96.4 63.4 NT5DC3 "FLJ11266, TU12B1-TY" ENSG00000111696 "5'-nucleotidase domain containing 3" Q86UY8 12 103770453-103841197 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.0" "Cell type enhanced" "Detected in many" 9 "Intestinal endocrine cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 22.0" "Low region specificity" "Detected in all" HPA041634 Approved Mitochondria,Cytosol "Secreted - unknown location" NA NA Mitochondria Cytosol "HPA041634: AB_10795597" "unprognostic (2.61e-2)" "unprognostic (1.16e-1)" "unprognostic (7.30e-2)" "unprognostic (2.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.31e-4)" "unprognostic (1.57e-1)" "unprognostic (2.19e-1)" "unprognostic (2.45e-2)" "unprognostic (5.43e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.72e-6)" "unprognostic (8.60e-3)" "unprognostic (7.42e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (8.11e-4)" 4.2 5.4 14.8 3.2 10.5 23.9 5.4 2.7 16.2 12.2 52.0 2.9 9.4 2.0 17.9 8.4 8.9 3.5 2.6 2.2 13.3 5.7 2.2 4.0 2.8 2.3 2.8 11.7 3.8 3.5 1.8 4.2 4.5 10.4 9.8 12.5 3.7 3.9 9.1 7.0 2.8 4.2 32.9 2.1 1.9 6.6 3.5 2.7 0.0 2.9 0.9 2.4 22.4 5.2 4.1 4.9 2.4 1.6 1.5 3.3 0.8 3.3 6.0 3.5 4.0 4.9 3.9 6.5 5.5 3.3 3.9 2.5 4.1 0.9 5.6 1.1 6.5 4.3 3.8 4.9 10.9 5.7 4.1 4.0 7.0 2.2 4.7 2.8 3.7 1.9 3.4 2.4 5.0 22.0 8.0 2.3 2.9 11.0 2.9 8.7 3.0 3.2 6.0 4.3 4.8 6.5 4.5 6.1 2.1 6.2 2.3 4.7 1.9 4.6 5.2 6.5 3.3 2.9 3.5 3.0 3.9 4.7 5.3 11.0 2.6 3.1 4.2 3.7 5.7 5.6 0.8 1.5 0.1 1.7 1.6 3.3 3.5 2.4 1.4 3.8 4.1 2.1 1.8 2.4 1.5 1.0 4.9 0.6 0.8 14.8 10.5 2.7 16.2 13.3 5.7 2.8 11.7 10.4 2.7 0.0 2.9 0.8 17.0 3.9 1.5 2.8 2.5 9.4 2.3 1.8 0.0 4.2 0.0 1.8 8.8 1.6 1.6 0.0 1.8 4.4 3.9 10.0 0.0 4.3 1.7 9.5 39.5 1.3 3.5 7.4 4.6 2.5 0.0 2.8 9.1 0.8 2.3 0.0 7.8 1.5 4.9 0.0 8.0 0.5 3.1 3.9 3.4 0.9 9.0 8.6 NT5E "CALJA, CD73, eN, eNT, NT5" ENSG00000135318 "5'-nucleotidase ecto" P21589 6 85449584-85495791 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3" "Group enriched" "Detected in many" 47 "B-cells: 19.9;T-cells: 17.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017357 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1600000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017357: AB_1846330" "unprognostic (1.92e-2)" "unprognostic (4.44e-3)" "unprognostic (1.54e-1)" "unprognostic (1.57e-3)" "unprognostic (9.33e-2)" "unprognostic (1.82e-3)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.49e-2)" "unprognostic (2.26e-1)" "unprognostic (2.78e-1)" 12.2 3.2 9.3 7.7 11.6 0.5 16.6 1.1 6.9 58.8 13.9 3.6 8.1 18.6 33.3 14.8 7.6 12.2 15.4 6.1 5.7 5.5 8.8 26.0 3.4 6.8 6.3 6.6 25.4 1.4 1.6 9.3 42.2 5.3 16.4 15.6 15.3 4.6 17.8 5.7 4.5 14.9 35.3 6.3 7.0 6.0 12.4 4.2 1.6 26.5 7.3 7.1 16.6 20.2 19.9 0.0 0.2 0.0 0.4 17.3 3.9 5.3 2.8 4.9 0.1 11.2 35.7 0.0 34.5 37.8 17.0 32.0 0.0 53.0 0.0 12.4 30.1 43.8 2.7 0.0 34.7 40.6 0.0 0.0 0.0 0.8 0.6 5.6 0.0 0.0 9.1 0.4 34.7 22.1 93.4 14.1 0.0 0.0 0.1 105.7 0.9 0.0 0.0 0.1 0.9 3.8 0.1 1.1 0.1 36.8 2.4 0.0 0.6 0.4 2.1 11.7 0.2 0.0 0.9 61.2 13.9 0.1 17.5 56.1 2.6 1.6 0.0 95.4 0.0 43.5 0.0 0.0 0.2 2.0 0.0 3.5 13.4 2.3 6.6 0.0 19.9 2.4 17.3 0.2 0.4 0.0 0.0 0.8 3.9 9.3 11.6 1.1 6.9 5.7 5.5 6.3 6.6 5.3 4.2 0.0 4.3 15.6 1.0 4.6 4.6 0.8 20.4 6.7 6.8 1.8 9.8 0.4 3.3 3.7 0.5 13.5 10.3 0.0 3.7 1.5 16.9 0.9 0.0 29.0 1.3 0.0 0.0 45.4 5.3 0.9 12.0 2.5 6.8 0.0 33.2 5.6 72.9 31.7 24.1 20.6 77.4 0.0 8.0 0.0 0.2 4.3 12.7 2.2 13.8 5.9 NTMT1 "AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1" ENSG00000148335 "N-terminal Xaa-Pro-Lys N-methyltransferase 1" Q9BV86 9 129608884-129636131 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 302.3;Late spermatids: 570.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020092, HPA058420" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020092: AB_1853831, HPA058420: AB_2683713" "unprognostic (4.74e-3)" "unprognostic (1.77e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (4.17e-3)" "unprognostic (4.92e-2)" "unprognostic (1.24e-1)" "unprognostic (8.57e-2)" "unprognostic (3.63e-1)" "unprognostic (4.35e-2)" "unprognostic (1.00e-3)" "unprognostic (1.11e-3)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (3.50e-3)" 10.2 25.7 11.9 11.5 13.1 13.8 10.0 13.2 15.3 8.9 10.7 9.0 14.4 11.7 8.8 13.6 10.2 7.8 16.6 31.8 11.5 11.5 11.7 16.8 8.9 11.5 15.7 11.3 8.8 19.5 9.4 10.8 12.1 13.8 10.2 7.4 9.4 13.0 11.4 54.6 10.7 10.2 13.6 10.3 13.1 10.5 56.2 10.7 10.8 12.3 22.1 9.8 12.3 14.5 27.1 28.4 20.3 34.2 14.8 26.6 19.4 16.7 34.8 14.4 24.4 9.2 13.7 15.5 31.9 18.9 32.3 28.0 28.5 22.0 21.6 16.4 22.7 23.3 32.7 30.2 28.1 20.4 16.6 16.2 9.0 31.3 28.7 29.5 18.1 13.7 14.6 14.3 33.8 16.9 10.4 17.6 19.3 33.0 16.2 16.8 55.4 20.4 24.5 18.8 31.2 30.4 19.4 17.0 43.2 13.0 9.6 29.3 15.3 15.7 29.5 21.8 9.6 24.5 9.5 11.9 38.9 19.7 36.0 33.4 12.8 15.2 32.8 17.7 18.8 22.2 15.1 27.3 20.3 25.2 28.7 24.8 23.4 25.5 26.6 26.4 27.1 26.4 22.0 7.6 14.8 34.2 28.4 23.4 19.4 11.9 13.1 13.2 15.3 11.5 11.5 15.7 11.3 13.8 10.7 3.0 11.5 55.2 60.7 88.7 16.0 2.8 20.4 10.7 18.2 21.0 21.6 61.3 82.9 57.5 302.3 31.5 59.1 0.0 48.7 71.0 52.7 55.2 30.0 42.9 59.3 39.7 19.4 20.3 27.3 570.1 32.5 46.3 52.3 28.9 25.6 18.8 57.3 24.6 23.3 72.8 22.1 25.8 84.4 60.3 47.2 86.8 113.4 40.1 37.2 65.8 NTPCR "C1orf57, HCR-NTPase, MGC13186" ENSG00000135778 "Nucleoside-triphosphatase, cancer-related" Q9BSD7 1 232950605-232983882 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028125, HPA054304" Uncertain Approved Cytosol NA NA Cytosol "HPA028125: AB_10601091, HPA054304: AB_2682443" "unprognostic (2.67e-1)" "unprognostic (2.28e-2)" "unprognostic (1.63e-2)" "unprognostic (7.59e-2)" "unprognostic (5.85e-3)" "unprognostic (1.04e-1)" "unprognostic (8.70e-3)" "unprognostic (2.12e-1)" "unprognostic (6.00e-2)" "unprognostic (5.03e-3)" "unprognostic (4.78e-2)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (2.74e-2)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "unprognostic (6.37e-3)" 5.4 9.8 13.2 5.8 14.9 2.5 8.7 14.5 15.9 9.9 8.0 11.1 4.1 5.1 9.6 9.5 8.0 11.3 9.6 10.3 13.3 13.1 8.4 6.1 7.4 6.5 13.7 10.8 12.9 13.4 16.9 8.0 6.3 18.5 8.8 10.3 10.8 10.1 10.0 26.8 9.9 6.8 9.9 12.6 6.3 5.8 11.2 11.0 5.7 13.6 11.1 6.5 7.1 7.4 2.4 1.5 3.3 1.8 1.6 4.3 1.3 2.5 6.2 7.1 3.5 5.3 7.0 0.1 1.7 5.5 5.3 7.2 4.4 3.0 3.9 3.8 3.4 3.0 3.4 4.7 6.3 5.8 2.9 8.9 1.2 3.9 5.6 5.5 2.1 2.4 9.3 12.3 5.1 5.2 5.3 4.3 7.5 3.4 6.1 6.2 1.8 5.5 5.6 7.0 5.1 7.4 3.6 4.6 5.7 7.8 3.1 6.2 10.3 2.4 2.1 2.5 5.6 5.2 4.8 3.2 4.4 3.6 4.8 4.7 6.9 5.6 4.5 5.2 5.2 6.3 1.1 1.6 0.8 2.1 1.8 2.5 1.6 3.0 1.3 1.5 2.4 4.3 3.5 3.3 1.6 1.6 0.6 3.5 1.3 13.2 14.9 14.5 15.9 13.3 13.1 13.7 10.8 18.5 11.0 17.9 19.7 13.4 32.1 17.2 15.2 58.9 28.1 12.0 11.4 24.4 25.5 55.1 79.6 53.6 28.3 24.0 38.0 0.0 56.9 49.7 26.7 31.6 16.1 32.1 37.9 9.5 24.8 26.4 19.2 21.4 18.7 22.0 21.9 33.3 46.4 34.1 37.9 21.0 28.7 60.8 20.0 12.9 24.7 60.2 34.9 20.8 23.5 17.5 61.5 31.6 NTRK1 "MTC, TRK, TRKA" ENSG00000198400 "Neurotrophic receptor tyrosine kinase 1" P04629 1 156815640-156881850 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 15.8;blood: 32.3;brain: 28.3" "Group enriched" "Detected in some" 8 "granulocytes: 56.4;Horizontal cells: 54.0" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enriched" "Detected in many" 5 "pons and medulla: 28.3" "Cell type enriched" "Detected in single" 127 "basophil: 32.3" "Lineage enriched" "Detected in single" 323 "granulocytes: 32.3" "Cell line enriched" "Detected in some" 4 "HMC-1: 42.1" "Region enhanced" "Detected in some" "basal ganglia: 8.2" "Low region specificity" "Detected in all" "CAB004606, HPA035799, HPA076570" Approved Approved Vesicles,Cytosol NA NA 140000 "Vesicles, Cytosol" "CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: " "unprognostic (5.89e-3)" "unprognostic (7.56e-2)" "unprognostic (2.74e-2)" "unprognostic (5.99e-3)" "unprognostic (7.26e-2)" "unprognostic (1.43e-3)" "unprognostic (1.56e-1)" "unprognostic (7.42e-3)" "unprognostic (7.63e-2)" "unprognostic (1.35e-1)" "unprognostic (6.73e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-11)" "unprognostic (2.18e-3)" "unprognostic (3.79e-2)" "unprognostic (1.07e-1)" "unprognostic (4.89e-1)" 1.0 15.8 0.5 0.8 6.0 0.9 0.4 0.0 0.7 0.9 1.1 0.1 0.0 0.8 1.6 2.0 0.7 0.6 2.1 1.5 0.0 1.2 2.9 0.2 1.9 0.3 2.1 0.6 0.3 0.3 0.3 1.1 0.5 28.3 2.2 0.2 3.1 1.2 0.5 0.7 0.2 0.4 1.1 1.2 0.2 1.0 2.4 1.5 0.4 0.3 0.0 0.4 0.7 0.8 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 6.8 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.6 1.2 0.0 0.1 0.0 0.0 0.8 9.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 32.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 0.0 0.6 0.0 1.2 2.1 0.6 28.3 1.5 0.0 2.2 0.0 0.0 0.0 6.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 56.4 0.0 0.1 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 2.5 0.1 0.0 0.0 0.0 0.0 NTRK2 TRKB ENSG00000148053 "Neurotrophic receptor tyrosine kinase 2" Q16620 9 84668551-85027070 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Epilepsy, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 133.8;thyroid gland: 63.4" "Cell type enhanced" "Detected in many" 12 "Horizontal cells: 228.8;Leydig cells: 96.4;Muller glia cells: 248.1;Sertoli cells: 122.9;Smooth muscle cells: 96.9" "Group enriched" "Detected in many" 5 "glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.7;SH-SY5Y: 13.4;SuSa: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007637, CAB010346, HPA074873" Enhanced Approved Cytosol NA NA 13000000 Cytosol "CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: " "unprognostic (2.75e-3)" "unprognostic (3.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (1.29e-2)" "unprognostic (9.16e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (4.25e-2)" "unprognostic (2.18e-2)" "unprognostic (2.66e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-3)" 19.8 2.7 66.1 2.0 56.7 1.2 33.2 15.1 133.8 6.4 4.4 27.4 0.0 1.4 3.0 3.3 5.6 3.7 18.7 5.8 61.0 30.7 12.5 2.1 6.3 2.7 32.4 41.4 6.6 18.9 1.6 3.0 2.1 34.1 3.8 3.1 2.0 8.6 11.9 2.0 7.2 1.6 3.0 22.1 6.5 1.4 2.4 34.1 0.0 63.4 2.6 3.4 3.5 3.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 11.7 0.8 0.9 13.4 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 66.1 56.7 15.1 45.6 61.0 30.7 32.4 41.4 34.1 34.1 0.0 0.3 0.0 1.0 50.4 24.4 8.7 0.0 2.7 0.0 8.7 5.9 0.0 23.2 26.5 1.5 4.5 0.0 0.0 0.6 0.1 10.6 0.9 0.0 0.0 0.2 228.8 0.0 5.5 0.0 1.7 96.4 1.2 16.9 1.0 0.0 248.1 0.5 7.2 45.3 7.9 9.1 122.9 96.9 0.7 1.1 21.5 0.0 0.0 5.4 0.8 NUAK2 "FLJ90349, SNARK" ENSG00000163545 "NUAK family kinase 2" Q9H093 1 205302059-205321791 "Enzymes, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.4" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 31.4;Ductal cells: 40.9;monocytes: 48.7;Mucus-secreting cells: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 42.4" "Group enriched" "Detected in all" 4 "B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7" "Cell line enhanced" "Detected in many" "BEWO: 22.8;RPMI-8226: 17.6;RPTEC TERT1: 20.9;SuSa: 24.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA008958 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008958: AB_1080040" "unprognostic (2.24e-2)" "unprognostic (6.33e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.01e-7)" "unprognostic (8.24e-3)" "unprognostic (1.58e-2)" "unprognostic (3.00e-2)" "unprognostic (1.08e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "prognostic favorable (7.94e-6)" "unprognostic (3.71e-2)" "unprognostic (3.17e-2)" "unprognostic (4.90e-2)" "unprognostic (5.80e-2)" "unprognostic (4.54e-2)" "unprognostic (1.61e-1)" 1.4 2.8 0.8 12.5 2.4 8.3 0.9 9.2 1.5 18.9 10.4 3.9 2.4 13.6 2.7 3.8 31.3 3.4 1.3 1.1 1.7 1.0 14.5 3.6 16.2 20.3 5.5 1.5 3.3 13.2 0.1 2.3 7.2 2.0 1.5 7.5 9.8 9.7 2.0 0.7 12.9 15.4 0.9 2.7 10.4 2.0 5.6 2.4 5.5 14.5 20.1 31.7 2.8 24.6 15.3 3.6 42.4 5.6 5.7 10.7 5.4 2.1 11.6 7.1 0.3 0.1 0.3 22.8 2.8 2.9 7.6 3.1 12.2 0.4 3.4 1.7 0.7 12.5 4.2 1.6 4.2 3.3 0.0 0.2 0.0 0.7 2.1 4.9 0.0 0.0 1.3 3.1 4.4 2.6 1.7 0.3 0.0 0.4 0.9 1.4 0.5 0.0 0.0 4.5 1.5 0.3 0.0 0.5 17.6 20.9 0.0 1.1 0.1 0.8 3.3 0.3 24.7 3.3 0.0 0.8 2.7 1.3 0.3 4.3 6.2 0.9 2.1 0.4 0.0 1.0 3.4 5.6 13.2 3.9 4.2 2.8 14.2 4.8 4.6 3.6 15.3 10.7 8.1 42.4 5.7 4.1 1.4 2.8 5.4 0.8 2.4 9.2 1.5 1.7 1.0 5.5 1.5 2.0 2.4 6.0 5.0 9.1 0.8 1.0 0.8 1.4 20.4 2.7 0.0 31.4 0.0 6.5 5.0 40.9 1.7 2.2 20.3 0.0 1.5 27.7 4.0 1.8 0.0 2.9 4.6 0.0 10.4 1.3 11.7 1.2 0.0 6.5 6.8 48.7 40.0 1.7 7.2 2.9 0.0 15.0 0.5 6.5 2.5 0.5 0.9 4.6 3.4 4.5 18.7 0.2 NUBP1 "NBP1, NBP35" ENSG00000103274 "Nucleotide binding protein 1" P53384 16 10743786-10769351 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041656, HPA041799" Enhanced Supported Cytosol NA NA Cytosol "HPA041656: AB_10960278, HPA041799: AB_10960692" "unprognostic (2.51e-2)" "prognostic favorable (2.81e-5)" "unprognostic (4.01e-3)" "unprognostic (1.66e-3)" "unprognostic (2.81e-1)" "unprognostic (7.04e-2)" "unprognostic (1.33e-1)" "unprognostic (7.30e-3)" "unprognostic (8.28e-2)" "unprognostic (5.08e-2)" "unprognostic (1.61e-1)" "unprognostic (2.50e-1)" "prognostic favorable (7.61e-8)" "unprognostic (2.12e-1)" "unprognostic (1.04e-1)" "unprognostic (8.23e-2)" "unprognostic (1.69e-2)" 16.1 31.4 10.8 25.0 11.2 18.3 19.3 12.8 11.4 17.7 19.0 15.8 20.4 14.8 18.8 20.7 15.2 18.4 18.2 31.8 10.2 9.6 26.8 39.6 15.0 24.2 11.0 8.8 21.7 24.8 25.1 14.2 25.3 14.4 20.3 14.2 18.2 23.3 20.3 26.3 11.8 21.0 19.8 13.7 25.4 21.1 15.4 10.7 16.8 23.2 20.6 24.6 19.0 22.7 27.1 33.5 14.8 32.4 12.5 17.2 18.1 13.7 25.2 17.1 10.5 7.9 14.7 16.4 13.5 12.7 23.8 19.6 21.8 15.0 23.6 28.2 16.4 18.5 15.1 15.8 13.8 17.8 37.5 20.2 13.4 18.0 35.3 15.9 12.1 15.8 13.7 10.5 16.0 8.9 13.2 15.6 9.3 18.6 14.5 17.4 31.8 7.8 17.6 21.1 11.3 13.7 31.8 22.1 25.9 16.9 16.8 10.6 15.5 23.4 17.6 13.1 11.4 17.9 13.4 13.9 18.6 19.1 23.0 16.9 25.8 22.3 18.5 17.1 24.5 21.7 1.4 31.9 14.8 15.6 32.4 14.4 27.1 14.0 15.7 33.5 26.5 12.3 12.7 3.8 12.5 23.7 16.3 17.2 18.1 10.8 11.2 12.8 11.4 10.2 9.6 11.0 8.8 14.4 10.7 6.0 17.2 38.3 24.0 12.7 13.6 4.8 33.1 28.1 22.7 22.7 5.9 42.3 56.3 47.0 1.8 18.1 16.8 0.0 69.3 24.1 18.0 17.0 24.2 24.1 51.2 6.4 16.1 16.0 33.8 3.0 23.9 47.4 15.1 96.4 14.9 25.8 42.9 14.2 18.4 46.4 13.4 6.5 17.5 35.6 29.4 10.5 50.8 17.1 17.9 24.5 NUBP2 CFD1 ENSG00000095906 "Nucleotide binding protein 2" Q9Y5Y2 16 1782901-1789191 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041704 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041704: AB_10804006" "unprognostic (1.94e-1)" "unprognostic (5.73e-3)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.02e-2)" "unprognostic (8.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.42e-1)" "unprognostic (1.53e-1)" "unprognostic (8.64e-2)" "unprognostic (1.20e-1)" "prognostic favorable (9.63e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (5.83e-2)" 16.9 22.8 12.9 15.4 12.4 19.5 14.7 16.3 19.8 13.9 15.1 14.9 16.1 21.6 14.1 14.2 20.3 15.6 15.2 13.8 12.0 10.4 16.5 32.3 12.1 18.0 14.4 17.4 14.6 37.6 8.3 13.8 14.7 12.9 17.7 6.4 14.8 26.9 16.3 30.2 17.2 19.1 16.4 12.0 17.9 18.8 14.5 13.2 22.7 19.4 20.7 16.6 15.3 13.6 25.8 44.1 28.8 29.7 25.8 41.3 31.1 9.2 30.3 5.3 15.9 4.3 3.1 17.1 11.3 4.8 6.9 7.9 17.0 14.1 15.0 12.4 2.4 5.2 10.8 3.6 10.2 1.3 12.4 29.1 6.3 22.5 26.8 8.3 9.4 13.0 4.5 9.0 5.4 4.0 4.3 8.7 18.3 15.6 9.6 2.8 34.2 19.0 15.5 14.4 8.7 17.7 25.0 11.5 33.3 5.5 7.1 20.1 23.5 11.2 16.5 11.3 1.5 25.2 11.2 9.6 11.0 14.5 10.9 10.9 22.0 14.0 17.4 6.6 11.9 14.3 25.6 29.1 28.8 34.7 29.7 31.7 24.3 30.9 30.5 30.2 25.8 25.8 24.2 14.4 25.8 28.2 44.1 41.3 31.1 12.9 12.4 16.3 19.8 12.0 10.4 14.4 17.4 12.9 13.2 14.9 25.7 52.2 36.7 31.8 32.4 21.2 45.9 13.4 23.9 29.6 19.6 88.5 56.3 58.2 27.4 31.5 37.8 0.0 64.8 66.3 45.0 34.5 19.7 60.6 55.1 22.3 36.7 27.6 44.1 62.9 33.9 27.6 55.6 48.7 43.9 38.9 54.9 31.6 29.0 50.1 34.0 45.3 42.8 35.1 28.3 36.3 34.6 50.1 53.3 20.0 NUDC NudC ENSG00000090273 "Nuclear distribution C, dynein complex regulator" Q9Y266 1 26900238-26946862 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027183, HPA028105" Enhanced Enhanced Cytosol NA NA 18000 Cytosol "HPA027183: AB_10600086, HPA028105: AB_10601988" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.61e-2)" "unprognostic (6.52e-3)" "unprognostic (2.30e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-2)" "unprognostic (3.82e-1)" "unprognostic (3.26e-2)" "unprognostic (2.90e-2)" "unprognostic (1.55e-1)" "unprognostic (2.53e-1)" "unprognostic (5.10e-2)" 30.7 57.9 49.9 25.8 44.9 31.8 30.9 40.1 59.0 30.5 35.7 32.0 31.7 25.8 30.0 53.0 26.6 69.2 28.2 41.8 39.3 41.0 28.2 46.8 26.4 27.3 39.6 49.7 34.5 44.7 36.7 32.3 29.2 38.6 34.2 23.7 25.0 35.0 43.9 65.6 30.8 22.9 39.0 32.9 29.2 36.6 41.4 35.9 30.0 36.8 24.8 29.5 37.6 84.4 73.7 69.0 63.1 62.8 57.9 71.8 64.8 42.6 44.7 23.5 32.6 18.8 16.9 26.7 34.3 21.2 46.3 34.2 41.0 29.9 35.9 30.4 23.4 34.1 33.6 49.9 45.2 35.8 27.8 51.7 44.6 45.5 70.1 33.2 47.0 33.0 18.1 29.6 55.6 36.0 20.2 33.9 42.2 63.5 20.2 31.1 37.1 47.2 60.9 61.7 56.1 58.1 49.5 29.8 36.6 39.4 16.9 39.2 29.4 37.3 23.8 30.2 23.1 23.2 29.0 33.4 33.1 39.5 41.3 43.9 40.7 63.9 43.3 35.7 66.5 37.1 63.1 60.3 57.5 69.1 62.8 69.7 72.0 70.4 65.3 59.8 73.7 70.0 71.8 41.0 57.9 60.0 69.0 66.5 64.8 49.9 44.9 40.1 59.0 39.3 41.0 39.6 49.7 38.6 35.9 125.0 96.1 101.3 254.2 136.9 88.8 139.6 127.4 592.9 157.0 104.7 49.1 182.7 222.2 232.6 46.2 119.1 64.9 0.0 274.8 170.3 125.0 214.5 143.3 551.3 129.0 104.9 125.9 76.1 61.3 97.3 125.7 95.2 143.4 146.1 65.8 130.4 273.1 71.9 143.9 157.8 81.0 109.9 158.4 185.6 247.7 129.7 136.0 118.6 82.6 183.4 NUDCD1 "CML66, FLJ14991" ENSG00000120526 "NudC domain containing 1" Q96RS6 8 109240919-109334385 "Predicted intracellular proteins" Immunity "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023183 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023183: AB_1854695" "unprognostic (5.08e-3)" "unprognostic (3.73e-2)" "unprognostic (2.52e-2)" "unprognostic (9.03e-3)" "unprognostic (7.52e-2)" "unprognostic (3.62e-3)" "prognostic unfavorable (1.39e-5)" "prognostic unfavorable (4.37e-5)" "unprognostic (2.13e-1)" "unprognostic (9.49e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (8.22e-2)" "prognostic unfavorable (8.71e-6)" "unprognostic (1.95e-1)" "unprognostic (1.63e-1)" "unprognostic (3.35e-1)" "unprognostic (1.65e-1)" 22.1 9.2 9.4 10.2 12.7 3.2 17.1 16.4 12.2 14.0 9.1 4.4 9.0 5.0 14.4 9.8 10.9 12.3 9.0 10.9 9.9 8.4 13.6 10.8 12.3 14.1 12.6 8.9 12.0 13.1 9.1 15.2 25.4 9.7 10.7 12.1 4.8 11.4 12.7 10.9 7.5 8.6 13.8 8.6 19.0 10.3 20.1 8.4 19.5 15.6 11.0 14.0 13.8 13.4 4.4 4.4 1.2 4.2 5.1 5.2 2.3 13.1 7.9 11.3 6.4 6.5 8.8 6.2 9.7 11.5 27.1 25.7 8.8 10.3 8.9 6.2 10.2 7.6 7.9 17.1 15.7 37.8 11.3 6.1 13.6 5.4 8.9 13.1 5.9 5.1 5.8 8.7 13.4 18.9 8.4 24.5 10.6 14.9 4.6 22.9 11.2 15.8 6.9 8.0 26.5 10.8 10.0 9.4 8.6 16.7 6.9 9.4 8.3 4.3 11.6 9.2 12.3 9.2 4.6 6.7 13.4 8.1 6.2 8.3 3.5 4.4 10.4 5.1 10.1 11.3 0.0 1.9 1.2 3.3 4.1 4.4 4.4 3.7 4.9 4.4 3.8 4.6 5.2 0.1 5.1 4.2 3.2 4.0 2.3 9.4 12.7 16.4 12.2 9.9 8.4 12.6 8.9 9.7 8.4 3.0 10.6 12.6 15.2 15.8 5.1 7.7 0.0 18.7 27.3 3.5 5.9 22.1 6.6 15.9 72.7 22.5 2.6 0.0 9.4 19.1 11.5 9.5 17.3 5.0 8.7 4.8 8.6 7.4 4.9 13.1 12.0 9.0 6.8 21.6 4.5 4.3 12.3 5.9 6.3 11.0 8.5 0.0 12.8 44.7 31.3 14.6 6.9 8.7 9.0 17.2 NUDCD2 "DKFZp686E10109, NudCL2" ENSG00000170584 "NudC domain containing 2" Q8WVJ2 5 163446526-163460140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037384, HPA037385" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA037384: AB_2675447, HPA037385: AB_10673630" "unprognostic (3.96e-1)" "unprognostic (3.69e-2)" "prognostic favorable (2.80e-4)" "unprognostic (1.46e-1)" "unprognostic (9.12e-2)" "unprognostic (3.75e-3)" "unprognostic (1.84e-1)" "unprognostic (4.74e-1)" "unprognostic (3.47e-2)" "unprognostic (7.63e-3)" "unprognostic (1.81e-1)" "unprognostic (2.45e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" "unprognostic (6.86e-2)" "unprognostic (3.40e-2)" "unprognostic (7.85e-2)" 18.3 17.3 19.1 17.4 20.2 14.0 16.6 10.4 21.8 8.5 15.1 23.2 12.7 20.2 12.5 9.7 15.0 14.3 9.9 10.1 19.9 15.1 16.2 20.1 11.8 18.9 27.0 14.5 13.4 24.4 9.6 13.2 14.5 19.3 12.7 9.1 9.3 19.4 10.6 25.7 11.7 18.0 14.1 30.5 16.6 15.9 12.5 20.9 16.9 14.6 11.0 13.4 12.8 11.5 34.3 30.3 14.1 21.6 28.5 36.5 24.4 23.5 12.2 9.3 14.6 5.7 4.2 12.3 9.5 2.8 3.4 5.5 10.9 18.1 13.4 23.0 1.5 15.9 11.9 4.9 5.4 4.1 26.7 13.7 12.4 15.5 9.9 6.2 13.9 14.1 1.5 3.2 3.3 4.8 4.9 3.8 15.3 13.0 16.8 3.5 9.6 20.6 30.7 10.2 7.0 13.5 17.4 15.5 23.8 3.1 5.5 23.7 13.4 15.0 9.7 24.7 5.8 18.6 14.4 8.5 11.8 17.7 13.0 21.8 13.9 23.2 22.6 13.7 24.2 12.3 14.1 18.9 11.8 23.8 21.6 30.3 34.3 34.0 28.4 25.4 24.4 36.5 31.9 2.4 28.5 17.9 30.3 30.0 24.4 19.1 20.2 10.4 18.1 19.9 15.1 27.0 14.5 19.3 20.9 26.8 18.4 48.4 46.7 52.8 29.3 36.7 30.6 41.5 31.8 36.6 21.6 97.0 126.0 54.7 60.9 45.6 19.3 23.3 55.7 43.8 50.3 51.1 30.1 51.3 61.4 9.5 42.1 31.9 41.1 11.4 47.8 38.8 47.2 40.5 42.0 35.3 54.2 28.1 48.1 89.3 36.4 38.8 41.9 69.5 42.8 59.1 47.5 42.4 61.0 48.8 NUDCD3 "KIAA1068, NudCL" ENSG00000015676 "NudC domain containing 3" Q8IVD9 7 44379121-44490880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019136, HPA019528, HPA019529" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374" "unprognostic (3.72e-2)" "unprognostic (9.28e-3)" "unprognostic (2.33e-2)" "unprognostic (2.05e-3)" "unprognostic (2.18e-3)" "unprognostic (2.05e-2)" "unprognostic (4.73e-2)" "unprognostic (2.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "unprognostic (5.62e-2)" "prognostic favorable (9.16e-4)" "unprognostic (3.51e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-1)" "unprognostic (6.50e-2)" 8.3 6.3 15.3 5.4 20.8 7.3 7.2 10.9 26.0 7.8 5.8 7.7 6.4 4.0 6.9 7.3 8.0 10.3 6.7 19.5 15.2 13.0 6.0 5.8 7.2 6.2 12.5 16.8 9.3 6.8 12.8 4.7 5.3 10.1 8.4 5.7 6.1 7.1 9.9 18.3 7.0 5.0 8.8 10.1 5.8 5.9 9.9 7.1 4.1 8.1 4.8 6.6 6.3 5.3 4.7 2.8 3.2 3.1 2.5 4.7 3.5 3.1 5.9 4.3 7.8 5.4 4.5 1.7 5.2 5.0 6.0 6.3 4.0 2.2 10.1 3.9 6.7 8.4 3.7 5.9 6.8 3.5 5.8 6.3 2.9 3.6 2.9 5.0 4.8 1.8 4.0 4.6 4.5 5.2 3.6 7.3 3.4 7.2 3.3 4.4 2.8 2.1 4.5 5.5 3.1 7.9 3.3 4.7 3.7 3.4 4.9 4.7 13.5 3.0 5.6 2.3 4.5 4.3 6.9 7.1 4.3 4.4 2.7 4.1 9.2 9.6 5.1 4.5 5.8 7.4 2.0 2.8 3.2 4.6 2.7 4.7 3.5 4.4 3.8 2.6 4.7 4.6 4.0 1.8 2.5 3.1 2.8 4.4 3.5 15.3 20.8 10.9 26.0 15.2 13.0 12.5 16.8 10.1 7.1 11.9 19.2 17.2 11.6 10.1 37.9 38.9 12.7 21.4 13.6 36.6 51.1 17.0 19.9 27.0 56.9 21.1 21.5 0.0 18.7 15.8 15.0 14.2 9.2 28.8 15.6 46.1 16.7 21.5 19.8 67.6 28.1 11.6 15.1 19.8 21.4 25.5 23.6 21.2 26.5 21.3 40.2 32.3 15.5 52.1 13.7 14.2 12.0 15.8 25.0 10.8 NUDT1 MTH1 ENSG00000106268 "Nudix hydrolase 1" P36639 7 2242222-2251146 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 59.5" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 233.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012636 Approved Supported Cytosol No No Cytosol "HPA012636: AB_1854696" "unprognostic (1.31e-1)" "unprognostic (1.19e-2)" "unprognostic (2.13e-2)" "unprognostic (2.37e-1)" "unprognostic (3.01e-3)" "unprognostic (3.37e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (2.15e-2)" "unprognostic (4.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.81e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (3.49e-2)" "unprognostic (1.70e-1)" 8.8 3.9 7.4 12.6 13.4 37.1 10.8 5.0 10.8 5.9 9.0 8.7 2.2 9.1 8.2 9.2 13.1 6.0 8.1 11.3 8.7 4.7 4.1 2.9 7.2 18.9 8.2 7.0 4.8 4.0 0.7 1.8 5.8 7.2 7.2 6.3 4.0 5.5 4.2 12.0 18.8 9.3 10.5 11.9 11.1 5.5 26.7 5.3 30.7 4.1 14.4 17.2 6.8 8.1 18.3 59.5 11.9 21.3 10.1 20.4 13.0 21.7 35.1 19.3 25.5 7.1 9.8 14.2 9.6 8.4 13.2 15.4 18.9 16.5 23.0 7.8 10.5 26.9 26.6 14.6 14.6 7.7 10.2 25.0 17.9 29.6 16.0 1.7 13.9 18.1 6.4 3.8 19.0 6.8 4.3 7.1 33.5 14.2 25.7 14.7 55.5 25.9 54.2 41.4 10.8 21.7 36.3 28.6 19.2 7.2 12.3 19.4 26.9 9.9 29.2 4.4 14.6 19.2 37.0 6.5 12.7 48.5 29.3 22.8 19.9 15.0 23.8 12.8 34.7 45.6 9.0 17.5 11.9 12.9 21.3 10.2 18.3 15.1 13.6 26.6 18.0 15.1 13.1 4.6 10.1 17.4 59.5 20.4 13.0 7.4 13.4 5.0 10.8 8.7 4.7 8.2 7.0 7.2 5.3 6.0 6.9 41.2 21.9 35.6 10.2 15.1 12.7 8.1 7.9 10.4 3.9 30.9 16.6 20.1 42.6 10.8 14.4 233.6 32.2 67.3 28.8 13.6 61.0 5.3 76.9 0.0 7.5 4.3 37.3 78.4 20.4 69.4 43.9 36.9 26.8 18.6 17.6 17.3 17.7 11.7 6.1 32.3 28.5 80.4 63.8 32.4 19.8 39.2 33.8 16.0 NUDT10 "DIPP3a, hDIPP3alpha" ENSG00000122824 "Nudix hydrolase 10" Q8NFP7 X 51332231-51337525 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2" "Group enriched" "Detected in some" 5 "Ito cells: 54.6;Peritubular cells: 27.3" "Group enriched" "Detected in many" 6 "glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 6.2;HAP1: 11.6;HEK 293: 8.6;NTERA-2: 21.3;SH-SY5Y: 4.6;SuSa: 4.4;U-2 OS: 10.7" "HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (2.61e-2)" "unprognostic (1.12e-2)" "unprognostic (7.40e-3)" "unprognostic (7.84e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.51e-3)" "unprognostic (1.80e-3)" "unprognostic (1.04e-2)" "unprognostic (1.12e-2)" "unprognostic (5.04e-5)" 1.0 2.3 9.3 1.4 10.7 1.8 1.4 6.0 13.1 4.4 2.0 0.9 28.8 1.1 5.5 18.3 1.7 3.4 2.0 0.9 4.9 13.6 3.1 1.9 0.7 0.9 5.3 8.0 19.2 0.6 0.5 4.5 0.5 6.2 17.9 1.3 0.8 1.0 36.3 0.5 1.0 1.2 4.9 1.9 3.1 1.1 27.2 1.2 0.0 0.8 0.0 0.9 2.8 2.9 0.8 0.1 0.0 0.7 2.1 1.0 0.3 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.0 11.6 0.5 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 21.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.1 0.0 0.8 1.0 0.0 0.1 0.3 0.0 0.6 0.0 2.1 0.5 0.0 0.0 0.3 9.3 10.7 6.0 11.7 4.9 13.6 5.3 8.0 6.2 1.2 0.0 2.2 0.0 4.6 0.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.4 0.4 2.1 0.0 0.0 0.2 0.0 0.0 54.6 3.4 4.0 5.5 0.0 1.7 0.0 0.0 1.8 0.0 0.0 27.3 0.0 0.4 0.0 1.9 2.4 7.9 0.1 0.3 0.0 0.0 0.0 NUDT11 "DIPP3b, FLJ10628, hDIPP3beta" ENSG00000196368 "Nudix hydrolase 11" Q96G61 X 51490011-51496596 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;testis: 35.5" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 13.6;Peritubular cells: 19.4;Smooth muscle cells: 12.7;Spermatocytes: 13.4;Spermatogonia: 11.9" "Cancer enhanced" "Detected in many" "testis cancer: 17.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 3.7" "Cell line enhanced" "Detected in many" "HAP1: 33.6;NTERA-2: 21.0" "HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (2.01e-1)" "unprognostic (2.57e-1)" "unprognostic (8.21e-2)" "unprognostic (1.93e-3)" "unprognostic (6.61e-2)" "unprognostic (1.13e-3)" "unprognostic (5.52e-3)" "unprognostic (1.25e-1)" "unprognostic (2.25e-2)" "unprognostic (2.18e-1)" "unprognostic (8.41e-2)" "unprognostic (1.33e-1)" "unprognostic (7.80e-12)" "unprognostic (4.34e-4)" "unprognostic (1.17e-2)" "unprognostic (2.78e-1)" "unprognostic (3.94e-4)" 1.2 5.4 11.2 1.4 21.9 1.6 2.8 7.4 26.1 3.8 2.6 0.8 4.4 1.7 5.9 4.3 1.9 1.6 2.2 0.8 7.0 17.9 0.9 0.6 0.8 1.1 5.3 12.7 10.0 3.8 0.5 2.8 0.6 5.3 10.1 1.4 0.5 1.3 11.9 0.6 1.7 1.5 5.0 1.8 0.9 0.9 35.5 1.1 3.6 1.0 0.2 1.1 1.7 1.6 0.5 0.4 0.0 0.2 1.9 3.7 1.0 0.0 0.5 10.1 0.0 8.8 11.2 0.0 4.7 1.3 0.2 0.2 0.0 0.0 0.0 0.2 5.7 5.6 0.7 33.6 11.5 0.1 0.0 2.2 0.0 0.0 0.0 4.1 0.0 2.2 6.8 4.6 3.0 11.1 1.9 7.9 10.4 0.0 0.0 9.5 0.2 12.7 0.0 21.0 0.0 8.5 0.0 7.1 0.0 2.1 0.0 0.0 6.6 2.0 0.0 1.8 5.2 0.0 0.0 4.6 2.4 11.1 0.7 0.0 4.4 2.0 7.2 1.5 0.0 0.9 0.0 0.0 0.0 3.7 0.0 1.4 0.5 1.2 1.9 0.4 0.3 0.2 3.1 0.0 1.9 0.2 0.2 0.0 1.0 11.2 21.9 7.4 14.9 7.0 17.9 5.3 12.7 5.3 1.1 0.0 0.0 0.0 4.8 13.6 1.5 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.2 9.4 0.0 0.0 0.0 1.3 0.9 4.1 9.3 0.0 0.0 0.1 0.0 0.0 0.0 0.8 10.2 8.1 0.6 5.0 0.0 0.0 0.9 2.2 0.0 19.4 0.0 0.1 0.0 12.7 13.4 11.9 8.0 0.2 0.0 0.0 1.1 NUDT16L1 SDOS ENSG00000168101 "Nudix hydrolase 16 like 1" Q9BRJ7 16 4693694-4695859 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044186, HPA063605" Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA044186: AB_10968571, HPA063605: AB_2685058" "unprognostic (1.35e-2)" "unprognostic (1.70e-1)" "unprognostic (6.65e-2)" "unprognostic (2.17e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-2)" "unprognostic (3.14e-1)" "prognostic favorable (2.79e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (6.12e-3)" "unprognostic (6.81e-2)" "prognostic favorable (1.02e-6)" "unprognostic (2.78e-1)" "unprognostic (1.47e-1)" "unprognostic (4.08e-2)" "unprognostic (6.81e-3)" 11.2 21.7 19.3 13.2 22.1 19.3 11.0 25.3 33.1 13.6 20.6 15.9 25.5 21.7 10.4 17.1 14.0 16.5 16.8 31.8 19.7 17.5 20.1 27.2 15.2 18.5 18.3 15.8 13.9 14.8 15.7 19.6 10.5 13.4 19.7 12.2 16.3 16.8 16.3 22.4 10.9 18.6 8.9 16.2 15.9 15.3 13.0 15.9 18.2 21.6 14.2 15.9 10.5 9.8 30.1 40.4 44.9 27.0 28.5 39.6 42.7 7.4 12.3 11.3 15.1 8.5 6.6 10.3 8.9 6.8 10.9 6.9 13.8 6.0 7.8 13.0 10.7 5.5 8.7 12.1 12.2 5.1 11.4 20.4 8.6 10.6 16.6 9.3 12.3 10.2 10.2 11.3 9.1 5.7 7.4 8.0 11.8 15.6 9.8 10.5 29.0 18.4 18.2 17.8 12.5 14.2 25.9 11.9 12.2 13.0 9.3 22.3 16.7 13.0 13.7 5.9 9.2 20.2 28.9 10.3 9.0 13.5 21.1 8.1 17.1 10.1 13.1 5.6 16.5 18.2 23.1 27.0 44.9 27.2 22.5 32.6 28.8 33.3 32.4 24.5 30.1 39.6 33.6 33.3 28.5 24.0 40.4 36.7 42.7 19.3 22.1 25.3 33.1 19.7 17.5 18.3 15.8 13.4 15.9 14.9 19.0 34.7 19.4 12.5 52.0 47.7 12.7 17.4 12.5 40.1 9.8 43.2 92.9 25.8 3.1 23.2 52.5 0.0 27.2 25.3 19.0 19.1 27.6 35.5 35.0 44.5 41.3 15.4 17.0 5.5 29.1 17.5 28.7 51.3 44.4 75.6 24.1 42.1 47.0 80.4 54.6 45.3 22.1 10.9 35.7 14.4 41.1 37.4 46.0 14.6 NUDT17 FLJ34433 ENSG00000186364 "Nudix hydrolase 17" P0C025 1 145845629-145848953 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 9.0;Spermatogonia: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 5.8;eosinophil: 11.5;plasmacytoid DC: 18.4" "Group enriched" "Detected in many" 8 "dendritic cells: 18.4;granulocytes: 11.5" "Cell line enhanced" "Detected in many" "T-47d: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030145 Approved Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA030145: AB_10603883" "unprognostic (8.93e-3)" "unprognostic (2.28e-1)" "unprognostic (2.63e-3)" "unprognostic (8.72e-3)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.07e-3)" "unprognostic (6.55e-2)" "unprognostic (6.03e-2)" "unprognostic (1.24e-2)" "unprognostic (5.40e-2)" "prognostic unfavorable (1.81e-7)" "unprognostic (5.59e-2)" "unprognostic (1.63e-1)" "unprognostic (6.16e-2)" "unprognostic (1.96e-1)" 4.6 3.3 8.3 3.9 13.5 6.7 4.9 8.9 10.9 3.8 3.4 5.1 1.5 1.2 4.6 3.1 3.5 7.0 4.4 8.4 6.6 7.7 3.8 2.6 3.4 9.0 5.9 8.1 6.8 6.2 6.2 4.7 2.2 5.4 4.2 2.9 8.0 6.3 5.8 6.7 4.3 3.3 11.1 5.5 6.0 3.3 7.1 2.2 3.5 5.7 3.4 7.7 4.1 3.2 0.9 18.4 11.5 1.8 0.2 1.1 0.7 4.2 3.1 2.9 1.6 1.6 2.4 2.9 2.0 3.4 2.1 3.0 1.9 3.1 6.2 2.2 3.5 0.5 0.8 2.1 1.2 1.4 0.7 3.6 2.4 2.5 2.8 4.7 1.9 8.0 2.5 2.0 1.4 2.4 2.7 4.2 10.1 5.2 5.8 3.8 6.7 2.1 3.6 2.4 2.6 0.3 5.4 1.1 1.9 3.3 1.0 1.4 3.2 1.3 2.6 3.5 3.1 14.5 8.6 2.5 2.5 1.7 1.2 0.8 5.1 2.4 1.5 2.4 2.6 1.9 5.8 0.6 11.5 0.6 1.8 0.4 0.9 0.5 0.3 0.6 0.6 1.1 0.8 0.1 0.2 1.1 18.4 0.5 0.7 8.3 13.5 8.9 10.9 6.6 7.7 5.9 8.1 5.4 2.2 3.0 5.6 0.0 0.9 1.5 1.9 0.4 0.0 2.7 4.5 0.0 0.0 0.4 1.7 1.2 2.9 1.0 0.7 0.0 0.6 0.6 1.9 0.9 2.3 0.6 2.6 0.0 1.2 2.5 0.8 1.3 1.4 1.2 1.7 0.0 0.2 9.0 1.2 0.6 0.4 0.6 3.9 0.0 1.4 6.9 11.7 1.1 0.5 1.3 1.2 0.7 NUDT19 RP2 ENSG00000213965 "Nudix hydrolase 19" A8MXV4 19 32691961-32713796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042761 Uncertain Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA042761: " "unprognostic (1.20e-1)" "unprognostic (2.90e-1)" "unprognostic (2.35e-3)" "unprognostic (6.61e-3)" "unprognostic (2.62e-2)" "unprognostic (2.44e-1)" "unprognostic (6.18e-3)" "unprognostic (1.97e-1)" "unprognostic (3.14e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (2.81e-1)" "unprognostic (1.23e-1)" "prognostic favorable (1.35e-4)" 9.9 18.7 7.2 11.1 7.0 10.8 10.7 7.4 7.6 5.6 12.8 6.1 8.4 10.2 6.6 8.8 16.9 6.3 7.6 19.3 6.1 6.5 10.5 16.4 15.9 9.2 6.2 5.5 8.5 18.9 9.5 9.3 6.6 6.1 11.2 10.7 9.4 14.7 11.8 29.5 13.2 12.9 6.9 5.6 8.9 11.3 6.8 6.6 6.8 5.9 13.1 13.0 9.9 8.4 8.4 11.9 9.0 23.6 18.7 14.8 6.5 13.7 16.0 1.8 15.9 5.5 7.2 0.3 7.8 2.9 5.8 5.5 9.0 7.6 0.2 9.4 9.0 4.5 9.0 11.0 9.1 7.7 15.8 6.6 17.8 6.4 3.3 7.6 13.3 5.5 5.8 12.1 4.9 12.0 6.8 8.5 2.8 13.7 10.2 10.4 9.1 0.1 12.3 1.9 3.8 7.6 0.1 3.5 7.7 9.6 10.3 7.2 10.3 13.9 11.9 9.8 3.3 6.5 16.3 6.8 8.1 5.2 8.0 13.9 12.0 10.1 4.5 9.7 12.8 7.4 6.6 17.3 9.0 11.9 21.7 12.8 8.4 12.5 14.8 11.9 5.9 10.0 13.8 3.3 18.7 23.6 9.5 13.8 6.5 7.2 7.0 7.4 7.6 6.1 6.5 6.2 5.5 6.1 6.6 11.9 12.6 8.2 6.5 19.5 12.8 18.7 5.1 4.0 4.5 7.0 11.8 9.8 23.2 2.6 7.7 4.5 9.7 0.0 9.9 9.4 9.4 8.5 1.1 9.3 12.6 3.2 11.6 12.3 12.1 3.1 3.7 10.8 11.8 7.2 13.0 5.5 9.5 14.0 8.9 14.8 26.4 0.0 6.6 1.4 1.9 27.6 6.5 13.3 15.8 7.9 NUDT3 DIPP ENSG00000272325 "Nudix hydrolase 3" O95989 6 34279679-34392674 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047027, HPA055953" Uncertain Approved Cytosol NA NA 110000 Cytosol "HPA047027: AB_2679907, HPA055953: AB_2682984" "unprognostic (2.42e-1)" "prognostic favorable (5.29e-4)" "unprognostic (9.63e-3)" "unprognostic (4.74e-3)" "unprognostic (3.60e-2)" "unprognostic (1.84e-1)" "unprognostic (1.41e-3)" "unprognostic (4.21e-2)" "unprognostic (4.93e-3)" "unprognostic (1.08e-1)" "unprognostic (3.16e-1)" "unprognostic (4.63e-1)" "unprognostic (1.24e-2)" "unprognostic (3.28e-2)" "unprognostic (1.09e-1)" "unprognostic (1.54e-1)" "unprognostic (6.24e-2)" 10.5 11.4 38.8 9.3 28.6 8.8 12.6 33.4 40.0 15.4 11.4 16.8 10.3 7.7 11.4 25.9 10.8 15.2 8.5 16.9 33.8 30.0 15.3 10.1 11.2 10.5 29.4 25.6 17.4 9.1 27.9 9.3 8.9 26.1 11.4 9.7 11.2 9.4 15.6 50.7 11.2 8.0 11.2 20.3 13.0 8.4 7.3 21.3 5.4 21.3 8.7 12.1 8.6 9.9 4.5 6.4 12.4 5.9 2.1 3.9 2.6 5.4 4.0 10.8 21.1 7.2 12.2 4.7 4.0 6.7 4.1 3.0 4.8 3.8 19.6 5.4 7.1 2.7 4.6 6.1 10.8 7.7 7.3 7.8 21.6 5.6 10.4 7.2 20.3 11.3 11.0 10.0 5.0 9.4 5.3 11.8 10.2 21.4 7.1 6.6 5.7 14.0 23.8 6.9 16.1 4.0 12.3 8.9 20.4 9.4 11.4 15.2 17.0 8.8 12.5 15.9 3.4 12.5 14.6 12.9 8.3 3.0 7.2 8.6 6.1 14.1 14.4 5.0 20.8 12.9 1.9 5.8 12.4 3.4 5.9 3.9 3.4 3.4 3.2 6.4 4.5 3.2 3.7 4.1 2.1 5.8 3.2 2.4 2.6 38.8 28.6 33.4 40.0 33.8 30.0 29.4 25.6 26.1 21.3 14.9 22.4 43.5 59.4 53.1 115.6 43.3 63.7 46.8 14.8 40.1 111.9 28.0 11.6 15.4 3.0 55.9 18.4 0.0 24.5 26.3 42.3 39.4 12.8 52.1 67.2 160.5 47.2 84.7 91.0 4.0 34.8 58.5 50.6 22.6 24.7 115.6 20.8 19.8 59.4 19.2 125.0 58.2 46.4 44.7 78.0 52.7 16.4 20.1 25.2 59.3 NUDT4 "DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487" ENSG00000173598 "Nudix hydrolase 4" Q9NZJ9 12 93377883-93408146 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 140.7" "Cell type enhanced" "Detected in all" 5 "Muller glia cells: 411.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA017593, HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (1.44e-2)" "unprognostic (2.15e-1)" "unprognostic (4.40e-3)" "unprognostic (4.25e-1)" "unprognostic (3.08e-3)" "unprognostic (1.42e-1)" "unprognostic (8.12e-2)" "unprognostic (9.09e-3)" "unprognostic (1.88e-1)" "unprognostic (1.51e-1)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.75e-1)" "unprognostic (2.87e-1)" "unprognostic (5.01e-1)" "unprognostic (8.32e-3)" 17.2 29.7 14.1 14.7 9.5 37.4 20.4 7.0 29.0 15.2 14.7 6.7 17.5 6.5 13.6 24.8 13.7 12.8 40.0 140.7 12.4 12.4 47.9 11.2 11.3 10.9 9.4 13.7 41.9 21.1 16.1 11.9 19.2 13.9 27.1 16.9 25.1 65.2 14.8 40.3 8.1 12.7 13.8 12.6 9.2 13.1 10.6 6.3 14.6 25.5 22.4 8.9 19.6 32.9 6.0 4.1 13.6 3.6 7.6 6.6 2.5 5.8 5.0 9.1 10.2 34.0 14.1 11.5 16.3 13.0 9.4 6.9 46.9 14.6 8.2 3.6 13.0 6.1 7.4 25.5 8.2 14.4 12.5 5.4 30.7 4.4 23.9 32.7 15.9 7.4 30.5 27.5 9.6 21.6 47.1 53.1 14.8 31.1 11.5 10.7 6.0 14.8 15.2 14.4 14.4 12.0 12.4 8.2 8.8 11.2 42.3 7.4 9.5 13.2 25.9 36.5 15.3 18.8 20.8 20.1 8.0 4.7 12.0 10.3 6.5 8.1 12.1 4.2 12.6 24.4 8.2 2.8 13.6 3.9 3.6 6.6 6.0 5.8 3.9 2.6 4.7 6.2 5.8 2.4 7.6 2.9 4.1 5.2 2.5 14.1 9.5 7.0 29.0 12.4 12.4 9.4 13.7 13.9 6.3 17.9 42.6 40.8 110.6 103.7 39.3 226.3 94.3 91.0 31.8 59.3 58.9 156.3 306.7 20.9 78.9 50.0 102.5 327.1 14.7 23.0 86.0 142.6 25.3 48.9 37.7 39.7 146.0 28.8 34.5 17.0 36.2 31.8 101.3 12.6 83.5 411.5 37.2 85.6 43.9 43.1 40.3 71.1 166.9 28.7 7.7 84.6 137.0 29.9 64.3 133.5 NUDT4B NUDT4P1 ENSG00000177144 "Nudix hydrolase 4B" 1 148748894-148750099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "eosinophil: 4.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.5" "Cell line enhanced" "Detected in many" "CACO-2: 23.3;RT4: 21.1" "HPA017593, HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (1.24e-1)" "unprognostic (4.01e-2)" 0.5 1.2 0.0 5.4 0.0 0.0 0.5 0.7 0.7 0.2 0.0 2.0 1.4 5.5 6.5 2.0 0.2 0.0 1.2 4.5 3.0 2.1 1.5 1.4 1.0 5.7 0.0 0.0 0.0 0.5 0.1 0.0 0.1 1.6 1.7 0.1 5.8 0.0 0.3 4.5 0.8 0.2 0.6 0.4 1.6 2.2 0.5 2.6 3.4 3.3 5.0 1.3 3.3 2.4 2.4 23.3 8.5 1.4 0.5 1.7 2.5 2.5 2.8 1.3 1.4 4.8 1.8 3.8 1.4 2.7 3.7 2.8 0.8 5.4 4.5 3.2 2.9 2.1 8.4 1.1 6.9 9.2 2.4 1.4 1.8 0.5 3.0 1.4 2.2 3.4 0.9 5.4 2.0 21.1 1.3 2.1 1.8 3.4 14.4 0.5 6.0 6.0 4.6 3.2 2.0 5.5 3.0 0.8 2.4 1.5 1.6 4.9 9.3 0.0 0.1 4.5 0.0 0.2 0.6 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUDT8 FLJ41567 ENSG00000167799 "Nudix hydrolase 8" Q8WV74 11 67627938-67629930 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 96.8;Hepatocytes: 168.1;Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 68.5" "Low region specificity" "Detected in all" "HPA041252, HPA041466" Enhanced Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041252: AB_10794551, HPA041466: AB_10793967" "unprognostic (8.31e-2)" "unprognostic (7.26e-3)" "unprognostic (7.31e-2)" "unprognostic (7.32e-2)" "unprognostic (2.87e-1)" "unprognostic (2.36e-3)" "unprognostic (2.69e-1)" "unprognostic (4.12e-2)" "unprognostic (8.28e-2)" "unprognostic (2.69e-2)" "unprognostic (3.11e-2)" "unprognostic (2.74e-1)" "prognostic favorable (3.70e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (2.19e-1)" 5.5 2.0 3.0 4.1 4.1 2.1 10.8 4.1 2.7 3.9 8.1 3.5 10.1 10.6 1.7 4.8 22.0 2.4 5.9 32.5 2.6 3.0 16.0 21.4 3.8 4.3 4.9 2.3 2.2 7.7 4.3 1.3 2.5 5.9 4.2 4.2 2.0 28.3 8.2 38.2 12.4 12.2 2.4 4.1 1.9 6.9 1.4 2.3 2.0 13.6 25.0 15.3 1.6 4.7 7.1 11.8 1.0 11.2 8.1 3.4 2.1 10.4 4.2 1.6 2.7 1.5 2.0 2.6 2.2 1.0 0.9 0.9 3.5 2.7 10.9 3.4 1.7 1.3 5.1 1.9 1.3 0.1 10.6 4.6 0.6 1.8 10.6 0.4 3.4 5.3 1.2 2.6 1.1 0.3 0.2 1.9 13.9 3.0 9.8 0.7 17.5 5.7 5.0 0.9 18.4 8.6 3.5 0.8 68.5 2.7 1.8 0.8 1.1 0.5 6.1 2.1 0.6 3.3 1.4 0.5 2.3 3.3 14.9 0.4 7.0 4.6 2.1 1.6 4.7 1.3 0.0 1.0 1.0 3.1 3.9 2.6 3.3 1.8 3.4 4.3 7.1 1.6 1.9 0.0 8.1 11.2 11.8 1.1 2.1 3.0 4.1 4.1 2.7 2.6 3.0 4.9 2.3 5.9 2.3 0.0 6.2 15.0 11.1 10.8 4.3 66.8 17.8 2.7 0.0 27.9 0.0 21.3 71.3 11.4 2.7 7.5 96.8 23.3 20.8 17.7 10.7 20.1 9.2 168.1 7.9 4.8 2.4 9.8 4.7 5.6 4.6 3.0 27.0 2.8 66.6 7.0 11.3 22.4 4.9 147.8 6.0 6.5 11.3 9.1 6.3 22.3 14.5 9.6 56.6 16.3 NUF2 "CDCA1, CT106, NUF2R" ENSG00000143228 "NUF2, NDC80 kinetochore complex component" Q9BZD4 1 163266576-163355764 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 38.6;testis: 29.0" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 232.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059692, HPA076604" Supported Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA059692: AB_2684103, HPA076604: " "unprognostic (9.41e-2)" "unprognostic (2.61e-1)" "unprognostic (2.56e-1)" "unprognostic (5.32e-3)" "unprognostic (6.20e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.04e-5)" "prognostic unfavorable (9.16e-4)" "prognostic unfavorable (4.83e-4)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (3.70e-2)" "unprognostic (0.00e+0)" "unprognostic (9.79e-2)" "unprognostic (7.88e-2)" "unprognostic (2.69e-1)" "unprognostic (5.96e-2)" 1.3 0.9 0.8 9.8 0.9 14.1 0.6 0.5 0.9 1.4 2.5 0.6 0.9 2.3 0.6 2.1 6.1 0.5 0.7 1.5 0.8 0.6 0.7 0.6 1.9 9.9 0.8 0.6 0.7 0.4 0.3 0.4 3.6 0.7 0.6 2.9 0.8 1.3 0.0 0.5 2.2 3.2 1.0 1.4 4.4 1.6 29.0 0.3 38.6 0.5 5.1 9.2 1.5 1.8 1.4 0.6 2.6 0.2 3.0 7.7 1.0 26.3 9.2 24.5 10.2 0.7 2.5 13.3 16.7 11.8 27.2 23.9 7.0 23.3 22.7 14.0 6.7 11.3 15.5 14.9 6.3 34.5 23.7 10.7 8.9 10.6 10.0 0.0 15.3 18.4 0.3 0.6 13.7 9.7 5.1 12.3 22.3 16.7 31.5 25.7 5.1 27.9 20.6 13.3 19.4 14.2 19.0 21.4 20.1 7.7 3.6 18.3 21.1 8.9 9.7 9.2 15.9 14.9 32.1 8.7 20.3 22.8 15.2 33.6 22.6 31.8 43.3 6.7 12.6 22.4 2.6 0.2 2.5 2.4 0.1 1.0 1.2 3.6 2.4 0.5 1.4 2.5 2.1 0.9 3.0 0.2 0.6 7.7 1.0 0.8 0.9 0.5 0.9 0.8 0.6 0.8 0.6 0.7 0.3 0.0 0.3 3.7 1.8 5.3 1.0 0.8 0.0 0.0 4.5 0.0 0.0 2.7 0.0 0.7 15.8 0.1 0.8 46.7 0.2 23.9 1.8 0.4 4.6 0.2 11.3 0.0 0.0 1.8 3.7 10.7 2.3 2.5 0.0 1.0 0.9 2.5 0.2 0.0 2.1 0.0 2.0 6.5 0.5 232.2 40.5 2.0 3.3 3.8 2.2 1.4 NUFIP2 "182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1" ENSG00000108256 "NUFIP2, FMR1 interacting protein 2" Q7Z417 17 29255836-29294118 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067443 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA067443: AB_2685841" "unprognostic (6.51e-2)" "unprognostic (6.96e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-2)" "unprognostic (3.38e-1)" "unprognostic (2.12e-1)" "unprognostic (4.94e-3)" "unprognostic (1.40e-1)" "unprognostic (3.79e-2)" "unprognostic (9.42e-3)" "unprognostic (1.60e-3)" "unprognostic (5.24e-2)" "unprognostic (1.28e-3)" "unprognostic (3.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.18e-2)" "unprognostic (6.04e-3)" 21.6 20.6 25.0 25.4 28.6 83.5 25.1 38.8 39.0 17.3 18.0 15.5 17.4 19.6 17.8 15.9 27.1 17.0 17.7 21.8 24.1 15.6 16.9 28.9 31.5 22.2 24.2 15.5 20.0 19.8 26.2 40.8 44.4 28.9 18.4 16.6 13.9 25.4 27.5 43.7 17.9 20.3 13.3 30.5 24.6 22.0 17.0 27.2 18.3 20.2 15.6 22.9 19.0 42.6 6.9 9.8 21.2 6.9 4.1 6.1 1.6 15.2 24.9 14.6 10.1 12.6 14.8 24.5 15.2 9.2 11.7 10.8 27.4 8.4 24.8 22.8 10.4 10.5 21.6 11.6 10.6 15.0 26.5 20.8 18.7 22.7 7.1 11.7 23.8 20.3 12.7 13.1 12.9 14.0 13.6 8.6 9.2 30.5 18.5 12.0 12.6 25.0 10.8 15.0 11.7 9.2 20.6 25.1 10.6 9.9 25.1 14.0 8.9 27.2 51.2 16.6 20.4 17.6 16.1 14.1 22.5 22.5 13.1 25.9 25.9 23.8 28.8 14.9 12.7 19.1 8.8 5.2 6.2 4.9 5.0 3.7 6.8 4.7 5.2 4.1 6.9 6.1 5.0 21.2 4.1 6.9 9.8 2.4 1.6 25.0 28.6 38.8 39.0 24.1 15.6 24.2 15.5 28.9 27.2 74.5 64.2 22.8 72.9 88.5 53.5 62.1 45.9 93.7 81.9 29.6 90.3 51.9 13.3 28.1 31.3 71.7 45.3 0.0 24.0 25.9 79.0 66.2 44.0 49.9 37.9 54.0 46.3 54.0 64.2 19.1 32.8 71.6 38.8 19.8 49.9 42.9 31.3 40.1 32.9 24.5 57.0 19.4 63.4 26.4 24.5 85.4 152.2 34.6 41.7 98.3 NUMA1 ENSG00000137497 "Nuclear mitotic apparatus protein 1" Q14980 11 72002864-72080693 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019841, HPA019859, HPA029912" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811" "unprognostic (1.60e-2)" "unprognostic (3.31e-1)" "unprognostic (2.06e-2)" "unprognostic (2.84e-1)" "unprognostic (1.14e-1)" "unprognostic (6.47e-2)" "unprognostic (5.75e-2)" "unprognostic (8.74e-3)" "unprognostic (5.91e-2)" "unprognostic (9.45e-2)" "unprognostic (1.60e-2)" "unprognostic (2.51e-2)" "prognostic favorable (7.92e-4)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (1.49e-1)" "unprognostic (1.39e-1)" 29.7 33.5 23.6 20.6 28.1 26.8 33.1 38.4 31.8 51.9 37.7 55.6 40.1 25.5 58.3 30.9 34.1 37.8 31.2 21.2 21.6 19.4 23.0 13.1 28.3 23.3 37.6 24.8 51.4 30.0 70.7 29.5 26.0 28.3 50.3 24.2 41.2 35.3 40.1 43.7 41.9 30.2 45.3 29.5 23.0 31.2 25.9 39.5 39.4 32.6 22.5 31.8 50.5 37.2 10.3 12.9 4.9 5.7 7.0 9.7 6.6 18.5 23.6 29.6 19.9 26.4 27.5 15.1 25.1 29.1 26.2 22.9 24.5 34.4 25.3 22.0 30.7 18.8 39.9 27.0 25.4 24.0 26.0 12.7 31.0 37.1 18.6 21.2 23.4 22.6 29.0 16.8 25.6 25.9 40.7 22.1 22.9 18.2 30.6 17.9 35.8 30.2 13.1 18.4 35.6 17.1 37.1 51.7 19.5 19.6 29.1 35.8 50.8 40.1 37.1 37.3 13.4 49.9 13.7 30.5 27.8 21.7 39.3 16.6 19.9 19.6 35.6 18.6 11.1 15.8 4.9 5.6 2.5 9.7 3.5 7.4 5.2 6.0 7.5 4.9 10.3 7.5 5.2 4.6 7.0 5.7 12.9 7.2 6.6 23.6 28.1 38.4 31.8 21.6 19.4 37.6 24.8 28.3 39.5 38.7 32.9 12.4 27.2 23.0 61.9 5.2 35.7 32.1 30.7 50.6 68.7 24.3 14.9 24.4 28.1 29.2 50.4 0.0 27.8 11.2 25.5 31.2 30.1 20.3 24.6 49.3 45.5 31.3 31.9 14.3 63.9 23.2 18.6 20.8 58.2 49.2 27.3 31.6 47.7 22.6 57.0 38.8 21.7 11.9 20.4 24.6 37.6 28.4 48.3 21.6 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.3" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA061750: AB_2684602, HPA063942: AB_2685156" "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favorable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 10.2 11.1 7.6 12.6 9.2 14.3 14.0 13.3 8.7 9.2 9.3 10.1 9.6 5.8 9.8 6.7 16.6 8.3 7.6 9.2 5.6 6.3 8.1 9.6 13.1 16.6 6.5 6.7 10.8 13.3 12.6 13.6 9.1 7.3 9.5 9.3 11.2 9.9 8.3 10.9 16.4 9.0 11.0 7.7 12.2 9.5 60.3 7.3 26.5 9.2 11.3 17.3 8.5 10.5 6.1 7.9 6.3 10.7 6.0 12.0 7.0 10.9 21.0 17.4 23.7 13.2 13.1 15.6 15.4 12.2 28.3 18.9 25.3 8.8 19.2 5.8 16.9 18.3 32.6 39.0 19.1 21.2 15.4 18.8 17.1 39.2 19.9 8.4 29.2 17.3 9.1 9.0 29.7 15.2 8.3 16.2 25.0 37.5 13.7 19.9 27.8 24.9 11.9 23.3 21.1 20.2 22.9 37.7 19.6 8.7 12.4 24.5 11.8 39.9 15.2 5.9 13.4 16.7 10.8 13.1 23.5 16.7 23.6 27.5 11.7 21.6 26.0 13.7 18.7 17.3 6.3 5.3 1.9 9.3 10.7 12.0 6.1 7.9 9.0 7.9 5.9 8.1 8.6 0.8 6.0 5.9 3.3 9.5 7.0 7.6 9.2 13.3 8.7 5.6 6.3 6.5 6.7 7.3 7.3 0.0 13.0 7.5 5.2 5.8 14.9 2.7 7.6 4.0 2.3 5.2 43.2 6.4 1.7 5.5 10.1 6.8 3.2 0.0 5.6 5.9 6.9 7.5 5.8 3.8 7.4 19.1 8.7 12.9 4.9 3.1 8.9 7.2 1.7 4.6 6.7 7.5 7.5 0.0 11.0 1.9 25.0 25.8 4.2 41.6 37.7 9.8 7.2 7.0 6.0 7.2 NUP43 "bA350J20.1, FLJ13287" ENSG00000120253 "Nucleoporin 43" Q8NFH3 6 149724315-149749665 "Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027126, HPA027291, HPA028500" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287" "prognostic unfavorable (2.08e-4)" "unprognostic (3.02e-1)" "unprognostic (3.86e-2)" "unprognostic (1.45e-3)" "unprognostic (2.29e-1)" "unprognostic (8.19e-3)" "prognostic unfavorable (7.13e-7)" "unprognostic (5.14e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-2)" "unprognostic (6.25e-3)" "unprognostic (2.02e-1)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" 16.9 14.2 12.7 15.2 13.8 7.6 19.6 15.6 13.5 20.1 13.1 17.9 18.3 12.4 18.4 11.5 17.4 13.1 9.1 14.7 10.9 10.0 15.7 13.7 12.6 20.3 15.2 9.2 15.7 22.6 14.1 13.2 18.8 12.9 16.6 14.1 17.7 14.2 14.2 20.0 18.7 16.6 16.2 12.1 22.7 14.4 13.8 16.4 28.6 18.9 12.1 24.2 18.4 14.2 10.6 8.1 5.1 8.6 6.1 9.7 3.3 9.0 15.8 13.9 21.8 8.9 11.2 21.8 15.7 9.0 15.4 19.5 22.6 8.5 26.1 16.8 8.6 14.4 14.5 23.8 13.8 26.2 12.2 16.7 29.9 16.8 21.0 6.1 30.6 19.5 6.8 7.3 22.4 14.3 5.8 12.1 15.1 30.5 14.6 12.8 9.7 22.0 12.7 12.2 10.3 9.4 21.6 19.2 8.7 10.1 12.6 5.7 9.6 18.7 11.9 6.1 12.0 12.7 13.0 9.4 12.6 13.7 17.9 23.9 9.0 18.3 28.0 11.2 21.3 17.6 4.4 8.3 5.1 6.3 8.6 6.6 7.3 7.4 6.2 4.2 10.6 7.8 9.7 3.3 6.1 7.2 8.1 7.9 3.3 12.7 13.8 15.6 13.5 10.9 10.0 15.2 9.2 12.9 16.4 3.0 5.6 6.2 4.5 7.0 11.7 12.6 10.2 2.7 4.5 3.5 5.9 9.5 3.3 7.6 27.2 5.3 3.4 0.0 6.7 10.5 4.7 5.3 0.0 3.2 6.7 6.4 9.8 6.2 10.3 58.0 9.5 6.0 8.5 10.0 5.8 11.1 5.5 0.0 9.9 3.8 9.5 12.9 8.2 4.9 10.0 7.4 5.5 6.9 7.6 5.6 NUP85 "FLJ12549, NUP75" ENSG00000125450 "Nucleoporin 85" Q9BW27 17 75205659-75235758 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061910, HPA062595" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA061910: AB_2684634, HPA062595: AB_2684801" "unprognostic (2.30e-1)" "unprognostic (5.10e-2)" "unprognostic (5.12e-3)" "unprognostic (2.52e-3)" "unprognostic (2.25e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (1.73e-7)" "unprognostic (3.46e-1)" "unprognostic (1.09e-2)" "unprognostic (9.93e-2)" "unprognostic (2.94e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (3.32e-6)" "unprognostic (1.03e-3)" "unprognostic (2.16e-1)" "unprognostic (9.10e-3)" "unprognostic (2.11e-1)" 21.6 12.9 13.7 22.1 14.2 17.9 19.1 43.0 17.9 17.1 17.2 17.2 12.5 16.1 24.1 16.9 19.6 19.0 15.8 14.7 12.7 8.8 14.9 19.8 17.5 25.4 17.5 12.7 21.4 18.5 12.0 13.5 18.8 13.9 17.3 21.8 15.3 16.8 16.3 17.0 23.5 18.4 20.1 15.6 24.6 16.1 24.5 14.1 28.5 17.8 14.0 26.2 15.8 18.2 17.1 19.0 17.6 20.8 12.6 20.5 13.5 22.5 25.7 18.9 13.0 7.3 11.4 26.3 16.4 13.0 38.6 36.3 22.0 21.7 20.8 9.5 14.0 25.1 19.5 30.9 17.3 34.4 6.5 25.0 17.3 29.6 19.2 6.0 17.8 14.5 10.9 10.8 26.9 11.7 8.9 29.5 17.1 21.3 13.4 18.7 24.9 33.4 21.9 14.1 28.1 23.7 23.4 40.9 18.9 14.7 16.5 14.4 13.8 20.2 26.0 14.4 22.0 29.3 20.3 10.8 28.9 26.8 18.5 26.0 8.3 6.8 26.6 14.9 16.3 17.7 5.2 20.8 17.6 14.6 18.1 20.5 14.2 15.7 14.0 17.1 17.1 15.5 11.8 6.7 12.6 12.9 19.0 13.3 13.5 13.7 14.2 43.0 17.9 12.7 8.8 17.5 12.7 13.9 14.1 6.0 12.2 15.0 7.2 5.5 7.8 7.5 10.2 9.4 11.4 7.0 9.8 17.8 6.6 14.0 2.0 14.2 7.3 46.7 16.9 18.4 14.3 6.5 10.5 19.5 19.7 6.4 7.5 20.9 11.1 2.5 13.3 16.2 8.5 13.6 9.7 4.5 15.0 7.0 9.2 7.9 7.4 32.3 6.1 17.4 30.4 6.1 10.6 12.9 10.7 6.7 NWD1 ENSG00000188039 "NACHT and WD repeat domain containing 1" Q149M9 19 16719976-16817963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 14.1" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 101.7" "Cancer enriched" "Detected in many" 6 "prostate cancer: 9.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "MCF7: 3.4;U-937: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075476 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA075476: " "unprognostic (5.29e-3)" "unprognostic (3.08e-2)" "unprognostic (3.05e-2)" "prognostic favorable (2.55e-4)" "unprognostic (2.49e-1)" "unprognostic (4.20e-4)" "unprognostic (6.54e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.94e-2)" "unprognostic (1.76e-1)" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (5.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.25e-1)" 0.6 0.7 6.9 0.6 8.1 0.8 1.0 0.9 5.9 1.7 0.9 11.3 0.5 0.7 1.1 6.5 0.6 14.1 0.8 0.7 10.9 4.2 1.0 0.7 1.8 0.7 3.9 7.8 0.7 4.3 0.6 1.3 0.7 27.8 10.6 0.9 10.3 2.7 3.9 0.8 0.6 0.7 0.8 2.2 0.6 1.0 1.4 4.6 0.0 1.6 0.0 0.6 0.8 0.5 0.5 0.1 1.3 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.5 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 1.3 0.5 0.0 0.1 0.0 0.1 6.9 8.1 0.9 5.9 10.9 4.2 3.9 7.8 27.8 4.6 0.0 1.0 0.0 1.6 0.2 0.1 0.6 0.0 101.7 5.7 0.0 0.0 0.1 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.1 0.0 1.2 0.0 0.0 2.7 0.6 0.2 0.0 0.0 0.6 9.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.4 1.4 NXN "FLJ12614, NRX" ENSG00000167693 Nucleoredoxin Q6DKJ4 17 799313-979770 "Enzymes, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Oxidoreductase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 74.7;Urothelial cells: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 31.7;HHSteC: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023566 Approved Approved Cytosol NA NA Cytosol "HPA023566: AB_1854737" "unprognostic (1.68e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (3.48e-2)" "unprognostic (7.29e-2)" "unprognostic (1.00e-1)" "unprognostic (1.75e-2)" "unprognostic (6.98e-2)" "unprognostic (1.65e-3)" "unprognostic (2.27e-2)" "unprognostic (3.16e-2)" "unprognostic (1.43e-1)" "unprognostic (5.76e-2)" "unprognostic (3.56e-2)" "unprognostic (2.34e-1)" "unprognostic (2.68e-2)" "unprognostic (2.05e-3)" 11.9 4.9 5.8 11.5 5.9 1.0 12.8 5.0 5.0 21.7 27.1 4.7 16.9 4.0 21.5 19.2 14.0 13.8 14.5 7.6 6.0 4.2 5.1 3.8 15.8 7.2 3.9 3.1 13.9 23.1 1.1 3.2 10.0 5.6 18.9 3.6 12.3 10.9 19.0 48.9 10.6 8.1 25.8 4.4 2.9 13.0 6.4 4.3 6.0 5.7 17.4 11.8 20.8 26.3 0.9 1.2 1.5 0.2 1.8 1.6 0.3 4.4 6.6 26.1 16.8 1.7 0.3 1.4 14.0 9.3 14.9 23.8 15.6 4.6 0.1 27.0 17.9 3.4 31.7 16.8 26.2 11.8 0.2 9.8 0.0 4.1 13.7 35.0 0.1 0.7 10.6 24.3 1.9 11.7 3.0 13.3 3.6 2.2 0.0 3.9 1.8 0.8 0.3 12.5 13.1 0.4 1.9 0.6 0.1 10.5 6.4 6.7 4.4 6.6 0.0 0.3 16.9 4.7 4.0 0.0 0.3 6.3 0.1 3.9 2.4 1.5 0.1 0.1 0.5 0.2 0.8 0.2 0.1 0.2 0.1 0.1 0.9 0.4 0.2 1.2 0.3 1.6 0.2 1.5 1.8 0.1 1.2 1.4 0.3 5.8 5.9 5.0 5.0 6.0 4.2 3.9 3.1 5.6 4.3 29.8 13.2 0.8 42.2 15.5 1.8 6.3 0.0 10.7 11.4 3.5 31.4 0.4 0.0 3.1 20.4 29.2 0.0 0.0 21.1 0.6 18.8 21.1 1.1 6.7 4.8 4.8 1.7 11.6 0.3 74.7 14.4 3.8 6.8 1.0 0.0 9.6 8.6 0.0 6.7 0.3 16.7 12.9 19.8 10.6 9.1 10.8 0.3 0.0 0.0 52.9 NXNL2 "C9orf121, RdCVF2" ENSG00000130045 "Nucleoredoxin like 2" Q5VZ03 9 88535101-88584274 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 11.7" "Group enriched" "Detected in some" 5 "Early spermatids: 8.6;Proximal tubular cells: 12.2" "Group enriched" "Detected in some" 7 "breast cancer: 1.7;endometrial cancer: 4.0;ovarian cancer: 7.2;renal cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA045526 Uncertain Approved Cytosol NA NA Cytosol "HPA045526: AB_10961044" "prognostic favorable (6.53e-4)" "unprognostic (9.70e-2)" "unprognostic (4.78e-3)" "prognostic favorable (3.83e-8)" "unprognostic (2.70e-2)" "unprognostic (3.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-4)" "unprognostic (1.92e-2)" "unprognostic (1.69e-1)" "unprognostic (2.62e-3)" "unprognostic (5.58e-2)" "prognostic favorable (9.60e-4)" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-2)" 7.2 0.4 1.6 1.0 1.6 4.4 3.2 0.6 1.1 6.7 0.5 2.0 0.4 0.6 6.2 9.7 0.8 6.6 0.7 0.5 1.8 2.9 4.4 5.1 0.4 0.4 1.3 1.0 11.7 0.5 0.0 0.7 3.9 1.2 0.8 0.0 2.0 1.4 3.7 1.0 1.3 0.5 0.4 1.8 0.8 0.5 2.2 0.4 0.4 1.2 0.4 0.4 1.2 1.5 1.2 1.1 4.8 1.0 1.7 2.4 0.7 2.0 4.2 1.7 1.5 0.2 1.1 1.2 3.9 1.0 0.5 0.7 0.9 1.3 1.0 1.6 0.4 1.0 2.0 0.6 0.2 1.4 0.6 1.3 1.9 4.0 1.3 0.8 1.2 1.4 0.8 0.3 0.4 0.4 0.6 0.0 1.4 1.3 4.2 1.0 1.0 1.1 1.9 2.1 0.7 0.9 0.8 0.8 1.4 15.3 1.4 1.1 0.7 2.3 1.3 0.7 1.1 1.7 1.0 1.5 1.5 2.9 2.1 0.9 1.4 1.2 1.1 1.3 1.6 1.0 4.8 1.0 2.3 2.1 0.5 2.1 0.8 1.2 2.4 0.3 1.2 2.1 2.4 2.8 1.7 0.5 1.1 2.0 0.7 1.6 1.6 0.6 1.1 1.8 2.9 1.3 1.0 1.2 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.5 8.6 0.0 0.0 0.0 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 2.1 12.2 0.7 0.0 0.8 0.3 0.4 0.1 0.9 0.0 0.0 1.8 NXT1 "MTR2, P15" ENSG00000132661 "Nuclear transport factor 2 like export factor 1" Q9UKK6 20 23350736-23354777 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 208.9;Suprabasal keratinocytes: 221.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 61.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047471 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047471: AB_2680061" "unprognostic (6.44e-2)" "unprognostic (2.89e-1)" "unprognostic (3.07e-2)" "unprognostic (1.02e-3)" "unprognostic (1.99e-1)" "unprognostic (2.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.89e-2)" "unprognostic (1.17e-1)" "unprognostic (6.89e-2)" "unprognostic (5.54e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.15e-7)" "unprognostic (2.07e-1)" "unprognostic (1.98e-1)" "unprognostic (9.11e-3)" "unprognostic (9.31e-2)" 16.0 9.7 6.2 11.9 6.8 35.0 16.7 5.9 7.1 14.0 11.1 6.0 11.9 6.2 14.0 15.8 16.7 16.7 11.6 15.1 5.7 6.4 12.8 18.0 13.7 15.4 8.1 5.2 23.8 15.0 5.8 13.9 17.6 7.5 19.2 9.4 11.0 12.7 14.0 18.1 14.9 9.5 13.6 7.6 17.4 11.1 17.2 5.7 18.3 24.7 15.9 16.3 20.5 24.1 41.8 34.2 9.9 19.9 30.5 32.0 25.6 14.1 15.8 9.6 10.0 6.7 6.6 8.9 8.7 9.7 14.2 14.3 10.4 13.9 16.9 13.0 8.6 23.6 16.6 11.2 22.7 13.9 8.1 10.5 12.5 3.5 18.4 10.1 13.3 9.5 5.8 15.2 13.7 19.5 5.6 11.2 12.5 16.5 16.7 10.9 18.3 27.4 23.4 8.0 25.4 35.0 19.0 15.5 19.7 8.5 11.9 15.6 9.1 7.9 21.3 16.1 6.1 11.9 15.4 7.1 14.5 11.9 12.0 16.6 11.6 11.0 19.2 4.1 61.8 10.7 9.7 14.5 9.9 25.7 19.9 31.4 41.8 26.0 26.7 20.8 37.2 32.0 28.9 3.5 30.5 14.2 34.2 17.7 25.6 6.2 6.8 5.9 7.1 5.7 6.4 8.1 5.2 7.5 5.7 14.9 13.3 51.6 95.5 208.9 10.2 6.9 10.2 17.4 18.2 19.2 3.9 59.8 34.9 30.3 19.6 43.0 5.5 46.7 27.1 61.1 67.7 54.5 76.0 12.8 40.7 11.1 18.0 29.4 12.1 10.0 47.8 37.4 102.9 27.9 21.2 17.6 31.6 7.0 37.8 18.2 16.0 6.5 78.3 63.1 77.2 221.6 33.6 44.0 27.7 89.4 NXT2 P15-2 ENSG00000101888 "Nuclear transport factor 2 like export factor 2" Q9NPJ8 X 109535781-109544690 "Predicted intracellular proteins" "mRNA transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.7" "Cell type enhanced" "Detected in many" 5 "monocytes: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 48.9;U-937: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024199, HPA072010" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA024199: AB_1854738, HPA072010: AB_2686483" "unprognostic (1.72e-1)" "unprognostic (1.39e-2)" "unprognostic (7.99e-2)" "unprognostic (5.31e-2)" "unprognostic (6.58e-2)" "unprognostic (3.69e-2)" "unprognostic (5.39e-2)" "unprognostic (3.14e-1)" "unprognostic (8.77e-2)" "unprognostic (3.36e-3)" "unprognostic (2.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.16e-3)" "unprognostic (2.59e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (4.90e-2)" 10.1 6.5 10.4 6.0 9.7 12.3 12.9 3.7 8.4 8.1 6.2 9.0 1.3 7.4 4.7 6.1 10.1 5.8 5.0 3.3 9.9 6.9 7.7 9.6 6.4 9.2 10.1 6.3 5.5 7.9 5.5 2.6 17.4 10.6 6.9 7.0 3.8 8.8 3.6 2.6 10.0 9.1 5.9 11.4 7.6 6.7 38.7 9.1 14.0 7.3 6.3 11.1 7.4 7.2 7.4 11.4 4.2 11.6 12.3 11.6 9.3 4.4 3.9 3.8 6.6 5.7 4.6 8.4 2.8 4.8 3.7 4.8 3.0 6.3 5.7 9.0 3.5 10.0 3.4 5.0 4.4 5.6 7.4 3.1 4.8 3.8 5.0 2.3 48.9 20.1 3.3 3.9 3.5 2.2 2.7 3.2 6.0 5.0 23.6 3.6 4.6 7.4 5.2 6.1 6.3 5.9 2.9 5.4 6.8 3.4 4.4 1.5 4.8 12.2 6.9 3.8 3.5 2.9 16.6 2.4 5.3 3.0 7.0 2.9 4.9 6.0 8.7 4.6 53.7 5.4 3.9 8.5 4.2 11.6 11.6 7.5 7.4 8.7 9.5 11.4 6.8 8.6 8.4 1.8 12.3 9.2 7.0 9.9 9.3 10.4 9.7 3.7 8.4 9.9 6.9 10.1 6.3 10.6 9.1 3.0 6.2 5.6 17.9 17.1 1.3 25.0 0.0 8.1 12.5 3.5 0.0 13.0 18.3 10.9 10.7 4.7 5.5 0.0 12.3 20.9 7.8 17.5 5.7 4.4 10.2 0.0 1.2 3.7 7.5 4.0 4.4 9.0 1.7 45.9 5.0 7.1 7.8 8.4 4.2 12.5 0.9 12.9 6.8 17.7 31.4 20.5 24.4 9.5 5.9 19.2 NYAP2 KIAA1486 ENSG00000144460 "Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2" Q9P242 2 225399710-225654018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.9;pituitary gland: 13.5" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 17.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.2;U-2 OS: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045531, HPA056945" Uncertain Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA045531: AB_10960749, HPA056945: " "unprognostic (2.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.24e-1)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "unprognostic (6.13e-3)" "unprognostic (3.33e-1)" "unprognostic (2.08e-1)" "unprognostic (1.32e-8)" "unprognostic (9.83e-2)" "unprognostic (2.92e-1)" "unprognostic (6.46e-2)" "unprognostic (1.27e-1)" 0.8 1.1 10.8 1.0 16.4 1.4 0.7 17.9 11.9 0.6 0.7 0.8 0.0 1.0 0.7 0.7 1.2 0.6 0.8 0.7 8.5 2.5 0.7 0.7 1.9 1.1 2.6 8.5 0.6 0.8 0.6 13.5 0.7 2.5 0.7 0.8 0.0 0.7 0.6 2.6 1.2 0.9 0.6 2.7 0.9 0.8 1.0 2.9 0.0 0.6 0.0 0.8 1.2 0.6 0.5 0.5 2.1 0.3 0.2 0.4 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.7 1.0 2.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.1 0.3 0.2 0.3 0.2 0.4 0.3 0.2 0.1 0.0 0.5 0.3 0.4 1.2 0.2 0.2 0.5 0.1 0.1 10.8 16.4 17.9 11.9 8.5 2.5 2.6 8.5 2.5 2.9 0.0 2.9 0.0 1.1 1.1 17.8 0.3 0.0 0.0 1.2 0.0 2.0 0.2 0.0 0.4 0.4 0.0 0.0 0.0 1.0 0.1 0.4 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.2 0.9 0.1 0.0 0.0 0.8 OAS1 "IFI-4, OIAS, OIASI" ENSG00000089127 "2'-5'-oligoadenylate synthetase 1" P00973 12 112906777-112933222 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.9" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 91.2;Urothelial cells: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 83.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 50.8;BJ hTERT+ SV40 Large T+ RasG12V: 73.0;OE19: 48.0;U-266/70: 71.6;U-266/84: 54.4" "HPA003657, CAB021104" Uncertain Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "CAB021104: AB_10057722, HPA003657: AB_1854747" "unprognostic (1.03e-1)" "unprognostic (6.59e-2)" "unprognostic (8.56e-3)" "unprognostic (2.20e-3)" "unprognostic (2.78e-1)" "unprognostic (1.30e-1)" "unprognostic (2.00e-2)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.20e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (5.37e-2)" "unprognostic (1.63e-2)" "unprognostic (6.91e-2)" "unprognostic (3.68e-2)" "unprognostic (5.67e-2)" "prognostic favorable (6.12e-6)" 31.2 7.3 6.1 16.6 7.1 5.7 8.4 2.1 6.0 16.4 25.4 11.0 2.6 23.6 5.8 21.0 39.1 5.1 10.7 5.1 4.2 5.7 18.3 23.3 20.7 17.3 5.9 5.3 7.4 3.2 4.3 6.1 18.8 8.6 11.5 20.5 11.7 31.8 4.2 2.9 6.3 27.2 7.6 9.4 30.1 22.7 4.2 6.2 21.6 9.4 13.5 27.3 20.9 13.0 18.2 24.4 4.1 83.9 4.5 16.8 29.0 1.0 5.8 0.0 0.0 2.0 1.5 0.4 0.0 7.5 50.8 73.0 3.3 6.2 7.9 2.2 0.0 27.5 2.6 0.0 0.7 0.7 5.8 0.0 0.2 10.4 1.2 0.6 0.1 0.4 0.1 2.2 1.9 0.0 0.8 2.7 0.2 0.0 3.5 0.0 0.1 0.2 3.6 0.3 48.0 5.0 1.6 0.0 3.3 2.5 16.4 0.1 0.3 0.8 1.0 19.4 0.0 0.2 1.3 10.0 0.0 0.1 0.7 0.1 71.6 54.4 5.5 0.6 2.3 0.4 1.0 40.9 0.5 4.9 63.6 4.6 18.2 6.5 6.1 24.4 13.6 2.5 3.3 4.1 4.5 83.9 22.1 16.8 29.0 6.1 7.1 2.1 6.0 4.2 5.7 5.9 5.3 8.6 6.2 3.0 2.1 16.4 10.9 3.1 0.2 1.2 15.3 12.0 7.9 5.2 0.0 11.1 5.0 15.7 0.2 16.3 40.3 23.3 10.7 32.3 5.9 6.4 4.7 9.4 91.2 0.0 4.1 12.3 28.2 0.9 6.6 27.7 5.0 10.0 56.5 14.1 14.1 45.6 9.9 19.4 0.4 6.5 1.4 0.0 0.2 1.9 4.8 7.5 10.4 142.9 OAS3 ENSG00000111331 "2'-5'-oligoadenylate synthetase 3" Q9Y6K5 12 112938352-112973249 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 64.2;BJ hTERT+ SV40 Large T+ RasG12V: 70.2;GAMG: 31.4" "Not detected" "Not detected" "HPA041253, HPA041372" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" Yes No 21000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041253: AB_10794990, HPA041372: AB_10795590" "unprognostic (8.47e-2)" "unprognostic (9.13e-2)" "unprognostic (1.27e-2)" "unprognostic (4.39e-3)" "unprognostic (2.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.14e-3)" "unprognostic (8.06e-3)" "unprognostic (3.19e-1)" "unprognostic (1.73e-2)" "unprognostic (2.29e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.23e-5)" "unprognostic (4.25e-2)" "unprognostic (1.37e-2)" "unprognostic (3.29e-2)" "unprognostic (2.93e-2)" 36.9 4.9 5.1 11.2 5.4 18.3 7.0 2.9 5.5 10.5 6.8 5.5 3.2 7.3 10.0 11.8 17.9 4.2 9.4 6.7 4.5 5.3 10.3 7.1 19.9 13.3 5.1 5.1 6.1 3.2 3.3 4.6 19.3 8.7 5.6 6.9 8.9 24.7 3.4 3.3 6.0 9.3 8.3 6.2 22.0 9.5 3.0 3.3 21.3 9.9 6.7 13.5 9.9 8.2 2.6 4.8 10.1 14.7 5.0 3.8 3.9 6.3 9.5 0.0 1.5 0.3 1.4 0.8 1.2 8.3 64.2 70.2 7.2 5.8 0.4 2.3 2.9 31.4 5.5 1.2 7.8 5.4 4.7 0.3 4.9 4.4 2.3 1.2 1.7 2.7 0.5 2.5 9.1 0.5 1.1 3.3 1.3 0.1 1.0 0.8 4.1 2.7 0.9 0.5 11.7 5.6 3.9 3.4 0.1 3.0 17.6 0.2 0.0 5.8 2.2 5.7 0.0 7.6 0.5 2.2 1.7 1.2 1.5 2.6 0.5 19.2 0.1 1.4 4.8 5.2 0.9 7.9 1.6 2.0 8.6 2.5 2.6 3.0 3.0 4.8 1.3 2.2 2.6 10.1 5.0 14.7 0.2 3.8 3.9 5.1 5.4 2.9 5.5 4.5 5.3 5.1 5.1 8.7 3.3 3.0 4.6 2.4 4.8 3.1 0.4 1.7 0.0 0.0 2.3 3.5 0.0 4.0 3.3 10.8 6.1 13.4 4.1 0.0 8.6 15.8 5.4 6.5 1.1 1.5 16.5 0.0 1.7 9.2 4.7 5.9 9.5 6.6 1.7 6.4 6.3 4.4 14.5 4.0 14.2 2.1 0.2 0.0 3.1 0.5 0.2 4.1 1.6 4.6 3.7 25.3 OASL "OASL1, p59OASL, TRIP14" ENSG00000135114 "2'-5'-oligoadenylate synthetase like" Q15646 12 121019111-121039242 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.5;bone marrow: 33.1" "Cell type enriched" "Detected in many" 4 "Urothelial cells: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 52.2;BJ hTERT+ SV40 Large T+ RasG12V: 26.9;GAMG: 14.8;hTEC/SVTERT24-B: 20.9" "Not detected" "Not detected" HPA001474 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001474: AB_1079518" "unprognostic (2.39e-2)" "unprognostic (7.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" "unprognostic (1.62e-2)" "unprognostic (6.22e-2)" "unprognostic (5.93e-3)" "prognostic unfavorable (9.20e-4)" "unprognostic (4.61e-1)" "prognostic unfavorable (3.70e-9)" "unprognostic (2.52e-1)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (3.17e-2)" 20.5 0.5 1.0 8.3 1.4 33.1 2.7 0.4 1.9 3.6 5.9 1.7 0.1 1.6 1.7 1.3 4.7 0.6 3.1 2.2 0.7 0.9 4.0 22.6 16.5 1.9 1.3 1.2 1.4 0.4 0.2 0.8 3.6 2.3 2.5 3.0 2.3 3.4 0.3 1.1 0.8 2.0 1.1 1.9 5.2 15.7 2.1 0.6 6.0 3.2 3.7 7.6 2.9 1.5 0.8 3.2 44.5 10.8 6.9 23.6 10.8 1.0 0.2 0.0 0.3 0.4 0.9 0.0 0.1 0.5 52.2 26.9 0.0 5.0 0.3 1.5 0.0 14.8 2.7 0.0 0.3 3.8 9.2 0.0 0.0 5.2 0.0 0.3 0.0 0.7 0.3 0.2 20.9 0.0 0.1 0.1 0.3 0.0 1.8 0.2 0.5 0.0 2.7 0.0 1.8 1.1 0.0 0.1 0.6 0.2 4.9 0.0 0.0 0.4 0.2 8.2 0.0 0.1 0.8 0.0 0.2 0.4 0.6 0.1 2.0 3.7 0.0 7.8 0.4 0.1 4.2 10.3 22.4 20.4 10.8 5.3 0.8 14.1 23.6 3.2 0.3 4.0 15.7 44.5 6.9 7.4 0.1 9.9 10.8 1.0 1.4 0.4 1.9 0.7 0.9 1.3 1.2 2.3 0.6 0.0 6.2 0.0 3.8 1.9 0.0 0.3 0.0 4.0 3.4 0.0 0.0 0.2 0.0 2.7 3.1 2.1 4.2 0.0 3.4 0.6 0.5 1.1 11.5 3.9 12.3 0.0 1.7 0.0 4.0 2.5 0.3 6.8 0.0 4.6 15.9 0.0 7.4 3.5 0.0 0.3 0.0 0.0 2.2 1.9 0.1 0.9 0.1 17.3 1.2 72.1 OBSCN "ARHGEF30, KIAA1556, KIAA1639, UNC89" ENSG00000154358 "Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF" Q5VST9 1 228208130-228378874 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 180.2;tongue: 48.4" "Cell type enriched" "Detected in many" 14 "Cardiomyocytes: 136.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 16.0" "Low region specificity" "Detected in single" "HPA021186, HPA065801" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021186: AB_1854761, HPA065801: " "unprognostic (8.47e-3)" "unprognostic (1.56e-1)" "unprognostic (9.99e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (5.30e-3)" "unprognostic (6.36e-2)" "unprognostic (4.54e-3)" "unprognostic (1.82e-1)" "unprognostic (8.81e-2)" "unprognostic (1.93e-2)" "unprognostic (3.38e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (3.53e-1)" "unprognostic (1.16e-2)" 2.5 0.9 0.5 0.9 4.4 0.6 0.7 3.1 0.6 0.6 0.8 0.5 0.5 0.6 0.8 4.4 2.4 1.0 0.6 21.2 0.5 0.7 1.6 0.5 1.0 1.0 0.5 0.5 1.7 1.4 0.4 2.4 0.5 0.9 1.7 0.3 5.2 2.6 1.1 180.2 1.1 0.8 0.5 0.6 1.4 0.5 0.7 0.6 0.5 2.2 48.4 3.5 0.6 0.7 1.0 1.1 0.1 0.4 0.6 3.2 0.7 2.9 2.8 8.0 4.5 0.2 0.1 5.6 1.5 0.5 1.0 0.9 2.0 2.1 5.7 8.1 0.5 0.6 1.0 0.4 1.1 0.2 2.2 5.1 1.9 16.0 0.0 2.0 1.3 6.1 3.0 1.0 0.4 0.2 5.4 0.4 9.4 5.3 1.3 0.3 5.0 2.1 1.6 8.8 0.8 1.8 8.1 0.1 1.3 4.6 1.5 3.0 9.0 0.2 2.9 1.1 2.4 8.0 3.7 0.7 0.0 9.3 0.2 0.1 4.7 0.9 1.4 0.0 0.8 2.1 0.1 0.4 0.0 0.9 0.1 0.9 0.5 0.9 0.7 0.9 1.0 3.2 0.5 0.1 0.6 0.1 1.1 0.8 0.7 0.5 4.4 3.1 0.6 0.5 0.7 0.5 0.5 0.9 0.6 0.0 5.6 0.0 5.9 1.9 3.2 136.5 2.5 1.4 4.5 5.2 9.8 0.1 10.0 2.9 3.8 1.6 0.4 0.0 0.4 0.4 1.5 1.9 6.9 0.5 0.1 0.0 0.0 1.3 0.0 4.0 2.8 0.3 1.7 0.0 1.7 9.7 1.0 0.0 4.2 4.2 2.8 0.0 1.2 0.1 2.5 1.5 1.0 1.8 1.1 3.4 OCA2 "BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P" ENSG00000104044 "OCA2 melanosomal transmembrane protein" Q04671 15 27754875-28099358 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Albinism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.9;skin 1: 12.3" "Cell type enhanced" "Detected in some" 24 "Leydig cells: 8.6;Melanocytes: 40.5;Peritubular cells: 13.8" "Cancer enriched" "Detected in many" 17 "melanoma: 19.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SH-SY5Y: 5.9;SK-MEL-30: 22.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036402 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA036402: " "unprognostic (6.07e-3)" "unprognostic (1.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.82e-2)" "unprognostic (4.60e-4)" "unprognostic (7.11e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.96e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-6)" "unprognostic (2.61e-1)" "unprognostic (4.21e-1)" "unprognostic (3.28e-2)" "unprognostic (2.28e-2)" 0.4 0.1 0.9 1.3 4.8 0.0 0.3 0.2 2.9 2.4 0.3 3.6 0.2 0.0 0.4 1.7 2.9 1.6 0.5 0.2 1.3 3.6 0.4 0.4 1.2 3.1 0.3 0.4 0.4 0.2 0.0 1.0 2.9 9.5 0.9 0.2 37.9 1.9 2.7 0.4 12.3 0.2 0.2 0.2 2.0 0.1 2.6 0.2 0.3 7.0 0.5 1.5 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 5.9 0.0 0.0 22.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 4.8 0.2 2.9 1.3 3.6 0.3 0.4 9.5 0.2 0.0 0.0 0.0 0.1 1.8 0.0 0.3 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 8.6 0.0 40.5 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 1.7 2.9 3.9 0.6 0.1 0.0 0.0 0.1 OCM OCM1 ENSG00000122543 Oncomodulin P0CE72 7 5879827-5886362 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;brain: 9.5;lymphoid tissue: 5.5" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 1.7;Late spermatids: 1.8;Spermatogonia: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 2.1;PC-3: 1.9;THP-1: 1.5;U-937: 2.2" "HPA046422, HPA052483" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046422: AB_2679659, HPA052483: " "unprognostic (1.79e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (1.50e-1)" "unprognostic (5.39e-2)" "unprognostic (1.31e-2)" "unprognostic (2.30e-2)" "unprognostic (7.62e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-1)" "unprognostic (1.92e-3)" "unprognostic (6.13e-2)" "unprognostic (2.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.02e-1)" "unprognostic (3.23e-1)" "unprognostic (3.90e-4)" 0.1 0.5 9.5 0.7 1.7 1.8 1.6 3.1 1.4 0.2 0.5 0.0 0.2 2.7 0.3 0.3 0.5 0.0 2.0 1.8 0.3 0.1 0.1 5.5 0.9 0.5 0.3 0.0 0.2 0.0 0.2 0.6 0.9 0.8 0.0 2.0 0.7 0.2 0.8 1.4 0.1 2.3 0.6 2.3 0.3 0.1 2.1 0.1 2.0 0.8 0.0 5.7 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.8 0.4 0.6 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.5 0.1 0.0 0.0 1.5 0.0 0.0 0.2 0.5 0.4 0.3 0.3 0.1 0.0 2.2 0.0 0.0 0.8 2.0 1.1 0.5 0.4 0.9 2.8 0.8 0.1 2.1 3.7 1.0 1.6 0.0 0.4 0.0 5.7 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 OCM2 ENSG00000135175 "Oncomodulin 2" P0CE71 7 97984684-97991169 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "WM-115: 1.7" "HPA046422, HPA052483" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046422: AB_2679659, HPA052483: " 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OCRL OCRL1 ENSG00000122126 "OCRL, inositol polyphosphate-5-phosphatase" Q01968 X 129539849-129592561 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" Hydrolase "Cataract, Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 6.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012495 Approved Approved "Microtubules,Centriolar satellite,Cytosol" NA NA Cytosol "Microtubules, Centriolar satellite" "HPA012495: AB_1851804" "prognostic unfavorable (2.93e-5)" "unprognostic (3.17e-2)" "unprognostic (2.30e-1)" "unprognostic (6.34e-3)" "unprognostic (9.88e-2)" "unprognostic (1.35e-1)" "unprognostic (2.82e-2)" "unprognostic (2.68e-1)" "unprognostic (3.08e-3)" "unprognostic (2.56e-2)" "unprognostic (6.30e-3)" "unprognostic (1.74e-1)" "unprognostic (4.61e-3)" "unprognostic (4.10e-1)" "unprognostic (5.83e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" 12.1 20.5 10.7 6.0 18.2 5.3 10.8 13.4 23.1 12.7 13.4 10.1 28.8 9.1 15.8 19.7 13.3 12.8 13.8 8.6 13.0 20.5 10.9 11.3 8.6 6.0 12.9 15.1 33.0 12.4 37.3 20.3 13.2 17.8 21.7 14.1 15.3 8.5 27.7 11.4 9.6 9.8 21.5 8.0 6.3 11.4 23.2 6.4 4.3 19.0 5.6 4.1 18.0 9.2 0.4 2.4 0.3 6.6 0.0 0.7 0.7 9.7 11.2 9.3 10.5 16.4 13.7 9.1 14.9 11.9 15.5 14.4 7.5 7.1 0.8 25.7 12.6 18.2 6.1 17.1 11.4 16.1 0.0 11.5 3.0 10.1 7.5 12.2 3.0 0.3 11.4 15.0 15.2 15.1 15.4 11.5 4.5 4.0 7.4 16.0 12.7 2.2 4.2 3.3 12.9 16.7 2.2 9.6 5.8 8.8 10.1 11.3 14.3 7.1 10.1 7.8 12.4 7.2 5.3 9.6 12.6 5.8 13.1 14.8 2.1 1.6 2.0 8.9 11.1 9.9 0.0 2.1 0.0 0.2 2.4 0.7 0.3 0.1 0.1 2.4 0.4 0.6 0.2 0.3 0.0 6.6 0.9 0.1 0.7 10.7 18.2 13.4 23.1 13.0 20.5 12.9 15.1 17.8 6.4 3.0 8.5 0.8 3.1 4.1 9.9 7.9 5.1 4.0 10.3 17.4 5.9 5.1 3.3 4.9 19.5 5.3 13.7 0.0 3.1 4.7 5.1 5.7 0.0 10.9 4.3 12.7 16.8 7.4 10.4 5.9 21.3 4.4 8.5 2.8 11.7 8.6 6.7 10.7 32.2 3.9 6.0 0.0 5.7 6.4 14.0 6.5 4.8 0.0 9.7 6.0 ODAM "APin, FLJ20513" ENSG00000109205 "Odontogenic, ameloblast associated" A1E959 4 70196496-70204576 "Cancer-related genes, Predicted intracellular proteins" Biomineralization "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "salivary gland: 157.7" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.4;Ductal cells: 6.3;Exocrine glandular cells: 7.3;Pancreatic endocrine cells: 3.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Hep G2: 24.2;OE19: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036279, HPA036543, HPA070297" Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA036279: , HPA036543: AB_10669797, HPA070297: " "unprognostic (2.34e-2)" "unprognostic (2.43e-1)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "unprognostic (3.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.88e-2)" "unprognostic (3.47e-1)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-2)" "unprognostic (2.50e-2)" 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.0 2.5 0.2 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.2 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.0 0.4 0.1 0.0 157.7 2.6 0.0 0.0 0.3 1.9 0.1 0.0 2.5 0.0 0.0 0.0 5.1 10.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 3.4 0.0 1.1 0.0 0.0 0.0 2.5 0.0 2.3 1.8 0.0 0.3 0.0 6.3 0.0 0.0 0.0 0.0 7.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 ODC1 ODC ENSG00000115758 "Ornithine decarboxylase 1" P11926 2 10439968-10448504 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Polyamine biosynthesis" "Decarboxylase, Lyase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 459.5;Late spermatids: 626.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001536, CAB035996" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB035996: , HPA001536: AB_1079521" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (7.25e-3)" "unprognostic (5.21e-3)" "unprognostic (4.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (3.06e-2)" "unprognostic (4.18e-2)" "unprognostic (6.27e-2)" "unprognostic (3.04e-1)" "unprognostic (6.65e-2)" "unprognostic (1.67e-3)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (2.26e-2)" "unprognostic (5.86e-2)" 13.2 8.2 11.6 33.5 11.1 41.8 9.1 7.2 11.8 11.7 17.4 11.5 33.8 8.6 22.9 21.6 16.5 16.5 30.0 33.8 9.7 10.6 31.5 48.7 14.2 42.3 11.3 6.5 29.2 48.7 13.4 35.4 6.9 11.2 26.3 20.7 18.2 11.0 27.2 64.2 9.6 14.9 26.2 10.2 20.4 19.2 54.6 6.3 31.0 16.4 19.8 39.6 16.1 14.6 13.4 10.8 2.4 2.4 1.2 4.4 3.0 19.0 15.3 21.3 25.2 3.8 11.4 49.4 27.6 13.6 26.1 12.1 81.2 8.9 100.7 13.8 16.8 25.2 3.5 65.2 31.3 31.8 38.3 27.2 46.0 26.3 49.5 30.9 77.6 11.0 7.6 8.5 59.0 74.1 13.5 20.9 28.1 76.4 32.8 14.4 12.5 76.8 30.6 38.8 26.5 49.9 54.9 66.9 67.9 15.8 14.0 29.8 25.3 34.6 10.6 13.9 17.1 7.1 34.8 14.6 21.2 43.7 27.3 59.1 15.3 46.3 91.6 19.0 51.5 13.0 0.0 1.3 2.4 2.7 2.4 3.2 13.4 3.8 4.4 3.0 11.0 2.7 4.3 0.5 1.2 1.5 10.8 3.8 3.0 11.6 11.1 7.2 11.8 9.7 10.6 11.3 6.5 11.2 6.3 41.7 217.2 112.6 112.8 51.5 34.5 48.8 71.4 25.4 36.4 38.4 29.5 1.0 61.3 55.5 459.5 35.3 38.6 0.0 23.5 53.1 21.2 276.8 57.7 46.1 43.4 6.4 260.2 11.6 30.9 626.4 14.4 29.0 21.9 12.6 143.2 85.1 24.6 48.9 10.6 101.8 62.6 0.0 40.8 91.4 74.0 76.5 2.9 37.6 120.9 94.9 OGFOD1 "FLJ10826, KIAA1612, TPA1" ENSG00000087263 "2-oxoglutarate and iron dependent oxygenase domain containing 1" Q8N543 16 56451490-56479100 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003215, HPA003722" Approved Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003215: AB_1078881, HPA003722: " "unprognostic (1.13e-1)" "unprognostic (4.52e-2)" "unprognostic (3.80e-3)" "unprognostic (2.86e-2)" "unprognostic (2.48e-3)" "prognostic unfavorable (6.65e-4)" "prognostic unfavorable (7.02e-4)" "unprognostic (5.51e-2)" "unprognostic (6.87e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-2)" "unprognostic (4.59e-2)" "unprognostic (7.49e-2)" "unprognostic (7.20e-2)" "unprognostic (6.11e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-2)" 8.8 13.4 10.0 8.0 11.6 3.3 9.4 10.3 14.3 10.8 7.0 12.4 6.0 7.4 9.5 8.4 18.1 10.1 7.8 12.9 7.7 11.1 12.9 13.9 7.5 7.5 9.1 10.4 10.2 6.5 13.7 13.1 8.3 15.6 8.0 8.9 8.5 8.4 10.0 56.1 8.8 5.8 15.1 11.1 8.6 7.4 8.2 6.2 10.6 9.3 12.6 13.0 9.6 8.3 7.8 7.5 11.8 8.9 8.7 12.1 6.5 11.3 13.4 13.2 16.4 15.0 18.1 12.4 18.5 14.9 26.3 19.1 16.3 8.3 20.8 9.5 14.7 11.2 16.3 27.9 12.6 29.8 6.4 15.0 15.1 11.7 16.8 11.5 16.3 17.8 12.0 14.4 19.5 16.3 11.4 21.3 14.0 21.0 4.0 22.2 7.3 12.9 9.3 22.4 10.1 23.2 24.2 20.2 24.2 11.8 8.2 10.6 11.8 22.9 14.8 12.4 14.7 13.5 13.5 13.9 14.7 11.7 11.2 16.3 8.2 15.8 30.5 11.7 11.8 11.6 11.8 4.7 4.8 8.8 6.3 11.9 7.8 11.2 10.4 7.1 6.1 12.1 10.0 1.7 8.7 8.9 7.5 9.3 6.5 10.0 11.6 10.3 14.3 7.7 11.1 9.1 10.4 15.6 6.2 3.0 13.6 19.9 10.7 15.8 10.3 17.9 17.8 8.1 18.2 8.7 9.8 14.3 21.6 13.0 17.1 11.2 3.9 23.3 12.0 16.6 20.5 7.5 45.0 15.3 10.6 12.7 2.4 9.8 8.1 14.5 11.2 11.3 10.1 19.8 6.3 12.1 13.7 5.8 14.9 11.0 14.1 12.9 17.8 14.6 28.1 16.6 9.7 15.0 9.5 7.1 OLA1 "GTPBP9, PTD004" ENSG00000138430 "Obg like ATPase 1" Q9NTK5 2 174072447-174248698 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035790, HPA041443" Approved Enhanced Cytosol NA NA 3600000 Cytosol "HPA035790: AB_10601977, HPA041443: AB_2677483" "unprognostic (3.30e-1)" "unprognostic (1.06e-1)" "unprognostic (2.23e-2)" "unprognostic (2.85e-3)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "prognostic unfavorable (9.73e-8)" "unprognostic (6.51e-3)" "unprognostic (7.66e-2)" "unprognostic (1.09e-2)" "unprognostic (3.50e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-3)" "unprognostic (4.32e-2)" "unprognostic (2.51e-2)" "unprognostic (2.62e-2)" "unprognostic (9.75e-2)" 28.5 23.1 39.3 18.0 40.6 23.0 29.1 39.4 52.4 18.5 23.5 14.7 12.2 24.9 17.9 20.6 29.9 19.8 20.0 27.9 35.4 34.3 28.4 33.3 14.7 26.1 28.8 27.9 17.1 31.1 19.7 23.8 20.7 45.3 21.5 27.3 15.1 18.9 18.2 50.1 25.9 24.0 18.8 27.0 18.7 19.2 23.1 16.5 36.1 31.9 27.2 25.6 21.9 18.4 12.7 24.5 9.6 16.3 16.7 16.6 13.9 40.4 19.2 31.6 52.5 16.8 37.0 57.0 32.7 33.1 45.8 35.0 45.5 24.1 55.8 32.9 26.2 34.0 32.3 38.3 37.8 54.1 25.4 32.7 52.1 18.6 47.2 32.6 58.8 21.3 32.4 47.3 48.5 51.7 42.1 40.4 20.3 56.7 19.2 39.6 26.1 53.2 61.1 37.1 43.9 63.1 40.5 51.1 38.4 57.2 43.9 51.4 29.4 22.2 33.1 46.2 35.1 23.5 50.0 29.2 30.2 38.3 30.0 47.5 17.9 44.8 42.5 29.6 40.7 26.7 9.6 16.3 4.6 11.5 16.0 16.6 12.7 13.4 14.6 24.5 11.1 15.8 15.1 1.4 16.7 12.4 15.0 16.6 13.9 39.3 40.6 39.4 52.4 35.4 34.3 28.8 27.9 45.3 16.5 32.8 27.0 45.5 62.9 55.6 45.7 65.7 33.1 36.1 45.5 29.6 33.4 127.3 87.9 131.0 196.0 41.5 47.7 0.0 92.2 85.5 49.4 49.5 40.4 23.6 86.6 31.8 67.9 20.3 55.3 68.3 37.4 50.8 30.4 66.7 72.7 43.8 98.5 38.6 48.1 106.1 29.4 25.8 61.3 77.1 35.2 56.0 88.6 58.0 102.0 66.2 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 41.2;Horizontal cells: 36.5;Ito cells: 74.3;Leydig cells: 41.1" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Cell line enhanced" "Detected in some" "HeLa: 25.5;MCF7: 21.5;NTERA-2: 28.6;OE19: 20.3;SCLC-21H: 41.3;SiHa: 34.2;T-47d: 53.0;U-2197: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" NA NA 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: AB_2683443" "unprognostic (6.77e-2)" "prognostic favorable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.6 3.2 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 13.1 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.5 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 21.5 0.1 0.0 28.6 20.3 0.0 0.0 0.0 12.0 0.0 0.0 41.3 5.5 34.2 0.1 2.1 2.2 53.0 0.0 0.0 2.0 4.6 23.1 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 0.0 9.3 0.0 2.8 8.7 20.7 5.8 7.6 0.0 3.4 0.0 41.2 0.0 0.0 7.4 5.8 26.1 0.0 0.0 2.3 0.0 8.2 6.1 2.3 0.5 0.3 36.5 2.4 74.3 4.5 8.9 41.1 2.8 20.3 0.0 1.7 32.6 3.6 2.9 27.6 0.0 12.0 0.0 11.7 0.6 3.4 5.5 0.0 0.0 5.5 0.9 OLFM4 "GC1, GW112, OlfD" ENSG00000102837 "Olfactomedin 4" Q6UX06 13 53028759-53052057 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 280.2;pancreas: 105.8" "Group enriched" "Detected in many" 6 "Exocrine glandular cells: 804.6;Pancreatic endocrine cells: 1519.9;Undifferentiated cells: 937.7;Urothelial cells: 2045.0" "Group enriched" "Detected in many" 14 "colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 4.4;BJ hTERT+: 15.3;HaCaT: 21.4;OE19: 8.3;RPMI-8226: 4.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA077718 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" "Secreted in other tissues" Yes NA "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA077718: AB_2732358" "prognostic favorable (8.77e-4)" "unprognostic (4.84e-2)" "unprognostic (1.65e-3)" "unprognostic (2.33e-1)" "unprognostic (7.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.74e-2)" "unprognostic (5.16e-2)" "unprognostic (1.40e-1)" "unprognostic (1.22e-1)" "unprognostic (4.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-2)" "unprognostic (4.84e-3)" 0.3 0.0 0.3 18.1 0.3 11.4 2.5 0.3 0.5 50.3 132.5 0.4 0.2 121.4 0.8 3.3 0.5 0.9 6.0 1.1 0.3 0.1 7.5 0.3 1.6 0.4 0.3 0.2 0.7 105.8 0.0 0.2 0.9 0.3 16.2 58.9 0.2 2.9 0.2 0.3 0.1 280.2 5.6 0.2 2.2 2.4 1.4 0.3 1.8 0.3 0.4 0.3 18.4 40.9 0.0 0.0 1.4 0.6 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 4.4 1.9 15.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 21.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 8.3 0.0 0.0 0.7 4.7 0.1 0.0 0.9 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.9 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.2 0.3 0.3 0.0 0.0 0.0 149.7 0.1 0.0 0.4 0.0 0.0 0.0 132.6 0.0 0.0 1.7 216.4 0.2 0.0 104.8 0.0 804.6 0.0 0.0 16.5 0.0 0.0 0.1 0.0 88.9 0.0 0.0 0.0 0.0 0.0 0.0 18.0 135.9 3.2 1519.9 238.2 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 937.7 2045.0 OLFML2A FLJ00237 ENSG00000185585 "Olfactomedin like 2A" Q68BL7 9 124777158-124814885 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 12.1;Endothelial cells: 14.2;Fibroblasts: 13.1;Sertoli cells: 12.9;Smooth muscle cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 58.3;GAMG: 12.1;HeLa: 14.7;hTERT-RPE1: 13.5;WM-115: 22.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021180, HPA022254" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA "Nucleoplasm, Cytosol" "HPA021180: AB_1854790, HPA022254: AB_1854791" "unprognostic (1.12e-1)" "unprognostic (3.07e-2)" "unprognostic (3.16e-1)" "unprognostic (2.45e-1)" "unprognostic (4.01e-2)" "unprognostic (1.27e-1)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (1.26e-3)" "unprognostic (7.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (3.73e-5)" "unprognostic (5.72e-3)" "unprognostic (3.30e-2)" "unprognostic (7.91e-2)" "unprognostic (1.05e-2)" 17.3 2.1 1.0 7.4 1.7 0.1 10.9 1.9 3.4 34.2 18.9 3.1 6.3 2.3 29.2 8.3 11.8 4.2 7.6 12.5 1.2 1.0 3.0 0.6 10.3 1.5 2.1 1.5 13.2 3.4 3.6 2.1 5.0 4.0 16.1 4.6 18.9 4.7 9.5 9.8 11.6 5.0 33.7 1.6 23.8 4.0 3.1 0.6 3.7 20.0 11.9 5.0 22.0 10.4 1.4 0.7 2.6 0.9 0.6 0.6 0.4 0.3 5.2 0.4 0.1 6.1 58.3 0.0 0.8 2.9 1.2 1.2 0.0 0.7 0.0 1.5 0.0 12.1 9.7 0.1 0.3 1.4 0.0 0.0 0.0 14.7 0.0 0.3 0.0 0.0 4.1 0.9 3.6 0.5 13.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 1.3 0.0 0.5 0.0 3.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 1.5 10.6 1.4 0.1 0.0 1.8 1.9 2.0 0.2 0.7 0.0 0.0 5.6 0.3 22.8 1.9 0.9 0.4 0.4 0.3 0.3 0.5 0.3 0.3 0.7 1.4 0.4 0.6 2.6 0.6 0.3 0.6 0.3 0.4 1.0 1.7 1.9 3.4 1.2 1.0 2.1 1.5 4.0 0.6 0.0 2.2 0.0 3.7 10.6 0.5 12.1 0.0 1.4 0.0 0.0 2.0 0.2 0.0 0.1 0.6 14.2 0.0 0.0 0.6 0.2 13.1 1.0 0.0 0.0 0.1 0.0 0.0 3.1 2.4 1.2 2.6 0.5 10.1 0.0 0.0 0.2 0.0 0.0 1.4 0.0 3.9 12.9 28.8 0.2 0.7 7.3 0.0 0.0 0.0 1.6 OLFML2B DKFZP586L151 ENSG00000162745 "Olfactomedin like 2B" Q68BL8 1 161983192-162023854 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 56.2;Hofbauer cells: 31.7;Kupffer cells: 20.4;Leydig cells: 19.2;Peritubular cells: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 8.8;non-classical monocyte: 6.5" "Lineage enriched" "Detected in single" 10 "monocytes: 8.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 16.0;HSkMC: 45.3;RH-30: 34.6" "Region enriched" "Detected in many" 6 "hippocampal formation: 45.1" "Low region specificity" "Detected in many" "HPA054136, HPA062739" Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA054136: AB_2682397, HPA062739: AB_2684858" "unprognostic (2.97e-2)" "unprognostic (1.79e-1)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (6.01e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (5.97e-3)" "unprognostic (7.32e-2)" "unprognostic (7.68e-3)" "unprognostic (1.16e-1)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.01e-12)" "unprognostic (1.64e-3)" "unprognostic (2.11e-2)" "unprognostic (4.53e-3)" "unprognostic (1.97e-2)" 19.6 6.6 1.7 12.8 3.0 0.3 12.3 0.6 4.1 13.0 14.5 2.9 6.5 1.5 14.2 21.8 3.2 9.8 33.7 25.4 2.9 1.6 3.9 1.2 12.8 24.1 2.9 1.2 7.0 2.3 3.2 2.6 27.6 2.2 6.6 2.2 14.5 9.0 6.1 6.1 8.9 5.0 15.1 3.6 22.4 3.4 12.5 2.1 1.9 18.3 13.7 8.5 12.4 7.3 0.0 0.8 0.3 8.8 0.0 0.1 0.2 0.0 0.1 2.6 0.8 8.4 16.0 0.0 0.8 4.1 1.7 4.6 0.0 0.0 0.0 0.1 9.7 1.7 0.0 0.2 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 45.3 0.0 2.0 0.0 0.8 0.2 0.0 0.0 0.4 7.4 0.0 0.0 0.1 0.8 0.0 0.4 0.0 34.6 3.3 0.6 0.0 0.3 0.1 3.4 0.0 0.2 8.0 0.0 0.0 0.0 1.0 0.2 1.5 1.3 0.0 0.0 0.0 9.9 1.0 0.5 0.0 0.6 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.3 0.0 6.5 0.0 0.0 0.2 1.7 3.0 0.6 4.1 2.9 1.6 2.9 1.2 2.2 2.1 0.0 1.1 0.0 0.0 3.0 0.0 2.5 0.0 0.0 1.2 1.8 0.0 0.2 0.0 0.0 56.2 0.0 0.0 0.0 0.0 0.3 9.3 0.1 1.1 0.0 31.7 0.0 0.0 1.8 20.4 4.5 19.2 9.9 1.7 1.0 0.0 0.9 0.0 0.0 27.6 0.0 0.0 6.5 12.6 1.5 0.9 1.9 0.2 0.0 0.0 0.0 OPA3 "FLJ22187, MGA3" ENSG00000125741 "OPA3, outer mitochondrial membrane lipid metabolism regulator" Q9H6K4 19 45527427-45602212 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044881 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA044881: AB_10964052" "unprognostic (3.37e-1)" "unprognostic (3.89e-2)" "unprognostic (2.66e-1)" "unprognostic (5.71e-3)" "unprognostic (1.24e-2)" "unprognostic (2.87e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (3.14e-3)" "unprognostic (4.53e-2)" "unprognostic (8.06e-3)" "unprognostic (1.72e-3)" "unprognostic (8.73e-2)" "prognostic favorable (9.30e-12)" "unprognostic (5.85e-2)" "unprognostic (1.94e-1)" "unprognostic (3.82e-2)" "unprognostic (1.81e-1)" 21.6 14.8 8.5 9.4 15.9 7.9 21.8 8.5 13.1 6.2 8.9 7.2 5.7 8.4 10.5 7.7 11.3 7.6 9.8 21.8 9.8 9.6 15.9 16.4 19.3 9.7 11.0 4.5 8.9 9.3 23.9 12.3 11.4 18.4 7.9 8.7 12.1 8.2 9.4 19.7 12.5 9.7 10.2 12.4 12.0 9.2 15.7 11.1 5.3 11.8 9.7 9.6 9.5 30.3 6.7 7.8 7.4 13.0 10.9 6.2 4.5 11.5 14.7 5.9 5.9 3.9 4.8 9.0 7.6 7.0 8.1 8.6 6.8 8.3 10.0 5.5 7.5 9.3 9.3 9.9 10.3 7.1 18.1 10.0 15.4 8.2 7.0 7.1 10.8 20.1 7.3 8.1 8.9 9.8 4.7 5.7 6.0 13.1 11.2 5.5 7.1 8.4 4.5 5.2 9.7 10.1 8.5 5.3 5.4 6.3 20.9 4.5 5.3 9.7 8.9 4.1 5.5 5.0 6.2 12.3 6.9 7.9 5.7 12.8 7.6 14.0 8.3 6.7 7.8 10.3 6.0 7.4 3.8 5.3 10.5 5.6 6.7 4.8 4.5 7.8 5.6 6.0 5.9 7.4 10.9 13.0 7.3 6.2 4.5 8.5 15.9 8.5 13.1 9.8 9.6 11.0 4.5 18.4 11.1 11.9 9.4 14.3 16.9 16.7 22.0 21.8 22.9 10.7 9.1 10.4 49.1 23.1 21.6 16.0 12.7 14.1 19.6 0.0 18.5 25.8 9.8 12.5 16.1 19.4 14.5 19.1 13.2 14.1 11.6 15.7 5.8 15.3 13.5 19.0 10.4 13.8 14.0 17.3 6.0 13.4 35.6 0.0 18.6 13.0 14.0 17.1 30.3 13.1 12.1 13.9 OPN1SW "BCP, BOP, CBT" ENSG00000128617 "Opsin 1, short wave sensitive" P03999 7 128772491-128775790 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 11.4;retina: 23.9" "Cell type enriched" "Detected in some" 12 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 37.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013562, HPA014083" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytokinetic bridge, Cytosol" "HPA013562: AB_2668850, HPA014083: AB_2668938" "unprognostic (2.88e-1)" "unprognostic (5.17e-2)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (8.50e-5)" "unprognostic (1.13e-1)" "unprognostic (1.27e-1)" "unprognostic (6.33e-2)" "unprognostic (3.79e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (5.98e-8)" "unprognostic (2.53e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (9.33e-4)" 0.9 1.8 0.7 3.7 0.9 1.7 0.7 1.0 2.3 0.7 2.2 0.7 0.7 0.5 2.6 0.7 2.4 0.8 4.2 11.4 0.7 0.8 0.7 0.7 0.9 1.0 0.7 1.3 0.7 0.7 0.0 0.7 0.7 0.7 1.4 0.0 23.9 1.1 0.7 1.9 0.9 0.9 0.7 0.7 1.1 1.4 1.1 0.7 0.7 2.3 0.7 0.7 4.3 0.7 0.5 1.2 0.6 1.4 0.0 1.4 0.3 1.7 2.2 5.2 1.7 0.0 0.0 1.5 9.8 0.0 0.0 0.0 5.0 2.1 2.6 1.5 0.0 1.6 1.4 0.0 0.0 0.0 0.3 3.6 1.6 3.0 2.5 0.0 2.0 1.6 0.0 0.0 0.0 0.0 7.0 0.0 1.7 2.2 0.6 1.1 0.7 2.0 3.6 4.7 1.7 3.0 1.0 5.4 3.0 0.0 0.6 0.7 6.9 2.3 5.2 4.4 7.3 0.5 2.0 4.0 10.0 1.0 7.7 8.7 2.1 2.2 1.6 37.6 4.6 9.3 0.0 0.3 0.6 1.4 1.4 0.9 0.2 0.8 1.0 1.2 0.5 0.3 0.9 0.0 0.0 1.0 0.7 0.4 0.3 0.7 0.9 1.0 0.9 0.7 0.8 0.7 1.3 0.7 0.7 0.0 0.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225716-53251697 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;prostate: 6.7" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 7.3;Leydig cells: 4.4" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: AB_2732770" "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.7 0.7 15.9 0.3 18.0 0.4 0.3 2.2 8.8 0.4 0.4 0.3 0.0 0.4 0.4 0.6 0.5 0.7 0.4 0.8 4.5 6.2 0.3 0.5 0.8 0.4 1.7 5.8 0.4 0.3 0.4 0.8 2.8 3.1 6.7 0.4 0.0 0.3 0.4 3.8 0.4 0.5 0.5 0.5 0.6 0.3 2.8 1.6 0.2 0.9 0.0 0.3 0.3 0.1 0.2 0.8 1.2 0.2 0.1 0.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 22.1 0.1 1.2 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 15.9 18.0 2.2 8.8 4.5 6.2 1.7 5.8 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 OPTN "FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP" ENSG00000123240 Optineurin Q96CV9 10 13099449-13138308 "Disease related genes, Predicted intracellular proteins" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 170.7" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 620.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003279, HPA003360, CAB019303" Approved Enhanced Cytosol NA NA Cytosol "CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528" "unprognostic (2.84e-2)" "unprognostic (3.37e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-3)" "unprognostic (5.58e-2)" "unprognostic (3.74e-2)" "unprognostic (5.15e-3)" "unprognostic (3.14e-2)" "unprognostic (2.68e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-2)" "unprognostic (6.14e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (7.62e-2)" "unprognostic (5.67e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" 19.3 21.4 16.1 8.4 15.4 9.6 17.9 17.1 20.4 9.5 11.8 9.4 5.8 14.3 9.4 6.9 14.5 7.3 10.1 32.5 11.9 13.6 16.6 16.7 12.0 9.5 16.2 18.0 22.1 8.2 8.9 9.9 13.0 21.0 9.9 13.4 5.8 10.2 10.2 170.7 17.6 16.0 10.3 16.9 12.4 12.7 16.0 12.5 4.9 6.4 24.5 8.4 11.0 19.8 6.0 1.8 11.9 1.1 16.0 34.5 9.2 18.4 5.3 3.0 4.1 40.9 42.2 3.5 22.2 25.4 16.9 28.0 9.2 24.8 0.1 8.8 30.4 26.5 17.3 3.9 21.3 12.9 42.9 2.1 3.8 7.4 4.9 41.9 0.1 14.0 22.6 16.9 16.1 16.9 41.8 14.3 5.4 4.7 28.7 22.7 3.9 1.8 0.5 1.2 5.0 2.3 0.3 5.9 1.9 20.6 13.2 0.8 3.1 19.3 5.9 14.4 12.2 12.6 2.6 39.0 13.9 6.9 18.8 6.2 14.8 5.1 0.1 20.9 3.2 2.6 11.9 0.8 0.1 19.7 0.5 15.0 6.0 24.9 22.6 0.1 3.4 10.1 12.3 0.7 16.0 1.1 1.8 34.5 9.2 16.1 15.4 17.1 20.4 11.9 13.6 16.2 18.0 21.0 12.5 62.5 31.4 21.6 40.4 66.1 34.5 210.2 58.6 71.0 84.2 29.6 17.7 73.8 28.2 124.6 229.9 71.6 159.4 93.5 100.1 33.9 80.3 54.6 67.2 28.0 27.2 85.8 40.9 41.7 11.3 620.2 88.6 13.1 86.0 59.5 91.3 27.5 138.2 161.4 97.2 125.5 92.1 109.9 116.4 72.2 7.5 68.1 63.0 86.3 38.1 54.0 OR6B2 OR6B2P ENSG00000182083 "Olfactory receptor family 6 subfamily B member 2" Q6IFH4 2 240028965-240030456 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.5" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B3 "OR6B3P, OR6B3Q" ENSG00000178586 "Olfactory receptor family 6 subfamily B member 3" Q8NGW1 2 240045077-240047027 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 6 "brain: 1.6;epididymis: 6.5;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.2" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ORAI1 "CRACM1, FLJ14466, TMEM142A" ENSG00000276045 "ORAI calcium release-activated calcium modulator 1" Q96D31 12 121626550-121642677 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 26.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016583, HPA061823" Approved Enhanced Cytosol NA NA Cytosol "HPA016583: AB_1848720, HPA061823: AB_2684619" "unprognostic (2.22e-2)" "unprognostic (3.78e-3)" "unprognostic (7.82e-3)" "unprognostic (8.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.99e-3)" "unprognostic (4.25e-3)" "unprognostic (1.92e-1)" "unprognostic (2.00e-2)" "prognostic favorable (4.30e-4)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "unprognostic (6.84e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" 4.3 1.3 0.0 6.2 1.1 3.7 7.1 0.0 1.3 2.1 9.8 1.7 5.0 10.6 2.3 2.2 3.4 1.7 4.8 3.5 0.4 4.9 9.6 7.5 14.1 2.5 0.6 4.8 5.9 1.4 0.0 4.6 5.6 3.3 0.1 10.6 6.8 3.0 26.0 17.0 14.0 4.4 0.9 11.4 3.9 6.8 0.9 8.1 6.5 7.0 9.1 3.8 2.3 6.9 5.6 6.3 4.3 4.9 14.4 5.1 6.1 13.1 1.4 6.0 1.5 2.0 6.7 7.4 1.2 3.4 2.2 11.3 5.0 4.4 12.3 1.4 5.1 11.3 1.1 5.1 0.0 14.8 3.1 8.0 2.2 4.9 4.2 5.0 15.0 0.6 2.1 5.1 0.2 1.9 5.5 13.3 6.4 1.0 1.0 13.6 14.3 35.2 6.2 4.5 15.6 6.5 2.3 7.1 2.5 3.4 5.4 0.8 2.8 3.8 5.5 0.1 8.7 1.9 6.5 7.8 3.5 9.2 5.6 3.8 2.5 1.8 5.2 8.8 5.8 6.3 4.2 5.7 14.1 4.3 10.9 4.4 11.5 14.4 5.6 6.9 11.2 9.8 5.2 4.9 3.7 1.4 10.0 5.1 26.8 16.0 20.4 7.7 20.0 1.9 3.7 22.9 8.1 15.9 1.8 3.9 2.0 1.7 10.9 2.7 38.3 8.6 23.3 17.0 12.5 10.4 5.4 6.9 14.3 32.8 0.0 2.4 32.5 19.7 9.7 12.4 33.8 20.3 19.8 7.1 4.5 23.1 7.0 8.9 9.0 6.5 0.0 8.2 1.2 3.2 32.6 6.5 41.5 16.4 7.5 ORAI3 "MGC13024, TMEM142C" ENSG00000175938 "ORAI calcium release-activated calcium modulator 3" Q9BRQ5 16 30949066-30956461 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015022 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015022: AB_1854807" "unprognostic (1.17e-1)" "unprognostic (3.88e-2)" "unprognostic (2.94e-3)" "unprognostic (1.15e-2)" "unprognostic (8.29e-2)" "unprognostic (1.46e-1)" "unprognostic (8.60e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (3.87e-5)" "unprognostic (2.30e-2)" "unprognostic (4.46e-2)" "unprognostic (6.43e-3)" "unprognostic (9.17e-3)" 13.4 22.9 5.5 13.0 5.6 12.4 14.8 6.0 8.1 17.0 12.8 9.1 13.3 7.5 12.4 16.9 19.9 13.6 16.5 10.8 4.9 5.1 16.5 39.6 15.4 20.7 5.9 3.6 16.9 14.5 13.5 12.1 14.8 5.8 26.2 7.3 13.3 10.3 15.3 9.4 10.2 9.9 16.4 5.1 20.0 10.4 19.7 5.2 14.2 25.6 6.3 13.7 29.1 15.2 5.1 6.8 17.9 8.5 8.1 2.8 2.2 1.0 5.8 3.0 4.0 26.1 23.5 0.2 3.3 23.0 2.5 6.5 0.5 9.6 1.4 7.8 6.5 10.3 4.7 0.5 6.4 1.7 4.4 1.9 3.7 1.8 5.7 36.5 4.0 11.5 25.2 17.2 4.9 9.7 24.2 4.3 0.8 4.1 7.7 8.2 3.8 0.2 15.0 2.4 3.2 1.6 3.1 2.3 10.8 9.7 2.5 0.7 5.0 3.1 0.9 5.2 7.7 7.3 16.5 3.1 1.9 1.3 4.2 0.7 18.9 1.3 1.1 9.6 9.4 2.9 14.1 6.5 17.9 2.5 6.3 2.8 5.1 1.4 2.0 6.1 4.8 1.7 2.3 10.9 8.1 8.5 6.8 1.9 2.2 5.5 5.6 6.0 8.1 4.9 5.1 5.9 3.6 5.8 5.2 6.0 9.6 31.2 20.7 7.0 1.7 5.6 5.1 8.1 3.4 15.7 2.0 19.6 11.6 14.8 48.3 11.6 5.1 0.0 10.1 2.1 16.0 14.7 6.9 65.7 77.4 33.4 14.5 17.2 29.5 24.4 49.2 21.5 20.3 28.9 12.9 22.3 8.7 16.9 40.7 47.0 3.4 25.8 6.6 24.5 1.5 4.0 3.7 15.0 6.2 19.2 ORC2 ORC2L ENSG00000115942 "Origin recognition complex subunit 2" Q13416 2 200908973-200963680 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003693, HPA073881" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB003693: AB_425574, HPA073881: AB_2686640" "unprognostic (3.04e-1)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (8.12e-3)" "unprognostic (3.40e-2)" "unprognostic (1.52e-2)" "unprognostic (2.37e-3)" "unprognostic (3.28e-1)" "prognostic unfavorable (8.42e-4)" "unprognostic (6.18e-2)" "unprognostic (4.56e-2)" "unprognostic (4.63e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (9.67e-2)" "unprognostic (3.74e-1)" "unprognostic (1.42e-1)" "unprognostic (5.31e-3)" 11.7 10.6 8.3 15.9 14.0 9.0 14.0 19.0 14.6 12.6 16.1 11.8 15.1 15.7 18.4 12.9 12.3 10.3 10.7 14.6 9.8 9.2 10.8 9.5 9.5 13.5 8.6 10.4 14.6 14.3 13.7 18.0 14.4 12.9 11.8 12.3 10.3 18.1 22.0 16.1 14.6 16.9 8.9 9.0 14.1 12.1 33.2 6.8 20.3 14.7 12.7 14.2 10.9 11.7 8.1 6.9 5.1 3.6 4.6 8.9 2.2 11.3 8.1 9.0 9.0 3.7 6.3 15.4 11.7 7.3 10.7 10.6 16.6 9.1 7.0 8.5 6.8 12.1 9.2 19.6 13.1 16.2 15.7 18.5 16.4 14.3 20.3 7.3 12.9 11.8 6.0 7.8 10.9 13.4 8.4 12.2 11.9 26.1 8.7 9.3 10.7 17.9 12.2 22.0 10.8 19.2 12.8 9.2 10.4 11.2 9.1 14.5 10.9 10.1 9.0 6.4 18.5 6.5 6.4 9.3 9.4 9.8 8.0 11.6 6.3 14.9 11.6 7.4 12.6 8.8 0.3 3.6 5.1 5.0 1.4 6.3 8.1 6.8 4.7 3.0 7.2 8.9 6.0 1.8 4.6 2.4 6.9 4.6 2.2 8.3 14.0 19.0 14.6 9.8 9.2 8.6 10.4 12.9 6.8 8.9 14.4 7.5 8.0 16.9 14.2 14.9 12.7 14.7 20.5 8.7 23.6 18.1 6.6 8.1 29.1 11.7 9.8 0.0 10.9 15.4 8.0 7.9 10.4 9.0 7.8 6.4 4.1 13.5 6.8 6.2 11.2 5.7 10.1 6.4 13.8 8.7 8.4 7.0 7.8 7.0 14.7 19.4 7.1 63.3 19.6 13.6 9.0 12.9 13.4 6.1 ORC5 "ORC5L, Orc5p, ORC5T, PPP1R117" ENSG00000164815 "Origin recognition complex subunit 5" O43913 7 104126341-104208047 "Predicted intracellular proteins" "DNA replication, Photosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019730 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019730: AB_10696205" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (6.72e-2)" "unprognostic (4.77e-2)" "unprognostic (7.42e-2)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" "unprognostic (3.47e-2)" "unprognostic (9.26e-2)" "unprognostic (2.33e-1)" "unprognostic (1.77e-1)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (6.52e-2)" "unprognostic (9.71e-2)" "unprognostic (2.53e-2)" "unprognostic (7.73e-2)" 12.4 13.7 10.6 9.3 17.9 6.2 16.3 18.7 21.6 12.9 14.2 12.1 9.0 10.1 14.4 17.5 14.1 11.3 8.5 8.2 13.0 12.9 12.6 20.3 10.2 13.7 10.1 11.8 13.8 17.4 10.8 15.9 11.4 17.6 21.5 16.0 14.0 11.8 13.8 10.9 14.8 11.0 14.2 8.6 12.0 12.3 27.3 10.0 20.5 12.6 7.9 15.8 13.4 12.7 14.0 7.2 6.8 7.4 12.5 18.6 8.2 16.3 17.2 10.0 18.0 10.6 10.6 8.9 14.5 13.9 16.4 13.7 11.2 10.7 24.2 12.2 9.0 18.1 15.6 20.0 13.9 19.7 13.1 12.9 8.9 9.8 11.3 14.8 16.8 7.9 10.0 13.3 18.8 17.5 6.9 15.4 13.5 29.0 14.0 13.9 23.2 23.5 17.0 10.7 22.2 18.0 9.8 18.1 24.0 12.6 12.2 13.4 11.3 13.6 27.8 18.6 8.2 9.3 13.0 8.9 14.9 17.5 24.3 18.2 15.5 33.4 31.9 10.7 22.9 18.7 6.8 6.3 4.5 13.1 7.4 17.1 14.0 13.6 15.0 7.2 11.9 17.2 18.6 0.8 12.5 6.0 7.0 11.3 8.2 10.6 17.9 18.7 21.6 13.0 12.9 10.1 11.8 17.6 10.0 3.0 7.4 9.1 2.8 3.9 5.9 4.8 10.2 16.0 7.9 3.5 0.0 18.8 1.7 8.0 4.0 8.0 4.7 0.0 7.7 11.6 5.8 4.1 4.7 8.3 7.7 3.2 5.2 4.9 4.5 4.5 5.8 5.3 1.7 8.2 8.3 2.9 6.4 3.5 7.4 5.7 11.5 0.0 12.3 30.5 22.8 7.4 8.8 9.6 9.1 1.4 OSBP OSBP1 ENSG00000110048 "Oxysterol binding protein" P22059 11 59574398-59616144 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039227, HPA043625" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039227: AB_2676401, HPA043625: AB_2678587" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "prognostic favorable (2.08e-5)" "unprognostic (7.80e-3)" "unprognostic (7.32e-2)" "unprognostic (2.79e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (7.42e-2)" "unprognostic (1.42e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.08e-7)" "unprognostic (1.25e-1)" "unprognostic (9.00e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" 15.6 36.6 12.3 10.6 16.3 13.8 16.5 14.7 18.0 16.1 18.8 13.7 35.4 17.3 15.9 19.9 15.9 13.8 19.5 14.7 10.3 11.6 26.3 54.8 12.9 9.7 12.4 12.7 16.6 30.2 31.4 14.7 29.4 17.9 16.1 17.3 12.6 27.7 26.2 32.5 20.9 22.3 15.1 9.5 12.5 19.1 11.3 12.1 18.8 19.6 12.5 13.8 16.7 13.7 4.6 7.9 3.5 3.1 4.0 6.1 2.1 17.7 14.9 11.1 14.9 26.2 24.6 12.2 14.5 18.9 17.5 15.8 16.8 18.1 18.0 19.5 16.7 21.5 18.7 20.4 19.3 19.8 17.3 9.4 12.1 11.6 11.3 28.1 15.4 24.0 18.8 24.1 16.4 43.4 18.3 18.7 16.9 20.7 16.8 15.5 8.2 14.5 11.4 12.6 26.1 14.7 14.1 17.8 12.4 20.8 20.7 13.1 9.3 17.2 21.6 19.8 16.0 30.2 9.9 20.2 15.0 10.5 22.4 9.7 23.5 19.0 18.3 16.9 11.2 12.0 3.5 3.1 2.8 5.9 2.9 5.5 4.6 6.1 4.6 3.2 3.4 5.6 4.7 3.0 4.0 2.5 7.9 2.6 2.1 12.3 16.3 14.7 18.0 10.3 11.6 12.4 12.7 17.9 12.1 23.8 7.0 11.2 14.5 35.1 21.6 29.9 33.1 20.1 17.0 26.2 21.6 11.7 6.6 12.1 7.6 17.2 30.7 0.0 16.0 10.9 16.4 26.0 27.6 56.3 13.4 25.4 28.8 10.4 12.9 10.6 14.7 12.1 13.5 3.6 35.0 16.7 18.6 22.9 18.7 17.9 19.4 6.5 13.7 21.8 13.2 41.4 25.7 10.2 25.1 19.0 OSBP2 "KIAA1664, ORP-4, ORP4, OSBPL1" ENSG00000184792 "Oxysterol binding protein 2" Q969R2 22 30693782-30907824 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.1;retina: 45.7" "Cell type enhanced" "Detected in many" 24 "Early spermatids: 112.6;Late spermatids: 239.9;Rod photoreceptor cells: 571.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 15.6;HeLa: 55.9;hTERT-HME1: 15.0;SiHa: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021514 Uncertain Approved Cytosol NA NA Cytosol "HPA021514: AB_1854813" "unprognostic (2.89e-1)" "unprognostic (2.04e-1)" "unprognostic (2.83e-1)" "unprognostic (6.94e-3)" "unprognostic (2.61e-1)" "unprognostic (1.10e-1)" "unprognostic (1.38e-5)" "unprognostic (3.01e-1)" "unprognostic (2.57e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-1)" "unprognostic (2.31e-1)" "prognostic favorable (3.79e-6)" "unprognostic (9.00e-2)" "unprognostic (2.68e-1)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" 1.0 8.5 5.7 2.3 11.6 36.1 1.2 17.0 14.4 1.4 1.6 8.5 1.3 6.3 1.9 13.0 3.3 2.0 2.7 10.0 7.7 5.6 2.1 0.7 1.8 1.9 7.1 6.2 1.7 4.9 8.8 14.1 4.0 7.3 2.2 1.7 45.7 2.5 2.4 2.3 4.6 4.6 1.2 6.4 3.4 3.2 19.6 5.5 0.0 2.9 0.3 1.3 4.3 2.2 1.9 1.6 2.5 3.1 2.7 3.2 6.2 2.6 5.8 0.5 2.5 0.4 2.3 0.6 0.5 1.2 1.8 1.9 5.2 1.4 4.6 2.2 0.7 0.6 1.5 2.3 0.2 1.3 2.5 0.7 15.6 55.9 1.0 0.3 0.1 0.9 0.1 6.5 4.6 15.0 0.6 4.6 1.8 9.7 0.2 4.2 2.9 0.4 1.6 1.4 1.2 5.4 1.3 0.2 0.2 0.2 1.0 6.5 2.7 14.9 1.6 0.1 1.2 1.8 0.8 3.3 1.3 7.0 1.2 2.6 1.2 1.7 0.8 5.2 0.0 1.0 0.6 1.8 1.1 1.5 3.1 3.1 1.7 2.9 1.4 1.6 1.9 3.0 3.2 2.5 2.7 2.3 0.7 1.9 6.2 5.7 11.6 17.0 14.4 7.7 5.6 7.1 6.2 7.3 5.5 0.0 1.9 0.0 1.0 4.6 89.3 8.5 0.0 1.4 1.2 1.8 76.6 0.2 1.7 1.4 112.6 1.8 0.4 23.3 1.3 0.2 2.5 1.0 0.0 0.0 0.2 17.5 6.9 0.0 0.0 239.9 2.3 0.2 1.7 0.0 2.3 23.7 0.7 5.8 1.8 0.4 571.4 0.0 1.2 16.2 3.4 8.3 0.2 0.0 1.3 1.6 OSBPL10 ENSG00000144645 "Oxysterol binding protein like 10" Q9BXB5 3 31657890-32077580 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 39.6" "Group enriched" "Detected in many" 13 "Early spermatids: 436.6;Late spermatids: 951.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 17 "memory B-cell: 11.5;naive B-cell: 6.6" "Lineage enriched" "Detected in single" 22 "B-cells: 11.5" "Cell line enhanced" "Detected in many" "hTERT-HME1: 31.5;RPTEC TERT1: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003636 Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA003636: AB_1079529" "unprognostic (5.28e-3)" "unprognostic (2.06e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.98e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-2)" "unprognostic (3.63e-2)" "unprognostic (8.55e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.15e-1)" "prognostic favorable (1.51e-4)" "unprognostic (5.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (4.85e-4)" 11.7 3.5 3.8 8.7 4.3 1.0 6.7 1.4 7.6 8.6 5.6 0.4 5.9 2.5 11.8 6.7 10.0 5.5 16.7 2.9 2.6 2.6 14.5 1.6 4.6 8.2 3.1 3.6 4.1 2.5 1.3 12.0 16.5 2.5 12.8 6.0 8.5 7.3 16.6 2.0 5.5 7.3 39.6 1.2 9.5 4.4 24.0 1.2 0.4 4.3 4.3 15.1 25.2 11.8 11.5 0.1 0.5 0.0 0.0 0.0 0.2 6.2 3.5 0.6 12.5 1.1 2.3 20.9 1.7 1.9 1.6 2.3 8.7 4.5 14.7 16.8 0.4 5.7 3.7 2.7 14.7 1.9 0.1 2.7 0.0 8.7 5.5 0.9 0.0 0.1 2.4 12.4 2.5 31.5 6.1 7.2 0.0 0.0 0.0 6.8 5.1 0.0 0.0 7.9 20.0 9.0 0.1 0.2 0.2 33.2 2.5 0.9 0.1 3.1 5.4 1.7 12.3 3.6 0.0 5.1 2.0 21.5 0.2 8.2 1.4 1.0 14.0 2.9 0.0 12.7 0.2 0.0 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 6.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 3.8 4.3 1.4 7.6 2.6 2.6 3.1 3.6 2.5 1.2 8.9 3.8 36.5 6.8 9.6 4.8 2.0 5.1 6.7 4.5 7.0 0.0 12.6 8.3 1.9 436.6 17.1 5.7 0.0 4.4 21.8 5.4 16.4 0.0 0.0 2.2 0.0 14.5 20.9 1.2 951.1 10.3 0.9 8.5 1.8 3.5 52.0 10.6 4.5 3.9 20.7 1.7 19.4 9.4 6.5 4.1 10.8 25.3 2.9 7.4 8.6 OSBPL1A "ORP-1, ORP1, OSBPL1B" ENSG00000141447 "Oxysterol binding protein like 1A" Q9BXW6 18 24162044-24397880 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 18 "basophil: 33.7" "Lineage enriched" "Detected in many" 18 "granulocytes: 33.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040959, HPA043401" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040959: AB_10964295, HPA043401: AB_10960208" "unprognostic (1.75e-2)" "unprognostic (3.35e-2)" "unprognostic (9.84e-3)" "unprognostic (4.92e-3)" "unprognostic (2.34e-1)" "unprognostic (3.06e-2)" "unprognostic (5.82e-2)" "unprognostic (2.06e-1)" "unprognostic (5.88e-2)" "unprognostic (2.62e-2)" "unprognostic (2.41e-1)" "unprognostic (8.53e-2)" "prognostic favorable (4.98e-13)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.18e-2)" "unprognostic (5.42e-3)" "unprognostic (1.56e-1)" 32.3 14.3 33.3 5.9 28.9 7.0 23.8 6.2 43.1 27.7 13.8 33.9 6.2 10.2 24.4 9.0 15.5 15.2 10.6 24.7 37.6 22.6 21.7 6.6 11.9 5.0 40.6 27.7 14.3 8.3 21.0 8.8 4.2 29.9 12.0 11.5 16.6 23.3 13.9 73.2 8.7 9.8 20.4 49.0 4.8 9.7 6.9 29.0 1.0 14.6 9.9 4.1 12.0 29.7 0.2 1.8 33.7 1.8 0.1 0.4 0.6 15.3 4.6 11.0 20.5 25.8 21.1 10.3 5.7 16.7 5.2 4.3 2.9 16.1 0.0 6.8 10.2 8.3 15.7 4.3 10.0 4.8 0.0 8.1 4.8 3.3 0.0 12.9 12.1 2.5 27.3 14.5 3.9 16.3 22.9 6.5 4.3 0.0 0.1 6.4 6.5 2.7 3.6 9.0 7.9 15.3 0.0 8.8 1.3 1.4 11.3 7.2 7.0 13.4 15.7 18.3 10.8 5.7 8.7 1.4 19.5 4.1 6.2 5.5 0.1 2.1 0.4 9.4 3.5 11.1 33.7 1.8 0.4 0.1 0.9 0.0 0.0 0.4 0.2 1.7 0.2 0.2 0.2 0.7 0.1 0.3 1.8 0.3 0.6 33.3 28.9 6.2 43.1 37.6 22.6 40.6 27.7 29.9 29.0 14.9 16.3 3.2 36.9 17.9 60.0 66.8 28.1 24.1 23.9 19.2 21.6 9.0 54.7 10.3 58.6 58.9 23.8 0.0 6.7 7.0 27.8 29.4 17.3 10.4 24.0 23.8 4.6 33.7 16.4 59.6 39.7 21.9 55.6 1.8 32.2 86.9 8.0 14.8 51.6 55.2 92.0 32.3 45.3 6.7 10.6 8.9 5.4 4.3 8.6 23.1 OSBPL2 "DFNA67, KIAA0772, ORP-2" ENSG00000130703 "Oxysterol binding protein like 2" Q9H1P3 20 62231922-62296213 "Disease related genes, Predicted intracellular proteins" "Lipid transport, Transport" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 38.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 38.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041127, HPA042659" Uncertain Approved Cytosol NA NA Cytosol "HPA041127: AB_10962008, HPA042659: AB_10960683" "unprognostic (1.00e-3)" "unprognostic (7.20e-3)" "unprognostic (1.31e-1)" "unprognostic (6.00e-2)" "unprognostic (1.82e-1)" "unprognostic (1.73e-3)" "unprognostic (3.79e-2)" "unprognostic (9.60e-2)" "unprognostic (6.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.73e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.20e-5)" "unprognostic (3.86e-2)" "unprognostic (8.13e-2)" "unprognostic (4.00e-1)" "unprognostic (3.32e-2)" 12.7 12.7 17.0 13.2 22.7 25.8 17.4 41.6 28.8 15.5 21.2 23.3 16.9 20.0 14.8 16.6 35.0 14.7 20.3 22.0 16.4 16.0 15.4 14.9 13.8 11.6 17.4 15.2 15.1 34.7 26.8 21.3 19.5 24.3 17.0 20.6 15.7 27.3 18.5 16.2 35.1 19.6 20.0 19.1 19.3 24.2 15.2 17.1 14.7 20.0 13.2 19.5 19.8 22.4 6.0 4.0 38.7 4.6 6.5 6.7 4.1 11.4 8.3 9.7 9.0 9.9 9.9 9.2 7.0 13.7 23.5 16.2 29.6 11.8 5.5 18.7 13.8 21.1 20.1 9.3 20.8 13.0 6.6 8.7 14.7 10.3 15.1 9.8 5.6 13.3 9.0 30.7 10.4 11.8 11.1 9.4 14.5 9.5 10.4 6.7 9.5 8.1 9.4 3.1 21.0 7.4 7.6 11.7 7.2 12.0 23.5 12.9 8.4 12.7 24.0 11.9 13.6 15.8 10.1 6.4 11.7 8.7 12.3 8.3 12.2 17.3 8.2 13.1 4.0 7.2 6.0 3.7 13.6 5.5 4.6 5.0 6.0 4.6 5.9 4.0 4.7 4.2 5.0 38.7 6.5 4.0 2.8 6.7 4.1 17.0 22.7 41.6 28.8 16.4 16.0 17.4 15.2 24.3 17.1 14.9 19.4 16.1 18.7 17.9 18.1 54.5 12.7 37.5 22.7 10.4 5.9 12.1 26.6 18.9 17.7 14.6 28.0 23.3 17.5 13.1 10.1 31.4 10.4 10.9 10.8 17.5 15.6 16.0 10.0 12.3 16.1 8.9 8.5 17.2 26.0 18.1 29.1 26.8 12.4 11.2 14.2 12.9 10.3 21.1 13.0 24.3 31.0 15.2 21.1 53.8 OSBPL3 "KIAA0704, ORP-3, ORP3, OSBP3" ENSG00000070882 "Oxysterol binding protein like 3" Q9H4L5 7 24796539-24981634 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 75.0;Club cells: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000691, HPA048401" Enhanced Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA000691: AB_1854814, HPA048401: AB_2680386" "unprognostic (3.57e-1)" "unprognostic (1.14e-1)" "unprognostic (6.11e-3)" "unprognostic (3.89e-2)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.57e-3)" "unprognostic (4.51e-2)" "unprognostic (2.26e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (2.34e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-2)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (2.06e-2)" 3.7 2.2 3.9 18.2 9.5 3.8 6.6 1.2 16.0 12.1 6.1 6.2 0.7 9.8 3.8 3.7 10.2 6.2 10.4 5.3 4.3 4.3 14.4 1.9 9.0 10.9 4.2 7.4 8.4 3.9 23.1 4.2 6.3 3.1 4.3 6.7 3.7 6.9 2.9 6.7 12.8 10.4 4.0 6.7 10.2 8.7 3.5 4.1 13.9 16.8 7.2 14.7 12.4 9.6 3.7 3.5 6.3 2.1 8.1 9.8 2.4 14.7 4.0 3.0 5.5 6.8 13.7 6.7 16.7 18.7 7.9 12.5 10.0 19.7 8.2 2.4 17.9 10.4 13.0 9.0 12.6 12.2 4.9 3.7 1.9 5.9 7.5 9.7 5.6 44.0 6.7 10.5 10.2 12.4 10.1 11.7 7.2 10.3 11.5 13.3 0.0 3.4 6.8 5.8 14.1 5.2 2.7 8.3 3.3 7.9 10.5 0.6 6.2 11.4 8.2 2.5 9.3 4.2 0.5 13.9 3.5 7.0 18.9 12.5 8.0 11.5 20.7 7.6 9.2 38.7 6.3 2.1 1.5 9.8 1.8 8.4 3.7 6.2 6.3 3.5 1.7 2.1 4.2 0.4 8.1 1.2 2.5 9.8 2.4 3.9 9.5 1.2 16.0 4.3 4.3 4.2 7.4 3.1 4.1 0.0 25.0 4.5 6.6 10.8 0.0 4.7 0.0 75.0 30.7 24.4 0.0 7.1 3.3 3.3 0.3 2.9 2.9 0.0 3.4 1.3 2.6 2.1 0.0 0.2 9.4 0.0 1.7 4.3 12.0 0.0 0.6 9.2 15.1 7.2 0.5 5.8 14.9 3.5 0.0 0.5 0.1 0.0 2.2 0.5 4.1 6.9 3.3 13.1 3.4 12.9 OSBPL7 "MGC71150, ORP7" ENSG00000006025 "Oxysterol binding protein like 7" Q9BZF2 17 47807372-47821834 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 37.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 25.9;Mucus-secreting cells: 23.6;Paneth cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036076, HPA053083, HPA073967" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: " "unprognostic (3.88e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.55e-3)" "unprognostic (2.05e-3)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.08e-1)" "prognostic favorable (1.19e-5)" 4.1 3.4 9.0 9.6 13.4 7.3 3.9 10.7 11.9 6.8 16.8 12.0 7.5 24.6 6.7 3.7 2.8 6.1 10.5 4.6 9.7 7.3 7.2 1.4 6.3 7.9 13.9 9.8 7.4 11.4 5.3 7.8 3.2 10.3 10.1 10.3 7.7 8.8 10.1 20.2 1.9 32.2 6.2 6.6 12.3 37.9 1.4 16.4 7.9 8.4 2.9 8.1 6.8 5.2 2.6 2.9 1.7 1.4 1.1 5.5 2.1 3.8 4.6 2.0 2.3 2.2 3.2 1.7 1.5 2.1 2.5 2.9 4.6 11.8 3.9 5.8 2.1 0.9 28.9 1.1 3.1 0.8 13.1 1.6 2.9 8.6 3.0 2.0 6.0 0.1 5.0 0.6 1.6 1.1 7.9 5.1 6.9 2.8 5.4 3.9 5.0 6.0 6.4 1.2 15.5 5.8 5.6 3.1 5.4 3.4 3.0 2.0 4.8 2.4 0.8 2.2 2.6 4.2 3.9 5.9 3.9 3.4 0.0 1.2 9.9 3.6 3.8 4.2 5.1 1.4 0.0 1.4 1.7 5.5 1.0 2.3 2.6 2.2 3.1 1.7 1.4 1.6 2.3 0.9 1.1 0.0 2.9 2.7 2.1 9.0 13.4 10.7 11.9 9.7 7.3 13.9 9.8 10.3 16.4 0.0 3.8 4.5 1.0 0.1 5.7 2.8 2.5 1.4 7.9 3.5 5.9 0.2 0.0 2.4 0.0 3.7 25.9 0.0 13.3 0.1 1.5 2.4 2.3 0.4 2.3 11.1 5.8 5.5 2.8 0.0 2.6 0.8 1.7 1.0 23.6 7.7 6.3 26.8 2.5 0.8 7.7 0.0 1.0 0.0 0.2 0.1 0.5 7.2 13.6 0.5 OSBPL8 "MST120, MSTP120, ORP8, OSBP10" ENSG00000091039 "Oxysterol binding protein like 8" Q9BZF1 12 76351797-76559809 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "granulocytes: 242.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001309 Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001309: AB_1079530" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.77e-1)" "unprognostic (1.70e-1)" "unprognostic (5.20e-2)" "unprognostic (1.23e-1)" "unprognostic (6.55e-3)" "unprognostic (2.84e-1)" "unprognostic (7.88e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (9.79e-4)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (5.63e-3)" "unprognostic (2.96e-1)" "unprognostic (1.16e-1)" "unprognostic (3.19e-3)" 29.3 11.4 13.9 18.4 41.9 23.1 17.2 13.7 20.2 20.0 11.5 6.8 8.4 7.5 18.5 10.7 20.1 10.4 15.0 19.3 13.4 12.9 30.2 15.2 20.5 22.7 12.1 13.2 14.9 11.2 12.4 16.5 14.4 13.9 16.2 9.7 9.2 15.8 11.1 21.5 22.9 12.6 15.5 14.8 24.9 12.4 12.8 14.7 41.0 11.7 10.6 24.8 18.0 24.5 11.7 15.8 57.2 15.0 9.9 10.9 8.1 12.4 8.0 17.8 12.6 24.8 35.1 11.3 19.2 27.0 12.4 11.3 11.5 5.2 17.5 11.0 22.8 7.7 5.2 13.2 11.1 18.7 14.9 11.7 46.9 7.9 6.8 15.3 29.7 19.1 18.5 21.2 18.4 23.0 22.3 10.6 10.2 32.1 8.1 20.3 8.6 19.8 14.1 8.7 4.5 7.9 10.4 24.3 10.0 9.5 10.6 9.7 10.2 16.4 6.0 11.9 14.6 4.6 18.1 24.8 20.0 10.0 20.6 10.3 8.1 12.7 19.3 7.6 16.7 11.6 27.5 15.0 20.1 9.0 10.8 8.5 11.7 9.6 7.3 13.2 11.6 8.7 7.1 57.2 9.9 11.7 15.8 10.9 8.1 13.9 41.9 13.7 19.9 13.4 12.9 12.1 13.2 13.9 14.7 53.6 69.1 48.0 37.5 103.3 37.1 37.6 20.4 40.2 34.2 48.8 84.4 28.5 51.4 49.5 35.1 65.2 13.0 23.3 47.9 23.5 68.6 48.2 242.1 32.5 69.5 39.7 9.1 50.3 88.2 15.3 60.9 125.5 33.7 85.6 23.5 51.8 73.4 24.6 77.8 126.3 27.5 45.3 89.0 45.6 131.8 108.8 40.3 78.4 14.9 59.7 OSCAR ENSG00000170909 "Osteoclast associated, immunoglobulin-like receptor" Q8IYS5 19 54094668-54102692 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 36.7;Kupffer cells: 33.7;Macrophages: 28.2;monocytes: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 34 "classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2" "Group enriched" "Detected in many" 75 "dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6" "Cell line enhanced" "Detected in some" "EFO-21: 13.6;HHSteC: 9.3;hTERT-HME1: 4.9;NB-4: 5.4;U-937: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073996 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 72000000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA073996: " "unprognostic (9.09e-2)" "unprognostic (6.79e-3)" "unprognostic (8.47e-3)" "unprognostic (2.14e-1)" "unprognostic (2.12e-2)" "unprognostic (9.04e-2)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.05e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (1.84e-1)" "unprognostic (2.88e-2)" "unprognostic (9.69e-2)" "unprognostic (4.28e-2)" 4.5 1.0 1.4 3.8 2.8 18.9 1.4 0.4 1.5 1.3 0.9 3.5 0.0 0.4 0.7 1.3 1.2 2.2 2.3 1.1 3.8 1.9 1.0 1.7 40.4 4.7 3.5 0.4 1.2 0.7 0.3 0.5 2.2 4.0 0.8 0.7 1.0 1.3 0.8 0.7 1.9 1.0 2.8 5.6 20.2 1.3 0.6 2.4 1.7 1.0 0.0 1.2 1.7 3.1 0.0 9.4 18.3 20.6 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.4 0.0 13.6 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 9.3 0.7 0.0 0.0 0.2 0.6 4.9 0.8 0.0 0.1 0.0 0.4 0.1 0.1 0.0 5.4 0.3 0.2 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.6 0.5 16.8 0.0 0.0 20.6 11.7 0.1 12.8 0.0 0.0 0.1 0.2 9.4 0.0 0.0 0.0 18.3 0.0 11.2 0.4 0.1 7.0 1.4 2.8 0.4 1.4 3.8 1.9 3.5 0.4 4.0 2.4 3.0 5.1 0.0 0.5 0.7 0.0 0.3 2.5 6.7 3.4 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.2 1.1 0.0 36.7 0.0 0.0 0.0 33.7 0.0 0.0 28.2 0.0 39.7 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.6 0.1 0.2 0.0 0.0 0.3 OSGIN1 "BDGI, OKL38" ENSG00000140961 "Oxidative stress induced growth inhibitor 1" Q9UJX0 16 83948282-83966332 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 63.5" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 47.5;Enterocytes: 69.2;Hepatocytes: 52.5;Late spermatids: 191.7" "Cancer enriched" "Detected in all" 5 "liver cancer: 65.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 12.3" "Group enriched" "Detected in many" 8 "granulocytes: 4.5;monocytes: 12.3" "Cell line enhanced" "Detected in many" "A549: 25.7;Hep G2: 38.6;T-47d: 28.7;WM-115: 24.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA019239 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019239: AB_1854779" "unprognostic (8.36e-2)" "unprognostic (9.44e-2)" "unprognostic (4.28e-2)" "prognostic favorable (4.89e-5)" "unprognostic (3.31e-3)" "unprognostic (9.14e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" "unprognostic (2.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.20e-2)" "unprognostic (2.80e-2)" "unprognostic (2.45e-2)" "unprognostic (2.48e-2)" "unprognostic (8.28e-3)" "unprognostic (1.89e-1)" 4.0 9.8 1.7 3.0 6.5 0.8 28.2 0.6 3.7 1.7 17.4 2.1 0.7 18.1 1.3 1.7 5.6 1.8 5.1 6.9 1.3 1.4 13.8 63.5 8.2 1.6 13.4 0.0 3.2 5.2 2.5 1.4 1.2 6.6 2.1 1.8 5.1 2.0 1.7 7.8 1.6 21.3 5.5 13.7 5.4 5.0 5.6 1.9 0.0 5.2 13.5 2.9 6.0 10.6 0.0 1.0 4.5 12.3 0.0 0.0 0.8 1.7 25.7 0.2 1.1 1.6 2.4 2.0 2.9 2.8 2.6 1.0 6.3 9.3 0.0 6.9 2.4 11.9 4.7 1.1 1.9 1.0 0.3 0.3 0.4 5.7 38.6 5.6 0.9 10.1 1.4 1.5 7.0 1.6 1.5 2.6 1.8 2.3 2.5 3.4 11.9 0.3 0.3 0.2 6.2 5.9 0.8 2.6 1.2 1.8 2.2 0.1 0.6 6.2 2.0 12.5 0.7 28.7 1.0 8.9 4.2 6.3 6.1 2.0 1.1 0.4 0.1 14.0 1.3 24.0 0.1 2.1 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 4.5 0.0 12.3 0.0 0.0 0.8 1.7 6.5 0.6 3.7 1.3 1.4 13.4 0.0 6.6 1.9 14.9 3.8 0.5 8.2 1.3 0.5 6.9 10.2 1.4 1.2 1.8 0.0 1.2 5.0 10.5 47.5 2.7 69.2 0.0 5.7 0.3 2.1 9.5 1.1 52.5 8.5 0.0 4.1 6.7 8.6 191.7 3.7 3.2 6.8 2.8 7.3 7.5 11.6 10.5 11.3 8.7 0.2 12.9 8.0 1.9 1.0 1.5 1.1 0.0 7.1 5.8 OSTF1 "bA235O14.1, OSF, SH3P2" ENSG00000134996 "Osteoclast stimulating factor 1" Q92882 9 75088543-75147265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 448.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 73.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020514 Approved Supported Cytosol NA NA 190000 Cytosol "HPA020514: AB_2670461" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (7.54e-2)" "prognostic favorable (3.67e-5)" "unprognostic (1.36e-1)" "unprognostic (2.43e-1)" "unprognostic (9.73e-2)" "unprognostic (1.48e-2)" "unprognostic (2.40e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-3)" "unprognostic (3.76e-1)" "unprognostic (7.89e-2)" "unprognostic (6.36e-3)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (1.53e-1)" 25.8 18.5 19.1 29.8 22.7 24.2 30.6 12.2 25.5 18.5 19.9 16.7 9.0 18.0 11.5 19.4 62.0 11.9 20.7 21.7 19.5 14.4 20.3 30.9 32.5 36.9 21.5 18.6 10.6 14.8 33.4 12.7 41.5 21.5 14.0 22.6 12.4 24.0 13.8 7.4 31.0 24.8 13.8 22.5 52.9 19.1 9.6 17.8 21.3 16.1 17.2 38.9 26.1 30.1 18.7 25.4 84.5 40.1 27.2 30.8 40.9 16.7 4.0 1.9 2.8 11.8 10.9 20.7 17.9 11.8 6.9 6.3 2.0 12.7 17.4 9.0 14.6 8.8 27.9 3.2 12.9 19.9 73.4 4.0 9.6 6.2 10.3 9.6 17.2 36.2 7.6 12.5 8.0 5.6 6.1 22.9 14.9 3.2 40.0 16.5 8.7 25.7 10.8 3.6 39.6 7.7 4.9 13.3 15.3 14.4 24.1 1.6 0.1 13.2 18.7 8.6 15.5 24.6 19.5 21.5 14.4 5.0 27.5 7.5 7.7 12.4 6.5 17.2 20.1 11.6 50.9 30.8 75.5 29.3 33.0 30.8 18.7 20.5 24.0 25.4 16.5 11.8 20.6 84.5 27.2 40.1 19.0 27.5 40.9 19.1 22.7 12.2 25.5 19.5 14.4 21.5 18.6 21.5 17.8 20.8 26.1 58.4 52.5 73.0 2.9 6.7 30.6 18.7 21.6 31.4 5.9 102.0 64.6 43.9 8.0 51.3 60.1 0.0 46.0 197.4 51.6 40.1 135.0 27.1 196.0 9.5 26.2 79.2 180.5 4.2 22.2 143.3 72.6 448.2 31.4 5.8 47.2 91.7 14.5 51.6 7.5 19.4 35.8 4.6 15.3 100.1 112.0 179.9 33.8 77.0 OSTM1 "GL, HSPC019" ENSG00000081087 "Osteopetrosis associated transmembrane protein 1" Q86WC4 6 108041409-108165854 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Osteopetrosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Melanocytes: 143.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010851 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No 130000 Cytosol "Nucleoplasm, Vesicles" "HPA010851: AB_1079533" "prognostic unfavorable (4.36e-4)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (1.72e-3)" "prognostic unfavorable (4.26e-4)" "unprognostic (9.40e-2)" "unprognostic (2.56e-1)" "unprognostic (2.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.34e-6)" "prognostic unfavorable (1.20e-4)" "unprognostic (2.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" 26.3 21.9 9.0 18.1 13.5 5.5 16.7 13.7 17.2 14.4 17.8 12.8 9.9 8.4 21.8 10.3 14.1 15.0 13.5 23.2 10.4 16.5 22.0 15.9 17.0 17.2 11.0 10.5 15.6 9.7 11.8 26.0 24.7 20.0 15.4 12.4 29.7 10.8 19.0 18.0 10.4 12.9 24.7 13.1 21.7 14.3 11.1 10.7 13.6 12.4 8.1 13.9 21.0 19.4 10.8 12.4 20.9 28.1 14.5 16.4 16.9 2.1 6.4 7.6 11.1 23.0 7.5 10.9 16.0 16.1 11.7 19.5 3.8 3.6 5.0 13.2 11.1 31.6 4.1 7.5 5.4 18.1 11.5 5.9 10.6 4.1 4.7 17.8 11.6 24.7 10.9 13.6 14.4 11.5 10.8 5.9 5.7 8.3 18.5 18.9 3.0 2.5 2.6 3.0 2.6 4.9 4.1 11.1 2.7 8.4 5.8 0.8 4.5 12.9 3.3 28.5 10.6 3.7 16.9 7.2 10.3 3.8 22.7 22.6 7.1 12.1 4.4 30.4 7.9 22.6 16.8 13.9 15.2 15.0 19.9 16.0 10.8 12.8 16.4 12.4 6.2 12.0 15.0 20.9 14.5 28.1 8.9 15.4 16.9 9.0 13.5 13.7 17.2 10.4 16.5 11.0 10.5 20.0 10.7 8.9 21.3 25.4 14.7 41.4 29.2 18.5 12.7 5.3 6.8 12.2 9.8 18.7 1.7 10.8 3.4 18.0 10.3 0.0 19.8 29.3 16.9 16.3 24.2 12.4 46.3 27.0 4.1 28.8 46.6 2.7 13.3 33.0 143.4 10.8 4.2 24.0 15.6 12.9 26.9 21.0 15.7 25.8 33.9 19.8 19.5 27.1 51.1 27.7 2.9 14.0 OTOGL "C12orf64, FLJ90579" ENSG00000165899 "Otogelin like" Q3ZCN5 12 80099537-80380879 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 6.1;Distal tubular cells: 1.7;Early spermatids: 1.1;Proximal tubular cells: 3.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in many" 4 "amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.9;U-2 OS: 2.5;U-87 MG: 7.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 5.2" "HPA040364, HPA053392" Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA040364: AB_10795365, HPA053392: AB_2682135" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (2.55e-2)" "unprognostic (1.50e-1)" "unprognostic (5.99e-2)" "unprognostic (3.10e-1)" "unprognostic (3.34e-3)" "unprognostic (4.76e-2)" "unprognostic (2.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.79e-2)" "unprognostic (1.57e-1)" "unprognostic (1.95e-5)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.79e-2)" "unprognostic (2.04e-2)" 0.4 0.2 3.5 0.2 4.3 0.1 0.4 0.2 5.8 0.4 2.7 0.0 0.0 0.2 0.5 3.1 0.5 0.5 0.4 9.8 1.0 0.4 13.3 0.1 0.3 0.5 0.5 3.6 0.2 0.7 0.2 21.0 1.4 0.3 0.5 0.3 1.4 0.3 0.5 1.0 0.3 0.6 0.6 0.3 0.4 0.4 0.8 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.5 3.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.4 0.5 2.5 0.0 0.2 0.9 0.0 0.1 7.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 0.2 5.8 1.0 0.4 0.5 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OTUB1 "FLJ20113, FLJ40710" ENSG00000167770 "OTU deubiquitinase, ubiquitin aldehyde binding 1" Q96FW1 11 63985853-64001811 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039176, CAB072836" Approved Supported Approved Nucleoplasm,Cytosol NA NA 630000 "Nucleoplasm, Cytosol" "CAB072836: , HPA039176: AB_10674980" "unprognostic (2.50e-1)" "unprognostic (5.70e-3)" "unprognostic (3.93e-2)" "unprognostic (1.63e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.45e-1)" "unprognostic (1.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (6.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.84e-2)" "unprognostic (1.82e-1)" 19.8 24.7 41.9 24.1 61.6 32.6 20.8 41.8 101.9 24.3 25.0 31.9 22.3 24.7 21.9 23.6 37.8 34.5 21.6 31.6 46.9 37.8 27.2 27.6 23.0 31.9 33.1 45.4 23.4 23.0 26.0 21.6 30.7 60.4 23.8 24.1 24.2 30.4 27.7 26.7 36.9 26.0 23.1 26.7 25.7 23.9 22.1 21.2 27.8 29.9 24.5 32.8 27.1 22.9 46.0 60.8 56.1 71.3 44.8 64.5 78.2 30.7 55.7 30.7 27.2 20.8 23.0 23.7 18.6 27.6 41.4 30.6 37.4 29.5 16.4 35.3 29.8 36.0 38.6 39.7 46.3 25.7 19.0 30.7 27.4 33.5 47.3 29.2 27.1 30.0 24.4 30.1 31.6 20.2 21.5 39.0 15.3 19.1 18.6 27.7 63.4 29.6 35.9 36.1 26.1 26.5 24.3 12.0 28.1 43.0 45.1 23.3 33.6 21.0 32.3 33.9 22.0 50.1 24.0 28.1 22.1 21.5 29.5 24.4 22.0 13.8 23.6 28.6 17.7 21.1 55.1 56.3 54.3 53.1 71.3 41.4 46.0 49.1 48.6 60.8 41.9 38.4 42.6 56.1 44.8 60.9 42.1 64.5 78.2 41.9 61.6 41.8 101.9 46.9 37.8 33.1 45.4 60.4 21.2 17.9 66.5 50.3 60.6 42.8 41.6 27.7 35.7 62.9 52.4 43.6 37.3 125.6 63.0 73.0 63.0 39.3 99.3 23.3 74.8 89.9 46.6 44.0 46.3 28.0 78.9 28.6 84.2 34.4 55.6 67.0 31.7 66.2 49.0 114.6 62.4 40.9 72.8 56.1 24.1 69.5 48.4 25.8 45.3 45.7 63.7 45.9 162.9 67.3 48.9 63.9 OTUD3 "DUBA4, KIAA0459" ENSG00000169914 "OTU deubiquitinase 3" Q5T2D3 1 19882513-19912945 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028543, HPA028544" Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA028543: AB_10599302, HPA028544: AB_10602277" "unprognostic (6.45e-3)" "unprognostic (9.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" "unprognostic (3.16e-3)" "unprognostic (1.70e-3)" "unprognostic (3.15e-3)" "unprognostic (4.99e-2)" "unprognostic (1.09e-1)" "unprognostic (8.81e-2)" "unprognostic (4.68e-2)" "unprognostic (1.08e-1)" "unprognostic (9.83e-2)" "unprognostic (1.94e-1)" "unprognostic (7.28e-2)" "unprognostic (2.21e-2)" 6.5 11.0 15.0 6.9 19.2 11.4 10.0 19.3 23.2 10.6 8.9 6.6 6.4 10.2 14.2 13.0 6.1 8.2 7.2 5.2 12.6 7.3 7.1 4.8 8.5 7.0 9.9 12.5 11.2 7.2 9.3 20.2 5.4 9.0 9.8 8.3 6.9 6.2 9.2 9.2 13.0 9.6 11.9 8.1 7.7 7.3 28.4 9.7 6.0 6.9 2.9 6.3 7.0 7.6 1.7 0.6 0.8 0.4 0.6 2.2 0.3 5.1 1.9 8.7 10.4 3.8 3.3 8.6 5.5 3.2 2.8 2.8 9.1 4.9 8.1 4.5 12.1 2.0 5.0 8.1 3.2 5.5 5.3 10.8 7.8 10.4 6.3 2.1 5.7 7.2 2.7 3.2 4.4 5.7 6.0 3.7 8.3 5.5 3.5 4.8 2.8 4.3 5.7 4.1 4.1 5.1 10.1 22.3 3.0 4.7 5.6 7.7 5.5 3.9 3.2 4.2 8.9 4.8 4.2 4.5 6.8 8.7 7.5 4.7 4.0 3.4 5.0 4.8 7.6 3.1 0.8 0.4 0.1 1.5 0.3 1.4 1.7 1.7 1.4 0.3 1.3 2.2 1.8 0.7 0.6 0.1 0.6 0.9 0.3 15.0 19.2 19.3 23.2 12.6 7.3 9.9 12.5 9.0 9.7 14.9 6.9 3.0 5.2 12.6 13.5 3.6 0.0 10.7 1.2 8.7 15.7 2.3 0.0 4.5 9.9 4.5 3.8 0.0 4.0 4.7 4.2 8.8 1.1 2.1 1.6 25.4 11.5 9.2 1.6 11.5 5.2 3.3 5.0 2.8 6.7 10.2 3.9 5.9 5.6 3.4 16.0 6.5 3.5 19.1 21.2 7.8 2.1 4.4 5.9 3.0 OTUD4 "DUBA6, HSHIN1, KIAA1046" ENSG00000164164 "OTU deubiquitinase 4" Q01804 4 145110838-145180161 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036623 Uncertain Supported Cytosol NA NA Cytosol "HPA036623: AB_10696780" "unprognostic (1.67e-1)" "unprognostic (4.18e-2)" "unprognostic (3.41e-2)" "unprognostic (1.95e-1)" "unprognostic (2.80e-1)" "unprognostic (4.06e-2)" "unprognostic (3.42e-2)" "unprognostic (2.66e-2)" "unprognostic (1.21e-1)" "unprognostic (1.74e-2)" "unprognostic (5.21e-3)" "unprognostic (2.03e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.62e-1)" 14.3 11.8 16.6 11.6 16.7 24.7 12.0 22.7 15.9 14.0 15.3 16.0 10.1 10.0 13.9 13.3 14.8 14.9 11.2 15.6 12.0 9.2 11.1 17.7 15.5 13.1 14.1 8.4 14.3 13.4 22.4 12.2 17.9 12.7 10.6 11.2 10.6 12.7 11.0 36.2 13.6 16.2 12.4 10.1 13.5 10.8 26.8 18.8 13.1 13.4 13.6 12.3 11.5 12.8 3.3 2.8 2.8 2.8 1.6 3.5 1.0 15.2 8.7 10.5 9.6 12.4 15.1 14.0 13.3 15.1 17.3 13.8 9.4 18.9 28.1 6.1 18.7 10.6 9.3 18.0 18.7 22.7 12.0 8.6 13.4 10.6 8.5 14.5 28.2 10.2 11.8 19.1 21.1 27.7 14.6 15.2 12.4 22.2 21.1 16.9 9.1 17.4 12.3 11.6 14.8 10.0 14.4 11.5 6.6 16.7 11.2 10.1 8.3 12.3 18.7 13.3 14.4 6.2 11.6 18.3 19.5 12.4 10.0 17.7 15.6 15.3 18.6 13.5 20.1 18.8 0.0 1.7 2.8 3.5 2.1 2.6 3.3 2.7 2.8 1.6 2.4 2.7 2.4 0.5 1.6 2.8 2.8 2.0 1.0 16.6 16.7 22.7 15.9 12.0 9.2 14.1 8.4 12.7 18.8 59.6 19.7 15.9 40.5 56.1 15.3 18.5 28.1 42.8 23.9 26.2 23.6 17.2 8.3 11.1 130.8 21.8 10.5 0.0 12.7 17.3 25.9 44.8 19.7 20.2 11.8 6.4 14.6 22.1 18.0 63.1 18.7 17.9 30.4 5.4 12.1 7.5 18.4 14.0 28.3 6.6 19.1 0.0 29.9 28.8 41.0 47.6 13.4 14.6 14.3 50.2 OTUD5 "DKFZp761A052, DUBA" ENSG00000068308 "OTU deubiquitinase 5" Q96G74 X 48922028-48958386 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "U-266/70: 187.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017375 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli fibrillar center" "HPA017375: AB_1854844" "unprognostic (9.73e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.67e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (6.65e-2)" "unprognostic (2.33e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "prognostic favorable (8.20e-4)" "unprognostic (1.32e-1)" "unprognostic (3.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-2)" "unprognostic (5.05e-3)" 23.5 27.5 32.4 26.8 40.9 38.4 21.9 35.0 52.4 21.3 22.9 28.2 23.4 30.5 25.5 26.8 20.5 25.1 20.9 16.6 29.8 31.3 22.6 24.5 25.2 30.8 25.4 29.8 30.0 25.4 29.6 26.8 23.1 29.4 24.0 17.8 20.4 26.9 27.4 24.4 24.5 29.1 27.1 21.4 34.5 22.3 12.7 24.0 34.8 24.5 14.4 27.2 22.1 22.7 7.8 6.3 8.6 5.1 18.6 7.5 3.5 6.2 9.5 4.4 11.0 7.5 6.8 5.2 5.5 6.5 7.0 7.6 4.7 7.0 7.0 3.6 6.9 6.1 7.7 6.7 5.6 6.5 8.2 8.1 5.3 9.6 5.4 6.4 5.0 5.9 7.5 5.2 7.2 4.9 7.7 5.5 5.8 6.7 11.1 4.9 6.3 7.9 10.9 8.0 2.3 7.5 6.3 6.5 9.1 4.9 5.6 4.3 7.6 7.3 4.7 7.3 10.8 6.3 4.6 7.8 4.6 5.8 12.0 4.5 187.1 46.7 6.7 7.0 7.1 3.1 5.2 3.4 7.0 7.0 5.1 5.8 7.8 5.5 6.0 4.8 6.0 5.2 7.5 8.6 18.6 4.7 6.3 7.0 3.5 32.4 40.9 35.0 52.4 29.8 31.3 25.4 29.8 29.4 24.0 8.9 21.1 23.0 19.4 19.7 31.7 8.5 10.2 17.4 17.0 26.2 25.5 11.3 8.3 13.0 1.5 18.5 26.4 0.0 15.9 12.0 16.5 23.0 6.9 22.9 14.5 27.0 46.2 18.4 24.7 1.5 19.2 19.5 25.3 21.6 26.6 16.0 17.8 15.8 22.3 20.3 25.0 12.9 13.3 5.9 10.9 22.3 25.7 30.9 17.4 22.8 OTUD6A "DUBA2, FLJ25831, HSHIN6" ENSG00000189401 "OTU deubiquitinase 6A" Q7L8S5 X 70062491-70064179 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 3.8;testis: 13.6" "Group enriched" "Detected in some" 7 "Spermatocytes: 20.9;Spermatogonia: 6.6" "Cancer enriched" "Detected in single" 57 "testis cancer: 2.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "MCF7: 2.0;U-2 OS: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA053304 Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA053304: AB_2682107" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 13.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.4 3.8 0.4 0.7 0.6 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.6 0.4 1.0 0.5 0.0 0.7 0.8 0.4 0.3 0.2 0.0 0.0 0.5 0.8 0.8 0.0 0.3 0.7 0.3 0.4 0.2 0.3 0.2 0.0 1.1 0.2 0.6 0.0 2.0 0.3 0.9 0.6 0.0 0.2 0.0 0.0 0.0 0.8 0.7 0.6 0.3 0.5 0.2 0.0 0.5 0.1 0.1 0.0 0.2 1.9 0.3 0.5 1.6 0.3 1.5 0.1 0.2 0.2 3.8 0.4 0.3 0.4 0.2 0.4 0.3 0.3 0.2 0.0 0.9 0.3 0.6 2.6 0.7 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.4 0.3 1.1 0.0 0.1 0.0 0.0 0.0 1.2 0.7 0.3 0.5 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 1.9 0.0 0.0 20.9 6.6 0.5 0.2 0.0 0.0 0.3 OTUD6B "CGI-77, DUBA5" ENSG00000155100 "OTU domain containing 6B" Q8N6M0 8 91070196-91087095 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024046, HPA024503, HPA024772" Approved Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846" "prognostic unfavorable (7.50e-4)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (4.78e-3)" "unprognostic (4.91e-2)" "unprognostic (1.49e-1)" "unprognostic (1.52e-2)" "unprognostic (1.16e-3)" "unprognostic (2.17e-1)" "unprognostic (5.51e-2)" "unprognostic (1.27e-2)" "unprognostic (8.61e-3)" "unprognostic (1.87e-2)" "unprognostic (1.96e-1)" "unprognostic (4.53e-1)" "unprognostic (8.78e-2)" "unprognostic (5.71e-2)" 11.4 11.3 14.6 14.1 18.2 8.9 13.2 13.8 19.6 12.3 11.3 9.9 10.3 9.2 12.1 9.0 13.2 9.1 8.6 14.0 14.9 13.7 11.0 10.5 10.0 13.8 18.5 15.5 12.5 9.9 11.2 14.4 14.9 16.2 11.6 11.3 6.0 9.5 14.8 35.3 11.2 9.1 12.4 19.9 11.3 8.8 11.9 17.4 13.9 11.8 11.0 11.9 11.9 14.0 7.2 12.9 8.8 7.8 7.8 6.8 2.9 16.3 9.4 8.5 6.3 3.8 2.9 8.8 13.0 4.9 12.1 7.9 8.1 10.3 17.3 6.3 6.8 4.9 5.6 17.5 10.6 18.8 13.9 10.7 23.6 9.8 6.1 8.2 12.0 12.5 4.8 5.1 9.7 23.1 7.2 9.8 13.7 23.6 10.9 10.3 8.9 20.1 7.9 4.5 12.5 18.7 9.1 8.1 15.5 9.4 11.8 2.0 7.6 1.2 28.8 12.5 11.5 14.7 5.8 10.0 7.2 10.9 11.0 12.3 10.9 20.7 25.5 10.6 15.1 13.8 8.8 6.5 4.3 5.9 7.8 6.8 7.2 4.8 5.7 8.1 6.8 6.7 5.9 0.9 7.8 5.8 12.9 3.6 2.9 14.6 18.2 13.8 19.6 14.9 13.7 18.5 15.5 16.2 17.4 8.9 9.9 12.4 5.2 20.6 13.1 14.0 10.2 9.4 13.6 1.8 31.4 9.3 8.3 4.7 0.4 7.5 3.1 0.0 4.3 8.3 5.1 4.0 18.4 9.2 7.0 11.1 10.4 9.2 7.5 0.9 8.9 9.4 3.3 8.2 4.2 13.4 5.3 4.2 3.9 6.2 16.7 0.0 7.2 1.9 6.6 15.8 5.6 7.9 5.6 4.7 OTUD7A "C15orf16, CEZANNE2, OTUD7" ENSG00000169918 "OTU deubiquitinase 7A" Q8TE49 15 31475398-31870789 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 20.5;Horizontal cells: 23.8;Spermatogonia: 6.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044554 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA044554: AB_10794895" "unprognostic (3.61e-2)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.25e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (3.24e-3)" "unprognostic (1.34e-1)" "unprognostic (1.79e-11)" "unprognostic (6.78e-2)" "unprognostic (2.76e-1)" "unprognostic (8.27e-2)" "unprognostic (1.79e-1)" 2.6 2.0 12.4 1.7 13.9 5.9 1.5 13.2 17.0 1.8 3.4 16.0 0.0 1.5 1.9 1.9 1.9 2.0 2.3 2.1 10.0 4.6 2.3 1.0 1.5 3.5 20.4 7.1 2.0 2.5 4.6 1.7 0.9 10.5 1.2 3.1 0.7 1.6 2.0 1.8 3.2 2.1 2.9 9.1 2.2 2.3 8.2 17.4 0.0 2.3 0.0 2.4 1.9 1.3 0.1 3.2 0.3 1.4 0.1 0.7 0.4 3.7 4.1 4.5 6.1 0.4 1.3 3.2 2.5 1.3 3.9 2.0 2.5 3.2 2.9 2.2 0.9 2.2 4.6 4.9 2.1 3.2 5.9 6.6 3.7 8.3 2.0 0.3 4.1 5.8 0.0 0.2 3.9 4.3 1.1 3.5 6.4 6.0 5.5 1.8 2.9 3.1 3.9 2.1 4.8 2.0 5.7 3.1 1.4 1.6 3.9 11.0 6.0 3.4 3.0 1.0 2.3 2.5 4.3 2.3 5.4 5.3 3.0 6.3 3.4 2.4 3.0 2.9 5.8 4.5 0.0 0.4 0.3 0.6 0.5 0.3 0.0 0.3 0.7 0.2 0.1 0.2 0.2 0.0 0.1 1.4 3.2 0.0 0.4 12.4 13.9 13.2 13.8 10.0 4.6 20.4 7.1 10.5 17.4 3.0 0.0 0.0 0.6 0.3 20.5 2.2 0.0 0.0 1.2 1.8 2.0 0.0 0.0 0.4 1.0 1.0 0.9 0.0 0.8 0.0 0.7 1.3 0.0 0.8 0.2 23.8 3.5 1.3 0.0 1.1 0.9 0.0 1.7 0.0 1.0 3.7 0.4 0.0 2.5 1.2 2.9 0.0 1.0 4.1 6.1 0.4 0.1 0.0 1.0 0.8 OTX1 ENSG00000115507 "Orthodenticle homeobox 1" P32242 2 63050057-63057836 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 1.4;Ciliated cells: 6.7;Club cells: 2.3;Suprabasal keratinocytes: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 113 "neutrophil: 11.3" "Lineage enriched" "Detected in single" 113 "granulocytes: 11.3" "Cell line enriched" "Detected in many" 9 "THP-1: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB012341, HPA052122" Uncertain Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "CAB012341: AB_2157155, HPA052122: AB_2681736" "unprognostic (2.25e-2)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-3)" "unprognostic (2.32e-1)" "unprognostic (1.67e-2)" "unprognostic (6.92e-3)" "unprognostic (3.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (2.26e-3)" "unprognostic (1.71e-1)" "unprognostic (0.00e+0)" "unprognostic (4.64e-2)" "unprognostic (2.31e-1)" "unprognostic (3.80e-4)" "unprognostic (3.67e-3)" 0.5 0.4 8.2 0.4 4.3 0.4 1.1 0.2 7.2 0.4 0.4 5.8 0.0 0.6 0.4 0.4 1.4 0.5 0.5 0.4 9.0 1.4 0.4 0.5 0.8 0.4 2.0 3.4 0.6 0.6 0.4 0.1 0.4 0.1 2.3 0.4 18.9 19.6 0.4 0.4 14.3 0.4 0.4 0.1 0.6 1.0 0.9 4.4 0.0 0.4 4.4 5.6 0.6 0.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 1.5 0.8 2.8 1.7 0.0 0.1 3.9 0.0 0.2 0.2 0.2 2.8 1.5 0.1 0.5 0.0 0.7 2.0 1.8 1.2 0.3 0.7 1.6 1.8 1.4 3.2 0.0 1.2 1.3 0.0 0.5 0.0 0.5 0.5 0.0 1.7 1.5 0.0 0.1 1.3 1.6 2.9 0.0 1.4 1.0 1.5 2.4 0.4 0.7 0.5 0.3 0.4 1.1 0.1 0.9 0.0 0.6 34.7 0.1 0.6 1.1 0.0 0.6 1.0 0.7 2.6 0.2 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 8.2 4.3 0.2 7.2 9.0 1.4 2.0 3.4 0.1 4.4 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.0 6.7 2.3 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.3 0.1 0.0 0.0 0.0 OVCA2 ENSG00000262664 "OVCA2, serine hydrolase domain containing" Q8WZ82 17 2041936-2043430 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059002 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA059002: AB_2683875" 17.0 25.7 13.6 22.3 16.4 23.1 14.4 11.2 17.2 15.4 20.5 12.1 12.1 20.0 12.2 19.1 23.6 12.0 28.4 17.6 12.2 11.3 31.0 46.4 15.6 37.2 11.5 11.8 14.2 25.5 9.6 21.7 26.5 13.3 16.6 17.5 24.5 30.2 21.1 20.4 18.5 32.1 12.4 8.3 28.9 19.0 28.1 9.6 29.7 22.3 34.8 30.3 22.0 12.6 26.2 30.7 12.5 30.7 29.9 43.0 28.4 21.4 21.2 8.9 18.0 11.0 14.6 14.5 14.2 15.5 15.7 14.8 24.3 14.2 4.7 14.5 19.2 11.2 16.8 9.5 22.8 11.5 11.3 24.1 10.6 13.0 8.9 30.1 7.1 21.8 19.0 20.6 15.2 10.3 6.6 26.3 10.4 5.9 22.9 23.3 15.0 10.4 12.0 7.6 16.4 13.6 8.8 9.0 7.3 23.9 14.2 5.9 21.8 9.3 14.6 19.2 9.8 17.1 14.3 20.7 22.9 7.4 16.5 27.6 13.8 14.1 4.1 20.5 16.1 22.5 8.5 30.7 12.5 26.8 26.6 26.9 26.2 26.7 28.3 26.5 21.5 18.5 18.0 8.6 29.9 20.4 30.7 43.0 28.4 13.6 16.4 11.2 17.2 12.2 11.3 11.5 11.8 13.3 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OVOL2 "bA504H3.3, CHED, CHED1, HOVO2, ZNF339" ENSG00000125850 "Ovo like zinc finger 2" Q9BRP0 20 17956979-18059188 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Corneal dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.3;CACO-2: 4.9;CAPAN-2: 8.4;HaCaT: 6.3;OE19: 11.6;SCLC-21H: 9.8;SK-BR-3: 6.5" "Group enriched" "Detected in some" 4 "cerebral cortex: 10.5;hippocampal formation: 6.8" "Group enriched" "Detected in some" 4 "cerebral cortex: 7.6;hippocampal formation: 5.8" HPA038531 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038531: AB_10673012" "unprognostic (2.85e-2)" "unprognostic (5.13e-2)" "unprognostic (2.41e-2)" "unprognostic (7.35e-2)" "unprognostic (2.14e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.40e-1)" "unprognostic (2.61e-1)" "unprognostic (2.63e-2)" "unprognostic (1.62e-1)" "unprognostic (1.84e-4)" "unprognostic (4.77e-3)" "unprognostic (2.92e-1)" "unprognostic (2.57e-2)" "unprognostic (3.76e-2)" 0.0 0.0 0.0 3.4 0.0 0.0 3.7 0.0 0.6 3.0 9.8 0.0 18.2 5.0 1.0 3.3 7.6 1.6 8.9 0.0 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.0 0.6 8.7 1.0 1.8 2.5 0.0 7.0 2.6 0.0 10.5 14.2 0.1 7.6 8.7 0.5 0.0 0.0 14.7 1.5 0.0 0.3 18.1 5.0 4.4 2.6 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 4.9 8.4 0.0 1.2 0.0 0.4 6.3 1.5 1.6 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 11.6 0.1 0.0 0.0 2.4 0.1 3.1 9.8 0.0 0.0 6.5 0.1 0.1 3.3 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 6.0 6.7 0.0 9.2 7.3 0.0 0.6 10.2 1.4 7.9 1.8 0.0 1.6 0.0 6.7 14.4 0.0 12.7 0.0 9.7 2.5 0.1 8.2 0.0 0.0 0.1 1.6 3.5 0.0 0.0 3.2 0.3 0.0 0.0 0.0 13.4 0.5 11.5 10.2 0.4 1.2 0.0 0.0 0.1 3.9 0.2 8.5 0.1 0.0 9.7 9.7 OXLD1 "C17orf90, MGC104712" ENSG00000204237 "Oxidoreductase like domain containing 1" Q5BKU9 17 81665036-81666635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 29.7" "Low region specificity" "Detected in all" "HPA056878, HPA057019" Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA056878: AB_2683265, HPA057019: AB_2683310" "unprognostic (1.08e-1)" "prognostic favorable (2.91e-4)" "unprognostic (1.37e-1)" "unprognostic (1.38e-1)" "unprognostic (9.03e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "unprognostic (1.92e-2)" "unprognostic (2.14e-1)" "unprognostic (7.60e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-1)" "unprognostic (3.06e-2)" "unprognostic (3.64e-1)" "unprognostic (8.71e-2)" "unprognostic (2.01e-1)" "unprognostic (2.30e-2)" 13.7 12.2 11.0 10.1 11.5 16.0 8.4 6.0 15.1 6.4 12.4 7.0 16.0 14.0 6.5 11.8 10.3 8.7 9.2 11.4 10.2 8.5 9.2 11.9 7.7 9.9 9.6 6.5 4.2 19.6 2.7 4.6 8.2 8.0 8.2 1.9 9.4 27.7 10.8 17.3 12.9 10.3 4.7 7.1 15.1 11.2 18.5 7.1 11.6 10.2 7.2 11.4 7.8 5.6 22.8 23.7 13.3 18.5 25.1 27.9 18.7 8.0 29.7 0.3 7.0 1.9 0.5 5.2 3.2 0.1 0.1 1.1 7.9 7.9 2.4 6.5 0.0 4.3 7.1 0.0 4.6 0.0 4.0 14.6 2.3 13.7 19.2 12.7 1.5 6.1 3.1 3.9 1.7 1.8 0.4 2.9 11.4 3.8 4.2 0.6 19.5 5.8 6.1 3.9 4.1 12.8 4.9 0.2 10.4 1.5 4.4 1.5 6.5 1.6 10.6 14.7 0.1 16.0 9.2 2.1 6.0 4.2 6.6 4.6 10.6 3.7 3.3 8.3 6.2 6.2 12.9 18.5 13.3 19.1 15.1 20.0 19.7 25.9 22.2 17.2 22.8 27.9 21.5 13.1 25.1 15.6 23.7 21.8 18.7 11.0 11.5 6.0 15.1 10.2 8.5 9.6 6.5 8.0 7.1 29.8 17.9 22.7 17.7 7.6 18.5 15.6 35.7 26.8 6.8 22.7 5.9 32.3 61.3 31.9 57.7 14.5 42.4 23.3 41.5 25.7 13.5 32.7 13.9 43.3 38.3 22.3 20.8 20.9 33.7 24.3 30.8 16.8 15.1 37.9 30.8 30.3 38.4 28.8 22.3 52.3 25.8 25.8 12.5 76.4 20.2 7.4 23.3 23.8 30.0 22.2 OXSM "CEM1, FASN2D, FLJ20604, KS" ENSG00000151093 "3-oxoacyl-ACP synthase, mitochondrial" Q9NWU1 3 25782917-25794534 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021293, HPA021300, HPA021337" Enhanced Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776" "unprognostic (2.20e-2)" "unprognostic (3.28e-1)" "prognostic favorable (1.35e-4)" "prognostic favorable (5.51e-4)" "unprognostic (1.01e-1)" "unprognostic (8.17e-2)" "unprognostic (2.15e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-1)" "unprognostic (2.83e-2)" "unprognostic (3.06e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.18e-9)" "unprognostic (1.79e-2)" "unprognostic (2.42e-1)" "unprognostic (3.10e-1)" "unprognostic (1.73e-2)" 6.2 13.7 6.7 9.8 10.5 3.7 10.3 8.3 11.9 6.0 11.8 6.2 13.7 10.1 6.4 16.2 10.3 7.7 7.9 13.5 6.6 6.4 14.9 26.1 10.0 7.7 6.6 6.5 6.4 18.7 8.3 13.0 7.3 7.0 8.0 13.8 10.4 15.5 15.6 19.4 8.3 8.9 5.8 6.7 9.6 8.9 19.9 8.0 8.1 11.7 12.3 11.3 7.9 6.4 8.4 9.0 3.7 6.5 10.3 11.8 6.6 7.7 12.9 2.7 7.6 8.0 8.8 8.0 6.2 9.0 11.7 8.3 9.8 9.3 14.3 8.4 5.7 6.8 8.2 11.4 11.9 11.0 8.6 11.5 15.8 10.9 11.8 9.8 12.7 10.1 8.2 14.8 9.3 9.8 7.6 10.0 13.6 16.2 11.6 9.9 11.5 9.3 9.8 0.5 6.2 14.9 12.4 7.2 23.4 17.1 4.8 3.9 7.2 9.9 17.0 12.6 4.6 18.6 11.9 6.1 7.3 8.8 9.6 8.9 11.1 12.8 4.5 10.3 11.2 7.5 2.1 5.4 3.7 9.4 6.0 10.8 8.4 9.7 11.6 8.6 8.2 11.4 11.8 0.9 10.3 6.5 9.0 6.0 6.6 6.7 10.5 8.3 11.9 6.6 6.4 6.6 6.5 7.0 8.0 0.0 10.3 2.9 5.0 2.7 6.2 9.8 7.6 5.3 4.5 10.4 3.9 17.5 10.0 11.3 38.3 4.9 6.3 0.0 5.9 13.9 6.5 5.4 9.3 13.9 7.7 4.8 2.4 6.7 2.7 11.5 6.6 3.7 5.0 6.4 9.8 8.3 7.4 7.6 3.9 16.1 6.5 0.0 3.1 26.1 12.0 3.9 11.8 5.0 9.6 2.4 OXSR1 "KIAA1101, OSR1" ENSG00000172939 "Oxidative stress responsive 1" O95747 3 38165089-38255488 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008237, CAB017181" Supported Enhanced Cytosol NA NA 21000000 Cytosol "CAB017181: , HPA008237: AB_1079540" "unprognostic (2.16e-1)" "unprognostic (2.36e-2)" "unprognostic (1.79e-2)" "unprognostic (4.55e-3)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (3.53e-3)" "unprognostic (4.05e-2)" "unprognostic (4.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.95e-3)" "unprognostic (1.88e-2)" "unprognostic (1.87e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.71e-1)" "unprognostic (6.99e-3)" 17.6 16.8 9.4 18.3 13.4 24.2 15.9 17.4 14.9 16.8 15.4 9.2 35.7 12.4 14.9 14.7 31.6 11.6 18.9 15.5 11.9 9.0 18.3 17.6 14.6 13.9 13.6 9.3 16.7 12.3 23.7 15.3 21.4 12.3 16.5 16.8 13.0 15.1 23.9 32.6 17.4 21.4 17.0 12.9 15.8 14.0 11.2 13.2 26.2 14.2 24.1 19.6 23.5 19.2 2.3 4.4 10.1 4.8 5.0 4.7 1.6 17.7 8.1 16.3 11.3 11.4 13.2 18.5 15.7 21.6 22.8 24.8 10.5 11.6 19.7 8.0 18.8 9.8 11.1 21.8 16.2 30.1 20.8 8.9 21.5 17.3 11.4 13.6 13.3 13.2 10.4 19.1 21.0 34.1 21.5 14.2 25.5 16.3 11.4 39.0 5.0 25.6 9.6 17.1 11.5 9.7 8.9 13.6 15.2 14.0 13.5 8.5 13.1 17.2 43.6 10.7 18.7 14.3 8.7 12.9 14.3 14.2 21.7 23.2 8.7 10.3 14.5 19.7 16.6 28.5 10.1 2.8 6.1 3.3 4.8 3.5 1.9 4.0 3.1 4.4 2.3 3.0 3.7 5.5 5.0 4.1 2.5 4.7 1.6 9.4 13.4 17.4 14.9 11.9 9.0 13.6 9.3 12.3 13.2 11.9 26.3 13.3 24.0 39.2 11.8 26.6 2.5 12.0 27.3 26.2 19.6 9.4 16.6 25.2 3.1 17.1 28.7 0.0 12.5 15.6 14.9 44.7 15.1 17.8 13.4 20.6 23.2 12.3 32.9 1.4 8.9 28.2 6.8 33.3 18.0 7.6 33.8 24.6 12.0 19.4 5.5 12.9 26.7 12.7 15.0 45.4 27.6 17.5 15.3 110.3 P2RX5 "LRH-1, P2X5" ENSG00000083454 "Purinergic receptor P2X 5" Q93086 17 3672199-3696404 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4" "Cell type enriched" "Detected in some" 7 "B-cells: 69.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 18 "memory B-cell: 28.1;naive B-cell: 30.4" "Lineage enriched" "Detected in many" 19 "B-cells: 30.4" "Cell line enhanced" "Detected in many" "Daudi: 24.5;Karpas-707: 15.9;RPMI-8226: 27.6;U-698: 22.8" "HPA021948, HPA067827" Supported Supported Cytosol NA NA Cytosol "HPA021948: AB_1854878, HPA067827: AB_2685908" "unprognostic (1.08e-3)" "unprognostic (9.16e-2)" "unprognostic (1.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.79e-1)" "unprognostic (1.06e-1)" "unprognostic (8.33e-2)" "unprognostic (4.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.14e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.99e-8)" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (3.50e-2)" "unprognostic (3.63e-2)" 0.6 0.3 2.2 32.0 4.9 4.8 0.5 4.1 5.1 0.3 1.4 0.0 0.4 0.9 0.2 0.2 2.4 0.2 0.8 4.9 1.8 3.0 0.8 0.4 1.0 39.1 1.5 2.1 0.2 0.8 0.1 1.2 0.2 1.7 0.5 1.2 0.0 5.4 0.1 11.4 0.2 12.0 0.4 0.6 29.6 1.8 0.6 0.2 9.3 0.5 1.9 27.6 2.2 0.3 30.4 0.1 0.7 0.0 0.0 1.6 1.6 3.9 3.2 0.0 0.0 0.1 0.6 0.0 4.1 1.9 0.4 1.3 2.4 4.8 24.5 2.5 1.9 1.3 2.1 8.8 0.0 0.8 0.4 1.5 1.2 8.7 2.9 0.6 1.6 2.1 1.0 0.9 0.1 5.7 3.2 0.0 5.8 0.2 15.9 8.9 0.0 11.0 3.7 2.4 1.9 9.9 0.5 0.0 27.6 0.1 3.0 2.0 0.0 3.4 1.1 1.8 0.0 1.0 1.5 0.0 0.0 2.3 0.1 0.7 5.6 11.9 22.8 0.0 2.4 0.2 0.0 0.0 0.7 1.1 0.0 1.6 28.1 1.0 0.8 0.1 30.4 0.1 0.1 0.0 0.0 0.0 0.0 0.5 1.6 2.2 4.9 4.1 5.1 1.8 3.0 1.5 2.1 1.7 0.2 0.0 1.1 69.3 0.1 0.3 0.4 2.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.6 0.4 0.2 0.0 0.0 0.6 1.2 2.2 1.4 0.6 3.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.7 0.0 0.0 9.6 0.0 0.0 P2RX6 "MGC129625, P2RXL1, P2X6, P2XM" ENSG00000099957 "Purinergic receptor P2X 6" O15547 22 21009808-21028830 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 12.4" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 7.4;Ciliated cells: 4.0;Intestinal endocrine cells: 3.4" "Cancer enhanced" "Detected in some" "melanoma: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 11.4;LHCN-M2: 7.7;RH-30: 4.8;U-87 MG: 13.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028776, HPA028777" Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028776: AB_2672771, HPA028777: AB_2672772" "unprognostic (1.81e-2)" "unprognostic (5.15e-3)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.28e-2)" "unprognostic (1.79e-5)" "unprognostic (1.70e-2)" "unprognostic (6.20e-2)" "unprognostic (1.49e-1)" "unprognostic (2.59e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-2)" "unprognostic (2.88e-10)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (7.33e-2)" "unprognostic (2.39e-3)" 0.2 1.6 0.0 0.2 0.2 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 1.1 1.9 0.2 0.8 0.1 0.0 0.2 0.0 0.6 0.3 0.0 0.0 1.6 1.1 0.2 0.0 0.1 1.1 12.4 0.0 0.0 0.0 0.8 2.3 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.8 0.3 0.1 0.0 1.0 0.1 1.9 0.8 1.4 0.0 0.0 0.0 1.3 0.5 3.4 1.6 0.0 0.1 0.1 0.3 0.0 2.1 0.8 0.0 3.3 0.0 2.8 0.4 0.0 1.4 0.1 11.4 0.0 0.0 2.3 0.7 7.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.8 0.2 0.0 0.0 0.2 3.6 1.4 0.1 0.6 0.2 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.2 0.0 0.0 13.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.1 7.4 2.4 0.0 4.0 0.0 1.8 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 2.3 0.0 0.1 1.6 3.4 2.5 0.0 1.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.4 0.0 0.6 0.0 0.0 1.4 0.4 0.1 0.3 0.0 0.0 0.0 P2RY2 P2U ENSG00000175591 "Purinergic receptor P2Y2" P41231 11 73218298-73236352 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.1;skeletal muscle: 29.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 14.0;Enterocytes: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 28.1" "Group enriched" "Detected in many" 12 "granulocytes: 28.1;monocytes: 10.4" "Cell line enhanced" "Detected in many" "HaCaT: 16.4;HL-60: 15.5;MCF7: 12.4;NB-4: 12.6;PC-3: 12.9;SK-BR-3: 14.3;THP-1: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB022642 Uncertain Uncertain Cytosol NA NA Cytosol "CAB022642: " "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (6.50e-4)" "unprognostic (2.04e-2)" "unprognostic (4.66e-3)" "unprognostic (8.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (9.69e-2)" "unprognostic (4.92e-4)" "unprognostic (1.34e-1)" "unprognostic (2.82e-1)" "unprognostic (1.05e-1)" "unprognostic (8.57e-3)" 0.4 2.3 0.9 1.4 1.2 10.8 1.3 0.3 1.1 5.5 3.1 1.1 0.3 2.2 1.3 2.3 20.0 1.2 2.8 11.7 0.6 0.3 0.9 2.6 2.9 1.5 1.2 0.6 1.7 1.7 6.1 1.1 10.3 1.0 1.7 2.4 3.3 4.0 1.6 29.5 3.4 10.8 0.4 0.4 6.6 0.6 0.7 0.6 0.6 20.2 20.6 12.8 2.1 10.9 0.0 1.6 28.1 10.4 0.0 0.0 1.2 3.6 3.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 8.4 2.8 0.0 5.6 0.2 0.0 16.4 0.4 7.7 0.0 0.0 0.3 1.2 0.2 1.5 0.0 15.5 0.0 0.0 3.6 1.2 0.2 0.0 0.7 0.0 0.7 0.0 0.0 12.4 0.0 12.6 0.2 3.3 12.9 0.0 0.0 0.5 1.2 8.8 0.0 0.0 0.2 14.3 0.0 0.1 6.6 36.3 5.3 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 2.8 0.0 0.2 3.4 28.1 0.0 10.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 1.2 0.9 1.2 0.3 1.1 0.6 0.3 1.2 0.6 1.0 0.6 3.0 0.3 0.0 6.8 3.3 0.5 5.3 7.6 0.0 4.5 0.0 0.0 14.0 1.7 5.0 5.3 0.5 12.9 0.0 5.6 0.5 0.4 1.1 0.0 4.5 2.3 0.0 0.0 0.0 2.7 6.7 0.0 0.9 0.0 0.0 2.9 5.2 11.6 10.5 0.0 0.3 0.2 0.0 0.2 0.0 0.0 6.4 9.2 0.0 2.3 11.1 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 74.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Alveolar cells type 2: 62.9;Collecting duct cells: 41.8;Ito cells: 44.8;Muller glia cells: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 20.3" "Lineage enriched" "Detected in single" 104 "dendritic cells: 20.3" "Cell line enhanced" "Detected in many" "GAMG: 38.1;HaCaT: 34.0;RPTEC TERT1: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles, Cytosol" "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 2.4 22.6 2.9 4.0 3.9 0.2 3.1 0.7 2.2 14.3 11.8 6.2 11.5 1.2 15.0 13.5 8.9 4.6 8.4 3.8 2.8 2.1 74.5 3.5 22.5 3.6 8.1 1.0 11.2 3.9 1.4 6.1 11.0 5.6 19.9 5.3 10.3 2.7 14.3 0.6 8.6 3.6 16.3 7.6 33.7 12.0 2.8 5.3 2.0 1.7 6.3 2.7 5.7 9.8 0.0 20.3 0.1 0.1 0.0 0.0 0.1 14.0 5.6 11.0 0.0 0.2 0.4 13.3 15.0 5.9 2.4 4.0 4.5 5.5 0.0 8.5 2.6 38.1 34.0 0.0 20.1 5.1 0.1 1.9 0.0 3.8 0.0 11.4 0.0 0.1 5.4 6.8 4.8 1.7 23.3 0.4 0.0 0.0 0.1 3.8 0.3 0.0 0.1 3.4 9.4 1.1 0.0 2.2 0.8 34.7 23.7 0.8 0.1 20.4 1.1 8.9 16.9 0.0 0.2 7.5 14.6 5.5 0.1 2.7 1.0 0.0 0.1 3.3 0.0 18.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.1 2.9 3.9 0.7 2.2 2.8 2.1 8.1 1.0 5.6 5.3 44.7 62.9 1.9 7.4 0.0 2.2 1.0 5.1 0.0 5.7 41.8 3.9 30.9 5.0 3.8 14.3 4.5 0.0 0.0 0.7 11.7 2.0 13.7 1.1 0.6 9.1 9.5 0.0 44.8 4.6 11.4 4.4 4.7 0.0 1.0 0.2 49.8 18.0 0.0 0.0 24.5 0.8 0.0 2.7 0.5 0.4 0.0 32.3 0.0 0.0 2.8 P3H3 "GRCB, HSU47926, LEPREL2" ENSG00000110811 "Prolyl 3-hydroxylase 3" Q8IVL6 12 6828410-6839851 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Bipolar cells: 28.3;Cone photoreceptor cells: 94.2;Horizontal cells: 41.3;Leydig cells: 46.1;Peritubular cells: 36.0;Rod photoreceptor cells: 26.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 21 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "BJ: 22.1;hTERT-RPE1: 15.7;NTERA-2: 15.7;U-251 MG: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 17.6" HPA043695 Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA043695: AB_10797146" "unprognostic (2.54e-1)" "unprognostic (6.66e-2)" "unprognostic (1.14e-1)" "unprognostic (3.34e-2)" "unprognostic (5.76e-2)" "unprognostic (6.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.92e-1)" "unprognostic (6.90e-2)" "unprognostic (1.44e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.64e-4)" "unprognostic (2.58e-2)" "unprognostic (9.67e-2)" "unprognostic (2.27e-1)" "unprognostic (7.77e-3)" 3.7 3.1 1.2 2.2 2.6 0.3 3.0 10.7 2.5 12.1 2.7 0.0 7.6 1.1 11.0 8.5 2.5 2.1 5.6 4.4 1.2 1.1 0.4 1.6 1.9 0.0 2.2 9.3 3.6 12.1 7.4 2.5 0.8 5.6 0.5 8.1 5.9 6.5 0.5 1.8 1.7 8.8 0.5 1.0 2.8 2.1 0.1 0.0 3.5 1.2 1.4 5.9 4.7 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.8 4.2 7.9 4.9 6.0 0.1 22.1 12.7 7.0 7.7 0.3 0.0 0.0 0.3 8.3 0.2 0.0 2.5 0.2 1.6 0.0 10.6 0.5 2.3 1.0 3.4 0.5 0.0 6.5 0.2 3.4 1.9 15.7 7.4 0.7 2.0 0.0 3.3 0.0 0.0 0.2 15.7 0.0 0.6 0.0 3.9 0.1 0.3 0.0 1.6 6.0 0.0 0.0 2.4 2.1 0.1 0.1 12.9 6.9 10.3 10.6 15.3 0.0 0.1 0.2 5.9 0.0 2.7 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.9 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 28.3 9.0 2.5 2.7 3.4 5.2 94.2 0.3 1.7 1.6 0.7 2.3 0.0 0.0 2.3 0.4 7.4 4.6 0.0 0.0 1.2 41.3 1.2 3.7 0.0 1.3 46.1 0.0 0.0 1.8 2.5 4.8 1.9 0.0 36.0 0.3 26.9 6.5 9.2 0.7 0.9 0.0 0.8 0.0 0.4 1.4 P4HTM "EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4" ENSG00000178467 "Prolyl 4-hydroxylase, transmembrane" Q9NXG6 3 48989886-49007154 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007199 Supported Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA007199: AB_1855272" "unprognostic (1.95e-2)" "unprognostic (3.12e-2)" "unprognostic (9.47e-2)" "prognostic favorable (8.18e-4)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-2)" "prognostic favorable (3.28e-5)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (2.60e-2)" "unprognostic (9.65e-3)" 7.4 25.5 22.1 6.4 28.5 4.7 8.9 17.6 32.9 13.5 10.8 15.9 13.8 10.4 9.7 18.9 5.4 34.7 13.0 18.6 23.0 26.5 14.1 5.4 10.6 5.6 18.7 20.3 11.4 29.9 20.8 35.7 9.6 15.7 15.5 6.7 14.1 16.0 16.5 10.0 4.3 7.8 7.0 14.3 6.3 15.7 11.7 16.4 3.4 21.5 3.3 6.7 7.5 6.1 9.8 7.8 6.7 7.6 4.9 14.4 4.8 3.7 10.3 1.9 0.0 5.8 6.9 0.1 6.7 8.9 5.1 5.5 2.3 20.2 3.2 7.1 8.2 4.1 2.0 4.4 2.2 1.5 12.1 7.6 0.0 15.3 0.0 15.3 3.1 0.1 4.0 2.2 5.1 0.4 19.2 5.7 0.0 0.0 14.0 2.4 16.1 0.4 0.4 2.8 18.8 12.1 0.0 0.0 18.8 9.0 5.8 8.0 0.1 7.6 8.1 0.0 0.5 7.1 5.2 4.0 3.0 2.6 7.6 5.3 19.9 11.0 0.0 22.5 0.3 3.1 6.7 7.6 4.8 6.4 2.7 8.7 7.0 11.6 10.3 7.8 9.8 12.0 8.3 0.8 4.9 3.6 1.4 14.4 4.8 22.1 28.5 17.6 32.9 23.0 26.5 18.7 20.3 15.7 16.4 20.8 12.9 13.4 30.2 8.1 71.6 10.6 22.9 76.3 21.6 43.6 82.5 24.6 16.6 32.6 102.4 11.9 34.1 0.0 34.1 8.5 27.3 29.0 23.0 7.6 14.9 111.2 77.7 12.3 8.1 112.9 28.1 11.2 11.8 12.6 33.5 60.4 23.6 40.3 24.4 25.5 55.3 19.4 27.4 37.5 7.9 9.2 21.9 22.4 42.1 30.2 PA2G4 ENSG00000170515 "Proliferation-associated 2G4" Q9UQ80 12 56104319-56113907 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation, Translation regulation" "Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB011711, CAB012428, HPA016484" Supported Approved Cytosol NA NA 1200000 Cytosol "CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912" "unprognostic (5.53e-2)" "unprognostic (1.06e-1)" "unprognostic (2.35e-2)" "unprognostic (2.34e-2)" "unprognostic (3.87e-1)" "unprognostic (6.03e-3)" "prognostic unfavorable (6.31e-7)" "unprognostic (4.25e-3)" "unprognostic (2.77e-1)" "unprognostic (3.79e-3)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (4.59e-7)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (1.32e-1)" "unprognostic (4.67e-2)" 41.1 32.1 26.6 41.4 29.8 52.5 38.5 35.1 38.8 33.7 39.2 31.0 27.1 34.4 36.1 22.4 69.4 31.2 31.9 55.6 26.6 25.5 36.1 51.6 32.6 43.3 26.7 28.0 43.3 44.3 42.8 20.5 39.0 28.2 40.3 44.2 23.6 34.6 33.4 77.3 53.0 31.7 39.4 32.3 46.7 34.4 27.9 23.9 70.8 39.7 57.2 54.0 45.5 39.6 25.5 27.1 13.5 25.1 37.4 48.9 36.0 53.5 47.6 32.7 36.0 15.1 23.0 65.7 56.8 27.2 69.9 39.0 58.2 39.9 107.3 38.2 26.8 20.6 44.2 74.5 63.3 68.3 30.4 63.9 82.4 32.5 49.6 29.6 111.8 30.5 23.2 32.4 60.5 54.7 28.9 42.4 36.7 100.0 49.9 38.2 47.5 86.9 58.4 53.6 33.4 58.5 71.6 59.1 72.7 35.3 40.2 49.1 29.7 37.4 59.1 34.7 25.3 63.8 43.5 33.9 34.1 48.2 39.2 62.6 30.7 42.0 105.1 30.9 67.3 44.2 7.8 23.0 13.5 36.6 25.1 48.9 25.5 38.9 39.4 27.1 22.2 37.6 37.3 3.7 37.4 20.0 26.3 43.3 36.0 26.6 29.8 35.1 38.8 26.6 25.5 26.7 28.0 28.2 23.9 50.6 76.2 104.2 176.7 327.3 53.9 31.3 112.1 121.8 170.6 123.9 17.7 192.6 164.2 166.6 352.5 140.6 87.8 373.8 214.0 240.3 114.2 91.6 164.3 167.1 182.5 31.8 89.5 96.3 99.0 161.4 122.3 128.8 123.2 116.4 123.0 92.6 216.5 94.7 119.2 155.9 42.6 142.3 166.0 162.3 110.4 317.1 161.8 164.1 218.3 201.6 PAAF1 "FLJ11848, Rpn14, WDR71" ENSG00000175575 "Proteasomal ATPase associated factor 1" Q9BRP4 11 73876699-73931124 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cone photoreceptor cells: 106.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039952, HPA040020" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039952: AB_10793925, HPA040020: AB_2676802" "unprognostic (3.13e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.13e-2)" "unprognostic (4.51e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (1.74e-1)" "unprognostic (4.48e-1)" "unprognostic (2.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (2.73e-1)" "unprognostic (4.42e-1)" 9.5 12.8 32.4 6.9 30.6 5.2 12.3 18.0 23.2 11.7 8.7 34.4 7.6 7.8 11.5 17.2 10.0 13.9 8.0 9.9 30.5 27.4 16.0 13.8 7.9 7.6 37.4 19.6 17.8 19.8 16.8 10.1 7.7 25.4 14.5 11.5 12.9 9.9 14.5 11.9 12.8 7.8 12.1 38.9 7.1 6.8 18.8 27.0 8.2 13.0 2.1 11.1 7.9 6.3 22.6 19.3 22.1 15.1 16.5 22.6 15.1 5.6 13.1 11.9 9.3 13.0 13.4 6.8 9.7 11.3 15.6 11.1 25.6 4.5 17.1 15.2 9.9 14.5 13.0 14.5 11.7 23.2 12.7 9.0 17.4 12.9 21.0 15.6 16.2 6.7 13.7 18.4 17.0 20.9 12.6 11.7 13.8 21.0 14.7 14.4 11.0 14.3 16.9 5.5 30.0 10.3 13.3 31.9 27.9 11.5 9.8 12.7 14.9 11.5 7.7 30.0 11.7 23.1 9.2 8.4 11.0 7.0 15.5 9.4 18.2 20.4 34.8 7.7 10.6 11.5 22.1 15.1 17.4 16.0 9.5 17.5 22.6 17.5 16.2 19.3 18.8 22.6 19.4 1.3 16.5 3.4 14.0 19.6 15.1 32.4 30.6 18.0 22.3 30.5 27.4 37.4 19.6 25.4 27.0 3.0 12.2 13.7 9.7 4.1 48.0 18.3 12.7 10.7 9.1 15.7 106.0 29.8 11.6 14.3 27.2 7.1 7.7 23.3 12.1 3.2 10.4 7.7 18.5 11.9 16.3 44.5 3.5 11.1 7.3 17.7 15.5 10.4 13.5 16.2 8.0 35.5 8.4 7.0 17.0 42.1 46.1 6.5 13.7 49.6 25.8 7.0 15.3 11.5 10.3 6.5 PABPC1 "PAB1, PABP1, PABPC2, PABPL1" ENSG00000070756 "Poly(A) binding protein cytoplasmic 1" P11940 8 100685816-100722809 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011536, HPA045423, HPA067156" Supported Supported Cytosol NA NA 2700000 Cytosol "CAB011536: AB_777008, HPA045423: AB_2679320, HPA067156: AB_2685793" "unprognostic (5.00e-2)" "unprognostic (2.64e-2)" "unprognostic (3.18e-1)" "unprognostic (4.50e-1)" "prognostic favorable (2.51e-4)" "unprognostic (1.93e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (2.51e-3)" "unprognostic (5.70e-2)" "unprognostic (1.50e-2)" "unprognostic (3.21e-3)" "unprognostic (7.24e-2)" "prognostic unfavorable (5.70e-12)" "unprognostic (6.22e-2)" "unprognostic (2.55e-1)" "unprognostic (6.98e-3)" "unprognostic (1.40e-2)" 85.6 49.6 33.6 66.1 38.8 94.2 80.5 35.8 32.5 84.2 80.7 41.9 57.2 64.1 85.3 48.8 195.5 54.6 56.4 35.1 32.3 19.3 43.6 83.2 72.8 156.2 40.6 24.3 111.1 106.9 31.8 34.1 50.6 36.8 88.2 71.5 43.4 192.9 79.0 35.1 95.4 104.0 89.9 65.2 135.3 73.4 98.7 37.6 137.2 65.4 63.0 157.9 120.9 116.4 70.8 98.4 32.3 106.7 65.9 106.0 90.6 181.7 45.4 35.6 64.6 66.7 132.7 61.5 44.5 64.5 47.9 52.2 54.4 85.6 230.7 173.5 78.2 25.9 70.6 55.8 87.0 82.0 70.4 36.8 118.9 34.3 69.9 82.7 50.9 84.2 123.2 137.8 44.6 219.4 111.2 74.8 88.1 99.9 88.8 71.0 53.0 253.4 106.1 79.8 152.0 64.6 83.7 43.3 83.3 57.9 118.3 49.7 55.3 29.7 46.4 103.8 70.3 83.5 84.5 69.7 43.2 80.6 63.3 74.8 87.1 60.3 129.2 50.8 114.5 43.4 27.6 83.3 28.8 39.7 99.9 84.2 70.8 78.3 64.4 98.4 62.6 106.0 85.1 32.3 65.9 106.7 65.5 67.4 90.6 33.6 38.8 35.8 32.5 32.3 19.3 40.6 24.3 36.8 37.6 345.4 847.8 973.7 893.3 699.5 56.6 119.8 412.7 665.1 1209.1 104.7 47.1 409.0 223.8 411.2 1289.9 466.5 396.9 443.9 663.3 702.0 352.5 474.8 995.7 223.1 549.7 68.3 458.2 554.9 1326.0 159.3 462.0 1050.9 350.9 954.0 755.7 118.9 569.7 462.9 398.9 263.5 88.4 491.5 506.8 1312.8 244.0 669.1 650.6 839.7 923.8 1043.9 PABPC1L "C20orf119, dJ1069P2.3, ePAB, PABPC1L1" ENSG00000101104 "Poly(A) binding protein cytoplasmic 1 like" Q4VXU2 20 44910062-44959035 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 17.4;Club cells: 25.0;Collecting duct cells: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Group enriched" "Detected in many" 5 "B-cells: 3.3;granulocytes: 3.9;T-cells: 1.9" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA066650 Approved "Nuclear bodies,Cytosol" NA Yes Cytosol "Nuclear bodies" "HPA066650: AB_2685698" "unprognostic (4.98e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (1.73e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (1.77e-3)" "unprognostic (4.92e-3)" "unprognostic (3.69e-2)" "unprognostic (2.44e-1)" "unprognostic (2.28e-3)" "unprognostic (7.96e-2)" "prognostic unfavorable (4.00e-15)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (8.63e-2)" "prognostic favorable (8.84e-4)" 4.7 8.1 9.8 29.3 20.4 14.0 16.0 3.4 6.0 8.4 5.7 6.2 20.4 6.9 8.3 26.1 7.6 9.1 13.0 3.7 8.6 4.2 21.7 29.2 14.6 16.3 5.6 9.3 16.9 29.3 7.7 23.7 5.1 7.1 15.2 6.4 7.6 10.2 14.7 0.9 10.3 10.0 6.2 10.9 12.5 10.0 9.2 6.5 20.3 28.1 6.3 12.9 9.0 12.1 3.3 0.4 3.9 0.5 0.3 1.9 0.1 6.6 8.7 11.7 16.9 4.4 9.4 26.8 14.7 3.0 5.7 7.6 23.7 12.2 8.7 24.8 5.8 9.2 15.5 5.2 13.5 4.7 5.2 10.6 7.0 23.8 21.9 10.1 6.0 2.9 9.9 23.8 12.1 21.5 6.5 1.4 13.5 7.8 12.6 6.8 19.0 7.4 14.3 4.6 6.9 15.3 9.6 2.5 4.6 8.0 8.3 7.3 7.3 5.8 18.3 19.9 15.4 35.8 4.8 4.7 25.5 17.2 11.1 7.0 16.6 16.5 4.4 8.2 2.5 8.4 0.1 0.5 0.1 0.9 0.1 1.9 1.4 0.2 0.7 0.2 3.3 0.3 0.5 3.9 0.3 0.2 0.4 0.5 0.1 9.8 20.4 3.4 6.0 8.6 4.2 5.6 9.3 7.1 6.5 6.0 17.4 0.5 2.5 1.6 0.3 1.4 7.6 12.0 25.0 19.2 0.0 4.5 0.0 2.9 0.4 0.7 1.6 0.0 0.4 3.8 2.3 3.2 3.5 5.0 2.5 0.0 4.1 0.6 0.6 0.0 1.7 2.2 0.0 1.8 2.3 2.4 2.2 3.1 1.8 0.8 1.1 0.0 0.9 0.7 2.1 1.5 3.2 4.4 3.1 2.4 PABPC3 "PABP3, PABPL3, tPABP" ENSG00000151846 "Poly(A) binding protein cytoplasmic 3" Q9H361 13 25095868-25099254 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 50.9" "Group enriched" "Detected in many" 9 "Early spermatids: 131.2;Late spermatids: 106.4;Spermatocytes: 81.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 14 "U-266/84: 11.7" "HPA045423, HPA067156" Approved Approved Cytosol NA NA Cytosol "HPA045423: AB_2679320, HPA067156: AB_2685793" "unprognostic (2.17e-2)" "unprognostic (6.50e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.78e-1)" "unprognostic (2.98e-1)" "unprognostic (8.76e-3)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (8.00e-4)" "unprognostic (5.26e-4)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" "unprognostic (5.18e-2)" "unprognostic (5.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.61e-3)" 0.5 0.2 0.2 0.5 0.8 0.2 1.0 0.1 1.1 0.7 0.5 0.1 0.0 0.2 0.2 0.3 0.7 0.2 0.2 0.2 0.3 0.1 0.2 0.2 1.2 2.0 0.2 0.4 0.4 0.3 0.1 0.4 0.2 0.3 0.4 0.2 0.0 0.6 0.9 0.2 0.4 0.5 0.2 0.1 0.4 0.2 50.9 0.0 0.8 0.3 0.0 0.2 0.3 0.4 1.6 1.9 0.5 2.2 1.8 2.5 1.9 0.4 0.0 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.8 0.7 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.8 0.2 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.4 0.2 0.4 11.7 0.2 0.1 0.3 0.1 0.4 1.4 0.5 0.7 2.1 1.6 1.6 1.7 1.3 1.9 1.3 2.5 2.2 0.5 1.8 2.2 1.1 1.5 1.9 0.2 0.8 0.1 1.1 0.3 0.1 0.2 0.4 0.3 0.0 0.0 0.0 0.5 4.6 10.4 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 131.2 3.6 0.6 0.0 0.3 1.4 3.5 3.4 4.6 0.6 1.4 1.6 4.1 3.1 5.6 106.4 2.8 3.9 5.0 0.0 1.3 1.0 0.1 3.5 4.6 0.8 0.0 6.5 4.1 81.1 4.6 11.3 2.4 2.2 3.3 3.1 PABPC4 "APP-1, iPABP" ENSG00000090621 "Poly(A) binding protein cytoplasmic 4" Q13310 1 39560816-39576790 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 137.3;skeletal muscle: 117.8" "Cell type enhanced" "Detected in all" 6 "Kupffer cells: 414.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027301, HPA056496" Supported Enhanced Cytosol NA NA Cytosol "HPA027301: AB_2672208, HPA056496: AB_2683153" "unprognostic (6.81e-2)" "unprognostic (7.01e-3)" "unprognostic (2.93e-2)" "unprognostic (5.45e-2)" "unprognostic (3.63e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (1.14e-7)" "unprognostic (2.22e-1)" "unprognostic (2.62e-1)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (3.00e-10)" "unprognostic (1.87e-1)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.08e-1)" 30.0 19.2 9.0 23.0 7.9 20.8 19.6 7.2 9.6 19.1 26.0 14.0 22.0 12.4 22.2 21.1 20.3 13.7 20.2 32.0 8.6 7.2 12.3 28.8 24.9 38.2 8.3 7.3 28.6 137.3 9.1 8.2 16.2 8.6 20.7 11.5 15.4 16.4 22.9 117.8 12.9 21.1 22.4 16.4 27.5 28.0 29.2 6.4 21.5 18.1 51.1 21.0 25.3 20.3 13.9 13.7 6.7 21.2 8.2 21.4 5.5 57.5 15.7 16.7 27.7 41.8 83.0 54.9 34.1 23.9 26.5 19.7 31.4 30.2 49.8 33.9 42.8 12.6 30.8 31.8 38.1 34.3 25.4 26.2 41.9 17.9 31.2 41.9 27.7 28.2 71.9 45.1 32.2 49.1 37.4 33.2 39.6 44.4 27.6 42.5 22.5 28.7 35.8 51.6 19.4 18.0 22.1 53.5 37.7 25.5 56.9 15.8 24.0 23.8 22.7 51.5 31.7 24.2 82.2 29.9 25.8 35.8 62.4 43.0 71.2 78.1 38.7 38.3 28.1 14.7 6.7 13.9 3.5 9.9 18.0 10.6 13.8 16.1 10.3 13.7 13.9 21.4 15.1 1.4 8.2 21.2 13.5 11.2 5.5 9.0 7.9 7.2 9.6 8.6 7.2 8.3 7.3 8.6 6.4 17.9 49.3 108.2 65.3 49.6 24.0 117.4 112.1 8.1 54.6 45.4 76.6 73.5 34.9 38.4 37.3 38.0 79.4 70.0 78.6 128.3 61.8 38.6 51.9 117.5 95.8 31.8 56.9 82.3 414.4 19.0 63.9 76.1 54.0 32.5 56.2 26.4 58.7 46.3 43.5 34.2 89.3 6.5 60.6 30.6 120.1 36.5 89.6 43.3 61.7 91.4 PACS1 "FLJ10209, KIAA1175" ENSG00000175115 "Phosphofurin acidic cluster sorting protein 1" Q6VY07 11 66070363-66244747 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038914 Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA038914: AB_10672831" "unprognostic (7.03e-2)" "unprognostic (3.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.40e-1)" "unprognostic (3.49e-2)" "unprognostic (1.46e-1)" "unprognostic (3.80e-3)" "unprognostic (1.40e-2)" "unprognostic (3.55e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (5.31e-2)" "unprognostic (5.23e-2)" "unprognostic (3.46e-1)" 20.0 14.6 18.0 33.7 23.1 17.7 25.5 33.6 25.5 17.7 16.6 12.5 12.8 10.5 17.4 16.9 19.6 18.1 19.8 33.1 17.3 15.0 17.7 7.4 20.7 42.3 12.8 19.0 26.2 16.7 19.9 16.9 14.6 12.8 21.3 8.5 19.0 66.8 18.8 15.2 16.2 15.1 23.5 11.7 24.0 16.0 28.4 13.6 33.9 21.6 15.6 33.7 21.9 17.7 7.2 1.9 11.2 3.7 2.9 5.8 3.6 16.6 17.6 8.2 5.5 15.8 18.8 9.6 22.6 16.7 16.7 10.4 10.8 13.8 10.5 15.2 39.8 15.5 10.9 6.2 17.1 21.3 16.7 6.9 16.9 15.4 15.5 19.2 2.4 14.0 19.2 8.0 15.1 19.1 31.5 15.6 7.2 6.4 20.7 18.0 31.5 18.0 6.5 3.9 4.6 8.4 12.1 8.4 18.5 11.7 16.8 11.8 13.4 23.6 14.0 11.7 14.0 15.7 3.2 20.6 21.4 9.4 28.6 9.8 10.5 6.7 2.8 18.2 4.0 10.5 5.2 2.0 3.9 5.2 1.5 3.5 4.6 4.9 4.5 1.9 7.2 5.6 5.0 11.2 2.9 3.7 1.2 5.8 3.6 18.0 23.1 33.6 25.5 17.3 15.0 12.8 19.0 12.8 13.6 3.0 4.0 29.6 15.2 9.0 31.1 14.6 10.2 8.1 10.3 12.2 47.1 6.5 5.0 18.0 12.8 13.0 1.3 0.0 54.4 8.1 12.3 21.2 23.1 3.4 11.5 87.4 5.8 23.4 12.3 21.6 17.3 11.0 10.1 36.1 2.7 12.8 46.9 0.0 17.0 12.9 40.9 12.9 9.2 21.3 21.3 8.7 4.8 27.1 2.9 15.9 PACSIN2 SDPII ENSG00000100266 "Protein kinase C and casein kinase substrate in neurons 2" Q9UNF0 22 42835412-43015145 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 37.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049854, HPA056520" Enhanced Supported "Nuclear speckles,Vesicles,Plasma membrane,Cytosol" NA NA 83000 "Nuclear speckles, Vesicles, Cytosol" "Plasma membrane" "HPA049854: AB_2680915, HPA056520: AB_2683163" "unprognostic (5.62e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-3)" "unprognostic (1.63e-2)" "unprognostic (3.96e-1)" "prognostic unfavorable (7.33e-4)" "unprognostic (4.48e-2)" "unprognostic (3.40e-2)" "unprognostic (2.82e-3)" "unprognostic (3.09e-2)" "unprognostic (1.00e-1)" "prognostic favorable (1.09e-13)" "unprognostic (2.87e-1)" "unprognostic (1.11e-1)" "unprognostic (6.20e-2)" "unprognostic (2.95e-1)" 20.1 42.0 19.4 19.4 20.7 14.3 22.9 32.3 21.3 18.7 28.4 17.5 21.1 22.5 20.8 18.9 19.3 17.5 33.3 28.0 17.9 19.5 32.5 20.7 25.8 16.9 20.6 15.7 17.4 77.3 14.3 21.5 33.8 32.4 24.6 23.5 26.6 31.7 16.6 23.9 19.4 25.6 25.1 17.8 22.5 27.8 12.6 19.2 13.1 31.0 15.8 18.4 17.7 17.6 4.7 8.3 37.9 12.6 6.7 4.5 5.0 24.7 26.0 21.9 14.0 11.3 12.1 18.0 22.6 13.7 20.5 17.1 27.0 14.6 11.5 19.2 16.7 14.0 17.6 14.3 24.0 13.5 11.7 14.2 18.6 13.3 38.4 16.1 13.1 40.4 11.6 23.8 26.9 11.8 16.7 16.8 10.7 16.0 8.4 17.6 16.2 13.8 20.6 12.1 36.2 11.0 17.0 32.9 7.7 23.5 14.7 14.3 6.4 27.0 18.7 50.7 14.8 13.5 17.4 24.7 15.3 19.5 16.9 13.3 6.3 8.6 12.6 14.6 11.6 33.2 7.9 7.0 17.4 2.8 12.6 3.0 4.2 3.2 2.4 8.3 4.7 3.2 2.4 37.9 6.7 12.1 3.1 4.5 5.0 19.4 20.7 32.3 21.3 17.9 19.5 20.6 15.7 32.4 19.2 65.5 52.9 11.5 38.7 20.6 14.4 20.9 28.1 28.1 35.2 43.6 37.3 28.5 38.1 63.1 2.7 25.4 95.4 0.0 56.4 21.0 22.1 70.2 69.3 19.8 37.7 6.4 23.7 14.1 37.5 4.3 20.1 36.1 79.2 65.9 46.1 7.8 79.7 43.8 21.9 34.2 23.4 90.5 44.3 22.0 26.4 14.8 40.3 17.5 33.5 27.3 PACSIN3 SDPIII ENSG00000165912 "Protein kinase C and casein kinase substrate in neurons 3" Q9UKS6 11 47177525-47186443 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 102.9;Muller glia cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039480, HPA043904" Approved Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039480: AB_2676531, HPA043904: AB_2678725" "unprognostic (1.75e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (6.89e-2)" "unprognostic (4.66e-2)" "unprognostic (8.17e-2)" "unprognostic (2.85e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.86e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-2)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" 4.1 17.0 3.9 2.2 5.7 0.4 4.3 3.5 4.7 6.5 8.5 8.6 7.1 1.6 6.7 7.6 12.6 4.8 5.8 40.6 4.0 2.4 2.9 10.0 3.9 0.8 7.6 3.6 6.3 14.6 4.8 1.0 8.0 4.4 8.6 1.1 4.6 11.3 6.7 121.6 11.9 1.9 7.4 8.3 1.5 6.0 1.6 6.5 0.3 8.5 44.6 7.1 6.4 5.7 0.0 0.1 0.0 0.9 0.0 0.2 0.9 16.7 8.4 3.9 16.9 3.4 3.4 19.0 5.3 7.6 11.1 6.2 12.5 2.4 0.1 1.6 2.9 7.3 27.7 7.7 12.7 4.4 2.6 13.2 2.6 32.0 28.9 6.7 0.5 2.6 9.5 17.2 5.8 9.3 8.9 4.9 4.5 5.6 0.2 4.5 33.3 0.3 12.4 4.8 13.6 16.9 10.3 14.7 2.7 4.6 16.0 0.1 13.3 8.3 5.9 7.7 8.6 41.9 2.2 2.3 19.3 19.4 2.4 14.4 2.9 1.3 1.5 6.3 5.9 9.9 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.9 5.7 3.5 4.7 4.0 2.4 7.6 3.6 4.4 6.5 0.0 7.2 0.0 23.5 31.9 0.2 102.9 25.5 1.4 7.9 5.2 0.0 27.6 8.3 35.7 0.0 5.9 0.0 0.0 13.1 53.0 16.3 28.4 0.0 29.9 5.0 0.0 0.0 9.2 1.8 0.0 15.0 1.9 16.9 0.0 0.0 62.8 30.4 0.0 11.7 18.2 2.3 32.3 27.0 0.2 10.2 26.1 15.3 0.0 0.2 20.9 PADI1 "HPAD10, PAD1, PDI, PDI1" ENSG00000142623 "Peptidyl arginine deiminase 1" Q9ULC6 1 17205126-17246005 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 48.7;lymphoid tissue: 60.2" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 12.6;Extravillous trophoblasts: 10.0;Urothelial cells: 3.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.5;EFO-21: 4.6;HaCaT: 2.9;LHCN-M2: 3.6;RPTEC TERT1: 4.9" "Region enhanced" "Detected in single" "olfactory region: 0.5" "Not detected" "Not detected" HPA062294 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA062294: AB_2684741" "unprognostic (9.30e-2)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.40e-1)" "unprognostic (5.22e-2)" "unprognostic (7.27e-2)" "unprognostic (3.84e-1)" "unprognostic (3.37e-2)" "unprognostic (1.41e-1)" "unprognostic (7.75e-2)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "prognostic unfavorable (8.34e-11)" "unprognostic (2.00e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.3 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.1 0.0 4.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.1 60.2 1.3 6.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.1 9.5 0.0 4.6 0.4 0.4 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 4.9 0.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 12.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.2 3.8 PAFAH1B2 ENSG00000168092 "Platelet activating factor acetylhydrolase 1b catalytic subunit 2" P68402 11 117144267-117176894 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051836 Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 1600000 Cytosol "Nucleoli, Plasma membrane" "HPA051836: AB_2681630" "unprognostic (1.08e-2)" "unprognostic (3.14e-2)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (9.94e-2)" "unprognostic (1.21e-3)" "prognostic unfavorable (9.44e-4)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.01e-1)" "prognostic favorable (4.25e-4)" "prognostic unfavorable (7.79e-5)" "unprognostic (8.18e-2)" "unprognostic (1.11e-2)" "unprognostic (9.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" 21.5 34.1 30.6 19.2 29.7 33.5 32.3 43.5 41.3 21.6 20.2 33.3 12.7 21.1 23.4 22.8 23.3 20.8 19.3 26.2 31.9 36.8 24.6 22.5 20.5 17.7 39.3 31.6 23.6 23.0 23.1 24.2 26.9 39.6 22.2 19.6 17.3 19.3 17.4 14.1 20.8 18.0 19.9 51.6 18.3 21.4 29.9 26.3 15.1 30.9 10.8 20.4 25.9 20.3 26.8 21.6 36.8 35.7 18.9 31.4 26.9 15.0 17.2 19.9 28.7 22.2 15.6 15.5 25.3 22.1 14.1 12.9 31.4 33.2 16.2 36.3 30.3 14.1 24.1 28.9 32.7 18.6 14.5 11.1 41.8 15.7 20.1 19.9 14.4 16.0 17.2 25.9 28.1 35.5 15.4 23.0 9.1 22.1 12.4 21.5 9.6 13.9 21.2 18.2 20.9 13.6 15.6 22.5 17.8 21.5 23.5 22.2 29.4 29.2 22.1 9.6 17.6 24.6 12.4 36.8 25.8 17.1 12.6 17.9 3.9 6.0 21.8 10.4 27.7 21.6 32.1 30.8 26.7 24.2 33.3 28.2 26.8 28.0 25.3 21.6 25.4 29.3 31.4 36.8 18.9 35.7 15.8 19.5 26.9 30.6 29.7 43.5 37.8 31.9 36.8 39.3 31.6 39.6 26.3 26.8 33.3 41.0 38.7 108.6 36.9 31.1 68.8 17.4 26.1 62.8 45.2 36.3 39.7 52.6 7.3 54.4 31.6 0.0 34.5 77.2 42.9 53.9 18.5 39.2 38.5 44.5 79.3 57.7 59.6 8.9 42.0 55.7 47.2 49.5 37.2 33.5 72.8 46.7 32.2 44.8 33.5 12.9 46.4 45.1 75.6 101.4 45.7 38.5 39.1 38.8 PAICS "ADE2H1, AIRC, PAIS" ENSG00000128050 "Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase" P22234 4 56435741-56464579 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Decarboxylase, Ligase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 137.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035895, HPA041538" Approved Approved Cytosol Yes No 340000 Cytosol "HPA035895: AB_10669660, HPA041538: AB_2677540" "unprognostic (2.59e-3)" "unprognostic (7.90e-3)" "unprognostic (3.84e-3)" "unprognostic (2.88e-2)" "unprognostic (9.85e-2)" "unprognostic (2.82e-3)" "prognostic unfavorable (1.50e-4)" "unprognostic (8.07e-3)" "unprognostic (1.23e-2)" "prognostic favorable (8.44e-4)" "unprognostic (1.48e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (5.85e-5)" "unprognostic (7.11e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.41e-4)" "unprognostic (2.16e-1)" 15.5 27.1 21.6 20.4 17.4 21.4 29.3 15.8 20.6 17.5 22.5 18.5 18.4 17.2 19.6 12.6 29.0 19.6 11.4 13.4 16.7 22.6 26.5 63.7 11.3 25.6 26.4 19.2 23.3 27.7 26.2 17.9 24.3 29.8 17.5 30.5 13.1 15.7 16.8 23.8 20.0 16.1 19.4 23.5 19.8 12.8 18.3 15.9 44.9 17.8 26.8 33.1 18.7 18.9 13.7 12.8 3.2 6.4 10.9 14.4 6.7 34.3 25.8 53.3 33.0 11.4 25.9 45.9 29.8 21.6 42.8 42.2 40.9 40.9 79.6 34.7 19.9 23.3 21.3 84.1 43.3 73.4 15.9 29.6 43.2 39.5 45.3 21.9 76.8 19.3 21.9 31.4 45.4 34.3 23.7 35.0 45.7 74.5 29.7 36.8 22.9 88.1 38.5 61.1 66.2 32.3 71.6 22.8 52.3 40.5 24.1 57.3 34.3 29.3 41.0 18.0 45.5 27.1 24.6 18.8 33.9 44.4 33.3 60.8 21.0 18.0 83.7 35.7 56.3 37.3 3.2 3.7 0.3 4.1 6.4 11.8 13.7 11.5 7.3 11.4 8.9 14.4 12.1 0.9 10.9 4.8 12.8 8.3 6.7 21.6 17.4 15.8 20.6 16.7 22.6 26.4 19.2 29.8 15.9 20.8 19.3 31.8 57.8 50.4 26.0 20.9 56.0 21.4 31.8 31.4 5.9 117.2 31.5 30.5 45.8 21.6 14.2 46.7 22.8 137.4 35.6 28.6 20.7 68.6 45.7 27.0 23.8 11.6 15.8 6.6 27.6 17.1 16.9 22.6 34.9 13.2 23.3 7.0 21.9 41.1 22.9 0.0 17.9 39.4 47.7 44.2 45.7 16.0 65.0 44.1 PAIP1 ENSG00000172239 "Poly(A) binding protein interacting protein 1" Q9H074 5 43526267-43557758 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073653, HPA076187" Approved Enhanced "Plasma membrane,Cytosol" No No 18000 "Plasma membrane, Cytosol" "HPA073653: AB_2732234, HPA076187: AB_2686784" "unprognostic (4.70e-2)" "unprognostic (4.30e-2)" "unprognostic (5.37e-2)" "unprognostic (2.65e-2)" "unprognostic (1.62e-2)" "unprognostic (4.74e-2)" "unprognostic (1.13e-3)" "unprognostic (2.98e-1)" "unprognostic (3.17e-2)" "unprognostic (1.62e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (3.54e-1)" "unprognostic (1.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" 30.1 26.6 26.9 15.4 26.0 20.6 35.9 22.7 32.6 30.2 27.8 25.0 19.6 18.3 28.4 26.0 26.1 22.8 23.3 45.6 26.8 24.4 34.0 38.3 21.3 20.8 28.6 21.5 24.8 23.5 30.9 24.0 29.0 23.0 32.1 24.3 21.3 23.4 31.7 62.8 16.6 24.2 38.7 33.4 21.0 23.8 44.3 27.3 29.9 38.5 20.6 18.6 31.5 36.8 14.1 35.0 23.4 12.4 12.5 16.4 10.9 22.3 19.9 39.1 37.8 41.0 32.5 32.0 19.7 44.0 37.6 32.8 18.5 27.5 14.9 34.2 27.8 56.7 14.7 60.9 23.8 38.5 12.3 23.6 11.7 39.9 29.1 36.2 17.4 18.5 34.4 46.1 25.4 48.0 38.3 35.8 11.1 27.0 20.2 37.5 24.0 19.2 24.1 19.3 21.3 25.7 15.1 29.5 20.8 46.7 27.6 22.2 33.7 63.2 24.4 43.7 37.5 34.8 25.4 19.9 34.2 28.4 17.0 24.7 15.3 25.8 22.3 19.9 27.1 29.4 17.4 12.4 23.4 10.5 10.4 14.0 14.1 13.1 14.5 12.4 13.2 16.4 13.0 4.6 12.5 11.1 35.0 11.4 10.9 26.9 26.0 22.7 32.6 26.8 24.4 28.6 21.5 23.0 27.3 29.8 43.3 27.5 65.7 65.1 49.0 115.4 68.8 36.1 22.7 41.8 19.6 65.0 134.3 105.9 128.9 65.0 26.0 0.0 80.1 76.8 67.2 70.0 23.2 46.9 51.3 33.4 43.1 41.7 35.2 40.9 70.8 42.8 79.2 64.1 51.5 68.8 98.5 49.1 62.6 115.0 51.4 25.8 65.1 136.3 84.8 58.1 57.0 27.4 45.2 69.7 PAIP2B KIAA1155 ENSG00000124374 "Poly(A) binding protein interacting protein 2B" Q9ULR5 2 71182739-71227083 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.9;pancreas: 47.8;skeletal muscle: 39.4" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 60.6;Hepatocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 13.2;SCLC-21H: 20.5" "Low region specificity" "Detected in all" "HPA046784, HPA072371" Approved Approved Cytosol NA NA Cytosol "HPA046784: AB_2679804, HPA072371: AB_2686514" "unprognostic (8.70e-2)" "unprognostic (8.20e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (8.17e-5)" "unprognostic (4.56e-2)" "unprognostic (1.34e-1)" "unprognostic (9.67e-3)" "unprognostic (1.51e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (2.76e-1)" "prognostic favorable (6.96e-12)" "unprognostic (1.63e-2)" "unprognostic (3.87e-1)" "unprognostic (1.21e-2)" "unprognostic (4.61e-2)" 2.8 2.4 36.3 2.3 28.8 1.8 4.8 11.9 15.7 3.3 4.2 50.9 5.1 4.0 3.5 2.5 6.2 7.4 1.8 17.8 39.5 25.1 9.9 16.6 3.3 2.5 47.7 9.7 11.6 47.8 6.4 2.1 1.4 21.9 5.2 4.2 2.7 29.9 5.6 39.4 15.1 3.2 3.4 44.9 2.7 6.7 2.7 24.6 0.6 11.1 3.5 4.7 2.7 2.3 5.8 4.5 1.0 0.9 1.5 4.6 1.2 2.1 0.5 0.9 3.1 0.3 0.5 3.9 0.3 0.1 0.3 0.1 0.8 0.9 2.7 0.6 0.0 2.1 1.7 5.3 3.1 1.0 1.4 4.3 2.6 0.3 0.1 1.5 0.7 0.2 0.6 2.9 0.1 3.2 0.8 0.5 6.2 4.6 2.7 0.1 2.7 0.8 1.5 2.3 4.9 2.0 0.0 9.2 13.2 1.7 1.4 20.5 1.2 2.3 1.5 0.9 5.0 6.5 0.1 0.1 0.2 1.7 1.7 0.9 5.3 4.5 3.4 0.2 1.0 0.5 1.0 0.7 1.0 2.0 0.9 2.6 4.9 2.8 2.0 0.8 5.8 4.6 4.0 0.5 1.5 0.8 4.5 1.1 1.2 36.3 28.8 11.9 15.7 39.5 25.1 47.7 9.7 21.9 24.6 3.0 5.0 3.0 6.2 6.9 10.8 60.6 15.3 12.0 0.0 7.0 5.9 3.0 18.3 4.1 33.7 3.6 1.1 0.0 35.4 5.9 2.7 8.7 1.1 52.1 1.6 6.4 39.9 4.9 2.2 18.6 4.9 2.1 13.5 3.6 5.9 7.8 16.3 3.5 4.9 43.1 39.1 0.0 3.1 9.3 7.5 17.6 5.3 3.8 7.5 4.7 PAK1 ENSG00000149269 "P21 (RAC1) activated kinase 1" Q13153 11 77321707-77474635 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Exocytosis" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.0;brain: 71.4" "Cell type enhanced" "Detected in many" 4 "granulocytes: 126.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4" "Group enriched" "Detected in all" 11 "dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003565, CAB005312" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 200000 "Plasma membrane, Cytosol" "CAB005312: AB_2160720, HPA003565: AB_1854935" "unprognostic (1.15e-2)" "unprognostic (3.23e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.62e-2)" "unprognostic (8.19e-3)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (1.22e-3)" "unprognostic (1.86e-2)" "unprognostic (2.76e-1)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (1.57e-1)" "unprognostic (4.00e-3)" "unprognostic (1.52e-2)" 5.4 6.0 30.5 13.8 39.5 22.9 7.8 49.1 71.4 9.8 18.2 8.4 2.3 18.2 9.1 13.3 9.9 9.8 13.2 5.3 19.0 16.9 11.3 6.0 6.9 7.5 12.8 40.6 10.4 9.2 11.8 10.8 11.9 39.2 12.2 20.2 5.4 10.4 8.8 34.0 6.7 18.9 11.6 7.8 11.7 17.1 11.1 6.6 7.6 17.7 3.9 9.4 10.5 10.4 2.7 42.3 70.0 30.4 4.3 2.4 12.2 11.4 7.7 16.8 7.6 6.8 11.5 13.4 13.1 9.4 12.4 14.7 11.0 15.3 10.2 4.8 11.3 16.2 5.9 11.7 13.8 19.7 11.8 9.4 10.8 5.2 0.7 4.5 18.2 16.0 8.5 8.4 14.6 21.7 11.0 2.9 12.0 7.1 18.0 22.6 0.8 11.6 8.4 24.7 47.4 6.6 17.8 21.7 0.4 3.1 9.5 7.2 7.1 7.0 3.0 5.5 17.3 13.4 8.3 0.2 8.3 14.4 44.3 10.9 49.6 25.5 6.8 6.9 12.2 8.9 0.3 29.3 45.0 1.9 28.7 1.5 2.7 1.4 1.8 42.3 1.9 1.3 2.4 70.0 4.3 30.4 3.6 1.1 12.2 30.5 39.5 49.1 71.4 19.0 16.9 12.8 40.6 39.2 6.6 3.0 21.5 16.1 27.9 10.5 48.2 3.1 33.1 41.5 33.0 24.4 7.9 23.0 38.1 26.3 31.5 3.0 46.3 0.0 49.4 46.4 13.1 25.6 126.2 10.9 45.2 1.6 36.2 3.1 43.9 20.0 13.3 71.3 28.7 94.6 47.0 14.0 41.8 55.2 12.4 28.6 6.7 12.9 18.2 25.6 42.1 9.2 79.4 12.2 47.1 27.2 PALLD "CGI-151, KIAA0992, SIH002" ENSG00000129116 "Palladin, cytoskeletal associated protein" Q8WX93 4 168497066-168928457 "Disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 203.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 352.0;Cardiomyocytes: 495.5;Peritubular cells: 375.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035905, CAB070159" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" No No "Plasma membrane, Actin filaments" Cytosol "CAB070159: AB_1726016, HPA035905: AB_2674854" "unprognostic (3.59e-2)" "unprognostic (3.99e-1)" "unprognostic (2.55e-2)" "unprognostic (5.03e-3)" "unprognostic (2.51e-1)" "unprognostic (7.03e-2)" "unprognostic (2.60e-1)" "unprognostic (2.40e-2)" "unprognostic (3.57e-2)" "unprognostic (4.21e-2)" "unprognostic (2.38e-1)" "unprognostic (3.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.28e-4)" 17.3 8.9 8.5 19.6 7.5 0.1 28.1 2.1 6.7 58.4 71.9 5.7 46.4 6.7 82.2 25.6 84.3 31.3 30.8 95.0 9.2 3.2 12.7 3.6 24.9 17.0 4.6 4.7 28.0 3.0 25.6 3.9 14.0 6.0 71.4 17.9 9.2 11.4 50.9 30.5 8.9 16.8 203.3 6.7 25.8 31.4 14.1 6.9 2.2 12.7 17.2 5.8 140.3 82.7 0.2 2.2 13.6 3.2 0.6 5.1 1.5 17.7 8.7 19.5 12.0 17.9 19.6 27.3 12.1 30.5 10.7 15.2 0.2 1.0 7.7 3.1 5.2 6.5 3.7 11.8 30.8 13.7 16.0 3.6 0.1 25.2 2.2 31.4 0.0 0.2 29.7 19.3 19.1 28.7 25.8 4.5 4.4 0.0 0.1 64.5 0.8 5.1 0.3 5.6 4.5 5.2 1.7 18.0 0.1 1.2 3.5 2.0 10.5 22.8 1.7 1.6 35.4 10.8 0.1 14.5 11.2 42.5 4.7 19.7 10.9 0.1 0.3 9.4 0.2 3.1 13.6 3.2 0.0 5.1 1.9 0.2 0.1 0.6 2.7 2.2 0.2 0.6 2.0 0.8 0.6 1.2 0.2 0.5 1.5 8.5 7.5 2.1 6.7 9.2 3.2 4.6 4.7 6.0 6.9 29.8 10.3 2.4 352.0 83.1 5.7 495.5 28.1 104.4 76.2 41.8 17.7 42.5 1.7 24.0 99.1 28.5 10.3 0.0 44.7 98.6 137.0 124.3 50.8 12.3 21.9 25.4 42.9 68.7 21.6 111.6 120.6 22.6 21.9 88.4 27.7 54.5 57.6 17.3 375.5 14.4 3.4 174.6 188.1 18.6 3.9 43.2 18.7 4.5 24.8 88.9 PAM "PAL, PHM" ENSG00000145730 "Peptidylglycine alpha-amidating monooxygenase" P19021 5 102753981-103031105 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 304.2" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 852.6;Intestinal endocrine cells: 308.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 75.3;fHDF/TERT166: 96.5;hTERT-RPE1: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026119, HPA042260" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA 59000000 "Golgi apparatus, Cytosol" "CAB026119: , HPA042260: AB_2677919" "unprognostic (4.30e-3)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "prognostic favorable (1.63e-4)" "unprognostic (4.23e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (6.20e-4)" "unprognostic (7.58e-2)" "unprognostic (6.62e-2)" "unprognostic (2.71e-1)" "unprognostic (9.91e-2)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.08e-1)" "unprognostic (9.79e-2)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" 16.5 24.5 8.2 6.5 16.4 0.8 17.3 6.6 16.5 74.9 14.0 5.4 9.5 5.8 21.3 83.8 11.7 10.6 11.5 304.2 8.8 23.5 13.7 2.1 13.2 5.8 10.0 7.6 17.0 16.4 49.5 18.3 26.3 15.5 13.4 9.5 8.7 53.8 29.4 22.0 8.5 8.5 18.5 4.8 8.9 17.2 7.2 4.6 1.8 21.7 13.2 7.3 15.8 15.3 0.5 2.0 10.1 5.3 16.2 14.1 6.3 14.7 2.2 27.1 12.0 75.3 45.1 10.8 41.8 62.6 12.4 37.8 7.1 19.5 0.0 9.0 96.5 17.5 5.0 1.5 18.4 34.3 1.8 6.1 3.0 8.8 2.3 11.4 0.9 3.3 24.6 7.9 9.1 6.9 78.8 25.5 1.2 0.1 2.0 35.1 3.0 0.0 0.4 4.8 2.6 8.1 1.1 15.1 8.1 47.8 1.7 12.8 8.9 17.8 1.1 10.9 16.6 4.6 0.9 19.6 39.4 10.2 18.4 12.4 4.6 1.1 0.0 45.2 4.1 33.9 1.9 5.3 0.1 14.1 0.9 10.0 0.5 8.5 10.4 2.0 0.3 2.9 4.8 10.1 16.2 1.9 1.1 12.1 6.3 8.2 16.4 6.6 16.5 8.8 23.5 10.0 7.6 15.5 4.6 50.6 28.7 3.7 10.4 25.0 10.9 852.6 0.0 10.7 27.3 57.6 2.0 0.7 6.6 11.6 5.0 54.1 6.8 0.0 18.6 37.1 102.7 20.4 9.2 2.4 5.5 7.9 308.8 70.0 12.0 4.7 55.8 6.7 35.4 5.4 12.6 13.0 34.7 2.9 55.2 41.6 2.8 19.4 47.4 1.6 2.1 20.7 5.6 15.3 6.6 13.1 PANK2 "C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN" ENSG00000125779 "Pantothenate kinase 2" Q9BZ23 20 3888839-3929882 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008440 Approved Supported Cytosol NA NA Cytosol "HPA008440: AB_1079559" "unprognostic (4.50e-2)" "unprognostic (7.96e-3)" "unprognostic (2.26e-1)" "unprognostic (1.39e-2)" "unprognostic (1.68e-1)" "unprognostic (6.00e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (2.75e-1)" "unprognostic (3.39e-1)" "unprognostic (2.52e-1)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" "unprognostic (6.01e-3)" "unprognostic (1.73e-2)" "unprognostic (2.18e-3)" "unprognostic (2.63e-1)" "unprognostic (1.81e-1)" 15.2 21.5 18.7 18.5 18.9 20.8 19.7 21.8 24.8 14.7 14.4 16.8 10.7 11.8 15.5 15.5 28.9 19.1 14.3 11.0 17.4 18.6 18.8 20.3 16.1 18.5 16.2 16.2 14.4 13.5 15.3 15.7 18.1 20.8 14.5 16.4 17.0 15.8 13.2 14.4 12.8 14.5 16.6 12.3 20.6 12.1 28.9 14.1 23.2 17.0 10.5 24.6 17.3 16.4 5.8 8.6 8.0 12.8 8.3 6.4 3.1 20.8 13.5 14.6 7.4 17.5 15.2 8.0 13.7 15.0 18.1 23.5 18.2 11.2 17.0 6.4 15.3 36.2 17.3 15.7 26.7 23.1 5.0 6.9 23.2 9.7 33.9 14.7 15.4 7.7 13.4 11.6 20.2 13.0 6.9 16.9 12.0 17.0 15.9 19.4 5.2 13.2 13.6 14.6 8.6 10.2 10.9 20.4 10.7 11.2 19.2 19.0 9.3 17.0 18.6 34.0 14.9 11.3 12.5 11.6 21.7 10.9 28.3 21.0 8.9 25.9 12.9 6.4 14.1 16.9 1.6 11.2 4.7 4.4 12.8 4.3 4.7 4.3 4.5 8.6 5.8 4.4 4.0 8.0 8.3 10.7 3.0 6.4 3.1 18.7 18.9 21.8 24.8 17.4 18.6 16.2 16.2 20.8 14.1 17.9 9.4 18.5 15.5 22.7 20.0 9.0 7.6 16.0 9.1 14.0 23.6 25.6 19.9 16.8 63.9 22.4 12.3 23.3 15.4 29.5 18.0 15.9 7.0 13.0 29.7 33.4 19.4 20.3 37.4 13.0 19.5 30.0 18.6 36.1 9.9 13.3 12.2 11.5 21.2 15.3 20.0 6.5 16.9 32.6 21.8 21.2 15.6 25.5 12.6 16.5 PANK4 FLJ10782 ENSG00000157881 "Pantothenate kinase 4" Q9NVE7 1 2508533-2526628 "Enzymes, Predicted intracellular proteins" "Coenzyme A biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.1" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 9.0;HDLM-2: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011723, HPA012036, HPA027961" Uncertain Approved Cytosol NA NA Cytosol "HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042" "unprognostic (1.23e-1)" "unprognostic (2.31e-1)" "unprognostic (3.36e-1)" "unprognostic (1.13e-1)" "unprognostic (4.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-1)" "unprognostic (6.51e-2)" "unprognostic (1.80e-1)" "unprognostic (1.18e-2)" "unprognostic (3.29e-2)" "prognostic favorable (1.57e-5)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (2.25e-1)" "unprognostic (8.15e-2)" 5.3 14.4 10.7 17.8 12.6 4.2 5.4 14.9 12.4 5.5 7.1 6.8 4.9 4.2 7.0 4.2 9.8 5.6 9.2 11.8 8.0 5.2 7.2 7.0 6.7 12.5 9.0 6.8 5.7 5.8 4.2 8.3 6.7 7.4 5.8 6.1 8.9 5.6 5.3 43.1 19.0 7.6 9.1 4.4 8.1 6.3 11.0 9.7 9.4 6.8 6.8 7.2 7.2 5.7 4.5 4.8 11.7 6.9 11.4 8.9 5.3 2.5 6.7 2.3 0.0 0.0 2.7 1.6 9.0 0.0 8.2 7.7 0.0 0.0 1.1 3.1 2.5 0.0 3.9 1.9 0.0 1.8 9.4 5.7 0.0 3.9 5.6 2.6 0.0 4.7 0.0 0.0 0.0 0.0 1.2 1.9 1.3 2.5 0.0 2.2 0.0 1.3 0.3 0.0 0.8 2.8 0.0 0.0 1.8 0.0 0.0 2.0 0.0 5.1 1.9 0.0 0.9 0.0 3.4 0.0 0.0 1.9 4.7 2.2 1.3 4.6 6.1 3.0 0.9 0.0 11.7 4.9 4.5 6.2 6.6 5.1 4.5 3.9 6.4 4.8 3.0 7.4 8.0 6.4 11.4 6.9 0.9 8.9 5.3 10.7 12.6 14.9 12.4 8.0 5.2 9.0 6.8 7.4 9.7 6.0 3.2 5.6 4.9 3.7 7.2 22.5 2.5 0.0 2.3 3.5 9.8 6.5 6.6 5.2 1.1 5.2 4.9 0.0 6.0 4.2 7.0 3.2 1.1 7.6 4.6 3.2 2.9 3.7 5.9 0.4 5.5 5.9 5.0 8.2 4.0 4.5 4.7 7.0 8.5 3.6 13.0 19.4 5.9 4.8 5.2 3.9 8.1 8.5 5.0 3.1 PAPD4 "FLJ38499, GLD2, TUT2" ENSG00000164329 "Poly(A) RNA polymerase D4, non-canonical" Q6PIY7 5 79612120-79686648 "Enzymes, Predicted intracellular proteins" "mRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054468 Approved Cytosol No No Cytosol "HPA054468: AB_2682497" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.25e-3)" "unprognostic (1.91e-1)" "unprognostic (8.03e-2)" "unprognostic (2.80e-3)" "unprognostic (2.10e-2)" "unprognostic (1.10e-1)" "unprognostic (6.80e-2)" "unprognostic (1.57e-3)" "unprognostic (9.37e-2)" "unprognostic (2.21e-1)" "unprognostic (7.71e-2)" "unprognostic (2.38e-1)" "unprognostic (8.43e-3)" "unprognostic (5.84e-3)" "unprognostic (2.67e-3)" 25.4 21.1 15.8 34.4 22.1 42.1 27.9 20.9 30.3 23.8 22.6 24.7 22.7 19.2 34.4 28.1 22.0 20.7 23.3 16.5 16.5 14.6 20.0 25.3 25.6 34.7 19.4 20.2 29.6 21.4 18.0 23.1 25.7 17.2 20.6 23.3 23.8 21.4 28.3 21.0 25.5 25.4 23.1 22.2 37.4 21.0 26.0 21.2 33.8 24.9 21.3 29.3 22.6 21.9 20.2 19.5 22.3 22.1 19.3 29.9 15.7 11.6 8.1 9.1 14.3 15.9 18.5 14.6 14.1 21.7 16.6 26.5 7.2 13.9 21.8 7.4 15.6 19.6 11.2 11.6 15.7 19.0 16.2 10.6 12.4 10.1 11.2 20.7 18.3 17.2 16.3 17.1 11.7 22.0 16.2 14.0 16.0 14.1 16.1 18.2 6.3 20.8 23.6 8.4 8.9 5.8 18.7 9.1 24.3 16.0 16.7 6.0 10.9 11.2 12.3 22.1 15.0 10.5 29.0 12.8 9.0 6.1 8.7 15.6 17.0 14.1 21.6 15.8 19.3 12.5 22.3 19.1 18.6 18.2 22.1 29.9 20.2 19.9 19.9 19.5 16.2 19.3 19.8 17.3 19.3 21.7 10.7 20.2 15.7 15.8 22.1 20.9 30.3 16.5 14.6 19.4 20.2 17.2 21.2 17.9 15.6 14.7 16.3 26.1 21.3 0.0 12.7 24.1 14.8 0.0 21.6 23.1 0.0 0.0 7.5 20.4 16.9 23.3 0.0 18.7 18.8 16.8 20.9 23.2 29.3 31.8 13.8 33.2 52.9 6.6 17.8 36.5 15.1 0.0 17.6 17.1 0.0 20.9 25.1 0.0 33.2 12.9 12.5 24.2 15.0 27.5 28.1 35.0 18.4 20.3 PAQR7 "MPRA, mSR" ENSG00000182749 "Progestin and adipoQ receptor family member 7" Q86WK9 1 25861210-25871253 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 12 "Early spermatids: 346.5;Late spermatids: 1377.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.3;HaCaT: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046936 Approved Approved Cytosol NA NA Cytosol "HPA046936: AB_2679869" "unprognostic (1.12e-1)" "unprognostic (2.08e-2)" "unprognostic (8.03e-2)" "unprognostic (4.54e-3)" "unprognostic (1.32e-1)" "unprognostic (3.41e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.47e-1)" "unprognostic (4.59e-3)" "unprognostic (7.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "prognostic favorable (1.05e-5)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.15e-2)" "unprognostic (1.54e-2)" 1.2 9.5 1.8 0.7 2.3 1.0 1.4 1.8 1.8 2.8 1.6 6.7 4.1 10.2 6.1 6.8 2.1 0.6 1.7 2.6 11.9 1.9 1.6 0.6 2.0 13.2 1.8 3.9 2.1 6.9 2.4 0.4 1.5 8.9 0.2 10.7 5.7 2.9 1.4 3.5 2.3 16.2 1.4 1.0 6.3 4.6 3.2 5.5 10.8 11.7 2.4 1.4 0.8 11.7 2.3 2.4 7.8 2.9 6.2 8.4 7.7 6.9 7.8 7.0 3.9 30.3 0.1 5.5 7.6 2.5 24.9 1.3 13.1 4.7 4.6 1.3 10.0 3.3 4.7 4.9 0.1 1.3 6.3 17.5 5.5 4.1 6.9 2.9 1.1 1.0 0.8 5.7 2.7 0.0 0.7 3.7 1.2 4.0 0.8 0.2 1.4 15.8 9.1 1.2 4.7 12.6 16.5 5.7 3.5 4.7 1.8 3.2 1.3 4.0 4.1 2.1 0.1 0.1 0.5 5.9 0.3 2.6 3.1 5.7 10.8 1.1 10.2 1.1 3.2 0.6 0.8 5.5 1.2 1.0 1.4 2.6 2.4 11.7 0.6 0.2 0.8 0.0 1.9 1.9 4.7 16.1 1.9 1.6 17.8 10.7 6.8 73.3 0.0 36.5 18.3 4.9 346.5 4.5 1.3 0.0 12.5 10.0 7.5 1.0 6.9 4.9 9.2 3.2 4.6 10.4 7.3 1377.7 18.4 5.3 20.3 5.4 1.5 2.0 7.0 3.5 14.2 49.2 0.6 12.9 4.0 11.1 9.1 11.4 29.9 0.9 2.9 2.2 PARD6A "PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40" ENSG00000102981 "Par-6 family cell polarity regulator alpha" Q9NPB6 16 67660946-67662778 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.8;pancreas: 31.0" "Cell type enriched" "Detected in many" 5 "Late spermatids: 203.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009733, HPA041551" Approved Supported "Cell Junctions,Actin filaments,Cytosol" No No "Cell Junctions, Actin filaments" Cytosol "CAB009733: AB_2159676, HPA041551: AB_2677545" "prognostic favorable (5.40e-4)" "unprognostic (6.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (4.08e-3)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (6.59e-2)" "unprognostic (2.09e-1)" "unprognostic (1.98e-3)" "unprognostic (9.13e-2)" "prognostic favorable (3.08e-7)" "unprognostic (9.22e-3)" "unprognostic (6.69e-2)" "unprognostic (1.25e-1)" "unprognostic (1.39e-2)" 2.7 6.1 11.7 3.5 12.4 2.1 2.8 26.8 16.1 2.0 3.0 2.2 3.7 2.0 2.4 3.6 2.7 2.5 3.1 2.3 13.8 7.2 5.5 3.1 3.5 4.0 7.9 5.7 3.3 31.0 5.3 13.9 1.5 7.4 2.7 2.0 1.4 3.8 4.6 7.0 1.5 2.5 2.7 3.7 3.7 3.2 16.9 3.4 2.5 2.3 1.4 3.4 2.9 3.1 11.4 5.3 3.7 1.0 1.2 8.5 2.1 5.5 6.0 1.7 14.8 1.2 0.2 3.1 0.1 0.7 2.2 2.1 3.0 2.3 9.4 2.8 0.1 0.8 4.4 3.4 0.7 0.5 4.4 3.2 3.8 2.8 3.4 1.6 1.5 8.9 0.1 0.3 2.1 0.8 1.4 1.1 14.1 0.3 2.2 0.4 5.5 9.6 2.0 2.0 7.7 3.9 17.4 1.1 15.2 5.9 3.2 14.3 7.7 0.9 2.1 2.3 0.5 12.9 0.6 0.9 0.2 0.5 1.4 2.9 2.3 7.3 8.4 1.7 3.4 0.6 2.1 1.0 0.4 4.5 0.5 8.5 11.4 6.4 5.9 1.2 7.4 3.2 2.4 3.7 1.2 0.1 5.3 6.1 2.1 11.7 12.4 26.8 16.1 13.8 7.2 7.9 5.7 7.4 3.4 3.0 4.3 8.1 1.4 0.8 9.7 1.0 12.7 4.0 2.3 19.2 3.9 4.6 28.2 6.6 42.8 2.7 2.1 0.0 13.1 0.2 2.4 2.1 5.7 3.8 4.0 30.2 32.6 1.3 3.2 203.1 3.4 3.1 5.0 1.0 2.4 15.2 5.2 2.6 1.4 12.9 7.6 0.0 2.1 4.6 2.6 1.4 2.4 9.6 2.9 1.4 PARD6B PAR-6B ENSG00000124171 "Par-6 family cell polarity regulator beta" Q9BYG5 20 50731544-50756795 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 40.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 175.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 15.8;MCF7: 27.8;T-47d: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013376 Uncertain Supported Cytosol NA NA Cytosol "HPA013376: AB_1854972" "unprognostic (1.13e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.39e-3)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.02e-5)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (9.33e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.27e-1)" "prognostic favorable (6.38e-5)" "unprognostic (1.84e-2)" "unprognostic (1.97e-1)" "unprognostic (4.18e-2)" "unprognostic (1.07e-2)" 3.7 2.3 1.6 3.1 2.3 2.6 7.9 3.5 2.0 2.7 13.9 1.4 11.3 4.5 2.2 12.1 5.8 5.7 6.6 2.1 2.0 1.9 40.0 8.0 15.4 1.9 1.5 1.3 3.4 9.9 7.3 3.7 24.1 2.7 4.0 3.0 12.2 3.6 17.2 4.3 3.8 17.5 1.0 1.6 2.4 8.3 6.4 0.5 2.9 14.4 1.0 5.8 3.5 5.5 3.6 3.1 3.4 1.5 3.8 6.1 1.1 2.9 3.4 1.0 2.1 0.6 0.2 4.5 0.2 0.3 0.5 0.4 15.8 7.0 1.3 3.0 0.0 2.2 2.4 1.4 2.1 0.8 0.6 0.8 0.7 1.1 6.2 0.6 0.5 0.7 0.0 1.0 0.3 0.9 1.0 0.0 1.2 1.6 0.9 0.0 27.8 1.3 1.2 1.7 4.9 1.3 0.7 0.9 1.1 7.1 3.2 0.6 0.9 2.2 5.3 1.5 4.2 27.2 0.7 0.1 0.3 1.8 0.3 0.5 1.1 0.7 1.1 0.7 0.5 0.6 2.9 0.7 3.4 3.6 0.9 4.0 2.9 3.7 3.6 0.8 3.6 6.1 3.8 2.8 3.8 1.5 3.1 2.3 1.1 1.6 2.3 3.5 2.0 2.0 1.9 1.5 1.3 2.7 0.5 175.7 50.3 4.5 51.0 55.9 12.3 3.3 28.1 25.4 33.0 85.5 51.1 28.8 34.9 22.0 3.2 1.1 39.4 0.0 21.2 12.5 2.6 39.6 1.1 17.8 3.1 4.8 14.3 2.5 0.3 2.2 1.7 2.5 15.1 1.0 18.0 10.0 40.3 18.2 0.7 63.2 52.4 6.5 2.3 11.2 9.8 59.7 40.5 4.6 12.1 85.3 PARG ENSG00000227345 "Poly(ADP-ribose) glycohydrolase" Q86W56 10 49818279-49970203 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021819, HPA053007" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA021819: AB_1854974, HPA053007: AB_2682014" "unprognostic (5.77e-3)" "unprognostic (6.74e-2)" "unprognostic (3.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.22e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.57e-5)" "unprognostic (1.21e-1)" "unprognostic (3.97e-1)" "unprognostic (8.34e-2)" "unprognostic (1.47e-1)" "unprognostic (4.06e-2)" "unprognostic (5.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (8.54e-2)" "unprognostic (1.13e-1)" 4.0 5.6 4.3 4.2 5.4 1.4 5.3 7.8 6.3 4.8 5.1 6.7 4.9 3.0 6.2 4.3 3.6 6.6 4.6 5.9 9.2 5.2 3.5 5.8 4.5 4.7 3.5 8.1 4.7 5.8 4.9 6.1 4.7 5.1 8.1 6.7 5.1 4.7 4.0 5.9 4.7 5.8 4.9 6.9 4.4 4.8 6.9 7.0 12.5 7.7 8.3 9.4 5.5 12.7 10.6 18.6 13.7 9.0 11.2 13.7 12.7 14.0 14.8 14.2 8.5 11.9 9.6 8.3 10.7 6.6 14.4 15.7 8.0 15.9 14.7 14.6 9.8 8.7 9.3 10.2 14.1 8.2 7.2 15.5 12.4 20.5 10.1 9.0 12.7 16.6 8.5 11.1 7.1 15.5 12.7 18.4 7.8 24.3 18.6 21.2 11.1 11.9 8.2 12.9 16.3 10.3 16.4 13.3 18.8 18.8 7.9 9.1 9.2 11.3 9.6 14.2 9.4 14.0 20.5 15.9 15.0 6.7 12.5 6.2 3.0 5.2 5.5 7.9 6.9 7.1 6.7 7.0 6.9 9.4 9.1 3.0 8.3 7.7 5.4 5.5 5.5 8.9 11.7 8.3 4.6 5.5 13.2 23.8 12.7 29.4 12.5 12.2 25.5 6.5 8.3 6.3 3.5 8.3 8.5 23.3 5.6 5.2 6.7 4.0 13.9 9.6 8.2 4.8 6.3 7.4 13.2 3.3 6.9 7.0 3.3 9.0 8.1 8.9 6.7 2.9 7.8 27.7 20.8 0.0 5.5 15.7 12.1 5.3 3.9 7.5 9.7 3.8 PARK7 "DJ-1, DJ1, GATD2" ENSG00000116288 "Parkinsonism associated deglycase" Q99497 1 7954291-7985505 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response" "Chaperone, Hydrolase, Protease, RNA-binding" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004190, CAB005870" Supported Supported Nucleoplasm,Cytosol NA NA 69000000 "Nucleoplasm, Cytosol" "CAB005870: AB_444361, HPA004190: AB_1079566" "unprognostic (6.88e-3)" "unprognostic (7.50e-2)" "unprognostic (3.48e-2)" "unprognostic (1.16e-2)" "unprognostic (4.08e-2)" "unprognostic (5.68e-2)" "unprognostic (7.45e-2)" "unprognostic (9.63e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (1.96e-3)" "unprognostic (8.17e-2)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" "unprognostic (7.43e-2)" 44.6 67.9 69.3 38.1 64.9 33.7 45.4 57.2 62.7 34.0 36.4 33.4 43.2 27.3 35.8 56.6 40.9 39.0 41.6 71.7 56.9 57.2 60.5 77.1 28.6 46.1 61.6 57.2 45.9 60.4 66.6 48.4 44.6 41.2 44.7 39.5 38.6 46.5 39.4 128.7 19.8 27.5 48.1 52.5 37.5 37.2 38.2 32.2 38.8 71.6 43.3 46.5 41.3 43.4 49.5 141.8 38.8 61.0 52.8 87.2 90.6 68.3 61.6 61.4 70.6 66.1 63.6 30.1 63.7 59.8 62.8 50.7 56.2 75.0 84.8 72.1 68.4 44.1 49.2 66.2 85.2 81.6 75.5 71.6 91.2 92.1 83.3 57.1 87.0 56.2 59.9 36.4 63.9 76.9 49.2 65.7 44.7 88.5 63.2 87.0 64.1 60.5 110.6 50.1 84.9 63.7 46.6 82.5 116.3 98.4 35.2 71.9 60.4 63.7 98.5 99.5 53.8 54.9 64.8 62.3 57.9 46.2 53.4 69.8 61.4 98.5 120.8 76.4 133.2 82.0 22.7 61.0 38.8 52.6 55.4 49.7 49.5 52.7 62.2 73.9 38.6 45.6 52.4 21.0 52.8 44.1 141.8 87.2 90.6 69.3 64.9 57.2 62.7 56.9 57.2 61.6 57.2 41.2 32.2 122.1 136.9 226.3 328.5 185.6 175.5 422.7 221.7 227.5 176.3 235.5 74.6 504.6 721.2 419.3 26.4 207.3 136.6 46.7 416.0 502.3 279.0 413.5 199.9 332.4 385.8 176.4 228.6 156.5 174.9 43.1 331.6 265.8 340.8 806.1 224.5 530.4 359.6 213.9 356.1 742.4 177.0 271.7 346.0 212.8 299.8 125.7 392.7 243.9 261.6 388.0 PARM1 "Cipar1, DKFZP564O0823, WSC4" ENSG00000169116 "Prostate androgen-regulated mucin-like protein 1" Q6UWI2 4 74933095-75050115 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 143.3;Mucus-secreting cells: 90.2;Paneth cells: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4" "Group enriched" "Detected in many" 15 "B-cells: 10.1;dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "ASC diff: 24.5;Karpas-707: 23.9;U-266/70: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038236 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA038236: AB_10675789" "unprognostic (2.57e-2)" "unprognostic (5.20e-2)" "unprognostic (1.26e-3)" "unprognostic (8.61e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-3)" "unprognostic (3.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.73e-1)" "unprognostic (9.74e-2)" "unprognostic (9.44e-2)" "unprognostic (3.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.23e-1)" 23.1 21.5 5.7 25.0 15.2 0.3 16.4 1.3 29.4 18.7 36.0 1.2 28.5 2.8 20.3 18.0 5.8 12.2 11.5 39.8 6.9 13.0 27.5 1.1 15.1 10.2 3.3 10.3 11.9 29.2 23.2 32.1 16.1 4.8 35.0 45.8 70.2 25.6 27.6 7.4 6.2 8.3 29.3 2.4 9.7 5.5 11.2 1.2 6.3 79.8 3.7 8.0 24.9 19.7 10.1 4.6 0.1 0.5 0.0 0.0 0.7 0.5 1.0 0.9 0.0 24.5 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.2 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 4.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.9 0.4 0.2 2.6 0.1 2.3 0.0 1.4 0.0 2.2 6.0 0.1 4.9 1.5 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 1.4 1.6 0.1 2.1 26.8 2.5 6.8 2.5 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 10.1 0.0 0.0 4.6 6.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.7 5.7 15.2 1.3 29.4 6.9 13.0 3.3 10.3 4.8 1.2 14.9 63.1 13.4 17.1 2.9 7.9 143.3 30.6 1.4 11.4 0.0 0.0 0.3 3.3 0.1 6.8 3.8 80.6 23.3 43.2 0.6 15.4 43.3 1.1 0.0 1.4 0.0 19.1 3.1 0.0 20.6 33.9 7.2 8.5 1.0 90.2 0.0 26.9 120.2 70.0 27.6 1.0 45.3 52.3 1.7 3.3 1.6 0.7 1.5 46.2 8.4 PARP10 FLJ14464 ENSG00000178685 "Poly(ADP-ribose) polymerase family member 10" Q53GL7 8 143977153-144012772 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 16.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA028122, HPA052427" Approved Supported "Nucleoli rim,Golgi apparatus,Cytosol" No No "Nucleoli rim" "Golgi apparatus, Cytosol" "HPA028122: AB_10601979, HPA052427: AB_2681828" "unprognostic (9.80e-3)" "unprognostic (5.89e-2)" "unprognostic (2.63e-3)" "unprognostic (9.10e-2)" "unprognostic (1.74e-2)" "unprognostic (1.46e-2)" "unprognostic (7.37e-2)" "unprognostic (3.61e-1)" "unprognostic (9.05e-2)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (1.05e-1)" "unprognostic (4.69e-3)" "unprognostic (1.09e-3)" "unprognostic (4.17e-2)" "unprognostic (8.69e-2)" "unprognostic (5.30e-3)" 14.2 18.8 8.8 27.4 9.5 15.7 18.6 5.3 8.7 14.4 16.5 9.3 20.7 20.5 20.3 18.3 15.8 18.0 21.8 6.4 8.9 4.1 20.5 19.1 21.4 23.6 10.4 6.8 22.4 15.3 9.3 14.2 10.4 9.2 17.7 3.8 12.7 27.7 14.9 12.5 14.3 21.8 9.6 8.9 31.1 13.1 15.8 9.8 27.8 15.4 10.4 21.6 8.8 12.9 2.4 16.4 3.2 2.8 1.9 4.6 2.4 8.4 0.8 0.6 1.5 4.2 3.8 4.6 1.4 1.8 9.5 10.7 0.4 14.8 10.5 20.1 4.5 10.9 3.2 0.2 5.0 0.4 23.6 0.0 11.6 4.9 5.3 4.1 4.5 14.0 2.4 5.0 4.7 1.9 1.0 1.4 15.1 0.2 8.4 1.8 10.3 15.7 7.9 0.5 0.1 6.8 14.7 1.7 14.1 3.9 10.7 0.5 0.5 9.8 1.0 18.6 0.2 11.0 6.8 6.5 4.9 7.4 8.2 5.2 14.3 8.4 2.4 7.1 15.3 2.6 0.0 1.9 3.2 4.6 2.8 3.0 1.2 2.2 3.7 2.3 2.4 1.6 2.3 1.1 1.9 2.7 16.4 1.6 2.4 8.8 9.5 5.3 8.7 8.9 4.1 10.4 6.8 9.2 9.8 3.0 6.9 15.7 7.9 6.8 5.9 2.0 7.6 1.4 1.2 8.7 13.7 1.9 1.7 7.6 4.3 7.1 15.1 0.0 4.9 3.0 6.7 4.0 19.5 19.5 10.9 0.0 18.4 11.1 13.9 5.9 14.7 9.2 6.8 30.7 13.6 11.1 6.5 11.2 10.6 20.3 20.2 6.5 8.9 10.0 1.3 4.1 1.1 20.8 12.7 3.3 PARP11 C12orf6 ENSG00000111224 "Poly(ADP-ribose) polymerase family member 11" Q9NR21 12 3791047-3873448 "Enzymes, Predicted intracellular proteins" "Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026895 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026895: AB_1854980" "unprognostic (9.58e-2)" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (3.58e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (2.11e-1)" "unprognostic (7.52e-2)" "unprognostic (3.81e-2)" "unprognostic (2.87e-2)" 7.1 14.5 11.2 8.6 9.2 3.7 8.3 11.0 9.1 6.4 5.4 5.6 4.8 4.9 10.2 7.5 5.0 6.3 5.6 5.1 6.1 5.7 5.7 5.7 6.3 12.8 5.0 5.7 13.1 6.6 10.0 10.4 4.1 7.6 12.0 5.7 7.2 6.6 6.0 4.1 3.9 6.5 7.2 6.1 9.2 4.2 12.8 5.6 16.9 12.3 2.7 12.1 8.3 5.8 10.7 10.2 18.3 10.2 8.2 12.5 7.1 2.3 1.9 12.8 2.0 4.1 6.5 3.6 2.8 4.8 5.0 5.0 7.3 1.8 7.0 1.8 6.2 6.3 2.0 4.2 4.2 8.1 14.1 4.2 10.0 0.0 5.4 4.6 6.7 3.8 5.2 3.3 3.9 11.1 0.0 3.7 13.7 2.6 5.7 7.0 3.3 3.5 2.6 4.7 2.4 0.3 7.1 8.7 1.6 2.3 5.3 0.8 2.9 2.8 2.4 3.6 14.6 0.4 6.1 7.2 4.3 4.3 6.6 3.8 2.7 5.9 9.8 4.1 3.7 1.1 18.3 10.2 10.2 9.2 8.5 12.5 10.7 10.2 6.7 10.2 10.1 11.7 9.4 10.2 8.2 6.4 8.9 4.3 7.1 11.2 9.2 11.0 9.1 6.1 5.7 5.0 5.7 7.6 5.6 8.9 7.4 11.8 4.3 1.6 11.1 3.2 2.5 6.7 2.3 1.8 2.0 3.0 0.0 3.1 60.8 4.5 2.1 0.0 2.6 1.5 4.6 8.0 14.9 3.4 6.2 3.2 3.5 8.0 9.1 25.5 9.8 6.9 1.7 3.6 3.7 6.2 2.9 4.2 8.1 3.3 6.9 6.5 5.1 7.5 8.7 1.6 2.2 10.2 4.3 3.4 PARP14 "KIAA1268, pART8" ENSG00000173193 "Poly(ADP-ribose) polymerase family member 14" Q460N5 3 122680618-122730840 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 229.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 29.6;BJ hTERT+ SV40 Large T+ RasG12V: 45.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008846, HPA012063" Supported Supported Cytosol NA NA Cytosol "HPA008846: AB_1854982, HPA012063: AB_1854981" "unprognostic (4.38e-2)" "unprognostic (1.07e-2)" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-1)" "unprognostic (2.50e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (1.44e-1)" "unprognostic (4.20e-2)" "unprognostic (1.74e-3)" "unprognostic (1.62e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (7.87e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-3)" "unprognostic (1.71e-2)" 21.6 10.3 5.6 15.8 7.2 11.7 9.3 2.3 6.0 11.6 13.3 5.9 6.4 11.4 10.6 12.7 11.7 7.2 10.0 6.5 5.2 4.8 13.7 21.5 26.0 16.7 7.3 5.2 10.0 6.7 7.2 6.8 17.5 6.3 12.3 6.7 7.5 8.5 5.5 5.2 5.7 22.3 11.9 6.8 29.7 7.6 4.6 4.9 18.7 20.4 6.4 18.9 12.8 12.4 15.9 4.2 20.8 10.5 7.4 7.0 2.8 5.9 5.0 3.2 3.4 4.5 10.7 0.0 2.3 15.6 29.6 45.6 2.6 11.9 0.0 9.8 5.2 16.6 4.6 4.6 4.8 6.0 9.1 0.5 5.5 2.3 4.0 10.9 2.4 2.7 6.4 2.4 5.1 2.0 7.2 12.8 4.9 2.6 8.9 1.0 3.1 9.1 1.6 0.4 0.9 4.3 12.8 3.2 1.6 7.2 6.2 0.2 0.0 6.0 1.3 6.7 0.4 2.2 4.3 8.6 1.6 3.9 0.9 2.1 3.5 0.6 1.0 4.8 5.7 2.8 8.3 8.2 4.0 6.9 10.5 6.0 10.2 3.8 4.5 4.2 15.9 3.2 3.4 20.8 7.4 9.3 0.6 7.0 2.8 5.6 7.2 2.3 6.0 5.2 4.8 7.3 5.2 6.3 4.9 229.3 87.3 41.0 15.2 14.9 1.1 10.1 30.6 52.2 84.2 24.4 3.9 12.0 3.3 28.1 0.3 61.9 21.0 0.0 35.6 24.3 19.7 23.9 30.2 29.6 32.4 0.0 10.3 67.5 50.6 0.2 25.9 50.6 15.1 94.6 14.3 18.7 33.8 17.5 16.3 7.0 0.8 12.9 18.4 1.6 1.1 9.3 4.0 27.4 11.0 21.3 PARP4 "ADPRTL1, p193, VAULT3, VPARP, VWA5C" ENSG00000102699 "Poly(ADP-ribose) polymerase family member 4" Q9UKK3 13 24420926-24512810 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Ribonucleoprotein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 83.0;granulocytes: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011739 Approved Supported Cytosol Yes No Cytosol "HPA011739: AB_1854986" "unprognostic (1.61e-1)" "unprognostic (2.34e-2)" "unprognostic (1.62e-2)" "unprognostic (4.35e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" "unprognostic (2.52e-1)" "unprognostic (2.45e-1)" "unprognostic (2.02e-2)" "unprognostic (4.12e-3)" "unprognostic (2.97e-2)" "prognostic favorable (1.21e-5)" "unprognostic (3.23e-2)" "unprognostic (1.71e-1)" "unprognostic (3.80e-2)" "unprognostic (2.84e-3)" 25.3 24.7 6.6 16.7 12.9 11.6 14.6 2.3 7.0 17.8 39.4 16.7 21.6 22.9 19.1 11.2 22.2 14.9 23.8 11.3 7.9 5.6 28.8 17.3 17.8 16.5 14.6 4.4 15.9 15.5 11.2 12.6 14.8 12.5 16.1 24.1 14.0 17.7 30.9 6.5 10.2 49.9 15.5 20.5 28.4 20.4 7.0 12.1 28.8 18.2 11.3 26.2 23.3 13.2 9.0 16.4 26.1 18.6 11.8 12.9 10.6 14.6 13.1 6.4 11.6 17.8 25.4 5.4 17.1 22.4 15.0 13.4 5.3 38.2 11.0 17.1 15.5 16.6 17.1 9.6 17.3 12.3 25.1 6.7 15.7 12.2 12.3 10.2 20.1 15.6 14.6 5.8 12.4 6.6 29.4 24.6 8.6 4.4 4.9 17.7 6.8 12.6 9.7 7.3 34.7 16.2 12.0 12.1 15.4 27.9 30.2 5.9 7.5 12.5 5.0 11.8 8.8 2.5 16.6 34.8 6.8 7.1 8.7 17.4 5.6 6.4 14.5 12.4 10.6 14.8 25.2 12.4 26.1 12.9 15.3 12.9 9.0 10.8 12.8 16.4 5.1 8.1 9.6 14.3 11.8 18.6 6.2 12.7 10.6 6.6 12.9 2.3 7.0 7.9 5.6 14.6 4.4 12.5 12.1 47.6 43.8 12.3 5.6 2.5 6.0 15.5 20.4 83.0 64.8 24.4 2.0 4.6 5.0 20.5 3.5 18.8 54.7 0.0 19.4 7.7 6.9 8.6 92.8 12.9 15.7 1.6 4.7 36.2 23.1 3.1 10.9 25.1 8.5 31.5 26.9 7.0 25.8 48.9 7.8 15.6 6.9 6.5 6.2 2.8 7.2 3.3 1.6 15.2 26.0 14.8 PARP8 "FLJ21308, pART16" ENSG00000151883 "Poly(ADP-ribose) polymerase family member 8" Q8N3A8 5 50665899-50846522 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "T-cells: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049183 Approved Approved "Nucleoplasm,Midbody ring,Cytosol" Yes No Nucleoplasm "Midbody ring, Cytosol" "HPA049183: AB_2680667" "unprognostic (1.22e-2)" "unprognostic (2.53e-1)" "unprognostic (1.77e-1)" "unprognostic (1.05e-1)" "unprognostic (2.12e-1)" "unprognostic (6.33e-2)" "unprognostic (8.86e-3)" "unprognostic (7.27e-2)" "unprognostic (1.86e-2)" "unprognostic (8.96e-2)" "unprognostic (2.85e-1)" "unprognostic (6.81e-2)" "unprognostic (9.63e-2)" "unprognostic (2.84e-2)" "unprognostic (4.42e-2)" "unprognostic (4.23e-2)" "prognostic favorable (1.12e-4)" 6.2 7.8 8.8 17.1 9.5 33.5 5.3 2.4 18.7 5.6 5.5 3.3 0.6 6.8 5.2 5.4 5.2 7.4 12.3 3.6 12.8 8.0 5.8 4.2 10.9 18.2 4.9 11.0 5.9 7.1 9.8 14.4 5.6 5.4 6.1 4.3 4.1 7.6 4.2 1.7 4.2 14.2 5.4 7.0 20.1 10.2 6.4 2.8 9.9 21.9 1.1 12.3 8.8 7.0 7.1 3.9 13.1 5.9 15.5 32.0 9.5 11.6 0.0 5.4 8.6 1.5 2.6 8.6 1.9 7.0 1.9 5.5 0.3 15.4 6.9 8.2 0.2 19.8 5.8 0.9 5.8 4.5 9.7 7.4 5.1 4.7 0.4 2.8 11.9 0.1 3.3 4.9 3.8 2.7 11.6 0.1 10.9 0.7 4.2 2.6 3.8 14.2 15.0 5.8 0.2 2.8 7.2 11.4 7.9 3.5 5.8 6.0 9.3 6.2 10.2 1.6 8.3 0.4 42.0 0.0 0.4 7.3 0.5 5.7 3.1 0.1 13.4 6.5 3.3 7.9 10.3 5.9 13.1 20.6 1.6 32.0 6.0 16.1 23.0 3.9 7.1 10.0 16.7 12.3 15.5 1.1 1.8 9.5 9.5 8.8 9.5 2.4 18.7 12.8 8.0 4.9 11.0 5.4 2.8 29.8 22.6 12.3 4.8 7.1 13.4 4.5 12.7 21.4 21.6 21.0 0.0 17.5 6.6 11.2 19.7 4.5 6.9 0.0 8.8 5.9 9.1 8.6 13.9 3.6 12.9 6.4 14.5 8.6 28.5 11.4 1.1 17.1 8.5 13.6 3.6 0.5 14.3 7.6 2.8 3.7 2.1 6.5 6.9 5.1 5.5 3.4 20.7 90.6 6.5 13.5 PARP9 "BAL, BAL1" ENSG00000138496 "Poly(ADP-ribose) polymerase family member 9" Q8IXQ6 3 122527924-122564577 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 35.1;BJ hTERT+ SV40 Large T+ RasG12V: 41.9;SK-MEL-30: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066708 Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA066708: AB_2685707" "unprognostic (3.06e-2)" "unprognostic (4.80e-2)" "unprognostic (1.55e-3)" "unprognostic (6.70e-3)" "unprognostic (1.11e-1)" "unprognostic (6.38e-2)" "unprognostic (4.73e-3)" "unprognostic (3.39e-3)" "unprognostic (1.31e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.00e-3)" "unprognostic (5.63e-3)" "unprognostic (1.56e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-2)" "unprognostic (9.65e-3)" "unprognostic (1.56e-2)" 27.1 20.2 8.7 17.2 12.4 9.1 13.8 2.9 13.9 13.1 13.1 9.9 7.4 10.4 23.3 10.1 15.6 12.3 14.9 8.5 7.4 6.0 17.8 38.6 18.9 17.5 8.5 6.0 12.1 14.4 16.0 20.3 11.9 10.3 15.1 10.1 11.5 19.1 6.6 8.6 5.7 21.2 14.8 16.3 27.3 11.1 5.4 10.3 21.8 17.5 9.0 19.1 13.7 9.8 7.3 11.9 38.2 18.0 13.0 10.6 9.1 8.0 2.7 1.0 0.7 6.3 13.0 0.9 2.7 14.7 35.1 41.9 4.2 8.9 1.8 6.0 5.4 22.1 8.9 2.3 4.8 7.3 14.0 1.6 8.7 2.8 2.2 6.7 2.8 5.8 10.6 4.7 5.0 1.2 7.0 7.5 5.6 0.8 7.5 1.4 3.5 8.9 3.5 0.4 1.6 7.6 9.5 9.9 0.6 13.4 4.6 0.6 2.4 7.2 1.2 32.4 0.5 3.8 3.1 4.5 1.5 4.4 0.3 1.6 4.7 2.4 3.3 5.2 3.1 2.7 14.4 12.7 15.3 9.2 17.7 8.6 7.3 9.8 10.3 11.9 5.0 7.5 9.1 38.2 13.0 18.0 1.4 10.6 9.1 8.7 12.4 2.9 13.9 7.4 6.0 8.5 6.0 10.3 10.3 38.7 36.9 16.7 9.4 6.4 0.8 5.2 10.2 61.6 44.3 19.2 0.0 4.3 1.7 24.9 1.3 19.0 15.3 0.0 34.9 16.2 11.4 10.4 9.3 43.1 36.1 0.0 10.3 21.5 31.3 2.6 17.0 29.4 6.8 32.5 9.7 14.7 28.4 7.2 22.6 18.9 0.8 19.4 9.6 1.0 0.9 5.8 1.4 12.7 6.6 15.5 PARVA "FLJ10793, FLJ12254, MXRA2" ENSG00000197702 "Parvin alpha" 11 12377185-12530801 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 4.0;memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 40 "T-cells: 4.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 53.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005964 Approved Supported "Actin filaments,Focal adhesion sites,Cytosol" NA NA "Actin filaments, Focal adhesion sites" Cytosol "HPA005964: AB_1079569" "unprognostic (3.87e-2)" "unprognostic (7.38e-2)" "unprognostic (3.30e-2)" "prognostic favorable (1.76e-4)" "unprognostic (7.37e-3)" "unprognostic (1.38e-2)" "unprognostic (6.78e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (1.76e-2)" "unprognostic (2.80e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-2)" "unprognostic (6.73e-2)" "unprognostic (6.58e-3)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.82e-2)" 30.5 8.3 7.1 14.4 6.5 0.0 44.0 3.9 8.3 29.2 39.2 3.5 25.8 6.9 40.5 17.6 27.0 17.2 35.2 21.3 6.4 5.3 15.3 10.7 13.2 8.5 5.3 7.8 22.7 16.2 10.1 6.3 16.3 5.5 31.7 16.4 18.3 13.4 35.1 6.4 7.7 13.1 55.9 5.0 8.4 24.2 8.4 2.8 0.4 10.5 8.1 5.0 38.8 33.4 0.0 0.0 0.0 0.0 0.0 4.0 0.1 7.7 7.7 7.2 9.3 36.8 28.6 16.7 29.7 30.7 21.0 19.7 5.7 12.1 0.0 9.9 53.9 2.3 4.8 0.1 15.5 25.1 0.1 3.9 0.0 10.9 4.3 28.3 0.0 0.2 22.5 6.3 8.8 13.8 26.1 26.1 0.0 0.0 0.0 31.2 4.6 0.0 0.0 3.3 4.6 6.7 0.0 17.9 0.0 11.6 7.6 1.1 0.0 22.8 9.2 15.3 16.8 4.3 0.2 32.2 25.4 10.6 13.6 8.1 0.0 0.0 0.0 14.1 0.0 27.9 0.0 0.0 0.0 0.5 0.0 4.0 0.0 1.3 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 7.1 6.5 3.9 8.3 6.4 5.3 5.3 7.8 5.5 2.8 92.3 24.1 1.7 21.5 12.2 1.5 37.0 20.4 69.6 28.4 26.2 0.0 36.9 33.2 52.3 0.4 35.1 27.4 0.0 58.4 78.2 48.2 29.5 4.7 15.3 5.7 0.0 26.0 40.5 1.6 0.9 38.0 2.5 43.9 1.8 21.5 21.4 55.2 21.0 48.8 29.7 2.1 51.8 48.4 1.1 3.4 7.9 15.9 3.8 29.3 20.3 PARVB CGI-56 ENSG00000188677 "Parvin beta" Q9HBI1 22 43999211-44172949 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 64.5;Hofbauer cells: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 44.5;RPMI-8226: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062601, HPA072217" Enhanced Approved Cytosol NA NA 90000000 Cytosol "HPA062601: AB_2684803, HPA072217: " "unprognostic (2.41e-1)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.83e-2)" "unprognostic (2.10e-3)" "unprognostic (7.65e-3)" "unprognostic (1.28e-1)" "unprognostic (1.73e-2)" "unprognostic (2.28e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-2)" "unprognostic (6.45e-2)" "unprognostic (1.28e-2)" "unprognostic (4.87e-3)" "unprognostic (3.19e-2)" "unprognostic (4.19e-2)" "unprognostic (7.05e-3)" 15.9 10.7 6.4 9.7 7.3 16.8 17.4 3.1 8.3 8.0 7.2 3.5 6.3 3.7 8.6 8.7 7.3 6.8 5.3 28.5 5.6 8.8 7.3 7.3 12.6 19.7 8.0 6.3 13.4 4.8 8.6 9.3 10.2 5.8 7.8 4.4 9.3 5.3 7.2 82.1 5.1 6.3 11.9 8.3 15.2 5.4 5.7 4.5 2.3 4.9 22.4 7.9 11.7 26.0 6.3 14.1 4.8 6.4 0.7 2.2 8.3 6.4 7.7 0.1 5.4 8.2 10.4 0.0 9.1 5.6 5.9 4.5 7.9 3.8 0.0 5.0 24.2 4.7 0.2 12.9 0.6 3.3 9.0 8.0 27.6 13.4 0.0 13.6 20.7 24.8 16.1 6.8 4.3 0.0 4.3 44.5 0.1 9.8 18.9 6.4 4.3 0.1 13.7 2.7 5.6 5.3 0.0 0.2 43.4 0.1 0.1 7.0 4.9 2.4 0.4 22.8 0.9 4.5 8.4 27.6 5.4 5.8 8.3 0.9 4.7 4.1 0.2 23.8 6.1 29.8 4.5 6.1 1.4 1.0 6.4 1.6 6.0 1.7 1.4 6.8 6.3 0.4 0.9 4.8 0.7 2.6 14.1 2.2 8.3 6.4 7.3 3.1 8.3 5.6 8.8 8.0 6.3 5.8 4.5 0.0 11.7 29.8 2.6 4.6 9.2 34.8 5.1 6.7 1.2 1.8 15.7 0.9 23.2 1.0 5.5 46.8 0.0 46.7 2.7 8.6 19.0 3.2 64.5 9.8 82.8 6.4 1.2 46.1 44.1 13.6 18.4 40.4 18.6 44.1 0.1 6.7 5.5 0.0 10.3 11.6 13.3 6.5 6.9 1.4 3.2 3.9 1.5 12.8 0.6 1.1 PASK "KIAA0135, PASKIN, STK37" ENSG00000115687 "PAS domain containing serine/threonine kinase" Q96RG2 2 241106099-241150264 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 24.1;testis: 22.0" "Cell type enhanced" "Detected in many" 6 "Ito cells: 27.0;Peritubular cells: 23.0;Rod photoreceptor cells: 17.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 24.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA016450, HPA021079" Uncertain Supported Cytosol NA NA Cytosol "HPA016450: AB_1854992, HPA021079: AB_1854993" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.84e-1)" "unprognostic (1.41e-2)" "unprognostic (1.14e-1)" "unprognostic (8.99e-6)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.60e-3)" "unprognostic (1.58e-2)" "unprognostic (1.02e-2)" "unprognostic (6.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.52e-3)" "unprognostic (1.68e-1)" "unprognostic (6.44e-2)" "unprognostic (4.38e-3)" 1.5 1.1 2.4 10.3 24.1 8.9 3.1 6.3 5.2 2.2 2.1 2.2 2.1 3.8 2.9 6.7 3.1 7.2 3.3 1.1 2.9 2.7 3.7 1.3 3.0 14.5 1.3 1.6 1.9 3.3 4.4 4.9 1.1 3.6 12.1 2.8 4.7 2.7 1.8 2.0 4.9 3.9 1.4 1.6 4.4 3.4 22.0 7.2 9.0 4.8 1.9 9.9 2.7 1.9 7.1 1.1 4.8 1.0 2.7 6.0 3.0 5.0 6.8 9.2 11.6 0.8 1.4 12.3 4.8 1.5 4.5 6.3 5.5 5.1 2.6 1.0 1.1 10.0 12.6 10.4 4.2 3.3 10.6 9.9 7.2 12.6 9.7 0.5 9.8 11.3 0.7 3.3 4.6 1.3 1.9 3.2 11.2 9.3 3.6 3.1 5.7 11.6 10.3 10.2 5.9 4.1 18.5 9.3 3.2 1.7 11.4 16.3 4.9 2.9 5.6 2.1 5.1 4.7 7.1 4.2 6.1 5.6 7.8 6.4 4.8 4.9 12.4 3.8 7.4 5.6 4.8 1.0 0.7 1.7 0.6 1.5 7.1 5.9 5.3 1.1 6.6 3.7 3.9 1.3 2.7 1.0 0.7 6.0 3.0 2.4 24.1 6.3 5.2 2.9 2.7 1.3 1.6 3.6 7.2 3.0 9.3 10.6 1.0 2.4 2.3 2.8 2.5 6.7 1.2 3.5 3.9 0.8 0.0 1.2 7.7 2.4 1.8 0.0 1.8 1.5 0.9 2.5 3.5 1.0 1.6 1.6 0.0 27.0 5.3 2.2 5.5 1.9 11.8 1.0 2.9 1.6 0.6 0.0 23.0 1.0 17.7 0.0 0.3 14.7 12.7 1.3 0.2 13.1 2.7 0.7 PATJ "Cipp, INADL" ENSG00000132849 "PATJ, crumbs cell polarity complex component" Q8NI35 1 61742406-62178675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4" "Group enriched" "Detected in some" 9 "Alveolar cells type 1: 80.4;Alveolar cells type 2: 49.2;Ciliated cells: 49.5;Club cells: 71.7;Collecting duct cells: 54.1;Ductal cells: 30.3;Exocrine glandular cells: 23.0;Pancreatic endocrine cells: 38.8;Proximal tubular cells: 28.9;Syncytiotrophoblasts: 22.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 19.2;RPTEC TERT1: 16.9;RT4: 18.1" "Low region specificity" "Detected in many" "HPA066352, HPA066960, HPA069079" Approved Supported "Cell Junctions,Centriolar satellite,Cytosol" NA NA "Cell Junctions" "Centriolar satellite, Cytosol" "HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079" "unprognostic (1.81e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (7.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.88e-1)" "unprognostic (9.90e-2)" "unprognostic (3.39e-3)" "unprognostic (2.99e-2)" "prognostic favorable (1.47e-5)" "unprognostic (3.05e-3)" "unprognostic (6.72e-3)" "unprognostic (2.21e-2)" "unprognostic (2.43e-1)" 2.6 4.6 3.4 6.3 4.4 1.9 11.6 66.4 3.2 5.7 9.6 2.0 17.9 5.5 4.4 17.7 11.6 5.3 10.3 27.8 2.3 5.1 19.8 7.7 12.5 6.1 4.6 2.0 4.7 17.9 15.2 21.4 2.8 14.2 8.4 7.0 4.4 24.8 24.3 25.4 13.9 15.7 5.2 15.8 2.2 6.3 2.7 3.0 1.3 17.0 11.1 9.6 7.4 7.5 1.8 0.3 9.9 0.2 3.2 4.1 0.8 19.2 3.9 1.3 1.7 0.7 1.9 16.3 1.1 1.5 1.2 1.6 6.7 7.3 0.1 5.2 2.4 10.5 11.6 2.8 10.2 2.1 1.9 4.8 0.1 5.6 5.9 1.6 0.0 0.1 0.7 10.9 2.0 4.6 3.0 0.6 0.0 0.0 0.0 1.0 6.7 0.0 0.0 6.7 8.7 1.0 0.0 1.4 2.7 16.9 18.1 3.3 1.1 4.9 16.0 4.2 13.8 12.7 0.2 0.1 1.0 2.4 0.1 2.2 0.8 1.4 2.5 0.9 0.0 0.2 0.4 0.1 9.9 1.9 0.1 3.5 1.8 3.1 2.6 0.1 1.5 4.1 2.6 0.9 3.2 0.2 0.3 2.7 0.8 3.4 4.4 66.4 3.2 2.3 5.1 4.6 2.0 14.2 3.0 80.4 49.2 0.0 0.0 0.0 0.0 0.0 0.0 49.5 71.7 54.1 0.0 2.5 5.0 30.3 0.0 0.0 0.0 0.0 23.0 0.6 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 PAX5 BSAP ENSG00000196092 "Paired box 5" Q02548 9 36833275-37034185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 21.6;lymphoid tissue: 33.4" "Cell type enriched" "Detected in some" 27 "B-cells: 57.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "midbrain: 1.6" "Group enriched" "Detected in some" 209 "memory B-cell: 20.1;naive B-cell: 21.6" "Lineage enriched" "Detected in single" 216 "B-cells: 21.6" "Group enriched" "Detected in some" 8 "Daudi: 21.5;REH: 62.5;U-698: 28.2" "Region enriched" "Detected in single" 11 "midbrain: 4.7" "Group enriched" "Detected in some" 6 "hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2" "CAB026269, CAB026869, HPA056394, HPA068498" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997" "unprognostic (4.69e-4)" "unprognostic (3.83e-1)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.46e-2)" "unprognostic (1.11e-3)" "unprognostic (3.15e-1)" "unprognostic (8.96e-2)" "unprognostic (6.03e-2)" "unprognostic (1.01e-1)" 0.4 0.2 0.2 33.4 0.2 5.5 0.2 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.4 0.2 0.2 0.3 0.5 0.3 0.3 23.2 1.6 0.0 0.2 0.2 0.0 0.5 0.1 0.2 0.3 0.3 0.4 2.5 0.0 0.6 0.2 8.7 0.0 0.3 16.5 0.7 0.9 0.0 2.3 0.4 0.2 30.1 1.3 0.2 21.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.1 62.5 0.1 0.1 0.0 0.0 4.4 1.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 1.6 0.0 0.2 0.0 0.0 0.0 57.6 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 PAXBP1 "C21orf66, fSAP105, GCFC, GCFC1" ENSG00000159086 "PAX3 and PAX7 binding protein 1" Q9Y5B6 21 32733899-32771858 "Plasma proteins, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NTERA-2: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003757 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003757: AB_10600796" "unprognostic (8.21e-2)" "unprognostic (7.50e-2)" "unprognostic (1.04e-1)" "unprognostic (1.67e-1)" "unprognostic (6.53e-2)" "unprognostic (2.03e-3)" "unprognostic (2.38e-3)" "unprognostic (2.54e-2)" "unprognostic (6.89e-2)" "unprognostic (2.65e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (9.43e-4)" "prognostic unfavorable (1.50e-5)" "unprognostic (3.16e-1)" "unprognostic (3.78e-2)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" 8.9 10.6 11.9 16.6 19.6 42.0 11.6 25.7 20.0 13.5 14.1 11.3 10.1 15.8 16.3 12.4 10.3 11.6 10.1 8.3 11.2 9.7 11.3 10.3 10.1 13.7 22.7 10.0 19.8 12.3 11.6 19.3 13.2 14.7 11.2 12.6 6.9 10.2 10.5 15.2 12.6 12.8 10.8 19.0 11.2 9.5 12.9 19.7 18.5 11.3 5.0 12.3 11.2 18.9 2.2 1.6 0.3 1.3 0.7 3.1 0.4 7.5 6.2 12.5 9.8 4.9 3.9 17.9 5.6 3.6 7.4 5.4 13.0 6.8 9.0 4.4 3.1 5.7 7.7 12.5 5.2 7.7 7.3 10.4 15.5 10.2 9.4 2.4 17.3 9.2 2.1 7.9 8.6 3.8 4.8 4.8 9.5 18.0 8.3 5.4 6.6 11.8 10.1 35.4 8.4 6.3 11.0 11.9 13.1 5.8 7.0 10.3 5.9 8.0 9.3 6.3 8.1 5.9 9.7 4.2 5.5 7.6 6.4 8.7 8.2 10.2 16.7 4.0 15.8 5.5 0.0 1.3 0.3 2.2 0.6 3.1 1.6 2.5 1.9 1.6 2.2 2.7 2.6 0.0 0.7 0.8 1.1 1.4 0.4 11.9 19.6 25.7 20.0 11.2 9.7 22.7 10.0 14.7 19.7 11.9 16.3 9.8 17.0 22.7 51.8 11.5 15.3 28.1 20.5 19.2 58.9 13.9 5.0 6.5 28.6 16.1 13.2 0.0 6.8 10.2 16.4 18.1 11.5 9.9 9.0 20.6 21.2 12.9 11.8 25.3 13.6 15.8 20.3 2.8 15.4 37.6 6.3 12.2 15.9 5.7 78.8 32.3 15.1 24.2 15.5 22.2 14.9 13.1 18.8 22.8 PBDC1 "CXorf26, MGC874" ENSG00000102390 "Polysaccharide biosynthesis domain containing 1" Q9BVG4 X 76172936-76178204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003155 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA 88000 Nucleoplasm "Nucleoli, Cytosol" "HPA003155: AB_1078592" "unprognostic (6.95e-2)" "unprognostic (9.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.78e-2)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (2.47e-3)" "unprognostic (7.23e-2)" "unprognostic (1.78e-1)" "unprognostic (1.56e-3)" "unprognostic (8.82e-3)" "unprognostic (3.64e-1)" "unprognostic (1.39e-2)" "unprognostic (1.05e-1)" "unprognostic (4.98e-2)" "prognostic favorable (8.57e-4)" "unprognostic (1.62e-1)" 24.9 25.4 12.7 15.1 14.3 28.9 17.1 15.3 14.9 21.3 31.5 10.0 14.8 28.5 21.3 18.4 26.9 15.1 14.2 14.7 12.5 12.5 36.3 39.1 16.6 17.0 17.6 8.8 23.1 16.1 15.2 22.8 21.9 15.0 22.3 20.9 10.3 18.0 14.3 19.2 19.5 48.9 22.3 22.7 23.8 17.8 8.4 14.6 21.1 22.5 21.2 18.2 20.8 17.6 28.1 24.0 17.0 27.8 27.1 30.6 17.1 12.1 17.7 15.2 10.4 19.5 19.5 13.1 21.6 18.5 19.9 17.2 16.9 16.8 16.6 14.6 21.8 24.8 17.5 25.3 24.2 26.0 12.3 16.0 12.3 9.9 25.3 30.7 36.1 18.1 15.5 19.9 27.2 23.3 12.1 25.3 6.0 17.4 8.3 24.3 14.2 17.0 26.5 42.2 30.2 27.8 14.6 16.0 2.1 29.1 22.5 8.9 11.5 9.5 15.9 0.1 20.5 9.7 13.6 21.7 14.9 14.9 17.7 19.7 14.6 25.8 9.9 16.5 12.7 11.7 6.7 17.6 17.0 30.6 25.6 22.2 28.1 27.5 29.7 22.5 23.7 28.2 26.9 3.3 27.1 27.8 24.0 22.5 17.1 12.7 14.3 15.3 14.9 12.5 12.5 17.6 8.8 15.0 14.6 32.8 23.2 24.8 69.4 47.1 21.4 36.9 33.1 33.5 30.7 38.4 13.7 48.2 41.4 60.7 1.0 28.6 58.6 0.0 54.4 49.7 36.0 52.4 50.7 46.4 62.6 7.9 26.5 19.6 30.5 1.1 44.3 40.9 43.9 80.2 37.2 21.5 53.5 34.8 36.4 66.3 19.3 51.8 41.1 2.3 16.4 61.6 46.0 44.5 46.0 68.1 PBK "CT84, FLJ14385, Nori-3, SPK, TOPK" ENSG00000168078 "PDZ binding kinase" Q96KB5 8 27809620-27838095 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "lymphoid tissue: 19.4;testis: 67.9" "Group enriched" "Detected in many" 4 "Early spermatids: 218.2;Spermatocytes: 187.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.1;T-reg: 1.6" "Group enriched" "Detected in many" 10 "NK-cells: 2.1;T-cells: 1.6" "Cell line enhanced" "Detected in many" "A-431: 61.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA005753, HPA050656" Enhanced Supported Approved Cytosol NA Yes Cytosol "HPA005753: AB_1855018, HPA050656: AB_2681205" "unprognostic (7.17e-2)" "unprognostic (7.21e-3)" "unprognostic (1.04e-3)" "unprognostic (2.77e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.29e-5)" "unprognostic (3.65e-3)" "unprognostic (7.38e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.18e-12)" "unprognostic (9.61e-2)" "unprognostic (1.86e-1)" "unprognostic (8.30e-2)" "unprognostic (8.68e-2)" 0.6 0.8 0.2 7.7 0.3 3.3 1.3 0.3 0.4 1.1 3.8 0.3 0.2 3.7 0.4 0.6 6.2 0.3 0.8 3.3 0.3 0.2 0.7 0.9 1.2 5.4 0.3 0.2 0.4 0.4 0.0 0.2 2.2 0.3 0.4 4.6 0.2 1.1 0.2 0.4 1.9 3.6 0.9 0.6 1.7 1.7 67.9 0.2 19.4 0.3 4.7 5.3 0.7 1.9 0.1 0.0 0.0 0.0 2.1 1.6 0.5 61.3 20.0 19.7 12.5 1.9 3.5 8.3 28.2 13.4 29.0 24.5 6.9 11.4 32.7 10.0 10.8 32.3 16.3 18.9 9.5 31.9 8.0 10.2 7.8 14.2 10.1 0.1 5.1 11.7 0.9 7.8 13.4 7.2 5.2 14.6 16.2 11.5 22.0 34.2 6.9 19.3 6.0 3.5 16.6 17.4 12.1 27.4 8.8 10.9 9.5 7.8 12.2 10.5 12.4 15.8 5.7 13.0 7.8 8.5 19.1 46.0 24.2 29.9 3.1 8.7 15.1 11.6 9.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 1.6 0.5 0.2 0.3 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.9 7.9 0.0 0.3 5.1 0.0 2.3 0.0 0.0 3.1 0.0 0.5 218.2 0.0 1.3 46.7 0.0 40.6 2.9 0.7 0.0 1.0 4.2 0.0 0.0 7.4 1.9 37.5 7.8 0.6 0.0 0.0 4.3 0.0 0.2 0.0 2.8 0.0 0.0 6.5 0.5 187.0 31.0 2.0 5.6 0.0 5.3 0.7 PBX1 ENSG00000185630 "PBX homeobox 1" P40424 1 164555584-164899296 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "HEL: 30.9;NTERA-2: 30.3;SK-BR-3: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003505, HPA003881, CAB018768" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020" "unprognostic (2.26e-2)" "unprognostic (1.95e-1)" "unprognostic (9.09e-2)" "unprognostic (2.14e-2)" "unprognostic (5.21e-3)" "unprognostic (6.94e-3)" "unprognostic (5.95e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "unprognostic (2.24e-3)" "unprognostic (2.30e-1)" "unprognostic (8.81e-2)" "unprognostic (1.34e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 13.2 17.3 14.9 8.3 15.0 1.4 16.4 14.1 17.4 73.4 26.3 11.2 15.9 13.6 67.2 15.3 20.8 35.1 25.8 12.6 10.9 9.7 15.4 4.2 10.4 2.3 11.6 14.6 35.2 29.4 21.3 12.4 9.6 8.1 27.6 9.3 10.2 19.6 25.1 16.8 6.0 14.6 56.8 8.0 5.1 13.9 9.7 8.7 2.7 17.4 8.5 6.6 32.2 24.7 0.0 0.1 2.9 0.0 0.3 0.2 2.5 1.1 22.6 22.3 6.0 15.1 7.3 1.3 9.5 6.1 2.6 1.8 4.3 4.0 0.0 2.0 12.9 1.4 7.9 8.8 2.5 1.0 1.1 9.4 30.9 18.2 0.0 10.0 0.0 7.9 7.2 0.0 1.6 0.7 5.6 0.1 0.0 0.0 0.0 0.7 14.9 0.0 0.1 30.3 1.3 1.1 0.0 7.4 9.0 1.8 13.5 0.8 13.2 10.9 62.4 0.0 21.3 23.7 0.0 0.1 1.3 3.1 8.8 2.7 2.8 21.3 0.0 0.1 0.0 0.1 2.9 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.1 0.0 2.5 14.9 15.0 14.1 17.4 10.9 9.7 11.6 14.6 8.1 8.7 20.8 15.2 0.9 91.3 20.3 27.6 44.2 91.7 25.4 21.6 31.4 104.1 89.0 28.2 41.5 72.1 39.2 28.0 0.0 58.9 4.5 75.2 44.0 71.4 17.3 8.6 4.8 87.2 60.8 1.6 78.2 59.0 6.8 15.1 1.8 35.4 34.9 31.8 59.6 97.6 49.4 28.8 38.8 62.7 0.9 11.5 24.6 87.5 3.2 39.4 82.1 PBX3 ENSG00000167081 "PBX homeobox 3" P40426 9 125747345-125967377 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.7" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 16.1" "Lineage enriched" "Detected in all" 4 "dendritic cells: 16.1" "Cell line enhanced" "Detected in many" "THP-1: 36.5" "Region enhanced" "Detected in all" "olfactory region: 205.0" "Region enriched" "Detected in all" 4 "olfactory region: 287.4" HPA003881 Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA003881: AB_1855020" "unprognostic (1.97e-2)" "unprognostic (3.78e-2)" "unprognostic (1.15e-1)" "unprognostic (1.93e-2)" "unprognostic (1.27e-1)" "unprognostic (2.35e-1)" "unprognostic (2.20e-1)" "unprognostic (3.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.88e-1)" "unprognostic (2.42e-3)" "unprognostic (7.02e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (8.03e-2)" "unprognostic (6.29e-2)" 8.0 25.0 4.4 16.2 11.6 3.0 10.4 6.6 3.4 16.6 18.9 3.7 6.5 3.1 10.7 10.9 9.1 5.9 22.8 16.1 2.9 6.3 3.4 7.6 9.4 6.1 9.5 3.4 35.0 12.9 86.7 6.8 3.1 13.0 18.8 6.1 7.1 10.5 12.3 3.6 8.2 6.0 21.2 17.6 5.5 10.0 5.1 6.2 6.8 14.7 5.5 3.8 13.3 12.0 1.8 16.1 2.9 1.8 3.8 2.1 1.0 4.7 4.6 20.8 19.2 5.8 9.5 3.7 12.4 7.1 8.7 6.2 5.9 9.4 4.7 1.5 9.9 8.9 3.6 11.7 5.0 17.2 5.0 8.3 4.0 3.5 2.3 7.4 4.4 7.3 4.8 5.7 6.8 4.4 19.2 9.7 3.2 0.2 4.5 17.9 2.5 4.1 2.1 15.3 5.7 3.1 7.7 31.0 0.6 6.6 2.8 11.2 19.4 8.6 1.6 3.8 8.2 7.1 36.5 11.7 17.6 4.8 10.3 23.2 3.2 5.0 4.9 8.4 6.2 9.0 2.9 1.8 2.3 0.9 1.6 1.2 1.4 1.2 1.0 2.1 1.8 2.1 1.0 1.7 3.8 1.3 16.1 1.8 1.0 4.4 11.6 6.6 3.4 2.9 6.3 9.5 3.4 13.0 6.2 8.9 14.7 3.2 9.5 20.1 6.8 52.9 2.5 9.4 13.6 12.2 35.3 0.3 6.6 9.5 11.1 10.8 0.9 0.0 2.2 0.8 11.1 16.7 16.1 9.6 14.6 39.7 11.1 11.1 29.5 8.8 18.4 15.9 6.8 9.0 6.2 8.0 2.8 15.9 10.6 1.5 38.9 0.0 12.0 12.2 7.9 23.1 0.3 7.2 2.3 7.6 PBXIP1 HPIP ENSG00000163346 "PBX homeobox interacting protein 1" Q96AQ6 1 154944076-154956123 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 200.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "Karpas-707: 159.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006949 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA006949: AB_1079572" "unprognostic (6.17e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (8.94e-2)" "unprognostic (2.16e-1)" "prognostic favorable (7.19e-4)" "unprognostic (1.62e-1)" "prognostic favorable (8.99e-4)" "unprognostic (1.21e-1)" "unprognostic (2.46e-1)" "prognostic favorable (2.64e-4)" "unprognostic (1.20e-2)" "prognostic favorable (9.22e-6)" "unprognostic (3.89e-1)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.26e-3)" 25.3 48.1 35.4 24.9 54.9 13.7 19.9 18.3 31.4 26.8 36.2 26.1 28.1 25.5 28.3 29.8 23.6 22.8 31.1 21.9 46.6 28.6 18.1 13.3 22.6 28.6 41.8 34.4 50.1 17.6 42.4 56.7 21.2 47.8 26.4 14.3 38.6 20.7 48.3 57.2 13.2 28.6 52.6 29.0 27.5 28.1 15.9 33.8 27.9 33.1 22.4 26.8 37.5 25.7 9.2 4.0 42.9 6.6 13.0 46.8 14.4 1.0 2.7 4.3 2.9 15.1 4.7 3.2 3.6 8.0 1.7 3.4 0.7 3.5 4.3 11.6 4.3 2.5 3.8 1.0 2.3 1.2 2.3 1.6 1.0 3.6 2.7 7.0 1.2 12.2 7.1 3.8 2.2 0.4 20.3 6.5 3.4 0.5 159.6 4.3 1.5 2.4 3.8 1.6 2.7 2.0 2.8 6.2 9.5 4.8 2.0 0.7 5.5 4.6 1.4 3.6 8.6 4.5 5.1 6.1 1.7 1.3 1.1 1.1 21.9 18.3 1.0 6.2 1.7 1.3 26.7 2.5 42.9 11.0 3.6 30.4 9.2 29.5 17.2 2.2 5.7 19.7 12.1 23.7 13.0 6.6 4.0 46.8 14.4 35.4 54.9 18.3 31.4 46.6 28.6 41.8 34.4 47.8 33.8 62.5 78.3 31.8 22.2 9.0 23.1 34.4 22.9 26.8 37.5 40.1 15.7 14.6 0.0 37.4 112.5 21.6 20.0 23.3 16.1 20.0 28.9 16.8 49.8 14.3 13.0 1.6 80.4 24.5 16.1 134.8 59.5 13.3 25.3 31.5 22.2 200.0 21.7 25.9 121.3 9.1 6.5 51.8 57.0 2.4 12.9 10.0 22.7 93.7 14.3 12.9 PCBD1 "DCOH, PCBD, PCD" ENSG00000166228 "Pterin-4 alpha-carbinolamine dehydratase 1" P61457 10 70882280-70888784 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation" "Activator, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 99.0" "Cell type enhanced" "Detected in all" 7 "Hepatocytes: 577.2;Proximal tubular cells: 733.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 67.0;Hep G2: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037575, HPA061723" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 210000 Nucleoplasm Cytosol "HPA037575: AB_10671761, HPA061723: AB_2684594" "unprognostic (1.02e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (3.69e-1)" "unprognostic (5.39e-2)" "unprognostic (4.80e-3)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (2.40e-2)" "unprognostic (2.95e-1)" "unprognostic (5.63e-2)" "unprognostic (3.38e-2)" "unprognostic (9.26e-2)" "unprognostic (1.74e-1)" "unprognostic (5.76e-2)" "unprognostic (7.43e-3)" 18.3 25.5 18.1 9.6 15.6 4.3 19.7 13.2 14.8 13.9 18.4 7.8 24.3 12.6 13.9 21.4 26.5 25.6 22.9 32.5 10.8 23.7 38.7 99.0 14.0 7.8 16.7 12.3 18.5 73.0 15.8 15.5 11.7 16.4 26.9 20.3 16.3 16.2 20.7 23.1 5.8 17.2 18.1 14.5 10.2 19.2 7.0 8.7 4.3 36.8 16.2 12.3 22.4 31.8 11.8 20.9 3.5 19.4 8.0 16.9 7.5 20.2 48.2 2.9 29.9 10.9 10.2 3.9 6.6 10.9 10.2 8.2 67.0 36.0 4.1 19.1 7.2 7.9 13.5 18.2 10.5 7.0 10.9 32.8 3.6 7.7 65.8 11.5 3.6 13.5 10.0 11.5 10.1 4.8 15.5 27.4 2.6 7.1 0.3 7.1 33.9 0.4 12.1 4.0 54.9 45.1 1.9 4.0 13.3 42.9 21.0 12.6 21.4 5.4 37.3 14.2 8.4 10.8 7.0 11.3 1.7 14.3 2.5 16.0 0.1 0.8 0.1 9.3 11.8 2.6 0.0 10.7 3.5 8.8 19.4 6.9 11.8 11.6 12.6 20.9 4.1 3.8 7.9 0.6 8.0 13.3 15.3 16.9 7.5 18.1 15.6 13.2 14.8 10.8 23.7 16.7 12.3 16.4 8.7 38.7 59.6 41.0 140.4 44.3 32.7 140.4 142.7 72.3 73.9 177.9 5.9 105.7 384.7 161.2 1.3 33.8 116.6 23.3 147.5 63.7 71.1 169.6 31.1 577.2 160.3 33.4 169.3 32.5 54.4 5.8 62.5 71.4 74.2 90.2 228.3 70.5 157.8 147.3 89.8 733.2 28.5 84.1 57.7 4.9 7.9 40.0 64.9 33.8 199.7 158.3 PCBP2 "hnRNP-E2, HNRNPE2, HNRPE2" ENSG00000197111 "Poly(rC) binding protein 2" Q15366 12 53452102-53481162 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038356, HPA073145" Approved Supported Nucleoplasm,Cytosol NA NA 2000000 Nucleoplasm Cytosol "HPA038356: AB_10697248, HPA073145: " "unprognostic (1.44e-1)" "unprognostic (2.08e-1)" "unprognostic (9.89e-2)" "unprognostic (2.92e-3)" "unprognostic (4.34e-3)" "unprognostic (2.69e-2)" "prognostic unfavorable (1.82e-5)" "unprognostic (2.52e-1)" "unprognostic (2.05e-2)" "prognostic favorable (8.23e-4)" "unprognostic (3.53e-2)" "unprognostic (2.12e-1)" "unprognostic (2.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.35e-1)" "unprognostic (1.99e-1)" "unprognostic (8.20e-2)" 105.3 106.7 110.8 85.7 93.4 158.1 180.8 136.5 131.5 84.1 67.2 50.5 75.7 69.2 101.7 84.5 75.3 89.5 71.0 112.1 105.0 53.1 112.6 108.3 83.8 118.8 94.5 88.9 124.5 148.2 98.1 88.7 62.4 93.2 61.7 71.0 65.0 88.3 61.2 96.5 94.4 71.3 90.8 115.4 73.0 86.2 98.7 104.2 106.8 91.2 57.1 93.5 76.8 132.5 20.9 31.5 17.2 18.5 12.4 28.8 13.7 55.5 86.6 84.7 68.1 123.4 95.5 65.0 59.3 81.3 97.3 69.7 100.8 83.8 99.8 58.0 88.8 43.8 54.7 93.3 80.8 93.1 61.7 67.3 100.3 67.7 98.8 124.5 97.8 66.2 109.9 67.8 82.2 132.3 162.7 93.2 64.6 85.6 179.3 86.8 151.3 91.9 110.2 108.2 47.1 60.8 73.9 77.0 116.9 76.9 87.1 83.7 73.5 81.1 73.1 57.9 87.6 102.3 85.3 68.0 50.5 69.2 46.0 60.1 99.8 68.7 92.3 59.2 62.9 54.8 8.3 18.1 13.1 15.9 18.5 26.1 20.9 24.5 20.5 22.5 20.9 28.8 23.6 17.2 12.4 17.0 31.5 27.4 13.7 110.8 93.4 136.5 131.5 105.0 53.1 94.5 88.9 93.2 104.2 107.2 169.7 269.4 252.9 347.0 77.7 65.9 252.3 107.1 114.9 280.9 104.1 303.4 417.8 203.7 54.9 263.7 254.4 140.2 207.3 313.2 278.0 194.7 148.2 266.4 321.3 96.9 198.2 268.2 433.2 53.3 286.2 303.9 221.0 344.5 257.9 86.2 233.7 238.4 215.3 588.4 177.3 187.5 295.1 298.6 154.1 334.2 370.7 264.2 295.7 283.3 PCBP4 "LIP4, MCG10" ENSG00000090097 "Poly(rC) binding protein 4" P57723 3 51957454-51974016 "Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.5" "Group enriched" "Detected in many" 7 "Bipolar cells: 389.4;Cone photoreceptor cells: 616.5;Rod photoreceptor cells: 516.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 20 "B-cells: 4.6;granulocytes: 4.6;T-cells: 10.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 49.4;SK-MEL-30: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057754 Supported Cytosol NA NA Cytosol "HPA057754: AB_2683517" "unprognostic (7.17e-2)" "unprognostic (8.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.34e-2)" "unprognostic (4.94e-3)" "unprognostic (1.94e-2)" "unprognostic (4.97e-3)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (5.45e-2)" "unprognostic (1.62e-1)" "unprognostic (3.13e-2)" "unprognostic (6.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (4.72e-2)" 19.5 16.6 27.2 9.6 21.9 3.0 10.6 86.0 56.3 12.7 16.7 36.2 16.0 15.1 15.4 12.1 14.5 10.4 18.3 36.5 29.2 29.9 21.2 38.9 13.9 17.0 28.9 13.0 16.3 22.0 22.9 15.8 7.8 16.4 20.1 8.6 47.3 20.3 19.6 97.5 13.6 29.0 14.4 44.4 10.9 13.3 10.6 19.7 11.9 17.3 11.0 15.7 13.3 9.6 4.6 0.3 4.6 0.0 0.1 10.2 2.4 10.2 3.5 14.1 20.5 6.4 11.5 2.4 23.6 11.5 14.2 9.2 13.0 3.7 0.3 3.5 18.6 12.6 2.4 13.1 8.2 6.7 16.2 2.1 1.3 11.8 13.5 10.4 1.3 10.0 15.5 15.4 9.0 4.0 17.7 7.1 6.0 0.6 4.6 22.7 4.8 0.5 1.6 6.8 6.5 9.5 7.1 6.8 1.8 5.0 7.3 27.8 49.4 6.4 3.5 41.8 3.9 6.5 5.0 14.1 15.2 28.8 4.8 12.5 3.1 1.9 2.0 17.6 2.9 22.1 4.6 0.0 3.1 10.2 0.0 7.1 4.6 9.6 9.8 0.3 2.3 4.6 3.5 0.0 0.1 0.0 0.1 10.0 2.4 27.2 21.9 86.0 24.2 29.2 29.9 28.9 13.0 16.4 19.7 3.0 2.7 2.2 13.9 7.7 389.4 6.7 2.5 1.4 4.5 8.7 616.5 1.2 14.9 28.1 52.1 11.2 7.3 0.0 20.1 1.1 16.4 16.8 1.1 3.9 1.0 39.7 59.5 12.3 0.3 76.2 20.8 1.1 21.9 1.0 8.6 56.4 34.6 14.0 15.2 7.9 516.1 6.5 15.3 0.9 2.3 10.3 0.5 6.9 4.8 9.7 PCDH17 "PCDH68, PCH68" ENSG00000118946 "Protocadherin 17" O14917 13 57631810-57729311 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 31.0;Endothelial cells: 49.1;Ito cells: 86.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "AF22: 16.2;HEK 293: 10.1;U-87 MG: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026817 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA 31000 Cytosol "Vesicles, Plasma membrane" "HPA026817: AB_1855044" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-1)" "unprognostic (6.52e-2)" "unprognostic (6.98e-3)" "unprognostic (1.95e-2)" "unprognostic (8.26e-4)" "unprognostic (3.56e-1)" "unprognostic (2.38e-2)" "unprognostic (2.82e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.40e-2)" 2.0 2.4 8.0 2.1 11.2 0.3 0.9 4.6 18.2 2.9 1.2 6.2 0.3 1.1 2.6 1.3 1.7 2.5 3.6 2.3 6.5 12.1 1.6 1.4 13.5 0.9 7.4 4.8 0.8 6.2 2.0 1.0 4.7 4.4 1.2 1.2 1.1 1.0 1.1 1.8 0.6 0.7 2.6 4.4 32.7 1.8 8.9 7.7 0.0 3.4 0.4 0.8 3.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.1 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 2.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 1.4 0.0 1.0 0.0 0.0 0.0 6.1 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 11.2 4.6 7.8 6.5 12.1 7.4 4.8 4.4 7.7 0.0 7.0 0.0 0.0 2.4 3.5 4.2 0.0 9.4 15.9 1.8 0.0 0.2 0.0 6.9 31.0 49.1 0.0 0.0 7.0 0.1 1.8 0.3 0.0 0.0 0.5 0.0 0.0 86.5 2.8 11.9 1.7 0.8 10.1 2.8 0.0 2.1 2.1 0.0 1.1 0.0 0.0 6.5 7.6 15.8 10.1 0.9 0.0 0.0 0.0 0.1 PCDH18 "KIAA1562, PCDH68L" ENSG00000189184 "Protocadherin 18" Q9HCL0 4 137518918-137532494 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Fibroblasts: 43.4;Leydig cells: 35.1;Peritubular cells: 55.2;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.3;memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 35.8;ASC diff: 43.2;ASC TERT1: 48.1;BJ hTERT+: 21.1;fHDF/TERT166: 34.1;HHSteC: 31.9;HSkMC: 48.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017976 Approved Approved "Golgi apparatus,Cytosol" No NA 1200000 Cytosol "Golgi apparatus" "HPA017976: AB_1855045" "unprognostic (2.77e-1)" "unprognostic (1.86e-2)" "unprognostic (3.73e-3)" "unprognostic (9.19e-2)" "unprognostic (1.59e-1)" "unprognostic (3.39e-2)" "unprognostic (2.36e-1)" "unprognostic (4.30e-2)" "unprognostic (1.97e-3)" "unprognostic (2.20e-2)" "unprognostic (8.76e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.79e-2)" "unprognostic (6.27e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (4.71e-4)" 28.4 3.5 4.2 7.2 4.0 0.0 16.2 2.0 2.7 30.4 13.3 2.1 9.8 6.0 34.0 8.7 11.2 8.6 14.9 8.9 2.7 3.6 5.4 3.0 5.9 2.6 5.2 1.4 14.9 2.4 1.8 3.5 29.0 5.4 23.3 9.5 21.8 6.3 9.5 10.3 5.1 9.0 25.4 5.4 4.0 5.5 9.7 4.0 1.0 8.2 7.7 1.9 17.5 16.3 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 35.8 0.0 43.2 48.1 0.0 6.4 21.1 1.2 1.9 0.0 0.0 0.0 0.0 34.1 0.1 0.0 8.3 0.1 0.6 0.0 0.2 0.0 0.0 0.0 31.9 0.0 0.0 48.9 0.0 2.3 0.9 1.2 0.2 0.1 0.0 0.1 0.6 0.0 0.9 0.0 0.0 0.0 0.6 2.7 1.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 9.8 0.2 0.0 0.0 16.7 1.0 3.3 0.1 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.2 4.0 2.0 2.7 2.7 3.6 5.2 1.4 5.4 4.0 0.0 0.3 0.0 0.2 3.7 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.2 43.4 0.0 0.0 0.0 2.6 0.0 0.0 4.3 0.0 0.2 35.1 0.0 1.7 0.0 0.0 6.5 0.0 0.0 55.2 0.0 0.1 19.4 8.6 0.7 0.1 2.3 0.7 0.0 0.0 0.0 PCDH19 "EFMR, EIEE9, KIAA1313" ENSG00000165194 "Protocadherin 19" Q8TAB3 X 100291644-100410273 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 27.1" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 7.1;Cholangiocytes: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027533 Approved Approved Cytosol NA NA Cytosol "HPA027533: AB_10602043" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (5.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (4.77e-2)" "unprognostic (3.64e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-1)" "unprognostic (2.79e-1)" "unprognostic (9.77e-3)" "unprognostic (2.82e-3)" "unprognostic (1.53e-1)" "unprognostic (1.80e-4)" "unprognostic (1.37e-1)" 4.9 1.1 19.8 1.3 10.5 0.7 3.7 1.0 22.5 5.5 4.0 1.9 0.0 1.2 3.8 1.3 2.9 2.2 2.0 1.6 27.1 12.8 1.4 0.9 1.0 1.3 3.7 14.2 3.6 1.1 1.2 2.1 1.0 7.3 1.4 5.5 6.4 2.1 1.6 2.4 3.3 1.8 3.1 3.7 0.8 2.0 2.3 1.0 0.0 1.1 0.7 0.9 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 3.5 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 10.5 1.0 22.5 27.1 12.8 3.7 14.2 7.3 1.0 0.0 0.3 0.0 0.0 2.7 7.1 1.4 7.6 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.7 2.8 0.0 0.0 0.0 0.1 1.8 0.4 0.0 0.0 0.1 0.0 1.7 1.3 0.0 1.9 3.1 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.4 0.0 1.6 0.0 0.5 0.0 0.7 1.4 0.0 0.0 0.0 0.0 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.6" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 31.8" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AF22: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.8 0.9 11.5 1.1 18.6 0.8 0.8 0.4 20.6 0.9 1.0 1.1 0.0 0.9 1.0 0.8 0.8 0.8 0.8 0.8 18.2 4.8 0.8 0.8 0.9 0.8 3.6 8.4 0.8 0.8 0.8 1.4 0.8 0.8 1.7 0.9 0.8 0.8 0.8 1.4 0.8 1.1 0.9 0.9 0.8 1.2 2.3 2.5 0.0 1.4 0.0 0.8 0.9 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.6 0.4 20.6 18.2 4.8 3.6 8.4 0.8 2.5 0.0 0.0 0.0 2.5 0.1 4.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 1.3 PCDHA12 PCDH-ALPHA12 ENSG00000251664 "Protocadherin alpha 12" Q9UN75 5 140875302-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 26.8;Bipolar cells: 11.2;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.2;AN3-CA: 4.1;hTCEpi: 6.4;PC-3: 7.8;RT4: 7.7;SH-SY5Y: 4.4" HPA035812 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA035812: AB_2674796" "unprognostic (3.95e-2)" "unprognostic (7.74e-2)" "unprognostic (7.55e-2)" "unprognostic (3.87e-2)" "unprognostic (2.74e-2)" "unprognostic (2.24e-2)" "unprognostic (2.08e-2)" "unprognostic (4.29e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-4)" "unprognostic (3.18e-4)" "unprognostic (1.11e-1)" "unprognostic (3.21e-3)" "unprognostic (6.97e-2)" 1.0 1.7 0.9 0.3 1.2 0.0 0.9 14.6 3.7 3.5 0.4 1.1 0.0 0.1 1.0 0.5 0.2 1.9 4.3 0.3 1.0 0.7 3.8 1.7 5.7 0.2 0.5 0.8 0.3 2.4 0.9 4.6 0.0 2.3 0.4 0.1 1.5 5.7 0.3 0.1 0.2 0.2 0.6 0.8 0.2 0.3 2.1 0.2 0.0 3.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 2.4 2.6 7.8 0.0 0.0 0.0 0.3 7.7 0.3 4.4 0.0 0.9 0.1 0.5 1.6 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 14.6 3.7 1.0 0.7 0.5 0.8 2.3 0.2 26.8 3.2 0.0 0.0 0.0 11.2 0.4 5.1 0.0 0.0 1.8 5.9 0.0 0.0 0.9 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.3 0.0 0.4 0.2 2.9 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Ciliated cells: 5.3;granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 9.1;AF22: 8.9;EFO-21: 7.7;T-47d: 7.7" "Low region specificity" "Detected in all" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: AB_2686608" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.9 0.8 5.1 0.9 6.5 3.2 1.7 12.1 8.7 2.1 1.1 1.6 0.4 0.9 2.3 2.0 0.6 1.6 5.1 1.2 4.5 3.2 2.0 0.6 1.7 1.5 1.9 2.1 1.1 4.1 1.0 1.4 0.7 3.9 1.8 1.1 0.4 1.1 1.3 1.1 2.0 0.9 1.1 3.0 1.1 1.0 1.4 2.4 0.0 1.3 0.1 0.7 1.3 0.8 1.5 1.3 2.0 0.7 0.8 1.1 0.0 0.2 9.1 8.9 0.4 0.1 0.3 0.3 0.2 0.1 0.1 0.1 0.2 1.8 0.3 7.7 0.2 0.4 0.3 0.0 0.1 0.2 0.2 0.2 0.4 0.6 0.3 0.1 0.3 0.5 0.4 2.4 0.2 0.4 0.6 0.5 0.4 0.2 1.2 0.3 0.2 0.2 0.3 2.5 1.9 1.3 0.2 0.2 0.3 0.3 0.4 0.4 3.8 0.1 2.0 0.8 1.6 7.7 0.3 0.9 2.0 1.3 0.7 0.2 0.5 0.2 0.2 0.3 0.4 0.8 1.8 0.7 0.7 1.1 0.4 0.8 0.8 0.8 0.7 0.3 1.5 0.8 1.1 2.0 0.8 0.7 1.3 0.6 0.0 5.1 6.5 12.1 6.6 4.5 3.2 1.9 2.1 3.9 2.4 3.0 1.3 0.0 0.5 0.0 0.9 0.8 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.7 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.3 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121799-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 5.1;Horizontal cells: 7.9;Peritubular cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Group enriched" "Detected in some" 5 "SCLC-21H: 13.0;SH-SY5Y: 8.8" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 7.1 5.3 13.0 2.0 12.0 0.6 5.9 11.3 11.4 8.0 3.4 12.9 0.1 1.9 12.3 9.1 4.0 5.8 5.7 4.3 10.9 6.3 4.1 1.3 5.1 1.4 13.1 11.3 9.9 18.2 7.3 5.1 0.9 11.0 6.1 2.7 3.7 5.0 5.1 3.8 3.1 2.6 7.9 21.1 2.0 2.6 1.6 12.3 0.0 2.8 1.5 1.1 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 2.1 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 13.0 8.8 0.0 0.0 0.0 0.4 0.4 0.1 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 13.0 12.0 11.3 11.4 10.9 6.3 13.1 11.3 11.0 12.3 0.0 0.3 0.0 0.4 1.0 5.1 0.6 0.0 4.0 4.5 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.0 0.0 1.4 0.0 3.8 0.9 0.0 0.0 0.1 7.9 0.0 4.3 0.0 0.0 1.4 0.0 1.7 0.0 0.0 3.5 0.4 0.0 6.0 0.0 0.6 0.0 3.1 1.1 0.2 1.8 0.0 0.0 0.0 0.2 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Bipolar cells: 1.6;Cardiomyocytes: 1.7;Horizontal cells: 3.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 7.0;T-47d: 11.5;WM-115: 5.2" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.1 0.3 1.7 1.1 0.5 1.0 0.5 0.2 0.5 2.8 1.1 0.9 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.8 0.5 0.0 0.7 3.4 0.1 0.3 0.2 0.8 7.0 0.1 0.2 0.8 0.3 0.1 0.3 3.1 2.7 0.3 0.3 0.3 1.8 2.1 0.3 0.9 1.7 0.5 11.5 0.4 0.8 3.3 0.7 1.6 0.4 0.3 1.0 0.2 3.9 0.2 5.2 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 3.0 0.0 0.0 0.0 0.0 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 27.0;Cone photoreceptor cells: 15.7;Horizontal cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.2;HSkMC: 13.8;T-47d: 16.3;U-2197: 9.6" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.2 6.2 5.4 2.3 5.8 2.1 0.1 3.0 4.8 0.3 0.7 0.7 8.1 3.0 0.2 0.3 2.9 1.9 2.4 0.8 0.0 0.0 0.3 0.0 2.2 1.2 0.2 13.8 0.3 2.0 0.8 0.3 1.1 0.3 0.0 0.1 7.4 0.0 0.1 0.3 1.2 0.0 0.1 0.1 1.0 0.0 2.1 0.1 1.6 0.6 0.3 0.0 0.3 3.0 16.3 1.5 2.7 5.6 0.3 9.6 0.1 0.2 0.9 0.1 2.9 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 0.0 1.3 0.0 1.8 0.1 27.0 2.3 2.5 0.0 2.3 1.8 15.7 1.7 0.0 0.9 0.0 2.1 0.4 0.0 1.2 1.1 1.2 3.2 1.1 1.1 0.8 22.3 1.2 3.1 0.0 0.0 3.1 0.3 1.7 0.0 1.1 8.7 2.1 0.0 2.1 0.0 5.2 6.5 1.1 0.3 0.7 0.4 0.3 0.0 0.8 0.9 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.9;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "ASC diff: 12.0;ASC TERT1: 13.0;GAMG: 22.7;hTERT-RPE1: 33.8;WM-115: 20.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 3.4 2.5 7.4 2.8 9.4 0.5 2.1 4.1 8.5 2.4 2.5 8.5 0.0 1.2 2.6 1.7 3.1 2.1 2.1 3.4 11.6 1.9 1.9 1.2 2.3 1.8 4.5 5.2 3.8 2.3 1.3 1.9 8.3 5.0 2.5 1.5 3.3 2.8 3.4 2.8 6.6 1.2 3.3 4.9 1.6 1.8 2.2 7.1 0.1 3.4 0.6 1.7 1.7 2.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 1.1 12.0 13.0 0.4 2.6 5.0 2.0 3.2 0.0 0.1 0.3 4.3 2.6 22.7 1.7 0.0 0.3 3.2 0.0 1.1 0.0 0.0 0.0 2.0 0.2 0.0 9.3 0.1 3.5 0.0 33.8 3.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 5.0 0.2 1.5 3.6 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.4 9.4 4.1 8.5 11.6 1.9 4.5 5.2 5.0 7.1 0.0 0.6 0.0 0.1 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 3.5;Cardiomyocytes: 1.8;Ito cells: 1.3" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 7.7;BJ hTERT+: 12.9;fHDF/TERT166: 19.1;HHSteC: 6.3;HSkMC: 14.3;TIME: 6.1" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.7 12.9 0.0 0.0 0.0 0.0 0.4 0.0 19.1 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 14.3 0.0 3.8 0.0 0.0 4.5 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 6.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 0.0 0.0 0.0 0.2 0.0 3.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480" "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.8 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.3 0.8 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.0 0.2 0.1 0.3 5.8 2.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.5 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 0.0 0.0 0.0 0.1 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.3 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 2.4;Cardiomyocytes: 1.1;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 11.2;BJ: 3.7;EFO-21: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 4.0 4.5 11.7 1.4 10.5 0.7 2.5 6.9 13.7 4.7 1.3 7.9 0.0 0.7 4.5 3.5 1.5 2.9 3.5 12.2 8.5 5.8 2.5 2.5 2.6 1.0 6.6 7.7 8.6 3.6 1.8 6.3 5.7 8.7 3.0 1.3 4.6 2.9 3.2 1.5 1.9 1.1 3.6 6.0 1.5 1.2 5.2 3.8 0.0 3.3 1.3 1.0 1.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.1 0.2 1.5 0.0 3.7 0.3 0.0 0.1 0.0 0.0 0.1 9.2 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.1 0.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 10.5 6.9 13.7 8.5 5.8 6.6 7.7 8.7 3.8 0.0 0.0 0.0 0.1 0.0 2.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355025-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 7 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.3;BJ: 5.7;HSkMC: 6.0;HUVEC TERT2: 5.7;U-87 MG: 8.2" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 5.4 4.7 6.5 1.8 8.3 0.5 3.0 8.5 11.2 4.8 2.0 10.4 1.5 1.2 5.0 3.0 1.9 3.4 3.1 4.8 6.3 5.9 2.0 2.7 3.6 0.9 5.6 8.1 5.8 6.7 8.5 3.4 2.8 6.1 4.1 1.4 3.5 4.3 4.2 1.5 1.8 1.2 5.0 5.9 1.3 1.4 2.7 4.0 0.0 2.6 2.7 0.9 2.3 2.5 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 1.0 0.6 4.5 10.3 0.0 5.7 4.6 0.3 1.1 0.0 0.1 1.0 2.0 4.8 1.8 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.4 6.0 0.2 0.1 0.0 3.5 5.7 0.0 0.2 0.3 2.4 0.8 0.3 0.2 0.2 0.0 0.3 0.3 1.6 0.1 0.3 0.0 0.8 1.7 0.3 0.3 1.1 0.5 2.2 0.0 3.7 2.4 0.7 3.2 0.5 0.2 0.3 0.2 8.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.3 8.5 9.3 6.3 5.9 5.6 8.1 6.1 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 10.6;Horizontal cells: 9.5;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "ASC diff: 18.9;ASC TERT1: 7.5" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.5 0.3 0.1 18.9 7.5 0.0 0.8 0.2 0.1 0.4 0.0 0.0 0.9 0.4 0.3 1.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.6 0.8 0.3 0.5 0.7 0.1 0.0 0.3 0.9 0.7 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 0.3 1.6 0.0 1.0 0.7 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.8 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 0.0 0.6 0.0 0.6 0.1 10.6 1.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.3 1.1 0.0 0.1 9.5 0.0 1.8 0.3 0.0 3.4 0.0 0.0 0.0 0.0 3.3 0.2 0.0 1.8 0.0 1.1 6.5 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 9.7;Cardiomyocytes: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 5.8;SCLC-21H: 11.2;T-47d: 6.5;WM-115: 14.0" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.4 3.2 0.5 1.6 5.4 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.2 3.1 3.7 1.2 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.9 0.1 0.1 5.8 0.4 0.3 0.1 1.1 1.8 0.1 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 0.1 1.5 0.4 0.0 0.4 0.1 11.2 0.9 0.1 0.3 0.7 0.7 6.5 0.1 5.5 0.9 0.4 0.9 0.8 0.4 1.8 0.4 0.9 0.8 14.0 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 0.0 2.1 0.5 0.5 0.0 9.7 4.5 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.0 0.0 1.3 0.1 0.3 0.4 0.0 0.5 0.1 1.6 0.0 1.8 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 2.1 0.0 1.0 0.0 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.1 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 3.5;Cardiomyocytes: 1.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;hTERT-RPE1: 9.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 9.3 1.4 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 3.3 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 0.0 0.0 0.0 0.4 0.0 3.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 7.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 10.4;Cardiomyocytes: 2.5;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 2.9;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.6 0.7 0.8 0.7 0.6 2.5 0.7 2.3 2.2 1.2 1.2 1.0 7.1 0.4 2.3 1.5 2.1 0.7 0.9 2.0 1.4 0.5 0.5 0.9 1.1 0.7 0.5 0.4 2.6 0.6 0.2 1.9 1.4 3.5 0.9 0.8 0.4 0.8 0.5 2.2 2.5 1.1 0.7 1.6 0.7 0.7 1.0 1.3 1.1 2.4 0.4 0.6 0.6 1.2 0.7 0.4 2.9 0.4 0.5 0.3 0.1 0.3 0.2 1.1 0.6 1.1 2.6 0.6 2.4 1.5 1.7 0.7 0.2 0.4 1.1 1.0 1.8 0.3 0.4 0.0 0.0 1.3 0.3 0.2 0.3 0.5 0.3 0.1 0.4 0.8 1.4 0.1 0.5 0.1 0.5 0.4 0.2 0.2 0.9 0.2 0.2 0.5 0.7 2.6 0.0 0.1 1.0 0.2 0.1 0.1 0.3 0.7 0.6 0.3 0.9 0.4 2.4 1.2 1.7 2.5 2.6 0.9 0.6 0.2 0.3 0.3 0.4 1.3 0.4 1.3 2.9 0.4 0.5 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.2 0.3 2.8 0.5 0.3 0.4 0.2 0.1 0.8 0.6 2.3 2.2 1.4 0.5 0.5 0.4 3.5 1.3 0.0 1.1 0.0 0.8 0.0 10.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 3.2 0.0 0.6 0.8 0.0 2.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.4 0.0 1.7 0.0 0.2 0.6 0.9 0.0 0.0 0.0 0.0 0.4 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 3.7;Club cells: 1.2;Horizontal cells: 3.2;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 4.1;HSkMC: 4.6;hTERT-RPE1: 19.1;TIME: 5.0;U-87 MG: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 5.6 5.4 12.0 2.6 12.6 0.9 3.7 11.5 17.3 6.9 2.7 11.2 0.1 2.1 7.6 3.9 4.8 6.3 6.5 3.2 10.3 8.5 3.0 2.8 5.0 2.1 9.6 7.1 9.1 3.0 3.8 3.0 3.6 10.9 5.2 2.7 7.7 3.8 7.3 1.9 5.5 2.0 5.9 13.0 3.6 2.9 2.0 5.9 0.0 4.6 1.4 2.5 4.8 3.7 0.5 0.3 1.0 0.5 0.2 1.0 0.0 0.0 0.2 0.7 1.8 0.1 0.3 0.2 0.8 0.0 0.7 0.7 0.3 0.4 1.4 4.1 2.2 0.3 0.1 0.1 0.2 0.8 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.3 4.6 0.2 0.4 0.3 19.1 1.1 0.1 0.1 0.2 0.4 0.4 0.2 0.5 0.2 0.1 0.0 0.2 0.5 0.0 0.2 0.2 0.5 1.2 0.4 0.1 0.6 0.5 1.1 0.5 5.0 0.3 0.3 0.1 2.7 0.2 0.1 0.1 5.8 0.1 1.0 1.0 0.5 0.3 1.0 0.3 0.6 0.3 0.4 0.2 0.1 0.5 0.4 0.7 1.0 0.2 0.2 0.3 0.1 0.0 12.0 12.6 11.5 16.2 10.3 8.5 9.6 7.1 10.9 5.9 0.0 0.0 0.0 0.1 0.2 3.7 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PCDHGB2 PCDH-GAMMA-B2 ENSG00000253910 "Protocadherin gamma subfamily B, 2" Q9Y5G2 5 141360042-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Cancer enriched" "Detected in many" 5 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077526" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" Nucleoplasm "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350" "unprognostic (7.14e-3)" "unprognostic (8.79e-3)" "unprognostic (3.21e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-4)" "unprognostic (2.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.78e-1)" "unprognostic (1.05e-1)" "unprognostic (8.46e-3)" "unprognostic (4.59e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (3.36e-4)" 4.9 3.6 11.3 2.2 9.7 0.9 3.7 8.7 12.2 7.2 2.4 11.6 0.3 1.2 9.2 3.2 3.2 5.6 6.2 4.6 9.3 7.0 2.7 2.7 5.4 1.4 7.0 8.6 9.0 2.6 7.5 3.0 3.9 7.3 4.4 2.8 3.1 2.4 4.4 1.9 2.9 2.1 5.0 7.0 2.2 2.0 1.8 7.8 0.1 2.6 1.3 1.4 2.8 3.3 0.9 0.9 0.5 0.0 0.0 0.7 0.0 0.1 0.3 2.1 0.2 14.4 10.5 0.1 2.2 3.0 0.6 3.4 0.0 0.3 3.8 1.0 1.7 7.5 0.5 0.5 0.3 1.0 0.0 0.2 0.0 0.3 0.4 0.6 0.2 0.2 2.7 0.5 0.2 0.1 4.9 1.7 0.1 0.2 1.2 8.5 0.4 2.9 0.6 0.1 0.9 0.9 7.8 2.7 0.2 0.2 0.3 1.6 1.7 0.2 0.4 0.4 1.6 3.1 0.2 6.0 3.0 0.7 4.6 3.9 0.2 2.2 0.7 3.3 1.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.9 0.0 0.0 11.3 9.7 8.7 10.6 9.3 7.0 7.0 8.6 7.3 7.8 0.0 0.3 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 "Protocadherin gamma subfamily B, 3" Q9Y5G1 5 141370264-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 13.5;ASC TERT1: 10.9;TIME: 6.8" "HPA008755, HPA010580, HPA035822, HPA035823" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802" "unprognostic (6.93e-3)" "unprognostic (9.10e-4)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (7.83e-2)" "unprognostic (1.92e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.81e-2)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" 4.1 1.7 3.3 1.6 6.5 0.5 3.1 3.5 5.6 3.0 3.0 7.2 0.7 0.7 4.9 3.7 3.3 3.3 2.9 4.6 3.3 2.3 2.9 2.0 2.5 3.7 1.9 3.8 5.2 4.2 4.6 5.4 2.3 2.6 2.6 2.2 3.1 6.6 2.6 1.9 3.3 1.4 4.3 2.9 2.4 2.3 1.5 2.8 0.3 3.4 3.2 3.5 2.7 4.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.5 0.3 13.5 10.9 0.2 1.4 2.5 0.9 1.1 0.0 0.0 2.2 0.4 4.3 0.8 0.6 0.0 0.3 0.7 0.0 0.3 0.0 0.3 0.1 0.6 0.1 0.0 2.7 0.6 0.2 0.1 0.2 1.2 0.0 0.3 1.0 0.3 0.4 0.7 1.1 0.1 0.0 0.1 1.9 0.7 0.0 0.2 0.1 3.0 0.6 0.0 0.1 0.3 0.4 0.8 0.0 6.8 0.6 0.1 0.7 0.7 0.3 2.1 0.2 0.6 0.6 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 6.5 3.5 5.6 3.3 2.3 1.9 3.8 2.6 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB4 "CDH20, FIB2, PCDH-GAMMA-B4" ENSG00000253953 "Protocadherin gamma subfamily B, 4" Q9UN71 5 141387698-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 2: 1.1;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 28.6;SuSa: 10.9;TIME: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.33e-1)" "unprognostic (1.83e-3)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-2)" "unprognostic (9.25e-3)" "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.70e-2)" "unprognostic (2.62e-1)" "unprognostic (1.13e-1)" "unprognostic (3.27e-2)" 2.4 2.2 2.4 0.7 4.2 0.0 1.2 1.8 2.1 2.6 1.4 0.2 3.2 3.5 1.1 2.1 0.8 2.8 2.3 4.1 2.9 3.3 2.1 0.0 1.8 5.1 1.9 3.0 2.5 6.2 2.6 0.7 3.0 3.1 1.2 3.4 0.3 1.9 2.0 0.6 0.4 0.9 3.6 0.2 1.6 2.0 0.0 0.2 0.0 0.0 1.6 0.2 0.2 0.0 0.7 7.1 0.0 4.6 5.9 0.8 6.8 28.6 2.9 1.9 0.0 0.0 0.2 5.5 0.2 0.1 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.6 1.8 0.0 0.0 5.7 0.0 2.7 0.0 0.1 4.4 0.0 0.2 0.0 0.0 0.0 0.6 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 10.9 3.6 2.6 14.3 3.9 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 11.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 1.7;Ciliated cells: 1.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;ASC TERT1: 24.8;BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.1 1.9 0.8 0.3 3.2 0.0 3.6 2.0 4.3 1.4 0.4 2.5 1.9 0.0 2.1 2.5 1.1 2.1 0.8 1.9 0.0 1.6 3.1 6.8 2.6 0.9 1.5 4.9 2.8 11.2 2.1 9.5 1.5 2.2 0.2 3.7 3.2 3.2 1.4 2.6 0.0 1.9 3.0 0.5 0.7 1.0 2.2 0.8 3.5 0.0 0.7 1.9 1.4 0.5 0.2 0.0 0.3 0.0 1.9 0.1 0.0 1.2 0.1 0.0 32.8 24.8 0.6 8.7 0.0 14.2 16.0 1.4 4.7 4.9 11.4 9.6 0.0 6.6 0.0 3.6 8.0 0.0 1.4 0.0 0.0 0.0 3.4 0.0 3.1 8.7 0.7 0.8 4.6 6.1 4.3 0.0 0.1 0.0 0.4 3.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.8 2.6 0.0 0.0 0.0 0.0 0.0 1.0 9.2 0.0 4.4 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.3 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 6.4;Cone photoreceptor cells: 5.9;Horizontal cells: 9.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 18.6;EFO-21: 6.3;HSkMC: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 6.7 7.2 8.8 2.6 9.9 1.6 4.4 6.1 26.6 5.8 4.1 10.1 0.3 1.8 7.2 5.7 3.0 5.1 4.4 4.6 8.9 5.7 3.2 9.4 4.4 2.2 6.9 4.4 13.3 5.2 16.1 4.7 6.8 5.9 4.0 2.3 9.0 5.3 5.9 5.7 4.7 2.2 4.8 4.1 4.0 2.5 2.1 6.7 0.3 6.1 1.9 2.1 4.2 5.1 0.8 0.5 3.2 0.4 0.5 0.9 0.2 0.0 0.1 18.6 0.2 0.6 0.7 0.9 1.7 0.0 0.4 1.0 0.2 0.3 1.5 6.3 1.0 0.3 0.3 0.0 0.4 1.2 0.0 0.3 0.0 0.2 0.1 1.5 0.1 0.1 4.3 2.1 0.9 0.1 0.2 0.6 0.4 0.1 0.3 0.1 0.3 0.1 1.2 0.8 0.0 0.0 0.2 0.1 0.1 3.0 0.2 0.2 0.3 0.0 0.1 0.1 0.4 1.5 0.4 3.0 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.9 1.1 0.4 0.2 0.9 0.3 0.2 0.6 0.4 0.2 0.1 0.8 0.4 0.3 3.2 0.5 0.3 0.5 0.2 0.2 8.8 9.9 6.1 7.9 8.9 5.7 6.9 4.4 5.9 6.7 3.0 0.3 0.0 1.3 0.0 6.4 2.5 0.0 1.4 2.3 0.0 5.9 0.1 0.0 0.4 0.0 0.9 0.0 0.0 1.1 0.1 0.4 0.6 0.0 0.8 0.2 9.5 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 3.3 1.6 0.0 1.1 0.0 2.4 0.0 1.0 0.2 0.3 0.1 0.1 0.0 0.0 0.6 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Bipolar cells: 7.4;Horizontal cells: 3.2" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AN3-CA: 38.8;HSkMC: 12.3;hTERT-RPE1: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 10.1 9.8 12.6 3.8 13.5 0.8 8.0 19.1 12.9 10.2 7.0 16.1 1.2 2.3 11.6 5.0 6.8 7.8 9.2 8.5 14.5 7.9 5.4 3.5 11.6 2.6 10.4 7.3 17.3 5.5 9.5 5.3 11.0 9.4 8.3 3.8 15.5 7.1 12.0 5.6 6.8 3.2 10.5 20.1 5.3 4.5 4.2 14.3 0.6 8.4 3.0 2.3 4.6 6.9 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 38.8 0.9 0.1 0.4 2.5 0.3 0.9 1.9 0.0 2.3 0.3 2.1 5.1 0.3 0.6 0.0 0.4 0.9 0.0 0.2 0.0 0.0 0.0 2.9 0.2 0.0 12.3 0.3 0.7 0.4 32.9 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 4.3 0.8 0.0 0.1 0.0 4.2 5.8 0.1 0.0 0.0 0.5 0.4 0.4 5.0 4.7 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.6 13.5 19.1 12.9 14.5 7.9 10.4 7.3 9.4 14.3 3.0 2.2 0.0 0.5 0.3 7.4 1.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.4 0.1 0.8 0.3 1.1 0.0 0.1 3.2 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.7 0.0 1.8 0.2 0.4 0.0 1.4 0.0 0.1 0.4 0.0 0.0 0.0 0.1 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell type enhanced" "Detected in single" 32 "Horizontal cells: 3.2" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "REH: 9.3;SCLC-21H: 7.9;SH-SY5Y: 15.2;SuSa: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.2 0.2 0.8 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.9 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 1.5 0.0 0.0 9.3 0.5 0.0 0.0 0.1 7.9 15.2 0.1 0.0 0.2 11.2 0.1 0.3 0.1 0.8 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.0;SuSa: 8.4;U-138 MG: 16.0;U-251 MG: 6.8;U-87 MG: 9.8" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.5 0.0 5.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 8.4 0.1 0.2 0.1 16.0 0.2 0.2 6.8 0.0 0.0 0.0 9.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCED1A "bA12M19.1, C20orf81, FAM113A, FLJ22376" ENSG00000132635 "PC-esterase domain containing 1A" Q9H1Q7 20 2835314-2841190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050816 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA050816: AB_2681246" "unprognostic (3.20e-1)" "unprognostic (3.25e-2)" "unprognostic (2.42e-3)" "unprognostic (1.90e-2)" "unprognostic (3.42e-1)" "unprognostic (6.91e-3)" "prognostic unfavorable (7.31e-4)" "unprognostic (1.00e-1)" "unprognostic (8.02e-2)" "unprognostic (2.99e-1)" "prognostic favorable (5.96e-5)" "unprognostic (1.03e-1)" "unprognostic (1.29e-2)" "unprognostic (4.10e-1)" "unprognostic (2.48e-1)" "unprognostic (7.30e-2)" "unprognostic (2.97e-3)" 18.0 17.3 25.5 21.9 29.1 13.1 14.4 18.7 29.0 17.6 13.4 27.6 18.8 17.1 23.8 20.3 12.6 22.4 23.0 9.7 24.2 17.1 23.1 21.0 16.4 23.5 30.0 20.8 28.4 16.1 38.2 27.0 16.4 25.1 25.4 9.1 21.6 23.7 18.3 6.9 12.7 18.2 15.2 14.5 33.1 20.0 9.4 28.7 14.2 36.0 4.8 16.7 15.8 17.6 9.4 8.2 3.1 7.4 14.2 12.0 6.8 12.5 16.6 16.9 9.3 17.7 24.5 12.2 12.1 13.9 13.0 14.2 11.6 23.2 3.7 8.4 8.2 21.7 20.7 4.0 11.3 6.1 18.2 12.4 14.5 18.4 16.0 14.3 2.8 4.9 32.5 24.1 15.9 21.2 18.7 9.3 18.9 11.4 17.4 9.5 8.7 2.0 18.3 18.6 9.6 9.9 10.0 5.6 7.6 14.6 10.6 15.7 24.2 12.0 15.9 20.8 11.2 20.4 9.8 8.9 12.8 8.8 13.1 5.8 28.7 14.2 1.0 3.1 10.3 15.0 2.9 7.4 3.1 11.0 6.6 10.6 8.6 6.4 9.3 8.2 9.4 12.0 10.6 0.6 14.2 6.1 7.1 4.5 6.8 25.5 29.1 18.7 29.0 24.2 17.1 30.0 20.8 25.1 28.7 14.9 20.3 6.4 10.6 3.5 10.9 4.0 5.1 6.7 10.3 8.7 9.8 4.4 11.6 3.2 0.4 8.3 6.8 0.0 1.8 2.2 8.9 7.3 0.0 11.3 6.1 11.1 8.1 11.6 8.6 2.8 8.3 8.0 1.7 2.8 6.7 9.3 4.1 7.0 2.1 8.4 11.9 6.5 7.6 11.5 7.6 3.1 2.9 11.7 5.4 5.2 PCM1 PTC4 ENSG00000078674 "Pericentriolar material 1" Q15154 8 17922840-18029944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 451.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023370, HPA023374, CAB058695" Enhanced Enhanced "Nuclear membrane,Centrosome,Cytosol" NA NA Centrosome "Nuclear membrane, Cytosol" "CAB058695: AB_2665588, HPA023370: AB_1855072, HPA023374: AB_1855073" "unprognostic (1.52e-2)" "unprognostic (1.77e-2)" "unprognostic (6.54e-3)" "unprognostic (3.35e-2)" "unprognostic (9.52e-2)" "unprognostic (1.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.74e-3)" "unprognostic (1.09e-1)" "unprognostic (2.26e-1)" "unprognostic (2.84e-1)" "unprognostic (2.83e-1)" "unprognostic (1.76e-2)" "unprognostic (2.16e-1)" "unprognostic (4.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.45e-1)" 19.6 19.0 26.2 26.7 40.4 25.1 25.1 29.2 29.0 25.0 21.1 21.6 22.8 12.4 23.3 27.3 16.4 26.4 17.8 23.0 22.9 18.4 18.8 22.0 19.1 21.1 24.5 24.9 29.1 27.0 42.0 35.8 19.8 26.4 20.2 16.3 16.2 19.4 25.3 63.1 17.6 18.3 26.7 27.2 20.8 17.9 80.0 28.0 40.2 28.2 19.1 20.4 27.0 22.6 11.5 14.9 19.9 7.5 11.2 13.0 4.3 20.6 22.1 34.0 45.0 19.2 20.0 17.6 17.5 21.5 18.7 21.1 14.9 12.4 27.1 12.1 17.4 16.1 15.0 21.7 16.1 31.9 8.9 8.4 46.6 15.6 30.3 21.4 20.4 12.0 17.4 17.2 21.7 24.1 16.4 21.4 28.4 31.4 21.1 22.8 10.3 43.6 33.7 28.0 17.3 6.4 26.3 30.4 9.7 15.5 28.8 26.0 19.6 18.7 10.3 26.8 15.2 16.2 29.7 19.1 17.1 14.0 20.8 14.7 9.0 19.9 24.3 14.4 22.5 17.4 19.9 6.0 14.4 11.5 3.8 12.0 11.1 10.4 13.0 5.9 11.5 11.6 11.6 6.4 11.2 7.5 14.9 10.3 4.3 26.2 40.4 29.2 29.0 22.9 18.4 24.5 24.9 26.4 28.0 119.1 118.7 34.0 55.5 30.0 182.6 220.7 38.2 392.1 177.5 82.0 329.9 42.5 24.9 61.5 377.1 62.9 27.3 70.0 51.3 30.8 46.8 39.6 133.4 45.3 37.2 122.3 68.3 61.4 51.5 176.2 85.4 63.1 52.3 59.5 45.1 137.5 50.9 39.3 91.9 20.6 207.3 122.9 58.7 451.7 165.6 33.4 50.6 87.1 43.7 42.1 PCMT1 ENSG00000120265 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase" P22061 6 149749443-149811420 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 968.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003239 Approved Supported Cytosol No No 8200000 Cytosol "HPA003239: AB_1079580" "prognostic unfavorable (4.02e-7)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.35e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.88e-4)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.91e-2)" "unprognostic (1.58e-2)" "unprognostic (9.02e-2)" "unprognostic (6.45e-2)" "unprognostic (6.77e-2)" "unprognostic (6.14e-2)" "unprognostic (4.38e-1)" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "prognostic unfavorable (6.38e-4)" 19.1 18.4 35.7 13.0 43.0 28.5 19.3 33.5 58.3 20.2 16.9 19.2 12.4 14.7 16.0 22.2 17.9 15.8 11.0 43.9 35.0 38.8 21.3 29.5 15.1 14.6 35.1 46.0 16.2 14.6 16.4 15.5 17.2 57.4 22.1 18.1 11.6 17.2 21.4 69.5 14.7 13.6 19.6 28.6 12.0 12.7 29.1 19.2 18.1 19.3 15.9 17.9 14.4 13.7 31.6 53.0 51.2 58.0 30.0 37.4 51.6 21.8 17.3 17.7 22.1 38.1 31.5 19.7 35.9 20.5 28.5 36.1 50.2 16.7 27.6 30.5 30.3 33.9 27.2 30.4 35.8 41.2 19.2 44.0 42.2 32.5 49.0 25.5 50.2 51.9 15.7 26.5 32.5 35.2 20.6 26.9 23.4 60.3 27.1 34.0 65.0 24.3 38.3 14.4 21.5 19.4 20.2 23.0 19.9 27.7 16.1 33.8 13.0 27.2 43.5 23.3 22.7 26.3 35.8 20.0 16.8 21.4 31.9 38.9 17.1 26.6 28.2 26.5 33.6 33.4 40.0 58.0 51.2 30.2 53.6 30.1 31.6 30.6 32.7 53.0 24.2 28.5 32.5 30.8 30.0 52.2 23.9 37.4 51.6 35.7 43.0 33.5 58.3 35.0 38.8 35.1 46.0 57.4 19.2 50.6 33.8 61.0 64.4 155.6 73.9 150.1 58.6 62.9 33.0 75.0 35.3 145.0 66.3 107.5 968.1 68.2 50.9 46.7 96.6 180.3 97.5 60.4 104.1 112.2 107.3 62.0 53.0 50.3 78.3 318.9 66.4 94.5 131.6 139.7 62.0 111.0 87.2 56.9 69.3 69.4 50.7 109.9 107.2 205.7 85.4 137.8 124.0 71.9 52.4 51.7 PCNX3 "FLJ22427, PCNXL3" ENSG00000197136 "Pecanex homolog 3" Q9H6A9 11 65615773-65637439 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 8.3;Collecting duct cells: 12.2;Ductal cells: 8.4;Exocrine glandular cells: 7.5;Hofbauer cells: 7.7;Pancreatic endocrine cells: 10.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018084 Uncertain Approved Cytosol NA NA Cytosol "HPA018084: AB_1855083" "unprognostic (9.93e-2)" "unprognostic (1.33e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-2)" "unprognostic (2.54e-1)" "unprognostic (1.70e-2)" "unprognostic (3.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (7.69e-3)" "unprognostic (7.06e-2)" "unprognostic (2.44e-2)" "unprognostic (8.52e-3)" "unprognostic (6.51e-3)" "unprognostic (1.93e-1)" "unprognostic (2.32e-2)" "unprognostic (4.82e-1)" 11.0 14.0 11.6 17.0 12.5 20.4 11.8 18.1 16.8 10.3 14.4 13.5 15.6 18.4 16.4 12.6 15.4 13.9 13.6 9.0 11.9 7.1 12.4 18.8 15.1 17.6 12.6 10.6 13.1 18.1 13.9 13.9 16.1 11.7 13.0 7.8 12.1 16.9 13.3 8.2 14.5 18.8 12.1 11.1 18.0 15.3 26.6 11.7 21.6 15.3 8.8 14.2 13.7 10.9 2.6 3.3 6.0 2.5 1.7 3.6 1.3 12.0 18.2 6.7 16.5 5.2 4.1 15.2 8.6 7.5 8.4 6.2 8.7 13.8 8.9 16.7 7.6 11.5 19.9 7.1 9.9 2.5 7.5 12.5 11.6 16.9 7.1 5.9 11.3 14.3 7.7 5.0 8.3 6.6 3.8 8.2 9.5 13.3 7.6 4.9 18.0 9.5 8.8 13.6 5.2 11.7 13.5 6.0 11.6 3.7 19.6 8.3 12.4 9.1 12.1 10.2 3.1 21.2 7.8 11.6 14.7 13.9 12.1 8.6 12.5 7.4 8.0 11.7 5.5 12.8 6.0 2.5 1.5 3.6 1.2 3.0 1.5 2.0 2.1 1.3 2.6 1.5 2.1 3.5 1.7 1.7 3.3 0.8 1.3 11.6 12.5 18.1 16.8 11.9 7.1 12.6 10.6 11.7 11.7 6.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 12.2 0.0 5.6 0.0 8.4 0.0 0.0 0.0 0.0 7.5 4.6 0.0 0.0 4.7 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.6 0.0 0.0 10.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 PCNX4 "C14orf135, PCNXL4" ENSG00000126773 "Pecanex homolog 4" Q63HM2 14 60091911-60169133 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 62.9;Club cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002076, HPA003390" Uncertain Approved Cytosol NA NA Cytosol "HPA002076: AB_1078322, HPA003390: AB_2066703" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (1.89e-1)" "unprognostic (9.87e-2)" "unprognostic (2.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.83e-3)" "unprognostic (2.01e-1)" "unprognostic (1.54e-1)" "unprognostic (3.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.81e-1)" "prognostic favorable (6.84e-5)" "unprognostic (2.13e-1)" "unprognostic (2.08e-1)" "unprognostic (4.14e-2)" "unprognostic (8.59e-2)" 12.0 16.5 13.6 14.7 18.2 9.1 14.3 19.4 18.6 18.8 10.2 15.2 14.0 8.2 21.2 13.6 10.4 22.7 14.2 17.8 12.7 13.6 20.6 11.1 12.2 11.0 12.5 12.4 27.4 12.1 26.3 39.8 13.7 16.1 21.3 11.2 17.7 12.7 17.2 15.2 13.0 11.3 16.2 14.5 13.1 10.0 23.0 11.6 24.6 16.5 11.1 11.7 11.6 13.9 7.3 7.7 5.3 8.1 13.4 11.4 5.3 40.1 6.3 12.1 8.2 10.4 12.3 5.4 13.4 22.0 16.1 20.3 6.7 12.2 7.2 5.6 11.2 13.2 5.3 8.1 7.9 27.4 9.1 3.7 11.4 4.6 5.2 22.0 11.8 8.3 9.9 5.5 11.1 18.9 13.0 7.5 16.6 5.8 10.1 25.0 5.3 16.3 4.2 6.2 4.6 8.1 9.5 15.5 2.9 8.9 5.5 9.1 10.7 12.5 4.9 9.7 7.2 10.9 5.2 14.9 33.1 25.3 7.8 10.3 3.3 3.2 9.6 12.6 4.2 16.0 4.8 6.9 5.3 8.7 7.2 11.4 7.3 6.3 7.5 7.0 5.5 7.2 8.0 3.2 13.4 8.1 7.7 6.2 5.3 13.6 18.2 19.4 18.6 12.7 13.6 12.5 12.4 16.1 11.6 14.9 22.2 0.0 0.0 0.0 0.0 0.0 0.0 62.9 35.2 24.4 0.0 14.5 14.9 16.8 0.0 0.0 0.0 0.0 11.2 6.9 0.0 0.0 14.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 18.0 0.0 0.0 15.8 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 PCOLCE2 PCPE2 ENSG00000163710 "Procollagen C-endopeptidase enhancer 2" Q9UKZ9 3 142815922-142889203 "Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 55.6" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 99.1;Extravillous trophoblasts: 55.3;Fibroblasts: 87.7;Syncytiotrophoblasts: 202.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "ASC diff: 25.9;RPMI-8226: 13.5;U-2197: 29.0;U-266/70: 28.7;U-266/84: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA013203 Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cytosol" "HPA013203: AB_1855084" "unprognostic (1.31e-1)" "unprognostic (3.75e-2)" "unprognostic (5.71e-6)" "unprognostic (8.36e-6)" "unprognostic (3.03e-2)" "unprognostic (1.06e-3)" "unprognostic (2.78e-2)" "unprognostic (9.39e-2)" "unprognostic (1.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.96e-5)" "unprognostic (1.85e-4)" "unprognostic (1.43e-1)" "unprognostic (1.74e-4)" "prognostic unfavorable (1.08e-4)" 35.2 1.2 1.0 2.0 0.5 5.5 29.0 0.3 0.7 12.4 3.6 0.5 9.1 0.0 3.9 6.0 16.8 2.1 3.8 55.6 1.4 1.2 7.3 7.9 6.9 1.6 0.6 0.7 2.5 0.6 0.1 13.8 20.1 0.4 14.2 2.1 2.5 2.7 3.9 6.3 2.7 1.5 41.6 0.8 1.2 2.0 1.9 0.3 0.0 3.5 6.2 0.9 28.2 30.6 0.0 0.0 1.4 0.2 0.0 0.0 0.3 0.5 4.3 1.4 0.0 25.9 7.2 0.0 0.3 0.1 1.2 1.5 0.2 0.5 0.0 1.2 1.9 6.4 0.0 5.1 0.0 1.4 0.0 8.5 0.9 2.8 0.0 0.0 0.5 0.0 2.9 0.0 2.6 0.7 5.9 0.0 0.7 0.2 0.0 0.5 0.7 1.5 0.4 2.1 0.1 9.0 0.0 3.2 13.5 1.3 0.0 2.7 1.7 6.7 0.0 2.5 1.9 0.0 1.8 0.0 2.3 5.2 29.0 2.1 28.7 13.2 0.0 6.4 0.7 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 1.0 0.5 0.3 0.7 1.4 1.2 0.6 0.7 0.4 0.3 0.0 2.7 0.0 0.5 6.5 13.2 33.1 0.0 0.0 1.2 12.2 23.6 99.1 0.0 0.0 0.5 2.7 0.0 0.0 0.0 55.3 87.7 0.6 1.1 12.1 13.7 6.4 0.0 0.6 0.6 0.6 0.6 2.6 3.3 0.0 0.0 13.7 0.5 0.0 0.0 0.0 11.1 0.0 6.3 8.7 49.4 6.5 202.1 0.0 0.0 0.1 PCYT1A "CT, CTPCT, PCYT1" ENSG00000161217 "Phosphate cytidylyltransferase 1, choline, alpha" P49585 3 196214222-196287957 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Cone-rod dystrophy, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 73.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035428 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035428: AB_10602045" "unprognostic (8.58e-3)" "unprognostic (2.63e-1)" "unprognostic (8.45e-2)" "unprognostic (8.61e-3)" "unprognostic (2.87e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.65e-5)" "unprognostic (8.52e-2)" "unprognostic (5.99e-2)" "unprognostic (1.65e-2)" "unprognostic (6.72e-3)" "unprognostic (1.74e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.47e-2)" "unprognostic (7.16e-3)" "unprognostic (2.41e-2)" 24.8 22.2 15.3 19.9 18.7 25.8 18.0 14.2 17.8 13.6 25.3 23.0 21.1 41.1 18.2 18.7 25.2 15.0 19.8 36.0 14.8 13.8 20.2 17.8 18.7 15.6 16.6 14.1 15.6 13.9 16.0 12.1 14.2 20.5 13.3 16.5 14.4 17.1 19.2 45.8 32.8 37.2 19.5 18.3 23.4 18.1 19.4 18.6 13.2 14.8 28.0 19.0 17.6 16.7 7.8 8.7 20.5 9.8 7.9 13.5 4.6 28.7 11.6 8.1 11.9 16.7 18.6 12.3 22.0 15.7 18.9 16.7 28.3 10.5 7.4 73.8 25.2 19.9 22.5 12.9 16.9 16.2 13.4 9.0 21.2 12.2 12.0 15.0 10.2 18.2 15.7 13.0 18.3 13.1 12.2 20.2 6.9 11.8 16.5 18.8 24.3 6.4 5.4 7.0 18.1 17.3 10.6 10.4 11.9 11.6 16.2 8.0 5.9 14.9 25.7 14.3 11.8 37.7 12.8 30.2 15.1 8.4 20.5 29.7 15.3 29.1 13.6 23.1 14.3 18.9 7.5 8.7 9.2 9.6 9.2 8.0 7.8 7.2 10.2 8.7 5.7 4.6 6.8 20.5 7.9 9.8 5.6 13.5 4.6 15.3 18.7 14.2 17.8 14.8 13.8 16.6 14.1 20.5 18.6 14.9 18.8 17.9 8.2 12.9 14.3 58.5 17.8 33.5 15.9 14.0 23.6 10.4 11.6 21.4 63.4 19.5 43.0 0.0 19.9 14.2 13.7 9.7 19.7 31.7 32.6 7.9 21.2 25.2 28.9 52.1 18.4 30.0 18.6 33.3 20.4 11.8 20.8 14.8 26.5 19.4 12.4 25.8 13.7 30.0 10.6 18.7 15.6 22.7 20.5 11.0 PCYT2 ET ENSG00000185813 "Phosphate cytidylyltransferase 2, ethanolamine" Q99447 17 81900965-81911464 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.8" "Group enriched" "Detected in many" 11 "Early spermatids: 615.4;Late spermatids: 2143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023033, HPA023034" Enhanced Approved Nucleoplasm,Cytosol NA NA 7000 Cytosol Nucleoplasm "HPA023033: AB_1855094, HPA023034: AB_1855095" "unprognostic (4.05e-3)" "unprognostic (4.39e-3)" "unprognostic (3.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (9.86e-2)" "unprognostic (1.24e-2)" "unprognostic (1.06e-1)" "unprognostic (4.24e-1)" "unprognostic (8.97e-3)" "unprognostic (1.84e-1)" "unprognostic (2.34e-1)" "prognostic favorable (4.29e-6)" "unprognostic (1.19e-1)" "unprognostic (8.59e-2)" "unprognostic (1.63e-1)" "unprognostic (4.47e-2)" 13.6 5.5 13.3 5.7 12.7 5.3 10.4 12.2 17.0 6.5 16.2 13.4 6.4 30.7 5.8 8.6 7.6 12.2 8.0 17.7 14.0 11.8 21.7 46.5 7.2 6.3 13.4 16.0 7.8 11.5 8.2 4.6 6.0 15.9 10.1 8.5 5.8 10.8 6.6 13.5 4.5 26.5 5.0 14.3 4.1 11.5 70.8 11.0 5.6 6.7 6.8 5.8 7.5 4.4 7.3 6.6 2.1 3.5 4.7 8.4 4.0 11.8 6.8 5.5 15.5 27.6 14.5 8.1 8.5 18.4 12.0 14.3 26.7 12.4 4.1 4.7 8.9 22.3 9.8 8.3 15.9 7.0 1.2 6.8 9.0 9.4 61.2 29.5 9.0 7.6 11.9 9.2 10.8 8.4 4.3 11.1 12.7 16.7 8.6 8.9 10.0 10.7 11.1 4.4 41.7 7.3 7.1 5.9 14.7 14.4 22.5 7.0 6.4 6.4 35.5 8.3 11.3 9.8 21.4 7.4 8.9 5.8 6.6 7.0 5.6 2.3 4.0 9.2 12.1 8.7 2.1 3.5 1.2 7.1 3.4 4.6 6.0 8.4 7.2 6.6 7.3 7.0 7.2 1.0 4.7 3.0 6.5 5.0 4.0 13.3 12.7 12.2 17.0 14.0 11.8 13.4 16.0 15.9 11.0 0.0 15.9 13.0 6.8 4.7 11.8 14.9 56.0 10.7 4.5 24.4 0.0 67.4 101.2 15.9 615.4 7.1 65.6 23.3 16.0 30.7 6.8 9.0 9.2 125.6 20.2 15.9 13.4 20.3 10.0 2143.8 25.6 9.3 32.1 21.6 22.6 19.8 17.5 17.3 24.4 119.0 7.1 25.8 11.4 131.3 17.2 5.0 42.4 12.5 30.7 4.5 PDAP1 "HASPP28, PAP, PAP1" ENSG00000106244 "PDGFA associated protein 1" Q13442 7 99392048-99408829 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021103, HPA050294, HPA060836" Approved Enhanced "Plasma membrane,Cytosol" NA NA 40000 Cytosol "Plasma membrane" "CAB021103: AB_10057973, HPA050294: AB_2681077, HPA060836: AB_2684374" "unprognostic (2.27e-1)" "unprognostic (1.45e-1)" "unprognostic (3.87e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.67e-4)" "unprognostic (5.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.65e-2)" "unprognostic (2.63e-1)" "unprognostic (3.35e-2)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (1.79e-1)" "unprognostic (3.49e-1)" "unprognostic (2.97e-2)" 26.7 25.7 25.5 25.0 23.9 23.0 22.4 23.4 28.5 22.8 25.9 18.3 21.6 21.1 25.8 21.6 32.2 20.5 23.4 30.2 23.4 20.4 25.2 31.8 20.5 20.2 23.2 23.5 23.4 28.2 23.3 18.0 28.8 24.2 23.0 22.0 19.0 27.8 26.4 103.5 24.8 19.6 26.9 22.2 20.5 22.6 19.7 24.3 20.1 22.4 37.2 25.2 24.1 28.2 11.3 15.8 24.2 11.9 20.4 14.2 4.6 31.3 27.4 18.6 23.6 14.4 15.0 12.0 26.0 15.1 21.1 17.9 27.7 15.7 13.8 23.1 24.5 26.8 17.0 22.3 26.1 20.6 19.7 24.8 14.0 26.5 24.1 21.1 26.2 13.9 15.7 19.7 23.1 38.0 19.1 21.0 22.9 33.0 25.3 20.6 65.4 36.3 35.8 23.7 32.0 29.8 16.8 18.6 23.9 21.3 24.2 19.0 38.2 19.5 31.1 13.2 21.8 13.7 13.8 19.0 28.4 31.5 33.7 40.7 24.3 27.8 30.7 22.8 23.5 29.6 7.6 9.4 8.6 12.4 11.9 11.1 11.3 11.5 8.9 7.4 11.1 8.3 10.3 24.2 20.4 10.6 15.8 14.2 4.6 25.5 23.9 23.4 28.5 23.4 20.4 23.2 23.5 24.2 24.3 80.4 78.5 58.8 93.4 55.3 99.3 58.0 66.2 127.2 88.7 40.1 31.4 195.3 142.6 147.5 43.9 96.1 85.9 0.0 148.5 178.1 80.5 110.4 69.4 70.3 101.3 73.1 113.2 60.8 32.4 62.9 77.3 76.3 97.8 137.1 82.1 110.3 138.1 86.8 86.7 87.8 76.8 51.8 85.5 104.4 108.0 57.3 154.2 80.4 92.4 105.8 PDCD1LG2 "B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2" ENSG00000197646 "Programmed cell death 1 ligand 2" Q9BQ51 9 5510570-5571254 "Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 15.1;monocytes: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 25.9;BJ hTERT+: 40.8;HDLM-2: 31.1;TIME: 18.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013411 Approved Uncertain Cytosol "Secreted - unknown location" NA NA 34000000 Cytosol "HPA013411: AB_1855102" "unprognostic (3.93e-2)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (6.68e-3)" "unprognostic (7.66e-2)" "unprognostic (6.77e-2)" "unprognostic (5.72e-2)" "unprognostic (2.91e-1)" "unprognostic (1.68e-1)" "unprognostic (4.37e-3)" "unprognostic (5.79e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (5.00e-2)" "unprognostic (4.66e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-3)" 15.2 1.8 1.2 7.7 1.4 0.2 9.5 0.7 1.2 7.0 1.9 2.3 0.0 0.8 2.9 7.2 3.9 3.8 4.0 5.8 1.2 1.3 2.5 6.4 13.3 10.8 1.6 0.5 4.1 1.8 0.5 1.1 12.9 1.9 5.0 2.5 2.4 2.9 1.7 5.5 3.6 2.5 4.6 3.7 19.5 1.9 4.2 1.2 8.1 3.5 3.5 8.1 6.0 5.4 0.5 0.9 4.1 3.6 0.0 3.0 0.7 2.1 0.0 0.0 0.0 1.8 2.1 0.0 25.9 40.8 12.5 15.2 0.0 0.1 0.0 0.1 10.5 1.8 0.2 0.0 3.5 12.5 31.1 0.0 0.0 0.0 0.0 10.1 0.0 0.0 1.9 0.0 5.8 6.9 3.6 8.2 0.0 0.0 3.1 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 18.0 9.0 0.5 4.3 7.1 0.4 0.0 0.0 5.1 0.0 1.1 4.1 0.9 0.0 1.4 3.6 1.9 0.5 2.2 0.9 0.9 0.3 0.0 1.0 2.0 0.0 0.5 0.0 3.0 0.7 1.2 1.4 0.7 1.2 1.2 1.3 1.6 0.5 1.9 1.2 6.0 0.3 0.8 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.0 0.0 0.2 15.1 2.1 0.1 3.5 0.0 2.8 0.0 0.0 6.7 4.3 0.0 5.5 2.2 1.7 45.9 0.0 0.0 2.1 0.0 2.1 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.7 0.0 0.0 0.0 PDCD5 "MGC9294, TFAR19" ENSG00000105185 "Programmed cell death 5" O14737 19 32581068-32587452 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018471 Enhanced Approved Nucleoplasm,Cytosol NA NA 31000 Cytosol Nucleoplasm "HPA018471: AB_1855108" "unprognostic (1.04e-1)" "unprognostic (2.08e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (2.02e-1)" "unprognostic (8.64e-2)" "unprognostic (3.64e-3)" "unprognostic (2.43e-2)" "unprognostic (6.22e-2)" "unprognostic (8.49e-2)" "unprognostic (3.87e-2)" "unprognostic (1.93e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.00e-2)" "unprognostic (3.35e-2)" "unprognostic (1.10e-1)" "unprognostic (9.54e-2)" 34.1 40.6 42.1 32.3 35.9 18.9 28.9 28.7 33.0 21.2 31.7 16.4 27.0 31.4 22.9 24.8 33.8 21.4 23.1 63.7 33.0 34.2 37.0 52.0 20.6 25.9 32.9 31.9 25.8 47.6 14.7 38.8 29.5 31.0 23.2 27.6 14.7 27.3 24.5 107.4 23.9 27.1 32.1 26.4 26.8 28.0 52.4 23.5 15.2 25.4 42.7 26.6 30.6 31.8 34.6 29.1 11.2 44.8 24.2 49.8 26.9 69.3 86.3 20.8 22.4 35.2 54.4 26.9 51.2 33.0 41.6 35.9 69.9 26.7 37.8 74.8 25.0 38.4 18.6 28.8 39.1 31.9 68.1 46.3 57.1 37.9 41.7 41.9 72.7 23.0 34.5 37.2 28.2 46.4 20.3 27.7 30.0 51.9 41.5 35.0 44.4 32.5 37.8 22.8 54.1 29.3 32.0 32.0 45.7 31.9 18.1 43.9 25.0 48.6 47.4 35.3 15.2 20.7 42.6 42.7 37.4 41.8 40.3 82.5 40.3 57.1 65.7 44.5 66.7 33.0 6.9 23.1 11.2 26.7 34.9 33.9 34.6 42.9 33.0 28.5 25.5 30.4 29.3 3.2 24.2 44.8 29.1 49.8 26.9 42.1 35.9 28.7 33.0 33.0 34.2 32.9 31.9 31.0 23.5 68.5 54.2 33.4 145.9 108.0 36.9 288.5 96.8 120.5 73.9 71.5 25.5 162.5 160.8 234.0 357.7 120.8 81.3 0.0 214.8 167.1 134.8 123.3 46.1 120.1 128.8 47.7 68.5 80.4 43.1 361.1 132.0 84.8 118.1 147.9 102.5 60.5 238.5 74.8 115.6 146.4 36.6 71.1 140.0 373.0 377.8 104.8 119.6 62.3 133.4 113.1 PDCD6 "ALG-2, PEF1B" ENSG00000249915 "Programmed cell death 6" O75340 5 271621-353856 "Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047221 Supported Nucleoplasm,Cytosol No No 2100000 Cytosol Nucleoplasm "HPA047221: " "unprognostic (1.32e-1)" "unprognostic (5.01e-2)" "unprognostic (2.10e-2)" "unprognostic (4.41e-3)" "unprognostic (4.94e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.47e-5)" "unprognostic (1.56e-1)" "unprognostic (1.27e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (7.97e-2)" "unprognostic (1.48e-1)" "unprognostic (2.67e-1)" "prognostic favorable (2.19e-4)" 28.3 48.5 44.6 36.3 42.1 21.0 44.6 42.1 52.0 37.1 47.3 33.7 35.7 41.4 31.5 59.7 58.0 38.9 46.5 23.5 44.4 39.7 35.5 37.1 39.8 48.1 39.2 38.6 36.9 46.2 28.8 36.2 35.4 39.3 32.9 51.0 26.8 40.3 40.4 19.2 31.1 44.3 31.4 38.4 36.6 32.0 31.7 35.1 31.0 42.3 31.9 41.2 31.3 37.7 69.8 67.2 79.9 62.3 70.6 69.9 89.4 27.3 38.5 16.9 25.2 30.7 27.8 34.7 21.3 28.4 27.4 25.8 27.1 34.7 21.5 53.2 28.7 35.6 20.8 25.5 53.6 22.3 72.7 31.6 19.1 99.1 35.0 37.6 27.6 24.5 24.8 33.1 22.2 40.0 28.5 25.7 15.2 24.0 17.0 24.5 42.8 22.4 48.3 17.9 33.5 54.4 18.4 15.7 30.7 64.8 35.3 16.3 22.0 54.2 58.1 39.7 18.3 40.4 38.5 19.8 18.2 14.7 15.7 18.2 22.6 28.0 25.5 26.6 36.2 24.1 40.8 62.3 79.9 49.6 58.7 61.7 69.8 62.2 55.8 67.2 60.9 69.9 56.2 69.0 70.6 56.1 53.8 66.7 89.4 44.6 42.1 42.1 52.0 44.4 39.7 39.2 38.6 39.3 35.1 59.6 50.2 74.3 103.0 72.9 44.2 43.4 84.1 89.7 69.4 97.7 35.3 208.9 213.9 147.4 51.9 103.4 116.6 23.3 113.2 262.6 88.0 103.4 81.8 70.0 126.3 60.4 76.5 63.8 70.9 40.4 108.7 80.4 118.1 180.3 159.6 116.3 131.1 136.8 109.6 163.7 39.4 84.1 82.4 81.7 129.8 80.8 298.3 82.9 170.4 145.4 PDCL "DKFZp564M1863, PhLP" ENSG00000136940 "Phosducin like" Q13371 9 122798389-122828631 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021571, HPA021647, CAB026473" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115" "unprognostic (3.51e-2)" "unprognostic (4.11e-2)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.39e-1)" "unprognostic (8.74e-3)" "unprognostic (1.77e-1)" "unprognostic (3.13e-2)" "unprognostic (1.49e-2)" "unprognostic (1.52e-1)" "unprognostic (1.50e-1)" "prognostic favorable (7.00e-4)" "unprognostic (9.84e-2)" "unprognostic (1.35e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-1)" 20.7 14.8 17.5 14.1 21.0 23.8 23.0 20.5 21.9 19.6 15.1 23.7 11.4 13.2 21.5 12.8 18.4 15.9 14.9 14.6 18.4 17.3 13.7 10.1 19.7 17.5 20.2 17.1 15.5 13.0 17.5 13.7 20.6 22.2 17.1 15.9 13.9 21.7 14.7 8.1 15.4 14.7 17.2 22.8 18.4 15.5 12.1 18.8 19.1 17.3 13.3 17.6 15.8 16.4 12.6 14.7 20.6 16.3 16.2 25.3 10.8 9.6 13.3 23.1 8.5 21.0 14.2 12.8 13.5 14.3 12.5 12.9 8.8 12.8 16.1 11.1 16.2 13.8 18.9 14.2 13.3 14.0 15.7 7.2 16.6 17.8 14.7 10.8 14.0 32.9 12.1 9.7 12.3 6.2 11.8 25.7 10.3 16.6 9.5 14.1 14.8 14.9 12.6 16.9 16.6 10.5 15.7 21.9 11.9 15.2 0.0 18.5 16.5 18.3 10.4 8.1 15.8 15.7 9.7 28.0 11.7 13.9 17.0 13.0 7.3 14.6 17.2 10.0 11.3 11.1 20.6 11.9 19.6 13.9 10.4 15.0 11.4 16.7 12.8 12.3 12.6 17.5 15.2 9.8 16.2 16.3 14.7 25.3 10.8 17.5 21.0 20.5 21.9 18.4 17.3 20.2 17.1 22.2 18.8 8.9 8.6 12.8 13.9 21.5 41.4 3.6 10.2 18.7 4.5 19.2 21.6 24.0 8.3 18.4 4.7 30.5 7.9 0.0 15.8 22.8 25.4 15.3 56.5 6.6 22.4 38.1 12.1 26.4 23.7 2.1 21.3 16.0 18.6 41.5 17.7 34.4 14.0 15.9 15.9 11.8 34.6 19.4 22.7 12.0 17.2 20.3 26.7 20.8 12.1 14.0 PDCL3 VIAF1 ENSG00000115539 "Phosducin like 3" Q9H2J4 2 100562690-100576735 "Predicted intracellular proteins" "Angiogenesis, Apoptosis" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 154.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018469, HPA027094" Approved Enhanced Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA018469: AB_1855116, HPA027094: AB_10601387" "unprognostic (1.34e-1)" "unprognostic (8.30e-2)" "unprognostic (2.20e-1)" "unprognostic (3.32e-2)" "unprognostic (5.07e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.07e-5)" "unprognostic (1.44e-1)" "unprognostic (5.46e-2)" "unprognostic (1.66e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (8.22e-2)" "prognostic favorable (4.23e-4)" 12.9 15.9 14.7 16.4 16.2 12.0 18.0 10.7 16.5 12.7 18.8 14.3 15.3 10.5 20.1 23.5 22.5 14.9 13.1 17.6 14.6 15.8 20.9 12.2 13.5 14.0 24.4 15.9 15.4 10.4 10.8 11.4 17.1 17.4 19.6 17.9 10.2 12.0 15.4 35.7 22.0 12.1 49.6 18.3 14.5 13.3 14.0 14.5 13.4 13.0 18.8 19.6 29.9 16.8 26.5 33.4 22.2 43.6 25.6 31.4 23.3 12.8 18.0 19.0 16.4 6.1 8.6 21.1 16.0 9.9 29.0 18.1 22.6 8.0 20.7 24.4 18.7 39.1 10.8 23.4 15.4 23.0 33.3 20.2 21.9 9.7 26.4 16.2 23.1 23.4 9.5 28.3 25.6 16.4 7.6 17.8 16.6 18.1 14.1 21.5 21.9 23.1 35.5 24.8 13.8 26.5 22.6 20.3 14.5 17.7 29.8 17.8 15.7 12.6 17.2 17.6 16.0 13.5 16.0 13.9 18.2 19.4 14.1 22.0 8.5 15.8 21.8 11.3 27.0 14.3 18.6 19.3 22.2 19.4 34.9 22.1 26.5 29.7 21.5 33.4 20.8 31.0 23.8 2.1 25.6 43.6 18.4 31.4 23.3 14.7 16.2 10.7 16.5 14.6 15.8 24.4 15.9 17.4 14.5 17.9 28.0 24.3 30.3 58.3 10.6 33.9 20.4 22.7 33.0 14.0 5.9 56.6 51.4 45.5 25.5 21.8 14.2 0.0 33.9 42.2 26.3 23.8 88.1 14.7 52.5 11.1 19.0 15.4 12.4 11.4 13.6 57.2 33.7 154.1 22.6 13.5 29.8 17.5 31.5 63.2 11.2 51.8 50.5 5.2 45.8 50.3 43.8 40.8 28.7 30.1 PDE2A ENSG00000186642 "Phosphodiesterase 2A" O00408 11 72576141-72674591 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0;lymphoid tissue: 65.4" "Group enriched" "Detected in some" 6 "Endothelial cells: 33.1;Intestinal endocrine cells: 33.1;Ito cells: 118.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 30.4;basal ganglia: 34.2;cerebral cortex: 48.0;hippocampal formation: 18.0;olfactory region: 27.0" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.7;T-cells: 9.6" "Cell line enriched" "Detected in some" 8 "HeLa: 107.5" "Group enriched" "Detected in all" 5 "amygdala: 111.5;basal ganglia: 166.3;cerebral cortex: 98.9;hippocampal formation: 120.9" "CAB009752, HPA031192" Enhanced Supported Cytosol NA NA Cytosol "CAB009752: AB_2268159, HPA031192: AB_2673781" "unprognostic (1.92e-1)" "unprognostic (1.52e-3)" "unprognostic (4.58e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-1)" "unprognostic (2.50e-1)" "prognostic favorable (1.76e-6)" "unprognostic (3.06e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-3)" "unprognostic (3.13e-3)" "unprognostic (1.50e-2)" "unprognostic (1.77e-2)" "unprognostic (2.85e-3)" "unprognostic (6.31e-2)" "unprognostic (7.72e-2)" "unprognostic (7.96e-4)" 27.8 18.4 30.4 3.0 34.2 2.5 25.4 1.0 48.0 8.9 7.7 3.8 1.9 3.5 9.4 4.9 10.2 11.6 12.0 11.3 18.0 6.1 7.0 10.4 5.1 3.8 3.8 27.0 3.4 2.4 4.4 3.4 6.6 6.7 4.8 5.2 3.0 2.3 6.3 6.6 4.8 4.2 10.3 2.1 65.4 4.2 2.9 7.4 0.1 7.0 3.9 2.2 8.3 11.2 3.7 1.2 0.2 1.0 0.1 9.6 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 2.6 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 107.5 0.1 0.2 0.0 1.6 0.0 0.2 0.5 4.4 0.2 2.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.0 2.9 0.0 0.0 0.2 0.0 0.0 9.6 0.5 0.0 0.0 0.4 0.1 0.0 0.0 13.7 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 9.6 1.0 5.6 3.7 5.7 5.6 1.2 2.5 3.7 3.0 0.2 0.1 0.5 0.0 2.3 1.9 30.4 34.2 1.0 48.0 18.0 6.1 3.8 27.0 6.7 7.4 0.0 0.3 0.0 0.0 2.3 2.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 33.1 0.0 0.0 0.0 0.2 0.9 0.1 1.1 0.9 0.5 1.6 33.1 118.4 10.0 1.5 0.3 1.0 1.7 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.4 0.0 4.3 1.4 0.8 2.5 0.0 0.0 0.0 0.3 PDE4B DPDE4 ENSG00000184588 "Phosphodiesterase 4B" Q07343 1 65792514-66374579 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 48.2" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 81.5;Horizontal cells: 108.1;monocytes: 104.6" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 36.6" "Group enriched" "Detected in all" 5 "B-cells: 16.1;granulocytes: 36.6;T-cells: 13.3" "Cell line enhanced" "Detected in many" "AN3-CA: 24.4;HUVEC TERT2: 36.6;NTERA-2: 22.2;SK-MEL-30: 22.0;TIME: 20.4;U-266/84: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003005 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA003005: AB_1079587" "unprognostic (7.86e-2)" "unprognostic (3.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.90e-1)" "unprognostic (3.21e-1)" "unprognostic (3.33e-3)" "unprognostic (1.35e-1)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (6.10e-2)" "unprognostic (8.78e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (5.04e-4)" "unprognostic (2.89e-2)" "unprognostic (3.54e-1)" "unprognostic (9.04e-3)" "unprognostic (8.33e-3)" 14.9 2.9 21.5 28.4 29.0 48.2 15.0 12.7 31.9 6.4 6.6 39.2 0.7 3.9 6.7 2.1 3.9 3.5 8.1 16.1 20.7 18.8 3.7 8.7 10.0 15.9 36.3 14.2 2.0 1.7 1.7 3.4 13.1 32.2 18.3 8.6 6.6 15.9 10.3 28.2 6.2 8.5 9.5 37.4 18.5 4.2 3.2 36.9 2.3 5.5 5.5 14.7 16.1 3.9 16.1 2.6 36.6 2.8 4.4 13.3 3.7 0.1 7.0 13.8 24.4 0.7 0.7 0.0 4.5 5.3 4.2 5.6 0.0 0.0 2.0 0.1 8.4 0.1 0.0 0.1 0.0 4.2 5.9 0.0 0.1 2.0 0.0 0.5 4.9 0.0 1.4 0.2 2.1 0.1 0.6 36.6 0.0 0.0 1.3 1.8 0.1 0.0 2.8 22.2 0.0 0.3 1.0 2.4 1.3 3.4 0.0 0.1 10.6 0.0 1.2 22.0 1.2 0.1 1.7 20.4 3.3 0.8 1.8 0.7 0.6 19.1 7.5 3.4 5.1 1.4 2.7 2.8 8.4 4.4 2.4 8.4 15.4 8.3 6.2 2.4 16.1 9.4 6.5 36.6 4.4 2.1 2.6 13.3 3.7 21.5 29.0 12.7 24.6 20.7 18.8 36.3 14.2 32.2 36.9 8.9 16.4 50.2 24.5 18.0 35.4 29.1 0.0 2.7 12.5 5.2 0.0 5.2 0.0 0.5 7.9 23.2 0.0 0.0 0.8 1.6 9.3 81.5 14.0 1.6 12.6 108.1 4.1 12.3 25.8 5.6 0.3 42.5 49.0 104.6 1.2 12.2 0.1 0.0 2.5 1.6 3.3 0.0 10.3 0.1 0.7 7.0 4.7 36.2 1.1 5.7 PDE4C DPDE1 ENSG00000105650 "Phosphodiesterase 4C" Q08493 19 18208652-18248200 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 28.6" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 141.8;Paneth cells: 179.9;Undifferentiated cells: 66.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.0;Hep G2: 4.0;U-87 MG: 9.0" "HPA048975, HPA054218" Approved Approved "Midbody ring,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Midbody ring" "HPA048975: AB_2680581, HPA054218: " "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (5.22e-4)" "unprognostic (1.44e-2)" "unprognostic (7.70e-2)" "unprognostic (1.15e-1)" "unprognostic (4.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.50e-3)" "unprognostic (2.21e-1)" "unprognostic (7.25e-10)" "unprognostic (2.73e-2)" "unprognostic (2.65e-1)" "unprognostic (9.21e-2)" "unprognostic (2.45e-2)" 2.0 1.3 1.8 1.5 2.8 1.0 2.0 0.8 6.1 4.1 4.4 1.5 3.1 1.5 6.4 6.8 1.3 4.2 5.6 4.2 1.6 1.9 4.1 2.0 4.1 0.5 1.7 5.1 2.0 0.8 0.3 3.5 7.0 2.8 5.8 1.3 2.5 1.3 5.4 13.4 0.6 4.1 3.4 0.7 2.3 5.2 2.6 1.1 0.4 1.2 28.6 0.7 1.8 3.3 1.3 0.6 3.5 0.7 1.0 0.7 0.2 0.1 0.3 0.2 0.3 0.1 0.3 6.0 0.1 0.0 0.2 0.3 1.2 0.2 0.2 0.6 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.4 4.0 0.2 0.2 0.6 0.7 0.1 2.6 0.0 0.5 0.0 0.3 0.9 2.1 0.1 0.4 0.2 0.3 0.2 0.4 0.2 0.2 0.3 0.4 0.1 0.2 0.2 0.8 0.3 0.5 0.0 1.6 0.5 0.3 0.0 0.4 0.2 0.7 0.1 1.3 0.6 0.2 9.0 0.2 0.3 3.4 0.7 1.0 0.6 0.4 0.5 0.5 0.5 0.4 0.2 1.3 0.5 0.7 3.5 1.0 0.4 0.6 0.3 0.2 1.8 2.8 0.8 6.1 1.6 1.9 1.7 5.1 2.8 1.1 3.0 8.8 0.0 2.2 4.8 3.0 28.1 5.1 0.0 1.2 0.0 5.9 1.9 0.0 0.0 29.1 3.6 141.8 0.0 0.0 3.5 4.2 1.8 4.6 0.0 0.4 0.0 6.9 1.3 2.2 26.0 0.6 1.1 1.7 0.0 34.4 2.7 0.0 179.9 3.9 0.0 3.3 45.3 13.4 1.9 1.9 3.3 0.9 0.0 66.4 18.4 PDE4D DPDE3 ENSG00000113448 "Phosphodiesterase 4D" Q08499 5 58969038-60522120 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.0" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 76.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 28.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 28.1" "Cell line enhanced" "Detected in many" "A549: 25.3;AN3-CA: 29.1;HeLa: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045895 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA045895: AB_10960275" "unprognostic (1.14e-1)" "unprognostic (8.73e-3)" "unprognostic (4.35e-2)" "unprognostic (7.87e-2)" "unprognostic (5.97e-2)" "unprognostic (2.03e-1)" "unprognostic (8.10e-4)" "unprognostic (1.17e-1)" "unprognostic (6.59e-2)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (2.65e-1)" "prognostic favorable (4.00e-5)" "unprognostic (1.51e-1)" "unprognostic (8.20e-2)" "unprognostic (1.77e-2)" "unprognostic (2.56e-2)" 8.2 1.9 4.4 6.8 8.6 46.2 5.3 4.2 13.0 13.5 18.6 1.4 14.7 4.1 17.1 14.0 10.3 6.6 12.7 15.5 4.5 5.8 12.8 3.4 11.1 3.7 5.2 6.6 5.3 2.9 7.0 9.0 11.8 2.7 18.2 11.2 8.6 24.4 16.5 60.0 5.1 7.5 35.8 5.0 3.8 10.2 2.6 2.8 4.4 6.2 11.3 9.5 20.0 11.2 6.1 0.7 28.1 1.1 0.1 0.8 0.5 0.0 25.3 5.3 29.1 1.0 1.9 4.2 0.6 0.7 1.4 2.1 9.9 0.8 1.9 0.1 0.2 4.3 4.3 0.0 1.1 2.5 1.1 2.9 3.7 41.9 2.1 3.9 1.7 0.2 3.9 0.9 4.0 0.7 0.4 3.0 0.1 0.0 0.6 2.4 1.8 1.4 4.1 1.0 0.7 1.3 0.4 6.7 4.2 6.6 9.5 0.9 3.3 6.7 11.3 5.7 5.0 0.8 3.7 3.4 0.3 0.1 5.0 1.3 1.4 0.0 0.2 4.3 7.0 1.1 2.0 1.1 28.1 0.8 0.0 0.8 6.1 0.7 0.3 0.7 6.1 0.5 0.4 1.5 0.1 0.1 0.0 0.4 0.5 4.4 8.6 4.2 13.0 4.5 5.8 5.2 6.6 2.7 2.8 29.8 76.9 9.1 30.5 9.4 13.6 32.7 10.2 22.7 48.9 40.1 68.7 9.2 10.0 0.5 16.6 12.4 16.7 0.0 1.6 14.8 13.1 46.1 21.9 0.8 4.3 1.6 32.0 14.1 6.0 29.3 1.4 9.4 10.1 4.6 18.4 16.1 5.4 10.5 4.6 17.7 52.1 0.0 5.3 0.5 7.1 7.8 2.6 37.3 10.1 21.1 PDE5A ENSG00000138735 "Phosphodiesterase 5A" O76074 4 119494395-119628991 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Allosteric enzyme, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Peritubular cells: 98.6;Smooth muscle cells: 79.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 27.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.6;HHSteC: 35.4;hTERT-RPE1: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004729, HPA012873" Approved Approved Cytosol NA NA 3100000 Cytosol "HPA004729: AB_1079588, HPA012873: AB_1855124" "unprognostic (6.95e-2)" "prognostic favorable (5.20e-4)" "unprognostic (1.28e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (7.36e-2)" "unprognostic (2.58e-2)" "unprognostic (2.29e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-2)" "unprognostic (2.54e-1)" "unprognostic (2.16e-2)" "unprognostic (1.52e-2)" "unprognostic (8.98e-2)" "unprognostic (8.71e-3)" "prognostic unfavorable (1.17e-4)" 12.3 4.9 2.0 28.2 2.3 0.4 8.1 3.0 2.3 21.3 28.0 1.7 20.1 6.5 17.3 21.4 30.7 10.7 13.3 5.3 2.0 2.8 3.8 1.2 11.4 4.1 2.4 3.4 10.0 7.8 5.1 3.4 8.9 4.4 31.8 11.7 20.2 8.5 23.7 6.8 4.2 15.6 45.6 2.0 2.1 9.1 7.6 1.2 0.9 9.1 8.1 2.2 25.9 15.9 1.5 0.5 1.4 0.4 0.6 2.1 4.2 8.1 0.4 5.7 0.6 2.0 3.0 1.0 5.5 24.6 0.2 0.5 0.5 0.7 0.8 0.2 6.8 1.5 3.0 1.8 0.8 0.7 0.2 3.7 9.1 1.4 0.4 35.4 1.9 0.9 3.3 1.7 0.6 0.0 12.9 0.7 1.9 1.0 1.5 0.8 0.4 2.4 0.3 1.2 0.9 1.4 0.3 2.9 2.1 2.1 2.5 2.2 4.6 6.3 8.0 0.6 4.4 1.4 1.0 1.2 3.2 2.8 1.7 0.7 2.1 1.0 0.7 3.1 0.5 0.4 0.0 0.3 0.0 0.6 0.1 2.1 1.5 1.3 0.4 0.2 1.0 0.6 0.9 1.4 0.6 0.4 0.5 0.4 4.2 2.0 2.3 3.0 2.3 2.0 2.8 2.4 3.4 4.4 1.2 6.0 4.6 0.0 2.3 3.1 8.1 3.5 12.7 1.4 5.7 1.8 13.7 0.2 0.0 12.0 25.6 3.3 6.3 0.0 2.5 0.2 3.8 2.4 1.1 1.0 0.2 4.8 2.4 1.3 0.0 9.4 19.2 0.7 5.0 0.0 10.1 28.4 4.2 9.1 98.6 0.5 5.9 19.4 79.9 2.9 5.5 2.0 0.2 0.0 8.6 1.6 PDE6B "CSNB3, CSNBAD2, PDEB, rd1, RP40" ENSG00000133256 "Phosphodiesterase 6B" P35913 4 625584-670782 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2;retina: 64.2" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 453.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;JURKAT: 11.8;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054148, HPA059929" Enhanced Approved Cytosol NA NA Cytosol "HPA054148: AB_2682401, HPA059929: AB_2684166" "unprognostic (2.43e-2)" "unprognostic (1.33e-4)" "unprognostic (2.45e-4)" "unprognostic (7.18e-3)" "unprognostic (1.88e-2)" "unprognostic (5.04e-3)" "unprognostic (7.32e-3)" "prognostic favorable (5.34e-4)" "unprognostic (9.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.37e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" 1.6 1.9 12.1 4.6 19.1 6.7 3.8 2.3 13.2 2.3 1.3 30.2 1.5 0.8 2.5 3.9 1.4 9.6 3.2 5.2 18.1 10.2 4.6 0.7 4.2 12.0 29.6 9.8 2.6 1.4 9.1 3.2 2.6 14.5 2.5 1.0 64.2 3.5 2.9 0.7 1.8 2.2 2.1 20.2 8.7 2.5 3.6 22.4 4.3 11.4 0.2 8.3 4.1 1.1 16.5 14.1 11.2 5.8 10.2 13.1 7.1 0.0 0.2 0.8 0.4 0.2 0.3 0.2 0.0 0.0 0.5 1.4 0.0 0.1 0.2 8.0 0.2 0.7 0.1 1.7 0.4 0.0 0.1 0.0 0.6 0.2 0.0 4.1 0.1 0.3 0.5 0.1 2.4 0.0 0.5 0.7 11.8 0.1 0.6 0.0 0.2 20.5 0.2 6.5 0.4 0.2 11.1 0.2 0.4 1.4 0.9 14.0 8.2 0.0 0.3 0.1 3.3 0.4 0.0 0.2 0.1 0.8 0.1 0.3 5.4 15.2 0.2 0.2 0.2 0.1 11.2 4.2 0.6 11.5 5.8 10.5 10.0 7.7 7.9 6.6 16.5 12.2 13.1 1.1 10.2 5.6 14.1 11.4 7.1 12.1 19.1 2.3 10.0 18.1 10.2 29.6 9.8 14.5 22.4 3.0 5.3 4.5 1.2 0.3 18.2 3.7 0.0 16.0 5.7 0.0 78.5 0.1 1.7 5.1 0.4 1.8 0.0 0.0 0.6 0.2 0.8 0.9 3.5 0.0 9.2 11.1 1.7 2.5 3.9 0.0 1.4 3.4 3.3 7.2 0.2 20.9 0.7 0.0 1.4 6.7 453.5 0.0 0.2 3.9 2.7 0.3 0.2 7.0 0.1 0.6 PDE8B ENSG00000113231 "Phosphodiesterase 8B" O95263 5 77210449-77429807 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "Cushing syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "thyroid gland: 67.7" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 26.4;Cone photoreceptor cells: 51.1;Glandular cells: 41.8;Horizontal cells: 65.2;Muller glia cells: 77.6" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 35.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "BJ hTERT+: 12.4;HeLa: 28.4;SK-BR-3: 7.6" "HPA036911, HPA036912" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036911: AB_2675378, HPA036912: AB_10670377" "unprognostic (1.30e-1)" "unprognostic (7.95e-2)" "unprognostic (3.35e-2)" "unprognostic (7.61e-4)" "unprognostic (1.59e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-2)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.98e-2)" "unprognostic (2.44e-1)" "unprognostic (9.04e-3)" "unprognostic (3.40e-2)" "unprognostic (3.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.19e-2)" 6.8 2.5 9.9 0.7 14.2 0.4 3.8 1.1 16.3 6.3 1.2 2.3 0.3 1.2 11.3 3.2 1.1 10.1 2.1 7.9 8.2 9.2 3.1 1.2 2.2 0.7 5.4 8.3 1.9 4.2 0.3 3.8 13.1 8.6 10.5 0.8 2.0 5.3 7.1 0.4 0.7 1.3 10.3 2.3 0.4 1.5 1.5 5.7 0.3 67.7 0.3 0.7 0.8 1.4 0.2 0.8 1.4 2.3 0.4 0.4 0.1 0.3 3.4 1.4 0.4 1.2 0.0 0.5 1.1 12.4 0.2 0.1 1.4 0.2 0.5 0.2 0.1 0.3 0.9 0.1 0.0 0.2 0.2 1.1 0.7 28.4 0.3 0.0 0.5 0.6 0.5 0.0 0.0 0.0 0.6 0.0 0.6 0.2 0.3 0.0 0.2 0.6 0.7 0.8 0.3 0.1 0.8 1.4 0.7 0.0 0.3 3.8 1.1 1.7 7.6 0.8 1.1 1.6 1.1 0.6 0.4 0.2 0.2 0.6 0.9 0.5 0.6 1.6 0.7 0.4 0.0 0.3 1.4 0.3 2.2 0.1 0.2 0.2 0.3 0.8 0.2 0.4 0.0 0.3 0.4 2.3 0.5 0.1 0.1 9.9 14.2 1.1 16.3 8.2 9.2 5.4 8.3 8.6 5.7 3.0 3.2 0.0 1.6 0.3 11.8 26.4 0.0 0.0 2.3 1.8 51.1 0.0 0.0 1.8 3.6 0.7 0.0 0.0 0.0 0.0 2.3 41.8 1.1 0.0 0.3 65.2 4.7 4.3 0.6 3.0 5.5 0.0 1.7 0.0 0.6 77.6 0.2 0.0 0.0 0.8 4.6 6.5 8.2 0.6 2.1 1.0 0.0 0.0 0.5 2.4 PDE9A ENSG00000160191 "Phosphodiesterase 9A" O76083 21 42653636-42775509 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 168.7;Paneth cells: 77.2" "Cancer enhanced" "Detected in all" "prostate cancer: 31.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.8" "Group enriched" "Detected in many" 4 "NK-cells: 1.7;T-cells: 6.8" "Cell line enhanced" "Detected in many" "AF22: 16.3;EFO-21: 16.5;MCF7: 12.2;NB-4: 18.2;NTERA-2: 22.5;SCLC-21H: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011380, HPA011978" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA011380: AB_1855132, HPA011978: " "unprognostic (5.75e-2)" "unprognostic (9.92e-3)" "unprognostic (3.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (5.06e-2)" "unprognostic (3.99e-2)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-2)" "unprognostic (5.01e-2)" "unprognostic (1.90e-2)" "unprognostic (4.01e-3)" "unprognostic (1.97e-1)" "unprognostic (6.55e-2)" "unprognostic (1.79e-1)" 6.1 6.6 9.9 6.8 15.2 0.8 9.4 13.7 9.0 3.7 37.1 11.9 14.0 3.0 5.7 18.8 6.1 10.3 7.7 3.5 6.2 7.7 13.2 2.5 4.7 4.6 10.0 4.9 4.1 4.0 4.7 6.0 9.6 6.9 33.2 15.8 9.7 8.8 15.9 2.3 3.8 26.1 22.3 8.0 15.9 8.4 1.5 8.9 4.9 5.2 2.1 4.1 12.6 4.0 0.5 0.9 1.0 0.1 1.7 6.8 0.5 0.0 1.5 16.3 2.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.8 9.8 0.0 16.5 0.0 1.1 0.0 1.4 5.3 0.0 0.0 5.6 0.0 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 12.2 0.8 18.2 22.5 8.0 0.0 0.0 0.0 0.6 11.2 4.5 12.5 7.4 2.8 0.0 0.2 4.0 0.1 10.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.1 0.6 0.2 0.5 6.8 1.7 1.0 1.7 0.1 0.9 2.2 0.5 9.9 15.2 13.7 6.7 6.2 7.7 10.0 4.9 6.9 8.9 3.0 5.3 0.0 8.5 0.9 21.0 1.4 5.1 1.4 0.0 17.4 0.0 0.0 24.9 6.2 0.3 6.7 168.7 0.0 2.1 0.1 3.1 27.6 1.1 0.8 5.6 33.4 12.6 3.7 0.6 1.7 10.9 1.0 27.0 1.8 19.3 9.4 5.1 77.2 5.6 7.6 2.7 12.9 5.9 0.4 0.7 0.5 0.3 2.1 22.2 13.1 PDGFC "fallotein, SCDGF" ENSG00000145431 "Platelet derived growth factor C" Q9NRA1 4 156760454-156971394 "Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 44.1;Cholangiocytes: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 2.1;intermediate monocyte: 1.0;non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 11 "monocytes: 2.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.1;hTERT-RPE1: 26.6;U-138 MG: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009134 Approved Supported "Plasma membrane,Cytosol" "Secreted to blood" NA NA "Plasma membrane, Cytosol" "HPA009134: AB_10601981" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (5.79e-2)" "unprognostic (3.67e-2)" "unprognostic (3.97e-1)" "unprognostic (3.41e-2)" "unprognostic (8.78e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (8.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" "prognostic favorable (1.35e-5)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "prognostic unfavorable (3.17e-4)" 11.5 9.1 3.2 6.5 3.4 0.7 7.9 1.3 3.5 21.8 6.1 1.9 8.4 2.2 21.3 9.4 6.1 9.0 12.7 3.6 2.4 2.0 9.7 10.3 6.9 4.3 2.2 3.8 10.4 9.8 28.0 2.2 4.9 1.9 17.7 2.4 5.5 26.6 9.3 6.5 4.1 5.4 11.9 2.0 4.1 5.6 4.3 1.7 2.2 10.4 4.4 1.5 8.3 4.7 0.0 0.2 0.0 2.1 0.0 0.0 0.7 1.0 1.6 17.8 11.7 3.3 6.5 0.4 9.3 9.9 5.6 7.5 1.0 4.2 0.0 1.6 27.1 4.3 1.1 4.9 6.1 7.7 0.0 2.2 10.8 1.6 1.0 8.7 1.6 0.1 6.7 3.0 14.2 10.2 26.6 2.7 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.2 0.0 0.7 0.0 3.7 0.0 10.6 0.4 0.0 0.0 0.0 0.0 0.1 2.9 1.4 0.5 12.0 19.4 0.2 4.9 7.5 0.0 0.0 0.0 7.4 0.0 0.7 0.0 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.7 3.2 3.4 1.3 3.5 2.4 2.0 2.2 3.8 1.9 1.7 6.0 13.9 0.0 18.3 44.1 0.3 13.7 45.9 0.0 7.9 12.2 0.0 0.4 0.0 13.8 31.1 4.9 0.4 0.0 6.2 0.2 15.8 6.7 1.1 13.0 10.6 0.0 0.0 11.6 21.7 18.1 4.9 14.8 10.1 16.2 2.0 6.7 12.6 0.0 21.5 14.9 0.3 6.5 17.3 0.2 2.2 11.8 0.5 0.5 1.3 4.3 PDIA6 "ERp5, P5, TXNDC7" ENSG00000143870 "Protein disulfide isomerase family A member 6" Q15084 2 10783391-10837977 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Extravillous trophoblasts: 955.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034347, HPA034652, HPA034653" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 53000000 "Endoplasmic reticulum, Cytosol" "CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982" "unprognostic (8.16e-2)" "prognostic unfavorable (1.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.20e-4)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" "unprognostic (5.25e-3)" "unprognostic (6.03e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (6.59e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-2)" "unprognostic (3.69e-3)" 26.9 32.7 16.7 25.0 29.9 19.9 28.7 11.3 16.8 33.4 26.1 13.9 53.7 20.4 30.4 76.1 27.1 25.5 22.4 32.7 14.2 13.9 42.1 118.4 30.4 36.3 17.8 12.7 26.5 141.6 24.9 23.3 39.5 19.0 22.6 30.1 14.6 53.4 45.0 15.7 16.1 28.4 26.5 14.3 35.1 30.9 12.4 19.5 18.1 97.9 20.1 29.7 21.9 30.6 45.2 61.0 52.0 46.2 51.5 52.2 59.7 33.2 36.1 51.7 81.1 66.6 57.6 92.0 80.9 75.1 42.5 57.3 51.2 65.7 54.0 57.0 79.1 82.6 27.3 38.8 67.7 45.7 42.3 30.6 43.8 28.3 83.1 72.1 44.8 32.9 41.5 52.1 41.1 74.2 78.8 95.7 20.5 37.6 116.5 41.9 39.4 17.2 46.5 43.2 108.3 28.6 41.4 52.7 97.8 60.5 40.2 33.2 66.5 31.9 46.8 45.4 70.0 16.5 76.1 47.0 39.9 51.0 35.9 46.7 110.0 67.8 35.0 53.9 56.4 55.8 52.0 44.4 20.5 47.5 46.2 52.2 45.2 37.7 44.7 48.6 33.1 18.4 31.0 8.1 51.5 33.9 61.0 37.7 59.7 16.7 29.9 11.3 16.8 14.2 13.9 17.8 12.7 19.0 19.5 53.6 94.6 111.7 205.7 91.5 66.3 27.4 152.8 108.4 161.5 186.7 27.5 420.2 36.5 263.9 6.1 114.4 100.2 23.3 210.7 955.4 173.7 256.1 129.2 285.4 369.6 39.7 151.3 244.9 137.9 12.1 112.2 137.1 189.0 126.2 149.4 95.2 191.3 100.8 126.9 98.3 45.7 84.1 115.4 95.8 139.7 89.6 463.4 112.4 196.3 240.5 PDLIM3 ALP ENSG00000154553 "PDZ and LIM domain 3" Q53GG5 4 185500660-185535612 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 447.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 159.2;Ductal cells: 168.1;Melanocytes: 118.1;Peritubular cells: 184.2;Smooth muscle cells: 182.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 51.1;RH-30: 12.6;U-266/70: 41.1;U-266/84: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004749 Enhanced Supported Cytosol NA NA 270000 Cytosol "HPA004749: AB_1855150" "unprognostic (2.75e-1)" "unprognostic (3.85e-2)" "unprognostic (3.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.08e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (9.46e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.97e-7)" "unprognostic (1.64e-3)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.78e-3)" 7.8 1.2 1.6 5.2 1.9 0.1 3.7 2.2 1.0 6.6 16.5 1.4 7.9 2.3 22.2 17.0 27.2 9.3 9.9 29.5 1.5 1.6 0.8 0.8 5.6 1.4 1.6 1.0 11.1 2.1 0.1 1.9 2.2 1.6 15.2 3.6 4.8 5.3 18.7 447.7 1.0 6.1 49.5 1.4 3.4 10.2 3.9 0.7 0.1 6.2 87.3 9.1 28.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.4 0.5 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.4 1.9 5.6 0.0 0.0 4.0 0.0 1.2 0.0 5.1 4.2 0.0 0.0 0.0 51.1 0.0 0.0 0.0 0.9 0.0 0.4 0.0 12.6 0.1 0.0 0.0 7.6 5.7 0.0 0.0 3.0 1.5 0.3 0.0 2.8 0.0 3.0 0.0 2.6 41.1 11.6 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.9 2.2 1.0 1.5 1.6 1.6 1.0 1.6 0.7 8.9 5.9 0.0 9.4 7.9 7.2 159.2 7.6 5.3 3.4 0.0 11.8 1.4 0.0 168.1 0.3 50.8 0.0 0.0 14.6 2.1 51.6 14.4 0.0 0.6 1.3 4.8 3.4 65.1 2.7 1.5 18.1 4.4 118.1 5.4 0.0 30.9 51.1 0.0 184.2 0.0 39.4 103.5 182.4 2.8 12.4 6.1 10.2 0.0 0.0 4.1 PDLIM4 RIL ENSG00000131435 "PDZ and LIM domain 4" P50479 5 132257671-132273454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 247.7;Glandular cells: 292.2;Urothelial cells: 373.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 13 "NK-cells: 1.3" "Cell line enhanced" "Detected in many" "HaCaT: 27.7;HBEC3-KT: 32.4;HHSteC: 32.2;hTEC/SVTERT24-B: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011912 Uncertain Approved "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA011912: AB_1856277" "unprognostic (1.36e-3)" "unprognostic (1.93e-1)" "unprognostic (1.62e-2)" "unprognostic (8.08e-3)" "unprognostic (4.70e-3)" "unprognostic (2.01e-2)" "unprognostic (1.89e-1)" "unprognostic (2.39e-1)" "unprognostic (1.34e-1)" "unprognostic (3.38e-2)" "unprognostic (3.94e-2)" "unprognostic (4.20e-2)" "unprognostic (5.84e-3)" "unprognostic (1.13e-2)" "unprognostic (2.61e-1)" "unprognostic (3.57e-2)" "unprognostic (3.40e-3)" 11.5 5.0 7.1 12.8 13.1 0.6 30.4 2.4 5.9 11.5 32.9 7.4 8.9 5.0 33.4 28.7 27.9 16.2 19.1 21.8 12.2 6.9 6.9 0.6 3.4 8.2 6.5 3.8 15.0 4.8 4.6 10.1 19.8 35.9 17.3 3.7 9.6 19.8 21.9 3.8 21.2 8.7 44.8 23.4 2.8 13.4 6.9 3.8 3.5 4.8 25.2 10.6 22.6 13.8 0.0 0.0 0.0 0.0 1.3 0.0 0.3 13.5 0.0 2.9 0.0 4.1 11.4 1.0 3.9 1.9 3.9 1.3 0.0 1.3 0.1 2.7 20.1 20.0 27.7 0.0 32.4 1.9 0.0 1.4 0.0 0.0 0.6 32.2 0.0 0.0 14.4 2.4 35.6 13.3 14.0 22.2 0.0 5.7 0.0 17.1 0.0 0.0 0.1 1.0 0.0 8.3 0.6 20.0 0.0 8.7 0.0 0.0 12.2 8.8 0.0 0.0 2.4 0.0 1.4 14.0 14.2 15.5 14.8 21.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 7.1 13.1 2.4 5.9 12.2 6.9 6.5 3.8 35.9 3.8 0.0 4.1 0.0 247.7 93.9 0.1 6.3 0.0 65.6 28.4 14.0 2.0 3.0 91.2 100.6 12.4 43.8 1.2 0.0 8.6 10.0 50.7 292.2 4.6 0.0 6.7 0.0 16.1 16.0 0.3 12.8 33.6 5.5 156.9 1.8 8.1 14.8 64.7 23.0 25.8 3.9 0.2 25.8 52.6 9.5 9.2 72.4 19.1 1.3 0.8 373.7 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926066 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 71.4;Early spermatids: 99.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 39.5;hTERT-RPE1: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Yes No "Nucleoplasm, Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavorable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favorable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 5.1 32.3 11.0 4.6 38.9 5.9 7.9 7.5 62.2 7.5 4.3 4.7 1.6 3.3 7.7 8.6 8.0 6.1 9.6 22.9 10.1 8.0 6.3 2.2 6.0 5.6 5.1 32.5 9.7 9.3 20.6 4.2 6.6 4.4 5.2 6.2 4.4 6.6 4.7 31.8 3.2 5.5 5.5 3.4 5.8 5.5 12.9 4.8 4.1 9.3 7.0 5.8 7.7 5.1 11.0 12.7 7.8 21.5 2.8 19.5 8.8 7.9 3.9 8.6 3.6 7.1 13.1 2.8 6.3 7.0 7.4 8.7 4.1 29.6 4.4 21.2 10.0 39.5 17.7 3.6 5.3 11.0 0.4 1.8 2.1 4.9 1.4 8.2 1.0 3.0 8.4 10.5 12.6 20.2 39.3 16.7 4.0 0.7 7.3 9.0 1.9 6.2 3.2 3.9 8.6 5.1 1.5 5.1 0.8 5.1 5.5 0.8 3.7 4.1 0.4 19.3 7.3 1.3 1.2 29.6 9.0 5.8 21.0 7.4 4.1 1.7 3.7 11.5 3.7 7.9 3.1 15.4 7.8 5.6 14.3 5.3 9.3 9.1 7.2 12.7 11.0 5.5 4.8 1.8 2.8 21.5 2.1 19.5 8.8 11.0 38.9 7.5 62.2 10.1 8.0 5.1 32.5 4.4 4.8 11.9 5.6 13.4 11.2 11.6 34.7 71.4 22.9 22.7 17.0 15.7 7.9 3.5 5.0 24.3 99.2 14.7 6.0 0.0 11.9 3.2 11.6 13.3 5.8 2.5 5.7 9.5 9.8 14.1 20.8 22.0 10.6 16.2 10.1 2.8 5.2 19.0 22.2 7.0 12.7 8.6 10.6 6.5 12.7 7.2 9.7 9.5 3.7 10.1 8.9 17.0 PDPK1 PDK1 ENSG00000140992 "3-phosphoinositide dependent protein kinase 1" O15530 16 2537964-2603188 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004272, HPA035199" Supported Supported Cytosol NA NA Cytosol "CAB004272: AB_626657, HPA035199: AB_2674514" "unprognostic (2.67e-2)" "unprognostic (1.63e-1)" "unprognostic (3.12e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (4.69e-3)" "unprognostic (8.37e-2)" "unprognostic (3.18e-2)" "unprognostic (8.17e-2)" "unprognostic (3.70e-2)" "unprognostic (1.52e-2)" "unprognostic (3.28e-2)" "prognostic favorable (1.29e-14)" "unprognostic (2.04e-2)" "unprognostic (5.96e-2)" "unprognostic (1.95e-1)" "unprognostic (2.16e-1)" 11.1 14.9 21.0 11.6 31.9 14.2 14.2 29.6 26.4 10.5 15.6 14.5 10.4 17.2 13.0 14.0 13.8 15.3 10.8 14.8 17.2 13.5 17.6 12.6 13.4 13.5 11.3 20.6 14.8 28.2 34.5 13.9 17.1 16.7 13.6 15.3 12.8 16.5 13.2 18.2 14.1 19.1 12.9 10.9 13.7 13.4 14.2 10.1 14.1 16.1 10.6 13.9 12.3 13.3 5.1 9.1 14.7 9.4 5.4 6.0 4.5 8.5 11.0 13.8 9.1 14.2 11.9 14.6 14.3 9.2 12.8 10.8 11.0 10.3 14.1 9.8 13.8 10.9 13.6 16.4 10.3 12.2 25.1 11.1 7.5 14.5 18.2 12.4 12.3 19.7 10.8 19.0 13.8 9.2 12.4 11.7 12.9 13.9 11.5 15.0 18.1 12.4 8.7 8.7 16.0 9.8 25.4 13.7 12.8 12.4 7.7 21.7 11.2 18.5 21.3 7.7 9.2 19.7 15.5 14.3 14.0 13.9 13.6 12.3 15.3 14.6 22.1 6.7 8.6 12.1 3.9 7.9 9.0 5.1 9.3 4.8 5.1 4.7 6.0 6.7 4.5 5.3 4.9 14.7 5.4 9.4 9.1 2.3 4.5 21.0 31.9 29.6 26.4 17.2 13.5 11.3 20.6 16.7 10.1 14.9 18.4 17.1 18.3 23.7 56.0 28.1 43.3 21.4 14.8 10.4 51.1 38.1 11.6 20.5 12.0 15.5 32.9 0.0 20.5 24.1 22.4 24.3 7.0 38.5 22.9 69.9 20.7 23.9 46.7 21.8 29.4 21.5 20.3 30.7 31.7 39.4 25.3 17.5 41.8 34.2 41.5 45.3 18.6 36.7 40.5 29.7 87.5 17.5 27.9 19.6 PDSS1 "COQ1, TPRT, TPT" ENSG00000148459 "Decaprenyl diphosphate synthase subunit 1" Q5T2R2 10 26697659-26746798 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 22.4;lymphoid tissue: 31.8" "Cell type enhanced" "Detected in many" 5 "Undifferentiated cells: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038032, HPA042741" Uncertain Approved Cytosol NA NA Cytosol "HPA038032: AB_10670650, HPA042741: AB_2678139" "unprognostic (1.41e-2)" "unprognostic (3.92e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (1.66e-4)" "unprognostic (6.79e-3)" "unprognostic (5.43e-2)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.47e-2)" "unprognostic (9.43e-2)" "unprognostic (2.33e-2)" "unprognostic (2.20e-1)" "unprognostic (4.11e-2)" "unprognostic (2.99e-3)" "unprognostic (2.93e-3)" "unprognostic (8.85e-2)" "unprognostic (9.83e-2)" "unprognostic (6.36e-2)" 3.1 2.6 2.4 7.0 3.1 5.6 3.5 5.6 5.1 3.1 18.2 1.5 1.2 20.6 3.8 2.1 8.3 3.4 3.7 4.2 2.2 2.2 8.6 7.2 4.0 7.8 2.1 2.3 2.8 3.8 1.7 2.5 2.8 2.9 2.3 17.0 3.2 3.5 1.8 10.4 2.7 22.4 3.6 3.1 5.7 3.8 3.0 1.6 31.8 2.1 4.7 5.0 2.9 4.0 3.2 5.2 0.9 5.3 0.8 3.4 1.3 7.6 5.9 4.5 8.3 1.5 2.8 6.3 7.1 1.9 10.3 7.0 9.1 4.3 17.4 3.7 3.5 3.9 9.7 14.5 10.8 8.8 7.3 12.1 15.1 5.2 6.6 2.2 10.0 6.0 3.5 4.7 9.6 2.6 1.8 5.4 11.5 13.8 4.6 7.2 12.0 31.5 7.0 9.1 12.3 5.8 14.7 13.0 12.6 6.0 3.6 13.3 8.2 6.8 14.2 7.7 4.9 5.0 11.7 3.4 5.8 9.2 11.8 11.2 1.8 6.7 12.7 5.7 25.5 4.4 0.0 5.3 0.9 0.9 4.1 2.1 0.5 1.8 1.3 5.2 3.2 3.4 1.5 0.3 0.8 2.1 1.4 0.1 1.3 2.4 3.1 5.6 5.1 2.2 2.2 2.1 2.3 2.9 1.6 0.0 0.0 3.7 3.2 6.2 2.8 1.8 7.6 1.4 3.4 3.5 3.9 5.3 6.6 6.6 9.3 2.2 14.7 0.0 3.3 10.1 2.9 2.7 0.0 3.4 7.9 1.6 10.4 3.1 6.8 2.5 2.0 5.1 1.7 2.8 9.8 1.2 4.2 7.0 2.5 17.7 4.7 0.0 3.8 7.0 9.8 2.8 5.3 3.3 23.4 2.5 PDSS2 "bA59I9.3, C6orf210" ENSG00000164494 "Decaprenyl diphosphate synthase subunit 2" Q86YH6 6 107152557-107459564 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Cancer-related genes, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029685, HPA029686" Approved Supported Cytosol NA NA Cytosol "HPA029685: AB_10600219, HPA029686: AB_10602309" "prognostic unfavorable (1.34e-5)" "unprognostic (1.44e-1)" "prognostic favorable (5.74e-5)" "unprognostic (5.76e-2)" "unprognostic (1.42e-1)" "unprognostic (3.30e-2)" "unprognostic (3.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (9.38e-2)" "unprognostic (2.19e-1)" "prognostic favorable (3.75e-7)" "unprognostic (2.25e-1)" "unprognostic (2.86e-1)" "unprognostic (1.29e-1)" "unprognostic (2.11e-2)" 10.6 27.3 7.2 17.0 8.3 8.3 19.6 9.0 10.3 10.4 12.7 9.0 13.7 9.6 13.1 11.4 11.5 9.2 11.2 16.0 7.0 6.8 22.1 27.4 18.2 18.3 9.2 5.3 10.8 14.0 11.4 19.4 7.0 9.6 15.6 13.9 12.0 19.9 19.9 13.1 9.0 10.1 11.0 8.1 9.1 10.5 12.8 10.1 11.3 14.1 11.1 10.6 10.9 12.9 8.5 9.4 4.1 12.1 4.6 8.3 4.3 5.7 7.7 6.7 10.3 11.5 14.7 15.2 10.2 12.9 9.8 9.5 7.6 8.4 11.0 9.3 11.3 10.5 7.9 16.0 12.7 13.4 7.0 7.8 10.9 9.2 12.7 12.2 14.0 8.8 10.9 15.1 15.5 12.3 8.6 10.3 12.9 15.5 15.0 9.5 7.1 4.0 14.9 4.2 13.3 10.0 7.3 5.9 8.8 12.1 7.9 6.6 5.7 7.0 12.2 14.5 7.5 9.9 17.0 6.4 7.0 4.2 9.8 8.7 4.2 5.1 8.5 13.0 20.9 12.9 4.1 6.6 3.5 5.3 7.6 8.3 6.6 5.6 6.8 9.4 8.5 7.3 6.9 0.9 4.6 12.1 4.5 7.1 4.3 7.2 8.3 9.0 10.3 7.0 6.8 9.2 5.3 9.6 10.1 14.9 15.5 8.3 11.4 3.8 8.1 15.1 10.2 20.1 11.4 14.0 2.0 22.3 29.9 10.8 31.9 6.8 11.2 0.0 12.7 14.4 6.2 15.1 13.9 24.1 10.3 6.4 9.9 5.5 14.1 4.4 4.9 10.4 6.8 6.4 16.1 10.9 11.0 11.5 8.9 33.4 10.1 25.8 5.9 18.1 12.5 5.1 10.0 6.2 17.4 10.7 PDZD2 "KIAA0300, PDZK3" ENSG00000133401 "PDZ domain containing 2" O15018 5 31639410-32110931 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.8" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 92.3;Early spermatids: 193.7;Rod photoreceptor cells: 66.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 9.1;EFO-21: 5.1;SiHa: 12.7;SK-BR-3: 11.8;T-47d: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020784, HPA036503, HPA036504, HPA064387, HPA076072" Uncertain Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "CAB020784: , HPA036503: AB_2675161, HPA036504: , HPA064387: AB_2685252, HPA076072: " "unprognostic (3.65e-2)" "unprognostic (4.06e-2)" "unprognostic (6.63e-2)" "unprognostic (5.42e-5)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (2.55e-1)" "unprognostic (6.49e-2)" "unprognostic (3.38e-2)" "unprognostic (2.45e-2)" "unprognostic (1.71e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-3)" "unprognostic (4.13e-2)" "unprognostic (6.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.79e-1)" 16.3 1.3 7.8 1.0 28.8 0.3 5.6 3.6 18.1 2.9 1.9 5.1 2.4 0.8 3.0 7.4 6.1 2.8 1.2 19.6 6.6 4.8 9.5 0.4 10.0 0.5 5.4 8.8 16.7 1.5 0.8 2.6 11.9 11.5 2.0 1.1 4.3 2.3 2.5 2.6 11.1 1.1 2.9 3.2 0.5 2.0 6.2 6.1 0.3 1.3 0.7 2.0 1.1 2.9 0.4 0.7 0.7 0.6 0.2 1.0 0.0 0.1 0.0 3.5 0.1 0.0 0.0 9.1 0.0 0.0 0.6 0.6 0.0 0.0 0.0 5.1 0.0 1.3 4.7 1.8 1.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 2.7 0.3 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.8 0.0 0.0 0.0 4.0 0.1 0.1 0.8 12.7 11.8 0.0 3.1 6.1 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 3.0 0.0 0.0 1.2 0.4 0.5 0.4 0.5 0.1 1.0 0.1 0.3 0.1 0.1 0.4 0.1 0.1 0.7 0.2 0.6 0.7 0.0 0.0 7.8 28.8 3.6 18.1 6.6 4.8 5.4 8.8 11.5 6.1 41.7 30.5 0.0 3.4 14.9 5.2 41.8 0.0 1.4 5.7 5.2 92.3 19.5 0.0 0.1 193.7 6.8 0.0 0.0 0.2 2.5 5.6 1.0 1.1 0.0 1.9 14.3 0.0 6.2 0.3 37.2 6.9 1.7 6.8 0.0 0.0 5.2 2.1 0.0 9.9 8.7 66.0 45.3 2.0 10.1 2.7 16.2 17.6 0.0 0.0 1.3 PDZK1 "NHERF3, PDZD1" ENSG00000174827 "PDZ domain containing 1" Q5T2W1 1 145670852-145708148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 49.2;kidney: 124.3" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 758.4" "Group enriched" "Detected in many" 12 "breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3" "Region enriched" "Detected in single" 17 "cerebellum: 10.0" "Cell type enriched" "Detected in many" 4 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 4 "NK-cells: 7.6" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 43.1;T-47d: 112.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005755, HPA006155, CAB008971" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163" "unprognostic (4.56e-3)" "unprognostic (3.07e-1)" "unprognostic (8.79e-2)" "unprognostic (4.41e-2)" "unprognostic (9.15e-2)" "unprognostic (2.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.42e-1)" "unprognostic (2.08e-1)" "unprognostic (3.27e-1)" "unprognostic (2.34e-2)" "unprognostic (9.87e-3)" "prognostic favorable (2.54e-7)" "unprognostic (9.90e-2)" "unprognostic (3.02e-1)" "unprognostic (1.00e-3)" "unprognostic (8.87e-2)" 0.1 0.6 0.2 0.2 0.3 0.0 5.8 10.0 0.2 0.3 16.5 0.2 0.8 13.2 0.3 6.7 0.1 0.1 10.6 0.1 0.2 0.2 124.3 25.7 0.4 0.1 0.3 0.2 0.2 4.2 0.0 0.1 0.9 0.5 0.1 1.3 1.2 0.1 0.1 0.1 0.7 49.2 0.1 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 1.0 1.1 0.5 0.2 7.6 1.8 0.5 1.3 0.2 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 18.9 0.1 0.1 0.2 1.1 0.0 0.6 0.0 0.1 0.1 1.8 0.3 0.1 0.4 7.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 1.1 0.1 0.2 0.2 0.2 0.5 0.0 1.3 0.2 43.1 0.0 0.1 1.2 0.3 0.3 0.0 1.2 112.0 0.1 0.1 0.2 0.2 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 1.5 0.2 0.6 1.0 0.4 1.8 0.2 1.0 0.4 0.7 0.4 7.6 0.1 1.1 0.1 0.5 0.2 0.3 10.0 0.2 0.2 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.9 0.0 0.1 0.4 0.4 61.1 0.0 0.0 54.1 0.0 0.0 117.7 1.7 8.9 0.0 18.0 0.0 1.6 0.1 0.2 0.1 0.0 45.6 0.2 0.0 6.3 1.8 1.2 5.2 0.0 0.0 0.0 0.0 0.5 0.0 1.8 2.9 0.0 758.4 0.3 0.0 0.3 0.2 0.2 0.0 0.1 0.0 1.0 0.0 PDZK1IP1 "DD96, MAP17, SPAP" ENSG00000162366 "PDZK1 interacting protein 1" Q13113 1 47183593-47191044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 281.3" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 4006.8" "Cancer enhanced" "Detected in all" "renal cancer: 340.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "EFO-21: 31.5;RPTEC TERT1: 104.5" "Not detected" "Not detected" HPA014907 Enhanced Approved "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA014907: AB_1855166" "unprognostic (2.97e-1)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "prognostic unfavorable (6.92e-4)" "unprognostic (8.14e-3)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.65e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (2.64e-2)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (1.75e-3)" "unprognostic (1.89e-1)" 2.7 1.2 0.6 2.4 0.6 3.9 4.1 0.6 0.6 9.2 9.1 0.6 0.6 2.2 1.3 4.8 30.4 2.9 23.9 0.7 0.5 0.0 281.3 1.6 7.2 0.5 0.6 0.5 2.3 16.8 0.0 0.6 3.2 0.6 2.1 3.4 0.8 33.9 12.4 0.7 19.9 9.5 0.5 0.5 0.7 9.0 1.4 0.6 1.1 1.0 18.3 18.5 4.1 8.3 0.1 0.5 2.1 1.1 0.2 0.3 42.4 11.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.6 0.0 31.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 104.5 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.1 0.2 0.0 0.5 0.3 42.4 0.6 0.6 0.6 0.6 0.5 0.0 0.6 0.5 0.6 0.6 71.5 39.6 6.7 11.1 12.6 0.0 0.0 359.2 6.7 34.2 221.6 0.0 0.0 351.5 818.0 0.0 1.6 60.9 140.2 656.9 0.0 0.9 37.3 10.4 1.0 0.2 0.0 38.1 2.5 0.3 0.0 3.1 1.5 8.5 21.6 123.8 0.5 959.8 81.8 0.0 4006.8 0.0 0.0 2.3 0.0 0.1 47.2 0.7 1.5 119.5 16.8 PDZRN3 "KIAA1095, LNX3, SEMACAP3" ENSG00000121440 "PDZ domain containing ring finger 3" Q9UPQ7 3 73382433-73624940 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 61.9;Fibroblasts: 24.4;Peritubular cells: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 52 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 52 "dendritic cells: 5.2" "Cell line enhanced" "Detected in many" "AF22: 15.4;ASC diff: 28.1;ASC TERT1: 14.8;BJ hTERT+: 20.0;HSkMC: 20.5;U-87 MG: 14.8" "Group enriched" "Detected in many" 5 "amygdala: 12.4;basal ganglia: 7.4;cerebral cortex: 17.9;hippocampal formation: 14.5" "Low region specificity" "Detected in many" "HPA038822, HPA061420" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA038822: AB_10675952, HPA061420: AB_2684512" "unprognostic (3.22e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-2)" "prognostic favorable (3.35e-5)" "unprognostic (1.09e-1)" "unprognostic (5.54e-2)" "unprognostic (8.47e-2)" "unprognostic (3.67e-1)" "unprognostic (1.60e-1)" "unprognostic (7.51e-2)" "prognostic favorable (4.93e-4)" "unprognostic (8.38e-2)" "prognostic favorable (3.65e-7)" "unprognostic (8.63e-3)" "unprognostic (1.63e-1)" "unprognostic (3.72e-2)" "unprognostic (2.86e-3)" 13.0 17.4 11.5 4.8 12.9 0.0 10.3 1.7 26.8 18.7 32.6 4.5 4.6 4.3 29.0 12.4 13.6 11.6 13.1 19.8 9.1 2.5 5.3 0.9 6.3 1.9 3.6 11.2 35.1 2.9 0.3 2.2 8.1 6.8 15.4 6.9 9.7 9.7 14.9 38.3 7.5 10.2 26.3 3.8 1.0 19.3 3.4 2.9 0.2 1.6 5.1 1.1 21.3 18.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 28.1 14.8 0.0 8.0 20.0 2.4 1.5 7.5 0.0 0.0 0.0 10.7 0.3 0.0 0.0 0.0 2.4 0.0 1.0 0.0 0.0 0.0 4.7 0.0 0.0 20.5 0.0 6.7 0.0 2.9 0.0 0.0 0.0 0.0 2.3 0.9 0.0 0.1 2.2 0.0 0.0 0.0 4.1 0.0 0.0 0.0 1.8 5.1 0.0 3.7 5.8 4.7 2.2 0.0 0.0 10.1 0.7 11.3 1.0 0.3 0.0 0.1 14.8 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 11.5 12.9 1.7 26.8 9.1 2.5 3.6 11.2 6.8 2.9 0.0 0.0 0.0 9.3 2.2 9.5 61.9 0.0 0.0 0.0 5.2 5.9 0.6 1.7 0.0 0.4 1.3 0.0 0.0 0.4 0.2 24.4 12.7 0.0 0.0 0.7 0.0 20.3 0.0 0.0 0.4 21.6 0.9 15.1 0.0 7.0 20.0 0.4 0.0 26.5 6.3 1.5 0.0 15.5 0.2 4.1 1.6 0.7 0.0 2.3 4.3 PEA15 "HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15" ENSG00000162734 "Proliferation and apoptosis adaptor protein 15" Q15121 1 160205337-160215376 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 199.4" "Cell type enhanced" "Detected in many" 7 "monocytes: 420.2;Muller glia cells: 271.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 30.6" "Group enriched" "Detected in all" 6 "B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028356, HPA070820" Enhanced Supported Nucleoplasm,Cytosol NA NA 240000 Cytosol Nucleoplasm "HPA028356: AB_10602814, HPA070820: AB_2732166" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (1.64e-2)" "unprognostic (1.99e-3)" "unprognostic (6.10e-2)" "unprognostic (4.57e-1)" "unprognostic (1.25e-1)" "unprognostic (6.31e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (6.53e-7)" "unprognostic (2.60e-2)" "unprognostic (1.39e-1)" "unprognostic (2.82e-3)" "unprognostic (1.24e-1)" 45.3 20.4 105.3 28.7 83.6 3.8 25.3 30.5 173.1 25.1 15.5 68.1 5.0 8.0 21.5 21.8 22.6 19.2 22.1 53.9 70.5 81.3 14.8 10.4 23.8 16.6 106.5 67.0 19.7 9.7 14.9 10.2 25.1 74.1 24.4 15.3 18.2 12.3 31.1 10.2 16.9 8.8 47.4 199.4 23.8 10.0 17.5 53.7 1.6 12.6 6.0 22.9 22.4 17.5 7.6 22.1 1.8 30.6 3.1 3.5 5.4 16.9 5.9 24.6 10.6 45.6 25.6 8.2 73.6 64.4 61.3 43.1 13.0 9.2 7.9 26.7 91.9 29.5 18.6 9.1 23.0 48.0 4.2 5.1 6.5 4.1 3.3 56.4 2.1 8.0 21.4 13.0 33.7 43.1 33.9 46.0 5.8 6.7 14.4 81.9 8.4 2.5 5.1 16.3 20.1 17.0 4.2 25.9 5.4 22.2 8.9 4.9 13.0 39.0 26.7 22.4 55.7 16.4 15.3 61.3 40.8 32.0 30.3 31.6 11.4 7.0 15.0 37.6 4.1 57.7 0.3 15.3 1.8 3.5 30.6 2.7 7.6 2.6 2.8 22.1 5.0 1.6 1.8 0.7 3.1 13.9 9.7 2.9 5.4 105.3 83.6 30.5 78.2 70.5 81.3 106.5 67.0 74.1 53.7 14.9 34.6 27.0 105.8 71.2 125.0 203.8 12.7 14.7 27.3 5.2 68.7 17.0 24.9 58.7 49.2 107.8 6.4 0.0 40.4 47.2 66.7 105.1 31.1 4.9 63.6 87.4 11.5 95.2 34.2 51.6 61.9 76.5 70.9 420.2 11.3 271.7 77.0 3.5 103.3 8.1 109.8 45.3 97.6 12.7 2.7 64.1 37.9 14.9 9.7 151.1 PEAK3 "C19orf35, FLJ45778" ENSG00000188305 "PEAK family member 3" Q6ZS72 19 2274622-2282176 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5;lymphoid tissue: 19.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 1.4;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 24.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 24.5" "Cell line enriched" "Detected in some" 10 "HMC-1: 16.9" "Group enriched" "Detected in many" 5 "basal ganglia: 6.4;cerebellum: 6.0" HPA057806 Uncertain Uncertain Cytosol NA NA Cytosol "HPA057806: AB_2683534" "unprognostic (9.42e-2)" "unprognostic (3.26e-2)" "unprognostic (7.27e-2)" "unprognostic (6.23e-2)" "unprognostic (2.65e-2)" "unprognostic (8.40e-3)" "unprognostic (3.67e-1)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (2.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.19e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-2)" "unprognostic (3.20e-2)" "unprognostic (1.90e-1)" 1.9 1.3 1.4 4.7 3.3 8.2 0.9 0.8 2.0 1.3 1.7 2.1 0.1 1.1 0.7 1.0 0.8 1.6 0.9 2.1 2.0 0.9 3.8 2.0 4.4 14.3 3.3 0.9 1.0 0.8 0.6 1.2 0.8 2.3 1.0 1.1 0.7 0.8 0.6 1.5 1.0 2.5 0.9 4.0 19.1 1.1 0.6 1.7 0.6 0.8 0.0 2.7 0.9 1.9 0.2 1.1 24.5 3.4 2.8 1.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.1 0.2 0.6 0.1 16.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 5.3 2.7 6.6 1.0 3.4 0.1 0.1 0.1 0.1 1.1 0.2 0.0 0.2 24.5 2.8 1.1 0.1 0.0 0.5 1.4 3.3 0.8 2.0 2.0 0.9 3.3 0.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PEBP1 "HCNP, PBP, PEBP, RKIP" ENSG00000089220 "Phosphatidylethanolamine binding protein 1" P30086 12 118135858-118145584 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 260.7" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 3140.1;Proximal tubular cells: 3872.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA008819, CAB009906, CAB013493, HPA063904" Enhanced Approved "Plasma membrane,Cytosol" NA NA 62000000 "Plasma membrane, Cytosol" "CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708" "unprognostic (4.57e-1)" "unprognostic (1.03e-3)" "unprognostic (3.28e-2)" "unprognostic (3.39e-3)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-2)" "unprognostic (7.35e-3)" "unprognostic (5.67e-2)" "unprognostic (3.55e-2)" "prognostic favorable (1.52e-4)" "unprognostic (1.63e-1)" "prognostic favorable (2.15e-13)" "unprognostic (2.17e-1)" "unprognostic (7.72e-2)" "unprognostic (7.96e-2)" "unprognostic (8.80e-2)" 26.8 207.3 83.0 15.2 82.3 13.5 32.3 63.3 102.7 35.5 50.4 58.0 18.9 75.3 22.9 52.8 24.3 28.5 22.6 57.6 77.6 69.7 132.7 260.7 22.1 16.0 77.8 71.5 43.5 46.2 139.2 30.8 16.5 59.1 35.4 25.4 41.2 43.6 33.1 65.1 20.9 75.4 23.4 79.1 15.3 20.6 22.7 43.5 8.7 94.9 26.1 19.7 20.2 17.8 45.2 37.3 3.0 12.1 20.9 45.3 36.4 32.2 27.6 39.1 40.6 61.7 30.2 60.8 25.7 30.0 40.6 20.9 16.4 11.1 52.0 25.9 38.4 16.2 23.2 57.8 23.9 31.7 13.0 55.3 26.1 31.1 114.3 35.7 47.2 11.4 29.9 39.7 24.0 16.7 46.7 18.8 27.8 43.3 19.4 40.6 38.2 25.7 95.7 37.9 27.1 33.4 50.8 29.1 94.8 49.8 31.5 46.9 36.4 53.4 37.1 50.3 25.0 53.4 32.2 20.4 31.2 17.8 30.5 25.8 19.0 33.7 26.8 36.7 35.4 33.8 0.7 11.0 3.0 26.9 12.1 42.4 45.2 45.3 33.3 33.3 32.5 43.9 35.3 1.2 20.9 10.3 37.3 41.2 36.4 83.0 82.3 63.3 102.7 77.6 69.7 77.8 71.5 59.1 43.5 375.2 339.6 254.0 392.9 282.7 501.7 637.3 598.7 327.9 273.0 743.2 90.3 819.2 3140.1 396.3 35.6 178.6 306.2 116.8 213.3 686.7 314.8 422.6 353.3 1736.5 486.8 681.7 307.9 178.0 167.5 50.5 502.8 218.5 705.2 448.2 324.1 1385.1 201.0 263.6 687.7 3872.6 306.7 362.2 321.6 273.2 133.6 284.3 514.8 194.5 466.9 324.1 PEF1 PEF1A ENSG00000162517 "Penta-EF-hand domain containing 1" Q9UBV8 1 31629862-31644896 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061608 Approved Nucleoplasm,Vesicles,Cytosol NA NA 660000 "Nucleoplasm, Cytosol" Vesicles "HPA061608: AB_2684567" "unprognostic (2.92e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-1)" "unprognostic (8.40e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (5.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.79e-2)" "unprognostic (1.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.35e-1)" "unprognostic (8.85e-3)" "unprognostic (2.38e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-3)" 34.0 27.0 26.9 15.3 28.7 17.0 27.1 22.5 40.8 26.6 23.4 25.9 21.1 16.2 27.1 46.5 29.7 29.0 26.1 26.4 24.3 23.8 28.3 38.7 24.9 20.8 25.0 17.3 31.1 20.8 31.6 21.6 44.2 28.6 29.8 24.2 25.7 24.8 33.4 25.5 32.5 20.7 31.9 22.4 23.6 20.5 17.8 16.5 27.4 85.9 20.3 30.7 23.7 21.9 39.1 40.4 60.9 39.5 42.0 49.2 48.7 17.7 20.8 17.4 13.4 20.6 21.6 16.7 16.9 29.1 41.0 36.2 12.2 26.9 19.0 23.7 37.7 21.1 18.7 33.6 43.2 33.3 23.8 36.4 15.7 16.8 24.6 36.3 15.3 14.9 22.2 50.0 40.0 37.6 26.2 39.6 23.5 16.2 19.7 29.3 20.9 23.3 14.9 24.1 22.0 23.7 22.7 16.9 20.7 32.0 19.3 24.9 14.4 19.3 18.2 25.2 28.6 16.2 11.2 20.9 17.8 15.3 30.2 22.3 12.7 12.8 20.4 22.4 22.6 21.3 60.9 39.5 46.2 49.2 35.3 47.5 37.8 42.1 44.6 40.4 39.1 39.9 40.0 40.1 42.0 32.7 37.4 41.9 48.7 26.9 28.7 22.5 40.8 24.3 23.8 25.0 17.3 28.6 16.5 38.7 33.6 34.3 57.8 32.2 37.2 14.6 20.4 20.1 21.6 66.3 11.8 131.6 96.2 58.8 67.1 60.4 35.8 0.0 54.4 80.4 36.6 45.7 71.5 20.5 54.6 50.9 42.5 31.9 17.0 60.2 41.7 26.1 47.2 124.4 29.6 55.3 47.2 34.8 55.2 41.2 20.3 19.4 42.2 34.5 41.5 44.9 152.9 34.6 33.2 48.8 PEG10 "HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1" ENSG00000242265 "Paternally expressed 10" Q86TG7 7 94656325-94669695 "Predicted intracellular proteins" "Apoptosis, Differentiation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4" "Group enriched" "Detected in many" 13 "Cytotrophoblasts: 1669.7;Syncytiotrophoblasts: 2388.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 143.8" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 95.0;HAP1: 123.3;Hep G2: 95.0;SCLC-21H: 60.4" "Region enhanced" "Detected in many" "hypothalamus: 130.3" "Low region specificity" "Detected in all" "HPA021324, HPA029915, HPA051038" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372" "unprognostic (1.03e-1)" "unprognostic (2.98e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (1.06e-1)" "unprognostic (5.70e-3)" "unprognostic (9.70e-3)" "unprognostic (2.61e-3)" "unprognostic (5.43e-2)" "unprognostic (1.68e-2)" "unprognostic (1.99e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-2)" "unprognostic (5.48e-2)" "unprognostic (6.01e-2)" "unprognostic (2.40e-2)" 2.3 67.5 32.0 2.1 143.8 1.4 10.6 25.6 16.8 4.2 2.1 7.4 0.0 1.5 3.3 1.9 2.0 5.1 2.4 1.8 21.0 47.0 4.0 2.0 7.3 2.9 13.1 21.3 27.0 5.4 2.3 102.6 171.4 27.4 2.2 1.9 1.8 4.3 2.2 1.9 1.4 1.6 2.6 14.4 1.8 2.1 19.8 11.1 1.5 5.4 0.0 2.3 1.8 1.0 2.6 0.0 0.0 0.0 2.7 0.7 0.2 2.6 13.4 95.0 40.1 2.0 3.6 5.5 7.3 4.3 5.2 7.1 22.3 4.4 0.2 0.2 8.4 10.8 0.8 123.3 5.2 7.3 0.3 13.0 0.0 15.3 95.0 1.5 15.1 0.0 8.0 1.7 13.0 9.0 4.6 3.1 0.0 0.0 29.8 10.2 0.6 0.0 0.0 43.5 2.2 8.5 5.7 30.4 7.9 23.9 9.9 60.4 3.4 0.0 2.0 7.2 24.9 12.9 0.0 0.0 4.2 0.2 0.5 5.5 8.0 5.3 11.8 9.4 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.7 0.0 2.6 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.2 32.0 143.8 25.6 14.4 21.0 47.0 13.1 21.3 27.4 11.1 142.9 64.2 2.4 7.4 0.7 70.4 25.2 7.6 16.0 126.3 15.7 7.9 1669.7 54.7 10.7 2.8 2.4 0.0 0.0 4.3 85.1 27.1 7.0 2.3 2.9 150.9 35.0 58.0 2.5 0.0 11.4 8.3 1.4 13.5 0.0 0.7 118.3 4.2 0.0 3.9 10.0 25.7 6.5 12.5 16.4 5.1 0.6 2388.4 0.5 0.1 0.6 PEMT "PEMPT, PEMT2" ENSG00000133027 "Phosphatidylethanolamine N-methyltransferase" Q9UBM1 17 17505563-17591708 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 95.7;liver: 103.5" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 168.4;Peritubular cells: 326.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042375, HPA073930" Approved Supported "Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol" NA NA "Endoplasmic reticulum, Mitochondria" "Vesicles, Cytosol" "HPA042375: AB_10796905, HPA073930: " "unprognostic (1.39e-2)" "unprognostic (3.43e-1)" "unprognostic (2.43e-2)" "prognostic favorable (6.77e-6)" "unprognostic (2.85e-1)" "unprognostic (7.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (3.41e-2)" "unprognostic (5.47e-3)" "unprognostic (2.67e-1)" "unprognostic (8.63e-3)" "unprognostic (2.08e-1)" "unprognostic (2.10e-1)" "unprognostic (6.66e-2)" "unprognostic (7.60e-2)" 21.8 7.5 5.6 2.8 6.2 4.2 26.5 2.9 8.1 16.1 6.1 6.4 13.2 7.4 8.7 95.7 5.6 10.5 4.7 5.3 5.3 6.1 8.5 103.5 5.5 6.7 6.3 4.8 7.7 11.4 4.4 5.7 7.1 6.2 7.3 2.2 7.3 12.7 12.9 7.4 7.3 5.8 4.0 6.4 2.8 4.6 19.1 3.2 3.8 9.9 6.3 5.4 3.9 5.2 12.8 17.0 1.6 23.4 15.1 14.4 11.6 14.2 27.3 7.2 18.8 15.4 10.8 10.8 9.1 8.2 12.5 9.9 15.9 9.7 12.5 16.6 9.3 9.4 17.0 10.6 5.5 3.2 9.2 37.0 6.2 14.9 22.8 17.0 5.5 9.3 11.0 11.5 8.3 12.7 4.2 6.7 17.6 5.9 5.3 5.5 27.2 9.8 9.9 10.1 27.3 22.4 9.2 11.6 11.4 10.3 5.3 7.2 17.2 6.5 4.4 16.3 14.5 6.7 2.1 5.8 12.3 12.4 20.5 7.9 7.3 4.9 2.2 11.4 7.7 10.1 1.0 23.4 1.1 10.1 20.8 14.4 12.6 13.2 12.7 17.0 12.8 10.6 11.9 1.6 15.1 14.2 15.5 12.0 11.6 5.6 6.2 2.9 8.1 5.3 6.1 6.3 4.8 6.2 3.2 14.9 13.7 17.0 16.7 16.3 4.4 12.5 12.7 16.0 26.1 26.2 0.0 16.2 14.9 26.3 2.2 18.3 14.6 0.0 33.6 18.8 27.5 23.7 12.7 168.4 21.4 4.8 66.0 9.2 11.1 6.8 87.8 10.8 20.3 1.0 24.8 26.7 26.0 10.5 326.0 21.4 4.8 6.5 30.9 11.1 18.5 15.8 12.2 7.0 22.8 16.6 PER1 "PER, RIGUI" ENSG00000179094 "Period circadian regulator 1" O15534 17 8140472-8156506 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.7;hTCEpi: 27.6;hTERT-HME1: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047947, HPA067064" Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA047947: AB_2680219, HPA067064: AB_2685774" "unprognostic (7.64e-2)" "prognostic favorable (3.89e-4)" "unprognostic (5.54e-2)" "unprognostic (1.20e-1)" "unprognostic (2.59e-1)" "unprognostic (9.44e-2)" "prognostic favorable (2.56e-4)" "unprognostic (5.28e-2)" "unprognostic (6.67e-2)" "unprognostic (6.21e-3)" "unprognostic (6.87e-2)" "unprognostic (4.68e-2)" "unprognostic (7.09e-3)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.08e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-2)" 39.4 33.4 13.2 21.6 15.0 27.3 31.3 19.5 23.9 27.8 24.6 20.9 27.8 6.9 19.5 17.2 31.6 25.2 36.9 24.0 13.3 6.3 14.2 18.6 25.8 10.8 15.6 11.3 50.1 61.8 19.3 29.8 12.7 20.1 23.1 8.1 36.6 23.3 43.5 70.3 47.9 16.9 29.3 17.5 16.7 23.6 13.8 17.1 4.6 28.5 33.1 12.1 30.2 25.0 1.6 4.9 3.3 3.6 0.5 2.1 1.2 1.0 3.9 4.5 6.5 14.8 10.9 2.5 1.5 2.8 2.0 2.4 3.9 2.5 7.3 1.2 2.2 2.2 3.1 4.5 23.7 1.4 2.3 5.6 3.8 8.5 1.1 20.4 1.5 5.8 16.3 27.6 3.4 27.0 2.6 4.3 5.6 4.7 10.1 3.6 3.5 4.4 3.0 3.8 1.2 2.6 6.1 2.5 3.8 4.7 0.8 1.9 4.8 3.3 3.8 3.1 1.9 2.8 1.1 7.3 2.3 4.3 0.8 1.3 6.0 2.2 2.5 3.1 1.9 1.6 0.0 3.6 1.7 1.9 2.5 2.1 1.0 1.7 1.2 4.9 1.6 1.6 1.1 3.3 0.5 1.2 0.7 1.1 1.2 13.2 15.0 19.5 23.9 13.3 6.3 15.6 11.3 20.1 17.1 50.6 66.2 20.2 37.2 47.3 37.1 20.0 33.1 30.8 42.1 26.2 92.3 5.0 5.0 4.0 27.7 50.9 21.9 23.3 3.5 3.3 40.1 42.6 67.1 35.2 17.4 19.1 48.1 36.2 45.9 38.0 38.0 57.8 45.5 7.2 12.9 31.6 7.5 14.4 31.8 3.3 48.6 32.3 42.8 5.2 7.8 52.2 11.3 20.8 9.3 9.3 PER2 KIAA0347 ENSG00000132326 "Period circadian regulator 2" O15055 2 238244038-238290102 "Disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 74.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053136, HPA060510" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053136: , HPA060510: AB_2684298" "unprognostic (1.96e-2)" "unprognostic (4.41e-2)" "unprognostic (1.88e-2)" "unprognostic (9.28e-2)" "unprognostic (2.52e-1)" "prognostic favorable (2.29e-4)" "unprognostic (2.47e-2)" "unprognostic (2.17e-2)" "unprognostic (3.59e-3)" "unprognostic (3.59e-2)" "unprognostic (1.76e-2)" "unprognostic (2.13e-1)" "unprognostic (6.81e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (2.58e-1)" "unprognostic (5.22e-2)" 12.7 3.8 5.1 11.4 10.3 7.8 16.1 16.0 13.4 16.4 8.8 9.2 12.8 5.5 15.4 9.7 15.2 11.8 15.6 6.7 5.8 4.7 4.9 13.7 7.9 4.8 4.7 6.8 14.6 15.7 5.5 11.1 8.4 8.0 12.9 7.1 11.6 23.0 20.7 11.9 20.0 9.1 13.5 4.5 4.9 14.8 19.0 5.3 6.0 9.9 21.3 13.7 11.1 11.3 4.5 4.8 4.1 5.6 3.1 4.5 0.8 1.4 10.1 2.2 3.7 0.1 1.1 7.3 1.0 3.6 1.3 1.3 1.5 5.1 8.8 1.0 2.3 1.4 7.5 2.1 3.0 1.9 2.5 1.5 7.7 5.2 6.9 1.8 11.6 8.2 1.4 7.4 1.6 5.4 1.3 0.7 3.6 3.7 5.6 1.1 6.5 5.7 12.8 3.1 6.5 2.0 13.9 4.9 2.9 1.3 2.9 8.6 1.0 2.5 5.5 1.6 0.7 5.2 7.3 1.8 3.2 3.8 2.5 3.5 6.3 1.4 10.7 6.0 5.1 3.9 4.1 3.7 0.9 2.9 5.6 4.5 4.4 4.5 3.4 3.7 4.5 4.4 4.5 2.9 3.1 5.1 4.8 3.1 0.8 5.1 10.3 16.0 13.4 5.8 4.7 4.7 6.8 8.0 5.3 14.9 26.7 4.2 49.4 65.7 21.5 5.2 20.4 41.5 52.4 26.2 2.0 7.0 6.6 6.4 4.2 9.3 14.6 0.0 9.0 5.4 17.7 14.6 9.2 32.6 3.4 11.1 23.6 8.6 8.9 2.5 10.3 9.3 23.6 1.0 21.2 13.2 7.0 24.3 17.3 3.3 8.0 6.5 25.8 24.7 15.9 74.5 10.9 7.2 24.4 18.4 PER3 ENSG00000049246 "Period circadian regulator 3" P56645 1 7784320-7845177 "Disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Bipolar cells: 194.4;Cone photoreceptor cells: 76.6;Horizontal cells: 117.6;Muller glia cells: 119.7;Rod photoreceptor cells: 141.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-937: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019530 Approved Supported Cytosol NA NA Cytosol "HPA019530: AB_1855201" "unprognostic (5.11e-2)" "prognostic favorable (7.14e-4)" "unprognostic (2.45e-2)" "unprognostic (2.97e-3)" "unprognostic (1.74e-1)" "prognostic favorable (1.34e-4)" "unprognostic (3.87e-1)" "unprognostic (5.53e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-2)" "prognostic favorable (2.20e-5)" "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (3.46e-1)" "unprognostic (1.62e-1)" 10.2 9.1 10.9 6.0 15.6 0.5 10.4 42.4 17.5 13.5 14.5 22.5 11.2 5.0 16.2 8.9 13.9 10.8 13.5 17.2 10.1 9.4 10.4 20.5 9.6 3.3 11.2 10.7 15.7 13.3 16.0 15.2 2.1 13.4 13.0 5.5 23.2 18.8 17.7 20.4 11.1 7.4 18.5 16.2 6.7 14.0 8.7 10.9 0.9 19.0 15.6 7.1 13.2 9.5 1.3 1.8 1.1 3.3 0.9 5.1 1.6 4.2 1.2 3.8 1.1 0.7 0.3 1.1 1.8 3.3 3.4 4.7 5.1 16.9 1.9 1.0 7.4 5.8 2.0 13.5 0.8 5.2 0.1 0.7 13.5 5.0 0.7 4.3 0.4 4.7 1.9 1.5 3.7 3.8 7.1 1.2 1.0 10.9 3.6 1.4 3.4 7.4 6.0 2.0 9.5 3.6 6.5 1.3 0.1 1.9 0.8 4.9 5.2 15.9 0.0 6.8 4.0 4.1 0.5 2.5 9.3 13.6 2.8 2.4 0.5 0.3 1.6 6.5 21.5 12.9 0.9 1.6 1.1 4.2 2.0 5.1 1.3 2.0 3.8 1.8 0.8 1.7 2.1 0.2 0.9 3.3 1.4 3.1 1.6 10.9 15.6 42.4 17.5 10.1 9.4 11.2 10.7 13.4 10.9 17.9 8.9 1.5 10.8 26.8 194.4 12.3 12.7 12.0 12.5 8.7 76.6 1.4 8.3 2.2 12.3 14.6 4.5 0.0 4.0 0.2 16.4 8.7 25.4 22.2 7.6 117.6 6.3 6.2 4.5 5.0 11.5 7.2 11.8 2.8 2.7 119.7 4.4 1.4 25.8 4.4 141.4 6.5 24.4 17.6 21.8 22.3 0.5 4.4 1.2 6.1 PEX5 "PTS1R, PXR1" ENSG00000139197 "Peroxisomal biogenesis factor 5" P50542 12 7188685-7218574 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Early spermatids: 256.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 66.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039259, HPA039260" Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA039259: AB_10673419, HPA039260: AB_2676417" "unprognostic (7.44e-2)" "unprognostic (2.54e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-1)" "unprognostic (1.27e-1)" "unprognostic (4.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (5.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.63e-2)" "unprognostic (2.92e-1)" "unprognostic (5.70e-2)" "unprognostic (7.31e-3)" "unprognostic (1.96e-1)" "unprognostic (2.13e-2)" "unprognostic (1.13e-1)" 24.8 20.7 24.5 13.4 27.3 7.8 16.9 23.4 28.8 14.4 12.2 20.8 13.2 12.3 15.1 12.6 13.7 17.3 20.2 15.6 25.5 22.2 22.5 27.0 14.4 17.6 28.3 21.0 25.2 26.7 22.0 26.5 10.6 17.4 13.3 12.5 13.1 16.5 15.4 41.4 17.3 12.4 16.6 26.3 9.7 11.4 31.4 15.1 22.3 15.7 13.5 19.4 12.3 18.4 4.5 9.2 4.6 7.3 5.2 7.8 4.2 6.5 13.3 5.7 15.1 13.6 9.0 11.4 6.7 8.6 8.4 8.4 16.8 10.3 66.8 3.5 8.1 11.9 8.9 10.6 9.4 8.2 10.0 9.9 6.2 8.7 11.5 7.2 8.8 6.1 11.3 15.6 5.9 16.5 10.8 6.7 35.6 12.1 2.4 6.4 8.5 22.2 8.5 18.4 12.5 7.1 10.5 12.2 9.7 6.3 9.4 5.1 11.0 9.3 20.6 8.5 13.4 4.9 5.3 6.2 8.6 14.7 6.8 7.6 4.1 4.8 23.8 8.4 9.3 5.6 0.1 3.3 4.6 6.5 2.9 7.8 4.5 4.8 5.7 5.3 3.7 6.5 5.8 2.9 5.2 7.3 9.2 1.9 4.2 24.5 27.3 23.4 28.8 25.5 22.2 28.3 21.0 17.4 15.1 11.9 16.1 4.7 6.3 12.9 7.1 9.3 17.8 12.0 6.8 7.0 7.9 9.7 8.3 6.9 256.2 9.3 7.3 0.0 12.8 4.9 7.3 6.1 3.5 13.9 4.0 12.7 6.9 4.9 4.6 30.1 13.3 4.3 5.0 2.8 7.3 12.3 9.4 12.4 13.1 13.4 6.5 19.4 11.4 37.9 16.2 13.4 6.4 5.7 9.4 4.6 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245039-140303121 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 10000 "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavorable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 36.1 24.8 39.5 18.8 38.8 26.4 25.8 28.5 48.7 23.1 27.0 29.3 15.8 20.9 28.2 29.6 26.8 22.5 18.6 46.7 38.2 34.7 32.7 20.2 24.2 21.6 38.8 35.3 20.6 18.1 26.5 19.9 26.9 45.6 24.3 23.0 19.8 23.1 24.4 69.5 20.9 22.0 32.1 37.1 23.1 19.2 19.6 24.1 23.7 24.4 28.7 25.5 23.0 19.2 38.9 36.3 45.6 46.4 39.5 45.1 37.2 39.1 18.4 32.8 18.9 21.5 22.1 31.7 53.6 26.7 41.2 45.9 39.1 25.1 26.4 54.2 28.5 43.1 14.6 23.8 52.6 48.6 27.9 24.0 23.4 18.8 25.2 25.3 48.1 18.4 23.5 28.0 35.0 36.9 26.7 45.2 31.1 20.9 17.3 34.6 17.5 32.7 33.0 21.7 16.0 27.6 23.2 46.7 19.4 46.0 18.0 18.6 19.6 40.1 35.3 30.6 32.1 24.1 28.5 58.1 29.1 28.9 17.1 47.9 16.9 43.3 68.4 29.4 31.8 33.7 43.2 31.1 45.6 33.4 46.4 35.3 38.9 38.4 38.4 36.3 35.9 38.5 34.6 5.1 39.5 44.1 33.9 45.1 37.2 39.5 38.8 28.5 48.7 38.2 34.7 38.8 35.3 45.6 24.1 62.5 27.0 57.4 56.0 33.8 39.1 71.1 56.0 54.9 56.9 62.8 43.2 99.5 104.5 108.2 2.6 70.9 60.6 70.0 88.5 69.1 54.6 45.1 52.1 56.2 74.9 23.8 44.7 68.2 54.4 9.4 48.3 63.8 70.9 117.2 33.8 53.2 101.0 51.8 49.1 83.4 38.8 64.7 38.1 20.0 47.7 30.6 71.6 50.7 39.3 59.1 PFDN2 ENSG00000143256 "Prefoldin subunit 2" Q9UHV9 1 161100556-161118111 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 570.2;Suprabasal keratinocytes: 561.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028700, HPA058304" Approved Enhanced Cytosol NA NA 60000 Cytosol "HPA028700: AB_10603983, HPA058304: AB_2683673" "unprognostic (2.56e-1)" "unprognostic (2.76e-2)" "unprognostic (1.01e-2)" "unprognostic (2.62e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (9.10e-4)" "unprognostic (9.59e-3)" "unprognostic (1.00e-1)" "unprognostic (1.45e-1)" "unprognostic (1.50e-2)" "unprognostic (8.46e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (4.39e-8)" "unprognostic (1.01e-1)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (3.66e-2)" 36.5 30.4 47.2 22.7 41.7 40.9 20.9 25.1 38.8 19.6 19.9 27.8 15.1 19.1 20.8 29.1 19.7 18.5 16.0 38.2 41.4 48.6 25.9 41.1 18.5 23.5 52.2 32.9 18.5 20.8 13.6 29.3 25.1 42.7 20.1 17.9 12.9 21.2 20.8 62.2 15.0 18.4 19.4 48.6 21.2 17.8 22.1 31.8 14.7 18.3 20.9 24.3 22.7 26.2 34.4 61.7 33.4 37.3 18.2 28.5 21.0 43.4 29.2 22.7 29.4 20.7 19.8 24.8 32.4 29.4 28.0 22.2 38.4 33.1 29.5 38.1 21.0 27.7 32.3 34.4 39.7 33.8 32.1 35.5 32.6 41.5 54.2 61.0 44.7 32.7 22.2 52.3 45.0 128.2 21.3 31.4 30.8 47.8 20.8 25.1 44.1 33.4 53.1 44.5 51.2 73.2 28.7 23.0 35.2 30.3 26.1 30.0 50.0 24.9 32.9 51.6 30.9 27.1 56.4 27.6 29.0 42.6 36.4 67.6 32.0 30.4 56.6 35.3 30.6 39.8 24.7 32.7 33.4 19.2 31.4 21.8 34.1 23.5 23.1 39.1 34.4 24.8 24.1 16.2 18.2 37.3 61.7 28.5 21.0 47.2 41.7 25.1 38.8 41.4 48.6 52.2 32.9 42.7 31.8 29.8 37.8 97.5 214.7 570.2 76.9 106.9 73.9 81.7 40.9 109.9 15.7 156.1 290.1 151.8 21.8 101.2 75.9 0.0 130.4 209.7 150.8 165.7 97.0 123.5 154.2 20.6 97.3 81.6 57.7 15.7 117.1 160.7 175.5 129.8 71.4 55.8 186.7 64.2 103.6 225.6 50.4 77.6 263.3 153.5 288.9 561.7 150.2 74.8 76.8 356.8 PFDN5 "MM-1, PFD5" ENSG00000123349 "Prefoldin subunit 5" Q99471 12 53295291-53299450 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008587 Approved Supported "Intermediate filaments,Cytosol" NA NA 110000 "Intermediate filaments, Cytosol" "HPA008587: AB_1079597" "unprognostic (3.56e-3)" "unprognostic (2.31e-2)" "unprognostic (2.87e-2)" "unprognostic (4.02e-3)" "unprognostic (1.59e-1)" "unprognostic (3.44e-1)" "unprognostic (3.44e-2)" "unprognostic (1.99e-2)" "unprognostic (2.65e-2)" "unprognostic (2.12e-1)" "prognostic favorable (5.45e-4)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.54e-6)" "unprognostic (5.34e-2)" "unprognostic (9.48e-2)" "unprognostic (2.30e-2)" "unprognostic (2.01e-3)" 75.9 73.7 105.0 82.3 85.4 119.3 142.4 53.8 66.7 97.0 77.1 56.3 102.5 39.7 94.3 156.8 80.3 94.6 91.0 77.0 82.7 76.7 81.8 83.5 64.9 117.2 94.3 69.2 134.5 155.8 49.6 81.2 67.3 63.3 96.1 65.4 60.1 116.4 99.9 87.0 71.6 54.1 108.1 91.0 83.8 64.7 60.5 64.9 60.5 128.1 108.9 101.1 91.8 144.9 163.9 98.0 63.7 127.8 69.4 158.4 329.0 34.6 53.5 51.8 46.6 100.5 139.9 37.8 86.8 118.2 80.9 54.7 48.8 53.4 46.9 52.5 93.3 31.5 31.9 45.0 62.2 78.4 44.3 63.0 42.7 66.1 67.0 64.6 69.4 46.7 133.3 91.4 57.2 44.7 142.1 71.9 57.5 49.8 63.3 80.3 122.5 48.6 103.5 48.8 38.2 82.7 39.6 56.2 55.4 92.3 51.3 43.8 50.0 55.8 49.3 63.0 55.5 64.1 88.7 62.9 45.8 34.9 21.6 38.8 47.5 50.6 69.0 50.2 55.5 41.8 63.7 127.8 46.5 80.9 97.0 110.9 163.9 123.2 97.6 98.0 156.8 158.4 125.9 38.3 69.4 100.2 91.0 95.8 329.0 105.0 85.4 53.8 66.7 82.7 76.7 94.3 69.2 63.3 64.9 244.2 498.3 821.4 978.4 1337.0 168.6 512.1 654.7 603.6 410.6 537.3 96.2 782.3 1197.0 474.2 740.9 714.2 762.1 327.1 835.6 808.8 895.0 782.4 633.6 473.3 1556.7 68.3 634.1 613.9 1908.4 2168.6 878.5 1189.4 1459.3 1100.1 742.2 240.0 653.0 927.0 616.0 1515.7 241.4 543.3 956.8 450.5 191.9 1334.3 732.5 827.4 772.2 931.8 PFDN6 "H2-KE2, HKE2, KE-2, PFD6" ENSG00000204220 "Prefoldin subunit 6" O15212 6 33289302-33298401 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043032, HPA048123" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 110000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA043032: AB_2678278, HPA048123: AB_2680273" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (7.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.35e-2)" "unprognostic (8.29e-2)" "unprognostic (3.36e-1)" "unprognostic (1.55e-1)" "prognostic favorable (1.01e-4)" "unprognostic (6.93e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (8.97e-4)" "unprognostic (1.79e-1)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.68e-3)" 12.5 19.1 29.2 15.4 27.8 15.0 15.6 13.2 33.9 12.0 17.7 12.9 13.1 13.8 14.4 22.4 15.1 12.5 11.4 16.2 31.6 24.8 19.1 23.2 10.8 15.7 27.0 31.9 14.5 21.3 15.3 14.6 14.0 20.7 12.5 16.2 8.2 15.8 16.0 43.6 10.8 13.7 13.4 20.7 11.3 12.2 33.1 17.5 10.7 12.2 22.5 18.9 11.8 9.8 6.8 5.0 3.4 7.1 3.9 7.5 4.3 15.0 10.1 7.0 14.5 7.9 6.7 11.5 11.6 5.9 10.1 9.7 9.5 7.5 22.2 14.1 6.5 19.4 11.0 11.5 13.3 15.3 14.9 12.2 19.9 11.2 15.8 8.8 15.2 13.0 6.0 15.3 14.3 10.2 8.0 9.9 13.1 24.2 9.6 10.9 10.3 18.2 16.1 11.7 10.0 8.8 15.7 10.3 22.4 16.4 7.2 16.3 19.7 10.1 26.4 16.7 7.4 15.2 22.0 8.3 7.2 10.7 8.9 19.1 19.3 52.6 24.8 7.0 20.2 10.3 3.2 5.1 3.4 4.1 6.5 4.2 5.9 5.6 7.5 4.9 6.8 3.3 4.6 2.7 3.9 7.1 5.0 5.3 4.3 29.2 27.8 13.2 33.9 31.6 24.8 27.0 31.9 20.7 17.5 23.8 8.3 51.5 39.3 49.5 21.5 17.7 71.4 17.4 17.0 52.4 9.8 107.5 102.8 74.2 74.3 28.8 70.3 0.0 89.2 103.2 41.2 43.0 62.1 64.4 70.1 17.5 48.4 19.0 26.8 30.2 57.2 47.3 67.4 83.0 47.0 38.4 78.6 71.9 46.3 154.1 21.2 38.8 32.0 200.4 54.7 55.8 92.7 37.6 54.6 43.9 PFKP "PFK-C, PFKF" ENSG00000067057 "Phosphofructokinase, platelet" Q01813 10 3066333-3137712 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 368.5;Late spermatids: 396.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018257, HPA056484" Uncertain Supported Cytosol No No 4500000 Cytosol "HPA018257: AB_10960391, HPA056484: AB_2683147" "unprognostic (1.16e-1)" "unprognostic (2.41e-3)" "unprognostic (5.79e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.55e-4)" "prognostic unfavorable (8.72e-6)" "unprognostic (1.36e-3)" "unprognostic (2.38e-1)" "unprognostic (8.51e-2)" "unprognostic (2.37e-2)" "unprognostic (8.82e-2)" "unprognostic (6.02e-3)" "unprognostic (2.60e-2)" "unprognostic (9.74e-2)" "unprognostic (2.06e-1)" "unprognostic (4.54e-3)" 14.6 7.9 29.6 22.0 28.9 9.2 8.1 34.2 61.4 9.7 20.5 11.5 7.9 26.8 19.2 11.0 36.0 12.8 19.8 62.0 29.3 32.9 20.0 2.8 9.2 18.2 22.2 29.8 9.3 8.8 1.5 16.8 8.8 21.3 20.3 19.4 14.7 13.4 36.5 24.4 16.5 31.1 34.3 21.1 11.3 20.7 71.8 14.8 9.6 19.3 11.7 13.3 26.9 15.6 8.9 12.5 16.2 4.7 14.3 20.4 8.9 47.8 67.3 4.5 0.1 4.5 9.5 58.8 29.8 10.7 30.2 36.4 70.9 50.9 5.7 23.8 21.4 28.0 38.9 23.0 46.5 31.8 16.1 17.7 20.7 32.4 3.8 10.7 8.3 34.8 4.4 10.5 31.7 15.8 45.8 58.1 24.3 5.7 0.2 33.4 37.4 28.3 9.0 7.4 21.0 23.6 22.2 7.5 23.1 32.7 18.8 12.4 10.7 21.1 18.0 26.4 56.5 14.8 13.1 69.9 20.6 11.1 62.1 32.4 32.7 29.5 20.5 52.9 16.0 12.6 16.2 4.7 1.6 15.9 2.3 12.6 8.2 15.9 14.8 8.0 8.9 6.0 9.5 0.7 14.3 0.9 12.5 20.4 8.9 29.6 28.9 34.2 51.7 29.3 32.9 22.2 29.8 21.3 14.8 3.0 6.5 16.7 44.9 25.4 38.3 113.1 10.2 21.4 27.3 61.1 51.1 2.1 36.5 101.2 368.5 28.8 46.6 0.0 9.2 171.9 17.4 35.9 56.4 0.8 28.5 39.7 35.7 14.1 12.6 396.4 6.9 16.2 18.6 21.6 19.5 104.9 80.1 28.1 6.3 2.1 105.7 12.9 30.8 39.9 3.2 19.7 22.2 27.3 24.5 48.7 PFN1 ENSG00000108518 "Profilin 1" P07737 17 4945652-4949061 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 509.4" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 4080.6;monocytes: 7018.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037134, CAB037140" Enhanced Approved Cytosol NA NA 1100000000 Cytosol "CAB037134: AB_1079599, CAB037140: AB_1079598" "unprognostic (1.07e-1)" "unprognostic (3.57e-1)" "unprognostic (1.60e-1)" "unprognostic (5.45e-3)" "unprognostic (1.65e-1)" "unprognostic (7.54e-2)" "unprognostic (4.01e-3)" "unprognostic (7.83e-3)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" "unprognostic (2.17e-1)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.62e-1)" "unprognostic (8.17e-2)" "unprognostic (1.02e-2)" "unprognostic (1.28e-1)" 65.2 48.2 24.0 125.4 36.7 118.0 61.3 15.6 25.9 63.8 102.3 33.1 46.7 66.4 97.4 52.9 96.6 67.5 87.8 40.7 22.0 19.6 80.5 137.3 70.5 159.4 37.4 17.3 53.7 37.2 18.3 27.5 82.8 28.5 62.0 68.2 39.3 46.0 52.6 51.6 51.2 96.4 119.4 33.3 138.7 70.4 27.2 30.5 199.3 46.6 65.3 116.3 97.9 54.4 154.4 263.4 356.5 322.9 223.0 288.9 509.4 140.1 169.1 63.5 50.9 32.8 40.9 95.3 119.9 78.8 104.2 79.0 65.4 49.5 101.9 104.3 101.3 63.0 88.6 56.6 122.1 83.9 177.2 111.3 104.3 86.6 84.9 90.0 65.7 248.2 48.5 53.7 80.7 80.5 63.7 93.4 69.8 57.5 74.4 124.7 69.7 125.2 141.8 98.8 60.2 103.9 125.5 85.3 65.6 100.8 75.0 26.0 77.5 80.5 50.5 73.4 55.5 47.3 55.8 114.2 91.1 84.5 68.3 174.1 53.1 53.8 82.1 78.5 79.0 138.3 168.7 216.8 356.5 286.3 278.7 190.1 154.4 236.8 270.9 263.4 135.2 154.8 221.1 255.4 223.0 322.9 212.4 288.9 509.4 24.0 36.7 15.6 25.9 22.0 19.6 37.4 17.3 28.5 30.5 104.2 205.8 866.8 636.2 1604.2 21.1 131.7 501.9 111.1 149.0 703.1 0.0 1882.1 840.6 1770.0 14.2 550.7 1316.6 93.5 1422.2 4080.6 968.1 512.4 473.6 682.9 3613.7 36.5 580.1 689.9 1477.5 18.5 244.2 2021.5 828.4 7018.1 1219.5 67.9 2136.3 1369.2 352.5 1192.8 11.6 498.0 1013.7 95.6 348.1 1322.9 1407.4 2210.4 1246.9 991.4 PGAM2 PGAM-M ENSG00000164708 "Phosphoglycerate mutase 2" P15259 7 44062727-44065587 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0" "Group enriched" "Detected in many" 13 "Early spermatids: 421.0;Late spermatids: 1332.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 39.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA043801, HPA050314, HPA060173" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA 60000000 Nucleoplasm "Nucleoli, Cytosol" "HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215" 1.4 0.8 2.0 0.4 2.2 0.4 0.5 6.9 2.1 0.5 0.5 3.6 0.0 0.6 0.5 9.1 6.1 0.6 0.7 111.6 2.1 3.2 0.8 0.4 0.4 0.4 4.2 1.6 0.5 0.6 0.6 1.3 0.4 2.0 1.9 0.4 2.3 7.6 0.5 379.1 0.4 0.4 0.4 3.2 0.5 0.5 16.7 1.1 4.8 1.5 119.0 4.8 0.4 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 4.3 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.3 1.7 0.2 2.0 2.2 6.9 2.1 2.1 3.2 4.2 1.6 2.0 1.1 0.0 0.0 0.5 0.2 1.0 4.3 0.0 0.0 0.0 0.0 0.0 9.8 0.0 68.0 0.0 421.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 22.0 0.0 0.3 1332.7 7.2 0.4 1.7 0.0 0.0 3.8 0.2 0.2 5.6 1.9 4.2 25.8 3.1 30.5 5.6 0.5 0.0 0.0 0.2 0.4 PGAP3 "CAB2, MGC9753, PER1, PERLD1, PP1498" ENSG00000161395 "Post-GPI attachment to proteins 3" Q96FM1 17 39671122-39696797 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "OE19: 133.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016591 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016591: AB_1855203" "unprognostic (1.29e-1)" "unprognostic (8.64e-2)" "unprognostic (1.65e-1)" "unprognostic (6.53e-3)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "prognostic favorable (3.94e-4)" "unprognostic (1.61e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.57e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.89e-4)" "unprognostic (5.16e-2)" "unprognostic (1.31e-1)" "unprognostic (9.05e-2)" "unprognostic (1.94e-2)" 6.8 8.2 8.9 7.6 14.3 3.4 10.2 6.4 17.3 11.3 19.2 10.0 15.1 12.5 8.3 16.5 16.2 14.0 19.7 9.9 11.3 7.3 13.7 20.7 9.5 6.5 6.3 10.7 9.7 22.7 16.0 10.1 39.2 6.1 11.2 11.7 14.2 16.7 15.6 5.0 16.0 20.7 7.3 5.5 8.1 13.4 9.0 7.3 4.4 20.3 8.7 15.8 8.1 8.9 7.8 5.3 4.0 10.5 9.0 15.1 6.3 0.6 1.6 1.3 1.2 1.4 1.4 1.3 0.7 1.7 1.1 1.0 0.9 4.0 0.6 3.3 1.3 0.3 2.1 0.4 0.4 0.5 1.4 1.3 0.8 0.9 1.5 1.8 2.1 2.2 2.6 2.6 0.5 1.1 1.3 0.3 0.3 0.7 1.6 1.0 1.4 0.4 1.9 1.3 133.7 0.3 0.5 0.8 1.9 1.8 2.0 1.2 0.8 1.9 22.9 1.1 0.1 1.9 2.0 0.5 1.2 1.3 0.6 0.5 1.4 0.3 0.2 1.4 0.8 1.3 2.4 6.7 4.0 15.1 10.5 8.3 7.8 10.6 12.3 5.3 7.6 10.5 10.1 1.7 9.0 3.8 3.6 5.1 6.3 8.9 14.3 6.4 17.3 11.3 7.3 6.3 10.7 6.1 7.3 3.0 12.2 0.0 3.5 3.4 12.1 5.2 12.7 4.0 9.1 14.0 7.9 6.8 1.7 6.0 0.1 4.3 16.0 0.0 9.6 5.2 6.7 4.9 9.2 7.7 4.0 12.7 8.1 4.3 2.7 0.0 2.8 3.5 1.7 1.8 16.3 7.8 5.1 11.5 1.4 3.5 21.6 0.0 2.3 0.7 2.0 2.5 8.7 1.7 13.0 2.5 PGBD1 "dJ874C20.4, HUCEP-4, SCAND4" ENSG00000137338 "PiggyBac transposable element derived 1" Q96JS3 6 28281572-28302549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5;plasmacytoid DC: 4.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007267 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007267: AB_1079601" "unprognostic (2.26e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-1)" "unprognostic (1.96e-3)" "unprognostic (1.28e-2)" "unprognostic (8.81e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (5.38e-3)" "prognostic favorable (6.79e-4)" "unprognostic (7.32e-3)" "prognostic unfavorable (4.97e-4)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (5.23e-2)" "unprognostic (2.68e-1)" 6.1 4.5 7.4 3.8 7.2 2.8 8.5 9.6 12.8 6.1 7.4 4.0 1.3 3.0 9.2 6.0 4.5 4.3 4.0 7.0 7.1 6.3 5.9 5.1 5.4 3.1 7.0 7.7 6.0 4.0 6.6 8.6 4.3 5.1 6.0 4.6 4.4 3.8 7.4 4.1 3.0 4.0 11.7 7.0 4.9 4.8 5.2 3.6 8.9 4.0 3.1 3.4 5.2 3.8 1.0 4.4 3.5 0.2 1.2 1.2 0.3 5.1 2.8 9.1 12.9 7.4 5.3 3.0 6.8 4.7 8.6 9.8 3.2 2.2 3.4 4.3 4.6 9.8 2.3 9.9 5.5 11.3 3.7 5.7 6.2 5.8 4.0 3.5 7.7 0.8 4.3 2.6 8.5 2.9 4.9 10.5 6.7 8.0 0.4 9.5 1.5 6.5 9.7 3.4 0.1 5.8 11.2 11.6 0.0 4.3 2.8 6.3 12.1 4.6 0.8 5.1 9.5 2.5 4.8 7.4 12.9 8.6 0.9 10.6 3.3 3.3 4.4 2.9 4.5 6.0 3.5 0.1 0.0 0.6 0.2 0.3 0.5 0.2 1.2 0.7 1.0 0.1 0.5 0.0 1.2 0.1 4.4 0.5 0.3 7.4 7.2 9.6 12.8 7.1 6.3 7.0 7.7 5.1 3.6 6.0 0.6 1.4 2.2 0.2 6.7 7.0 0.0 6.7 0.0 0.0 2.0 0.6 0.0 0.9 0.4 4.2 0.3 0.0 2.3 2.8 1.6 1.0 3.5 0.0 1.4 4.8 1.2 1.8 2.9 0.9 1.7 1.1 3.3 3.6 0.3 4.1 1.2 0.0 3.2 3.7 3.9 0.0 1.4 4.2 7.5 0.3 0.3 0.5 1.0 0.5 PGD ENSG00000142657 "Phosphogluconate dehydrogenase" P52209 1 10398592-10420144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Gluconate utilization, Pentose shunt" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 115.1;esophagus: 123.8" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 204.0;monocytes: 212.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4" "Group enriched" "Detected in all" 5 "granulocytes: 115.1;monocytes: 32.0" "Cell line enhanced" "Detected in all" "A549: 181.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031314, HPA031315" Enhanced Supported Approved "Intermediate filaments,Cytosol" No No 59000000 "Intermediate filaments, Cytosol" "HPA031314: AB_10610278, HPA031315: AB_2673825" "unprognostic (4.65e-2)" "unprognostic (2.58e-1)" "unprognostic (8.65e-2)" "unprognostic (9.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.90e-2)" "unprognostic (2.83e-1)" "unprognostic (1.40e-2)" "unprognostic (4.92e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" 29.8 12.7 10.9 14.2 11.8 85.5 23.7 8.0 19.1 16.0 14.1 13.8 8.1 22.9 6.3 12.5 123.8 8.4 24.9 14.3 10.3 12.1 15.4 23.2 25.6 34.9 12.4 11.4 14.3 8.3 16.2 10.8 17.0 19.3 7.9 12.9 19.7 31.8 6.8 8.5 10.6 25.3 9.5 12.6 27.6 13.4 27.0 7.4 16.8 21.2 68.8 49.9 14.8 26.1 3.9 15.9 115.1 32.0 2.0 3.0 19.0 23.1 181.8 45.3 48.7 69.0 42.7 9.8 15.7 27.8 21.8 29.8 26.6 26.7 22.8 19.4 16.1 29.9 19.7 33.1 28.1 14.7 15.7 28.9 30.8 32.7 55.9 21.0 50.8 34.2 30.4 14.1 34.4 8.5 27.8 51.4 32.0 41.0 20.2 27.8 26.3 41.9 25.5 27.2 31.8 16.0 32.5 41.6 41.9 30.4 12.5 24.4 21.3 13.4 21.3 18.5 31.2 23.5 43.6 48.1 11.5 20.4 13.7 17.3 15.3 27.9 40.8 25.1 55.2 10.3 98.6 32.0 115.1 2.6 15.3 3.0 3.9 2.5 2.4 15.9 2.3 2.4 2.6 38.4 2.0 10.9 11.4 2.4 19.0 10.9 11.8 8.0 19.1 10.3 12.1 12.4 11.4 19.3 7.4 17.9 31.2 16.0 28.9 11.6 7.9 9.5 50.9 17.4 23.9 19.2 17.7 114.8 44.7 45.3 7.1 17.5 32.9 0.0 35.1 31.4 28.8 33.1 24.4 48.2 117.8 1.6 22.4 16.0 204.0 9.8 15.8 88.3 16.9 212.8 23.7 12.9 39.9 25.9 9.9 40.3 16.4 19.4 9.8 33.4 37.9 14.4 68.0 16.0 44.1 66.7 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955784 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 177.3" "Group enriched" "Detected in many" 16 "Extravillous trophoblasts: 1478.5;Syncytiotrophoblasts: 1775.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "BEWO: 93.4;HUVEC TERT2: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" No No 20800 Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavorable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 4.3 2.7 1.9 4.4 2.4 0.0 4.3 1.6 3.5 13.1 2.3 2.3 4.0 1.3 2.9 6.3 3.9 9.2 3.4 5.1 2.4 4.1 3.1 2.6 3.6 4.9 2.9 2.0 3.8 1.9 5.4 2.0 177.3 4.6 7.5 1.1 3.5 3.8 6.7 3.3 6.0 4.3 4.6 1.7 1.2 1.7 3.3 2.0 1.4 24.2 4.4 2.9 5.1 5.9 0.7 0.7 1.1 1.0 0.0 2.4 0.2 0.3 0.3 0.3 0.3 0.4 0.0 93.4 0.8 0.8 0.4 0.5 2.2 0.1 0.0 2.0 0.6 0.0 0.1 0.4 4.2 0.3 0.0 0.5 0.0 0.0 2.2 0.3 0.0 2.4 1.1 1.0 1.7 0.4 0.1 44.0 0.0 0.0 0.0 12.4 0.1 0.0 0.1 0.4 0.0 0.7 0.0 11.6 0.0 0.1 0.2 7.0 3.8 0.0 0.1 1.6 5.9 0.0 0.1 8.9 0.0 2.3 0.0 3.7 0.0 0.0 0.1 1.4 0.1 0.1 0.0 0.2 1.1 2.4 1.0 0.0 0.7 0.3 0.7 0.3 0.3 0.6 1.0 0.0 0.0 0.8 0.7 0.5 0.2 1.9 2.4 1.6 2.2 2.4 4.1 2.9 2.0 4.6 2.0 8.9 5.8 0.8 13.0 21.9 0.8 2.8 0.0 1.4 7.9 0.0 13.7 75.1 0.0 0.9 0.1 15.8 0.5 0.0 0.4 1478.5 42.9 3.3 5.8 0.0 33.1 0.0 6.8 7.4 0.3 0.6 12.0 4.5 20.3 0.0 1.1 1.9 0.6 0.2 18.4 0.4 7.5 103.5 62.6 0.2 3.4 17.1 1775.1 0.9 1.7 4.7 PGGHG "ATHL1, FLJ22635" ENSG00000142102 "Protein-glucosylgalactosylhydroxylysine glucosidase" Q32M88 11 289135-296107 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "pancreas: 148.7" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 148.9;Alveolar cells type 2: 104.9;Club cells: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 54.5;U-266/70: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA039383, HPA058829" Uncertain Enhanced Cytosol NA Yes Cytosol "HPA039383: AB_10796225, HPA058829: AB_2683830" "unprognostic (1.40e-3)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (1.36e-2)" "unprognostic (5.83e-2)" "unprognostic (7.95e-3)" "unprognostic (2.77e-2)" "unprognostic (2.16e-2)" "unprognostic (2.14e-2)" "unprognostic (2.71e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (2.85e-3)" "unprognostic (1.09e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.12e-4)" 5.6 1.8 6.0 16.7 9.3 6.3 10.5 2.9 7.7 12.7 5.6 3.3 10.4 21.1 6.9 14.9 5.6 8.4 8.3 4.4 6.3 1.7 14.8 17.0 15.7 24.6 7.6 2.5 3.5 148.7 2.6 3.6 3.4 8.0 8.5 3.0 7.1 8.9 21.8 5.6 2.4 23.2 5.2 10.1 24.2 4.7 2.3 7.5 6.3 18.0 6.4 15.4 7.3 8.7 2.3 2.5 4.9 4.2 6.9 8.5 2.7 2.1 2.3 4.4 4.8 1.8 1.6 3.3 1.7 1.4 1.0 0.8 2.0 6.1 0.0 2.2 2.0 2.1 1.3 0.3 0.7 0.1 5.2 1.6 1.0 1.5 2.6 2.2 0.1 9.4 5.9 0.6 0.3 0.3 3.7 3.3 54.5 4.0 6.5 0.5 3.1 8.9 4.7 3.4 0.7 0.3 8.5 0.8 3.0 2.3 0.7 0.0 1.0 0.6 3.2 2.9 2.0 2.3 1.1 3.0 2.1 2.9 0.6 0.2 14.3 0.4 2.3 0.3 1.7 2.4 1.5 0.9 1.2 8.5 4.2 7.2 2.1 1.3 4.7 0.6 2.3 3.1 6.1 4.9 6.9 3.2 2.5 0.2 2.7 6.0 9.3 2.9 7.7 6.3 1.7 7.6 2.5 8.0 7.5 148.9 104.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 58.0 31.4 0.0 0.3 0.0 4.9 0.0 0.0 0.0 0.0 7.1 2.9 0.0 0.0 5.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.8 0.0 0.0 14.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PGGT1B "BGGI, GGTI" ENSG00000164219 "Protein geranylgeranyltransferase type I subunit beta" P53609 5 115204012-115262872 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 111.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030646 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Endoplasmic reticulum" Cytosol "HPA030646: AB_10602019" "unprognostic (2.73e-2)" "unprognostic (1.67e-1)" "unprognostic (3.92e-2)" "unprognostic (7.34e-2)" "unprognostic (5.57e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (3.25e-2)" "unprognostic (1.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (4.38e-2)" "unprognostic (1.58e-1)" "unprognostic (3.75e-1)" "unprognostic (5.93e-3)" "unprognostic (1.15e-2)" 10.5 12.4 7.3 13.3 10.1 10.9 13.9 8.8 22.1 10.8 13.8 7.7 7.9 12.3 9.2 4.6 14.9 7.3 7.0 13.5 9.5 5.9 8.2 13.7 22.2 22.2 10.2 10.0 9.6 10.1 12.0 13.4 7.8 8.2 8.4 15.1 5.7 10.6 8.4 10.2 9.9 10.4 9.5 6.9 10.4 11.0 5.1 10.5 10.2 8.8 9.9 10.1 9.6 10.5 8.0 11.5 21.8 16.7 6.7 6.3 6.4 10.2 11.2 12.8 16.5 7.5 6.3 6.3 12.7 7.5 10.6 11.0 12.2 11.0 20.9 17.3 8.8 11.0 8.0 16.8 16.7 15.9 23.0 9.3 12.0 14.6 9.7 10.0 16.5 17.8 9.4 10.3 10.4 10.9 6.8 10.6 12.4 9.7 8.9 12.1 16.0 14.4 5.5 9.5 11.6 8.7 15.8 17.1 21.2 11.1 19.4 12.5 9.5 15.1 11.5 12.1 8.0 15.4 12.4 12.1 10.9 10.3 7.5 14.8 15.0 16.7 11.0 7.9 17.2 15.1 8.3 12.8 21.8 5.0 16.6 5.6 6.8 5.7 6.3 11.5 8.0 5.4 5.0 13.1 6.7 16.7 10.3 4.9 6.4 7.3 10.1 8.8 22.1 9.5 5.9 10.2 10.0 8.2 10.5 11.9 14.4 20.7 10.2 8.9 22.7 15.7 5.1 25.4 18.2 15.7 45.2 12.3 23.2 17.0 28.4 16.1 17.8 0.0 18.9 11.6 11.7 13.7 23.1 24.5 19.5 22.3 28.9 20.3 18.3 8.1 12.4 23.0 10.1 12.6 23.0 25.4 17.9 21.0 14.5 18.3 111.9 12.9 14.1 11.4 15.6 10.8 11.3 19.1 23.3 17.8 PGLS 6PGL ENSG00000130313 6-phosphogluconolactonase O95336 19 17511629-17521288 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040744, HPA042032" Approved Supported Nucleoplasm,Cytosol NA NA 10000000 Nucleoplasm Cytosol "HPA040744: AB_2677111, HPA042032: AB_2677809" "unprognostic (3.68e-2)" "unprognostic (8.98e-3)" "unprognostic (1.25e-1)" "unprognostic (9.64e-3)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (3.55e-3)" "unprognostic (2.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.30e-1)" "unprognostic (4.75e-3)" "unprognostic (2.39e-1)" "unprognostic (1.99e-1)" "unprognostic (5.05e-2)" "unprognostic (9.26e-3)" 27.3 31.5 15.6 23.6 13.9 29.3 33.7 9.0 20.1 23.8 29.5 16.0 17.9 21.9 16.6 18.7 38.0 25.9 27.8 18.5 13.9 11.6 25.9 42.7 27.5 60.0 14.3 11.8 32.0 42.1 19.1 16.4 26.5 10.9 23.5 13.5 16.8 31.5 20.7 10.9 27.2 30.8 13.3 16.8 31.4 20.8 15.8 12.2 46.6 26.7 19.2 27.6 18.5 21.6 17.6 46.4 45.8 44.5 17.4 14.9 22.4 18.9 17.1 10.7 7.3 16.5 27.4 20.6 13.0 21.2 13.1 16.9 8.1 28.7 21.0 14.6 20.3 9.3 13.1 6.0 20.3 3.9 10.4 23.5 9.9 7.9 14.5 28.3 10.4 11.0 32.1 28.2 7.8 23.5 13.5 17.6 8.2 11.1 5.1 16.1 20.8 22.9 29.5 14.4 19.7 71.7 15.5 6.9 13.3 17.7 15.3 13.7 16.5 8.3 9.2 18.3 6.1 13.3 19.0 16.4 13.6 3.8 27.1 7.3 9.2 6.4 8.9 19.4 26.9 13.3 15.2 40.8 45.8 14.9 44.5 12.1 16.4 13.2 13.2 46.4 17.6 12.5 12.6 39.6 17.4 41.5 34.4 14.0 22.4 15.6 13.9 9.0 20.1 13.9 11.6 14.3 11.8 10.9 12.2 26.8 37.6 86.9 79.0 57.4 21.4 7.6 91.7 29.4 39.8 45.4 15.7 102.5 94.5 158.8 26.8 57.1 173.6 23.3 181.6 135.6 85.0 78.7 25.3 85.9 223.6 25.4 127.8 76.1 277.9 55.5 84.0 130.9 70.9 196.6 120.1 61.4 172.0 171.9 65.0 148.8 22.8 51.8 55.6 36.4 23.4 84.1 88.0 79.9 140.5 131.2 PGLYRP1 "PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L" ENSG00000008438 "Peptidoglycan recognition protein 1" O75594 19 46019153-46023065 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 73.7;bone marrow: 130.1" "Cell type enhanced" "Detected in single" 35 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 190 "eosinophil: 63.0;neutrophil: 73.7" "Lineage enriched" "Detected in single" 205 "granulocytes: 73.7" "Cell line enhanced" "Detected in some" "A549: 7.3;HEK 293: 4.1;HeLa: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045702, HPA070227" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 47000000 Vesicles "Nucleoplasm, Cytosol" "HPA045702: AB_10960204, HPA070227: " "unprognostic (2.87e-2)" "unprognostic (4.26e-1)" "unprognostic (1.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.58e-1)" "unprognostic (4.93e-3)" "unprognostic (2.20e-1)" "unprognostic (6.46e-2)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (8.51e-3)" "unprognostic (7.18e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (1.73e-1)" "unprognostic (4.37e-3)" 0.7 0.1 0.2 0.5 0.4 130.1 0.2 0.4 0.2 0.1 0.3 0.3 0.0 0.2 0.1 0.1 0.2 0.4 0.1 10.9 0.2 0.2 0.2 1.5 10.9 1.0 0.2 0.0 0.7 0.2 0.1 1.4 4.1 0.1 0.1 0.1 0.5 0.7 0.1 1.3 0.3 0.2 0.1 0.1 26.9 0.2 0.9 0.0 7.5 1.3 0.0 0.5 0.1 5.5 0.0 0.0 73.7 0.3 0.0 0.0 0.4 0.6 7.3 1.2 0.8 0.0 0.0 2.0 0.6 0.0 0.0 0.0 1.2 0.6 2.0 0.2 0.0 0.6 2.7 0.0 0.0 0.0 1.9 4.1 0.8 3.5 0.3 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.7 0.6 0.0 0.5 0.4 2.2 0.4 0.0 2.7 1.6 0.2 0.2 0.0 2.6 0.8 0.2 0.5 0.1 0.0 0.6 0.3 0.1 0.0 0.1 0.3 0.7 1.1 1.6 1.3 0.8 1.1 1.7 0.1 0.0 0.0 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.7 0.0 0.3 0.0 0.0 0.4 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PGM1 ENSG00000079739 "Phosphoglucomutase 1" P36871 1 63593276-63660245 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 233.5" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 209.3;Hepatocytes: 186.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004666, HPA024190, HPA024637, HPA046329" Enhanced Approved Cytosol NA NA 20000000 Cytosol "CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625" "unprognostic (2.50e-1)" "unprognostic (2.26e-3)" "unprognostic (1.74e-2)" "unprognostic (5.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.28e-2)" "unprognostic (1.86e-3)" "unprognostic (2.42e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.74e-5)" "unprognostic (7.07e-2)" "unprognostic (1.55e-2)" "unprognostic (6.58e-3)" "unprognostic (1.37e-1)" "unprognostic (2.46e-1)" "unprognostic (9.74e-3)" 17.8 14.1 7.0 4.4 8.3 3.5 9.8 4.4 8.3 6.7 12.9 5.2 4.6 10.6 4.6 7.7 8.8 3.3 8.9 36.9 6.4 5.4 10.0 56.4 7.6 2.7 6.2 6.3 9.7 21.6 12.9 6.2 11.5 8.5 8.7 9.1 5.4 7.9 9.4 233.5 5.3 12.4 8.4 5.6 3.0 5.7 3.0 5.5 3.0 6.0 42.8 6.3 9.4 4.7 12.2 25.9 25.6 17.9 21.1 23.3 16.6 29.8 12.5 4.7 15.5 31.2 23.1 38.3 12.3 16.7 13.4 22.0 10.3 13.9 9.4 25.8 19.0 29.7 7.1 6.5 25.9 15.8 11.5 8.7 19.9 21.2 10.6 25.8 17.4 1.1 29.1 16.7 15.6 24.8 36.0 8.0 9.8 0.0 12.6 21.5 1.8 5.0 9.6 21.4 0.9 20.1 7.1 22.0 3.0 19.5 9.4 2.8 18.4 26.9 28.2 41.0 22.9 8.8 6.6 0.7 19.9 10.2 17.6 10.4 8.0 11.7 15.4 32.5 15.3 8.5 20.5 17.9 25.6 23.3 12.0 18.6 12.2 13.7 17.5 25.9 6.9 12.5 14.5 21.2 21.1 10.2 7.5 10.6 16.6 7.0 8.3 4.4 8.3 6.4 5.4 6.2 6.3 8.5 5.5 86.4 31.4 19.9 24.0 15.9 8.1 140.8 50.9 14.7 10.3 15.7 9.8 71.5 74.6 42.0 24.0 10.7 74.3 0.0 209.3 136.9 28.0 18.3 4.7 186.6 22.2 0.0 12.6 16.0 18.3 5.2 20.4 10.7 25.3 32.5 40.1 54.2 92.3 23.0 35.7 59.8 10.7 12.9 17.9 4.7 7.5 15.8 49.2 21.8 71.1 13.6 PGM3 "AGM1, DKFZP434B187, PAGM" ENSG00000013375 "Phosphoglucomutase 3" O95394 6 83161150-83193936 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004998, HPA029759, HPA029760" Enhanced Approved Nucleoplasm,Cytosol NA NA 73000 "Nucleoplasm, Cytosol" "CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109" "prognostic unfavorable (8.78e-4)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.45e-2)" "unprognostic (3.03e-2)" "unprognostic (1.51e-2)" "unprognostic (4.04e-2)" "unprognostic (1.09e-3)" "unprognostic (6.72e-3)" "unprognostic (3.11e-1)" "prognostic favorable (9.96e-4)" "unprognostic (4.00e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.39e-7)" "unprognostic (2.21e-1)" "unprognostic (7.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.22e-3)" 15.5 16.7 11.2 10.4 13.7 4.8 12.3 19.1 13.3 15.4 10.1 9.0 30.7 8.9 10.6 26.2 10.3 8.8 14.2 12.2 11.0 8.6 12.2 44.9 13.4 6.3 13.5 9.9 15.5 36.3 9.3 36.2 27.6 18.1 30.9 13.7 7.4 29.2 23.4 5.5 7.5 11.6 11.1 9.7 8.1 14.4 16.8 11.3 4.0 14.9 7.6 8.7 11.1 10.0 8.2 7.4 11.1 6.5 5.3 8.7 3.9 10.1 6.8 13.1 15.6 21.3 22.8 15.2 34.8 25.3 16.9 26.6 17.5 4.8 5.4 7.4 34.8 17.2 6.5 11.9 14.6 32.4 4.0 11.6 6.9 13.3 29.2 24.2 6.7 3.4 14.4 12.1 29.7 37.7 17.1 19.9 3.7 22.5 5.9 18.2 10.6 1.1 4.4 5.8 9.1 9.3 4.7 29.3 3.1 13.1 10.1 5.2 8.2 10.0 9.0 7.0 20.5 7.8 7.5 28.9 11.6 6.4 23.3 18.7 11.5 4.4 3.8 9.1 5.4 18.2 11.1 6.4 3.8 5.0 6.0 6.7 8.2 5.2 6.2 5.5 5.0 8.7 8.2 2.7 5.3 6.5 7.4 3.6 3.9 11.2 13.7 19.1 13.3 11.0 8.6 13.5 9.9 18.1 11.3 26.8 20.1 3.7 21.9 14.1 16.1 5.2 20.4 12.0 28.4 10.4 9.8 27.6 6.6 29.3 40.4 10.8 14.0 23.3 43.3 56.1 40.5 76.0 4.7 30.5 15.6 7.9 15.4 16.5 4.7 15.6 31.1 8.3 10.1 12.6 25.8 25.2 36.6 17.5 17.3 18.1 20.4 6.5 18.6 54.3 31.1 13.7 53.9 7.5 15.5 17.9 PGM5 PGMRP ENSG00000154330 "Phosphoglucomutase 5" Q15124 9 68328308-68531061 "Predicted intracellular proteins" "Carbohydrate metabolism, Cell adhesion, Glucose metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 123.0" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 88.7;Endothelial cells: 35.0;Ito cells: 31.9;Sertoli cells: 51.8;Smooth muscle cells: 36.4" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 89 "neutrophil: 8.9" "Lineage enriched" "Detected in single" 89 "granulocytes: 8.9" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 15.9;PC-3: 29.8;RH-30: 20.7;SK-BR-3: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB034397, HPA046329, HPA067102" Enhanced Uncertain Cytosol NA NA 380000 Cytosol "CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758" "unprognostic (3.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.98e-3)" "unprognostic (5.75e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-4)" "unprognostic (1.22e-3)" "unprognostic (2.79e-1)" "unprognostic (5.28e-3)" "unprognostic (4.78e-2)" "unprognostic (2.28e-2)" "prognostic favorable (1.83e-5)" "unprognostic (3.04e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-1)" "unprognostic (4.73e-2)" 5.9 13.6 0.8 7.5 1.3 0.0 4.1 2.1 1.5 25.9 52.2 1.8 26.1 2.9 36.9 10.3 22.6 20.9 11.1 31.6 1.0 0.4 2.0 1.5 2.7 5.9 0.9 1.3 9.3 1.9 0.5 1.2 1.7 1.3 37.1 7.6 4.3 2.9 51.1 8.5 2.2 15.4 123.0 1.5 1.7 16.6 4.3 0.9 0.9 2.8 4.5 1.5 57.4 24.5 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 4.2 3.4 2.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 29.8 0.0 20.7 0.9 0.9 0.0 0.0 0.1 0.0 25.9 1.4 0.6 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.8 1.3 2.1 1.5 1.0 0.4 0.9 1.3 1.3 0.9 0.0 1.7 0.0 5.1 2.1 22.3 88.7 0.0 1.4 3.4 12.2 3.9 0.0 1.7 0.1 1.2 35.0 0.0 0.0 0.0 0.1 3.3 2.7 0.0 0.0 0.1 0.0 0.0 31.9 3.2 0.0 7.5 1.9 3.3 1.8 0.0 8.4 0.1 0.0 4.6 0.6 1.1 51.8 36.4 0.1 0.2 2.0 0.0 0.0 0.0 1.3 PGRMC2 "DG6, PMBP" ENSG00000164040 "Progesterone receptor membrane component 2" O15173 4 128269237-128288829 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 229.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 87.8" "Low region specificity" "Detected in all" "HPA041172, HPA058652" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA 64000 "Nuclear bodies, Plasma membrane, Cytosol" "HPA041172: AB_2677345, HPA058652: AB_2683786" "unprognostic (6.16e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "prognostic favorable (3.62e-4)" "unprognostic (6.03e-2)" "unprognostic (6.57e-3)" "unprognostic (2.53e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (8.24e-2)" "unprognostic (9.04e-2)" "unprognostic (3.80e-2)" "prognostic favorable (9.60e-4)" "unprognostic (3.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (6.03e-2)" 47.9 29.5 18.3 13.3 20.4 12.8 38.3 17.7 19.3 27.3 46.6 14.8 42.5 46.8 26.1 20.2 32.8 21.1 31.2 27.2 18.4 18.4 36.5 64.7 22.4 13.6 17.4 18.5 24.1 41.6 25.6 34.4 95.6 18.0 29.4 24.8 22.0 29.8 33.4 17.9 46.0 69.1 29.5 16.3 16.7 35.1 19.3 19.2 15.3 33.1 15.7 16.2 35.1 33.8 3.2 6.0 4.7 2.5 2.6 4.8 1.4 23.4 8.6 16.0 12.8 69.4 36.5 16.1 32.2 36.0 23.9 32.0 8.9 24.2 16.5 37.8 41.4 27.8 13.7 14.6 15.9 30.1 9.4 8.4 11.1 22.8 16.9 87.8 16.0 8.3 28.7 32.3 20.0 24.8 55.8 21.4 10.8 18.4 20.9 34.3 7.2 14.8 7.4 12.5 28.5 7.8 11.9 12.8 11.3 35.3 8.3 12.6 12.0 18.0 20.5 18.3 27.5 15.7 7.3 39.6 20.2 16.5 20.7 14.9 24.2 19.6 17.7 22.1 14.4 13.8 4.7 2.5 4.6 3.9 2.1 1.9 3.2 4.8 3.9 1.4 2.7 4.4 4.0 2.2 2.6 1.8 6.0 4.7 1.4 18.3 20.4 17.7 19.3 18.4 18.4 17.4 18.5 18.0 19.2 50.6 34.2 23.8 45.7 89.0 20.4 51.2 48.4 24.1 39.8 41.8 9.8 66.3 24.9 50.1 71.9 50.2 83.0 70.0 64.9 109.7 60.6 46.0 11.5 114.3 31.8 11.1 34.1 27.6 12.7 27.3 42.8 25.2 64.1 18.0 64.6 72.5 60.7 56.1 35.3 99.8 34.3 12.9 59.7 27.7 25.9 97.7 229.9 23.5 49.5 29.8 PHACTR4 "FLJ13171, PPP1R124" ENSG00000204138 "Phosphatase and actin regulator 4" Q8IZ21 1 28369582-28500369 "Predicted intracellular proteins" Neurogenesis "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028985 Approved Approved "Plasma membrane,Intermediate filaments,Cytosol" NA Yes "Plasma membrane, Cytosol" "Intermediate filaments" "HPA028985: AB_10602142" "unprognostic (1.55e-1)" "unprognostic (2.61e-2)" "unprognostic (4.50e-3)" "unprognostic (1.73e-1)" "unprognostic (5.27e-1)" "prognostic favorable (1.05e-4)" "unprognostic (9.65e-3)" "unprognostic (8.77e-2)" "unprognostic (2.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (2.94e-2)" "unprognostic (3.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.03e-2)" "unprognostic (2.26e-2)" 11.0 12.3 10.0 17.2 17.4 11.5 11.6 18.7 15.2 17.2 14.2 16.5 11.7 9.9 22.7 12.1 37.0 15.1 12.6 10.7 11.4 7.9 16.4 18.7 13.8 10.4 15.3 8.9 15.3 15.4 22.3 18.1 11.6 12.1 13.7 15.8 15.4 18.1 10.3 14.9 19.1 15.4 15.7 13.6 14.4 12.1 15.7 18.5 17.8 15.2 18.1 30.0 12.1 20.6 5.3 5.6 4.0 6.3 4.8 7.7 3.4 12.4 8.6 19.3 13.9 4.9 5.5 2.9 9.0 9.2 19.7 20.5 8.2 14.2 12.0 8.2 10.7 12.4 8.9 13.3 9.0 17.7 9.0 7.4 25.0 14.7 12.7 7.4 14.9 28.9 4.9 8.4 12.6 22.3 7.3 25.9 9.3 12.6 8.3 12.5 3.9 10.5 3.7 14.6 6.8 5.9 11.1 18.4 8.9 10.2 11.3 10.2 12.8 20.1 8.3 10.4 8.0 11.2 5.5 16.8 9.6 18.0 6.7 17.3 6.4 9.1 10.1 9.3 12.6 10.1 3.4 4.6 4.0 7.7 4.1 6.8 3.3 5.9 7.2 4.5 5.3 4.0 5.4 3.5 4.8 6.3 5.6 2.7 3.4 10.0 17.4 18.7 15.2 11.4 7.9 15.3 8.9 12.1 18.5 65.5 49.1 30.2 22.5 34.3 33.3 35.0 28.1 81.7 67.1 22.7 19.6 15.0 14.9 29.8 4.7 40.9 48.1 23.3 31.5 14.3 20.1 21.0 45.2 50.0 20.2 22.3 47.4 41.1 23.6 5.9 17.8 29.3 16.9 19.0 49.8 18.4 39.7 31.6 28.0 40.8 37.3 38.8 26.8 48.3 31.1 47.3 12.7 29.4 44.9 29.8 PHF14 KIAA0783 ENSG00000106443 "PHD finger protein 14" O94880 7 10973336-11169630 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000538, HPA017376" Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA000538: AB_1079604, HPA017376: AB_2732420" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "unprognostic (3.73e-3)" "unprognostic (7.38e-3)" "unprognostic (8.05e-2)" "unprognostic (3.38e-1)" "unprognostic (4.66e-3)" "unprognostic (1.80e-1)" "unprognostic (5.32e-3)" "unprognostic (6.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.84e-3)" "unprognostic (1.24e-1)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" "unprognostic (2.33e-1)" 12.5 10.9 25.0 12.4 20.4 6.4 18.4 21.4 23.8 14.0 12.7 10.7 7.2 10.3 17.9 11.0 10.6 12.4 12.6 7.7 24.7 22.1 12.2 14.8 11.3 12.0 18.5 15.5 20.2 9.8 18.4 21.4 11.0 20.0 13.9 14.3 7.1 10.0 11.5 9.3 11.3 10.1 14.9 16.2 12.9 13.3 12.0 14.9 31.5 12.7 7.6 12.9 11.9 10.6 3.9 5.8 1.6 2.0 3.4 4.6 0.8 6.7 14.1 20.7 21.4 7.3 7.1 9.9 5.3 4.5 6.5 7.1 12.5 12.2 26.4 9.8 5.0 14.3 9.5 18.4 6.3 7.1 9.5 7.0 13.0 12.5 16.3 6.7 28.8 12.4 6.4 6.8 7.5 13.8 9.0 9.3 10.4 17.2 9.4 7.7 8.7 11.4 12.8 17.3 28.2 10.1 19.3 13.3 8.3 6.7 13.2 18.5 26.0 8.2 28.0 8.9 15.4 14.9 21.2 8.5 9.0 12.0 5.7 10.3 12.1 20.9 18.5 6.3 24.5 21.1 1.6 2.0 1.2 2.9 1.8 2.3 3.9 3.2 3.7 1.2 3.4 4.6 3.8 0.1 3.4 1.6 5.8 4.1 0.8 25.0 20.4 21.4 23.8 24.7 22.1 18.5 15.5 20.0 14.9 38.7 34.5 48.8 62.8 51.1 77.9 19.4 30.6 36.1 53.4 31.4 55.0 57.8 23.2 78.4 17.7 69.7 43.4 0.0 73.0 66.3 61.3 43.8 56.4 39.4 36.4 74.7 88.5 58.9 35.9 9.5 95.3 36.0 35.4 30.7 59.7 49.5 75.4 42.1 110.0 27.0 64.0 51.8 48.4 133.9 124.4 45.8 33.3 30.5 59.7 46.9 PHF20 "C20orf104, dJ1121G12.1, TDRD20A" ENSG00000025293 "PHD finger protein 20" Q9BVI0 20 35771974-35950381 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 349.5;Late spermatids: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029619, HPA029620, HPA029621" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201" "unprognostic (1.21e-3)" "unprognostic (7.30e-2)" "unprognostic (3.20e-2)" "unprognostic (2.35e-3)" "unprognostic (1.36e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.76e-1)" "unprognostic (2.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (7.23e-2)" "unprognostic (1.01e-2)" 19.1 11.6 14.0 16.8 19.0 14.1 17.2 25.1 19.2 15.9 15.9 16.1 8.1 8.1 19.1 11.6 16.5 14.2 14.8 15.2 14.1 13.8 11.2 11.1 16.5 17.3 14.9 13.0 18.9 9.4 17.9 20.0 15.6 15.0 14.7 11.7 14.7 15.3 15.7 46.6 12.9 12.3 17.2 18.9 20.8 12.7 17.4 15.2 19.4 14.2 14.5 20.8 18.7 21.8 12.0 8.2 23.6 11.9 13.0 12.4 6.5 9.7 7.8 13.7 20.3 10.0 11.5 12.8 11.2 10.7 11.3 9.9 22.8 7.4 16.4 10.2 14.9 13.9 6.1 12.6 15.6 13.8 7.4 5.4 30.5 15.0 8.4 10.0 14.6 11.9 9.0 22.0 11.9 18.4 13.4 12.3 11.7 12.5 10.6 12.9 5.8 14.7 8.5 6.8 6.5 9.8 10.8 20.3 9.7 9.0 6.8 12.5 10.2 20.0 23.2 10.2 13.0 18.3 10.9 17.2 25.1 5.7 13.0 11.4 9.8 11.6 12.0 18.5 10.7 12.8 11.9 8.6 23.6 10.6 9.0 11.3 12.0 10.5 11.9 8.2 9.8 12.0 12.4 20.5 13.0 11.9 7.7 5.5 6.5 14.0 19.0 25.1 19.0 14.1 13.8 14.9 13.0 15.0 15.2 35.7 39.9 77.0 65.2 30.9 75.5 47.0 30.6 57.6 40.9 36.6 92.3 85.9 31.5 25.8 349.5 40.9 11.8 0.0 17.4 39.0 36.8 47.3 136.5 15.3 46.9 108.1 34.5 39.3 53.1 510.4 33.1 60.9 37.1 31.5 24.9 44.2 20.8 25.7 50.2 19.5 75.2 19.4 39.6 55.4 46.4 24.7 18.7 82.0 29.0 53.3 PHF21B "BHC80L, FLJ34161, PHF4" ENSG00000056487 "PHD finger protein 21B" Q96EK2 22 44881162-45009999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 12.5;Cone photoreceptor cells: 21.6;Early spermatids: 12.7;Horizontal cells: 27.0;Late spermatids: 30.5;Rod photoreceptor cells: 25.4" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.2;AN3-CA: 7.3;JURKAT: 6.4;NTERA-2: 5.2;SCLC-21H: 6.4;SH-SY5Y: 28.4;U-2 OS: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053834, HPA074665" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA053834: AB_2682276, HPA074665: " "unprognostic (1.04e-1)" "unprognostic (7.76e-2)" "unprognostic (2.00e-1)" "unprognostic (7.44e-2)" "unprognostic (1.37e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-3)" "unprognostic (1.86e-3)" "unprognostic (2.02e-1)" "unprognostic (9.35e-2)" "unprognostic (2.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.22e-1)" 0.7 3.5 8.4 0.8 7.4 0.5 0.8 3.7 10.9 10.1 0.7 3.6 0.9 0.7 8.6 1.7 1.6 2.3 0.8 1.3 7.8 3.4 2.2 0.5 0.6 0.6 4.7 3.2 5.6 1.8 2.0 17.9 0.6 4.2 4.8 0.6 6.5 0.8 2.1 0.7 0.5 0.7 2.3 4.4 0.6 1.0 8.5 7.3 0.0 3.0 0.0 0.6 0.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.3 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.2 0.4 0.0 0.0 6.4 0.0 0.0 0.1 0.6 0.9 0.0 5.2 0.0 0.3 0.0 1.9 0.1 0.0 0.1 6.4 28.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 6.4 0.0 0.2 0.3 0.0 3.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 7.4 3.7 7.3 7.8 3.4 4.7 3.2 4.2 7.3 0.0 0.0 0.0 0.8 0.1 12.5 1.3 0.0 1.4 0.0 0.0 21.6 0.0 1.7 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 27.0 0.0 0.0 0.0 30.5 0.6 0.0 0.0 0.0 0.0 4.6 0.1 0.0 1.8 0.0 25.4 0.0 0.0 0.7 3.4 0.0 0.0 0.0 0.0 0.1 PHGDH "PDG, PGDH, SERA" ENSG00000092621 "Phosphoglycerate dehydrogenase" O43175 1 119648411-119744226 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 16.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 99.3" "Low region specificity" "Detected in all" "CAB003681, HPA021241, HPA024031, CAB068216" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No 9000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300" "unprognostic (2.30e-1)" "unprognostic (2.16e-1)" "unprognostic (1.80e-2)" "prognostic unfavorable (1.48e-4)" "prognostic favorable (1.62e-4)" "unprognostic (9.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.24e-2)" "unprognostic (4.45e-3)" "unprognostic (8.80e-3)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (1.78e-3)" 18.8 1.9 33.3 4.4 32.1 4.4 13.8 7.8 27.2 11.9 5.8 49.7 9.4 4.2 6.1 41.0 16.7 24.5 3.9 5.3 26.7 20.5 14.0 53.2 4.3 5.7 42.0 20.7 17.3 58.2 67.5 5.7 6.4 23.3 24.5 4.7 8.7 62.9 16.4 1.7 35.9 3.0 8.1 28.3 1.9 9.0 8.6 38.1 9.9 15.8 7.3 7.3 7.9 14.1 6.7 3.2 2.9 0.7 1.2 16.5 3.2 13.6 5.6 14.6 35.0 8.4 11.0 27.2 12.3 22.3 17.7 29.3 28.8 2.4 0.0 5.4 33.0 1.9 18.4 27.0 25.7 12.5 0.1 24.6 4.3 19.6 19.9 17.3 27.5 0.1 15.8 43.0 16.9 20.0 9.9 12.7 48.8 7.9 32.6 7.8 53.5 18.4 8.4 36.4 10.6 42.5 16.2 25.3 2.3 1.2 16.2 15.7 14.4 9.0 6.1 99.3 13.9 12.3 47.0 0.1 2.9 15.3 17.9 13.8 26.9 6.7 27.5 35.8 38.5 22.7 2.9 0.7 0.2 2.9 0.2 0.2 6.7 1.8 4.9 3.2 2.7 9.1 16.5 2.0 1.2 0.2 1.8 2.4 3.2 33.3 32.1 7.8 27.2 26.7 20.5 42.0 20.7 23.3 38.1 3.0 9.3 9.7 92.1 46.0 0.8 2.0 84.1 21.4 7.9 19.2 2.0 32.1 114.4 48.9 40.9 3.3 0.2 0.0 120.7 43.3 25.5 86.4 5.7 90.0 8.0 0.0 1.7 2.5 1.3 81.6 62.7 4.8 54.0 19.0 1.1 79.1 39.9 2.5 120.2 80.4 2.9 12.9 16.0 5.2 3.4 67.4 21.2 5.0 1.5 39.9 PHKA1 PHKA ENSG00000067177 "Phosphorylase kinase regulatory subunit alpha 1" P46020 X 72578814-72714319 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Muscle protein" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 57.4" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "HDLM-2: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001081, HPA075355" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001081: AB_1079607, HPA075355: " "unprognostic (3.68e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.84e-4)" "unprognostic (3.52e-1)" "unprognostic (5.48e-2)" "unprognostic (1.23e-2)" "unprognostic (9.64e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (2.18e-1)" "unprognostic (4.76e-1)" "unprognostic (9.45e-3)" "unprognostic (9.94e-2)" "unprognostic (2.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" 2.7 10.3 3.8 1.9 7.2 0.7 3.4 3.2 3.5 2.2 2.1 2.0 7.8 1.0 2.7 4.7 4.8 2.8 2.6 5.5 3.0 3.0 2.1 1.8 1.6 1.0 4.2 1.6 5.8 4.2 16.9 14.2 1.8 4.7 4.3 2.5 6.5 6.8 5.1 57.4 2.5 1.3 3.4 3.1 2.3 3.7 3.5 2.7 0.8 6.5 12.6 2.8 3.1 3.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 8.6 12.2 0.7 7.3 4.3 4.1 7.6 1.6 1.5 0.3 0.1 3.5 7.7 0.0 4.9 0.2 8.9 3.4 14.4 5.9 0.4 22.1 14.7 4.0 9.9 3.2 4.5 0.0 0.0 5.5 6.0 1.4 9.9 7.4 8.4 7.3 6.1 0.0 7.9 6.2 6.2 0.4 9.6 14.3 16.3 0.0 0.0 0.0 2.2 4.1 7.6 9.0 7.7 10.1 0.1 9.5 3.6 0.3 4.3 0.0 3.7 1.5 4.2 10.1 9.4 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 7.2 3.2 2.9 3.0 3.0 4.2 1.6 4.7 2.7 0.0 3.0 0.0 4.0 2.2 1.8 5.6 2.5 6.7 2.3 10.4 7.9 0.8 0.0 1.5 0.3 3.5 0.5 0.0 2.2 0.9 0.5 8.7 5.8 1.5 1.3 3.2 2.4 6.2 6.0 0.0 2.8 0.2 1.7 0.0 2.0 1.3 4.4 0.0 8.1 1.1 2.9 0.0 1.3 0.0 0.7 3.0 0.5 0.0 2.4 7.0 PHKG2 ENSG00000156873 "Phosphorylase kinase catalytic subunit gamma 2" P15735 16 30748270-30761176 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 44.5;testis: 95.4" "Group enriched" "Detected in many" 6 "Early spermatids: 304.4;Late spermatids: 1171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065618, HPA068751" Supported Cytosol NA NA Cytosol "HPA065618: AB_2685520, HPA068751: AB_2686025" "unprognostic (7.63e-3)" "prognostic favorable (7.90e-4)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "prognostic favorable (1.90e-4)" "unprognostic (6.45e-2)" "unprognostic (1.25e-2)" "prognostic favorable (8.02e-4)" "unprognostic (6.15e-2)" "unprognostic (5.27e-2)" "unprognostic (1.36e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" 4.3 8.3 8.7 6.9 8.0 15.9 5.8 9.1 12.0 4.7 7.9 7.3 9.0 6.8 5.6 7.8 5.3 6.8 7.2 6.4 9.0 9.3 8.2 11.0 5.8 6.8 8.6 9.2 4.7 5.1 17.3 8.5 6.3 11.8 7.7 7.6 6.4 7.0 9.9 6.4 8.4 7.3 6.3 5.8 6.9 7.2 95.4 7.3 5.5 8.6 5.5 7.7 5.2 4.7 8.8 21.2 44.5 22.7 23.5 16.8 17.6 13.7 9.0 7.6 9.3 7.1 5.8 17.1 9.6 14.4 13.2 15.1 7.8 6.9 11.9 11.4 9.9 6.7 13.2 7.9 12.2 10.6 6.4 21.9 6.5 15.0 21.8 11.0 10.0 9.3 7.8 6.6 12.6 5.9 6.3 13.4 8.5 8.8 6.9 9.5 31.5 11.8 14.8 10.5 9.9 10.5 16.0 11.9 15.8 15.1 15.5 10.2 7.0 7.8 21.8 9.2 7.2 17.1 8.7 7.9 8.1 9.0 10.1 8.8 13.9 7.5 8.1 16.1 19.6 6.5 14.0 22.7 44.5 16.2 22.4 13.3 8.8 11.6 16.4 21.2 8.5 10.4 12.1 18.2 23.5 15.9 18.2 16.8 17.6 8.7 8.0 9.1 12.0 9.0 9.3 8.6 9.2 11.8 7.3 11.9 23.7 12.6 12.5 18.7 8.9 10.6 2.5 25.4 29.6 17.4 9.8 26.7 23.2 11.4 304.4 9.9 23.2 0.0 21.4 32.3 12.9 24.0 12.7 19.5 25.4 19.1 15.6 9.2 22.4 1171.9 16.1 24.0 11.8 42.3 15.6 9.8 16.8 15.0 21.9 32.7 8.4 0.0 12.5 127.4 23.3 20.1 63.2 26.2 19.6 12.4 PHLDB2 "FLJ21791, LL5b, LL5beta" ENSG00000144824 "Pleckstrin homology like domain family B member 2" Q86SQ0 3 111732497-111976517 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 104.0" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 138.6;Basal keratinocytes: 222.0;Smooth muscle cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 32.4;HaCaT: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035146, HPA035147" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035146: AB_10600927, HPA035147: AB_2674492" "unprognostic (2.83e-2)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (8.01e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (5.14e-2)" "unprognostic (2.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-2)" "unprognostic (2.00e-2)" "unprognostic (3.53e-1)" "prognostic favorable (7.03e-8)" "unprognostic (3.24e-3)" "unprognostic (3.47e-2)" "unprognostic (1.53e-1)" "unprognostic (2.83e-1)" 15.5 3.8 1.3 13.2 1.9 0.4 9.9 1.6 2.9 13.9 22.8 1.4 8.4 2.8 17.4 10.1 10.7 10.7 9.1 21.7 1.3 1.2 36.6 24.6 14.4 2.2 2.1 1.9 8.5 6.4 0.9 5.3 104.0 7.1 16.7 4.4 6.9 7.0 14.3 6.0 5.8 6.5 49.3 2.4 7.9 11.4 4.3 0.4 1.7 5.9 6.8 2.3 33.8 17.8 1.0 1.0 0.4 0.1 1.7 5.6 1.3 32.4 3.6 20.4 0.0 6.6 10.9 8.4 18.8 9.2 12.5 14.8 10.2 2.4 0.0 19.8 7.2 12.6 33.8 0.3 12.1 22.8 0.5 0.4 0.0 8.7 3.3 7.2 0.0 0.1 12.8 7.2 8.6 16.0 14.1 20.0 0.3 0.0 0.1 3.7 0.0 1.3 0.0 8.2 0.3 6.3 2.8 26.3 0.0 7.4 7.8 0.5 1.5 18.5 0.3 1.9 11.7 0.6 0.1 17.4 3.4 28.6 9.0 4.5 1.7 0.0 0.0 3.4 0.0 6.4 0.2 0.0 0.0 5.2 0.0 3.7 0.4 3.6 5.6 0.1 1.0 0.0 2.3 0.4 1.7 0.1 1.0 0.8 1.3 1.3 1.9 1.6 2.9 1.3 1.2 2.1 1.9 7.1 0.4 74.5 9.8 2.4 138.6 222.0 0.1 94.0 25.5 5.3 12.5 31.4 2.0 21.1 19.9 56.7 10.2 32.4 0.0 0.0 17.6 42.7 33.9 48.7 6.9 28.4 3.0 0.0 10.4 43.6 3.2 3.9 13.3 3.2 21.9 1.8 3.4 0.0 37.0 0.0 21.2 28.0 0.3 12.9 129.6 0.3 2.1 100.2 55.8 7.0 1.4 85.9 PHLDB3 FLJ40193 ENSG00000176531 "Pleckstrin homology like domain family B member 3" Q6NSJ2 19 43474954-43504935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 48.5;Urothelial cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043425 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles" "Plasma membrane, Cytosol" "HPA043425: AB_10797142" "unprognostic (2.50e-2)" "unprognostic (4.22e-3)" "unprognostic (3.06e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.22e-3)" "unprognostic (4.43e-1)" "unprognostic (1.93e-1)" "unprognostic (2.15e-1)" "unprognostic (3.60e-2)" "prognostic favorable (6.36e-6)" "unprognostic (4.62e-2)" "prognostic unfavorable (4.11e-5)" "prognostic unfavorable (5.77e-4)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (2.37e-1)" 2.7 8.5 6.6 11.7 5.9 3.6 6.0 2.1 5.2 8.7 4.8 1.8 7.1 5.8 8.8 6.5 28.4 7.3 15.9 4.5 5.2 2.9 4.8 9.6 4.0 7.8 3.5 5.8 9.5 7.7 6.8 7.9 6.4 3.2 11.7 2.2 6.7 11.1 7.6 9.0 28.7 9.4 7.5 3.0 6.4 5.4 18.7 3.0 12.2 5.7 15.2 23.2 9.3 14.8 4.4 8.1 0.9 3.3 2.6 5.5 2.3 5.3 5.6 2.3 5.8 2.1 4.4 15.2 3.8 3.4 3.8 2.7 5.7 5.6 3.2 12.1 2.3 3.0 6.2 1.7 6.7 0.7 7.5 5.3 3.5 5.3 6.8 5.3 1.3 6.8 3.7 8.5 4.1 2.5 3.0 3.4 8.0 6.2 4.9 1.9 8.3 5.4 0.3 1.4 12.7 4.6 6.4 3.1 2.1 1.8 18.0 0.1 5.1 4.9 10.7 4.6 1.5 7.6 4.5 4.3 2.5 6.6 3.0 3.6 12.6 13.7 3.5 2.3 2.6 4.1 0.3 3.3 0.5 4.0 2.3 2.9 3.7 3.7 3.0 6.9 4.4 5.5 4.8 0.9 2.6 0.2 8.1 3.6 2.3 6.6 5.9 2.1 5.2 5.2 2.9 3.5 5.8 3.2 3.0 0.0 1.7 13.7 24.7 25.8 1.0 1.7 7.6 10.7 2.3 8.7 0.0 18.0 1.7 4.8 7.6 5.0 6.4 0.0 2.1 4.1 8.5 20.4 5.7 9.5 3.2 0.0 2.9 4.9 3.7 7.4 3.4 4.1 5.0 5.4 3.9 3.7 2.4 3.1 3.2 5.5 1.8 6.5 15.5 20.7 5.3 33.5 48.5 6.9 3.3 40.7 PHLPP2 "KIAA0931, PHLPPL, PPM3B" ENSG00000040199 "PH domain and leucine rich repeat protein phosphatase 2" Q6ZVD8 16 71637835-71724701 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 29.9" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 98.2;Enterocytes: 51.9;Rod photoreceptor cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040761, HPA041837, HPA048598" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" NA No Cytosol "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA040761: , HPA041837: , HPA048598: AB_2680459" "unprognostic (5.67e-2)" "unprognostic (2.00e-1)" "unprognostic (2.29e-2)" "unprognostic (2.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.27e-1)" "unprognostic (1.22e-1)" "unprognostic (3.43e-1)" "unprognostic (1.97e-4)" "unprognostic (3.08e-2)" "unprognostic (8.85e-3)" "unprognostic (6.41e-2)" "unprognostic (4.92e-2)" "unprognostic (8.46e-3)" "unprognostic (8.27e-2)" 6.4 4.7 12.5 7.0 10.9 8.1 8.4 17.4 14.9 4.4 16.6 4.6 4.3 15.8 5.8 4.9 2.7 4.7 4.1 4.6 11.7 9.0 5.4 4.9 4.8 5.0 6.2 14.9 7.2 4.9 10.2 7.3 4.3 12.6 4.7 17.8 13.2 2.9 5.7 5.3 3.0 29.9 7.0 7.6 3.9 4.2 10.8 4.7 1.0 9.9 1.1 4.9 4.7 9.8 2.4 2.2 1.2 0.7 3.5 1.5 0.4 4.9 6.5 7.1 7.9 5.7 6.9 4.1 7.4 6.7 10.7 8.8 5.9 1.6 9.8 2.9 12.2 7.7 10.5 10.2 3.8 13.9 3.4 5.5 2.7 5.6 3.9 4.5 2.3 4.3 5.1 2.2 15.2 5.0 4.5 4.0 3.4 2.4 2.7 7.4 10.4 3.2 1.8 5.5 1.5 1.7 5.1 6.2 3.2 5.1 3.8 6.2 3.3 15.9 4.4 2.6 5.7 5.4 1.4 5.5 10.8 7.8 4.5 6.1 6.1 4.3 10.1 6.7 1.9 2.4 0.8 0.5 0.2 1.0 0.7 0.9 2.4 0.8 1.5 0.6 1.6 1.1 0.9 1.2 3.5 0.7 2.2 1.3 0.4 12.5 10.9 17.4 14.9 11.7 9.0 6.2 14.9 12.6 4.7 8.9 2.1 5.2 4.7 8.2 18.7 2.3 0.0 2.7 4.5 3.5 98.2 3.8 0.0 2.4 9.7 3.7 51.9 0.0 2.0 0.3 7.2 5.0 10.3 3.9 1.3 22.3 5.8 3.1 5.4 3.6 4.9 2.2 13.5 2.8 6.7 6.3 2.8 31.6 4.9 4.3 60.3 6.5 5.6 29.1 18.3 8.0 1.1 3.5 7.2 2.1 PHPT1 "bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14" ENSG00000054148 "Phosphohistidine phosphatase 1" Q9NRX4 9 136848724-136851027 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013584, HPA020952" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 430000 Cytosol "Nucleoplasm, Nuclear bodies, Plasma membrane" "CAB013584: , HPA020952: AB_1855331" "unprognostic (7.34e-2)" "unprognostic (9.21e-2)" "unprognostic (7.90e-2)" "unprognostic (1.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.30e-1)" "unprognostic (4.64e-2)" "unprognostic (1.69e-2)" "unprognostic (3.23e-2)" "unprognostic (1.82e-1)" "unprognostic (1.26e-3)" "unprognostic (5.85e-2)" "unprognostic (9.66e-3)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (3.95e-2)" "unprognostic (8.49e-2)" 15.8 26.4 31.5 12.1 28.0 11.7 15.3 14.7 27.2 19.2 15.7 18.5 13.7 14.7 11.2 21.7 13.7 21.1 14.2 59.1 22.7 19.3 18.4 12.6 12.1 12.7 27.0 21.0 13.7 46.5 15.6 21.2 14.7 20.8 20.2 11.6 14.1 30.5 22.6 86.0 9.2 16.3 16.9 24.3 10.3 13.4 13.8 18.6 7.5 20.7 19.8 10.4 12.0 9.8 24.9 48.8 3.3 35.4 20.0 24.3 32.1 7.1 52.0 29.7 18.9 19.2 34.9 43.7 16.6 21.2 20.3 18.1 18.9 16.3 15.2 20.2 20.5 24.3 18.9 6.4 37.5 6.4 13.6 13.2 4.8 34.2 41.5 23.9 9.5 19.5 43.5 30.9 11.6 14.0 18.4 26.6 11.9 11.5 14.1 31.4 40.6 13.8 20.0 23.5 47.6 22.4 11.5 13.0 25.1 32.1 11.9 14.6 13.8 17.9 21.0 8.6 14.8 15.9 26.4 21.6 42.5 13.2 11.7 15.3 9.4 9.1 9.3 24.0 6.9 25.4 2.9 35.4 3.3 24.3 34.2 20.9 24.9 21.1 21.9 37.5 16.5 15.0 21.3 1.7 20.0 24.0 48.8 22.9 32.1 31.5 28.0 14.7 27.2 22.7 19.3 27.0 21.0 20.8 18.6 89.3 132.7 80.4 156.2 133.5 37.9 336.8 191.1 136.5 125.1 205.9 21.6 300.5 633.3 164.3 214.6 110.1 411.5 70.0 220.3 372.9 227.8 244.3 120.2 179.9 249.5 63.5 254.7 94.5 103.8 640.4 189.8 148.3 317.2 367.9 241.4 126.9 202.0 354.2 210.0 509.4 53.8 84.1 248.0 93.6 149.9 141.4 220.8 93.5 262.8 160.3 PHTF2 DKFZp434D166 ENSG00000006576 "Putative homeodomain transcription factor 2" Q8N3S3 7 77798792-77957503 "Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 18.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012312 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012312: AB_2668649" "unprognostic (1.96e-1)" "unprognostic (2.60e-3)" "unprognostic (4.04e-1)" "unprognostic (1.44e-1)" "unprognostic (5.70e-2)" "unprognostic (1.99e-3)" "unprognostic (5.36e-3)" "unprognostic (2.81e-2)" "unprognostic (1.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (3.09e-7)" "unprognostic (8.28e-3)" "unprognostic (2.28e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (5.53e-2)" 7.5 4.5 5.6 15.1 8.6 7.7 5.9 8.7 10.3 7.0 5.9 8.9 5.3 3.2 7.3 4.6 6.4 5.7 7.8 9.1 7.0 5.2 5.4 4.7 6.8 13.7 7.0 6.3 7.4 4.7 27.7 8.2 11.4 9.3 5.9 5.1 4.7 5.7 6.9 67.0 5.5 7.8 8.5 8.2 12.1 4.7 9.1 5.8 9.2 5.7 18.2 15.5 7.9 6.3 6.7 2.1 9.2 18.2 3.8 6.2 2.0 15.2 7.0 9.6 19.5 8.4 9.3 8.0 27.0 24.7 16.2 18.4 11.9 12.4 13.7 2.2 20.9 17.6 12.7 13.7 7.0 23.1 9.2 10.9 5.6 7.7 3.5 9.2 7.4 15.5 5.5 6.7 9.4 14.2 10.4 5.7 7.7 9.1 24.4 17.2 9.6 6.0 4.8 8.7 4.3 8.3 6.1 19.5 11.2 4.4 20.6 9.3 13.0 15.1 17.2 9.8 14.8 18.2 5.8 5.7 27.9 15.0 15.6 15.8 11.5 13.4 17.1 8.8 12.0 24.0 9.2 2.1 3.4 1.5 9.2 3.0 6.7 4.7 1.4 2.1 4.2 1.4 1.5 1.2 3.8 18.2 1.0 6.2 2.0 5.6 8.6 8.7 10.3 7.0 5.2 7.0 6.3 9.3 5.8 6.0 17.5 23.8 17.3 14.2 7.8 21.5 15.3 9.4 9.1 7.0 11.8 11.2 0.0 4.0 10.8 9.0 5.3 0.0 5.8 7.0 14.7 6.5 37.1 4.3 10.4 3.2 5.2 23.4 33.1 4.4 11.2 29.4 10.1 1.8 6.0 4.0 6.0 5.8 12.7 1.8 9.3 12.9 12.8 22.9 32.2 15.6 12.4 35.5 4.5 20.4 PHYHIPL "Em:AC025038.1, KIAA1796" ENSG00000165443 "Phytanoyl-CoA 2-hydroxylase interacting protein like" Q96FC7 10 59176590-59247774 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 131.3;Early spermatids: 143.9;Horizontal cells: 136.7;Late spermatids: 172.3;Muller glia cells: 208.8;Spermatocytes: 91.0" "Group enriched" "Detected in many" 5 "glioma: 21.1;renal cancer: 8.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.8;Hep G2: 24.9;SCLC-21H: 4.5;SH-SY5Y: 14.9;SK-BR-3: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038746 Uncertain Approved Cytosol NA NA Cytosol "HPA038746: AB_10673293" "unprognostic (6.34e-3)" "unprognostic (2.40e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-3)" "unprognostic (7.06e-2)" "unprognostic (3.37e-1)" "unprognostic (5.63e-2)" "unprognostic (3.78e-2)" "unprognostic (1.06e-1)" "unprognostic (4.00e-3)" "unprognostic (2.67e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.60e-7)" "unprognostic (1.29e-3)" "unprognostic (1.30e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 1.9 23.1 22.2 2.0 22.4 1.6 1.8 17.6 70.3 2.1 2.1 25.4 0.4 11.2 2.5 3.8 2.0 2.5 1.8 1.7 20.8 21.4 14.8 2.7 1.7 1.6 28.0 25.0 2.5 5.6 1.6 4.4 10.6 24.8 4.4 2.0 7.6 2.2 4.9 1.6 1.6 11.5 1.7 27.4 1.6 2.2 8.9 31.0 0.0 1.6 0.0 1.6 1.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 14.9 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 22.4 17.6 32.6 20.8 21.4 28.0 25.0 24.8 31.0 0.0 0.0 0.0 11.5 0.0 131.3 0.4 0.0 0.0 0.0 3.5 11.8 0.9 11.6 0.3 143.9 0.3 0.0 0.0 5.7 0.2 0.2 3.3 0.0 2.1 0.5 136.7 0.0 1.3 0.0 172.3 12.0 0.0 1.7 0.0 0.0 208.8 2.8 0.0 0.4 46.1 49.8 0.0 0.1 91.0 13.2 0.0 41.0 0.0 0.0 3.2 PI15 P25TI ENSG00000137558 "Peptidase inhibitor 15" O43692 8 74824537-74855029 "Predicted secreted proteins" "Developmental protein, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 23 "Basal glandular cells: 31.8;Glandular cells: 15.4;Urothelial cells: 11.4" "Group enriched" "Detected in many" 7 "breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 16.1;SH-SY5Y: 15.9;SK-MEL-30: 21.2;U-266/70: 5.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006593, HPA030057" Uncertain Approved Vesicles,Cytosol "Secreted in other tissues" NA NA Vesicles Cytosol "HPA006593: AB_1078568, HPA030057: AB_10602143" "unprognostic (2.77e-1)" "unprognostic (1.57e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-2)" "unprognostic (3.22e-1)" "unprognostic (3.24e-1)" "unprognostic (2.94e-2)" "unprognostic (2.33e-3)" "unprognostic (1.87e-1)" "unprognostic (2.25e-1)" "unprognostic (3.65e-2)" "unprognostic (1.85e-2)" "unprognostic (8.63e-14)" "unprognostic (2.54e-3)" "unprognostic (1.34e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" 4.2 1.4 3.7 33.4 6.5 0.2 23.4 0.5 2.2 17.3 8.8 0.0 6.5 0.3 26.5 33.8 1.8 18.5 1.2 18.8 1.3 0.9 2.5 0.4 2.3 4.6 3.5 0.0 28.7 0.5 0.2 0.7 0.4 5.9 21.4 3.3 0.0 1.9 5.2 0.6 0.5 8.3 30.7 6.0 15.2 1.0 2.6 1.7 0.1 0.8 0.9 0.3 7.8 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 15.9 0.0 0.0 21.2 0.3 0.3 0.4 0.0 0.0 0.3 0.0 0.1 5.5 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 6.5 0.5 2.2 1.3 0.9 3.5 0.0 5.9 1.7 0.0 0.0 0.0 31.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 15.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.2 0.0 0.0 0.0 0.1 0.0 0.0 11.4 PI4K2B "FLJ11105, PI4KIIB, PIK42B" ENSG00000038210 "Phosphatidylinositol 4-kinase type 2 beta" Q8TCG2 4 25233975-25279092 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 49.3" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA004099 Approved Supported Cytosol NA NA Cytosol "HPA004099: AB_1855353" "unprognostic (1.02e-1)" "unprognostic (6.34e-3)" "prognostic favorable (9.64e-5)" "unprognostic (2.75e-2)" "unprognostic (1.98e-2)" "unprognostic (2.68e-2)" "unprognostic (7.54e-2)" "unprognostic (7.75e-2)" "unprognostic (5.06e-1)" "unprognostic (6.39e-3)" "unprognostic (1.71e-1)" "unprognostic (1.32e-1)" "unprognostic (9.07e-2)" "unprognostic (9.61e-2)" "unprognostic (2.39e-2)" "unprognostic (2.02e-2)" "unprognostic (4.47e-2)" 9.2 7.1 3.4 13.6 2.9 3.9 8.0 3.2 2.3 8.7 48.4 4.1 11.3 19.4 7.4 8.0 13.5 4.9 9.5 4.2 3.1 2.7 12.9 38.6 14.3 9.4 3.5 2.3 6.9 10.5 4.2 5.7 7.7 2.9 6.4 9.8 3.3 22.6 12.0 4.4 8.6 49.3 6.9 4.5 13.8 11.3 8.0 2.7 18.6 16.2 12.9 14.1 7.8 10.3 1.4 1.8 1.5 1.0 0.4 4.1 0.4 11.5 2.1 4.9 5.2 6.6 12.3 11.9 17.4 16.4 15.2 19.5 3.7 12.4 29.9 4.0 13.1 10.6 4.8 11.1 8.7 15.1 9.1 3.9 9.5 5.2 9.2 6.3 19.2 7.5 8.2 7.9 5.7 6.0 4.6 10.3 8.5 6.3 25.1 14.8 4.4 18.5 17.2 8.5 13.8 4.7 11.2 19.2 17.4 13.4 8.2 10.2 2.2 8.8 7.0 3.6 5.5 9.9 11.1 10.5 10.8 2.8 6.6 11.2 28.8 13.8 22.8 12.7 16.3 11.0 1.5 0.4 0.0 1.3 1.0 0.9 1.4 1.5 1.2 0.3 1.0 1.4 1.3 0.2 0.4 0.9 1.8 4.1 0.4 3.4 2.9 3.2 2.3 3.1 2.7 3.5 2.3 2.9 2.7 6.0 14.4 14.1 11.2 13.4 1.9 0.0 7.6 2.7 12.5 8.7 0.0 18.1 5.0 5.1 0.6 6.4 14.2 23.3 6.2 10.1 8.3 11.3 0.0 36.0 9.1 1.6 8.1 6.7 12.4 0.9 4.0 7.0 5.0 12.6 12.8 1.1 5.0 8.6 4.2 15.6 3.0 0.0 7.2 8.0 12.7 13.7 11.3 5.0 12.7 11.9 PICK1 "dJ1039K5, MGC15204, PRKCABP" ENSG00000100151 "Protein interacting with PRKCA 1" Q9NRD5 22 38056311-38075701 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 106.4;Late spermatids: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000819, HPA072674" Approved Supported Cytosol NA NA Cytosol "HPA000819: , HPA072674: AB_2686547" "unprognostic (1.97e-2)" "unprognostic (4.61e-3)" "unprognostic (7.79e-2)" "unprognostic (9.26e-2)" "unprognostic (1.29e-2)" "unprognostic (1.81e-1)" "unprognostic (6.04e-2)" "unprognostic (1.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "unprognostic (1.68e-3)" "unprognostic (1.20e-1)" "unprognostic (8.56e-2)" "prognostic favorable (5.26e-5)" "unprognostic (1.36e-1)" "unprognostic (2.74e-1)" "unprognostic (4.61e-3)" 7.7 11.9 16.9 5.7 32.7 5.3 14.9 18.4 26.2 8.9 12.5 21.3 18.6 10.8 11.3 15.5 13.0 18.1 10.0 14.7 17.2 14.8 12.4 14.5 10.8 8.1 47.4 21.5 15.6 16.1 36.6 22.7 8.7 24.7 25.5 13.4 11.4 19.1 18.9 18.0 11.5 9.8 12.5 17.6 8.1 15.0 18.6 36.5 2.5 13.4 6.8 8.5 8.9 8.6 2.5 4.6 1.9 2.7 1.4 3.2 1.7 10.3 7.4 4.2 5.5 3.0 2.4 6.3 5.8 7.0 12.5 12.7 7.9 6.5 4.6 6.5 7.0 9.5 11.3 11.5 23.4 10.8 2.8 18.4 1.6 8.9 9.0 11.0 5.3 11.3 7.6 13.8 8.2 12.2 12.8 4.8 6.1 3.3 3.4 2.6 6.6 3.1 0.5 6.6 23.7 8.1 2.7 0.2 4.1 14.5 16.8 17.5 8.9 6.5 15.9 5.9 6.4 9.2 3.9 1.3 3.6 6.7 4.7 3.4 7.6 1.8 1.3 7.7 1.8 5.1 0.0 2.7 0.0 1.8 1.5 0.6 1.1 1.8 3.2 4.6 2.5 3.1 1.8 1.9 1.4 1.5 0.9 1.7 1.7 16.9 32.7 18.4 26.2 17.2 14.8 47.4 21.5 24.7 36.5 8.9 11.7 5.1 10.6 7.1 11.8 8.9 5.1 10.7 5.7 7.0 7.9 20.7 10.0 16.8 106.4 8.0 19.0 0.0 13.6 13.0 5.4 17.5 9.2 8.5 13.1 19.1 9.9 6.7 22.6 63.9 10.3 9.9 6.8 21.6 16.2 14.5 17.0 14.8 15.9 13.3 11.7 12.9 5.1 10.9 6.0 8.4 32.2 4.4 15.7 13.1 PIDD1 "DKFZp434D229, LRDD, MGC16925, PIDD" ENSG00000177595 "P53-induced death domain protein 1" Q9HB75 11 799179-809753 "Predicted intracellular proteins" Apoptosis Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.9" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 23.0;Spermatogonia: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 21.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB012647, HPA055473, HPA066948" Supported Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus, Cytosol" "CAB012647: , HPA055473: AB_2682827, HPA066948: " "unprognostic (1.38e-1)" "prognostic favorable (8.19e-5)" "unprognostic (5.07e-3)" "prognostic favorable (3.32e-5)" "unprognostic (7.25e-2)" "prognostic favorable (3.91e-4)" "unprognostic (8.17e-3)" "unprognostic (5.97e-2)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (2.17e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.84e-3)" "unprognostic (8.46e-2)" "unprognostic (2.24e-1)" "unprognostic (2.22e-2)" 3.4 3.0 3.3 6.7 3.7 15.0 3.9 7.7 10.0 4.4 4.3 2.2 0.4 7.1 3.2 4.1 6.8 3.3 3.0 2.2 4.7 2.9 2.9 5.6 3.1 7.0 4.4 10.9 2.9 5.6 3.0 2.8 10.1 3.2 5.2 2.0 2.7 6.1 3.5 7.1 7.9 6.5 2.0 5.9 5.3 5.9 5.0 1.9 21.9 3.9 4.3 9.2 3.3 2.8 1.9 3.1 0.1 1.8 0.4 3.3 1.2 4.2 4.9 2.3 4.9 0.5 1.9 21.5 5.9 1.6 2.2 2.9 4.4 8.1 3.5 1.9 0.8 2.0 6.2 1.7 2.4 0.4 6.9 9.9 2.9 3.4 9.1 5.7 3.3 7.5 7.0 4.3 1.1 0.3 0.4 4.0 8.2 3.4 2.6 0.9 1.9 9.2 5.5 3.2 4.5 3.5 15.0 3.4 6.7 0.8 1.5 4.1 5.5 2.5 6.6 1.6 1.4 4.8 5.6 2.2 2.8 6.2 2.0 3.8 8.5 4.8 6.6 3.6 2.7 4.4 0.0 1.7 0.1 1.9 1.8 1.8 1.5 1.4 1.5 3.1 1.9 1.7 1.7 0.0 0.4 1.6 0.8 3.3 1.2 3.3 3.7 7.7 10.0 4.7 2.9 4.4 10.9 3.2 1.9 3.0 9.1 8.1 3.4 0.0 13.1 2.8 7.6 0.0 10.3 3.5 9.8 23.0 1.7 2.5 1.1 2.2 8.6 0.0 4.0 5.2 1.3 3.4 1.1 8.9 4.7 1.6 8.6 1.8 1.9 0.7 6.6 2.8 0.0 1.8 7.9 5.7 3.4 8.0 3.9 3.1 16.2 0.0 1.7 9.2 24.7 0.0 8.1 5.3 8.6 2.6 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11148762 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell type enhanced" "Detected in some" 10 "Cholangiocytes: 10.2;Ciliated cells: 13.4;Early spermatids: 23.3;Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.6;BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 14.9;HeLa: 23.8;U-266/70: 15.2;U-698: 9.9" "Low region specificity" "Detected in single" "HPA015986, HPA031974, HPA040616" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043" "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 0.9 0.3 3.1 0.9 2.3 0.0 1.9 0.1 3.6 0.9 3.3 0.0 0.3 1.6 5.8 0.8 5.9 0.0 5.2 2.1 0.9 4.5 7.4 0.5 5.8 0.6 1.7 0.0 0.6 0.0 3.4 1.3 0.0 3.3 0.0 0.8 0.9 1.9 10.3 2.7 1.4 0.9 1.3 0.2 4.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.2 9.6 0.0 0.0 0.0 0.0 0.5 2.8 10.7 14.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.9 0.0 0.3 0.0 23.8 5.6 3.4 0.0 0.0 0.0 0.2 2.7 0.7 0.1 3.3 0.3 0.0 0.2 1.7 0.0 0.1 0.0 3.0 4.1 0.0 0.0 0.0 4.2 0.0 3.3 8.3 0.0 0.1 0.0 0.5 4.5 0.0 2.7 0.0 0.0 3.8 0.2 0.5 15.2 0.1 9.9 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.4 0.7 0.0 1.4 10.2 13.4 1.2 0.0 0.0 0.0 0.0 0.1 23.3 0.9 0.0 0.0 0.2 0.0 3.1 0.1 4.7 4.5 0.7 0.0 0.0 22.1 4.0 8.6 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.4 0.6 0.3 0.0 0.0 0.0 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 9.5 11.9 5.7 13.0 11.9 11.2 10.4 3.9 9.3 7.1 8.5 8.2 6.6 9.1 10.5 13.2 11.1 9.5 10.0 6.3 5.9 5.9 12.4 10.3 8.8 20.1 6.9 6.8 8.7 8.1 19.2 12.5 8.7 8.6 9.7 9.4 13.0 9.6 8.4 3.2 8.1 11.6 7.0 8.9 14.2 9.3 17.4 6.0 11.5 16.3 6.2 16.2 10.7 9.3 8.4 8.1 20.1 11.5 5.6 8.9 6.4 7.5 8.7 4.0 3.1 4.4 9.0 5.7 6.3 12.7 7.1 11.4 3.8 7.9 7.3 8.4 8.8 11.0 12.7 2.5 6.6 6.0 7.3 5.7 7.2 10.9 4.7 7.9 20.5 6.3 9.4 8.2 5.6 7.2 9.1 8.8 6.6 8.5 6.2 9.4 6.6 2.5 8.0 2.5 5.8 4.4 3.2 3.9 16.7 11.0 8.3 2.3 4.5 5.8 9.4 11.0 3.8 10.1 14.9 6.7 9.6 3.2 2.5 12.7 6.2 11.1 6.5 8.5 23.1 6.9 10.5 8.9 4.1 8.3 10.4 8.9 8.4 8.3 8.6 8.1 5.4 7.0 7.8 20.1 5.6 11.5 6.3 8.6 6.4 5.7 11.9 3.9 9.3 5.9 5.9 6.9 6.8 8.6 6.0 8.9 7.4 8.6 8.7 4.0 2.7 2.6 2.5 8.1 12.5 0.0 11.8 10.0 1.7 6.2 16.8 4.5 5.2 0.0 9.7 9.3 4.1 4.1 8.1 3.8 7.5 1.6 6.3 7.4 6.5 2.4 1.4 6.3 3.3 8.2 3.7 3.1 5.9 4.2 1.4 8.2 9.1 6.5 4.7 2.6 3.0 3.4 5.5 8.6 3.7 3.3 PIGL ENSG00000108474 "Phosphatidylinositol glycan anchor biosynthesis class L" Q9Y2B2 17 16217191-16351797 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "GPI-anchor biosynthesis" Hydrolase "Deafness, Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012739 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" No No "Nucleoplasm, Cytosol" "HPA012739: AB_1855367" "unprognostic (3.07e-2)" "unprognostic (2.65e-1)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (7.70e-2)" "unprognostic (6.14e-2)" "unprognostic (9.39e-5)" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (2.57e-4)" "prognostic unfavorable (1.47e-4)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (3.38e-1)" "unprognostic (2.75e-3)" 17.3 12.6 11.1 14.3 18.8 8.6 18.0 14.6 15.6 12.9 13.0 17.6 12.8 17.1 19.8 20.2 12.6 13.1 12.7 8.8 8.5 7.5 11.2 18.5 12.5 12.0 14.5 10.7 16.5 16.5 11.9 18.1 10.3 13.6 14.0 14.4 15.5 14.8 16.3 13.4 20.0 15.8 10.1 9.7 12.3 14.8 11.1 13.6 13.7 15.7 11.1 20.4 10.9 12.3 5.2 7.4 5.5 3.7 5.4 9.3 3.3 7.9 11.4 7.7 6.3 11.0 10.4 3.2 4.4 5.3 7.5 13.3 11.6 10.2 3.9 9.1 4.3 4.5 11.6 9.5 5.6 10.7 8.3 24.8 7.7 7.9 13.8 11.8 3.3 5.0 8.8 14.7 13.0 14.8 7.6 8.5 13.1 9.1 5.0 5.9 7.9 6.0 7.7 3.0 15.9 5.9 5.9 6.5 11.2 8.4 4.3 4.1 5.8 4.6 3.3 9.0 20.8 3.5 3.0 5.5 6.8 4.2 4.4 12.5 3.5 0.1 6.3 8.4 8.2 4.2 0.0 3.7 5.5 6.5 3.2 5.6 5.2 8.5 5.0 2.7 4.4 9.3 7.5 0.0 5.4 2.4 7.4 6.7 3.3 11.1 18.8 14.6 15.6 8.5 7.5 14.5 10.7 13.6 13.6 8.9 16.0 3.7 8.0 3.9 11.3 1.7 7.6 10.7 12.5 12.2 9.8 13.3 5.0 5.6 2.1 5.8 6.8 0.0 6.4 6.1 6.0 6.8 4.7 9.4 4.5 6.4 7.5 3.1 2.7 1.9 7.2 5.1 3.3 1.8 10.0 6.7 7.4 7.0 10.6 4.4 12.3 0.0 6.6 13.7 8.3 5.3 8.0 8.7 10.8 8.8 PIGN "MDC4, PIG-N" ENSG00000197563 "Phosphatidylinositol glycan anchor biosynthesis class N" O95427 18 61905255-62187118 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 13 "Alveolar cells type 1: 300.7;Alveolar cells type 2: 289.2;Ciliated cells: 257.0;Club cells: 244.5;granulocytes: 147.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039922, HPA040374" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039922: AB_10805597, HPA040374: AB_10794738" "unprognostic (1.93e-2)" "unprognostic (1.71e-1)" "prognostic favorable (6.51e-4)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (3.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.99e-1)" "unprognostic (1.64e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.81e-1)" "unprognostic (1.78e-1)" "unprognostic (6.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.75e-2)" "unprognostic (2.71e-1)" 12.6 14.1 8.3 10.2 13.2 13.7 13.5 10.5 12.4 15.1 13.2 16.6 12.2 12.0 18.3 12.7 33.2 9.2 11.0 12.8 9.6 7.8 11.2 15.9 9.0 9.5 10.4 8.8 12.9 16.6 19.7 27.2 17.1 11.9 15.2 15.7 14.7 20.3 13.7 15.2 19.0 12.7 9.6 15.4 9.3 17.4 16.2 12.2 18.6 15.3 12.7 18.6 16.8 18.1 13.1 13.4 14.8 10.0 16.3 11.5 4.5 16.7 10.1 10.0 12.7 12.5 17.0 13.4 16.7 13.1 10.9 13.1 13.0 17.1 18.5 24.4 12.6 9.8 23.2 13.4 14.1 17.3 15.4 9.0 11.3 15.5 10.2 9.0 23.1 13.2 9.9 9.5 11.0 12.9 11.9 13.7 13.3 13.3 27.8 12.0 15.2 11.5 7.0 16.9 13.3 9.4 12.4 18.7 17.9 13.5 25.8 11.4 11.8 22.2 15.7 7.0 29.1 25.0 14.8 15.6 22.2 16.3 8.8 12.4 29.5 27.4 9.2 12.2 13.2 21.6 11.4 10.0 7.6 9.6 8.5 9.9 10.3 9.7 9.2 10.8 13.1 11.2 11.5 14.8 16.3 9.0 13.4 7.8 4.5 8.3 13.2 10.5 12.4 9.6 7.8 10.4 8.8 11.9 12.2 300.7 289.2 3.4 7.8 7.1 6.5 7.7 17.8 257.0 244.5 10.4 3.9 7.7 1.7 9.6 3.9 5.3 5.9 0.0 8.3 8.5 5.8 12.6 147.5 11.3 8.7 6.4 6.4 11.6 5.9 5.3 6.6 7.5 3.3 8.2 13.4 8.0 8.7 10.5 3.5 3.7 6.8 6.5 4.1 18.4 4.7 14.9 8.7 5.0 11.9 10.7 PIGU "bA346K17.2, CDC91L1, GAB1" ENSG00000101464 "Phosphatidylinositol glycan anchor biosynthesis class U" Q9H490 20 34560542-34698790 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041706, HPA046766" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041706: AB_2677627, HPA046766: AB_2679794" "unprognostic (1.87e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.64e-1)" "unprognostic (8.42e-3)" "unprognostic (7.94e-3)" "unprognostic (2.69e-1)" "unprognostic (9.86e-2)" "unprognostic (8.82e-3)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (5.27e-2)" "unprognostic (4.21e-3)" 16.8 17.6 18.9 12.9 23.6 10.0 15.2 15.7 26.5 14.7 21.5 43.0 10.8 13.3 21.8 22.8 20.0 28.2 12.7 17.4 21.4 20.2 18.4 16.3 11.3 11.6 21.5 11.9 23.9 16.2 34.4 21.7 17.3 26.9 14.1 24.9 20.1 17.9 15.9 16.4 14.0 14.2 19.6 30.5 11.1 11.5 22.1 18.1 16.5 14.7 15.9 19.5 14.2 15.0 10.0 10.8 9.4 6.3 12.1 15.0 6.7 11.7 15.0 19.1 14.0 12.6 15.2 19.2 12.1 14.5 20.6 18.2 27.7 25.1 15.2 19.8 11.9 26.4 22.0 17.4 22.9 21.0 6.2 9.4 34.2 9.9 31.1 11.7 20.8 8.2 13.4 14.8 11.8 13.5 9.5 14.8 15.0 17.1 13.5 17.4 13.2 17.6 21.2 9.6 26.8 22.7 12.8 24.0 24.3 18.2 11.0 12.3 11.6 22.7 41.2 14.8 11.2 22.7 14.7 8.7 33.9 12.1 18.3 12.1 9.1 12.7 10.1 20.7 21.8 14.6 9.4 4.4 1.9 13.4 6.3 12.2 9.2 12.4 15.0 10.8 10.0 12.7 12.5 0.9 12.1 5.3 10.6 11.2 6.7 18.9 23.6 15.7 26.5 21.4 20.2 21.5 11.9 26.9 18.1 8.9 3.7 1.5 11.9 3.9 8.5 5.2 12.7 26.8 9.1 10.4 15.7 33.8 1.7 16.1 13.6 5.0 10.3 0.0 15.2 23.8 8.0 10.0 8.1 6.7 13.7 1.6 9.8 8.6 5.6 11.0 5.2 3.5 1.7 6.4 13.8 8.1 9.8 21.0 7.4 8.4 9.5 19.4 12.0 31.9 12.2 5.1 17.7 7.0 22.1 7.6 PIGV FLJ20477 ENSG00000060642 "Phosphatidylinositol glycan anchor biosynthesis class V" Q9NUD9 1 26787472-26798398 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 65.1;Spermatocytes: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054181 Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA054181: " "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.02e-2)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (8.40e-2)" "unprognostic (4.44e-2)" "prognostic favorable (7.60e-7)" "unprognostic (1.71e-1)" "unprognostic (4.24e-1)" "unprognostic (8.92e-2)" "unprognostic (5.96e-3)" 6.2 14.6 8.1 5.3 8.9 4.6 9.2 6.1 10.3 10.5 7.5 9.9 9.3 7.3 8.3 14.7 8.7 10.6 8.9 4.4 7.2 6.6 10.6 24.6 6.8 5.1 11.6 6.8 9.0 13.5 15.8 13.5 9.3 9.7 11.5 8.4 6.6 9.9 10.6 5.0 10.1 10.7 7.1 7.5 7.2 7.7 31.3 10.0 7.2 20.0 8.2 7.8 9.3 7.6 8.3 9.7 23.5 12.9 18.0 19.1 9.2 9.4 5.7 4.6 4.0 8.9 11.0 3.9 6.5 15.4 6.2 7.6 3.1 19.6 5.6 5.9 8.1 6.9 16.9 2.4 7.6 7.7 9.5 4.0 4.9 7.6 7.8 10.0 8.9 12.1 11.4 31.6 8.5 10.4 13.2 4.7 9.1 8.9 9.0 11.1 5.3 4.4 5.0 6.9 13.9 4.6 3.2 5.3 10.6 9.8 2.4 6.6 3.5 6.4 3.2 6.3 8.3 11.0 4.4 7.8 11.2 4.8 5.4 2.2 3.2 2.1 3.0 9.2 9.5 6.6 23.5 10.3 7.7 13.3 10.1 19.1 7.4 9.0 13.0 9.7 8.3 9.1 11.1 12.5 18.0 12.9 3.8 7.7 9.2 8.1 8.9 6.1 10.3 7.2 6.6 11.6 6.8 9.7 10.0 3.0 5.9 6.7 10.3 3.8 2.9 1.8 2.5 8.1 1.2 7.0 7.9 22.6 6.6 6.3 40.4 5.0 6.1 23.3 4.0 12.3 8.7 6.7 0.0 14.1 8.1 7.9 3.4 7.4 4.7 65.1 6.6 4.0 6.8 10.0 6.5 10.3 4.6 2.9 9.2 7.9 2.7 0.0 5.1 82.9 13.9 3.6 11.8 6.1 9.8 5.8 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 34.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029409, HPA073301" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029409: AB_10610280, HPA073301: " "unprognostic (8.83e-2)" "prognostic favorable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 19.1 13.7 25.1 12.7 25.5 9.3 19.2 16.9 25.8 13.1 15.5 13.1 7.8 12.3 15.2 18.5 16.6 12.6 12.7 13.9 23.2 25.4 18.1 12.5 15.6 27.0 24.8 13.4 10.9 16.0 28.1 18.2 17.7 14.5 18.6 17.1 16.3 12.9 18.5 18.6 12.3 11.8 17.1 21.7 18.4 10.6 9.0 14.2 24.6 15.5 10.6 14.7 13.6 10.7 1.7 3.2 34.5 4.4 3.6 2.1 1.5 22.3 10.2 13.4 9.4 14.2 10.8 7.6 10.1 12.2 12.4 12.9 9.8 14.6 11.0 33.9 10.1 15.4 12.3 11.4 9.6 15.4 10.0 10.6 9.1 7.1 6.6 13.1 10.2 17.0 8.1 15.0 10.0 9.5 9.9 6.7 18.0 6.2 22.1 11.3 20.3 26.3 13.3 6.0 17.8 11.6 14.3 15.8 15.9 12.8 7.5 13.0 14.4 17.0 11.7 13.9 10.5 40.5 9.5 3.5 11.9 5.2 13.0 15.5 27.9 32.1 20.8 10.8 12.6 12.3 15.5 3.0 34.5 1.5 4.4 1.3 1.7 1.4 2.1 3.2 1.7 1.6 1.4 8.6 3.6 4.4 1.4 1.7 1.5 25.1 25.5 16.9 25.8 23.2 25.4 24.8 13.4 14.5 14.2 17.9 21.8 19.9 24.6 15.1 31.0 10.7 20.4 9.4 11.4 27.9 45.2 17.1 29.9 6.9 19.9 15.7 18.7 0.0 4.9 17.4 22.4 27.9 11.5 14.4 17.0 31.8 15.1 17.8 18.3 17.2 25.9 19.4 20.3 10.8 17.7 33.8 5.4 14.4 32.9 29.9 34.6 25.8 19.4 21.4 33.5 13.9 9.7 17.8 26.3 16.3 PIH1D1 "FLJ20643, NOP17" ENSG00000104872 "PIH1 domain containing 1" Q9NWS0 19 49446298-49453497 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047258 Approved Approved Cytosol NA NA Cytosol "HPA047258: AB_10964561" "unprognostic (2.28e-1)" "unprognostic (1.56e-1)" "unprognostic (2.14e-1)" "unprognostic (8.99e-2)" "unprognostic (7.77e-3)" "unprognostic (9.66e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-1)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (5.13e-2)" "unprognostic (1.22e-2)" "unprognostic (1.86e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" 23.1 24.3 29.5 21.1 24.4 22.3 23.7 31.1 36.9 27.3 31.9 25.8 32.9 31.9 23.2 18.1 29.0 30.6 23.0 21.1 25.2 23.2 26.7 41.6 19.2 28.4 23.4 24.7 21.4 36.9 24.4 23.2 27.6 24.8 25.8 22.4 23.0 40.8 27.3 44.7 31.4 27.3 19.9 19.2 25.8 24.9 16.8 23.7 43.6 37.2 34.0 30.6 23.8 24.2 38.6 35.9 49.7 36.4 33.0 52.5 32.6 36.3 18.7 24.1 36.8 11.8 11.0 15.4 14.8 19.5 22.8 35.4 20.0 25.0 24.5 14.0 15.8 5.7 22.3 12.5 27.1 13.4 23.4 24.0 21.9 24.9 25.2 18.3 23.7 33.1 12.8 11.5 16.9 16.0 21.6 21.2 22.3 32.2 21.7 14.3 16.4 26.4 47.0 28.7 32.6 17.9 22.6 27.0 24.6 18.5 29.9 31.2 45.2 15.1 25.8 14.5 12.3 12.3 28.7 12.6 19.2 15.1 7.6 23.1 58.9 46.0 13.4 10.5 25.7 13.4 49.7 36.4 39.3 32.4 34.9 27.4 38.6 36.3 34.4 35.9 34.2 29.5 27.4 4.2 33.0 34.6 34.2 52.5 32.6 29.5 24.4 31.1 36.9 25.2 23.2 23.4 24.7 24.8 23.7 35.7 35.8 57.4 48.9 49.6 17.7 8.7 30.6 46.8 26.1 19.2 17.7 87.9 53.0 65.4 12.8 32.1 42.6 0.0 40.6 102.6 54.6 54.9 51.9 38.6 60.9 22.3 55.2 35.6 35.3 6.2 57.8 45.4 60.8 70.3 50.2 50.7 43.4 63.3 44.2 89.8 19.3 25.8 51.8 33.4 28.1 58.6 78.6 51.7 56.6 56.2 PIH1D2 ENSG00000150773 "PIH1 domain containing 2" Q8WWB5 11 112064010-112074274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 41.9" "Group enriched" "Detected in many" 10 "Ciliated cells: 123.1;Early spermatids: 307.7;Late spermatids: 93.6;Spermatocytes: 103.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039496 Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039496: AB_10959385" "unprognostic (8.74e-2)" "unprognostic (6.64e-3)" "unprognostic (1.29e-1)" "unprognostic (3.01e-3)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (3.74e-2)" "unprognostic (1.17e-1)" "unprognostic (2.43e-3)" "unprognostic (5.82e-2)" "unprognostic (9.05e-3)" "unprognostic (1.03e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.08e-2)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" 0.7 1.0 1.5 0.3 3.3 0.2 1.6 0.9 2.0 1.6 0.8 3.2 2.3 0.4 1.5 8.1 1.0 14.4 1.2 0.9 2.6 2.0 4.9 0.5 2.8 0.3 1.1 1.8 2.5 1.2 4.4 10.5 0.5 9.7 1.4 0.7 2.7 1.1 1.5 0.9 0.9 0.5 0.9 0.8 0.4 0.8 41.9 1.2 0.1 5.8 0.6 0.3 0.9 0.8 1.2 1.0 0.7 1.2 0.3 0.3 0.2 2.9 1.5 4.6 2.0 2.3 2.6 3.2 1.1 3.8 3.8 3.7 5.7 9.4 1.3 4.0 2.2 4.5 3.7 1.0 2.4 3.7 1.4 3.8 2.1 2.5 2.5 2.1 2.2 1.4 1.6 2.8 7.0 4.0 3.4 2.0 2.7 2.7 0.8 2.3 1.1 0.9 2.8 1.3 1.6 2.5 1.8 3.0 3.2 9.8 1.5 5.9 1.5 3.7 1.4 1.9 1.9 12.6 0.6 1.1 2.1 2.4 1.3 1.0 1.1 0.4 1.6 3.1 0.3 1.7 0.0 0.3 0.7 0.0 1.2 0.3 1.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.2 1.5 3.3 0.9 2.0 2.6 2.0 1.1 1.8 9.7 1.2 6.0 0.3 0.0 1.6 0.6 2.0 2.0 7.6 123.1 10.3 3.5 2.0 0.8 13.3 3.1 307.7 0.9 0.2 0.0 2.0 0.6 0.9 0.7 1.1 0.0 0.6 1.6 2.9 0.6 0.3 93.6 2.6 0.8 3.3 1.0 0.3 3.4 1.5 0.0 1.4 6.8 15.4 0.0 1.0 103.7 7.7 0.9 0.2 0.0 0.4 0.8 PIK3AP1 "BCAP, FLJ35564" ENSG00000155629 "Phosphoinositide-3-kinase adaptor protein 1" Q6ZUJ8 10 96593312-96720514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 66.5;Kupffer cells: 114.3;Macrophages: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9" "Group enriched" "Detected in all" 6 "B-cells: 17.5;monocytes: 38.9" "Cell line enhanced" "Detected in some" "Daudi: 24.7;NB-4: 17.8;REH: 52.8;THP-1: 26.9;U-698: 33.7;U-937: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026136, HPA038452" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB026136: , HPA038452: AB_2676019" "unprognostic (2.83e-2)" "unprognostic (4.61e-3)" "unprognostic (7.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.79e-1)" "unprognostic (1.49e-1)" "unprognostic (4.60e-2)" "unprognostic (1.10e-1)" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" "unprognostic (2.10e-1)" "unprognostic (5.11e-2)" "unprognostic (1.28e-1)" "unprognostic (4.69e-2)" "unprognostic (5.45e-1)" "unprognostic (1.13e-1)" 5.8 2.2 2.9 16.8 7.1 14.7 4.8 1.0 3.0 1.4 2.2 3.2 0.0 1.9 1.3 2.3 1.3 2.0 8.5 3.3 3.1 2.4 6.2 38.4 6.0 19.5 5.3 0.5 3.3 16.1 0.3 3.0 10.9 5.1 1.8 2.7 1.6 29.7 0.8 1.1 1.5 6.6 2.4 7.3 32.0 1.9 1.7 4.3 2.0 2.4 0.6 19.2 4.1 2.2 17.5 4.4 4.7 38.9 4.5 4.8 4.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.4 24.7 2.5 0.0 0.4 0.0 5.2 0.0 0.2 13.7 0.9 3.7 0.0 0.4 0.0 10.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.3 17.8 0.2 7.0 0.3 52.8 1.2 5.8 0.0 0.0 1.1 0.6 0.0 0.0 0.3 0.1 0.0 26.9 0.0 0.0 0.8 0.0 0.2 0.2 0.0 33.7 0.0 27.7 0.0 1.7 5.4 3.3 4.8 15.5 1.7 17.5 0.1 1.5 4.4 16.2 0.0 1.2 4.7 4.5 38.9 3.9 0.1 4.2 2.9 7.1 1.0 3.0 3.1 2.4 5.3 0.5 5.1 4.3 3.0 3.8 29.6 0.0 1.3 0.2 2.2 28.1 1.4 3.4 1.8 2.0 0.4 1.7 26.1 3.3 1.4 2.6 0.0 25.2 0.7 1.0 0.5 13.9 66.5 41.2 0.0 1.7 8.0 114.3 0.4 1.1 53.7 5.0 2.8 2.5 0.2 22.8 18.4 2.1 12.8 3.3 0.0 1.7 0.2 0.2 1.0 1.9 27.7 2.9 0.1 PIK3C2A PI3K-C2alpha ENSG00000011405 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha" O00443 11 17077730-17207983 "Enzymes, Predicted intracellular proteins" "Endocytosis, Exocytosis" "Kinase, Transferase" "Cataract, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037641, HPA037642" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA037641: AB_10671878, HPA037642: AB_10697081" "unprognostic (2.35e-1)" "unprognostic (2.16e-2)" "unprognostic (3.71e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-1)" "unprognostic (6.63e-2)" "unprognostic (2.47e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (1.86e-2)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.20e-2)" "unprognostic (1.51e-1)" "unprognostic (1.18e-1)" "unprognostic (1.37e-1)" 22.3 16.8 17.6 17.2 26.3 9.2 20.0 22.6 17.2 22.1 17.2 13.9 22.2 15.6 20.3 19.2 16.8 18.2 20.2 16.3 14.5 11.6 25.7 16.3 22.2 11.3 17.6 16.1 17.6 14.2 62.9 23.0 23.5 28.5 18.7 14.3 15.2 15.6 27.5 15.4 13.1 17.9 19.5 31.8 17.5 18.3 19.4 18.0 11.4 32.2 9.3 11.5 23.1 20.5 4.4 5.2 6.0 7.2 4.2 4.8 1.6 23.1 10.6 17.8 11.1 12.9 13.2 16.0 14.7 15.9 10.8 15.1 25.8 2.6 6.8 7.3 12.6 17.7 15.4 14.2 11.2 19.2 5.8 12.3 4.2 12.9 10.1 14.1 5.2 6.7 10.2 7.9 10.6 20.9 10.1 25.6 4.3 9.9 6.6 8.3 7.1 2.8 3.3 10.1 13.0 8.2 2.9 18.5 4.7 13.4 20.6 10.5 9.3 22.3 9.6 10.3 15.6 5.7 5.3 31.9 8.7 12.6 22.5 8.9 2.7 5.9 5.6 10.4 4.9 10.0 4.1 4.1 2.9 4.6 2.5 3.0 3.6 3.7 3.6 5.2 4.4 4.8 2.8 6.0 4.2 7.2 3.7 2.3 1.6 17.6 26.3 22.6 17.2 14.5 11.6 17.6 16.1 28.5 18.0 71.5 56.0 17.6 19.9 31.4 47.8 22.4 22.9 29.4 39.8 34.9 66.8 25.6 16.6 15.8 21.3 80.2 17.1 0.0 21.6 14.0 19.7 34.1 30.2 28.6 16.4 33.4 27.5 108.1 38.5 12.0 23.9 23.8 18.6 11.8 20.1 82.7 22.6 11.5 29.4 17.0 41.1 38.8 29.8 36.4 15.5 29.6 120.0 19.2 17.2 27.3 PIK3C2B "C2-PI3K, PI3K-C2beta" ENSG00000133056 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta" O00750 1 204422628-204494724 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 32.3;Ito cells: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 32.3;RT4: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030515, HPA050360" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030515: AB_10670043, HPA050360: AB_2681104" "unprognostic (5.77e-2)" "unprognostic (1.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.45e-1)" "unprognostic (2.19e-3)" "prognostic unfavorable (5.42e-4)" "unprognostic (3.35e-3)" "unprognostic (3.57e-3)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (5.36e-2)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "prognostic favorable (1.16e-4)" 12.9 4.5 11.0 16.0 19.3 5.3 11.0 9.1 17.5 7.4 17.0 36.0 9.6 15.5 10.5 5.8 14.6 7.7 14.7 10.7 14.4 9.1 7.6 5.8 18.0 23.9 24.2 11.2 3.9 6.1 4.7 4.3 20.4 14.5 7.3 14.5 6.3 8.0 14.1 20.0 22.6 15.7 11.2 16.2 14.2 20.7 2.4 23.0 31.8 9.8 8.1 23.1 13.1 11.8 7.4 0.3 0.5 0.2 1.6 2.0 0.4 3.2 6.6 5.9 5.4 3.5 0.3 32.3 0.4 1.3 1.3 0.9 3.9 8.7 5.6 1.2 0.7 1.1 8.2 3.5 2.3 0.5 3.4 0.9 0.1 13.1 1.4 0.2 1.9 4.3 0.4 2.5 0.3 0.2 0.5 8.6 5.7 2.0 3.8 0.1 7.3 6.7 5.6 5.4 12.9 4.2 7.3 1.5 1.0 1.6 33.8 6.5 3.6 11.7 16.4 3.8 2.2 7.3 1.0 0.3 0.2 2.1 0.6 0.1 4.1 1.1 7.3 0.2 3.0 0.8 0.1 0.2 0.0 1.2 0.0 1.0 2.9 1.3 0.8 0.3 7.4 0.7 0.6 0.5 1.6 0.0 0.1 2.0 0.4 11.0 19.3 9.1 17.5 14.4 9.1 24.2 11.2 14.5 23.0 0.0 12.6 11.1 1.9 3.4 16.6 6.4 0.0 2.7 4.5 3.5 0.0 3.8 0.0 1.1 0.6 20.0 14.8 0.0 3.0 3.4 4.1 2.2 32.3 3.9 3.3 14.3 9.2 27.0 2.2 0.0 1.1 2.3 3.3 2.8 23.7 2.5 3.3 10.5 7.1 1.9 1.0 0.0 3.1 0.0 1.5 6.9 1.8 2.5 13.2 6.3 PIK3CA PI3K ENSG00000121879 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha" P42336 3 179148114-179240093 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Phagocytosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009985, CAB017804" Approved Supported Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB017804: , HPA009985: AB_1079610" "unprognostic (1.81e-1)" "unprognostic (2.77e-1)" "unprognostic (2.18e-1)" "unprognostic (2.69e-3)" "unprognostic (6.49e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (1.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-3)" "unprognostic (5.21e-2)" "unprognostic (4.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.48e-1)" "unprognostic (9.74e-2)" "unprognostic (3.82e-2)" 20.1 12.3 13.7 11.5 13.4 25.7 22.4 17.1 24.5 12.9 14.0 5.2 5.7 6.5 15.3 7.9 11.6 11.1 13.2 14.2 18.4 9.7 11.7 10.8 13.2 13.8 9.8 15.7 15.4 9.2 24.7 11.6 16.5 16.3 10.7 8.9 7.2 10.9 10.9 15.2 12.0 10.5 12.8 14.4 16.2 10.6 9.3 9.8 29.6 11.0 7.3 13.9 15.1 15.7 6.2 2.6 7.8 3.8 2.4 5.0 1.1 14.6 5.0 8.0 7.4 19.0 22.2 5.9 9.4 12.7 9.3 14.7 4.3 10.9 13.4 16.1 11.2 13.2 6.0 6.6 8.1 13.5 22.4 5.8 18.4 5.5 3.8 9.1 10.3 10.5 14.0 8.6 10.2 11.7 10.4 13.3 9.7 9.1 15.0 13.3 5.8 7.9 9.3 6.4 7.3 6.8 12.0 8.1 16.1 7.3 9.0 4.5 7.7 10.2 9.1 12.2 7.3 15.2 8.9 14.0 8.7 5.7 13.7 9.3 7.3 10.3 24.1 7.9 7.8 5.1 2.1 3.8 1.6 5.0 2.9 3.9 5.8 4.2 2.8 2.2 6.2 4.6 3.8 7.8 2.4 3.0 2.6 4.1 1.1 13.7 13.4 17.1 24.5 18.4 9.7 9.8 15.7 16.3 9.8 29.8 23.2 13.7 15.2 13.1 26.3 15.4 7.6 18.7 17.0 7.0 29.5 8.1 1.7 9.8 1.7 21.4 4.9 0.0 11.9 5.0 18.3 27.3 30.1 17.4 9.5 36.5 2.4 29.4 21.2 1.6 30.2 16.4 13.5 16.2 9.6 15.6 13.1 12.7 37.1 11.2 26.2 25.8 22.1 9.6 7.6 13.0 7.3 14.0 9.2 27.6 PIK3CG ENSG00000105851 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma" P48736 7 106865278-106907145 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8" "Cell type enhanced" "Detected in some" 8 "B-cells: 17.3;Early spermatids: 26.6;granulocytes: 19.7;monocytes: 24.4;T-cells: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HL-60: 12.1;HMC-1: 15.5;Karpas-707: 12.9;MOLT-4: 23.5;U-266/70: 31.5;U-937: 22.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069976 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA069976: AB_2686224" "unprognostic (8.34e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (1.71e-2)" "unprognostic (3.20e-2)" "unprognostic (3.82e-3)" "unprognostic (3.02e-1)" "unprognostic (6.77e-2)" "unprognostic (1.16e-1)" "unprognostic (7.06e-3)" "unprognostic (1.15e-1)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (9.08e-2)" "unprognostic (1.23e-1)" "unprognostic (5.38e-1)" "unprognostic (5.24e-2)" 5.0 1.8 2.2 16.0 3.1 27.8 2.3 0.8 1.7 1.7 4.1 2.7 0.0 2.8 1.7 2.0 2.0 1.8 3.5 1.7 1.7 1.5 1.9 1.5 4.3 13.1 3.0 1.0 1.7 1.5 0.6 1.4 2.0 2.5 2.2 2.6 1.9 3.1 0.5 1.1 1.3 6.1 1.9 6.4 17.4 2.5 7.6 3.0 40.8 2.3 0.9 21.2 4.1 1.5 6.2 5.6 14.2 24.5 5.3 5.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.6 0.0 0.0 0.0 12.1 15.5 0.0 0.0 0.0 0.0 0.0 4.8 7.4 8.6 12.9 0.0 0.0 23.5 4.6 0.0 0.0 0.0 6.2 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 1.2 0.0 0.1 0.0 0.0 31.5 0.0 11.7 0.0 22.2 2.9 4.6 3.4 14.2 5.6 10.6 5.1 4.7 2.6 4.2 5.6 6.2 2.8 3.8 13.9 5.3 24.5 4.9 2.6 3.6 2.2 3.1 0.8 1.7 1.7 1.5 3.0 1.0 2.5 3.0 0.0 2.6 17.3 0.0 0.7 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 26.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 19.7 0.5 5.9 0.0 0.0 1.8 11.0 12.8 0.6 13.3 6.8 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 3.1 0.3 0.1 17.5 0.0 0.0 PIK3R1 "GRB1, p85, p85-ALPHA" ENSG00000145675 "Phosphoinositide-3-kinase regulatory subunit 1" P27986 5 68215720-68301821 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Protein transport, Stress response, Transport" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 241.2;Leydig cells: 159.3;Muller glia cells: 180.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001216, CAB004268" Approved Supported Cytosol NA NA Cytosol "CAB004268: AB_628126, HPA001216: AB_1079612" "unprognostic (5.74e-2)" "unprognostic (6.58e-2)" "unprognostic (2.01e-1)" "unprognostic (1.31e-2)" "unprognostic (1.18e-1)" "unprognostic (1.33e-2)" "prognostic favorable (8.09e-4)" "unprognostic (3.78e-3)" "unprognostic (1.78e-1)" "unprognostic (2.71e-1)" "unprognostic (6.10e-2)" "unprognostic (1.32e-1)" "unprognostic (4.59e-3)" "unprognostic (5.66e-3)" "unprognostic (1.27e-1)" "unprognostic (5.92e-2)" "unprognostic (1.54e-1)" 26.2 13.4 26.0 13.0 24.3 51.6 42.3 15.3 50.3 27.1 20.3 12.8 12.8 8.1 41.3 22.1 20.8 33.0 18.1 33.9 24.0 13.4 17.9 46.5 16.3 12.0 22.0 40.8 25.8 6.8 22.3 9.4 15.0 18.2 15.2 10.8 8.7 54.6 16.2 48.9 19.1 16.1 36.3 17.6 18.8 13.1 7.6 23.6 16.2 12.8 8.5 10.8 25.2 24.4 2.2 2.1 10.6 4.1 8.2 14.8 4.0 1.1 2.1 6.4 19.1 73.1 21.4 2.8 6.1 2.8 2.3 2.5 5.3 1.9 5.6 10.5 8.4 1.1 2.6 1.8 12.4 3.0 23.5 2.3 6.7 1.8 4.3 24.6 6.9 5.4 22.6 28.2 4.3 22.9 1.1 3.1 6.6 1.0 4.3 2.1 2.9 16.7 2.7 1.8 3.8 1.1 15.8 3.0 4.4 3.1 12.6 1.2 5.8 1.0 1.6 4.0 3.9 9.2 4.9 3.7 2.8 2.8 4.6 3.8 4.8 7.1 6.5 3.0 8.6 2.0 10.6 1.2 5.9 9.2 1.7 12.7 1.2 11.5 8.4 2.1 2.2 14.8 10.8 1.5 8.2 4.1 0.9 8.5 4.0 26.0 24.3 15.3 50.3 24.0 13.4 22.0 40.8 18.2 23.6 47.6 25.6 14.3 14.9 12.8 45.1 241.2 28.1 12.0 27.3 5.2 23.6 12.3 61.3 13.7 9.4 23.1 20.0 0.0 8.1 13.0 36.6 8.2 66.0 142.1 25.9 46.1 9.2 39.9 52.0 6.8 159.3 29.5 32.1 21.6 24.8 180.6 9.7 19.3 114.9 31.6 85.9 19.4 26.7 0.9 2.6 8.9 8.4 132.3 21.7 6.0 PIK3R5 "p101, P101-PI3K" ENSG00000141506 "Phosphoinositide-3-kinase regulatory subunit 5" Q8WYR1 17 8878911-8965712 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 51.0" "Cell type enhanced" "Detected in some" 9 "B-cells: 14.4;Hofbauer cells: 16.8;Kupffer cells: 22.6;Macrophages: 26.2;monocytes: 12.6;T-cells: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 28.0;HMC-1: 4.2;JURKAT: 10.1;U-937: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044505, HPA052247, HPA052412" Uncertain Supported "Centriolar satellite,Cytosol" No NA Cytosol "Centriolar satellite" "HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823" "unprognostic (2.81e-1)" "unprognostic (1.31e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-2)" "unprognostic (3.44e-2)" "unprognostic (9.89e-3)" "unprognostic (1.42e-1)" "unprognostic (5.70e-2)" "unprognostic (1.38e-1)" "unprognostic (7.95e-2)" "unprognostic (1.33e-2)" "unprognostic (2.66e-1)" "unprognostic (7.59e-3)" "unprognostic (6.89e-2)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (1.24e-1)" 13.8 4.1 2.0 13.0 3.4 51.0 7.2 0.6 1.8 2.1 5.6 3.6 0.0 2.5 1.9 3.1 3.1 3.8 5.7 3.1 3.4 1.6 2.7 2.4 16.4 22.9 5.0 0.6 2.5 1.8 0.7 1.3 2.3 3.0 2.7 2.1 2.4 3.1 1.0 1.0 1.8 10.4 2.9 5.3 23.8 2.6 4.0 2.5 17.6 2.2 1.9 12.4 4.5 2.8 3.6 8.0 23.8 12.1 5.7 13.6 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.3 1.0 0.0 0.0 0.0 0.4 4.2 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.2 1.0 1.8 0.4 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 4.9 10.6 3.7 13.6 10.0 8.8 3.2 7.5 11.4 8.0 3.6 5.8 8.9 23.8 5.7 12.1 6.4 9.2 9.5 2.0 3.4 0.6 1.8 3.4 1.6 5.0 0.6 3.0 2.5 0.0 9.6 14.4 0.0 0.9 0.0 2.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.2 1.1 0.1 4.7 0.2 16.8 0.0 0.0 1.8 22.6 6.3 0.3 26.2 1.7 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.6 0.3 17.9 0.0 0.0 PIK3R6 "C17orf38, FLJ34500, HsT41028, p87PIKAP" ENSG00000276231 "Phosphoinositide-3-kinase regulatory subunit 6" Q5UE93 17 8802723-8867677 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.1;lymphoid tissue: 12.2" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 8.7;granulocytes: 45.2;Late spermatids: 13.8" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "eosinophil: 32.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 32.1" "Cell line enriched" "Detected in some" 8 "HMC-1: 58.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023077 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA023077: AB_1854909" "unprognostic (4.29e-2)" "unprognostic (8.56e-3)" "unprognostic (9.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.46e-1)" "unprognostic (5.25e-3)" "unprognostic (4.50e-3)" "unprognostic (2.29e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (2.20e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-1)" "unprognostic (8.98e-2)" 2.2 0.0 2.1 12.2 5.4 5.3 1.0 0.0 3.7 1.5 1.9 2.5 1.4 3.5 2.6 2.3 1.2 0.4 6.6 2.6 3.1 0.0 0.6 3.4 4.4 2.5 0.0 0.3 0.8 0.3 0.0 1.4 3.2 2.4 1.5 1.4 0.9 0.7 1.0 1.8 5.2 2.2 3.1 6.3 2.3 1.1 2.7 6.9 0.0 0.8 6.4 3.0 3.3 1.3 4.9 32.1 4.3 0.5 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 7.5 0.0 0.0 0.0 0.0 58.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 7.7 3.4 32.1 0.2 4.3 0.2 1.3 0.0 0.1 4.9 0.1 0.0 0.1 0.5 0.5 3.3 0.0 0.0 1.4 0.0 2.2 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 45.2 0.0 6.3 0.0 0.0 0.0 2.6 13.8 0.0 3.2 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.5 0.0 0.0 PIM1 PIM ENSG00000137193 "Pim-1 proto-oncogene, serine/threonine kinase" P11309 6 37170203-37175426 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Suprabasal keratinocytes: 199.7;Urothelial cells: 399.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 64.6" "Group enriched" "Detected in all" 5 "granulocytes: 64.6;T-cells: 19.0" "Cell line enhanced" "Detected in many" "HEL: 35.7;HMC-1: 66.4;K-562: 30.6;U-698: 119.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003941, CAB017040" Uncertain Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB017040: , HPA003941: AB_1079618" "unprognostic (1.25e-2)" "unprognostic (4.77e-1)" "unprognostic (3.61e-2)" "prognostic unfavorable (9.73e-4)" "unprognostic (1.91e-2)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (4.64e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (7.32e-2)" "unprognostic (2.14e-3)" "unprognostic (8.16e-3)" "unprognostic (1.04e-1)" "unprognostic (5.26e-3)" "unprognostic (2.90e-1)" 39.3 5.4 7.4 18.5 8.9 80.9 20.1 8.1 9.9 23.0 17.9 4.7 4.2 17.9 15.4 9.8 56.3 21.6 24.7 20.8 8.2 3.7 7.5 24.5 14.5 35.7 7.4 2.2 20.0 9.6 2.0 5.6 28.7 12.7 15.6 8.8 6.9 12.8 4.5 26.5 31.3 26.1 31.6 10.7 21.4 12.1 6.8 7.6 15.0 7.2 20.1 28.8 32.6 31.2 1.7 1.4 64.6 1.7 8.4 19.0 8.5 3.0 1.3 2.0 1.1 4.7 2.5 24.0 1.1 3.4 2.3 3.6 4.6 4.3 6.2 1.7 1.3 5.1 3.6 2.1 3.3 2.1 28.1 1.4 35.7 1.3 5.9 4.8 0.6 66.4 8.5 4.1 2.1 1.4 2.5 0.6 1.5 30.6 10.0 0.3 0.8 1.9 3.2 3.8 5.7 2.0 4.8 3.7 7.3 0.6 18.8 10.0 2.0 2.4 0.3 0.6 4.9 0.5 1.0 1.2 1.3 4.0 6.0 1.3 4.7 2.5 119.4 0.5 9.0 1.3 64.6 1.7 24.4 14.7 1.6 19.0 1.7 13.1 12.9 1.4 1.3 11.9 9.0 14.1 8.4 0.9 0.4 9.4 8.5 7.4 8.9 8.1 9.9 8.2 3.7 7.4 2.2 12.7 7.6 20.8 23.1 27.2 134.9 113.6 4.2 17.3 12.7 4.0 22.7 8.7 0.0 27.3 5.0 30.7 3.8 14.3 33.2 46.7 15.5 92.9 73.9 69.5 46.4 27.1 44.8 14.3 35.6 9.2 40.0 10.4 7.5 45.8 42.2 101.0 11.9 4.3 37.7 17.5 2.8 13.0 0.9 0.0 57.5 3.3 34.5 199.7 67.5 126.4 6.6 399.5 PIM2 ENSG00000102096 "Pim-2 proto-oncogene, serine/threonine kinase" Q9P1W9 X 48913182-48919024 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 63.4;lymphoid tissue: 71.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 48.0;B-cells: 109.2;Melanocytes: 89.4;monocytes: 163.3;T-cells: 70.8" "Cancer enriched" "Detected in all" 6 "testis cancer: 171.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HDLM-2: 60.3;Karpas-707: 74.7;RPMI-8226: 73.6;U-266/70: 136.0;U-266/84: 120.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000285 Approved Cytosol NA NA Cytosol "HPA000285: AB_1079619" "unprognostic (2.34e-3)" "prognostic favorable (4.05e-5)" "unprognostic (8.04e-2)" "unprognostic (7.30e-2)" "unprognostic (6.41e-3)" "unprognostic (2.74e-3)" "unprognostic (2.84e-1)" "unprognostic (5.23e-2)" "unprognostic (2.47e-2)" "unprognostic (4.01e-2)" "unprognostic (1.33e-3)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.17e-11)" "unprognostic (3.36e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-1)" "unprognostic (4.38e-2)" 3.6 3.4 4.3 37.2 7.2 30.4 3.4 7.1 7.9 4.5 13.4 2.1 2.2 29.5 2.8 4.3 10.0 5.6 8.3 3.1 5.6 6.7 5.2 5.4 10.6 59.7 3.8 4.6 5.4 3.0 1.0 4.9 2.4 6.7 3.6 17.7 6.1 16.9 4.9 1.5 3.0 19.2 2.2 3.1 71.2 14.7 5.7 1.3 39.4 4.8 3.6 47.9 24.6 3.3 26.0 2.9 46.9 3.0 17.0 63.4 13.2 1.8 1.6 0.8 1.7 0.3 0.2 1.3 1.1 1.4 1.6 1.4 1.4 1.4 8.0 0.5 0.5 0.6 1.1 2.7 1.0 1.5 60.3 2.1 9.7 1.6 1.4 0.7 2.3 6.5 0.6 0.9 1.7 1.0 1.3 0.6 1.0 10.2 74.7 0.9 1.3 0.8 4.8 18.2 0.6 2.5 1.0 0.6 73.6 1.6 0.2 0.6 0.8 1.2 0.8 0.8 4.3 2.1 3.1 0.3 0.4 0.2 0.3 1.1 136.0 120.2 15.3 1.5 2.0 0.4 46.9 1.5 14.3 12.5 1.9 21.2 26.0 34.4 17.6 2.5 15.9 36.9 23.0 38.3 17.0 3.0 2.9 63.4 13.2 4.3 7.2 7.1 7.9 5.6 6.7 3.8 4.6 6.7 1.3 11.9 48.0 109.2 9.5 18.0 2.3 2.0 0.0 14.7 12.5 3.5 2.0 5.3 3.3 2.8 1.4 4.3 4.0 0.0 3.1 5.0 7.5 4.0 22.0 5.4 6.3 11.1 12.6 3.1 9.1 1.4 1.7 18.6 89.4 163.3 6.6 2.3 1.6 3.5 3.9 5.4 2.2 0.0 8.1 2.1 1.5 12.0 2.1 70.8 8.1 3.9 PIM3 ENSG00000198355 "Pim-3 proto-oncogene, serine/threonine kinase" Q86V86 22 49960513-49964080 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 46.5;SK-BR-3: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068758 Supported Cytosol NA Yes Cytosol "HPA068758: AB_2686026" "unprognostic (3.67e-2)" "unprognostic (7.69e-3)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (3.67e-2)" "unprognostic (5.83e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.09e-4)" "unprognostic (5.59e-3)" "unprognostic (1.71e-1)" "unprognostic (3.92e-3)" "unprognostic (7.27e-3)" 32.5 15.5 6.8 19.9 16.7 62.4 50.5 7.6 11.9 16.4 22.6 11.3 20.9 15.9 14.4 17.6 25.0 15.9 37.8 23.6 7.5 7.9 29.1 25.7 38.3 29.4 21.1 4.9 13.9 36.4 4.8 14.9 31.4 15.1 28.4 7.6 9.7 27.6 22.7 39.9 31.3 20.9 12.2 10.1 25.4 33.6 13.0 13.5 9.7 19.1 19.9 19.0 25.6 18.3 6.1 5.7 16.9 4.0 1.2 4.5 1.9 7.3 4.9 3.3 6.2 2.6 1.9 18.9 4.6 7.5 5.6 4.0 8.1 6.3 13.2 5.9 1.2 11.3 6.3 6.3 3.5 2.0 9.9 26.2 5.4 11.7 9.8 12.2 11.7 10.5 3.7 11.7 3.4 5.8 3.0 18.0 9.0 7.4 46.5 1.6 16.5 5.9 20.9 6.9 7.7 7.9 27.7 5.5 15.6 2.9 5.6 11.8 8.2 9.0 41.3 28.9 3.2 5.4 15.6 4.7 3.5 15.0 5.7 7.5 23.9 15.2 11.2 8.7 6.6 9.4 0.0 3.1 0.1 1.9 3.2 2.3 3.4 4.4 3.8 2.5 6.1 4.1 1.7 16.9 1.2 4.0 5.7 4.5 1.9 6.8 16.7 7.6 11.9 7.5 7.9 21.1 4.9 15.1 13.5 59.6 91.3 64.7 240.2 201.8 30.4 27.9 68.8 20.1 45.5 76.8 2.0 51.0 71.3 44.7 2.1 87.2 56.5 0.0 46.7 226.7 51.4 225.9 70.2 37.5 64.3 58.8 93.7 59.5 30.8 4.1 30.0 74.6 102.9 46.9 56.5 11.1 57.1 46.3 10.6 48.8 15.3 25.8 117.4 19.9 37.3 178.9 326.1 26.6 49.6 261.0 PIN1 dod ENSG00000127445 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 1" Q13526 19 9835257-9849682 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.2" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 571.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004528, CAB009326, HPA068650, HPA070887" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 30000 Nucleoplasm Cytosol "CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: " "unprognostic (2.54e-1)" "unprognostic (6.14e-3)" "unprognostic (6.50e-2)" "unprognostic (4.36e-2)" "unprognostic (1.71e-2)" "unprognostic (6.50e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (2.67e-1)" "unprognostic (7.23e-3)" "prognostic favorable (3.25e-4)" "unprognostic (9.43e-2)" "prognostic favorable (7.80e-5)" "unprognostic (2.20e-2)" "unprognostic (2.56e-1)" "unprognostic (3.13e-2)" "unprognostic (1.21e-2)" 24.5 36.3 40.0 18.7 38.8 25.6 9.3 27.4 66.0 9.2 15.8 18.1 8.5 22.9 14.0 8.3 11.3 16.4 10.1 25.9 38.0 35.2 17.4 14.5 13.2 14.8 38.7 37.2 13.9 21.1 9.5 13.6 13.3 57.3 23.2 6.5 14.1 21.3 15.7 50.2 10.2 21.7 11.1 19.6 15.4 19.6 24.8 15.0 19.7 9.9 8.1 9.3 11.1 9.7 36.4 72.8 88.2 44.9 40.7 53.8 46.2 26.2 24.1 18.0 16.7 6.3 5.6 10.6 19.7 8.5 14.7 14.2 22.3 8.4 16.3 31.4 7.3 15.3 13.5 12.4 11.9 4.7 34.7 52.6 42.4 29.6 19.2 10.3 19.7 24.9 7.7 8.0 9.5 4.5 11.0 11.9 29.3 19.1 24.8 8.8 18.4 29.9 77.2 17.2 11.0 37.1 27.4 18.7 27.3 10.5 12.9 22.7 26.7 19.0 9.5 22.0 7.7 12.2 23.7 20.1 20.4 16.3 31.5 31.5 32.1 30.1 21.9 21.7 25.3 25.0 52.2 43.4 88.2 42.0 44.9 39.2 35.6 41.5 42.1 39.7 36.4 33.1 37.2 26.8 40.7 41.7 72.8 53.8 46.2 40.0 38.8 27.4 66.0 38.0 35.2 38.7 37.2 57.3 15.0 26.8 21.5 49.1 53.7 42.8 68.5 65.3 43.3 56.2 14.8 59.3 11.8 107.3 139.3 95.7 197.0 54.9 69.5 46.7 95.4 80.4 81.4 55.2 63.4 41.4 123.0 57.2 95.8 47.3 50.0 571.0 83.4 67.4 118.1 174.1 57.9 60.8 85.6 73.7 122.0 109.4 50.6 64.7 97.1 136.8 72.0 57.6 46.0 94.4 62.6 47.8 PIP4K2A "PIP5K2A, PIP5KIIA, PIP5KIIalpha" ENSG00000150867 "Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha" P48426 10 22534849-22714555 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 92.0" "Cell type enhanced" "Detected in all" 7 "Erythroid cells: 93.5;Melanocytes: 99.5;T-cells: 152.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065440, HPA068771" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 8800000 "Golgi apparatus" "Plasma membrane, Cytosol" "HPA065440: AB_2685490, HPA068771: AB_2686030" "unprognostic (1.11e-1)" "unprognostic (2.71e-3)" "unprognostic (1.57e-3)" "unprognostic (4.20e-3)" "unprognostic (1.55e-1)" "unprognostic (8.80e-3)" "unprognostic (1.56e-3)" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (7.08e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.52e-3)" "unprognostic (2.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.92e-3)" 13.0 7.3 43.8 20.3 63.8 17.3 6.9 6.6 41.4 13.2 7.8 75.5 1.0 5.9 9.9 5.6 9.2 7.2 15.1 5.9 56.0 31.7 7.6 8.3 11.5 33.4 65.7 22.9 4.3 4.9 29.5 4.2 10.5 36.5 4.4 9.0 5.7 3.9 6.3 2.6 4.0 8.1 14.4 92.0 26.6 8.4 5.4 59.8 10.1 5.9 1.0 38.5 11.5 5.8 14.7 12.0 26.3 16.6 38.4 46.7 39.3 8.9 8.8 10.3 3.3 16.5 22.5 7.8 16.6 17.7 9.0 11.1 8.2 14.3 18.7 6.0 33.3 19.8 3.1 8.9 4.6 9.1 41.4 9.3 35.2 6.4 18.1 29.3 6.7 27.6 11.2 4.2 12.2 11.9 13.9 13.3 25.3 19.5 36.6 16.6 3.7 26.9 6.0 4.2 4.3 6.3 10.9 14.7 25.4 13.3 1.7 1.8 4.3 5.3 2.7 26.4 12.2 2.3 11.7 16.0 7.0 10.2 12.8 10.1 23.3 13.1 13.6 18.9 20.5 5.3 16.1 8.8 26.3 34.5 15.6 46.7 14.7 27.5 40.0 11.6 8.6 18.6 34.9 10.9 38.4 16.6 12.0 19.6 39.3 43.8 63.8 6.6 30.3 56.0 31.7 65.7 22.9 36.5 59.8 3.0 7.9 43.2 3.6 15.7 4.1 6.8 15.3 1.4 7.9 17.4 2.0 6.7 10.0 8.7 15.7 24.8 2.6 93.5 9.3 4.0 17.1 5.4 22.0 6.4 27.8 12.7 4.7 68.2 77.2 23.8 15.5 49.0 99.5 85.6 2.8 4.0 16.5 3.5 9.6 9.8 8.1 19.4 21.1 4.1 2.3 14.8 10.4 152.2 2.3 5.5 PIP4K2C "FLJ22055, PIP5K2C" ENSG00000166908 "Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma" Q8TBX8 12 57591174-57603418 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028658 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028658: AB_10601245" "unprognostic (7.84e-3)" "unprognostic (1.51e-1)" "unprognostic (2.42e-1)" "unprognostic (2.77e-2)" "unprognostic (2.49e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (3.17e-2)" "unprognostic (6.00e-2)" "unprognostic (5.51e-2)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.06e-6)" "unprognostic (1.87e-1)" "unprognostic (2.16e-1)" "unprognostic (3.27e-1)" "unprognostic (3.42e-1)" 9.3 13.3 13.9 9.2 25.9 16.7 15.0 18.9 45.5 12.5 17.5 14.6 15.8 11.6 14.2 62.0 20.0 20.0 12.1 10.8 15.4 10.9 26.9 14.4 14.4 9.2 14.3 21.2 12.3 14.9 29.6 13.7 11.1 18.8 16.7 19.4 17.4 18.6 14.6 9.4 18.4 13.3 11.9 12.7 10.7 27.6 25.6 12.1 5.9 17.9 8.5 13.1 14.6 14.1 6.8 5.4 29.7 8.4 9.4 16.1 6.5 19.1 13.5 5.5 6.6 0.0 0.0 17.8 8.0 15.0 14.5 13.5 17.2 27.7 4.1 17.6 9.3 17.9 17.5 9.0 15.7 11.7 6.2 10.1 7.5 6.5 12.1 12.8 6.9 13.5 5.0 26.7 5.5 10.3 17.8 7.3 4.6 9.6 12.6 7.5 18.9 6.2 6.0 10.5 11.7 11.8 0.1 49.9 6.2 15.2 32.8 9.3 11.5 17.2 11.5 10.9 19.4 31.6 6.4 1.6 7.3 10.1 10.7 8.4 9.7 11.3 9.3 14.4 5.9 12.1 29.7 5.2 15.3 16.1 6.2 10.7 5.9 9.9 12.0 5.4 6.8 9.6 11.5 10.2 9.4 8.4 2.3 12.1 6.5 13.9 25.9 18.9 45.5 15.4 10.9 14.3 21.2 18.8 12.1 8.9 7.5 3.0 5.7 11.0 13.1 112.2 15.3 13.4 9.1 33.2 17.7 9.3 18.3 16.2 23.8 3.5 18.0 0.0 17.1 13.6 4.9 9.9 3.5 11.6 7.9 7.9 21.4 9.8 2.9 35.3 6.4 4.1 11.8 8.2 16.1 6.5 28.1 13.6 4.9 10.1 8.3 19.4 6.4 11.9 7.1 11.2 14.5 8.7 8.6 7.1 PIP5K1A ENSG00000143398 "Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha" Q99755 1 151197949-151249536 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029366 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA029366: AB_10602116" "unprognostic (1.05e-1)" "unprognostic (2.36e-2)" "unprognostic (8.64e-2)" "unprognostic (7.94e-3)" "unprognostic (1.17e-1)" "unprognostic (3.28e-2)" "unprognostic (1.26e-2)" "unprognostic (3.01e-1)" "unprognostic (8.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.16e-7)" "unprognostic (1.44e-1)" "unprognostic (8.14e-2)" "unprognostic (2.93e-1)" "unprognostic (1.59e-1)" 18.1 19.5 15.7 15.4 21.0 9.6 20.2 22.6 27.6 19.8 18.0 20.3 14.7 16.4 24.8 22.6 20.7 19.4 20.7 18.9 17.3 13.4 17.8 18.3 21.7 17.1 12.7 17.5 20.4 16.6 21.8 25.3 44.6 14.6 17.3 15.6 29.5 17.8 15.2 26.1 20.4 20.4 27.2 16.1 20.1 16.8 42.1 14.0 19.3 20.1 13.9 22.3 16.2 17.7 9.1 8.7 11.7 6.2 4.7 5.9 6.3 17.7 13.8 21.4 24.7 14.1 15.0 21.1 23.5 33.0 43.9 39.4 25.1 17.2 16.2 25.0 25.0 19.8 15.1 27.7 16.1 38.5 24.3 19.8 12.8 18.3 12.0 26.7 22.9 16.2 19.9 15.0 27.3 34.6 19.4 17.8 25.8 12.5 13.8 22.0 24.9 22.8 11.4 31.7 13.6 21.5 22.1 18.7 12.0 22.5 10.3 14.4 19.0 31.7 24.4 20.6 37.4 25.6 21.7 17.1 17.5 24.4 16.1 28.2 19.3 32.1 36.5 17.0 6.7 20.8 0.1 5.5 7.3 5.3 6.2 4.1 9.1 5.0 5.9 8.4 4.6 5.4 4.2 11.7 4.7 4.8 8.7 3.9 6.3 15.7 21.0 22.6 27.6 17.3 13.4 12.7 17.5 14.6 14.0 29.8 13.5 19.0 21.3 58.7 33.2 17.3 12.7 12.0 11.4 29.6 92.3 21.0 8.3 11.8 2.8 13.2 15.9 0.0 7.5 24.0 19.1 15.9 11.5 11.6 11.1 25.4 5.8 17.8 10.1 3.6 12.4 11.5 11.8 10.0 8.4 13.8 13.3 8.4 10.3 7.9 43.5 12.9 19.6 46.5 22.4 43.7 53.1 8.7 9.5 32.5 PIP5K1C "KIAA0589, LCCS3, PIP5Kgamma" ENSG00000186111 "Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma" O60331 19 3630183-3700479 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017168 Approved Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA017168: AB_1855395" "unprognostic (1.20e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.36e-3)" "prognostic favorable (7.28e-5)" "unprognostic (7.03e-2)" "unprognostic (4.02e-3)" "unprognostic (5.80e-3)" "unprognostic (8.50e-2)" "unprognostic (1.31e-1)" "unprognostic (2.57e-3)" "prognostic favorable (2.32e-4)" "unprognostic (1.51e-1)" "prognostic favorable (3.00e-4)" "unprognostic (2.25e-1)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" 16.1 10.2 20.5 12.8 25.8 4.5 8.0 58.6 46.3 10.7 23.5 8.5 14.8 10.9 19.8 10.0 12.3 12.8 12.7 13.8 22.8 10.7 7.5 3.8 11.5 7.5 11.3 17.1 11.5 17.2 10.0 9.2 13.7 19.0 16.7 6.4 16.9 20.0 33.4 13.5 10.2 11.5 19.2 6.3 15.8 13.6 23.9 8.7 5.3 9.3 3.9 6.0 17.3 19.0 2.5 3.2 3.6 3.0 1.7 2.8 2.0 9.2 8.8 6.9 8.9 13.5 11.0 10.4 17.9 11.3 7.7 6.2 7.8 2.6 3.9 6.9 19.1 8.5 8.2 3.2 5.8 3.2 13.8 5.8 4.4 7.3 6.3 11.3 4.5 13.8 12.2 5.5 6.3 2.4 5.5 13.0 5.9 6.7 7.2 7.2 7.7 5.4 3.3 7.2 3.4 12.2 10.2 5.3 5.3 5.7 8.0 7.0 6.0 9.2 5.0 5.4 9.0 4.0 6.8 28.6 10.8 6.2 38.1 8.3 8.3 6.6 1.7 14.5 9.5 7.7 3.6 2.8 0.0 2.8 2.6 1.2 2.5 2.1 2.0 3.2 1.3 1.0 1.6 2.2 1.7 3.0 2.2 1.4 2.0 20.5 25.8 58.6 46.3 22.8 10.7 11.3 17.1 19.0 8.7 6.0 5.3 5.4 2.8 4.7 40.8 5.5 7.6 2.7 0.0 15.7 35.3 6.2 1.7 6.9 8.4 12.0 7.0 0.0 6.2 6.0 8.5 4.9 1.1 3.6 13.3 28.6 8.1 16.0 11.0 17.7 13.8 10.8 5.0 13.6 9.2 10.5 9.9 7.0 22.6 5.7 26.6 12.9 10.7 19.0 10.4 5.9 13.7 6.4 5.7 3.8 PIP5KL1 "bA203J24.5, MGC46424" ENSG00000167103 "Phosphatidylinositol-4-phosphate 5-kinase like 1" Q5T9C9 9 127920879-127930797 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 9.4;Ciliated cells: 9.4;Early spermatids: 20.0;Late spermatids: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "intermediate monocyte: 1.2;MAIT T-cell: 1.0;memory B-cell: 1.0;myeloid DC: 1.0;naive B-cell: 2.4;plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Karpas-707: 29.6;RPMI-8226: 19.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA056240 Uncertain Supported Cytosol NA NA Cytosol "HPA056240: AB_2683075" "unprognostic (2.15e-2)" "unprognostic (3.06e-1)" "unprognostic (1.23e-3)" "unprognostic (8.51e-5)" "unprognostic (1.44e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-1)" "unprognostic (6.29e-2)" "unprognostic (5.20e-2)" "unprognostic (5.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.57e-3)" "unprognostic (9.95e-8)" "unprognostic (1.87e-1)" "unprognostic (7.21e-2)" "unprognostic (6.05e-2)" "unprognostic (1.59e-1)" 0.6 0.7 3.1 0.6 1.0 1.4 2.5 2.4 5.3 2.1 0.6 1.9 0.6 0.5 1.3 0.6 3.7 1.8 1.2 0.6 2.1 2.9 1.3 0.6 2.9 0.6 1.4 2.6 0.7 1.3 6.5 4.8 1.6 8.3 3.3 0.2 1.0 8.7 4.1 0.6 4.7 0.6 1.0 1.5 0.6 2.4 2.5 1.2 0.6 2.9 0.6 0.6 1.2 4.0 2.4 1.3 0.0 1.2 0.0 1.0 0.3 0.0 0.5 0.4 0.5 0.5 1.3 2.8 0.6 0.5 0.1 0.1 0.2 3.6 0.3 1.1 2.4 1.1 1.1 0.0 2.6 0.1 0.3 1.7 0.0 0.8 0.0 0.9 0.0 0.1 1.4 1.7 0.3 0.0 0.9 0.0 2.4 0.0 29.6 0.0 2.5 0.0 1.0 0.2 1.1 0.4 0.2 0.0 19.3 0.0 0.0 1.0 1.8 0.1 0.7 0.0 0.3 1.1 1.4 0.3 0.3 1.0 0.6 0.1 2.6 1.7 0.7 5.3 0.4 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.0 0.1 0.0 1.0 2.4 0.2 0.1 0.0 0.0 0.1 1.3 0.0 0.3 3.1 1.0 2.4 5.3 2.1 2.9 1.4 2.6 8.3 1.2 0.0 9.4 0.5 3.7 1.9 0.2 0.5 0.0 9.4 1.2 5.2 0.0 0.7 1.7 1.2 20.0 0.6 0.0 0.0 1.3 3.8 0.8 1.9 0.0 0.0 0.3 4.8 0.0 0.6 0.3 14.7 0.9 0.0 0.0 0.0 0.2 1.7 1.2 0.0 0.4 0.0 0.7 0.0 0.8 1.1 0.9 1.0 2.6 0.0 0.2 1.8 PIR ENSG00000087842 Pirin O00625 X 15384799-15493564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 74.0;Syncytiotrophoblasts: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 51.0;HUVEC TERT2: 117.2;SK-MEL-30: 44.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000697 Approved Supported Cytosol NA NA Cytosol "HPA000697: AB_1079621" "unprognostic (3.46e-3)" "prognostic favorable (2.78e-4)" "unprognostic (4.26e-2)" "unprognostic (5.62e-3)" "unprognostic (4.16e-3)" "unprognostic (2.09e-2)" "unprognostic (6.70e-3)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "prognostic favorable (4.94e-4)" "unprognostic (3.78e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (6.11e-7)" "unprognostic (1.99e-2)" "unprognostic (8.90e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" 20.9 16.1 14.1 5.9 16.8 5.7 26.5 8.5 13.5 8.1 7.5 14.0 21.8 7.7 11.2 18.8 20.7 16.2 13.4 14.0 11.7 12.1 13.9 23.7 18.6 8.6 20.8 9.8 13.0 2.6 5.4 9.1 12.1 15.6 12.1 8.3 25.0 7.5 18.0 9.8 13.7 6.9 24.6 26.0 15.5 13.8 7.2 14.4 1.3 12.1 19.9 9.1 26.5 11.7 0.0 0.5 1.0 0.5 0.0 2.2 0.3 2.3 12.9 7.8 11.4 4.6 5.2 2.5 0.7 4.5 1.9 4.3 3.6 20.3 0.0 25.7 2.0 51.0 16.5 9.0 3.6 0.7 0.0 1.9 1.4 14.6 10.5 5.9 0.7 5.2 1.4 12.5 7.2 2.5 3.3 117.2 0.0 1.0 3.3 1.6 4.9 0.5 0.6 8.3 10.4 8.2 0.0 1.5 6.4 3.8 22.9 3.0 8.3 6.2 3.5 44.1 14.0 7.3 4.4 7.3 1.0 1.9 4.9 1.4 1.5 6.4 0.0 5.0 2.6 10.2 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.3 14.1 16.8 8.5 13.5 11.7 12.1 20.8 9.8 15.6 14.4 0.0 2.6 1.9 20.5 7.7 2.5 5.1 10.2 24.1 4.5 1.8 0.0 74.0 8.3 3.8 0.4 25.9 4.0 0.0 2.2 8.6 8.9 8.4 0.0 21.3 18.4 19.1 10.9 17.2 6.4 0.2 34.8 2.9 38.8 20.8 2.4 26.6 4.6 1.4 26.9 7.7 4.5 12.9 8.6 0.5 2.4 11.0 71.6 0.9 3.3 43.0 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822475-10838445 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.3;brain: 24.8;intestine: 7.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042337 Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.4 7.3 9.9 3.2 14.0 0.3 0.3 5.6 5.2 0.4 6.3 10.8 0.0 2.9 0.4 0.4 0.8 0.9 0.7 0.3 13.1 11.6 0.3 0.3 0.4 0.3 12.5 2.3 0.4 0.3 0.3 0.1 0.3 24.8 0.4 7.5 0.0 0.4 0.4 0.4 0.4 5.2 2.5 19.9 0.3 4.9 0.5 12.8 0.0 0.3 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 14.0 5.6 5.2 13.1 11.6 12.5 2.3 24.8 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PISD "dJ858B16.2, PSDC" ENSG00000241878 "Phosphatidylserine decarboxylase" Q9UG56 22 31618491-31662432 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 177.5;Syncytiotrophoblasts: 204.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 39.6" "Low region specificity" "Detected in all" "HPA031090, HPA031091" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA031090: AB_10600114, HPA031091: AB_10600893" "unprognostic (7.96e-2)" "unprognostic (5.41e-3)" "unprognostic (2.60e-1)" "unprognostic (8.31e-2)" "unprognostic (5.61e-2)" "unprognostic (4.55e-3)" "unprognostic (2.44e-3)" "unprognostic (8.13e-3)" "unprognostic (6.37e-3)" "unprognostic (1.23e-1)" "unprognostic (1.11e-3)" "unprognostic (1.70e-2)" "unprognostic (4.18e-3)" "unprognostic (1.91e-2)" "unprognostic (4.85e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.27e-5)" 38.3 12.3 9.5 15.1 10.9 20.9 18.5 34.5 12.3 5.9 7.3 6.2 7.4 11.4 9.6 14.4 7.0 10.0 9.5 6.9 6.4 6.9 11.9 8.4 12.9 14.6 8.3 10.1 7.5 10.9 6.0 11.7 38.1 8.6 8.2 3.3 7.7 7.9 7.9 6.4 10.2 8.0 6.2 5.8 16.5 9.7 17.8 7.7 4.2 10.6 5.3 9.8 6.2 7.0 6.9 11.0 28.6 12.9 5.7 6.8 7.9 10.5 9.8 3.0 2.9 9.0 3.5 6.8 8.7 6.9 6.1 6.6 14.1 3.3 6.4 9.3 4.4 8.1 12.0 4.0 7.7 1.0 7.0 8.5 6.7 5.9 11.6 18.8 13.9 17.5 6.5 4.4 10.8 4.7 2.5 5.3 4.5 19.3 3.8 3.4 39.6 6.0 6.0 2.9 7.0 4.1 8.5 3.3 6.4 3.9 9.4 7.3 4.3 5.0 16.3 5.6 2.5 13.4 7.6 10.4 7.7 9.2 4.9 8.0 4.5 6.3 7.9 7.3 9.4 6.1 9.9 12.9 9.3 6.8 9.5 6.5 6.9 4.9 5.7 11.0 6.3 6.7 5.5 28.6 5.7 5.0 5.4 4.7 7.9 9.5 10.9 34.5 12.3 6.4 6.9 8.3 10.1 8.6 7.7 14.9 14.1 13.5 30.6 22.8 22.8 39.5 12.7 4.0 27.3 40.1 19.6 177.5 10.0 26.6 41.3 19.1 11.7 0.0 14.6 14.4 14.5 37.7 17.4 6.6 31.6 17.5 20.1 9.2 32.2 61.8 8.9 19.4 3.3 13.6 11.8 11.0 14.6 8.6 6.7 11.6 25.8 19.4 11.3 16.3 18.1 18.6 204.9 8.7 11.8 36.8 PITPNA "PITPN, VIB1A" ENSG00000174238 "Phosphatidylinositol transfer protein alpha" Q00169 17 1517718-1562816 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000528 Uncertain Approved Vesicles,Cytosol NA NA 100000 Cytosol Vesicles "HPA000528: AB_1079622" "unprognostic (1.54e-1)" "unprognostic (6.63e-2)" "unprognostic (2.43e-1)" "prognostic favorable (2.29e-4)" "unprognostic (7.88e-2)" "unprognostic (8.89e-3)" "unprognostic (2.37e-1)" "unprognostic (1.37e-1)" "unprognostic (7.33e-2)" "unprognostic (3.17e-2)" "prognostic favorable (1.80e-6)" "unprognostic (7.41e-2)" "prognostic favorable (9.35e-4)" "unprognostic (1.72e-1)" "unprognostic (1.23e-1)" "unprognostic (8.10e-2)" "unprognostic (6.81e-3)" 20.2 22.2 31.1 28.1 34.0 38.5 20.8 43.5 54.1 27.5 22.3 21.0 35.0 27.0 29.2 29.8 37.7 33.1 22.2 18.7 30.2 34.2 20.4 22.7 22.5 17.5 34.0 37.5 18.0 17.4 29.3 21.1 31.2 60.7 27.6 27.7 88.0 38.7 33.2 14.3 44.1 42.4 27.0 26.4 21.9 19.7 25.0 18.8 12.4 31.9 15.4 26.8 21.0 23.5 6.4 5.2 12.3 4.0 5.3 7.5 2.5 20.9 23.4 23.9 20.5 26.4 29.4 37.7 23.5 27.4 24.9 18.4 26.9 8.6 27.1 21.3 32.5 15.5 26.4 22.8 23.7 35.1 22.1 23.1 14.5 20.1 12.0 26.3 10.1 18.0 21.2 32.4 25.0 26.5 25.5 42.4 22.4 20.2 15.1 26.7 11.8 25.7 9.2 16.7 34.5 11.4 20.7 9.2 15.2 24.9 24.7 8.6 18.8 27.7 20.5 16.8 25.1 17.5 8.2 38.8 15.4 13.5 44.2 32.0 9.2 15.6 9.2 26.8 15.8 19.5 5.0 3.7 4.6 3.4 4.0 6.4 6.4 5.1 4.6 5.2 4.2 4.8 4.1 12.3 5.3 2.8 4.1 7.5 2.5 31.1 34.0 43.5 54.1 30.2 34.2 34.0 37.5 60.7 18.8 32.8 34.9 20.6 13.7 27.5 27.2 20.1 20.4 12.0 19.4 24.4 7.9 40.9 11.6 13.7 8.5 30.4 46.3 0.0 16.0 40.7 19.5 30.3 18.5 27.0 35.9 38.1 21.2 33.2 25.6 12.5 11.5 25.2 18.6 33.3 28.2 32.9 20.1 20.1 20.5 14.0 14.7 6.5 17.8 33.6 37.7 36.5 100.3 13.1 20.8 25.5 PITPNB VIB1B ENSG00000180957 "Phosphatidylinositol transfer protein beta" P48739 22 27851669-27920134 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000528 Uncertain Approved Vesicles,Cytosol NA NA 150000 Cytosol Vesicles "HPA000528: AB_1079622" "unprognostic (9.29e-2)" "unprognostic (1.64e-1)" "unprognostic (4.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.28e-4)" "unprognostic (1.34e-1)" "unprognostic (7.52e-3)" "unprognostic (4.78e-2)" "unprognostic (8.22e-3)" "unprognostic (1.56e-3)" "unprognostic (2.42e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (6.28e-2)" "unprognostic (2.89e-2)" "unprognostic (1.64e-1)" 32.5 22.2 29.6 24.8 29.3 14.8 25.0 20.8 38.0 23.9 37.8 16.2 24.5 17.1 32.9 23.8 42.2 21.7 28.4 31.3 24.7 24.5 20.5 43.8 23.9 24.6 25.7 29.0 24.8 22.3 21.8 26.9 38.1 27.2 26.5 24.6 15.1 20.2 31.2 16.1 23.5 21.2 49.6 22.6 20.6 28.8 14.7 21.1 19.9 20.0 15.2 30.9 45.3 43.3 24.4 17.1 20.4 14.7 17.7 27.2 16.9 30.3 13.2 24.2 18.0 21.5 26.0 18.5 29.5 25.8 32.4 31.4 20.8 14.4 21.0 15.7 28.3 24.0 32.1 34.4 29.4 45.7 35.9 32.5 21.5 21.4 19.0 23.2 48.9 34.9 23.2 28.8 39.1 40.9 21.4 31.4 14.9 30.4 44.0 29.6 16.2 20.7 24.1 18.3 31.8 17.4 26.5 38.2 30.8 26.8 28.9 28.4 35.6 20.2 24.4 23.8 27.0 13.2 17.5 30.8 32.5 47.6 24.6 30.7 18.0 21.1 41.4 27.9 24.3 27.4 20.4 12.8 12.4 22.7 14.7 25.0 24.4 22.2 23.6 17.1 20.8 21.6 21.1 11.6 17.7 13.7 15.4 27.2 16.9 29.6 29.3 20.8 38.0 24.7 24.5 25.7 29.0 27.2 21.1 26.8 29.6 43.6 108.4 85.3 23.7 52.2 28.1 24.1 59.1 29.6 13.7 34.6 31.5 42.4 12.0 54.0 15.5 0.0 43.4 43.6 48.3 61.5 19.8 43.3 24.1 30.2 24.2 31.9 19.6 5.0 29.7 32.9 25.3 69.5 22.6 16.4 50.2 17.5 45.3 23.0 13.1 25.8 124.0 41.7 35.6 71.8 40.6 38.4 19.0 101.1 PITPNC1 "RDGB-BETA, RDGBB, RDGBB1" ENSG00000154217 "Phosphatidylinositol transfer protein, cytoplasmic 1" Q9UKF7 17 67377281-67697261 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026563, HPA031250" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA026563: AB_1855409, HPA031250: AB_2673808" "unprognostic (1.33e-1)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (1.14e-3)" "unprognostic (4.17e-2)" "prognostic favorable (4.85e-5)" "unprognostic (6.57e-2)" "unprognostic (6.32e-3)" "unprognostic (1.23e-3)" "unprognostic (1.19e-1)" "unprognostic (5.70e-2)" "unprognostic (2.31e-2)" "unprognostic (1.34e-2)" "unprognostic (9.83e-2)" "unprognostic (7.88e-2)" "unprognostic (2.65e-3)" "unprognostic (1.16e-2)" 20.8 10.0 22.9 18.0 31.0 11.3 16.6 18.9 33.5 12.0 7.5 18.7 7.0 4.6 10.7 11.7 11.0 22.4 12.5 11.7 23.4 19.1 17.3 14.3 13.5 24.3 21.4 17.0 16.7 23.3 5.4 12.3 19.0 22.7 11.2 9.1 31.2 18.3 13.1 5.1 5.2 8.1 11.7 14.8 13.9 11.8 5.1 17.8 14.5 10.4 6.0 27.0 12.0 16.8 1.6 1.6 16.1 5.5 7.2 16.4 5.0 5.9 2.3 5.9 11.6 5.2 7.1 6.9 6.7 5.3 1.3 1.0 0.0 8.8 7.3 2.2 6.2 2.2 2.5 10.5 10.1 1.4 13.4 6.1 0.8 9.8 4.8 1.4 1.4 13.8 5.5 4.4 0.8 5.4 0.7 5.1 9.9 0.6 26.6 5.1 12.8 17.0 6.2 10.1 2.8 12.1 21.6 1.3 6.5 12.6 7.2 7.3 19.3 2.6 5.1 6.0 6.6 3.8 7.3 5.1 3.2 1.3 4.0 3.2 17.3 8.6 5.6 20.2 6.0 2.5 1.1 2.5 16.1 16.4 4.0 9.6 1.0 10.7 15.5 1.6 1.6 12.3 13.0 3.1 7.2 5.5 0.4 4.0 5.0 22.9 31.0 18.9 25.3 23.4 19.1 21.4 17.0 22.7 17.8 8.9 0.6 10.0 40.5 4.7 18.6 5.3 20.4 2.7 2.3 0.0 2.0 7.0 18.3 38.5 0.3 48.5 1.3 0.0 43.0 8.8 5.8 29.8 4.7 7.9 12.4 69.9 5.8 17.2 15.8 1.0 4.6 11.0 10.1 19.0 1.3 25.9 36.1 3.5 13.8 12.6 22.1 25.8 21.1 0.5 3.8 3.8 2.9 45.7 2.8 41.1 PITPNM1 "DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1" ENSG00000110697 "Phosphatidylinositol transfer protein membrane associated 1" O00562 11 67491768-67506263 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 60.9;Enterocytes: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060227 Approved Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA060227: AB_2684226" "unprognostic (1.13e-1)" "unprognostic (1.90e-1)" "unprognostic (1.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.83e-2)" "unprognostic (8.68e-2)" "unprognostic (8.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.77e-1)" "unprognostic (2.26e-2)" "unprognostic (4.61e-1)" "unprognostic (3.27e-2)" "unprognostic (2.32e-2)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (4.62e-2)" "unprognostic (5.69e-2)" 6.5 14.3 20.1 19.6 17.6 20.4 3.5 23.2 30.7 6.0 12.1 6.4 11.0 16.0 7.0 7.2 10.0 20.5 8.0 10.6 16.6 21.6 14.7 7.3 8.6 21.9 17.8 14.2 3.0 6.4 9.3 15.0 6.9 18.6 5.6 6.7 15.6 5.2 9.9 4.6 3.5 17.7 5.2 6.3 15.2 13.6 4.9 8.0 9.3 11.1 4.5 14.6 12.1 4.7 1.6 2.1 2.9 6.8 0.2 2.5 2.0 5.7 14.5 8.9 6.5 9.8 5.9 14.5 5.6 10.1 7.0 4.0 13.0 10.5 5.7 13.7 8.1 13.5 15.0 6.8 12.5 2.3 41.2 2.8 7.7 25.0 4.9 7.8 8.7 16.8 7.3 8.0 10.6 7.0 13.1 8.4 8.7 5.9 5.1 5.8 8.6 14.8 20.6 9.1 16.4 6.3 10.7 2.8 7.7 11.7 11.6 8.6 5.5 12.6 17.7 13.8 4.5 3.4 7.7 8.2 12.7 9.8 8.0 4.0 7.6 3.6 5.1 17.8 10.4 4.9 0.0 2.6 1.8 2.5 6.8 2.2 1.6 1.7 2.2 2.1 1.2 0.7 1.7 2.9 0.2 5.3 0.8 1.5 2.0 20.1 17.6 23.2 30.7 16.6 21.6 17.8 14.2 18.6 8.0 3.0 7.2 11.3 4.7 7.2 38.1 6.5 7.6 21.4 6.8 19.2 60.9 4.2 3.3 9.8 4.4 3.3 49.0 0.0 8.0 7.6 4.3 5.7 2.3 3.4 7.5 36.5 10.9 4.3 10.3 10.5 2.0 6.9 3.3 8.2 13.3 14.6 13.5 35.1 1.1 12.9 47.1 0.0 10.2 1.1 5.3 2.9 12.7 11.7 16.6 15.5 PKD2L2 TRPP5 ENSG00000078795 "Polycystin 2 like 2, transient receptor potential cation channel" Q9NZM6 5 137887968-137942747 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 7.5;testis: 29.3" "Group enriched" "Detected in many" 5 "Early spermatids: 25.9;Spermatocytes: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 5.9;U-266/70: 4.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041903, HPA043634" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA041903: AB_2677734, HPA043634: AB_2678591" "unprognostic (7.53e-3)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (3.59e-1)" "unprognostic (4.04e-1)" "unprognostic (1.21e-2)" "unprognostic (3.06e-1)" "unprognostic (1.40e-4)" "unprognostic (1.64e-2)" "unprognostic (2.13e-2)" "unprognostic (3.00e-2)" "unprognostic (5.85e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" 0.5 1.5 2.0 0.6 2.5 2.2 1.2 1.7 1.9 0.5 0.3 0.7 0.7 0.3 0.5 1.0 0.5 0.4 0.6 1.7 1.0 0.8 0.4 0.3 0.4 1.3 1.2 1.3 0.6 1.1 0.0 1.5 0.2 1.8 0.5 0.1 0.2 0.7 0.0 3.3 0.8 0.3 0.0 0.7 1.0 0.6 29.3 0.4 0.0 1.0 0.0 0.2 0.4 0.6 3.9 3.5 7.5 1.7 1.9 1.9 0.8 1.6 1.2 0.2 0.1 0.4 0.5 1.8 0.6 0.0 0.0 0.0 0.1 3.2 2.3 3.5 0.0 0.1 0.7 0.1 0.0 0.1 1.5 1.1 1.3 4.2 0.1 0.0 0.4 1.8 0.1 0.2 0.0 0.0 0.7 0.6 3.3 1.5 5.9 0.8 0.5 1.1 2.4 0.6 0.1 1.0 0.0 0.1 0.0 0.0 2.3 0.8 0.9 1.5 0.2 0.9 0.7 0.4 0.5 0.5 1.0 1.8 0.7 1.0 4.6 3.4 0.4 2.3 0.7 1.8 7.1 1.7 3.0 1.8 1.2 1.0 2.5 1.6 1.4 0.9 3.9 1.9 1.7 7.5 1.9 1.0 3.5 1.1 0.8 2.0 2.5 1.7 1.9 1.0 0.8 1.2 1.3 1.8 0.4 3.0 2.1 0.5 1.6 1.9 2.3 1.5 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.1 25.9 0.8 0.0 0.0 0.0 0.1 1.3 1.3 1.1 0.2 0.2 3.2 0.0 1.3 0.6 4.7 0.6 0.2 3.3 0.0 0.0 0.9 0.1 0.0 0.4 0.2 3.9 0.0 1.2 19.5 2.2 1.0 0.1 0.7 0.0 0.5 PKIG ENSG00000168734 "CAMP-dependent protein kinase inhibitor gamma" Q9Y2B9 20 44531785-44624247 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 177.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "memory B-cell: 58.2;naive B-cell: 62.1" "Lineage enriched" "Detected in many" 10 "B-cells: 62.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 104.3;HSkMC: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042703, HPA063690" Uncertain Supported Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA042703: AB_10797018, HPA063690: AB_2685091" "unprognostic (3.15e-2)" "unprognostic (5.65e-2)" "unprognostic (8.07e-2)" "unprognostic (1.44e-3)" "unprognostic (3.16e-1)" "unprognostic (9.49e-2)" "unprognostic (3.96e-2)" "unprognostic (6.46e-3)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "prognostic favorable (4.90e-5)" "unprognostic (6.26e-2)" "unprognostic (9.08e-2)" "unprognostic (1.19e-2)" "unprognostic (1.35e-2)" "unprognostic (4.22e-1)" "unprognostic (3.96e-2)" 21.1 25.1 39.2 22.7 31.9 7.5 18.4 12.9 37.7 28.0 44.0 13.5 15.4 12.5 31.8 19.3 31.7 31.4 29.3 107.1 23.0 17.2 22.9 14.4 39.0 17.9 16.7 25.9 17.2 13.3 13.8 19.5 32.6 14.3 30.2 13.3 26.2 18.8 32.5 25.6 8.0 17.9 52.8 11.9 13.2 24.1 41.5 11.4 3.2 25.8 18.6 18.2 42.2 20.3 62.1 6.2 0.4 0.3 0.7 1.6 3.1 5.3 5.4 8.8 5.8 13.4 27.4 1.3 12.8 104.3 14.5 11.0 12.4 2.4 20.5 10.5 11.2 12.1 2.0 1.7 2.8 4.7 10.4 3.2 3.2 0.8 8.8 12.4 0.4 0.2 42.3 5.7 7.0 1.6 7.3 32.3 5.7 2.5 0.5 1.3 6.7 3.2 5.2 4.7 0.0 7.8 0.5 0.2 0.5 8.0 1.1 3.6 11.8 3.3 1.5 8.6 4.0 4.1 2.6 20.9 19.9 8.9 8.8 6.1 2.8 7.7 14.4 9.9 0.3 8.5 0.4 0.3 0.1 0.2 0.2 0.2 58.2 0.3 0.3 1.5 62.1 1.0 1.6 0.4 0.7 0.2 6.2 0.1 3.1 39.2 31.9 12.9 37.7 23.0 17.2 16.7 25.9 14.3 11.4 8.9 6.7 86.2 15.6 22.3 17.8 177.7 22.9 76.3 13.6 43.6 19.6 11.6 107.8 61.0 80.2 91.6 30.7 0.0 27.2 12.5 63.7 12.6 46.2 28.4 7.2 9.5 42.4 39.3 3.1 23.1 67.6 9.1 47.2 11.8 13.1 46.7 31.9 44.8 57.7 115.7 24.6 116.4 170.2 111.2 27.2 26.2 30.7 5.2 21.3 9.2 PKLR ENSG00000143627 "Pyruvate kinase L/R" P30613 1 155289293-155301434 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.2;kidney: 12.4;liver: 47.8" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 8.3;Hepatocytes: 15.1;Late spermatids: 16.6;Proximal tubular cells: 43.2" "Cancer enriched" "Detected in some" 9 "liver cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "K-562: 48.5" "Region enhanced" "Detected in single" "basal ganglia: 1.7" "Not detected" "Not detected" "HPA006653, CAB034376, CAB034378" Enhanced Approved "Golgi apparatus,Cytosol" No NA 2900000 "Golgi apparatus, Cytosol" "CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632" "unprognostic (9.16e-2)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (5.98e-2)" "unprognostic (2.62e-1)" "unprognostic (7.86e-4)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (8.79e-2)" "unprognostic (1.89e-1)" "unprognostic (4.07e-1)" "unprognostic (4.53e-2)" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (6.21e-3)" 0.1 0.0 0.1 0.3 0.1 7.2 0.1 0.9 0.2 0.1 4.9 0.1 0.1 5.8 0.1 1.3 0.1 0.0 0.7 0.1 0.1 0.4 12.4 47.8 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 17.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 8.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.2 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 PKM "OIP3, PK3, PKM2, THBP1" ENSG00000067225 "Pyruvate kinase M1/2" P14618 15 72199029-72231822 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Translation regulation" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 541.2" "Cell type enhanced" "Detected in all" 5 "monocytes: 1878.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019421, HPA029501" Uncertain Enhanced Cytosol No No 540000000 Cytosol "CAB019421: AB_2252325, HPA029501: AB_10602118" "unprognostic (8.73e-3)" "unprognostic (4.63e-3)" "unprognostic (1.68e-2)" "unprognostic (3.09e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (1.30e-4)" "prognostic unfavorable (2.74e-6)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.51e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (5.17e-5)" "unprognostic (3.16e-1)" "unprognostic (3.22e-1)" "unprognostic (7.85e-2)" "unprognostic (3.17e-2)" "unprognostic (1.44e-1)" "unprognostic (1.25e-2)" 23.2 76.8 53.8 49.8 70.4 57.5 41.6 56.6 85.9 65.7 31.2 32.1 31.5 26.4 24.7 41.8 76.4 37.9 32.9 94.8 50.1 57.1 60.9 6.1 33.3 39.4 62.5 63.6 26.2 15.6 33.3 28.3 27.1 80.5 34.8 31.9 54.4 47.1 47.5 541.2 51.8 25.1 44.7 34.9 30.7 26.7 29.0 29.4 23.5 23.8 114.4 60.6 53.1 40.9 25.1 79.6 14.9 90.6 11.6 37.4 114.9 81.9 210.9 42.5 50.3 51.2 57.5 35.1 88.9 207.7 142.9 144.6 59.3 101.0 62.4 90.0 166.4 106.4 119.5 134.4 181.0 112.0 109.5 63.5 38.2 106.1 49.1 35.6 49.5 82.5 52.2 84.3 110.0 45.2 185.5 84.1 32.1 9.5 50.1 225.2 50.9 18.5 21.3 52.6 125.8 80.5 55.0 136.1 118.9 189.6 105.5 44.2 48.3 116.0 71.6 90.9 74.7 50.2 36.1 65.4 162.8 89.0 159.0 161.3 64.4 90.9 55.0 200.4 82.0 159.4 12.6 90.6 14.9 23.5 52.6 22.8 25.1 31.3 23.2 79.6 16.1 27.3 20.2 11.8 11.6 40.2 16.2 37.4 114.9 53.8 70.4 56.6 85.9 50.1 57.1 62.5 63.6 80.5 29.4 110.2 78.1 134.8 464.1 502.3 450.3 279.7 94.3 129.8 157.0 786.9 347.5 523.8 679.8 1147.1 307.8 224.6 361.4 70.0 528.2 1096.0 273.6 329.6 203.1 2.0 698.2 1005.9 270.8 71.2 307.3 1333.1 145.6 439.7 337.4 1878.3 130.3 624.4 887.7 231.5 252.1 165.5 510.0 122.9 245.6 32.6 84.3 340.0 481.5 163.0 247.6 730.1 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 35.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 35.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 21.9 20.7 12.2 21.2 13.7 33.5 27.6 25.6 16.6 28.6 39.3 12.6 15.1 22.9 20.0 20.2 28.2 17.1 13.3 16.2 10.3 8.9 15.9 15.9 26.0 16.4 13.7 8.7 27.2 18.9 24.6 29.7 20.8 13.3 19.6 23.6 14.1 19.5 25.1 15.9 17.5 49.0 17.5 12.5 18.0 15.9 12.4 16.2 29.1 20.3 14.4 13.1 21.9 22.0 4.0 3.7 35.7 4.5 1.4 3.0 1.0 23.7 9.3 18.5 11.1 12.4 14.1 12.0 14.1 13.0 15.8 16.5 9.9 17.1 9.4 16.8 13.4 19.5 18.8 18.0 10.7 21.7 3.3 13.1 6.9 19.4 8.4 10.9 6.8 2.1 11.6 11.1 12.4 15.0 12.6 18.0 7.5 11.5 6.9 17.0 4.8 7.8 5.9 9.3 9.0 10.9 7.5 28.2 3.8 14.0 46.8 9.0 5.9 21.1 12.2 18.1 14.6 9.1 6.2 16.8 13.5 12.1 17.2 14.7 3.8 3.2 6.4 5.6 6.7 5.0 4.9 4.5 6.8 2.6 2.5 2.3 3.3 2.3 2.4 2.1 4.0 3.0 2.6 35.7 1.4 3.2 3.7 1.8 1.0 12.2 13.7 25.6 16.6 10.3 8.9 13.7 8.7 13.3 16.2 38.7 52.6 24.5 42.6 42.9 83.6 41.1 40.8 45.5 39.8 66.3 84.4 37.5 10.0 51.4 2.1 51.2 79.8 70.0 52.5 29.4 35.1 52.3 15.1 32.6 20.4 62.0 42.5 51.0 34.3 2.9 50.3 29.0 30.4 41.5 55.9 64.3 62.0 87.7 45.3 22.4 151.6 38.8 29.8 35.8 18.8 45.8 31.2 21.0 50.9 118.4 PLA2G4A "cPLA2-alpha, PLA2G4" ENSG00000116711 "Phospholipase A2 group IVA" P47712 1 186828953-186988981 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 19.1;Peritubular cells: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4" "Cell line enhanced" "Detected in many" "HeLa: 23.0;OE19: 33.2;RPMI-8226: 28.5;U-2197: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010050, HPA050062, HPA054206" Approved Supported Vesicles,Cytosol NA NA 78000 Cytosol Vesicles "CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417" "prognostic favorable (9.07e-4)" "unprognostic (1.18e-1)" "unprognostic (2.03e-1)" "prognostic favorable (2.85e-4)" "unprognostic (5.55e-2)" "unprognostic (1.51e-3)" "unprognostic (2.67e-2)" "unprognostic (2.43e-1)" "unprognostic (2.63e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-1)" "unprognostic (1.68e-1)" "unprognostic (2.96e-2)" "unprognostic (8.07e-2)" "unprognostic (1.58e-1)" "unprognostic (1.90e-2)" "unprognostic (4.26e-2)" 6.0 8.6 3.4 3.5 5.3 2.2 3.8 1.5 4.7 8.5 10.9 2.9 52.6 5.4 7.7 7.4 7.0 12.3 4.2 6.6 3.3 2.5 6.7 1.1 4.9 5.2 6.5 1.4 5.1 3.8 63.5 2.7 2.9 5.6 10.9 4.2 2.9 5.8 56.1 0.6 6.1 10.3 14.6 7.5 4.2 5.1 2.7 5.3 0.4 2.7 5.9 2.3 19.4 9.4 0.0 7.8 7.7 8.4 1.1 0.2 1.5 0.0 15.8 0.0 0.0 9.9 4.0 0.0 0.6 6.1 0.7 1.3 0.1 6.2 0.0 0.0 0.0 2.8 1.1 9.9 2.9 0.3 4.8 0.2 2.9 23.0 0.0 6.1 4.3 1.5 2.2 2.0 7.9 1.6 1.0 6.6 1.3 6.4 2.3 0.0 0.0 0.0 0.0 0.8 33.2 2.1 0.0 0.0 28.5 0.0 2.1 0.0 0.0 2.3 0.8 2.8 0.3 0.3 5.8 1.3 5.9 0.8 27.0 1.2 0.9 0.0 0.0 2.1 12.8 8.3 0.1 7.1 7.7 0.0 8.4 0.2 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.6 1.1 3.9 3.2 0.0 1.5 3.4 5.3 1.5 4.7 3.3 2.5 6.5 1.4 5.6 5.3 0.0 0.6 0.0 2.8 19.1 0.0 0.8 0.0 1.4 1.2 0.0 0.0 0.1 1.7 1.6 0.7 6.0 1.3 0.0 0.0 0.0 4.3 1.7 10.4 0.0 5.5 0.0 1.2 1.3 8.8 0.6 9.8 6.0 5.0 1.0 1.7 0.0 1.1 2.8 13.8 0.1 0.2 0.0 3.4 0.5 0.1 7.9 0.0 0.0 2.9 10.5 PLA2G4C cPLA2-gamma ENSG00000105499 "Phospholipase A2 group IVC" Q9UP65 19 48047843-48110817 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Lipid metabolism, Phospholipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;skeletal muscle: 45.0" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 54.2;Cone photoreceptor cells: 62.8;Muller glia cells: 53.7;Rod photoreceptor cells: 133.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 8.2;HHSteC: 13.4;TIME: 18.6" "Not detected" "Not detected" HPA043083 Approved Approved Cytosol NA NA Cytosol "HPA043083: AB_10795714" "unprognostic (1.27e-1)" "unprognostic (3.88e-2)" "unprognostic (4.18e-2)" "unprognostic (2.82e-2)" "unprognostic (7.37e-2)" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (6.53e-2)" "unprognostic (8.30e-2)" "unprognostic (1.94e-1)" "unprognostic (5.11e-3)" "unprognostic (1.90e-1)" "unprognostic (4.66e-2)" "unprognostic (9.45e-2)" "unprognostic (2.28e-3)" "unprognostic (1.87e-1)" "unprognostic (9.01e-2)" 4.0 11.7 8.9 4.2 23.2 0.4 3.0 12.9 14.5 3.4 3.5 23.4 2.0 5.1 6.8 5.2 3.6 4.3 4.6 18.5 10.0 10.0 4.4 3.8 5.9 7.2 31.8 8.5 2.0 4.1 14.8 4.6 4.1 16.9 5.7 2.9 5.4 3.1 6.7 45.0 4.9 6.7 8.1 18.6 8.1 2.4 2.4 17.1 0.7 3.3 7.5 4.3 4.9 2.1 5.4 2.0 0.0 7.9 1.5 0.8 2.0 0.7 1.1 0.0 0.3 5.2 3.0 0.1 1.3 8.2 1.2 3.5 0.0 2.1 0.0 1.8 3.2 2.6 0.2 0.0 0.2 2.0 0.8 0.1 0.0 0.3 1.2 13.4 0.0 1.8 0.6 0.3 0.5 5.4 2.5 5.1 0.0 0.0 7.4 2.0 2.0 0.0 0.1 0.1 0.9 0.1 0.1 1.8 0.7 2.5 0.4 0.8 0.1 1.5 2.6 6.3 4.2 0.7 1.8 18.6 2.3 0.7 2.5 0.9 0.5 1.4 0.2 1.6 0.0 4.4 0.0 3.2 0.0 0.2 7.9 0.6 5.4 0.8 0.0 2.0 1.6 0.0 0.0 0.0 1.5 2.0 1.4 0.2 2.0 8.9 23.2 12.9 14.5 10.0 10.0 31.8 8.5 16.9 17.1 3.0 1.7 0.5 0.8 2.5 54.2 30.9 10.2 0.0 0.0 0.0 62.8 0.1 1.7 7.7 0.2 16.9 1.6 0.0 2.5 0.2 3.8 1.7 0.0 1.0 5.0 31.8 0.0 3.1 0.3 0.0 0.6 2.8 6.8 4.6 1.5 53.7 4.1 0.3 7.4 3.4 133.4 12.9 11.8 0.3 0.5 2.6 0.1 0.0 0.0 0.1 PLA2G6 "iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9" ENSG00000184381 "Phospholipase A2 group VI" O60733 22 38111495-38205690 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Lipid metabolism, Phospholipid metabolism" "Calmodulin-binding, Hydrolase" "Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 31.8;HMC-1: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001171 Approved Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA001171: AB_1079145" "unprognostic (5.26e-2)" "prognostic favorable (7.29e-4)" "unprognostic (8.74e-2)" "unprognostic (6.27e-2)" "unprognostic (3.83e-1)" "unprognostic (3.70e-3)" "unprognostic (8.67e-3)" "unprognostic (9.55e-2)" "unprognostic (3.48e-1)" "unprognostic (1.91e-1)" "unprognostic (2.37e-3)" "unprognostic (4.95e-2)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (3.00e-1)" "unprognostic (1.48e-1)" "prognostic favorable (1.55e-4)" 16.2 17.7 15.6 8.5 20.5 13.1 15.6 15.9 26.3 14.8 7.9 36.9 18.5 9.8 16.3 20.5 8.7 21.6 25.3 6.3 19.7 7.2 18.1 8.6 9.0 12.4 19.3 16.7 21.3 12.8 24.2 12.7 6.8 19.5 17.6 6.3 12.9 20.2 17.4 7.4 18.1 8.7 7.8 14.9 12.1 9.5 30.0 23.2 16.3 45.7 4.1 11.3 12.1 11.2 1.8 5.4 4.1 0.9 8.8 5.7 1.9 0.7 2.8 3.0 7.8 10.1 5.0 8.2 0.9 1.0 0.8 1.1 3.1 1.8 5.9 6.6 2.3 1.3 3.6 3.5 1.9 1.0 9.0 13.2 31.8 3.9 3.6 2.8 3.5 20.3 16.3 4.3 2.8 4.5 8.2 1.0 13.0 5.2 10.7 1.5 4.6 6.6 2.1 2.6 2.1 1.8 4.9 1.2 4.5 2.9 7.0 5.8 2.4 1.3 3.1 7.2 4.5 3.3 2.5 1.3 2.6 4.5 1.1 0.6 17.6 3.1 3.1 3.7 4.1 1.6 4.1 0.9 0.4 3.8 0.3 1.9 1.8 3.1 5.7 1.5 1.5 1.4 3.9 3.3 8.8 0.6 5.4 3.7 1.9 15.6 20.5 15.9 26.3 19.7 7.2 19.3 16.7 19.5 23.2 3.0 2.4 4.4 3.6 2.7 9.4 1.5 2.5 5.3 5.7 12.2 3.9 2.5 0.0 1.4 16.1 1.9 11.0 0.0 0.9 2.4 2.1 4.2 0.0 3.4 1.4 14.3 10.9 3.7 1.5 13.7 5.5 1.0 1.7 3.6 6.9 4.5 1.4 11.5 3.5 0.8 7.0 6.5 1.7 23.8 7.5 3.0 4.1 6.9 6.9 1.3 PLA2R1 "CLEC13C, PLA2-R, PLA2G1R, PLA2IR" ENSG00000153246 "Phospholipase A2 receptor 1" Q13018 2 159932006-160062610 "Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 46.1" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 31.4;Muller glia cells: 30.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 19.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 9.2;ASC TERT1: 12.5;BJ hTERT+: 9.9;hTERT-RPE1: 16.5;TIME: 28.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB068217, CAB068218" Approved Approved Cytosol "Secreted to blood" NA NA 99000 Cytosol "CAB068217: AB_2665660, CAB068218: AB_2665661" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (4.91e-3)" "unprognostic (6.01e-2)" "unprognostic (9.71e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.38e-3)" "unprognostic (4.30e-3)" "unprognostic (2.82e-1)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (2.62e-1)" "unprognostic (6.58e-2)" "unprognostic (2.02e-1)" 4.6 2.1 0.6 2.3 1.1 0.0 9.4 19.5 1.9 11.3 7.0 1.0 2.4 2.4 17.8 4.7 4.7 4.8 6.9 2.7 0.7 1.0 15.0 0.9 2.3 1.8 0.8 0.7 8.7 0.8 14.5 2.6 6.6 3.3 3.3 2.0 7.8 46.1 2.0 0.8 9.6 9.4 5.7 2.5 3.0 1.6 1.3 0.2 0.3 27.6 6.6 5.1 4.5 9.4 0.6 0.6 2.3 0.8 1.0 0.6 0.2 0.1 1.0 0.3 0.0 9.2 12.5 0.0 4.1 9.9 0.8 1.1 0.0 2.1 0.0 0.2 4.3 0.9 2.0 0.0 3.0 0.8 0.0 0.0 0.0 6.9 0.0 0.7 0.0 0.0 5.0 3.3 1.2 1.3 16.5 5.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 7.2 1.3 0.0 1.1 1.6 0.1 28.7 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.5 0.5 0.5 0.6 0.5 0.4 0.3 0.3 0.6 0.6 0.6 2.3 1.0 0.8 0.6 0.4 0.2 0.6 1.1 19.5 1.9 0.7 1.0 0.8 0.7 3.3 0.2 6.0 3.2 0.0 2.2 8.4 0.8 3.6 5.1 6.7 2.3 31.4 0.0 4.3 0.0 0.7 0.0 3.6 2.6 0.0 1.8 1.1 6.7 2.3 1.1 0.0 0.5 15.9 1.2 8.0 0.0 0.9 15.0 0.0 6.8 0.0 6.1 30.3 3.2 5.8 15.6 1.1 1.1 6.5 2.2 0.0 0.6 4.6 1.3 0.0 6.5 2.2 PLAA "DOA1, FLJ11281, FLJ12699, PLA2P, PLAP" ENSG00000137055 "Phospholipase A2 activating protein" Q9Y263 9 26904083-26947463 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005035, HPA020994, HPA020996" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 5300 "Plasma membrane, Cytosol" Nucleoplasm "CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (4.00e-3)" "unprognostic (5.00e-1)" "unprognostic (1.61e-1)" "unprognostic (4.06e-2)" "unprognostic (4.50e-3)" "unprognostic (2.48e-1)" "unprognostic (5.54e-2)" "prognostic favorable (7.87e-4)" "unprognostic (3.24e-2)" "unprognostic (1.44e-1)" "unprognostic (9.29e-3)" "unprognostic (1.86e-2)" "unprognostic (6.68e-2)" "unprognostic (1.39e-2)" "unprognostic (5.10e-1)" 13.6 20.1 9.4 12.4 13.1 29.6 11.9 12.9 18.0 13.4 12.3 11.1 13.5 10.5 15.6 12.8 16.2 10.8 13.6 26.2 10.1 10.2 15.0 19.6 14.4 16.4 9.6 10.9 12.3 12.9 15.0 10.0 17.4 13.4 12.1 13.1 9.5 13.4 11.6 52.6 13.5 12.3 16.1 10.0 16.1 12.0 15.7 7.9 27.0 13.0 18.2 14.6 14.9 12.7 13.2 12.2 19.2 17.9 13.5 16.5 8.6 27.8 16.5 20.9 21.1 14.2 18.1 15.8 26.2 15.0 20.1 19.7 5.8 13.4 25.2 21.9 20.0 14.0 11.2 20.7 20.7 22.2 33.1 8.7 15.6 27.2 11.1 14.5 12.5 21.4 16.1 12.5 24.5 17.9 15.2 20.0 18.9 9.5 25.6 21.6 11.6 24.2 12.2 30.3 14.4 14.4 17.3 13.1 14.9 15.6 16.7 13.4 23.0 14.0 16.6 8.2 21.4 11.5 9.7 24.2 0.0 24.9 13.0 21.2 8.4 18.3 26.2 14.2 17.9 10.4 19.2 11.9 18.7 11.2 16.8 12.5 13.2 11.6 11.3 12.2 11.5 10.7 12.2 11.2 13.5 17.9 6.3 16.5 8.6 9.4 13.1 12.9 18.0 10.1 10.2 9.6 10.9 13.4 7.9 14.9 9.1 11.2 9.4 9.7 8.3 21.0 2.5 12.0 13.6 8.7 0.0 21.0 8.3 14.9 21.7 15.3 9.5 0.0 14.0 21.7 10.4 9.6 40.3 9.0 18.5 4.8 9.2 12.9 13.3 3.6 8.1 9.9 1.7 10.8 7.3 8.5 12.8 8.7 7.8 7.9 6.1 19.4 17.8 24.7 22.0 8.3 41.2 13.8 11.4 10.2 PLAC8 "C15, onzin" ENSG00000145287 "Placenta specific 8" Q9NZF1 4 83090048-83137075 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 181.6;intestine: 66.5;lymphoid tissue: 74.8" "Cell type enhanced" "Detected in many" 8 "B-cells: 305.1;Ciliated cells: 487.2;Enterocytes: 398.3;Extravillous trophoblasts: 527.8;Kupffer cells: 319.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 181.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 32.2;CAPAN-2: 93.1;HL-60: 57.7;NB-4: 28.4;RPMI-8226: 41.6;THP-1: 33.5;U-937: 26.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040465, HPA077912" Enhanced Approved Cytosol NA NA Cytosol "HPA040465: AB_10794875, HPA077912: AB_2686870" "unprognostic (6.82e-5)" "prognostic favorable (3.03e-4)" "unprognostic (3.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.05e-1)" "unprognostic (4.86e-2)" "unprognostic (1.14e-1)" "unprognostic (1.94e-3)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (7.44e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-7)" "unprognostic (3.89e-2)" "unprognostic (2.85e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" 2.3 1.3 1.7 47.9 5.9 62.0 1.6 0.7 4.1 6.1 44.1 0.6 0.2 14.6 1.0 0.9 34.5 3.1 7.5 2.4 1.4 1.9 1.6 12.4 23.4 51.6 2.5 0.2 1.9 1.2 0.0 1.3 32.3 3.0 2.0 31.4 1.3 9.7 1.0 0.8 0.7 66.5 3.1 5.2 74.8 21.8 0.7 2.7 18.2 1.5 1.4 53.1 3.4 2.5 41.5 181.6 7.0 47.8 77.6 32.9 36.0 32.2 0.2 0.1 0.2 0.0 0.0 5.3 0.8 0.2 2.0 2.5 0.6 93.1 5.4 0.2 9.4 3.2 3.4 0.5 0.2 7.7 0.0 0.1 0.1 6.4 2.7 0.3 57.7 0.3 0.1 0.6 0.3 0.4 0.0 0.1 2.8 0.0 0.4 5.3 0.1 10.9 28.4 0.2 2.5 0.1 1.4 1.9 41.6 0.1 0.9 4.7 0.0 0.2 5.4 0.1 1.7 0.3 33.5 0.2 0.2 6.0 0.1 0.1 0.3 0.0 14.4 0.4 26.6 0.0 2.7 11.0 7.0 32.9 47.8 24.9 41.5 15.7 18.7 10.0 38.4 19.4 22.0 2.4 77.6 25.8 181.6 1.0 36.0 1.7 5.9 0.7 4.1 1.4 1.9 2.5 0.2 3.0 2.7 181.7 50.7 305.1 1.9 0.3 0.0 0.4 2.5 487.2 61.4 0.0 0.0 7.9 0.0 0.0 0.2 1.4 398.3 0.0 3.3 527.8 0.9 0.9 25.5 1.5 20.9 1.6 83.1 171.9 319.5 0.4 0.0 79.4 6.8 1.0 179.6 1.3 57.7 270.0 0.0 0.8 0.1 6.5 0.3 0.2 0.1 0.1 11.9 261.7 36.3 8.4 PLAG1 ZNF912 ENSG00000181690 "PLAG1 zinc finger" Q6DJT9 8 56160904-56211324 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 24.0;Horizontal cells: 30.2;Rod photoreceptor cells: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 13.1;ASC TERT1: 17.5;HSkMC: 12.3;hTERT-HME1: 12.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA072290 Supported "Nucleoplasm,Nuclear speckles,Centrosome,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" "Centrosome, Cytosol" "HPA072290: AB_2686508" "unprognostic (1.89e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-3)" "unprognostic (1.63e-4)" "unprognostic (6.81e-2)" "unprognostic (1.07e-1)" "unprognostic (5.63e-3)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (7.99e-2)" "unprognostic (3.42e-2)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (2.83e-2)" "unprognostic (3.94e-1)" "unprognostic (1.21e-2)" "unprognostic (6.14e-2)" 1.9 3.6 2.4 3.5 2.9 2.1 2.5 11.0 2.7 7.6 3.8 4.1 9.0 3.4 3.4 9.8 2.0 7.5 2.1 6.8 1.9 1.8 3.7 1.2 4.6 6.7 4.8 2.1 11.6 2.2 2.1 17.8 8.0 4.6 5.1 1.6 7.9 7.5 9.2 1.4 3.4 5.5 2.5 6.3 6.2 3.0 5.2 4.5 11.7 3.5 1.5 5.2 4.8 7.0 3.5 0.2 1.1 0.5 0.7 4.6 1.0 1.5 0.0 9.6 0.1 13.1 17.5 3.0 4.3 5.5 2.0 0.9 0.6 5.0 0.2 4.2 2.3 0.5 0.3 2.7 5.7 2.1 0.1 5.9 6.1 0.5 1.4 2.8 2.0 1.9 12.3 3.2 1.1 12.8 5.6 3.8 4.3 2.6 0.1 4.2 0.0 0.5 3.6 2.8 0.4 1.4 4.7 0.7 3.7 2.6 0.5 0.1 0.0 0.1 0.0 0.3 6.8 0.1 1.9 5.7 3.0 3.8 4.8 1.0 1.5 1.1 2.3 3.4 0.7 0.8 1.1 0.1 1.1 0.3 0.1 0.2 3.5 1.0 0.6 0.1 2.0 4.6 4.3 1.0 0.7 0.5 0.2 0.2 1.0 2.4 2.9 11.0 2.7 1.9 1.8 4.8 2.1 4.6 4.5 6.0 2.7 6.2 2.3 0.9 24.0 9.4 2.5 1.4 2.3 5.2 23.6 6.8 0.0 0.6 4.6 3.3 2.1 0.0 1.2 3.6 3.7 2.8 1.1 0.5 4.5 30.2 5.2 19.6 1.3 4.5 14.1 1.9 15.1 0.0 3.0 18.4 1.2 0.9 9.6 0.5 28.0 0.0 0.7 4.3 6.8 0.6 5.9 1.0 1.6 5.3 PLAGL2 ZNF900 ENSG00000126003 "PLAG1 like zinc finger 2" Q9UPG8 20 32192503-32207791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 46.8;Late spermatids: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "intermediate monocyte: 11.7;non-classical monocyte: 20.7" "Lineage enriched" "Detected in many" 14 "monocytes: 20.7" "Cell line enhanced" "Detected in all" "CACO-2: 34.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005900 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005900: AB_1079629" "unprognostic (9.40e-2)" "unprognostic (1.67e-1)" "unprognostic (6.95e-3)" "unprognostic (1.09e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.11e-3)" "unprognostic (8.63e-2)" "unprognostic (8.97e-2)" "unprognostic (2.99e-1)" "unprognostic (1.29e-2)" "unprognostic (2.26e-1)" "unprognostic (3.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (7.90e-2)" "unprognostic (1.09e-1)" 5.9 5.1 6.1 9.0 7.8 30.2 5.8 10.5 7.7 6.9 10.6 6.8 5.6 11.5 9.6 6.6 17.9 10.9 5.8 5.6 6.2 4.0 7.0 6.1 9.3 9.0 5.8 4.9 11.7 11.6 8.5 12.9 5.4 7.2 7.6 9.2 9.8 10.2 6.7 10.1 10.4 24.8 8.3 4.2 10.4 10.1 33.2 7.4 16.4 7.9 13.7 12.9 6.8 11.4 0.9 1.4 1.4 20.7 0.3 1.0 1.2 7.9 4.6 12.2 4.4 4.6 3.5 7.7 3.1 5.0 6.9 6.3 34.2 4.0 8.2 4.4 3.2 9.7 7.9 15.2 7.3 9.2 4.9 6.8 33.2 3.7 16.4 5.6 14.5 7.4 4.3 6.5 5.5 3.9 3.2 4.9 8.8 11.6 7.5 3.6 4.5 15.9 10.0 5.7 6.1 5.3 10.3 15.8 5.2 2.9 6.1 5.6 6.1 7.8 4.2 6.9 7.4 6.3 17.8 3.7 8.4 9.0 6.0 6.4 20.5 11.3 10.6 4.9 30.7 5.1 1.4 2.1 0.5 0.5 11.7 1.0 0.9 0.6 1.0 1.4 0.6 0.8 0.4 0.6 0.3 20.7 0.3 0.5 1.2 6.1 7.8 10.5 7.7 6.2 4.0 5.8 4.9 7.2 7.4 11.9 19.7 6.6 11.4 6.6 6.9 2.9 2.5 4.0 14.8 1.8 29.5 2.9 3.3 3.2 46.8 3.8 13.1 0.0 4.5 2.6 4.0 10.4 2.3 2.4 5.0 3.2 10.3 4.9 5.1 113.2 2.3 6.6 0.0 1.0 10.4 6.6 5.6 8.6 6.7 2.6 20.2 6.5 2.5 9.4 9.2 10.2 3.4 4.4 13.9 20.2 PLCB2 FLJ38135 ENSG00000137841 "Phospholipase C beta 2" Q00722 15 40278176-40307935 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 30.5;lymphoid tissue: 36.3" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 25.1;granulocytes: 25.5;Hofbauer cells: 26.0;Kupffer cells: 49.0;Macrophages: 28.1;T-cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 31.5;HMC-1: 39.3;THP-1: 11.4;U-937: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009443, HPA041298, HPA068595, HPA069308" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: " "unprognostic (5.52e-2)" "unprognostic (4.96e-3)" "unprognostic (6.09e-3)" "unprognostic (1.88e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.00e-4)" "unprognostic (1.66e-1)" "unprognostic (3.08e-2)" "unprognostic (1.28e-1)" "unprognostic (2.34e-1)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.20e-5)" "unprognostic (9.89e-2)" "unprognostic (2.06e-3)" "unprognostic (5.81e-2)" "unprognostic (1.13e-1)" 6.3 3.6 8.1 17.6 11.6 30.5 2.9 1.1 7.5 2.9 3.3 16.2 1.7 4.0 2.8 3.2 2.4 4.6 6.5 3.3 6.9 5.1 3.3 4.2 12.5 17.2 12.7 2.4 1.6 2.0 1.3 2.9 4.6 9.3 3.2 5.5 4.1 5.2 2.9 1.3 1.5 10.2 4.8 17.9 36.3 3.6 1.4 10.9 12.2 2.8 1.8 17.6 6.9 2.5 1.0 4.5 8.5 4.3 1.8 3.1 2.0 0.1 0.0 0.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 7.8 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 6.7 39.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.3 1.7 0.0 0.0 1.8 3.6 0.4 0.0 0.1 5.5 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.3 0.0 11.4 4.1 0.0 3.8 0.0 0.0 0.0 0.0 1.5 0.0 21.6 0.0 2.7 4.2 8.5 3.1 4.3 2.0 0.7 1.6 1.6 4.5 1.0 1.6 1.8 6.9 1.8 4.2 1.6 2.9 2.0 8.1 11.6 1.1 7.5 6.9 5.1 12.7 2.4 9.3 10.9 6.0 25.1 3.4 0.1 0.8 0.0 2.8 2.5 6.7 5.7 1.8 0.0 0.4 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.4 1.0 0.0 25.5 0.2 26.0 0.0 0.0 1.8 49.0 0.4 0.3 28.1 3.3 0.0 0.8 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.3 0.2 2.1 0.5 0.3 15.9 1.2 0.0 PLCD4 ENSG00000115556 "Phospholipase C delta 4" Q9BRC7 2 218607765-218637184 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1" "Group enriched" "Detected in some" 8 "Bipolar cells: 81.4;Cone photoreceptor cells: 231.7;Rod photoreceptor cells: 181.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009914, HPA038139, HPA038140" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA Cytosol "Endoplasmic reticulum, Plasma membrane" "CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.76e-2)" "unprognostic (5.65e-5)" "unprognostic (7.77e-2)" "unprognostic (1.45e-2)" "unprognostic (7.06e-3)" "unprognostic (2.86e-2)" "unprognostic (3.15e-1)" "unprognostic (8.87e-3)" "unprognostic (7.54e-5)" "unprognostic (3.28e-2)" "unprognostic (2.49e-1)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (8.46e-3)" "unprognostic (3.09e-1)" 1.1 2.5 1.5 1.0 1.6 0.5 1.0 0.9 2.4 0.6 6.4 0.3 3.8 0.9 0.8 1.1 3.7 0.6 0.9 0.9 1.0 1.5 3.9 0.5 0.7 0.7 1.6 1.0 0.7 0.4 1.4 4.7 0.6 2.6 6.4 1.5 23.0 1.4 0.6 62.5 0.8 1.4 33.1 1.1 0.5 3.5 3.9 0.5 0.0 1.4 6.8 0.5 9.6 5.3 0.9 1.2 0.3 0.4 0.9 0.9 1.0 0.6 1.6 2.2 0.4 0.2 1.4 1.2 1.2 2.6 0.4 1.4 2.4 0.3 1.4 1.8 0.4 1.0 1.0 0.0 1.5 0.3 0.5 1.8 1.2 3.6 1.9 0.2 1.2 0.6 3.0 0.1 2.0 0.5 4.8 2.8 0.8 1.0 1.1 2.3 1.8 0.4 1.2 0.7 0.2 3.4 0.9 0.8 0.5 4.4 3.0 2.3 21.5 1.0 0.8 0.3 1.3 2.6 0.5 6.1 1.6 1.2 0.7 0.7 0.5 0.8 0.9 4.7 0.3 1.6 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.3 0.9 0.3 0.9 0.7 0.8 0.3 0.9 0.0 1.2 0.7 1.0 1.5 1.6 0.9 2.4 1.0 1.5 1.6 1.0 2.6 0.5 0.0 1.4 0.0 0.2 0.5 81.4 0.8 0.0 0.0 0.0 0.0 231.7 0.1 0.0 0.2 14.2 1.1 0.0 0.0 0.0 12.6 0.6 0.0 0.0 0.0 0.5 7.9 0.0 0.0 0.0 22.0 0.3 0.0 0.0 0.0 0.0 8.8 0.4 0.0 0.0 1.4 181.4 0.0 1.4 2.2 0.8 0.1 0.7 0.0 0.0 0.1 PLCE1 "KIAA1516, NPHS3, PLCE" ENSG00000138193 "Phospholipase C epsilon 1" Q9P212 10 94030812-94332823 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 44.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 65.5;Enterocytes: 45.9;Muller glia cells: 98.6;Paneth cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015597, HPA015598" Enhanced Supported Cytosol NA NA Cytosol "HPA015597: AB_1855321, HPA015598: AB_1855322" "unprognostic (4.73e-2)" "unprognostic (1.16e-1)" "unprognostic (4.03e-2)" "unprognostic (3.59e-3)" "unprognostic (3.01e-1)" "unprognostic (2.96e-1)" "unprognostic (1.73e-2)" "unprognostic (4.76e-3)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-3)" "unprognostic (3.56e-1)" "unprognostic (3.92e-2)" "unprognostic (3.54e-2)" "unprognostic (4.30e-2)" 3.2 2.4 4.1 9.1 5.5 0.0 2.2 1.8 7.9 9.2 13.8 3.1 1.6 5.0 11.4 4.6 4.5 4.2 3.8 12.8 4.1 2.6 6.3 0.7 7.2 0.4 2.4 6.8 3.2 12.8 0.1 5.2 3.1 6.4 3.3 12.6 44.6 2.1 7.7 4.3 0.7 4.6 5.8 2.4 5.8 8.7 1.7 2.3 0.0 15.1 7.3 1.1 7.9 5.4 3.2 1.2 0.8 0.9 1.1 2.3 0.5 5.8 8.1 1.7 0.9 0.9 5.7 2.3 3.6 1.0 0.8 1.1 5.2 1.4 0.6 1.8 2.9 2.9 2.5 4.1 1.0 1.3 0.3 2.0 0.4 4.4 0.4 0.1 0.7 0.3 2.3 0.0 2.2 0.0 9.7 0.0 0.3 0.4 0.3 7.0 0.2 0.6 0.8 0.6 11.0 8.4 0.1 5.5 0.2 0.2 18.2 0.8 1.4 4.2 5.8 0.5 7.9 4.9 0.5 0.5 3.7 10.9 2.3 4.7 0.5 0.2 0.3 3.0 1.0 3.3 0.4 0.5 0.1 1.5 0.9 1.3 2.6 1.6 1.1 0.6 3.2 2.3 1.8 0.8 1.1 0.8 1.2 0.6 0.5 4.1 5.5 1.8 7.9 4.1 2.6 2.4 6.8 6.4 2.3 65.5 4.8 9.3 7.4 7.2 11.5 32.3 0.0 10.7 13.6 0.0 0.0 3.2 1.7 1.3 15.0 7.4 45.9 0.0 5.7 2.0 7.3 2.9 0.0 1.1 0.6 6.4 1.7 6.2 0.6 3.4 11.2 1.4 6.8 1.0 6.4 98.6 3.2 46.7 21.9 2.1 19.4 6.5 19.4 3.5 7.8 6.5 1.6 4.3 28.0 6.0 PLCG1 "NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1" ENSG00000124181 "Phospholipase C gamma 1" P19174 20 41136960-41196801 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "gdT-cell: 5.9;MAIT T-cell: 8.0;memory CD4 T-cell: 5.2;memory CD8 T-cell: 4.9;naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.4;NK-cell: 4.0;T-reg: 4.4" "Group enriched" "Detected in many" 8 "NK-cells: 4.0;T-cells: 8.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004277, HPA036681, HPA036682" Approved Enhanced Cytosol NA NA Cytosol "CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246" "unprognostic (2.77e-1)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (4.31e-2)" "unprognostic (5.82e-2)" "unprognostic (2.09e-2)" "unprognostic (4.45e-3)" "unprognostic (1.25e-2)" "unprognostic (2.29e-2)" "unprognostic (1.16e-1)" "prognostic favorable (4.72e-4)" "unprognostic (3.32e-1)" "unprognostic (2.73e-3)" "unprognostic (1.82e-1)" "unprognostic (2.65e-1)" "unprognostic (9.27e-2)" "unprognostic (2.79e-2)" 20.2 15.1 25.1 20.9 22.1 8.3 34.9 52.6 26.8 19.9 13.9 23.4 12.5 16.5 27.6 13.9 13.5 17.0 18.7 20.9 25.4 13.6 15.3 6.8 19.3 30.7 18.5 20.5 28.7 9.1 16.9 14.2 22.2 18.7 18.4 13.2 20.0 13.2 20.6 13.4 22.3 17.1 22.2 15.4 20.1 12.4 19.9 23.9 48.1 28.5 11.9 21.9 17.1 21.1 0.7 0.0 0.0 0.0 4.0 8.0 3.3 5.4 6.9 33.2 24.3 13.3 9.3 10.6 8.9 11.5 18.0 15.3 16.6 1.8 12.1 11.0 9.7 18.9 10.1 14.4 16.0 10.5 3.4 7.7 0.8 11.5 19.5 10.1 4.7 3.3 11.9 9.0 13.3 10.4 16.3 20.0 26.0 9.0 8.0 16.2 40.4 29.2 3.7 12.3 7.0 12.7 23.3 24.2 5.9 9.9 10.0 11.8 22.5 16.0 7.5 16.0 19.4 8.7 5.6 21.6 43.1 14.0 13.7 10.8 8.9 3.9 10.0 10.2 5.2 17.8 0.0 0.0 0.0 5.9 0.0 8.0 0.3 5.2 4.9 0.0 0.7 5.7 5.4 0.0 4.0 0.0 0.0 4.4 3.3 25.1 22.1 52.6 26.8 25.4 13.6 18.5 20.5 18.7 23.9 14.9 6.5 0.8 1.8 4.9 3.7 9.2 0.0 1.4 3.4 3.5 9.8 1.3 0.0 2.7 5.1 15.8 6.4 0.0 1.4 1.6 6.1 1.9 1.1 2.5 3.2 3.2 1.7 13.5 2.2 5.3 14.1 1.7 3.3 1.0 9.8 7.2 2.8 3.7 17.3 2.4 4.6 12.9 5.1 11.6 11.5 6.0 0.7 6.9 5.1 0.9 PLCG2 ENSG00000197943 "Phospholipase C gamma 2" P16885 16 81739097-81962693 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 211.5;Muller glia cells: 142.4;Rod photoreceptor cells: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 40.5;HMC-1: 19.4;REH: 16.5;U-698: 90.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004280, HPA020099, HPA020100" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 21000 "Vesicles, Cytosol" Nucleoplasm "CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325" "unprognostic (2.86e-2)" "unprognostic (1.34e-1)" "unprognostic (1.09e-3)" "unprognostic (1.10e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.71e-4)" "unprognostic (6.23e-2)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" "unprognostic (4.58e-2)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" "prognostic favorable (4.88e-4)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-1)" "unprognostic (3.40e-3)" 8.4 3.8 3.3 55.8 4.9 14.1 10.7 1.0 2.4 5.6 10.3 5.3 3.1 8.7 11.2 12.2 6.0 4.7 10.1 4.4 3.3 2.8 20.6 8.8 10.7 35.5 5.2 1.8 2.0 3.6 1.0 1.8 4.1 4.5 4.3 3.6 4.6 8.8 2.8 2.0 4.1 17.6 4.6 8.6 33.6 4.2 2.3 4.2 6.3 5.3 2.6 44.6 7.5 7.7 18.8 3.9 26.8 12.2 14.0 1.1 2.3 0.3 0.7 0.1 0.6 0.0 0.0 0.9 0.0 0.1 0.5 0.2 0.2 1.8 40.5 6.9 0.0 1.7 0.9 0.9 0.1 0.3 0.3 0.4 4.8 0.0 0.0 0.3 4.8 19.4 0.0 0.4 0.3 0.2 0.0 0.9 1.8 0.5 3.4 0.1 1.2 0.5 12.1 0.7 0.5 0.2 16.5 0.0 5.2 0.1 0.8 0.3 0.1 1.1 0.3 0.3 0.9 0.7 15.0 0.2 0.0 0.7 0.1 0.1 8.1 13.2 90.0 0.0 6.7 0.3 2.8 4.4 26.8 0.7 5.7 0.3 18.8 0.2 1.1 3.9 17.3 0.3 0.8 24.8 14.0 12.2 2.6 0.1 2.3 3.3 4.9 1.0 2.4 3.3 2.8 5.2 1.8 4.5 4.2 11.9 81.1 49.9 1.4 2.6 211.5 5.2 40.8 10.7 21.6 15.7 98.2 11.2 11.6 2.3 17.0 11.7 1.0 70.0 0.0 1.8 5.8 2.7 38.3 37.2 23.7 95.3 20.6 36.2 45.8 26.9 10.3 15.6 8.5 7.2 0.4 142.4 0.1 5.8 4.6 4.5 205.4 6.5 2.3 4.4 2.9 1.9 9.3 26.2 1.2 4.8 PLCXD1 FLJ11323 ENSG00000182378 "Phosphatidylinositol specific phospholipase C X domain containing 1" Q9NUJ7 X 276322-303356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.3" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 25.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 53.8" "Low region specificity" "Detected in many" HPA007721 Approved Approved Cytosol NA Yes Cytosol "HPA007721: AB_1079630" "unprognostic (2.73e-2)" "unprognostic (5.67e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.80e-2)" "prognostic favorable (2.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.92e-2)" "unprognostic (1.72e-2)" "unprognostic (4.80e-2)" "unprognostic (7.25e-2)" "unprognostic (1.11e-3)" "prognostic unfavorable (7.82e-14)" "unprognostic (6.01e-2)" "unprognostic (1.95e-1)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" 7.4 1.5 6.5 5.3 42.3 18.8 8.7 24.6 19.1 8.9 3.7 2.1 2.1 5.3 9.1 2.1 11.4 3.5 5.3 2.8 7.1 4.2 3.1 5.4 3.5 10.0 4.8 3.6 19.3 4.3 2.3 5.5 12.5 29.2 3.5 3.5 2.1 7.0 2.4 4.5 11.6 5.9 2.1 22.2 10.5 17.3 3.6 6.7 2.1 5.1 2.1 5.4 4.7 7.9 5.8 2.9 6.3 11.9 1.8 4.1 2.7 8.8 33.9 8.2 12.3 1.7 1.3 6.5 8.0 0.9 4.3 4.2 13.7 9.6 11.4 5.6 3.5 6.4 2.8 2.0 5.3 2.3 6.8 15.1 53.8 11.0 18.2 5.3 5.5 21.2 7.0 0.7 15.8 1.6 2.9 3.3 18.6 14.0 6.2 3.1 2.8 16.6 8.1 17.4 2.3 6.6 9.4 4.4 16.6 1.3 4.1 8.8 4.7 8.1 4.8 7.4 5.9 9.2 7.7 2.3 5.7 9.1 6.2 8.8 2.1 5.6 26.3 3.7 14.6 6.1 4.3 3.8 6.3 2.8 8.1 3.9 2.3 2.2 3.4 2.9 5.8 2.8 2.7 4.9 1.8 11.9 2.7 4.1 2.7 6.5 42.3 24.6 19.1 7.1 4.2 4.8 3.6 29.2 6.7 8.9 25.9 6.1 8.4 6.2 8.1 2.2 7.6 0.0 2.3 0.0 2.0 8.4 0.0 5.1 0.6 3.9 11.5 0.0 1.6 9.0 3.4 4.9 3.5 6.4 4.8 7.9 2.9 6.2 6.5 0.6 2.3 6.4 0.0 1.0 7.5 2.8 12.0 8.7 3.5 1.4 6.1 12.9 4.1 7.9 18.3 7.5 22.5 4.4 7.4 7.1 PLD3 HU-K4 ENSG00000105223 "Phospholipase D family member 3" Q8IV08 19 40348456-40380439 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 638.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 149.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 149.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012800, CAB020812" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA 490000 "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB020812: , HPA012800: AB_1855330" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.64e-3)" "unprognostic (2.56e-3)" "unprognostic (2.06e-3)" "unprognostic (2.68e-1)" "unprognostic (4.52e-2)" "unprognostic (3.89e-2)" "unprognostic (1.09e-1)" "unprognostic (4.60e-2)" "prognostic favorable (6.44e-4)" "unprognostic (4.34e-2)" "prognostic favorable (2.21e-4)" "unprognostic (3.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (6.42e-2)" 45.7 57.5 44.6 23.1 79.0 12.8 21.9 35.5 126.1 31.2 23.5 25.4 17.1 22.6 26.3 35.0 18.3 30.0 30.8 33.0 46.4 73.4 22.1 25.6 49.7 25.2 44.7 53.9 44.8 42.5 32.9 122.1 38.9 62.2 29.6 16.1 31.6 35.3 37.2 27.4 24.2 23.5 25.6 28.6 48.9 23.0 17.0 19.3 11.9 20.6 11.2 12.9 27.3 20.7 3.6 23.0 149.2 24.6 9.7 7.8 16.8 14.1 43.7 28.3 44.5 78.9 37.6 21.6 35.1 35.8 25.5 29.2 8.3 16.0 6.1 36.9 30.5 8.3 6.6 6.8 13.8 11.2 22.9 24.9 6.6 15.0 10.4 53.9 2.7 75.9 71.5 28.9 19.4 13.4 42.8 21.4 10.1 23.3 24.9 18.3 18.5 4.8 13.1 18.5 23.2 9.0 6.1 21.6 25.2 13.1 10.6 20.3 33.8 16.8 10.4 18.8 30.9 14.3 47.6 37.6 21.5 10.3 18.2 7.8 26.0 27.7 6.3 34.6 11.0 13.3 149.2 24.6 35.3 7.8 12.8 6.4 3.6 6.2 6.9 23.0 3.1 6.5 6.5 2.5 9.7 5.7 3.3 6.1 16.8 44.6 79.0 35.5 126.1 46.4 73.4 44.7 53.9 62.2 19.3 29.8 62.9 34.4 70.6 31.5 98.5 18.5 25.5 12.0 28.4 54.1 31.4 137.8 18.3 50.7 5.8 46.8 52.7 0.0 51.3 94.8 142.4 49.1 59.9 35.8 638.2 114.4 69.9 90.9 219.8 8.6 140.4 84.2 87.7 44.1 36.8 99.5 49.7 41.2 135.1 30.0 39.3 19.4 53.1 13.9 57.5 29.2 163.8 35.4 34.5 52.0 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524696 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.8;retina: 37.7" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 6.3;Horizontal cells: 3.2;Late spermatids: 9.5;Leydig cells: 4.6" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enriched" "Detected in all" 4 "cerebellum: 54.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 4.0;AF22: 14.0;HDLM-2: 6.9;SH-SY5Y: 3.9;U-2 OS: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol No No Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: AB_2681105" "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 1.1 5.4 5.0 0.4 3.7 0.4 1.6 54.8 7.6 2.2 0.8 7.7 0.0 0.4 3.5 0.9 1.6 1.8 0.8 0.8 4.4 4.6 1.5 0.5 0.8 3.3 5.4 2.5 6.6 3.1 1.4 7.2 1.5 12.7 2.7 0.6 37.7 2.2 9.3 0.8 0.6 0.5 2.9 6.0 2.2 0.8 4.2 6.2 0.0 1.0 0.0 1.5 0.4 1.0 0.4 0.2 1.0 0.2 0.3 0.4 0.0 0.0 4.0 14.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.4 0.3 0.4 1.0 0.3 0.2 0.2 0.2 0.0 5.0 3.7 54.8 5.5 4.4 4.6 5.4 2.5 12.7 6.2 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 9.5 4.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.5 0.0 0.7 0.5 0.2 0.1 0.2 0.0 0.0 0.0 PLEC "EBS1, PCN, PLEC1, PLTN" ENSG00000178209 Plectin Q15149 8 143915147-143976734 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease mutation, Epidermolysis bullosa, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 144.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 73.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003847, HPA025967, HPA029906" Enhanced Supported "Intermediate filaments,Focal adhesion sites,Cytosol" NA NA 7100000 "Intermediate filaments, Cytosol" "Focal adhesion sites" "CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279" "unprognostic (1.02e-1)" "unprognostic (1.37e-3)" "prognostic unfavorable (4.29e-4)" "unprognostic (2.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.72e-3)" "unprognostic (1.13e-2)" "unprognostic (2.85e-3)" "unprognostic (5.48e-2)" "prognostic unfavorable (7.98e-6)" "unprognostic (2.30e-1)" "unprognostic (4.04e-2)" "unprognostic (6.58e-2)" "unprognostic (5.58e-3)" 20.9 11.0 15.9 16.5 13.3 27.9 13.1 15.0 20.7 20.7 17.7 14.6 16.7 13.1 20.2 16.8 25.1 18.2 29.0 23.4 18.9 10.7 11.2 10.9 16.6 15.0 9.9 13.0 18.0 14.0 8.8 12.0 24.2 13.2 17.5 9.8 13.0 17.8 14.8 144.9 36.4 24.1 24.7 11.0 16.9 21.4 6.7 12.7 16.3 9.2 44.2 24.5 20.2 19.2 1.5 3.4 0.8 4.1 0.7 2.9 3.2 16.5 52.1 3.3 4.1 6.1 13.6 11.9 24.4 10.8 6.5 3.6 7.2 17.4 1.7 19.0 35.8 11.6 19.8 2.2 34.1 2.6 12.4 1.8 6.3 52.9 5.9 9.7 2.0 5.3 15.7 6.7 17.5 34.2 5.8 7.6 1.5 3.0 5.4 7.5 29.2 1.2 3.4 2.2 5.2 73.4 0.3 9.6 4.5 10.9 30.8 3.5 3.5 41.6 8.9 4.0 4.5 10.8 2.4 24.3 25.2 45.7 22.2 28.9 0.8 0.6 1.2 24.1 2.7 35.8 0.0 4.1 0.2 1.4 3.8 2.8 1.4 2.7 2.0 3.4 1.5 2.0 1.1 0.8 0.7 2.7 2.8 2.9 3.2 15.9 13.3 15.0 17.3 18.9 10.7 9.9 13.0 13.2 12.7 26.8 17.0 14.3 46.9 95.9 11.5 31.5 35.7 18.7 31.8 38.4 23.6 26.8 0.0 34.1 0.9 56.3 142.5 0.0 17.6 23.1 42.0 88.8 8.1 52.0 34.6 28.6 30.9 54.0 64.5 2.4 41.1 45.0 32.1 26.2 69.7 11.4 96.9 52.6 70.4 3.3 9.5 6.5 55.6 0.5 5.7 67.0 57.7 11.5 29.8 96.8 PLEK2 ENSG00000100558 "Pleckstrin 2" Q9NYT0 14 67386983-67412200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 132.3;Pancreatic endocrine cells: 114.0;Suprabasal keratinocytes: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.0;naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in single" 8 "T-cells: 6.5" "Cell line enhanced" "Detected in many" "A-431: 26.7;CAPAN-2: 28.6;HBEC3-KT: 53.3;PC-3: 19.5;TIME: 20.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA001208 Enhanced Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA001208: AB_1079631" "unprognostic (4.41e-3)" "unprognostic (3.77e-1)" "unprognostic (1.15e-1)" "unprognostic (6.23e-2)" "unprognostic (6.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.97e-1)" "unprognostic (9.21e-3)" "prognostic unfavorable (8.26e-5)" "unprognostic (1.06e-1)" "unprognostic (3.09e-3)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (8.98e-2)" "unprognostic (4.59e-2)" 1.7 28.8 0.5 7.6 1.1 4.1 1.5 0.5 0.8 2.4 14.9 1.4 1.6 12.4 1.1 14.9 9.7 0.4 7.4 0.5 0.5 0.2 6.0 29.1 1.9 0.5 0.5 0.5 1.0 16.5 2.5 0.9 2.6 0.7 5.1 12.7 0.9 6.9 2.3 1.4 12.1 28.1 1.2 0.7 0.6 8.5 2.4 0.5 13.9 28.6 6.5 6.5 4.8 4.4 0.0 0.8 0.0 0.1 0.0 6.5 1.2 26.7 4.0 0.0 0.0 0.0 0.3 2.7 5.4 0.8 1.3 1.6 14.6 28.6 0.0 5.3 0.7 0.0 12.8 0.0 53.3 3.0 0.0 0.2 0.0 6.2 0.1 1.1 0.0 0.0 0.6 3.8 1.4 17.1 0.0 4.4 0.0 0.1 0.1 0.9 8.5 0.0 0.0 0.1 17.3 19.5 0.0 0.0 4.1 9.1 0.7 0.2 0.0 5.1 2.4 1.5 0.2 3.5 0.2 20.7 0.0 16.7 0.1 0.1 0.0 0.0 0.1 3.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.7 0.8 0.0 6.5 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.5 1.1 0.5 0.8 0.5 0.2 0.5 0.5 0.7 0.5 0.0 0.6 0.0 20.4 132.3 0.0 0.3 5.1 1.4 3.4 5.2 0.0 0.9 3.3 40.6 0.1 0.7 36.5 0.0 41.0 5.1 9.3 10.8 0.0 9.4 7.0 0.0 8.1 0.0 1.0 0.0 0.3 15.0 20.3 9.0 44.7 0.0 114.0 21.0 0.0 1.6 0.0 0.0 5.1 0.3 0.9 79.3 1.3 0.0 46.5 23.8 PLEKHA1 TAPP1 ENSG00000107679 "Pleckstrin homology domain containing A1" Q9HB21 10 122374696-122442602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 261.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 6.9;NK-cells: 11.6;T-cells: 16.5" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 64.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002043, HPA064795" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002043: AB_1079632, HPA064795: AB_2685354" "unprognostic (1.79e-2)" "unprognostic (3.18e-2)" "unprognostic (2.70e-1)" "unprognostic (5.44e-3)" "unprognostic (7.41e-2)" "unprognostic (1.69e-1)" "unprognostic (5.50e-2)" "unprognostic (4.07e-2)" "unprognostic (3.88e-1)" "unprognostic (2.69e-1)" "unprognostic (7.98e-2)" "unprognostic (7.63e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (7.42e-2)" "unprognostic (4.31e-2)" "unprognostic (5.23e-2)" 11.7 7.4 18.2 8.7 30.2 2.6 13.6 15.8 37.9 13.6 14.9 25.4 11.4 17.1 17.9 14.5 26.7 8.8 16.3 19.4 19.8 16.6 27.1 25.4 24.4 9.0 15.6 24.4 13.9 18.1 18.8 22.9 30.6 20.7 12.7 13.9 9.5 16.0 13.6 22.5 43.9 17.2 16.0 19.6 8.7 14.0 25.5 15.0 3.4 18.7 13.9 11.7 16.1 16.1 6.9 1.8 1.3 1.6 11.6 16.5 6.2 7.8 7.3 7.4 5.1 10.8 12.3 8.9 8.8 15.4 5.3 5.8 6.1 10.0 4.9 4.3 7.9 5.4 17.4 7.0 26.9 4.9 3.5 6.8 0.0 7.2 7.2 7.1 0.9 2.3 6.7 22.3 4.4 18.8 8.8 17.9 10.4 7.3 0.0 4.9 3.0 4.4 0.7 5.7 12.1 4.9 1.2 10.6 0.9 64.9 8.8 10.1 4.9 11.4 8.5 8.9 10.9 4.7 0.1 17.0 4.5 3.7 4.9 4.4 0.0 0.0 1.6 7.0 0.0 2.8 0.1 1.5 1.3 16.5 1.4 10.8 2.9 10.0 13.2 1.8 6.9 15.9 13.5 0.5 11.6 1.6 0.9 6.6 6.2 18.2 30.2 15.8 37.9 19.8 16.6 15.6 24.4 20.7 15.0 134.0 37.7 19.5 46.6 64.7 41.5 49.8 43.3 33.5 60.3 54.1 70.7 47.5 34.9 55.8 165.5 60.9 41.2 0.0 73.6 39.9 30.4 51.3 4.7 42.4 29.9 25.4 21.5 27.6 18.2 261.8 40.9 15.7 23.6 28.9 21.1 25.4 58.5 28.1 33.9 98.4 50.3 25.8 30.1 90.5 82.0 74.2 33.2 33.3 24.5 60.8 PLEKHA2 TAPP2 ENSG00000169499 "Pleckstrin homology domain containing A2" 8 38901235-38973909 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004706 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA004706: AB_1079633" "unprognostic (2.78e-1)" "unprognostic (8.80e-3)" "unprognostic (4.15e-3)" "unprognostic (3.03e-1)" "unprognostic (8.61e-2)" "unprognostic (9.07e-3)" "unprognostic (6.16e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (6.59e-2)" "prognostic unfavorable (1.95e-6)" "unprognostic (2.39e-2)" "unprognostic (1.00e-1)" "unprognostic (4.55e-2)" "unprognostic (9.60e-3)" 7.7 9.7 8.8 19.1 6.6 14.2 6.4 3.4 6.9 8.6 8.2 4.8 11.8 3.7 9.0 11.5 6.7 6.9 8.9 17.7 7.0 4.7 7.3 4.0 9.7 29.9 6.6 6.9 10.5 4.5 15.3 6.9 6.9 4.8 9.0 5.0 16.7 5.9 10.3 5.4 5.4 8.8 9.9 8.0 16.3 6.4 5.0 5.7 5.2 7.8 3.2 26.2 12.8 8.6 14.2 5.3 7.5 2.0 3.8 2.7 0.9 9.5 2.2 1.4 3.4 3.6 7.2 1.5 11.6 9.2 8.9 7.6 1.2 6.6 53.5 13.9 10.7 8.0 6.0 3.7 7.4 13.5 13.5 0.3 27.3 19.0 1.3 13.2 8.7 11.2 16.4 5.1 4.6 8.3 21.0 1.5 8.9 2.7 15.5 8.3 1.2 17.8 4.1 1.3 7.7 3.4 4.6 7.4 11.3 10.9 8.3 0.1 2.1 13.6 2.5 9.3 2.2 5.7 4.3 2.1 6.5 5.1 1.1 9.2 4.9 4.5 24.9 10.3 9.5 1.4 5.2 1.5 7.5 2.0 2.0 2.1 8.9 2.3 2.3 1.8 14.2 1.5 2.7 3.4 3.8 2.0 5.3 1.9 0.9 8.8 6.6 3.4 6.9 7.0 4.7 6.6 6.9 4.8 5.7 3.0 22.7 61.4 10.3 7.8 1.4 36.3 12.7 16.0 7.9 38.4 0.0 6.5 1.7 7.0 0.6 10.3 9.7 0.0 4.7 13.6 10.8 9.2 35.8 10.2 42.5 55.6 12.6 26.4 69.1 0.9 21.0 38.7 15.1 13.6 10.4 15.1 16.5 3.5 23.7 11.5 1.4 12.9 14.1 0.5 6.1 5.8 3.8 36.2 12.1 26.6 PLEKHA4 PEPP1 ENSG00000105559 "Pleckstrin homology domain containing A4" Q9H4M7 19 48837097-48868632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Peritubular cells: 50.2;Smooth muscle cells: 103.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 28.0;ASC TERT1: 19.1;BJ hTERT+ SV40 Large T+ RasG12V: 22.3;SK-MEL-30: 32.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA042978, HPA048473" Uncertain Approved "Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol" Yes No "Plasma membrane, Cytosol" "Cytokinetic bridge, Centriolar satellite" "HPA042978: AB_2678249, HPA048473: AB_2680409" "prognostic favorable (1.97e-4)" "unprognostic (4.39e-1)" "unprognostic (8.16e-2)" "unprognostic (2.85e-2)" "unprognostic (3.98e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (8.68e-4)" "unprognostic (5.09e-2)" "unprognostic (1.01e-2)" "unprognostic (1.17e-1)" "unprognostic (1.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.84e-2)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-3)" "unprognostic (6.38e-2)" 14.0 10.2 5.0 10.1 7.7 0.3 11.4 4.5 5.5 9.4 14.6 6.1 3.5 4.7 13.2 5.6 8.7 10.2 9.7 19.3 3.9 3.0 9.7 10.8 9.6 5.7 28.9 2.6 22.8 11.4 3.1 13.3 5.2 12.4 9.7 3.4 12.5 6.0 8.1 8.9 5.9 5.1 23.3 13.5 8.0 7.9 6.2 4.4 7.4 12.9 5.8 6.3 11.0 7.3 7.4 2.0 1.4 0.7 1.2 5.3 1.6 3.8 0.2 4.4 28.0 6.5 19.1 3.5 3.0 10.9 12.0 22.3 2.5 1.1 0.1 5.3 4.2 4.7 1.2 1.5 1.5 1.9 0.0 1.5 1.0 0.6 2.8 5.0 0.0 6.4 9.8 1.0 6.9 0.4 4.9 3.5 4.9 4.0 2.3 3.2 2.3 1.3 0.2 0.6 2.5 0.3 0.1 14.0 0.2 3.6 0.0 0.0 4.9 1.3 1.1 32.2 1.1 1.7 1.3 0.5 3.8 3.1 4.9 0.7 12.7 10.5 2.2 4.5 0.3 10.1 0.0 0.6 1.4 3.1 0.7 2.3 3.0 3.0 2.0 0.2 7.4 5.3 4.7 0.3 1.2 0.5 2.0 1.0 1.6 5.0 7.7 4.5 5.5 3.9 3.0 28.9 2.6 12.4 4.4 0.0 18.9 0.0 26.3 8.5 0.7 29.1 5.1 28.1 43.3 7.0 0.0 2.7 1.7 16.3 0.4 6.6 1.0 0.0 4.4 4.2 39.8 15.0 0.0 12.1 2.4 0.0 1.2 5.5 0.3 0.4 38.3 2.8 11.8 1.8 1.0 8.4 6.8 0.0 50.2 9.9 0.7 6.5 103.2 3.5 2.5 8.5 2.4 1.3 1.8 19.6 PLEKHA5 "FLJ10667, KIAA1686, PEPP2" ENSG00000052126 "Pleckstrin homology domain containing A5" Q9HAU0 12 19129752-19376400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 290.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 14.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 27.2;NTERA-2: 27.8;SuSa: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035923, HPA035924, HPA041455" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: AB_2677490" "unprognostic (3.16e-1)" "unprognostic (8.35e-3)" "unprognostic (1.30e-1)" "unprognostic (4.85e-3)" "unprognostic (6.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.35e-2)" "unprognostic (3.62e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (5.41e-5)" "unprognostic (3.71e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.27e-1)" "unprognostic (2.43e-1)" "unprognostic (4.03e-2)" "unprognostic (1.07e-2)" 7.7 52.3 13.8 7.8 22.0 2.9 11.9 13.0 22.4 23.5 9.8 7.2 19.4 10.0 23.1 25.7 16.0 16.0 16.7 25.2 11.2 11.5 32.2 12.1 9.9 2.4 10.7 16.3 26.1 11.3 27.2 14.4 10.2 15.0 17.6 10.8 22.2 11.4 22.7 2.0 13.2 10.0 23.1 23.7 2.8 13.7 14.8 13.0 6.1 11.5 5.9 4.3 18.1 18.1 0.4 2.7 14.8 0.4 1.7 6.4 0.4 10.7 5.3 19.4 0.2 6.6 8.9 6.9 4.6 10.0 2.8 4.4 7.9 9.7 0.2 1.5 5.1 5.7 4.6 13.0 8.5 5.9 27.2 4.6 6.4 11.8 3.8 6.2 0.2 0.9 5.2 9.0 8.0 15.3 15.4 3.0 5.5 2.7 0.4 2.9 3.3 4.1 0.8 27.8 8.7 2.8 0.1 9.0 0.1 19.6 12.7 1.8 4.0 4.4 2.6 16.4 27.5 3.2 1.5 4.5 1.8 7.7 0.4 0.2 0.3 0.2 0.2 4.2 0.1 3.5 14.8 0.4 0.3 2.7 0.3 6.4 0.2 2.5 2.3 1.8 0.4 0.4 1.9 1.0 1.7 0.2 2.7 2.1 0.4 13.8 22.0 13.0 22.4 11.2 11.5 10.7 16.3 15.0 13.0 23.8 23.3 2.7 42.8 18.2 89.3 123.9 50.9 72.3 50.0 43.6 129.6 22.7 29.9 26.9 20.2 15.5 24.5 0.0 28.7 34.1 41.5 27.0 3.5 36.2 5.8 119.2 31.2 16.5 8.6 11.8 37.4 12.0 111.3 290.4 12.7 99.2 39.4 30.6 26.5 85.1 145.1 32.3 27.2 41.2 47.8 22.5 22.1 10.7 33.8 41.1 PLEKHA7 DKFZp686M22243 ENSG00000166689 "Pleckstrin homology domain containing A7" Q6IQ23 11 16777317-17014443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 6.8;MAIT T-cell: 4.5" "Group enriched" "Detected in many" 6 "granulocytes: 6.8;T-cells: 4.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.4;HaCaT: 28.7;OE19: 23.8;RT4: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038610, HPA066103" Approved Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA038610: AB_10671746, HPA066103: AB_2732738" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (4.30e-2)" "unprognostic (2.51e-2)" "unprognostic (6.95e-3)" "unprognostic (2.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-3)" "unprognostic (3.13e-2)" "prognostic favorable (1.89e-15)" "unprognostic (9.74e-2)" "unprognostic (1.17e-2)" "unprognostic (4.81e-1)" "unprognostic (2.65e-2)" 6.8 1.2 5.3 6.6 8.0 0.1 10.7 2.9 4.9 7.7 18.1 10.9 10.0 17.7 4.7 6.0 30.6 6.0 15.1 13.6 7.5 4.2 18.1 9.0 6.4 1.2 7.2 4.6 8.1 18.9 19.1 3.2 18.7 14.5 6.0 11.5 18.2 15.0 16.3 2.7 8.9 32.0 2.7 8.1 1.7 15.2 7.4 7.9 1.4 7.2 1.9 5.5 10.7 12.4 0.5 0.9 6.8 0.3 0.2 4.5 0.3 5.1 4.6 4.9 2.2 0.2 0.0 8.1 0.0 0.1 1.7 3.2 7.9 43.4 0.0 2.0 0.6 0.2 28.7 6.5 0.0 1.2 1.5 6.3 13.3 3.7 5.4 0.1 0.0 0.1 0.2 2.5 0.0 0.1 4.0 0.0 5.6 0.5 0.1 0.7 3.3 3.0 0.1 2.7 23.8 4.5 4.1 0.0 1.0 4.2 39.3 3.1 0.3 5.9 16.9 0.2 9.3 4.3 1.5 1.1 0.0 1.6 1.2 1.0 2.9 0.9 5.8 0.0 0.2 0.0 0.2 0.3 6.8 0.6 0.1 4.5 0.5 0.8 0.6 0.3 0.2 0.2 0.4 0.6 0.2 0.1 0.9 0.1 0.3 5.3 8.0 2.9 4.9 7.5 4.2 7.2 4.6 14.5 7.9 3.0 13.4 0.0 1.2 0.6 1.2 8.7 5.1 6.7 12.5 10.4 23.6 5.4 3.3 4.7 11.7 2.3 8.4 0.0 5.3 0.8 0.6 0.8 2.3 2.4 1.7 0.0 0.0 0.6 1.0 4.5 0.6 2.4 0.0 1.0 4.6 3.9 7.6 3.5 0.4 8.1 10.6 0.0 0.3 0.2 0.5 0.4 5.0 0.5 2.6 4.6 PLEKHG2 "ARHGEF42, CLG, FLJ00018" ENSG00000090924 "Pleckstrin homology and RhoGEF domain containing G2" Q9H7P9 19 39412585-39428415 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Leukodystrophy, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 30.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017973, HPA048054" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017973: AB_2669719, HPA048054: AB_2680241" "unprognostic (3.55e-1)" "unprognostic (6.73e-2)" "prognostic unfavorable (3.53e-4)" "unprognostic (3.97e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-3)" "unprognostic (1.24e-2)" "unprognostic (4.48e-2)" "unprognostic (1.39e-1)" "unprognostic (8.09e-2)" "unprognostic (2.10e-1)" "unprognostic (4.99e-1)" "prognostic unfavorable (3.79e-8)" "unprognostic (8.01e-2)" "unprognostic (3.90e-2)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" 15.7 6.1 2.9 30.8 4.4 14.8 14.2 2.8 4.0 18.7 12.4 3.9 5.6 5.9 20.3 10.1 9.7 12.6 17.6 13.5 3.5 2.6 10.7 5.1 21.4 20.2 4.5 2.2 17.5 4.4 5.8 7.6 17.4 7.4 12.3 3.9 13.6 6.8 15.0 7.1 4.4 9.6 14.1 6.9 24.8 8.8 8.7 3.6 49.3 11.1 9.5 24.6 13.0 10.1 3.9 4.2 2.8 1.8 1.4 4.4 2.7 3.5 17.6 32.2 17.4 3.1 4.1 4.6 9.5 7.5 6.6 5.7 11.3 6.4 6.3 7.0 12.3 5.5 1.2 4.8 8.4 3.5 20.7 4.4 8.1 9.2 5.1 5.3 0.9 10.2 9.3 1.4 7.9 3.8 11.5 8.4 18.2 5.4 7.4 10.5 7.1 10.1 3.2 7.6 3.3 1.7 36.4 3.9 1.9 5.6 6.6 0.8 10.4 2.1 0.8 3.1 11.7 9.5 9.3 10.7 17.3 13.6 6.4 6.0 5.5 1.7 9.1 9.6 3.7 9.5 2.8 1.4 0.4 4.4 0.8 2.6 3.9 2.1 2.5 1.0 3.6 2.8 3.5 2.6 1.4 1.8 4.2 3.9 2.7 2.9 4.4 2.8 4.0 3.5 2.6 4.5 2.2 7.4 3.6 6.0 30.1 7.5 3.2 3.5 0.6 5.6 5.1 2.7 9.1 0.0 0.0 0.7 0.0 5.3 9.7 8.1 2.6 0.0 4.3 2.3 6.4 2.6 2.3 0.8 8.9 0.0 1.2 10.4 12.9 11.7 6.6 11.4 5.0 7.2 2.6 1.2 3.0 2.3 7.8 0.2 2.6 6.5 8.0 2.6 2.2 2.5 0.9 6.7 3.0 1.3 PLEKHG3 "ARHGEF43, KIAA0599" ENSG00000126822 "Pleckstrin homology and RhoGEF domain containing G3" A1L390 14 64704102-64750247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2" "Cell line enhanced" "Detected in many" "A-431: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063455, HPA065323, HPA073702, HPA074734" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol" Yes No "Plasma membrane, Cytosol" "Nucleoplasm, Cytokinetic bridge, Centrosome" "HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265" "unprognostic (8.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.38e-2)" "unprognostic (4.04e-2)" "unprognostic (2.18e-1)" "unprognostic (7.22e-2)" "unprognostic (7.21e-2)" "unprognostic (5.53e-3)" "unprognostic (1.49e-1)" "unprognostic (3.34e-3)" "unprognostic (3.63e-1)" "unprognostic (3.54e-2)" "prognostic favorable (7.39e-8)" "unprognostic (2.29e-1)" "unprognostic (2.67e-1)" "unprognostic (4.24e-2)" "unprognostic (2.67e-3)" 12.8 2.9 17.2 7.8 36.9 11.4 19.8 7.3 29.4 15.2 15.9 67.3 9.3 10.2 31.6 9.9 26.4 19.8 17.5 12.5 24.2 12.8 19.5 16.5 8.4 4.0 40.7 21.6 16.8 22.7 17.9 3.7 22.3 19.5 12.3 12.1 13.6 19.6 31.6 5.9 19.6 10.0 20.7 24.5 16.0 11.5 5.1 40.9 1.2 14.5 6.4 5.3 16.6 17.1 0.0 0.7 16.7 1.9 6.4 12.2 2.9 29.0 13.5 11.3 17.1 1.2 0.0 19.7 3.3 3.9 5.2 4.2 14.2 12.9 0.0 5.9 3.1 1.8 28.1 7.6 25.9 1.8 0.0 6.6 12.9 16.7 3.4 1.5 0.4 6.2 1.5 15.0 1.1 9.4 8.7 3.4 0.1 0.0 0.1 1.7 13.7 0.0 11.8 3.8 7.7 14.5 0.1 5.6 2.0 14.3 21.3 3.9 6.9 6.7 10.1 9.7 10.9 11.0 2.9 6.5 2.3 23.4 0.1 4.5 0.0 0.0 0.0 0.2 1.3 4.0 4.5 1.9 11.7 12.2 1.1 8.6 0.0 3.7 5.2 0.7 0.0 0.4 2.7 16.7 6.4 0.7 0.0 1.1 2.9 17.2 36.9 7.3 29.4 24.2 12.8 40.7 21.6 19.5 40.9 3.0 3.8 0.8 15.7 17.2 3.6 6.9 17.8 2.7 3.4 45.4 0.0 6.9 10.0 25.0 0.7 3.0 14.7 0.0 17.7 8.6 8.4 13.8 1.1 9.6 4.4 0.0 33.4 1.8 6.0 0.9 6.9 3.3 5.0 0.0 22.8 11.7 28.1 20.1 24.1 7.0 0.8 25.8 16.5 0.0 1.1 18.7 2.2 5.7 15.0 33.4 PLEKHH2 "KIAA2028, PLEKHH1L" ENSG00000152527 "Pleckstrin homology, MyTH4 and FERM domain containing H2" Q8IVE3 2 43637273-43767987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 35.7;Collecting duct cells: 62.8;Peritubular cells: 47.4;Sertoli cells: 45.3" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.3;RPTEC TERT1: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077225 Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA077225: AB_2686828" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.49e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (4.27e-3)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (6.99e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-3)" "unprognostic (3.03e-2)" "unprognostic (1.29e-1)" "unprognostic (8.57e-3)" "unprognostic (1.82e-2)" 10.1 2.7 3.7 9.2 6.5 0.3 7.5 5.4 5.6 27.2 8.5 2.9 3.6 4.1 30.0 9.5 5.2 9.8 8.1 3.7 4.2 2.7 8.7 1.8 21.7 3.0 3.4 3.3 19.4 2.5 9.6 1.8 4.2 8.3 7.9 5.0 7.4 3.8 7.8 5.4 6.9 5.7 13.1 9.7 4.7 4.1 4.2 4.0 0.0 4.7 4.7 4.3 11.1 8.6 0.8 0.6 1.4 0.4 0.7 1.0 0.0 0.6 5.2 2.1 0.1 4.3 10.3 0.4 0.7 2.7 1.1 2.8 0.0 1.8 1.3 0.3 0.9 4.5 3.5 0.6 0.8 2.0 0.1 1.5 0.1 0.7 0.2 0.7 0.0 0.7 3.0 0.8 2.6 0.1 1.5 2.3 2.1 4.9 0.2 0.9 1.4 1.0 0.2 1.2 0.8 5.2 0.0 6.2 0.1 8.5 0.3 1.7 0.8 0.5 0.0 5.2 1.6 0.7 0.2 0.2 6.1 1.8 0.3 1.8 1.2 0.3 0.0 2.5 0.0 0.6 0.8 0.4 0.4 0.4 0.2 0.4 0.3 0.7 0.5 0.2 0.8 1.0 0.6 1.4 0.7 0.3 0.6 0.5 0.0 3.7 6.5 5.4 5.6 4.2 2.7 3.4 3.3 8.3 4.0 35.7 8.3 0.5 14.5 7.7 0.7 1.2 10.2 8.1 15.9 62.8 5.9 0.3 5.0 4.0 1.3 2.9 0.0 0.0 1.2 0.3 31.9 6.8 1.1 0.0 0.7 0.0 0.0 3.7 0.3 2.5 33.1 1.1 11.8 0.0 0.0 7.2 4.4 0.0 47.4 2.2 4.1 45.3 15.1 4.3 6.1 7.3 0.5 1.3 0.0 7.2 PLEKHM3 "DAPR, PLEKHM1L" ENSG00000178385 "Pleckstrin homology domain containing M3" Q6ZWE6 2 207821288-208025560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.1;Club cells: 10.3;Cone photoreceptor cells: 11.8;Rod photoreceptor cells: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035046 Uncertain Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA035046: AB_10603128" "unprognostic (3.62e-1)" "unprognostic (1.58e-2)" "unprognostic (8.27e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (4.77e-2)" "unprognostic (6.06e-2)" "unprognostic (8.20e-2)" "unprognostic (4.13e-2)" "unprognostic (2.92e-3)" "unprognostic (2.17e-1)" "unprognostic (1.09e-1)" "unprognostic (4.86e-4)" "unprognostic (2.42e-1)" "unprognostic (3.12e-1)" "unprognostic (5.72e-2)" "unprognostic (1.33e-2)" 6.5 10.9 10.0 4.1 11.2 11.1 5.1 11.8 16.8 5.6 5.0 10.6 2.1 3.3 6.2 3.4 4.2 4.5 4.5 6.6 7.3 7.8 5.1 6.8 6.2 4.3 6.2 11.4 9.1 4.8 17.3 7.2 4.6 13.1 6.4 4.9 6.5 5.4 4.8 5.1 5.2 3.9 5.9 8.6 4.9 4.6 5.3 7.5 4.1 10.6 2.3 4.5 4.8 5.4 2.3 1.9 6.7 2.1 2.0 2.7 0.6 1.5 1.3 3.4 1.9 5.6 5.7 5.1 3.1 3.3 2.5 2.3 1.7 1.3 1.3 3.1 3.5 2.4 1.6 3.4 4.4 3.3 2.4 5.3 2.6 4.2 2.7 3.4 2.8 1.5 4.7 5.4 2.8 3.3 3.8 2.6 4.2 1.6 3.6 3.1 0.8 3.4 1.9 3.2 1.1 1.6 2.7 2.8 2.7 1.2 1.7 7.2 3.8 2.8 0.3 3.0 5.7 0.9 2.3 3.7 3.9 2.4 2.4 2.0 4.0 4.7 1.3 4.5 1.7 2.9 3.0 2.1 0.9 2.5 0.8 1.0 2.3 2.3 2.2 1.9 1.7 2.7 2.3 6.7 2.0 1.7 1.9 1.3 0.6 10.0 11.2 11.8 16.8 7.3 7.8 6.2 11.4 13.1 7.5 17.9 17.1 0.0 0.3 0.0 3.0 0.8 2.5 1.4 10.3 1.8 11.8 0.2 0.0 2.5 2.1 0.1 1.1 0.0 3.0 0.4 0.2 0.3 0.0 0.4 0.5 6.4 0.0 0.0 1.2 3.3 0.3 2.5 0.0 7.2 0.0 3.1 3.2 1.4 0.0 3.8 9.9 0.0 0.4 0.2 0.7 0.1 0.1 0.5 0.3 0.0 PLEKHO2 "DKFZp761K2312, PLEKHQ1, PP1628, pp9099" ENSG00000241839 "Pleckstrin homology domain containing O2" Q8TD55 15 64841883-64868007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.9" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 56.4;Ito cells: 42.4;Kupffer cells: 40.1;Muller glia cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6" "Cell line enhanced" "Detected in many" "ASC diff: 31.3" HPA040055 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 450000 "Plasma membrane, Cytosol" Nucleoplasm "HPA040055: AB_10793954" "unprognostic (4.32e-2)" "unprognostic (7.32e-3)" "unprognostic (8.60e-2)" "unprognostic (9.10e-2)" "unprognostic (1.11e-1)" "unprognostic (2.90e-2)" "unprognostic (3.05e-2)" "unprognostic (2.80e-1)" "unprognostic (7.70e-2)" "unprognostic (2.05e-2)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.08e-3)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (1.78e-1)" "unprognostic (5.85e-3)" 22.1 17.4 12.9 19.9 16.6 29.4 12.4 6.2 9.9 10.3 12.2 11.5 5.2 6.8 11.9 13.3 10.7 13.0 17.4 9.3 13.3 8.0 8.1 8.2 22.4 19.6 10.1 8.7 10.4 5.7 5.1 6.4 22.6 17.2 10.5 5.6 17.0 6.1 10.2 5.9 6.0 9.4 16.9 14.5 57.9 10.2 7.0 11.3 5.1 18.6 6.6 13.8 17.1 14.1 4.0 10.4 30.2 26.6 2.7 5.4 10.3 2.7 1.8 3.5 3.4 31.3 18.0 8.3 8.1 12.2 8.7 8.9 2.2 1.7 7.4 4.3 16.5 8.8 1.0 4.0 3.3 5.1 11.4 1.2 7.4 0.8 2.5 24.1 8.3 11.1 13.0 2.9 10.8 3.5 7.5 12.0 1.5 2.2 26.5 11.5 0.8 1.7 9.0 6.7 1.4 1.7 6.4 8.5 5.3 1.4 1.9 0.3 3.0 3.4 1.2 11.1 6.0 1.2 11.3 15.5 6.7 6.2 6.3 3.3 9.9 15.5 2.5 7.2 10.8 3.9 7.0 14.3 9.2 5.4 20.4 5.0 4.0 3.1 5.0 10.4 2.6 1.3 2.7 30.2 2.7 26.6 1.2 4.1 10.3 12.9 16.6 6.2 9.9 13.3 8.0 10.1 8.7 17.2 11.3 0.0 9.3 8.6 2.1 4.9 0.7 2.6 2.5 1.4 2.3 8.7 0.0 3.3 3.3 2.2 3.2 18.3 0.0 0.0 1.3 4.0 9.3 2.4 18.4 0.8 56.4 0.0 0.0 42.4 40.1 1.8 17.0 30.6 13.5 6.4 0.1 62.2 2.1 0.0 24.1 2.1 3.2 12.9 8.0 0.9 1.9 3.9 5.0 11.5 0.2 3.1 PLIN4 "KIAA1881, S3-12" ENSG00000167676 "Perilipin 4" Q96Q06 19 4502180-4518465 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 31.3;Cholangiocytes: 10.2;Hepatocytes: 25.9;Ito cells: 10.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enhanced" "Detected in single" "granulocytes: 1.3" "Cell line enriched" "Detected in some" 9 "ASC diff: 77.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044682, HPA054657" Enhanced Enhanced "Lipid droplets,Plasma membrane,Cytosol" NA NA 11000 "Plasma membrane, Cytosol" "Lipid droplets" "HPA044682: AB_2679044, HPA054657: AB_2682559" "unprognostic (2.97e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (8.31e-4)" "prognostic unfavorable (2.31e-4)" "unprognostic (6.65e-2)" "unprognostic (6.77e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-2)" "unprognostic (9.89e-3)" "unprognostic (1.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.81e-1)" "unprognostic (1.90e-1)" "unprognostic (6.09e-3)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" 155.0 1.2 0.9 7.4 0.8 0.8 80.6 0.5 0.9 2.4 8.5 0.6 2.4 0.8 3.7 2.2 3.8 2.5 8.3 15.5 0.6 0.1 0.6 11.1 0.4 2.0 0.8 0.8 2.9 3.3 0.3 0.2 0.3 0.9 2.8 1.2 0.7 6.8 3.9 45.2 1.8 2.4 10.3 1.3 0.4 3.5 0.7 0.8 0.1 0.7 8.2 0.7 5.9 3.9 0.0 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 77.0 0.5 2.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.4 1.1 0.0 0.0 2.5 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 8.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.0 0.9 0.8 0.5 0.9 0.6 0.1 0.8 0.8 0.9 0.8 0.0 4.5 0.0 1.0 0.2 0.1 31.3 10.2 0.0 3.4 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 1.3 0.3 0.0 0.4 0.0 25.9 0.1 0.0 0.0 10.4 2.7 0.0 0.0 0.0 1.7 0.0 0.0 0.5 0.9 0.0 3.9 0.8 0.0 6.5 0.5 0.5 0.5 0.3 0.3 0.0 0.0 1.3 PLK2 SNK ENSG00000145632 "Polo like kinase 2" Q9NYY3 5 58453982-58460260 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 180.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 147.8;T-47d: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009624, HPA069329" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009624: AB_2167745, HPA069329: " "unprognostic (4.82e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (2.44e-2)" "unprognostic (1.06e-2)" "unprognostic (1.01e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" "unprognostic (3.46e-1)" "unprognostic (1.95e-3)" 11.4 3.7 19.6 4.0 40.2 4.4 23.4 1.3 39.4 20.6 5.7 3.7 5.0 5.1 19.2 7.1 17.7 9.5 18.2 28.1 18.8 5.1 6.9 17.6 17.7 3.8 4.2 20.6 11.8 12.6 3.8 3.3 25.9 8.7 8.7 8.7 12.6 22.1 6.2 8.7 20.9 6.1 15.4 2.7 54.7 4.7 19.8 7.4 1.0 8.9 16.6 7.5 14.2 15.5 1.2 2.9 3.0 1.6 10.4 1.2 0.6 16.4 14.9 5.2 0.4 2.7 4.5 2.0 3.5 5.9 11.7 6.8 1.1 14.6 0.0 23.2 12.6 28.5 20.7 0.2 8.1 10.7 0.0 0.4 0.0 6.7 1.2 14.8 0.0 0.4 2.6 11.3 4.5 12.7 147.8 23.5 0.0 0.0 0.5 23.1 6.0 0.0 0.0 0.9 1.6 2.4 0.8 14.3 0.0 30.8 3.3 0.3 0.7 10.8 2.1 9.5 9.7 51.9 0.2 30.0 3.2 8.7 1.4 28.1 0.0 0.0 0.0 2.5 0.0 14.4 3.0 0.7 2.3 0.1 1.6 0.0 1.2 0.7 0.0 2.9 0.9 1.2 0.6 1.9 10.4 0.6 2.0 0.5 0.6 19.6 40.2 1.3 39.4 18.8 5.1 4.2 20.6 8.7 7.4 17.9 18.6 2.7 128.0 125.8 2.8 105.2 22.9 18.7 68.2 17.4 3.9 55.6 8.3 96.4 5.7 109.7 37.3 0.0 69.2 180.6 32.4 45.1 9.2 6.0 13.5 0.0 80.9 51.5 8.9 2.3 11.8 11.2 23.6 5.4 25.3 3.5 71.6 40.7 10.3 2.5 2.7 0.0 79.3 72.4 10.4 90.5 108.6 6.4 24.3 54.0 PLK4 "Sak, STK18" ENSG00000142731 "Polo like kinase 4" O00444 4 127880861-127899195 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 48.9;Erythroid cells: 23.3;Late spermatids: 60.1;Spermatocytes: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017327, HPA035026, HPA043198" Approved Supported Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504" "unprognostic (2.44e-1)" "unprognostic (4.24e-2)" "prognostic favorable (7.46e-5)" "unprognostic (2.18e-1)" "unprognostic (3.79e-1)" "unprognostic (9.20e-2)" "unprognostic (1.06e-5)" "prognostic unfavorable (5.13e-4)" "unprognostic (1.44e-3)" "unprognostic (5.66e-2)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.27e-1)" "unprognostic (2.22e-11)" "unprognostic (2.29e-2)" "unprognostic (3.58e-1)" "unprognostic (4.75e-2)" "unprognostic (7.93e-2)" 1.4 1.3 1.5 4.7 2.4 16.5 2.2 0.5 2.2 2.0 3.2 0.3 0.6 2.3 1.3 1.3 5.4 1.1 1.2 2.0 1.2 1.3 1.5 0.9 1.5 5.9 1.2 1.4 1.5 0.9 0.3 0.6 5.0 2.6 1.4 3.7 0.8 1.7 0.7 0.4 2.7 3.2 1.9 1.8 2.7 1.6 21.7 1.0 21.7 1.0 2.1 6.0 1.5 2.2 0.7 0.7 1.5 0.8 1.4 4.0 0.8 11.8 5.6 21.1 10.8 0.7 2.1 9.6 11.6 8.2 15.5 16.0 7.8 12.2 16.0 4.3 6.4 12.6 7.8 14.8 9.3 23.9 12.4 6.1 14.5 9.0 7.3 0.2 20.4 17.1 0.6 0.9 14.1 6.5 2.8 11.9 12.3 16.8 21.4 13.0 8.2 31.4 9.1 9.8 12.1 6.4 16.4 14.7 5.5 5.1 7.6 11.6 9.6 7.3 6.7 3.5 9.3 5.4 8.8 5.1 12.2 11.8 8.3 14.4 11.0 12.1 22.8 6.2 15.5 13.5 0.0 0.4 1.5 1.6 0.8 1.1 0.3 1.8 1.7 0.7 0.7 0.6 2.3 0.0 1.4 0.3 0.4 4.0 0.8 1.5 2.4 0.5 2.2 1.2 1.3 1.2 1.4 2.6 1.0 0.0 1.1 0.8 0.6 1.4 2.1 0.5 0.0 2.7 0.0 1.8 0.0 3.6 0.0 0.6 48.9 0.4 0.0 23.3 0.3 10.4 0.7 0.4 1.1 0.2 3.1 0.0 2.4 0.6 1.0 60.1 2.6 1.6 0.0 1.8 1.9 1.1 0.1 0.0 0.4 0.3 0.7 0.0 0.3 27.0 12.1 0.6 3.2 1.8 2.1 0.9 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.1" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Cell line enhanced" "Detected in many" "HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" NA NA "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavorable (7.64e-10)" "prognostic unfavorable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.99e-11)" "prognostic unfavorable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 36.7 14.1 11.2 18.0 12.1 0.7 28.5 7.9 13.5 8.8 25.2 5.1 8.3 21.6 14.8 7.5 12.0 8.0 22.3 16.6 12.5 8.2 16.4 73.1 9.3 3.0 10.7 4.8 17.7 14.4 13.9 7.8 41.0 13.0 11.1 16.1 7.2 7.7 11.3 4.8 3.2 24.7 24.2 19.4 3.2 13.6 6.3 10.9 6.1 47.6 3.5 3.0 21.8 28.7 0.0 0.0 1.5 0.3 0.0 0.0 1.9 16.4 11.8 3.7 1.2 13.5 14.5 9.4 58.5 17.9 31.9 60.2 0.9 1.7 0.0 11.4 9.9 14.6 3.5 4.3 50.3 82.6 0.0 6.8 4.1 11.5 8.2 34.7 0.0 0.0 25.4 7.2 27.6 13.5 93.9 44.0 0.0 5.4 0.2 56.3 6.0 0.0 0.0 2.3 0.0 5.1 0.0 2.4 0.0 13.4 0.8 1.8 0.0 46.6 5.0 4.9 18.1 13.6 0.5 55.2 39.5 12.0 12.5 34.9 17.9 2.5 0.0 73.6 0.0 7.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 11.2 12.1 7.9 13.5 12.5 8.2 10.7 4.8 13.0 10.9 14.9 10.7 0.5 5.9 6.3 14.5 10.6 61.1 12.0 13.6 26.2 33.4 6.8 8.3 62.8 0.4 21.2 46.1 0.0 45.9 109.4 34.5 8.1 0.0 50.8 4.7 0.0 19.0 18.4 1.5 1.3 12.0 2.7 13.5 1.0 18.3 65.1 83.0 31.5 4.6 6.9 22.4 19.4 38.1 8.0 16.3 4.8 15.7 0.7 21.3 5.4 PLPBP PROSC ENSG00000147471 "Pyridoxal phosphate binding protein" O94903 8 37762593-37779767 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 86.2;Exocrine glandular cells: 43.8;Hofbauer cells: 41.9;Proximal tubular cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017033, HPA023646, HPA023733" Approved Enhanced Cytosol NA NA 20000 Cytosol "CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742" "unprognostic (1.55e-2)" "unprognostic (2.17e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-2)" "unprognostic (1.34e-1)" "unprognostic (2.35e-2)" "unprognostic (2.36e-1)" "unprognostic (7.78e-3)" "unprognostic (1.80e-1)" "unprognostic (4.28e-2)" "unprognostic (2.83e-2)" "unprognostic (2.59e-2)" "unprognostic (9.41e-3)" "unprognostic (3.16e-2)" "unprognostic (3.99e-2)" "unprognostic (2.90e-1)" "unprognostic (7.85e-2)" 23.3 18.2 22.0 14.6 23.3 8.4 20.6 19.7 23.2 15.7 29.1 16.1 18.3 21.3 17.2 16.2 14.0 18.9 16.4 30.1 19.7 21.4 37.0 48.2 16.5 14.7 20.7 20.3 17.8 38.4 26.2 17.9 13.2 15.3 19.5 25.5 15.2 18.6 19.2 32.6 11.0 24.7 19.4 18.5 15.1 20.0 7.2 15.4 16.6 30.6 15.7 18.3 20.1 28.8 27.4 40.0 46.1 46.5 24.1 39.2 34.2 17.4 17.1 14.2 12.8 10.7 13.1 11.1 20.0 18.1 13.9 15.8 20.3 9.1 21.0 23.9 15.9 22.4 16.0 26.4 21.0 23.3 17.4 11.1 29.1 6.8 19.4 21.1 13.2 19.8 9.6 19.6 13.4 21.8 15.5 20.9 30.1 15.3 16.8 11.6 12.9 42.6 12.3 16.8 36.1 14.0 28.0 17.4 12.3 22.7 22.9 8.4 9.2 16.5 8.0 20.8 10.9 17.4 17.4 18.5 7.7 23.5 25.8 13.0 16.5 32.4 15.6 10.8 19.4 13.7 46.1 38.4 45.6 31.8 43.8 33.3 27.4 32.6 30.5 40.0 22.9 29.2 27.8 16.2 24.1 46.5 23.7 39.2 34.2 22.0 23.3 19.7 23.2 19.7 21.4 20.7 20.3 15.3 15.4 8.9 24.5 0.0 0.0 0.0 0.0 0.0 0.0 25.4 14.8 29.6 0.0 17.4 86.2 32.4 0.0 0.0 0.0 0.0 43.8 26.8 0.0 0.0 11.6 0.0 41.9 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 20.8 0.0 0.0 30.6 0.0 0.0 63.4 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 PLPP6 "FLJ46512, FLJ90191, PDP1, PPAPDC2" ENSG00000205808 "Phospholipid phosphatase 6" Q8IY26 9 4662315-4665258 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 74.5;Late spermatids: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HDLM-2: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018096 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA018096: AB_1855609" "unprognostic (2.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.03e-1)" "unprognostic (4.36e-3)" "unprognostic (1.17e-1)" "unprognostic (4.38e-2)" "unprognostic (6.95e-3)" "unprognostic (1.33e-1)" "unprognostic (5.26e-2)" "unprognostic (9.06e-2)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.99e-4)" "unprognostic (2.56e-1)" "unprognostic (2.28e-2)" "unprognostic (2.87e-2)" "unprognostic (5.88e-2)" 4.0 8.3 4.4 7.2 6.8 1.1 7.3 11.9 9.7 5.7 9.4 6.2 4.2 10.2 4.9 13.2 9.2 4.1 9.7 3.0 4.9 4.8 6.3 20.0 4.7 8.3 8.6 6.3 4.2 19.2 8.7 5.5 13.1 9.4 16.9 10.0 4.7 10.4 8.5 2.2 8.6 15.4 3.3 4.9 7.1 10.7 8.4 3.4 16.2 7.2 6.9 9.6 7.4 5.5 4.3 5.1 8.5 5.1 4.7 13.0 5.1 3.9 4.1 4.4 5.4 3.6 4.0 4.4 2.7 3.5 2.2 2.5 1.0 2.6 3.8 1.1 2.6 5.5 4.9 3.1 3.8 2.3 47.7 2.9 7.6 3.9 5.4 3.2 2.7 5.7 4.4 3.1 1.7 3.8 2.9 3.3 4.3 1.3 4.0 2.8 4.2 2.5 7.2 4.0 4.0 1.4 2.5 0.0 2.9 3.8 4.5 11.1 5.6 3.2 2.9 1.6 5.7 4.1 6.1 3.8 2.0 1.7 2.6 1.7 0.8 3.0 1.0 3.1 1.9 1.8 8.5 5.1 4.1 4.2 4.4 4.6 3.5 7.4 6.3 5.1 4.3 13.0 9.2 2.1 4.7 4.9 3.9 10.0 5.1 4.4 6.8 11.9 9.7 4.9 4.8 8.6 6.3 9.4 3.4 6.0 2.4 3.4 2.0 0.0 6.8 0.0 5.1 0.0 2.3 1.8 2.0 14.4 1.7 10.9 74.5 1.4 8.5 0.0 12.1 2.1 0.0 7.1 0.0 13.2 5.4 3.2 10.5 4.3 5.3 33.5 2.6 2.2 0.0 1.8 8.4 3.8 8.7 7.4 4.6 2.6 4.3 0.0 0.0 0.6 1.0 0.0 8.7 1.5 6.4 2.6 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Cell type enhanced" "Detected in single" 21 "Horizontal cells: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Group enriched" "Detected in some" 6 "NB-4: 24.1;THP-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: AB_2681787, HPA057034: AB_2683316" "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 5.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.1 0.9 0.0 0.0 0.0 2.1 0.0 0.6 0.0 0.2 1.7 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.4 0.0 24.1 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.1 0.0 0.0 2.7 2.2 51.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.9 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 18.6;testis: 5.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 7.2;Horizontal cells: 3.2" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 12.3;SH-SY5Y: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: AB_2732631" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.5 1.8 7.8 0.7 8.7 0.5 0.5 0.8 18.6 1.4 0.6 2.1 0.0 0.7 0.7 0.5 0.6 0.5 0.6 0.5 8.0 6.6 0.7 0.5 0.7 0.5 2.5 4.5 0.6 1.6 0.5 0.3 0.5 3.6 0.6 0.8 1.8 0.5 1.0 0.9 0.6 0.7 0.6 1.0 0.5 0.7 5.5 1.8 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 12.3 0.0 0.0 0.0 0.5 0.1 0.4 22.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 8.7 0.8 11.6 8.0 6.6 2.5 4.5 3.6 1.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.7 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 PLS3 T-plastin ENSG00000102024 "Plastin 3" P13797 X 115561174-115650861 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 196.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 13.1" "Group enriched" "Detected in many" 6 "dendritic cells: 13.1;NK-cells: 4.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020433, HPA076083" Approved Approved "Plasma membrane,Cytosol" NA NA 110000000 "Plasma membrane, Cytosol" "HPA020433: AB_2670440, HPA076083: AB_2686773" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "unprognostic (6.10e-2)" "unprognostic (4.37e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (6.07e-5)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (1.83e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (5.15e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.72e-4)" "prognostic unfavorable (7.04e-4)" 41.9 11.0 11.8 9.8 12.5 0.2 24.6 3.6 16.7 43.8 14.3 13.9 24.1 6.0 37.4 27.6 54.4 21.5 23.6 18.8 12.2 8.2 40.7 100.5 64.7 6.0 14.7 13.7 44.4 8.9 2.7 4.6 21.9 22.7 21.6 9.2 10.6 16.6 31.4 17.7 38.4 8.2 34.6 14.5 31.6 13.3 14.9 13.0 5.1 64.8 34.7 12.5 38.7 29.0 0.0 13.1 0.4 0.1 4.2 1.5 0.2 28.1 29.0 25.4 7.3 25.7 24.0 38.8 29.4 33.2 28.2 34.2 31.4 23.5 0.1 85.2 24.2 20.9 36.3 26.9 47.9 45.9 0.4 33.7 2.7 36.0 13.1 23.3 0.0 1.4 15.2 23.0 43.6 30.8 45.6 61.1 2.3 0.0 0.0 26.9 8.2 0.0 0.3 33.7 12.2 34.8 0.0 17.0 0.6 33.7 15.3 0.0 5.3 61.8 15.4 12.4 38.4 8.5 0.4 66.8 45.8 7.8 46.6 58.8 1.1 4.1 0.5 20.0 0.1 18.9 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.1 4.2 0.0 13.1 1.5 0.2 11.8 12.5 3.6 16.7 12.2 8.2 14.7 13.7 22.7 13.0 196.5 74.7 2.9 91.8 110.9 0.2 12.5 20.4 13.4 73.9 94.2 0.0 2.1 11.6 57.0 8.6 106.8 2.5 0.0 46.9 97.6 65.4 15.9 0.0 74.6 3.6 0.0 12.7 79.2 6.3 6.5 48.1 4.7 54.0 1.0 5.7 24.0 49.2 4.3 77.8 17.5 1.2 51.8 106.6 1.2 20.9 117.2 3.8 4.3 11.8 92.1 PLVAP "FELS, gp68, PV-1, PV1" ENSG00000130300 "Plasmalemma vesicle associated protein" Q9BX97 19 17351448-17377350 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.3" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 20.4;Endothelial cells: 32.1;Ito cells: 41.7;Melanocytes: 21.9;Suprabasal keratinocytes: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 22.1" "Cell line enriched" "Detected in some" 28 "EFO-21: 112.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA002279 Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA 53000 Cytosol "Plasma membrane, Centrosome" "HPA002279: AB_1079636" "unprognostic (3.19e-1)" "unprognostic (8.22e-2)" "unprognostic (7.87e-2)" "unprognostic (2.38e-2)" "unprognostic (1.93e-2)" "unprognostic (2.49e-3)" "unprognostic (4.17e-3)" "unprognostic (1.01e-1)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" "unprognostic (8.96e-2)" "unprognostic (4.24e-3)" "unprognostic (4.70e-3)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (8.17e-2)" 128.3 9.8 0.8 16.4 0.9 0.0 56.3 0.4 1.5 28.7 29.8 3.2 12.8 20.2 32.0 19.8 27.4 16.6 43.1 18.9 1.1 0.4 33.7 4.6 13.1 34.6 0.9 0.5 14.3 22.9 13.8 16.1 12.6 2.7 26.1 5.2 26.3 16.0 10.4 20.7 11.5 23.7 13.5 1.2 77.8 22.1 9.5 0.7 3.8 88.3 13.9 15.2 30.1 87.7 0.0 22.1 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.0 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 22.1 0.0 0.3 0.8 0.9 0.4 1.5 1.1 0.4 0.9 0.5 2.7 0.7 6.0 0.0 0.0 0.7 20.4 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.7 32.1 0.0 0.0 2.3 0.1 5.6 1.4 0.0 0.0 1.4 0.0 0.0 41.7 2.7 0.6 0.0 3.8 21.9 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 10.8 0.4 0.4 14.6 0.1 0.0 0.0 1.7 PLXNA1 "NOV, PLXN1" ENSG00000114554 "Plexin A1" Q9UIW2 3 126988594-127037392 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007499, CAB012483" Uncertain Supported Nucleoplasm,Cytosol NA NA 2600000 Nucleoplasm Cytosol "CAB012483: , HPA007499: AB_1079637" "unprognostic (1.87e-1)" "unprognostic (1.11e-1)" "unprognostic (4.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "prognostic unfavorable (4.13e-6)" "unprognostic (1.79e-2)" "unprognostic (9.06e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (3.77e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.64e-5)" "unprognostic (4.50e-3)" "unprognostic (7.62e-3)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 4.6 2.1 4.4 3.8 2.5 0.0 3.1 5.2 9.3 3.6 2.5 2.5 2.5 1.6 3.8 5.2 3.7 3.3 2.7 10.2 6.2 5.3 2.5 5.3 6.3 3.1 2.9 5.0 5.0 4.9 18.7 2.5 4.9 3.9 3.7 0.7 2.5 7.9 4.1 5.6 8.8 2.5 2.9 2.5 5.6 2.3 5.2 2.5 2.5 3.2 2.5 2.5 3.5 12.6 0.6 0.0 0.0 0.9 0.0 1.1 0.5 18.0 8.6 9.5 7.5 12.6 14.1 15.2 10.8 9.2 6.2 6.2 28.5 8.5 2.0 16.3 11.6 8.4 28.0 4.9 21.2 2.6 2.9 7.7 0.2 5.0 7.3 8.3 2.1 1.5 14.1 14.9 11.5 9.0 6.3 3.1 6.1 10.4 3.8 6.6 10.6 4.2 4.0 9.2 5.7 7.7 5.6 24.4 5.6 5.4 36.5 8.5 9.3 7.8 7.5 10.3 6.5 12.0 13.7 11.4 10.0 12.9 18.2 11.3 2.3 1.5 3.9 14.3 4.1 10.5 0.0 0.0 0.0 0.7 0.1 1.1 0.5 0.6 0.3 0.0 0.6 0.3 0.4 0.0 0.0 0.9 0.0 0.8 0.5 4.4 2.5 5.2 9.3 6.2 5.3 2.9 5.0 3.9 2.5 44.7 2.6 1.5 4.5 14.1 3.8 10.9 2.5 5.3 18.2 12.2 3.9 16.8 0.0 7.4 1.2 4.3 5.1 0.0 6.0 2.1 11.4 4.7 0.0 1.0 11.3 19.1 9.2 2.5 5.6 0.8 7.2 2.8 8.5 1.8 4.5 2.4 12.9 2.9 6.0 1.1 2.9 6.5 9.5 6.3 9.2 14.1 6.1 0.0 3.9 5.0 PMM1 Sec53 ENSG00000100417 "Phosphomannomutase 1" Q92871 22 41576894-41589890 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030712, HPA074950" Uncertain Supported Cytosol NA NA Cytosol "HPA030712: AB_10669600, HPA074950: " "unprognostic (2.66e-1)" "prognostic favorable (5.92e-4)" "unprognostic (3.25e-2)" "prognostic favorable (6.09e-6)" "unprognostic (1.25e-1)" "unprognostic (2.85e-2)" "unprognostic (1.01e-2)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "unprognostic (1.78e-1)" "prognostic favorable (2.05e-4)" "unprognostic (6.56e-3)" "unprognostic (5.76e-3)" "unprognostic (2.78e-2)" "unprognostic (1.72e-1)" "unprognostic (1.40e-2)" "unprognostic (2.70e-1)" 20.8 25.1 24.3 15.2 28.8 15.3 15.0 15.5 27.9 24.7 29.5 12.6 14.1 25.3 12.1 20.1 36.5 24.8 14.7 17.7 19.6 20.6 32.8 32.2 21.7 10.8 20.3 25.5 34.8 30.5 7.7 8.7 9.7 17.8 13.7 13.9 11.8 13.0 17.3 6.6 13.6 22.0 14.3 15.2 6.0 24.5 27.6 13.2 8.8 8.9 12.7 14.7 15.2 13.2 10.6 13.2 24.5 12.7 6.8 27.1 10.3 5.3 9.8 6.7 14.4 19.4 30.2 7.8 21.1 24.1 19.5 21.5 7.8 5.1 5.0 7.1 25.1 14.0 8.0 8.8 13.6 11.0 10.3 13.5 1.2 12.3 16.4 30.8 7.4 8.1 25.1 13.2 20.1 8.5 21.7 3.1 8.1 5.5 17.8 26.4 14.0 5.6 10.7 2.1 25.2 13.2 4.3 7.2 10.3 8.2 5.7 1.9 3.8 17.2 6.2 25.2 5.5 7.0 8.2 2.4 22.0 12.1 20.5 10.8 11.2 10.8 7.9 24.6 6.2 13.2 9.6 12.7 24.5 16.3 10.2 13.8 10.4 16.8 13.8 13.2 10.6 18.3 12.9 16.6 6.8 12.0 5.0 27.1 10.3 24.3 28.8 15.5 27.9 19.6 20.6 20.3 25.5 17.8 13.2 32.8 81.3 24.1 11.2 13.2 18.0 10.2 61.1 46.8 36.4 33.2 5.9 49.2 91.2 22.6 11.4 5.8 103.9 23.3 9.6 78.2 28.7 9.3 3.5 75.7 29.4 27.0 46.8 10.4 11.3 10.8 25.9 14.0 42.2 25.2 41.2 49.6 15.1 112.2 28.7 109.0 19.6 38.8 39.8 45.9 10.4 12.3 54.6 20.3 47.6 5.5 PMM2 "CDG1, CDG1a, CDGS, PMI, PMI1" ENSG00000140650 "Phosphomannomutase 2" O15305 16 8788823-8849331 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Club cells: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "basophil: 52.2" "Lineage enriched" "Detected in all" 10 "granulocytes: 52.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040852, HPA063649" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040852: AB_10794069, HPA063649: AB_2685074" "unprognostic (8.62e-3)" "unprognostic (8.00e-3)" "prognostic favorable (1.04e-4)" "unprognostic (3.58e-2)" "unprognostic (1.79e-1)" "unprognostic (1.98e-2)" "unprognostic (6.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (5.14e-3)" "unprognostic (2.62e-1)" "prognostic unfavorable (8.97e-6)" "unprognostic (1.22e-1)" "unprognostic (2.50e-2)" "unprognostic (6.89e-2)" "unprognostic (5.02e-2)" 14.8 13.1 6.8 15.4 9.0 4.3 13.6 8.2 8.2 11.4 19.4 7.0 11.6 18.9 9.7 13.1 22.7 10.0 13.9 10.7 4.7 2.9 14.6 43.3 11.8 11.2 6.6 4.3 7.8 40.4 7.8 28.3 19.9 6.6 12.0 20.4 8.8 21.2 13.5 12.5 13.2 19.6 9.5 5.7 12.0 15.2 9.7 7.8 7.6 10.0 12.0 22.0 10.5 12.2 2.9 3.5 52.2 4.9 1.6 3.6 3.0 10.8 24.3 5.4 14.1 9.6 15.2 12.0 17.0 20.6 17.1 18.5 18.2 13.5 17.4 7.2 29.7 9.0 15.1 11.0 20.8 17.5 12.9 12.9 5.7 14.7 31.0 18.3 15.2 13.8 22.7 14.8 18.2 16.8 7.9 17.4 10.8 7.8 17.0 11.3 28.5 15.6 14.0 22.9 25.4 15.8 19.8 12.0 34.6 19.0 19.3 10.3 19.3 14.0 30.9 10.2 9.0 20.1 13.4 20.1 12.3 13.9 33.2 16.6 21.0 17.6 21.9 10.3 19.2 16.3 52.2 4.9 0.9 2.5 3.7 3.6 2.9 2.2 3.2 3.5 2.4 2.5 2.4 7.8 1.6 2.3 3.2 1.6 3.0 6.8 9.0 8.2 8.2 4.7 2.9 6.6 4.3 6.6 7.8 14.9 17.9 9.8 6.8 3.4 4.8 2.4 5.1 26.8 46.6 0.0 13.7 7.4 8.3 10.9 0.2 4.5 10.2 23.3 24.6 9.5 5.4 9.5 22.0 11.3 5.1 1.6 7.5 3.7 6.0 0.6 5.8 6.3 1.7 8.2 11.5 2.3 17.8 10.2 2.1 10.0 8.9 0.0 5.2 1.6 3.1 3.6 8.9 5.1 9.2 11.3 PNCK "CaMK1b, MGC45419" ENSG00000130822 "Pregnancy up-regulated nonubiquitous CaM kinase" Q6P2M8 X 153669730-153689010 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4;seminal vesicle: 38.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 16.5;Cone photoreceptor cells: 21.6;Extravillous trophoblasts: 44.0;Rod photoreceptor cells: 19.4;Syncytiotrophoblasts: 41.4" "Cancer enhanced" "Detected in many" "renal cancer: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "AN3-CA: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007458 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA007458: AB_1079644" "unprognostic (1.56e-1)" "unprognostic (2.56e-1)" "unprognostic (1.16e-2)" "unprognostic (5.95e-3)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-2)" "unprognostic (3.60e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.04e-6)" "unprognostic (2.86e-3)" "unprognostic (1.43e-1)" "unprognostic (2.66e-1)" "unprognostic (6.26e-3)" 1.6 1.8 21.4 2.2 35.4 0.6 0.9 3.7 24.9 0.9 21.9 0.9 6.9 3.8 4.2 3.1 14.5 2.9 2.9 3.8 19.5 17.0 1.0 0.5 0.7 0.6 6.1 15.5 0.7 0.5 1.4 0.3 2.4 3.8 12.6 4.2 0.4 0.7 38.5 2.2 1.4 5.2 15.3 2.6 0.7 5.5 4.7 1.7 0.0 0.5 0.0 0.7 10.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 27.1 0.0 0.0 2.9 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.3 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 3.2 0.0 0.1 2.2 0.8 0.3 0.3 0.0 0.2 1.1 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 35.4 3.7 23.2 19.5 17.0 6.1 15.5 3.8 1.7 0.0 0.0 0.0 0.4 0.6 16.5 2.8 0.0 0.0 0.0 0.0 21.6 8.3 0.0 0.2 0.2 0.3 2.0 0.0 0.3 44.0 0.2 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.4 2.7 4.8 0.0 0.4 0.1 19.4 0.0 0.4 0.5 0.6 0.5 41.4 0.0 0.0 0.9 PNISR "bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130" ENSG00000132424 "PNN interacting serine and arginine rich protein" Q8TF01 6 99398051-99425331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038796, HPA075076" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles" "Plasma membrane, Cytosol" "HPA038796: AB_10672652, HPA075076: " "unprognostic (2.95e-1)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "unprognostic (9.72e-3)" "unprognostic (1.68e-2)" "unprognostic (8.55e-3)" "unprognostic (4.41e-2)" "unprognostic (1.58e-3)" "unprognostic (5.82e-2)" "unprognostic (4.32e-3)" "prognostic favorable (5.27e-4)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (3.43e-2)" "unprognostic (2.59e-1)" "unprognostic (8.89e-2)" "prognostic favorable (1.09e-4)" 24.7 28.5 48.9 28.3 49.8 53.7 29.9 123.3 69.7 35.5 38.3 22.8 39.9 26.7 43.1 58.7 19.8 29.4 22.3 31.0 46.9 17.5 25.5 21.7 26.6 42.2 48.0 29.8 49.3 24.7 34.7 83.9 21.7 41.0 34.1 28.2 24.1 30.8 34.5 39.4 31.9 34.4 31.5 61.0 39.3 28.2 17.4 57.1 32.1 44.7 18.0 30.7 29.5 30.3 18.0 13.1 20.4 7.4 15.6 12.3 2.2 11.1 7.5 40.3 27.6 14.4 21.4 18.7 17.6 9.7 10.5 13.1 13.5 20.2 34.1 11.8 9.9 12.3 17.0 20.2 15.4 21.4 28.0 22.6 19.8 37.4 13.5 10.9 27.4 28.0 21.0 21.9 11.7 15.3 38.3 15.4 18.1 23.0 22.4 13.9 11.1 13.0 31.5 22.5 10.2 7.0 26.3 11.4 12.2 20.7 19.3 16.3 21.6 8.8 11.4 15.1 33.0 15.3 24.2 16.9 10.6 12.6 10.3 15.0 15.6 10.7 31.3 16.0 28.2 12.3 6.9 7.4 6.6 8.6 4.2 8.5 12.0 8.4 6.8 3.3 18.0 12.3 11.8 20.4 15.6 4.8 13.1 7.7 2.2 48.9 49.8 123.3 69.7 46.9 17.5 48.0 29.8 41.0 57.1 172.7 197.8 329.9 282.6 173.4 521.3 112.2 109.5 187.4 202.4 169.3 420.2 132.4 63.0 108.9 13.5 170.1 148.0 70.0 90.8 86.5 187.1 270.2 182.8 89.8 87.1 470.4 237.9 98.8 88.1 13.3 549.4 181.7 158.6 221.0 84.6 269.4 105.3 147.3 414.8 35.6 432.5 245.8 215.3 310.7 171.1 151.8 151.3 236.8 126.4 254.3 PNMA1 MA1 ENSG00000176903 "PNMA family member 1" Q8ND90 14 73711783-73714372 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003817, HPA015007" Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA Cytosol "Nucleoplasm, Focal adhesion sites" "HPA003817: AB_1079646, HPA015007: AB_1855502" "unprognostic (2.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (7.49e-5)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.90e-1)" "unprognostic (5.35e-2)" "unprognostic (3.63e-1)" "unprognostic (5.58e-2)" "unprognostic (4.58e-2)" "unprognostic (1.67e-3)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (2.23e-3)" "prognostic unfavorable (4.51e-5)" 19.6 18.0 39.1 11.1 42.4 4.7 17.4 30.4 68.2 16.0 19.3 11.2 15.8 8.2 20.5 32.4 13.9 20.9 14.3 13.1 29.6 33.5 16.4 3.1 8.4 12.5 25.8 39.4 31.8 5.7 6.7 20.9 12.3 27.0 29.0 10.1 8.9 4.6 53.4 5.8 4.5 9.1 29.5 19.8 10.1 10.9 38.1 17.3 6.0 11.0 2.5 7.3 14.8 21.2 3.3 3.6 4.0 4.6 4.8 12.8 6.4 15.0 13.7 23.7 17.6 17.9 19.0 9.8 16.0 9.0 14.7 10.8 12.9 9.4 0.3 11.2 19.4 14.0 10.1 18.2 9.5 15.2 14.3 11.2 8.6 11.5 9.6 19.2 4.7 13.7 16.7 11.5 17.5 11.1 29.0 22.1 9.3 7.4 9.6 19.9 37.0 9.4 11.6 7.1 7.8 48.5 14.9 14.8 0.3 19.3 0.4 28.2 21.6 28.2 6.5 12.6 15.0 31.6 8.1 21.3 29.7 23.9 18.0 12.9 8.5 13.1 4.5 29.3 6.8 9.8 2.6 1.7 4.0 8.4 3.3 5.6 2.9 10.8 8.5 3.6 3.3 10.6 9.7 1.6 4.8 4.6 0.6 12.8 6.4 39.1 42.4 30.4 59.9 29.6 33.5 25.8 39.4 27.0 17.3 6.0 4.0 2.4 6.5 3.4 46.6 16.9 0.0 17.4 3.4 14.0 11.8 6.4 13.3 8.4 68.4 12.6 3.1 0.0 5.9 9.3 17.3 7.4 16.1 0.9 13.5 55.6 18.0 22.1 5.4 42.0 30.2 13.2 18.6 19.8 3.7 60.0 19.1 0.0 79.5 17.9 44.9 71.1 44.2 97.4 36.5 3.3 5.0 13.8 1.7 3.1 PNMA8A "FLJ10781, KIAA1183L, PNMAL1" ENSG00000182013 "PNMA family member 8A" Q86V59 19 46466491-46471563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0" "Group enriched" "Detected in some" 4 "Ciliated cells: 20.1;Collecting duct cells: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 17.9;K-562: 18.9;LHCN-M2: 19.6;SH-SY5Y: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012956, HPA077702" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA012956: AB_1844328, HPA077702: " "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "unprognostic (9.35e-3)" "unprognostic (1.01e-1)" "unprognostic (6.90e-3)" "unprognostic (1.76e-3)" "unprognostic (9.56e-2)" "unprognostic (1.78e-2)" "unprognostic (2.85e-2)" "unprognostic (1.82e-1)" "unprognostic (6.48e-3)" 1.2 17.4 18.6 1.2 26.4 1.1 3.9 24.8 61.0 2.9 1.6 5.1 1.2 1.2 9.7 12.7 1.5 16.7 4.3 10.7 16.6 29.9 7.2 0.9 1.8 0.8 14.1 25.7 13.5 5.0 3.8 14.5 2.4 19.5 7.1 1.1 5.4 4.4 8.1 1.2 1.5 1.3 5.9 8.9 0.9 1.4 16.1 4.4 4.3 11.7 0.0 1.0 1.9 0.7 1.1 1.1 3.0 0.5 0.8 2.6 0.3 0.0 7.4 10.8 10.7 3.2 7.2 2.0 0.7 0.1 1.3 0.7 0.1 0.8 0.0 10.1 0.5 3.8 0.1 17.9 2.9 0.9 0.0 6.7 0.0 0.2 0.2 5.3 0.1 0.1 1.8 3.6 4.5 0.0 1.0 1.0 6.4 18.9 0.1 19.6 0.0 0.1 0.1 9.1 0.0 0.0 0.0 11.9 0.0 4.5 0.0 8.8 17.4 0.0 0.2 0.0 10.4 0.1 0.2 0.6 0.0 0.1 0.1 3.6 0.0 0.0 0.1 0.1 0.0 1.2 3.0 0.5 0.3 0.3 0.3 0.2 1.1 0.3 0.9 0.1 0.7 0.4 2.6 1.3 0.8 0.1 1.1 0.2 0.3 18.6 26.4 24.8 37.2 16.6 29.9 14.1 25.7 19.5 4.4 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 20.1 3.4 10.4 0.0 0.7 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PNP "NP, PUNP" ENSG00000198805 "Purine nucleoside phosphorylase" P00491 14 20468954-20477094 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 153.1" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 276.6;Syncytiotrophoblasts: 540.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 82.7;U-937: 94.3" "Low region specificity" "Detected in all" HPA001625 Enhanced Supported Cytosol NA NA 100000000 Cytosol "HPA001625: AB_1854577" "unprognostic (1.20e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" "unprognostic (1.70e-1)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (4.94e-3)" "unprognostic (3.87e-2)" "unprognostic (7.45e-2)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "prognostic favorable (2.24e-4)" "unprognostic (1.69e-1)" "unprognostic (7.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" 24.7 7.6 9.5 15.0 14.0 69.4 15.7 13.9 11.8 9.5 19.1 6.2 25.2 29.4 5.9 153.1 34.0 7.8 15.7 12.1 11.5 8.4 49.7 24.2 18.3 13.2 13.5 3.4 3.6 11.0 8.7 8.4 45.3 17.7 6.0 16.1 3.8 9.2 7.9 3.3 10.6 32.0 9.8 16.3 18.0 17.0 4.5 12.5 7.0 7.1 21.7 19.1 7.5 14.7 13.1 20.7 4.1 12.4 15.7 33.7 12.1 13.4 18.2 3.8 8.7 4.4 3.5 11.9 13.8 6.5 11.3 11.1 10.5 12.3 36.0 16.0 7.3 13.3 14.6 20.4 26.0 15.0 11.6 17.9 30.1 15.5 17.3 4.1 82.7 15.7 2.4 9.4 34.0 15.1 6.2 48.1 22.3 14.8 22.5 14.1 12.5 24.3 48.8 11.0 34.4 30.4 20.6 5.8 14.0 40.1 12.8 16.9 3.7 26.5 33.7 2.1 5.6 12.4 14.7 38.5 7.7 10.3 17.3 23.4 10.3 17.2 40.7 6.6 94.3 0.7 4.0 12.4 4.1 18.1 11.5 33.7 11.2 20.3 20.0 20.7 13.1 12.9 16.3 1.6 15.7 10.6 11.7 6.9 12.1 9.5 14.0 13.9 11.8 11.5 8.4 13.5 3.4 17.7 12.5 0.0 26.3 18.6 51.4 75.2 4.8 3.1 28.1 8.1 17.0 78.5 13.7 276.6 33.2 38.4 1.0 60.2 56.3 93.5 44.5 26.6 19.4 21.8 56.6 23.1 63.4 15.9 44.5 19.6 22.4 0.0 0.3 46.2 28.7 1.0 31.7 70.2 85.7 56.1 0.7 91.5 17.0 0.0 33.8 0.2 0.6 55.8 540.4 19.3 34.8 70.5 PNPLA3 "adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon" ENSG00000100344 "Patatin like phospholipase domain containing 3" Q9NST1 22 43923739-43964488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 31.1;retina: 39.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.5;LHCN-M2: 15.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA058058 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA Nucleoli "Mitochondria, Cytosol" "HPA058058: AB_2683590" "unprognostic (4.74e-3)" "unprognostic (4.52e-2)" "unprognostic (1.76e-1)" "unprognostic (2.31e-1)" "unprognostic (1.36e-2)" "unprognostic (1.89e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.63e-1)" "unprognostic (2.93e-1)" "unprognostic (2.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-3)" "unprognostic (2.52e-3)" "unprognostic (5.91e-2)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" 2.8 0.4 0.5 0.7 1.0 0.3 4.0 0.3 2.4 0.8 1.3 0.4 0.0 1.0 0.5 1.9 0.4 1.1 0.5 0.9 0.8 0.6 4.6 31.1 1.4 0.4 0.3 1.8 0.5 0.2 0.6 0.2 0.4 2.2 0.2 0.2 39.3 0.9 0.2 2.2 5.3 0.6 0.2 0.5 0.6 0.3 0.5 0.3 0.0 0.2 0.0 0.3 0.2 0.4 1.2 0.7 1.8 0.6 0.9 0.8 0.0 3.9 1.3 13.5 5.5 3.8 4.3 0.4 2.4 1.4 3.3 7.2 3.9 7.1 0.0 2.1 4.0 1.9 3.4 8.4 3.9 2.8 0.0 0.7 0.2 3.2 7.2 6.2 0.0 0.2 4.9 3.1 10.6 0.5 5.7 0.4 0.1 0.0 0.0 15.3 0.6 0.2 0.0 9.2 0.4 0.0 0.0 7.3 0.1 1.5 0.2 1.2 0.1 2.7 1.1 3.8 2.4 4.2 4.6 0.4 1.3 4.1 0.1 0.1 0.0 0.0 0.0 11.6 0.0 4.8 1.5 0.6 0.4 0.5 0.4 0.3 0.7 0.4 0.3 0.2 1.2 0.6 0.8 1.8 0.9 0.3 0.7 0.2 0.0 0.5 1.0 0.3 2.4 0.8 0.6 0.3 1.8 2.2 0.3 0.0 0.0 0.0 0.5 0.3 37.1 1.1 15.3 0.0 0.0 0.0 17.7 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.4 0.0 42.7 0.6 0.0 1.7 0.6 2.6 0.0 0.3 0.0 1.7 0.0 0.5 1.3 1.5 0.0 0.7 5.0 34.3 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.4 PNPLA6 "iPLA2delta, NTE, SPG39, sws" ENSG00000032444 "Patatin like phospholipase domain containing 6" Q8IY17 19 7534004-7561764 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007522, HPA064773" Uncertain Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA007522: AB_1079649, HPA064773: " "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.52e-1)" "unprognostic (3.23e-2)" "unprognostic (2.78e-1)" "prognostic favorable (5.25e-4)" "unprognostic (3.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.07e-2)" "unprognostic (1.62e-1)" "prognostic favorable (3.51e-5)" "unprognostic (3.36e-1)" "prognostic favorable (7.53e-4)" "unprognostic (3.10e-3)" "unprognostic (3.50e-1)" "unprognostic (3.25e-1)" "unprognostic (2.17e-1)" 12.9 19.7 25.9 25.0 29.3 22.3 17.8 22.1 35.8 10.2 15.9 26.1 10.0 26.3 13.7 6.3 16.4 12.6 14.0 12.0 22.6 19.1 17.1 13.7 30.4 17.6 36.3 19.2 12.5 14.2 15.6 21.6 13.9 29.2 13.4 8.9 15.8 13.7 14.3 27.0 15.3 28.7 14.5 23.5 28.3 12.2 31.3 33.0 7.1 14.7 6.1 8.8 15.9 14.7 3.8 7.3 21.8 19.0 5.0 3.9 4.1 13.2 31.9 6.3 15.2 11.0 16.0 14.5 17.2 17.7 13.4 12.4 7.4 18.3 10.9 29.3 22.2 8.3 17.0 5.3 16.2 6.9 26.6 12.3 7.2 17.0 5.6 12.7 8.0 22.5 13.8 9.4 17.2 10.0 21.3 26.4 13.0 5.9 15.1 11.9 6.2 8.8 10.5 6.9 6.2 29.3 7.1 3.8 12.8 11.9 12.6 8.0 13.9 14.6 6.6 18.7 8.9 5.9 11.5 27.9 16.3 9.6 22.3 18.0 17.9 11.5 4.8 27.4 9.5 15.2 7.9 6.1 21.8 3.5 12.1 3.5 3.8 2.5 3.8 7.3 2.8 2.2 2.9 1.9 5.0 19.0 2.4 3.9 4.1 25.9 29.3 22.1 35.8 22.6 19.1 36.3 19.2 29.2 33.0 6.0 11.8 6.5 2.7 4.2 10.9 8.6 17.8 8.1 6.8 31.4 25.5 14.9 1.7 13.7 60.0 10.8 52.1 0.0 6.1 12.2 4.1 4.5 11.5 19.2 24.9 20.6 16.7 10.4 55.8 82.5 8.9 23.8 8.5 10.0 13.4 10.6 8.4 12.9 7.1 17.0 16.2 0.0 6.2 58.2 10.0 4.8 10.4 10.0 14.0 3.1 PNPLA7 "C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2" ENSG00000130653 "Patatin like phospholipase domain containing 7" Q6ZV29 9 137459953-137550534 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 16.6" "Cancer enhanced" "Detected in many" "prostate cancer: 9.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6;T-reg: 3.5" "Group enriched" "Detected in many" 5 "B-cells: 3.6;T-cells: 3.5" "Cell line enriched" "Detected in some" 23 "HMC-1: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009130 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA009130: AB_2268411" "unprognostic (1.49e-1)" "unprognostic (1.40e-2)" "unprognostic (3.61e-3)" "unprognostic (2.38e-2)" "unprognostic (3.68e-2)" "unprognostic (6.69e-3)" "unprognostic (2.72e-3)" "unprognostic (5.14e-4)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "prognostic favorable (2.24e-5)" "unprognostic (1.09e-1)" "unprognostic (2.23e-3)" "unprognostic (2.42e-1)" "unprognostic (6.80e-2)" "unprognostic (8.81e-2)" "unprognostic (3.45e-3)" 9.3 5.6 10.6 2.8 11.0 2.8 6.3 17.0 11.4 6.4 4.5 6.7 3.8 3.1 7.6 2.1 2.2 5.8 4.7 4.8 8.4 2.6 2.3 7.4 4.1 5.4 9.7 9.7 9.7 17.7 3.3 7.1 1.1 6.6 14.7 2.1 5.4 18.7 4.8 19.1 15.4 4.8 7.2 6.7 5.4 9.6 1.8 11.6 0.4 7.6 4.2 2.8 7.8 3.7 3.6 0.7 0.0 0.4 0.0 3.5 0.5 0.0 0.5 0.1 0.2 0.4 0.3 0.2 0.4 0.4 0.1 0.1 0.0 0.2 0.3 0.4 0.2 0.2 0.1 0.0 0.0 0.0 0.8 0.4 0.4 0.4 0.1 0.3 0.2 43.9 0.6 0.1 0.1 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.8 0.1 0.8 0.0 0.6 0.5 1.0 0.7 1.3 0.0 0.2 0.8 0.2 0.0 0.3 0.1 0.1 1.9 0.6 0.3 0.0 0.1 0.2 0.0 0.4 0.1 0.1 0.6 0.4 0.0 0.0 0.4 0.0 0.8 0.3 0.0 0.8 0.5 0.4 0.7 3.6 1.2 0.9 0.0 0.0 0.1 0.4 3.5 0.5 10.6 11.0 17.0 11.4 8.4 2.6 9.7 9.7 6.6 11.6 8.9 5.1 3.7 1.0 1.3 2.5 3.2 2.5 1.4 3.4 1.8 5.9 0.1 0.0 0.4 0.3 0.7 3.5 0.0 0.0 0.2 1.0 3.5 6.9 6.7 2.1 4.8 16.6 2.5 2.5 0.2 4.0 0.9 0.0 1.8 7.4 3.5 0.8 5.8 1.8 0.8 9.1 0.0 0.9 1.6 1.4 2.9 0.0 0.0 1.8 0.7 PNPLA8 "IPLA2-2, IPLA2G, iPLA2gamma" ENSG00000135241 "Patatin like phospholipase domain containing 8" Q9NP80 7 108470422-108569666 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020083 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA020083: AB_1851849" "unprognostic (4.48e-2)" "unprognostic (3.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (4.61e-1)" "unprognostic (2.73e-2)" "unprognostic (3.48e-2)" "unprognostic (3.32e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (2.49e-1)" "prognostic favorable (1.86e-6)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (4.28e-3)" "unprognostic (1.24e-1)" 21.5 35.7 29.3 12.4 28.9 51.5 15.0 15.6 27.2 15.4 13.4 9.5 9.3 8.6 13.4 13.7 18.3 9.7 15.9 17.9 23.0 22.1 23.1 24.6 16.7 12.0 20.7 17.5 15.6 10.1 20.7 33.4 25.2 23.2 14.4 11.4 6.0 11.4 13.9 29.8 11.4 10.8 15.3 20.3 19.5 11.1 10.8 21.1 16.1 22.6 13.0 15.3 22.5 12.8 20.0 19.3 16.7 26.8 14.6 12.5 13.7 14.1 6.4 11.3 10.1 25.2 17.4 16.7 13.5 23.8 11.1 18.6 6.1 8.1 7.9 17.1 13.2 22.4 5.4 19.1 8.6 16.9 11.8 5.3 5.4 10.5 4.5 18.4 3.7 11.2 15.7 16.3 14.9 13.8 12.2 15.0 8.9 6.3 22.7 13.8 9.3 8.7 8.9 5.0 8.9 9.1 3.2 11.9 16.7 13.3 18.0 9.4 13.2 12.9 14.0 16.2 14.9 5.9 6.4 12.1 18.3 8.2 27.2 7.4 19.3 19.5 11.7 17.4 5.7 11.8 14.1 19.7 16.7 10.5 21.8 12.5 20.0 10.3 10.3 19.3 18.7 11.2 10.7 16.5 14.6 26.8 7.6 12.5 13.7 29.3 28.9 15.6 27.2 23.0 22.1 20.7 17.5 23.2 21.1 38.7 43.0 28.7 103.5 82.5 61.7 43.5 10.2 81.7 58.0 22.7 17.7 46.4 79.6 26.9 49.7 39.4 25.7 0.0 33.2 30.6 50.6 71.1 70.4 40.3 28.4 30.2 54.7 19.6 49.4 40.1 29.7 48.1 52.3 17.2 16.2 37.9 25.2 14.1 37.1 33.7 29.7 19.4 38.2 17.7 27.4 118.6 108.9 23.5 13.6 109.8 PNPO PDXPO ENSG00000108439 "Pyridoxamine 5'-phosphate oxidase" Q9NVS9 17 47941506-47949308 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Pyridoxine biosynthesis" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.7" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 53.0;Hepatocytes: 47.2;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023204, HPA027776" Enhanced Approved Nucleoplasm,Cytosol NA NA 150000 "Nucleoplasm, Cytosol" "HPA023204: AB_1855506, HPA027776: AB_10601246" "unprognostic (1.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (9.25e-2)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (2.62e-1)" "unprognostic (1.97e-2)" "unprognostic (6.65e-2)" "unprognostic (8.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.47e-3)" "unprognostic (8.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.74e-1)" 6.0 13.1 9.9 5.1 13.0 2.9 8.6 8.3 16.5 6.2 7.0 8.6 6.9 8.5 4.2 9.6 8.1 8.4 10.1 10.2 8.7 12.0 26.0 64.7 5.3 7.7 11.2 9.9 8.0 13.7 17.3 7.4 5.8 11.1 6.9 7.4 8.4 8.3 7.1 14.7 5.5 9.6 5.2 7.1 6.8 6.7 6.4 6.0 5.2 14.4 8.2 6.1 5.4 5.2 6.8 12.2 2.4 16.4 7.7 8.2 8.7 17.6 14.6 1.1 2.7 7.5 5.8 0.0 6.0 3.9 6.7 5.8 23.9 13.0 16.8 28.6 5.9 2.7 10.6 9.1 16.3 9.7 20.4 7.8 11.8 6.8 24.8 8.0 10.5 8.2 7.6 12.7 12.4 15.5 6.2 8.7 12.6 11.1 5.8 7.8 13.1 10.6 3.4 2.1 17.5 18.1 9.0 5.1 12.2 18.6 9.1 5.9 4.9 5.5 8.9 5.0 4.3 15.7 3.8 9.1 10.8 6.4 10.8 12.4 13.9 15.3 8.9 8.8 9.1 5.5 2.1 11.0 2.4 6.8 16.4 8.0 6.8 6.2 7.4 12.2 5.7 8.2 7.9 1.1 7.7 10.4 8.9 6.4 8.7 9.9 13.0 8.3 16.5 8.7 12.0 11.2 9.9 11.1 6.0 11.9 15.2 1.5 5.9 1.3 0.7 1.7 22.9 5.3 7.9 12.2 3.9 7.5 53.0 15.3 0.4 3.6 11.0 0.0 13.5 2.0 3.1 7.8 12.7 47.2 15.2 3.2 3.5 4.9 7.0 0.4 9.2 8.5 1.7 8.2 9.9 6.7 13.1 10.5 5.6 75.4 1.7 0.0 1.7 0.7 1.3 1.9 5.3 1.0 13.6 4.8 PNPT1 "DFNB70, old-35, OLD35, PNPase" ENSG00000138035 "Polyribonucleotide nucleotidyltransferase 1" Q8TCS8 2 55634265-55693910 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transport" "Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase" "Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033424, HPA034602, HPA034603" Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130" "unprognostic (9.09e-2)" "unprognostic (7.40e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (3.40e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (1.95e-7)" "unprognostic (1.88e-1)" "unprognostic (5.93e-3)" "unprognostic (5.23e-2)" "prognostic unfavorable (5.44e-5)" "unprognostic (2.19e-2)" "unprognostic (2.11e-2)" "unprognostic (6.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 11.1 11.7 13.3 6.5 21.7 11.7 10.8 13.3 18.8 5.7 8.2 12.8 5.4 5.7 8.3 8.8 9.5 7.9 5.8 11.0 12.4 10.9 9.8 11.4 9.1 7.1 24.1 7.4 6.9 9.1 7.4 14.3 5.1 15.2 7.7 10.1 4.2 9.0 6.3 23.5 10.1 7.0 7.9 17.6 10.4 7.6 13.5 22.5 9.6 10.0 7.8 5.9 5.3 7.4 9.8 7.4 6.1 6.5 3.8 8.6 4.7 6.8 3.7 5.1 2.3 3.6 6.4 6.8 10.2 6.2 16.2 10.9 10.7 3.2 14.3 4.3 4.7 5.2 5.5 6.5 7.9 7.5 5.1 14.4 8.3 4.7 5.4 9.7 18.6 5.6 7.1 5.5 6.7 5.8 3.9 4.9 6.0 8.7 3.2 6.4 3.9 11.3 13.1 12.3 7.2 6.2 11.3 8.5 12.6 6.8 4.3 12.4 7.4 3.6 11.3 12.4 4.7 3.0 8.3 5.1 3.8 3.2 3.4 10.4 14.5 1.1 3.1 7.4 16.3 6.5 4.2 6.5 6.1 8.1 5.7 4.8 5.4 3.7 8.6 2.8 9.8 6.9 7.9 6.1 3.8 5.1 7.4 2.4 4.7 13.3 21.7 13.3 18.8 12.4 10.9 24.1 7.4 15.2 22.5 44.7 72.6 7.5 15.0 21.5 40.4 23.8 12.7 46.8 69.4 19.2 55.0 17.7 8.3 14.2 15.0 19.3 7.4 0.0 13.8 18.9 14.2 10.3 54.6 14.7 13.8 28.6 9.8 12.9 11.1 1.9 16.1 15.2 15.1 9.0 12.3 27.5 11.7 14.1 17.3 16.7 61.4 25.8 18.4 39.0 20.0 17.7 10.3 17.3 16.4 14.2 POLA1 "NSX, p180, POLA" ENSG00000101868 "DNA polymerase alpha 1, catalytic subunit" P09884 X 24693919-24996986 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA replication, Host-virus interaction" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease mutation, Dwarfism, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002947, CAB012274" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012274: , HPA002947: AB_1079652" "unprognostic (6.92e-2)" "unprognostic (4.43e-3)" "unprognostic (3.27e-3)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.87e-1)" "unprognostic (9.25e-3)" "unprognostic (2.48e-2)" "unprognostic (8.41e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-2)" "unprognostic (3.08e-1)" 10.5 5.5 8.0 15.0 10.2 14.3 10.9 12.0 9.6 10.1 9.7 11.8 5.8 5.7 11.2 7.7 10.2 8.9 5.5 9.3 7.8 6.6 6.1 4.9 7.2 12.7 10.3 4.5 12.9 7.3 8.5 8.5 10.7 8.7 7.3 11.0 7.5 7.9 9.3 22.4 9.3 7.5 9.7 13.1 9.0 7.9 5.7 10.0 30.1 7.0 8.5 14.7 9.9 10.6 4.6 2.5 1.2 4.6 2.7 3.8 1.7 14.3 10.7 14.1 11.4 2.6 3.2 3.1 10.7 5.8 11.5 13.2 8.8 7.5 18.3 3.6 4.5 10.3 11.8 26.8 8.6 15.6 9.5 11.4 13.6 20.9 6.6 1.1 17.8 7.3 2.0 1.8 14.3 4.1 2.9 5.9 9.5 12.5 9.3 8.0 9.9 19.3 5.9 13.7 9.6 9.0 17.3 37.0 13.8 4.2 9.4 12.8 7.9 12.6 6.0 5.7 16.3 11.8 5.9 4.6 10.2 7.0 19.4 10.2 5.6 8.1 14.7 5.9 8.5 11.3 0.0 2.0 1.2 3.0 4.6 2.9 4.6 3.4 3.8 2.5 3.2 2.4 2.4 0.6 2.7 1.3 1.6 3.6 1.7 8.0 10.2 12.0 9.6 7.8 6.6 10.3 4.5 8.7 10.0 8.9 6.2 2.2 3.8 2.5 2.9 9.3 0.0 9.4 11.4 1.8 2.0 4.3 3.3 2.8 0.3 3.6 1.5 46.7 2.6 4.3 2.4 2.0 9.2 2.8 3.9 1.6 4.1 3.7 4.3 0.4 5.8 2.4 0.0 1.8 3.7 4.5 1.3 0.0 3.2 1.2 7.2 6.5 3.8 3.4 4.2 1.9 1.9 2.9 4.3 2.2 POLA2 FLJ21662 ENSG00000014138 "DNA polymerase alpha 2, accessory subunit" Q14181 11 65261762-65305589 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037570 Supported Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA037570: AB_10672280" "unprognostic (2.28e-1)" "prognostic favorable (4.61e-4)" "unprognostic (1.67e-2)" "unprognostic (7.44e-2)" "unprognostic (5.20e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.14e-1)" "unprognostic (2.87e-2)" "unprognostic (1.15e-2)" "unprognostic (4.05e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.09e-8)" "unprognostic (1.60e-3)" "unprognostic (8.26e-2)" "unprognostic (8.16e-2)" "unprognostic (6.25e-3)" 7.5 6.6 4.9 11.9 8.8 9.8 7.5 14.1 8.8 12.0 9.6 9.8 6.4 6.7 10.1 5.5 10.4 9.3 5.9 6.1 5.2 4.5 7.9 7.0 7.5 14.7 10.3 5.5 10.3 7.9 8.0 4.8 9.3 6.5 7.1 9.6 6.7 8.9 7.5 6.5 8.0 9.2 10.7 10.2 13.6 8.8 15.0 8.4 35.7 7.9 10.3 19.7 8.6 7.3 6.0 13.3 8.0 10.1 4.9 7.3 7.7 14.4 13.3 22.0 10.2 3.3 3.9 7.5 9.9 15.8 32.0 23.7 5.3 12.7 17.4 11.4 8.6 15.5 9.1 17.9 14.8 27.4 9.4 6.7 13.1 20.2 6.0 1.9 12.1 10.8 2.7 2.1 27.7 5.8 5.8 11.9 8.9 12.6 11.8 21.6 20.0 26.0 5.4 16.4 10.7 8.5 14.1 12.8 16.8 9.6 10.0 14.4 8.6 9.5 10.4 3.3 14.4 13.0 6.2 4.3 11.8 9.5 15.6 7.2 5.5 6.6 17.9 8.5 7.7 15.8 8.0 10.1 3.9 6.5 9.5 7.3 6.0 6.9 7.1 13.3 5.6 5.6 5.1 5.0 4.9 7.6 10.4 7.1 7.7 4.9 8.8 14.1 8.8 5.2 4.5 10.3 5.5 6.5 8.4 0.0 4.3 0.8 3.8 1.4 2.5 2.7 5.1 2.7 3.4 5.2 2.0 8.3 3.3 5.7 2.1 3.5 1.0 0.0 3.0 14.9 4.4 2.2 0.0 1.6 8.4 3.2 2.9 3.7 2.1 2.9 6.9 4.3 0.0 10.8 2.2 2.3 3.6 2.6 7.1 1.4 4.9 6.5 3.6 12.0 14.5 1.3 6.1 5.1 5.3 3.2 POLE4 p12 ENSG00000115350 "DNA polymerase epsilon 4, accessory subunit" Q9NR33 2 74958492-74970128 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054979, HPA071815" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054979: AB_2682661, HPA071815: AB_2686453" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.19e-2)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (3.09e-1)" "unprognostic (1.99e-1)" "unprognostic (2.95e-1)" "unprognostic (1.39e-2)" "unprognostic (4.44e-2)" "unprognostic (8.64e-3)" "unprognostic (6.61e-2)" "unprognostic (3.73e-1)" "unprognostic (3.47e-2)" "unprognostic (1.95e-1)" 19.2 14.5 23.6 15.2 17.3 27.1 21.4 4.4 15.5 18.4 13.4 8.6 7.0 9.0 10.4 9.0 10.0 9.7 13.1 18.1 15.9 10.6 11.6 18.8 10.7 17.0 13.9 12.6 12.8 12.5 2.8 3.9 9.6 12.2 12.0 8.8 13.9 16.2 11.2 28.1 8.1 12.4 14.1 11.7 12.2 12.5 11.0 10.0 5.5 13.1 15.1 10.4 13.9 31.9 14.7 14.7 8.0 22.2 4.4 9.9 12.3 11.8 11.3 1.0 1.0 3.9 8.6 0.0 8.0 10.0 12.9 11.0 15.0 5.3 11.6 6.8 9.1 3.2 5.4 5.4 6.7 15.1 5.3 14.5 9.0 6.5 14.8 14.0 12.7 14.2 8.7 13.1 5.4 11.9 4.0 5.6 1.6 11.0 6.8 9.8 11.5 3.7 35.8 7.9 6.9 21.2 4.5 9.7 9.3 10.7 0.3 3.6 5.4 11.0 4.6 6.4 0.6 3.4 4.1 6.2 2.9 3.3 2.0 7.7 2.4 1.6 4.3 10.5 19.1 14.2 2.3 22.2 8.0 6.3 13.2 7.0 14.7 8.9 7.8 12.9 13.7 9.9 6.9 1.6 4.4 12.4 14.7 8.5 12.3 23.6 17.3 4.4 15.5 15.9 10.6 13.9 12.6 12.2 10.0 23.8 36.0 84.1 81.2 75.1 21.9 40.6 58.6 34.8 21.6 69.8 41.2 124.8 126.0 43.1 10.2 56.2 119.0 23.3 70.2 125.8 83.2 82.4 61.1 123.4 106.6 17.5 11.7 68.7 111.2 19.3 62.2 91.0 92.8 30.7 80.6 78.1 62.4 147.3 51.2 125.5 104.8 77.6 87.3 41.3 86.7 85.4 78.6 69.3 78.6 82.9 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.5;lymphoid tissue: 21.4" "Cell type enhanced" "Detected in some" 10 "Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.2" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.5 0.8 0.2 8.2 0.7 9.5 0.6 0.6 0.4 0.9 3.5 0.2 0.8 2.0 0.9 0.6 6.0 0.3 0.4 0.8 0.3 0.2 0.4 0.6 0.9 4.7 0.3 0.0 0.4 0.4 0.0 0.2 2.8 0.3 0.4 3.7 0.1 1.1 0.8 1.2 2.4 3.9 0.5 0.4 2.6 1.1 5.8 0.6 21.4 0.3 5.6 7.5 0.6 1.7 0.5 1.1 1.6 0.4 0.0 0.4 0.0 13.5 9.2 7.9 5.6 0.7 0.9 7.2 6.4 2.5 7.6 10.2 7.3 5.0 16.1 2.9 3.5 9.2 10.7 9.3 4.1 12.9 4.7 5.1 10.3 5.7 4.5 0.0 11.1 9.5 0.1 0.3 6.9 4.3 1.3 3.7 6.0 6.8 12.3 7.9 5.2 10.0 6.5 7.5 4.1 4.5 8.5 9.5 5.7 2.4 7.8 4.3 3.9 7.4 4.0 2.6 7.2 3.7 11.1 2.9 6.7 8.8 2.6 8.3 6.2 5.0 16.7 3.2 8.3 4.9 1.6 0.2 0.0 0.3 0.2 0.0 0.3 0.4 0.3 0.4 0.5 0.0 0.2 0.0 0.0 0.4 1.1 0.1 0.0 0.2 0.7 0.6 0.4 0.3 0.2 0.3 0.0 0.3 0.6 0.0 0.3 0.0 0.4 0.8 0.3 1.4 0.0 1.4 3.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.4 0.0 0.0 2.8 0.7 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.2 0.3 1.5 0.0 1.0 0.4 0.5 0.3 0.3 0.0 0.1 0.1 0.0 0.5 7.0 3.3 0.1 0.2 0.9 0.9 0.9 POLR1B "FLJ10816, FLJ21921, RPA2, Rpo1-2" ENSG00000125630 "RNA polymerase I subunit B" Q9H9Y6 2 112541915-112577150 "Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 133.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037528 Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA037528: AB_10671627" "unprognostic (1.66e-1)" "unprognostic (3.17e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (2.07e-1)" "unprognostic (1.16e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "unprognostic (2.05e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (6.12e-2)" "unprognostic (1.29e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-1)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" 8.8 11.0 6.4 10.6 6.8 4.9 15.7 8.0 8.2 7.6 7.0 7.7 8.6 5.8 9.3 7.4 12.8 9.2 9.2 6.1 5.7 6.1 11.3 20.5 8.0 11.3 6.8 3.7 11.3 25.2 20.7 11.5 7.2 5.2 7.7 8.5 7.3 10.0 8.3 14.7 9.2 8.0 7.9 4.8 11.4 8.1 15.7 5.0 9.6 15.7 11.5 14.6 8.9 11.8 9.4 11.0 2.5 6.3 10.2 17.1 7.3 9.5 10.0 6.3 13.1 6.9 6.6 11.9 7.2 5.5 12.2 10.6 22.4 5.7 22.9 10.7 4.7 9.5 13.5 26.7 14.6 14.1 10.3 13.5 13.2 9.9 16.9 7.3 21.1 9.2 6.3 10.6 12.6 19.5 5.1 9.4 4.8 23.9 8.3 6.3 8.4 9.5 13.7 30.9 14.1 19.8 14.3 10.5 24.3 8.4 9.1 16.1 14.9 6.6 16.6 9.0 7.1 7.7 7.5 8.5 7.5 11.0 6.8 10.5 11.2 18.4 19.8 5.7 13.6 6.2 0.2 6.0 2.5 8.3 6.3 17.1 9.4 8.4 8.9 11.0 9.3 10.3 10.4 0.4 10.2 4.8 2.6 11.3 7.3 6.4 6.8 8.0 8.2 5.7 6.1 6.8 3.7 5.2 5.0 14.9 5.1 8.2 2.2 13.4 3.4 5.7 10.2 2.7 7.9 8.7 2.0 2.9 5.0 4.0 133.9 5.6 1.2 0.0 3.9 2.3 2.8 2.2 4.7 8.5 3.3 1.6 3.5 1.8 2.5 29.4 2.8 2.9 1.7 1.8 4.4 3.8 2.9 6.0 2.8 4.1 2.9 0.0 2.8 9.5 7.5 15.1 0.5 6.4 4.5 3.4 POLR2A "POLR2, POLRA, RPB1" ENSG00000181222 "RNA polymerase II subunit A" P24928 17 7484366-7514616 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Transcription" "DNA-binding, Nucleotidyltransferase, RNA-directed RNA polymerase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.9" "Cell line enhanced" "Detected in some" "HEK 293: 3.0;HL-60: 2.7;HMC-1: 4.0" "CAB012226, CAB016388, CAB022311" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012226: AB_304749, CAB016388: AB_677353, CAB022311: " "unprognostic (2.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.58e-1)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (5.43e-2)" "unprognostic (8.77e-3)" "unprognostic (1.48e-1)" "unprognostic (5.19e-3)" "unprognostic (1.81e-1)" "unprognostic (1.52e-1)" "unprognostic (3.70e-2)" "unprognostic (1.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.30e-2)" "unprognostic (1.49e-1)" "unprognostic (4.70e-2)" 5.0 5.9 4.5 5.7 7.4 26.4 8.5 5.8 7.8 7.2 4.3 4.8 4.5 4.3 5.5 5.4 7.0 4.6 4.2 4.5 6.0 3.5 4.6 4.4 6.4 11.5 4.7 4.2 5.2 5.8 5.4 4.8 4.2 5.4 4.3 4.9 6.3 5.5 8.1 6.6 6.6 6.0 4.5 6.1 6.2 5.3 13.2 2.9 15.0 5.6 4.1 5.0 5.3 4.6 0.7 0.7 4.9 1.0 0.0 1.2 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.4 0.1 0.6 0.2 0.0 0.2 0.0 0.2 0.4 3.0 0.7 1.2 0.2 0.0 2.7 4.0 0.4 0.0 0.3 0.0 0.4 0.2 0.7 0.3 0.0 0.5 0.0 0.1 0.8 0.5 0.0 0.9 1.2 0.0 0.0 0.0 1.4 0.3 0.9 1.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.3 0.5 0.8 0.4 0.2 0.4 0.0 0.6 0.3 3.0 0.5 0.6 1.2 0.4 0.3 0.3 0.5 0.4 0.1 0.7 0.6 0.5 4.9 0.0 1.0 0.7 0.5 0.0 4.5 7.4 5.8 7.8 6.0 3.5 4.7 4.2 5.4 2.9 20.8 47.7 32.5 35.2 38.0 86.4 20.7 38.2 29.4 23.9 22.7 104.1 31.3 3.3 23.3 19.9 38.6 39.3 0.0 26.5 23.6 28.9 29.0 41.5 22.9 39.8 52.4 73.6 38.6 32.1 7.2 34.2 31.4 35.4 35.1 39.1 29.5 28.0 30.0 39.3 10.6 80.9 6.5 33.7 53.7 121.1 36.0 45.0 39.2 30.5 29.3 POLR2C RPB3 ENSG00000102978 "RNA polymerase II subunit C" P19387 16 57462387-57472010 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040919, HPA041826" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040919: AB_10795483, HPA041826: AB_10793935" "unprognostic (2.10e-2)" "unprognostic (4.42e-2)" "unprognostic (7.52e-3)" "unprognostic (1.82e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.90e-1)" "unprognostic (9.54e-2)" "unprognostic (1.95e-1)" "unprognostic (2.48e-2)" "unprognostic (2.60e-2)" "unprognostic (6.63e-2)" "prognostic favorable (3.03e-6)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.20e-1)" "unprognostic (5.43e-3)" 26.2 30.1 24.2 18.4 26.9 23.9 25.8 34.1 37.6 27.2 22.9 28.8 23.1 21.5 26.0 45.0 26.2 30.3 29.9 32.6 24.5 25.9 38.3 44.8 29.9 30.2 25.0 30.1 37.2 39.4 33.7 35.0 29.2 25.5 29.2 26.0 29.6 30.4 31.4 47.5 23.7 27.9 26.1 24.1 22.4 25.2 26.4 21.9 30.5 35.8 27.3 27.1 27.5 22.2 21.8 16.2 41.7 19.8 26.2 28.6 21.9 17.7 29.4 24.6 22.3 22.3 20.1 21.9 23.5 25.6 37.7 24.9 37.6 22.6 20.1 27.6 25.8 22.9 18.7 32.5 24.7 42.0 9.2 24.2 15.4 17.6 42.8 25.3 27.9 29.7 18.0 20.4 28.7 26.6 20.6 22.7 27.5 26.7 11.4 24.6 24.5 30.9 29.6 36.9 21.4 44.8 45.1 29.2 35.6 30.5 17.6 31.3 36.5 38.0 21.3 24.6 24.2 16.2 25.8 17.5 23.8 24.3 18.1 26.7 26.3 22.5 40.9 24.0 24.1 31.4 24.8 17.3 29.0 20.7 16.4 22.6 21.8 23.6 19.1 16.2 20.9 28.6 26.8 41.7 26.2 19.8 13.2 22.5 21.9 24.2 26.9 34.1 37.6 24.5 25.9 25.0 30.1 25.5 21.9 23.8 34.7 45.5 39.7 27.5 84.3 9.7 33.1 28.1 14.8 26.2 53.0 65.7 77.9 47.3 3.0 36.0 36.6 0.0 57.8 72.3 37.6 40.0 61.0 18.5 36.7 49.3 36.7 22.1 18.6 6.6 47.8 21.9 38.8 64.9 27.6 87.9 46.7 36.8 48.8 96.7 87.2 45.3 39.2 40.2 65.5 26.2 77.7 42.4 33.6 35.9 POLR3G "RPC32, RPC7" ENSG00000113356 "RNA polymerase III subunit G" O15318 5 90471748-90514553 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.2" "Cell type enhanced" "Detected in many" 10 "Spermatogonia: 27.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010109, HPA052658, HPA074330" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: " "unprognostic (4.31e-1)" "unprognostic (5.35e-2)" "unprognostic (2.62e-2)" "unprognostic (3.55e-3)" "unprognostic (1.18e-1)" "unprognostic (3.42e-2)" "unprognostic (4.19e-6)" "unprognostic (2.17e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-2)" "unprognostic (3.52e-2)" "unprognostic (9.71e-2)" "unprognostic (1.21e-14)" "unprognostic (3.86e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-2)" "unprognostic (8.17e-5)" 2.7 1.6 7.1 3.6 10.2 4.4 3.8 7.2 7.2 3.7 2.6 6.7 1.4 2.8 2.7 8.4 7.3 2.7 2.4 2.7 7.7 7.7 1.7 4.0 2.9 8.1 10.3 6.1 4.1 4.1 11.1 3.9 3.1 20.2 2.9 3.1 2.6 4.2 1.5 4.4 7.4 2.3 4.2 16.0 3.3 2.1 8.0 8.1 1.0 5.9 8.5 3.2 4.4 4.7 3.9 2.1 6.8 2.8 5.4 3.2 0.8 10.7 6.2 7.4 1.9 2.3 4.1 3.4 5.4 1.7 8.6 7.0 3.6 8.0 29.4 1.8 2.2 8.5 4.5 9.2 8.6 30.8 13.5 8.2 10.8 2.9 5.5 3.9 7.5 2.7 2.7 4.0 14.3 10.9 1.7 10.6 11.7 15.3 2.7 3.1 5.2 7.9 4.7 34.9 1.5 27.7 7.0 3.2 16.6 2.5 1.0 9.4 2.5 2.2 4.1 14.9 3.4 2.2 2.1 12.7 4.7 9.0 6.6 20.3 6.8 17.4 21.7 10.4 10.0 37.3 6.8 0.6 0.3 3.2 0.8 1.6 3.9 1.1 2.0 0.9 2.4 2.4 2.6 1.6 5.4 2.8 2.1 0.5 0.8 7.1 10.2 7.2 7.2 7.7 7.7 10.3 6.1 20.2 8.1 6.0 2.1 0.8 1.2 3.2 2.7 3.4 0.0 2.7 0.0 1.8 7.9 0.7 3.3 2.6 3.0 1.4 0.5 0.0 3.9 5.2 1.5 3.0 6.9 2.4 1.5 3.2 6.4 3.7 0.3 1.0 0.3 0.6 1.7 0.0 1.3 0.6 2.9 2.0 1.1 1.3 0.8 0.0 1.4 7.7 27.4 7.4 0.7 0.0 1.6 0.6 POLR3K RPC11 ENSG00000161980 "RNA polymerase III subunit K" Q9Y2Y1 16 46407-53628 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA005891 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005891: AB_1079653" "unprognostic (3.00e-1)" "unprognostic (1.50e-3)" "unprognostic (1.53e-1)" "unprognostic (7.16e-3)" "unprognostic (1.47e-1)" "unprognostic (1.40e-1)" "unprognostic (8.03e-3)" "unprognostic (9.06e-2)" "unprognostic (7.40e-2)" "unprognostic (5.72e-2)" "unprognostic (9.96e-2)" "unprognostic (1.84e-1)" "unprognostic (7.36e-3)" "unprognostic (2.68e-2)" "unprognostic (3.63e-2)" "unprognostic (3.53e-2)" "unprognostic (9.63e-2)" 7.3 12.4 15.4 16.6 17.6 11.3 8.3 14.3 18.8 8.0 9.1 9.0 11.9 9.8 8.3 9.3 9.8 9.3 7.4 12.0 13.7 15.4 9.1 10.3 7.6 19.6 11.9 15.5 9.1 11.0 12.1 7.5 8.0 9.0 10.0 9.2 5.9 11.1 12.7 21.8 5.7 9.3 8.2 9.8 14.0 9.1 5.7 7.9 13.7 11.5 12.4 18.6 9.9 8.6 39.6 25.3 32.2 18.9 13.5 30.0 18.2 10.8 18.7 11.9 12.3 4.9 3.0 9.5 15.5 4.9 13.8 9.1 24.1 11.7 28.2 11.8 5.4 5.5 10.8 27.7 7.1 9.9 16.9 25.5 20.7 14.0 17.1 3.7 18.6 20.4 3.0 6.3 15.3 7.8 3.2 6.7 12.6 29.5 9.0 8.9 26.9 22.3 12.3 19.5 13.7 17.9 27.1 13.8 29.4 7.8 7.8 17.5 10.3 10.6 19.9 9.1 5.2 11.7 16.8 6.4 8.9 10.9 11.9 18.7 5.8 13.9 55.5 3.8 13.7 13.3 9.0 13.6 32.2 15.8 18.9 16.2 39.6 20.3 18.2 12.4 35.1 18.4 17.2 9.8 13.5 17.3 25.3 30.0 18.2 15.4 17.6 14.3 18.8 13.7 15.4 11.9 15.5 9.0 7.9 3.0 9.9 34.1 17.9 29.7 15.1 25.5 25.5 12.0 7.9 17.4 3.9 34.6 41.4 28.4 0.6 20.3 13.2 0.0 30.5 38.6 19.5 23.0 21.9 26.0 38.9 9.5 17.2 19.0 13.1 0.4 19.5 22.5 21.9 56.9 19.5 12.9 29.0 14.0 15.6 36.1 8.4 12.9 17.5 4.7 15.1 38.6 10.8 27.7 24.8 19.5 POMK "FLJ23356, SgK196" ENSG00000185900 "Protein-O-mannose kinase" Q9H5K3 8 43093506-43123434 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 1.4;Club cells: 2.3;Melanocytes: 1.7;monocytes: 1.8;Spermatogonia: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013321 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA013321: AB_2668809" "unprognostic (1.66e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-1)" "unprognostic (4.37e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.56e-2)" "unprognostic (2.42e-1)" "unprognostic (2.50e-1)" "unprognostic (8.10e-2)" "unprognostic (1.23e-3)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (7.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.10e-2)" 4.7 5.5 9.8 5.6 14.3 12.5 5.1 12.3 18.6 6.9 4.8 8.3 2.2 4.5 6.9 4.4 7.1 6.2 4.8 3.8 7.7 7.0 3.4 4.5 5.5 6.0 4.8 11.1 5.8 9.3 6.3 7.4 6.1 10.5 5.6 5.9 6.1 6.8 4.0 6.2 7.1 5.6 6.4 6.7 7.6 6.8 7.1 7.2 7.5 7.4 3.2 7.4 4.6 5.0 2.6 2.6 6.7 2.9 1.0 3.3 1.3 3.5 7.6 5.8 15.2 2.8 3.5 5.5 2.1 3.2 5.5 4.1 5.5 9.2 5.0 4.7 3.8 2.3 5.9 8.3 6.4 5.4 1.9 1.4 14.0 5.6 2.5 2.0 4.7 7.9 3.8 2.7 7.4 5.3 1.7 5.4 7.1 3.3 14.9 3.7 1.6 10.0 2.0 11.9 2.1 1.0 6.8 6.8 2.9 1.5 9.9 5.6 4.2 9.1 3.2 3.0 4.4 9.8 3.3 7.5 8.4 8.5 8.7 4.2 4.9 8.6 9.4 3.6 3.2 10.0 0.8 2.9 1.9 2.3 2.4 3.3 1.8 1.3 1.3 2.6 2.6 1.8 2.3 6.7 1.0 1.5 2.5 1.1 1.3 9.8 14.3 12.3 18.6 7.7 7.0 4.8 11.1 10.5 7.2 0.0 0.3 0.0 0.1 0.3 1.4 0.3 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 1.8 0.0 0.5 0.3 0.0 0.0 0.0 0.8 0.0 0.1 0.4 1.4 0.1 0.5 0.0 0.2 0.1 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320884 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 6.7 10.8 10.4 6.8 11.4 3.8 7.7 12.5 13.3 6.8 6.3 18.0 9.8 4.6 6.9 17.1 5.7 8.7 6.9 7.7 9.3 7.7 8.1 8.3 6.2 3.0 11.7 6.2 7.6 10.6 14.7 16.1 11.4 9.7 7.3 5.8 8.2 10.1 12.3 17.0 4.3 4.6 7.8 8.4 5.2 5.6 30.9 14.4 2.5 11.5 4.9 3.8 5.7 5.0 1.4 1.9 0.8 1.9 0.0 1.7 0.4 10.4 13.4 13.0 14.7 9.3 7.5 10.4 9.2 7.6 13.8 11.8 6.6 9.4 3.1 7.5 8.6 19.1 11.7 6.1 9.2 9.6 4.6 8.3 1.9 6.6 5.4 11.4 2.1 6.3 7.6 9.8 12.9 12.6 9.6 8.0 3.1 4.9 7.3 9.0 20.6 3.6 10.1 3.7 14.5 11.3 3.5 12.7 2.8 14.3 7.7 11.0 10.8 6.0 10.2 7.7 8.9 10.5 4.4 6.6 10.4 16.4 12.0 8.0 4.8 9.4 1.4 5.3 3.2 9.1 0.0 0.4 0.0 1.7 1.9 0.4 1.4 0.0 0.3 0.9 0.2 0.1 0.0 0.8 0.0 0.8 1.9 0.0 0.4 10.4 11.4 12.5 13.3 9.3 7.7 11.7 6.2 9.7 14.4 6.0 3.2 2.2 2.3 2.7 6.5 4.0 5.1 0.0 0.0 1.8 15.7 5.0 0.0 6.6 8.0 2.8 3.9 0.0 6.4 8.6 6.0 3.5 2.3 4.4 4.8 7.9 17.2 3.1 2.4 12.1 1.7 2.2 1.7 3.6 3.0 8.2 5.8 1.9 3.9 3.0 15.0 0.0 3.9 9.8 8.5 1.6 4.8 0.0 2.6 1.4 POPDC3 "bA355M14.1, MGC22671, POP3" ENSG00000132429 "Popeye domain containing 3" Q9HBV1 6 105158280-105179995 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "heart muscle: 23.9;skeletal muscle: 68.9" "Cell type enhanced" "Detected in some" 27 "Cardiomyocytes: 40.0;Early spermatids: 75.0;Late spermatids: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 25.2;LHCN-M2: 11.9;RH-30: 13.4;U-87 MG: 12.0;WM-115: 11.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA012514 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA012514: " "unprognostic (2.17e-1)" "unprognostic (2.15e-2)" "unprognostic (3.65e-1)" "unprognostic (1.14e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.79e-4)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (5.12e-3)" "unprognostic (2.37e-1)" "unprognostic (2.83e-9)" "unprognostic (6.25e-2)" "unprognostic (1.24e-1)" "unprognostic (3.75e-3)" "unprognostic (1.33e-2)" 0.9 0.8 2.2 1.4 4.5 0.6 2.5 0.4 6.8 0.8 1.4 2.1 0.8 0.7 1.3 2.2 2.1 0.7 1.1 23.9 3.7 2.3 0.6 0.6 0.7 0.7 6.1 3.5 0.7 0.6 0.6 3.2 1.2 4.0 1.2 0.6 1.9 1.0 0.8 68.9 0.6 0.6 0.6 3.6 0.6 1.6 3.6 4.0 0.0 0.8 8.8 0.6 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.4 0.1 2.4 6.3 0.5 2.4 2.6 4.3 5.2 0.0 1.4 0.0 1.0 4.9 25.2 0.0 1.2 1.1 3.6 0.0 2.6 0.0 0.9 0.0 0.1 0.0 0.0 2.5 0.2 6.9 0.9 1.2 0.3 0.0 2.6 7.3 11.9 0.0 0.0 0.9 2.8 0.0 4.1 0.4 13.4 0.0 0.0 0.0 6.1 11.0 0.0 0.0 8.6 1.5 0.0 4.7 5.4 2.6 0.0 1.7 9.0 0.0 0.0 0.0 12.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.5 0.4 6.8 3.7 2.3 6.1 3.5 4.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 75.0 0.0 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.6 0.6 0.0 0.0 3.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 1.6 1.4 0.0 0.1 0.0 0.0 0.0 POR "CYPOR, FLJ26468" ENSG00000127948 "Cytochrome p450 oxidoreductase" P16435 7 75899200-75986855 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 443.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 74.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004372, HPA010136" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB004372: AB_627391, HPA010136: AB_1079657" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "unprognostic (2.81e-3)" "unprognostic (8.67e-2)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (4.32e-2)" "unprognostic (1.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (9.89e-2)" 12.8 48.2 7.4 7.5 10.8 3.6 15.0 5.3 16.4 11.0 20.8 9.6 32.1 24.9 9.0 8.2 13.4 12.8 9.9 8.4 7.1 7.2 12.0 78.4 13.7 9.9 5.2 10.1 14.4 12.8 12.1 18.5 18.6 7.1 9.3 5.3 10.8 7.8 58.7 13.1 10.0 24.3 7.0 5.2 11.7 9.8 22.4 5.0 8.2 33.3 9.9 8.6 9.8 10.2 5.7 20.6 26.7 18.4 11.2 9.9 13.9 12.8 28.2 12.9 24.0 48.9 18.6 21.6 5.4 17.7 10.2 14.3 21.1 57.3 12.3 5.0 11.7 34.8 6.3 16.9 8.5 4.4 10.5 12.5 5.7 8.3 39.0 34.0 5.7 10.2 38.1 10.7 13.4 9.8 8.2 9.4 6.1 17.0 5.3 9.1 18.9 6.1 10.2 16.1 20.2 16.0 8.8 8.5 13.2 11.5 15.6 13.5 12.9 14.5 74.1 19.5 7.6 21.2 9.6 8.5 9.6 10.6 14.4 10.6 5.2 8.0 8.4 13.6 8.7 12.3 26.7 18.4 25.3 9.9 17.7 8.3 5.4 8.4 9.2 20.6 5.7 8.4 7.1 24.3 11.2 13.0 5.8 8.7 13.9 7.4 10.8 5.3 16.4 7.1 7.2 5.2 10.1 7.1 5.0 35.7 31.2 12.6 24.7 15.1 30.1 9.3 56.0 78.9 37.5 69.8 11.8 88.1 1.7 55.5 13.2 25.3 144.8 0.0 25.7 71.6 24.8 20.8 24.3 443.8 58.9 14.3 19.0 27.6 38.6 6.1 70.2 40.5 11.8 16.2 29.0 33.2 24.3 119.3 105.7 27.5 21.8 64.7 30.9 14.7 32.6 12.8 161.6 20.0 36.8 40.7 POU1F1 "GHF-1, PIT1, POU1F1a" ENSG00000064835 "POU class 1 homeobox 1" P28069 3 87259404-87276587 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 49 "pituitary gland: 138.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.8;SiHa: 1.1;U-87 MG: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041646, HPA050624" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041646: AB_10794672, HPA050624: AB_2681192" "unprognostic (1.88e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.93e-1)" "unprognostic (1.87e-2)" "unprognostic (7.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.50e-1)" "unprognostic (4.69e-3)" "unprognostic (1.55e-1)" "unprognostic (1.52e-2)" "unprognostic (1.87e-2)" "unprognostic (1.22e-1)" "unprognostic (1.05e-4)" 0.3 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 138.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.8 0.3 0.1 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319944 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favorable (8.14e-4)" "unprognostic (1.45e-1)" 0.2 0.2 0.1 0.2 0.1 0.0 1.6 0.1 0.1 1.2 0.9 0.0 36.5 0.7 0.4 1.2 2.5 0.3 0.4 0.2 0.1 0.1 0.3 0.2 1.6 0.4 0.1 0.0 0.2 0.3 6.4 1.3 4.4 0.1 1.1 0.1 0.0 1.1 13.2 0.1 38.2 1.0 0.2 0.1 0.2 0.4 0.6 0.0 0.4 4.5 4.8 2.2 0.7 2.6 1.0 0.7 2.1 0.5 0.9 0.6 0.2 2.5 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.6 0.0 0.0 0.1 7.2 0.3 2.7 0.0 0.1 1.3 0.0 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.4 0.2 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.2 0.3 0.1 0.6 0.0 0.0 0.1 0.0 1.9 0.5 0.1 0.1 5.3 0.0 0.9 9.7 0.4 0.8 0.0 0.2 0.4 0.1 0.1 0.1 0.0 1.1 0.2 0.1 1.4 0.4 0.5 0.5 0.3 0.5 0.5 0.6 0.4 0.1 1.0 0.6 0.6 2.1 0.9 0.5 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 5.1 0.0 9.0 18.5 0.0 0.8 0.0 1.4 2.3 10.4 0.0 1.2 0.0 3.6 1.7 0.0 0.3 0.0 1.2 0.2 0.2 5.0 0.0 0.4 0.1 0.0 2.9 0.0 0.0 3.8 0.0 0.0 5.0 0.0 0.0 0.2 12.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 33.0 6.6 0.0 0.5 10.1 POU5F1 "MGC22487, OCT3, Oct4, OTF3" ENSG00000204531 "POU class 5 homeobox 1" Q01860 6 31164337-31180731 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 15.3;Collecting duct cells: 8.7;Enterocytes: 8.4;Pancreatic endocrine cells: 8.5" "Cancer enriched" "Detected in many" 34 "testis cancer: 355.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HAP1: 49.8;NTERA-2: 132.5;SuSa: 87.3" "CAB025600, CAB026380, HPA058267, CAB079773" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659" "unprognostic (3.25e-2)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-2)" "unprognostic (2.11e-2)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (2.59e-1)" "unprognostic (9.27e-2)" "unprognostic (2.27e-2)" "unprognostic (4.79e-2)" "unprognostic (1.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.35e-1)" "unprognostic (3.86e-2)" "prognostic favorable (2.04e-5)" 1.2 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 2.3 2.3 1.2 1.2 4.9 3.1 5.7 1.2 5.2 4.3 1.2 1.2 0.0 11.1 5.0 2.0 1.2 1.2 1.2 1.2 8.8 0.0 1.2 1.2 1.2 4.7 1.0 1.2 1.2 3.0 1.2 1.8 5.9 1.2 1.2 1.2 6.3 2.2 1.2 1.2 1.2 1.2 1.2 11.2 1.2 3.0 1.8 1.8 1.0 1.1 0.9 0.3 0.5 0.2 7.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.6 49.8 0.6 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 132.5 0.2 0.0 0.1 0.1 0.1 1.0 1.0 0.0 0.0 0.2 0.0 0.0 87.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 1.4 1.0 0.5 0.8 0.7 0.5 1.0 0.4 0.4 0.2 3.0 0.9 0.6 1.8 1.1 0.5 1.8 0.3 0.3 1.2 1.2 1.2 1.2 1.2 0.0 1.2 1.2 1.2 1.2 0.0 1.4 0.5 2.4 4.6 0.7 0.4 15.3 1.4 1.2 8.7 2.0 0.0 0.0 4.8 0.0 0.7 8.4 0.0 5.8 0.1 0.5 3.6 0.0 1.5 0.1 0.0 1.2 0.6 0.0 0.0 0.0 0.8 1.7 1.0 3.1 0.0 8.5 3.7 0.7 2.1 0.9 0.0 1.2 0.0 0.4 3.3 0.1 0.0 2.9 3.8 PPARGC1B "PERC, PGC1B" ENSG00000155846 "PPARG coactivator 1 beta" Q86YN6 5 149730298-149855022 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 105.6;Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 72.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050543 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA050543: AB_2681165" "unprognostic (2.86e-1)" "unprognostic (1.07e-2)" "unprognostic (5.09e-3)" "unprognostic (1.13e-3)" "unprognostic (2.63e-1)" "unprognostic (2.00e-3)" "unprognostic (4.51e-3)" "unprognostic (6.55e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.21e-1)" "unprognostic (9.01e-6)" "unprognostic (8.45e-2)" "unprognostic (5.09e-2)" "unprognostic (1.51e-1)" "unprognostic (2.77e-3)" 4.5 2.4 3.9 9.5 7.1 4.3 3.5 16.3 8.7 3.9 15.6 1.6 16.3 13.1 5.4 2.6 9.0 5.5 6.2 10.0 3.3 4.1 2.3 3.7 7.4 3.0 3.3 4.8 3.2 3.4 17.7 2.0 3.2 7.2 6.4 11.6 7.6 4.0 19.7 10.3 6.6 16.6 18.6 2.7 4.2 7.9 2.0 1.3 2.2 1.7 8.4 5.8 11.5 5.6 1.9 2.4 2.2 6.2 0.8 0.7 0.5 0.5 1.9 0.8 4.6 1.8 0.6 7.4 0.3 0.0 0.5 0.7 8.3 1.9 9.0 1.3 0.0 2.1 5.6 6.8 3.4 0.6 0.5 5.9 8.4 3.2 1.7 0.5 11.5 3.4 0.9 4.6 1.8 3.1 0.3 1.0 4.0 5.7 3.0 0.4 2.2 4.2 5.4 3.0 2.5 4.9 8.0 5.0 5.0 1.4 11.0 2.5 0.6 1.3 9.8 1.5 1.4 2.6 3.8 1.3 1.1 1.7 3.7 1.8 3.7 2.7 5.3 2.3 7.3 0.9 1.0 2.0 0.7 0.4 3.8 0.7 1.9 0.4 0.3 2.4 0.9 0.6 0.6 2.2 0.8 6.2 0.3 0.3 0.5 3.9 7.1 16.3 8.7 3.3 4.1 3.3 4.8 7.2 1.3 0.0 0.6 1.5 3.2 4.5 105.6 18.8 2.5 0.0 1.2 1.8 127.6 1.5 1.7 0.2 0.2 3.5 17.2 0.0 0.7 1.2 1.8 1.7 1.1 3.4 6.9 7.9 5.2 5.5 9.5 0.0 1.4 8.3 3.3 1.0 8.5 3.6 0.5 3.5 0.4 1.9 72.0 6.5 6.1 0.2 3.2 9.4 4.1 0.0 19.0 3.4 PPCDC "FLJ14585, MDS018" ENSG00000138621 "Phosphopantothenoylcysteine decarboxylase" Q96CD2 15 75023555-75117462 "Enzymes, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 19.9;granulocytes: 40.4;monocytes: 18.1" "Cell line enhanced" "Detected in all" "Karpas-707: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045667 Approved Approved Cytosol NA NA Cytosol "HPA045667: AB_2679412" "unprognostic (8.66e-2)" "unprognostic (1.07e-3)" "unprognostic (6.03e-2)" "unprognostic (2.57e-2)" "unprognostic (2.95e-2)" "unprognostic (6.53e-2)" "unprognostic (1.76e-2)" "unprognostic (8.40e-2)" "unprognostic (1.72e-1)" "unprognostic (1.53e-1)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (1.60e-2)" "unprognostic (7.67e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-1)" "unprognostic (2.13e-3)" 10.4 18.5 7.7 11.1 9.3 16.7 14.5 10.8 10.2 8.4 10.8 16.0 15.1 9.4 16.3 13.3 17.5 10.9 12.1 7.8 7.3 7.9 12.5 12.0 13.9 14.0 16.8 5.9 9.2 22.1 14.4 11.3 8.9 11.0 12.0 9.3 15.6 17.5 8.0 10.5 8.3 11.6 6.1 13.6 18.0 10.7 9.7 11.3 7.4 11.0 11.5 16.5 14.2 9.4 4.2 19.9 40.4 18.1 4.5 5.6 4.2 6.0 11.4 4.7 3.7 2.9 2.7 4.1 6.1 2.7 8.3 6.5 6.7 16.5 6.9 11.0 3.0 5.1 6.3 7.7 10.2 4.2 24.3 9.4 12.1 7.1 7.1 8.3 7.0 15.8 3.6 6.8 8.5 13.1 3.3 6.5 10.3 8.1 54.0 5.9 11.7 4.2 10.9 7.6 12.9 5.3 7.1 9.3 14.8 6.2 8.7 11.5 3.3 9.0 12.6 13.2 5.7 15.6 9.1 3.7 8.5 5.9 4.2 10.8 16.5 10.8 11.4 5.2 17.9 9.5 10.9 6.5 40.4 3.4 17.5 5.6 4.2 3.1 3.8 4.9 2.3 3.6 4.3 39.3 4.5 18.1 19.9 3.3 4.2 7.7 9.3 10.8 10.2 7.3 7.9 16.8 5.9 11.0 11.3 14.9 6.9 2.2 6.1 3.4 2.6 3.4 5.1 12.0 3.4 8.7 0.0 14.7 21.6 15.1 0.7 9.8 11.1 0.0 13.4 11.5 7.2 5.7 11.5 4.2 16.7 7.9 4.1 4.9 12.5 2.9 4.0 15.4 13.5 21.6 8.5 3.5 16.2 31.7 4.9 14.9 8.4 6.5 8.2 6.5 16.4 3.4 9.2 13.1 10.0 11.9 PPFIA1 "LIP.1, LIPRIN" ENSG00000131626 "PTPRF interacting protein alpha 1" Q13136 11 70270700-70385312 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 163.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 80.2;SK-MEL-30: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017032, HPA042271" Uncertain Supported "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "CAB017032: , HPA042271: AB_2677923" "unprognostic (1.89e-1)" "unprognostic (1.28e-2)" "unprognostic (6.27e-2)" "unprognostic (9.92e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.58e-4)" "unprognostic (7.20e-3)" "unprognostic (2.20e-1)" "unprognostic (3.02e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (8.26e-4)" "unprognostic (1.14e-1)" "prognostic favorable (3.76e-4)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (2.14e-2)" 28.9 18.6 20.9 17.5 20.8 20.8 40.5 22.8 24.1 15.9 18.3 27.7 18.5 15.5 26.2 20.4 19.4 16.9 23.9 19.3 19.7 12.0 18.1 15.5 25.4 15.9 18.9 17.8 21.0 17.7 21.2 34.1 24.9 20.7 13.8 16.3 21.9 19.0 18.5 38.7 24.2 17.8 18.4 30.0 14.7 15.6 29.8 22.5 17.0 25.2 10.0 13.6 18.7 18.6 2.6 2.8 10.0 4.8 1.1 2.2 1.0 80.2 10.8 10.0 6.7 9.3 5.8 10.6 9.4 7.7 11.7 7.8 20.5 7.2 7.5 12.3 7.5 12.0 11.6 8.4 8.1 10.1 5.0 5.9 6.0 11.3 6.5 9.5 7.9 7.4 7.4 13.0 15.1 12.4 9.4 7.5 6.4 10.1 6.1 10.2 10.9 5.4 4.7 5.9 17.1 9.3 6.3 25.1 6.5 5.7 11.0 9.7 6.6 14.0 17.7 46.1 10.8 11.9 8.4 10.3 11.8 9.2 16.3 10.0 7.5 4.7 10.5 9.8 5.5 13.7 0.0 3.6 1.7 1.3 1.9 2.2 2.6 2.2 1.9 2.8 2.3 1.7 1.0 10.0 1.1 4.8 2.8 2.1 1.0 20.9 20.8 22.8 21.4 19.7 12.0 18.9 17.8 20.7 22.5 23.8 49.3 8.8 18.7 24.4 31.5 23.0 22.9 26.8 25.0 17.4 29.5 30.5 10.0 19.2 163.8 25.1 26.3 0.0 17.6 12.0 18.6 32.7 8.1 19.8 21.9 31.8 25.8 20.3 35.7 71.1 25.6 27.2 20.3 20.8 17.6 75.0 27.2 20.3 24.1 18.0 43.9 19.4 21.9 47.9 72.2 29.0 62.1 17.3 16.9 36.9 PPFIBP1 "hSGT2, hSgt2p, L2, SGT2" ENSG00000110841 "PPFIA binding protein 1" Q86W92 12 27523431-27695564 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 154.9;Endothelial cells: 139.6;Ito cells: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 53.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001924 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA001924: AB_1079665" "unprognostic (5.27e-2)" "unprognostic (5.71e-2)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (4.73e-2)" "unprognostic (6.94e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.11e-4)" "unprognostic (7.33e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.92e-2)" "prognostic favorable (5.11e-7)" "unprognostic (8.54e-2)" "unprognostic (7.54e-2)" "unprognostic (2.64e-1)" "unprognostic (4.09e-2)" 21.3 17.1 15.5 8.0 16.8 2.2 22.6 4.9 25.0 18.3 15.4 13.3 13.0 7.1 28.1 9.3 17.1 16.5 12.2 43.3 17.1 9.0 23.8 15.7 25.0 7.8 13.1 16.4 53.1 13.7 12.7 22.2 34.5 15.3 15.3 11.1 8.1 14.2 18.4 13.7 17.8 10.0 20.5 11.2 16.6 15.1 7.1 13.3 6.2 23.9 14.9 6.2 17.2 18.4 7.0 2.0 1.5 0.6 0.3 1.8 0.6 4.4 8.9 7.3 6.2 12.1 33.8 13.0 16.1 18.1 9.5 13.7 23.4 13.5 3.3 18.8 32.6 12.7 11.1 3.9 14.7 17.1 7.6 2.2 7.4 6.8 3.4 5.3 2.2 4.1 26.2 10.3 27.6 28.4 18.6 32.4 4.5 3.8 3.4 33.7 3.4 2.1 0.6 13.0 6.3 6.9 3.4 18.1 1.2 14.1 9.8 0.6 3.0 8.0 4.3 22.4 53.2 5.5 3.4 31.5 26.8 9.0 14.6 16.4 0.0 0.0 0.2 29.8 3.2 42.2 1.5 0.6 0.3 0.7 0.2 1.4 0.7 1.3 0.7 0.6 7.0 1.3 1.3 1.5 0.3 0.2 2.0 1.8 0.6 15.5 16.8 4.9 25.0 17.1 9.0 13.1 16.4 15.3 13.3 92.3 20.3 24.3 55.3 36.5 2.3 154.9 2.5 9.4 14.8 76.8 3.9 28.5 10.0 37.2 2.6 139.6 7.0 0.0 21.6 18.9 41.3 34.7 3.5 12.7 8.3 42.9 17.9 144.9 21.5 3.1 19.5 6.4 59.1 3.6 14.6 7.5 26.9 14.4 39.6 16.6 1.7 19.4 44.8 1.7 9.1 24.1 76.9 5.9 11.5 75.3 PPID CYP-40 ENSG00000171497 "Peptidylprolyl isomerase D" Q08752 4 158709134-158723396 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Protein transport, Transport" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019520, HPA019692" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA019520: AB_1847400, HPA019692: AB_1847401" "unprognostic (4.26e-2)" "unprognostic (2.03e-2)" "unprognostic (8.91e-3)" "unprognostic (8.17e-3)" "unprognostic (1.50e-1)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.62e-2)" "unprognostic (4.72e-2)" "unprognostic (5.92e-2)" "unprognostic (4.54e-2)" "unprognostic (1.46e-2)" "unprognostic (2.66e-3)" "unprognostic (8.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.64e-1)" "unprognostic (1.09e-1)" 16.8 25.8 20.1 15.5 21.4 14.9 22.3 26.7 26.8 12.6 16.8 14.4 18.2 33.4 14.6 13.6 16.5 15.4 13.0 28.8 19.4 22.1 21.5 45.3 11.0 17.4 22.6 18.9 14.6 17.5 11.3 30.3 14.5 26.0 16.1 14.2 9.1 15.4 13.7 53.3 24.0 29.2 13.1 22.7 16.5 15.5 16.9 23.4 22.7 21.7 16.0 16.8 15.4 55.0 15.6 17.2 33.4 22.2 23.9 24.4 17.1 15.5 14.5 14.6 20.0 21.7 16.3 22.1 15.4 8.4 14.2 10.8 18.8 10.7 16.5 6.9 14.3 22.3 12.0 44.2 17.7 17.3 54.5 15.4 29.5 13.1 25.8 16.8 18.4 22.2 10.3 14.4 12.1 18.2 18.4 15.4 28.2 36.7 29.4 15.8 14.9 26.4 16.7 20.1 25.5 19.4 12.0 7.2 14.1 15.6 7.8 24.7 16.6 11.5 24.0 21.9 22.1 11.0 17.7 14.9 14.2 16.0 15.6 20.3 16.9 35.0 21.0 18.1 20.0 14.2 33.4 15.3 33.2 21.2 22.2 24.4 14.6 20.7 19.6 16.7 15.6 21.5 22.0 20.9 23.9 22.0 17.2 22.4 17.1 20.1 21.4 26.7 26.8 19.4 22.1 22.6 18.9 26.0 23.4 6.0 12.0 18.8 25.3 9.0 24.6 50.0 28.1 76.3 33.0 26.2 21.6 33.4 31.5 34.8 23.6 25.6 19.0 0.0 20.1 39.2 21.3 25.8 31.2 16.1 36.7 71.5 18.8 18.4 11.0 15.7 19.0 21.8 13.5 63.1 22.9 21.7 26.7 21.6 21.2 24.9 25.3 6.5 30.2 78.8 76.3 10.3 39.8 27.4 24.2 17.2 PPIG "CARS-Cyp, SCAF10, SRCyp" ENSG00000138398 "Peptidylprolyl isomerase G" Q13427 2 169584340-169641406 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021788, HPA057469" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA021788: AB_1847408, HPA057469: AB_2683445" "unprognostic (2.70e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (3.49e-2)" "unprognostic (1.55e-3)" "unprognostic (3.66e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-3)" "unprognostic (2.47e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (4.56e-4)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (3.41e-2)" "unprognostic (3.39e-2)" 26.2 25.3 28.5 23.8 45.3 39.2 26.7 45.0 40.7 33.1 27.1 14.6 26.0 25.3 27.1 28.1 29.4 24.3 21.2 24.2 30.0 20.3 26.0 41.1 25.5 30.4 27.7 35.9 29.5 22.8 39.4 56.7 26.0 38.0 29.3 23.9 13.8 28.6 28.8 27.8 24.5 30.8 31.9 39.7 29.7 24.1 19.8 33.7 24.1 28.4 22.6 29.9 37.4 27.6 36.4 23.7 41.7 24.7 18.7 29.6 13.3 19.5 9.3 26.3 14.4 14.6 17.9 24.8 22.4 16.8 16.5 17.1 25.4 22.6 33.7 20.6 16.1 20.7 18.8 20.6 18.3 24.5 23.4 16.6 50.7 13.9 30.9 14.1 47.7 22.6 15.0 20.7 22.4 25.2 15.7 18.1 20.6 48.9 28.2 18.8 15.8 35.2 29.3 37.7 15.9 9.5 32.4 26.3 32.9 20.4 29.4 23.0 15.2 24.0 17.9 24.3 21.1 16.7 27.6 20.8 21.6 16.5 14.4 18.3 16.4 23.6 47.1 15.9 25.6 19.7 20.7 20.0 29.9 20.3 20.1 23.2 27.6 27.0 23.8 14.9 36.4 29.6 23.7 41.7 18.7 24.7 23.7 22.9 13.3 28.5 45.3 45.0 40.7 30.0 20.3 27.7 35.9 38.0 33.7 205.4 160.5 152.0 169.4 134.5 178.8 130.1 61.1 132.5 155.8 89.0 51.1 146.0 68.0 90.9 6.8 121.2 97.1 70.0 90.5 147.9 117.4 133.0 172.3 157.2 134.3 208.2 100.6 106.2 118.2 8.4 131.5 135.1 104.6 124.4 115.6 123.1 82.2 108.7 137.9 99.6 103.2 161.7 154.6 225.0 148.0 150.9 171.9 152.4 132.6 136.1 PPIL4 ENSG00000131013 "Peptidylprolyl isomerase like 4" Q8WUA2 6 149504733-149546038 "Enzymes, Predicted intracellular proteins" "Isomerase, RNA-binding, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031599, HPA031600" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031599: AB_2673950, HPA031600: AB_10600928" "unprognostic (6.12e-2)" "unprognostic (4.90e-2)" "unprognostic (3.85e-2)" "unprognostic (8.42e-2)" "unprognostic (7.53e-2)" "unprognostic (6.36e-3)" "unprognostic (2.91e-3)" "unprognostic (2.22e-1)" "unprognostic (4.22e-2)" "unprognostic (1.09e-1)" "unprognostic (2.38e-1)" "unprognostic (4.62e-2)" "unprognostic (3.88e-2)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (8.50e-2)" "unprognostic (7.94e-2)" 20.0 20.1 20.6 15.0 35.5 30.6 21.2 35.1 27.8 24.0 15.3 19.7 10.1 14.1 21.1 27.2 15.7 18.0 19.8 18.3 21.3 15.6 18.8 23.0 17.9 15.7 20.9 18.0 32.9 16.0 20.8 36.6 22.6 23.9 20.5 16.8 15.7 18.2 16.7 14.8 15.4 16.0 20.0 22.7 17.6 16.0 15.9 19.4 27.0 26.8 8.2 16.8 22.0 19.2 21.4 16.6 24.9 17.8 28.7 24.6 14.8 11.1 6.0 21.0 17.3 12.5 16.4 19.6 22.0 21.0 24.1 25.7 12.6 11.4 11.8 15.2 16.9 14.4 10.1 16.0 8.4 38.3 17.1 15.1 13.0 13.2 21.6 19.7 23.6 11.1 12.8 14.4 24.6 20.6 13.5 13.1 8.6 28.3 7.1 18.7 11.9 13.4 20.3 16.6 11.2 9.5 18.2 19.4 5.9 18.3 8.5 12.4 9.5 26.2 11.5 15.0 15.2 13.5 17.2 15.3 16.0 12.5 28.3 20.9 9.4 4.8 18.5 13.5 19.0 23.0 24.9 16.1 18.1 14.7 17.8 20.4 21.4 19.5 16.9 16.6 16.6 24.6 18.7 13.4 28.7 16.1 16.2 20.7 14.8 20.6 35.5 35.1 27.8 21.3 15.6 20.9 18.0 23.9 19.4 62.5 64.3 22.6 54.3 43.4 44.2 33.3 17.8 80.3 61.4 43.6 7.9 43.1 36.5 34.7 17.2 37.3 15.2 0.0 23.1 37.9 55.5 27.1 73.0 18.7 31.8 27.0 22.3 30.7 21.3 9.6 57.2 29.9 38.8 47.7 19.7 40.0 26.4 22.9 52.6 27.5 35.5 51.8 68.4 58.2 53.4 39.5 54.6 41.5 20.0 32.7 PPIL6 "bA425D10.6, dJ919F19.1, MGC41939, RSPH12" ENSG00000185250 "Peptidylprolyl isomerase like 6" Q8IXY8 6 109390215-109441171 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 36.5" "Group enriched" "Detected in many" 4 "Ciliated cells: 187.4;Early spermatids: 262.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 6.5;ASC diff: 10.4;ASC TERT1: 12.9;hTERT-RPE1: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036717, HPA058165" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA036717: AB_10671969, HPA058165: " "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (5.68e-2)" "unprognostic (2.68e-2)" "unprognostic (3.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (5.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.03e-2)" "unprognostic (1.42e-3)" "unprognostic (2.51e-2)" "unprognostic (4.71e-2)" "unprognostic (1.95e-1)" "unprognostic (3.29e-2)" "unprognostic (5.86e-2)" "unprognostic (2.32e-1)" 1.5 1.4 5.5 1.1 8.6 0.7 3.6 5.0 4.8 4.6 1.7 7.2 7.4 1.9 3.8 12.7 2.0 36.5 1.7 2.6 6.0 5.4 4.9 1.2 8.9 1.1 3.4 3.2 6.3 4.3 6.6 7.6 1.6 18.3 1.8 1.6 2.6 2.8 5.0 3.9 1.7 1.1 5.4 3.2 1.3 2.3 20.4 5.3 0.0 17.2 1.4 1.1 2.9 2.0 5.1 1.7 2.0 1.3 1.7 1.3 1.1 1.8 1.0 1.2 6.5 10.4 12.9 1.1 0.0 2.3 0.5 0.2 0.1 1.8 0.0 0.5 0.6 0.9 1.2 1.0 0.0 0.3 0.5 0.9 0.5 0.1 0.0 5.2 0.6 0.3 2.7 6.2 0.2 3.9 9.3 0.8 1.4 0.9 0.3 0.4 0.6 0.1 0.6 0.2 4.2 1.3 0.8 0.0 0.6 5.0 0.1 1.5 2.5 0.2 0.3 4.3 0.3 0.5 1.0 0.4 0.1 0.2 1.1 0.2 0.3 0.1 0.1 2.1 0.1 0.4 2.0 1.2 1.2 0.9 1.3 0.9 5.1 1.2 1.1 1.7 3.2 1.1 1.0 1.6 1.7 1.1 1.7 1.3 1.1 5.5 8.6 5.0 4.8 6.0 5.4 3.4 3.2 18.3 5.3 6.0 5.8 0.0 3.5 1.9 2.1 3.3 5.1 187.4 22.7 3.5 2.0 0.5 21.6 1.6 262.5 1.5 0.7 0.0 1.0 0.7 1.7 2.9 0.0 0.0 0.3 1.6 2.9 0.6 0.0 40.8 4.9 0.5 3.3 1.0 1.8 4.9 0.7 0.0 4.9 8.0 11.5 0.0 1.2 52.6 22.0 2.6 0.6 0.5 1.7 1.1 PPIP5K1 "HISPPD2A, IPS1, KIAA0377, VIP1" ENSG00000168781 "Diphosphoinositol pentakisphosphate kinase 1" Q6PFW1 15 43533462-43590253 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 42.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039380 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039380: AB_10673528" "unprognostic (8.72e-2)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-1)" "unprognostic (2.38e-1)" "unprognostic (2.78e-1)" "unprognostic (8.18e-2)" "unprognostic (5.78e-2)" "unprognostic (2.59e-3)" "prognostic unfavorable (8.57e-4)" "unprognostic (6.67e-2)" "unprognostic (2.85e-3)" "prognostic favorable (7.14e-8)" "unprognostic (2.67e-2)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (7.95e-3)" 1.7 5.2 3.4 1.8 6.4 1.1 3.4 28.4 7.0 2.8 6.1 9.1 2.2 5.6 3.7 3.1 2.5 2.1 3.6 5.0 2.5 1.4 1.4 2.0 3.3 3.0 2.9 13.4 7.6 0.9 3.4 6.5 4.7 2.7 6.3 7.2 8.8 2.3 2.8 2.3 5.3 4.5 5.0 3.0 3.3 2.7 5.3 3.2 4.3 2.8 3.5 3.8 3.0 8.4 5.6 4.9 9.1 3.0 1.9 8.4 4.2 5.4 6.1 9.0 6.4 8.1 7.9 6.4 5.8 9.1 23.1 9.5 18.4 6.2 7.8 7.5 11.9 16.9 3.4 6.8 13.6 12.4 3.4 16.2 7.4 11.4 8.3 6.4 18.6 8.6 11.8 4.5 6.6 4.5 7.7 2.4 15.9 6.0 9.7 5.0 4.0 6.6 15.3 14.8 4.6 10.9 10.4 4.1 7.3 19.2 11.4 2.8 5.3 6.4 6.7 10.2 2.6 3.2 9.8 10.0 15.6 5.1 4.3 1.4 0.0 2.7 2.8 3.8 5.3 3.3 3.6 3.2 3.6 2.7 2.5 1.0 3.5 2.1 2.4 0.8 3.0 0.0 2.1 0.0 1.5 3.5 15.3 4.0 5.1 0.0 2.3 7.0 39.3 2.7 0.0 2.1 1.7 2.4 8.8 0.0 1.3 0.8 0.8 1.3 0.0 1.1 1.6 9.5 2.4 4.3 2.7 1.6 1.7 1.6 0.0 1.0 5.0 4.3 1.8 3.5 6.7 1.4 42.3 6.5 1.0 6.6 1.3 2.9 1.8 2.1 7.6 3.2 PPL ENSG00000118898 Periplakin O60437 16 4882507-4960741 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 68.5;Collecting duct cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.2;HaCaT: 57.0;MCF7: 20.8;SiHa: 30.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA042550, HPA059859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 310000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA042550: AB_2678048, HPA059859: AB_2684145" "unprognostic (2.12e-2)" "unprognostic (1.78e-1)" "unprognostic (1.16e-1)" "unprognostic (3.90e-2)" "unprognostic (2.84e-2)" "unprognostic (1.40e-1)" "unprognostic (3.70e-3)" "unprognostic (5.58e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (2.41e-2)" "unprognostic (1.31e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" 10.8 0.7 2.2 1.4 0.7 0.2 6.8 0.6 3.0 23.5 2.9 0.2 4.1 1.7 2.6 5.1 126.9 2.9 5.8 1.8 1.8 0.2 3.0 3.3 4.7 0.2 0.0 0.9 1.7 2.8 1.6 2.8 2.9 0.5 4.6 1.0 0.7 24.3 3.3 3.2 30.7 2.0 5.0 0.0 0.2 2.1 1.5 0.0 0.5 7.2 57.8 60.9 5.0 39.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.9 2.5 0.0 0.0 18.7 27.2 9.0 0.0 0.4 0.0 0.1 11.6 17.8 0.1 4.1 0.3 1.0 57.0 0.3 6.8 0.0 0.0 0.4 0.0 13.8 2.0 1.2 0.0 0.0 1.3 6.3 0.0 2.2 1.4 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 1.8 9.2 5.4 0.0 0.0 8.7 13.6 11.1 9.4 0.1 30.5 10.2 0.1 2.8 5.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.6 3.0 1.8 0.2 0.0 0.9 0.5 0.0 68.5 23.2 0.5 33.9 31.1 7.7 3.5 30.6 12.0 30.7 54.1 5.9 1.6 1.7 15.3 0.6 6.4 4.5 0.0 4.0 1.2 11.0 30.6 0.0 10.9 0.6 1.6 37.8 4.3 0.8 0.2 51.2 1.8 16.9 1.8 3.9 5.3 16.8 5.8 3.9 0.8 11.2 0.0 5.6 3.9 2.9 44.8 1.1 0.7 5.0 47.5 PPM1A "MGC9201, PP2CA, PP2Calpha" ENSG00000100614 "Protein phosphatase, Mg2+/Mn2+ dependent 1A" P35813 14 60245752-60299087 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 362.9;Late spermatids: 423.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029209 Approved Supported "Plasma membrane,Cytosol" NA NA 850000 Cytosol "Plasma membrane" "HPA029209: AB_2672951" "unprognostic (3.14e-1)" "unprognostic (2.14e-1)" "unprognostic (5.64e-2)" "unprognostic (1.85e-1)" "unprognostic (4.00e-2)" "unprognostic (2.30e-2)" "unprognostic (4.50e-2)" "unprognostic (1.11e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.57e-9)" "unprognostic (1.58e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" 16.2 11.7 13.8 15.0 18.3 64.0 15.1 20.5 28.6 15.5 32.4 13.3 9.4 19.1 17.4 12.7 15.2 10.7 10.8 37.1 13.5 16.1 22.8 26.7 14.6 11.8 15.6 19.1 12.1 13.3 18.2 12.2 15.8 24.3 16.5 19.4 12.3 18.7 13.5 56.1 16.7 25.2 15.0 13.8 11.6 14.9 29.7 12.7 23.4 13.3 11.6 13.4 15.2 16.5 4.0 2.7 8.0 2.1 4.7 4.5 1.9 48.6 11.0 9.6 8.1 14.7 13.6 12.2 13.4 15.7 10.0 9.5 6.2 14.4 29.3 12.8 15.1 7.4 10.8 9.9 13.8 17.5 26.3 5.6 18.0 7.8 9.6 12.3 20.4 12.9 11.5 16.6 11.7 16.0 11.7 9.7 15.0 9.9 23.3 12.1 21.3 26.5 4.8 9.0 9.7 9.3 9.5 22.2 9.4 12.0 23.4 16.3 12.2 13.9 16.3 11.3 9.1 16.4 8.9 13.4 20.8 20.8 9.1 9.5 18.2 10.3 34.3 9.5 8.1 10.5 6.7 1.8 5.1 3.5 1.8 3.8 1.7 2.8 3.1 2.7 4.0 2.2 2.1 8.0 4.7 2.1 1.6 4.5 1.9 13.8 18.3 20.5 28.6 13.5 16.1 15.6 19.1 24.3 12.7 14.9 23.5 24.8 36.4 68.7 40.5 85.1 38.2 9.4 15.9 36.6 60.9 27.7 28.2 22.7 362.9 29.7 97.1 70.0 21.2 20.1 41.4 73.1 26.5 65.2 24.8 55.6 58.3 21.5 27.7 423.8 39.1 33.5 57.3 16.2 52.8 37.7 29.2 66.2 49.1 73.2 62.7 38.8 44.2 46.9 24.8 72.0 61.4 35.5 36.5 38.6 PPM1B "PP2CB, PP2CBETA, PPC2BETAX" ENSG00000138032 "Protein phosphatase, Mg2+/Mn2+ dependent 1B" O75688 2 44167969-44244384 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016745 Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA016745: AB_1855622" "unprognostic (5.49e-2)" "unprognostic (2.67e-2)" "unprognostic (1.11e-2)" "unprognostic (2.96e-3)" "unprognostic (1.92e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-2)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (2.25e-1)" "unprognostic (6.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (1.75e-2)" 23.7 13.8 31.2 12.2 33.8 24.7 15.2 32.6 25.2 16.3 18.2 26.0 13.6 13.2 15.7 20.4 14.9 12.7 14.3 21.1 29.6 24.6 19.4 27.7 13.4 16.6 34.6 22.4 15.8 20.9 34.6 17.9 12.1 22.9 20.7 19.0 24.3 16.4 16.4 72.0 12.5 14.3 21.1 27.3 16.1 14.8 13.3 34.1 19.1 15.0 13.1 16.8 18.2 15.9 6.5 5.5 11.1 5.0 4.7 9.5 1.6 17.0 15.3 20.4 14.8 25.4 11.9 23.1 13.2 15.3 13.8 12.2 20.5 11.1 18.8 20.8 15.3 11.2 9.3 22.7 8.7 20.4 18.9 8.8 19.8 9.1 14.1 20.6 17.7 16.6 11.4 15.2 10.9 18.6 10.8 11.2 8.8 14.4 20.0 12.3 14.2 17.5 28.5 25.1 15.8 5.2 18.6 22.7 12.6 32.1 17.3 16.4 20.7 11.9 17.9 15.3 31.7 9.7 12.4 10.2 12.1 17.4 10.0 12.7 17.5 11.4 17.6 6.4 29.5 8.7 8.3 3.3 11.1 7.2 4.5 6.2 5.8 6.9 6.1 5.5 6.5 9.5 6.4 9.2 4.7 5.0 5.3 6.2 1.6 31.2 33.8 32.6 24.9 29.6 24.6 34.6 22.4 22.9 34.1 17.9 17.3 29.6 37.1 53.8 47.2 45.6 28.1 5.3 20.5 38.4 60.9 27.6 39.7 35.0 59.2 17.3 39.4 0.0 41.1 24.4 27.3 58.6 26.5 49.9 23.3 101.7 38.6 16.5 48.5 32.9 33.1 41.2 54.0 37.9 27.4 54.4 35.2 40.3 31.8 30.8 128.5 25.8 38.7 33.8 26.0 54.5 54.0 54.2 32.8 45.7 PPM1L PP2CE ENSG00000163590 "Protein phosphatase, Mg2+/Mn2+ dependent 1L" Q5SGD2 3 160755602-161078907 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 59.9;Cardiomyocytes: 33.6;Cone photoreceptor cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "HDLM-2: 35.6;U-266/70: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019891, HPA019953" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA019891: AB_1855631, HPA019953: AB_2170360" "prognostic unfavorable (4.90e-4)" "unprognostic (7.29e-3)" "unprognostic (2.01e-1)" "unprognostic (2.59e-2)" "unprognostic (8.03e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (1.63e-2)" "unprognostic (2.49e-2)" "unprognostic (1.92e-1)" "unprognostic (4.51e-2)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (9.13e-3)" "unprognostic (2.07e-1)" 7.7 8.5 7.4 3.5 11.5 3.3 6.3 15.8 23.2 11.3 7.0 5.5 1.1 3.0 6.2 3.7 8.7 6.1 12.6 9.9 6.3 7.8 8.4 6.0 4.6 1.9 8.0 10.1 3.7 5.4 33.6 26.3 11.5 13.8 9.6 5.9 5.6 18.9 3.7 25.7 7.6 3.6 16.4 4.6 3.4 8.4 2.8 3.7 5.6 14.4 9.6 3.5 16.6 10.8 0.7 1.3 4.9 7.6 1.1 2.6 2.0 1.2 0.8 4.1 2.1 2.4 0.0 2.5 0.2 0.1 0.4 0.1 0.2 0.2 0.2 0.4 0.1 0.9 3.7 3.4 0.2 0.1 35.6 3.6 3.5 3.3 0.4 0.1 2.1 4.1 0.4 1.6 0.1 0.2 0.3 0.2 1.7 0.1 5.6 0.0 1.9 0.8 0.2 2.3 6.5 0.8 4.2 0.7 0.8 0.1 3.8 4.9 4.2 2.0 2.4 0.1 1.4 2.7 2.1 0.2 0.4 0.4 0.3 1.3 35.6 0.1 2.0 0.6 1.8 0.8 0.7 2.3 4.9 2.6 5.5 0.2 0.2 0.6 1.7 1.3 0.7 1.0 1.8 0.2 1.1 7.6 0.8 0.0 2.0 7.4 11.5 15.8 17.9 6.3 7.8 8.0 10.1 13.8 3.7 6.0 2.4 0.0 5.2 7.7 59.9 33.6 10.2 13.4 5.7 1.8 33.4 2.4 0.0 1.5 1.1 2.4 3.8 0.0 3.7 1.6 7.0 6.0 0.0 14.9 5.9 6.4 13.3 0.6 12.4 0.4 4.6 7.2 3.3 2.8 7.6 9.3 1.7 7.0 4.9 3.3 10.1 0.0 11.2 1.5 3.1 7.5 2.2 2.9 4.9 18.0 PPOX "PPO, VP" ENSG00000143224 "Protoporphyrinogen oxidase" P50336 1 161166410-161178013 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030123 Uncertain Approved Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "HPA030123: AB_10603987" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (9.88e-2)" "unprognostic (2.13e-2)" "unprognostic (3.24e-1)" "unprognostic (1.64e-2)" "unprognostic (9.58e-3)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.17e-1)" "unprognostic (2.18e-3)" "unprognostic (7.12e-3)" "prognostic unfavorable (9.89e-4)" "unprognostic (6.12e-2)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "unprognostic (1.80e-2)" 7.3 14.8 11.6 9.1 12.1 31.7 10.2 23.5 16.5 11.0 9.9 13.2 8.5 6.0 11.7 13.5 7.5 33.2 9.5 9.5 11.5 12.5 12.0 9.1 10.2 11.2 14.2 16.1 13.0 13.1 10.5 12.3 10.1 12.1 11.0 6.7 14.4 11.3 14.6 8.5 15.9 7.1 10.0 10.6 12.0 8.2 6.9 13.7 9.2 11.0 6.1 8.7 8.7 8.2 9.8 11.5 6.9 7.7 12.3 16.7 8.9 7.1 6.6 9.9 6.4 7.5 8.0 3.3 4.9 5.7 6.1 8.1 7.7 6.9 5.6 11.9 3.4 3.1 4.9 7.6 7.9 5.5 3.9 15.0 6.7 14.8 17.6 8.0 2.2 3.7 6.4 8.0 5.9 8.4 9.2 11.5 5.2 19.9 8.7 4.4 6.7 8.9 7.1 7.1 9.0 14.1 10.9 6.8 13.2 11.6 3.1 7.8 12.7 6.0 8.7 9.9 12.5 15.8 10.5 4.0 5.6 6.2 4.9 6.3 15.5 11.3 8.6 5.7 4.9 4.3 6.9 7.7 5.5 12.7 7.7 8.4 9.8 9.8 8.8 11.5 8.6 8.6 8.8 1.6 12.3 5.3 7.2 16.7 8.9 11.6 12.1 23.5 16.5 11.5 12.5 14.2 16.1 12.1 13.7 3.0 13.6 4.5 7.2 10.6 16.2 7.7 7.6 62.9 13.6 7.0 21.6 17.7 18.3 8.8 8.4 9.1 4.9 0.0 4.9 8.3 10.3 3.6 5.8 5.8 8.0 14.3 5.8 8.0 4.3 10.0 9.5 7.9 1.7 10.0 6.5 9.6 6.4 3.6 6.3 14.8 17.3 6.5 6.7 9.6 6.1 13.0 8.7 13.1 7.6 4.7 PPP1CA "PP-1A, PP1A, PP1alpha, PPP1A" ENSG00000172531 "Protein phosphatase 1 catalytic subunit alpha" P62136 11 67398183-67421183 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 177.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004545, HPA046833" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 8100000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB004545: AB_628177, HPA046833: AB_2679829" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.51e-2)" "unprognostic (3.15e-3)" "unprognostic (3.93e-2)" "unprognostic (2.07e-1)" "unprognostic (3.89e-2)" "unprognostic (5.05e-3)" "unprognostic (8.00e-2)" "unprognostic (1.66e-1)" "unprognostic (9.96e-2)" "unprognostic (7.69e-2)" "prognostic favorable (1.17e-4)" "unprognostic (7.60e-2)" 28.4 35.4 24.2 42.0 32.3 42.1 25.1 19.6 33.4 23.9 39.6 22.1 29.9 33.9 19.6 25.8 59.7 22.8 28.6 33.0 21.8 17.1 43.7 55.0 27.6 49.3 19.9 19.9 20.1 53.3 23.1 21.6 44.0 19.3 27.2 33.2 23.2 49.7 31.1 39.0 34.4 47.3 20.5 21.3 53.7 35.1 15.7 19.4 77.7 38.5 40.5 63.9 25.5 25.7 78.8 76.6 126.2 118.0 68.2 113.9 177.2 45.3 52.4 31.1 45.8 15.5 19.0 31.7 22.5 26.4 45.4 34.5 74.9 54.8 39.1 38.4 34.1 33.8 39.8 35.9 46.8 27.9 41.1 24.4 37.5 24.7 39.2 33.9 47.6 48.5 21.4 31.0 38.6 22.8 21.6 45.5 38.3 34.8 32.4 36.7 103.5 60.3 93.6 51.6 86.5 41.5 42.9 43.0 33.8 44.6 37.6 24.3 40.4 26.1 46.9 69.4 24.3 56.1 33.0 32.4 35.1 35.9 41.3 29.1 32.5 30.1 44.4 42.0 32.7 36.9 81.4 80.1 126.2 88.6 100.5 69.3 78.8 79.8 90.5 76.6 77.0 49.1 69.2 93.3 68.2 118.0 54.4 113.9 177.2 24.2 32.3 19.6 33.4 21.8 17.1 19.9 19.9 19.3 19.4 71.5 93.0 166.0 108.0 88.8 35.0 7.9 117.2 41.5 46.6 82.0 9.8 320.7 180.8 238.7 1.8 77.3 292.4 23.3 272.4 398.0 69.2 127.9 107.3 102.4 338.5 41.3 93.0 87.2 194.1 5.3 45.5 157.2 129.9 390.5 160.1 42.9 250.4 210.5 26.9 236.5 23.6 97.0 60.9 13.0 106.5 106.3 357.3 222.6 164.6 168.4 PPP1CB "PP-1B, PP1B, PP1beta" ENSG00000213639 "Protein phosphatase 1 catalytic subunit beta" P62140 2 28751640-28802940 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022558, HPA065425, CAB069426" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 7700000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022558: , CAB069426: , HPA065425: AB_2685489" "unprognostic (2.90e-1)" "unprognostic (5.03e-2)" "unprognostic (5.49e-2)" "unprognostic (2.00e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.52e-6)" "unprognostic (3.47e-2)" "unprognostic (2.44e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-3)" "unprognostic (3.95e-1)" "unprognostic (1.68e-1)" "unprognostic (3.66e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-1)" "unprognostic (2.26e-2)" 28.5 22.6 30.0 20.5 37.6 29.5 32.4 19.1 29.8 51.1 39.3 21.1 30.7 24.4 58.0 31.8 86.0 37.0 33.3 67.1 27.8 27.9 32.0 20.0 35.3 22.3 27.4 24.4 39.7 21.9 48.9 28.7 42.3 22.0 46.4 27.7 25.2 36.5 38.6 99.6 25.1 30.0 100.8 27.5 25.2 31.4 25.5 21.4 28.1 27.5 32.9 25.3 82.1 50.5 15.6 25.4 41.5 42.7 23.5 28.3 17.9 37.1 23.4 81.7 25.2 28.0 26.1 47.6 20.0 22.8 19.5 19.3 20.7 22.0 29.7 25.1 20.6 21.6 23.0 23.2 26.7 23.2 47.1 12.0 22.5 28.8 22.4 61.0 25.4 10.6 20.0 38.0 21.0 44.0 20.5 23.5 15.8 20.4 29.5 25.5 18.6 26.9 22.0 26.8 28.6 18.6 26.4 72.4 22.6 63.3 44.9 22.4 27.7 31.0 34.6 27.1 24.4 16.7 14.2 28.1 26.1 28.7 18.6 24.0 21.1 33.1 60.9 27.7 27.4 19.3 22.5 24.8 32.1 16.8 37.8 21.3 15.6 25.5 19.6 25.4 13.4 22.7 25.5 41.5 23.5 42.7 19.6 28.3 17.9 30.0 37.6 19.1 29.8 27.8 27.9 27.4 24.4 22.0 21.4 86.4 80.7 105.5 134.5 437.2 53.8 298.4 104.4 129.8 72.8 294.8 25.5 104.9 207.2 242.7 375.6 106.2 128.9 163.5 183.3 167.5 182.4 291.0 146.3 81.8 104.3 154.1 271.6 108.6 144.9 304.1 182.1 233.4 318.9 92.8 133.9 100.9 238.2 181.4 283.9 113.6 53.2 620.9 265.8 57.5 61.8 400.4 328.6 110.8 99.3 394.6 PPP1R12A "M130, MBS, MYPT1" ENSG00000058272 "Protein phosphatase 1 regulatory subunit 12A" O14974 12 79773563-79935460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041296, HPA071956" Approved Supported "Actin filaments,Cytosol" NA NA 300000 "Actin filaments, Cytosol" "HPA041296: AB_2677394, HPA071956: AB_2732192" "unprognostic (3.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-1)" "unprognostic (5.60e-3)" "unprognostic (6.19e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.61e-1)" "unprognostic (9.69e-3)" "unprognostic (1.85e-1)" "unprognostic (2.04e-2)" "unprognostic (1.04e-1)" "unprognostic (2.44e-3)" "unprognostic (5.50e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "unprognostic (1.38e-1)" 20.1 8.9 17.2 19.4 17.2 23.8 15.9 18.3 18.3 28.0 45.2 6.5 20.9 10.1 36.6 16.5 34.2 28.1 17.0 13.7 12.6 8.8 8.7 6.6 15.8 13.3 9.9 15.4 17.3 7.0 11.0 15.2 18.9 10.4 33.1 17.2 24.0 11.4 42.1 13.7 12.9 19.3 73.7 8.8 14.6 23.2 10.8 10.4 18.8 14.2 9.9 12.4 47.6 29.3 14.9 11.0 50.6 16.9 25.5 18.7 10.8 15.6 13.0 19.2 11.0 14.9 14.7 16.8 32.2 18.0 20.8 14.1 12.2 7.9 13.8 13.2 43.7 8.4 12.5 14.9 12.4 25.7 18.5 9.1 37.3 15.5 8.9 11.6 24.2 23.4 12.1 9.6 21.1 19.6 24.0 14.4 14.1 15.1 16.7 22.4 10.0 26.6 12.8 14.9 7.0 9.6 22.0 21.3 10.2 12.4 25.8 9.1 6.8 24.9 8.7 10.9 18.7 12.2 11.7 21.2 22.4 11.7 15.3 18.0 10.7 10.0 18.5 7.6 13.7 19.0 35.6 11.7 50.0 17.9 12.5 16.1 14.9 17.1 18.7 11.0 13.5 13.8 17.7 50.6 25.5 16.9 9.3 18.0 10.8 17.2 17.2 18.3 18.3 12.6 8.8 9.9 15.4 10.4 10.4 71.5 63.6 52.0 60.6 75.1 79.7 110.0 25.5 49.5 62.6 50.6 33.4 58.8 13.3 43.4 67.9 84.6 33.8 23.3 34.9 68.3 73.7 42.9 115.8 22.2 66.4 96.9 43.0 57.7 55.3 51.0 80.0 90.4 57.3 107.4 33.9 52.9 43.8 38.4 138.6 22.1 61.7 207.0 241.7 118.7 90.3 70.9 70.0 98.0 31.1 53.8 PPP1R13B "ASPP1, KIAA0771, p53BP2-like, p85" ENSG00000088808 "Protein phosphatase 1 regulatory subunit 13B" Q96KQ4 14 103733752-103847590 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006394, CAB015454" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB015454: AB_2252775, HPA006394: AB_1079668" "unprognostic (1.20e-1)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "prognostic favorable (1.41e-4)" "unprognostic (3.22e-3)" "unprognostic (5.13e-2)" "unprognostic (5.39e-2)" "unprognostic (1.62e-3)" "prognostic favorable (3.28e-11)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.23e-1)" 7.1 5.5 12.1 5.0 13.2 1.0 7.7 23.3 16.6 8.6 9.0 7.8 6.4 8.7 9.1 4.5 13.5 12.3 5.8 24.5 10.0 6.5 8.3 5.9 11.9 3.3 5.3 9.8 13.3 13.2 12.2 15.6 7.1 10.5 13.3 7.3 13.9 11.6 8.2 7.6 12.9 11.2 6.7 5.2 13.0 11.9 21.2 6.3 1.1 28.4 4.3 7.9 10.1 7.3 0.7 0.0 0.0 0.0 0.2 2.0 0.3 4.0 3.4 0.4 4.7 0.8 0.3 1.7 2.5 1.9 3.5 1.6 2.6 3.6 1.0 9.8 2.1 4.0 8.4 4.9 3.7 2.9 2.1 3.4 0.0 1.2 4.4 3.2 0.4 3.8 0.9 4.3 0.3 4.0 1.3 6.8 2.4 0.5 1.7 2.2 16.3 0.0 0.3 0.8 9.7 4.3 10.2 2.8 2.3 7.2 10.1 5.5 14.8 7.9 6.2 1.9 2.2 15.5 0.6 5.7 2.5 3.3 2.0 2.4 3.7 4.5 6.8 1.6 2.5 1.2 0.0 0.0 0.0 1.4 0.0 2.0 0.7 1.3 0.0 0.0 0.5 0.2 0.5 0.0 0.2 0.0 0.0 0.9 0.3 12.1 13.2 23.3 16.6 10.0 6.5 5.3 9.8 10.5 6.3 17.9 36.1 4.2 14.2 11.9 13.6 40.4 20.4 6.7 14.8 7.0 11.8 2.3 3.3 6.3 46.9 17.7 20.6 0.0 5.6 0.9 6.1 16.9 0.0 8.6 2.2 14.3 15.0 9.8 0.6 48.7 4.0 2.0 3.3 0.0 14.5 4.5 6.1 19.5 19.1 5.4 12.5 6.5 5.3 14.6 12.3 11.3 1.8 4.3 14.4 13.2 PPP1R13L "IASPP, RAI" ENSG00000104881 "Protein phosphatase 1 regulatory subunit 13 like" Q8WUF5 19 45379634-45406349 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 78.3" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 77.1;Syncytiotrophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 35.6;hTCEpi: 52.2;hTERT-HME1: 36.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB005016, HPA041231, HPA059883" Approved Enhanced Cytosol NA Yes Cytosol "CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: AB_2684151" "unprognostic (1.87e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (2.92e-1)" "unprognostic (3.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.31e-3)" "prognostic unfavorable (3.39e-5)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.40e-4)" "unprognostic (2.52e-3)" "unprognostic (1.92e-2)" "unprognostic (1.55e-3)" "unprognostic (1.34e-1)" "unprognostic (7.69e-2)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" 6.7 6.6 2.5 3.6 4.1 0.6 14.5 3.5 3.4 13.2 6.2 2.4 8.5 2.9 5.8 8.2 51.6 3.6 4.7 37.2 4.0 1.2 8.0 5.7 8.5 1.6 3.9 2.5 4.4 12.4 6.6 6.6 38.7 3.9 11.5 3.8 5.1 17.8 15.7 3.8 78.3 7.1 3.8 3.3 2.5 4.4 1.6 6.1 2.7 10.6 24.4 25.6 13.2 22.9 0.6 0.7 0.0 1.5 0.0 2.3 0.2 21.2 3.0 1.2 1.0 1.3 0.8 18.5 3.8 0.6 4.8 6.7 6.0 19.8 2.5 1.7 3.0 9.9 28.4 1.0 35.6 4.4 6.5 1.5 0.3 9.8 2.2 2.8 0.2 0.9 1.1 52.2 7.6 36.2 21.7 8.9 2.1 2.1 0.9 0.3 17.4 0.4 0.4 1.4 9.7 5.0 1.9 1.5 0.4 6.2 25.5 0.6 2.2 19.7 18.9 0.4 8.5 16.5 0.5 13.6 6.1 18.7 0.4 18.7 10.6 10.9 1.6 0.9 0.7 1.5 0.0 0.0 0.0 1.5 0.4 0.7 0.6 2.3 0.4 0.2 0.2 0.1 0.7 0.0 0.0 1.5 0.7 1.3 0.2 2.5 4.1 3.5 3.4 4.0 1.2 3.9 2.5 3.9 6.1 32.8 8.8 0.5 77.1 61.0 2.0 34.3 20.4 8.1 22.7 19.2 9.8 69.5 5.0 28.4 0.5 11.2 15.4 0.0 13.4 33.0 6.1 31.1 4.6 2.1 6.7 0.0 6.9 8.0 2.6 0.2 5.5 2.7 11.8 1.8 6.2 2.2 35.6 14.0 11.7 2.7 25.6 6.5 10.4 2.9 1.9 62.0 107.4 0.7 7.1 62.2 PPP1R2 "IPP2, PPP1R2A" ENSG00000184203 "Protein phosphatase 1 regulatory inhibitor subunit 2" P41236 3 195514425-195543386 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 363.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 67.5" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043729: AB_2678639, HPA059420: AB_2684009" "unprognostic (1.85e-2)" "unprognostic (3.71e-3)" "unprognostic (6.26e-2)" "unprognostic (3.58e-1)" "unprognostic (5.66e-2)" "unprognostic (1.44e-1)" "unprognostic (4.17e-2)" "unprognostic (3.92e-1)" "unprognostic (4.20e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" "unprognostic (8.32e-2)" "unprognostic (4.99e-2)" "unprognostic (2.28e-1)" "unprognostic (3.74e-1)" "unprognostic (2.71e-1)" "unprognostic (2.13e-1)" 16.4 12.7 19.9 17.7 26.0 45.2 18.3 16.2 22.9 16.1 21.2 11.4 17.4 19.5 18.9 20.7 25.6 15.3 15.8 23.3 18.6 21.7 16.7 13.0 21.7 30.4 16.5 15.4 17.1 12.0 9.5 17.6 16.1 21.2 17.0 16.0 13.7 15.0 19.0 57.1 14.1 22.6 17.7 15.4 24.2 13.9 21.8 7.0 38.1 19.1 25.2 23.5 26.5 15.5 26.0 26.6 63.2 16.9 22.8 50.2 30.1 11.6 2.5 4.3 4.9 7.3 7.8 7.9 7.3 10.6 7.8 6.7 39.5 5.3 4.6 29.2 8.9 8.4 5.2 4.5 7.4 9.6 9.1 8.5 5.3 4.2 13.2 11.3 5.5 5.5 9.5 5.7 5.8 11.8 6.2 6.7 4.9 4.0 9.9 6.8 8.1 9.8 6.2 4.5 14.0 11.8 4.6 7.5 13.7 9.3 8.9 10.2 5.6 8.8 9.7 13.1 8.3 15.3 5.6 7.4 5.0 5.8 8.2 9.9 67.5 29.3 22.1 7.0 10.1 9.7 26.3 16.7 63.2 19.6 16.9 26.9 26.0 41.2 27.0 17.6 23.6 50.2 34.0 39.4 22.8 16.4 26.6 41.7 30.1 19.9 26.0 16.2 22.9 18.6 21.7 16.5 15.4 21.2 7.0 20.8 39.2 125.0 121.2 83.7 47.5 46.2 25.5 66.9 38.7 21.0 55.0 57.7 106.1 61.4 363.0 65.1 53.1 46.7 57.9 34.5 51.3 104.3 109.6 24.6 55.6 49.3 55.0 39.3 59.0 190.1 47.8 82.0 92.8 141.5 44.1 50.2 58.5 55.2 59.8 82.6 79.3 25.8 64.1 239.4 84.1 67.9 86.3 140.6 44.9 143.1 PPP1R27 "DYSFIP1, toonin" ENSG00000182676 "Protein phosphatase 1 regulatory subunit 27" Q86WC6 17 81833492-81835050 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "skeletal muscle: 211.0" "Cell type enriched" "Detected in some" 10 "Early spermatids: 22.1" "Cancer enriched" "Detected in single" 10 "head and neck cancer: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 23 "HL-60: 63.9;THP-1: 123.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042227, HPA048632" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042227: , HPA048632: AB_2680469" "unprognostic (3.35e-2)" "unprognostic (1.12e-4)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.29e-1)" "unprognostic (1.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.21e-2)" "unprognostic (7.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.98e-6)" "unprognostic (7.97e-2)" "unprognostic (1.21e-1)" "unprognostic (2.19e-3)" "unprognostic (1.30e-1)" 1.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.7 0.0 0.0 1.7 0.0 211.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 9.6 1.2 0.0 0.0 0.8 0.4 3.2 0.4 0.7 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 123.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.4 0.3 0.3 0.2 0.3 0.4 0.2 0.2 0.3 0.8 0.3 0.4 3.2 0.7 0.3 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 22.1 0.0 2.0 0.0 0.4 2.1 0.2 0.1 0.0 1.0 0.5 0.0 1.2 0.0 0.0 0.5 0.9 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.7 0.7 0.1 1.1 0.0 0.9 0.1 PPP1R2B "MGC87149, PPP1R2P3" ENSG00000231989 "PPP1R2 family member B" 5 156850538-156852528 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "testis: 36.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 13 "U-266/84: 5.3" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043729: AB_2678639, HPA059420: AB_2684009" "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (9.36e-2)" "unprognostic (1.46e-2)" "unprognostic (1.89e-1)" "unprognostic (4.47e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-2)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 36.0 0.0 0.4 0.4 0.0 0.2 0.1 0.0 0.5 0.4 0.9 0.5 0.5 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 0.0 0.1 0.0 0.1 0.5 0.1 0.9 0.2 0.5 0.5 0.5 0.6 0.5 0.4 0.2 1.1 0.5 0.6 0.5 0.2 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP1R37 LRRC68 ENSG00000104866 "Protein phosphatase 1 regulatory subunit 37" O75864 19 45091396-45148077 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "memory B-cell: 2.3" "Lineage enriched" "Detected in single" 23 "B-cells: 2.3" "Cell line enhanced" "Detected in all" "RT4: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041500 Approved Approved Cytosol NA NA Cytosol "HPA041500: AB_10795122" "unprognostic (8.45e-2)" "unprognostic (5.23e-2)" "unprognostic (8.34e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "unprognostic (1.79e-1)" "unprognostic (1.04e-3)" "unprognostic (2.16e-1)" "unprognostic (1.08e-1)" "unprognostic (2.89e-3)" "unprognostic (7.72e-3)" "unprognostic (5.44e-2)" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (1.40e-1)" "unprognostic (4.71e-2)" "prognostic favorable (2.04e-4)" 12.7 19.2 17.3 9.8 17.5 8.1 12.6 27.9 27.2 12.8 13.3 10.4 23.0 20.7 11.6 11.2 13.3 10.1 18.8 11.7 15.9 11.4 13.8 9.3 11.0 8.6 12.9 19.1 10.4 18.2 11.5 28.3 11.1 11.4 13.7 7.0 13.9 25.5 17.0 25.2 19.2 19.2 8.4 10.2 13.1 27.4 16.6 11.2 10.7 14.7 10.3 8.8 18.3 14.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.2 5.0 7.2 6.3 4.3 9.7 9.8 5.7 6.9 7.9 5.9 7.5 3.7 7.1 5.2 6.4 10.7 3.3 7.6 2.0 4.7 8.5 3.2 6.4 7.0 7.9 2.9 5.3 5.5 5.9 6.5 4.2 7.4 5.5 5.0 5.3 2.9 3.7 17.0 6.9 4.5 4.8 9.7 8.0 8.4 5.7 2.6 4.4 35.5 15.3 7.0 8.4 17.7 14.8 2.7 11.3 4.8 8.7 8.2 9.8 4.8 8.6 5.0 3.1 2.7 10.7 3.3 7.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 17.5 27.9 27.2 15.9 11.4 12.9 19.1 11.4 11.2 6.0 4.3 4.7 9.9 6.8 45.1 5.1 15.3 4.0 2.3 3.5 37.3 18.4 6.6 15.9 5.0 6.7 20.3 0.0 8.7 16.3 8.2 8.3 0.0 6.2 15.6 73.1 29.4 9.8 6.5 5.7 11.2 3.0 11.8 4.6 22.2 20.6 10.2 18.1 11.7 14.1 44.4 19.4 8.5 13.4 22.0 8.3 15.3 6.5 22.6 9.7 PPP1R3B "FLJ14005, GL, PPP1R4" ENSG00000173281 "Protein phosphatase 1 regulatory subunit 3B" Q86XI6 8 9136255-9151574 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 66.2;Hepatocytes: 135.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "basophil: 18.0;eosinophil: 7.4;neutrophil: 25.3" "Lineage enriched" "Detected in many" 17 "granulocytes: 25.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 26.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA028731 Enhanced Approved Cytosol NA NA Cytosol "HPA028731: AB_10602120" "unprognostic (4.97e-3)" "unprognostic (1.45e-2)" "unprognostic (2.82e-1)" "unprognostic (3.46e-2)" "unprognostic (2.39e-1)" "unprognostic (5.81e-2)" "unprognostic (1.52e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (4.98e-2)" "prognostic unfavorable (4.08e-7)" "prognostic unfavorable (6.03e-5)" "unprognostic (3.33e-1)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" 26.6 4.3 1.2 3.2 3.4 4.4 21.4 0.8 1.7 19.7 8.3 1.5 10.3 1.9 22.8 11.0 12.8 6.5 4.3 17.3 1.5 1.4 4.7 58.5 7.8 6.9 3.3 1.0 16.2 4.1 40.7 2.4 18.7 4.7 25.3 4.0 3.3 12.9 15.5 34.8 6.7 4.5 33.7 5.1 5.4 6.3 8.6 2.8 1.6 11.5 6.8 4.5 37.0 21.7 0.8 0.8 25.3 0.7 0.9 1.5 0.6 3.6 1.4 4.1 1.4 10.3 8.8 14.9 1.3 4.4 1.6 2.0 5.5 1.7 1.3 2.2 2.7 9.1 0.6 0.7 1.0 1.7 3.9 0.6 2.2 0.6 0.0 4.6 1.1 9.7 7.2 3.3 1.4 8.3 12.5 26.3 6.5 1.6 3.1 0.6 2.2 5.9 2.0 5.9 8.2 1.2 2.4 5.2 2.2 16.0 14.8 0.0 7.7 2.4 0.1 10.3 6.9 1.9 2.2 18.2 4.8 1.6 0.9 1.7 1.7 3.9 0.0 8.4 3.4 1.4 18.0 0.7 7.4 1.1 0.6 0.9 0.8 1.0 0.6 0.4 0.7 1.5 0.7 25.3 0.9 0.3 0.8 0.7 0.6 1.2 3.4 0.8 1.7 1.5 1.4 3.3 1.0 4.7 2.8 11.9 34.6 3.0 17.9 9.5 3.4 66.2 35.7 48.2 30.7 8.7 5.9 10.1 3.3 8.3 10.4 20.6 8.4 0.0 11.2 25.5 12.1 10.8 32.4 135.4 6.1 6.4 0.0 32.5 10.8 2.7 8.9 13.6 5.0 1.0 8.9 3.5 13.2 3.5 17.0 5.3 13.5 12.9 15.5 1.9 4.7 10.7 15.3 6.4 4.7 1.6 PPP2R1A "PP2A-Aalpha, PP2AA, PR65A" ENSG00000105568 "Protein phosphatase 2 scaffold subunit Aalpha" P30153 19 52190039-52229533 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chromosome partition" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018599 Approved Cytosol NA NA 3400000 Cytosol "CAB018599: AB_628178" "unprognostic (1.78e-1)" "unprognostic (2.31e-2)" "unprognostic (4.52e-2)" "unprognostic (2.87e-1)" "unprognostic (6.67e-2)" "unprognostic (7.82e-2)" "prognostic unfavorable (1.76e-4)" "prognostic unfavorable (2.50e-4)" "unprognostic (4.30e-2)" "unprognostic (3.06e-1)" "unprognostic (6.48e-3)" "unprognostic (8.28e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.97e-1)" "unprognostic (3.57e-2)" "unprognostic (1.70e-2)" "unprognostic (9.19e-2)" 25.3 57.3 60.7 20.5 71.0 18.0 21.4 47.5 82.1 29.6 31.2 26.6 21.5 33.4 26.4 37.9 37.7 47.0 39.9 74.7 70.2 44.8 31.0 29.3 20.0 27.5 44.0 50.9 45.8 24.3 37.8 29.5 24.6 51.0 31.0 29.8 31.0 24.3 35.6 50.6 33.5 25.3 34.5 25.2 20.5 19.8 21.7 18.1 29.0 28.9 35.9 30.6 27.3 23.1 52.8 62.8 51.9 67.2 69.8 56.3 67.8 30.9 52.6 42.0 37.3 34.2 35.8 22.1 26.1 34.2 34.9 30.6 26.4 24.5 27.1 18.8 41.5 19.2 22.4 45.0 39.4 20.3 20.0 121.9 19.9 29.0 29.7 31.3 21.5 19.0 48.0 32.6 32.7 30.1 32.8 33.1 18.2 23.1 19.1 38.7 35.8 30.0 41.0 41.5 31.2 46.5 29.5 24.4 30.3 56.1 51.0 31.7 33.9 32.0 32.0 19.5 28.6 28.9 38.0 31.4 27.7 25.1 13.5 29.8 19.8 29.0 31.8 29.8 21.8 34.9 45.0 55.3 51.9 50.4 67.2 45.8 48.4 45.1 47.1 62.8 52.8 37.7 43.0 33.7 69.8 59.8 39.0 56.3 67.8 60.7 71.0 47.5 82.1 70.2 44.8 44.0 50.9 51.0 18.1 41.7 30.7 69.2 78.9 62.5 111.3 81.8 68.8 52.2 36.4 113.4 23.6 183.6 99.5 195.0 3.8 51.7 133.3 0.0 136.1 214.1 70.0 78.9 68.0 44.8 127.2 136.7 102.6 66.9 55.1 6.8 67.0 47.0 50.6 131.7 108.9 97.9 137.7 175.6 80.2 103.3 48.5 77.6 81.4 14.8 54.1 55.3 152.2 70.3 147.4 93.1 PPP2R1B "PP2A-Abeta, PR65B" ENSG00000137713 "Protein phosphatase 2 scaffold subunit Abeta" P30154 11 111726908-111766427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.9" "Group enriched" "Detected in all" 5 "Early spermatids: 249.6;Hepatocytes: 68.4;Late spermatids: 93.2;Spermatocytes: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004034, HPA018908" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004034: AB_490763, HPA018908: AB_1855655" "unprognostic (8.37e-2)" "unprognostic (3.87e-2)" "unprognostic (4.84e-3)" "unprognostic (3.27e-3)" "unprognostic (3.43e-1)" "unprognostic (4.93e-2)" "prognostic favorable (3.80e-4)" "unprognostic (4.58e-1)" "unprognostic (8.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-2)" "unprognostic (1.25e-3)" "unprognostic (1.25e-1)" "unprognostic (5.30e-1)" "unprognostic (2.12e-2)" "unprognostic (1.22e-1)" 31.6 7.2 7.1 7.6 9.8 7.7 13.5 14.8 7.1 7.9 8.2 13.6 5.7 7.7 6.3 5.6 7.9 5.0 7.8 4.6 7.4 5.0 10.3 94.9 5.4 6.2 12.6 3.4 8.7 18.5 5.4 19.4 6.7 9.8 4.6 8.5 6.6 8.8 4.0 6.2 6.7 9.4 5.9 8.7 4.2 11.9 28.6 13.9 10.1 6.1 7.2 9.4 6.0 5.1 11.5 14.7 9.9 11.9 14.1 14.3 12.0 13.0 8.8 12.7 8.6 12.8 6.9 12.8 13.0 9.1 9.7 8.9 29.7 13.8 16.6 9.8 8.4 9.2 12.4 18.8 10.7 12.4 11.5 5.8 16.2 5.2 12.9 6.3 18.9 12.9 7.8 6.5 10.9 8.0 6.8 11.9 17.4 19.6 22.1 10.6 4.2 20.4 7.7 15.6 14.2 9.6 15.7 8.4 20.3 14.4 14.5 4.1 11.3 11.6 10.7 2.1 14.3 12.4 7.1 12.8 11.3 13.7 5.6 8.2 2.3 5.8 60.8 4.0 22.1 14.3 5.4 10.0 9.9 13.7 11.9 13.4 10.4 13.9 12.7 14.7 11.5 12.3 13.1 2.5 14.1 10.7 6.3 14.3 12.0 7.1 9.8 14.8 7.1 7.4 5.0 12.6 3.4 9.8 13.9 17.9 8.0 12.6 9.8 12.7 4.9 3.0 10.2 16.0 6.8 12.2 7.9 11.5 11.6 16.5 249.6 12.3 16.1 23.3 20.0 14.9 9.4 9.7 8.1 68.4 8.4 1.6 15.0 8.6 7.8 93.2 6.1 5.6 8.5 11.8 11.5 9.1 21.0 7.0 7.1 15.9 10.5 12.9 9.5 71.5 18.5 12.8 14.8 7.5 11.5 13.6 PPP2R2A "B55A, B55alpha, PR52A, PR55A, PR55alpha" ENSG00000221914 "Protein phosphatase 2 regulatory subunit Balpha" P63151 8 26291491-26372680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042122, HPA042770, CAB079289" Approved Approved Cytosol NA NA Cytosol "CAB079289: AB_659890, HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (1.17e-1)" "unprognostic (2.68e-2)" "unprognostic (4.29e-3)" "unprognostic (5.34e-2)" "unprognostic (3.44e-2)" "unprognostic (2.11e-2)" "unprognostic (4.64e-3)" "unprognostic (3.65e-1)" "unprognostic (2.48e-1)" "unprognostic (3.87e-2)" "unprognostic (2.71e-2)" "unprognostic (8.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (2.90e-1)" "unprognostic (3.44e-2)" "unprognostic (1.16e-1)" 26.1 14.8 25.1 19.1 30.3 21.2 41.7 23.7 28.0 25.2 18.2 27.9 16.0 23.4 20.5 16.0 50.3 19.1 16.8 24.6 21.2 16.2 21.5 32.0 21.7 17.6 28.9 22.3 22.5 13.3 19.3 18.3 39.4 24.8 20.6 18.4 11.3 24.3 18.3 41.6 31.7 16.2 21.1 22.6 15.9 15.3 19.2 32.1 18.3 21.6 29.1 30.4 21.8 29.9 8.0 4.8 6.5 4.8 7.9 10.1 3.6 18.9 18.4 23.8 17.0 14.9 21.3 25.4 29.6 19.0 27.8 26.7 22.6 14.1 26.2 9.0 15.8 18.3 22.8 28.7 24.0 38.1 11.5 15.1 19.8 18.4 11.9 23.5 11.4 15.4 16.9 34.0 24.0 33.4 18.2 43.2 14.8 27.0 25.5 25.3 12.1 25.9 12.7 31.4 45.1 13.0 18.6 17.8 21.8 17.4 28.7 10.0 13.1 14.2 14.3 23.1 22.9 15.1 10.3 23.2 17.4 21.6 17.7 20.7 9.3 12.1 33.9 20.7 20.8 29.3 3.1 2.3 6.1 4.3 4.4 5.4 8.0 6.0 7.6 4.3 6.8 6.1 7.9 6.5 7.9 4.8 4.8 10.1 3.6 25.1 30.3 23.7 28.0 21.2 16.2 28.9 22.3 24.8 32.1 68.5 57.4 46.7 211.9 121.3 52.2 30.0 30.6 123.1 100.1 14.0 45.2 66.8 41.4 40.1 32.5 64.2 45.3 70.0 28.2 56.0 37.8 125.3 54.3 29.2 32.0 35.0 73.7 52.2 31.3 86.3 43.4 50.2 57.3 42.3 32.7 48.8 45.2 26.2 68.9 36.8 37.6 51.8 57.7 28.9 62.2 125.0 56.0 43.7 33.3 178.5 PPP2R2B "B55beta, PR52B, PR55-BETA, SCA12" ENSG00000156475 "Protein phosphatase 2 regulatory subunit Bbeta" Q00005 5 146581146-147084784 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 73.2" "Cell type enhanced" "Detected in many" 20 "Cone photoreceptor cells: 141.4;Early spermatids: 312.5;Late spermatids: 670.1;Rod photoreceptor cells: 261.9" "Cancer enriched" "Detected in some" 8 "glioma: 7.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0" "Group enriched" "Detected in many" 33 "NK-cells: 9.5;T-cells: 16.1" "Cell line enriched" "Detected in some" 4 "HDLM-2: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038118, HPA042122, HPA042770" Approved Uncertain Cytosol NA NA Cytosol "HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (4.54e-5)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.80e-4)" "unprognostic (2.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-2)" "unprognostic (2.68e-1)" "unprognostic (3.20e-2)" "unprognostic (9.73e-4)" "unprognostic (4.51e-2)" "unprognostic (1.49e-8)" "unprognostic (2.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.48e-5)" "unprognostic (1.14e-4)" 2.0 9.7 30.8 2.5 35.2 2.9 1.8 10.2 73.2 1.6 2.7 26.0 0.0 3.0 1.7 1.8 2.9 14.5 2.9 2.9 26.4 20.9 4.7 2.4 2.5 4.3 25.5 22.4 1.6 2.9 16.0 6.4 2.6 27.5 2.7 2.8 4.6 2.0 2.9 1.5 4.9 2.3 3.5 18.6 2.9 2.2 15.7 29.3 0.0 4.2 0.0 2.4 6.8 1.1 0.0 0.0 0.3 0.0 9.5 16.1 4.1 0.4 0.4 2.4 1.0 0.1 0.1 0.2 0.5 0.2 1.1 1.6 1.3 4.8 0.2 0.1 0.0 0.0 10.2 0.8 1.0 1.1 47.5 0.2 0.6 2.8 0.5 0.2 0.0 0.2 0.1 0.7 0.0 0.2 0.7 0.1 0.4 0.6 0.5 0.7 0.3 0.0 0.0 6.3 0.0 1.1 0.7 0.1 0.1 4.2 10.9 1.9 0.2 0.3 0.0 0.2 1.7 0.4 0.1 0.3 0.2 0.7 2.5 0.4 0.4 0.2 0.0 1.7 4.3 1.4 0.2 0.0 0.0 15.1 0.0 13.8 0.0 7.1 16.1 0.0 0.0 1.3 12.0 0.3 9.5 0.0 0.0 8.0 4.1 30.8 35.2 10.2 34.1 26.4 20.9 25.5 22.4 27.5 29.3 3.0 2.6 0.0 1.1 1.8 83.2 1.2 12.7 0.0 1.2 8.7 141.4 14.1 18.3 1.3 312.5 2.1 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.0 0.8 44.5 12.5 0.0 1.2 670.1 3.1 1.7 5.0 0.0 0.0 31.8 0.8 0.0 2.1 4.0 261.9 0.0 8.6 3.7 1.6 1.3 4.5 16.7 0.0 0.7 PPP2R2C "B55gamma, IMYPNO, MGC33570, PR52, PR55G" ENSG00000074211 "Protein phosphatase 2 regulatory subunit Bgamma" Q9Y2T4 4 6320578-6563600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.4" "Group enriched" "Detected in some" 5 "Early spermatids: 52.2;Late spermatids: 144.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 14.2;A549: 21.0;CAPAN-2: 14.0;GAMG: 34.1;MCF7: 17.3;PC-3: 19.9;SCLC-21H: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042122, HPA042770, HPA060473" Approved Approved Cytosol NA NA Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291" "unprognostic (9.39e-2)" "unprognostic (7.10e-2)" "unprognostic (9.12e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (5.91e-2)" "unprognostic (2.70e-4)" "prognostic unfavorable (4.94e-4)" "unprognostic (1.77e-1)" "unprognostic (3.90e-1)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (1.36e-13)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.66e-3)" "unprognostic (9.90e-3)" 1.5 6.6 28.2 1.6 33.9 1.1 2.4 17.0 78.4 11.8 1.5 13.8 0.5 1.7 25.3 7.0 25.2 10.5 1.4 1.9 25.8 19.5 1.2 1.1 1.1 1.3 25.6 19.3 1.3 1.7 1.1 5.9 1.1 19.1 5.5 1.4 0.4 1.4 14.4 1.7 28.8 2.0 11.8 32.0 1.3 1.9 4.7 13.5 0.0 1.1 3.9 3.6 1.5 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.2 21.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 9.2 0.0 34.1 6.6 10.3 0.3 0.0 0.0 1.2 0.0 1.4 1.6 0.3 0.0 0.0 3.0 5.5 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.8 17.3 0.0 0.0 1.0 0.3 19.9 0.0 0.0 0.6 0.0 0.0 19.3 3.6 0.6 0.0 0.0 0.6 8.9 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 33.9 17.0 40.2 25.8 19.5 25.6 19.3 19.1 13.5 0.0 0.0 0.0 0.5 13.1 10.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.2 0.1 0.0 0.0 0.2 0.0 0.2 1.2 0.0 0.0 0.1 3.2 0.0 0.0 0.0 144.3 6.4 0.0 0.0 0.0 0.0 4.1 1.3 0.0 4.2 0.0 2.4 0.0 1.4 1.0 0.9 19.3 0.0 0.0 0.0 0.1 PPP2R2D "B55D, B55delta, MDS026" ENSG00000175470 "Protein phosphatase 2 regulatory subunit Bdelta" Q66LE6 10 131900644-131959834 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042122, HPA042770" Approved Approved Cytosol NA NA Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (7.75e-3)" "unprognostic (7.11e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.40e-1)" "unprognostic (3.57e-1)" "unprognostic (9.64e-3)" "unprognostic (1.83e-1)" "unprognostic (3.13e-2)" "unprognostic (1.76e-2)" "unprognostic (8.74e-2)" "unprognostic (8.46e-2)" "unprognostic (8.04e-2)" "unprognostic (4.41e-3)" "unprognostic (1.10e-1)" "unprognostic (6.57e-2)" "unprognostic (6.66e-2)" "unprognostic (1.90e-2)" 4.5 8.1 5.4 4.0 6.6 1.6 11.4 13.5 12.5 3.7 5.2 5.4 2.4 5.3 3.9 5.2 4.2 4.6 4.7 7.9 5.5 4.7 4.9 4.3 5.5 6.0 4.9 5.2 8.5 34.3 9.9 6.3 5.3 4.7 4.8 5.4 4.9 7.8 5.7 11.4 6.8 5.8 6.0 4.4 5.1 4.4 4.4 5.1 6.3 6.1 3.0 4.4 5.6 6.4 0.4 0.0 0.3 0.6 0.1 0.3 0.0 5.2 4.6 2.5 1.5 3.5 2.6 4.1 1.8 3.7 3.5 3.7 3.2 3.6 2.1 1.3 1.9 2.0 9.2 3.7 0.6 3.5 5.4 5.2 3.6 3.9 1.5 0.8 3.2 3.4 0.9 8.4 3.9 5.6 5.7 2.1 2.9 4.7 0.7 3.7 2.1 1.6 8.9 1.8 1.6 4.5 2.1 1.9 0.4 2.8 0.4 2.2 2.9 2.4 1.9 2.0 2.8 1.2 2.9 3.1 1.9 0.7 2.7 9.5 3.2 1.8 2.5 1.7 2.2 0.6 0.0 0.2 0.0 0.2 0.4 0.1 0.4 0.1 0.3 0.0 0.0 0.1 0.3 0.3 0.1 0.6 0.0 0.1 0.0 5.4 6.6 13.5 9.2 5.5 4.7 4.9 5.2 4.7 5.1 17.9 11.0 20.7 31.2 33.2 46.6 33.4 15.3 4.0 11.4 8.7 9.8 9.2 16.6 7.9 7.9 16.9 20.4 0.0 15.3 11.1 13.4 31.3 5.8 18.7 12.5 49.3 10.3 14.1 7.9 5.8 16.1 16.7 11.8 3.6 15.1 24.9 15.7 18.2 19.4 18.8 30.8 25.8 14.4 12.3 14.9 29.6 9.8 10.0 15.6 30.1 PPP2R3B "PPP2R3L, PPP2R3LY, PR48, PR70" ENSG00000167393 "Protein phosphatase 2 regulatory subunit B''beta" Q9Y5P8 X 333963-386955 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 43.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 62.0;Cone photoreceptor cells: 25.5;Spermatogonia: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 15.5;U-698: 24.3" "Low region specificity" "Detected in all" HPA026606 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026606: " "unprognostic (1.25e-1)" "unprognostic (4.35e-3)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (6.03e-2)" "unprognostic (2.46e-3)" "unprognostic (1.56e-2)" "unprognostic (2.73e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-2)" "prognostic favorable (2.92e-5)" "unprognostic (4.65e-2)" "unprognostic (2.29e-8)" "unprognostic (1.15e-1)" "unprognostic (4.97e-2)" "unprognostic (3.17e-1)" "prognostic favorable (1.90e-5)" 1.8 1.3 8.8 1.1 11.7 3.8 4.8 9.1 8.7 7.6 1.2 0.0 0.0 1.4 6.6 0.7 2.4 2.3 1.4 17.7 12.2 2.9 4.1 1.1 1.5 1.7 15.4 6.2 6.9 2.9 1.5 11.0 8.9 13.0 2.4 0.7 0.0 1.6 1.2 43.5 3.9 1.3 1.6 8.3 1.8 1.8 4.1 15.0 0.0 1.0 0.0 0.9 2.9 2.6 0.1 0.6 2.3 0.1 0.0 1.3 0.1 0.5 5.3 0.7 2.2 0.1 0.2 7.1 5.9 1.5 5.3 6.3 5.3 0.0 0.0 3.2 4.5 0.6 0.0 0.2 0.0 1.4 3.7 4.3 1.2 1.8 0.2 0.0 1.9 2.2 0.1 0.1 0.0 3.2 0.2 0.1 3.2 1.0 0.3 1.2 2.6 9.0 7.8 2.3 0.1 15.5 4.1 3.4 0.3 1.4 1.5 0.0 9.2 0.0 0.9 4.2 4.2 0.0 2.3 0.3 3.1 2.9 0.0 2.0 0.0 0.0 24.3 0.1 2.7 3.9 0.0 0.0 2.3 0.1 0.1 1.3 0.1 0.1 0.0 0.6 0.1 0.3 0.3 0.1 0.0 0.1 0.5 0.0 0.1 8.8 11.7 9.1 8.7 12.2 2.9 15.4 6.2 13.0 15.0 0.0 1.7 0.9 7.8 6.1 11.5 62.0 2.5 2.7 1.2 0.0 25.5 5.6 0.0 2.8 0.5 3.5 1.4 0.0 3.5 5.6 3.0 2.2 0.0 1.0 3.2 6.4 4.6 4.3 2.1 1.5 3.7 5.3 5.0 3.6 3.8 11.2 2.6 0.0 2.8 1.3 19.8 0.0 3.8 12.9 25.5 6.6 3.3 1.9 3.1 3.9 PPP2R3C "C14orf10, FLJ20644, G4-1, G5PR" ENSG00000092020 "Protein phosphatase 2 regulatory subunit B''gamma" Q969Q6 14 35085467-35122517 "Predicted intracellular proteins" "Cone-rod dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 382.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040835, HPA058834" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA040835: AB_10794152, HPA058834: AB_2683831" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (7.32e-3)" "unprognostic (5.33e-2)" "unprognostic (9.73e-2)" "unprognostic (1.10e-3)" "unprognostic (3.05e-1)" "unprognostic (7.85e-2)" "unprognostic (9.48e-3)" "unprognostic (1.17e-2)" "unprognostic (1.91e-1)" "unprognostic (2.18e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-3)" "unprognostic (8.55e-2)" "unprognostic (8.29e-2)" 14.5 12.5 19.1 15.5 23.8 26.4 12.2 17.9 22.1 12.9 13.8 11.4 9.5 14.1 10.9 11.0 8.9 10.0 12.5 14.8 17.9 11.4 10.1 10.5 12.1 18.9 28.4 17.2 12.6 9.5 11.3 30.8 12.7 20.6 11.8 14.7 6.8 10.2 9.7 20.0 6.5 15.3 14.5 22.8 21.5 13.1 46.8 24.1 18.9 8.7 7.5 16.4 14.7 10.4 12.2 12.7 32.1 19.2 13.9 14.7 11.4 15.6 8.6 14.9 13.3 9.8 19.8 11.2 12.6 10.7 14.9 18.3 6.8 11.3 16.8 5.0 12.0 6.1 6.7 6.7 4.8 22.2 18.4 7.8 9.4 4.6 24.9 14.4 17.4 18.5 15.2 4.5 11.2 6.9 8.0 20.2 9.9 9.9 17.1 21.4 11.3 18.3 16.3 13.5 9.2 10.0 18.2 11.5 13.8 5.2 9.1 16.1 14.0 15.5 11.2 20.3 7.1 7.4 20.8 17.1 16.3 7.0 13.7 14.4 15.3 20.1 34.2 8.3 16.7 18.5 20.0 15.0 32.1 10.7 19.2 11.7 12.2 10.8 13.8 12.7 11.0 9.6 11.7 28.1 13.9 16.4 8.1 14.7 11.4 19.1 23.8 17.9 22.1 17.9 11.4 28.4 17.2 20.6 24.1 14.9 24.8 50.1 18.1 10.2 15.8 23.0 25.5 22.7 12.5 19.2 3.9 16.4 28.2 26.6 382.3 29.2 28.5 23.3 31.4 21.7 23.5 24.4 33.4 19.2 53.2 7.9 30.0 26.4 42.9 134.4 26.2 49.9 27.0 72.1 21.2 18.8 38.8 20.3 28.7 31.1 19.1 32.3 31.1 103.4 61.7 11.8 29.1 39.5 20.2 26.5 PPP2R5A "B56A, B56alpha, PR61A" ENSG00000066027 "Protein phosphatase 2 regulatory subunit B'alpha" Q15172 1 212285537-212361863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 187.3;Late spermatids: 383.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059288, HPA078841" Approved Supported Cytosol NA NA Cytosol "HPA059288: AB_2683966, HPA078841: " "unprognostic (3.56e-1)" "unprognostic (2.71e-1)" "unprognostic (8.48e-2)" "unprognostic (2.54e-1)" "unprognostic (9.21e-2)" "unprognostic (1.01e-1)" "unprognostic (5.01e-2)" "unprognostic (1.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.84e-2)" "unprognostic (3.04e-1)" "unprognostic (5.63e-2)" "unprognostic (1.40e-3)" "unprognostic (8.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" 40.9 8.4 21.9 23.2 24.1 46.6 26.5 13.7 17.6 19.5 23.9 19.6 18.9 15.9 21.2 13.4 36.7 12.9 25.7 31.9 17.5 16.6 22.4 34.0 37.9 17.1 25.6 14.2 11.8 27.5 17.0 14.4 21.5 16.4 30.6 23.2 16.5 22.2 20.0 24.3 20.0 27.6 28.5 21.1 28.6 26.4 10.0 24.4 35.2 27.6 29.2 18.3 28.8 38.8 2.1 1.6 14.5 3.0 3.1 4.9 1.4 17.6 7.3 3.7 7.6 41.5 25.4 30.7 7.8 14.9 8.7 8.3 21.9 17.8 12.4 5.9 12.1 9.1 12.6 7.1 10.8 9.1 10.7 9.4 8.0 8.1 8.0 13.4 16.3 12.4 10.6 14.8 7.9 11.6 11.0 20.9 10.9 11.4 13.1 4.8 7.6 6.4 11.2 6.4 15.5 16.0 8.4 6.0 15.4 15.6 8.0 5.5 3.7 10.6 33.3 25.2 16.6 20.7 14.8 4.4 6.1 6.3 9.6 8.3 20.8 15.9 16.1 7.4 12.7 4.5 14.5 2.0 9.4 4.6 2.2 3.1 1.4 3.6 4.1 1.3 2.1 2.1 4.2 9.9 3.1 3.0 1.6 4.9 1.4 21.9 24.1 13.7 16.1 17.5 16.6 25.6 14.2 16.4 24.4 92.3 86.7 14.7 20.8 60.9 18.6 59.8 30.6 18.7 19.4 14.0 2.0 9.1 82.9 20.6 187.3 37.9 31.9 0.0 30.1 21.8 19.8 31.9 39.3 45.7 19.2 49.3 15.5 47.3 26.0 383.1 17.8 23.5 16.9 18.0 33.3 34.4 24.1 31.6 13.4 14.6 10.7 32.3 35.6 13.5 9.5 71.0 6.9 39.8 26.7 33.1 PPP2R5C "B56G, B56gamma, PR61G" ENSG00000078304 "Protein phosphatase 2 regulatory subunit B'gamma" Q13362 14 101761798-101927989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "T-cells: 251.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027553 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA027553: AB_10602081" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (1.23e-1)" "unprognostic (1.99e-1)" "unprognostic (1.31e-3)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.72e-1)" 25.5 29.4 52.6 37.7 45.3 48.1 27.4 25.7 38.9 27.8 31.1 25.6 30.1 22.4 24.0 29.2 32.7 22.3 25.4 48.4 49.3 35.6 25.5 38.1 34.5 53.8 44.7 32.4 28.4 25.6 27.6 35.3 19.5 27.5 23.1 33.3 26.6 28.9 27.8 30.5 28.9 31.7 27.7 45.5 36.8 25.4 27.6 29.5 51.4 29.6 28.3 52.1 33.2 21.9 20.1 24.9 35.3 25.3 16.8 60.5 20.9 21.0 14.5 24.6 23.7 22.3 31.5 23.8 19.9 26.4 25.0 24.0 14.5 36.8 57.7 19.3 25.8 17.6 22.2 22.4 21.1 32.6 25.9 10.6 16.7 17.2 14.1 16.5 25.6 35.9 20.7 27.4 17.2 16.0 22.3 22.4 31.5 34.7 24.4 23.8 32.1 25.7 28.3 14.3 42.5 24.2 21.8 27.7 14.2 24.0 24.0 19.3 36.1 27.0 17.9 33.7 18.0 32.8 19.7 22.1 15.8 15.1 60.7 19.7 34.1 51.0 96.2 23.7 19.0 17.5 20.1 19.8 18.2 60.5 24.3 38.9 20.1 39.7 47.5 16.9 17.8 28.6 44.1 35.3 16.8 25.3 24.9 39.7 20.9 52.6 45.3 25.7 38.9 49.3 35.6 44.7 32.4 27.5 29.5 77.4 85.3 74.9 37.2 52.1 31.6 113.5 48.4 68.3 52.4 34.9 55.0 41.1 39.7 33.2 55.5 45.2 45.9 46.7 40.7 39.2 41.8 41.7 66.0 70.6 61.7 25.4 45.5 59.5 108.0 50.8 48.6 71.4 81.0 136.1 71.3 33.5 39.8 66.8 42.8 53.6 38.0 38.8 46.4 23.7 25.4 61.5 43.8 251.6 58.7 59.3 PPP2R5D "B56D, B56delta" ENSG00000112640 "Protein phosphatase 2 regulatory subunit B'delta" Q14738 6 42984499-43012342 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029045, HPA029046" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029045: AB_10598912, HPA029046: AB_10600988" "unprognostic (2.25e-1)" "unprognostic (7.14e-2)" "unprognostic (4.73e-2)" "unprognostic (6.89e-2)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (3.89e-4)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (9.44e-2)" "unprognostic (2.59e-1)" "unprognostic (2.71e-1)" "unprognostic (1.21e-1)" "unprognostic (9.96e-2)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (6.05e-2)" 17.9 14.4 19.7 17.0 31.5 15.1 14.2 28.3 41.0 20.2 24.5 13.7 15.9 31.1 20.7 11.4 18.1 19.0 14.3 22.0 17.7 18.4 15.7 15.8 15.0 16.2 16.6 25.1 20.7 16.5 17.4 11.2 16.6 26.3 18.4 18.6 16.5 13.7 19.2 41.0 17.9 36.4 20.8 11.2 14.4 14.9 27.1 13.1 35.5 13.4 11.1 14.7 19.1 18.5 9.2 12.5 17.9 11.3 11.8 19.7 15.3 24.4 12.9 19.8 25.8 12.3 16.9 11.1 13.6 9.7 27.2 24.1 20.9 6.7 18.3 13.2 16.5 18.8 13.9 26.6 15.6 24.4 15.6 23.1 21.9 16.0 19.6 8.5 15.1 16.1 9.3 10.3 21.7 9.9 15.5 20.7 23.1 22.9 14.2 15.7 10.4 38.8 13.8 8.8 55.4 12.3 27.2 24.5 12.0 8.3 11.6 25.1 16.5 18.4 12.3 14.7 17.1 17.2 14.1 19.6 19.6 18.2 20.5 21.6 14.7 18.5 37.6 7.7 14.1 16.9 14.8 11.3 17.9 16.8 9.8 17.6 9.2 15.3 19.0 11.6 9.0 11.8 14.1 6.9 11.8 7.4 12.5 19.7 15.3 19.7 31.5 28.3 41.0 17.7 18.4 16.6 25.1 26.3 13.1 8.9 7.0 5.2 2.5 7.4 11.6 4.0 5.1 4.0 7.9 7.0 9.8 6.2 5.0 5.8 4.2 6.2 21.7 0.0 6.8 8.7 8.5 2.9 8.1 10.9 8.0 3.2 8.6 8.0 5.9 5.3 8.9 4.2 10.1 6.4 7.6 7.3 7.9 8.4 13.8 3.8 7.5 6.5 8.0 7.5 9.4 8.3 3.8 7.4 9.5 1.7 PPP2R5E "B56E, B56epsilon" ENSG00000154001 "Protein phosphatase 2 regulatory subunit B'epsilon" Q16537 14 63371357-63543374 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 254.8;Horizontal cells: 247.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006034, CAB072342" Approved Supported Cytosol NA NA Cytosol "CAB072342: , HPA006034: AB_1079670" "unprognostic (1.58e-1)" "unprognostic (1.65e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (2.06e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (2.26e-1)" "unprognostic (2.91e-1)" "unprognostic (1.57e-2)" "unprognostic (1.70e-2)" "unprognostic (4.62e-2)" "prognostic favorable (4.16e-4)" "unprognostic (1.23e-1)" "unprognostic (9.51e-2)" "unprognostic (1.92e-1)" "unprognostic (8.22e-2)" 20.9 19.3 18.1 27.2 18.8 16.9 26.5 27.6 32.7 21.3 22.3 11.7 14.2 14.1 20.5 19.2 29.2 16.3 18.9 20.2 19.2 20.5 20.1 22.9 27.7 19.1 16.4 20.1 21.5 14.7 29.0 18.8 21.0 18.5 18.5 27.3 15.7 17.3 28.3 31.2 19.2 17.6 23.2 17.7 20.2 16.6 25.1 13.5 35.5 27.4 21.3 21.7 28.5 20.8 3.3 3.6 2.7 3.4 9.2 5.1 1.1 39.5 11.6 21.4 10.0 14.8 17.5 20.4 16.6 13.8 18.2 18.2 14.7 16.0 17.5 10.2 17.0 13.5 16.3 21.7 15.4 31.5 15.8 5.3 11.3 8.8 12.2 15.8 18.1 14.0 12.7 17.3 17.8 19.8 13.3 18.2 17.9 14.4 19.1 19.9 26.4 18.0 8.2 16.1 16.6 21.2 18.4 21.9 13.2 17.5 30.4 12.2 23.8 21.4 17.8 11.1 19.3 26.1 9.2 16.9 28.6 32.0 14.5 14.6 7.0 10.4 22.8 13.2 11.7 19.3 2.7 2.5 2.4 4.2 2.7 3.9 2.3 4.6 5.1 2.3 3.3 3.6 3.9 2.0 9.2 3.4 3.6 2.6 1.1 18.1 18.8 27.6 32.7 19.2 20.5 16.4 20.1 18.5 13.5 83.4 46.8 36.6 41.8 71.4 62.8 54.9 28.1 36.1 33.0 21.0 60.9 22.8 24.9 40.7 254.8 48.8 30.7 0.0 40.9 34.6 38.6 52.0 23.1 40.2 25.7 247.9 26.0 43.6 33.9 30.7 40.6 30.0 35.4 31.5 45.9 35.2 34.8 17.5 40.7 28.7 78.0 25.8 53.3 47.0 18.3 80.0 25.6 44.9 62.1 42.8 PPP3CA "CALN, CALNA, CNA1, PPP2B" ENSG00000138814 "Protein phosphatase 3 catalytic subunit alpha" Q08209 4 101023409-101348278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.8" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 7 "prostate cancer: 98.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012778, CAB018581" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 35000 Nucleoplasm Cytosol "CAB018581: AB_2168324, HPA012778: AB_1855660" "unprognostic (6.66e-2)" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.56e-1)" "unprognostic (7.81e-2)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "unprognostic (7.87e-2)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.82e-4)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (5.12e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-2)" "unprognostic (5.74e-2)" 12.2 9.2 22.7 7.4 71.8 7.7 10.6 42.1 52.4 9.4 9.5 4.8 9.8 5.8 6.2 6.9 7.4 7.2 6.8 4.3 36.0 13.5 5.8 8.4 10.0 6.7 10.1 22.1 9.6 4.7 7.0 4.2 6.6 11.9 34.6 8.4 2.6 10.4 21.1 23.7 11.4 6.4 7.9 7.5 6.9 11.0 5.3 13.0 3.8 6.8 6.8 8.9 8.4 6.8 27.7 18.3 44.3 14.9 22.3 15.5 6.6 19.4 13.8 3.8 7.5 21.6 16.4 7.4 21.5 19.8 8.7 9.2 8.0 24.4 9.3 9.0 19.4 10.8 9.8 13.9 28.6 14.8 22.7 6.4 14.7 19.8 10.2 15.9 23.6 7.5 17.0 15.0 19.0 21.8 16.6 16.3 6.0 5.7 25.6 13.9 23.4 4.9 17.7 6.4 22.5 9.0 9.0 35.0 10.7 8.4 15.4 30.4 11.5 17.7 15.2 10.3 5.5 13.6 13.5 19.0 20.6 23.5 18.8 14.2 12.0 12.2 16.4 11.4 13.4 5.5 24.6 11.8 24.8 13.6 11.4 15.5 27.7 12.9 13.1 9.9 23.4 6.2 12.3 44.3 22.3 14.9 18.3 8.6 6.6 22.7 71.8 42.1 51.5 36.0 13.5 10.1 22.1 11.9 13.0 71.5 48.8 59.1 33.3 149.9 74.7 24.1 33.1 32.1 20.5 29.6 37.3 28.9 28.2 18.2 1.8 105.6 33.9 0.0 27.3 76.5 53.9 157.6 33.6 37.0 32.1 17.5 122.2 43.6 52.2 4.7 60.1 49.5 87.7 44.1 39.6 19.3 41.1 107.8 57.3 31.7 81.9 12.9 39.4 7.2 22.1 150.4 23.0 55.4 39.9 32.0 PPP3R1 "CALNB1, CNB, CNB1" ENSG00000221823 "Protein phosphatase 3 regulatory subunit B, alpha" P63098 2 68178857-68256237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.2" "Cell type enhanced" "Detected in all" 5 "Rod photoreceptor cells: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005610, HPA047157" Approved Approved "Plasma membrane,Cytosol" NA NA 43000 "Plasma membrane, Cytosol" "CAB005610: AB_325975, HPA047157: AB_2679960" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.08e-6)" "unprognostic (5.90e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.59e-1)" "unprognostic (3.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.70e-5)" "unprognostic (5.24e-3)" "unprognostic (5.35e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-1)" 25.8 20.1 43.3 15.9 66.2 32.3 25.7 47.9 78.2 14.8 14.0 7.7 6.9 13.1 16.6 14.2 15.7 10.5 14.7 10.2 56.2 28.7 11.3 29.6 15.5 18.8 23.7 45.1 13.6 9.8 9.4 8.9 18.5 25.4 14.3 14.8 6.8 12.1 16.6 41.7 17.1 12.0 18.5 21.6 16.5 12.6 10.4 16.5 12.7 12.6 7.7 20.1 14.4 13.3 1.0 1.8 6.4 1.4 0.9 1.4 0.9 17.8 15.2 20.6 14.1 14.2 16.5 21.0 25.9 22.1 29.3 25.9 21.9 16.2 24.9 8.9 17.5 20.9 12.1 21.7 18.7 35.8 17.5 15.5 80.8 12.4 20.1 28.1 31.7 27.3 16.6 17.0 22.7 23.3 16.6 19.6 21.1 19.5 28.5 21.3 15.4 26.8 27.9 24.2 15.0 13.0 19.6 27.2 39.6 18.1 19.0 27.2 19.2 14.9 21.2 18.6 14.0 10.0 14.8 20.5 25.3 23.2 19.1 22.3 16.1 17.7 36.9 18.4 33.4 15.8 3.2 1.2 2.9 0.7 0.8 1.4 0.5 0.8 0.5 1.3 1.0 0.9 1.4 6.4 0.9 1.4 1.8 0.9 0.9 43.3 66.2 47.9 78.2 56.2 28.7 23.7 45.1 25.4 16.5 8.9 16.7 16.6 10.6 66.4 21.5 16.1 10.2 2.7 6.8 15.7 49.1 9.8 10.0 5.9 11.6 21.5 14.4 23.3 7.5 14.8 14.0 14.4 19.6 18.5 21.1 11.1 14.6 15.4 42.9 6.5 9.2 22.7 33.7 4.6 14.0 20.4 10.5 10.1 8.1 12.9 86.2 12.9 17.3 2.6 5.3 61.6 10.1 20.3 12.0 16.8 PPP3R2 PPP3RL ENSG00000188386 "Protein phosphatase 3 regulatory subunit B, beta" Q96LZ3 9 101591615-101595021 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 81.9" "Group enriched" "Detected in some" 25 "Early spermatids: 271.7;Late spermatids: 141.7;Spermatocytes: 319.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Low region specificity" "Detected in single" HPA047157 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA047157: AB_2679960" "unprognostic (8.81e-2)" "unprognostic (2.65e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 271.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 141.7 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 6.5 0.0 319.9 3.0 0.0 0.0 0.0 0.0 0.0 PPP4C "PP4, PPX" ENSG00000149923 "Protein phosphatase 4 catalytic subunit" P60510 16 30075978-30085377 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043837 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA043837: AB_2678695" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (4.74e-2)" "unprognostic (2.16e-1)" "unprognostic (5.79e-3)" "unprognostic (3.28e-3)" "unprognostic (2.60e-3)" "unprognostic (3.82e-1)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (9.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" 24.7 26.6 13.5 26.1 14.1 26.7 18.6 16.0 15.9 19.2 28.4 14.5 20.5 22.5 19.2 28.4 39.1 17.7 31.9 28.5 12.6 12.1 28.9 52.3 27.4 25.3 12.5 12.8 22.5 26.3 23.9 16.2 51.6 11.9 18.3 17.4 18.8 22.0 14.9 26.0 26.1 38.8 15.9 11.9 36.2 22.6 39.0 9.5 59.7 27.1 26.5 37.9 22.2 21.1 19.5 30.3 57.3 28.2 12.4 23.6 12.0 30.8 34.6 23.1 32.2 21.9 18.5 36.0 27.5 30.7 36.2 40.2 30.4 40.3 24.0 35.4 32.4 23.6 25.2 28.6 34.1 21.4 30.1 51.2 16.3 21.5 67.2 33.3 22.9 30.9 26.8 30.2 33.0 21.0 21.7 42.0 31.3 31.8 22.0 27.6 88.9 39.9 41.8 44.0 24.5 18.4 44.7 24.0 41.8 34.2 31.8 22.5 33.3 13.5 40.8 23.5 20.2 37.6 39.0 26.7 21.2 22.3 17.1 21.1 37.8 41.5 28.1 30.2 29.6 25.6 21.4 26.9 57.3 18.3 28.2 13.1 17.0 19.2 20.6 30.3 19.5 17.2 15.2 56.9 12.4 24.5 23.5 23.6 12.0 13.5 14.1 16.0 15.9 12.6 12.1 12.5 12.8 11.9 9.5 47.6 33.1 81.7 96.8 130.7 20.0 9.3 89.2 54.9 23.9 73.3 27.5 268.8 134.3 208.0 127.6 84.2 174.4 0.0 169.7 278.1 71.4 111.6 69.1 85.6 210.3 33.4 120.5 58.9 91.3 98.3 58.1 124.3 75.9 252.5 114.3 41.8 254.7 168.4 49.1 156.3 25.7 71.1 65.1 231.9 141.6 150.8 352.1 111.4 129.3 192.9 PPP4R3A "FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1" ENSG00000100796 "Protein phosphatase 4 regulatory subunit 3A" Q6IN85 14 91457611-91510554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002568, HPA063917" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA002568: AB_1079207, HPA063917: AB_2685153" "unprognostic (5.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-1)" "unprognostic (1.40e-1)" "unprognostic (4.40e-2)" "unprognostic (9.95e-3)" "unprognostic (4.10e-2)" "unprognostic (5.71e-3)" "unprognostic (1.05e-1)" "unprognostic (8.34e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (4.53e-2)" 19.0 14.2 22.1 25.7 19.7 48.5 20.1 33.2 22.6 20.6 22.7 15.0 22.0 19.8 22.0 17.7 22.7 21.0 23.4 15.7 19.4 14.2 20.7 27.8 21.4 29.0 20.8 16.8 23.4 21.7 25.6 24.0 25.1 16.3 21.6 20.9 14.7 20.5 29.1 34.8 25.4 27.1 19.9 18.0 29.1 21.2 25.3 18.3 44.6 19.6 20.3 27.5 19.9 25.6 9.0 7.4 8.5 4.7 12.1 10.0 3.6 14.8 17.8 22.4 15.7 12.3 12.2 30.6 12.8 12.5 14.5 14.4 15.4 19.5 33.4 16.4 11.3 9.9 16.1 21.8 16.5 22.8 27.2 8.9 17.2 12.5 12.6 13.9 33.6 18.8 8.5 25.6 11.3 17.1 12.2 14.7 18.0 15.5 24.8 16.1 23.9 25.2 16.3 16.4 24.0 12.6 29.3 24.2 14.3 14.6 24.1 26.2 14.4 19.0 46.4 16.1 20.1 24.3 19.4 14.5 12.9 11.6 13.3 16.2 19.1 28.6 38.5 15.5 15.8 20.1 8.5 3.1 3.6 7.2 3.5 10.0 7.1 7.3 6.5 2.9 9.0 9.0 7.3 3.4 12.1 4.7 7.4 9.3 3.6 22.1 19.7 33.2 22.6 19.4 14.2 20.8 16.8 16.3 18.3 29.8 38.7 24.8 38.8 0.0 25.4 0.0 28.1 30.8 55.7 43.6 19.6 27.8 24.9 17.8 7.1 24.8 26.2 0.0 21.5 23.8 19.2 43.0 18.6 43.3 22.6 30.2 12.9 29.4 42.3 4.7 34.8 35.8 0.0 19.0 36.6 23.0 22.0 35.1 40.0 19.2 27.4 25.8 0.0 69.4 52.6 0.0 37.1 40.5 33.2 68.0 PPP4R4 "CFAP14, KIAA1622, PP4R4" ENSG00000119698 "Protein phosphatase 4 regulatory subunit 4" Q6NUP7 14 94146128-94279735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3;testis: 14.0" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 20.1;Cone photoreceptor cells: 70.7;Spermatocytes: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "RH-30: 16.6;T-47d: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041866, HPA050321" Approved Supported Cytosol NA NA Cytosol "HPA041866: AB_10804120, HPA050321: AB_2681086" "unprognostic (2.65e-3)" "unprognostic (3.06e-1)" "unprognostic (9.07e-2)" "unprognostic (9.49e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (2.45e-1)" "unprognostic (1.25e-1)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (1.72e-2)" "unprognostic (8.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.35e-2)" "unprognostic (1.77e-1)" "unprognostic (6.24e-2)" 1.0 1.7 15.2 1.3 15.5 1.1 3.5 4.9 21.3 6.9 1.0 1.9 0.1 1.0 2.1 4.0 1.4 4.0 1.5 1.1 11.1 6.9 1.3 3.0 3.1 1.2 4.7 9.8 11.5 1.6 1.1 7.1 1.7 8.0 1.4 1.1 2.3 1.2 1.8 1.0 2.0 1.0 1.3 5.2 1.0 2.1 14.0 4.1 0.0 1.3 0.0 1.8 1.2 1.3 0.3 0.0 1.1 0.0 0.0 0.3 0.0 0.7 0.0 1.8 0.9 0.4 0.0 0.5 0.2 1.6 1.0 0.4 0.1 0.5 0.9 0.0 0.0 3.6 0.0 4.1 4.2 0.4 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.3 0.0 0.4 0.0 3.9 0.0 0.0 1.2 0.0 0.1 0.4 0.5 0.0 0.1 1.1 0.0 0.9 0.1 16.6 0.0 0.2 0.9 0.2 0.1 0.0 0.0 0.1 0.8 17.6 0.0 0.0 3.2 1.7 0.1 0.1 0.8 0.1 0.3 1.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 15.2 15.5 4.9 13.2 11.1 6.9 4.7 9.8 8.0 4.1 3.0 7.4 0.0 4.2 4.2 0.6 0.4 0.0 20.1 3.4 0.0 70.7 0.0 0.0 2.1 12.4 0.1 0.0 0.0 0.3 0.1 0.0 3.0 0.0 1.0 0.1 1.6 0.0 8.6 2.6 13.6 5.5 0.0 0.0 0.0 0.0 5.7 0.3 0.0 5.3 0.0 0.6 0.0 0.1 26.5 4.9 2.3 0.0 0.0 0.0 7.3 PPP5C "PP5, PPP5" ENSG00000011485 "Protein phosphatase 5 catalytic subunit" P53041 19 46346994-46392981 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022641, HPA029065, HPA056933" Approved Supported Vesicles,Cytosol NA NA 47000 "Vesicles, Cytosol" "CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278" "unprognostic (8.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.44e-1)" "unprognostic (6.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.29e-1)" "unprognostic (1.04e-2)" "unprognostic (8.25e-2)" "unprognostic (5.56e-2)" "unprognostic (2.20e-2)" "unprognostic (3.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.37e-1)" 18.9 24.7 23.0 18.1 28.8 13.4 15.9 25.2 50.8 20.4 21.1 19.4 15.2 18.0 23.0 15.2 20.1 27.8 20.5 48.2 20.8 23.9 22.6 22.1 17.4 19.3 21.9 29.8 16.7 21.5 26.3 23.9 17.3 34.5 19.5 17.5 19.7 21.0 21.4 40.8 16.4 15.3 23.5 16.2 21.7 20.6 19.0 15.3 15.6 18.1 20.5 16.1 17.1 18.1 10.6 11.1 1.9 14.1 14.0 19.8 8.9 19.5 36.8 22.0 16.6 16.6 17.8 10.2 24.4 19.8 29.6 26.7 26.4 15.6 30.1 13.3 17.7 16.2 16.1 28.9 28.8 8.9 20.8 39.3 25.0 27.0 18.7 18.6 33.8 17.5 16.2 13.6 20.8 15.5 11.4 25.4 25.7 24.0 15.5 16.8 21.2 18.9 63.4 16.6 35.1 20.1 28.2 19.0 24.1 17.7 26.8 31.3 23.0 20.4 26.0 8.7 10.4 16.3 21.6 21.1 13.0 21.6 9.6 25.5 12.5 28.7 36.0 13.9 28.4 21.6 0.0 6.8 1.9 19.8 12.1 12.7 10.6 9.2 15.3 11.1 8.7 8.9 12.0 0.1 14.0 14.1 7.9 9.3 8.9 23.0 28.8 25.2 50.8 20.8 23.9 21.9 29.8 34.5 15.3 6.0 12.2 13.4 14.5 8.4 19.1 4.7 50.9 9.4 10.3 15.7 15.7 20.7 28.2 26.1 1.0 13.4 17.7 0.0 16.8 30.9 14.6 11.3 4.6 22.8 19.0 15.9 14.3 30.7 10.8 1.7 16.1 7.6 15.1 14.4 15.1 19.1 22.4 11.5 17.3 17.3 16.9 38.8 20.6 14.6 39.2 11.5 21.5 17.0 21.3 8.4 PPP5D1 ENSG00000230510 "PPP5 tetratricopeptide repeat domain containing 1" E7EU14 19 46480796-46601200 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 19.6;Early spermatids: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 6.7" HPA073186 Uncertain Uncertain Cytosol NA NA Cytosol "HPA073186: AB_2732220" "unprognostic (2.84e-2)" "unprognostic (3.26e-1)" "unprognostic (3.50e-2)" "unprognostic (2.26e-1)" "unprognostic (7.10e-2)" "unprognostic (1.89e-1)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (2.22e-2)" "unprognostic (1.62e-2)" "unprognostic (1.00e-4)" "unprognostic (3.90e-1)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (3.62e-1)" "unprognostic (1.41e-1)" "unprognostic (1.96e-1)" 1.9 4.5 8.9 0.9 6.8 1.5 2.2 3.6 7.5 3.5 1.5 5.8 6.6 0.9 3.9 7.4 1.1 6.8 2.6 2.8 6.5 8.7 1.6 1.2 2.2 1.4 6.9 5.9 5.8 2.3 2.8 6.9 2.3 4.1 4.4 0.9 3.7 7.2 4.3 2.4 2.2 0.9 1.9 5.4 1.9 1.8 5.3 4.7 1.0 5.8 0.6 1.4 1.9 2.4 2.0 2.2 6.2 1.4 2.6 1.8 0.5 1.7 1.0 1.4 1.0 0.9 3.0 0.3 1.0 0.9 2.6 0.6 0.1 1.2 1.8 1.7 3.4 2.6 1.0 2.3 0.4 1.4 2.1 5.8 3.0 1.5 1.7 1.4 1.0 2.4 2.3 3.6 0.4 1.2 2.1 0.8 3.1 1.2 1.4 2.3 6.7 1.0 3.0 0.7 0.3 1.4 3.3 0.6 0.5 1.3 1.0 4.4 1.6 1.0 0.6 0.7 0.3 0.8 1.6 1.9 0.2 0.6 0.4 0.8 0.9 0.8 1.5 0.9 3.1 0.7 6.2 1.4 0.7 0.9 1.0 0.5 1.7 0.4 0.7 2.2 2.0 0.8 1.8 2.0 2.6 0.4 0.9 0.4 0.5 8.9 6.8 3.6 7.5 6.5 8.7 6.9 5.9 4.1 4.7 3.0 1.3 2.7 2.4 1.4 8.1 1.6 10.2 1.4 0.0 1.8 19.6 1.7 1.7 1.2 14.6 3.0 1.6 0.0 1.6 1.4 2.8 2.4 0.0 0.8 2.5 9.5 0.0 5.5 2.9 2.7 3.7 2.1 3.3 4.6 0.6 8.6 0.7 0.0 2.8 0.4 9.1 0.0 1.7 4.9 3.6 1.1 1.4 2.9 1.7 1.7 PPP6R1 "KIAA1115, SAP190, SAPS1" ENSG00000105063 "Protein phosphatase 6 regulatory subunit 1" Q9UPN7 19 55229780-55258995 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 195.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043989, HPA063681" Approved Enhanced Cytosol No No Cytosol "HPA043989: AB_10987309, HPA063681: AB_2685087" "unprognostic (1.15e-1)" "unprognostic (2.34e-1)" "unprognostic (1.20e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.82e-6)" "unprognostic (2.22e-2)" "unprognostic (5.44e-2)" "unprognostic (5.41e-2)" "unprognostic (3.35e-3)" "unprognostic (1.63e-3)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (3.65e-2)" "unprognostic (3.30e-2)" "unprognostic (2.20e-1)" 13.2 18.4 27.8 30.8 26.2 49.7 9.8 12.5 28.0 11.2 20.7 14.0 9.0 22.9 13.5 11.3 17.5 16.8 17.7 12.8 27.3 12.4 12.5 25.1 14.6 45.2 13.0 14.0 11.9 12.5 13.9 15.3 15.8 9.8 11.7 7.8 11.5 13.7 14.4 18.4 13.3 22.9 11.3 9.2 31.6 25.1 39.9 13.4 57.3 14.0 13.4 31.0 17.7 12.6 2.6 21.2 4.4 3.0 6.1 9.2 4.2 20.3 29.6 6.0 9.6 7.2 6.7 15.5 13.1 11.5 13.8 11.8 19.5 14.1 53.2 7.2 11.6 10.2 10.0 2.1 13.6 5.4 19.8 50.5 40.3 14.2 14.3 12.5 59.5 39.9 9.8 7.9 13.6 9.3 7.4 8.8 37.3 21.0 23.6 8.8 13.0 43.5 21.4 8.2 16.7 24.4 26.7 11.9 44.0 9.7 26.1 17.4 9.6 12.1 14.7 12.8 5.4 8.0 44.9 11.4 21.7 10.7 8.3 19.6 11.8 21.3 37.7 19.7 49.2 16.5 0.0 2.0 4.4 9.2 3.0 5.3 2.6 3.8 7.2 3.0 2.3 4.0 5.9 2.3 6.1 2.4 21.2 2.7 4.2 27.8 26.2 12.5 28.0 27.3 12.4 13.0 14.0 9.8 13.4 11.9 23.2 31.3 6.8 2.5 16.6 2.2 17.8 20.1 10.3 17.4 9.8 9.6 0.0 20.1 195.4 11.7 24.0 0.0 24.5 7.5 9.9 16.6 7.0 18.1 27.5 28.6 14.6 16.0 29.7 28.2 17.3 25.3 0.0 13.6 17.4 13.7 32.0 21.2 18.4 9.8 14.2 19.4 2.1 31.4 32.1 3.0 9.5 27.3 13.0 36.9 PPP6R2 "dJ579N16.1, KIAA0685, SAP190, SAPS2" ENSG00000100239 "Protein phosphatase 6 regulatory subunit 2" O75170 22 50343304-50445090 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030656, CAB034919" Uncertain Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB034919: AB_2183817, HPA030656: AB_10602926" "unprognostic (1.24e-1)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favorable (1.70e-5)" "unprognostic (2.17e-1)" "unprognostic (3.79e-3)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-2)" "prognostic favorable (7.51e-4)" "unprognostic (6.89e-2)" "unprognostic (1.42e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (7.77e-3)" 16.8 22.1 21.3 19.6 20.7 17.9 32.2 39.0 52.7 13.0 15.8 18.5 20.6 23.1 17.2 13.3 18.6 16.2 17.3 25.6 19.8 18.3 18.7 40.6 19.0 32.8 19.8 22.4 16.8 23.7 19.7 26.7 14.9 19.4 19.8 11.7 20.2 26.3 18.2 47.3 25.8 20.0 21.2 20.4 21.2 22.5 37.8 17.3 21.1 21.1 11.7 18.5 15.6 13.6 9.8 12.3 16.0 10.3 6.4 14.3 8.5 16.2 9.5 15.0 19.0 11.1 11.9 13.5 16.3 17.4 17.4 17.7 8.0 10.1 19.6 8.0 16.0 9.6 13.3 9.2 12.1 6.6 10.1 17.0 10.4 18.4 19.8 14.5 24.5 28.8 17.6 13.1 10.5 5.6 13.8 15.2 16.7 10.6 17.2 12.6 26.3 16.7 17.8 6.2 10.3 11.9 23.6 11.5 12.8 12.8 19.3 9.4 12.7 16.7 26.0 13.1 5.8 9.4 18.7 17.4 16.3 14.8 13.5 10.7 18.5 4.4 17.3 17.0 12.0 22.4 4.0 9.6 6.3 10.8 10.3 12.7 9.5 7.6 11.5 9.8 9.8 7.4 9.5 16.0 6.4 7.4 12.3 14.3 8.5 21.3 20.7 39.0 52.7 19.8 18.3 19.8 22.4 19.4 17.3 20.8 19.4 29.5 12.3 7.8 42.7 15.3 30.6 13.4 13.6 26.2 53.0 14.5 26.6 17.5 58.7 14.3 27.1 0.0 27.9 9.9 9.7 16.4 32.2 48.4 13.8 62.0 25.8 19.6 21.9 27.9 18.1 15.0 10.1 25.2 20.5 22.7 26.7 28.1 18.7 15.3 43.8 25.8 11.2 65.7 42.4 7.4 23.8 20.3 16.2 13.9 PPP6R3 "C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3" ENSG00000110075 "Protein phosphatase 6 regulatory subunit 3" Q5H9R7 11 68460731-68615334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017183, HPA038467, HPA038468" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030" "unprognostic (9.46e-3)" "unprognostic (1.45e-1)" "unprognostic (4.62e-2)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (6.19e-2)" "unprognostic (1.97e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.33e-2)" "unprognostic (1.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.20e-3)" "unprognostic (3.29e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.54e-2)" "unprognostic (6.43e-2)" 33.0 29.8 16.7 25.7 24.1 36.5 26.8 35.7 25.8 33.2 29.6 27.9 24.9 21.5 43.8 24.3 29.9 26.6 24.6 27.5 17.3 16.5 28.8 28.2 27.9 26.8 25.0 18.5 36.4 23.8 49.0 48.1 40.0 23.7 28.3 27.5 28.2 28.2 29.2 46.4 25.8 31.5 35.5 24.3 31.1 27.7 28.2 24.0 45.5 39.2 34.8 31.8 34.3 26.9 14.8 15.0 16.9 16.7 11.7 17.7 7.1 24.4 29.0 30.1 21.0 16.1 16.4 23.3 21.5 20.9 25.0 23.0 50.3 24.9 28.2 21.2 20.0 26.4 23.2 33.0 24.3 33.2 27.3 13.9 32.6 29.5 16.9 15.4 30.9 29.2 16.2 16.4 25.7 27.9 14.1 22.8 22.7 27.5 21.1 17.8 32.8 31.0 23.9 15.0 48.5 17.2 29.2 41.0 27.4 16.7 35.6 17.0 20.3 30.5 24.2 44.3 26.2 35.9 16.6 22.6 24.7 23.4 26.2 18.2 16.7 23.2 37.1 17.9 13.7 26.2 14.6 11.5 14.4 14.7 15.2 14.0 14.1 15.6 14.4 7.4 14.8 17.7 16.1 16.9 11.7 16.7 15.0 15.0 7.1 16.7 24.1 35.7 25.8 17.3 16.5 25.0 18.5 23.7 24.0 41.7 36.5 27.5 21.7 29.5 48.6 33.5 28.1 24.1 38.7 26.2 53.0 16.9 13.3 13.4 59.6 29.4 28.0 23.3 14.3 14.1 23.1 34.0 26.6 21.2 15.0 25.4 29.2 29.4 18.4 17.8 28.7 25.2 20.3 10.8 26.5 31.9 19.2 28.3 29.7 13.5 49.0 19.4 28.1 27.7 29.7 31.0 27.5 26.6 23.4 35.3 PPTC7 TA-PP2C ENSG00000196850 "PTC7 protein phosphatase homolog" Q8NI37 12 110533245-110583320 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.8" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039335, HPA040614" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039335: AB_10805474, HPA040614: AB_10795526" "unprognostic (2.44e-1)" "unprognostic (2.38e-2)" "unprognostic (1.11e-1)" "unprognostic (9.44e-2)" "unprognostic (2.38e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.43e-5)" "prognostic unfavorable (6.76e-4)" "unprognostic (1.09e-1)" "prognostic favorable (4.48e-5)" "unprognostic (5.34e-2)" "unprognostic (2.83e-1)" "unprognostic (5.01e-3)" "unprognostic (1.83e-1)" 10.4 15.3 6.5 10.3 9.6 26.2 10.3 8.3 12.9 9.7 11.8 5.7 4.9 7.5 9.3 4.6 12.6 7.8 8.8 35.3 9.0 9.0 12.6 11.9 13.1 10.9 10.4 6.8 8.9 7.5 13.0 12.7 6.9 15.3 7.7 9.8 8.0 12.9 8.2 53.8 13.4 11.7 13.1 7.4 9.4 8.4 8.2 6.5 16.1 8.0 15.5 13.1 12.4 12.4 2.1 1.4 6.1 1.7 1.7 2.4 0.6 12.2 7.0 6.0 6.3 15.0 13.2 8.6 5.6 7.5 6.2 6.2 7.9 4.8 21.5 5.9 5.5 8.9 11.9 12.0 13.1 12.6 15.6 10.0 19.0 7.5 8.5 14.3 21.0 15.7 11.4 21.6 8.8 25.9 9.3 11.7 15.0 14.1 6.1 10.0 3.1 18.5 18.0 8.5 6.6 13.1 15.5 8.1 13.1 25.7 13.7 9.7 7.6 10.7 14.8 12.4 6.1 7.0 11.3 13.4 5.7 6.1 17.3 9.5 17.8 19.7 24.0 9.6 11.6 11.2 0.1 1.7 1.3 2.3 1.5 2.4 1.3 1.9 1.8 1.3 2.1 2.2 1.9 6.1 1.7 1.1 1.4 1.3 0.6 6.5 9.6 8.3 12.9 9.0 9.0 10.4 6.8 15.3 6.5 20.8 21.2 21.7 47.9 81.6 8.5 96.6 15.3 25.4 22.7 8.7 13.7 6.3 14.9 6.8 29.6 22.2 18.4 23.3 7.1 7.0 37.6 42.4 23.1 24.9 15.0 12.7 16.1 14.7 25.1 17.5 10.6 19.9 32.1 10.0 14.2 3.9 11.1 14.4 9.2 10.5 24.1 12.9 39.1 12.5 22.5 91.1 5.6 20.8 13.8 64.3 PQLC3 "C2orf22, MGC33602" ENSG00000162976 "PQ loop repeat containing 3" Q8N755 2 11155198-11178874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 30.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061607 Approved Cytosol NA NA Cytosol "HPA061607: AB_2797264" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (2.19e-1)" "unprognostic (5.55e-2)" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.09e-3)" "unprognostic (9.11e-2)" "unprognostic (3.14e-1)" "unprognostic (2.24e-1)" "unprognostic (4.93e-3)" "unprognostic (2.93e-1)" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.21e-1)" "unprognostic (2.34e-1)" "unprognostic (4.00e-2)" 26.9 21.3 5.1 16.5 6.2 4.2 16.7 2.4 6.2 22.2 14.4 11.3 8.6 5.6 19.7 27.0 18.1 15.4 19.5 14.9 5.4 5.1 20.6 9.8 21.0 26.9 7.9 5.8 20.7 33.3 5.3 5.4 15.5 7.8 18.5 10.5 15.5 14.1 11.2 14.0 9.8 16.5 19.8 13.1 26.3 12.7 12.0 5.7 12.0 17.6 13.0 15.0 15.7 14.7 11.4 36.9 37.0 46.9 14.4 18.4 33.0 3.1 10.8 2.0 6.1 30.8 21.1 7.3 6.6 8.7 3.1 3.7 2.0 12.5 1.1 5.0 12.9 13.6 4.1 3.1 3.4 3.2 20.0 1.6 3.0 1.4 1.3 12.3 1.5 9.3 15.3 11.6 2.0 4.5 6.9 7.0 7.1 2.8 7.0 8.5 14.3 2.2 3.0 4.3 11.2 3.8 2.8 3.3 3.4 11.6 5.4 0.7 3.4 5.6 17.6 12.4 9.3 15.7 5.5 9.9 4.5 1.9 4.8 1.8 12.0 8.7 0.5 11.9 7.1 8.8 15.1 37.3 37.0 18.4 45.7 16.1 11.4 18.2 18.0 36.9 7.7 10.1 13.9 2.3 14.4 46.9 7.1 18.2 33.0 5.1 6.2 2.4 6.2 5.4 5.1 7.9 5.8 7.8 5.7 23.8 6.2 18.0 19.8 22.2 1.7 2.4 20.4 12.0 14.8 50.6 15.7 16.2 8.3 32.7 0.5 17.5 10.7 0.0 56.6 70.6 37.3 19.5 12.7 10.9 53.1 1.6 6.4 38.6 87.8 0.7 43.4 62.1 55.6 84.8 10.7 4.5 41.4 3.5 55.5 11.7 0.9 58.2 38.7 2.1 18.5 20.5 9.4 45.9 11.5 16.9 PRAC1 "C17orf92, PRAC" ENSG00000159182 "PRAC1 small nuclear protein" Q96KF2 17 48721719-48722522 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 62.1;prostate: 40.3" "Group enriched" "Detected in some" 5 "Intestinal endocrine cells: 873.8;Mucus-secreting cells: 545.9;Undifferentiated cells: 434.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 291.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 33 "PC-3: 92.5" HPA047871 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047871: AB_2680195" "unprognostic (7.59e-2)" "unprognostic (2.43e-2)" "unprognostic (2.04e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.6 2.0 30.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 40.3 62.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 9.9 5.1 0.8 0.0 2.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 92.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.5 0.0 0.2 0.5 0.0 0.4 0.0 0.8 0.1 0.1 2.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 97.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 67.9 0.0 0.0 0.0 0.1 118.0 0.0 0.0 0.0 0.0 873.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 545.9 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 434.0 46.7 PRDX4 AOE37-2 ENSG00000123131 "Peroxiredoxin 4" Q13162 X 23664262-23686399 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "liver: 127.6;pancreas: 320.8" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 604.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008659, CAB027389, CAB047362, HPA067039" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 11000000 "Endoplasmic reticulum, Cytosol" "CAB008659: AB_1620984, CAB027389: , CAB047362: , HPA067039: " "unprognostic (3.82e-2)" "unprognostic (6.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.06e-3)" "unprognostic (1.64e-1)" "unprognostic (1.65e-2)" "unprognostic (1.29e-3)" "unprognostic (1.08e-1)" "unprognostic (8.32e-2)" "unprognostic (3.75e-2)" "unprognostic (2.97e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (7.44e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-1)" "unprognostic (4.10e-2)" 11.6 14.8 3.8 7.0 6.4 3.9 11.2 3.3 5.4 13.2 10.7 6.5 17.4 8.9 11.5 10.5 13.1 9.6 12.9 17.6 3.8 4.0 11.8 127.6 8.9 16.9 7.2 4.0 14.6 320.8 6.1 15.8 21.9 7.4 9.3 11.4 8.0 25.4 14.1 7.8 7.2 10.6 8.8 8.1 12.6 12.8 25.2 6.1 4.7 12.0 10.0 15.0 10.8 8.7 27.9 31.4 2.0 39.3 24.1 22.7 21.3 23.9 33.1 14.0 27.1 76.5 39.1 19.7 32.3 35.2 29.4 42.8 34.6 30.2 20.6 15.2 41.8 34.1 29.1 40.3 20.0 28.1 12.6 77.5 14.6 29.2 43.8 31.9 18.8 13.9 41.4 26.0 28.5 28.7 32.0 36.7 6.9 28.2 76.2 27.1 35.7 9.6 29.5 48.4 47.1 48.6 13.3 35.1 116.3 26.2 8.4 20.6 17.5 29.8 35.3 23.8 80.2 37.3 24.0 24.2 21.0 13.8 54.0 24.2 25.0 30.2 22.1 37.5 24.4 29.8 1.7 20.6 2.0 17.8 32.2 21.8 27.9 22.7 18.6 31.4 16.2 16.4 16.7 1.5 24.1 39.3 22.0 22.1 21.3 3.8 6.4 3.3 5.4 3.8 4.0 7.2 4.0 7.4 6.1 53.6 69.3 34.3 72.4 53.0 14.1 33.1 117.2 62.9 56.9 47.1 7.9 283.9 8.3 219.7 305.3 87.4 33.6 23.3 310.3 449.8 156.0 130.0 41.6 497.8 155.7 11.1 56.3 100.1 55.2 604.6 233.8 49.6 189.0 103.6 79.9 51.0 268.1 31.6 135.4 36.5 17.9 142.3 69.0 183.9 270.0 45.7 216.3 25.4 110.8 64.0 PRDX6 "1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX" ENSG00000117592 "Peroxiredoxin 6" P30041 1 173477266-173488807 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006983, CAB008663" Supported Supported "Plasma membrane,Cytosol" NA NA 180000000 "Plasma membrane, Cytosol" "CAB008663: AB_1620994, HPA006983: AB_1079595" "unprognostic (9.92e-2)" "unprognostic (1.50e-1)" "unprognostic (3.67e-1)" "unprognostic (2.99e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (5.71e-3)" "unprognostic (2.80e-2)" "unprognostic (5.27e-3)" "unprognostic (3.96e-3)" "unprognostic (3.19e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.51e-4)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (1.15e-1)" "unprognostic (4.73e-3)" 80.0 42.1 32.8 30.8 38.9 21.8 106.3 19.8 32.8 27.2 46.7 37.4 35.8 12.1 30.8 54.1 39.9 40.2 22.3 70.5 29.0 23.9 45.9 116.1 29.2 37.5 34.0 28.2 31.5 39.3 63.9 19.1 36.9 30.3 40.0 56.0 21.3 22.6 35.4 128.0 25.7 20.2 40.5 19.7 23.1 33.2 44.9 24.1 17.4 46.9 68.6 25.7 36.5 46.2 17.2 37.9 14.3 23.9 12.0 25.0 30.6 52.1 16.0 26.6 29.5 103.2 50.5 22.5 106.5 36.3 44.5 31.6 30.2 35.1 33.9 34.1 87.2 16.4 30.5 34.8 34.3 36.2 29.8 32.1 22.5 27.4 34.1 58.2 23.5 7.4 41.8 34.8 24.4 34.2 28.0 43.6 14.2 50.0 7.0 50.5 10.7 15.9 31.0 58.5 28.7 99.6 19.1 30.8 34.6 66.6 11.9 12.4 23.0 36.7 43.2 24.4 40.0 36.5 33.2 29.3 17.3 19.9 26.2 28.9 10.6 15.7 27.9 20.8 20.5 15.8 13.9 23.9 12.9 17.0 20.6 18.9 17.2 17.6 21.1 29.3 13.6 23.2 25.0 14.3 12.0 17.5 37.9 20.4 30.6 32.8 38.9 19.8 32.8 29.0 23.9 34.0 28.2 30.3 24.1 163.8 131.5 140.0 350.9 209.2 31.5 477.5 249.7 195.4 161.5 263.5 27.5 589.1 729.5 163.2 193.0 183.6 264.7 256.9 175.5 640.5 290.3 337.6 341.6 875.0 302.1 42.9 136.4 174.3 152.8 441.3 315.2 140.2 173.7 230.0 253.4 390.8 159.2 306.9 391.7 634.8 41.0 181.1 254.2 113.1 58.3 231.0 805.7 161.9 278.6 280.8 PREP ENSG00000085377 "Prolyl endopeptidase" P48147 6 105277565-105403084 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025414, HPA031388, HPA031389, HPA031390" Supported Supported Cytosol NA NA 1400000 Cytosol "CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857" "unprognostic (3.05e-2)" "unprognostic (9.09e-3)" "unprognostic (2.85e-2)" "unprognostic (5.46e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.33e-4)" "unprognostic (2.63e-3)" "unprognostic (2.39e-1)" "unprognostic (6.78e-2)" "unprognostic (5.81e-2)" "unprognostic (2.66e-2)" "unprognostic (1.15e-1)" "unprognostic (4.47e-3)" "unprognostic (2.74e-2)" "unprognostic (8.98e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" 13.0 14.2 10.1 22.2 10.1 10.4 36.2 10.9 24.9 11.9 27.2 5.2 11.2 20.2 13.2 10.9 16.4 10.5 15.0 19.0 8.8 7.1 8.9 14.6 23.9 31.4 8.3 15.4 13.6 18.8 16.1 11.1 15.4 9.7 9.4 33.0 8.9 14.9 11.5 58.0 24.2 19.0 15.3 8.5 11.9 14.0 20.1 8.8 17.4 10.2 18.5 13.3 18.2 21.0 8.3 15.3 7.1 18.7 16.6 16.3 11.2 11.0 13.5 14.5 16.2 34.3 20.3 14.3 14.9 14.0 19.7 20.9 17.2 7.0 14.2 14.7 17.5 18.2 17.2 21.3 43.6 22.4 21.4 20.8 19.0 11.4 19.6 13.2 19.2 13.9 18.8 26.6 14.1 36.5 14.9 18.3 25.1 32.4 25.4 23.8 18.0 12.8 19.5 14.0 21.4 13.6 19.8 24.9 9.2 14.7 26.4 19.0 27.1 13.1 21.9 10.4 19.2 9.4 30.8 18.4 9.0 12.6 11.3 18.3 7.4 4.9 18.6 16.0 20.9 28.1 4.8 13.6 7.1 16.0 15.4 15.6 8.3 13.7 16.3 15.3 6.8 12.9 15.2 0.7 16.6 18.7 6.5 12.0 11.2 10.1 10.1 10.9 24.9 8.8 7.1 8.3 15.4 9.7 8.8 3.0 7.0 6.1 5.7 9.6 5.3 13.2 5.1 1.4 7.9 7.0 13.7 16.0 5.0 9.1 0.9 9.0 15.7 0.0 10.2 27.4 9.0 4.3 13.8 13.9 13.4 12.7 18.6 9.2 15.8 2.4 10.0 10.0 5.0 18.0 33.1 3.3 12.9 17.3 8.5 6.7 9.5 0.0 12.3 2.1 17.9 7.4 56.8 11.3 34.9 7.6 PREX1 "KIAA1415, P-REX1" ENSG00000124126 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1" Q8TCU6 20 48624252-48827883 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.7;brain: 35.5" "Cell type enhanced" "Detected in many" 11 "Kupffer cells: 81.5;Macrophages: 39.6;T-cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 44.2;SK-BR-3: 46.4;T-47d: 41.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001927 Supported Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001927: AB_1079674" "unprognostic (8.07e-2)" "unprognostic (3.16e-2)" "unprognostic (2.15e-2)" "unprognostic (2.55e-1)" "unprognostic (7.47e-2)" "prognostic favorable (8.56e-4)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (5.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.70e-2)" "unprognostic (5.86e-3)" "unprognostic (6.84e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" 10.8 8.1 20.5 25.1 24.9 32.7 12.4 11.4 25.0 9.6 5.1 35.5 0.2 4.6 3.2 2.7 4.8 3.7 9.5 4.9 21.8 15.5 4.1 4.0 17.7 28.3 26.2 12.1 2.2 3.9 5.2 5.8 8.4 17.4 3.9 4.6 7.7 4.0 2.8 4.6 2.7 8.6 5.6 27.6 28.7 6.1 4.5 23.9 2.8 6.7 1.0 15.1 10.3 2.5 2.0 2.1 11.7 2.7 2.1 9.3 2.2 0.6 1.7 22.5 0.0 0.3 1.7 7.8 0.7 1.0 3.2 0.8 0.1 0.0 4.5 14.3 2.0 6.1 0.2 1.1 0.0 2.1 1.0 0.5 0.6 2.5 0.0 1.3 2.4 14.7 1.8 0.0 7.4 0.0 2.2 19.4 2.0 0.0 0.1 4.2 44.2 0.0 6.9 0.9 2.2 1.8 6.6 6.5 2.7 0.1 0.0 4.7 0.7 4.1 46.4 5.1 1.3 41.4 18.9 21.6 1.3 4.6 0.0 1.2 0.2 0.9 5.5 21.0 4.9 6.9 5.2 2.3 2.5 5.0 2.7 3.0 2.0 2.7 4.2 2.1 1.7 0.4 1.5 11.7 2.1 2.3 1.7 9.3 2.2 20.5 24.9 11.4 17.7 21.8 15.5 26.2 12.1 17.4 23.9 3.0 10.0 24.1 0.2 2.3 0.2 2.5 2.5 8.1 4.5 1.8 7.9 0.6 0.0 0.1 2.8 13.4 0.2 0.0 1.1 2.7 6.0 0.8 1.1 1.5 28.2 0.0 1.2 20.3 81.5 2.3 0.9 39.6 8.5 16.2 1.0 17.2 0.2 0.0 0.4 0.0 0.6 0.0 4.7 1.9 10.2 2.0 7.8 41.5 2.9 0.4 PRF1 "HPLH2, P1, PFP" ENSG00000180644 "Perforin 1" P14222 10 70597348-70602775 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Cytolysis "Cancer-related genes, Disease mutation, Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 100.3;lymphoid tissue: 38.7" "Cell type enriched" "Detected in some" 9 "T-cells: 203.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "gdT-cell: 100.3;MAIT T-cell: 70.9;memory CD8 T-cell: 54.9;naive CD8 T-cell: 36.1;NK-cell: 65.1" "Group enriched" "Detected in many" 48 "NK-cells: 65.1;T-cells: 100.3" "Cell line enriched" "Detected in some" 11 "HDLM-2: 72.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002436, HPA037940" Approved Approved Cytosol "Intracellular and membrane" NA NA 960000 Cytosol "CAB002436: AB_563955, HPA037940: AB_2675747" "unprognostic (6.11e-3)" "unprognostic (1.26e-2)" "unprognostic (1.71e-1)" "prognostic favorable (2.09e-4)" "unprognostic (1.87e-2)" "prognostic favorable (3.54e-4)" "unprognostic (6.98e-3)" "unprognostic (2.62e-1)" "unprognostic (1.44e-3)" "unprognostic (1.69e-2)" "unprognostic (5.22e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (7.38e-2)" "unprognostic (2.70e-1)" "unprognostic (7.97e-3)" "unprognostic (5.22e-3)" 8.8 1.3 0.9 5.5 1.1 15.3 2.4 0.5 0.7 1.7 3.8 0.4 0.2 1.4 4.4 2.9 2.7 1.7 5.3 4.1 0.8 0.9 1.8 6.5 19.6 11.3 2.5 0.3 2.1 1.6 0.0 1.1 3.1 1.2 3.3 0.8 3.9 2.5 3.3 2.6 0.9 5.1 1.2 1.4 38.7 3.1 1.6 0.2 12.7 2.8 1.0 10.3 3.2 1.7 0.4 0.3 1.7 0.2 65.1 100.3 46.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.7 0.0 0.4 0.0 2.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.2 0.0 100.3 0.1 70.9 0.4 14.6 54.9 0.2 0.2 6.2 36.1 1.7 65.1 0.2 0.3 11.1 46.7 0.9 1.1 0.5 0.7 0.8 0.9 2.5 0.3 1.2 0.2 3.0 22.3 6.5 0.0 0.3 0.0 0.8 0.0 2.7 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.1 8.1 2.1 0.1 0.0 0.0 8.6 5.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.6 0.6 203.1 0.0 0.0 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788481 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 26.2" "Cell type enriched" "Detected in some" 11 "Muller glia cells: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.5;Hep G2: 4.8;NTERA-2: 3.0;SCLC-21H: 13.2;SH-SY5Y: 7.5" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: AB_2679744, HPA060047: AB_2684194" "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavorable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 4.6 6.0 4.2 5.9 16.7 0.4 2.4 4.5 8.2 7.7 26.2 21.7 4.2 4.6 7.9 7.9 13.7 10.7 3.3 4.8 5.8 3.3 1.2 0.7 1.0 0.7 20.2 4.0 6.9 1.2 0.6 0.3 2.2 15.5 8.6 7.6 9.9 4.6 10.2 0.7 2.1 11.6 14.9 24.3 0.7 12.1 1.8 14.7 0.0 1.3 0.9 4.4 4.7 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 7.5 0.0 0.0 0.2 0.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 13.2 7.5 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 16.7 4.5 8.2 5.8 3.3 20.2 4.0 15.5 14.7 0.0 0.0 0.0 1.0 0.5 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.4 2.6 0.0 0.0 0.0 0.0 33.7 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.1 PRIMPOL "CCDC111, FLJ33167" ENSG00000164306 "Primase and DNA directed polymerase" Q96LW4 4 184649613-184694963 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Mucus-secreting cells: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054372 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA054372: AB_2682466" "unprognostic (1.68e-1)" "unprognostic (1.27e-3)" "unprognostic (1.67e-1)" "unprognostic (1.18e-1)" "unprognostic (2.67e-2)" "unprognostic (4.75e-2)" "unprognostic (2.02e-2)" "unprognostic (3.34e-2)" "unprognostic (3.32e-3)" "unprognostic (5.86e-2)" "unprognostic (2.52e-2)" "unprognostic (5.02e-1)" "unprognostic (3.04e-1)" "unprognostic (3.04e-2)" "unprognostic (3.81e-1)" "unprognostic (1.49e-1)" "unprognostic (1.05e-1)" 12.3 12.6 8.3 17.0 11.5 9.1 13.5 14.6 11.0 17.7 14.3 15.4 18.1 6.9 25.4 13.1 12.0 15.1 14.6 12.0 8.0 8.3 8.6 9.9 11.3 10.8 8.4 11.5 18.7 9.0 9.8 14.0 10.8 10.2 14.8 13.2 12.0 11.0 17.9 10.3 10.0 11.2 14.8 14.7 11.9 11.0 8.0 10.2 15.0 12.1 6.4 10.8 16.3 15.9 3.3 2.5 18.6 4.1 3.6 4.9 2.6 9.4 3.8 9.6 11.0 12.8 16.7 6.5 9.2 15.2 16.2 14.3 3.0 9.2 5.4 3.5 7.1 9.3 5.6 7.8 9.8 17.2 10.9 4.0 5.7 5.5 3.6 8.3 4.9 8.5 10.5 8.1 14.8 9.8 9.5 8.5 14.7 11.3 18.7 11.5 3.1 9.4 4.2 3.2 4.3 3.4 8.6 7.0 6.1 8.1 5.7 7.3 9.1 5.7 1.6 10.4 8.0 4.9 8.6 4.5 5.4 7.3 4.4 6.2 9.5 6.8 2.7 8.0 6.3 13.5 7.8 2.0 18.6 3.5 1.9 4.9 3.1 3.2 3.4 2.5 3.3 2.7 2.7 1.0 3.6 4.1 2.2 3.7 2.6 8.3 11.5 14.6 11.0 8.0 8.3 8.4 11.5 10.2 10.2 6.0 7.5 3.7 10.1 8.5 5.8 2.0 10.2 17.4 9.1 5.2 0.0 11.3 5.0 6.4 4.0 4.2 6.1 0.0 4.5 8.4 8.3 4.1 15.0 5.4 8.3 7.9 6.4 8.0 11.8 4.1 11.5 6.1 8.5 6.4 61.4 10.1 3.6 7.0 8.5 4.7 8.2 12.9 7.0 18.0 9.4 8.5 4.1 8.6 8.1 3.3 PRKAA1 AMPKa1 ENSG00000132356 "Protein kinase AMP-activated catalytic subunit alpha 1" Q13131 5 40759379-40798374 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 230.0;Late spermatids: 337.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005050, HPA035409, HPA064946" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390" "unprognostic (2.07e-1)" "unprognostic (1.41e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (3.97e-1)" "unprognostic (1.05e-1)" "unprognostic (3.51e-2)" "unprognostic (7.53e-2)" "unprognostic (1.66e-2)" "unprognostic (2.88e-1)" "unprognostic (3.34e-3)" "unprognostic (2.63e-1)" "unprognostic (2.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.10e-2)" 40.6 15.7 9.4 15.9 16.1 29.0 26.2 14.3 17.7 30.2 24.0 19.9 18.9 21.7 23.5 20.9 22.5 20.4 21.3 15.0 10.5 11.7 35.9 40.7 24.8 16.7 12.2 8.5 28.8 20.6 25.3 20.0 16.8 35.7 26.1 22.3 20.0 23.2 17.9 18.5 16.6 32.6 20.7 14.1 25.1 22.1 29.3 11.4 21.4 28.0 20.5 22.9 32.5 17.9 8.4 6.5 15.9 8.9 10.8 12.6 6.5 11.4 11.9 9.6 12.7 23.7 24.8 9.1 19.6 20.0 14.7 13.2 11.2 14.9 6.7 9.1 20.0 19.2 9.3 8.8 17.8 27.7 19.8 8.0 13.4 27.6 8.9 19.6 12.7 14.2 22.8 8.7 19.6 20.3 16.3 21.6 8.7 6.3 19.6 21.9 5.5 11.8 10.0 4.2 11.7 14.4 9.9 20.5 9.9 22.5 19.5 8.3 8.4 34.3 22.8 11.6 5.4 12.0 10.6 23.1 26.5 14.3 15.2 15.9 7.8 6.1 8.1 16.6 27.7 14.1 14.1 6.6 12.7 10.0 8.1 12.6 8.4 9.4 9.4 6.5 7.7 11.5 10.0 15.9 10.8 8.9 2.0 11.3 6.5 9.4 16.1 14.3 17.7 10.5 11.7 12.2 8.5 35.7 11.4 38.7 27.4 25.1 20.8 21.4 19.2 15.3 43.3 22.7 28.4 45.4 33.4 10.9 6.6 24.4 230.0 32.8 33.8 0.0 39.5 11.7 23.6 34.6 17.4 73.6 17.7 14.3 20.3 36.2 21.5 337.0 28.1 24.1 33.7 36.1 27.4 15.4 29.5 31.7 24.4 26.4 25.7 0.0 33.0 20.4 16.8 28.5 15.6 28.8 30.2 28.0 PRKAB1 ENSG00000111725 "Protein kinase AMP-activated non-catalytic subunit beta 1" Q9Y478 12 119667753-119681630 "FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004247, CAB005058" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005058: AB_562038, HPA004247: AB_1078149" "unprognostic (1.20e-1)" "unprognostic (3.08e-2)" "unprognostic (7.42e-2)" "prognostic favorable (8.66e-4)" "unprognostic (2.33e-1)" "unprognostic (2.89e-2)" "unprognostic (8.97e-3)" "unprognostic (1.46e-2)" "unprognostic (6.26e-2)" "unprognostic (3.63e-2)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "prognostic favorable (5.40e-9)" "unprognostic (5.60e-2)" "unprognostic (2.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.32e-2)" 16.3 17.2 8.1 16.6 11.9 23.4 13.8 12.5 20.7 16.8 22.8 14.6 6.7 20.4 13.6 13.2 17.9 11.6 19.3 9.2 8.3 7.2 40.1 12.3 21.4 20.6 8.9 9.8 14.2 21.7 11.7 10.8 19.1 11.1 9.7 22.7 20.6 15.3 10.7 12.0 10.6 23.9 12.5 10.5 20.7 25.0 33.4 8.3 20.0 17.5 9.4 16.6 16.3 10.6 26.4 17.4 38.8 19.9 22.1 20.9 18.3 4.7 12.8 10.2 9.6 8.7 7.6 13.4 7.7 10.0 12.6 9.6 13.4 10.9 15.9 10.2 10.5 5.6 6.7 10.2 15.9 11.6 10.2 9.4 24.9 5.6 19.4 15.7 11.5 31.7 11.4 13.5 11.4 15.4 14.2 9.3 23.7 38.0 6.2 9.7 13.1 26.0 12.9 14.3 7.0 14.3 15.1 8.8 9.2 14.3 15.2 8.1 13.8 10.2 3.9 10.5 13.1 12.6 15.1 11.0 7.7 8.2 5.9 7.7 20.0 17.6 11.8 7.6 7.8 11.0 24.8 16.4 38.8 17.2 18.4 20.9 26.4 18.3 18.3 17.4 21.7 19.9 18.6 19.1 22.1 19.9 15.4 19.7 18.3 8.1 11.9 12.5 20.7 8.3 7.2 8.9 9.8 11.1 8.3 44.7 42.5 11.8 5.5 3.0 12.0 4.1 10.2 10.7 17.0 21.0 3.9 15.7 39.7 7.1 1.0 13.5 16.9 0.0 27.0 8.5 8.2 5.6 11.5 5.0 10.3 20.6 18.9 4.3 5.6 1.8 5.2 9.0 3.3 12.6 16.7 11.9 10.0 14.1 6.0 29.4 17.3 6.5 6.0 25.0 9.4 3.8 12.6 10.2 21.5 7.6 PRKAB2 ENSG00000131791 "Protein kinase AMP-activated non-catalytic subunit beta 2" O43741 1 147155106-147172550 "Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.1" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044342 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044342: AB_10966508" "prognostic unfavorable (4.55e-4)" "unprognostic (2.03e-2)" "unprognostic (1.84e-1)" "unprognostic (4.03e-2)" "unprognostic (9.59e-3)" "prognostic unfavorable (7.32e-4)" "unprognostic (6.30e-2)" "unprognostic (1.23e-1)" "unprognostic (3.06e-2)" "unprognostic (6.78e-2)" "unprognostic (4.65e-2)" "unprognostic (1.98e-1)" "unprognostic (5.34e-2)" "unprognostic (1.31e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (6.78e-7)" "unprognostic (4.78e-2)" 7.7 7.6 5.6 4.6 7.1 4.7 7.6 13.3 10.9 9.3 24.6 8.9 8.9 19.1 13.0 8.1 10.0 7.4 6.5 15.2 5.6 5.2 6.2 32.6 6.3 3.8 5.9 9.3 8.1 21.0 18.4 6.2 7.5 7.8 10.9 6.9 6.3 5.7 12.6 52.1 9.4 19.1 20.5 8.4 5.7 11.1 6.9 5.5 2.6 5.8 19.9 4.7 19.0 10.3 1.2 1.7 2.9 1.6 5.1 2.5 0.8 3.9 2.2 5.9 4.5 14.0 12.1 21.3 7.5 4.1 5.0 5.5 8.8 7.9 7.2 3.8 5.9 2.9 10.6 6.8 8.4 4.9 2.8 4.7 3.2 7.0 14.2 9.6 3.7 1.4 9.5 16.9 5.2 24.7 7.5 4.9 5.6 4.4 2.9 4.3 4.0 2.7 2.1 12.3 6.8 9.8 4.3 7.9 3.5 3.6 3.2 3.8 7.1 5.6 6.4 26.7 22.0 6.0 4.6 5.6 5.7 12.6 5.2 12.1 4.7 5.1 3.7 5.9 3.3 7.4 2.9 1.2 1.9 1.5 1.2 2.5 1.2 1.6 0.9 1.7 1.1 1.7 1.1 0.3 5.1 1.6 0.8 0.7 0.8 5.6 7.1 13.3 10.9 5.6 5.2 5.9 9.3 7.8 5.5 3.0 1.3 5.0 9.8 14.7 13.2 57.1 25.5 4.0 2.3 17.4 13.7 15.9 1.7 5.0 0.4 6.7 25.7 0.0 6.0 30.8 10.6 4.3 1.1 35.0 5.1 11.1 10.9 6.7 7.3 1.1 8.9 4.1 15.1 9.0 10.7 6.6 7.4 10.1 15.2 4.7 18.6 19.4 21.1 12.4 9.4 12.3 17.2 7.5 8.8 3.9 PRKACA PKACa ENSG00000072062 "Protein kinase cAMP-activated catalytic subunit alpha" P17612 19 14091688-14118084 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cushing syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 110.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010361, HPA071185" Approved Approved "Cytokinetic bridge,Cytosol" NA NA 1300000 Cytosol "Cytokinetic bridge" "CAB010361: AB_2268772, HPA071185: AB_2686356" "unprognostic (1.08e-1)" "prognostic favorable (6.28e-6)" "unprognostic (2.09e-2)" "prognostic unfavorable (6.26e-5)" "unprognostic (1.38e-2)" "unprognostic (2.95e-1)" "unprognostic (1.64e-1)" "unprognostic (9.36e-3)" "unprognostic (7.01e-2)" "unprognostic (3.41e-1)" "prognostic favorable (6.47e-4)" "unprognostic (2.86e-1)" "unprognostic (1.17e-1)" "unprognostic (4.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.66e-2)" "unprognostic (6.14e-3)" 25.6 43.4 19.6 17.8 22.7 9.1 34.1 29.1 39.6 20.6 17.5 16.0 16.2 13.4 19.8 15.6 20.9 18.8 16.4 91.6 20.7 29.4 14.7 34.5 16.5 28.2 21.6 27.5 47.0 15.6 20.8 24.6 15.4 26.9 16.6 16.2 18.4 15.5 24.9 92.4 13.4 14.4 29.0 16.2 28.1 13.9 24.4 11.1 15.2 15.7 26.2 14.8 21.1 17.3 1.7 2.4 8.6 5.3 0.7 1.7 1.2 26.2 15.3 34.7 41.3 30.7 32.7 6.3 28.0 25.9 39.8 36.5 18.6 9.4 11.4 22.7 44.3 19.4 17.2 24.4 26.5 37.8 20.7 12.3 20.9 28.9 18.0 26.3 12.9 22.2 31.1 12.8 31.6 11.0 24.6 33.5 18.7 19.6 29.8 40.6 38.9 29.0 9.7 12.4 26.6 34.1 26.2 32.0 26.3 19.4 16.7 27.4 17.5 25.3 15.5 11.5 17.5 22.1 12.5 25.9 47.0 13.1 62.9 26.1 20.6 21.1 16.8 31.5 19.6 17.6 0.3 3.4 0.4 1.7 5.3 0.8 1.7 0.9 1.1 2.4 1.3 1.2 1.7 8.6 0.7 4.6 1.6 0.8 1.2 19.6 22.7 29.1 39.6 20.7 29.4 21.6 27.5 26.9 11.1 6.0 4.3 11.5 6.1 7.8 40.4 110.4 28.1 4.0 2.3 14.0 25.5 5.8 6.6 10.7 25.7 21.6 16.0 0.0 16.2 4.8 14.3 7.3 0.0 30.1 29.0 3.2 16.8 31.9 44.8 12.8 45.5 32.4 13.5 7.2 14.3 24.1 13.5 7.0 48.8 9.6 23.0 19.4 17.3 25.7 6.4 9.8 6.8 7.2 11.4 6.4 PRKACB PKACb ENSG00000142875 "Protein kinase cAMP-activated catalytic subunit beta" P22694 1 84078062-84238498 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 85.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010363, HPA029754, HPA071185" Approved Approved "Cytokinetic bridge,Cytosol" NA NA 1500000 Cytosol "Cytokinetic bridge" "CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356" "unprognostic (9.38e-2)" "unprognostic (1.18e-1)" "unprognostic (6.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (9.49e-4)" "unprognostic (1.28e-1)" "unprognostic (3.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.31e-1)" "unprognostic (4.62e-2)" "prognostic favorable (1.89e-6)" "unprognostic (1.22e-1)" "unprognostic (3.28e-1)" "unprognostic (1.12e-2)" "unprognostic (2.48e-1)" 7.0 21.5 40.0 10.5 57.0 6.2 8.0 54.7 85.5 9.4 23.6 16.9 3.9 4.8 8.7 17.6 8.1 5.2 11.5 10.1 43.1 52.1 10.6 9.0 6.9 16.2 38.3 33.5 8.3 11.9 12.2 18.3 5.1 35.5 13.8 22.6 4.9 32.9 12.7 3.2 2.6 6.3 12.6 47.7 14.6 14.2 3.6 25.9 25.5 11.1 1.8 15.3 13.5 4.6 13.5 7.1 17.1 5.4 25.9 27.6 22.0 3.1 6.3 10.1 12.1 11.7 10.3 4.7 15.6 11.9 8.0 7.5 0.1 2.8 16.6 10.8 12.2 14.6 2.2 4.7 5.1 8.5 16.1 2.6 36.5 8.6 1.2 11.5 14.4 0.8 6.1 2.3 7.7 4.3 11.6 36.6 6.2 1.1 9.6 12.9 0.6 18.7 7.6 9.9 0.0 4.4 14.5 15.7 10.0 19.4 11.2 3.3 12.9 8.6 3.3 9.5 7.9 3.0 3.0 32.4 11.1 8.6 11.2 11.8 7.1 8.5 16.7 5.3 15.4 13.8 17.1 2.7 5.8 23.3 3.6 18.7 13.5 17.3 20.6 7.1 10.2 26.4 27.6 1.5 25.9 5.4 4.1 15.9 22.0 40.0 57.0 54.7 58.2 43.1 52.1 38.3 33.5 35.5 25.9 0.0 1.0 20.3 6.7 4.5 44.0 38.9 15.3 4.0 5.7 14.0 33.4 1.4 28.2 6.9 2.4 8.4 61.7 0.0 10.3 1.0 11.0 15.2 57.7 14.8 23.2 44.5 20.8 26.4 52.7 2.6 13.8 32.7 15.1 1.0 61.1 36.9 13.3 28.8 20.5 15.6 30.0 12.9 13.7 5.9 6.9 2.5 0.6 69.2 52.4 6.5 PRKACG PKACg ENSG00000165059 "Protein kinase cAMP-activated catalytic subunit gamma" P22612 9 69012529-69014113 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 27.4" "Group enriched" "Detected in some" 8 "Early spermatids: 55.1;Late spermatids: 73.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.3" "CAB004530, HPA071185" Supported Uncertain "Cytokinetic bridge,Cytosol" NA NA Cytosol "Cytokinetic bridge" "CAB004530: AB_628137, HPA071185: AB_2686356" "unprognostic (2.74e-1)" "unprognostic (3.61e-2)" "unprognostic (7.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 1.5 0.0 0.0 0.0 0.0 0.0 PRKAG1 ENSG00000181929 "Protein kinase AMP-activated non-catalytic subunit gamma 1" P54619 12 49002274-49019197 "Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 80.1" "Low region specificity" "Detected in all" HPA077805 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA077805: AB_2686855" "unprognostic (3.24e-2)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (2.84e-7)" "unprognostic (1.45e-1)" "unprognostic (4.68e-2)" "unprognostic (1.93e-2)" "unprognostic (5.35e-2)" "unprognostic (8.49e-2)" "prognostic favorable (1.83e-4)" "unprognostic (3.40e-1)" "unprognostic (2.57e-1)" "unprognostic (1.97e-2)" "unprognostic (5.57e-2)" 23.8 30.3 18.5 13.6 18.6 22.6 25.5 14.2 27.0 19.2 18.8 19.6 18.0 13.3 16.0 23.9 26.8 14.1 14.2 39.4 15.2 18.2 27.1 30.8 13.9 14.9 19.7 18.4 18.9 19.6 19.2 22.2 18.9 22.1 19.1 17.0 20.3 18.4 21.0 58.4 21.7 19.8 20.4 15.9 18.7 17.4 19.2 10.7 22.5 22.5 24.9 23.0 23.2 15.7 29.2 41.0 44.0 35.9 40.1 36.9 37.9 18.1 11.3 12.9 20.2 33.0 33.9 7.3 20.0 26.3 20.4 13.1 11.1 16.2 11.7 18.0 23.0 12.1 15.9 9.3 25.8 19.8 13.4 15.4 15.9 17.5 8.9 27.4 21.0 12.5 26.6 20.3 14.8 31.2 27.1 19.6 17.3 12.1 16.8 27.4 11.7 8.7 8.0 7.9 80.1 23.8 4.9 11.4 14.8 27.4 15.3 10.7 13.7 14.2 26.1 30.3 9.4 31.9 11.8 18.2 9.6 13.0 21.9 15.1 27.7 27.0 7.8 23.3 15.1 8.7 41.1 35.9 33.6 31.5 34.2 30.3 29.2 28.4 29.4 41.0 26.4 25.9 26.8 44.0 40.1 33.0 27.6 36.9 37.9 18.5 18.6 14.2 27.0 15.2 18.2 19.7 18.4 22.1 10.7 8.9 24.3 32.2 25.2 17.7 28.4 45.2 15.3 16.0 11.4 34.9 35.3 58.2 64.6 42.7 7.4 19.4 28.4 0.0 40.9 47.6 27.3 19.9 20.8 18.7 46.3 14.3 20.2 30.7 29.3 10.2 33.9 31.8 35.4 65.9 24.8 35.9 39.1 11.5 25.5 49.6 28.2 19.4 26.9 45.8 41.6 22.7 56.1 26.6 29.9 18.7 PRKAR1A "CNC1, PRKAR1, TSE1" ENSG00000108946 "Protein kinase cAMP-dependent type I regulatory subunit alpha" P10644 17 68511780-68551319 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Cushing syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 608.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019378, HPA049979" Approved Approved Cytosol NA NA 11000000 Cytosol "CAB019378: , HPA049979: AB_2680980" "unprognostic (8.69e-2)" "unprognostic (6.97e-2)" "unprognostic (5.34e-2)" "unprognostic (2.04e-1)" "unprognostic (1.68e-1)" "unprognostic (4.39e-2)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (2.27e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-2)" "unprognostic (5.55e-2)" "unprognostic (8.56e-3)" "unprognostic (6.26e-2)" "unprognostic (6.92e-2)" "unprognostic (3.29e-2)" "unprognostic (1.11e-1)" 47.1 48.0 41.7 34.5 54.8 14.6 38.7 40.4 57.4 48.2 23.8 44.9 31.4 15.1 43.6 37.7 29.6 43.2 37.4 122.7 42.5 52.3 49.2 43.4 47.3 29.5 50.1 43.6 62.5 19.1 107.8 41.9 47.3 57.7 35.6 24.2 32.2 47.5 43.6 99.8 22.8 19.3 39.4 52.8 35.3 25.1 36.9 40.1 28.2 51.8 23.6 29.2 33.8 33.4 11.3 26.9 52.6 28.7 18.5 13.0 22.9 16.6 32.1 41.2 24.6 55.0 62.5 6.2 22.5 46.5 35.2 31.2 12.5 22.5 16.9 15.5 49.1 36.1 13.8 30.4 36.5 50.6 11.4 10.9 26.2 27.9 40.8 39.9 20.0 29.4 44.6 38.0 40.6 34.3 39.6 58.4 14.5 11.8 26.7 42.6 31.6 22.0 10.7 15.2 17.2 21.9 15.4 68.2 18.7 53.4 36.3 15.0 20.3 20.6 37.7 86.7 40.0 29.5 28.3 41.4 49.7 23.7 22.4 20.9 22.3 15.8 25.2 30.1 19.1 30.9 31.1 26.1 46.3 13.0 25.5 13.0 11.3 9.8 11.6 26.9 8.5 8.9 9.8 52.6 18.5 28.7 8.8 12.3 22.9 41.7 54.8 40.4 57.4 42.5 52.3 50.1 43.6 57.7 40.1 137.0 210.8 75.1 77.8 126.8 93.4 608.0 89.2 258.3 168.4 239.0 62.8 66.4 150.9 74.2 287.1 138.4 34.9 23.3 45.5 74.3 135.4 82.7 180.2 101.7 123.8 131.9 131.3 160.2 157.1 53.4 123.7 102.2 182.2 93.8 51.5 115.8 62.1 52.9 179.3 150.9 56.6 84.1 208.1 100.7 40.5 115.2 69.0 106.6 36.6 95.0 PRKCA PKCA ENSG00000154229 "Protein kinase C alpha" P17252 17 66302636-66810743 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 77.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0" "Cell line enhanced" "Detected in many" "U-87 MG: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003844, HPA006563, HPA006564, CAB016290" Enhanced Approved Enhanced "Plasma membrane,Cytosol" NA NA 1900000 Cytosol "Plasma membrane" "CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625" "unprognostic (3.06e-1)" "unprognostic (3.56e-2)" "unprognostic (1.38e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (7.41e-3)" "unprognostic (7.43e-2)" "unprognostic (6.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" "unprognostic (2.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.35e-3)" "unprognostic (8.77e-2)" 4.0 19.6 26.5 9.0 22.8 2.5 3.0 10.8 33.9 7.0 13.8 19.0 3.5 14.6 14.8 6.7 4.7 6.1 10.8 5.8 31.6 15.6 16.7 6.5 6.0 8.4 18.7 15.6 20.4 5.5 1.7 6.0 6.5 17.6 17.2 11.2 7.0 3.1 22.3 6.6 3.8 12.7 13.7 15.0 7.9 7.9 3.7 14.4 0.4 4.5 1.3 5.9 9.5 9.5 0.0 1.4 0.1 2.7 0.1 4.0 1.0 2.3 12.5 2.6 2.6 6.3 16.1 0.3 13.4 8.8 9.7 8.3 1.4 1.5 3.1 3.6 21.7 16.3 0.3 1.3 1.6 21.2 5.2 3.0 0.0 7.4 6.5 8.6 3.9 21.1 7.0 0.6 12.1 10.4 14.2 8.3 15.1 8.1 0.0 15.0 0.7 7.8 2.4 1.0 6.1 6.7 1.4 19.1 0.0 3.4 2.1 1.5 8.6 4.4 2.6 0.1 2.8 0.3 5.5 24.8 16.9 9.8 10.5 8.4 0.0 0.0 0.3 53.7 0.0 8.3 0.1 0.6 0.0 0.5 0.8 1.5 0.0 2.5 1.2 1.1 0.0 4.0 2.3 0.0 0.1 2.7 1.4 0.5 1.0 26.5 22.8 10.8 28.2 31.6 15.6 18.7 15.6 17.6 14.4 0.0 9.6 3.9 15.4 9.4 33.9 7.9 40.8 5.3 4.5 38.4 2.0 3.3 6.6 11.3 2.5 3.0 24.2 0.0 5.9 2.8 11.0 12.4 20.7 11.9 19.7 9.5 8.1 36.8 8.2 1.3 49.5 7.7 10.1 1.8 32.8 43.1 7.2 20.1 45.6 16.8 77.1 25.8 17.0 1.1 1.7 9.2 12.7 24.1 21.3 12.3 PRKCB "PKCB, PRKCB1, PRKCB2" ENSG00000166501 "Protein kinase C beta" P05771 16 23835946-24220611 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.2;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in many" 11 "B-cells: 149.8;Bipolar cells: 172.0;Horizontal cells: 74.7;Kupffer cells: 192.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 41.7;HMC-1: 41.8;K-562: 59.4;THP-1: 18.8;U-937: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003843, HPA048321, HPA054203" Approved Supported Nucleoplasm,Cytosol NA NA 3400000 Nucleoplasm Cytosol "CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416" "unprognostic (1.53e-3)" "unprognostic (4.53e-4)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (1.72e-1)" "unprognostic (7.13e-3)" "unprognostic (2.06e-1)" "unprognostic (1.67e-3)" "unprognostic (3.19e-2)" "unprognostic (1.79e-1)" "unprognostic (7.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.17e-3)" "unprognostic (2.08e-1)" "unprognostic (2.12e-2)" "unprognostic (3.28e-1)" "unprognostic (4.95e-2)" 4.0 1.9 13.9 20.8 55.6 20.4 1.8 14.1 57.2 4.1 4.7 4.4 0.6 4.9 3.5 1.2 3.2 2.6 3.9 1.5 23.4 7.8 1.8 3.7 5.4 31.0 11.0 20.4 1.2 1.4 0.9 1.4 2.5 8.3 6.2 4.4 3.5 1.9 8.4 1.2 4.6 9.1 5.8 7.3 31.2 3.8 6.4 6.4 24.1 3.9 0.0 27.7 7.6 1.7 23.6 18.5 21.8 14.6 20.1 19.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 41.7 2.0 0.0 0.0 6.0 41.8 0.0 0.2 0.0 0.0 0.0 0.0 7.2 59.4 0.1 0.0 0.0 13.1 13.2 0.4 0.0 0.0 12.5 0.1 2.4 0.1 3.6 7.3 0.0 0.0 0.0 0.6 0.2 0.0 18.8 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 16.8 0.0 17.5 7.6 14.4 14.5 10.7 6.7 23.6 9.5 17.2 6.2 22.1 7.8 19.0 21.8 20.1 14.6 18.5 6.7 7.5 13.9 55.6 14.1 57.2 23.4 7.8 11.0 20.4 8.3 6.4 3.0 8.2 149.8 3.5 5.4 172.0 1.7 5.1 2.7 1.2 1.8 2.0 0.1 0.0 0.0 16.3 1.4 1.7 0.0 0.2 0.2 1.3 0.7 69.4 1.6 41.0 74.7 0.0 16.5 192.8 10.0 0.0 22.7 3.3 6.4 0.7 9.9 0.0 9.5 0.4 0.1 7.3 0.0 2.2 3.6 3.7 12.5 0.7 57.5 1.2 4.3 PRKCD ENSG00000163932 "Protein kinase C delta" Q05655 3 53156009-53192717 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5" "Group enriched" "Detected in all" 7 "dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9" "Cell line enhanced" "Detected in all" "SK-BR-3: 64.7;THP-1: 46.1" "Group enriched" "Detected in many" 5 "basal ganglia: 124.2;thalamus: 366.1" "Low region specificity" "Detected in all" "HPA001863, HPA001890, CAB010469, CAB013225" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA 300000 Cytosol "Endoplasmic reticulum, Golgi apparatus" "CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628" "unprognostic (3.59e-1)" "unprognostic (4.85e-2)" "unprognostic (2.66e-2)" "unprognostic (1.90e-1)" "unprognostic (1.17e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.24e-4)" "prognostic favorable (9.01e-4)" "unprognostic (1.95e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.89e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (2.48e-2)" "unprognostic (2.06e-3)" "unprognostic (2.95e-3)" 27.8 33.4 9.4 29.7 11.5 30.3 17.6 5.7 10.7 10.3 27.8 10.1 43.7 21.4 5.5 21.3 18.3 16.1 33.7 11.9 8.3 3.7 16.5 4.5 29.2 24.5 10.2 5.6 8.1 13.4 6.1 5.1 7.5 7.1 17.9 16.1 10.3 14.1 40.7 3.9 17.1 42.9 17.4 10.2 32.1 24.8 9.6 8.0 10.5 26.9 13.4 26.3 22.9 12.7 3.1 17.6 20.7 22.9 2.4 1.5 6.4 7.9 3.0 1.2 2.1 9.2 5.3 11.4 4.8 6.1 5.9 5.8 7.4 7.8 20.4 2.1 10.4 10.3 3.6 8.1 11.8 4.9 17.8 6.1 11.3 4.2 7.9 5.9 14.9 25.7 4.1 8.6 6.1 5.6 5.3 5.1 2.2 2.2 2.9 8.5 19.5 1.6 25.5 3.2 11.9 5.6 1.7 3.1 4.9 6.4 17.0 2.0 1.4 3.6 64.7 9.9 6.3 5.4 46.1 7.4 2.9 3.6 3.8 4.5 4.5 6.9 10.5 6.8 25.8 5.5 17.7 22.9 17.0 1.5 22.2 1.0 3.1 1.1 1.2 17.6 2.9 0.8 0.7 20.7 2.4 15.3 8.5 1.1 6.4 9.4 11.5 5.7 10.7 8.3 3.7 10.2 5.6 7.1 8.0 3.0 19.7 17.6 21.2 26.0 0.0 4.5 12.7 16.0 17.0 14.0 0.0 2.5 3.3 7.6 26.7 1.8 56.8 0.0 9.6 13.5 8.7 14.8 5.7 1.7 38.4 1.6 25.5 3.7 43.0 59.4 8.3 35.2 10.1 21.6 29.0 1.8 10.3 49.1 6.3 10.9 0.0 6.5 9.4 5.2 1.9 24.3 7.3 7.5 20.6 28.8 PRKCE ENSG00000171132 "Protein kinase C epsilon" Q02156 2 45651345-46187990 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.5" "Group enriched" "Detected in many" 5 "Early spermatids: 209.3;Late spermatids: 297.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 19.4;TIME: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001948, HPA008236, HPA044496" Enhanced Supported Supported "Vesicles,Plasma membrane,Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "Vesicles, Plasma membrane" "CAB001948: , HPA008236: , HPA044496: AB_2678959" "unprognostic (1.10e-1)" "unprognostic (1.78e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (9.61e-2)" "unprognostic (5.70e-2)" "unprognostic (1.51e-1)" "prognostic favorable (9.62e-4)" "unprognostic (3.05e-1)" "unprognostic (6.72e-2)" "unprognostic (7.49e-3)" "unprognostic (9.99e-2)" "prognostic favorable (2.63e-7)" "unprognostic (1.21e-1)" "unprognostic (7.11e-2)" "unprognostic (6.43e-3)" "unprognostic (2.23e-2)" 5.5 7.4 15.3 7.2 14.2 9.3 8.1 28.8 36.5 6.6 5.5 3.8 5.9 3.6 5.6 4.6 4.7 7.6 4.7 7.7 22.5 10.0 12.8 15.5 17.5 6.9 6.0 15.0 4.1 4.2 16.3 6.0 10.4 9.1 3.6 4.7 3.7 3.6 8.6 7.2 3.0 3.7 6.2 4.4 4.9 4.4 7.2 3.7 1.5 6.5 1.2 5.4 5.0 6.5 5.5 2.2 1.7 1.4 0.9 1.3 0.6 5.4 2.0 2.9 2.9 4.4 5.2 2.3 3.8 7.0 3.2 3.5 0.5 5.4 8.2 3.6 4.0 4.6 1.3 1.8 2.0 4.6 4.9 3.5 0.0 1.4 1.1 5.0 0.6 2.9 4.6 2.3 4.8 3.5 2.7 11.8 1.8 1.1 2.0 3.7 2.8 2.6 0.3 1.0 3.0 1.0 19.4 13.8 8.8 2.9 3.7 2.0 4.4 1.7 5.8 12.5 1.1 4.7 1.9 19.5 6.3 6.6 4.6 3.8 0.0 0.0 6.9 5.2 4.6 6.3 0.0 1.2 1.7 1.0 0.4 1.1 3.6 0.7 0.7 2.2 5.5 1.3 0.4 0.4 0.9 1.4 0.9 0.0 0.6 15.3 14.2 28.8 33.2 22.5 10.0 6.0 15.0 9.1 3.7 6.0 8.6 20.1 6.3 4.4 47.5 9.3 12.7 22.7 27.3 10.4 13.7 0.3 3.3 3.0 209.3 9.9 4.5 0.0 3.3 6.9 8.0 5.7 6.9 7.3 2.6 11.1 7.5 12.3 17.0 297.3 4.9 11.1 13.5 7.2 5.3 7.0 3.0 3.5 5.6 21.3 6.7 12.9 6.6 2.7 2.2 4.3 2.4 4.3 6.2 7.1 PRKCH "PKC-L, PKCL, PRKCL" ENSG00000027075 "Protein kinase C eta" P24723 14 61187559-61550976 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 56.0;Erythroid cells: 70.0;Ito cells: 55.9;T-cells: 137.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6" "Group enriched" "Detected in many" 14 "NK-cells: 27.3;T-cells: 35.3" "Cell line enhanced" "Detected in many" "BEWO: 30.4;HUVEC TERT2: 39.9;MOLT-4: 26.5;RT4: 16.8;TIME: 26.1" "Group enriched" "Detected in many" 6 "basal ganglia: 25.0;thalamus: 19.5" "Low region specificity" "Detected in many" "HPA026294, HPA053709" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA026294: AB_10603988, HPA053709: AB_2682237" "unprognostic (1.42e-1)" "unprognostic (3.89e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-3)" "unprognostic (1.04e-1)" "prognostic favorable (8.55e-6)" "unprognostic (1.14e-2)" "unprognostic (2.97e-2)" "unprognostic (4.14e-1)" "unprognostic (1.94e-1)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (6.98e-2)" "unprognostic (4.73e-3)" 17.5 5.4 5.0 21.6 22.0 11.2 14.7 2.8 6.1 13.6 10.3 6.2 6.9 5.1 19.1 7.0 20.1 8.6 12.7 10.1 6.8 4.4 8.1 5.5 24.1 27.6 5.9 2.5 7.1 5.9 8.8 15.5 22.7 7.2 9.8 5.0 9.1 24.7 10.8 9.1 15.9 16.0 10.5 5.7 25.9 6.0 4.3 6.4 54.6 15.1 10.6 34.6 13.2 14.4 0.4 2.2 1.5 0.7 27.3 35.3 17.9 6.4 2.2 0.3 1.7 1.0 0.2 30.4 0.1 0.5 0.3 0.3 0.7 3.8 0.1 4.6 0.0 0.6 4.4 0.2 4.9 0.5 0.8 2.9 0.0 0.7 0.2 0.4 0.0 0.9 0.8 5.1 0.2 3.5 0.4 39.9 12.9 0.0 0.1 2.3 11.7 26.5 0.2 0.5 4.6 3.1 2.2 1.1 0.0 0.0 16.8 1.1 1.9 0.7 5.9 3.6 5.6 5.8 0.5 26.1 0.7 5.2 0.8 0.3 0.5 0.1 0.2 1.1 0.4 1.3 0.1 0.7 0.5 30.0 0.4 23.9 0.4 23.0 35.3 2.2 0.3 28.5 27.6 1.5 27.3 0.2 0.7 18.6 17.9 5.0 22.0 2.8 6.1 6.8 4.4 5.9 2.5 7.2 6.4 6.0 10.7 4.6 15.8 16.7 0.2 3.9 10.2 10.7 18.2 0.0 0.0 23.4 3.3 4.6 25.5 56.0 1.7 70.0 5.9 16.9 3.7 13.1 1.1 1.0 5.6 0.0 11.3 55.9 11.1 3.6 1.7 9.0 15.1 5.4 2.6 9.3 4.4 2.9 6.3 0.8 0.3 0.0 4.1 0.0 2.1 23.3 40.4 137.1 0.7 24.4 PRKCI "DXS1179E, PKCI" ENSG00000163558 "Protein kinase C iota" P41743 3 170222365-170305981 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026574, HPA038635" Approved Supported "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA026574: AB_1855428, HPA038635: AB_2676124" "unprognostic (2.26e-1)" "unprognostic (6.75e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (3.93e-6)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.52e-1)" "unprognostic (7.10e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (5.32e-3)" "prognostic favorable (3.10e-4)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" 10.3 7.5 11.4 5.9 15.5 2.1 9.5 14.8 16.6 12.5 11.1 7.0 6.0 10.4 13.1 8.4 20.6 15.1 10.5 10.1 9.5 7.7 13.0 6.7 14.8 3.9 5.6 9.4 15.2 7.7 12.4 14.7 9.8 11.0 16.3 12.2 7.3 25.8 12.6 12.7 11.0 11.6 12.5 6.8 6.1 30.2 15.0 5.3 12.6 23.1 8.4 9.9 16.3 13.0 1.9 1.8 1.0 1.3 5.8 4.8 1.4 34.3 8.7 8.8 9.4 7.8 10.9 14.2 8.8 13.0 11.7 12.7 12.7 16.8 10.5 29.1 12.3 16.1 16.1 16.5 17.3 20.1 7.6 10.2 9.7 11.0 7.0 12.4 8.7 4.4 9.8 12.1 10.0 15.7 19.0 9.1 5.8 10.7 8.7 11.7 11.8 12.6 3.4 18.4 36.7 9.7 9.2 13.5 17.3 18.4 10.5 14.0 11.4 19.0 25.0 8.6 13.6 27.5 6.0 9.6 12.2 9.4 11.4 14.5 15.0 14.4 15.0 8.8 6.9 4.7 0.1 1.3 1.0 2.6 1.2 4.0 1.8 3.6 4.8 1.8 1.9 3.9 2.2 0.7 5.8 1.1 1.8 2.3 1.4 11.4 15.5 14.8 16.6 9.5 7.7 5.6 9.4 11.0 5.3 68.5 56.0 2.2 46.0 50.7 15.9 14.9 25.5 22.7 46.6 47.1 13.7 23.8 21.6 13.9 5.5 18.0 21.2 0.0 19.5 22.1 25.6 78.7 8.1 17.8 8.9 14.3 28.2 16.5 20.8 3.6 21.6 10.0 16.9 6.4 28.1 8.1 36.5 17.5 26.9 15.1 9.3 19.4 11.4 12.9 15.1 55.7 17.3 5.7 27.7 69.1 PRKCZ PKC2 ENSG00000067606 "Protein kinase C zeta" Q05513 1 2050470-2185395 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.6;placenta: 93.0" "Group enriched" "Detected in many" 4 "Late spermatids: 539.8;Syncytiotrophoblasts: 926.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 15.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Cell line enhanced" "Detected in many" "BEWO: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021851 Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA021851: AB_1855433" "unprognostic (1.25e-2)" "unprognostic (2.61e-1)" "unprognostic (5.10e-2)" "unprognostic (1.14e-2)" "unprognostic (2.08e-1)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (5.13e-2)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "prognostic favorable (1.64e-9)" "unprognostic (3.57e-2)" "unprognostic (3.27e-2)" "unprognostic (1.39e-1)" "unprognostic (7.85e-2)" 1.2 7.8 15.9 3.0 31.8 1.4 3.9 39.8 43.6 3.2 8.6 17.1 2.3 20.0 1.7 5.5 10.1 6.5 3.1 6.4 15.5 6.4 11.3 6.8 22.3 5.0 12.2 23.6 1.9 8.5 9.8 12.0 93.0 27.3 5.8 7.5 2.6 7.0 3.0 0.4 8.8 18.4 1.2 8.4 6.9 6.1 17.5 13.5 0.6 14.1 0.9 5.0 4.0 4.6 0.4 0.3 15.0 0.3 0.8 2.6 0.3 7.3 4.7 1.7 8.7 0.0 0.0 23.0 0.5 0.2 5.5 0.3 11.9 16.0 0.0 14.6 1.8 4.8 12.9 9.9 12.3 3.9 0.5 11.0 0.0 7.6 15.8 1.6 0.0 5.7 0.3 7.4 0.0 4.2 0.0 0.0 1.9 3.2 0.1 0.1 9.0 0.4 0.0 3.3 20.2 11.4 0.0 0.0 2.5 9.4 7.8 12.0 9.7 6.0 13.4 2.5 14.9 9.4 2.0 0.0 0.0 6.9 0.0 0.0 3.5 0.6 0.1 0.6 0.1 8.3 0.3 0.0 15.0 0.6 0.3 2.6 0.3 1.0 0.6 0.0 0.4 0.8 0.4 1.2 0.8 0.0 0.3 0.8 0.3 15.9 31.8 39.8 43.6 15.5 6.4 12.2 23.6 27.3 13.5 113.2 71.1 0.8 10.2 11.6 22.8 1.2 2.5 21.4 26.1 7.0 3.9 84.1 6.6 10.9 181.6 6.0 56.7 0.0 9.3 48.8 3.1 16.4 8.1 12.5 12.7 58.8 9.8 6.7 1.0 539.8 8.9 3.3 6.8 5.4 22.1 15.6 12.2 31.6 8.1 19.0 21.6 0.0 2.2 15.8 26.8 11.7 926.6 7.7 25.3 11.9 PRKD1 "PKC-mu, PKCM, PKD, PRKCM" ENSG00000184304 "Protein kinase D1" Q15139 14 29576479-30191898 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 24.9;Early spermatids: 31.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 18.2;fHDF/TERT166: 19.3;HSkMC: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018367, HPA029834" Uncertain Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" Cytosol "CAB018367: AB_2253119, HPA029834: AB_10602821" "unprognostic (5.35e-2)" "unprognostic (3.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.70e-2)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-3)" "unprognostic (8.88e-2)" "unprognostic (2.37e-2)" "unprognostic (5.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.56e-1)" "prognostic favorable (2.44e-5)" "unprognostic (9.45e-4)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (3.89e-1)" 7.4 10.6 8.0 5.3 9.7 0.7 19.0 4.9 8.9 5.1 8.7 5.1 24.1 3.1 8.3 9.0 3.5 6.8 9.0 6.3 9.8 5.9 15.1 2.3 14.9 1.6 5.6 6.6 15.7 7.3 35.7 9.2 4.5 10.8 20.1 3.5 4.9 3.5 24.4 3.1 2.7 3.5 19.7 16.4 2.4 4.8 16.1 8.6 0.5 8.2 2.9 1.8 14.1 12.2 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.6 4.1 18.2 17.0 0.1 12.3 9.5 12.6 6.8 0.0 0.5 0.0 1.2 19.3 4.3 0.1 6.0 1.4 6.9 0.0 4.2 0.0 0.1 0.4 9.2 0.0 0.1 18.0 0.6 0.9 1.5 6.5 2.5 0.0 1.2 0.4 11.8 1.4 0.0 0.0 2.5 0.0 6.4 0.0 7.1 3.2 13.5 5.7 3.6 7.2 2.1 0.0 4.7 4.9 0.0 0.1 6.4 12.0 4.9 1.0 3.5 0.0 0.0 0.0 3.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 8.0 9.7 4.9 8.9 9.8 5.9 5.6 6.6 10.8 8.6 0.0 6.1 0.0 3.8 0.5 1.2 1.4 7.6 0.0 0.0 12.2 5.9 0.0 24.9 1.5 31.1 4.5 0.0 23.3 3.6 0.1 3.8 16.3 0.0 1.5 0.2 1.6 2.9 12.3 2.6 12.4 6.9 0.3 6.8 0.0 0.2 16.1 3.2 0.0 12.0 3.7 2.8 0.0 4.7 3.4 4.9 0.6 0.2 0.0 0.0 0.9 PRKD2 "DKFZP586E0820, HSPC187, PKD2" ENSG00000105287 "Protein kinase D2" Q9BZL6 19 46674275-46717127 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Cell adhesion, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/84: 58.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021490, HPA056727" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021490: AB_1855708, HPA056727: AB_2683217" "unprognostic (3.01e-2)" "unprognostic (1.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.06e-2)" "unprognostic (8.91e-2)" "unprognostic (1.99e-2)" "unprognostic (8.79e-3)" "unprognostic (2.61e-1)" "unprognostic (6.22e-2)" "unprognostic (4.21e-3)" "unprognostic (8.89e-2)" "unprognostic (2.74e-1)" "unprognostic (3.45e-3)" "unprognostic (1.04e-2)" "unprognostic (7.19e-2)" "unprognostic (4.34e-2)" "prognostic favorable (9.15e-4)" 17.1 7.6 7.0 25.8 6.5 18.1 18.0 2.5 6.8 16.8 13.7 5.8 18.7 13.7 14.8 16.5 23.4 15.6 17.4 7.4 6.3 3.1 13.2 9.1 21.3 24.8 7.5 2.7 17.0 12.5 10.3 17.2 20.1 6.6 14.8 7.7 11.9 15.6 21.5 7.5 26.8 19.8 11.7 6.8 34.8 15.2 6.6 7.2 41.5 18.7 10.5 33.0 17.4 37.5 6.6 0.4 7.3 1.0 2.9 6.1 1.9 8.8 13.7 5.4 6.6 4.5 3.6 7.0 4.6 7.3 9.6 10.6 7.6 8.6 10.3 8.1 6.1 5.2 13.2 4.8 12.3 3.0 8.7 7.1 10.8 4.2 3.9 6.0 7.9 16.1 4.4 6.0 5.5 4.7 7.2 16.9 9.7 6.9 14.9 3.9 9.3 15.1 25.6 4.6 12.8 7.0 9.9 2.6 16.7 5.9 13.2 3.5 11.0 8.6 7.2 1.8 5.9 5.7 3.1 8.0 4.1 8.2 3.4 3.7 14.6 58.2 5.1 4.3 6.5 4.3 0.9 1.0 3.4 5.6 0.9 4.9 6.1 5.7 6.1 0.4 6.6 5.1 4.9 7.3 2.9 0.7 0.0 4.0 1.9 7.0 6.5 2.5 6.8 6.3 3.1 7.5 2.7 6.6 7.2 8.9 13.5 45.5 26.8 19.6 5.8 11.5 17.8 4.0 10.3 8.7 0.0 11.1 6.6 16.0 0.9 29.2 30.9 23.3 24.3 11.4 10.0 21.5 13.9 7.3 7.7 1.6 20.7 36.2 12.7 2.4 10.9 7.2 11.8 5.4 17.7 6.1 22.1 24.6 6.3 7.1 4.5 12.9 5.9 2.8 15.8 23.3 24.8 23.0 11.2 24.6 PRKD3 "EPK2, PRKCN" ENSG00000115825 "Protein kinase D3" O94806 2 37250502-37324808 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029529 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029529: AB_10602082" "unprognostic (1.39e-1)" "unprognostic (7.34e-2)" "prognostic favorable (4.84e-4)" "unprognostic (1.23e-2)" "unprognostic (5.61e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.10e-1)" "unprognostic (1.16e-1)" "unprognostic (2.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.81e-1)" "unprognostic (7.62e-3)" "unprognostic (2.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.35e-1)" 16.1 22.1 9.5 20.7 10.7 5.3 35.1 4.8 9.2 17.2 18.0 7.2 7.2 6.0 19.2 16.0 9.8 11.3 10.0 11.6 12.7 6.1 9.9 8.4 20.4 22.3 11.4 3.7 15.0 7.6 12.9 20.7 11.1 10.3 14.4 8.3 27.8 11.1 13.3 19.1 11.5 12.1 16.5 15.4 22.0 10.5 16.8 10.8 16.2 11.8 9.3 21.2 12.4 17.7 16.4 8.2 5.7 8.3 6.3 11.5 3.4 12.8 5.4 14.5 11.9 11.1 18.6 10.6 8.3 15.5 9.4 9.6 8.7 4.5 18.8 7.0 12.4 14.1 5.1 9.8 10.2 12.7 24.3 14.4 12.4 8.4 5.8 4.5 8.8 7.6 8.8 5.2 14.9 9.8 8.7 16.7 6.3 10.4 23.2 10.9 2.1 3.8 6.9 15.3 0.1 5.3 13.0 22.9 16.1 6.2 14.4 10.9 28.3 8.0 4.6 48.8 7.8 4.9 8.1 16.1 27.0 14.0 10.7 9.3 26.5 49.1 22.0 9.4 3.7 16.2 5.7 8.3 5.5 10.5 6.6 9.1 12.4 8.8 8.4 7.8 16.4 10.4 11.5 1.5 6.3 3.3 8.2 4.1 3.4 9.5 10.7 4.8 9.2 12.7 6.1 11.4 3.7 10.3 10.8 38.7 16.2 38.3 20.7 33.7 29.6 7.1 15.3 5.3 13.6 17.4 64.8 9.1 3.3 10.9 42.2 44.7 5.4 0.0 9.0 28.2 34.8 27.0 77.1 11.3 11.1 41.3 18.1 38.1 28.4 78.9 31.1 24.5 47.2 12.6 6.1 16.0 12.3 3.5 29.0 7.1 110.0 25.8 26.9 56.0 44.5 20.8 8.1 27.4 11.0 32.3 PRKG1 "PGK, PKG, PRKG1B, PRKGR1B" ENSG00000185532 "Protein kinase, cGMP-dependent, type I" Q13976 10 50990891-52298350 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 43.8;Late spermatids: 40.9;Peritubular cells: 37.1;Sertoli cells: 38.8;Smooth muscle cells: 47.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "basophil: 8.0" "Lineage enriched" "Detected in single" 24 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "AN3-CA: 11.6;BJ hTERT+: 15.9;fHDF/TERT166: 13.1;U-138 MG: 9.7;U-87 MG: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007699, CAB009629" Enhanced Approved Vesicles,Cytosol NA NA 33000 "Vesicles, Cytosol" "CAB009629: AB_2170663, HPA007699: AB_1079677" "unprognostic (3.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.44e-2)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (5.54e-1)" "unprognostic (2.23e-1)" "unprognostic (4.94e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (3.40e-1)" "unprognostic (9.26e-2)" "unprognostic (5.50e-3)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (3.78e-4)" 8.0 10.9 5.2 6.6 7.3 0.8 6.9 2.8 5.4 19.2 14.4 2.1 6.8 2.9 22.8 10.7 6.0 9.9 12.6 14.8 7.0 4.9 4.4 2.1 19.5 2.6 3.1 4.8 8.9 2.6 13.7 8.4 11.0 4.6 9.5 6.2 6.2 6.4 9.4 24.9 2.8 5.3 28.2 2.7 2.7 5.9 5.0 3.1 0.2 9.2 12.7 1.2 13.4 15.8 0.1 0.1 8.0 0.1 0.3 0.0 0.1 0.0 0.1 1.5 11.6 5.6 5.3 0.0 5.0 15.9 1.6 2.4 0.1 0.8 0.2 0.0 13.1 1.7 0.1 0.0 0.0 1.5 0.0 4.3 0.8 0.3 0.0 4.8 0.0 0.0 6.8 0.0 4.2 0.1 0.4 0.0 0.0 0.0 0.1 4.4 0.1 0.0 0.0 3.3 0.0 2.0 0.0 3.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.1 1.6 0.1 0.0 0.0 9.7 1.7 4.9 2.9 1.2 0.6 0.0 8.6 0.0 2.0 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.1 5.2 7.3 2.8 5.4 7.0 4.9 3.1 4.8 4.6 3.1 14.9 9.6 0.0 1.4 0.8 6.8 29.7 0.0 1.4 0.0 3.5 0.0 0.8 0.0 1.8 43.8 3.7 2.6 0.0 3.3 0.9 13.0 0.4 4.6 0.0 0.3 0.0 0.0 4.3 0.0 40.9 30.2 0.3 3.3 0.0 4.3 23.0 3.5 11.4 37.1 0.0 1.3 38.8 47.0 0.7 0.6 0.5 1.8 0.0 3.2 0.7 PRKN "AR-JP, PARK2, parkin, PDJ" ENSG00000185345 "Parkin RBR E3 ubiquitin protein ligase" O60260 6 161347420-162727771 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 41.8" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.4;Distal tubular cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.7;HEL: 9.2;Karpas-707: 5.9;RPMI-8226: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016257, HPA036012" Enhanced Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB016257: AB_628104, HPA036012: AB_2732471" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (6.48e-2)" "unprognostic (2.69e-3)" "unprognostic (9.85e-2)" "unprognostic (5.85e-2)" "unprognostic (7.07e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" "unprognostic (1.03e-3)" "unprognostic (8.16e-2)" "prognostic favorable (6.75e-12)" "unprognostic (9.93e-2)" "unprognostic (1.51e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-1)" 6.8 7.1 7.9 2.3 12.2 1.5 4.2 7.2 13.4 5.3 4.3 6.3 4.6 2.8 7.8 4.4 6.1 3.4 4.3 17.7 9.2 6.2 17.4 3.6 2.6 3.0 5.8 5.2 6.4 3.0 5.6 8.6 2.0 5.5 4.0 2.4 8.3 3.5 4.8 41.8 4.0 3.3 6.6 5.9 2.7 3.5 10.3 6.8 0.6 3.8 4.7 2.7 4.9 2.1 4.6 1.2 4.2 0.8 1.8 4.6 1.3 0.1 0.3 1.3 3.7 0.9 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.2 0.0 0.9 0.0 0.2 0.2 0.0 0.4 0.6 9.2 0.2 0.0 0.9 0.2 0.1 3.2 0.1 0.0 0.5 0.6 0.0 0.4 0.4 5.9 1.0 0.5 0.1 0.1 0.2 0.6 0.9 0.0 0.0 5.9 0.7 0.1 1.0 2.5 0.0 0.0 0.3 1.2 0.0 0.6 0.0 0.1 0.3 0.1 0.3 0.8 0.1 0.0 0.1 0.2 2.2 2.8 0.8 4.2 2.1 0.5 3.5 1.5 2.0 2.2 1.2 4.6 4.4 4.6 1.5 1.8 0.4 0.3 0.2 1.3 7.9 12.2 7.2 11.7 9.2 6.2 5.8 5.2 5.5 6.8 8.9 7.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 0.4 16.6 0.8 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PRKRA "DYT16, HSD14, PACT, RAX" ENSG00000180228 "Protein activator of interferon induced protein kinase EIF2AK2" O75569 2 178431414-178451512 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, RNA-mediated gene silencing" RNA-binding "Disease mutation, Dystonia, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 249.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004648, HPA034996, HPA034997" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (5.38e-2)" "unprognostic (4.02e-3)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (8.33e-5)" "unprognostic (9.66e-2)" "unprognostic (7.10e-3)" "unprognostic (2.32e-3)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (2.16e-3)" "unprognostic (8.99e-2)" "prognostic favorable (5.45e-4)" "unprognostic (1.38e-1)" "unprognostic (6.78e-2)" 15.7 14.5 18.3 11.3 20.3 13.0 31.2 17.1 30.9 15.7 18.7 16.9 10.8 11.0 18.0 19.4 16.6 13.9 13.1 22.2 17.4 17.5 18.0 14.5 13.7 12.1 18.3 17.2 14.9 19.8 17.4 21.5 8.7 18.8 17.4 14.8 13.2 13.8 18.1 55.3 18.2 10.9 33.1 20.2 9.4 15.2 23.5 15.7 13.8 16.7 14.8 14.1 18.5 17.7 19.4 29.2 13.5 13.9 13.5 20.1 16.4 11.0 8.5 25.1 12.3 23.2 26.6 19.8 17.1 16.7 21.6 23.6 23.6 15.9 22.7 19.4 19.6 16.2 10.4 19.6 13.5 24.1 20.2 12.8 14.0 10.2 22.5 27.0 11.0 7.7 15.3 31.1 20.3 22.7 22.7 20.5 18.6 12.8 19.4 29.2 11.6 21.4 28.1 22.8 18.4 17.2 18.9 42.1 22.9 24.3 12.6 15.7 19.7 11.1 10.9 22.2 20.7 15.2 14.3 11.8 18.1 20.5 16.4 14.2 26.8 16.7 27.6 21.0 16.8 10.6 3.1 13.9 13.5 11.0 13.5 15.9 19.4 17.2 13.4 19.9 15.3 19.5 15.9 3.7 13.5 13.2 29.2 20.1 16.4 18.3 20.3 17.1 30.9 17.4 17.5 18.3 17.2 18.8 15.7 14.9 30.2 31.4 76.5 56.0 47.4 39.5 17.8 16.0 18.2 24.4 41.2 34.1 106.1 43.4 109.2 28.7 17.6 0.0 36.9 43.7 38.9 66.8 27.7 15.8 28.1 9.5 46.0 22.1 18.4 249.4 36.5 30.4 65.8 41.5 33.8 31.0 32.9 21.0 35.0 60.8 77.6 45.3 75.2 62.1 50.4 68.5 36.3 27.3 35.9 56.5 PRKRIP1 "C114, FLJ13902, KRBOX3" ENSG00000128563 "PRKR interacting protein 1" Q9H875 7 102363872-102426676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051146 Uncertain Supported "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA051146: AB_2681361" "unprognostic (4.78e-3)" "unprognostic (7.23e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (8.25e-2)" "unprognostic (2.99e-3)" "unprognostic (3.15e-2)" "unprognostic (1.99e-2)" "unprognostic (4.38e-3)" "unprognostic (1.57e-3)" "unprognostic (1.50e-2)" "unprognostic (2.61e-3)" "unprognostic (9.79e-3)" "prognostic unfavorable (4.39e-4)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" "unprognostic (4.88e-1)" "prognostic favorable (1.94e-4)" 14.9 19.3 20.1 21.1 22.6 31.0 15.2 28.0 23.0 15.9 14.0 19.2 24.2 14.9 17.6 20.4 15.0 16.2 13.9 16.5 19.0 21.2 16.7 12.3 14.6 22.4 19.1 20.3 18.9 17.0 26.6 18.9 18.1 17.9 17.7 11.6 17.1 21.5 17.8 20.7 27.0 14.5 16.6 20.1 19.1 14.6 43.7 19.0 15.8 16.8 12.4 19.6 14.1 14.4 15.3 18.5 21.7 15.7 14.7 15.1 10.7 12.8 8.9 11.0 13.9 6.5 5.7 10.6 9.8 8.3 14.7 13.9 12.2 12.6 11.9 16.8 7.8 11.8 11.3 7.0 8.6 9.3 13.7 13.0 5.9 9.8 9.0 10.0 9.0 8.1 5.4 9.0 11.9 8.7 9.2 8.3 12.2 14.1 27.3 11.3 26.7 23.0 27.9 11.0 10.9 9.1 15.3 9.1 19.2 8.0 8.8 9.0 17.8 15.5 21.5 13.1 10.0 10.3 11.4 9.3 16.9 16.4 19.0 12.7 23.8 19.5 22.9 12.5 14.3 20.4 5.3 12.7 20.1 13.8 12.4 13.0 15.3 13.1 14.2 8.1 15.1 15.1 14.1 21.7 14.7 15.7 18.5 13.4 10.7 20.1 22.6 28.0 20.8 19.0 21.2 19.1 20.3 17.9 19.0 29.8 17.9 24.4 16.5 11.8 21.4 19.9 20.4 34.8 27.3 15.7 29.5 23.5 26.6 20.9 55.7 18.0 11.8 23.3 21.7 24.1 15.5 18.3 22.0 12.3 24.0 22.3 15.6 11.6 8.5 62.4 15.8 16.9 11.8 25.2 11.4 21.7 24.2 10.5 15.6 22.1 19.4 32.3 17.0 45.4 43.5 15.4 35.0 21.3 9.8 15.3 PRM1 CT94.1 ENSG00000175646 "Protamine 1" P04553 16 11280836-11281350 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 125 "testis: 747.3" "Group enriched" "Detected in some" 154 "Early spermatids: 123959.8;Late spermatids: 465852.4" "Cancer enriched" "Detected in single" 161 "testis cancer: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Hep G2: 1.1;NB-4: 6.0;U-2197: 4.5;U-698: 2.0" "HPA055150, HPA059371" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055150: AB_2682718, HPA059371: " "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 747.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123959.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 465852.4 1718.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1588.2 0.0 0.0 1138.3 0.0 1916.0 855.6 0.0 0.0 0.0 0.0 0.0 PRMT2 "HRMT1L1, MGC111373" ENSG00000160310 "Protein arginine methyltransferase 2" P55345 21 46635167-46665124 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018976, HPA029591" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA018976: AB_1855719, HPA029591: AB_10601250" "unprognostic (1.82e-1)" "unprognostic (2.96e-1)" "unprognostic (8.61e-3)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (1.58e-2)" "unprognostic (1.29e-3)" "unprognostic (1.34e-1)" "unprognostic (2.23e-1)" "unprognostic (6.78e-2)" "unprognostic (4.34e-3)" "unprognostic (1.72e-1)" "unprognostic (4.62e-3)" "unprognostic (8.76e-3)" "unprognostic (2.86e-2)" "unprognostic (1.91e-3)" "unprognostic (2.23e-1)" 19.9 14.7 37.1 21.8 43.6 18.7 28.4 21.4 37.2 25.5 25.2 35.4 12.0 14.7 24.5 15.9 30.7 27.1 23.4 29.4 37.4 53.1 19.9 8.5 21.7 28.7 44.8 32.2 48.5 15.1 19.9 20.1 26.2 44.9 22.0 17.1 20.6 21.0 28.0 9.5 28.1 20.0 28.5 69.6 25.6 17.4 10.1 40.3 13.8 20.1 7.4 28.3 23.1 26.0 18.9 27.6 64.2 26.1 50.8 60.2 41.6 22.7 19.5 39.5 14.7 28.9 28.2 9.7 21.5 24.2 24.4 22.4 27.4 18.6 13.4 27.4 38.3 33.3 6.7 18.4 27.1 14.2 33.4 17.7 34.7 16.5 20.4 14.0 10.3 16.5 17.4 27.0 29.6 21.2 27.4 35.3 19.2 22.0 25.2 37.3 25.5 14.8 19.4 21.7 14.5 23.1 19.1 10.0 8.8 19.0 19.5 28.6 17.8 22.7 10.4 41.1 6.1 14.0 10.7 31.8 23.9 16.4 12.7 14.1 6.7 6.1 8.5 21.9 28.1 34.5 44.2 19.6 64.2 60.2 26.0 43.6 18.9 40.5 51.0 27.6 16.7 49.9 56.9 26.3 50.8 26.1 23.8 29.0 41.6 37.1 43.6 21.4 37.2 37.4 53.1 44.8 32.2 44.9 40.3 86.4 33.4 59.7 59.7 41.0 46.0 58.2 71.4 75.0 52.4 71.5 27.5 55.8 76.3 68.8 2.4 76.8 42.4 23.3 45.8 37.4 57.5 64.0 111.2 26.7 91.9 35.0 34.3 129.5 113.7 5.6 51.5 104.6 82.7 214.6 26.3 44.1 63.8 35.4 58.4 73.2 53.9 64.7 66.1 20.2 31.9 39.4 57.9 132.0 32.2 56.9 PRMT5 "HRMT1L5, SKB1, SKB1Hs" ENSG00000100462 "Protein arginine methyltransferase 5" O14744 14 22920511-22929585 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005525, CAB012459, HPA064708" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330" "unprognostic (8.34e-2)" "unprognostic (5.14e-3)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (4.56e-3)" "prognostic unfavorable (1.82e-4)" "prognostic unfavorable (4.77e-5)" "unprognostic (3.64e-2)" "unprognostic (6.80e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.69e-2)" "unprognostic (1.99e-3)" "unprognostic (1.21e-1)" "unprognostic (7.04e-2)" "unprognostic (6.28e-2)" "prognostic unfavorable (1.04e-4)" 17.0 21.6 18.3 17.8 22.8 12.0 21.2 18.4 24.9 20.3 25.0 18.1 24.9 16.1 24.9 19.6 33.1 28.0 16.6 22.3 15.3 13.2 25.7 22.2 15.8 15.6 17.2 15.2 30.2 30.9 30.8 17.4 24.3 15.9 21.1 22.6 16.9 19.0 21.7 42.0 21.7 14.5 22.2 13.4 17.9 19.5 22.1 17.3 22.7 30.9 19.6 22.1 20.8 22.0 17.6 23.8 4.3 17.6 9.8 15.6 15.5 40.7 39.4 28.5 28.2 13.6 15.5 31.1 28.1 20.9 43.6 37.0 36.0 37.9 39.8 23.0 20.7 25.9 32.6 56.4 47.2 50.5 25.5 27.2 24.7 26.6 55.3 26.1 51.8 21.6 15.2 25.2 33.7 61.6 17.8 20.6 31.8 35.0 21.8 22.5 36.8 37.1 23.2 25.5 35.5 49.8 43.8 34.5 28.9 21.2 28.0 30.7 20.1 30.7 32.9 14.3 25.5 22.2 19.6 19.3 18.5 26.4 26.3 35.8 29.9 63.7 52.9 11.7 25.2 28.9 1.7 16.8 0.2 8.2 17.6 13.4 17.6 11.3 13.5 23.8 15.5 15.6 12.5 4.3 9.8 13.2 14.1 9.4 15.5 18.3 22.8 18.4 24.9 15.3 13.2 17.2 15.2 15.9 17.3 17.9 10.8 4.5 23.8 23.6 9.5 0.8 28.1 26.8 11.4 7.0 7.9 33.6 19.9 25.6 1.9 11.2 6.3 0.0 23.3 26.7 18.6 11.3 6.9 15.5 17.4 15.9 5.8 11.1 4.9 2.7 15.3 10.4 25.3 11.8 15.7 19.1 60.5 8.6 19.8 18.4 7.5 6.5 27.8 34.9 54.7 24.3 27.9 10.1 19.0 16.8 PRMT9 "FLJ46629, PRMT10" ENSG00000164169 "Protein arginine methyltransferase 9" Q6P2P2 4 147637785-147684230 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 79.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036844, HPA042537" Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Microtubules "Nucleoplasm, Cytosol" "HPA036844: AB_10672341, HPA042537: AB_2678043" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" "unprognostic (4.65e-3)" "unprognostic (2.35e-1)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (4.14e-2)" "unprognostic (7.29e-2)" "unprognostic (2.11e-2)" "unprognostic (2.33e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.72e-1)" "unprognostic (4.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.30e-2)" 6.0 17.2 6.0 5.2 8.6 12.4 6.9 8.0 8.9 5.6 4.5 4.2 7.9 2.5 8.6 7.6 5.0 7.5 8.4 6.5 5.6 5.0 7.5 5.8 7.6 5.3 5.8 5.3 22.6 7.2 16.3 10.0 5.0 7.1 6.0 4.5 9.8 5.8 11.3 6.7 5.6 4.3 6.1 4.6 4.5 5.9 11.2 3.9 11.6 15.8 2.8 5.4 5.5 5.2 9.6 6.0 10.8 6.1 5.1 10.4 2.7 3.5 2.3 5.7 4.3 4.4 7.6 5.0 3.9 6.3 6.0 6.4 1.8 4.0 12.3 1.8 3.4 3.1 2.5 6.7 3.4 8.3 4.4 3.9 6.8 4.5 3.0 3.3 9.8 3.8 5.2 3.5 3.7 3.3 4.9 5.0 6.2 6.7 7.2 5.1 2.0 8.3 3.9 2.9 3.4 4.3 5.6 4.8 4.5 4.9 2.8 3.5 5.4 6.3 5.0 3.2 3.9 2.1 2.2 4.2 3.9 3.1 4.3 4.3 8.2 6.5 8.1 4.3 6.1 2.8 7.4 6.0 10.8 6.7 6.1 6.5 9.5 8.1 8.2 4.0 9.6 10.4 9.0 4.2 5.1 4.4 6.0 6.8 2.7 6.0 8.6 8.0 8.9 5.6 5.0 5.8 5.3 7.1 3.9 0.0 7.7 61.1 2.9 0.0 54.5 5.5 7.6 2.7 1.2 33.2 106.0 12.1 5.0 5.9 58.8 4.3 5.9 0.0 5.8 8.6 8.5 4.1 34.5 5.7 15.3 47.7 16.7 12.3 31.0 9.5 16.7 14.9 0.0 9.0 4.8 26.9 5.9 3.6 15.9 3.3 79.2 12.9 4.6 29.1 14.0 0.0 12.7 30.5 4.7 1.4 PRNP "AltPrP, CD230, CJD, GSS, PRIP, PRP" ENSG00000171867 "Prion protein" P04156 20 4686236-4701590 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" Prion "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 366.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 108.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 108.1" "Cell line enhanced" "Detected in many" "WM-115: 116.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042754, HPA043398" Enhanced Approved "Nuclear membrane,Vesicles,Cytosol" "Intracellular and membrane" NA NA 2200000 "Nuclear membrane, Cytosol" Vesicles "HPA042754: AB_10964203, HPA043398: AB_2678461" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.96e-4)" "prognostic unfavorable (4.64e-4)" "prognostic unfavorable (2.52e-4)" "unprognostic (1.94e-2)" "prognostic unfavorable (7.41e-5)" "unprognostic (7.60e-3)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (3.44e-1)" "unprognostic (1.04e-1)" "unprognostic (6.75e-2)" "unprognostic (7.28e-3)" "unprognostic (3.37e-1)" "unprognostic (2.04e-1)" "unprognostic (1.69e-2)" 24.6 27.3 63.4 14.2 73.1 19.8 30.5 87.5 116.1 42.0 43.4 61.6 8.5 10.6 36.3 17.7 23.0 24.1 31.4 54.1 64.6 48.9 38.5 22.2 22.2 14.7 47.2 65.6 49.6 11.8 20.7 24.9 18.7 71.6 43.8 20.9 34.1 17.1 45.0 21.8 26.7 13.5 40.8 53.1 20.3 18.1 19.1 51.4 2.9 25.6 11.8 16.4 27.0 22.3 4.6 10.5 108.1 11.7 3.6 16.7 10.0 24.6 20.3 4.6 7.2 37.9 23.2 4.1 40.8 58.9 19.8 20.2 6.7 19.1 4.5 9.5 79.5 44.9 57.4 5.1 55.6 37.2 3.7 4.4 0.0 2.3 21.0 46.6 8.0 1.8 21.0 80.2 84.7 66.2 29.2 17.0 3.3 2.4 16.0 22.8 5.5 3.1 4.9 3.8 10.8 30.2 3.8 12.4 4.1 9.9 4.4 5.5 0.8 11.6 16.2 58.0 6.7 3.3 4.2 25.5 32.3 14.8 18.0 33.2 7.4 14.9 15.0 26.0 5.9 116.2 108.1 11.7 0.8 11.9 9.7 16.7 4.2 9.8 9.4 10.5 4.6 5.8 6.8 0.7 3.6 7.6 3.7 11.4 10.0 63.4 73.1 87.5 90.4 64.6 48.9 47.2 65.6 71.6 51.4 74.5 42.1 34.0 181.6 366.5 230.5 189.4 33.1 26.8 70.5 31.4 110.0 6.3 10.0 50.5 4.7 46.7 2.0 0.0 12.7 5.7 171.5 79.9 168.6 29.7 58.0 42.9 28.7 42.4 184.5 8.0 132.6 109.3 160.3 13.6 4.9 133.0 16.9 2.9 159.8 69.9 78.9 12.9 124.6 28.3 4.3 248.5 12.0 52.2 6.9 105.0 PRODH2 HSPOX1 ENSG00000250799 "Proline dehydrogenase 2" Q9UF12 19 35799988-35813299 "Enzymes, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "kidney: 51.2;liver: 49.3" "Group enriched" "Detected in some" 8 "Hepatocytes: 140.6;Proximal tubular cells: 216.9" "Group enriched" "Detected in some" 50 "liver cancer: 28.1;renal cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "Hep G2: 26.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA051287 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051287: AB_2681420" "unprognostic (2.58e-1)" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (7.03e-2)" "unprognostic (1.73e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.7 0.1 0.0 0.3 0.1 0.1 0.0 51.2 49.3 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 3.4 0.0 0.1 0.3 0.3 0.0 0.0 0.0 12.2 0.0 0.0 23.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.6 0.1 0.0 0.0 1.3 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 216.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PROSER1 "bA50D16.2, C13orf23, FLJ12661" ENSG00000120685 "Proline and serine rich 1" Q86XN7 13 39009866-39038076 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034225, HPA055687" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB034225: AB_1564157, HPA055687: AB_2682886" "unprognostic (6.75e-3)" "unprognostic (9.56e-3)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (7.06e-2)" "unprognostic (2.92e-2)" "unprognostic (3.73e-3)" "unprognostic (5.98e-2)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (3.60e-1)" "unprognostic (1.07e-1)" "unprognostic (2.93e-1)" "unprognostic (9.31e-3)" "unprognostic (2.33e-1)" "unprognostic (1.87e-1)" "unprognostic (1.95e-1)" 10.8 9.9 10.6 12.8 13.3 26.8 11.3 22.6 14.3 8.5 13.7 17.4 9.6 12.9 11.9 11.8 14.5 9.2 8.0 8.8 10.7 6.9 12.6 11.3 15.0 15.2 14.8 9.0 10.0 19.0 7.0 19.5 35.4 12.2 13.4 17.3 11.0 17.9 8.3 11.8 18.5 15.0 9.9 16.3 16.6 12.8 19.0 15.0 26.1 14.3 8.2 17.3 10.8 11.2 4.1 4.8 6.0 4.4 7.5 6.4 4.2 7.2 5.6 17.7 12.2 6.1 4.9 28.2 6.9 6.1 6.9 7.5 17.9 11.4 17.0 5.6 6.7 9.4 12.6 19.0 12.4 11.4 25.7 15.6 25.0 6.1 12.3 13.9 26.0 15.5 6.5 15.0 11.0 25.2 4.3 11.3 19.6 12.3 10.3 7.4 12.7 15.8 13.9 26.4 14.4 6.1 16.7 18.8 10.7 7.0 11.4 10.0 11.5 4.8 12.7 10.2 14.4 13.6 15.1 10.3 4.0 6.5 7.9 8.7 9.7 9.9 18.5 6.5 14.5 7.9 6.0 3.4 0.6 5.7 3.2 6.4 4.1 5.5 6.1 4.1 3.1 4.9 5.3 0.9 7.5 4.4 4.8 3.0 4.2 10.6 13.3 22.6 14.3 10.7 6.9 14.8 9.0 12.2 15.0 3.0 15.4 11.2 4.5 6.3 10.5 5.2 2.5 4.0 4.5 0.0 7.9 16.6 1.7 6.4 15.1 7.7 6.3 0.0 11.6 15.4 5.4 9.9 11.5 5.6 9.0 15.9 10.9 6.7 18.3 5.0 6.1 6.5 5.0 4.6 16.0 4.0 13.2 14.4 4.6 2.8 9.3 0.0 3.8 13.4 12.4 6.4 22.4 9.2 13.6 7.4 PROSER2 "C10orf47, MGC35403" ENSG00000148426 "Proline and serine rich 2" Q86WR7 10 11823339-11872277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 40.8" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 26.1;Urothelial cells: 72.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 32.9;CAPAN-2: 39.5;HBEC3-KT: 25.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 32.0" HPA041337 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041337: AB_10794663" "unprognostic (2.36e-3)" "unprognostic (1.39e-1)" "unprognostic (3.55e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (7.60e-3)" "unprognostic (4.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (1.25e-3)" "unprognostic (1.61e-1)" "unprognostic (1.26e-2)" "unprognostic (4.04e-2)" "unprognostic (3.01e-1)" "unprognostic (5.06e-2)" "unprognostic (8.69e-2)" 2.7 1.1 0.7 1.8 1.4 9.5 9.8 1.0 1.3 3.7 2.5 0.4 2.4 1.2 2.5 1.7 6.2 3.0 2.2 1.4 1.5 0.7 8.6 40.8 10.2 0.2 1.4 0.3 1.7 21.7 0.0 1.5 9.2 1.2 7.3 2.0 9.9 4.5 2.7 1.7 3.2 1.1 1.3 1.0 8.2 7.1 7.5 0.5 4.3 12.0 3.6 5.6 6.5 9.9 0.0 1.9 0.0 1.0 0.0 0.7 0.9 32.9 4.7 0.3 0.1 1.0 1.3 1.9 1.5 0.7 1.2 0.6 10.9 39.5 0.0 6.1 0.1 0.5 8.7 3.3 25.2 0.6 0.0 8.1 3.8 2.0 7.0 5.9 0.0 2.4 1.4 5.5 7.1 8.1 0.1 3.6 0.6 5.6 0.0 1.7 4.5 0.0 1.2 2.1 4.4 2.7 5.3 4.3 0.0 2.6 1.6 0.0 0.4 2.4 10.0 4.2 1.7 5.2 2.0 2.5 0.0 8.0 13.2 0.1 0.0 0.0 0.0 0.0 1.3 1.8 0.0 1.0 0.0 0.0 0.3 0.7 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.9 0.7 1.4 1.0 1.3 1.5 0.7 1.4 0.3 1.2 0.5 8.9 5.1 0.0 22.8 5.0 0.0 0.9 20.4 6.7 5.7 5.2 0.0 4.7 5.0 9.6 2.5 2.8 0.8 0.0 3.3 16.0 3.1 21.4 0.0 26.1 0.7 0.0 1.7 1.8 0.8 2.3 1.7 0.3 3.3 0.0 1.3 0.0 13.3 0.0 4.2 0.3 0.0 0.0 1.0 1.7 2.8 4.1 0.6 0.0 3.3 72.6 PROX1 ENSG00000117707 "Prospero homeobox 1" Q92786 1 213983181-214041502 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 72.4" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 195.1;Hepatocytes: 270.2;Horizontal cells: 494.2" "Cancer enhanced" "Detected in many" "liver cancer: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enhanced" "Detected in some" "Hep G2: 16.0;RH-30: 8.5;SH-SY5Y: 41.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000842, HPA001030, HPA027298" Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: " "unprognostic (3.07e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (3.42e-1)" "unprognostic (7.71e-2)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (6.59e-2)" "unprognostic (1.85e-2)" "unprognostic (2.31e-1)" "unprognostic (3.29e-3)" "unprognostic (6.64e-2)" "unprognostic (4.56e-6)" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.71e-4)" "unprognostic (1.05e-1)" 2.3 9.6 3.7 2.1 8.1 1.0 2.9 14.0 5.8 1.8 3.0 13.1 0.3 2.7 1.9 2.0 1.5 3.0 2.6 13.1 6.2 4.1 5.4 72.4 2.0 13.5 8.4 4.3 7.3 13.9 1.0 11.4 1.3 5.5 1.4 3.2 2.4 1.1 1.3 4.1 1.5 3.1 1.7 9.6 14.9 2.8 5.9 9.2 0.0 7.5 0.6 1.5 1.6 2.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.5 0.3 0.0 16.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.8 1.2 2.8 0.0 0.2 0.0 0.2 0.0 0.8 1.0 0.7 0.0 8.5 1.2 0.1 0.2 1.2 41.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.3 0.1 0.5 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 8.1 14.0 5.8 6.2 4.1 8.4 4.3 5.5 9.2 0.0 2.9 0.0 1.0 5.3 195.1 97.2 84.1 1.4 2.3 8.7 2.0 0.0 13.3 17.3 37.5 17.8 2.6 0.0 2.4 0.1 6.7 2.3 0.0 270.2 0.7 494.2 64.2 4.9 4.5 5.9 1.1 1.1 10.1 0.0 15.2 38.7 5.2 79.3 1.1 0.3 8.6 0.0 2.7 0.2 0.1 4.0 0.0 0.0 8.0 0.6 PRPF18 hPrp18 ENSG00000165630 "Pre-mRNA processing factor 18" Q99633 10 13586927-13630868 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037599, HPA047950" Supported Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA037599: AB_10795137, HPA047950: AB_2680221" "unprognostic (5.82e-2)" "unprognostic (7.86e-3)" "unprognostic (4.07e-2)" "unprognostic (1.20e-2)" "unprognostic (3.00e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (6.12e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-3)" "unprognostic (2.82e-2)" "unprognostic (2.20e-1)" "unprognostic (8.09e-2)" "unprognostic (1.63e-1)" 21.7 20.4 22.8 21.1 21.3 40.5 22.6 29.3 22.9 18.5 18.5 15.9 25.3 18.3 20.8 32.1 20.7 15.6 17.1 19.5 17.1 14.8 22.8 23.5 17.9 17.9 17.2 21.4 18.4 19.8 20.1 40.8 20.2 21.6 16.4 20.5 9.8 22.3 28.5 34.1 20.9 20.1 20.9 21.9 17.4 18.6 19.4 22.0 25.6 26.2 16.0 20.7 18.0 21.9 20.0 19.9 30.3 25.0 27.0 25.8 11.6 16.7 12.6 11.2 9.6 15.7 15.4 14.1 19.6 9.8 21.5 20.7 11.9 25.8 14.1 11.1 17.9 9.6 14.0 14.8 16.2 25.0 20.7 14.7 16.4 10.8 9.3 18.8 12.8 19.8 11.8 26.4 18.7 9.2 13.1 20.8 20.6 16.9 19.0 19.5 17.3 23.8 8.8 10.6 16.5 6.3 17.1 13.7 17.4 14.2 7.2 7.9 19.7 15.4 11.1 16.6 14.4 17.2 21.0 17.6 13.4 15.8 21.7 14.6 18.7 20.0 20.1 19.8 16.2 9.1 16.9 20.4 25.9 21.6 18.1 18.6 20.0 19.7 18.5 19.9 18.2 21.0 25.8 30.3 27.0 25.0 17.4 23.6 11.6 22.8 21.3 29.3 22.9 17.1 14.8 17.2 21.4 21.6 22.0 17.9 21.9 26.2 18.8 40.5 13.3 8.1 17.8 34.8 30.7 21.0 9.8 26.7 34.9 26.2 15.5 20.1 20.0 23.3 25.4 33.7 18.6 14.4 25.5 22.9 22.9 20.6 12.1 12.3 20.4 12.0 16.4 20.6 23.6 32.5 18.8 16.0 28.3 28.1 12.4 36.6 19.9 19.4 18.9 113.0 28.5 40.9 34.9 39.2 17.5 21.0 PRPF40B HYPC ENSG00000110844 "Pre-mRNA processing factor 40 homolog B" Q6NWY9 12 49568218-49644666 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 50.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038426, HPA038599" Enhanced Approved "Nucleoplasm,Nuclear bodies,Aggresome,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Aggresome, Cytosol" "HPA038426: AB_10674684, HPA038599: AB_10674689" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (2.44e-3)" "unprognostic (2.36e-2)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (7.50e-6)" "unprognostic (1.02e-1)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-3)" "unprognostic (3.31e-1)" "unprognostic (3.29e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (2.80e-2)" 6.2 12.3 16.6 5.8 12.6 1.5 9.7 15.6 20.3 12.8 8.8 11.7 13.2 5.5 14.7 13.8 8.5 15.2 8.3 16.3 12.6 10.6 12.9 5.5 6.6 4.1 13.3 14.5 22.0 10.3 30.3 17.5 11.8 12.0 11.0 4.9 10.4 14.2 17.9 22.3 13.1 4.7 10.4 9.6 7.3 8.9 25.1 12.9 2.3 19.4 5.5 5.2 9.9 9.1 1.8 1.5 0.0 0.4 3.1 3.5 0.8 5.2 7.6 7.7 7.5 6.4 4.1 7.2 4.3 6.0 4.6 2.3 8.8 11.7 4.2 9.2 5.6 6.5 3.1 4.6 14.8 2.4 3.1 1.8 4.4 2.8 3.1 8.1 1.4 5.9 5.9 12.6 4.6 16.7 9.9 3.6 8.7 2.1 2.3 5.4 4.9 1.0 3.0 3.2 5.9 2.9 3.7 1.2 3.3 9.7 4.8 8.2 9.9 3.4 9.6 5.2 7.4 18.3 4.0 1.5 2.8 11.5 3.7 1.8 5.4 3.0 1.6 8.5 1.1 2.6 0.0 0.4 0.0 2.4 0.3 3.5 1.1 2.3 1.1 0.6 1.8 2.7 2.9 0.0 3.1 0.2 1.5 1.0 0.8 16.6 12.6 15.6 20.3 12.6 10.6 13.3 14.5 12.0 12.9 11.9 16.9 0.5 8.0 3.2 18.1 1.0 5.1 29.4 22.7 17.4 9.8 17.6 6.6 11.1 22.9 3.5 0.7 0.0 9.6 6.1 6.7 4.7 2.3 2.6 4.6 11.1 7.5 8.0 1.0 17.7 10.9 1.4 3.3 8.2 2.7 9.4 7.1 0.0 11.3 4.4 17.6 12.9 7.2 50.8 17.7 5.3 22.1 2.5 4.5 3.9 PRPSAP1 PAP39 ENSG00000161542 "Phosphoribosyl pyrophosphate synthetase associated protein 1" Q14558 17 76309486-76384521 "Predicted intracellular proteins" "Nucleotide biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062396 Approved Cytosol NA NA Cytosol "HPA062396: AB_2684750" "unprognostic (1.12e-1)" "unprognostic (3.37e-2)" "prognostic favorable (1.39e-5)" "unprognostic (3.31e-2)" "unprognostic (3.11e-2)" "unprognostic (8.45e-3)" "unprognostic (1.09e-1)" "unprognostic (7.19e-2)" "unprognostic (2.66e-2)" "unprognostic (2.37e-2)" "unprognostic (6.51e-2)" "unprognostic (4.10e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (8.20e-2)" "unprognostic (5.37e-2)" 18.4 20.5 19.7 14.9 21.3 15.4 27.9 25.7 24.7 16.4 17.3 22.4 16.8 12.9 17.9 22.8 26.1 16.9 14.7 15.4 19.4 22.8 21.0 52.7 23.6 12.8 32.4 20.6 16.3 18.5 27.2 17.1 16.1 27.4 16.5 20.2 22.1 49.2 22.0 11.6 16.9 14.6 18.3 21.1 11.8 16.2 28.1 23.6 12.8 38.3 16.1 19.3 15.0 25.1 16.5 13.1 19.3 15.2 16.7 22.2 11.6 13.8 17.1 20.6 10.1 14.0 12.6 8.1 12.5 17.5 21.1 17.5 12.3 12.0 16.0 6.9 18.7 16.9 8.2 18.5 14.9 21.2 6.2 16.6 11.8 14.0 54.0 17.4 10.0 9.4 13.6 12.2 15.2 13.3 20.6 41.2 16.4 14.2 15.1 13.9 14.8 18.0 9.3 5.2 23.9 15.4 14.8 26.8 11.8 16.1 16.1 11.8 19.3 13.8 14.1 27.9 24.2 22.9 11.8 15.6 24.4 17.9 14.4 15.4 10.2 6.4 11.3 10.8 9.3 10.3 14.4 15.2 19.3 16.2 13.2 17.1 16.5 16.3 15.5 13.1 11.9 14.1 13.6 5.0 16.7 12.3 13.0 22.2 11.6 19.7 21.3 25.7 24.7 19.4 22.8 32.4 20.6 27.4 23.6 0.0 13.9 15.6 34.7 11.6 29.6 15.2 15.3 30.8 13.6 14.0 33.4 41.1 41.4 49.2 21.3 39.3 19.1 0.0 25.7 56.4 18.3 21.4 19.7 33.0 26.4 57.2 15.1 17.8 11.8 20.9 27.0 18.1 30.4 92.0 25.7 119.8 32.0 17.5 43.5 20.7 38.4 58.2 24.7 96.5 84.4 12.8 25.6 24.0 30.4 16.5 PRPSAP2 PAP41 ENSG00000141127 "Phosphoribosyl pyrophosphate synthetase associated protein 2" O60256 17 18840085-18931287 "Predicted intracellular proteins" "Nucleotide biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 82.5" "Low region specificity" "Detected in all" HPA021881 Approved Approved Nucleoplasm,Cytosol NA NA 28000 "Nucleoplasm, Cytosol" "HPA021881: AB_1855782" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.78e-2)" "unprognostic (1.18e-1)" "unprognostic (2.01e-2)" "unprognostic (1.90e-1)" "unprognostic (3.25e-2)" "unprognostic (9.82e-2)" "unprognostic (1.36e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.71e-4)" "unprognostic (4.57e-2)" "unprognostic (8.98e-3)" "unprognostic (1.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-1)" "unprognostic (9.08e-2)" 9.5 15.5 18.9 22.7 20.0 16.0 12.7 42.9 23.0 13.6 16.1 27.2 13.7 19.0 16.3 14.6 15.9 16.6 16.6 13.9 20.5 22.0 22.9 16.2 13.7 35.9 23.6 19.4 20.9 16.2 18.5 24.9 10.4 20.2 13.1 19.1 16.2 13.4 13.6 9.8 15.3 16.4 13.5 35.0 14.8 17.0 22.7 22.6 28.1 20.5 10.3 41.1 12.7 13.5 26.0 18.9 17.0 14.7 21.4 29.9 16.7 11.2 12.4 18.0 12.9 7.9 5.0 18.5 8.5 6.6 11.1 10.4 15.5 5.3 28.7 8.7 7.3 11.2 13.7 21.1 10.6 12.2 12.9 16.9 9.0 10.4 12.9 10.9 5.7 8.1 5.7 7.1 14.0 10.8 11.3 10.4 16.2 13.2 4.8 9.9 12.4 12.0 6.7 12.8 22.2 8.2 17.0 29.7 12.7 6.9 7.1 10.6 13.8 12.9 5.1 13.0 82.5 14.2 8.3 6.8 4.6 9.1 15.5 10.4 7.8 9.1 11.9 9.4 8.4 9.4 12.7 13.8 17.0 16.7 14.1 18.5 26.0 21.2 17.1 18.9 24.3 29.9 22.3 5.8 21.4 14.7 13.1 21.1 16.7 18.9 20.0 42.9 20.1 20.5 22.0 23.6 19.4 20.2 22.6 14.9 24.8 27.4 16.5 14.1 35.2 8.6 28.1 30.8 13.6 10.4 27.5 11.2 23.2 20.4 42.2 12.0 14.5 0.0 19.3 30.7 13.4 14.7 45.1 16.3 20.6 15.9 25.4 18.4 14.5 33.2 13.0 15.5 11.8 23.4 21.1 23.3 18.4 11.5 12.7 22.8 31.0 19.4 12.4 47.7 58.0 18.2 11.7 17.5 20.0 13.4 PRR12 KIAA1205 ENSG00000126464 "Proline rich 12" Q9ULL5 19 49591643-49626439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011959 Approved Approved Cytosol NA NA Cytosol "HPA011959: AB_10610286" "unprognostic (8.30e-2)" "unprognostic (8.64e-2)" "unprognostic (5.20e-3)" "unprognostic (5.04e-2)" "unprognostic (2.59e-1)" "unprognostic (1.05e-2)" "unprognostic (4.40e-3)" "unprognostic (5.00e-2)" "unprognostic (1.59e-1)" "unprognostic (1.25e-2)" "unprognostic (3.52e-3)" "unprognostic (8.59e-2)" "unprognostic (6.18e-2)" "unprognostic (2.00e-2)" "unprognostic (2.76e-1)" "unprognostic (9.32e-2)" "unprognostic (9.65e-3)" 15.3 14.3 17.3 14.6 16.3 11.1 11.3 33.6 21.9 14.0 11.9 12.7 14.7 13.7 17.0 10.1 11.6 14.4 13.7 8.9 16.5 10.7 10.5 6.2 11.7 15.4 11.6 17.3 17.3 12.0 12.0 22.4 10.5 10.3 14.0 5.7 13.2 19.9 25.5 27.7 27.0 13.1 8.6 7.5 21.1 16.7 8.9 14.6 20.0 15.8 7.9 12.3 14.7 15.3 0.5 1.8 0.4 0.5 0.4 0.9 0.4 10.8 16.9 9.3 10.2 4.3 3.8 7.4 6.9 3.4 3.9 3.1 6.4 6.5 11.1 5.9 4.9 3.6 10.1 4.3 6.0 1.2 9.3 12.6 11.3 8.6 6.3 3.0 10.6 17.1 4.8 6.1 4.3 2.9 4.7 4.3 6.9 7.8 6.6 3.4 8.2 12.0 12.9 13.2 5.6 15.8 15.7 7.2 4.1 3.5 13.6 7.4 13.8 10.0 9.4 4.7 3.9 6.6 7.8 10.0 13.5 12.9 5.1 11.2 8.5 9.9 7.6 8.4 6.1 8.2 0.0 0.4 0.0 0.4 0.2 0.8 0.3 0.3 0.9 0.1 0.5 0.3 0.5 0.4 0.4 0.5 1.8 0.3 0.4 17.3 16.3 33.6 21.9 16.5 10.7 11.6 17.3 10.3 14.6 6.0 1.6 4.2 1.3 3.5 7.2 2.6 7.6 2.7 1.2 12.2 3.9 4.5 1.7 3.6 0.6 3.2 5.6 0.0 6.4 2.8 4.0 1.5 10.3 2.4 5.6 4.8 9.8 4.9 7.8 1.1 13.0 2.2 3.3 2.8 7.2 3.5 9.6 7.0 13.8 2.1 3.2 12.9 2.8 2.6 6.1 6.8 0.9 4.4 6.4 1.0 PRR15L "ATAD4, MGC11242" ENSG00000167183 "Proline rich 15 like" Q9BU68 17 47951967-47957878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 113.1;pancreas: 75.4;thyroid gland: 61.0" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 144.2;Enterocytes: 169.7;Mucus-secreting cells: 103.4;Paneth cells: 199.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.2" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "OE19: 67.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 19.0" HPA022918 Approved Approved Cytosol No NA Cytosol "HPA022918: AB_2060743" "unprognostic (9.91e-2)" "unprognostic (4.77e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-3)" "unprognostic (1.83e-1)" "unprognostic (2.31e-2)" "unprognostic (2.48e-1)" "unprognostic (5.22e-2)" "unprognostic (2.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.32e-2)" "prognostic favorable (6.29e-13)" "prognostic favorable (1.69e-5)" "unprognostic (1.36e-1)" "unprognostic (8.26e-2)" "unprognostic (3.34e-2)" 0.9 0.2 0.2 13.5 0.2 0.0 10.0 0.2 0.3 3.2 88.7 0.6 22.9 44.9 0.6 8.3 4.9 6.6 21.2 0.3 0.4 0.2 37.3 1.6 20.3 0.2 0.2 0.2 1.9 75.4 0.0 8.5 0.2 2.2 8.1 32.0 0.4 38.7 26.7 0.2 3.7 113.1 0.5 0.2 0.2 27.2 1.3 0.2 0.3 61.0 2.5 5.8 2.1 2.4 1.3 0.5 0.0 0.2 1.2 2.2 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 1.9 0.0 0.1 0.0 0.0 6.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.1 0.1 0.0 67.3 0.2 0.1 0.0 0.4 0.3 0.8 4.0 0.1 0.0 12.0 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.2 2.2 0.1 0.0 0.5 0.5 1.3 0.8 0.6 0.0 1.2 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.4 0.2 0.2 0.2 2.2 0.2 20.8 13.7 0.0 1.4 0.0 0.0 0.0 73.9 16.0 17.0 15.7 0.0 0.0 144.2 20.3 4.5 0.0 169.7 0.0 32.6 0.0 0.0 25.3 0.0 0.5 0.1 0.0 30.3 0.0 0.0 6.7 1.1 0.0 0.0 1.0 103.4 0.0 11.5 199.8 0.4 24.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 76.5 6.8 PRR16 DSC54 ENSG00000184838 "Proline rich 16" Q569H4 5 120464278-120687332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 13.7;Early spermatids: 13.9;Fibroblasts: 10.5;Horizontal cells: 14.3;Smooth muscle cells: 8.3" "Cancer enriched" "Detected in many" 5 "prostate cancer: 13.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 24.5;BJ hTERT+: 25.5;fHDF/TERT166: 30.7;HSkMC: 19.7;hTERT-RPE1: 32.1;LHCN-M2: 29.7;U-138 MG: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049254 Approved Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA049254: AB_2680693" "unprognostic (1.71e-1)" "unprognostic (3.87e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-1)" "unprognostic (6.61e-2)" "unprognostic (7.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.42e-2)" "unprognostic (8.33e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-2)" "unprognostic (2.06e-1)" "unprognostic (2.54e-8)" "unprognostic (3.05e-2)" "unprognostic (9.13e-2)" "unprognostic (2.65e-1)" "unprognostic (2.38e-3)" 11.6 4.4 4.7 7.0 4.9 0.9 11.3 21.1 7.6 20.3 5.2 2.2 1.8 2.9 15.7 4.6 4.1 5.8 8.2 16.9 4.7 3.8 3.6 1.5 10.0 3.1 2.3 4.9 6.9 2.4 1.8 2.5 12.8 9.6 10.9 6.7 1.4 3.2 3.9 30.4 4.4 4.9 11.6 3.0 4.3 4.3 3.2 1.6 0.0 4.9 14.2 1.8 8.7 23.2 0.5 1.4 0.7 3.2 0.2 0.2 1.0 1.0 0.0 2.5 0.0 7.0 24.5 0.0 11.1 25.5 15.9 12.2 0.0 0.0 0.0 0.0 30.7 2.8 0.0 2.4 0.2 16.8 0.0 0.6 0.0 0.3 0.0 6.7 0.0 0.0 19.7 2.7 4.7 15.0 32.1 0.5 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 1.9 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.3 2.0 0.0 0.0 0.1 36.7 4.2 1.1 5.7 0.1 0.0 0.0 2.1 0.0 1.2 0.5 3.2 0.2 0.1 1.8 0.1 0.2 0.1 0.0 1.4 0.5 0.1 0.2 0.7 0.2 1.1 0.5 0.1 1.0 4.7 4.9 21.1 7.6 4.7 3.8 2.3 4.9 9.6 1.6 0.0 0.0 0.0 6.4 1.1 2.0 2.5 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.1 13.9 0.1 0.0 0.0 0.0 0.0 10.5 6.0 0.0 0.0 0.5 14.3 0.0 0.6 1.2 7.4 2.6 1.2 1.7 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.5 0.0 8.3 0.6 1.5 0.5 0.5 0.0 0.0 0.5 PRR22 MGC24975 ENSG00000212123 "Proline rich 22" Q8IZ63 19 5782960-5784765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 82.5" "Group enriched" "Detected in many" 13 "Early spermatids: 151.0;Late spermatids: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 16.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044157 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA044157: AB_10960694" "unprognostic (8.09e-2)" "unprognostic (1.53e-3)" "unprognostic (5.19e-3)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-1)" "unprognostic (3.20e-2)" "unprognostic (2.89e-2)" "unprognostic (1.20e-1)" "unprognostic (3.77e-2)" "unprognostic (3.42e-3)" "unprognostic (9.37e-3)" "unprognostic (4.18e-2)" "unprognostic (9.93e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-1)" "unprognostic (2.79e-3)" 1.1 1.0 1.1 1.7 1.5 2.0 1.1 1.1 1.7 1.1 1.3 1.2 1.1 3.1 1.1 1.1 1.6 2.5 1.1 1.1 1.1 0.7 2.4 4.4 1.1 1.5 1.1 1.1 1.1 2.7 1.0 1.2 1.1 1.1 2.7 0.3 1.1 3.2 1.1 1.1 5.4 3.3 1.1 1.1 2.7 2.4 82.5 1.1 1.1 2.3 1.1 1.1 1.1 1.1 0.2 0.0 0.0 0.2 0.0 0.9 0.1 1.8 3.2 1.4 6.6 0.0 0.2 6.6 1.3 0.6 1.0 1.6 3.2 1.8 2.9 3.7 0.2 0.7 2.4 1.0 1.3 0.2 4.5 10.3 1.4 1.4 1.1 0.6 3.1 16.1 0.8 1.1 1.4 0.4 0.1 0.2 3.6 7.2 0.0 0.8 6.9 3.6 3.8 8.3 0.3 3.3 3.5 1.2 4.6 0.3 2.1 1.8 3.3 0.3 2.4 3.7 0.3 2.8 2.5 1.0 2.5 6.8 8.7 1.6 9.4 7.3 5.6 0.2 6.2 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.4 0.0 0.0 0.2 0.0 0.0 0.1 1.1 1.5 1.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 3.0 0.3 0.8 0.4 0.2 5.3 0.3 2.5 0.0 2.3 3.5 0.0 1.9 0.0 0.7 151.0 0.4 2.6 0.0 0.6 0.7 0.8 1.1 0.0 2.1 0.9 4.8 2.4 0.6 1.0 60.2 2.0 0.0 0.0 0.0 2.6 2.2 0.7 1.5 0.4 1.0 5.3 6.5 0.0 8.3 6.6 1.0 1.5 0.0 2.7 0.5 PRR23A ENSG00000206260 "Proline rich 23A" A6NEV1 3 139005468-139006268 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "testis: 6.1" "Cell type enriched" "Detected in single" 6 "Spermatocytes: 1.1" "Cancer enriched" "Detected in single" 17 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 2.8" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 4.7" "Group enriched" "Detected in some" 13 "Spermatocytes: 6.6;Spermatogonia: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 4.1 0.0 0.0 0.0 0.0 0.1 PRR23C FLJ46210 ENSG00000233701 "Proline rich 23C" Q6ZRP0 3 139042102-139044892 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 3.4;testis: 4.3" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 3.0;Late spermatids: 1.5;Spermatocytes: 1.4;Spermatogonia: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "HeLa: 1.2" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.00e-1)" 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.1 4.3 0.0 0.0 0.0 0.0 1.0 0.4 3.4 0.4 0.8 0.4 0.2 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.9 1.2 0.0 0.3 0.6 0.3 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 3.4 0.4 0.6 0.2 0.2 0.2 0.3 0.3 0.1 0.0 1.0 0.3 0.4 2.2 0.8 0.1 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.5 0.1 0.0 0.0 0.0 0.0 PRR3 "CAT56, Em:AB014077.1, Em:AB023052.2" ENSG00000204576 "Proline rich 3" P79522 6 30556886-30563723 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 10.0;HAP1: 12.6;JURKAT: 8.8;U-266/84: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064061 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064061: AB_2685185" "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (8.90e-2)" "unprognostic (2.10e-3)" "unprognostic (1.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.65e-3)" "unprognostic (1.25e-2)" "unprognostic (3.73e-2)" "prognostic favorable (6.49e-6)" "prognostic favorable (5.61e-5)" "unprognostic (4.71e-2)" "prognostic unfavorable (7.84e-7)" "unprognostic (2.80e-1)" "unprognostic (2.82e-1)" "unprognostic (3.66e-1)" "unprognostic (1.21e-3)" 7.6 5.6 9.7 5.5 7.4 4.0 3.5 15.0 13.8 5.4 4.5 5.6 3.1 2.5 7.3 15.3 3.6 6.2 4.0 3.2 10.1 12.1 4.3 3.8 4.9 6.1 5.9 7.6 13.5 5.4 10.6 8.8 3.4 8.0 4.4 5.3 6.9 2.6 6.9 3.1 6.5 3.4 3.8 4.6 5.0 5.9 8.6 5.7 11.1 4.9 1.7 5.6 6.4 4.0 2.0 2.3 1.5 1.2 1.3 1.9 0.4 0.6 1.6 5.3 10.0 2.6 0.9 0.0 0.0 0.0 0.0 0.0 4.6 0.5 4.6 3.9 0.9 3.5 0.6 12.6 1.0 0.0 2.7 4.5 6.7 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.1 0.0 0.0 0.0 8.8 7.3 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.2 0.0 6.8 2.3 0.6 0.0 0.0 0.0 3.1 0.7 4.0 0.0 0.0 0.0 7.6 8.5 4.4 0.0 2.6 2.9 1.5 1.2 0.3 0.5 0.3 1.0 1.0 1.6 1.2 1.0 2.0 0.9 1.9 1.0 1.3 0.6 2.3 0.0 0.4 9.7 7.4 15.0 13.8 10.1 12.1 5.9 7.6 8.0 5.7 8.9 22.1 16.0 6.3 5.0 9.0 2.4 7.6 14.7 13.6 3.5 13.7 12.1 6.6 4.0 0.6 5.0 7.9 0.0 8.1 6.2 9.1 4.6 11.5 3.9 7.0 6.4 7.5 9.2 6.2 1.8 9.5 7.7 10.1 10.0 7.6 8.0 4.9 5.3 9.6 8.2 18.5 6.5 7.2 8.1 5.9 5.0 8.2 10.2 6.5 3.4 PRR5L "FLJ14213, PROTOR-2" ENSG00000135362 "Proline rich 5 like" Q6MZQ0 11 36296288-36465204 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1;intestine: 25.7;lymphoid tissue: 26.1" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 30.1;Paneth cells: 31.7;T-cells: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 16.6;HMC-1: 27.5;hTERT-HME1: 28.6;SiHa: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070174 Approved "Cytokinetic bridge,Cytosol" Yes No "Cytokinetic bridge, Cytosol" "HPA070174: AB_2686231" "unprognostic (6.76e-2)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" "prognostic favorable (7.30e-5)" "unprognostic (2.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.63e-1)" "unprognostic (7.45e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (7.71e-8)" "prognostic unfavorable (4.86e-4)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (2.98e-2)" 2.9 1.5 4.2 8.1 15.5 3.1 2.4 1.7 9.5 9.5 25.7 34.1 1.1 2.5 2.6 1.6 1.4 4.9 5.3 1.6 7.2 5.1 3.8 2.3 10.4 6.2 24.9 3.8 11.4 2.0 1.0 2.7 2.8 16.6 2.3 21.4 3.3 6.3 1.6 0.7 1.6 9.3 4.8 22.8 26.1 2.6 1.2 19.7 1.1 3.0 0.2 2.6 3.6 3.6 1.1 4.2 16.9 12.3 4.6 20.1 7.2 0.0 2.8 5.0 0.1 0.7 0.0 0.0 6.0 4.7 12.8 13.2 0.0 0.0 0.0 2.0 7.5 2.9 0.2 1.0 3.1 6.2 2.3 1.7 0.6 16.6 0.0 1.6 0.0 27.5 2.0 4.3 1.2 28.6 12.0 5.3 0.0 0.0 0.0 6.5 1.5 0.3 0.0 0.3 0.0 1.1 1.7 0.5 0.5 13.0 3.1 0.0 0.2 18.9 0.0 1.2 3.3 0.0 0.2 3.7 10.8 3.4 0.0 7.5 0.1 0.0 0.0 4.6 0.6 3.3 16.9 1.1 13.3 20.1 11.8 4.6 0.0 7.2 16.8 1.3 1.1 1.6 10.8 6.5 4.6 12.3 4.2 0.0 7.2 4.2 15.5 1.7 9.5 7.2 5.1 24.9 3.8 16.6 19.7 17.9 6.2 0.0 0.2 0.3 0.0 0.8 2.5 10.7 6.8 7.0 0.0 0.1 1.7 1.2 12.4 4.7 18.8 0.0 2.1 0.1 1.3 0.2 4.7 0.5 7.3 0.0 1.7 14.1 9.5 30.1 0.6 1.5 0.0 3.6 17.0 1.0 2.3 31.7 0.4 0.3 0.3 6.5 1.2 0.4 0.5 0.5 0.2 21.3 13.3 0.3 PRR7 MGC10772 ENSG00000131188 "Proline rich 7, synaptic" Q8TB68 5 177446445-177456286 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 41.2;Suprabasal keratinocytes: 58.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 17.4;SK-MEL-30: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046636 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046636: AB_2679730" "unprognostic (3.69e-1)" "unprognostic (9.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (4.08e-2)" "unprognostic (7.94e-3)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (4.75e-2)" "unprognostic (5.86e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.84e-3)" "unprognostic (2.22e-1)" "unprognostic (3.76e-2)" "unprognostic (1.69e-1)" 1.9 2.4 12.5 3.2 22.0 15.1 1.7 4.1 28.5 1.1 2.9 9.8 0.0 2.9 1.7 1.3 1.9 3.2 1.9 1.1 14.1 7.6 1.5 2.2 2.0 3.6 4.8 8.4 1.2 4.0 2.6 6.2 1.3 6.2 2.0 1.4 4.7 5.2 1.5 1.7 8.8 2.6 1.2 4.4 4.9 4.6 3.2 4.6 1.2 1.2 0.8 2.3 1.5 0.9 3.2 3.0 10.8 0.6 2.0 7.3 1.5 7.2 2.8 0.8 5.7 0.0 0.4 2.5 3.4 0.6 1.0 1.3 0.6 3.9 7.0 9.0 0.5 2.9 6.1 0.4 3.1 0.4 6.1 9.0 2.1 2.7 2.1 0.6 4.2 5.1 0.6 1.3 0.4 0.2 0.9 0.4 2.7 1.1 5.0 0.9 9.7 3.5 10.7 1.4 1.1 17.4 9.9 2.6 7.0 1.2 0.6 14.1 10.1 1.3 3.4 16.1 0.0 3.0 0.6 2.6 5.7 9.7 5.1 8.2 2.7 1.5 3.4 5.6 6.8 4.1 2.4 0.1 10.8 3.0 0.5 7.3 2.1 3.4 5.1 0.1 3.2 3.2 4.1 4.8 2.0 0.6 3.0 2.5 1.5 12.5 22.0 4.1 28.5 14.1 7.6 4.8 8.4 6.2 4.6 3.0 0.0 13.7 25.0 38.5 12.6 1.2 10.2 0.0 1.2 7.0 0.0 0.9 8.3 10.1 10.8 4.5 7.1 0.0 9.4 0.7 3.9 23.6 27.5 2.8 1.4 6.4 41.2 1.8 2.2 9.7 0.9 2.9 27.0 1.0 9.4 15.2 9.0 7.8 2.1 9.8 13.1 0.0 9.8 3.3 11.7 58.5 1.1 25.5 9.1 15.4 PRR9 ENSG00000203783 "Proline rich 9" Q5T870 1 153217584-153219317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 33.1;tongue: 13.0" "Group enriched" "Detected in some" 16 "Early spermatids: 3.6;Late spermatids: 8.1;Syncytiotrophoblasts: 7.4" "Group enriched" "Detected in many" 6 "cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SuSa: 20.7" "Not detected" "Not detected" HPA027714 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA027714: AB_10602194" "unprognostic (1.45e-1)" "unprognostic (1.46e-1)" "unprognostic (4.17e-1)" "unprognostic (3.48e-1)" "unprognostic (7.02e-2)" "unprognostic (8.27e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-2)" 1.0 0.0 0.0 0.0 0.0 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.6 0.3 13.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 20.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 PRRC2A "BAT2, D6S51E, G2" ENSG00000204469 "Proline rich coiled-coil 2A" P48634 6 31620720-31637771 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 26.4;HEK 293: 48.2;U-266/70: 24.8;U-266/84: 26.3;U-698: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026383, HPA046791, HPA066501" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747" "unprognostic (2.07e-1)" "unprognostic (6.84e-2)" "unprognostic (3.82e-1)" "unprognostic (2.25e-3)" "unprognostic (5.04e-2)" "unprognostic (4.63e-1)" "unprognostic (2.42e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-3)" "unprognostic (2.38e-1)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.57e-1)" "unprognostic (5.40e-2)" "unprognostic (3.10e-1)" 10.9 18.4 20.7 28.9 22.1 5.0 12.2 25.2 29.1 15.0 24.6 18.4 11.9 4.8 19.7 51.5 47.2 32.3 13.8 24.2 18.4 13.2 16.0 10.2 41.7 14.9 14.3 20.4 29.3 12.2 4.8 18.5 8.6 15.9 30.9 7.1 15.0 12.3 15.9 35.1 28.8 23.0 12.8 11.5 43.5 34.6 46.3 16.7 27.1 16.8 10.4 14.4 16.0 13.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 0.0 11.9 11.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.5 13.4 0.0 0.0 0.0 26.4 0.0 0.0 48.2 0.1 0.1 0.0 0.0 0.1 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 24.8 26.3 25.1 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 22.1 25.2 29.1 18.4 13.2 14.3 20.4 15.9 16.7 0.0 5.6 32.9 25.1 29.2 36.4 5.9 22.9 4.0 3.4 38.4 56.9 23.5 5.0 21.7 40.5 23.2 27.9 0.0 22.0 18.4 28.7 31.4 10.4 23.6 28.8 35.0 37.4 33.2 22.9 13.8 45.5 23.5 18.6 25.2 37.1 21.4 27.4 37.9 42.1 12.2 34.7 19.4 30.3 66.6 44.4 24.8 15.3 26.2 41.7 23.6 PRRC2B "BAT2L, BAT2L1, KIAA0515, LQFBS-1, MGC10526" ENSG00000130723 "Proline rich coiled-coil 2B" Q5JSZ5 9 131373636-131500197 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021022, HPA064301" Uncertain Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA021022: AB_1852324, HPA064301: AB_2685237" "unprognostic (4.78e-3)" "unprognostic (9.21e-2)" "unprognostic (5.40e-2)" "unprognostic (5.87e-2)" "unprognostic (1.22e-1)" "unprognostic (6.86e-3)" "unprognostic (1.02e-1)" "unprognostic (5.00e-2)" "unprognostic (1.62e-1)" "unprognostic (5.76e-2)" "unprognostic (1.46e-1)" "unprognostic (4.02e-1)" "prognostic favorable (5.42e-9)" "unprognostic (1.11e-2)" "unprognostic (2.08e-1)" "unprognostic (5.07e-2)" "unprognostic (1.11e-2)" 27.4 29.1 43.3 30.3 44.1 30.3 22.1 54.6 56.3 29.4 26.3 32.7 27.3 18.9 33.8 19.7 35.7 36.1 27.5 28.0 39.0 34.1 24.7 18.1 22.5 31.8 26.8 36.8 51.4 30.2 42.0 35.5 23.6 28.9 28.2 15.1 31.8 23.0 29.9 29.4 42.4 23.0 27.2 21.4 27.4 22.2 21.9 26.9 28.1 29.9 18.3 28.1 26.0 29.5 10.3 6.9 4.1 4.5 5.8 7.4 3.0 17.8 34.6 37.0 25.6 28.3 29.2 37.0 18.1 17.7 21.1 17.5 32.4 15.2 30.9 21.4 20.7 24.0 43.0 36.9 15.4 16.0 31.7 19.9 19.2 60.9 14.2 19.1 25.5 25.5 28.6 20.4 22.8 26.6 21.2 24.4 12.4 34.8 23.1 18.9 37.4 21.3 16.5 26.9 17.9 14.2 41.3 37.7 29.7 15.3 28.0 50.0 31.4 43.8 26.7 18.2 24.5 54.1 15.8 35.2 47.4 22.0 20.9 23.6 10.2 25.4 41.5 16.6 13.8 23.4 4.1 4.5 2.7 7.4 1.9 5.5 5.5 4.4 6.6 2.3 10.3 7.2 6.3 3.2 5.8 1.1 6.9 3.6 3.0 43.3 44.1 54.6 54.7 39.0 34.1 26.8 36.8 28.9 26.9 26.8 34.8 28.7 29.5 37.2 106.8 8.4 40.8 36.1 40.9 54.1 72.6 26.9 1.7 29.1 7.3 39.4 18.8 0.0 26.2 28.6 31.7 42.9 26.6 34.7 23.4 138.2 59.8 41.7 40.8 7.8 55.5 20.7 27.0 32.5 26.8 32.1 30.4 14.4 50.2 17.4 66.0 25.8 34.8 7.7 14.5 37.1 19.5 37.3 30.7 40.7 PRRC2C "BAT2D1, BAT2L2, KIAA1096, XTP2" ENSG00000117523 "Proline rich coiled-coil 2C" Q9Y520 1 171485551-171593511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025766, HPA028659" Approved Enhanced Cytosol NA NA Cytosol "HPA025766: AB_1845277, HPA028659: AB_10600786" "unprognostic (4.16e-1)" "unprognostic (2.40e-2)" "unprognostic (6.66e-3)" "unprognostic (8.71e-2)" "unprognostic (6.07e-3)" "unprognostic (1.85e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-2)" "unprognostic (2.28e-1)" "unprognostic (8.19e-3)" "unprognostic (5.56e-2)" "prognostic unfavorable (7.76e-6)" "unprognostic (7.03e-2)" "unprognostic (2.62e-1)" "unprognostic (1.82e-1)" "unprognostic (4.34e-2)" 33.1 21.2 32.9 40.1 35.7 61.2 32.6 44.3 37.0 35.1 26.0 19.8 41.4 21.2 32.9 38.8 37.3 28.5 26.3 23.5 27.4 25.4 25.5 30.2 35.2 39.8 33.8 30.2 37.3 29.6 47.2 43.7 35.9 30.6 28.7 32.4 18.2 31.4 53.9 24.5 38.5 33.2 32.9 36.7 37.3 27.6 27.3 36.9 45.3 29.5 30.3 41.1 35.3 33.8 4.8 4.4 7.5 2.9 5.8 3.0 1.0 26.6 20.7 29.0 19.1 20.6 24.0 21.5 15.4 22.0 18.1 16.6 31.6 19.1 39.3 24.3 22.5 14.7 23.9 31.4 24.5 28.0 22.1 16.7 29.9 16.0 22.0 21.4 48.3 24.4 23.1 18.9 30.6 45.8 16.4 26.3 21.6 39.3 21.8 20.5 12.7 28.8 20.5 38.3 21.4 36.0 21.8 21.6 19.2 25.6 29.9 18.8 19.3 23.4 28.0 17.8 40.1 19.0 34.0 32.7 20.6 19.0 19.9 31.9 18.3 19.5 57.8 13.1 23.9 18.4 3.4 2.9 1.5 2.9 2.7 3.0 3.7 2.8 2.8 1.2 4.8 2.6 3.0 7.5 5.8 2.8 4.4 2.1 1.0 32.9 35.7 44.3 37.0 27.4 25.4 33.8 30.2 30.6 36.9 276.9 218.4 153.4 214.3 148.4 154.9 94.9 127.4 184.7 273.0 82.0 131.6 168.2 21.6 138.0 25.6 177.6 134.0 46.7 131.7 178.0 148.4 210.4 252.2 99.5 112.3 130.3 158.3 113.5 118.5 20.7 128.9 166.9 91.1 219.2 79.1 116.7 164.6 91.2 90.5 36.1 164.3 77.6 114.7 173.0 161.2 127.5 398.8 179.9 89.0 320.3 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591015 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 38.8;Paneth cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.7;OE19: 13.8;RT4: 9.0;SK-BR-3: 10.5;T-47d: 11.4;U-266/84: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favorable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 0.9 0.4 0.5 1.1 0.6 0.0 4.8 1.1 1.3 4.0 14.3 0.4 17.5 8.3 1.9 9.6 13.7 3.3 9.8 0.7 0.5 0.4 15.0 12.1 5.2 0.4 0.7 0.4 1.9 13.4 13.8 16.1 8.6 0.7 5.4 5.3 0.7 24.9 14.6 1.2 10.1 23.2 1.4 0.5 1.0 7.1 1.7 0.4 2.1 21.9 9.8 7.8 4.2 4.2 1.2 4.2 2.1 0.9 0.0 1.4 0.4 8.4 0.3 0.2 0.7 1.0 0.0 3.6 0.2 0.0 0.3 0.3 1.7 11.7 0.5 1.3 0.1 0.2 6.8 0.2 6.6 0.3 0.8 0.9 0.4 0.5 0.6 0.7 0.3 0.9 0.7 5.8 0.2 0.2 0.6 2.6 0.7 0.2 0.6 0.0 1.8 0.1 0.7 0.5 13.8 1.1 0.2 0.3 6.6 5.2 9.0 1.9 0.2 1.0 10.5 0.1 0.9 11.4 0.1 0.4 0.7 0.5 0.3 0.1 4.1 13.7 0.4 0.1 0.2 0.3 0.0 0.9 0.4 1.4 0.1 0.7 1.2 0.6 0.6 0.1 0.7 0.8 0.7 2.1 0.0 0.7 4.2 0.6 0.4 0.5 0.6 1.1 1.3 0.5 0.4 0.7 0.4 0.7 0.4 6.0 12.0 1.3 12.1 3.7 1.9 0.8 10.2 4.0 9.1 12.2 2.0 11.6 3.3 27.3 0.7 6.2 38.8 0.0 29.0 5.4 0.8 11.8 2.3 4.9 2.1 4.8 15.5 0.6 3.2 0.0 0.3 2.3 1.7 12.6 13.9 0.8 24.3 31.6 0.0 12.1 3.7 0.0 1.8 0.5 1.5 4.1 10.6 0.8 14.2 12.8 PRSS21 "ESP-1, TEST1" ENSG00000007038 "Serine protease 21" Q9Y6M0 16 2817180-2826304 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 21.0;salivary gland: 20.9;testis: 37.5" "Cell type enhanced" "Detected in many" 17 "Late spermatids: 257.7;Spermatocytes: 426.2;Spermatogonia: 234.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 23.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 10.5;eosinophil: 21.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 21.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.4;HEL: 11.6;HeLa: 29.8;K-562: 13.7;U-698: 42.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 27 "basal ganglia: 6.7" HPA008477 Enhanced Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA008477: AB_1079697" "unprognostic (4.35e-2)" "unprognostic (3.46e-2)" "unprognostic (7.06e-2)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (2.61e-2)" "unprognostic (2.33e-1)" "unprognostic (5.21e-2)" "unprognostic (8.83e-3)" "unprognostic (1.52e-3)" "unprognostic (2.97e-2)" "unprognostic (1.14e-2)" "unprognostic (5.07e-2)" "unprognostic (7.79e-2)" "unprognostic (2.99e-1)" 0.8 0.0 0.2 0.2 0.2 5.5 1.0 0.4 0.4 1.4 0.4 0.2 1.4 0.2 0.3 0.2 0.8 2.2 2.1 0.2 0.2 0.0 0.2 0.2 2.1 3.3 0.2 0.2 0.3 0.9 1.7 0.2 0.3 0.4 1.8 0.2 0.2 20.9 0.2 0.5 0.4 0.4 0.2 0.2 0.9 0.4 37.5 0.2 0.9 0.2 1.2 1.1 0.3 0.6 0.8 1.4 21.0 2.3 1.0 3.3 1.3 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 11.6 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 5.5 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 10.5 2.3 21.0 2.2 1.6 3.3 0.8 1.1 1.8 0.6 0.6 1.5 2.2 0.2 1.0 0.3 1.4 0.5 1.3 0.2 0.2 0.4 0.4 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 10.2 29.2 1.0 0.0 81.1 0.0 0.0 1.2 0.0 0.0 0.2 0.0 1.1 94.4 0.0 0.2 0.0 0.3 6.3 0.2 21.6 0.0 0.0 11.5 0.0 0.0 0.0 0.0 257.7 6.1 1.8 0.0 0.0 0.9 0.0 0.8 0.0 3.5 0.0 0.0 45.3 1.1 426.2 234.2 0.5 0.1 2.5 1.6 11.1 PRTFDC1 HHGP ENSG00000099256 "Phosphoribosyl transferase domain containing 1" Q9NRG1 10 24848607-24952604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 7.9" "Lineage enriched" "Detected in many" 7 "NK-cells: 7.9" "Cell line enhanced" "Detected in many" "CACO-2: 30.1;CAPAN-2: 38.0;HEL: 22.1" HPA021458 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA021458: AB_1855793" "unprognostic (2.61e-1)" "unprognostic (3.47e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (9.49e-3)" "unprognostic (2.03e-1)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (7.66e-3)" "unprognostic (1.94e-2)" 4.1 18.3 18.1 3.3 18.2 0.6 6.1 6.1 24.0 8.1 7.7 29.0 2.4 13.9 12.9 6.1 4.5 5.9 11.8 8.6 16.8 13.0 4.0 2.2 3.4 2.8 18.1 12.6 17.1 3.6 10.2 11.0 2.3 16.2 6.5 9.2 6.0 7.2 6.9 0.9 1.4 13.2 8.0 22.5 2.3 13.8 1.7 20.7 2.3 3.7 1.1 2.4 6.0 4.6 0.0 0.3 0.1 0.0 7.9 1.1 1.7 7.6 16.5 12.3 5.0 2.0 10.3 0.0 8.1 6.1 5.8 8.0 30.1 38.0 0.0 1.3 9.4 0.4 4.3 14.0 0.0 9.1 0.0 0.6 22.1 3.0 0.0 6.1 0.0 0.0 3.0 0.1 3.1 0.0 5.5 9.1 0.9 7.2 4.2 2.7 0.2 3.4 0.0 8.5 1.3 0.3 3.8 0.0 0.0 5.2 0.2 8.8 0.4 7.7 0.0 0.0 0.3 0.4 1.7 4.9 2.6 6.5 9.4 4.8 0.4 0.0 0.0 6.9 0.0 0.3 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.4 0.5 0.3 0.0 0.1 0.3 0.1 7.9 0.0 0.2 0.0 1.7 18.1 18.2 6.1 15.8 16.8 13.0 18.1 12.6 16.2 20.7 0.0 0.3 0.0 3.7 2.4 10.4 6.9 5.1 1.4 4.5 3.5 2.0 0.5 5.0 4.6 1.0 1.6 4.1 0.0 0.5 4.3 14.2 0.7 0.0 0.0 5.4 6.4 5.2 9.2 1.6 0.8 11.2 0.3 3.3 1.8 4.2 32.0 2.4 2.6 9.2 0.0 15.3 0.0 9.5 2.3 4.1 2.5 0.7 0.0 14.3 0.9 PRTG "FLJ25756, IGDCC5" ENSG00000166450 Protogenin Q2VWP7 15 55611546-55743090 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.5;thyroid gland: 23.9" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 180.6;Rod photoreceptor cells: 63.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 18 "monocytes: 1.7" "Group enriched" "Detected in some" 7 "AF22: 47.4;SuSa: 57.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA032138 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA032138: AB_10669675" "unprognostic (2.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.32e-1)" "unprognostic (4.64e-2)" "unprognostic (2.07e-2)" "unprognostic (4.96e-4)" "unprognostic (1.82e-4)" "unprognostic (1.31e-1)" "unprognostic (3.19e-1)" "unprognostic (4.76e-3)" "unprognostic (1.37e-1)" "unprognostic (5.32e-2)" "unprognostic (5.67e-2)" "unprognostic (2.42e-6)" "unprognostic (8.81e-2)" "unprognostic (3.17e-2)" "unprognostic (2.70e-1)" 1.3 2.2 1.5 1.1 1.8 0.6 2.4 1.2 2.2 4.7 1.4 3.6 1.1 0.7 11.0 4.6 0.7 2.4 1.0 1.3 1.6 1.6 2.6 0.6 5.0 0.6 3.0 2.0 4.5 0.6 6.4 2.7 6.5 4.3 1.4 0.9 16.5 0.9 1.4 3.9 0.6 0.9 2.9 3.5 0.5 1.5 6.5 2.3 0.0 23.9 0.8 0.9 1.2 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 1.0 47.4 1.0 0.0 0.0 4.8 0.4 1.4 1.2 1.7 7.9 0.2 0.0 2.0 0.0 1.8 0.0 0.1 0.1 1.7 0.0 2.5 0.3 0.3 3.0 0.3 0.3 0.0 0.1 0.0 0.5 0.8 0.9 0.8 0.0 0.8 0.0 0.7 0.6 0.0 0.0 1.9 0.0 1.1 0.0 7.5 0.0 0.9 0.1 0.6 2.7 0.4 0.6 2.6 57.9 0.2 0.1 0.0 0.6 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.5 1.8 1.2 2.2 1.6 1.6 3.0 2.0 4.3 2.3 8.9 13.2 0.0 0.0 0.2 9.5 4.6 0.0 0.0 4.5 15.7 180.6 18.0 0.0 0.0 13.5 5.3 0.0 0.0 0.2 4.2 1.9 0.1 0.0 0.0 1.5 0.0 0.0 2.5 0.0 18.8 4.9 0.0 0.0 0.0 0.0 2.8 0.4 0.0 2.5 1.1 63.9 0.0 1.0 7.2 13.4 0.0 5.0 0.0 0.0 0.1 PRTN3 "ACPA, AGP7, C-ANCA, MBT, P29, PR-3" ENSG00000196415 "Proteinase 3" P24158 19 840960-848175 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 167.3" "Cell type enhanced" "Detected in some" 23 "Cholangiocytes: 2.5;Kupffer cells: 1.2" "Cancer enhanced" "Detected in single" "stomach cancer: 1.0" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.9" "Cell line enriched" "Detected in some" 5 "THP-1: 151.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA005938, CAB017558" Enhanced Approved Vesicles,Cytosol "Secreted to blood" NA NA 120000 Cytosol Vesicles "CAB017558: AB_2172317, HPA005938: AB_1855764" "unprognostic (2.81e-2)" "unprognostic (2.10e-1)" "unprognostic (3.83e-3)" "unprognostic (4.20e-1)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (9.98e-3)" "unprognostic (3.67e-2)" "unprognostic (8.62e-6)" "unprognostic (5.31e-2)" "unprognostic (2.00e-1)" "unprognostic (5.14e-2)" 0.3 0.2 0.9 0.2 1.0 167.3 0.2 0.0 2.3 0.2 0.2 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.2 31.0 0.3 0.6 0.2 1.7 8.1 3.5 0.1 0.1 0.4 0.2 0.2 0.8 4.2 0.8 0.2 0.2 0.3 0.3 0.2 0.5 0.3 0.2 0.2 0.0 25.5 0.2 0.2 0.1 35.0 0.9 0.0 0.2 0.2 0.0 0.0 0.0 1.9 0.1 0.0 0.2 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 6.8 0.9 1.0 0.0 2.3 0.3 0.6 0.1 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRUNE1 "DRES-17, H-PRUNE, HTCD37, PRUNE" ENSG00000143363 "Prune exopolyphosphatase 1" Q86TP1 1 151008420-151035713 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 7 "Alveolar cells type 2: 8.8;Collecting duct cells: 10.4;Proximal tubular cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028411 Uncertain Supported Cytosol NA NA 210000 Cytosol "HPA028411: AB_10603229" "unprognostic (6.24e-2)" "unprognostic (2.24e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (6.91e-2)" "unprognostic (2.02e-1)" "unprognostic (2.12e-3)" "unprognostic (7.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.92e-2)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (3.48e-4)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" 9.3 9.7 9.3 8.8 11.6 3.7 16.0 15.7 16.4 15.0 12.5 10.9 16.2 11.7 17.9 15.7 11.5 15.6 12.8 31.3 10.5 10.3 18.0 12.8 10.1 11.8 11.9 9.2 17.1 16.2 16.5 16.2 7.2 8.8 12.2 14.0 12.7 13.3 18.2 24.4 10.5 11.8 14.7 7.9 11.0 10.5 16.3 8.6 15.0 41.6 8.5 12.9 13.8 13.6 12.1 9.5 14.7 8.9 14.3 19.0 18.3 3.9 4.2 7.5 7.2 9.4 2.6 4.2 1.9 4.1 7.0 6.1 5.1 4.7 8.1 8.2 2.5 2.0 5.7 7.3 4.9 5.6 8.7 8.3 9.5 4.4 7.4 5.1 6.2 4.8 3.2 9.3 3.7 3.6 5.8 3.3 10.7 7.4 6.8 3.3 9.4 9.5 5.1 7.0 14.3 5.5 8.7 4.8 7.7 5.0 5.4 10.9 8.9 6.3 8.8 5.8 11.1 12.1 9.4 2.3 2.5 3.0 2.7 2.9 16.6 14.0 62.0 2.4 4.7 6.2 12.5 6.4 13.4 14.0 6.0 16.9 12.1 15.5 15.7 9.5 11.6 19.0 15.0 14.7 14.3 8.9 5.1 14.5 18.3 9.3 11.6 15.7 16.4 10.5 10.3 11.9 9.2 8.8 8.6 6.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.7 10.4 0.0 3.6 0.0 4.9 0.0 0.0 0.0 0.0 4.9 3.8 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 2.8 0.0 0.0 5.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 PRY "PRY1, PTPN13LY" ENSG00000169789 "PTPN13-like, Y-linked" O14603 Y 22490397-22514637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 1.9;epididymis: 2.3;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "memory CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "A549: 3.1;HDLM-2: 2.3;SK-MEL-30: 1.5" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRY2 PTPN13LY2 ENSG00000169807 "PTPN13-like, Y-linked 2" O14603 Y 22071756-22096007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.4;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.4;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in single" "SK-MEL-30: 3.6" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSAPL1 ENSG00000178597 "Prosaposin like 1 (gene/pseudogene)" Q6NUJ1 4 7430294-7434973 "Predicted secreted proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skin 1: 42.2;stomach 1: 23.9;testis: 19.9" "Cell type enriched" "Detected in single" 14 "Suprabasal keratinocytes: 2.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 11.9;OE19: 23.0;RPMI-8226: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038013, HPA038482" Approved Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA038013: AB_10673652, HPA038482: AB_2676037" "unprognostic (2.64e-2)" "unprognostic (2.40e-1)" "unprognostic (9.33e-2)" "unprognostic (2.40e-1)" "unprognostic (2.61e-1)" "unprognostic (7.90e-3)" "unprognostic (2.52e-1)" "unprognostic (2.08e-2)" "unprognostic (2.75e-1)" "unprognostic (2.63e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 1.4 0.6 0.0 1.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 42.2 0.1 0.1 0.1 0.1 23.9 19.9 0.1 2.5 0.1 0.1 2.1 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 PSAT1 PSA ENSG00000135069 "Phosphoserine aminotransferase 1" Q9Y617 9 78297143-78330093 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 56.0;liver: 112.2" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 129.9;Proximal tubular cells: 244.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 13.3" "Lineage enriched" "Detected in many" 4 "T-cells: 13.3" "Cell line enhanced" "Detected in many" "hTCEpi: 147.9;SK-MEL-30: 90.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014882, CAB040567, HPA042924" Enhanced Enhanced Cytosol NA NA 1700000 Cytosol "CAB014882: , CAB040567: , HPA042924: AB_2678223" "unprognostic (8.26e-3)" "unprognostic (4.69e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (5.62e-5)" "unprognostic (4.05e-3)" "unprognostic (1.41e-1)" "unprognostic (2.21e-3)" "unprognostic (1.86e-1)" "unprognostic (9.85e-2)" "unprognostic (2.25e-2)" "unprognostic (4.53e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.00e-7)" "unprognostic (3.87e-3)" "unprognostic (1.21e-1)" "unprognostic (8.07e-3)" "unprognostic (1.71e-1)" 3.1 25.0 44.6 3.8 33.4 1.7 3.0 8.5 50.5 2.4 3.3 44.8 0.9 3.2 2.7 28.4 9.3 16.0 1.6 1.4 33.9 22.3 56.0 112.2 1.6 4.5 42.2 24.6 3.7 54.6 4.8 2.1 2.2 21.9 5.3 3.3 8.1 26.2 2.8 1.1 24.7 2.8 2.3 29.8 2.4 7.0 5.1 35.0 2.2 13.7 4.9 5.9 4.2 2.6 3.0 0.2 0.2 0.1 0.0 13.3 3.1 26.7 18.0 15.2 26.9 4.5 5.3 35.9 22.7 16.2 11.6 21.7 4.6 5.2 17.4 10.1 51.1 10.5 26.6 25.9 25.1 17.4 17.0 9.2 5.9 8.3 35.4 41.6 33.1 10.7 16.9 147.9 15.3 41.1 2.8 10.5 68.0 6.3 44.8 9.6 10.0 11.3 5.3 34.8 50.3 19.7 5.6 9.8 20.4 15.8 6.2 6.9 16.0 6.3 10.9 90.5 10.0 5.2 41.8 2.4 2.9 9.5 10.8 18.4 30.5 28.1 0.1 34.2 26.2 13.9 0.0 0.0 0.0 4.9 0.0 5.7 3.0 4.8 6.5 0.2 1.0 7.9 7.3 0.2 0.0 0.1 0.0 13.3 3.1 44.6 33.4 8.5 24.9 33.9 22.3 42.2 24.6 21.9 35.0 0.0 0.0 16.4 6.8 37.3 0.8 0.5 0.0 2.7 0.0 10.4 0.0 25.8 53.0 14.1 1.3 2.1 0.7 46.7 41.7 10.5 2.4 14.9 0.0 129.9 4.4 4.8 3.5 3.7 3.2 1.7 4.6 1.8 18.6 6.4 2.0 22.2 28.4 0.0 1.8 244.0 1.3 0.0 1.0 1.4 2.8 44.4 7.8 4.4 3.0 11.2 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 51.6;Cone photoreceptor cells: 90.3;Rod photoreceptor cells: 65.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 10.3;MOLT-4: 5.5;SCLC-21H: 9.7;SH-SY5Y: 8.5;U-2 OS: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: AB_2683954" "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 1.2 9.8 48.7 4.3 59.4 1.6 1.5 8.0 66.8 6.7 21.5 1.7 0.0 6.7 23.9 2.4 3.2 11.1 9.4 1.9 48.7 12.2 1.5 1.4 1.7 1.8 7.6 26.7 5.6 4.7 2.5 13.6 1.8 4.2 6.2 4.4 3.7 1.5 2.2 1.2 2.1 5.8 20.7 1.8 1.5 4.8 4.6 7.0 0.0 1.2 0.0 1.5 11.7 3.0 0.8 0.0 1.1 0.2 0.9 1.3 0.0 0.3 0.1 3.9 3.5 1.4 0.8 0.3 0.3 0.0 0.1 0.0 2.7 0.4 0.3 2.5 0.1 0.3 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 2.2 0.0 0.1 10.3 0.3 0.6 0.1 1.7 0.0 1.4 0.6 0.9 0.0 2.1 5.5 0.3 0.5 0.3 0.0 1.5 0.0 0.1 0.0 0.2 9.7 8.5 0.1 0.1 0.2 0.3 0.6 0.5 0.0 2.9 4.7 0.2 0.0 2.5 0.3 0.1 0.3 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.8 0.3 1.3 1.1 0.9 0.0 0.0 0.0 0.0 48.7 59.4 8.0 41.2 48.7 12.2 7.6 26.7 4.2 7.0 3.0 0.3 0.0 0.2 0.6 51.6 1.2 5.1 0.0 2.3 0.0 90.3 0.2 1.7 0.1 4.1 0.3 0.8 0.0 1.7 0.1 1.7 0.3 0.0 0.5 0.6 12.7 17.2 0.0 0.0 2.0 3.4 0.0 0.0 0.0 0.6 8.6 0.7 0.6 3.9 0.7 65.1 0.0 0.3 3.7 3.4 0.1 0.6 0.0 0.8 0.1 PSD3 "DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942" ENSG00000156011 "Pleckstrin and Sec7 domain containing 3" Q9NYI0 8 18527301-19084730 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.6" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 598.4;Late spermatids: 164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.2;hTERT-RPE1: 22.8;LHCN-M2: 22.0;U-87 MG: 23.6" "Low region specificity" "Detected in all" HPA002455 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No "Nucleoplasm, Vesicles" Cytosol "HPA002455: AB_2666597" "unprognostic (3.87e-2)" "unprognostic (2.52e-2)" "prognostic favorable (7.55e-4)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.56e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.84e-2)" "unprognostic (7.27e-2)" "unprognostic (3.39e-1)" "unprognostic (2.50e-3)" "unprognostic (2.13e-1)" "unprognostic (7.18e-3)" "unprognostic (3.71e-2)" "unprognostic (8.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.45e-1)" 2.3 15.5 18.3 2.7 40.5 1.3 5.2 51.6 50.7 11.3 5.7 13.4 2.5 4.2 7.8 3.6 4.8 2.6 6.5 21.8 23.2 9.3 2.1 15.6 4.1 2.2 10.0 27.6 16.0 8.3 9.5 9.6 5.6 10.7 3.7 6.5 5.4 3.2 5.5 1.3 3.9 4.3 5.2 7.4 8.4 8.0 12.7 11.4 0.0 5.4 1.4 3.1 6.1 3.3 3.1 0.6 2.3 1.3 1.9 2.0 0.7 4.9 2.6 11.7 0.0 4.2 26.2 0.6 2.6 4.1 2.4 5.0 1.5 2.0 2.9 1.7 10.7 10.6 0.4 3.4 4.7 4.6 0.0 3.0 0.2 2.0 0.2 7.7 0.0 0.1 6.8 2.9 13.3 2.3 22.8 3.1 0.7 0.3 2.3 22.0 1.7 0.0 0.5 2.3 4.3 6.8 2.3 10.2 1.3 6.1 6.4 5.0 5.6 1.1 0.5 1.8 2.6 0.0 1.1 12.9 7.5 5.2 17.6 2.3 0.2 0.3 6.7 23.6 1.2 2.5 2.3 1.3 1.3 1.0 0.8 1.3 1.6 1.0 0.6 0.5 3.1 0.5 0.6 1.5 1.9 1.1 0.6 2.0 0.7 18.3 40.5 51.6 50.7 23.2 9.3 10.0 27.6 10.7 11.4 3.0 2.4 0.5 11.9 19.5 56.4 111.0 5.1 32.1 13.6 8.7 111.9 2.6 1.7 13.2 598.4 4.9 21.3 0.0 7.4 1.2 30.9 8.6 0.0 36.1 11.0 17.5 5.8 6.2 9.7 164.8 30.8 10.6 1.7 103.6 15.1 80.8 19.5 14.4 50.5 0.2 50.2 12.9 11.5 10.0 15.8 8.7 0.9 0.0 13.0 24.0 PSKH1 ENSG00000159792 "Protein serine kinase H1" P11801 16 67893272-67929678 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053927, HPA062763" Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA053927: AB_2682312, HPA062763: " "unprognostic (2.57e-2)" "unprognostic (8.91e-3)" "unprognostic (1.88e-1)" "unprognostic (5.79e-2)" "unprognostic (3.26e-1)" "unprognostic (3.89e-1)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-2)" "unprognostic (9.85e-3)" "unprognostic (8.32e-2)" "prognostic favorable (4.28e-10)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (4.15e-2)" "unprognostic (3.90e-3)" 14.3 18.3 13.6 14.0 16.6 4.8 15.1 13.3 13.3 11.0 14.7 17.7 24.0 14.0 19.2 14.6 17.7 20.2 19.3 17.8 12.2 8.4 18.8 15.1 13.1 10.4 16.2 12.7 21.2 35.3 33.2 13.0 9.8 16.1 14.3 11.4 16.2 19.0 14.8 19.9 14.0 15.2 16.3 11.3 12.8 19.1 31.7 15.0 12.5 14.9 12.9 8.6 14.8 18.7 4.0 5.2 4.5 5.8 5.2 5.6 3.5 7.4 13.3 15.2 16.7 23.6 12.0 9.8 9.0 13.7 9.6 8.5 10.0 10.8 7.0 13.7 15.1 7.6 11.3 8.7 9.2 3.2 2.7 9.8 8.0 9.9 12.7 16.2 7.6 4.8 22.0 16.1 11.3 11.9 12.9 13.9 13.3 12.2 3.0 9.9 16.6 10.3 4.9 14.5 8.1 8.3 15.9 5.8 14.5 11.2 9.3 13.2 15.7 27.9 7.6 9.1 6.3 14.0 13.9 12.2 10.8 3.8 9.0 4.5 9.2 4.9 15.2 13.0 5.1 11.8 0.0 4.3 4.5 5.6 5.8 3.8 4.0 3.9 5.3 5.2 3.5 3.4 4.3 2.7 5.2 3.6 3.8 2.3 3.5 13.6 16.6 13.3 13.3 12.2 8.4 16.2 12.7 16.1 15.0 0.0 2.2 5.1 2.5 1.0 10.7 1.7 7.6 4.0 2.3 5.2 5.9 5.2 10.0 5.5 10.8 2.9 8.1 0.0 6.5 4.0 3.9 3.5 5.8 7.7 4.1 6.4 10.4 4.3 5.6 16.9 4.4 1.2 5.0 3.6 6.3 8.2 6.9 3.5 7.4 6.3 6.7 12.9 4.7 3.5 5.7 1.4 4.9 3.1 6.3 1.4 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86048373-86088621 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "kidney: 1.9;placenta: 1.2;testis: 2.0" "Cell type enhanced" "Detected in single" 35 "Rod photoreceptor cells: 1.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "HEL: 14.3" "HPA015095, HPA056839" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSMA4 "HC9, HsT17706" ENSG00000041357 "Proteasome subunit alpha 4" P25789 15 78540405-78552419 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004973, HPA055466, HPA060613" Supported Supported Nucleoplasm,Vesicles,Cytosol No No 12000000 "Nucleoplasm, Cytosol" Vesicles "CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332" "unprognostic (1.80e-1)" "unprognostic (7.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-1)" "unprognostic (4.71e-2)" "unprognostic (5.35e-2)" "unprognostic (6.26e-3)" "unprognostic (1.09e-1)" "unprognostic (3.28e-2)" "unprognostic (2.08e-3)" "unprognostic (2.75e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (6.74e-10)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.78e-3)" "unprognostic (6.32e-3)" 41.2 38.8 24.9 36.7 25.8 33.4 33.0 25.3 37.5 32.4 38.0 17.9 23.7 39.4 35.3 32.5 49.9 27.1 24.4 37.7 29.8 27.6 55.7 76.3 37.4 45.1 25.5 26.9 31.2 24.4 20.2 25.9 55.4 33.8 35.3 41.3 19.1 26.0 25.0 60.3 26.3 49.1 36.6 28.1 45.5 31.5 36.5 21.4 61.6 42.6 75.0 44.8 41.3 28.3 29.4 61.9 31.4 75.6 37.7 40.0 61.4 40.8 59.2 51.2 45.1 32.4 30.6 40.2 38.4 30.9 47.4 50.8 61.4 59.6 89.1 56.8 35.3 53.1 55.9 103.3 41.6 45.8 36.5 72.0 74.8 44.3 49.5 52.5 76.0 46.2 24.7 26.1 39.8 39.7 29.2 51.0 49.1 80.2 35.0 38.6 58.7 51.2 71.4 48.2 47.5 34.8 44.6 67.8 29.8 47.9 71.5 45.2 33.0 61.6 45.0 46.8 66.1 41.6 62.6 40.6 35.4 47.2 38.9 65.3 32.0 75.4 84.0 33.2 114.3 39.0 18.8 47.4 31.4 27.8 75.6 28.5 29.4 29.2 29.0 61.9 22.9 23.3 28.3 21.7 37.7 69.7 35.3 40.0 61.4 24.9 25.8 25.3 37.5 29.8 27.6 25.5 26.9 33.8 21.4 119.1 93.9 158.5 221.9 205.7 52.1 151.9 114.7 164.6 121.7 115.1 9.8 396.5 263.6 267.2 515.0 152.3 149.0 93.5 255.0 368.3 172.3 213.0 169.8 170.4 287.4 68.3 140.2 108.6 138.2 238.7 139.8 214.9 126.5 342.7 139.0 49.5 230.5 135.3 138.6 288.5 32.6 148.8 177.5 257.9 168.3 185.9 373.9 156.9 171.4 236.4 PSMA5 ZETA ENSG00000143106 "Proteasome subunit alpha 5" P28066 1 109399031-109426427 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 31.2" "Low region specificity" "Detected in all" "HPA028392, HPA028398, HPA028441" Approved Supported Cytosol NA NA 22000000 Cytosol "HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003" "unprognostic (3.82e-2)" "unprognostic (3.09e-3)" "prognostic favorable (1.45e-5)" "unprognostic (1.57e-1)" "unprognostic (2.71e-1)" "unprognostic (1.52e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (5.95e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-3)" "unprognostic (4.20e-3)" "unprognostic (3.05e-1)" "unprognostic (1.07e-3)" "unprognostic (3.99e-2)" "unprognostic (2.34e-1)" "unprognostic (8.81e-3)" "unprognostic (1.05e-1)" 12.1 23.7 13.2 17.3 15.0 7.7 16.2 8.2 40.5 13.3 16.1 9.8 16.7 15.1 15.8 23.0 21.5 17.6 16.7 20.8 13.8 13.5 27.5 41.9 17.1 24.2 13.4 14.9 13.6 21.4 12.6 11.5 20.9 12.8 12.3 14.9 10.2 16.8 14.2 31.6 15.8 21.8 14.4 12.9 18.5 15.2 16.3 10.3 31.5 27.9 23.4 19.8 14.0 11.7 2.1 1.2 7.3 2.2 2.8 7.1 1.6 1.2 1.0 1.7 1.2 3.9 4.2 1.4 0.9 9.3 6.1 3.6 1.3 1.1 5.3 1.2 4.1 0.4 1.7 2.4 3.1 3.8 1.1 1.5 2.3 0.9 1.6 2.9 3.0 1.2 1.9 3.1 1.8 3.0 1.5 2.3 1.6 1.8 1.4 2.5 1.6 31.2 1.3 1.4 1.3 1.5 0.8 3.1 0.9 4.9 1.6 1.4 1.2 1.6 5.5 2.0 1.4 1.2 2.7 1.5 1.0 0.8 2.1 1.2 0.9 1.8 6.7 6.8 6.7 1.1 7.3 1.0 0.7 4.0 2.2 4.8 1.8 5.8 4.9 1.2 2.1 7.1 6.5 0.3 2.8 2.0 0.8 5.3 1.6 13.2 15.0 8.2 17.5 13.8 13.5 13.4 14.9 12.8 10.3 38.7 52.0 75.2 57.4 56.4 28.9 80.5 71.4 113.8 56.9 40.1 5.9 188.1 119.3 151.2 42.4 54.0 101.9 93.5 159.8 154.0 44.1 63.2 80.8 125.2 151.4 12.7 54.1 53.4 54.0 13.6 62.7 72.3 55.6 215.6 84.3 42.7 167.1 91.2 58.4 151.0 27.9 45.3 54.2 105.7 86.6 57.6 201.7 98.3 114.8 81.6 PSMB10 "beta2i, LMP10, MECL1, MGC1665" ENSG00000205220 "Proteasome subunit beta 10" P40306 16 67934502-67937087 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 117.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 36.6;U-266/70: 41.0" "HPA030224, HPA030225, CAB034384" Enhanced Approved Vesicles,Cytosol NA NA 1400000 Cytosol Vesicles "CAB034384: AB_2171876, HPA030224: AB_2673382, HPA030225: AB_10603231" "unprognostic (1.18e-2)" "unprognostic (1.90e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-3)" "unprognostic (2.00e-1)" "unprognostic (1.85e-2)" "unprognostic (7.22e-2)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-1)" "unprognostic (8.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.32e-2)" "unprognostic (2.97e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-2)" "prognostic favorable (5.44e-4)" 11.5 13.0 9.1 24.9 11.8 23.9 11.4 4.0 7.8 8.0 21.6 5.6 8.5 42.4 9.3 9.5 10.6 12.4 16.6 12.0 6.9 4.9 16.9 17.2 19.5 38.3 9.5 5.6 8.7 61.5 0.9 6.9 11.2 8.5 13.5 6.3 5.8 27.9 11.6 6.9 7.0 35.6 7.7 6.5 49.7 23.8 2.5 7.8 39.2 13.1 10.4 20.5 13.2 8.4 50.8 75.2 100.0 98.1 69.1 68.8 117.3 6.0 5.3 0.4 0.8 0.4 3.5 21.3 2.0 8.7 7.0 9.9 2.8 29.5 22.0 3.8 2.7 2.1 8.9 0.1 2.0 0.5 9.7 0.5 7.8 1.8 3.1 12.2 14.5 24.0 5.4 1.2 3.1 0.0 2.2 4.0 5.3 0.7 8.4 2.0 7.5 28.5 14.9 0.3 0.2 2.0 36.6 2.2 30.0 4.8 10.5 0.3 0.4 6.8 12.0 2.6 0.4 2.4 31.5 6.8 4.5 1.2 1.9 2.3 41.0 7.4 14.6 11.1 19.0 9.6 57.1 89.4 67.1 68.8 98.1 50.2 50.8 54.0 57.3 74.6 49.1 45.3 50.1 100.0 69.1 71.4 75.2 60.8 117.3 9.1 11.8 4.0 7.8 6.9 4.9 9.5 5.6 8.5 7.8 20.8 23.2 54.7 11.4 15.2 0.6 1.4 38.2 73.6 15.9 17.4 0.0 24.0 19.9 48.2 11.5 22.9 90.1 23.3 91.6 28.8 24.3 10.7 49.8 10.0 80.6 0.0 15.6 31.3 88.4 25.3 27.9 74.2 45.5 124.4 58.4 1.3 49.6 106.6 19.8 53.7 1.0 19.4 23.4 16.6 6.8 8.7 18.9 122.2 72.8 19.2 PSMB6 "DELTA, Y" ENSG00000142507 "Proteasome subunit beta 6" P28072 17 4796144-4798503 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023312, HPA063656" Supported Supported Nucleoplasm,Cytosol NA NA 2800000 Nucleoplasm Cytosol "HPA023312: AB_1855828, HPA063656: AB_2685078" "unprognostic (2.71e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (3.32e-3)" "unprognostic (8.80e-2)" "unprognostic (1.44e-1)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.64e-2)" "unprognostic (1.98e-2)" "unprognostic (7.47e-2)" "prognostic unfavorable (5.93e-4)" "unprognostic (1.81e-1)" "unprognostic (2.34e-1)" "unprognostic (5.27e-2)" "unprognostic (5.66e-2)" 28.6 35.0 33.7 23.2 36.4 31.7 34.0 24.2 41.5 29.6 31.7 26.7 26.8 22.6 33.4 47.1 41.9 30.3 24.2 72.0 30.4 30.5 41.4 67.1 25.7 35.3 33.4 34.0 25.3 41.8 40.8 26.6 49.6 35.9 26.4 36.1 23.5 30.6 36.6 97.4 33.6 23.2 40.5 29.7 29.0 31.2 27.0 28.0 35.8 34.6 53.8 39.6 27.9 26.0 93.9 96.3 51.1 95.3 60.4 81.2 107.9 46.8 82.1 44.3 37.8 37.8 34.0 51.1 24.9 52.1 76.0 59.7 61.0 38.3 36.5 49.4 59.5 43.8 47.6 67.3 69.6 74.2 47.4 71.0 21.6 54.0 70.8 43.6 22.3 34.5 32.0 53.5 66.4 63.2 42.9 73.8 58.3 33.0 55.5 58.2 55.8 39.4 37.3 37.5 60.6 57.0 44.2 31.5 48.3 57.1 31.6 25.9 31.8 35.7 27.9 25.6 48.4 34.0 25.1 35.2 37.5 28.4 50.4 60.1 23.2 30.9 22.2 53.7 40.8 45.1 51.1 95.3 50.5 57.1 87.5 57.8 93.9 62.3 62.6 96.3 79.8 53.7 56.1 32.9 60.4 78.0 89.7 81.2 107.9 33.7 36.4 24.2 41.5 30.4 30.5 33.4 34.0 35.9 28.0 125.0 90.0 86.3 149.5 203.5 62.3 388.1 150.3 148.5 136.5 127.4 15.7 501.8 303.4 283.2 179.9 152.8 127.2 46.7 303.5 339.8 176.1 166.1 102.7 181.7 306.8 30.2 142.4 94.5 116.6 27.7 101.5 205.7 224.4 422.0 103.5 128.7 291.3 143.8 115.6 455.7 57.6 109.9 242.8 120.2 84.7 242.3 555.7 109.0 129.8 191.2 PSMB7 ENSG00000136930 "Proteasome subunit beta 7" Q99436 9 124353466-124415444 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052408, HPA054902" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No 2700000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA052408: AB_2681820, HPA054902: AB_2682635" "unprognostic (7.75e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (3.64e-3)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.24e-3)" "unprognostic (9.03e-2)" "unprognostic (3.60e-1)" "unprognostic (2.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.26e-2)" "unprognostic (1.67e-1)" "unprognostic (3.45e-1)" "unprognostic (1.93e-3)" "unprognostic (3.98e-2)" 36.9 56.9 51.0 32.8 55.1 53.4 41.9 33.7 52.7 26.6 33.3 34.0 27.9 32.5 33.6 52.1 41.9 32.6 29.2 59.6 44.5 41.3 53.7 87.1 27.0 33.6 43.6 46.9 32.7 67.1 38.5 24.1 53.2 47.3 28.8 37.1 31.1 48.2 26.9 76.7 48.7 32.2 31.4 39.9 28.6 33.1 50.3 36.5 48.2 32.7 67.7 39.5 32.3 30.8 53.4 67.9 45.2 62.7 53.6 66.2 69.0 52.6 64.4 44.1 53.3 31.2 37.2 63.6 51.3 70.8 74.4 51.4 84.6 51.6 60.1 41.5 48.0 73.5 75.4 54.9 54.3 68.4 57.8 47.4 37.7 102.4 70.2 70.5 74.7 37.6 44.5 48.0 77.5 77.7 57.5 62.4 54.6 76.8 42.8 57.4 91.7 53.5 50.2 65.2 80.2 92.2 47.4 65.8 70.2 52.6 34.5 52.1 42.3 48.8 62.5 76.0 45.2 72.1 32.9 49.4 48.2 38.9 61.4 76.8 46.5 130.1 60.7 80.6 46.1 67.6 40.4 61.7 45.2 41.8 62.7 45.0 53.4 48.1 46.1 67.9 47.5 46.3 44.9 27.3 53.6 58.4 57.8 66.2 69.0 51.0 55.1 33.7 52.7 44.5 41.3 43.6 46.9 47.3 36.5 71.5 73.0 111.6 140.8 172.4 37.7 121.6 112.1 101.7 62.6 66.3 21.6 382.0 280.2 281.6 279.3 121.5 147.6 46.7 340.4 299.5 140.7 127.9 102.7 222.4 205.6 31.8 135.5 87.8 123.1 322.3 128.9 128.4 189.0 172.3 121.7 86.0 308.8 129.0 117.8 341.8 43.4 84.1 126.0 246.2 184.2 191.3 408.7 106.6 146.6 177.4 PSMB9 "beta1i, LMP2, PSMB6i, RING12" ENSG00000240065 "Proteasome subunit beta 9" P28065 6 32844136-32859585 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 69.1;lymphoid tissue: 54.9" "Cell type enhanced" "Detected in many" 6 "monocytes: 319.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 29.5;REH: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB015180, HPA042818, HPA053280" Enhanced Supported Cytosol NA NA 420000 Cytosol "CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098" "unprognostic (1.09e-2)" "unprognostic (1.68e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-3)" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (5.68e-2)" "unprognostic (6.67e-2)" "unprognostic (1.56e-2)" "unprognostic (6.50e-3)" "unprognostic (1.87e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.96e-3)" "unprognostic (5.99e-2)" 13.3 9.7 5.0 30.0 7.9 10.7 11.6 1.6 5.3 7.6 16.5 6.0 3.4 15.7 8.8 7.1 10.8 7.4 10.8 8.9 5.1 4.7 12.2 12.2 17.7 32.7 7.3 3.7 9.2 5.4 1.2 4.5 5.5 6.3 12.5 5.8 7.7 9.0 3.5 6.2 7.6 36.1 5.7 9.8 54.9 11.2 3.0 6.7 35.4 14.4 9.3 35.2 15.9 8.8 31.8 17.2 69.1 30.5 23.4 31.1 45.7 0.0 1.4 0.0 0.1 1.2 3.0 2.0 0.2 3.3 4.2 9.9 0.0 9.2 29.5 0.4 2.7 10.8 6.0 0.4 6.3 0.6 16.6 0.0 18.0 0.5 1.1 15.9 3.1 1.3 1.4 0.2 2.7 0.4 2.3 1.5 8.5 0.7 5.5 1.4 0.5 13.6 4.2 0.0 0.0 0.9 21.8 0.0 7.0 2.8 0.5 0.0 0.0 2.7 1.8 2.0 0.0 2.4 6.6 1.5 4.6 0.4 8.6 2.6 10.2 15.5 9.4 4.7 11.9 3.8 21.9 22.4 39.3 28.7 30.5 23.8 31.8 23.3 27.5 17.2 23.4 17.5 22.9 69.1 23.4 29.4 12.7 31.1 45.7 5.0 7.9 1.6 5.3 5.1 4.7 7.3 3.7 6.3 6.7 38.7 64.6 199.7 29.6 64.5 1.9 5.3 73.9 30.8 34.2 24.4 0.0 0.9 16.6 87.6 1.0 123.4 127.8 46.7 101.9 4.2 38.3 33.2 76.1 23.2 118.3 0.0 32.1 108.1 113.4 0.7 27.0 117.7 33.7 319.2 103.0 19.5 69.2 118.1 14.9 33.5 1.1 32.3 41.0 1.4 6.5 51.3 1.1 214.2 55.9 33.0 PSMC1 "p56, S4" ENSG00000100764 "Proteasome 26S subunit, ATPase 1" P62191 14 90256495-90275429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 178.0" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 478.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000872, HPA016885" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 46000 "Nucleoplasm, Cytosol" "HPA000872: AB_1079705, HPA016885: " "unprognostic (4.10e-1)" "unprognostic (9.70e-2)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (1.23e-2)" "unprognostic (1.00e-2)" "unprognostic (1.58e-1)" "unprognostic (1.03e-3)" "unprognostic (1.12e-2)" "unprognostic (1.10e-2)" "unprognostic (1.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.85e-1)" "unprognostic (1.11e-2)" 23.7 21.6 28.2 16.7 26.6 26.9 24.6 17.1 39.1 18.4 21.0 11.8 14.3 12.7 23.7 27.9 23.4 18.0 13.7 34.5 37.8 19.1 22.8 29.7 17.9 16.2 19.8 29.3 16.1 20.4 21.8 15.9 25.3 37.2 19.0 23.0 12.1 18.9 22.8 178.0 22.9 17.2 23.2 31.3 19.3 20.0 42.1 15.6 14.4 18.0 29.2 25.4 23.3 17.2 21.4 37.7 57.0 38.1 28.7 36.4 37.8 32.4 30.9 35.5 37.0 31.2 28.7 37.4 31.5 44.2 69.7 52.6 28.5 36.7 27.7 48.2 38.1 32.0 33.8 43.4 36.8 81.7 33.1 19.0 21.7 20.7 24.4 27.0 32.9 29.1 25.7 29.2 45.3 33.4 29.2 41.9 30.9 30.6 16.7 47.8 61.7 24.4 42.9 31.3 42.0 38.3 29.4 46.0 22.6 39.2 33.9 37.4 25.0 25.7 67.0 26.3 30.8 42.1 29.1 31.7 26.9 24.0 28.8 45.5 29.0 45.7 41.1 38.9 30.0 40.9 30.9 37.6 57.0 26.6 34.1 26.2 21.4 27.5 27.2 37.7 20.7 25.3 24.8 41.7 28.7 38.1 26.4 36.4 37.8 28.2 26.6 17.1 39.1 37.8 19.1 19.8 29.3 37.2 15.6 95.3 66.7 41.0 73.5 57.8 47.2 33.6 99.3 137.9 116.0 52.4 49.1 265.6 101.2 136.5 478.8 81.7 77.7 46.7 171.7 144.5 72.1 66.8 95.8 167.6 133.3 74.7 54.8 77.3 91.6 350.7 70.8 81.8 64.1 188.4 56.4 79.4 161.0 64.3 77.1 126.3 54.1 84.1 75.2 77.1 45.5 43.8 392.6 74.6 66.8 81.4 PSMC2 "MSS1, Nbla10058, S7" ENSG00000161057 "Proteasome 26S subunit, ATPase 2" P35998 7 103344254-103369395 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019238, HPA049621" Supported Supported "Cytosol,Cytoplasmic bodies" NA NA 39000 "Cytosol, Cytoplasmic bodies" "HPA019238: AB_1855834, HPA049621: AB_2680833" "unprognostic (4.00e-2)" "unprognostic (6.66e-2)" "unprognostic (2.55e-1)" "unprognostic (3.58e-1)" "unprognostic (1.57e-3)" "unprognostic (3.55e-2)" "unprognostic (2.08e-2)" "unprognostic (6.08e-2)" "unprognostic (7.73e-2)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" "unprognostic (4.71e-1)" "unprognostic (5.09e-3)" "unprognostic (1.30e-1)" "unprognostic (2.18e-1)" "unprognostic (9.76e-2)" "unprognostic (1.41e-1)" 29.3 35.8 29.4 27.2 35.3 41.6 24.4 25.9 39.7 23.2 23.4 26.2 22.0 22.8 28.2 26.6 29.9 22.5 19.5 38.5 30.1 24.7 36.9 58.8 24.4 26.2 32.0 29.9 23.7 18.5 27.8 33.6 31.1 37.0 23.1 24.8 23.2 24.1 24.8 83.5 31.2 23.2 29.2 31.5 28.4 24.9 23.4 34.3 27.5 25.5 35.2 31.8 26.5 22.2 25.7 40.7 65.7 52.3 29.6 50.2 35.1 51.8 36.4 31.2 45.8 33.6 25.1 28.7 38.7 35.9 45.2 45.3 44.2 46.2 35.0 83.0 34.0 67.0 32.0 39.3 27.5 47.5 55.7 26.5 31.3 30.1 32.1 29.5 51.0 39.1 22.3 22.5 45.0 15.1 24.0 33.7 26.9 72.4 47.7 38.6 74.2 50.4 33.8 38.8 43.9 38.4 28.4 39.0 40.9 30.6 32.5 28.4 25.4 36.3 53.9 33.8 38.2 24.8 26.1 35.9 39.7 48.2 74.8 61.1 42.9 99.6 68.5 44.0 53.8 60.9 65.7 30.5 28.1 26.5 44.2 30.1 25.7 31.0 28.2 40.7 20.1 27.5 27.6 4.6 29.6 52.3 23.8 50.2 35.1 29.4 35.3 25.9 39.7 30.1 24.7 32.0 29.9 37.0 34.3 44.7 22.7 24.6 35.9 35.3 36.2 50.6 38.2 34.8 33.0 26.2 13.7 151.6 56.3 91.2 87.1 38.3 24.9 116.8 84.4 92.2 48.9 32.9 55.4 45.1 116.9 25.4 8.1 33.2 43.1 22.7 54.1 47.1 30.4 71.3 25.6 66.8 71.7 26.9 60.5 70.1 44.5 58.2 44.5 67.6 45.8 37.5 193.8 45.8 28.1 36.7 PSMC3 "TBP-1, TBP1" ENSG00000165916 "Proteasome 26S subunit, ATPase 3" P17980 11 47418769-47426473 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 134.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006065 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 180000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA006065: AB_1079706" "unprognostic (2.01e-2)" "unprognostic (5.08e-3)" "unprognostic (9.43e-2)" "unprognostic (8.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.71e-2)" "unprognostic (8.99e-3)" "unprognostic (1.63e-1)" "unprognostic (9.95e-2)" "unprognostic (1.27e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" 27.9 25.9 37.3 24.1 49.3 31.8 26.2 25.6 39.7 25.1 28.2 24.9 21.1 20.3 27.2 26.0 29.4 25.0 21.8 45.7 32.8 28.0 30.7 60.2 21.5 22.8 36.1 27.3 21.0 25.2 31.0 16.8 39.8 28.2 22.6 24.0 21.3 32.1 29.8 134.7 34.8 20.9 30.8 24.3 25.7 24.9 24.0 22.9 33.5 27.1 38.3 28.8 25.5 25.3 39.2 45.1 32.6 54.7 45.0 51.1 61.3 39.2 44.7 43.0 31.6 20.7 22.3 41.9 32.8 48.8 82.5 58.6 39.8 23.0 31.9 20.4 41.2 36.3 39.5 37.6 42.9 37.3 47.4 48.7 30.6 54.7 38.4 26.8 35.6 32.8 24.8 23.2 33.4 37.8 18.3 46.3 33.2 43.3 30.1 50.2 87.5 44.9 45.4 42.1 49.9 54.0 47.6 84.6 27.9 38.4 29.6 31.5 27.2 26.8 37.8 20.6 19.0 46.8 37.2 32.6 47.3 59.9 66.9 83.9 32.7 37.7 36.9 48.9 35.8 59.1 24.4 43.5 32.6 47.9 53.1 43.7 39.2 40.4 43.8 45.1 32.8 35.6 36.2 9.8 45.0 54.7 45.1 51.1 61.3 37.3 49.3 25.6 39.7 32.8 28.0 36.1 27.3 28.2 22.9 53.6 40.7 50.7 95.5 76.6 41.9 207.9 76.5 49.5 45.5 64.6 15.7 229.8 129.3 164.4 108.0 86.3 137.8 116.8 176.4 216.8 106.9 72.7 72.8 141.0 139.1 35.0 61.9 63.8 58.5 158.2 82.0 66.5 94.5 170.5 67.3 81.7 174.0 108.7 94.0 148.2 36.4 116.4 134.6 87.3 61.8 67.5 295.1 69.6 93.3 88.7 PSMC4 "MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7" ENSG00000013275 "Proteasome 26S subunit, ATPase 4" P43686 19 39971005-39981441 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 334.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002044, HPA005471" Approved Supported Nucleoplasm,Cytosol NA NA 66000 "Nucleoplasm, Cytosol" "HPA002044: AB_1079707, HPA005471: AB_1855838" "unprognostic (1.66e-1)" "unprognostic (9.08e-2)" "unprognostic (1.69e-1)" "unprognostic (1.83e-2)" "unprognostic (7.46e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.53e-2)" "unprognostic (4.45e-1)" "unprognostic (4.42e-2)" "unprognostic (9.90e-2)" "unprognostic (8.45e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.81e-1)" "unprognostic (2.32e-1)" 24.0 31.3 23.4 26.1 26.9 15.0 20.3 23.9 37.1 22.8 25.0 26.1 24.9 26.4 29.8 34.0 29.9 25.1 22.2 35.9 24.1 25.4 40.4 65.6 20.1 21.3 25.6 27.4 22.7 19.6 33.1 22.1 29.7 32.3 22.5 24.6 21.8 21.1 28.1 57.3 25.8 24.8 27.1 26.0 25.2 24.1 29.7 25.5 27.9 30.2 28.0 28.5 28.9 20.1 18.1 34.4 16.0 43.1 19.8 28.1 25.8 22.6 73.8 15.0 19.6 12.9 10.7 17.2 13.5 16.5 30.0 23.3 42.6 16.5 11.3 26.3 15.9 17.9 12.3 20.1 18.2 22.8 20.0 21.0 16.7 13.9 34.7 18.9 17.3 20.1 11.3 14.8 24.4 16.7 8.9 19.6 14.4 21.4 17.3 18.3 34.3 20.6 10.0 27.0 28.1 22.5 18.0 18.0 16.3 20.0 34.2 19.4 25.0 15.2 24.3 12.1 14.4 16.8 15.3 12.9 19.7 19.6 17.9 32.7 20.9 36.3 17.5 24.9 18.5 21.6 14.8 20.5 16.0 23.6 32.2 20.0 18.1 21.1 23.9 34.4 16.9 17.1 17.6 11.1 19.8 43.1 17.1 28.1 25.8 23.4 26.9 23.9 37.1 24.1 25.4 25.6 27.4 32.3 25.5 29.8 16.6 42.4 70.2 56.8 48.5 34.4 48.4 48.2 30.7 41.8 13.7 160.1 77.9 114.4 141.3 51.7 104.4 46.7 97.0 94.8 52.8 56.5 40.4 40.6 138.7 39.7 56.7 28.3 37.6 88.3 50.9 55.7 42.2 126.2 23.8 57.9 103.2 84.2 65.7 117.8 40.5 90.5 51.4 54.2 45.4 50.8 334.1 60.9 43.9 72.7 PSMC5 "p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1" ENSG00000087191 "Proteasome 26S subunit, ATPase 5" P62195 17 63827152-63832026 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 1134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017871, HPA064293" Enhanced Supported "Plasma membrane,Cytosol" NA NA 100000 "Plasma membrane, Cytosol" "HPA017871: AB_1857638, HPA064293: AB_2685234" "unprognostic (9.65e-2)" "unprognostic (1.63e-2)" "unprognostic (4.44e-1)" "unprognostic (2.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.35e-1)" "unprognostic (8.29e-3)" "unprognostic (1.24e-2)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" "unprognostic (2.17e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (3.13e-6)" "unprognostic (9.54e-2)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" 36.8 43.1 44.8 35.8 42.6 26.7 30.3 47.7 48.3 29.5 36.5 30.3 40.8 26.2 32.0 42.4 46.0 32.2 42.0 41.7 38.6 42.9 52.3 48.7 26.3 33.5 50.1 42.2 28.2 36.7 77.0 32.6 42.9 41.8 32.7 36.7 26.7 36.0 41.7 94.2 45.2 28.9 41.8 39.3 33.4 33.2 32.7 35.7 33.0 37.8 60.4 43.9 33.3 32.4 30.4 31.2 30.9 40.9 34.2 57.7 40.5 42.1 63.6 44.4 28.8 31.2 33.1 36.6 43.0 30.9 52.1 41.5 68.3 26.4 28.5 29.6 43.0 40.3 31.5 44.7 39.9 74.8 25.5 47.2 62.6 52.1 55.6 31.2 62.7 41.9 32.9 30.0 53.4 49.4 24.4 47.0 30.6 47.0 36.5 48.3 74.0 46.2 23.7 39.1 42.8 54.9 43.4 88.2 41.3 36.8 49.7 37.4 50.9 29.5 52.0 24.3 46.9 51.3 30.4 44.0 64.0 60.1 29.4 86.3 38.8 59.9 46.1 38.4 45.1 40.6 22.8 25.6 30.9 37.8 37.2 51.4 30.4 44.8 40.4 31.2 24.4 37.7 42.2 8.1 34.2 40.9 22.4 57.7 40.5 44.8 42.6 47.7 48.3 38.6 42.9 50.1 42.2 41.8 35.7 47.6 76.5 84.8 121.6 84.0 80.6 136.5 122.3 78.9 86.4 64.6 17.7 224.0 208.9 141.7 473.4 88.7 101.6 140.2 187.9 149.0 99.1 113.3 89.9 118.0 143.6 68.3 87.2 75.5 81.1 1134.0 123.1 93.9 94.5 174.1 65.9 151.7 136.7 83.4 144.2 267.3 72.5 109.9 142.6 128.6 136.3 89.8 308.6 95.8 77.1 118.0 PSMC6 p42 ENSG00000100519 "Proteasome 26S subunit, ATPase 6" P62333 14 52707172-52728587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042823 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No 190000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042823: AB_2678188" "unprognostic (2.38e-2)" "unprognostic (2.72e-2)" "unprognostic (9.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-2)" "unprognostic (4.26e-3)" "unprognostic (3.14e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (2.79e-2)" "unprognostic (3.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.52e-2)" "unprognostic (5.00e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (4.67e-1)" 30.4 31.1 29.1 23.0 36.8 19.9 30.7 30.1 40.9 26.4 26.4 19.7 29.8 25.6 27.8 27.0 38.0 26.1 19.3 39.7 30.6 28.3 36.1 45.7 21.6 25.7 29.9 35.0 27.8 25.2 26.5 34.7 37.1 44.0 25.5 28.8 14.7 23.4 25.3 73.3 23.0 26.4 29.5 30.1 28.2 24.9 15.5 31.1 30.0 28.6 44.9 32.9 31.6 24.5 37.6 43.1 37.0 40.9 29.8 48.5 40.6 47.1 30.6 36.8 27.3 25.8 27.0 39.8 37.2 35.8 60.4 45.5 38.3 38.8 41.1 46.6 32.2 30.5 36.0 46.8 32.6 63.6 39.4 20.4 30.1 25.2 40.8 31.2 42.6 29.3 20.0 32.6 30.5 30.9 33.0 37.9 20.7 44.7 17.8 44.0 43.2 33.2 29.6 29.7 44.7 42.1 28.4 64.7 18.3 39.8 48.1 26.5 19.7 33.1 20.7 31.7 34.6 42.6 31.2 29.0 33.7 47.3 26.1 38.1 12.6 32.1 46.0 21.8 29.3 30.5 35.8 36.5 37.0 32.1 40.9 37.1 37.6 39.6 34.9 43.1 34.2 38.2 37.3 30.6 29.8 39.9 22.4 48.5 40.6 29.1 36.8 30.1 40.9 30.6 28.3 29.9 35.0 44.0 31.1 65.5 57.0 70.1 126.5 76.5 60.1 71.1 58.6 97.7 95.5 54.1 64.8 139.1 114.4 111.7 19.5 70.0 62.6 46.7 92.7 114.5 84.1 71.0 64.8 74.2 82.7 58.8 67.5 44.2 77.8 18.3 62.2 71.9 75.9 72.1 50.7 62.8 96.7 45.6 61.5 108.8 98.3 71.1 100.0 39.9 74.1 63.0 198.6 69.5 59.8 107.7 PSMD10 p28 ENSG00000101843 "Proteasome 26S subunit, non-ATPase 10" O75832 X 108084207-108091618 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002920, CAB010434" Approved Supported "Intermediate filaments,Cytosol" NA NA 82000 Cytosol "Intermediate filaments" "CAB010434: AB_640866, HPA002920: AB_1079708" "unprognostic (1.59e-3)" "unprognostic (4.12e-3)" "unprognostic (3.83e-1)" "unprognostic (3.00e-1)" "unprognostic (4.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.85e-3)" "unprognostic (2.35e-1)" "unprognostic (1.44e-1)" "unprognostic (2.06e-2)" "unprognostic (4.95e-2)" "unprognostic (7.37e-3)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (2.09e-1)" "unprognostic (5.07e-2)" "unprognostic (1.09e-1)" 15.8 23.6 35.5 14.3 32.1 14.2 20.9 27.4 31.1 21.7 19.0 30.3 13.4 14.8 22.4 29.8 21.6 27.1 15.1 14.7 32.0 50.2 20.5 19.0 16.5 18.0 38.9 29.6 19.9 11.1 20.3 20.9 26.1 39.0 19.4 19.8 17.1 14.6 19.0 13.3 15.3 17.4 21.6 38.9 14.8 15.7 15.6 23.8 21.2 24.3 12.2 21.8 22.0 16.1 28.1 30.7 40.2 38.8 32.2 32.4 35.1 31.6 32.2 22.2 19.9 33.7 25.4 20.1 26.1 21.7 23.7 20.7 19.1 20.4 27.0 40.1 24.9 35.1 17.2 34.7 25.2 36.5 29.3 30.0 15.8 31.3 24.0 17.1 24.4 17.7 19.3 27.5 21.9 26.6 23.7 58.3 26.7 30.5 36.7 29.5 41.5 23.1 21.4 40.2 30.3 44.0 23.4 31.7 28.6 25.4 20.5 14.3 13.7 40.0 16.6 26.2 29.4 18.0 21.2 41.8 18.9 10.9 31.7 19.3 29.3 40.3 28.6 26.1 34.2 22.1 38.3 26.9 40.2 28.2 33.0 30.2 28.1 28.6 30.1 30.4 27.2 28.8 32.2 13.2 32.2 38.8 30.7 32.4 35.1 35.5 32.1 27.4 31.1 32.0 50.2 38.9 29.6 39.0 23.8 17.9 16.6 18.6 21.6 20.0 14.1 9.3 7.6 89.7 40.9 10.4 2.0 25.9 26.6 15.8 3.4 24.3 13.1 46.7 16.5 28.7 22.2 23.5 32.4 22.6 28.0 12.7 13.8 23.4 25.1 3.8 23.9 19.4 16.9 20.8 18.3 16.6 20.4 8.6 19.8 27.9 6.3 0.0 16.4 25.4 40.6 25.5 20.9 15.8 18.8 29.4 PSMD12 "p55, Rpn5" ENSG00000197170 "Proteasome 26S subunit, non-ATPase 12" O00232 17 67337916-67366627 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023119 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA 44000 Microtubules "Nucleoplasm, Cytosol" "HPA023119: AB_1855845" "unprognostic (6.06e-2)" "unprognostic (3.16e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.35e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.28e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.32e-4)" "unprognostic (2.63e-1)" "unprognostic (7.32e-3)" "prognostic unfavorable (4.73e-6)" "unprognostic (1.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" 16.4 18.0 16.0 12.3 16.0 11.8 14.1 19.5 26.7 11.7 11.8 8.8 11.5 9.4 12.5 13.3 16.4 9.9 11.4 14.9 17.0 19.7 17.1 31.4 10.8 11.3 23.6 15.3 12.6 17.6 15.7 12.9 13.7 32.5 12.8 13.8 8.1 12.5 11.0 42.3 11.6 10.8 15.7 13.4 12.0 12.4 15.5 11.3 12.7 12.2 18.9 16.7 17.2 19.6 8.8 10.8 12.1 18.1 11.4 14.0 8.9 28.4 17.4 13.8 15.1 10.6 12.9 18.9 20.3 13.0 22.6 20.1 18.0 12.7 16.4 13.1 16.5 17.8 16.9 23.9 20.8 34.0 7.9 17.8 19.1 14.5 18.5 13.8 19.8 11.8 14.2 13.9 21.4 16.9 10.1 22.2 12.7 25.4 9.8 21.2 19.5 18.1 19.2 16.6 13.7 23.1 9.3 35.5 14.7 16.8 23.8 13.2 19.1 15.0 29.4 19.6 17.0 21.0 16.8 22.8 24.1 16.2 18.0 36.6 10.0 15.3 13.9 28.4 21.0 13.8 12.1 10.6 8.8 9.9 17.4 14.0 8.6 13.0 11.1 10.8 8.8 11.7 12.3 7.6 11.4 18.1 7.0 12.1 8.9 16.0 16.0 19.5 26.7 17.0 19.7 23.6 15.3 32.5 11.3 44.7 50.4 33.7 90.9 99.7 41.1 95.7 28.1 60.2 102.4 43.6 23.6 81.6 59.7 68.1 139.8 67.3 22.6 23.3 68.5 68.6 54.6 70.8 48.6 75.5 49.5 87.4 31.6 41.1 43.5 155.9 42.8 55.9 45.5 62.3 25.6 57.8 66.4 21.0 41.4 62.2 40.5 25.8 111.2 105.1 101.1 82.8 102.9 48.5 28.3 110.7 PSMD13 "p40.5, Rpn9" ENSG00000185627 "Proteasome 26S subunit, non-ATPase 13" Q9UNM6 11 236546-252984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038691, HPA038692" Approved Approved "Nuclear speckles,Cytosol" NA NA 49000 "Nuclear speckles" Cytosol "HPA038691: AB_2676153, HPA038692: AB_10671749" "unprognostic (1.32e-2)" "unprognostic (7.98e-2)" "unprognostic (9.19e-2)" "prognostic favorable (5.74e-4)" "unprognostic (2.24e-2)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.76e-5)" "unprognostic (7.54e-3)" "unprognostic (2.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.52e-13)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" 24.2 17.9 18.4 20.9 21.3 29.1 28.6 22.1 25.6 24.0 23.6 19.2 20.0 15.6 25.3 20.3 26.8 20.6 19.1 31.8 19.6 20.4 23.4 34.9 23.0 29.8 17.1 19.1 18.1 26.5 15.1 18.0 31.7 21.8 24.0 19.5 16.8 20.9 21.1 56.5 25.5 20.5 21.3 17.0 26.9 18.8 21.2 12.9 32.8 23.3 30.0 27.0 20.5 17.9 20.8 33.5 25.1 32.6 26.4 26.6 39.0 31.1 18.6 22.2 22.9 22.4 20.4 12.8 21.4 30.4 47.0 34.7 16.4 42.1 29.6 20.9 26.1 17.1 29.5 28.0 32.3 37.4 23.8 21.3 13.1 7.2 11.3 25.0 31.9 27.8 18.0 23.2 23.4 20.3 11.5 42.6 21.2 33.1 23.1 35.9 12.3 26.6 19.6 29.7 15.4 27.0 20.6 21.8 20.9 27.5 8.3 18.0 14.2 15.7 16.8 16.6 12.1 10.3 19.8 27.9 13.8 13.2 7.0 25.0 21.0 24.2 38.4 24.8 25.6 22.8 22.2 31.4 20.5 23.5 30.6 26.3 20.8 24.1 23.6 33.5 18.5 21.3 23.3 25.1 26.4 32.6 22.7 26.6 39.0 18.4 21.3 22.1 25.6 19.6 20.4 17.1 19.1 21.8 12.9 44.7 33.8 60.3 44.1 31.8 40.7 42.3 58.6 57.6 36.4 29.6 29.5 145.8 69.6 99.0 33.5 47.1 60.8 23.3 114.2 117.3 41.0 50.8 65.8 52.5 89.1 35.0 46.1 53.4 49.4 36.2 63.6 57.7 43.9 94.6 55.5 65.1 96.7 55.4 56.3 59.8 35.5 84.1 46.4 67.4 79.3 33.9 172.1 62.3 58.8 45.6 PSMD3 "P58, Rpn3, S3, TSTA2" ENSG00000108344 "Proteasome 26S subunit, non-ATPase 3" O43242 17 39980797-39997960 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 141.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017038, HPA048972" Approved Enhanced Nucleoplasm,Cytosol No No 380000 Nucleoplasm Cytosol "CAB017038: , HPA048972: AB_2680579" "unprognostic (3.44e-2)" "unprognostic (3.10e-1)" "unprognostic (2.22e-2)" "unprognostic (5.21e-2)" "unprognostic (7.87e-2)" "unprognostic (8.36e-3)" "unprognostic (5.75e-3)" "unprognostic (7.46e-2)" "unprognostic (6.19e-2)" "unprognostic (1.61e-1)" "unprognostic (6.89e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (4.47e-7)" "unprognostic (1.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.85e-2)" "unprognostic (7.45e-2)" 25.1 27.7 20.0 25.0 26.1 22.0 21.3 30.0 40.3 22.5 28.1 22.4 16.8 23.2 26.8 21.2 27.7 22.7 23.7 36.1 20.6 21.4 23.8 54.4 20.8 22.3 19.2 23.7 24.0 23.6 28.1 20.8 33.8 24.5 23.2 25.4 21.4 22.5 21.9 93.2 33.2 23.5 24.7 17.6 26.9 21.1 19.9 17.5 35.7 24.3 39.2 26.3 20.7 21.2 15.6 24.3 14.4 17.0 13.1 17.7 12.0 32.7 40.9 22.5 32.3 18.4 11.9 26.8 24.2 25.2 43.7 34.0 33.8 28.3 39.5 61.0 25.9 29.3 51.5 39.9 31.6 29.6 39.7 44.5 22.8 21.0 33.4 16.7 30.7 25.6 15.8 27.0 46.2 20.3 14.7 24.6 27.7 46.5 24.7 20.2 23.9 47.5 21.1 31.2 21.3 24.3 35.0 31.3 37.0 21.8 22.2 29.7 22.5 23.1 141.9 19.9 28.6 31.9 26.6 21.9 18.9 33.5 27.9 43.2 26.9 34.1 44.0 29.0 23.2 30.5 6.6 16.8 14.4 15.1 17.0 15.1 14.4 14.6 17.7 24.3 15.6 13.7 16.5 5.5 13.1 14.3 16.7 12.6 12.0 20.0 26.1 30.0 40.3 20.6 21.4 19.2 23.7 24.5 17.5 41.7 37.3 61.7 49.4 41.4 70.1 17.3 15.3 16.0 29.6 15.7 19.6 147.2 39.7 91.3 204.0 32.3 72.1 23.3 91.5 109.0 44.2 48.0 24.3 44.4 86.1 57.2 25.3 27.0 23.7 35.1 58.1 39.1 62.4 73.1 44.9 81.4 81.7 58.8 50.9 43.1 47.4 25.8 47.6 47.1 57.9 39.0 227.2 36.2 61.2 47.1 PSMD4 "AF, AF-1, Rpn10, S5A" ENSG00000159352 "Proteasome 26S subunit, non-ATPase 4" P55036 1 151254703-151267479 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038807, HPA039252, CAB047300" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418" "unprognostic (3.83e-2)" "unprognostic (7.89e-2)" "unprognostic (6.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-2)" "unprognostic (1.79e-3)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.61e-2)" "unprognostic (7.57e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (6.66e-10)" "unprognostic (9.80e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (3.91e-1)" 27.5 28.0 44.3 24.4 46.4 25.5 29.9 25.7 50.4 21.9 28.6 28.3 16.5 22.7 25.1 41.5 26.7 31.4 21.8 38.7 37.5 36.8 25.3 44.7 20.2 28.2 47.5 44.8 26.7 27.7 27.4 19.3 30.0 43.2 23.0 28.1 24.3 25.6 31.2 86.7 28.0 20.5 39.3 29.6 26.3 25.8 35.9 29.1 23.1 23.7 25.7 36.2 28.0 19.8 62.7 65.1 111.6 76.0 54.2 74.2 88.2 42.3 51.0 37.7 30.8 41.1 30.5 41.1 28.7 35.3 45.9 36.7 66.7 48.5 34.4 70.6 40.5 31.8 44.4 48.4 43.4 39.3 56.1 42.2 33.6 43.5 68.7 45.4 39.4 39.2 33.0 36.1 52.4 48.5 34.5 40.0 38.7 52.2 43.8 38.4 124.8 36.2 48.0 71.6 65.6 51.6 30.8 36.7 62.1 45.0 36.3 29.6 50.5 31.9 46.9 38.0 58.2 49.0 78.0 35.1 22.9 36.0 28.1 49.0 52.5 65.1 73.4 38.0 37.2 41.7 59.6 71.5 111.6 43.0 76.0 48.4 62.7 50.5 47.3 65.1 61.1 46.4 46.0 95.8 54.2 75.5 39.2 74.2 88.2 44.3 46.4 25.7 50.4 37.5 36.8 47.5 44.8 43.2 29.1 53.6 55.8 113.9 90.7 78.8 48.8 216.6 79.0 80.3 42.1 57.6 25.5 289.4 142.6 149.2 182.3 103.4 106.2 93.5 163.0 189.2 97.9 84.2 80.9 96.2 163.2 31.8 80.8 69.3 92.1 179.3 97.5 96.7 99.5 354.3 71.9 58.4 143.7 95.1 92.6 161.4 44.8 116.4 130.8 169.8 77.8 75.7 346.7 94.7 97.0 85.8 PSMD5 "KIAA0072, S5B" ENSG00000095261 "Proteasome 26S subunit, non-ATPase 5" Q16401 9 120815496-120842984 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003216 Uncertain Approved Nucleoplasm,Cytosol No No 12000000 Cytosol Nucleoplasm "HPA003216: AB_1079709" "unprognostic (7.72e-2)" "unprognostic (5.20e-2)" "unprognostic (2.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.44e-3)" "unprognostic (8.02e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-1)" "unprognostic (3.45e-2)" "unprognostic (2.04e-3)" "unprognostic (4.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.87e-1)" 14.1 20.1 10.2 12.2 16.2 14.7 32.5 20.7 21.8 14.6 12.9 10.2 12.3 10.3 14.8 14.1 17.3 13.8 10.6 12.7 11.7 12.3 11.5 21.0 34.8 23.6 9.8 14.1 16.7 32.2 13.3 11.7 10.5 14.5 16.1 12.5 8.8 15.1 15.7 10.0 16.7 11.2 24.5 9.9 12.3 14.4 11.3 8.1 13.0 12.6 9.2 15.5 14.9 13.5 17.5 14.4 15.2 17.9 14.2 25.2 14.2 13.1 17.1 8.3 15.4 18.6 18.5 9.8 19.5 15.3 18.5 16.9 15.2 8.7 13.4 8.9 19.8 14.6 19.7 0.0 19.2 21.6 12.2 1.9 11.2 23.8 8.4 14.0 3.9 4.2 15.5 12.5 17.9 19.2 9.2 10.7 14.7 41.0 9.0 17.2 16.3 11.9 8.1 12.3 32.1 12.2 11.0 18.1 10.6 17.0 11.6 11.4 7.3 23.6 20.1 9.3 6.5 24.0 9.5 16.5 0.0 10.0 7.7 17.2 5.4 5.4 14.7 11.4 12.9 16.3 15.2 14.9 12.3 17.1 16.5 18.6 17.5 19.9 20.5 14.4 13.2 19.4 15.1 8.1 14.2 17.9 10.5 25.2 14.2 10.2 16.2 20.7 21.8 11.7 12.3 9.8 14.1 14.5 8.1 8.9 14.2 12.8 9.5 11.0 14.0 7.5 12.7 6.7 21.6 8.7 11.8 10.1 10.0 10.8 5.2 10.9 9.5 0.0 11.6 9.5 13.9 12.5 13.9 22.2 10.6 4.8 7.5 16.0 13.9 3.2 12.0 10.6 13.5 7.2 14.3 9.5 13.9 10.8 15.2 12.9 10.4 6.5 15.1 21.1 20.0 11.8 9.2 17.5 9.3 8.4 PSMD8 "HIP6, HYPF, Nin1p, p31, Rpn12, S14" ENSG00000099341 "Proteasome 26S subunit, non-ATPase 8" P48556 19 38374536-38383824 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 704.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006702, CAB021101" Supported Approved "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "CAB021101: AB_10061018, HPA006702: AB_1079710" "unprognostic (9.50e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.59e-1)" "unprognostic (5.54e-3)" "unprognostic (1.94e-3)" "unprognostic (5.03e-2)" "unprognostic (2.85e-2)" "unprognostic (1.73e-2)" "unprognostic (4.61e-1)" "unprognostic (8.79e-2)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.28e-1)" "unprognostic (2.08e-2)" "unprognostic (2.58e-3)" "unprognostic (4.84e-2)" 53.0 35.1 30.0 23.9 35.6 32.9 43.0 28.1 49.4 26.5 31.8 25.8 30.1 31.5 30.9 40.9 39.1 32.5 28.0 75.3 32.2 29.3 40.9 71.1 28.8 28.8 27.1 37.0 24.4 48.2 30.6 29.2 56.6 30.0 33.6 32.9 24.6 32.6 29.7 157.1 42.2 33.2 34.5 25.0 27.6 28.9 55.8 21.4 38.1 35.4 50.1 33.9 28.3 27.1 40.4 60.8 32.0 68.1 38.8 65.6 68.7 60.5 96.6 38.1 43.4 62.1 50.0 20.0 44.1 60.2 68.0 71.1 66.2 36.5 42.7 46.1 58.7 41.8 21.1 63.6 54.8 61.5 70.3 42.0 46.4 31.9 40.8 80.4 46.7 41.3 50.4 54.8 58.5 78.0 37.6 53.3 52.0 57.8 48.1 74.7 60.3 44.1 26.3 29.6 89.7 52.8 46.0 61.2 33.9 48.1 50.5 39.9 40.6 45.8 59.3 42.8 37.1 30.9 44.1 39.2 52.0 48.1 54.4 64.6 48.7 56.2 57.0 78.2 48.1 57.7 32.0 55.2 29.2 46.1 59.9 39.1 40.4 40.4 44.2 60.8 37.0 33.6 32.6 20.8 38.8 68.1 42.3 65.6 68.7 30.0 35.6 28.1 49.4 32.2 29.3 27.1 37.0 30.0 21.4 62.5 58.2 119.9 188.9 182.9 97.2 223.0 73.9 99.0 68.2 76.8 51.1 304.9 295.1 231.4 321.4 92.0 206.5 70.0 232.9 276.1 132.4 178.0 91.2 110.9 262.3 73.1 140.2 70.6 89.4 704.4 109.6 143.2 189.0 308.4 120.9 153.3 230.1 154.3 110.7 228.8 89.3 148.8 173.9 203.2 136.5 185.6 476.9 127.8 132.9 185.9 PSMD9 "p27, Rpn4" ENSG00000110801 "Proteasome 26S subunit, non-ATPase 9" O00233 12 121888731-121918297 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040512, HPA044220" Enhanced Supported "Plasma membrane,Cytosol" NA NA 330000 Cytosol "Plasma membrane" "HPA040512: AB_2677014, HPA044220: AB_2678860" "unprognostic (2.24e-1)" "unprognostic (2.48e-3)" "unprognostic (2.12e-1)" "unprognostic (3.36e-1)" "unprognostic (1.20e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (9.64e-3)" "unprognostic (3.17e-2)" "unprognostic (5.73e-2)" "unprognostic (6.19e-2)" "unprognostic (8.63e-2)" 25.6 10.7 11.5 12.9 12.1 27.8 18.7 15.3 12.0 9.6 22.1 9.2 14.8 19.5 14.4 13.6 12.3 10.7 12.5 13.9 10.6 11.2 19.2 19.8 12.3 14.8 10.6 9.0 13.0 28.6 4.9 8.3 8.7 12.7 9.5 4.8 9.4 15.3 14.2 28.6 12.4 16.3 15.7 11.6 14.8 24.7 13.6 8.7 13.8 10.9 17.1 9.2 8.2 11.8 24.5 36.7 29.6 26.3 14.9 25.9 27.3 20.5 31.6 2.6 4.8 4.4 4.5 5.5 21.1 6.8 10.6 6.0 23.1 2.5 15.4 17.9 10.8 3.6 8.4 7.5 11.1 6.3 29.6 16.7 12.5 14.7 11.4 11.0 8.8 8.9 8.0 5.3 11.8 4.5 3.8 6.3 9.6 11.2 2.2 6.6 24.1 17.6 6.6 5.5 2.6 24.7 13.4 7.2 9.4 5.1 20.7 5.5 7.7 21.1 3.1 11.3 2.3 9.1 4.4 16.7 10.1 11.6 19.8 14.7 12.0 26.0 22.4 18.1 11.5 9.2 20.3 26.3 29.6 20.9 25.4 16.7 24.5 20.1 18.9 22.2 19.5 15.8 13.6 24.1 14.9 22.0 36.7 25.9 27.3 11.5 12.1 15.3 12.0 10.6 11.2 10.6 9.0 12.7 8.7 44.7 31.8 34.3 9.8 53.8 6.7 7.1 30.6 33.5 38.7 33.2 17.7 25.4 44.7 101.5 24.4 23.2 71.9 93.5 106.1 25.7 39.1 8.6 43.8 24.3 35.7 14.3 44.7 28.8 45.7 8.3 35.1 46.2 52.3 130.8 56.1 12.5 112.4 56.1 36.4 69.8 12.6 38.8 43.4 26.5 32.8 62.6 31.6 49.0 62.2 9.2 PSME1 "IFI5111, PA28alpha" ENSG00000092010 "Proteasome activator subunit 1" Q06323 14 24136158-24138967 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 1206.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006632 Approved Approved "Nuclear bodies,Cytosol" NA NA 8600000 Cytosol "Nuclear bodies" "HPA006632: AB_1079686" "prognostic favorable (8.87e-5)" "unprognostic (1.02e-2)" "unprognostic (9.90e-2)" "unprognostic (2.84e-1)" "unprognostic (2.65e-1)" "unprognostic (1.97e-1)" "unprognostic (5.16e-1)" "unprognostic (7.04e-2)" "unprognostic (9.63e-3)" "unprognostic (5.06e-3)" "unprognostic (1.49e-2)" "unprognostic (1.38e-2)" "unprognostic (1.14e-2)" "unprognostic (1.45e-1)" "unprognostic (4.50e-1)" "prognostic favorable (4.60e-4)" "unprognostic (1.62e-3)" 37.6 59.1 19.1 64.4 23.0 37.2 59.7 9.9 16.9 34.8 53.9 15.3 47.4 48.2 40.3 50.4 45.4 39.4 53.4 59.1 19.6 17.2 67.7 70.3 61.7 114.2 24.8 17.4 46.7 47.2 26.4 30.6 42.7 21.3 39.2 44.8 28.4 38.0 57.0 38.0 33.7 82.3 45.0 20.4 82.8 38.9 14.5 22.5 70.5 58.4 54.3 52.0 35.8 40.4 68.2 72.2 112.1 93.3 81.2 87.8 132.3 17.7 14.8 11.3 21.6 24.6 28.4 17.3 11.3 37.1 36.4 52.4 9.5 43.3 45.8 8.5 18.9 19.4 25.8 16.0 23.5 24.5 38.2 9.9 20.3 7.3 52.3 54.1 25.8 26.0 24.8 15.2 16.5 14.5 34.7 27.5 29.5 3.1 41.0 14.2 45.1 66.5 31.6 1.0 29.6 25.5 52.9 23.1 32.8 46.0 47.1 7.2 12.8 14.4 37.7 21.9 7.0 24.7 25.4 15.5 10.0 11.8 11.4 16.8 38.2 39.3 21.7 13.7 23.1 16.1 53.2 74.4 89.4 87.0 93.3 87.0 68.2 82.0 82.6 72.2 61.6 59.4 72.7 112.1 81.2 89.4 68.5 87.8 132.3 19.1 23.0 9.9 16.9 19.6 17.2 24.8 17.4 21.3 22.5 193.5 156.8 343.2 204.1 138.9 26.6 52.0 236.9 155.2 184.2 268.7 9.8 343.2 270.2 429.0 2.7 231.5 431.2 116.8 481.9 234.7 186.7 203.3 233.3 201.1 286.2 6.4 182.0 199.5 245.3 8.6 175.2 260.5 178.8 1206.5 304.4 72.8 372.3 455.9 117.4 453.6 19.7 103.5 168.3 2.3 26.2 136.4 254.6 355.3 342.0 230.4 PSMF1 PI31 ENSG00000125818 "Proteasome inhibitor subunit 1" Q92530 20 1113263-1189415 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 19 "Early spermatids: 1123.3;Late spermatids: 3219.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041122, HPA041300" Approved Enhanced Cytosol NA NA 270000 Cytosol "HPA041122: AB_10805838, HPA041300: AB_10794370" "unprognostic (1.79e-2)" "unprognostic (8.96e-2)" "unprognostic (7.22e-2)" "unprognostic (3.88e-2)" "unprognostic (1.68e-3)" "unprognostic (1.43e-2)" "unprognostic (9.14e-3)" "unprognostic (1.56e-1)" "unprognostic (7.03e-2)" "unprognostic (4.71e-1)" "unprognostic (2.45e-1)" "unprognostic (7.41e-2)" "unprognostic (3.72e-3)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (4.18e-2)" "unprognostic (8.32e-2)" 27.3 21.5 23.4 23.9 26.4 27.3 23.0 22.9 32.7 21.8 26.5 26.9 19.8 27.2 24.6 24.1 29.3 22.5 27.4 27.7 21.6 21.2 25.1 63.7 23.7 29.9 23.2 19.8 28.2 48.3 23.7 20.4 20.5 28.2 21.2 19.3 26.2 33.6 24.0 67.2 25.3 28.4 23.9 23.4 22.8 25.7 86.2 19.2 31.9 27.7 42.1 24.5 26.2 25.7 31.4 28.7 51.5 33.9 24.1 33.6 26.2 38.6 35.2 8.5 20.2 18.2 19.3 14.8 23.6 17.9 21.4 19.2 33.1 27.2 19.7 15.9 24.4 23.0 35.1 21.8 40.0 26.9 11.5 13.1 28.1 6.3 60.1 24.5 32.9 9.5 19.3 23.2 24.2 37.5 13.2 23.0 15.7 28.0 39.6 17.4 20.6 41.9 28.8 12.6 22.2 21.7 20.2 18.0 32.3 18.9 32.8 21.6 15.3 26.0 45.6 21.4 8.4 30.6 11.9 27.4 27.5 18.8 31.8 31.8 24.6 48.2 21.1 12.2 22.8 20.9 43.2 28.6 51.5 23.0 33.9 26.5 31.4 30.8 25.0 28.7 27.6 28.4 24.7 31.1 24.1 33.2 16.4 33.6 26.2 23.4 26.4 22.9 32.7 21.6 21.2 23.2 19.8 28.2 19.2 32.8 43.6 51.3 52.3 36.6 32.7 45.6 25.5 32.1 27.3 38.4 3.9 59.1 69.6 90.2 1123.3 44.7 57.7 46.7 90.0 73.1 49.0 49.8 49.5 57.6 88.7 20.6 64.8 52.8 47.0 3219.2 71.7 56.6 49.0 82.0 52.3 45.6 80.0 65.4 83.4 64.4 26.8 116.4 64.1 69.0 63.9 42.4 61.9 53.2 59.6 60.7 PSMG1 "c21-LRP, DSCR2, LRPC21, PAC1" ENSG00000183527 "Proteasome assembly chaperone 1" O95456 21 39174769-39183851 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 408.1;Spermatocytes: 226.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057193, HPA070225" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Nucleoplasm, Golgi apparatus, Cytosol" "HPA057193: AB_2683363, HPA070225: AB_2686236" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.10e-1)" "unprognostic (9.38e-2)" "unprognostic (5.06e-3)" "unprognostic (2.02e-1)" "unprognostic (1.66e-2)" "unprognostic (5.09e-2)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.84e-1)" "unprognostic (8.98e-2)" "unprognostic (1.32e-2)" "unprognostic (4.17e-3)" 7.0 11.0 8.2 8.7 8.0 15.1 6.9 7.7 13.1 7.0 10.2 4.7 5.2 9.2 8.2 9.2 12.5 6.9 9.4 7.6 7.5 8.9 11.7 21.4 6.1 8.1 6.9 10.2 7.9 21.5 5.1 10.0 7.5 8.5 5.7 10.0 7.3 8.0 5.2 13.0 7.0 8.4 8.3 7.1 7.0 7.1 67.3 4.6 7.8 10.6 10.4 7.6 6.7 7.4 11.4 11.5 7.3 7.9 6.7 14.9 7.9 27.1 8.9 6.5 8.9 3.2 3.7 17.3 15.0 6.6 11.8 7.6 16.3 7.1 29.4 8.0 4.2 10.5 7.8 10.2 8.0 7.7 12.6 16.1 55.6 13.8 21.1 5.8 26.4 11.1 5.1 6.0 12.5 12.6 2.6 6.2 12.8 40.9 16.9 7.0 14.4 16.2 14.3 22.4 10.4 13.9 26.5 8.1 29.9 4.9 8.1 20.7 6.1 18.9 10.7 14.9 1.2 10.1 13.3 7.0 13.6 4.7 18.2 21.2 13.0 20.5 25.5 11.5 44.7 10.4 7.3 6.4 3.5 10.6 7.8 12.2 11.4 14.9 12.2 11.5 9.0 11.9 10.4 0.5 6.7 7.9 10.5 12.6 7.9 8.2 8.0 7.7 13.1 7.5 8.9 6.9 10.2 8.5 4.6 6.0 18.3 19.9 34.3 120.8 14.8 21.8 22.9 12.0 29.6 19.2 3.9 93.4 56.3 35.1 408.1 22.4 14.4 0.0 43.3 92.9 37.1 22.6 34.7 28.1 51.9 7.9 28.7 19.6 18.1 33.7 29.4 26.6 43.9 26.2 40.2 9.4 31.9 21.0 31.1 76.3 16.1 25.8 31.9 226.4 91.0 85.4 45.5 20.3 50.8 26.7 PSPH PSP ENSG00000146733 "Phosphoserine phosphatase" P78330 7 56011051-56051604 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 91.2;Early spermatids: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020376, HPA029515" Approved Approved Cytosol NA NA Cytosol "HPA020376: AB_1855867, HPA029515: AB_10601492" "prognostic unfavorable (2.30e-4)" "unprognostic (7.80e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.66e-3)" "prognostic unfavorable (2.75e-5)" "unprognostic (1.74e-1)" "unprognostic (2.13e-1)" "unprognostic (4.45e-2)" "prognostic favorable (3.77e-4)" "unprognostic (3.78e-2)" "unprognostic (5.74e-2)" "unprognostic (2.64e-1)" "unprognostic (3.01e-2)" "unprognostic (1.90e-3)" "unprognostic (9.05e-3)" 7.5 13.4 14.1 5.9 16.6 5.1 11.0 10.1 14.6 5.4 8.0 13.2 11.4 6.9 7.0 9.0 11.0 26.3 10.6 12.8 13.2 12.5 14.7 9.8 5.4 7.4 14.8 10.0 13.9 15.9 7.8 17.1 6.4 11.1 10.6 6.9 6.9 6.8 11.5 6.8 6.4 6.2 8.5 15.2 5.7 8.5 9.1 13.3 10.2 12.2 6.9 8.5 7.1 16.0 7.8 11.9 6.8 8.5 5.3 6.2 5.8 46.9 14.4 8.8 32.9 7.4 10.0 6.1 11.9 7.0 6.6 11.8 12.9 8.2 23.2 8.0 11.0 16.7 9.8 19.5 10.1 6.9 17.6 10.9 6.5 3.9 21.7 15.9 6.5 10.0 12.5 19.0 10.5 12.2 9.4 6.5 22.0 15.5 15.0 10.0 6.3 9.9 15.5 14.1 16.8 20.2 13.0 5.3 13.3 6.3 2.4 16.1 18.6 8.6 5.3 23.8 7.5 15.9 13.7 5.5 5.8 9.2 17.9 10.8 10.4 18.0 26.3 8.3 14.3 18.2 2.2 7.7 6.8 4.2 5.3 3.0 7.2 4.0 5.1 11.9 7.8 6.2 5.5 3.6 5.3 8.5 11.3 5.1 5.8 14.1 16.6 10.1 14.6 13.2 12.5 14.8 10.0 11.1 13.3 3.0 1.0 9.7 8.3 6.1 4.4 9.4 17.8 34.8 9.1 5.2 2.0 11.9 91.2 7.9 131.4 3.6 1.3 0.0 6.8 6.3 5.3 5.3 1.1 7.3 7.9 1.6 4.6 6.7 6.5 38.2 7.8 4.8 6.8 4.6 3.9 41.4 7.8 3.5 5.6 39.1 2.8 12.9 5.7 23.6 26.0 7.4 3.9 5.0 7.5 4.7 PSRC1 DDA3 ENSG00000134222 "Proline and serine rich coiled-coil 1" Q6PGN9 1 109279556-109283186 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 23.6;Extravillous trophoblasts: 28.6;Peritubular cells: 42.1;Rod photoreceptor cells: 70.6" "Cancer enhanced" "Detected in all" "glioma: 50.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 12.3" "Group enriched" "Detected in many" 10 "dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in some" 6 "amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3" "Low region specificity" "Detected in all" HPA056561 Approved Nucleoplasm,Cytosol NA Yes Cytosol Nucleoplasm "HPA056561: AB_2683175" "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.42e-3)" "unprognostic (6.78e-3)" "unprognostic (2.17e-1)" "unprognostic (4.76e-2)" "prognostic unfavorable (1.36e-9)" "unprognostic (3.51e-2)" "unprognostic (6.21e-2)" "unprognostic (4.88e-3)" "unprognostic (1.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.43e-2)" "unprognostic (2.08e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" 1.7 2.4 17.1 4.3 21.6 8.3 3.0 3.8 27.3 2.0 4.0 31.2 0.3 5.1 3.0 3.4 6.3 3.2 3.7 2.0 25.9 11.2 1.7 2.6 2.2 4.0 29.8 12.9 3.6 1.4 0.8 1.7 4.8 16.8 4.0 3.3 4.5 2.9 5.9 1.0 6.1 5.3 4.7 30.6 2.3 2.4 8.6 20.7 5.5 2.0 0.4 5.0 2.6 2.3 0.0 5.4 7.3 12.3 0.2 0.7 3.2 18.8 9.8 40.0 19.3 1.6 3.2 11.0 15.0 12.2 20.5 19.7 15.0 7.9 9.6 5.5 7.4 9.6 13.6 21.5 12.3 17.2 3.7 10.4 6.0 13.1 12.2 1.8 6.4 6.9 3.6 1.1 8.1 5.8 7.7 10.0 11.5 13.6 4.4 16.4 17.1 9.7 4.3 16.5 8.7 11.2 15.1 38.5 3.2 6.9 5.0 16.8 9.7 8.4 12.9 15.4 15.2 7.8 6.1 5.1 12.7 21.0 8.9 24.6 3.4 2.2 3.3 10.2 15.3 35.3 0.0 12.3 1.8 0.7 4.8 0.5 0.0 0.7 0.2 5.4 0.0 0.4 0.4 7.3 0.2 2.6 0.0 0.7 3.2 17.1 21.6 3.8 16.4 25.9 11.2 29.8 12.9 16.8 20.7 0.0 3.8 0.0 2.3 1.8 6.5 0.9 2.5 1.4 0.0 1.8 23.6 3.4 0.0 0.9 0.5 0.4 0.5 0.0 0.7 28.6 2.3 0.6 1.1 0.9 9.2 3.2 0.0 1.3 4.0 1.9 5.5 1.6 1.7 0.0 3.2 7.7 0.4 0.0 42.1 2.3 70.6 0.0 2.3 2.7 1.2 1.0 2.4 0.0 2.0 0.7 PTCHD4 "C6orf138, dJ402H5.2, FLJ41841, PTCH53" ENSG00000244694 "Patched domain containing 4" Q6ZW05 6 47878028-48068689 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 1.4;Collecting duct cells: 1.8" "Group enriched" "Detected in some" 6 "melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.1;BEWO: 13.5;Hep G2: 22.5;LHCN-M2: 10.7;SuSa: 22.9;TIME: 11.4;WM-115: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041276 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041276: AB_10796570" "unprognostic (1.35e-4)" "unprognostic (1.66e-2)" "unprognostic (3.25e-1)" "unprognostic (3.11e-3)" "unprognostic (1.07e-2)" "unprognostic (1.57e-3)" "unprognostic (7.94e-2)" "unprognostic (3.59e-3)" "unprognostic (2.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.49e-6)" "unprognostic (5.03e-4)" "unprognostic (9.84e-2)" "unprognostic (1.57e-2)" "unprognostic (5.56e-3)" 2.1 0.7 4.6 0.1 7.4 0.2 1.3 2.7 11.3 3.8 1.2 0.3 0.0 0.6 1.7 3.7 1.9 3.2 1.4 1.4 2.2 1.3 2.2 2.1 3.1 0.2 1.4 5.5 1.1 1.1 0.4 3.9 1.9 1.8 2.3 1.2 1.6 2.1 6.4 0.6 0.3 0.4 1.9 1.3 0.2 0.5 0.9 0.8 0.0 3.6 0.0 0.3 2.8 1.3 0.4 0.4 0.8 0.2 0.1 0.2 0.0 0.0 0.0 10.1 0.0 1.7 5.0 13.5 1.5 3.2 0.1 0.4 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 22.5 0.5 0.0 0.0 7.4 7.2 0.0 0.1 5.4 1.5 2.3 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.5 0.0 0.0 0.0 22.9 0.0 0.0 11.4 2.5 1.6 0.0 0.2 0.0 0.0 0.0 3.4 0.0 9.9 0.8 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.2 0.4 0.0 0.0 4.6 7.4 2.7 11.3 2.2 1.3 1.4 5.5 1.8 0.8 0.0 0.6 0.0 0.0 0.1 0.4 0.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PTEN "BZS, MHAM, MMAC1, PTEN1, TEP1" ENSG00000171862 "Phosphatase and tensin homolog" P60484 10 87863113-87971930 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Lipid metabolism, Neurogenesis" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 29.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004076, HPA031335" Approved Supported Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "CAB004076: AB_390810, HPA031335: AB_2797221" "unprognostic (8.72e-2)" "unprognostic (2.45e-1)" "unprognostic (5.43e-1)" "unprognostic (1.50e-2)" "unprognostic (3.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.18e-1)" "unprognostic (2.08e-1)" "unprognostic (2.07e-1)" "unprognostic (6.87e-2)" "unprognostic (9.77e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (7.35e-4)" "unprognostic (1.57e-1)" "unprognostic (2.73e-1)" "unprognostic (6.54e-3)" "unprognostic (2.41e-1)" 42.4 24.1 17.7 20.9 17.7 13.5 32.8 39.9 19.7 43.1 26.7 9.9 19.0 15.1 29.8 22.8 26.8 30.3 21.0 19.1 16.0 17.4 19.6 32.4 27.2 30.4 15.7 19.5 29.1 21.3 16.4 23.6 36.4 14.2 35.3 17.7 21.6 16.8 20.8 16.8 20.4 25.4 26.0 11.7 40.9 17.8 18.7 12.5 49.7 25.2 13.3 18.6 29.6 30.9 4.3 5.1 29.6 11.0 4.3 4.7 2.0 10.2 4.8 5.5 5.0 12.8 8.8 5.0 5.5 12.2 6.5 9.1 4.9 12.6 12.1 3.7 9.0 3.8 6.2 7.4 6.3 10.3 6.0 2.1 4.0 12.5 6.0 13.7 13.5 6.9 6.0 17.6 8.2 10.6 27.6 9.1 7.7 3.0 32.9 5.9 7.8 7.6 24.6 2.0 8.9 0.0 11.8 2.9 8.9 10.1 5.8 2.0 9.0 7.3 3.5 9.2 4.6 9.7 19.6 7.9 21.4 5.0 8.3 4.4 10.8 14.0 13.8 6.6 12.8 1.2 8.3 7.9 12.2 3.6 11.0 3.9 4.3 4.0 3.5 5.1 3.7 4.7 4.5 29.6 4.3 7.2 4.2 3.5 2.0 17.7 17.7 39.9 19.7 16.0 17.4 15.7 19.5 14.2 12.5 32.8 55.3 40.2 50.0 49.8 113.3 39.2 40.8 25.4 28.4 27.9 37.3 22.6 28.2 23.2 57.0 44.4 33.9 0.0 25.8 44.5 52.3 36.9 25.3 58.6 31.3 42.9 30.0 47.9 167.4 70.7 52.6 69.1 59.1 27.9 44.1 54.1 30.2 24.6 51.2 30.8 55.8 90.5 118.8 24.9 24.0 52.6 47.9 35.7 39.2 51.2 PTER ENSG00000165983 "Phosphotriesterase related" Q96BW5 10 16436943-16513745 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 86.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 21.6;cerebellum: 8.9;cerebral cortex: 30.8;hippocampal formation: 22.7;hypothalamus: 8.9" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038044, HPA038045" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038044: AB_2675803, HPA038045: AB_10672616" "unprognostic (5.57e-2)" "unprognostic (1.04e-1)" "unprognostic (2.76e-2)" "unprognostic (3.14e-2)" "unprognostic (9.72e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.17e-1)" "unprognostic (4.51e-2)" "unprognostic (2.86e-1)" "unprognostic (2.05e-3)" "unprognostic (1.86e-1)" "prognostic favorable (6.52e-6)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (1.54e-2)" "unprognostic (5.36e-3)" 11.1 5.4 21.6 10.6 2.9 1.3 8.7 8.9 30.8 6.2 12.1 1.6 14.5 9.2 5.8 8.1 6.9 3.4 3.8 7.8 22.7 8.9 31.3 21.9 9.2 12.6 4.2 1.3 5.3 17.9 11.1 3.4 11.2 3.1 11.3 5.4 6.8 10.6 12.9 6.2 4.0 21.9 5.7 2.6 11.8 9.2 2.9 1.5 17.2 12.0 3.9 9.6 7.7 10.9 15.3 11.7 6.9 16.7 7.6 19.5 9.4 16.1 9.7 0.1 2.9 4.1 8.1 9.7 4.8 0.5 1.8 2.7 8.9 15.3 17.0 4.0 3.2 1.0 7.4 5.5 3.2 2.7 16.6 7.2 15.8 4.6 3.6 4.9 5.1 4.8 5.9 10.4 5.5 0.9 0.0 0.8 15.4 10.8 6.0 2.8 5.4 11.9 5.1 3.9 11.1 2.4 8.9 1.3 8.9 25.5 5.1 12.3 0.8 8.5 2.4 14.0 3.5 5.7 16.2 2.1 0.1 4.3 3.9 0.1 4.5 5.6 18.0 2.0 9.4 6.0 3.5 11.7 6.9 12.7 16.7 13.5 15.3 14.6 12.6 11.7 8.8 11.0 10.9 2.2 7.6 14.5 9.9 19.5 9.4 21.6 2.9 8.9 30.8 22.7 8.9 4.2 1.3 3.1 1.5 26.8 19.9 5.7 12.7 9.7 0.8 22.7 15.3 17.4 28.4 27.9 0.0 17.1 44.7 19.3 0.2 7.1 13.2 0.0 29.9 14.6 7.8 8.8 23.1 21.2 13.0 0.0 11.1 10.4 11.6 0.0 0.9 17.5 8.5 9.0 12.4 13.5 21.4 28.8 0.0 86.8 8.0 6.5 10.3 0.9 6.8 10.8 10.1 12.5 16.8 19.7 PTGES3 "cPGES, p23, TEBP" ENSG00000110958 "Prostaglandin E synthase 3" Q15185 12 56663341-56688408 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 358.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034319, HPA038672, HPA038673" Enhanced Approved Nucleoplasm,Cytosol NA NA 580000 Cytosol Nucleoplasm "CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786" "prognostic unfavorable (2.15e-5)" "unprognostic (2.60e-1)" "unprognostic (8.67e-3)" "unprognostic (7.07e-2)" "unprognostic (2.24e-1)" "unprognostic (2.96e-3)" "prognostic unfavorable (4.44e-6)" "unprognostic (4.33e-3)" "unprognostic (3.64e-2)" "prognostic favorable (4.36e-4)" "unprognostic (2.73e-2)" "unprognostic (2.31e-2)" "unprognostic (3.05e-3)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (2.07e-1)" 44.7 41.4 56.0 41.2 55.7 39.6 175.0 44.2 51.7 49.0 51.9 38.1 49.5 46.4 57.7 52.0 52.6 69.8 36.0 46.0 54.6 57.2 52.1 67.1 46.4 62.0 67.0 41.4 82.3 55.1 43.2 49.2 50.3 57.0 60.7 55.3 24.0 36.6 49.4 64.2 37.0 46.7 64.7 72.5 42.7 36.6 39.7 65.1 53.5 72.5 36.7 55.1 72.7 358.9 40.6 36.9 27.3 74.8 29.2 42.5 60.5 81.4 71.0 57.7 34.3 42.5 38.6 87.9 53.4 40.8 68.8 51.4 60.1 85.9 90.3 81.1 45.5 46.3 52.5 108.0 69.7 87.2 66.3 71.9 70.5 44.9 69.5 31.1 83.7 51.2 27.9 51.0 51.9 63.1 65.5 70.7 58.1 113.0 86.5 67.1 50.8 83.1 79.6 98.5 71.9 83.0 72.7 54.4 121.2 60.5 63.8 74.8 43.7 54.5 78.6 46.2 79.6 90.5 70.3 42.3 41.3 48.1 49.5 73.7 36.5 100.4 72.6 45.0 69.1 74.3 27.3 37.5 23.2 32.0 59.0 42.0 40.6 42.5 38.1 36.9 28.5 42.3 36.4 14.8 29.2 74.8 31.3 42.5 60.5 56.0 55.7 44.2 51.7 54.6 57.2 67.0 41.4 57.0 65.1 166.7 121.6 178.4 623.1 343.3 128.5 151.7 150.3 313.2 146.7 179.7 72.6 370.5 316.7 252.0 38.5 189.7 176.9 116.8 186.9 545.4 268.2 456.4 232.8 165.2 311.0 106.5 250.8 168.1 180.7 81.6 221.2 245.7 268.2 312.0 185.6 201.5 190.6 194.6 200.5 268.7 99.7 142.3 307.9 546.1 341.1 330.1 473.4 233.5 241.8 443.4 PTGES3L-AARSD1 ENSG00000108825 "PTGES3L-AARSD1 readthrough" Q9BTE6 17 42950526-42980528 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 46.6" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 4.0;Club cells: 1.2;granulocytes: 3.5" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 4.5" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 5.3" "Lineage enriched" "Detected in single" 28 "dendritic cells: 5.3" "Cell line enhanced" "Detected in many" "RH-30: 6.7;THP-1: 13.2" "Low region specificity" "Detected in all" "HPA021408, HPA022869, HPA023714" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (6.47e-2)" "unprognostic (1.25e-1)" "unprognostic (2.87e-1)" "unprognostic (5.44e-2)" "unprognostic (9.34e-4)" "unprognostic (1.56e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-2)" "unprognostic (1.82e-1)" "unprognostic (5.13e-1)" "unprognostic (3.27e-2)" "unprognostic (1.91e-4)" "unprognostic (1.83e-1)" 0.7 0.1 0.7 1.2 4.5 1.2 0.5 0.6 1.6 1.5 5.5 0.3 0.1 1.7 4.7 2.4 2.2 1.6 3.6 13.8 0.5 0.7 0.3 0.2 0.6 0.7 0.6 0.8 0.7 0.3 0.4 1.5 0.4 0.4 2.0 3.2 1.6 0.7 3.1 46.6 0.2 1.6 10.6 0.2 0.4 2.4 3.8 0.2 0.5 0.5 14.4 0.8 5.1 1.4 0.1 5.3 0.0 0.0 0.0 0.0 0.4 1.0 0.0 2.7 2.7 0.3 0.0 0.8 2.2 2.0 1.2 1.1 1.7 0.3 0.3 1.7 0.2 0.8 0.0 0.4 1.1 1.9 1.0 0.4 5.6 2.2 4.1 0.0 0.5 4.0 0.1 0.7 1.9 0.1 0.8 0.6 1.8 2.0 0.4 2.2 0.0 1.8 1.4 0.7 3.5 0.5 1.5 6.7 0.7 0.3 0.5 1.3 3.5 1.4 0.5 1.5 3.5 0.9 13.2 0.0 0.9 1.7 0.0 0.7 3.7 1.1 0.4 0.3 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.4 0.7 4.5 0.6 1.6 0.5 0.7 0.6 0.8 0.4 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PTHLH "HHM, PLP, PTHR, PTHRP" ENSG00000087494 "Parathyroid hormone like hormone" P12272 12 27958084-27972705 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 45.6" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 7.9;Melanocytes: 21.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 64.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "T-reg: 3.0" "Lineage enriched" "Detected in single" 30 "T-cells: 3.0" "Group enriched" "Detected in some" 4 "HaCaT: 64.7;HBEC3-KT: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035982 Approved Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA035982: AB_10794631" "unprognostic (1.67e-1)" "unprognostic (5.26e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.60e-2)" "unprognostic (1.18e-1)" "unprognostic (5.16e-2)" "unprognostic (4.09e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (1.82e-9)" "unprognostic (2.01e-2)" "unprognostic (1.34e-1)" "unprognostic (5.23e-3)" "unprognostic (7.87e-3)" 2.9 1.0 6.5 3.5 5.3 0.0 20.2 1.4 8.7 11.0 2.3 1.4 2.1 2.4 11.2 2.0 17.0 1.2 45.6 4.0 4.3 3.5 0.4 0.2 1.3 1.1 1.4 4.3 2.6 1.7 0.7 2.3 3.6 3.1 5.5 1.8 2.4 5.3 2.6 0.7 1.5 1.6 13.4 0.8 3.6 1.9 1.3 1.0 0.1 1.4 15.8 3.4 8.0 12.3 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.0 0.2 0.1 0.2 0.0 1.7 0.0 0.1 0.5 2.1 64.7 0.2 80.0 0.0 1.6 0.3 0.1 0.4 0.0 0.2 0.0 0.1 0.0 4.4 2.0 7.9 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.7 0.0 0.3 0.1 7.7 0.0 0.0 0.0 3.6 0.0 0.4 2.7 0.1 0.0 1.2 0.3 2.0 1.1 17.0 1.0 0.0 2.6 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 6.5 5.3 1.4 6.2 4.3 3.5 1.4 4.3 3.1 1.0 0.0 0.0 0.0 1.1 4.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.0 4.2 1.3 0.0 0.0 7.9 0.0 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.9 0.2 21.9 1.0 0.0 2.2 5.5 0.0 0.0 0.0 0.3 6.5 2.8 0.4 0.1 1.3 0.0 0.0 0.0 0.1 PTK2 "FADK, FAK, FAK1, PPP1R71" ENSG00000169398 "Protein tyrosine kinase 2" Q05397 8 140657900-141002216 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Angiogenesis "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001842, CAB004036, HPA029671" Approved Supported "Vesicles,Focal adhesion sites,Cytosol" NA NA 32000 "Focal adhesion sites" "Vesicles, Cytosol" "CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288" "prognostic unfavorable (3.21e-4)" "unprognostic (3.86e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.93e-1)" "unprognostic (2.28e-1)" "unprognostic (3.02e-2)" "unprognostic (1.27e-1)" "unprognostic (1.97e-1)" "unprognostic (2.96e-2)" "unprognostic (1.06e-2)" "unprognostic (2.38e-1)" "unprognostic (2.80e-2)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (1.53e-1)" "unprognostic (2.90e-2)" 22.6 20.4 36.0 14.4 42.3 3.1 19.3 20.5 40.8 24.9 17.9 55.7 23.5 14.5 20.2 29.9 14.6 18.7 18.4 20.0 43.5 23.9 22.3 17.0 21.5 13.0 41.4 31.4 19.4 18.2 33.1 13.0 42.1 30.0 19.2 20.7 11.0 21.9 25.5 17.9 13.5 16.3 21.9 38.0 12.2 17.5 21.2 46.1 2.8 22.5 10.2 14.0 22.2 17.8 8.6 7.2 1.8 3.9 5.2 5.7 4.1 14.5 23.1 32.1 11.5 13.5 14.5 20.7 14.4 20.0 13.4 13.2 10.1 12.0 8.8 32.6 18.3 18.9 17.1 18.8 32.8 20.4 0.1 8.8 19.5 12.8 13.9 18.5 0.0 9.2 9.8 16.2 16.8 23.7 35.4 39.6 12.5 19.6 0.2 17.9 25.2 0.2 0.1 12.4 31.5 25.8 12.9 17.6 0.4 28.4 33.1 12.7 15.9 22.4 7.2 14.5 29.6 17.0 0.3 23.9 13.3 25.0 15.6 16.1 0.0 0.1 0.9 17.2 0.1 17.9 1.8 3.9 0.0 0.3 1.6 0.0 6.8 0.8 0.1 5.3 8.6 5.7 2.0 1.7 5.2 0.9 7.2 0.2 4.1 36.0 42.3 20.5 40.8 43.5 23.9 41.4 31.4 30.0 46.1 29.8 24.9 2.7 51.7 29.7 51.6 26.2 33.1 25.4 20.5 52.4 56.9 27.2 19.9 23.3 34.0 35.8 21.0 0.0 20.0 45.5 28.2 67.2 9.2 14.7 6.8 63.5 24.8 33.7 11.7 33.3 22.2 7.9 23.6 1.0 23.1 41.5 33.4 21.0 20.5 22.6 56.8 97.0 121.7 43.2 62.8 22.6 27.8 1.8 21.0 67.4 PTK2B "CADTK, CAKB, FAK2, PTK, PYK2, RAFTK" ENSG00000120899 "Protein tyrosine kinase 2 beta" Q14289 8 27311482-27459391 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 46.7;brain: 65.2" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 73.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.7;REH: 41.9" "Group enriched" "Detected in many" 4 "amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5" "Low region specificity" "Detected in all" "CAB003850, HPA026091, HPA026276" Approved Supported "Plasma membrane,Cytosol" NA NA 84000 "Plasma membrane, Cytosol" "CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234" "unprognostic (2.36e-2)" "prognostic favorable (3.32e-4)" "unprognostic (1.06e-1)" "unprognostic (7.36e-3)" "unprognostic (3.72e-2)" "unprognostic (3.11e-2)" "unprognostic (2.70e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-2)" "unprognostic (3.32e-1)" "unprognostic (2.40e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "prognostic favorable (5.11e-4)" "unprognostic (3.33e-3)" 7.2 4.7 20.4 24.3 30.0 46.7 4.9 65.2 48.3 5.4 14.5 7.8 5.0 16.6 4.3 4.7 7.9 6.8 6.4 4.7 30.5 7.0 6.8 5.0 11.5 35.6 4.3 25.4 2.4 5.4 5.2 5.3 4.1 3.9 10.1 11.9 8.3 12.6 6.7 2.2 15.1 18.4 5.5 4.8 32.0 10.8 4.3 3.7 37.8 5.6 2.9 35.4 13.0 6.0 26.9 18.7 24.0 25.8 14.7 19.0 21.5 11.1 3.1 0.8 0.9 24.0 1.7 6.5 0.9 0.6 0.6 0.8 2.9 6.5 37.7 1.2 1.7 0.9 10.3 0.3 9.4 0.3 2.5 0.2 7.8 3.0 0.6 4.9 8.3 14.0 13.0 14.0 0.8 5.4 4.0 0.3 10.9 9.1 26.3 0.6 1.1 14.3 16.8 0.6 9.7 0.8 41.9 0.2 25.8 2.6 8.8 6.0 1.1 4.0 2.8 1.5 2.1 3.3 21.6 5.3 0.4 0.8 0.7 0.3 21.1 9.1 20.4 1.6 18.1 0.7 22.3 23.7 18.0 19.0 22.4 12.5 25.5 9.6 13.3 18.7 26.9 12.1 14.2 24.0 14.7 25.8 6.2 9.5 21.5 20.4 30.0 65.2 48.3 30.5 7.0 4.3 25.4 3.9 3.7 3.0 30.9 54.0 32.1 33.5 4.1 3.1 12.7 13.4 13.6 14.0 0.0 2.4 0.0 6.4 1.1 7.5 48.3 0.0 7.0 23.9 3.8 16.5 27.7 21.8 20.9 7.9 7.5 3.1 73.4 0.8 1.4 42.5 8.5 34.3 18.6 3.4 9.4 35.1 0.7 14.7 4.0 0.0 1.6 4.2 5.5 26.3 1.6 39.9 14.9 14.8 PTK6 BRK ENSG00000101213 "Protein tyrosine kinase 6" Q13882 20 63528001-63537370 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.0;intestine: 24.2;skin 1: 24.2" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 34.1;Enterocytes: 90.1;Mucus-secreting cells: 39.1;Paneth cells: 65.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 10.6;CAPAN-2: 20.4;HaCaT: 16.6;hTCEpi: 22.5;OE19: 27.4;RT4: 13.0;T-47d: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB032952, HPA036070, HPA036071" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane, Cytosol" "CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982" "unprognostic (2.32e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "unprognostic (2.42e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (3.03e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.26e-9)" "unprognostic (4.19e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (4.24e-2)" 0.7 0.0 0.4 5.3 0.4 0.0 1.7 0.4 0.4 7.6 18.1 0.5 0.8 13.6 0.6 0.5 44.0 0.0 11.7 0.4 0.4 0.0 0.8 1.7 1.1 0.4 0.4 0.4 0.4 1.4 0.0 0.4 0.6 0.4 2.2 7.4 0.4 7.6 0.4 0.4 24.2 24.2 0.9 0.4 0.4 12.5 0.4 0.4 0.4 0.4 18.9 17.2 6.5 15.0 1.3 4.5 1.2 2.4 0.3 1.9 0.9 10.6 1.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 20.4 0.0 3.6 0.0 0.0 16.6 0.0 0.0 0.0 2.6 0.2 0.0 4.3 0.0 0.0 0.0 3.4 0.0 22.5 0.0 0.1 0.1 0.0 0.0 0.1 1.2 0.1 5.9 0.0 0.1 0.1 27.4 7.7 0.0 0.6 0.2 0.0 13.0 0.1 1.1 1.2 4.0 0.0 0.0 12.5 0.8 0.1 0.1 0.2 0.4 0.1 0.2 0.0 0.0 0.2 0.2 0.5 1.2 2.4 0.4 0.5 1.7 1.9 1.2 0.4 0.1 4.5 1.3 0.4 0.6 1.2 0.3 1.3 0.3 0.5 0.9 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 11.9 34.1 0.0 2.8 5.3 2.0 0.4 12.7 9.4 17.0 0.0 2.0 0.2 0.0 1.4 0.0 0.3 90.1 0.0 1.4 0.1 0.4 1.3 9.2 1.5 0.7 0.0 5.2 0.6 4.1 0.0 0.3 2.8 0.0 0.0 39.1 2.4 10.3 65.1 0.0 0.1 3.9 0.0 0.4 0.2 0.2 13.6 0.1 0.0 18.8 13.8 PTMA TMSA ENSG00000187514 "Prothymosin alpha" P06454 2 231706895-231713541 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047183 Approved Enhanced Nucleoplasm,Cytosol No Yes 610000 Nucleoplasm Cytosol "HPA047183: AB_2679972" "unprognostic (1.49e-3)" "prognostic favorable (6.56e-4)" "unprognostic (3.73e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (5.99e-2)" "unprognostic (1.56e-2)" "unprognostic (3.72e-3)" "unprognostic (2.35e-3)" "unprognostic (9.24e-2)" "prognostic unfavorable (1.99e-7)" "unprognostic (5.54e-2)" "unprognostic (6.07e-2)" "unprognostic (3.81e-3)" "unprognostic (8.64e-3)" 72.8 37.7 60.0 78.4 65.2 161.4 76.1 38.2 64.2 75.0 80.9 53.9 33.9 56.3 84.8 59.9 83.7 66.7 47.2 38.7 66.3 48.3 67.3 73.5 63.5 104.0 68.7 59.6 80.5 79.5 31.3 97.9 59.1 54.2 50.0 82.7 42.2 55.5 53.4 60.6 92.5 62.8 58.4 86.6 90.1 69.2 113.9 67.2 127.5 73.4 50.4 118.6 70.0 69.9 189.1 134.7 114.4 126.9 117.0 167.3 255.0 99.6 59.9 85.5 76.2 26.0 34.7 87.8 68.1 57.2 59.5 62.5 58.0 116.9 157.9 78.1 53.1 41.2 52.8 120.2 83.9 75.7 125.1 94.5 203.5 49.5 93.6 32.3 230.8 87.1 50.3 31.5 52.7 43.6 56.8 97.0 129.0 118.2 67.2 51.9 142.5 324.2 314.8 128.7 99.1 50.0 223.4 60.9 107.3 72.8 89.1 174.5 107.4 78.2 78.3 59.4 70.5 59.0 183.6 72.0 50.2 89.1 61.3 73.1 81.5 40.1 316.2 34.3 141.6 80.4 114.4 113.6 75.3 99.1 114.0 143.5 189.1 143.8 120.6 126.3 160.4 160.6 134.8 23.1 117.0 126.9 134.7 167.3 255.0 60.0 65.2 38.2 64.2 66.3 48.3 68.7 59.6 54.2 67.2 902.2 1420.8 3111.4 3331.5 6879.8 692.5 258.3 1666.3 1917.9 1803.9 2156.5 276.9 2179.3 3208.0 2815.5 89.5 3767.9 1421.2 1752.0 3609.4 4317.6 3273.0 2682.0 2759.5 1209.1 2876.6 767.5 1629.9 1539.5 3031.9 138.7 1209.6 4164.5 3499.0 2458.1 2866.2 2213.1 3219.9 1988.5 1320.3 2161.4 753.7 1895.0 6501.7 798.6 2809.8 6944.4 2286.6 2724.1 3072.9 3503.3 PTPA "PPP2R4, PR53" ENSG00000119383 "Protein phosphatase 2 phosphatase activator" Q15257 9 129110950-129148946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 50.6;Cytotrophoblasts: 42.8;Distal tubular cells: 46.4;Ductal cells: 58.5;Exocrine glandular cells: 54.1;Hofbauer cells: 45.3;Pancreatic endocrine cells: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005695, CAB022068, CAB035999" Approved Enhanced Nucleoplasm,Cytosol NA NA 4800000 Nucleoplasm Cytosol "CAB022068: , CAB035999: , HPA005695: AB_1855658" "unprognostic (4.97e-2)" "unprognostic (1.70e-2)" "unprognostic (1.13e-2)" "prognostic favorable (6.50e-5)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.65e-2)" "unprognostic (6.44e-3)" "unprognostic (2.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" 16.5 35.1 41.6 19.8 41.2 18.1 23.9 32.0 74.2 27.5 27.4 27.2 30.1 18.3 26.7 26.0 31.8 30.1 28.7 42.1 38.0 32.4 32.6 41.0 22.1 19.8 30.8 35.5 23.2 22.4 55.0 22.5 21.4 37.0 33.4 21.7 20.8 36.0 41.5 110.7 27.2 18.8 35.3 21.9 24.4 23.8 62.4 17.6 23.7 27.2 37.0 21.3 22.1 23.9 12.6 19.2 7.8 15.5 17.7 18.4 14.9 24.3 43.2 26.6 49.3 18.0 22.1 26.6 25.5 28.9 35.0 24.5 23.1 30.1 25.4 19.3 43.2 39.8 39.7 27.8 31.4 30.2 45.0 15.2 15.7 45.7 21.9 53.6 27.0 34.1 26.5 31.0 25.6 24.4 53.1 35.6 26.6 23.2 28.2 29.4 63.2 24.6 16.7 41.9 66.2 43.0 24.6 24.6 46.6 36.7 30.6 28.9 20.4 51.6 53.3 31.9 26.4 56.5 11.8 26.1 29.1 26.3 30.0 35.9 25.8 65.9 22.9 35.8 17.7 40.1 5.8 15.5 7.8 18.4 15.5 17.6 9.6 14.0 16.4 19.2 12.6 13.1 13.1 5.4 17.7 14.4 13.8 14.0 14.9 41.6 41.2 32.0 74.2 38.0 32.4 30.8 35.5 37.0 17.6 3.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 50.6 0.0 42.8 46.4 58.5 0.0 0.0 0.0 0.0 54.1 37.3 0.0 0.0 8.1 0.0 45.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 37.9 0.0 0.0 49.9 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 PTPN11 "BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2" ENSG00000179295 "Protein tyrosine phosphatase, non-receptor type 11" Q06124 12 112418351-112509913 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 136.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005377 Approved Supported "Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol" NA NA 160000 "Nucleoli rim" "Nucleoplasm, Actin filaments, Cytosol" "CAB005377: AB_632401" "unprognostic (2.18e-3)" "unprognostic (1.73e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.63e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "unprognostic (4.25e-2)" "unprognostic (3.55e-2)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (8.85e-2)" "unprognostic (3.75e-3)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.62e-2)" "unprognostic (1.80e-2)" 25.4 16.8 38.6 14.4 39.0 17.7 30.8 17.5 39.5 18.3 14.7 26.9 9.9 11.9 19.1 13.3 17.6 11.1 13.1 30.1 38.0 32.2 18.0 23.1 15.1 14.5 45.3 22.5 13.1 14.0 29.3 12.9 16.6 26.2 16.2 13.9 9.4 12.0 20.0 34.0 14.1 11.1 28.0 45.7 10.9 12.8 7.6 32.1 10.9 21.2 8.2 13.7 17.4 15.4 17.3 17.1 22.0 11.8 11.3 15.4 6.3 35.4 33.8 24.7 23.4 36.0 35.2 29.2 43.1 47.0 34.0 25.6 33.7 13.7 37.5 22.5 39.8 21.5 21.2 31.7 38.2 56.5 28.4 26.1 54.5 31.5 18.4 35.9 43.7 34.8 28.4 38.5 36.5 51.9 32.8 28.0 29.0 41.4 13.2 32.8 25.6 30.7 21.3 29.9 34.7 22.2 31.6 36.4 21.5 31.3 39.9 17.2 21.1 41.5 31.8 26.5 26.1 36.6 30.3 34.1 40.0 35.9 23.7 37.6 25.6 42.2 37.5 33.3 30.7 37.3 22.0 11.0 15.0 14.8 9.5 14.1 15.5 13.4 12.1 12.6 17.3 15.4 11.8 10.3 11.3 11.8 17.1 9.8 6.3 38.6 39.0 17.5 39.5 38.0 32.2 45.3 22.5 26.2 32.1 56.6 53.2 13.4 22.8 22.8 27.6 136.3 30.6 20.1 50.0 34.9 15.7 20.0 28.2 34.0 65.9 35.8 17.2 0.0 36.7 21.0 25.9 57.9 26.7 93.6 22.8 12.7 12.6 27.0 32.4 19.0 47.8 23.7 13.5 16.2 19.6 59.0 45.4 20.4 75.0 29.8 21.4 32.3 31.9 7.7 5.3 24.0 29.4 19.8 18.7 65.6 PTPN12 "PTP-PEST, PTPG1" ENSG00000127947 "Protein tyrosine phosphatase, non-receptor type 12" Q05209 7 77537275-77640071 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007097 Approved Approved "Plasma membrane,Cytosol" NA NA 1100000 "Plasma membrane, Cytosol" "HPA007097: AB_1079689" "unprognostic (2.28e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.35e-1)" "unprognostic (3.35e-2)" "unprognostic (1.40e-3)" "unprognostic (4.48e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.29e-1)" "unprognostic (5.83e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (2.01e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.27e-6)" "unprognostic (4.99e-2)" "unprognostic (2.97e-1)" "unprognostic (1.81e-1)" "unprognostic (3.21e-1)" 29.6 15.1 14.3 20.5 19.6 29.7 25.1 15.7 22.7 20.0 28.9 8.1 13.8 8.8 20.7 9.6 22.0 18.1 19.8 45.6 17.3 12.6 16.9 14.8 34.7 17.4 15.3 13.4 19.0 10.7 12.4 19.8 36.0 18.6 14.1 13.8 9.9 12.8 17.1 17.6 17.6 14.6 23.0 24.0 25.0 14.4 13.9 17.7 9.7 16.7 11.9 12.9 23.2 61.2 2.5 3.9 9.9 4.9 12.8 3.8 2.8 17.2 10.6 25.2 12.8 17.7 18.5 13.5 18.0 23.0 14.2 20.3 5.2 27.0 2.0 5.8 21.0 31.1 12.3 8.4 18.0 28.7 5.0 4.7 10.8 10.7 21.2 17.4 6.1 7.2 15.1 20.1 30.9 39.9 25.5 30.0 0.5 12.9 3.0 45.2 11.8 0.8 17.1 20.3 23.5 12.2 3.6 20.2 1.0 24.4 9.3 3.1 16.7 22.1 20.3 17.5 45.3 9.8 22.5 21.8 30.8 18.6 11.2 33.9 3.1 1.7 5.3 18.1 15.9 53.3 3.7 4.2 6.6 3.6 2.9 1.4 2.5 1.2 2.7 3.9 1.1 0.6 3.8 9.9 12.8 4.9 0.3 1.5 2.8 14.3 19.6 15.7 22.7 17.3 12.6 15.3 13.4 18.6 17.7 65.5 54.6 13.7 41.5 61.1 15.5 35.1 22.9 16.0 46.6 19.2 7.9 34.1 3.3 38.7 2.6 99.1 17.1 0.0 34.2 48.2 53.7 44.4 13.9 19.2 45.4 33.4 11.6 98.8 74.4 5.4 43.1 86.9 33.7 25.2 19.9 63.0 55.1 20.1 44.2 15.8 14.3 64.7 55.6 14.7 57.8 88.7 60.3 26.2 18.0 78.6 PTPN13 "PTP-BAS, PTP-BL, PTP1E, PTPL1" ENSG00000163629 "Protein tyrosine phosphatase, non-receptor type 13" Q12923 4 86594315-86815171 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 152.9;Basal keratinocytes: 97.1;Rod photoreceptor cells: 171.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.0;MAIT T-cell: 2.3;memory CD4 T-cell: 2.2;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 7 "monocytes: 4.9;T-cells: 2.3" "Cell line enhanced" "Detected in many" "AF22: 45.2;RT4: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002213, HPA063119" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "CAB002213: AB_564089, HPA063119: " "unprognostic (5.36e-2)" "unprognostic (4.46e-1)" "unprognostic (1.11e-1)" "unprognostic (2.54e-3)" "unprognostic (4.02e-1)" "unprognostic (9.03e-3)" "unprognostic (4.43e-2)" "unprognostic (4.38e-2)" "unprognostic (2.46e-1)" "unprognostic (7.05e-2)" "unprognostic (3.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-3)" "unprognostic (3.95e-3)" "unprognostic (2.26e-1)" "unprognostic (2.66e-1)" "unprognostic (2.85e-2)" 10.3 5.9 10.8 2.7 16.9 0.7 9.9 5.7 11.6 15.9 4.1 13.0 7.6 1.2 10.8 21.2 18.7 11.4 6.5 5.3 10.4 5.7 22.1 1.6 18.0 4.3 16.9 7.9 24.1 4.3 26.6 38.3 3.0 14.2 12.0 2.4 39.0 5.9 9.4 1.0 43.0 2.3 8.7 10.3 3.5 3.6 12.2 17.6 1.9 16.9 12.4 11.8 15.7 17.6 0.0 0.5 0.1 4.9 0.1 2.3 0.1 5.1 2.6 45.2 4.4 19.1 16.7 0.0 9.5 19.4 3.6 4.6 0.0 2.6 0.0 2.1 10.5 1.3 17.0 7.8 14.3 7.0 0.1 5.8 4.3 5.6 0.0 2.3 7.5 0.0 10.7 4.6 2.6 8.7 7.6 0.0 0.0 0.0 7.4 0.0 2.3 0.6 2.7 10.3 0.0 1.9 1.5 0.0 0.0 13.8 21.5 2.6 3.8 2.8 6.3 5.2 7.6 3.7 0.2 0.0 3.5 2.7 0.0 1.2 7.7 0.0 0.0 3.7 0.0 1.5 0.0 0.2 0.0 0.2 3.0 2.3 0.0 2.2 0.3 0.5 0.0 0.0 0.0 0.1 0.1 4.9 0.0 0.1 0.1 10.8 16.9 5.7 11.6 10.4 5.7 16.9 7.9 14.2 17.6 44.7 152.9 0.0 21.0 97.1 9.8 1.7 10.2 32.1 75.1 45.4 86.4 0.2 3.3 4.3 20.2 2.2 0.0 0.0 3.0 0.1 20.2 12.1 4.7 0.0 0.2 1.6 4.6 1.8 2.2 14.8 42.3 5.7 18.6 0.0 0.5 14.1 4.3 3.5 30.8 9.2 171.6 12.9 12.5 24.4 21.6 86.9 0.2 4.4 0.2 45.5 PTPN21 "PTPD1, PTPRL10" ENSG00000070778 "Protein tyrosine phosphatase, non-receptor type 21" Q16825 14 88465778-88554733 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 53.6;Syncytiotrophoblasts: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 23.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB011468, HPA073999" Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus, Centriolar satellite" "CAB011468: AB_442979, HPA073999: AB_2732247" "unprognostic (2.18e-1)" "unprognostic (4.21e-2)" "unprognostic (7.60e-2)" "unprognostic (3.09e-2)" "unprognostic (4.60e-2)" "unprognostic (5.71e-2)" "unprognostic (6.55e-2)" "unprognostic (5.19e-3)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-3)" "unprognostic (3.04e-3)" "prognostic favorable (3.16e-9)" "unprognostic (6.52e-2)" "unprognostic (2.69e-1)" "unprognostic (2.56e-1)" "unprognostic (7.67e-2)" 10.5 4.7 5.3 8.6 7.3 0.0 13.2 4.4 5.8 10.7 8.7 10.7 7.4 4.9 10.6 10.7 8.9 8.3 12.7 17.4 7.4 4.2 8.1 6.0 15.3 1.6 6.6 4.2 15.8 7.8 10.6 3.9 15.6 6.4 11.9 6.5 12.6 6.5 10.5 8.8 24.2 10.5 15.7 7.3 3.7 7.4 15.2 6.5 0.8 16.0 8.4 3.1 12.0 26.1 0.8 0.0 0.0 0.1 0.0 0.1 0.0 3.6 2.9 7.7 3.0 8.2 7.2 8.0 9.8 7.5 5.8 8.1 5.2 6.6 0.0 2.4 12.4 5.2 3.4 1.1 3.4 8.5 0.2 1.7 0.0 3.2 2.1 9.2 0.0 0.1 4.7 6.8 4.8 5.8 7.5 4.7 0.0 1.1 0.1 14.8 3.0 0.0 0.1 2.2 3.9 5.6 0.0 23.1 0.0 5.0 2.6 0.5 9.0 5.6 14.1 3.2 6.8 6.9 1.5 9.2 10.8 8.5 4.4 6.7 0.3 1.2 0.0 4.0 0.1 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.3 4.4 5.8 7.4 4.2 6.6 4.2 6.4 6.5 53.6 5.9 0.0 4.0 9.3 7.3 31.1 5.1 9.4 7.9 7.0 33.4 7.6 0.0 4.4 12.7 4.5 9.3 0.0 7.2 4.4 9.3 7.8 2.3 9.0 1.6 1.6 4.6 7.4 1.2 3.5 15.8 0.7 0.0 0.0 14.6 4.9 8.2 5.8 25.5 3.3 9.0 0.0 8.5 12.1 6.1 10.5 85.2 0.0 4.6 4.7 PTPN4 PTPMEG ENSG00000088179 "Protein tyrosine phosphatase, non-receptor type 4" P29074 2 119759631-119983818 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 53.9;Cone photoreceptor cells: 98.2;Horizontal cells: 152.6;Rod photoreceptor cells: 80.5;T-cells: 90.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "NK-cells: 12.2;T-cells: 19.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019351 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA019351: AB_1855928" "unprognostic (1.45e-1)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-2)" "unprognostic (9.00e-2)" "unprognostic (9.57e-2)" "unprognostic (2.34e-1)" "prognostic favorable (5.16e-4)" "unprognostic (3.31e-2)" "unprognostic (3.34e-3)" "unprognostic (3.13e-1)" "unprognostic (1.10e-1)" "unprognostic (3.34e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.81e-1)" 6.8 6.9 10.0 5.9 12.2 7.3 7.2 37.4 16.9 9.6 5.5 7.2 5.2 8.1 7.2 6.6 6.9 8.9 6.3 8.9 10.2 8.4 12.0 6.6 8.0 7.9 7.3 13.1 8.9 6.3 11.6 16.3 4.1 8.3 6.2 4.0 7.1 7.9 6.6 11.2 5.8 5.5 4.7 7.3 9.2 8.9 7.7 6.5 18.9 22.5 6.8 6.5 5.3 5.8 0.5 0.3 0.9 0.4 12.2 19.3 4.7 7.4 4.4 5.8 7.7 5.2 5.4 9.9 3.4 9.6 1.9 5.3 6.6 11.6 5.4 8.2 3.8 5.8 6.6 4.5 5.3 5.2 12.6 3.8 3.7 4.2 6.2 3.5 3.8 2.8 4.9 10.0 9.0 4.1 6.6 8.5 5.5 6.4 5.5 5.1 5.7 5.2 4.4 7.6 4.2 7.2 3.6 10.0 7.6 7.0 10.2 7.6 9.4 4.7 6.0 3.9 5.1 2.9 2.4 10.6 0.3 6.7 2.3 4.1 9.5 13.2 6.8 5.1 0.2 3.2 0.2 0.2 0.9 19.3 0.3 15.6 0.5 9.6 15.1 0.3 0.5 3.2 11.0 0.7 12.2 0.4 0.3 5.6 4.7 10.0 12.2 37.4 16.9 10.2 8.4 7.3 13.1 8.3 6.5 3.0 10.5 14.0 12.8 7.2 53.9 13.9 10.2 6.7 6.8 15.7 98.2 8.5 6.6 6.1 3.8 12.8 8.1 0.0 6.3 9.0 7.6 8.7 11.5 9.0 3.6 152.6 8.7 13.5 5.6 7.1 16.1 5.3 8.5 7.2 7.8 23.6 5.5 10.1 13.4 10.4 80.5 0.0 5.0 21.2 20.6 5.8 3.1 90.0 10.6 7.8 PTPN7 "HEPTP, LC-PTP" ENSG00000143851 "Protein tyrosine phosphatase, non-receptor type 7" P35236 1 202147013-202161588 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.5;lymphoid tissue: 63.7" "Group enriched" "Detected in many" 5 "B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basal ganglia: 9.4;thalamus: 2.9" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6" "Cell line enhanced" "Detected in some" "HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2" "Region enriched" "Detected in single" 10 "basal ganglia: 5.5" "Region enriched" "Detected in all" 4 "basal ganglia: 10.9" "CAB009530, HPA019118" Approved Supported "Microtubules,Mitotic spindle,Cytosol" NA NA Cytosol "Microtubules, Mitotic spindle" "CAB009530: AB_2173845, HPA019118: AB_1855755" "unprognostic (4.19e-3)" "unprognostic (1.08e-3)" "unprognostic (3.09e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.91e-2)" "prognostic favorable (1.84e-4)" "unprognostic (3.01e-2)" "unprognostic (3.16e-2)" "unprognostic (1.43e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.42e-8)" "unprognostic (1.46e-1)" "unprognostic (4.51e-2)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" 2.6 3.1 0.5 27.1 9.4 24.5 0.6 0.4 0.5 0.6 2.3 0.6 0.0 3.0 0.7 0.6 1.7 0.8 2.9 0.5 0.6 0.8 1.1 0.9 3.2 16.5 1.2 0.2 0.6 0.6 0.0 0.7 0.4 0.8 1.3 1.9 0.7 5.3 0.3 0.4 0.6 3.7 0.9 1.6 15.4 1.4 12.7 2.9 63.7 0.9 0.6 24.8 2.9 0.8 2.6 2.6 17.0 1.1 9.9 10.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 16.7 0.0 0.0 0.0 36.3 48.9 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.7 1.5 0.0 0.0 4.9 15.8 0.0 0.0 0.0 0.7 0.0 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.1 0.0 0.0 7.4 1.8 10.5 0.0 26.2 0.0 11.5 1.1 17.0 10.6 1.1 9.5 1.9 7.1 10.5 2.0 2.6 5.3 6.4 7.1 9.9 0.4 2.6 9.0 2.8 0.5 9.4 0.4 0.5 0.6 0.8 1.2 0.2 0.8 2.9 3.0 9.0 40.6 1.0 2.1 2.4 0.7 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.2 0.4 2.9 0.0 0.0 0.0 0.1 1.7 0.5 137.4 0.5 15.6 0.0 0.0 4.9 6.2 1.3 4.9 23.4 8.5 9.0 0.0 5.6 0.1 0.0 2.1 0.6 4.4 0.0 0.9 0.9 0.4 2.0 0.7 156.8 0.0 0.5 PTPRQ DFNB84 ENSG00000139304 "Protein tyrosine phosphatase, receptor type Q" 12 80402178-80680271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6;urinary bladder: 19.2" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 14.9;Club cells: 7.9;Early spermatids: 7.0;Late spermatids: 3.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 24 "basal ganglia: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.4;BJ: 6.2;HBF TERT88: 4.4;RH-30: 4.9;RT4: 5.4;SiHa: 3.1;U-2197: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA053245 Uncertain Approved Cytosol No NA Cytosol "HPA053245: AB_2682087" "unprognostic (9.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (1.37e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (4.47e-11)" "unprognostic (8.51e-3)" "unprognostic (1.47e-1)" "unprognostic (1.73e-2)" "unprognostic (2.66e-2)" 4.6 0.2 0.3 1.0 12.6 0.0 5.2 0.2 0.3 1.7 1.3 0.0 1.6 0.0 0.5 4.7 1.6 4.1 0.5 1.3 0.4 0.5 6.5 0.2 5.4 2.1 0.2 0.0 0.9 0.6 0.0 1.1 6.4 0.0 6.5 0.0 0.0 0.4 0.5 0.5 0.3 0.2 4.0 0.2 0.2 0.2 5.8 0.0 0.0 3.9 0.0 0.6 19.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 6.2 1.3 1.9 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.9 0.0 0.8 0.2 0.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 5.4 0.0 0.0 3.1 0.1 0.0 0.3 0.3 0.0 0.0 0.5 0.1 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.6 0.2 0.3 0.4 0.5 0.2 0.0 0.0 0.0 14.9 0.6 0.0 1.5 0.0 0.0 1.7 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 PTPRR "EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ" ENSG00000153233 "Protein tyrosine phosphatase, receptor type R" Q15256 12 70638073-70920843 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 56.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 11.2;Club cells: 5.7;Enterocytes: 7.3;Horizontal cells: 15.9;Paneth cells: 11.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 14.3;RT4: 27.4" "Region enriched" "Detected in all" 5 "cerebellum: 100.5" "Low region specificity" "Detected in all" "CAB011461, HPA011851, HPA071067" Uncertain Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340" "unprognostic (4.98e-2)" "unprognostic (1.91e-2)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "unprognostic (3.63e-3)" "unprognostic (3.48e-5)" "unprognostic (5.44e-3)" "unprognostic (1.77e-3)" "unprognostic (1.13e-1)" "unprognostic (9.01e-2)" "unprognostic (1.37e-3)" "unprognostic (8.06e-2)" "unprognostic (1.10e-2)" "unprognostic (1.92e-2)" "unprognostic (4.78e-2)" "unprognostic (2.72e-1)" "prognostic favorable (1.40e-5)" 0.4 3.8 18.8 1.6 11.3 0.3 0.4 56.1 20.9 0.5 11.2 0.1 0.0 5.1 8.4 0.3 0.4 0.5 1.9 0.4 8.6 4.9 0.4 0.4 0.4 0.4 1.3 13.2 0.4 0.6 0.3 0.9 0.7 3.3 0.5 7.8 0.8 0.4 2.1 0.4 0.4 11.3 4.9 3.1 0.4 4.4 0.4 1.4 0.0 0.4 0.0 0.3 4.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 27.4 0.1 4.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.8 11.3 56.1 20.9 8.6 4.9 1.3 13.2 3.3 1.4 0.0 0.0 0.0 0.1 0.5 11.2 2.5 0.0 0.0 5.7 0.0 0.0 0.0 0.0 2.1 1.7 1.5 7.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 15.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 1.9 11.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.3 PTPRS ENSG00000105426 "Protein tyrosine phosphatase, receptor type S" Q13332 19 5158495-5340803 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 54.1;Melanocytes: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 82 "plasmacytoid DC: 13.4" "Lineage enriched" "Detected in single" 82 "dendritic cells: 13.4" "Cell line enhanced" "Detected in many" "AN3-CA: 41.4;HaCaT: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054747 Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA 92000000 "Plasma membrane, Cytosol" "HPA054747: AB_2682591" "unprognostic (8.14e-2)" "unprognostic (4.59e-3)" "unprognostic (2.57e-2)" "unprognostic (9.20e-2)" "unprognostic (2.15e-1)" "unprognostic (6.96e-3)" "unprognostic (6.85e-2)" "unprognostic (2.36e-1)" "unprognostic (3.12e-3)" "unprognostic (1.86e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-1)" "unprognostic (3.46e-2)" 59.1 17.3 14.4 9.4 14.8 3.1 32.0 27.6 53.3 28.7 11.4 29.6 14.4 4.6 21.4 15.4 13.3 24.0 22.2 18.6 15.9 15.1 10.7 6.9 13.9 8.6 20.5 12.1 29.2 38.4 10.5 16.6 4.3 12.0 23.1 3.6 28.9 21.5 20.1 11.9 23.8 6.5 17.5 13.8 8.3 12.7 10.8 18.7 4.4 21.1 7.2 7.5 19.1 22.7 0.0 13.4 0.0 0.0 0.0 0.1 0.0 3.7 21.3 19.2 41.4 8.8 7.2 2.5 6.4 7.7 7.8 6.4 0.2 2.0 0.0 15.3 10.8 6.2 42.1 5.1 0.0 3.5 0.4 8.2 0.0 8.7 13.2 4.0 0.0 4.8 7.6 1.8 1.6 0.3 10.2 0.2 2.6 5.9 0.0 3.1 15.7 1.6 4.0 10.8 0.1 9.1 0.0 4.2 0.0 1.6 7.5 14.8 20.3 6.1 1.1 11.7 3.9 7.4 1.6 0.9 7.0 12.1 16.0 7.8 2.1 0.0 12.2 3.6 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 14.4 14.8 27.6 17.6 15.9 15.1 20.5 12.1 12.0 18.7 6.0 0.6 3.2 32.4 54.1 33.8 10.9 12.7 1.4 2.3 12.2 2.0 0.5 8.3 1.4 2.3 10.2 0.0 0.0 0.8 23.7 30.9 35.7 0.0 18.3 1.5 11.1 2.9 28.3 0.3 2.9 43.1 1.4 75.9 0.0 0.0 37.3 0.5 0.0 33.9 2.4 7.7 12.9 39.2 7.2 5.3 32.0 0.8 0.0 0.0 21.1 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase, receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 118.1" "Cell type enhanced" "Detected in some" 17 "Club cells: 27.3;Horizontal cells: 62.0;Muller glia cells: 107.0" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 94.3;NTERA-2: 26.3;WM-115: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" NA NA 950000 Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavorable (9.36e-4)" 2.0 2.5 33.1 2.3 44.1 1.5 4.0 15.4 118.1 2.4 2.2 19.3 0.0 1.9 1.6 2.0 7.0 1.7 1.9 2.0 39.6 15.9 1.6 1.6 2.1 1.5 18.6 17.8 2.0 3.3 1.5 1.6 1.6 67.6 2.1 2.3 0.8 2.4 2.0 1.5 19.3 1.9 2.4 76.6 2.1 9.8 1.7 23.6 0.0 1.5 1.8 3.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 1.1 0.0 0.1 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 44.1 15.4 39.6 39.6 15.9 18.6 17.8 67.6 23.6 0.0 1.0 0.0 5.6 22.3 14.1 0.8 0.0 17.4 27.3 0.0 3.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 1.1 1.1 0.0 0.0 0.1 62.0 0.0 0.0 0.0 0.4 0.3 0.0 18.6 0.0 0.0 107.0 0.6 0.0 0.0 0.0 6.2 0.0 0.4 0.0 0.2 18.7 0.2 0.0 0.0 7.4 PTS PTPS ENSG00000150787 "6-pyruvoyltetrahydropterin synthase" Q03393 11 112226365-112269955 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Lyase "Disease mutation, Phenylketonuria" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001481 Uncertain Approved Cytosol NA NA Cytosol "HPA001481: AB_1079716" "unprognostic (2.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.66e-3)" "unprognostic (8.38e-3)" "unprognostic (4.58e-1)" "unprognostic (3.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.81e-2)" "unprognostic (2.05e-2)" "unprognostic (8.74e-2)" "unprognostic (2.59e-1)" "unprognostic (7.07e-2)" "unprognostic (3.81e-2)" "unprognostic (1.20e-2)" "unprognostic (2.97e-1)" "unprognostic (1.52e-3)" "unprognostic (1.65e-1)" 6.7 37.1 13.9 6.3 16.6 12.2 13.9 8.9 16.5 10.4 12.7 10.2 6.1 10.7 9.3 20.3 17.9 8.2 14.7 11.6 11.8 28.9 21.9 40.7 5.6 10.4 23.5 14.3 6.7 11.9 12.1 21.5 12.1 18.8 14.9 14.4 9.9 10.9 11.4 11.7 11.5 10.9 12.4 16.8 5.1 18.8 6.7 9.8 3.6 16.3 13.2 7.7 9.3 16.1 6.3 6.8 1.9 5.5 3.4 5.9 2.9 10.4 11.0 12.0 5.1 8.6 10.3 15.9 31.1 14.2 17.1 18.1 24.8 10.5 11.1 23.8 18.2 22.9 15.1 17.0 20.0 18.5 9.0 14.3 2.8 17.0 20.2 27.2 6.8 1.5 17.9 28.3 16.3 19.3 13.2 12.8 9.5 10.6 6.0 10.7 11.5 5.2 9.0 9.0 19.4 21.7 3.5 2.4 15.9 36.6 15.0 13.6 13.7 17.5 17.1 9.7 40.8 12.8 6.1 16.1 16.8 18.3 20.0 24.4 4.2 8.3 26.5 11.6 7.2 17.4 0.9 2.1 1.9 3.8 2.3 3.8 5.5 5.0 4.7 3.6 6.3 3.5 4.5 1.0 3.4 5.5 6.8 5.9 2.9 13.9 16.6 8.9 16.5 11.8 28.9 23.5 14.3 18.8 9.8 17.9 24.5 24.0 66.3 109.0 14.8 83.9 56.0 54.9 21.6 52.4 0.0 48.3 179.1 80.8 4.1 41.9 57.6 23.3 68.2 99.5 46.6 67.1 19.7 115.0 33.0 9.5 76.7 34.4 17.3 6.9 13.6 30.6 25.3 34.3 50.0 26.2 90.3 66.6 24.4 114.8 16.5 25.8 69.5 15.8 93.0 114.6 58.8 33.1 39.6 98.4 PTTG1 "EAP1, HPTTG, PTTG, securin, TUTR1" ENSG00000164611 "Pituitary tumor-transforming 1" O95997 5 160421822-160428744 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.5;testis: 100.1" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 470.4;Erythroid cells: 654.1;Spermatocytes: 278.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 54.5" "Lineage enriched" "Detected in all" 7 "T-cells: 54.5" "Low cell line specificity" "Detected in all" "CAB008373, HPA008890, HPA045034" Enhanced Supported Nucleoli,Cytosol NA Yes Cytosol Nucleoli "CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (6.48e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.46e-3)" "unprognostic (5.81e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (7.50e-3)" "unprognostic (5.24e-2)" "unprognostic (3.47e-2)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.23e-2)" "unprognostic (3.35e-2)" 1.5 1.7 2.1 16.2 5.5 34.1 2.9 1.4 4.6 3.8 8.2 1.0 0.7 5.8 1.3 2.6 24.1 1.0 1.9 2.3 5.1 2.7 1.7 1.4 3.8 19.2 1.5 2.2 1.1 1.2 0.2 2.0 5.0 2.2 1.6 11.3 1.5 4.5 1.1 1.2 8.7 5.8 4.5 1.4 7.5 3.4 100.1 1.0 29.8 23.9 23.2 35.1 3.3 7.2 8.1 6.1 2.4 2.1 3.3 54.5 4.7 45.7 23.8 53.8 38.5 9.1 9.0 16.8 24.3 55.7 64.6 70.8 46.0 40.3 50.0 21.7 27.6 74.3 24.0 33.4 67.6 92.7 57.1 30.3 26.4 32.2 27.7 1.8 23.9 23.2 4.2 11.3 43.8 26.6 19.8 45.5 33.5 21.1 39.0 66.3 21.5 28.6 58.8 27.1 37.7 34.6 26.7 63.3 42.9 32.9 9.3 33.5 21.3 35.1 21.4 72.2 45.5 43.7 26.2 19.4 29.2 39.1 22.8 70.9 33.6 29.9 57.2 31.5 41.4 51.7 1.9 0.7 2.4 7.0 2.1 2.5 8.1 14.4 16.2 6.1 5.5 3.6 8.9 0.8 3.3 1.4 5.8 54.5 4.7 2.1 5.5 1.4 4.6 5.1 2.7 1.5 2.2 2.2 1.0 6.0 15.5 20.5 54.1 220.3 1.3 4.9 7.6 1.4 11.4 5.2 0.0 50.4 3.3 4.0 470.4 10.3 6.3 654.1 4.5 163.8 37.7 15.3 38.0 2.9 72.7 0.0 5.8 17.8 20.0 39.3 10.3 35.9 82.7 39.7 15.4 2.7 3.5 9.1 7.4 1.2 0.7 6.5 35.3 278.1 72.8 136.5 26.7 44.5 34.5 30.7 PTTG2 ENSG00000250254 "Pituitary tumor-transforming 2" Q9NZH5 4 37960435-37961125 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.8" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 4.1;Early spermatids: 3.1;Spermatocytes: 1.9;Suprabasal keratinocytes: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.4;T-reg: 1.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 1.5;MOLT-4: 3.1;U-698: 2.1" "HPA008890, HPA045034" Uncertain Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (3.29e-1)" "unprognostic (4.41e-4)" "unprognostic (1.11e-1)" "unprognostic (2.07e-2)" "unprognostic (1.74e-2)" "unprognostic (9.58e-2)" "unprognostic (2.27e-1)" "unprognostic (2.74e-1)" "unprognostic (7.07e-2)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.34e-1)" "unprognostic (3.32e-1)" "unprognostic (8.60e-5)" 1.0 0.4 0.9 5.2 1.2 5.0 0.5 2.2 2.4 1.1 3.9 0.2 0.0 0.0 1.6 2.2 3.3 1.8 1.5 2.5 1.0 0.4 0.7 0.5 0.9 1.0 0.7 0.4 1.2 1.0 1.4 0.4 1.8 0.3 0.8 0.7 0.0 0.2 1.4 1.9 0.6 3.1 2.0 0.9 2.3 1.0 5.3 0.0 15.8 1.3 7.5 7.3 1.8 0.7 0.4 0.0 1.4 0.4 0.0 1.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 3.1 0.5 0.0 0.0 0.0 0.7 0.5 0.9 0.0 0.5 0.3 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 1.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.0 1.4 0.0 0.0 0.0 1.0 0.1 0.9 1.2 2.2 2.4 1.0 0.4 0.7 0.4 0.3 0.0 0.0 0.0 1.4 0.5 4.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.7 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.2 2.5 0.0 0.0 0.0 0.3 PUM1 "KIAA0099, PUMH1" ENSG00000134644 "Pumilio RNA binding family member 1" Q14671 1 30931506-31065991 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" RNA-binding "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027424, HPA027449" Approved Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA027424: AB_10602918, HPA027449: AB_2672281" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.44e-3)" "unprognostic (1.10e-1)" "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" "unprognostic (2.44e-2)" "unprognostic (3.19e-3)" "unprognostic (4.42e-2)" "prognostic favorable (7.62e-8)" "unprognostic (1.57e-1)" "unprognostic (5.41e-2)" "unprognostic (1.19e-1)" "unprognostic (2.74e-1)" 25.1 26.3 30.1 17.1 35.0 36.3 27.0 38.1 35.9 24.0 20.8 28.1 16.5 17.6 27.6 24.5 22.6 29.1 18.3 22.0 24.2 29.7 23.6 20.3 20.4 18.8 22.8 25.5 33.9 21.8 38.1 31.7 31.4 33.1 22.8 24.0 25.8 25.4 23.9 40.7 29.7 22.8 25.9 20.1 19.1 20.6 15.9 22.1 27.9 28.3 15.6 27.1 23.4 24.1 18.9 25.2 27.6 24.8 28.5 27.1 22.0 16.4 22.1 36.0 22.8 28.4 24.6 24.7 19.8 24.2 20.6 23.5 23.2 28.6 19.5 20.9 26.7 12.9 24.3 29.5 21.8 26.7 16.1 25.7 21.0 25.9 27.5 19.9 25.6 20.2 26.2 27.7 27.3 29.0 27.3 28.1 18.6 28.9 18.4 23.5 13.8 25.0 18.5 36.8 20.6 15.5 26.0 24.6 20.7 30.1 25.1 29.8 22.7 27.3 21.2 23.4 41.7 21.4 19.5 29.2 17.2 15.6 22.8 19.6 14.8 13.6 21.5 15.4 19.0 21.7 27.6 24.8 18.5 25.7 23.8 26.3 18.9 23.2 25.0 25.2 18.8 26.6 26.9 14.8 28.5 24.6 14.6 27.1 22.0 30.1 35.0 38.1 35.9 24.2 29.7 22.8 25.5 33.1 22.1 68.5 50.4 39.5 44.5 80.1 52.6 70.4 76.5 18.7 44.3 34.9 74.6 42.5 19.9 36.8 23.3 48.8 36.7 70.0 31.4 36.3 46.0 63.4 17.4 50.5 29.7 31.8 100.5 44.2 71.5 13.3 66.7 39.7 16.9 15.4 66.5 44.7 48.2 31.6 75.7 38.8 56.7 32.3 42.2 36.3 19.1 81.9 65.2 34.6 58.4 78.2 PUM2 "KIAA0235, PUMH2" ENSG00000055917 "Pumilio RNA binding family member 2" Q8TB72 2 20248691-20352234 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030316, HPA049670" Approved Enhanced Cytosol NA NA Cytosol "HPA030316: AB_10610289, HPA049670: AB_2680845" "unprognostic (2.41e-1)" "unprognostic (8.77e-2)" "unprognostic (1.97e-1)" "unprognostic (2.31e-2)" "unprognostic (9.89e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (3.86e-2)" "unprognostic (1.23e-1)" "unprognostic (4.49e-3)" "unprognostic (1.05e-2)" "unprognostic (6.87e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (2.41e-1)" "unprognostic (4.81e-2)" "unprognostic (2.87e-2)" 20.3 20.7 21.1 35.2 20.0 18.3 25.2 41.2 26.0 31.4 35.4 19.5 13.5 20.5 26.1 20.5 25.1 19.9 25.7 25.7 22.1 19.8 22.9 25.6 24.6 26.8 20.7 21.1 29.1 23.2 32.9 24.2 39.3 17.5 24.3 22.9 21.8 22.7 42.6 19.2 27.7 27.8 20.5 18.5 25.4 23.5 14.6 20.2 56.2 35.7 21.7 28.1 26.8 29.0 6.6 5.6 15.3 8.6 9.4 10.0 4.8 24.0 17.6 21.5 15.4 13.3 14.0 23.2 17.6 17.4 15.8 14.3 14.6 11.3 32.3 4.0 14.8 18.7 13.5 21.7 12.0 24.3 30.1 13.9 32.9 12.9 19.9 14.6 34.6 31.5 10.1 25.7 15.0 27.2 15.4 18.2 18.5 25.2 27.1 18.6 11.6 31.0 20.2 19.0 21.7 11.6 26.5 37.4 24.3 14.5 21.9 18.6 26.6 14.7 19.3 15.3 15.0 11.3 19.4 18.1 20.6 20.1 13.1 21.6 32.3 39.1 61.2 12.5 25.0 17.7 11.8 5.5 7.4 8.1 6.7 9.8 6.4 9.0 9.8 5.6 6.6 10.0 8.0 15.3 9.4 8.6 4.7 6.8 4.8 21.1 20.0 41.2 26.0 22.1 19.8 20.7 21.1 17.5 20.2 32.8 45.9 28.4 26.0 70.7 87.4 35.5 25.5 24.1 31.8 45.4 58.9 28.4 10.0 15.5 6.9 34.6 29.0 0.0 13.2 14.8 36.0 39.5 19.7 48.2 24.9 55.6 33.3 44.2 65.6 4.9 31.7 30.6 30.4 14.4 46.3 24.3 19.1 20.1 24.8 23.8 68.2 32.3 38.1 16.1 17.7 93.0 43.5 39.6 37.7 44.8 PUS3 FKSG32 ENSG00000110060 "Pseudouridylate synthase 3" Q9BZE2 11 125893485-125903221 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038040, HPA063802" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038040: AB_10697092, HPA063802: AB_2685126" "unprognostic (5.89e-2)" "unprognostic (7.24e-2)" "unprognostic (1.29e-1)" "unprognostic (4.37e-3)" "unprognostic (4.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (7.67e-2)" "unprognostic (1.77e-1)" "unprognostic (8.92e-3)" "unprognostic (4.47e-3)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.08e-3)" "unprognostic (9.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.13e-1)" "unprognostic (2.44e-1)" 8.6 8.8 5.9 7.4 7.7 2.3 8.7 9.0 8.4 7.4 9.2 3.6 4.6 9.9 8.4 8.6 8.1 6.4 5.9 7.6 8.0 6.4 9.6 36.6 6.1 11.0 8.7 7.2 7.7 17.9 8.2 21.1 7.6 7.7 10.4 7.4 5.4 10.6 5.1 15.2 8.2 11.5 13.9 9.7 8.9 9.3 5.3 7.3 9.6 12.4 10.6 9.2 11.1 7.3 13.0 8.8 9.9 12.3 13.0 16.5 7.1 3.5 4.3 13.2 14.7 13.5 17.2 6.3 11.7 9.8 6.7 7.5 13.9 13.3 17.9 19.4 5.2 9.8 12.2 21.3 10.9 6.8 15.2 10.3 18.4 5.4 10.0 14.3 11.5 5.4 13.6 13.1 8.0 17.1 9.9 12.3 13.5 18.7 9.3 7.2 2.1 12.8 12.3 11.4 26.3 8.4 2.5 12.0 10.1 11.0 5.6 15.3 13.6 8.0 11.2 6.4 9.9 24.0 7.5 8.3 14.2 5.8 6.7 9.6 7.0 10.5 18.8 3.8 18.6 9.7 9.9 9.7 7.8 13.0 9.4 15.2 13.0 12.8 12.5 8.8 12.2 16.5 15.6 3.7 13.0 12.3 7.8 12.9 7.1 5.9 7.7 9.0 8.4 8.0 6.4 8.7 7.2 7.7 7.3 8.9 8.6 9.0 9.4 11.4 9.1 5.2 15.3 8.1 14.8 5.2 27.5 7.4 5.0 12.3 5.9 7.7 4.2 23.3 23.5 10.6 5.6 7.1 12.7 28.8 7.2 4.8 4.6 7.4 3.2 4.3 7.2 5.4 1.7 3.6 3.9 8.9 13.5 3.5 7.4 14.6 10.4 6.5 11.0 4.6 6.9 10.3 11.7 7.5 6.0 9.3 PWP2 "EHOC-17, PWP2H, UTP1" ENSG00000241945 "PWP2, small subunit processome component" Q15269 21 44107290-44131181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 9.5;Smooth muscle cells: 13.4;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 31.0;Daudi: 26.8" HPA024573 Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (1.85e-1)" "unprognostic (4.73e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.39e-2)" "unprognostic (3.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (3.31e-3)" "unprognostic (9.48e-2)" "unprognostic (1.50e-1)" "unprognostic (6.36e-4)" "unprognostic (6.37e-5)" "unprognostic (6.12e-2)" "unprognostic (5.62e-2)" "unprognostic (1.55e-1)" 6.1 6.1 11.3 7.7 14.6 3.6 6.3 9.7 12.8 4.0 9.0 9.6 2.4 4.4 7.8 9.2 8.2 5.9 4.8 4.6 6.8 4.8 6.9 8.7 5.0 7.9 15.4 5.7 5.0 12.8 1.4 4.0 7.6 8.9 8.1 1.8 4.9 8.2 5.2 8.0 14.7 5.6 2.2 6.4 8.8 10.6 5.3 17.2 3.6 4.8 8.6 16.8 5.0 5.7 6.8 2.6 2.9 4.3 3.4 6.9 5.0 1.2 0.4 0.3 1.2 3.6 3.6 9.3 12.0 6.3 16.0 10.8 31.0 0.5 26.8 0.4 0.0 0.9 1.4 0.5 9.1 9.2 6.6 19.4 3.2 5.6 7.2 2.3 2.4 0.9 0.3 0.0 11.1 0.0 2.8 0.5 11.4 10.2 10.8 5.3 0.4 0.1 0.7 0.3 0.7 1.2 1.5 0.1 13.9 0.0 0.4 9.4 1.6 0.6 1.0 7.5 4.6 0.0 1.0 6.1 6.5 1.1 14.4 1.4 14.5 17.3 1.2 0.4 2.9 9.2 0.2 2.2 2.9 6.0 3.1 6.6 6.8 4.9 6.9 1.6 4.1 4.9 6.1 1.2 3.4 4.3 2.6 3.5 5.0 11.3 14.6 9.7 12.8 6.8 4.8 15.4 5.7 8.9 17.2 0.0 1.3 0.5 0.1 9.5 0.1 3.4 0.0 1.4 2.3 0.0 0.0 0.1 1.7 0.0 0.1 1.4 2.6 0.0 0.0 1.2 1.0 0.7 0.0 0.0 1.7 0.0 2.4 3.1 5.4 0.0 1.1 0.0 1.7 0.0 4.7 0.2 0.0 3.2 0.0 0.0 0.2 0.0 13.4 0.6 1.7 7.4 0.6 2.9 4.7 0.0 PXDNL "FLJ25471, PMR1" ENSG00000147485 "Peroxidasin like" A1KZ92 8 51319578-51809445 "Enzymes, Predicted intracellular proteins" "Hydrogen peroxide" "Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 59.1" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 29.9;Early spermatids: 34.8;Muller glia cells: 18.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 4 "B-cells: 1.5" "Group enriched" "Detected in some" 7 "AF22: 11.1;Daudi: 8.3;SH-SY5Y: 8.9" HPA007919 Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA007919: AB_1855966" "prognostic unfavorable (3.27e-5)" "unprognostic (4.59e-4)" "unprognostic (5.57e-3)" "unprognostic (2.83e-3)" "unprognostic (2.71e-1)" "unprognostic (5.14e-2)" "unprognostic (1.18e-1)" "unprognostic (7.18e-3)" "unprognostic (1.85e-1)" "unprognostic (1.15e-1)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-4)" "unprognostic (2.28e-2)" "unprognostic (3.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.97e-4)" 1.1 0.1 0.3 0.1 0.2 0.0 0.2 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.3 7.9 0.4 0.1 0.7 59.1 0.2 0.3 1.0 0.1 0.2 0.3 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 1.8 1.1 0.3 0.9 0.2 0.2 0.1 0.2 0.3 0.1 5.2 0.0 0.1 0.2 2.5 0.3 0.2 0.1 1.5 0.3 0.3 0.0 0.0 0.1 0.0 0.7 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.5 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.1 0.9 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.7 29.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.6 0.1 0.0 0.0 0.0 0.0 PXK "FLJ20335, Slob" ENSG00000168297 "PX domain containing serine/threonine kinase like" Q7Z7A4 3 58332880-58426126 "Enzymes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 81.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 48.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024068 Approved Supported "Plasma membrane,Centriolar satellite,Cytosol" NA NA Cytosol "Plasma membrane, Centriolar satellite" "HPA024068: AB_1855967" "unprognostic (2.98e-2)" "unprognostic (3.29e-1)" "unprognostic (2.71e-3)" "unprognostic (1.61e-1)" "unprognostic (2.40e-1)" "unprognostic (6.62e-3)" "unprognostic (5.03e-3)" "prognostic favorable (5.68e-4)" "unprognostic (3.90e-1)" "unprognostic (8.09e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-3)" "unprognostic (2.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" 9.3 9.4 20.7 17.0 51.4 33.6 7.6 22.6 31.4 28.9 8.9 81.1 2.4 6.3 14.2 5.3 6.6 8.0 9.6 7.5 33.7 19.9 10.4 5.7 8.2 23.8 68.6 23.4 11.1 8.5 13.7 6.1 17.5 43.9 6.0 6.4 4.4 8.8 7.7 7.6 7.5 7.7 11.8 55.9 13.5 8.3 6.7 56.6 3.7 40.3 2.5 26.1 9.8 13.1 31.3 18.8 31.8 22.5 8.7 11.2 13.4 4.3 2.5 1.9 3.5 26.9 23.9 5.7 6.9 14.7 6.7 9.4 1.2 0.9 22.8 1.6 11.7 9.7 1.3 6.0 4.4 7.1 5.7 3.8 3.9 3.1 1.7 31.4 33.9 6.9 20.4 10.6 8.4 14.6 23.6 5.9 14.6 4.8 7.5 12.0 1.6 7.4 35.0 2.3 1.3 6.3 12.8 3.3 4.1 4.2 2.4 1.7 1.2 4.7 3.4 5.5 3.6 11.5 35.1 6.0 8.4 3.5 15.9 7.3 5.9 5.8 22.7 12.1 48.2 3.5 14.6 20.1 29.4 11.2 16.2 9.9 29.0 8.1 9.4 18.8 31.3 7.1 8.4 31.8 8.7 22.5 13.5 8.7 13.4 20.7 51.4 22.6 31.4 33.7 19.9 68.6 23.4 43.9 56.6 8.9 4.6 34.0 4.9 12.6 29.2 11.8 7.6 8.1 6.8 22.7 19.6 13.3 28.2 5.9 60.8 14.3 6.3 23.3 5.0 6.5 30.9 6.4 19.6 6.8 12.0 19.1 7.5 18.4 24.8 27.6 28.4 16.3 16.9 8.2 5.2 29.3 3.5 3.5 23.7 9.1 20.8 19.4 15.5 14.0 19.4 11.4 29.4 15.9 4.4 3.2 PXN ENSG00000089159 Paxillin P49023 12 120210439-120265771 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 124.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 49.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003841, HPA051309" Supported Enhanced "Focal adhesion sites,Centrosome,Cytosol" NA NA "Focal adhesion sites" "Centrosome, Cytosol" "CAB003841: AB_562188, HPA051309: AB_2681436" "unprognostic (4.00e-2)" "unprognostic (1.94e-2)" "unprognostic (3.51e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (1.09e-4)" "prognostic unfavorable (3.72e-5)" "prognostic unfavorable (7.12e-5)" "prognostic unfavorable (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (9.19e-3)" "unprognostic (2.66e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-2)" "unprognostic (3.35e-2)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (2.75e-2)" 35.4 26.2 17.9 26.7 16.5 31.6 45.9 15.5 18.6 25.0 29.0 12.4 31.7 25.6 27.6 30.9 16.0 29.8 31.8 26.2 18.0 7.6 27.6 13.1 35.8 42.9 15.7 8.1 14.8 16.3 17.6 13.9 34.0 15.8 24.9 23.5 24.7 22.1 40.1 98.5 19.7 34.7 44.4 20.3 34.0 20.6 19.8 14.4 9.9 26.7 22.8 11.6 30.1 45.7 0.5 7.6 49.5 12.3 14.4 26.3 14.5 33.2 16.5 5.9 5.9 11.9 31.0 40.1 28.2 24.6 23.0 12.1 19.2 21.0 2.3 18.5 28.6 22.3 23.8 4.1 51.4 18.4 1.8 3.7 0.4 12.2 6.9 17.2 0.5 0.7 15.1 33.6 24.0 27.4 26.0 40.8 6.2 5.9 3.8 44.9 22.1 2.0 0.7 8.4 14.5 57.5 4.9 9.8 2.0 23.6 32.0 9.7 2.9 25.3 7.8 15.2 14.5 19.2 2.7 53.7 16.0 17.5 19.9 33.5 4.0 2.2 0.8 46.0 5.0 31.2 9.8 12.3 13.4 26.3 4.4 14.2 0.5 12.1 17.2 7.6 0.4 9.6 12.8 49.5 14.4 0.2 1.2 9.1 14.5 17.9 16.5 15.5 18.6 18.0 7.6 15.7 8.1 15.8 14.4 53.6 30.4 3.0 29.8 37.5 7.1 11.5 25.5 28.1 35.2 40.1 31.4 31.3 16.6 30.3 1.2 56.8 59.3 0.0 34.6 124.5 18.0 29.6 17.4 15.3 29.4 11.1 52.5 57.1 49.0 1.6 22.5 13.7 25.3 10.0 49.9 6.9 56.8 50.3 17.7 11.6 30.4 6.5 10.5 3.8 8.0 16.9 20.9 28.7 28.4 33.9 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201485-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 130.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 312.0;Hofbauer cells: 375.8;Kupffer cells: 516.6;Macrophages: 364.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0" "Group enriched" "Detected in all" 6 "dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4" "Cell line enhanced" "Detected in many" "MCF7: 34.5;NB-4: 54.4;THP-1: 40.1;U-937: 24.9" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA 1100000 Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 11.6 4.4 3.6 16.7 4.6 22.4 8.6 3.6 3.3 8.2 26.8 6.8 4.1 38.7 5.4 7.9 20.7 6.8 8.5 6.6 2.4 2.6 5.6 6.8 15.0 32.8 6.4 1.8 6.6 6.1 1.3 3.2 6.6 4.0 9.7 4.4 4.7 9.6 5.6 3.5 31.2 29.9 3.5 6.4 34.1 13.3 3.7 3.3 20.6 5.5 22.3 26.3 7.9 11.8 17.1 66.8 130.8 90.4 16.0 16.0 53.1 5.7 13.5 0.1 0.0 1.3 3.0 0.1 2.8 4.0 1.8 1.2 0.0 7.2 2.4 0.0 2.7 0.0 16.0 0.7 10.7 0.0 17.3 0.0 2.2 1.6 4.4 4.6 20.1 16.0 4.0 5.6 0.8 0.1 0.0 3.9 0.0 9.9 3.7 0.5 34.5 0.0 54.4 3.7 2.3 0.0 17.5 0.0 7.6 0.1 5.6 0.1 0.0 2.4 0.0 2.7 0.0 3.3 40.1 2.6 0.1 0.2 2.4 0.0 0.1 0.0 0.0 1.4 24.9 0.0 37.8 90.4 71.4 15.1 87.5 9.5 17.1 12.7 15.5 66.8 15.2 8.9 12.3 130.8 16.0 85.0 61.0 16.0 53.1 3.6 4.6 3.6 3.3 2.4 2.6 6.4 1.8 4.0 3.3 20.8 28.2 73.7 67.5 65.8 0.1 2.8 28.1 36.1 29.6 24.4 0.0 46.3 5.0 83.5 0.3 38.6 312.0 23.3 50.3 8.9 26.7 26.8 108.5 3.0 375.8 0.0 56.6 41.7 516.6 1.5 43.7 364.0 92.8 16.2 110.6 0.0 56.2 271.9 21.2 1.4 0.6 25.8 23.3 0.3 1.1 143.2 14.9 75.0 247.3 42.2 PYCR3 "FLJ13852, PYCRL" ENSG00000104524 "Pyrroline-5-carboxylate reductase 3" Q53H96 8 143603913-143609773 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 8.1;Collecting duct cells: 14.0;Ductal cells: 7.1;Exocrine glandular cells: 7.9;Extravillous trophoblasts: 10.5;Proximal tubular cells: 10.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053776, HPA063416, HPA069706" Uncertain Supported "Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA Cytosol "Cytokinetic bridge, Mitotic spindle" "HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178" "unprognostic (2.12e-2)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.06e-2)" "unprognostic (2.30e-1)" "unprognostic (7.68e-3)" "unprognostic (1.79e-1)" "unprognostic (1.96e-1)" "unprognostic (2.26e-2)" "unprognostic (5.85e-2)" "unprognostic (5.44e-2)" "unprognostic (1.82e-2)" "unprognostic (3.64e-2)" "unprognostic (2.96e-1)" "unprognostic (3.54e-2)" "unprognostic (2.54e-1)" 6.1 8.1 11.5 6.7 9.7 4.8 5.6 5.3 13.4 6.9 5.4 6.1 10.8 4.4 4.7 5.2 6.1 10.1 6.3 4.4 12.2 8.5 7.7 20.5 5.9 6.7 7.6 12.1 6.7 10.6 4.3 9.1 3.5 9.7 7.5 4.0 4.5 13.7 9.1 4.8 4.7 4.9 4.0 4.4 5.9 7.0 8.6 4.5 3.8 9.5 6.3 6.1 3.6 3.1 11.1 5.4 0.4 1.4 3.2 3.2 2.1 5.9 11.1 2.0 4.3 1.9 1.2 4.2 5.3 2.2 4.3 2.4 4.9 5.8 7.8 7.1 3.8 1.6 5.0 1.9 6.2 0.8 5.3 6.8 3.8 4.2 3.2 1.9 1.7 1.2 2.1 1.6 4.9 2.8 1.4 2.4 5.0 5.9 2.4 2.0 18.2 7.4 1.3 1.8 5.5 18.0 5.2 1.9 11.7 3.9 3.8 7.2 2.4 8.5 10.9 2.0 0.8 13.4 2.2 2.1 3.8 8.0 5.9 4.9 4.2 1.0 4.9 4.5 2.4 3.5 0.3 1.4 0.2 3.2 1.1 3.1 5.8 2.1 2.6 2.1 11.1 3.0 3.0 0.4 3.2 1.0 5.4 1.8 2.1 11.5 9.7 5.3 13.4 12.2 8.5 7.6 12.1 9.7 4.5 3.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 14.0 0.0 4.9 3.3 7.1 0.0 0.0 0.0 0.0 7.9 10.5 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 6.1 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 PYGB ENSG00000100994 "Glycogen phosphorylase B" P11216 20 25248069-25298014 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 101.9" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 93.8;Enterocytes: 83.8;Peritubular cells: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 71.7;SK-MEL-30: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031067 Approved Approved Cytosol NA NA 16000000 Cytosol "HPA031067: AB_2673722" "unprognostic (6.13e-2)" "unprognostic (5.98e-2)" "unprognostic (1.21e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.37e-4)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.23e-3)" "unprognostic (8.39e-3)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "unprognostic (3.41e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.43e-4)" 19.0 11.3 24.2 12.1 22.9 6.1 28.4 38.3 34.8 14.3 47.0 21.5 19.0 12.5 15.9 13.8 49.6 14.1 21.1 72.5 21.1 21.3 13.5 4.4 14.8 8.1 22.9 24.7 11.9 9.7 8.0 18.2 6.2 28.0 42.2 33.8 11.0 58.4 52.0 5.0 23.9 13.1 101.9 17.8 8.2 24.1 14.5 17.4 9.5 21.1 8.4 10.3 56.7 14.8 4.5 11.2 5.2 16.8 8.1 10.6 16.0 5.3 38.3 6.9 6.7 17.7 33.4 5.1 10.8 14.2 9.1 7.7 8.6 6.6 6.3 12.8 14.4 17.1 21.5 7.8 28.8 5.0 3.5 4.8 5.1 3.1 14.7 21.0 7.5 7.1 19.4 27.0 23.1 34.3 11.3 11.6 4.0 2.7 16.1 12.7 14.8 7.5 5.8 6.2 6.5 71.7 5.7 12.6 8.4 49.9 9.8 10.4 6.5 7.4 13.0 89.9 5.7 9.1 4.8 25.5 10.8 6.6 11.5 22.0 6.2 9.6 2.4 12.1 5.9 58.7 2.6 10.2 5.2 8.5 15.5 8.3 4.5 6.8 7.5 11.2 4.2 8.8 10.6 2.5 8.1 16.8 5.5 7.5 16.0 24.2 22.9 38.3 34.8 21.1 21.3 22.9 24.7 28.0 17.4 8.9 28.8 2.2 18.7 10.5 23.6 93.8 15.3 9.4 9.1 24.4 35.3 5.9 10.0 15.4 2.4 10.8 83.8 0.0 14.5 5.7 9.1 20.1 5.8 5.9 10.0 17.5 27.1 8.6 15.2 6.8 25.3 11.0 33.7 18.0 47.4 20.4 19.1 57.9 81.3 9.9 9.4 0.0 17.6 1.7 4.9 8.8 3.7 12.8 52.1 7.1 PYGL ENSG00000100504 "Glycogen phosphorylase L" P06737 14 50857891-50944736 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 117.8;Hofbauer cells: 137.9;Muller glia cells: 253.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 36.0;neutrophil: 41.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 57.0;HMC-1: 63.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000962, HPA004119" Enhanced Supported "Plasma membrane,Cytosol" NA NA 17000000 "Plasma membrane, Cytosol" "HPA000962: AB_1079722, HPA004119: AB_1079723" "unprognostic (2.70e-2)" "unprognostic (8.64e-3)" "unprognostic (1.46e-2)" "unprognostic (8.55e-2)" "unprognostic (9.41e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (1.66e-1)" "unprognostic (1.34e-2)" "unprognostic (3.34e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (2.63e-4)" "unprognostic (4.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.95e-2)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.12e-3)" 47.6 9.9 4.9 9.7 6.8 40.0 28.1 1.3 3.9 17.2 10.1 3.0 23.7 1.7 10.9 7.3 24.8 7.8 5.5 15.0 3.9 3.4 6.8 58.8 19.6 25.6 6.5 1.6 15.4 4.1 12.5 3.7 23.3 5.3 11.4 10.3 17.8 11.8 55.2 7.1 15.3 3.5 11.2 8.7 38.8 4.5 6.8 5.4 2.4 7.1 9.1 7.3 18.4 24.3 0.0 7.3 41.4 13.8 0.1 0.0 5.5 28.7 8.1 2.1 13.4 10.0 12.0 23.4 5.8 4.9 16.0 24.4 21.4 3.7 0.0 11.3 34.4 19.0 57.0 21.7 29.2 27.8 0.1 9.2 5.5 13.0 16.6 17.9 20.9 63.0 25.5 11.9 21.6 9.1 15.9 14.1 0.1 2.2 0.1 11.3 28.7 0.0 28.9 8.1 2.6 30.2 0.5 7.5 1.1 22.1 19.3 0.9 0.9 26.3 9.1 0.3 8.5 4.3 41.1 0.6 6.2 10.4 11.5 18.6 0.2 0.0 0.0 5.7 21.7 3.3 11.3 13.8 36.0 0.0 6.3 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 41.4 0.1 3.9 0.3 0.0 5.5 4.9 6.8 1.3 3.9 3.9 3.4 6.5 1.6 5.3 5.4 20.8 7.5 2.7 8.9 27.2 4.1 2.0 7.6 10.7 15.9 7.0 0.0 29.4 3.3 9.4 0.4 6.0 3.4 0.0 1.8 117.8 14.4 8.6 5.8 53.3 137.9 1.6 1.2 6.7 43.8 0.7 13.3 29.1 18.6 15.4 6.9 253.1 7.2 0.0 20.5 3.4 9.1 6.5 7.1 0.7 0.6 19.4 17.6 2.9 11.5 7.4 PYGO1 ENSG00000171016 "Pygopus family PHD finger 1" Q9Y3Y4 15 55538890-55588947 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 26.6" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 11.3;Spermatocytes: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-698: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042248 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042248: AB_10794272" "unprognostic (5.55e-2)" "unprognostic (9.82e-2)" "unprognostic (2.61e-2)" "unprognostic (4.54e-2)" "unprognostic (7.20e-2)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "unprognostic (2.29e-1)" "unprognostic (6.72e-6)" "unprognostic (3.36e-4)" "unprognostic (4.84e-2)" "unprognostic (2.30e-2)" "unprognostic (1.80e-2)" 3.0 3.8 3.8 1.6 8.2 0.6 3.1 10.1 5.1 10.8 5.1 2.8 8.2 0.9 9.8 5.8 3.3 4.2 3.9 2.6 5.2 4.3 1.8 0.6 3.2 1.0 4.2 2.8 14.2 2.3 26.6 6.9 3.2 5.0 7.9 1.9 5.5 1.9 9.4 18.7 1.5 1.8 7.9 5.2 0.8 2.8 6.0 3.2 0.0 10.1 5.7 1.0 7.6 9.2 0.6 0.2 0.9 0.2 0.3 0.4 0.0 2.8 5.1 8.9 4.7 3.4 7.7 3.7 6.1 6.7 4.8 5.6 3.4 0.0 0.0 1.8 3.9 6.8 0.0 9.1 0.0 6.2 0.0 3.1 1.3 1.4 0.3 4.9 4.9 0.0 4.1 4.7 4.3 0.7 4.9 2.5 0.7 0.1 0.0 7.6 0.1 0.2 0.0 2.4 0.6 2.6 0.0 11.4 0.0 1.5 2.0 4.9 5.8 5.5 0.0 4.2 1.3 1.7 1.5 0.0 12.1 5.5 0.2 7.1 0.1 0.1 25.9 3.8 0.0 2.8 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.3 0.0 0.0 0.6 0.3 0.4 0.9 0.3 0.1 0.2 0.1 0.0 3.8 8.2 10.1 2.8 5.2 4.3 4.2 2.8 5.0 3.2 8.9 4.6 0.0 4.1 1.4 4.9 3.9 0.0 2.7 3.4 8.7 0.0 0.9 0.0 0.3 1.7 0.7 0.0 0.0 0.0 0.1 6.6 4.8 0.0 0.0 0.4 0.0 0.0 0.6 0.6 1.9 9.2 0.8 6.8 0.0 0.0 6.3 0.8 0.0 11.3 0.0 3.1 0.0 4.1 10.7 2.1 0.6 0.2 0.0 0.0 0.5 PYM1 "PYM, WIBG" ENSG00000170473 "PYM homolog 1, exon junction complex associated factor" Q9BRP8 12 55901413-55932618 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012803, HPA039717, HPA046200" Supported Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" No No "Nucleoplasm, Nucleoli, Cytosol" "Cell Junctions" "CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556" "unprognostic (3.03e-2)" "unprognostic (1.00e-1)" "unprognostic (5.65e-2)" "unprognostic (8.82e-2)" "unprognostic (1.97e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (3.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.29e-1)" "unprognostic (1.32e-2)" "unprognostic (1.59e-2)" "unprognostic (2.22e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.34e-4)" 17.5 21.4 16.2 21.2 14.8 13.2 20.3 16.3 17.1 15.2 21.2 14.2 27.1 21.8 16.1 30.8 46.7 16.3 21.5 13.6 14.0 14.7 19.4 31.3 14.4 28.6 14.7 14.0 13.3 24.8 15.3 19.8 21.5 12.8 20.7 21.5 18.3 22.9 24.5 18.2 27.2 29.9 16.3 13.2 25.5 15.8 21.1 14.1 26.3 22.5 31.2 39.1 16.5 19.9 29.5 35.9 21.6 27.2 14.4 53.6 24.1 17.5 14.1 20.6 11.4 12.5 16.3 33.8 13.0 15.7 12.3 10.4 20.5 21.0 22.1 19.8 12.5 5.7 13.9 15.8 27.8 9.9 17.0 11.8 18.0 12.0 25.2 15.3 20.8 16.5 14.7 17.9 13.8 20.8 15.6 13.0 9.9 15.3 24.6 14.4 26.5 13.3 37.2 35.9 20.1 7.3 12.0 8.2 25.3 25.2 25.0 13.9 16.0 16.6 22.3 11.6 20.0 27.1 44.1 10.1 7.4 10.5 11.5 9.4 13.0 19.7 34.1 12.7 14.5 11.6 3.9 24.5 21.6 18.7 27.2 22.9 29.5 34.0 26.1 35.9 25.2 22.6 22.6 5.8 14.4 18.5 19.6 53.6 24.1 16.2 14.8 16.3 17.1 14.0 14.7 14.7 14.0 12.8 14.1 17.9 15.9 15.9 26.4 0.0 13.6 0.0 28.1 30.8 26.1 22.7 7.9 72.4 66.3 34.7 9.6 12.4 38.3 23.3 44.0 61.6 11.5 34.5 17.4 32.7 48.8 6.4 7.0 19.0 44.8 7.4 21.6 40.2 0.0 146.1 41.7 34.7 43.4 37.0 22.3 44.1 10.6 12.9 0.0 18.1 24.3 0.0 51.8 37.4 37.7 28.0 QARS ENSG00000172053 "Glutaminyl-tRNA synthetase" P47897 3 49095932-49105135 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Epilepsy, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 438.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036986, HPA036987" Enhanced Enhanced Cytosol No No 21000 Cytosol "HPA036986: AB_10672344, HPA036987: AB_2675418" "prognostic favorable (1.43e-4)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (1.10e-2)" "unprognostic (5.13e-3)" "unprognostic (6.62e-3)" "unprognostic (6.53e-3)" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-1)" "unprognostic (4.33e-1)" "unprognostic (9.14e-2)" "prognostic favorable (5.60e-6)" "unprognostic (2.73e-3)" "unprognostic (1.65e-1)" "unprognostic (2.74e-2)" "unprognostic (3.11e-1)" 20.9 16.3 9.7 19.3 10.2 18.4 22.7 15.8 13.2 17.6 27.3 13.1 27.7 17.2 12.3 19.8 35.1 16.4 20.0 22.0 9.8 9.6 27.1 26.0 15.0 33.9 12.4 7.2 21.6 33.8 20.3 13.7 25.7 9.6 16.2 29.9 15.2 31.7 28.7 33.3 26.7 31.8 16.7 11.2 21.1 16.9 30.1 11.3 36.8 16.5 34.8 33.3 19.4 18.5 20.4 40.0 8.9 32.3 21.8 24.0 19.6 18.8 19.2 32.1 45.9 41.3 44.9 33.1 21.0 48.1 41.7 41.0 24.3 24.5 58.4 13.5 34.8 23.4 24.0 45.5 34.6 30.0 16.6 36.3 46.0 30.8 42.3 21.8 37.4 28.4 47.3 30.3 32.1 27.3 44.8 45.5 34.2 20.5 26.0 30.5 10.1 26.9 33.6 27.5 38.6 30.0 17.8 27.0 43.0 28.0 28.1 11.8 32.8 18.6 47.3 28.9 33.0 39.2 43.7 26.2 19.0 27.0 31.3 23.4 22.4 38.1 32.8 19.5 33.7 12.0 8.9 23.1 8.7 13.5 32.3 18.1 20.4 16.8 14.9 40.0 15.2 15.5 15.4 2.6 21.8 26.1 16.9 24.0 19.6 9.7 10.2 15.8 13.2 9.8 9.6 12.4 7.2 9.6 11.3 20.8 57.3 55.9 52.1 59.8 10.1 50.4 40.8 22.7 35.2 38.4 9.8 160.6 58.0 67.5 150.2 50.3 110.2 23.3 94.9 127.6 48.0 47.5 38.1 41.8 85.6 19.1 62.3 50.3 98.5 438.0 54.4 55.2 45.5 120.0 127.2 20.6 67.1 71.9 34.3 63.0 13.0 45.3 43.4 18.4 46.6 75.3 156.4 69.2 176.8 57.2 QPCT "GCT, QC" ENSG00000115828 "Glutaminyl-peptide cyclotransferase" Q16769 2 37344574-37373322 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.6;blood: 137.6" "Group enriched" "Detected in many" 6 "Intestinal endocrine cells: 208.4;Melanocytes: 501.0" "Cancer enhanced" "Detected in all" "melanoma: 97.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "neutrophil: 137.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 137.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 17.9;SCLC-21H: 24.3;SK-MEL-30: 81.6;U-266/84: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008406 Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA008406: AB_1855981" "unprognostic (6.25e-3)" "unprognostic (6.69e-2)" "unprognostic (4.95e-2)" "unprognostic (1.44e-1)" "unprognostic (1.44e-2)" "unprognostic (9.32e-2)" "unprognostic (1.13e-3)" "unprognostic (9.73e-2)" "unprognostic (2.71e-3)" "unprognostic (7.86e-2)" "unprognostic (3.67e-2)" "unprognostic (1.17e-1)" "unprognostic (6.78e-2)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (9.48e-3)" "unprognostic (3.62e-3)" 3.2 77.6 4.3 5.4 5.8 17.0 6.4 1.2 11.6 9.2 11.3 2.2 1.5 2.2 6.2 43.7 2.4 1.9 5.5 2.9 6.7 17.9 12.4 1.3 6.1 7.4 3.9 5.0 1.4 5.5 9.6 31.6 7.8 5.9 3.5 4.2 21.2 14.7 2.8 4.0 14.2 2.3 3.4 3.0 8.5 3.4 2.6 0.5 2.3 1.8 4.4 4.8 7.0 2.9 0.2 10.7 137.6 29.7 0.0 0.0 12.1 0.1 8.0 0.0 0.0 1.1 2.7 0.0 1.1 17.9 1.3 2.1 0.5 1.4 0.0 0.6 6.0 15.2 0.0 0.5 0.0 2.1 0.1 15.6 3.6 0.0 1.5 0.1 0.5 0.0 1.5 0.0 9.9 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 8.8 2.2 24.3 0.0 1.3 0.0 81.6 1.6 0.1 0.6 3.8 0.0 0.0 0.0 0.1 3.1 63.8 0.0 5.5 0.0 0.0 0.6 29.7 0.2 0.0 3.4 0.0 0.2 0.0 0.0 10.7 0.1 0.0 0.0 137.6 0.0 0.3 0.2 0.0 12.1 4.3 5.8 1.2 11.6 6.7 17.9 3.9 5.0 5.9 0.5 3.0 2.9 8.2 9.7 34.7 10.9 1.1 2.5 1.4 0.0 21.0 2.0 0.5 1.7 45.4 0.4 7.3 2.0 0.0 2.1 4.3 11.0 9.5 55.3 0.2 21.3 41.3 208.4 22.7 29.2 2.2 2.8 35.6 501.0 10.8 5.8 1.2 25.4 1.9 22.3 4.7 2.9 12.9 15.5 2.1 0.6 12.7 3.9 1.9 6.9 5.5 QSER1 FLJ21924 ENSG00000060749 "Glutamine and serine rich 1" Q2KHR3 11 32893178-32993316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005682 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005682: AB_1855985" "unprognostic (2.94e-1)" "unprognostic (6.55e-2)" "unprognostic (1.36e-1)" "unprognostic (2.76e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (7.94e-5)" "unprognostic (1.14e-1)" "unprognostic (4.75e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (6.77e-2)" "prognostic unfavorable (6.87e-4)" "unprognostic (1.80e-2)" "unprognostic (7.20e-2)" "unprognostic (8.12e-2)" "unprognostic (7.96e-2)" 10.8 8.3 13.6 9.1 11.3 8.3 22.0 21.3 14.9 13.1 8.7 9.8 9.5 5.4 13.8 13.1 15.9 11.2 8.9 10.0 12.5 7.1 9.3 9.5 9.1 8.2 13.1 10.9 21.4 15.6 16.5 11.4 9.0 11.5 11.5 9.2 10.9 16.7 9.7 9.8 20.1 7.9 10.4 11.5 10.1 9.3 14.2 12.8 14.2 14.2 14.0 10.1 11.8 24.8 2.0 2.2 0.3 2.4 1.7 1.1 0.4 11.4 14.2 16.6 15.3 6.5 12.6 8.0 10.0 9.0 7.3 9.0 12.3 5.4 12.0 6.5 12.1 12.2 14.9 15.2 9.0 15.6 5.1 9.8 11.2 13.7 10.2 4.9 13.5 6.1 6.1 9.6 9.3 15.1 8.9 10.0 7.0 17.1 5.4 11.4 10.2 6.5 5.4 17.6 7.1 8.7 10.8 32.8 5.0 7.5 12.6 8.7 12.4 18.9 10.1 6.3 12.8 10.4 7.1 9.8 17.8 17.9 31.9 21.4 3.7 5.0 12.6 11.5 6.4 11.4 0.0 1.2 0.3 1.1 2.4 0.5 2.0 0.7 1.0 1.1 0.9 0.6 0.7 0.0 1.7 0.6 2.2 0.2 0.4 13.6 11.3 21.3 14.9 12.5 7.1 13.1 10.9 11.5 12.8 17.9 12.0 7.3 8.6 24.7 16.5 26.8 12.7 13.4 19.4 7.0 13.7 10.6 3.3 8.1 11.1 13.5 4.2 0.0 10.3 10.6 16.9 9.2 3.5 9.0 12.2 9.5 0.0 13.5 16.4 7.6 22.7 13.3 15.1 1.8 11.0 11.8 10.0 11.6 19.8 6.9 14.1 6.5 12.0 19.7 19.1 24.1 3.5 4.3 10.4 11.1 R3HCC1 DKFZp564N123 ENSG00000104679 "R3H domain and coiled-coil containing 1" Q9Y3T6 8 23270120-23296279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023073, HPA023153" Uncertain Approved Nucleoplasm,Cytosol Yes No Cytosol Nucleoplasm "HPA023073: AB_1855987, HPA023153: AB_2237834" "unprognostic (5.80e-2)" "unprognostic (4.70e-3)" "prognostic favorable (4.08e-4)" "unprognostic (7.46e-3)" "unprognostic (1.97e-1)" "unprognostic (7.26e-2)" "unprognostic (8.49e-3)" "unprognostic (1.02e-2)" "unprognostic (7.73e-2)" "unprognostic (2.92e-1)" "prognostic favorable (8.66e-4)" "unprognostic (7.65e-2)" "prognostic favorable (6.80e-5)" "unprognostic (1.22e-2)" "unprognostic (1.17e-1)" "unprognostic (4.18e-1)" "unprognostic (3.43e-1)" 14.8 14.2 21.4 14.8 20.9 18.4 24.6 16.5 36.3 13.9 18.4 26.0 14.8 14.5 16.4 18.2 12.5 17.9 16.4 23.8 21.5 16.9 13.2 16.6 18.8 15.9 30.1 16.3 22.1 50.3 16.0 14.7 10.4 20.7 14.8 12.0 15.3 24.8 20.7 36.6 16.3 14.4 18.3 33.7 13.0 16.9 17.4 21.4 15.8 13.6 14.7 13.9 12.9 12.6 28.5 29.7 41.6 27.1 29.7 36.5 25.7 21.2 26.7 21.5 20.8 9.2 12.5 14.6 14.0 13.6 24.1 17.6 18.5 10.0 21.5 15.0 17.3 16.5 16.0 22.6 26.2 16.3 13.7 22.2 20.0 18.4 15.5 21.8 13.6 15.0 14.8 20.8 20.6 9.7 17.8 18.4 24.4 23.1 18.2 14.1 17.4 30.7 22.8 17.1 23.0 19.5 21.0 26.2 12.8 11.5 23.4 27.5 23.7 16.0 19.1 22.9 15.4 17.4 16.4 15.6 22.2 18.5 18.4 28.6 13.4 11.9 22.1 17.2 19.1 27.4 17.8 27.1 41.6 36.5 22.6 31.5 28.5 29.6 30.4 29.7 21.0 23.2 26.6 16.6 29.7 24.2 27.7 30.5 25.7 21.4 20.9 16.5 36.3 21.5 16.9 30.1 16.3 20.7 21.4 23.8 14.3 5.2 14.0 13.3 22.4 21.3 17.8 24.1 10.3 5.2 25.5 16.1 48.0 25.7 28.8 17.9 24.9 0.0 43.9 18.7 27.2 9.6 22.0 17.3 25.7 17.5 18.4 12.9 13.7 72.6 16.4 14.0 20.3 15.4 21.3 35.2 32.4 19.2 20.5 24.7 93.2 12.9 29.3 43.5 32.0 14.2 6.4 20.0 22.8 9.9 R3HDM1 "KIAA0029, R3HDM" ENSG00000048991 "R3H domain containing 1" Q15032 2 135531455-135725270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030936 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA030936: AB_10670835" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (8.16e-3)" "unprognostic (1.10e-3)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-3)" "prognostic unfavorable (8.02e-4)" "unprognostic (3.51e-2)" "unprognostic (9.52e-2)" "unprognostic (5.51e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (5.83e-7)" "unprognostic (1.16e-2)" "unprognostic (7.23e-2)" "unprognostic (4.32e-3)" "unprognostic (2.47e-1)" 6.5 6.4 23.2 8.3 27.8 13.4 5.3 22.2 57.6 6.7 7.5 4.5 2.4 4.5 6.9 6.6 6.2 5.5 6.3 5.3 17.9 15.5 6.0 6.2 5.0 11.0 11.5 32.7 5.3 8.4 20.1 13.2 4.2 7.7 5.4 10.3 4.3 4.3 6.1 13.5 5.3 5.6 8.6 7.9 6.6 5.4 14.3 7.6 14.2 8.7 3.6 13.2 8.4 4.3 6.5 12.7 3.5 8.4 9.6 9.6 5.0 20.2 12.5 17.7 20.4 9.5 13.0 10.4 12.7 13.4 12.9 14.1 22.3 14.1 32.2 10.2 18.1 9.4 9.2 23.0 23.7 22.6 20.2 11.6 26.0 15.9 22.2 11.4 22.1 16.8 12.2 10.6 22.6 29.1 11.7 20.6 35.2 26.8 27.7 14.7 20.9 38.3 15.2 13.6 15.2 14.7 22.8 12.2 19.3 12.8 17.9 18.1 14.1 20.5 8.4 9.2 16.1 11.3 11.9 15.0 11.9 11.9 15.0 16.0 22.2 30.4 30.3 13.5 18.2 15.2 3.5 7.8 3.0 6.1 8.4 5.8 6.5 6.6 9.1 11.2 4.4 6.4 7.2 1.0 9.6 7.1 12.7 9.6 5.0 23.2 27.8 22.2 57.6 17.9 15.5 11.5 32.7 7.7 7.6 6.0 1.9 14.1 5.9 7.0 44.7 14.0 12.7 4.0 18.2 7.0 19.6 6.4 16.6 7.5 37.1 12.0 3.8 23.3 6.5 8.3 7.5 7.5 17.4 10.2 10.6 25.4 22.0 13.5 20.0 33.7 12.7 14.2 6.8 10.8 9.7 8.7 7.2 3.5 10.6 9.0 38.8 0.0 8.6 22.3 25.1 8.4 2.6 13.8 10.3 5.2 R3HDM4 "C19orf22, MGC16353" ENSG00000198858 "R3H domain containing 4" Q96D70 19 896503-913245 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 93.1" "Lineage enriched" "Detected in all" 12 "granulocytes: 93.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043025, HPA048638" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043025: AB_2678275, HPA048638: AB_2680472" "unprognostic (9.22e-2)" "unprognostic (2.32e-2)" "unprognostic (1.28e-2)" "prognostic favorable (7.33e-6)" "unprognostic (4.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (4.28e-1)" "unprognostic (1.46e-3)" "unprognostic (7.44e-2)" "unprognostic (4.52e-1)" "unprognostic (2.08e-1)" "unprognostic (6.74e-2)" 15.4 11.7 23.3 33.2 19.5 57.7 15.4 12.7 26.6 15.9 16.5 16.3 10.0 17.1 15.3 13.2 33.0 15.7 20.1 12.5 20.2 11.9 18.8 24.1 22.7 43.3 14.8 11.9 19.2 34.9 10.0 16.2 18.5 12.8 17.7 12.6 15.5 24.2 14.5 21.6 22.4 18.0 13.4 10.3 41.1 24.1 8.1 12.5 31.9 14.6 19.6 43.0 20.6 19.0 6.4 2.2 93.1 2.0 1.2 7.7 3.8 17.8 10.5 11.2 15.2 7.1 12.7 18.5 12.2 9.7 12.3 10.9 11.1 15.4 13.0 10.1 13.7 2.6 16.4 6.5 14.4 5.6 19.8 13.7 17.8 9.2 19.4 21.5 9.7 31.6 16.8 27.9 7.9 16.8 11.3 14.1 15.5 32.9 26.5 11.4 32.0 13.9 18.7 14.5 21.8 17.3 13.7 5.4 24.6 20.3 18.8 19.8 19.2 10.7 23.7 19.9 9.0 20.9 23.6 14.2 22.5 12.5 26.1 12.0 29.5 15.4 18.9 14.3 14.1 19.5 14.6 2.0 16.2 2.5 1.5 3.9 6.4 5.0 3.4 2.2 3.8 4.8 3.3 93.1 1.2 2.0 0.9 7.7 3.8 23.3 19.5 12.7 26.6 20.2 11.9 14.8 11.9 12.8 12.5 17.9 28.7 41.0 33.3 31.1 15.9 6.0 20.4 12.0 13.6 17.4 7.9 34.5 6.6 39.6 0.9 18.0 18.6 23.3 47.7 40.0 23.1 40.7 23.1 10.5 23.7 27.0 31.4 12.9 21.9 1.7 10.3 25.3 23.6 54.1 28.0 6.0 48.9 26.9 11.0 13.6 10.4 25.8 23.1 0.7 3.9 27.7 57.7 29.8 20.7 65.5 RAB13 ENSG00000143545 "RAB13, member RAS oncogene family" P51153 1 153981617-153986358 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 7.7;myeloid DC: 10.7;plasmacytoid DC: 12.0" "Group enriched" "Detected in many" 9 "dendritic cells: 12.0;monocytes: 7.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 116.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003996 Approved Supported "Plasma membrane,Cytosol" NA NA 4600000 "Plasma membrane, Cytosol" "HPA003996: AB_1079728" "unprognostic (4.39e-3)" "unprognostic (1.20e-1)" "unprognostic (2.51e-2)" "unprognostic (4.11e-2)" "unprognostic (4.28e-3)" "unprognostic (3.20e-2)" "unprognostic (1.18e-3)" "unprognostic (2.80e-1)" "unprognostic (3.53e-2)" "unprognostic (2.11e-2)" "unprognostic (2.10e-1)" "unprognostic (5.93e-2)" "unprognostic (1.06e-3)" "unprognostic (2.45e-1)" "unprognostic (1.03e-1)" "unprognostic (9.51e-3)" "unprognostic (1.28e-2)" 49.0 40.4 18.1 28.7 30.2 29.7 52.1 13.6 23.5 33.1 33.6 13.7 46.6 17.8 28.5 47.1 43.2 25.0 46.7 36.9 21.9 17.0 61.3 51.5 40.8 36.7 22.9 11.1 39.2 65.6 28.4 11.1 29.0 29.1 41.5 24.5 21.6 47.4 44.4 26.8 25.0 28.7 35.3 31.3 44.8 34.5 24.0 24.7 5.9 54.8 35.0 24.9 41.0 78.4 1.0 12.0 0.9 7.7 0.0 0.7 2.4 17.2 21.3 19.3 20.3 65.0 116.2 6.3 21.1 50.0 19.1 19.5 21.5 14.7 0.0 31.8 25.1 9.7 11.9 11.4 19.2 26.6 11.1 8.8 14.4 13.4 12.0 27.3 0.0 10.2 84.5 16.6 32.9 14.6 53.9 33.2 0.0 3.0 0.0 32.4 35.9 0.0 7.3 31.0 23.7 20.4 4.2 25.2 0.0 43.0 18.3 1.2 16.0 27.6 23.9 42.5 30.0 39.3 11.5 61.5 34.8 20.6 21.5 22.8 0.1 0.0 0.2 54.2 2.5 52.7 0.0 7.7 0.1 0.0 1.4 0.1 0.8 0.1 0.1 10.7 1.0 0.1 0.7 0.9 0.0 0.2 12.0 0.0 2.4 18.1 30.2 13.6 23.5 21.9 17.0 22.9 11.1 29.1 24.7 38.7 70.7 13.4 148.7 81.7 1.1 69.4 104.4 56.2 63.7 102.9 2.0 102.3 114.4 187.9 86.7 180.9 76.1 0.0 130.8 137.5 109.8 182.0 40.3 126.2 237.1 0.0 85.5 141.2 101.8 184.7 98.4 112.5 94.5 413.0 147.2 16.7 149.6 95.1 116.7 162.0 3.2 148.8 189.5 61.2 17.1 85.7 77.7 12.5 130.8 173.5 RAB1A "RAB1, YPT1" ENSG00000138069 "RAB1A, member RAS oncogene family" P62820 2 65070701-65130106 "Plasma proteins, Predicted intracellular proteins" "Autophagy, ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 746.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005331, HPA056141" Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 19000000 "Endoplasmic reticulum, Cytosol" "CAB005331: AB_632290, HPA056141: AB_2683051" "unprognostic (4.78e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (4.19e-4)" "unprognostic (1.55e-3)" "unprognostic (2.61e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (4.30e-3)" "unprognostic (2.79e-1)" "unprognostic (4.81e-2)" "unprognostic (2.77e-1)" "unprognostic (7.80e-2)" "unprognostic (1.83e-2)" "unprognostic (8.63e-2)" 53.0 57.6 54.6 34.8 58.4 80.8 54.0 47.7 63.2 49.2 50.3 24.8 53.8 52.7 46.7 75.8 58.8 40.7 40.9 49.9 48.1 52.8 77.8 75.4 48.2 40.7 44.0 55.3 37.1 53.5 38.5 59.7 108.6 47.3 40.5 52.2 34.0 68.7 57.1 43.8 35.5 51.6 47.6 49.6 34.5 53.2 30.9 42.4 21.5 56.9 53.1 34.9 52.2 45.1 19.1 33.2 45.0 37.1 24.4 25.1 22.2 39.2 29.1 35.8 20.8 86.7 51.1 56.5 58.4 39.8 25.9 27.5 50.2 26.0 15.9 33.7 57.6 43.7 25.3 32.5 52.0 41.0 19.6 19.5 20.1 23.2 73.7 55.0 20.8 18.3 45.1 53.1 34.0 30.4 41.1 50.9 12.9 28.6 18.5 50.9 35.2 12.2 25.1 28.3 61.0 26.3 12.6 34.0 25.4 50.1 44.1 25.9 23.1 26.8 44.0 49.2 44.0 27.3 19.6 48.8 33.5 42.7 35.3 32.6 29.0 17.8 38.3 44.5 32.3 32.3 35.3 37.1 32.2 19.5 36.8 21.5 19.1 21.1 21.0 33.2 13.9 20.5 20.4 45.0 24.4 31.6 27.6 25.1 22.2 54.6 58.4 47.7 63.2 48.1 52.8 44.0 55.3 47.3 42.4 77.4 77.9 67.8 291.2 264.0 45.0 107.0 101.9 97.7 81.9 118.7 5.9 278.0 278.5 190.5 294.3 131.9 149.5 23.3 192.4 316.0 221.3 287.0 49.7 169.6 323.3 55.6 128.1 101.9 104.9 746.6 134.9 144.4 187.3 121.8 119.0 115.2 187.9 110.1 200.1 344.5 38.6 71.1 188.1 130.7 123.3 256.8 588.6 66.1 113.3 383.2 RAB23 ENSG00000112210 "RAB23, member RAS oncogene family" Q9ULC3 6 57186992-57222314 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Developmental protein" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 62.4;urinary bladder: 48.9" "Cell type enhanced" "Detected in many" 6 "Fibroblasts: 23.8;Leydig cells: 18.4;Peritubular cells: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.6;U-2197: 57.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029135, HPA029136" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA029135: AB_10602070, HPA029136: AB_10601794" "unprognostic (8.78e-2)" "unprognostic (6.55e-2)" "unprognostic (7.17e-2)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (2.28e-2)" "unprognostic (2.55e-2)" "unprognostic (5.33e-3)" "unprognostic (6.41e-2)" "unprognostic (6.55e-2)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "unprognostic (9.12e-3)" "unprognostic (1.36e-2)" "unprognostic (2.38e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-3)" 6.0 3.0 6.7 5.7 5.1 0.2 4.0 7.3 4.8 23.1 32.9 5.1 9.6 3.0 34.1 8.0 9.7 8.1 12.4 7.0 7.4 4.5 3.3 1.8 4.9 1.7 6.4 5.4 8.2 1.6 2.9 3.5 12.3 6.7 24.9 7.5 3.6 2.8 26.9 4.7 3.1 7.0 62.4 6.6 1.1 8.7 4.3 7.2 1.4 15.1 3.9 1.7 48.9 11.2 0.3 1.5 1.3 0.6 0.9 2.0 0.3 4.8 1.9 7.0 4.9 10.7 32.6 6.4 14.3 24.8 12.6 13.1 4.2 2.3 0.9 4.4 22.9 6.3 1.7 7.2 5.2 15.0 3.6 3.4 3.5 3.2 3.3 6.6 1.8 0.5 12.1 6.0 15.6 14.7 6.1 6.5 2.1 5.4 3.0 13.9 4.0 1.6 1.9 2.6 3.2 2.6 1.7 10.3 1.4 8.7 3.4 3.6 2.5 7.1 3.4 3.6 9.1 3.1 2.1 8.7 19.6 6.1 57.6 8.3 2.6 2.8 2.4 11.0 3.9 9.6 0.3 0.4 1.3 0.3 0.4 0.0 0.3 1.1 0.5 0.3 0.3 2.0 0.8 0.0 0.9 0.6 1.5 0.0 0.3 6.7 5.1 7.3 4.8 7.4 4.5 6.4 5.4 6.7 7.2 11.9 5.3 0.0 1.6 3.7 2.9 3.1 2.5 6.7 1.2 0.0 2.0 10.0 0.0 2.8 2.1 1.4 1.3 0.0 2.5 8.4 23.8 3.6 0.0 3.0 3.7 1.6 1.2 4.9 0.6 1.3 18.4 1.3 5.0 12.6 1.2 3.2 2.8 0.0 28.7 4.4 0.7 0.0 9.0 6.7 7.1 4.4 11.4 0.0 1.2 1.4 RAB25 CATX-8 ENSG00000132698 "RAB25, member RAS oncogene family" P57735 1 156061160-156070514 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 98.3" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 238.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.3;naive CD4 T-cell: 3.4" "Lineage enriched" "Detected in single" 24 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "BEWO: 24.3;CAPAN-2: 23.6;MCF7: 32.8;OE19: 75.9;RT4: 29.8;SK-BR-3: 48.5;T-47d: 45.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010872, CAB033645" Enhanced Uncertain "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "CAB033645: AB_1128883, HPA010872: AB_1079729" "unprognostic (2.43e-1)" "unprognostic (4.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (4.27e-2)" "unprognostic (4.63e-2)" "unprognostic (2.82e-1)" "unprognostic (2.03e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.38e-6)" "unprognostic (2.31e-2)" "unprognostic (3.24e-2)" "unprognostic (3.14e-2)" "unprognostic (4.94e-2)" 0.4 0.3 0.3 10.9 0.3 0.0 10.8 0.5 0.4 23.6 28.4 0.3 28.1 14.8 4.0 15.9 98.3 9.7 33.3 0.3 0.3 0.3 18.2 1.0 19.1 0.6 0.3 0.2 2.3 27.4 8.6 9.5 19.1 0.3 13.3 16.2 0.4 44.1 26.8 0.4 48.0 43.0 2.1 0.4 0.3 16.2 1.1 0.2 3.7 36.1 74.6 60.9 13.0 31.8 0.1 0.0 0.0 0.0 0.0 3.4 0.8 17.8 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 17.5 23.6 0.0 0.0 0.0 0.0 21.5 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 0.9 75.9 0.0 0.0 0.0 0.0 0.0 29.8 2.6 0.0 0.0 48.5 0.0 4.4 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 2.8 0.8 0.0 0.0 3.4 2.9 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.3 0.5 0.4 0.3 0.3 0.3 0.2 0.3 0.2 26.8 27.6 0.0 90.6 48.9 0.0 0.1 79.0 53.5 27.3 82.0 0.0 84.0 140.9 146.8 0.0 0.1 182.7 0.0 132.5 23.0 3.7 95.3 5.7 0.0 6.1 0.0 82.1 0.0 0.0 0.0 0.3 2.5 20.3 6.4 160.3 0.0 154.4 238.4 0.0 16.8 0.0 0.0 2.1 0.2 0.7 135.3 67.2 1.5 195.0 192.0 RAB27B ENSG00000041353 "RAB27B, member RAS oncogene family" O00194 18 54717860-54895516 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0;stomach 1: 36.6" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 200.3;granulocytes: 234.0;Late spermatids: 149.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 4.6;NK-cell: 5.0" "Group enriched" "Detected in many" 4 "NK-cells: 5.0;T-cells: 4.6" "Cell line enhanced" "Detected in many" "HEL: 20.9;hTCEpi: 16.0;hTERT-HME1: 19.4;U-87 MG: 56.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017712, HPA019849" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 37000000 "Golgi apparatus, Plasma membrane" Cytosol "CAB017712: , HPA019849: AB_1856000" "unprognostic (1.59e-1)" "unprognostic (5.20e-2)" "unprognostic (9.89e-3)" "unprognostic (7.51e-2)" "unprognostic (8.89e-2)" "unprognostic (1.84e-2)" "unprognostic (1.52e-1)" "unprognostic (2.73e-3)" "unprognostic (6.82e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.39e-2)" "unprognostic (1.20e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (5.75e-1)" "unprognostic (1.29e-1)" 1.1 2.4 13.8 2.3 11.3 1.0 10.8 0.8 30.0 4.5 4.4 0.3 0.0 4.5 1.1 0.7 17.0 1.3 9.8 0.9 12.0 7.9 0.8 1.4 6.2 0.7 4.6 18.4 0.7 5.3 1.3 3.6 2.4 8.6 18.0 4.8 0.0 12.8 3.3 0.6 13.2 4.3 1.1 2.1 1.8 36.6 4.8 0.4 0.1 0.7 13.9 5.9 6.8 7.1 0.0 0.0 1.1 0.0 5.0 4.6 3.4 2.5 7.4 0.2 0.0 0.5 6.8 0.0 0.5 4.5 0.6 0.4 0.0 2.9 0.4 0.0 1.3 5.8 4.9 0.0 3.0 0.1 0.0 0.2 20.9 1.8 0.0 0.9 1.1 2.3 5.4 16.0 8.8 19.4 7.3 0.2 0.1 0.0 1.3 5.5 2.5 0.0 2.4 0.1 4.6 5.0 0.0 0.0 0.1 1.4 9.6 0.0 3.6 0.7 4.5 0.0 0.0 2.8 0.1 0.1 6.5 0.2 3.3 0.6 0.1 0.0 0.0 56.8 11.9 0.3 1.1 0.0 0.2 4.6 0.0 1.1 0.0 1.5 2.3 0.0 0.0 0.6 2.3 0.5 5.0 0.0 0.0 0.0 3.4 13.8 11.3 0.8 30.0 12.0 7.9 4.6 18.4 8.6 0.4 44.7 32.8 0.0 6.7 22.8 1.7 0.4 15.3 6.7 21.6 5.2 2.0 5.4 1.7 5.2 200.3 0.7 3.1 0.0 35.6 4.0 2.5 73.1 234.0 0.8 0.6 6.4 4.1 3.1 0.8 149.0 2.0 2.4 6.8 1.8 17.2 1.3 24.0 17.5 0.4 0.0 0.4 6.5 1.3 2.2 1.2 43.0 2.4 20.1 8.1 27.8 RAB29 "RAB7L, RAB7L1" ENSG00000117280 "RAB29, member RAS oncogene family" O14966 1 205767986-205775460 "Predicted intracellular proteins" "Differentiation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 97.4;Proximal tubular cells: 145.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020822, HPA026303" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB020822: , HPA026303: AB_1856016" "unprognostic (5.38e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.82e-5)" "unprognostic (9.50e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.60e-2)" "unprognostic (3.14e-1)" "unprognostic (5.50e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-1)" "unprognostic (1.53e-1)" "unprognostic (8.20e-3)" "unprognostic (1.42e-1)" 10.7 14.4 13.8 12.0 16.5 4.0 12.3 5.9 16.2 6.1 10.3 10.4 3.0 6.8 6.9 16.2 11.0 5.1 11.0 9.5 12.6 8.6 46.6 19.9 9.3 20.1 19.0 9.2 5.8 7.9 11.1 8.3 4.6 13.3 9.4 6.7 8.9 15.4 9.6 5.2 4.4 10.4 13.0 20.2 16.8 8.7 3.2 15.9 6.5 21.8 3.1 17.3 13.7 10.8 17.9 11.6 23.5 17.8 32.1 34.8 15.9 8.2 7.7 1.2 5.6 23.0 13.1 4.1 5.9 18.2 12.4 14.9 2.3 12.0 8.9 5.8 10.0 14.7 4.7 13.8 15.5 11.4 36.1 6.4 6.7 3.2 3.9 11.2 6.6 10.0 12.7 10.6 9.9 14.1 10.4 15.6 8.3 6.5 10.3 17.4 3.2 7.1 3.4 5.5 10.4 5.9 1.5 18.3 7.3 14.5 11.5 1.9 5.4 4.1 19.2 15.3 4.6 9.3 5.4 16.2 12.8 6.6 18.5 8.4 16.9 34.5 4.7 13.0 10.9 9.5 23.5 7.7 20.8 34.8 14.8 32.6 17.9 19.5 29.3 11.6 16.6 14.2 24.4 3.1 32.1 17.8 3.5 18.0 15.9 13.8 16.5 5.9 16.2 12.6 8.6 19.0 9.2 13.3 15.9 17.9 15.3 43.0 5.5 0.0 0.4 17.3 28.1 5.3 11.4 29.6 0.0 9.9 24.9 13.4 5.2 11.8 2.6 0.0 8.9 5.2 2.9 11.3 12.7 27.1 27.5 0.0 4.7 12.3 22.5 2.7 13.3 29.4 0.0 97.4 3.0 22.5 8.7 3.5 19.4 145.9 1.4 6.5 2.0 0.9 10.2 0.0 2.4 40.3 5.0 7.1 RAB32 ENSG00000118508 "RAB32, member RAS oncogene family" Q13637 6 146543693-146554965 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.8" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 26.5" "Group enriched" "Detected in many" 40 "dendritic cells: 16.0;granulocytes: 26.5;monocytes: 17.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025731 Approved Approved Cytosol NA NA 330000 Cytosol "HPA025731: AB_1856001" "unprognostic (3.07e-1)" "unprognostic (5.32e-2)" "prognostic favorable (1.56e-4)" "prognostic unfavorable (6.51e-4)" "unprognostic (1.26e-1)" "unprognostic (2.34e-3)" "prognostic unfavorable (1.08e-7)" "unprognostic (2.64e-2)" "unprognostic (9.71e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.54e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.67e-1)" 18.4 9.0 5.2 11.0 4.9 57.8 29.9 1.1 4.4 8.4 14.6 6.6 6.3 6.7 14.8 12.8 10.2 10.2 11.2 15.3 5.2 3.0 10.7 23.0 16.5 26.4 6.2 3.5 11.0 7.4 1.5 2.8 5.9 7.4 12.5 14.9 11.3 10.1 6.9 6.3 10.2 9.0 28.2 7.5 29.4 10.6 20.8 5.5 10.4 5.8 7.0 5.6 15.6 15.2 0.0 16.0 26.5 17.3 0.5 0.0 4.9 12.0 6.4 7.5 12.5 11.4 19.4 0.0 23.5 26.1 32.2 53.6 3.9 6.0 0.0 8.6 24.7 35.8 16.0 0.4 15.1 43.5 0.0 5.8 15.3 16.1 14.1 49.6 21.1 22.7 17.1 25.4 18.4 26.2 16.9 20.8 0.0 2.9 0.0 17.5 2.8 9.6 11.5 0.9 0.0 12.4 0.0 8.0 0.1 12.6 8.4 0.0 9.9 27.5 3.3 40.5 6.9 6.4 17.2 16.6 9.8 13.4 25.7 28.5 0.0 1.7 0.0 22.5 15.9 13.2 26.5 17.3 2.9 0.0 7.7 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 6.3 0.5 5.3 0.8 0.0 4.9 5.2 4.9 1.1 4.4 5.2 3.0 6.2 3.5 7.4 5.5 44.7 6.5 5.3 93.5 47.6 1.4 1.4 48.4 2.7 9.1 10.4 3.9 1.7 21.6 146.0 64.9 29.2 39.3 0.0 90.9 5.3 38.7 32.5 57.6 67.1 193.4 0.0 57.7 31.9 182.0 123.7 22.7 98.6 160.3 72.1 30.8 9.1 140.5 43.2 24.1 61.7 1.3 19.4 20.6 31.1 12.3 16.7 2.6 5.7 62.4 55.7 RAB3A ENSG00000105649 "RAB3A, member RAS oncogene family" P20336 19 18196784-18204074 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 114.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 94.1;Distal tubular cells: 33.2;Horizontal cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 13.8;SCLC-21H: 25.3;SH-SY5Y: 12.1;U-2197: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, CAB009949, CAB078998" Enhanced Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731" "unprognostic (1.82e-1)" "unprognostic (2.22e-1)" "unprognostic (6.80e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (1.13e-1)" "prognostic favorable (6.14e-7)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (6.14e-2)" 2.3 13.0 32.3 2.6 50.5 2.0 2.0 39.1 114.7 2.8 3.1 6.3 0.0 3.6 2.7 2.6 2.4 3.2 2.8 17.0 40.8 32.7 4.1 2.2 2.5 2.4 31.5 35.6 8.0 2.3 5.0 7.5 2.4 38.2 3.8 2.8 5.8 4.2 4.4 7.5 2.5 3.0 2.9 7.0 2.5 2.5 2.2 4.8 0.0 2.9 0.1 2.1 2.9 0.7 4.6 6.0 5.1 3.0 0.7 4.2 2.6 0.9 1.0 2.4 3.2 3.8 1.0 1.4 2.1 1.2 1.4 1.9 0.9 0.6 3.4 2.3 1.7 1.3 2.7 11.0 1.3 0.7 0.7 3.5 1.3 4.0 3.8 1.0 2.3 4.2 3.2 1.3 0.8 0.4 2.8 0.4 4.2 0.7 1.2 1.3 3.2 5.1 0.6 1.9 2.8 13.8 3.6 0.2 2.8 1.5 0.5 25.3 12.1 1.0 4.4 2.4 1.0 0.9 0.4 0.4 1.3 0.9 17.5 1.2 2.1 4.6 0.8 3.3 1.7 1.1 0.0 3.0 3.8 3.0 2.2 4.0 4.6 3.2 3.0 6.0 2.2 4.1 4.2 5.1 0.7 2.7 5.5 1.8 2.6 32.3 50.5 39.1 95.0 40.8 32.7 31.5 35.6 38.2 4.8 0.0 0.0 0.9 2.1 2.9 94.1 1.1 2.5 0.0 0.0 15.7 7.9 1.4 33.2 2.1 2.4 1.4 1.4 0.0 0.8 3.6 3.9 1.4 0.0 1.5 4.3 87.4 9.2 3.1 1.6 0.0 4.0 4.3 10.1 2.8 2.3 11.3 0.8 2.0 5.3 6.3 28.8 0.0 8.6 0.3 2.8 4.3 1.5 2.2 3.7 1.4 RAB3C ENSG00000152932 "RAB3C, member RAS oncogene family" Q96E17 5 58582221-58859394 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 13.6;brain: 47.4;pituitary gland: 14.1" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 35.2;Early spermatids: 17.4;Intestinal endocrine cells: 55.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEL: 3.5;NB-4: 2.2;SCLC-21H: 14.6;SH-SY5Y: 5.3" "Low region specificity" "Detected in all" "HPA003160, HPA048156" Enhanced Approved Cytosol NA NA Cytosol "HPA003160: AB_1079731, HPA048156: AB_2680291" "unprognostic (1.30e-1)" "unprognostic (3.35e-2)" "unprognostic (9.94e-2)" "unprognostic (2.23e-2)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (8.73e-3)" "unprognostic (3.40e-2)" "unprognostic (6.90e-2)" "unprognostic (7.58e-2)" "unprognostic (9.52e-4)" "unprognostic (1.51e-3)" "unprognostic (3.70e-5)" "unprognostic (4.70e-2)" "unprognostic (1.05e-1)" "unprognostic (9.65e-2)" "unprognostic (3.61e-3)" 2.5 13.6 19.8 2.5 36.1 1.1 1.3 7.7 47.4 1.3 1.8 2.1 0.0 3.1 2.1 1.0 1.3 1.3 1.9 1.1 22.9 23.6 1.2 1.2 1.2 1.3 14.5 23.6 1.2 3.3 1.4 14.1 1.2 25.6 1.1 2.1 0.0 1.1 1.1 1.1 1.1 3.3 2.0 3.2 1.0 2.3 1.3 4.1 0.0 1.1 0.0 1.4 1.7 0.4 0.3 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.8 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.6 5.3 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 19.8 36.1 7.7 32.4 22.9 23.6 14.5 23.6 25.6 4.1 0.0 1.1 0.0 0.0 0.1 35.2 0.6 0.0 0.0 0.0 0.0 3.9 0.0 3.3 0.1 17.4 3.3 0.0 0.0 8.4 0.7 0.2 0.0 2.3 0.4 0.1 3.2 55.3 6.7 0.0 7.7 0.9 0.0 1.7 0.0 0.3 1.5 6.4 0.0 0.7 0.0 6.8 12.9 0.0 2.5 1.7 0.1 0.0 0.0 0.0 0.0 RAB3GAP1 "KIAA0066, RAB3GAP, RAB3GAP130, WARBM1" ENSG00000115839 "RAB3 GTPase activating protein catalytic subunit 1" Q15042 2 135052265-135176394 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034494, HPA034495" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034494: AB_2674188, HPA034495: AB_10670158" "unprognostic (1.02e-2)" "unprognostic (2.43e-2)" "unprognostic (5.73e-2)" "prognostic unfavorable (2.96e-4)" "unprognostic (2.18e-1)" "unprognostic (9.57e-2)" "unprognostic (2.96e-2)" "unprognostic (7.00e-2)" "unprognostic (3.18e-1)" "unprognostic (1.13e-2)" "unprognostic (3.15e-2)" "unprognostic (2.05e-1)" "unprognostic (8.40e-3)" "unprognostic (2.41e-2)" "unprognostic (3.75e-1)" "unprognostic (4.11e-1)" "unprognostic (2.15e-1)" 24.1 18.4 22.1 20.8 32.9 27.3 21.8 27.1 37.2 25.1 24.0 21.2 20.0 15.7 42.2 27.0 26.1 20.1 18.3 28.4 21.4 29.1 20.1 16.9 18.6 19.7 24.5 28.1 31.3 29.4 31.7 50.0 33.0 34.5 26.0 24.0 23.2 37.3 25.4 37.4 25.1 19.4 26.4 26.0 17.5 22.7 19.6 21.3 28.8 26.2 20.9 24.6 25.2 24.8 9.1 5.4 9.3 7.1 3.6 10.7 2.4 19.6 8.0 14.2 11.6 27.9 23.8 13.1 30.3 25.0 24.1 23.9 17.7 16.2 29.3 18.8 30.9 9.2 16.7 14.9 27.9 29.5 13.9 15.1 14.5 10.2 15.4 19.5 17.9 15.9 20.7 37.0 22.1 40.2 21.8 17.4 13.4 18.8 17.1 21.9 11.6 9.1 7.0 10.8 11.9 13.5 15.8 18.2 12.2 14.2 17.6 11.4 9.0 20.5 12.3 14.3 12.9 10.8 13.1 20.9 24.5 18.7 10.5 12.6 12.2 6.8 22.1 16.0 10.9 13.6 9.3 5.0 7.6 2.0 6.7 1.8 7.0 5.0 2.8 5.4 9.1 10.7 5.3 2.0 3.6 7.1 2.9 6.5 2.4 22.1 32.9 27.1 37.2 21.4 29.1 24.5 28.1 34.5 21.3 23.8 26.1 28.6 33.7 26.9 27.2 50.9 43.3 33.5 35.2 29.6 47.1 19.8 10.0 18.0 25.6 25.5 29.6 23.3 23.1 14.0 23.7 41.6 45.1 21.5 19.7 28.6 33.3 27.0 20.9 19.3 28.4 29.1 21.9 17.2 33.0 18.1 30.5 20.1 33.6 17.0 32.0 45.3 27.8 34.5 21.1 26.0 32.7 11.4 20.3 42.6 RAB3GAP2 "DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69" ENSG00000118873 "RAB3 GTPase activating non-catalytic protein subunit 2" Q9H2M9 1 220148293-220272454 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Cataract, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026273, HPA027299" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA026273: AB_1856007, HPA027299: AB_1856008" "prognostic unfavorable (3.05e-4)" "unprognostic (2.80e-3)" "unprognostic (1.76e-2)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (7.00e-2)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (4.63e-2)" "unprognostic (2.13e-1)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.17e-1)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 16.7 16.2 14.9 19.6 18.7 14.3 17.8 24.2 22.4 15.6 13.5 14.3 13.9 12.2 16.8 14.9 15.6 12.8 12.8 15.3 16.5 18.8 18.9 15.6 14.3 18.2 17.1 15.6 16.2 14.5 35.6 28.3 19.8 21.9 14.2 13.5 11.6 15.6 15.8 19.9 13.1 15.0 14.9 15.2 14.9 14.5 10.1 15.5 26.1 20.5 11.9 21.7 16.0 15.8 7.1 5.2 12.3 5.1 3.6 8.9 4.6 13.9 10.6 12.9 9.7 14.8 17.7 14.6 14.4 13.7 13.0 15.4 9.7 11.6 17.3 10.2 13.8 9.8 13.3 13.3 11.0 15.1 14.5 8.7 13.5 14.1 9.1 19.6 19.3 13.9 14.0 12.6 12.6 19.7 14.6 11.8 7.6 23.3 11.3 14.6 3.9 14.8 6.8 27.7 7.5 6.3 8.1 17.8 15.4 11.1 11.5 12.9 15.6 14.9 14.5 23.3 14.5 15.2 18.4 17.1 14.3 6.7 9.8 15.3 10.0 12.1 15.3 12.2 16.3 16.7 12.3 3.9 7.5 7.1 4.9 8.6 7.1 7.0 8.9 5.2 5.5 6.3 7.4 2.5 3.6 5.1 3.3 8.0 4.6 14.9 18.7 24.2 22.4 16.5 18.8 17.1 15.6 21.9 15.5 38.7 21.6 17.1 12.0 10.3 54.4 31.3 22.9 12.0 23.9 24.4 64.8 15.7 5.0 16.3 2.6 17.6 16.9 0.0 14.3 11.2 17.7 17.2 18.5 20.3 21.2 39.7 34.0 25.8 29.8 1.6 16.7 20.6 13.5 16.2 20.3 46.1 17.6 14.0 24.4 14.5 51.3 6.5 14.4 15.6 11.8 8.5 19.3 19.3 18.8 11.3 RAB3IL1 GRAB ENSG00000167994 "RAB3A interacting protein like 1" Q8TBN0 11 61897301-61920269 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 103.3;Erythroid cells: 46.7;Hofbauer cells: 50.1;Late spermatids: 98.4;Leydig cells: 52.0;Peritubular cells: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 18.0;HHSteC: 18.7;K-562: 20.2;RPMI-8226: 20.9;U-2197: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039723 Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA039723: AB_10795406" "unprognostic (1.62e-1)" "unprognostic (3.59e-2)" "prognostic unfavorable (6.08e-4)" "unprognostic (1.97e-2)" "unprognostic (8.95e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (7.93e-2)" "unprognostic (2.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.86e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (1.42e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.59e-3)" 24.1 7.1 8.2 6.8 8.0 12.9 13.3 4.0 6.5 18.5 7.8 6.8 4.5 4.3 18.0 9.5 7.2 13.3 10.0 11.2 8.2 3.4 10.0 7.4 6.2 5.9 10.1 3.8 28.6 3.2 6.1 5.4 14.0 8.7 11.9 2.6 13.4 6.7 5.1 9.1 8.5 5.0 8.5 7.7 22.7 5.4 22.1 6.9 6.6 8.8 6.5 2.4 13.4 26.3 0.0 0.0 0.0 0.2 0.0 0.0 0.6 3.2 6.9 0.2 3.5 13.4 9.9 0.7 2.6 6.7 3.9 2.7 0.9 0.7 0.0 4.9 3.9 18.0 1.7 4.6 0.2 0.7 0.0 1.0 6.5 2.5 3.3 18.7 0.2 0.1 5.6 3.4 2.0 4.4 0.6 0.4 3.4 20.2 0.2 2.2 5.8 0.0 0.0 2.0 0.6 6.9 0.3 0.9 20.9 0.3 0.3 0.2 2.4 1.6 1.4 11.9 1.1 1.0 0.7 0.5 14.5 6.5 27.5 1.1 0.2 0.9 0.0 2.8 7.5 6.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.2 8.0 4.0 6.2 8.2 3.4 10.1 3.8 8.7 6.9 0.0 0.0 0.5 0.9 4.5 0.0 1.7 0.0 0.0 1.2 1.8 0.0 1.2 1.7 1.9 103.3 3.6 0.0 46.7 0.8 1.6 15.6 1.3 0.0 0.9 50.1 1.6 0.0 22.7 12.1 98.4 52.0 2.9 8.5 0.0 0.0 6.0 1.7 0.0 42.5 9.7 7.6 0.0 5.7 0.7 8.3 3.4 1.1 0.0 0.0 0.1 RAB9A RAB9 ENSG00000123595 "RAB9A, member RAS oncogene family" P51151 X 13689125-13710506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "monocytes: 563.5;Syncytiotrophoblasts: 309.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003094, CAB016411" Supported Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016411: AB_630176, HPA003094: AB_1079736" "unprognostic (3.40e-2)" "unprognostic (1.36e-2)" "unprognostic (3.56e-3)" "unprognostic (3.08e-2)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.77e-2)" "unprognostic (8.23e-2)" "unprognostic (1.27e-2)" "unprognostic (4.88e-2)" "prognostic favorable (3.35e-5)" "unprognostic (3.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.46e-1)" "unprognostic (2.68e-2)" 17.1 36.0 17.7 20.3 17.1 30.6 48.4 16.2 24.1 14.8 17.6 20.2 19.7 9.3 18.8 14.3 19.7 11.9 14.5 23.1 16.9 14.3 19.6 15.6 17.3 21.0 24.7 13.8 18.9 23.6 19.1 11.3 17.8 18.1 13.5 16.2 8.0 22.8 17.6 12.0 21.2 12.3 15.3 25.5 15.1 14.2 6.4 23.4 9.8 16.8 13.2 19.3 16.1 19.7 13.1 19.1 17.7 25.7 19.8 27.3 13.9 12.5 6.7 8.6 20.4 29.0 23.2 7.7 7.0 24.7 10.8 15.7 7.2 14.0 11.4 17.4 11.0 25.8 12.9 12.8 14.9 10.6 25.1 19.9 3.6 14.8 8.2 17.4 6.3 9.8 24.9 26.4 13.5 14.6 17.4 9.9 6.4 6.9 16.8 11.5 8.6 5.9 10.3 9.3 8.7 12.7 8.2 9.1 33.9 29.5 11.6 7.1 5.0 14.9 21.2 24.2 22.5 11.7 6.7 7.7 8.2 4.3 29.0 4.2 13.4 23.2 4.5 8.2 5.5 8.0 17.7 25.7 11.1 27.3 16.6 21.1 13.1 15.0 22.4 17.6 10.0 11.3 19.4 15.3 19.8 14.5 19.1 11.7 13.9 17.7 17.1 16.2 24.1 16.9 14.3 24.7 13.8 18.1 23.4 44.7 26.4 18.5 59.6 57.6 9.0 13.8 43.3 33.5 26.1 31.4 0.0 70.1 68.0 112.1 0.4 21.5 28.9 0.0 55.4 48.9 36.8 75.0 44.9 17.8 51.1 14.3 23.5 13.5 35.6 1.1 34.8 34.0 54.0 563.5 26.2 40.0 73.2 70.2 37.8 51.9 8.8 12.9 28.8 5.9 19.0 72.9 309.7 49.6 23.6 72.2 RABEP2 "FLJ23282, FRA" ENSG00000177548 "Rabaptin, RAB GTPase binding effector protein 2" Q9H5N1 16 28904421-28936526 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047641 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA047641: AB_2680111" "unprognostic (4.93e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-2)" "unprognostic (7.06e-2)" "unprognostic (1.44e-1)" "prognostic favorable (5.84e-4)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (8.41e-2)" "unprognostic (6.13e-2)" "unprognostic (1.26e-3)" "unprognostic (5.86e-2)" "prognostic favorable (1.24e-6)" "unprognostic (7.50e-2)" "unprognostic (8.20e-2)" "unprognostic (1.08e-1)" "unprognostic (5.92e-3)" 4.7 13.7 5.4 19.8 10.0 8.5 6.0 4.4 8.6 5.6 7.8 9.9 17.3 14.3 5.9 7.3 11.6 5.3 14.1 8.7 6.5 5.8 10.8 6.6 6.7 35.5 11.9 6.0 5.5 11.3 10.3 11.2 9.1 8.1 17.3 4.1 11.2 16.7 13.9 5.1 17.8 17.5 7.1 6.9 31.5 9.3 8.8 8.4 8.3 9.2 7.5 23.0 10.2 7.6 14.9 3.6 2.4 3.0 5.1 3.5 2.7 8.3 14.0 3.5 6.5 1.9 3.0 6.3 10.2 6.1 7.2 7.0 9.7 7.6 16.0 16.0 3.8 2.9 10.6 1.3 6.0 1.2 6.1 5.8 6.2 10.0 13.7 4.3 4.4 19.7 5.0 5.1 8.5 1.4 4.1 9.9 4.5 3.0 5.8 5.2 19.4 5.6 10.0 4.6 3.4 6.6 19.8 3.2 10.8 4.8 11.0 5.5 7.0 4.5 21.6 4.4 0.7 17.5 9.7 16.4 11.3 5.4 7.6 9.8 9.1 2.8 12.1 11.8 11.4 8.0 0.5 2.5 2.4 3.5 2.8 2.6 12.2 2.5 3.3 3.6 14.9 2.3 2.1 0.7 5.1 3.0 2.1 2.1 2.7 5.4 10.0 4.4 8.6 6.5 5.8 11.9 6.0 8.1 8.4 3.0 10.6 36.5 13.4 4.5 10.7 1.4 12.7 2.7 4.5 19.2 33.4 20.5 14.9 15.7 0.4 13.1 28.5 0.0 18.1 6.2 7.8 15.9 18.4 3.4 11.2 14.3 16.6 5.5 7.1 0.4 3.7 9.6 10.1 12.6 28.7 8.2 16.4 40.3 6.0 10.3 43.4 12.9 6.9 5.2 5.3 7.3 18.4 18.7 22.9 15.3 RABGAP1 "GAPCenA, TBC1D11" ENSG00000011454 "RAB GTPase activating protein 1" Q9Y3P9 9 122940833-123104866 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041651, HPA064860, HPA072273" Enhanced Enhanced Cytosol NA NA Cytosol "HPA041651: AB_10794673, HPA064860: AB_2685372, HPA072273: AB_2686504" "prognostic unfavorable (8.09e-4)" "unprognostic (3.45e-1)" "unprognostic (3.85e-3)" "unprognostic (3.90e-1)" "unprognostic (4.16e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-1)" "unprognostic (3.75e-2)" "unprognostic (5.19e-2)" "unprognostic (3.52e-2)" "unprognostic (1.88e-2)" "unprognostic (2.76e-1)" "prognostic favorable (6.06e-6)" "unprognostic (1.39e-1)" "unprognostic (2.75e-1)" "unprognostic (8.72e-2)" "unprognostic (3.05e-2)" 16.9 12.6 24.2 12.5 31.0 5.1 17.1 16.9 36.3 18.8 27.6 19.5 16.4 9.5 23.6 20.9 25.5 18.2 15.2 20.0 22.4 20.8 16.2 9.0 15.0 14.0 23.9 25.0 19.6 12.6 29.1 17.7 18.5 23.9 24.1 18.6 19.4 18.1 25.4 23.7 17.3 12.8 25.6 23.0 13.5 17.8 16.4 17.5 11.4 31.2 8.6 16.2 22.9 16.4 4.1 3.9 6.1 5.5 2.1 4.5 1.4 8.9 12.0 19.0 15.7 22.0 18.0 11.7 9.4 17.0 14.6 13.7 13.9 8.8 12.4 7.5 14.6 19.5 30.5 12.1 11.8 15.8 11.5 7.3 9.7 19.4 10.5 18.9 7.8 8.4 17.3 18.1 12.5 14.2 21.1 16.5 12.4 8.3 9.5 17.5 19.9 10.2 6.2 7.0 25.8 9.3 16.9 34.7 10.5 12.2 10.0 10.7 8.3 16.8 15.2 8.6 14.9 28.9 4.3 12.6 12.4 7.4 13.6 9.4 9.3 15.1 13.0 11.7 4.0 10.8 6.1 3.6 4.3 2.6 5.5 2.0 3.0 2.7 2.3 2.8 4.1 4.5 2.9 5.6 2.1 2.4 3.9 3.1 1.4 24.2 31.0 16.9 36.3 22.4 20.8 23.9 25.0 23.9 17.5 23.8 43.2 18.2 20.2 16.0 47.9 39.5 10.2 33.5 34.2 10.4 47.1 17.8 3.3 9.1 11.8 24.1 12.7 0.0 12.8 7.4 18.2 30.8 13.9 13.7 13.6 54.0 16.3 27.0 26.4 10.7 37.7 15.9 13.5 18.0 17.1 36.5 10.0 10.5 48.4 9.0 35.9 84.1 32.0 71.1 34.5 15.2 34.8 8.7 14.4 15.5 RABGEF1 "rabex-5, RABEX5" ENSG00000154710 "RAB guanine nucleotide exchange factor 1" Q9UJ41 7 66682164-66811464 "Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA001407 Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA001407: AB_1856024" "unprognostic (6.65e-2)" "unprognostic (6.44e-4)" "unprognostic (7.32e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.06e-5)" "unprognostic (3.77e-1)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (3.32e-1)" "unprognostic (4.64e-4)" "unprognostic (6.45e-2)" "prognostic favorable (1.27e-4)" "unprognostic (1.43e-1)" "unprognostic (5.55e-1)" "unprognostic (2.83e-1)" "unprognostic (1.39e-1)" 18.4 15.2 13.0 14.7 14.4 59.2 12.0 22.4 16.8 16.9 14.1 12.6 9.4 9.1 16.4 9.5 20.6 12.0 13.5 10.8 13.5 15.6 14.9 17.2 10.5 10.6 12.8 12.1 14.7 13.2 13.3 10.2 18.8 13.5 13.1 11.0 13.8 10.6 16.1 12.1 21.9 15.5 15.3 11.9 15.3 11.9 21.5 9.8 13.1 22.3 20.7 18.2 19.1 16.3 15.7 10.4 18.1 13.5 15.4 10.9 7.6 20.6 6.2 5.4 9.1 14.7 20.6 5.4 18.2 23.3 19.2 18.3 5.8 13.4 10.1 7.1 26.3 14.1 8.7 7.4 9.8 26.8 6.9 5.9 5.4 7.3 5.7 11.7 9.2 7.7 10.2 12.7 24.7 27.4 15.9 5.0 6.9 9.9 7.4 19.0 10.4 6.2 12.9 7.1 9.6 9.0 5.5 9.4 7.6 16.8 9.5 6.2 9.7 8.4 18.6 9.8 9.4 10.7 5.8 6.5 31.2 6.5 19.1 14.2 9.6 12.5 12.0 14.4 10.3 9.9 18.1 7.8 9.4 8.6 6.9 9.3 11.2 8.1 10.9 7.3 15.7 8.8 8.2 15.1 15.4 13.5 10.4 6.7 7.6 13.0 14.4 22.4 16.8 13.5 15.6 12.8 12.1 13.5 9.8 11.9 13.8 5.2 6.5 3.7 9.7 4.2 0.0 20.1 18.2 5.2 15.7 3.2 10.0 4.5 4.1 5.8 5.9 0.0 4.8 3.0 5.1 10.1 13.9 5.9 4.2 7.9 17.2 4.9 12.3 1.8 5.5 9.3 1.7 5.4 5.1 4.8 12.5 14.0 8.9 4.0 16.7 0.0 7.3 6.6 6.4 5.8 11.3 2.5 4.7 11.1 RABL6 "bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1" ENSG00000196642 "RAB, member RAS oncogene family like 6" Q3YEC7 9 136807943-136841187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044037 Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA044037: AB_10966437" "unprognostic (3.10e-3)" "unprognostic (8.52e-3)" "unprognostic (1.20e-1)" "prognostic favorable (4.00e-4)" "unprognostic (9.23e-2)" "unprognostic (2.44e-2)" "unprognostic (1.90e-3)" "unprognostic (7.55e-3)" "unprognostic (1.65e-1)" "unprognostic (4.92e-2)" "prognostic favorable (1.46e-4)" "unprognostic (5.23e-2)" "unprognostic (1.03e-3)" "prognostic favorable (9.14e-4)" "unprognostic (4.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.15e-1)" 20.8 17.7 31.0 21.6 42.8 32.9 17.9 43.6 41.4 12.5 25.1 18.0 14.8 29.4 13.7 14.6 17.9 12.8 22.2 29.4 28.2 22.2 17.1 7.3 17.2 18.5 22.7 21.6 13.9 39.6 17.4 23.3 16.0 16.7 24.3 16.6 13.1 24.8 16.9 98.6 21.5 29.4 15.6 20.6 20.0 24.5 16.5 17.2 20.9 13.9 22.6 13.9 13.8 19.9 4.7 4.1 2.9 5.7 6.1 5.2 1.4 19.2 25.6 18.4 21.5 7.5 8.5 48.4 17.5 11.3 17.0 12.5 28.5 20.5 27.3 11.0 13.6 17.9 42.3 20.4 15.5 5.8 28.4 26.3 16.7 32.0 33.3 13.6 30.9 21.5 9.4 16.0 10.5 11.7 10.4 17.7 23.6 36.3 13.4 11.6 38.5 33.0 21.4 34.4 23.7 22.1 43.3 22.0 26.6 11.2 17.2 60.6 25.1 30.9 36.3 21.6 10.2 31.2 31.2 21.3 22.1 19.2 23.2 28.3 11.5 13.1 22.2 18.5 15.1 20.6 1.2 4.8 2.9 3.7 5.7 3.8 4.5 3.9 3.6 3.3 4.7 3.2 4.1 2.3 6.1 2.0 4.1 5.2 1.4 31.0 42.8 43.6 41.4 28.2 22.2 22.7 21.6 16.7 17.2 26.8 48.3 8.9 15.4 16.0 37.2 29.1 0.0 8.1 7.9 24.4 19.6 20.7 26.6 28.0 10.1 16.9 100.2 0.0 49.7 27.9 22.0 31.8 15.0 0.0 27.4 36.5 49.8 0.0 0.0 10.9 18.1 26.0 38.8 26.2 55.1 18.1 55.1 51.0 25.1 38.5 38.3 0.0 17.3 15.4 26.4 16.9 23.7 12.9 57.2 21.6 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374523-6403977 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 44000000 "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: AB_2680167" "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (1.74e-5)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 45.2 35.0 71.0 28.4 64.0 24.4 46.5 42.1 93.0 48.7 58.9 75.5 22.5 51.6 48.7 49.5 93.4 47.2 40.0 48.4 73.8 59.8 47.8 42.9 45.6 38.3 76.7 60.9 45.1 29.2 51.0 25.2 55.8 54.9 40.5 64.0 37.2 43.3 48.9 57.4 58.6 49.8 57.3 88.2 35.0 49.7 28.1 47.1 41.3 40.9 42.8 50.7 52.2 54.0 11.0 32.0 49.1 31.9 7.3 11.8 10.7 75.1 34.1 35.3 38.3 41.9 53.5 21.1 42.4 52.1 56.6 57.7 33.5 71.1 21.2 27.5 59.1 58.6 53.6 37.6 51.4 72.5 9.9 31.2 21.3 27.6 24.1 50.4 19.2 17.4 35.6 46.0 40.7 45.7 43.1 49.8 21.0 38.0 16.8 60.9 54.8 10.5 45.2 63.2 38.3 40.9 18.7 35.9 31.1 72.7 47.7 26.8 45.1 29.9 109.6 34.0 42.1 61.8 57.8 52.2 37.2 56.0 45.5 48.9 12.8 14.0 20.0 34.3 36.7 70.4 7.6 31.9 16.4 7.2 22.2 4.5 11.0 8.1 9.2 32.0 11.0 9.8 6.5 49.1 7.3 22.1 18.2 11.8 10.7 71.0 64.0 42.1 93.0 73.8 59.8 76.7 60.9 54.9 47.1 137.0 112.5 192.8 745.4 829.8 84.3 183.1 481.6 92.3 104.6 338.5 23.6 691.3 454.3 121.1 58.5 522.9 706.2 303.7 149.3 914.8 466.9 1152.5 132.3 288.4 738.1 138.2 323.2 535.2 736.9 43.7 441.0 745.3 435.3 408.4 531.5 280.9 231.2 471.0 444.5 611.5 54.4 472.1 495.6 210.1 328.6 1004.1 707.0 194.1 436.1 1582.5 RACK1 "Gnb2-rs1, GNB2L1, H12.3" ENSG00000204628 "Receptor for activated C kinase 1" P63244 5 181236909-181248096 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 2715.9;Exocrine glandular cells: 2901.4;Extravillous trophoblasts: 3765.3;Pancreatic endocrine cells: 2156.8;Syncytiotrophoblasts: 2681.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004288, HPA021676" Uncertain Supported Nucleoplasm,Cytosol NA NA 130000 "Nucleoplasm, Cytosol" "CAB004288: AB_2247471, HPA021676: AB_1849868" "unprognostic (4.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.03e-2)" "unprognostic (1.07e-2)" "unprognostic (7.43e-2)" "prognostic unfavorable (2.98e-6)" "unprognostic (4.19e-1)" "unprognostic (3.04e-1)" "unprognostic (2.00e-1)" "unprognostic (2.07e-1)" "unprognostic (3.81e-1)" "unprognostic (1.05e-3)" "unprognostic (3.67e-1)" "unprognostic (1.78e-1)" "unprognostic (3.50e-1)" "unprognostic (2.62e-1)" 100.5 72.1 32.2 92.0 32.8 74.9 185.3 45.0 34.3 102.3 85.7 36.2 66.0 43.0 86.0 82.9 128.1 98.3 81.8 102.5 29.8 29.2 80.6 113.7 95.7 223.3 38.2 27.6 189.2 330.4 48.8 68.3 72.3 31.8 102.6 61.2 57.8 119.7 66.9 133.8 115.5 72.1 92.8 37.6 107.8 70.5 52.9 32.4 197.4 115.4 117.0 141.8 99.7 113.5 92.9 69.4 19.2 50.8 47.1 81.4 138.7 67.0 57.2 87.0 108.8 133.7 245.8 87.9 60.5 165.0 142.1 143.6 122.8 59.5 136.9 79.3 105.0 94.1 46.4 99.3 336.3 105.2 136.1 107.1 46.7 63.3 61.2 167.3 107.4 47.4 235.1 181.3 106.8 148.8 152.4 144.4 142.6 61.8 100.6 109.0 104.1 106.1 69.1 60.6 79.0 51.9 82.9 53.9 114.2 150.1 64.3 72.4 85.3 30.9 103.3 152.3 58.0 70.5 93.7 76.1 49.3 45.0 43.4 91.4 75.5 108.6 85.3 47.3 83.9 50.2 19.2 50.8 16.3 45.9 43.6 69.5 91.9 70.3 53.8 69.4 92.9 81.4 65.2 7.8 47.1 37.1 53.3 68.6 138.7 32.2 32.8 45.0 34.3 29.8 29.2 38.2 27.6 31.8 32.4 536.0 821.6 0.0 0.0 0.0 0.0 0.0 0.0 465.7 831.4 472.8 0.0 2715.9 1482.2 1555.6 0.0 0.0 0.0 0.0 2901.4 3765.3 0.0 0.0 618.5 0.0 1726.4 0.0 0.0 0.0 0.0 0.0 0.0 340.2 0.0 2040.6 0.0 0.0 2156.8 0.0 0.0 2023.5 0.0 0.0 0.0 0.0 0.0 0.0 2681.1 0.0 0.0 0.0 RAD23A "HHR23A, MGC111083" ENSG00000179262 "RAD23 homolog A, nucleotide excision repair protein" P54725 19 12945855-12953642 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 225.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026418, HPA053901, HPA057003, HPA065599" Approved Enhanced Nucleoplasm,Cytosol NA NA 3100000 Nucleoplasm Cytosol "HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516" "unprognostic (2.09e-1)" "unprognostic (1.58e-3)" "unprognostic (1.23e-3)" "unprognostic (7.90e-3)" "unprognostic (1.45e-1)" "unprognostic (1.48e-1)" "unprognostic (3.78e-3)" "unprognostic (3.57e-3)" "unprognostic (3.13e-1)" "unprognostic (3.12e-3)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-3)" "unprognostic (2.32e-3)" "unprognostic (9.99e-2)" "unprognostic (8.56e-2)" "unprognostic (6.59e-3)" 19.6 15.2 19.1 13.4 17.7 19.9 16.0 15.1 25.3 12.9 18.0 14.6 10.7 13.6 15.3 14.3 19.9 17.7 13.6 34.3 16.6 16.0 13.2 24.5 14.2 14.1 15.4 15.6 17.1 21.1 14.0 12.3 17.3 15.5 15.1 10.7 12.6 18.6 15.8 225.3 19.8 11.9 16.5 15.4 15.7 14.9 19.1 12.5 14.6 17.2 37.7 13.8 20.7 17.0 29.5 30.0 22.7 35.6 26.5 32.1 22.5 31.6 11.7 13.6 14.0 22.6 26.0 22.8 15.5 31.2 36.9 33.6 13.1 22.9 27.0 35.8 23.3 24.9 24.6 18.6 32.2 14.0 38.1 23.6 10.9 15.2 12.6 44.1 23.5 32.0 26.5 48.4 26.6 51.0 22.0 25.3 42.9 27.9 24.9 33.2 31.0 29.2 29.1 18.6 28.7 29.1 15.5 14.1 43.9 28.7 12.7 25.2 19.8 17.2 31.3 34.3 10.4 24.4 40.8 19.8 53.1 14.2 63.0 47.3 36.0 30.2 19.7 43.7 44.5 43.6 10.4 27.9 22.7 29.7 35.6 32.1 29.2 25.3 25.1 23.4 29.5 24.6 27.8 3.9 26.5 34.9 30.0 27.0 22.5 19.1 17.7 15.1 25.3 16.6 16.0 15.4 15.6 15.5 12.5 80.4 45.1 117.4 151.7 107.0 47.8 58.9 99.3 85.6 69.4 52.4 19.6 181.0 140.9 124.8 141.7 106.7 99.7 397.1 165.8 204.0 114.4 158.2 108.6 79.1 154.6 49.3 83.8 66.9 72.2 22.4 109.6 119.4 135.0 233.6 105.8 52.4 156.1 119.3 107.1 115.4 44.7 109.9 155.2 223.5 168.2 128.1 204.7 114.9 143.0 156.7 RAD23B "HHR23B, HR23B, P58" ENSG00000119318 "RAD23 homolog B, nucleotide excision repair protein" P54727 9 107283137-107332194 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Late spermatids: 940.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029718, HPA029720, CAB033868" Enhanced Supported Nucleoplasm,Cytosol No No 8200000 "Nucleoplasm, Cytosol" "CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008" "unprognostic (3.95e-3)" "unprognostic (1.01e-2)" "unprognostic (2.28e-2)" "unprognostic (8.14e-2)" "unprognostic (4.71e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (2.94e-1)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.34e-1)" "unprognostic (3.72e-1)" "unprognostic (3.31e-2)" "unprognostic (1.20e-1)" "unprognostic (2.94e-3)" "unprognostic (2.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" 41.0 30.1 21.9 23.5 24.5 37.0 28.9 33.3 28.1 28.9 31.4 18.4 28.2 21.8 27.0 38.0 45.3 22.6 24.1 45.5 22.2 23.0 29.7 82.0 27.7 20.7 20.8 23.3 31.6 45.9 21.0 24.8 66.1 25.6 31.1 25.9 17.3 28.7 25.8 98.2 38.2 29.1 29.4 22.6 29.8 23.0 38.5 18.6 32.8 30.4 34.0 27.1 42.1 32.6 5.2 2.5 7.1 2.7 5.0 4.9 1.2 32.4 29.0 41.0 26.3 28.2 44.8 46.3 50.5 41.6 44.9 30.9 47.9 35.6 45.6 20.5 55.1 40.8 45.7 56.5 44.9 45.5 31.0 18.5 23.7 30.5 36.6 37.6 42.4 20.4 37.5 42.0 43.0 64.9 35.8 31.2 20.3 38.2 34.4 40.5 53.1 41.3 21.6 43.6 58.0 33.8 30.9 53.8 21.6 38.6 30.8 37.5 25.4 34.9 49.4 31.0 64.7 50.4 17.4 28.6 33.6 33.0 41.4 37.7 23.6 43.2 24.7 35.8 25.3 35.2 1.7 2.7 2.3 4.4 2.7 4.9 4.0 2.6 3.7 2.2 5.2 4.4 3.5 7.1 5.0 1.7 2.5 4.6 1.2 21.9 24.5 33.3 27.4 22.2 23.0 20.8 23.3 25.6 18.6 41.7 36.8 34.3 97.8 173.7 41.1 108.8 76.5 32.1 30.7 33.2 25.5 238.3 43.1 77.6 384.7 63.9 55.5 23.3 67.0 220.2 83.7 122.4 35.7 191.4 88.0 47.7 96.9 48.5 67.6 940.0 69.9 68.6 70.9 80.2 75.4 36.1 76.0 42.1 82.0 75.7 41.1 77.6 91.4 34.9 59.0 210.7 244.1 43.6 64.4 130.5 RAD51 "BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA" ENSG00000051180 "RAD51 recombinase" Q06609 15 40694774-40732339 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.9;testis: 24.0" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 46.7;Extravillous trophoblasts: 57.9;Spermatocytes: 52.6;Spermatogonia: 26.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB010381, HPA039310" Enhanced Supported "Nucleoli rim,Cytosol" NA Yes "Nucleoli rim" Cytosol "CAB010381: AB_2253533, HPA039310: AB_2676434" "prognostic unfavorable (7.94e-4)" "unprognostic (7.20e-3)" "unprognostic (1.22e-1)" "unprognostic (2.72e-2)" "unprognostic (8.23e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (9.33e-4)" "unprognostic (3.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-3)" "unprognostic (2.53e-3)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (2.34e-1)" "unprognostic (9.59e-2)" "unprognostic (1.94e-2)" 1.0 0.9 0.4 6.6 0.9 5.3 1.0 0.7 0.9 1.1 5.7 0.4 0.3 1.7 0.8 2.0 4.9 0.5 1.7 1.8 0.5 0.5 1.0 1.0 1.9 7.4 0.5 0.3 0.9 0.7 0.0 0.4 6.2 0.7 0.8 7.6 0.4 1.4 0.3 1.3 2.1 2.6 1.2 1.1 5.0 1.5 24.0 0.5 27.9 0.6 3.7 9.7 1.0 1.9 3.1 1.7 2.7 2.2 2.2 8.8 1.7 12.4 5.5 13.2 5.0 1.3 3.6 12.0 22.0 6.1 19.5 19.7 13.0 8.5 7.0 10.9 7.8 7.5 26.4 24.9 10.3 19.1 14.6 8.5 17.6 10.8 9.9 0.1 14.2 12.1 0.5 1.7 13.1 5.8 3.0 10.6 19.9 23.1 19.7 16.9 10.9 20.3 13.1 15.1 29.3 6.9 23.2 18.7 11.8 7.1 16.8 5.9 11.1 9.7 17.1 3.5 16.7 10.3 11.8 4.4 14.1 9.0 19.8 11.3 5.0 24.6 23.4 6.1 29.7 12.4 2.0 0.9 2.7 4.1 2.0 0.8 3.1 4.3 5.5 1.7 1.6 1.2 2.1 1.3 2.2 2.2 1.2 8.8 1.7 0.4 0.9 0.7 0.9 0.5 0.5 0.5 0.3 0.7 0.5 0.0 0.0 0.8 1.2 3.2 0.4 0.8 0.0 0.0 1.2 0.0 0.0 16.0 0.0 0.0 2.6 0.1 0.9 46.7 0.0 57.9 0.6 0.7 0.0 0.0 10.9 0.0 0.0 1.8 2.4 4.0 0.6 0.5 0.0 0.0 3.2 0.2 0.1 3.7 0.7 0.0 0.0 0.0 0.2 52.6 26.0 1.4 21.2 1.5 5.2 1.3 RAD51C "FANCO, RAD51L2" ENSG00000108384 "RAD51 paralog C" O43502 17 58692573-58735611 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 79.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045198 Supported "Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol" NA NA "Nucleoplasm, Mitochondria, Cytosol" "Vesicles, Cell Junctions" "HPA045198: AB_2679250" "unprognostic (5.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (6.20e-2)" "unprognostic (1.83e-1)" "unprognostic (4.59e-2)" "prognostic unfavorable (8.68e-5)" "unprognostic (3.65e-2)" "unprognostic (2.91e-2)" "unprognostic (1.03e-2)" "prognostic favorable (5.33e-4)" "unprognostic (2.55e-1)" "unprognostic (2.62e-2)" "unprognostic (7.62e-2)" "unprognostic (2.41e-1)" "unprognostic (9.52e-2)" "unprognostic (2.42e-2)" 11.1 22.7 22.1 10.1 20.8 19.4 15.4 20.8 31.0 12.3 13.7 16.0 11.1 7.3 14.3 23.1 13.2 11.8 10.9 24.9 20.2 17.4 13.7 13.9 8.9 19.6 17.2 21.4 13.4 11.2 20.0 18.3 15.1 28.9 18.3 15.0 13.2 10.6 12.7 15.5 10.3 9.6 14.4 14.0 14.4 13.2 18.9 12.7 23.8 12.6 11.7 18.6 12.6 11.8 14.4 13.0 18.8 11.3 11.2 21.7 9.2 15.7 18.3 11.3 12.4 6.2 5.3 25.8 8.6 4.0 11.6 14.8 7.8 10.2 9.3 12.8 5.9 15.3 6.0 15.1 12.2 21.6 22.6 31.3 13.1 20.6 29.4 6.1 16.8 11.7 3.2 11.0 12.9 10.5 6.2 12.9 15.6 20.3 12.8 9.9 79.0 23.8 23.4 3.0 10.5 17.0 15.3 17.9 17.5 7.0 9.9 14.0 13.0 6.9 3.4 13.0 3.0 10.2 17.8 4.1 9.8 26.0 8.8 10.5 12.0 44.5 27.2 9.9 16.6 11.2 18.8 7.5 9.8 13.7 11.3 13.3 14.1 15.0 14.9 13.0 14.4 16.4 15.4 4.6 11.2 9.8 11.7 21.7 9.2 22.1 20.8 20.8 31.0 20.2 17.4 17.2 21.4 28.9 12.7 17.9 11.5 15.2 17.6 10.5 14.6 54.1 10.2 10.7 13.6 15.7 5.9 46.3 49.7 22.6 78.9 14.9 4.2 70.0 16.3 78.6 13.4 14.4 23.0 12.5 29.2 15.9 6.4 14.1 13.4 51.1 16.1 22.9 23.6 22.6 13.1 21.7 12.0 10.5 14.5 19.5 23.0 32.3 22.1 113.9 80.6 9.4 30.3 21.3 12.5 8.4 RAD54L2 "ARIP4, KIAA0809, SRISNF2L" ENSG00000164080 "RAD54 like 2" Q9Y4B4 3 51541144-51668667 "Enzymes, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035004, HPA039992, HPA077351" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: " "unprognostic (1.46e-2)" "unprognostic (3.67e-2)" "unprognostic (2.61e-1)" "unprognostic (5.01e-2)" "unprognostic (1.15e-1)" "unprognostic (4.38e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-2)" "unprognostic (9.24e-2)" "unprognostic (2.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.71e-5)" "unprognostic (3.72e-2)" "unprognostic (3.19e-1)" "unprognostic (3.30e-2)" "unprognostic (6.63e-2)" 4.4 4.1 3.3 3.5 4.3 5.2 4.1 7.8 4.3 3.6 4.4 2.2 5.3 4.6 3.6 3.9 2.5 3.1 3.4 3.5 3.4 8.8 4.2 3.8 3.4 5.6 5.0 5.3 3.9 4.9 3.8 3.5 3.7 4.2 7.3 4.6 4.1 4.3 4.1 4.7 4.4 4.7 4.2 5.2 3.8 3.5 6.9 5.2 6.5 7.1 6.3 8.3 4.0 5.6 4.4 11.4 11.2 6.4 4.6 6.0 4.8 6.8 6.6 6.3 7.8 3.3 14.8 1.4 8.4 6.9 4.4 17.9 6.0 8.2 7.8 4.0 12.7 9.5 5.1 5.8 14.1 7.6 5.2 4.8 10.1 9.8 4.2 7.3 12.9 8.3 8.1 5.2 4.3 12.6 6.4 9.0 2.8 4.8 5.8 8.8 2.0 3.3 7.3 4.7 8.9 7.6 7.3 4.9 7.2 4.7 8.5 9.5 7.0 8.0 7.1 9.3 8.7 8.8 15.0 7.5 8.0 8.8 6.5 4.8 4.7 8.1 6.0 8.3 4.3 7.1 6.6 5.2 6.9 4.7 5.4 2.2 6.3 7.1 5.2 6.3 4.0 8.9 11.8 9.0 6.6 8.1 33.3 9.7 10.2 10.7 7.9 8.7 29.5 13.5 1.7 8.3 6.1 11.1 4.2 0.0 9.0 7.3 8.0 8.9 17.4 20.7 7.7 44.5 15.6 11.1 11.4 1.9 14.1 6.8 13.5 4.6 6.8 10.4 10.2 6.2 15.9 3.4 31.5 12.9 9.2 37.2 39.4 7.9 24.8 9.6 7.0 9.8 RAET1E "bA350J20.7, LETAL, ULBP4" ENSG00000164520 "Retinoic acid early transcript 1E" Q8TD07 6 149883375-149898102 "Predicted intracellular proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 1.9;Early spermatids: 5.0;Late spermatids: 4.2;Suprabasal keratinocytes: 5.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HBEC3-KT: 15.9;HeLa: 21.8;hTCEpi: 15.8;SiHa: 7.5;U-87 MG: 6.8" HPA054022 Supported "Focal adhesion sites,Cytosol" "Intracellular and membrane" NA NA "Focal adhesion sites" Cytosol "HPA054022: AB_2797250" "unprognostic (1.67e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "unprognostic (2.71e-2)" "unprognostic (1.36e-3)" "unprognostic (4.80e-4)" "unprognostic (1.11e-1)" "unprognostic (3.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (7.47e-5)" "unprognostic (2.41e-2)" "unprognostic (3.18e-2)" "unprognostic (3.17e-2)" "unprognostic (1.06e-1)" 1.6 0.5 0.2 0.5 0.2 0.0 1.4 0.2 0.2 10.4 0.3 0.2 0.2 0.2 0.8 0.6 39.7 0.6 0.2 0.2 0.2 0.0 2.8 0.2 0.6 0.2 0.2 0.2 0.6 0.2 0.1 0.2 0.5 0.2 0.4 0.3 0.2 7.0 0.2 0.7 14.6 0.3 0.3 0.2 0.6 0.2 0.5 0.3 0.3 0.2 19.8 22.5 1.3 12.6 0.6 0.4 2.3 0.6 0.5 0.7 0.1 1.5 0.9 0.0 0.0 0.2 1.3 0.1 0.1 0.9 0.1 0.3 0.0 3.7 0.0 2.1 3.1 2.0 1.7 0.0 15.9 0.2 0.4 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.3 15.8 0.9 3.3 0.5 0.1 0.0 0.0 1.3 0.9 0.1 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.2 0.3 0.7 0.2 0.0 7.5 2.0 0.0 0.0 1.1 0.0 3.0 1.1 0.4 0.1 0.9 0.0 0.0 0.0 6.8 0.3 0.0 2.0 0.6 0.4 0.4 0.3 0.2 0.2 0.6 0.3 0.1 0.6 0.7 0.4 2.3 0.5 0.2 0.4 0.3 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.9 1.9 0.6 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 1.8 RAI14 "DKFZp564G013, KIAA1334, NORPEG, RAI13" ENSG00000039560 "Retinoic acid induced 14" Q9P0K7 5 34656237-34832627 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 64.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 166.4;Early spermatids: 198.0;Late spermatids: 250.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 59.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036949, HPA036950" Supported Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Nucleoplasm "Actin filaments, Cytosol" "HPA036949: AB_10670568, HPA036950: AB_10669721" "unprognostic (7.63e-2)" "unprognostic (9.86e-2)" "unprognostic (4.87e-2)" "unprognostic (1.40e-1)" "unprognostic (3.38e-2)" "unprognostic (4.75e-2)" "unprognostic (5.49e-2)" "unprognostic (6.18e-2)" "unprognostic (6.28e-2)" "unprognostic (2.62e-1)" "unprognostic (8.18e-2)" "unprognostic (4.58e-2)" "prognostic unfavorable (9.75e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.33e-1)" "unprognostic (4.81e-2)" "unprognostic (4.34e-2)" 5.6 4.5 3.9 8.3 5.9 0.5 5.1 4.4 3.2 23.3 9.1 5.5 14.1 2.5 29.2 8.2 8.8 6.8 8.8 3.6 4.4 3.5 7.7 11.2 10.4 5.1 6.9 1.5 9.5 4.8 6.4 2.7 64.4 5.6 10.4 4.0 8.2 8.4 10.8 2.0 7.6 3.6 34.7 17.0 21.2 6.0 26.6 5.7 2.1 6.7 2.7 3.8 22.5 14.9 0.8 0.6 2.5 0.8 2.5 3.3 0.3 2.7 10.8 12.5 8.3 6.7 23.5 16.0 32.7 26.4 18.9 19.0 8.2 3.5 0.6 13.1 16.0 20.7 1.8 14.2 24.1 41.1 0.0 6.8 4.5 10.2 5.0 20.8 0.1 0.4 21.9 7.6 33.9 27.1 31.2 59.9 1.0 6.3 0.2 24.6 2.2 0.4 0.1 9.7 1.6 10.5 3.9 19.1 0.1 22.0 15.6 3.3 1.8 19.3 2.9 8.8 19.1 3.3 0.5 38.5 30.8 16.5 7.5 14.2 0.7 0.0 0.0 26.0 0.0 11.9 2.5 0.8 0.3 3.3 0.3 0.4 0.5 1.0 0.2 0.2 0.8 0.3 0.6 1.6 2.5 0.1 0.6 0.1 0.3 3.9 5.9 4.4 3.2 4.4 3.5 6.9 1.5 5.6 5.7 98.3 166.4 1.7 20.2 10.6 1.9 3.3 5.1 24.1 95.5 33.2 64.8 23.9 6.6 30.0 198.0 51.8 3.2 0.0 24.7 59.3 26.2 11.8 3.5 21.9 6.5 14.3 1.7 16.5 2.4 250.8 66.7 4.2 5.0 1.8 0.8 18.5 39.1 1.9 29.7 18.0 4.7 0.0 17.3 8.1 12.4 13.8 130.6 2.5 2.3 63.1 RALBP1 "RIP, RIP1, RLIP76" ENSG00000017797 "RalA binding protein 1" Q15311 18 9475009-9538116 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transport "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Collecting duct cells: 455.4;Extravillous trophoblasts: 356.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 10 "neutrophil: 55.1" "Lineage enriched" "Detected in all" 10 "granulocytes: 55.1" "Cell line enhanced" "Detected in all" "OE19: 74.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046010, HPA046651" Approved Approved "Nuclear membrane,Vesicles,Cytosol" NA NA Cytosol "Nuclear membrane, Vesicles" "CAB046010: AB_11126824, HPA046651: AB_2679738" "unprognostic (1.23e-1)" "unprognostic (5.84e-3)" "unprognostic (1.58e-1)" "unprognostic (1.74e-2)" "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (5.72e-2)" "unprognostic (9.90e-2)" "unprognostic (1.53e-1)" "prognostic favorable (8.47e-4)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "prognostic favorable (5.39e-6)" "unprognostic (1.28e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (1.26e-1)" 19.7 14.6 23.2 14.8 24.3 17.9 19.1 27.1 27.2 17.1 20.7 14.0 54.7 12.5 15.9 16.7 33.7 17.5 13.7 21.4 24.7 19.6 30.6 14.2 15.1 14.6 23.1 13.7 18.8 10.4 19.8 15.3 28.8 19.6 24.3 17.4 9.8 17.6 44.8 24.3 47.5 13.4 22.7 20.6 19.3 17.4 8.5 23.1 15.4 15.7 23.4 16.4 24.3 26.3 2.5 5.5 55.1 4.5 4.3 3.2 1.2 18.4 12.4 11.1 12.5 12.8 20.1 14.7 22.3 12.1 11.4 12.3 13.8 18.3 23.5 16.3 20.4 16.3 10.6 15.3 16.7 14.4 23.3 14.8 12.4 11.5 10.2 10.4 36.4 14.4 14.0 16.8 16.0 16.0 15.4 19.3 20.7 17.7 21.7 18.1 14.6 21.8 16.0 8.6 74.7 12.7 29.5 19.8 17.2 15.8 25.7 14.9 12.2 19.3 16.9 9.9 17.8 10.5 16.9 23.0 34.1 26.2 23.6 26.5 13.4 13.3 25.4 14.8 17.3 12.8 3.1 2.8 4.3 3.2 2.9 2.7 2.5 2.7 2.6 2.4 2.4 2.3 2.9 55.1 4.3 4.5 5.5 1.7 1.2 23.2 24.3 27.1 27.2 24.7 19.6 23.1 13.7 19.6 23.1 53.6 33.1 41.7 69.2 138.9 39.0 58.4 94.3 28.1 45.5 455.4 27.5 88.3 104.5 97.1 10.8 89.6 83.8 93.5 79.0 356.6 77.0 126.4 39.3 76.9 61.7 49.3 71.2 62.0 61.6 4.2 67.3 70.3 55.6 119.0 76.9 41.2 124.5 79.5 82.0 81.7 31.3 64.7 79.6 48.8 70.5 212.0 37.3 67.5 84.5 98.4 RALGAPA1 "DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1" ENSG00000174373 "Ral GTPase activating protein catalytic alpha subunit 1" Q6GYQ0 14 35538352-35809304 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 371.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000851 Approved Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "HPA000851: AB_1078945" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (8.90e-2)" "unprognostic (6.76e-2)" "unprognostic (1.85e-1)" "unprognostic (1.19e-2)" "unprognostic (7.65e-2)" "unprognostic (1.17e-2)" "unprognostic (2.88e-1)" "unprognostic (3.38e-2)" "unprognostic (1.25e-2)" "unprognostic (5.00e-2)" "prognostic favorable (9.76e-5)" "unprognostic (2.75e-1)" "unprognostic (2.46e-1)" "unprognostic (3.09e-2)" "unprognostic (1.46e-1)" 13.9 21.8 19.5 13.1 25.6 8.3 22.5 31.7 28.3 20.2 18.3 23.2 13.6 10.7 21.0 19.2 15.1 15.0 13.0 11.7 21.8 22.2 17.1 13.9 13.4 11.7 21.5 17.9 28.1 15.4 43.6 42.6 10.1 28.1 20.4 20.2 14.2 15.0 15.2 15.9 27.0 13.8 17.5 23.6 11.6 14.1 13.7 21.3 14.9 21.3 12.2 13.0 15.0 19.2 1.6 1.5 0.1 1.1 2.3 3.3 0.5 5.7 6.7 9.1 8.0 13.8 10.7 5.8 4.3 4.8 5.4 5.1 4.2 5.1 5.7 6.4 5.7 7.6 9.5 10.8 8.3 5.5 12.2 4.7 5.2 8.7 20.2 7.2 8.7 8.5 7.7 15.0 4.8 12.1 9.1 7.6 11.5 5.0 14.5 5.0 9.2 6.6 4.1 3.9 14.3 10.8 5.3 6.4 3.4 10.9 9.2 8.5 13.8 9.2 15.4 7.4 9.1 14.7 4.3 6.9 5.5 4.1 6.2 5.3 11.8 10.7 7.3 2.6 5.7 5.9 0.0 0.6 0.1 2.4 1.1 3.3 1.6 2.5 3.1 1.1 1.3 1.8 2.5 0.1 2.3 0.9 1.5 2.7 0.5 19.5 25.6 31.7 26.0 21.8 22.2 21.5 17.9 28.1 21.3 14.9 25.7 18.7 22.2 33.9 87.3 18.1 17.8 18.7 31.8 22.7 371.1 9.0 0.0 11.1 12.0 26.1 25.2 0.0 13.7 4.6 28.2 31.9 54.1 13.9 8.1 49.3 29.9 16.0 7.8 4.7 31.7 16.0 18.6 13.6 22.7 37.9 12.8 28.1 27.3 8.2 125.6 38.8 34.0 37.1 36.6 40.4 12.7 20.0 26.9 23.1 RALGAPA2 "AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2" ENSG00000188559 "Ral GTPase activating protein catalytic alpha subunit 2" Q2PPJ7 20 20389552-20712488 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 47.7;SCLC-21H: 26.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042707, HPA043622" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042707: AB_2678124, HPA043622: AB_2678585" "unprognostic (7.40e-2)" "unprognostic (1.71e-1)" "unprognostic (1.69e-2)" "unprognostic (1.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.34e-2)" "unprognostic (3.36e-1)" "unprognostic (3.29e-2)" "unprognostic (1.95e-1)" "unprognostic (3.56e-2)" "unprognostic (1.74e-1)" "unprognostic (8.23e-2)" "prognostic favorable (3.77e-5)" "unprognostic (6.52e-2)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (5.33e-2)" 26.5 7.0 7.3 9.9 8.1 19.4 16.9 11.4 8.7 10.6 12.7 9.6 14.9 10.5 15.2 9.6 8.9 10.7 13.0 7.8 8.3 4.2 11.0 26.4 26.5 13.0 10.8 4.4 8.0 18.5 14.1 20.9 18.5 7.4 13.2 13.5 8.2 22.6 12.8 26.0 15.3 10.0 9.6 8.4 8.2 18.1 8.6 9.3 8.2 23.2 6.0 10.2 13.9 15.7 1.7 2.0 7.0 2.1 2.6 2.4 0.6 3.5 2.3 4.7 2.5 2.4 1.9 5.3 0.9 0.9 1.2 1.5 1.9 4.9 1.6 3.1 1.4 5.1 3.7 4.9 4.0 2.2 7.1 2.4 5.4 1.2 3.3 0.9 6.9 3.2 1.7 3.1 1.9 0.9 2.0 6.7 7.5 1.1 3.0 1.8 2.3 2.6 9.2 2.0 11.3 2.1 3.8 3.2 2.2 4.1 47.7 26.7 2.3 3.6 2.6 3.0 4.7 1.8 6.6 1.7 1.9 1.8 1.4 1.3 1.7 1.2 0.7 1.6 4.5 2.6 5.9 2.1 6.0 1.7 0.7 2.4 1.4 1.1 1.6 1.0 1.7 2.1 1.5 7.0 2.6 1.6 2.0 1.4 0.6 7.3 8.1 11.4 8.7 8.3 4.2 10.8 4.4 7.4 9.3 6.0 34.4 5.2 8.3 9.4 35.1 8.9 48.4 26.8 14.8 14.0 25.5 7.9 1.7 18.0 18.9 55.4 19.6 0.0 21.5 4.6 5.2 14.5 8.1 37.6 10.2 49.3 23.6 58.3 18.1 6.4 1.7 8.1 8.5 4.6 24.1 10.1 20.9 21.0 6.3 9.2 13.0 12.9 6.2 8.6 10.7 14.4 9.4 9.6 26.2 25.0 RALGPS2 "FLJ10244, FLJ25604, KIAA0351" ENSG00000116191 "Ral GEF with PH domain and SH3 binding motif 2" Q86X27 1 178725147-178921841 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Alzheimer disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell type enhanced" "Detected in all" 10 "Cone photoreceptor cells: 194.4;Rod photoreceptor cells: 376.7;Spermatocytes: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 17.8;naive B-cell: 14.6" "Lineage enriched" "Detected in many" 12 "B-cells: 17.8" "Cell line enhanced" "Detected in many" "U-266/84: 62.7;U-698: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027143, HPA028328" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027143: AB_10602071, HPA028328: AB_10601889" "unprognostic (8.13e-2)" "unprognostic (1.46e-2)" "unprognostic (4.06e-3)" "unprognostic (2.71e-1)" "unprognostic (1.23e-1)" "unprognostic (1.50e-1)" "unprognostic (5.72e-2)" "unprognostic (6.63e-3)" "unprognostic (4.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-2)" "unprognostic (7.77e-2)" "unprognostic (1.55e-1)" "unprognostic (3.45e-1)" "unprognostic (6.35e-2)" "unprognostic (4.37e-2)" "unprognostic (8.97e-2)" 5.5 6.4 5.0 27.9 10.5 6.2 5.4 8.9 5.1 8.0 9.9 1.2 7.2 5.8 8.2 7.3 14.0 8.7 4.7 4.7 6.0 3.2 6.1 16.4 3.7 25.3 2.2 4.1 11.5 5.0 6.2 8.4 4.6 3.8 5.3 6.4 9.9 9.2 7.4 2.1 10.0 19.7 6.1 3.2 26.1 6.8 37.7 2.1 16.0 4.3 4.7 29.4 7.5 8.4 17.8 0.5 1.4 0.1 0.3 0.5 0.8 10.3 3.4 10.5 0.1 11.8 17.3 4.1 9.1 20.1 7.4 6.7 4.1 10.2 22.0 3.0 26.7 3.7 8.6 4.6 2.3 9.7 0.0 2.7 0.0 2.2 3.8 2.0 2.8 0.1 7.6 2.0 9.5 6.7 5.1 6.4 4.1 5.3 0.8 4.8 1.6 4.3 0.9 7.2 4.0 3.6 6.1 10.8 0.2 2.5 6.6 1.6 4.7 5.9 6.6 12.8 7.5 7.9 1.4 4.7 3.4 3.3 12.3 4.3 25.1 62.7 51.4 1.9 1.5 3.8 0.5 0.1 1.4 0.2 0.0 0.2 17.8 0.1 0.1 0.2 14.6 0.5 0.1 0.8 0.3 0.0 0.5 0.0 0.8 5.0 10.5 8.9 5.1 6.0 3.2 2.2 4.1 3.8 2.1 11.9 8.6 135.8 14.0 13.2 83.6 11.7 5.1 26.8 7.9 14.0 194.4 6.4 18.3 12.8 103.8 2.7 23.8 23.3 10.3 8.6 12.0 23.1 8.1 51.8 5.0 12.7 34.4 3.1 7.5 137.4 46.3 3.6 8.5 1.8 18.2 23.8 20.4 24.6 43.9 6.6 376.7 19.4 8.1 162.4 24.7 29.7 2.7 4.8 13.0 54.0 RANBP1 HTF9A ENSG00000099901 "RAN binding protein 1" P43487 22 20115938-20127357 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 603.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 217.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065868, HPA065931" Supported Enhanced Cytosol NA NA 910000 Cytosol "HPA065868: AB_2685572, HPA065931: AB_2685580" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.35e-2)" "unprognostic (2.50e-2)" "prognostic unfavorable (1.58e-6)" "unprognostic (2.83e-2)" "unprognostic (2.21e-2)" "unprognostic (5.67e-3)" "unprognostic (1.54e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (2.40e-2)" "unprognostic (3.95e-1)" "unprognostic (4.44e-2)" "unprognostic (7.30e-2)" 26.4 28.6 27.9 34.7 28.0 57.1 26.0 32.4 46.0 23.3 33.3 25.7 17.2 30.5 29.6 15.7 38.7 26.4 23.1 18.2 25.1 28.3 22.5 41.1 21.8 50.4 28.4 34.9 26.8 37.0 16.0 22.0 26.8 28.4 20.5 25.7 18.1 24.1 21.9 22.8 23.0 27.8 30.7 24.4 30.4 24.9 58.3 26.7 58.2 22.0 27.6 40.7 22.2 25.9 37.6 37.7 24.2 33.7 29.7 37.1 31.4 39.2 20.2 45.5 24.7 7.6 9.2 38.4 36.2 15.9 47.2 34.3 36.9 14.1 61.3 16.2 14.5 21.4 36.6 42.2 31.6 25.9 26.3 100.4 51.4 20.7 38.7 11.7 82.4 28.0 10.1 15.1 37.3 13.3 10.9 21.3 28.0 217.8 24.7 21.2 30.7 59.6 56.3 51.8 50.7 35.8 60.7 64.1 15.7 16.2 21.6 45.6 33.8 33.2 18.5 20.7 21.0 12.9 34.5 16.3 32.8 63.8 24.5 40.0 24.9 33.7 97.3 17.8 37.2 27.4 6.6 32.8 24.2 25.8 33.7 28.3 37.6 37.0 32.7 37.7 33.8 37.1 28.3 3.3 29.7 29.6 35.0 36.9 31.4 27.9 28.0 32.4 46.0 25.1 28.3 28.4 34.9 28.4 26.7 32.8 33.3 117.6 133.4 243.8 42.1 38.6 86.6 38.8 30.7 85.5 5.9 311.0 235.4 167.8 320.8 110.1 58.6 93.5 98.1 603.6 164.4 101.1 64.5 166.2 238.0 35.0 113.0 81.0 79.6 149.2 134.3 122.3 168.7 160.5 134.9 84.0 127.5 115.8 128.7 162.5 29.7 97.0 178.2 431.1 339.5 257.8 162.8 117.1 220.6 182.0 RANBP17 ENSG00000204764 "RAN binding protein 17" Q9H2T7 5 170861870-171300015 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.3" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 76.6;Late spermatids: 31.1;Spermatocytes: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBF TERT88: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029568, HPA029569" Uncertain Approved "Nuclear membrane,Nuclear bodies,Cytosol" Yes No "Nuclear bodies" "Nuclear membrane, Cytosol" "HPA029568: AB_10599825, HPA029569: AB_10601571" "unprognostic (4.63e-2)" "unprognostic (2.63e-3)" "unprognostic (1.06e-1)" "unprognostic (8.28e-2)" "unprognostic (1.75e-3)" "unprognostic (5.12e-3)" "unprognostic (1.50e-1)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (1.64e-2)" "unprognostic (2.19e-3)" "unprognostic (2.72e-1)" "unprognostic (1.35e-1)" "unprognostic (2.56e-3)" 1.6 4.9 1.3 1.8 2.1 0.8 1.8 10.4 3.6 1.8 2.0 2.9 1.1 1.5 5.3 2.8 1.0 2.2 2.7 1.5 1.4 2.2 2.4 1.8 4.1 2.4 1.5 1.7 1.8 7.2 3.6 9.4 5.0 5.3 2.4 2.3 5.4 5.1 2.7 1.0 1.1 2.6 2.4 3.1 1.0 2.5 16.3 0.4 0.1 4.7 0.1 1.4 1.5 1.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.1 5.5 4.5 1.5 0.5 3.4 4.0 1.8 2.9 1.7 2.3 0.0 0.1 3.3 3.8 0.0 0.0 0.0 1.7 5.8 0.0 4.3 1.1 2.2 0.0 1.6 0.0 0.0 4.5 0.3 0.3 0.0 0.3 2.6 0.0 0.4 0.0 1.6 2.8 0.0 0.0 0.4 0.8 0.5 0.0 3.6 0.0 0.9 1.4 0.3 2.0 0.0 5.5 2.8 2.5 0.9 1.5 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 2.1 10.4 3.6 1.4 2.2 1.5 1.7 5.3 0.4 8.9 1.3 0.0 5.2 0.2 20.8 1.4 5.1 0.0 2.3 0.0 13.7 8.7 0.0 6.3 76.6 2.8 2.8 0.0 1.2 2.7 2.6 5.1 0.0 1.3 1.6 0.0 5.2 3.1 1.2 31.1 2.6 0.0 1.7 1.8 3.3 5.6 3.6 3.5 2.8 0.7 24.1 0.0 2.2 27.1 24.0 0.0 2.1 0.0 4.5 6.1 RANBP9 RanBPM ENSG00000010017 "RAN binding protein 9" Q96S59 6 13621498-13711564 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 73.9;Late spermatids: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033767, HPA050007, HPA076784" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: " "unprognostic (3.59e-2)" "unprognostic (6.57e-2)" "unprognostic (4.37e-2)" "unprognostic (2.67e-1)" "unprognostic (1.78e-1)" "prognostic favorable (9.97e-4)" "unprognostic (1.30e-1)" "unprognostic (4.61e-2)" "unprognostic (5.87e-3)" "prognostic favorable (2.47e-4)" "unprognostic (1.61e-1)" "unprognostic (6.74e-2)" "unprognostic (3.51e-1)" "unprognostic (7.19e-3)" "unprognostic (1.52e-1)" "unprognostic (3.49e-1)" "unprognostic (3.09e-1)" 12.4 12.7 15.1 14.0 13.6 30.1 24.8 13.1 24.0 14.5 14.4 9.8 9.8 8.3 13.2 14.3 40.8 9.7 15.5 12.2 15.0 16.0 11.8 16.0 17.9 10.5 18.0 14.3 12.4 11.9 14.7 10.6 15.7 13.7 13.9 11.4 8.3 14.4 11.4 31.8 16.9 9.1 14.7 12.4 9.5 11.0 60.1 12.6 20.9 10.7 20.0 18.0 14.4 21.0 2.0 2.3 3.8 2.0 2.7 8.1 1.2 16.4 7.2 17.5 17.6 23.7 22.1 18.5 20.2 22.8 21.2 22.4 11.0 9.7 14.6 33.0 23.5 16.3 9.0 13.4 11.7 29.3 24.4 12.5 14.7 14.3 20.3 32.9 22.8 11.0 22.2 15.2 25.0 20.8 17.2 17.1 25.8 31.0 11.7 23.5 16.5 26.1 19.1 7.7 15.8 10.2 20.9 13.7 20.7 16.8 19.0 22.0 15.5 16.3 30.2 29.9 34.8 16.1 19.5 16.9 19.3 13.7 15.8 20.7 28.2 34.3 19.8 8.9 14.6 35.7 0.8 1.3 3.8 1.9 1.8 3.8 2.0 4.0 2.0 1.4 1.7 3.8 2.6 1.8 2.7 2.0 2.3 8.1 1.2 15.1 13.6 13.1 24.0 15.0 16.0 18.0 14.3 13.7 12.6 17.9 26.2 5.2 7.4 22.0 22.2 34.0 10.2 14.7 19.4 17.4 13.7 13.9 1.7 7.7 73.9 29.8 11.6 0.0 9.3 7.6 18.5 14.9 9.3 15.6 15.1 6.4 12.7 19.0 23.5 76.0 14.7 15.7 16.9 11.8 16.6 18.6 13.3 3.5 23.3 9.1 16.1 6.5 13.7 65.4 35.1 22.8 23.8 15.3 9.9 10.2 RANGAP1 "Fug1, KIAA1835, SD" ENSG00000100401 "Ran GTPase activating protein 1" P46060 22 41245611-41286251 "Plasma proteins, Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 1320.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004293, HPA050110, HPA062034" Supported Enhanced "Nuclear membrane,Vesicles,Cytosol" Yes Yes "Nuclear membrane" "Vesicles, Cytosol" "CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667" "unprognostic (1.30e-2)" "unprognostic (3.16e-2)" "unprognostic (1.66e-1)" "unprognostic (7.97e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.28e-3)" "unprognostic (8.09e-2)" "unprognostic (9.87e-2)" "unprognostic (5.84e-2)" "unprognostic (7.56e-2)" "unprognostic (7.07e-3)" "prognostic favorable (5.39e-4)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" 12.2 30.7 23.5 16.9 28.4 28.5 16.1 17.6 41.1 8.5 11.8 23.1 7.3 12.7 9.5 9.4 26.1 11.5 13.7 11.5 26.9 30.4 12.0 25.1 11.5 19.5 31.7 28.6 10.6 20.2 11.0 17.7 16.1 28.1 11.4 9.6 7.1 16.3 13.3 12.5 51.6 12.8 12.3 22.0 14.2 16.0 64.3 28.3 22.1 12.7 14.4 21.7 13.3 29.2 8.7 7.6 8.2 14.8 7.1 13.1 9.7 58.2 30.6 20.0 20.9 10.8 8.9 24.3 50.5 27.6 51.0 26.7 37.1 19.2 31.4 40.8 37.0 24.6 54.3 36.3 39.8 30.8 25.4 56.3 26.6 29.9 28.9 13.5 42.9 20.0 8.6 19.0 36.3 32.2 16.8 26.7 11.8 34.1 22.4 29.0 49.9 25.0 34.9 21.8 53.1 36.4 30.7 19.7 33.1 19.9 33.4 18.2 12.1 35.9 31.8 18.5 19.2 18.7 17.3 41.2 39.1 37.5 21.5 41.5 16.7 22.2 29.9 27.3 30.5 22.5 2.8 9.5 8.2 11.2 11.2 13.1 7.9 11.3 10.3 7.1 8.7 10.5 8.0 2.7 7.1 14.8 7.6 11.6 9.7 23.5 28.4 17.6 41.1 26.9 30.4 31.7 28.6 28.1 28.3 3.0 24.7 28.1 17.5 20.5 15.2 17.4 22.9 9.4 9.1 8.7 13.7 15.1 3.3 34.2 259.8 12.7 10.1 0.0 17.4 28.1 9.3 32.2 5.8 17.9 14.0 14.3 24.0 11.6 13.4 1320.8 13.8 17.1 11.8 10.0 13.9 7.8 29.0 6.5 11.3 11.2 24.4 0.0 9.0 18.0 19.2 27.0 19.8 23.8 10.9 19.2 RANGRF "HSPC165, HSPC236, MOG1, RANGNRF" ENSG00000108961 "RAN guanine nucleotide release factor" Q9HD47 17 8288497-8290092 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 361.7;Late spermatids: 822.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057280, HPA057888" Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA057280: AB_2683393, HPA057888: AB_2683549" "unprognostic (2.87e-2)" "unprognostic (2.93e-2)" "unprognostic (7.41e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (1.90e-3)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (2.01e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.34e-2)" "unprognostic (3.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.14e-1)" "unprognostic (1.13e-2)" 14.5 14.7 24.7 11.7 29.1 11.8 26.5 10.9 19.2 31.5 15.4 7.9 13.5 10.5 20.0 22.5 10.6 21.5 10.9 23.4 15.1 17.8 17.0 11.5 18.9 26.9 16.2 19.2 21.0 6.3 16.2 17.1 14.6 18.8 15.9 10.8 17.2 6.0 19.4 11.4 9.8 11.9 18.8 12.2 15.4 16.7 70.1 15.9 16.8 11.6 9.1 20.3 14.1 10.5 26.8 22.3 25.3 16.3 21.8 40.2 18.2 16.0 18.9 13.9 14.2 10.2 12.9 11.7 9.4 18.6 26.1 24.4 10.1 6.4 30.7 10.2 11.3 10.4 18.2 25.6 12.7 18.7 21.4 32.4 15.3 14.9 13.9 23.1 9.6 22.4 12.6 23.2 22.2 21.3 12.5 20.6 29.8 6.7 8.7 15.9 0.4 29.4 31.5 9.7 9.7 7.3 26.0 10.8 18.3 14.1 7.1 5.4 15.1 7.6 11.3 20.0 9.1 0.9 9.3 11.4 5.7 10.0 11.0 19.0 14.8 11.7 37.0 12.1 19.1 8.3 4.9 16.2 25.3 24.2 16.3 22.6 24.2 29.3 27.4 17.3 26.8 26.2 22.4 2.1 21.8 12.5 22.3 40.2 18.2 24.7 29.1 10.9 19.2 15.1 17.8 16.2 19.2 18.8 15.9 8.9 25.0 41.4 21.7 16.1 23.2 4.0 0.0 14.7 14.8 24.4 11.8 83.8 58.0 22.9 361.7 25.3 11.9 23.3 16.5 38.1 26.0 20.4 26.6 13.6 42.0 19.1 19.0 19.6 11.9 822.0 26.2 23.5 16.9 36.1 15.2 23.5 17.8 24.5 29.7 43.5 28.7 19.4 20.8 112.7 18.1 17.1 94.4 41.5 22.9 11.9 RAP1GAP "KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII" ENSG00000076864 "RAP1 GTPase activating protein" P47736 1 21596215-21669363 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.3;thyroid gland: 72.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 66.1;Distal tubular cells: 61.3;Horizontal cells: 87.4;Mucus-secreting cells: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "A549: 16.5;OE19: 57.5;SCLC-21H: 19.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 286.1" "HPA001922, CAB003851" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB003851: AB_562338, HPA001922: AB_1079743" "unprognostic (1.17e-2)" "unprognostic (4.33e-2)" "unprognostic (7.84e-2)" "unprognostic (2.45e-2)" "unprognostic (4.52e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (8.33e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (3.43e-2)" "unprognostic (1.35e-2)" "prognostic favorable (1.12e-6)" "unprognostic (1.11e-1)" "unprognostic (9.85e-3)" "unprognostic (4.86e-3)" "unprognostic (3.64e-2)" 0.9 38.2 30.2 1.9 89.3 1.1 3.1 27.1 40.1 4.7 10.5 5.7 0.0 6.9 1.7 1.8 2.9 3.0 13.4 2.7 17.8 12.9 33.2 10.3 7.8 1.2 8.6 20.6 1.6 49.3 7.1 8.2 5.8 14.6 7.4 9.4 2.4 43.9 1.2 0.7 2.1 11.6 1.1 3.2 0.9 28.4 2.1 14.2 0.0 72.5 0.9 1.6 2.5 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.3 2.1 16.5 0.1 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 2.3 0.0 1.7 0.0 11.1 2.8 1.6 0.1 0.0 0.3 0.8 0.7 1.5 7.7 0.2 0.0 2.4 0.1 1.1 0.0 0.0 0.0 0.0 8.0 10.2 0.4 0.0 5.5 2.6 0.2 1.0 57.5 2.5 1.5 0.4 0.3 3.8 1.2 19.2 3.4 2.7 10.0 3.2 0.7 1.0 1.8 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 30.2 89.3 27.1 30.4 17.8 12.9 8.6 20.6 14.6 14.2 8.9 21.1 0.5 0.9 1.1 66.1 3.3 25.5 0.0 6.8 14.0 0.0 0.1 61.3 10.9 0.6 0.0 4.2 23.3 24.6 1.1 0.6 8.3 0.0 5.6 0.2 87.4 6.4 0.0 0.8 0.0 0.0 0.7 15.1 1.0 97.4 10.0 20.3 10.2 0.0 10.2 6.2 0.0 0.4 1.0 3.4 1.0 1.3 0.0 6.9 1.1 RAP1GAP2 "GARNL4, KIAA1039" ENSG00000132359 "RAP1 GTPase activating protein 2" Q684P5 17 2755705-3037739 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.5;pancreas: 26.0" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 31.4;Horizontal cells: 35.0;Intestinal endocrine cells: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022148, HPA022896" Approved Supported "Nuclear membrane,Cytosol" NA NA 110000 "Nuclear membrane, Cytosol" "HPA022148: AB_1849474, HPA022896: AB_1849476" "unprognostic (1.85e-3)" "unprognostic (1.02e-2)" "unprognostic (8.92e-2)" "unprognostic (5.39e-1)" "unprognostic (4.04e-2)" "unprognostic (3.92e-1)" "unprognostic (6.52e-5)" "unprognostic (1.18e-2)" "unprognostic (2.91e-1)" "unprognostic (2.22e-1)" "unprognostic (1.66e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.36e-6)" "unprognostic (3.44e-2)" "unprognostic (6.38e-2)" "unprognostic (9.33e-2)" "unprognostic (7.50e-2)" 1.2 4.6 6.7 2.9 13.5 16.8 3.1 27.5 22.9 2.7 5.3 2.2 0.0 5.9 3.7 1.0 2.5 5.8 2.7 9.9 6.5 6.3 3.9 0.7 3.4 3.4 4.3 16.4 3.3 26.0 4.5 8.0 3.3 15.8 2.6 5.6 2.6 9.0 3.5 0.8 2.7 5.5 2.3 4.3 3.2 15.4 2.3 3.1 1.6 2.1 0.3 3.0 1.6 2.2 0.5 3.0 7.2 6.3 2.9 5.2 2.0 4.5 5.7 1.1 4.7 0.0 0.0 9.4 6.1 2.9 0.8 0.7 12.5 2.0 1.7 1.7 0.8 8.0 6.3 3.7 11.5 0.2 0.0 4.0 2.1 8.0 5.6 1.1 0.4 2.3 0.3 10.0 3.2 8.3 4.3 0.1 2.1 11.8 0.8 0.0 5.1 1.7 1.1 6.8 2.2 5.5 7.6 4.0 4.4 3.5 2.3 12.7 30.9 8.9 9.2 4.0 4.6 4.6 1.3 1.4 5.4 8.6 0.9 5.2 0.0 0.0 0.7 0.3 3.9 8.7 1.5 2.3 3.3 5.2 4.7 2.0 0.5 1.7 3.7 1.8 0.4 0.3 1.9 7.2 2.9 6.3 3.0 1.6 2.0 6.7 13.5 27.5 22.9 6.5 6.3 4.3 16.4 15.8 3.1 6.0 4.5 1.3 5.8 1.8 13.0 14.2 7.6 4.0 2.3 12.2 31.4 5.9 8.3 5.3 3.4 1.4 6.8 0.0 10.5 4.8 2.9 11.6 5.8 0.4 2.9 35.0 46.3 2.5 13.9 5.4 1.7 3.9 3.3 1.0 20.7 2.0 11.4 21.0 1.4 0.6 4.7 0.0 2.8 0.4 3.0 0.4 2.9 4.3 12.1 9.6 RAP1GDS1 SmgGDS ENSG00000138698 "Rap1 GTPase-GDP dissociation stimulator 1" P52306 4 98261384-98443861 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 332.5;Late spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019060 Approved Supported Cytosol NA NA 120000 Cytosol "HPA019060: AB_1856068" "unprognostic (8.12e-2)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (1.66e-1)" "unprognostic (9.11e-2)" "unprognostic (1.35e-2)" "unprognostic (1.57e-3)" "unprognostic (3.44e-1)" "unprognostic (6.31e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (4.60e-1)" "prognostic favorable (2.00e-4)" "unprognostic (7.11e-2)" "unprognostic (3.09e-1)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" 11.3 9.7 25.8 12.9 28.2 9.0 13.1 28.0 43.6 9.3 12.0 20.0 9.0 7.3 8.9 8.7 13.7 6.1 8.6 6.8 29.7 28.0 12.3 15.2 10.1 15.3 36.9 20.5 7.9 13.8 8.4 15.3 9.6 30.1 8.0 14.0 8.0 8.6 11.9 3.6 10.5 9.0 16.3 37.0 12.5 8.2 15.5 26.2 16.2 13.0 4.8 17.0 12.5 7.6 13.9 31.9 16.0 14.7 19.5 22.7 8.4 17.9 10.5 13.4 11.5 17.3 20.7 5.4 30.6 17.0 18.3 14.4 7.8 23.3 21.3 10.0 22.8 8.9 10.3 16.5 28.0 24.8 21.8 6.8 13.2 13.5 10.2 34.3 21.9 9.2 24.1 17.1 16.1 25.0 15.2 23.9 21.9 8.7 18.3 45.2 9.4 36.2 10.9 4.9 14.7 7.6 15.1 8.0 7.2 18.6 14.1 19.9 12.1 12.8 28.8 16.9 7.7 6.5 14.3 23.5 19.0 13.6 8.7 18.1 6.3 11.0 18.0 15.7 16.5 24.6 16.0 10.6 5.7 14.2 14.6 14.3 13.9 14.5 13.6 16.7 11.0 7.8 11.9 1.6 19.5 14.7 31.9 22.7 8.4 25.8 28.2 28.0 30.5 29.7 28.0 36.9 20.5 30.1 26.2 14.9 9.8 23.0 8.8 12.4 41.4 10.1 20.4 5.3 15.9 15.7 47.1 5.8 19.9 16.8 332.5 13.5 11.1 23.3 18.3 13.9 11.6 11.1 15.0 16.3 22.1 14.3 20.1 16.0 29.4 174.5 8.6 23.3 16.9 29.7 13.9 15.6 19.2 16.7 10.3 15.9 66.0 0.0 11.8 14.6 22.5 14.6 3.8 30.8 17.4 12.8 RAPGEF2 "DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF" ENSG00000109756 "Rap guanine nucleotide exchange factor 2" Q9Y4G8 4 159103013-159360174 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, GTPase activation, Guanine-nucleotide releasing factor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.4" "Group enriched" "Detected in many" 5 "granulocytes: 9.4;NK-cells: 5.2" "Cell line enhanced" "Detected in many" "HMC-1: 40.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068798 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA068798: " "unprognostic (4.88e-2)" "unprognostic (7.42e-2)" "unprognostic (1.67e-2)" "unprognostic (7.79e-3)" "unprognostic (8.16e-2)" "unprognostic (4.71e-3)" "unprognostic (4.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (9.71e-2)" "unprognostic (1.07e-1)" "prognostic favorable (1.76e-7)" "unprognostic (2.29e-1)" "unprognostic (2.07e-1)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" 16.7 8.0 28.4 8.8 23.8 51.0 16.3 21.5 34.1 12.6 14.5 11.3 10.4 10.9 12.7 7.3 9.9 10.2 14.1 14.9 23.4 15.3 16.4 20.9 18.1 8.5 14.1 29.6 10.2 13.4 20.7 13.8 26.1 16.9 9.3 14.8 10.0 18.7 9.4 15.7 12.7 11.9 14.0 13.9 19.2 13.7 6.7 14.3 9.3 27.5 8.9 7.8 11.9 13.8 0.4 1.4 9.4 1.4 5.2 1.5 0.3 3.3 4.5 21.5 6.6 8.5 9.6 33.1 6.5 8.2 5.9 4.3 13.9 7.4 19.0 2.4 6.4 8.6 3.0 7.3 8.3 7.1 3.2 5.1 29.5 9.5 8.0 6.2 3.5 40.9 5.6 4.7 14.2 5.0 12.6 16.9 7.9 6.5 17.8 7.3 5.9 8.8 0.5 9.1 3.9 4.5 7.3 5.4 0.7 5.3 7.6 6.1 8.2 9.5 4.6 7.9 10.8 2.3 2.4 17.8 9.4 9.9 11.9 5.3 19.9 11.7 0.3 11.1 1.5 5.7 2.7 1.4 1.0 0.8 0.8 1.0 0.4 0.7 0.5 0.8 0.3 0.9 0.4 9.4 5.2 0.9 1.4 1.5 0.3 28.4 23.8 21.5 34.1 23.4 15.3 14.1 29.6 16.9 14.3 53.6 26.7 7.5 10.9 18.1 16.3 32.9 12.7 16.0 17.0 7.0 39.3 9.4 0.0 8.1 4.0 30.0 12.3 46.7 10.8 8.1 15.0 16.7 48.7 25.6 10.1 31.8 13.8 31.9 25.1 3.8 7.2 14.1 32.1 7.2 10.8 29.8 16.9 17.5 8.1 6.4 23.4 51.8 17.8 3.6 6.5 17.6 4.9 7.5 6.4 12.8 RAPGEF3 "bcm910, cAMP-GEFI, EPAC" ENSG00000079337 "Rap guanine nucleotide exchange factor 3" O95398 12 47734367-47771040 "Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Collecting duct cells: 66.3;Endothelial cells: 26.0;Proximal tubular cells: 32.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 13.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 22.3;HUVEC TERT2: 9.5;NB-4: 10.9;RPTEC TERT1: 10.7;TIME: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004386, HPA040365, HPA043518" Approved Approved Cytosol NA NA Cytosol "CAB004386: AB_627521, HPA040365: AB_2676941, HPA043518: AB_2678524" "unprognostic (2.12e-1)" "unprognostic (2.88e-2)" "unprognostic (2.99e-2)" "unprognostic (1.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-4)" "unprognostic (9.35e-2)" "unprognostic (1.25e-2)" "unprognostic (5.32e-3)" "unprognostic (4.67e-2)" "unprognostic (4.37e-2)" "prognostic favorable (6.67e-7)" "unprognostic (9.16e-2)" "unprognostic (2.92e-1)" "unprognostic (2.61e-3)" "unprognostic (3.38e-2)" 26.5 2.8 18.2 3.0 19.7 1.9 22.1 3.9 23.0 12.7 4.8 28.8 19.4 4.7 10.6 11.9 10.4 15.9 13.7 15.9 20.7 7.3 22.8 1.6 6.9 4.7 24.2 14.9 30.9 5.4 4.9 3.0 9.8 19.1 7.1 3.2 3.3 20.5 16.9 10.6 6.9 4.8 6.0 12.0 10.9 6.3 2.5 27.4 0.0 27.3 4.8 2.7 8.6 11.5 1.1 0.6 0.5 0.7 0.0 1.2 0.4 1.8 0.5 0.6 1.9 0.2 1.9 0.6 1.4 1.1 0.5 0.3 0.2 4.7 0.1 22.3 2.3 0.9 1.9 0.7 3.4 0.3 2.3 0.3 0.2 1.7 0.1 0.1 0.3 0.2 0.7 0.3 1.0 0.6 2.9 9.5 0.4 0.1 2.4 0.4 1.2 0.0 10.9 0.5 0.7 3.0 0.3 0.1 0.8 10.7 2.0 0.2 0.3 0.2 1.3 0.3 0.7 5.1 0.4 9.5 5.6 0.9 1.2 0.4 1.0 0.3 0.1 3.4 2.3 0.6 0.0 0.7 0.0 0.1 0.4 0.6 0.5 0.1 1.2 0.3 1.1 0.2 0.3 0.5 0.0 0.5 0.6 0.4 0.4 18.2 19.7 3.9 23.0 20.7 7.3 24.2 14.9 19.1 27.4 0.0 13.2 0.0 3.9 2.4 0.6 10.6 0.0 2.7 3.4 66.3 0.0 0.2 6.6 0.7 0.9 26.0 0.4 0.0 0.6 0.3 4.1 6.6 3.5 0.0 0.8 0.0 0.0 18.4 0.3 2.1 22.5 1.5 5.0 0.0 5.5 1.2 3.5 2.9 8.1 32.2 0.3 6.5 2.1 0.6 0.8 2.9 0.2 0.0 0.4 18.0 RAPGEF6 "PDZ-GEF2, PDZGEF2, RA-GEF-2" ENSG00000158987 "Rap guanine nucleotide exchange factor 6" Q8TEU7 5 131423921-131635236 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037982, HPA037983" Approved Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA037982: AB_10670535, HPA037983: AB_2675769" "unprognostic (1.86e-1)" "unprognostic (5.16e-2)" "unprognostic (5.64e-2)" "unprognostic (2.69e-1)" "unprognostic (3.54e-2)" "unprognostic (1.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" "unprognostic (1.76e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (3.72e-3)" "prognostic unfavorable (3.87e-4)" "unprognostic (3.57e-1)" "unprognostic (4.10e-2)" "unprognostic (6.31e-2)" "unprognostic (2.81e-4)" 7.2 7.3 8.4 15.2 11.2 15.7 9.9 34.1 12.7 7.2 6.7 13.7 6.1 5.0 6.9 5.9 6.5 6.1 7.7 6.6 9.4 10.5 6.2 8.4 9.5 24.6 13.1 9.0 8.6 6.2 12.5 9.5 8.0 17.1 7.2 7.8 5.4 6.9 7.9 6.9 8.1 7.3 6.9 10.9 11.3 6.5 19.7 14.5 21.2 7.1 5.5 22.0 7.7 7.2 5.4 1.6 8.7 2.0 5.3 14.2 5.4 7.0 5.1 7.2 6.7 3.8 4.3 6.9 7.8 6.2 6.7 10.1 9.3 5.0 16.5 5.2 5.2 10.3 5.7 10.0 8.2 13.6 8.0 5.5 10.4 7.4 5.0 3.1 7.2 11.0 3.1 3.9 9.7 9.5 4.7 5.9 9.3 5.9 10.0 5.9 3.6 7.4 5.8 3.1 3.9 3.8 11.1 10.4 8.7 4.8 5.5 24.9 5.7 8.1 3.7 9.7 8.2 5.2 6.3 5.7 8.9 6.3 7.1 8.9 5.8 6.9 17.9 5.1 9.5 7.5 1.4 1.7 6.3 6.3 2.0 10.7 4.5 8.5 6.8 1.4 5.4 14.2 10.1 8.7 5.3 1.5 1.6 9.6 5.4 8.4 11.2 34.1 12.7 9.4 10.5 13.1 9.0 17.1 14.5 11.9 16.2 5.3 4.7 14.1 10.0 3.6 0.0 8.1 7.9 7.0 19.6 4.9 1.7 3.6 30.7 3.8 3.6 0.0 2.4 2.9 7.4 5.7 2.3 4.4 6.6 1.6 13.3 8.0 11.4 13.2 4.0 11.2 13.5 7.2 7.8 4.2 3.8 5.8 4.9 1.9 8.8 0.0 5.1 11.6 10.6 15.3 5.8 14.4 6.8 4.7 RAPH1 "ALS2CR18, ALS2CR9, KIAA1681" ENSG00000173166 "Ras association (RalGDS/AF-6) and pleckstrin homology domains 1" Q70E73 2 203394345-203535410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.1" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 68.3;Ito cells: 89.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.8;non-classical monocyte: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016744, HPA020027" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane" Cytosol "HPA016744: AB_1844781, HPA020027: AB_1844782" "unprognostic (9.78e-2)" "unprognostic (9.05e-2)" "unprognostic (7.17e-4)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (8.32e-2)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.24e-4)" "unprognostic (1.92e-1)" "unprognostic (1.40e-2)" "unprognostic (5.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.19e-2)" "unprognostic (2.79e-1)" 11.0 6.1 7.3 6.3 7.6 2.7 17.6 8.4 12.7 9.8 7.9 3.7 6.8 6.9 6.8 8.4 9.2 6.3 12.5 8.3 5.2 5.0 8.2 51.1 17.2 6.8 4.2 8.4 3.6 5.8 4.0 9.9 11.1 6.0 7.2 6.7 8.5 11.2 4.4 8.3 10.2 10.2 7.1 4.8 26.7 7.8 7.9 3.1 1.7 25.8 7.9 5.6 9.6 8.7 0.0 1.1 0.0 2.8 1.1 0.6 0.3 5.5 3.8 8.1 4.6 6.4 8.3 7.2 7.7 5.7 8.0 10.2 17.7 5.9 0.0 1.9 11.7 5.9 2.7 4.2 6.6 16.8 1.1 2.4 0.0 9.2 3.1 16.0 0.0 0.1 11.5 5.6 14.7 15.5 8.8 12.5 0.8 0.4 4.3 16.0 3.1 0.0 0.0 4.8 2.8 4.9 0.1 11.5 3.1 5.8 17.9 2.8 3.8 5.3 5.1 6.4 11.2 2.8 0.2 14.8 19.8 6.4 9.4 8.1 2.0 3.4 0.0 16.3 0.1 4.4 0.0 0.8 0.0 0.2 2.8 0.6 0.0 0.5 0.1 1.1 0.0 0.4 0.1 0.0 1.1 2.6 0.1 0.5 0.3 7.3 7.6 8.4 12.7 5.2 5.0 4.2 8.4 6.0 3.1 14.9 6.7 2.2 16.6 43.6 9.3 0.8 15.3 5.3 10.3 14.0 13.7 7.1 6.6 5.8 10.1 18.9 21.2 0.0 8.0 5.9 19.4 17.6 1.1 68.3 15.3 9.5 2.4 89.0 14.9 3.2 4.4 15.9 11.8 2.8 7.2 20.0 14.3 14.0 4.6 2.4 4.6 19.4 16.1 15.7 10.4 35.8 9.2 1.8 11.2 19.1 RAPSN "CMS1D, CMS1E, RNF205" ENSG00000165917 "Receptor associated protein of the synapse" Q13702 11 47437757-47449178 "Disease related genes, Predicted intracellular proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "skeletal muscle: 45.3;tongue: 14.8" "Cell type enriched" "Detected in some" 4 "Late spermatids: 10.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "RH-30: 72.9" "Low region specificity" "Detected in single" HPA039475 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA039475: AB_10794196" "unprognostic (5.37e-2)" "unprognostic (1.02e-1)" "unprognostic (7.34e-2)" "unprognostic (4.58e-2)" "unprognostic (2.95e-2)" "unprognostic (1.44e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-3)" "unprognostic (1.35e-1)" "unprognostic (5.38e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.64e-4)" "unprognostic (3.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.48e-2)" 1.7 0.8 0.2 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 2.7 0.7 0.1 0.1 1.4 0.4 0.0 0.1 0.2 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 1.2 0.3 0.4 0.0 0.3 0.8 0.0 45.3 0.2 0.2 0.1 0.2 0.3 0.1 0.2 0.1 0.1 0.4 14.8 0.4 0.0 0.0 0.2 0.1 2.6 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.7 0.0 2.6 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.3 10.0 0.0 0.0 0.0 1.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 RARA "NR1B1, RAR" ENSG00000131759 "Retinoic acid receptor alpha" P10276 17 40309192-40357643 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 26.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 63.9;SK-BR-3: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058282, HPA071548" Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA Nucleoplasm "Nucleoli, Actin filaments, Cytosol" "HPA058282: AB_2683666, HPA071548: " "unprognostic (8.05e-3)" "unprognostic (1.89e-1)" "unprognostic (9.48e-3)" "prognostic favorable (2.60e-4)" "unprognostic (8.67e-3)" "unprognostic (4.87e-3)" "unprognostic (2.77e-1)" "unprognostic (5.73e-2)" "unprognostic (1.45e-1)" "unprognostic (3.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.29e-3)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" 27.6 13.5 5.0 18.6 7.6 32.3 23.7 11.5 15.2 30.2 29.6 5.0 16.8 18.0 23.8 23.9 17.3 23.3 30.2 24.3 5.9 6.1 14.6 24.0 32.0 23.4 4.6 7.8 50.0 9.3 7.4 18.1 16.6 6.5 22.9 8.5 26.8 12.1 32.7 43.1 14.3 31.6 18.6 3.7 31.1 14.3 21.8 2.9 9.7 16.3 15.4 20.2 31.5 20.3 1.0 6.1 26.6 9.3 2.5 2.6 1.9 5.1 12.1 3.6 6.1 7.1 10.9 3.6 4.2 6.4 6.2 4.0 8.3 4.4 2.7 6.6 9.5 5.7 15.0 4.1 10.0 3.6 20.5 6.1 7.8 6.1 8.1 11.4 2.8 24.7 15.3 2.9 6.6 8.4 23.7 9.2 2.4 4.9 6.0 7.0 63.9 1.8 9.5 3.1 4.7 3.8 3.6 21.3 10.3 3.6 4.1 1.5 12.4 9.0 40.6 12.4 3.6 38.2 11.2 10.7 7.8 13.3 13.6 4.6 14.4 4.8 2.3 13.1 5.5 23.0 8.7 4.2 15.7 1.6 6.9 2.6 1.0 1.7 1.7 6.1 0.9 0.8 1.3 26.6 2.5 9.3 1.8 1.4 1.9 5.0 7.6 11.5 15.2 5.9 6.1 4.6 7.8 6.5 2.9 3.0 9.5 5.6 22.6 17.3 24.2 3.2 10.2 4.0 2.3 7.0 5.9 1.9 11.6 14.3 58.0 20.4 52.7 0.0 16.9 5.1 23.8 11.2 34.6 22.8 11.3 3.2 9.2 22.7 35.4 50.8 38.6 37.4 27.0 0.0 14.2 9.3 16.8 24.6 21.5 11.8 8.2 32.3 33.0 2.9 6.9 16.6 4.3 11.5 13.2 19.2 RARS DALRD1 ENSG00000113643 "Arginyl-tRNA synthetase" P54136 5 168486445-168519299 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003979, HPA004130" Approved Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA003979: AB_1856083, HPA004130: AB_1856084" "unprognostic (1.06e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-3)" "unprognostic (2.82e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.59e-5)" "prognostic unfavorable (1.10e-8)" "unprognostic (3.26e-3)" "unprognostic (5.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.92e-2)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" "unprognostic (6.43e-2)" "unprognostic (2.35e-1)" "unprognostic (2.39e-1)" "unprognostic (1.33e-2)" 21.8 26.3 16.0 18.3 15.3 6.2 22.6 17.1 18.4 21.2 29.4 9.1 20.4 33.3 22.9 21.4 34.7 19.5 14.4 21.7 19.8 12.3 29.8 33.5 18.7 18.6 13.9 15.2 21.3 33.0 19.9 34.5 30.3 15.8 18.9 27.4 15.5 34.0 15.4 27.8 27.9 48.7 21.5 14.5 22.1 24.4 17.2 11.8 20.5 21.5 32.3 23.7 22.4 22.6 11.1 21.8 5.2 17.7 16.8 16.3 11.7 27.2 32.4 24.0 26.6 33.2 38.1 41.3 40.2 34.6 41.9 49.0 55.0 29.8 29.0 33.0 38.2 43.1 26.5 31.4 54.1 54.7 30.1 21.6 19.5 29.5 34.5 28.8 46.0 20.8 29.2 28.9 45.6 21.9 25.8 33.5 15.9 29.1 14.7 44.8 25.2 19.1 18.3 39.4 24.0 22.1 8.4 35.0 27.6 37.3 31.1 22.9 28.2 30.7 35.5 41.5 30.5 32.3 19.3 33.2 30.4 27.9 23.4 46.8 14.7 26.9 29.8 33.1 32.9 28.8 3.4 14.4 5.2 12.5 17.7 14.3 11.1 12.6 13.3 21.8 6.6 15.6 16.3 4.0 16.8 16.4 10.3 12.8 11.7 16.0 15.3 17.1 18.4 19.8 12.3 13.9 15.2 15.8 11.8 53.6 32.3 25.1 37.6 26.3 25.0 43.6 35.7 46.8 39.8 24.4 25.5 88.8 14.9 80.1 16.6 27.5 40.6 23.3 83.1 79.2 34.8 24.5 26.6 31.4 51.1 12.7 12.6 33.2 24.6 11.6 23.0 35.0 27.0 72.1 36.7 22.7 61.2 38.7 23.0 36.0 22.7 19.4 28.9 27.7 42.2 31.1 70.5 20.1 44.8 35.2 RASAL1 RASAL ENSG00000111344 "RAS protein activator like 1" O95294 12 113098819-113136239 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 64.0" "Cell type enriched" "Detected in many" 9 "Collecting duct cells: 34.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 8.5;EFO-21: 11.1;REH: 12.3;RPMI-8226: 27.4;RPTEC TERT1: 10.9;U-698: 23.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7" HPA041650 Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA041650: AB_2677598" "unprognostic (9.95e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-3)" "prognostic unfavorable (3.26e-5)" "unprognostic (1.27e-2)" "unprognostic (7.73e-3)" "unprognostic (1.57e-2)" "unprognostic (1.43e-2)" "unprognostic (2.65e-1)" "unprognostic (3.02e-3)" "unprognostic (3.16e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-2)" "unprognostic (2.85e-3)" "unprognostic (1.15e-1)" "unprognostic (3.34e-2)" "unprognostic (2.64e-1)" 0.9 10.4 8.6 2.5 11.2 1.2 1.6 0.4 18.2 2.5 2.1 18.8 3.7 1.2 0.9 0.9 16.9 2.2 1.8 0.8 11.8 4.9 7.4 0.9 0.9 1.7 7.3 10.9 0.8 1.4 64.0 3.9 1.0 4.0 0.9 1.7 0.0 22.4 7.4 0.8 8.0 1.1 0.9 1.8 1.0 9.6 1.1 8.4 0.0 8.0 6.0 5.0 1.0 3.7 0.4 0.2 1.3 0.2 0.3 1.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 8.5 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 2.3 0.0 0.0 0.3 3.0 0.0 12.3 0.0 27.4 10.9 0.0 0.3 0.0 0.0 4.1 0.0 0.0 1.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 1.3 0.2 0.1 0.1 0.0 1.6 0.2 0.9 0.4 0.0 0.4 1.2 0.5 0.4 0.3 0.0 0.2 0.4 0.3 8.6 11.2 0.4 18.2 11.8 4.9 7.3 10.9 4.0 8.4 0.0 0.0 0.5 0.0 0.5 0.5 3.5 2.5 0.0 0.0 34.9 0.0 1.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 2.1 1.7 1.8 4.1 2.3 3.0 3.5 0.0 3.9 0.0 0.0 0.1 0.0 0.3 1.0 1.0 0.0 2.3 0.4 RASD2 "MGC:4834, Rhes, TEM2" ENSG00000100302 "RASD family member 2" Q96D21 22 35540868-35554001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.0;seminal vesicle: 25.2" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5" "Region enriched" "Detected in many" 8 "basal ganglia: 527.8" "Region enriched" "Detected in all" 8 "basal ganglia: 265.8" HPA005839 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005839: AB_1079745" "unprognostic (1.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.33e-2)" "unprognostic (7.00e-2)" "unprognostic (1.43e-1)" "unprognostic (7.07e-3)" "unprognostic (9.76e-2)" "unprognostic (5.49e-2)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.00e-3)" "prognostic unfavorable (2.22e-5)" "unprognostic (3.75e-2)" "unprognostic (1.61e-1)" "unprognostic (8.42e-3)" "unprognostic (6.22e-2)" 1.6 7.9 8.6 2.5 71.0 3.4 1.3 1.8 23.5 1.1 8.3 2.2 3.2 2.5 3.5 16.4 5.2 6.2 2.5 2.8 4.1 5.0 0.8 0.5 1.5 0.6 3.4 8.0 0.8 1.0 0.9 1.0 0.4 2.1 9.6 4.4 3.5 4.0 25.2 13.6 0.8 3.4 7.5 2.2 0.4 1.8 0.6 15.3 0.0 1.4 0.1 1.4 3.8 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 2.8 0.0 0.5 0.0 0.0 0.1 0.7 0.2 1.1 0.9 0.1 0.5 0.0 0.2 2.4 4.3 0.1 0.2 0.0 1.0 0.0 0.7 0.0 0.1 0.0 1.4 0.0 0.0 0.2 3.3 2.2 0.3 13.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 1.3 0.0 0.9 0.0 0.0 2.0 0.3 2.2 7.6 0.0 0.2 0.6 0.2 0.1 1.8 4.4 0.2 0.8 1.9 0.6 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.6 71.0 1.8 23.5 4.1 5.0 3.4 8.0 2.1 15.3 0.0 0.0 0.0 0.2 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.2 0.7 0.0 0.1 45.3 4.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 RASGRP1 "CalDAG-GEFII, RASGRP" ENSG00000172575 "RAS guanyl releasing protein 1" O95267 15 38488103-38565575 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Disease mutation, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.1;lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 31.4;Muller glia cells: 101.6;T-cells: 55.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 10.4" "Group enriched" "Detected in some" 4 "HDLM-2: 25.3;JURKAT: 33.6;MOLT-4: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039389 Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039389: AB_2732481" "unprognostic (3.44e-3)" "unprognostic (1.86e-2)" "unprognostic (1.17e-2)" "unprognostic (3.43e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-3)" "unprognostic (9.63e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (4.50e-1)" "unprognostic (3.01e-2)" "unprognostic (2.54e-1)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (9.30e-2)" 1.7 1.0 5.7 9.9 17.0 7.8 1.9 33.1 18.5 1.4 1.6 0.8 0.0 2.5 1.6 1.6 6.7 4.7 2.7 1.6 6.1 3.2 5.9 1.2 4.2 20.0 3.0 6.2 0.8 2.0 0.3 1.2 4.9 22.3 1.0 2.3 1.4 2.5 1.0 0.8 7.3 3.7 0.7 1.6 8.6 4.8 2.2 1.1 55.8 1.2 1.6 16.3 4.3 2.4 1.2 0.0 0.8 0.0 2.4 10.4 1.4 0.0 0.1 0.5 0.1 0.0 0.0 0.0 1.9 0.6 1.0 0.8 2.1 0.0 5.4 0.4 0.0 0.1 0.1 1.1 0.0 0.9 25.3 1.0 0.4 0.2 0.0 0.3 0.2 0.4 0.0 0.0 0.5 0.0 0.0 0.0 33.6 0.2 1.7 0.0 0.8 23.9 0.0 0.3 0.0 0.0 6.7 0.1 0.0 1.0 0.0 2.3 0.8 1.2 0.0 0.1 0.7 0.6 0.0 0.1 0.2 0.8 2.7 0.3 4.2 2.0 6.4 0.1 0.0 0.2 0.0 0.0 0.8 5.7 0.0 4.2 1.2 6.4 5.7 0.0 0.7 6.0 6.0 0.3 2.4 0.0 0.0 10.4 1.4 5.7 17.0 33.1 11.7 6.1 3.2 3.0 6.2 22.3 1.1 6.0 15.4 11.3 0.4 2.2 9.4 2.6 10.2 0.0 0.0 31.4 9.8 0.2 3.3 16.1 1.2 0.0 0.0 0.0 8.9 0.1 1.0 0.4 3.5 0.0 0.6 6.4 0.0 0.6 0.3 0.2 0.0 0.0 6.8 0.0 0.5 101.6 22.6 0.0 0.0 5.9 18.1 0.0 1.5 0.9 2.8 7.2 0.0 55.4 0.4 0.3 RASGRP4 ENSG00000171777 "RAS guanyl releasing protein 4" Q8TDF6 19 38409051-38426305 "Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 10.9;granulocytes: 26.5;Hofbauer cells: 12.0;Kupffer cells: 34.4;Macrophages: 11.0" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 19.4;HMC-1: 19.4;U-937: 5.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041929 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041929: AB_10961405" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (1.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.00e-1)" "unprognostic (5.23e-4)" "unprognostic (6.54e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (2.19e-2)" "unprognostic (1.05e-1)" "unprognostic (4.56e-1)" "unprognostic (2.66e-2)" 4.5 1.8 2.4 8.0 3.3 23.3 5.4 0.7 1.8 1.8 1.7 2.8 0.1 1.4 1.6 2.9 1.6 2.6 3.4 6.2 2.0 1.3 1.5 1.8 11.8 23.1 3.4 0.2 1.1 1.6 0.5 0.9 3.0 1.8 1.7 1.2 1.7 1.6 0.8 1.5 1.4 2.4 2.7 4.2 19.2 1.9 0.8 2.4 0.5 1.0 0.2 1.0 2.6 3.1 0.1 5.2 22.4 9.5 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 19.4 0.0 0.0 0.0 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 6.0 7.1 10.6 0.0 8.5 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.0 22.4 0.0 9.5 0.4 0.7 2.1 2.4 3.3 0.7 1.8 2.0 1.3 3.4 0.2 1.8 2.4 0.0 1.1 0.0 0.0 0.7 0.0 10.9 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.0 26.5 0.0 12.0 0.0 0.0 1.8 34.4 0.0 0.0 11.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 RASSF10 ENSG00000189431 "Ras association domain family member 10" A6NK89 11 13009577-13012106 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.3" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 13.4;Distal tubular cells: 21.6;Pancreatic endocrine cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 9.5;CAPAN-2: 8.5;HaCaT: 13.1;HMC-1: 6.5;RPTEC TERT1: 13.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040406 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA040406: AB_2732485" "unprognostic (6.71e-2)" "unprognostic (5.12e-2)" "unprognostic (5.06e-2)" "unprognostic (2.41e-3)" "unprognostic (6.25e-3)" "prognostic favorable (2.76e-4)" "unprognostic (3.43e-3)" "unprognostic (8.04e-2)" "unprognostic (5.89e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (4.12e-5)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (2.88e-1)" "unprognostic (1.65e-2)" 0.2 0.0 0.4 0.2 1.0 0.0 3.9 0.0 1.7 1.1 1.4 1.0 0.0 1.8 0.0 1.3 9.3 5.2 2.5 0.2 1.0 4.7 0.0 1.8 0.0 0.0 0.6 1.2 0.0 3.8 0.1 0.0 0.6 1.6 0.5 0.4 8.0 0.1 0.8 4.1 0.6 0.0 0.1 0.0 5.6 2.4 1.0 1.1 0.1 8.1 7.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 9.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.5 0.0 0.6 0.0 0.3 13.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.4 0.0 1.3 0.0 0.0 13.3 1.4 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 3.8 0.0 0.0 0.8 0.0 13.4 4.5 1.8 0.0 0.1 21.6 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 1.1 0.0 0.1 0.0 2.4 0.6 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.5 6.7 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 5.3 3.5 RASSF2 "CENP-34, KIAA0168" ENSG00000101265 "Ras association domain family member 2" P50749 20 4780023-4823645 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 106.1" "Cell type enhanced" "Detected in many" 9 "Kupffer cells: 93.0;monocytes: 117.2;Peritubular cells: 140.7;Rod photoreceptor cells: 154.5" "Cancer enhanced" "Detected in all" "glioma: 48.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 19.6;BEWO: 20.6;Daudi: 21.0;HL-60: 24.6;NB-4: 31.8;U-937: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051200 Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane, Cytosol" "HPA051200: AB_2681386" "unprognostic (6.51e-2)" "unprognostic (3.67e-3)" "unprognostic (5.31e-2)" "unprognostic (1.47e-2)" "unprognostic (3.15e-1)" "unprognostic (1.46e-3)" "unprognostic (2.80e-1)" "unprognostic (7.01e-2)" "unprognostic (1.38e-2)" "unprognostic (2.41e-2)" "unprognostic (4.93e-2)" "unprognostic (3.90e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (3.51e-2)" "unprognostic (1.35e-1)" "unprognostic (3.49e-1)" "unprognostic (6.46e-2)" 8.3 5.1 26.5 21.5 26.9 38.6 3.6 10.2 45.8 14.9 4.1 59.5 0.1 2.7 13.0 11.6 5.2 9.8 7.8 2.4 33.2 22.4 2.0 3.0 10.1 26.2 54.7 8.7 3.5 1.7 0.7 2.6 4.5 39.7 3.9 5.0 19.8 2.0 4.8 1.2 2.2 5.7 18.6 106.1 14.9 3.3 9.9 27.3 4.7 2.5 0.6 34.2 10.7 2.7 7.9 14.1 42.1 17.9 2.4 4.7 10.6 0.0 4.9 12.1 19.6 0.1 0.0 20.6 1.2 3.4 0.2 0.0 1.1 0.0 21.0 1.9 1.0 0.4 0.0 1.7 0.0 0.3 7.5 0.7 13.7 0.0 0.2 0.0 24.6 14.0 0.0 0.0 0.4 0.0 0.4 8.0 2.4 0.0 8.3 0.0 0.0 3.6 31.8 2.7 0.0 0.4 5.6 1.3 8.0 0.0 9.7 0.1 0.9 0.0 0.3 0.6 2.7 0.0 15.7 0.2 0.5 2.6 0.2 1.5 0.1 1.9 12.9 0.1 39.2 0.1 21.1 17.9 29.5 2.4 15.4 4.7 7.9 3.9 3.3 14.1 5.3 2.6 2.1 42.1 2.4 16.8 9.4 3.4 10.6 26.5 26.9 10.2 19.3 33.2 22.4 54.7 8.7 39.7 27.3 0.0 14.9 27.7 0.0 4.1 37.9 1.6 2.5 0.0 3.4 0.0 25.5 2.4 1.7 1.0 5.0 12.7 0.0 0.0 0.8 4.8 8.2 0.8 51.0 0.8 24.8 6.4 0.0 16.0 93.0 15.3 30.8 38.0 8.5 117.2 0.0 12.7 0.4 0.0 140.7 0.2 154.5 0.0 3.3 0.7 0.6 2.3 1.1 10.2 0.0 0.9 RASSF3 ENSG00000153179 "Ras association domain family member 3" Q86WH2 12 64507001-64697567 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 44.4" "Lineage enriched" "Detected in all" 6 "granulocytes: 44.4" "Cell line enhanced" "Detected in all" "SK-MEL-30: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022664, CAB034035, HPA038469" Supported Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743" "unprognostic (1.63e-1)" "unprognostic (1.33e-1)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (2.55e-3)" "unprognostic (3.73e-1)" "unprognostic (2.37e-1)" "unprognostic (6.21e-2)" "unprognostic (3.66e-2)" "unprognostic (1.49e-1)" "unprognostic (1.45e-3)" "unprognostic (7.16e-2)" "unprognostic (2.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.59e-2)" 22.4 13.8 4.2 24.0 4.5 5.9 48.4 2.5 4.5 15.3 64.1 6.5 21.6 8.3 18.5 12.5 27.0 9.4 30.1 37.4 4.6 4.4 5.8 6.4 19.4 22.2 7.4 2.9 13.6 10.0 1.0 4.3 16.0 7.6 26.5 17.8 14.1 18.9 21.2 16.0 5.0 18.0 80.1 10.8 25.7 25.6 6.9 5.5 7.6 5.3 6.3 14.5 57.4 30.9 5.5 3.2 44.4 6.6 4.1 7.9 0.9 9.8 11.1 3.5 6.8 3.8 5.6 21.6 4.3 22.4 5.8 6.9 7.9 10.5 15.5 9.2 3.1 7.0 4.3 10.7 4.5 7.1 12.7 4.1 10.1 4.9 9.0 10.5 10.7 7.1 3.7 3.9 13.3 9.9 17.1 24.7 7.5 5.4 7.7 6.8 9.3 7.0 7.0 7.8 23.4 6.7 11.3 11.4 6.5 7.6 12.0 8.0 8.4 7.2 1.4 51.3 8.9 6.3 6.8 35.6 4.8 5.8 4.9 4.6 7.2 7.6 10.1 5.7 9.4 13.7 5.9 6.6 4.2 5.1 6.3 4.2 5.5 7.6 5.6 3.2 3.7 7.7 7.9 44.4 4.1 5.9 3.0 7.7 0.9 4.2 4.5 2.5 4.5 4.6 4.4 7.4 2.9 7.6 5.5 3.0 19.1 15.9 14.0 14.4 0.0 43.1 30.6 2.7 9.1 5.2 0.0 27.0 0.0 11.5 0.3 26.6 22.5 46.7 18.3 14.0 12.2 23.2 5.8 3.9 22.4 0.0 25.3 16.5 63.0 0.4 2.3 34.1 45.5 33.3 14.0 2.5 20.7 15.3 13.4 1.1 0.0 12.9 28.9 0.6 24.9 10.5 16.5 26.7 15.2 21.6 RASSF4 "AD037, MGC44914" ENSG00000107551 "Ras association domain family member 4" Q9H2L5 10 44959407-44995891 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Hofbauer cells: 128.5;monocytes: 389.5;Muller glia cells: 247.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5" "Group enriched" "Detected in many" 9 "dendritic cells: 28.5;monocytes: 28.3" "Cell line enhanced" "Detected in many" "Karpas-707: 21.5;RH-30: 54.6;RPMI-8226: 17.8;U-937: 27.9;WM-115: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038834, HPA077069" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA038834: AB_10795576, HPA077069: " "unprognostic (1.83e-1)" "unprognostic (8.21e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (5.14e-2)" "unprognostic (3.15e-2)" "unprognostic (2.18e-2)" "unprognostic (8.81e-2)" "unprognostic (4.83e-2)" "unprognostic (8.75e-3)" "unprognostic (4.20e-1)" "unprognostic (4.11e-3)" "unprognostic (4.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.42e-1)" "unprognostic (6.20e-2)" 23.4 5.9 16.7 17.0 25.5 6.0 8.4 12.5 36.5 3.6 8.2 26.7 12.1 11.2 2.6 14.9 4.3 3.3 9.0 29.1 16.6 15.1 37.2 10.5 9.7 14.1 34.5 9.7 3.0 11.5 2.2 8.4 10.4 19.4 4.5 5.3 8.4 14.0 9.9 7.6 2.9 10.8 7.0 21.8 12.6 4.3 5.7 31.5 1.2 23.0 2.9 7.4 8.3 3.9 0.0 28.5 0.9 28.3 2.2 3.0 13.8 0.4 0.1 2.0 3.9 6.1 0.3 1.4 0.2 0.3 0.6 1.2 1.6 0.2 0.0 0.7 0.2 1.3 0.0 0.8 0.9 0.9 12.2 0.0 0.0 0.0 12.7 6.5 0.8 0.0 4.5 0.0 0.6 0.0 3.7 0.9 0.5 0.0 21.5 0.9 0.0 0.9 13.9 0.4 0.0 0.4 2.6 54.6 17.8 0.1 0.3 0.3 0.3 0.0 0.1 0.6 3.7 0.3 10.6 0.2 0.1 1.2 1.0 2.1 0.2 0.2 0.0 6.4 27.9 18.1 0.0 28.3 0.0 3.0 21.7 0.0 0.0 0.2 1.3 28.5 0.0 0.2 1.0 0.9 2.2 11.5 0.7 0.1 13.8 16.7 25.5 12.5 18.2 16.6 15.1 34.5 9.7 19.4 31.5 17.9 15.0 4.7 1.2 3.3 17.2 38.7 38.2 6.7 10.3 15.7 3.9 0.9 14.9 40.8 1.2 4.7 11.8 0.0 3.4 1.1 7.0 1.3 1.1 15.5 128.5 35.0 11.1 8.0 63.6 3.2 9.8 81.9 8.5 389.5 8.7 247.8 4.1 14.0 2.1 98.2 13.3 25.8 17.6 0.3 0.9 1.5 2.2 6.4 16.6 0.5 RASSF8 "C12orf2, HoJ-1" ENSG00000123094 "Ras association domain family member 8" Q8NHQ8 12 25959029-26079892 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 534.5;Horizontal cells: 406.8;Late spermatids: 509.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038163, HPA038164" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA038163: AB_2675874, HPA038164: AB_10672621" "unprognostic (2.77e-1)" "unprognostic (1.71e-1)" "unprognostic (3.10e-1)" "unprognostic (6.10e-3)" "unprognostic (3.88e-1)" "unprognostic (3.15e-1)" "unprognostic (6.10e-3)" "unprognostic (8.28e-2)" "unprognostic (2.86e-1)" "unprognostic (6.29e-3)" "unprognostic (2.08e-1)" "unprognostic (1.07e-1)" "unprognostic (7.00e-2)" "unprognostic (1.32e-3)" "unprognostic (3.14e-1)" "unprognostic (2.61e-1)" "unprognostic (4.58e-2)" 9.8 14.1 14.6 6.4 14.0 1.3 14.6 8.0 10.4 20.9 12.7 10.3 7.0 2.5 23.9 10.5 6.7 10.0 14.6 11.9 16.0 8.5 19.7 5.2 12.5 2.2 15.1 8.0 26.3 5.2 4.3 16.1 10.6 14.8 14.2 4.6 14.7 4.4 12.7 12.0 3.3 4.4 17.3 19.9 5.0 7.0 44.7 13.6 0.3 9.7 5.2 2.2 10.1 18.8 0.6 4.1 0.9 0.3 1.4 0.6 0.1 3.3 2.7 11.8 1.4 18.3 20.8 16.4 18.2 26.7 7.7 8.5 5.8 1.0 0.2 14.4 19.6 8.6 1.3 2.5 2.1 9.9 1.2 3.4 0.6 6.7 0.3 9.1 2.0 0.1 12.3 2.1 17.1 11.5 12.0 9.2 4.2 0.6 2.4 8.9 4.5 2.4 0.4 11.7 0.0 25.2 3.1 11.4 0.1 4.7 5.0 0.5 8.5 9.6 0.1 8.9 10.7 1.7 1.7 10.8 15.3 7.9 38.7 13.6 1.0 0.7 0.3 14.1 0.2 21.4 0.7 0.3 0.2 0.6 0.1 0.2 0.3 0.2 0.2 0.0 0.6 0.3 0.2 0.9 1.4 0.1 4.1 0.1 0.1 14.6 14.0 8.0 10.4 16.0 8.5 15.1 8.0 14.8 13.6 35.7 16.5 0.0 33.0 6.9 12.8 30.8 17.8 1.4 12.5 21.0 9.8 8.1 11.6 7.5 534.5 18.0 0.0 0.0 3.6 14.5 30.9 26.1 1.1 6.7 4.5 406.8 0.0 9.8 1.8 509.0 16.7 7.4 13.5 0.0 0.0 27.8 4.4 0.0 14.2 17.4 9.6 12.9 18.6 20.9 8.9 4.6 3.8 0.0 0.0 12.6 RB1CC1 "ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131" ENSG00000023287 "RB1 inducible coiled-coil 1" Q8TDY2 8 52622456-52745843 "Predicted intracellular proteins" "Autophagy, Cell cycle, Transcription, Transcription regulation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024391, HPA053049" Approved Supported "Nuclear membrane,Cytosol" NA NA Cytosol "Nuclear membrane" "HPA024391: AB_2671554, HPA053049: AB_2682025" "unprognostic (1.58e-2)" "unprognostic (7.51e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.22e-1)" "unprognostic (4.21e-2)" "unprognostic (7.39e-2)" "unprognostic (1.38e-2)" "unprognostic (9.34e-2)" "unprognostic (1.21e-1)" "unprognostic (8.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.56e-3)" "unprognostic (7.67e-2)" "unprognostic (4.41e-1)" "unprognostic (8.00e-2)" "unprognostic (2.42e-1)" 16.2 13.7 36.6 9.8 19.8 38.0 15.0 21.8 36.8 14.5 13.3 7.9 11.9 11.0 15.5 11.9 15.0 11.0 12.2 22.7 31.1 17.0 15.2 18.3 13.5 10.5 16.5 22.5 18.4 14.6 21.5 15.2 13.3 17.0 14.2 10.1 7.6 12.9 11.4 35.9 13.2 13.2 13.4 12.2 11.7 12.0 28.2 17.0 21.6 15.7 10.3 10.9 16.4 14.1 7.1 7.6 25.5 9.7 8.5 8.4 6.6 13.3 11.9 14.8 12.9 16.5 18.8 8.4 10.2 20.9 10.8 13.5 8.3 15.2 9.8 17.2 15.0 27.4 17.9 18.2 9.5 20.5 7.4 15.9 16.7 12.4 11.4 20.3 5.9 9.5 17.5 19.7 10.7 29.5 22.7 14.6 15.5 19.8 16.0 13.1 8.7 15.1 8.8 14.6 12.7 6.2 7.7 7.1 9.9 10.0 10.5 14.3 14.9 10.6 12.2 22.6 18.1 13.9 10.9 17.2 10.4 14.6 16.3 8.9 15.9 13.7 9.8 16.4 10.4 11.6 22.3 8.0 14.7 7.8 7.6 7.8 7.1 6.5 7.9 7.6 6.2 8.0 7.4 25.5 8.5 9.7 3.9 8.4 6.6 36.6 19.8 21.8 36.8 31.1 17.0 16.5 22.5 17.0 17.0 181.7 102.5 28.4 53.1 78.5 76.8 142.2 12.7 147.2 72.8 17.4 64.8 22.9 8.3 41.1 35.1 49.4 36.0 140.2 42.8 21.5 70.2 73.7 24.4 38.4 20.5 82.6 42.4 33.2 36.1 39.4 71.7 44.0 40.5 35.1 29.8 34.2 55.5 30.8 68.9 23.0 54.0 45.3 68.0 171.7 121.8 80.4 50.6 41.5 24.7 56.8 RBFOX1 "A2BP1, FOX-1, HRNBP1" ENSG00000078328 "RNA binding fox-1 homolog 1" Q9NWB1 16 5239802-7713338 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 81.4" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "RH-30: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040809, HPA066746, HPA075862" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" No No Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA040809: AB_10796228, HPA066746: , HPA075862: " "unprognostic (3.75e-3)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (5.19e-3)" "unprognostic (8.82e-5)" "unprognostic (5.02e-1)" "unprognostic (3.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.43e-2)" "unprognostic (3.24e-2)" "unprognostic (2.23e-1)" "unprognostic (5.00e-2)" "unprognostic (2.28e-1)" 1.2 2.4 19.9 1.5 33.0 1.6 1.3 31.5 57.2 1.4 1.9 1.9 0.0 1.3 1.3 5.0 2.0 2.2 1.3 17.6 16.4 6.7 1.5 1.3 1.2 1.2 3.7 21.7 1.4 1.3 1.2 0.5 1.3 13.5 2.6 1.7 0.0 1.7 4.9 67.6 1.5 1.4 1.2 3.5 1.2 1.4 1.7 5.6 0.0 1.3 9.7 1.2 1.5 0.3 1.7 0.7 3.1 0.7 1.2 1.4 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 25.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 2.4 0.6 2.0 1.1 0.3 0.7 1.0 0.9 0.8 0.3 1.7 1.4 1.0 3.1 1.2 0.7 0.7 1.0 0.0 19.9 33.0 31.5 34.3 16.4 6.7 3.7 21.7 13.5 5.6 0.0 0.3 0.0 0.0 0.0 2.3 81.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 1.1 0.0 1.7 1.0 0.4 7.1 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 RBFOX2 "FOX-2, HNRBP2, HRNBP2, RBM9" ENSG00000100320 "RNA binding fox-1 homolog 2" O43251 22 35738736-36028425 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.1" "Lineage enriched" "Detected in single" 4 "T-cells: 3.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006240, HPA075862" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006240: AB_1079750, HPA075862: " "unprognostic (3.17e-1)" "unprognostic (4.80e-2)" "unprognostic (9.30e-2)" "unprognostic (3.21e-3)" "unprognostic (3.42e-1)" "unprognostic (2.74e-2)" "unprognostic (2.28e-1)" "unprognostic (2.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-1)" "unprognostic (5.78e-3)" "unprognostic (2.13e-2)" "unprognostic (1.53e-2)" "unprognostic (6.08e-2)" 14.0 11.6 25.7 7.6 30.5 0.4 12.7 58.4 37.2 26.4 23.2 7.4 11.2 7.9 38.5 13.8 22.9 20.4 16.7 20.8 19.6 15.9 10.2 10.6 12.7 3.7 12.0 26.3 43.3 9.3 20.5 20.6 21.3 22.8 18.3 13.6 9.7 10.3 20.5 40.7 12.6 10.6 32.6 9.7 5.4 13.3 10.4 10.1 1.8 18.7 5.7 5.3 18.1 15.9 0.0 0.7 0.0 0.0 0.1 3.1 0.1 15.1 9.9 32.3 18.9 20.3 34.2 13.3 28.4 38.1 21.2 23.3 18.9 6.5 9.7 13.7 32.2 12.4 14.7 11.7 13.0 27.1 7.7 13.5 5.4 8.8 7.0 6.1 1.5 4.1 24.8 16.8 20.2 23.0 19.3 25.7 2.4 4.1 1.2 23.2 5.9 1.5 0.8 12.6 5.7 13.7 2.3 28.7 2.2 14.6 17.0 10.0 37.9 32.4 5.1 10.0 17.1 6.0 1.8 31.7 30.3 17.9 17.9 13.1 1.1 3.1 12.0 14.2 2.2 17.1 0.0 0.0 0.0 1.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.1 25.7 30.5 58.4 37.2 19.6 15.9 12.0 26.3 22.8 10.1 62.5 32.6 0.5 41.3 33.0 3.3 54.1 25.5 14.7 33.0 26.2 0.0 50.4 29.9 47.1 14.6 43.8 18.4 0.0 27.9 74.6 68.9 41.7 2.3 20.9 8.6 111.2 54.8 32.5 1.3 5.4 73.6 3.3 15.1 4.6 22.3 15.4 54.8 2.9 87.7 14.0 5.9 51.8 71.0 35.7 22.7 29.5 24.3 2.5 23.4 50.4 RBKS "DKFZp686G13268, RBSK" ENSG00000171174 Ribokinase Q9H477 2 27781364-27891098 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 57.6;Proximal tubular cells: 88.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 10.5;RPTEC TERT1: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019725, HPA028285" Enhanced Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA019725: AB_1856105, HPA028285: AB_10601480" "unprognostic (1.25e-1)" "unprognostic (2.16e-1)" "unprognostic (2.51e-2)" "unprognostic (5.54e-3)" "unprognostic (4.15e-3)" "unprognostic (2.44e-1)" "unprognostic (1.43e-2)" "unprognostic (4.77e-2)" "unprognostic (2.45e-1)" "unprognostic (5.35e-2)" "unprognostic (1.46e-1)" "unprognostic (3.98e-1)" "unprognostic (1.20e-1)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" "unprognostic (9.27e-2)" 14.4 22.2 2.5 2.4 5.2 4.1 2.2 2.1 4.1 2.6 3.0 1.7 4.9 12.4 4.7 4.7 3.1 7.4 10.7 3.5 3.7 4.3 15.1 22.6 10.4 0.8 3.0 2.4 24.2 2.4 3.5 10.3 6.2 12.3 6.9 2.4 2.2 1.4 16.8 7.6 1.0 11.8 3.8 4.7 1.7 1.6 4.8 1.4 0.3 4.5 2.8 1.1 4.8 12.0 5.8 5.1 5.6 3.8 4.9 6.5 3.4 3.1 2.1 0.3 0.4 0.4 0.7 2.1 0.8 0.6 0.4 0.6 4.8 1.5 1.1 10.5 1.7 1.5 1.3 0.2 1.0 0.8 0.4 0.2 0.1 0.5 4.1 1.6 0.9 0.2 1.0 1.7 2.7 3.7 0.7 0.6 1.9 0.1 1.3 2.0 4.1 0.7 2.3 0.0 2.1 1.7 0.9 0.2 0.7 22.1 0.2 0.9 1.2 2.9 4.0 1.7 1.1 1.8 4.6 0.2 0.7 0.5 1.9 1.2 6.7 7.9 2.1 1.9 3.1 0.1 5.6 3.8 1.9 3.0 1.6 6.1 5.8 4.0 6.5 5.1 4.6 4.2 3.6 5.6 4.9 0.8 0.8 5.8 3.4 2.5 5.2 2.1 4.1 3.7 4.3 3.0 2.4 12.3 1.4 6.0 5.3 1.9 2.8 1.8 10.3 6.4 2.5 57.6 7.9 17.4 3.9 3.3 39.7 9.3 26.8 4.1 18.8 0.0 11.1 1.1 1.9 1.1 2.3 25.3 5.5 7.9 3.5 1.8 1.8 21.9 1.4 7.2 1.7 2.8 3.2 12.1 7.7 7.0 2.5 88.0 18.7 0.0 2.1 15.4 14.5 1.4 1.3 5.0 6.4 1.7 RBL2 "p130, Rb2" ENSG00000103479 "RB transcriptional corepressor like 2" Q08999 16 53433977-53491649 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 410.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016547, HPA019703" Supported Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Nucleoli rim, Mitotic chromosome" Cytosol "CAB016547: AB_785011, HPA019703: AB_1856106" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (6.88e-2)" "unprognostic (6.43e-2)" "unprognostic (5.03e-2)" "unprognostic (2.46e-2)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (4.70e-1)" "unprognostic (8.12e-2)" "prognostic favorable (3.57e-5)" "unprognostic (9.57e-3)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (7.51e-2)" 27.8 20.6 15.7 22.2 20.0 11.1 25.5 24.1 18.7 26.3 23.7 24.7 25.6 15.4 30.0 20.2 21.5 25.1 19.5 19.9 15.5 11.7 23.8 34.2 24.0 31.6 25.8 13.7 29.3 30.7 55.3 22.6 12.4 15.8 28.2 18.9 20.2 26.2 30.5 28.3 20.8 24.6 26.1 17.9 27.2 24.9 28.6 22.8 54.4 31.0 10.3 31.6 36.5 26.8 9.1 8.0 20.2 9.8 26.2 35.1 24.5 12.6 8.6 11.6 10.7 30.3 29.3 5.4 9.3 13.3 11.7 4.0 5.6 16.0 18.6 14.2 15.8 11.0 16.0 8.7 14.5 18.6 6.6 12.0 8.3 8.8 10.4 13.1 11.6 26.2 18.6 17.8 7.9 11.4 23.5 18.0 20.6 6.8 11.7 13.0 3.7 23.0 15.6 4.7 14.4 7.9 16.8 21.1 21.3 11.4 13.0 9.4 7.9 21.2 9.3 9.1 10.1 12.1 15.2 14.9 14.5 7.7 11.9 6.9 17.9 10.6 21.8 18.0 14.5 9.9 16.4 8.2 20.2 21.2 5.9 23.7 8.7 23.8 24.3 8.0 9.1 35.1 29.6 15.7 26.2 9.8 4.9 17.5 24.5 15.7 20.0 24.1 18.7 15.5 11.7 25.8 13.7 15.8 22.8 38.7 83.1 23.6 26.7 20.5 27.2 10.1 40.8 42.8 43.3 26.2 19.6 4.5 14.9 10.6 410.5 23.6 18.8 0.0 8.9 12.0 22.6 37.9 53.2 40.8 10.1 33.4 19.0 33.2 46.3 128.8 38.9 26.4 10.1 23.4 31.9 37.2 10.2 10.5 40.3 21.4 22.5 38.8 24.7 118.2 42.4 24.1 3.4 79.1 23.7 30.9 RBM14-RBM4 ENSG00000248643 "RBM14-RBM4 readthrough" 11 66616626-66646469 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Ciliated cells: 6.7;Club cells: 9.1;Cone photoreceptor cells: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.3;SK-MEL-30: 7.0" HPA047849 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047849: AB_2680180" "unprognostic (2.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" "unprognostic (2.52e-2)" "unprognostic (2.01e-2)" "unprognostic (1.37e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-4)" "unprognostic (3.92e-2)" "unprognostic (2.52e-1)" "unprognostic (3.77e-4)" "unprognostic (5.74e-7)" "unprognostic (1.43e-1)" "unprognostic (2.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.10e-2)" 7.3 5.9 5.7 7.4 7.7 13.9 5.0 12.3 8.2 5.4 7.5 6.9 7.5 2.8 8.1 11.4 6.4 4.9 7.1 12.2 5.9 5.4 6.2 14.7 6.3 6.4 8.5 4.9 6.0 7.9 2.8 9.1 5.9 5.5 7.6 4.8 7.5 5.8 5.8 9.3 4.0 6.3 7.3 5.3 7.5 7.7 11.9 6.5 13.2 7.2 4.9 9.2 6.7 5.7 8.6 10.8 7.5 6.4 4.3 5.4 4.4 2.1 1.5 0.8 1.8 1.6 0.2 1.1 1.1 0.5 2.1 0.4 3.5 0.6 0.7 1.2 0.2 1.7 3.7 1.4 0.4 0.5 0.0 0.7 3.3 1.3 2.4 0.6 1.8 1.7 0.0 0.3 0.9 0.2 0.5 0.0 0.6 4.7 1.5 1.1 3.8 2.6 12.3 1.2 2.2 4.7 1.8 5.2 0.6 0.4 2.3 2.6 0.9 0.6 1.7 7.0 0.4 0.8 1.3 0.0 2.7 2.6 1.7 1.5 0.2 0.7 1.6 0.9 1.2 0.8 6.4 6.4 7.5 5.4 5.6 3.8 8.6 3.6 4.1 6.7 8.0 1.3 3.1 3.5 4.3 5.3 10.8 2.3 4.4 5.7 7.7 12.3 8.2 5.9 5.4 8.5 4.9 5.5 6.5 0.0 0.6 0.0 0.5 0.0 0.9 0.0 0.0 6.7 9.1 0.0 3.9 0.4 0.0 0.4 1.4 0.4 0.0 0.0 0.2 0.3 0.2 0.6 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.1 0.7 0.0 0.0 0.7 0.9 0.1 0.9 0.0 0.2 0.7 RBM18 MGC2734 ENSG00000119446 "RNA binding motif protein 18" Q96H35 9 122237624-122264839 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057281, HPA077955" Uncertain Enhanced "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA057281: AB_2683394, HPA077955: " "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (9.39e-3)" "unprognostic (7.27e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "prognostic favorable (8.00e-7)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 12.8 14.8 16.5 9.1 16.5 15.1 24.6 18.1 20.3 14.4 13.4 10.5 13.7 10.4 13.6 16.2 11.8 11.6 11.7 27.2 16.7 18.6 17.3 12.2 10.7 10.9 17.8 13.2 15.1 13.7 16.0 18.2 16.2 16.3 17.2 12.6 8.2 12.6 13.9 29.4 10.1 10.8 13.2 16.0 12.4 12.3 7.6 15.0 11.9 15.3 13.5 11.1 13.0 14.4 8.7 9.5 16.0 13.0 7.7 10.0 8.2 5.8 6.1 8.4 9.2 12.4 15.4 7.3 13.3 10.9 9.1 8.5 7.0 5.8 10.2 5.8 8.6 10.1 13.7 13.1 13.8 11.5 10.4 5.9 7.6 10.2 5.9 14.0 15.1 10.5 13.1 15.7 9.6 19.6 9.2 13.1 8.3 10.4 8.0 13.6 6.3 7.8 9.3 6.5 19.8 10.2 7.0 17.4 13.8 12.7 6.6 17.6 9.3 10.0 14.1 15.0 6.9 8.2 8.6 7.2 8.6 4.9 13.7 13.0 11.7 21.5 8.5 14.1 9.4 10.2 6.8 9.2 16.0 10.0 10.5 9.6 8.7 8.9 9.7 9.5 6.0 9.3 9.7 9.7 7.7 13.0 6.9 9.1 8.2 16.5 16.5 18.1 20.3 16.7 18.6 17.8 13.2 16.3 15.0 29.8 10.9 16.7 9.8 19.3 11.8 46.6 7.6 17.4 13.6 24.4 2.0 28.1 23.2 20.9 61.1 24.8 12.3 0.0 14.0 35.6 16.0 18.9 17.3 13.7 24.5 3.2 18.9 13.5 21.4 54.6 12.4 16.2 18.6 10.0 16.7 15.8 18.5 13.9 15.9 18.9 11.6 19.4 23.1 10.1 19.4 22.6 47.6 17.3 13.6 14.1 RBM24 "dJ259A10.1, FLJ30829, RNPC6" ENSG00000112183 "RNA binding motif protein 24" Q9BX46 6 17281346-17293875 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 165.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enhanced" "Detected in many" "LHCN-M2: 29.0;RH-30: 29.8;T-47d: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA066927, HPA067231" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA066927: AB_2685750, HPA067231: AB_2685808" "unprognostic (9.05e-3)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-3)" "unprognostic (1.53e-1)" "unprognostic (4.54e-4)" "unprognostic (3.34e-2)" "unprognostic (1.33e-2)" "unprognostic (2.97e-3)" "unprognostic (3.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.16e-2)" "unprognostic (3.06e-2)" "unprognostic (1.08e-2)" "unprognostic (2.33e-4)" 3.4 0.2 1.4 0.9 2.2 0.1 1.1 0.3 1.9 7.0 2.7 0.1 3.0 0.5 9.7 7.3 3.4 7.8 1.7 41.0 1.5 1.7 0.3 0.4 0.4 0.2 0.5 1.1 2.1 0.2 0.1 1.8 0.2 0.3 3.6 2.4 1.6 2.5 2.2 153.8 0.4 1.2 9.3 0.5 0.4 0.8 1.3 0.1 0.1 1.4 37.3 1.9 5.1 2.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.7 4.5 6.0 0.0 0.0 0.0 0.0 9.1 3.3 6.2 6.6 0.0 0.5 0.0 2.9 6.5 9.8 0.0 5.6 0.2 11.3 0.0 0.2 0.0 0.5 3.1 0.2 0.0 0.5 3.3 0.0 1.2 0.2 8.0 0.7 0.0 0.0 0.0 29.0 1.3 0.0 0.0 2.0 0.0 0.7 0.0 29.8 0.0 0.0 0.0 3.9 0.4 0.0 0.0 0.1 4.9 13.9 0.2 0.0 2.1 5.0 0.0 7.8 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.3 1.9 1.5 1.7 0.5 1.1 0.3 0.1 0.0 0.0 0.0 0.2 1.0 1.6 165.8 0.0 20.1 2.3 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 9.2 0.8 0.2 1.1 0.0 0.2 1.6 4.6 0.0 0.0 1.0 0.0 0.0 1.7 0.0 3.9 0.6 0.2 0.0 0.7 0.1 0.0 6.5 16.2 0.3 7.7 0.9 0.7 0.0 1.5 0.1 RBM38 "dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D" ENSG00000132819 "RNA binding motif protein 38" Q9H0Z9 20 57391407-57409333 "Predicted intracellular proteins" "Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 64.3;skeletal muscle: 107.9" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;Intestinal endocrine cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 39.4;U-698: 41.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" CAB017036 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB017036: " "unprognostic (1.03e-1)" "prognostic favorable (3.64e-7)" "unprognostic (3.71e-2)" "unprognostic (7.73e-3)" "unprognostic (4.16e-2)" "unprognostic (4.85e-2)" "unprognostic (1.53e-2)" "unprognostic (4.37e-3)" "unprognostic (3.04e-1)" "unprognostic (9.04e-3)" "unprognostic (3.90e-2)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.13e-2)" "unprognostic (2.29e-1)" "prognostic favorable (1.63e-4)" "unprognostic (1.83e-1)" 4.4 3.5 4.5 22.8 4.9 64.3 4.3 10.0 5.2 9.2 28.1 6.4 7.1 5.9 13.0 6.7 16.3 10.4 6.5 24.4 4.2 3.9 5.3 6.7 9.8 23.3 4.7 2.3 17.2 5.9 1.9 4.4 9.9 5.0 12.2 3.4 10.9 11.6 8.3 107.9 2.7 12.9 27.4 3.4 22.0 8.1 16.7 4.1 26.8 4.1 18.9 28.0 25.1 11.4 6.4 2.2 3.5 2.9 5.5 7.6 3.4 5.5 5.7 2.9 7.3 0.0 0.4 16.3 1.8 0.4 3.9 1.0 23.4 5.9 39.4 15.6 0.5 3.9 5.1 2.4 2.3 0.6 7.9 9.7 33.4 2.2 14.8 1.8 16.1 15.7 0.5 1.1 1.6 0.3 0.6 2.6 15.1 27.2 7.2 0.4 24.0 11.6 16.6 10.5 3.1 7.2 22.6 7.1 32.0 2.9 2.6 11.9 7.6 4.4 14.6 7.3 2.7 8.1 22.6 4.7 1.3 12.5 1.7 7.6 17.3 22.9 41.5 0.3 11.5 1.2 0.0 1.0 3.5 5.4 2.9 3.5 5.6 4.5 3.7 1.8 6.4 5.7 5.0 1.3 5.5 2.7 2.2 7.6 3.4 4.5 4.9 10.0 5.2 4.2 3.9 4.7 2.3 5.0 4.1 3.0 6.9 45.5 27.2 8.0 0.9 37.4 7.6 12.0 5.7 1.8 0.0 1.3 8.3 5.5 4.0 9.3 25.7 70.0 4.3 4.4 6.0 14.9 8.1 4.5 8.5 0.0 60.3 6.2 7.0 2.7 4.0 11.1 1.7 1.0 49.7 11.8 6.1 28.8 5.6 13.3 1.3 6.5 4.4 1.2 15.1 7.3 1.9 48.7 40.0 16.2 RBM4 "LARK, RBM4A, ZCCHC21, ZCRB3A" ENSG00000173933 "RNA binding motif protein 4" Q9BWF3 11 66638617-66666682 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042174: AB_2677885, HPA047849: AB_2680180" "unprognostic (8.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.17e-1)" "unprognostic (1.53e-2)" "unprognostic (9.46e-3)" "unprognostic (1.13e-1)" "unprognostic (5.41e-3)" "unprognostic (6.42e-2)" "unprognostic (4.34e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (4.42e-2)" "unprognostic (2.53e-1)" "unprognostic (2.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.76e-2)" "unprognostic (3.07e-3)" 41.6 50.3 37.1 34.4 37.2 57.5 38.3 55.5 43.9 40.6 39.1 35.5 43.4 33.9 42.2 48.3 44.5 37.4 33.6 33.0 32.1 31.0 40.9 37.2 34.3 44.7 30.1 32.7 51.1 63.9 44.9 41.5 42.5 31.1 42.7 33.2 41.3 54.6 33.2 40.8 37.4 36.2 36.7 26.9 48.5 42.1 47.3 32.2 68.2 59.5 37.9 48.7 36.5 37.2 51.4 45.0 61.7 51.9 57.5 72.7 54.3 26.9 35.7 54.3 30.6 20.0 21.7 33.0 28.5 23.1 30.1 21.6 59.5 35.2 34.9 39.4 28.5 27.1 30.1 57.9 33.9 32.3 34.6 30.2 47.5 36.6 35.5 39.6 32.4 20.7 31.8 29.5 34.6 49.1 30.7 39.8 34.4 37.3 25.8 31.3 55.8 53.3 33.4 68.2 52.8 39.4 50.0 50.9 38.6 39.8 43.7 45.8 32.9 50.2 36.9 79.8 38.3 70.0 32.7 40.4 31.4 27.7 19.4 23.0 32.5 33.9 56.4 25.1 25.6 44.9 61.7 45.7 48.6 56.8 46.8 51.0 48.0 59.0 61.8 45.0 51.4 63.8 63.5 53.6 57.5 51.9 40.6 72.7 54.3 37.1 37.2 55.5 43.9 32.1 31.0 30.1 32.7 31.1 32.2 26.8 35.6 27.0 53.2 15.9 54.4 4.1 12.7 41.5 33.0 19.2 88.4 31.8 13.3 19.9 32.7 23.2 24.5 23.3 20.1 24.9 21.1 36.2 35.8 8.5 12.6 58.8 33.4 19.0 14.3 5.2 25.3 23.5 18.6 25.2 13.9 15.1 17.3 18.2 19.1 8.1 77.2 19.4 25.8 24.7 32.8 19.4 36.6 42.7 18.0 55.6 RBM41 FLJ11016 ENSG00000089682 "RNA binding motif protein 41" Q96IZ5 X 107064420-107118823 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042881 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA042881: AB_10794536" "unprognostic (1.07e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.39e-1)" "unprognostic (2.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-2)" "unprognostic (1.98e-2)" "unprognostic (2.19e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" "unprognostic (2.80e-2)" "unprognostic (1.92e-1)" 10.0 10.3 9.2 9.1 10.8 5.0 9.5 23.7 14.2 13.4 11.9 10.1 8.2 12.7 12.2 11.5 11.1 12.4 7.6 8.8 8.7 6.8 11.8 13.7 8.3 8.9 9.7 9.4 9.7 10.6 21.0 14.1 12.0 11.6 10.8 11.2 9.0 10.7 9.0 14.6 11.6 15.5 11.2 14.2 11.5 8.2 15.6 12.8 12.2 15.7 8.0 9.9 12.4 9.8 6.3 4.8 10.6 7.0 8.6 6.3 3.4 14.4 11.6 7.5 6.0 5.0 8.7 8.7 8.6 8.5 6.3 8.6 7.7 12.1 7.9 16.3 6.2 11.1 12.0 10.8 8.0 9.7 9.8 16.0 9.7 21.0 9.4 5.6 9.8 7.6 6.1 15.9 7.7 7.7 8.9 9.5 7.5 16.7 11.1 7.6 7.0 8.3 5.6 11.0 8.0 13.3 6.7 6.3 6.8 9.4 9.2 6.2 9.8 10.7 7.7 6.9 10.7 7.1 5.1 9.2 8.9 5.2 10.5 6.7 5.2 9.6 8.9 5.0 4.5 6.6 10.6 7.0 10.6 6.3 3.7 3.9 6.3 5.5 6.3 4.7 6.3 4.1 2.8 1.0 8.6 3.7 4.8 4.9 3.4 9.2 10.8 23.7 14.2 8.7 6.8 9.7 9.4 11.6 12.8 11.9 14.2 10.3 5.1 4.6 20.6 20.4 7.6 14.7 6.8 7.0 25.5 7.0 1.7 12.0 4.0 5.8 11.8 23.3 6.9 4.6 6.2 5.2 12.7 7.8 5.7 11.1 7.5 6.2 7.9 1.3 13.3 10.5 5.0 6.4 9.0 10.5 10.6 10.5 11.0 6.9 20.7 0.0 9.5 6.8 7.2 6.5 3.8 10.1 11.0 5.5 RBM42 MGC10433 ENSG00000126254 "RNA binding motif protein 42" Q9BTD8 19 35629030-35637686 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 321.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043671 Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043671: AB_10794890" "unprognostic (4.77e-3)" "unprognostic (3.37e-2)" "unprognostic (6.33e-2)" "unprognostic (7.03e-2)" "unprognostic (3.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-2)" "unprognostic (3.34e-1)" "unprognostic (1.53e-1)" "unprognostic (8.81e-2)" "unprognostic (4.95e-3)" "unprognostic (3.26e-2)" "unprognostic (5.78e-3)" "unprognostic (3.37e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (7.33e-2)" 26.0 22.0 16.6 20.3 16.0 29.2 23.6 12.1 23.4 20.4 27.3 22.6 18.8 24.2 25.5 21.8 25.5 18.3 23.6 24.9 13.7 12.0 22.2 33.3 19.3 19.2 15.7 17.6 27.6 17.7 20.7 15.0 41.3 16.0 19.5 9.9 15.9 25.1 24.6 44.6 31.5 24.7 18.6 18.1 25.4 22.0 23.7 16.0 41.1 25.8 21.9 21.3 21.2 22.4 43.6 49.1 61.3 48.9 38.9 45.6 33.9 32.4 51.2 11.4 15.5 10.4 8.3 31.2 22.4 12.4 26.4 20.8 30.2 21.2 18.1 41.0 14.2 14.3 13.4 13.1 15.7 7.7 46.8 23.5 25.0 17.1 24.6 27.1 22.0 24.1 11.7 12.6 19.4 10.7 8.4 14.4 19.1 25.9 14.9 11.9 37.0 27.9 29.1 13.1 29.5 21.1 30.5 15.6 18.0 12.5 15.1 15.0 21.8 25.4 21.0 17.0 6.6 16.7 34.7 22.0 18.9 25.8 24.9 38.9 36.5 38.4 27.9 18.2 21.0 26.3 46.1 42.1 61.3 45.6 48.9 39.3 41.0 37.9 45.5 49.1 43.6 34.2 37.7 38.6 38.9 45.4 45.4 41.9 33.9 16.6 16.0 12.1 23.4 13.7 12.0 15.7 17.6 16.0 16.0 35.7 21.1 26.7 41.9 46.0 19.2 12.0 50.9 26.8 28.4 50.6 11.8 174.8 63.0 68.5 26.2 42.7 70.6 0.0 78.3 85.4 48.9 29.9 50.7 27.6 78.2 9.5 50.1 48.5 29.8 12.0 53.8 45.9 50.6 83.8 42.6 43.4 64.2 45.6 59.4 63.4 13.9 51.8 59.0 62.6 56.9 38.0 321.4 45.9 48.9 38.9 RBM46 "CT68, MGC27016" ENSG00000151962 "RNA binding motif protein 46" Q8TBY0 4 154781213-154828813 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 34.5" "Group enriched" "Detected in some" 13 "Spermatocytes: 74.4;Spermatogonia: 75.5" "Cancer enriched" "Detected in single" 15 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 2.7;SuSa: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079488 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA079488: " "unprognostic (4.79e-1)" "unprognostic (1.14e-2)" "unprognostic (3.23e-1)" "unprognostic (1.59e-2)" "unprognostic (3.33e-3)" "unprognostic (1.13e-1)" "unprognostic (8.11e-2)" "unprognostic (2.24e-2)" "unprognostic (2.99e-7)" "unprognostic (4.86e-2)" "unprognostic (7.31e-2)" "unprognostic (4.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 5.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 74.4 75.5 0.0 0.0 0.0 0.0 0.0 RBM47 "FLJ20273, NET18" ENSG00000163694 "RNA binding motif protein 47" A0AV96 4 40423267-40630875 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 42.4" "Group enriched" "Detected in many" 11 "dendritic cells: 11.3;granulocytes: 42.4;monocytes: 14.2" "Cell line enhanced" "Detected in many" "A549: 16.8;BEWO: 50.3;CAPAN-2: 22.1;SK-BR-3: 16.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA006347 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA006347: AB_2181208" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.49e-3)" "unprognostic (2.38e-2)" "unprognostic (7.72e-2)" "unprognostic (1.52e-2)" "unprognostic (7.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.22e-1)" "unprognostic (9.42e-2)" "unprognostic (3.04e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.33e-16)" "unprognostic (1.62e-2)" "unprognostic (9.81e-2)" "unprognostic (1.72e-1)" "unprognostic (5.77e-2)" 8.2 33.6 1.9 8.2 2.4 2.6 10.9 0.8 1.2 5.4 22.9 3.3 28.7 24.1 2.6 15.4 27.3 5.3 12.7 4.0 2.4 1.1 37.0 16.1 14.5 11.3 3.0 0.3 4.6 19.2 8.0 2.9 27.2 6.6 13.2 17.3 9.2 60.8 36.0 0.9 6.0 42.8 2.2 4.1 15.0 22.2 7.1 2.2 1.6 31.5 13.7 20.6 7.8 9.7 2.0 11.3 42.4 14.2 0.1 0.1 4.8 11.6 16.8 0.0 0.5 0.0 0.0 50.3 0.3 0.3 0.1 0.1 9.8 22.1 0.0 8.8 0.3 0.9 4.6 0.3 3.3 0.1 0.0 2.8 0.0 1.2 2.7 0.2 0.1 0.1 0.2 2.0 0.0 0.0 0.3 0.0 0.0 0.6 2.5 0.0 6.6 0.0 0.3 5.1 16.3 0.9 0.0 0.0 13.0 15.5 14.8 0.5 0.1 6.6 16.8 0.1 3.8 7.4 3.1 0.0 0.1 0.6 0.1 0.3 8.9 13.2 1.4 1.5 1.4 0.0 0.1 14.2 0.1 0.0 10.9 0.1 2.0 0.0 0.0 11.3 1.2 0.1 0.0 42.4 0.1 8.1 4.6 0.0 4.8 1.9 2.4 0.8 1.2 2.4 1.1 3.0 0.3 6.6 2.2 74.5 109.6 29.8 66.4 52.3 0.0 2.0 63.7 107.1 92.1 106.4 0.0 84.5 54.7 73.9 0.9 3.4 253.2 0.0 99.6 71.8 8.3 174.3 6.9 117.3 81.1 1.6 116.9 35.0 113.3 1.5 2.3 85.9 35.4 57.7 177.9 0.4 94.8 165.8 1.1 114.0 0.0 0.0 3.1 1.9 11.4 65.9 219.6 0.0 144.7 244.6 RBM4B "MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B" ENSG00000173914 "RNA binding motif protein 4B" Q9BQ04 11 66664998-66677921 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042174: AB_2677885, HPA047849: AB_2680180" "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (3.32e-2)" "unprognostic (1.98e-3)" "unprognostic (3.57e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.28e-1)" "unprognostic (1.09e-2)" "unprognostic (6.22e-2)" "prognostic favorable (2.10e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.29e-2)" "unprognostic (1.71e-2)" 7.1 12.3 17.6 9.6 17.3 4.0 10.2 35.9 19.3 13.4 10.0 22.8 13.5 9.3 19.0 20.2 10.1 18.3 9.8 9.2 17.5 17.4 9.9 9.8 8.8 13.8 15.4 16.2 29.8 11.8 15.7 25.6 12.2 17.3 14.6 11.5 14.5 14.1 15.0 13.9 17.4 10.3 14.0 16.4 11.8 9.8 17.0 18.7 8.5 12.3 7.6 15.5 11.3 11.5 21.8 11.4 26.8 15.1 13.2 12.5 8.4 13.1 13.2 29.1 24.2 14.3 14.7 9.8 12.7 12.7 14.2 14.6 18.5 13.9 14.7 18.2 16.0 13.9 17.2 19.1 17.5 15.1 14.2 13.0 16.0 16.6 19.7 10.5 16.2 15.8 15.3 12.0 14.5 12.4 16.3 13.7 12.0 12.1 14.8 19.1 21.2 10.0 12.5 17.3 29.7 17.8 20.6 23.2 15.1 12.9 13.3 17.9 16.4 15.1 7.8 28.3 19.5 20.8 15.4 12.6 15.7 16.2 15.3 11.3 7.3 12.3 15.1 14.5 11.5 13.8 12.7 9.6 26.8 10.8 14.1 10.4 21.8 10.1 10.4 11.4 18.6 12.5 9.2 6.1 13.2 15.1 9.4 7.4 8.4 17.6 17.3 35.9 19.3 17.5 17.4 15.4 16.2 17.3 18.7 11.9 5.1 15.9 14.0 7.1 35.5 4.5 7.6 21.4 10.3 17.4 31.4 32.2 10.0 12.0 21.2 7.0 8.5 0.0 5.0 14.2 17.8 7.3 9.2 7.4 11.1 23.8 18.4 6.7 8.7 36.0 17.0 8.2 15.1 9.0 8.6 21.8 5.3 7.4 12.7 11.2 56.8 6.5 11.3 42.1 40.0 6.1 18.5 13.4 10.3 4.3 RBMS1 "C2orf12, DKFZp564H0764, HCC-4, MSSP-1, MSSP-2, MSSP-3, SCR2, YC1" ENSG00000153250 "RNA binding motif single stranded interacting protein 1" P29558 2 160272151-160493794 "Predicted intracellular proteins" "DNA replication" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 333.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 55.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047943, HPA061791" Enhanced Cytosol NA NA Cytosol "HPA047943: AB_2797235, HPA061791: AB_2684611" "unprognostic (2.81e-1)" "unprognostic (2.44e-2)" "unprognostic (3.78e-2)" "unprognostic (1.38e-3)" "unprognostic (2.50e-1)" "unprognostic (6.81e-3)" "prognostic unfavorable (4.45e-4)" "unprognostic (6.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.14e-1)" "unprognostic (7.16e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (1.33e-7)" "unprognostic (1.84e-3)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (2.32e-1)" 29.4 8.7 4.0 15.6 9.4 11.6 23.0 2.6 7.1 25.9 19.1 2.9 11.4 4.4 29.1 13.5 15.8 17.0 17.5 30.1 4.1 4.1 16.2 8.1 22.8 25.3 4.0 2.9 22.9 4.4 24.3 12.7 74.2 7.2 18.6 5.9 11.2 11.7 16.0 10.5 14.1 9.7 21.7 5.3 23.3 11.5 7.1 5.6 15.7 12.3 11.7 7.8 23.9 23.9 1.2 7.3 24.2 11.0 6.6 16.8 5.7 13.7 5.1 18.2 2.3 26.4 46.0 22.1 17.6 25.2 12.2 12.7 14.1 10.4 0.1 22.0 29.6 5.7 8.4 8.8 12.9 20.0 11.1 6.5 5.2 12.7 11.2 24.1 8.3 0.3 55.0 10.2 21.1 9.5 16.3 19.0 4.2 0.3 6.5 29.2 10.7 7.7 8.5 11.2 2.3 11.3 5.9 15.9 6.9 18.6 17.0 2.3 6.2 10.9 6.5 16.1 23.7 3.3 13.2 22.8 21.8 13.8 19.9 15.8 3.5 0.1 5.9 17.5 12.8 13.8 2.1 11.0 13.5 5.0 6.3 16.8 0.5 8.7 7.6 7.3 1.2 14.2 6.4 24.2 6.6 3.5 4.1 1.3 5.7 4.0 9.4 2.6 7.1 4.1 4.1 4.0 2.9 7.2 5.6 104.2 86.2 18.1 101.0 80.9 1.1 52.3 12.7 41.5 39.8 66.3 0.0 87.3 21.6 25.4 38.4 101.2 0.0 0.0 41.2 91.7 155.8 97.0 19.7 19.5 105.1 1.6 0.0 160.8 119.6 15.3 82.3 73.9 52.3 19.0 0.0 19.2 65.7 0.6 93.0 29.9 1.0 77.6 83.0 1.8 8.5 72.1 333.1 71.0 0.4 131.7 RBMS2 SCR3 ENSG00000076067 "RNA binding motif single stranded interacting protein 2" Q15434 12 56521929-56596196 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039225, HPA058784" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA039225: AB_10963056, HPA058784: AB_2683819" "unprognostic (1.35e-1)" "unprognostic (5.31e-2)" "unprognostic (2.61e-1)" "unprognostic (5.29e-2)" "unprognostic (9.09e-2)" "unprognostic (3.19e-3)" "unprognostic (4.78e-2)" "unprognostic (1.89e-2)" "unprognostic (7.01e-2)" "unprognostic (2.80e-1)" "unprognostic (2.86e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.22e-4)" "unprognostic (2.67e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (2.63e-2)" 24.5 7.2 5.7 5.8 10.0 3.6 31.3 8.5 8.7 12.2 9.9 6.0 6.1 4.7 17.5 11.9 9.3 10.4 10.4 19.3 8.6 5.1 12.4 4.4 53.1 8.0 7.5 5.2 12.6 7.5 11.5 12.1 24.8 11.4 9.6 9.6 14.3 10.3 9.8 9.3 7.5 7.5 12.9 19.2 13.2 8.0 4.8 7.4 2.7 16.5 8.1 5.3 11.7 19.2 1.1 4.9 3.0 8.3 2.1 2.3 1.5 11.7 9.8 4.2 6.1 10.4 10.0 4.3 14.9 15.4 11.5 10.1 7.7 20.9 0.2 17.8 15.1 4.5 8.5 3.9 23.7 12.9 3.9 3.1 1.4 7.6 2.3 6.7 1.7 2.8 8.9 6.0 11.9 14.1 13.4 21.1 2.5 0.7 2.9 19.4 1.5 1.6 1.9 2.5 0.0 3.6 0.9 4.7 0.2 14.2 2.8 0.4 3.2 17.3 6.3 2.1 9.9 6.7 3.1 32.2 7.2 15.3 3.9 3.5 2.6 1.1 0.8 2.6 0.4 10.0 1.0 8.3 2.6 1.6 2.6 1.7 0.6 0.7 2.3 4.9 1.1 1.8 1.2 3.0 2.1 0.6 1.3 0.9 1.5 5.7 10.0 8.5 8.7 8.6 5.1 7.5 5.2 11.4 7.4 38.7 15.6 0.0 8.0 3.3 4.1 6.7 15.3 6.7 17.0 12.2 9.8 17.8 1.7 19.9 9.7 41.2 4.1 0.0 14.6 31.2 7.2 11.1 8.1 1.0 9.3 7.9 5.2 47.9 21.6 17.0 16.1 7.3 0.0 2.8 6.9 6.1 28.5 11.2 23.3 9.1 1.6 25.8 8.3 0.7 1.1 1.8 19.8 0.9 6.6 11.5 RBP1 "CRABP-I, CRBP, CRBP1, CRBPI, RBPC" ENSG00000114115 "Retinol binding protein 1" P09455 3 139517434-139539829 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 161.0;pancreas: 107.4;retina: 85.3" "Group enriched" "Detected in many" 7 "Ductal cells: 920.8;Exocrine glandular cells: 932.2;Ito cells: 319.8;Pancreatic endocrine cells: 450.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 136.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 56.8" "HPA007338, CAB018603, CAB019276" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814" "unprognostic (9.62e-3)" "unprognostic (7.67e-2)" "unprognostic (9.53e-3)" "unprognostic (5.17e-1)" "unprognostic (7.48e-3)" "unprognostic (2.27e-2)" "unprognostic (6.29e-2)" "unprognostic (1.16e-1)" "unprognostic (7.12e-2)" "unprognostic (3.91e-3)" "unprognostic (2.74e-2)" "unprognostic (8.86e-2)" "unprognostic (1.11e-3)" "unprognostic (2.60e-2)" "unprognostic (1.71e-1)" "unprognostic (4.50e-2)" "unprognostic (1.28e-3)" 1.9 43.1 6.5 3.3 11.3 0.1 7.5 5.1 7.8 7.8 3.2 11.5 8.4 4.5 26.8 11.3 3.3 58.4 42.7 7.5 7.7 8.1 3.7 20.1 4.9 6.5 10.4 4.9 161.0 107.4 4.3 26.2 20.6 31.5 9.8 2.1 85.3 4.7 6.4 1.8 2.9 4.8 17.5 8.7 4.7 2.8 12.9 4.3 0.9 3.3 2.6 2.0 7.7 7.2 0.5 0.5 2.1 0.9 0.7 0.4 0.2 1.2 0.3 1.1 26.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.2 0.0 8.7 0.0 0.4 0.0 6.1 0.1 0.0 0.0 0.7 0.0 0.4 11.2 25.8 0.0 0.0 0.4 0.0 0.0 0.0 26.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 5.2 0.0 0.0 0.0 3.2 136.6 5.6 0.0 0.0 2.3 0.5 0.1 0.0 0.0 20.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 1.2 0.9 0.8 0.4 0.8 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 2.1 0.7 0.5 0.5 0.1 0.2 6.5 11.3 5.1 7.8 7.7 8.1 10.4 4.9 31.5 4.3 29.8 5.1 10.5 43.6 15.7 12.3 15.5 63.7 5.3 12.5 22.7 2.0 2.6 11.6 920.8 3.9 54.2 0.0 0.0 932.2 6.9 95.1 21.2 0.0 6.6 16.2 3.2 41.3 319.8 11.5 8.3 25.0 2.8 8.5 23.4 0.5 79.7 450.0 0.0 4.2 2.7 7.0 25.8 22.5 2.3 4.1 30.6 3.2 2.5 0.8 27.7 RBP7 CRBPIV ENSG00000162444 "Retinol binding protein 7" Q96R05 1 9997206-10016020 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 68.1;breast: 210.2" "Group enriched" "Detected in many" 5 "Endothelial cells: 121.4;Kupffer cells: 402.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6" "Group enriched" "Detected in many" 30 "granulocytes: 60.6;monocytes: 54.1" "Cell line enhanced" "Detected in some" "EFO-21: 10.5;SK-MEL-30: 7.1;T-47d: 26.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA034749 Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA034749: AB_10602084" "unprognostic (1.93e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (9.59e-2)" "unprognostic (2.31e-1)" "unprognostic (6.28e-2)" "unprognostic (1.39e-2)" "unprognostic (1.85e-1)" "unprognostic (1.05e-3)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (7.90e-2)" "unprognostic (5.07e-2)" "unprognostic (2.38e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" 68.1 3.7 3.8 3.0 11.4 7.5 210.2 2.1 5.5 4.3 10.9 8.7 2.7 0.5 6.4 4.5 7.2 2.4 14.7 29.7 5.3 2.8 7.6 2.5 2.5 4.5 7.6 3.0 2.6 3.7 14.7 3.5 4.4 6.2 4.7 1.2 3.5 4.8 2.7 5.9 6.6 2.0 4.4 8.9 21.5 3.0 2.6 5.2 1.2 11.3 1.8 1.4 4.5 17.5 0.0 1.8 60.6 54.1 0.0 0.1 15.0 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.8 1.8 2.4 0.0 10.5 1.0 0.0 0.0 0.0 0.8 3.4 0.0 2.5 0.0 0.1 0.9 1.2 0.0 0.0 0.0 1.6 1.6 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 4.4 0.0 0.0 0.0 0.5 0.0 0.1 0.4 1.9 0.1 7.1 2.9 26.8 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 54.1 0.4 0.0 23.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 60.6 0.0 11.1 0.3 0.1 15.0 3.8 11.4 2.1 5.5 5.3 2.8 7.6 3.0 6.2 5.2 0.0 2.2 11.2 7.8 18.3 0.0 17.6 10.2 1.4 1.2 1.8 0.0 4.5 19.9 1.3 2.6 121.4 0.0 0.0 2.3 2.2 8.2 19.2 3.5 1.3 54.6 0.0 0.0 49.7 402.1 4.7 5.8 23.1 20.3 0.0 0.0 1.3 3.7 0.0 0.7 0.7 1.1 0.0 5.3 1.2 1.5 15.4 5.1 1.3 0.4 4.3 RBPMS HERMES ENSG00000157110 "RNA binding protein, mRNA processing factor" Q93062 8 30384479-30572261 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.9" "Cell line enhanced" "Detected in many" "ASC diff: 71.1;RPTEC TERT1: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA056999 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056999: AB_2683306" "unprognostic (1.65e-1)" "unprognostic (7.81e-2)" "unprognostic (1.53e-1)" "unprognostic (2.23e-3)" "unprognostic (8.66e-2)" "unprognostic (1.54e-1)" "unprognostic (2.42e-2)" "unprognostic (3.47e-3)" "unprognostic (4.63e-2)" "unprognostic (2.32e-1)" "unprognostic (4.67e-2)" "unprognostic (2.88e-2)" "unprognostic (1.76e-2)" "unprognostic (4.76e-2)" "unprognostic (2.52e-1)" "unprognostic (4.91e-2)" "unprognostic (2.16e-3)" 71.3 20.4 2.3 28.4 6.9 0.2 112.8 1.4 2.9 81.7 66.1 4.4 46.3 6.9 90.8 31.8 66.2 35.7 50.4 53.8 2.8 2.7 69.1 34.5 36.7 19.3 5.4 3.4 65.5 15.0 12.2 10.4 29.2 9.3 77.3 13.7 41.2 22.9 59.8 14.5 11.8 22.3 181.8 10.3 28.9 38.1 27.4 2.9 4.8 54.1 8.5 10.9 155.4 88.9 0.5 3.9 0.3 0.2 0.7 0.3 0.0 0.1 11.0 12.5 0.0 71.1 21.3 31.3 15.7 21.5 19.4 16.1 16.1 6.6 0.1 8.4 20.1 17.8 6.2 14.3 11.4 23.4 0.0 3.0 0.3 5.2 16.5 30.6 0.1 2.5 24.7 2.9 18.6 2.4 21.8 11.1 0.5 0.1 0.0 9.4 6.7 0.0 0.2 32.1 12.8 7.2 0.7 3.4 0.9 49.1 18.6 0.2 2.5 1.6 11.8 7.8 43.3 2.4 0.0 10.2 9.6 0.9 16.5 2.6 0.0 0.0 0.0 15.8 0.0 4.2 0.0 0.1 0.0 0.2 0.2 0.3 0.3 0.1 0.0 0.0 0.5 0.2 0.2 0.3 0.7 0.0 3.9 0.1 0.0 2.3 6.9 1.4 2.9 2.8 2.7 5.4 3.4 9.3 2.9 50.6 90.6 2.2 53.3 8.2 6.3 93.4 68.8 17.4 43.3 134.3 2.0 85.5 96.2 84.7 73.8 58.9 0.5 0.0 81.9 170.5 37.3 65.0 9.3 48.4 31.6 0.0 1.7 44.8 2.7 22.7 158.5 7.2 13.5 3.6 0.0 0.8 62.0 0.0 169.4 182.3 5.0 109.9 122.1 30.7 15.5 6.9 34.4 4.9 0.0 117.1 RC3H1 "KIAA2025, RNF198, roquin, RP5-1198E17.5" ENSG00000135870 "Ring finger and CCCH-type domains 1" Q5TC82 1 173931214-174022297 "Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027428, HPA027434, HPA027448" Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683" "unprognostic (6.91e-2)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" "unprognostic (2.33e-2)" "unprognostic (7.73e-2)" "unprognostic (1.61e-2)" "unprognostic (5.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-2)" "unprognostic (2.04e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (5.25e-2)" "unprognostic (2.15e-1)" "unprognostic (3.43e-3)" "unprognostic (6.83e-3)" 10.4 7.8 11.8 8.0 10.3 32.6 10.6 26.7 14.0 9.9 10.3 12.3 8.3 6.9 10.9 8.4 11.8 9.4 8.1 9.0 11.9 7.4 8.1 11.2 11.3 8.8 10.4 7.1 10.8 9.8 10.2 14.6 9.1 12.4 8.7 8.6 13.3 9.0 7.6 19.1 14.0 10.6 8.4 9.3 13.6 9.1 9.7 9.0 15.2 9.9 7.7 13.6 8.4 9.8 2.8 1.6 10.4 3.9 2.3 2.7 1.1 7.3 10.2 5.7 8.8 10.8 8.4 7.8 5.0 7.2 5.8 5.1 9.4 8.2 10.4 9.0 8.1 4.5 7.1 8.5 7.1 8.2 7.2 2.1 9.0 7.6 7.8 6.6 11.7 10.5 8.0 5.5 8.4 5.7 5.4 8.9 5.1 10.2 6.4 7.0 5.5 7.0 10.6 9.8 6.8 1.1 7.7 10.2 7.6 10.3 14.2 6.8 6.1 9.5 12.3 4.8 10.0 8.2 11.9 12.9 7.6 7.6 6.5 6.4 8.0 8.1 13.4 5.1 5.3 7.6 4.5 3.2 4.0 2.0 3.2 2.1 2.1 1.9 2.3 1.6 2.8 2.7 2.3 10.4 2.3 3.9 1.3 1.5 1.1 11.8 10.3 26.7 14.0 11.9 7.4 10.4 7.1 12.4 9.0 38.7 30.9 19.0 14.5 30.6 34.5 22.4 22.9 25.4 19.4 22.7 76.6 8.9 8.3 21.9 9.1 26.3 25.0 0.0 16.3 6.7 36.9 24.8 15.1 29.4 10.0 36.5 32.8 33.7 35.2 6.7 14.7 18.5 28.7 19.8 27.4 25.7 19.9 17.5 9.9 8.1 44.8 19.4 26.8 35.6 11.7 35.8 9.7 30.5 23.4 26.1 RCAN1 DSCR1 ENSG00000159200 "Regulator of calcineurin 1" P53805 21 34513142-34615142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 220.2" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 195.4;Hepatocytes: 146.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "SK-MEL-30: 156.7;WM-115: 102.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037218, HPA068436" Enhanced Approved Cytosol NA NA Cytosol "CAB037218: AB_2179743, HPA068436: " "unprognostic (3.83e-2)" "unprognostic (4.40e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (9.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.82e-3)" "unprognostic (5.27e-2)" "unprognostic (7.99e-2)" "unprognostic (4.83e-2)" "unprognostic (2.71e-1)" "unprognostic (2.04e-1)" "unprognostic (4.07e-3)" "unprognostic (1.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-2)" "unprognostic (2.60e-3)" 21.5 7.9 22.2 15.8 25.8 2.8 20.7 14.8 19.6 29.3 12.2 27.7 3.2 10.6 10.6 7.4 10.1 4.2 18.8 18.6 22.4 22.4 27.1 77.3 15.0 7.5 27.2 11.1 5.0 20.3 220.2 11.2 30.4 18.1 8.9 13.3 12.6 6.9 5.9 10.9 9.7 13.5 15.4 41.3 5.2 13.1 3.7 19.4 19.9 19.8 12.2 6.9 19.8 6.9 1.6 5.2 8.0 3.9 0.2 1.9 0.9 5.8 1.1 6.0 3.8 3.3 2.0 3.7 21.9 22.6 9.0 9.0 6.6 5.6 0.1 1.0 12.7 17.9 0.5 4.3 4.4 12.2 3.3 2.6 1.1 2.0 3.1 12.8 1.8 3.7 5.3 4.0 10.7 7.5 2.2 2.9 4.0 2.2 5.7 5.9 2.8 17.4 1.4 3.4 5.8 2.9 6.6 4.7 2.7 2.8 10.1 2.9 1.2 16.0 10.4 156.7 5.7 14.0 3.1 3.2 30.5 3.1 5.0 5.3 5.0 3.1 1.0 10.0 5.4 102.2 0.0 2.0 8.0 1.3 3.4 1.9 1.6 1.6 1.2 2.7 1.2 0.7 1.3 1.0 0.2 3.9 5.2 1.8 0.9 22.2 25.8 14.8 19.6 22.4 22.4 27.2 11.1 18.1 19.4 89.3 64.0 6.7 17.3 84.0 14.8 21.4 22.9 16.0 17.0 195.4 25.5 6.3 18.3 67.7 38.0 57.3 62.2 0.0 16.3 10.7 35.7 12.5 8.1 146.7 46.2 3.2 3.5 25.2 24.5 9.6 6.6 30.2 54.0 38.7 22.2 10.6 25.9 38.4 9.2 96.4 6.7 0.0 82.6 11.9 2.3 69.4 9.3 5.2 8.4 34.1 RCC1L WBSCR16 ENSG00000274523 "RCC1 like" Q96I51 7 75027122-75074228 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 33.4" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 50.0;Distal tubular cells: 41.4;Extravillous trophoblasts: 33.6;monocytes: 29.7;Syncytiotrophoblasts: 45.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052184, HPA060643" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA052184: AB_2681752, HPA060643: AB_2684335" "unprognostic (9.73e-2)" "unprognostic (9.42e-2)" "unprognostic (1.69e-1)" "unprognostic (5.87e-2)" "prognostic unfavorable (4.88e-4)" "unprognostic (8.91e-2)" "unprognostic (3.34e-3)" "unprognostic (7.36e-2)" "unprognostic (1.94e-1)" "unprognostic (7.40e-2)" "unprognostic (1.28e-3)" "unprognostic (6.35e-2)" "unprognostic (1.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.43e-1)" 7.4 8.5 4.4 7.0 5.1 4.2 3.3 4.3 5.6 5.8 6.4 7.0 7.2 6.4 5.0 4.8 7.4 4.8 7.7 11.5 3.7 7.9 12.0 3.9 5.5 5.6 4.0 7.1 9.1 4.9 3.3 6.5 3.8 7.2 3.2 7.3 7.8 6.4 33.4 4.3 6.0 9.5 2.3 6.8 4.8 5.4 5.7 3.6 8.7 8.4 6.8 5.8 7.7 6.8 5.5 4.8 4.9 6.7 9.2 2.6 15.3 23.5 12.4 21.1 8.9 7.3 17.2 15.0 10.8 12.9 10.6 23.7 18.9 16.3 6.9 12.1 16.9 18.2 10.5 10.0 5.4 17.9 16.7 12.0 15.7 22.1 12.6 19.2 19.5 9.0 8.3 11.2 9.1 8.7 11.4 3.5 38.4 10.6 9.9 32.6 0.9 29.1 29.0 18.6 18.5 9.3 10.1 34.0 11.2 14.0 13.5 20.2 20.1 42.6 18.3 9.1 30.0 20.1 12.8 17.1 14.3 15.2 19.5 11.9 9.4 25.6 13.1 20.4 22.5 4.8 3.8 2.2 7.3 4.9 5.7 5.7 7.8 6.4 5.3 6.8 7.5 9.2 1.4 6.7 3.5 5.5 5.9 2.6 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 21.0 0.0 50.0 41.4 21.1 0.0 0.0 0.0 0.0 17.7 33.6 0.0 0.0 4.7 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 29.7 0.0 0.0 16.6 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 RCCD1 MGC14386 ENSG00000166965 "RCC1 domain containing 1" A6NED2 15 90954870-90963125 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039683, HPA040776" Enhanced Enhanced "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA039683: AB_10794752, HPA040776: AB_10795478" "unprognostic (1.01e-2)" "unprognostic (1.69e-2)" "unprognostic (7.22e-3)" "unprognostic (8.63e-2)" "unprognostic (6.18e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (5.86e-2)" "unprognostic (4.83e-2)" "unprognostic (5.10e-2)" "unprognostic (5.69e-2)" "unprognostic (2.72e-2)" "unprognostic (1.49e-3)" "unprognostic (1.32e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-2)" "unprognostic (3.94e-2)" 5.2 9.9 6.1 12.5 8.1 6.1 17.3 14.3 7.0 5.3 9.2 3.3 5.8 8.0 6.4 5.9 9.2 6.2 8.7 6.2 5.5 6.7 8.5 11.3 6.6 5.7 8.4 1.5 8.2 12.1 9.3 3.2 9.4 6.0 5.6 7.4 3.1 8.2 6.2 5.2 11.8 9.7 8.6 5.6 10.1 6.5 18.9 7.2 21.9 11.0 8.3 14.5 6.4 5.7 3.1 2.3 0.1 2.0 1.7 2.9 0.8 4.9 7.3 1.7 3.6 4.3 5.1 12.9 5.7 1.0 1.6 1.7 3.5 9.4 17.3 9.2 3.5 0.1 10.6 5.6 1.5 2.8 14.5 11.5 12.5 12.3 5.0 3.6 5.9 4.9 3.8 5.1 1.7 2.3 6.6 2.7 10.2 9.4 11.4 4.9 1.6 7.1 6.2 6.6 5.9 3.0 8.5 8.7 18.4 7.7 2.3 5.6 6.4 9.9 6.3 6.7 9.5 7.3 11.5 4.3 1.0 7.2 4.2 0.2 20.5 8.4 10.3 1.9 13.2 4.8 0.1 0.7 0.1 0.8 2.0 2.1 3.1 1.7 2.7 1.6 2.1 2.9 1.0 0.1 1.7 1.1 2.3 2.1 0.8 6.1 8.1 14.3 7.0 5.5 6.7 8.4 1.5 6.0 7.2 0.0 2.1 13.7 10.1 6.5 6.0 8.1 0.0 1.4 1.2 7.0 3.9 12.3 3.3 7.2 1.8 4.5 11.8 70.0 4.2 16.3 7.1 7.3 0.0 7.4 10.2 0.0 21.2 3.1 7.5 3.9 8.1 5.4 5.0 4.6 16.7 10.6 4.9 14.0 7.4 10.4 2.7 25.8 6.4 20.6 18.3 7.9 7.6 3.2 21.5 7.4 RCHY1 "ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363" ENSG00000163743 "Ring finger and CHY zinc finger domain containing 1" Q96PM5 4 75479037-75514764 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030338, HPA030339" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA030338: , HPA030339: AB_10603232" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "prognostic favorable (9.09e-4)" "unprognostic (1.90e-1)" "unprognostic (3.45e-3)" "unprognostic (1.19e-2)" "unprognostic (7.87e-3)" "unprognostic (5.82e-2)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.60e-2)" "prognostic favorable (3.62e-5)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "prognostic favorable (7.89e-5)" 8.8 12.1 15.7 9.9 20.1 15.6 17.8 20.7 16.8 10.2 12.7 9.8 8.7 9.0 11.0 7.5 8.4 12.9 7.2 17.6 14.1 16.2 17.1 12.5 10.4 12.2 15.9 15.7 16.2 10.6 14.9 13.0 10.5 17.1 12.0 14.2 7.7 12.3 11.3 29.7 5.9 9.2 12.4 16.7 12.2 10.3 13.4 15.4 14.9 20.3 8.0 12.7 9.7 12.1 4.4 7.4 18.9 8.8 4.6 7.4 4.3 6.1 3.2 9.5 8.9 10.0 8.8 5.4 4.1 9.7 8.6 10.2 8.7 7.6 10.2 7.9 5.9 8.5 3.7 24.1 7.3 13.1 8.3 7.9 13.2 6.0 11.1 8.6 17.8 7.3 8.1 9.2 9.9 9.3 10.4 17.3 13.3 12.2 10.4 20.0 9.9 16.3 7.2 15.8 16.8 5.6 8.8 22.4 8.7 13.4 10.5 14.7 8.1 6.8 16.0 17.7 10.9 9.0 8.1 6.8 5.7 5.6 5.0 6.9 11.1 7.9 14.5 6.9 12.7 8.9 18.9 8.8 8.5 4.3 5.2 7.4 4.4 5.3 5.0 7.4 2.2 3.9 5.5 3.7 4.6 4.7 3.8 5.2 4.3 15.7 20.1 20.7 16.8 14.1 16.2 15.9 15.7 17.1 15.4 17.9 6.4 18.7 28.1 36.1 36.0 49.4 12.7 6.7 7.9 22.7 19.6 28.8 58.0 26.3 26.2 18.6 15.4 0.0 19.8 19.5 23.5 31.2 4.7 21.3 16.6 22.3 13.3 23.9 33.0 39.2 20.8 22.4 27.0 14.4 23.7 22.1 21.3 24.6 23.7 44.0 19.0 32.3 22.7 60.0 42.9 27.0 28.3 34.8 27.1 23.7 RCOR3 FLJ10876 ENSG00000117625 "REST corepressor 3" Q9P2K3 1 211258377-211316385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007413, HPA007621, HPA071997" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193" "unprognostic (2.39e-2)" "unprognostic (1.23e-1)" "unprognostic (9.35e-2)" "unprognostic (3.07e-2)" "prognostic favorable (1.35e-5)" "unprognostic (4.02e-3)" "unprognostic (2.28e-2)" "prognostic favorable (5.75e-5)" "unprognostic (2.04e-1)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (9.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.62e-2)" "unprognostic (1.82e-1)" "unprognostic (3.95e-1)" "unprognostic (3.56e-3)" 15.1 15.0 17.2 14.9 19.6 25.8 18.9 33.7 21.7 17.3 16.2 17.3 26.8 11.8 19.1 21.9 13.5 16.0 17.1 20.8 16.3 14.4 15.7 13.5 15.8 15.3 18.8 20.8 27.5 18.2 21.4 23.8 14.1 18.6 23.7 13.4 17.3 18.0 35.5 55.3 17.7 16.5 23.6 18.1 17.5 14.4 31.4 21.3 20.6 30.0 16.4 13.4 17.9 16.3 10.0 9.5 27.3 8.5 11.8 10.7 5.4 9.9 7.8 15.9 8.9 13.8 12.9 17.7 11.3 11.3 12.8 13.3 7.6 13.0 14.6 7.9 14.5 9.0 15.0 12.7 11.2 10.0 14.9 7.5 13.3 14.0 10.1 15.5 20.1 12.9 14.3 10.6 13.9 17.2 14.1 7.9 14.5 13.8 18.3 18.5 6.6 10.3 11.6 17.4 6.8 9.6 11.3 30.8 16.7 10.6 17.2 10.2 22.2 29.0 15.1 21.1 15.7 18.9 14.4 10.8 11.4 13.0 14.7 12.7 16.2 10.6 18.3 9.5 12.0 10.0 15.3 8.1 27.3 6.0 7.5 7.9 10.0 6.5 6.2 8.5 8.0 10.7 7.6 13.7 11.8 8.5 9.5 7.6 5.4 17.2 19.6 33.7 21.7 16.3 14.4 18.8 20.8 18.6 21.3 35.7 41.5 10.2 9.5 12.9 43.2 61.3 28.1 25.4 29.6 14.0 33.4 21.6 18.3 8.4 51.5 15.5 17.7 0.0 13.4 12.4 17.2 13.2 18.5 18.7 17.5 22.3 32.8 20.9 20.2 93.2 20.8 21.1 21.9 17.2 17.5 25.7 9.1 16.7 25.5 19.9 49.5 0.0 20.2 56.9 31.5 14.8 21.3 17.5 16.9 7.6 RDH13 SDR7C3 ENSG00000160439 "Retinol dehydrogenase 13" Q8NBN7 19 55039108-55071291 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Syncytiotrophoblasts: 175.4;Urothelial cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042006 Approved Supported Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA042006: AB_10960270" "unprognostic (9.26e-2)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.15e-2)" "unprognostic (8.74e-2)" "unprognostic (1.08e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-1)" "unprognostic (9.42e-3)" "unprognostic (1.61e-1)" "unprognostic (2.45e-3)" "prognostic favorable (2.09e-4)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.12e-2)" "unprognostic (1.66e-3)" 4.4 6.8 4.0 6.0 6.6 5.5 4.2 8.7 9.4 7.5 8.3 3.5 9.0 5.1 5.0 5.0 17.6 4.2 7.1 11.4 3.0 5.4 8.8 7.5 5.6 5.1 4.7 5.2 3.8 10.7 8.8 6.1 34.0 10.0 5.7 4.0 6.4 11.6 13.1 9.4 18.0 6.9 5.2 2.2 6.8 9.5 4.4 3.0 2.1 7.2 8.6 8.9 8.5 10.2 7.4 6.0 5.4 6.7 6.1 8.5 3.5 3.1 3.6 0.6 1.9 0.4 0.4 5.8 2.9 0.3 2.1 1.5 5.4 3.6 1.8 2.4 0.7 0.4 3.2 3.8 2.3 0.2 1.6 10.1 2.0 4.7 3.7 0.9 4.8 1.4 1.3 0.9 1.9 1.4 0.7 2.8 1.6 4.0 1.0 0.7 5.2 0.8 3.1 0.8 6.9 4.7 2.5 1.0 10.0 1.3 5.5 2.2 2.7 2.8 8.0 3.6 0.6 3.9 4.7 2.9 0.3 1.1 0.2 3.9 2.0 3.6 2.2 1.5 3.4 2.0 4.1 4.1 5.4 8.5 6.7 7.7 6.1 7.0 7.7 4.5 7.4 8.4 6.8 2.6 6.1 5.9 6.0 5.7 3.5 4.0 6.6 8.7 9.4 3.0 5.4 4.7 5.2 10.0 3.0 14.9 16.2 5.1 19.9 9.5 17.3 22.2 28.1 6.7 11.4 14.0 39.3 30.2 10.0 12.3 18.5 6.5 27.1 0.0 5.7 26.9 6.0 23.1 8.1 6.0 9.9 23.8 11.5 16.5 4.1 11.2 3.4 5.0 6.8 1.8 19.8 10.0 11.4 26.2 3.2 3.4 27.0 6.5 5.1 1.4 9.6 15.3 175.4 8.7 21.9 72.9 RDH14 "PAN2, SDR7C4" ENSG00000240857 "Retinol dehydrogenase 14" Q9HBH5 2 18554723-18560680 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056686, HPA078577" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056686: AB_2683209, HPA078577: " "unprognostic (5.79e-2)" "unprognostic (3.96e-2)" "unprognostic (1.64e-1)" "unprognostic (7.03e-2)" "unprognostic (1.99e-2)" "unprognostic (8.71e-3)" "unprognostic (1.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (8.98e-2)" "unprognostic (1.58e-2)" "unprognostic (4.32e-2)" "unprognostic (3.69e-2)" 13.8 16.2 10.7 8.7 14.3 5.1 14.0 14.2 15.4 11.3 14.1 11.0 9.6 12.7 16.2 14.3 16.0 12.7 11.0 29.0 12.2 10.4 23.0 22.1 12.5 14.6 11.7 9.0 11.7 21.0 23.5 13.5 14.2 13.2 20.7 12.0 10.6 13.8 13.1 27.8 9.9 16.3 22.9 10.3 15.4 15.9 11.1 8.8 17.4 18.1 13.6 10.7 18.1 17.9 9.9 7.6 7.2 2.0 3.7 7.6 1.6 18.6 5.9 5.0 4.1 15.1 16.1 16.8 11.4 11.7 10.3 10.3 4.6 9.7 18.4 6.8 6.8 13.4 10.2 7.2 13.3 12.1 10.2 19.8 7.2 6.5 13.8 12.9 8.7 9.8 12.2 13.6 10.0 15.7 14.5 9.5 7.5 12.8 6.3 16.9 6.0 7.5 15.4 13.5 14.3 16.9 11.0 13.6 7.9 20.2 12.2 7.7 13.4 6.2 13.7 16.2 10.9 6.8 5.0 9.5 14.7 9.1 11.6 13.5 17.9 14.7 13.7 10.5 6.0 11.5 1.7 1.8 7.2 4.4 2.0 7.6 7.4 5.1 6.3 2.3 9.9 7.3 6.0 0.8 3.7 1.9 7.6 5.8 1.6 10.7 14.3 14.2 15.4 12.2 10.4 11.7 9.0 13.2 8.8 14.9 10.9 21.4 26.0 21.8 22.4 43.0 22.9 2.7 6.8 15.7 5.9 40.0 26.6 32.8 16.1 17.9 14.0 0.0 30.8 42.8 33.7 31.0 12.7 26.8 21.0 14.3 12.7 17.2 15.1 9.4 61.9 14.8 21.9 22.6 27.1 25.0 23.9 32.3 42.1 30.5 18.0 32.3 30.7 71.9 28.2 16.3 38.2 17.5 29.8 23.7 RDH8 "PRRDH, SDR28C2" ENSG00000080511 "Retinol dehydrogenase 8 (all-trans)" 19 10013249-10022279 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 29.4" "Cell type enhanced" "Detected in some" 28 "Bipolar cells: 33.9;Cone photoreceptor cells: 51.1;Early spermatids: 58.4;Rod photoreceptor cells: 203.6" "Group enriched" "Detected in some" 8 "melanoma: 2.2;stomach cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.9;SK-MEL-30: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA064473 Approved "Nucleoplasm,Midbody ring,Cytosol" NA NA Nucleoplasm "Midbody ring, Cytosol" "HPA064473: " "unprognostic (4.12e-1)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (9.98e-3)" "unprognostic (4.58e-3)" "unprognostic (2.66e-1)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (3.86e-1)" "unprognostic (2.63e-1)" 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.9 0.8 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 0.3 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.4 0.0 203.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 RDM1 "MGC33977, RAD52B" ENSG00000278023 "RAD52 motif containing 1" Q8NG50 17 35918066-35930773 "Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;lymphoid tissue: 6.2;testis: 24.0" "Group enriched" "Detected in some" 16 "Early spermatids: 50.7;Late spermatids: 58.2;Spermatocytes: 19.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 5.7" "Group enriched" "Detected in many" 14 "NK-cells: 1.5;T-cells: 5.7" "Cell line enhanced" "Detected in many" "CACO-2: 10.2;JURKAT: 14.1;T-47d: 16.7" "Low region specificity" "Detected in all" "HPA024794, HPA067546" Enhanced Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024794: AB_1856039, HPA067546: AB_2732769" "unprognostic (9.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.00e-2)" "unprognostic (4.57e-3)" "unprognostic (1.91e-2)" "unprognostic (1.26e-1)" "unprognostic (2.06e-4)" "unprognostic (5.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.71e-2)" "unprognostic (2.58e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-8)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (7.00e-3)" "unprognostic (1.53e-1)" 0.0 0.0 0.9 0.9 1.2 0.6 0.0 0.0 1.8 0.0 0.9 0.1 0.0 1.3 0.2 0.7 0.3 0.1 0.3 0.0 1.0 0.1 0.0 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.2 0.2 1.7 0.0 0.0 0.0 0.0 1.1 1.5 0.1 0.2 0.1 1.1 24.0 0.0 6.2 0.3 0.0 2.8 0.0 0.0 0.1 0.2 0.0 0.0 1.5 5.7 0.3 5.7 6.8 1.3 2.4 0.1 0.0 2.1 1.4 0.1 0.8 1.3 10.2 5.7 6.3 2.8 0.4 3.8 0.9 3.9 1.7 3.9 1.5 8.0 4.1 1.8 0.0 0.0 0.2 2.9 0.0 0.7 0.5 0.4 1.0 0.1 14.1 1.8 0.0 0.5 2.3 2.2 2.2 0.9 5.0 2.5 0.7 0.0 0.0 1.5 3.3 4.6 0.8 1.8 1.7 2.5 3.7 16.7 0.3 0.0 0.1 2.0 0.0 0.4 5.3 1.9 2.2 3.3 2.3 1.0 0.0 0.0 0.0 1.4 0.0 2.3 0.1 1.6 5.7 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 50.7 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.0 0.4 1.4 0.0 1.2 0.6 0.0 58.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 19.7 2.6 0.0 0.6 0.0 0.6 0.3 RECQL5 "FLJ90603, RecQ5" ENSG00000108469 "RecQ like helicase 5" O94762 17 75626845-75667189 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, DNA replication" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029971 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029971: AB_10611389" "unprognostic (2.19e-1)" "unprognostic (6.16e-3)" "unprognostic (2.26e-2)" "prognostic unfavorable (1.73e-6)" "unprognostic (8.39e-2)" "unprognostic (2.34e-2)" "unprognostic (3.57e-3)" "unprognostic (5.83e-2)" "unprognostic (3.15e-1)" "unprognostic (5.84e-2)" "prognostic favorable (4.34e-4)" "unprognostic (4.07e-2)" "unprognostic (7.01e-2)" "unprognostic (6.37e-2)" "unprognostic (1.42e-1)" "unprognostic (4.78e-1)" "unprognostic (1.81e-2)" 7.4 12.9 12.6 11.7 16.0 10.0 9.8 11.4 17.7 9.4 10.6 24.4 17.4 22.9 10.5 13.2 20.4 11.8 12.4 6.7 12.9 8.6 14.9 15.8 8.4 16.8 14.5 11.0 14.3 10.8 17.6 21.9 32.3 14.3 12.2 9.8 13.2 15.6 14.0 6.8 21.1 23.2 9.6 13.2 16.6 23.8 21.0 17.0 12.1 21.4 6.2 16.0 12.1 12.8 5.2 16.4 6.0 3.9 3.8 4.2 3.2 11.2 20.9 8.5 12.0 11.8 7.9 19.6 8.3 7.0 10.9 9.7 9.2 12.0 13.4 9.1 7.3 14.5 10.8 8.8 10.0 10.4 7.2 16.4 24.4 25.3 13.2 11.9 7.9 12.2 11.2 12.3 10.8 13.1 12.5 14.2 14.9 12.3 11.9 8.0 10.0 16.1 10.7 5.5 10.8 16.2 13.1 19.8 13.5 9.2 13.4 10.2 9.9 9.1 16.4 11.2 12.2 29.5 6.3 7.2 14.1 16.2 7.7 8.6 17.0 9.7 12.9 11.6 7.9 10.1 6.0 3.1 4.4 4.2 3.9 2.7 3.6 2.7 3.1 3.8 5.2 4.1 2.9 2.1 3.8 1.9 16.4 2.2 3.2 12.6 16.0 11.4 17.7 12.9 8.6 14.5 11.0 14.3 17.0 0.0 9.9 5.4 2.9 0.9 7.9 6.1 5.1 14.7 2.3 26.2 17.7 6.8 5.0 4.6 3.7 3.6 11.1 0.0 2.9 4.2 3.1 2.9 1.1 6.0 4.4 9.5 4.6 8.0 5.9 1.5 3.7 3.9 3.3 1.8 8.5 7.4 5.3 8.2 2.5 3.7 12.8 0.0 1.0 10.9 10.5 1.8 9.7 4.4 6.3 8.9 REEP2 "C5orf19, SGC32445, SPG72, Yip2d" ENSG00000132563 "Receptor accessory protein 2" Q9BRK0 5 138439017-138446969 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.9" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 50.6;Cone photoreceptor cells: 66.8;Horizontal cells: 46.1;Rod photoreceptor cells: 59.8" "Cancer enriched" "Detected in many" 9 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 21 "dendritic cells: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "AN3-CA: 41.9;SCLC-21H: 17.6;SH-SY5Y: 19.8;U-87 MG: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031813, HPA076571" Enhanced Approved Cytosol NA NA Cytosol "HPA031813: AB_2674054, HPA076571: " "prognostic favorable (7.83e-5)" "unprognostic (1.11e-2)" "unprognostic (3.97e-6)" "unprognostic (3.70e-3)" "prognostic unfavorable (6.65e-4)" "unprognostic (5.43e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-1)" "prognostic favorable (9.31e-4)" "unprognostic (5.93e-2)" "unprognostic (3.70e-3)" "unprognostic (9.78e-2)" "unprognostic (6.54e-3)" "unprognostic (7.54e-2)" "unprognostic (1.47e-3)" "unprognostic (6.19e-3)" "unprognostic (1.13e-3)" 5.2 10.9 27.2 3.4 27.2 1.2 2.0 37.0 58.9 3.0 4.4 5.9 0.4 2.8 3.7 2.6 5.6 2.8 3.6 10.5 29.3 32.1 1.6 1.0 1.5 1.4 27.9 19.6 3.5 2.9 2.8 13.9 1.6 25.8 6.1 3.3 7.9 2.1 9.9 15.6 2.0 3.1 13.6 9.7 1.2 2.2 4.5 6.3 0.0 1.4 0.5 1.5 4.1 1.1 0.0 1.0 0.0 0.0 0.0 3.2 0.3 0.2 3.1 12.0 41.9 1.8 4.7 0.0 3.6 1.7 4.9 5.7 2.2 0.4 0.0 0.6 4.4 0.1 0.2 11.4 2.3 3.8 1.2 10.1 0.0 0.8 5.4 4.4 0.0 0.0 1.5 0.1 2.8 0.2 8.9 1.0 11.7 0.0 3.0 1.6 1.8 1.0 0.7 7.4 0.0 0.1 4.0 1.1 0.0 0.9 0.0 17.6 19.8 1.2 0.0 3.0 3.2 1.1 0.4 0.1 2.8 2.9 2.7 6.7 7.8 4.9 0.3 15.8 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 3.2 0.3 27.2 27.2 37.0 35.6 29.3 32.1 27.9 19.6 25.8 6.3 0.0 0.0 0.0 0.8 0.6 50.6 8.7 0.0 0.0 0.0 1.8 66.8 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.1 46.1 4.6 0.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 16.1 0.1 0.0 2.5 0.2 59.8 0.0 3.4 0.4 3.0 0.4 0.0 0.0 0.0 0.1 REEP4 "C8orf20, FLJ22246, FLJ22277, PP432, Yip2c" ENSG00000168476 "Receptor accessory protein 4" Q9H6H4 8 22138020-22141951 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 93.5;Syncytiotrophoblasts: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042683 Approved Approved Cytosol No Yes Cytosol "HPA042683: AB_2571730" "unprognostic (2.38e-1)" "unprognostic (9.96e-3)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (3.41e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (4.14e-5)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (7.15e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.88e-5)" "unprognostic (5.72e-2)" "unprognostic (1.06e-1)" "unprognostic (2.25e-1)" "unprognostic (6.65e-2)" 6.3 4.3 3.9 9.2 6.2 18.1 22.9 2.3 4.3 12.8 11.9 6.9 4.0 8.4 5.6 5.4 39.8 5.5 11.1 4.5 3.4 2.9 5.2 6.4 18.0 16.5 7.2 2.5 4.9 11.0 3.2 5.6 35.8 5.7 9.2 8.8 4.5 11.0 6.0 3.0 43.1 8.6 5.2 7.5 19.9 12.3 19.1 6.8 14.5 10.8 20.4 24.9 12.4 20.8 4.4 17.7 25.9 23.6 9.8 10.9 10.2 12.3 25.7 8.3 13.0 3.6 3.6 14.7 11.1 6.3 14.6 13.3 14.8 12.6 15.1 14.6 6.1 12.9 32.0 9.9 19.2 7.5 8.4 11.3 16.2 13.6 15.1 3.9 7.4 25.1 3.3 37.1 11.1 9.4 4.7 8.9 18.4 12.7 52.8 7.5 19.0 19.1 26.9 12.0 18.9 16.1 10.8 6.9 30.9 6.6 13.3 6.7 12.3 9.0 10.5 16.0 5.8 20.8 11.3 9.1 9.7 15.8 21.6 15.6 12.1 9.1 9.9 10.9 16.8 19.2 17.7 23.6 25.9 10.9 23.0 8.5 4.4 9.6 9.1 17.7 2.2 4.5 5.9 6.8 9.8 15.3 6.9 6.1 10.2 3.9 6.2 2.3 4.3 3.4 2.9 7.2 2.5 5.7 6.8 3.0 8.6 6.7 15.8 24.8 5.4 1.4 7.6 2.7 5.7 12.2 2.0 42.2 0.0 21.3 7.0 6.7 17.0 93.5 13.4 42.8 9.8 4.1 10.3 4.9 49.9 0.0 16.7 13.5 40.7 7.4 8.3 23.4 3.3 11.8 28.1 2.1 18.6 28.6 7.8 1.8 1.6 12.9 10.3 28.2 16.8 34.4 78.7 13.1 29.0 18.3 REG3A "HIP, PAP, PAP1, PBCGF, REG-III, REG3" ENSG00000172016 "Regenerating family member 3 alpha" Q06141 2 79157003-79159753 "Plasma proteins, Predicted secreted proteins, Transporters" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "intestine: 354.2;pancreas: 502.4" "Cell type enriched" "Detected in some" 5 "Pancreatic endocrine cells: 8841.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 710.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 12.4;EFO-21: 11.8;HDLM-2: 10.9;NB-4: 12.2;RPMI-8226: 15.7;SH-SY5Y: 10.2;U-2 OS: 19.4;U-251 MG: 7.2;U-266/84: 10.2" "HPA047894, HPA048334, HPA060705" Supported Approved Cytosol "Secreted to digestive system" NA NA 22000000 Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (2.43e-2)" "unprognostic (2.12e-1)" "unprognostic (3.62e-2)" "unprognostic (1.42e-1)" 0.2 0.4 0.2 0.4 0.2 0.0 0.2 0.2 0.2 0.2 73.1 0.2 0.2 276.3 0.2 0.2 0.2 0.0 1.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 502.4 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 354.2 0.2 0.2 0.2 6.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.1 0.2 0.0 0.0 0.0 15.7 0.0 0.0 1.2 10.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.4 3.8 7.2 0.0 10.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.8 4.3 0.0 5.2 0.0 1666.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 97.4 19.1 0.0 8841.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 REG3G "LPPM429, PAP1B, UNQ429" ENSG00000143954 "Regenerating family member 3 gamma" Q6UW15 2 79025686-79028505 "Predicted secreted proteins" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 262.6" "Group enriched" "Detected in some" 25 "Exocrine glandular cells: 161.0;Pancreatic endocrine cells: 87.4" "Cancer enriched" "Detected in many" 13 "pancreatic cancer: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.0;RPMI-8226: 1.0;SK-MEL-30: 3.1;U-2 OS: 1.6;U-266/84: 1.3" "HPA047894, HPA048334, HPA060705" Uncertain Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (3.29e-1)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (8.82e-2)" "unprognostic (7.20e-3)" "unprognostic (5.64e-2)" 0.1 3.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.8 0.6 0.1 61.1 0.1 0.0 0.1 0.1 0.1 0.0 7.1 0.1 0.1 0.1 0.1 0.1 0.1 262.6 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 2.8 0.3 0.1 0.1 0.0 19.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 1.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 161.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.6 0.0 0.0 1.0 0.0 0.0 87.4 0.0 0.7 2.4 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 RELA "NFKB3, p65" ENSG00000173039 "RELA proto-oncogene, NF-kB subunit" Q04206 11 65653596-65663094 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004264, CAB005030, HPA063461" Supported Enhanced Cytosol NA NA Cytosol "CAB004264: AB_628017, CAB005030: AB_562171, HPA063461: AB_2685016" "unprognostic (9.17e-2)" "unprognostic (1.79e-1)" "unprognostic (2.04e-1)" "unprognostic (3.22e-1)" "unprognostic (7.67e-2)" "unprognostic (5.39e-2)" "prognostic unfavorable (9.18e-4)" "unprognostic (1.30e-3)" "unprognostic (1.69e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (5.66e-4)" "unprognostic (2.78e-1)" "unprognostic (1.46e-1)" "unprognostic (9.81e-2)" "unprognostic (2.53e-1)" 36.2 23.1 21.4 27.6 32.0 50.2 37.8 21.5 28.2 35.6 32.3 22.9 23.6 23.6 36.9 26.8 36.4 32.8 33.6 28.9 21.1 12.9 28.4 38.5 37.7 30.8 35.6 13.3 51.9 29.0 27.3 19.3 27.1 22.6 31.1 19.7 23.9 32.8 39.2 46.5 35.2 26.7 33.5 29.5 38.1 31.8 20.6 30.1 34.3 26.3 30.6 36.4 54.7 38.8 15.2 13.2 18.3 14.4 21.3 23.3 12.4 26.2 27.0 12.1 16.8 19.3 18.8 12.2 20.2 24.5 23.3 18.9 12.3 26.7 19.9 33.9 28.3 27.4 23.5 13.8 24.5 16.5 23.4 19.9 21.8 20.2 17.8 21.2 16.2 31.0 21.6 24.2 25.9 30.7 22.7 28.2 15.9 21.9 23.1 18.7 35.0 29.3 13.6 7.9 16.0 23.8 24.5 11.8 29.7 19.5 23.8 9.9 22.9 17.2 27.1 26.9 9.6 31.5 10.6 38.4 25.2 21.6 38.5 19.1 35.2 32.3 21.2 28.5 11.1 24.0 10.5 11.3 15.1 20.5 14.4 23.3 15.2 18.2 20.4 13.2 13.7 17.3 18.2 18.3 21.3 12.5 13.1 17.8 12.4 21.4 32.0 21.5 28.2 21.1 12.9 35.6 13.3 22.6 30.1 29.8 26.7 18.2 42.0 42.0 8.6 20.2 15.3 14.7 21.6 10.4 7.9 20.6 24.9 37.4 3.6 38.3 20.1 0.0 39.0 20.1 24.9 50.9 42.8 17.9 21.7 14.3 18.9 33.2 23.4 5.6 26.7 20.1 30.4 41.5 22.3 13.7 49.8 20.1 24.8 13.7 9.0 12.9 37.1 9.9 17.9 37.8 36.5 29.6 19.6 63.8 RELB REL-B ENSG00000104856 "RELB proto-oncogene, NF-kB subunit" Q01201 19 45001430-45038198 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 90.3;Glandular cells: 104.0;monocytes: 170.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 14.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 25.4;HDLM-2: 32.4;U-698: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB007753, HPA040506" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB007753: AB_562340, HPA040506: AB_2677011" "prognostic favorable (1.55e-4)" "unprognostic (1.20e-1)" "unprognostic (7.13e-2)" "unprognostic (5.52e-2)" "unprognostic (1.12e-2)" "unprognostic (3.41e-2)" "unprognostic (1.71e-2)" "unprognostic (4.30e-2)" "unprognostic (5.81e-3)" "unprognostic (1.02e-3)" "unprognostic (6.01e-2)" "unprognostic (6.48e-2)" "prognostic unfavorable (2.99e-6)" "unprognostic (2.68e-2)" "unprognostic (4.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.20e-2)" 8.0 6.8 2.2 27.6 3.6 27.8 6.8 1.2 3.1 4.9 12.2 2.1 1.6 8.8 8.5 4.7 6.4 5.2 10.9 11.9 1.8 1.6 10.1 7.4 12.8 18.2 3.6 0.9 7.8 12.3 1.9 2.1 4.7 2.8 9.9 3.4 3.6 7.3 4.8 8.1 8.3 13.0 8.4 3.9 17.2 8.3 3.7 1.7 17.7 5.6 7.2 24.8 8.8 6.1 8.2 3.9 14.5 5.0 2.1 2.2 1.7 8.9 5.3 0.5 2.4 1.2 4.0 1.9 1.6 11.6 2.5 4.1 1.8 9.9 25.4 4.7 2.6 8.9 4.1 0.2 3.7 2.2 32.4 0.8 0.9 0.3 1.0 10.4 1.9 15.1 6.5 1.5 5.2 6.1 2.3 1.6 0.7 0.2 16.5 0.9 2.1 0.4 6.0 0.8 2.5 1.0 1.9 1.3 3.0 4.2 13.9 0.0 0.8 1.7 4.8 4.6 0.6 1.7 4.9 5.2 6.1 3.0 2.2 5.9 21.0 12.4 27.3 6.7 0.7 3.4 0.0 5.0 2.1 1.4 3.2 2.1 8.2 2.2 2.0 3.6 7.9 1.8 0.9 14.5 2.1 2.6 3.9 1.1 1.7 2.2 3.6 1.2 3.1 1.8 1.6 3.6 0.9 2.8 1.7 6.0 14.3 26.4 90.3 33.7 0.0 1.7 12.7 1.4 11.4 3.5 0.0 3.5 8.3 30.3 5.1 11.3 45.5 0.0 27.0 5.8 13.4 104.0 51.7 3.4 17.6 3.2 21.9 6.7 13.3 2.4 4.4 25.4 23.6 170.5 12.4 0.6 29.3 80.7 2.5 14.3 0.2 6.5 41.2 0.5 1.2 27.9 8.2 7.5 8.1 75.4 REPS1 ENSG00000135597 "RALBP1 associated Eps domain containing 1" Q96D71 6 138903493-138988261 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029961, HPA029962" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "HPA029961: AB_10603233, HPA029962: AB_2673269" "unprognostic (1.72e-3)" "unprognostic (9.61e-2)" "unprognostic (5.82e-3)" "unprognostic (2.77e-2)" "unprognostic (6.30e-3)" "unprognostic (1.90e-1)" "prognostic unfavorable (9.47e-4)" "unprognostic (3.79e-1)" "unprognostic (2.49e-1)" "unprognostic (9.71e-3)" "unprognostic (4.29e-3)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.27e-1)" "unprognostic (3.83e-2)" "unprognostic (2.69e-2)" 9.5 9.4 18.9 11.5 22.0 15.5 18.4 25.9 25.5 12.9 12.9 14.8 15.3 11.7 17.5 32.5 20.9 14.6 14.0 17.7 17.7 17.6 12.1 23.1 11.5 13.3 15.1 19.4 17.0 13.9 32.8 28.3 14.0 20.0 13.6 13.7 13.6 21.6 13.4 12.1 22.6 12.2 16.3 10.8 15.8 12.4 27.7 11.7 30.7 13.9 13.5 18.4 14.7 14.3 4.6 6.2 8.0 7.5 5.2 6.9 2.0 12.8 10.1 19.4 24.2 11.0 19.7 21.2 12.5 13.8 14.7 17.8 24.0 11.2 15.5 10.6 17.4 17.5 15.1 22.0 18.9 19.6 16.5 19.0 13.1 6.1 14.5 16.6 41.2 21.2 16.0 15.5 26.9 32.7 14.0 15.1 23.1 17.4 16.0 18.8 21.7 23.3 22.6 18.5 16.5 9.7 27.4 11.9 8.8 12.1 19.5 17.4 17.2 11.5 17.7 16.5 29.9 8.4 28.5 14.7 8.2 13.7 22.2 17.1 15.8 14.3 21.8 9.8 17.0 12.0 8.0 2.3 3.2 4.2 6.5 6.9 4.6 5.4 5.8 3.4 3.4 5.5 6.5 1.5 5.2 7.5 6.2 5.4 2.0 18.9 22.0 25.9 25.5 17.7 17.6 15.1 19.4 20.0 11.7 17.9 6.1 13.7 10.2 11.8 11.3 25.0 12.7 17.4 13.6 5.2 15.7 22.4 6.6 7.0 9.2 9.3 8.3 0.0 6.1 24.3 8.0 9.3 16.1 34.5 11.5 12.7 5.8 17.2 21.9 5.1 6.6 11.5 5.0 3.6 14.7 32.3 7.5 10.5 8.1 6.9 14.7 19.4 7.6 35.6 32.8 13.0 23.9 20.0 14.5 15.4 RERG MGC15754 ENSG00000134533 "RAS like estrogen regulated growth inhibitor" Q96A58 12 15107783-15348675 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 73.6" "Cell type enhanced" "Detected in many" 10 "Sertoli cells: 90.5;Smooth muscle cells: 84.3" "Cancer enhanced" "Detected in all" "breast cancer: 19.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "AN3-CA: 8.2;BEWO: 18.8;T-47d: 36.0;U-2 OS: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041387 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA041387: AB_10796669" "unprognostic (5.33e-2)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "prognostic unfavorable (7.56e-4)" "unprognostic (8.72e-2)" "unprognostic (9.42e-3)" "unprognostic (2.47e-1)" "unprognostic (2.38e-2)" "unprognostic (1.85e-3)" "unprognostic (2.76e-2)" "unprognostic (5.07e-2)" "unprognostic (2.69e-1)" "unprognostic (7.16e-3)" "unprognostic (2.61e-3)" "unprognostic (3.30e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" 12.6 21.9 3.5 8.2 23.9 0.2 22.8 0.8 9.3 31.9 14.5 0.8 24.6 2.0 73.6 43.2 7.3 29.0 6.7 6.0 4.2 4.8 19.5 1.3 7.8 2.0 4.3 4.1 23.6 5.1 0.9 0.9 15.4 17.6 12.6 4.6 2.9 6.0 38.9 3.5 4.2 7.4 40.3 2.3 15.2 9.8 11.7 3.5 0.0 2.6 2.8 1.8 15.7 10.6 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.1 8.2 3.4 0.2 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 0.0 3.3 0.0 2.6 0.0 1.1 0.4 0.5 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.7 0.3 0.1 0.1 0.9 0.0 0.5 0.0 0.0 0.1 3.2 0.1 0.0 1.2 1.3 1.4 0.0 0.6 36.0 0.0 0.0 0.5 12.1 0.2 0.1 0.1 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 23.9 0.8 9.3 4.2 4.8 4.3 4.1 17.6 3.5 0.0 2.1 0.0 7.7 3.4 1.0 0.7 5.1 0.0 5.7 7.0 0.0 10.8 13.3 6.3 15.0 2.2 0.0 0.0 9.0 11.7 23.8 2.4 0.0 0.0 1.8 3.2 1.7 1.8 0.0 13.1 20.4 2.3 6.8 0.0 0.0 6.0 1.6 0.0 30.1 20.9 0.6 90.5 84.3 7.9 14.5 4.8 11.7 0.0 0.0 4.2 REST "NRSF, XBR" ENSG00000084093 "RE1 silencing transcription factor" Q13127 4 56907876-56966678 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006079, CAB068222" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB068222: AB_2665651, HPA006079: AB_1079801" "unprognostic (7.49e-3)" "unprognostic (3.36e-2)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (1.39e-1)" "unprognostic (7.47e-3)" "unprognostic (2.30e-1)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.32e-3)" "unprognostic (1.73e-1)" "prognostic favorable (9.50e-5)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" 14.4 11.4 6.0 15.6 8.9 21.5 39.7 2.1 6.3 13.7 11.0 5.6 13.0 6.5 14.2 13.7 14.5 11.2 13.8 22.1 6.1 4.5 13.9 12.0 18.2 35.6 8.2 3.0 13.9 15.9 22.4 4.5 14.4 11.8 17.3 7.6 7.2 14.0 27.6 13.8 11.6 12.0 16.3 15.2 18.7 10.4 15.3 8.2 43.4 13.4 8.3 14.0 15.6 19.5 16.7 10.7 9.0 8.4 16.7 15.3 4.2 7.1 9.0 12.6 12.4 9.5 11.9 15.9 10.6 9.5 11.3 10.3 9.0 11.0 16.9 17.0 11.5 7.5 6.5 9.2 11.2 17.9 8.9 5.5 15.4 7.2 7.9 11.5 19.5 9.3 11.8 10.0 10.9 11.2 14.2 14.0 12.6 9.9 18.2 13.1 11.3 22.4 13.3 10.6 8.0 5.9 19.9 10.8 5.3 12.8 12.8 0.2 5.7 12.8 12.5 9.5 18.1 13.3 12.7 19.7 14.5 12.9 8.1 9.5 7.3 5.4 10.3 9.3 11.1 7.4 9.0 3.6 7.7 10.6 5.3 8.9 12.0 10.5 10.4 8.1 16.7 15.3 9.3 3.7 16.7 8.4 10.7 10.3 4.2 6.0 8.9 2.1 6.3 6.1 4.5 8.2 3.0 11.8 8.2 65.5 53.4 33.5 45.2 50.7 0.7 41.7 45.9 45.5 45.5 27.9 76.6 44.5 19.9 50.7 6.8 41.7 19.2 23.3 33.6 47.5 36.3 41.5 50.7 27.6 29.0 0.0 3.5 39.9 29.8 7.6 36.5 34.3 20.3 92.8 21.2 48.8 37.7 26.8 34.6 18.5 36.6 32.3 40.1 56.1 40.7 40.0 55.5 57.1 21.8 42.5 RET "CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51" ENSG00000165731 "Ret proto-oncogene" P07949 10 43077027-43130351 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 63.9" "Cell type enriched" "Detected in some" 44 "Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "breast cancer: 11.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.7" "Group enriched" "Detected in many" 13 "dendritic cells: 2.1;monocytes: 6.7" "Cell line enhanced" "Detected in some" "MCF7: 18.0;NB-4: 11.8;SH-SY5Y: 91.8;THP-1: 27.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "midbrain: 95.5" "CAB002581, HPA008356, HPA008495" Approved Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" No NA 260000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: " "unprognostic (7.94e-2)" "unprognostic (3.68e-2)" "unprognostic (4.49e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (9.13e-4)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (2.86e-1)" "unprognostic (2.01e-1)" "unprognostic (1.54e-3)" "unprognostic (4.43e-1)" "unprognostic (9.35e-5)" "unprognostic (1.64e-3)" "unprognostic (8.28e-2)" "unprognostic (3.67e-3)" "unprognostic (2.02e-2)" 1.8 15.2 1.1 1.8 1.3 0.7 1.2 4.1 9.0 1.9 3.1 0.9 1.1 1.5 0.9 0.6 1.2 0.7 1.0 1.2 1.5 5.8 1.0 11.7 0.7 0.8 17.5 1.2 0.8 1.3 63.9 6.3 0.8 16.8 2.2 1.5 2.8 13.6 2.0 4.5 1.1 2.6 1.1 2.8 0.6 2.1 2.0 0.0 0.1 0.8 5.1 0.6 1.9 1.4 0.2 2.1 0.0 6.7 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 11.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 91.8 0.0 0.0 0.0 0.1 1.3 27.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 6.7 2.1 0.3 0.4 1.1 1.3 4.1 9.0 1.5 5.8 17.5 1.2 16.8 0.0 0.0 0.3 0.0 0.5 0.2 0.1 1.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 1.7 1.0 1.2 1.1 0.8 0.1 74.7 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.4 1.1 0.5 0.0 0.0 0.0 0.1 RETREG2 "C2orf17, FAM134A, MAG-2, MGC3035" ENSG00000144567 "Reticulophagy regulator family member 2" Q8NC44 2 219176225-219185479 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 43.6;Ductal cells: 36.6;Exocrine glandular cells: 41.9;Extravillous trophoblasts: 32.2;Hofbauer cells: 31.4;Pancreatic endocrine cells: 35.3;Proximal tubular cells: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011170, HPA011844" Approved Approved Cytosol NA NA Cytosol "HPA011170: AB_1845713, HPA011844: AB_2668544" "unprognostic (2.63e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (7.95e-4)" "unprognostic (1.03e-1)" "unprognostic (2.88e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (1.49e-4)" "unprognostic (8.74e-2)" "unprognostic (9.61e-2)" "unprognostic (1.34e-2)" "unprognostic (4.37e-2)" "unprognostic (2.36e-1)" "unprognostic (4.29e-3)" "unprognostic (4.45e-2)" "unprognostic (4.47e-2)" "unprognostic (1.53e-2)" "unprognostic (3.70e-2)" 14.8 22.4 27.8 14.8 34.2 23.8 22.3 38.5 56.9 20.9 20.0 24.1 20.0 18.6 19.9 28.8 18.7 23.8 18.9 10.8 28.2 28.7 31.2 24.0 17.4 18.1 26.6 35.7 32.7 29.5 38.0 20.2 16.6 26.7 18.4 23.5 20.0 20.7 19.1 10.6 19.5 18.1 20.7 21.5 17.4 17.6 61.4 16.5 15.1 28.0 12.8 19.7 18.6 24.7 6.8 5.8 21.1 7.3 4.2 8.7 2.9 12.5 13.4 11.6 17.5 44.0 18.7 12.3 15.4 26.7 18.8 16.4 13.4 21.7 10.3 15.5 29.0 38.7 16.3 13.9 13.8 20.8 14.4 11.6 13.7 18.6 22.1 25.3 14.8 19.0 20.2 36.2 21.1 20.4 32.5 16.9 11.2 9.4 23.8 26.0 18.5 8.9 16.1 8.5 16.1 15.7 11.4 12.8 8.3 15.5 14.8 16.6 17.1 9.9 19.2 36.4 18.9 16.0 16.5 13.3 21.1 11.4 29.8 11.5 24.1 13.7 11.6 22.1 14.8 11.6 8.5 5.7 5.3 8.5 7.3 7.8 6.8 7.0 8.7 3.8 5.8 6.4 8.1 21.1 4.2 6.6 5.8 8.1 2.9 27.8 34.2 38.5 56.9 28.2 28.7 26.6 35.7 26.7 16.5 14.9 13.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 11.4 43.6 0.0 25.1 18.3 36.6 0.0 0.0 0.0 0.0 41.9 32.2 0.0 0.0 4.7 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 19.8 0.0 0.0 35.3 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 0.0 RETREG3 "DKFZp686B1036, FAM134C, FLJ33806" ENSG00000141699 "Reticulophagy regulator family member 3" Q86VR2 17 42579513-42610623 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 28.0;Collecting duct cells: 29.6;Exocrine glandular cells: 21.8;Pancreatic endocrine cells: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016492 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA016492: AB_1853027" "unprognostic (6.79e-2)" "unprognostic (1.29e-2)" "unprognostic (2.78e-1)" "prognostic favorable (1.61e-4)" "unprognostic (5.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.53e-2)" "unprognostic (2.21e-1)" "unprognostic (2.61e-1)" "unprognostic (2.58e-2)" "unprognostic (1.00e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.24e-1)" "unprognostic (5.68e-1)" "unprognostic (9.64e-3)" "unprognostic (5.43e-2)" 23.2 17.4 11.9 15.8 15.6 5.8 16.3 23.1 21.9 17.0 18.8 13.2 15.5 13.1 25.4 20.9 21.6 15.0 20.8 10.0 11.2 12.3 16.0 28.7 16.2 19.0 11.3 9.8 17.4 43.2 19.6 16.5 29.4 13.7 19.4 16.1 32.5 24.6 14.1 18.5 31.1 17.5 15.7 7.8 24.0 17.1 27.2 8.5 29.9 17.8 16.7 26.3 14.8 17.1 14.1 7.8 22.6 11.4 13.7 27.8 16.6 6.6 20.6 9.0 14.7 23.3 13.0 13.0 9.5 12.9 11.3 13.3 9.7 14.3 14.6 13.4 15.4 11.6 26.0 11.6 14.2 11.0 15.6 11.1 5.9 12.6 17.2 16.0 10.1 15.3 19.8 19.6 12.4 12.6 12.6 12.1 10.8 12.1 14.5 8.9 11.5 14.8 14.8 5.7 12.5 5.1 8.1 14.1 14.9 12.9 21.4 16.3 11.2 10.2 8.3 14.4 17.4 23.7 7.9 15.3 12.3 7.6 12.1 9.0 25.1 29.8 13.0 11.2 6.5 9.3 22.6 8.0 17.7 24.2 10.0 21.2 13.0 20.0 23.0 7.8 14.1 19.8 22.2 7.2 13.7 11.4 7.7 27.8 16.6 11.9 15.6 23.1 21.9 11.2 12.3 11.3 9.8 13.7 8.5 23.8 28.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 11.4 29.6 0.0 17.6 6.6 15.5 0.0 0.0 0.0 0.0 21.8 13.6 0.0 0.0 7.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 12.6 0.0 0.0 25.9 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 REV1 REV1L ENSG00000135945 "REV1, DNA directed polymerase" Q9UBZ9 2 99400475-99490035 "Predicted intracellular proteins" "DNA damage, DNA repair, DNA synthesis" "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044534, HPA051036" Uncertain Approved Cytosol NA NA Cytosol "HPA044534: AB_2678975, HPA051036: AB_2681319" "unprognostic (3.05e-1)" "unprognostic (3.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (7.87e-3)" "unprognostic (1.30e-3)" "unprognostic (3.56e-3)" "unprognostic (2.78e-3)" "unprognostic (1.01e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (3.17e-1)" "unprognostic (1.45e-1)" "unprognostic (4.36e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-3)" 12.0 15.5 11.0 15.8 16.9 7.8 14.5 32.5 15.6 14.1 10.4 12.2 13.4 7.6 18.3 23.1 13.7 14.8 10.3 14.4 10.1 9.1 11.3 12.4 14.1 12.2 10.5 11.3 16.5 11.1 13.7 16.7 9.1 10.8 14.9 12.1 14.1 12.1 16.2 17.8 12.9 14.3 15.4 10.5 11.2 10.1 11.8 11.1 10.1 13.3 12.8 15.7 16.0 18.2 1.6 1.1 0.4 0.6 1.3 3.3 0.6 7.0 1.8 11.3 4.3 8.9 8.8 12.3 8.0 9.7 9.1 10.5 4.0 6.7 14.3 6.4 8.1 9.6 9.8 8.4 10.3 14.3 6.6 6.8 7.4 6.5 9.1 10.0 9.2 15.3 8.5 12.6 8.1 12.0 10.2 11.6 7.3 8.5 4.9 10.0 4.5 9.6 16.8 8.2 4.5 5.9 15.4 8.6 6.1 11.2 11.9 7.5 7.9 7.2 5.8 10.1 12.8 6.0 13.4 8.8 10.9 9.2 4.5 5.1 6.6 6.8 11.6 4.4 11.9 8.3 0.0 0.6 0.2 1.3 0.6 0.8 0.4 1.8 1.6 1.1 1.6 3.3 2.8 0.4 1.3 0.5 0.6 1.1 0.6 11.0 16.9 32.5 15.6 10.1 9.1 10.5 11.3 10.8 11.1 65.5 45.7 19.7 49.2 42.8 81.5 48.1 5.1 32.1 45.5 21.0 37.3 27.9 5.0 16.0 21.1 28.7 23.3 70.0 16.0 16.9 25.3 37.2 24.3 12.9 16.6 77.9 16.8 22.7 13.8 17.5 25.0 25.0 18.6 25.2 16.6 40.2 13.4 21.0 43.5 9.8 61.1 25.8 21.2 56.7 48.5 31.0 29.4 19.7 17.7 53.5 RFLNB "Cfm1, FAM101B, MGC45871, RefilinB" ENSG00000183688 "Refilin B" Q8N5W9 17 439978-445939 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 48.4;bone marrow: 40.9" "Cell type enhanced" "Detected in some" 25 "Alveolar cells type 2: 5.5;Hofbauer cells: 30.7;monocytes: 10.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 48.4" "Lineage enriched" "Detected in many" 16 "granulocytes: 48.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 28.0;HMC-1: 67.5;NB-4: 21.5;U-937: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030879, HPA060388" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Actin filaments" "Plasma membrane, Cytosol" "HPA030879: AB_2673643, HPA060388: AB_2732649" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (3.14e-1)" "unprognostic (3.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (2.87e-2)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (3.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-3)" 6.8 1.6 1.9 4.1 2.3 40.9 5.6 1.1 1.5 2.6 4.9 1.8 4.2 2.2 1.1 2.1 2.7 3.7 2.1 1.5 2.7 1.7 5.2 2.9 1.8 1.8 1.0 0.8 1.3 6.3 3.6 1.1 1.2 1.7 2.8 1.9 3.2 3.6 2.3 4.1 3.2 0.9 3.0 2.7 4.5 1.4 0.0 2.5 48.4 2.1 0.5 3.0 1.0 8.8 2.3 1.2 5.6 4.0 2.9 6.3 14.5 6.3 4.8 2.3 0.1 0.3 0.0 0.3 28.0 2.1 0.8 3.3 0.3 4.4 0.0 1.9 0.4 0.4 0.6 5.9 3.2 67.5 1.6 0.1 1.5 0.6 1.8 4.8 1.4 1.3 0.1 5.4 0.1 0.1 21.5 2.6 0.2 0.0 0.9 2.6 0.0 0.8 0.0 0.1 13.2 5.8 0.0 5.1 4.7 0.1 10.1 0.9 3.7 3.4 2.2 0.0 2.1 2.2 0.0 0.0 18.7 5.8 48.4 2.1 21.6 1.8 1.4 1.8 0.0 1.8 1.5 0.6 0.0 3.0 2.7 10.2 0.5 1.8 2.5 1.1 1.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 1.1 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 10.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RFPL4A "RFPL4, RNF210" ENSG00000223638 "Ret finger protein like 4A" A6NLU0 19 55759014-55763175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.9" "Cell type enhanced" "Detected in some" "classical monocyte: 12.7" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;monocytes: 12.7" "Cell line enriched" "Detected in some" 17 "U-2 OS: 44.7" HPA046368 Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA046368: AB_2679640" "unprognostic (3.74e-1)" "unprognostic (2.96e-2)" "unprognostic (9.20e-2)" 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.2 0.0 0.1 0.2 0.0 0.0 0.0 0.4 7.1 0.0 0.8 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.6 0.4 3.8 0.0 0.1 0.0 0.0 0.0 3.8 1.7 12.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 44.7 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 12.7 0.0 0.0 2.7 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 1.7 0.0 0.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 RFPL4AL1 RNF210B ENSG00000229292 "Ret finger protein like 4A like 1" F8VTS6 19 55769141-55773179 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 5.4;myeloid DC: 2.5" "Group enriched" "Detected in many" 9 "dendritic cells: 2.5;monocytes: 5.4" "Cell line enriched" "Detected in some" 24 "U-2 OS: 24.8" HPA046368 Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA046368: AB_2679640" "unprognostic (8.87e-2)" 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.0 0.0 0.0 0.3 3.0 0.0 0.4 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 2.3 0.2 1.5 0.3 0.0 0.3 0.0 0.0 2.5 0.4 5.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 RFWD3 "FANCW, FLJ10520, RNF201" ENSG00000168411 "Ring finger and WD repeat domain 3" Q6PCD5 16 74621394-74666881 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 46.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048258, HPA075649" Approved Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA048258: AB_2680332, HPA075649: AB_2686761" "unprognostic (4.79e-2)" "unprognostic (6.45e-3)" "unprognostic (6.35e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-3)" "unprognostic (5.04e-2)" "unprognostic (3.64e-2)" "unprognostic (1.01e-1)" "unprognostic (4.03e-3)" "unprognostic (2.53e-3)" "unprognostic (1.73e-3)" "unprognostic (2.84e-1)" "unprognostic (4.31e-1)" "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" 7.3 5.2 4.2 12.2 6.1 33.9 7.8 7.8 5.6 7.4 6.7 8.4 8.4 5.5 9.7 10.0 12.8 6.3 5.5 5.4 3.9 3.7 6.5 5.6 6.5 12.0 6.1 4.8 7.7 9.6 8.5 7.5 11.5 5.3 6.5 8.1 7.2 8.0 8.4 4.5 11.6 7.8 5.6 4.8 9.7 6.2 35.1 7.2 40.5 7.0 7.5 18.0 7.2 8.6 9.3 7.1 13.8 10.9 9.1 11.7 6.5 14.1 18.2 13.8 10.0 2.9 4.0 15.5 12.8 9.9 20.5 17.9 23.7 14.9 19.8 10.5 10.0 10.3 17.1 22.4 13.3 25.2 6.2 13.4 17.5 14.8 13.3 2.5 17.6 18.3 2.8 4.2 25.8 16.0 5.3 8.7 16.9 26.4 8.9 15.4 22.6 25.6 16.1 27.1 8.3 8.8 39.9 9.3 17.4 7.3 15.1 10.2 10.9 20.6 7.3 9.1 13.0 13.4 15.0 8.4 15.0 14.4 8.4 16.1 12.1 22.4 59.4 10.7 13.6 18.2 13.8 6.8 9.9 9.3 6.3 10.2 7.8 7.7 8.6 7.1 9.3 11.7 8.1 7.7 9.1 10.9 5.5 10.9 6.5 4.2 6.1 7.8 5.6 3.9 3.7 6.1 4.8 5.3 7.2 0.0 5.1 11.2 5.0 9.6 5.8 2.4 2.5 2.7 5.7 1.8 9.8 9.1 10.0 5.6 4.2 5.2 4.2 23.3 6.6 6.6 4.8 9.2 4.6 6.4 7.6 3.2 9.1 10.4 13.7 5.4 3.4 6.1 15.1 3.6 8.3 3.5 8.2 0.0 3.9 3.4 6.8 6.5 5.6 46.5 30.6 8.2 6.3 7.5 7.3 12.0 RFX2 FLJ14226 ENSG00000087903 "Regulatory factor X2" P48378 19 5993164-6199572 "Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 120.5;Early spermatids: 120.3;Late spermatids: 146.0;Spermatocytes: 95.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "neutrophil: 18.3" "Lineage enriched" "Detected in many" 9 "granulocytes: 18.3" "Cell line enhanced" "Detected in many" "HMC-1: 16.3;SCLC-21H: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048969 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA048969: AB_2680577" "unprognostic (1.31e-1)" "prognostic favorable (2.80e-4)" "unprognostic (6.72e-2)" "prognostic favorable (2.67e-4)" "unprognostic (1.37e-1)" "unprognostic (4.15e-2)" "unprognostic (1.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.86e-2)" "unprognostic (3.84e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" 6.7 2.0 8.4 5.3 9.4 8.6 6.4 8.3 7.0 6.9 11.3 7.2 0.7 4.1 15.7 7.0 9.0 22.0 6.4 5.4 9.5 3.6 1.9 2.5 10.0 2.1 4.4 4.0 7.2 5.3 2.9 12.9 2.2 9.9 4.1 2.6 3.1 2.4 3.3 2.5 6.6 5.7 14.8 9.0 2.1 5.9 51.5 7.5 4.1 3.0 12.1 3.1 8.7 5.3 0.3 1.6 18.3 2.0 0.5 0.5 0.6 4.0 3.3 5.3 10.3 2.8 1.6 3.1 2.6 3.6 2.2 3.5 1.4 5.1 4.6 2.8 3.4 4.8 6.4 1.3 5.2 3.0 1.1 0.8 7.2 3.3 1.4 3.2 3.1 16.3 1.9 4.5 4.9 2.6 2.7 3.3 6.4 4.6 0.2 2.2 2.0 6.2 4.3 1.4 5.6 2.0 1.7 3.2 0.5 2.8 7.9 20.1 2.5 2.5 2.0 1.4 0.6 3.4 3.5 4.8 0.9 4.6 3.6 2.6 6.7 2.2 2.6 2.8 11.6 1.9 0.0 2.0 0.8 0.1 0.4 0.0 0.3 0.4 0.3 1.6 0.1 0.4 0.5 18.3 0.5 1.1 0.0 0.0 0.6 8.4 9.4 8.3 7.0 9.5 3.6 4.4 4.0 9.9 7.5 23.8 40.1 2.2 23.8 23.5 3.3 7.2 15.3 120.5 40.9 3.5 2.0 5.2 3.3 3.9 120.3 9.9 3.0 0.0 1.5 5.4 9.7 5.5 44.0 2.0 7.0 0.0 13.2 6.7 8.7 146.0 7.5 13.6 6.8 5.4 4.4 5.5 2.3 1.5 3.9 1.5 3.6 25.8 14.6 95.0 13.0 19.3 4.7 4.9 5.2 17.3 RGL3 FLJ32585 ENSG00000205517 "Ral guanine nucleotide dissociation stimulator like 3" Q3MIN7 19 11384341-11419342 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 65.1;thyroid gland: 38.2" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 48.8;Muller glia cells: 28.8;Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 14.8;CACO-2: 8.4;RT4: 17.4;SK-BR-3: 7.7;T-47d: 12.8" "Region enriched" "Detected in single" 6 "cerebellum: 10.1" "HPA042763, HPA043615, HPA064578" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: " "prognostic favorable (7.35e-4)" "unprognostic (3.12e-2)" "unprognostic (2.92e-1)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (6.60e-2)" "unprognostic (3.82e-2)" "unprognostic (5.31e-2)" "unprognostic (1.24e-2)" "unprognostic (1.48e-2)" "unprognostic (3.19e-3)" "unprognostic (5.99e-2)" "prognostic favorable (6.61e-4)" "unprognostic (4.17e-2)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (7.12e-3)" 4.3 6.2 5.3 1.2 7.9 0.7 4.3 1.9 6.8 7.6 1.9 3.4 23.3 1.8 4.9 14.5 1.1 5.3 6.5 5.2 8.2 1.3 20.7 6.0 7.5 1.2 6.7 3.0 1.6 12.1 65.1 9.1 5.8 7.9 4.1 1.8 7.3 3.5 23.9 5.0 1.1 1.2 1.4 9.5 5.1 6.8 1.1 7.3 0.0 38.2 0.4 0.9 4.5 4.5 0.3 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.1 14.8 0.9 1.1 0.5 1.6 8.4 6.0 0.0 5.4 1.0 2.1 3.7 0.0 0.0 0.0 0.0 0.0 0.1 3.1 2.6 2.3 0.0 0.0 0.0 0.1 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 1.1 0.0 0.6 1.6 5.1 17.4 0.8 4.4 0.2 7.7 2.6 3.1 12.8 0.0 0.0 2.7 0.0 2.0 0.7 0.0 0.4 0.7 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 5.3 7.9 1.9 6.8 8.2 1.3 6.7 3.0 7.9 7.3 17.9 15.2 0.0 2.0 0.1 0.1 2.5 5.1 2.7 22.7 48.8 0.0 12.2 10.0 8.3 0.0 3.9 0.0 0.0 3.6 9.6 4.6 1.0 1.1 4.3 2.6 0.0 9.9 25.8 4.3 0.0 3.4 0.6 5.0 0.0 7.1 28.8 5.8 5.3 0.4 3.0 0.4 38.8 12.4 0.5 1.2 0.0 10.1 0.0 2.7 1.4 RGMA "RGM, RGMa" ENSG00000182175 "Repulsive guidance molecule BMP co-receptor a" Q96B86 15 93035273-93089204 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.0;skeletal muscle: 85.5" "Group enriched" "Detected in many" 5 "Leydig cells: 110.1;Peritubular cells: 110.0;Spermatogonia: 37.2" "Cancer enriched" "Detected in many" 6 "glioma: 26.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 31.0;BEWO: 9.1;MOLT-4: 9.2;NTERA-2: 13.9;REH: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012343, HPA039880, HPA044222" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 1400000 Nucleoplasm Cytosol "CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861" "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (8.85e-2)" "unprognostic (3.96e-3)" "unprognostic (5.73e-2)" "unprognostic (4.72e-3)" "unprognostic (2.53e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (6.25e-2)" "unprognostic (3.59e-4)" "unprognostic (8.11e-2)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" "unprognostic (7.98e-5)" 12.2 3.3 17.4 17.6 24.7 1.8 9.3 11.0 59.0 21.0 22.2 22.2 0.9 9.1 21.8 9.4 23.1 12.1 9.5 7.7 19.3 16.2 2.3 1.6 2.8 3.1 23.0 12.8 16.6 9.1 1.9 2.1 2.5 30.9 5.5 6.5 2.3 16.2 7.0 85.5 4.9 12.3 46.9 36.8 2.2 26.6 15.8 23.1 0.2 2.9 12.2 5.6 4.1 8.8 1.3 0.7 1.7 1.0 0.7 0.5 0.2 1.2 0.2 31.0 0.5 6.5 3.6 9.1 0.2 0.0 0.0 0.0 0.3 0.4 0.1 0.1 0.2 0.0 2.0 5.2 0.1 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.1 0.1 3.8 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.6 9.2 0.1 13.9 0.0 0.0 8.0 7.1 0.0 0.0 0.3 3.3 1.8 0.3 0.1 0.0 1.7 2.5 1.6 0.1 0.0 6.7 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.8 1.4 0.7 0.6 0.4 1.0 0.3 0.6 0.5 0.5 0.1 1.3 0.4 0.5 1.7 0.7 0.4 0.7 0.3 0.2 17.4 24.7 11.0 21.3 19.3 16.2 23.0 12.8 30.9 23.1 0.0 1.0 0.0 15.6 4.8 0.2 3.2 0.0 1.4 2.3 0.0 2.0 3.8 0.0 4.7 0.8 1.1 0.0 0.0 0.6 1.0 7.4 13.3 0.0 0.0 1.8 0.0 0.0 3.1 3.7 2.6 110.1 1.1 3.3 0.0 0.0 4.1 0.6 0.0 110.0 0.0 1.1 12.9 12.3 0.7 37.2 2.5 2.1 0.7 0.0 12.0 RGN "RC, SMP30" ENSG00000130988 Regucalcin Q15493 X 47078355-47093314 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 51.0;liver: 118.8" "Cell type enhanced" "Detected in many" 13 "Distal tubular cells: 49.7;Hepatocytes: 141.5;Muller glia cells: 48.0;Peritubular cells: 65.4;Proximal tubular cells: 86.9" "Cancer enriched" "Detected in many" 6 "liver cancer: 47.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 16.5;fHDF/TERT166: 5.3;Hep G2: 24.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029102, HPA029103, HPA029104" Enhanced Approved Cytosol NA NA 47000 Cytosol "HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: " "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (5.56e-3)" "unprognostic (8.22e-3)" "unprognostic (1.32e-2)" "prognostic favorable (7.55e-4)" "unprognostic (2.60e-3)" "unprognostic (2.23e-2)" "unprognostic (8.38e-2)" "unprognostic (3.37e-2)" "unprognostic (1.14e-2)" "prognostic favorable (5.10e-10)" "unprognostic (1.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.82e-2)" "unprognostic (5.22e-2)" 2.6 51.0 6.7 0.6 6.5 0.4 1.5 8.4 6.2 2.8 1.9 6.2 2.5 4.5 2.3 6.1 1.5 1.7 2.0 4.5 6.1 4.2 17.6 118.8 4.9 0.7 5.9 4.5 7.5 12.7 6.2 2.5 4.2 5.0 4.8 1.1 8.4 7.5 6.3 3.8 0.6 4.6 4.9 4.4 1.1 2.9 1.5 5.2 0.0 6.5 1.6 0.6 2.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.3 0.6 0.0 0.0 16.5 0.0 0.0 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.6 0.8 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.7 6.5 8.4 6.2 6.1 4.2 5.9 4.5 5.0 5.2 6.0 2.2 0.0 2.9 0.5 10.2 25.8 7.6 2.7 1.2 14.0 0.0 0.1 49.7 8.4 0.4 1.8 0.0 0.0 7.9 0.1 7.5 0.9 0.0 141.5 0.1 4.8 4.6 6.2 4.0 0.6 23.0 0.0 1.7 0.0 0.0 48.0 7.8 0.0 65.4 86.9 1.9 12.9 8.0 0.2 0.2 0.3 0.2 0.0 0.3 1.1 RGP1 KIAA0258 ENSG00000107185 "RGP1 homolog, RAB6A GEF complex partner 1" Q92546 9 35749287-35758575 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020414, HPA021085" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA020414: AB_1852289, HPA021085: AB_1852291" "unprognostic (2.10e-1)" "unprognostic (3.22e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (7.09e-4)" "unprognostic (2.22e-1)" "unprognostic (5.42e-2)" "unprognostic (1.51e-3)" "unprognostic (1.81e-3)" "unprognostic (9.77e-2)" "prognostic favorable (8.55e-13)" "unprognostic (2.46e-2)" "unprognostic (1.68e-1)" "unprognostic (3.03e-3)" "unprognostic (1.18e-1)" 13.4 18.2 12.0 11.4 16.8 7.1 12.3 13.7 24.8 12.2 17.7 18.3 23.8 14.9 15.3 12.5 14.0 12.3 12.1 17.6 11.6 11.2 16.7 14.2 13.2 9.8 10.7 14.8 15.0 17.6 32.6 18.3 14.1 13.0 12.9 19.1 15.4 18.3 22.5 25.8 13.1 17.2 14.1 10.6 12.8 16.5 13.2 13.7 11.2 17.3 11.9 13.0 13.5 10.6 4.0 2.1 3.4 1.9 3.7 3.7 0.9 11.3 10.7 12.5 10.3 11.7 12.7 7.4 9.0 13.1 12.5 11.7 9.1 4.3 8.8 6.5 11.4 23.2 6.5 11.9 17.0 10.4 11.7 7.0 7.6 20.4 6.8 11.0 8.2 10.7 12.7 21.7 13.2 16.1 18.0 14.8 6.9 5.1 4.9 11.3 5.3 2.5 2.9 5.2 9.4 12.6 8.3 8.9 6.2 11.0 8.0 9.2 9.9 7.9 11.2 7.3 11.5 9.3 3.9 18.7 10.1 12.8 6.9 7.5 7.4 10.2 9.4 14.4 3.4 12.9 3.4 0.9 1.4 2.6 1.5 3.7 2.8 1.9 3.0 0.6 4.0 2.3 2.4 2.3 3.7 1.9 2.1 1.6 0.9 12.0 16.8 13.7 24.8 11.6 11.2 10.7 14.8 13.0 13.7 6.0 9.3 26.0 21.1 5.0 40.9 16.3 20.4 8.1 10.3 26.2 19.6 9.3 11.6 16.1 16.4 13.4 35.4 0.0 15.2 8.8 6.0 21.5 5.7 15.3 6.4 15.9 41.6 8.0 10.3 27.7 7.8 5.6 1.7 7.2 23.9 21.8 17.1 31.7 10.3 12.9 22.1 6.5 7.2 15.8 4.3 4.5 8.6 15.2 26.3 26.2 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 118.6;Suprabasal keratinocytes: 96.1;Urothelial cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA054646: AB_2682555, HPA067421: AB_2685836" "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 4.7 4.4 20.7 4.1 22.0 2.3 4.4 10.2 37.2 5.4 2.9 10.2 1.5 5.3 6.4 5.6 13.5 7.5 4.4 4.7 13.4 5.6 4.4 6.7 6.5 3.4 12.3 16.3 8.9 3.1 3.1 6.1 4.1 9.4 6.8 2.2 3.1 6.5 5.7 6.8 20.6 4.6 3.0 18.9 4.1 3.2 5.5 9.9 4.3 3.8 3.4 3.6 5.5 7.9 1.0 1.5 1.6 3.9 0.4 1.3 0.7 4.0 5.1 10.3 7.4 3.5 2.7 4.3 4.3 3.5 4.5 3.3 4.1 2.4 1.0 2.7 3.8 6.6 3.9 2.0 13.9 1.5 0.1 1.6 0.4 2.9 10.0 3.1 0.3 5.7 2.3 9.5 2.3 3.2 4.1 9.9 3.6 4.7 0.2 4.1 3.4 0.7 10.8 4.9 2.3 4.9 10.2 4.0 3.3 2.3 12.0 11.7 12.0 2.7 1.9 9.1 2.6 4.7 6.9 7.4 8.8 5.8 1.8 4.6 5.1 4.0 2.3 5.1 6.0 6.2 1.0 1.2 0.3 0.9 3.9 0.3 0.2 0.8 0.5 1.5 1.0 1.3 0.5 1.6 0.4 3.7 0.8 0.6 0.7 20.7 22.0 10.2 37.2 13.4 5.6 12.3 16.3 9.4 9.9 6.0 8.3 0.5 118.6 75.0 19.0 7.5 15.3 29.4 20.5 5.2 27.5 5.3 3.3 9.0 3.8 21.1 5.1 0.0 9.2 1.0 10.0 34.2 13.9 22.7 19.8 9.5 14.3 25.8 6.1 4.2 13.8 19.0 16.9 5.4 9.9 38.9 11.1 0.0 7.4 18.1 18.7 0.0 8.8 20.2 14.9 96.1 5.6 4.5 8.0 169.4 RGS16 "A28-RGS14, RGS-r" ENSG00000143333 "Regulator of G protein signaling 16" O15492 1 182598623-182604408 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 67.5" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 519.8;Smooth muscle cells: 484.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 32.0;NB-4: 17.6;SCLC-21H: 33.4;U-266/70: 37.8;U-698: 47.2" "Region enriched" "Detected in many" 5 "thalamus: 87.4" "Group enriched" "Detected in many" 6 "midbrain: 92.1;pons and medulla: 72.2;thalamus: 126.3" "HPA053250, HPA055824" Uncertain Approved Cytosol NA NA Cytosol "HPA053250: AB_2682090, HPA055824: AB_2682934" "unprognostic (4.03e-2)" "unprognostic (6.08e-2)" "unprognostic (4.87e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (2.38e-2)" "unprognostic (3.55e-2)" "unprognostic (2.01e-2)" "unprognostic (2.10e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.93e-2)" "unprognostic (3.65e-2)" "unprognostic (9.07e-3)" "unprognostic (5.39e-2)" 17.8 7.5 4.5 18.6 9.8 3.0 5.2 3.3 9.9 2.4 6.4 20.7 7.2 2.3 2.6 3.7 4.5 8.0 10.8 3.6 7.4 12.3 6.7 6.8 13.3 10.8 12.0 1.3 2.9 4.3 6.0 28.1 7.9 16.5 3.7 4.1 9.1 3.3 40.8 5.2 3.0 3.5 8.0 25.0 6.1 5.1 1.2 10.7 0.3 67.5 16.2 4.9 6.1 4.2 5.8 11.5 2.2 0.9 3.4 5.4 1.4 0.2 0.0 1.9 0.0 0.3 0.0 14.8 0.0 0.5 0.0 0.0 0.0 0.1 32.0 0.1 0.0 0.0 0.1 3.5 0.3 0.0 3.6 2.6 3.3 0.3 0.0 0.5 5.3 2.9 0.7 5.4 0.0 0.2 0.0 0.0 1.1 0.1 5.6 0.0 3.5 0.1 17.6 10.3 0.2 1.0 0.0 10.6 7.6 0.0 1.5 33.4 3.5 0.0 2.7 0.0 2.0 1.1 4.2 0.0 0.1 0.7 0.9 1.6 37.8 1.7 47.2 0.1 3.4 1.7 2.2 0.4 0.7 0.4 0.5 0.8 5.8 5.4 0.6 0.6 2.3 2.5 0.8 1.4 3.4 0.9 11.5 3.2 1.4 4.5 9.8 3.3 9.9 7.4 12.3 12.0 1.3 16.5 10.7 125.0 148.7 13.4 6.7 73.2 519.8 16.5 0.0 4.0 31.8 8.7 17.7 6.1 0.0 1.6 0.4 67.1 1.3 23.3 2.0 125.4 54.3 12.1 72.5 1.0 15.6 30.2 48.3 25.8 3.7 0.0 0.3 13.9 77.6 20.8 3.8 129.8 2.8 0.9 0.4 0.3 30.5 64.7 484.2 0.0 1.5 55.2 28.8 5.7 1.9 9.0 RGS2 G0S8 ENSG00000116741 "Regulator of G protein signaling 2" P41220 1 192809039-192812283 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Translation regulation" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 234.2" "Cell type enhanced" "Detected in many" 16 "granulocytes: 1743.9;Macrophages: 609.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 135.8;neutrophil: 234.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 234.2" "Cell line enhanced" "Detected in many" "hTCEpi: 39.9;hTERT-HME1: 27.6;Karpas-707: 26.2;PC-3: 63.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013385 Supported Cytosol NA NA Cytosol "HPA013385: AB_2668827" "prognostic favorable (2.43e-4)" "unprognostic (9.75e-2)" "unprognostic (1.28e-3)" "unprognostic (4.43e-2)" "unprognostic (1.79e-1)" "unprognostic (1.93e-1)" "unprognostic (2.09e-3)" "unprognostic (1.29e-2)" "unprognostic (2.59e-1)" "unprognostic (2.79e-2)" "unprognostic (1.36e-1)" "unprognostic (6.49e-2)" "prognostic unfavorable (2.90e-5)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.16e-1)" "unprognostic (4.34e-3)" "unprognostic (1.01e-3)" 22.7 62.0 8.1 39.2 20.1 84.9 23.3 6.0 10.0 20.7 57.5 4.5 50.6 23.2 43.3 34.2 45.5 27.4 35.0 14.2 8.2 13.2 9.4 10.8 24.3 32.6 8.9 6.6 25.1 84.3 1.9 52.6 16.7 16.9 99.8 19.1 44.0 5.0 54.5 4.4 6.4 33.9 135.0 19.0 50.6 22.5 13.0 7.9 3.9 4.2 5.7 6.2 72.1 28.5 0.3 6.2 234.2 26.6 0.1 1.8 12.2 0.0 5.5 7.1 0.6 14.1 2.2 0.4 2.7 3.4 0.9 0.9 4.8 3.2 0.4 0.7 2.5 0.7 2.6 4.6 4.8 0.8 0.7 3.4 1.3 3.6 0.1 6.2 3.2 0.8 2.3 39.9 1.8 27.6 5.1 6.6 2.4 1.1 26.2 2.7 0.0 1.7 4.5 9.5 0.5 63.1 1.7 1.6 1.4 4.6 4.4 2.6 13.4 1.9 0.1 3.0 7.6 0.2 1.6 1.8 1.3 1.2 1.4 1.4 15.6 0.4 1.4 19.2 0.6 4.8 135.8 26.6 38.0 0.8 10.5 1.8 0.3 0.5 0.5 6.2 0.1 0.3 0.3 234.2 0.1 17.7 0.8 0.3 12.2 8.1 20.1 6.0 10.0 8.2 13.2 8.9 6.6 16.9 7.9 47.6 315.5 133.6 46.1 37.5 21.4 56.8 2.5 30.8 62.6 129.1 17.7 168.7 0.0 22.6 22.0 24.3 61.9 23.3 26.0 21.8 64.8 43.7 1743.9 2.1 326.0 20.6 335.5 23.9 383.7 13.9 15.3 609.2 84.4 77.5 43.4 36.4 13.0 20.1 59.1 2.2 35.7 0.0 69.0 5.0 9.4 27.1 103.9 144.7 17.8 7.5 RGS22 "CT145, DKFZP434I092, PRTD-NY2" ENSG00000132554 "Regulator of G protein signaling 22" Q8NE09 8 99960936-100131268 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.3" "Group enriched" "Detected in some" 7 "Early spermatids: 519.1;Late spermatids: 1277.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 2.0;HL-60: 3.2;HMC-1: 2.2;RPMI-8226: 4.2;SCLC-21H: 1.8;U-2 OS: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053026 Supported "Nucleoli fibrillar center,Actin filaments,Cytosol" NA NA "Nucleoli fibrillar center" "Actin filaments, Cytosol" "HPA053026: " "unprognostic (3.04e-2)" "unprognostic (2.62e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-1)" "unprognostic (3.47e-5)" "unprognostic (1.61e-1)" "unprognostic (2.32e-1)" "unprognostic (3.19e-2)" "unprognostic (1.47e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-2)" "unprognostic (7.96e-3)" "unprognostic (1.98e-5)" "unprognostic (3.71e-2)" "unprognostic (1.31e-2)" "unprognostic (3.25e-3)" "unprognostic (8.36e-4)" 2.8 1.0 1.8 0.3 2.5 0.3 1.0 0.4 1.4 2.0 0.5 3.4 2.0 0.2 2.9 6.8 0.5 8.5 1.2 0.7 2.6 1.7 0.4 0.3 3.9 0.5 0.9 1.6 6.5 0.6 0.2 10.9 0.6 9.0 2.3 0.3 0.9 0.4 2.2 0.4 0.7 0.5 1.5 1.7 0.3 0.5 43.3 1.3 0.0 0.5 0.0 0.5 0.8 0.8 0.6 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 3.2 2.2 1.2 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.6 0.4 0.0 0.3 0.3 1.3 4.2 0.5 0.3 1.8 0.2 0.0 0.0 0.0 0.9 0.3 0.8 0.0 0.0 2.8 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.1 1.8 2.5 0.4 1.4 2.6 1.7 0.9 1.6 9.0 1.3 0.0 0.0 0.0 0.0 1.9 1.3 0.6 0.0 91.0 21.6 0.0 0.0 0.1 0.0 0.0 519.1 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1277.1 121.7 0.5 0.0 0.0 0.0 9.3 0.0 0.0 59.1 0.0 0.2 0.0 0.9 64.9 7.4 1.8 0.7 0.0 0.0 0.0 RGS7 ENSG00000182901 "Regulator of G protein signaling 7" P49802 1 240775515-241357230 "Plasma proteins, Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.5;brain: 38.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 19.9;Horizontal cells: 58.8" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.6" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.2;HaCaT: 6.9;hTERT-HME1: 8.4;RH-30: 7.4;SH-SY5Y: 6.5;U-2 OS: 7.4;U-251 MG: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017561 Enhanced Supported Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB017561: AB_2285043" "unprognostic (6.48e-2)" "unprognostic (4.30e-2)" "unprognostic (4.67e-2)" "unprognostic (6.65e-2)" "unprognostic (7.84e-3)" "unprognostic (4.09e-2)" "unprognostic (1.49e-2)" "unprognostic (3.61e-1)" "unprognostic (1.42e-2)" "unprognostic (2.51e-4)" "unprognostic (3.54e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (2.28e-1)" 0.7 11.5 9.1 0.8 18.3 0.7 0.9 27.6 38.1 0.9 0.8 1.6 1.7 1.0 1.0 0.8 0.9 0.7 1.3 0.7 11.5 8.3 4.2 0.8 0.9 1.1 3.6 8.9 1.3 1.4 0.7 2.8 0.7 4.7 0.8 0.9 1.3 0.7 1.4 0.7 0.9 0.9 0.7 1.4 1.0 4.6 7.8 1.8 0.0 0.7 0.0 1.0 0.7 0.1 0.7 3.6 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.3 0.9 0.0 2.7 5.3 7.2 0.5 0.0 0.0 0.0 0.4 3.7 4.0 6.9 0.0 0.1 3.6 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.4 0.5 0.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.9 0.3 0.2 0.0 7.4 0.0 0.0 0.0 6.0 6.5 0.4 0.3 0.3 0.2 0.0 0.0 2.8 0.0 7.4 0.4 8.0 0.0 4.3 0.0 1.1 0.0 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 9.1 18.3 27.6 20.7 11.5 8.3 3.6 8.9 4.7 1.8 0.0 0.0 0.8 0.0 0.0 19.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 58.8 6.9 0.6 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 2.0 0.0 0.0 6.4 9.3 0.0 0.0 0.0 0.0 0.0 RGS7BP R7BP ENSG00000186479 "Regulator of G protein signaling 7 binding protein" Q6MZT1 5 64506257-64612312 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.1" "Cell type enhanced" "Detected in some" 14 "Ito cells: 20.3;Leydig cells: 6.6;Peritubular cells: 13.1;Sertoli cells: 6.5;Smooth muscle cells: 7.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039600 Approved Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039600: AB_2676591" "unprognostic (2.93e-1)" "unprognostic (3.39e-1)" "unprognostic (7.35e-2)" "unprognostic (4.77e-2)" "unprognostic (7.57e-2)" "unprognostic (8.59e-2)" "unprognostic (5.22e-2)" "unprognostic (8.81e-3)" "unprognostic (1.86e-2)" "unprognostic (7.64e-2)" "unprognostic (5.49e-3)" "unprognostic (1.83e-1)" "unprognostic (1.65e-3)" "unprognostic (3.39e-3)" "unprognostic (2.06e-3)" "unprognostic (6.46e-2)" "unprognostic (8.50e-3)" 2.8 4.7 10.2 1.1 22.6 0.4 1.1 10.4 31.1 6.0 1.3 1.5 0.5 1.6 3.7 5.7 2.7 10.9 2.7 3.7 10.8 4.3 3.3 1.7 2.2 0.8 4.0 16.0 3.8 0.8 0.7 1.7 0.4 8.2 7.8 1.4 1.8 2.7 10.9 0.7 1.0 1.7 2.3 1.9 1.3 1.5 1.5 6.7 0.0 1.0 0.0 0.6 2.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 22.6 10.4 25.1 10.8 4.3 4.0 16.0 8.2 6.7 0.0 0.0 0.0 0.1 0.0 4.3 1.8 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 0.0 1.3 6.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 13.1 0.0 1.7 6.5 7.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 RHOA "ARH12, ARHA, Rho12, RhoA, RHOH12" ENSG00000067560 "Ras homolog family member A" P61586 3 49359145-49412998 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Host-virus interaction" Hydrolase "Cancer-related genes, Disease mutation, Ectodermal dysplasia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005052 Approved Supported "Plasma membrane,Cytosol" NA NA 65000000 "Plasma membrane, Cytosol" "CAB005052: AB_562216" "unprognostic (1.50e-1)" "unprognostic (3.38e-1)" "prognostic favorable (3.08e-4)" "unprognostic (8.75e-2)" "unprognostic (1.63e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.15e-4)" "unprognostic (1.39e-1)" "unprognostic (8.83e-2)" "unprognostic (9.44e-3)" "unprognostic (2.21e-2)" "unprognostic (4.29e-2)" "prognostic favorable (3.21e-6)" "unprognostic (5.14e-2)" "unprognostic (7.50e-2)" "unprognostic (1.57e-1)" "unprognostic (4.52e-2)" 141.1 89.5 63.0 79.8 60.6 91.4 93.1 34.3 77.3 80.3 79.1 100.4 48.9 63.6 84.4 66.4 116.7 67.8 74.2 72.5 57.6 54.8 104.0 80.7 104.6 102.4 74.0 43.8 102.7 64.9 45.8 48.2 105.3 68.8 76.0 80.3 81.6 66.5 72.0 86.0 73.9 90.8 88.9 97.3 116.0 73.4 57.3 60.3 127.1 108.1 80.1 99.8 103.4 75.7 42.6 78.4 124.2 125.7 38.3 50.5 151.5 55.7 43.0 54.0 57.9 62.0 94.0 42.2 121.4 77.8 84.9 78.3 36.4 58.5 81.8 34.9 145.8 49.3 31.8 59.3 66.2 87.2 63.1 35.3 78.1 57.9 42.7 66.5 77.0 58.6 73.4 47.1 69.4 55.9 85.8 108.6 43.5 41.6 51.5 100.6 26.6 83.8 75.1 51.6 56.0 54.8 38.8 54.3 64.3 73.4 63.7 19.8 45.1 72.9 52.8 54.7 55.8 34.2 86.8 117.2 68.2 61.8 89.9 87.2 51.2 103.7 93.9 66.4 75.8 77.8 52.5 99.7 106.8 49.1 125.7 41.6 42.6 41.4 47.6 78.4 37.5 32.2 40.1 124.2 38.3 120.4 58.7 50.5 151.5 63.0 60.6 34.3 77.3 57.6 54.8 74.0 43.8 68.8 60.3 360.3 233.2 266.1 228.8 240.6 42.2 113.5 155.4 182.0 182.0 171.0 5.9 328.4 288.5 303.4 30.3 372.7 339.7 93.5 302.0 572.5 345.6 260.3 251.7 153.0 691.2 77.9 225.0 312.5 712.8 42.2 310.4 490.6 310.4 582.5 261.8 172.7 313.0 270.7 383.3 255.4 33.0 271.7 354.1 227.5 221.8 244.4 439.3 304.1 267.8 270.4 RHOBTB1 KIAA0740 ENSG00000072422 "Rho related BTB domain containing 1" O94844 10 60869438-61001440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.9;skeletal muscle: 63.5" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 127.6;Horizontal cells: 316.2;Syncytiotrophoblasts: 252.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;NK-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040205, HPA040226" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040205: AB_2676883, HPA040226: AB_10795377" "unprognostic (1.25e-1)" "unprognostic (2.72e-2)" "unprognostic (6.69e-3)" "unprognostic (2.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-3)" "unprognostic (1.64e-1)" "unprognostic (2.25e-1)" "unprognostic (4.31e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-2)" "unprognostic (8.54e-3)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (7.16e-2)" "unprognostic (2.57e-2)" 7.6 9.8 2.7 2.0 5.8 0.5 4.5 0.8 5.0 8.8 4.7 7.2 16.5 3.4 10.2 4.9 1.9 6.8 6.3 6.6 3.7 2.5 20.5 3.4 5.4 1.4 6.7 2.3 6.9 6.0 7.4 2.2 50.9 4.6 4.9 2.6 13.3 1.4 20.3 63.5 1.9 3.5 7.7 3.8 7.4 11.7 8.5 5.7 0.6 2.3 5.2 0.9 5.0 5.2 0.5 1.6 0.7 0.6 1.3 0.0 1.3 0.1 6.2 9.5 0.0 4.5 4.0 0.0 2.7 2.5 2.3 3.5 0.3 0.1 0.0 11.7 14.5 1.1 0.1 2.8 0.8 2.7 0.0 2.5 0.5 4.5 34.5 4.9 0.7 0.2 5.7 1.6 1.4 1.4 8.8 10.8 2.0 5.1 0.0 10.1 0.2 2.6 0.0 4.1 0.1 4.1 2.3 13.3 3.2 7.5 0.3 2.6 10.2 3.3 3.6 3.6 6.2 0.7 1.2 9.6 4.4 11.7 0.1 3.0 0.0 0.0 0.0 2.2 2.0 2.4 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.7 1.3 0.6 0.0 0.0 1.3 2.7 5.8 0.8 5.0 3.7 2.5 6.7 2.3 4.6 5.7 14.9 8.3 0.0 0.8 1.5 2.7 24.9 2.5 12.0 3.4 1.8 127.6 49.5 1.7 3.2 49.1 7.1 0.6 0.0 13.6 3.6 9.0 1.0 0.0 1.8 10.1 316.2 7.9 16.5 12.3 26.5 7.5 3.2 1.7 0.0 6.7 20.9 14.1 3.4 4.6 30.1 26.0 6.5 4.1 1.6 1.0 1.3 252.8 0.0 2.3 0.2 RHOQ "ARHQ, RASL7A, TC10" ENSG00000119729 "Ras homolog family member Q" P17081 2 46541806-46583121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 155.1;Horizontal cells: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 63.1;ASC TERT1: 49.4;SK-MEL-30: 53.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044938 Approved Vesicles,Cytosol No No "Vesicles, Cytosol" "HPA044938: AB_2679149" "unprognostic (1.24e-1)" "unprognostic (1.30e-2)" "unprognostic (5.82e-2)" "unprognostic (2.07e-2)" "unprognostic (3.61e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.60e-5)" "unprognostic (2.01e-2)" "unprognostic (9.24e-2)" "unprognostic (2.11e-2)" "unprognostic (1.97e-1)" "unprognostic (5.43e-2)" "unprognostic (3.88e-3)" "unprognostic (1.39e-2)" "unprognostic (1.87e-1)" "unprognostic (7.68e-2)" "unprognostic (3.52e-2)" 43.3 13.1 20.9 14.1 19.4 4.9 16.7 6.5 15.1 16.4 16.6 12.7 11.7 4.9 15.5 32.9 9.8 13.8 15.0 65.2 16.8 13.0 13.9 6.0 14.2 10.0 19.5 14.9 16.0 12.9 20.4 8.2 13.8 20.4 14.6 6.9 16.0 9.6 19.2 63.8 7.2 8.9 19.3 15.4 13.2 9.3 6.3 13.4 8.0 18.0 17.2 9.1 17.7 12.1 3.9 2.9 8.9 4.8 0.7 0.8 1.3 4.2 4.4 7.3 10.2 63.1 49.4 1.0 12.1 30.6 5.9 9.3 2.1 1.3 10.3 13.2 21.4 20.5 1.7 7.6 3.6 10.8 3.5 5.2 2.4 3.3 7.1 30.9 3.0 3.7 43.7 6.2 7.8 8.4 14.5 7.0 0.9 4.1 17.1 12.7 2.9 2.4 5.5 7.6 3.1 5.5 1.6 13.3 3.5 8.0 8.2 5.8 18.9 4.4 6.0 53.6 12.7 3.3 7.1 4.8 19.3 18.1 18.9 4.9 17.6 6.3 10.8 28.2 7.6 6.8 2.7 4.6 7.8 0.7 4.8 0.6 3.4 0.4 0.8 2.9 3.9 0.1 0.6 8.9 0.7 3.4 1.3 0.6 1.3 20.9 19.4 6.5 15.1 16.8 13.0 19.5 14.9 20.4 13.4 53.6 21.9 25.1 25.9 19.9 21.3 155.1 17.8 13.4 21.6 19.2 9.8 9.5 14.9 18.9 11.1 26.2 0.1 0.0 27.2 2.8 51.4 36.9 11.5 9.0 39.2 114.4 5.8 18.4 69.5 9.0 32.8 63.6 40.5 19.0 2.2 43.0 24.6 0.0 40.0 23.0 22.3 45.3 57.7 1.7 2.9 17.2 21.6 14.4 0.9 26.7 RHOXF1 "OTEX, PEPP1" ENSG00000101883 "Rhox homeobox family member 1" Q8NHV9 X 120109053-120115937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.1;brain: 9.2;testis: 27.8" "Cell type enriched" "Detected in some" 39 "Spermatogonia: 154.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 9.2" "Cell type enriched" "Detected in some" 6 "T-reg: 8.1" "Lineage enriched" "Detected in single" 30 "T-cells: 8.1" "Cell line enhanced" "Detected in some" "HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8" "HPA052560, HPA056506" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052560: , HPA056506: AB_2683157" "unprognostic (5.03e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (2.31e-2)" "unprognostic (8.65e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (3.15e-1)" "unprognostic (3.89e-1)" "unprognostic (2.15e-1)" "unprognostic (7.50e-4)" "unprognostic (1.97e-1)" "unprognostic (5.85e-4)" "unprognostic (3.00e-1)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.73e-3)" 2.8 0.5 0.9 0.5 1.1 0.3 0.9 9.2 1.7 0.5 0.7 0.5 0.5 0.2 0.5 0.5 0.5 1.5 0.5 0.5 0.8 2.4 0.8 0.5 0.5 0.6 0.8 0.5 2.2 0.5 0.8 0.9 1.1 0.5 0.5 0.1 0.5 0.8 0.6 0.5 2.4 0.5 0.5 0.5 0.5 0.2 27.8 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.2 3.9 0.4 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 8.1 0.0 0.9 1.1 9.2 1.7 0.8 2.4 0.8 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 2.7 0.0 0.0 3.9 0.1 1.7 0.1 1.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.4 0.0 1.3 0.0 0.0 2.9 154.2 0.3 0.0 0.0 0.1 0.0 RIC8A "synembryn, synembryn-A" ENSG00000177963 "RIC8 guanine nucleotide exchange factor A" Q9NPQ8 11 207511-215113 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041491, CAB046012" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB046012: AB_11129402, HPA041491: AB_2677510" "unprognostic (3.93e-2)" "unprognostic (8.69e-2)" "unprognostic (1.62e-1)" "prognostic favorable (8.60e-4)" "unprognostic (1.61e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (2.13e-3)" "unprognostic (8.70e-2)" "unprognostic (7.68e-2)" "unprognostic (1.56e-1)" "unprognostic (8.35e-2)" "unprognostic (2.63e-3)" "unprognostic (5.35e-2)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.60e-1)" 30.9 30.2 31.4 27.1 35.4 28.8 27.5 27.8 51.7 29.3 31.4 25.9 32.5 24.1 35.8 36.6 36.5 35.4 33.2 31.9 27.0 25.5 33.9 39.5 28.4 28.7 23.8 30.0 35.1 38.0 34.9 30.2 43.7 27.4 29.8 26.1 33.2 29.4 36.1 22.5 32.2 35.1 41.3 21.2 32.5 28.4 40.3 18.6 43.9 33.2 24.9 33.3 33.3 27.3 31.3 20.7 40.2 26.6 31.9 40.1 37.2 51.4 25.1 20.4 20.3 28.1 23.2 14.2 37.3 30.1 51.1 35.5 21.6 36.6 20.6 15.6 56.4 38.8 28.0 23.2 39.5 28.6 24.8 23.2 11.6 17.8 19.9 22.7 19.3 38.8 25.3 35.0 31.6 28.7 26.4 25.0 22.0 19.8 20.1 39.1 20.8 23.0 15.4 18.6 21.9 31.2 21.7 20.2 14.0 29.6 13.6 21.3 19.2 28.9 32.7 19.9 20.6 23.1 15.6 28.0 33.9 29.9 12.4 34.6 22.3 33.0 19.8 33.4 17.6 25.3 27.5 19.7 40.2 40.1 23.0 39.3 31.3 35.9 34.6 20.7 27.2 31.1 31.4 28.8 31.9 26.6 17.0 29.8 37.2 31.4 35.4 27.8 51.7 27.0 25.5 23.8 30.0 27.4 18.6 14.9 19.7 27.6 17.9 15.8 27.4 23.6 22.9 14.7 18.2 24.4 9.8 34.7 23.2 48.4 11.7 22.4 23.8 23.3 38.3 50.5 25.4 17.7 17.3 14.7 40.7 30.2 19.4 23.4 24.1 12.3 28.4 15.8 27.0 47.7 15.8 41.3 55.2 21.0 37.4 18.6 28.2 19.4 27.4 85.8 53.0 16.9 27.1 34.1 21.0 14.8 RIC8B "FLJ10620, hSyn, RIC8" ENSG00000111785 "RIC8 guanine nucleotide exchange factor B" Q9NVN3 12 106774595-106889316 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039970, HPA042746" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039970: , HPA042746: AB_2678143" "unprognostic (1.18e-1)" "unprognostic (1.61e-1)" "unprognostic (9.87e-3)" "unprognostic (5.43e-2)" "unprognostic (3.28e-2)" "unprognostic (8.09e-2)" "unprognostic (5.74e-2)" "unprognostic (2.60e-1)" "unprognostic (1.99e-2)" "unprognostic (3.83e-1)" "unprognostic (1.10e-3)" "unprognostic (5.13e-2)" "unprognostic (3.65e-3)" "unprognostic (2.21e-1)" "unprognostic (3.18e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-2)" 7.4 6.4 10.9 6.0 32.3 1.7 6.1 13.0 12.7 8.0 6.3 5.1 11.5 4.3 7.9 6.4 4.6 8.2 8.1 9.9 6.6 7.5 10.5 6.9 5.3 3.3 6.5 6.7 8.7 6.2 20.4 13.1 5.3 8.2 6.6 5.6 7.5 4.2 12.5 8.3 3.1 4.2 9.4 5.8 5.4 4.4 5.1 17.2 8.7 13.4 0.9 4.1 5.9 7.2 1.1 3.6 3.3 4.0 2.4 6.0 2.8 2.8 8.9 16.9 6.8 8.1 10.2 2.0 9.6 7.6 8.7 8.0 2.9 2.3 1.7 6.6 5.7 3.4 5.0 6.8 3.8 10.3 20.1 8.4 6.2 4.6 3.9 6.8 6.5 4.4 5.7 4.2 6.2 2.9 10.1 7.9 6.3 3.6 0.1 7.6 2.3 6.3 5.9 8.6 4.5 9.0 5.6 9.9 5.6 7.1 3.3 12.4 8.0 6.7 4.3 5.0 6.7 3.8 4.7 7.6 6.9 3.8 4.6 6.6 5.1 10.6 0.1 3.3 3.9 10.2 2.3 4.0 3.3 5.1 2.0 6.0 1.1 2.9 2.6 3.6 0.6 2.2 2.3 1.7 2.4 1.8 2.2 3.1 2.8 10.9 32.3 13.0 12.7 6.6 7.5 6.5 6.7 8.2 17.2 6.0 5.6 3.9 3.8 3.0 12.6 27.4 20.4 10.7 5.7 3.5 9.8 5.8 6.6 17.9 4.6 10.0 6.2 0.0 3.5 3.1 6.5 1.8 8.1 7.3 3.1 6.4 17.9 16.5 7.1 4.0 11.8 4.7 6.8 1.0 7.2 5.7 5.5 3.5 18.0 5.9 42.2 12.9 7.2 16.2 9.2 2.5 1.1 7.5 6.2 1.0 RIIAD1 "C1orf230, FLJ36032, NCRNA00166" ENSG00000178796 "Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1" A6NNX1 1 151710433-151729805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 43.4;pituitary gland: 29.2" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 113.8;Early spermatids: 62.9;Intestinal endocrine cells: 44.4;Late spermatids: 46.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "CACO-2: 6.6;SCLC-21H: 3.6;SH-SY5Y: 7.1;SK-BR-3: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045703 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA045703: AB_10965795" "unprognostic (8.28e-3)" "unprognostic (3.42e-1)" "unprognostic (8.21e-2)" "prognostic favorable (5.46e-4)" "unprognostic (1.06e-2)" "unprognostic (3.09e-1)" "unprognostic (8.99e-2)" "unprognostic (3.20e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-2)" "unprognostic (3.65e-3)" "unprognostic (8.50e-2)" "unprognostic (1.57e-3)" "unprognostic (2.79e-2)" "unprognostic (3.06e-2)" "unprognostic (2.48e-4)" 0.5 2.7 4.0 0.5 9.3 0.5 1.1 0.5 5.6 1.6 1.1 0.8 1.2 0.6 2.1 6.1 0.7 43.4 0.9 0.5 4.6 5.1 0.6 0.5 3.1 0.5 2.5 5.2 2.6 1.2 1.1 29.2 0.5 3.6 1.0 1.3 1.2 0.5 1.9 0.5 0.6 0.8 1.1 0.5 0.5 2.0 14.7 2.1 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 7.1 0.0 11.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 9.3 0.5 5.6 4.6 5.1 2.5 5.2 3.6 2.1 17.9 1.0 0.0 0.0 0.0 6.7 14.0 0.0 113.8 15.9 5.2 15.7 0.0 3.3 3.1 62.9 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.1 0.0 44.4 0.0 0.0 46.5 0.6 0.3 3.3 0.0 2.0 0.8 0.2 0.0 1.4 2.2 2.7 0.0 1.0 14.9 7.8 0.0 0.0 0.0 0.8 0.0 RILPL1 FLJ39378 ENSG00000188026 "Rab interacting lysosomal protein like 1" Q5EBL4 12 123470054-123533718 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041314 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041314: AB_10795587" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (3.71e-2)" "unprognostic (5.36e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-3)" "unprognostic (1.94e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (2.30e-2)" "unprognostic (8.30e-2)" "unprognostic (4.25e-2)" "unprognostic (2.98e-1)" "unprognostic (2.32e-1)" "unprognostic (6.07e-3)" "unprognostic (2.81e-1)" 6.1 5.7 9.9 3.5 12.3 3.0 3.7 5.2 11.3 4.8 4.7 12.6 4.4 2.1 6.6 5.0 4.8 5.0 4.3 43.8 9.6 7.5 3.8 3.0 5.5 2.3 21.1 5.8 7.2 3.2 5.7 3.6 7.1 11.1 6.2 2.2 4.9 8.0 7.8 66.2 6.2 2.7 9.8 14.4 3.8 3.0 2.9 15.1 0.3 8.2 9.7 1.9 4.7 5.3 1.6 1.2 4.6 1.2 1.2 2.0 0.7 5.9 8.4 7.6 5.9 8.6 8.1 8.0 10.8 6.1 5.9 5.3 5.2 1.4 0.3 5.4 10.5 4.3 6.5 5.6 5.2 2.4 6.1 10.3 0.8 5.4 7.6 15.1 0.3 2.3 9.2 10.3 6.6 9.6 14.8 6.0 1.1 4.7 0.4 5.9 9.9 0.6 1.9 5.6 1.7 8.9 1.0 4.2 0.3 4.2 6.3 1.2 7.1 5.8 5.1 12.9 4.4 6.7 0.2 11.8 7.8 3.9 11.2 6.8 1.3 0.6 0.2 8.0 0.1 4.8 1.4 1.0 0.7 0.9 0.5 0.8 0.9 1.0 0.8 0.3 1.6 2.0 1.6 4.6 1.2 1.2 1.2 0.9 0.7 9.9 12.3 5.2 9.9 9.6 7.5 21.1 5.8 11.1 15.1 35.7 13.2 0.0 4.3 4.0 13.4 9.2 5.1 5.3 11.4 10.4 5.9 7.9 1.7 1.8 1.3 4.6 0.0 0.0 1.8 5.2 5.6 3.2 1.1 1.3 4.4 22.3 0.0 10.4 1.3 0.9 14.4 1.0 5.0 1.0 1.0 20.0 2.1 0.0 7.8 1.8 6.2 6.5 6.1 0.9 2.3 3.3 7.8 1.3 0.5 2.6 RILPL2 "FLJ30380, FLJ32372, MGC7036" ENSG00000150977 "Rab interacting lysosomal protein like 2" Q969X0 12 123410683-123436717 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Macrophages: 123.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 16.5;NB-4: 35.7;THP-1: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028958 Uncertain Supported Cytosol NA NA Cytosol "HPA028958: AB_10602124" "unprognostic (1.94e-3)" "unprognostic (3.29e-3)" "unprognostic (1.02e-1)" "prognostic favorable (5.24e-7)" "unprognostic (2.62e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.69e-2)" "unprognostic (4.08e-2)" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (1.11e-1)" "unprognostic (8.57e-2)" "unprognostic (2.10e-1)" "unprognostic (4.74e-2)" 14.8 5.6 5.8 13.2 7.1 42.9 13.6 3.8 5.7 25.1 7.7 5.3 12.8 4.1 17.8 10.6 10.2 14.2 13.4 7.4 6.3 5.1 12.8 7.8 21.6 15.3 6.3 4.7 12.2 5.0 6.0 7.0 7.7 7.2 18.2 3.8 8.2 21.4 15.6 4.4 6.5 9.8 9.6 7.6 29.9 7.6 7.8 5.8 8.6 25.7 7.4 14.3 14.0 22.0 8.5 13.6 26.2 19.0 3.1 9.0 7.8 2.5 2.5 1.2 4.6 5.2 4.2 2.9 3.1 6.4 2.4 2.1 2.7 1.4 1.6 2.6 4.3 1.7 2.1 1.9 2.1 2.5 5.1 2.0 16.5 2.6 3.9 5.5 12.5 9.7 3.4 1.6 2.6 1.9 3.8 2.5 3.6 2.3 2.0 2.1 1.7 4.5 35.7 1.1 0.9 2.6 3.7 2.6 2.9 2.6 4.3 0.6 1.6 3.6 0.8 2.8 1.8 3.5 22.8 3.1 2.5 2.8 4.3 1.9 2.2 1.7 3.2 2.5 8.9 1.2 12.5 19.0 21.5 3.8 14.4 3.5 8.5 7.8 6.5 13.6 5.7 3.4 3.7 26.2 3.1 15.7 6.9 9.0 7.8 5.8 7.1 3.8 5.7 6.3 5.1 6.3 4.7 7.2 5.8 32.8 66.4 47.4 59.9 21.8 1.0 3.7 28.1 50.9 42.1 21.0 2.0 8.6 21.6 16.7 1.7 50.1 1.1 0.0 18.6 6.2 24.9 47.9 60.2 11.9 67.8 1.6 4.1 49.1 107.3 0.9 46.6 123.1 35.4 92.0 7.5 12.2 16.2 3.7 62.2 44.4 1.6 6.5 38.1 0.7 14.0 13.4 6.8 70.5 3.7 63.3 RIMBP2 "KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2" ENSG00000060709 "RIMS binding protein 2" O15034 12 130396137-130716281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 19.7;Cone photoreceptor cells: 29.5;Intestinal endocrine cells: 72.5;Rod photoreceptor cells: 13.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive B-cell: 2.7" "Lineage enriched" "Detected in single" 28 "B-cells: 2.7" "Group enriched" "Detected in some" 6 "SCLC-21H: 17.6;SH-SY5Y: 34.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041494, HPA044114" Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA041494: , HPA044114: AB_2678815" "unprognostic (4.15e-4)" "unprognostic (9.77e-3)" "unprognostic (1.20e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-3)" "unprognostic (3.63e-1)" "unprognostic (1.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.86e-1)" "unprognostic (6.41e-3)" "unprognostic (5.27e-2)" "unprognostic (2.07e-1)" "unprognostic (1.03e-1)" "unprognostic (4.73e-2)" 0.9 11.9 14.1 1.1 13.0 0.6 0.6 1.1 24.7 6.1 1.5 1.6 0.0 2.5 2.5 2.4 0.8 6.6 1.1 0.4 15.3 11.0 2.8 0.6 0.7 0.5 5.6 12.9 2.1 2.3 49.1 42.7 0.4 4.9 1.3 1.8 4.1 0.6 1.4 0.5 2.4 2.3 2.3 5.6 1.1 5.2 2.3 1.6 0.0 0.9 0.0 0.5 0.8 0.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.2 4.2 0.0 0.0 17.6 34.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 13.0 1.1 24.7 15.3 11.0 5.6 12.9 4.9 1.6 0.0 0.0 0.0 0.0 1.8 19.7 0.8 0.0 1.4 0.0 0.0 29.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.5 72.5 0.0 0.0 1.7 0.9 0.0 0.0 0.0 1.2 3.1 0.1 0.0 0.7 0.0 13.7 0.0 0.0 1.1 1.2 0.5 0.0 0.0 0.6 0.0 RIMS2 "KIAA0751, OBOE, RAB3IP3, RIM2" ENSG00000176406 "Regulating synaptic membrane exocytosis 2" Q9UQ26 8 103500748-104256094 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 51.1;brain: 28.7" "Group enriched" "Detected in many" 10 "Bipolar cells: 397.4;Cone photoreceptor cells: 665.6;Rod photoreceptor cells: 1047.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 6.0;Daudi: 11.7;RT4: 8.4;SCLC-21H: 20.8;SuSa: 8.3" "Low region specificity" "Detected in all" "HPA046538, HPA066498, CAB079049" Enhanced Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB079049: , HPA046538: , HPA066498: AB_2685678" "unprognostic (2.98e-2)" "unprognostic (7.14e-2)" "unprognostic (4.47e-2)" "unprognostic (5.51e-2)" "unprognostic (2.82e-1)" "unprognostic (7.09e-3)" "unprognostic (2.02e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (8.01e-3)" "unprognostic (1.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.67e-5)" "unprognostic (8.12e-4)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" 0.9 51.1 15.8 1.0 21.8 1.1 1.8 14.5 28.7 8.5 0.9 0.5 0.9 1.2 1.4 1.7 1.0 6.3 1.7 0.9 10.3 4.9 1.1 0.9 1.0 1.1 3.1 17.5 2.8 1.6 0.9 12.4 1.1 8.6 2.8 1.0 5.8 1.0 1.8 1.0 1.0 1.4 2.0 4.0 0.9 1.7 3.9 8.7 0.0 2.9 0.0 1.0 1.5 1.6 0.7 0.7 2.9 0.6 1.6 0.6 0.2 3.7 0.0 6.0 0.0 0.0 0.0 0.0 0.4 0.3 1.1 1.4 0.1 0.3 11.7 0.1 0.0 1.2 0.3 1.8 0.7 1.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.9 2.1 0.0 1.3 0.1 0.5 0.0 0.5 0.8 0.0 4.6 0.0 0.6 0.0 0.0 0.0 0.0 8.4 20.8 5.1 0.0 0.1 0.5 8.3 0.3 0.2 0.0 0.0 5.6 0.1 0.1 1.5 0.0 0.1 0.4 0.2 0.2 2.7 0.6 0.6 0.6 0.3 0.4 0.4 0.3 0.4 0.1 0.7 0.3 0.5 2.9 1.6 0.4 0.7 0.3 0.2 15.8 21.8 14.5 28.7 10.3 4.9 3.1 17.5 8.6 8.7 26.8 32.3 0.0 1.6 0.2 397.4 0.7 2.5 18.7 29.6 0.0 665.6 0.5 1.7 0.0 29.0 0.5 0.0 0.0 0.0 0.2 0.8 4.9 15.1 0.0 0.2 63.5 8.1 0.6 0.3 13.5 66.7 0.4 1.7 0.0 0.2 71.8 0.4 0.0 27.6 0.1 1047.7 0.0 0.3 15.3 9.9 0.4 0.1 0.5 0.0 0.9 RIN2 RASSF4 ENSG00000132669 "Ras and Rab interactor 2" Q8WYP3 20 19886521-20002457 "Disease related genes, Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 81.6;Ito cells: 94.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "dendritic cells: 1.2;granulocytes: 2.2;monocytes: 3.3" "Cell line enhanced" "Detected in many" "PC-3: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034641 Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoli, Golgi apparatus" "HPA034641: AB_10671230" "unprognostic (8.23e-3)" "unprognostic (8.09e-3)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (3.12e-2)" "unprognostic (3.86e-2)" "unprognostic (1.61e-2)" "unprognostic (3.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.78e-3)" "unprognostic (2.49e-1)" "unprognostic (6.27e-2)" "prognostic favorable (8.34e-6)" "unprognostic (3.10e-1)" "unprognostic (2.08e-2)" "unprognostic (8.02e-3)" "unprognostic (3.63e-2)" 19.2 6.7 9.9 6.1 8.7 4.0 24.4 4.3 10.2 11.7 21.6 9.5 7.6 10.5 12.7 6.6 11.1 9.7 14.7 13.7 10.0 6.2 12.2 4.6 26.8 4.3 8.3 4.4 12.7 5.1 4.2 4.9 16.7 9.3 8.0 10.4 16.5 12.0 11.3 10.9 6.6 23.4 13.2 7.7 17.5 6.5 3.5 9.9 0.3 13.1 5.5 3.7 9.9 15.6 0.3 1.2 2.2 3.3 0.1 0.3 0.4 3.4 11.4 2.1 6.8 12.5 7.7 7.1 2.8 11.8 3.0 1.7 5.4 3.1 0.0 12.4 7.1 5.7 12.7 0.1 18.1 3.3 1.4 0.0 0.0 2.0 0.4 2.8 0.0 0.0 11.2 3.1 5.7 6.3 6.8 16.2 0.0 0.0 0.2 9.0 2.5 0.0 0.2 0.3 1.6 25.3 0.1 7.6 1.8 3.9 4.9 1.8 0.4 2.7 11.2 0.0 2.2 1.0 0.9 17.5 6.3 1.4 3.7 4.7 0.0 0.0 0.0 4.0 0.0 1.0 0.6 3.3 0.2 0.2 2.7 0.2 0.2 0.2 0.2 1.2 0.3 0.3 0.3 2.2 0.1 2.8 0.6 0.1 0.4 9.9 8.7 4.3 10.2 10.0 6.2 8.3 4.4 9.3 9.9 59.6 13.7 4.7 21.9 37.3 5.7 26.6 10.2 13.4 15.9 29.6 7.9 3.8 36.5 15.5 0.6 37.6 17.0 0.0 30.1 5.9 38.6 19.7 0.0 3.8 81.6 6.4 13.8 94.5 62.1 0.8 17.8 36.0 20.3 4.6 16.1 26.2 24.4 7.0 14.5 34.2 0.7 0.0 17.4 0.0 0.1 47.2 5.9 2.5 18.9 24.1 RING1 RNF1 ENSG00000204227 "Ring finger protein 1" Q06587 6 33208495-33212722 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008701 Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008701: AB_1079814" "unprognostic (2.12e-3)" "unprognostic (7.98e-2)" "unprognostic (3.77e-2)" "unprognostic (1.37e-1)" "unprognostic (3.91e-2)" "unprognostic (3.21e-1)" "unprognostic (1.53e-1)" "unprognostic (4.75e-2)" "unprognostic (7.76e-2)" "unprognostic (1.26e-2)" "unprognostic (3.70e-2)" "unprognostic (1.62e-2)" "unprognostic (2.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.55e-1)" "unprognostic (2.13e-1)" "unprognostic (9.88e-2)" 26.7 22.6 17.8 15.9 21.3 12.0 14.6 27.6 24.2 22.2 17.6 22.0 21.0 18.2 31.9 17.3 14.5 18.8 21.4 14.4 17.3 18.2 19.3 21.6 16.8 14.5 24.0 15.4 25.0 18.3 24.0 34.0 14.9 17.0 21.8 7.6 20.0 19.0 20.5 18.0 21.7 19.5 22.9 18.5 23.2 24.1 16.9 20.8 25.5 29.3 13.1 14.3 13.9 17.1 1.2 2.2 0.8 1.5 0.2 2.2 0.2 4.2 3.6 4.2 4.1 4.3 1.4 9.8 11.2 6.8 4.6 4.7 3.8 3.2 7.0 4.7 4.5 5.8 7.7 3.6 3.4 3.2 8.6 2.9 8.4 5.9 7.2 9.7 4.8 6.9 0.0 3.4 4.1 7.6 3.6 1.7 3.8 12.1 5.4 4.8 0.0 0.3 3.7 1.9 3.1 4.6 4.5 7.0 7.7 5.0 3.7 8.4 5.2 4.0 4.3 11.6 1.1 5.0 8.4 2.3 5.1 3.8 0.0 9.2 6.1 6.2 6.7 3.8 4.4 3.1 0.0 1.5 0.8 2.2 0.4 0.4 1.1 0.7 1.0 0.7 1.2 1.7 0.9 0.3 0.2 0.5 2.2 0.4 0.2 17.8 21.3 27.6 24.2 17.3 18.2 24.0 15.4 17.0 20.8 0.0 22.7 20.1 35.5 24.5 30.5 21.4 17.8 17.4 14.8 21.0 15.7 36.0 13.3 28.6 21.1 23.2 23.3 0.0 30.3 27.6 28.0 27.3 19.6 30.5 26.3 23.8 29.4 30.7 29.6 13.2 37.2 20.0 16.9 20.8 19.8 38.3 26.5 21.0 28.0 26.9 18.0 25.8 22.7 32.9 18.8 26.7 52.7 25.4 21.0 24.7 RIOK1 "AD034, bA288G3.1, FLJ30006, RRP10" ENSG00000124784 "RIO kinase 1" Q9BRS2 6 7389496-7418037 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017866, HPA051446" Enhanced Supported Cytosol NA NA Cytosol "HPA017866: AB_2669670, HPA051446: AB_2681488" "unprognostic (2.33e-2)" "unprognostic (1.24e-1)" "unprognostic (2.38e-1)" "unprognostic (1.03e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.41e-5)" "unprognostic (2.23e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (3.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.85e-5)" "unprognostic (2.33e-1)" "unprognostic (2.09e-1)" "unprognostic (6.12e-3)" "unprognostic (2.59e-2)" 13.8 10.6 7.7 13.2 13.0 17.5 13.1 12.2 13.5 12.7 11.6 7.3 4.0 7.3 15.4 6.0 15.6 12.3 8.5 11.8 8.0 8.1 8.7 11.7 10.1 14.2 11.6 9.4 13.8 15.3 7.7 17.8 13.9 13.3 10.7 9.6 7.2 10.2 10.3 18.8 12.5 9.9 15.5 9.4 14.4 10.3 21.3 9.2 19.2 10.1 14.7 16.8 10.9 12.6 15.4 14.9 7.7 11.1 18.6 15.0 8.2 7.6 4.4 7.2 16.8 11.2 9.2 11.0 9.6 6.5 9.0 7.4 12.9 3.9 19.9 17.1 7.8 7.8 7.8 18.1 7.7 11.5 13.1 19.5 10.6 7.1 13.8 9.5 30.5 13.9 6.8 10.7 9.7 20.0 4.3 7.9 15.0 27.0 4.7 8.4 10.0 20.7 14.5 15.4 14.2 10.5 15.9 9.4 21.6 5.0 7.4 24.0 11.8 8.1 4.9 14.0 19.4 7.4 10.1 7.9 9.8 7.4 6.5 14.5 6.4 12.2 29.6 3.0 15.7 15.0 7.7 8.5 5.9 11.5 11.1 13.8 15.2 11.9 12.1 14.9 15.4 13.7 15.0 1.7 18.6 9.7 12.4 11.3 8.2 7.7 13.0 12.2 13.5 8.0 8.1 11.6 9.4 13.3 9.2 6.0 26.6 22.4 26.7 46.9 9.2 20.4 2.5 25.4 45.5 7.0 9.8 29.8 3.3 13.2 34.2 23.9 5.8 0.0 10.2 28.8 22.0 11.9 32.4 8.9 20.4 4.8 6.9 17.2 6.5 6.5 18.4 16.7 16.9 11.8 10.4 5.5 10.9 5.8 18.7 9.0 10.4 19.4 26.4 55.6 78.8 56.7 23.3 22.0 15.3 20.6 RIOK2 FLJ11159 ENSG00000058729 "RIO kinase 2" Q9BVS4 5 97160867-97183260 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA005681 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA005681: AB_1856286" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-2)" "unprognostic (8.04e-2)" "unprognostic (1.38e-1)" "unprognostic (4.51e-2)" "unprognostic (2.71e-3)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.11e-1)" "unprognostic (8.76e-2)" "unprognostic (6.63e-2)" "unprognostic (1.26e-3)" "unprognostic (3.60e-1)" "unprognostic (9.98e-2)" "unprognostic (1.43e-2)" "unprognostic (1.39e-2)" 22.2 20.1 14.8 17.1 17.5 24.4 19.7 26.3 18.6 19.1 17.0 8.9 14.0 17.3 17.5 17.1 17.0 15.0 10.7 19.6 15.7 13.4 21.0 23.6 13.3 17.6 20.0 11.1 20.7 21.5 15.1 37.5 15.8 19.7 19.5 17.3 10.3 18.7 16.6 24.9 13.3 20.2 16.3 20.7 22.5 16.4 14.8 18.6 25.8 21.7 20.7 17.4 20.7 21.0 15.2 17.8 9.4 18.7 17.8 24.1 13.5 8.8 10.4 9.7 18.8 12.8 14.0 15.5 22.3 13.8 15.8 21.0 14.2 15.6 19.6 25.4 10.0 24.9 10.5 16.5 13.0 21.7 13.8 9.1 9.8 20.1 19.8 11.5 18.6 13.8 9.2 10.2 19.3 19.6 12.1 12.8 14.6 14.8 12.7 18.1 14.8 21.8 22.3 11.5 5.3 11.2 24.5 18.9 28.8 12.4 8.1 12.1 9.0 13.5 14.1 15.4 15.1 14.7 17.8 13.7 20.3 14.1 16.1 24.3 12.5 16.2 44.0 12.1 19.1 18.5 7.0 16.0 9.4 16.3 18.7 22.3 15.2 20.7 17.8 17.8 11.0 22.5 24.1 3.2 17.8 13.4 17.8 18.5 13.5 14.8 17.5 26.3 18.6 15.7 13.4 20.0 11.1 19.7 18.6 8.9 10.9 13.0 14.3 23.5 16.4 15.9 12.7 10.7 11.4 7.0 11.8 16.7 14.9 14.2 1.1 14.0 7.0 0.0 13.1 19.4 15.8 9.9 27.6 7.8 15.9 12.7 9.2 6.2 11.0 1.8 12.4 11.5 5.0 13.6 11.2 12.3 10.5 10.5 15.2 12.2 17.2 6.5 21.7 20.7 20.2 16.6 14.5 14.4 12.1 11.4 RIOK3 SUDD ENSG00000101782 "RIO kinase 3" O14730 18 23452823-23486603 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001620, HPA024184" Approved Approved "Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus, Centriolar satellite" "HPA001620: AB_1079815, HPA024184: AB_1856289" "unprognostic (7.99e-2)" "unprognostic (1.71e-2)" "unprognostic (2.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.05e-1)" "unprognostic (7.48e-2)" "unprognostic (8.98e-3)" "unprognostic (1.01e-1)" "unprognostic (5.10e-2)" "unprognostic (4.20e-1)" "prognostic unfavorable (4.10e-4)" "prognostic unfavorable (5.80e-4)" "unprognostic (3.90e-2)" "unprognostic (1.46e-1)" "unprognostic (5.44e-2)" "unprognostic (1.39e-1)" "unprognostic (2.71e-2)" 10.1 8.7 6.9 11.7 7.7 52.4 10.9 8.9 10.1 14.7 21.4 8.5 5.9 15.6 8.8 9.3 41.0 7.8 10.7 11.5 6.1 5.5 10.5 19.9 10.1 10.7 9.1 6.2 7.6 10.7 7.5 11.6 21.4 11.6 6.8 14.7 6.0 14.9 7.0 40.0 13.3 36.5 15.2 10.5 8.9 12.9 22.7 7.6 11.1 7.3 16.0 16.5 13.7 21.5 11.7 11.0 21.7 21.5 8.3 11.2 10.0 14.8 5.8 6.1 7.9 11.1 12.4 11.0 14.9 11.0 10.6 10.2 6.7 16.1 10.3 19.6 16.6 10.8 19.5 10.3 17.0 16.4 10.2 4.3 9.6 10.9 8.4 27.8 27.0 8.4 14.8 32.4 18.8 26.0 12.1 14.7 6.5 13.9 13.0 15.9 7.9 9.3 4.4 5.6 21.7 11.7 10.5 12.7 12.5 12.1 19.5 14.2 10.2 19.1 8.7 10.9 15.9 7.7 14.6 23.1 17.5 4.4 7.7 9.6 23.5 19.7 15.3 10.3 12.5 13.1 21.7 13.5 8.0 9.1 19.6 6.9 8.2 7.6 7.9 11.0 11.7 6.1 6.9 9.3 8.3 21.5 5.1 11.2 10.0 6.9 7.7 8.9 10.1 6.1 5.5 9.1 6.2 11.6 7.6 74.5 51.9 21.7 78.2 107.0 43.0 61.7 43.3 56.2 67.1 24.4 53.0 38.5 21.6 40.3 191.3 39.6 193.3 116.8 45.8 56.7 46.6 92.4 61.2 72.5 37.1 27.0 60.3 33.7 55.0 227.3 20.8 49.5 40.5 47.7 85.9 17.1 98.8 75.8 28.3 40.3 43.8 6.5 38.7 23.6 9.5 125.6 73.9 34.1 42.3 194.9 RIPK1 RIP ENSG00000137275 "Receptor interacting serine/threonine kinase 1" Q13546 6 3063991-3115187 "Enzymes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Inflammatory response, Necrosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010302, HPA015257" Supported Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB010302: AB_2178118, HPA015257: AB_1856294" "unprognostic (1.24e-1)" "unprognostic (6.83e-2)" "unprognostic (1.87e-1)" "unprognostic (7.75e-2)" "unprognostic (6.08e-2)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (1.96e-1)" "unprognostic (9.46e-2)" "unprognostic (1.46e-1)" "unprognostic (5.00e-2)" "unprognostic (3.29e-1)" "unprognostic (9.65e-3)" "unprognostic (3.44e-1)" "unprognostic (9.01e-2)" "unprognostic (1.38e-2)" "prognostic favorable (6.71e-4)" 24.5 12.0 6.9 15.7 12.4 10.5 28.0 11.9 11.0 16.4 18.9 9.6 22.9 14.5 16.8 17.7 17.1 13.5 17.9 12.3 7.5 6.8 18.5 36.7 16.7 19.8 11.8 6.6 13.2 19.9 14.4 17.9 24.4 10.2 17.8 16.6 10.9 21.1 18.7 11.4 18.9 24.8 21.3 6.9 19.4 15.8 9.0 9.4 18.6 18.5 15.2 19.2 15.0 20.4 4.1 3.2 6.6 3.9 6.6 7.6 2.1 9.5 6.8 10.3 10.6 22.0 14.1 5.7 15.0 20.4 15.9 18.3 9.2 6.6 8.9 14.5 21.5 16.7 11.0 12.8 12.3 17.4 18.4 6.9 11.5 4.5 6.7 12.4 9.9 14.7 19.0 11.0 14.7 10.7 13.0 13.7 5.5 12.9 5.1 15.3 12.3 6.8 10.8 6.5 11.5 8.5 8.3 7.6 10.0 14.2 19.1 8.9 8.8 9.9 6.2 16.6 21.9 11.4 7.1 16.6 17.4 9.3 6.6 11.1 7.9 10.2 9.5 7.3 5.5 19.2 1.1 3.0 6.4 6.1 3.7 4.9 2.0 4.9 7.6 3.2 4.1 4.1 5.4 6.6 6.6 3.9 2.9 5.7 2.1 6.9 12.4 11.9 11.0 7.5 6.8 11.8 6.6 10.2 9.4 6.0 8.1 8.8 8.6 9.7 3.4 6.9 12.7 21.4 20.5 8.7 11.8 7.3 5.0 8.1 1.6 15.8 13.6 0.0 11.3 5.6 9.8 8.2 10.4 12.3 10.1 4.8 6.3 11.6 5.1 0.4 6.4 11.1 3.3 17.2 15.4 7.2 10.3 10.1 5.6 8.2 21.0 19.4 15.1 0.9 2.5 8.7 10.0 12.5 9.3 12.2 RIPK2 "CARD3, CARDIAK, RICK, RIP2" ENSG00000104312 "Receptor interacting serine/threonine kinase 2" O43353 8 89757747-89791063 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Apoptosis, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015273, HPA016499" Approved Enhanced Cytosol NA NA Cytosol "HPA015273: AB_1856299, HPA016499: AB_1856300" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (2.35e-1)" "unprognostic (3.82e-2)" "unprognostic (1.67e-1)" "unprognostic (6.20e-2)" "unprognostic (1.43e-3)" "prognostic unfavorable (6.33e-5)" "unprognostic (2.06e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (5.00e-6)" "unprognostic (6.39e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.84e-2)" "unprognostic (5.08e-2)" "unprognostic (1.05e-2)" "prognostic favorable (8.05e-4)" 12.0 5.5 9.3 11.2 7.9 13.6 10.0 3.0 9.3 9.7 7.9 10.6 5.2 3.5 10.9 7.8 8.3 7.0 17.3 11.6 9.2 8.6 7.7 10.4 18.7 10.9 11.8 5.8 8.9 13.2 14.7 7.3 20.8 9.1 10.7 5.6 4.6 10.2 5.8 3.1 10.4 6.9 10.4 16.5 14.2 8.3 5.6 11.5 5.1 8.5 4.9 11.8 15.0 7.6 7.5 6.9 19.4 11.2 3.8 5.5 4.3 10.3 3.6 1.8 2.6 4.5 6.3 3.4 11.5 19.6 6.1 7.9 3.1 5.4 8.0 17.9 6.4 4.9 2.5 4.9 3.8 11.3 5.7 4.9 6.7 1.7 3.1 12.7 2.4 3.3 5.0 3.1 8.7 28.1 6.5 6.4 0.0 3.2 2.6 5.6 2.1 0.0 5.1 1.0 4.7 8.5 1.7 2.6 3.9 14.3 4.6 0.3 2.0 2.7 7.2 5.4 2.5 7.0 3.0 5.7 3.7 3.5 6.3 5.3 5.3 2.4 4.8 9.1 0.2 2.4 8.8 5.7 19.4 3.6 10.6 4.1 7.5 5.5 4.7 6.9 4.3 5.2 5.5 4.5 3.8 11.2 2.3 1.2 4.3 9.3 7.9 3.0 7.4 9.2 8.6 11.8 5.8 9.1 11.5 32.8 17.8 13.4 31.1 51.2 2.4 2.8 5.1 10.7 22.7 3.5 0.0 10.6 5.0 66.4 5.0 9.5 2.3 0.0 53.1 35.2 38.5 46.3 42.7 2.6 39.0 3.2 0.0 5.5 25.3 1.6 7.2 48.6 18.6 50.5 5.2 10.0 41.2 0.0 5.6 6.7 0.1 12.9 22.7 8.1 10.9 42.2 70.0 12.7 6.6 40.4 RIPOR1 "FAM65A, FLJ13725" ENSG00000039523 "RHO family interacting cell polarization regulator 1" Q6ZS17 16 67518418-67546788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 23.1;Ductal cells: 13.7;Hofbauer cells: 25.5;Pancreatic endocrine cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 8.2;eosinophil: 6.4;intermediate monocyte: 12.0;memory B-cell: 12.3;myeloid DC: 7.6;naive B-cell: 8.1;neutrophil: 4.9;non-classical monocyte: 10.4;plasmacytoid DC: 10.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005923 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA005923: AB_1078809" "unprognostic (7.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.56e-3)" "unprognostic (3.71e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.38e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.82e-8)" "unprognostic (8.51e-2)" "unprognostic (3.52e-2)" "unprognostic (1.19e-1)" "unprognostic (7.46e-2)" 26.6 16.7 21.2 20.8 28.5 21.9 23.7 31.8 35.1 18.8 16.6 13.1 8.4 8.7 24.2 11.4 15.1 17.6 20.4 35.6 21.2 15.8 30.8 11.7 27.8 17.6 12.8 18.6 20.6 22.4 20.4 14.4 27.9 16.9 15.7 7.6 27.1 15.8 20.7 24.3 12.1 15.6 24.0 10.0 37.5 13.4 11.6 12.5 6.7 19.0 13.1 16.2 17.0 22.6 12.3 10.8 6.4 12.0 1.1 1.4 3.7 15.7 13.4 6.1 9.5 15.4 13.9 13.4 16.8 16.7 19.5 16.3 27.5 11.7 2.1 23.6 28.8 9.9 9.0 12.1 15.2 12.6 6.9 6.2 20.9 18.4 6.2 17.3 1.6 10.6 13.7 7.1 26.2 17.8 13.9 20.5 3.8 2.3 2.4 14.4 17.2 4.9 5.2 1.6 3.0 10.8 16.8 10.9 11.2 14.9 8.1 4.5 12.0 31.3 5.3 10.6 6.2 11.3 3.9 35.5 22.3 13.1 18.7 11.6 3.4 2.3 6.5 14.8 4.0 11.8 0.0 8.2 6.4 1.0 12.0 1.4 12.3 0.8 0.4 7.6 8.1 0.6 0.5 4.9 1.1 10.4 10.8 0.5 3.7 21.2 28.5 31.8 35.1 21.2 15.8 12.8 18.6 16.9 12.5 14.9 23.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 7.0 0.0 0.5 0.0 13.7 0.0 0.0 0.0 0.0 10.8 1.1 0.0 0.0 9.3 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 7.2 0.0 0.0 25.5 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221751 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "retina: 164.1" "Cell type enriched" "Detected in some" 43 "Muller glia cells: 2424.2" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Group enriched" "Detected in many" 4 "amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7" "Group enriched" "Detected in some" 7 "basophil: 3.3;neutrophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Cell line enriched" "Detected in single" 48 "SK-MEL-30: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042051: AB_2732495, HPA044083: AB_2678802" "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.2 0.7 6.9 0.6 10.6 0.6 0.2 0.6 11.5 0.2 0.8 0.3 0.1 0.9 0.2 1.0 0.3 0.2 0.3 0.2 3.7 1.3 0.2 0.2 0.3 0.3 1.6 0.6 0.2 0.2 0.2 1.7 0.3 0.4 0.2 0.8 164.1 0.2 0.2 0.5 0.3 0.6 0.5 0.5 0.3 0.2 1.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 3.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 6.9 10.6 0.6 7.0 3.7 1.3 1.6 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.0 0.0 0.0 0.0 37.3 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2424.2 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.1 0.0 0.0 16.7 0.0 0.0 0.0 RLIM "MGC15161, NY-REN-43, RNF12" ENSG00000131263 "Ring finger protein, LIM domain interacting" Q9NVW2 X 74585217-74614617 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018895 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018895: AB_1856323" "unprognostic (1.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-1)" "unprognostic (1.31e-3)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.25e-1)" "unprognostic (3.82e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.20e-1)" 11.8 14.3 17.5 10.6 25.6 37.4 12.4 12.6 20.5 12.2 7.4 8.3 5.6 6.4 10.6 8.0 10.2 9.5 10.7 10.5 17.1 16.6 11.6 9.7 13.8 9.2 12.4 13.7 12.4 9.7 19.5 18.5 10.5 28.6 11.9 7.6 5.2 8.9 8.7 11.2 10.2 7.1 10.1 13.9 9.8 8.4 6.9 12.4 9.7 13.0 6.2 10.1 10.5 9.3 3.5 4.8 16.3 7.4 5.2 4.6 3.0 13.7 14.0 13.6 11.3 13.7 14.5 13.4 13.2 15.4 11.9 14.7 10.9 14.4 7.4 15.5 16.6 16.1 11.9 27.3 15.9 18.2 6.7 14.4 13.0 24.7 6.6 12.2 19.5 23.2 14.0 10.0 16.9 29.1 10.2 13.8 12.4 11.2 13.5 15.6 10.5 14.5 11.1 20.9 8.5 13.5 13.9 28.8 12.5 11.0 16.5 10.0 11.7 24.9 12.1 15.4 13.0 6.8 15.4 18.3 14.4 14.0 14.7 11.5 7.2 13.8 11.9 15.7 19.9 14.0 16.3 5.9 5.6 3.2 7.4 3.3 3.0 4.1 4.0 4.8 3.5 4.5 4.1 11.4 5.2 5.4 2.6 4.6 3.0 17.5 25.6 12.6 20.5 17.1 16.6 12.4 13.7 28.6 12.4 14.9 17.1 2.9 24.0 31.8 12.3 26.3 15.3 24.1 20.5 24.4 13.7 14.1 10.0 12.7 5.5 27.4 7.8 0.0 9.2 17.5 26.4 21.1 36.9 11.9 16.0 20.6 22.2 20.3 20.2 3.3 9.2 23.6 16.9 3.6 9.8 13.7 11.6 8.6 17.7 9.6 13.8 6.5 17.6 7.2 17.2 33.9 22.0 17.0 10.2 31.0 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 38.4" "Group enriched" "Detected in many" 6 "Early spermatids: 207.9;Late spermatids: 131.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 17.7" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" Yes No "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: AB_2674292, HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favorable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.6 38.4 6.1 8.7 6.8 1.9 8.9 6.2 8.2 6.3 9.7 1.8 5.9 6.8 7.0 9.2 3.7 4.3 5.5 4.6 5.9 3.5 6.6 24.0 8.2 3.3 3.2 5.1 3.2 4.2 3.2 8.6 3.1 4.6 8.1 8.7 5.2 5.7 10.2 5.0 2.9 14.7 7.7 4.8 14.1 4.6 15.6 4.0 2.1 4.7 3.6 2.1 4.3 9.0 7.5 6.0 4.8 8.0 6.3 6.1 2.3 3.4 3.9 2.7 1.7 12.1 12.4 1.6 7.3 9.3 3.6 3.8 1.0 11.4 2.4 3.2 10.8 2.3 3.9 0.9 4.9 4.6 4.7 2.7 4.0 1.6 3.4 6.3 0.0 4.1 17.7 3.8 5.0 0.7 6.1 2.0 1.2 4.8 2.0 6.5 1.3 0.8 4.1 5.2 6.6 3.9 0.0 0.7 0.4 9.5 3.1 2.1 7.9 5.7 0.6 6.4 2.3 1.2 5.5 2.8 5.1 5.4 2.7 2.8 3.9 6.8 4.8 6.0 0.9 5.1 0.0 4.9 1.0 4.0 8.0 6.1 7.5 1.9 2.5 3.3 5.0 2.0 4.3 4.8 6.3 6.1 6.0 0.2 2.3 6.1 6.8 6.2 8.2 5.9 3.5 3.2 5.1 4.6 4.0 26.8 23.5 5.4 7.2 2.2 3.7 3.6 7.6 13.4 27.3 5.2 2.0 1.7 6.6 4.2 207.9 3.6 21.2 0.0 3.4 0.8 7.3 2.5 15.1 12.9 4.4 4.8 4.6 3.7 6.5 131.8 8.6 4.4 5.0 1.8 11.2 5.8 2.4 7.0 5.6 5.9 2.2 6.5 3.9 3.9 3.7 2.0 0.7 3.8 15.9 2.0 RMI2 "BLAP18, C16orf75, MGC24665" ENSG00000175643 "RecQ mediated genome instability 2" Q96E14 16 11249619-11351762 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.7;testis: 29.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 100.7;Peritubular cells: 40.0;Spermatogonia: 42.9;Syncytiotrophoblasts: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;T-cells: 3.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA040995 Uncertain Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "HPA040995: AB_10795531" "unprognostic (2.76e-1)" "prognostic favorable (5.69e-5)" "unprognostic (1.17e-1)" "unprognostic (3.09e-3)" "unprognostic (1.69e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (2.77e-5)" "unprognostic (3.98e-1)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (3.44e-3)" "unprognostic (3.89e-1)" "unprognostic (2.18e-1)" "unprognostic (5.50e-2)" "unprognostic (3.68e-2)" "unprognostic (3.60e-3)" "unprognostic (1.03e-1)" 1.0 1.8 4.2 18.0 5.1 4.8 2.8 0.7 4.1 2.8 7.3 1.0 0.4 4.3 2.5 3.2 11.8 1.0 2.6 1.9 2.5 1.5 3.1 2.3 2.9 17.9 1.6 5.6 3.6 1.6 0.7 1.1 13.2 1.2 2.6 9.0 0.8 2.9 1.7 1.1 8.7 5.6 1.1 1.4 4.2 4.0 29.6 1.2 31.7 1.4 2.8 20.4 3.6 4.5 6.5 0.6 0.9 0.0 0.3 3.0 0.3 19.2 12.9 25.4 10.8 1.1 5.5 10.6 11.2 8.9 10.6 17.7 4.9 22.9 26.7 9.7 5.2 12.0 11.3 10.8 10.7 17.3 5.2 10.1 14.6 7.6 32.6 0.4 5.6 6.6 1.2 2.1 4.6 4.4 4.2 5.8 11.8 20.1 21.3 5.5 22.2 19.3 26.2 21.3 26.9 5.1 23.5 27.4 28.5 6.3 12.5 14.6 11.6 9.5 15.9 8.3 15.3 27.0 8.4 1.8 8.5 8.0 16.3 1.6 5.8 9.6 31.7 7.9 18.5 15.7 0.0 0.0 0.9 0.6 0.0 0.0 6.5 0.2 0.0 0.4 2.5 1.8 0.7 0.2 0.3 0.0 0.6 3.0 0.3 4.2 5.1 0.7 4.1 2.5 1.5 1.6 5.6 1.2 1.2 0.0 0.3 4.9 6.4 6.1 0.1 0.8 5.1 0.0 2.3 7.0 0.0 100.7 5.0 2.3 2.2 0.7 1.1 23.3 0.4 27.0 2.6 1.6 0.0 0.8 15.8 0.0 2.4 1.3 1.0 4.3 14.7 3.4 3.3 1.8 5.9 0.0 1.1 3.5 40.0 0.0 0.5 32.3 0.9 31.4 42.9 4.6 39.9 0.0 7.0 2.8 RNASEH1 ENSG00000171865 "Ribonuclease H1" O60930 2 3544793-3558616 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA034817, HPA043037" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA034817: , HPA043037: AB_2678280" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "unprognostic (8.81e-3)" "unprognostic (4.32e-3)" "unprognostic (1.79e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.83e-6)" "unprognostic (9.43e-2)" "unprognostic (8.46e-3)" "unprognostic (6.38e-2)" "unprognostic (2.29e-3)" "unprognostic (2.67e-1)" "unprognostic (4.06e-2)" "unprognostic (2.34e-2)" "unprognostic (2.11e-1)" "unprognostic (3.06e-2)" "unprognostic (2.23e-3)" 16.6 12.8 10.1 14.5 15.4 14.7 16.1 11.0 13.1 9.7 12.1 11.4 10.8 11.8 13.3 14.0 14.1 10.0 11.0 18.5 13.1 10.3 10.9 17.0 11.2 18.3 12.9 11.4 10.1 15.1 10.5 10.8 11.5 12.3 11.2 12.6 9.5 11.2 16.0 35.3 11.3 11.3 17.7 11.9 12.4 11.8 13.8 12.5 10.9 10.1 10.3 14.5 12.8 11.8 16.6 15.9 7.4 12.8 17.2 14.6 10.8 8.8 20.6 7.1 12.1 7.5 7.8 15.9 14.5 12.6 12.4 10.0 15.7 10.7 17.0 15.7 13.0 17.8 9.7 11.9 11.8 9.9 12.7 7.8 14.7 12.2 26.3 14.2 19.1 13.9 6.9 9.9 13.4 15.8 5.4 10.9 27.2 20.0 17.0 12.7 17.5 11.3 10.7 13.8 17.7 15.4 13.8 11.7 17.8 7.5 15.6 12.0 15.7 12.3 8.6 12.1 6.9 7.3 7.3 11.2 16.4 11.2 13.0 20.1 25.2 34.1 28.4 15.3 14.4 21.4 2.8 11.5 7.4 14.5 12.8 14.6 16.6 12.7 13.6 14.2 13.8 12.9 12.5 3.2 17.2 11.1 15.9 11.2 10.8 10.1 15.4 11.0 13.1 13.1 10.3 12.9 11.4 12.3 12.5 20.8 5.8 33.5 22.9 6.6 24.6 21.5 10.2 13.4 6.8 3.5 19.6 27.2 31.5 32.0 2.8 17.3 13.6 0.0 42.6 35.7 17.7 24.8 27.6 15.3 27.4 33.4 14.5 14.1 16.4 2.3 12.7 15.4 10.1 37.9 11.2 16.4 36.8 7.0 24.8 20.1 17.0 19.4 19.0 18.4 29.0 10.7 30.6 16.0 14.7 29.8 RNASEH2A "AGS4, RNASEHI, RNHIA, RNHL" ENSG00000104889 "Ribonuclease H2 subunit A" O75792 19 12806556-12815201 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.8" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 97.8;Spermatocytes: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042692 Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA042692: AB_10793981" "unprognostic (6.74e-2)" "prognostic favorable (1.18e-4)" "prognostic favorable (6.18e-4)" "unprognostic (2.24e-1)" "unprognostic (2.62e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (8.48e-2)" "unprognostic (9.33e-2)" "prognostic favorable (1.22e-4)" "unprognostic (3.80e-3)" "unprognostic (8.71e-2)" "prognostic unfavorable (6.29e-6)" "unprognostic (3.40e-3)" "unprognostic (4.35e-2)" "unprognostic (5.35e-2)" "unprognostic (8.60e-2)" 6.5 5.5 6.4 11.4 10.6 21.9 6.6 11.0 7.5 6.8 6.6 9.2 1.6 8.6 6.8 4.4 14.1 6.0 5.7 5.1 6.7 4.8 8.7 5.9 5.5 9.2 10.6 5.8 7.3 7.0 6.2 4.1 11.8 6.1 5.3 5.7 5.5 8.8 4.3 7.1 13.4 7.1 4.4 7.8 12.0 7.4 14.1 8.4 44.8 8.6 13.4 17.4 6.0 8.0 11.3 7.8 7.1 6.8 12.9 8.6 5.0 14.9 11.3 6.8 6.8 1.0 1.9 8.4 7.0 2.9 10.5 12.1 8.9 5.7 16.0 10.5 1.6 5.9 8.9 5.6 6.9 5.8 8.7 15.1 7.7 12.0 6.8 0.8 7.0 7.1 1.0 1.7 8.8 3.2 2.0 4.0 13.1 10.6 4.8 5.0 25.7 12.9 7.0 6.8 5.6 19.7 13.9 9.9 11.5 2.6 5.9 14.2 8.3 7.5 2.8 3.2 3.1 7.4 4.4 3.8 12.5 6.3 17.7 11.5 11.6 12.8 12.7 7.4 11.3 10.0 7.1 6.8 6.4 8.6 6.6 7.0 9.8 7.0 6.1 4.2 11.3 6.6 6.5 6.8 12.9 5.9 7.8 5.5 5.0 6.4 10.6 11.0 7.5 6.7 4.8 10.6 5.8 6.1 8.4 0.0 1.6 10.4 15.3 12.5 15.9 2.4 10.2 4.0 1.2 0.0 3.9 40.3 0.0 3.9 12.7 4.9 4.6 0.0 5.4 97.8 9.3 6.6 3.5 3.4 41.5 7.9 8.1 10.4 10.3 15.1 7.8 11.9 11.8 6.4 7.7 10.1 1.9 7.0 4.6 0.8 11.2 6.5 11.3 51.9 45.0 11.5 19.0 12.5 19.0 7.3 RNASEK-C17orf49 ENSG00000161939 "RNASEK-C17orf49 readthrough" 17 7012635-7017520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.3" "Group enriched" "Detected in many" 8 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 63.9;Ciliated cells: 103.1;Club cells: 56.9;granulocytes: 55.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 5.3;THP-1: 6.3;U-87 MG: 6.9" "HPA022961, HPA024457" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (4.08e-2)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (9.37e-5)" "unprognostic (4.19e-1)" "unprognostic (1.71e-1)" "unprognostic (7.91e-2)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.77e-3)" "unprognostic (8.26e-3)" "unprognostic (8.58e-3)" "unprognostic (3.00e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.78e-1)" 4.8 4.8 2.8 3.5 3.5 5.3 2.9 3.6 4.0 2.0 2.8 0.4 1.5 1.4 4.9 3.3 2.3 2.7 3.2 6.3 2.5 3.3 6.6 14.5 16.7 20.3 2.9 2.4 2.4 7.9 1.4 4.7 2.5 1.8 1.8 1.4 0.4 1.6 5.0 4.2 1.9 6.3 2.3 1.7 9.1 1.6 6.4 0.7 4.1 2.0 4.6 3.4 2.3 1.6 1.9 4.0 7.5 4.3 0.9 1.7 2.8 1.2 3.6 0.5 0.5 0.0 0.0 1.1 2.3 1.9 2.8 2.2 2.3 1.1 1.9 0.2 0.0 0.3 0.6 0.7 5.3 0.8 0.0 4.4 0.0 2.9 1.0 2.8 0.0 0.6 0.0 0.0 1.6 0.0 0.4 0.7 0.2 0.6 0.0 0.0 1.2 1.9 2.3 2.3 0.5 1.2 1.4 0.0 0.0 0.8 0.7 0.5 1.8 0.0 0.0 0.2 0.3 0.6 6.3 0.0 0.0 0.2 3.5 1.0 0.0 0.8 0.2 6.9 0.5 0.0 3.6 4.3 3.4 1.2 3.0 1.7 1.9 1.5 0.8 3.8 1.8 1.4 1.2 7.5 0.9 3.1 4.0 0.9 2.8 2.8 3.5 3.6 4.0 2.5 3.3 2.9 2.4 1.8 0.7 59.6 63.9 0.0 0.0 0.3 0.0 0.0 0.0 103.1 56.9 0.0 0.0 0.2 3.3 6.7 0.0 0.1 2.9 0.0 7.0 0.1 0.2 0.1 55.8 0.0 0.6 0.0 5.2 0.6 1.2 0.0 0.3 1.0 0.0 8.2 4.7 0.0 6.7 6.8 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.7 0.0 2.7 0.1 RNASEL "PRCA1, RNS4" ENSG00000135828 "Ribonuclease L" Q05823 1 182573634-182589256 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002633, CAB010906" Approved Supported Cytosol NA NA Cytosol "CAB010906: AB_477444, HPA002633: AB_1856314" "unprognostic (3.46e-2)" "unprognostic (9.10e-2)" "unprognostic (7.74e-2)" "unprognostic (1.13e-1)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "unprognostic (3.89e-2)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.43e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.81e-1)" 8.1 10.8 7.4 9.5 10.9 3.7 8.3 5.7 7.7 12.5 9.3 6.7 8.5 8.0 12.4 11.9 10.0 8.8 8.0 5.8 7.0 5.3 9.9 3.9 8.4 10.1 7.7 3.3 14.0 5.3 13.5 18.0 8.5 10.1 10.5 10.8 13.3 10.5 10.3 4.1 6.3 12.2 9.6 7.4 10.5 8.8 3.5 6.7 13.3 13.3 2.8 11.0 13.9 11.0 5.0 7.2 26.9 13.5 5.0 9.2 4.9 2.3 3.3 1.4 0.5 7.7 13.4 2.6 4.5 5.7 4.7 4.3 1.9 5.2 5.1 8.0 5.1 2.1 4.3 3.4 4.7 1.8 4.1 2.8 6.0 1.2 0.2 3.9 11.1 11.9 9.5 10.8 2.5 0.7 3.0 2.0 7.6 2.1 4.0 4.0 3.4 3.2 4.6 1.1 7.6 0.9 4.8 1.1 2.6 4.9 3.1 0.7 0.2 4.1 5.0 3.9 3.8 5.1 12.4 2.6 2.4 1.9 2.6 2.5 3.5 1.2 0.6 3.8 6.8 3.5 16.8 7.2 24.6 4.9 7.6 6.4 5.0 5.8 5.2 6.0 3.8 9.2 6.7 26.9 5.0 13.5 7.2 4.6 4.9 7.4 10.9 5.7 7.7 7.0 5.3 7.7 3.3 10.1 6.7 6.0 3.4 2.4 2.7 0.9 1.9 1.2 2.5 8.1 5.7 3.5 3.9 3.4 6.6 5.6 0.0 3.6 6.3 0.0 1.6 2.6 3.7 2.7 5.7 1.5 5.5 1.6 2.4 3.1 10.0 0.0 2.6 4.6 0.0 1.0 7.1 9.1 2.6 3.5 6.0 6.1 6.3 19.4 2.1 0.1 0.9 0.9 2.2 6.9 3.0 4.2 RNF111 "ARK, Arkadia, DKFZP761D081, FLJ38008" ENSG00000157450 "Ring finger protein 111" Q6ZNA4 15 58865175-59097419 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038576, HPA038577" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038576: AB_10964492, HPA038577: AB_10960052" "unprognostic (7.30e-2)" "unprognostic (2.60e-2)" "unprognostic (2.39e-1)" "unprognostic (3.37e-1)" "unprognostic (7.94e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.21e-1)" "unprognostic (5.10e-2)" "unprognostic (6.12e-3)" "unprognostic (3.10e-2)" "unprognostic (1.42e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (9.74e-2)" 12.8 11.2 15.3 15.6 19.3 21.2 12.7 24.1 21.9 15.1 9.8 18.8 10.9 11.4 16.4 9.8 16.2 12.6 13.0 11.0 13.0 13.0 12.9 14.8 13.3 13.9 15.7 15.5 16.8 14.8 20.8 19.2 16.7 17.8 12.7 10.3 12.9 14.9 12.5 15.0 14.1 10.9 11.7 14.2 14.3 12.0 15.7 16.9 14.9 16.4 6.5 17.8 15.8 14.8 7.9 5.2 26.7 9.9 3.3 6.1 2.0 9.6 22.5 14.3 12.3 12.5 14.1 12.3 12.7 14.9 12.7 16.4 9.9 6.5 11.9 14.4 17.7 10.9 19.0 3.9 9.5 15.9 12.3 8.0 14.7 9.2 7.6 13.6 8.6 16.6 11.0 10.3 13.7 15.2 11.6 14.1 11.1 13.6 12.0 15.6 4.7 11.3 5.5 11.8 3.0 8.8 11.4 20.5 9.7 9.7 17.3 11.8 17.2 11.4 11.3 11.0 17.5 8.9 10.6 16.2 20.4 17.0 10.6 12.1 8.7 11.8 14.2 12.4 13.9 15.3 6.4 9.9 9.3 4.8 7.0 4.8 7.4 4.9 4.3 5.2 7.9 5.5 4.2 26.7 3.3 7.6 4.9 6.1 2.0 15.3 19.3 24.1 21.9 13.0 13.0 15.7 15.5 17.8 16.9 3.0 11.8 14.0 10.9 17.9 11.2 16.9 7.6 14.7 9.1 12.2 7.9 7.3 3.3 10.3 18.4 13.4 9.2 0.0 6.0 8.1 9.5 12.3 15.1 9.8 11.7 9.5 15.5 19.0 17.7 7.0 7.2 16.6 11.8 16.2 9.4 9.5 10.9 11.4 13.8 8.4 12.3 25.8 9.2 11.9 7.8 17.3 26.8 11.7 7.9 20.4 RNF114 "PSORS12, ZNF313" ENSG00000124226 "Ring finger protein 114" Q9Y508 20 49936336-49953892 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 1239.3;Late spermatids: 628.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 110.4" "Low region specificity" "Detected in all" HPA021184 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021184: AB_1859185" "unprognostic (8.38e-2)" "unprognostic (3.56e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (8.10e-6)" "unprognostic (1.56e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (2.50e-2)" "unprognostic (1.03e-2)" "unprognostic (2.12e-1)" "unprognostic (3.99e-1)" "unprognostic (2.70e-2)" "unprognostic (2.54e-3)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.36e-2)" 23.2 21.3 24.4 18.3 25.7 31.2 20.6 26.7 23.1 24.0 29.7 32.6 21.1 29.5 20.3 23.4 20.2 23.6 20.1 21.9 23.0 25.3 30.3 31.6 24.4 24.0 28.3 19.4 28.4 36.8 16.1 21.6 40.6 23.7 24.5 21.3 27.1 27.8 24.1 43.8 15.2 33.9 17.6 29.3 36.3 24.2 101.9 24.1 28.3 37.9 20.0 24.1 22.6 25.0 28.5 32.5 43.4 44.6 23.7 29.4 34.9 15.9 15.7 8.1 8.5 16.7 11.5 23.8 14.3 16.2 29.6 12.6 46.6 13.1 7.7 28.6 7.5 18.1 12.8 12.0 14.4 10.3 14.0 8.8 9.8 10.5 32.7 14.7 17.8 11.8 10.0 13.3 11.3 7.8 10.1 7.0 13.4 18.4 9.1 8.6 53.8 14.9 18.5 8.3 12.5 22.6 16.3 8.5 14.0 15.6 13.0 12.4 8.9 17.5 110.4 22.1 6.9 29.4 16.6 9.2 26.8 12.5 14.0 16.4 18.7 19.5 14.7 15.2 11.6 14.8 38.5 42.5 35.7 22.0 39.2 24.6 28.2 24.6 22.4 32.5 28.5 29.4 23.7 43.4 23.7 44.6 26.7 28.8 34.9 24.4 25.7 26.7 23.1 23.0 25.3 28.3 19.4 23.7 24.1 44.7 50.1 53.6 105.2 95.2 25.2 37.5 28.1 32.1 28.4 66.3 11.8 79.1 61.3 83.5 1239.3 54.7 64.9 23.3 88.7 65.1 64.6 89.9 43.9 57.8 95.3 38.1 58.0 44.8 69.1 628.0 65.3 62.5 67.4 101.0 68.6 36.1 81.0 69.1 56.3 87.7 19.7 38.8 75.9 206.1 156.2 76.2 104.4 48.0 73.6 96.0 RNF123 "FLJ12565, KPC1" ENSG00000164068 "Ring finger protein 123" Q5XPI4 3 49689499-49721529 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065983, HPA071879" Supported Approved Cytosol NA NA Cytosol "HPA065983: AB_2685592, HPA071879: AB_2686468" "unprognostic (2.68e-1)" "unprognostic (3.34e-1)" "unprognostic (2.67e-1)" "unprognostic (1.04e-1)" "unprognostic (2.21e-1)" "unprognostic (9.51e-2)" "unprognostic (2.04e-1)" "unprognostic (3.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.07e-1)" "unprognostic (7.51e-2)" "unprognostic (5.03e-3)" "prognostic favorable (1.33e-8)" "unprognostic (5.69e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-2)" "unprognostic (3.83e-1)" 5.3 8.0 7.7 8.0 10.4 17.5 5.0 13.8 13.6 5.2 6.8 6.2 7.8 12.7 6.4 8.0 7.5 6.4 7.0 12.9 8.5 6.8 8.4 21.8 5.7 6.1 7.3 6.6 5.1 7.7 8.9 8.4 7.3 6.6 7.3 4.8 7.6 6.9 6.7 81.2 7.7 12.5 6.2 6.7 7.6 6.9 8.8 7.8 8.3 6.2 12.0 9.1 6.6 4.8 11.3 12.7 11.8 10.9 7.7 11.4 5.3 6.7 9.6 11.4 11.8 17.4 10.8 12.3 8.8 11.7 11.3 12.6 10.2 11.7 16.5 8.1 12.6 10.0 8.5 8.6 13.3 7.9 10.9 11.8 13.4 18.9 22.3 17.4 13.0 14.6 13.6 13.1 10.6 12.3 11.2 11.6 16.8 14.1 14.3 9.5 10.1 13.7 21.1 6.3 8.5 15.5 6.5 7.0 17.0 15.4 11.5 7.8 15.7 12.2 10.8 13.4 6.7 11.1 23.4 12.0 9.9 12.1 8.9 10.9 19.5 19.1 6.6 14.1 16.5 14.9 11.8 10.9 7.9 11.4 9.5 6.8 9.8 7.2 6.8 8.6 11.3 8.7 8.2 6.3 7.7 9.7 12.7 5.5 5.3 7.7 10.4 13.8 13.6 8.5 6.8 7.3 6.6 6.6 7.8 8.9 4.0 4.4 2.4 2.1 8.6 1.0 20.4 1.4 4.5 3.5 3.9 5.6 5.0 4.9 10.6 3.6 13.1 0.0 4.8 3.6 4.9 4.4 6.9 23.8 4.8 6.4 6.4 9.8 9.9 12.6 6.9 3.2 3.3 4.6 5.9 3.5 6.0 7.0 5.3 8.5 8.2 0.0 4.9 8.7 9.1 2.6 7.1 2.9 6.3 3.7 RNF126 FLJ20552 ENSG00000070423 "Ring finger protein 126" Q9BV68 19 647526-663277 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043050 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043050: AB_10794768" "unprognostic (2.24e-1)" "unprognostic (1.64e-1)" "unprognostic (1.97e-1)" "unprognostic (2.48e-3)" "unprognostic (1.90e-1)" "unprognostic (2.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (9.96e-3)" "unprognostic (7.04e-3)" "unprognostic (3.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.67e-2)" 14.2 14.2 13.4 17.0 13.7 18.7 14.5 12.2 24.7 9.8 16.0 14.8 7.4 24.3 10.4 9.2 19.8 9.5 13.1 14.2 13.1 10.2 11.6 27.9 10.4 19.9 11.4 11.6 12.1 22.4 5.9 10.0 14.1 12.3 10.0 6.3 10.1 13.2 9.3 50.3 21.9 20.3 9.9 10.0 18.6 21.0 33.6 9.3 16.1 8.6 19.5 18.6 13.1 11.2 15.9 13.6 7.5 13.8 17.1 17.3 9.2 25.9 8.6 7.3 10.3 1.7 2.4 12.5 13.6 5.2 7.9 7.5 17.4 9.1 21.5 8.9 5.7 3.1 17.4 4.4 10.2 2.2 14.2 31.8 10.9 9.0 14.4 6.6 21.6 16.1 4.1 8.1 6.5 5.1 3.2 7.2 17.7 21.9 21.7 4.1 20.9 22.1 10.1 19.5 5.5 17.0 16.1 6.3 33.8 6.0 14.5 17.4 13.6 10.3 13.6 13.9 2.6 8.7 17.0 9.4 14.4 10.4 21.1 23.3 38.3 19.0 25.2 18.3 12.7 14.8 0.6 9.8 7.5 17.3 11.5 14.2 15.9 15.7 16.7 12.4 15.6 12.2 11.4 2.2 17.1 13.8 13.6 16.8 9.2 13.4 13.7 12.2 24.7 13.1 10.2 11.4 11.6 12.3 9.3 11.9 6.1 54.8 41.2 122.5 31.3 24.2 15.3 12.0 10.3 8.7 15.7 58.6 46.4 55.4 113.7 26.1 51.9 0.0 66.1 118.3 35.3 49.3 14.9 20.2 38.3 30.2 20.8 20.3 27.6 18.2 19.8 38.3 40.5 56.9 34.2 27.0 95.1 54.9 18.4 25.6 22.0 58.2 45.0 118.2 66.8 126.6 73.7 55.3 49.7 76.9 RNF13 RZF ENSG00000082996 "Ring finger protein 13" O43567 3 149812708-149962139 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 72.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064784 Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA064784: AB_2685350" "unprognostic (1.27e-1)" "unprognostic (2.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (8.49e-2)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (1.25e-1)" "unprognostic (6.94e-3)" "unprognostic (1.13e-1)" "prognostic favorable (2.00e-8)" "unprognostic (2.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.17e-1)" "unprognostic (1.79e-1)" 24.0 21.3 30.6 19.0 39.4 9.8 28.5 19.9 30.4 19.0 17.7 39.9 16.2 14.3 16.8 33.7 16.8 15.9 20.4 16.4 40.5 29.7 35.8 39.2 31.7 19.6 60.9 26.8 18.1 19.6 23.5 14.9 32.4 40.7 25.5 20.3 19.5 36.1 20.9 18.0 18.4 16.3 20.4 102.2 25.5 17.0 12.5 51.2 13.3 32.1 18.8 15.9 21.4 16.5 8.8 15.7 72.4 31.5 7.8 8.5 14.6 19.7 12.3 8.3 9.5 32.8 20.1 13.9 10.9 28.2 10.6 15.8 10.8 28.4 8.2 16.0 13.4 19.5 18.8 11.1 14.0 14.9 10.0 8.1 9.9 5.7 10.5 21.8 10.6 14.1 21.2 26.6 8.9 24.2 12.8 11.7 7.9 3.1 16.7 9.4 11.1 7.6 7.0 5.5 19.1 9.6 5.5 8.9 34.8 20.5 9.2 4.4 12.7 9.0 13.6 35.2 6.8 25.9 11.2 12.2 14.4 5.8 15.2 7.0 28.4 18.7 16.9 12.1 9.9 7.7 12.9 20.3 16.6 6.8 25.2 8.5 8.8 7.6 7.6 15.7 8.3 7.3 7.5 72.4 7.8 31.5 11.2 8.3 14.6 30.6 39.4 19.9 29.2 40.5 29.7 60.9 26.8 40.7 51.2 101.3 59.5 39.3 61.2 65.4 43.7 25.6 38.2 34.8 61.4 45.4 27.5 86.4 36.5 54.3 2.2 62.6 27.6 0.0 62.0 65.2 68.3 63.5 58.9 46.6 172.6 20.6 19.4 77.3 168.9 4.7 70.5 155.4 97.8 42.3 26.4 85.9 48.5 29.6 82.7 59.8 32.2 90.5 50.9 19.7 29.6 63.2 43.8 51.0 24.3 45.5 RNF14 "ARA54, HFB30, TRIAD2" ENSG00000013561 "Ring finger protein 14" Q9UBS8 5 141958328-141990291 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 162.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008716, HPA064746" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008716: AB_1856337, HPA064746: " "unprognostic (7.45e-3)" "unprognostic (1.38e-1)" "unprognostic (8.56e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-2)" "unprognostic (7.24e-3)" "unprognostic (2.35e-1)" "unprognostic (4.05e-2)" "unprognostic (5.22e-2)" "unprognostic (7.42e-2)" "unprognostic (7.92e-2)" "unprognostic (1.46e-1)" "prognostic favorable (1.71e-4)" "unprognostic (6.89e-3)" "unprognostic (2.82e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.06e-2)" 21.2 29.5 23.7 11.2 33.9 7.8 22.0 22.5 40.2 18.4 18.7 26.2 16.0 15.3 21.0 21.5 15.6 14.3 15.4 32.9 23.6 24.7 31.3 31.3 13.8 13.3 28.9 17.3 15.9 17.1 26.3 28.8 23.6 47.7 21.6 19.8 20.9 18.1 20.1 27.7 11.9 20.9 20.5 26.3 13.8 15.7 33.7 15.0 16.2 26.3 13.3 14.9 16.7 14.0 12.3 17.1 32.6 18.8 16.8 17.0 12.2 12.7 21.4 15.0 29.5 27.1 28.4 10.1 26.3 14.7 18.5 20.5 17.7 14.9 22.6 30.8 26.9 27.9 7.0 19.1 25.8 16.6 17.0 16.5 14.4 11.2 8.0 29.8 15.7 12.9 21.3 22.8 24.6 30.9 16.1 22.9 15.8 17.4 31.6 37.8 15.2 15.2 5.0 6.3 15.6 24.4 10.1 16.7 24.5 25.4 22.2 16.6 13.5 23.0 42.2 44.6 17.6 29.3 12.3 23.6 24.6 7.9 11.6 24.9 19.9 23.2 20.7 21.1 19.3 30.3 32.6 13.4 13.0 17.0 15.8 16.5 12.3 15.0 16.9 16.2 10.6 11.5 16.7 3.3 16.8 18.8 17.1 16.7 12.2 23.7 33.9 22.5 40.2 23.6 24.7 28.9 17.3 47.7 15.0 8.9 22.9 9.0 14.0 9.5 20.9 36.8 7.6 13.4 13.6 21.0 15.7 24.8 58.0 23.0 162.7 16.9 20.2 23.3 21.8 21.4 16.2 17.2 21.9 29.6 21.4 22.3 14.5 17.8 25.5 22.0 17.8 19.3 30.4 10.8 14.1 20.6 22.7 11.5 31.5 34.8 14.6 38.8 25.8 42.6 27.1 9.3 50.6 17.5 13.3 12.7 RNF145 FLJ31951 ENSG00000145860 "Ring finger protein 145" Q96MT1 5 159157409-159210053 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036562 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA036562: AB_10696657" "unprognostic (1.57e-1)" "unprognostic (9.02e-3)" "unprognostic (4.11e-2)" "unprognostic (3.88e-2)" "unprognostic (3.24e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.64e-6)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.54e-1)" "unprognostic (3.53e-1)" "unprognostic (1.67e-1)" "unprognostic (8.92e-3)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" 13.3 20.1 23.9 15.6 23.0 7.1 24.1 30.2 27.3 11.3 11.7 5.7 5.3 4.7 12.6 13.6 26.7 11.4 20.8 16.8 22.0 8.4 8.2 6.1 30.7 36.3 17.5 9.7 14.1 6.0 26.9 29.0 21.9 18.5 11.8 12.6 10.2 17.8 14.8 5.5 14.9 11.0 13.8 12.4 12.7 11.2 7.9 18.0 12.4 14.3 8.0 19.6 19.3 15.7 8.9 2.7 14.4 2.6 2.1 6.2 1.3 20.3 20.1 31.0 37.2 32.8 14.6 6.0 16.3 28.5 15.1 24.6 6.9 16.9 7.0 29.4 14.3 28.8 26.7 24.4 21.5 26.7 28.8 8.7 14.7 22.9 5.7 14.1 9.7 14.1 9.0 38.9 14.1 20.7 21.2 14.8 17.1 14.6 27.1 14.2 0.5 11.0 3.0 13.4 6.4 10.3 14.7 13.5 14.0 20.2 7.0 11.3 20.9 16.5 17.7 26.8 22.1 12.4 8.9 15.8 17.0 15.6 13.6 28.9 6.0 8.3 6.5 19.8 12.1 36.3 2.8 2.6 14.4 3.2 2.5 3.7 8.9 4.7 3.8 1.9 4.4 6.2 4.3 9.7 2.1 2.2 2.7 5.7 1.3 23.9 23.0 30.2 27.3 22.0 8.4 17.5 9.7 18.5 18.0 104.2 213.5 76.8 93.4 109.1 103.7 10.0 79.0 48.2 106.9 34.9 55.0 2.7 16.6 63.7 22.1 50.7 48.5 46.7 99.7 20.5 58.0 100.6 68.1 16.3 39.0 108.1 52.0 127.7 90.9 29.9 42.8 54.8 62.4 223.6 41.8 63.1 90.1 51.8 48.8 8.4 48.6 45.3 49.5 14.9 33.0 86.9 9.2 73.0 57.2 150.2 RNF146 "dactylidin, dJ351K20.1, DKFZp434O1427" ENSG00000118518 "Ring finger protein 146" Q9NTX7 6 127266610-127288567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027158, HPA027209" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" Nucleoplasm "HPA027158: AB_10600772, HPA027209: AB_10602312" "unprognostic (8.22e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-1)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.37e-1)" "unprognostic (5.47e-3)" "unprognostic (1.87e-1)" "unprognostic (6.74e-2)" "prognostic favorable (5.26e-5)" "unprognostic (2.65e-2)" "prognostic favorable (7.32e-4)" "unprognostic (4.04e-2)" "unprognostic (1.29e-1)" "unprognostic (6.13e-2)" "unprognostic (2.15e-2)" 27.3 20.9 28.5 16.6 29.1 5.1 23.9 63.7 34.5 22.7 18.6 29.2 10.5 11.8 32.0 35.2 14.2 17.9 21.3 25.2 26.3 21.7 20.9 16.8 21.0 17.3 30.0 27.7 28.5 12.6 26.5 27.4 27.8 31.3 18.6 17.6 17.5 16.7 20.3 55.9 16.0 15.2 26.1 28.7 24.6 15.5 16.3 27.7 9.2 26.7 15.5 17.6 19.2 18.7 11.7 14.2 22.8 22.8 11.5 10.3 9.1 5.5 7.0 26.7 23.5 24.8 24.9 9.7 18.9 30.3 10.1 14.6 9.1 8.4 10.0 13.4 15.4 15.9 7.1 7.9 8.9 14.8 11.5 6.9 12.7 8.4 12.7 24.6 7.5 9.1 21.7 18.7 11.4 22.8 23.4 17.7 10.0 13.7 9.9 22.3 10.6 7.4 13.6 9.7 3.4 7.3 9.4 6.9 5.0 14.4 6.1 16.0 16.2 7.4 10.5 11.6 16.5 7.1 26.1 20.8 17.9 5.9 18.5 13.3 14.3 8.8 6.6 13.7 13.2 16.8 16.8 18.9 16.1 9.3 20.0 9.7 11.1 8.0 10.3 14.2 11.7 7.3 10.2 22.8 11.5 22.8 7.1 8.6 9.1 28.5 29.1 63.7 34.5 26.3 21.7 30.0 27.7 31.3 27.7 32.8 24.8 20.8 11.4 15.8 34.0 33.0 38.2 20.1 7.9 8.7 3.9 25.1 34.9 24.3 40.1 34.9 12.8 0.0 14.1 22.7 38.1 21.4 21.9 25.2 22.8 28.6 19.7 28.3 67.8 33.7 64.5 25.0 43.9 24.4 11.5 36.1 15.1 13.9 62.6 42.1 18.1 32.3 33.5 44.7 12.2 17.6 32.2 28.7 10.9 14.1 RNF151 ENSG00000179580 "Ring finger protein 151" Q2KHN1 16 1966823-1968975 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "testis: 64.1" "Group enriched" "Detected in some" 131 "Early spermatids: 2032.5;Late spermatids: 1079.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "T-reg: 2.1" "Lineage enriched" "Detected in single" 8 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA055054 Approved "Nuclear speckles,Vesicles,Cytosol" NA NA Cytosol "Nuclear speckles, Vesicles" "HPA055054: " "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (2.54e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-2)" "unprognostic (4.01e-3)" "unprognostic (1.15e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-1)" "unprognostic (3.20e-1)" "unprognostic (4.39e-3)" "unprognostic (4.63e-1)" "unprognostic (1.98e-4)" "unprognostic (1.46e-1)" "unprognostic (4.19e-2)" "unprognostic (1.10e-1)" "unprognostic (2.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 64.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.2 0.6 1.2 0.6 0.0 0.0 0.9 0.3 0.0 0.0 0.3 0.6 0.0 1.6 0.2 0.5 0.0 2.0 0.0 0.0 0.0 0.2 2.0 0.4 1.7 1.6 0.0 0.6 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.0 1.2 0.0 1.6 0.8 0.3 0.9 0.0 0.0 2.5 0.0 0.0 0.8 0.1 0.0 0.6 0.3 0.2 1.4 0.0 0.0 1.1 1.1 0.7 0.8 0.2 0.9 1.4 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2032.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1079.9 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 6.5 0.1 11.9 5.1 0.0 0.0 0.0 0.0 0.0 RNF166 "MGC14381, MGC2647" ENSG00000158717 "Ring finger protein 166" Q96A37 16 88696495-88706421 "Predicted intracellular proteins" "Autophagy, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.9" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 37.7;Macrophages: 37.5;T-cells: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042970 Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "HPA042970: AB_10796682" "unprognostic (3.01e-2)" "unprognostic (6.98e-3)" "unprognostic (3.96e-2)" "unprognostic (5.36e-3)" "unprognostic (1.23e-1)" "unprognostic (2.71e-2)" "unprognostic (6.52e-2)" "unprognostic (5.86e-2)" "unprognostic (4.88e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.04e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.54e-1)" "unprognostic (3.91e-2)" "unprognostic (1.28e-1)" "unprognostic (2.69e-2)" 9.2 8.1 9.2 22.8 8.9 63.9 10.5 13.7 15.3 6.7 7.2 11.2 3.7 12.0 8.1 8.3 6.4 9.1 12.3 10.0 8.6 7.3 9.6 9.7 20.8 30.5 8.9 6.5 9.7 11.4 5.3 8.5 7.5 8.4 8.9 4.9 11.0 12.1 6.0 14.8 8.2 16.0 8.3 11.1 47.2 10.9 9.2 9.1 21.6 8.8 7.8 23.8 9.7 6.7 2.0 11.8 28.7 12.5 5.5 17.1 9.7 4.2 6.8 5.3 8.4 2.6 2.2 10.1 4.3 2.8 5.1 2.3 4.6 2.7 5.1 5.6 2.5 2.9 4.7 3.1 2.8 2.0 2.6 9.2 6.9 5.0 7.7 6.9 6.8 8.8 2.6 2.7 4.0 3.3 2.8 5.3 8.7 11.5 3.8 2.1 8.3 15.9 44.6 8.7 1.8 9.1 14.9 3.3 13.2 2.3 1.9 4.9 5.5 9.8 2.0 5.3 2.7 5.8 23.3 7.3 3.8 5.7 5.7 5.1 8.6 5.0 12.4 3.4 25.9 5.3 3.0 12.5 28.7 17.1 9.1 14.8 2.0 10.4 14.8 11.8 1.9 8.7 12.5 20.4 5.5 10.5 7.3 10.5 9.7 9.2 8.9 13.7 15.3 8.6 7.3 8.9 6.5 8.4 9.1 8.9 5.1 15.7 4.7 4.2 10.1 2.4 7.6 1.4 3.4 7.0 5.9 7.4 8.3 5.2 1.1 8.0 2.0 0.0 8.0 7.5 8.2 3.6 20.7 4.0 34.7 7.9 4.7 10.4 37.7 1.8 8.6 37.5 10.1 11.8 2.7 8.9 4.6 0.0 7.4 5.6 8.6 6.5 7.1 9.4 8.6 5.1 3.1 66.8 4.1 1.3 RNF167 DKFZP566H073 ENSG00000108523 "Ring finger protein 167" Q9H6Y7 17 4940008-4945222 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049810 Approved Approved "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" NA NA "Vesicles, Cytosol" "Mitotic spindle, Centriolar satellite" "HPA049810: AB_2680894" "unprognostic (1.13e-1)" "unprognostic (5.12e-2)" "unprognostic (2.29e-3)" "unprognostic (1.63e-2)" "unprognostic (3.43e-2)" "unprognostic (7.32e-2)" "unprognostic (2.18e-1)" "unprognostic (6.77e-2)" "unprognostic (7.46e-2)" "unprognostic (2.07e-2)" "prognostic favorable (2.03e-6)" "unprognostic (2.16e-1)" "prognostic favorable (4.47e-4)" "unprognostic (7.62e-2)" "unprognostic (1.93e-1)" "unprognostic (3.26e-1)" "unprognostic (1.12e-1)" 30.5 45.9 45.8 32.1 47.0 40.7 38.3 37.9 67.9 44.3 43.5 54.6 49.2 42.7 43.1 55.8 51.6 44.0 47.4 40.1 43.1 39.9 44.1 84.1 35.6 38.7 43.7 43.6 42.6 52.4 52.8 40.7 49.0 41.2 43.6 46.7 38.5 49.1 51.7 56.5 51.6 51.1 42.4 46.4 47.1 42.7 42.0 33.1 53.9 55.1 47.3 47.6 48.1 40.7 25.6 18.2 54.4 26.7 27.6 53.0 37.9 24.2 35.2 15.3 18.8 37.8 18.9 22.9 15.0 21.0 31.7 25.1 24.5 11.2 17.9 29.2 24.8 15.8 37.3 26.6 29.2 23.7 17.3 42.8 30.6 44.4 24.1 28.6 14.4 64.6 22.1 46.1 33.0 31.4 19.9 20.4 26.7 11.9 61.3 25.3 17.3 22.7 17.9 18.3 25.7 22.6 15.7 15.3 22.3 36.5 20.4 12.1 15.0 13.8 23.7 20.0 22.4 22.6 14.7 12.5 19.0 12.6 17.0 28.5 20.4 20.6 5.9 26.1 20.8 19.8 22.4 21.4 54.4 53.0 22.6 41.1 25.6 40.6 52.7 18.2 24.0 28.5 42.3 52.1 27.6 26.7 18.0 37.7 37.9 45.8 47.0 37.9 67.9 43.1 39.9 43.7 43.6 41.2 33.1 0.0 3.8 37.8 33.1 60.9 40.7 13.4 66.2 2.7 2.3 47.1 19.6 101.9 48.0 68.5 41.4 35.8 73.2 46.7 58.4 102.1 39.8 31.4 13.9 83.9 52.2 17.5 30.5 38.1 36.1 68.6 45.1 42.0 37.1 57.7 40.4 45.0 52.7 40.3 50.5 53.1 25.5 38.8 27.8 111.1 83.5 72.8 104.7 90.0 54.4 39.3 RNF169 KIAA1991 ENSG00000166439 "Ring finger protein 169" Q8NCN4 11 74748868-74842413 "Enzymes, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038505, HPA046138, HPA047952" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Nucleoli, Nucleoli rim, Cytosol" "HPA038505: , HPA046138: AB_2679553, HPA047952: " "unprognostic (1.71e-1)" "unprognostic (4.18e-2)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (3.86e-2)" "unprognostic (3.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-1)" "unprognostic (6.47e-2)" "prognostic unfavorable (8.04e-4)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (3.23e-1)" "unprognostic (2.34e-1)" "unprognostic (9.55e-3)" "unprognostic (1.21e-1)" 12.3 7.0 12.0 11.6 14.0 23.1 12.0 22.6 15.6 13.1 11.2 12.2 6.3 7.4 14.2 8.2 20.6 10.7 10.8 9.2 12.6 5.9 8.9 9.3 16.9 11.3 15.4 9.1 14.6 10.7 17.5 10.4 8.6 13.9 10.5 10.0 8.4 12.4 8.8 15.0 14.1 10.3 14.2 10.1 12.6 10.3 7.2 14.9 12.6 11.5 7.4 12.5 13.1 15.8 0.6 0.8 5.0 1.9 1.2 1.6 0.6 8.3 6.4 7.8 7.6 5.0 6.8 3.1 6.5 6.2 7.3 6.4 10.7 6.3 14.9 6.7 7.8 5.0 8.1 10.4 7.8 9.6 7.4 6.7 10.3 11.8 4.2 5.8 5.4 8.6 6.2 6.2 8.3 19.0 8.2 11.8 10.2 9.1 12.0 7.3 7.0 9.3 9.8 3.0 10.6 4.2 8.7 18.5 8.1 4.7 8.7 3.5 6.3 8.8 6.7 14.2 6.5 8.4 7.0 7.8 12.2 10.3 7.6 5.8 8.7 4.5 17.7 2.4 6.0 7.0 2.8 1.9 1.5 1.6 1.1 1.2 0.3 1.5 0.9 0.8 0.6 1.1 0.9 5.0 1.2 1.0 0.8 1.2 0.6 12.0 14.0 22.6 15.6 12.6 5.9 15.4 9.1 13.9 14.9 8.9 10.7 13.0 26.3 17.6 51.9 2.8 2.5 5.3 7.9 3.5 49.1 5.0 5.0 8.8 2.2 11.7 6.7 0.0 9.5 5.0 9.3 37.6 6.9 11.0 7.6 35.0 11.5 8.6 10.7 2.2 6.9 9.2 10.1 1.8 7.8 33.2 9.1 5.8 9.9 9.1 32.5 25.8 15.1 10.4 10.9 16.3 6.8 16.6 9.7 39.6 RNF180 ENSG00000164197 "Ring finger protein 180" Q86T96 5 64165844-64372869 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 54.0" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 31.9;Muller glia cells: 32.9;Sertoli cells: 38.8" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006897 Approved Approved Cytosol NA NA Cytosol "HPA006897: AB_1856348" "unprognostic (7.46e-2)" "unprognostic (3.90e-3)" "unprognostic (3.19e-2)" "unprognostic (8.62e-2)" "unprognostic (2.45e-1)" "unprognostic (2.72e-1)" "unprognostic (5.57e-2)" "unprognostic (2.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (3.68e-2)" "prognostic favorable (6.81e-5)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.81e-2)" "unprognostic (9.81e-3)" 8.1 8.1 9.9 3.1 12.8 1.6 6.3 6.0 13.0 10.1 7.1 5.5 20.1 3.4 12.7 11.8 6.9 8.1 7.3 10.4 7.4 10.6 12.4 7.2 6.1 3.4 9.4 9.3 12.0 6.6 54.0 16.1 2.0 10.7 11.5 3.0 11.3 7.3 16.4 4.4 6.6 3.2 15.0 11.0 5.1 5.0 8.1 7.1 0.0 20.6 2.5 2.4 10.9 7.9 2.4 1.0 4.2 1.8 2.0 4.2 0.3 0.0 0.1 1.3 0.0 0.0 0.0 0.3 1.1 0.5 1.1 0.6 0.0 0.1 0.0 0.1 0.8 0.6 0.2 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.2 0.1 2.7 0.0 0.1 5.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.5 0.0 1.3 0.1 3.3 25.4 1.9 0.3 0.3 0.1 0.0 0.3 0.0 1.7 1.3 0.1 0.1 0.0 3.2 0.1 2.9 0.0 0.0 0.0 0.5 0.0 3.6 3.0 1.8 4.2 1.9 0.6 2.5 1.4 3.0 3.2 0.6 2.4 4.2 3.9 2.6 2.0 0.8 1.0 1.8 0.3 9.9 12.8 6.0 11.7 7.4 10.6 9.4 9.3 10.7 7.1 14.9 10.5 0.0 6.5 4.0 16.5 9.6 12.7 2.7 7.9 15.7 13.7 0.0 6.6 4.5 3.7 5.6 0.0 0.0 2.3 0.1 2.5 5.0 0.0 5.4 0.1 11.1 1.2 12.3 1.2 5.5 31.9 0.2 5.0 0.0 1.6 32.9 2.8 0.6 23.7 14.3 17.3 38.8 17.9 15.4 9.7 6.5 0.0 0.0 0.1 3.8 RNF181 HSPC238 ENSG00000168894 "Ring finger protein 181" Q9P0P0 2 85595725-85597613 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046112, HPA062121" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046112: AB_2679542, HPA062121: AB_2684687" "unprognostic (3.79e-1)" "unprognostic (8.31e-2)" "unprognostic (5.08e-2)" "unprognostic (2.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.67e-2)" "unprognostic (3.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.22e-2)" "unprognostic (5.85e-2)" "unprognostic (1.11e-1)" "unprognostic (4.96e-2)" "prognostic unfavorable (1.06e-6)" "unprognostic (3.24e-1)" "unprognostic (2.04e-1)" "prognostic favorable (4.59e-5)" "unprognostic (1.49e-2)" 32.9 41.5 42.2 26.4 36.2 32.8 40.4 19.0 38.7 34.4 40.5 33.0 36.0 34.5 28.1 44.5 40.2 33.3 34.8 52.4 34.5 32.9 57.8 85.1 36.0 33.1 41.2 29.3 31.6 85.1 21.8 20.2 50.7 36.0 34.2 35.4 32.1 42.1 45.7 47.0 30.4 46.5 33.2 42.2 37.2 35.7 36.3 31.3 31.0 43.7 39.2 42.6 43.8 29.4 53.2 80.2 78.6 94.7 39.3 54.4 83.3 32.7 33.2 25.9 28.1 26.4 32.8 41.8 27.7 54.6 59.1 56.3 50.6 34.8 31.2 54.5 41.1 56.1 30.7 22.3 44.3 63.6 35.6 27.5 23.7 17.2 60.8 46.5 26.2 32.5 34.2 59.0 39.4 65.9 45.5 49.1 29.4 27.8 32.5 79.8 52.5 24.7 61.1 18.0 43.3 50.2 26.5 54.4 44.4 55.2 30.5 15.5 20.4 23.4 34.1 45.5 32.5 33.8 34.9 42.4 29.0 20.7 58.0 39.5 45.4 37.8 39.1 45.4 39.7 25.5 40.4 94.7 71.6 40.7 69.3 37.7 53.2 42.6 39.1 71.0 44.3 36.7 36.8 78.6 39.3 51.8 80.2 54.4 83.3 42.2 36.2 19.0 38.7 34.5 32.9 41.2 29.3 36.0 31.3 137.0 86.2 115.3 81.4 103.8 25.0 99.1 145.2 88.3 91.0 143.1 2.0 196.4 353.1 216.8 308.0 104.6 151.4 70.0 252.2 207.3 131.6 104.1 100.4 194.3 230.7 17.5 67.4 87.8 155.3 193.3 81.7 162.9 161.9 198.4 101.4 48.2 256.8 175.4 73.6 513.2 19.4 58.2 121.5 89.5 30.4 103.6 185.0 97.2 90.7 92.8 RNF187 "RACO-1, RACO1" ENSG00000168159 "Ring finger protein 187" Q5TA31 1 228487061-228495766 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 42.3;U-266/70: 76.8" "Low region specificity" "Detected in all" HPA030098 Approved Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA030098: AB_10602923" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (2.83e-4)" "unprognostic (4.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.93e-2)" "unprognostic (3.46e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (5.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.92e-3)" "unprognostic (1.59e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" 15.7 30.3 25.6 12.5 28.1 12.3 10.3 33.2 54.7 11.4 10.7 15.5 12.5 14.7 12.9 12.2 18.0 14.2 14.5 17.7 25.2 24.9 16.2 20.4 11.5 9.8 20.2 29.3 20.2 19.4 22.3 16.4 8.8 22.7 15.0 6.6 12.3 30.3 12.6 55.5 15.5 13.2 8.6 16.3 19.0 14.2 9.5 11.4 11.1 27.9 19.4 11.2 10.0 13.1 2.0 1.7 8.7 2.1 1.0 2.3 0.6 9.4 7.1 5.0 10.5 5.5 3.6 9.7 7.9 4.9 5.0 3.8 3.6 6.6 21.6 16.6 9.0 4.1 7.6 6.3 6.7 1.9 9.8 8.1 6.5 5.3 4.7 15.0 7.4 12.8 6.3 12.1 3.8 5.2 6.1 4.4 16.5 10.4 42.3 3.6 5.3 11.8 6.6 11.2 6.7 7.3 10.1 4.6 20.3 3.6 6.0 11.1 11.2 8.1 16.8 21.4 1.7 11.8 17.8 10.1 6.2 6.4 6.7 7.5 76.8 23.0 11.8 16.7 7.8 10.4 0.0 1.1 8.7 1.3 2.1 1.5 1.2 1.5 2.3 1.4 2.0 1.4 1.2 0.3 1.0 1.4 1.7 1.3 0.6 25.6 28.1 33.2 47.3 25.2 24.9 20.2 29.3 22.7 11.4 23.8 13.3 36.1 41.5 32.2 84.0 56.1 38.2 8.1 18.2 38.4 17.7 14.3 96.2 13.8 0.5 22.6 33.3 0.0 20.8 20.1 31.6 30.3 44.9 56.2 24.8 52.4 38.4 29.4 29.7 2.5 22.7 23.8 37.1 6.4 26.7 103.2 20.8 20.4 24.4 99.3 37.8 19.4 38.1 4.4 22.0 48.3 14.8 41.5 27.6 24.7 RNF19B "FLJ90005, IBRDC3" ENSG00000116514 "Ring finger protein 19B" Q6ZMZ0 1 32936445-32964685 "Enzymes, Predicted membrane proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 54.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 16.1" "Cell line enhanced" "Detected in all" "Daudi: 39.3;Karpas-707: 47.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049587, HPA063640" Approved Approved Cytosol NA NA Cytosol "HPA049587: AB_2680826, HPA063640: " "unprognostic (2.83e-2)" "unprognostic (1.77e-2)" "unprognostic (1.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "prognostic favorable (3.39e-4)" "prognostic unfavorable (5.41e-6)" "unprognostic (8.78e-2)" "unprognostic (5.02e-1)" "unprognostic (1.69e-1)" "unprognostic (9.85e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.39e-5)" "unprognostic (2.58e-2)" "unprognostic (4.93e-2)" "unprognostic (3.30e-1)" "unprognostic (1.23e-2)" 8.6 11.3 8.0 13.1 10.5 36.4 12.0 14.1 14.1 9.9 13.2 10.1 4.8 14.1 10.8 6.9 23.3 7.9 10.1 8.5 6.0 7.2 12.0 6.5 13.8 12.9 9.6 9.3 7.1 7.0 6.4 5.7 9.4 10.2 7.4 15.3 9.0 10.8 5.7 10.2 13.6 15.5 10.6 8.0 9.0 7.4 54.7 8.3 6.8 8.2 11.1 16.7 11.3 12.8 1.3 1.3 16.1 2.0 0.8 1.6 0.7 6.7 5.2 4.5 4.1 2.7 3.9 30.0 3.1 3.8 5.7 6.1 6.1 20.3 39.3 5.5 4.1 7.0 9.7 5.5 7.5 5.2 14.4 3.6 3.4 4.1 6.1 8.8 5.2 7.2 3.1 14.0 12.5 15.4 6.6 11.9 3.9 4.2 47.3 5.5 2.2 3.4 6.4 7.2 7.7 5.9 4.6 6.4 4.0 4.4 9.8 7.1 3.6 10.0 3.4 22.4 11.5 2.9 7.6 13.0 3.1 4.3 7.8 5.4 11.3 5.7 13.9 4.5 5.3 4.6 5.3 2.0 3.5 1.6 1.8 1.2 1.2 1.4 0.8 1.3 1.3 0.4 0.6 16.1 0.8 1.5 0.6 1.5 0.7 8.0 10.5 14.1 14.1 6.0 7.2 9.6 9.3 10.2 8.3 11.9 4.1 1.9 20.3 41.0 4.4 12.0 15.3 6.7 2.3 7.0 2.0 11.0 1.7 9.3 30.1 8.7 34.3 0.0 9.9 5.4 7.1 22.8 4.6 3.4 12.6 3.2 10.9 3.7 20.2 18.4 2.0 28.7 5.0 43.3 16.5 2.0 19.2 17.5 3.5 7.1 7.4 0.0 5.4 29.3 12.6 28.4 6.2 3.2 10.5 35.3 RNF207 "C1orf188, FLJ32096, FLJ46380" ENSG00000158286 "Ring finger protein 207" Q6ZRF8 1 6205475-6221299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 24.2" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 28.2;Urothelial cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 2.7" "Lineage enriched" "Detected in single" 8 "monocytes: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.8;HaCaT: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028378, HPA042535" Uncertain Approved Cytosol NA NA Cytosol "HPA028378: AB_10601157, HPA042535: AB_2678042" "unprognostic (5.53e-3)" "unprognostic (1.23e-1)" "unprognostic (1.62e-2)" "unprognostic (4.46e-2)" "unprognostic (4.84e-2)" "unprognostic (5.91e-3)" "unprognostic (9.48e-2)" "unprognostic (1.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.74e-2)" "unprognostic (9.93e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.76e-2)" "unprognostic (2.93e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" 1.6 2.1 0.6 6.6 1.5 0.3 1.9 5.6 1.8 5.7 5.8 0.9 13.3 2.8 3.6 3.8 4.4 4.7 6.6 24.2 0.7 2.1 5.9 4.3 2.0 2.2 0.7 0.2 3.3 5.3 3.3 4.0 9.2 0.9 7.7 2.4 10.6 6.1 16.6 2.5 1.1 8.2 7.6 1.2 1.9 3.5 1.2 0.6 1.4 6.4 2.8 8.7 5.0 5.0 0.0 0.0 0.0 2.7 0.0 0.3 0.1 2.3 4.5 0.4 3.2 0.2 0.4 2.9 1.5 1.1 0.3 0.4 2.3 17.8 0.3 1.2 1.2 0.0 7.6 0.4 1.1 0.1 2.4 1.8 0.1 5.5 2.3 1.5 1.8 0.1 1.3 0.3 0.0 0.0 4.4 0.1 0.4 0.6 3.9 0.1 1.7 0.2 0.3 0.2 0.4 4.1 0.0 0.8 3.2 2.6 4.0 0.5 1.2 2.4 1.6 1.1 0.8 2.9 0.1 0.5 0.0 0.7 0.5 0.0 3.8 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.2 0.1 0.6 1.5 5.6 1.8 0.7 2.1 0.7 0.2 0.9 0.6 8.9 3.8 0.5 28.2 0.2 3.0 14.6 12.7 4.0 15.9 17.4 2.0 11.4 0.0 13.4 0.7 0.7 6.8 0.0 8.6 5.7 3.7 17.2 0.0 3.4 1.0 3.2 3.5 1.8 0.0 0.0 0.0 1.7 0.0 3.6 9.2 6.5 12.5 2.9 1.1 1.9 18.7 6.5 5.0 0.1 2.3 0.4 4.7 0.5 6.0 32.3 RNF213 "C17orf27, KIAA1554, KIAA1618, MYMY2, NET57" ENSG00000173821 "Ring finger protein 213" Q63HN8 17 80260866-80398786 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Ubl conjugation pathway" "Hydrolase, Transferase" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003347, HPA026790" Approved Supported Cytosol NA NA Cytosol "HPA003347: AB_1079204, HPA026790: AB_10602296" "unprognostic (8.98e-2)" "unprognostic (1.60e-1)" "unprognostic (8.97e-3)" "prognostic unfavorable (4.65e-5)" "unprognostic (7.39e-2)" "unprognostic (3.99e-2)" "unprognostic (2.23e-2)" "unprognostic (1.52e-1)" "unprognostic (4.57e-2)" "unprognostic (3.85e-1)" "unprognostic (1.96e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-3)" "unprognostic (8.92e-2)" "unprognostic (1.13e-2)" "unprognostic (1.40e-1)" "unprognostic (4.56e-2)" 17.0 15.1 7.4 16.9 10.3 22.4 10.2 4.7 7.5 11.0 12.2 15.6 14.9 8.5 16.6 13.0 13.2 9.7 12.1 8.5 7.8 7.8 17.1 11.6 15.4 17.9 10.9 5.6 11.5 9.0 41.1 11.4 15.1 10.0 11.2 8.0 12.3 11.7 12.5 9.0 8.7 14.8 13.6 14.3 17.0 10.6 5.9 8.7 24.5 15.9 7.5 18.2 13.6 15.4 7.2 13.9 37.9 9.6 11.4 12.1 1.8 16.2 28.9 2.9 2.0 10.6 16.2 2.2 4.1 9.0 18.6 15.9 3.1 7.5 1.0 3.5 8.6 19.9 9.5 3.9 5.3 6.3 36.8 1.8 2.5 11.7 5.4 4.5 2.7 2.6 8.9 3.6 10.4 4.5 5.8 14.3 11.8 4.7 6.1 6.9 3.9 10.6 1.1 2.1 3.0 6.7 7.3 6.7 1.2 5.2 14.1 2.8 3.9 10.0 21.2 7.6 6.8 4.8 3.4 18.5 10.4 8.3 6.1 4.2 2.7 2.5 2.9 7.8 3.2 3.7 6.9 9.6 4.2 12.1 8.0 8.1 6.2 8.6 9.7 2.3 7.2 6.9 8.5 37.9 11.4 6.9 13.9 6.4 1.8 7.4 10.3 4.7 7.5 7.8 7.8 10.9 5.6 10.0 8.7 83.4 56.5 111.7 32.9 31.8 18.0 28.5 79.0 38.8 38.7 96.0 47.1 18.7 11.6 100.5 1.1 68.4 78.6 23.3 139.5 24.8 43.3 49.8 44.1 45.9 84.7 22.3 44.2 79.2 104.8 2.0 56.4 97.6 28.7 162.3 61.5 23.6 181.0 73.7 48.4 56.6 71.2 64.7 34.9 1.4 4.4 30.1 18.2 168.3 34.5 65.7 RNF214 DKFZp547C195 ENSG00000167257 "Ring finger protein 214" Q8ND24 11 117232625-117286445 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 17.2" "Group enriched" "Detected in many" 5 "granulocytes: 4.3;T-cells: 17.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039332 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA039332: AB_10671874" "unprognostic (7.36e-2)" "unprognostic (4.91e-2)" "unprognostic (9.90e-2)" "unprognostic (1.66e-2)" "unprognostic (6.34e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.03e-5)" "unprognostic (2.06e-1)" "unprognostic (6.47e-2)" "unprognostic (1.40e-1)" "unprognostic (5.67e-2)" "unprognostic (8.48e-2)" "unprognostic (1.25e-2)" "unprognostic (3.04e-1)" "unprognostic (1.82e-1)" "unprognostic (2.33e-1)" "unprognostic (2.28e-2)" 12.9 14.0 13.3 10.5 18.5 11.8 12.3 19.7 21.3 15.4 11.2 22.3 11.7 11.0 17.6 11.8 10.1 11.5 9.6 11.3 13.9 11.3 11.1 12.7 11.6 12.1 14.9 17.4 17.1 28.0 21.5 16.3 12.8 16.6 10.8 12.1 16.8 13.4 13.3 18.4 10.9 10.7 22.2 17.7 12.5 12.9 22.3 14.9 10.9 15.5 11.1 13.6 13.3 12.6 1.8 2.2 4.3 2.1 0.9 17.2 1.3 6.5 8.3 18.7 11.0 9.9 11.2 9.6 12.6 10.5 11.3 12.1 13.1 16.8 9.0 18.5 13.1 11.7 9.7 20.6 9.4 14.2 15.0 5.5 27.8 7.2 9.9 19.0 14.7 10.6 9.0 11.1 14.1 20.9 15.5 14.1 16.0 16.5 9.4 13.8 5.3 11.0 13.1 10.0 11.3 7.1 11.9 12.8 12.1 11.4 11.8 11.6 13.0 13.4 8.7 6.2 15.4 16.2 11.2 13.9 11.2 9.6 7.4 8.6 5.4 4.3 11.2 4.7 11.8 14.6 4.3 2.1 2.2 2.1 2.0 1.2 1.8 7.2 3.6 1.7 1.7 1.9 1.9 0.9 0.9 1.8 2.2 17.2 1.3 13.3 18.5 19.7 21.3 13.9 11.3 14.9 17.4 16.6 14.9 23.8 13.7 8.9 8.0 4.4 21.8 10.1 5.1 13.4 18.2 5.2 9.8 11.8 8.3 10.9 35.5 8.4 8.7 0.0 11.1 11.0 7.3 6.1 4.7 7.4 11.0 12.7 8.6 6.2 7.8 16.5 9.5 9.3 8.5 12.6 7.8 16.7 8.7 8.4 12.0 7.8 39.9 12.9 10.3 49.2 49.3 4.4 16.2 8.4 8.6 5.0 RNF216 "TRIAD3, UBCE7IP1, ZIN" ENSG00000011275 "Ring finger protein 216" Q9NWF9 7 5620047-5781739 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 118.7;Late spermatids: 171.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018955, HPA021123" Supported Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA018955: AB_1858500, HPA021123: AB_1858501" "unprognostic (3.31e-2)" "unprognostic (4.24e-2)" "unprognostic (1.28e-2)" "unprognostic (1.58e-2)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.35e-1)" "unprognostic (2.40e-1)" "unprognostic (1.40e-2)" "prognostic favorable (6.24e-5)" "unprognostic (2.88e-2)" "unprognostic (9.01e-2)" "unprognostic (3.49e-1)" "unprognostic (1.73e-2)" "unprognostic (1.06e-2)" "unprognostic (3.69e-3)" 16.9 14.9 22.0 18.8 24.8 22.2 18.4 33.5 27.8 17.8 26.9 22.0 13.4 11.5 26.9 13.3 18.7 19.6 14.2 29.1 20.5 17.4 12.7 11.8 14.9 23.8 23.8 14.8 25.6 21.3 23.2 24.9 14.6 20.4 17.7 11.8 18.9 16.2 21.5 22.5 15.1 20.1 25.0 18.7 23.3 18.3 34.3 26.3 18.5 19.8 9.6 24.1 17.7 30.7 8.8 6.7 24.5 8.4 10.0 9.7 6.5 14.3 15.4 12.7 21.6 15.2 13.1 8.7 15.3 16.1 15.9 14.8 11.1 8.2 12.5 7.9 17.1 27.6 10.3 13.1 10.8 13.0 7.8 11.4 9.7 9.3 11.2 18.1 15.8 16.6 13.5 13.8 12.2 14.9 13.2 12.6 12.2 19.3 8.8 17.6 22.0 5.9 25.2 17.4 8.1 12.9 15.1 17.9 7.0 9.5 12.1 9.7 15.4 9.7 24.3 8.7 14.9 9.6 16.2 13.6 16.1 29.1 16.4 13.8 7.2 5.3 10.2 12.1 14.7 25.6 1.3 7.7 24.5 9.0 8.4 9.0 7.3 7.9 6.7 6.7 8.8 9.7 9.1 13.1 10.0 7.7 5.4 7.0 6.5 22.0 24.8 33.5 27.8 20.5 17.4 23.8 14.8 20.4 26.3 6.0 19.2 11.0 16.6 14.7 36.2 25.7 5.1 13.4 14.8 12.2 49.1 11.9 21.6 15.1 118.7 24.8 10.2 0.0 12.0 11.1 20.5 16.4 18.5 13.4 19.2 27.0 5.8 23.9 19.0 171.4 34.5 23.8 11.8 33.3 12.5 35.8 13.1 3.5 28.3 10.6 49.0 25.8 22.7 96.9 99.0 14.2 12.7 23.0 10.8 13.1 RNF219 "C13orf7, FLJ13449" ENSG00000152193 "Ring finger protein 219" Q5W0B1 13 78614291-78659179 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034785, HPA034786" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA034785: AB_10601496, HPA034786: AB_2674331" "unprognostic (2.99e-1)" "unprognostic (1.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.60e-1)" "unprognostic (7.88e-2)" "unprognostic (1.34e-2)" "unprognostic (2.83e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.84e-2)" "unprognostic (4.26e-3)" "prognostic unfavorable (4.99e-6)" "unprognostic (6.87e-2)" "unprognostic (2.01e-1)" "unprognostic (6.91e-2)" "unprognostic (2.53e-2)" 17.6 7.7 10.7 8.9 15.5 3.4 10.6 24.2 16.3 11.9 8.0 4.7 7.3 7.4 11.3 7.8 8.7 9.1 7.1 10.6 10.7 10.3 7.6 6.7 8.0 13.9 11.9 12.1 12.3 6.6 5.0 11.5 12.2 12.7 10.2 8.5 4.0 7.1 10.1 8.7 8.5 8.7 12.7 13.4 13.6 6.8 21.7 13.4 21.8 9.5 8.5 16.7 12.8 9.2 10.5 7.0 8.2 10.6 12.3 13.3 7.8 11.2 4.4 19.4 11.3 6.8 6.6 8.8 9.4 7.1 9.3 11.7 8.7 8.4 19.0 4.6 5.9 6.1 11.2 15.2 7.4 16.4 11.8 11.1 29.0 5.7 7.7 5.7 28.0 9.1 6.3 8.3 7.7 8.4 5.3 7.6 9.7 7.5 2.6 12.1 3.1 17.0 9.5 0.0 12.0 4.9 19.9 15.9 7.3 6.3 6.0 14.1 7.9 6.5 8.3 7.0 11.5 4.2 22.6 6.2 8.1 7.4 5.3 7.8 2.7 3.1 18.3 13.0 17.1 8.7 4.8 6.0 8.2 9.5 9.7 11.3 10.5 10.7 11.6 7.0 10.1 13.3 11.9 2.0 12.3 10.6 5.9 10.4 7.8 10.7 15.5 24.2 16.3 10.7 10.3 11.9 12.1 12.7 13.4 14.9 3.0 8.0 7.0 7.4 10.5 18.7 10.2 12.0 10.3 8.7 5.9 13.2 5.0 9.1 22.1 14.3 2.7 0.0 3.9 10.1 8.0 5.7 9.3 5.7 8.1 9.5 4.7 12.3 10.6 11.0 13.6 12.8 11.8 7.2 4.7 9.6 7.1 2.9 9.9 7.6 8.0 0.0 5.2 23.9 51.1 10.0 4.2 9.5 7.1 5.8 RNF25 "AO7, FLJ13906" ENSG00000163481 "Ring finger protein 25" Q96BH1 2 218663864-218672411 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036420, HPA036421" Uncertain Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Actin filaments" "HPA036420: AB_2675114, HPA036421: AB_10669604" "unprognostic (3.22e-2)" "unprognostic (7.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (3.46e-1)" "unprognostic (2.04e-3)" "unprognostic (8.82e-2)" "unprognostic (1.26e-3)" "unprognostic (2.50e-1)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.69e-2)" 13.4 12.7 13.9 11.1 16.1 6.2 13.7 13.4 27.6 17.3 13.3 17.1 9.8 4.3 16.6 16.2 12.2 16.8 11.8 17.2 13.1 16.5 13.7 15.6 11.9 12.1 12.1 11.6 17.8 13.0 19.3 14.8 17.7 15.4 14.7 9.0 15.3 13.6 17.9 16.9 15.7 10.3 16.0 10.0 12.9 11.8 18.4 9.1 15.3 16.8 12.7 16.8 14.0 11.8 13.3 8.2 23.3 11.2 14.8 15.0 13.9 5.9 7.6 6.9 8.0 10.6 6.5 7.5 6.8 17.1 23.4 21.8 12.7 4.0 4.0 5.4 14.3 12.9 5.4 8.0 13.3 10.2 4.3 10.9 5.4 5.6 12.0 13.0 4.8 5.9 14.3 12.4 21.2 14.3 6.5 12.7 15.4 9.1 6.2 15.0 17.0 5.4 5.9 11.0 4.9 8.7 7.6 4.4 5.8 14.3 6.4 7.0 7.9 5.2 5.9 10.1 5.0 7.0 8.8 7.3 13.3 6.3 5.2 9.6 5.4 4.2 6.7 11.2 6.0 8.0 23.3 10.6 14.9 13.9 10.3 12.6 11.9 13.7 13.6 8.2 13.3 15.0 11.7 8.9 14.8 11.2 7.4 11.5 13.9 13.9 16.1 13.4 27.6 13.1 16.5 12.1 11.6 15.4 9.1 0.0 0.3 4.7 4.6 5.6 7.4 3.1 5.1 5.3 2.3 1.8 7.9 11.1 13.3 10.5 10.3 5.9 6.4 0.0 11.4 8.1 7.2 3.0 6.9 6.4 11.3 4.8 1.2 9.2 5.9 3.4 6.6 4.6 8.5 10.0 4.9 7.0 10.2 8.6 12.0 11.5 4.5 25.8 6.1 14.4 11.9 5.9 8.4 10.1 4.8 3.9 RNF26 MGC2642 ENSG00000173456 "Ring finger protein 26" Q9BY78 11 119334527-119337313 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027620 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA Yes Nucleoplasm "Vesicles, Cytosol" "HPA027620: AB_1856356" "unprognostic (9.23e-3)" "unprognostic (3.54e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (3.40e-1)" "unprognostic (1.07e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.14e-2)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (7.24e-3)" "unprognostic (6.22e-2)" "prognostic favorable (3.45e-6)" "unprognostic (9.61e-2)" "unprognostic (3.50e-2)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.73e-4)" 19.0 21.5 13.6 15.4 21.6 25.6 16.9 18.4 38.9 19.8 22.0 17.6 14.5 20.3 31.2 15.6 26.0 24.4 19.8 15.1 17.1 13.8 22.3 28.7 17.3 17.5 15.0 16.6 25.6 18.5 31.4 14.3 27.5 27.2 19.2 18.2 20.2 20.0 28.5 17.6 19.8 21.4 27.0 14.3 19.8 24.3 27.6 13.0 26.7 20.6 14.0 21.1 25.8 18.1 13.8 14.2 7.1 15.5 9.8 16.7 16.2 15.7 17.5 16.4 19.3 16.2 12.8 17.4 17.2 18.6 20.1 15.9 29.5 33.2 14.0 23.8 20.4 30.5 28.8 23.2 25.9 12.6 16.6 12.8 36.8 8.2 24.3 12.4 15.4 15.3 13.3 13.3 25.0 22.6 13.2 15.2 21.7 17.8 22.0 13.8 34.5 14.1 16.0 16.4 18.3 22.4 14.7 16.8 11.1 12.3 11.5 11.7 11.3 13.9 17.6 4.6 16.5 39.9 12.9 10.0 24.3 16.2 12.7 15.6 5.3 8.6 0.1 8.1 26.1 18.9 7.1 15.5 3.9 16.7 14.5 11.0 9.0 12.7 14.5 14.2 13.8 14.5 12.4 1.1 9.8 14.1 8.1 6.6 16.2 13.6 21.6 18.4 38.9 17.1 13.8 15.0 16.6 27.2 13.0 3.0 6.5 9.0 12.0 6.2 9.1 0.5 28.1 2.7 7.9 10.4 2.0 31.3 5.0 17.7 3.4 7.5 10.0 0.0 15.0 54.3 13.5 11.2 7.0 19.8 18.0 4.8 13.2 8.6 9.9 4.9 13.0 8.8 1.7 12.6 10.2 9.7 11.8 10.2 16.6 10.3 7.6 6.5 10.3 12.2 8.3 7.4 20.4 9.6 14.5 8.6 RNF31 "FLJ10111, FLJ23501, HOIP, Paul, ZIBRA" ENSG00000092098 "Ring finger protein 31" Q96EP0 14 24146683-24160661 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 5.8;Club cells: 5.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB009063, HPA048745" Approved Approved Cytosol NA NA Cytosol "CAB009063: AB_2127706, HPA048745: AB_2680509" "unprognostic (3.58e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (9.05e-2)" "unprognostic (2.52e-1)" "unprognostic (6.24e-2)" "unprognostic (9.09e-3)" "unprognostic (1.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (6.21e-3)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" "unprognostic (1.41e-2)" "unprognostic (1.99e-1)" 14.4 18.5 11.7 21.5 17.4 20.0 15.1 20.0 26.4 17.7 17.3 18.4 19.9 13.4 22.4 22.3 15.4 17.4 17.2 14.5 10.7 9.8 17.2 14.8 15.3 19.3 11.0 18.0 20.6 23.6 20.0 19.2 18.7 13.4 16.4 14.1 16.9 19.6 23.1 39.5 29.1 16.1 19.7 9.1 27.3 16.5 21.8 11.0 33.6 17.4 13.1 24.9 16.3 13.5 2.4 4.6 3.8 3.7 2.5 4.8 1.3 4.5 10.6 9.9 12.2 6.7 7.0 20.1 7.9 11.7 15.6 12.5 9.6 11.5 9.0 5.0 11.3 9.2 7.8 5.6 11.3 9.3 9.4 4.2 8.4 10.8 21.0 11.1 14.1 15.0 12.8 9.7 7.1 11.1 9.7 9.9 7.5 4.9 11.9 6.9 14.1 13.3 8.3 5.3 7.9 11.6 8.9 7.3 5.7 7.9 18.8 8.8 11.0 7.3 19.3 9.6 9.0 6.8 10.4 9.7 11.0 8.4 8.0 7.4 16.0 14.1 8.8 4.1 5.6 10.2 0.0 2.1 1.5 1.9 3.7 4.8 2.4 1.9 2.1 1.8 1.1 2.3 1.3 3.8 2.5 2.1 4.6 3.0 1.3 11.7 17.4 20.0 26.4 10.7 9.8 11.0 18.0 13.4 11.0 0.0 5.8 0.5 0.2 0.6 0.7 0.2 0.0 1.4 5.7 0.0 0.0 0.4 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.3 0.4 0.2 0.0 0.6 0.3 0.0 0.0 0.6 0.8 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.7 0.0 0.1 0.7 0.4 0.6 0.5 0.8 0.0 0.3 RNF32 "FKSG33, HSD15, LMBR2" ENSG00000105982 "Ring finger protein 32" Q9H0A6 7 156640281-156677130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 55.2" "Group enriched" "Detected in many" 4 "Early spermatids: 227.1;Late spermatids: 367.1;Spermatocytes: 116.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 11.3;HDLM-2: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019516, HPA073560" Enhanced Supported "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA019516: , HPA073560: AB_2686616" "unprognostic (9.23e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (7.85e-2)" "unprognostic (3.98e-2)" "unprognostic (2.21e-2)" "unprognostic (5.73e-3)" "unprognostic (1.71e-2)" "unprognostic (8.72e-3)" "unprognostic (6.08e-4)" "unprognostic (4.64e-2)" "unprognostic (2.06e-1)" "unprognostic (8.15e-3)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" "unprognostic (3.81e-3)" "unprognostic (1.44e-1)" 1.1 1.0 2.2 0.8 2.6 0.9 0.8 1.0 2.2 0.6 1.2 4.7 0.8 1.0 0.6 7.7 0.6 2.2 1.6 0.4 2.0 1.9 1.5 0.8 1.0 1.2 1.8 2.2 1.8 2.6 0.8 2.6 0.9 2.0 1.5 1.0 0.7 1.4 0.6 0.6 1.4 0.9 0.1 2.8 0.8 1.9 55.2 1.9 1.1 1.7 0.0 0.9 0.6 0.6 3.7 3.5 10.5 0.6 0.6 2.8 0.9 4.2 2.2 0.4 1.1 1.0 0.6 0.6 0.7 0.1 1.1 0.9 11.3 4.9 6.9 5.4 0.7 1.2 0.1 0.0 0.2 2.2 12.5 2.9 0.6 0.8 0.4 1.0 1.9 4.0 1.7 0.8 0.6 2.3 0.7 0.5 6.1 9.9 1.9 3.4 7.4 2.7 4.8 2.4 7.1 5.5 2.7 0.1 3.1 1.6 1.4 7.1 5.5 4.2 0.4 2.1 1.1 1.2 1.4 1.8 0.0 0.1 0.9 0.5 10.1 4.3 3.9 0.8 4.5 1.7 10.5 0.5 1.8 0.6 0.3 2.2 3.7 2.3 0.6 1.4 2.6 0.6 0.7 0.1 0.6 0.6 3.5 2.8 0.9 2.2 2.6 1.0 2.2 2.0 1.9 1.8 2.2 2.0 1.9 6.0 1.6 0.5 1.9 0.2 2.3 1.2 5.1 54.9 7.9 3.5 0.0 0.0 5.0 1.8 227.1 0.1 2.1 0.0 2.9 0.4 0.6 1.8 5.7 2.1 0.3 1.6 4.1 1.3 0.0 367.1 6.1 1.1 1.7 0.0 2.9 2.7 2.3 0.0 3.9 4.1 2.0 0.0 0.5 116.1 17.9 0.5 0.1 0.0 2.1 0.8 RNF7 "CKBBP1, ROC2, SAG" ENSG00000114125 "Ring finger protein 7" Q9UBF6 3 141738204-141747560 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 615.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036995 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036995: AB_10673627" "unprognostic (5.68e-2)" "unprognostic (4.94e-3)" "unprognostic (1.83e-1)" "unprognostic (3.24e-1)" "unprognostic (9.11e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (4.53e-2)" "unprognostic (1.24e-2)" "unprognostic (3.98e-3)" "unprognostic (5.17e-3)" "unprognostic (8.58e-3)" "prognostic unfavorable (1.54e-9)" "unprognostic (4.60e-1)" "unprognostic (2.20e-1)" "unprognostic (3.69e-2)" "unprognostic (2.36e-2)" 26.0 44.0 31.4 21.7 37.0 30.7 38.3 19.4 28.6 26.1 37.0 17.5 36.3 38.6 30.4 42.0 37.1 22.9 41.8 47.6 27.4 27.6 33.2 35.3 27.2 32.1 26.7 21.6 30.5 57.6 16.2 33.9 40.6 20.5 37.3 34.5 29.2 36.2 28.9 69.9 35.7 42.7 36.2 23.9 23.7 26.8 44.4 18.7 27.0 35.1 50.6 27.4 37.5 35.2 32.7 44.9 36.3 52.2 22.5 41.7 42.9 46.6 18.9 28.2 22.7 26.9 37.2 18.6 26.2 24.8 22.5 23.9 22.0 23.3 15.7 61.5 29.0 55.4 22.9 17.4 24.6 28.6 15.0 32.6 15.5 17.9 31.8 35.9 24.3 15.2 34.7 27.8 17.9 30.7 30.2 31.8 27.0 16.3 22.0 33.3 35.9 15.3 27.4 29.9 47.4 31.5 16.8 18.0 33.9 48.0 20.6 15.6 19.5 30.0 31.1 43.6 38.3 29.1 32.0 24.1 22.6 21.6 39.9 22.0 21.0 17.5 32.3 35.2 27.0 25.5 36.3 52.2 33.7 33.0 44.5 33.1 32.7 35.6 35.0 44.9 29.3 34.7 35.9 18.5 22.5 46.6 41.4 41.7 42.9 31.4 37.0 19.4 28.6 27.4 27.6 26.7 21.6 20.5 18.7 56.6 51.0 67.8 126.0 117.7 34.2 80.9 84.1 76.3 55.7 96.0 25.5 151.5 215.5 196.2 256.9 96.6 240.4 0.0 216.5 209.1 117.2 147.3 71.5 105.8 191.8 27.0 120.6 99.4 110.4 615.6 109.0 126.7 136.7 155.1 160.5 58.0 201.5 213.1 114.5 270.8 43.1 84.1 120.7 194.2 117.2 126.5 108.6 109.0 157.3 138.1 RNF8 KIAA0646 ENSG00000112130 "Ring finger protein 8" O76064 6 37353972-37394738 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 40.7" "Low region specificity" "Detected in all" "HPA050731, HPA064925" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050731: AB_2681222, HPA064925: AB_2685385" "unprognostic (1.80e-2)" "unprognostic (2.23e-1)" "unprognostic (1.39e-2)" "unprognostic (8.20e-2)" "unprognostic (5.17e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (3.33e-5)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (2.26e-3)" "unprognostic (3.38e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (7.95e-3)" "unprognostic (1.78e-1)" "unprognostic (3.41e-2)" "unprognostic (3.66e-3)" "unprognostic (1.09e-1)" 8.0 11.7 13.1 8.2 17.8 8.9 11.5 25.7 18.7 9.2 9.5 10.6 6.8 6.9 13.5 5.7 18.3 12.0 8.8 17.6 13.4 14.8 11.8 7.5 10.8 8.3 12.0 16.0 13.2 6.5 11.9 16.4 10.2 13.7 8.6 8.2 8.0 10.2 11.9 15.2 9.9 8.4 10.7 9.6 7.7 7.6 19.8 13.8 6.6 8.0 9.4 13.3 12.9 15.2 8.8 8.3 2.6 8.1 7.6 10.8 5.5 6.6 4.0 9.7 11.5 7.8 11.3 2.8 6.9 8.6 13.2 14.5 6.0 3.7 8.3 4.2 6.7 11.4 6.3 13.5 8.8 13.8 8.7 13.1 14.2 7.0 8.9 4.5 7.6 10.5 5.6 8.5 7.8 9.1 8.1 12.6 9.8 9.6 2.9 7.5 4.4 9.1 9.4 6.7 3.4 5.3 7.2 8.9 5.7 6.7 4.7 19.1 6.4 5.2 5.9 9.5 6.6 5.3 7.4 5.7 8.7 7.7 8.2 10.2 8.6 11.3 40.7 4.2 10.8 10.0 1.0 4.6 2.6 10.8 6.0 10.0 8.8 8.1 10.2 8.3 6.0 7.1 9.4 0.6 7.6 8.1 3.6 9.3 5.5 13.1 17.8 25.7 18.7 13.4 14.8 12.0 16.0 13.7 13.8 17.9 23.4 13.0 21.7 16.3 26.0 28.3 10.2 28.1 15.9 24.4 37.3 20.9 13.3 20.8 35.2 15.8 8.6 0.0 16.6 21.6 23.9 20.0 27.7 14.7 15.4 47.7 21.4 22.1 14.2 20.2 24.7 13.8 10.1 20.8 16.1 21.5 23.6 15.6 29.0 16.8 29.6 12.9 16.4 43.0 33.1 19.3 4.9 15.8 16.2 17.0 RNFT2 "FLJ14627, TMEM118" ENSG00000135119 "Ring finger protein, transmembrane 2" Q96EX2 12 116738178-116853631 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.3;Cone photoreceptor cells: 15.7;Early spermatids: 40.0;Late spermatids: 40.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064161 Enhanced Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA064161: AB_2685202" "unprognostic (1.56e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (3.59e-1)" "unprognostic (3.98e-1)" "unprognostic (3.10e-2)" "unprognostic (8.14e-5)" "unprognostic (8.62e-2)" "unprognostic (6.28e-3)" "unprognostic (2.58e-1)" "unprognostic (9.25e-3)" "unprognostic (2.75e-1)" "unprognostic (7.61e-3)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.36e-3)" "unprognostic (4.01e-4)" 1.7 3.2 8.8 2.6 15.1 3.5 1.4 13.6 21.0 1.5 1.6 6.6 0.0 2.0 1.5 4.3 1.5 1.5 1.6 1.4 9.9 12.1 2.0 1.0 1.5 4.1 9.7 9.8 1.7 1.4 2.6 7.5 2.9 19.0 1.2 1.7 3.6 2.6 1.2 2.1 2.7 1.8 1.4 6.2 2.9 1.9 7.0 3.4 2.5 2.1 0.0 4.4 1.2 0.4 4.3 2.2 4.0 1.1 2.8 3.1 0.9 1.5 9.2 4.8 15.6 0.2 0.0 8.0 0.6 0.7 1.9 1.7 3.6 1.8 8.1 2.3 0.1 2.4 1.9 10.2 0.7 1.9 7.6 5.1 1.5 7.4 4.9 2.1 0.6 4.7 0.2 0.2 3.2 1.0 1.6 0.3 5.7 6.2 2.9 0.2 7.8 7.8 1.9 4.8 2.0 1.8 5.1 2.7 4.1 3.7 1.9 7.4 6.7 2.3 1.2 2.2 3.3 7.3 1.8 0.5 1.3 5.3 3.1 3.1 3.7 12.2 8.4 5.9 0.8 1.0 4.0 1.1 1.3 2.0 0.7 0.6 4.3 1.8 1.4 0.6 3.3 2.9 3.1 3.4 2.8 0.8 2.2 1.1 0.9 8.8 15.1 13.6 20.9 9.9 12.1 9.7 9.8 19.0 3.4 0.0 0.3 0.0 0.2 0.0 15.3 0.8 2.5 1.4 0.0 7.0 15.7 2.7 0.0 0.8 40.0 2.1 0.4 0.0 0.2 2.3 0.6 0.3 0.0 0.0 1.8 9.5 4.1 0.0 2.2 40.6 0.6 1.0 1.7 1.0 0.4 6.9 0.7 0.0 1.4 0.8 8.9 0.0 0.4 2.6 3.6 0.0 1.4 0.0 0.6 0.1 RNH1 "RAI, RNH" ENSG00000023191 "Ribonuclease/angiogenin inhibitor 1" P13489 11 494512-507300 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039223, HPA040781" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 27000000 "Nucleoplasm, Cytosol" "HPA039223: AB_10795581, HPA040781: AB_10796227" "unprognostic (1.87e-1)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (1.59e-3)" "unprognostic (2.48e-3)" "unprognostic (6.09e-2)" "unprognostic (4.82e-3)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.44e-1)" "prognostic favorable (2.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-2)" "unprognostic (4.35e-2)" 39.8 35.7 18.5 27.6 25.7 40.8 57.9 14.7 33.1 34.9 27.8 43.0 25.9 27.3 36.6 34.2 51.4 30.5 32.8 49.5 20.4 16.5 32.6 46.2 36.1 36.6 37.1 25.3 36.2 32.4 25.7 21.1 35.1 24.3 30.7 8.7 25.6 37.5 33.2 41.6 60.7 26.0 37.7 31.7 29.8 25.3 37.9 29.6 17.1 41.4 41.9 25.8 35.5 38.6 12.9 47.8 10.3 53.3 9.8 12.1 35.3 21.3 30.3 3.3 11.3 18.5 26.3 12.5 20.0 13.9 18.3 15.9 17.0 26.1 11.8 15.5 38.1 11.7 20.0 5.8 20.1 2.9 15.0 27.6 7.9 8.4 15.6 62.3 10.4 25.6 22.4 29.8 10.6 13.2 8.1 12.4 7.6 10.3 20.1 10.4 21.3 8.1 19.8 5.5 12.2 30.9 10.3 7.3 15.1 11.2 7.8 9.7 6.6 12.0 17.5 19.9 2.1 12.5 33.0 22.2 31.3 9.2 11.3 13.4 12.8 13.6 8.7 34.2 23.8 20.5 5.7 44.4 10.3 10.4 53.3 12.1 12.9 11.2 10.4 47.8 9.5 10.5 9.3 3.2 9.8 48.7 13.9 10.7 35.3 18.5 25.7 14.7 33.1 20.4 16.5 37.1 25.3 24.3 29.6 104.2 68.6 78.2 202.3 179.6 102.0 71.4 86.6 58.9 50.0 75.0 104.1 190.2 190.6 176.0 77.4 124.7 114.8 23.3 144.3 181.6 179.4 129.6 138.4 60.6 342.3 158.9 55.0 87.8 170.9 28.6 195.9 258.9 183.9 413.0 69.3 139.4 142.6 119.3 169.0 169.2 137.1 174.6 167.4 144.3 173.7 227.2 255.5 84.8 86.0 194.1 ROCK2 ENSG00000134318 "Rho associated coiled-coil containing protein kinase 2" O75116 2 11179761-11348330 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007459, CAB008666, HPA044109" Approved Supported Cytosol NA NA 3700000 Cytosol "CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813" "unprognostic (4.55e-2)" "unprognostic (1.05e-2)" "unprognostic (4.18e-3)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "unprognostic (2.71e-1)" "unprognostic (1.39e-2)" "unprognostic (2.72e-1)" "unprognostic (3.62e-2)" "unprognostic (6.66e-2)" "unprognostic (3.83e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.57e-5)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "unprognostic (2.52e-2)" "unprognostic (3.47e-2)" 26.9 7.8 14.6 9.5 21.9 4.4 21.4 26.1 26.4 16.6 16.5 5.6 8.6 12.3 22.4 11.0 12.4 13.2 11.9 12.3 13.4 7.6 11.4 12.3 16.7 6.8 7.2 16.7 15.1 8.6 12.9 14.8 18.4 10.3 14.4 20.3 5.6 10.3 14.4 28.0 8.7 13.8 42.9 7.1 12.6 10.7 5.8 9.6 5.9 10.5 5.1 6.2 22.1 20.8 2.5 3.0 3.6 2.2 3.5 3.3 0.9 6.6 16.2 13.4 13.1 24.3 17.1 8.6 15.8 14.8 10.3 10.9 15.3 14.6 8.4 9.4 24.9 12.5 7.4 9.7 9.1 16.3 11.9 5.8 16.7 27.9 30.5 8.7 9.3 4.8 13.3 5.8 12.7 9.1 8.4 16.4 4.6 14.5 3.4 15.3 5.6 6.8 4.8 7.4 14.1 10.0 8.2 29.5 2.7 5.6 18.9 6.3 6.8 31.0 10.8 10.8 10.6 4.4 5.2 22.3 21.3 15.4 8.4 13.8 2.7 3.3 7.5 9.2 11.0 29.6 3.6 1.8 1.7 2.7 2.2 3.3 1.6 2.2 1.8 1.3 2.5 1.9 2.1 3.0 3.5 1.7 3.0 1.8 0.9 14.6 21.9 26.1 26.4 13.4 7.6 7.2 16.7 10.3 9.6 107.2 64.4 9.3 35.3 35.4 33.2 94.7 35.7 41.5 86.4 21.0 55.0 22.5 1.7 25.4 6.5 88.7 62.6 0.0 34.0 15.9 43.2 45.6 26.7 37.6 16.5 76.3 20.4 58.9 19.8 3.5 40.6 24.0 21.9 8.2 82.3 34.2 30.5 38.6 73.9 13.6 42.5 129.4 101.5 21.4 17.7 24.3 26.3 11.4 40.0 38.2 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615120 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 108.1" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 2384.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 17.9;U-266/84: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028910, HPA073279" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA028910: AB_2672824, HPA073279: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favorable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 9.4 4.6 16.3 2.3 15.0 0.9 3.6 5.7 18.8 4.9 3.1 5.1 3.3 2.0 3.8 5.7 4.7 7.4 5.2 2.7 14.7 9.2 2.4 3.2 3.0 2.3 18.1 4.7 13.2 3.2 4.8 2.1 1.6 8.7 3.8 3.0 108.1 2.5 5.9 2.2 3.7 1.7 6.3 21.6 2.5 2.4 3.7 7.7 0.7 3.0 2.2 2.6 3.1 9.2 1.1 0.8 0.8 1.2 5.6 3.2 1.4 2.1 1.2 2.2 4.6 3.2 15.7 0.4 1.4 2.5 3.1 2.0 0.6 3.6 2.0 10.0 8.1 1.3 2.8 1.0 2.8 0.8 3.6 1.8 1.8 5.4 2.6 9.3 0.7 0.6 17.9 4.1 3.2 6.4 10.5 4.8 0.9 2.7 4.6 6.2 5.4 1.1 1.5 0.5 1.1 3.3 1.1 1.8 12.8 3.4 1.2 2.3 3.4 3.5 4.1 1.6 0.3 5.6 0.9 5.4 5.1 1.9 6.0 1.6 2.1 18.8 1.6 9.5 2.1 1.0 0.0 1.2 0.8 0.9 0.3 2.4 0.7 3.2 0.8 0.6 1.1 1.5 1.8 0.4 5.6 1.1 0.8 0.9 1.4 16.3 15.0 5.7 8.4 14.7 9.2 18.1 4.7 8.7 7.7 0.0 4.1 0.0 4.4 3.3 268.3 2.4 0.0 2.7 1.2 5.2 559.6 0.8 1.7 1.3 2.1 8.0 1.6 0.0 2.7 0.2 3.5 2.6 1.1 0.6 1.0 162.1 4.1 11.1 1.8 5.9 17.5 1.0 3.3 1.0 2.8 315.6 1.7 3.4 5.3 4.0 2384.7 0.0 3.4 0.9 2.7 0.9 0.6 0.0 2.9 2.0 RP9 PAP-1 ENSG00000164610 "RP9, pre-mRNA splicing factor" Q8TA86 7 33094797-33109401 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031523, HPA050778" Uncertain Enhanced Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA031523: AB_10603235, HPA050778: AB_2681233" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (1.07e-2)" "unprognostic (1.82e-1)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.22e-2)" "unprognostic (7.53e-2)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.65e-5)" "unprognostic (4.19e-2)" "unprognostic (2.63e-2)" "unprognostic (2.70e-1)" "unprognostic (1.61e-1)" 10.1 13.8 11.7 9.4 16.0 20.7 14.9 17.1 16.0 10.9 12.2 13.0 7.0 10.3 14.6 18.8 8.1 10.0 10.7 19.2 11.1 10.1 11.4 11.5 9.7 19.4 17.4 8.6 14.2 16.9 10.4 14.2 11.7 11.0 14.0 11.8 12.8 15.0 14.4 34.7 10.7 12.5 15.7 11.8 17.2 10.5 15.2 12.6 13.6 15.6 9.0 18.2 13.4 16.0 34.1 11.7 8.1 5.0 5.9 8.4 3.3 9.9 14.3 15.1 17.2 9.6 9.0 7.2 12.7 10.9 14.7 11.8 12.7 7.3 12.6 8.4 10.5 18.1 10.0 18.3 10.9 19.0 5.7 11.4 9.2 11.3 11.8 16.9 12.3 6.5 9.0 10.3 16.7 33.1 12.0 12.0 13.5 16.5 11.6 14.7 20.6 13.2 33.8 12.7 13.3 10.3 13.3 13.1 8.4 10.6 9.6 14.6 20.0 8.9 20.0 21.7 18.7 10.5 17.1 9.6 14.6 20.5 12.9 20.6 18.9 17.1 25.1 10.3 17.6 28.2 6.4 5.0 8.1 6.6 3.6 6.1 22.0 7.0 7.4 5.3 34.1 8.4 7.8 0.9 5.9 4.6 11.7 5.9 3.3 11.7 16.0 17.1 16.0 11.1 10.1 17.4 8.6 11.0 12.6 11.9 8.5 17.4 13.8 18.7 16.3 32.5 12.7 10.7 11.4 14.0 13.7 16.9 18.3 14.1 3.5 21.7 10.5 0.0 13.7 16.3 19.4 11.5 3.5 15.1 16.0 7.9 9.8 14.7 7.6 2.7 16.7 9.9 21.9 9.0 16.4 15.8 13.4 5.8 15.2 13.5 12.9 25.8 20.2 33.0 48.0 15.7 8.7 11.8 18.0 10.7 RPAP1 "DKFZP727M111, FLJ12732, KIAA1403, MGC858" ENSG00000103932 "RNA polymerase II associated protein 1" Q9BWH6 15 41517176-41544269 "Predicted intracellular proteins, Predicted membrane proteins" Transcription "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041739 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041739: AB_2677647" "unprognostic (8.83e-3)" "unprognostic (2.78e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (1.97e-1)" "unprognostic (8.61e-2)" "unprognostic (1.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-2)" "unprognostic (7.02e-2)" "unprognostic (3.73e-2)" "unprognostic (3.26e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (9.32e-4)" "unprognostic (4.30e-3)" 10.1 10.2 12.8 8.5 12.4 4.7 8.1 7.8 15.6 7.8 10.2 12.6 7.9 8.5 10.7 6.0 12.3 10.4 6.9 9.5 10.9 6.1 6.7 10.8 7.3 9.8 12.3 10.1 12.4 9.4 12.9 9.4 8.7 11.9 9.4 7.1 9.5 9.8 9.2 27.0 10.3 8.0 10.1 8.0 9.1 9.4 12.6 11.8 11.2 8.3 7.9 10.7 11.2 8.4 5.9 4.5 0.0 5.9 4.9 7.2 3.3 7.2 8.7 11.9 12.5 10.0 7.3 10.1 7.2 6.2 9.3 9.1 23.5 6.6 5.7 11.9 8.0 15.0 17.2 21.4 10.5 8.0 10.0 10.4 10.7 12.1 10.3 6.3 8.8 6.8 7.4 13.3 11.0 7.7 6.3 10.4 13.0 25.0 6.5 8.6 4.6 9.5 5.4 21.0 11.2 8.1 17.2 10.3 6.1 4.1 17.1 10.9 14.6 9.2 9.6 4.9 10.8 15.9 11.0 9.4 14.7 9.6 14.6 11.5 11.0 30.1 6.4 10.4 9.6 13.8 0.0 2.6 0.0 7.2 3.5 6.6 4.8 4.3 4.5 4.5 5.9 6.1 5.3 0.0 4.9 5.9 2.9 4.4 3.3 12.8 12.4 7.8 15.6 10.9 6.1 12.3 10.1 11.9 11.8 3.0 4.8 9.1 3.8 2.5 9.4 8.1 2.5 5.3 4.5 5.2 11.8 5.6 1.7 4.8 1.1 4.6 3.5 0.0 4.7 5.3 4.1 4.9 2.3 8.1 4.2 15.9 2.4 3.7 4.0 1.3 3.4 3.3 1.7 6.4 5.6 4.8 4.8 0.0 8.9 2.4 7.0 0.0 3.8 11.2 9.8 3.6 2.3 6.9 6.6 2.7 RPAP2 "C1orf82, FLJ13150, Rtr1" ENSG00000122484 "RNA polymerase II associated protein 2" Q8IXW5 1 92298965-92402056 "Enzymes, Predicted membrane proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 104.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046443 Approved Supported Nucleoli,Cytosol No No "Nucleoli, Cytosol" "HPA046443: AB_2679669" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.71e-2)" "unprognostic (4.12e-2)" "unprognostic (4.96e-3)" "unprognostic (5.73e-2)" "unprognostic (1.23e-3)" "unprognostic (3.29e-2)" "unprognostic (8.01e-3)" "unprognostic (4.09e-2)" "unprognostic (2.59e-1)" "unprognostic (6.09e-2)" "unprognostic (7.02e-4)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.62e-3)" "unprognostic (4.10e-2)" 6.8 7.0 7.8 7.3 10.5 12.0 7.6 27.2 11.6 8.4 6.3 7.1 7.2 6.6 11.1 11.5 5.6 6.3 5.5 5.9 8.1 8.6 8.1 10.6 5.2 8.2 7.7 6.7 8.2 8.6 9.4 16.1 6.7 11.7 7.6 5.8 6.4 7.2 7.1 10.5 10.7 6.3 7.4 9.9 7.6 6.4 6.7 8.7 12.8 9.4 6.5 6.3 6.6 7.6 4.4 3.5 4.9 2.4 4.0 4.8 1.2 6.3 3.9 6.8 6.3 5.6 7.2 5.8 5.0 3.5 3.3 2.7 2.8 2.9 9.5 8.7 3.7 4.5 4.4 5.6 3.2 5.1 6.5 4.0 5.8 7.0 3.7 3.3 10.0 5.8 3.7 4.0 4.2 4.1 4.9 3.5 5.9 5.9 6.4 5.0 3.3 8.4 6.3 5.3 3.6 4.4 6.3 9.0 4.1 4.3 5.7 6.4 4.7 8.1 7.5 4.0 5.3 3.9 7.7 6.1 5.0 6.4 5.7 7.1 6.2 7.1 5.0 3.5 6.3 3.4 4.8 2.4 1.9 4.1 1.7 4.8 3.4 3.2 3.5 1.8 4.4 3.5 3.8 4.9 4.0 1.9 3.5 2.8 1.2 7.8 10.5 27.2 11.6 8.1 8.6 7.7 6.7 11.7 8.7 59.6 66.2 8.2 15.1 8.1 55.5 21.2 5.1 75.0 68.2 7.0 104.1 17.6 10.0 16.4 39.3 17.1 7.7 23.3 11.9 12.3 13.6 12.8 59.1 7.4 8.5 33.4 12.1 8.0 10.8 4.7 17.5 8.8 1.7 15.4 11.9 39.3 12.8 10.7 20.1 13.0 87.8 25.8 12.0 18.9 18.8 8.5 19.8 24.2 11.1 9.8 RPAP3 "FLJ21908, hSpagh, spag" ENSG00000005175 "RNA polymerase II associated protein 3" Q9H6T3 12 47661249-47706061 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038311, HPA038312" Enhanced Enhanced Cytosol NA NA Cytosol "HPA038311: AB_10671527, HPA038312: AB_10672512" "unprognostic (5.76e-2)" "unprognostic (2.25e-1)" "unprognostic (1.37e-2)" "unprognostic (4.21e-2)" "unprognostic (7.28e-2)" "unprognostic (4.47e-1)" "prognostic unfavorable (2.01e-5)" "unprognostic (9.89e-2)" "unprognostic (9.87e-3)" "unprognostic (6.34e-2)" "unprognostic (9.48e-2)" "unprognostic (1.28e-2)" "unprognostic (2.01e-2)" "unprognostic (8.35e-2)" "unprognostic (5.11e-1)" "unprognostic (3.29e-1)" "unprognostic (1.35e-2)" 12.1 13.2 20.3 17.0 19.9 10.6 15.3 23.5 23.2 13.2 16.2 6.7 14.9 13.0 15.7 14.7 16.4 15.2 11.7 15.4 18.4 14.8 12.9 16.0 10.3 25.7 18.8 18.4 23.3 12.1 15.7 24.6 12.3 20.5 14.2 12.5 5.2 14.4 12.8 47.6 11.1 12.8 15.1 22.8 18.2 12.1 14.3 19.1 21.5 13.4 14.4 26.7 16.8 13.2 15.1 10.2 22.7 16.9 9.3 11.5 6.2 16.1 15.1 18.4 12.6 9.9 14.2 15.5 16.1 16.6 20.4 17.6 20.9 18.4 35.8 22.2 14.2 14.7 16.2 15.9 9.5 23.9 19.0 14.9 24.1 10.2 10.1 8.6 25.6 16.9 6.9 11.8 23.9 8.7 16.7 12.7 14.1 26.4 11.0 18.0 11.5 21.9 18.5 19.7 14.9 13.0 17.8 22.2 17.5 16.6 14.7 13.3 9.7 18.8 15.5 16.1 20.4 15.9 15.4 9.1 14.2 18.8 15.5 17.7 8.7 16.2 25.6 13.3 56.9 8.7 2.6 7.6 22.7 7.9 14.4 8.1 15.1 8.9 8.5 10.2 14.0 11.5 10.3 14.2 9.3 16.9 7.1 10.9 6.2 20.3 19.9 23.5 23.2 18.4 14.8 18.8 18.4 20.5 19.1 11.9 14.5 15.6 11.9 11.7 16.4 28.2 15.3 29.4 21.6 10.4 7.9 19.8 19.9 15.3 6.1 10.3 7.5 0.0 17.1 13.3 13.9 7.6 11.5 14.3 15.9 11.1 12.6 8.0 16.4 5.6 20.1 18.0 6.8 52.3 10.7 12.6 11.6 15.8 19.4 20.7 13.8 6.5 15.5 43.2 33.8 8.9 14.2 11.3 13.3 8.9 RPE ENSG00000197713 Ribulose-5-phosphate-3-epimerase Q96AT9 2 210002565-210022259 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (5.07e-2)" "unprognostic (8.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.34e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.42e-6)" "unprognostic (1.59e-3)" "unprognostic (1.69e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.00e-6)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "unprognostic (5.84e-2)" 19.4 26.9 20.6 16.7 28.0 14.6 22.6 26.4 27.7 18.7 19.7 23.3 20.7 17.4 27.8 21.5 24.0 17.6 17.3 17.2 21.1 21.0 26.7 23.3 19.4 21.6 21.7 21.7 22.9 14.1 14.8 41.9 24.4 18.6 20.5 26.6 18.9 18.3 27.9 12.3 17.2 16.0 27.1 25.8 15.6 19.8 11.9 19.7 23.5 25.2 14.5 23.2 24.1 20.2 8.6 28.9 8.0 20.5 30.5 10.7 11.3 20.6 26.8 17.4 17.5 28.3 27.4 29.9 27.2 21.8 25.9 34.8 38.5 31.7 13.9 17.9 21.0 35.1 20.3 25.6 29.0 39.6 16.7 18.1 25.8 39.3 35.9 38.6 27.3 19.9 19.2 28.9 29.7 38.7 23.6 33.7 13.9 25.9 19.4 21.2 32.9 14.8 23.8 25.5 41.7 19.6 18.7 20.8 19.9 29.9 30.9 20.9 12.0 23.0 22.5 18.2 32.8 19.4 31.4 27.6 34.8 23.2 16.9 25.1 11.7 14.8 29.9 25.2 27.0 22.5 6.9 17.3 8.0 10.2 20.5 8.9 8.6 8.0 9.6 28.9 8.4 10.7 9.6 1.7 30.5 13.7 10.6 10.7 11.3 20.6 28.0 26.4 27.7 21.1 21.0 21.7 21.7 18.6 19.7 6.0 6.9 14.7 13.5 14.7 12.5 5.3 7.6 13.4 19.4 17.4 19.6 32.4 26.6 20.5 8.8 11.9 12.3 23.3 15.1 36.8 15.5 12.1 5.8 15.5 33.1 9.5 9.8 17.2 17.6 9.3 10.3 20.4 13.5 16.2 14.2 8.2 17.4 14.0 13.8 37.0 12.9 6.5 14.1 16.4 16.1 17.8 21.4 11.4 18.9 12.0 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;brain: 1.2;pituitary gland: 1.2" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 2.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;NB-4: 1.1" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.1 0.1 1.0 0.3 0.1 0.1 1.2 0.2 0.0 0.0 0.3 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.8 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.4 1.0 0.3 0.7 1.4 0.6 0.2 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.4 0.7 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.3 1.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.2 1.1 0.7 0.2 0.0 0.0 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.4 0.2 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.2 0.3 0.1 0.3 0.7 0.4 0.1 0.3 0.7 0.2 0.5 0.7 0.5 0.4 0.4 0.3 1.0 0.4 0.5 0.6 0.0 1.4 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.5 0.0 0.0 1.2 0.0 7.9 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.2 0.3 0.3 0.0 0.7 0.0 RPGRIP1L "CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134" ENSG00000103494 "RPGRIP1 like" Q68CZ1 16 53598153-53703938 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 25.8" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 109.7;Spermatocytes: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039405, HPA040530" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039405: AB_10794636, HPA040530: AB_2677023" "prognostic unfavorable (6.93e-4)" "unprognostic (1.52e-1)" "unprognostic (2.19e-3)" "unprognostic (2.26e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-4)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (5.22e-3)" "unprognostic (1.52e-1)" "unprognostic (4.92e-4)" "unprognostic (5.95e-2)" 3.0 6.5 8.0 3.8 13.8 2.7 6.1 5.3 12.7 6.3 3.3 2.4 6.8 2.4 7.3 7.8 3.9 11.7 4.9 3.3 9.1 9.9 5.5 2.2 3.5 3.1 5.9 13.2 6.5 3.2 18.5 25.8 3.8 9.0 5.2 3.5 1.7 3.4 5.3 2.3 3.6 2.0 6.3 3.5 1.9 3.5 20.9 4.7 3.1 7.6 2.3 3.1 4.4 3.6 4.9 2.0 1.8 1.0 2.1 5.6 1.3 9.1 11.3 10.2 9.4 12.3 12.0 4.5 10.2 6.7 9.5 2.7 6.2 7.4 6.1 7.4 10.4 6.4 10.6 8.5 9.7 16.9 3.7 5.9 2.2 9.6 6.2 5.1 5.5 4.2 7.5 6.0 10.6 6.6 10.4 7.1 8.5 5.6 3.5 14.0 3.5 9.0 3.9 6.5 3.2 5.4 15.4 14.0 7.3 12.3 2.4 17.8 6.7 12.6 5.3 4.6 6.5 8.0 4.4 6.4 10.4 7.4 8.5 9.0 4.6 5.3 10.8 15.7 3.3 6.1 1.7 0.9 1.1 3.6 1.0 3.5 3.2 2.6 3.3 0.8 4.9 2.6 5.6 1.8 2.1 1.0 2.0 2.1 1.3 8.0 13.8 5.3 12.7 9.1 9.9 5.9 13.2 9.0 4.7 6.0 3.7 3.2 2.8 4.0 5.1 7.3 0.0 109.7 19.4 10.4 7.9 4.6 14.9 6.5 13.1 2.5 0.1 0.0 2.7 6.2 9.3 1.4 6.9 3.8 2.4 3.2 0.0 3.7 1.2 9.0 4.4 2.8 1.7 2.8 3.8 6.1 3.5 0.0 6.0 14.2 8.4 6.5 4.1 38.1 11.0 4.6 1.4 1.0 3.8 2.1 RPL10 "DXS648, DXS648E, FLJ23544, L10, NOV, QM" ENSG00000147403 "Ribosomal protein L10" P27635 X 154389955-154409168 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB010339, HPA011311" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA 130000 "Endoplasmic reticulum, Cytosol" "CAB010339: AB_2181277, HPA011311: AB_1856431" "unprognostic (2.46e-3)" "unprognostic (3.57e-2)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.25e-2)" "unprognostic (2.06e-1)" "unprognostic (6.11e-2)" "unprognostic (9.01e-3)" "unprognostic (1.91e-1)" "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (3.37e-1)" "prognostic unfavorable (7.67e-6)" "unprognostic (6.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.65e-2)" "unprognostic (5.68e-2)" 103.6 65.3 41.4 108.0 48.5 103.7 152.6 82.4 70.7 118.2 80.6 44.6 107.8 51.3 100.4 75.5 105.2 122.3 52.6 82.5 38.2 31.9 112.1 155.0 97.6 190.2 48.2 37.4 223.5 242.3 35.0 51.9 87.4 53.1 83.6 77.1 66.7 109.9 101.5 125.9 121.8 108.9 78.7 51.4 93.9 90.5 33.9 47.2 158.9 198.9 137.9 134.4 86.9 119.3 252.9 168.6 64.4 124.1 149.1 304.9 445.3 190.6 88.4 88.6 67.9 201.2 381.1 78.4 73.4 170.1 141.3 179.7 78.4 85.8 378.1 177.6 122.3 139.8 74.1 173.4 175.7 121.4 83.0 137.5 51.0 63.4 85.9 236.7 109.5 75.5 287.6 278.2 84.9 265.3 244.2 221.6 161.8 71.8 120.9 137.9 95.7 119.3 106.6 69.8 188.1 152.9 143.1 84.0 210.1 154.1 68.1 71.1 118.8 17.7 156.2 216.7 89.4 56.8 153.2 106.6 49.4 94.0 111.2 162.3 287.9 207.9 376.0 75.1 158.2 61.7 64.4 124.1 18.1 149.9 107.7 256.2 252.9 251.6 186.2 151.2 243.2 304.9 231.1 13.0 149.1 94.9 168.6 178.0 445.3 41.4 48.5 82.4 70.7 38.2 31.9 48.2 37.4 53.1 47.2 1664.5 2043.1 10322.4 11239.3 10721.6 451.7 309.0 3949.0 1271.5 2545.5 1934.9 233.7 5960.7 5721.4 3854.4 49.9 6113.6 2058.8 1915.6 11641.3 8484.3 6948.0 9869.1 2815.7 3204.1 6194.0 254.3 2785.1 5085.5 7653.2 131.8 7835.9 9465.3 7747.1 9437.5 6244.9 793.3 8332.0 5018.5 3353.3 5769.1 609.3 2942.7 9122.3 99.1 315.1 12724.6 6324.6 8194.7 7230.3 10693.0 RPL10A "Csa-19, L10A, NEDD6" ENSG00000198755 "Ribosomal protein L10a" P62906 6 35468408-35470785 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053803 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 360000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA053803: AB_2682268" "unprognostic (5.47e-2)" "unprognostic (8.02e-2)" "unprognostic (1.45e-1)" "unprognostic (3.37e-1)" "unprognostic (3.40e-2)" "unprognostic (1.36e-1)" "unprognostic (3.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.37e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.21e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (9.72e-2)" 55.0 41.7 35.5 80.8 28.0 79.0 96.9 25.3 37.6 71.5 76.4 22.8 62.3 35.0 91.2 62.5 88.7 91.0 72.6 45.2 28.1 23.1 45.4 71.1 44.8 94.0 28.5 38.0 155.3 141.2 18.6 35.6 56.6 25.6 86.5 55.2 34.7 104.5 66.1 98.5 92.9 47.2 56.8 27.3 51.4 55.5 33.2 20.1 70.6 62.0 121.6 76.5 77.4 86.4 165.3 104.4 8.5 62.8 101.1 186.5 235.1 66.6 68.9 78.3 73.6 117.4 214.2 88.8 69.1 142.3 97.5 77.8 99.6 64.6 200.2 63.8 93.6 47.9 59.2 105.5 157.7 81.0 69.4 92.9 76.8 63.8 139.1 174.0 112.0 64.1 249.0 185.0 71.4 239.9 158.1 142.7 100.7 90.5 99.0 110.5 117.8 118.1 136.2 82.2 105.4 60.8 93.6 75.5 154.9 123.2 110.4 55.3 81.0 42.5 97.8 195.2 66.0 105.8 204.3 82.3 31.9 57.7 42.3 86.9 62.6 101.9 132.2 40.0 130.7 57.0 8.5 62.8 5.9 82.7 61.2 146.9 165.3 137.8 106.1 104.4 146.8 186.5 145.8 6.1 101.1 52.4 98.5 104.4 235.1 35.5 28.0 25.3 37.6 28.1 23.1 28.5 38.0 25.6 20.1 497.3 826.2 3505.8 4941.4 4796.5 207.9 239.4 1668.8 799.0 1510.5 567.0 68.7 3327.1 2528.3 1289.0 177.8 1494.7 980.5 513.9 2845.5 4591.2 2345.1 3300.9 883.5 1243.6 1940.9 103.3 1454.5 1261.4 1687.0 354.9 2330.6 2284.0 2282.6 2326.4 2431.8 212.5 2052.4 1855.2 1390.9 2230.9 177.0 756.7 2794.2 210.8 382.0 5789.4 3433.4 2382.6 3597.4 4457.4 RPL10L ENSG00000165496 "Ribosomal protein L10 like" Q96L21 14 46651010-46651821 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 45.5" "Cell type enhanced" "Detected in many" 29 "Early spermatids: 439.0;Late spermatids: 154.0;Spermatocytes: 85.2" "Cancer enriched" "Detected in single" 15 "testis cancer: 6.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 45 "U-2 OS: 30.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA011311 Uncertain Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA011311: AB_1856431" "unprognostic (7.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.92e-2)" "unprognostic (4.18e-2)" "unprognostic (6.67e-2)" "unprognostic (2.92e-1)" "unprognostic (8.70e-4)" "unprognostic (4.69e-2)" "unprognostic (5.27e-3)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.83e-1)" "unprognostic (4.40e-2)" "unprognostic (1.44e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.3 0.6 0.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.4 0.3 0.5 1.0 0.6 0.8 0.2 0.7 0.9 0.9 0.0 0.4 0.2 0.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 8.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 439.0 0.6 0.2 0.0 0.0 0.2 1.7 5.2 0.0 0.0 0.3 0.0 0.0 0.0 0.3 154.0 5.8 2.0 10.1 0.0 1.8 0.0 0.0 0.0 2.1 0.0 0.0 6.5 4.7 85.2 11.5 16.4 0.2 0.0 2.3 2.6 RPL13 "BBC1, D16S444E, L13" ENSG00000167526 "Ribosomal protein L13" P26373 16 89560657-89566828 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051702 Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 53000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA051702: AB_2681579" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.14e-2)" "prognostic favorable (6.26e-4)" "unprognostic (1.57e-2)" "unprognostic (3.68e-2)" "unprognostic (7.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.57e-2)" "prognostic unfavorable (6.64e-4)" "unprognostic (4.34e-2)" "unprognostic (7.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" 82.5 56.0 46.7 105.0 38.4 112.7 150.9 37.7 44.0 114.5 114.9 31.3 76.9 65.5 118.4 85.4 144.0 98.4 101.6 85.2 38.6 32.1 60.8 118.3 90.4 385.1 38.8 37.4 231.3 255.8 36.5 57.5 66.0 27.0 136.2 44.4 43.0 267.3 87.6 197.4 137.7 66.7 90.2 44.8 104.7 71.1 106.5 24.6 135.0 102.4 129.6 98.6 109.3 156.8 277.8 163.1 26.9 96.9 120.7 299.0 355.4 67.5 75.1 53.4 86.5 96.1 160.2 111.9 42.7 92.6 89.3 36.3 113.4 104.8 95.0 88.2 72.4 35.5 94.0 63.4 112.3 44.6 26.6 176.0 32.3 41.9 150.3 205.8 39.2 39.5 194.0 239.4 57.2 144.3 145.7 93.0 120.4 98.7 54.2 68.5 211.6 107.4 308.2 109.2 133.6 79.9 160.2 56.6 133.5 108.4 56.8 75.3 110.2 59.1 77.3 128.1 35.2 152.0 233.4 54.2 57.7 62.3 50.8 58.5 82.2 77.2 96.9 75.3 138.7 60.5 26.9 96.9 15.3 129.1 74.9 239.2 252.5 234.3 176.5 116.8 277.8 299.0 230.2 10.7 120.7 56.7 163.1 163.7 355.4 46.7 38.4 37.7 44.0 38.6 32.1 38.8 37.4 27.0 24.6 1676.5 3076.1 8572.3 13242.6 11129.2 658.9 392.1 3263.7 1810.8 3433.9 1533.6 178.7 5497.3 3942.5 3304.0 3376.6 4985.3 2353.5 1588.5 9512.5 8594.0 5542.1 9230.0 2503.8 3991.9 4585.6 235.2 2827.6 3949.3 6200.5 9204.7 7634.3 6835.9 5176.0 5670.1 5289.2 713.9 6690.8 4380.2 3433.2 5399.2 577.3 2050.2 5882.2 1406.9 1082.9 14135.8 5156.1 7058.2 8155.8 12161.4 RPL13A "L13A, TSTA1" ENSG00000142541 "Ribosomal protein L13a" P40429 19 49487554-49492308 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038751 Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA038751: AB_10962004" "unprognostic (2.35e-3)" "unprognostic (2.15e-1)" "unprognostic (4.08e-2)" "unprognostic (2.02e-1)" "unprognostic (2.95e-3)" "unprognostic (2.55e-1)" "prognostic unfavorable (9.97e-4)" "unprognostic (1.21e-1)" "unprognostic (3.86e-2)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.81e-2)" "unprognostic (7.85e-2)" "unprognostic (3.22e-1)" "unprognostic (1.87e-1)" 85.4 87.0 45.7 114.3 46.9 132.5 106.4 38.9 41.2 103.8 145.5 38.8 89.2 84.1 129.4 80.7 117.7 83.5 119.9 112.5 37.2 31.2 65.4 113.9 71.8 265.3 41.5 37.0 203.8 334.9 21.8 54.2 76.7 44.1 114.3 46.8 65.4 169.0 95.4 216.0 122.9 77.0 121.1 44.2 121.4 87.8 54.5 27.8 124.0 119.8 147.0 115.0 112.7 196.5 284.6 144.9 40.5 81.3 148.0 268.3 354.3 120.1 147.8 70.3 205.2 134.2 212.6 83.8 105.2 130.3 75.9 82.4 125.3 92.4 304.9 84.7 78.6 31.8 79.7 87.6 152.2 45.0 85.4 206.5 153.9 96.2 178.5 163.5 231.1 122.4 245.8 254.2 53.8 182.8 168.6 122.3 107.9 132.5 115.1 87.3 104.5 161.5 234.8 135.9 114.9 133.0 157.1 160.5 132.9 103.1 204.3 120.6 158.6 54.9 244.9 232.4 58.8 108.0 266.7 150.6 95.8 103.4 59.4 138.5 116.5 157.9 137.6 59.9 158.5 87.8 40.5 81.3 20.7 132.2 70.3 194.3 284.6 226.2 180.3 126.7 264.8 268.3 212.3 13.6 148.0 60.4 144.9 165.3 354.3 45.7 46.9 38.9 41.2 37.2 31.2 41.5 37.0 44.1 27.8 1503.7 1729.8 9229.7 10612.9 10289.3 512.1 472.1 3870.0 2000.9 3534.0 1509.2 202.2 6720.7 4604.1 3662.2 243.1 4976.1 2426.8 1868.9 11119.9 8860.9 5735.6 8516.9 2404.2 3758.5 5124.9 208.2 3836.4 4121.8 6096.6 467.8 8451.2 6154.9 5402.0 6444.6 6340.8 679.2 7721.8 5811.0 4166.9 5142.4 507.0 2612.9 6508.5 432.4 584.7 12485.0 7026.2 7155.4 9081.3 10590.2 RPL14 "CTG-B33, hRL14, L14, RL14" ENSG00000188846 "Ribosomal protein L14" P50914 3 40457292-40468587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 95.3" "Low region specificity" "Detected in all" HPA004136 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 210000 "Endoplasmic reticulum, Cytosol" "HPA004136: AB_1079839" "unprognostic (1.36e-3)" "unprognostic (2.91e-1)" "unprognostic (2.48e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (2.54e-1)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (1.02e-1)" "unprognostic (4.94e-2)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (2.11e-1)" "unprognostic (1.54e-1)" "unprognostic (2.90e-2)" "unprognostic (6.14e-3)" "unprognostic (1.15e-1)" 49.9 33.5 28.3 57.4 43.8 47.2 134.4 28.7 57.6 85.4 68.2 21.4 48.0 29.8 87.0 30.9 66.0 61.0 56.7 46.7 40.8 22.8 42.5 69.8 44.6 61.7 24.7 22.2 151.9 117.3 48.4 34.4 60.8 40.6 81.8 42.0 36.2 162.9 73.6 72.3 66.7 39.0 59.1 24.7 69.6 52.4 23.8 11.7 42.9 63.3 100.2 58.5 48.7 77.0 26.6 16.0 4.6 11.6 14.3 38.3 47.9 9.4 5.2 32.0 11.4 25.9 91.2 18.6 14.5 48.6 54.7 41.5 11.0 3.7 41.3 12.3 14.3 20.9 2.9 16.2 25.4 32.3 14.0 17.9 19.8 9.1 10.5 39.7 28.1 10.7 44.1 95.3 15.5 33.0 66.1 50.1 49.6 23.2 5.8 37.8 9.1 9.2 25.6 9.1 46.3 17.1 4.3 12.1 20.0 40.5 7.0 10.0 16.0 7.6 7.4 22.0 38.0 11.5 15.5 16.6 11.1 8.1 14.0 18.3 18.1 21.7 22.5 5.0 21.2 10.2 3.7 11.6 4.6 21.1 11.6 35.5 26.6 31.7 27.7 16.0 24.1 38.3 34.9 1.8 14.3 9.9 14.6 24.9 47.9 28.3 43.8 28.7 57.6 40.8 22.8 24.7 22.2 40.6 11.7 771.2 883.3 2536.9 4403.4 2765.6 207.8 306.9 1449.7 777.6 1508.2 642.0 96.2 2943.8 2143.7 1521.6 222.8 1840.1 1118.8 887.7 3599.1 4111.4 1918.7 2744.5 1484.2 1016.8 1943.1 95.3 1181.4 1316.6 1781.7 387.3 2000.3 2174.5 1690.4 2539.2 2184.9 232.3 2849.1 1855.2 1019.7 2575.0 247.3 950.7 1701.5 263.4 350.5 2988.0 2771.9 1999.5 2848.8 3958.2 RPL17 "L17, rpL23" ENSG00000265681 "Ribosomal protein L17" P18621 18 49488453-49492523 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043724, HPA046385" Supported Supported "Endoplasmic reticulum,Cytosol" NA NA 28000 "Endoplasmic reticulum, Cytosol" "HPA043724: AB_2678637, HPA046385: AB_2679646" "unprognostic (1.11e-1)" "unprognostic (8.77e-2)" "unprognostic (1.33e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (3.34e-3)" "prognostic unfavorable (3.60e-5)" "unprognostic (2.69e-1)" "unprognostic (3.29e-3)" "unprognostic (2.11e-1)" "unprognostic (4.35e-3)" "unprognostic (2.72e-2)" "unprognostic (3.32e-1)" "unprognostic (1.66e-1)" "unprognostic (6.54e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-3)" 59.6 60.0 40.5 57.8 58.1 101.1 127.2 41.7 42.9 66.7 64.4 26.3 67.8 40.9 64.1 65.5 84.9 76.7 79.7 49.5 32.2 31.1 99.4 184.2 48.0 106.0 42.9 32.3 177.4 203.2 21.7 72.5 77.1 43.6 60.7 53.1 39.8 83.3 83.8 67.6 76.3 69.7 43.7 38.1 78.5 66.8 92.7 32.9 66.6 81.7 146.2 75.2 58.2 70.4 140.6 102.8 22.2 59.2 95.1 158.9 142.2 98.1 62.5 91.1 107.5 150.7 308.0 86.8 110.5 128.7 104.8 79.5 84.0 47.9 170.4 76.3 109.2 58.8 117.9 123.5 198.2 112.3 70.6 127.7 89.9 74.3 114.4 131.4 291.6 72.3 293.3 224.7 109.1 258.9 244.5 143.1 116.7 87.9 125.1 130.0 79.8 105.2 187.3 92.7 60.2 51.4 104.6 118.7 219.3 141.9 117.7 69.8 84.2 40.8 85.1 170.8 116.8 80.5 191.1 113.6 77.8 66.2 38.1 115.9 112.9 105.2 157.8 74.4 177.7 74.0 22.2 59.2 15.2 82.8 53.2 158.9 140.6 134.5 109.0 93.7 117.9 150.4 127.9 12.7 95.1 43.8 102.8 104.8 142.2 40.5 58.1 41.7 42.9 32.2 31.1 42.9 32.3 43.6 32.9 616.4 735.4 700.8 208.7 623.3 13.1 0.4 244.5 961.0 1629.9 97.7 9.8 382.5 421.1 712.5 158.5 310.1 430.2 93.5 1412.1 483.3 308.4 144.8 940.4 188.7 239.1 9.5 788.1 335.1 623.8 325.1 488.1 506.6 276.7 1072.2 977.1 22.1 1309.5 501.5 256.0 473.5 23.7 245.8 414.1 85.4 63.9 806.4 346.9 622.0 1301.1 184.7 RPL17-C18orf32 ENSG00000215472 "RPL17-C18orf32 readthrough" 18 49481681-49492479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 48 "Alveolar cells type 1: 142.9;Alveolar cells type 2: 140.3;Ciliated cells: 215.5;Club cells: 177.5;granulocytes: 60.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043724, HPA046385" Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA043724: AB_2678637, HPA046385: AB_2679646" "unprognostic (1.62e-1)" "unprognostic (1.67e-2)" "unprognostic (1.70e-3)" "unprognostic (3.83e-4)" "unprognostic (1.95e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" "unprognostic (2.38e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (5.42e-2)" 7.8 34.4 16.3 17.1 12.5 7.2 8.5 23.6 28.6 9.7 10.7 3.5 11.5 22.8 10.4 9.9 14.8 5.9 13.8 13.7 11.8 14.8 17.6 34.0 8.9 18.9 14.8 4.6 10.5 37.7 3.4 13.7 13.3 6.8 9.6 5.3 6.1 12.6 14.6 11.4 5.6 15.2 5.8 14.1 13.5 10.4 16.3 4.7 11.2 14.2 26.7 12.9 9.1 7.0 6.7 10.6 9.7 9.3 5.8 9.7 10.2 6.6 3.2 13.3 15.7 15.2 9.7 0.3 6.8 5.7 2.6 7.8 2.1 13.7 3.9 3.6 7.2 9.9 7.6 10.5 2.2 9.3 8.3 3.5 7.3 2.1 2.8 3.4 7.4 17.2 16.1 5.7 4.1 9.4 19.8 3.6 13.7 1.4 17.6 15.8 3.2 11.2 5.7 5.9 2.3 0.3 6.2 6.1 12.1 22.6 0.7 12.7 23.9 3.1 11.7 15.9 5.3 14.8 17.1 1.5 7.6 3.5 8.0 3.8 6.7 8.7 6.5 11.1 4.7 9.7 3.5 9.3 4.9 7.1 6.4 9.2 6.7 9.2 9.4 10.6 6.2 6.3 9.7 9.7 5.8 6.1 7.1 8.4 10.2 16.3 12.5 23.6 11.7 11.8 14.8 14.8 4.6 6.8 4.7 142.9 140.3 0.0 0.5 0.2 0.1 0.0 0.0 215.5 177.5 0.0 0.0 0.1 0.0 0.2 2.2 0.0 0.0 0.0 0.2 0.1 0.4 0.2 60.5 0.2 0.2 0.0 0.0 0.6 0.3 3.1 0.0 0.3 0.0 1.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.7 0.6 0.1 0.2 0.0 0.0 0.1 RPL18 L18 ENSG00000063177 "Ribosomal protein L18" Q07020 19 48615328-48619536 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "NB-4: 559.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046572 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 100000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA046572: AB_2679705" "unprognostic (2.12e-2)" "unprognostic (1.86e-2)" "unprognostic (7.30e-2)" "unprognostic (2.57e-2)" "unprognostic (3.48e-3)" "unprognostic (4.76e-2)" "unprognostic (3.21e-3)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (9.15e-2)" "unprognostic (6.15e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.40e-1)" "unprognostic (3.04e-2)" "unprognostic (6.36e-2)" "unprognostic (1.27e-2)" 56.2 57.3 50.3 79.1 40.8 122.4 84.9 35.2 51.1 89.8 76.6 44.8 60.8 66.1 100.6 56.1 129.6 78.2 99.2 43.4 38.3 33.1 56.4 101.9 62.1 194.1 40.3 27.0 206.5 260.5 19.8 57.1 74.8 26.8 100.5 39.6 54.6 136.7 62.3 78.8 108.6 60.5 69.1 39.7 88.7 64.0 45.8 28.6 114.9 115.8 116.5 122.2 91.2 90.5 137.1 84.5 19.0 57.5 71.1 144.1 148.6 58.3 91.0 33.5 58.2 34.2 67.5 49.0 26.8 44.7 55.7 46.9 82.1 54.3 85.4 28.2 25.6 21.1 48.4 30.4 61.0 21.2 36.4 105.9 30.9 42.6 78.4 69.2 43.0 48.3 79.5 89.5 29.8 40.2 40.8 54.7 62.6 43.6 75.3 34.9 74.1 67.6 559.5 53.4 76.1 45.4 70.8 27.0 77.4 45.0 72.2 47.7 62.1 24.2 85.4 81.0 16.2 48.0 83.8 31.2 41.3 45.9 25.6 61.5 62.6 72.9 50.9 26.0 66.4 48.6 19.0 57.5 12.2 65.7 47.6 115.3 130.3 116.4 88.1 79.2 137.1 144.1 113.9 8.6 71.1 37.3 84.5 89.6 148.6 50.3 40.8 35.2 51.1 38.3 33.1 40.3 27.0 26.8 28.6 550.9 838.5 3591.6 3815.8 3969.4 373.7 225.2 1370.7 546.0 953.2 671.7 135.5 3294.6 1175.5 1414.5 62.6 1818.4 1578.0 724.2 3930.9 4507.0 2016.4 3365.3 983.1 1161.9 1943.0 127.1 1609.4 1403.2 2086.4 135.2 3008.2 2285.6 2161.1 2417.6 2644.1 668.4 2833.8 2163.8 1372.2 1352.6 310.0 1015.4 2447.3 225.6 356.8 4859.7 3460.6 2407.5 3173.8 4275.2 RPL18A L18A ENSG00000105640 "Ribosomal protein L18a" Q02543 19 17859876-17864153 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 430.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055259 Approved Approved Nucleoli,Cytosol No No "Nucleoli, Cytosol" "HPA055259: AB_2682764" "unprognostic (3.40e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-2)" "unprognostic (1.09e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (6.71e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (5.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (1.36e-1)" 48.8 33.8 24.9 42.2 43.0 85.7 53.6 27.8 61.1 49.9 46.0 26.5 28.1 40.4 47.8 36.4 65.5 56.5 38.9 31.5 22.6 16.2 50.0 85.9 34.8 83.7 22.3 26.1 109.2 106.6 9.3 30.5 46.9 30.9 41.8 26.8 30.4 99.8 31.6 157.7 90.1 43.3 36.6 21.9 57.6 50.1 67.3 17.6 59.5 65.3 107.9 54.0 45.0 57.1 395.8 193.6 24.8 110.7 126.0 278.4 430.5 126.2 98.3 65.7 92.6 98.7 162.7 166.5 77.5 98.5 102.6 97.9 135.7 127.1 191.0 179.7 66.7 41.0 95.2 77.4 165.0 35.9 97.6 208.7 89.2 94.6 154.5 171.0 128.3 97.8 203.0 217.6 56.7 122.3 106.8 112.2 157.6 113.3 123.9 64.7 196.8 173.5 169.5 154.6 142.0 151.7 156.2 69.7 226.4 93.6 120.2 95.2 142.9 27.5 192.0 239.8 33.9 91.2 249.4 85.9 63.6 74.1 126.9 129.9 166.2 151.1 123.3 83.5 205.4 78.8 24.8 110.4 16.5 134.8 110.7 234.6 368.3 232.2 167.1 166.6 395.8 278.4 212.5 11.3 126.0 85.6 193.6 195.9 430.5 24.9 43.0 27.8 61.1 22.6 16.2 22.3 26.1 30.9 17.6 482.4 926.8 6413.8 4901.3 7713.4 240.4 390.4 1829.3 614.3 1162.5 875.9 119.8 4308.9 2022.7 2828.9 39.6 2919.7 1766.7 1097.9 7783.8 7254.8 3471.5 4168.2 1383.3 2046.3 2960.9 123.9 1772.7 2331.9 4202.4 100.2 3856.5 5199.5 4502.8 5216.5 3612.2 346.7 5814.1 2767.0 1530.2 2592.2 347.7 1235.3 4175.6 138.6 661.5 9733.7 3896.6 4323.4 4712.9 6201.7 RPL19 "DKFZp779D216, FLJ27452, L19, MGC71997" ENSG00000108298 "Ribosomal protein L19" P84098 17 39200283-39204727 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "SK-BR-3: 959.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043014, HPA051987" Approved Enhanced Nucleoli,Cytosol NA NA 100000 "Nucleoli, Cytosol" "HPA043014: AB_10965840, HPA051987: AB_2681682" "unprognostic (4.07e-3)" "unprognostic (1.33e-1)" "unprognostic (3.18e-1)" "unprognostic (4.46e-2)" "unprognostic (4.25e-2)" "unprognostic (6.40e-2)" "unprognostic (9.70e-3)" "unprognostic (1.50e-1)" "unprognostic (5.46e-1)" "unprognostic (1.16e-2)" "unprognostic (3.32e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.33e-1)" "unprognostic (2.20e-2)" "unprognostic (2.48e-2)" "unprognostic (8.60e-2)" 72.3 57.7 51.3 56.7 56.9 122.5 94.7 41.8 88.6 72.2 64.5 42.2 62.7 48.7 67.0 56.7 77.7 78.1 65.9 87.3 49.2 37.0 62.3 124.4 70.7 229.5 50.5 53.0 156.4 124.4 33.1 51.7 57.3 58.7 60.0 52.5 48.1 113.8 67.6 91.4 95.8 58.8 57.5 57.1 74.4 66.1 45.2 34.1 53.0 63.3 94.9 103.4 63.1 75.9 208.2 143.4 40.4 108.7 116.2 236.3 325.8 48.1 65.5 47.5 57.6 87.0 110.0 49.2 45.3 92.6 93.9 75.5 71.4 45.6 117.8 79.8 64.7 54.9 81.9 71.4 93.7 48.4 47.8 125.4 42.0 48.9 92.8 135.7 102.9 58.2 122.5 103.0 72.3 130.9 88.2 80.9 101.1 73.1 69.0 64.8 47.4 136.4 143.9 48.6 56.3 48.8 80.9 67.6 117.8 84.6 60.3 57.8 64.3 27.2 959.6 141.5 53.6 92.9 131.0 47.6 36.7 49.7 55.9 83.3 91.1 90.1 86.7 49.8 78.6 47.2 36.7 108.7 40.4 116.1 90.3 180.1 208.2 187.2 146.8 143.4 193.1 236.3 190.8 17.1 116.2 72.6 132.4 146.2 325.8 51.3 56.9 41.8 88.6 49.2 37.0 50.5 53.0 58.7 34.1 821.9 1155.8 5178.5 5153.7 4931.6 221.1 502.6 2265.0 995.7 1437.7 1080.0 88.4 3138.3 3070.4 2271.3 1107.8 2991.3 1604.9 1214.8 5434.8 4726.5 2858.0 4250.3 1510.1 1935.0 3620.1 125.5 1883.0 2240.5 3562.4 3346.4 3629.9 4014.1 3104.2 3202.1 2957.8 586.7 3801.6 2980.9 1917.8 3691.6 289.1 1506.9 3219.7 1098.4 764.8 5786.0 3261.3 3671.2 4220.8 5947.6 RPL21 "DKFZp686C06101, FLJ27458, L21, MGC104274, MGC104275, MGC71252" ENSG00000122026 "Ribosomal protein L21" P46778 13 27251309-27256691 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047252 Approved Supported "Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 22000 "Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol" "HPA047252: AB_2680000" "unprognostic (4.79e-2)" "unprognostic (3.69e-2)" "unprognostic (1.99e-1)" "unprognostic (2.31e-1)" "unprognostic (3.57e-1)" "unprognostic (1.90e-3)" "unprognostic (2.55e-2)" "unprognostic (7.72e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.47e-2)" "unprognostic (4.53e-2)" "unprognostic (4.83e-3)" "unprognostic (1.28e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-1)" 54.7 44.0 57.3 52.2 68.7 133.6 105.9 39.8 50.7 63.7 61.7 46.3 32.7 42.7 57.8 53.0 59.3 57.7 55.0 63.9 48.0 36.8 64.3 148.7 44.8 100.9 53.6 44.4 142.9 109.8 19.0 48.2 57.8 61.2 52.5 57.2 36.5 85.7 47.2 68.0 72.2 66.3 64.4 48.7 72.8 58.0 46.4 50.0 60.5 58.3 87.6 92.6 59.1 64.9 178.1 103.2 34.8 57.9 95.6 224.2 258.9 56.6 47.6 84.4 68.1 87.9 167.5 71.4 103.1 94.5 80.9 52.5 114.8 105.8 217.6 39.8 81.8 36.3 76.0 96.6 104.9 95.7 68.7 88.0 170.1 48.5 88.7 83.2 232.1 67.6 148.7 172.1 52.9 134.8 111.6 90.6 96.9 70.2 54.2 91.7 81.0 117.0 144.3 110.1 169.9 80.1 87.4 162.0 91.3 75.5 68.3 73.1 68.1 47.9 96.3 83.5 74.3 64.8 207.7 100.1 35.9 46.9 56.4 84.0 36.7 51.5 162.2 46.1 148.4 61.0 34.8 55.8 22.1 101.6 56.9 162.9 178.1 153.1 125.7 75.9 164.1 224.2 177.8 11.9 95.6 57.9 103.2 104.1 258.9 57.3 68.7 39.8 50.7 48.0 36.8 53.6 44.4 61.2 50.0 1566.3 2465.6 8666.4 5097.3 6791.1 357.6 159.0 3671.3 1711.8 3044.9 1484.8 135.5 4221.2 4483.0 2755.0 52.8 3084.7 1963.1 4088.2 6776.1 5196.5 3900.6 3121.1 2648.9 4092.7 3478.3 151.0 2295.8 3659.0 6728.2 139.6 3664.1 5222.3 4960.0 8005.6 4231.5 566.0 5014.1 3464.9 2259.0 4273.9 452.0 1869.1 3093.6 744.9 864.3 7190.7 4605.9 4837.7 5859.2 3904.4 RPL23 "L23, rpL17" ENSG00000125691 "Ribosomal protein L23" P62829 17 38847865-38853843 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003373 Approved Supported Cytosol NA NA 76000 Cytosol "HPA003373: AB_1856436" "unprognostic (1.02e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-2)" "unprognostic (5.31e-2)" "unprognostic (5.62e-2)" "unprognostic (2.48e-2)" "unprognostic (9.08e-3)" "unprognostic (9.95e-2)" "unprognostic (1.02e-1)" "unprognostic (7.07e-2)" "unprognostic (8.01e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (4.19e-5)" "unprognostic (1.18e-1)" "unprognostic (9.60e-2)" "unprognostic (6.46e-3)" "unprognostic (4.45e-1)" 103.1 79.0 47.1 86.5 56.3 125.2 175.1 35.2 54.6 117.2 86.6 26.4 106.1 48.7 93.4 115.8 132.6 92.1 119.4 163.9 58.9 39.5 79.6 107.5 112.3 239.3 52.1 51.0 240.1 329.6 33.8 55.3 68.4 73.2 99.9 76.1 52.5 114.5 101.3 150.0 119.8 69.5 192.7 72.8 95.5 80.1 49.2 42.6 89.3 95.2 117.3 132.0 152.4 207.2 160.0 168.4 29.0 94.3 87.5 176.7 163.2 92.0 92.6 122.4 103.6 218.9 287.8 85.9 92.5 140.2 116.7 87.8 133.5 82.3 205.2 92.2 101.6 86.6 163.0 106.0 179.3 143.2 70.9 158.4 75.3 121.5 190.0 164.6 207.5 79.4 269.7 223.7 101.2 212.4 209.8 123.4 143.8 119.1 104.1 149.7 82.5 181.9 222.3 89.4 121.5 56.5 124.0 179.6 201.3 162.9 117.3 83.4 124.0 49.6 85.9 186.2 176.6 142.0 261.1 86.2 53.9 82.7 84.0 153.3 67.4 103.6 160.7 82.5 124.7 69.2 29.0 94.3 19.6 82.3 76.6 101.9 160.0 130.7 100.1 134.8 149.7 176.7 145.4 15.2 87.5 65.5 168.4 95.4 163.2 47.1 56.3 35.2 54.6 58.9 39.5 52.1 51.0 73.2 42.6 941.0 1278.0 2023.1 1729.6 2173.4 127.8 440.2 1248.4 813.7 1579.9 448.4 64.8 1510.8 1145.6 1170.8 249.3 1286.4 637.4 560.6 1801.4 2205.2 1253.7 1567.9 1280.3 1237.0 1445.9 55.6 884.2 1308.7 2128.6 175.3 2483.5 2049.1 1051.1 2214.6 1221.7 291.3 2001.5 1052.1 1360.9 1581.2 153.2 737.3 1166.3 278.6 184.6 2766.5 1592.5 1392.4 1661.2 1922.3 RPL23A L23A ENSG00000198242 "Ribosomal protein L23a" P62750 17 28719393-28724359 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 261.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA051754, HPA077474" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 15000 "Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol" "HPA051754: AB_2681593, HPA077474: AB_2686841" "unprognostic (1.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (9.79e-2)" "unprognostic (7.76e-2)" "unprognostic (1.91e-3)" "unprognostic (1.23e-1)" "unprognostic (9.64e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (5.16e-6)" "unprognostic (3.91e-2)" "unprognostic (1.54e-1)" "unprognostic (3.98e-3)" "unprognostic (2.68e-1)" 49.1 38.5 48.6 43.3 62.1 67.9 87.0 40.6 75.5 63.8 47.0 27.3 48.5 34.8 53.2 44.0 56.5 64.1 35.1 48.8 56.6 28.7 39.5 93.2 62.3 108.0 42.6 39.6 142.1 63.3 21.4 45.3 51.0 40.5 44.9 48.8 27.6 61.3 41.7 64.9 70.5 44.6 39.8 63.4 59.1 47.8 108.1 35.7 56.1 44.4 78.8 84.9 51.1 61.0 261.4 139.2 30.6 75.3 142.1 254.7 206.1 59.4 121.4 73.5 91.1 97.3 156.9 71.6 55.8 98.0 94.6 80.0 123.5 57.7 134.5 52.6 77.5 49.4 81.4 96.7 124.6 98.1 71.1 267.4 64.2 119.3 131.4 88.7 133.4 67.3 152.5 160.5 75.3 119.1 137.4 102.4 62.4 83.4 91.3 94.6 98.2 148.9 176.0 69.9 152.8 74.0 88.2 132.7 158.9 102.5 121.5 75.9 88.6 39.6 288.0 125.0 107.5 143.2 156.7 60.7 52.1 74.2 60.6 98.7 113.9 105.2 78.5 82.6 73.8 57.4 30.6 66.3 19.4 156.5 75.3 232.3 261.4 227.4 203.4 108.7 227.4 254.7 229.5 9.4 142.1 59.6 139.2 154.0 206.1 48.6 62.1 40.6 75.5 56.6 28.7 42.6 39.6 40.5 35.7 801.0 1123.4 5775.1 4513.0 4612.6 216.8 263.3 2257.3 837.9 1637.9 820.0 66.8 3852.2 2612.9 1885.1 774.8 2545.4 1436.7 1541.8 4018.0 5653.9 2983.4 3636.7 1439.5 1994.3 2312.0 154.1 1776.5 2366.9 2960.5 235.1 4219.8 3481.8 2908.6 3701.6 2998.1 414.4 2891.2 3114.2 2224.7 2308.4 257.2 1681.6 3269.7 698.0 548.5 5416.5 4120.8 3800.4 4030.5 4740.6 RPL24 L24 ENSG00000114391 "Ribosomal protein L24" P83731 3 101681091-101686782 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA051653 Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 19000 "Endoplasmic reticulum, Cytosol" "HPA051653: AB_2681564" "unprognostic (7.32e-2)" "unprognostic (2.11e-1)" "unprognostic (9.46e-2)" "unprognostic (1.78e-2)" "unprognostic (2.95e-3)" "unprognostic (1.22e-1)" "unprognostic (1.79e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.29e-2)" "unprognostic (1.55e-1)" "unprognostic (7.43e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (4.98e-2)" "unprognostic (4.08e-1)" "prognostic favorable (8.25e-4)" "unprognostic (5.37e-2)" 61.3 58.9 60.6 99.3 68.8 87.9 135.5 73.0 90.1 94.7 64.0 15.8 84.3 49.6 74.2 98.0 75.5 65.4 82.9 110.0 45.6 43.8 58.3 70.3 122.0 256.0 50.7 46.3 174.7 211.4 25.9 65.5 68.2 53.4 69.0 54.7 30.4 133.9 109.9 175.9 66.2 46.2 98.7 80.7 51.4 60.5 30.2 44.1 61.3 84.7 134.3 71.7 105.1 175.4 128.2 107.7 29.6 65.6 85.5 173.8 214.1 165.3 55.0 84.4 93.1 92.6 165.8 127.7 95.3 106.6 129.0 94.5 109.4 73.3 182.5 118.4 72.9 51.6 88.1 97.7 118.2 129.2 97.8 98.0 108.2 47.8 81.8 91.0 121.6 57.3 160.9 151.6 81.1 145.0 127.7 109.1 88.3 99.0 91.1 118.6 110.6 129.7 186.4 151.8 150.8 119.5 114.4 83.3 174.3 131.6 73.9 180.7 84.0 49.7 89.3 211.5 75.5 109.1 223.9 79.7 56.3 104.4 30.7 115.9 80.1 102.2 319.2 75.4 128.8 94.2 29.6 65.6 16.3 86.1 57.1 125.2 128.2 136.4 104.2 90.5 127.0 173.8 132.3 10.9 85.5 56.9 107.7 121.1 214.1 60.6 68.8 73.0 90.1 45.6 43.8 50.7 46.3 53.4 44.1 881.4 1070.5 2163.1 2834.4 2028.6 247.2 305.0 1187.2 758.8 1325.1 579.3 80.5 1779.8 1921.5 1279.6 726.1 1676.7 912.8 607.3 2525.7 2622.3 1595.4 2203.5 1283.3 1194.7 1386.3 111.2 1311.9 1225.8 1564.2 477.7 2781.1 1768.0 1307.5 1765.6 1777.1 437.9 2399.6 1553.6 1411.5 2120.0 319.1 860.2 1451.3 472.4 280.9 2033.8 1958.3 1532.8 2167.1 2738.5 RPL26 L26 ENSG00000161970 "Ribosomal protein L26" P61254 17 8377516-8383250 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 586.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030449, CAB037301" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "CAB037301: AB_796168, HPA030449: AB_10602125" "unprognostic (2.02e-2)" "unprognostic (3.73e-1)" "unprognostic (2.12e-1)" "unprognostic (2.76e-1)" "unprognostic (6.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (3.95e-1)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (7.15e-2)" "unprognostic (1.96e-3)" "unprognostic (2.73e-1)" "unprognostic (1.08e-1)" "unprognostic (5.44e-2)" "unprognostic (2.38e-1)" 122.5 64.5 70.2 102.5 49.8 132.2 170.4 44.4 52.4 127.6 131.6 34.8 68.1 53.1 76.4 97.0 161.2 87.6 98.6 68.1 54.8 42.5 100.6 138.3 97.5 117.5 61.6 32.6 183.0 586.0 32.2 41.1 82.2 47.7 129.0 84.0 41.5 95.3 87.4 170.8 106.3 98.6 103.6 62.9 129.0 75.9 53.0 45.1 104.9 131.6 145.8 107.9 154.7 127.6 154.9 120.8 25.1 92.1 93.0 158.2 165.0 103.5 95.3 93.8 111.0 177.2 291.8 91.7 90.0 133.9 122.3 92.4 100.7 53.4 181.0 103.5 106.6 50.0 115.1 119.2 184.4 144.0 67.6 214.8 70.6 105.2 116.1 207.2 104.9 91.7 248.7 369.2 101.2 304.3 172.0 150.5 104.1 79.9 54.6 128.4 71.3 115.6 143.5 88.1 108.9 63.3 115.5 95.3 112.6 164.3 77.9 39.0 83.3 48.5 90.6 208.1 86.7 92.7 140.5 94.3 49.5 61.8 68.2 157.5 43.9 51.2 79.1 81.0 149.3 73.3 25.1 92.1 18.2 89.9 78.3 130.5 154.9 134.3 116.8 120.8 140.1 158.2 136.0 10.9 93.0 69.5 104.5 111.3 165.0 70.2 49.8 44.4 52.4 54.8 42.5 61.6 32.6 47.7 45.1 833.7 960.0 5357.4 2721.4 4954.5 234.8 252.2 2797.5 959.6 1909.7 952.6 125.7 3974.4 3344.0 2212.2 695.5 2535.1 1389.0 1425.0 4263.0 6092.8 2980.6 2437.9 1777.7 2307.8 2989.4 128.7 2198.5 2802.7 4762.9 1400.7 4423.2 3635.2 3033.3 3719.6 3654.9 300.8 3633.9 3236.9 2028.4 4497.4 340.9 1487.5 2382.4 569.4 578.1 6200.9 3820.5 3284.3 5356.2 2887.4 RPL26L1 RPL26P1 ENSG00000037241 "Ribosomal protein L26 like 1" Q9UNX3 5 172958729-172969771 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.6" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 286.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030449 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA030449: AB_10602125" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (3.39e-2)" "unprognostic (4.12e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.04e-3)" "unprognostic (2.45e-1)" "unprognostic (7.51e-2)" "unprognostic (5.86e-3)" "unprognostic (3.18e-1)" "unprognostic (1.06e-1)" "unprognostic (7.17e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-3)" 11.2 23.0 17.9 14.7 17.9 18.0 15.2 10.5 21.1 13.1 12.8 8.2 14.4 13.5 14.5 21.6 18.1 14.7 11.9 19.5 20.7 16.8 20.0 25.9 10.5 16.7 16.2 18.0 14.1 25.5 9.1 15.4 14.2 16.3 12.1 14.6 11.5 18.4 16.7 19.0 9.7 10.8 14.0 12.8 13.3 12.2 73.6 11.8 20.0 16.2 18.2 14.9 13.1 11.9 19.7 40.0 17.5 36.2 14.6 21.7 20.9 29.6 26.9 24.4 33.5 16.9 17.9 31.6 28.4 16.7 41.1 36.7 32.8 32.0 22.3 73.0 38.9 43.8 19.3 40.2 56.3 38.0 28.5 52.3 16.5 31.5 40.1 33.2 24.0 14.7 22.3 23.8 42.3 29.7 16.7 23.5 22.0 22.6 18.8 29.2 65.8 29.3 38.0 15.5 13.8 42.8 21.4 37.8 29.6 23.9 18.7 24.6 15.1 26.0 23.9 37.7 16.3 29.3 25.9 24.7 47.0 26.1 27.4 21.2 16.9 26.3 41.8 37.0 30.2 27.8 7.8 36.2 15.5 14.3 31.4 18.3 19.7 17.4 19.6 40.0 15.1 14.5 18.4 17.5 14.6 26.8 27.5 21.7 20.9 17.9 17.9 10.5 21.1 20.7 16.8 16.2 18.0 16.3 11.8 38.7 26.2 23.1 45.5 43.4 14.3 38.4 50.9 62.9 35.2 55.8 17.7 94.5 154.2 102.8 286.5 45.0 32.9 93.5 97.7 103.7 39.0 47.6 25.5 104.6 100.3 14.3 38.7 41.7 51.6 40.1 35.1 50.7 49.0 97.4 42.9 42.9 113.2 38.6 38.5 146.6 13.9 19.4 39.1 214.9 161.4 46.2 66.0 27.7 55.4 43.0 RPL27A L27A ENSG00000166441 "Ribosomal protein L27a" P46776 11 8682411-8714759 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 555.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060776, HPA063379" Supported Enhanced "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA060776: AB_2684359, HPA063379: AB_2684997" "prognostic favorable (7.84e-5)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (9.94e-3)" "unprognostic (3.16e-1)" "unprognostic (1.25e-1)" "unprognostic (1.90e-3)" "unprognostic (2.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-1)" "prognostic unfavorable (2.83e-10)" "unprognostic (2.28e-2)" "unprognostic (6.87e-2)" "unprognostic (3.37e-2)" "unprognostic (7.68e-2)" 65.9 58.8 49.6 116.1 81.5 146.4 149.4 47.8 80.5 69.7 69.9 25.1 64.2 60.1 73.2 74.9 98.4 76.4 88.5 103.5 59.9 33.9 57.0 71.3 111.1 316.9 44.5 49.3 132.2 278.5 10.4 54.6 64.8 64.0 70.1 75.7 42.1 115.8 70.1 124.6 97.9 69.2 109.2 47.1 92.0 72.4 56.8 28.5 74.6 89.3 127.5 120.5 71.0 128.7 341.9 188.5 71.3 122.3 161.9 351.8 555.6 169.7 118.2 75.5 90.6 104.1 199.1 114.2 110.4 139.5 126.6 97.4 149.4 158.7 240.8 87.3 96.5 54.0 124.3 99.6 154.0 95.5 87.9 214.1 106.0 115.4 184.3 172.7 192.0 124.8 217.5 275.3 19.9 211.4 174.9 125.4 144.2 109.1 76.0 106.9 127.9 143.0 289.5 122.7 126.4 123.8 125.3 79.3 146.3 118.9 170.2 86.5 155.5 40.9 157.2 171.4 83.3 69.5 220.1 113.9 41.3 111.3 106.0 139.4 86.6 189.8 197.0 94.8 131.6 74.8 71.3 122.3 37.8 208.1 119.1 266.8 341.9 295.7 244.4 188.5 301.2 351.8 290.3 29.7 161.9 108.1 180.0 198.2 555.6 49.6 81.5 47.8 80.5 59.9 33.9 44.5 49.3 64.0 28.5 1042.2 1639.1 5447.5 5197.7 4315.3 211.8 780.0 2010.1 1169.7 2127.0 936.9 108.0 4955.4 2420.5 2120.6 640.6 2975.9 1990.9 1378.3 4688.2 6270.1 2784.5 3963.3 2012.4 2288.9 3821.7 76.3 2038.1 2441.8 3815.0 1497.4 3355.1 4578.8 2687.5 3973.9 4593.3 390.8 4009.3 4780.0 1839.6 2272.7 251.4 1532.8 3189.9 395.7 439.9 5297.8 5030.9 4388.7 5800.0 5583.1 RPL28 "FLJ43307, L28" ENSG00000108107 "Ribosomal protein L28" P46779 19 55385345-55403250 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA050459 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA050459: AB_2681135" "unprognostic (4.70e-3)" "unprognostic (1.38e-1)" "unprognostic (6.86e-3)" "unprognostic (6.53e-2)" "unprognostic (9.73e-2)" "unprognostic (3.38e-2)" "unprognostic (2.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.93e-1)" "unprognostic (3.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.61e-5)" "unprognostic (4.28e-1)" "unprognostic (2.15e-1)" "unprognostic (1.33e-1)" "unprognostic (8.93e-3)" 91.7 86.3 81.9 112.8 68.3 166.7 88.9 32.8 84.1 117.1 107.7 86.7 71.1 89.9 144.6 81.3 224.2 105.0 118.0 72.9 66.2 54.4 87.1 228.8 133.0 398.1 70.4 50.7 200.5 198.5 25.5 73.7 88.7 53.2 122.7 61.2 88.0 143.3 77.9 102.1 136.4 108.1 76.8 70.7 205.5 85.8 75.9 27.4 375.5 144.6 108.5 269.6 131.8 121.7 139.5 93.6 27.8 77.2 66.7 146.6 190.9 119.8 139.6 48.6 96.6 86.9 140.0 82.1 81.4 78.0 71.3 66.2 136.0 64.1 180.3 58.6 73.8 30.4 75.5 55.2 104.7 31.7 69.7 313.8 111.2 88.3 165.4 144.5 129.2 98.0 196.3 150.5 53.0 107.3 94.2 76.5 87.2 85.9 148.5 63.4 138.7 144.5 120.2 116.4 102.7 152.8 146.7 70.1 137.2 90.3 240.3 61.9 102.4 51.8 170.9 122.7 28.2 71.0 138.7 92.7 63.8 71.9 51.0 129.1 122.4 176.4 112.5 81.5 158.3 53.7 27.8 77.2 21.9 77.0 67.8 119.7 137.8 129.9 101.2 93.6 139.5 146.6 130.8 24.4 66.7 56.3 88.3 117.7 190.9 81.9 68.3 32.8 84.1 66.2 54.4 70.4 50.7 53.2 27.4 291.8 450.6 5533.4 3559.5 3364.2 265.4 142.6 1745.2 448.3 752.9 1106.2 153.2 2957.6 2161.9 2047.1 1154.7 2503.9 2388.1 1308.2 3801.8 5038.4 2290.4 3623.5 840.2 2219.1 3594.0 170.0 2198.1 2534.5 5084.5 2612.5 3193.3 4690.0 2006.0 3396.8 4331.0 518.7 4110.9 3699.9 1545.1 2484.8 343.9 957.2 2029.1 824.7 973.3 4286.9 2830.6 4025.5 5879.2 5548.6 RPL29 "HIP, HUMRPL29, L29, RPL29P10" ENSG00000162244 "Ribosomal protein L29" P47914 3 51993600-51995942 "Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 434.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA069064 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA069064: AB_2686077" "unprognostic (3.77e-3)" "unprognostic (2.72e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (2.89e-3)" "unprognostic (5.46e-2)" "unprognostic (6.79e-3)" "unprognostic (1.79e-1)" "unprognostic (2.16e-1)" "unprognostic (5.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (9.99e-2)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" 91.6 61.7 42.5 64.6 33.0 110.2 111.0 30.1 39.7 102.4 98.1 30.3 57.1 53.6 59.6 72.8 124.7 76.0 68.7 72.1 33.8 26.0 55.7 122.9 64.8 219.4 36.0 26.0 150.1 434.1 16.3 34.3 50.7 26.3 91.1 41.2 38.9 103.7 54.8 160.8 102.5 73.8 80.2 38.1 83.9 59.7 58.7 25.2 85.9 83.3 123.3 92.4 88.5 87.1 137.9 98.1 32.8 80.0 74.8 132.2 202.9 69.9 91.0 70.2 107.0 125.2 196.8 99.0 78.3 96.8 107.6 89.5 108.3 107.5 195.7 34.1 79.5 65.9 63.7 101.2 166.6 51.5 79.6 137.7 101.3 117.7 180.6 148.5 146.9 97.8 240.5 236.9 79.3 141.3 123.3 120.4 87.9 79.0 150.3 79.2 159.8 127.5 191.1 116.5 106.6 154.5 59.3 77.3 189.8 137.5 146.3 56.8 110.8 58.5 135.2 133.7 46.8 101.2 251.4 104.3 60.4 81.1 93.1 116.7 98.1 139.0 139.2 79.9 176.2 79.8 32.8 80.0 22.6 68.8 61.7 115.0 137.9 112.2 87.6 98.1 128.2 132.2 109.9 10.8 74.8 48.4 82.8 100.8 202.9 42.5 33.0 30.1 39.7 33.8 26.0 36.0 26.0 26.3 25.2 175.7 330.0 3392.7 4367.8 3531.6 218.0 72.2 1398.7 310.5 437.9 675.2 96.2 2332.5 1848.6 1477.5 867.6 2040.8 1839.8 957.8 3975.0 4390.8 2112.5 3132.4 683.0 1270.4 2074.0 101.7 1376.0 1509.4 2270.2 3389.8 3344.0 2646.2 2103.8 1980.2 2585.2 359.2 2990.7 2489.9 1488.6 2639.2 288.1 1125.4 2454.4 526.4 450.8 4436.8 2053.3 2519.7 3632.3 5133.1 RPL3 L3 ENSG00000100316 "Ribosomal protein L3" P39023 22 39312882-39320389 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003365, HPA055361" Uncertain Supported Nucleoli,Cytosol NA NA 120000 "Nucleoli, Cytosol" "HPA003365: AB_1079841, HPA055361: AB_2732594" "unprognostic (9.79e-3)" "unprognostic (2.06e-1)" "unprognostic (2.31e-1)" "unprognostic (1.68e-3)" "unprognostic (5.44e-3)" "unprognostic (1.72e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (3.63e-1)" "unprognostic (5.81e-2)" "unprognostic (5.87e-2)" "unprognostic (7.09e-2)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (6.09e-2)" "unprognostic (2.72e-1)" "unprognostic (4.32e-2)" 71.7 71.8 51.3 72.3 50.3 107.0 134.5 50.8 49.3 102.2 94.4 42.7 78.1 63.1 207.5 79.6 126.9 101.6 96.2 54.5 41.4 38.8 66.6 102.5 74.5 205.9 47.4 57.7 217.8 453.1 50.9 75.0 74.5 58.0 138.7 57.0 74.8 216.3 68.5 48.9 118.1 62.6 115.6 50.7 84.3 74.4 76.4 23.3 105.5 158.5 82.3 109.8 119.9 105.7 198.9 114.8 18.9 56.4 150.3 249.0 326.4 87.2 80.8 92.5 102.2 118.4 256.8 124.7 67.7 128.8 67.7 60.9 101.6 66.7 361.2 93.8 81.4 40.8 58.2 98.7 144.7 45.1 61.4 97.2 90.9 96.7 151.9 174.9 129.1 76.7 248.1 196.1 58.5 208.7 177.2 131.6 96.4 102.3 125.6 97.9 112.4 131.1 188.1 96.8 92.9 56.4 105.3 89.8 181.3 125.1 129.4 84.7 100.1 42.5 139.0 221.5 61.4 104.7 210.6 130.4 45.5 72.0 47.7 77.0 96.5 72.9 159.9 102.6 114.2 51.4 18.9 56.4 11.9 132.5 51.7 205.6 198.9 192.1 153.7 101.2 175.8 249.0 195.2 8.1 150.3 44.5 114.8 126.1 326.4 51.3 50.3 50.8 49.3 41.4 38.8 47.4 57.7 58.0 23.3 914.2 2163.5 5410.7 7867.8 9248.8 998.0 126.1 2876.4 1092.1 2307.8 1367.8 400.5 4667.0 4993.6 2515.3 1583.9 3488.3 1382.2 934.5 5706.5 6677.9 4026.4 5687.6 1692.6 1824.7 2890.1 338.5 2624.6 2557.1 2528.9 3527.0 5167.6 3086.7 4841.9 3599.8 3269.3 905.4 3905.0 2588.2 3289.3 3749.1 924.0 1552.2 5807.1 1006.7 702.5 10743.1 4590.8 4458.7 5068.7 8140.4 RPL30 L30 ENSG00000156482 "Ribosomal protein L30" P62888 8 98024851-98046469 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002651 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA 52000 "Endoplasmic reticulum, Cytosol" "HPA002651: AB_1079842" "unprognostic (3.28e-2)" "unprognostic (2.19e-1)" "unprognostic (7.36e-2)" "unprognostic (2.42e-2)" "unprognostic (3.48e-3)" "unprognostic (1.02e-1)" "unprognostic (2.95e-2)" "unprognostic (2.00e-1)" "unprognostic (3.34e-1)" "unprognostic (2.89e-1)" "unprognostic (2.49e-2)" "unprognostic (4.76e-2)" "prognostic unfavorable (1.41e-9)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" "unprognostic (2.67e-2)" "unprognostic (5.97e-3)" 146.2 68.8 77.6 75.4 56.2 153.1 195.1 54.3 62.0 158.8 123.2 64.1 96.3 57.5 146.1 120.3 164.9 126.6 113.5 147.3 64.5 53.1 75.7 140.6 121.2 383.2 78.6 46.4 284.8 344.3 44.6 62.1 97.5 49.3 154.7 96.3 66.2 172.7 131.4 191.2 144.8 90.1 164.3 85.2 146.6 96.3 79.5 58.7 168.1 170.4 102.5 176.5 153.6 197.4 180.4 94.5 42.1 70.0 94.2 238.2 179.6 140.6 96.6 104.1 99.8 150.1 278.4 100.3 83.1 145.4 140.3 123.3 106.6 133.1 184.2 217.7 118.6 61.8 92.4 129.6 154.4 146.2 72.6 108.3 160.4 96.7 139.7 221.0 85.4 80.2 236.1 245.3 103.9 298.2 166.0 144.0 163.1 114.4 122.2 119.0 187.2 199.2 160.3 93.1 345.6 140.4 107.9 79.3 169.4 114.4 130.8 150.5 128.9 48.1 120.3 189.7 109.9 158.4 203.3 80.0 55.0 59.1 81.9 99.4 129.0 104.4 150.8 77.2 174.8 80.2 42.1 70.0 31.6 104.4 63.1 154.1 180.4 181.2 138.9 94.5 171.7 238.2 186.0 26.3 94.2 55.6 94.0 117.8 179.6 77.6 56.2 54.3 62.0 64.5 53.1 78.6 46.4 49.3 58.7 792.1 1260.6 3527.5 3700.2 3367.9 233.0 62.5 1253.5 748.2 1387.6 526.9 131.6 2248.9 1518.6 1338.6 1083.1 1770.9 1274.6 771.0 3239.9 3233.6 1966.2 2865.1 1485.8 1753.3 1997.4 136.7 1584.7 1633.3 2339.1 2033.5 4049.5 3046.8 1886.1 2374.3 2539.3 588.0 2447.0 2198.9 2259.0 2091.2 300.7 1384.1 2144.4 839.5 561.5 3649.2 2426.7 3150.2 3341.5 3592.2 RPL32 L32 ENSG00000144713 "Ribosomal protein L32" P62910 3 12834485-12841588 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 406.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047501, HPA051994" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 140000 "Endoplasmic reticulum, Cytosol" "HPA047501: AB_2680070, HPA051994: AB_2681686" "unprognostic (6.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-2)" "unprognostic (1.88e-2)" "unprognostic (2.55e-1)" "unprognostic (4.58e-3)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (1.68e-2)" "unprognostic (2.20e-1)" "unprognostic (6.93e-2)" "unprognostic (1.94e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (8.36e-2)" "unprognostic (1.44e-2)" 80.5 42.2 62.9 55.4 44.5 106.7 109.0 33.2 50.8 101.5 58.9 34.9 38.3 37.3 63.1 91.5 94.8 82.3 49.5 53.5 46.5 36.5 68.4 132.9 63.7 117.4 50.1 41.1 167.0 406.2 20.4 38.6 48.6 32.8 62.6 68.4 41.8 67.9 43.3 121.4 90.5 48.6 78.0 48.4 77.7 52.0 55.9 30.7 103.9 66.9 87.7 121.5 91.2 68.9 230.3 119.2 38.8 86.1 104.4 281.7 293.2 74.3 89.4 78.1 99.5 122.9 220.1 258.1 61.4 114.5 129.9 89.1 118.1 76.3 129.7 56.2 88.2 42.7 46.7 88.5 127.7 106.9 59.8 148.2 75.4 113.4 127.6 183.7 121.4 76.5 197.5 278.9 99.1 191.7 128.7 113.3 95.8 92.5 120.7 106.1 224.3 136.5 209.9 131.5 107.3 169.8 109.0 70.2 168.9 131.2 123.8 49.6 99.3 41.4 111.2 132.1 73.0 162.7 234.2 65.3 56.4 72.1 74.0 112.7 81.6 128.1 226.8 71.8 174.4 83.9 38.8 86.1 22.9 99.1 66.7 178.3 230.3 197.2 143.1 119.2 214.7 281.7 213.1 12.7 104.4 53.6 118.2 147.0 293.2 62.9 44.5 33.2 50.8 46.5 36.5 50.1 41.1 32.8 30.7 994.6 1705.3 6619.8 6646.5 8194.1 323.1 436.2 2817.8 1037.3 2033.7 1385.3 157.1 4359.8 3864.6 2400.6 1607.7 4582.5 1755.3 1822.2 5640.8 6521.8 3945.6 4507.1 2255.6 2952.6 3734.4 170.0 2220.9 3848.6 5359.1 5126.5 6169.0 6114.9 4595.6 3626.7 4532.6 595.4 4264.1 3517.5 2818.3 4510.9 491.8 1933.8 4140.6 977.2 891.7 9583.4 4079.8 4680.5 6188.5 6735.9 RPL34 L34 ENSG00000109475 "Ribosomal protein L34" P49207 4 108620566-108630412 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 400.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035139 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA035139: AB_10602925" "unprognostic (1.49e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-2)" "prognostic favorable (2.76e-5)" "unprognostic (2.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (8.22e-2)" "unprognostic (7.14e-2)" "unprognostic (2.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (3.72e-3)" "unprognostic (6.17e-2)" "unprognostic (8.96e-3)" "unprognostic (2.71e-1)" "unprognostic (1.19e-2)" 68.5 52.6 65.9 77.6 63.7 118.0 165.2 43.7 52.9 82.0 70.1 25.5 57.5 47.3 106.0 111.1 76.4 75.2 61.9 59.2 53.7 41.4 60.2 98.4 56.1 110.1 54.6 49.7 157.4 305.1 17.8 68.3 63.8 59.0 74.3 61.0 35.2 129.9 60.2 87.1 77.6 57.6 87.5 57.5 70.8 60.3 43.2 32.2 63.3 82.2 109.5 95.4 67.6 102.3 300.5 153.8 56.2 116.4 134.2 331.0 400.6 59.2 43.3 78.7 111.9 170.9 270.5 77.5 91.6 116.4 75.6 63.3 109.7 105.5 180.4 55.2 89.0 37.8 42.3 84.6 142.9 99.3 66.5 135.5 75.3 91.0 167.9 143.9 188.8 84.4 240.5 204.2 61.7 140.4 146.0 135.9 100.8 131.9 103.6 124.5 115.1 115.6 230.6 90.3 132.9 87.7 106.2 84.6 109.2 157.8 100.0 84.5 108.2 37.4 218.5 128.3 65.5 72.6 172.7 100.3 51.9 70.4 54.2 80.9 77.4 100.9 145.4 70.7 118.0 63.4 56.2 116.4 35.6 122.0 86.8 207.8 300.5 247.8 165.5 121.2 257.1 331.0 244.9 24.9 134.2 74.9 153.8 176.2 400.6 65.9 63.7 43.7 52.9 53.7 41.4 54.6 49.7 59.0 32.2 1313.2 2435.5 8127.2 9688.6 11162.7 321.1 1043.1 4914.6 1694.4 3137.0 2053.6 70.7 5336.7 5859.0 3087.8 1166.8 4211.1 1851.3 2850.1 7573.3 5633.2 3960.7 4740.0 3107.4 4896.8 3604.2 146.2 2618.2 5127.8 6804.9 1575.7 6923.4 6371.5 5538.7 4548.4 5463.9 625.8 5524.0 4699.4 3790.7 6994.4 382.0 1882.0 3701.7 706.0 481.2 13381.8 5336.0 5116.7 7038.7 7765.2 RPL35 L35 ENSG00000136942 "Ribosomal protein L35" P42766 9 124857880-124861981 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA006047 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA006047: AB_1856443" "unprognostic (1.16e-2)" "unprognostic (5.42e-3)" "unprognostic (3.04e-2)" "unprognostic (3.69e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" "unprognostic (2.67e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.37e-3)" "unprognostic (6.58e-2)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" 91.6 70.1 81.9 116.6 59.2 178.1 156.1 49.2 55.6 109.3 118.5 45.8 86.8 63.0 95.1 98.9 158.5 98.4 89.9 97.0 60.2 55.0 77.5 140.3 89.1 228.4 65.9 48.1 189.1 492.3 25.7 67.0 71.8 45.8 118.3 56.6 63.9 150.9 98.5 247.1 142.7 75.6 131.5 60.8 113.4 78.2 60.5 46.0 113.3 128.4 154.6 130.1 125.5 176.4 201.4 172.2 31.1 82.2 105.1 165.8 281.7 92.1 144.0 81.7 112.1 89.4 189.6 112.2 72.8 117.7 151.9 103.7 237.6 91.4 138.3 75.8 81.0 90.8 178.8 94.8 159.3 55.8 84.6 164.0 55.9 195.6 153.5 159.7 124.3 74.8 174.5 249.4 89.8 159.9 83.9 111.5 132.0 119.8 175.6 113.8 299.6 146.3 285.2 153.2 277.3 177.6 125.0 126.1 307.8 130.3 109.5 110.7 89.9 66.1 156.8 147.5 42.4 159.3 205.3 57.1 67.8 71.7 117.5 147.7 99.1 230.7 206.2 95.2 131.0 113.8 28.5 82.2 31.1 116.6 72.1 155.1 201.4 156.5 133.8 121.0 189.4 165.8 143.9 10.8 105.1 58.8 172.2 122.6 281.7 81.9 59.2 49.2 55.6 60.2 55.0 65.9 48.1 45.8 46.0 592.6 1127.4 4054.2 3642.8 4892.3 209.9 654.8 1602.5 592.9 1178.4 1076.5 80.5 2511.2 2289.6 1953.2 1188.8 2070.4 1494.7 1448.3 5315.3 3981.0 2376.0 2324.3 1249.1 2646.1 2485.0 103.3 1248.3 1951.4 2954.3 3494.2 2571.6 3157.2 2675.7 2877.4 2738.3 357.7 3375.0 1946.4 1208.2 2550.5 284.6 976.6 2381.7 761.7 853.4 6349.1 2061.3 2553.9 3546.1 3372.3 RPL36 "DKFZp566B023, L36" ENSG00000130255 "Ribosomal protein L36" Q9Y3U8 19 5674947-5691876 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047153 Supported Uncertain "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA047153: AB_2679958" "unprognostic (2.81e-2)" "unprognostic (5.70e-3)" "unprognostic (8.16e-2)" "unprognostic (6.28e-3)" "unprognostic (2.25e-2)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (5.48e-2)" "unprognostic (1.29e-1)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.32e-4)" "unprognostic (7.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" 52.2 101.2 56.3 80.9 43.1 120.2 88.4 40.8 71.1 59.7 63.4 21.2 58.0 60.4 72.2 64.9 79.6 63.2 66.2 69.6 39.7 33.9 48.4 59.7 58.6 201.6 38.7 52.9 225.0 196.1 12.9 48.0 38.6 34.9 65.0 36.7 29.4 129.4 70.4 78.7 101.9 61.4 60.8 39.5 75.3 64.7 53.8 32.3 39.9 40.9 106.1 55.5 48.4 103.1 163.2 79.0 29.1 57.6 68.6 180.7 220.0 101.3 50.9 35.7 88.2 42.7 82.5 52.8 55.9 36.5 56.9 47.0 94.3 51.7 69.2 135.4 26.3 26.9 71.5 32.0 66.4 17.3 52.3 225.5 43.5 52.2 77.6 94.6 93.8 61.2 70.2 109.4 35.2 74.1 57.0 48.0 89.6 55.7 225.4 33.1 108.2 116.3 130.1 119.9 60.9 173.0 72.3 41.9 187.7 54.9 67.9 63.5 85.2 32.9 94.5 156.1 17.8 72.9 161.5 51.3 37.6 50.4 54.9 121.9 111.3 101.0 108.4 71.4 150.5 52.3 29.1 57.6 21.4 77.3 48.3 125.2 161.4 157.2 113.1 79.0 163.2 180.7 146.6 8.0 68.6 40.4 74.6 120.6 220.0 56.3 43.1 40.8 71.1 39.7 33.9 38.7 52.9 34.9 32.3 539.0 792.8 4383.3 2587.1 5914.7 210.4 280.4 1931.2 633.0 1136.3 1175.9 76.6 2530.1 2224.9 2450.7 422.3 2391.0 1994.6 934.5 7046.1 4296.7 2490.5 2459.5 1236.6 2515.3 2437.5 92.2 1971.2 2721.6 3281.5 1128.6 3011.7 2570.0 2884.9 4260.7 4637.6 399.1 5342.0 3492.9 1450.3 2290.2 228.2 911.9 2225.2 393.6 813.8 8042.2 2327.4 2040.6 4783.5 2658.3 RPL36A "L36A, RPL44" ENSG00000241343 "Ribosomal protein L36a" P83881 X 101390824-101396154 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Undifferentiated cells: 3155.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA063979, HPA077586" Uncertain Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA063979: AB_2685164, HPA077586: AB_2686846" "unprognostic (3.38e-2)" "unprognostic (2.11e-2)" "unprognostic (7.04e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (4.19e-3)" "unprognostic (4.15e-3)" "unprognostic (1.28e-1)" "unprognostic (2.86e-2)" "unprognostic (2.77e-1)" "unprognostic (2.19e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (8.81e-11)" "unprognostic (1.87e-2)" "unprognostic (4.50e-3)" "unprognostic (3.57e-3)" "unprognostic (4.06e-2)" 62.9 40.7 50.7 81.5 53.8 139.8 136.1 27.7 46.8 65.3 71.0 25.1 53.4 45.6 67.5 71.4 77.1 59.0 60.6 54.9 43.1 31.1 47.3 60.1 43.4 190.1 42.1 50.6 165.3 171.4 15.0 35.1 44.7 41.8 55.9 68.3 26.1 158.1 71.5 125.7 96.5 54.1 65.5 44.6 67.9 54.6 26.3 32.6 60.8 69.3 118.6 104.0 71.9 74.0 162.9 113.2 13.7 74.2 86.7 175.5 199.2 121.6 65.9 101.2 49.8 124.8 224.0 64.8 93.8 102.9 123.1 188.1 78.0 62.6 235.8 93.9 77.8 75.9 82.2 151.3 131.4 128.3 83.0 166.0 109.0 116.2 71.9 179.5 198.3 105.1 212.5 248.1 99.7 184.9 165.2 113.8 103.1 131.7 126.8 99.1 175.3 91.8 236.6 134.6 252.8 134.0 86.2 221.6 184.8 112.5 50.8 68.0 135.7 87.6 98.4 167.8 84.2 47.5 224.4 105.0 36.6 89.6 101.0 95.0 108.0 154.1 186.4 45.0 295.6 39.0 12.5 74.2 13.7 86.6 73.6 140.3 162.9 162.3 120.6 111.4 134.0 175.5 156.7 7.2 86.7 70.4 113.2 84.9 199.2 50.7 53.8 27.7 46.8 43.1 31.1 42.1 50.6 41.8 32.6 408.0 871.7 1431.2 350.0 815.0 25.3 12.6 713.4 501.9 1443.4 165.7 13.7 675.4 368.1 934.6 6.2 708.2 731.9 397.1 2614.9 904.3 568.3 225.8 1204.1 656.9 533.8 14.3 1058.9 1162.0 2037.4 20.4 977.8 917.6 497.7 1450.9 2170.9 77.3 2295.7 1329.1 393.5 579.9 33.5 232.8 598.3 23.3 110.3 980.8 628.4 1100.0 3155.0 282.8 RPL36A-HNRNPH2 ENSG00000257529 "RPL36A-HNRNPH2 readthrough" X 101391011-101412297 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 29.9;Ciliated cells: 33.5;Club cells: 53.4;granulocytes: 25.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 14.8" HPA077586 Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA077586: AB_2686846" "unprognostic (3.69e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.65e-3)" "unprognostic (1.63e-1)" "unprognostic (2.96e-1)" "unprognostic (1.79e-1)" "unprognostic (5.34e-2)" "unprognostic (2.27e-2)" "unprognostic (2.15e-2)" "unprognostic (2.56e-1)" "unprognostic (1.49e-3)" "unprognostic (2.04e-4)" "unprognostic (1.56e-1)" "unprognostic (4.81e-2)" "unprognostic (3.94e-1)" 6.7 6.0 3.7 8.5 5.0 7.2 6.1 15.3 5.2 5.9 9.9 1.4 4.9 1.5 6.7 7.2 6.9 4.5 5.8 5.1 3.7 5.4 4.3 5.8 4.5 22.1 4.6 4.6 12.7 19.7 1.5 3.6 4.2 3.5 5.2 4.5 1.5 18.1 7.2 14.0 5.3 4.4 6.4 5.0 6.5 4.3 2.5 2.3 5.9 6.9 13.1 6.2 7.3 7.5 16.2 19.8 13.6 16.1 10.6 14.3 22.4 3.7 0.0 5.1 1.0 2.3 5.2 1.7 14.8 0.7 3.0 2.2 0.0 2.2 3.5 4.6 2.1 0.2 0.4 4.4 0.6 1.0 4.4 1.7 4.1 2.7 1.3 4.0 3.6 1.7 5.6 2.8 1.6 1.1 3.8 1.8 2.2 1.4 4.3 4.0 0.6 5.7 2.3 0.4 1.9 2.0 7.2 5.3 2.8 1.3 0.6 3.2 4.6 1.8 1.6 1.8 1.3 1.8 2.0 2.1 0.5 2.8 2.5 2.6 3.7 6.4 1.2 1.4 3.5 3.1 7.5 14.9 13.6 13.1 16.1 11.5 16.2 12.3 12.4 19.8 15.4 14.3 13.6 4.7 10.6 9.9 10.7 9.0 22.4 3.7 5.0 15.3 5.2 3.7 5.4 4.6 4.6 3.5 2.3 11.9 29.9 0.0 0.0 0.0 0.0 0.0 0.0 33.5 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPL36AL RPL36A ENSG00000165502 "Ribosomal protein L36a like" Q969Q0 14 49618519-49620685 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA077586 Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA Yes "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA077586: AB_2686846" "unprognostic (1.55e-2)" "unprognostic (2.44e-2)" "unprognostic (8.73e-2)" "unprognostic (3.15e-3)" "unprognostic (1.52e-1)" "unprognostic (2.55e-2)" "unprognostic (1.31e-1)" "unprognostic (6.37e-2)" "unprognostic (4.18e-2)" "unprognostic (1.38e-3)" "unprognostic (2.29e-1)" "unprognostic (4.72e-1)" "unprognostic (1.16e-3)" "unprognostic (8.32e-2)" "unprognostic (2.80e-1)" "prognostic favorable (2.83e-4)" "unprognostic (1.00e-1)" 60.3 55.8 45.9 46.5 40.9 68.2 66.5 35.9 37.7 69.3 74.3 29.2 56.6 52.1 54.9 102.1 61.8 45.9 31.5 48.2 38.0 34.4 69.9 139.2 54.8 63.6 45.3 34.1 105.3 131.9 35.7 62.0 56.9 40.3 62.9 50.5 30.8 85.2 68.6 82.4 40.8 99.8 71.1 48.0 78.8 61.8 36.7 41.8 65.4 72.5 67.6 71.0 87.6 63.9 105.8 112.7 119.5 66.7 84.5 132.0 139.8 73.4 55.4 40.1 23.2 57.7 79.8 23.5 60.7 67.1 56.9 64.5 57.6 50.9 96.9 57.9 50.2 40.1 53.0 34.0 51.8 66.6 33.2 39.2 60.7 58.5 74.3 73.1 96.9 52.2 81.6 79.4 43.5 58.8 67.6 72.0 43.8 38.5 86.3 43.7 94.8 57.0 87.0 22.5 52.9 57.0 36.1 63.1 51.9 86.3 111.8 35.1 21.7 53.4 42.4 60.8 39.8 91.8 53.9 55.4 35.7 56.8 46.4 46.7 52.6 53.7 97.8 25.8 43.9 33.9 119.5 66.7 99.6 98.6 63.2 132.0 105.8 129.3 123.0 68.7 79.9 120.7 112.6 74.0 84.5 55.9 112.7 118.2 139.8 45.9 40.9 35.9 37.7 38.0 34.4 45.3 34.1 40.3 41.8 285.9 358.6 508.2 1190.5 840.1 106.5 561.0 550.3 325.2 378.7 296.6 23.6 568.2 843.9 636.4 440.5 541.3 862.9 397.1 1188.0 608.8 559.0 968.4 688.3 743.7 689.7 76.3 351.4 449.9 649.0 160.8 672.0 707.1 799.7 1234.5 570.5 159.8 1112.3 813.6 502.0 790.1 95.2 478.6 799.2 285.3 135.9 733.7 431.8 698.8 483.1 1226.2 RPL37A L37A ENSG00000197756 "Ribosomal protein L37a" P61513 2 216498189-216579180 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065327 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA065327: AB_2685469" "unprognostic (9.94e-3)" "unprognostic (2.17e-1)" "unprognostic (2.99e-1)" "unprognostic (3.19e-1)" "unprognostic (5.12e-3)" "unprognostic (6.92e-2)" "unprognostic (1.76e-2)" "unprognostic (2.67e-1)" "unprognostic (8.26e-2)" "unprognostic (2.33e-1)" "unprognostic (2.62e-1)" "unprognostic (8.84e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.49e-1)" "unprognostic (4.92e-2)" "unprognostic (1.05e-2)" "unprognostic (1.67e-1)" 115.0 109.4 130.0 114.9 104.2 153.1 252.9 78.4 82.8 134.5 129.9 66.0 80.5 79.8 188.5 123.9 154.9 131.5 90.7 154.0 91.2 81.7 81.0 116.7 100.7 283.5 108.6 91.0 281.8 423.2 47.3 84.3 74.1 89.0 134.7 115.2 77.9 265.7 107.8 307.2 159.0 76.6 171.8 98.6 97.6 99.0 130.3 60.1 117.2 123.7 186.1 154.7 137.2 195.1 215.6 197.7 39.6 103.3 119.1 222.5 229.2 81.9 70.2 152.5 102.6 159.6 281.3 113.4 111.8 150.3 114.2 97.7 177.9 80.1 90.7 157.1 137.3 122.8 86.3 144.1 164.9 118.2 103.1 152.7 148.1 127.2 251.1 273.3 162.6 93.3 304.6 347.5 98.7 279.0 313.3 157.3 180.8 115.3 133.2 147.6 165.4 154.1 334.9 176.5 183.8 80.3 112.0 114.6 110.4 159.0 144.6 99.1 111.5 41.3 129.4 254.7 226.8 81.9 281.6 105.4 82.7 90.3 80.9 122.2 141.7 199.6 173.0 92.2 114.0 83.5 39.6 103.3 24.2 122.9 77.1 168.0 215.2 190.4 151.9 143.0 215.6 222.5 198.2 13.5 119.1 63.9 197.7 136.5 229.2 130.0 104.2 78.4 82.8 91.2 81.7 108.6 91.0 89.0 60.1 1113.6 1605.4 4470.7 2849.7 4385.4 480.1 1288.8 2771.9 1195.1 2353.3 1200.4 174.7 2558.5 2674.2 2235.0 3158.6 2255.3 1994.6 1401.6 7324.8 4423.3 2457.1 2614.9 2050.5 4095.4 2673.7 189.1 2525.5 3209.1 4083.5 6452.6 5314.9 2718.4 2706.1 2655.6 4289.5 857.5 5221.5 4229.5 2791.1 2456.8 499.9 1972.6 2514.2 2077.9 1466.6 6429.9 2683.3 2745.2 5422.7 2918.7 RPL38 L38 ENSG00000172809 "Ribosomal protein L38" P63173 17 74203582-74210655 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052543 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA052543: AB_2681864" "unprognostic (1.68e-3)" "unprognostic (1.84e-1)" "unprognostic (7.15e-2)" "unprognostic (2.99e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (1.01e-2)" "unprognostic (1.05e-1)" "unprognostic (1.83e-1)" "unprognostic (7.71e-3)" "unprognostic (4.95e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (6.17e-8)" "unprognostic (1.89e-1)" "unprognostic (6.00e-2)" "unprognostic (1.18e-1)" "unprognostic (3.39e-2)" 105.7 85.6 114.6 92.9 94.2 140.7 148.5 58.8 142.3 91.1 107.6 42.6 88.1 74.9 88.2 104.6 89.3 88.2 86.2 152.3 87.3 69.2 67.5 83.5 132.5 313.8 111.4 104.1 258.2 305.8 26.7 59.9 62.8 95.4 73.0 79.4 41.2 118.9 101.8 283.6 108.0 73.8 150.8 162.9 108.0 77.7 99.6 108.3 77.1 67.7 143.5 133.2 92.9 195.6 174.9 141.2 54.0 106.3 80.4 217.6 213.6 95.8 95.3 91.9 93.7 125.9 149.2 91.0 104.5 67.5 95.7 67.1 106.9 73.7 169.8 73.3 89.3 88.8 86.8 109.5 135.6 75.1 47.3 175.7 97.1 80.9 137.9 147.1 181.1 86.7 286.5 190.8 89.7 146.4 129.2 139.8 137.6 119.0 94.7 79.8 101.0 175.3 219.0 107.4 216.2 144.4 127.0 194.9 150.7 113.3 75.3 83.4 155.5 43.6 182.7 225.9 119.9 139.1 188.6 91.3 80.1 130.5 73.6 136.3 128.8 198.4 175.1 65.6 120.1 76.0 54.0 106.3 37.3 112.2 84.4 132.9 174.9 190.5 140.5 115.2 174.7 217.6 185.8 34.0 80.4 74.5 141.2 117.4 213.6 114.6 94.2 58.8 142.3 87.3 69.2 111.4 104.1 95.4 108.3 419.9 815.0 2505.1 1061.7 2071.2 181.9 640.3 1464.9 655.8 904.3 582.7 68.7 1161.4 1221.8 1260.5 1133.6 1076.0 1322.1 1027.9 2476.7 1954.3 1215.5 1111.3 1165.0 1997.2 1559.4 82.6 1413.5 1769.7 2441.1 2536.5 2793.1 1753.9 1150.6 2001.8 2524.9 303.2 2314.6 1848.1 1418.9 1584.9 191.2 944.3 1350.6 946.2 865.8 2351.9 1212.7 1556.7 2721.5 1107.0 RPL4 L4 ENSG00000174444 "Ribosomal protein L4" P36578 15 66498015-66524532 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034600 Uncertain Supported "Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol" Yes No 830000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Nuclear bodies" "HPA034600: AB_10601483" "unprognostic (1.51e-2)" "unprognostic (3.77e-1)" "unprognostic (6.02e-2)" "unprognostic (3.68e-2)" "unprognostic (6.23e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-2)" "unprognostic (3.20e-2)" "unprognostic (3.73e-1)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.20e-5)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (4.63e-2)" "unprognostic (2.27e-1)" 63.6 33.4 37.0 59.0 40.4 70.6 88.2 34.5 42.2 73.6 60.5 33.5 42.3 18.8 67.3 49.8 81.3 65.7 39.4 38.8 31.7 26.4 53.2 84.5 46.1 103.9 35.1 26.3 139.1 159.9 33.1 42.0 52.0 34.1 67.6 50.9 35.9 66.2 51.0 87.2 77.1 36.4 67.3 47.9 60.3 46.3 42.8 20.0 81.3 66.1 91.7 102.8 74.2 55.9 72.5 58.7 5.9 40.9 45.0 97.0 135.7 45.1 91.1 38.6 64.9 173.7 316.0 68.1 55.1 113.9 85.4 66.3 100.7 79.3 178.9 62.9 131.3 40.4 82.2 275.6 213.2 94.6 49.4 165.2 109.6 81.7 83.7 244.9 114.8 54.9 310.0 278.0 92.8 371.0 105.2 136.6 84.9 100.3 70.4 127.7 74.5 76.4 51.1 84.4 100.9 65.3 85.8 88.0 173.6 117.4 89.7 68.6 71.7 34.0 96.8 136.2 84.5 71.5 166.0 80.0 44.7 67.5 41.5 87.6 69.2 107.3 119.6 55.0 154.6 50.2 3.5 40.9 5.9 38.2 36.2 71.1 72.5 74.6 53.7 58.7 60.5 97.0 75.7 2.7 45.0 33.5 37.4 57.0 135.7 37.0 40.4 34.5 42.2 31.7 26.4 35.1 26.3 34.1 20.0 419.9 882.0 1803.2 2287.0 2152.7 118.6 357.6 588.5 738.8 1063.5 324.5 76.6 1844.2 1399.3 929.4 510.9 791.2 291.1 327.1 1855.6 3103.9 1180.5 1227.4 901.9 616.8 1082.4 38.1 731.3 578.2 1045.6 1022.7 1235.2 1320.8 1032.5 1779.1 995.5 130.7 1271.8 480.5 936.2 1212.4 111.6 452.7 1291.3 308.9 412.0 2258.1 2005.7 1400.6 1218.5 2270.0 RPL5 "L5, PPP1R135" ENSG00000122406 "Ribosomal protein L5" P46777 1 92831983-92841924 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Cancer-related genes, Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043717, HPA054444" Approved Supported "Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol" NA NA 130000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Nucleoli rim" "HPA043717: AB_10964719, HPA054444: AB_2732584" "unprognostic (5.81e-3)" "unprognostic (3.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (9.44e-3)" "unprognostic (1.96e-1)" "unprognostic (1.03e-3)" "unprognostic (9.95e-2)" "unprognostic (8.68e-2)" "unprognostic (1.23e-1)" "unprognostic (3.98e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (6.81e-5)" "unprognostic (2.26e-2)" "unprognostic (3.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-1)" 119.4 80.3 50.0 70.0 50.1 113.8 140.5 46.9 46.8 158.6 111.4 45.0 75.1 61.7 135.2 114.6 159.4 100.5 73.1 73.0 43.5 43.1 99.7 114.9 89.9 148.2 54.5 36.2 296.8 306.5 40.8 90.3 90.2 44.3 175.4 78.8 64.3 121.5 73.2 109.1 97.8 95.3 153.4 61.9 130.1 90.0 68.8 45.7 156.6 210.0 97.7 118.9 191.2 146.6 104.5 85.2 12.8 45.9 72.4 143.0 142.1 118.8 51.1 91.0 76.7 118.4 239.2 146.0 71.1 95.2 88.5 63.5 135.2 52.0 224.2 114.2 79.8 84.0 76.0 104.3 133.2 113.2 71.0 142.8 116.3 85.0 124.4 142.0 178.1 49.1 195.6 210.2 78.6 173.1 160.6 122.3 118.5 144.0 118.2 101.4 67.4 141.8 201.9 140.6 90.4 96.5 130.3 176.3 144.8 107.4 99.0 77.6 92.9 46.3 129.2 206.7 78.2 71.2 245.0 74.2 44.7 81.8 84.6 128.1 73.2 69.5 151.7 30.3 153.6 30.3 12.8 45.9 7.2 60.9 44.8 122.1 104.5 111.5 91.6 85.2 88.4 143.0 123.9 4.4 72.4 38.3 71.1 83.2 142.1 50.0 50.1 46.9 46.8 43.5 43.1 54.5 36.2 44.3 45.7 607.4 848.7 2690.4 3540.6 2525.4 316.8 352.2 1200.0 674.6 1189.7 390.8 84.4 2237.8 1689.4 1278.7 1159.8 1643.6 564.1 537.3 2338.5 3530.6 1572.9 2535.7 1002.7 856.3 1297.7 138.2 1189.1 1198.2 1468.3 888.7 2620.2 1565.9 1334.5 1646.5 1585.6 343.0 1936.2 1164.3 2027.0 1766.3 226.7 1034.8 1885.9 531.9 457.4 2528.9 2185.2 1965.9 2487.8 3230.9 RPL7 "humL7-1, L7" ENSG00000147604 "Ribosomal protein L7" P18124 8 73290267-73295789 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 536.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 638.4" HPA058373 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 170000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA058373: AB_2683694" "unprognostic (3.75e-1)" "unprognostic (3.60e-2)" "unprognostic (6.99e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (7.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.41e-2)" "unprognostic (8.31e-2)" "unprognostic (4.78e-2)" "unprognostic (1.76e-1)" "unprognostic (3.09e-1)" "unprognostic (1.63e-2)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.14e-1)" "unprognostic (2.31e-1)" 54.7 36.5 54.6 37.9 49.3 67.6 86.9 55.9 54.1 57.5 46.2 36.4 41.0 33.6 54.9 50.6 59.5 50.6 26.5 36.7 32.1 22.0 46.4 67.6 40.3 53.3 55.9 20.5 125.8 87.5 22.9 67.7 33.4 55.0 43.6 44.9 44.1 51.8 36.6 61.9 72.7 37.0 49.5 46.9 46.5 51.2 135.1 54.9 33.7 42.6 69.0 66.6 50.8 58.5 338.1 231.5 66.1 171.7 205.0 464.0 536.3 99.7 72.5 78.0 93.8 159.2 204.1 76.7 109.7 88.2 75.0 59.2 87.2 104.6 296.9 89.8 88.4 51.2 95.8 102.9 140.1 117.1 79.8 85.4 162.5 94.9 89.7 95.7 114.5 83.4 191.0 165.6 69.4 217.2 138.4 121.5 100.9 144.9 112.7 106.4 84.7 181.7 175.2 90.9 182.4 78.0 122.9 89.3 115.7 116.9 100.1 108.0 78.7 51.5 638.4 153.6 67.0 161.3 150.6 114.0 57.7 88.3 73.3 101.3 65.2 92.3 191.6 60.3 142.3 94.7 66.1 171.7 41.1 179.1 138.9 322.3 338.1 314.4 232.5 231.5 282.6 464.0 327.0 22.3 205.0 118.6 192.4 237.0 536.3 54.6 49.3 55.9 54.1 32.1 22.0 55.9 20.5 55.0 54.9 759.3 1377.6 4083.1 8227.6 7155.0 251.0 580.3 2023.0 1007.8 1723.2 1244.0 117.8 3979.6 4725.1 2246.6 1393.0 2953.4 897.4 1004.5 4388.5 6073.2 3431.1 4195.6 1418.7 1830.9 2853.5 89.0 1556.2 2090.7 3232.1 609.0 3931.9 3610.7 3514.2 2982.9 2652.3 679.5 3206.0 2051.6 2172.0 4500.4 280.8 1435.8 4545.3 828.4 372.8 8292.9 4080.0 3000.7 4416.0 6170.5 RPL8 L8 ENSG00000161016 "Ribosomal protein L8" P62917 8 144789765-144792587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 323.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045095, HPA050165" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 240000000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA045095: AB_2679213, HPA050165: AB_2681038" "unprognostic (2.52e-2)" "unprognostic (2.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (9.84e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.54e-1)" "unprognostic (9.28e-2)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (2.31e-1)" "unprognostic (4.13e-2)" 65.9 45.5 32.1 53.7 34.7 120.1 115.2 31.0 61.9 63.9 78.4 26.4 51.1 95.2 106.4 57.1 76.0 51.2 68.9 78.7 27.2 23.6 48.2 62.6 54.5 169.4 29.0 28.8 125.7 349.6 11.8 45.2 38.4 28.8 61.3 15.7 45.6 174.7 57.3 202.1 89.0 82.8 84.9 29.2 79.7 96.4 48.9 17.0 61.2 73.2 103.2 72.8 64.7 100.0 174.8 117.5 31.1 82.7 77.9 136.8 251.3 120.9 142.8 10.2 44.4 11.5 26.1 98.2 87.7 16.5 26.9 19.1 124.7 65.5 162.8 126.9 10.3 8.9 73.3 13.4 30.5 4.9 70.7 162.5 96.5 110.0 87.9 28.7 63.2 52.7 28.1 34.8 12.1 20.7 12.7 19.7 35.6 130.0 37.8 11.4 323.4 90.3 85.7 95.4 33.2 162.0 88.5 59.1 153.0 14.3 91.8 62.5 104.4 84.2 45.9 120.4 4.3 106.3 61.3 78.7 35.7 135.8 74.4 105.3 69.1 58.9 140.8 71.0 105.2 48.8 24.1 80.3 31.1 70.5 82.7 117.9 166.8 119.3 86.9 117.5 174.8 136.8 105.0 9.8 77.9 78.5 64.5 113.8 251.3 32.1 34.7 31.0 61.9 27.2 23.6 29.0 28.8 28.8 17.0 792.1 1172.5 3639.8 5704.0 5720.2 400.0 926.5 1594.9 667.9 1239.8 975.3 253.3 3837.7 3756.8 1939.3 708.6 1998.1 1895.6 1261.4 5072.3 5914.7 2684.9 4292.9 1005.1 1181.4 2697.5 157.3 1633.5 1478.1 2282.6 2004.1 2891.5 2666.3 3338.7 2696.1 3081.8 500.6 3359.4 2949.4 1346.4 3180.5 483.0 1060.7 3222.8 573.1 569.6 7189.2 3651.1 2078.6 4568.6 6042.4 RPL9 L9 ENSG00000163682 "Ribosomal protein L9" P32969 4 39452521-39458949 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003372 Approved Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 24000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA003372: AB_1079843" "unprognostic (1.08e-3)" "unprognostic (2.14e-1)" "unprognostic (1.24e-1)" "unprognostic (8.06e-3)" "unprognostic (5.59e-2)" "unprognostic (1.27e-2)" "unprognostic (3.16e-2)" "unprognostic (2.14e-1)" "unprognostic (8.58e-2)" "unprognostic (6.68e-2)" "unprognostic (2.50e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (7.34e-4)" "unprognostic (1.34e-1)" "unprognostic (2.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-2)" 52.6 35.2 42.2 73.9 44.4 179.1 202.3 35.7 51.6 63.0 59.8 34.5 42.2 69.8 50.4 226.8 49.9 48.1 69.7 58.2 42.3 27.6 47.4 73.2 35.8 48.7 34.7 51.7 158.5 126.2 37.4 44.7 38.7 42.5 47.8 59.1 31.7 93.7 71.4 66.3 62.9 38.8 49.5 34.0 45.2 46.5 56.9 25.9 36.0 63.2 70.1 59.0 46.0 56.6 118.3 72.5 26.2 41.4 63.0 145.0 148.9 3.2 2.8 122.9 2.8 6.6 9.0 4.8 57.9 87.4 72.3 54.8 8.1 65.7 143.5 6.6 58.2 57.3 65.4 5.5 6.3 79.1 52.3 115.6 4.5 24.2 7.8 8.6 9.3 38.0 11.9 181.8 4.4 83.1 107.6 5.5 5.8 109.7 67.0 5.0 4.3 77.9 9.9 109.8 79.6 3.9 71.9 123.2 4.9 89.9 3.8 4.6 49.0 2.0 47.5 7.4 118.9 104.9 6.8 4.1 3.1 4.6 84.1 8.0 103.0 144.6 124.7 83.4 87.3 3.3 26.2 41.4 12.3 52.1 40.1 101.2 118.3 102.2 71.4 57.2 103.8 145.0 111.7 6.9 63.0 31.2 72.5 77.0 148.9 42.2 44.4 35.7 51.6 42.3 27.6 34.7 51.7 42.5 25.9 616.4 695.5 3946.9 4635.1 3670.9 362.7 367.2 1765.6 426.9 687.0 673.4 151.2 2652.9 2316.1 1697.3 1288.9 2348.7 1394.0 817.7 3813.6 4743.2 2040.6 3407.8 885.2 1749.4 2435.4 187.5 1780.1 1927.4 2668.8 1161.7 4462.6 2606.9 1756.2 2952.2 2900.0 510.1 3233.5 2563.6 2250.5 2828.8 405.3 1487.5 2143.4 695.4 462.3 4086.9 2843.5 2427.5 4009.2 4396.5 RPLP0 "L10E, LP0, P0, PRLP0, RPP0" ENSG00000089157 "Ribosomal protein lateral stalk subunit P0" P05388 12 120196686-120201235 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 408.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003512, HPA073501" Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA003512: AB_1079844, HPA073501: " "unprognostic (2.39e-3)" "unprognostic (2.46e-1)" "unprognostic (1.78e-1)" "unprognostic (8.49e-3)" "unprognostic (2.99e-2)" "unprognostic (2.44e-1)" "unprognostic (2.54e-3)" "unprognostic (5.99e-2)" "unprognostic (1.67e-1)" "unprognostic (4.82e-2)" "unprognostic (2.34e-1)" "unprognostic (3.35e-1)" "prognostic unfavorable (7.66e-12)" "unprognostic (2.74e-1)" "unprognostic (2.39e-1)" "unprognostic (3.06e-1)" "unprognostic (1.47e-1)" 67.3 59.5 20.6 76.6 31.6 100.5 119.8 26.8 26.0 58.4 76.8 22.0 61.8 50.5 95.9 66.0 128.3 74.8 88.6 49.8 28.9 16.2 47.1 121.7 55.4 59.7 21.9 26.6 117.5 408.6 13.5 36.6 70.1 41.5 72.4 60.8 32.8 138.5 54.6 101.0 113.9 57.3 63.8 23.4 60.0 69.0 73.0 18.7 89.6 90.8 162.5 82.8 64.2 116.6 135.9 143.3 10.7 63.4 82.7 172.4 193.3 125.7 108.9 92.6 158.4 189.2 311.6 132.1 96.9 168.3 151.7 98.8 120.4 77.5 275.6 97.9 169.5 37.7 100.0 163.9 201.2 96.1 106.4 124.9 131.5 72.3 102.8 204.1 176.6 99.5 280.8 344.6 106.2 315.7 258.9 179.1 158.6 161.0 79.9 144.1 136.1 177.8 119.5 176.4 128.2 145.8 129.7 130.3 215.9 151.7 145.2 98.8 120.4 69.8 104.6 190.4 114.2 186.7 213.6 120.3 71.5 109.2 90.6 120.1 180.7 190.1 137.5 128.5 127.1 60.2 10.7 63.4 5.3 71.5 58.3 172.4 135.9 131.9 97.1 137.0 123.2 131.4 104.4 5.0 82.7 35.1 143.3 83.4 193.3 20.6 31.6 26.8 26.0 28.9 16.2 21.9 26.6 41.5 18.7 544.9 1103.9 2148.7 3806.4 3443.2 197.9 209.4 1085.3 926.2 1446.8 533.9 145.3 3866.1 1598.2 1545.3 333.2 1285.7 1169.7 864.3 4155.9 5327.9 1860.1 2549.8 765.8 1006.6 1782.0 89.0 1170.4 829.9 1076.1 733.9 1611.7 1293.2 1612.9 1872.0 2272.8 178.1 2945.4 1050.9 747.5 1579.0 330.6 413.9 1621.9 303.3 717.8 4153.8 3690.5 1762.1 3426.9 4264.4 RPLP1 LP1 ENSG00000137818 "Ribosomal protein lateral stalk subunit P1" P05386 15 69452784-69456194 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 1030.2" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 24827.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003368 Supported "Endoplasmic reticulum,Cytosol" NA NA 1000000 "Endoplasmic reticulum, Cytosol" "HPA003368: AB_1079845" "unprognostic (5.04e-3)" "unprognostic (2.26e-2)" "unprognostic (2.02e-2)" "unprognostic (4.29e-2)" "unprognostic (6.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (2.79e-1)" "unprognostic (9.55e-2)" "prognostic unfavorable (2.30e-9)" "unprognostic (7.75e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "unprognostic (5.83e-2)" 59.6 57.2 47.5 76.8 42.9 171.7 451.2 68.8 103.3 70.1 79.0 20.8 57.9 87.5 73.5 76.3 100.7 65.7 80.6 341.6 35.5 29.7 55.8 69.9 290.9 1030.2 42.4 33.3 134.3 209.0 8.6 36.0 52.3 45.6 71.0 33.3 61.3 102.8 60.7 262.9 155.2 74.3 128.2 38.8 77.4 77.1 45.7 32.7 73.0 50.8 146.9 71.8 72.3 95.5 329.0 226.3 79.6 176.1 169.8 267.2 368.8 83.9 85.9 38.5 88.8 55.3 66.7 82.8 73.9 43.9 41.4 33.1 87.1 85.6 117.5 110.5 38.8 38.0 114.9 59.3 58.1 9.1 117.8 181.4 99.0 98.7 85.0 96.8 87.5 90.4 83.8 101.9 30.1 56.5 67.8 49.8 104.3 93.0 100.2 29.2 78.6 95.5 258.3 144.0 52.7 82.8 98.0 125.9 171.9 39.8 90.9 61.8 120.3 74.2 91.8 301.5 36.5 75.8 201.8 87.5 60.0 134.3 71.6 120.0 205.5 327.6 99.6 71.8 223.7 49.5 79.6 176.1 60.4 119.5 124.7 220.2 329.0 247.2 162.7 215.0 278.5 267.2 223.0 26.2 169.8 70.2 226.3 202.7 368.8 47.5 42.9 68.8 103.3 35.5 29.7 42.4 33.3 45.6 32.7 1756.9 3079.2 10545.4 15462.2 21484.5 610.5 1535.2 3648.4 2472.0 4955.7 2149.5 329.9 7737.4 4357.0 4586.1 334.7 5371.3 2418.0 3387.3 6194.3 10107.4 5970.9 9644.5 2461.9 5669.3 7196.3 352.8 2817.1 4601.8 7392.9 1146.7 7821.5 8502.7 8585.5 10174.3 7223.7 1445.4 6675.7 4201.4 4449.0 6344.8 808.4 2490.0 6776.3 667.6 1530.1 24827.4 7946.7 8933.3 9955.9 14669.5 RPN1 OST1 ENSG00000163902 "Ribophorin I" P04843 3 128619970-128681075 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009748, HPA026828, HPA051520" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA 8200000 "Endoplasmic reticulum" Cytosol "CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521" "unprognostic (4.83e-2)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (7.67e-2)" "unprognostic (2.36e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (4.80e-4)" "unprognostic (2.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" "unprognostic (4.58e-3)" "unprognostic (2.87e-1)" "unprognostic (7.68e-2)" "unprognostic (7.86e-2)" "unprognostic (1.52e-2)" "unprognostic (1.44e-1)" "unprognostic (9.74e-2)" 52.3 37.5 22.2 26.6 23.8 24.4 48.2 20.9 31.4 45.8 40.8 31.9 58.8 28.5 38.3 110.2 32.2 38.3 38.8 47.1 23.0 28.0 55.4 174.0 47.4 50.6 26.4 18.3 37.8 62.9 43.5 36.9 58.3 24.3 31.4 41.1 28.6 54.1 55.5 34.4 24.0 37.0 33.5 31.8 48.0 33.7 26.9 23.3 34.3 69.1 27.3 36.5 32.7 39.7 26.7 53.1 64.4 43.5 23.4 45.1 53.3 60.5 33.0 27.6 50.7 74.7 50.1 62.5 52.2 68.7 69.4 80.9 68.4 57.1 37.9 49.3 75.3 64.7 61.0 44.5 46.5 68.0 27.2 28.6 66.8 24.6 56.2 82.4 54.2 35.2 41.5 54.4 45.6 67.5 46.5 54.2 28.7 27.5 50.9 45.5 55.4 30.0 59.6 35.0 81.1 30.3 32.9 37.1 91.2 48.1 36.4 42.5 24.5 42.9 44.5 52.8 36.9 47.6 56.1 35.2 35.9 28.1 52.5 38.7 54.9 43.2 40.5 58.9 40.4 51.8 38.8 43.5 35.7 37.3 40.0 45.1 26.7 30.7 33.8 43.5 18.3 19.1 29.2 64.4 23.4 40.2 53.1 30.5 53.3 22.2 23.8 20.9 31.4 23.0 28.0 26.4 18.3 24.3 23.3 56.6 71.5 37.3 71.3 44.0 11.5 35.3 61.1 66.9 47.8 106.4 7.9 108.3 13.3 99.9 13.7 58.2 107.9 46.7 81.2 161.1 79.3 88.0 42.7 155.3 122.7 19.1 41.6 107.4 134.1 20.7 87.2 73.4 55.6 36.9 102.4 27.5 98.9 83.4 60.5 80.2 11.7 45.3 39.6 49.9 59.8 46.7 131.0 50.0 106.2 66.4 RPP14 P14 ENSG00000163684 "Ribonuclease P/MRP subunit p14" O95059 3 58306247-58324695 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036194 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036194: AB_10672082" "unprognostic (6.05e-2)" "unprognostic (2.02e-2)" "unprognostic (1.50e-3)" "unprognostic (1.36e-1)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.95e-3)" "unprognostic (3.76e-2)" "prognostic favorable (3.07e-10)" "unprognostic (5.19e-3)" "unprognostic (2.36e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (5.78e-2)" 7.1 8.5 8.3 5.7 12.9 5.3 7.1 15.8 10.7 6.6 8.6 5.9 6.6 10.2 8.2 7.8 8.5 7.4 6.2 11.8 7.2 6.8 11.2 15.0 5.6 7.6 6.5 9.9 8.4 11.9 10.8 9.4 6.0 7.2 7.4 8.2 9.0 8.5 7.0 53.5 7.4 9.1 11.7 5.5 7.7 7.7 9.1 5.9 6.3 8.1 18.5 8.5 7.2 7.0 4.6 6.6 4.7 9.8 9.8 6.4 3.5 10.1 8.1 9.4 7.5 7.9 8.5 10.4 8.6 9.3 12.4 14.0 12.3 6.7 12.2 2.0 11.5 10.8 6.2 14.1 12.8 12.1 8.5 7.4 11.6 9.7 6.7 7.7 19.9 9.7 9.3 12.4 14.7 14.1 6.2 9.7 15.0 9.9 8.7 12.0 5.5 13.5 7.0 12.3 8.4 15.4 5.5 7.4 11.8 9.0 14.6 5.9 10.5 8.1 9.7 11.6 6.8 9.3 9.6 8.8 9.4 10.5 9.9 16.3 13.0 22.3 17.6 10.7 14.0 6.6 3.0 5.7 4.7 4.2 4.9 5.6 4.1 5.5 5.8 6.6 4.6 6.4 6.2 2.6 9.8 9.8 6.2 3.0 3.5 8.3 12.9 15.8 10.7 7.2 6.8 6.5 9.9 7.2 5.9 8.9 11.0 7.0 7.1 27.7 24.7 26.6 5.1 8.1 5.7 3.5 23.6 7.2 10.0 5.3 0.7 7.2 11.7 0.0 5.3 5.2 8.4 6.9 3.5 17.9 5.4 17.5 9.2 12.3 11.4 0.9 11.5 9.5 21.9 8.2 12.5 12.9 6.2 3.5 9.2 10.1 28.1 0.0 20.5 8.6 13.5 37.6 8.6 7.0 13.4 6.2 RPP30 TSG15 ENSG00000148688 "Ribonuclease P/MRP subunit p30" P78346 10 90871716-90908553 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037578 Approved Approved "Nucleoplasm,Nucleoli,Microtubule ends,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Microtubule ends, Cytosol" "HPA037578: AB_10696939" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" "unprognostic (2.35e-1)" "unprognostic (4.08e-1)" "unprognostic (5.64e-2)" "unprognostic (3.05e-2)" "unprognostic (3.80e-3)" "unprognostic (1.27e-1)" "unprognostic (2.73e-1)" "unprognostic (1.03e-1)" "unprognostic (2.27e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.01e-6)" "unprognostic (1.98e-1)" "unprognostic (9.84e-3)" "unprognostic (3.43e-2)" "unprognostic (2.10e-2)" 24.2 19.0 20.9 16.8 20.3 27.2 22.3 26.0 24.0 18.9 19.0 16.2 16.3 11.5 25.2 18.6 23.8 19.2 16.0 26.6 19.8 16.8 20.6 18.4 17.1 23.2 18.5 20.4 23.9 17.7 37.7 23.6 23.6 19.3 18.8 19.3 18.7 19.2 16.5 35.9 23.5 16.4 20.6 19.2 21.3 19.2 32.0 21.6 31.2 18.1 24.0 26.3 21.7 18.9 19.4 22.2 16.2 19.5 14.2 20.3 16.2 28.6 19.1 20.0 24.1 13.0 14.1 7.1 20.5 18.5 34.4 36.1 32.2 23.1 16.9 15.7 13.0 22.4 20.1 26.6 18.2 35.5 27.1 18.3 11.4 12.2 25.4 12.4 23.0 14.4 11.5 11.9 25.9 29.4 14.5 19.4 15.6 22.6 15.5 22.7 17.7 26.6 31.3 12.4 16.3 21.7 14.9 17.1 17.8 12.9 13.6 10.9 10.9 12.0 8.7 24.1 19.2 23.5 14.6 11.0 17.2 17.2 9.7 42.3 10.5 26.8 36.3 21.5 12.5 13.1 4.3 19.5 16.2 17.1 18.7 18.6 19.4 19.6 18.7 22.2 16.7 17.0 18.5 2.2 14.2 15.3 20.7 20.3 16.2 20.9 20.3 26.0 24.0 19.8 16.8 18.5 20.4 19.3 21.6 29.8 20.0 24.7 27.9 30.6 18.6 39.9 22.9 17.4 20.5 14.0 17.7 50.9 26.6 34.6 73.2 18.4 8.7 0.0 30.3 55.9 20.4 16.0 23.1 12.4 49.9 15.9 19.0 20.3 22.6 37.3 26.7 27.6 21.9 32.5 17.8 20.3 27.7 14.0 27.6 27.1 20.1 38.8 28.1 53.2 47.3 29.6 28.3 27.3 17.5 21.8 RPS10 "MGC88819, S10" ENSG00000124614 "Ribosomal protein S10" P46783 6 34417454-34426125 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047268, HPA048084" Approved Approved Cytosol NA NA 170000 Cytosol "HPA047268: AB_2680007, HPA048084: AB_2680255" "unprognostic (1.92e-1)" "unprognostic (1.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.78e-1)" "unprognostic (8.92e-3)" "unprognostic (3.79e-2)" "unprognostic (9.72e-3)" "unprognostic (1.93e-2)" "unprognostic (4.30e-3)" "unprognostic (2.04e-1)" "unprognostic (3.59e-1)" "unprognostic (3.82e-1)" "prognostic unfavorable (2.57e-6)" "unprognostic (4.98e-2)" "unprognostic (7.66e-2)" "unprognostic (1.94e-1)" "unprognostic (2.45e-1)" 84.5 76.6 68.1 142.7 49.5 158.8 142.0 35.9 54.3 130.3 132.7 48.2 97.2 65.1 149.8 103.9 169.7 113.6 74.7 84.9 51.3 44.1 80.7 122.5 96.3 180.1 54.8 31.9 189.4 323.2 20.3 59.1 88.0 39.5 129.7 64.5 59.4 248.9 75.5 153.2 131.9 76.4 105.6 49.4 132.5 85.3 66.7 41.0 110.5 151.0 158.8 127.4 127.1 169.7 150.1 105.0 31.6 61.5 83.1 176.2 227.6 98.7 64.0 66.6 151.0 114.8 169.3 110.1 81.5 112.8 134.7 97.5 155.2 50.5 190.9 84.5 90.2 68.8 74.6 124.3 139.4 81.2 80.1 221.5 85.4 70.6 147.1 158.8 135.0 91.9 187.0 243.0 94.3 179.1 119.1 117.5 108.6 145.6 96.8 100.6 154.1 109.7 202.9 100.4 244.7 94.4 104.1 78.0 180.1 101.2 109.3 111.4 68.2 58.6 98.8 225.6 65.5 128.4 346.0 80.6 60.8 77.8 69.1 132.3 80.2 178.5 160.0 33.1 175.6 109.0 31.6 61.5 18.8 78.9 50.6 116.3 150.1 136.2 111.1 88.7 147.7 176.2 136.7 13.6 83.1 47.2 105.0 90.2 227.6 68.1 49.5 35.9 54.3 51.3 44.1 54.8 31.9 39.5 41.0 333.5 603.3 2152.2 474.9 1201.0 51.9 57.2 950.3 406.9 664.3 249.5 27.5 1272.5 507.3 1182.8 376.5 678.3 1089.4 654.1 2086.5 1615.5 676.8 419.9 573.0 927.7 904.0 49.3 1185.7 891.2 1556.1 890.1 786.1 881.2 600.6 1996.4 2188.6 195.4 1807.7 1595.7 444.1 950.3 80.4 258.7 675.6 285.7 224.9 1448.4 1216.1 1389.4 2844.5 431.7 RPS10-NUDT3 ENSG00000270800 "RPS10-NUDT3 readthrough" 6 34284887-34426071 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 46.7;Ciliated cells: 21.4;Club cells: 35.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 21.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 21.2" "Low cell line specificity" "Detected in all" "HPA047027, HPA047268, HPA048084, HPA055953" Uncertain Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA047268: AB_2680007, HPA048084: AB_2680255, HPA055953: AB_2682984" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.85e-2)" "unprognostic (7.54e-3)" "unprognostic (1.28e-2)" "unprognostic (6.85e-2)" "unprognostic (8.95e-2)" "unprognostic (2.67e-1)" "unprognostic (5.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.63e-1)" "unprognostic (5.17e-8)" "unprognostic (5.80e-2)" "unprognostic (9.49e-2)" "unprognostic (2.23e-1)" "unprognostic (1.42e-1)" 14.5 10.9 28.0 24.9 21.7 35.6 12.1 9.9 25.4 22.6 23.0 7.3 16.4 9.5 26.2 17.7 29.9 10.0 12.2 20.8 23.7 23.2 13.4 21.1 16.3 31.8 25.2 4.3 33.2 58.4 5.3 7.6 18.8 5.7 22.5 7.7 9.4 44.6 12.4 49.4 6.4 12.9 18.0 17.2 23.0 14.4 23.4 6.0 18.9 26.4 27.9 22.0 22.0 29.9 3.7 4.7 21.2 4.8 2.9 2.3 2.1 9.6 2.9 8.1 14.4 6.0 4.1 8.4 6.7 3.4 5.1 5.3 3.2 4.5 9.3 13.0 4.2 12.1 6.2 11.1 3.5 6.4 7.6 4.9 16.6 6.0 10.2 1.2 15.9 21.2 1.6 7.3 7.3 15.3 7.0 5.0 10.3 16.2 12.6 6.3 8.4 18.1 9.2 4.5 18.7 1.7 10.1 6.8 5.3 5.0 10.4 12.6 4.1 4.7 5.3 17.7 5.1 7.9 33.5 3.9 7.7 12.7 3.9 10.2 6.7 9.2 15.2 1.0 9.6 12.6 6.9 3.9 21.2 2.1 4.8 2.1 3.7 2.3 2.0 4.7 3.5 2.3 1.9 3.1 2.9 4.1 3.3 2.2 2.1 28.0 21.7 9.9 25.4 23.7 23.2 25.2 4.3 5.7 6.0 32.8 46.7 0.0 0.1 0.7 0.0 0.0 0.0 21.4 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 RPS11 S11 ENSG00000142534 "Ribosomal protein S11" P62280 19 49496365-49499689 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049719 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA049719: AB_2680860" "unprognostic (1.49e-3)" "unprognostic (3.71e-2)" "unprognostic (1.22e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-3)" "unprognostic (3.57e-1)" "unprognostic (1.04e-2)" "unprognostic (4.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.47e-1)" "unprognostic (5.68e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.50e-7)" "unprognostic (5.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "unprognostic (1.71e-3)" 103.0 76.8 80.6 187.8 68.7 161.8 165.7 50.4 75.3 138.6 134.1 43.2 105.8 67.0 149.4 132.4 142.8 132.3 133.0 135.9 63.2 53.5 84.3 105.7 101.9 354.2 71.5 64.2 242.4 490.0 41.7 89.7 72.2 63.4 116.6 103.4 72.7 193.2 104.0 223.4 140.8 88.1 198.4 69.9 132.6 96.3 67.2 48.3 137.3 119.0 190.7 169.5 145.6 230.6 232.4 173.3 45.1 96.7 91.3 161.6 231.8 109.9 171.4 130.3 201.2 188.4 285.3 87.3 93.6 185.0 133.4 127.9 118.7 91.9 269.9 58.4 127.4 58.2 74.2 153.6 185.5 131.5 115.1 266.6 163.2 112.8 170.5 176.0 288.2 121.3 283.0 302.6 89.1 229.4 226.9 192.4 166.1 161.1 143.9 143.9 122.9 134.5 217.1 120.3 276.2 176.8 129.7 165.0 143.5 191.4 259.9 139.2 185.8 63.7 214.8 139.2 132.5 69.8 299.8 110.2 106.0 95.2 51.4 123.1 144.1 219.0 191.9 44.1 198.6 90.3 45.1 96.7 29.9 95.6 82.8 127.6 232.4 137.5 110.9 144.1 221.1 161.6 135.7 25.9 91.3 70.6 173.3 109.8 231.8 80.6 68.7 50.4 75.3 63.2 53.5 71.5 64.2 63.4 48.3 777.2 1364.0 2990.9 2041.9 2385.3 290.8 613.7 1123.6 1019.8 1465.0 450.1 135.5 1657.4 1031.2 1067.3 717.3 1435.9 1074.1 934.5 2445.2 2866.6 1515.8 1592.1 1273.2 1366.5 1658.3 89.0 1443.9 1317.9 2294.0 1350.9 2974.6 2278.1 1459.3 1700.6 2280.4 469.1 1978.0 1439.5 1446.5 1386.6 340.6 860.2 1282.2 599.4 586.0 2983.4 1970.5 1736.0 2339.2 2255.1 RPS12 S12 ENSG00000112306 "Ribosomal protein S12" P25398 6 132814441-132817564 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006124, HPA006365" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 280000 Cytosol "Golgi apparatus, Vesicles" "HPA006124: AB_1856460, HPA006365: AB_2667570" "unprognostic (6.58e-2)" "unprognostic (3.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (6.37e-2)" "unprognostic (4.95e-3)" "unprognostic (1.46e-1)" "unprognostic (3.95e-2)" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (7.04e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (2.04e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-1)" "unprognostic (5.66e-2)" 95.6 65.1 66.4 169.3 53.2 199.6 187.3 49.6 66.9 98.4 83.8 42.5 93.7 73.1 106.1 99.2 129.4 88.0 113.7 152.2 56.1 44.6 78.0 108.8 182.0 515.8 67.8 42.0 222.2 403.5 23.2 46.3 87.7 44.5 94.4 82.1 56.5 220.6 71.5 100.5 153.8 79.5 162.6 71.8 122.9 85.4 62.6 52.5 139.6 116.7 155.1 130.9 109.7 196.8 159.2 101.3 17.4 54.3 70.9 211.8 222.0 67.7 51.5 80.0 124.2 154.6 196.5 95.1 86.4 116.5 91.9 89.0 105.9 65.1 150.2 119.9 110.5 47.7 66.1 86.9 144.7 84.4 98.3 111.8 102.3 67.6 149.5 173.3 287.6 80.0 210.4 237.3 79.4 281.5 158.1 120.7 124.0 167.5 99.9 111.6 138.2 121.1 167.6 98.7 116.1 84.2 137.2 64.0 95.1 122.2 70.5 68.2 55.6 29.1 187.4 231.2 79.8 79.4 292.9 105.0 39.3 112.7 131.6 159.4 150.1 122.2 111.9 129.8 163.5 56.0 17.4 54.3 7.8 95.6 50.7 147.0 159.2 168.0 123.1 73.4 139.3 211.8 174.2 5.7 70.9 40.7 101.3 90.8 222.0 66.4 53.2 49.6 66.9 56.1 44.6 67.8 42.0 44.5 52.5 1542.4 2505.6 7624.6 6638.1 7352.8 495.9 774.7 3589.8 892.7 2634.3 1174.2 168.9 6440.4 3876.2 3101.2 589.5 3918.9 1905.6 3387.3 6989.0 7823.6 3608.9 7408.3 1688.4 3952.6 5017.5 200.2 2756.2 3903.9 5319.7 1401.7 5625.0 4474.4 3735.1 4011.8 6131.1 754.9 6107.0 3738.4 2810.9 3874.6 503.2 1591.0 3387.1 860.2 1688.1 9189.4 6602.5 5004.5 7735.2 7372.2 RPS14 "EMTB, S14" ENSG00000164587 "Ribosomal protein S14" P62263 5 150442635-150449756 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 708.0;pancreas: 483.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018504 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 540000 "Endoplasmic reticulum, Cytosol" "HPA018504: AB_1856463" "unprognostic (5.70e-3)" "unprognostic (1.94e-1)" "unprognostic (6.72e-2)" "unprognostic (8.17e-3)" "unprognostic (7.51e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.36e-1)" "unprognostic (1.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (3.26e-1)" "prognostic unfavorable (8.69e-4)" "unprognostic (1.47e-1)" "unprognostic (8.81e-2)" "unprognostic (2.29e-1)" "unprognostic (8.14e-2)" 60.9 43.2 50.1 64.3 39.1 92.8 111.6 22.6 37.2 85.1 70.3 28.0 50.6 33.6 59.6 86.4 79.4 91.7 57.2 59.2 35.7 30.3 53.6 74.7 57.0 96.6 39.8 32.5 115.1 483.0 17.4 38.9 62.0 35.3 69.7 61.5 41.1 61.8 50.8 93.4 95.0 60.6 67.0 37.0 68.4 58.3 48.5 33.8 84.5 93.9 71.2 83.6 87.1 65.2 360.5 205.3 51.0 166.0 157.4 465.9 708.0 89.3 163.8 85.3 173.6 130.6 245.7 140.0 68.6 115.1 112.0 102.2 223.2 115.2 202.7 101.1 129.6 97.8 71.6 127.5 305.2 76.2 94.0 154.0 73.7 152.0 167.5 185.8 210.2 76.3 186.5 119.5 114.1 269.2 114.3 155.6 135.1 97.1 80.3 141.7 241.1 90.7 177.3 87.8 132.7 139.2 89.1 98.2 217.1 146.5 164.3 94.0 107.1 49.8 249.0 197.0 72.6 109.7 230.7 96.4 60.6 50.9 51.2 92.3 108.9 153.2 133.2 75.6 206.1 39.9 51.0 166.0 36.7 186.2 114.2 261.9 360.5 313.3 226.8 181.1 299.4 465.9 319.4 25.7 157.4 97.0 205.3 196.8 708.0 50.1 39.1 22.6 37.2 35.7 30.3 39.8 32.5 35.3 33.8 1241.7 2223.5 5848.4 7839.1 10367.0 470.3 1738.9 3103.1 1474.9 2518.3 1402.8 174.7 6156.5 3836.4 2863.1 930.3 4248.1 1996.7 1495.1 7588.8 7324.6 4606.0 5276.5 2165.3 3416.6 4101.9 192.3 2300.5 3299.3 4925.3 1358.8 4034.1 6269.0 6141.0 5451.9 4847.3 751.5 5031.6 4334.6 2100.9 3824.8 499.4 1578.1 4450.7 718.4 798.9 13425.3 5960.1 3922.9 6829.3 8560.7 RPS15 "MGC111130, RIG, S15" ENSG00000115268 "Ribosomal protein S15" P62841 19 1438358-1440494 "Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054510, HPA057793" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 170000 "Endoplasmic reticulum, Cytosol" "HPA054510: AB_2682510, HPA057793: AB_2683528" "unprognostic (4.47e-3)" "unprognostic (1.30e-1)" "unprognostic (6.58e-2)" "unprognostic (1.08e-3)" "unprognostic (5.98e-2)" "unprognostic (2.05e-1)" "unprognostic (4.33e-3)" "unprognostic (4.42e-2)" "unprognostic (2.58e-1)" "unprognostic (2.73e-2)" "unprognostic (3.28e-2)" "unprognostic (5.00e-2)" "unprognostic (1.44e-3)" "unprognostic (5.21e-2)" "unprognostic (5.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.61e-2)" 61.7 61.2 63.0 67.5 51.4 123.6 74.2 46.0 87.5 56.2 66.4 46.1 41.2 69.0 73.6 52.3 80.9 61.2 73.7 72.1 50.4 40.5 64.8 103.7 43.0 95.3 52.1 52.6 144.8 136.0 21.6 59.3 60.9 45.2 66.9 37.1 61.2 123.7 53.2 154.9 102.4 67.6 51.8 51.0 76.2 63.5 60.8 24.9 70.7 74.2 127.6 82.9 47.6 70.9 237.3 149.5 48.6 106.7 103.8 218.1 269.2 103.9 111.1 48.8 66.4 45.8 66.8 84.2 54.5 43.5 65.4 51.2 178.1 36.8 129.0 49.0 35.0 23.1 66.3 47.6 67.5 25.7 107.3 248.7 42.2 101.7 168.2 48.5 107.3 80.6 82.0 81.6 44.2 43.4 63.5 57.5 118.1 85.6 185.9 40.8 182.9 88.7 144.3 110.5 83.3 142.8 92.4 58.3 168.5 59.4 114.5 78.7 93.4 46.0 79.3 156.2 27.1 60.6 144.8 58.0 55.4 63.4 110.4 120.2 161.5 159.8 125.4 55.0 98.1 63.3 48.6 106.7 44.5 116.2 89.5 160.8 237.3 179.3 146.1 149.5 222.5 218.1 177.4 21.6 103.8 68.2 124.2 162.9 269.2 63.0 51.4 46.0 87.5 50.4 40.5 52.1 52.6 45.2 24.9 845.7 1291.0 5528.5 5609.3 8137.2 413.6 279.6 2101.9 934.2 1767.5 1455.1 164.9 3608.1 3294.2 1842.6 725.7 3005.1 2262.4 2453.0 4593.9 5682.0 3308.9 4379.3 1687.8 2548.8 3281.3 144.6 1742.9 2587.2 4363.2 2200.3 3679.4 4495.5 4398.2 3907.2 3542.4 728.2 3370.7 3075.6 1974.7 3966.5 432.6 1319.4 2967.7 790.1 989.9 11039.2 3219.2 4153.4 4441.6 5090.7 RPS16 S16 ENSG00000105193 "Ribosomal protein S16" P62249 19 39433207-39435948 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064222 Approved Enhanced "Endoplasmic reticulum,Cytosol" No No 36000 "Endoplasmic reticulum, Cytosol" "HPA064222: AB_2685218" "unprognostic (4.63e-3)" "unprognostic (4.78e-2)" "unprognostic (2.73e-1)" "unprognostic (9.49e-2)" "unprognostic (2.20e-2)" "unprognostic (1.53e-1)" "unprognostic (1.62e-2)" "unprognostic (8.89e-2)" "unprognostic (2.96e-1)" "unprognostic (1.89e-3)" "unprognostic (4.40e-2)" "unprognostic (5.28e-2)" "unprognostic (5.73e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-2)" "unprognostic (2.06e-1)" "unprognostic (4.62e-2)" 89.8 60.8 49.0 123.2 46.1 127.3 126.9 39.8 46.8 124.8 120.7 48.6 80.0 67.2 97.9 80.8 150.1 108.1 105.9 118.7 41.7 35.7 81.5 147.6 103.7 243.2 49.2 29.9 248.1 457.6 19.9 48.8 97.0 35.5 129.5 52.8 73.8 130.5 87.6 205.5 113.4 110.9 126.3 52.2 136.7 92.1 57.4 37.7 153.9 125.1 183.6 151.0 143.8 159.8 153.7 106.4 17.6 71.8 71.7 179.1 225.5 138.9 297.8 80.0 90.7 120.5 148.7 74.3 64.1 75.0 83.8 77.2 189.4 77.2 117.8 83.2 79.9 31.8 46.4 93.6 155.9 53.0 137.6 221.5 93.0 101.4 195.7 123.1 135.7 63.1 173.4 243.1 73.8 117.9 114.0 107.3 152.3 118.7 133.3 87.3 214.7 185.4 136.9 98.8 176.8 109.0 124.3 82.7 142.4 91.9 156.9 81.5 117.2 48.1 216.7 164.7 56.2 62.1 263.7 64.5 69.9 91.6 74.0 139.4 185.8 192.2 149.3 72.3 129.9 67.4 17.6 71.8 11.0 84.5 57.9 120.9 153.7 140.8 105.6 91.9 143.2 179.1 143.0 13.2 71.7 48.2 106.4 94.7 225.5 49.0 46.1 39.8 46.8 41.7 35.7 49.2 29.9 35.5 37.7 1051.1 1483.9 3949.0 3037.8 3456.7 300.0 882.4 2025.5 1279.5 2023.5 772.9 182.6 3919.4 1871.8 1658.2 460.7 2103.8 1281.1 1471.8 3703.3 5212.0 2075.3 2629.1 1071.8 2095.9 2461.9 108.1 1421.1 1433.3 2612.0 1078.8 3908.0 3281.4 1931.7 3389.6 2360.5 436.5 2661.2 1690.0 1746.6 2505.6 404.4 1261.2 2305.1 506.0 777.6 3962.5 3964.9 2423.2 3346.2 3508.5 RPS17 "MGC72007, RPS17L, RPS17L1, RPS17L2, S17" ENSG00000182774 "Ribosomal protein S17" P08708 15 82536750-82540564 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 149.0" "Low region specificity" "Detected in all" HPA055060 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 39000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA055060: AB_2682686" "unprognostic (3.37e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-2)" "unprognostic (6.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-2)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.49e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.83e-1)" "unprognostic (5.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.31e-1)" 40.1 37.3 23.9 41.5 28.0 78.5 93.7 20.5 39.7 41.3 35.4 18.0 32.7 12.0 34.4 69.6 58.2 48.5 36.3 36.2 24.9 16.0 33.0 56.8 30.4 75.5 22.2 22.4 100.0 160.7 8.0 28.1 28.7 29.1 32.2 54.1 21.2 64.2 38.1 47.5 60.8 33.0 54.2 26.6 40.9 38.1 29.3 19.2 36.1 38.5 85.2 82.2 34.1 55.8 42.1 34.6 12.5 19.7 26.5 48.5 63.4 10.4 75.5 24.4 15.8 41.3 57.4 18.9 5.7 10.6 18.1 16.6 107.6 34.5 14.9 10.7 23.1 32.1 33.1 58.8 58.3 32.6 9.1 149.0 2.6 78.0 72.2 56.4 13.2 14.4 73.9 107.7 22.3 76.5 48.5 38.3 39.2 10.2 39.9 27.8 84.1 16.9 46.6 36.7 67.8 60.3 11.4 6.2 26.8 53.9 95.3 17.8 11.5 2.3 32.0 31.5 42.3 38.9 40.7 9.9 28.2 20.6 17.4 12.6 12.0 18.6 13.0 23.1 34.1 15.4 12.5 19.7 4.5 16.6 17.2 43.6 39.9 41.3 26.8 27.2 42.1 48.5 42.4 2.5 26.5 14.8 34.6 23.7 63.4 23.9 28.0 20.5 39.7 24.9 16.0 22.2 22.4 29.1 19.2 756.3 1289.8 2965.8 4861.9 38.4 77.5 373.2 1826.7 922.1 1902.9 167.5 47.1 3046.0 462.6 1389.5 55.8 1090.9 569.4 1962.4 2604.1 5603.8 1698.1 3804.0 863.8 2556.7 2408.0 39.7 929.1 1950.1 2775.5 119.3 4074.2 1038.9 28.7 2043.3 2571.6 141.3 2469.3 1560.6 1761.1 737.0 85.0 1164.2 222.0 396.6 646.1 55.8 2855.8 2041.0 4254.9 4758.2 RPS18 "D6S218E, HKE3, KE-3, KE3, S18" ENSG00000231500 "Ribosomal protein S18" P62269 6 33272010-33276510 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 484.7" "Cell type enhanced" "Detected in all" 5 "Suprabasal keratinocytes: 27922.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050159, HPA055007" Approved Supported Cytosol NA NA 90000 Cytosol "HPA050159: AB_2681035, HPA055007: AB_2682668" "prognostic favorable (9.81e-4)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (7.74e-2)" "unprognostic (4.00e-2)" "unprognostic (3.95e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.67e-1)" "unprognostic (4.63e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.15e-10)" "unprognostic (7.00e-2)" "unprognostic (4.00e-2)" "unprognostic (2.85e-1)" "unprognostic (9.19e-2)" 67.0 49.1 43.4 126.4 32.2 109.6 132.5 20.9 37.7 99.8 105.5 17.8 48.6 44.6 83.1 109.2 120.3 66.7 92.9 71.5 31.2 26.1 48.1 69.1 69.1 263.7 34.5 35.4 154.5 484.7 8.9 33.0 56.3 26.6 95.9 65.2 37.0 168.4 53.7 107.6 140.4 56.9 99.6 35.8 89.9 56.8 40.2 32.3 94.1 94.3 155.9 90.6 101.6 114.8 98.8 55.7 7.8 30.3 49.6 92.4 130.1 52.1 30.2 40.1 105.2 68.8 136.2 64.6 52.3 76.2 68.8 52.1 76.1 30.5 171.9 56.4 55.4 33.0 38.4 62.9 82.8 54.1 53.8 98.9 64.1 36.0 100.1 134.2 110.7 34.2 147.1 164.0 52.5 157.0 65.0 65.2 51.3 85.1 54.0 60.6 87.3 55.8 123.3 55.2 61.5 43.6 66.8 64.8 115.1 63.3 67.6 46.1 68.0 20.4 104.8 164.4 30.3 71.8 193.0 53.9 32.4 37.8 34.4 68.4 64.8 131.5 131.7 18.1 120.7 39.4 7.8 30.3 3.9 42.7 27.4 72.8 98.8 83.0 60.9 55.7 80.2 92.4 78.5 3.1 49.6 20.2 50.6 61.4 130.1 43.4 32.2 20.9 37.7 31.2 26.1 34.5 35.4 26.6 32.3 1375.7 2198.7 12042.6 13399.3 18243.0 341.9 558.4 4063.7 1350.4 3447.5 1746.4 217.9 7435.2 4327.1 3565.1 899.4 6848.9 2783.6 2266.0 11029.6 11450.2 6671.8 8883.4 2873.3 3644.3 5551.7 151.0 2974.8 4982.4 5437.2 2221.6 9162.8 7322.1 8013.6 5403.2 6713.5 580.3 7620.3 4990.4 3813.6 4409.9 516.0 1972.6 5953.7 913.9 1583.7 27922.0 7341.1 7120.5 12043.3 13812.9 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 32.8 38.8 38.9 29.5 30.6 36.9 47.5 24.2 34.7 26.4 28.0 19.2 40.6 31.4 18.8 25.2 24.1 18.0 25.0 30.5 38.9 28.4 30.8 40.7 22.5 29.4 40.3 27.0 23.4 45.0 15.4 18.8 21.9 31.9 31.6 14.4 19.2 65.2 35.4 55.0 19.8 30.9 28.5 31.1 27.1 32.6 28.8 24.6 16.3 40.8 28.0 23.7 24.3 54.5 64.2 73.5 67.3 57.7 42.8 60.3 50.5 20.9 25.9 12.5 17.6 14.1 9.2 26.3 24.1 19.6 21.1 16.8 28.7 13.9 26.2 25.2 14.2 17.2 17.0 19.6 24.7 7.3 37.7 62.7 25.2 22.0 25.3 20.6 36.8 32.9 13.8 18.7 18.1 22.2 11.4 14.3 19.9 28.1 19.0 13.3 23.2 17.6 36.7 21.7 46.7 49.7 28.1 16.3 39.4 22.1 20.8 27.9 15.6 19.5 31.1 43.3 8.0 22.4 29.8 16.9 17.6 40.2 19.6 31.4 33.1 30.4 40.7 23.9 25.6 41.1 42.1 57.7 67.3 53.4 52.1 49.2 62.0 54.4 55.2 46.3 64.2 53.2 54.1 63.4 42.8 42.0 73.5 60.3 50.5 38.9 30.6 24.2 34.7 38.9 28.4 40.3 27.0 31.9 24.6 41.7 44.3 107.2 91.0 121.8 95.6 68.3 109.5 34.8 36.4 92.5 49.1 134.1 184.1 166.7 17.8 129.5 196.8 46.7 167.0 202.1 94.9 166.3 69.2 175.1 185.7 33.4 136.9 111.1 105.7 22.2 126.8 125.3 102.9 172.3 137.0 80.8 187.2 164.9 118.5 232.2 81.9 77.6 104.0 59.0 146.0 129.4 110.1 136.4 130.8 112.7 RPS2 "LLREP3, S2" ENSG00000140988 "Ribosomal protein S2" P15880 16 1962052-1964860 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 284.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055133 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA 140000 "Endoplasmic reticulum, Cytosol" "HPA055133: AB_2682708" "unprognostic (2.98e-2)" "unprognostic (2.44e-1)" "unprognostic (8.43e-2)" "unprognostic (3.49e-2)" "unprognostic (4.15e-2)" "unprognostic (4.39e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (7.43e-2)" "unprognostic (3.17e-1)" "unprognostic (7.23e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-1)" "prognostic unfavorable (3.04e-7)" "unprognostic (1.61e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.47e-1)" 46.1 41.0 28.0 101.8 40.4 97.6 65.9 34.7 30.7 48.2 47.0 22.2 28.8 39.9 45.7 27.1 100.7 61.7 55.7 38.2 19.5 16.0 34.2 107.4 71.1 104.2 36.6 18.6 112.6 284.3 9.6 32.2 45.4 30.1 43.6 32.5 18.3 53.6 28.9 67.3 78.3 47.5 25.8 22.4 131.9 47.8 18.9 28.1 115.2 50.3 114.5 78.3 51.6 77.6 137.5 69.0 18.2 44.9 53.6 125.4 54.7 82.1 119.4 69.2 222.4 100.5 248.0 122.5 56.4 135.8 148.3 105.4 212.5 57.6 157.7 90.4 97.6 49.6 103.4 99.8 189.4 55.8 99.4 197.5 53.2 133.2 190.4 245.5 124.7 87.7 331.0 271.7 123.9 206.3 151.2 143.8 142.6 108.6 89.6 102.3 381.5 156.5 218.6 219.8 106.7 107.9 191.9 112.1 188.6 135.4 78.3 124.1 112.7 55.3 173.7 133.8 63.0 117.1 219.0 65.6 80.0 105.5 19.2 118.1 34.9 57.3 200.7 43.1 108.1 100.4 4.9 37.6 18.2 50.7 44.9 84.6 137.5 99.9 78.4 68.7 117.9 125.4 93.8 7.6 53.6 36.0 69.0 68.1 54.7 28.0 40.4 34.7 30.7 19.5 16.0 36.6 18.6 30.1 28.1 482.4 958.5 7786.3 8744.5 10604.5 334.0 200.5 2094.2 638.4 1375.2 863.7 176.7 7309.9 2722.3 3301.1 203.5 3456.8 1531.9 1775.4 9857.9 13493.6 4843.2 5941.0 994.5 1678.5 5355.9 262.2 2031.1 2492.1 3769.8 337.5 3898.8 5677.6 4852.0 6570.0 4025.4 405.5 5646.9 1494.2 1481.1 1482.6 356.9 1235.3 5926.4 173.6 2431.8 13172.5 6844.1 5004.5 6746.1 10161.2 RPS20 S20 ENSG00000008988 "Ribosomal protein S20" P60866 8 56067295-56074581 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003570 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 100000 "Endoplasmic reticulum, Cytosol" "HPA003570: AB_1856466" "unprognostic (2.57e-2)" "unprognostic (6.91e-2)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.51e-1)" "unprognostic (1.99e-1)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (6.75e-2)" "unprognostic (9.78e-2)" "unprognostic (4.83e-2)" "unprognostic (3.46e-1)" "prognostic unfavorable (1.21e-8)" "unprognostic (3.64e-2)" "unprognostic (8.80e-3)" "unprognostic (2.33e-3)" "unprognostic (2.19e-2)" 164.6 74.7 74.1 177.3 61.8 191.2 193.8 30.4 57.8 148.1 118.9 49.5 104.1 58.3 100.6 108.4 161.3 91.2 108.3 140.0 57.3 47.0 88.0 136.5 124.0 280.9 67.7 41.8 267.4 218.0 28.5 69.2 77.9 48.1 136.7 60.5 70.2 165.9 104.1 161.5 132.2 86.1 152.5 75.9 157.1 98.5 79.6 47.5 168.0 141.7 143.6 140.8 179.7 157.7 214.3 142.6 64.0 77.1 78.0 248.9 267.6 143.4 128.7 126.9 123.3 182.2 210.6 107.7 96.7 143.7 115.1 105.8 133.3 139.4 211.8 119.7 101.8 80.8 90.7 79.1 152.6 97.4 91.6 109.9 175.6 118.5 166.2 175.1 97.9 115.6 205.7 159.8 75.2 217.6 188.6 139.3 163.1 140.3 126.9 113.3 177.1 267.8 196.1 170.2 197.1 55.5 147.2 46.8 109.4 138.2 155.9 42.5 132.0 41.7 113.6 189.1 109.2 164.9 203.7 91.1 87.0 149.6 114.6 152.7 138.4 119.1 154.6 132.0 171.8 77.4 64.0 77.1 31.3 101.6 64.5 144.7 214.3 189.1 135.6 100.5 180.9 248.9 181.3 14.6 78.0 59.0 142.6 125.7 267.6 74.1 61.8 30.4 57.8 57.3 47.0 67.7 41.8 48.1 47.5 1170.3 1705.4 3250.1 3140.9 3331.0 118.5 883.4 1505.7 1205.9 1967.7 657.8 106.0 2526.9 1865.2 1585.6 1562.5 1721.8 878.7 887.7 3526.4 3548.9 1962.4 2542.1 1581.7 1854.2 2209.3 52.4 1161.6 1947.6 2779.3 1231.8 4163.7 2722.3 1849.0 3059.6 1734.1 312.3 3157.9 1195.9 1870.7 2420.8 238.0 1377.6 1760.0 1442.2 1214.3 3430.4 2525.1 2932.0 2190.1 3494.3 RPS21 S21 ENSG00000171858 "Ribosomal protein S21" P63220 20 62387116-62388520 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003371 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA003371: AB_1079846" "unprognostic (1.92e-2)" "unprognostic (1.41e-1)" "unprognostic (1.31e-1)" "unprognostic (3.26e-2)" "unprognostic (1.99e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (8.46e-4)" "unprognostic (6.17e-2)" "unprognostic (9.82e-2)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-3)" "unprognostic (2.63e-1)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "unprognostic (4.60e-1)" 69.0 66.0 93.6 140.3 61.5 191.6 177.7 59.2 89.7 93.5 105.1 24.3 84.0 72.0 121.5 85.7 99.6 93.3 97.8 66.0 65.6 47.3 62.9 86.1 66.4 199.9 74.0 86.6 189.4 321.2 12.8 49.2 53.0 52.7 76.3 61.9 33.1 164.2 97.3 172.3 129.6 71.5 120.0 51.1 94.9 73.3 92.9 60.0 92.9 86.3 175.2 90.8 84.4 229.7 170.4 122.5 18.1 59.8 71.0 175.9 158.2 100.3 104.9 53.5 101.2 59.7 105.9 70.7 64.9 52.0 162.9 62.1 349.8 134.6 123.3 134.4 50.0 57.8 141.0 59.3 180.7 56.2 30.6 154.2 203.1 150.4 265.9 121.8 156.1 91.6 117.8 253.0 61.6 112.2 65.5 75.5 138.1 103.7 102.8 55.7 152.7 175.2 222.3 81.9 177.5 321.0 119.0 136.0 186.4 76.4 113.6 98.6 97.7 66.7 299.0 135.7 34.9 127.1 205.0 79.3 96.4 127.4 81.5 126.9 164.5 186.8 134.2 115.2 95.3 51.0 18.1 59.8 13.9 85.7 50.5 122.2 170.4 146.0 112.6 87.6 170.0 175.9 152.7 9.4 71.0 40.0 122.5 92.7 158.2 93.6 61.5 59.2 89.7 65.6 47.3 74.0 86.6 52.7 60.0 544.9 871.0 2744.2 1386.7 2358.7 131.9 315.5 1105.7 568.8 1113.5 464.1 210.1 1422.8 586.9 1199.5 94.5 989.5 1167.3 1261.4 3073.7 1728.6 985.1 983.6 913.6 1456.6 1120.9 141.4 1166.7 1306.8 1870.6 83.0 1440.9 1380.7 924.5 1612.3 2330.7 235.6 2068.5 1690.4 754.2 950.5 251.0 549.7 1020.7 274.4 908.8 2741.5 1370.2 1658.2 3629.5 1316.9 RPS23 S23 ENSG00000186468 "Ribosomal protein S23" P62266 5 82273358-82278577 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054853 Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 130000 "Endoplasmic reticulum, Cytosol" "HPA054853: AB_2682625" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (6.61e-2)" "unprognostic (5.80e-2)" "unprognostic (2.24e-1)" "unprognostic (8.29e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (3.87e-2)" "unprognostic (6.47e-2)" "unprognostic (2.22e-1)" "unprognostic (1.67e-1)" 114.6 62.1 72.6 129.7 54.8 139.2 191.8 45.1 53.7 141.2 118.9 46.5 83.5 62.2 131.8 94.1 145.2 118.3 114.4 79.4 61.4 52.9 92.8 134.8 90.1 200.7 74.4 34.7 269.5 211.6 41.6 65.6 94.6 51.9 134.3 89.8 52.9 126.7 84.7 205.4 134.3 97.0 129.6 77.7 150.1 83.8 61.4 51.5 194.5 141.5 171.9 173.8 160.7 165.8 140.7 110.8 11.1 56.6 63.8 136.1 158.2 92.5 36.5 105.3 80.7 177.2 239.7 107.3 89.0 134.9 134.6 134.0 51.2 63.3 218.4 62.4 115.1 83.5 47.7 157.3 255.9 139.9 79.2 88.8 89.3 54.1 49.7 234.1 128.9 64.9 230.0 304.6 102.7 269.9 202.2 173.4 139.1 92.8 68.8 116.2 60.2 142.0 130.9 67.3 49.6 85.1 95.2 150.8 196.3 130.7 39.2 67.7 88.5 45.8 79.8 180.2 109.7 60.6 200.0 123.0 19.2 74.8 46.7 139.7 99.0 144.6 153.5 45.4 167.0 42.1 11.1 56.6 8.7 60.1 52.4 92.2 140.7 103.0 81.1 97.6 130.8 136.1 112.3 6.0 63.8 43.3 110.8 73.4 158.2 72.6 54.8 45.1 53.7 61.4 52.9 74.4 34.7 51.9 51.5 988.6 1141.9 5759.9 4914.2 5245.2 367.5 259.5 2438.2 829.8 1736.9 1080.0 163.0 4238.7 3231.3 2015.9 794.6 3082.6 1557.8 1238.1 4142.3 6097.5 3274.2 3882.5 1615.9 2361.6 3614.8 220.9 1831.3 2502.0 3505.0 1289.5 5717.9 4715.7 2717.9 3404.0 3317.6 563.2 3460.3 2745.9 2903.9 4001.7 470.7 1675.1 2898.4 786.8 872.2 6212.4 4350.9 3718.5 5163.2 5114.9 RPS24 S24 ENSG00000138326 "Ribosomal protein S24" P62847 10 78033732-78056813 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003364, HPA073508" Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 70000 "Endoplasmic reticulum, Cytosol" "HPA003364: AB_1079847, HPA073508: " "prognostic favorable (1.50e-4)" "unprognostic (1.58e-1)" "unprognostic (4.95e-2)" "unprognostic (1.09e-1)" "unprognostic (6.95e-2)" "unprognostic (8.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.25e-1)" "unprognostic (9.48e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.10e-10)" "unprognostic (3.18e-2)" "unprognostic (1.38e-1)" "unprognostic (6.65e-2)" "unprognostic (8.22e-2)" 171.6 122.0 127.7 80.8 79.0 186.2 231.3 56.2 68.4 242.4 201.1 37.9 112.4 86.2 159.2 148.8 277.8 125.1 128.5 123.9 90.4 83.8 134.4 176.6 147.0 263.8 100.6 70.2 369.4 279.3 49.1 86.1 139.3 64.6 251.6 130.0 49.8 176.0 139.5 320.4 192.3 148.9 182.4 111.7 175.8 85.3 87.9 79.5 197.1 221.4 130.0 123.5 271.7 237.7 171.5 180.5 49.6 123.2 156.4 187.3 213.6 111.1 43.4 109.4 170.7 135.6 239.4 98.6 119.5 164.6 126.3 111.1 62.5 78.5 231.0 65.7 103.3 43.9 86.6 126.0 154.0 115.9 76.9 142.8 94.1 28.9 59.5 153.8 224.8 53.6 226.9 230.8 89.3 324.4 254.4 149.9 99.2 127.6 46.3 136.1 45.3 119.9 370.7 76.7 199.9 406.5 81.5 130.9 111.0 161.2 52.2 55.3 108.3 60.1 202.3 147.6 119.9 114.0 249.9 127.0 38.3 91.3 51.9 158.0 60.9 123.1 178.1 47.3 313.4 31.3 49.6 123.2 46.5 102.4 118.3 167.4 171.5 140.6 129.8 180.5 145.4 187.3 168.2 16.9 156.4 91.0 155.4 112.3 213.6 127.7 79.0 56.2 68.4 90.4 83.8 100.6 70.2 64.6 79.5 690.8 1269.5 3209.8 4202.0 3647.0 323.7 537.2 1994.9 927.5 1705.0 760.7 102.1 2994.5 2778.6 1946.3 1157.3 2319.7 1458.1 1097.9 3916.2 5172.5 2049.1 2966.1 1188.1 1848.0 2894.9 143.0 2011.7 1935.4 4187.3 3507.5 5250.7 4018.5 1926.6 2732.2 3111.1 529.6 2893.5 2823.1 2432.9 2781.3 330.7 1248.2 2260.6 575.1 551.3 4012.4 2962.0 2362.2 4939.3 4132.1 RPS25 S25 ENSG00000118181 "Ribosomal protein S25" P62851 11 119015712-119018691 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031801, HPA078683" Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 54000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA031801: AB_10610419, HPA078683: " "unprognostic (1.60e-2)" "unprognostic (1.79e-1)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "unprognostic (8.32e-2)" "unprognostic (1.78e-2)" "unprognostic (1.55e-2)" "unprognostic (8.47e-2)" "unprognostic (5.23e-2)" "unprognostic (1.54e-2)" "unprognostic (2.36e-2)" "unprognostic (7.75e-3)" "prognostic unfavorable (3.00e-7)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (8.58e-2)" "unprognostic (2.20e-1)" 72.3 68.1 54.9 99.5 60.7 117.7 140.7 38.1 62.2 84.9 69.4 26.8 87.7 53.5 79.6 93.4 92.9 68.0 78.6 87.3 44.4 41.7 58.6 76.5 88.4 256.5 57.1 48.1 190.0 274.5 34.3 67.5 52.5 54.3 77.1 52.2 41.6 113.5 131.7 173.6 82.0 57.7 125.4 68.3 80.7 68.3 35.3 47.3 78.5 83.9 128.8 86.4 112.2 110.6 136.6 83.3 30.0 43.2 64.7 166.9 150.1 39.1 22.5 48.5 48.5 65.3 101.1 39.8 53.0 47.7 31.3 27.3 59.5 68.7 99.1 92.7 36.9 37.1 54.4 42.9 57.0 35.7 48.7 46.8 141.1 19.9 49.9 50.7 100.2 44.1 91.0 101.7 29.9 74.7 98.9 56.9 80.2 73.3 59.8 43.5 80.7 78.3 137.7 50.0 99.7 54.5 68.7 50.9 107.6 57.8 34.5 35.6 67.8 28.2 87.8 54.8 57.4 70.6 109.3 54.0 30.7 35.7 31.1 50.8 50.7 41.3 81.9 21.3 99.7 36.2 30.0 43.2 27.1 75.8 42.5 120.7 136.6 133.4 102.4 69.1 112.6 166.9 128.2 11.7 64.7 37.2 83.3 88.7 150.1 54.9 60.7 38.1 62.2 44.4 41.7 57.1 48.1 54.3 47.3 753.4 1471.8 4134.9 3644.0 3526.8 272.7 156.5 1931.2 1062.7 1885.9 884.5 108.0 3031.7 2773.7 1545.4 1495.6 2111.7 1048.3 1191.4 2746.5 3534.5 2149.5 2685.4 1909.4 2155.6 2228.4 127.1 1279.9 2210.4 2932.5 2021.0 3541.3 3243.7 2073.4 4078.5 2284.3 466.6 2362.4 1995.5 1610.5 3361.8 311.5 1312.9 2458.2 606.9 848.3 4074.2 3057.4 2507.2 2899.2 3437.7 RPS26 S26 ENSG00000197728 "Ribosomal protein S26" P62854 12 56041351-56044676 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043961, HPA055803" Uncertain Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA043961: AB_10963579, HPA055803: AB_2682927" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (3.36e-1)" "unprognostic (9.58e-2)" "unprognostic (3.74e-1)" "unprognostic (7.84e-3)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.06e-2)" "unprognostic (1.41e-1)" "unprognostic (4.40e-2)" "unprognostic (2.18e-1)" "unprognostic (7.99e-2)" 36.5 66.6 33.3 29.0 48.8 39.2 49.7 23.8 73.7 44.5 45.6 34.9 20.5 20.0 35.9 50.4 49.9 43.5 28.4 39.8 25.8 24.8 61.8 154.3 29.5 56.0 31.4 26.2 75.8 80.4 25.6 29.7 28.7 45.1 35.4 49.1 28.5 38.0 41.1 62.2 50.9 57.5 36.9 30.0 51.6 40.3 47.0 32.5 47.3 58.4 60.0 78.4 46.7 41.2 93.0 69.8 29.8 42.8 63.6 107.4 108.8 53.4 65.8 75.0 27.8 103.9 154.2 75.2 54.5 81.0 90.9 53.2 101.0 24.2 119.3 34.5 57.5 30.0 25.2 84.2 46.9 62.3 47.2 135.1 63.0 43.9 60.2 96.0 40.9 34.6 93.3 150.3 47.9 54.6 35.9 69.0 85.6 42.9 39.8 73.5 82.9 30.6 74.3 73.6 65.4 149.1 41.7 22.5 73.4 75.9 54.2 28.2 48.8 21.3 47.2 30.9 23.3 41.7 45.8 22.3 22.6 46.3 28.8 43.7 34.3 65.6 64.4 25.1 81.7 28.9 29.8 41.4 27.1 74.6 42.8 83.8 93.0 97.8 81.8 55.3 79.8 107.4 99.3 17.0 63.6 38.2 69.8 101.7 108.8 33.3 48.8 23.8 73.7 25.8 24.8 31.4 26.2 45.1 32.5 208.4 201.5 1424.8 560.8 1563.9 119.2 23.8 1184.7 333.3 536.9 408.2 58.9 1212.8 824.0 801.2 63.2 800.7 1808.5 1004.5 2275.1 2554.3 1158.0 914.2 500.2 1753.2 1234.1 71.5 826.4 935.4 838.0 37.7 273.5 701.1 1386.7 874.7 1010.7 278.9 1348.0 1392.2 208.2 969.4 134.7 304.0 900.2 204.7 313.7 1585.9 1428.5 824.9 1127.8 1109.2 RPS27 "MPS-1, MPS1, S27" ENSG00000177954 "Ribosomal protein S27" P42677 1 153990755-153992155 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 778.4;lymphoid tissue: 769.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "prognostic favorable (9.69e-4)" "unprognostic (1.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.35e-1)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (8.62e-2)" "unprognostic (5.88e-3)" "unprognostic (2.05e-2)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (4.86e-7)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (2.44e-1)" "unprognostic (8.81e-2)" 120.7 72.5 74.9 188.7 118.6 186.7 268.2 51.3 91.4 172.5 114.2 35.9 136.4 58.1 169.0 135.6 107.5 129.0 144.1 176.5 59.6 50.1 98.6 102.5 167.8 769.0 92.1 76.0 317.8 227.2 44.6 91.5 67.5 71.2 117.6 113.6 63.5 248.2 116.1 243.8 160.1 115.9 254.3 65.6 159.3 111.5 119.0 81.9 118.2 113.0 224.0 270.9 162.9 286.0 720.2 296.5 132.9 139.9 324.1 750.5 778.4 103.7 121.7 160.9 87.6 378.8 373.5 99.8 125.8 301.7 169.5 153.2 243.8 114.7 236.3 105.7 181.5 56.5 104.6 141.7 208.3 143.3 114.7 182.7 93.1 161.4 158.1 251.1 206.9 122.8 362.6 409.8 134.8 248.4 252.8 138.9 197.5 113.6 128.5 160.9 260.8 222.5 131.0 194.8 347.8 177.5 142.6 117.8 183.8 156.6 210.3 85.5 190.7 72.1 254.0 218.7 229.1 141.6 415.8 82.0 58.6 97.1 93.4 125.7 258.2 263.2 286.4 101.7 116.2 80.3 132.9 139.9 68.1 393.0 138.9 473.7 720.2 594.4 502.0 179.5 637.3 750.5 579.6 32.4 324.1 127.0 296.5 397.8 778.4 74.9 118.6 51.3 91.4 59.6 50.1 92.1 76.0 71.2 81.9 2045.7 3610.2 12664.6 4456.3 11098.6 390.9 812.1 5699.4 2137.4 3923.0 2044.8 182.6 5213.2 3755.2 3414.7 2254.7 2990.8 2165.3 4461.9 9085.2 5382.4 5444.6 3827.3 4020.8 6408.4 3759.0 181.1 2910.0 5208.2 8634.5 6446.8 6571.4 6944.5 5609.6 8769.4 6097.0 734.9 5926.8 6112.7 3330.7 4371.1 465.9 2690.5 3231.1 1566.2 1451.5 12519.6 5337.4 8309.1 7958.0 4025.9 RPS27A "S27A, Uba80, UBCEP80" ENSG00000143947 "Ribosomal protein S27a" P62979 2 55231903-55235853 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033319, HPA041344, HPA049132, HPA054087" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "CAB033319: AB_793618, HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373" "unprognostic (7.32e-2)" "unprognostic (1.41e-2)" "unprognostic (1.11e-1)" "unprognostic (3.20e-3)" "unprognostic (2.16e-1)" "unprognostic (9.75e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (2.46e-1)" "unprognostic (6.89e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (1.09e-1)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (3.60e-1)" 54.1 45.0 46.8 66.0 85.5 111.5 120.1 33.3 77.9 74.5 60.0 21.4 43.0 37.3 66.0 57.8 68.3 61.4 51.2 47.1 57.0 32.7 71.1 172.7 43.9 84.3 42.4 68.3 167.1 88.9 20.7 53.7 57.1 52.1 57.7 52.5 25.3 70.5 46.9 101.9 69.1 52.5 46.3 40.4 77.1 58.9 48.6 36.4 62.8 64.0 144.0 82.1 52.1 71.1 194.8 130.9 42.2 62.9 122.8 253.3 267.6 106.0 61.7 67.7 112.4 94.5 180.5 129.4 83.7 96.3 91.9 58.2 115.1 120.4 148.5 141.5 79.8 54.7 100.8 97.7 114.4 107.5 125.9 113.1 136.8 66.4 153.9 137.5 204.0 93.8 162.3 227.7 61.6 168.3 153.5 124.6 92.0 122.0 136.4 105.0 83.0 119.2 245.7 162.6 130.4 79.0 113.8 172.4 175.6 103.9 101.6 89.5 71.0 57.4 250.0 186.5 110.1 111.1 174.3 118.6 84.3 128.3 75.2 141.6 122.8 85.1 96.5 120.6 173.6 83.9 42.2 62.9 24.1 129.3 59.1 183.5 194.8 197.3 154.8 91.1 179.3 253.3 206.8 14.4 122.8 52.5 130.9 120.7 267.6 46.8 85.5 33.3 77.9 57.0 32.7 42.4 68.3 52.1 36.4 1182.1 2168.7 6366.0 7790.9 7391.5 428.3 362.3 2830.5 1535.1 2713.9 1326.0 202.2 4414.5 3436.8 2947.8 844.4 3491.0 1693.7 1752.0 6390.1 5764.5 3524.5 5396.1 2833.4 2701.0 3058.4 206.6 1979.6 3107.2 4338.7 1140.7 4705.1 4812.5 3451.8 4888.3 3292.1 886.8 4792.0 3026.5 2708.4 4047.2 553.4 1616.9 4201.8 922.6 805.1 7807.0 4507.9 4717.9 5337.4 6552.6 RPS27L ENSG00000185088 "Ribosomal protein S27 like" Q71UM5 15 63125872-63158021 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Proximal tubular cells: 1955.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "unprognostic (4.62e-2)" "unprognostic (5.81e-2)" "unprognostic (1.38e-1)" "prognostic favorable (9.08e-6)" "unprognostic (1.75e-1)" "unprognostic (7.24e-2)" "unprognostic (1.42e-3)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (1.80e-1)" "unprognostic (2.19e-3)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (5.31e-2)" "unprognostic (1.36e-1)" "unprognostic (1.97e-3)" "unprognostic (5.10e-3)" 46.8 64.2 21.3 19.8 29.7 18.2 53.6 16.3 23.4 29.4 58.5 15.5 30.4 46.0 30.2 49.3 40.4 27.0 38.3 47.1 22.8 22.2 61.0 75.2 31.7 23.4 32.6 19.2 26.5 65.9 19.2 38.8 35.6 43.9 56.2 55.3 18.3 99.8 46.0 47.1 18.1 80.4 54.8 39.9 28.2 41.9 15.7 27.3 19.4 53.9 25.7 19.8 55.0 36.3 34.5 30.9 51.5 47.6 27.2 75.4 38.3 16.5 46.4 42.1 11.3 61.6 73.0 42.2 52.4 37.4 11.5 28.2 8.5 23.1 15.6 18.8 50.1 20.6 6.4 14.2 25.8 19.5 11.5 19.2 12.8 39.2 60.7 70.9 10.2 35.7 57.1 34.7 26.1 19.8 87.6 65.3 9.8 11.8 15.7 96.0 23.0 13.1 15.9 12.4 21.2 13.6 10.2 20.2 17.6 32.4 33.6 6.1 9.3 19.0 8.0 37.1 88.4 17.8 23.7 69.0 61.2 57.6 13.2 23.2 17.7 15.0 13.8 64.9 28.2 55.1 51.5 34.3 40.0 27.5 35.9 33.9 34.5 41.6 32.0 30.9 26.9 32.9 33.1 11.4 27.2 47.6 30.8 75.4 38.3 21.3 29.7 16.3 23.4 22.8 22.2 32.6 19.2 43.9 27.3 89.3 200.0 257.3 226.5 226.9 32.3 318.9 598.7 234.2 153.6 389.0 45.2 244.0 766.0 754.9 35.9 230.2 819.3 233.6 678.9 1142.2 251.0 333.1 292.5 900.4 483.1 12.7 274.1 300.8 377.4 21.8 291.4 318.2 442.1 1587.0 624.8 110.3 1030.5 691.6 279.7 1955.0 68.4 258.7 357.4 142.8 82.2 216.4 196.7 234.3 638.5 176.3 RPS28 S28 ENSG00000233927 "Ribosomal protein S28" P62857 19 8321158-8323340 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047132 Approved Approved Cytosol NA NA Cytosol "HPA047132: AB_10962147" "unprognostic (3.47e-2)" "unprognostic (7.47e-3)" "unprognostic (1.49e-1)" "prognostic favorable (2.47e-4)" "unprognostic (3.09e-2)" "unprognostic (2.84e-3)" "unprognostic (2.16e-1)" "unprognostic (6.34e-2)" "unprognostic (1.56e-1)" "unprognostic (3.61e-2)" "unprognostic (2.80e-2)" "unprognostic (2.19e-2)" "unprognostic (3.22e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-2)" "unprognostic (8.82e-2)" "unprognostic (1.81e-2)" 20.3 19.0 24.1 19.2 22.0 45.2 29.7 23.4 38.9 18.2 16.9 8.2 16.3 23.5 20.4 17.5 32.5 23.1 17.4 35.6 15.1 14.5 18.7 45.0 17.5 35.8 18.4 23.1 49.5 71.9 6.4 17.7 17.0 22.4 20.4 8.6 21.1 42.4 12.2 40.7 36.3 20.7 16.3 13.7 29.3 20.9 48.6 11.2 22.2 25.0 35.9 17.7 21.9 33.5 30.3 26.5 5.3 16.6 11.1 30.8 38.4 33.6 13.7 12.4 28.2 18.0 27.2 19.7 22.1 20.4 25.8 21.1 18.5 14.8 50.6 27.3 12.9 11.0 25.8 16.5 38.0 3.7 30.6 109.9 24.4 14.9 18.4 32.5 28.0 27.2 43.6 44.0 18.7 16.9 16.1 23.7 39.7 34.1 57.7 11.4 21.1 42.7 99.6 37.3 19.6 83.8 30.5 13.4 53.5 17.0 16.2 24.0 23.4 15.9 29.6 39.3 4.2 22.4 47.4 29.6 21.4 18.2 41.3 36.8 67.4 35.4 34.4 22.6 53.9 14.3 5.3 16.6 3.5 16.9 10.6 22.8 30.3 27.1 19.7 15.8 26.8 30.8 21.4 2.6 11.1 9.8 26.5 16.4 38.4 24.1 22.0 23.4 38.9 15.1 14.5 18.4 23.1 22.4 11.2 1354.9 2501.9 6198.1 3612.6 7018.3 462.3 334.0 2894.3 1209.9 2587.6 1271.9 278.8 3255.4 2826.8 2557.8 200.6 2505.3 1869.9 1728.7 6319.3 3886.7 2995.5 2958.6 1841.3 4636.2 3871.6 252.6 2554.9 3833.9 4924.3 397.0 3625.0 3606.8 3342.1 4294.1 4940.9 645.3 4721.1 3391.2 1546.1 3475.5 503.9 1067.2 2167.5 225.8 948.4 9504.9 3550.0 3573.0 6794.8 3480.6 RPS29 S29 ENSG00000213741 "Ribosomal protein S29" P62273 14 49570984-49599164 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 526.9;pancreas: 892.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004107 Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA004107: AB_1079848" "prognostic favorable (2.66e-4)" "unprognostic (1.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (4.40e-3)" "unprognostic (4.13e-2)" "unprognostic (9.95e-2)" "unprognostic (4.21e-2)" "unprognostic (2.98e-2)" "unprognostic (1.12e-1)" "unprognostic (8.62e-2)" "unprognostic (1.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.18e-2)" "unprognostic (1.66e-1)" "unprognostic (7.48e-3)" "unprognostic (7.71e-2)" 59.9 53.6 54.5 108.8 58.9 140.0 155.5 34.4 88.2 68.6 89.6 17.9 67.6 71.4 54.9 67.9 75.3 56.1 63.5 108.2 43.1 33.8 54.5 75.3 74.3 232.1 64.3 56.2 128.3 892.4 8.5 41.6 44.5 53.1 50.6 58.9 29.2 86.0 67.9 177.4 102.6 70.9 76.3 74.6 98.1 63.3 94.0 60.6 53.2 45.6 136.9 101.6 47.1 83.8 303.1 164.3 62.9 102.0 123.1 363.7 526.9 145.4 96.5 101.0 90.4 116.2 198.2 133.8 99.9 85.3 91.3 74.9 97.4 135.0 132.8 114.5 83.9 45.1 127.6 116.0 142.1 101.6 86.6 209.6 104.0 87.5 169.4 142.4 265.3 90.5 204.9 232.7 59.9 175.0 161.0 129.9 232.4 115.9 174.6 88.3 193.6 181.0 165.4 123.2 244.9 272.8 152.2 125.9 152.0 110.0 130.4 76.6 88.3 70.9 131.2 231.4 102.1 171.0 232.2 119.8 70.0 187.8 64.9 88.2 201.8 223.9 179.8 49.3 109.6 67.3 62.9 102.0 46.1 175.8 81.1 219.7 303.1 322.1 227.3 122.6 281.3 363.7 295.6 24.4 123.1 73.4 164.3 181.8 526.9 54.5 58.9 34.4 88.2 43.1 33.8 64.3 56.2 53.1 60.6 1051.1 2086.9 7098.8 857.1 3036.7 210.9 491.6 2858.6 1213.9 2286.2 1018.9 121.7 2892.9 2054.1 2102.7 1067.1 1733.4 2036.9 2266.0 6120.8 4195.6 1983.5 887.8 2827.7 5978.4 2666.5 101.7 2573.6 3469.9 4942.1 2443.6 3469.6 4021.8 1899.7 4276.1 6903.3 431.8 4513.7 4892.2 1520.7 2216.4 241.3 1073.6 1689.2 1106.2 954.6 4278.5 3071.9 5097.1 8179.1 1080.6 RPS3 "FLJ26283, FLJ27450, MGC87870, S3" ENSG00000149273 "Ribosomal protein S3" P23396 11 75399486-75422280 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063339 Uncertain Supported "Endoplasmic reticulum,Cytosol" NA NA 430000 "Endoplasmic reticulum, Cytosol" "HPA063339: AB_2684990" "unprognostic (3.62e-2)" "unprognostic (6.94e-3)" "unprognostic (2.64e-1)" "unprognostic (1.44e-2)" "unprognostic (5.55e-2)" "unprognostic (1.08e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-2)" "unprognostic (3.27e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (6.92e-6)" "unprognostic (3.22e-1)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (2.19e-1)" 72.2 52.7 36.6 108.4 41.2 122.2 136.6 32.1 33.8 105.1 102.0 32.5 65.2 65.8 102.4 84.7 136.5 92.2 107.7 58.5 29.7 26.5 52.9 78.1 71.0 218.6 47.6 30.6 224.7 288.7 13.8 51.3 75.9 35.0 105.7 65.7 47.6 151.0 61.8 86.9 117.6 78.0 110.6 42.1 121.4 75.4 54.1 36.5 126.5 119.4 134.7 130.1 110.3 118.9 104.5 69.7 22.6 44.5 64.6 144.2 213.9 84.0 52.1 74.1 81.7 93.8 167.4 95.9 80.6 103.9 107.1 69.8 150.4 100.7 294.1 98.8 72.4 59.0 121.9 95.7 150.0 98.7 77.8 74.8 120.4 52.0 66.4 140.0 194.4 79.0 196.4 205.0 73.1 203.4 126.2 140.4 131.7 120.0 83.7 96.1 92.3 116.6 93.5 93.1 295.8 61.9 110.8 260.2 214.2 105.1 70.4 63.9 90.6 59.4 141.4 82.0 75.2 144.2 149.0 112.4 51.8 86.3 70.5 72.8 76.9 94.8 325.8 31.1 109.1 52.3 22.6 44.5 14.7 94.2 31.6 129.1 104.5 123.0 99.4 69.7 95.6 144.2 111.8 11.2 64.6 30.1 60.8 78.2 213.9 36.6 41.2 32.1 33.8 29.7 26.5 47.6 30.6 35.0 36.5 866.5 1237.3 4967.7 6162.8 5594.2 395.4 375.5 1814.0 683.9 1733.4 689.2 125.7 5421.9 1850.2 2098.6 348.9 3202.9 1729.9 1308.2 4686.8 7893.8 2767.0 3521.3 1562.3 1179.0 3205.3 125.5 1988.8 2139.1 2727.1 762.5 3476.8 3124.5 2689.2 3452.7 3995.8 368.1 3769.5 2872.2 1695.0 1677.7 343.0 1099.5 3088.9 437.8 578.7 6855.6 4907.0 4548.4 5852.6 6063.3 RPS3A "MFTL, S3A" ENSG00000145425 "Ribosomal protein S3A" P61247 4 151099573-151104652 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Differentiation "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 440.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047100, HPA053454" Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No 63000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA047100: AB_2679931, HPA053454: AB_2682156" "unprognostic (6.24e-3)" "unprognostic (3.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.27e-1)" "unprognostic (6.81e-3)" "unprognostic (2.36e-1)" "unprognostic (1.96e-1)" "unprognostic (2.00e-1)" "unprognostic (3.39e-1)" 71.7 46.9 48.4 69.2 47.7 124.7 160.3 40.4 43.5 114.1 98.4 30.4 61.9 45.0 75.3 84.4 142.8 73.3 53.9 51.1 36.8 33.3 72.8 94.2 79.4 102.5 42.6 43.5 179.5 143.8 18.1 49.3 70.5 38.0 113.3 62.4 39.0 113.8 48.5 116.8 97.1 73.5 62.0 43.1 94.2 64.2 61.9 30.7 120.4 126.8 111.6 90.6 111.4 86.3 211.6 187.7 44.3 92.8 142.9 282.7 440.7 80.5 59.3 113.1 111.1 145.6 285.0 115.5 85.9 132.7 121.8 75.4 114.6 117.8 365.6 43.0 93.6 43.0 53.5 114.6 143.5 115.8 80.5 110.9 78.9 73.3 132.3 168.6 187.3 81.9 211.3 296.1 74.9 199.3 172.0 144.4 137.0 126.9 191.5 144.6 120.4 202.3 222.6 106.1 129.0 45.9 148.2 110.4 122.3 141.0 97.9 108.8 107.7 38.6 141.4 189.2 83.4 94.6 227.8 87.6 59.6 78.9 65.7 94.5 148.9 239.5 223.9 76.5 136.8 70.6 44.3 92.8 27.2 120.6 74.5 203.9 211.6 203.1 157.9 156.5 185.7 282.7 226.9 15.1 142.9 62.1 187.7 145.5 440.7 48.4 47.7 40.4 43.5 36.8 33.3 42.6 43.5 38.0 30.7 902.2 1351.4 4981.2 6887.5 5470.3 389.5 334.4 1689.1 1088.1 1918.8 783.4 113.9 3954.4 3630.9 1946.8 1331.3 2405.0 1231.3 1425.0 3246.4 6519.9 2822.1 4092.8 1400.9 1318.9 2985.4 154.1 2072.9 2006.5 3842.5 3230.8 4100.5 4536.3 3092.4 3236.3 3439.0 634.6 3016.2 2304.0 2436.9 3691.6 432.9 1739.7 3595.7 655.4 688.2 5905.5 3840.1 4239.4 5672.4 6561.2 RPS5 S5 ENSG00000083845 "Ribosomal protein S5" P46782 19 58386400-58394806 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 503.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055878, HPA061979" Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA 860000 "Endoplasmic reticulum, Cytosol" "HPA055878: AB_2682954, HPA061979: AB_2684650" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" "unprognostic (3.06e-1)" "unprognostic (1.53e-1)" "unprognostic (2.37e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (4.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.77e-1)" "unprognostic (1.81e-1)" "unprognostic (5.06e-1)" "prognostic unfavorable (4.75e-4)" "unprognostic (2.79e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (1.01e-1)" 93.2 62.4 40.6 71.7 36.4 118.0 111.7 28.4 34.9 105.3 100.7 34.6 69.1 51.1 108.4 66.2 159.0 103.7 81.4 50.9 33.3 28.9 63.1 160.1 79.1 162.1 37.8 30.9 199.2 376.8 19.4 45.0 72.5 31.9 112.3 50.9 45.5 145.6 54.9 162.7 122.7 63.3 81.1 39.0 103.1 66.0 66.8 34.0 136.8 134.5 144.1 129.6 104.5 131.0 150.0 86.6 16.9 44.9 64.8 138.0 156.5 76.4 112.5 43.0 68.3 83.7 108.5 67.2 42.8 71.2 52.7 33.6 83.7 56.5 159.0 53.9 60.6 51.5 49.9 68.2 105.3 21.9 43.1 503.9 62.9 62.6 105.7 103.9 105.4 53.7 137.6 175.3 54.7 125.0 58.7 68.7 73.9 79.9 85.1 56.2 62.1 101.9 72.5 71.3 121.1 151.9 99.0 61.6 139.4 58.2 96.7 64.5 80.5 30.0 86.1 87.8 26.4 49.6 128.2 43.2 79.7 58.5 31.8 93.1 114.5 194.0 117.2 49.8 79.0 43.7 16.9 44.9 8.6 54.2 41.1 99.7 150.0 94.6 70.4 82.9 141.7 138.0 106.0 6.5 64.8 30.1 86.6 74.7 156.5 40.6 36.4 28.4 34.9 33.3 28.9 37.8 30.9 31.9 34.0 631.3 923.7 3948.5 4136.7 5255.7 230.2 214.1 1398.7 744.2 1369.4 499.0 115.8 2770.1 1545.2 1264.7 385.1 1386.8 1114.0 957.8 3964.4 3619.5 2102.1 2995.6 962.6 1143.3 1752.2 154.1 1188.7 1112.8 1555.1 982.1 2000.1 1866.3 2306.2 1598.8 2098.1 277.7 2061.4 1315.1 888.5 1782.0 311.8 685.6 2561.6 411.2 549.1 6343.4 2655.0 2337.7 2937.0 3861.2 RPS6 S6 ENSG00000137154 "Ribosomal protein S6" P62753 9 19375715-19380254 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 584.2" "Low region specificity" "Detected in all" "CAB004027, HPA031153" Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 100000 "Endoplasmic reticulum, Cytosol" "CAB004027: AB_2238583, HPA031153: AB_10602245" "unprognostic (3.95e-3)" "unprognostic (2.08e-1)" "unprognostic (6.34e-2)" "prognostic favorable (4.12e-4)" "unprognostic (1.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (8.16e-2)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" "unprognostic (2.76e-1)" "unprognostic (1.90e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (8.36e-3)" "unprognostic (2.06e-3)" 90.0 65.3 64.1 110.2 70.2 166.3 152.8 37.0 50.4 125.4 149.9 38.8 57.4 73.0 91.6 97.7 166.8 87.7 81.5 70.0 51.5 44.4 88.5 91.3 104.0 243.5 66.0 36.2 206.6 441.2 26.1 64.0 67.9 64.7 152.5 83.9 53.3 109.1 72.1 129.5 139.9 96.3 157.8 84.5 137.8 87.5 67.2 53.2 127.9 147.0 119.7 125.8 207.4 143.4 237.2 135.7 30.1 75.5 129.7 274.9 399.9 108.2 71.2 72.4 84.8 122.8 189.6 87.0 73.2 95.6 88.0 73.7 59.2 50.2 249.0 72.5 69.9 31.2 53.3 81.1 112.7 95.7 129.7 77.6 164.1 92.2 107.3 150.0 86.9 82.0 157.2 206.1 58.6 172.9 126.7 105.8 112.5 68.9 101.6 94.9 65.2 184.0 584.2 135.8 86.0 48.5 144.1 73.3 118.4 121.8 93.2 72.4 97.4 27.7 118.0 151.3 60.7 76.8 317.7 77.5 50.7 54.3 52.4 114.4 48.1 93.1 169.0 34.3 130.7 29.6 30.1 75.5 23.3 111.6 67.1 193.2 237.2 205.0 150.5 135.7 196.8 274.9 215.8 12.8 129.7 60.6 126.1 152.7 399.9 64.1 70.2 37.0 50.4 51.5 44.4 66.0 36.2 64.7 53.2 1536.5 2830.0 6502.2 11967.4 8648.0 283.0 709.9 2662.4 2307.4 4835.2 1210.9 119.8 4727.3 4907.4 2480.2 2006.9 4335.8 1389.0 2149.2 5906.0 7578.1 3573.8 7361.0 3033.7 1998.6 3545.0 71.5 1975.3 3407.3 3797.3 4913.1 4288.0 4784.3 4367.8 4093.0 4198.5 516.9 4659.6 3594.7 2278.1 5890.0 305.7 1461.7 5142.7 1143.2 654.9 10561.7 4523.6 5315.7 7244.9 10415.6 RPS6KA1 "HU-1, p90Rsk, RSK, RSK1" ENSG00000117676 "Ribosomal protein S6 kinase A1" Q15418 1 26529761-26575030 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 45.2" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 85.8;monocytes: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 29.9;U-937: 32.2" "Region enriched" "Detected in all" 5 "cerebellum: 60.4" "Low region specificity" "Detected in all" "CAB003852, HPA007981" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB003852: AB_289590, HPA007981: AB_1079850" "unprognostic (1.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.61e-3)" "prognostic favorable (7.20e-7)" "unprognostic (7.35e-2)" "unprognostic (3.69e-1)" "unprognostic (6.93e-3)" "unprognostic (1.12e-2)" "unprognostic (1.09e-1)" "unprognostic (7.51e-3)" "unprognostic (2.37e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.84e-4)" "prognostic favorable (4.58e-4)" "unprognostic (4.77e-2)" "unprognostic (7.61e-2)" "prognostic favorable (8.33e-4)" 11.0 8.2 6.3 24.2 9.7 15.8 5.0 14.4 6.3 4.9 23.2 11.1 4.4 24.5 2.1 3.6 8.9 6.0 8.0 3.4 5.3 5.1 13.6 5.4 26.1 32.7 10.3 3.5 2.1 10.1 10.0 7.4 3.3 8.6 8.6 15.8 3.6 19.0 5.5 1.1 9.0 45.2 2.8 7.9 27.0 9.7 2.7 9.0 15.9 13.9 4.9 17.3 6.2 4.5 5.0 22.0 40.1 18.0 7.9 8.3 17.1 9.9 3.5 2.8 3.7 0.1 0.0 3.8 0.8 1.6 4.2 4.1 4.0 8.2 18.5 4.6 0.5 5.1 11.7 6.4 22.9 3.0 15.3 4.1 20.3 8.6 7.1 1.3 23.9 29.9 0.7 8.4 3.9 7.0 1.9 1.8 7.4 3.4 6.7 0.2 5.5 0.8 23.6 7.3 19.3 11.1 12.8 3.6 8.1 12.1 2.7 4.1 1.6 7.0 6.6 3.2 3.1 4.2 20.6 1.2 0.2 5.4 0.7 3.3 4.2 4.9 10.1 2.5 32.2 4.1 9.6 18.0 40.1 8.3 16.4 6.9 4.9 6.1 7.3 22.0 5.0 3.9 5.5 34.5 7.9 17.3 8.6 6.0 17.1 6.3 9.7 14.4 6.3 5.3 5.1 10.3 3.5 8.6 9.0 14.9 23.5 13.7 7.4 16.6 1.3 1.2 10.2 10.7 5.7 8.7 3.9 1.2 6.6 15.5 1.8 4.2 85.8 0.0 16.3 14.5 1.9 13.9 32.2 3.8 43.9 0.0 15.6 12.3 57.1 0.5 0.0 36.8 1.7 68.5 34.3 0.4 21.8 41.9 0.0 13.6 1.7 6.5 2.1 1.1 2.7 10.2 3.4 41.5 32.9 6.8 RPS6KA3 "CLS, HU-3, MRX19, RSK, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 69.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 19.7 12.5 9.9 23.0 12.5 8.2 16.5 15.2 12.1 11.4 23.2 4.4 22.1 13.7 12.4 10.1 13.6 12.7 15.7 21.3 9.7 8.8 14.1 25.8 21.6 34.0 9.9 10.0 12.7 14.0 36.6 9.8 11.0 10.2 14.5 18.8 7.7 14.3 11.3 45.2 11.7 23.7 16.1 11.7 25.8 11.8 4.8 9.7 29.4 13.5 15.0 18.2 20.3 19.0 4.2 8.6 12.5 6.9 8.3 11.3 2.7 12.9 22.7 8.6 4.4 8.4 14.8 2.6 11.2 17.1 8.4 11.6 25.7 16.7 8.5 3.9 11.8 12.3 9.2 9.8 9.5 15.7 7.1 7.8 10.0 14.3 69.0 8.6 19.5 10.4 9.4 7.6 13.2 16.7 7.4 30.4 9.0 6.6 24.4 8.8 6.1 12.6 6.0 6.2 16.9 13.7 6.7 18.2 9.8 7.3 10.9 4.0 3.9 15.1 4.6 16.4 11.2 0.0 5.8 16.9 9.2 6.4 29.1 6.3 19.5 11.9 9.5 17.4 9.7 21.7 12.5 4.7 9.5 6.3 6.9 11.3 2.9 7.3 6.9 7.0 4.2 5.0 6.0 7.5 8.3 6.9 8.6 3.5 2.7 9.9 12.5 15.2 12.1 9.7 8.8 9.9 10.0 10.2 9.7 41.7 68.2 18.2 31.8 48.3 33.6 19.4 38.2 21.4 51.2 15.7 21.6 3.3 3.3 23.3 0.1 48.1 43.4 0.0 26.0 5.7 28.8 47.0 42.8 61.1 20.6 12.7 24.0 29.4 46.1 1.1 12.0 60.4 35.4 20.8 53.4 26.6 30.0 46.0 19.8 23.7 8.7 19.4 35.0 3.3 7.7 48.6 3.0 56.7 46.1 54.2 RPS6KA4 "MSK2, RSK-B" ENSG00000162302 "Ribosomal protein S6 kinase A4" O75676 11 64359148-64372215 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 12.6" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008649, HPA023225" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "CAB008649: AB_1619460, HPA023225: AB_1854144" "unprognostic (2.30e-1)" "unprognostic (7.05e-2)" "unprognostic (2.03e-1)" "unprognostic (4.07e-2)" "unprognostic (2.40e-1)" "unprognostic (7.47e-2)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.45e-1)" "unprognostic (9.03e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-3)" "unprognostic (1.98e-2)" "unprognostic (3.93e-3)" "unprognostic (5.25e-2)" "unprognostic (1.09e-1)" "unprognostic (2.85e-1)" 14.9 9.1 13.3 15.7 17.1 13.2 7.6 37.6 22.7 7.7 12.4 13.1 5.8 14.0 11.0 6.9 18.5 8.1 10.5 7.8 10.9 10.1 8.7 9.6 10.9 15.0 16.7 9.9 6.5 9.2 5.7 4.7 16.6 9.8 8.3 8.4 10.0 10.9 8.9 16.3 17.3 15.4 9.8 11.5 22.2 18.3 3.3 13.5 7.6 6.7 16.7 16.4 9.7 8.8 0.5 12.6 1.4 3.0 0.3 1.0 2.1 28.1 15.8 2.3 5.7 5.1 4.8 32.6 15.0 7.9 11.8 5.8 15.6 14.8 2.9 17.5 8.6 15.0 26.1 2.7 12.2 5.8 8.9 5.3 6.6 13.5 7.9 5.1 6.7 12.4 4.7 11.5 10.0 8.2 4.2 7.1 5.4 2.7 4.1 5.9 25.8 6.0 10.5 2.5 10.9 33.3 11.8 9.4 9.4 8.1 13.0 3.4 2.7 15.5 9.5 13.0 3.4 11.1 8.3 14.1 16.1 20.2 29.0 13.3 4.9 3.8 2.9 10.6 7.7 8.1 1.1 3.0 1.4 0.9 2.4 1.0 0.5 0.7 0.7 2.7 0.4 0.4 0.4 0.2 0.3 1.4 12.6 0.6 2.1 13.3 17.1 37.6 22.7 10.9 10.1 16.7 9.9 9.8 13.5 3.0 4.0 5.7 4.6 10.8 6.3 11.8 5.1 0.0 1.2 3.5 3.9 60.8 5.0 13.7 0.2 7.4 17.0 0.0 21.8 31.5 9.1 7.1 19.5 6.4 26.9 7.9 8.1 11.6 29.2 0.7 10.3 15.3 8.5 12.6 11.6 3.1 40.7 10.7 6.3 7.3 2.0 0.0 9.2 0.7 7.2 9.4 39.0 8.7 13.9 8.5 RPS6KB2 "KLS, P70-BETA, p70S6Kb, STK14B" ENSG00000175634 "Ribosomal protein S6 kinase B2" Q9UBS0 11 67428460-67435408 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010010, CAB019404" Approved Supported Cytosol NA NA Cytosol "CAB019404: AB_331355, HPA010010: AB_1856469" "unprognostic (1.38e-1)" "unprognostic (2.36e-3)" "unprognostic (8.50e-2)" "unprognostic (2.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.41e-1)" "unprognostic (9.01e-3)" "unprognostic (5.10e-2)" "unprognostic (1.22e-1)" "unprognostic (9.49e-3)" "unprognostic (7.66e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.03e-7)" "unprognostic (1.28e-2)" "unprognostic (1.55e-1)" "unprognostic (2.12e-1)" "unprognostic (2.66e-1)" 8.7 14.1 8.5 12.8 9.2 18.0 11.2 12.9 11.5 13.1 13.0 12.5 12.3 19.8 10.2 10.1 36.1 11.0 10.7 10.7 8.8 4.2 11.3 27.8 10.7 12.0 11.4 8.7 9.5 18.7 9.6 11.7 13.8 8.7 17.2 9.9 11.7 18.1 15.8 25.0 41.4 17.7 8.8 7.6 18.6 17.1 7.5 8.8 21.8 11.4 28.6 21.8 10.1 15.6 15.7 27.1 16.4 28.3 17.8 20.7 20.2 21.3 16.2 8.9 15.0 4.1 8.0 11.7 10.3 13.0 19.4 13.5 25.3 14.4 7.9 18.0 10.1 12.1 16.0 10.0 15.8 7.8 13.6 26.6 12.7 20.7 20.6 14.0 16.1 15.7 10.1 16.6 10.2 10.5 4.9 14.4 21.0 20.4 21.2 9.7 32.8 24.7 25.3 9.5 31.4 20.9 18.3 12.3 37.5 9.0 12.3 13.4 14.4 10.7 29.7 22.1 5.4 34.9 13.4 6.0 10.1 10.8 24.5 11.5 19.0 15.6 12.7 16.6 10.1 12.7 9.7 22.6 16.4 15.7 25.2 15.9 15.7 14.9 15.3 27.1 14.3 10.9 11.9 15.1 17.8 28.3 18.7 20.7 20.2 8.5 9.2 12.9 11.5 8.8 4.2 11.4 8.7 8.7 8.8 8.9 18.6 37.3 23.0 44.3 24.7 1.1 40.8 4.0 9.1 7.0 9.8 63.1 36.5 40.3 10.4 15.8 75.3 23.3 56.9 74.1 22.2 38.7 27.6 48.6 53.5 31.8 44.4 16.0 37.6 22.0 18.7 27.9 18.6 55.1 53.9 19.0 40.6 63.3 16.3 27.7 26.0 19.4 22.7 13.1 13.8 55.7 86.6 44.9 49.3 30.7 RPS7 S7 ENSG00000171863 "Ribosomal protein S7" P62081 2 3575205-3580919 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056586 Approved Approved "Endoplasmic reticulum,Cytosol" NA Yes 1000000 "Endoplasmic reticulum, Cytosol" "HPA056586: AB_2683179" "unprognostic (3.28e-3)" "unprognostic (1.85e-1)" "unprognostic (7.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.00e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (5.27e-4)" "unprognostic (6.41e-2)" "unprognostic (6.02e-3)" "unprognostic (7.08e-2)" "unprognostic (5.60e-2)" "unprognostic (6.27e-2)" "prognostic unfavorable (1.34e-8)" "unprognostic (3.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" 54.0 42.1 41.7 57.4 47.8 91.9 112.1 35.1 52.6 57.9 54.4 22.5 35.3 38.3 49.4 70.5 75.2 60.6 80.9 42.7 35.6 28.9 88.1 184.7 40.5 73.8 35.4 49.9 128.7 94.3 19.0 42.3 56.0 46.5 49.6 61.0 27.5 61.1 46.8 96.7 74.9 53.8 46.2 35.2 74.2 55.7 120.7 30.3 59.0 49.0 129.1 89.6 54.8 62.3 124.7 91.6 22.4 53.7 83.8 117.9 145.9 62.6 61.4 94.7 101.7 94.2 206.7 155.5 76.2 133.1 126.8 74.0 106.1 99.2 209.9 127.4 88.0 88.2 69.2 107.0 123.7 112.2 65.7 144.3 76.6 45.1 152.7 227.3 132.6 79.8 173.5 186.7 78.6 171.0 137.4 148.1 194.4 118.2 106.7 128.2 84.5 146.9 296.0 139.7 189.1 95.4 117.4 96.6 186.7 143.2 77.2 108.0 162.4 40.3 155.3 231.8 83.4 85.4 192.4 69.1 76.4 50.2 52.5 122.0 119.8 218.3 205.7 80.3 159.9 85.0 22.4 53.7 19.9 74.4 47.3 109.5 124.7 107.1 94.6 91.6 107.1 117.9 103.2 11.4 83.8 44.3 87.8 90.6 145.9 41.7 47.8 35.1 52.6 35.6 28.9 35.4 49.9 46.5 30.3 461.6 611.6 3582.6 3530.2 3485.1 365.6 144.4 1480.3 812.4 1235.2 614.1 306.3 3079.2 2208.3 1634.1 1148.8 1674.5 681.7 724.2 2971.3 4852.3 1818.6 2622.1 1119.4 1214.5 2053.4 133.5 1202.6 1662.2 2169.7 372.0 2710.8 2469.9 1898.0 2610.5 1831.6 516.1 2628.7 1420.3 1643.8 3007.3 556.0 1429.3 2159.8 1061.8 775.2 4415.0 3108.3 2545.2 2502.1 3299.7 RPS8 S8 ENSG00000142937 "Ribosomal protein S8" P62241 1 44775251-44778779 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029266 Enhanced "Endoplasmic reticulum,Cytosol" NA NA 52000 "Endoplasmic reticulum, Cytosol" "HPA029266: AB_10601611" "unprognostic (9.70e-3)" "unprognostic (2.26e-1)" "unprognostic (3.02e-1)" "unprognostic (9.75e-2)" "unprognostic (1.62e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.02e-1)" "unprognostic (6.17e-2)" "unprognostic (7.30e-2)" "unprognostic (9.31e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (9.05e-9)" "unprognostic (1.94e-1)" "unprognostic (8.55e-2)" "unprognostic (8.83e-2)" "unprognostic (5.57e-2)" 55.7 60.7 44.8 44.4 46.3 100.1 82.0 50.1 65.5 69.6 47.8 33.8 37.0 40.7 61.9 48.4 78.0 66.7 43.9 36.8 34.6 23.7 41.6 74.1 36.5 77.7 34.8 34.6 195.0 98.3 13.1 37.2 45.4 36.8 53.5 42.5 32.3 61.0 72.7 53.7 91.2 45.6 39.4 35.6 57.0 47.4 71.9 29.0 64.8 40.9 97.3 72.0 52.7 71.2 146.1 98.0 15.3 50.2 61.2 128.4 168.5 102.3 51.3 82.4 108.5 143.3 225.6 134.8 75.3 119.5 106.5 85.7 87.9 112.1 194.1 83.1 91.2 68.6 70.3 105.6 131.1 78.8 70.2 184.5 72.3 73.0 116.8 203.7 143.7 71.0 179.4 217.6 70.9 190.6 153.6 127.2 117.8 107.4 136.5 99.0 81.0 157.9 153.8 180.0 86.4 88.8 127.3 100.9 216.6 119.5 88.1 88.2 101.8 40.7 228.4 298.5 83.3 79.8 289.3 86.7 53.0 92.9 81.2 127.8 107.8 105.6 146.7 64.8 172.7 63.4 10.3 50.2 15.3 55.1 49.1 94.1 146.1 101.4 76.7 79.2 124.5 128.4 106.7 5.0 61.2 38.1 98.0 84.2 168.5 44.8 46.3 50.1 65.5 34.6 23.7 34.8 34.6 36.8 29.0 1316.1 1723.1 6218.3 8263.7 7023.7 212.5 618.5 2667.5 1619.4 2842.4 1036.4 86.4 4856.6 3516.4 2080.0 402.3 3276.6 1407.7 2826.7 5263.3 6516.1 3553.3 5089.6 1744.1 1895.9 3113.3 57.2 2060.2 2974.6 3941.2 529.4 5688.8 4066.1 2795.5 3230.1 3644.2 416.1 4072.9 3794.5 2586.4 2671.8 154.0 1481.1 4301.1 393.8 413.6 9798.1 4485.5 3459.3 5777.2 7011.6 RPSA "37LRP, LAMR1, LRP, p40, SA" ENSG00000168028 "Ribosomal protein SA" P08865 3 39406689-39412542 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB009561 Approved Supported "Plasma membrane,Cytosol" NA NA 710000 "Plasma membrane, Cytosol" "CAB009561: AB_2182543" "unprognostic (3.67e-3)" "unprognostic (2.92e-1)" "unprognostic (3.97e-2)" "unprognostic (3.72e-2)" "unprognostic (5.38e-2)" "unprognostic (5.10e-2)" "unprognostic (5.84e-3)" "unprognostic (2.54e-1)" "unprognostic (1.69e-1)" "unprognostic (2.36e-2)" "unprognostic (8.56e-2)" "unprognostic (7.50e-2)" "unprognostic (2.91e-2)" "unprognostic (3.18e-1)" "unprognostic (2.77e-1)" "unprognostic (1.73e-1)" "unprognostic (1.46e-1)" 47.5 42.9 48.8 88.4 56.9 107.0 76.7 26.3 56.2 50.9 63.6 29.1 65.6 48.4 73.5 50.1 93.4 82.4 52.2 67.3 43.2 33.7 44.1 63.8 67.5 300.2 41.7 37.7 145.1 264.7 35.7 42.2 45.0 43.5 58.9 71.5 31.4 148.1 50.2 60.4 70.5 53.0 73.9 48.1 76.8 58.4 60.2 26.8 83.5 72.8 105.2 112.4 53.8 80.4 92.4 64.0 6.9 24.8 61.5 101.2 114.8 94.0 86.2 75.0 123.6 66.0 150.6 117.9 67.2 109.0 153.3 89.8 94.2 82.0 213.0 41.3 132.2 40.9 37.6 162.1 155.2 132.2 76.8 84.8 96.4 81.9 91.4 127.9 135.4 90.9 167.2 258.7 117.8 189.1 111.8 157.7 127.2 100.1 103.3 110.7 65.8 157.2 101.3 250.8 146.3 148.3 74.3 107.5 156.3 107.1 43.5 54.3 110.8 36.6 283.1 116.5 106.9 82.6 188.5 62.1 47.1 86.9 78.3 163.4 79.9 121.4 127.0 75.6 131.9 62.2 6.9 20.6 4.8 53.8 24.8 93.5 92.4 89.8 71.4 58.1 89.5 101.2 88.4 3.0 61.5 20.4 64.0 66.1 114.8 48.8 56.9 26.3 56.2 43.2 33.7 41.7 37.7 43.5 26.8 482.4 691.4 2495.2 2051.4 1601.1 264.3 56.9 960.5 540.7 781.4 308.8 90.3 2456.3 840.6 1172.8 115.3 934.8 552.2 584.0 2956.9 3841.9 1034.7 1574.0 748.4 620.0 1468.8 163.7 993.6 761.1 1046.6 195.0 1148.6 961.8 700.1 1430.1 1771.7 254.3 1913.9 673.4 702.5 847.9 249.3 465.7 1029.7 293.8 1026.5 1675.1 2024.4 2012.8 2593.9 2441.2 RPUSD1 "C16orf40, MGC19600, RLUCL" ENSG00000007376 "RNA pseudouridylate synthase domain containing 1" Q9UJJ7 16 784974-788397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041144, HPA041938" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cell Junctions, Cytosol" "HPA041144: AB_10794265, HPA041938: AB_10795601" "unprognostic (1.51e-2)" "unprognostic (1.26e-3)" "unprognostic (2.03e-1)" "unprognostic (4.01e-1)" "unprognostic (2.99e-1)" "unprognostic (9.05e-3)" "unprognostic (1.07e-3)" "unprognostic (3.45e-2)" "unprognostic (1.08e-1)" "unprognostic (3.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (6.25e-2)" "unprognostic (8.07e-3)" "unprognostic (5.44e-2)" "unprognostic (2.95e-1)" "unprognostic (1.41e-1)" 9.5 9.7 12.0 16.5 14.8 20.9 10.4 15.3 23.8 7.4 11.2 9.4 6.2 17.6 10.5 14.0 13.9 8.6 11.2 8.1 12.7 10.4 10.7 13.4 8.2 18.2 9.5 11.3 10.0 15.3 9.9 8.9 8.2 11.2 11.3 5.1 10.9 19.8 10.5 11.1 16.8 12.8 8.3 7.0 17.4 15.1 6.2 9.2 15.5 8.5 15.1 15.6 10.8 10.7 17.3 23.1 17.7 19.9 18.0 20.4 15.8 10.6 12.6 3.1 14.0 2.7 3.2 14.4 8.9 5.1 11.7 8.5 29.3 10.1 14.9 9.7 4.2 8.2 18.3 7.1 9.0 2.1 13.5 29.0 7.3 19.3 10.5 4.4 13.5 12.4 4.8 8.7 10.1 2.7 3.4 8.0 8.8 17.1 6.7 4.0 33.8 16.8 14.1 15.8 4.9 21.8 30.0 8.3 30.6 4.2 6.6 16.3 11.7 10.2 16.8 9.8 1.9 8.6 16.9 9.0 11.7 15.2 12.2 12.8 10.8 10.8 17.1 5.6 10.6 9.5 17.5 19.9 17.7 18.3 18.0 18.1 14.9 15.5 20.4 23.1 17.3 16.2 16.3 12.7 18.0 17.4 21.2 18.7 15.8 12.0 14.8 15.3 23.8 12.7 10.4 9.5 11.3 11.2 9.2 3.0 3.5 18.7 3.5 14.2 38.1 3.3 2.5 2.7 0.0 8.7 2.0 17.7 6.6 13.7 0.4 6.8 18.6 0.0 23.3 22.4 8.9 4.4 0.0 4.0 17.2 1.6 12.7 10.4 1.6 1.4 6.4 7.9 13.5 23.4 11.0 7.8 22.5 14.0 6.0 8.1 3.3 12.9 5.6 4.2 12.0 14.6 12.2 10.2 16.7 4.7 RRAS2 TC21 ENSG00000133818 "RAS related 2" P62070 11 14277926-14364506 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 12.3" "Group enriched" "Detected in many" 5 "B-cells: 12.3;NK-cells: 3.5;T-cells: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010420, HPA050942" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB010420: AB_2253855, HPA050942: AB_2681285" "unprognostic (6.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (7.80e-4)" "prognostic unfavorable (3.31e-4)" "unprognostic (4.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (4.50e-2)" "unprognostic (4.15e-1)" "unprognostic (9.02e-2)" "unprognostic (1.05e-1)" "unprognostic (6.80e-2)" "unprognostic (1.63e-1)" 22.3 11.8 8.3 27.5 7.8 2.3 22.6 9.5 7.0 14.1 16.9 6.4 7.8 11.9 16.2 9.8 13.5 11.1 12.9 29.8 8.7 8.1 25.6 33.0 18.1 15.2 6.5 7.6 16.6 18.5 13.5 7.4 50.8 8.4 16.7 11.0 14.5 15.1 12.9 31.4 9.2 37.7 31.4 7.6 17.6 13.7 21.0 5.2 11.3 26.2 14.4 20.8 27.3 15.0 12.3 0.4 1.5 0.0 3.5 6.2 0.9 15.3 6.7 6.4 5.6 22.9 22.4 9.5 54.3 28.4 46.9 59.6 13.5 19.2 17.7 9.1 36.4 15.2 17.7 10.8 19.4 47.3 15.7 10.5 1.1 4.0 10.7 24.5 0.0 0.1 23.7 36.8 18.7 60.1 19.3 23.3 4.3 7.7 0.0 40.7 7.4 3.7 0.9 18.2 3.1 6.3 3.7 21.2 0.3 24.0 8.5 1.7 3.3 13.1 8.4 7.4 22.6 5.4 1.1 53.1 25.4 14.1 48.7 14.7 0.0 0.0 8.3 10.2 0.0 5.1 1.5 0.0 0.0 6.2 0.0 2.6 12.3 1.1 3.2 0.0 6.9 0.6 2.5 0.4 3.5 0.0 0.4 0.0 0.9 8.3 7.8 9.5 7.0 8.7 8.1 6.5 7.6 8.4 5.2 17.9 17.6 46.8 50.4 61.6 5.2 23.2 43.3 10.7 18.2 17.4 0.0 32.7 19.9 40.3 48.4 18.0 39.6 0.0 16.1 49.9 26.8 69.2 9.2 27.6 6.9 12.7 18.3 12.9 1.6 34.5 15.3 2.5 25.3 2.8 16.6 18.6 42.0 25.9 10.6 70.4 10.3 19.4 21.2 34.6 41.4 43.5 24.3 26.6 19.6 64.4 RRM1 ENSG00000167325 "Ribonucleotide reductase catalytic subunit M1" P23921 11 4094707-4138876 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Allosteric enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 78.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022093, HPA057265, HPA064297" Enhanced Supported Cytosol NA Yes 13000 Cytosol "CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236" "unprognostic (4.47e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-3)" "unprognostic (3.65e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.31e-2)" "unprognostic (3.43e-2)" "unprognostic (6.90e-2)" "unprognostic (1.06e-3)" "unprognostic (4.21e-2)" "unprognostic (6.88e-3)" "unprognostic (9.20e-3)" "unprognostic (6.16e-2)" "unprognostic (8.41e-2)" "unprognostic (9.93e-3)" 13.9 25.3 8.0 15.2 12.2 18.5 14.4 18.0 12.6 15.7 15.9 11.1 11.5 11.9 13.0 9.8 25.4 10.7 8.7 11.9 7.9 9.0 9.2 13.1 11.0 20.2 9.0 10.3 13.6 10.7 24.2 11.2 22.7 18.4 14.0 18.9 12.0 15.4 10.7 28.3 26.8 12.5 17.5 10.7 12.4 13.8 10.5 9.1 78.6 9.8 28.0 27.1 17.5 18.5 5.6 4.3 3.3 8.3 5.7 24.3 6.0 46.1 25.1 41.1 23.9 6.3 12.6 16.0 42.5 21.1 48.4 50.0 22.5 35.1 50.0 10.3 21.2 21.0 37.1 38.1 30.6 57.3 24.5 40.4 25.4 37.6 17.5 2.5 43.4 18.6 5.9 8.3 26.5 19.1 10.6 23.2 30.2 33.1 23.6 40.3 20.9 51.1 9.4 26.0 32.1 25.5 41.4 32.1 17.8 13.3 13.1 35.2 19.3 37.4 22.6 6.8 17.3 22.3 15.2 13.2 45.5 23.8 45.1 31.2 15.5 21.4 54.6 25.3 29.1 28.2 3.3 2.5 2.6 7.7 6.5 13.3 5.6 14.2 10.7 4.3 3.5 11.3 9.2 0.0 5.7 8.3 2.7 24.3 6.0 8.0 12.2 18.0 12.6 7.9 9.0 9.0 10.3 18.4 9.1 17.9 11.8 16.4 16.8 29.8 14.7 30.7 17.8 17.4 21.6 17.4 5.9 33.4 6.6 22.3 59.0 10.8 9.7 70.0 19.4 48.6 21.4 12.0 6.9 14.8 24.3 17.5 17.3 11.6 8.6 43.8 12.0 10.6 10.1 9.0 17.5 21.8 14.0 11.8 15.6 6.3 20.0 12.9 21.5 60.8 31.3 25.3 33.2 15.8 24.7 13.6 RRM2 ENSG00000171848 "Ribonucleotide reductase regulatory subunit M2" P31350 2 10120698-10131419 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 120.9" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 93.5;Extravillous trophoblasts: 192.1;Spermatogonia: 44.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in many" 6 "T-cells: 10.4" "Low cell line specificity" "Detected in many" HPA056994 Enhanced Supported Cytosol Yes Yes Cytosol "HPA056994: AB_2683304" "unprognostic (2.10e-2)" "unprognostic (1.62e-1)" "unprognostic (6.40e-3)" "unprognostic (4.42e-3)" "unprognostic (5.70e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.04e-3)" "unprognostic (6.67e-3)" "unprognostic (4.53e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.11e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-1)" "unprognostic (2.09e-2)" 4.7 2.2 0.4 32.6 0.4 29.0 4.2 0.4 0.9 3.5 9.3 0.4 0.4 5.2 2.1 1.7 21.6 0.7 5.0 3.3 0.4 0.5 2.0 3.9 5.7 16.4 0.6 0.1 0.9 2.9 0.0 0.7 5.4 0.3 1.0 10.6 0.1 2.9 0.0 0.5 2.8 11.3 3.2 0.8 19.8 5.4 8.0 0.0 120.9 0.8 22.3 33.1 3.8 5.2 1.4 0.3 0.6 0.2 1.8 10.4 2.6 29.5 17.9 25.4 17.4 2.2 4.1 25.1 48.3 24.0 34.5 37.6 29.9 14.1 27.1 6.7 15.1 35.0 14.5 41.0 24.9 42.3 60.8 15.8 52.3 17.2 26.3 0.1 38.7 25.1 1.5 0.5 42.2 3.6 5.7 27.9 21.0 21.9 80.5 42.9 22.3 42.7 20.8 20.5 30.4 21.0 32.2 55.4 18.6 17.0 22.5 25.1 20.7 39.7 28.2 4.9 11.0 15.2 6.9 9.7 26.5 38.5 19.8 67.7 52.3 41.0 55.4 18.8 32.9 38.0 0.3 0.1 0.1 3.7 0.0 0.0 1.4 2.6 2.9 0.2 0.4 0.2 1.2 0.6 1.8 0.2 0.3 10.4 2.6 0.4 0.4 0.4 0.9 0.4 0.5 0.6 0.1 0.3 0.0 3.0 1.0 2.2 1.0 9.3 0.0 1.2 2.5 5.3 1.2 0.0 0.0 5.4 1.7 0.5 3.0 0.3 2.6 93.5 0.0 192.1 3.6 1.1 5.7 1.7 40.1 0.0 0.0 5.5 5.9 5.7 0.3 3.5 0.0 0.0 7.9 0.0 0.5 0.0 0.4 1.6 0.0 0.0 0.3 5.2 44.5 1.4 40.7 7.2 13.0 2.0 RRM2B p53R2 ENSG00000048392 "Ribonucleotide reductase regulatory TP53 inducible subunit M2B" Q7LG56 8 102204502-102239118 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, DNA replication" Oxidoreductase "Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006854, HPA028812" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB006854: , HPA028812: AB_10602246" "unprognostic (7.76e-3)" "unprognostic (4.14e-2)" "unprognostic (9.41e-3)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.28e-1)" "unprognostic (5.51e-2)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (9.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-2)" "unprognostic (4.32e-1)" "unprognostic (1.47e-1)" "unprognostic (2.52e-1)" "unprognostic (7.17e-2)" 11.8 18.6 11.7 11.5 11.4 4.3 9.3 8.5 13.5 9.5 10.1 9.8 9.5 10.2 8.2 10.8 8.0 9.7 8.2 11.3 17.5 12.8 17.5 15.1 15.8 12.6 14.9 10.6 9.7 9.5 34.7 24.8 11.6 23.1 11.2 11.1 7.7 9.7 10.9 34.6 7.4 7.6 8.2 26.1 10.6 7.1 6.6 9.4 6.3 37.1 8.1 13.1 10.7 7.0 7.4 6.2 18.3 8.4 3.0 3.3 2.8 5.6 10.0 11.9 7.0 16.8 16.2 9.4 13.0 15.8 7.0 8.2 3.5 4.5 35.8 12.3 14.3 7.1 2.1 5.7 13.2 9.9 5.8 6.2 9.0 4.2 7.5 13.6 2.7 19.2 20.5 24.9 7.7 11.8 16.7 19.6 6.2 6.6 5.5 22.4 5.5 4.7 5.2 6.6 6.1 7.4 3.0 4.8 7.2 16.3 6.4 3.0 5.9 6.8 3.6 7.7 31.0 9.7 6.2 14.9 10.9 21.1 7.5 3.5 5.8 5.3 32.6 16.0 4.2 11.5 10.0 5.1 5.3 2.2 4.5 3.3 5.6 2.0 2.8 6.2 7.4 2.3 2.5 18.3 3.0 8.4 1.8 1.4 2.8 11.7 11.4 8.5 13.5 17.5 12.8 14.9 10.6 23.1 9.4 53.6 24.0 7.2 8.1 17.2 13.1 17.9 20.4 38.8 25.0 38.4 13.7 11.2 21.6 6.2 1.6 16.4 6.4 0.0 7.0 4.9 10.4 10.8 10.5 20.3 11.1 9.5 28.3 18.4 21.8 1.1 13.3 17.8 16.9 7.2 10.3 23.6 5.5 7.0 13.8 18.1 14.7 6.5 10.8 8.2 10.0 16.2 4.0 12.8 11.7 5.4 RRNAD1 "C1orf66, CGI-41, METTL25B" ENSG00000143303 "Ribosomal RNA adenine dimethylase domain containing 1" Q96FB5 1 156728442-156736960 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047426 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047426: AB_2680041" "unprognostic (2.12e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (2.00e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-1)" "unprognostic (2.89e-3)" "unprognostic (2.24e-1)" "unprognostic (2.76e-1)" "unprognostic (2.14e-1)" "unprognostic (3.35e-2)" "unprognostic (1.49e-1)" "unprognostic (5.03e-3)" 14.1 19.4 12.4 22.6 19.0 8.7 19.1 15.3 18.8 17.6 25.7 20.8 31.2 22.5 20.3 22.9 18.4 24.4 20.2 12.5 13.3 10.9 15.9 25.8 14.5 14.4 19.9 14.5 24.5 29.2 24.3 18.8 20.5 16.1 21.8 14.8 20.2 22.5 24.5 21.9 23.9 26.6 12.9 14.7 18.5 19.3 25.9 17.7 11.9 30.3 13.5 15.9 21.7 27.9 4.9 5.9 7.0 4.0 6.5 8.6 2.9 5.9 11.8 8.8 8.6 23.7 10.9 13.4 4.5 13.9 7.8 5.9 6.4 27.6 10.2 13.6 7.1 11.0 25.6 12.2 10.6 3.2 20.2 10.3 6.1 11.2 4.7 14.9 9.1 16.8 16.8 20.4 7.8 14.9 9.3 6.5 9.2 14.6 23.1 4.1 14.4 4.6 10.7 10.1 26.0 3.7 7.6 5.8 23.6 9.3 6.5 11.4 16.5 8.0 16.5 9.8 14.0 21.8 19.6 6.3 4.9 6.0 7.5 6.0 26.9 26.3 12.6 5.4 10.3 5.8 6.7 3.3 4.7 6.8 2.5 6.9 3.4 6.6 4.8 5.9 4.9 5.3 6.0 7.0 6.5 4.0 2.2 8.6 2.9 12.4 19.0 15.3 18.8 13.3 10.9 19.9 14.5 16.1 17.7 6.0 10.8 9.7 21.1 9.0 9.9 6.1 20.4 6.7 10.3 3.5 11.8 21.2 8.3 10.3 44.1 11.3 18.0 0.0 11.6 14.3 9.4 17.5 4.7 18.5 9.6 7.9 9.2 9.2 10.2 10.3 10.3 6.6 8.5 9.0 16.6 20.3 9.4 17.5 8.9 11.6 11.6 12.9 6.2 15.8 22.8 10.0 27.1 8.3 16.5 15.9 RRP12 KIAA0690 ENSG00000052749 "Ribosomal RNA processing 12 homolog" Q5JTH9 10 97356358-97426076 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049945, HPA074403" Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" No No Nucleoli "Vesicles, Plasma membrane, Cytosol" "HPA049945: AB_2680965, HPA074403: " "unprognostic (2.79e-1)" "unprognostic (7.65e-2)" "unprognostic (5.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.42e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.12e-8)" "unprognostic (2.64e-1)" "unprognostic (1.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (2.54e-5)" "unprognostic (2.58e-2)" "unprognostic (3.32e-1)" "unprognostic (4.81e-2)" "unprognostic (6.99e-3)" 7.1 8.4 5.9 7.4 11.9 62.6 4.6 3.8 15.7 4.1 4.0 5.4 2.9 5.2 6.4 3.9 7.1 6.4 6.4 8.4 4.4 7.2 4.4 9.3 5.6 6.0 5.9 6.1 6.0 16.4 9.6 10.6 3.9 9.6 5.5 3.6 4.1 6.6 3.9 31.7 8.2 3.8 5.3 3.2 7.1 5.3 13.9 6.1 4.6 4.9 7.2 5.4 4.2 4.3 3.4 4.3 19.3 11.1 1.2 2.4 3.7 15.9 21.4 5.7 12.3 4.4 5.2 12.5 10.1 6.1 10.5 8.2 23.2 14.8 17.6 13.2 6.4 9.4 20.6 15.6 11.7 7.1 9.6 18.7 13.6 8.0 18.0 7.3 21.1 17.9 5.4 16.6 25.8 23.9 11.9 5.9 9.9 19.4 11.8 5.9 20.8 14.3 13.6 24.5 8.5 14.5 15.7 7.8 17.4 7.3 8.9 7.7 16.4 8.1 7.8 10.1 4.6 18.8 11.0 7.7 7.1 12.2 15.8 31.9 24.2 21.0 20.7 10.1 27.2 7.5 0.2 7.3 4.6 2.0 9.3 2.4 2.9 1.2 1.6 4.3 3.4 1.9 2.1 19.3 1.2 11.1 3.6 0.8 3.7 5.9 11.9 3.8 15.7 4.4 7.2 5.9 6.1 9.6 6.1 32.8 39.8 13.7 10.9 20.8 6.2 9.5 7.6 25.4 34.2 14.0 39.3 4.4 0.0 9.1 5.6 6.7 3.9 0.0 7.4 5.9 7.6 10.1 39.4 6.8 10.4 4.8 20.6 4.9 10.8 3.6 3.4 8.4 6.8 1.0 7.2 2.2 7.8 5.1 2.5 6.8 12.3 0.0 6.1 9.9 18.4 17.1 7.7 4.4 7.8 12.4 RRP8 "KIAA0409, NML" ENSG00000132275 "Ribosomal RNA processing 8" O43159 11 6595075-6603620 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038487, HPA057562" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA038487: AB_10672518, HPA057562: AB_2683468" "unprognostic (9.01e-2)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.10e-7)" "unprognostic (4.64e-2)" "unprognostic (2.48e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.23e-2)" "unprognostic (3.81e-3)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.87e-2)" 13.8 11.9 13.9 15.8 14.8 32.1 17.9 18.1 15.3 15.9 24.9 16.1 10.5 14.0 15.5 21.3 13.8 11.9 15.4 16.2 16.0 10.3 13.3 24.7 14.3 16.0 18.4 13.6 12.4 12.7 12.0 12.3 12.8 14.2 19.8 14.4 11.8 10.9 19.7 18.6 15.5 12.8 19.5 11.0 17.7 15.1 12.3 18.6 11.8 14.2 9.7 16.6 20.2 13.9 13.3 14.4 20.3 12.0 14.4 13.8 10.2 10.1 10.2 4.1 5.2 8.5 7.4 5.8 5.2 6.6 12.2 11.5 10.4 12.0 14.3 5.2 5.0 9.0 10.3 11.6 9.3 13.0 6.8 16.6 6.7 12.2 11.8 9.8 12.2 9.4 6.3 12.1 5.8 10.6 8.1 12.5 6.7 13.3 8.4 9.6 12.6 11.8 18.2 10.0 17.9 9.2 10.6 3.3 3.2 11.4 8.2 6.3 7.4 7.5 15.4 8.6 7.0 8.4 10.7 6.4 11.6 5.3 11.2 10.1 9.4 8.4 13.6 9.8 12.3 7.4 20.3 11.0 10.7 13.7 11.8 13.2 10.9 13.5 12.6 14.4 13.3 13.3 13.8 4.4 14.4 12.0 11.0 12.6 10.2 13.9 14.8 18.1 15.3 16.0 10.3 18.4 13.6 14.2 18.6 20.8 12.9 13.7 14.7 20.6 17.1 18.3 7.6 10.7 15.9 8.7 13.7 19.6 10.0 15.6 5.3 16.6 10.9 23.3 13.9 17.0 14.6 9.7 17.3 19.1 16.3 3.2 6.9 9.8 8.4 10.4 12.0 12.0 8.5 19.8 12.8 13.3 18.6 13.3 9.2 16.5 27.4 0.0 20.9 21.2 17.2 23.7 16.7 14.9 15.9 12.2 RSPH3 "dJ111C20.1, RSHL2, RSP3" ENSG00000130363 "Radial spoke head 3 homolog" Q86UC2 6 158972871-159000187 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 113.8;Early spermatids: 110.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039109, HPA040230" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "HPA039109: AB_10794423, HPA040230: AB_10796119" "unprognostic (6.18e-3)" "unprognostic (3.62e-3)" "unprognostic (4.54e-2)" "unprognostic (6.20e-2)" "unprognostic (1.88e-1)" "unprognostic (9.18e-2)" "unprognostic (1.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.15e-1)" "unprognostic (6.74e-3)" "unprognostic (6.98e-2)" "unprognostic (2.52e-1)" "prognostic favorable (2.19e-4)" "unprognostic (5.89e-2)" "unprognostic (1.67e-1)" "unprognostic (5.14e-2)" "unprognostic (1.79e-2)" 4.9 9.0 7.1 3.8 9.8 3.1 6.2 6.3 12.7 6.8 8.2 7.0 14.3 11.3 7.4 12.8 15.5 10.7 6.0 6.6 8.0 6.8 10.7 5.4 8.5 2.6 4.8 10.6 7.3 8.6 25.9 14.4 5.5 10.4 8.9 6.5 5.5 10.3 14.9 3.8 7.6 12.2 6.6 6.0 3.9 7.5 24.3 7.0 2.1 12.8 5.1 3.9 9.1 8.4 2.3 5.8 13.0 7.7 1.8 1.8 1.6 9.8 5.1 2.3 5.4 5.4 6.9 2.9 7.0 8.2 2.8 3.7 2.0 6.0 2.1 6.5 7.5 7.6 7.5 1.5 6.6 3.1 4.8 4.4 2.7 5.0 3.4 5.2 2.5 1.9 8.5 11.8 4.5 8.9 10.7 2.7 2.7 3.1 3.4 4.6 5.6 1.5 3.1 1.5 4.3 3.4 2.4 0.4 2.1 8.8 3.2 3.5 4.4 13.2 4.4 2.5 2.9 5.4 6.2 6.4 2.9 7.4 5.6 3.8 3.6 6.9 1.8 12.4 3.3 4.6 0.7 5.2 0.6 0.8 3.6 1.8 1.3 1.2 1.6 5.4 2.3 1.0 1.4 13.0 1.8 7.7 5.8 1.4 1.6 7.1 9.8 6.3 12.7 8.0 6.8 4.8 10.6 10.4 7.0 23.8 13.2 0.5 14.8 6.5 12.2 15.9 15.3 113.8 25.0 21.0 33.4 9.0 11.6 12.7 110.2 5.8 27.3 0.0 9.0 8.8 8.9 17.9 2.3 7.5 9.2 3.2 12.6 6.7 10.3 47.9 13.0 11.6 6.8 1.0 18.0 13.4 10.9 14.4 16.6 16.5 29.6 6.5 6.1 45.3 8.7 7.8 4.9 8.7 10.0 19.7 RSRC2 FLJ11021 ENSG00000111011 "Arginine and serine rich coiled-coil 2" Q7L4I2 12 122503458-122527000 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040070, HPA048183" Uncertain Approved "Nucleoli fibrillar center,Nuclear speckles,Cytosol" No No "Nuclear speckles" "Nucleoli fibrillar center, Cytosol" "HPA040070: AB_10673430, HPA048183: AB_2680302" "unprognostic (4.76e-2)" "unprognostic (1.41e-1)" "unprognostic (1.32e-2)" "unprognostic (1.44e-1)" "unprognostic (6.42e-3)" "unprognostic (6.90e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" "unprognostic (2.74e-2)" "unprognostic (3.26e-1)" "unprognostic (3.19e-2)" "unprognostic (1.06e-2)" "unprognostic (2.23e-2)" "unprognostic (8.87e-2)" "unprognostic (4.84e-2)" "unprognostic (1.53e-2)" 18.5 19.4 24.8 20.2 31.9 82.6 20.1 34.9 45.9 19.3 21.0 16.0 19.9 14.3 21.4 21.4 26.9 19.6 21.0 20.2 28.9 21.4 20.6 18.2 19.1 23.0 24.9 24.1 25.2 19.0 11.3 43.2 20.6 28.1 20.0 18.6 10.7 19.1 21.3 36.8 18.7 19.2 20.4 45.1 18.6 16.0 20.7 29.4 21.1 23.5 17.7 15.7 25.0 28.0 24.6 16.3 22.3 18.4 16.4 19.3 9.8 11.8 14.4 13.6 5.7 10.8 7.0 9.8 22.1 7.1 9.5 5.4 20.1 5.0 13.5 18.8 7.6 5.6 7.7 14.9 6.2 9.3 12.8 13.8 23.7 17.4 21.5 6.0 20.3 14.4 8.8 7.3 8.1 13.8 11.9 6.7 5.9 15.0 8.5 8.3 9.5 14.7 15.2 11.2 10.0 11.8 11.2 12.3 8.8 12.3 22.4 11.0 9.9 17.2 5.8 12.1 14.0 9.3 7.5 10.0 9.7 11.8 10.7 12.1 9.7 22.6 21.9 6.1 11.8 5.4 19.8 16.6 22.3 16.4 13.5 13.9 22.8 15.0 13.3 16.3 24.6 19.3 15.2 17.7 16.4 18.4 15.4 19.0 9.8 24.8 31.9 34.9 45.9 28.9 21.4 24.9 24.1 28.1 29.4 80.4 89.6 138.1 368.8 179.7 109.7 83.7 94.3 141.8 109.2 89.0 74.6 125.3 165.8 92.9 188.3 119.6 104.7 46.7 84.2 129.5 131.9 177.4 209.2 101.1 82.4 141.4 149.8 73.6 78.5 80.0 111.0 114.7 119.8 97.4 81.2 130.5 83.8 101.7 99.3 86.6 122.3 122.9 136.3 196.1 162.4 163.4 234.2 162.4 74.8 247.2 RTCB "C22orf28, FAAP, HSPC117" ENSG00000100220 "RNA 2',3'-cyclic phosphate and 5'-OH ligase" Q9Y3I0 22 32387582-32412255 "Enzymes, Predicted intracellular proteins" "tRNA processing" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000535, HPA001103" Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA 43000 Nucleoplasm "Vesicles, Cytosol" "HPA000535: AB_2666021, HPA001103: AB_1078351" "unprognostic (1.84e-1)" "unprognostic (6.48e-2)" "unprognostic (1.07e-2)" "unprognostic (2.71e-3)" "unprognostic (7.21e-3)" "unprognostic (1.43e-2)" "unprognostic (1.75e-3)" "unprognostic (1.49e-1)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (5.07e-2)" "prognostic favorable (4.25e-5)" "unprognostic (6.91e-2)" "unprognostic (5.35e-2)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" 26.4 30.1 20.1 20.4 29.7 15.1 29.2 22.9 34.5 25.7 35.6 35.2 32.7 51.6 29.7 25.8 30.8 26.9 22.9 26.4 19.6 24.6 42.4 55.1 23.1 22.7 29.1 26.2 29.0 29.4 38.4 29.9 33.7 36.7 27.0 42.3 27.1 29.9 28.6 40.9 46.6 61.7 31.8 24.4 29.3 29.7 30.8 25.5 32.0 32.7 30.1 46.6 26.5 24.2 44.6 51.5 29.0 47.7 37.0 40.5 44.0 32.2 29.0 36.4 27.3 31.9 23.8 29.0 28.3 34.1 45.3 43.1 37.6 13.2 8.0 19.0 33.0 27.9 22.0 41.6 41.1 58.7 40.4 41.8 22.8 24.6 34.1 22.0 53.3 20.9 23.4 27.3 44.8 43.6 25.0 40.7 22.6 27.0 22.8 33.0 26.9 22.6 18.5 20.8 37.5 26.6 35.2 39.3 41.2 31.1 28.1 37.6 20.8 30.7 19.9 35.9 40.0 21.8 20.7 30.6 25.0 36.9 21.7 27.1 15.9 12.7 28.9 25.9 24.2 32.6 29.0 43.5 27.4 31.7 47.7 35.5 44.6 33.3 33.0 51.5 43.6 39.9 34.6 4.3 37.0 35.5 28.9 40.5 44.0 20.1 29.7 22.9 34.5 19.6 24.6 29.1 26.2 36.7 25.5 29.8 30.2 40.2 48.9 53.8 50.9 32.3 48.4 37.5 22.7 33.2 19.6 98.9 56.3 89.0 3.8 37.9 93.2 0.0 84.1 74.7 40.4 51.2 42.6 54.7 75.2 49.3 44.9 35.0 41.7 7.0 32.5 40.0 28.7 107.4 50.3 61.1 82.4 59.7 44.9 108.7 48.0 25.8 37.2 57.2 58.8 66.5 81.8 30.9 51.3 61.4 RTF1 KIAA0252 ENSG00000137815 "RTF1 homolog, Paf1/RNA polymerase II complex component" Q92541 15 41408408-41483563 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006714 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA006714: AB_1079855" "unprognostic (1.10e-1)" "unprognostic (5.03e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.88e-1)" "unprognostic (8.87e-2)" "unprognostic (5.36e-2)" "unprognostic (4.21e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.19e-1)" "unprognostic (1.69e-2)" "unprognostic (8.22e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (9.50e-2)" 20.4 27.8 27.6 21.6 33.8 34.3 20.4 40.5 34.5 23.7 22.5 14.3 17.6 16.9 25.7 18.4 22.4 18.5 18.4 24.8 26.5 21.4 17.6 19.6 17.2 23.0 17.0 35.1 27.7 15.2 37.0 20.3 36.9 27.2 22.0 20.6 15.4 19.5 23.2 55.2 24.8 20.7 24.7 14.9 23.5 19.0 25.4 13.5 25.3 26.7 15.6 21.6 27.8 20.2 8.0 7.4 11.6 4.3 8.6 5.7 1.4 15.3 10.1 33.4 27.1 19.0 22.6 15.8 20.6 23.2 28.3 23.7 19.7 9.8 14.6 16.7 21.5 12.6 27.4 19.3 17.1 24.3 22.2 18.0 30.7 22.9 14.7 13.3 27.3 18.0 16.2 17.4 15.1 15.3 21.1 22.7 26.8 23.3 17.0 23.1 11.7 26.1 16.9 18.0 19.2 13.9 28.4 26.1 13.9 18.4 33.1 17.2 22.8 18.5 23.7 9.3 19.0 19.4 26.5 18.6 27.8 17.7 27.6 22.5 19.7 30.3 24.3 20.0 26.1 16.9 5.9 4.3 8.4 4.8 2.8 4.4 8.0 4.7 4.1 3.0 6.5 5.7 4.7 11.6 8.6 3.3 7.4 5.4 1.4 27.6 33.8 40.5 34.5 26.5 21.4 17.0 35.1 27.2 13.5 119.1 70.9 118.3 89.5 128.8 209.3 81.2 112.1 69.6 75.1 116.9 88.4 138.6 139.3 89.0 242.0 101.3 97.3 116.8 95.9 97.3 120.4 91.4 89.0 170.3 83.7 139.8 84.2 119.7 72.1 267.8 134.3 89.8 102.9 103.6 107.1 106.0 103.7 94.8 150.3 100.0 188.1 84.1 92.0 109.4 66.6 142.4 183.4 97.8 106.5 90.9 RTL1 "HUR1, Mar1, MART1, PEG11, SIRH2" ENSG00000254656 "Retrotransposon Gag like 1" A6NKG5 14 100880655-100884847 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 5.0;brain: 7.6;placenta: 8.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "SH-SY5Y: 121.1" "Region enhanced" "Detected in single" "hypothalamus: 2.1" "HPA066979, HPA077601" Enhanced Approved Cytosol No NA Cytosol "HPA066979: AB_2685759, HPA077601: " "unprognostic (1.61e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-1)" "unprognostic (1.42e-3)" "unprognostic (2.10e-1)" 0.0 5.0 0.2 0.0 0.9 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 1.8 1.3 0.1 0.0 0.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL4 "FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16" ENSG00000187823 "Retrotransposon Gag like 4" Q6ZR62 X 112454500-112457112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "kidney: 3.5;liver: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "testis cancer: 1.4;thyroid cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003272 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003272: AB_2257414" "unprognostic (9.86e-2)" "unprognostic (2.04e-4)" "unprognostic (6.35e-2)" "unprognostic (5.33e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.5 4.7 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL6 "dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3" ENSG00000188636 "Retrotransposon Gag like 6" Q6ICC9 22 44492572-44498298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 13.4;Collecting duct cells: 12.2;Ductal cells: 6.3;Exocrine glandular cells: 5.6;Pancreatic endocrine cells: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005697 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA005697: AB_1079244" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (1.57e-1)" "unprognostic (9.64e-3)" "unprognostic (5.40e-2)" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.57e-2)" "unprognostic (1.65e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" 11.6 14.1 19.3 7.7 17.4 3.2 10.2 16.2 30.0 13.6 12.2 14.7 15.2 9.7 17.8 14.2 9.4 19.1 12.4 16.7 17.1 16.1 10.9 4.9 10.4 6.3 16.9 11.4 22.6 12.1 18.9 9.9 5.9 11.9 11.5 10.4 9.2 7.7 16.3 15.5 3.7 9.2 19.0 16.5 7.9 10.7 12.6 9.5 14.4 11.6 7.2 5.3 11.8 10.2 0.2 1.1 0.1 1.4 0.9 4.5 2.1 7.0 9.8 12.7 16.9 10.0 8.1 3.3 9.3 11.1 13.1 10.4 3.2 4.2 0.0 5.9 17.4 9.9 6.1 8.5 9.2 8.2 3.3 16.7 0.0 18.9 0.0 12.4 0.9 4.7 8.8 9.0 12.0 9.3 18.0 11.7 11.3 3.9 0.0 8.9 12.4 22.3 2.0 7.8 7.8 10.5 6.1 6.7 0.0 11.3 8.2 13.7 16.0 15.2 7.4 9.4 6.4 7.4 9.9 12.0 10.3 14.0 13.6 7.4 4.4 1.7 0.0 15.4 2.3 15.4 0.0 1.4 0.1 4.3 0.6 4.5 0.0 2.5 3.6 1.1 0.2 1.0 2.5 0.0 0.9 0.8 0.1 0.4 2.1 19.3 17.4 16.2 27.8 17.1 16.1 16.9 11.4 11.9 9.5 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 13.4 4.5 12.2 0.0 2.2 0.0 6.3 0.0 0.0 0.0 0.0 5.6 2.6 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.8 0.0 0.0 6.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 RTTN DKFZP434G145 ENSG00000176225 Rotatin Q86VV8 18 70003031-70205945 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 15.9;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041343, HPA041967, HPA075089" Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA041343: AB_10794409, HPA041967: AB_10796790, HPA075089: " "unprognostic (1.76e-1)" "unprognostic (2.13e-1)" "unprognostic (1.36e-1)" "unprognostic (4.11e-2)" "unprognostic (3.44e-2)" "unprognostic (6.16e-3)" "unprognostic (4.63e-3)" "unprognostic (2.36e-1)" "unprognostic (1.40e-1)" "unprognostic (4.66e-2)" "unprognostic (1.90e-1)" "unprognostic (8.25e-2)" "unprognostic (6.94e-3)" "unprognostic (1.07e-1)" "unprognostic (3.81e-1)" "unprognostic (1.32e-1)" "unprognostic (1.96e-2)" 5.5 6.2 6.2 8.1 13.0 12.9 8.0 12.3 8.0 8.0 5.2 26.5 4.0 5.6 12.1 6.1 4.7 6.0 5.9 8.3 7.2 6.4 8.9 9.0 6.3 8.5 14.2 5.9 11.0 8.4 13.0 7.0 6.8 12.8 5.5 6.2 13.9 5.2 6.4 5.9 6.0 6.1 7.5 12.4 7.9 5.4 14.3 12.5 20.4 5.2 5.5 13.0 5.0 6.8 2.5 1.3 0.6 0.9 1.5 3.1 0.5 3.5 5.4 8.4 2.0 1.2 1.4 3.1 6.4 2.9 5.8 5.7 2.4 2.1 2.9 0.9 3.7 5.6 3.9 5.4 9.3 9.3 11.1 2.8 3.3 5.4 2.2 0.8 5.0 3.4 1.2 10.2 6.4 19.9 2.4 3.3 4.9 3.2 6.8 5.1 1.2 5.6 1.8 1.4 0.7 4.2 4.7 7.3 2.8 0.8 2.4 3.0 3.8 3.5 1.6 2.2 5.1 2.3 3.6 3.3 7.5 2.0 2.4 4.7 3.1 2.9 6.5 4.5 3.4 4.8 0.6 0.9 0.6 1.1 0.2 1.9 2.5 2.1 1.3 0.4 1.7 3.1 1.9 0.4 1.5 0.3 1.3 1.3 0.5 6.2 13.0 12.3 8.0 7.2 6.4 14.2 5.9 12.8 12.5 0.0 11.3 1.9 1.4 1.3 7.0 4.5 0.0 0.0 6.8 0.0 0.0 3.2 0.0 1.0 4.8 2.3 2.0 0.0 1.4 1.6 2.3 1.0 4.7 3.4 2.0 15.9 0.0 1.8 1.0 2.6 2.0 2.6 0.0 0.0 1.6 2.9 1.5 3.1 1.8 2.7 9.6 12.9 2.3 9.2 6.5 1.5 2.5 2.2 1.7 1.8 RUBCN "KIAA0226, rubicon, rundataxin" ENSG00000145016 "RUN and cysteine rich domain containing beclin 1 interacting protein" Q92622 3 197671393-197749727 "Disease related genes, Predicted intracellular proteins" "Autophagy, Endocytosis, Immunity, Phagocytosis" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 105.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050908, HPA054497" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA050908: , HPA054497: AB_2682507" "unprognostic (2.91e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.34e-3)" "unprognostic (1.46e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (9.91e-5)" "unprognostic (1.99e-1)" "unprognostic (6.71e-2)" "unprognostic (2.86e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (2.22e-2)" "unprognostic (2.92e-2)" "unprognostic (1.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.23e-1)" 10.7 8.4 19.3 15.5 24.0 10.7 6.8 30.0 24.6 7.9 9.8 12.4 6.4 10.7 9.1 6.5 14.5 7.7 10.4 10.3 18.1 18.8 7.8 5.7 12.4 19.8 14.6 19.4 14.0 11.0 13.3 16.6 8.5 18.3 7.4 8.8 8.3 7.1 11.2 9.7 11.7 12.0 11.4 15.1 22.3 11.3 22.0 15.8 7.9 7.4 7.0 22.3 9.6 8.0 7.8 14.7 12.8 4.1 1.5 4.4 1.2 15.1 3.5 4.3 8.6 7.5 4.3 4.4 7.0 4.6 8.4 7.2 6.3 4.2 17.4 13.8 7.6 8.3 8.3 7.9 3.8 6.9 4.4 7.0 10.6 6.1 2.3 4.3 6.0 8.9 3.5 5.0 7.4 8.8 3.9 5.1 7.4 5.8 43.4 5.6 12.2 7.2 3.8 3.6 4.5 11.7 7.2 4.3 10.8 4.9 6.6 17.3 4.1 5.1 10.0 5.6 2.9 14.8 3.9 6.9 5.1 4.9 13.9 9.3 20.6 16.5 13.2 6.7 11.1 4.4 0.6 2.4 12.8 3.6 3.5 2.3 6.6 3.0 4.4 1.4 7.8 2.2 3.0 2.7 1.5 4.1 14.7 3.6 1.2 19.3 24.0 30.0 24.6 18.1 18.8 14.6 19.4 18.3 15.8 6.0 12.8 22.8 4.6 0.0 17.7 0.0 2.5 1.4 7.9 12.2 17.7 1.5 1.7 5.8 13.1 4.7 3.8 23.3 5.5 3.0 2.7 6.2 2.3 3.9 7.7 20.6 0.0 11.1 12.6 11.4 4.6 8.5 0.0 105.6 3.6 15.3 6.3 0.0 6.0 2.2 13.7 6.5 0.0 21.4 15.6 0.0 5.4 6.9 3.1 10.0 RUBCNL "C13orf18, FLJ21562, KIAA0226L" ENSG00000102445 "RUN and cysteine rich domain containing beclin 1 interacting protein like" Q9H714 13 46342000-46438190 "Predicted intracellular proteins" "Autophagy, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.1;lymphoid tissue: 24.0" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 9.6;Club cells: 4.5;Hofbauer cells: 13.4" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 17.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "memory B-cell: 29.9;naive B-cell: 31.1;neutrophil: 31.1;plasmacytoid DC: 22.5" "Group enriched" "Detected in many" 17 "B-cells: 31.1;dendritic cells: 22.5;granulocytes: 31.1" "Group enriched" "Detected in some" 5 "Daudi: 40.0;U-698: 66.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026614 Approved Approved Cytosol NA NA Cytosol "HPA026614: AB_10602693" "unprognostic (3.35e-2)" "unprognostic (2.61e-1)" "unprognostic (1.94e-3)" "prognostic favorable (3.76e-5)" "unprognostic (1.09e-2)" "unprognostic (8.30e-4)" "unprognostic (7.83e-2)" "unprognostic (2.62e-3)" "unprognostic (1.07e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "unprognostic (5.95e-5)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (7.47e-2)" "unprognostic (7.00e-3)" 3.7 1.6 4.5 21.2 4.3 15.0 5.7 2.9 3.6 5.5 8.1 2.9 1.3 1.5 3.0 3.2 1.0 2.0 3.8 1.5 3.4 3.7 1.5 1.7 5.5 20.2 4.5 2.7 0.9 1.2 0.1 2.7 3.3 5.2 2.2 11.2 3.0 6.5 1.8 0.8 2.7 14.9 2.8 8.8 24.0 1.6 15.9 3.7 10.1 2.2 0.2 21.7 2.9 2.0 31.1 22.5 31.1 1.6 0.3 0.0 1.2 0.1 0.0 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 1.5 0.0 40.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.4 11.5 0.1 1.6 0.0 0.0 0.8 0.0 0.1 0.0 0.6 2.3 0.0 9.2 0.0 0.0 0.3 0.0 0.1 0.2 9.2 66.1 0.4 0.1 0.0 0.0 1.0 0.0 0.0 1.6 0.0 29.9 0.0 0.0 1.0 31.1 0.0 0.0 31.1 0.3 0.9 22.5 0.0 1.2 4.5 4.3 2.9 3.6 3.4 3.7 4.5 2.7 5.2 3.7 3.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 2.3 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RUFY1 "FLJ22251, RABIP4, ZFYVE12" ENSG00000176783 "RUN and FYVE domain containing 1" Q96T51 5 179550558-179610026 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038804 Approved Supported "Nuclear speckles,Vesicles,Cytosol" NA NA 9600 "Vesicles, Cytosol" "Nuclear speckles" "HPA038804: AB_10673290" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.50e-1)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (9.74e-2)" "unprognostic (1.31e-1)" "unprognostic (2.73e-2)" "unprognostic (3.60e-1)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" 20.9 27.9 19.7 24.7 22.4 21.1 36.9 22.4 18.9 18.2 20.2 16.9 27.9 16.9 22.5 16.9 25.9 18.8 20.7 14.8 19.7 14.8 23.9 17.5 20.8 23.1 18.8 17.1 19.4 19.8 22.6 21.5 17.3 19.7 20.9 15.5 16.4 21.2 18.3 26.7 24.2 18.8 17.5 14.7 27.9 18.6 12.2 20.5 20.1 27.3 14.1 20.1 20.7 34.3 3.2 3.4 7.9 4.5 1.2 2.9 21.5 7.2 12.0 6.4 8.4 12.4 10.3 7.3 12.9 9.2 7.7 9.0 11.6 17.0 11.8 7.4 15.7 8.9 6.7 11.7 16.9 9.1 37.3 8.8 20.6 9.2 8.3 12.7 11.4 11.3 10.3 9.3 5.1 14.9 13.5 8.3 6.7 8.3 11.3 6.9 22.0 12.1 7.9 6.8 7.9 5.6 10.9 4.6 10.9 12.8 11.9 6.4 9.2 18.9 12.3 6.7 8.5 9.8 14.0 10.0 10.2 3.4 5.4 10.1 7.0 10.8 21.2 9.3 20.7 9.3 7.4 3.4 7.9 1.7 3.6 1.0 2.7 2.0 1.7 3.0 3.2 1.4 1.8 5.9 1.2 4.5 3.4 2.9 21.5 19.7 22.4 22.4 18.9 19.7 14.8 18.8 17.1 19.7 20.5 32.8 25.0 14.2 10.0 9.2 9.7 19.3 20.4 38.8 31.8 14.0 19.6 18.9 8.3 18.0 5.6 17.8 13.0 0.0 12.5 12.9 13.5 12.4 28.9 12.4 28.1 11.1 10.4 8.0 29.4 3.2 21.3 26.8 10.1 38.7 17.2 13.6 18.3 18.1 25.5 25.0 11.0 6.5 16.5 10.9 7.4 9.9 17.7 13.8 13.4 8.1 RUFY3 "KIAA0871, RIPx, Singar1, ZFYVE30" ENSG00000018189 "RUN and FYVE domain containing 3" Q7L099 4 70704204-70807315 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 80.2" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022952, HPA022970" Enhanced Supported Cytosol NA NA Cytosol "HPA022952: AB_2671005, HPA022970: AB_1856307" "unprognostic (4.33e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (3.96e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.28e-4)" "prognostic unfavorable (8.95e-4)" "unprognostic (1.69e-2)" "unprognostic (2.00e-1)" "unprognostic (3.50e-2)" "prognostic favorable (8.02e-5)" "unprognostic (7.90e-3)" "unprognostic (1.31e-3)" "unprognostic (1.26e-1)" "unprognostic (1.21e-2)" "unprognostic (7.45e-3)" "unprognostic (5.41e-1)" 10.9 24.5 39.1 11.8 53.4 6.9 12.5 36.4 66.3 12.3 8.7 24.1 6.7 8.1 20.6 16.3 15.3 9.3 12.7 8.9 64.5 34.4 15.5 13.6 14.8 13.6 37.0 51.3 25.5 9.8 8.5 61.4 12.0 54.2 13.8 11.4 12.8 10.1 11.5 15.4 29.9 9.9 15.1 80.2 16.0 12.8 25.3 32.5 7.1 31.6 5.9 11.5 9.3 12.3 3.5 6.0 0.0 3.1 2.2 2.8 1.0 3.7 2.6 31.2 7.3 15.1 17.6 12.4 12.2 4.7 4.0 4.5 4.5 9.2 15.0 5.1 10.1 8.9 3.8 4.7 5.4 6.4 8.1 6.0 3.2 3.6 4.9 8.6 3.7 1.9 12.4 8.4 5.3 6.2 18.6 8.4 16.2 8.8 15.5 8.7 4.6 23.2 3.9 7.5 6.6 3.4 5.7 9.7 6.8 7.8 3.6 29.2 14.4 4.4 7.9 7.4 12.6 5.4 1.8 7.1 13.6 9.5 4.0 2.8 17.3 7.8 16.0 14.1 2.7 2.7 0.0 3.1 0.0 2.2 3.0 2.8 3.5 1.5 2.0 6.0 3.1 1.5 1.6 0.0 2.2 2.8 4.8 1.0 1.0 39.1 53.4 36.4 66.3 64.5 34.4 37.0 51.3 54.2 32.5 32.8 68.4 13.4 19.5 17.2 119.8 18.3 10.2 34.8 45.5 22.7 249.4 12.7 6.6 12.7 57.5 30.2 8.7 0.0 17.9 5.7 21.6 29.3 20.7 21.8 9.7 131.9 14.5 34.4 31.8 95.1 43.7 29.7 40.5 83.8 8.3 45.6 18.9 3.5 47.7 12.8 190.1 25.8 29.9 13.4 29.3 25.2 6.4 8.7 8.3 16.0 RUNDC1 DKFZp761H0421 ENSG00000198863 "RUN domain containing 1" Q96C34 17 42980565-42993690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023726 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023726: AB_2184078" "unprognostic (4.24e-2)" "unprognostic (1.26e-1)" "unprognostic (9.39e-2)" "prognostic favorable (6.93e-5)" "unprognostic (9.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.40e-2)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (3.84e-2)" "unprognostic (1.22e-1)" "unprognostic (1.53e-3)" "unprognostic (2.87e-3)" "unprognostic (1.25e-1)" "unprognostic (1.12e-2)" "unprognostic (4.77e-3)" 7.3 11.0 23.4 8.7 23.1 8.4 14.7 18.6 24.6 13.0 12.9 7.9 12.2 9.0 12.3 17.9 9.0 20.9 9.5 8.7 17.2 13.0 12.1 6.6 9.6 9.3 9.2 16.9 7.7 14.2 17.7 17.2 6.7 12.2 17.9 11.0 8.9 11.1 12.9 14.5 9.1 10.0 12.3 7.5 10.7 13.9 11.9 12.5 9.6 14.5 4.4 10.4 12.7 8.1 5.6 7.5 10.0 5.2 1.4 2.6 1.2 11.3 20.0 8.1 10.9 13.9 8.4 8.7 11.0 11.5 15.8 11.9 12.6 6.6 7.7 10.0 10.9 10.8 14.3 10.3 11.1 17.7 8.6 16.3 5.1 11.3 12.0 8.9 11.0 11.0 6.2 13.7 14.0 9.3 12.7 8.4 8.5 9.8 4.9 9.1 8.3 13.6 7.9 9.1 16.3 12.7 9.9 11.4 7.6 13.3 15.3 11.8 11.0 8.7 8.3 9.1 12.5 16.0 12.4 6.9 14.5 9.0 8.5 13.1 11.7 11.2 6.7 10.3 5.9 9.0 5.0 3.3 10.0 1.9 5.2 2.4 4.6 2.3 1.6 2.5 5.6 2.3 2.5 7.6 1.4 3.6 7.5 2.6 1.2 23.4 23.1 18.6 24.6 17.2 13.0 9.2 16.9 12.2 12.5 41.7 48.0 16.4 9.9 13.4 18.8 12.2 20.4 20.1 22.7 5.2 21.6 8.9 18.3 10.8 7.7 6.6 17.5 0.0 8.4 6.0 6.8 16.2 10.5 5.8 7.2 36.5 18.4 8.0 7.9 2.5 9.2 11.3 3.3 10.0 13.2 14.5 8.7 17.5 13.4 10.3 33.5 19.4 8.1 19.7 13.6 12.8 4.6 11.4 13.6 14.4 RUNDC3B "RPIB9, RPIP9" ENSG00000105784 "RUN domain containing 3B" Q96NL0 7 87627548-87832296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 13.2;brain: 16.4" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 13.7;Hepatocytes: 16.6;Spermatocytes: 20.2;Spermatogonia: 21.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.0;HEK 293: 2.5;SCLC-21H: 6.7;SH-SY5Y: 3.0;U-138 MG: 2.5;U-266/70: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056968, HPA057155, HPA075760" Uncertain Uncertain Vesicles,Cytosol NA NA Cytosol Vesicles "HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: " "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" "unprognostic (2.12e-1)" "unprognostic (1.83e-1)" "unprognostic (2.20e-2)" "unprognostic (1.77e-3)" "unprognostic (1.19e-2)" "unprognostic (4.16e-2)" "unprognostic (2.56e-1)" "unprognostic (1.19e-1)" "unprognostic (9.42e-5)" "unprognostic (4.44e-1)" "prognostic favorable (2.62e-6)" "unprognostic (1.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.32e-1)" "unprognostic (9.55e-2)" 1.1 13.2 3.6 0.8 9.4 0.1 1.4 16.4 7.9 2.7 3.7 1.0 1.0 4.7 3.4 1.2 1.0 2.0 1.7 1.4 2.8 5.1 3.3 9.7 0.8 0.4 2.8 4.8 2.3 0.5 0.5 2.0 0.2 7.9 1.1 2.7 0.7 0.9 0.8 1.1 0.9 5.2 3.8 2.2 0.4 0.6 3.1 1.0 0.0 0.6 0.1 0.5 1.6 1.1 0.1 0.0 0.4 0.0 0.0 2.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 3.0 0.4 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 2.5 0.1 1.5 1.0 0.1 1.2 0.4 0.0 0.7 0.0 0.4 0.0 1.2 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.2 6.7 3.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 2.5 0.0 0.2 0.0 3.9 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.4 2.1 0.0 0.8 0.1 0.0 1.7 0.0 0.1 0.3 1.2 0.3 0.0 0.0 0.0 0.0 0.1 3.6 9.4 16.4 6.5 2.8 5.1 2.8 4.8 7.9 1.0 0.0 0.0 0.0 0.1 4.2 8.0 2.2 5.1 0.0 0.0 0.0 5.9 0.5 1.7 0.9 2.0 13.7 9.7 0.0 0.2 0.3 0.1 0.1 0.0 16.6 0.1 11.1 0.0 1.8 0.0 1.0 3.7 0.0 3.3 0.0 2.9 0.7 0.8 5.8 1.4 8.7 7.6 0.0 1.2 20.2 21.5 2.6 1.0 0.0 3.8 0.0 RUNX3 "AML2, CBFA3, PEBP2A3" ENSG00000020633 "Runt related transcription factor 3" Q13761 1 24899511-24965121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.5;lymphoid tissue: 47.6" "Cell type enhanced" "Detected in many" 17 "B-cells: 38.9;granulocytes: 46.0;Macrophages: 35.5;Melanocytes: 43.9;monocytes: 68.5;T-cells: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 39.5;Karpas-707: 53.2;SK-MEL-30: 29.5;U-266/70: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004195, CAB025416, HPA059006" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB025416: , HPA004195: , HPA059006: AB_2683877" "unprognostic (7.75e-3)" "unprognostic (6.51e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.42e-1)" "unprognostic (7.60e-2)" "unprognostic (1.81e-2)" "unprognostic (6.51e-2)" "unprognostic (6.95e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "prognostic unfavorable (5.59e-5)" "unprognostic (1.10e-1)" "unprognostic (4.42e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" 3.0 1.1 0.9 25.4 1.1 31.5 3.4 0.5 1.0 11.9 8.0 1.2 0.3 2.5 1.7 1.4 3.5 1.7 6.2 1.3 0.9 1.1 2.2 2.3 11.7 28.8 2.8 0.7 1.3 1.0 0.0 1.0 1.3 1.8 2.3 2.3 2.8 6.5 2.2 2.2 9.5 13.7 1.3 1.8 30.6 2.7 2.1 0.8 14.2 1.8 3.1 47.6 8.9 2.2 4.5 1.0 4.3 4.6 18.1 15.1 3.1 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 6.3 6.2 5.4 0.0 0.1 3.7 0.0 0.2 39.5 0.6 0.1 0.6 0.0 0.0 1.4 13.7 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 53.2 0.0 0.0 0.4 12.2 0.2 0.0 1.0 0.0 0.0 7.4 0.0 0.1 1.2 0.0 2.4 0.0 29.5 1.0 0.0 8.5 0.0 0.0 0.6 0.0 0.1 18.4 12.8 6.0 0.0 13.8 1.5 0.4 0.7 4.3 15.1 3.0 8.1 4.5 5.7 13.2 0.9 3.8 2.8 10.3 0.9 18.1 4.6 1.0 5.7 3.1 0.9 1.1 0.5 1.0 0.9 1.1 2.8 0.7 1.8 0.8 0.0 5.1 38.9 0.7 6.8 0.0 2.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.2 0.1 1.2 0.7 46.0 0.8 4.9 0.0 0.0 1.8 17.0 0.8 0.0 35.5 43.9 68.5 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 4.7 0.2 2.7 5.1 0.2 144.9 0.0 0.4 RUSC1 NESCA ENSG00000160753 "RUN and SH3 domain containing 1" Q9BVN2 1 155320896-155331114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028510, HPA029922, HPA029923" Approved Enhanced Cytosol NA NA Cytosol "HPA028510: AB_10599847, HPA029922: AB_10611390, HPA029923: AB_10602288" "unprognostic (1.98e-1)" "unprognostic (2.82e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-1)" "unprognostic (5.25e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (7.78e-6)" "unprognostic (1.42e-1)" "unprognostic (1.38e-1)" "unprognostic (1.73e-1)" "unprognostic (8.29e-2)" "prognostic unfavorable (2.65e-4)" "prognostic unfavorable (9.24e-6)" "unprognostic (7.59e-2)" "unprognostic (4.25e-2)" "unprognostic (2.05e-2)" "unprognostic (1.40e-1)" 10.9 15.9 24.8 8.7 24.1 8.9 12.2 46.1 45.4 16.6 20.2 5.6 9.2 17.5 13.0 7.4 21.8 12.4 13.6 12.2 18.5 22.3 12.9 4.9 11.0 7.4 14.4 26.4 13.3 12.5 11.5 21.5 14.7 26.1 16.3 19.0 8.7 18.1 18.1 8.7 22.7 19.5 15.3 8.9 7.6 14.2 3.1 6.2 12.6 8.4 11.4 8.8 12.1 16.1 3.4 7.5 5.1 18.9 2.6 6.4 4.2 22.7 14.4 8.3 12.2 10.3 11.3 16.1 10.9 7.0 14.4 16.2 16.5 15.1 4.5 8.3 11.0 8.2 31.8 12.8 15.8 6.2 6.1 16.4 6.4 14.3 8.6 8.5 6.4 11.2 11.5 10.0 14.4 5.0 7.0 14.8 9.9 9.7 3.1 12.4 43.4 8.0 8.2 16.3 42.0 23.0 10.9 5.8 7.9 13.5 17.4 8.6 14.0 9.2 25.9 5.5 14.1 38.6 11.0 6.7 18.6 15.4 17.4 21.5 2.5 5.6 2.7 13.0 8.6 5.0 5.1 6.8 3.2 5.8 8.1 6.4 3.4 4.7 5.8 7.5 1.5 2.6 5.5 0.9 2.6 18.9 7.1 4.7 4.2 24.8 24.1 46.1 45.4 18.5 22.3 14.4 26.4 26.1 6.2 8.9 10.1 10.9 16.6 24.8 14.6 9.0 10.2 6.7 18.2 17.4 5.9 25.0 19.9 19.9 0.3 23.5 60.7 0.0 15.6 61.6 23.7 24.2 8.1 6.4 18.6 35.0 15.0 12.9 10.4 0.0 17.0 11.5 18.6 10.0 42.2 12.8 20.4 37.4 17.0 22.0 6.6 19.4 21.7 1.8 7.2 30.6 31.8 13.8 33.3 22.1 RUVBL1 "ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a" ENSG00000175792 "RuvB like AAA ATPase 1" Q9Y265 3 128064778-128153914 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 208.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019947, HPA019948" Enhanced Supported Nucleoplasm,Cytosol NA NA 47000 "Nucleoplasm, Cytosol" "HPA019947: AB_1856516, HPA019948: AB_1856514" "unprognostic (7.40e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (4.73e-2)" "unprognostic (3.55e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.21e-8)" "unprognostic (2.43e-2)" "unprognostic (3.31e-2)" "unprognostic (1.39e-1)" "unprognostic (2.25e-2)" "unprognostic (7.39e-2)" "unprognostic (2.98e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 17.6 15.1 10.7 15.8 14.2 11.9 13.9 7.9 14.0 12.5 11.6 12.9 14.3 8.4 19.2 11.4 19.2 37.3 11.3 18.6 11.4 13.6 20.9 13.7 12.9 18.7 10.0 9.8 15.4 13.6 26.5 14.2 19.9 13.0 12.0 14.1 11.5 10.2 12.0 12.9 11.8 10.2 16.1 8.8 21.9 10.9 44.7 10.3 33.4 15.2 18.1 23.9 12.6 15.0 10.6 8.7 1.5 7.9 10.9 20.2 7.2 26.9 24.5 15.1 24.5 11.8 11.5 19.7 13.2 11.4 25.5 17.6 25.6 16.1 38.3 13.2 12.6 19.7 21.5 40.1 28.1 29.8 15.6 19.7 31.8 14.2 17.1 12.2 29.7 10.2 11.7 14.8 21.4 27.6 9.7 17.1 14.6 26.0 9.0 14.5 38.4 31.8 22.5 37.9 30.5 21.0 26.2 18.3 26.6 15.3 10.2 25.3 22.7 14.6 12.1 20.2 14.6 22.0 22.0 11.0 11.6 14.2 17.4 20.0 9.2 14.6 37.6 14.3 18.3 14.5 0.8 4.8 1.5 11.3 7.9 14.6 10.6 13.6 14.0 7.7 10.2 11.5 12.8 0.2 10.9 7.4 8.7 20.2 7.2 10.7 14.2 7.9 14.0 11.4 13.6 10.0 9.8 13.0 10.3 20.8 11.7 25.1 16.5 17.7 16.3 18.7 22.9 208.8 31.8 21.0 2.0 45.7 39.7 29.2 14.5 21.2 2.9 0.0 26.3 53.6 20.6 11.7 25.4 13.2 26.2 22.3 16.3 11.1 5.6 19.6 14.1 10.5 10.1 12.6 12.4 26.0 22.8 14.0 17.3 41.5 16.2 12.9 13.3 96.8 64.3 14.8 20.1 24.9 23.0 11.9 RUVBL2 "ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b" ENSG00000183207 "RuvB like AAA ATPase 2" Q9Y230 19 48993448-49015995 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.0" "Group enriched" "Detected in all" 4 "Ciliated cells: 184.7;Early spermatids: 493.7;Late spermatids: 663.3;Spermatocytes: 292.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012432, HPA042880, HPA067966" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933" "unprognostic (1.71e-1)" "unprognostic (9.06e-3)" "unprognostic (3.51e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (7.06e-3)" "unprognostic (6.25e-2)" "unprognostic (3.28e-1)" "unprognostic (8.13e-2)" "unprognostic (7.58e-2)" "unprognostic (2.81e-2)" "unprognostic (2.21e-2)" "unprognostic (7.61e-3)" "unprognostic (1.61e-1)" "unprognostic (2.58e-1)" 6.9 5.3 6.7 7.5 7.1 13.4 4.8 8.2 10.4 4.8 9.9 7.6 6.3 11.2 8.3 5.5 16.1 5.5 7.2 9.1 6.9 6.0 7.6 10.3 5.5 8.2 7.7 8.1 6.5 8.7 1.6 6.4 5.5 6.7 6.0 3.2 6.5 10.0 6.6 27.8 7.7 10.0 3.7 7.1 6.9 10.7 59.0 5.8 14.6 8.8 9.4 8.1 6.4 12.9 12.6 16.4 5.6 14.3 11.0 12.5 15.2 28.9 29.8 3.5 20.0 1.5 2.7 9.4 15.7 6.8 18.0 11.8 15.4 12.6 27.2 12.1 3.1 5.1 15.4 2.2 10.3 2.1 16.5 12.2 17.7 9.0 7.8 5.0 34.8 12.4 3.1 2.1 4.0 2.1 3.3 6.6 23.0 30.7 11.6 1.6 5.9 30.7 4.1 10.8 6.0 4.4 25.5 16.1 17.5 3.2 11.2 14.3 20.6 15.8 13.2 5.6 1.1 11.6 13.4 9.7 11.4 16.8 7.5 38.7 23.5 26.8 28.1 8.4 17.1 16.3 5.6 14.3 4.2 11.1 11.1 11.2 10.9 11.1 9.1 16.4 12.6 12.2 8.0 1.0 11.0 10.8 12.5 12.5 15.2 6.7 7.1 8.2 10.4 6.9 6.0 7.7 8.1 6.7 5.8 11.9 20.2 23.7 40.9 24.6 15.0 38.6 28.1 184.7 36.4 31.4 31.4 91.2 39.7 59.0 493.7 24.1 23.6 23.3 61.9 63.4 32.5 34.0 12.7 31.1 44.6 17.5 16.8 27.6 18.3 663.3 33.4 26.7 25.3 43.3 33.6 23.6 48.7 31.6 40.3 61.6 24.1 19.4 37.1 292.2 46.3 24.1 96.9 25.3 49.4 33.5 RYK "D3S3195, JTK5, JTK5A, RYK1" ENSG00000163785 "Receptor-like tyrosine kinase" 3 134065303-134250744 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034117, HPA045503, HPA075430" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293" "unprognostic (7.84e-2)" "unprognostic (5.82e-2)" "unprognostic (2.22e-2)" "unprognostic (2.34e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (2.60e-2)" "unprognostic (6.59e-2)" "unprognostic (1.62e-1)" "unprognostic (1.07e-3)" "unprognostic (9.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-1)" "unprognostic (3.43e-1)" "unprognostic (2.85e-2)" 23.8 13.2 8.5 12.1 9.3 6.3 27.5 10.6 9.5 26.5 19.3 12.7 18.2 8.8 25.8 19.1 21.1 16.7 15.8 17.1 8.1 6.7 12.9 12.7 12.4 9.1 10.8 7.3 39.7 17.7 14.1 17.9 18.8 8.6 26.9 12.1 16.4 15.2 21.5 15.3 15.5 13.3 28.6 8.4 13.8 14.3 20.3 10.0 13.6 23.2 11.4 15.2 27.5 31.9 2.8 0.7 6.7 1.6 3.1 4.3 1.1 26.0 6.9 21.9 16.7 28.2 30.1 16.9 17.3 40.2 23.1 26.0 21.9 20.0 5.1 28.8 21.2 22.2 24.4 15.5 21.8 33.1 8.5 7.0 13.5 7.5 14.0 22.1 6.5 11.9 19.9 25.7 14.3 28.8 25.3 19.3 9.0 4.7 2.5 22.6 12.4 9.1 8.5 18.4 21.7 8.3 4.5 16.8 10.7 18.9 19.3 10.7 15.9 21.0 15.3 26.2 14.7 19.1 11.9 14.2 19.2 17.4 20.0 13.9 1.1 1.3 2.8 12.2 11.0 13.5 6.7 1.6 3.1 2.5 1.6 2.9 1.5 4.2 3.0 0.7 2.8 4.3 3.4 0.6 3.1 1.6 0.0 1.0 1.1 8.5 9.3 10.6 9.5 8.1 6.7 10.8 7.3 8.6 10.0 11.9 24.7 11.9 30.3 36.7 18.8 28.1 22.9 5.3 22.7 41.8 27.5 16.4 0.0 14.3 7.9 26.0 12.7 0.0 18.1 11.9 35.7 30.8 17.3 17.4 9.7 12.7 13.4 39.9 17.7 4.0 30.8 14.0 13.5 10.0 21.0 26.7 18.6 17.3 30.8 8.1 37.2 45.3 26.4 27.0 33.8 33.2 9.0 12.5 20.0 36.3 RYR1 "CCO, MHS, MHS1, PPP1R137, RYR" ENSG00000196218 "Ryanodine receptor 1" P21817 19 38433699-38587564 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 231.0" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 46.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;monocytes: 6.3" "Cell line enhanced" "Detected in some" "A549: 5.7;HaCaT: 14.0;hTCEpi: 5.7;RH-30: 11.5;SiHa: 22.8;U-2 OS: 9.6" "Low region specificity" "Detected in some" HPA056416 Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" Cytosol "HPA056416: AB_2683121" "unprognostic (2.22e-3)" "unprognostic (1.91e-3)" "unprognostic (9.59e-2)" "unprognostic (5.34e-4)" "unprognostic (2.50e-1)" "unprognostic (6.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (3.20e-3)" "unprognostic (3.52e-1)" "unprognostic (2.35e-1)" "unprognostic (1.07e-5)" "unprognostic (1.13e-2)" "unprognostic (8.10e-2)" "unprognostic (6.62e-3)" "unprognostic (1.34e-1)" 5.3 0.7 3.0 0.6 1.9 0.4 0.6 2.7 1.7 0.6 0.4 2.7 0.0 0.4 0.4 6.7 3.0 0.6 0.5 0.4 1.8 4.0 0.5 0.4 0.7 0.6 1.5 1.3 0.4 0.4 0.3 0.3 0.6 1.9 0.9 0.4 0.4 2.2 0.6 231.0 2.4 0.5 0.4 1.1 0.6 0.5 1.6 1.9 0.0 1.6 55.1 3.2 0.6 0.5 0.7 5.3 0.1 6.3 0.0 0.6 0.6 0.0 5.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.0 0.3 0.3 4.8 0.0 0.0 14.0 0.2 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.4 1.3 5.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.0 0.0 11.5 1.1 0.6 0.0 0.0 1.1 22.8 0.0 0.0 0.4 0.5 4.3 0.0 0.0 9.6 0.2 0.0 0.3 1.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.4 3.2 0.5 0.4 0.3 0.6 5.3 0.7 0.0 0.0 0.1 0.0 6.3 0.0 0.6 0.6 3.0 1.9 2.7 1.7 1.8 4.0 1.5 1.3 1.9 1.9 0.0 0.6 0.0 3.4 10.1 4.1 3.4 0.0 0.0 0.0 0.0 2.0 0.1 5.0 0.1 5.2 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 7.1 1.6 0.0 0.6 1.9 4.7 2.8 4.5 0.0 0.0 0.0 46.0 0.0 0.0 1.8 0.0 1.5 0.0 0.3 5.5 6.9 4.1 0.2 0.0 0.0 0.1 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042205-237833988 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 106.6" "Cell type enriched" "Detected in many" 30 "Cardiomyocytes: 1960.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 1.1 0.9 6.2 0.9 18.7 0.5 1.1 14.8 10.5 1.3 1.2 0.0 1.2 0.7 1.1 0.7 1.8 1.0 1.8 106.6 5.7 1.1 0.9 0.9 1.4 0.6 1.0 7.3 2.2 4.2 0.5 2.0 1.1 1.6 2.0 0.8 0.2 0.9 1.4 0.9 1.0 1.0 4.6 1.0 1.0 1.2 1.1 3.0 0.0 2.7 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.0 0.0 7.8 10.7 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 2.7 4.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 18.7 14.8 10.5 5.7 1.1 1.0 7.3 1.6 3.0 0.0 0.3 0.0 0.0 0.3 65.2 1960.0 0.0 1.4 2.3 1.8 9.8 0.0 0.0 0.0 15.8 1.5 0.0 0.0 2.5 0.0 2.1 0.0 0.0 0.0 0.1 1.6 3.4 1.3 0.0 10.2 1.1 0.0 8.5 0.0 0.0 1.5 0.3 0.0 0.0 0.0 4.7 0.0 18.6 3.2 0.9 0.0 0.0 0.0 0.0 0.0 S100A1 "S100-alpha, S100A" ENSG00000160678 "S100 calcium binding protein A1" P23297 1 153627926-153632039 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 465.5;skeletal muscle: 423.5" "Cell type enhanced" "Detected in many" 22 "Collecting duct cells: 146.5;Distal tubular cells: 137.6;Hofbauer cells: 149.3;Melanocytes: 323.9;Proximal tubular cells: 712.0" "Group enriched" "Detected in all" 5 "melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Hep G2: 43.7;SK-MEL-30: 149.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002599, HPA006462" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 240000 Cytosol "Nucleoplasm, Golgi apparatus" "CAB002599: AB_2315307, HPA006462: AB_1079857" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (5.96e-5)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.19e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-3)" "unprognostic (6.83e-3)" "unprognostic (5.22e-1)" "unprognostic (5.04e-3)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.68e-1)" "unprognostic (4.56e-2)" "unprognostic (2.70e-3)" "unprognostic (9.74e-4)" 27.7 3.2 70.0 2.8 67.3 2.2 14.3 4.1 42.5 2.0 2.4 47.3 0.0 3.5 2.6 8.5 14.1 8.8 2.6 465.5 44.9 42.9 20.0 2.6 2.4 2.5 85.0 30.7 2.2 4.5 2.0 4.3 4.5 31.4 6.3 2.1 4.3 99.3 3.7 423.5 4.0 2.9 2.1 87.7 2.4 3.3 2.8 31.8 0.0 29.0 57.6 4.7 2.9 0.1 0.6 0.6 2.1 1.0 0.3 0.5 0.5 0.7 0.3 0.5 4.6 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.9 0.4 0.5 19.6 0.0 0.2 1.1 0.0 0.0 0.0 0.5 0.4 1.0 0.6 43.7 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.0 0.1 3.5 0.5 0.0 1.2 0.1 0.5 0.2 0.5 0.4 3.1 0.4 1.1 0.8 1.7 0.7 0.2 0.3 1.4 149.9 1.4 4.5 2.3 0.4 0.4 0.3 0.3 0.4 0.7 0.7 0.7 0.3 0.8 0.2 2.1 0.3 0.0 0.1 0.3 0.1 0.0 0.2 0.5 0.0 0.6 0.3 0.0 0.0 0.3 1.0 0.6 0.0 0.5 70.0 67.3 4.1 42.5 44.9 42.9 85.0 30.7 31.4 31.8 0.0 0.0 0.0 1.1 8.7 0.6 57.3 5.1 0.0 0.0 146.5 2.0 0.9 137.6 0.7 0.5 2.1 0.9 0.0 3.4 0.8 2.3 1.2 0.0 3.2 149.3 0.0 1.7 13.5 0.6 1.5 6.1 1.3 323.9 0.0 2.2 60.1 1.1 0.0 8.5 712.0 2.2 0.0 2.1 0.9 0.7 1.9 2.9 0.0 1.5 0.6 S100A13 ENSG00000189171 "S100 calcium binding protein A13" Q99584 1 153618787-153631360 "Predicted intracellular proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 714.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.4" "Group enriched" "Detected in many" 5 "dendritic cells: 8.4;NK-cells: 19.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 94.7;SuSa: 111.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019592, CAB025494" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "CAB025494: , HPA019592: AB_10601499" "unprognostic (1.50e-2)" "unprognostic (9.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (7.77e-2)" "unprognostic (9.72e-3)" "unprognostic (1.75e-3)" "unprognostic (9.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.83e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.43e-2)" "unprognostic (8.10e-2)" "unprognostic (1.82e-3)" "unprognostic (1.72e-2)" 38.2 20.9 49.6 13.8 48.3 1.2 61.8 11.5 28.2 39.1 32.3 25.0 13.9 9.4 23.5 25.0 19.9 34.5 32.0 56.3 30.3 32.0 28.0 20.2 23.3 12.7 54.2 32.7 29.9 13.9 45.9 9.7 21.6 37.7 23.0 19.3 21.1 19.8 21.7 73.8 14.1 13.7 27.2 38.9 13.7 11.9 10.3 28.5 2.4 79.0 28.2 14.6 21.1 16.0 2.6 8.4 3.0 1.5 19.4 0.9 0.8 21.1 17.7 20.5 13.0 18.1 53.1 7.4 29.4 46.6 17.8 20.5 17.2 23.6 0.5 55.9 49.8 2.6 20.2 8.5 18.2 15.8 0.0 7.9 1.3 22.2 14.6 12.0 0.6 4.6 42.7 6.9 15.9 17.2 52.5 40.2 0.1 6.8 0.0 55.3 74.9 0.0 0.3 16.5 18.2 53.5 3.3 21.2 0.1 94.7 16.2 6.3 0.2 62.8 32.4 63.5 111.1 26.4 0.7 56.9 12.3 6.9 16.4 35.3 0.2 0.5 0.9 22.0 0.3 7.2 3.0 1.5 0.1 0.3 0.7 0.6 2.6 0.3 0.2 5.0 1.6 0.5 0.3 0.2 19.4 0.9 8.4 0.9 0.8 49.6 48.3 11.5 28.2 30.3 32.0 54.2 32.7 37.7 28.5 26.8 88.4 17.1 154.8 98.1 2.0 108.1 175.8 60.2 93.3 441.4 0.0 118.0 210.5 277.9 6.5 300.3 126.3 46.7 281.2 170.7 294.9 188.4 23.1 34.1 128.8 0.0 119.8 371.4 32.4 21.5 714.6 43.9 226.0 20.8 107.7 97.5 336.0 115.8 295.2 330.9 5.7 0.0 84.3 7.5 18.3 66.1 62.5 8.6 64.8 157.7 S100A14 "BCMP84, S100A15" ENSG00000189334 "S100 calcium binding protein A14" Q9HCY8 1 153614255-153616986 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.0;tongue: 189.3" "Cell type enhanced" "Detected in many" 15 "Basal keratinocytes: 2079.3;Enterocytes: 1153.1;Suprabasal keratinocytes: 3157.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 61.0;HaCaT: 84.7;HBEC3-KT: 120.1;hTCEpi: 179.0;OE19: 129.5;SK-BR-3: 126.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027613 Enhanced Approved "Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA 110000 "Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol" "HPA027613: AB_10602298" "unprognostic (1.73e-1)" "unprognostic (1.85e-1)" "unprognostic (1.48e-1)" "unprognostic (3.94e-2)" "unprognostic (1.75e-2)" "unprognostic (6.27e-2)" "unprognostic (2.30e-2)" "unprognostic (9.48e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (2.75e-3)" "unprognostic (2.89e-1)" "unprognostic (3.16e-3)" "unprognostic (8.41e-2)" "unprognostic (1.80e-1)" "unprognostic (4.81e-2)" "unprognostic (9.53e-2)" 0.6 0.0 0.6 4.3 0.6 0.0 6.4 0.6 0.6 38.0 19.2 0.6 3.9 21.4 5.7 2.6 256.0 1.2 7.9 0.6 0.6 0.0 2.4 1.2 7.5 0.6 0.6 0.6 0.7 4.6 6.6 0.8 1.4 0.7 1.9 19.6 0.7 41.8 3.1 0.6 41.4 23.8 1.0 0.6 0.6 9.4 0.9 0.6 8.9 9.6 189.3 71.0 2.2 79.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.6 11.1 0.0 0.1 0.0 0.0 84.7 0.0 120.1 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 179.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 129.5 0.1 0.0 0.0 0.2 0.6 4.0 0.0 0.0 0.1 126.4 0.1 3.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.7 0.6 56.6 133.0 0.5 298.4 2079.3 0.0 4.4 214.0 18.7 91.0 33.2 0.0 0.6 41.4 164.9 0.0 0.2 1153.1 0.0 59.6 1.7 22.4 341.3 28.7 5.8 0.3 0.0 147.3 1.3 0.0 0.0 0.0 5.3 229.5 3.6 470.4 0.0 202.6 775.0 0.0 3.1 0.0 0.0 33.3 0.0 0.0 3157.3 0.2 0.7 410.3 819.7 S100A16 "DT1P1A7, MGC17528, S100F" ENSG00000188643 "S100 calcium binding protein A16" Q96FQ6 1 153606886-153613145 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 223.9;tongue: 102.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 744.7;Glandular cells: 697.0;Pancreatic endocrine cells: 790.1;Suprabasal keratinocytes: 794.3;Urothelial cells: 1359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 2.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 117.9;SK-BR-3: 142.9" "Low region specificity" "Detected in all" HPA045841 Enhanced Approved "Plasma membrane,Cytosol" NA NA 92000 Cytosol "Plasma membrane" "HPA045841: AB_10966282" "unprognostic (9.86e-3)" "unprognostic (1.69e-1)" "unprognostic (2.23e-2)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (3.18e-4)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.70e-1)" "unprognostic (4.59e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.91e-5)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.45e-2)" "unprognostic (5.29e-3)" 20.1 5.5 9.3 8.0 7.2 0.0 11.9 3.4 8.3 37.2 21.1 8.3 3.2 16.2 8.7 7.2 223.9 7.6 18.2 9.5 6.7 5.4 14.3 27.0 18.3 7.5 7.1 5.7 15.3 4.1 6.5 3.3 14.9 7.2 9.3 14.5 5.1 35.5 5.4 9.8 43.1 31.2 10.6 5.9 13.4 10.6 12.3 4.6 3.2 11.3 102.1 87.5 11.3 51.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 56.4 27.2 1.4 3.2 9.4 35.7 3.7 32.3 29.7 26.6 23.6 25.5 31.6 0.0 51.9 48.3 6.0 41.5 0.0 72.5 15.6 0.1 0.0 0.0 23.7 7.5 10.8 0.0 0.0 16.9 69.7 64.4 50.7 34.8 117.9 0.0 0.6 0.0 58.5 75.0 0.0 0.1 6.0 100.1 73.6 0.0 16.4 0.1 100.2 20.3 0.0 0.1 23.8 142.9 4.7 12.9 44.4 0.3 63.2 16.0 25.6 15.4 73.0 0.0 0.2 0.1 47.6 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.3 7.2 3.4 8.3 6.7 5.4 7.1 5.7 7.2 4.6 35.7 18.0 15.1 744.7 563.0 0.4 29.7 119.8 26.8 103.5 102.9 2.0 12.3 61.3 584.7 3.2 283.5 336.2 0.0 172.2 7.2 105.8 697.0 19.5 109.5 4.7 0.0 133.3 333.3 22.5 10.0 62.2 11.1 106.3 12.6 178.6 38.3 790.1 294.7 57.7 126.7 1.8 6.5 41.5 1.7 1.2 794.3 6.9 12.8 201.3 1359.9 S100A2 "CAN19, S100L" ENSG00000196754 "S100 calcium binding protein A2" P29034 1 153561108-153567890 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 224.8;tongue: 246.5" "Cell type enhanced" "Detected in many" 20 "Basal glandular cells: 2667.8;Basal keratinocytes: 10183.7;Suprabasal keratinocytes: 3170.0;Urothelial cells: 4604.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 1229.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 11.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.9" "Group enriched" "Detected in some" 5 "HBEC3-KT: 671.5;RT4: 262.5" "Not detected" "Not detected" "CAB002600, CAB047340, HPA062451" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA 130000 "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "CAB002600: , CAB047340: , HPA062451: AB_2684767" "unprognostic (8.47e-3)" "unprognostic (5.54e-2)" "unprognostic (1.57e-2)" "unprognostic (1.42e-3)" "unprognostic (1.98e-1)" "unprognostic (3.20e-1)" "unprognostic (4.21e-4)" "unprognostic (9.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.52e-2)" "unprognostic (8.91e-2)" "unprognostic (1.35e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" 0.4 0.0 0.4 0.5 0.4 0.0 2.1 0.4 0.5 16.9 0.4 0.4 0.9 0.0 1.8 1.9 224.8 0.5 0.4 0.4 0.4 0.0 16.6 0.4 1.6 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.6 0.6 3.3 0.0 0.4 23.3 2.1 0.7 27.5 0.4 1.5 0.5 0.4 0.0 0.5 0.4 0.7 1.0 246.5 48.4 36.2 43.8 0.5 2.6 11.9 0.6 0.0 2.9 0.7 25.4 0.2 0.0 0.0 0.3 0.1 0.0 0.3 0.3 0.2 0.2 0.0 0.8 0.0 13.5 0.5 0.5 63.2 0.0 671.5 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.0 0.0 0.2 89.4 0.7 102.0 0.7 0.4 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.6 4.9 0.0 16.0 0.0 15.9 262.5 0.5 0.0 1.1 0.1 0.2 0.2 0.1 0.1 0.1 0.4 22.2 2.9 8.6 0.0 0.0 0.1 0.8 0.0 0.7 11.9 0.5 0.0 2.9 0.0 1.8 0.5 2.0 1.6 0.4 0.0 0.6 0.5 5.0 0.0 0.6 2.6 1.8 0.7 0.4 0.4 0.4 0.5 0.4 0.0 0.4 0.4 0.6 0.4 8.9 15.9 2.2 2667.8 10183.7 0.0 2.0 2.5 307.9 1714.1 207.6 0.0 0.1 1039.5 26.2 3.0 3.6 1.3 0.0 24.2 0.9 117.2 609.3 16.2 0.0 1.8 0.0 1.7 0.6 1.5 3.8 0.6 38.5 720.4 9.0 1.7 1.0 390.7 2.9 0.7 9.8 0.0 0.0 213.2 0.2 2.3 3170.0 0.2 1.3 1.5 4604.3 S100A3 S100E ENSG00000188015 "S100 calcium binding protein A3" P33764 1 153547329-153549372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 44.7" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 19.6;Exocrine glandular cells: 21.7;Pancreatic endocrine cells: 15.4;Smooth muscle cells: 12.7" "Cancer enhanced" "Detected in all" "urothelial cancer: 26.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "intermediate monocyte: 3.6;non-classical monocyte: 6.9;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 10 "dendritic cells: 8.9;monocytes: 6.9" "Cell line enhanced" "Detected in many" "A549: 33.9;HBEC3-KT: 18.1;HeLa: 22.1;U-2197: 19.8" "Low region specificity" "Detected in some" "HPA042674, HPA056140" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA 390000 Cytosol "Golgi apparatus, Plasma membrane" "HPA042674: AB_10796581, HPA056140: AB_2683050" "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (4.53e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-1)" "unprognostic (2.08e-1)" "unprognostic (5.34e-3)" "unprognostic (3.97e-3)" "prognostic unfavorable (1.61e-6)" "unprognostic (8.13e-2)" "unprognostic (3.46e-1)" "unprognostic (6.21e-2)" "unprognostic (8.10e-2)" 4.7 0.6 0.6 3.3 3.1 1.5 2.2 0.6 1.7 3.7 1.2 1.3 0.1 0.4 2.4 1.6 7.4 1.6 1.6 7.9 0.5 0.7 10.2 0.1 14.2 4.6 1.7 0.1 1.2 5.3 0.0 0.3 5.6 3.5 3.6 1.0 0.3 2.0 1.6 2.5 44.7 1.0 1.8 1.5 2.1 0.7 1.4 0.4 0.5 1.7 2.1 4.9 3.7 4.0 0.7 8.9 0.0 6.9 0.0 0.3 0.4 2.9 33.9 0.0 0.0 3.3 2.1 0.0 2.3 12.4 2.9 4.9 1.0 1.1 0.0 7.6 5.9 4.3 9.0 0.0 18.1 1.6 0.1 0.0 0.1 22.1 6.1 0.8 0.0 0.1 1.6 9.3 7.2 8.2 1.8 0.6 0.0 0.0 0.0 16.0 0.2 0.0 0.0 0.2 0.0 4.1 0.0 2.4 1.8 9.9 7.3 0.5 0.0 2.1 2.5 0.7 10.1 0.1 0.2 3.0 1.2 1.9 19.8 2.5 0.6 0.6 0.0 15.9 0.2 7.5 0.0 0.2 0.0 0.0 3.6 0.3 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.9 8.9 0.1 0.4 0.6 3.1 0.6 1.7 0.5 0.7 1.7 0.1 3.5 0.4 3.0 0.3 0.0 1.2 9.2 0.0 0.1 2.5 0.0 4.5 0.0 0.0 0.2 1.7 19.6 0.0 7.0 0.0 0.0 21.7 1.6 8.1 0.6 0.0 0.0 0.3 0.0 0.0 3.7 0.0 0.0 3.7 0.9 1.7 6.4 0.0 0.0 15.4 0.0 0.4 0.0 0.0 0.0 12.7 0.0 0.0 5.6 1.3 0.0 0.0 1.7 S100A6 "2A9, CABP, CACY, PRA" ENSG00000197956 "S100 calcium binding protein A6" P06703 1 153534599-153536244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Pancreatic endocrine cells: 22500.8;Urothelial cells: 12910.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 325.2;RPTEC TERT1: 363.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002601, HPA007575, CAB040549, CAB047354" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 5100000 "Plasma membrane, Cytosol" "CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859" "unprognostic (8.80e-3)" "unprognostic (6.96e-2)" "unprognostic (2.31e-1)" "unprognostic (2.47e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (1.36e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-1)" "unprognostic (6.86e-3)" "unprognostic (1.66e-1)" "unprognostic (3.59e-1)" "unprognostic (1.10e-1)" "unprognostic (2.88e-1)" "unprognostic (1.46e-2)" "prognostic favorable (7.56e-4)" 126.4 32.6 14.8 104.9 29.9 73.8 223.6 13.3 14.6 95.4 176.8 10.1 51.2 70.2 65.0 135.5 126.5 42.2 264.5 112.3 13.0 22.5 103.4 6.0 151.9 61.5 45.6 7.9 38.1 13.5 0.5 17.7 100.1 27.3 85.1 85.5 28.5 58.7 55.2 59.1 45.1 98.1 88.9 35.5 27.5 69.9 29.6 17.8 4.9 76.9 183.0 36.2 150.9 145.0 30.7 130.1 303.7 180.7 9.1 69.2 201.7 75.2 84.2 0.0 6.9 141.8 184.0 0.2 92.3 230.5 46.8 61.5 5.8 157.5 0.1 29.3 137.0 43.4 32.7 1.5 132.6 22.1 31.0 0.0 15.8 56.4 5.1 53.7 0.7 10.8 85.8 110.2 50.1 86.8 64.3 103.8 0.0 0.0 0.1 116.7 11.3 0.2 6.4 0.1 325.2 138.6 0.0 10.4 27.2 363.5 69.9 21.7 3.8 125.5 127.9 94.9 0.0 17.6 24.4 151.6 45.2 11.8 92.4 149.8 0.2 0.2 0.2 175.8 16.8 96.6 139.8 180.7 74.1 62.0 96.8 67.3 30.7 58.5 60.3 130.1 17.2 37.3 49.5 303.7 9.1 86.9 68.3 69.2 201.7 14.8 29.9 13.3 14.6 13.0 22.5 45.6 7.9 27.3 17.8 4374.3 2209.1 330.5 4451.5 1322.1 4.2 292.3 1518.5 3121.1 4082.2 7746.6 0.0 1050.2 6310.0 5079.5 17.9 1309.7 5409.4 186.9 8886.8 1881.7 3759.3 5823.6 1721.8 17.4 2462.8 55.6 1958.6 890.1 3762.1 37.4 2790.2 5314.3 2911.9 5195.8 5391.4 88.0 22500.8 7016.5 1075.2 111.0 7.4 129.4 3153.8 7.1 13.9 872.0 1315.7 897.0 2304.5 12910.1 S100A7 "PSOR1, S100A7c" ENSG00000143556 "S100 calcium binding protein A7" P31151 1 153457744-153460701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 78.3;Syncytiotrophoblasts: 22.1" "Group enriched" "Detected in many" 5 "cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 7.4;SK-BR-3: 17.3" "CAB001453, HPA006997, CAB033766" Enhanced Uncertain Cytosol "Secreted in other tissues" NA NA 17000000 Cytosol "CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860" "unprognostic (3.28e-1)" "unprognostic (9.85e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-2)" "unprognostic (3.17e-1)" "unprognostic (2.94e-2)" "unprognostic (1.03e-2)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 2.2 0.1 0.1 45.2 0.1 0.1 0.1 0.0 3.7 3.9 116.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 6.2 0.1 0.1 45.7 0.1 0.2 0.1 0.1 0.0 0.3 0.1 1.2 0.1 409.9 156.7 0.2 85.3 0.0 0.4 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 7.4 0.0 2.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 0.8 17.3 0.0 1.1 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 78.3 22.1 0.0 0.0 0.4 S100A7A "S100A15, S100A7f, S100A7L1" ENSG00000184330 "S100 calcium binding protein A7A" Q86SG5 1 153416524-153423225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "tongue: 178.1" "Group enriched" "Detected in some" 6 "Early spermatids: 1.1;Late spermatids: 1.6;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SK-BR-3: 3.4" HPA006997 Supported Uncertain Cytosol NA NA Cytosol "HPA006997: AB_1079860" "unprognostic (2.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" "unprognostic (1.17e-1)" "unprognostic (4.40e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.9 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 178.1 12.5 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 S100A8 "60B8AG, CAGA, CFAG, CGLA, MRP8, P8" ENSG00000143546 "S100 calcium binding protein A8" P05109 1 153390032-153391188 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" Antimicrobial "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1" "Cell type enriched" "Detected in many" 13 "Kupffer cells: 10543.8" "Cancer enhanced" "Detected in all" "cervical cancer: 2290.9;head and neck cancer: 2382.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "classical monocyte: 320.7;neutrophil: 720.9" "Group enriched" "Detected in many" 8 "granulocytes: 720.9;monocytes: 320.7" "Group enriched" "Detected in some" 28 "hTCEpi: 28.2;SK-BR-3: 103.3;THP-1: 54.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB002791, HPA024372" Enhanced Supported "Intermediate filaments,Cytosol" "Secreted to blood" NA NA 10900000 530000000 "Intermediate filaments" Cytosol "CAB002791: , HPA024372: AB_1856536" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-2)" "unprognostic (8.60e-3)" "unprognostic (9.26e-3)" "unprognostic (4.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (8.94e-7)" "unprognostic (1.17e-1)" "unprognostic (8.90e-2)" "unprognostic (8.27e-2)" "unprognostic (8.94e-3)" 14.0 0.8 0.8 30.5 2.6 718.8 1.1 0.5 1.6 123.0 2.8 0.7 0.4 0.4 12.0 1.2 532.3 5.5 2.1 36.7 1.5 0.5 1.4 4.3 26.2 37.3 3.3 0.4 2.1 2.7 0.1 0.9 4.7 3.3 1.4 0.4 1.3 92.4 0.3 2.5 6.2 1.0 9.0 1.8 72.4 2.0 1.9 0.9 2.6 4.6 597.1 257.6 5.0 224.1 0.6 63.7 720.9 320.7 0.3 0.6 244.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.7 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 28.2 0.0 0.9 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.4 103.3 0.0 0.0 0.7 54.9 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 1.6 0.0 8.2 320.7 38.9 0.4 26.5 0.6 0.6 0.3 0.2 63.7 0.3 0.3 0.3 720.9 0.3 6.4 2.5 0.4 244.7 0.8 2.6 0.5 1.6 1.5 0.5 3.3 0.4 3.3 0.9 208.4 808.2 43.2 0.7 17.4 0.0 2.9 56.0 117.8 215.0 14.0 0.0 4.1 0.0 0.1 217.1 1.6 0.0 23.3 0.8 8.6 1.6 0.4 209.3 16.4 431.8 0.0 0.0 84.7 10543.8 69.5 3.7 783.2 0.0 0.0 0.0 0.0 0.9 0.0 1.4 14.7 0.0 0.0 1.0 2.2 0.5 99.0 5.6 20.3 0.0 19.6 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6" "Cell type enriched" "Detected in many" 7 "Kupffer cells: 11072.0" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 381.5;neutrophil: 638.3" "Group enriched" "Detected in many" 6 "granulocytes: 638.3;monocytes: 381.5" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 233.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA 10600000 1400000000 "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 19.5 2.1 1.3 41.9 4.2 820.1 4.1 0.9 2.1 143.6 4.4 0.7 0.4 0.7 4.9 4.0 642.6 9.9 4.4 51.2 2.5 0.4 2.8 4.8 29.2 169.0 5.3 0.6 3.4 4.4 0.1 0.9 10.4 5.2 2.2 0.7 2.0 109.6 0.5 3.4 7.5 1.4 13.1 2.1 103.2 3.5 2.9 1.4 3.8 6.7 477.6 228.0 24.3 237.0 0.5 87.5 638.3 381.5 0.3 1.0 323.2 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 36.6 0.0 0.0 2.2 0.0 15.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 12.7 0.0 0.8 0.0 0.0 0.0 0.7 0.3 0.0 2.9 0.0 0.3 0.0 0.2 0.0 0.0 0.5 7.7 0.0 9.5 0.1 0.0 0.3 233.1 0.1 0.1 3.6 29.6 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 6.7 0.0 5.3 381.5 46.4 0.5 31.6 1.0 0.4 0.4 0.3 87.5 0.5 0.3 0.3 638.3 0.3 15.0 2.9 0.5 323.2 1.3 4.2 0.9 2.1 2.5 0.4 5.3 0.6 5.2 1.4 214.4 574.2 57.1 52.5 17.7 0.0 2.5 66.2 112.4 185.4 34.9 0.0 111.0 5.0 49.4 1.3 7.0 0.5 23.3 32.9 44.2 7.1 19.6 151.1 16.4 1627.6 0.0 0.0 71.2 11072.0 2.2 5.5 1162.8 0.0 4.6 2.1 0.0 10.3 0.8 0.0 16.3 0.2 0.0 2.5 0.3 1.3 29.1 1033.7 24.9 1.9 291.7 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598962-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 342.0" "Cell type enhanced" "Detected in some" 16 "Kupffer cells: 25.7;Macrophages: 53.7;Melanocytes: 94.5;monocytes: 55.9" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 78.0" "Lineage enriched" "Detected in many" 7 "T-cells: 78.0" "Group enriched" "Detected in some" 7 "SK-MEL-30: 82.9;WM-115: 163.0" "Low region specificity" "Detected in all" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA 120000 "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 67.7 14.0 60.9 5.6 51.0 2.0 13.2 39.4 151.2 5.2 9.1 101.0 3.0 4.7 1.5 7.6 8.6 2.1 8.3 6.6 74.6 65.4 1.5 1.6 2.9 9.8 152.0 36.5 2.4 3.0 1.1 3.1 1.4 90.3 3.0 8.3 7.4 10.1 15.3 1.3 5.7 7.5 4.3 342.0 5.7 4.3 1.5 46.4 0.0 1.3 1.8 10.8 8.2 1.6 0.1 3.4 0.7 1.9 11.0 78.0 10.6 0.1 0.0 18.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 82.9 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.0 163.0 0.0 0.1 0.0 78.0 1.8 22.4 0.0 0.2 14.5 3.4 0.1 0.6 33.3 0.7 11.0 1.9 0.8 0.0 10.6 60.9 51.0 39.4 37.6 74.6 65.4 152.0 36.5 90.3 46.4 3.0 7.4 0.9 0.2 14.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.2 7.6 0.0 0.0 4.9 25.7 0.4 5.2 53.7 94.5 55.9 0.0 9.7 0.1 0.0 0.0 0.0 4.0 0.0 2.1 0.0 0.1 11.0 0.1 0.5 0.0 0.1 S100G "CABP1, CABP9K, CALB3" ENSG00000169906 "S100 calcium binding protein G" P29377 X 16650158-16654670 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "intestine: 74.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "breast cancer: 4.7;renal cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.1;PC-3: 2.2;RPMI-8226: 7.0;SH-SY5Y: 1.3" "Region enriched" "Detected in single" 5 "pons and medulla: 1.2" "Low region specificity" "Detected in many" "CAB017688, HPA028920, HPA055873" Enhanced Approved Cytosol NA NA Cytosol "CAB017688: AB_1119899, HPA028920: , HPA055873: AB_2682952" "unprognostic (2.68e-2)" "unprognostic (2.78e-1)" "unprognostic (9.88e-3)" 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.2 18.0 0.0 0.0 74.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.2 0.0 0.0 7.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.4 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAC3D1 "HSU79266, SHD1" ENSG00000168061 "SAC3 domain containing 1" 11 65040901-65044828 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 26.3" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 67.9;Late spermatids: 96.5;Spermatocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042677 Uncertain Approved Cytosol NA NA Cytosol "HPA042677: AB_10797506" "unprognostic (1.35e-1)" "unprognostic (5.45e-3)" "unprognostic (5.00e-1)" "unprognostic (8.01e-2)" "unprognostic (3.56e-1)" "unprognostic (3.53e-2)" "prognostic unfavorable (9.67e-6)" "unprognostic (4.11e-1)" "unprognostic (1.70e-1)" "unprognostic (4.45e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (5.66e-5)" "unprognostic (2.97e-3)" "unprognostic (5.71e-1)" "unprognostic (4.53e-2)" "unprognostic (2.49e-1)" 6.3 6.1 5.1 5.1 5.8 7.1 10.9 7.1 8.4 3.7 7.7 3.0 5.0 5.8 4.3 4.2 5.1 4.0 6.4 4.2 4.8 4.5 3.7 6.6 4.7 4.4 5.1 3.0 3.2 8.6 2.6 4.1 3.0 6.5 4.2 3.5 1.4 6.7 5.7 12.4 6.4 3.9 4.9 4.4 4.5 5.0 26.3 4.6 16.2 3.3 6.2 4.8 3.6 4.6 2.3 3.6 0.4 3.6 0.1 2.7 0.8 18.7 11.1 7.7 7.3 4.1 2.9 4.8 12.2 3.2 9.4 7.9 7.9 4.9 10.0 8.5 4.7 10.2 10.4 6.3 8.9 1.3 12.4 10.4 7.9 7.2 14.1 3.0 5.3 2.9 0.8 8.0 7.2 3.2 2.3 3.3 11.4 11.0 5.6 3.2 10.3 8.3 21.7 2.5 6.7 22.6 6.2 5.5 11.0 4.0 4.3 9.5 7.9 9.3 10.3 6.8 2.2 8.1 7.6 3.2 4.5 13.7 14.6 7.8 13.4 9.4 7.5 2.7 7.0 2.0 0.0 3.1 0.4 1.6 2.6 1.5 2.3 1.9 1.2 1.5 2.2 2.7 1.8 0.3 0.1 3.6 3.6 2.2 0.8 5.1 5.8 7.1 8.4 4.8 4.5 5.1 3.0 6.5 4.6 3.0 0.3 5.2 5.1 7.7 6.8 5.2 5.1 1.4 1.2 8.7 0.0 15.5 6.6 1.8 67.9 5.8 14.6 0.0 1.4 37.0 8.9 8.3 5.7 13.1 25.4 4.8 6.9 4.3 16.1 96.5 16.4 8.3 10.1 2.8 12.1 12.7 2.3 11.9 13.1 10.3 6.9 0.0 8.2 199.6 43.9 6.8 5.6 9.6 20.7 3.1 SAE1 "AOS1, FLJ3091, Sua1" ENSG00000142230 "SUMO1 activating enzyme subunit 1" Q9UBE0 19 47113274-47210636 "Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041906, HPA043552" Supported Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041906: AB_2677735, HPA043552: AB_2678548" "unprognostic (9.69e-3)" "unprognostic (1.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.68e-1)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.49e-8)" "unprognostic (9.86e-2)" "unprognostic (1.62e-2)" "unprognostic (1.58e-1)" "unprognostic (1.93e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.15e-5)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.27e-1)" 20.1 17.8 26.7 22.8 30.5 24.0 18.6 21.9 45.9 23.6 50.1 17.6 21.6 14.0 30.2 13.1 27.5 21.3 17.1 22.5 21.2 23.9 14.6 16.0 19.2 30.6 20.4 34.6 19.0 14.4 28.0 13.9 26.8 24.3 20.2 27.3 20.9 15.7 28.6 24.1 19.0 20.1 38.5 15.9 25.8 30.5 60.2 16.2 32.7 37.5 17.2 37.5 33.0 25.8 19.1 22.3 22.8 19.0 35.2 41.3 29.4 36.2 39.8 62.5 29.8 21.5 25.3 21.2 44.9 39.2 50.7 62.0 34.2 24.2 43.7 17.7 36.0 26.9 17.3 64.0 28.3 55.2 36.6 46.5 42.5 26.9 39.0 23.7 47.0 26.5 18.8 14.6 27.7 29.9 20.0 48.5 31.5 50.5 22.1 47.8 29.1 30.8 129.8 31.2 39.3 21.3 48.5 41.9 17.9 22.7 43.0 24.7 27.2 46.0 31.7 27.1 35.8 25.9 28.7 25.2 26.7 30.7 17.5 48.2 27.6 80.2 62.1 18.8 39.1 39.0 22.8 19.0 10.4 23.0 16.9 24.8 19.1 29.0 23.2 22.3 15.7 41.3 31.3 7.9 35.2 11.3 15.0 33.5 29.4 26.7 30.5 21.9 45.9 21.2 23.9 20.4 34.6 24.3 16.2 8.9 16.0 34.0 28.7 22.8 17.8 18.6 7.6 4.0 10.3 12.2 5.9 57.7 10.0 35.8 11.1 31.4 10.5 23.3 30.4 80.2 33.8 28.6 15.0 17.4 48.9 19.1 18.5 20.3 19.0 12.8 14.4 20.0 43.9 71.3 22.5 18.0 30.8 14.4 17.7 11.5 15.0 51.8 35.6 95.2 109.0 21.5 48.1 33.2 28.3 25.8 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.9;kidney: 26.8;liver: 32.0" "Group enriched" "Detected in some" 14 "Cholangiocytes: 7.6;Collecting duct cells: 8.7;Cone photoreceptor cells: 23.6;Distal tubular cells: 10.0;Hepatocytes: 27.2;Proximal tubular cells: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.2;BJ hTERT+: 12.9;NTERA-2: 24.6;RPTEC TERT1: 20.9;U-87 MG: 24.1" "Region enriched" "Detected in many" 5 "olfactory region: 64.6" "Low region specificity" "Detected in many" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: AB_2680902, HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favorable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favorable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.8 0.7 12.2 1.2 14.5 0.7 0.9 1.7 18.9 16.1 3.1 31.9 0.0 1.6 17.8 1.5 0.8 10.4 1.1 1.2 13.6 5.5 26.8 32.0 0.6 0.6 21.8 9.1 5.2 1.6 0.9 4.3 4.3 17.6 1.3 3.2 0.0 0.9 2.3 0.6 0.7 1.4 9.4 19.7 0.7 3.0 2.2 19.4 0.0 23.7 0.0 0.6 2.2 4.8 1.0 1.9 2.3 3.1 0.1 1.1 1.1 0.0 0.8 15.2 0.1 0.4 0.3 0.0 5.0 12.9 0.3 0.7 0.0 0.0 0.0 5.8 7.1 4.5 0.0 9.4 0.0 0.4 0.0 5.7 0.0 0.0 9.1 0.3 0.0 4.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 1.8 0.9 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 24.1 0.0 5.0 0.6 3.1 2.3 0.7 2.0 0.7 1.0 1.0 0.9 1.9 0.8 0.6 0.6 1.8 0.1 1.5 1.9 1.1 1.1 12.2 14.5 1.7 10.3 13.6 5.5 21.8 9.1 17.6 19.4 0.0 0.0 0.0 0.0 0.2 0.0 1.1 7.6 0.0 0.0 8.7 23.6 0.0 10.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 27.2 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 16.7 0.2 0.0 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.1 SAMD1 ENSG00000141858 "Sterile alpha motif domain containing 1" 19 14087840-14091036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 79.1" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041662, HPA049059" Uncertain Approved Mitochondria,Cytosol "Intracellular and membrane" NA NA Cytosol Mitochondria "HPA041662: AB_2677605, HPA049059: AB_2680616" "unprognostic (2.93e-2)" "prognostic favorable (7.41e-4)" "unprognostic (8.43e-2)" "unprognostic (3.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (2.66e-1)" "unprognostic (9.92e-2)" "unprognostic (3.86e-3)" "unprognostic (9.26e-3)" "unprognostic (4.00e-1)" "prognostic unfavorable (7.98e-5)" "prognostic favorable (8.31e-4)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" "unprognostic (2.45e-1)" 16.0 9.5 23.5 17.4 20.2 19.6 47.9 17.2 21.2 15.3 21.3 19.7 12.2 20.6 14.7 9.8 18.2 14.0 12.8 16.8 21.2 17.9 13.1 11.1 15.9 20.1 20.9 10.3 14.5 20.3 7.2 7.3 11.3 16.5 12.7 15.5 7.8 15.4 16.1 27.2 25.9 21.5 12.4 21.3 18.0 16.7 11.4 16.1 79.1 14.8 10.8 17.9 12.9 20.5 3.5 2.3 4.5 2.9 8.0 2.7 1.5 22.8 17.4 15.4 21.7 9.7 9.9 23.5 12.6 3.0 12.9 10.4 13.1 11.3 39.9 17.2 8.1 6.1 18.6 16.8 9.4 6.5 26.7 13.8 17.4 23.1 23.6 8.6 10.2 10.9 6.9 15.6 8.9 3.0 12.5 7.6 25.6 21.1 10.9 7.4 34.4 21.7 40.3 31.6 16.7 15.5 29.6 13.6 28.6 10.9 11.1 28.3 28.3 11.1 15.1 8.4 8.7 9.5 22.0 8.2 22.6 20.8 22.6 15.9 20.7 17.8 32.9 13.5 28.0 9.1 0.3 2.9 4.5 1.7 0.9 2.0 3.5 1.9 2.0 2.3 2.1 2.7 2.0 0.5 8.0 1.0 1.8 2.1 1.5 23.5 20.2 17.2 19.6 21.2 17.9 20.9 10.3 16.5 16.1 3.0 7.9 9.7 3.5 10.2 27.7 10.1 20.4 2.7 2.3 10.4 5.9 1.6 1.7 9.4 0.3 9.0 29.0 23.3 9.6 7.2 8.0 6.8 8.1 13.5 13.4 49.3 23.8 14.7 17.4 0.5 17.8 9.4 10.1 9.0 25.3 18.6 10.9 17.3 17.7 5.0 8.6 12.9 8.4 0.7 16.2 15.1 1.5 4.9 24.7 3.9 SAMD12 FLJ39458 ENSG00000177570 "Sterile alpha motif domain containing 12" Q8N8I0 8 118189459-118621995 "Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 104.2;Alveolar cells type 2: 67.7;Ciliated cells: 112.4;Club cells: 92.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 6.8;dendritic cells: 4.3;T-cells: 3.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 23.6;U-266/70: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024634 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA024634: AB_1856549" "unprognostic (6.96e-2)" "unprognostic (9.35e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (4.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.92e-2)" "unprognostic (2.99e-2)" "unprognostic (1.68e-1)" "unprognostic (3.94e-3)" "unprognostic (2.01e-1)" "prognostic favorable (1.52e-6)" "unprognostic (3.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (6.35e-3)" 2.1 3.0 14.1 3.1 16.2 1.1 5.0 13.8 20.2 4.6 6.9 7.7 8.9 7.1 2.7 8.0 9.7 8.8 6.7 10.8 10.8 7.0 8.3 4.0 6.2 2.3 9.6 13.7 2.1 4.7 12.7 20.8 0.9 13.7 6.3 8.1 2.6 5.7 12.8 2.0 2.3 4.8 1.9 10.9 4.2 9.5 3.2 8.6 0.7 15.8 2.5 4.5 10.8 3.0 6.8 4.3 0.2 0.0 1.1 3.7 0.9 7.5 0.3 0.6 0.0 0.0 0.0 2.0 3.5 5.5 6.3 3.3 1.7 7.1 10.5 0.7 4.3 1.6 1.8 2.4 4.1 9.2 0.2 0.8 0.1 4.7 0.0 0.0 0.0 0.3 0.2 1.3 4.6 0.7 1.6 0.2 5.9 0.0 6.2 3.2 1.9 2.2 0.0 1.0 6.7 1.2 0.0 0.0 7.3 2.8 11.4 3.3 0.0 2.3 23.6 0.3 1.9 1.7 0.0 0.0 0.1 3.1 1.4 0.8 12.1 9.9 0.8 1.4 0.0 1.3 0.1 0.0 0.0 0.6 0.0 3.7 6.8 2.6 1.7 0.3 2.9 3.7 1.8 0.2 1.1 0.0 4.3 2.4 0.9 14.1 16.2 13.8 20.2 10.8 7.0 9.6 13.7 13.7 8.6 104.2 67.7 0.5 8.7 1.4 16.8 9.4 15.3 112.4 92.1 27.9 41.2 0.0 16.6 9.9 4.9 4.0 7.3 0.0 10.9 0.1 0.5 3.4 52.3 3.2 0.1 28.6 13.7 3.7 0.0 3.8 0.3 0.9 6.8 1.0 9.8 3.4 10.8 0.0 0.4 14.0 26.5 0.0 1.0 0.5 1.9 1.5 0.0 2.5 11.1 10.8 SAMD4A "DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA" ENSG00000020577 "Sterile alpha motif domain containing 4A" Q9UPU9 14 54567097-54793315 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 48.7;testis: 44.6" "Group enriched" "Detected in many" 6 "Early spermatids: 1164.1;Late spermatids: 1577.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.9;non-classical monocyte: 3.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043061, HPA065309" Approved Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "HPA043061: AB_2678299, HPA065309: AB_2685462" "unprognostic (1.46e-1)" "unprognostic (8.10e-3)" "unprognostic (9.66e-3)" "unprognostic (1.18e-4)" "unprognostic (2.79e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-1)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (1.09e-2)" "unprognostic (2.83e-2)" "unprognostic (8.27e-2)" "unprognostic (5.41e-2)" "unprognostic (1.51e-1)" 7.5 2.9 7.8 9.0 6.0 0.5 4.0 5.6 7.0 8.9 10.1 8.0 3.0 2.3 11.1 5.5 5.4 4.2 6.5 28.2 5.5 7.3 2.5 7.6 6.4 2.9 10.6 5.2 2.1 4.1 4.8 2.0 6.0 10.8 7.7 3.3 3.4 2.4 6.3 48.7 2.6 3.3 23.8 26.5 4.6 3.9 44.6 6.1 0.7 2.4 1.3 4.8 15.9 5.8 0.9 2.6 0.0 3.9 0.0 0.4 0.8 17.0 1.7 3.4 1.7 7.2 11.4 6.3 14.9 21.3 11.8 12.0 17.5 4.1 1.0 7.6 20.6 5.2 11.8 3.3 7.4 16.6 9.7 1.6 0.0 2.0 3.6 4.1 0.0 0.1 6.4 2.5 8.5 12.6 3.3 9.2 0.0 1.3 0.0 5.5 1.1 0.2 0.0 1.7 0.1 4.1 0.5 6.8 0.0 5.5 5.5 0.5 5.6 2.3 2.9 7.7 7.2 11.2 0.2 18.6 14.0 23.1 3.4 4.6 0.1 0.0 0.0 4.0 0.3 4.5 0.0 2.3 0.0 0.0 3.9 0.0 0.3 0.0 0.0 2.6 0.9 0.0 0.0 0.0 0.0 3.6 0.0 0.4 0.8 7.8 6.0 5.6 5.7 5.5 7.3 10.6 5.2 10.8 6.1 23.8 1.0 3.2 34.8 35.1 0.5 244.5 12.7 0.0 5.7 17.4 7.9 7.5 3.3 8.2 1164.1 32.1 4.2 0.0 6.7 1.7 65.1 37.0 22.0 48.2 10.0 9.5 5.8 12.3 13.0 1577.3 13.6 11.7 23.6 0.0 1.3 1.0 14.6 5.8 22.3 19.2 4.2 12.9 48.5 12.7 7.2 21.2 1.6 1.0 1.3 37.6 SAMD4B "FLJ10211, hSmaug2, MGC99832, SMGB" ENSG00000179134 "Sterile alpha motif domain containing 4B" Q5PRF9 19 39342396-39385710 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 157.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016800, HPA059385" Approved Enhanced Cytosol No No Cytosol "HPA016800: AB_1856552, HPA059385: AB_2684000" "unprognostic (2.56e-1)" "unprognostic (6.76e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (2.17e-6)" "unprognostic (3.41e-2)" "unprognostic (8.66e-2)" "unprognostic (6.24e-3)" "unprognostic (2.31e-2)" "unprognostic (1.15e-1)" "unprognostic (4.98e-2)" "unprognostic (2.30e-1)" "unprognostic (4.92e-2)" "unprognostic (1.34e-2)" "unprognostic (1.32e-1)" "unprognostic (9.91e-3)" "unprognostic (2.12e-1)" "unprognostic (1.89e-2)" 24.9 24.6 34.8 19.5 43.9 15.0 19.5 24.9 34.3 26.3 19.5 40.0 18.8 15.9 24.5 15.2 32.7 27.9 22.5 18.8 29.2 19.5 16.5 14.1 20.4 11.8 37.3 24.0 35.2 22.5 37.5 23.5 21.9 32.6 21.1 13.7 20.9 19.9 30.4 18.1 25.1 18.4 23.7 28.7 19.0 18.9 23.0 37.7 13.6 21.2 12.3 15.2 21.8 24.2 3.0 2.5 6.8 2.8 2.1 3.7 1.2 31.6 43.5 22.3 16.9 21.8 26.3 18.4 18.3 20.2 14.7 12.3 38.0 17.8 10.6 24.0 29.2 19.1 15.4 21.9 16.8 10.1 21.2 35.8 10.6 17.9 15.8 22.5 11.4 11.2 25.8 19.9 24.1 18.0 18.1 13.8 14.4 31.2 11.6 17.9 21.7 12.3 5.6 17.6 20.8 17.7 15.0 14.3 9.2 12.3 25.8 22.9 22.3 24.1 16.6 13.1 17.7 13.4 12.4 18.1 24.1 17.6 52.1 32.0 21.8 19.6 11.8 32.1 9.0 23.5 2.9 2.8 3.9 3.0 1.1 2.2 3.0 2.2 2.4 2.0 2.0 3.7 2.6 6.8 2.1 0.9 2.5 0.9 1.2 34.8 43.9 24.9 34.3 29.2 19.5 37.3 24.0 32.6 37.7 11.9 34.9 22.6 53.6 29.7 54.1 6.3 22.9 22.7 12.5 34.9 157.1 21.2 5.0 24.8 5.4 24.0 21.3 0.0 23.6 18.1 28.6 59.6 17.4 24.5 17.8 49.3 49.0 43.6 19.3 1.8 40.6 19.2 18.6 9.0 26.3 29.5 31.1 17.3 31.1 9.9 67.9 64.7 25.5 62.7 26.6 38.0 45.7 19.2 21.8 58.6 SAMD9 "C7orf5, FLJ20073, KIAA2004" ENSG00000205413 "Sterile alpha motif domain containing 9" Q5K651 7 93099513-93118023 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.6;lymphoid tissue: 35.4" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 59.6;T-cells: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 29.4;GAMG: 28.8" "Low region specificity" "Detected in all" "HPA021318, HPA021319" Approved Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA021318: AB_2183383, HPA021319: AB_1856554" "unprognostic (3.66e-2)" "unprognostic (5.35e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (8.96e-2)" "unprognostic (1.38e-1)" "unprognostic (7.48e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (4.76e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (8.31e-5)" "unprognostic (6.00e-2)" "prognostic unfavorable (8.40e-7)" "unprognostic (5.91e-2)" "unprognostic (1.37e-2)" "unprognostic (2.18e-2)" "unprognostic (3.64e-1)" 9.6 4.0 2.3 9.2 2.4 5.2 2.6 1.0 1.6 9.3 6.8 0.6 0.9 4.3 2.8 3.0 34.6 2.7 4.3 2.5 1.3 1.5 6.3 3.5 7.8 10.8 2.5 1.1 6.3 2.3 0.1 6.4 11.3 3.1 5.3 7.0 0.7 5.7 1.6 2.4 1.5 12.7 2.2 2.5 21.7 6.3 2.5 1.7 35.4 3.3 9.9 9.5 4.8 9.7 5.5 3.0 15.6 9.8 7.4 7.6 2.6 11.7 1.5 0.4 0.1 5.3 6.8 0.1 4.6 19.3 22.2 29.4 0.0 13.1 4.9 7.3 11.4 28.8 13.9 0.0 4.2 7.5 16.8 0.5 7.2 7.9 0.0 2.4 8.0 10.0 3.0 6.1 7.3 2.0 1.2 3.3 5.5 0.5 12.3 4.6 0.0 11.9 6.6 0.0 0.0 3.3 3.9 3.9 5.6 0.1 1.5 1.9 0.2 3.6 1.4 3.8 0.0 0.4 3.9 14.2 5.2 1.9 15.5 2.5 7.4 1.4 4.6 5.4 4.7 5.1 15.6 3.6 12.7 7.6 7.0 7.3 5.0 5.9 6.5 3.0 5.5 6.3 5.7 15.5 7.4 9.8 2.1 7.2 2.6 2.3 2.4 1.0 1.6 1.3 1.5 2.5 1.1 3.1 1.7 8.9 3.0 23.2 7.5 2.1 1.6 0.9 2.5 20.1 9.1 14.0 0.0 1.5 0.0 20.9 0.0 24.8 12.1 0.0 10.8 4.6 8.3 6.6 41.7 1.0 10.7 6.4 2.9 8.0 24.0 0.2 14.1 26.3 3.3 13.6 20.9 2.0 32.1 59.6 11.7 2.1 0.0 12.9 9.2 0.2 0.0 1.6 0.3 50.7 3.3 25.5 SAMD9L "C7orf6, FLJ39885, KIAA2005" ENSG00000177409 "Sterile alpha motif domain containing 9 like" Q8IVG5 7 93130055-93148369 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 71.3;Paneth cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 21.0;GAMG: 17.0;HDLM-2: 18.6;Karpas-707: 50.1" "Low region specificity" "Detected in all" "HPA019461, HPA019465, HPA019488" Enhanced Approved Cytosol NA NA Cytosol "HPA019461: AB_1856555, HPA019465: AB_2183384, HPA019488: AB_1856557" "unprognostic (6.93e-3)" "unprognostic (6.12e-2)" "unprognostic (5.00e-2)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (5.03e-2)" "unprognostic (7.10e-2)" "unprognostic (4.21e-2)" "unprognostic (2.32e-1)" "unprognostic (6.18e-3)" "unprognostic (1.05e-3)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.63e-5)" "unprognostic (1.36e-1)" "unprognostic (2.07e-2)" "unprognostic (1.85e-2)" "unprognostic (1.22e-1)" 25.1 6.8 6.0 16.5 7.9 5.9 7.1 5.1 5.7 10.0 6.7 3.3 3.2 7.4 5.9 11.4 8.8 7.0 9.4 5.5 5.7 3.3 9.1 3.7 14.8 17.3 4.5 5.9 11.1 3.9 1.2 6.4 11.3 7.4 8.8 7.7 4.2 8.1 4.5 3.6 2.6 13.2 5.8 6.5 28.4 9.3 3.9 6.0 26.7 11.7 5.5 10.3 9.1 7.8 11.2 4.5 21.7 9.7 5.9 10.1 2.4 2.6 0.1 0.0 0.1 3.6 7.4 0.0 2.3 9.7 13.2 21.0 0.0 6.0 1.7 2.9 6.2 17.0 1.1 0.0 0.8 2.1 18.6 0.0 1.6 0.6 0.0 2.9 3.4 2.6 2.8 0.3 2.6 0.4 2.4 5.7 2.6 0.0 50.1 5.5 0.0 5.5 3.1 0.2 0.0 0.6 2.3 0.8 4.0 0.7 0.2 0.0 0.1 0.4 0.0 3.6 0.0 0.1 1.8 13.2 3.9 0.8 11.3 1.4 13.9 4.6 0.5 4.1 3.1 3.8 14.3 4.9 11.4 10.1 9.7 8.9 11.2 5.8 7.4 4.5 7.9 3.3 5.7 21.7 5.9 8.9 3.3 8.2 2.4 6.0 7.9 5.1 5.7 5.7 3.3 4.5 5.9 7.4 6.0 32.8 9.1 23.1 2.1 2.1 0.0 1.2 5.1 17.4 7.9 10.4 0.0 0.3 8.3 10.9 0.0 20.7 2.6 0.0 5.3 0.7 7.6 2.8 33.5 0.0 23.8 0.0 1.2 23.9 18.6 0.7 8.9 22.7 6.8 71.3 8.4 16.3 9.9 51.8 11.0 3.3 0.0 6.5 5.6 0.2 0.0 1.9 0.1 28.7 2.4 7.3 SAP18 "2HOR0202, MGC27131, SAP18p" ENSG00000150459 "Sin3A associated protein 18" O00422 13 21140514-21149084 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011352, CAB012273" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB012273: , HPA011352: AB_1856563" "unprognostic (5.08e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-3)" "unprognostic (2.84e-1)" "unprognostic (5.21e-2)" "unprognostic (3.02e-1)" "unprognostic (3.18e-1)" "unprognostic (8.15e-2)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (4.14e-2)" "unprognostic (2.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.70e-2)" "unprognostic (3.70e-3)" "unprognostic (2.78e-2)" 35.3 67.0 55.2 45.3 57.4 81.0 38.0 35.2 49.1 30.0 44.8 43.9 37.6 53.1 37.5 40.3 59.5 32.4 33.0 66.3 68.4 61.3 63.2 47.5 34.8 41.7 64.9 50.2 37.3 52.3 16.2 38.8 43.1 54.9 34.4 23.8 26.4 50.1 34.5 121.6 31.4 48.6 48.1 73.5 31.6 41.6 79.2 49.3 34.0 34.9 51.0 24.4 37.3 48.6 90.1 107.4 97.9 96.4 70.0 94.1 143.8 29.7 16.8 27.3 29.4 29.6 24.9 42.3 38.1 28.4 35.4 26.2 30.3 57.8 30.9 47.1 31.5 38.5 31.3 33.5 23.9 40.0 47.1 17.0 44.0 22.2 50.2 33.7 59.7 35.7 25.0 27.3 27.0 32.4 27.4 26.5 37.6 20.8 17.7 31.9 38.1 67.4 98.2 34.2 83.3 18.5 42.8 43.1 30.7 49.6 26.8 31.8 27.8 24.5 36.5 47.1 31.8 35.2 87.7 32.2 21.8 24.3 39.4 44.3 27.5 38.1 85.1 21.2 35.6 39.9 69.6 82.9 97.9 70.0 89.0 70.6 90.1 86.2 82.4 81.2 77.6 84.2 83.2 83.4 70.0 96.4 107.4 94.1 143.8 55.2 57.4 35.2 49.1 68.4 61.3 64.9 50.2 54.9 49.3 125.0 120.4 256.8 291.2 407.4 98.9 565.8 201.2 230.2 162.7 221.6 39.3 478.6 643.2 319.3 984.2 273.5 352.1 93.5 320.2 439.3 341.9 285.9 252.8 227.3 346.1 112.8 225.1 143.1 173.7 111.6 316.9 273.6 386.3 458.1 262.9 223.0 331.8 354.2 285.3 790.7 102.1 200.5 388.3 329.4 303.0 369.1 759.6 214.2 268.2 375.5 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062124-137070588 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.8;Mucus-secreting cells: 6.4;Paneth cells: 4.9;Undifferentiated cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavorable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 1.0 0.4 11.5 10.5 7.0 3.3 2.6 1.4 14.4 2.5 6.2 10.1 0.0 7.6 1.0 0.4 7.8 0.8 5.4 0.4 9.6 7.5 1.2 0.4 2.7 4.7 8.0 3.8 0.3 0.8 0.3 0.4 1.8 5.4 5.4 3.5 0.0 7.3 0.4 0.4 5.4 7.7 1.0 7.0 2.7 4.6 1.5 2.7 9.2 0.6 3.5 10.0 1.0 1.9 0.5 0.8 0.5 1.7 0.0 0.4 0.4 16.0 8.7 3.4 10.2 0.1 0.2 18.5 2.6 1.8 2.8 1.3 16.4 7.4 16.8 8.6 1.3 2.6 22.8 10.8 3.0 0.6 11.5 12.4 7.3 9.6 18.3 0.0 8.3 12.7 0.0 0.5 1.0 1.8 0.7 4.6 8.6 10.1 7.6 0.8 37.7 2.4 22.4 6.4 37.2 19.8 25.6 13.1 18.6 3.5 4.6 17.9 10.6 10.2 28.6 3.9 0.8 23.1 15.8 2.9 2.6 8.8 7.7 13.0 2.6 7.6 8.1 6.0 9.9 8.1 0.2 1.7 0.0 0.0 0.5 0.4 0.5 0.3 0.0 0.8 0.2 0.1 0.0 0.5 0.0 0.8 0.2 0.3 0.4 11.5 7.0 1.4 6.1 9.6 7.5 8.0 3.8 5.4 2.7 0.0 0.0 0.0 0.6 3.8 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.3 0.0 0.0 0.4 0.0 0.0 2.7 0.6 2.1 0.0 0.0 2.5 0.0 0.0 0.6 3.0 0.0 0.0 1.8 0.0 0.0 6.4 0.6 0.3 4.9 0.0 0.0 0.5 0.0 0.3 0.0 1.2 2.4 0.5 1.0 4.5 0.5 SARS SERS ENSG00000031698 "Seryl-tRNA synthetase" P49591 1 109213918-109238169 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis, Transcription, Transcription regulation" "Aminoacyl-tRNA synthetase, DNA-binding, Ligase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016939, HPA064668" Uncertain Enhanced Cytosol NA NA 100000 Cytosol "HPA016939: AB_1856585, HPA064668: AB_2685316" "unprognostic (4.92e-2)" "unprognostic (2.61e-1)" "unprognostic (5.87e-2)" "unprognostic (6.78e-2)" "prognostic favorable (9.47e-4)" "prognostic unfavorable (5.75e-4)" "prognostic unfavorable (6.13e-5)" "unprognostic (3.02e-1)" "unprognostic (1.77e-1)" "unprognostic (2.68e-2)" "unprognostic (3.23e-1)" "unprognostic (2.06e-1)" "unprognostic (1.69e-1)" "unprognostic (1.71e-1)" "unprognostic (1.56e-1)" "unprognostic (3.85e-2)" "unprognostic (3.45e-3)" 35.8 42.6 46.1 28.2 45.9 16.3 38.3 42.6 60.6 40.1 37.6 31.2 30.9 33.5 39.4 36.0 42.0 39.6 28.7 43.9 55.9 47.3 37.6 58.6 44.5 28.8 46.4 56.0 44.4 68.7 55.3 40.1 44.9 64.1 34.3 41.0 22.0 54.2 42.3 72.3 46.1 31.1 42.9 41.0 29.4 46.0 20.9 35.0 25.3 75.0 32.9 38.7 41.8 60.4 54.3 45.9 48.6 48.3 41.0 66.1 88.9 33.3 13.1 25.2 37.9 37.9 34.4 43.4 35.1 36.4 30.5 38.1 25.3 10.3 36.0 18.2 49.4 17.0 18.3 39.2 49.6 35.5 25.4 23.9 13.9 16.2 18.3 76.2 17.5 15.7 42.3 86.8 35.9 78.3 26.0 36.3 45.5 31.8 45.1 29.6 31.9 19.4 8.9 10.5 20.0 31.0 16.1 32.2 16.1 23.2 17.7 35.0 18.6 16.8 27.1 95.1 20.0 15.3 20.9 28.6 18.2 22.9 25.8 24.5 34.4 13.9 29.5 57.4 19.3 61.8 35.6 44.5 48.6 56.0 48.2 58.4 54.3 59.3 55.4 45.9 52.5 61.8 57.7 21.3 41.0 48.3 29.6 66.1 88.9 46.1 45.9 42.6 60.6 55.9 47.3 46.4 56.0 64.1 35.0 47.6 92.0 61.1 90.9 109.9 51.2 87.9 81.5 66.9 81.9 68.0 21.6 157.2 112.7 120.1 15.1 64.7 75.8 70.0 195.0 122.6 80.4 56.7 96.0 112.9 78.0 55.6 66.7 63.8 59.4 21.0 73.1 68.8 60.8 110.0 61.3 56.1 142.9 49.1 65.4 85.4 34.4 129.4 118.7 46.1 22.4 95.2 157.6 64.0 84.6 77.6 SASH1 "dJ323M4.1, KIAA0790, SH3D6A" ENSG00000111961 "SAM and SH3 domain containing 1" O94885 6 148272304-148552050 "Predicted intracellular proteins" "Disease mutation, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 97.4;Muller glia cells: 93.7;Sertoli cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.9;intermediate monocyte: 5.5;non-classical monocyte: 2.6" "Lineage enriched" "Detected in single" 32 "monocytes: 5.5" "Cell line enhanced" "Detected in many" "ASC diff: 60.2;ASC TERT1: 22.8;HUVEC TERT2: 21.8;WM-115: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029947, HPA029949" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029947: AB_10598915, HPA029949: AB_10602280" "unprognostic (9.71e-2)" "unprognostic (4.74e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (3.55e-2)" "unprognostic (4.79e-3)" "unprognostic (6.69e-2)" "unprognostic (4.76e-2)" "unprognostic (2.06e-1)" "unprognostic (8.65e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-1)" "unprognostic (2.13e-3)" "unprognostic (5.45e-2)" "unprognostic (3.53e-1)" "unprognostic (8.04e-3)" "unprognostic (1.54e-1)" 41.4 5.4 19.6 5.3 21.7 0.7 25.7 9.9 28.1 16.8 9.2 22.2 4.4 5.6 11.2 9.3 35.6 10.0 15.6 13.2 21.9 14.2 13.5 7.7 16.7 4.7 26.3 11.4 5.3 7.7 15.0 3.5 23.5 22.8 9.8 8.3 9.2 12.2 8.1 10.6 17.5 6.7 13.2 28.6 10.3 6.0 4.8 22.3 0.2 30.9 10.4 8.2 13.2 17.9 0.0 0.0 0.1 5.5 0.0 0.1 0.6 1.3 0.8 6.9 2.3 60.2 22.8 1.1 7.9 19.1 6.0 9.2 1.7 1.6 0.0 4.2 21.1 3.0 1.6 2.1 1.9 5.0 0.0 1.5 0.0 3.9 1.6 1.8 0.0 0.4 10.6 1.9 9.0 2.4 2.4 21.8 0.0 0.1 0.0 5.6 1.5 0.0 0.0 2.0 0.7 1.1 0.0 5.0 0.0 4.4 4.3 0.2 0.0 2.4 8.9 6.2 1.8 0.7 3.9 18.9 5.9 1.2 18.6 1.7 0.0 0.0 0.0 9.4 0.0 27.8 0.1 2.9 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.6 19.6 21.7 9.9 17.9 21.9 14.2 26.3 11.4 22.8 22.3 14.9 20.8 0.8 6.3 36.5 12.5 18.3 7.6 14.7 21.6 43.6 5.9 16.4 6.6 2.2 0.5 97.4 2.5 0.0 2.1 55.4 26.8 6.2 2.3 6.6 8.1 3.2 4.6 63.8 31.8 1.1 17.0 12.1 40.5 0.0 4.5 93.7 1.2 2.9 26.5 12.2 3.9 77.6 64.3 0.3 4.5 28.9 27.3 0.0 6.4 5.7 SASS6 "DKFZp761A078, FLJ22097, SAS-6, SAS6" ENSG00000156876 "SAS-6 centriolar assembly protein" Q6UVJ0 1 100083563-100132955 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 71.0;Spermatogonia: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028187 Uncertain Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite" Cytosol "HPA028187: AB_10602220" "unprognostic (1.57e-1)" "unprognostic (2.52e-1)" "unprognostic (3.07e-2)" "unprognostic (2.06e-2)" "unprognostic (1.31e-1)" "unprognostic (3.02e-3)" "unprognostic (1.21e-4)" "unprognostic (1.27e-1)" "unprognostic (8.43e-3)" "unprognostic (4.73e-2)" "unprognostic (6.56e-2)" "unprognostic (3.71e-2)" "unprognostic (7.76e-8)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.54e-1)" 6.2 3.8 3.8 6.1 5.4 10.9 5.9 17.8 6.9 6.4 6.1 5.0 8.3 6.4 4.8 5.5 6.2 4.3 2.5 3.2 5.4 3.5 3.3 3.5 3.3 8.5 5.5 3.3 5.3 4.2 10.2 12.0 5.9 5.8 6.9 6.4 3.1 5.1 4.8 3.8 4.5 7.0 4.9 6.2 7.3 4.6 15.0 6.9 17.1 4.6 5.0 7.7 4.5 4.8 5.1 1.4 8.1 2.3 2.3 3.6 1.4 11.4 3.9 9.4 9.1 1.1 2.0 13.7 7.2 3.5 9.6 11.4 6.0 6.2 12.3 6.3 2.9 5.5 10.6 12.7 4.4 12.9 6.8 12.8 10.4 8.3 7.7 0.6 17.6 10.6 1.0 2.1 7.9 7.0 2.0 5.0 9.1 16.8 12.1 4.4 3.4 15.7 8.5 12.2 7.8 7.8 11.3 18.4 6.4 4.5 5.3 6.7 10.0 7.2 11.7 6.0 6.9 5.8 10.7 2.4 6.6 8.4 7.7 10.2 6.1 12.4 17.2 5.5 11.7 3.7 8.1 1.2 4.8 3.5 2.3 3.6 5.1 3.4 2.9 1.4 3.9 3.1 3.0 3.5 2.3 1.7 1.4 3.1 1.4 3.8 5.4 17.8 6.9 5.4 3.5 5.5 3.3 5.8 6.9 0.0 2.9 10.4 2.1 3.5 17.2 2.4 5.1 6.7 5.7 1.8 15.7 8.3 1.7 6.0 11.7 4.7 1.6 0.0 4.9 17.1 5.2 3.5 5.7 2.9 8.1 7.9 4.1 6.7 5.0 4.0 7.5 4.9 1.7 5.4 4.1 10.9 5.1 2.9 10.3 3.7 21.0 0.0 4.7 71.0 34.5 3.6 4.2 6.4 6.3 1.7 SATL1 ENSG00000184788 "Spermidine/spermine N1-acetyl transferase like 1" Q86VE3 X 85092287-85243961 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 11.7;Ciliated cells: 17.4;Club cells: 12.5;Late spermatids: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HAP1: 3.5;HEL: 1.2;RH-30: 1.5;SH-SY5Y: 1.4;SuSa: 1.0" HPA060369 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060369: AB_2684265" "unprognostic (1.77e-1)" "unprognostic (2.06e-1)" "unprognostic (4.69e-3)" "unprognostic (7.88e-2)" 0.3 2.7 2.9 0.4 2.6 0.4 0.4 5.4 4.6 0.4 0.4 0.2 0.0 0.3 0.4 0.3 0.3 0.4 0.3 0.5 2.2 2.0 1.1 0.4 0.3 0.3 1.1 2.7 0.4 0.3 0.3 7.2 0.4 2.2 0.5 0.4 0.0 0.4 0.3 0.7 0.6 0.3 0.3 1.4 0.4 0.3 4.8 0.4 0.0 0.4 0.2 0.3 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 3.5 0.0 0.0 0.0 0.6 1.2 0.1 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.5 0.0 0.0 0.1 0.5 1.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.6 5.4 4.6 2.2 2.0 1.1 2.7 2.2 0.4 11.9 11.7 0.0 0.0 0.0 0.0 0.0 0.0 17.4 12.5 0.0 0.0 0.0 3.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SAV1 "salvador, WW45, WWP4" ENSG00000151748 "Salvador family WW domain containing protein 1" Q9H4B6 14 50632058-50668331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001808 Approved Supported Cytosol NA NA Cytosol "HPA001808: AB_2666441" "prognostic favorable (2.92e-5)" "unprognostic (5.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.52e-2)" "unprognostic (4.38e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-3)" "unprognostic (3.00e-2)" "unprognostic (1.82e-1)" "unprognostic (1.37e-1)" "unprognostic (1.41e-3)" "unprognostic (5.20e-2)" "prognostic favorable (3.83e-6)" "unprognostic (2.32e-1)" "unprognostic (2.05e-1)" "unprognostic (1.28e-2)" "unprognostic (1.90e-3)" 28.5 13.5 13.9 10.8 16.2 5.0 30.3 11.9 13.9 23.3 18.9 19.9 13.8 11.7 19.3 15.5 13.9 17.1 20.7 23.1 15.6 12.5 18.4 13.5 22.1 10.9 17.3 11.1 30.8 31.3 24.5 11.2 17.0 15.6 29.2 10.1 18.6 34.0 19.8 25.6 15.9 18.3 16.0 20.1 16.6 16.5 22.5 17.7 5.5 32.1 12.1 11.0 23.5 36.7 7.1 2.3 1.1 0.7 0.9 1.9 0.9 37.1 4.3 7.2 5.0 18.0 16.6 9.1 10.5 34.9 13.8 17.7 6.3 19.1 5.8 26.1 10.4 7.3 17.1 10.3 11.4 25.8 17.7 8.0 6.4 6.8 4.5 8.8 6.9 5.9 10.3 14.8 6.2 13.8 10.5 9.8 6.4 10.5 2.9 17.0 6.9 5.8 4.3 13.5 8.4 6.7 6.6 20.1 2.4 8.7 5.4 9.1 7.1 18.7 11.2 15.7 12.4 8.1 7.0 7.0 6.6 22.6 9.0 6.4 4.5 5.8 3.5 4.6 2.8 8.8 1.1 0.7 0.1 1.7 0.6 1.9 6.2 1.4 1.2 0.7 7.1 1.1 1.4 1.1 0.9 0.7 2.3 1.6 0.9 13.9 16.2 11.9 13.9 15.6 12.5 17.3 11.1 15.6 17.7 32.8 41.9 22.9 32.5 58.5 16.9 34.0 15.3 38.8 46.6 17.4 23.6 17.6 14.9 36.3 55.9 45.2 9.7 0.0 41.0 16.7 43.1 61.4 2.3 12.8 9.3 4.8 5.2 51.5 12.9 18.4 61.9 17.6 28.7 13.6 10.7 21.7 59.9 11.5 40.0 11.7 24.7 6.5 54.3 39.0 38.3 51.9 19.3 7.5 9.5 29.0 SBDS "CGI-97, FLJ10917, SDS, SWDS" ENSG00000126524 "SBDS, ribosome maturation factor" Q9Y3A5 7 66987677-66995601 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 1381.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028891 Approved Supported Nucleoplasm,Cytosol NA NA 55000 "Nucleoplasm, Cytosol" "HPA028891: AB_10601500" "prognostic unfavorable (1.49e-4)" "unprognostic (1.87e-2)" "unprognostic (5.73e-2)" "unprognostic (1.71e-3)" "unprognostic (8.06e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.07e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (6.99e-2)" "unprognostic (7.84e-3)" "unprognostic (4.59e-1)" "unprognostic (1.04e-2)" "unprognostic (9.38e-3)" "unprognostic (1.83e-1)" "unprognostic (2.30e-1)" "unprognostic (5.06e-3)" 40.9 34.5 37.7 18.7 44.0 41.7 44.5 23.6 43.2 30.7 37.5 35.3 20.2 39.1 35.6 27.3 40.8 27.7 34.0 70.0 39.2 40.9 36.9 38.4 32.1 16.7 50.6 36.6 31.9 27.5 50.4 26.9 38.6 44.6 35.1 35.7 20.1 23.5 40.5 130.7 26.1 34.4 52.0 63.2 16.7 32.8 15.9 48.2 7.2 33.9 38.7 15.6 54.0 38.0 21.6 15.5 20.8 12.6 16.6 39.1 19.4 31.4 13.3 11.8 10.7 43.2 32.3 13.2 53.5 44.1 41.0 31.5 27.4 16.2 11.7 40.6 48.9 27.1 15.3 19.9 31.8 44.1 11.1 26.3 5.7 24.9 16.4 38.5 14.6 8.0 29.1 42.8 31.1 54.2 21.2 25.2 7.7 42.2 12.8 63.6 18.8 7.7 21.2 13.1 43.4 31.7 5.9 25.5 24.4 43.2 14.1 18.2 12.5 26.8 46.4 35.5 27.3 34.6 12.4 33.5 55.4 18.9 28.0 39.0 7.9 9.3 26.7 19.0 24.0 30.6 20.8 11.1 20.2 23.4 12.6 29.6 21.6 30.6 27.2 11.3 18.7 39.1 31.5 4.7 16.6 11.2 15.5 25.9 19.4 37.7 44.0 23.6 43.2 39.2 40.9 50.6 36.6 44.6 48.2 282.9 101.3 66.6 339.3 412.4 74.2 273.7 79.0 58.9 128.5 87.2 11.8 116.1 222.2 161.5 544.8 139.6 267.8 46.7 145.1 193.1 210.9 212.5 144.6 97.2 95.0 55.6 97.9 127.7 39.0 1381.2 117.6 84.1 243.0 99.2 183.0 124.0 212.7 199.9 158.4 222.6 46.7 161.7 333.7 75.3 45.3 375.9 333.3 96.2 134.2 299.8 SBF2 "CMT4B2, DENND7B, KIAA1766, MTMR13" ENSG00000133812 "SET binding factor 2" Q86WG5 11 9778667-10294207 "Disease related genes, Predicted intracellular proteins" Autophagy "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050933 Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Intermediate filaments, Cytosol" "HPA050933: AB_2681280" "unprognostic (2.26e-1)" "unprognostic (1.45e-2)" "unprognostic (1.91e-2)" "unprognostic (1.00e-1)" "unprognostic (2.28e-1)" "unprognostic (5.36e-2)" "unprognostic (5.55e-2)" "unprognostic (6.44e-3)" "unprognostic (2.84e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-3)" "unprognostic (2.43e-1)" "prognostic favorable (3.66e-5)" "unprognostic (3.72e-2)" "unprognostic (8.77e-2)" "unprognostic (3.43e-1)" "unprognostic (4.11e-2)" 26.2 12.7 19.8 8.9 22.5 6.1 17.9 26.7 17.4 23.6 15.6 18.4 13.2 9.8 19.1 14.2 16.9 15.3 14.9 13.7 16.3 12.3 20.8 13.8 13.8 8.7 14.6 12.0 26.8 8.0 33.9 23.2 20.5 13.7 16.8 15.3 15.6 14.7 17.7 8.8 13.2 11.1 22.0 16.1 12.4 13.3 15.3 19.1 7.8 24.0 9.1 9.2 20.2 25.5 0.6 1.0 3.9 3.9 0.9 0.6 0.5 6.7 6.1 9.6 6.8 12.9 17.2 49.3 5.3 9.6 6.3 8.9 4.0 8.3 2.6 2.8 9.3 9.2 4.5 5.7 4.3 11.0 2.7 4.1 1.0 4.4 5.4 5.2 2.4 3.6 8.7 5.8 3.3 12.3 9.6 10.2 5.6 2.2 2.5 7.4 2.0 3.5 0.7 4.1 6.1 6.1 3.3 6.7 3.4 5.6 6.1 3.2 7.1 7.3 10.2 4.5 5.2 3.0 1.7 11.1 11.3 5.6 11.2 4.3 0.9 1.9 3.7 8.4 1.2 7.9 0.0 1.9 0.1 0.2 1.8 0.6 0.3 0.2 0.4 1.0 0.6 0.3 0.1 3.9 0.9 3.9 0.4 0.2 0.5 19.8 22.5 26.7 17.4 16.3 12.3 14.6 12.0 13.7 19.1 41.7 103.3 8.8 32.8 22.7 31.5 23.8 15.3 38.8 31.8 15.7 70.7 11.6 3.3 11.0 12.7 38.3 13.8 0.0 7.5 10.5 31.5 47.0 19.8 14.7 16.3 35.0 42.1 51.0 51.2 6.2 47.2 31.9 28.7 15.4 17.1 13.0 10.9 21.8 25.5 9.8 76.6 25.8 28.8 16.8 16.8 26.8 11.6 34.6 17.2 43.4 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase O75845 11 121292453-121308694 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 143.5" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 117.3;Ito cells: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066283, HPA070248" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" No No "Nucleoplasm, Endoplasmic reticulum" "Plasma membrane, Cytosol" "HPA066283: AB_2685648, HPA070248: AB_2686240" "unprognostic (4.78e-2)" "unprognostic (7.29e-2)" "unprognostic (2.26e-2)" "unprognostic (2.36e-1)" "unprognostic (3.98e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (2.79e-2)" "unprognostic (7.96e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (4.03e-2)" "unprognostic (3.18e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.07e-7)" "unprognostic (4.29e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.98e-1)" 10.9 15.3 16.9 5.5 18.4 2.7 23.3 10.4 26.9 9.4 9.4 17.8 24.5 17.4 6.8 30.1 19.5 7.2 7.4 9.4 18.7 19.6 19.7 143.5 10.1 5.5 20.8 17.8 7.8 8.9 17.5 14.7 6.3 40.8 40.3 8.6 8.2 9.5 24.0 3.9 7.7 13.4 7.6 43.4 4.1 8.8 9.7 16.0 3.7 10.4 8.2 8.1 14.0 14.6 6.0 9.8 7.5 6.3 6.8 10.0 3.8 6.8 3.4 51.8 11.0 20.1 17.5 7.3 7.7 14.5 5.2 9.2 21.6 25.5 6.5 24.4 8.4 41.5 25.7 16.1 19.5 5.1 3.2 22.0 9.6 22.6 17.2 16.4 6.0 3.3 14.3 16.0 16.4 16.9 4.4 7.8 6.4 6.2 9.4 24.0 7.1 2.4 7.9 16.1 19.8 11.0 3.4 13.0 5.5 36.5 30.8 13.7 7.7 17.7 4.0 10.1 36.2 16.2 10.4 14.9 5.0 8.1 8.8 3.6 1.8 2.9 8.7 1.9 13.4 8.6 7.5 4.8 1.2 5.0 6.3 8.5 6.0 6.8 6.0 8.5 6.0 10.0 9.5 0.4 6.8 4.5 9.8 6.9 3.8 16.9 18.4 10.4 26.9 18.7 19.6 20.8 17.8 40.8 16.0 17.9 26.4 26.2 53.7 8.7 21.9 17.8 15.3 14.7 18.2 19.2 29.5 13.8 5.0 17.3 2.2 8.4 23.5 0.0 25.4 14.2 17.3 59.7 17.3 117.3 17.9 22.3 13.8 163.9 25.6 1.0 17.8 15.1 18.6 22.6 12.7 40.5 14.5 11.4 15.9 14.6 29.6 12.9 16.7 6.0 13.0 13.6 15.6 21.7 11.9 45.5 SCAF1 "FLJ00034, SR-A1" ENSG00000126461 "SR-related CTD associated factor 1" Q9H7N4 19 49642125-49658642 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046828, HPA054593" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046828: AB_10961907, HPA054593: AB_2682536" "unprognostic (1.16e-1)" "unprognostic (3.08e-1)" "prognostic unfavorable (9.59e-4)" "unprognostic (3.38e-2)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (4.43e-3)" "unprognostic (4.11e-3)" "unprognostic (1.01e-1)" "unprognostic (8.30e-3)" "unprognostic (1.29e-2)" "unprognostic (3.52e-3)" "unprognostic (4.78e-2)" "unprognostic (3.03e-1)" "unprognostic (2.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.18e-2)" 21.6 15.6 22.2 17.0 30.5 14.4 12.9 24.9 48.3 14.1 15.0 27.0 7.4 18.2 18.9 7.4 27.2 24.0 17.2 21.3 21.4 18.9 12.4 13.9 13.9 17.7 17.5 21.6 24.1 21.1 13.7 17.5 18.4 26.1 15.0 8.6 14.1 20.8 11.8 28.4 18.5 17.0 14.6 14.8 20.2 17.0 15.9 15.7 19.7 18.4 8.4 13.1 16.9 13.6 5.1 5.1 7.8 2.9 1.9 4.2 3.2 26.5 46.7 12.8 21.1 6.1 5.8 15.6 20.1 6.6 9.4 8.0 25.3 16.6 15.5 13.8 7.4 14.3 20.5 9.2 12.3 2.8 23.9 26.2 17.4 23.1 12.6 10.5 16.5 17.3 9.7 7.8 11.3 8.0 9.2 7.6 6.4 22.4 16.0 7.4 17.1 16.5 8.8 16.3 12.1 28.0 20.5 17.8 16.0 6.2 38.5 19.1 20.9 20.7 21.9 7.4 8.2 15.2 9.2 20.8 34.4 19.9 12.2 29.4 22.7 33.7 14.8 20.7 10.5 19.4 4.0 2.9 2.7 4.2 2.5 2.7 5.1 2.4 2.8 2.3 4.7 2.2 2.4 7.8 1.9 2.2 5.1 0.5 3.2 22.2 30.5 24.9 48.3 21.4 18.9 17.5 21.6 26.1 15.7 6.0 0.0 14.5 7.4 10.8 11.9 2.4 12.7 0.0 0.0 21.0 3.9 12.5 6.6 11.8 26.1 4.5 25.6 0.0 11.2 11.6 9.9 10.2 5.7 14.4 12.3 9.5 13.8 17.8 9.2 73.7 20.4 6.3 10.1 10.8 18.1 9.9 13.8 17.6 22.3 11.2 6.9 12.9 8.2 13.7 19.2 10.5 18.4 8.9 17.2 10.2 SCAPER "Zfp291, ZNF291" ENSG00000140386 "S-phase cyclin A associated protein in the ER" Q9BY12 15 76347904-76905444 "Predicted intracellular proteins" "Disease mutation, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 237.6;Rod photoreceptor cells: 661.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046253, HPA048077" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA No "Nucleoplasm, Nuclear speckles" Cytosol "HPA046253: AB_2679600, HPA048077: " "unprognostic (3.67e-1)" "unprognostic (8.60e-2)" "unprognostic (6.08e-2)" "unprognostic (8.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (4.94e-2)" "unprognostic (3.74e-2)" "unprognostic (5.40e-2)" "unprognostic (1.02e-1)" "prognostic favorable (2.69e-9)" "unprognostic (2.14e-1)" "unprognostic (3.79e-1)" "unprognostic (1.86e-1)" "unprognostic (2.89e-3)" 9.0 10.9 17.0 9.3 15.6 8.8 9.4 26.0 20.7 10.3 8.3 10.7 9.8 8.9 10.0 10.8 12.1 9.0 7.5 17.8 15.9 17.2 12.6 9.9 8.4 7.1 17.3 13.2 16.8 10.9 24.1 36.3 24.6 15.6 9.9 6.3 7.7 9.7 9.5 17.9 9.8 8.3 10.4 20.6 7.5 7.9 25.7 14.7 12.6 16.3 8.7 7.7 9.4 9.5 13.2 6.6 20.4 4.6 12.0 14.3 2.8 5.0 4.7 6.6 3.8 3.3 6.2 5.5 7.0 4.9 3.2 4.6 5.0 4.1 5.1 6.1 2.3 8.6 5.5 15.5 2.9 4.8 11.9 7.6 2.7 5.7 2.4 4.3 7.2 6.4 5.1 5.2 3.8 6.2 7.0 4.3 10.5 3.8 14.6 5.5 2.1 7.0 2.2 2.0 4.7 2.8 6.4 10.5 1.8 2.9 5.2 15.7 7.6 9.2 3.2 7.5 8.4 4.8 6.0 5.2 7.4 6.9 3.5 6.0 8.9 18.6 7.6 4.3 9.1 4.9 20.4 4.6 11.5 8.6 2.5 9.8 11.0 8.7 7.6 2.5 13.2 14.3 9.1 7.7 12.0 2.9 6.6 6.6 2.8 17.0 15.6 26.0 17.1 15.9 17.2 17.3 13.2 15.6 14.7 92.3 52.8 16.4 22.9 18.3 84.2 167.4 15.3 16.0 40.9 12.2 237.6 23.7 1.7 11.6 45.9 22.0 20.2 0.0 5.1 9.4 13.4 12.1 20.9 7.9 11.7 73.1 15.5 19.0 11.0 17.8 19.0 10.3 10.1 3.6 7.7 46.4 5.9 11.6 18.0 5.7 661.5 19.4 11.7 121.4 69.5 16.4 43.5 21.2 12.4 19.7 SCARB2 "CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII" ENSG00000138760 "Scavenger receptor class B member 2" Q14108 4 76158733-76234536 "Disease related genes, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 18.3;granulocytes: 6.2;monocytes: 15.3" "Cell line enhanced" "Detected in many" "ASC diff: 88.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015415, HPA018014" Supported Approved Cytosol NA NA Cytosol "CAB015415: AB_831511, HPA018014: AB_1852881" "prognostic unfavorable (2.82e-5)" "unprognostic (2.73e-2)" "unprognostic (4.09e-2)" "unprognostic (4.96e-2)" "unprognostic (4.17e-3)" "unprognostic (1.12e-3)" "unprognostic (2.08e-1)" "unprognostic (5.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.25e-2)" "unprognostic (4.11e-2)" "unprognostic (1.67e-1)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (6.88e-2)" "unprognostic (5.06e-2)" "unprognostic (3.89e-2)" 33.6 20.6 30.7 13.0 32.9 4.1 34.1 22.9 42.8 40.1 34.9 63.7 21.4 22.7 26.8 37.0 20.3 24.9 34.5 29.7 35.7 30.3 29.0 51.6 43.8 21.7 43.9 31.6 37.0 32.3 47.5 14.5 41.0 44.1 44.2 32.7 23.1 40.3 34.1 54.3 16.5 27.6 24.4 70.5 26.7 36.1 16.1 40.7 6.2 39.2 16.5 10.8 31.7 40.3 2.6 18.3 6.2 15.3 0.7 3.0 3.6 5.7 4.6 7.2 13.9 88.2 43.1 6.1 19.3 44.4 16.9 31.4 8.2 15.9 0.0 15.3 41.3 16.3 4.9 5.1 12.0 17.9 24.8 5.8 0.5 4.2 3.9 21.6 3.0 2.0 31.9 12.1 17.9 10.3 39.3 30.2 1.5 2.7 29.2 26.0 8.8 0.2 0.6 1.7 17.1 4.5 3.6 14.7 4.9 11.9 3.8 17.1 17.7 16.5 11.5 16.7 9.4 5.2 3.0 19.9 17.1 8.6 14.1 6.0 27.1 17.0 0.0 19.9 3.9 25.2 6.2 8.8 2.1 1.8 15.3 1.9 2.6 1.5 1.1 5.2 2.0 1.8 3.0 1.5 0.7 14.7 18.3 1.8 3.6 30.7 32.9 22.9 41.1 35.7 30.3 43.9 31.6 44.1 40.7 163.8 38.3 16.4 69.4 21.3 92.5 50.2 96.8 45.5 37.5 94.2 56.9 29.5 6.6 100.8 5.0 72.9 82.1 0.0 63.0 42.1 60.9 149.5 3.5 90.6 138.6 57.2 98.3 91.4 117.9 2.9 42.0 58.7 64.1 26.2 73.9 73.8 79.5 66.0 62.6 27.2 69.7 90.5 54.8 3.4 13.2 29.5 49.7 10.5 48.8 82.4 SCARF2 "HUMZD58C02, SREC-II, SREC2" ENSG00000244486 "Scavenger receptor class F member 2" Q96GP6 22 20424815-20437826 "Disease related genes, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 28.8;Fibroblasts: 17.0;Leydig cells: 12.4;Peritubular cells: 16.6;Sertoli cells: 12.9;Smooth muscle cells: 14.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 14.2;SH-SY5Y: 15.8;SK-MEL-30: 15.7;U-138 MG: 21.8;U-2 OS: 22.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035079 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA035079: AB_10670287" "unprognostic (2.12e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-3)" "unprognostic (2.29e-1)" "unprognostic (2.92e-1)" "unprognostic (7.68e-2)" "unprognostic (7.87e-2)" "unprognostic (8.27e-2)" "unprognostic (2.18e-2)" "unprognostic (1.68e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.38e-3)" "unprognostic (3.18e-2)" "unprognostic (3.00e-3)" "prognostic unfavorable (4.28e-4)" 6.5 2.4 0.0 4.1 0.3 0.1 9.2 0.0 1.2 10.6 3.2 0.4 2.9 1.4 8.1 6.6 1.8 2.6 11.3 3.4 0.6 3.2 1.1 5.9 5.1 0.8 0.4 12.6 1.6 0.0 0.6 5.6 0.9 5.5 0.0 9.2 1.1 6.8 1.8 2.2 1.9 9.9 0.5 5.3 1.4 2.5 0.0 0.0 5.4 3.3 1.4 7.1 10.9 0.1 0.1 0.9 0.0 0.0 1.8 0.0 0.4 0.2 3.2 5.5 1.9 2.7 1.3 14.2 5.9 3.4 1.8 0.0 0.0 0.2 8.3 6.8 0.2 0.1 1.8 0.0 0.4 0.4 11.9 1.1 0.2 2.5 11.8 0.0 0.6 4.6 0.0 1.7 0.8 1.6 1.7 0.0 0.1 0.1 1.2 0.6 0.0 0.2 4.3 0.0 1.8 0.3 9.0 0.0 0.0 0.0 1.4 15.8 0.1 0.0 15.7 0.6 0.5 0.0 2.1 21.8 22.9 0.5 3.2 0.6 0.2 0.2 0.1 0.3 10.8 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 1.7 2.5 3.0 28.8 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.2 3.3 0.0 0.0 0.0 1.2 17.0 2.2 0.0 0.0 0.5 0.0 0.0 2.5 0.6 0.0 12.4 0.6 3.3 0.0 0.0 0.5 0.0 0.0 16.6 0.0 0.4 12.9 14.4 0.5 0.2 2.4 0.3 0.0 0.0 0.5 SCEL "FLJ21667, MGC22531" ENSG00000136155 Sciellin O95171 13 77535674-77645263 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 145.6;skin 1: 70.8;tongue: 62.2" "Cell type enriched" "Detected in many" 13 "Alveolar cells type 1: 631.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.4;HaCaT: 23.3;HBEC3-KT: 11.1;OE19: 31.1;RPTEC TERT1: 45.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039737, HPA040154" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Plasma membrane" "Nucleoplasm, Cytosol" "HPA039737: AB_10805485, HPA040154: AB_10795359" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.07e-4)" "unprognostic (5.91e-2)" "unprognostic (4.54e-2)" "unprognostic (6.62e-2)" "unprognostic (3.51e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (1.24e-4)" "unprognostic (4.57e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.81e-1)" "unprognostic (2.82e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (1.73e-5)" 0.4 0.0 0.1 0.2 0.4 0.0 4.9 0.1 0.2 15.2 0.2 0.2 0.1 0.0 0.8 0.2 145.6 0.0 0.3 0.1 0.1 0.0 0.4 0.1 27.8 0.1 0.1 0.1 0.2 0.1 0.0 0.1 3.7 0.2 0.1 0.4 0.1 11.8 0.1 0.3 70.8 0.2 0.1 0.2 0.1 0.0 0.5 0.1 0.4 0.5 62.2 35.1 0.4 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.7 0.0 0.0 23.3 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 6.3 0.0 0.0 0.0 45.3 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 631.3 30.6 0.0 0.0 9.5 0.0 0.2 0.0 6.7 42.1 0.0 0.0 0.3 0.0 4.1 5.8 0.0 0.0 0.0 0.2 0.0 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.6 1.7 0.0 4.3 1.5 26.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.7 48.8 0.1 0.0 0.0 2.6 SCFD1 "C14orf163, KIAA0917, RA410, SLY1, STXBP1L2" ENSG00000092108 "Sec1 family domain containing 1" Q8WVM8 14 30622112-30735812 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003579 Approved Approved Nucleoplasm,Cytosol NA NA 59000 Nucleoplasm Cytosol "HPA003579: AB_1079872" "unprognostic (2.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.07e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.24e-2)" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (3.07e-2)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (7.52e-3)" "unprognostic (1.05e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-1)" "unprognostic (6.32e-2)" 22.4 22.7 20.6 17.6 29.7 15.5 21.7 21.9 28.1 27.7 20.0 12.6 19.3 17.1 20.5 23.3 25.9 19.0 13.4 20.9 19.2 17.8 24.5 33.9 18.8 16.6 16.5 19.4 21.8 33.8 28.5 68.5 29.4 26.0 20.3 21.9 14.5 34.5 22.3 24.7 15.7 22.0 19.6 15.6 20.4 18.8 18.8 17.1 24.4 31.0 18.0 19.0 17.2 22.3 14.3 16.3 18.8 17.2 19.4 15.9 9.2 24.4 10.6 13.6 9.0 22.4 25.3 19.8 18.3 25.5 27.0 32.1 17.2 18.5 13.5 8.8 28.9 12.0 14.2 16.7 19.3 31.5 18.9 9.2 9.3 14.9 58.0 28.1 17.4 12.1 18.8 14.8 16.6 28.3 19.2 18.3 8.5 15.3 25.8 26.6 28.8 10.7 10.1 13.0 24.3 18.7 9.4 14.9 16.3 21.8 21.2 14.2 11.9 17.7 17.7 18.1 14.4 25.9 13.0 14.7 18.7 14.4 15.6 15.2 17.8 16.6 18.5 8.8 13.5 19.4 18.8 13.4 15.6 9.6 14.4 12.4 14.3 11.1 12.0 16.3 12.3 10.5 10.7 4.3 19.4 17.2 13.3 15.9 9.2 20.6 29.7 21.9 28.1 19.2 17.8 16.5 19.4 26.0 17.1 47.6 25.3 39.5 46.3 22.1 34.1 32.1 20.4 52.2 36.4 24.4 41.2 55.2 54.7 40.9 20.1 30.2 26.5 23.3 44.2 52.3 39.9 39.2 51.0 18.5 40.8 28.6 45.3 22.1 24.6 13.2 35.6 40.1 35.4 67.7 33.2 29.7 37.5 25.9 37.8 30.5 39.0 12.9 31.2 66.2 51.7 21.3 69.5 39.9 24.8 40.0 SCGN "CALBL, DJ501N12.8, SECRET, SEGN" ENSG00000079689 "Secretagogin, EF-hand calcium binding protein" O76038 6 25652201-25701783 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3;pancreas: 39.7;pituitary gland: 47.9" "Cell type enriched" "Detected in some" 6 "Intestinal endocrine cells: 576.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 38.2" "Group enriched" "Detected in many" 11 "cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 23.6" "Region enriched" "Detected in single" 16 "olfactory region: 100.5" "Region enriched" "Detected in some" 9 "olfactory region: 282.4" "CAB004005, HPA006641, CAB044060, CAB062563, CAB068232" Enhanced Supported Supported Cytosol "Intracellular and membrane" NA NA Cytosol "CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874" "unprognostic (8.15e-2)" "unprognostic (4.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.25e-2)" "unprognostic (4.70e-1)" "unprognostic (1.78e-2)" "unprognostic (2.01e-1)" "unprognostic (5.14e-2)" "unprognostic (5.41e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-1)" 1.5 2.1 0.7 6.0 0.8 0.1 2.0 22.3 1.5 0.4 10.5 0.5 0.9 7.2 0.1 0.3 0.3 0.0 0.5 5.0 6.2 22.0 3.8 2.5 0.4 0.1 0.5 1.2 0.2 39.7 0.0 47.9 1.8 1.4 1.1 11.7 1.8 3.7 3.0 0.1 0.3 8.0 0.7 1.0 0.1 12.5 0.6 0.1 0.5 1.1 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 23.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 22.3 1.5 6.2 22.0 0.5 1.2 1.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 99.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.3 0.1 0.0 4.7 0.0 0.0 0.1 0.0 576.5 1.8 0.0 0.0 0.6 0.0 0.0 1.8 2.8 0.0 7.8 2.9 0.0 2.2 0.0 12.9 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 11.3;Horizontal cells: 14.3" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 58 "dendritic cells: 9.7;granulocytes: 3.1" "Cell line enhanced" "Detected in some" "AF22: 9.5;AN3-CA: 17.3;HUVEC TERT2: 20.5;NTERA-2: 10.5;SH-SY5Y: 59.6" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: AB_2732142" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favorable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 3.9 30.1 1.5 22.0 2.0 1.9 23.9 55.0 3.7 3.6 21.1 0.0 2.2 4.7 2.0 4.2 3.4 3.0 65.9 29.6 17.9 3.5 1.9 3.1 1.7 22.8 24.1 1.8 1.6 1.4 6.0 10.3 15.6 6.2 2.3 0.7 2.9 2.6 54.5 1.4 1.9 5.9 28.9 5.1 2.0 2.7 24.3 0.0 2.0 7.6 1.6 1.9 0.6 0.0 9.7 3.1 0.0 0.1 0.0 0.1 0.0 0.0 9.5 17.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.4 0.1 4.0 0.1 20.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 59.6 0.0 0.0 0.0 2.6 0.0 1.0 3.7 0.2 0.5 0.1 0.8 0.7 0.0 0.0 0.2 0.7 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 9.7 0.0 0.1 30.1 22.0 23.9 28.9 29.6 17.9 22.8 24.1 15.6 24.3 6.0 1.7 0.0 4.6 0.3 4.2 11.3 0.0 4.0 3.4 3.5 2.0 1.0 0.0 0.2 0.0 4.6 0.0 0.0 0.2 0.4 0.6 0.5 0.0 0.5 0.2 14.3 0.0 1.8 0.0 0.0 0.0 0.0 3.3 0.0 0.0 4.9 0.9 0.0 0.0 0.7 0.5 0.0 1.8 0.0 0.4 0.5 0.7 0.0 0.0 1.4 SCMH1 Scml3 ENSG00000010803 "Scm polycomb group protein homolog 1" Q96GD3 1 41027200-41242154 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048898, HPA053292" Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No Nucleoplasm "Nuclear bodies, Cytosol" "HPA048898: , HPA053292: AB_2797246" "unprognostic (6.02e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (1.98e-2)" "unprognostic (8.77e-2)" "unprognostic (8.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.40e-1)" "unprognostic (7.38e-2)" "unprognostic (9.47e-2)" "unprognostic (1.63e-1)" "unprognostic (8.08e-2)" "prognostic favorable (5.80e-4)" 12.5 13.1 14.7 18.2 15.3 11.2 21.3 15.9 13.9 15.8 27.9 6.7 23.4 9.0 21.4 16.7 11.1 16.5 17.2 27.2 12.6 8.8 14.8 9.5 11.4 10.5 7.6 12.5 24.8 30.2 26.5 23.0 7.8 10.7 22.7 12.6 16.8 19.2 23.8 28.4 8.4 12.7 36.9 7.4 8.7 18.5 26.6 6.7 11.3 14.3 11.1 8.3 22.7 25.7 4.3 7.6 2.2 2.2 2.9 4.2 1.7 9.0 6.1 14.5 13.3 6.7 12.7 0.0 7.3 12.8 12.3 12.8 5.8 11.7 16.6 5.6 13.2 10.3 2.3 11.2 9.8 10.6 11.4 8.5 7.7 8.2 14.4 29.0 16.5 12.8 13.8 10.0 8.1 19.8 14.9 12.3 20.7 7.2 12.9 12.0 4.9 16.5 14.3 13.3 7.7 6.5 18.3 15.2 9.8 9.8 11.4 10.2 11.0 12.7 10.2 10.5 10.3 9.0 42.5 9.0 12.9 10.1 7.9 13.3 13.2 7.4 18.1 8.1 14.8 11.7 1.3 1.2 2.2 3.3 2.2 4.2 4.3 3.9 3.1 3.7 2.1 2.9 2.4 0.0 2.9 0.5 7.6 2.7 1.7 14.7 15.3 15.9 13.9 12.6 8.8 7.6 12.5 10.7 6.7 8.9 6.7 8.0 23.8 6.0 13.8 13.5 10.2 4.0 7.9 12.2 15.7 6.7 1.7 8.8 7.2 6.8 7.8 0.0 18.3 2.6 8.0 20.7 4.7 4.7 5.2 7.9 8.1 6.7 4.8 9.4 15.3 3.1 8.5 2.8 6.2 6.0 11.3 3.5 17.0 11.5 13.5 19.4 8.0 50.0 28.6 3.1 4.0 4.8 11.7 11.9 SCML2 ENSG00000102098 "Scm polycomb group protein like 2" Q9UQR0 X 18239314-18354727 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Spermatocytes: 22.8;Spermatogonia: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 7.0" "Lineage enriched" "Detected in single" 7 "dendritic cells: 7.0" "Cell line enhanced" "Detected in many" "NTERA-2: 20.0;REH: 17.8" "Low region specificity" "Detected in all" "HPA001662, HPA064713" Enhanced Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA001662: AB_1079879, HPA064713: AB_2685333" "unprognostic (5.15e-2)" "unprognostic (2.57e-2)" "unprognostic (7.93e-2)" "unprognostic (7.26e-5)" "unprognostic (1.24e-1)" "unprognostic (2.24e-2)" "unprognostic (4.95e-5)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (1.18e-1)" "unprognostic (6.15e-4)" "unprognostic (1.83e-1)" "unprognostic (2.35e-4)" "unprognostic (3.30e-1)" "unprognostic (2.54e-1)" "unprognostic (1.97e-2)" "unprognostic (3.31e-3)" 2.4 7.7 3.1 2.1 4.1 8.6 3.1 3.4 3.8 3.7 3.7 3.7 2.0 2.1 4.9 2.5 2.3 2.9 2.8 2.0 2.3 2.0 1.5 2.6 1.3 2.0 3.6 0.5 9.5 3.9 3.2 8.0 7.1 2.3 2.9 2.3 3.6 10.0 2.2 2.0 3.4 2.0 6.5 2.2 2.3 1.7 19.0 4.2 12.5 4.3 2.3 2.1 2.7 4.2 0.8 7.0 0.2 0.2 0.9 0.7 0.2 0.9 3.3 11.8 3.0 0.9 1.5 3.5 2.0 1.4 4.0 4.5 4.8 0.7 0.0 0.4 0.9 2.9 0.0 16.5 0.2 4.9 0.0 13.5 0.0 3.0 2.1 0.5 10.3 2.7 0.6 0.6 2.9 3.4 1.0 0.2 10.5 7.7 0.0 2.8 1.5 16.5 5.5 20.0 0.3 4.2 17.8 5.9 2.4 0.0 0.2 7.2 8.4 3.5 3.3 0.0 13.6 4.2 4.6 0.3 3.6 2.6 8.0 1.8 0.0 9.4 16.6 1.2 7.1 2.7 0.0 0.2 0.2 0.7 0.2 0.7 0.2 0.3 0.2 0.9 0.8 0.2 0.1 0.2 0.9 0.1 7.0 0.0 0.2 3.1 4.1 3.4 3.8 2.3 2.0 3.6 0.5 2.3 4.2 0.0 0.3 0.8 1.0 3.2 2.2 1.0 0.0 0.0 1.2 0.0 0.0 1.2 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.3 1.3 0.7 0.0 0.9 1.5 6.4 1.2 0.0 0.0 1.1 1.7 0.0 0.0 0.0 0.5 2.1 0.3 0.0 1.1 0.6 3.6 0.0 0.4 22.8 28.0 3.6 0.3 0.0 1.2 0.3 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 70.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 15.3;Early spermatids: 12.8;Horizontal cells: 19.1;Late spermatids: 24.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTCEpi: 9.6;RH-30: 4.3;SCLC-21H: 9.5;SH-SY5Y: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041707 Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA041707: AB_2732493" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 2.2 8.5 17.7 1.5 23.5 1.3 2.0 2.8 70.3 1.6 1.5 1.2 0.0 1.6 1.5 1.5 1.5 1.8 1.4 1.9 26.2 13.2 1.6 1.0 1.4 1.2 5.2 18.8 1.7 1.9 3.9 12.6 1.1 3.8 1.8 1.6 3.7 1.2 1.4 5.8 1.7 1.5 2.1 1.5 1.3 1.4 2.2 1.2 0.0 3.7 0.0 1.2 1.1 0.4 1.2 1.3 2.7 0.6 1.1 0.8 0.1 0.0 0.2 0.3 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.0 3.0 0.1 0.3 1.5 0.4 3.1 0.2 1.0 0.1 0.2 0.1 0.6 0.0 0.5 0.3 0.1 0.0 0.6 0.4 9.6 0.1 0.1 0.0 0.3 0.3 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.3 0.1 0.2 4.3 0.0 0.0 0.2 9.5 7.2 0.6 0.1 0.0 1.0 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.6 0.6 0.5 0.6 0.4 0.4 0.7 0.7 0.7 0.3 1.2 0.5 0.8 2.7 1.1 0.5 1.3 0.4 0.1 17.7 23.5 2.8 39.5 26.2 13.2 5.2 18.8 3.8 1.2 0.0 0.3 0.0 0.8 5.0 15.3 1.4 0.0 0.0 0.0 1.8 5.9 0.1 0.0 0.3 12.8 8.7 0.0 0.0 0.9 0.1 1.1 1.0 0.0 0.0 0.2 19.1 4.1 0.6 0.0 24.3 0.0 0.5 0.0 0.0 0.0 8.3 0.4 0.0 0.4 0.1 5.9 6.5 0.7 0.3 1.5 4.8 0.0 0.0 0.0 0.4 SCRN1 KIAA0193 ENSG00000136193 "Secernin 1" Q12765 7 29920103-29990289 "Enzymes, Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.8" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 65.2;Muller glia cells: 76.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 69.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024517 Enhanced Approved Cytosol No No 110000 Cytosol "HPA024517: AB_2184811" "prognostic unfavorable (8.32e-4)" "prognostic unfavorable (8.46e-4)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.00e-5)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (1.13e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (1.09e-2)" "unprognostic (1.02e-1)" "prognostic favorable (1.15e-5)" "unprognostic (2.57e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (2.60e-4)" 6.8 14.8 32.0 6.3 31.5 3.6 7.6 62.8 55.4 12.4 8.1 23.2 4.5 3.4 13.3 8.8 10.0 13.9 8.5 9.8 26.6 30.7 12.8 1.5 8.3 6.7 42.7 26.6 17.5 18.5 42.9 12.1 8.0 26.3 15.0 5.6 7.8 8.4 20.2 1.0 5.7 5.0 17.7 42.9 5.2 7.1 11.4 23.3 8.2 7.1 1.5 10.6 9.4 5.8 10.4 7.8 6.9 16.7 4.8 8.1 2.2 21.8 15.8 25.8 10.4 18.3 28.2 0.1 20.4 27.4 22.2 24.0 18.2 17.4 2.7 18.2 26.1 49.4 9.9 29.3 8.7 32.5 0.1 6.1 9.0 10.6 11.7 23.4 0.0 0.1 23.5 12.6 20.1 10.8 30.3 20.4 5.9 0.1 7.1 31.2 12.3 3.1 0.0 23.5 0.0 17.0 0.0 27.5 0.2 15.5 10.8 9.4 22.4 21.1 13.7 23.6 33.9 18.5 1.4 22.5 28.9 24.9 0.3 25.8 2.3 35.4 0.2 13.6 0.1 69.6 2.2 2.3 6.9 0.6 10.2 8.1 10.4 0.1 0.8 7.7 5.0 0.6 1.0 0.4 4.8 16.7 7.8 0.0 2.2 32.0 31.5 62.8 43.1 26.6 30.7 42.7 26.6 26.3 23.3 26.8 13.1 8.2 9.7 2.7 63.5 12.6 20.4 21.4 22.7 31.4 43.2 0.3 13.3 18.8 49.3 5.8 0.0 0.0 21.5 1.6 7.7 14.1 8.1 0.5 4.8 65.2 11.6 2.5 10.0 48.7 12.7 10.6 6.8 4.6 0.9 76.1 21.8 17.3 19.8 1.8 39.0 6.5 8.5 2.3 12.3 1.5 0.8 4.3 1.0 17.0 SCRN3 FLJ23142 ENSG00000144306 "Secernin 3" Q0VDG4 2 174395730-174429575 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034689, HPA034690" Approved Approved Vesicles,Cytosol NA NA 9300 "Vesicles, Cytosol" "HPA034689: AB_2674282, HPA034690: AB_10670574" "unprognostic (5.39e-3)" "unprognostic (4.58e-2)" "unprognostic (2.06e-2)" "unprognostic (3.58e-1)" "unprognostic (1.91e-1)" "unprognostic (1.89e-1)" "unprognostic (9.89e-2)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (5.85e-2)" "unprognostic (8.81e-2)" "unprognostic (1.30e-1)" "unprognostic (6.62e-3)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" 12.4 15.9 19.2 7.6 18.4 3.7 11.4 13.2 27.0 8.4 10.4 16.7 12.5 15.4 10.3 10.1 14.2 9.1 9.4 21.2 20.2 20.0 17.4 18.0 10.1 10.5 23.5 21.1 11.7 12.1 26.6 20.6 10.9 25.9 13.4 11.3 8.7 10.6 12.3 30.3 11.5 11.5 11.8 27.9 9.3 10.2 8.4 20.2 10.4 17.3 6.2 9.5 11.2 9.1 9.9 6.9 18.5 4.6 5.5 7.5 2.2 9.1 5.6 14.6 13.5 11.3 12.8 8.2 14.1 10.9 10.9 13.0 5.5 6.7 1.7 9.3 13.9 8.3 9.1 11.2 12.1 14.1 19.8 10.1 17.0 12.3 4.3 17.1 12.9 9.0 14.4 15.2 20.1 14.8 12.2 12.5 9.5 11.2 6.6 14.8 10.2 10.7 12.6 7.1 20.1 23.9 5.3 15.3 10.0 12.2 9.4 9.5 26.7 9.7 9.6 17.7 16.6 12.9 12.5 9.2 12.7 6.6 14.9 11.8 17.6 18.2 0.2 13.8 6.4 12.7 4.8 4.6 1.9 4.6 2.7 3.3 7.0 4.7 4.3 4.3 9.9 7.5 5.9 18.5 5.5 3.6 6.9 4.8 2.2 19.2 18.4 13.2 27.0 20.2 20.0 23.5 21.1 25.9 20.2 8.9 10.4 3.7 9.8 3.2 12.8 20.6 7.6 13.4 7.9 8.7 9.8 9.3 11.6 7.8 2.2 4.9 6.3 0.0 8.6 5.9 6.3 5.6 8.1 8.3 7.8 17.5 5.8 10.4 6.9 2.3 4.4 4.9 3.3 3.6 6.5 22.0 9.9 3.5 6.3 9.8 14.7 0.0 6.2 18.1 5.2 4.3 5.7 2.5 6.4 10.1 SCYL1 "GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP" ENSG00000142186 "SCY1 like pseudokinase 1" Q96KG9 11 65525077-65538704 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 115.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015015 Uncertain Supported Cytosol NA NA Cytosol "HPA015015: AB_1856643" "unprognostic (5.56e-2)" "unprognostic (1.16e-1)" "unprognostic (1.03e-1)" "unprognostic (3.99e-1)" "unprognostic (1.23e-2)" "unprognostic (7.87e-2)" "unprognostic (1.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.14e-1)" "unprognostic (7.23e-2)" "unprognostic (4.41e-1)" "unprognostic (4.29e-1)" "unprognostic (7.86e-3)" "unprognostic (6.49e-3)" "unprognostic (4.27e-1)" "unprognostic (8.29e-2)" "unprognostic (2.29e-3)" 24.1 35.5 24.1 20.2 24.4 22.8 49.4 24.6 47.3 25.0 21.6 19.0 27.8 22.5 26.9 30.0 24.1 26.7 21.4 35.8 25.1 21.1 24.1 61.4 22.4 22.9 21.7 23.9 34.1 40.7 27.0 24.3 30.7 19.6 24.7 14.3 24.9 34.0 30.3 51.2 23.6 19.8 23.0 17.1 24.7 24.4 31.4 20.6 18.0 27.3 20.2 20.2 24.9 24.1 10.7 15.5 27.9 13.7 11.1 14.7 12.1 19.9 17.2 13.9 19.2 25.5 22.3 19.0 24.8 33.8 29.7 23.3 24.8 12.1 14.4 25.2 32.2 25.3 18.3 14.6 18.7 10.4 16.9 18.7 16.9 18.9 28.4 36.3 11.1 24.5 30.8 18.5 25.5 19.0 21.0 19.4 14.9 17.6 20.4 18.4 43.5 14.8 25.6 13.3 13.5 24.1 15.1 10.8 26.4 18.3 17.9 12.9 13.6 15.3 33.9 27.0 8.9 33.6 14.1 19.1 23.6 15.9 38.2 14.6 28.3 19.7 15.0 27.4 9.3 16.5 1.9 13.7 17.6 14.7 13.2 11.8 10.0 13.8 14.6 15.5 10.7 11.2 10.5 27.9 11.1 8.5 11.3 9.5 12.1 24.1 24.4 24.6 47.3 25.1 21.1 21.7 23.9 19.6 20.6 17.9 11.8 17.1 26.0 19.5 23.4 5.6 15.3 10.7 13.6 19.2 11.8 53.7 31.5 31.7 20.6 21.5 42.3 0.0 37.5 60.7 33.0 37.9 25.3 33.7 33.9 15.9 29.3 23.4 18.4 17.2 42.3 21.4 28.7 44.1 26.8 20.3 31.3 24.6 42.8 30.5 17.4 12.9 34.2 22.4 22.6 20.3 115.9 19.1 29.9 27.8 SDC2 "CD362, fibroglycan, HSPG, HSPG1, SYND2" ENSG00000169439 "Syndecan 2" P34741 8 96493351-96611780 "CD markers, Predicted membrane proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.1;thyroid gland: 111.2" "Cell type enhanced" "Detected in many" 5 "Fibroblasts: 194.4;Hepatocytes: 184.9;Smooth muscle cells: 188.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 13.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.9" "Cell line enhanced" "Detected in many" "AF22: 102.6;EFO-21: 48.2;fHDF/TERT166: 44.4;RPTEC TERT1: 53.6;U-138 MG: 49.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025123, HPA044416" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB025123: , HPA044416: AB_2678934" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (6.52e-3)" "unprognostic (4.18e-2)" "unprognostic (2.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.89e-2)" "unprognostic (4.56e-1)" "unprognostic (1.48e-1)" "unprognostic (6.16e-2)" "unprognostic (1.56e-2)" "unprognostic (1.45e-3)" "unprognostic (1.91e-1)" "unprognostic (2.50e-2)" "unprognostic (1.23e-1)" 43.2 9.9 13.9 9.1 16.9 2.5 17.0 12.7 8.4 43.4 18.7 7.3 21.2 5.8 21.9 15.3 13.3 21.0 15.0 19.1 12.0 12.6 23.9 115.1 14.4 4.4 9.7 9.3 45.9 16.8 1.6 24.0 31.3 10.7 25.9 10.7 51.4 6.3 28.1 9.4 6.5 9.6 34.3 9.5 7.5 11.9 8.7 9.3 0.5 111.2 13.8 3.5 35.9 26.3 0.0 1.3 13.9 1.9 0.0 0.2 0.5 0.0 0.0 102.6 0.0 37.1 34.7 0.1 14.8 17.6 8.6 9.6 3.0 0.0 0.0 48.2 44.4 1.2 0.0 17.7 0.2 7.4 0.0 6.9 0.0 9.9 37.7 1.2 0.2 0.4 13.3 0.4 19.5 0.5 33.3 0.3 0.0 9.7 0.0 3.6 0.8 0.0 2.5 10.8 0.0 0.1 0.1 16.1 0.3 53.6 8.7 3.0 8.0 0.0 0.0 0.7 35.9 4.4 11.4 8.0 49.7 15.2 0.2 8.2 0.9 0.0 0.1 15.8 0.0 15.5 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 13.9 0.0 0.1 0.0 0.0 0.5 13.9 16.9 12.7 8.4 12.0 12.6 9.7 9.3 10.7 9.3 53.6 30.2 4.7 67.2 47.9 22.0 25.8 33.1 5.3 3.4 54.1 11.8 1.8 24.9 11.7 25.6 10.2 0.1 23.3 13.2 2.0 194.4 44.9 1.1 184.9 114.7 4.8 3.4 20.3 22.0 14.5 48.6 87.0 59.1 118.2 0.5 18.4 12.7 0.0 98.6 44.8 10.2 32.3 188.5 3.2 57.1 34.4 3.2 3.2 1.2 14.5 SDCBP "MDA-9, SYCL" ENSG00000137575 "Syndecan binding protein" O00560 8 58552924-58582860 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Melanocytes: 843.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 166.5" "Group enriched" "Detected in all" 5 "granulocytes: 166.5;monocytes: 44.8" "Cell line enhanced" "Detected in many" "HHSteC: 100.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012245, HPA023840" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA 1500000 "Nucleoplasm, Cytosol" "Nuclear membrane" "CAB012245: , HPA023840: AB_1857712" "unprognostic (2.39e-2)" "unprognostic (3.34e-2)" "unprognostic (1.84e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (2.60e-3)" "unprognostic (7.14e-2)" "unprognostic (1.04e-3)" "unprognostic (1.11e-1)" "unprognostic (5.68e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.92e-1)" 106.2 32.0 28.5 37.6 45.2 51.5 67.4 20.9 29.0 42.7 28.4 18.8 22.2 19.7 38.4 28.2 37.8 28.0 47.9 36.9 32.1 25.8 41.4 41.7 73.1 49.7 33.4 16.9 35.5 20.1 36.4 16.4 68.5 47.6 35.5 33.6 53.0 41.5 20.7 22.5 24.7 34.3 37.9 39.0 70.1 31.0 25.4 22.2 34.3 44.4 23.4 21.4 50.0 44.2 5.9 21.7 166.5 44.8 3.4 9.8 29.7 14.5 22.6 24.1 12.5 90.5 78.0 10.6 15.0 53.8 21.9 28.8 9.0 30.7 0.0 24.2 20.1 40.3 6.1 13.0 17.3 27.1 2.6 11.1 22.0 20.1 7.2 100.5 5.6 35.8 53.2 23.4 22.0 66.1 34.2 52.4 15.3 10.8 12.9 49.6 3.8 12.3 6.6 15.1 57.5 6.5 6.0 7.3 2.8 34.8 15.3 10.6 19.1 16.0 6.9 73.8 27.9 6.3 15.3 45.0 21.1 9.1 24.9 9.6 3.9 5.2 8.8 53.8 0.0 18.9 52.9 44.8 43.7 5.7 30.0 7.1 5.9 7.6 6.0 21.7 5.4 9.8 7.4 166.5 3.4 26.4 6.0 8.5 29.7 28.5 45.2 20.9 29.0 32.1 25.8 33.4 16.9 47.6 22.2 196.5 114.3 99.6 291.9 300.9 9.9 48.4 58.6 61.6 77.3 195.4 15.7 224.5 190.6 334.0 5.9 318.0 108.1 46.7 256.7 631.9 182.6 258.8 390.0 80.9 683.1 14.3 107.7 330.8 517.6 7.7 216.6 535.9 843.5 212.0 105.0 74.6 227.0 96.2 150.3 153.5 9.7 97.0 282.9 12.5 6.5 151.4 403.9 126.8 84.4 372.9 SDCBP2 "SITAC18, ST-2" ENSG00000125775 "Syndecan binding protein 2" Q9H190 20 1309909-1329239 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 104.7" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 454.6;Pancreatic endocrine cells: 472.7;Paneth cells: 448.9;Urothelial cells: 654.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.2;OE19: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005804, HPA064490" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA005804: , HPA064490: AB_2732713" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (2.37e-1)" "unprognostic (5.85e-2)" "unprognostic (2.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.01e-1)" "unprognostic (3.78e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (3.17e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.37e-4)" 1.7 0.4 5.2 10.6 6.7 0.2 1.5 1.5 4.9 6.6 59.4 1.2 0.9 46.1 1.5 9.1 32.4 0.9 35.1 1.3 3.5 3.6 2.5 3.8 3.7 0.9 2.8 1.0 1.2 4.4 0.2 1.4 1.9 1.4 3.7 19.0 1.0 6.4 1.9 1.1 13.4 104.7 2.5 1.1 1.1 34.0 1.5 1.6 1.0 4.0 12.5 24.3 17.0 9.8 1.2 2.6 4.4 2.0 2.1 5.3 1.8 6.3 0.3 0.9 0.3 3.7 3.3 0.6 1.9 3.9 1.8 1.7 1.3 11.2 0.7 1.3 0.7 1.2 5.0 0.3 9.3 0.9 0.2 0.6 0.5 0.4 0.9 3.7 0.6 0.7 1.1 6.6 1.4 1.4 3.8 6.1 1.2 0.9 0.5 0.7 1.5 1.0 1.8 0.9 33.8 0.4 1.0 0.4 1.2 0.7 8.7 1.5 1.2 1.0 5.7 2.1 0.4 0.3 0.5 4.1 0.9 0.4 1.8 0.7 1.7 1.6 0.6 0.4 2.5 0.5 0.4 2.0 4.4 2.4 0.7 1.8 0.6 3.2 2.5 2.6 1.2 2.7 4.7 2.2 2.1 1.3 1.7 5.3 1.8 5.2 6.7 1.5 4.9 3.5 3.6 2.8 1.0 1.4 1.6 14.9 6.2 5.0 56.0 49.5 0.7 0.7 81.5 4.0 6.8 15.7 0.0 1.3 23.2 94.6 12.4 13.0 454.6 0.0 187.2 0.8 4.4 102.5 9.2 4.9 0.9 1.6 34.4 4.9 1.6 1.1 1.4 2.2 8.5 3.6 127.5 1.0 472.7 448.9 0.0 1.3 1.0 0.0 4.2 1.7 6.6 83.6 1.4 2.5 60.5 654.3 SDE2 "C1orf55, FLJ35382" ENSG00000143751 "SDE2 telomere maintenance homolog" Q6IQ49 1 225982702-225999331 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028467, HPA031255, HPA031256" Approved Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nuclear speckles" "Golgi apparatus, Plasma membrane, Cytosol" "HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568" "unprognostic (9.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.10e-1)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (9.59e-2)" "unprognostic (2.68e-1)" "unprognostic (3.63e-2)" "unprognostic (1.84e-2)" "unprognostic (3.34e-2)" "unprognostic (9.01e-2)" "unprognostic (1.41e-3)" "unprognostic (3.90e-2)" "unprognostic (3.51e-1)" "unprognostic (3.98e-2)" "unprognostic (3.84e-2)" 25.6 11.2 10.7 13.3 12.8 33.6 21.6 10.8 11.5 12.3 10.6 17.9 9.0 11.0 15.1 11.5 14.3 12.8 13.4 12.2 10.8 11.0 11.9 17.9 16.2 13.9 14.1 9.8 16.2 14.2 15.6 13.9 14.5 12.5 12.9 11.6 11.1 12.0 11.2 20.9 18.0 12.9 12.7 13.5 14.4 11.5 14.1 14.4 33.9 15.8 11.0 14.1 15.6 16.9 8.2 7.8 17.9 7.2 12.5 11.2 6.3 8.5 6.2 10.1 10.7 7.1 7.9 12.6 9.1 8.7 12.5 9.6 9.0 9.8 12.5 14.3 7.7 4.9 11.0 12.6 7.9 15.3 9.5 10.3 13.8 5.3 8.2 13.0 13.5 16.8 8.7 11.5 13.3 16.9 7.1 8.6 15.1 25.1 15.2 9.2 2.5 18.8 10.8 14.0 13.2 6.6 15.9 13.0 16.2 7.5 6.0 9.1 15.1 10.4 11.4 17.1 8.5 11.2 16.7 8.4 10.7 7.6 13.8 19.9 9.1 6.5 15.5 11.0 8.4 21.1 16.3 6.0 5.5 8.2 6.2 11.2 8.2 8.3 7.9 6.7 7.1 8.6 8.0 17.9 12.5 7.2 7.8 6.4 6.3 10.7 12.8 10.8 11.5 10.8 11.0 14.1 9.8 12.5 14.4 26.8 23.5 17.7 14.0 38.7 5.2 7.3 2.5 13.4 25.0 8.7 0.0 7.6 13.3 5.8 47.5 16.2 11.3 23.3 6.1 8.4 15.4 11.4 34.6 17.9 9.7 14.3 16.7 12.9 16.1 12.7 9.2 13.9 18.6 5.4 10.7 11.4 8.2 10.7 6.0 9.0 7.7 6.5 17.3 15.1 13.9 51.7 11.9 15.0 9.8 16.6 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61447529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 23.7 33.0 22.2 22.4 27.2 34.1 24.8 19.9 33.8 20.5 22.1 23.4 21.0 22.3 23.3 33.5 25.3 25.8 21.1 32.5 20.8 26.9 26.8 39.1 19.9 36.7 24.3 25.0 25.7 22.7 23.3 38.4 26.7 25.2 26.1 24.9 32.0 28.1 21.5 31.4 22.9 27.9 26.6 20.8 32.2 24.3 19.2 21.1 36.1 27.0 20.2 30.9 24.0 19.2 31.3 23.2 44.6 25.4 32.7 43.7 26.7 15.4 22.3 13.2 9.2 19.2 15.7 10.3 12.0 17.4 16.3 12.5 20.8 16.7 15.6 22.1 17.4 22.2 16.8 17.2 17.1 17.5 23.1 16.3 13.4 18.3 30.0 20.0 15.8 18.8 19.4 20.9 17.7 17.3 11.6 26.2 16.8 15.4 20.1 19.6 34.2 16.1 35.9 20.4 15.9 32.8 17.4 17.1 28.8 23.2 23.0 14.2 17.7 16.5 19.3 33.4 14.1 30.1 18.9 16.3 16.6 13.5 19.7 14.2 12.4 19.3 19.9 16.1 14.1 17.4 41.9 25.4 44.6 32.4 22.8 38.4 31.3 35.9 34.7 20.3 29.9 39.5 38.4 37.0 32.7 17.9 23.2 43.7 26.7 22.2 27.2 19.9 33.8 20.8 26.9 24.3 25.0 25.2 21.1 32.8 38.1 35.3 31.0 18.3 14.0 20.5 12.7 32.1 21.6 27.9 5.9 61.5 46.4 50.2 11.4 29.8 27.1 23.3 52.7 47.1 28.8 26.8 31.2 37.0 45.9 14.3 32.8 36.8 33.7 13.8 29.1 32.1 42.2 81.2 28.5 36.7 49.4 31.7 29.0 38.3 14.1 32.3 24.7 15.8 23.5 19.6 83.3 44.5 23.9 29.9 SDK1 FLJ31425 ENSG00000146555 "Sidekick cell adhesion molecule 1" Q7Z5N4 7 3301448-4269000 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 99.7;Late spermatids: 120.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 28 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 28 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "AF22: 7.9;BEWO: 9.8;RPTEC TERT1: 8.2;RT4: 10.2;SuSa: 9.9;U-2 OS: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011392 Approved Approved Cytosol NA NA 2700000 Cytosol "HPA011392: AB_1856648" "unprognostic (2.39e-1)" "unprognostic (1.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.83e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.23e-1)" "unprognostic (9.93e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.16e-1)" "unprognostic (2.49e-2)" "unprognostic (7.84e-2)" "unprognostic (1.59e-1)" "unprognostic (8.44e-2)" "unprognostic (1.37e-1)" 5.8 1.1 2.2 6.1 1.7 1.4 5.8 0.9 3.1 16.6 6.2 1.4 6.8 1.8 6.1 10.9 2.9 4.5 4.8 1.9 3.4 2.2 3.9 0.7 7.0 8.7 1.6 1.4 4.3 22.4 1.5 6.3 2.9 2.1 6.9 2.4 5.6 2.6 9.4 1.8 2.9 4.2 16.5 1.9 16.3 3.6 7.7 1.9 1.8 1.5 3.6 3.4 9.5 13.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.0 1.7 7.9 0.0 0.0 0.0 9.8 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.3 0.0 3.1 0.1 0.8 0.0 0.2 0.0 4.6 0.0 0.3 0.2 3.9 0.0 0.0 1.6 0.0 0.3 0.5 0.0 0.6 0.1 0.0 0.0 3.9 2.0 0.0 0.0 2.7 0.1 0.0 5.6 5.5 0.0 8.2 10.2 4.9 7.2 0.0 0.0 0.0 9.9 0.0 2.5 0.2 0.0 12.3 0.0 3.4 0.0 0.0 0.0 0.0 1.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 2.2 1.7 0.9 3.1 3.4 2.2 1.6 1.4 2.1 1.9 0.0 4.0 0.0 0.4 1.1 10.0 20.4 2.5 9.4 7.9 5.2 0.0 2.3 0.0 1.0 99.7 0.6 0.0 0.0 4.7 0.8 4.1 0.6 0.0 0.0 0.5 1.6 4.7 1.3 0.0 120.8 1.7 0.5 5.0 0.0 0.5 0.3 3.5 0.0 5.3 1.4 0.7 6.5 2.1 6.6 5.1 0.4 1.6 0.0 0.0 0.3 SDR39U1 "C14orf124, HCDI" ENSG00000100445 "Short chain dehydrogenase/reductase family 39U member 1" Q9NRG7 14 24439766-24442905 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044294, HPA075356" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044294: AB_10961400, HPA075356: " "unprognostic (2.99e-2)" "unprognostic (1.21e-1)" "unprognostic (4.13e-2)" "unprognostic (2.42e-2)" "unprognostic (2.36e-1)" "unprognostic (6.28e-2)" "unprognostic (2.06e-2)" "unprognostic (1.67e-3)" "unprognostic (4.24e-1)" "unprognostic (2.87e-3)" "prognostic favorable (2.34e-4)" "unprognostic (9.13e-2)" "unprognostic (1.13e-3)" "unprognostic (7.47e-2)" "unprognostic (2.48e-1)" "unprognostic (1.63e-1)" "unprognostic (5.32e-2)" 19.5 29.3 21.6 12.4 24.1 21.4 15.6 47.7 26.9 13.9 13.5 23.0 17.1 14.8 16.3 16.5 12.0 19.6 10.4 37.1 21.7 18.5 22.2 18.6 11.8 17.0 32.5 19.6 19.2 22.3 17.2 27.9 12.9 22.0 17.2 8.7 19.5 31.1 21.9 64.2 16.2 14.9 13.9 18.8 22.4 16.5 15.2 29.8 13.3 18.0 17.0 12.2 13.9 14.7 25.8 30.6 17.2 19.5 27.5 24.5 15.6 10.6 17.7 12.6 14.8 17.6 13.5 12.9 6.3 7.9 13.1 15.2 13.7 13.3 14.4 15.6 6.4 10.1 18.7 11.2 14.1 5.7 19.6 19.7 12.6 13.2 34.9 8.6 11.5 12.7 15.0 17.1 9.4 13.6 13.5 13.9 32.6 11.3 12.3 12.8 18.6 18.9 18.6 12.1 15.0 16.5 24.3 6.5 10.1 23.0 13.4 22.0 19.1 15.5 27.7 13.6 7.9 19.1 17.0 7.4 4.1 13.8 11.9 7.8 21.2 13.3 17.3 10.8 14.7 10.9 17.2 19.5 11.5 21.9 11.6 21.0 25.8 16.6 17.1 21.9 25.2 23.7 24.5 6.0 27.5 9.5 30.6 19.3 15.6 21.6 24.1 47.7 26.9 21.7 18.5 32.5 19.6 22.0 29.8 26.8 20.8 26.1 35.9 23.6 34.7 0.2 35.7 17.4 26.1 38.4 11.8 43.4 102.8 23.4 11.6 31.5 17.8 46.7 17.5 20.7 25.9 23.5 34.7 34.4 25.8 27.0 26.5 16.5 18.1 19.8 30.5 19.8 40.5 15.4 21.6 56.9 16.4 11.5 29.7 56.4 36.7 0.0 31.9 63.7 13.0 23.8 46.9 27.7 21.3 26.3 SDS SDH ENSG00000135094 "Serine dehydratase" P20132 12 113392445-113426301 "Enzymes, Plasma proteins, Predicted intracellular proteins" Gluconeogenesis Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 276.9" "Group enriched" "Detected in many" 4 "Hepatocytes: 317.5;Hofbauer cells: 211.0;monocytes: 169.5" "Cancer enriched" "Detected in all" 31 "liver cancer: 165.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "myeloid DC: 12.8" "Lineage enriched" "Detected in single" 15 "dendritic cells: 12.8" "Cell line enhanced" "Detected in some" "HMC-1: 5.5;SK-BR-3: 3.4" "Low region specificity" "Detected in single" HPA039230 Uncertain Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "HPA039230: AB_10674281" "unprognostic (1.31e-1)" "prognostic favorable (5.24e-4)" "unprognostic (6.37e-3)" "unprognostic (6.94e-2)" "unprognostic (9.19e-3)" "unprognostic (2.65e-2)" "unprognostic (2.35e-2)" "unprognostic (8.85e-2)" "unprognostic (1.79e-1)" "unprognostic (2.55e-1)" "unprognostic (4.89e-2)" "unprognostic (3.20e-1)" "unprognostic (4.08e-3)" "unprognostic (2.12e-1)" "unprognostic (2.07e-2)" "unprognostic (4.35e-1)" "unprognostic (2.99e-2)" 0.9 0.9 2.2 1.4 5.9 0.5 0.4 0.6 2.1 0.5 0.9 0.8 0.0 0.7 0.4 0.2 0.2 0.2 1.4 0.2 1.7 2.5 0.2 276.9 0.6 0.6 4.2 0.7 0.3 0.4 0.1 0.0 1.0 2.8 0.3 0.8 1.3 0.3 0.2 0.2 0.2 0.7 0.3 1.3 0.5 0.9 0.3 0.8 0.1 0.3 0.0 0.3 0.8 0.0 0.0 12.8 0.6 0.8 0.2 0.0 0.3 0.0 0.4 0.2 1.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.2 0.4 2.3 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.5 1.3 0.6 0.6 0.1 0.8 5.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.6 0.0 1.4 0.1 0.4 0.8 0.0 0.9 0.0 0.8 0.1 0.2 0.6 0.1 0.1 1.6 3.4 0.7 0.1 1.2 1.7 0.6 0.0 0.9 1.1 0.3 0.7 0.4 0.2 1.1 0.8 0.3 0.1 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.6 0.2 0.1 1.3 0.0 0.3 2.2 5.9 0.6 1.6 1.7 2.5 4.2 0.7 2.8 0.8 0.0 1.1 21.2 0.2 2.2 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.7 0.0 2.1 0.0 0.3 0.0 23.3 0.3 0.7 0.8 0.2 0.0 317.5 211.0 0.0 0.0 10.4 27.7 0.0 0.0 55.6 1.7 169.5 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 2.8 2.1 3.3 0.0 0.0 SDSL "cSDH, SDS-RS1" ENSG00000139410 "Serine dehydratase like" Q96GA7 12 113422237-113438276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 53.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 118.4;Hofbauer cells: 93.1;monocytes: 174.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 6.5;intermediate monocyte: 7.1;myeloid DC: 13.2;plasmacytoid DC: 12.8" "Group enriched" "Detected in many" 8 "dendritic cells: 13.2;monocytes: 7.1" "Cell line enhanced" "Detected in many" "HMC-1: 22.6;MCF7: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005740 Approved Approved Cytosol NA NA Cytosol "HPA005740: AB_10601486" "unprognostic (1.34e-1)" "unprognostic (8.33e-2)" "unprognostic (3.62e-2)" "unprognostic (3.54e-2)" "unprognostic (2.24e-2)" "unprognostic (6.17e-3)" "unprognostic (1.57e-1)" "unprognostic (6.46e-2)" "unprognostic (8.22e-2)" "unprognostic (2.00e-2)" "prognostic favorable (8.58e-4)" "unprognostic (2.93e-1)" "prognostic favorable (3.09e-5)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (7.33e-2)" 3.1 15.3 4.2 3.8 5.1 1.4 2.8 1.5 7.1 2.6 7.1 5.5 6.2 10.0 2.5 9.7 1.3 4.6 5.2 7.2 3.6 6.1 15.5 53.2 2.8 2.8 9.5 4.2 4.6 15.3 5.0 7.6 3.1 7.8 4.2 5.0 4.6 4.9 4.5 2.1 0.7 7.8 2.9 8.8 3.0 5.2 7.0 2.6 1.5 20.3 1.3 1.6 4.0 1.5 1.1 13.2 0.3 7.1 1.3 0.2 1.7 3.6 14.2 2.0 6.0 0.4 0.9 1.4 2.1 0.5 2.2 1.9 6.1 3.8 0.2 10.7 3.4 6.2 3.7 0.9 4.8 0.8 8.6 3.6 9.1 3.4 2.6 12.0 1.1 22.6 1.9 6.8 5.5 8.2 2.6 3.3 0.0 7.1 2.8 2.7 38.7 0.0 4.5 2.1 3.9 6.1 0.0 3.0 6.8 5.9 4.4 0.6 0.2 8.8 10.0 8.5 1.9 12.3 10.4 3.0 2.7 5.3 12.1 1.8 0.6 0.5 0.1 11.6 3.7 3.3 0.1 6.5 0.0 0.0 7.1 0.0 1.1 0.0 0.0 13.2 0.1 0.0 0.0 0.3 1.3 0.9 12.8 0.2 1.7 4.2 5.1 1.5 7.1 3.6 6.1 9.5 4.2 7.8 2.6 0.0 6.1 8.6 2.1 0.8 0.2 15.7 25.5 0.0 0.0 27.9 2.0 11.4 66.3 30.4 0.4 2.9 43.5 23.3 17.7 2.6 3.8 6.0 43.8 118.4 93.1 3.2 30.5 4.9 12.3 1.1 2.6 14.9 3.3 174.9 28.9 19.5 17.4 40.3 5.3 76.8 1.5 0.0 5.7 0.0 0.2 0.5 6.1 4.3 25.5 4.3 SEC14L1 "PRELID4A, SEC14L" ENSG00000129657 "SEC14 like lipid binding 1" Q92503 17 77086716-77217101 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Ito cells: 287.8;Late spermatids: 570.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 71.8" "Lineage enriched" "Detected in all" 11 "granulocytes: 71.8" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 92.7;TIME: 57.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021463, HPA028703" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021463: AB_2670712, HPA028703: AB_10602300" "unprognostic (1.19e-1)" "unprognostic (8.61e-2)" "unprognostic (1.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.26e-1)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (7.37e-2)" "unprognostic (1.21e-1)" "unprognostic (7.40e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (1.37e-1)" "unprognostic (1.33e-3)" "unprognostic (3.09e-1)" "unprognostic (4.30e-2)" 40.8 34.0 25.4 25.3 39.1 33.4 40.6 42.3 33.2 27.7 11.1 21.9 12.2 13.3 15.8 18.9 18.8 15.9 21.2 18.2 27.0 19.5 25.1 15.8 38.4 25.8 31.6 20.6 12.6 18.3 17.3 18.6 49.3 22.5 10.8 10.5 24.2 21.4 12.9 51.0 11.9 12.2 16.2 25.8 33.9 18.4 35.4 24.4 10.0 24.0 14.4 26.0 15.7 14.7 2.4 2.3 71.8 6.2 1.5 2.0 1.9 11.9 8.7 15.5 23.8 6.5 8.0 5.5 10.9 9.4 12.8 11.2 11.6 7.8 32.0 22.0 15.0 15.8 4.6 6.9 10.6 16.7 5.9 6.2 16.7 6.8 15.1 11.1 3.4 7.8 11.3 4.3 10.7 11.2 17.1 92.7 3.9 10.2 27.1 18.1 6.1 5.9 4.4 5.6 5.2 7.9 4.5 24.9 23.7 21.9 4.8 11.9 9.3 12.0 6.4 6.7 14.9 5.3 3.7 57.9 14.6 13.7 7.9 7.7 15.5 12.1 16.8 6.3 3.5 4.3 4.2 3.2 9.2 0.7 5.5 0.6 2.4 0.7 0.5 2.3 1.2 0.8 0.5 71.8 1.5 6.2 0.8 2.0 1.9 25.4 39.1 42.3 33.2 27.0 19.5 31.6 20.6 22.5 24.4 38.7 24.7 57.3 18.3 26.1 28.1 14.2 15.3 62.9 25.0 26.2 17.7 8.9 84.6 15.6 199.7 196.1 10.7 23.3 18.0 9.4 22.0 33.6 32.5 9.4 43.6 35.0 18.9 287.8 111.7 570.5 24.5 46.3 33.7 53.3 13.7 19.7 30.2 13.5 16.3 18.1 16.8 38.8 18.7 27.0 43.4 26.6 11.1 35.5 10.7 33.3 SEC14L2 "C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1" ENSG00000100003 "SEC14 like lipid binding 2" O76054 22 30396857-30425317 "Predicted intracellular proteins" "Transcription, Transcription regulation, Transport" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 43.0;liver: 112.3" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 123.4;Muller glia cells: 99.0;Pancreatic endocrine cells: 69.1;Rod photoreceptor cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 2.6;naive CD4 T-cell: 7.1;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 8 "T-cells: 7.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 37.7;hTCEpi: 20.5;hTERT-RPE1: 24.0" HPA064466 Approved Supported Nucleoplasm,Cytosol NA NA 190000 Nucleoplasm Cytosol "HPA064466: AB_2685270" "prognostic favorable (3.05e-4)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (5.59e-3)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.63e-6)" "unprognostic (1.25e-3)" "unprognostic (3.76e-3)" "unprognostic (2.23e-1)" "unprognostic (2.40e-1)" "unprognostic (2.76e-2)" "unprognostic (5.63e-3)" "unprognostic (1.17e-3)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.34e-3)" "unprognostic (2.01e-1)" 1.9 1.2 13.6 1.9 14.2 2.4 22.7 7.3 15.0 2.2 5.7 12.6 7.3 10.1 2.4 43.0 8.0 2.3 4.3 1.1 10.8 10.4 3.6 112.3 1.8 2.1 16.1 10.4 1.3 1.9 3.7 5.0 1.5 10.6 25.7 1.4 24.2 4.0 7.8 1.0 2.9 13.5 2.4 8.9 1.0 3.4 1.2 10.4 1.1 4.3 0.6 2.7 1.8 2.9 0.8 0.9 0.5 0.2 0.1 7.1 1.5 9.8 2.4 1.9 2.7 2.9 7.4 0.1 8.0 6.4 4.7 4.9 0.6 6.6 0.2 2.4 9.6 8.0 7.6 1.2 37.7 5.2 0.9 1.9 0.1 2.4 3.5 4.0 0.0 2.5 5.1 20.5 4.3 7.7 24.0 11.8 1.8 0.0 0.2 9.4 1.7 1.0 0.2 0.0 5.1 3.3 0.4 3.4 0.2 8.3 3.3 1.2 1.3 4.9 1.1 4.4 0.1 6.4 0.1 17.9 6.6 4.2 2.7 4.8 0.1 0.0 0.3 14.5 0.0 5.2 0.1 0.2 0.4 0.9 0.2 0.4 0.8 2.6 0.6 0.1 0.6 7.1 4.7 0.5 0.1 0.1 0.9 1.1 1.5 13.6 14.2 7.3 13.4 10.8 10.4 16.1 10.4 10.6 10.4 3.0 4.3 0.5 13.2 3.7 7.5 1.0 20.4 1.4 4.5 0.0 15.7 2.6 5.0 21.9 6.6 1.5 1.7 0.0 16.4 0.2 3.6 18.3 5.7 123.4 0.4 12.7 1.2 4.3 4.7 7.5 1.1 0.0 6.8 0.0 0.5 99.0 69.1 0.0 0.7 6.1 51.4 0.0 2.0 0.5 1.0 1.8 2.5 5.3 0.2 7.0 SEC14L5 "KIAA0420, PRELID4B" ENSG00000103184 "SEC14 like lipid binding 5" O43304 16 4958317-5019158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0" "Cell type enriched" "Detected in some" 9 "Cone photoreceptor cells: 80.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;RPMI-8226: 4.2;SCLC-21H: 6.5;T-47d: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041492, HPA041825" Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA041492: AB_10794519, HPA041825: AB_10794526" "unprognostic (1.90e-3)" "unprognostic (4.08e-2)" "unprognostic (5.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (5.68e-2)" "unprognostic (7.33e-3)" "unprognostic (8.71e-4)" "unprognostic (6.87e-2)" "unprognostic (1.56e-4)" "unprognostic (1.01e-3)" "unprognostic (7.12e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" 1.1 1.7 7.4 1.3 17.5 1.5 1.2 2.2 22.1 2.8 1.7 29.4 0.0 1.4 0.9 1.2 2.0 2.2 1.1 7.5 13.5 6.1 1.1 0.8 1.0 1.4 25.8 8.8 1.7 1.8 0.8 1.7 1.3 15.2 1.7 2.1 0.3 1.9 1.1 11.0 2.9 1.1 0.9 25.2 1.2 3.7 1.4 15.6 0.0 0.9 0.5 1.7 0.9 0.4 0.1 0.4 1.6 0.0 0.1 0.2 2.9 0.0 0.4 0.6 0.3 0.6 4.2 0.6 0.1 0.0 0.1 0.0 0.5 0.2 0.2 0.3 0.5 0.1 0.6 0.2 0.1 0.0 0.0 0.5 2.0 0.4 1.1 0.3 0.0 0.4 0.6 0.9 0.1 0.1 0.3 0.1 0.2 0.2 0.4 0.1 0.3 0.0 0.2 1.3 1.0 0.3 0.1 0.4 4.2 0.3 0.1 6.5 0.2 0.4 0.3 0.5 0.7 4.3 0.0 0.5 0.2 0.4 0.3 0.0 0.2 0.0 0.2 1.1 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 1.6 0.1 0.0 0.4 0.0 2.9 7.4 17.5 2.2 20.0 13.5 6.1 25.8 8.8 15.2 15.6 0.0 0.0 0.0 0.1 0.2 3.7 8.9 0.0 0.0 0.0 0.0 80.5 0.6 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.0 SEC31A "ABP125, ABP130, KIAA0905, SEC31L1" ENSG00000138674 "SEC31 homolog A, COPII coat complex component" O94979 4 82818661-82901166 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005457 Approved Supported Vesicles,Cytosol NA NA 22000 "Vesicles, Cytosol" "HPA005457: AB_1079896" "unprognostic (3.50e-2)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (6.14e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "unprognostic (4.21e-3)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (5.53e-3)" "unprognostic (2.92e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.69e-4)" 41.3 40.6 22.5 28.0 29.2 30.6 34.5 27.4 30.6 46.4 36.0 26.4 39.2 35.7 53.6 50.2 37.7 34.8 36.1 42.8 23.7 23.8 47.3 57.8 33.9 26.6 25.3 25.3 67.1 79.1 42.7 62.7 54.1 36.0 37.2 38.1 32.6 47.8 46.0 38.7 34.1 51.4 46.2 24.5 28.4 35.9 23.3 23.3 35.7 50.0 31.0 39.5 47.1 37.6 29.4 34.6 34.8 36.0 40.5 40.0 30.5 25.1 11.4 33.1 23.3 59.0 73.6 24.1 46.9 52.7 26.5 32.8 19.8 32.4 32.7 20.7 93.6 15.3 12.1 32.6 31.0 36.6 33.3 13.0 19.9 19.7 51.7 58.7 21.3 25.4 70.4 39.5 40.3 46.4 45.7 42.8 14.8 30.3 32.5 47.0 22.0 28.0 17.2 22.6 26.9 10.5 20.9 17.9 24.2 42.6 14.5 21.4 23.8 18.7 32.5 30.3 35.2 25.3 24.1 43.7 34.8 18.1 30.5 29.4 24.4 10.4 44.9 34.8 25.7 39.9 34.8 31.1 23.3 32.6 34.8 40.0 29.4 29.2 31.8 34.6 24.4 29.3 28.0 9.5 40.5 36.0 28.9 24.0 30.5 22.5 29.2 27.4 30.6 23.7 23.8 25.3 25.3 36.0 23.3 98.3 74.0 44.9 45.0 53.8 48.4 69.9 50.9 80.3 120.6 45.4 51.1 47.9 23.2 54.7 22.3 50.3 62.5 23.3 61.8 70.7 94.4 74.7 70.7 86.8 41.3 39.7 36.8 58.3 42.7 13.0 128.9 48.4 49.0 43.3 90.1 43.6 63.6 38.6 118.5 55.5 61.5 51.8 81.2 28.3 33.4 64.7 68.2 34.8 46.5 74.0 SEC31B "DKFZP434M183, SEC31B-1, SEC31L2" ENSG00000075826 "SEC31 homolog B, COPII coat complex component" Q9NQW1 10 100486642-100519864 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Bipolar cells: 34.2;Collecting duct cells: 10.4;Cone photoreceptor cells: 37.3;Horizontal cells: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.4;JURKAT: 12.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035882, HPA040819, HPA060052" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: " "unprognostic (1.23e-1)" "unprognostic (3.13e-3)" "unprognostic (3.39e-3)" "unprognostic (1.03e-2)" "unprognostic (4.85e-2)" "unprognostic (1.42e-3)" "unprognostic (1.97e-3)" "unprognostic (6.63e-2)" "unprognostic (2.22e-1)" "unprognostic (2.25e-2)" "unprognostic (1.10e-4)" "unprognostic (8.23e-3)" "prognostic unfavorable (6.41e-7)" "unprognostic (2.31e-2)" "unprognostic (2.54e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-4)" 2.8 2.4 3.3 3.2 5.0 6.4 2.6 12.1 11.8 2.7 2.8 5.4 4.3 1.9 3.0 3.5 1.4 2.9 2.6 5.6 3.1 3.6 2.7 3.4 2.4 4.3 3.3 5.6 3.9 0.8 3.9 5.0 2.4 6.3 2.9 2.7 6.1 2.8 2.5 13.6 2.4 2.9 3.2 3.4 4.9 1.9 16.2 3.4 0.0 2.6 5.2 3.6 2.3 1.9 0.9 0.0 0.1 0.2 0.0 2.1 0.1 0.2 0.2 2.8 0.9 0.9 1.6 0.3 0.5 1.3 0.2 0.9 0.3 0.4 0.6 0.8 0.0 0.1 0.3 1.5 0.4 0.8 3.5 0.8 1.4 1.8 0.3 1.2 1.0 1.2 2.4 1.4 0.2 1.7 12.4 0.5 12.5 0.3 1.7 0.0 0.0 1.8 3.1 0.0 0.2 0.6 2.7 0.1 1.1 0.9 0.0 0.2 0.9 0.3 0.0 0.6 2.1 0.7 0.3 0.0 0.4 0.4 0.3 0.2 1.3 0.6 0.8 0.1 3.4 0.4 0.0 0.1 0.0 0.5 0.2 2.1 0.0 0.0 0.4 0.0 0.9 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 3.3 5.0 12.1 11.8 3.1 3.6 3.3 5.6 6.3 3.4 6.0 5.0 0.0 0.8 1.0 34.2 6.5 5.1 2.7 2.3 10.4 37.3 1.0 0.0 0.4 0.9 2.1 2.1 0.0 0.2 0.3 1.9 1.8 1.1 6.4 1.9 38.1 5.2 3.1 4.3 0.8 3.1 1.8 1.7 3.6 3.9 4.3 0.3 0.0 3.9 0.6 6.7 0.0 1.2 7.5 3.2 1.0 0.7 2.6 4.0 0.9 SELENOF SEP15 ENSG00000183291 "Selenoprotein F" 1 86862445-86914424 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 217.7;Extravillous trophoblasts: 290.7;Hofbauer cells: 216.8;Syncytiotrophoblasts: 263.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054937 Approved Nucleoli,Cytosol "Intracellular and membrane" No No Nucleoli Cytosol "HPA054937: AB_2682642" "unprognostic (6.15e-2)" "unprognostic (6.98e-3)" "prognostic favorable (6.53e-4)" "unprognostic (6.20e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.65e-1)" "unprognostic (6.51e-3)" "unprognostic (3.38e-2)" "unprognostic (3.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (2.39e-2)" "unprognostic (1.09e-1)" "unprognostic (8.24e-3)" "unprognostic (1.34e-2)" 41.5 48.9 34.7 32.4 33.2 27.1 41.4 20.4 33.9 44.3 37.0 28.9 42.7 32.9 34.9 62.0 36.9 36.8 36.1 31.4 33.4 35.8 68.4 85.3 47.8 45.4 36.0 25.1 47.6 38.5 20.6 46.9 65.6 34.3 41.5 37.4 30.8 35.8 33.7 22.0 21.7 51.1 30.2 45.0 58.7 32.3 36.4 29.0 57.0 100.7 22.8 33.7 40.0 29.7 68.9 57.5 44.3 41.8 26.8 41.3 51.1 39.1 26.9 22.5 24.8 73.7 87.7 36.8 49.4 56.6 46.5 47.4 38.0 47.7 48.4 63.4 43.8 40.3 24.7 25.4 27.5 54.9 45.1 35.9 49.2 25.7 35.9 46.6 64.3 33.6 56.3 43.6 30.9 46.7 37.9 39.1 40.2 45.5 50.6 45.1 17.6 46.7 43.3 33.0 40.7 37.2 39.1 41.6 47.2 64.5 40.5 29.2 24.2 49.2 44.9 65.1 21.5 19.6 56.1 40.8 34.1 25.4 65.6 53.9 30.5 30.9 49.5 19.9 53.2 39.9 44.3 40.0 36.8 32.8 38.4 41.3 56.7 35.8 34.7 39.0 68.9 37.1 37.5 36.7 26.8 41.8 57.5 38.3 51.1 34.7 33.2 20.4 33.9 33.4 35.8 36.0 25.1 34.3 29.0 110.2 143.1 0.0 0.0 0.0 0.0 0.0 0.0 128.5 137.6 102.9 0.0 217.7 63.0 187.2 0.0 0.0 0.0 0.0 170.1 290.7 0.0 0.0 59.3 0.0 216.8 0.0 0.0 0.0 0.0 0.0 0.0 83.2 0.0 111.8 0.0 0.0 167.0 0.0 0.0 129.7 0.0 0.0 0.0 0.0 0.0 0.0 263.6 0.0 0.0 0.0 SELENOK SELK ENSG00000113811 "Selenoprotein K" Q9Y6D0 3 53884410-53891988 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 244.0;Pancreatic endocrine cells: 237.2;Proximal tubular cells: 306.1;Syncytiotrophoblasts: 292.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 78.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 78.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008196 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008196: AB_1856665" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (3.85e-1)" "prognostic favorable (7.18e-4)" "unprognostic (9.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.02e-2)" "prognostic favorable (3.76e-4)" "unprognostic (2.75e-1)" "unprognostic (5.21e-2)" "unprognostic (8.34e-2)" "unprognostic (1.14e-1)" "unprognostic (3.40e-2)" "unprognostic (8.43e-2)" "unprognostic (8.12e-2)" "unprognostic (9.35e-2)" "unprognostic (2.56e-3)" 20.4 33.5 29.2 19.0 30.2 38.8 24.1 19.7 21.7 18.9 20.5 20.9 28.3 17.3 15.8 49.4 15.0 16.3 17.1 43.2 25.3 26.2 27.6 38.5 18.0 15.1 32.8 16.8 24.8 72.6 20.0 33.0 18.4 27.9 19.3 22.1 27.3 34.2 20.6 41.0 11.5 20.4 16.7 30.1 16.9 18.4 16.8 27.4 8.7 37.7 18.6 20.3 20.2 18.7 12.4 13.4 78.6 10.9 9.9 15.2 15.4 8.8 6.0 13.1 9.7 20.3 12.4 15.5 12.7 14.8 15.1 18.6 13.4 13.6 13.3 5.7 8.2 18.8 5.5 14.6 8.5 13.9 23.3 20.8 8.3 27.0 31.7 18.0 10.9 20.0 7.1 15.1 10.9 14.8 10.2 13.6 9.5 8.0 36.1 14.6 10.0 7.0 13.4 13.6 10.8 22.6 4.6 8.2 24.8 18.8 15.4 7.1 20.5 8.1 12.1 12.6 16.0 7.9 18.0 8.6 10.2 11.8 25.4 17.9 24.9 29.2 11.7 15.4 14.3 15.3 78.6 8.9 21.9 15.2 9.4 14.6 12.4 14.1 15.1 7.5 9.9 12.3 14.1 19.6 9.9 10.9 13.4 14.3 15.4 29.2 30.2 19.7 21.6 25.3 26.2 32.8 16.8 27.9 27.4 125.0 114.9 0.0 0.0 0.0 0.0 0.0 0.0 99.0 99.0 141.3 0.0 144.5 160.8 244.0 0.0 0.0 0.0 0.0 174.6 157.8 0.0 0.0 218.6 0.0 145.4 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.0 130.8 0.0 0.0 237.2 0.0 0.0 306.1 0.0 0.0 0.0 0.0 0.0 0.0 292.8 0.0 0.0 0.0 SELENOM "SELM, SEPM" ENSG00000198832 "Selenoprotein M" Q8WWX9 22 31104772-31120069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 293.1;Distal tubular cells: 261.9;Exocrine glandular cells: 512.5;Pancreatic endocrine cells: 240.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 23.0;MAIT T-cell: 29.7;memory B-cell: 32.4;memory CD4 T-cell: 38.3;memory CD8 T-cell: 27.4;naive B-cell: 24.2;naive CD4 T-cell: 51.6;naive CD8 T-cell: 30.4;T-reg: 34.7" "Group enriched" "Detected in all" 6 "B-cells: 32.4;T-cells: 51.6" "Cell line enhanced" "Detected in many" "BJ: 40.4;BJ hTERT+: 38.8;HHSteC: 51.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008667, HPA019601" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 110000 "Nucleoplasm, Cytosol" "CAB008667: AB_1622762, HPA019601: AB_1856666" "unprognostic (5.29e-3)" "unprognostic (1.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.59e-3)" "unprognostic (1.45e-1)" "unprognostic (1.60e-2)" "unprognostic (1.60e-1)" "unprognostic (3.51e-3)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.55e-6)" "unprognostic (1.32e-2)" "unprognostic (3.80e-1)" "unprognostic (5.20e-2)" "unprognostic (3.19e-2)" 35.9 19.5 19.8 31.3 20.6 2.4 33.4 13.5 20.8 83.5 66.2 9.1 38.3 22.0 67.5 34.2 53.4 46.1 67.2 25.5 19.1 20.6 19.2 6.6 18.2 35.1 20.7 11.7 49.9 38.1 18.1 27.2 22.1 15.9 59.5 10.7 41.4 57.3 89.1 29.4 11.6 24.0 76.2 14.1 18.2 35.2 21.9 8.8 1.4 45.7 12.2 12.8 92.5 36.1 32.4 1.3 2.4 7.5 7.5 51.6 21.9 3.2 6.8 2.0 11.4 19.1 22.4 22.3 40.4 38.8 18.8 13.7 0.2 0.5 0.4 8.4 23.7 8.5 0.3 1.8 2.4 1.3 1.8 6.8 0.7 2.1 3.4 51.1 0.0 3.5 21.8 7.3 8.9 3.4 9.0 2.4 0.6 0.6 3.9 4.7 1.7 0.1 0.4 2.6 3.0 7.3 0.0 0.0 4.6 2.9 0.0 4.4 9.7 12.6 11.2 0.1 0.7 15.5 0.2 8.2 5.7 16.1 21.1 0.0 3.6 1.6 0.2 22.8 0.0 3.6 2.4 2.2 0.9 23.0 3.8 29.7 32.4 38.3 27.4 1.3 24.2 51.6 30.4 1.6 7.5 7.5 0.4 34.7 21.9 19.8 20.6 13.5 20.8 19.1 20.6 20.7 11.7 15.9 8.8 50.6 112.8 0.0 0.0 0.0 0.0 0.0 0.0 37.5 59.1 293.1 0.0 11.2 261.9 97.3 0.0 0.0 0.0 0.0 512.5 132.0 0.0 0.0 27.9 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 74.9 0.0 0.0 240.3 0.0 0.0 109.7 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 SELENON "MDRS1, RSMD1, RSS, SELN, SEPN1" ENSG00000162430 "Selenoprotein N" Q9NZV5 1 25800176-25818224 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Desmin-related myopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 19.2;Ductal cells: 16.8;Exocrine glandular cells: 36.9;Hofbauer cells: 25.2;Pancreatic endocrine cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA058076 Approved Uncertain Cytosol "Intracellular and membrane" NA NA Cytosol "HPA058076: AB_2683598" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (4.11e-1)" "prognostic favorable (2.23e-4)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (3.40e-5)" "unprognostic (1.94e-1)" "unprognostic (4.72e-1)" "unprognostic (3.32e-3)" "unprognostic (6.01e-2)" "unprognostic (3.07e-1)" "unprognostic (1.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.10e-1)" "unprognostic (5.56e-3)" "unprognostic (5.89e-2)" 41.4 27.2 26.3 26.4 24.8 12.4 53.6 22.0 29.7 32.2 21.9 26.5 26.3 14.3 30.7 20.4 25.4 34.3 27.4 29.3 26.3 16.3 33.0 15.1 35.2 47.8 19.2 18.2 35.3 39.9 23.0 23.7 31.6 22.0 37.5 17.8 30.0 29.1 35.0 30.0 18.0 16.5 45.8 21.0 29.1 24.4 11.6 19.1 10.7 31.4 17.6 16.8 26.1 28.0 1.7 2.1 5.9 3.3 0.7 2.6 1.0 12.2 11.7 39.1 33.4 25.5 44.9 13.2 14.8 22.5 16.5 13.2 3.0 13.0 0.0 9.9 22.4 18.3 11.9 10.2 15.7 12.6 12.9 7.8 12.0 4.5 3.7 18.4 2.5 28.5 47.8 10.6 17.3 8.7 19.6 51.5 4.2 4.2 1.7 15.5 6.2 0.5 3.6 14.7 9.6 8.1 10.5 17.1 1.5 6.8 3.5 8.2 13.9 9.3 8.5 12.4 11.0 8.6 8.4 42.8 16.8 11.5 30.7 8.6 1.4 0.0 0.3 23.3 3.7 20.2 5.9 3.3 3.8 1.8 2.6 1.1 1.7 1.7 1.3 2.1 1.1 2.6 1.6 0.5 0.7 2.5 0.3 1.7 1.0 26.3 24.8 22.0 29.7 26.3 16.3 19.2 18.2 22.0 19.1 8.9 9.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 6.8 19.2 0.0 12.7 0.0 16.8 0.0 0.0 0.0 0.0 36.9 9.5 0.0 0.0 2.3 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 5.4 0.0 0.0 23.6 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 SELL "CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR" ENSG00000188404 "Selectin L" P14151 1 169690667-169711698 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 227.5;lymphoid tissue: 77.8" "Group enriched" "Detected in many" 6 "B-cells: 178.5;Kupffer cells: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 7.0;EFO-21: 6.8;JURKAT: 18.6;MOLT-4: 12.8;U-266/70: 24.1;U-698: 11.2;U-937: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002144, HPA051972" Enhanced Uncertain Cytosol NA NA 8100000000 Cytosol "CAB002144: AB_563862, HPA051972: AB_2797242" "prognostic favorable (3.76e-4)" "prognostic favorable (2.25e-4)" "unprognostic (1.52e-2)" "unprognostic (2.89e-2)" "unprognostic (7.87e-3)" "prognostic favorable (6.43e-4)" "unprognostic (1.39e-3)" "unprognostic (3.43e-1)" "unprognostic (2.70e-3)" "prognostic favorable (3.14e-4)" "unprognostic (1.42e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (4.76e-2)" "unprognostic (8.71e-3)" "unprognostic (9.57e-2)" "unprognostic (1.01e-1)" 6.9 0.9 2.0 25.1 4.6 30.3 1.5 1.1 2.5 0.9 1.4 1.1 0.0 0.4 1.0 1.1 4.2 3.2 5.4 4.1 2.5 2.2 2.3 2.5 11.4 77.8 5.2 0.2 0.8 1.0 10.7 7.9 3.4 2.7 1.2 1.3 3.8 12.1 0.1 0.9 0.8 8.8 2.9 5.2 67.7 1.7 1.0 2.3 43.8 1.9 1.3 64.0 8.1 6.1 40.4 40.7 227.5 49.7 130.8 69.5 90.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.2 7.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.8 0.8 0.3 0.0 0.0 0.0 0.0 1.2 18.6 0.0 0.9 0.0 0.8 12.8 0.1 0.0 0.2 0.2 4.9 0.1 0.3 3.9 0.2 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 24.1 0.0 11.2 1.3 7.0 0.1 170.8 49.7 88.6 16.5 11.2 4.5 33.8 30.7 17.0 40.7 40.4 69.5 39.6 227.5 130.8 4.5 32.8 52.7 90.1 2.0 4.6 1.1 2.5 2.5 2.2 5.2 0.2 2.7 2.3 8.9 20.2 178.5 0.3 0.3 0.0 0.3 2.5 2.7 3.4 10.4 0.0 9.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.6 0.8 0.0 9.3 0.4 5.6 0.0 0.0 1.8 97.5 0.0 0.6 7.5 1.7 0.0 0.0 2.3 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 23.8 20.3 0.0 0.5 SEM1 "C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1" ENSG00000127922 "SEM1, 26S proteasome complex subunit" "P60896, Q6ZVN7" 7 96481626-96709891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 543.9;Exocrine glandular cells: 464.8;Extravillous trophoblasts: 599.1;Syncytiotrophoblasts: 729.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020429, HPA072648" Uncertain Approved Cytosol NA NA Cytosol "HPA020429: AB_1859527, HPA072648: AB_2686543" "unprognostic (5.41e-3)" "unprognostic (6.25e-2)" "unprognostic (1.62e-2)" "unprognostic (2.14e-3)" "unprognostic (1.24e-3)" "unprognostic (6.16e-3)" "unprognostic (4.29e-1)" "unprognostic (1.17e-1)" "unprognostic (1.43e-1)" "prognostic favorable (2.52e-4)" "unprognostic (4.55e-1)" "unprognostic (6.92e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.32e-1)" "unprognostic (2.67e-2)" "unprognostic (2.64e-1)" "prognostic favorable (8.00e-5)" 44.1 58.5 33.3 38.6 48.7 23.1 29.0 25.0 36.3 29.6 48.4 16.8 44.0 41.5 33.5 44.1 45.4 24.0 29.5 69.9 34.8 27.9 34.7 91.6 24.3 28.2 31.7 31.8 45.7 43.6 14.8 51.2 63.5 32.2 32.2 27.8 22.0 43.4 34.5 109.5 34.2 39.0 42.1 43.8 25.0 40.0 52.5 28.8 28.8 28.7 61.8 28.0 31.5 34.0 50.6 94.9 36.7 65.7 42.0 79.0 48.9 63.4 37.5 52.3 54.3 22.4 19.5 28.2 51.9 25.5 21.9 27.4 33.9 52.8 41.9 129.0 25.2 67.7 32.9 43.7 35.0 31.1 48.7 33.0 50.2 55.2 52.6 20.5 74.2 37.6 24.8 27.5 32.7 33.5 34.3 29.2 50.4 65.0 51.8 22.2 80.4 83.8 105.3 70.7 64.4 34.3 32.6 67.4 49.5 31.0 63.2 43.1 54.5 96.9 81.4 52.8 83.8 23.2 56.6 60.0 43.2 75.2 79.8 64.7 32.6 87.4 121.2 47.2 65.6 59.4 36.7 61.3 15.8 45.5 65.7 43.2 50.6 59.3 53.1 86.3 45.3 46.9 47.2 4.1 42.0 55.4 94.9 79.0 48.9 33.3 48.7 25.0 36.3 34.8 27.9 31.7 31.8 32.2 28.8 160.8 197.7 0.0 0.0 0.0 0.0 0.0 0.0 274.4 190.0 232.1 0.0 543.9 349.8 309.5 0.0 0.0 0.0 0.0 464.8 599.1 0.0 0.0 94.2 0.0 339.5 0.0 0.0 0.0 0.0 0.0 0.0 130.5 0.0 421.2 0.0 0.0 446.5 0.0 0.0 414.8 0.0 0.0 0.0 0.0 0.0 0.0 729.5 0.0 0.0 0.0 SEMA3C "SEMAE, SemE" ENSG00000075223 "Semaphorin 3C" Q99985 7 80742538-80922359 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 109.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "basophil: 25.8" "Lineage enriched" "Detected in many" 8 "granulocytes: 25.8" "Cell line enhanced" "Detected in many" "GAMG: 49.5;hTERT-RPE1: 43.2;RT4: 45.2;T-47d: 51.2;U-2197: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042418 Approved "Golgi apparatus,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA "Golgi apparatus, Cytosol" "Plasma membrane" "HPA042418: AB_10797389" "unprognostic (1.93e-2)" "unprognostic (2.54e-3)" "unprognostic (4.94e-1)" "unprognostic (9.86e-2)" "unprognostic (6.74e-2)" "prognostic unfavorable (5.72e-5)" "unprognostic (9.28e-3)" "unprognostic (1.91e-3)" "unprognostic (1.39e-2)" "unprognostic (9.01e-2)" "prognostic unfavorable (4.08e-5)" "unprognostic (2.07e-2)" "unprognostic (1.55e-3)" "unprognostic (1.78e-2)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-2)" 27.1 4.1 3.7 11.9 5.6 0.2 25.1 1.2 6.8 37.0 31.7 7.6 21.6 4.3 26.9 25.1 20.0 7.1 16.4 12.4 5.2 6.1 5.8 1.1 12.3 0.3 13.1 3.0 23.5 1.5 0.0 4.1 5.9 25.5 29.6 14.1 27.4 13.6 19.7 7.3 9.7 10.6 48.8 8.5 8.9 13.3 11.6 6.0 0.2 2.5 15.2 1.5 35.5 14.5 0.0 2.0 25.8 3.2 0.0 0.0 0.8 1.1 14.6 30.4 0.1 6.8 16.5 0.0 9.9 11.4 5.0 6.4 2.3 27.6 0.0 0.4 3.3 49.5 5.9 0.1 8.9 8.2 0.0 3.0 1.8 13.1 0.1 8.2 0.1 0.0 7.2 5.9 12.4 12.2 43.2 0.0 0.0 0.1 0.0 8.4 21.1 0.0 0.0 0.2 4.1 2.3 0.0 14.7 0.2 26.3 45.2 0.1 15.7 27.8 7.2 1.7 13.5 51.2 0.0 23.8 27.5 12.6 66.4 17.4 0.2 0.0 0.0 10.4 0.0 27.2 25.8 3.2 0.5 0.0 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.5 0.0 1.0 1.8 0.0 0.8 3.7 5.6 1.2 6.8 5.2 6.1 13.1 3.0 25.5 6.0 8.9 12.8 0.0 33.4 23.5 0.0 35.1 0.0 109.7 19.4 7.0 5.9 0.3 1.7 3.6 0.4 3.5 25.9 0.0 5.8 0.5 25.3 36.0 4.7 0.0 9.3 0.0 5.8 1.3 2.6 1.7 7.2 8.6 52.3 4.6 16.2 1.3 40.1 15.8 49.1 0.1 0.3 0.0 16.2 0.3 0.2 16.6 0.2 0.0 23.4 52.9 SEMA5B "FLJ10372, KIAA1445, SEMAG, SemG" ENSG00000082684 "Semaphorin 5B" Q9P283 3 122909193-123028605 "Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;heart muscle: 11.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 2.5;Cardiomyocytes: 3.2;Cholangiocytes: 2.5;Ito cells: 3.1;Muller glia cells: 10.6" "Cancer enhanced" "Detected in many" "renal cancer: 18.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 42.4;NTERA-2: 8.2;SH-SY5Y: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066548 Enhanced Supported Cytosol NA NA Cytosol "HPA066548: AB_2685689" "unprognostic (7.34e-2)" "unprognostic (1.84e-3)" "unprognostic (1.92e-4)" "unprognostic (3.01e-2)" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "unprognostic (4.72e-2)" "unprognostic (1.58e-2)" "unprognostic (7.66e-3)" "unprognostic (2.87e-2)" "unprognostic (4.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (1.31e-3)" "unprognostic (5.96e-2)" "unprognostic (6.12e-2)" "unprognostic (2.12e-1)" 1.5 1.2 12.0 0.7 12.3 0.3 1.1 0.8 13.6 2.1 1.5 4.3 0.4 1.9 2.8 5.5 1.5 3.0 4.7 11.7 13.0 3.3 6.1 1.4 2.2 1.1 2.5 3.3 1.3 3.1 1.1 2.5 5.0 2.0 1.8 1.8 6.0 0.9 3.1 1.6 1.2 1.3 3.8 1.7 0.5 0.7 1.1 5.7 0.1 2.2 2.5 1.3 3.3 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 42.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 11.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.0 12.3 0.8 13.2 13.0 3.3 2.5 3.3 2.0 5.7 0.0 0.6 0.0 0.0 0.0 2.5 3.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 1.0 0.0 10.6 0.0 0.0 0.0 0.0 0.9 0.0 2.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SEMA6C KIAA1869 ENSG00000143434 "Semaphorin 6C" Q9H3T2 1 151131685-151146664 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 124.1;tongue: 43.4" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 15.3;Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 11.9;HUVEC TERT2: 20.9;TIME: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076150, HPA077625" Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 290000 "Nucleoplasm, Plasma membrane" "Nucleoli fibrillar center, Cytosol" "HPA076150: , HPA077625: " "unprognostic (6.97e-2)" "unprognostic (8.40e-2)" "unprognostic (1.56e-3)" "prognostic unfavorable (3.27e-4)" "unprognostic (2.79e-1)" "unprognostic (2.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" "unprognostic (4.25e-2)" "prognostic favorable (3.06e-5)" "unprognostic (3.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.12e-2)" "unprognostic (9.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" 3.2 1.9 2.3 1.5 3.0 1.3 3.4 16.8 5.8 4.2 2.6 1.5 0.8 6.7 4.1 3.5 3.2 2.9 3.9 12.7 2.3 3.5 3.0 3.3 1.9 3.4 1.7 3.3 4.8 1.7 1.7 4.3 1.6 2.7 2.8 1.6 3.4 3.1 1.9 124.1 3.4 5.2 3.6 1.1 1.3 1.6 15.0 0.6 0.5 1.3 43.4 2.9 2.2 3.6 0.9 0.6 0.7 0.0 0.1 1.4 0.2 0.8 0.8 11.9 4.6 5.1 1.7 1.1 0.8 0.4 0.8 1.1 0.2 0.5 0.5 3.4 2.7 1.7 1.2 1.1 0.4 0.7 1.0 3.5 6.2 0.5 1.0 0.7 0.1 2.3 2.9 1.4 1.0 0.5 2.4 20.9 3.4 0.5 0.6 2.0 0.4 1.0 0.8 5.4 0.1 1.4 7.4 2.6 0.3 0.4 0.3 6.1 7.9 1.1 0.5 1.0 3.1 1.3 1.0 9.7 2.0 2.9 3.0 0.4 5.0 0.9 5.1 0.5 0.2 0.7 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.2 0.0 0.0 0.9 0.5 0.0 0.5 0.1 0.0 0.6 0.3 0.2 2.3 3.0 16.8 5.8 2.3 3.5 1.7 3.3 2.7 0.6 0.0 3.2 1.7 0.8 1.4 4.2 15.3 2.5 0.0 1.2 0.0 19.6 0.2 0.0 0.3 0.5 3.1 0.3 0.0 0.4 0.4 2.1 0.5 0.0 2.4 0.3 6.4 0.0 4.9 1.6 2.1 5.2 0.0 1.7 0.0 0.0 1.7 0.4 0.0 2.5 2.7 6.9 0.0 2.0 2.8 1.1 0.9 0.1 0.0 0.2 0.5 SENP2 "AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2" ENSG00000163904 "SUMO1/sentrin/SMT3 specific peptidase 2" Q9HC62 3 185582496-185633551 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 190.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029247, HPA029248" Approved Supported Cytosol NA NA Cytosol "HPA029247: AB_10599305, HPA029248: AB_10601855" "unprognostic (4.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.80e-2)" "prognostic unfavorable (7.98e-5)" "unprognostic (7.85e-2)" "unprognostic (2.90e-2)" "unprognostic (4.41e-3)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "unprognostic (8.41e-3)" "unprognostic (5.12e-2)" "unprognostic (6.92e-2)" "unprognostic (1.60e-1)" "unprognostic (1.92e-1)" "unprognostic (1.56e-1)" 10.3 10.1 16.0 7.6 19.8 13.8 11.6 18.8 20.2 8.7 8.8 13.8 7.8 9.2 9.5 15.4 9.3 9.7 7.0 10.9 15.2 15.1 11.3 14.2 9.5 8.6 14.6 12.0 16.0 9.1 15.6 16.7 13.4 13.9 9.7 9.6 9.1 11.0 10.3 24.6 13.9 8.5 9.2 12.9 9.2 9.4 34.9 17.1 11.0 11.2 7.3 8.9 8.5 9.3 4.2 4.4 7.8 3.2 5.1 3.8 1.9 15.3 3.1 7.6 8.7 13.7 9.3 9.9 7.2 8.1 9.0 9.6 11.6 4.9 8.3 13.6 6.4 15.6 8.2 15.9 5.8 13.4 6.1 7.5 5.6 6.4 6.9 7.3 8.2 3.7 5.8 8.8 5.1 6.3 6.6 6.2 8.0 6.6 11.8 7.7 7.6 6.9 9.2 28.1 7.8 5.3 8.2 10.4 13.8 5.0 5.1 7.9 8.9 6.0 13.3 11.1 16.1 18.2 11.1 3.9 6.0 6.5 10.9 11.2 13.7 16.3 15.2 9.8 8.8 8.1 7.2 3.0 5.4 3.7 2.8 3.8 3.0 3.1 3.0 2.2 4.2 3.7 3.6 7.8 5.1 3.2 4.4 2.7 1.9 16.0 19.8 18.8 20.2 15.2 15.1 14.6 12.0 13.9 17.1 26.8 21.4 9.0 19.8 9.6 23.0 20.5 10.2 32.1 35.2 8.7 29.5 21.4 5.0 11.3 190.6 11.3 16.0 0.0 13.3 16.4 13.4 15.3 10.4 15.8 11.1 11.1 5.2 16.5 9.1 24.4 21.0 9.5 16.9 8.2 13.7 15.6 13.8 3.5 16.6 14.7 34.4 19.4 13.4 83.9 30.9 10.9 33.2 16.7 14.4 18.2 SENP5 MGC27076 ENSG00000119231 "SUMO1/sentrin specific peptidase 5" Q96HI0 3 196867856-196934714 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006575 Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol NA NA "Nucleoplasm, Nucleoli" "Centrosome, Cytosol" "HPA006575: " "unprognostic (4.07e-2)" "unprognostic (4.91e-3)" "unprognostic (7.63e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (2.95e-1)" "unprognostic (2.20e-1)" "unprognostic (2.88e-1)" "unprognostic (2.89e-1)" "unprognostic (9.57e-3)" "prognostic unfavorable (2.14e-5)" "unprognostic (2.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (6.71e-2)" 13.8 13.5 20.0 15.3 20.0 25.7 16.1 28.3 23.8 15.0 15.1 16.1 14.5 11.3 14.6 16.2 16.3 12.9 14.4 15.9 18.9 21.7 13.6 19.5 15.2 15.9 19.4 18.4 17.5 15.7 19.8 21.5 17.8 23.5 15.1 14.0 12.0 13.2 15.9 17.8 16.4 13.0 16.8 18.2 17.1 14.0 36.6 16.4 19.3 14.1 9.2 21.1 14.9 20.1 8.9 7.8 15.8 8.7 7.6 8.9 4.2 13.3 6.1 9.8 8.8 8.3 9.9 7.8 8.5 9.1 9.3 15.0 10.6 5.3 12.5 23.8 9.3 15.9 9.2 10.1 4.5 15.1 6.7 6.6 16.9 9.1 7.4 9.6 14.0 8.0 8.5 12.3 9.5 10.1 6.7 9.0 11.2 11.2 19.4 10.8 11.5 13.1 8.2 7.6 7.3 12.0 8.5 7.9 8.5 4.5 7.6 6.1 8.1 9.5 10.8 10.5 10.3 18.1 10.7 10.1 9.1 9.3 12.4 17.4 20.8 36.3 27.0 12.2 11.3 10.3 15.8 7.6 7.1 8.9 8.1 8.1 8.9 8.6 8.8 5.0 8.5 8.0 8.6 14.9 7.6 8.7 7.8 6.9 4.2 20.0 20.0 28.3 23.8 18.9 21.7 19.4 18.4 23.5 16.4 20.8 13.0 17.1 20.7 54.0 26.0 12.5 10.2 9.4 14.8 8.7 15.7 15.8 10.0 14.8 27.7 20.4 12.4 0.0 12.2 12.8 21.0 19.3 25.5 16.6 12.0 27.0 20.7 13.5 16.1 36.8 15.0 18.8 13.5 14.4 13.2 15.4 20.6 17.5 15.6 14.7 27.7 25.8 24.0 36.7 40.5 54.3 19.1 26.7 10.1 28.1 SENP6 "KIAA0797, SUSP1" ENSG00000112701 "SUMO1/sentrin specific peptidase 6" Q9GZR1 6 75601509-75718278 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024376 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024376: AB_1856678" "unprognostic (9.86e-2)" "unprognostic (1.20e-2)" "unprognostic (4.84e-2)" "unprognostic (1.87e-2)" "unprognostic (6.38e-3)" "unprognostic (7.33e-2)" "unprognostic (1.13e-2)" "unprognostic (2.97e-1)" "unprognostic (3.93e-2)" "unprognostic (5.32e-3)" "unprognostic (7.81e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.78e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.83e-5)" "unprognostic (1.72e-1)" 25.9 20.0 24.3 21.8 24.5 27.1 25.9 35.0 24.3 32.5 27.7 23.5 24.9 16.8 37.7 21.2 21.0 27.4 21.5 20.0 22.8 19.8 24.1 22.5 22.5 21.1 29.6 20.3 38.7 21.8 40.1 44.2 26.8 27.0 27.7 21.8 23.0 20.4 25.7 27.8 22.0 24.1 43.0 27.2 24.7 21.3 26.1 28.6 28.5 34.8 15.8 23.9 27.1 34.0 9.9 10.9 19.4 13.1 9.8 11.2 5.5 10.9 11.5 26.2 18.7 20.4 27.2 19.5 19.8 22.1 16.8 21.0 15.8 10.6 18.6 18.8 22.8 19.8 14.1 24.6 13.2 26.0 27.4 21.3 28.2 13.9 14.7 28.4 24.5 20.8 21.0 22.1 15.7 35.1 20.4 27.7 15.6 34.1 20.7 20.5 13.4 9.7 13.2 15.9 14.8 9.8 18.3 13.8 27.2 17.9 16.4 22.9 23.7 16.9 15.0 17.2 22.0 13.5 23.4 23.1 15.0 16.4 7.7 20.4 23.8 23.6 14.9 7.5 23.4 15.8 5.2 7.4 19.4 7.7 7.9 11.2 9.3 7.8 10.2 8.7 9.9 11.2 9.9 14.7 9.8 13.1 10.9 6.5 5.5 24.3 24.5 35.0 24.3 22.8 19.8 29.6 20.3 27.0 28.6 62.5 112.5 47.7 47.5 41.3 58.8 66.9 35.7 56.2 105.8 27.9 86.4 28.4 14.9 28.8 30.6 40.8 33.0 0.0 28.8 23.6 46.3 54.5 61.4 29.8 25.4 57.2 26.5 36.8 38.9 28.6 65.6 37.8 33.7 39.7 33.3 61.0 28.0 24.6 59.4 24.5 62.7 25.8 62.7 116.1 58.3 42.3 34.4 34.8 39.8 53.1 SENP7 ENSG00000138468 "SUMO1/sentrin specific peptidase 7" Q9BQF6 3 101324205-101513241 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027259, HPA071998" Approved Supported "Nucleoplasm,Nuclear bodies,Centrosome,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Centrosome, Cytosol" "HPA027259: AB_1856679, HPA071998: " "unprognostic (1.50e-1)" "unprognostic (6.12e-2)" "unprognostic (2.78e-2)" "unprognostic (7.31e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.38e-3)" "unprognostic (9.25e-3)" "unprognostic (8.80e-2)" "unprognostic (2.24e-1)" "unprognostic (7.77e-3)" "unprognostic (1.94e-1)" "unprognostic (9.85e-2)" "unprognostic (8.08e-3)" "unprognostic (3.27e-1)" "unprognostic (9.03e-2)" "unprognostic (2.23e-2)" 17.0 9.0 11.0 19.1 14.5 19.5 16.5 35.5 19.5 21.7 13.1 11.8 8.2 6.4 24.3 15.2 11.9 18.6 12.8 10.0 13.2 9.1 10.5 7.7 11.5 19.0 12.9 10.8 27.9 15.9 22.4 24.4 17.0 18.7 15.1 10.0 9.2 10.2 11.1 11.1 18.6 13.8 16.0 17.3 14.1 13.6 7.9 16.8 32.1 16.0 9.4 15.4 17.2 14.0 6.8 3.2 24.5 4.1 6.2 7.6 3.8 7.0 4.8 23.6 13.0 4.5 6.9 4.3 4.1 3.0 6.8 8.5 3.1 6.6 5.4 6.4 3.9 6.3 7.1 7.3 3.7 13.8 10.1 2.2 9.8 3.7 4.2 3.7 5.7 9.7 5.3 6.8 3.4 7.8 6.2 9.8 10.7 8.1 14.0 6.4 4.6 10.4 6.6 4.8 3.7 5.1 11.6 6.3 4.9 8.2 4.1 9.1 7.0 3.8 3.9 5.1 12.7 6.3 7.6 8.0 9.5 5.9 3.2 4.0 9.9 5.9 12.8 3.3 7.6 7.7 24.5 4.1 3.8 4.2 3.6 5.2 4.2 5.6 4.2 3.2 6.8 7.6 5.1 12.6 6.2 3.8 2.8 4.5 3.8 11.0 14.5 35.5 19.5 13.2 9.1 12.9 10.8 18.7 16.8 14.9 26.4 9.5 7.3 8.0 47.4 19.3 5.1 38.8 25.0 15.7 19.6 5.0 5.0 6.0 2.1 22.9 5.6 0.0 4.5 2.2 13.9 6.7 34.8 9.6 6.7 49.3 12.6 42.4 22.1 2.5 17.0 11.6 10.1 1.8 6.3 20.1 6.1 2.9 18.4 6.7 33.6 45.3 9.9 20.4 17.1 8.7 2.1 22.4 4.9 3.9 SEPT11 FLJ10849 ENSG00000138758 "Septin 11" Q9NVA2 4 76949703-77040384 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 227.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 91.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003459, HPA005665" Approved Approved Cytosol NA NA 6500000 Cytosol "HPA003459: AB_1856696, HPA005665: AB_1079910" "unprognostic (1.69e-1)" "unprognostic (2.93e-1)" "unprognostic (3.39e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.70e-5)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.58e-2)" "unprognostic (2.58e-2)" "unprognostic (5.85e-2)" "prognostic favorable (2.40e-4)" "unprognostic (5.70e-3)" "unprognostic (6.84e-2)" "unprognostic (1.55e-1)" "unprognostic (2.57e-1)" 39.9 6.4 25.0 12.1 36.6 3.2 28.0 24.8 49.7 21.1 22.8 9.9 7.8 10.1 16.7 12.2 10.9 11.1 21.8 14.6 17.2 13.7 25.5 16.0 18.8 10.3 11.4 27.1 10.2 10.4 7.8 5.7 39.1 14.3 12.3 19.5 7.9 8.5 13.1 17.4 6.7 16.2 19.2 10.5 11.6 11.5 4.5 13.9 2.7 10.1 5.9 10.3 15.9 16.8 2.7 12.0 18.2 3.8 21.2 6.9 3.7 12.9 5.3 51.0 45.2 30.5 24.4 14.7 75.7 58.5 17.2 24.3 9.6 9.6 0.3 15.8 91.1 8.1 5.5 16.8 11.2 26.8 16.9 5.6 25.5 7.1 6.9 26.7 13.7 10.9 30.9 5.3 24.9 9.3 13.7 25.8 5.2 10.5 7.2 50.6 7.5 18.0 0.4 17.1 10.6 2.7 21.2 58.0 1.5 9.7 14.2 17.5 13.1 14.7 8.4 12.0 34.2 7.6 5.5 28.0 57.8 17.3 28.3 13.9 4.4 3.5 0.1 22.0 1.5 11.6 6.6 1.4 18.2 5.1 1.2 3.1 2.0 5.8 6.9 4.5 2.7 2.2 5.9 0.4 21.2 3.8 12.0 3.2 3.7 25.0 36.6 24.8 49.7 17.2 13.7 11.4 27.1 14.3 13.9 14.9 13.2 17.5 0.0 20.4 51.2 11.2 15.3 36.1 21.6 82.0 23.6 74.7 33.2 0.0 3.4 49.3 65.6 46.7 0.0 227.1 109.2 0.0 81.0 42.3 44.8 58.8 35.2 60.8 13.0 3.1 99.5 34.0 28.7 0.0 49.9 32.4 0.0 56.1 112.8 45.9 25.0 135.8 45.3 1.4 8.1 13.4 50.6 27.4 62.6 0.0 SEPT5 "H5, HCDCREL-1, PNUTL1" ENSG00000184702 "Septin 5" Q99719 22 19714464-19724224 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2;parathyroid gland: 86.4" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 9.2;Late spermatids: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "eosinophil: 11.9;neutrophil: 4.4" "Lineage enriched" "Detected in single" 46 "granulocytes: 11.9" "Cell line enhanced" "Detected in many" "K-562: 67.2;THP-1: 21.5" "CAB016120, HPA029095, HPA063885" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA 1600000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: AB_2685141" "unprognostic (4.07e-2)" "unprognostic (1.47e-1)" "unprognostic (6.78e-3)" "unprognostic (1.39e-2)" "unprognostic (3.92e-1)" "unprognostic (1.86e-1)" "unprognostic (2.50e-2)" "unprognostic (3.77e-1)" "unprognostic (5.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.88e-3)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.87e-6)" "unprognostic (3.39e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (3.30e-2)" 4.2 6.4 60.7 2.3 62.9 12.5 5.1 31.2 86.2 12.2 3.0 5.5 1.1 2.2 7.4 17.0 15.0 14.1 5.5 50.9 52.9 14.6 2.0 1.1 3.7 3.0 12.4 38.7 9.0 5.5 86.4 11.1 4.4 14.9 4.3 2.7 5.3 3.6 4.0 2.8 42.9 2.5 6.4 3.6 2.2 3.4 6.2 9.5 1.9 6.7 4.1 3.1 3.5 5.6 0.0 0.2 11.9 0.1 0.0 0.2 6.3 0.1 3.1 12.2 18.9 1.2 4.0 0.1 4.7 5.9 5.3 3.1 0.2 1.6 0.4 1.8 10.4 7.8 1.7 8.9 1.7 2.7 3.2 1.1 0.2 0.6 0.0 4.9 0.2 13.0 5.3 2.2 1.7 0.7 1.5 2.2 6.7 67.2 0.2 8.3 1.2 1.3 7.5 1.6 0.3 3.3 13.6 0.4 2.1 0.3 0.4 19.6 16.0 0.7 1.0 0.8 3.2 4.9 21.5 0.8 14.0 18.8 0.6 0.9 1.3 0.0 0.1 1.7 0.6 4.5 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 4.4 0.0 0.0 0.2 0.0 6.3 60.7 62.9 31.2 86.2 52.9 14.6 12.4 38.7 14.9 9.5 0.0 3.4 0.0 0.0 0.8 4.8 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 9.2 0.5 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.1 3.2 5.1 1.3 0.0 35.9 2.6 0.0 3.3 0.0 0.0 1.9 0.0 0.0 3.2 0.0 0.3 0.0 7.2 2.3 2.7 7.0 0.0 0.0 0.0 0.0 SEPT6 "KIAA0128, MGC16619, MGC20339, SEP2, SEPT2" ENSG00000125354 "Septin 6" Q14141 X 119615724-119693370 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 145.4" "Cell type enhanced" "Detected in many" 6 "B-cells: 130.4;Horizontal cells: 100.1;T-cells: 146.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 52.7;MOLT-4: 56.0;REH: 51.6;SH-SY5Y: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003459, HPA005665" Supported Approved Cytosol NA NA 10000000 Cytosol "HPA003459: AB_1856696, HPA005665: AB_1079910" "unprognostic (6.35e-3)" "unprognostic (1.64e-3)" "unprognostic (1.38e-1)" "unprognostic (9.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.09e-1)" "unprognostic (1.73e-1)" "unprognostic (6.23e-2)" "unprognostic (2.13e-1)" "unprognostic (7.24e-2)" "unprognostic (6.27e-2)" "unprognostic (1.46e-1)" "unprognostic (1.95e-1)" "unprognostic (2.55e-1)" "unprognostic (2.88e-1)" "unprognostic (1.92e-1)" "unprognostic (2.60e-2)" 5.1 39.1 6.9 34.0 6.5 20.6 5.6 23.6 13.1 6.1 22.5 3.8 5.6 5.4 6.7 7.2 9.5 7.3 9.9 8.8 6.7 17.2 8.2 9.8 7.0 42.9 9.5 6.9 6.0 2.2 3.4 5.5 14.1 13.3 6.5 7.3 8.4 12.4 16.7 2.3 3.8 17.6 9.3 5.4 31.8 9.5 24.7 3.3 145.4 4.3 4.5 43.8 9.8 5.3 24.3 22.6 13.0 12.9 27.5 38.5 16.8 1.2 1.9 7.5 13.4 0.7 1.5 10.6 3.6 8.1 6.2 10.8 0.6 2.8 24.9 2.9 4.6 6.5 0.7 11.7 2.3 4.3 15.2 2.7 11.0 4.0 4.4 1.8 12.4 5.8 2.8 0.5 4.9 0.1 2.6 9.0 52.7 8.1 13.4 3.6 0.9 56.0 7.0 7.9 0.3 6.0 51.6 6.2 20.1 6.6 1.3 3.3 78.6 9.5 3.5 4.0 8.4 4.7 6.4 5.6 1.7 3.5 5.4 0.9 6.7 2.6 33.0 0.1 13.2 1.2 9.8 5.6 13.0 22.3 9.4 23.3 24.3 28.4 25.6 12.0 22.9 30.5 26.0 4.4 27.5 12.9 22.6 38.5 16.8 6.9 6.5 23.6 13.1 6.7 17.2 9.5 6.9 13.3 3.3 8.9 16.2 130.4 0.0 6.4 23.2 7.3 2.5 13.4 9.1 21.0 45.2 40.1 46.4 0.0 2.3 21.7 1.2 0.0 0.0 43.9 20.5 0.0 41.6 14.7 47.3 100.1 7.5 25.8 33.0 6.5 31.1 58.0 15.1 0.0 2.6 32.6 0.0 2.9 71.8 1.1 34.4 25.8 7.4 1.4 9.8 6.0 35.9 146.6 5.3 0.0 SEPT7 "CDC10, CDC3, SEPT7A" ENSG00000122545 "Septin 7" Q16181 7 35800932-35907105 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 1164.8;Sertoli cells: 802.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023309, HPA029524" Enhanced Enhanced "Nucleoli,Actin filaments,Midbody,Cytosol" Yes No 16000000 "Actin filaments" "Nucleoli, Midbody, Cytosol" "HPA023309: AB_10600093, HPA029524: AB_10601573" "unprognostic (7.91e-3)" "unprognostic (6.89e-3)" "unprognostic (9.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (2.22e-2)" "prognostic unfavorable (2.37e-4)" "unprognostic (2.00e-2)" "unprognostic (4.43e-2)" "unprognostic (7.13e-2)" "unprognostic (3.56e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.86e-2)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.43e-3)" 35.5 28.5 89.0 26.8 77.8 31.9 29.5 41.9 81.5 35.1 28.7 54.3 11.5 15.7 37.8 36.2 31.7 25.4 34.2 47.5 86.4 58.1 24.3 21.5 28.3 38.8 79.6 66.2 42.8 11.2 22.9 31.9 41.0 72.0 28.4 28.2 9.6 14.9 29.9 21.7 29.1 20.1 42.6 76.8 29.5 18.1 19.3 98.2 33.0 22.6 17.3 41.4 36.9 24.0 40.4 24.0 47.3 24.8 69.1 56.8 48.6 36.1 17.4 44.5 29.2 50.2 51.9 22.8 46.7 43.1 39.9 34.4 27.0 28.1 34.3 31.7 47.5 53.6 27.5 31.4 31.1 57.0 23.4 16.5 27.6 24.4 14.6 29.3 33.2 30.5 33.6 24.4 31.3 30.9 41.8 41.5 27.1 21.6 27.1 64.7 16.9 33.5 55.8 47.7 33.9 24.7 34.6 42.4 19.7 38.6 27.0 23.9 42.0 32.6 42.0 27.9 76.2 31.0 36.8 35.0 40.3 47.8 24.7 51.4 32.0 29.1 86.5 25.7 55.6 85.0 47.3 20.7 34.9 55.4 24.0 56.8 40.4 39.6 50.5 24.0 37.4 35.6 44.9 39.3 69.1 24.8 17.2 34.2 48.6 89.0 77.8 41.9 81.5 86.4 58.1 79.6 66.2 72.0 98.2 142.9 97.9 186.4 0.0 141.0 199.4 207.8 40.8 222.1 184.2 129.1 43.2 148.6 127.6 0.0 342.3 214.2 64.6 23.3 0.0 161.3 239.6 0.0 368.3 69.5 168.4 1164.8 58.6 187.2 128.6 256.8 324.7 171.1 178.8 0.0 61.0 328.2 0.0 106.6 426.0 108.1 113.7 802.0 509.2 101.6 233.2 140.9 103.9 294.1 77.5 0.0 SEPT8 "KIAA0202, SEP2" ENSG00000164402 "Septin 8" Q92599 5 132750817-132807241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "brain: 150.3" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 154.1;Muller glia cells: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005665, HPA036534" Enhanced Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA005665: AB_1079910, HPA036534: AB_2797226" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (9.24e-2)" "unprognostic (7.10e-3)" "unprognostic (2.70e-1)" "unprognostic (2.15e-2)" "unprognostic (2.86e-2)" "unprognostic (1.41e-2)" "unprognostic (1.58e-2)" "unprognostic (2.97e-2)" "unprognostic (2.38e-2)" "unprognostic (3.12e-1)" "prognostic unfavorable (6.98e-5)" "unprognostic (2.86e-2)" "unprognostic (4.30e-1)" "unprognostic (8.04e-3)" "unprognostic (2.70e-1)" 9.5 8.4 43.1 7.0 49.4 2.9 7.1 27.8 74.9 9.3 10.2 66.8 5.2 10.7 6.7 8.2 13.4 7.0 10.7 13.1 56.3 37.0 9.2 4.3 8.4 5.6 76.1 29.3 10.9 9.4 15.9 5.0 18.5 45.8 8.1 11.5 7.9 13.6 9.3 4.1 20.4 10.5 9.0 150.3 5.9 11.0 2.9 64.1 1.5 9.5 5.2 7.5 18.3 6.2 0.8 2.4 1.1 2.0 0.3 5.2 1.7 17.0 8.3 11.9 24.4 16.7 16.4 39.3 18.5 17.8 17.6 21.6 14.5 12.4 0.1 16.5 17.8 10.5 13.3 22.4 30.3 19.5 21.9 16.1 16.8 10.5 12.4 12.2 5.9 24.4 11.8 9.8 8.1 11.6 17.3 24.4 14.9 25.6 3.3 9.4 16.3 19.1 5.5 6.3 10.4 5.4 17.6 14.0 1.4 10.3 44.2 16.0 10.0 15.7 3.6 10.4 36.2 32.1 7.8 25.4 19.7 12.9 4.8 13.1 4.6 4.3 0.6 12.5 8.8 14.7 1.1 2.0 0.0 4.1 1.1 4.2 0.8 3.4 5.2 2.4 0.3 0.9 2.2 0.0 0.3 0.5 0.0 3.6 1.7 43.1 49.4 27.8 44.6 56.3 37.0 76.1 29.3 45.8 64.1 11.9 6.7 1.4 0.0 8.9 15.4 15.7 15.3 5.3 6.8 47.1 13.7 26.2 11.6 0.0 1.1 15.7 16.8 0.0 0.0 9.8 22.2 0.0 12.7 6.7 10.4 154.1 11.6 16.5 4.3 1.5 14.4 7.2 15.1 0.0 16.9 82.2 0.0 20.3 19.4 9.4 18.4 45.3 25.0 4.7 4.8 15.1 8.5 6.9 17.2 0.0 SERBP1 "CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1" ENSG00000142864 "SERPINE1 mRNA binding protein 1" Q8NC51 1 67407810-67430415 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020559, CAB026297" Supported Enhanced Cytosol NA NA 430000 Cytosol "CAB026297: AB_425924, HPA020559: AB_1856701" "unprognostic (1.58e-1)" "unprognostic (6.35e-2)" "unprognostic (1.45e-2)" "unprognostic (6.80e-3)" "unprognostic (2.71e-3)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (1.98e-2)" "unprognostic (1.32e-3)" "unprognostic (5.97e-2)" "unprognostic (8.25e-3)" "unprognostic (3.04e-1)" "unprognostic (1.33e-2)" "unprognostic (1.40e-2)" "unprognostic (4.76e-1)" "unprognostic (6.64e-2)" "unprognostic (1.34e-3)" 38.3 30.4 22.5 35.7 30.0 33.8 36.9 25.4 27.7 35.4 32.8 25.5 28.6 30.9 36.4 35.2 68.4 25.9 39.4 32.6 22.3 19.1 30.6 48.4 27.5 47.9 29.7 18.6 33.5 56.1 52.2 21.8 28.7 25.0 34.8 27.1 23.2 41.8 28.5 87.5 50.5 29.9 42.0 26.8 31.9 31.5 35.8 28.7 48.9 42.6 54.1 41.3 36.0 40.7 34.3 35.4 16.8 30.2 46.7 44.4 33.9 59.2 36.2 38.9 38.7 34.7 31.9 57.7 62.6 24.6 43.5 36.9 69.8 26.5 114.7 46.9 33.7 40.4 45.7 61.0 58.6 47.2 51.2 73.4 105.6 68.0 61.8 30.4 85.5 40.5 32.5 39.5 55.8 51.0 28.8 47.1 37.5 117.6 40.5 34.7 41.3 64.3 51.9 135.3 39.5 47.9 74.3 85.4 57.3 33.7 49.4 65.7 46.1 48.6 52.9 56.6 33.9 28.9 52.3 49.1 40.0 48.6 57.6 84.1 37.7 48.2 102.9 32.9 81.2 44.6 9.8 27.4 16.8 35.0 30.2 44.4 34.3 35.2 35.3 35.4 33.4 41.4 37.4 9.0 46.7 27.4 32.3 41.7 33.9 22.5 30.0 25.4 27.7 22.3 19.1 29.7 18.6 25.0 28.7 232.3 185.1 214.5 341.9 609.6 146.7 119.8 186.0 238.3 320.8 111.7 86.4 217.4 205.6 253.5 407.2 294.6 134.6 186.9 310.6 429.9 231.1 212.2 213.7 301.4 265.1 135.1 220.8 148.0 205.2 164.8 204.8 212.7 182.2 266.1 277.0 146.7 292.1 133.3 262.0 212.1 123.4 135.8 315.9 477.7 288.9 629.1 191.8 235.2 341.4 442.1 SERGEF "DelGEF, Gnefr" ENSG00000129158 "Secretion regulating guanine nucleotide exchange factor" Q9UGK8 11 17788048-18013162 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 115.8;Late spermatids: 197.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037811, HPA037812, HPA074086" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658" "unprognostic (2.67e-2)" "unprognostic (7.15e-2)" "unprognostic (7.00e-2)" "unprognostic (9.04e-3)" "prognostic unfavorable (5.67e-4)" "unprognostic (6.94e-2)" "unprognostic (1.30e-3)" "unprognostic (1.87e-1)" "unprognostic (3.69e-2)" "unprognostic (1.70e-1)" "unprognostic (3.74e-3)" "unprognostic (5.56e-2)" "unprognostic (4.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.43e-1)" "unprognostic (1.24e-2)" "unprognostic (5.82e-2)" 8.2 14.2 30.1 7.5 22.3 4.7 15.2 24.4 31.4 13.1 10.7 9.5 4.3 6.1 11.8 17.7 9.6 13.9 10.3 9.9 28.6 24.1 15.6 12.3 10.0 8.0 27.9 18.1 26.1 17.4 17.7 19.3 4.8 23.0 13.6 11.5 10.1 12.3 17.1 11.8 11.1 6.2 14.4 10.4 7.6 10.1 3.9 10.7 7.8 25.3 8.8 11.8 9.5 15.6 15.4 14.4 8.9 11.8 11.3 22.0 14.1 6.4 7.4 7.1 13.3 12.3 12.7 4.3 5.1 11.6 6.0 7.9 5.3 2.1 5.8 6.7 6.5 17.4 8.4 25.1 16.5 5.2 12.7 20.4 8.9 6.8 21.9 13.8 7.8 10.3 11.4 18.1 2.9 12.9 18.7 6.5 13.2 5.4 11.2 9.2 10.0 7.6 17.1 5.4 21.9 8.9 11.0 7.8 6.4 14.6 9.7 16.6 3.9 9.6 9.6 9.7 15.0 4.5 7.4 3.3 6.3 7.3 8.2 6.1 7.7 9.3 7.5 9.7 9.1 6.0 7.2 11.8 8.9 21.1 9.3 17.4 15.4 21.3 16.0 14.4 11.1 21.7 19.2 1.2 11.3 9.4 5.9 22.0 14.1 30.1 22.3 24.4 31.4 28.6 24.1 27.9 18.1 23.0 10.7 6.0 5.0 11.3 18.7 23.6 13.1 10.4 10.2 5.3 7.9 10.4 2.0 6.2 33.2 14.7 115.8 11.3 7.9 0.0 21.5 10.6 11.8 15.5 13.9 12.3 12.5 11.1 46.6 7.4 15.5 197.3 18.1 11.9 20.3 10.8 13.0 15.2 13.8 7.0 20.1 30.0 8.2 6.5 20.0 6.2 5.6 17.7 2.6 20.6 12.4 17.2 SERINC1 "KIAA1253, TDE1L, TDE2, TMS-2" ENSG00000111897 "Serine incorporator 1" Q9NRX5 6 122443354-122471822 "Plasma proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035738, HPA035739" Uncertain Approved Cytosol NA NA Cytosol "HPA035738: AB_10672990, HPA035739: AB_10669536" "unprognostic (2.83e-3)" "unprognostic (2.68e-3)" "unprognostic (1.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.65e-1)" "unprognostic (2.84e-2)" "unprognostic (2.04e-1)" "unprognostic (7.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.27e-2)" "unprognostic (9.07e-3)" "unprognostic (2.84e-1)" "unprognostic (5.50e-3)" "unprognostic (1.80e-3)" "unprognostic (9.22e-2)" "unprognostic (3.58e-1)" "unprognostic (1.00e-2)" 49.0 62.0 72.0 21.6 74.5 31.4 39.6 67.3 96.4 40.4 25.1 61.5 17.0 23.9 36.7 27.8 23.8 27.0 31.6 39.1 75.5 78.4 48.7 58.1 38.9 20.6 91.6 57.7 42.7 24.4 56.4 32.9 47.0 109.2 36.0 25.2 29.7 22.5 37.8 37.4 20.5 27.2 35.4 120.6 28.4 23.1 15.6 57.5 12.9 50.8 13.0 18.7 33.2 22.8 10.0 12.6 44.1 20.4 17.7 20.7 17.4 7.4 9.2 23.3 21.3 88.4 48.6 12.4 39.2 49.2 21.5 33.4 10.7 20.2 5.0 30.9 44.1 24.7 14.9 13.7 16.9 32.3 15.9 16.3 14.1 15.7 19.5 39.6 14.1 28.2 50.4 33.3 26.7 37.0 49.6 18.5 13.2 14.0 28.5 44.4 8.5 6.3 9.4 7.5 11.7 11.7 7.8 11.5 12.0 46.2 13.1 12.2 22.1 17.3 19.3 26.5 21.6 13.3 19.9 37.7 25.9 11.3 21.2 20.3 21.6 24.1 6.6 34.3 11.5 30.2 44.1 15.0 31.4 16.8 18.8 18.1 10.0 17.6 16.2 12.6 8.7 20.7 17.9 38.9 17.7 20.4 9.9 18.6 17.4 72.0 74.5 67.3 86.9 75.5 78.4 91.6 57.7 109.2 57.5 140.0 86.4 39.7 67.4 58.7 103.2 138.9 89.2 52.2 54.6 73.3 66.8 48.9 8.3 55.1 2.4 116.4 66.3 46.7 42.2 46.7 95.4 88.7 119.2 115.6 64.9 130.3 81.1 105.6 142.0 5.6 117.3 84.8 89.4 25.2 36.8 98.4 63.7 38.6 123.4 38.5 56.5 58.2 75.4 17.9 19.6 65.5 100.1 71.3 29.3 78.2 SERINC5 "C5orf12, TPO1" ENSG00000164300 "Serine incorporator 5" Q86VE9 5 80111651-80256079 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 145.8;Urothelial cells: 161.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037898, HPA037899" Supported Supported "Vesicles,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Vesicles, Centrosome" "HPA037898: AB_10673649, HPA037899: AB_2675727" "unprognostic (2.95e-1)" "unprognostic (1.80e-1)" "unprognostic (4.98e-3)" "unprognostic (1.08e-2)" "unprognostic (5.05e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-2)" "unprognostic (8.00e-2)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" "unprognostic (7.71e-2)" "unprognostic (1.62e-1)" "unprognostic (1.40e-2)" "unprognostic (4.81e-2)" "unprognostic (8.09e-2)" "unprognostic (4.93e-2)" "unprognostic (9.17e-2)" 6.9 21.1 9.0 7.8 11.2 3.0 6.7 5.3 15.6 10.2 16.3 28.8 11.2 5.1 6.9 12.9 9.7 9.6 8.4 4.1 9.5 7.3 5.3 26.3 8.0 9.3 13.4 7.0 9.8 7.8 4.2 5.3 24.7 12.1 20.3 17.5 3.6 9.8 8.4 3.1 10.9 9.5 4.4 9.7 8.3 9.7 18.9 15.0 7.8 5.2 6.7 12.3 9.3 7.7 0.8 4.0 6.2 6.9 0.4 17.5 4.7 4.9 8.9 3.0 1.9 4.2 4.4 9.1 4.1 2.7 1.8 1.9 18.0 25.9 0.8 4.2 5.2 4.2 14.5 4.1 10.8 2.6 0.7 2.2 0.6 1.1 9.6 1.5 0.6 1.9 5.1 6.0 4.7 12.3 5.1 3.3 24.6 1.6 4.3 4.8 8.6 10.0 2.4 4.2 7.0 3.1 12.0 2.7 1.3 5.3 24.7 0.2 2.9 3.6 8.5 15.9 16.2 3.7 3.1 3.6 5.3 1.5 5.3 5.0 5.6 1.5 13.0 9.9 1.7 21.5 6.2 6.9 4.4 1.6 3.4 1.2 0.5 13.9 4.2 4.0 0.8 17.5 10.5 3.6 0.4 1.0 0.9 4.5 4.7 9.0 11.2 5.3 10.9 9.5 7.3 13.4 7.0 12.1 15.0 56.6 23.8 3.7 42.8 5.7 3.7 7.5 22.9 2.7 23.9 15.7 0.0 14.2 8.3 21.5 1.4 17.5 72.2 0.0 16.8 20.9 20.6 145.8 8.1 74.0 19.5 3.2 57.7 43.0 25.4 4.2 17.0 27.0 5.0 36.1 63.6 60.6 25.3 57.5 37.4 4.6 4.8 32.3 3.8 1.2 7.9 8.5 108.0 16.7 74.3 161.9 SERPINA10 "PZI, ZPI" ENSG00000140093 "Serpin family A member 10" Q9UK55 14 94280455-94293271 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 223 "liver: 169.5" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 200.2" "Cancer enriched" "Detected in some" 51 "liver cancer: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 8 "Hep G2: 21.2" "Not detected" "Not detected" HPA048739 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 3960000000 5900000000 Nucleoplasm Cytosol "HPA048739: AB_2797237" "unprognostic (7.14e-2)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-1)" "prognostic favorable (9.00e-4)" "unprognostic (6.11e-2)" "unprognostic (2.81e-4)" "unprognostic (2.31e-4)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (7.93e-3)" 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 169.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.1 0.1 0.2 0.0 0.6 0.3 2.1 0.8 0.8 0.8 0.5 0.6 0.6 1.0 0.9 2.6 0.6 2.3 0.4 0.4 0.2 0.3 2.4 0.6 1.5 0.9 1.5 2.1 0.7 21.2 0.5 1.7 1.2 0.7 0.5 0.3 0.8 1.2 1.1 1.1 0.6 1.4 1.1 0.3 1.4 1.1 0.9 0.2 0.6 1.0 1.1 0.9 0.6 0.7 1.0 0.9 0.5 0.5 0.2 1.2 1.5 0.9 0.6 0.8 0.4 0.7 0.6 1.2 0.5 1.0 1.0 1.9 0.5 0.7 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.9 0.0 0.0 0.2 0.4 2.5 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 200.2 0.0 0.0 6.3 4.3 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINB10 "bomapin, PI10" ENSG00000242550 "Serpin family B member 10" P48595 18 63897174-63936111 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 43.9;tongue: 15.3" "Group enriched" "Detected in some" 10 "Ciliated cells: 6.7;Club cells: 2.3;Kupffer cells: 3.2;monocytes: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 4.2;eosinophil: 3.3;neutrophil: 1.8;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 9 "dendritic cells: 2.1;granulocytes: 3.3;monocytes: 4.2" "Cell line enriched" "Detected in some" 7 "U-937: 48.6" "Low region specificity" "Detected in all" "HPA015480, HPA059582" Uncertain Supported Nucleoplasm,Cytosol NA NA 42000 Nucleoplasm Cytosol "HPA015480: AB_1855456, HPA059582: AB_2684072" "unprognostic (4.66e-1)" "unprognostic (5.11e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (9.56e-2)" "unprognostic (2.56e-1)" "unprognostic (4.59e-1)" "unprognostic (1.10e-1)" "unprognostic (3.64e-1)" "unprognostic (1.25e-4)" 1.3 0.1 0.0 2.3 0.2 43.9 0.1 0.3 0.1 1.1 0.7 0.0 0.0 0.1 0.2 0.3 3.1 0.1 0.1 5.5 0.0 0.0 0.0 0.2 3.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 4.8 0.2 0.1 0.1 0.0 1.0 0.1 1.3 2.5 0.1 0.1 0.0 2.8 0.1 0.1 0.1 4.0 0.9 15.3 1.5 0.1 1.3 0.3 2.1 3.3 4.2 0.3 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 48.6 0.0 0.2 4.2 3.3 0.2 0.1 0.1 0.2 0.1 0.1 0.4 0.3 0.1 0.1 1.8 0.3 0.0 2.1 0.1 0.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 SERPINB13 "headpin, HUR7, hurpin, PI13" ENSG00000197641 "Serpin family B member 13" Q9UIV8 18 63586989-63604639 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 8.1;Club cells: 29.6;Urothelial cells: 8.5" "Cancer enhanced" "Detected in many" "cervical cancer: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 132 "HaCaT: 65.6;hTCEpi: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052630, HPA057129" Enhanced Approved "Nuclear speckles,Cytosol" NA NA 59000 "Nuclear speckles, Cytosol" "HPA052630: AB_2681891, HPA057129: AB_2683347" "unprognostic (3.49e-2)" "unprognostic (3.73e-1)" "unprognostic (1.11e-1)" "unprognostic (7.27e-2)" "unprognostic (2.28e-1)" "unprognostic (4.29e-2)" "unprognostic (2.81e-1)" "unprognostic (6.04e-3)" 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.1 37.7 0.1 0.0 0.0 0.1 3.1 0.1 70.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 10.9 0.1 0.2 5.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.0 0.1 107.2 54.2 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 8.1 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 8.5 SERPINB3 "HsT1196, SCC, SCCA1, T4-A" ENSG00000057149 "Serpin family B member 3" P29508 18 63655197-63661963 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0" "Group enriched" "Detected in some" 8 "Ciliated cells: 141.8;Club cells: 465.2;Urothelial cells: 238.3" "Cancer enhanced" "Detected in many" "cervical cancer: 186.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;HaCaT: 9.1;HBEC3-KT: 2.2;SiHa: 5.6;U-2197: 11.6" "CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992" Enhanced Approved "Plasma membrane,Cytosol" NA NA 11000000 Cytosol "Plasma membrane" "CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998" "unprognostic (2.95e-3)" "unprognostic (1.66e-1)" "unprognostic (2.03e-1)" "unprognostic (2.91e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.19e-4)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (4.19e-3)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 50.7 0.2 0.2 0.2 0.0 3.8 0.2 140.0 0.0 0.2 0.2 0.2 0.0 0.2 0.2 5.4 0.2 0.2 0.2 0.2 0.2 0.0 2.4 0.2 0.2 1.1 0.0 0.2 13.0 0.2 0.2 7.1 0.2 0.2 0.2 0.2 0.0 0.2 0.2 1.4 0.2 21.3 3.1 13.1 80.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.2 9.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 10.3 0.0 15.8 0.0 0.0 0.0 0.0 141.8 465.2 0.0 0.0 0.0 0.0 3.7 24.6 0.0 0.0 0.0 7.4 0.0 0.0 36.6 2.3 0.0 0.1 0.0 0.0 0.0 0.0 33.0 1.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 238.3 SERPINB8 "CAP2, PI8" ENSG00000166401 "Serpin family B member 8" P50452 18 63969925-64019779 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.6" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 37.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB034300 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB034300: AB_2186486" "unprognostic (8.49e-2)" "unprognostic (4.87e-2)" "unprognostic (4.10e-3)" "unprognostic (2.86e-2)" "unprognostic (1.52e-2)" "unprognostic (7.71e-2)" "unprognostic (4.50e-2)" "unprognostic (2.19e-1)" "unprognostic (2.67e-1)" "unprognostic (2.98e-3)" "unprognostic (6.58e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (8.73e-2)" "unprognostic (3.48e-2)" "unprognostic (1.25e-1)" "unprognostic (1.90e-1)" 12.4 7.4 2.9 9.3 4.2 16.0 6.1 1.3 5.5 7.7 7.4 7.1 0.0 3.7 4.1 4.3 20.6 3.7 13.7 4.5 3.1 3.3 7.1 23.7 8.2 10.1 4.7 4.0 8.1 4.2 1.1 5.0 9.5 7.4 4.2 6.1 3.4 8.1 2.1 4.5 36.6 8.7 4.4 6.0 9.8 4.2 2.9 3.5 4.2 5.0 17.5 11.3 9.6 11.0 5.1 25.3 5.9 20.5 2.1 4.2 5.0 7.6 1.5 1.3 9.4 4.7 6.6 0.6 24.7 24.0 15.7 15.7 0.3 3.4 0.1 9.1 14.7 7.7 12.4 0.2 15.6 22.5 10.5 0.3 0.0 2.9 0.8 10.7 37.9 3.3 6.3 13.6 21.1 6.9 10.2 16.6 1.6 0.2 4.4 10.8 0.6 0.6 4.2 0.5 1.3 7.6 0.5 3.4 0.6 7.0 8.7 0.7 0.7 4.9 0.7 9.1 1.1 0.3 14.3 25.8 24.0 5.1 2.9 9.9 1.9 0.3 0.0 24.6 22.1 20.6 1.1 20.5 0.8 3.8 16.1 3.4 3.6 3.1 2.3 25.3 5.1 1.7 2.6 5.9 2.1 8.0 13.7 4.2 5.0 2.9 4.2 1.3 5.5 3.1 3.3 4.7 4.0 7.4 3.5 3.0 11.7 4.7 24.0 36.5 0.2 1.2 7.6 6.7 12.5 0.0 0.0 2.9 0.0 27.3 0.6 8.8 8.1 0.0 16.7 4.1 9.3 12.1 4.6 10.4 15.0 0.0 1.7 4.9 24.1 1.1 0.9 25.5 15.1 16.2 3.1 1.6 29.4 2.0 0.0 1.6 0.2 0.0 8.6 2.3 1.0 42.3 26.2 3.9 2.8 32.4 SERPINB9 "CAP3, PI9" ENSG00000170542 "Serpin family B member 9" P50453 6 2887266-2903280 "Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.0;lymphoid tissue: 39.6" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 116.9;monocytes: 105.6;Syncytiotrophoblasts: 226.0" "Cancer enhanced" "Detected in all" "testis cancer: 46.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 59.1;SuSa: 62.4;U-698: 25.4" "Low region specificity" "Detected in all" HPA030067 Uncertain Approved Nucleoplasm,Cytosol NA NA 4900000 Nucleoplasm Cytosol "HPA030067: AB_2673295" "unprognostic (6.82e-3)" "unprognostic (8.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-1)" "unprognostic (4.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.12e-2)" "unprognostic (9.48e-2)" "unprognostic (2.12e-2)" "unprognostic (3.83e-3)" "unprognostic (1.06e-1)" "unprognostic (9.85e-2)" "prognostic unfavorable (1.66e-6)" "unprognostic (9.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-2)" 5.6 5.1 3.3 15.9 4.1 7.2 2.6 3.6 6.7 3.9 2.1 4.4 1.3 1.7 1.9 1.9 4.6 4.1 5.3 4.9 3.4 3.6 2.5 7.6 13.7 39.6 4.8 3.9 3.8 1.3 4.7 4.9 24.5 4.7 2.6 2.9 3.5 7.5 1.3 2.0 1.0 5.5 2.4 7.1 14.4 2.0 4.4 2.0 6.4 4.2 2.1 18.9 3.4 3.8 10.3 6.4 2.9 38.0 18.8 17.9 12.3 0.0 2.5 0.0 0.0 0.1 0.0 59.1 0.5 0.1 0.6 0.9 0.7 4.8 9.6 6.0 0.5 0.0 0.0 7.1 0.0 0.5 3.1 0.7 0.9 0.9 1.4 3.4 0.0 0.0 2.7 0.0 1.0 0.0 0.0 12.9 0.8 4.4 0.1 0.4 0.2 0.0 0.0 8.2 0.0 0.0 0.9 0.0 0.1 0.4 0.0 0.4 0.1 5.8 0.0 0.0 62.4 0.0 0.1 13.4 0.0 0.1 0.0 0.0 0.0 12.1 25.4 0.0 0.0 0.0 1.7 18.3 0.1 17.9 38.0 14.7 8.3 13.0 16.8 6.1 10.3 12.1 17.5 2.9 18.8 22.0 6.4 13.0 12.3 3.3 4.1 3.6 6.7 3.4 3.6 4.8 3.9 4.7 2.0 17.9 24.9 31.6 1.9 31.4 1.5 4.2 2.5 13.4 14.8 5.2 0.0 62.3 0.0 14.4 0.9 42.0 1.6 0.0 0.2 116.9 44.8 2.2 45.1 6.8 16.6 7.9 14.9 60.2 47.5 2.5 4.0 98.8 84.4 105.6 3.1 4.8 6.2 5.8 16.6 1.4 2.9 12.9 18.1 0.5 2.2 32.2 226.0 48.4 3.5 7.4 SERPINE1 "PAI, PAI1, PLANH1" ENSG00000106366 "Serpin family E member 1" P05121 7 101127089-101139266 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 253.6" "Cell type enhanced" "Detected in many" 22 "Pancreatic endocrine cells: 138.9;Syncytiotrophoblasts: 545.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 20 "NK-cell: 10.8" "Lineage enriched" "Detected in single" 20 "NK-cells: 10.8" "Cell line enhanced" "Detected in many" "BJ: 142.8;HUVEC TERT2: 165.7;LHCN-M2: 160.0;TIME: 409.8;U-138 MG: 195.1;U-251 MG: 171.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA050039, CAB068501" Uncertain Approved Cytosol "Secreted to blood" No No 142000000 14000000 Cytosol "CAB068501: AB_1642775, HPA050039: AB_2680997" "unprognostic (5.02e-2)" "prognostic unfavorable (5.01e-4)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.10e-2)" "unprognostic (9.04e-3)" "prognostic unfavorable (2.84e-5)" "unprognostic (6.80e-3)" "prognostic unfavorable (4.41e-6)" "unprognostic (2.33e-1)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (5.88e-8)" "prognostic unfavorable (3.27e-6)" "unprognostic (1.05e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (5.51e-4)" 45.5 14.0 1.1 16.7 1.8 0.1 11.4 0.5 1.5 13.3 7.0 3.4 3.3 1.2 6.6 14.4 6.8 9.3 69.6 29.2 1.5 0.6 7.8 65.3 56.3 3.3 4.1 1.8 19.7 24.7 1.4 2.6 253.6 5.9 7.6 0.9 2.3 2.4 6.2 12.4 4.1 2.3 13.5 4.1 5.8 6.6 8.6 2.2 0.6 11.3 3.7 2.8 71.7 18.1 0.2 0.4 0.5 0.2 10.8 0.3 1.0 3.0 2.6 0.0 0.2 32.7 65.2 3.7 142.8 27.0 72.1 63.0 0.3 0.2 0.1 34.2 45.4 99.7 0.7 0.0 11.0 74.4 0.1 0.0 0.0 0.2 2.4 65.8 0.0 0.1 25.5 4.4 110.5 58.1 39.1 165.7 0.0 0.2 0.1 160.0 0.0 0.0 0.0 0.7 0.0 1.7 0.0 0.2 0.1 0.2 1.2 0.0 0.0 11.7 3.2 0.3 18.0 0.1 0.4 409.8 195.1 8.5 66.4 171.5 0.0 0.1 0.1 48.7 0.0 1.8 0.5 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.3 0.2 0.0 0.1 0.2 10.8 0.0 0.4 0.0 1.0 1.1 1.8 0.5 1.5 1.5 0.6 4.1 1.8 5.9 2.2 0.0 11.4 0.0 30.0 35.5 0.4 1.9 7.6 8.1 7.9 5.2 0.0 34.4 0.0 22.9 0.0 53.9 0.0 0.0 3.8 35.1 24.7 5.4 10.3 90.0 15.2 0.0 5.1 60.2 4.7 0.4 16.4 7.5 6.8 1.8 0.0 0.3 138.9 0.0 11.3 0.0 0.2 38.8 16.5 0.0 0.0 21.7 545.0 0.7 0.0 5.9 SERPINI1 "neuroserpin, PI12" ENSG00000163536 "Serpin family I member 1" Q99574 3 167735243-167825568 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 96.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 71.8;Muller glia cells: 71.6;Smooth muscle cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 15.9;HeLa: 16.5;Karpas-707: 18.5;U-266/84: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001565, HPA056092" Enhanced Uncertain Cytosol "Secreted in brain" NA NA 200000 Cytosol "HPA001565: AB_1079924, HPA056092: AB_2683036" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (4.09e-3)" "unprognostic (1.35e-1)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.48e-1)" "unprognostic (2.61e-1)" "unprognostic (6.07e-3)" "unprognostic (2.18e-2)" "unprognostic (1.01e-1)" "unprognostic (1.58e-3)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 5.9 8.2 31.9 2.4 27.9 1.3 6.1 3.6 96.0 4.2 2.8 7.1 0.4 1.5 4.3 4.3 3.2 3.9 3.4 6.4 35.9 35.3 14.5 2.5 3.4 2.3 36.9 35.7 4.0 16.3 3.7 10.3 3.5 22.9 5.8 2.5 2.4 9.9 3.6 1.7 2.1 2.5 3.1 51.6 4.1 3.6 7.0 15.9 0.0 5.2 0.3 3.8 3.1 1.6 15.4 4.4 1.0 0.4 6.0 16.0 3.4 0.4 2.0 3.2 0.2 6.0 1.6 0.2 1.2 1.8 0.8 1.3 0.7 3.9 15.9 6.1 0.8 2.7 0.9 2.1 2.2 0.9 5.0 4.5 5.4 16.5 6.7 0.4 0.8 0.6 2.3 0.8 0.4 0.8 1.8 0.2 6.1 10.1 18.5 0.7 1.5 0.4 1.1 2.0 2.5 2.5 1.8 0.1 2.0 6.9 0.5 1.3 8.4 2.3 4.3 5.1 7.8 6.6 2.4 0.5 3.5 0.3 0.3 5.7 13.9 17.1 11.6 2.9 4.1 2.0 1.0 0.2 0.5 6.2 0.4 4.5 12.7 6.5 6.6 0.3 15.4 4.7 5.7 0.6 6.0 0.3 4.4 16.0 3.4 31.9 27.9 3.6 78.9 35.9 35.3 36.9 35.7 22.9 15.9 6.0 1.0 8.0 12.2 3.3 71.8 7.3 0.0 13.4 7.9 5.2 13.7 5.0 6.6 1.5 0.3 9.2 0.0 0.0 15.6 4.7 5.2 9.8 2.3 0.6 2.3 4.8 4.6 3.1 0.8 1.8 3.7 1.9 6.8 1.8 0.1 71.6 4.6 0.0 2.5 31.2 31.4 25.8 68.9 1.8 13.2 1.5 4.2 5.3 0.0 1.6 SERTAD2 "KIAA0127, Sei-2, TRIP-Br2" ENSG00000179833 "SERTA domain containing 2" Q14140 2 64631621-64751005 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 157.8;Suprabasal keratinocytes: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019021, HPA020904" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019021: AB_1856740, HPA020904: AB_1856741" "unprognostic (1.40e-2)" "unprognostic (7.41e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (2.15e-2)" "unprognostic (8.15e-2)" "unprognostic (3.39e-3)" "unprognostic (1.06e-1)" "unprognostic (9.55e-2)" "unprognostic (5.95e-3)" "unprognostic (1.98e-3)" "unprognostic (7.04e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.21e-3)" "unprognostic (6.78e-2)" "unprognostic (4.98e-2)" "unprognostic (3.84e-1)" 14.3 5.5 4.3 11.3 5.5 52.1 10.4 6.4 5.9 12.4 8.6 9.1 5.6 4.6 9.6 7.6 24.7 7.8 8.4 10.9 4.7 3.5 6.7 11.0 11.8 12.5 7.2 4.4 12.1 5.8 8.4 6.2 17.4 6.0 8.6 6.5 10.2 18.4 7.5 10.8 18.8 9.9 9.5 6.7 24.5 7.2 7.4 8.4 53.8 7.6 16.7 25.7 22.0 16.7 5.4 8.8 3.8 3.1 2.6 4.2 1.4 14.6 4.3 8.2 8.1 7.0 18.0 9.4 11.8 11.4 7.0 6.6 11.1 11.3 12.4 6.5 19.2 9.8 5.8 5.3 7.2 14.9 1.1 8.0 8.2 4.1 8.0 1.5 7.2 4.2 12.2 9.5 16.0 10.5 10.5 4.2 6.2 5.1 6.9 16.3 3.5 7.7 7.9 4.5 8.1 11.6 6.8 14.0 4.8 9.5 13.5 9.5 3.7 8.3 5.8 14.8 8.0 3.9 5.8 12.7 38.0 19.6 22.2 9.5 11.9 4.5 14.4 14.1 13.3 14.8 2.3 2.7 3.8 1.8 2.8 1.1 4.7 1.8 2.0 2.8 5.4 4.2 3.1 3.8 2.6 3.1 8.8 0.9 1.4 4.3 5.5 6.4 5.8 4.7 3.5 7.2 4.4 6.0 8.4 6.0 23.4 29.1 32.3 157.8 20.0 20.7 38.2 14.7 23.9 8.7 17.7 31.4 1.7 11.5 39.6 24.5 17.4 46.7 8.6 22.2 26.8 30.6 8.1 23.2 19.8 9.5 10.9 25.2 34.9 27.3 15.8 37.9 37.1 12.6 14.8 16.7 14.4 17.5 9.9 7.8 23.0 12.9 34.0 5.4 2.7 129.6 50.2 17.5 11.5 61.7 SESN2 "DKFZp761M0212, HI95, SES2, SEST2" ENSG00000130766 "Sestrin 2" P58004 1 28259527-28282491 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 23.1;SK-MEL-30: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018191 Uncertain Approved Cytosol NA NA Cytosol "HPA018191: AB_1856750" "unprognostic (7.05e-2)" "unprognostic (4.95e-3)" "unprognostic (1.43e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.78e-4)" "unprognostic (8.97e-2)" "unprognostic (2.50e-3)" "unprognostic (1.41e-1)" "unprognostic (1.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (2.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.84e-1)" "unprognostic (1.60e-1)" 9.2 7.7 7.0 6.8 6.7 32.0 7.6 6.1 11.1 6.1 9.6 3.5 4.6 14.3 7.2 4.0 15.2 6.2 7.6 4.3 4.5 6.1 12.5 18.4 7.7 4.1 8.4 4.5 22.4 10.4 7.5 5.4 9.3 7.6 5.2 8.3 6.9 14.5 4.6 5.8 4.9 12.6 6.2 10.9 5.8 7.2 9.2 4.3 4.8 7.0 4.2 9.7 7.3 14.9 1.9 2.8 6.2 2.7 3.9 9.6 2.5 2.6 1.4 3.5 5.8 5.7 4.5 19.2 5.1 4.7 3.1 3.7 2.0 1.9 3.0 2.1 2.3 3.5 2.6 4.1 3.6 2.2 2.7 3.8 1.2 2.0 3.4 18.8 4.5 6.8 14.3 23.1 8.4 20.1 1.4 3.4 7.1 7.1 14.5 2.9 1.5 1.6 1.2 2.8 1.2 2.9 2.5 0.9 6.6 2.1 4.5 1.2 1.3 1.4 1.2 27.9 4.0 3.2 6.4 1.9 1.6 4.9 3.6 3.1 18.8 4.7 4.7 3.7 4.6 3.5 0.0 2.3 1.9 9.6 1.9 4.7 1.9 3.4 4.6 2.4 1.4 2.1 4.3 6.2 3.9 2.7 2.8 3.9 2.5 7.0 6.7 6.1 11.1 4.5 6.1 8.4 4.5 7.6 4.3 0.0 5.3 7.3 16.1 15.0 12.1 6.1 7.6 1.4 1.2 7.0 7.9 25.1 3.3 20.3 2.0 5.8 23.8 0.0 14.6 17.0 10.4 12.6 4.6 18.8 11.7 0.0 12.6 8.0 3.3 2.7 2.3 10.9 6.8 7.2 10.7 5.8 23.7 11.5 3.2 20.7 7.4 0.0 21.9 4.7 3.3 10.9 56.0 12.8 11.5 19.1 SESN3 "MGC29667, SEST3" ENSG00000149212 "Sestrin 3" P58005 11 95165513-95232541 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 511.2;Late spermatids: 396.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.6;ASC TERT1: 21.5;SuSa: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037935 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037935: AB_10670534" "unprognostic (2.72e-2)" "unprognostic (3.06e-1)" "unprognostic (2.67e-1)" "unprognostic (8.09e-3)" "unprognostic (5.45e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (8.19e-3)" "unprognostic (1.38e-1)" "unprognostic (3.78e-1)" "unprognostic (2.34e-3)" "unprognostic (4.43e-2)" "unprognostic (1.67e-3)" "unprognostic (1.69e-1)" "unprognostic (1.96e-1)" "unprognostic (1.76e-2)" "unprognostic (9.42e-2)" 7.3 14.2 22.3 10.4 38.6 11.9 11.6 10.2 20.8 10.3 6.8 11.1 3.3 5.2 9.3 11.7 7.6 7.0 9.9 5.1 15.9 12.9 8.7 6.0 7.2 17.3 12.6 12.0 18.4 3.3 27.7 10.7 6.6 13.9 8.5 5.4 19.7 9.1 4.8 5.4 8.4 10.6 7.6 11.6 12.7 3.9 41.6 14.1 11.3 17.3 4.0 18.3 10.0 7.7 4.2 1.1 1.0 3.5 0.8 4.5 0.8 0.0 0.4 11.6 0.0 19.6 21.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 3.0 1.4 0.0 0.5 2.3 7.0 5.0 0.0 2.5 3.6 1.5 6.1 0.4 0.3 1.3 0.2 11.8 8.8 0.0 2.6 3.6 0.4 1.8 0.1 0.5 0.9 0.0 0.9 3.5 4.7 0.0 0.5 2.2 0.7 0.2 2.6 7.6 1.5 3.2 0.1 0.1 0.6 47.8 0.0 4.3 0.1 1.3 3.0 0.2 0.4 0.1 0.0 0.4 0.5 1.6 2.8 1.0 0.8 0.6 0.7 1.7 0.8 4.2 2.3 1.3 0.7 2.7 4.5 1.7 0.8 0.8 3.5 1.1 4.0 0.8 22.3 38.6 10.2 20.8 15.9 12.9 12.6 12.0 13.9 14.1 23.8 6.4 52.8 25.9 20.5 48.2 7.5 0.0 2.7 14.8 33.2 21.6 0.8 1.7 4.1 511.2 29.0 9.7 23.3 2.0 0.3 22.8 17.2 6.9 4.9 19.2 0.0 7.0 28.3 40.6 396.5 37.7 20.8 30.4 114.6 14.1 93.1 1.9 5.8 82.0 14.6 12.5 6.5 24.7 35.4 8.3 10.9 1.4 15.2 16.3 9.1 SETBP1 "KIAA0437, SEB" ENSG00000152217 "SET binding protein 1" Q9Y6X0 18 44680173-45068510 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 58.1;Peritubular cells: 37.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.9;naive B-cell: 7.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "AF22: 9.5;Karpas-707: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049022, HPA057259" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA049022: AB_2680602, HPA057259: AB_2683384" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.11e-1)" "unprognostic (1.97e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "unprognostic (1.91e-1)" "unprognostic (3.57e-2)" "unprognostic (3.49e-1)" "unprognostic (2.01e-2)" "unprognostic (2.71e-3)" "unprognostic (6.52e-2)" "prognostic favorable (6.34e-8)" "unprognostic (2.18e-2)" "unprognostic (2.29e-1)" "unprognostic (6.06e-2)" "unprognostic (7.81e-5)" 10.6 2.9 3.8 13.2 8.7 2.1 9.8 16.0 12.6 16.9 14.6 4.2 19.9 2.5 14.0 17.5 6.6 11.0 7.9 6.8 3.6 3.5 15.0 7.2 9.8 7.0 2.9 7.4 12.8 8.2 9.1 5.1 10.2 3.2 12.2 5.3 14.0 6.9 21.3 14.5 6.6 6.9 19.9 3.7 5.9 9.1 5.5 1.2 3.4 8.4 8.7 8.8 11.9 13.3 7.5 4.3 0.2 1.6 0.0 0.6 0.2 0.0 1.7 9.5 0.0 2.7 0.7 0.6 0.8 1.7 0.9 0.7 0.1 0.0 0.5 0.3 1.0 0.5 2.8 1.0 3.0 0.6 0.8 0.5 0.0 1.0 0.6 0.0 0.0 0.0 2.3 1.1 0.0 1.8 1.6 0.3 0.0 0.0 37.9 0.2 0.5 0.0 0.0 1.3 0.0 0.6 3.1 0.0 3.3 3.2 2.2 4.8 2.5 0.0 0.0 0.5 4.5 1.3 0.0 0.0 5.6 2.1 0.0 4.4 5.0 0.3 0.0 3.4 0.1 3.2 0.2 0.0 0.0 0.6 1.1 0.0 4.9 0.1 0.5 0.1 7.5 0.0 0.2 0.0 0.0 1.6 4.3 0.0 0.2 3.8 8.7 16.0 12.6 3.6 3.5 2.9 7.4 3.2 1.2 0.0 2.6 26.0 8.5 13.7 11.5 3.6 10.2 2.7 3.4 15.7 17.7 1.3 3.3 4.1 0.9 9.5 0.4 0.0 2.9 1.2 27.4 6.4 0.0 13.5 1.6 3.2 11.5 12.3 1.6 1.8 58.1 2.7 3.3 0.0 2.5 9.1 3.3 8.4 37.4 6.8 19.3 6.5 30.7 0.0 0.1 13.2 0.7 4.9 4.6 1.0 SETD2 "FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A" ENSG00000181555 "SET domain containing 2" Q9BYW2 3 47016429-47163967 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042451 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA042451: AB_10806239" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (6.08e-2)" "unprognostic (1.01e-1)" "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.40e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.19e-2)" "unprognostic (2.45e-1)" "unprognostic (7.84e-2)" "prognostic favorable (7.99e-6)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (8.79e-2)" "unprognostic (5.43e-2)" 13.2 10.5 12.2 15.2 15.4 20.0 11.7 22.4 16.4 13.4 14.0 9.1 12.9 9.5 15.8 7.5 10.8 11.4 8.7 8.8 10.6 6.8 11.4 10.3 10.4 11.8 11.7 9.5 16.0 13.4 21.4 16.3 10.7 11.3 12.4 10.9 7.7 12.7 14.8 27.6 12.5 11.5 11.9 9.8 13.8 10.4 12.8 12.8 23.2 15.8 5.5 12.8 16.1 15.5 4.8 2.6 6.0 2.3 7.1 3.9 1.0 11.6 9.2 15.4 7.9 9.3 10.7 6.5 10.7 10.4 12.6 11.5 9.7 7.6 25.7 6.7 14.8 12.3 7.1 16.7 10.2 17.1 14.7 6.6 26.4 15.3 7.5 7.0 19.7 15.3 9.2 9.9 12.4 15.4 10.2 11.6 13.3 16.9 9.7 10.3 6.1 14.5 2.6 11.7 5.6 7.7 9.6 15.0 13.3 6.4 15.3 6.7 10.6 18.1 7.1 6.7 11.5 7.5 14.7 14.8 13.9 10.4 11.8 17.1 12.5 13.9 26.0 8.0 11.3 8.1 2.4 2.2 5.2 3.9 2.3 2.4 3.7 2.4 3.0 2.5 4.8 3.5 3.0 6.0 7.1 1.9 2.6 1.0 1.0 12.2 15.4 22.4 16.4 10.6 6.8 11.7 9.5 11.3 12.8 44.7 53.3 20.6 20.5 29.7 33.4 58.5 22.9 66.9 80.8 10.4 39.3 16.3 10.0 17.4 24.0 29.3 26.5 0.0 19.3 10.1 20.8 25.9 55.6 26.7 14.3 25.4 21.2 23.4 27.2 20.8 28.1 21.6 16.9 20.8 27.8 21.7 20.0 17.5 31.1 9.3 37.0 12.9 21.7 78.1 18.9 31.1 15.4 27.7 24.8 34.2 SETD6 FLJ21148 ENSG00000103037 "SET domain containing 6" Q8TBK2 16 58515479-58521181 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041481, HPA053546" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041481: AB_10804004, HPA053546: AB_2682182" "unprognostic (1.32e-1)" "unprognostic (2.98e-3)" "unprognostic (3.35e-1)" "unprognostic (2.81e-1)" "unprognostic (7.90e-3)" "unprognostic (1.95e-1)" "unprognostic (1.93e-3)" "unprognostic (1.65e-1)" "unprognostic (3.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (3.74e-3)" "unprognostic (2.14e-1)" "unprognostic (3.73e-1)" "unprognostic (5.93e-3)" "unprognostic (1.55e-1)" 7.8 11.3 7.7 7.4 8.8 4.3 12.6 18.6 11.8 8.4 7.1 6.6 17.0 7.0 10.2 14.0 11.5 10.3 9.6 8.6 8.8 7.0 11.7 12.1 7.9 7.9 8.9 9.0 9.0 20.0 22.1 17.1 7.0 8.3 12.2 8.2 7.2 15.5 19.7 14.7 14.4 7.8 9.2 7.7 9.2 9.6 10.2 9.7 5.5 13.6 9.5 8.8 7.4 10.3 3.2 3.9 3.8 3.0 8.6 4.9 2.7 1.8 3.8 0.8 7.3 2.8 2.0 13.7 3.1 3.4 4.4 2.6 6.5 3.8 13.6 5.0 3.1 0.6 5.7 5.7 4.1 3.2 1.7 20.6 0.6 6.3 11.6 2.9 9.9 6.2 2.5 8.3 3.7 5.7 3.2 3.2 0.1 10.8 1.7 0.9 6.6 0.2 11.9 15.5 5.9 8.4 0.2 1.7 18.5 4.6 0.2 13.6 9.6 13.6 10.4 5.1 4.1 6.7 1.2 2.7 1.7 4.9 2.1 5.2 9.4 5.7 10.1 3.5 4.8 3.3 3.8 2.4 0.2 4.6 3.0 3.3 3.2 3.9 4.9 3.9 3.1 4.8 4.8 0.1 8.6 2.9 3.8 3.2 2.7 7.7 8.8 18.6 11.8 8.8 7.0 8.9 9.0 8.3 9.7 6.0 5.8 7.9 8.7 12.4 13.5 7.6 10.2 13.4 7.9 8.7 13.7 14.4 1.7 7.0 6.6 6.7 4.9 0.0 10.5 7.4 5.2 8.3 1.1 6.2 3.2 11.1 4.6 3.7 3.5 14.2 8.3 4.5 5.0 7.2 4.0 12.1 5.3 2.9 9.6 8.4 11.9 12.9 6.3 9.8 20.4 10.7 10.5 5.3 6.8 5.4 SFN YWHAS ENSG00000175793 Stratifin P31947 1 26863138-26864457 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 6884.3;Suprabasal keratinocytes: 9365.4;Urothelial cells: 2426.4" "Cancer enhanced" "Detected in all" "head and neck cancer: 2526.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "basophil: 7.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.1" "Cell line enhanced" "Detected in many" "A-431: 70.1;HaCaT: 110.7;HBEC3-KT: 170.4;hTCEpi: 114.4" "Low region specificity" "Detected in some" "CAB006268, HPA011105, CAB040552, HPA061603" Enhanced Supported "Nucleoli rim,Cytosol" "Secreted in other tissues" NA NA 54000000 Cytosol "Nucleoli rim" "CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: " "unprognostic (5.70e-2)" "unprognostic (1.26e-1)" "unprognostic (8.37e-2)" "prognostic favorable (1.92e-4)" "unprognostic (1.26e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (1.71e-2)" "unprognostic (2.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (7.45e-6)" "unprognostic (7.90e-3)" "unprognostic (3.25e-1)" "unprognostic (8.12e-2)" "unprognostic (2.06e-2)" 0.4 0.0 0.5 3.1 0.5 0.0 3.8 0.4 0.7 37.5 10.7 0.5 0.5 5.9 3.3 0.7 256.2 0.0 6.0 0.3 0.6 0.1 1.2 0.5 8.2 0.3 0.4 0.3 0.3 0.3 0.0 0.3 3.4 0.8 5.9 4.0 0.3 25.5 0.4 0.4 123.8 13.2 0.5 0.7 0.3 6.6 0.4 0.4 3.1 0.4 256.0 107.4 9.1 47.7 0.0 0.0 7.1 0.0 0.0 0.6 0.0 70.1 11.8 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.3 37.1 0.6 3.1 0.0 0.0 110.7 0.0 170.4 0.0 16.7 0.5 0.0 11.8 12.5 0.0 0.0 0.1 0.0 114.4 0.0 29.9 0.0 0.0 0.0 0.1 0.4 0.0 15.0 0.0 0.0 0.2 12.2 19.7 0.0 0.0 3.9 26.5 16.2 0.0 0.0 16.9 3.0 0.1 0.2 7.9 0.1 0.0 0.0 32.4 0.0 0.4 0.1 0.5 0.3 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.4 0.7 0.6 0.1 0.4 0.3 0.8 0.4 166.7 216.2 0.5 1339.8 6884.3 0.0 0.3 33.1 30.8 122.8 15.7 0.0 6.7 3.3 52.1 0.0 0.6 409.5 0.0 68.0 45.3 37.0 487.4 31.2 0.0 1.6 0.0 64.7 0.6 0.3 0.0 0.0 15.6 506.2 1.8 78.2 0.0 315.2 136.8 0.0 0.0 0.0 0.0 110.7 0.0 0.2 9365.4 5.0 0.0 146.1 2426.4 SFRP1 "FRP, FRP-1, SARP2" ENSG00000104332 "Secreted frizzled related protein 1" Q8N474 8 41261958-41309497 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Cardiomyocytes: 175.8;Leydig cells: 535.6;Peritubular cells: 122.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "hTERT-RPE1: 270.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB008116, HPA064870" Approved Approved Nucleoli,Cytosol "Secreted in other tissues" Yes No 1600000 Nucleoli Cytosol "CAB008116: AB_2187070, HPA064870: AB_2685376" "unprognostic (1.23e-3)" "unprognostic (7.01e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-1)" "unprognostic (7.13e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.79e-1)" "unprognostic (2.69e-3)" "unprognostic (2.15e-2)" "unprognostic (4.67e-3)" "unprognostic (3.52e-3)" "unprognostic (4.74e-2)" "unprognostic (1.72e-2)" "unprognostic (1.75e-2)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (3.12e-4)" 20.1 3.4 4.6 2.4 7.5 0.3 73.2 10.8 5.6 58.4 6.1 15.2 8.0 3.0 35.6 19.3 9.7 25.9 15.5 43.9 7.8 2.5 30.6 1.5 1.8 0.9 4.5 6.7 12.5 1.5 0.6 0.7 9.9 24.1 12.8 7.8 19.3 73.2 27.1 1.9 20.8 5.4 21.4 2.8 5.0 11.0 11.1 13.7 0.0 3.3 18.4 5.1 10.9 41.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 6.3 0.1 5.7 0.3 1.2 10.9 57.4 16.6 15.8 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.8 4.4 23.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 1.0 21.4 1.6 1.6 270.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 17.1 0.0 0.0 0.0 1.3 0.0 35.3 0.0 0.3 1.5 0.4 0.0 3.3 23.2 0.0 0.1 0.1 0.0 1.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 7.5 10.8 5.6 7.8 2.5 4.5 6.7 24.1 13.7 0.0 0.0 0.0 104.7 10.0 1.5 175.8 0.0 0.0 1.2 59.3 2.0 0.7 68.0 3.1 4.8 6.7 0.0 0.0 0.0 55.3 47.0 19.9 0.0 0.0 1.7 1.6 0.0 15.4 0.0 13.0 535.6 1.4 94.5 0.0 0.0 51.5 0.1 0.0 122.4 3.5 1.5 0.0 4.1 1.6 20.6 4.8 0.7 0.0 0.0 8.5 SFSWAP "SFRS8, SWAP" ENSG00000061936 "Splicing factor SWAP" Q12872 12 131711081-131799737 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039362, HPA040063" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA039362: AB_10794089, HPA040063: AB_10795413" "unprognostic (1.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.39e-3)" "unprognostic (2.04e-1)" "unprognostic (4.45e-2)" "unprognostic (2.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.44e-1)" "unprognostic (1.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (7.50e-2)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" 20.2 15.0 17.7 23.2 24.0 47.1 17.9 31.1 23.8 16.6 15.7 31.1 11.6 20.4 25.7 15.1 15.7 15.7 16.5 11.9 20.5 15.9 15.7 12.3 16.4 20.7 27.0 17.2 21.4 19.8 19.5 18.0 16.6 16.6 14.7 9.9 16.9 22.1 15.5 27.4 30.0 19.0 17.3 21.1 23.7 18.4 17.5 26.4 21.9 17.1 15.9 16.8 16.7 20.5 6.6 11.0 8.5 6.4 8.4 5.5 2.6 13.8 12.5 8.9 9.4 7.1 5.9 20.0 10.8 7.5 12.8 8.8 12.2 6.7 17.1 10.1 8.0 6.6 13.0 12.5 9.9 7.5 5.2 19.7 15.5 6.8 14.2 7.6 19.9 15.3 6.7 11.4 11.5 14.0 10.2 7.9 13.3 21.4 6.8 5.7 17.4 16.7 30.3 23.2 7.5 20.9 19.6 9.0 13.4 7.3 10.2 14.0 15.8 10.2 8.6 12.8 7.3 12.4 15.6 10.1 10.6 14.0 8.2 12.0 19.5 21.2 17.2 10.5 13.7 14.2 3.0 6.4 2.6 5.2 4.4 5.0 3.5 4.6 4.2 4.5 6.6 4.9 5.5 8.5 8.4 5.0 11.0 3.8 2.6 17.7 24.0 31.1 23.8 20.5 15.9 27.0 17.2 16.6 26.4 68.5 35.6 23.8 31.0 34.6 46.7 18.0 30.6 41.5 52.4 14.0 62.8 26.1 0.0 18.1 18.1 30.8 17.4 0.0 22.9 26.0 25.5 26.3 36.9 13.9 19.7 39.7 20.7 21.5 25.9 9.6 27.9 25.3 21.9 30.7 20.8 35.2 22.5 16.7 28.0 9.9 59.1 45.3 25.8 31.1 42.7 40.9 36.5 37.1 19.3 46.4 SFT2D1 "C6orf83, MGC19825, pRGR1" ENSG00000198818 "SFT2 domain containing 1" Q8WV19 6 166319728-166342591 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014677 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA014677: AB_2238986" "unprognostic (8.45e-2)" "unprognostic (1.43e-3)" "unprognostic (2.29e-1)" "unprognostic (1.41e-2)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.47e-4)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.68e-1)" "unprognostic (6.53e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (4.20e-2)" "unprognostic (5.05e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.75e-2)" 21.1 24.6 33.6 21.7 31.8 16.4 24.5 15.6 25.0 20.2 27.9 43.4 23.4 23.5 14.7 37.0 19.6 18.8 18.6 15.6 34.9 26.2 27.6 12.5 27.2 23.9 43.9 18.6 18.3 32.6 13.4 11.8 25.9 27.8 27.3 26.8 15.0 38.0 19.4 11.2 12.5 24.9 16.0 61.2 24.6 27.6 18.3 32.8 20.6 24.9 15.3 23.7 17.1 16.1 25.5 57.6 50.1 30.1 14.9 21.7 24.2 13.3 13.0 10.7 22.4 19.6 17.5 16.8 20.8 17.9 14.7 22.3 27.1 27.5 11.8 15.9 17.0 25.7 16.3 15.6 17.1 22.5 16.3 28.5 13.9 11.0 38.2 17.7 35.2 28.3 16.4 20.4 16.9 14.8 21.2 7.8 19.6 25.7 11.9 22.6 21.5 10.3 60.1 10.5 39.9 12.8 7.3 12.3 27.5 36.0 13.9 2.0 9.3 14.2 23.2 18.5 12.6 12.6 63.7 7.3 9.2 17.7 24.3 21.5 11.4 8.2 12.9 19.5 22.2 22.4 29.5 28.5 34.7 18.1 28.1 11.3 25.5 14.7 15.1 30.4 21.2 15.9 15.9 50.1 14.9 30.1 57.6 21.7 24.2 33.6 31.8 15.6 25.0 34.9 26.2 43.9 18.6 27.8 32.8 38.7 55.2 94.6 100.0 76.8 8.2 23.0 58.6 44.2 44.3 102.9 0.0 131.5 76.3 136.4 33.1 53.4 86.8 23.3 110.4 203.9 98.4 175.7 146.5 20.8 187.8 14.3 27.6 63.3 172.6 14.5 78.9 142.4 94.5 228.2 114.9 23.5 133.8 128.7 44.6 126.0 8.4 84.1 53.6 137.2 79.4 89.8 109.7 82.0 105.5 178.5 SGCB "A3b, LGMD2E, SGC" ENSG00000163069 "Sarcoglycan beta" Q16585 4 52020706-52038482 "Disease related genes, Predicted membrane proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011422, HPA058656" Enhanced Approved Cytosol NA NA Cytosol "HPA011422: AB_1856795, HPA058656: AB_2683790" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (1.03e-1)" "unprognostic (1.60e-3)" "unprognostic (9.80e-2)" "unprognostic (3.42e-2)" "unprognostic (3.57e-3)" "unprognostic (1.86e-2)" "unprognostic (2.84e-2)" "unprognostic (6.04e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.53e-6)" "unprognostic (3.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (7.61e-4)" 17.7 13.2 17.6 5.4 19.0 0.5 8.8 18.6 20.7 14.9 18.3 17.5 3.7 7.7 17.1 7.0 13.2 11.5 11.6 32.4 16.5 14.5 20.5 6.4 9.0 3.4 20.4 12.9 12.6 4.0 29.9 17.5 13.9 17.9 15.4 9.9 7.9 7.8 17.0 54.1 4.4 8.7 21.8 24.7 6.3 9.0 9.2 20.3 0.9 7.9 10.4 2.8 13.5 11.8 4.3 1.7 0.9 2.0 0.5 6.6 2.0 3.4 4.2 8.9 3.3 34.4 26.0 3.2 19.7 25.3 11.1 11.7 1.1 4.7 0.9 3.8 25.8 17.2 1.7 6.6 7.2 11.9 5.7 2.5 0.0 4.0 2.1 14.1 2.0 1.1 28.5 5.1 9.6 5.6 29.1 14.5 3.4 0.0 0.0 23.6 1.3 4.5 0.0 3.2 1.4 6.5 0.0 4.7 0.0 9.3 1.2 5.2 9.1 12.5 0.6 4.3 10.4 1.6 1.2 14.7 16.5 5.5 7.7 17.4 4.8 6.1 1.7 12.1 0.7 18.8 0.4 2.0 0.1 3.9 0.8 3.7 4.3 4.6 4.1 0.9 3.6 3.3 4.1 0.9 0.5 0.6 1.7 6.6 2.0 17.6 19.0 18.6 17.5 16.5 14.5 20.4 12.9 17.9 20.3 29.8 12.5 7.0 23.0 11.8 22.7 71.9 20.4 18.7 12.5 12.2 5.9 4.3 1.7 23.7 46.3 25.1 15.9 0.0 46.3 44.3 51.2 9.7 2.3 14.3 2.6 27.0 15.6 35.0 2.2 132.8 35.9 5.1 25.3 1.8 2.6 22.7 35.3 3.5 85.9 54.8 13.4 45.3 63.4 9.8 15.8 9.3 5.3 7.5 11.3 12.3 SGMS1 "MGC17342, MOB, SMS1, TMEM23" ENSG00000198964 "Sphingomyelin synthase 1" 10 50305586-50625163 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045191 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA045191: AB_10959605" "unprognostic (1.13e-1)" "unprognostic (5.75e-2)" "unprognostic (1.87e-1)" "unprognostic (9.08e-2)" "unprognostic (8.69e-3)" "unprognostic (8.34e-2)" "unprognostic (7.98e-2)" "unprognostic (2.29e-1)" "unprognostic (1.30e-2)" "unprognostic (5.75e-2)" "unprognostic (9.20e-2)" "unprognostic (2.05e-1)" "prognostic favorable (1.95e-7)" "unprognostic (8.38e-2)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" "unprognostic (3.05e-1)" 14.7 19.6 16.9 12.3 19.4 17.6 13.2 17.5 20.1 15.8 12.8 24.0 11.9 11.7 12.5 18.1 13.7 14.8 13.6 16.6 18.2 14.6 17.9 23.5 18.6 11.6 22.9 14.0 16.9 19.1 64.6 22.9 20.7 18.6 17.6 10.7 15.5 19.8 15.8 13.2 25.6 13.7 15.2 31.7 13.6 12.8 9.6 24.9 11.4 21.5 8.7 14.9 15.2 21.3 5.3 3.7 20.1 6.7 7.6 11.0 4.2 16.1 7.7 2.3 5.0 8.2 10.8 10.5 10.8 10.9 7.6 7.2 6.4 16.8 12.0 6.3 14.1 6.9 10.3 5.3 11.3 8.0 10.4 5.6 17.2 10.3 4.8 9.5 3.9 4.3 6.9 13.3 10.1 12.4 4.9 10.7 4.4 33.1 18.0 8.1 6.8 1.7 2.2 5.1 7.4 7.4 2.9 10.3 4.6 11.1 17.1 3.4 2.7 7.9 7.9 4.1 6.6 11.9 1.5 14.9 8.3 10.1 7.9 7.9 6.1 4.8 3.4 10.3 6.5 6.7 2.4 6.7 20.1 3.7 3.4 8.2 5.3 4.9 5.4 3.7 5.0 6.8 4.3 12.5 7.6 2.7 2.3 11.0 4.2 16.9 19.4 17.5 20.1 18.2 14.6 22.9 14.0 18.6 24.9 41.7 27.0 11.0 24.2 48.3 16.3 20.6 7.6 25.4 38.7 27.9 3.9 8.7 13.3 15.3 12.1 17.0 9.3 23.3 18.7 6.6 21.6 31.8 19.7 14.5 23.8 4.8 14.3 20.9 40.7 21.3 15.0 16.6 11.8 5.4 11.2 16.5 10.7 3.5 9.9 7.9 35.9 0.0 15.5 8.1 1.9 72.9 4.1 10.7 11.5 23.2 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186292 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 40.1" "Cell type enhanced" "Detected in some" 27 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.6 0.6 0.4 9.1 0.4 8.9 1.0 0.4 1.5 0.9 3.4 0.3 0.6 2.7 0.8 0.5 4.0 0.3 1.7 0.4 0.3 0.4 0.8 1.0 0.9 6.9 0.4 0.1 0.5 0.5 0.0 0.4 3.7 0.2 0.6 3.5 0.1 1.0 0.1 0.3 1.1 3.4 0.8 0.4 4.9 1.5 8.6 0.2 40.1 0.5 2.4 7.4 1.2 1.5 9.0 4.5 8.3 0.2 0.3 2.7 0.6 9.5 10.9 14.9 9.1 0.7 1.3 10.1 10.3 5.3 15.0 16.5 7.7 11.8 14.6 5.2 4.2 10.6 5.6 14.0 5.7 19.0 18.6 9.3 16.6 7.5 6.1 0.1 15.1 14.3 0.1 0.4 16.5 7.0 2.1 8.9 17.4 14.2 26.2 12.4 9.4 23.7 8.5 15.8 10.2 8.3 15.2 19.1 8.5 3.8 7.0 7.4 7.8 11.4 14.1 6.8 11.6 9.1 10.6 2.4 11.4 13.7 10.2 20.5 11.3 26.2 17.0 6.2 15.3 17.1 8.3 0.1 1.5 0.3 0.2 0.1 8.6 0.7 0.8 0.4 9.0 0.2 0.4 1.6 0.3 0.2 4.5 2.7 0.6 0.4 0.4 0.4 1.5 0.3 0.4 0.4 0.1 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 5.4 0.0 1.1 0.0 0.0 0.0 0.0 1.6 33.5 0.0 0.0 1.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 SGSM2 "KIAA0397, RUTBC1" ENSG00000141258 "Small G protein signaling modulator 2" O43147 17 2337498-2381058 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 8.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021641, HPA024553" Approved Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA021641: AB_2188702, HPA024553: AB_1856512" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-2)" "unprognostic (4.88e-2)" "prognostic favorable (3.11e-4)" "unprognostic (1.49e-1)" "unprognostic (7.84e-2)" "unprognostic (7.63e-2)" "unprognostic (1.90e-1)" "prognostic favorable (9.00e-6)" "unprognostic (2.78e-2)" "unprognostic (8.27e-2)" "unprognostic (1.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-2)" 11.1 15.3 51.8 13.3 45.8 17.3 15.9 14.4 43.7 11.6 12.1 12.6 14.9 10.8 13.3 38.6 16.5 12.7 15.1 12.3 43.2 24.9 12.6 6.6 14.7 15.4 13.9 34.8 11.3 14.8 25.4 30.7 11.1 18.9 20.6 7.4 13.6 23.0 18.1 13.4 23.0 13.0 14.2 13.7 16.6 14.2 10.0 17.6 9.4 15.7 6.0 10.8 16.1 10.9 0.6 0.9 8.6 0.4 1.3 2.1 0.7 10.2 15.9 14.5 20.2 8.3 10.0 21.6 8.9 10.5 12.4 12.6 15.9 19.8 4.9 9.7 12.9 4.6 14.5 8.9 10.5 4.3 7.2 18.2 8.7 24.0 16.8 7.1 5.1 13.1 10.7 7.0 12.6 7.3 18.0 12.8 13.6 5.1 7.5 7.4 21.8 11.0 6.9 7.1 7.4 7.0 24.2 7.4 4.0 15.9 21.6 7.1 16.7 11.1 8.4 6.7 9.5 21.7 6.2 14.9 10.0 11.4 14.6 11.7 6.2 0.9 4.5 8.7 6.8 8.7 8.6 0.4 2.1 1.7 0.3 1.5 0.1 0.7 1.0 0.7 0.6 2.1 1.1 0.2 1.3 0.0 0.9 1.0 0.7 51.8 45.8 14.4 43.7 43.2 24.9 13.9 34.8 18.9 17.6 6.0 24.8 3.4 7.1 6.1 54.4 12.4 10.2 6.7 15.9 12.2 127.6 11.8 0.0 5.5 14.7 11.9 6.4 0.0 3.9 7.6 9.1 14.0 19.7 6.8 6.6 28.6 13.3 16.0 6.9 25.3 7.5 8.2 5.0 2.8 9.9 11.7 5.4 3.5 11.3 3.4 55.1 19.4 5.7 3.0 6.7 6.8 11.8 7.5 8.0 11.5 SH2B2 APS ENSG00000160999 "SH2B adaptor protein 2" 7 102285091-102321711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 37.8" "Cell type enhanced" "Detected in many" 13 "B-cells: 20.7;Extravillous trophoblasts: 58.6;Syncytiotrophoblasts: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 5.2;neutrophil: 3.9" "Group enriched" "Detected in many" 5 "B-cells: 5.2;granulocytes: 3.9;monocytes: 3.3" "Cell line enhanced" "Detected in many" "Daudi: 23.5;Karpas-707: 22.9;RPMI-8226: 16.8;U-266/70: 21.3;U-266/84: 37.3;U-698: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051131 Uncertain Approved Cytosol NA NA Cytosol "HPA051131: AB_2681354" "unprognostic (2.01e-2)" "unprognostic (4.00e-1)" "unprognostic (2.43e-2)" "unprognostic (7.32e-3)" "unprognostic (4.65e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-3)" "unprognostic (2.42e-1)" "unprognostic (3.65e-1)" "unprognostic (1.29e-1)" "unprognostic (8.29e-2)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.99e-7)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "unprognostic (2.02e-3)" "unprognostic (3.42e-2)" 5.5 1.3 4.2 11.8 5.1 3.9 2.4 6.5 4.3 2.9 2.0 1.3 0.0 3.1 3.3 1.1 2.3 2.9 2.2 1.7 2.7 5.0 3.2 1.1 9.2 12.6 3.6 1.5 2.2 2.6 1.9 1.9 5.7 4.3 2.9 1.1 0.9 2.0 1.5 37.8 2.4 3.5 1.9 5.0 16.7 2.9 2.2 4.1 0.6 2.8 2.6 10.4 3.1 3.9 5.2 0.7 3.9 3.3 0.0 0.2 0.1 1.3 1.0 1.1 2.4 0.2 0.1 10.4 0.4 0.1 0.3 0.2 0.3 0.2 23.5 2.4 0.1 1.0 1.3 0.2 0.3 0.1 2.9 1.0 0.0 0.6 0.2 0.2 0.1 0.8 0.2 0.3 0.2 0.0 0.4 0.0 0.6 0.1 22.9 0.4 2.5 0.1 4.1 2.6 0.8 4.3 2.9 1.2 16.8 0.8 0.3 1.2 4.3 0.8 2.1 0.5 0.9 0.3 3.0 0.0 0.4 2.4 4.1 0.4 21.3 37.3 31.7 1.5 0.8 0.5 0.0 0.6 0.0 0.2 3.3 0.0 1.4 0.0 0.0 0.7 5.2 0.0 0.0 3.9 0.0 1.3 0.0 0.0 0.1 4.2 5.1 6.5 2.9 2.7 5.0 3.6 1.5 4.3 4.1 0.0 0.0 20.7 2.1 2.3 5.9 1.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.1 0.3 3.5 0.0 0.0 0.0 58.6 1.8 2.8 0.0 0.8 7.1 4.8 1.7 1.3 7.1 0.7 0.6 6.4 6.8 0.0 0.6 8.5 0.1 0.0 0.4 10.3 1.4 0.0 2.5 0.9 12.6 1.4 48.6 0.0 1.2 1.8 SH2D4A "FLJ20967, PPP1R38, SH2A" ENSG00000104611 "SH2 domain containing 4A" Q9H788 8 19313617-19396218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 1.4;neutrophil: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 1.4;granulocytes: 5.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 50.7;U-2197: 37.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001871, HPA001919" Enhanced Enhanced Cytosol NA NA Cytosol "HPA001871: AB_1079949, HPA001919: AB_1079947" "unprognostic (9.08e-2)" "unprognostic (8.40e-3)" "unprognostic (4.04e-3)" "unprognostic (2.72e-3)" "unprognostic (3.51e-2)" "unprognostic (4.07e-3)" "unprognostic (2.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.67e-1)" "unprognostic (2.70e-2)" "unprognostic (8.84e-3)" "unprognostic (2.81e-1)" "prognostic favorable (6.02e-8)" "unprognostic (1.67e-2)" "unprognostic (2.18e-1)" "unprognostic (3.51e-3)" "unprognostic (4.11e-2)" 4.1 8.5 2.1 6.8 1.8 0.0 3.3 0.7 3.2 7.4 8.9 1.7 15.2 6.3 2.5 3.7 17.5 4.6 12.8 2.9 3.7 1.3 10.0 20.0 8.8 2.2 1.8 2.0 20.5 12.8 6.1 3.6 13.5 2.2 7.6 5.5 5.1 16.3 20.1 2.6 5.9 10.6 6.5 1.4 1.8 15.6 3.2 2.4 0.6 20.7 14.6 9.9 11.9 14.1 0.7 1.4 5.3 0.0 0.4 0.6 0.1 16.5 18.8 0.0 0.0 1.9 2.3 12.9 20.8 10.3 20.3 19.8 15.4 15.1 0.0 5.0 50.7 3.2 8.6 0.7 5.6 21.3 0.0 0.2 0.0 11.8 2.3 11.2 0.4 0.0 2.2 7.0 13.9 2.5 12.3 0.1 0.0 0.0 0.0 3.3 7.4 0.0 0.1 4.5 28.2 7.2 0.0 0.0 5.3 5.5 17.4 1.1 0.0 18.6 20.1 0.0 3.1 3.8 1.4 0.3 6.6 0.0 37.4 6.2 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 1.4 0.7 0.6 0.0 5.3 0.4 0.0 0.1 0.4 0.1 2.1 1.8 0.7 3.2 3.7 1.3 1.8 2.0 2.2 2.4 59.6 26.9 2.0 13.2 1.3 1.6 1.6 30.6 52.2 18.2 43.6 25.5 71.2 36.5 42.0 23.9 4.5 17.7 0.0 58.5 63.3 6.6 11.3 1.1 34.2 28.8 1.6 2.9 3.1 6.9 38.5 5.8 3.2 0.0 1.0 19.3 2.4 70.7 7.0 10.6 6.5 34.6 19.4 2.0 0.1 1.9 2.3 25.6 0.0 21.7 24.5 SH2D5 ENSG00000189410 "SH2 domain containing 5" Q6ZV89 1 20719732-20732837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 19.5;placenta: 14.8;testis: 9.4" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 4.2;Suprabasal keratinocytes: 1.9;Syncytiotrophoblasts: 4.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 25.3;hTERT-HME1: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030182 Approved Cytosol NA NA Cytosol "HPA030182: AB_10670431" "unprognostic (2.32e-1)" "unprognostic (2.80e-2)" "unprognostic (3.85e-2)" "unprognostic (5.37e-3)" "unprognostic (1.20e-4)" "unprognostic (4.41e-2)" "unprognostic (1.80e-6)" "unprognostic (1.11e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-3)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (2.34e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-2)" 0.4 0.9 4.5 1.3 19.5 0.4 0.3 0.5 19.2 0.6 0.5 0.3 0.0 1.2 1.4 0.3 0.5 0.5 0.6 0.3 3.9 4.1 0.4 0.3 0.4 0.3 1.5 7.3 1.7 0.3 0.6 0.1 14.8 2.1 0.5 0.3 0.0 0.4 1.8 0.3 0.6 0.5 1.2 0.3 0.4 0.6 9.4 0.7 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.7 3.9 0.8 0.0 0.0 0.0 0.1 4.6 6.6 4.6 3.1 1.6 1.6 0.0 1.2 1.4 10.0 0.4 3.3 25.3 1.9 0.0 1.7 0.0 0.5 1.2 3.8 0.0 0.0 0.2 5.3 8.6 32.4 1.6 0.1 0.8 0.0 0.0 1.9 0.9 0.5 0.0 1.5 0.5 5.0 0.1 0.1 0.2 4.8 0.6 1.5 0.2 0.3 0.1 1.5 0.7 0.0 0.0 0.0 5.6 9.9 8.3 2.2 0.0 0.0 0.4 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.5 19.5 0.5 12.3 3.9 4.1 1.5 7.3 2.1 0.7 0.0 0.0 0.0 1.0 4.2 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.9 1.9 4.2 0.0 0.0 0.3 SH2D7 LOC646892 ENSG00000183476 "SH2 domain containing 7" A6NKC9 15 78077808-78104909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "testis: 37.1" "Group enriched" "Detected in some" 4 "Early spermatids: 17.9;Late spermatids: 23.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;AN3-CA: 2.8;BEWO: 2.6;HEK 293: 2.0;SCLC-21H: 2.4;SH-SY5Y: 4.4;SuSa: 2.3" "Low region specificity" "Detected in all" "HPA051320, HPA058382, HPA076728" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA051320: AB_2681439, HPA058382: , HPA076728: " "unprognostic (1.22e-2)" "unprognostic (4.31e-2)" "unprognostic (2.24e-1)" "unprognostic (1.24e-2)" "unprognostic (2.53e-1)" "unprognostic (1.42e-1)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-3)" "unprognostic (4.73e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-3)" "unprognostic (5.15e-3)" "unprognostic (1.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 0.1 0.2 0.6 0.5 0.4 0.0 0.1 0.5 0.5 0.1 4.3 0.1 0.1 5.0 0.1 0.1 0.1 0.0 1.0 0.2 0.4 0.4 0.1 0.1 0.6 0.1 0.3 0.1 0.1 0.3 0.0 0.2 0.3 0.1 0.2 0.5 0.2 0.2 0.1 0.1 0.1 4.2 0.1 0.3 0.1 0.3 37.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 2.1 2.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 1.5 0.1 0.0 1.1 1.4 0.0 0.0 0.4 2.4 4.4 0.4 0.6 0.2 2.3 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.5 0.5 0.4 0.4 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 2.5 0.0 0.0 0.0 SH3BGR 21-GARP ENSG00000185437 "SH3 domain binding glutamate rich protein" P55822 21 39445855-39515506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 219.7" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 161.5;Early spermatids: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 15.6;U-87 MG: 48.5" "Group enriched" "Detected in many" 5 "cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7" "Low region specificity" "Detected in all" "CAB003685, HPA030690" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB003685: AB_425682, HPA030690: AB_2673570" "unprognostic (3.41e-2)" "unprognostic (1.26e-1)" "unprognostic (5.84e-3)" "unprognostic (1.68e-3)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (3.89e-2)" "unprognostic (9.78e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-3)" "unprognostic (3.59e-2)" "unprognostic (4.75e-1)" "unprognostic (5.98e-3)" "unprognostic (7.16e-2)" "unprognostic (4.60e-2)" "unprognostic (1.68e-2)" "unprognostic (2.06e-2)" 2.4 5.2 7.2 1.2 7.3 0.9 2.9 1.1 4.3 2.9 6.1 3.0 2.0 1.9 2.1 6.6 5.3 2.1 5.0 30.0 6.6 5.4 3.2 2.8 1.5 0.9 7.5 5.0 1.8 2.8 2.1 4.5 1.1 6.1 5.8 2.0 1.2 3.2 5.2 219.7 0.9 1.4 12.4 7.9 1.2 2.9 3.7 5.9 0.1 3.9 41.5 2.2 7.3 8.6 2.7 11.5 2.6 1.7 2.8 4.0 1.2 1.1 1.3 1.7 2.5 3.8 4.4 0.5 2.0 0.9 0.9 0.7 0.7 2.2 3.4 5.2 5.1 7.0 0.1 0.9 1.5 1.4 2.0 3.5 3.4 0.6 1.4 7.7 1.2 0.7 3.6 6.3 3.2 6.4 3.2 1.0 6.5 2.6 4.4 3.6 4.1 2.2 2.0 1.7 2.9 2.9 3.6 6.5 2.1 4.7 0.8 5.0 2.1 3.0 2.4 3.1 1.6 9.2 0.6 0.8 2.6 0.3 1.5 3.8 15.6 3.3 3.4 48.5 3.0 3.3 2.3 0.7 0.0 1.2 1.7 3.1 2.7 1.1 1.8 1.9 1.4 4.0 3.0 2.6 2.8 1.7 11.5 0.7 1.2 7.2 7.3 1.1 4.3 6.6 5.4 7.5 5.0 6.1 5.9 3.0 3.8 0.9 6.0 2.4 2.1 161.5 5.1 5.3 2.3 5.2 3.9 3.1 39.7 3.5 91.7 1.8 1.3 0.0 19.1 1.3 3.5 3.4 4.6 6.4 2.2 4.8 1.2 1.8 2.1 20.4 2.0 1.3 11.8 1.8 1.9 14.0 5.8 1.9 5.3 11.9 6.1 6.5 27.4 23.3 21.1 1.5 1.6 1.9 3.2 4.8 SH3BP1 ARHGAP43 ENSG00000100092 "SH3 domain binding protein 1" Q9Y3L3 22 37634654-37656119 "Predicted intracellular proteins" Phagocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "T-cells: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 20.3;HMC-1: 20.9;NB-4: 21.2" HPA000757 Supported Approved Cytosol NA NA Cytosol "HPA000757: AB_1079951" "unprognostic (7.81e-3)" "unprognostic (7.91e-3)" "unprognostic (3.42e-1)" "unprognostic (2.62e-2)" "unprognostic (5.38e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.55e-4)" "unprognostic (1.39e-1)" "unprognostic (3.08e-1)" "unprognostic (1.89e-1)" "unprognostic (2.59e-2)" "unprognostic (4.78e-1)" "prognostic unfavorable (3.48e-7)" "prognostic favorable (3.39e-4)" "unprognostic (1.74e-1)" "unprognostic (5.37e-2)" "unprognostic (8.48e-3)" 4.1 3.0 3.2 17.9 4.5 12.8 2.6 5.0 5.7 7.9 12.0 3.6 2.0 20.6 2.6 3.6 25.1 3.2 4.2 2.2 2.9 2.1 2.8 2.2 6.2 11.7 3.1 2.9 4.3 2.2 1.9 1.8 9.1 3.2 5.7 5.0 2.7 7.0 2.6 1.1 16.8 18.2 2.4 4.2 19.9 5.1 3.8 4.1 15.4 2.0 15.2 23.4 9.8 13.5 0.6 2.1 7.3 5.9 1.6 2.8 1.1 10.0 0.5 1.7 1.4 0.4 1.7 14.2 1.6 2.8 2.7 3.0 2.6 1.0 5.7 1.4 1.0 0.9 20.3 0.8 11.0 1.1 17.7 6.6 8.0 0.3 3.6 1.4 11.5 20.9 2.1 2.7 3.4 0.4 2.3 0.4 2.8 2.7 2.1 0.2 5.4 1.4 21.2 3.5 5.9 1.6 7.3 1.5 4.9 0.3 10.7 1.9 4.8 0.5 2.4 8.4 1.8 3.0 10.2 0.5 1.0 5.4 0.3 0.1 15.0 5.3 4.4 1.4 11.9 5.7 3.2 2.7 7.3 2.0 3.2 2.2 0.6 2.2 2.2 1.4 0.3 1.4 2.8 1.8 1.6 5.9 2.1 2.1 1.1 3.2 4.5 5.0 5.7 2.9 2.1 3.1 2.9 3.2 4.1 0.0 11.1 18.4 16.5 16.9 0.2 0.8 5.1 4.0 0.0 0.0 2.0 41.3 0.0 2.3 0.3 1.1 41.3 0.0 4.0 37.2 3.9 5.0 13.9 0.0 43.7 7.9 4.1 4.3 24.1 0.0 4.6 26.8 5.0 26.2 28.9 2.7 2.0 35.1 1.8 0.2 0.4 0.0 1.9 2.8 3.9 13.4 31.4 48.5 20.0 36.7 SH3D19 "DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19" ENSG00000109686 "SH3 domain containing 19" Q5HYK7 4 151102751-151325632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.3" "Lineage enriched" "Detected in single" 10 "dendritic cells: 2.3" "Cell line enhanced" "Detected in many" "ASC diff: 55.5;ASC TERT1: 47.4;HSkMC: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016424, HPA058562" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016424: AB_1856814, HPA058562: AB_2683758" "unprognostic (1.09e-1)" "unprognostic (6.14e-2)" "unprognostic (1.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (5.09e-1)" "unprognostic (7.37e-2)" "unprognostic (1.48e-1)" "unprognostic (6.40e-3)" "unprognostic (1.86e-1)" "prognostic favorable (1.38e-5)" "unprognostic (7.90e-2)" "unprognostic (1.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.64e-2)" 56.0 9.5 6.8 11.2 14.2 0.0 24.2 4.4 9.2 19.2 28.5 20.1 10.7 20.3 22.8 13.9 23.6 17.3 29.6 31.7 7.8 5.1 12.8 23.1 26.1 3.7 13.6 5.5 27.2 7.8 15.4 6.0 16.8 12.7 18.8 23.0 12.4 14.1 19.8 12.8 17.4 35.9 26.6 7.7 3.1 14.6 12.3 15.1 0.3 15.6 12.8 6.7 27.7 23.8 0.0 2.3 0.0 0.0 0.0 0.2 0.0 7.1 5.3 3.4 2.6 55.5 47.4 7.4 8.9 9.5 3.9 4.1 6.8 8.9 0.0 3.6 8.3 6.5 5.3 3.6 10.2 3.9 0.0 2.8 0.0 6.5 7.3 13.4 0.0 0.0 37.6 7.9 5.9 9.2 6.8 23.0 0.0 0.0 0.0 10.4 2.9 0.0 0.1 6.9 11.1 7.7 0.0 0.2 0.1 4.9 5.0 0.2 4.7 6.3 6.5 5.2 7.4 2.1 0.0 16.6 12.5 4.5 5.5 3.5 0.0 0.0 0.0 6.5 0.0 15.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 6.8 14.2 4.4 9.2 7.8 5.1 13.6 5.5 12.7 15.1 20.8 30.4 2.9 11.9 25.3 5.6 85.4 28.1 40.2 40.9 15.7 13.7 21.5 5.0 10.4 3.7 29.2 75.0 0.0 13.3 16.3 37.6 28.4 19.8 40.8 6.5 6.4 17.9 27.6 5.7 4.7 57.5 5.6 25.3 0.0 33.2 19.1 18.2 54.7 45.3 23.1 11.4 12.9 20.6 2.1 6.6 33.6 22.8 5.0 42.0 28.8 SH3GL1 "CNSA1, EEN, MGC111371, SH3D2B, SH3P8" ENSG00000141985 "SH3 domain containing GRB2 like 1, endophilin A2" Q99961 19 4360370-4400547 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Endocytosis "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021485 Approved Enhanced Cytosol NA NA Cytosol "HPA021485: AB_1856816" "unprognostic (1.32e-1)" "prognostic favorable (1.50e-4)" "unprognostic (6.85e-2)" "prognostic favorable (1.86e-4)" "unprognostic (1.84e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.92e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.36e-8)" "unprognostic (5.48e-3)" "unprognostic (2.45e-1)" "unprognostic (1.02e-3)" "unprognostic (4.10e-2)" 20.5 22.4 12.8 17.7 14.5 28.9 17.5 19.1 25.9 21.6 18.7 13.3 11.9 25.4 16.9 12.1 66.0 15.0 16.1 13.2 13.0 8.0 13.8 19.7 14.8 13.0 11.4 13.0 23.5 20.5 5.6 17.3 33.9 9.4 17.1 6.2 14.9 22.1 16.8 8.6 40.4 29.8 18.8 9.0 19.5 16.4 13.7 11.3 10.1 14.2 19.1 33.0 22.2 30.0 6.1 6.5 9.7 5.1 3.8 7.4 3.4 31.7 14.4 15.0 19.8 17.6 27.5 27.7 27.7 24.0 24.8 24.7 22.5 16.8 7.2 11.8 27.5 12.0 26.3 10.6 30.5 6.6 9.5 17.7 8.6 19.9 29.4 25.5 7.7 9.8 23.0 21.3 20.8 12.9 12.3 29.1 7.0 22.3 16.4 19.8 26.6 7.5 8.1 37.6 11.6 16.1 5.9 20.9 12.5 19.5 28.2 14.8 22.8 24.5 24.5 17.4 7.4 16.8 12.3 43.8 23.9 17.4 49.9 28.1 10.5 6.4 7.6 34.3 20.2 32.7 1.0 3.8 4.8 5.0 1.9 4.8 6.1 7.4 6.9 5.0 4.5 4.2 4.5 9.7 3.8 5.1 6.5 6.6 3.4 12.8 14.5 19.1 25.9 13.0 8.0 11.4 13.0 9.4 11.3 8.9 22.1 14.3 32.2 54.0 16.6 3.3 7.6 6.7 9.1 8.7 5.9 32.6 11.6 31.4 5.6 21.5 32.5 23.3 25.4 128.0 43.2 30.1 9.2 18.8 42.1 9.5 9.8 33.7 15.9 4.9 30.2 14.3 21.9 16.2 16.3 12.4 36.0 15.0 22.6 17.9 8.0 12.9 23.1 13.3 12.4 75.0 37.0 13.8 16.4 59.9 SH3GLB1 "Bif-1, CGI-61, KIAA0491, PPP1R70" ENSG00000097033 "SH3 domain containing GRB2 like, endophilin B1" Q9Y371 1 86704570-86748184 "Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 468.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 69.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 69.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004650, HPA015608, HPA019900" Enhanced Supported Cytosol NA NA 18000 Cytosol "CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356" "unprognostic (1.72e-2)" "unprognostic (1.76e-1)" "unprognostic (5.52e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (8.34e-2)" "unprognostic (1.75e-1)" "unprognostic (4.29e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (1.56e-1)" "unprognostic (4.04e-3)" "unprognostic (7.70e-2)" "unprognostic (2.65e-1)" "unprognostic (1.88e-2)" "unprognostic (1.69e-1)" 42.3 19.9 15.0 22.1 18.8 23.7 50.5 13.7 16.9 20.1 24.1 17.8 25.7 20.0 19.9 25.6 42.4 15.2 20.0 48.1 15.4 12.6 22.4 24.0 27.6 40.2 18.2 14.8 18.0 28.5 18.2 18.4 23.7 20.3 19.7 24.8 11.7 30.2 24.5 89.7 19.4 24.4 26.6 24.5 33.6 16.1 45.4 16.2 19.0 20.0 29.7 20.8 28.5 35.6 8.9 10.4 69.7 16.3 13.9 14.5 10.0 19.3 7.1 11.4 10.4 47.9 41.6 18.8 29.3 29.4 27.9 29.6 20.5 16.2 9.9 18.9 36.3 34.8 11.3 10.1 19.1 26.6 21.4 7.2 23.6 10.9 21.7 29.0 12.7 24.1 29.7 22.2 30.7 33.8 30.0 43.9 10.6 8.8 28.0 37.3 5.7 11.4 8.1 11.1 14.2 12.2 13.2 48.0 7.3 24.0 33.4 12.5 9.1 16.5 21.3 34.9 17.8 8.4 13.0 38.4 26.9 16.3 33.5 24.1 14.8 13.6 14.6 13.3 13.1 16.2 29.4 13.7 14.7 10.6 14.5 10.4 8.9 9.9 10.6 10.4 8.1 4.8 8.5 69.7 13.9 16.3 10.2 14.5 10.0 15.0 18.8 13.7 16.9 15.4 12.6 18.2 14.8 20.3 16.2 77.4 64.0 67.1 96.1 79.6 31.2 138.8 43.3 80.3 58.0 52.4 49.1 72.5 72.9 127.2 468.5 101.4 103.4 46.7 149.1 181.7 92.1 83.8 111.9 70.0 131.7 15.9 83.1 143.6 150.6 144.3 65.0 116.4 77.6 140.7 120.2 67.6 162.6 110.1 79.9 93.5 53.0 77.6 110.4 217.9 73.1 103.3 85.2 73.9 68.5 158.5 SH3GLB2 KIAA1848 ENSG00000148341 "SH3 domain containing GRB2 like, endophilin B2" Q9NR46 9 129007036-129028303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cytotrophoblasts: 90.7;Syncytiotrophoblasts: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 63.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021438, HPA024734" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA021438: AB_1856820, HPA024734: AB_1856821" "unprognostic (2.59e-1)" "prognostic favorable (1.56e-6)" "unprognostic (1.88e-1)" "unprognostic (7.51e-2)" "unprognostic (2.94e-1)" "unprognostic (1.09e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (5.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.81e-2)" "unprognostic (6.25e-2)" "prognostic favorable (2.32e-4)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-3)" "prognostic favorable (4.28e-4)" 9.3 18.8 36.9 11.7 27.0 30.4 16.6 31.3 47.2 15.8 16.4 33.0 43.7 25.7 14.4 14.2 29.5 21.0 13.6 14.8 34.2 24.4 15.8 6.6 14.9 13.6 28.8 37.9 20.0 35.9 29.1 26.8 45.2 26.3 21.3 10.1 13.4 30.0 33.8 19.4 46.6 20.4 16.6 30.9 14.9 25.8 7.8 24.1 16.9 16.4 15.0 15.8 27.8 18.1 7.7 7.6 6.6 4.6 5.0 4.9 2.8 13.4 11.4 5.6 7.6 3.4 4.3 16.8 4.7 10.7 9.4 8.6 7.1 23.3 14.2 3.7 8.3 7.2 33.2 1.7 10.2 2.7 9.1 7.7 3.6 18.2 6.2 7.1 3.2 8.7 3.1 11.7 4.8 4.3 10.3 7.8 18.8 4.8 19.0 4.7 33.1 18.2 8.5 5.0 22.8 8.0 37.1 10.6 63.5 10.4 16.3 17.7 14.3 6.8 17.8 7.3 4.9 25.5 4.8 7.1 4.4 7.5 11.1 10.3 18.5 9.0 9.0 10.1 4.0 2.3 4.4 3.3 6.6 4.1 1.6 4.9 7.7 4.7 3.8 2.7 3.8 3.4 3.0 2.7 5.0 4.6 7.6 3.9 2.8 36.9 27.0 31.3 47.2 34.2 24.4 28.8 37.9 26.3 24.1 14.9 30.8 10.4 24.5 18.4 20.3 9.0 12.7 5.3 19.4 45.4 7.9 90.7 13.3 12.2 8.2 11.3 41.2 23.3 22.8 15.3 16.4 24.4 5.8 7.8 17.9 44.5 24.3 11.6 11.6 14.9 17.5 9.8 13.5 4.6 31.4 26.6 19.7 49.9 19.1 6.2 15.6 12.9 16.5 6.1 6.6 46.9 125.1 10.4 29.9 48.9 SH3KBP1 CIN85 ENSG00000147010 "SH3 domain containing kinase binding protein 1" Q96B97 X 19533975-19887601 "Predicted intracellular proteins" "Apoptosis, Endocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 356.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003351, HPA003355, CAB021892" Enhanced Supported Cytosol NA NA Cytosol "CAB021892: , HPA003351: AB_1079956, HPA003355: AB_1079954" "unprognostic (1.17e-2)" "unprognostic (1.33e-1)" "unprognostic (9.48e-2)" "unprognostic (4.65e-3)" "unprognostic (1.62e-1)" "unprognostic (2.88e-2)" "unprognostic (6.47e-2)" "unprognostic (9.91e-2)" "unprognostic (9.75e-2)" "unprognostic (1.76e-3)" "unprognostic (5.96e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (4.00e-1)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (4.92e-2)" 25.0 6.6 17.2 31.0 23.7 32.2 25.3 3.3 18.1 10.6 19.3 23.6 2.6 7.1 6.3 6.6 4.6 6.6 11.3 14.4 17.2 20.1 7.9 8.2 16.6 32.9 30.2 11.4 5.7 3.6 13.1 10.2 17.0 22.6 5.1 19.1 6.8 12.5 4.1 6.1 14.7 12.2 7.9 28.8 22.0 9.6 3.0 27.0 19.5 11.5 5.5 34.9 10.7 17.1 13.6 35.8 51.3 24.5 17.8 51.2 39.4 12.7 13.5 2.1 4.9 10.8 21.0 11.2 11.6 16.9 5.9 9.6 9.1 26.5 23.8 12.2 16.7 17.1 1.4 4.9 4.6 9.6 7.8 3.3 5.1 3.5 7.3 7.1 32.4 41.0 12.3 4.6 12.3 36.5 16.6 8.9 16.9 1.9 28.9 15.0 5.7 19.2 32.9 3.7 15.4 17.9 11.9 20.9 2.2 6.9 2.6 1.5 1.5 10.7 1.4 16.3 14.3 1.3 38.1 28.2 10.4 9.0 13.2 12.7 42.3 28.0 21.2 22.2 26.9 46.1 10.4 24.5 39.6 46.1 18.7 36.0 13.6 45.1 47.7 31.9 12.2 37.6 37.3 51.3 17.8 21.5 35.8 51.2 39.4 17.2 23.7 3.3 18.1 17.2 20.1 30.2 11.4 22.6 27.0 14.9 61.5 58.7 3.2 10.6 5.9 69.4 15.3 21.4 26.1 8.7 15.7 19.0 1.7 7.2 0.4 20.2 105.1 0.0 16.8 31.2 53.0 3.4 90.5 13.9 50.5 7.9 48.8 30.7 83.0 0.9 48.9 91.2 32.1 356.1 29.9 0.0 30.5 103.5 36.0 28.6 2.8 58.2 51.8 3.8 12.1 9.5 18.9 108.8 44.7 7.6 SH3TC1 FLJ20356 ENSG00000125089 "SH3 domain and tetratricopeptide repeats 1" Q8TE82 4 8182072-8241803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 36.2;Kupffer cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 15.3;MOLT-4: 26.5;SK-MEL-30: 15.2;U-2197: 11.5" "Low region specificity" "Detected in many" "HPA038132, HPA056807" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA038132: AB_10673041, HPA056807: AB_2683239" "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "unprognostic (1.61e-3)" "unprognostic (5.46e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.59e-2)" "unprognostic (4.24e-2)" "unprognostic (2.46e-1)" "unprognostic (3.77e-3)" "unprognostic (1.15e-2)" "unprognostic (4.29e-2)" 16.8 4.2 3.7 12.7 7.6 7.5 8.5 0.9 4.0 5.7 3.2 8.6 3.3 1.9 3.2 7.9 9.7 3.9 10.0 4.5 6.6 3.5 19.9 11.2 10.1 14.2 7.4 1.0 2.8 8.6 1.1 3.3 5.8 7.2 5.9 2.4 6.4 5.9 6.0 2.0 3.3 5.6 4.1 9.6 17.0 9.6 1.7 5.8 24.4 5.6 3.8 14.5 9.9 6.3 6.5 14.5 1.0 8.6 0.4 2.0 2.6 2.2 3.5 0.1 0.0 0.0 0.4 2.6 0.2 0.2 0.3 0.5 1.8 1.3 3.1 3.0 0.0 0.5 1.3 0.0 6.6 0.0 8.1 0.1 0.0 2.8 2.9 2.6 0.0 0.4 0.1 8.2 0.1 6.7 0.2 15.3 2.0 0.4 4.3 0.3 2.5 26.5 2.1 0.1 1.3 2.9 1.7 0.9 0.9 0.3 0.4 0.2 1.4 1.0 0.3 15.2 1.0 0.0 0.5 6.2 0.0 1.8 11.5 0.2 0.1 0.6 2.7 0.1 1.2 2.0 0.0 7.5 1.0 0.7 6.9 0.7 4.2 1.5 0.9 6.2 6.5 0.7 0.6 0.2 0.4 8.6 14.5 2.0 2.6 3.7 7.6 0.9 4.0 6.6 3.5 7.4 1.0 7.2 5.8 0.0 8.0 7.4 10.1 0.7 0.8 2.8 7.6 1.4 3.4 24.4 0.0 1.8 6.6 3.2 0.5 6.9 0.2 0.0 4.8 2.7 1.7 4.0 17.3 7.3 19.3 22.3 1.2 36.2 27.9 1.0 0.6 18.1 0.0 5.4 0.9 18.4 7.4 2.9 0.7 12.5 0.6 0.0 2.1 0.0 0.0 0.5 2.5 6.9 1.2 15.7 SH3TC2 "CMT4C, KIAA1985" ENSG00000169247 "SH3 domain and tetratricopeptide repeats 2" Q8TF17 5 148923639-149063163 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.1;placenta: 22.7;testis: 14.4" "Cell type enhanced" "Detected in many" 14 "Rod photoreceptor cells: 24.7;Syncytiotrophoblasts: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 6.2;RT4: 9.9;SK-MEL-30: 8.9;WM-115: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037683, HPA037684" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA037683: AB_2675608, HPA037684: AB_10672603" "unprognostic (6.30e-2)" "unprognostic (4.07e-2)" "unprognostic (4.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.70e-1)" "unprognostic (1.92e-2)" "unprognostic (2.49e-1)" "unprognostic (2.17e-4)" "unprognostic (2.18e-2)" "unprognostic (4.53e-1)" "unprognostic (6.21e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (6.48e-2)" "unprognostic (1.84e-1)" "unprognostic (6.62e-2)" "unprognostic (1.40e-1)" 1.3 0.8 3.3 0.8 15.4 1.2 1.4 0.9 8.6 2.2 1.0 32.1 0.0 0.6 1.0 1.7 2.0 1.3 1.3 3.7 6.0 3.0 0.6 0.7 1.0 0.7 22.7 4.6 0.6 0.5 0.8 0.5 22.7 12.0 0.9 1.8 0.0 1.4 1.4 1.5 1.1 0.7 1.3 12.9 1.0 0.7 14.4 15.6 0.0 0.8 0.0 1.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.7 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.3 0.5 0.2 6.2 5.1 0.0 5.6 0.3 1.7 4.3 0.0 4.1 0.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.4 2.0 1.8 1.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 3.1 5.7 0.0 3.9 0.0 2.1 9.9 0.0 0.0 0.0 0.3 8.9 0.2 0.0 0.0 0.3 0.2 1.1 0.2 3.5 0.0 0.0 0.0 0.2 1.3 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 15.4 0.9 8.6 6.0 3.0 22.7 4.6 12.0 15.6 3.0 5.9 0.0 0.6 0.8 1.1 1.7 2.5 1.4 4.5 0.0 3.9 0.7 0.0 0.7 4.8 1.4 0.0 0.0 0.2 0.2 0.9 1.0 2.3 0.0 0.3 0.0 0.0 1.3 2.4 1.5 0.3 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 24.7 0.0 0.4 1.4 0.8 0.6 10.0 0.0 0.0 2.6 SHARPIN "DKFZP434N1923, SIPL1" ENSG00000179526 "SHANK associated RH domain interactor" Q9H0F6 8 144098633-144108124 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 99.4" "Group enriched" "Detected in many" 5 "Early spermatids: 302.5;Late spermatids: 974.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024825, HPA044453" Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA024825: , HPA044453: AB_10962490" "unprognostic (4.91e-2)" "unprognostic (3.47e-2)" "unprognostic (1.35e-2)" "unprognostic (7.88e-2)" "unprognostic (3.32e-2)" "unprognostic (9.54e-2)" "unprognostic (1.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.13e-3)" "unprognostic (5.44e-2)" "unprognostic (7.91e-2)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.55e-1)" "unprognostic (2.24e-1)" "unprognostic (1.00e-1)" 12.0 14.5 15.8 7.9 11.7 13.2 10.9 9.0 15.3 11.3 12.3 13.7 17.3 11.5 11.4 14.7 11.4 12.9 10.3 14.7 14.0 8.9 14.1 25.7 10.0 9.3 14.6 11.3 11.9 14.0 11.7 10.2 9.6 13.3 12.2 7.2 10.5 16.8 11.8 25.5 13.5 10.7 9.4 9.2 12.5 12.0 99.4 12.3 6.1 10.9 10.8 7.1 10.1 9.5 12.7 22.4 26.1 21.2 17.3 22.1 11.0 8.7 12.8 7.2 5.6 11.7 12.0 8.3 8.1 9.6 10.8 10.8 9.0 14.1 3.8 14.9 9.8 6.3 10.0 3.5 12.2 3.1 11.3 9.6 9.5 14.6 10.7 20.7 3.3 8.8 13.5 20.2 9.1 10.3 13.3 11.5 12.2 6.3 8.9 9.9 14.3 11.2 9.4 2.9 18.4 46.6 7.8 5.4 12.6 11.4 10.0 7.3 11.3 13.9 21.0 13.3 6.1 22.0 12.2 9.7 8.5 13.5 12.1 10.9 11.0 8.3 5.0 12.4 8.1 6.7 12.5 18.1 26.1 16.7 21.2 18.6 12.7 16.6 22.1 16.6 12.3 13.8 15.0 9.3 17.3 18.4 22.4 16.5 11.0 15.8 11.7 9.0 15.3 14.0 8.9 14.6 11.3 13.3 12.3 8.9 17.8 26.6 26.7 21.3 23.2 18.2 17.8 4.0 9.1 33.2 3.9 48.0 101.2 49.2 302.5 33.1 72.2 0.0 43.4 40.8 41.3 29.5 12.7 33.1 51.8 46.1 34.0 30.7 32.4 974.5 45.5 32.9 43.9 73.9 40.9 35.3 67.6 63.1 41.1 69.5 24.9 51.8 34.4 141.6 64.2 28.2 36.0 45.7 50.7 29.1 SHB ENSG00000107338 "SH2 domain containing adaptor protein B" Q15464 9 37919134-38069211 "Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 74.8;Urothelial cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 71 "basophil: 8.1" "Lineage enriched" "Detected in single" 71 "granulocytes: 8.1" "Cell line enhanced" "Detected in many" "OE19: 35.0" "CAB010161, HPA049911, HPA052108" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Nucleoplasm, Cytoplasmic bodies" "CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730" "unprognostic (4.57e-2)" "unprognostic (1.13e-1)" "unprognostic (5.45e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.42e-2)" "unprognostic (2.10e-1)" "unprognostic (3.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (5.96e-3)" "unprognostic (2.48e-2)" "unprognostic (3.31e-3)" "unprognostic (7.68e-3)" "unprognostic (1.01e-1)" "unprognostic (3.29e-1)" "unprognostic (1.10e-1)" 8.6 5.6 7.5 5.3 15.9 7.2 8.0 1.4 12.5 8.2 8.4 16.1 3.2 10.1 6.1 5.6 19.6 5.9 29.4 20.2 8.9 5.0 13.6 34.2 11.6 3.1 17.9 5.3 5.6 17.8 13.7 13.1 7.7 12.6 12.9 7.0 7.6 18.9 11.3 6.4 13.0 9.5 11.9 7.6 6.7 14.1 3.5 16.3 2.7 7.7 10.3 11.1 10.7 11.9 0.0 0.0 8.1 0.0 0.0 0.1 0.0 8.1 12.9 1.4 0.2 1.5 3.6 2.3 9.0 11.0 6.3 4.9 3.0 5.7 0.0 10.9 7.7 14.6 7.8 5.1 13.3 4.4 6.9 10.3 0.0 4.5 9.5 10.0 0.4 0.4 3.2 4.2 9.9 7.6 14.7 6.4 1.3 3.2 2.7 7.3 5.5 1.0 0.4 3.4 35.0 12.3 0.4 3.8 0.4 13.1 2.9 13.9 11.1 1.2 9.8 2.2 11.5 6.2 0.5 7.9 2.9 10.6 1.5 14.3 0.8 0.3 0.1 17.4 0.8 2.8 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 15.9 1.4 12.5 8.9 5.0 17.9 5.3 12.6 16.3 6.0 6.4 0.5 74.8 18.1 0.3 8.1 35.7 2.7 6.8 21.0 7.9 8.6 13.3 14.6 1.8 9.8 10.5 0.0 17.2 1.0 5.7 35.8 0.0 19.8 5.2 0.0 7.5 5.5 1.3 3.4 0.6 2.1 6.8 0.0 10.6 2.0 17.9 8.6 0.4 18.2 1.4 0.0 4.7 0.5 6.8 29.6 3.3 0.0 7.4 45.7 SHC1 "p66, SHC, ShcA" ENSG00000160691 "SHC adaptor protein 1" P29353 1 154962298-154974395 "Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Growth regulation, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001844, CAB005374, CAB016305" Supported Enhanced Cytosol NA NA Cytosol "CAB005374: AB_632395, CAB016305: AB_628249, HPA001844: AB_1856826" "unprognostic (4.12e-2)" "prognostic unfavorable (6.74e-4)" "unprognostic (1.10e-2)" "unprognostic (3.77e-2)" "unprognostic (6.40e-2)" "unprognostic (4.08e-3)" "unprognostic (2.94e-3)" "prognostic unfavorable (1.92e-4)" "unprognostic (9.13e-2)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.22e-16)" "unprognostic (7.19e-2)" "unprognostic (1.40e-1)" "unprognostic (9.21e-2)" "unprognostic (1.31e-1)" 45.1 36.4 14.6 27.8 15.9 20.4 43.6 11.8 12.6 33.9 30.5 11.1 32.9 23.1 34.8 28.1 31.4 32.5 30.5 23.4 11.7 8.5 30.1 54.7 37.5 36.5 13.9 8.7 36.1 21.5 23.0 44.7 47.3 18.9 31.9 23.7 31.5 22.4 24.9 22.1 20.3 39.5 35.4 16.0 38.6 25.8 16.2 11.1 19.9 37.7 21.1 29.8 40.4 31.2 13.9 21.8 31.9 27.0 12.7 23.7 19.8 13.8 28.7 22.1 35.5 24.2 48.6 11.6 50.5 46.0 29.4 22.4 10.2 33.4 7.4 41.4 60.7 8.4 11.9 5.8 50.0 26.5 9.1 3.2 19.1 23.6 18.0 63.4 6.1 21.7 72.2 59.4 36.6 45.6 80.2 64.3 3.2 8.4 60.2 61.4 11.3 7.0 3.7 19.3 11.3 12.2 6.4 7.3 15.4 14.1 10.5 2.8 76.9 30.2 16.9 16.5 40.4 24.7 13.0 76.3 46.4 29.0 9.8 26.4 27.2 17.4 12.6 45.3 8.3 60.0 17.0 20.8 31.9 23.7 27.0 23.5 13.9 19.0 20.9 21.8 13.3 15.6 14.1 17.0 12.7 25.7 10.0 14.1 19.8 14.6 15.9 11.8 12.6 11.7 8.5 13.9 8.7 18.9 11.1 26.8 24.2 12.3 42.7 31.7 4.8 2.0 20.4 6.7 15.9 5.2 5.9 21.8 6.6 27.1 0.6 78.8 30.8 0.0 24.3 49.6 36.6 37.1 17.3 38.1 20.4 23.8 12.1 79.2 21.7 1.5 21.3 17.3 16.9 10.8 23.3 10.0 25.1 25.1 32.5 7.7 6.8 19.4 41.2 2.8 5.0 31.9 50.9 14.1 20.4 37.3 SHC2 "SCK, SHCB, SLI" ENSG00000129946 "SHC adaptor protein 2" P98077 19 416583-460996 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 44.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 51.6;Horizontal cells: 46.1;Ito cells: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.6;HHSteC: 6.5;SCLC-21H: 14.1;SH-SY5Y: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006136 Approved Approved Cytosol NA NA Cytosol "HPA006136: AB_1856827" "unprognostic (2.54e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (4.58e-4)" "unprognostic (6.40e-2)" "unprognostic (1.64e-1)" "unprognostic (1.50e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.36e-1)" "prognostic favorable (8.53e-4)" "unprognostic (4.45e-2)" "unprognostic (5.30e-2)" "unprognostic (1.99e-2)" "unprognostic (3.37e-1)" "unprognostic (8.86e-2)" "unprognostic (4.43e-2)" 9.8 11.3 18.5 2.7 15.1 1.0 6.8 5.0 17.6 7.9 6.3 10.2 3.7 8.9 11.7 5.9 2.6 8.1 14.6 7.9 15.7 15.2 3.8 20.6 6.5 2.8 15.2 11.3 5.1 44.8 7.8 18.6 10.7 15.6 13.7 1.4 9.9 19.5 8.2 3.4 8.5 6.2 4.7 9.6 11.5 10.5 6.0 15.0 0.0 9.7 0.7 1.3 3.8 6.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.7 0.5 2.8 0.3 0.0 0.0 0.5 0.0 5.6 0.0 1.4 0.4 1.3 0.0 0.0 1.2 1.8 0.0 0.0 3.0 6.5 0.0 2.1 0.3 0.0 0.0 0.0 2.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 2.1 0.0 14.1 12.7 0.0 0.0 0.0 2.7 0.3 2.1 0.0 0.6 3.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 18.5 15.1 5.0 17.6 15.7 15.2 15.2 11.3 15.6 15.0 6.0 12.0 0.0 1.8 1.6 4.3 7.7 20.4 0.0 0.0 0.0 2.0 0.1 0.0 20.6 1.9 11.9 0.0 0.0 32.6 0.1 4.3 12.6 0.0 51.6 0.8 46.1 8.1 57.7 6.5 6.0 8.3 0.5 8.5 1.8 3.4 28.9 30.9 0.0 10.6 0.3 2.7 0.0 5.0 15.4 8.2 2.8 0.0 1.7 0.1 3.3 SHC4 "RaLP, SHCD" ENSG00000185634 "SHC adaptor protein 4" Q6S5L8 15 48823735-48963444 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7;testis: 19.5" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 4.0;Ductal cells: 4.1;Melanocytes: 6.8;Spermatocytes: 6.0" "Cancer enhanced" "Detected in some" "melanoma: 9.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "eosinophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.5" "Cell line enhanced" "Detected in some" "AN3-CA: 9.6;SK-MEL-30: 17.9;WM-115: 15.3" "Low region specificity" "Detected in all" HPA074146 Approved Cytosol NA NA Cytosol "HPA074146: AB_2686667" "unprognostic (4.34e-3)" "unprognostic (1.01e-3)" "unprognostic (6.70e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.05e-3)" "unprognostic (1.23e-2)" "unprognostic (3.47e-2)" "unprognostic (2.59e-1)" "unprognostic (2.21e-2)" "unprognostic (3.80e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-5)" "unprognostic (9.84e-3)" "unprognostic (3.26e-2)" "unprognostic (3.49e-2)" "unprognostic (1.36e-2)" 1.5 2.3 9.0 2.3 24.8 0.7 3.7 2.0 15.8 2.5 2.5 18.9 0.3 1.1 1.3 2.5 1.5 1.9 3.2 6.6 11.2 6.2 1.2 0.8 1.2 1.1 25.7 9.4 1.6 0.9 0.7 1.1 1.3 13.2 1.3 1.6 1.7 4.8 3.3 2.0 1.3 1.1 1.9 16.2 0.9 1.0 19.5 23.8 0.0 1.1 0.0 0.8 1.7 0.9 0.0 0.0 2.5 0.0 0.0 0.3 0.0 0.0 0.3 0.9 9.6 0.4 1.3 0.0 1.4 2.7 0.6 1.1 0.0 0.2 0.1 2.4 0.5 0.1 0.0 0.2 0.4 0.8 1.9 0.1 0.6 0.0 0.0 1.0 0.0 0.1 1.8 0.0 1.2 0.1 1.2 0.1 0.9 0.0 0.2 1.3 1.5 0.3 0.2 0.1 0.0 3.5 0.2 2.5 0.3 2.0 0.4 0.5 0.7 0.2 0.1 17.9 0.9 0.0 0.1 0.0 0.8 0.4 0.6 1.0 0.7 0.1 0.0 0.8 0.5 15.3 0.2 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 24.8 2.0 13.4 11.2 6.2 25.7 9.4 13.2 23.8 0.0 0.0 0.0 0.0 0.2 0.5 1.8 0.0 4.0 2.3 0.0 0.0 0.6 0.0 4.1 2.2 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.1 1.6 0.0 1.3 0.0 3.6 1.1 0.0 6.8 0.0 0.0 2.7 0.1 0.0 3.2 0.0 0.7 0.0 0.2 6.0 2.8 0.3 0.7 0.0 0.0 0.0 SHD ENSG00000105251 "Src homology 2 domain containing transforming protein D" Q96IW2 19 4278601-4290724 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 14.8;brain: 23.1;heart muscle: 17.3" "Group enriched" "Detected in some" 5 "Enterocytes: 82.3;Hepatocytes: 45.0;Mucus-secreting cells: 54.3;Paneth cells: 66.4;Undifferentiated cells: 41.3" "Cancer enhanced" "Detected in some" "glioma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 148 "plasmacytoid DC: 14.8" "Lineage enriched" "Detected in single" 148 "dendritic cells: 14.8" "Group enriched" "Detected in some" 46 "RH-30: 19.2;SH-SY5Y: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017955 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA017955: AB_1856828" "unprognostic (2.41e-3)" "unprognostic (7.68e-3)" "unprognostic (4.77e-3)" "unprognostic (3.67e-2)" "unprognostic (3.48e-2)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "unprognostic (1.43e-1)" "unprognostic (5.93e-2)" "unprognostic (3.73e-1)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (3.48e-1)" "unprognostic (1.21e-1)" "unprognostic (5.21e-2)" "unprognostic (9.69e-2)" "unprognostic (8.16e-4)" 0.5 0.7 4.0 1.4 2.5 1.2 0.4 4.1 23.1 0.4 0.9 2.4 0.0 0.7 0.4 0.4 0.4 0.4 0.6 17.3 3.3 4.5 0.4 1.7 0.5 1.2 4.7 2.3 0.4 0.5 0.4 0.2 0.4 6.1 0.5 0.7 0.0 0.5 0.4 0.8 0.4 0.6 0.4 2.5 0.6 0.4 0.5 1.1 0.0 0.4 0.0 0.8 0.5 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.1 62.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 4.0 2.5 4.1 20.4 3.3 4.5 4.7 2.3 6.1 1.1 0.0 0.0 0.0 0.0 0.0 1.3 7.5 0.0 0.0 0.0 0.0 0.0 1.4 1.7 0.0 0.1 0.0 82.3 0.0 0.0 0.4 0.0 0.0 9.2 45.0 0.3 9.5 12.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 54.3 0.4 0.0 66.4 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 3.7 0.0 41.3 0.0 SHISA3 hShisa3 ENSG00000178343 "Shisa family member 3" A0PJX4 4 42397839-42402487 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 30.0" "Group enriched" "Detected in some" 9 "Distal tubular cells: 36.5;Ito cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "memory B-cell: 2.1;naive B-cell: 2.4" "Lineage enriched" "Detected in single" 25 "B-cells: 2.4" "Group enriched" "Detected in some" 7 "AN3-CA: 70.7;PC-3: 41.0" "Region enriched" "Detected in single" 24 "olfactory region: 63.3" "Low region specificity" "Detected in some" HPA054754 Approved "Lipid droplets,Cytosol" NA NA Cytosol "Lipid droplets" "HPA054754: AB_2682593" "unprognostic (9.04e-3)" "unprognostic (3.47e-3)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.26e-1)" "unprognostic (6.78e-3)" "unprognostic (1.26e-2)" "unprognostic (2.86e-1)" "unprognostic (3.04e-1)" "unprognostic (1.37e-3)" "unprognostic (3.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.99e-2)" "unprognostic (5.32e-2)" "unprognostic (3.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.99e-3)" 4.5 2.1 1.0 2.3 3.5 0.1 1.8 0.7 1.3 0.9 5.0 0.1 2.9 2.9 0.3 6.2 8.6 0.4 4.2 12.9 0.9 1.5 30.0 1.0 4.7 15.4 8.3 0.7 1.4 0.3 0.1 0.5 0.2 3.3 2.6 4.1 0.3 1.2 1.5 3.4 0.4 8.4 10.7 1.0 0.6 3.5 2.0 2.2 0.0 4.6 2.6 1.1 6.8 4.7 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 41.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 3.5 0.7 1.3 0.9 1.5 8.3 0.7 3.3 2.2 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 3.5 0.0 0.0 36.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 23.9 0.8 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SHISA7 ENSG00000187902 "Shisa family member 7" A6NL88 19 55428740-55442863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.9" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 1.8;Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 9 "glioma: 2.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 6.7;HMC-1: 7.0;THP-1: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058935 Uncertain Approved Cytosol NA NA Cytosol "HPA058935: AB_2683857" "unprognostic (3.98e-2)" "unprognostic (5.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.28e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.08e-1)" "unprognostic (4.40e-1)" "unprognostic (7.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.22e-2)" "unprognostic (6.87e-7)" "unprognostic (7.53e-3)" "unprognostic (2.82e-1)" "unprognostic (3.29e-4)" "unprognostic (4.04e-1)" 0.7 1.7 11.3 0.7 16.7 2.6 0.7 4.0 24.9 0.7 0.8 7.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 11.2 8.2 0.7 0.7 0.7 0.7 8.3 3.1 0.7 0.8 0.7 2.4 0.7 5.5 0.7 0.8 0.0 0.7 0.7 0.7 0.8 0.8 0.7 4.0 0.7 0.8 2.2 14.6 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 6.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 1.2 0.6 0.0 1.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 16.7 4.0 10.9 11.2 8.2 8.3 3.1 5.5 14.6 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 SHISA9 ENSG00000237515 "Shisa family member 9" B4DS77 16 12901620-13240413 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 15.3;Ciliated cells: 21.4;Club cells: 12.5;granulocytes: 10.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "EFO-21: 29.8;LHCN-M2: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072399 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA072399: AB_2686517" "unprognostic (1.88e-2)" "unprognostic (3.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.69e-5)" "unprognostic (2.23e-2)" "unprognostic (2.03e-2)" "unprognostic (5.90e-5)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.53e-4)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" 1.2 4.8 17.2 1.6 23.5 2.7 1.3 0.9 21.3 0.9 3.4 3.6 0.4 1.6 1.1 2.3 1.2 0.7 0.9 1.3 10.2 6.7 3.4 1.4 0.7 1.0 3.3 12.6 1.1 1.3 0.6 1.9 1.0 10.2 6.9 1.8 0.6 1.7 1.4 4.2 1.9 1.7 1.2 2.1 1.0 1.3 1.6 4.0 0.0 3.5 0.0 0.8 0.8 0.9 2.0 1.2 3.9 0.9 1.2 0.9 0.0 0.6 0.3 0.5 0.5 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.3 0.5 0.5 29.8 0.1 0.6 0.5 0.1 0.1 0.1 0.5 0.2 0.7 0.6 0.3 0.0 0.5 0.8 0.9 0.0 0.1 2.1 0.3 0.1 0.5 0.4 1.2 24.2 3.3 0.4 0.7 6.4 0.5 0.3 0.6 0.4 0.3 6.6 1.1 6.4 0.5 0.3 1.0 0.4 3.1 0.8 0.4 0.4 0.6 3.9 0.6 0.4 1.2 1.2 0.6 0.4 0.2 0.8 3.9 0.9 0.4 0.8 0.5 0.6 1.1 0.7 0.8 0.3 2.0 0.9 0.8 3.2 1.2 0.7 1.2 0.7 0.0 17.2 23.5 0.9 18.8 10.2 6.7 3.3 12.6 10.2 4.0 23.8 15.3 0.0 0.5 0.1 0.6 0.8 0.0 21.4 12.5 1.8 0.0 0.0 1.7 0.7 3.8 0.3 0.0 0.0 0.0 0.0 0.2 1.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.2 0.0 0.0 0.0 0.5 0.1 2.9 0.0 0.9 0.3 0.0 0.0 0.2 0.9 0.1 0.1 0.0 0.3 0.5 SHISAL1 KIAA1644 ENSG00000138944 "Shisa like 1" Q3SXP7 22 44243667-44312851 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9" "Cell type enriched" "Detected in single" 4 "Ciliated cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SiHa: 17.0;U-2197: 38.7;U-87 MG: 22.5;WM-115: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051178 Uncertain Approved Vesicles,Cytosol No No "Vesicles, Cytosol" "HPA051178: AB_2681374" "unprognostic (4.07e-3)" "unprognostic (9.01e-2)" "unprognostic (1.83e-1)" "unprognostic (1.14e-1)" "unprognostic (6.54e-2)" "unprognostic (1.22e-1)" "unprognostic (7.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.10e-3)" "unprognostic (1.93e-3)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (1.51e-7)" "unprognostic (1.48e-2)" "unprognostic (2.41e-1)" "unprognostic (1.99e-4)" "unprognostic (1.10e-4)" 0.7 1.3 13.8 1.3 3.6 0.0 0.5 1.6 13.0 22.5 7.7 0.5 6.9 1.4 34.2 4.5 1.5 1.9 2.3 0.5 5.4 9.1 0.5 0.5 0.6 0.5 3.6 0.5 1.7 0.6 0.1 0.8 5.7 0.5 5.8 1.5 0.5 0.5 8.9 0.5 0.4 0.8 31.9 0.5 0.5 0.5 1.5 0.5 0.5 0.5 0.5 0.5 11.9 3.3 0.0 0.1 0.7 0.0 0.2 0.1 0.0 0.0 0.1 1.7 0.6 0.0 0.0 0.0 0.4 1.1 1.1 0.6 0.0 0.0 0.0 0.0 1.0 7.0 0.0 2.3 0.1 0.1 0.0 1.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.9 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.2 0.0 17.0 0.0 0.1 0.2 0.0 0.1 0.0 6.4 1.0 38.7 0.2 0.0 0.0 0.0 22.5 0.0 12.9 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.0 13.8 3.6 1.6 11.8 5.4 9.1 3.6 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SHMT1 "CSHMT, MGC15229, MGC24556, SHMT" ENSG00000176974 "Serine hydroxymethyltransferase 1" P34896 17 18327860-18363563 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 57.8;liver: 108.3" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 213.8;Proximal tubular cells: 332.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023314, HPA078682" Enhanced Supported Nucleoplasm,Cytosol NA NA 240000 Cytosol Nucleoplasm "HPA023314: AB_1856830, HPA078682: " "unprognostic (4.76e-2)" "unprognostic (1.98e-2)" "unprognostic (5.46e-2)" "unprognostic (3.76e-1)" "unprognostic (2.45e-1)" "unprognostic (8.44e-3)" "prognostic favorable (2.52e-4)" "unprognostic (7.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.42e-1)" "unprognostic (2.14e-1)" "unprognostic (1.70e-1)" "prognostic favorable (8.54e-6)" "unprognostic (1.70e-2)" "unprognostic (2.66e-1)" "unprognostic (2.57e-3)" "unprognostic (4.04e-2)" 10.9 3.2 2.2 4.9 4.1 2.1 10.4 6.5 3.0 4.6 15.2 5.3 7.3 12.3 2.8 7.4 16.3 3.9 4.0 2.0 2.6 1.8 57.8 108.3 4.3 3.8 3.5 1.9 4.1 3.5 30.1 1.6 2.8 3.6 3.4 3.5 7.2 9.8 8.0 5.7 6.2 15.1 2.3 2.9 8.6 3.9 6.3 3.8 11.1 10.9 10.8 8.7 4.3 6.3 8.6 6.7 6.2 10.6 13.0 18.7 7.9 22.6 23.0 7.3 11.4 18.6 11.6 27.0 4.8 5.9 16.1 17.8 22.8 10.1 17.6 14.3 4.1 11.7 22.4 15.2 19.3 9.2 10.5 22.2 7.9 18.0 17.2 4.7 5.2 8.6 9.7 7.6 12.5 5.6 6.5 11.0 22.7 6.6 4.0 5.7 16.7 26.1 7.3 9.1 34.5 7.5 21.4 28.9 14.9 25.6 15.4 10.0 5.3 32.6 6.2 8.2 38.7 25.4 7.5 2.6 3.1 9.3 28.4 15.1 8.2 7.8 7.1 6.1 12.4 7.4 6.0 8.2 6.2 10.1 10.6 17.1 8.6 12.3 12.8 6.7 6.9 12.3 13.0 0.1 13.0 7.5 3.1 18.7 7.9 2.2 4.1 6.5 3.0 2.6 1.8 3.5 1.9 3.6 3.8 11.9 26.5 19.1 16.8 9.2 2.8 2.2 25.5 2.7 9.1 34.9 3.9 17.7 69.6 11.6 4.9 4.3 8.4 0.0 7.0 62.1 4.8 6.6 8.1 213.8 31.1 0.0 1.2 10.4 27.9 4.1 5.5 5.0 11.8 5.4 10.3 31.2 5.1 7.0 2.8 332.8 3.9 19.4 3.8 15.6 21.8 9.3 7.1 10.0 29.5 4.8 SHOC2 "KIAA0862, SOC-2, SOC2, SUR-8, SUR8" ENSG00000108061 "SHOC2, leucine rich repeat scaffold protein" Q9UQ13 10 110919547-111013667 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009164, HPA048134" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA009164: AB_1079960, HPA048134: " "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" "unprognostic (4.23e-3)" "unprognostic (3.27e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (6.09e-2)" "unprognostic (5.56e-2)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (4.33e-2)" "unprognostic (1.01e-1)" "unprognostic (3.70e-3)" "unprognostic (6.97e-3)" "unprognostic (8.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.67e-1)" 22.9 13.2 22.3 17.2 32.4 31.2 18.0 24.9 25.2 19.3 16.7 8.9 12.1 12.5 17.3 17.4 19.1 14.1 15.8 14.6 19.0 24.8 20.9 18.2 16.8 20.9 22.3 20.1 21.9 15.7 26.5 33.4 17.9 17.7 18.1 17.0 9.8 13.9 14.4 21.7 15.8 24.2 25.0 23.3 23.2 13.9 26.7 17.7 29.4 21.5 9.4 23.3 23.7 17.1 16.4 11.3 34.6 13.7 9.8 9.6 11.2 11.4 7.2 9.2 15.4 21.1 21.6 5.9 14.0 20.9 13.1 15.9 6.5 10.3 24.9 7.0 25.0 8.1 9.7 11.1 10.0 19.1 13.5 6.6 11.3 11.2 6.3 15.4 19.2 20.4 23.9 15.9 15.1 28.5 17.9 13.2 8.8 7.0 17.8 18.5 6.1 9.4 15.4 5.7 6.1 7.5 13.6 18.5 7.0 13.7 7.8 4.8 9.6 12.2 6.1 13.6 11.0 31.2 16.4 13.3 10.6 9.4 13.3 9.5 16.5 16.8 39.9 12.6 19.9 7.5 20.9 12.0 16.7 7.0 13.7 8.4 16.4 8.3 8.1 11.3 13.0 8.8 8.5 34.6 9.8 13.5 8.1 9.6 11.2 22.3 32.4 24.9 25.2 19.0 24.8 22.3 20.1 17.7 17.7 50.6 40.8 46.7 30.7 49.6 25.8 74.4 40.8 61.6 47.8 29.6 15.7 18.3 54.7 41.5 33.1 58.5 52.5 46.7 51.5 19.5 32.4 33.4 70.6 59.6 26.2 28.6 25.2 48.5 70.5 69.4 60.7 61.5 47.2 51.3 31.7 24.7 51.5 29.4 76.0 48.4 31.4 71.1 53.3 95.1 56.7 61.1 50.7 52.9 26.9 47.7 SHPRH "bA545I5.2, FLJ90837, KIAA2023" ENSG00000146414 "SNF2 histone linker PHD RING helicase" Q149N8 6 145864245-145964423 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Helicase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 175.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034854, HPA044852" Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Cytosol" "HPA034854: AB_10964488, HPA044852: " "unprognostic (3.10e-2)" "unprognostic (4.46e-2)" "unprognostic (5.61e-3)" "unprognostic (1.53e-2)" "unprognostic (7.40e-3)" "unprognostic (2.20e-2)" "unprognostic (2.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (5.03e-1)" "unprognostic (7.90e-2)" "unprognostic (6.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" "unprognostic (3.01e-1)" 10.9 7.3 8.3 11.0 10.0 5.5 10.4 38.0 11.5 10.6 8.0 4.5 10.8 6.0 14.1 9.2 8.5 9.8 6.7 7.2 7.2 4.2 8.4 6.5 7.1 9.0 7.6 5.9 18.8 8.7 11.4 19.7 6.6 8.5 8.3 7.4 7.3 10.2 13.7 11.4 13.9 8.2 11.0 10.3 8.8 8.5 10.7 8.7 8.4 12.5 7.2 8.0 10.7 11.5 6.7 4.8 4.4 2.4 3.4 4.3 1.2 3.0 2.3 11.7 6.8 5.4 5.8 5.6 3.6 2.9 4.5 5.8 5.3 2.1 10.6 4.5 2.7 3.5 5.2 7.1 5.1 5.9 4.7 8.1 10.7 5.3 4.4 4.0 22.4 6.7 4.0 5.9 4.2 6.2 4.4 4.8 7.6 14.8 6.0 3.8 2.7 14.4 8.3 7.8 5.0 4.1 10.4 18.1 3.6 6.1 3.0 9.6 6.7 6.4 5.9 4.0 8.4 3.1 10.8 5.3 2.9 5.4 5.6 4.2 4.9 7.0 12.7 3.0 9.6 4.4 1.6 2.3 4.4 4.3 2.4 3.7 3.9 3.6 2.9 2.7 6.7 4.1 3.3 0.1 3.4 2.4 4.8 3.3 1.2 8.3 10.0 38.0 11.5 7.2 4.2 7.6 5.9 8.5 8.7 26.8 18.9 20.8 15.3 18.8 113.2 15.9 17.8 12.0 23.9 21.0 198.3 12.7 6.6 15.4 8.3 19.7 10.0 0.0 11.1 5.8 14.4 13.4 12.7 14.8 10.2 89.0 18.5 14.1 21.8 5.1 46.9 15.5 13.5 15.4 14.3 57.4 13.0 10.5 32.2 4.5 175.4 71.1 21.7 76.9 67.5 17.2 5.5 20.3 15.0 9.6 SHROOM2 APXL ENSG00000146950 "Shroom family member 2" Q13796 X 9786456-9949443 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Cone photoreceptor cells: 45.2;Peritubular cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RT4: 12.8;SuSa: 13.4;WM-115: 15.6" "Low region specificity" "Detected in many" HPA051646 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" No No "Plasma membrane, Cell Junctions" Cytosol "HPA051646: AB_2681562" "unprognostic (8.65e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-2)" "unprognostic (4.06e-2)" "unprognostic (6.99e-3)" "unprognostic (8.05e-2)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.51e-1)" "unprognostic (6.54e-2)" "unprognostic (2.82e-2)" "unprognostic (9.73e-2)" "prognostic favorable (1.35e-7)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (1.93e-1)" "unprognostic (7.67e-3)" 1.3 3.6 6.8 1.3 7.7 0.5 2.5 2.8 17.0 4.7 3.2 3.7 4.6 1.8 3.3 5.8 7.2 3.6 6.3 1.5 7.4 5.5 5.3 7.6 8.1 1.0 5.7 9.1 13.8 7.2 5.5 6.1 14.3 5.8 10.6 3.0 3.6 6.0 5.8 0.7 7.9 1.4 2.1 7.9 1.7 2.6 5.8 2.5 1.8 3.1 3.4 3.4 6.4 4.3 0.0 0.9 1.1 0.0 0.0 0.2 0.0 4.0 0.5 7.5 1.0 0.4 1.2 4.2 0.4 1.3 1.6 2.6 4.9 0.0 0.0 1.4 1.0 0.3 3.2 3.8 10.7 1.9 0.0 2.9 0.0 0.0 0.8 2.5 0.0 5.1 0.2 7.5 12.3 0.5 2.7 9.2 0.0 0.0 0.0 2.6 4.3 0.0 0.0 6.6 0.0 0.0 0.0 8.3 0.0 7.0 12.8 1.1 0.6 0.3 0.1 12.0 13.4 4.4 0.2 4.3 12.0 1.5 0.0 0.4 0.0 0.0 0.0 7.9 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 6.8 7.7 2.8 17.0 7.4 5.5 5.7 9.1 5.8 2.5 0.0 1.0 0.0 2.7 1.6 5.1 3.1 5.1 1.4 2.3 3.5 45.2 7.7 3.3 2.7 0.5 5.8 0.3 0.0 0.0 1.0 0.5 5.4 0.0 4.9 0.5 1.6 1.2 11.6 0.6 0.0 3.4 0.0 0.0 0.0 0.5 1.8 1.5 0.0 78.1 0.9 17.7 0.0 0.9 0.0 1.3 1.8 1.7 0.5 0.4 4.8 SHTN1 "KIAA1598, shootin-1, shootin1" ENSG00000187164 "Shootin 1" A0MZ66 10 116881482-117126586 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 43 "dendritic cells: 13.2;monocytes: 14.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037942, HPA037943" Enhanced Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA037942: AB_2675748, HPA037943: AB_10671637" "unprognostic (1.00e-1)" "unprognostic (2.50e-2)" "unprognostic (6.77e-3)" "unprognostic (2.81e-1)" "unprognostic (7.85e-2)" "unprognostic (1.61e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.56e-1)" "unprognostic (1.35e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.08e-6)" 3.5 6.5 51.5 6.8 50.1 1.6 8.7 9.8 34.1 5.5 7.0 42.3 0.3 6.7 4.4 8.4 5.4 5.2 6.5 2.6 58.9 37.0 7.8 12.1 9.8 4.5 67.8 22.7 6.8 10.9 18.6 20.4 5.4 36.3 7.3 8.6 2.0 9.9 3.0 0.9 9.6 7.8 3.8 67.4 7.0 9.0 9.9 54.5 0.4 11.9 1.4 4.1 4.0 2.4 0.0 13.2 0.3 14.0 0.0 0.2 3.5 15.8 8.9 0.9 1.9 0.0 0.0 8.9 1.3 3.5 2.7 5.2 10.0 10.5 0.0 2.7 4.9 8.1 8.2 7.1 6.0 2.8 0.0 7.4 0.0 9.4 6.2 1.2 2.8 2.5 0.4 5.3 2.7 5.2 7.2 6.6 4.3 4.3 0.0 1.9 6.3 0.0 0.1 3.4 3.0 6.0 0.0 12.0 3.5 7.4 2.2 9.9 3.9 10.7 15.6 9.7 10.9 12.5 2.5 11.3 0.9 6.7 0.0 7.8 1.7 0.0 0.0 4.9 0.0 4.9 0.0 14.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.3 0.0 4.0 8.9 0.2 3.5 51.5 50.1 9.8 30.2 58.9 37.0 67.8 22.7 36.3 54.5 71.5 33.1 2.4 13.5 0.0 78.9 3.4 28.1 33.5 43.3 22.7 58.9 35.1 18.3 40.5 5.8 1.3 14.6 0.0 45.7 25.7 3.1 31.7 2.3 42.7 35.4 46.1 16.4 3.1 79.2 9.0 10.3 62.9 0.0 91.0 20.8 13.1 41.7 50.9 4.9 44.5 55.6 12.9 3.5 17.4 41.4 0.0 16.7 0.0 17.7 11.9 SIGIRR "IL-1R8, TIR8" ENSG00000185187 "Single Ig and TIR domain containing" Q6IA17 11 405716-417455 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 67.0" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 346.4;Proximal tubular cells: 462.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023188 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA023188: AB_1856856" "unprognostic (6.21e-3)" "prognostic favorable (7.44e-5)" "unprognostic (7.30e-2)" "prognostic favorable (1.34e-5)" "unprognostic (6.85e-2)" "prognostic favorable (9.08e-4)" "unprognostic (4.03e-1)" "unprognostic (1.39e-2)" "unprognostic (8.44e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-2)" "unprognostic (1.31e-1)" "prognostic favorable (7.61e-6)" "unprognostic (1.00e-3)" "unprognostic (1.76e-1)" "unprognostic (7.63e-2)" "prognostic favorable (1.54e-5)" 11.0 3.2 11.8 19.3 12.3 18.1 17.7 2.4 12.3 10.7 16.9 11.2 16.2 18.6 11.0 14.5 13.7 16.3 12.8 12.9 11.1 10.1 29.4 67.0 14.9 25.6 11.7 8.5 9.6 22.7 10.0 7.3 6.2 15.6 14.2 9.2 15.2 22.1 13.4 6.4 4.5 20.4 11.2 17.7 28.7 17.7 7.4 10.2 12.4 15.4 8.8 18.0 11.3 13.3 11.4 12.9 17.4 16.7 27.8 38.9 22.8 7.9 21.8 1.3 7.6 1.2 6.5 16.0 1.2 1.8 3.7 3.3 10.0 50.0 2.2 5.9 6.9 0.4 11.5 3.5 4.1 0.6 6.8 13.2 4.3 4.3 0.2 4.0 3.6 7.6 3.5 0.8 0.6 0.5 2.1 10.6 8.7 4.4 0.1 1.0 26.7 10.5 12.3 7.9 16.2 11.9 13.6 0.0 7.8 2.6 5.4 13.5 6.6 0.1 7.4 9.5 3.5 9.4 3.0 12.3 1.2 1.5 1.8 0.0 2.7 4.6 5.5 5.0 8.4 4.2 17.4 13.0 11.2 38.9 13.9 30.9 11.4 32.5 33.7 12.9 8.6 29.8 28.9 7.0 27.8 16.7 4.9 29.9 22.8 11.8 12.3 2.4 12.3 11.1 10.1 11.7 8.5 15.6 10.2 26.8 33.8 47.6 28.4 14.4 8.9 15.9 56.0 56.2 20.5 52.4 11.8 14.2 53.0 49.0 1.0 55.6 127.0 0.0 64.0 7.7 36.0 31.6 40.3 346.4 43.4 25.4 75.7 73.6 54.3 2.9 29.1 39.7 81.0 27.1 78.4 65.1 64.4 129.8 28.0 462.2 18.5 25.8 33.1 7.0 66.2 11.2 8.5 121.8 72.6 38.0 SIGLEC10 "MGC126774, PRO940, SIGLEC-10, SLG2" ENSG00000142512 "Sialic acid binding Ig like lectin 10" Q96LC7 19 51410021-51417803 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 99.9;lymphoid tissue: 74.6" "Group enriched" "Detected in some" 5 "B-cells: 17.9;granulocytes: 39.2;Kupffer cells: 67.4;Macrophages: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 99.9;intermediate monocyte: 33.9;non-classical monocyte: 66.7" "Group enriched" "Detected in many" 14 "granulocytes: 99.9;monocytes: 66.7" "Cell line enhanced" "Detected in some" "Daudi: 21.3;HDLM-2: 6.5;HEL: 10.9;HMC-1: 8.7;NB-4: 6.7;U-698: 15.7;U-937: 9.0" "CAB025807, HPA027093" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane, Actin filaments" "CAB025807: , HPA027093: AB_1856858" "unprognostic (7.18e-2)" "unprognostic (3.90e-3)" "unprognostic (1.11e-2)" "unprognostic (3.67e-2)" "unprognostic (3.95e-2)" "unprognostic (9.41e-2)" "unprognostic (8.18e-2)" "unprognostic (2.11e-1)" "unprognostic (3.16e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "unprognostic (3.12e-1)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.73e-1)" "unprognostic (1.69e-2)" "unprognostic (1.39e-1)" "unprognostic (9.05e-2)" 2.6 6.2 4.5 24.6 9.8 9.1 1.4 0.7 4.9 2.7 3.7 5.7 0.0 5.3 1.3 0.7 2.2 2.7 2.7 1.6 3.3 3.0 2.6 7.2 7.7 74.6 6.6 1.8 1.2 2.4 0.2 2.5 1.1 7.7 2.6 3.3 0.7 2.3 0.7 0.6 0.9 9.6 3.2 7.4 37.0 3.1 0.9 4.8 2.0 1.2 0.2 13.2 4.8 1.3 5.8 5.1 99.9 66.7 0.0 0.1 4.4 0.1 0.0 0.4 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.0 21.3 0.6 0.0 0.3 0.4 0.0 0.1 0.0 6.5 1.6 10.9 0.2 0.1 0.0 4.9 8.7 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.5 1.1 0.0 0.4 0.1 6.7 0.6 0.5 0.3 1.4 0.1 0.4 0.0 0.2 0.3 0.3 0.3 0.1 0.2 0.4 0.1 4.0 0.5 0.6 1.0 0.4 0.2 1.0 0.2 15.7 0.4 9.0 0.3 1.5 5.6 99.9 0.1 33.9 0.0 5.8 0.0 0.0 5.1 3.6 0.0 0.0 11.5 0.0 66.7 0.2 0.1 4.4 4.5 9.8 0.7 4.9 3.3 3.0 6.6 1.8 7.7 4.8 3.0 2.2 17.9 0.9 0.1 1.4 0.3 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.1 0.3 1.0 39.2 0.5 7.8 0.0 0.0 0.6 67.4 0.0 0.0 34.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.3 1.1 0.1 2.2 0.0 0.8 SIGLEC6 "CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6" ENSG00000105492 "Sialic acid binding Ig like lectin 6" O43699 19 51519525-51531856 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "placenta: 87.4" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 56.9;granulocytes: 52.1;Syncytiotrophoblasts: 157.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 33 "B-cells: 6.5;dendritic cells: 6.8;granulocytes: 2.3" "Cell line enriched" "Detected in some" 7 "HMC-1: 103.0" "HPA008945, HPA009084, HPA018198" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868" "unprognostic (1.97e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (9.31e-3)" "unprognostic (8.46e-4)" "unprognostic (2.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.64e-1)" "unprognostic (8.96e-2)" "unprognostic (2.03e-1)" "unprognostic (6.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.15e-2)" "unprognostic (4.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.57e-3)" 1.8 0.0 0.0 5.6 0.0 0.1 0.8 0.0 0.1 1.2 1.7 0.0 0.3 0.9 2.0 1.2 1.5 0.5 8.6 0.4 0.0 0.0 0.4 0.1 4.2 1.5 0.0 0.0 0.1 0.3 0.1 0.1 87.4 0.0 3.7 1.5 0.5 1.4 1.0 0.2 1.3 6.0 3.1 0.0 1.3 1.7 1.0 0.0 0.3 0.2 1.0 2.6 2.2 1.9 6.5 6.8 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 103.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 52.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.8 0.0 0.0 0.0 SIGLEC8 "MGC59785, SAF2, SIGLEC-8, SIGLEC8L" ENSG00000105366 "Sialic acid binding Ig like lectin 8" Q9NYZ4 19 51450847-51458456 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 63.0" "Cell type enriched" "Detected in some" 4 "granulocytes: 42.8" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 42 "eosinophil: 63.0" "Lineage enriched" "Detected in single" 623 "granulocytes: 63.0" "Cell line enriched" "Detected in some" 45 "HMC-1: 58.8" HPA012556 Uncertain Uncertain Cytosol NA NA Cytosol "HPA012556: AB_1856869" "unprognostic (1.27e-1)" "unprognostic (1.88e-4)" "unprognostic (1.28e-1)" "unprognostic (6.70e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-2)" "unprognostic (2.51e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-1)" "unprognostic (1.10e-1)" "unprognostic (4.19e-1)" "unprognostic (8.62e-3)" "unprognostic (7.18e-2)" "unprognostic (6.02e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" 0.6 6.7 5.8 2.4 8.4 0.7 2.3 0.7 7.0 1.4 2.9 7.4 0.0 2.9 1.0 1.1 1.1 1.1 2.7 0.3 8.6 4.8 0.4 1.6 4.1 9.6 8.3 3.6 0.3 0.7 0.7 1.2 0.1 7.5 1.0 2.8 0.1 1.1 0.9 0.3 0.8 4.5 1.5 14.8 9.2 2.1 0.5 6.2 0.6 0.7 0.0 4.1 2.0 0.7 0.0 0.0 63.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.5 0.1 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.8 8.4 0.7 5.6 8.6 4.8 8.3 3.6 7.5 6.2 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 42.8 0.0 0.3 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SIK2 "DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2" ENSG00000170145 "Salt inducible kinase 2" Q9H0K1 11 111602391-111730853 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 62.8;Rod photoreceptor cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016026, HPA071049" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Vesicles" "Nuclear speckles, Intermediate filaments, Cytosol" "HPA016026: AB_1857321, HPA071049: " "unprognostic (2.35e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (1.10e-2)" "unprognostic (1.59e-2)" "unprognostic (4.81e-2)" "prognostic favorable (4.93e-4)" "unprognostic (6.41e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.72e-3)" "unprognostic (9.27e-2)" "prognostic favorable (1.17e-9)" "unprognostic (1.23e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-3)" "unprognostic (2.13e-2)" 32.8 10.7 10.1 6.6 17.2 4.0 22.5 10.6 17.3 10.0 9.9 15.1 5.2 7.7 9.5 7.0 7.9 9.7 12.7 14.5 10.5 10.3 14.6 24.4 13.6 5.4 9.7 9.9 16.4 37.8 22.0 28.6 7.5 11.9 8.4 8.3 14.9 15.4 8.6 35.1 8.7 7.7 8.7 9.6 5.8 19.6 4.2 13.0 4.4 11.1 7.9 5.8 8.6 10.0 2.2 2.7 2.8 3.6 2.2 3.5 2.1 5.9 4.0 7.0 7.5 34.8 10.3 4.1 5.2 7.5 4.0 4.6 13.4 6.4 4.7 7.3 6.1 4.7 8.4 5.4 3.9 5.2 3.5 2.3 5.1 3.5 6.6 7.5 4.9 3.3 10.0 5.8 5.8 7.6 8.0 4.7 4.7 4.7 6.9 6.2 2.8 5.1 4.5 2.4 5.0 3.9 6.9 7.4 5.6 8.9 5.4 3.3 7.7 7.7 3.1 3.1 6.6 7.7 4.0 6.5 8.8 5.3 5.6 7.1 2.0 1.5 9.9 2.8 7.0 5.9 1.1 3.3 2.8 3.5 3.6 1.9 2.0 2.5 2.5 2.7 2.2 1.4 2.0 1.4 2.2 2.9 1.5 2.4 2.1 10.1 17.2 10.6 16.4 10.5 10.3 9.7 9.9 11.9 13.0 17.9 32.3 9.1 6.7 13.1 14.4 16.6 22.9 13.4 11.4 15.7 62.8 3.5 5.0 7.1 12.4 18.0 9.5 46.7 6.7 4.1 14.4 5.8 9.2 34.2 4.8 30.2 17.3 9.8 12.4 9.7 10.6 8.6 18.6 2.8 10.2 13.3 9.2 8.6 13.8 20.7 60.3 0.0 13.7 3.2 5.9 10.5 4.3 7.4 9.9 6.5 SINHCAF "C12orf14, FAM60A, TERA" ENSG00000139146 "SIN3-HDAC complex associated factor" Q9NP50 12 31280584-31327058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 108.4;Club cells: 103.5;Extravillous trophoblasts: 98.9;monocytes: 269.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 83.1" "Low region specificity" "Detected in all" "HPA038167, HPA057585" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038167: AB_10675629, HPA057585: AB_2732615" "unprognostic (2.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (2.80e-3)" "unprognostic (1.84e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (1.15e-1)" "prognostic favorable (7.89e-4)" "unprognostic (3.22e-1)" "unprognostic (2.49e-1)" "unprognostic (3.07e-1)" "unprognostic (9.75e-2)" 13.1 6.5 1.6 21.4 5.1 7.9 11.1 4.5 1.9 25.4 15.8 3.4 15.8 6.7 28.3 16.8 19.8 14.6 8.4 5.6 2.9 1.8 16.6 3.3 17.0 22.5 3.4 0.9 18.5 19.6 7.6 19.6 18.9 5.2 18.6 8.3 6.0 16.3 20.1 3.2 12.7 17.0 11.7 3.8 18.5 7.0 13.6 3.7 39.0 14.9 12.3 27.3 19.3 13.6 22.8 28.3 7.9 8.0 19.0 15.1 10.4 3.4 5.1 17.2 3.4 1.0 2.1 31.9 1.8 1.3 3.5 4.7 13.7 9.0 11.9 14.6 0.5 3.8 6.2 14.4 6.9 6.9 12.6 6.4 8.2 3.5 8.5 4.3 13.3 8.0 1.9 10.8 3.0 14.7 6.9 8.1 14.2 11.3 4.6 1.5 2.6 23.8 9.8 83.1 10.7 2.8 20.2 8.2 10.2 7.9 10.3 24.0 16.2 4.2 7.6 9.9 39.4 3.2 7.9 8.9 0.8 5.2 0.4 5.9 5.3 7.6 24.0 2.4 5.1 4.6 7.9 4.8 7.5 8.8 5.8 10.3 22.8 12.3 10.4 10.4 17.9 15.1 11.8 1.5 19.0 8.0 28.3 5.8 10.4 1.6 5.1 4.5 1.9 2.9 1.8 3.4 0.9 5.2 3.7 71.5 30.2 0.0 0.0 0.0 0.0 0.0 0.0 108.4 103.5 43.6 0.0 63.7 69.6 61.6 0.0 0.0 0.0 0.0 37.9 98.9 0.0 0.0 10.5 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 269.7 0.0 0.0 47.6 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 SIRT1 SIR2L1 ENSG00000096717 "Sirtuin 1" Q96EB6 10 67884669-67918390 "Predicted intracellular proteins" "Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 171.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003855, HPA006295, HPA052351" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Mitochondria, Cytosol" "CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796" "unprognostic (1.55e-1)" "unprognostic (2.78e-1)" "unprognostic (9.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-2)" "unprognostic (2.48e-1)" "unprognostic (4.95e-2)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (2.18e-2)" "unprognostic (2.83e-2)" "unprognostic (9.67e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" 17.2 32.3 12.6 21.1 17.8 17.0 18.1 22.6 14.5 24.2 20.5 15.7 14.0 9.2 19.0 12.7 12.7 15.1 15.2 14.7 14.1 10.4 13.9 17.3 12.6 16.1 17.0 10.1 26.6 14.4 16.4 13.3 14.7 12.1 21.7 12.5 12.1 12.3 16.1 19.9 12.9 15.0 21.0 17.7 13.5 13.2 25.4 16.3 28.1 15.2 9.3 14.7 21.6 37.5 4.9 3.9 3.8 3.5 3.6 7.1 1.8 8.3 9.6 15.2 16.9 14.5 11.2 9.5 11.6 12.0 16.0 14.3 10.5 7.2 17.6 6.3 7.7 10.0 6.7 18.8 3.9 17.2 9.4 10.9 9.3 7.2 8.2 13.3 10.0 7.2 10.3 9.4 9.6 16.6 17.2 6.4 10.1 11.8 9.6 11.6 6.7 9.3 13.9 18.8 5.4 15.3 16.9 12.0 6.9 7.5 5.2 9.8 13.5 21.3 14.1 14.7 13.7 10.2 9.3 5.3 12.5 11.6 11.0 11.2 8.1 9.6 34.9 6.4 15.2 5.1 3.8 2.4 3.2 3.4 3.0 4.9 4.9 3.7 4.7 3.9 3.3 7.1 4.2 3.1 3.6 3.5 3.5 2.9 1.8 12.6 17.8 22.6 14.5 14.1 10.4 17.0 10.1 12.1 16.3 17.9 6.1 10.4 16.4 34.8 11.7 27.0 15.3 1.4 9.1 5.2 25.5 5.7 5.0 3.9 171.4 12.8 17.4 23.3 4.7 4.3 17.6 23.9 11.5 14.8 7.8 11.1 41.1 14.1 20.9 29.0 16.4 13.5 15.1 1.8 16.9 7.0 6.4 10.5 18.4 6.3 13.4 0.0 38.2 20.6 15.4 41.5 10.4 13.8 12.4 14.9 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.6;skeletal muscle: 108.7" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 14.1 11.0 30.2 8.1 36.0 10.7 9.1 14.3 38.8 11.0 8.4 78.1 4.0 9.3 9.7 7.8 17.1 12.9 10.7 20.3 36.9 23.5 9.0 12.0 10.8 8.8 52.3 20.5 17.3 9.5 10.1 6.2 7.7 40.8 9.8 7.6 5.8 14.9 11.2 108.7 13.7 9.3 12.8 86.6 9.9 9.0 7.9 46.3 3.2 10.1 23.4 8.9 10.6 7.1 13.2 21.5 28.0 33.0 16.6 23.5 22.1 8.2 5.2 4.4 11.1 25.6 17.6 3.0 6.1 10.9 9.5 12.3 9.3 5.3 2.9 13.3 11.3 7.3 4.5 8.1 13.1 5.8 13.2 8.4 5.6 5.9 5.6 18.1 3.9 12.4 18.4 15.8 7.8 9.4 11.8 16.7 9.4 5.2 22.9 14.5 4.7 7.8 3.0 0.7 14.1 7.3 10.4 12.6 8.0 7.7 7.4 11.3 5.1 7.1 9.5 6.7 3.9 4.3 10.1 15.8 12.9 2.8 19.9 9.0 9.4 4.5 6.6 10.3 9.8 11.9 19.5 27.3 28.0 23.5 33.0 14.6 12.2 11.4 16.1 21.1 13.2 7.5 12.5 20.7 16.6 25.8 21.5 15.5 22.1 30.2 36.0 14.3 38.8 36.9 23.5 52.3 20.5 40.8 46.3 14.9 20.8 11.4 27.5 45.8 26.8 30.8 7.6 29.4 20.5 12.2 33.4 28.9 31.5 27.0 174.5 26.3 34.2 23.3 15.3 12.8 23.1 19.4 25.3 16.2 56.7 28.6 16.8 23.9 33.7 57.6 28.7 34.2 43.9 14.4 20.4 20.6 21.1 18.6 38.5 23.3 27.0 19.4 35.0 12.7 5.9 52.6 35.4 43.6 15.8 22.6 SKA3 "C13orf3, MGC4832, RAMA1" ENSG00000165480 "Spindle and kinetochore associated complex subunit 3" Q8IX90 13 21153595-21176602 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 41.6;testis: 12.6" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 19.6;Spermatocytes: 18.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 2.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039272, HPA039356, HPA061534" Approved Supported "Mitotic spindle,Centrosome,Cytosol" Yes Yes "Mitotic spindle, Centrosome" Cytosol "HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: " "unprognostic (3.46e-2)" "unprognostic (7.21e-2)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (9.73e-6)" "unprognostic (2.03e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.39e-2)" "unprognostic (0.00e+0)" "unprognostic (2.24e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" 0.8 0.6 0.6 6.4 0.6 6.2 0.9 0.4 1.6 0.8 2.8 0.3 0.0 1.1 1.0 0.8 5.1 0.2 0.3 0.4 0.8 0.5 0.8 0.5 1.0 6.1 0.6 0.3 0.5 0.4 0.0 0.6 2.6 0.8 0.4 4.0 0.2 0.9 0.0 0.5 2.4 3.1 1.1 0.5 2.6 1.4 12.6 0.3 41.6 0.3 5.7 6.4 0.5 1.4 0.4 0.2 0.3 0.3 1.9 2.3 0.6 11.3 6.0 10.8 9.1 0.0 2.3 8.5 15.3 6.5 19.4 13.2 9.8 12.2 15.5 4.6 8.4 8.3 10.7 14.4 6.2 21.2 13.3 7.4 20.6 3.9 5.6 0.0 16.0 8.0 0.4 0.4 15.5 5.2 1.8 9.4 13.2 10.7 6.6 12.8 8.8 24.3 14.4 12.5 17.2 11.2 16.0 23.2 7.2 4.3 4.4 13.8 5.1 5.1 8.0 3.2 7.5 7.1 12.3 3.8 7.7 11.1 7.1 18.4 4.0 8.5 15.6 1.9 12.5 22.0 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.8 1.4 0.2 0.0 0.8 0.3 0.0 1.9 0.3 0.0 2.3 0.6 0.6 0.6 0.4 1.6 0.8 0.5 0.6 0.3 0.8 0.3 0.0 0.0 2.2 0.5 1.8 0.0 0.6 0.0 2.7 2.3 0.0 0.0 1.3 0.0 0.9 5.1 0.8 0.2 0.0 1.2 19.6 0.8 0.4 0.0 0.2 4.6 0.0 0.0 2.5 1.9 6.0 1.4 2.2 0.0 1.0 0.3 0.2 0.6 0.9 1.1 0.3 0.0 0.0 0.9 18.7 13.5 2.5 1.8 1.0 2.7 0.1 SKAP1 "SCAP1, SKAP55" ENSG00000141293 "Src kinase associated phosphoprotein 1" Q86WV1 17 48133440-48430275 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.9;lymphoid tissue: 52.1" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 48.5;granulocytes: 113.6;Late spermatids: 118.7;T-cells: 123.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.3;HDLM-2: 9.9;HMC-1: 8.5;JURKAT: 14.5;Karpas-707: 10.5;RPMI-8226: 12.4;RPTEC TERT1: 15.4;U-266/70: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002969, CAB025882, CAB055513" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB025882: , CAB055513: , HPA002969: AB_1079870" "prognostic favorable (5.07e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" "unprognostic (1.80e-2)" "unprognostic (2.28e-2)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.57e-2)" "unprognostic (8.39e-2)" "unprognostic (1.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (5.71e-2)" "unprognostic (6.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.94e-1)" "prognostic favorable (3.14e-4)" 1.9 9.4 0.5 28.0 0.6 2.9 4.5 0.4 0.6 5.9 3.8 0.6 10.9 1.1 2.2 10.6 2.1 8.0 6.2 2.1 1.3 1.1 12.9 2.0 5.2 20.0 0.7 0.4 2.4 2.8 11.6 17.5 0.7 1.2 3.0 2.4 1.6 10.2 7.4 0.5 1.2 6.1 1.2 1.9 11.7 2.2 7.8 0.6 52.1 1.8 1.3 27.7 5.1 4.3 11.9 0.1 2.1 0.2 22.3 50.9 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 19.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.2 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 10.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 15.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 9.6 6.8 0.0 0.0 0.0 0.0 2.1 0.1 0.3 35.9 0.0 30.1 2.8 29.6 32.2 0.1 11.9 26.1 28.9 0.7 22.3 0.2 0.1 50.9 22.3 0.5 0.6 0.4 0.6 1.3 1.1 0.7 0.4 1.2 0.6 3.0 14.6 10.4 0.1 1.8 0.0 0.6 0.0 2.7 5.7 8.7 0.0 0.1 39.7 0.2 48.5 1.6 0.3 0.0 1.6 0.1 1.3 0.3 113.6 25.1 0.2 0.0 1.2 6.2 3.7 118.7 1.4 1.7 1.7 0.0 0.6 2.0 1.5 0.0 0.7 1.1 0.3 6.5 0.3 34.8 4.1 1.1 0.2 123.7 0.1 0.4 SKAP2 "RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R" ENSG00000005020 "Src kinase associated phosphoprotein 2" O75563 7 26667062-26995239 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 255.1;Kupffer cells: 178.5;Late spermatids: 271.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005560, HPA024045" Enhanced Supported Nucleoplasm,Cytosol NA NA 3200000 Nucleoplasm Cytosol "HPA005560: AB_2667360, HPA024045: AB_2671416" "unprognostic (8.52e-2)" "unprognostic (5.57e-2)" "unprognostic (3.76e-1)" "unprognostic (5.62e-2)" "unprognostic (7.91e-3)" "unprognostic (1.30e-1)" "unprognostic (1.07e-3)" "unprognostic (4.15e-3)" "unprognostic (1.82e-1)" "unprognostic (1.41e-2)" "unprognostic (1.26e-2)" "unprognostic (3.80e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.12e-1)" "unprognostic (3.51e-2)" 20.8 22.5 11.5 29.4 12.9 12.8 28.5 6.0 12.8 7.7 15.3 7.6 11.0 10.5 5.2 15.4 14.0 9.4 9.6 12.6 9.5 12.1 20.4 7.8 31.6 36.4 12.0 8.9 13.3 6.1 25.1 10.9 5.3 15.5 10.2 15.0 2.5 5.8 9.8 8.3 8.6 16.5 21.1 42.6 31.8 11.7 10.1 11.5 6.4 6.1 1.9 19.3 19.3 28.1 9.9 12.3 37.3 18.0 8.3 5.1 6.7 11.7 6.2 0.6 15.5 2.9 2.4 3.8 4.8 7.2 2.4 6.0 4.9 47.4 9.1 21.1 9.0 17.5 6.3 8.5 4.9 5.0 5.1 13.7 10.0 1.8 6.5 3.9 18.4 35.4 10.6 4.6 6.9 9.5 0.4 14.4 0.0 5.3 4.7 9.4 2.2 0.0 9.3 0.5 10.5 6.1 11.9 1.5 0.7 29.3 9.2 7.7 0.2 8.7 4.7 6.3 3.7 6.5 9.7 21.0 4.0 0.1 13.3 4.9 7.5 9.5 15.9 9.5 23.9 15.2 8.2 12.6 19.4 3.7 15.0 5.1 9.9 2.1 3.0 9.6 8.0 0.5 2.9 37.3 8.3 18.0 12.3 3.5 6.7 11.5 12.9 6.0 12.8 9.5 12.1 12.0 8.9 15.5 11.5 17.9 29.9 77.3 32.3 23.6 12.3 4.7 5.1 14.7 9.1 22.7 11.8 11.1 54.7 7.9 255.1 35.8 46.2 23.3 20.3 18.4 9.5 16.9 50.9 8.3 82.6 4.8 41.3 90.9 178.5 271.4 8.3 120.8 18.6 28.9 64.6 13.0 15.8 31.6 10.3 65.3 12.7 0.0 12.0 19.9 34.3 37.9 15.6 34.8 45.4 27.2 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" 10 21513478-21526368 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 9.6" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 13.7;Early spermatids: 13.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 23.1;AN3-CA: 5.9;BEWO: 10.7;SH-SY5Y: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.9 1.9 1.9 0.4 3.3 1.7 2.2 3.1 5.9 1.3 1.7 0.0 0.0 0.3 1.0 1.0 0.9 1.7 0.6 5.5 2.5 1.8 4.1 4.3 1.0 0.3 1.4 3.4 4.2 1.5 7.3 1.8 2.5 3.0 1.1 0.6 4.1 2.6 2.0 0.5 2.9 0.5 1.0 1.2 0.4 0.6 4.6 0.3 0.9 9.6 0.7 0.3 1.1 1.1 0.6 0.5 1.5 0.6 0.5 0.3 0.1 0.4 1.0 23.1 5.9 0.5 0.2 10.7 0.5 0.3 0.0 0.0 2.1 0.1 0.2 0.9 0.3 0.1 1.4 2.1 0.4 0.0 0.0 2.6 0.1 1.0 0.2 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.2 0.1 0.9 0.7 0.1 1.4 0.0 0.0 0.3 0.7 0.0 0.4 0.6 2.5 5.3 0.8 4.0 0.1 2.0 0.4 4.6 0.3 0.2 0.7 0.2 0.5 0.1 0.0 0.3 1.4 0.0 0.2 1.5 0.3 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.3 0.6 0.3 0.3 1.3 0.5 0.6 0.5 0.2 0.1 1.9 3.3 3.1 5.9 2.5 1.8 1.4 3.4 3.0 0.3 0.0 1.0 0.0 0.8 1.3 13.7 5.2 5.1 0.0 2.3 1.8 0.0 4.6 6.6 0.1 13.5 3.5 0.0 0.0 0.6 3.1 1.7 0.6 1.1 8.9 2.4 1.6 0.0 3.1 1.5 6.6 1.4 0.0 0.0 0.0 0.0 6.8 0.5 0.0 2.1 5.1 4.0 6.5 0.6 4.8 3.2 1.6 2.9 0.0 0.0 0.2 SKIL "SNO, SnoA, SnoN" ENSG00000136603 "SKI like proto-oncogene" P12757 3 170357678-170396835 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "granulocytes: 200.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008472, HPA014233" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008472: AB_1856933, HPA014233: " "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (3.95e-2)" "unprognostic (3.51e-3)" "unprognostic (7.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.21e-2)" "unprognostic (1.68e-2)" "unprognostic (2.52e-2)" "unprognostic (7.79e-2)" "unprognostic (2.26e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.19e-7)" "unprognostic (2.94e-2)" "unprognostic (7.34e-2)" "unprognostic (8.73e-2)" "unprognostic (3.34e-1)" 16.2 15.0 10.5 21.1 14.7 22.8 12.4 5.0 18.2 14.0 11.8 12.2 13.4 15.9 17.1 12.7 14.4 12.0 26.8 21.7 11.2 11.4 15.0 18.0 23.8 15.2 11.6 10.6 17.8 11.4 9.6 21.1 26.6 16.0 15.8 11.7 14.8 14.2 17.0 19.5 10.3 28.0 13.5 17.3 12.6 17.9 14.4 8.3 14.0 18.9 13.5 21.1 15.3 16.3 5.7 2.9 5.4 11.3 3.2 2.6 2.3 8.3 10.3 6.9 4.4 8.9 3.9 12.7 8.4 5.8 5.8 4.6 2.1 18.1 10.4 27.0 7.6 9.9 19.2 4.2 3.9 9.3 17.9 4.1 13.8 10.0 4.5 7.7 5.8 7.6 6.7 3.8 8.5 6.6 19.4 14.7 1.0 6.1 11.7 12.2 8.9 2.4 1.8 26.9 9.3 3.6 5.7 23.2 2.1 8.8 13.2 5.1 6.3 20.9 21.3 4.4 14.6 14.2 6.3 28.1 16.9 15.8 14.3 15.6 15.7 7.3 19.9 6.4 3.0 7.8 3.4 4.3 2.0 1.6 9.8 2.3 4.6 1.4 2.1 2.9 5.7 2.5 2.6 5.4 3.2 11.3 2.0 0.5 2.3 10.5 14.7 5.0 18.2 11.2 11.4 11.6 10.6 16.0 8.3 68.5 62.7 31.1 75.8 64.6 24.9 9.5 10.2 92.3 77.3 33.2 51.1 7.8 13.3 46.2 69.5 57.1 35.2 0.0 98.8 47.2 82.2 47.0 200.8 27.0 26.1 50.9 22.8 70.6 59.0 24.0 35.1 68.2 33.7 39.7 42.7 11.8 128.3 18.2 64.0 35.6 30.1 25.8 66.2 51.9 26.9 83.9 34.4 25.5 13.8 127.8 SKIV2L "170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1" ENSG00000204351 "Ski2 like RNA helicase" Q15477 6 31959080-31969755 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 19.2" "Low region specificity" "Detected in all" "HPA047122, HPA051959, HPA054419" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Mitotic spindle, Cytosol" "HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482" "unprognostic (1.43e-1)" "unprognostic (5.75e-2)" "unprognostic (3.41e-2)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.36e-2)" "unprognostic (2.14e-2)" "unprognostic (7.75e-2)" "unprognostic (7.99e-3)" "unprognostic (1.53e-3)" "prognostic unfavorable (3.02e-7)" "unprognostic (6.77e-2)" "unprognostic (2.23e-1)" "unprognostic (1.20e-1)" "unprognostic (9.06e-2)" 14.5 32.8 12.4 19.4 15.2 19.0 11.3 15.4 20.2 11.6 12.6 16.0 10.6 36.7 12.5 37.4 14.8 11.7 10.3 12.3 10.7 8.2 12.6 27.8 17.9 13.9 12.3 10.1 13.6 13.1 3.8 21.6 11.3 12.7 17.2 11.1 14.6 11.5 14.3 17.1 14.3 15.7 17.8 10.6 21.7 22.7 10.7 13.7 17.4 14.9 7.5 15.0 13.6 10.7 2.2 2.3 1.1 4.3 0.4 3.2 1.2 0.3 8.1 7.2 0.7 2.1 4.1 8.3 5.8 3.4 4.4 7.6 0.4 0.1 0.3 12.6 8.6 6.9 5.8 0.0 10.0 3.5 8.3 15.9 0.0 0.5 0.7 0.0 0.3 0.4 10.3 8.8 0.1 0.1 6.0 0.0 9.7 0.1 7.2 0.0 0.5 0.5 0.7 10.2 0.0 0.1 1.1 0.1 0.5 2.3 0.1 0.3 0.4 9.3 0.1 5.0 6.3 0.4 7.8 6.6 8.6 2.9 10.3 0.2 16.0 19.2 3.4 12.3 0.4 0.3 1.0 1.3 0.3 2.4 4.3 1.6 1.5 2.2 1.6 2.3 2.2 3.2 2.6 1.1 0.4 2.9 0.6 0.2 1.2 12.4 15.2 15.4 20.2 10.7 8.2 12.3 10.1 12.7 13.7 14.9 9.9 13.0 4.1 2.5 5.7 6.7 2.5 10.7 4.5 7.0 7.9 10.4 1.7 8.8 2.3 5.8 20.0 0.0 7.4 6.8 3.9 7.1 8.1 15.3 8.2 0.0 12.1 9.2 4.7 1.6 8.6 4.6 6.8 8.2 12.1 6.3 7.9 14.0 5.6 5.1 7.8 0.0 5.0 3.9 8.3 3.1 10.4 7.7 9.0 4.2 SKP1 "EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L" ENSG00000113558 "S-phase kinase associated protein 1" P63208 5 134148935-134177038 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB012982, HPA053745, HPA058134" Approved Supported Nucleoplasm,Cytosol No No 600000 Nucleoplasm Cytosol "CAB012982: AB_2533076, HPA053745: AB_2682245, HPA058134: AB_2683617" "prognostic unfavorable (7.53e-4)" "unprognostic (1.97e-1)" "unprognostic (9.81e-3)" "unprognostic (1.07e-1)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (5.72e-4)" "unprognostic (4.47e-2)" "unprognostic (1.33e-1)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (3.07e-1)" "prognostic favorable (5.20e-4)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (8.26e-2)" "unprognostic (2.40e-1)" 63.7 90.2 101.8 35.1 113.6 59.2 110.3 109.3 152.1 94.0 70.5 78.8 55.7 43.6 73.9 99.3 72.9 84.5 64.4 116.0 112.7 100.7 113.8 83.5 52.8 52.3 109.9 121.7 98.4 44.6 116.8 81.4 83.1 114.2 84.8 69.1 68.5 54.7 113.4 141.7 59.9 55.2 82.3 106.3 47.0 58.8 69.3 79.7 57.5 108.0 82.1 60.9 71.8 58.2 113.5 78.4 136.3 90.7 96.4 157.1 209.1 67.3 52.7 78.5 105.5 121.7 99.4 56.0 78.6 100.0 92.4 95.7 80.8 65.8 49.9 118.0 105.9 105.7 37.7 78.4 118.8 107.7 45.6 55.5 39.3 82.7 57.4 57.4 30.2 48.9 85.0 95.8 80.9 64.1 115.4 98.7 64.7 47.4 44.1 138.1 53.3 65.0 32.4 45.5 64.4 56.7 36.0 84.0 61.1 103.1 75.9 64.3 50.4 106.6 27.3 71.7 106.8 79.0 47.3 74.1 59.7 37.1 62.3 79.6 27.5 45.7 74.2 83.1 57.9 64.6 132.3 83.2 136.3 91.3 78.3 102.0 113.5 131.3 111.8 78.4 99.8 157.1 123.5 78.0 96.4 90.7 69.6 130.2 209.1 101.8 113.6 109.3 152.1 112.7 100.7 109.9 121.7 114.2 79.7 265.0 270.4 263.0 830.1 598.8 220.4 653.1 438.2 570.2 337.8 563.5 68.7 766.8 1437.4 561.3 416.1 363.7 459.0 490.6 329.5 626.8 509.6 661.6 327.0 354.9 416.6 211.4 341.7 300.8 284.1 774.4 556.9 378.1 681.6 669.9 301.7 518.2 333.4 550.6 670.0 1023.7 167.2 498.0 623.8 684.9 643.7 564.2 1126.5 371.9 336.9 686.2 SKP2 "FBL1, FBXL1, p45" ENSG00000145604 "S-phase kinase associated protein 2" Q13309 5 36151989-36184319 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.1" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 117.2;Extravillous trophoblasts: 184.7;Syncytiotrophoblasts: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 75.1;RH-30: 94.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013491, CAB013533, HPA051196, HPA054633" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550" "unprognostic (2.32e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" "unprognostic (5.74e-2)" "unprognostic (9.56e-2)" "unprognostic (1.52e-2)" "unprognostic (1.21e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.72e-7)" "prognostic favorable (8.57e-4)" "unprognostic (5.06e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (4.77e-15)" "unprognostic (2.50e-2)" "unprognostic (3.73e-1)" "unprognostic (1.63e-1)" "unprognostic (2.19e-1)" 6.5 6.9 7.8 8.0 7.5 12.9 6.5 11.5 9.0 7.5 7.7 10.3 3.7 10.2 9.9 6.3 13.5 8.1 4.9 4.1 7.3 5.1 4.2 14.0 5.8 9.4 8.8 7.4 7.7 6.1 3.9 12.5 49.1 6.5 7.2 9.5 6.1 6.3 5.4 3.4 7.6 7.7 6.4 7.4 9.4 5.3 3.9 7.4 19.5 5.0 7.5 11.7 7.9 8.4 6.5 16.0 14.7 7.9 7.7 8.5 5.0 7.6 3.8 16.2 18.0 3.9 6.4 75.1 9.9 7.5 25.4 19.2 21.0 6.0 11.0 2.7 8.0 4.6 8.0 18.0 12.5 27.3 4.9 10.4 6.4 14.1 9.9 1.9 14.2 2.9 5.8 3.3 4.6 3.2 2.6 7.0 9.9 11.0 2.5 9.1 3.7 16.5 8.2 14.7 7.5 5.8 16.3 94.3 7.0 1.8 8.0 13.9 16.6 31.0 6.8 4.3 12.4 6.8 8.0 3.2 9.5 11.0 3.5 6.8 3.2 3.0 13.6 4.3 17.5 6.8 10.3 7.9 14.7 5.4 7.2 8.5 5.6 5.7 5.8 16.0 6.5 7.9 6.0 1.5 7.7 4.1 4.3 5.3 5.0 7.8 7.5 11.5 9.0 7.3 5.1 8.8 7.4 6.5 7.4 20.8 9.9 6.7 3.2 3.3 7.4 1.1 2.5 6.7 0.0 1.8 9.8 117.2 1.7 2.4 0.4 3.6 2.3 0.0 2.6 184.7 4.7 0.7 2.3 8.6 29.3 0.0 2.9 1.3 9.2 0.0 3.7 2.6 1.7 7.2 3.6 2.3 2.6 3.5 6.0 1.1 6.8 0.0 2.3 0.7 4.0 3.4 70.1 6.4 7.4 0.9 SLA "hSLAP, SLA1, SLAP, SLAP-1" ENSG00000155926 "Src like adaptor" Q13239 8 133036724-133103054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 61.6;lymphoid tissue: 152.5" "Cell type enhanced" "Detected in many" 14 "Hofbauer cells: 59.4;Kupffer cells: 193.1;Macrophages: 141.0;T-cells: 117.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 14.1;JURKAT: 59.1;Karpas-707: 37.9;U-266/84: 21.3;U-937: 14.9" "Group enriched" "Detected in many" 5 "amygdala: 14.8;basal ganglia: 9.9;cerebellum: 44.5;cerebral cortex: 11.2;hippocampal formation: 11.6" "Low region specificity" "Detected in all" "HPA012296, HPA074192" Enhanced Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA012296: AB_1856946, HPA074192: AB_2686673" "unprognostic (1.19e-2)" "unprognostic (6.29e-3)" "unprognostic (2.73e-3)" "unprognostic (6.07e-3)" "unprognostic (1.66e-2)" "unprognostic (1.10e-2)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (9.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.73e-1)" "unprognostic (2.80e-3)" "unprognostic (2.66e-1)" "unprognostic (3.05e-2)" "unprognostic (8.60e-2)" "unprognostic (1.65e-1)" 6.8 3.6 2.5 21.3 2.7 24.0 2.6 1.6 3.3 2.7 2.2 1.5 1.7 1.6 2.1 1.6 2.4 3.2 5.3 2.6 2.8 1.7 3.2 3.5 11.2 18.2 2.5 2.7 1.7 1.4 0.0 1.4 3.4 2.0 2.1 1.7 1.5 4.0 1.4 1.6 1.3 8.4 2.8 4.1 33.3 2.5 1.6 1.4 152.5 9.2 2.1 18.3 4.3 1.6 11.2 18.4 61.6 31.7 29.2 27.5 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 1.7 14.1 0.2 0.0 0.1 0.0 0.0 0.0 59.1 0.0 37.9 0.0 0.0 10.0 2.4 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 4.6 0.0 0.0 0.1 0.0 0.0 2.0 21.3 0.0 0.2 14.9 0.0 0.1 24.3 45.0 21.2 28.1 26.7 9.5 19.5 21.1 18.4 11.2 18.6 18.9 61.6 29.2 31.7 1.4 27.5 29.6 2.5 2.7 1.6 3.3 2.8 1.7 2.5 2.7 2.0 1.4 8.9 25.0 32.9 0.3 1.9 7.0 2.0 2.5 9.4 19.4 0.0 0.0 0.4 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.7 2.3 0.1 34.8 1.7 59.4 0.0 0.0 11.1 193.1 0.9 0.3 141.0 5.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 6.5 0.9 0.0 0.0 2.4 0.1 117.6 0.0 0.1 SLAIN2 "FLJ21611, KIAA1458" ENSG00000109171 "SLAIN motif family member 2" Q9P270 4 48341322-48426212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 234.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035824, HPA063599" Approved Enhanced Centrosome,Cytosol NA NA 13000 Centrosome Cytosol "HPA035824: AB_10602399, HPA063599: AB_2685056" "unprognostic (6.20e-2)" "unprognostic (1.80e-1)" "prognostic favorable (5.77e-4)" "prognostic favorable (7.98e-4)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "unprognostic (1.33e-3)" "unprognostic (2.58e-1)" "unprognostic (1.59e-1)" "unprognostic (2.23e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.57e-1)" "prognostic favorable (1.50e-4)" "unprognostic (1.75e-1)" "unprognostic (5.72e-2)" "unprognostic (1.85e-1)" "unprognostic (8.00e-2)" 14.8 9.3 6.8 11.7 8.6 7.0 12.6 9.2 10.7 18.4 20.7 6.1 11.7 6.9 18.1 12.2 24.0 14.3 12.3 21.3 7.3 5.6 12.8 16.1 14.0 10.6 7.6 7.2 16.4 10.4 17.2 9.4 29.7 8.0 19.0 13.1 14.1 15.2 17.3 49.2 20.1 15.5 30.6 6.2 11.4 13.2 23.6 5.8 23.8 12.1 22.2 16.9 24.9 23.7 7.7 8.5 10.9 8.6 10.7 13.5 4.2 12.5 4.9 9.0 8.8 13.9 17.2 6.3 19.4 24.8 17.4 18.1 4.9 10.6 7.6 12.0 22.2 31.3 8.3 36.7 18.2 30.7 6.2 3.7 13.3 7.3 5.6 15.0 12.1 13.6 14.6 27.0 20.1 23.5 13.1 10.2 6.8 8.4 8.5 17.4 6.4 13.9 10.0 3.8 9.9 7.1 7.9 17.5 4.8 15.2 13.9 6.0 7.6 7.9 5.9 8.3 8.6 7.4 8.7 12.9 19.1 18.1 12.0 19.7 11.6 12.0 6.5 15.0 13.8 13.7 10.9 8.0 9.6 8.8 5.8 9.9 6.1 11.0 13.5 8.5 7.7 9.1 9.8 7.5 10.7 8.6 2.9 7.1 4.2 6.8 8.6 9.2 10.7 7.3 5.6 7.6 7.2 8.0 5.8 50.6 34.2 23.6 40.6 74.9 14.4 68.6 15.3 75.0 27.3 26.2 13.7 24.2 18.3 26.4 122.5 23.3 27.7 0.0 30.2 23.9 23.6 48.5 21.8 28.9 19.9 33.4 24.2 22.1 17.5 234.7 25.3 24.3 18.6 29.7 30.2 19.7 25.2 28.8 34.6 20.7 38.1 32.3 32.3 69.6 47.8 79.9 63.2 29.8 19.0 50.2 SLAMF6 "CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000" ENSG00000162739 "SLAM family member 6" Q96DU3 1 160485030-160523262 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 51.9" "Cell type enhanced" "Detected in some" 15 "B-cells: 8.3;Early spermatids: 9.3;Late spermatids: 16.5;T-cells: 20.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 33.3;U-698: 49.0" "HPA051363, HPA051903" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051363: AB_2681454, HPA051903: AB_2681658" "prognostic favorable (9.42e-4)" "prognostic favorable (2.78e-4)" "unprognostic (8.65e-2)" "prognostic favorable (9.53e-4)" "unprognostic (5.85e-2)" "prognostic favorable (7.34e-5)" "unprognostic (3.16e-3)" "unprognostic (9.78e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.31e-3)" "unprognostic (2.09e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.33e-2)" "unprognostic (8.21e-3)" 3.9 0.8 0.4 21.0 0.4 1.2 1.0 0.4 0.4 1.1 3.8 0.3 0.4 1.1 1.0 0.6 2.3 1.6 2.8 1.2 0.4 0.4 2.1 1.6 4.7 51.9 0.6 0.4 0.6 0.8 0.0 0.6 1.7 0.7 1.4 1.5 1.5 5.6 1.0 0.5 0.7 11.9 0.4 0.8 29.6 2.3 0.9 0.2 12.9 1.8 0.6 30.4 4.1 1.3 15.2 0.3 8.4 1.0 15.9 28.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 0.0 0.0 8.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.2 49.0 0.0 0.2 0.0 2.5 0.1 8.4 22.9 0.3 15.8 14.7 14.6 28.6 0.1 15.2 8.2 16.4 1.0 15.9 1.0 0.3 16.8 7.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 0.7 0.2 0.0 2.2 8.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.8 0.9 0.0 0.0 3.7 3.8 16.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 20.8 0.0 0.0 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692800-1712555 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 268.0;Spermatogonia: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 19.8 18.1 26.9 30.4 28.0 60.7 27.5 23.8 30.0 19.3 19.3 14.2 20.7 16.3 20.4 21.9 25.0 19.0 15.8 17.9 25.1 26.5 23.7 21.2 18.7 43.9 19.9 24.0 23.1 17.8 13.0 19.5 27.7 16.0 20.0 21.3 17.9 24.7 21.2 15.1 24.7 17.0 20.5 17.1 26.1 18.2 50.6 12.4 52.4 24.9 17.7 42.8 23.7 26.6 24.4 24.1 45.3 29.8 19.8 36.1 30.4 29.4 12.1 17.5 18.4 15.5 17.7 18.2 25.9 22.2 31.5 31.9 25.0 34.4 38.9 15.5 21.4 37.2 18.1 35.1 23.5 37.0 15.9 19.0 48.8 15.1 25.1 19.2 45.1 23.8 12.2 18.9 23.9 15.9 18.3 17.9 26.1 34.9 38.5 38.5 10.6 69.4 41.1 21.8 31.1 21.6 52.3 28.6 24.6 30.3 22.4 19.9 15.3 22.0 14.3 15.3 24.7 23.7 29.8 15.1 26.5 15.2 27.9 40.3 22.4 40.7 93.0 24.8 38.7 26.0 9.3 29.8 21.8 23.6 22.3 21.4 24.4 30.8 33.2 24.1 18.0 26.5 25.1 45.3 19.8 19.8 19.1 36.1 30.4 26.9 28.0 23.8 30.0 25.1 26.5 19.9 24.0 16.0 12.4 14.9 16.8 53.9 86.5 93.4 17.7 7.1 25.5 8.1 7.9 34.9 23.6 121.4 91.2 43.6 64.1 31.8 21.2 23.3 27.3 39.1 59.3 64.3 23.1 26.1 70.1 23.8 34.4 29.4 34.0 32.9 40.9 44.4 62.4 61.3 27.5 27.6 30.6 23.0 41.4 37.4 11.4 12.9 49.1 268.0 323.2 92.5 37.4 59.9 37.5 71.2 SLC12A6 "ACCPN, KCC3" ENSG00000140199 "Solute carrier family 12 member 6" Q9UHW9 15 34229996-34338060 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" Neuropathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 9.4;neutrophil: 18.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 18.5" "Cell line enhanced" "Detected in many" "HaCaT: 27.2" "Low region specificity" "Detected in all" HPA034563 Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA034563: AB_10603887" "unprognostic (3.53e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (3.60e-1)" "unprognostic (3.55e-2)" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.58e-2)" "unprognostic (1.83e-1)" "prognostic favorable (3.33e-6)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (3.87e-2)" "unprognostic (1.41e-1)" 8.7 5.8 7.4 12.4 11.1 27.5 7.0 10.2 14.1 14.7 8.0 12.7 3.6 8.3 6.3 8.7 24.9 4.7 6.3 6.9 6.8 6.9 18.6 4.9 11.5 10.9 9.9 8.4 5.8 5.1 5.4 10.9 5.2 12.5 5.0 7.4 9.7 9.3 4.9 10.5 8.6 10.2 6.0 9.2 11.1 8.0 38.5 10.9 18.2 10.6 8.2 13.6 8.2 21.2 2.0 1.0 18.5 1.4 0.6 2.3 0.7 2.6 3.2 2.0 2.9 6.5 7.6 1.4 4.0 9.3 3.1 4.5 1.8 4.4 1.9 3.7 4.2 2.8 27.2 4.8 3.3 3.7 0.7 3.2 14.6 8.2 4.2 4.0 8.7 16.0 4.4 5.8 9.1 18.4 7.0 9.4 5.2 3.2 4.3 4.2 0.9 0.9 6.9 1.5 2.3 3.5 4.4 3.5 1.8 3.5 6.8 4.4 3.2 4.4 0.1 0.9 4.7 1.9 3.0 5.8 3.6 2.6 12.4 0.9 3.8 4.1 1.2 4.3 6.5 1.5 9.4 1.1 2.3 0.5 1.4 0.3 1.2 0.8 0.7 0.7 2.0 1.3 1.1 18.5 0.6 0.6 1.0 2.3 0.7 7.4 11.1 10.2 14.1 6.8 6.9 9.9 8.4 12.5 10.9 20.8 18.9 18.2 3.9 1.0 12.8 7.4 5.1 5.3 5.7 5.2 80.5 2.5 0.0 4.2 9.2 16.3 10.3 0.0 4.1 1.3 2.0 4.8 4.7 6.7 11.9 7.9 6.4 14.1 38.6 5.3 7.5 14.4 0.0 1.0 7.3 8.0 8.7 12.7 8.1 17.8 54.2 19.4 2.0 38.5 20.4 0.6 0.9 12.8 6.0 20.5 SLC12A7 "DKFZP434F076, KCC4" ENSG00000113504 "Solute carrier family 12 member 7" Q9Y666 5 1050376-1112035 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 265.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 25.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041652 Approved Uncertain Cytosol NA NA Cytosol "HPA041652: AB_10793971" "unprognostic (2.22e-2)" "unprognostic (1.56e-1)" "unprognostic (8.92e-2)" "unprognostic (2.86e-1)" "unprognostic (1.69e-2)" "unprognostic (8.72e-2)" "prognostic unfavorable (2.12e-6)" "unprognostic (1.67e-1)" "unprognostic (1.71e-3)" "unprognostic (4.40e-2)" "unprognostic (4.50e-2)" "unprognostic (3.44e-2)" "unprognostic (1.65e-3)" "unprognostic (1.17e-3)" "unprognostic (1.26e-1)" "unprognostic (3.93e-2)" "prognostic favorable (3.16e-5)" 10.1 6.4 5.7 14.1 7.3 4.3 13.0 2.4 8.3 6.5 11.5 5.6 6.6 28.0 7.2 7.6 4.7 8.9 29.4 27.9 6.1 3.8 20.4 31.3 10.0 10.3 5.8 3.2 8.5 12.4 8.2 11.5 3.8 7.9 10.2 7.0 15.5 10.9 8.7 3.2 7.9 20.3 8.2 4.9 17.9 15.2 14.5 7.4 12.2 13.3 5.5 6.9 7.1 34.5 1.4 4.2 0.5 6.9 2.5 2.7 2.2 2.1 6.0 3.3 10.4 0.5 0.5 5.2 0.1 0.7 0.5 0.0 14.3 3.8 0.0 11.8 0.2 4.1 4.4 2.7 3.6 0.0 13.0 3.6 2.8 7.5 4.9 7.6 0.0 6.3 1.1 0.5 0.0 1.1 0.2 3.3 1.3 4.0 0.1 0.0 6.9 8.4 0.0 7.2 8.4 9.6 25.3 14.4 11.8 4.0 8.7 1.8 2.3 3.2 0.0 3.6 2.1 5.8 1.6 2.8 0.0 3.4 0.0 0.0 0.2 0.0 1.4 0.0 0.4 1.7 0.5 3.4 0.0 2.5 5.4 2.6 1.1 2.4 2.7 4.2 1.4 2.5 2.5 0.0 2.5 6.9 1.8 2.4 2.2 5.7 7.3 2.4 8.3 6.1 3.8 5.8 3.2 7.9 7.4 8.9 17.5 5.4 5.2 6.3 17.7 32.1 40.8 10.7 14.8 27.9 2.0 0.2 1.7 23.0 0.3 14.9 28.8 0.0 15.7 0.3 7.3 14.6 8.1 29.2 15.8 265.4 12.7 9.2 20.4 1.3 3.4 12.2 15.1 1.8 16.5 6.6 28.0 17.5 5.3 26.1 2.9 19.4 7.2 0.7 4.5 5.9 0.2 3.3 14.2 13.2 SLC13A5 "INDY, NACT" ENSG00000141485 "Solute carrier family 13 member 5" Q86YT5 17 6684713-6713567 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 65 "liver: 150.4;salivary gland: 153.9" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 374.3" "Cancer enriched" "Detected in some" 15 "liver cancer: 27.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 61 "Hep G2: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044343 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044343: AB_10961771" "unprognostic (8.46e-3)" "unprognostic (3.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.75e-2)" "unprognostic (7.33e-2)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (8.79e-3)" "unprognostic (1.32e-1)" "unprognostic (3.23e-1)" "unprognostic (1.26e-3)" "unprognostic (1.30e-3)" "unprognostic (3.78e-11)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (2.05e-2)" "unprognostic (2.04e-1)" 0.2 0.8 1.0 0.1 1.9 0.1 0.2 0.6 2.3 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.9 0.1 0.1 0.9 0.7 0.4 150.4 0.1 0.2 0.8 1.2 0.3 0.2 0.1 0.2 0.1 0.6 0.1 0.1 0.0 153.9 0.1 0.1 0.1 0.1 0.1 0.2 0.9 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.9 0.6 2.3 0.9 0.7 0.8 1.2 0.6 0.0 0.0 0.0 7.0 0.6 0.5 0.2 0.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 23.3 0.4 0.1 0.0 0.3 0.0 374.3 0.0 0.0 0.0 15.4 21.0 0.0 0.6 0.3 0.0 0.0 0.0 7.4 9.8 0.0 0.0 0.0 1.4 0.0 0.0 0.9 1.5 0.4 0.1 0.0 0.0 0.2 SLC15A1 "HPECT1, HPEPT1, PEPT1" ENSG00000088386 "Solute carrier family 15 member 1" P46059 13 98683801-98752654 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "intestine: 134.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 30.6;Enterocytes: 51.2;Hepatocytes: 29.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 30.1;SK-BR-3: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002827 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002827: AB_1856974" "unprognostic (8.76e-2)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (6.26e-2)" "unprognostic (7.83e-2)" "unprognostic (5.47e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-1)" "unprognostic (6.79e-2)" "unprognostic (6.88e-4)" "unprognostic (2.11e-2)" "unprognostic (2.84e-1)" "unprognostic (2.64e-1)" "unprognostic (9.01e-2)" "unprognostic (3.87e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.1 51.7 0.2 0.3 42.7 1.9 2.2 0.9 0.1 16.6 0.1 0.1 0.1 6.3 8.2 0.2 0.1 0.1 0.1 0.2 7.1 4.3 0.3 1.0 0.3 0.9 0.5 0.2 0.3 0.3 0.1 9.9 134.9 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.7 0.4 0.5 1.9 1.1 1.1 2.3 0.7 1.2 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.9 30.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 6.8 0.0 0.0 0.0 1.7 1.7 0.6 0.1 0.3 0.0 29.9 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.7 0.9 0.3 0.8 0.8 0.7 0.7 0.2 1.1 0.9 0.8 2.2 1.2 0.4 1.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 3.0 0.0 0.0 0.1 0.1 0.0 0.4 30.6 1.4 2.3 1.8 0.0 0.0 1.7 9.1 0.0 0.0 51.2 0.0 0.7 0.0 0.0 0.8 0.0 29.9 0.1 0.0 3.5 0.6 0.3 0.0 0.0 0.0 1.7 0.0 1.7 0.0 2.9 5.8 0.0 9.8 0.0 0.0 0.2 0.0 0.2 0.6 0.1 0.0 1.7 0.3 SLC16A13 MCT13 ENSG00000174327 "Solute carrier family 16 member 13" Q7RTY0 17 7036075-7040121 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 55.9" "Cell type enhanced" "Detected in some" 7 "Collecting duct cells: 5.2;Hepatocytes: 6.8;T-cells: 4.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 16.9;GAMG: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065245 Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA065245: AB_2685443" "unprognostic (5.61e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (1.78e-1)" "unprognostic (2.22e-3)" "unprognostic (9.53e-2)" "unprognostic (1.62e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.44e-2)" "unprognostic (7.31e-3)" "unprognostic (9.70e-3)" "unprognostic (3.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.14e-1)" 2.5 1.3 1.4 3.5 0.8 0.2 1.6 1.5 1.0 1.8 4.9 0.7 1.2 8.0 1.1 1.4 5.0 1.5 3.2 1.3 1.2 0.7 12.0 55.9 2.9 7.6 0.8 0.5 1.7 2.8 2.7 1.0 3.3 0.7 1.5 1.3 1.8 3.5 1.5 0.5 4.5 10.2 0.7 0.6 4.8 1.6 0.7 0.3 3.6 3.0 2.4 5.8 1.8 2.4 6.8 2.8 2.4 2.2 2.7 3.9 1.3 9.5 16.9 4.0 2.4 2.5 1.4 1.7 1.0 2.5 2.2 5.0 5.4 10.7 6.1 1.6 1.5 20.0 15.0 3.1 5.2 0.9 7.5 2.1 2.5 1.3 13.0 2.8 0.8 5.8 1.6 6.0 3.3 2.7 2.9 8.9 5.5 2.8 1.7 2.3 4.7 3.6 1.5 1.6 4.9 1.3 1.7 1.4 1.0 2.1 2.7 0.1 1.1 3.0 1.7 1.3 6.2 4.6 1.3 3.3 1.4 3.3 2.3 1.4 3.0 6.3 0.3 4.1 2.2 0.6 0.0 2.0 2.2 3.2 1.9 2.3 2.3 2.9 3.9 2.1 6.8 3.1 2.9 2.4 2.7 2.2 2.8 3.0 1.3 1.4 0.8 1.5 1.0 1.2 0.7 0.8 0.5 0.7 0.3 0.0 1.0 2.2 0.7 0.5 0.1 0.3 0.0 1.4 0.0 5.2 0.0 1.6 0.0 0.8 0.0 1.8 1.5 0.0 0.2 0.4 0.4 0.7 3.5 6.8 0.4 3.2 0.0 2.5 0.3 0.0 0.9 1.7 0.0 1.0 0.3 0.9 0.5 0.0 0.0 1.0 0.4 0.0 0.4 0.0 0.0 1.4 2.1 4.3 0.4 0.9 SLC16A4 "MCT4, MCT5" ENSG00000168679 "Solute carrier family 16 member 4" O15374 1 110362848-110391082 "Predicted membrane proteins" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.4;placenta: 76.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 68.0;Proximal tubular cells: 176.8" "Cancer enhanced" "Detected in all" "renal cancer: 35.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.0" "Group enriched" "Detected in many" 4 "B-cells: 5.0;granulocytes: 1.3" "Cell line enhanced" "Detected in many" "BEWO: 11.6;BJ hTERT+: 11.7;CAPAN-2: 17.3;HHSteC: 11.6;hTERT-RPE1: 25.2;SK-MEL-30: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046986, HPA060163" Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" NA NA "Microtubules, Cytosol" "Cytokinetic bridge" "HPA046986: AB_2679892, HPA060163: " "unprognostic (2.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.56e-1)" "unprognostic (2.77e-3)" "unprognostic (1.53e-1)" "unprognostic (2.22e-1)" "unprognostic (2.00e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.70e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (3.68e-2)" "unprognostic (9.16e-2)" "unprognostic (1.71e-2)" "unprognostic (9.46e-2)" 3.8 2.4 1.9 2.1 2.8 0.6 3.4 2.3 1.7 2.7 4.5 2.9 2.7 4.7 2.3 11.9 4.3 2.4 9.6 4.0 2.6 2.1 61.4 7.9 6.1 1.4 2.7 1.4 21.3 0.8 0.5 3.5 76.5 6.9 3.7 0.9 17.3 1.9 3.2 1.1 0.8 14.0 1.8 3.6 2.0 2.5 4.0 1.8 0.0 8.0 1.3 1.3 3.1 3.0 5.0 0.1 1.3 0.6 0.0 0.7 0.3 0.2 5.5 1.2 1.8 4.0 7.8 11.6 3.0 11.7 1.0 2.9 1.7 17.3 0.3 3.3 9.4 0.1 0.3 0.0 1.1 1.1 0.3 1.4 0.3 1.1 1.7 11.6 0.3 0.3 5.7 0.1 1.7 0.1 25.2 2.4 0.4 0.2 0.6 1.9 0.5 0.2 0.3 0.3 0.0 0.2 0.1 0.8 0.1 2.0 0.2 0.7 0.4 0.3 5.6 17.8 5.6 0.3 0.0 0.2 0.7 0.4 0.2 0.8 0.3 0.0 0.9 0.6 0.2 3.2 0.0 0.6 0.3 0.5 0.2 0.2 5.0 0.6 0.1 0.1 1.0 0.6 0.7 1.3 0.0 0.2 0.0 0.2 0.3 1.9 2.8 2.3 1.7 2.6 2.1 2.7 1.4 6.9 1.8 11.9 17.3 3.2 5.2 2.7 11.1 1.1 15.3 0.0 5.7 68.0 5.9 28.5 3.3 2.9 0.4 4.4 1.3 23.3 0.8 29.3 13.9 2.7 4.7 4.5 3.7 3.2 3.4 3.1 1.0 1.1 16.7 0.8 10.1 1.0 0.9 2.3 1.3 0.2 11.0 176.8 17.7 0.0 5.2 3.0 2.0 3.1 29.4 4.6 0.5 5.0 SLC17A5 "AST, ISSD, NSD, SD, SIALIN, SIASD, SLD" ENSG00000119899 "Solute carrier family 17 member 5" Q9NRA2 6 73593379-73654155 "Disease related genes, Predicted membrane proteins" "Amino-acid transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 155.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 41.7;ASC TERT1: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044479 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA044479: " "unprognostic (6.48e-3)" "unprognostic (7.95e-3)" "unprognostic (9.23e-2)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.59e-3)" "unprognostic (4.44e-2)" "unprognostic (4.18e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (8.29e-2)" "unprognostic (4.59e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "prognostic favorable (3.52e-4)" "unprognostic (1.09e-1)" 7.2 5.8 6.4 2.9 6.8 2.9 9.6 6.3 6.8 4.9 7.8 4.7 12.5 6.5 5.1 17.2 5.0 3.4 6.2 6.2 4.5 6.7 24.3 13.2 7.6 4.9 5.0 4.5 3.4 8.7 155.6 9.3 12.6 6.7 6.9 8.6 6.6 15.5 8.6 3.5 4.8 12.9 4.6 5.9 4.3 6.0 4.1 4.7 3.0 30.5 2.6 7.1 5.9 4.3 5.2 9.9 12.4 10.6 12.0 9.4 6.0 2.8 3.8 3.9 6.2 41.7 31.1 5.2 9.3 23.5 2.5 8.9 2.5 6.9 2.6 4.5 13.1 5.9 5.0 5.4 2.3 4.5 1.8 6.3 1.1 2.1 5.9 8.4 2.1 4.4 14.2 3.5 5.7 4.0 10.7 6.4 3.5 2.7 2.9 8.8 1.9 0.8 1.2 2.8 11.9 2.3 1.9 4.8 11.1 6.6 7.9 1.5 2.7 1.9 5.6 5.4 6.0 2.5 13.2 9.3 1.2 1.1 5.0 2.2 8.2 11.4 0.7 4.2 4.6 3.7 12.4 10.6 4.2 8.5 9.7 8.3 5.2 9.4 8.1 9.9 3.7 7.8 8.6 7.4 12.0 6.0 7.4 8.2 6.0 6.4 6.8 6.3 6.8 4.5 6.7 5.0 4.5 6.7 4.7 20.8 20.2 7.8 12.1 8.5 7.8 5.3 15.3 14.7 9.1 48.8 27.5 14.4 3.3 12.2 27.9 15.0 21.9 0.0 11.9 12.0 22.1 30.0 13.9 31.0 53.7 0.0 11.6 25.8 26.5 32.1 6.9 22.4 10.1 7.2 42.3 7.3 16.7 17.5 10.6 30.8 24.7 0.0 8.0 11.1 2.3 9.8 19.1 7.9 15.0 18.6 SLC18B1 "C6orf192, dJ55C23.6" ENSG00000146409 "Solute carrier family 18 member B1" Q6NT16 6 132769370-132798553 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 48.4;Hofbauer cells: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 24.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029747, HPA049659" Approved Supported "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA029747: AB_10600797, HPA049659: AB_2680843" "unprognostic (1.84e-2)" "unprognostic (3.94e-1)" "unprognostic (4.22e-2)" "unprognostic (2.85e-1)" "unprognostic (2.41e-2)" "prognostic favorable (3.55e-4)" "prognostic unfavorable (7.90e-4)" "unprognostic (1.53e-1)" "unprognostic (2.39e-1)" "unprognostic (4.09e-1)" "unprognostic (6.97e-3)" "unprognostic (1.13e-1)" "prognostic favorable (9.24e-4)" "unprognostic (7.20e-3)" "unprognostic (1.08e-1)" "unprognostic (2.08e-2)" "unprognostic (7.88e-2)" 9.3 7.3 26.2 6.0 21.9 4.5 11.0 13.1 20.6 9.4 9.5 18.8 3.1 14.4 7.0 7.8 10.7 10.1 11.5 4.2 21.6 15.8 11.8 6.0 5.7 7.2 19.5 10.8 7.4 7.8 13.0 6.9 15.5 17.0 5.0 11.4 7.4 11.7 4.9 4.8 10.5 10.4 5.8 21.7 7.0 14.9 2.3 16.3 8.3 10.1 5.9 8.6 10.6 5.5 7.5 15.6 0.6 11.3 2.8 9.4 6.5 4.0 3.8 6.5 0.0 0.8 2.4 4.0 1.4 4.5 2.9 9.3 8.4 8.3 0.1 5.8 0.9 5.1 11.3 8.8 9.9 2.3 5.9 16.6 2.1 7.0 10.2 5.0 1.9 0.2 6.5 9.5 4.6 10.0 5.9 9.3 13.2 23.7 1.6 2.4 5.7 6.1 0.2 8.6 9.0 5.4 9.8 7.1 6.6 24.1 7.1 13.1 0.0 7.8 15.5 12.4 3.9 5.3 0.0 4.3 1.3 3.4 1.3 3.8 5.1 0.4 0.2 7.1 0.2 1.0 0.0 11.3 0.5 3.7 2.5 6.7 5.5 5.7 5.2 15.6 7.5 8.2 5.6 0.6 2.8 0.2 12.1 9.4 6.5 26.2 21.9 13.1 20.6 21.6 15.8 19.5 10.8 17.0 16.3 0.0 6.2 5.9 8.2 9.0 4.1 2.6 48.4 12.0 10.3 26.2 2.0 41.0 8.3 26.3 0.1 5.1 3.9 0.0 13.2 16.4 5.1 7.2 0.0 11.9 51.1 0.0 15.6 22.1 19.4 0.0 6.4 7.8 13.5 2.8 11.9 8.5 15.1 3.5 4.2 5.0 3.3 0.0 3.3 0.2 0.4 9.5 23.8 4.9 16.6 11.5 SLC19A2 "THTR1, TRMA" ENSG00000117479 "Solute carrier family 19 member 2" O60779 1 169463909-169486003 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.7" "Cell type enhanced" "Detected in many" 12 "Suprabasal keratinocytes: 44.2;Syncytiotrophoblasts: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006119, HPA016599" Uncertain Approved Cytosol NA NA Cytosol "HPA006119: AB_1079996, HPA016599: AB_1857005" "prognostic favorable (8.41e-4)" "unprognostic (8.82e-2)" "unprognostic (1.90e-1)" "unprognostic (3.29e-3)" "prognostic favorable (2.90e-4)" "unprognostic (4.45e-2)" "unprognostic (9.69e-2)" "unprognostic (1.45e-1)" "unprognostic (2.86e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.70e-5)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (3.60e-2)" "unprognostic (2.14e-2)" 23.1 11.1 1.9 5.3 4.4 4.8 14.2 7.4 6.1 5.9 5.4 2.8 2.7 2.1 5.0 9.0 7.5 10.0 17.5 14.8 2.7 2.1 8.6 23.4 9.2 3.1 2.8 1.7 10.3 14.4 6.8 16.3 22.1 4.7 9.4 2.8 16.4 10.4 4.6 75.7 7.5 6.6 11.3 3.7 1.8 9.4 7.3 1.8 3.6 7.9 21.6 3.9 10.4 9.8 1.4 1.9 3.0 4.6 2.6 3.3 0.7 4.5 3.2 7.3 5.7 22.8 8.4 16.2 3.6 2.7 3.0 4.2 13.1 4.8 4.0 4.2 2.4 5.5 4.9 8.8 5.4 3.3 11.5 8.2 3.8 10.4 11.9 12.4 9.6 3.8 9.9 7.9 4.8 12.3 4.2 4.4 7.1 15.4 2.6 5.0 3.0 4.9 4.3 16.6 8.8 4.9 0.0 15.8 4.6 7.9 9.7 6.4 8.6 5.0 8.7 17.8 8.7 5.5 6.3 3.7 3.6 5.0 4.4 7.1 3.6 3.3 1.3 5.3 3.7 4.7 0.0 1.7 3.0 0.9 0.7 3.3 1.4 1.1 2.1 1.9 1.2 3.1 3.0 1.1 2.6 4.6 0.7 1.0 0.7 1.9 4.4 7.4 6.1 2.7 2.1 2.8 1.7 4.7 1.8 8.9 17.1 0.9 13.6 26.3 4.7 24.0 7.6 13.4 11.4 5.2 2.0 19.6 0.0 7.1 4.4 2.3 6.3 0.0 4.6 3.0 20.6 10.4 10.3 23.1 6.2 6.4 8.6 0.6 3.7 0.4 6.4 5.7 20.3 0.0 4.4 2.6 8.2 5.7 4.6 1.8 4.7 0.0 9.4 3.4 3.4 44.2 130.8 1.5 4.7 21.3 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 134.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 14.3;BEWO: 7.4;CACO-2: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.3 0.4 7.4 0.1 0.2 0.3 0.6 18.7 0.5 0.4 0.2 0.1 4.6 0.5 0.5 0.5 0.8 0.1 1.2 0.1 1.0 0.8 1.7 0.2 0.2 3.3 0.4 0.1 0.9 0.3 0.0 0.3 0.2 0.9 0.0 1.8 0.1 0.7 3.2 0.6 0.3 0.3 0.2 0.2 0.2 0.3 1.1 0.1 0.6 2.1 0.5 2.7 0.3 0.2 0.5 0.5 0.5 4.2 0.4 0.2 0.1 0.7 1.4 0.3 0.5 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 8.9 3.2 0.0 0.4 0.0 2.9 0.3 0.0 0.0 0.0 1.8 0.0 45.5 1.7 1.7 0.3 0.5 6.4 0.0 0.0 7.0 0.9 0.3 0.0 11.4 4.6 0.0 1.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.8 0.6 0.0 0.0 2.2 0.1 0.0 1.0 0.0 0.1 0.0 134.3 0.0 5.6 0.3 SLC22A16 "CT2, FLIPT2, OAT6, OKB1" ENSG00000004809 "Solute carrier family 22 member 16" Q86VW1 6 110424687-110476641 "Predicted membrane proteins" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4" "Group enriched" "Detected in some" 5 "Early spermatids: 28.2;Erythroid cells: 23.3;Late spermatids: 23.1;Spermatocytes: 35.7" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 0.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 9.5" "Group enriched" "Detected in many" 66 "dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5" "Group enriched" "Detected in some" 18 "NB-4: 9.8;REH: 9.0;THP-1: 31.3;U-937: 18.4" "Low region specificity" "Detected in all" HPA036902 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA036902: AB_10672274" "unprognostic (1.01e-1)" "unprognostic (1.88e-2)" "unprognostic (5.11e-3)" "unprognostic (2.19e-3)" "unprognostic (2.70e-4)" "unprognostic (1.45e-1)" "unprognostic (8.15e-2)" "unprognostic (6.93e-2)" "unprognostic (1.48e-2)" "unprognostic (4.98e-2)" "unprognostic (1.02e-3)" "unprognostic (2.49e-1)" "unprognostic (2.61e-6)" "unprognostic (5.78e-4)" "unprognostic (2.72e-2)" "unprognostic (2.74e-2)" "unprognostic (2.65e-2)" 3.5 0.2 0.2 0.4 0.2 16.0 0.2 0.1 0.2 0.1 0.7 0.0 0.0 0.0 4.9 0.8 0.1 0.3 0.7 0.1 0.2 0.1 1.1 0.3 1.6 0.0 0.2 0.0 0.9 0.1 9.6 0.1 0.3 0.2 0.2 0.0 0.0 0.6 0.0 0.2 0.3 0.1 1.6 0.2 0.8 0.2 26.4 0.0 2.2 0.1 0.8 0.1 0.1 0.1 0.0 5.1 5.0 9.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 18.4 0.0 5.0 9.5 1.6 0.0 2.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 23.3 0.0 0.1 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.2 23.1 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 35.7 0.2 0.4 0.0 0.0 0.0 0.0 SLC22A23 "C6orf85, FLJ22174" ENSG00000137266 "Solute carrier family 22 member 23" A1A5C7 6 3268962-3457022 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 73.9;Late spermatids: 171.9;Mucus-secreting cells: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014697 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA014697: AB_1844371" "unprognostic (4.58e-2)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "prognostic favorable (6.57e-4)" "unprognostic (5.16e-3)" "unprognostic (3.25e-3)" "unprognostic (1.40e-1)" "unprognostic (4.53e-3)" "unprognostic (9.74e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.39e-4)" "unprognostic (8.91e-2)" "unprognostic (4.30e-1)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" 7.4 2.2 9.0 4.6 16.2 8.1 9.3 8.4 14.8 5.6 17.4 30.8 3.4 19.6 3.6 11.8 16.8 11.3 7.5 2.2 11.0 8.1 6.9 12.6 8.0 3.9 28.6 8.7 3.0 14.9 14.8 6.5 8.3 17.8 14.2 14.4 5.7 10.0 2.8 5.9 14.9 20.3 3.0 17.5 4.6 26.0 7.2 21.0 5.2 4.1 9.8 9.9 3.8 9.9 0.1 0.7 0.8 0.3 0.3 1.4 1.9 2.4 5.6 12.5 13.9 4.4 5.0 16.0 0.4 0.1 0.7 0.3 12.5 0.4 0.6 1.4 2.7 11.1 3.6 2.5 6.6 0.2 2.0 7.7 5.8 2.1 11.0 0.6 0.3 0.4 1.2 13.0 12.1 0.6 2.6 0.4 3.2 5.2 3.3 0.4 2.9 0.5 1.4 4.3 13.7 2.3 1.3 0.8 9.9 0.0 15.3 1.4 0.2 3.3 4.8 4.1 13.3 18.5 0.1 3.1 7.3 2.3 9.4 1.5 7.5 0.1 0.2 12.8 0.4 4.4 0.0 0.3 0.0 0.4 0.0 0.2 0.0 1.0 0.4 0.2 0.1 1.4 0.9 0.8 0.3 0.2 0.7 0.0 1.9 9.0 16.2 8.4 14.8 11.0 8.1 28.6 8.7 17.8 21.0 6.0 13.7 0.5 4.2 10.3 7.9 2.4 10.2 33.5 17.0 5.2 7.9 12.2 0.0 2.5 73.9 8.4 29.0 23.3 7.0 0.9 1.4 19.2 0.0 10.0 9.8 0.0 4.1 6.7 8.0 171.9 1.7 2.0 3.3 10.8 52.1 9.1 5.7 14.4 0.7 2.4 3.4 0.0 0.9 2.1 1.1 11.0 7.7 1.0 22.6 3.9 SLC22A3 "EMT, OCT3" ENSG00000146477 "Solute carrier family 22 member 3" O75751 6 160348268-160452581 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 98.6" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 62.8;Hepatocytes: 56.3;Leydig cells: 31.4;Pancreatic endocrine cells: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 17.6;HeLa: 23.6;Hep G2: 14.7;hTERT-RPE1: 6.2;OE19: 7.5;RPTEC TERT1: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029750 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA029750: AB_10603888" "unprognostic (8.61e-2)" "prognostic unfavorable (7.19e-5)" "unprognostic (4.14e-1)" "unprognostic (1.49e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (3.36e-2)" "unprognostic (9.74e-2)" "unprognostic (9.36e-4)" "unprognostic (1.33e-2)" "unprognostic (2.58e-2)" "unprognostic (7.28e-2)" "unprognostic (7.96e-2)" "unprognostic (5.21e-2)" "unprognostic (8.13e-4)" "prognostic unfavorable (7.26e-4)" 4.1 6.9 1.0 2.1 1.3 0.0 5.2 1.8 0.9 7.6 4.1 0.9 4.1 0.2 14.2 11.8 4.1 9.0 9.0 1.1 1.2 1.3 2.4 15.2 12.7 9.7 2.2 0.9 10.3 1.3 0.0 0.9 17.8 1.9 18.9 0.6 0.9 34.5 23.0 98.6 5.1 2.7 10.8 4.4 0.3 2.9 3.4 0.6 0.4 3.4 5.7 2.1 3.2 7.3 0.0 0.0 0.8 0.0 0.1 1.5 0.0 0.0 17.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.2 0.0 0.0 0.0 23.6 14.7 0.8 0.0 0.0 0.5 4.5 2.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 7.5 4.9 0.0 0.0 0.0 9.0 0.0 0.0 0.0 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.0 1.0 1.3 1.8 0.9 1.2 1.3 2.2 0.9 1.9 0.6 14.9 62.8 0.0 0.3 4.1 0.0 1.6 5.1 1.4 10.3 0.0 0.0 0.4 5.0 9.1 0.4 0.3 0.7 0.0 2.5 0.2 11.0 3.4 2.3 56.3 0.6 0.0 0.0 0.0 0.6 0.9 31.4 1.5 3.3 0.0 0.4 0.0 33.9 0.0 23.0 2.1 0.0 0.0 11.4 0.2 0.1 5.8 0.3 0.0 0.4 0.7 SLC24A3 ENSG00000185052 "Solute carrier family 24 member 3" Q9HC58 20 19212646-19722937 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 18.2;granulocytes: 26.5;Late spermatids: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 53 "basophil: 7.1;eosinophil: 3.3" "Lineage enriched" "Detected in single" 72 "granulocytes: 7.1" "Cell line enriched" "Detected in some" 4 "HMC-1: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043400, HPA045497" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA043400: AB_2678462, HPA045497: AB_2679349" "unprognostic (8.74e-2)" "unprognostic (1.13e-2)" "unprognostic (1.16e-1)" "unprognostic (1.41e-1)" "unprognostic (7.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.04e-2)" "unprognostic (3.25e-2)" "unprognostic (1.05e-1)" "unprognostic (5.40e-2)" "unprognostic (1.21e-3)" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (6.08e-4)" "unprognostic (7.36e-3)" 7.0 2.5 10.9 4.6 11.0 1.0 3.6 7.4 9.2 17.6 8.9 5.5 7.0 2.9 26.3 19.0 15.3 17.2 14.5 1.7 27.1 12.0 1.2 0.6 6.2 1.5 4.5 3.4 14.8 1.2 7.9 1.6 3.0 5.3 8.5 4.1 5.5 6.1 13.8 26.4 5.2 4.4 21.7 2.9 1.7 2.7 1.7 3.1 0.9 2.5 11.0 4.9 8.1 20.7 0.0 0.0 7.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 6.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.2 0.0 0.0 0.4 0.0 41.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 4.8 0.0 0.3 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.9 11.0 7.4 6.5 27.1 12.0 4.5 3.4 5.3 3.1 3.0 0.6 0.0 1.0 1.0 9.4 0.4 0.0 0.0 2.3 1.8 0.0 5.4 0.0 0.0 18.2 0.1 0.0 0.0 0.0 0.3 1.5 0.7 26.5 0.0 0.6 1.6 7.5 0.6 0.0 14.9 3.4 0.0 0.0 0.0 2.6 2.9 0.1 0.9 3.9 0.0 1.4 0.0 3.1 0.5 0.4 3.6 2.9 0.0 0.6 2.7 SLC25A12 Aralar ENSG00000115840 "Solute carrier family 25 member 12" O75746 2 171784370-171999859 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 84.7" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035333, HPA035334" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA035333: AB_10603028, HPA035334: AB_2674577" "unprognostic (3.24e-2)" "unprognostic (2.52e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (2.65e-2)" "unprognostic (7.27e-2)" "unprognostic (4.21e-3)" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (4.96e-2)" "unprognostic (7.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.91e-8)" "unprognostic (8.64e-3)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (2.70e-1)" 6.4 6.7 8.8 6.2 18.2 2.9 9.2 17.9 25.0 10.6 12.2 5.7 5.2 4.2 10.4 7.1 11.5 6.9 5.9 42.4 9.9 13.4 10.7 1.9 5.2 6.5 10.4 12.4 10.0 3.5 16.4 14.7 4.7 15.2 10.6 10.0 11.0 21.7 14.8 84.7 7.6 5.7 14.3 7.1 5.6 9.0 4.3 6.2 5.8 10.1 23.8 8.4 10.0 6.7 6.4 3.6 5.1 4.6 6.6 8.1 2.9 7.2 5.3 5.6 13.0 16.7 18.9 0.1 9.2 15.7 12.6 12.1 2.8 6.8 22.9 6.1 10.8 9.8 9.1 11.8 11.6 15.8 14.0 11.1 10.0 7.7 6.7 6.4 20.0 10.0 16.5 11.5 14.6 4.2 6.8 13.0 9.1 6.9 10.5 8.0 4.4 14.1 8.4 4.5 6.1 7.5 14.7 8.1 11.9 13.2 6.3 7.9 2.5 5.8 13.7 7.3 3.8 5.0 5.9 8.9 10.5 4.6 11.6 6.3 14.2 9.1 23.2 14.5 10.6 7.1 5.1 3.0 1.6 6.5 3.9 7.3 6.4 4.5 6.8 3.6 3.9 6.3 8.1 0.2 6.6 4.6 0.6 4.5 2.9 8.8 18.2 17.9 25.0 9.9 13.4 10.4 12.4 15.2 6.2 0.0 6.0 1.5 11.2 6.2 25.4 94.4 0.0 13.4 22.7 17.4 23.6 6.0 16.6 1.5 2.5 7.0 5.6 23.3 2.9 1.2 7.0 4.3 10.4 0.2 4.0 35.0 13.8 8.6 7.3 1.7 11.5 5.4 15.1 6.4 7.0 18.3 1.3 3.5 23.0 10.9 22.1 12.9 11.8 3.2 9.0 6.8 1.0 8.7 7.4 4.6 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856931-48898993 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.8;liver: 58.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 35.4;RPMI-8226: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Approved Mitochondria,Cytosol NA NA 13000 "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 11.9 13.7 6.7 5.6 7.3 3.4 10.2 3.0 5.6 3.3 19.7 4.7 5.2 25.0 4.7 3.1 3.3 5.0 9.9 37.1 7.3 4.6 16.8 58.3 6.6 4.9 8.5 5.1 2.7 16.8 5.9 5.1 3.3 5.8 5.0 9.1 5.4 7.4 3.7 27.4 4.0 32.2 5.7 5.5 8.8 7.5 4.4 6.6 9.1 5.5 5.5 5.9 4.5 9.8 9.4 33.3 57.8 29.0 17.3 28.4 24.7 1.4 4.5 3.6 5.0 11.5 4.4 0.7 8.0 4.3 5.6 5.8 5.6 6.9 6.6 5.7 12.6 6.8 1.4 8.8 3.5 4.2 16.8 4.2 9.2 7.0 7.1 5.2 9.6 17.8 5.6 4.0 7.5 1.2 2.2 7.2 10.1 8.2 35.4 7.3 3.7 10.5 4.8 1.8 8.1 10.2 3.8 2.1 48.7 6.0 3.5 1.4 5.1 7.4 0.0 4.0 5.2 11.3 4.5 5.8 6.4 1.1 9.3 5.8 13.1 9.1 7.7 9.1 6.8 8.4 13.8 29.0 57.8 28.4 21.0 18.1 9.4 16.1 20.8 27.0 7.8 12.7 21.3 13.5 17.3 21.4 33.3 16.1 24.7 6.7 7.3 3.0 5.6 7.3 4.6 8.5 5.1 5.8 6.6 6.0 2.4 7.5 2.3 1.5 1.1 31.1 7.6 5.3 2.3 0.0 5.9 1.7 3.3 3.2 1.1 3.1 38.0 0.0 3.7 1.9 4.1 2.4 1.1 55.2 15.8 0.0 7.0 9.2 13.2 1.0 9.8 7.5 1.7 40.5 10.8 2.8 4.0 13.5 11.7 12.5 1.1 0.0 2.2 7.1 7.0 1.1 1.0 13.8 12.8 2.0 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140979933 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favorable (1.55e-4)" 20.2 16.9 14.9 13.4 20.5 36.5 25.2 18.7 31.3 23.5 19.4 18.3 17.3 22.3 25.6 37.3 12.2 25.1 13.7 29.5 15.9 19.0 29.0 3.1 22.4 18.6 15.6 16.7 32.6 33.9 29.7 26.3 19.1 21.6 20.6 14.8 21.1 17.5 17.7 60.6 16.2 17.2 20.4 18.5 14.1 23.6 24.4 12.2 15.4 23.7 15.1 12.7 20.7 18.5 17.0 14.9 15.7 13.1 18.1 16.6 10.9 23.8 5.4 17.5 14.3 16.1 20.6 22.1 9.0 11.5 10.1 14.3 14.9 11.4 19.9 22.4 7.6 14.5 16.0 21.2 8.8 20.7 15.2 17.2 16.4 13.0 9.4 24.2 23.4 10.2 23.2 29.6 7.4 22.7 22.7 10.6 14.7 8.7 12.9 14.7 10.3 13.9 16.1 17.4 5.9 10.1 15.1 15.6 28.2 11.9 8.2 11.3 18.5 12.2 22.2 39.1 16.0 15.4 13.3 10.7 14.1 7.9 24.9 8.6 26.2 17.0 23.2 18.2 9.8 6.9 10.5 10.4 15.7 11.4 13.1 13.3 17.0 11.7 12.5 14.9 16.0 16.6 15.7 1.8 18.1 13.1 10.9 10.2 10.9 14.9 20.5 18.7 31.3 15.9 19.0 15.6 16.7 21.6 12.2 92.3 107.7 22.2 58.2 60.7 96.5 82.2 38.2 133.8 62.6 68.0 125.7 48.2 54.7 22.9 5.0 40.0 22.6 0.0 33.6 33.4 49.8 72.0 63.6 0.4 22.8 87.4 57.0 29.4 35.2 11.5 55.3 36.5 54.0 29.7 27.0 70.1 26.8 17.5 55.9 52.8 122.5 58.2 54.2 29.3 61.1 47.6 41.3 41.1 40.3 64.7 SLC25A37 "HT015, MFRN, MFRN1, MSCP" ENSG00000147454 "Solute carrier family 25 member 37" Q9NYZ2 8 23528805-23575463 "Predicted intracellular proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.8" "Cell type enriched" "Detected in all" 5 "Erythroid cells: 3550.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 18 "neutrophil: 28.9" "Lineage enriched" "Detected in many" 18 "granulocytes: 28.9" "Cell line enhanced" "Detected in many" "HEL: 47.7;hTERT-RPE1: 27.9" "Low region specificity" "Detected in all" HPA045680 Uncertain Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA045680: AB_10963693" "unprognostic (6.15e-3)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (5.12e-2)" "unprognostic (1.35e-1)" "unprognostic (1.68e-1)" "unprognostic (3.58e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.37e-6)" "unprognostic (8.27e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 8.2 18.3 5.8 13.7 8.3 88.8 13.1 4.2 8.2 13.4 16.4 6.5 11.7 39.7 10.3 6.8 8.2 9.5 8.5 16.8 6.2 5.2 9.4 11.8 25.7 18.5 12.2 5.1 17.2 14.8 15.6 8.8 23.9 10.3 17.1 5.8 7.9 21.1 17.4 13.8 7.6 17.6 7.9 10.2 28.7 8.0 15.0 8.6 1.9 9.0 5.9 5.7 13.9 33.0 1.2 1.4 28.9 1.6 0.7 1.2 0.8 3.8 4.2 4.5 4.1 5.9 7.3 6.6 3.0 3.9 2.2 2.5 4.1 8.2 6.2 3.7 2.5 14.5 4.9 4.1 8.2 3.0 1.0 2.2 47.7 7.0 1.4 4.9 2.7 1.9 6.2 8.0 4.8 4.8 27.9 3.4 5.0 10.5 3.1 3.5 1.6 3.2 11.3 2.3 4.7 3.3 3.3 2.2 2.4 6.8 2.1 1.4 1.9 4.1 6.4 3.0 4.4 1.8 4.1 5.5 10.9 1.6 6.4 5.8 2.5 0.9 3.9 10.2 6.5 6.8 0.6 1.6 1.4 0.6 0.6 0.6 1.2 0.4 0.3 1.4 0.8 1.2 0.7 28.9 0.7 0.8 0.4 0.7 0.8 5.8 8.3 4.2 8.2 6.2 5.2 12.2 5.1 10.3 8.6 35.7 79.2 39.5 104.8 82.9 35.3 31.5 48.4 21.4 84.2 73.3 64.8 32.1 13.3 81.9 645.6 82.4 66.7 3550.9 197.4 63.8 90.2 258.9 35.8 34.3 36.1 6.4 19.5 100.7 50.6 772.4 48.6 101.8 65.8 8.2 33.2 41.6 177.5 34.5 35.0 24.5 60.7 19.4 95.7 12.5 47.1 47.0 15.3 22.7 43.1 139.3 SLC25A43 ENSG00000077713 "Solute carrier family 25 member 43" Q8WUT9 X 119399060-119454478 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035188, HPA078530" Uncertain Approved Cytosol NA NA Cytosol "HPA035188: AB_10602400, HPA078530: " "unprognostic (6.05e-3)" "unprognostic (1.48e-1)" "unprognostic (9.92e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (4.99e-3)" "unprognostic (1.59e-2)" "unprognostic (3.26e-2)" "unprognostic (2.74e-2)" "unprognostic (7.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.80e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.06e-8)" "unprognostic (2.63e-1)" "unprognostic (2.62e-1)" "unprognostic (1.96e-2)" "unprognostic (4.92e-2)" 12.7 3.0 4.4 11.1 3.7 1.3 11.8 5.9 3.8 8.9 12.3 4.3 5.6 12.8 8.0 7.3 23.5 5.8 6.3 6.0 5.1 3.4 11.4 11.3 10.4 9.5 3.8 2.7 7.8 15.6 4.0 3.0 7.3 5.8 8.5 14.2 7.4 12.8 4.4 6.3 14.0 13.3 7.7 8.2 9.0 7.9 4.3 4.3 1.9 5.7 9.6 16.2 8.9 12.9 4.3 6.3 0.2 10.7 6.6 3.2 1.4 13.6 10.1 0.7 4.0 14.0 21.2 5.4 7.5 9.6 6.1 5.9 5.2 6.9 1.5 4.6 21.0 18.4 10.1 7.9 7.1 5.5 11.8 2.4 4.9 3.3 7.0 8.7 4.6 5.2 8.7 12.6 10.1 8.5 8.7 7.5 2.7 0.9 7.3 7.0 24.4 0.0 6.5 4.6 7.2 15.9 1.2 0.0 2.0 10.1 4.7 0.6 0.0 10.2 21.6 12.0 3.4 3.8 4.6 10.4 10.0 2.9 10.8 11.6 0.1 5.7 3.3 10.0 7.7 8.8 0.0 3.4 0.2 1.0 5.1 1.8 4.3 2.0 3.2 6.3 3.6 1.1 1.9 0.0 6.6 10.7 1.6 1.6 1.4 4.4 3.7 5.9 3.8 5.1 3.4 3.8 2.7 5.8 4.3 6.0 8.9 6.0 5.9 6.9 0.1 1.4 0.0 1.4 6.8 3.5 0.0 8.9 8.3 3.6 0.0 7.3 16.9 0.0 7.9 6.7 9.3 3.1 8.1 4.9 9.7 0.0 7.0 6.2 6.5 0.0 7.5 9.9 10.1 11.8 10.3 0.0 12.1 8.6 5.3 7.0 0.1 0.0 13.3 0.4 2.2 12.2 5.7 7.2 10.3 5.1 SLC25A45 ENSG00000162241 "Solute carrier family 25 member 45" Q8N413 11 65375192-65383701 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 60.5" "Cell type enhanced" "Detected in many" 5 "B-cells: 32.2;T-cells: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 13.8;Karpas-707: 18.7;RPMI-8226: 13.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA050821 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050821: AB_2681249" "unprognostic (3.73e-2)" "unprognostic (2.19e-3)" "unprognostic (8.44e-4)" "unprognostic (6.17e-3)" "unprognostic (2.57e-2)" "unprognostic (2.84e-7)" "unprognostic (7.57e-3)" "unprognostic (4.59e-2)" "unprognostic (1.44e-1)" "unprognostic (4.06e-2)" "prognostic favorable (2.83e-4)" "unprognostic (1.96e-1)" "unprognostic (1.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.54e-1)" "unprognostic (6.18e-2)" "unprognostic (1.43e-1)" 2.2 1.8 2.1 4.0 2.3 3.1 3.2 1.0 2.6 1.7 4.5 4.0 4.7 4.1 1.0 5.4 1.5 1.3 1.3 2.8 2.5 1.1 3.9 7.7 5.3 9.4 1.8 2.3 1.3 60.5 4.2 4.7 1.2 2.3 2.5 1.2 3.5 5.0 1.3 4.1 2.0 11.0 1.5 2.3 9.6 1.9 2.4 2.0 5.8 9.0 2.8 8.2 1.9 1.7 10.8 19.2 6.0 10.1 13.5 11.4 2.5 0.3 4.7 0.2 6.9 1.3 0.6 3.5 0.8 2.1 0.4 0.4 1.0 2.2 4.1 3.9 1.9 1.8 0.6 0.5 0.3 0.0 13.8 1.0 4.5 2.5 0.3 0.8 1.4 4.8 1.6 0.1 0.5 0.4 0.4 0.7 8.0 0.6 18.7 0.7 1.5 3.3 0.1 0.3 0.2 2.2 6.1 0.9 13.6 0.7 0.0 2.3 3.1 1.4 3.7 0.7 0.4 1.9 0.7 1.3 0.5 1.8 4.5 0.3 7.8 4.9 1.2 1.4 1.0 2.7 6.0 5.5 3.9 7.9 9.0 8.4 8.9 7.0 7.5 5.7 10.8 11.4 8.5 3.3 13.5 10.1 19.2 6.3 2.5 2.1 2.3 1.0 2.6 2.5 1.1 1.8 2.3 2.3 2.0 0.0 3.5 32.2 5.2 2.5 9.0 5.5 10.2 17.4 4.5 12.2 0.0 1.4 0.0 4.9 5.2 2.9 23.9 0.0 4.7 1.0 3.3 7.8 4.6 12.1 6.3 6.4 6.4 7.4 7.0 3.3 6.4 13.8 5.0 18.0 12.9 7.7 4.3 8.6 3.5 6.2 0.3 6.5 2.5 2.3 0.2 1.8 1.3 35.9 7.4 3.5 SLC26A6 DKFZp586E1422 ENSG00000225697 "Solute carrier family 26 member 6" Q9BXS9 3 48625723-48635493 "Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 43.3;Mucus-secreting cells: 32.0;Paneth cells: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048363 Approved Uncertain Cytosol NA NA Cytosol "HPA048363: AB_2680371" "unprognostic (1.54e-1)" "unprognostic (4.94e-2)" "unprognostic (3.34e-1)" "unprognostic (3.15e-2)" "unprognostic (2.15e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.39e-1)" "unprognostic (2.35e-1)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (9.66e-3)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.58e-2)" 5.3 5.7 6.4 12.3 9.8 18.8 5.7 6.8 6.9 6.3 24.8 6.0 7.3 9.7 6.8 7.4 6.5 4.7 6.3 6.7 4.9 3.1 13.6 6.2 7.8 7.4 9.4 3.1 6.7 14.9 6.8 5.8 6.5 9.3 10.2 25.4 7.7 9.6 7.4 8.8 6.7 19.5 6.8 4.8 10.6 19.7 7.7 9.9 7.7 5.5 5.4 6.3 5.1 6.6 0.9 8.8 5.2 10.7 0.5 3.3 4.5 4.5 5.1 7.3 8.2 23.1 11.6 6.2 7.5 9.9 14.6 15.7 9.7 4.2 6.5 2.6 6.4 16.2 6.1 6.8 6.9 4.2 4.8 6.8 5.9 14.5 18.7 16.8 2.8 9.2 15.8 24.8 9.9 7.2 12.6 4.5 6.7 4.5 7.4 3.5 5.4 5.4 14.8 10.4 12.5 9.9 2.8 2.7 7.9 10.7 4.5 1.8 3.5 9.8 12.1 14.1 10.6 6.3 10.5 3.6 6.3 5.3 8.5 17.1 8.8 9.2 2.9 5.3 11.1 15.9 5.2 10.7 2.1 3.1 10.0 2.8 0.9 1.9 2.0 8.8 0.2 1.1 1.6 1.5 0.5 8.9 5.0 3.3 4.5 6.4 9.8 6.8 6.9 4.9 3.1 9.4 3.1 9.3 9.9 3.0 5.1 0.8 2.4 2.9 1.5 6.4 2.5 2.7 1.2 1.8 13.7 7.5 0.0 2.5 1.2 2.9 43.3 0.0 5.6 13.1 4.3 1.9 0.0 4.2 6.2 4.8 19.5 5.5 5.2 0.7 3.4 7.0 5.0 4.6 32.0 2.0 5.2 36.6 8.9 5.1 6.4 0.0 5.7 2.5 5.7 3.0 8.8 3.8 23.5 0.8 SLC27A1 "ACSVL5, FATP, FATP1, FLJ00336, MGC71751" ENSG00000130304 "Solute carrier family 27 member 1" Q6PCB7 19 17468769-17506168 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 17.6;SK-MEL-30: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076520 Approved "Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane" "Mitochondria, Cytosol" "HPA076520: AB_2732311" "unprognostic (1.48e-3)" "unprognostic (3.03e-2)" "unprognostic (5.72e-3)" "unprognostic (5.84e-2)" "unprognostic (2.16e-3)" "unprognostic (4.36e-2)" "unprognostic (8.56e-2)" "unprognostic (3.36e-2)" "unprognostic (9.03e-2)" "unprognostic (1.85e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "prognostic favorable (4.70e-4)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" 14.5 14.3 13.1 5.2 13.9 2.0 9.3 20.1 19.3 11.8 6.4 44.1 10.1 4.6 8.9 6.4 5.9 14.7 11.0 18.3 12.9 10.0 5.2 5.2 8.5 6.7 22.0 17.2 23.2 14.5 26.1 9.8 7.5 16.1 11.0 2.6 9.6 26.7 13.0 24.2 13.7 3.7 5.5 13.4 7.1 10.9 9.6 19.3 1.3 9.9 4.7 5.3 6.9 8.8 0.5 7.4 0.3 9.9 1.7 3.2 4.6 3.6 1.8 2.5 6.1 17.6 9.8 2.1 2.6 7.0 3.0 4.5 0.2 11.3 1.2 5.0 4.4 2.8 4.4 0.2 4.1 0.7 1.4 0.8 0.7 0.2 1.3 3.4 0.3 4.0 9.0 2.9 3.0 1.2 12.5 2.0 2.4 0.4 0.7 1.9 1.5 2.0 2.9 0.7 3.6 3.2 2.8 2.0 0.8 1.9 1.1 0.8 1.8 1.8 0.9 29.1 1.6 3.2 0.9 1.2 5.9 3.9 4.7 1.8 2.5 1.8 0.4 6.1 3.2 4.1 0.0 9.9 0.3 1.7 4.7 3.2 0.5 1.2 2.1 7.2 0.3 1.6 2.1 0.0 1.7 1.8 7.4 0.7 4.6 13.1 13.9 20.1 19.3 12.9 10.0 22.0 17.2 16.1 19.3 3.0 14.0 1.5 14.9 6.0 8.2 16.7 10.2 4.0 9.1 8.7 25.5 3.7 1.7 9.3 0.7 4.7 0.1 0.0 4.1 14.7 9.7 10.3 2.3 5.8 24.7 6.4 5.2 9.2 20.6 1.7 19.8 9.1 8.5 5.4 2.6 9.7 4.9 0.0 11.0 2.7 17.6 6.5 5.2 8.1 4.3 4.0 1.9 6.1 1.3 7.0 SLC28A1 CNT1 ENSG00000156222 "Solute carrier family 28 member 1" O00337 15 84884654-84945796 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "intestine: 32.7;kidney: 35.6;liver: 43.8" "Group enriched" "Detected in some" 5 "Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5" "Group enriched" "Detected in some" 63 "liver cancer: 10.9;renal cancer: 33.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019551, HPA056247" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nuclear speckles, Cytosol" "HPA019551: AB_2670187, HPA056247: " "unprognostic (3.81e-2)" "unprognostic (1.60e-1)" "unprognostic (2.22e-1)" "unprognostic (7.49e-2)" "unprognostic (5.08e-2)" "unprognostic (7.08e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-2)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (1.35e-1)" "unprognostic (7.42e-2)" "unprognostic (7.72e-3)" "unprognostic (6.65e-2)" "unprognostic (1.55e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 5.0 0.1 0.1 17.3 0.1 1.5 0.1 0.1 0.1 0.5 0.1 0.1 35.6 43.8 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 32.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.5 0.0 0.9 0.1 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.1 0.4 0.1 1.8 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 7.6 1.4 0.0 7.0 0.0 0.4 10.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 34.1 40.6 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 88.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 28.7;epididymis: 41.0;testis: 19.5" "Group enriched" "Detected in some" 18 "Cardiomyocytes: 8.1;Early spermatids: 13.1;Late spermatids: 29.1;Peritubular cells: 14.2;Spermatocytes: 18.7;Spermatogonia: 9.4" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 9 "amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.0;HAP1: 8.8;Hep G2: 11.7;REH: 19.0;RH-30: 9.9" "Group enriched" "Detected in many" 5 "amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6" "Group enriched" "Detected in many" 7 "amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875" "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.5 1.9 15.8 0.5 11.4 0.5 0.4 0.4 28.7 0.5 0.5 0.0 1.9 0.4 0.5 41.0 0.4 0.7 0.4 5.0 10.2 0.8 0.4 0.5 0.5 0.8 1.1 12.1 0.5 0.4 0.6 0.4 0.4 1.6 0.6 0.5 0.7 0.4 0.9 0.4 0.4 0.5 0.5 0.7 0.5 0.4 19.5 0.0 0.0 0.4 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.0 1.5 0.0 0.2 0.1 0.0 0.0 1.0 1.0 0.3 0.4 0.0 0.0 0.0 8.0 0.2 8.8 0.0 0.2 0.0 1.0 5.0 0.2 11.7 0.2 0.1 2.0 0.0 0.0 0.5 0.0 0.1 0.7 2.4 1.4 0.0 0.1 3.8 0.0 0.3 1.5 0.2 0.0 19.0 9.9 1.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.2 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 15.8 11.4 0.4 28.7 10.2 0.8 1.1 12.1 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 29.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.3 18.7 9.4 0.1 0.1 0.0 0.0 0.0 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "kidney: 94.5" "Cell type enriched" "Detected in some" 16 "Proximal tubular cells: 128.7" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Group enriched" "Detected in some" 12 "HEL: 6.7;U-937: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" Yes NA "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: AB_2681409, HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 7.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SLC34A2 NAPI-3B ENSG00000157765 "Solute carrier family 34 member 2" O95436 4 25648011-25678748 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lung: 259.9;seminal vesicle: 69.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 443.7;Alveolar cells type 2: 1050.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 585.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 81 "BEWO: 12.6;EFO-21: 47.7;RPTEC TERT1: 34.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037989, HPA066474" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA037989: AB_10670536, HPA066474: " "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.38e-1)" "unprognostic (4.25e-2)" "unprognostic (7.33e-2)" "unprognostic (9.83e-2)" "unprognostic (2.37e-2)" "unprognostic (6.60e-3)" "unprognostic (6.27e-2)" "unprognostic (1.89e-2)" "unprognostic (5.77e-2)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (3.25e-1)" "unprognostic (6.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.93e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 3.2 0.2 0.1 13.0 0.1 0.0 24.7 2.9 6.9 2.1 0.5 13.0 3.4 0.1 0.1 0.1 10.8 0.5 259.9 0.0 0.1 0.0 2.9 4.4 0.0 0.6 2.6 0.8 0.3 0.0 1.6 27.4 69.1 0.1 0.7 2.1 0.0 0.1 0.1 0.4 0.5 0.0 0.4 27.9 0.1 1.9 0.0 0.1 0.4 0.2 1.9 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.9 0.5 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.0 0.4 0.3 0.2 1.5 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.8 0.0 443.7 1050.6 0.0 0.1 0.0 0.0 0.6 40.8 125.8 178.6 19.2 0.0 1.6 5.0 57.7 3.5 0.0 0.0 0.0 7.1 0.0 0.0 3.5 26.7 0.0 0.2 0.0 0.0 0.0 0.0 14.0 1.1 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 2.9 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 SLC35A4 ENSG00000176087 "Solute carrier family 35 member A4" "L0R6Q1, Q96G79" 5 140564456-140569103 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062210 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062210: AB_2684712" "unprognostic (3.01e-3)" "unprognostic (1.35e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-2)" "unprognostic (1.91e-3)" "unprognostic (9.63e-2)" "unprognostic (3.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.78e-2)" "unprognostic (2.87e-1)" "prognostic favorable (4.56e-5)" "unprognostic (2.96e-2)" "unprognostic (3.04e-2)" "unprognostic (2.06e-2)" "unprognostic (1.55e-1)" 22.0 30.4 12.3 18.6 17.1 8.4 19.6 14.0 21.8 18.2 25.5 24.9 22.6 19.2 18.2 19.8 30.3 20.6 26.0 25.7 13.1 10.3 35.1 39.2 23.1 22.5 16.0 11.1 19.0 28.3 28.2 14.9 24.6 19.4 20.4 26.5 20.5 32.6 15.9 54.3 28.3 30.6 19.8 13.0 28.5 21.7 30.5 15.3 26.0 29.2 28.0 27.5 18.3 18.0 15.4 32.8 15.8 36.9 26.9 27.6 32.4 15.5 46.7 18.7 35.2 25.7 16.1 27.9 22.7 15.3 27.7 29.2 56.5 18.0 46.0 28.1 21.3 32.3 17.2 0.0 33.1 23.8 55.9 25.6 34.4 45.6 0.2 18.3 33.6 26.0 21.3 25.9 27.5 24.7 13.0 23.7 22.8 26.6 46.5 27.4 28.8 35.0 14.6 12.7 22.4 23.9 26.1 37.9 39.9 20.7 30.8 20.9 27.9 28.7 47.8 22.3 19.2 39.7 14.4 27.7 24.9 17.4 24.7 25.4 19.3 45.3 19.3 18.4 38.0 28.9 7.5 26.9 15.8 27.6 36.9 26.3 14.3 22.1 24.7 32.8 15.4 25.9 23.0 9.9 26.9 33.3 12.0 14.7 32.4 12.3 17.1 14.0 21.8 13.1 10.3 16.0 11.1 19.4 15.3 11.9 24.8 21.9 20.2 9.3 12.2 23.8 43.3 6.7 17.0 15.7 3.9 26.8 38.1 28.1 58.7 14.7 37.1 0.0 30.4 42.8 19.5 22.2 20.7 19.5 28.5 12.7 24.2 27.6 21.1 94.4 11.5 15.8 16.9 31.5 27.2 20.3 31.1 21.0 11.7 31.1 8.5 32.3 12.6 5.4 16.4 10.2 25.5 20.3 28.7 29.1 SLC35E4 ENSG00000100036 "Solute carrier family 35 member E4" Q6ICL7 22 30635652-30669016 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 20.2;testis: 22.5" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 93.5;Late spermatids: 68.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 15.0;U-2197: 14.5;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049558 Approved Approved Cytosol NA NA Cytosol "HPA049558: AB_2680817" "unprognostic (2.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.05e-1)" "unprognostic (1.01e-2)" "unprognostic (4.99e-2)" "unprognostic (2.04e-1)" "unprognostic (3.03e-4)" "unprognostic (5.71e-2)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (3.45e-7)" "unprognostic (2.77e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (8.05e-3)" 4.0 2.5 5.6 3.3 11.8 3.4 2.6 4.0 11.4 2.7 5.9 8.1 2.1 2.7 4.2 3.5 4.5 3.1 2.9 5.6 5.2 4.7 2.0 1.1 2.4 2.1 13.0 6.3 2.8 4.1 3.1 2.8 1.6 6.6 2.9 4.2 2.4 2.6 3.5 20.2 7.3 2.5 3.5 2.6 2.4 3.8 22.5 10.1 0.0 2.0 6.6 2.1 3.6 7.6 0.7 3.6 1.6 2.8 2.1 3.2 0.9 6.5 2.9 1.1 2.2 3.0 7.7 0.6 4.3 3.8 3.0 2.8 0.2 1.8 0.4 2.3 4.4 4.2 4.2 1.9 2.5 1.5 15.0 2.1 0.1 2.1 0.2 4.3 0.3 1.8 2.4 1.1 11.9 3.7 4.7 10.1 0.5 0.6 2.0 4.6 1.9 0.2 1.3 1.3 1.9 10.9 1.2 2.2 0.2 1.4 0.5 6.0 2.3 4.4 1.9 2.1 0.5 1.3 0.5 13.4 12.7 4.0 14.5 4.1 0.6 0.5 0.2 15.5 0.2 3.3 1.6 2.1 0.3 0.9 2.8 1.4 0.3 2.1 3.2 3.6 0.7 2.1 1.7 0.8 2.1 2.2 1.0 2.3 0.9 5.6 11.8 4.0 11.4 5.2 4.7 13.0 6.3 6.6 10.1 0.0 1.0 0.9 2.0 12.9 8.8 1.6 0.0 8.1 1.2 1.8 21.6 0.0 0.0 3.2 93.5 4.9 2.6 0.0 2.1 0.4 3.7 1.5 1.1 0.0 1.7 11.1 2.4 4.9 0.3 68.4 3.1 4.5 3.3 2.8 2.6 17.3 1.9 5.7 3.5 0.3 9.3 0.0 4.1 21.8 3.4 16.7 0.1 2.5 4.4 1.4 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 11.0;Early spermatids: 10.7;Horizontal cells: 15.9;Late spermatids: 17.4;Melanocytes: 13.5;Muller glia cells: 27.9" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 9 "AF22: 23.9;WM-115: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.4 0.0 0.0 0.1 0.0 40.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 0.0 0.0 0.0 0.0 0.3 11.0 4.3 0.0 0.0 2.3 0.0 2.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.1 15.9 0.0 0.0 0.0 17.4 0.6 0.0 13.5 0.0 0.0 27.9 0.0 0.0 1.1 0.0 1.8 0.0 0.7 0.9 1.2 0.0 0.0 0.0 0.0 0.0 SLC35F6 "ANT2BP, C2orf18, FLJ20555, TANGO9" ENSG00000213699 "Solute carrier family 35 member F6" Q8N357 2 26764284-26781231 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 48.6;Karpas-707: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034655 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034655: AB_10696359" "unprognostic (2.26e-1)" "unprognostic (7.45e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-1)" "unprognostic (7.71e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.11e-4)" "prognostic unfavorable (3.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.35e-1)" "unprognostic (3.24e-1)" "unprognostic (2.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.07e-2)" "unprognostic (9.95e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-2)" 37.3 24.1 9.7 10.5 11.7 6.5 42.2 8.3 15.6 17.9 14.5 16.0 12.4 10.4 14.1 14.0 25.2 12.5 14.4 15.0 10.4 11.6 37.4 25.4 15.3 22.0 12.3 9.3 20.4 12.6 13.1 12.2 26.6 11.9 15.3 9.0 13.8 16.7 14.2 16.7 30.9 14.7 15.4 11.4 14.8 16.3 11.7 9.1 10.5 24.1 20.4 15.5 13.8 18.2 3.1 7.1 7.8 19.0 8.6 8.8 5.9 8.3 14.7 4.5 11.4 15.5 7.0 6.9 4.7 7.3 6.1 5.6 9.2 16.0 2.2 8.0 6.6 15.1 10.4 6.4 9.5 4.3 3.8 3.1 2.5 5.6 7.7 48.6 2.7 12.8 11.1 9.8 6.9 23.2 2.8 7.1 3.4 4.7 42.8 6.1 13.5 3.4 2.4 2.5 6.0 3.9 3.0 12.9 3.5 16.2 6.7 3.4 4.5 8.0 13.1 8.5 3.9 4.9 2.8 6.4 8.0 8.5 10.9 5.2 8.3 10.4 4.3 8.6 4.6 7.2 7.0 12.0 5.3 8.8 16.5 5.0 3.1 6.1 8.0 7.1 2.5 4.2 6.0 7.8 8.6 19.0 5.5 3.8 5.9 9.7 11.7 8.3 15.6 10.4 11.6 12.3 9.3 11.9 9.1 11.9 8.0 6.7 11.8 15.0 17.3 11.2 25.5 5.3 7.9 31.4 5.9 22.1 6.6 29.6 1.5 19.2 18.8 0.0 33.5 20.1 22.4 12.8 1.1 19.2 46.2 14.3 8.7 28.8 43.7 1.1 17.0 26.4 27.0 10.8 8.7 18.9 38.9 9.1 11.3 49.9 9.7 25.8 29.9 3.7 6.5 22.5 31.8 13.8 9.7 10.6 SLC36A4 "FLJ38932, PAT4" ENSG00000180773 "Solute carrier family 36 member 4" Q6YBV0 11 93144171-93197964 "Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017887 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA017887: AB_2190238" "unprognostic (1.23e-2)" "unprognostic (1.08e-1)" "unprognostic (2.17e-3)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" "unprognostic (8.77e-2)" "unprognostic (1.08e-3)" "unprognostic (7.83e-3)" "unprognostic (3.06e-2)" "unprognostic (7.97e-2)" "unprognostic (2.09e-2)" "unprognostic (8.04e-3)" "unprognostic (7.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.74e-1)" "unprognostic (9.45e-3)" "unprognostic (4.20e-2)" 8.0 11.0 16.0 12.6 19.3 24.1 6.5 20.7 20.2 8.0 7.3 8.7 2.1 3.0 10.4 3.6 7.8 6.2 8.4 9.2 14.2 14.8 13.7 11.0 8.2 7.0 16.8 10.3 8.6 8.0 8.0 17.2 8.7 17.6 7.5 9.4 5.4 5.4 9.1 3.4 5.9 4.2 11.5 20.0 5.7 6.4 6.0 13.4 5.6 12.7 2.3 9.2 8.6 7.7 1.6 2.9 8.1 7.7 0.8 2.6 1.8 5.1 9.3 19.0 3.8 6.7 13.7 10.7 9.0 15.0 13.4 16.3 7.4 17.0 6.3 5.2 8.3 7.0 6.4 5.8 3.3 12.3 10.5 6.8 7.2 19.5 4.9 5.3 18.1 10.8 6.6 10.4 7.7 4.9 6.3 7.1 9.0 0.6 0.1 13.6 1.3 7.9 13.7 7.6 2.0 9.4 3.6 11.3 2.6 4.5 7.7 17.6 22.9 13.1 5.1 3.2 14.5 9.3 5.3 7.9 25.3 7.8 14.9 13.0 2.6 5.2 0.0 5.7 7.6 13.0 0.2 7.7 8.1 1.3 3.9 1.8 1.3 1.0 1.6 2.9 1.6 2.6 1.7 2.5 0.8 2.5 1.1 0.8 1.8 16.0 19.3 20.7 20.2 14.2 14.8 16.8 10.3 17.6 13.4 11.9 8.6 18.2 35.2 27.2 21.1 7.7 12.7 21.4 6.8 19.2 21.6 9.5 29.9 19.1 1.7 18.0 0.7 0.0 37.9 21.2 11.6 37.1 4.6 6.4 13.1 25.4 26.5 10.4 59.0 3.1 16.7 44.6 20.3 10.0 17.4 13.3 27.9 5.8 14.5 12.3 23.0 6.5 17.6 6.2 2.7 28.0 13.6 10.7 4.3 23.7 SLC38A3 "G17, SN1" ENSG00000188338 "Solute carrier family 38 member 3" Q99624 3 50205246-50221486 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 107.8" "Group enriched" "Detected in many" 7 "Bipolar cells: 86.1;Cone photoreceptor cells: 176.7;Hepatocytes: 93.4;Muller glia cells: 75.9;Rod photoreceptor cells: 112.3" "Cancer enriched" "Detected in many" 9 "liver cancer: 140.0" "Cell type enhanced" "Detected in some" "basophil: 5.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Hep G2: 32.4;SCLC-21H: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031871 Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA031871: AB_2674080" "unprognostic (2.14e-1)" "unprognostic (2.10e-1)" "unprognostic (8.60e-2)" "unprognostic (6.19e-4)" "unprognostic (7.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.34e-2)" "unprognostic (2.30e-2)" "unprognostic (4.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.06e-1)" "unprognostic (5.71e-2)" "unprognostic (1.23e-3)" "unprognostic (1.90e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.96e-1)" 0.7 0.3 3.4 0.3 5.2 0.5 0.7 2.4 10.5 0.3 0.3 10.3 0.0 0.7 0.4 0.4 0.6 0.4 0.4 2.0 4.1 1.5 107.8 0.3 0.4 3.4 4.0 2.4 11.6 1.8 0.7 0.6 7.8 0.4 0.3 22.2 0.9 0.3 10.4 0.5 0.4 0.3 4.7 0.3 0.9 0.7 5.2 0.0 0.6 1.9 0.4 0.3 0.0 1.1 1.0 5.6 0.8 1.5 0.8 0.2 0.0 0.0 0.8 4.9 0.0 0.0 1.3 0.0 0.0 0.9 0.4 2.9 0.1 0.1 0.8 0.0 0.2 0.0 1.3 0.0 0.6 0.1 0.4 0.0 0.6 32.4 0.1 0.3 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.4 0.5 0.1 0.0 0.4 0.3 0.0 0.1 0.2 10.8 0.9 0.5 0.1 0.0 1.5 1.3 0.2 0.0 0.2 0.9 0.0 0.7 0.3 0.0 0.1 0.1 0.2 0.1 5.6 0.8 0.9 0.6 0.2 0.4 0.7 0.5 0.4 0.2 1.1 0.6 0.8 3.3 1.5 0.2 1.0 0.4 0.2 0.0 0.0 1.9 0.1 0.0 86.1 2.8 15.3 0.0 0.0 0.0 176.7 0.2 0.0 0.7 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 93.4 0.1 7.9 3.4 0.0 3.3 0.0 2.0 0.0 0.0 1.0 0.0 75.9 0.8 0.0 0.4 1.4 112.3 0.0 0.0 1.0 1.8 0.0 1.1 0.0 0.0 0.0 SLC38A5 "JM24, SN2" ENSG00000017483 "Solute carrier family 38 member 5" Q8WUX1 X 48458537-48470256 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 87.7" "Cell type enhanced" "Detected in many" 14 "Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 35.6;HBEC3-KT: 54.3;HeLa: 53.5;hTCEpi: 40.4;Karpas-707: 47.8;RPMI-8226: 87.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047411 Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" Cytosol "HPA047411: AB_10964355" "unprognostic (2.81e-1)" "unprognostic (4.87e-2)" "unprognostic (7.92e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-3)" "unprognostic (1.26e-1)" "unprognostic (7.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.13e-4)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.27e-3)" "unprognostic (1.45e-1)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" 1.5 0.9 5.3 4.7 7.1 17.3 0.9 3.5 11.6 4.0 4.9 7.7 0.1 5.1 1.8 1.3 3.7 2.0 1.5 2.4 6.9 5.7 0.7 0.4 9.4 3.3 7.0 2.7 3.7 87.7 0.4 0.4 2.8 14.6 5.1 6.4 1.5 4.4 3.7 0.4 8.0 3.5 2.8 7.3 4.8 4.5 0.5 4.6 2.4 7.9 3.6 3.4 4.8 3.1 7.4 8.3 0.3 0.4 5.4 16.2 5.7 23.0 0.0 0.0 0.2 0.4 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 24.2 0.0 10.2 0.0 35.6 27.6 54.3 0.0 7.7 0.0 13.1 53.5 16.6 4.0 26.8 0.0 3.8 40.4 0.5 0.1 0.0 0.4 5.9 24.1 47.8 5.4 0.0 5.8 9.3 12.5 0.0 0.1 21.3 0.1 87.9 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.1 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 8.7 0.2 0.1 0.1 0.0 0.2 0.2 11.5 0.4 16.2 7.4 12.6 10.8 1.5 4.7 6.0 7.7 0.3 5.4 0.0 8.3 13.0 5.7 5.3 7.1 3.5 11.6 6.9 5.7 7.0 2.7 14.6 4.6 0.0 1.1 0.8 1.6 23.7 0.6 0.4 0.0 1.4 0.0 5.2 17.7 0.1 0.0 4.9 0.4 3.1 2.3 23.3 67.4 0.4 5.6 0.9 4.6 0.4 2.5 0.0 0.0 0.0 0.0 0.7 2.3 1.1 8.5 2.8 12.3 0.0 93.7 3.5 1.1 0.0 0.2 0.0 1.0 0.0 0.0 7.4 0.0 8.5 19.1 0.9 SLC38A7 FLJ10815 ENSG00000103042 "Solute carrier family 38 member 7" Q9NVC3 16 58665109-58685104 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 273.8;Late spermatids: 600.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041777 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041777: AB_10796782" "unprognostic (2.16e-3)" "unprognostic (2.30e-2)" "unprognostic (6.23e-3)" "prognostic favorable (6.87e-4)" "unprognostic (3.49e-1)" "unprognostic (8.08e-3)" "unprognostic (9.76e-3)" "unprognostic (6.34e-3)" "unprognostic (1.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.77e-1)" "unprognostic (4.90e-2)" "prognostic favorable (2.87e-4)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (7.50e-2)" "unprognostic (4.93e-3)" 7.0 11.1 10.6 6.7 10.0 2.7 7.2 7.7 13.7 6.2 5.3 10.6 6.8 4.8 6.0 7.4 6.0 4.2 6.5 13.8 7.2 7.2 7.4 12.1 5.2 4.3 6.1 11.0 4.7 5.0 16.9 10.2 8.4 8.3 5.2 6.9 8.9 6.1 5.6 9.6 5.3 4.9 8.5 5.8 10.3 5.4 27.1 6.6 4.2 8.0 8.1 5.1 6.5 6.3 2.8 6.1 2.5 8.6 2.3 5.2 6.6 4.4 7.0 6.9 10.6 14.4 8.7 13.0 10.5 12.2 14.8 10.3 6.5 6.9 2.8 6.0 14.6 11.9 10.8 6.6 7.3 8.8 1.8 6.0 3.2 5.8 10.5 21.9 6.6 9.2 17.4 15.4 10.3 6.8 8.0 15.1 6.7 9.4 4.3 10.7 5.3 2.6 3.9 7.5 4.7 10.4 9.6 7.5 7.6 6.5 10.2 5.1 7.7 15.8 10.8 4.6 9.7 5.1 2.8 11.8 8.1 6.2 14.0 3.1 6.3 4.1 3.2 11.0 4.0 6.0 0.2 8.6 2.5 5.2 8.4 3.1 1.9 3.3 3.8 6.1 2.8 2.7 2.9 0.8 2.3 7.5 2.1 2.2 6.6 10.6 10.0 7.7 13.7 7.2 7.2 6.1 11.0 8.3 6.6 3.0 4.1 0.5 3.9 3.4 9.7 11.2 2.5 4.0 3.4 10.4 11.8 7.3 3.3 12.6 273.8 4.7 3.9 0.0 7.4 7.9 5.7 3.0 1.1 8.5 31.3 15.9 12.6 8.6 8.6 600.3 8.9 7.1 8.5 2.8 3.6 8.0 10.5 3.5 8.1 4.6 7.1 6.5 5.1 6.2 6.1 3.8 12.8 1.8 5.1 2.7 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.0;thyroid gland: 39.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 6.6 10.9 16.0 6.0 24.8 3.7 6.2 10.8 41.0 9.8 3.8 4.2 4.9 3.6 9.4 3.3 3.5 8.5 7.6 4.7 15.0 11.2 7.8 2.1 6.3 6.5 8.5 24.4 7.4 5.7 5.8 5.7 10.7 15.7 16.7 4.0 1.4 4.8 6.5 3.3 5.7 5.7 6.7 10.2 14.4 4.3 7.9 6.2 10.6 39.9 1.7 6.4 6.1 4.9 9.4 18.4 19.3 2.7 11.0 4.6 1.5 2.9 9.9 18.9 5.2 3.7 8.8 9.8 13.7 6.7 6.6 3.3 14.8 10.6 4.1 20.9 7.8 5.1 4.2 11.5 12.6 8.4 2.1 8.6 4.6 15.4 12.1 4.1 16.8 1.9 5.2 1.8 7.3 8.4 23.4 14.8 4.2 13.3 5.8 10.6 2.8 4.8 5.2 22.0 17.2 7.8 11.3 6.6 10.2 28.8 4.9 7.3 10.0 13.7 28.0 7.2 34.5 4.5 10.5 14.5 12.1 14.0 7.9 7.1 2.0 1.2 2.4 9.7 7.9 12.2 19.3 2.7 1.9 4.5 2.5 3.5 6.8 4.0 3.7 3.3 9.4 3.5 4.6 0.5 11.0 1.8 18.4 3.9 1.5 16.0 24.8 10.8 39.7 15.0 11.2 8.5 24.4 15.7 6.2 3.0 10.9 18.2 9.3 22.8 21.9 7.3 7.6 6.7 29.6 34.9 7.9 41.3 1.7 17.6 23.2 27.0 2.9 23.3 9.5 54.8 20.3 18.5 12.7 2.5 21.6 7.9 15.0 24.5 18.1 11.5 17.5 29.7 6.8 8.2 5.1 15.6 17.5 2.9 17.7 14.9 19.9 12.9 13.8 47.8 27.0 17.9 19.6 21.5 4.5 6.4 SLC39A6 LIV-1 ENSG00000141424 "Solute carrier family 39 member 6" Q13433 18 36108532-36129385 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 212.3" "Cancer enhanced" "Detected in all" "breast cancer: 361.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042377 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA042377: AB_2677968" "unprognostic (7.60e-2)" "unprognostic (2.27e-2)" "unprognostic (5.50e-3)" "unprognostic (2.58e-3)" "unprognostic (1.02e-1)" "unprognostic (4.87e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.19e-1)" "unprognostic (4.50e-2)" "unprognostic (7.63e-3)" "unprognostic (2.16e-1)" "unprognostic (4.74e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" 11.1 12.6 14.3 8.6 13.4 4.3 63.5 19.4 14.7 15.7 8.7 16.0 68.7 4.1 24.7 24.5 9.8 27.7 10.3 8.2 14.2 17.5 12.3 7.7 7.9 8.2 18.3 8.7 30.5 15.5 32.1 23.9 52.5 16.0 55.2 5.9 25.1 15.5 51.5 7.7 22.6 5.7 12.7 21.7 11.2 8.1 9.9 13.5 8.0 15.7 10.7 11.3 23.8 20.2 12.6 25.2 22.2 14.6 12.9 15.6 9.7 10.4 13.2 31.7 18.6 33.5 24.8 8.3 28.5 33.8 19.1 22.5 7.3 11.6 11.3 14.4 27.4 13.3 25.5 27.6 26.7 29.1 25.1 10.0 4.9 18.6 10.6 21.3 16.5 12.4 22.6 59.1 29.0 25.3 17.6 2.8 9.4 2.5 22.8 26.8 16.0 16.2 3.7 7.6 5.7 7.5 16.8 18.1 14.8 21.3 35.2 33.4 29.4 35.1 10.3 48.1 13.6 14.0 7.8 4.6 46.7 7.8 8.8 14.3 21.5 20.8 8.6 16.1 11.7 24.5 19.5 9.8 22.2 13.0 14.6 15.6 12.6 11.1 11.5 12.2 12.3 9.8 14.2 7.5 12.9 13.7 25.2 12.2 9.7 14.3 13.4 19.4 12.4 14.2 17.5 18.3 8.7 16.0 13.5 35.7 16.0 13.7 44.4 40.8 40.2 16.6 10.2 42.8 60.3 40.1 31.4 5.4 1.7 46.8 16.8 10.8 2.8 0.0 32.7 50.5 40.3 212.3 23.1 7.9 18.4 22.3 24.5 7.4 15.6 14.6 34.5 25.1 64.1 24.4 6.7 35.8 34.0 0.0 44.9 13.9 25.8 38.8 37.6 43.4 22.9 65.1 19.9 16.0 4.1 55.4 SLC40A1 "FPN1, HFE4, IREG1, MTP1, SLC11A3" ENSG00000138449 "Solute carrier family 40 member 1" Q9NP59 2 189560579-189583758 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 126.4;lymphoid tissue: 170.2" "Group enriched" "Detected in many" 5 "Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065634 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA065634: AB_2685524" "unprognostic (1.28e-2)" "unprognostic (1.73e-2)" "unprognostic (9.41e-2)" "unprognostic (1.83e-2)" "unprognostic (8.00e-3)" "unprognostic (1.36e-2)" "unprognostic (1.66e-1)" "unprognostic (6.22e-2)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "unprognostic (6.43e-2)" "unprognostic (6.44e-2)" "prognostic favorable (8.55e-5)" "unprognostic (4.66e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.11e-2)" 18.2 126.4 3.9 10.1 5.5 3.9 47.4 1.8 3.5 20.0 25.7 3.7 13.9 34.4 24.7 24.3 6.3 25.9 25.2 37.1 4.1 4.3 14.4 42.1 45.9 170.2 5.1 1.9 50.9 24.0 4.6 9.8 51.3 6.4 18.4 15.8 11.6 10.2 16.6 12.3 4.9 44.7 13.6 5.8 76.4 11.3 16.2 3.5 17.0 20.8 6.4 8.8 11.1 20.4 0.1 22.7 64.7 20.8 0.8 17.3 20.1 0.0 1.3 0.1 0.0 93.2 0.6 4.5 0.0 1.1 0.3 0.5 21.3 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.3 75.5 0.3 7.8 0.3 0.2 19.9 6.5 0.0 0.2 0.0 2.1 2.2 2.9 7.7 0.2 1.1 0.0 3.1 4.9 0.2 16.0 0.3 0.0 0.8 0.4 0.9 3.1 0.1 0.9 0.1 6.2 0.0 7.4 36.8 1.1 0.0 0.1 2.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 20.8 32.9 0.4 4.7 0.6 0.0 11.3 1.0 22.7 0.1 17.3 3.7 64.7 0.8 0.4 3.7 1.0 20.1 3.9 5.5 1.8 3.5 4.1 4.3 5.1 1.9 6.4 3.5 116.1 32.3 28.1 45.3 8.1 3.7 37.5 142.7 53.5 39.8 31.4 3.9 335.3 41.4 23.9 6.9 30.8 119.4 70.0 64.9 10.7 46.3 32.2 9.2 223.5 72.3 6.4 17.9 211.8 1044.2 4.7 112.2 26.2 8.5 1.8 50.3 9.6 51.2 77.2 55.2 100.1 43.2 64.7 18.1 5.0 0.9 7.0 2060.1 8.4 30.8 19.7 SLC44A5 "CTL5, MGC34032" ENSG00000137968 "Solute carrier family 44 member 5" Q8NCS7 1 75202131-75611116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.6" "Group enriched" "Detected in some" 7 "Early spermatids: 63.4;Late spermatids: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 7.2;RPTEC TERT1: 7.1;SH-SY5Y: 11.1;SuSa: 11.8;TIME: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047455, HPA051011" Uncertain Approved Cytosol NA NA Cytosol "HPA047455: AB_2680054, HPA051011: AB_2681309" "unprognostic (9.00e-2)" "unprognostic (1.91e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-3)" "unprognostic (4.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (5.78e-3)" "unprognostic (6.41e-2)" "unprognostic (9.19e-2)" "prognostic unfavorable (6.52e-4)" "unprognostic (1.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" "unprognostic (4.30e-1)" 1.0 0.4 2.4 1.0 1.5 0.0 6.3 1.0 3.6 1.0 1.8 1.0 1.0 0.9 1.0 1.0 7.7 3.7 1.0 2.2 2.8 2.8 2.0 1.0 1.0 1.0 2.3 1.0 1.0 1.8 5.6 3.7 3.8 1.0 1.0 2.9 1.0 1.6 1.0 1.5 11.3 1.0 1.0 1.0 1.0 1.3 32.6 1.0 1.0 1.0 1.0 1.8 2.2 1.9 3.2 0.3 0.6 0.3 0.5 1.1 0.3 0.2 0.2 4.5 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.2 0.0 0.0 2.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.5 0.6 1.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.8 0.4 2.4 2.6 0.0 0.0 1.7 0.0 4.5 2.9 0.6 0.0 0.0 2.1 7.1 4.8 1.0 11.1 0.0 4.6 0.0 11.8 0.2 0.0 13.7 0.4 1.2 0.0 1.4 2.0 1.9 3.0 0.2 0.0 0.7 0.4 0.3 0.2 0.4 0.1 0.9 3.2 0.8 1.1 0.1 2.4 0.6 0.4 0.6 0.5 0.2 0.3 0.6 0.3 2.4 1.5 1.0 3.4 2.8 2.8 2.3 1.0 1.0 1.0 0.0 0.6 0.0 0.6 1.6 3.7 0.6 0.0 2.7 1.2 0.0 0.0 6.8 0.0 0.1 63.4 0.4 0.4 0.0 0.8 3.2 0.2 0.8 0.0 0.0 1.0 0.0 2.4 3.1 0.0 27.3 0.9 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.2 5.8 3.2 0.0 0.2 3.1 SLC46A1 "HCP1, MGC9564, PCFT" ENSG00000076351 "Solute carrier family 46 member 1" Q96NT5 17 28394756-28407197 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.7" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 25.6;Hepatocytes: 24.9;Hofbauer cells: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "CACO-2: 67.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011614 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB011614: AB_2270597" "unprognostic (1.10e-1)" "unprognostic (8.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.59e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (9.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.36e-2)" "unprognostic (1.94e-1)" "unprognostic (3.80e-2)" "unprognostic (1.04e-3)" "unprognostic (6.15e-2)" "unprognostic (2.10e-3)" "unprognostic (2.16e-1)" "unprognostic (2.94e-1)" "unprognostic (2.15e-1)" "unprognostic (1.04e-1)" 3.1 17.8 4.6 2.5 7.0 1.3 5.1 13.2 5.2 2.9 43.8 5.2 9.4 45.4 2.2 4.5 1.8 6.7 3.0 2.2 4.4 6.0 3.8 17.9 3.2 4.9 4.0 4.0 4.4 5.0 8.1 7.8 5.0 5.0 3.7 2.7 6.1 5.7 5.8 2.0 2.0 52.7 2.6 4.6 4.9 2.3 2.2 4.2 2.2 4.0 0.4 1.2 2.4 2.4 2.7 2.6 7.1 5.9 2.9 1.7 0.8 1.7 7.4 2.5 4.1 2.0 0.4 7.8 2.1 1.5 1.7 2.0 67.6 2.1 0.2 1.2 1.1 5.0 5.8 2.8 4.7 1.5 4.3 6.6 0.0 4.6 5.7 0.7 0.0 3.4 1.0 8.7 1.8 5.4 2.4 0.1 0.6 2.8 0.4 0.3 2.3 0.0 0.2 1.5 1.7 1.0 0.1 2.0 0.8 1.3 3.9 6.6 3.5 14.5 6.8 0.9 3.6 5.3 1.1 0.2 0.2 3.0 0.4 2.2 3.1 3.5 0.1 0.4 0.4 1.6 7.1 1.6 1.1 0.8 5.9 1.4 2.7 0.9 0.7 2.6 1.7 1.0 1.7 2.3 2.9 4.3 1.1 1.6 0.8 4.6 7.0 13.2 5.2 4.4 6.0 4.0 4.0 5.0 4.2 11.9 4.0 3.2 1.9 0.3 25.6 1.8 15.3 4.0 1.2 7.0 3.9 16.6 0.0 2.8 3.4 1.0 1.3 0.0 3.9 7.3 3.1 2.2 1.1 24.9 21.1 19.1 1.2 2.5 13.0 13.5 3.7 3.9 0.0 1.0 2.1 1.6 3.5 0.9 3.2 4.1 5.6 6.5 1.0 0.0 0.2 0.3 3.7 0.0 1.2 1.4 SLC46A3 "DKFZp686A1775, FLJ42613" ENSG00000139508 "Solute carrier family 46 member 3" Q7Z3Q1 13 28700064-28718970 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 62.9;liver: 50.0" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 58.8;Hepatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 20.5;T-47d: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039930 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039930: AB_10673263" "unprognostic (5.16e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" "unprognostic (3.88e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "prognostic favorable (7.09e-4)" "unprognostic (3.13e-1)" "unprognostic (3.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.69e-2)" "unprognostic (7.35e-2)" "unprognostic (1.14e-1)" "unprognostic (5.60e-2)" "unprognostic (9.14e-3)" "unprognostic (6.47e-3)" 6.9 14.2 3.8 5.9 5.7 1.4 6.4 7.6 6.5 8.3 19.6 6.9 2.8 24.0 5.2 7.4 3.1 4.1 12.7 8.1 4.2 4.2 10.4 50.0 6.0 11.4 4.7 3.9 5.0 5.5 4.2 18.2 5.0 6.6 5.3 10.1 17.4 10.3 5.6 8.2 4.0 62.9 4.5 5.1 11.6 4.8 9.3 3.7 11.8 6.8 3.0 6.9 6.1 4.7 9.1 10.4 22.6 15.9 5.6 11.2 7.4 0.0 2.0 0.0 5.5 4.5 1.8 0.1 2.0 11.1 2.2 3.2 0.1 4.7 3.8 3.7 2.8 8.4 0.4 2.5 1.0 3.3 2.8 4.9 2.5 0.0 0.0 8.4 0.0 3.3 7.2 2.1 3.3 5.4 2.2 4.0 11.3 2.7 0.0 10.5 2.0 6.2 0.4 0.2 5.6 1.7 2.6 9.9 0.1 20.5 0.6 0.9 0.3 0.0 10.2 4.0 2.4 15.0 3.3 1.5 1.1 2.1 0.3 11.7 3.1 1.5 0.5 0.6 0.0 2.0 22.6 8.0 3.0 9.8 11.5 8.4 6.6 7.9 9.6 10.4 9.1 11.2 10.6 8.2 5.6 15.9 9.7 9.2 7.4 3.8 5.7 7.6 6.5 4.2 4.2 4.7 3.9 6.6 3.7 0.0 4.8 5.1 0.0 1.6 22.0 7.7 17.8 10.7 1.2 8.7 7.9 0.5 1.7 11.8 3.0 8.9 58.8 0.0 4.9 0.2 5.4 0.6 24.4 50.6 9.7 20.6 3.5 19.6 25.4 1.7 1.4 14.5 6.8 4.6 7.0 14.1 3.8 5.8 2.1 8.4 9.5 0.0 2.8 2.3 0.5 1.5 0.6 10.0 10.0 0.1 SLC4A2 "AE2, BND3L, EPB3L1, HKB3, NBND3" ENSG00000164889 "Solute carrier family 4 member 2" P04920 7 151057210-151076527 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.2;retina: 100.7" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 76.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 73.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA019339 Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Plasma membrane" Cytosol "HPA019339: AB_1844825" "unprognostic (1.19e-1)" "unprognostic (3.33e-3)" "unprognostic (8.12e-3)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.04e-6)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (3.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.26e-4)" "unprognostic (4.67e-3)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.36e-2)" 9.9 13.5 4.7 10.4 7.4 6.7 10.5 3.0 8.6 12.4 18.6 29.0 6.0 12.1 16.2 6.3 7.7 10.8 14.1 11.9 10.1 3.8 35.5 94.2 12.3 7.2 10.4 4.8 12.6 34.1 30.6 5.3 31.4 73.3 10.5 4.0 100.7 11.9 8.3 8.7 9.5 26.0 10.7 10.4 10.1 27.1 6.5 8.5 8.8 9.7 7.0 5.9 11.7 10.6 2.5 5.6 2.1 4.2 0.5 2.7 1.9 15.9 52.8 10.4 21.4 10.4 6.1 23.8 19.4 10.5 15.9 13.8 30.0 25.6 9.6 42.6 9.2 23.4 15.7 10.6 9.4 2.9 27.6 15.8 12.6 25.7 15.2 17.0 6.5 40.6 8.9 8.3 18.0 4.6 17.1 8.8 13.6 38.9 8.1 12.3 30.6 18.6 11.2 24.7 21.5 19.6 14.7 5.7 11.2 13.0 12.1 8.6 31.2 17.7 33.5 16.5 8.2 13.8 12.8 19.0 21.4 10.9 21.0 28.5 8.8 11.8 5.4 32.7 16.3 42.9 0.0 4.2 2.1 2.7 3.9 1.9 2.5 2.1 1.8 2.4 1.0 2.4 2.4 1.0 0.5 2.5 5.6 1.0 1.9 4.7 7.4 3.0 8.6 10.1 3.8 10.4 4.8 73.3 8.5 8.9 10.9 6.7 4.5 9.8 7.9 3.6 17.8 1.4 2.3 19.2 23.6 28.5 14.9 31.0 0.6 9.8 17.3 0.0 30.9 9.0 16.2 5.0 48.3 31.4 23.1 14.3 26.5 14.7 15.1 1.3 12.7 9.9 25.3 9.0 11.1 22.3 39.3 14.0 18.7 18.9 8.8 12.9 15.5 3.2 7.7 6.0 76.5 8.3 18.9 3.1 SLC4A7 "NBC3, SBC2, SLC4A6" ENSG00000033867 "Solute carrier family 4 member 7" Q9Y6M7 3 27372721-27484420 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 48.5" "Group enriched" "Detected in many" 10 "Cone photoreceptor cells: 691.1;Rod photoreceptor cells: 667.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 38.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022494, HPA035857" Enhanced Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Plasma membrane" "Focal adhesion sites, Cytosol" "CAB022494: , HPA035857: AB_10795135" "unprognostic (2.94e-2)" "unprognostic (6.34e-2)" "unprognostic (1.80e-3)" "unprognostic (1.91e-1)" "unprognostic (8.48e-3)" "unprognostic (2.68e-1)" "unprognostic (6.79e-4)" "unprognostic (4.13e-2)" "unprognostic (1.40e-1)" "unprognostic (1.64e-1)" "unprognostic (1.83e-1)" "unprognostic (8.58e-3)" "prognostic unfavorable (7.91e-6)" "unprognostic (1.09e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-1)" "unprognostic (7.26e-2)" 14.5 5.0 3.2 10.5 4.6 3.3 17.0 4.0 4.8 10.8 38.2 5.0 8.8 48.5 8.1 12.6 8.4 6.5 12.5 9.3 5.0 3.8 15.3 3.7 9.3 10.3 4.8 1.9 9.0 3.3 2.4 4.4 5.6 4.5 10.3 6.9 20.0 8.3 8.4 5.6 5.6 43.4 18.2 5.8 9.7 7.8 6.1 5.5 6.8 6.3 14.7 15.5 15.0 14.9 1.8 2.0 0.1 0.9 2.4 3.9 0.7 5.9 11.1 10.0 4.6 4.7 8.4 7.1 20.2 9.4 7.8 6.1 3.0 3.1 13.5 1.7 7.8 7.5 2.6 9.5 9.8 12.4 11.4 3.1 6.2 7.6 3.2 8.1 14.0 5.4 6.7 4.3 11.8 38.2 16.5 12.8 8.9 4.1 4.8 16.0 2.1 13.9 3.2 6.6 0.7 11.0 9.5 7.9 2.7 18.3 4.2 2.5 6.3 9.2 6.8 3.1 8.9 15.5 5.4 8.9 18.4 5.1 12.7 15.6 1.8 1.9 7.7 16.1 9.9 8.4 0.0 0.5 0.0 3.0 0.6 2.0 1.2 3.8 3.9 1.4 1.8 1.5 2.7 0.1 2.4 0.9 2.0 3.2 0.7 3.2 4.6 4.0 4.8 5.0 3.8 4.8 1.9 4.5 5.5 0.0 12.8 13.2 28.2 26.1 65.7 18.7 15.3 5.3 25.0 59.3 691.1 4.5 8.3 13.6 6.7 25.3 5.8 0.0 6.2 23.0 30.2 41.3 23.1 5.9 16.9 6.4 36.7 14.7 33.1 5.9 8.3 36.7 33.7 20.8 50.6 45.2 13.6 12.7 9.2 10.5 667.4 38.8 32.8 32.4 21.7 26.8 6.8 33.0 12.2 33.6 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043032-32113029 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 274.9" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "OE19: 27.0" "Region enriched" "Detected in single" 26 "cerebellum: 8.6" "Not detected" "Not detected" "CAB015467, HPA051805, HPA055106" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Nuclear membrane, Cytosol" "CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favorable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.2 0.0 0.2 1.3 0.2 0.0 1.5 0.2 0.2 2.2 181.5 0.2 2.9 95.5 0.3 0.8 1.9 0.0 14.1 24.5 0.2 0.0 1.0 0.9 0.3 0.2 0.2 0.2 0.2 0.4 0.0 1.0 0.2 0.2 0.8 1.6 0.2 5.7 3.5 0.2 4.6 274.9 0.2 0.2 0.7 1.2 0.8 0.2 0.2 0.2 3.5 1.5 0.2 2.0 0.3 0.1 0.6 0.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 27.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 1.8 0.6 0.0 111.5 117.2 0.0 4.5 0.0 0.0 0.0 0.0 2.4 40.8 0.0 26.1 0.0 1.2 0.0 0.2 19.7 0.0 0.0 0.0 0.0 24.5 0.0 0.0 54.9 1.1 0.0 0.0 0.0 8.7 0.0 0.6 14.7 1.4 1.9 0.0 0.0 0.0 4.2 0.5 4.8 0.0 0.0 19.6 4.8 SLC5A11 "KST1, SGLT6, SMIT2" ENSG00000158865 "Solute carrier family 5 member 11" Q8WWX8 16 24845841-24911628 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.0;intestine: 21.8" "Group enriched" "Detected in some" 4 "Enterocytes: 1.7;Paneth cells: 2.9;Proximal tubular cells: 5.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 18.9;Karpas-707: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035331 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035331: AB_10601489" "unprognostic (2.57e-1)" "unprognostic (7.90e-3)" "unprognostic (1.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.90e-2)" "unprognostic (8.08e-2)" "unprognostic (2.85e-1)" "unprognostic (2.85e-3)" "unprognostic (6.68e-2)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (1.45e-3)" 0.6 0.6 4.3 0.6 21.8 0.5 2.8 1.9 11.2 0.6 1.7 29.7 0.0 10.9 0.6 0.5 0.5 0.6 1.4 0.7 12.1 7.4 9.9 1.0 0.6 0.7 48.0 2.4 0.6 0.5 0.5 0.2 0.5 18.3 0.6 0.8 0.0 0.6 0.8 0.7 0.5 21.8 0.5 34.7 0.6 0.6 0.8 22.9 0.0 0.6 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.3 21.8 1.9 8.0 12.1 7.4 48.0 2.4 18.3 22.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 5.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 SLC5A9 SGLT4 ENSG00000117834 "Solute carrier family 5 member 9" Q2M3M2 1 48222685-48248644 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 77.3" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 20.8;Early spermatids: 5.8;granulocytes: 4.6;Late spermatids: 7.9" "Cancer enhanced" "Detected in many" "liver cancer: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA050263 Approved "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA050263: " "unprognostic (3.09e-3)" "unprognostic (1.89e-1)" "unprognostic (6.75e-2)" "unprognostic (5.66e-2)" "unprognostic (2.36e-1)" "unprognostic (1.35e-3)" "unprognostic (3.64e-2)" "unprognostic (4.59e-2)" "unprognostic (3.60e-2)" "unprognostic (1.59e-1)" "unprognostic (7.42e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (4.56e-1)" "unprognostic (2.11e-1)" "unprognostic (4.30e-3)" "unprognostic (1.06e-2)" 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 33.0 0.1 0.8 26.0 0.1 7.2 0.1 0.2 2.2 0.1 0.0 0.0 3.1 4.9 2.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 1.0 77.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 1.0 0.0 0.0 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 1.7 0.4 5.8 0.0 0.7 0.0 0.2 0.0 0.0 0.1 4.6 4.5 0.1 0.0 0.0 0.0 1.2 7.9 0.3 0.0 0.0 0.0 0.6 0.0 0.1 1.1 0.4 3.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 261.2" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 10.0;SuSa: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: AB_2675130, HPA052726: AB_2681927" "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 10.0 0.1 0.1 0.0 0.1 0.0 0.9 3.7 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 0.0 1.1 0.5 0.0 0.0 0.2 1.3 0.0 1.4 0.0 17.4 2.0 0.0 41.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.7 0.0 0.0 0.0 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.2 0.8 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.0 0.0 SLC6A2 "NAT1, NET, NET1, SLC6A5" ENSG00000103546 "Solute carrier family 6 member 2" P23975 16 55655604-55706192 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.4;placenta: 41.8" "Group enriched" "Detected in some" 5 "Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Region enriched" "Detected in single" 27 "pons and medulla: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "SH-SY5Y: 107.1" "Region enriched" "Detected in some" 4 "pons and medulla: 8.2" "Region enriched" "Detected in single" 32 "pons and medulla: 23.1" "HPA004057, HPA076311, CAB078195" Enhanced Supported Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307" "unprognostic (9.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.26e-4)" "unprognostic (4.07e-1)" "unprognostic (4.16e-1)" "unprognostic (8.38e-2)" "unprognostic (2.97e-2)" "unprognostic (3.29e-1)" "unprognostic (2.31e-1)" "unprognostic (3.27e-1)" "unprognostic (2.12e-2)" "unprognostic (2.95e-2)" "unprognostic (1.72e-1)" "unprognostic (6.02e-2)" "unprognostic (8.48e-2)" "unprognostic (1.43e-2)" 2.4 20.4 0.3 0.1 0.1 0.0 1.8 0.1 0.3 3.2 0.3 0.3 0.1 0.0 4.5 7.2 0.8 0.4 0.4 0.1 0.1 0.0 0.4 1.0 0.5 0.1 0.1 0.1 0.2 0.1 0.0 0.1 41.8 9.7 0.5 0.1 0.1 1.6 1.7 0.1 11.4 0.4 1.0 0.2 0.1 0.2 8.3 0.2 0.1 0.2 0.9 0.5 0.5 1.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 107.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.0 0.1 0.1 9.7 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 6.9 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.4 4.7 0.0 0.0 0.0 SLC6A6 TAUT ENSG00000131389 "Solute carrier family 6 member 6" P31641 3 14402576-14489349 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 76.4" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 502.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 33.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.2" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 45.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015028, HPA016488" Enhanced Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA015028: AB_1857200, HPA016488: AB_1857202" "unprognostic (8.25e-2)" "unprognostic (7.29e-3)" "unprognostic (2.63e-2)" "prognostic favorable (5.22e-5)" "prognostic unfavorable (5.75e-8)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.58e-1)" "unprognostic (2.56e-1)" "unprognostic (3.81e-1)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-2)" "unprognostic (9.65e-2)" "unprognostic (1.90e-1)" 10.2 25.9 5.7 18.0 16.5 46.4 8.1 11.1 12.2 11.3 9.5 8.7 3.6 8.5 14.5 4.4 7.0 7.0 14.5 23.2 5.6 4.6 16.6 2.3 18.6 12.9 18.0 7.6 31.3 2.8 3.8 9.6 18.0 13.3 5.0 4.1 76.4 15.7 7.7 26.6 16.8 22.2 8.2 11.1 20.3 14.0 4.0 12.6 6.2 10.4 11.3 11.2 8.8 6.1 1.6 1.9 33.2 6.9 0.7 3.9 2.3 4.6 17.3 6.2 4.7 8.1 2.5 12.8 7.0 27.8 8.3 6.1 6.3 8.0 13.5 6.4 11.0 12.0 3.7 4.2 5.7 7.4 1.5 5.2 12.8 22.7 9.4 0.2 3.5 27.8 1.3 1.7 7.6 2.0 7.2 9.0 6.3 7.1 2.7 7.3 4.9 9.8 6.8 9.6 6.5 5.0 7.0 7.4 21.1 45.5 9.7 11.5 4.1 5.2 2.8 1.5 24.4 10.7 1.9 22.7 10.6 5.7 2.6 5.0 3.0 3.4 5.0 24.7 6.9 32.4 2.5 5.1 5.0 1.3 4.2 0.7 1.6 1.4 1.7 1.9 0.9 0.2 0.3 33.2 0.7 6.9 0.7 3.9 2.3 5.7 16.5 11.1 12.2 5.6 4.6 18.0 7.6 13.3 12.6 6.0 22.1 4.7 11.2 43.8 102.1 3.6 2.5 12.0 12.5 19.2 538.0 2.2 0.0 9.6 17.0 16.1 0.7 0.0 7.1 12.8 16.4 5.5 12.7 0.4 26.7 9.5 13.8 11.6 62.5 13.3 16.1 47.4 16.9 129.0 2.9 28.2 21.5 2.9 16.3 26.3 502.9 0.0 8.2 0.5 1.5 20.8 4.2 22.4 1.2 10.6 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459584-170586074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.4;pituitary gland: 14.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 31.5;Horizontal cells: 27.0" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: AB_2679501" "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 1.1 5.8 12.1 1.9 17.7 1.4 1.1 14.9 33.4 1.0 1.8 8.0 0.0 1.6 1.1 1.2 1.1 1.1 1.3 1.1 11.5 12.1 1.3 1.2 1.1 1.1 6.7 12.8 1.3 2.4 1.1 14.5 1.1 11.8 1.2 1.9 0.1 1.1 1.1 1.2 1.3 1.7 1.3 9.0 1.1 1.5 1.3 6.3 0.0 1.1 0.0 1.1 1.1 0.3 1.0 0.6 2.1 0.5 0.7 0.6 0.1 0.0 0.0 0.4 0.1 1.3 2.0 0.1 0.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 1.8 0.0 0.1 1.3 0.8 0.2 0.1 0.0 0.2 7.2 0.0 0.0 0.2 1.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 7.2 2.1 0.0 0.1 0.0 0.3 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 2.1 0.5 0.5 0.4 0.3 0.3 0.8 0.3 0.3 0.1 1.0 0.6 0.5 1.2 0.7 0.3 0.6 0.3 0.1 12.1 17.7 14.9 16.9 11.5 12.1 6.7 12.8 11.8 6.3 3.0 2.1 0.0 0.3 0.3 31.5 0.8 0.0 5.3 4.5 0.0 2.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.2 2.3 1.0 0.0 27.0 1.7 0.0 0.0 0.4 2.0 0.9 3.3 0.0 0.0 1.8 0.1 0.0 2.5 0.0 3.9 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 SLC7A5 "CD98, D16S469E, E16, LAT1, MPE16" ENSG00000103257 "Solute carrier family 7 member 5" Q01650 16 87830023-87869488 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 71.2" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;granulocytes: 68.9;Intestinal endocrine cells: 82.6;Smooth muscle cells: 85.8;Syncytiotrophoblasts: 89.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 15.9" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 108.7;hTCEpi: 186.8;MCF7: 101.2;SiHa: 153.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052673, HPA056077" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA052673: AB_2681909, HPA056077: AB_2683031" "unprognostic (2.71e-3)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (3.22e-2)" "unprognostic (2.99e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (6.86e-2)" "unprognostic (4.46e-2)" "unprognostic (1.27e-1)" "unprognostic (3.17e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.93e-2)" "unprognostic (5.52e-3)" "unprognostic (1.64e-2)" "unprognostic (7.19e-3)" 8.2 3.2 18.3 14.7 24.5 71.2 4.3 15.9 45.8 7.9 4.6 16.7 8.9 6.2 5.3 30.4 38.7 3.3 6.4 8.2 19.8 22.1 3.6 9.7 3.8 11.1 23.9 9.6 5.1 12.1 1.5 9.0 28.4 23.4 4.3 3.4 34.9 11.5 15.4 11.2 10.7 5.7 4.8 17.7 6.4 12.7 34.9 19.8 3.7 4.2 16.7 15.0 11.5 7.7 0.5 15.9 0.6 0.0 0.2 1.4 0.4 14.9 56.6 1.1 15.9 0.4 0.9 40.8 12.0 4.3 7.3 4.7 36.9 21.4 13.7 10.6 15.2 2.5 67.4 11.7 108.7 5.1 14.3 5.9 11.2 53.1 26.4 17.1 10.4 20.7 3.0 186.8 9.0 66.8 2.4 1.4 48.5 16.7 15.3 5.8 101.2 12.5 15.3 5.2 9.4 13.8 12.2 4.3 20.9 8.1 1.2 9.1 3.6 153.4 30.7 32.9 10.8 14.1 13.8 1.1 2.6 17.1 10.6 9.3 20.0 16.3 59.1 10.1 25.9 24.4 0.6 0.0 0.0 1.0 0.0 1.2 0.5 0.5 0.8 0.3 0.0 0.1 0.4 0.1 0.2 0.0 15.9 1.4 0.4 18.3 24.5 15.9 28.1 19.8 22.1 23.9 9.6 23.4 19.8 0.0 1.1 16.4 11.1 65.1 12.7 2.8 2.5 0.0 0.0 1.8 15.7 12.4 0.0 16.8 0.8 4.3 1.7 70.0 8.0 28.4 10.4 13.9 68.9 14.5 8.2 9.5 82.6 2.5 3.5 4.0 1.7 6.6 37.1 2.8 2.8 13.3 19.5 0.2 1.4 0.5 50.1 0.0 85.8 1.7 2.5 32.9 89.8 8.6 1.6 26.1 SLC7A6OS FLJ13291 ENSG00000103061 "Solute carrier family 7 member 6 opposite strand" Q96CW6 16 68284503-68310946 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041533 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041533: AB_10794298" "unprognostic (1.43e-1)" "unprognostic (2.02e-2)" "unprognostic (7.59e-2)" "unprognostic (3.09e-1)" "unprognostic (5.51e-2)" "unprognostic (4.62e-4)" "unprognostic (2.44e-4)" "unprognostic (2.05e-1)" "unprognostic (3.41e-1)" "unprognostic (2.38e-1)" "unprognostic (2.61e-2)" "unprognostic (3.03e-2)" "prognostic favorable (2.35e-4)" "unprognostic (1.84e-1)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" 19.8 14.1 15.7 16.1 20.0 20.1 17.4 29.1 18.2 13.2 13.1 20.2 10.9 13.9 15.5 18.0 12.4 13.4 10.7 16.5 14.6 11.7 13.4 9.3 13.8 24.7 19.8 14.2 17.0 14.7 18.8 13.1 15.9 18.1 13.4 13.4 14.2 14.1 15.0 24.5 15.5 16.3 12.3 17.4 20.3 13.7 12.2 24.5 17.0 15.7 8.7 19.8 14.0 21.6 13.3 11.2 21.8 13.3 12.7 14.9 10.6 8.1 8.4 12.3 9.2 7.2 9.9 14.1 10.3 6.0 12.3 10.9 21.2 11.8 14.3 9.5 6.9 7.8 14.8 11.5 8.8 11.2 5.3 7.0 9.5 13.3 17.4 9.3 13.4 10.4 7.6 9.8 10.1 16.4 11.0 9.2 12.4 14.6 6.4 11.2 12.2 17.3 13.6 8.8 9.4 7.2 20.5 7.6 17.5 7.8 10.8 13.0 9.5 19.8 4.6 11.6 10.0 12.4 12.4 13.5 9.9 8.5 9.6 8.2 15.9 12.8 21.3 10.2 16.2 10.1 21.5 11.4 21.8 13.4 13.3 14.9 13.1 13.4 12.0 8.7 13.3 14.5 11.4 10.3 12.7 10.8 11.2 13.3 10.6 15.7 20.0 29.1 18.2 14.6 11.7 19.8 14.2 18.1 24.5 8.9 4.6 16.6 10.7 8.1 22.0 0.8 12.7 14.7 6.8 12.2 33.4 19.6 14.9 11.0 2.5 10.8 7.4 0.0 9.8 9.6 8.7 9.1 13.9 5.8 18.3 15.9 13.3 11.6 16.3 1.3 14.7 10.8 11.8 21.6 7.5 26.5 13.1 7.0 15.2 6.9 22.8 0.0 9.5 12.5 18.9 5.8 18.4 20.2 8.8 12.3 SLC9A5 NHE5 ENSG00000135740 "Solute carrier family 9 member A5" Q14940 16 67237683-67272190 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;lymphoid tissue: 14.5" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041004, HPA041329" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA041004: AB_10794433, HPA041329: AB_10794373" "unprognostic (8.90e-2)" "unprognostic (9.70e-2)" "unprognostic (3.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (5.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-3)" "unprognostic (4.84e-2)" "unprognostic (9.85e-11)" "unprognostic (9.21e-2)" "unprognostic (1.95e-1)" "unprognostic (8.12e-3)" "unprognostic (9.07e-2)" 1.7 1.7 2.9 1.1 8.8 0.5 1.1 13.5 8.6 0.9 1.4 0.5 3.6 1.3 1.1 3.2 0.6 0.6 1.9 2.3 2.9 3.6 1.1 0.6 2.9 2.1 2.1 2.3 1.4 1.5 0.5 0.6 1.7 4.3 1.0 1.1 0.5 1.0 2.5 1.7 4.2 0.9 0.6 2.7 14.5 0.8 3.3 1.2 0.0 1.0 0.0 1.3 1.6 0.4 1.5 0.8 1.0 0.5 0.6 0.9 0.1 0.5 4.1 3.7 1.2 6.8 4.7 0.4 1.3 5.8 3.4 3.1 0.2 2.9 0.0 0.8 1.6 1.7 0.2 1.0 0.7 1.3 1.2 1.2 3.2 0.3 0.9 0.8 1.4 6.7 5.3 1.4 1.9 0.4 6.3 0.7 1.2 0.7 1.9 2.2 2.3 0.1 0.3 2.5 0.2 0.4 0.0 0.8 0.9 0.6 0.7 2.1 0.9 3.5 0.2 1.8 0.9 1.4 0.3 1.0 8.8 1.4 1.6 0.6 3.6 0.9 1.8 6.3 0.7 2.2 0.0 0.4 0.0 0.0 0.0 0.6 1.5 0.4 0.9 0.1 0.0 0.4 0.4 1.0 0.6 0.5 0.8 0.0 0.1 2.9 8.8 13.5 8.6 2.9 3.6 2.1 2.3 4.3 1.2 3.0 3.2 0.0 0.1 0.6 1.9 1.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.1 0.6 0.4 0.0 0.0 0.1 15.9 1.2 2.5 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.4 0.0 2.1 0.0 0.6 0.0 0.7 1.7 1.1 0.6 0.0 0.0 0.2 0.1 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296549 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 55.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 38.8;Proximal tubular cells: 28.3" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3" "Cell line enhanced" "Detected in some" "Karpas-707: 8.1;RPTEC TERT1: 45.9;U-937: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.4 0.3 0.7 0.7 5.4 0.3 0.2 1.8 0.3 1.9 0.0 5.2 1.4 0.2 0.6 0.3 0.3 1.6 1.1 0.3 0.4 55.9 5.2 11.0 0.2 0.3 1.0 0.3 0.9 0.0 0.7 0.1 0.2 0.4 0.5 0.0 3.2 11.8 0.3 0.6 2.1 0.0 0.3 1.6 0.4 1.3 0.0 1.5 1.0 0.3 0.1 0.7 1.1 0.1 0.4 10.0 1.1 2.6 4.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 45.9 0.0 0.3 0.2 0.0 0.1 0.0 1.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 11.6 0.0 7.9 1.1 7.5 4.3 0.0 0.4 0.0 0.7 2.3 0.4 0.1 0.2 1.5 10.0 2.6 0.0 0.3 0.0 1.0 0.3 0.7 0.2 1.8 0.3 0.4 0.3 1.0 0.2 0.0 6.0 38.8 0.0 0.1 0.0 0.0 0.3 0.0 4.0 6.8 5.2 0.0 0.0 1.7 0.2 8.3 0.0 1.2 0.0 0.7 0.0 0.0 0.0 5.7 5.5 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 28.3 0.0 0.0 0.0 1.7 0.7 0.0 0.0 2.2 1.2 0.3 SLFN11 FLJ34922 ENSG00000172716 "Schlafen family member 11" Q7Z7L1 17 35350305-35373701 "Predicted intracellular proteins" "Antiviral defense, DNA damage, Immunity" "Helicase, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Fibroblasts: 26.8;Hofbauer cells: 27.4;Kupffer cells: 33.5;Macrophages: 35.9;Smooth muscle cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 32.5" "HPA023030, HPA062062" Uncertain Supported Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA023030: AB_1856613, HPA062062: AB_2684673" "unprognostic (1.93e-2)" "unprognostic (2.56e-1)" "unprognostic (3.04e-2)" "unprognostic (1.03e-2)" "unprognostic (3.48e-3)" "unprognostic (1.01e-1)" "unprognostic (5.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (9.93e-10)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (6.33e-2)" "unprognostic (8.81e-3)" 20.9 5.3 5.4 10.3 10.0 6.0 24.1 3.2 5.2 15.5 7.3 4.8 10.3 3.0 12.2 24.6 8.1 15.0 9.9 12.6 6.6 2.8 5.5 3.5 20.4 10.4 6.9 2.2 21.3 4.4 2.1 5.0 5.4 8.9 7.8 6.1 8.9 8.3 9.6 6.0 4.1 10.1 10.3 6.7 17.5 6.1 4.2 7.3 18.3 19.0 4.6 12.9 10.9 17.7 3.1 13.0 1.4 18.3 2.0 6.0 5.2 8.1 7.3 0.0 0.0 7.5 21.7 0.1 10.1 7.3 17.5 30.7 0.0 0.0 0.0 0.1 13.2 5.5 4.0 22.7 0.0 21.3 4.6 27.2 17.7 0.0 0.0 9.9 22.8 0.0 8.8 0.2 19.5 0.0 0.0 28.6 13.5 0.0 0.0 2.9 0.0 32.5 18.5 0.1 0.0 0.0 27.6 21.4 0.0 0.2 3.9 0.0 0.0 0.0 3.8 0.0 0.0 6.0 16.5 14.8 4.8 0.1 18.1 15.1 0.7 0.2 0.0 3.6 19.9 10.3 0.4 11.8 1.4 4.3 18.3 6.0 3.1 2.7 3.9 9.2 1.3 2.1 2.9 1.3 2.0 11.4 13.0 3.9 5.2 5.4 10.0 3.2 5.2 6.6 2.8 6.9 2.2 8.9 7.3 0.0 6.9 9.1 0.7 6.6 0.0 2.5 0.0 16.0 3.4 1.8 0.0 0.7 0.0 0.0 1.2 16.1 0.0 0.0 0.5 0.6 26.8 1.1 3.5 0.0 27.4 0.0 0.0 10.4 33.5 1.1 9.5 35.9 11.8 1.0 0.0 0.1 0.1 0.2 2.8 0.0 0.0 6.5 27.9 0.0 0.0 7.4 0.7 20.3 0.0 0.6 SLFNL1 FLJ23878 ENSG00000171790 "Schlafen like 1" Q499Z3 1 41015597-41023237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 49.7" "Group enriched" "Detected in some" 83 "Early spermatids: 200.0;Late spermatids: 500.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054956 Approved Cytosol NA NA Cytosol "HPA054956: AB_2682649" "unprognostic (7.01e-3)" "unprognostic (1.62e-1)" "unprognostic (1.54e-3)" "unprognostic (4.35e-2)" "unprognostic (3.39e-1)" "unprognostic (4.11e-4)" "unprognostic (8.98e-3)" "unprognostic (1.02e-3)" "unprognostic (8.40e-3)" "unprognostic (1.50e-1)" "unprognostic (2.51e-1)" "unprognostic (3.71e-4)" "unprognostic (2.70e-3)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (3.26e-1)" "unprognostic (2.43e-1)" 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.3 0.2 0.4 0.2 0.2 0.2 0.5 2.6 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.8 1.9 0.2 0.2 0.2 0.6 0.3 0.1 0.3 0.2 0.2 0.6 0.0 0.2 3.4 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.1 49.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.4 1.3 0.0 0.0 0.7 0.0 1.0 1.6 0.7 1.1 0.0 0.3 4.9 2.1 0.1 0.0 0.1 10.2 1.0 1.8 1.8 0.1 0.3 1.8 0.1 0.0 0.0 1.3 3.0 1.3 2.4 1.3 0.7 1.9 1.2 0.2 0.2 0.1 0.0 0.5 0.2 1.5 1.1 2.2 0.1 0.9 1.1 2.0 1.9 0.2 2.6 2.5 1.3 1.1 0.0 2.8 1.3 0.6 0.4 0.9 0.8 0.9 0.6 1.2 0.8 2.0 2.4 1.0 1.5 1.1 0.6 2.3 0.3 2.2 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.4 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 3.2 0.0 0.1 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 200.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 500.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 4.2 2.4 0.1 0.0 0.0 0.0 0.0 SLK "KIAA0204, se20-9, STK2" ENSG00000065613 "STE20 like kinase" Q9H2G2 10 103967201-104029233 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 181.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015757 Approved Approved "Plasma membrane,Cytosol" NA NA 17000 "Plasma membrane, Cytosol" "HPA015757: AB_1857236" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (8.67e-2)" "unprognostic (6.85e-2)" "unprognostic (1.01e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.95e-1)" "prognostic favorable (3.95e-5)" "unprognostic (8.48e-2)" "unprognostic (3.95e-1)" "unprognostic (3.09e-2)" "unprognostic (1.07e-1)" 15.2 11.2 13.7 11.0 36.7 14.6 16.1 16.7 13.1 16.6 19.0 9.9 10.9 9.1 17.0 12.1 40.2 12.1 13.6 17.2 10.6 7.1 14.9 12.2 17.1 10.1 11.2 13.4 17.2 12.5 22.6 13.1 17.4 12.8 19.3 13.6 11.4 19.8 12.7 19.3 16.6 15.5 29.8 13.0 12.1 15.7 10.2 12.8 12.0 15.8 21.6 12.5 24.9 23.6 1.4 2.2 6.5 1.4 1.3 3.6 0.7 21.6 12.7 15.1 10.8 16.4 22.9 6.4 13.5 18.0 10.1 9.5 8.0 23.3 11.5 8.5 13.9 8.6 23.6 8.0 17.1 14.8 9.2 11.0 11.7 10.4 6.7 12.3 13.9 10.1 11.7 22.5 13.6 39.9 14.1 18.1 7.5 14.6 8.0 13.2 7.5 9.7 7.7 3.7 14.0 8.1 9.5 18.6 6.0 13.2 25.0 3.5 6.2 11.7 11.4 11.2 8.0 5.9 10.1 27.3 7.4 7.8 13.6 15.8 9.7 11.8 7.3 11.0 18.8 4.7 1.2 1.4 3.3 3.6 1.2 3.6 1.1 2.2 2.2 1.2 1.4 1.5 2.5 6.5 1.3 1.0 2.2 1.4 0.7 13.7 36.7 16.7 13.1 10.6 7.1 11.2 13.4 12.8 12.8 166.7 108.1 23.8 57.3 50.6 27.3 89.7 28.1 66.9 138.8 41.8 23.6 27.8 3.3 28.4 6.3 53.4 45.3 23.3 46.5 11.5 39.3 60.5 32.5 21.7 17.3 23.8 17.7 41.7 24.0 11.0 43.1 31.1 8.5 37.9 31.8 23.4 61.5 54.9 59.4 11.3 24.1 6.5 34.9 42.3 39.1 59.8 43.8 21.8 29.4 181.1 SLX4 "BTBD12, FANCP, KIAA1784, KIAA1987" ENSG00000188827 "SLX4 structure-specific endonuclease subunit" Q8IY92 16 3581181-3611598 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.9;testis: 25.0" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 10.9;Spermatocytes: 18.6;Spermatogonia: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049421, HPA066238" Approved Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA049421: AB_2680759, HPA066238: AB_2685642" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-2)" "unprognostic (4.62e-1)" "unprognostic (6.08e-3)" "unprognostic (8.28e-5)" "unprognostic (6.52e-2)" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.97e-2)" "unprognostic (1.50e-1)" "unprognostic (4.32e-2)" "unprognostic (8.39e-3)" "unprognostic (1.20e-1)" "unprognostic (1.43e-3)" "unprognostic (5.74e-2)" 2.9 3.1 5.3 6.1 8.5 6.0 2.4 19.9 11.8 2.5 2.9 9.8 2.5 4.9 6.5 3.3 3.4 3.0 2.8 2.2 7.4 4.3 2.9 2.7 3.0 8.6 3.8 8.1 2.7 3.1 3.7 8.6 2.6 7.4 3.3 2.2 5.4 3.0 2.6 5.5 4.2 4.0 3.1 3.3 4.8 3.7 25.0 3.2 5.8 2.6 1.0 6.5 3.1 2.7 0.6 0.2 3.0 1.1 0.6 0.6 0.7 3.0 9.3 6.1 7.5 2.3 2.4 6.3 4.8 2.4 5.6 6.2 4.6 3.7 10.9 4.8 2.4 4.3 6.7 4.1 3.4 3.3 9.1 5.1 7.5 6.7 2.9 2.0 7.2 10.6 1.8 2.5 5.2 2.9 1.4 4.0 6.2 7.1 6.0 4.4 5.1 4.4 6.3 5.0 1.8 3.5 8.9 10.0 3.0 2.2 2.1 5.2 4.6 4.2 3.0 1.5 3.3 7.3 5.7 4.7 6.5 9.0 5.5 5.6 5.4 4.2 12.8 2.1 7.4 6.3 3.0 0.4 0.0 0.6 0.5 0.4 0.3 0.3 0.3 0.2 0.6 0.3 0.5 0.5 0.6 1.1 0.2 0.3 0.7 5.3 8.5 19.9 11.8 7.4 4.3 3.8 8.1 7.4 3.2 0.0 2.9 4.5 0.8 0.7 7.7 1.4 2.5 2.7 4.5 0.0 2.0 1.3 0.0 1.4 3.5 1.1 1.5 0.0 2.1 1.5 1.5 0.4 0.0 0.9 2.3 0.0 0.0 1.8 1.6 1.6 2.0 3.2 0.0 1.0 2.2 1.7 1.6 0.0 1.8 0.4 10.9 0.0 1.8 18.6 10.0 0.5 0.8 3.5 1.7 0.5 SLX4IP "C20orf94, dJ1099D15.3" ENSG00000149346 "SLX4 interacting protein" Q5VYV7 20 10435303-10636829 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046372 Approved Approved Cytosol NA NA Cytosol "HPA046372: AB_2679641" "unprognostic (4.96e-2)" "unprognostic (2.91e-1)" "unprognostic (2.34e-1)" "unprognostic (2.66e-1)" "unprognostic (1.05e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-3)" "unprognostic (1.58e-2)" "unprognostic (2.58e-1)" "unprognostic (1.14e-1)" "unprognostic (4.56e-3)" "unprognostic (3.91e-1)" "prognostic unfavorable (9.51e-4)" "unprognostic (6.52e-2)" "unprognostic (3.42e-1)" "unprognostic (1.30e-2)" "unprognostic (1.55e-2)" 4.9 6.4 4.7 7.1 8.1 4.2 5.9 6.6 7.9 5.5 5.7 9.9 9.1 5.1 5.2 13.1 7.2 6.1 5.2 4.2 5.3 5.4 6.7 6.9 5.7 5.5 7.3 4.1 5.2 8.4 13.8 25.4 4.4 6.8 5.6 6.4 9.5 6.2 6.4 9.9 9.6 5.8 3.0 6.1 6.2 6.1 6.1 7.7 11.2 7.2 3.9 9.1 6.4 6.0 3.9 5.6 2.5 4.4 3.7 4.0 1.3 3.8 7.3 3.7 10.0 2.2 2.9 3.1 1.9 2.2 3.1 3.3 5.4 4.9 6.0 3.2 2.3 4.3 7.6 5.5 5.7 4.9 0.0 2.1 5.5 2.5 7.3 3.6 5.9 3.3 4.0 5.0 3.8 7.6 4.0 3.0 5.4 4.4 5.3 3.7 3.2 8.8 8.7 6.6 4.6 2.5 6.4 9.7 5.4 4.5 3.8 6.6 5.0 5.6 8.9 5.7 5.4 9.7 3.1 4.4 2.5 5.2 3.1 2.2 5.5 12.5 7.7 1.9 5.7 4.3 0.7 2.9 1.2 2.3 3.8 3.8 3.6 3.3 2.7 3.5 3.9 3.4 2.7 2.5 3.7 4.4 5.6 4.0 1.3 4.7 8.1 6.6 7.9 5.3 5.4 7.3 4.1 6.8 7.7 6.0 5.4 3.0 4.5 0.6 11.2 3.2 10.2 4.0 10.3 1.8 15.7 9.2 10.0 7.0 1.6 1.9 5.9 0.0 3.5 6.9 4.1 4.1 8.1 5.7 7.0 9.5 9.8 6.7 3.5 2.9 4.6 3.1 5.0 10.8 6.3 11.0 3.9 7.4 4.2 8.4 18.4 0.0 5.3 7.4 9.6 1.4 5.5 5.3 6.8 4.7 SMAD1 "JV4-1, MADH1, MADR1" ENSG00000170365 "SMAD family member 1" Q15797 4 145481194-145558079 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 132.8;Endothelial cells: 56.4;Late spermatids: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 22.2;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 4 "granulocytes: 22.2;monocytes: 11.9" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005389 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB005389: AB_656608" "unprognostic (8.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-1)" "unprognostic (6.85e-2)" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (2.30e-1)" "unprognostic (8.24e-2)" "unprognostic (5.31e-2)" "unprognostic (4.68e-2)" "unprognostic (1.73e-3)" "unprognostic (1.48e-1)" "unprognostic (5.88e-2)" "unprognostic (1.14e-3)" "unprognostic (3.15e-2)" 20.4 7.8 19.9 7.9 21.3 3.8 21.1 17.9 17.8 18.5 15.5 14.3 13.6 11.9 33.2 22.7 16.2 20.3 13.7 10.3 13.5 10.3 12.7 37.4 11.0 11.9 9.3 10.0 12.3 13.1 33.7 14.7 8.7 12.2 13.6 16.9 7.8 17.5 16.0 22.6 20.2 15.3 24.6 12.6 10.1 11.4 10.5 14.3 15.3 15.2 14.9 10.3 16.5 21.9 0.0 4.0 22.2 11.9 1.2 0.7 0.8 3.9 5.2 9.7 11.7 3.8 5.5 4.8 5.6 13.6 9.2 7.1 2.5 14.5 3.4 3.4 12.9 4.1 5.8 11.0 12.6 5.5 0.0 5.5 0.0 4.3 5.1 10.1 6.5 1.0 7.5 15.0 4.9 9.7 7.5 46.6 8.5 4.4 0.1 11.7 3.8 9.8 0.1 9.0 6.3 6.3 18.9 9.0 11.7 10.0 6.9 15.2 7.3 8.0 17.5 3.5 6.2 5.9 0.0 14.0 4.5 6.2 4.6 3.4 12.9 0.0 22.8 7.2 0.1 4.6 22.2 2.1 0.8 0.0 5.3 0.0 0.0 0.4 0.0 4.0 0.0 0.2 0.0 0.0 1.2 11.9 0.0 0.7 0.8 19.9 21.3 17.9 14.9 13.5 10.3 9.3 10.0 12.2 14.3 8.9 10.4 0.0 14.6 10.2 5.7 3.9 12.7 10.7 12.5 14.0 13.7 4.1 6.6 10.1 132.8 56.4 8.0 0.0 16.1 2.7 6.2 12.3 0.0 10.5 2.1 9.5 8.7 9.8 6.3 63.2 4.0 2.3 1.7 1.0 8.6 4.8 11.9 5.8 5.3 9.8 6.1 0.0 4.6 5.6 11.9 11.0 1.8 0.0 7.5 15.4 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: AB_2685803" "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 38.5 39.2 29.0 26.2 25.9 19.6 31.4 19.5 28.9 28.8 34.2 29.4 28.9 21.5 26.6 26.3 33.5 28.8 25.7 31.1 26.1 27.1 26.4 20.9 28.3 23.8 30.9 24.3 36.6 28.1 25.7 24.4 34.8 28.6 27.8 29.8 31.7 29.7 28.7 33.9 28.0 26.4 34.6 35.4 34.1 26.3 29.2 26.2 60.7 46.1 23.6 31.5 35.1 35.7 12.0 21.8 28.9 24.7 24.5 25.9 19.7 22.2 32.0 19.5 18.9 31.2 38.2 22.3 24.3 29.2 25.4 29.7 12.2 21.4 34.6 17.5 30.8 35.6 24.6 21.9 27.1 34.1 37.6 11.2 29.4 48.3 19.8 36.4 40.8 30.1 28.2 35.0 21.7 50.3 29.6 28.0 28.2 13.6 29.0 31.2 14.5 28.0 19.6 9.6 1.1 7.6 20.5 28.5 23.6 57.0 38.4 18.1 21.2 29.2 20.1 23.8 19.9 15.2 27.2 31.3 37.7 21.8 10.2 17.6 28.5 27.3 30.2 26.1 27.9 27.5 28.9 22.6 25.0 16.9 24.7 21.2 12.0 23.1 20.9 21.8 9.4 25.8 19.8 22.7 24.5 20.8 15.5 25.9 19.7 29.0 25.9 19.5 28.9 26.1 27.1 30.9 24.3 28.6 26.2 41.7 29.7 22.0 39.2 48.3 44.4 40.0 40.8 30.8 45.5 73.3 200.3 37.8 33.2 31.7 53.8 44.7 32.0 46.7 38.2 33.2 34.3 51.4 20.8 22.6 38.9 33.4 49.0 57.7 52.1 97.0 38.6 38.2 49.0 44.1 42.5 37.9 37.5 24.6 50.2 32.1 82.1 32.3 35.9 26.3 39.6 54.1 58.1 38.1 35.7 55.8 SMAD3 "HsT17436, JV15-2, MADH3" ENSG00000166949 "SMAD family member 3" P84022 15 67063763-67195195 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Aortic aneurysm, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Glandular cells: 111.1;Urothelial cells: 247.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008094, HPA046386, HPA067203, CAB069409" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: AB_2679647, HPA067203: AB_2685803" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (1.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.98e-2)" "unprognostic (8.40e-3)" "unprognostic (1.80e-2)" "unprognostic (7.62e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (2.93e-1)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (1.79e-1)" "unprognostic (1.15e-1)" "unprognostic (5.97e-2)" 25.3 4.6 12.2 18.5 12.4 12.4 21.6 5.0 12.7 20.9 17.9 7.6 9.5 12.7 19.9 16.6 35.3 14.3 27.7 19.7 7.5 4.8 15.6 13.6 13.9 14.0 6.0 7.5 23.0 12.6 7.0 10.8 11.5 8.2 20.5 9.2 30.8 12.5 10.8 37.3 19.6 19.0 23.2 5.5 11.2 15.8 7.0 7.7 10.5 21.8 23.4 29.7 31.4 24.6 4.8 2.5 3.2 1.9 0.4 6.3 1.8 12.2 41.2 7.7 3.7 13.6 31.4 6.1 7.1 29.3 9.9 8.0 8.5 32.9 4.1 9.6 20.2 44.6 29.1 8.0 30.0 9.9 3.2 3.0 0.4 11.6 6.4 10.2 1.6 0.7 28.4 7.0 8.7 7.4 22.0 33.3 1.3 9.9 11.5 12.3 6.3 0.3 6.2 4.5 6.5 12.9 0.4 2.3 1.5 6.6 39.5 0.2 2.6 9.4 5.2 8.1 15.7 1.4 7.6 28.0 13.4 12.6 9.6 8.0 4.4 1.2 5.1 12.1 1.7 12.0 0.0 1.9 3.2 5.5 1.5 5.7 2.1 6.2 6.3 1.8 4.8 2.8 2.4 0.1 0.4 1.5 2.5 3.1 1.8 12.2 12.4 5.0 12.7 7.5 4.8 6.0 7.5 8.2 7.7 44.7 14.5 13.6 67.6 79.0 8.3 9.5 15.3 24.1 30.7 34.9 5.9 0.8 3.3 53.0 0.9 20.1 34.4 0.0 44.0 4.0 34.3 111.1 24.2 11.3 8.4 0.0 3.4 9.8 4.8 3.7 24.7 13.8 20.3 3.6 11.9 9.7 71.0 21.0 19.4 12.2 0.4 25.8 14.6 0.3 0.7 42.8 1.4 12.5 15.7 247.9 SMAD4 "DPC4, MADH4" ENSG00000141646 "SMAD family member 4" Q13485 18 51028394-51085045 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019154 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA019154: AB_1853480" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (4.83e-2)" "unprognostic (1.17e-2)" "unprognostic (4.05e-1)" "unprognostic (7.29e-3)" "unprognostic (9.00e-2)" "unprognostic (4.01e-2)" "unprognostic (2.51e-2)" "unprognostic (1.03e-3)" "unprognostic (4.40e-2)" "prognostic favorable (1.92e-5)" "unprognostic (2.62e-2)" "unprognostic (4.23e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" 25.6 17.5 16.0 14.0 16.7 11.4 24.9 29.7 16.0 27.9 22.6 17.9 21.3 15.1 28.2 18.8 21.7 20.5 17.5 19.6 15.3 11.5 21.0 22.0 20.1 16.0 17.2 13.3 30.5 25.0 30.0 28.9 30.6 14.2 27.8 17.4 18.4 23.1 22.8 39.7 18.2 23.4 27.6 13.9 21.7 19.3 17.6 18.4 38.8 35.0 13.9 18.1 29.0 24.1 3.6 3.6 3.4 1.8 2.9 4.7 1.3 8.5 11.4 30.9 8.9 12.8 19.8 17.4 15.1 16.6 20.3 25.5 7.0 2.0 14.3 4.5 13.0 10.4 14.2 17.3 6.8 21.6 12.4 9.8 9.9 11.4 8.0 12.7 17.2 7.8 8.9 11.5 10.0 14.7 19.6 14.7 7.3 11.1 13.2 12.0 4.5 10.2 5.0 16.1 4.6 7.1 13.3 15.7 14.0 9.7 3.7 19.1 11.3 14.1 2.6 9.4 13.7 7.0 10.0 11.0 17.2 8.0 4.3 10.0 19.9 13.8 12.4 11.2 6.7 11.3 0.8 1.8 1.8 3.2 1.1 3.7 2.2 3.3 2.6 3.6 3.6 4.0 4.7 3.4 2.9 1.3 2.9 4.3 1.3 16.0 16.7 29.7 16.0 15.3 11.5 17.2 13.3 14.2 18.4 20.8 23.2 11.8 18.4 22.8 13.2 33.5 40.8 16.0 19.4 21.0 19.6 15.5 10.0 16.2 7.3 23.2 15.6 0.0 10.8 16.8 23.8 31.7 4.6 40.0 13.2 14.3 38.1 23.9 26.1 11.4 30.8 16.7 27.0 5.4 33.8 18.9 18.1 24.3 28.7 18.5 20.8 25.8 29.2 13.9 16.2 23.8 10.5 13.8 26.2 22.5 SMAD5 "Dwfc, JV5-1, MADH5" ENSG00000113658 "SMAD family member 5" Q99717 5 136132845-136188747 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 33.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058931 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058931: AB_2683856" "unprognostic (6.04e-2)" "unprognostic (4.16e-2)" "unprognostic (9.99e-3)" "unprognostic (3.23e-1)" "unprognostic (5.98e-2)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (9.49e-2)" "unprognostic (4.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.27e-1)" "unprognostic (3.79e-2)" "unprognostic (4.69e-2)" "unprognostic (1.40e-3)" "unprognostic (3.22e-1)" "unprognostic (5.95e-2)" "unprognostic (2.15e-1)" 22.6 14.2 13.7 10.2 14.6 8.6 18.2 27.5 15.7 27.9 16.7 19.8 15.9 12.4 33.5 15.8 20.8 17.3 14.0 15.9 14.9 12.4 15.7 20.2 16.7 10.4 18.0 12.2 33.5 15.3 25.2 23.0 24.1 16.4 23.0 16.9 22.0 16.9 18.8 19.3 27.5 12.7 25.7 16.7 16.3 14.4 11.5 19.0 8.4 19.2 15.2 15.7 25.6 27.9 7.3 7.4 33.1 6.1 9.3 7.2 2.4 14.0 11.8 14.6 12.9 15.9 24.4 15.4 19.5 13.8 13.0 20.3 52.1 10.3 15.5 16.4 15.1 13.9 12.9 17.0 22.3 21.3 6.7 10.5 10.3 12.8 9.8 13.2 6.2 11.0 17.5 13.6 20.6 14.3 13.8 16.2 7.8 9.9 10.7 14.3 5.6 5.1 6.4 8.7 5.0 6.0 10.7 28.2 9.1 7.9 14.5 13.2 13.8 17.0 4.4 17.1 18.4 9.9 7.7 18.7 19.8 12.7 14.6 19.3 12.1 14.5 19.6 12.8 8.1 15.0 33.1 6.1 13.0 7.2 3.9 5.5 6.5 4.2 4.6 6.1 7.3 1.4 4.3 1.0 9.3 4.4 7.4 1.1 2.4 13.7 14.6 27.5 15.7 14.9 12.4 18.0 12.2 16.4 19.0 38.7 26.7 14.8 30.0 41.2 26.4 34.1 48.4 34.8 43.3 29.6 19.6 16.7 19.9 22.2 16.0 50.2 12.4 0.0 22.9 9.9 44.5 42.2 8.1 42.9 11.9 49.3 95.7 47.9 32.6 18.0 65.6 20.0 20.3 3.6 36.1 46.2 25.7 17.3 68.2 35.0 27.4 45.3 40.6 21.4 21.4 44.3 9.8 13.4 28.7 30.4 SMAD7 "MADH7, MADH8" ENSG00000101665 "SMAD family member 7" O15105 18 48919853-48950711 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 50.6;Ito cells: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026212, HPA028897" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB026212: , HPA028897: AB_10600811" "unprognostic (1.63e-1)" "unprognostic (3.72e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (5.61e-4)" "unprognostic (8.15e-2)" "unprognostic (5.35e-1)" "unprognostic (2.76e-1)" "unprognostic (6.02e-2)" "unprognostic (2.37e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (2.09e-1)" "unprognostic (1.91e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-2)" "unprognostic (4.44e-1)" 9.5 3.3 3.1 7.4 4.3 8.6 11.6 8.0 7.7 11.4 11.5 4.2 5.1 5.5 6.5 3.0 2.8 4.2 5.7 27.0 5.8 3.1 7.4 6.5 13.7 2.8 6.1 4.4 4.5 5.6 14.6 3.9 11.2 6.0 9.3 7.0 7.1 5.3 11.5 4.9 4.4 15.0 5.0 6.3 2.9 7.2 3.2 2.8 3.6 10.0 5.7 3.4 6.8 19.4 0.1 0.3 8.3 0.8 2.6 1.9 0.4 2.2 1.9 1.6 5.2 9.1 3.8 13.1 10.4 4.4 4.1 1.9 0.5 3.2 0.2 19.7 7.6 3.6 11.9 3.7 3.5 2.2 22.6 5.9 0.1 5.6 4.9 1.6 4.5 11.3 3.2 3.2 4.6 4.9 19.5 0.7 0.3 3.8 14.8 6.2 0.7 0.0 1.3 10.9 15.6 0.7 1.3 1.6 5.0 6.3 2.4 2.9 6.3 4.7 2.2 4.5 13.2 1.8 3.5 9.9 11.0 6.0 3.1 10.2 8.0 4.0 1.3 4.8 2.9 1.7 5.8 0.2 8.3 1.4 0.8 1.2 0.1 1.4 1.3 0.3 0.0 0.4 0.9 0.0 2.6 0.2 0.0 1.9 0.4 3.1 4.3 8.0 7.7 5.8 3.1 6.1 4.4 6.0 2.8 50.6 10.3 1.4 3.2 11.4 5.1 7.9 2.5 4.0 18.2 10.4 5.9 7.9 8.3 12.6 0.1 10.0 22.7 0.0 12.2 2.7 15.4 3.0 17.4 2.6 9.0 0.0 12.2 84.7 16.0 0.2 1.4 7.9 0.0 8.2 17.6 1.3 21.6 17.3 3.2 5.0 2.5 6.5 10.3 0.0 0.1 10.3 10.8 8.4 12.8 2.2 SMAD9 "MADH6, MADH9, SMAD8, SMAD8/9" ENSG00000120693 "SMAD family member 9" O15198 13 36844831-36920765 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.9" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 26.8;Intestinal endocrine cells: 49.5;Ito cells: 47.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 8.8;SH-SY5Y: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009119, HPA031162" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009119: AB_2286517, HPA031162: AB_2673767" "unprognostic (2.88e-1)" "unprognostic (1.38e-1)" "unprognostic (9.68e-3)" "unprognostic (3.50e-3)" "prognostic favorable (5.99e-4)" "unprognostic (1.30e-1)" "unprognostic (1.34e-1)" "unprognostic (3.71e-3)" "unprognostic (4.23e-2)" "unprognostic (6.62e-2)" "unprognostic (4.07e-3)" "unprognostic (3.74e-2)" "unprognostic (9.70e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.47e-2)" 4.4 3.1 7.0 3.2 6.2 0.6 4.1 10.7 11.8 6.3 8.2 14.3 4.1 2.6 10.0 11.3 5.8 5.1 7.4 6.9 15.0 6.2 5.0 1.4 5.3 2.6 10.7 8.9 10.1 1.3 3.0 6.2 6.7 10.2 14.9 6.0 11.9 17.7 12.4 13.8 2.1 4.0 8.4 15.5 1.5 5.9 2.7 11.0 0.0 38.9 1.9 3.4 7.7 12.6 1.7 1.7 1.1 0.8 0.7 1.4 0.2 0.0 0.1 0.5 5.9 1.8 0.8 0.2 6.8 0.7 1.9 1.1 0.0 0.1 0.2 4.3 8.8 0.6 0.3 5.9 0.1 2.0 0.2 8.4 0.0 3.0 4.7 1.8 0.5 0.1 3.0 0.5 0.0 0.0 4.0 3.6 0.8 0.0 0.0 4.3 0.4 0.1 0.5 0.9 0.2 0.6 0.1 6.4 0.0 0.0 1.0 5.3 28.2 1.4 0.2 0.3 1.7 0.4 0.2 6.4 2.8 2.2 1.6 1.6 0.1 0.0 0.0 1.9 0.2 0.4 1.1 0.4 0.3 1.2 0.8 0.8 1.0 1.2 1.3 0.2 1.7 1.2 1.4 0.9 0.7 0.5 1.7 0.4 0.2 7.0 6.2 10.7 7.8 15.0 6.2 10.7 8.9 10.2 11.0 26.8 7.8 0.0 4.2 2.5 8.3 4.2 0.0 2.7 11.4 10.4 3.9 0.1 1.7 0.2 0.1 21.5 0.0 0.0 0.2 0.4 6.6 17.1 0.0 0.0 0.1 0.0 49.5 47.9 2.4 0.0 17.3 0.0 0.0 0.0 13.7 16.3 0.7 3.5 14.2 4.3 3.2 0.0 7.9 0.2 4.7 1.6 0.2 0.9 5.7 0.9 SMAP1 "FLJ13159, SMAP-1" ENSG00000112305 "Small ArfGAP 1" Q8IYB5 6 70667776-70862015 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 261.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030574 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "HPA030574: AB_10601589" "unprognostic (1.55e-1)" "unprognostic (2.66e-3)" "unprognostic (1.01e-3)" "unprognostic (2.98e-3)" "unprognostic (7.06e-2)" "unprognostic (2.90e-2)" "unprognostic (1.66e-3)" "unprognostic (3.46e-1)" "unprognostic (6.50e-2)" "unprognostic (3.75e-2)" "unprognostic (7.80e-2)" "unprognostic (2.40e-2)" "unprognostic (1.32e-1)" "unprognostic (4.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.85e-1)" "unprognostic (1.22e-1)" 18.7 14.8 19.9 17.8 25.1 15.1 15.3 20.7 30.2 14.4 25.2 14.5 18.5 24.5 16.2 17.7 29.3 10.5 16.3 20.5 20.5 18.6 14.1 17.2 14.4 18.3 19.2 18.1 15.2 33.9 27.1 11.5 14.8 25.0 17.2 27.0 13.0 18.6 15.2 32.6 21.0 29.6 18.7 15.7 14.8 20.7 29.6 13.0 26.6 20.0 17.5 20.1 18.9 16.6 12.5 11.7 24.0 15.5 20.2 21.9 16.3 26.7 8.5 13.5 16.4 12.5 16.5 21.8 12.0 13.8 10.1 9.9 12.6 8.0 14.0 13.1 14.7 14.6 8.5 12.7 12.8 17.2 16.1 17.7 15.5 8.0 10.6 8.4 11.3 13.2 10.8 14.9 11.3 13.8 19.0 15.8 7.4 14.7 17.2 15.8 15.7 8.4 13.8 9.9 14.2 9.9 16.0 50.1 23.1 18.2 16.5 18.9 13.5 7.7 11.0 7.6 12.0 14.5 17.1 15.1 8.2 14.1 5.3 10.6 16.0 14.3 7.2 6.2 13.3 11.2 24.0 13.7 14.6 16.3 15.0 18.5 12.5 21.9 18.6 11.7 11.1 11.2 14.4 19.3 20.2 15.5 11.5 20.5 16.3 19.9 25.1 20.7 30.2 20.5 18.6 19.2 18.1 25.0 13.0 35.7 32.5 47.6 31.8 59.4 49.5 34.1 66.2 16.0 30.7 36.6 35.3 22.2 46.4 68.3 261.7 39.6 88.7 0.0 131.9 35.0 39.4 71.6 48.4 36.8 51.8 52.4 40.2 63.3 52.2 208.7 46.9 47.5 30.4 54.1 58.5 64.5 87.9 63.4 62.9 42.1 36.2 64.7 46.2 64.2 85.5 67.5 26.5 51.7 60.3 38.6 SMC1B "bK268H5, SMC1L2" ENSG00000077935 "Structural maintenance of chromosomes 1B" Q8NDV3 22 45344063-45413619 "Predicted intracellular proteins" "Cell cycle, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 46 "testis: 35.4" "Group enriched" "Detected in some" 5 "Spermatocytes: 487.9;Spermatogonia: 418.0" "Cancer enriched" "Detected in many" 6 "cervical cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.2;EFO-21: 4.4;SiHa: 19.1;U-266/70: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA001500 Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001500: AB_1080030" "unprognostic (1.18e-2)" "unprognostic (6.16e-3)" "unprognostic (2.22e-1)" "unprognostic (3.38e-3)" "unprognostic (1.77e-1)" "unprognostic (3.21e-2)" "unprognostic (6.18e-2)" "unprognostic (1.87e-3)" "unprognostic (3.41e-2)" "unprognostic (3.65e-1)" "unprognostic (4.49e-2)" "unprognostic (3.79e-1)" "unprognostic (3.83e-9)" "unprognostic (2.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.98e-3)" 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.7 0.2 0.0 0.5 0.0 9.2 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.1 0.0 19.1 0.1 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.0 0.3 2.0 0.0 0.2 0.7 0.4 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.1 0.3 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 63.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 28.8 5.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.2 0.0 1.0 97.0 0.0 487.9 418.0 0.0 0.7 0.0 0.0 0.1 SMC4 "CAP-C, hCAP-C, SMC4L1" ENSG00000113810 "Structural maintenance of chromosomes 4" Q9NTJ3 3 160399274-160434962 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.2" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 332.4;Spermatogonia: 238.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029449, CAB055509" Approved Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles, Cytosol" "CAB055509: , HPA029449: AB_10603891" "unprognostic (2.63e-1)" "unprognostic (1.01e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.54e-2)" "unprognostic (2.18e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (4.20e-5)" "prognostic unfavorable (9.00e-4)" "prognostic unfavorable (8.05e-7)" "unprognostic (3.03e-2)" "unprognostic (4.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" 4.8 5.5 3.0 25.4 4.4 15.1 4.0 3.1 3.2 5.3 10.1 1.7 5.3 6.5 5.2 4.9 19.3 4.6 7.0 5.7 2.4 1.7 4.4 6.3 7.9 16.5 3.1 1.3 4.7 4.2 1.7 10.8 7.4 2.6 4.4 6.9 2.7 5.7 6.9 5.9 4.6 7.0 6.2 3.1 13.1 5.7 20.7 3.2 70.2 5.1 7.6 14.3 7.8 6.3 8.8 6.1 30.5 7.6 7.8 15.8 4.8 63.3 11.7 26.7 12.3 5.1 5.2 12.3 31.6 14.9 36.6 31.7 14.8 36.5 40.1 18.5 13.0 24.3 36.6 30.3 15.3 58.8 53.1 21.1 38.8 20.1 4.7 2.8 25.7 31.8 2.6 2.2 19.3 15.8 13.3 15.5 17.1 22.3 46.7 21.8 11.4 31.5 6.4 15.7 15.7 27.6 32.0 41.9 29.1 6.8 7.9 16.1 16.7 24.1 22.3 11.0 13.1 26.8 19.2 14.6 23.4 19.6 21.3 57.6 31.2 31.8 73.2 16.8 26.4 25.9 30.5 3.2 12.1 6.7 4.7 6.5 8.8 10.5 8.0 3.5 7.2 6.7 6.0 5.7 7.8 7.6 6.1 15.8 4.8 3.0 4.4 3.1 3.2 2.4 1.7 3.1 1.3 2.6 3.2 98.3 146.6 24.2 16.6 36.2 14.2 31.9 22.9 32.1 44.3 33.2 7.9 29.7 3.3 18.2 26.7 45.6 21.1 116.8 12.6 126.9 41.4 11.7 76.3 15.6 51.1 0.0 28.9 39.3 26.0 21.5 23.3 45.4 16.9 37.9 24.6 9.8 11.3 20.1 45.3 6.2 24.1 129.4 30.3 332.4 238.9 31.1 28.5 48.4 46.6 17.6 SMG6 "C17orf31, EST1A, KIAA0732, SMG-6" ENSG00000070366 "SMG6, nonsense mediated mRNA decay factor" Q86US8 17 2059839-2303771 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042932 Approved Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA042932: AB_10964261" "unprognostic (5.22e-2)" "unprognostic (1.20e-1)" "unprognostic (5.30e-1)" "unprognostic (4.41e-2)" "unprognostic (1.33e-1)" "unprognostic (9.33e-3)" "unprognostic (1.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.75e-2)" "unprognostic (7.63e-2)" "unprognostic (4.78e-2)" "unprognostic (1.31e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.61e-1)" "unprognostic (3.08e-2)" 12.7 16.6 18.1 18.9 17.6 11.9 10.9 19.1 18.4 15.0 10.6 15.1 13.2 9.0 26.2 11.9 16.1 22.2 16.7 16.4 12.8 15.9 11.5 7.3 11.5 10.7 13.4 16.1 38.7 9.3 16.2 17.2 10.1 14.5 14.5 9.5 18.6 10.4 13.3 14.0 15.3 10.3 18.9 12.8 9.0 9.7 39.2 11.5 22.3 11.6 8.4 16.8 12.7 12.4 2.0 3.3 4.8 3.6 4.6 4.3 1.5 8.2 12.7 18.4 11.9 19.9 16.1 9.5 13.4 14.8 15.3 13.0 15.4 4.2 8.7 4.8 19.6 7.0 12.1 13.4 11.4 16.0 8.7 8.4 8.5 6.8 7.5 11.4 4.5 6.1 22.8 8.5 12.3 10.9 24.9 13.9 8.7 7.0 10.7 11.4 6.5 11.4 3.7 5.9 5.0 6.6 11.8 11.7 3.4 8.8 7.6 3.1 9.4 14.0 4.1 5.8 13.5 6.4 3.3 18.2 14.1 7.8 14.8 14.0 9.3 5.5 4.1 11.2 5.1 8.2 4.8 1.8 2.0 3.7 0.8 3.7 1.2 3.1 3.5 1.0 2.0 4.3 2.9 1.4 4.6 3.6 3.3 1.8 1.5 18.1 17.6 19.1 18.4 12.8 15.9 13.4 16.1 14.5 11.5 20.8 17.3 9.3 12.4 7.0 32.9 5.6 12.7 14.7 9.1 14.0 70.7 13.6 5.0 12.0 17.3 13.2 10.7 0.0 11.1 9.3 13.6 11.7 10.4 6.6 8.9 44.5 4.1 12.9 6.3 25.4 15.5 9.2 8.5 19.8 8.0 26.2 13.2 14.4 18.7 6.3 49.0 25.8 13.3 51.6 47.3 7.5 14.5 14.9 8.8 11.2 SMG7 "C1orf16, EST1C, KIAA0250, SGA56M, SMG-7" ENSG00000116698 "SMG7, nonsense mediated mRNA decay factor" Q92540 1 183472216-183598246 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029350 Supported Supported "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA029350: AB_10603031" "unprognostic (6.06e-2)" "unprognostic (1.79e-1)" "unprognostic (3.32e-1)" "unprognostic (2.67e-3)" "unprognostic (1.98e-2)" "unprognostic (1.36e-1)" "unprognostic (5.44e-2)" "unprognostic (6.15e-2)" "unprognostic (1.46e-1)" "unprognostic (9.01e-2)" "unprognostic (6.17e-2)" "unprognostic (2.69e-1)" "unprognostic (6.47e-3)" "unprognostic (7.82e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (4.40e-3)" 14.6 14.3 20.7 17.1 25.3 30.9 17.6 35.8 29.3 17.6 18.1 19.9 6.6 16.8 16.6 13.6 19.1 22.1 12.9 20.0 17.8 14.8 18.2 18.7 15.6 19.7 16.0 23.1 22.7 18.7 25.9 20.2 18.7 15.9 15.1 20.4 15.9 17.2 14.5 19.2 20.5 17.8 15.2 14.4 18.9 18.3 52.1 15.1 31.6 19.9 12.7 23.9 14.5 22.3 9.3 11.7 11.2 9.6 9.5 10.3 8.0 21.5 13.1 19.0 14.8 13.0 12.3 31.7 13.3 24.5 14.8 11.3 19.4 16.9 30.4 15.3 16.4 13.5 23.4 25.5 19.7 17.6 13.5 11.2 24.6 14.2 15.7 13.2 32.1 15.7 11.2 18.1 20.3 47.1 12.1 16.2 16.9 30.4 21.5 15.3 21.8 22.5 14.2 32.9 25.8 7.5 14.3 21.3 23.7 11.4 20.2 25.6 20.0 20.5 29.1 15.8 33.9 29.0 13.1 15.4 16.8 17.5 16.6 18.8 23.6 27.6 25.2 13.7 18.2 17.9 3.1 9.3 9.5 9.7 9.6 8.9 9.3 8.8 9.5 10.7 8.5 9.9 10.3 11.2 9.5 5.0 11.7 7.8 8.0 20.7 25.3 35.8 29.3 17.8 14.8 16.0 23.1 15.9 15.1 20.8 19.4 14.9 8.8 24.0 22.5 27.4 20.4 21.4 19.4 26.2 29.5 9.9 8.3 11.4 52.6 24.5 30.7 0.0 13.5 13.1 10.8 13.7 20.9 41.4 11.4 28.6 33.1 24.5 36.2 38.5 14.1 24.4 10.1 4.6 20.4 9.3 13.7 20.3 11.7 10.6 18.0 38.8 16.5 37.0 19.6 23.5 9.0 15.3 16.3 17.0 SMG9 "C19orf61, FLJ12886" ENSG00000105771 "SMG9, nonsense mediated mRNA decay factor" Q9H0W8 19 43727992-43754990 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 79.9;Late spermatids: 263.1;Syncytiotrophoblasts: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041763, HPA042096" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA041763: AB_2677659, HPA042096: AB_2677845" "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (7.41e-2)" "unprognostic (6.46e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-2)" "prognostic unfavorable (2.15e-5)" "unprognostic (2.71e-1)" "unprognostic (4.11e-2)" "unprognostic (9.24e-3)" "unprognostic (3.88e-2)" "unprognostic (8.76e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (8.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "prognostic favorable (8.09e-4)" 10.0 14.6 18.1 16.9 24.5 12.4 14.9 25.0 24.8 13.2 12.0 21.6 11.5 13.4 11.6 13.8 11.2 10.9 11.7 9.4 16.5 15.6 10.2 8.5 11.9 19.3 36.0 14.2 10.2 8.1 14.9 14.2 16.6 23.1 14.7 11.0 9.2 14.0 12.7 9.1 12.3 11.7 13.9 20.4 17.1 14.2 40.9 29.6 13.2 10.8 4.1 19.3 11.1 12.0 9.2 8.0 3.6 12.2 4.6 8.3 10.7 12.5 13.9 10.2 6.5 7.1 10.2 6.8 18.0 10.8 20.1 15.2 9.7 16.7 13.8 8.8 12.3 6.9 5.5 11.8 10.0 13.2 10.5 6.7 24.7 9.9 6.4 8.3 18.6 13.6 5.4 8.6 14.6 15.7 17.0 8.1 12.8 18.5 12.3 9.3 8.9 19.7 5.2 4.9 24.2 9.4 10.5 8.4 6.1 10.7 10.3 17.0 8.4 18.7 14.3 10.6 8.5 8.6 10.3 9.8 31.6 18.5 11.6 13.7 6.0 12.8 16.5 9.5 14.3 25.6 1.0 6.1 3.6 6.3 9.0 5.6 9.2 6.4 5.3 8.0 6.7 8.3 5.7 1.5 4.6 12.2 7.0 4.6 10.7 18.1 24.5 25.0 24.8 16.5 15.6 36.0 14.2 23.1 29.6 29.8 8.8 13.4 13.4 8.2 12.2 3.6 5.1 8.1 3.4 8.7 3.9 39.8 1.7 10.4 79.9 8.0 8.1 0.0 7.6 12.2 8.3 12.6 9.2 2.6 18.5 12.7 4.1 9.2 8.2 263.1 12.0 10.7 10.1 21.6 8.3 5.6 10.0 5.8 11.3 5.7 9.1 6.5 4.7 16.3 15.8 6.1 79.8 10.0 9.0 8.8 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favorable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 14.9 20.5 21.8 15.6 26.7 7.1 25.0 11.4 28.0 12.9 16.4 8.3 12.8 24.1 13.7 46.4 11.9 15.1 22.5 33.7 17.9 16.2 27.1 22.7 18.5 26.0 19.2 14.3 19.5 50.0 8.7 10.0 9.5 22.8 13.6 16.1 11.3 20.4 15.7 51.3 6.9 23.8 24.0 22.6 12.7 18.8 17.7 13.5 9.3 21.3 15.3 14.5 14.5 15.9 27.1 21.4 13.3 20.3 18.1 31.1 18.2 12.9 10.9 14.6 14.1 16.2 35.4 19.6 12.7 15.4 10.9 14.0 9.6 23.1 21.4 22.1 14.0 22.7 3.8 17.0 16.2 15.3 12.1 13.5 12.3 7.9 18.3 27.6 14.6 8.2 25.0 32.6 13.9 21.2 21.4 8.4 14.5 19.7 7.0 13.4 8.3 15.8 24.9 27.6 17.3 16.3 13.1 19.1 13.7 24.3 9.5 18.9 17.6 8.1 5.7 27.9 16.8 11.8 20.9 13.9 11.9 14.1 13.3 16.1 13.8 11.3 22.4 18.0 15.6 15.0 13.3 18.2 8.4 15.7 20.3 20.5 27.1 22.7 19.7 20.5 26.8 31.1 24.7 9.2 18.1 15.2 21.4 23.2 18.2 21.8 26.7 11.4 28.0 17.9 16.2 19.2 14.3 22.8 13.5 8.9 35.3 39.7 30.7 19.5 7.0 54.2 58.6 29.4 35.2 34.9 7.9 53.4 111.0 55.9 8.3 17.8 60.0 0.0 54.3 51.6 39.2 34.0 10.4 52.1 61.7 1.6 18.6 19.0 49.0 18.9 34.8 47.0 42.2 36.1 53.7 55.6 48.1 35.1 45.3 134.2 16.1 71.1 36.2 42.9 40.5 16.9 36.6 25.9 63.5 25.3 SMIM22 ENSG00000267795 "Small integral membrane protein 22" K7EJ46 16 4788397-4796491 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 1586.1;Mucus-secreting cells: 1138.7;Paneth cells: 989.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "CAPAN-2: 68.7;OE19: 58.6;RT4: 25.3;SCLC-21H: 17.9;SK-BR-3: 51.6" "Not detected" "Not detected" HPA077331 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA077331: AB_2686834" "unprognostic (6.55e-2)" "unprognostic (4.12e-2)" "unprognostic (4.84e-2)" "unprognostic (3.69e-3)" "unprognostic (7.82e-2)" "unprognostic (3.84e-2)" "unprognostic (4.63e-2)" "unprognostic (2.67e-2)" "unprognostic (6.20e-2)" "unprognostic (3.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (1.73e-3)" 0.8 0.0 0.8 14.4 0.8 0.2 10.9 0.8 0.8 10.8 47.0 0.9 37.8 27.5 2.5 12.1 2.6 18.0 28.1 0.8 0.8 0.0 6.2 0.9 6.8 0.8 0.8 0.8 2.8 36.2 0.0 12.1 4.1 0.8 10.2 28.1 0.8 42.2 35.3 0.8 2.2 54.3 1.7 0.8 0.8 41.7 27.2 0.8 1.0 0.9 2.8 4.5 18.5 3.6 1.9 1.5 3.9 1.3 0.9 1.6 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 68.7 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.1 0.2 58.6 0.0 0.1 0.1 5.8 0.3 25.3 17.9 0.3 0.1 51.6 0.0 0.1 4.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.1 3.9 1.3 1.6 1.3 0.5 0.6 0.7 1.3 0.6 0.3 1.9 1.6 0.7 3.3 0.9 0.6 1.5 0.9 0.3 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 0.8 0.8 44.7 91.2 2.2 16.6 1.9 3.3 0.4 239.5 456.4 104.6 237.3 0.0 3.6 21.6 209.7 33.3 0.4 1586.1 0.0 336.4 0.4 0.3 47.7 18.4 0.0 0.3 1.6 452.3 0.0 0.0 89.0 0.6 2.7 21.9 9.0 1138.7 0.5 428.0 989.0 1.1 55.8 4.1 0.0 0.2 15.1 0.4 1.9 3.1 0.0 572.8 123.6 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480542 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 160.8;intestine: 204.2;kidney: 76.9" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 1384.0" "Cancer enhanced" "Detected in many" "renal cancer: 78.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "NK-cell: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7" "Low region specificity" "Detected in many" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.1 0.7 0.6 0.9 7.0 0.3 0.2 2.2 0.2 137.0 0.4 2.4 71.4 0.2 160.8 0.3 0.3 46.7 0.3 0.4 0.5 76.9 7.2 0.3 0.3 0.4 0.6 0.3 1.6 0.0 0.9 0.2 0.3 0.3 2.0 0.2 0.3 0.4 0.2 0.3 204.2 0.2 0.6 0.4 24.8 1.2 0.3 8.8 0.2 0.2 0.2 0.2 0.2 3.2 2.4 3.0 0.0 8.6 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 42.4 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.2 31.7 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 30.2 4.2 0.0 50.3 0.0 16.6 0.0 1.1 0.4 0.0 0.4 0.6 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.0 23.7 0.0 3.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.7 1.7 0.0 8.6 0.0 2.4 2.1 1.1 0.7 0.9 0.2 2.2 0.4 0.5 0.4 0.6 0.3 0.3 0.0 0.0 1.7 0.1 0.0 12.1 0.2 229.3 0.0 0.0 55.8 25.5 0.0 202.2 3.9 5.0 0.0 64.6 23.3 11.3 0.1 0.0 0.3 1.1 8.5 0.1 0.0 133.5 0.6 0.8 11.2 0.3 0.0 0.0 1.0 34.7 2.7 11.1 51.8 0.0 1384.0 32.6 0.0 0.0 0.7 0.4 0.0 0.0 1.0 35.7 0.2 SMIM26 "LINC00493, LOC388789" ENSG00000232388 "Small integral membrane protein 26" A0A096LP01 20 18567347-18569563 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 330.0;Proximal tubular cells: 358.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068733 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA068733: AB_2686024" "unprognostic (1.20e-2)" "unprognostic (5.85e-2)" "unprognostic (2.83e-1)" "unprognostic (8.06e-2)" "unprognostic (2.68e-1)" "unprognostic (1.65e-1)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.67e-3)" "unprognostic (2.16e-1)" "unprognostic (2.68e-2)" "unprognostic (2.40e-2)" "unprognostic (2.02e-1)" "unprognostic (3.18e-1)" "prognostic favorable (7.84e-5)" 6.8 13.2 8.4 6.8 11.6 9.9 15.6 9.2 13.2 8.8 8.8 5.0 11.9 8.6 9.0 20.4 9.3 11.2 10.8 15.0 9.2 13.2 16.4 6.7 13.4 9.2 10.9 17.2 29.4 6.9 10.6 7.4 14.7 9.5 9.7 6.9 16.8 15.7 32.3 7.7 10.9 11.7 8.9 6.2 8.3 5.4 10.8 7.7 12.0 18.7 9.6 11.4 12.6 49.2 52.0 75.1 42.9 29.6 49.8 37.5 23.6 30.7 23.0 24.2 21.3 29.3 27.3 17.7 20.9 20.5 23.5 19.0 27.3 23.4 20.3 18.9 36.9 26.0 21.7 28.8 23.3 10.0 27.5 31.1 14.3 62.5 40.8 20.4 23.9 24.9 38.5 23.2 37.5 35.7 30.7 29.0 22.8 22.0 25.3 29.0 24.0 56.3 13.3 44.5 37.2 15.7 27.3 32.0 45.9 23.7 23.2 24.7 18.5 35.8 68.1 21.3 26.2 30.1 16.0 14.5 15.3 17.9 18.5 21.4 51.7 26.0 13.1 13.2 10.9 34.8 42.9 32.2 33.2 36.2 34.7 49.2 45.0 37.6 52.0 45.1 49.8 46.7 75.1 29.6 33.3 48.6 45.4 37.5 119.1 61.5 0.0 0.0 0.0 0.0 0.0 0.0 160.6 66.0 162.3 0.0 177.5 330.0 123.9 0.0 0.0 0.0 0.0 185.9 113.7 0.0 0.0 32.5 0.0 161.8 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 115.4 0.0 0.0 172.0 0.0 0.0 358.7 0.0 0.0 0.0 0.0 0.0 0.0 173.9 0.0 0.0 0.0 SMN1 "BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A" ENSG00000172062 "Survival of motor neuron 1, telomeric" Q16637 5 70925030-70953942 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 42.8;Club cells: 46.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 23.8;HEL: 21.4;MOLT-4: 37.9;T-47d: 29.3;WM-115: 39.0" "CAB016324, HPA045271, CAB069888, HPA073601" Supported Supported "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: AB_2679280, HPA073601: " "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (3.18e-1)" "unprognostic (2.09e-1)" "unprognostic (2.85e-1)" "unprognostic (9.52e-3)" "unprognostic (2.10e-2)" "unprognostic (2.43e-1)" "unprognostic (9.91e-3)" "unprognostic (1.13e-2)" "unprognostic (1.01e-1)" "unprognostic (4.41e-1)" "prognostic unfavorable (6.62e-13)" "unprognostic (2.04e-1)" "unprognostic (2.17e-1)" "unprognostic (8.06e-2)" "unprognostic (4.14e-2)" 4.3 3.3 5.1 4.7 4.4 23.9 5.1 6.0 4.3 6.1 4.0 2.8 5.2 7.4 4.7 5.7 8.0 3.5 5.2 5.0 6.8 7.0 3.7 16.4 4.6 8.0 5.3 6.4 5.2 4.7 4.6 6.0 3.8 3.5 5.8 5.9 3.1 9.2 5.2 5.2 6.1 6.9 4.9 2.5 10.7 5.1 15.8 14.7 5.2 11.3 9.0 16.1 7.1 2.9 0.7 1.1 1.3 3.1 4.6 15.4 1.1 1.8 1.8 1.3 1.3 1.3 1.4 23.8 2.3 1.9 1.5 1.8 1.2 1.6 0.3 1.7 21.4 1.7 1.9 0.4 2.5 1.9 0.5 3.8 0.6 0.6 4.7 1.0 1.3 0.9 2.1 0.9 1.0 37.9 15.9 1.4 0.2 0.6 2.0 4.7 11.3 0.9 1.7 1.8 3.7 1.5 4.2 19.9 0.8 29.3 4.0 10.7 11.1 1.3 1.0 2.4 1.4 0.9 14.2 1.6 1.5 39.0 5.2 9.1 3.4 10.1 11.3 16.1 15.8 10.3 9.4 13.4 12.5 14.2 13.4 3.1 9.0 10.5 14.7 12.5 7.1 8.9 7.8 1.4 3.2 12.4 3.9 20.1 10.2 42.8 46.6 1.8 9.8 7.1 5.0 5.3 13.1 7.1 2.2 0.0 3.9 6.8 5.7 2.2 18.5 2.4 4.4 3.2 5.8 3.7 3.8 11.2 8.6 4.2 5.0 5.4 3.8 1.2 5.7 0.0 6.0 3.6 6.5 12.9 14.4 14.2 18.8 10.9 7.3 7.9 4.2 3.0 SMN2 "BCD541, GEMIN1, SMNC, TDRD16B" ENSG00000205571 "Survival of motor neuron 2, centromeric" Q16637 5 70049612-70078522 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 35.4;Club cells: 30.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 38.4;MOLT-4: 34.4;NB-4: 32.3" "CAB009344, HPA045271, HPA073601" Supported Supported "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "CAB009344: AB_2193083, HPA045271: AB_2679280, HPA073601: " "unprognostic (2.07e-2)" "unprognostic (5.70e-3)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.77e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.21e-1)" "unprognostic (5.19e-2)" "unprognostic (2.98e-5)" "unprognostic (2.36e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (1.19e-1)" 3.9 2.7 5.4 3.7 4.8 10.4 4.2 5.6 9.8 3.9 4.0 0.2 4.9 19.1 10.0 2.9 11.5 3.2 5.2 5.1 6.6 5.4 6.2 8.6 4.1 7.0 7.9 11.4 5.0 3.8 4.7 6.9 8.5 5.4 5.2 3.3 2.6 12.1 5.5 4.0 5.4 9.8 5.1 0.0 10.9 4.8 15.0 14.0 4.7 14.9 9.2 15.6 6.2 16.9 0.2 0.1 0.0 6.7 8.1 38.4 9.0 5.8 11.7 11.6 0.1 0.1 0.3 26.1 9.3 0.3 7.6 0.2 0.0 7.8 0.2 0.3 18.4 0.0 0.6 0.0 0.3 0.0 0.0 15.0 0.0 0.3 6.7 0.2 0.0 0.0 0.1 0.0 0.1 34.4 32.3 0.1 0.0 0.1 0.0 13.2 19.6 7.7 0.0 9.6 21.0 17.1 3.8 24.1 0.0 12.2 7.6 16.1 8.0 0.3 0.1 0.2 0.1 0.3 21.6 0.1 0.0 21.9 3.9 6.1 4.7 8.1 14.9 15.0 13.7 13.1 9.3 13.1 15.0 15.6 13.1 1.2 9.2 10.1 14.0 13.1 6.2 6.0 5.6 1.9 3.1 12.0 0.1 35.4 0.0 20.1 30.7 1.8 0.0 5.9 5.0 2.4 10.8 5.2 1.0 0.0 0.9 4.2 6.6 1.2 8.1 2.4 2.3 1.6 1.7 3.1 2.2 5.4 6.6 5.1 1.7 4.6 2.7 0.5 2.9 0.0 4.9 3.1 0.9 0.0 7.2 9.4 10.2 11.0 5.9 5.0 3.3 2.0 SMOX "C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO" ENSG00000088826 "Spermine oxidase" Q9NWM0 20 4120980-4187747 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 48.0;Pancreatic endocrine cells: 84.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.1;neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 35.5;Karpas-707: 60.7;RPTEC TERT1: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047117, HPA060198" Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Vesicles, Cytosol" "HPA047117: AB_2679940, HPA060198: AB_2684220" "unprognostic (1.24e-2)" "unprognostic (6.55e-2)" "unprognostic (7.24e-3)" "unprognostic (2.77e-1)" "unprognostic (1.40e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (3.33e-6)" "prognostic unfavorable (1.36e-4)" "unprognostic (4.92e-2)" "unprognostic (3.37e-1)" "unprognostic (7.18e-2)" "unprognostic (7.58e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (4.08e-2)" "unprognostic (2.64e-3)" "unprognostic (1.26e-2)" "unprognostic (3.07e-1)" 3.5 3.1 26.0 4.1 22.7 24.2 3.4 10.1 29.0 9.6 6.7 23.5 17.6 9.5 10.2 6.9 6.1 4.7 14.0 2.9 28.8 16.2 3.8 4.4 2.1 4.0 25.1 16.5 9.2 28.9 8.7 6.0 5.7 20.7 8.1 1.4 6.5 10.6 10.2 2.5 7.8 7.1 3.9 25.9 2.9 7.4 3.9 24.1 0.3 3.9 3.4 2.6 5.3 5.2 0.1 2.1 3.5 0.9 0.2 0.2 15.3 3.2 35.5 2.5 1.8 1.7 2.6 4.5 4.6 8.9 3.4 2.3 14.6 8.9 0.0 1.5 4.2 5.5 6.5 2.0 2.2 1.4 0.0 1.1 6.2 1.1 14.8 10.9 1.2 2.5 9.8 4.0 7.1 3.0 4.1 6.0 5.0 1.3 60.7 2.0 1.0 2.3 3.5 3.1 3.1 4.9 2.0 3.1 8.4 28.0 2.4 0.5 2.1 8.6 1.0 15.9 1.3 0.1 1.5 7.1 3.9 3.7 0.7 3.6 2.8 0.4 0.0 3.2 1.5 3.0 0.0 0.9 0.1 0.0 0.4 0.0 0.1 0.2 0.2 2.1 0.0 0.0 0.0 3.5 0.2 0.1 1.0 0.0 15.3 26.0 22.7 10.1 17.6 28.8 16.2 25.1 16.5 20.7 24.1 0.0 0.3 1.5 9.5 11.2 0.5 1.4 12.7 1.4 4.5 10.4 0.0 0.3 0.0 48.0 3.1 5.6 2.1 23.3 26.4 0.6 9.5 12.1 5.7 2.0 16.2 0.0 5.8 14.1 3.4 5.6 13.6 10.4 8.5 36.9 2.1 28.2 84.5 0.8 12.7 1.4 1.3 0.0 8.1 4.2 4.9 9.3 0.2 0.0 2.9 8.8 SMPD4 "FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3" ENSG00000136699 "Sphingomyelin phosphodiesterase 4" Q9NXE4 2 130151392-130182750 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046279, HPA049426" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA046279: AB_2679611, HPA049426: AB_2680762" "unprognostic (5.02e-2)" "unprognostic (9.61e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.69e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (3.27e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.73e-4)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.74e-1)" "unprognostic (2.28e-1)" "unprognostic (1.47e-3)" "unprognostic (2.09e-1)" 13.2 16.1 12.4 17.1 20.7 39.1 14.8 22.1 25.1 19.9 15.8 31.4 15.3 15.5 22.5 14.1 19.3 19.5 12.7 13.4 13.2 16.0 14.3 18.5 14.7 20.5 21.3 12.2 22.2 22.2 24.1 31.2 24.3 19.5 16.3 16.7 17.7 17.1 15.2 17.0 17.5 15.2 18.3 16.0 16.4 14.5 23.6 21.6 27.9 22.8 19.6 27.1 16.9 16.6 10.5 9.8 14.5 11.4 11.7 15.2 9.7 32.0 15.8 20.0 14.8 10.3 7.6 26.1 17.1 12.7 25.2 21.1 45.8 16.5 20.9 15.2 17.1 14.4 18.2 25.5 22.6 17.5 27.7 24.7 23.5 17.0 36.3 8.8 26.2 15.0 8.8 15.2 28.3 11.3 9.3 14.5 20.9 29.2 17.0 14.1 17.3 27.4 13.2 30.7 13.7 21.1 29.1 15.2 22.7 10.7 15.2 27.8 15.6 16.8 20.6 7.5 11.6 14.0 11.5 11.2 21.6 21.0 14.1 20.0 14.8 16.6 28.1 19.5 15.0 15.3 1.8 9.3 14.5 13.9 11.4 15.2 9.5 10.4 12.4 9.8 10.5 10.2 11.4 4.5 11.7 8.0 6.4 9.4 9.7 12.4 20.7 22.1 25.1 13.2 16.0 21.3 12.2 19.5 21.6 3.0 9.9 10.2 9.1 13.4 20.0 3.2 5.1 6.7 6.8 7.0 11.8 19.8 8.3 8.1 17.4 7.4 7.1 0.0 10.5 21.1 10.3 8.6 5.8 13.5 12.1 14.3 12.6 9.8 9.4 32.6 13.6 6.5 15.1 5.4 12.5 7.8 11.0 9.1 17.3 5.6 15.1 0.0 8.0 24.0 22.0 18.1 13.0 12.8 12.1 7.9 SMPDL3B ASML3B ENSG00000130768 "Sphingomyelin phosphodiesterase acid like 3B" Q92485 1 27934993-27959157 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 24.4;Enterocytes: 33.4;Pancreatic endocrine cells: 24.8;Paneth cells: 43.2;Undifferentiated cells: 29.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 5.6" "Group enriched" "Detected in some" 7 "eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8" "Group enriched" "Detected in many" 8 "dendritic cells: 2.7;granulocytes: 6.3" "Cell line enhanced" "Detected in many" "BEWO: 23.1;CAPAN-2: 17.8;NTERA-2: 13.7;RPMI-8226: 14.3;SK-BR-3: 23.0;T-47d: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030561 Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 330000 Cytosol "Golgi apparatus" "HPA030561: AB_10604095" "unprognostic (1.22e-2)" "unprognostic (4.45e-1)" "unprognostic (4.58e-3)" "unprognostic (3.83e-2)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.50e-1)" "unprognostic (2.68e-1)" "unprognostic (3.95e-1)" "unprognostic (6.02e-2)" "unprognostic (1.64e-1)" "unprognostic (3.02e-1)" "unprognostic (2.48e-2)" "unprognostic (2.40e-1)" "unprognostic (1.48e-1)" "unprognostic (4.40e-2)" "unprognostic (3.09e-3)" 1.3 0.2 1.1 2.7 1.4 0.6 2.7 5.6 1.2 1.3 14.0 0.5 0.5 12.5 1.1 8.6 1.1 3.5 3.6 0.5 0.8 0.5 5.8 0.8 7.3 2.0 0.3 0.9 1.3 48.0 5.0 1.5 1.0 1.0 2.3 12.6 1.3 25.5 0.5 0.3 0.9 25.0 0.8 0.8 1.6 9.1 1.0 0.3 0.7 24.4 1.4 3.5 1.4 0.5 0.5 2.7 6.3 0.3 0.5 0.2 0.2 2.6 1.2 0.0 0.1 0.0 0.0 23.1 0.0 0.5 0.3 1.7 5.9 17.8 0.8 4.2 0.0 0.3 2.9 1.9 1.6 0.3 0.0 11.8 3.8 0.2 1.4 0.0 1.2 0.0 0.1 1.4 3.5 0.2 0.5 0.5 0.1 0.5 0.2 0.0 9.3 0.0 0.4 13.7 2.0 2.1 0.2 0.1 14.3 12.4 4.6 11.9 0.2 0.0 23.0 0.6 2.5 16.6 0.7 0.0 0.0 3.9 0.0 0.0 0.1 6.0 0.3 0.4 0.0 0.0 0.4 0.3 6.3 0.0 0.3 0.0 0.5 0.1 0.0 2.7 0.5 0.2 0.0 3.8 0.5 0.0 0.1 0.0 0.2 1.1 1.4 5.6 1.2 0.8 0.5 0.3 0.9 1.0 0.3 8.9 13.2 2.2 2.4 0.1 0.0 0.3 2.5 4.0 15.9 8.7 0.0 2.2 0.0 24.4 0.2 0.1 33.4 0.0 19.9 0.1 0.0 5.5 0.0 0.0 0.3 0.0 19.7 0.6 0.0 0.0 0.0 0.8 0.0 0.0 23.2 0.0 24.8 43.2 0.0 6.7 0.0 0.0 0.8 0.0 0.1 0.1 6.4 1.3 29.8 2.5 SMS "MRSR, SPMSY, SpS, SRS" ENSG00000102172 "Spermine synthase" P52788 X 21940573-21994835 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Polyamine biosynthesis" Transferase "FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 588.3;Distal tubular cells: 515.6;Syncytiotrophoblasts: 727.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029849, HPA029852" Approved Approved "Nuclear bodies,Cytosol" No No 26000 "Nuclear bodies" Cytosol "HPA029849: AB_10602072, HPA029852: AB_10611521" "unprognostic (2.51e-2)" "unprognostic (2.91e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (7.49e-4)" "prognostic unfavorable (7.79e-8)" "unprognostic (1.02e-2)" "unprognostic (2.72e-1)" "unprognostic (3.18e-3)" "unprognostic (3.95e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (7.85e-5)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" "unprognostic (8.50e-2)" 21.7 48.1 29.7 18.7 25.0 18.6 28.4 36.6 35.4 20.8 23.1 8.1 26.0 23.5 20.8 31.3 19.2 13.3 20.9 26.3 22.3 25.0 55.1 19.5 17.6 18.5 25.6 28.5 42.4 16.7 13.6 19.2 63.6 24.2 61.3 24.4 15.7 20.7 20.6 18.0 9.7 25.1 36.8 17.4 18.9 18.8 18.4 11.0 19.6 27.6 11.7 20.8 28.2 16.5 13.2 19.4 37.0 25.7 11.7 20.3 12.3 83.0 21.3 36.2 13.8 9.6 16.3 11.2 22.8 13.6 35.0 33.6 26.3 27.2 30.2 7.9 23.2 96.8 18.3 35.5 41.6 69.4 13.9 16.6 15.6 25.6 18.7 17.7 30.2 13.7 10.7 12.7 36.0 67.7 25.5 33.5 12.2 33.2 4.2 47.8 17.7 22.2 30.2 61.5 18.8 31.6 22.2 24.9 22.9 46.7 11.8 17.3 14.0 18.2 23.4 60.0 96.2 21.1 12.6 29.6 25.4 25.6 52.7 37.0 3.2 6.5 17.9 49.6 13.4 35.2 2.9 21.4 37.0 7.6 22.1 9.4 13.2 12.0 13.2 19.4 8.3 7.9 9.3 21.1 11.7 25.7 4.0 20.3 12.3 29.7 25.0 36.6 35.4 22.3 25.0 25.6 28.5 24.2 11.0 23.8 21.6 43.8 142.7 58.5 33.8 30.5 48.4 48.2 55.7 104.7 11.8 588.3 515.6 219.3 1.6 38.1 67.1 0.0 132.3 261.4 79.8 237.6 39.3 44.0 322.1 20.6 56.6 52.8 131.4 3.6 88.3 123.6 87.7 344.5 84.4 32.3 142.0 65.4 97.2 354.3 33.3 64.7 46.4 5.9 214.2 44.3 727.3 67.0 102.6 134.1 SMUG1 "FDG, HMUDG, UNG3" ENSG00000123415 "Single-strand-selective monofunctional uracil-DNA glycosylase 1" Q53HV7 12 54121277-54189008 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026804, HPA065892" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA026804: , HPA065892: " "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.58e-2)" "unprognostic (7.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.82e-1)" "unprognostic (6.12e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.67e-3)" "unprognostic (3.35e-1)" "unprognostic (2.41e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (2.46e-1)" "unprognostic (1.73e-1)" 9.5 15.2 17.3 7.0 16.4 4.9 15.5 13.2 16.1 9.8 11.1 11.7 13.5 9.2 9.5 24.1 19.2 14.2 9.2 10.7 15.0 7.8 13.8 23.5 7.8 17.0 11.5 15.0 10.3 23.6 8.3 11.5 14.9 14.4 11.9 10.5 14.2 16.2 10.9 13.6 16.4 16.2 9.2 10.4 11.2 15.2 12.1 14.1 12.6 12.4 6.1 13.1 10.0 9.8 24.2 23.8 38.0 25.0 13.0 20.8 17.0 13.1 24.3 9.6 9.9 17.8 13.9 16.2 10.2 13.4 16.1 14.7 24.3 29.5 7.9 26.2 14.7 15.1 17.3 6.7 26.9 10.4 8.2 14.1 11.8 19.4 17.3 21.3 7.9 14.7 15.9 42.0 18.9 18.8 17.6 12.9 14.1 19.6 17.3 17.6 25.4 9.8 15.4 11.9 22.6 22.0 7.2 9.8 14.2 19.9 19.4 14.3 17.0 11.7 20.2 17.9 20.3 31.5 14.9 6.2 10.8 12.0 9.7 11.6 16.2 12.7 5.3 15.7 6.2 16.3 38.0 25.0 28.7 15.8 19.7 15.7 24.2 15.6 17.0 21.1 18.8 14.1 14.1 24.5 13.0 15.8 23.8 20.8 17.0 17.3 16.4 13.2 16.1 15.0 7.8 11.5 15.0 14.4 14.1 6.0 13.6 25.1 12.2 6.6 9.3 17.5 17.8 29.4 11.4 24.4 7.9 73.8 51.4 31.2 3.9 10.8 34.2 0.0 34.9 84.6 11.8 15.7 2.3 42.7 39.7 6.4 11.1 16.5 16.8 8.1 17.3 14.0 5.0 41.5 23.4 10.0 39.3 24.6 16.6 49.7 9.3 32.3 9.6 25.1 29.2 9.2 83.6 15.0 23.3 16.5 SMYD2 "HSKM-B, KMT3C, ZMYND14" ENSG00000143499 "SET and MYND domain containing 2" Q9NRG4 1 214281102-214337131 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 75.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 109.6;Cytotrophoblasts: 142.7;Early spermatids: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029023 Uncertain Approved "Intermediate filaments,Mitochondria,Cytosol" NA NA Cytosol "Intermediate filaments, Mitochondria" "HPA029023: AB_10601605" "unprognostic (8.53e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (5.98e-2)" "unprognostic (1.00e-2)" "unprognostic (8.55e-2)" "unprognostic (2.53e-2)" "unprognostic (2.24e-2)" "unprognostic (1.72e-2)" "unprognostic (1.90e-3)" "unprognostic (1.65e-1)" "unprognostic (9.44e-2)" "unprognostic (2.77e-1)" "prognostic favorable (8.68e-4)" "unprognostic (2.65e-1)" "unprognostic (4.92e-2)" "unprognostic (8.10e-2)" "unprognostic (6.37e-2)" 5.9 5.7 8.8 5.6 7.3 2.7 10.0 5.0 23.9 4.9 4.7 2.1 3.1 4.8 3.8 6.7 7.3 10.4 4.5 75.7 7.0 8.4 7.7 9.7 8.1 8.0 5.3 10.0 4.7 7.8 2.9 7.5 10.6 6.9 4.6 5.8 3.1 6.2 3.0 29.5 4.3 4.7 3.8 4.7 6.2 6.2 8.9 2.2 8.0 7.8 5.1 5.6 5.2 4.0 9.3 5.5 8.1 5.9 17.6 14.5 7.3 24.5 7.1 9.7 6.8 10.0 17.5 41.3 13.9 11.5 17.6 20.0 28.0 21.0 12.7 14.3 15.7 9.6 11.6 9.2 25.8 17.1 10.6 10.7 4.1 12.0 22.3 9.0 17.8 2.9 18.7 14.6 12.2 9.7 12.2 12.7 12.2 12.9 3.2 15.7 12.8 12.4 11.2 8.7 14.4 9.7 7.7 23.5 10.8 17.4 18.0 9.6 22.4 10.8 38.9 28.6 23.3 30.3 11.9 14.6 13.7 20.2 7.5 21.5 13.1 4.9 14.6 17.8 14.2 15.6 6.7 5.9 8.1 9.5 3.2 11.2 9.3 14.5 12.7 5.5 4.8 12.7 11.6 0.6 17.6 1.2 3.8 14.5 7.3 8.8 7.3 5.0 23.9 7.0 8.4 5.3 10.0 6.9 2.2 17.9 11.9 11.2 14.0 18.3 3.8 109.6 22.9 48.2 12.5 3.5 0.0 142.7 26.6 32.4 113.6 10.8 12.7 0.0 17.4 93.2 12.2 8.9 3.5 15.5 33.9 14.3 4.1 22.1 17.4 93.5 10.9 9.9 15.1 10.8 15.2 15.2 22.5 10.5 3.5 27.8 4.6 12.9 15.7 15.2 43.7 15.7 71.9 12.8 20.8 7.6 SMYD3 "KMT3E, ZMYND1, ZNFN3A1" ENSG00000185420 "SET and MYND domain containing 3" Q9H7B4 1 245749342-246507312 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 108.5;Late spermatids: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 95.1;K-562: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012229, HPA045821, HPA054352" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458" "unprognostic (7.00e-3)" "unprognostic (7.45e-2)" "unprognostic (1.52e-1)" "unprognostic (6.18e-3)" "unprognostic (3.32e-2)" "unprognostic (5.08e-3)" "unprognostic (3.25e-3)" "unprognostic (1.72e-3)" "unprognostic (4.53e-2)" "unprognostic (1.57e-1)" "unprognostic (1.71e-1)" "unprognostic (2.10e-1)" "unprognostic (3.78e-5)" "unprognostic (9.03e-3)" "unprognostic (2.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.58e-1)" 6.0 12.0 9.9 9.7 16.2 7.6 10.6 25.9 14.7 8.9 6.5 6.4 3.7 4.5 8.7 21.8 6.1 10.0 7.7 5.8 10.3 12.0 8.9 5.5 9.2 6.3 12.0 10.2 8.0 7.2 6.7 11.9 4.6 15.3 6.8 8.3 9.5 5.3 5.9 9.5 6.7 5.2 7.6 6.8 5.3 6.1 10.5 8.1 7.5 18.8 3.6 9.3 8.3 6.6 11.3 5.9 8.3 3.4 19.4 12.9 8.7 4.7 2.9 4.2 3.6 4.8 6.6 4.2 6.7 5.0 7.9 17.8 3.7 5.5 7.7 5.4 6.2 4.9 3.1 3.8 7.5 26.5 4.0 3.9 4.5 4.3 4.5 9.0 4.6 95.1 17.7 1.8 10.4 6.7 6.0 5.4 5.5 35.9 2.7 7.7 1.6 8.7 8.8 3.7 6.6 4.7 8.1 5.1 11.2 5.7 6.9 10.0 4.8 3.1 0.4 6.1 4.7 3.9 7.8 4.1 3.8 2.6 2.7 7.9 13.6 3.7 4.0 7.3 6.3 4.4 8.1 3.4 8.3 10.5 3.0 10.8 11.3 11.1 12.8 5.9 11.1 12.3 12.9 2.4 19.4 3.3 3.8 11.8 8.7 9.9 16.2 25.9 14.7 10.3 12.0 12.0 10.2 15.3 8.1 6.0 27.8 5.3 13.2 10.9 5.8 7.7 2.5 44.2 13.6 12.2 21.6 7.8 13.3 20.6 46.2 11.7 4.2 0.0 28.1 33.5 15.4 5.4 108.5 4.2 10.3 9.5 24.1 9.2 3.8 74.1 10.3 6.0 11.8 1.8 8.3 9.1 16.5 2.9 16.3 14.6 13.9 0.0 15.1 17.3 24.7 10.0 6.1 13.6 9.2 6.4 SMYD4 "KIAA1936, ZMYND21" ENSG00000186532 "SET and MYND domain containing 4" Q8IYR2 17 1779485-1830634 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030059 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA030059: AB_2191728" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (2.47e-1)" "unprognostic (4.23e-2)" "unprognostic (1.13e-2)" "unprognostic (3.66e-2)" "unprognostic (4.03e-2)" "unprognostic (1.04e-1)" "unprognostic (1.79e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-3)" "unprognostic (9.26e-3)" "unprognostic (3.63e-2)" "unprognostic (1.33e-2)" "unprognostic (7.35e-2)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" 10.6 10.0 8.6 13.8 9.6 4.8 11.0 16.3 11.8 9.9 10.8 9.6 9.6 11.5 15.3 8.7 6.3 10.1 7.1 11.0 6.3 6.1 6.1 7.4 8.5 10.4 7.4 6.7 15.5 21.7 5.4 11.3 7.7 9.2 10.1 8.3 10.7 14.1 15.5 19.3 10.6 12.9 10.0 9.2 10.0 7.6 9.2 8.2 12.8 9.1 5.6 12.2 10.8 12.8 6.1 6.3 11.5 4.3 4.1 7.9 3.0 6.0 11.4 11.5 8.2 7.9 5.4 13.4 9.9 5.7 10.5 10.9 18.1 5.2 16.2 6.7 4.0 7.1 11.8 10.9 6.4 13.2 4.6 11.0 5.9 12.1 4.9 3.9 6.0 5.8 3.8 5.8 10.8 9.6 5.4 5.2 14.0 6.2 6.3 8.2 3.7 10.9 4.2 5.2 7.2 5.6 13.6 5.8 4.1 4.2 7.4 4.7 6.5 9.2 3.8 9.5 9.8 5.5 3.7 5.0 10.3 5.3 8.6 8.5 4.4 5.9 5.8 5.8 5.3 10.1 11.5 3.6 3.2 7.9 4.3 6.5 6.1 4.6 5.0 2.1 3.8 5.3 7.6 2.1 4.1 3.3 6.3 4.8 3.0 8.6 9.6 16.3 11.8 6.3 6.1 7.4 6.7 9.2 8.2 6.0 26.7 8.5 8.1 4.4 19.2 4.5 7.6 17.4 17.0 7.0 31.4 7.8 1.7 4.6 19.6 9.0 8.1 0.0 2.9 8.7 10.3 5.9 7.0 5.9 11.2 25.4 3.5 19.6 13.7 5.1 25.0 14.5 5.0 15.4 4.2 7.0 3.2 0.0 23.3 2.2 19.3 45.3 21.7 13.3 14.9 5.8 6.8 7.5 5.0 3.1 SNAP29 "CEDNIK, SNAP-29" ENSG00000099940 "Synaptosome associated protein 29" O95721 22 20858983-20891218 "Disease related genes, Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Protein transport, Transport" "Ichthyosis, Neuropathy, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 381.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031823, CAB037092, HPA056492" Supported Supported Nucleoplasm,Cytosol NA NA 34000 Cytosol Nucleoplasm "CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: AB_2683151" "unprognostic (1.76e-1)" "prognostic favorable (6.99e-4)" "unprognostic (3.72e-3)" "unprognostic (3.26e-2)" "unprognostic (7.83e-3)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (2.05e-2)" "unprognostic (1.34e-2)" "unprognostic (2.60e-2)" "unprognostic (3.68e-2)" "unprognostic (6.85e-2)" "unprognostic (1.22e-1)" "unprognostic (2.52e-1)" "unprognostic (1.45e-1)" "unprognostic (4.51e-3)" "unprognostic (6.08e-2)" 19.4 18.8 15.9 15.5 15.3 15.7 15.5 13.4 19.7 16.0 18.8 15.3 17.1 16.5 15.2 11.6 21.7 12.3 19.9 23.1 13.8 13.0 17.7 36.1 13.4 20.1 15.1 12.3 15.7 16.6 13.1 11.5 26.4 13.7 13.6 17.7 19.0 17.7 17.1 27.6 17.6 16.8 17.6 15.9 24.1 17.4 47.0 14.9 18.3 15.1 15.9 18.2 15.3 16.3 10.8 20.0 23.0 33.2 26.1 14.9 14.0 15.8 6.5 9.3 7.6 10.6 15.5 12.0 15.1 13.7 17.1 17.3 8.9 5.6 9.9 9.7 14.1 17.3 9.4 12.1 10.2 18.5 14.3 9.3 16.5 7.3 9.6 15.1 14.6 13.4 12.2 14.5 17.9 12.9 11.8 11.9 8.6 71.7 14.2 15.7 10.9 13.2 14.1 3.0 18.6 6.9 12.8 20.8 4.0 10.0 8.5 7.6 9.1 16.2 10.2 17.1 12.0 16.0 11.7 10.3 17.5 15.9 11.9 11.8 14.6 23.7 18.3 13.0 9.9 12.5 19.5 20.0 23.0 10.6 27.4 11.0 10.8 10.5 11.4 17.4 9.2 9.7 9.8 22.6 26.1 33.2 20.0 14.9 14.0 15.9 15.3 13.4 19.7 13.8 13.0 15.1 12.3 13.7 14.9 11.9 25.3 19.3 18.6 14.8 11.9 16.5 25.5 41.5 11.4 22.7 11.8 70.8 36.5 35.3 381.3 28.6 30.4 0.0 43.9 127.0 24.8 21.1 28.8 40.8 65.9 19.1 21.2 25.2 35.8 158.3 30.8 40.3 33.7 45.9 26.5 29.2 45.6 17.3 34.3 25.4 12.6 38.8 19.5 70.9 80.9 13.6 82.2 21.7 24.8 25.5 SNAP47 "C1orf142, SNAP-47, SVAP1" ENSG00000143740 "Synaptosome associated protein 47" Q5SQN1 1 227728539-227781231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028167 Supported Approved Cytosol NA NA Cytosol "HPA028167: AB_10603032" "unprognostic (3.31e-2)" "unprognostic (1.31e-1)" "unprognostic (1.93e-2)" "unprognostic (7.31e-2)" "unprognostic (4.88e-2)" "unprognostic (2.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.07e-1)" "unprognostic (1.34e-2)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (6.14e-2)" "unprognostic (4.81e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-1)" 7.4 23.8 21.2 10.8 27.8 6.7 16.2 21.2 29.0 12.4 10.0 10.7 6.9 8.3 21.3 13.4 10.8 15.7 9.8 30.7 21.0 15.1 11.9 14.7 10.0 13.5 12.9 17.4 29.5 17.1 20.7 15.8 16.2 11.6 11.3 8.5 12.6 14.8 10.4 20.4 11.2 8.0 16.6 8.4 9.0 9.2 25.5 11.4 11.6 15.6 9.2 11.9 11.5 9.9 15.4 14.7 20.2 15.1 18.2 29.8 14.7 17.3 24.1 15.2 14.5 18.7 14.7 19.5 11.3 18.1 18.5 15.5 15.9 16.1 12.5 20.7 18.2 14.9 19.1 19.3 21.4 15.9 24.5 34.2 10.7 17.0 10.8 11.5 15.5 9.8 16.8 17.8 24.0 12.9 16.3 15.5 15.1 19.4 12.9 19.1 11.4 15.6 14.8 24.2 22.9 35.0 17.6 17.1 19.3 13.4 15.9 30.2 17.8 17.4 24.6 17.0 16.6 29.8 15.0 11.6 17.6 21.2 16.9 27.5 16.3 11.8 15.2 16.0 12.1 22.4 10.1 13.0 20.2 19.2 12.4 18.4 15.4 21.8 22.0 14.3 13.9 18.6 17.0 4.7 18.2 15.1 14.7 29.8 14.7 21.2 27.8 21.2 29.0 21.0 15.1 12.9 17.4 11.6 11.4 6.0 12.5 22.7 14.5 11.8 28.6 10.1 12.7 9.4 11.4 14.0 25.5 21.8 29.9 17.7 39.1 9.0 8.9 0.0 15.7 23.8 13.7 11.9 5.7 11.6 14.4 39.7 15.5 9.2 6.7 71.2 23.9 6.4 11.8 23.4 7.5 28.1 14.4 0.0 19.4 14.6 31.0 12.9 10.3 24.5 23.0 13.4 23.0 22.0 9.5 8.4 SNAP91 "AP180, CALM, KIAA0656" ENSG00000065609 "Synaptosome associated protein 91" O60641 6 83552880-83709691 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 81.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 46.7;Cone photoreceptor cells: 58.9;Early spermatids: 16.0;Horizontal cells: 30.2;Rod photoreceptor cells: 59.2;Spermatocytes: 25.0" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.3" "Group enriched" "Detected in some" 11 "GAMG: 6.7;SCLC-21H: 21.5;SH-SY5Y: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009745, HPA029632, HPA029633" Enhanced Uncertain Centrosome,Cytosol NA NA "Centrosome, Cytosol" "CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615" "unprognostic (1.07e-2)" "unprognostic (1.74e-1)" "unprognostic (7.55e-3)" "unprognostic (3.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.54e-4)" "unprognostic (6.99e-2)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (2.15e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" 1.2 8.0 17.8 1.9 25.5 1.1 1.7 44.2 81.9 2.1 1.7 3.4 0.0 1.4 1.7 1.2 1.3 1.8 2.0 1.3 19.2 19.9 1.2 1.1 1.4 3.3 14.3 20.5 3.1 2.4 1.1 9.3 1.6 34.7 3.9 1.7 4.5 1.6 1.7 1.2 1.3 1.7 1.8 7.0 2.2 1.9 10.8 2.9 0.0 2.0 0.0 2.7 1.3 0.2 0.0 6.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 6.7 0.3 0.9 0.0 0.0 0.3 1.3 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.1 0.2 21.5 13.4 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 17.8 25.5 44.2 43.6 19.2 19.9 14.3 20.5 34.7 2.9 0.0 0.0 0.0 0.0 0.0 46.7 0.8 0.0 0.0 0.0 0.0 58.9 1.0 0.0 0.0 16.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 30.2 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.0 0.0 8.9 0.5 0.0 1.1 0.0 59.2 0.0 0.0 25.0 2.4 0.0 3.7 0.0 0.0 0.0 SNAPC2 "PTFdelta, SNAP45" ENSG00000104976 "Small nuclear RNA activating complex polypeptide 2" Q13487 19 7920316-7923250 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049843, HPA077597" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049843: AB_2680910, HPA077597: AB_2732354" "unprognostic (4.56e-3)" "unprognostic (1.89e-1)" "unprognostic (7.98e-3)" "unprognostic (8.11e-3)" "unprognostic (2.03e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (1.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (3.22e-1)" "unprognostic (5.30e-2)" "unprognostic (9.78e-2)" 12.5 15.1 11.0 14.2 17.1 20.3 12.0 19.3 19.8 30.8 20.0 13.2 11.9 14.2 32.4 11.8 20.3 21.8 12.1 12.1 11.7 11.6 15.6 11.1 12.3 12.4 10.6 13.6 24.2 15.1 12.0 16.5 13.6 12.2 24.8 6.0 10.8 18.0 27.0 8.1 16.4 11.3 22.8 9.1 14.8 11.9 28.7 12.3 18.3 17.5 10.4 11.4 29.9 16.1 11.5 20.1 14.7 20.9 17.7 15.5 10.4 9.1 10.7 5.1 19.7 7.0 15.1 4.6 9.7 10.5 9.7 8.8 4.9 8.0 7.9 12.2 11.4 7.7 11.3 3.5 7.3 2.8 10.1 9.0 11.0 4.7 6.9 12.8 6.8 18.3 12.3 11.3 11.4 7.0 7.9 11.0 8.4 10.8 13.3 5.9 8.1 8.7 19.5 6.4 4.7 23.8 10.4 5.0 7.8 8.9 3.2 6.0 13.4 5.0 5.5 21.8 2.3 8.9 7.5 14.1 32.8 11.6 30.6 12.1 12.7 20.8 4.8 20.5 14.3 10.3 4.5 16.4 14.7 13.7 20.9 13.7 11.5 11.7 11.8 20.1 11.0 12.2 12.2 2.4 17.7 20.7 13.3 15.5 10.4 11.0 17.1 19.3 19.8 11.7 11.6 10.6 13.6 12.2 12.3 3.0 3.0 13.5 18.0 21.6 7.9 2.6 7.6 0.0 3.4 10.4 0.0 10.4 14.9 20.2 1.4 15.7 11.6 0.0 21.1 18.3 26.1 27.3 18.4 4.7 26.0 22.3 11.5 11.6 20.4 5.2 12.7 24.4 18.6 41.5 10.5 5.7 22.2 3.5 13.4 12.9 5.4 12.9 30.3 8.6 21.2 21.2 8.2 21.9 12.0 19.5 SND1 "p100, TDRD11" ENSG00000197157 "Staphylococcal nuclease and tudor domain containing 1" Q7KZF4 7 127652180-128092609 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Endonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 195.0;Syncytiotrophoblasts: 223.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002529, HPA002632, CAB019323" Enhanced Enhanced Cytosol NA NA 1200000 Cytosol "CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316" "unprognostic (2.06e-1)" "unprognostic (8.27e-3)" "unprognostic (2.21e-1)" "prognostic favorable (1.95e-4)" "unprognostic (5.10e-3)" "unprognostic (6.83e-2)" "unprognostic (1.17e-2)" "unprognostic (2.91e-2)" "unprognostic (4.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.30e-1)" "unprognostic (1.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.42e-2)" "unprognostic (2.26e-3)" 21.5 29.8 25.3 25.3 19.8 22.5 45.4 28.1 28.1 33.3 20.0 13.0 57.7 21.3 36.1 38.4 24.8 26.7 25.3 28.3 20.9 16.6 17.3 39.6 38.8 64.2 20.2 19.0 39.7 130.3 22.2 30.3 33.7 27.6 24.5 20.2 13.9 37.5 66.7 20.5 21.5 19.2 41.0 40.1 24.9 30.8 37.0 18.0 22.3 26.6 13.5 24.9 26.5 24.2 28.1 34.9 16.1 30.0 21.0 30.9 28.5 28.5 25.9 19.8 35.9 30.1 31.5 27.2 33.6 39.8 30.8 34.6 33.4 24.8 37.9 17.0 41.2 26.0 24.0 27.9 36.4 30.1 20.7 23.6 20.9 30.9 32.0 54.8 32.3 20.6 46.3 40.7 26.3 44.1 35.1 38.2 15.7 23.1 38.1 30.7 21.3 35.1 24.2 22.2 29.0 32.3 24.5 17.7 84.8 24.1 20.1 25.0 27.0 24.3 113.2 38.9 31.1 14.1 23.0 37.9 25.1 16.4 45.5 26.1 47.0 17.6 39.8 50.3 27.9 45.3 16.1 30.0 5.9 26.1 28.1 30.9 28.1 19.8 21.0 32.3 16.2 14.3 15.8 2.2 21.0 22.8 34.9 15.8 28.5 25.3 19.8 28.1 28.1 20.9 16.6 20.2 19.0 27.6 18.0 14.9 43.1 29.8 20.4 17.4 11.2 26.2 38.2 14.7 20.5 27.9 19.6 195.0 14.9 60.6 12.9 28.0 32.8 23.3 83.7 91.7 29.4 34.2 34.6 43.3 73.2 28.6 70.2 26.4 48.3 40.2 42.3 43.7 32.1 80.2 55.0 15.6 63.2 31.6 38.9 25.1 32.0 32.3 19.5 19.2 29.2 24.0 223.8 27.7 53.0 21.3 SNF8 "Dot3, EAP30, VPS22" ENSG00000159210 "SNF8, ESCRT-II complex subunit" Q96H20 17 48929316-48945117 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059320 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA059320: AB_2683977" "unprognostic (7.85e-3)" "unprognostic (3.97e-3)" "unprognostic (2.25e-2)" "unprognostic (1.73e-1)" "unprognostic (4.39e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (7.64e-4)" "unprognostic (1.91e-1)" "unprognostic (1.58e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (2.81e-7)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (3.52e-1)" "unprognostic (1.38e-1)" 22.5 27.8 24.9 20.6 26.2 25.2 32.4 12.9 22.6 17.9 23.5 16.6 29.7 22.1 18.9 28.7 23.0 17.7 24.9 31.5 20.1 19.2 30.8 39.0 18.2 27.3 23.9 21.5 22.3 26.7 17.9 17.4 21.7 19.0 17.6 26.8 18.3 25.2 23.1 40.7 19.2 24.0 25.7 18.2 20.7 24.7 19.8 16.0 28.3 24.0 30.9 26.2 20.5 33.8 5.2 8.3 11.2 6.7 1.7 5.7 1.5 16.2 32.6 20.3 26.0 21.3 12.3 32.1 13.7 19.0 26.9 24.2 80.0 17.0 14.9 24.1 25.8 29.8 10.8 18.9 19.4 30.1 21.3 30.6 16.5 41.3 33.7 18.6 22.3 18.8 15.2 19.4 25.7 19.8 19.7 25.2 19.8 16.3 15.2 27.4 32.5 23.9 19.1 10.0 37.4 27.8 15.8 37.1 17.6 16.1 18.2 13.5 26.9 16.5 7.8 19.5 36.9 19.7 27.6 20.9 29.2 23.2 18.1 25.6 22.4 25.5 17.8 25.7 12.1 22.5 2.3 5.7 11.2 3.2 6.2 1.8 5.2 4.8 3.7 6.4 5.2 3.2 2.7 2.3 1.7 6.7 8.3 5.7 1.5 24.9 26.2 12.9 22.6 20.1 19.2 23.9 21.5 19.0 16.0 41.7 27.2 74.6 57.6 53.0 60.3 44.8 58.6 22.7 21.6 61.1 13.7 113.8 126.0 110.9 94.7 52.8 126.5 46.7 189.8 142.2 81.0 77.8 42.7 60.4 132.7 23.8 68.0 52.2 59.1 220.7 58.1 82.3 81.0 155.1 68.0 59.1 136.4 75.9 58.4 173.8 74.5 45.3 80.6 58.1 73.3 63.2 79.5 65.1 79.7 77.0 SNIP1 PML1 ENSG00000163877 "Smad nuclear interacting protein 1" Q8TAD8 1 37534449-37554344 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036896 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036896: AB_10670244" "unprognostic (1.37e-1)" "unprognostic (2.83e-1)" "unprognostic (1.65e-3)" "unprognostic (7.24e-2)" "unprognostic (5.83e-2)" "unprognostic (8.30e-3)" "unprognostic (3.26e-2)" "unprognostic (3.66e-2)" "unprognostic (7.74e-2)" "unprognostic (5.01e-2)" "unprognostic (9.30e-2)" "unprognostic (5.34e-3)" "unprognostic (3.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" 10.6 13.4 10.6 13.3 12.4 15.9 15.0 18.4 14.4 12.8 10.8 10.0 14.2 8.5 14.2 11.9 13.5 11.9 10.0 8.5 11.1 9.0 9.9 20.6 10.2 11.7 10.8 10.5 12.7 15.3 9.8 13.1 13.2 9.9 13.3 9.0 12.3 11.7 11.5 13.5 13.2 12.3 11.6 7.9 14.9 11.8 21.7 11.6 16.9 10.5 11.1 14.0 11.7 17.0 3.7 4.3 4.6 3.5 3.1 5.5 1.8 6.2 3.5 7.0 6.9 8.4 8.0 4.8 8.0 9.1 7.7 6.7 3.4 5.7 8.6 6.3 8.5 5.0 6.6 6.5 7.3 6.4 7.7 9.4 13.2 6.2 6.9 9.6 12.2 7.5 7.7 8.6 7.6 9.7 8.3 7.4 6.7 9.3 8.0 5.4 4.7 7.2 9.5 11.3 5.2 8.1 7.6 11.8 7.2 5.6 6.0 5.6 11.3 8.5 5.5 10.4 7.6 4.9 6.7 12.2 6.1 6.8 7.5 7.9 9.5 11.0 7.1 7.2 8.7 5.4 4.1 3.1 3.9 5.5 2.8 5.4 3.7 3.7 5.3 2.6 3.6 5.1 4.5 4.6 3.1 3.5 4.3 4.2 1.8 10.6 12.4 18.4 14.4 11.1 9.0 10.8 10.5 9.9 11.6 17.9 14.8 3.4 10.6 14.3 10.1 4.8 5.1 10.7 19.4 5.2 7.9 4.7 1.7 6.3 4.6 6.5 7.3 0.0 6.2 4.0 8.4 7.8 11.5 10.0 3.9 9.5 8.1 12.3 8.1 7.9 7.5 5.2 8.5 7.2 8.6 11.3 6.5 6.0 7.4 3.5 15.4 0.0 7.5 10.2 13.2 15.7 8.5 10.2 6.6 11.2 SNN ENSG00000184602 Stannin O75324 16 11668414-11679159 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Cell type enhanced" "Detected in many" 7 "monocytes: 71.3;Muller glia cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 31.5;REH: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011055 Approved Uncertain Cytosol NA NA Cytosol "HPA011055: AB_1857326" "unprognostic (1.94e-1)" "unprognostic (7.26e-2)" "unprognostic (2.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (1.85e-6)" "unprognostic (4.51e-2)" "unprognostic (3.45e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.83e-5)" "unprognostic (4.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.58e-1)" "unprognostic (4.72e-2)" 29.2 16.6 34.7 10.0 51.5 11.0 13.7 27.2 52.2 6.9 4.4 11.2 1.8 4.9 6.8 11.5 10.5 5.9 12.0 13.2 33.0 15.5 7.0 5.1 9.2 15.0 29.8 25.2 9.8 4.7 4.5 4.6 4.5 15.6 8.1 3.3 6.9 9.9 12.9 29.1 4.5 4.4 6.6 15.2 17.4 4.6 2.2 11.4 6.1 9.5 4.8 14.2 9.3 6.1 7.0 9.0 24.1 20.3 0.3 3.0 7.4 3.0 2.9 31.5 8.5 20.9 6.0 3.0 1.3 2.8 3.8 3.8 4.7 2.1 3.1 12.9 4.3 6.7 6.0 9.4 3.7 2.9 0.8 2.1 10.4 3.2 6.2 5.6 0.7 6.3 5.2 17.2 2.0 4.2 5.4 7.0 9.3 1.6 5.0 3.5 5.1 8.3 2.3 16.3 3.8 2.1 29.4 4.2 21.7 3.5 9.0 18.8 7.6 7.1 9.4 4.6 12.9 3.8 6.2 6.2 4.4 9.2 25.7 1.3 2.0 1.3 7.4 2.6 8.9 5.5 0.0 9.5 6.9 0.3 16.3 0.3 7.0 1.6 0.7 9.0 6.8 3.0 2.1 24.1 0.3 20.3 3.6 0.9 7.4 34.7 51.5 27.2 39.3 33.0 15.5 29.8 25.2 15.6 11.4 0.0 6.7 34.4 17.9 16.4 6.5 14.3 10.2 4.0 3.4 5.2 0.0 1.0 21.6 15.0 0.6 14.3 0.0 0.0 16.3 19.9 8.2 15.5 13.8 2.4 17.7 6.4 5.1 20.3 27.0 0.0 4.6 26.4 20.3 71.3 0.2 90.5 13.6 0.0 14.5 4.4 5.9 6.5 26.7 0.3 2.1 16.7 1.1 5.7 0.4 9.1 SNRNP25 "C16orf33, U11/U12-25K" ENSG00000161981 "Small nuclear ribonucleoprotein U11/U12 subunit 25" Q9BV90 16 53010-57669 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.9;skeletal muscle: 63.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 56.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041183, HPA044248" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041183: AB_2677353, HPA044248: AB_2678873" "unprognostic (7.87e-2)" "prognostic favorable (1.95e-4)" "unprognostic (6.04e-2)" "unprognostic (5.03e-2)" "unprognostic (2.04e-1)" "unprognostic (5.99e-2)" "unprognostic (1.17e-1)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (8.99e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.16e-5)" "unprognostic (1.51e-1)" "unprognostic (1.52e-1)" "unprognostic (1.45e-1)" "unprognostic (6.03e-3)" 7.1 10.1 31.4 11.5 25.4 15.6 7.4 15.7 31.2 7.1 9.7 6.8 5.4 7.2 6.6 9.6 8.8 8.8 6.3 28.7 25.0 22.6 11.7 16.4 5.4 16.4 28.1 20.3 10.9 10.8 7.7 10.8 4.9 24.7 9.8 10.1 7.5 12.6 8.4 63.7 4.3 6.4 8.6 13.5 6.6 10.2 6.4 7.7 9.4 9.4 11.0 16.4 6.8 4.8 18.0 56.9 23.2 9.9 5.2 6.5 5.7 11.6 26.5 14.7 17.1 5.3 6.3 7.2 9.9 6.4 22.2 18.8 35.6 11.4 37.0 11.8 8.1 11.9 12.0 26.9 18.2 17.1 13.3 20.9 21.4 37.0 35.6 5.6 39.1 25.5 8.0 6.5 19.7 5.5 4.8 11.9 22.4 32.0 8.8 12.6 55.2 20.5 16.3 17.6 20.8 13.0 33.1 15.7 44.2 11.7 8.2 16.2 10.5 22.3 29.0 4.8 15.1 18.7 19.1 9.3 9.8 12.3 12.6 15.8 9.2 21.7 57.4 5.2 21.0 15.0 2.8 6.6 23.2 4.0 9.9 5.0 17.5 4.2 4.9 12.8 18.0 4.5 4.5 4.5 5.2 8.5 56.9 6.5 5.7 31.4 25.4 15.7 31.2 25.0 22.6 28.1 20.3 24.7 7.7 11.9 11.0 47.7 21.4 16.6 18.1 96.8 15.3 44.2 9.1 31.4 3.9 47.2 132.6 34.7 1.7 16.8 21.9 23.3 44.3 49.4 26.3 35.5 4.6 52.5 99.3 11.1 42.3 11.6 18.6 4.5 19.8 52.0 59.1 138.9 29.1 45.5 30.9 42.9 28.0 74.2 12.0 6.5 32.0 32.0 47.5 19.2 21.9 20.1 45.1 16.3 SNRNP48 "C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234" ENSG00000168566 "Small nuclear ribonucleoprotein U11/U12 subunit 48" Q6IEG0 6 7590199-7611967 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029234 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029234: AB_10604097" "prognostic unfavorable (8.30e-4)" "unprognostic (3.46e-2)" "unprognostic (2.65e-1)" "unprognostic (9.65e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (9.46e-3)" "unprognostic (2.55e-1)" "unprognostic (9.87e-3)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (1.55e-1)" "unprognostic (8.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.03e-1)" 9.5 7.1 12.3 11.7 14.9 15.6 12.6 28.9 13.3 10.5 10.3 7.0 13.6 9.9 11.7 8.6 9.4 9.2 7.1 12.2 11.9 7.5 10.7 12.7 8.6 11.7 14.1 8.1 14.4 10.5 7.3 11.0 9.2 11.4 10.5 10.1 5.9 10.1 13.0 15.8 11.0 11.5 10.5 17.8 11.2 9.6 5.3 14.3 15.3 10.4 7.1 10.0 9.9 30.2 3.3 2.7 6.0 2.0 2.7 3.7 1.7 5.7 4.6 9.7 18.0 5.2 7.7 6.5 6.6 6.1 7.2 8.0 9.8 4.7 13.6 7.1 5.4 6.9 7.4 12.0 7.1 11.1 10.4 11.7 9.8 14.7 18.8 5.5 11.6 6.5 5.4 11.0 8.1 6.2 8.6 6.2 12.2 13.6 2.2 10.0 3.2 19.0 16.9 13.1 9.9 5.2 20.5 8.4 18.2 6.5 5.1 15.0 4.1 12.8 3.3 11.3 18.7 6.5 4.1 6.9 9.6 4.3 5.6 11.3 3.5 19.4 8.4 3.2 9.3 17.1 0.4 2.0 1.0 2.0 1.4 3.4 1.7 2.4 2.6 2.4 3.3 2.1 3.7 6.0 2.7 0.8 2.7 1.7 1.7 12.3 14.9 28.9 13.3 11.9 7.5 14.1 8.1 11.4 14.3 17.9 9.3 14.1 18.6 31.7 17.1 25.2 5.1 8.1 21.6 8.7 19.6 13.5 10.0 15.9 2.2 20.2 18.4 0.0 17.5 12.7 12.9 15.7 23.1 19.5 13.7 4.8 10.9 13.5 16.4 2.2 16.4 16.3 8.5 21.6 15.0 15.3 10.9 15.2 15.6 13.5 17.2 6.5 17.9 10.2 17.9 29.6 13.6 17.5 13.8 18.0 SNRPD2 "Sm-D2, SNRPD1" ENSG00000125743 "Small nuclear ribonucleoprotein D2 polypeptide" P62316 19 45687454-45692569 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041437 Supported Supported Cytosol NA NA Cytosol "HPA041437: AB_10795119" "unprognostic (1.48e-1)" "unprognostic (1.11e-1)" "unprognostic (2.18e-1)" "unprognostic (1.94e-2)" "unprognostic (6.63e-2)" "unprognostic (6.84e-2)" "unprognostic (1.23e-3)" "unprognostic (2.08e-1)" "unprognostic (7.71e-2)" "unprognostic (3.50e-1)" "unprognostic (4.79e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.58e-5)" "unprognostic (1.95e-1)" "unprognostic (6.57e-3)" "unprognostic (1.53e-1)" "unprognostic (7.12e-2)" 37.2 45.7 57.1 66.4 63.2 75.8 73.2 26.0 66.6 51.9 47.1 17.7 54.3 33.3 43.4 60.2 51.2 55.7 48.8 47.5 49.7 43.6 43.2 36.3 33.9 76.7 45.2 66.7 85.3 68.6 19.9 43.8 38.6 55.1 42.8 46.2 26.6 38.6 40.9 55.7 48.5 33.4 61.5 51.1 44.7 39.7 45.0 47.1 62.3 45.6 56.5 67.7 40.4 89.0 104.7 74.4 22.0 44.8 68.8 113.4 127.2 74.5 106.3 70.4 74.6 67.4 60.9 37.8 49.3 56.0 68.9 73.2 58.4 48.5 84.3 39.9 58.7 51.6 45.0 88.4 89.3 66.3 54.0 116.9 81.4 64.2 84.9 46.4 97.9 54.5 69.8 64.2 62.0 59.5 51.4 69.6 88.0 72.8 60.2 56.7 100.5 99.6 89.9 67.1 137.6 63.7 67.7 72.2 68.4 60.8 95.5 62.9 70.6 64.5 71.8 62.6 59.3 42.4 107.3 47.8 38.2 59.6 33.1 92.8 61.0 139.1 143.3 52.8 79.5 58.3 20.1 44.8 22.0 72.7 40.3 92.0 104.7 97.5 85.6 65.9 88.7 113.4 97.5 5.4 68.8 30.9 74.4 91.3 127.2 57.1 63.2 26.0 66.6 49.7 43.6 45.2 66.7 55.1 47.1 137.0 182.8 480.0 471.5 417.9 40.3 385.3 203.8 269.0 257.0 312.3 21.6 537.3 563.7 326.3 481.8 261.5 277.1 0.0 303.0 702.6 351.2 314.1 257.7 240.3 408.0 35.0 297.9 211.1 256.7 1076.8 322.2 277.6 411.7 402.2 416.7 90.0 299.7 291.0 217.8 520.2 47.3 161.7 380.1 213.2 223.6 369.5 403.8 424.2 482.9 435.3 SNRPD3 "Sm-D3, SMD3" ENSG00000100028 "Small nuclear ribonucleoprotein D3 polypeptide" P62318 22 24555503-24609980 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001170 Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA001170: AB_1080042" "unprognostic (3.30e-1)" "unprognostic (1.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.28e-3)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (4.44e-2)" "unprognostic (1.13e-3)" "unprognostic (1.20e-2)" "unprognostic (3.52e-2)" "unprognostic (3.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" 23.7 31.8 23.8 28.9 23.3 29.7 29.5 27.1 27.4 29.3 38.3 24.7 29.8 27.9 31.6 30.6 41.8 30.8 27.1 31.6 21.8 24.2 38.5 61.6 26.5 36.4 24.3 26.8 33.9 34.0 27.8 31.8 33.3 22.6 27.8 33.1 27.9 42.9 27.3 59.0 26.7 35.5 29.6 25.5 32.3 27.8 22.4 23.1 46.8 39.2 61.0 42.7 27.1 30.2 42.5 39.0 38.1 34.9 36.6 33.2 29.8 40.8 14.0 44.0 15.9 16.5 14.3 16.6 39.9 18.3 39.8 37.1 20.0 15.8 36.4 18.9 24.9 22.5 30.9 55.9 48.9 40.5 27.8 57.1 39.2 28.3 30.0 18.0 96.5 24.6 16.3 22.7 43.1 22.6 20.0 28.9 36.6 26.8 18.5 16.2 20.8 41.1 24.1 24.3 59.9 20.3 39.6 46.1 18.9 35.4 31.7 20.7 23.0 25.5 16.7 21.2 41.6 25.1 26.3 30.5 33.2 33.3 16.6 29.5 19.1 36.9 67.0 16.4 33.3 22.4 12.2 31.4 38.1 28.2 34.9 31.3 42.5 30.7 30.6 39.0 36.3 29.4 33.2 15.7 36.6 34.7 37.1 28.9 29.8 23.8 23.3 27.1 27.4 21.8 24.2 24.3 26.8 22.6 23.1 89.3 66.8 98.3 99.5 96.5 53.8 84.4 107.0 99.0 103.5 123.9 33.4 200.2 247.1 146.4 83.4 72.8 133.3 46.7 100.1 182.6 81.8 90.9 84.3 175.2 153.4 36.5 106.7 63.8 76.9 64.2 107.6 83.1 64.1 146.1 105.1 109.1 116.0 112.2 111.4 223.0 50.7 64.7 75.6 104.2 134.4 99.4 150.8 87.3 125.1 101.6 SNW1 "Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1" ENSG00000100603 "SNW domain containing 1" Q13573 14 77717599-77761207 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 252.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002457, CAB009931, HPA017370" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339" "unprognostic (1.24e-3)" "unprognostic (2.02e-1)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (4.27e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.07e-1)" "unprognostic (8.09e-3)" "unprognostic (2.88e-2)" "unprognostic (3.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-3)" "unprognostic (1.22e-2)" 30.5 23.4 20.3 24.0 24.8 59.5 28.3 32.1 26.2 26.1 27.6 29.6 21.5 24.6 32.5 24.3 29.1 25.4 20.5 26.3 20.6 18.3 23.5 25.3 24.8 31.5 23.9 26.7 32.1 26.5 19.8 31.6 32.3 26.8 29.8 24.9 22.3 23.4 17.6 41.8 33.3 30.7 30.8 23.7 32.3 24.2 36.3 24.3 37.5 34.1 24.2 30.4 33.0 25.0 32.5 38.2 47.8 44.1 47.6 47.1 35.5 39.3 29.1 30.0 31.8 24.7 27.9 34.9 27.1 23.9 29.8 27.6 28.9 36.2 38.5 24.8 20.1 22.7 38.8 35.9 25.7 40.7 30.6 28.4 31.1 26.3 28.9 35.5 21.7 36.9 21.4 34.5 27.0 37.4 32.5 28.9 37.0 44.4 28.9 22.8 40.3 38.6 36.9 33.5 44.5 39.3 41.8 38.8 26.4 27.7 36.5 32.3 34.9 37.3 33.0 37.3 32.2 47.3 41.8 30.6 32.8 37.5 29.5 32.3 28.7 40.6 42.8 29.7 35.0 36.1 42.0 38.0 47.8 32.1 40.6 36.0 30.9 36.2 36.3 38.2 32.5 38.3 36.0 36.1 47.6 44.1 22.7 47.1 35.5 20.3 24.8 32.1 26.2 20.6 18.3 23.9 26.7 26.8 24.3 86.4 43.0 62.2 66.5 50.3 55.1 46.0 43.3 109.7 79.6 50.6 33.4 68.5 64.6 65.3 25.3 65.0 31.6 46.7 61.0 83.4 54.9 37.6 88.0 26.6 66.2 36.5 41.9 45.4 48.4 16.5 72.2 71.0 37.1 92.0 37.1 67.4 58.2 45.0 69.6 39.6 63.7 64.7 69.5 252.6 138.5 47.4 91.2 73.9 40.5 62.2 SNX11 ENSG00000002919 "Sorting nexin 11" Q9Y5W9 17 48103357-48123074 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044787, HPA054660" Approved Approved Cytosol NA NA Cytosol "HPA044787: AB_10795988, HPA054660: AB_2682560" "unprognostic (1.75e-1)" "unprognostic (6.86e-3)" "unprognostic (4.34e-2)" "unprognostic (4.33e-3)" "unprognostic (2.45e-1)" "unprognostic (1.54e-1)" "unprognostic (2.68e-3)" "unprognostic (2.07e-1)" "unprognostic (9.27e-2)" "unprognostic (2.15e-1)" "unprognostic (5.42e-2)" "unprognostic (2.12e-1)" "unprognostic (5.22e-3)" "unprognostic (9.02e-3)" "unprognostic (2.70e-2)" "unprognostic (9.50e-2)" "unprognostic (3.89e-2)" 16.8 12.1 15.1 18.7 23.5 21.0 11.9 12.9 19.5 8.8 13.8 20.2 11.0 9.2 11.6 16.6 19.6 10.4 10.2 12.5 16.2 15.4 16.0 14.4 12.8 21.5 17.2 15.0 9.7 12.3 12.1 13.7 14.9 13.7 12.5 14.0 13.7 15.6 11.3 12.3 11.5 12.2 17.5 18.1 25.5 12.6 11.5 17.0 15.0 21.3 12.2 28.9 14.2 11.3 9.8 11.7 39.8 21.0 6.6 8.4 9.2 12.1 15.4 12.9 12.5 11.7 5.1 14.7 12.4 9.0 17.0 18.4 22.9 10.8 13.0 16.5 14.8 9.9 10.3 12.2 12.9 17.3 29.8 15.4 17.8 9.5 11.0 12.7 20.1 13.4 8.4 14.5 15.1 14.8 10.4 14.6 12.3 11.2 12.2 11.0 11.3 12.6 15.5 7.5 13.8 13.2 7.5 22.4 14.1 10.8 12.1 9.3 17.8 8.4 6.0 22.5 16.5 12.3 15.6 11.3 17.3 10.8 11.9 15.7 20.9 30.1 14.6 12.6 9.8 11.2 11.4 14.5 13.9 8.4 18.1 6.1 9.8 4.7 5.9 11.7 9.4 4.1 6.6 39.8 6.6 21.0 5.5 4.2 9.2 15.1 23.5 12.9 19.5 16.2 15.4 17.2 15.0 13.7 17.0 6.0 1.3 10.7 4.5 5.4 8.5 4.3 0.0 1.4 2.3 15.7 2.0 9.1 5.0 10.6 1.5 5.8 9.7 0.0 13.2 9.3 5.8 5.9 2.3 6.2 16.9 14.3 14.3 4.9 17.7 1.6 4.9 8.1 5.0 50.5 7.6 11.1 13.8 3.5 6.3 6.3 9.2 12.9 4.2 7.7 23.6 4.4 13.7 5.1 6.3 5.4 SNX14 RGS-PX2 ENSG00000135317 "Sorting nexin 14" Q9Y5W7 6 85505496-85594156 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017639 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA017639: AB_1857345" "unprognostic (1.16e-2)" "unprognostic (3.29e-2)" "unprognostic (2.19e-2)" "unprognostic (1.52e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (1.92e-2)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (1.57e-2)" "unprognostic (3.14e-2)" "unprognostic (2.37e-2)" "unprognostic (1.10e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.87e-3)" "unprognostic (4.72e-3)" 23.4 25.9 19.9 16.0 21.9 16.6 26.7 25.2 30.1 20.1 23.3 16.1 17.8 17.7 23.8 37.0 17.1 17.8 17.4 17.4 19.5 24.2 33.2 41.0 23.8 17.7 21.6 18.0 17.9 27.7 27.2 35.5 29.6 30.8 21.1 22.2 19.9 17.7 20.2 9.6 17.1 31.0 15.8 20.7 24.6 26.8 49.1 17.1 16.1 26.1 11.2 18.2 22.6 15.1 8.9 16.4 20.0 24.1 13.4 13.3 8.9 15.0 9.2 15.1 22.1 34.5 25.4 15.8 19.3 26.7 15.2 23.5 16.6 25.5 19.8 23.9 24.8 29.7 20.4 10.3 19.9 24.1 17.5 6.1 21.6 12.8 24.8 28.5 20.2 22.5 22.1 15.1 17.7 18.0 28.2 27.0 7.8 21.9 17.2 32.9 17.5 1.2 38.7 6.1 23.6 10.4 8.1 30.8 9.4 37.0 27.9 6.6 15.1 11.8 26.1 17.9 20.9 16.2 36.3 24.0 12.0 7.5 15.0 20.0 17.3 27.4 7.3 24.7 23.9 24.2 18.1 13.6 20.0 13.3 20.3 10.0 8.9 9.0 11.9 16.4 8.8 8.2 10.3 6.3 13.4 24.1 4.8 10.2 8.9 19.9 21.9 25.2 30.1 19.5 24.2 21.6 18.0 30.8 17.1 86.4 38.0 17.1 16.6 13.1 35.5 12.3 17.8 32.1 28.4 21.0 53.0 44.7 5.0 28.9 45.3 24.0 24.4 0.0 36.5 25.9 25.0 15.8 30.1 26.6 31.1 14.3 30.6 27.6 34.8 10.7 18.1 25.4 27.0 39.7 28.0 32.8 30.0 24.6 27.6 23.7 39.0 19.4 21.6 165.5 8.4 12.9 47.3 25.3 25.3 15.2 SNX15 ENSG00000110025 "Sorting nexin 15" Q9NRS6 11 65027408-65040572 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "granulocytes: 8.1;Intestinal endocrine cells: 7.5;monocytes: 12.6;Undifferentiated cells: 6.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038955 Approved Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoli, Cytosol" "Vesicles, Plasma membrane" "HPA038955: AB_10672834" "unprognostic (2.00e-2)" "unprognostic (4.90e-2)" "unprognostic (3.93e-1)" "unprognostic (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (4.06e-3)" "unprognostic (4.45e-3)" "unprognostic (4.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.55e-2)" "unprognostic (8.93e-3)" "unprognostic (1.79e-2)" "unprognostic (8.84e-2)" "unprognostic (7.86e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.68e-4)" 17.9 13.6 17.1 12.7 18.3 11.6 23.5 25.7 21.9 13.2 22.7 16.7 9.5 19.7 14.2 8.9 15.9 11.4 13.9 15.1 16.2 14.3 15.7 9.8 14.1 14.7 16.3 14.5 18.3 17.7 13.7 8.4 9.5 13.4 15.1 11.6 11.2 15.6 15.4 25.2 17.2 20.4 15.0 17.6 11.3 13.5 7.6 15.8 12.4 14.4 10.1 11.5 14.9 12.5 7.7 8.0 10.9 18.3 3.2 7.1 5.7 17.4 12.9 8.4 8.2 10.2 7.5 4.7 1.7 7.9 13.8 12.7 10.2 13.7 17.8 9.9 10.0 17.4 9.8 9.8 8.7 3.8 26.8 8.1 8.9 10.6 17.0 11.0 4.6 14.4 6.3 13.1 14.6 8.5 7.7 8.2 13.1 15.0 11.4 7.2 10.5 16.3 20.7 9.1 6.8 12.8 13.5 5.0 19.2 10.2 3.8 15.2 11.5 14.9 13.5 12.9 4.0 13.7 10.7 16.1 14.0 13.5 14.1 7.4 12.3 21.1 17.0 13.7 7.3 4.8 7.8 11.3 10.9 6.9 13.6 5.6 7.7 7.1 6.1 8.0 6.1 5.2 4.7 1.6 3.2 18.3 5.5 6.7 5.7 17.1 18.3 25.7 21.9 16.2 14.3 16.3 14.5 13.4 15.8 0.0 3.5 0.0 0.0 0.9 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.3 0.0 4.7 0.0 0.4 4.2 0.0 2.7 0.4 0.4 0.0 8.1 0.0 0.9 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 12.6 3.1 0.2 3.5 5.1 0.4 0.5 0.4 0.0 0.3 0.0 0.0 0.4 0.3 1.0 6.0 0.0 SNX17 KIAA0064 ENSG00000115234 "Sorting nexin 17" Q15036 2 27370496-27377533 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043867 Supported Enhanced Vesicles,Cytosol No No Vesicles Cytosol "HPA043867: AB_10961129" "unprognostic (2.57e-1)" "unprognostic (7.14e-3)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.06e-3)" "unprognostic (1.86e-1)" "unprognostic (4.73e-2)" "unprognostic (4.38e-2)" "unprognostic (1.04e-2)" "unprognostic (9.25e-2)" "unprognostic (1.33e-1)" "unprognostic (6.20e-2)" "unprognostic (1.37e-1)" "unprognostic (2.39e-1)" "unprognostic (6.32e-3)" 37.7 45.8 27.2 30.5 29.8 22.6 33.4 28.5 51.1 34.1 33.8 34.9 28.7 23.7 39.0 38.5 35.3 41.2 37.7 37.6 26.2 25.8 33.6 61.6 36.7 68.1 29.1 27.0 40.4 37.0 31.5 37.0 32.6 30.3 33.7 29.5 34.0 34.9 37.5 26.4 31.6 29.2 38.1 32.8 48.8 30.5 36.8 21.7 52.3 39.5 28.2 41.3 32.0 29.1 34.3 58.4 38.1 61.1 27.3 35.1 86.6 28.1 47.1 23.1 36.9 40.8 34.5 19.6 30.7 44.1 35.1 27.5 25.4 24.6 22.0 40.1 49.9 34.4 17.2 19.7 32.3 27.2 28.3 31.8 22.8 17.4 34.5 42.6 27.9 29.2 35.2 31.3 23.3 31.5 31.3 38.4 19.5 19.8 23.7 41.9 27.6 33.2 26.2 21.3 34.8 30.3 14.9 44.3 43.5 32.7 21.0 28.1 31.9 19.2 28.1 11.5 17.2 22.4 18.0 30.5 41.6 22.4 23.3 29.9 43.2 31.4 27.7 38.4 29.6 44.6 33.0 59.1 38.1 30.8 61.1 29.6 33.4 30.0 31.8 58.4 34.3 28.4 30.3 13.9 27.3 60.5 33.0 35.1 86.6 27.2 29.8 28.5 51.1 26.2 25.8 29.1 27.0 30.3 21.7 14.9 43.2 74.4 35.4 28.8 29.3 28.6 38.2 33.5 22.7 27.9 13.7 141.9 69.6 74.2 7.1 37.7 55.9 0.0 56.0 113.5 59.4 36.1 42.7 50.5 122.1 42.9 52.9 38.1 113.6 7.6 54.1 76.3 65.8 149.7 42.8 76.6 55.0 63.1 79.9 74.5 20.4 32.3 51.4 58.6 50.0 30.1 83.3 86.3 51.5 26.5 SNX18 "SH3PX2, SH3PXD3B, SNAG1" ENSG00000178996 "Sorting nexin 18" Q96RF0 5 54517759-54546585 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 68.7;Kupffer cells: 73.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037800 Approved Approved Cytosol NA NA Cytosol "HPA037800: AB_10672465" "unprognostic (2.22e-2)" "unprognostic (3.96e-3)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (4.12e-1)" "unprognostic (2.22e-1)" "unprognostic (9.26e-2)" "unprognostic (8.94e-2)" "unprognostic (3.98e-2)" "unprognostic (1.41e-1)" "unprognostic (9.13e-2)" "unprognostic (3.81e-3)" "prognostic favorable (1.58e-4)" "unprognostic (6.79e-3)" "unprognostic (7.96e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" 16.2 9.0 10.1 9.2 13.5 50.3 17.8 5.8 9.9 13.0 12.1 20.3 13.8 8.1 14.7 7.6 11.4 11.5 11.8 13.1 10.3 9.0 11.6 13.9 12.1 18.7 18.3 7.0 23.8 8.1 17.4 5.3 18.4 12.7 14.5 5.2 10.9 11.4 13.9 7.7 9.6 8.8 12.5 23.3 26.0 11.7 13.5 15.0 6.7 15.0 5.4 6.6 15.1 26.2 1.2 4.2 6.7 6.1 1.7 1.3 0.6 4.0 3.3 5.3 6.0 12.4 13.4 28.9 6.7 17.0 3.5 5.9 4.1 7.5 0.1 11.3 10.4 6.5 3.8 5.0 6.6 4.5 2.2 3.7 1.2 2.2 2.5 20.8 2.2 1.2 21.0 8.0 4.8 5.0 6.3 7.4 3.0 2.1 28.1 6.1 3.8 2.1 2.5 2.6 1.6 3.5 5.6 2.9 6.4 3.4 11.8 6.6 3.9 5.6 6.5 7.3 8.5 7.7 3.7 2.5 13.3 6.7 9.8 7.1 19.1 18.4 1.1 5.1 5.3 13.7 0.0 1.6 0.2 1.3 2.6 0.3 1.2 0.6 0.8 1.9 1.2 0.3 1.0 6.7 1.7 6.1 4.2 0.3 0.6 10.1 13.5 5.8 7.9 10.3 9.0 18.3 7.0 12.7 15.0 50.6 23.2 7.5 4.0 8.8 9.2 12.4 5.1 16.0 14.8 21.0 68.7 21.3 13.3 11.9 0.3 12.0 3.6 0.0 13.2 25.8 15.4 5.3 5.7 23.3 34.9 4.8 5.8 40.5 73.9 1.7 13.0 34.5 10.1 8.2 8.5 10.3 12.6 6.6 16.6 5.8 43.9 0.0 36.8 2.4 8.9 10.3 6.9 14.1 9.6 12.2 SNX27 "KIAA0488, MGC20471, MY014" ENSG00000143376 "Sorting nexin family member 27" Q96L92 1 151612006-151699091 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 9.5;classical monocyte: 18.6;intermediate monocyte: 16.1;myeloid DC: 8.4;neutrophil: 20.3;non-classical monocyte: 16.9" "Group enriched" "Detected in all" 4 "dendritic cells: 8.4;granulocytes: 20.3;monocytes: 18.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045816 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045816: " "unprognostic (3.35e-1)" "unprognostic (4.76e-1)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (2.79e-2)" "unprognostic (3.42e-1)" "unprognostic (2.41e-2)" "unprognostic (1.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (5.92e-2)" "unprognostic (1.63e-1)" "unprognostic (5.45e-2)" "unprognostic (2.81e-1)" "unprognostic (4.15e-1)" "unprognostic (7.30e-2)" "unprognostic (1.04e-1)" 10.9 12.5 21.5 12.5 28.6 13.4 12.6 25.0 27.7 14.8 15.9 23.4 13.5 9.1 12.1 16.2 12.1 13.9 11.5 12.1 23.0 21.3 24.2 12.8 13.6 10.4 23.7 19.2 17.2 10.0 26.0 14.8 17.5 20.3 14.8 13.0 13.1 9.7 20.6 25.6 16.0 10.1 21.3 23.1 17.0 11.2 12.8 18.7 8.8 12.8 7.7 10.8 17.4 21.7 2.5 8.4 20.3 18.6 1.7 3.6 7.3 5.9 8.9 9.5 11.9 15.0 11.1 21.1 3.2 6.7 5.7 6.2 7.2 8.0 5.7 7.1 5.2 6.2 7.5 12.1 6.5 7.2 8.1 4.5 9.1 5.2 8.1 10.0 10.8 6.3 8.8 4.9 6.5 7.5 5.8 6.4 9.1 5.5 35.1 7.5 10.7 6.4 7.5 16.7 11.8 5.8 6.7 9.2 7.3 8.9 9.0 9.5 8.1 8.7 16.2 6.2 10.7 10.4 9.2 8.5 8.1 5.5 8.4 6.7 7.4 7.4 11.5 9.7 7.0 9.0 9.5 18.6 2.6 2.6 16.1 3.6 1.8 3.2 2.3 8.4 2.5 3.1 2.5 20.3 1.7 16.9 2.1 2.5 7.3 21.5 28.6 25.0 24.6 23.0 21.3 23.7 19.2 20.3 18.7 11.9 21.9 11.2 13.8 18.8 42.4 25.5 20.4 8.1 15.9 27.9 25.5 40.5 21.6 21.5 23.7 16.1 12.3 23.3 18.3 18.4 17.5 15.0 3.5 17.9 37.8 38.1 18.0 22.7 76.7 6.6 28.1 28.6 28.7 32.5 15.2 22.7 21.5 10.5 37.4 51.8 27.3 32.3 19.4 41.7 29.4 21.7 87.6 12.9 15.8 13.2 SNX29 "FLJ12363, RUNDC2A" ENSG00000048471 "Sorting nexin 29" Q8TEQ0 16 11976737-12574289 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 333.8;Early spermatids: 117.2;Horizontal cells: 87.4;Late spermatids: 346.9;Rod photoreceptor cells: 256.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "naive B-cell: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008889, HPA062810" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoli, Cytosol" "HPA008889: AB_1079856, HPA062810: " "unprognostic (2.50e-1)" "unprognostic (4.12e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (9.82e-3)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" "unprognostic (6.08e-2)" "prognostic favorable (1.38e-7)" "unprognostic (3.85e-3)" "unprognostic (4.54e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (1.03e-4)" 11.4 5.5 8.2 9.8 14.4 10.7 8.3 13.2 11.9 9.4 6.7 22.7 5.2 3.3 9.6 9.1 9.9 11.1 6.4 6.6 9.0 8.1 24.5 3.6 8.7 14.8 13.7 9.1 13.7 4.8 32.1 16.1 10.0 14.4 5.4 4.9 15.4 6.9 6.8 11.7 8.2 5.8 12.2 18.5 10.8 6.1 16.9 13.1 12.5 8.6 4.9 19.2 9.8 7.4 19.2 5.8 3.0 5.7 1.0 4.3 1.4 3.1 1.8 2.8 2.3 16.9 13.9 3.7 6.8 18.7 2.8 3.1 0.3 3.6 11.7 9.1 10.5 1.8 2.7 1.8 4.3 4.1 4.5 1.9 1.5 1.6 4.0 3.2 1.6 4.3 12.7 2.8 4.1 1.8 4.2 4.9 3.9 2.4 3.3 2.8 4.2 3.1 1.9 1.6 2.0 1.7 7.0 3.6 9.4 12.5 2.9 3.4 2.8 7.7 4.6 1.6 2.5 2.6 2.0 7.4 5.0 2.0 3.7 1.3 19.2 14.6 7.3 9.2 1.8 3.1 3.0 5.7 1.2 1.7 3.7 2.1 8.3 3.6 2.2 2.0 19.2 4.3 3.1 2.0 1.0 1.8 5.8 3.1 1.4 8.2 14.4 13.2 11.9 9.0 8.1 13.7 9.1 14.4 13.1 11.9 19.3 51.4 5.6 13.6 52.7 9.5 5.1 16.0 13.6 15.7 333.8 15.9 18.3 3.8 117.2 11.2 3.4 0.0 2.5 4.2 17.2 3.4 41.5 5.0 24.8 87.4 12.6 16.5 21.8 346.9 19.8 27.4 11.8 11.8 3.6 21.7 5.8 3.5 14.5 32.0 256.7 6.5 10.8 21.5 7.6 13.6 14.3 9.6 3.3 4.6 SNX30 ATG24A ENSG00000148158 "Sorting nexin family member 30" Q5VWJ9 9 112750838-112881671 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 65.1;Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019346 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA019346: AB_2286395" "unprognostic (1.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.08e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-1)" "unprognostic (3.69e-1)" "unprognostic (8.05e-3)" "unprognostic (2.04e-3)" "unprognostic (4.48e-2)" "unprognostic (3.59e-3)" "unprognostic (3.39e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.01e-7)" "unprognostic (4.48e-3)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-2)" 4.9 4.4 12.2 7.7 12.6 8.3 7.7 18.1 18.5 10.9 11.1 25.6 3.6 7.9 6.4 4.1 5.3 3.8 5.4 3.4 14.2 12.0 23.7 5.2 23.4 8.8 14.8 12.8 6.9 5.2 6.9 6.3 5.1 14.7 4.1 11.7 4.9 7.1 4.3 2.6 5.7 8.9 7.5 20.3 7.4 4.7 12.7 11.8 2.3 3.1 2.6 8.7 5.4 4.6 0.7 4.2 1.5 5.1 0.8 1.7 1.6 6.0 3.8 6.6 5.2 8.3 7.6 5.5 5.2 10.9 4.4 4.2 13.5 1.4 10.1 4.4 13.4 7.9 7.2 7.9 3.1 6.9 3.2 3.7 3.1 3.4 5.4 6.0 3.1 5.6 6.2 4.3 6.8 5.1 11.2 3.8 2.6 4.8 5.8 5.9 4.2 2.0 3.6 7.2 9.8 4.0 4.3 15.4 2.6 8.6 10.6 9.8 3.1 6.8 9.4 13.0 7.0 7.0 5.6 4.2 6.6 7.0 19.3 4.4 15.1 13.9 4.8 8.5 2.9 12.8 0.0 5.1 1.5 0.8 2.0 1.7 0.0 0.8 1.0 4.2 0.7 0.7 0.6 0.7 0.8 2.1 0.7 1.6 1.6 12.2 12.6 18.1 18.5 14.2 12.0 14.8 12.8 14.7 11.8 6.0 65.1 0.0 1.9 7.2 5.7 3.8 5.1 1.4 9.1 5.2 9.8 0.4 5.0 2.1 5.3 3.0 12.4 46.7 2.8 1.6 5.7 3.1 6.9 5.9 11.9 7.9 4.6 12.3 19.7 6.3 5.2 12.5 20.3 1.0 9.7 2.6 3.4 17.3 7.4 33.2 2.7 0.0 1.4 5.5 10.5 9.7 0.3 3.8 8.6 5.4 SNX31 MGC39715 ENSG00000174226 "Sorting nexin 31" Q8N9S9 8 100572882-100663415 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 73.9" "Cancer enriched" "Detected in many" 22 "urothelial cancer: 24.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 50 "RT4: 42.9" "Region enriched" "Detected in single" 5 "thalamus: 2.9" "Region enhanced" "Detected in single" "olfactory region: 3.1" "HPA024284, HPA053466" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA024284: AB_1853894, HPA053466: AB_2682161" "unprognostic (1.39e-1)" "unprognostic (3.83e-2)" "unprognostic (7.99e-2)" "unprognostic (1.52e-1)" "unprognostic (7.20e-5)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.69e-1)" "unprognostic (7.79e-3)" "unprognostic (1.66e-1)" "prognostic favorable (1.47e-4)" "unprognostic (2.54e-1)" "unprognostic (4.05e-2)" 0.5 0.0 0.6 0.1 0.7 0.1 0.4 0.6 2.3 1.7 0.3 0.3 0.1 0.2 0.3 0.2 6.2 0.3 0.9 1.8 0.8 0.7 0.3 0.4 0.3 0.3 0.9 0.3 0.3 0.2 0.1 0.2 0.1 0.6 13.8 0.1 0.4 1.4 0.1 1.0 0.5 0.1 7.4 0.8 0.1 0.6 3.3 0.5 0.1 0.4 2.6 21.4 25.4 16.0 1.1 0.3 3.0 0.5 1.6 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 2.5 0.5 0.2 0.3 0.2 0.1 1.1 0.1 0.2 0.2 0.5 0.1 0.3 3.0 1.6 0.0 0.3 0.0 0.0 0.6 0.7 0.6 0.3 0.8 0.7 0.9 0.3 0.6 0.5 0.0 0.0 0.0 3.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 73.9 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.4 0.4 0.4 0.0 0.0 0.0 1.0 SNX5 ENSG00000089006 "Sorting nexin 5" Q9Y5X3 20 17941597-17968980 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 118.1" "Low region specificity" "Detected in all" "CAB020679, HPA051187, HPA076450" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB020679: , HPA051187: AB_2681379, HPA076450: " "unprognostic (6.00e-2)" "unprognostic (2.35e-1)" "unprognostic (3.08e-2)" "unprognostic (4.00e-2)" "unprognostic (4.47e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (2.30e-10)" "unprognostic (1.67e-1)" "unprognostic (6.19e-2)" "unprognostic (1.69e-1)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.77e-1)" "unprognostic (3.15e-2)" "unprognostic (6.50e-2)" "unprognostic (3.48e-2)" "unprognostic (2.99e-1)" 23.0 30.7 19.0 29.1 19.7 26.5 20.6 12.8 17.8 17.4 21.1 16.4 16.3 27.3 17.9 40.9 18.5 17.0 17.3 20.0 17.2 14.0 35.9 30.3 18.7 43.8 20.4 14.8 29.4 18.7 17.7 15.4 24.4 15.6 17.6 22.9 17.8 18.1 14.8 34.9 14.5 23.6 14.0 21.8 46.4 18.2 9.8 17.8 25.6 64.4 19.6 27.3 20.5 19.0 32.8 28.8 33.4 34.5 15.2 26.7 19.5 18.8 20.6 8.7 9.6 6.2 10.8 52.6 15.1 8.5 9.7 11.1 19.9 26.8 31.2 9.4 9.5 13.7 21.2 12.2 23.7 13.3 7.9 10.9 27.8 8.5 118.1 9.7 19.4 33.5 10.2 10.5 10.5 19.2 7.5 14.0 21.2 13.3 21.1 11.6 14.7 17.1 17.2 9.3 16.2 10.3 20.3 22.4 23.2 11.9 22.0 8.8 5.0 14.4 22.1 19.4 6.9 12.0 12.6 11.0 15.4 19.1 9.5 18.8 15.0 22.8 25.3 7.5 7.1 13.4 23.5 23.5 33.4 23.8 32.0 21.6 32.8 21.8 23.2 28.8 30.5 13.2 19.2 1.9 15.2 34.5 14.8 26.7 19.5 19.0 19.7 12.8 17.8 17.2 14.0 20.4 14.8 15.6 17.8 59.6 101.6 83.8 38.6 28.2 17.4 36.7 30.6 65.6 69.4 47.1 25.5 82.3 135.9 37.8 33.2 40.9 63.8 0.0 38.8 119.4 48.4 34.2 122.9 35.9 128.5 15.9 30.4 138.7 140.1 11.4 56.4 75.4 25.3 50.5 44.0 63.6 33.9 63.1 48.4 192.8 17.6 19.4 35.9 14.7 42.1 28.2 65.7 54.9 90.2 45.8 SNX7 ENSG00000162627 "Sorting nexin 7" Q9UNH6 1 98661701-98760500 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037419, HPA054338" Enhanced Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA037419: AB_10671754, HPA054338: AB_2682454" "unprognostic (3.19e-1)" "unprognostic (2.18e-1)" "prognostic favorable (5.10e-5)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (9.59e-7)" "unprognostic (1.53e-2)" "unprognostic (2.64e-1)" "unprognostic (1.41e-2)" "unprognostic (1.19e-3)" "unprognostic (1.88e-1)" "unprognostic (7.95e-3)" "unprognostic (1.68e-1)" "unprognostic (1.45e-1)" "unprognostic (8.65e-2)" "unprognostic (1.77e-1)" 19.2 13.6 12.0 8.2 11.3 0.2 22.4 3.1 9.8 18.6 24.7 9.7 12.5 19.4 18.7 18.7 17.7 13.5 15.4 18.0 12.0 15.6 22.1 13.0 9.6 4.7 13.6 9.3 13.8 13.7 14.7 13.2 13.9 15.6 17.7 25.4 6.6 15.0 14.8 5.8 11.5 27.2 21.8 17.3 6.4 13.9 14.7 12.7 2.0 13.9 10.3 7.4 18.7 21.9 0.6 0.3 0.0 1.4 0.0 0.3 0.3 16.3 8.9 5.4 7.3 19.2 30.4 3.0 10.4 19.1 15.7 20.5 5.1 6.2 0.0 13.6 25.6 12.9 4.7 5.6 14.8 15.7 0.0 10.9 0.0 14.1 8.8 11.3 0.0 0.0 15.2 16.0 12.9 5.7 17.8 21.8 0.2 0.0 0.0 24.7 3.3 0.1 0.0 5.1 6.5 12.8 0.0 12.1 0.0 15.6 13.2 2.7 32.1 13.9 13.2 7.5 9.4 0.0 0.6 14.9 15.4 8.6 11.9 21.0 0.0 0.0 0.0 21.8 0.0 7.4 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 12.0 11.3 3.1 9.8 12.0 15.6 13.6 9.3 15.6 12.7 17.9 4.1 0.5 35.3 13.1 0.2 45.7 12.7 20.1 4.5 22.7 0.0 25.2 31.5 40.0 13.7 15.7 27.6 0.0 71.6 28.2 36.3 18.9 1.1 10.6 10.1 3.2 20.2 8.6 1.6 16.0 31.7 10.8 33.7 64.9 25.3 10.1 46.0 20.1 49.5 51.2 0.2 32.3 47.5 3.3 10.5 14.3 11.8 0.0 44.8 39.6 SNX9 "SDP1, SH3PX1, SH3PXD3A" ENSG00000130340 "Sorting nexin 9" Q9Y5X1 6 157700387-157945077 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 42.9;GAMG: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031410, HPA057203" Approved Enhanced "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA031410: AB_10603339, HPA057203: AB_2683368" "unprognostic (1.63e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (1.39e-1)" "unprognostic (8.09e-2)" "unprognostic (8.09e-2)" "unprognostic (1.40e-2)" "unprognostic (4.06e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (7.93e-2)" "unprognostic (4.99e-3)" "unprognostic (4.45e-2)" "unprognostic (2.42e-1)" "prognostic favorable (9.95e-4)" "unprognostic (2.14e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" 44.7 18.9 13.0 16.5 14.7 17.2 35.4 6.7 16.2 27.4 24.6 19.8 43.5 18.1 32.1 19.5 31.4 17.2 26.4 20.4 12.2 10.8 17.8 25.4 14.6 22.5 19.7 11.4 19.8 22.5 17.7 10.8 45.0 13.3 25.0 17.7 11.1 25.2 41.7 16.5 21.2 28.0 44.6 16.4 19.8 21.5 10.9 18.4 5.0 18.4 17.9 20.3 34.0 40.2 4.1 11.2 1.3 7.3 0.5 6.7 1.0 7.5 5.0 5.3 6.2 26.5 23.6 11.2 15.2 42.9 10.4 13.9 4.3 7.7 0.0 7.6 23.5 41.6 5.0 6.2 10.2 8.7 6.2 7.2 4.8 7.6 6.6 13.3 2.5 9.7 14.0 9.1 10.7 10.5 18.8 14.4 7.4 24.1 0.0 5.1 4.3 0.0 3.8 4.2 5.1 6.4 0.0 5.3 8.6 16.7 4.5 3.4 6.2 9.7 4.5 23.2 5.5 2.1 5.5 11.7 11.5 5.2 36.8 8.0 0.0 0.0 0.0 23.0 1.9 6.7 0.0 1.0 1.3 0.6 3.2 2.4 4.1 1.7 1.3 2.0 3.4 6.7 2.1 0.1 0.5 7.3 11.2 2.8 1.0 13.0 14.7 6.7 16.2 12.2 10.8 19.7 11.4 13.3 18.4 0.0 0.6 20.4 84.5 38.5 12.7 24.6 17.8 12.0 18.2 8.7 0.0 31.7 18.3 44.5 37.1 48.9 55.8 46.7 48.8 32.8 55.0 114.0 11.5 28.7 37.1 3.2 15.1 32.5 39.6 18.9 41.4 29.1 20.3 62.3 31.0 12.4 78.9 45.0 43.9 32.7 1.5 38.8 46.7 17.9 13.8 26.1 91.9 10.2 26.0 107.8 SOCS3 "CIS3, Cish3, SOCS-3, SSI-3" ENSG00000184557 "Suppressor of cytokine signaling 3" O14543 17 78356778-78360077 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Endothelial cells: 259.3;Smooth muscle cells: 425.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 11.6" "Group enriched" "Detected in many" 6 "granulocytes: 11.6;T-cells: 4.3" "Cell line enhanced" "Detected in many" "HDLM-2: 49.9;HSkMC: 25.4;U-266/70: 25.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB012220, HPA068569" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB012220: AB_443287, HPA068569: AB_2686008" "prognostic favorable (4.80e-4)" "unprognostic (2.67e-1)" "unprognostic (5.05e-2)" "unprognostic (1.64e-3)" "unprognostic (4.41e-3)" "unprognostic (2.48e-3)" "unprognostic (1.81e-1)" "unprognostic (1.46e-1)" "unprognostic (6.88e-2)" "unprognostic (9.61e-3)" "unprognostic (1.84e-1)" "unprognostic (2.00e-2)" "prognostic unfavorable (9.34e-9)" "unprognostic (1.08e-2)" "unprognostic (8.80e-2)" "unprognostic (7.59e-3)" "unprognostic (8.40e-2)" 94.9 16.8 6.3 42.5 21.4 33.9 25.7 3.0 12.8 27.6 26.6 5.6 1.9 6.2 13.9 9.2 22.7 88.0 59.6 23.5 11.4 5.1 13.5 30.4 52.1 30.2 13.9 0.1 31.2 14.5 13.9 13.4 23.5 38.0 20.8 9.2 10.3 9.2 6.7 26.0 12.1 15.6 39.0 29.6 36.7 32.2 12.1 8.7 5.6 14.2 40.9 10.3 38.1 41.1 0.0 1.3 11.6 1.3 0.4 4.3 0.6 2.0 3.3 2.4 1.3 0.9 15.5 6.5 10.4 9.5 10.9 4.6 2.1 1.4 0.0 2.2 2.4 6.9 0.6 0.5 1.0 4.3 49.9 0.3 1.9 7.3 0.4 5.0 0.0 0.9 25.4 0.8 8.4 3.2 6.6 4.7 0.1 5.5 19.6 5.0 1.0 1.0 0.3 1.7 0.3 4.3 0.0 12.5 0.3 17.3 2.0 0.1 1.5 3.1 0.8 0.4 9.5 0.9 0.4 2.7 21.5 6.1 7.5 6.0 25.9 14.5 0.0 17.6 0.2 1.4 0.0 1.3 0.3 1.0 0.1 2.6 0.0 2.8 1.2 1.3 0.0 4.3 0.8 11.6 0.4 0.0 1.2 1.6 0.6 6.3 21.4 3.0 12.8 11.4 5.1 13.9 0.1 38.0 8.7 44.7 145.2 37.8 106.0 146.0 1.0 23.1 5.1 20.1 55.7 36.6 2.0 8.0 5.0 34.0 0.6 259.3 21.3 0.0 34.0 41.1 225.0 61.7 33.7 14.4 86.4 0.0 31.8 133.8 82.4 0.2 72.5 182.0 81.0 48.7 21.3 2.0 36.2 24.3 2.1 6.8 1.6 12.9 425.2 0.5 0.2 116.2 51.9 47.9 36.7 70.2 SOCS4 SOCS7 ENSG00000180008 "Suppressor of cytokine signaling 4" Q8WXH5 14 55027230-55049488 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013478, HPA057961" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB013478: , HPA057961: AB_2683564" "unprognostic (7.18e-3)" "unprognostic (1.49e-1)" "unprognostic (9.74e-3)" "unprognostic (4.57e-2)" "unprognostic (3.36e-3)" "unprognostic (3.82e-3)" "unprognostic (3.69e-3)" "unprognostic (2.70e-1)" "unprognostic (9.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (4.56e-2)" "unprognostic (7.61e-2)" "unprognostic (4.35e-3)" "unprognostic (1.13e-1)" 14.5 11.1 12.5 16.0 21.2 12.7 12.2 12.6 19.1 11.4 12.0 14.0 8.7 11.1 13.6 9.3 13.2 13.9 15.0 13.9 15.5 10.9 17.6 10.6 16.7 18.0 22.6 10.5 12.6 10.2 12.8 18.5 12.4 17.0 11.7 12.8 7.2 11.9 10.3 12.3 10.5 13.2 17.5 29.6 16.4 15.1 9.5 19.6 16.2 15.3 6.5 16.0 16.1 18.9 3.8 4.1 4.5 5.8 6.0 4.9 2.0 10.8 9.4 12.8 15.0 8.4 9.8 10.2 12.7 9.4 8.1 13.4 7.7 11.7 16.4 9.0 9.5 7.8 15.2 17.4 10.3 19.0 16.8 7.0 9.7 12.2 4.6 8.6 11.1 17.2 7.8 10.7 14.6 10.7 9.0 14.6 16.5 5.8 16.5 14.7 10.8 16.6 8.1 10.1 8.7 10.2 15.4 20.0 6.3 11.6 12.0 17.1 14.7 12.8 7.7 12.1 12.2 10.8 8.2 14.8 20.9 21.1 10.2 10.8 5.9 6.3 15.8 13.5 9.0 16.0 1.7 4.2 4.5 3.2 4.9 4.9 3.0 4.0 3.0 3.1 3.8 2.2 2.4 2.6 6.0 5.8 4.1 3.6 2.0 12.5 21.2 12.6 19.1 15.5 10.9 22.6 10.5 17.0 19.6 6.0 11.3 20.6 7.6 21.3 13.1 17.3 7.6 18.7 20.5 14.0 19.6 4.4 11.6 8.1 3.7 15.8 11.5 0.0 7.6 4.8 10.8 6.5 31.3 7.8 6.6 35.0 19.5 15.4 10.4 1.5 6.6 12.4 3.3 15.4 7.9 14.5 11.8 7.2 9.6 11.3 14.5 0.0 20.0 15.1 11.3 20.3 4.1 15.2 6.9 7.9 SOCS5 "CIS6, Cish5, CISH6, KIAA0671, SOCS-5" ENSG00000171150 "Suppressor of cytokine signaling 5" O75159 2 46698952-46763129 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 45.7;fHDF/TERT166: 44.5;U-138 MG: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020884, CAB025510" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB025510: , HPA020884: AB_1857356" "unprognostic (1.69e-1)" "unprognostic (1.98e-2)" "unprognostic (5.71e-2)" "unprognostic (1.64e-2)" "unprognostic (2.20e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.28e-4)" "unprognostic (4.52e-2)" "unprognostic (9.13e-2)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.10e-3)" "unprognostic (3.01e-1)" "unprognostic (1.47e-3)" "unprognostic (8.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" 12.2 10.1 16.9 5.6 24.9 6.2 21.3 26.4 14.9 13.6 9.4 6.3 7.6 4.8 14.0 8.8 8.2 9.6 11.2 11.2 11.9 8.1 9.1 6.3 10.1 9.9 9.1 10.8 23.8 6.0 14.8 9.0 6.9 11.8 9.9 6.5 5.8 9.3 13.0 8.8 6.9 6.8 13.6 10.8 8.1 7.2 9.5 8.8 10.9 9.8 5.0 6.1 9.4 9.0 4.8 1.3 6.3 3.7 2.3 3.3 1.6 5.2 4.0 3.5 5.1 11.2 16.2 4.3 24.7 45.7 12.1 7.1 3.8 2.6 2.7 4.8 44.5 3.7 2.6 3.8 3.9 15.4 2.6 3.5 4.2 3.7 4.5 7.0 2.4 4.7 12.8 5.9 10.3 4.1 13.5 4.1 1.1 3.6 2.9 7.7 1.8 2.1 3.9 3.9 5.5 3.3 2.8 5.9 3.4 4.9 4.0 2.7 7.5 6.0 4.0 4.6 3.5 1.6 3.5 4.6 30.2 6.8 10.0 4.8 3.7 2.2 2.3 13.8 4.8 9.3 1.2 1.1 6.3 2.4 1.0 3.0 4.5 1.5 1.6 1.2 4.8 2.7 3.3 1.1 2.3 3.7 1.3 2.5 1.6 16.9 24.9 26.4 14.9 11.9 8.1 9.1 10.8 11.8 8.8 3.0 6.7 6.0 6.3 14.7 12.1 13.6 15.3 5.3 9.1 3.5 21.6 3.1 5.0 6.3 8.5 22.4 6.3 0.0 5.9 1.9 12.1 8.8 16.2 6.4 4.0 17.5 10.4 20.3 6.3 5.1 16.1 7.2 6.8 6.4 7.6 8.9 5.5 7.0 15.9 6.3 5.3 12.9 17.9 11.9 15.6 12.7 2.3 4.4 6.0 4.8 SOCS6 "CIS4, Cish4, HSPC060, SOCS4, SSI4, STAI4, STATI4" ENSG00000170677 "Suppressor of cytokine signaling 6" O14544 18 70288901-70330200 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 6.0;myeloid DC: 6.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" CAB010189 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB010189: AB_661195" "unprognostic (1.76e-3)" "unprognostic (6.83e-3)" "unprognostic (8.90e-3)" "unprognostic (4.52e-2)" "unprognostic (1.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.07e-1)" "unprognostic (7.93e-2)" "unprognostic (5.83e-2)" "unprognostic (1.75e-1)" "unprognostic (6.90e-2)" "unprognostic (8.19e-2)" "prognostic favorable (1.02e-4)" "unprognostic (1.02e-1)" "unprognostic (1.52e-1)" "unprognostic (4.11e-2)" "unprognostic (1.80e-2)" 9.1 8.8 12.7 5.1 16.3 10.2 12.8 13.8 11.6 15.0 14.6 20.1 9.8 14.1 12.9 6.7 17.7 11.8 12.6 9.8 12.8 7.8 8.9 26.1 8.8 2.8 21.4 10.1 10.6 12.4 18.1 7.2 21.1 14.9 8.7 13.5 14.3 17.3 7.8 17.7 8.4 20.4 13.3 20.3 4.2 12.7 6.1 18.0 2.5 10.8 10.3 7.5 10.6 11.8 0.5 6.3 4.6 6.0 1.5 1.1 1.7 10.2 22.6 9.6 6.6 9.2 10.8 10.8 22.0 13.6 13.4 10.2 8.4 17.4 1.1 2.0 20.4 16.3 12.1 7.0 7.2 13.1 0.0 4.2 7.7 8.0 12.9 10.9 4.1 8.7 8.7 8.7 11.6 9.8 13.4 6.7 0.9 4.5 5.3 9.1 4.9 3.6 3.1 6.2 6.5 9.7 4.2 9.3 1.9 8.3 8.4 4.5 11.1 11.3 12.6 10.2 7.3 3.7 7.3 8.2 14.8 7.5 3.0 8.8 0.0 0.0 2.8 16.5 0.3 9.9 0.0 6.0 4.6 0.4 1.2 0.2 0.5 0.8 0.1 6.3 0.0 1.1 0.6 0.0 1.5 0.1 0.6 0.0 1.7 12.7 16.3 13.8 11.6 12.8 7.8 21.4 10.1 14.9 18.0 23.8 13.4 1.3 12.4 10.4 10.4 18.0 22.9 24.1 29.6 10.4 5.9 20.5 10.0 16.1 1.1 12.2 38.4 0.0 16.2 12.8 12.9 15.0 30.1 27.7 21.4 35.0 28.3 8.6 5.7 1.8 10.6 14.7 25.3 8.2 25.7 6.5 22.4 23.7 12.0 17.4 4.7 0.0 11.3 1.2 11.3 10.5 57.2 2.2 23.0 30.4 SOCS7 "NAP4, NCKAP4" ENSG00000274211 "Suppressor of cytokine signaling 7" O14512 17 38352228-38405593 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.9;testis: 19.7" "Group enriched" "Detected in many" 6 "Early spermatids: 232.7;Late spermatids: 410.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004475 Approved Approved Cytosol NA NA Cytosol "HPA004475: AB_2667194" "prognostic unfavorable (7.49e-4)" "unprognostic (7.93e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.87e-4)" "unprognostic (7.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.43e-3)" "unprognostic (1.23e-1)" "unprognostic (1.77e-1)" "unprognostic (4.12e-3)" "unprognostic (1.97e-3)" "unprognostic (6.62e-2)" "unprognostic (4.91e-3)" "unprognostic (1.55e-2)" "unprognostic (1.53e-1)" "unprognostic (6.65e-2)" "unprognostic (1.88e-1)" 2.4 1.9 6.1 2.5 6.7 2.1 3.2 22.9 7.8 2.6 2.3 3.5 3.3 2.2 3.6 4.2 3.5 3.2 2.3 2.7 5.1 2.4 0.9 2.6 1.8 3.3 5.1 5.1 9.1 5.1 0.9 2.2 2.9 3.1 2.7 2.9 3.6 3.2 6.0 5.2 2.1 3.6 1.4 1.7 1.4 19.7 4.3 4.7 5.2 1.8 2.8 2.4 2.4 0.8 1.0 0.2 0.9 0.7 2.6 0.3 8.9 10.1 11.3 8.8 6.4 5.4 9.4 3.9 3.4 4.8 3.9 7.9 2.7 6.1 6.0 6.2 6.8 6.0 9.6 2.8 6.1 11.4 8.6 6.5 11.4 8.2 2.2 14.2 11.2 3.3 11.3 5.0 6.9 6.0 4.0 3.2 5.3 4.2 5.9 4.9 12.2 9.4 3.7 9.8 1.6 12.2 19.0 5.6 3.2 11.0 20.0 10.9 9.7 6.3 6.9 10.0 11.7 8.0 4.0 4.8 4.3 8.6 12.0 14.7 10.2 9.0 6.4 7.2 9.7 0.2 0.9 0.1 2.1 0.5 2.6 0.8 0.7 0.3 0.4 0.7 0.4 0.6 0.2 0.7 0.5 1.0 1.1 0.3 14.9 8.5 0.8 6.0 0.7 43.1 19.2 2.5 9.4 14.8 1.8 27.5 7.8 1.7 5.2 232.7 3.6 3.6 0.0 5.6 4.0 4.3 6.6 0.0 7.8 2.8 33.4 4.7 7.4 7.0 410.0 9.8 2.2 1.7 2.8 6.1 12.0 5.6 7.0 8.5 2.2 16.6 0.0 2.6 58.3 22.2 0.6 6.8 6.9 6.3 6.8 SOD1 "ALS, ALS1, IPOA" ENSG00000142168 "Superoxide dismutase 1" P00441 21 31659622-31668931 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antioxidant, Oxidoreductase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 282.6" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 2529.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001401, CAB008670" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 44900000 91000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB008670: AB_1623312, HPA001401: AB_1080132" "unprognostic (1.73e-1)" "unprognostic (1.18e-2)" "unprognostic (4.43e-1)" "unprognostic (6.19e-2)" "unprognostic (1.39e-1)" "unprognostic (9.59e-3)" "unprognostic (8.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.47e-1)" "unprognostic (5.28e-2)" "unprognostic (9.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-2)" "unprognostic (1.57e-1)" "unprognostic (3.26e-2)" 39.2 86.5 71.1 29.1 74.3 24.6 108.6 35.6 74.9 26.8 37.7 19.1 35.4 62.5 24.6 42.2 25.8 36.0 46.8 96.5 77.8 73.1 84.0 282.6 23.0 26.8 80.2 67.0 53.9 27.2 27.1 30.4 29.7 96.1 35.1 32.6 19.3 19.7 39.3 83.9 20.5 45.5 45.2 88.2 19.2 25.8 22.2 43.8 12.3 30.1 34.7 25.6 25.4 124.0 57.6 32.3 24.9 57.2 29.6 95.6 55.6 56.2 49.2 34.5 34.5 46.2 32.3 28.7 47.5 28.3 32.3 24.4 63.7 35.8 67.3 50.0 43.7 58.6 20.4 49.5 34.9 26.6 49.7 61.4 108.7 64.6 91.1 30.6 47.9 40.7 33.4 26.6 45.2 25.2 36.8 36.2 51.6 74.9 86.2 38.9 91.3 51.4 48.4 51.9 89.1 52.5 44.3 69.6 104.7 63.1 34.6 37.8 31.7 87.9 46.5 45.6 32.5 53.5 42.4 42.4 25.1 55.7 33.9 34.9 65.8 142.4 79.8 51.3 70.0 33.3 22.1 21.9 24.9 45.0 30.2 51.6 57.6 73.1 56.9 28.6 40.9 76.2 59.3 5.1 29.6 57.2 32.3 95.6 55.6 71.1 74.3 35.6 74.9 77.8 73.1 80.2 67.0 96.1 43.8 273.9 132.0 321.6 545.9 436.4 220.9 652.4 591.1 509.9 249.1 371.6 45.2 624.2 1382.7 369.6 242.1 264.2 846.2 327.1 713.9 544.4 341.5 540.9 215.8 2529.1 314.9 267.0 277.0 292.2 203.5 693.0 483.3 265.6 398.1 397.7 279.9 378.3 307.6 522.5 496.4 1894.8 157.7 433.4 418.2 79.3 538.3 305.8 607.1 266.4 526.4 451.3 SOGA1 "C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA" ENSG00000149639 "Suppressor of glucose, autophagy associated 1" O94964 20 36777442-36863686 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.5" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043992 Approved Approved Nucleoli,Cytosol "Secreted to blood" NA Yes "Nucleoli, Cytosol" "HPA043992: AB_2678762" "unprognostic (2.34e-2)" "unprognostic (1.35e-1)" "unprognostic (6.58e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.48e-1)" "unprognostic (2.27e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (1.09e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (4.45e-3)" 6.2 11.4 10.8 4.5 10.6 1.4 6.0 55.5 12.5 11.3 8.3 20.5 7.2 2.5 8.8 5.3 7.2 9.4 9.9 6.7 9.9 7.5 4.7 1.3 6.1 3.0 12.7 8.9 12.6 3.7 11.5 4.4 7.9 8.7 10.7 3.9 6.7 4.4 12.3 2.9 11.0 4.6 14.1 7.9 5.3 5.3 14.8 14.7 0.9 16.0 4.7 4.1 8.0 10.5 1.0 2.1 1.4 0.7 0.7 0.2 0.2 7.5 10.3 12.5 13.5 7.3 6.7 3.3 6.6 7.2 9.5 5.6 4.1 1.2 3.3 2.5 11.6 8.2 10.2 10.0 6.2 10.0 0.5 2.0 5.4 9.6 5.4 3.8 1.2 5.3 3.8 7.6 9.0 6.4 4.1 6.1 3.7 3.8 0.7 10.3 7.3 3.8 2.8 3.2 0.8 8.0 9.0 11.7 1.3 5.5 2.3 15.0 9.4 13.8 15.2 4.4 5.8 19.3 8.1 9.3 23.8 4.6 11.6 14.4 1.4 0.3 3.4 10.1 1.6 15.0 1.4 0.7 0.2 0.1 0.4 0.2 1.0 0.1 0.1 0.4 1.0 0.2 0.2 1.4 0.7 0.3 2.1 0.1 0.2 10.8 10.6 55.5 12.0 9.9 7.5 12.7 8.9 8.7 14.7 0.0 2.6 1.4 4.8 11.2 18.8 12.1 0.0 2.7 7.9 19.2 35.3 12.5 1.7 3.4 0.4 10.5 1.7 0.0 1.3 8.6 11.0 5.2 10.4 0.2 8.5 22.3 5.8 9.8 5.3 1.5 11.2 6.0 5.0 1.0 1.3 19.4 1.8 0.0 17.7 1.2 3.7 12.9 11.3 0.7 1.0 14.1 2.7 1.0 2.5 2.5 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;pituitary gland: 11.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.4;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 6 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "AF22: 7.5;SCLC-21H: 24.3;SH-SY5Y: 13.9" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035388: AB_2674601, HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.8 2.8 5.0 1.8 5.3 0.4 0.4 11.4 15.3 1.0 0.8 3.7 0.0 0.5 2.1 0.2 2.0 1.0 1.9 0.8 4.2 4.5 0.6 0.6 1.7 0.8 6.7 5.0 3.3 1.7 0.2 11.9 1.2 7.9 1.1 0.6 0.7 1.1 0.5 0.3 1.0 1.9 0.6 11.4 1.4 3.9 1.8 4.3 0.0 1.9 0.0 0.3 1.6 0.8 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.2 3.3 7.5 1.1 0.0 0.6 0.3 0.7 0.9 0.9 2.4 0.2 0.3 0.4 0.2 0.1 6.2 0.0 0.8 0.0 0.7 0.7 0.1 0.6 0.0 0.1 0.0 0.2 0.1 1.2 0.0 3.7 0.0 0.8 0.0 1.1 0.3 0.2 0.5 0.5 4.9 0.0 3.4 0.0 0.8 0.4 1.8 0.0 0.1 0.0 24.3 13.9 0.0 0.0 0.2 0.9 0.0 0.3 0.2 6.0 1.2 0.4 1.7 0.2 0.1 0.1 4.5 1.1 5.9 0.0 0.0 0.0 0.3 0.0 0.4 0.3 2.3 0.8 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.0 5.3 11.4 8.2 4.2 4.5 6.7 5.0 7.9 4.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SORBS3 "SCAM-1, SH3D4, vinexin" ENSG00000120896 "Sorbin and SH3 domain containing 3" O60504 8 22544986-22575788 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 147.7;Late spermatids: 378.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015849 Approved Approved "Focal adhesion sites,Cytosol" NA NA 6600 Cytosol "Focal adhesion sites" "HPA015849: AB_1857365" "unprognostic (6.15e-3)" "unprognostic (2.09e-2)" "unprognostic (2.34e-1)" "unprognostic (3.90e-3)" "unprognostic (1.72e-1)" "unprognostic (9.30e-2)" "unprognostic (2.51e-2)" "unprognostic (2.44e-2)" "unprognostic (5.83e-3)" "unprognostic (1.70e-1)" "prognostic favorable (4.88e-4)" "unprognostic (4.21e-2)" "unprognostic (3.08e-3)" "unprognostic (7.41e-2)" "unprognostic (1.58e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.53e-5)" 52.2 22.6 25.0 16.8 23.2 3.3 56.5 31.4 27.0 49.3 28.9 21.9 19.2 19.6 40.6 32.0 27.5 33.8 42.8 32.8 27.3 12.8 28.1 41.8 38.9 28.7 21.3 18.0 49.0 21.7 27.0 24.1 43.3 22.8 38.0 23.7 45.8 36.6 34.5 29.5 32.0 34.5 41.9 24.1 28.6 20.4 36.0 21.2 3.4 29.7 36.2 15.7 38.4 44.7 0.8 5.6 0.4 3.2 4.0 17.4 3.3 22.6 28.6 15.6 17.6 25.4 33.9 16.0 23.3 36.2 27.3 17.0 28.9 10.2 0.2 15.9 36.3 11.0 19.5 23.4 21.3 14.2 15.9 10.2 1.9 16.1 13.2 28.9 0.2 0.1 21.3 15.9 9.5 14.0 30.5 21.1 12.1 4.9 0.7 19.4 8.9 1.9 0.7 5.5 3.9 12.0 21.7 10.6 2.1 12.4 4.4 0.9 14.1 11.4 2.8 14.4 17.1 4.7 8.1 32.8 24.3 17.4 17.7 16.4 0.4 0.6 3.0 14.2 5.4 16.4 0.0 1.6 0.4 8.6 3.2 17.4 0.6 9.4 9.9 5.6 0.8 9.7 5.6 0.4 4.0 0.7 1.9 0.4 3.3 25.0 23.2 31.4 27.0 27.3 12.8 21.3 18.0 22.8 21.2 17.9 4.5 3.0 20.1 26.0 2.0 8.0 25.5 9.4 11.4 12.2 0.0 21.8 8.3 18.5 147.7 38.9 46.6 0.0 16.9 25.1 46.3 33.6 17.3 37.5 30.7 4.8 14.0 75.5 27.9 378.2 56.7 18.7 23.6 1.8 35.7 20.2 20.5 48.2 55.2 20.3 3.1 58.2 68.3 5.5 6.1 18.6 17.2 14.1 25.3 21.6 SORCS1 sorCS1 ENSG00000108018 "Sortilin related VPS10 domain containing receptor 1" Q8WY21 10 106573663-107164534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 18.5" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 59.3" "Cancer enhanced" "Detected in some" "melanoma: 3.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "intermediate monocyte: 2.4" "Lineage enriched" "Detected in single" 24 "monocytes: 2.4" "Group enriched" "Detected in some" 12 "RH-30: 33.9;SH-SY5Y: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011948 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA011948: AB_1857366" "unprognostic (5.86e-3)" "unprognostic (8.45e-3)" "unprognostic (1.55e-2)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (2.92e-2)" "unprognostic (3.52e-2)" "unprognostic (5.58e-2)" "unprognostic (6.82e-3)" "unprognostic (5.81e-2)" "unprognostic (6.48e-4)" "unprognostic (2.51e-2)" "unprognostic (8.89e-3)" "unprognostic (2.22e-1)" "unprognostic (2.69e-4)" 1.4 5.8 6.0 4.5 14.1 0.4 1.8 0.5 13.2 2.2 10.7 1.1 1.9 1.4 2.1 1.2 2.0 3.2 2.8 4.2 2.6 4.7 8.0 0.5 0.5 1.9 2.1 6.6 1.2 3.0 0.6 1.2 0.4 3.3 2.7 3.6 6.5 2.4 4.9 0.8 2.3 4.5 2.7 2.1 1.7 3.4 2.3 2.7 0.2 18.5 1.1 2.7 4.7 3.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 33.9 0.0 0.0 0.0 0.0 44.4 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 14.1 0.5 11.3 2.6 4.7 2.1 6.6 3.3 2.7 0.0 0.3 0.0 0.0 0.6 1.8 1.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 14.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.3 3.4 0.0 0.0 1.7 0.0 0.0 59.3 0.1 0.0 0.4 2.2 1.7 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1" "Cell type enhanced" "Detected in many" 19 "Bipolar cells: 66.5;Muller glia cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.6;HaCaT: 16.6;HMC-1: 12.5;RPMI-8226: 7.4;SiHa: 12.0;THP-1: 7.0;U-937: 7.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061916 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA061916: AB_2684636" "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 4.9 2.6 12.0 6.4 16.6 3.3 1.8 4.8 22.4 13.8 4.0 32.1 3.2 3.1 6.0 8.2 4.7 3.5 7.1 3.2 10.7 6.9 7.4 5.2 8.3 2.0 9.9 11.2 7.4 1.7 0.8 2.7 0.9 11.2 7.5 2.6 7.5 2.6 5.3 2.4 1.9 4.2 11.5 11.2 1.3 1.9 3.4 11.3 0.8 6.2 2.2 2.7 5.2 3.7 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.9 1.1 0.2 0.1 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.5 0.0 6.6 4.2 1.1 16.6 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.2 0.1 0.0 12.5 0.2 3.7 5.2 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.7 0.0 1.3 7.4 0.2 0.0 0.7 0.6 12.0 0.0 0.0 0.7 0.0 7.0 0.0 4.3 1.3 0.0 0.1 0.0 0.0 0.0 1.4 7.3 0.2 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 12.0 16.6 4.8 17.7 10.7 6.9 9.9 11.2 11.2 11.3 3.0 13.7 0.0 0.2 0.1 66.5 2.0 0.0 2.7 7.9 5.2 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.2 0.2 1.6 0.0 0.0 0.3 10.2 11.8 0.3 1.7 0.0 0.0 31.9 0.7 0.0 7.4 0.7 2.4 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.4 SORD ENSG00000140263 "Sorbitol dehydrogenase" Q00796 15 45023104-45077185 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3" "Cell type enhanced" "Detected in many" 17 "Hepatocytes: 654.8;Proximal tubular cells: 226.9" "Cancer enhanced" "Detected in all" "prostate cancer: 72.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "eosinophil: 36.4" "Lineage enriched" "Detected in many" 13 "granulocytes: 36.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040260, HPA040621" Enhanced Approved Cytosol NA NA 430000 Cytosol "HPA040260: AB_10794872, HPA040621: AB_10795384" "unprognostic (8.18e-2)" "unprognostic (7.58e-2)" "unprognostic (8.19e-2)" "unprognostic (1.51e-1)" "unprognostic (5.69e-3)" "unprognostic (3.90e-2)" "prognostic favorable (6.14e-5)" "unprognostic (3.33e-3)" "unprognostic (1.67e-1)" "unprognostic (4.95e-2)" "unprognostic (7.04e-3)" "unprognostic (1.40e-1)" "unprognostic (4.26e-2)" "unprognostic (1.23e-2)" "unprognostic (8.53e-2)" "unprognostic (2.31e-2)" "unprognostic (1.56e-1)" 1.4 10.2 3.0 1.5 3.2 1.0 7.1 3.1 3.8 66.3 5.5 6.2 39.2 2.6 2.6 3.2 6.7 3.5 3.9 3.4 3.0 3.0 20.9 98.4 1.6 2.2 4.2 2.3 1.6 7.3 1.2 1.8 0.5 5.0 48.5 3.8 2.3 7.6 46.7 1.4 8.0 8.7 2.0 5.0 2.4 5.6 2.5 3.9 3.1 116.3 3.8 3.5 4.2 4.4 1.6 2.4 36.4 2.7 0.4 1.0 1.3 15.6 13.8 3.5 11.3 3.0 5.3 3.7 4.3 3.0 9.9 8.4 11.5 8.6 2.0 9.8 5.3 10.7 23.6 18.1 16.4 7.9 34.0 11.2 15.7 18.1 25.3 2.3 27.3 26.4 6.8 12.5 5.7 9.1 4.8 9.3 24.2 17.6 5.6 9.3 6.3 16.5 14.8 13.5 26.5 14.7 0.0 22.8 7.6 7.2 15.3 24.8 13.0 8.9 14.0 6.6 3.9 20.2 11.2 8.3 7.9 7.0 17.6 10.4 1.0 6.9 2.0 12.8 24.1 20.6 5.0 2.7 36.4 0.6 2.5 1.0 1.2 0.6 0.8 2.4 1.6 0.5 0.6 1.4 0.4 2.5 1.3 0.6 1.3 3.0 3.2 3.1 3.8 3.0 3.0 4.2 2.3 5.0 3.9 0.0 1.9 16.8 20.6 6.9 9.5 2.8 38.2 28.1 28.4 31.4 0.0 1.0 24.9 52.5 26.1 3.8 9.1 0.0 118.4 3.9 5.8 134.4 8.1 654.8 14.4 3.2 81.4 20.9 21.2 17.1 3.4 8.2 15.1 8.2 29.3 6.8 90.9 13.3 5.6 226.9 3.6 0.0 9.2 6.5 2.5 17.8 0.8 6.4 32.6 87.8 SORT1 "Gp95, NT3" ENSG00000134243 "Sortilin 1" Q99523 1 109309568-109397951 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Osteogenesis, Transport" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.1;epididymis: 75.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.0;non-classical monocyte: 10.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006889, CAB011498" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 7170000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB011498: AB_2192606, HPA006889: AB_1080056" "unprognostic (2.10e-2)" "unprognostic (7.46e-2)" "prognostic favorable (7.74e-6)" "unprognostic (4.12e-1)" "unprognostic (9.41e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (3.34e-3)" "unprognostic (4.27e-2)" "unprognostic (9.44e-2)" "unprognostic (2.42e-2)" "unprognostic (1.28e-2)" "unprognostic (1.23e-3)" "unprognostic (1.45e-2)" "unprognostic (2.15e-1)" "unprognostic (3.95e-1)" "unprognostic (4.46e-3)" 22.9 6.5 24.0 6.2 35.5 10.1 15.5 6.4 40.6 10.1 15.2 50.3 18.1 11.5 11.9 75.2 22.0 14.8 9.5 31.8 45.2 19.8 21.1 3.7 19.2 3.6 57.9 22.8 3.6 9.3 24.2 5.7 22.9 27.1 10.3 14.4 12.2 11.8 24.8 36.4 8.3 11.3 14.6 71.1 5.4 9.5 21.6 42.2 1.1 22.5 5.1 5.4 8.7 8.2 0.0 4.5 2.3 10.0 0.4 0.0 1.7 11.8 4.7 11.9 14.5 34.8 6.9 34.3 8.8 14.1 8.7 9.3 12.2 4.4 0.1 11.3 3.7 6.4 2.9 14.0 6.9 12.5 0.3 6.6 3.2 7.7 13.1 13.6 0.0 10.7 17.3 1.1 10.6 2.3 23.3 1.3 9.9 24.4 1.2 12.1 12.5 8.3 0.2 4.4 5.3 2.0 9.3 28.1 5.7 16.6 8.6 12.2 7.0 5.2 34.5 37.0 17.7 14.5 2.0 0.3 1.8 7.1 0.3 14.7 11.8 9.6 0.0 3.1 0.0 7.6 0.0 7.1 2.3 0.0 9.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.9 0.4 10.0 1.6 0.0 1.7 24.0 35.5 6.4 33.9 45.2 19.8 57.9 22.8 27.1 42.2 35.7 42.8 0.0 4.2 1.1 14.6 83.1 33.1 22.7 18.2 71.5 33.4 26.8 5.0 23.3 53.4 7.3 49.9 0.0 20.8 26.7 6.1 10.7 7.0 22.5 27.9 12.7 16.1 4.3 36.7 56.4 8.1 24.8 20.3 20.8 30.9 20.4 21.0 17.5 46.7 9.9 42.2 32.3 31.1 51.1 20.4 1.6 30.8 1.8 19.9 10.8 SOS1 "GF1, GINGF, HGF" ENSG00000115904 "SOS Ras/Rac guanine nucleotide exchange factor 1" Q07889 2 38981396-39124345 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005396 Uncertain Approved Cytosol NA NA Cytosol "CAB005396: AB_2270724" "unprognostic (6.68e-2)" "unprognostic (2.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.14e-3)" "unprognostic (4.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.74e-3)" "unprognostic (4.55e-2)" "unprognostic (1.10e-1)" "unprognostic (4.13e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-3)" "unprognostic (7.61e-2)" "unprognostic (5.59e-2)" "unprognostic (1.33e-2)" 25.9 13.2 19.2 18.8 18.1 12.0 26.1 33.3 18.6 18.6 21.9 12.1 15.3 18.3 19.1 14.6 17.4 17.0 18.1 16.4 17.9 14.1 14.6 15.2 19.9 19.9 18.2 14.0 28.1 13.0 33.5 21.7 21.5 17.8 18.4 16.8 14.6 15.9 18.1 26.2 15.0 23.1 22.3 14.6 16.2 20.1 12.7 20.1 23.1 19.4 12.9 21.8 25.1 22.0 3.2 1.4 3.2 2.0 6.2 4.6 0.9 9.9 6.1 9.6 6.8 13.0 15.5 10.0 6.3 7.8 5.0 4.8 6.6 6.0 14.5 4.3 8.2 7.8 6.0 11.2 5.7 9.4 14.5 5.0 22.4 5.3 9.1 5.3 7.1 57.0 9.5 9.2 6.8 6.7 8.6 7.9 3.3 9.5 6.8 6.4 5.4 7.6 6.6 6.0 12.3 4.4 8.6 8.6 4.2 5.3 8.1 9.3 9.3 7.5 13.5 7.8 8.3 4.3 3.8 8.8 8.4 6.8 6.6 6.2 8.1 8.2 7.6 6.7 7.1 5.0 0.0 1.2 3.2 3.2 1.8 4.6 3.2 3.3 3.3 1.0 2.4 3.7 3.4 1.4 6.2 2.0 1.4 1.9 0.9 19.2 18.1 33.3 18.6 17.9 14.1 18.2 14.0 17.8 20.1 14.9 31.1 14.3 12.7 18.4 17.6 28.1 17.8 21.4 19.4 8.7 9.8 7.5 1.7 8.3 24.4 32.8 15.5 0.0 10.3 6.5 15.3 19.0 3.5 14.8 9.1 7.9 11.5 10.4 14.6 4.9 21.0 14.4 6.8 8.2 17.7 15.7 10.1 10.5 20.5 10.0 11.2 6.5 11.2 7.6 5.3 22.1 8.7 22.3 16.4 25.8 SOWAHC "ANKRD57, C2orf26, FLJ21870" ENSG00000198142 "Sosondowah ankyrin repeat domain family member C" Q53LP3 2 109614334-109618990 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 131.1;Suprabasal keratinocytes: 174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 55.9;hTCEpi: 18.6;RT4: 23.6" "Low region specificity" "Detected in all" HPA056131 Enhanced Approved Cytosol No No Cytosol "HPA056131: AB_2683047" "unprognostic (6.76e-2)" "unprognostic (6.96e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.87e-1)" "unprognostic (8.91e-3)" "unprognostic (1.63e-2)" "unprognostic (1.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (5.11e-3)" "prognostic favorable (3.56e-5)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (3.50e-1)" "unprognostic (2.54e-2)" 4.9 2.7 2.7 3.7 2.7 0.1 6.5 0.8 2.3 8.9 11.8 3.5 5.3 3.3 3.7 6.4 30.4 3.6 7.2 2.2 2.5 3.2 11.5 35.4 5.1 3.7 5.7 0.8 9.2 4.1 4.1 2.2 20.7 3.6 9.8 5.9 3.9 8.1 6.3 1.1 14.4 17.9 7.8 5.7 3.6 4.4 7.8 2.8 3.2 5.3 30.4 15.9 11.5 10.5 0.8 0.5 1.3 2.3 0.5 1.1 0.5 6.7 1.3 3.9 2.1 2.0 3.3 12.8 14.8 8.7 2.6 2.7 6.0 2.1 0.0 6.1 2.2 4.9 6.4 0.9 9.7 2.8 55.9 6.5 0.0 3.0 8.5 1.8 0.0 1.7 1.7 18.6 5.6 4.0 2.2 0.6 0.0 0.1 0.0 1.9 2.2 0.0 0.6 2.8 6.2 5.9 0.0 0.8 0.1 3.9 23.6 4.9 2.1 5.0 0.9 3.9 4.0 1.9 0.1 0.9 2.1 7.9 1.2 1.0 1.9 1.8 0.0 2.4 0.2 4.7 1.3 2.3 0.3 0.3 0.9 0.4 0.8 0.7 0.3 0.2 0.6 0.5 0.7 1.2 0.5 0.8 0.5 1.1 0.5 2.7 2.7 0.8 2.3 2.5 3.2 5.7 0.8 3.6 2.8 14.9 9.8 3.0 32.5 131.1 10.3 4.2 20.4 2.7 12.5 12.2 9.8 3.1 3.3 14.2 38.3 6.8 30.2 0.0 6.2 25.3 12.3 14.5 0.0 44.5 6.9 0.0 15.0 7.4 7.2 8.5 10.9 6.1 18.6 1.8 27.8 8.0 11.7 40.3 14.2 17.4 18.6 12.9 15.3 10.4 6.9 174.3 8.4 1.5 31.7 73.5 SP4 "HF1B, MGC130008, MGC130009, SPR-1" ENSG00000105866 "Sp4 transcription factor" Q02446 7 21428034-21514822 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010246, HPA040395" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB010246: AB_2194481, HPA040395: AB_2676959" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" "unprognostic (6.04e-2)" "unprognostic (8.28e-2)" "unprognostic (9.14e-2)" "unprognostic (8.51e-2)" "unprognostic (1.09e-2)" "unprognostic (7.85e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.15e-3)" "unprognostic (1.89e-1)" "unprognostic (6.04e-3)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "unprognostic (6.18e-2)" "unprognostic (7.80e-3)" 5.8 4.7 7.9 8.9 11.0 10.2 6.3 25.9 9.5 8.6 4.4 6.4 3.8 3.1 9.2 5.8 4.1 7.8 4.6 6.5 8.3 6.1 5.4 3.4 6.0 11.7 8.6 6.9 19.8 5.2 17.1 11.8 3.7 6.7 7.3 4.3 6.0 5.0 5.7 10.5 5.0 5.6 5.3 6.8 9.1 4.9 6.0 10.0 27.0 13.1 4.8 11.2 6.8 6.3 5.4 1.5 7.2 1.8 3.5 8.3 3.1 2.2 1.7 5.1 8.1 1.5 1.0 1.5 2.3 1.7 2.7 3.7 3.5 2.7 9.2 1.4 1.5 7.2 2.8 7.5 2.2 5.3 2.7 2.8 4.8 3.3 1.5 1.1 4.0 5.7 1.1 1.9 2.9 3.3 1.4 5.4 6.7 6.0 7.0 2.2 1.0 9.3 2.9 12.3 4.3 2.1 20.9 8.7 3.3 0.9 1.6 6.6 8.2 5.3 2.4 1.8 5.1 2.6 2.9 2.3 4.4 5.5 2.7 4.2 9.3 7.3 14.4 2.5 6.4 6.1 4.3 0.8 7.2 6.8 0.9 8.3 3.7 6.4 6.6 0.9 5.4 7.6 7.1 1.9 3.5 1.8 1.5 7.6 3.1 7.9 11.0 25.9 9.5 8.3 6.1 8.6 6.9 6.7 10.0 3.0 7.0 5.0 11.4 11.2 15.9 7.6 10.2 1.4 7.9 0.0 7.9 1.0 0.0 1.7 5.5 5.8 1.1 0.0 1.8 1.0 6.1 7.1 4.7 4.0 1.5 17.5 10.3 11.6 6.5 4.1 5.2 5.9 6.8 2.8 1.8 9.8 1.4 8.6 6.3 1.4 18.8 0.0 4.1 7.9 8.3 9.7 1.3 14.6 2.8 4.3 SPAG1 "CILD28, CT140, FLJ32920, HSD-3.8, SP75, TPIS" ENSG00000104450 "Sperm associated antigen 1" Q07617 8 100157906-100259278 "Disease related genes, Predicted intracellular proteins" Fertilization Hydrolase "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 195.4;Spermatocytes: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023748, HPA053682" Enhanced Supported Cytosol NA NA Cytosol "HPA023748: AB_2671304, HPA053682: AB_2682229" "unprognostic (9.95e-2)" "unprognostic (5.37e-2)" "unprognostic (1.38e-2)" "unprognostic (4.24e-2)" "unprognostic (1.46e-1)" "unprognostic (2.57e-1)" "unprognostic (5.86e-2)" "unprognostic (9.19e-2)" "unprognostic (1.53e-1)" "unprognostic (5.62e-2)" "unprognostic (1.57e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.87e-4)" "unprognostic (9.11e-3)" "unprognostic (8.83e-3)" "unprognostic (1.54e-1)" "prognostic favorable (2.62e-4)" 2.0 1.5 3.9 3.5 6.8 9.1 3.6 6.4 5.9 6.0 12.8 7.8 13.5 3.0 3.0 8.5 8.1 10.4 4.4 5.4 5.6 6.1 7.5 10.8 10.0 2.6 4.1 2.6 4.5 3.3 13.0 21.2 1.9 26.2 4.8 19.3 2.8 6.1 14.4 0.7 8.0 3.4 2.0 5.7 2.7 6.5 18.2 5.4 1.3 4.5 0.5 4.3 5.6 3.9 2.9 0.8 2.5 0.6 3.2 0.6 0.2 20.5 5.5 0.3 1.2 1.3 1.1 3.2 3.8 2.3 4.7 5.0 5.5 9.1 0.8 13.9 1.2 7.0 10.9 4.0 7.4 4.4 12.0 4.2 3.4 6.3 2.1 1.7 0.9 3.1 0.9 4.0 5.8 4.6 3.7 3.9 3.8 0.1 11.1 0.7 7.3 2.0 0.9 0.3 10.3 6.2 0.3 0.9 3.1 18.0 9.9 3.3 2.4 5.3 4.4 4.5 1.6 6.3 3.9 3.6 4.7 6.8 2.5 9.9 7.5 5.7 0.6 4.5 3.3 2.3 0.0 0.4 1.8 0.5 0.0 0.3 2.9 0.4 0.5 0.4 1.2 0.1 0.6 2.5 3.2 0.6 0.8 0.0 0.2 3.9 6.8 6.4 5.9 5.6 6.1 4.1 2.6 26.2 5.4 44.7 21.4 0.8 7.5 4.9 1.1 5.4 25.5 195.4 42.1 17.4 0.0 1.0 5.0 14.3 59.8 6.8 12.0 0.0 7.6 4.6 4.1 9.0 9.3 6.8 2.3 7.9 21.2 2.5 0.6 20.5 4.6 3.5 1.7 6.4 16.7 10.8 13.8 17.8 3.5 9.1 2.2 0.0 3.3 93.3 3.8 4.6 1.9 12.9 24.0 21.4 SPAG16 "DKFZp666P1710, FLJ22724, PF20, WDR29" ENSG00000144451 "Sperm associated antigen 16" Q8N0X2 2 213284379-214410501 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Ciliated cells: 261.0;Early spermatids: 200.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 33.9" "Low region specificity" "Detected in many" HPA037542 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA037542: AB_10672353" "unprognostic (4.20e-2)" "unprognostic (2.73e-1)" "unprognostic (2.67e-1)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.90e-4)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-1)" "unprognostic (1.17e-1)" 11.1 13.0 28.2 5.4 29.8 1.7 15.8 12.0 22.0 16.7 11.5 21.9 23.1 13.7 14.0 24.8 16.0 34.8 17.0 15.7 27.7 24.6 22.6 13.8 8.1 7.7 31.5 22.0 20.2 11.2 24.0 32.8 7.3 25.7 17.1 13.1 11.1 11.8 19.8 6.1 18.2 7.9 14.3 36.9 5.7 19.2 34.3 18.1 10.5 19.9 11.4 9.8 14.8 11.9 7.5 4.1 1.1 1.1 12.1 10.6 3.0 12.4 5.0 14.3 0.0 9.8 17.6 0.1 6.8 8.2 8.9 9.5 9.8 13.8 5.2 8.2 7.5 14.3 8.8 6.4 8.3 19.0 0.0 5.1 2.7 12.7 12.7 10.9 2.9 0.0 15.0 11.5 7.9 4.6 12.3 3.6 5.5 8.7 6.0 8.9 0.0 9.8 0.0 7.9 0.0 4.2 10.5 15.0 0.2 14.3 12.2 10.4 12.3 7.9 7.3 9.6 12.9 33.9 1.2 3.8 8.6 5.2 4.5 7.1 9.8 4.4 0.2 14.0 0.0 3.8 1.1 0.2 0.7 7.1 1.1 10.1 7.5 8.0 8.9 2.5 7.3 10.6 9.2 0.4 12.1 0.8 4.1 7.4 3.0 28.2 29.8 12.0 22.0 27.7 24.6 31.5 22.0 25.7 18.1 14.9 17.9 11.0 36.9 37.5 34.4 59.6 58.6 261.0 58.0 38.4 90.3 41.9 64.6 34.0 200.5 21.0 10.6 23.3 21.5 17.0 30.9 34.4 9.3 16.0 10.0 38.1 36.7 9.2 4.5 48.7 38.3 6.9 21.9 49.5 35.2 69.4 27.0 10.5 42.1 72.5 64.3 12.9 31.9 158.7 19.0 49.3 19.7 12.1 36.5 43.0 SPAG5 "DEEPEST, hMAP126, MAP126" ENSG00000076382 "Sperm associated antigen 5" Q96R06 17 28577565-28599279 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.3;testis: 94.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 101.5;Spermatocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 10.1;T-reg: 6.2" "Group enriched" "Detected in many" 6 "granulocytes: 10.1;T-cells: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA022008, HPA022479, HPA024418" Approved Supported "Nuclear bodies,Mitotic spindle,Cytosol" NA Yes "Nuclear bodies, Mitotic spindle" Cytosol "HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: " "unprognostic (4.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.31e-3)" "unprognostic (2.32e-3)" "unprognostic (3.50e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (5.43e-5)" "unprognostic (3.37e-3)" "unprognostic (4.84e-3)" "unprognostic (5.97e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.49e-2)" "prognostic unfavorable (5.43e-13)" "unprognostic (2.64e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-2)" "unprognostic (2.01e-1)" 2.1 1.1 2.3 7.6 3.8 16.5 1.7 2.7 3.4 1.7 5.1 0.8 0.5 3.9 2.0 1.9 3.8 0.5 1.8 1.7 1.8 3.7 12.7 9.5 2.6 6.5 1.5 0.7 1.4 1.9 0.4 1.9 3.3 1.3 1.3 5.3 1.3 1.4 0.9 0.8 2.5 7.1 1.5 1.9 5.8 1.7 94.2 1.0 27.3 3.9 5.5 11.2 1.8 1.3 1.2 0.4 10.1 0.7 1.0 6.2 1.2 23.8 25.3 30.3 23.5 1.5 2.5 12.4 19.3 12.2 28.7 23.2 19.7 7.3 16.8 10.5 13.4 27.0 20.8 32.9 12.2 30.7 30.2 21.1 17.8 25.2 23.9 0.2 23.1 22.5 0.8 1.1 23.1 12.0 4.2 15.0 26.2 19.2 29.7 23.3 15.7 30.4 27.5 16.3 19.2 12.8 20.3 42.2 20.0 8.6 12.7 23.0 13.5 27.7 33.4 9.6 26.1 23.8 21.2 7.4 16.6 27.9 13.7 32.9 13.8 21.1 25.9 11.2 17.7 26.4 10.1 0.0 0.3 0.6 0.7 1.1 0.9 1.8 1.3 0.1 1.2 1.5 1.4 0.6 1.0 0.4 0.4 6.2 1.2 2.3 3.8 2.7 3.4 1.8 3.7 1.5 0.7 1.3 1.0 3.0 1.7 2.2 1.1 1.8 4.7 0.4 0.0 10.7 2.3 0.0 0.0 1.7 1.7 0.5 101.5 1.0 6.2 23.3 0.3 10.6 1.1 0.6 1.1 3.9 5.3 3.2 12.5 4.3 1.8 14.4 0.9 3.6 0.0 1.0 2.3 0.6 0.3 0.8 0.0 10.9 3.3 6.5 1.7 43.6 23.0 0.9 3.2 2.5 2.7 0.5 SPAG9 "CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1" ENSG00000008294 "Sperm associated antigen 9" O60271 17 50962174-51120865 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 6.3;neutrophil: 13.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040446, HPA061458" Enhanced Enhanced "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA040446: AB_10671691, HPA061458: AB_2684528" "unprognostic (1.36e-1)" "unprognostic (6.61e-2)" "unprognostic (6.04e-3)" "unprognostic (4.65e-2)" "unprognostic (3.52e-2)" "unprognostic (9.73e-2)" "unprognostic (8.13e-2)" "unprognostic (3.72e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" "unprognostic (2.83e-2)" "unprognostic (9.71e-2)" "unprognostic (2.23e-3)" "unprognostic (2.27e-2)" "unprognostic (9.53e-2)" "unprognostic (7.67e-2)" "prognostic unfavorable (8.10e-4)" 21.6 16.4 32.1 12.5 42.6 15.8 13.8 32.7 46.6 15.9 15.6 44.8 7.6 14.0 19.6 9.1 20.7 12.3 18.8 15.1 33.1 25.5 23.6 22.8 20.5 8.7 55.7 25.9 22.2 21.0 25.8 14.6 21.8 37.1 13.2 14.1 12.2 9.9 14.4 39.6 14.2 14.2 19.1 50.2 12.1 10.5 33.3 55.2 8.5 28.2 9.5 10.6 15.0 13.6 1.0 1.3 13.4 1.3 0.5 1.8 0.4 17.5 19.7 25.3 12.3 24.1 21.4 22.4 14.4 14.2 16.2 20.3 17.7 12.1 9.5 10.1 23.7 32.8 15.2 16.5 12.1 30.3 14.4 19.7 7.9 15.6 13.1 18.1 11.4 9.3 15.4 14.1 21.9 39.3 15.6 13.3 4.8 17.4 10.6 22.9 8.8 7.1 4.8 6.7 11.8 25.6 8.2 28.3 8.3 14.9 33.5 19.7 27.4 12.7 11.9 13.1 16.0 9.7 13.6 18.4 45.4 10.7 34.9 21.1 15.1 21.6 15.6 15.5 6.8 15.7 6.3 1.3 0.8 1.4 0.8 1.0 1.0 1.2 1.3 1.3 1.0 0.7 0.9 13.4 0.5 0.5 1.1 1.8 0.4 32.1 42.6 32.7 34.9 33.1 25.5 55.7 25.9 37.1 55.2 122.1 93.5 25.1 151.7 146.5 92.9 57.2 38.2 30.8 36.4 24.4 117.8 34.3 23.2 46.7 183.2 86.7 70.8 0.0 49.5 23.5 89.4 131.0 41.6 44.8 33.0 63.5 66.9 68.7 43.2 94.6 70.5 64.9 67.4 46.9 27.4 30.1 70.3 31.6 62.9 65.7 82.4 64.7 72.1 210.4 52.0 150.7 116.1 31.6 25.1 163.9 SPART "KIAA0610, SPG20, TAHCCP1" ENSG00000133104 Spartin Q8N0X7 13 36301638-36370180 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 120.5;Club cells: 73.9;Proximal tubular cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 45.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 45.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039053, HPA039054" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039053: AB_10672769, HPA039054: AB_2676323" "unprognostic (3.73e-2)" "unprognostic (9.39e-2)" "unprognostic (3.06e-2)" "unprognostic (4.60e-2)" "unprognostic (2.21e-2)" "unprognostic (1.10e-2)" "unprognostic (9.18e-3)" "unprognostic (9.58e-2)" "unprognostic (3.36e-2)" "unprognostic (2.22e-1)" "unprognostic (7.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.54e-1)" "unprognostic (9.26e-2)" "unprognostic (1.22e-1)" "unprognostic (1.54e-2)" "unprognostic (5.79e-2)" 28.7 34.7 23.2 12.1 28.0 14.5 44.9 21.3 26.7 37.1 22.5 23.1 26.2 9.1 29.9 48.4 17.7 26.1 26.2 17.5 24.7 22.3 33.7 13.7 18.4 12.9 31.8 19.4 46.1 10.3 13.2 29.8 32.2 28.9 26.6 10.0 17.2 11.9 27.0 20.6 12.4 9.7 37.0 35.7 20.2 14.4 18.3 32.5 7.0 25.1 8.7 7.8 31.4 58.7 3.2 6.0 45.8 6.8 4.1 8.3 5.3 0.0 5.9 16.1 0.0 35.4 29.8 11.5 14.4 21.7 14.5 14.4 0.0 0.0 0.0 9.0 17.3 26.7 8.3 21.7 10.0 15.7 1.1 12.5 17.9 7.7 3.8 35.6 18.6 36.3 29.4 16.1 12.0 16.9 36.0 21.2 5.0 7.8 3.1 26.1 1.3 5.5 31.2 8.1 0.0 2.1 0.0 27.0 0.6 16.9 7.4 1.6 3.9 12.2 4.9 15.2 24.2 2.8 22.1 17.5 10.9 5.5 15.0 8.4 3.8 0.0 0.0 12.1 16.2 18.9 45.8 6.7 8.7 4.4 6.7 4.3 3.2 6.2 1.8 4.8 3.2 8.3 4.4 10.6 4.1 6.8 6.0 1.5 5.3 23.2 28.0 21.3 26.7 24.7 22.3 31.8 19.4 28.9 32.5 32.8 45.1 0.0 0.0 0.0 0.0 0.0 0.0 120.5 73.9 26.2 0.0 37.7 56.3 22.0 0.0 0.0 0.0 0.0 13.1 50.7 0.0 0.0 53.5 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 42.3 0.0 0.0 15.2 0.0 0.0 72.6 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 SPAST "ADPSP, FSP2, KIAA1083, SPG4" ENSG00000021574 Spastin Q9UBP0 2 32063547-32157637 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis" "Allosteric enzyme, Developmental protein, Isomerase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017311 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017311: AB_1857415" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (5.33e-2)" "unprognostic (3.90e-2)" "unprognostic (3.75e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.26e-2)" "unprognostic (2.35e-2)" "unprognostic (7.39e-2)" "unprognostic (5.98e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (5.71e-2)" "unprognostic (3.04e-1)" "unprognostic (1.53e-2)" "unprognostic (1.13e-1)" 12.7 9.6 18.4 14.8 16.4 13.4 9.8 21.1 21.9 14.7 12.7 15.1 12.5 11.5 12.3 8.7 11.1 10.4 10.2 6.2 20.2 18.5 9.4 14.6 9.7 18.9 20.6 10.0 15.1 10.9 11.8 12.3 11.5 17.5 10.3 12.0 6.8 9.3 13.7 15.4 11.5 17.6 11.6 27.0 15.5 9.7 14.4 14.6 21.5 13.4 6.2 13.8 11.3 10.1 5.0 7.1 9.5 9.0 6.6 7.6 4.3 10.8 7.8 12.9 12.6 8.1 9.6 11.6 6.0 8.9 6.3 5.7 10.6 9.5 19.0 5.6 8.3 9.3 7.7 12.7 6.1 7.8 12.7 7.6 20.8 4.2 12.9 7.4 14.5 14.7 5.3 8.1 8.1 7.7 7.7 13.9 6.2 17.0 6.4 6.9 4.6 23.3 12.2 13.4 12.1 4.6 12.4 18.1 12.3 8.6 6.8 18.3 19.7 10.2 8.7 10.0 11.0 5.6 10.0 12.1 7.0 10.8 6.2 7.0 9.7 18.0 15.4 7.6 12.6 8.4 3.4 6.3 6.7 3.6 9.0 5.2 5.0 5.8 5.6 7.1 3.9 5.9 6.0 9.5 6.6 6.3 3.2 7.6 4.3 18.4 16.4 21.1 15.8 20.2 18.5 20.6 10.0 17.5 14.6 8.9 4.1 4.2 5.3 8.5 14.5 7.5 7.6 13.4 6.8 5.2 21.6 7.6 0.0 5.6 2.5 8.7 9.7 0.0 7.0 6.2 5.0 7.3 9.3 10.9 8.8 9.5 10.4 6.2 14.6 6.4 8.1 16.6 1.7 8.2 10.1 8.0 8.4 8.4 9.6 6.5 14.3 0.0 8.1 15.4 22.2 11.4 6.8 7.5 8.4 5.5 SPATA12 ENSG00000186451 "Spermatogenesis associated 12" Q7Z6I5 3 57060441-57075432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 26.6" "Group enriched" "Detected in some" 125 "Early spermatids: 496.6;Late spermatids: 837.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "GAMG: 5.4;HUVEC TERT2: 2.4;RH-30: 3.1" "HPA043323, HPA075578" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA043323: AB_10796792, HPA075578: " "unprognostic (2.31e-1)" "unprognostic (2.18e-4)" "unprognostic (3.47e-4)" "unprognostic (2.21e-2)" "unprognostic (2.66e-1)" "unprognostic (8.79e-3)" "unprognostic (1.69e-3)" "unprognostic (3.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (6.80e-2)" "unprognostic (1.76e-2)" "unprognostic (4.71e-3)" "unprognostic (7.29e-2)" "unprognostic (1.62e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-3)" 0.2 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.8 0.1 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 1.1 0.1 0.4 26.6 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.5 0.5 0.0 5.4 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.6 0.0 0.0 1.1 0.2 0.5 0.0 0.0 1.1 2.4 0.0 0.0 0.6 0.2 0.1 0.0 0.0 1.5 1.2 1.5 0.0 3.1 0.1 2.0 1.2 0.0 0.0 0.2 0.0 1.3 0.6 0.0 0.0 0.8 0.0 2.0 0.4 0.3 0.0 0.2 1.0 0.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 496.6 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 837.5 4.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 5.3 0.0 0.0 0.0 0.0 4.6 2.3 0.0 0.0 0.0 0.0 0.3 SPATA13 "ARHGEF29, FLJ31208" ENSG00000182957 "Spermatogenesis associated 13" Q96N96 13 23979805-24307074 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 19.6;HDLM-2: 26.4" "HPA040185, HPA041208" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040185: AB_10795521, HPA041208: AB_10794193" "unprognostic (8.80e-2)" "unprognostic (9.32e-3)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-3)" "unprognostic (6.23e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (2.00e-2)" "unprognostic (2.76e-3)" "unprognostic (9.15e-3)" "unprognostic (1.78e-1)" "unprognostic (4.21e-1)" "prognostic favorable (1.16e-4)" 5.5 11.8 14.7 13.9 23.7 21.4 11.8 5.5 15.2 9.2 8.8 33.7 10.9 9.4 7.8 11.9 3.2 8.2 9.8 6.4 15.3 10.5 13.1 17.8 15.3 16.8 27.9 7.4 12.1 29.7 6.1 8.3 13.7 17.7 12.1 10.2 7.5 6.8 9.8 2.4 6.3 11.5 6.2 25.7 47.8 13.8 5.2 27.2 11.9 10.7 3.1 12.8 6.5 4.5 1.2 2.5 19.3 4.7 9.6 17.7 5.8 1.8 2.9 15.3 1.9 0.5 1.3 0.6 4.5 19.6 2.3 2.0 3.7 7.7 11.7 2.4 4.1 1.2 3.4 4.3 1.3 5.9 26.4 5.2 2.8 2.2 4.3 0.7 4.5 2.2 1.7 0.2 2.5 1.4 2.0 3.8 6.3 0.0 9.9 2.4 6.4 8.2 1.5 5.0 12.4 3.8 7.2 5.9 6.2 10.4 5.8 5.6 4.3 0.9 9.7 8.7 3.5 1.4 2.6 4.4 3.0 2.4 0.2 3.2 2.3 0.0 0.0 2.6 4.3 14.4 2.4 3.1 0.0 17.3 4.0 13.5 1.2 14.7 17.7 2.2 1.0 15.6 16.0 19.3 9.6 4.7 2.5 13.8 5.8 14.7 23.7 5.5 15.2 15.3 10.5 27.9 7.4 17.7 27.2 3.0 25.8 4.5 1.9 4.7 0.7 3.6 0.0 45.5 27.3 14.0 0.0 1.0 3.3 16.3 8.1 18.2 21.2 0.0 13.6 11.9 11.0 26.3 66.1 0.0 10.1 0.0 31.0 0.0 0.0 5.1 6.9 13.4 5.0 1.0 24.3 20.0 17.3 31.7 7.1 4.7 0.5 0.0 7.1 1.9 1.9 5.4 18.7 13.1 22.8 7.8 SPATA21 "spergen-2, spergen2" ENSG00000187144 "Spermatogenesis associated 21" Q7Z572 1 16387117-16437424 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 4.6;testis: 11.3" "Group enriched" "Detected in some" 7 "Early spermatids: 35.1;Late spermatids: 31.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "Hep G2: 11.0" HPA032080 Approved Vesicles,Cytosol No NA "Vesicles, Cytosol" "HPA032080: " "unprognostic (3.09e-1)" "unprognostic (8.26e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-1)" "unprognostic (2.37e-1)" "unprognostic (5.17e-3)" "unprognostic (1.16e-1)" "unprognostic (2.76e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (3.14e-1)" "unprognostic (2.74e-10)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (1.87e-1)" "unprognostic (9.71e-2)" 0.0 0.2 0.0 0.0 0.1 1.3 0.0 1.1 0.0 0.1 0.0 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.3 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.2 0.3 11.3 0.0 0.0 0.3 0.0 1.3 0.6 4.6 0.8 0.9 0.8 0.4 0.2 0.8 0.4 0.7 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 1.5 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.1 0.0 1.5 11.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.6 0.1 0.2 0.2 0.7 0.2 0.1 0.5 0.2 0.3 0.0 0.4 0.3 0.1 0.2 0.1 0.3 0.2 0.0 0.0 1.2 0.6 0.3 0.6 0.2 0.3 0.2 0.1 0.4 0.0 0.4 0.4 0.2 0.3 0.3 0.0 4.6 0.5 0.9 0.7 0.8 0.5 1.1 0.7 0.6 0.4 1.3 0.8 0.3 2.3 0.9 0.5 0.6 0.7 0.4 0.0 0.6 0.0 0.2 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 35.1 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.1 4.8 0.0 0.0 1.2 31.7 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 1.1 0.0 0.3 1.1 0.1 0.4 0.2 0.0 0.0 0.1 SPATA24 "CCDC161, T6441" ENSG00000170469 "Spermatogenesis associated 24" Q86W54 5 139396563-139404088 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 52.2" "Group enriched" "Detected in many" 20 "Early spermatids: 924.4;Late spermatids: 2355.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044000 Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044000: AB_10959668" "unprognostic (2.19e-3)" "unprognostic (1.18e-1)" "unprognostic (2.09e-1)" "unprognostic (9.30e-2)" "unprognostic (3.82e-1)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.26e-2)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (5.36e-3)" "unprognostic (1.07e-1)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (3.44e-1)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" 1.0 2.8 3.6 1.0 3.2 0.3 1.4 1.5 2.7 1.3 1.6 2.7 1.8 2.5 1.6 9.4 1.4 6.4 2.9 8.5 3.4 2.6 6.2 1.9 1.9 2.5 2.4 2.1 1.6 2.2 6.1 7.0 1.0 3.2 2.2 0.9 1.7 3.2 1.5 8.7 0.9 2.6 1.9 2.7 1.9 1.5 52.2 2.1 1.8 2.9 3.4 1.9 1.8 3.5 5.7 3.6 2.0 3.1 2.4 7.7 2.5 6.5 4.1 5.9 3.1 1.7 3.3 4.7 1.6 3.1 3.4 6.1 9.4 8.7 10.4 4.9 3.2 11.7 3.6 4.4 7.2 3.8 41.6 5.1 3.2 7.7 7.1 6.5 0.7 5.7 2.8 3.6 5.1 6.2 3.9 4.1 6.7 3.1 18.3 4.6 3.7 6.5 5.0 4.3 2.6 3.6 15.4 3.9 14.1 8.1 3.3 4.5 4.1 6.3 12.3 2.9 14.8 3.5 7.2 7.6 2.0 2.8 3.9 4.7 4.5 4.2 9.6 4.0 5.4 1.7 0.0 3.1 2.0 4.6 2.3 6.5 5.7 4.9 5.5 3.6 3.3 5.5 7.7 0.2 2.4 0.9 2.1 2.4 2.5 3.6 3.2 1.5 2.7 3.4 2.6 2.4 2.1 3.2 2.1 0.0 2.6 9.0 5.0 1.4 0.2 20.1 7.6 24.1 3.4 5.2 7.9 5.0 11.6 4.0 924.4 4.2 3.2 0.0 1.6 2.8 2.1 3.1 0.0 3.4 4.1 1.6 0.0 4.9 2.1 2355.8 13.3 1.4 1.7 1.0 1.1 2.0 3.3 2.9 12.7 23.3 1.3 25.8 3.6 81.7 16.6 1.6 3.8 2.5 3.3 4.8 SPATA2L "C16orf76, MGC26885, tamo" ENSG00000158792 "Spermatogenesis associated 2 like" Q8IUW3 16 89696343-89701705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041182, HPA042453" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA041182: AB_2677352, HPA042453: AB_2678005" "unprognostic (1.22e-1)" "unprognostic (9.04e-2)" "unprognostic (5.23e-2)" "unprognostic (9.13e-3)" "unprognostic (2.21e-1)" "unprognostic (6.62e-2)" "unprognostic (2.72e-2)" "unprognostic (2.13e-1)" "unprognostic (4.86e-2)" "unprognostic (9.25e-2)" "unprognostic (1.40e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-3)" "unprognostic (8.86e-2)" "unprognostic (4.19e-2)" "unprognostic (5.84e-2)" "unprognostic (2.55e-1)" 6.8 5.3 6.3 5.4 10.3 8.8 3.7 6.8 14.1 4.1 6.9 1.6 4.9 12.3 4.7 7.2 3.9 4.6 7.7 2.8 7.2 4.9 7.5 11.4 6.3 3.6 3.4 7.6 5.4 17.0 5.1 12.9 6.5 2.8 4.2 2.2 4.9 6.1 3.4 1.8 5.0 10.7 3.3 2.0 5.6 7.7 4.6 2.6 6.7 5.6 0.7 5.4 4.0 2.2 5.8 5.9 16.5 7.8 2.4 7.3 4.7 5.3 4.2 1.5 7.0 1.2 1.2 8.2 3.7 1.7 1.7 1.1 8.0 4.5 1.8 5.0 1.2 2.3 9.3 1.3 2.0 0.3 1.7 15.1 1.2 1.5 10.8 3.9 1.0 3.7 1.2 2.6 2.8 0.8 2.0 1.9 2.1 5.5 1.3 1.2 24.2 3.1 5.7 4.3 5.4 5.7 6.8 0.7 5.2 2.5 1.9 8.3 5.4 3.9 4.0 4.5 0.7 10.3 4.1 4.8 1.7 6.4 0.3 1.7 3.2 1.9 1.6 5.3 3.0 3.2 3.3 4.9 6.0 7.3 7.8 5.1 4.8 5.2 5.3 5.3 5.8 4.6 4.9 16.5 2.4 5.8 5.9 3.9 4.7 6.3 10.3 6.8 14.1 7.2 4.9 3.4 7.6 2.8 2.6 3.0 0.3 1.4 16.6 14.0 6.6 0.4 5.1 0.0 0.0 10.4 0.0 7.5 1.7 11.7 4.4 4.9 29.5 0.0 11.8 4.1 5.7 10.1 4.6 5.0 6.8 3.2 22.8 5.5 7.5 1.0 2.6 7.2 8.5 3.6 6.8 5.1 10.5 17.3 2.1 8.4 7.4 0.0 9.2 1.0 2.5 17.3 20.8 5.0 6.2 11.6 SPATA45 "C1orf227, LOC149643" ENSG00000185523 "Spermatogenesis associated 45" Q537H7 1 212830141-212847649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 4.4;pancreas: 4.4;testis: 14.2" "Group enriched" "Detected in some" 23 "Early spermatids: 131.3;Late spermatids: 94.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 4.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA049921 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA049921: AB_2680953" "unprognostic (1.17e-1)" "unprognostic (2.83e-2)" "unprognostic (4.71e-1)" "unprognostic (2.06e-1)" "unprognostic (4.05e-2)" "unprognostic (6.14e-2)" "unprognostic (4.39e-4)" "unprognostic (1.07e-2)" "unprognostic (1.70e-1)" "unprognostic (3.12e-3)" "unprognostic (1.64e-2)" "unprognostic (3.14e-1)" "unprognostic (2.06e-2)" "unprognostic (6.14e-3)" "unprognostic (1.32e-2)" "unprognostic (9.50e-2)" "unprognostic (2.67e-3)" 0.1 0.1 0.4 0.0 0.3 0.1 0.3 0.1 0.2 0.1 0.2 0.0 0.3 0.9 0.0 0.9 0.4 0.1 0.3 0.3 0.2 0.4 0.4 0.8 0.4 0.1 4.4 0.0 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.5 0.5 0.1 14.2 0.3 0.4 0.0 0.1 2.8 0.7 4.4 0.9 0.5 1.2 0.5 0.4 4.0 0.9 2.6 0.8 2.1 2.6 0.4 0.0 0.8 1.2 0.8 0.6 0.9 0.1 0.0 1.7 0.3 1.7 0.0 1.0 3.7 0.0 0.0 0.0 2.1 1.2 0.0 1.7 1.5 0.0 0.4 0.0 0.0 0.0 1.7 0.0 1.8 2.3 2.5 0.2 0.9 0.6 0.8 1.4 2.1 0.2 0.0 2.1 0.4 0.9 2.7 1.6 0.0 0.0 0.9 0.6 1.3 0.0 0.9 0.1 1.9 1.1 1.1 1.7 4.4 0.3 1.6 1.1 0.0 0.4 4.4 0.7 0.9 0.9 0.3 0.1 0.0 0.7 2.8 0.6 1.2 2.4 0.5 0.7 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 0.0 5.0 0.0 131.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 94.9 1.4 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.9 1.5 0.0 0.0 0.0 0.0 0.0 SPATA5 "AFG2, SPAF" ENSG00000145375 "Spermatogenesis associated 5" Q8NB90 4 122923074-123319450 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Chaperone, Developmental protein, Hydrolase" "Deafness, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "Early spermatids: 147.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036450, HPA036451" Approved Approved Cytosol NA NA Cytosol "HPA036450: AB_2675131, HPA036451: AB_10670107" "unprognostic (4.28e-1)" "unprognostic (7.54e-2)" "unprognostic (7.37e-3)" "unprognostic (1.26e-1)" "unprognostic (5.16e-1)" "unprognostic (1.18e-1)" "unprognostic (7.65e-4)" "unprognostic (1.95e-3)" "unprognostic (9.00e-2)" "unprognostic (2.78e-1)" "unprognostic (4.43e-3)" "unprognostic (4.62e-2)" "unprognostic (1.26e-2)" "unprognostic (1.52e-1)" "unprognostic (5.68e-1)" "unprognostic (2.63e-2)" "unprognostic (1.79e-1)" 8.2 4.7 5.8 8.5 9.3 6.0 7.8 20.7 8.0 8.3 6.1 6.4 5.6 3.8 12.8 5.5 5.7 6.0 4.4 5.3 5.5 4.6 5.9 5.2 5.3 8.0 7.1 5.2 6.4 5.1 11.2 13.5 5.9 6.9 6.0 6.1 7.4 6.1 5.3 6.4 7.4 4.8 9.1 7.4 7.3 11.6 11.3 9.0 13.6 6.7 5.0 9.3 6.2 7.0 2.9 2.8 2.3 1.9 2.5 2.8 0.7 2.9 3.2 4.0 8.0 3.1 2.1 2.6 4.2 1.8 3.2 3.1 2.1 4.3 4.4 2.8 2.6 2.3 2.7 5.2 2.8 6.3 6.2 1.3 3.8 5.9 3.4 1.4 6.5 4.8 1.5 1.5 4.5 4.2 2.0 3.1 3.0 7.4 7.8 5.5 3.2 10.9 4.5 2.3 4.8 1.6 3.8 8.4 2.4 2.6 2.1 5.9 4.2 3.9 3.4 2.4 5.5 2.4 2.5 3.8 8.5 5.6 5.4 5.0 5.1 5.2 3.1 4.4 5.9 7.3 2.3 1.2 1.1 2.7 1.9 1.6 2.0 2.2 2.3 0.9 2.9 2.4 2.8 1.8 2.5 1.1 2.8 1.1 0.7 5.8 9.3 20.7 8.0 5.5 4.6 7.1 5.2 6.9 9.0 14.9 5.3 4.4 5.1 4.5 5.1 3.4 17.8 9.4 11.4 1.8 13.7 3.9 0.0 2.3 147.3 8.0 2.0 0.0 3.1 3.5 3.7 3.0 4.7 2.1 3.0 3.2 2.4 5.5 3.7 13.2 6.6 4.8 0.0 1.0 1.6 4.9 3.4 2.6 4.2 2.7 11.6 0.0 3.6 13.3 10.0 4.6 1.8 5.3 3.7 2.6 SPATA7 "HSD3, LCA3" ENSG00000042317 "Spermatogenesis associated 7" Q9P0W8 14 88384924-88470350 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.6" "Group enriched" "Detected in many" 24 "Early spermatids: 817.6;Late spermatids: 902.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038082, HPA038083" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA038082: AB_10671738, HPA038083: AB_10671519" "unprognostic (2.09e-2)" "unprognostic (6.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.50e-3)" "unprognostic (3.22e-2)" "unprognostic (6.75e-2)" "unprognostic (1.29e-3)" "unprognostic (4.70e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-3)" "prognostic favorable (4.16e-5)" "unprognostic (2.88e-1)" "prognostic favorable (2.50e-5)" "unprognostic (8.41e-2)" "unprognostic (1.29e-2)" "unprognostic (6.09e-2)" "unprognostic (2.81e-2)" 6.3 7.2 7.8 2.8 10.3 2.2 7.1 18.0 12.5 6.1 4.5 6.5 4.5 2.9 7.7 8.5 3.7 9.6 6.5 5.3 8.1 7.4 10.5 5.9 5.0 3.0 6.4 9.7 13.6 6.9 9.2 15.0 3.6 13.3 5.8 4.1 5.5 4.6 5.9 4.7 6.6 2.8 6.4 5.8 3.7 4.3 55.6 5.9 3.3 13.5 3.9 2.0 5.7 4.4 3.7 4.4 1.7 3.0 0.9 5.6 2.2 2.1 3.3 4.9 6.8 8.1 15.4 5.0 3.7 8.4 4.7 3.1 0.9 4.1 1.5 2.3 5.0 3.5 2.1 2.3 3.5 4.4 2.5 1.6 0.1 1.6 1.1 12.1 3.4 0.3 7.3 5.9 1.9 3.6 15.4 8.6 4.2 1.1 2.4 4.3 2.5 1.5 3.1 0.6 2.6 4.2 3.5 5.1 0.8 7.5 1.3 2.9 4.5 4.7 6.4 3.8 5.1 5.5 3.7 4.4 2.9 3.8 4.8 2.0 2.4 1.2 0.5 5.8 1.0 2.4 0.0 2.2 0.6 4.8 3.0 5.6 3.7 4.0 2.2 4.4 0.9 2.2 4.2 1.7 0.9 1.8 4.3 1.4 2.2 7.8 10.3 18.0 12.5 8.1 7.4 6.4 9.7 13.3 5.9 11.9 5.3 0.8 8.2 2.2 10.8 10.9 5.1 36.1 10.3 3.5 19.6 2.1 8.3 7.6 817.6 5.2 1.1 0.0 6.3 3.2 6.4 3.4 1.1 3.4 5.0 14.3 15.6 6.2 8.6 902.3 19.0 3.3 8.5 4.6 4.4 10.6 5.8 4.8 15.9 19.9 19.4 6.5 5.0 18.2 13.5 1.8 0.9 3.8 4.6 2.7 SPATC1L C21orf56 ENSG00000160284 "Spermatogenesis and centriole associated 1 like" Q9H0A9 21 46161148-46184476 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 174.7;Late spermatids: 364.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018979, HPA019165, HPA029394" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148" "unprognostic (1.46e-2)" "unprognostic (3.88e-2)" "unprognostic (3.95e-2)" "unprognostic (4.86e-2)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "prognostic favorable (2.16e-4)" "unprognostic (5.56e-2)" "unprognostic (2.35e-3)" "unprognostic (1.07e-1)" "unprognostic (1.47e-1)" "unprognostic (1.91e-2)" "unprognostic (2.58e-1)" 4.7 11.5 21.5 4.2 31.7 5.1 4.3 13.1 19.0 8.2 5.1 5.6 8.9 5.3 5.3 6.5 4.6 4.0 5.7 5.5 14.4 9.4 4.3 1.5 4.4 5.7 7.8 16.5 10.9 11.7 5.8 7.8 4.7 7.5 16.7 3.6 2.6 9.5 10.1 8.8 7.0 6.3 5.6 5.2 8.1 8.3 23.5 13.6 2.2 3.7 5.0 4.3 4.4 6.4 4.8 5.9 23.6 4.2 4.0 6.9 2.7 1.8 0.0 2.5 4.6 1.4 3.3 1.3 2.7 1.5 1.5 1.1 0.0 1.2 5.9 5.5 3.4 1.8 0.3 0.0 2.1 0.4 5.3 4.4 14.0 0.8 3.3 0.1 0.0 5.9 3.5 1.0 0.0 0.0 2.9 4.9 6.8 24.3 8.9 2.1 3.7 4.5 1.6 10.1 2.6 12.0 10.1 3.3 6.5 2.4 0.5 0.7 4.7 2.1 1.2 5.4 1.8 3.8 5.4 0.3 4.5 5.4 6.4 4.0 14.9 7.9 4.3 5.9 7.8 4.2 1.0 3.9 23.6 3.0 4.2 3.9 4.7 4.4 4.3 5.9 4.8 6.9 6.8 0.2 4.0 2.9 4.8 4.2 2.7 21.5 31.7 13.1 19.0 14.4 9.4 7.8 16.5 7.5 13.6 0.0 0.0 6.0 12.9 20.9 5.7 1.2 17.8 1.4 2.3 3.5 0.0 2.8 13.3 16.5 174.7 13.2 5.4 0.0 17.4 11.5 17.2 25.0 0.0 0.5 11.6 3.2 58.0 8.0 7.3 364.6 30.0 15.4 27.0 5.4 16.3 5.2 14.9 2.9 29.7 9.2 3.4 19.4 12.3 11.2 8.9 35.0 2.6 16.0 17.5 3.7 SPATS2 "FLJ13117, SCR59, SPATA10" ENSG00000123352 "Spermatogenesis associated serine rich 2" Q86XZ4 12 49366584-49527424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 114.2;Spermatogonia: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038642, HPA038643, HPA076823" Uncertain Enhanced Cytosol NA NA Cytosol "HPA038642: AB_2676128, HPA038643: AB_10672523, HPA076823: " "unprognostic (2.87e-2)" "unprognostic (2.63e-1)" "unprognostic (2.20e-2)" "unprognostic (1.89e-1)" "unprognostic (5.56e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (9.57e-8)" "unprognostic (4.55e-2)" "unprognostic (6.32e-2)" "prognostic favorable (1.44e-4)" "unprognostic (2.64e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (2.57e-1)" "unprognostic (4.81e-1)" 7.7 8.2 10.6 19.9 12.4 5.6 9.4 25.7 18.0 13.5 12.1 4.0 7.7 11.2 19.0 8.3 9.1 6.7 11.0 7.5 11.7 8.9 9.1 5.1 8.0 14.2 9.0 11.0 9.0 12.1 30.6 24.8 8.6 15.6 10.1 11.5 9.8 19.2 9.2 9.7 15.8 10.5 11.6 6.1 11.1 12.2 24.2 4.5 8.8 13.6 5.4 19.1 13.7 13.8 7.8 10.2 1.9 1.8 1.6 2.3 1.5 7.0 15.7 13.5 15.9 7.9 12.5 4.4 8.2 11.6 14.1 11.5 14.5 15.9 17.4 19.2 7.3 9.1 8.4 11.6 15.6 18.3 13.1 6.7 15.6 12.0 11.3 14.4 4.1 9.4 10.6 7.8 22.2 21.0 46.2 32.9 7.8 8.3 16.1 14.5 12.2 8.4 6.2 14.1 11.3 16.0 12.9 22.7 20.8 13.1 8.9 15.3 13.8 17.3 11.7 19.8 8.8 20.2 4.8 29.8 6.2 15.2 5.6 5.2 21.4 24.1 14.2 8.2 7.2 8.9 1.9 1.8 0.6 2.3 0.5 2.3 7.8 1.9 1.5 5.0 4.9 1.7 1.5 1.3 1.6 0.3 10.2 1.4 1.5 10.6 12.4 25.7 18.0 11.7 8.9 9.0 11.0 15.6 4.5 17.9 20.3 22.0 45.5 51.5 37.0 8.1 20.4 6.7 14.8 34.9 21.6 8.5 5.0 23.2 64.2 40.9 8.4 23.3 24.4 9.8 35.6 26.6 10.4 4.2 7.0 39.7 35.2 25.2 7.5 27.6 29.4 17.9 18.6 19.0 17.3 21.1 32.7 7.0 31.5 9.3 4.7 51.8 25.5 114.2 132.8 52.8 4.5 14.9 27.3 22.4 SPATS2L "DNAPTP6, SGNP" ENSG00000196141 "Spermatogenesis associated serine rich 2 like" Q9NUQ6 2 200305881-200482263 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 76.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055427, HPA066310" Uncertain Enhanced Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA055427: AB_2682813, HPA066310: AB_2685655" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" "unprognostic (9.35e-2)" "unprognostic (1.78e-2)" "unprognostic (4.39e-3)" "unprognostic (3.58e-2)" "unprognostic (2.17e-3)" "unprognostic (3.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (3.95e-1)" "unprognostic (7.84e-3)" "unprognostic (3.71e-2)" "unprognostic (5.67e-2)" "unprognostic (6.01e-2)" "unprognostic (2.99e-1)" 25.0 13.5 22.4 14.3 20.1 4.2 46.1 15.7 25.7 33.1 34.5 14.5 27.2 34.3 20.4 20.7 28.0 34.8 46.9 46.4 18.4 18.8 37.7 44.9 22.4 14.7 21.9 20.9 30.0 24.3 17.1 24.7 26.9 20.3 27.3 34.6 14.9 63.4 28.8 26.5 15.6 44.6 20.6 23.4 22.1 42.2 11.5 16.7 14.3 21.6 17.5 12.3 25.4 46.5 2.2 9.8 22.9 3.3 4.2 17.0 1.6 27.3 15.8 18.6 2.3 12.5 16.0 6.9 49.0 16.4 31.9 23.9 42.6 30.1 0.1 11.3 31.1 17.4 27.1 5.6 28.6 21.0 16.4 7.8 0.2 14.4 51.1 22.5 4.7 2.1 19.6 28.5 21.3 20.4 22.7 12.4 3.4 6.3 19.7 42.4 8.4 0.7 1.3 4.5 48.8 36.4 0.1 66.3 1.9 76.9 22.4 0.5 5.3 12.7 7.1 19.9 27.6 3.8 6.5 20.5 21.2 21.4 6.6 27.9 5.8 5.6 0.3 18.1 2.2 29.8 22.9 3.1 4.2 3.6 3.3 8.3 1.6 3.9 3.6 9.8 2.2 1.7 2.0 3.1 4.2 2.5 7.6 17.0 1.6 22.4 20.1 15.7 25.7 18.4 18.8 21.9 20.9 20.3 16.7 80.4 19.2 18.1 208.3 80.9 13.9 110.0 359.2 145.9 56.9 164.0 11.8 13.7 94.5 137.6 58.2 54.0 166.5 0.0 128.0 30.2 94.6 270.0 56.4 183.0 67.0 57.2 52.9 86.5 88.0 14.5 153.4 70.0 121.4 18.0 201.8 6.1 152.6 164.9 133.7 331.2 48.9 77.6 97.1 16.5 78.7 68.1 8.2 19.2 64.2 162.6 SPC25 "AD024, MGC22228, SPBC25" ENSG00000152253 "SPC25, NDC80 kinetochore complex component" Q9HBM1 2 168834132-168913371 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 38.0" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 31.3;Hofbauer cells: 12.6;Muller glia cells: 13.2;Spermatocytes: 21.2;Spermatogonia: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 2.5" "Group enriched" "Detected in many" 4 "B-cells: 1.1;T-cells: 2.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047144, HPA050544" Enhanced Enhanced Cytosol NA Yes Cytosol "HPA047144: AB_2679952, HPA050544: " "unprognostic (3.52e-2)" "unprognostic (2.28e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.74e-6)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.84e-3)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.30e-2)" "unprognostic (1.11e-16)" "unprognostic (9.91e-3)" "unprognostic (1.85e-1)" "unprognostic (3.43e-1)" "unprognostic (1.57e-1)" 0.9 1.6 3.6 7.2 2.2 6.7 2.1 0.4 3.5 1.3 4.0 0.9 0.0 6.8 1.3 1.5 8.5 0.6 1.0 1.1 2.7 1.6 1.5 1.6 1.9 7.5 1.2 2.5 1.2 2.6 0.7 0.2 3.3 1.1 0.8 3.1 1.3 2.1 0.0 0.7 2.1 3.8 1.8 0.7 4.1 3.0 5.9 1.1 38.0 0.6 5.6 8.0 1.5 2.7 1.1 0.0 0.4 0.1 0.0 2.5 0.4 1.0 8.4 19.6 10.9 0.9 0.9 7.1 11.3 4.3 11.4 9.1 4.3 7.9 7.0 5.0 1.8 15.0 10.4 7.5 0.0 10.1 4.7 11.5 14.0 5.3 2.0 0.0 10.4 4.2 0.0 0.5 7.3 0.1 2.3 5.7 14.8 1.1 7.9 3.2 5.2 7.5 12.6 0.6 5.0 11.2 13.6 19.5 3.1 4.6 6.6 14.7 0.9 10.1 6.9 1.9 6.6 0.5 7.3 1.7 1.7 20.7 6.7 9.5 15.3 26.6 6.9 2.2 1.6 6.7 0.0 0.1 0.2 0.0 0.1 0.0 0.9 0.4 0.0 0.0 1.1 0.2 0.5 0.4 0.0 0.0 0.0 2.5 0.4 3.6 2.2 0.4 3.5 2.7 1.6 1.2 2.5 1.1 1.1 0.0 0.6 1.5 1.1 4.7 0.0 0.4 0.0 0.0 3.4 0.0 0.0 2.8 0.0 0.0 1.2 0.4 1.0 0.0 0.0 31.3 0.8 0.2 0.0 0.8 12.6 0.0 0.0 4.3 1.6 0.6 0.6 1.6 0.0 0.0 1.4 13.2 0.8 0.0 1.1 0.0 0.3 0.0 0.3 21.2 17.6 1.3 4.8 1.7 3.0 0.9 SPDL1 "CCDC99, FLJ20364, hSpindly" ENSG00000040275 "Spindle apparatus coiled-coil protein 1" Q96EA4 5 169583634-169604778 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 97.4;Spermatogonia: 70.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA044700, HPA048146" Enhanced Approved Cytosol NA Yes Cytosol "HPA044700: AB_2679052, HPA048146: AB_2680284" "unprognostic (2.61e-2)" "unprognostic (1.94e-1)" "unprognostic (8.59e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (4.24e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.48e-6)" "unprognostic (2.63e-3)" "unprognostic (5.70e-3)" "unprognostic (8.27e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.81e-1)" "unprognostic (3.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.93e-1)" 5.5 4.7 6.5 9.0 11.5 9.9 8.0 14.5 11.0 5.5 5.6 6.6 3.4 5.9 6.4 4.4 9.7 4.9 4.9 4.0 7.8 5.8 5.1 3.6 4.7 13.9 8.3 7.1 7.2 4.1 5.6 8.0 8.4 11.6 4.1 6.0 2.0 5.1 3.6 5.0 5.3 5.9 7.7 16.7 8.2 5.3 33.7 10.4 23.9 4.5 8.5 13.6 5.4 5.8 10.7 16.5 3.2 4.6 6.4 9.3 3.0 14.6 17.6 18.0 12.6 4.8 4.5 15.9 46.6 6.2 34.9 31.7 23.1 9.9 13.8 30.9 38.1 24.0 10.3 14.6 20.0 38.3 14.2 16.3 16.1 31.7 9.0 2.2 16.9 13.9 2.1 1.7 14.6 9.2 7.4 15.8 14.3 10.1 10.2 37.1 14.2 13.8 7.2 13.1 7.3 17.1 16.2 17.7 10.2 22.8 5.2 11.6 8.5 21.7 6.2 9.1 13.3 7.0 11.3 11.2 39.8 12.6 11.3 36.1 8.1 17.0 18.6 9.6 15.6 13.3 3.2 2.2 2.9 7.3 3.0 7.7 8.8 6.6 7.7 2.2 10.7 9.3 7.4 0.4 6.4 4.6 16.5 6.4 3.0 6.5 11.5 14.5 11.0 7.8 5.8 8.3 7.1 11.6 10.4 3.0 7.5 6.7 1.7 3.5 7.1 7.2 0.0 4.0 7.9 1.8 0.0 7.9 5.0 4.9 7.6 3.9 0.5 23.3 4.2 21.7 7.5 1.1 8.1 2.9 10.0 3.2 1.7 11.6 4.0 8.7 4.0 6.1 3.3 6.4 1.9 6.1 5.4 1.7 6.0 5.1 3.9 6.5 9.2 97.4 70.9 3.9 4.1 4.4 5.1 2.1 SPECC1 "CYTSB, FLJ36955, HCMOGT-1, NSP" ENSG00000128487 "Sperm antigen with calponin homology and coiled-coil domains 1" Q5M775 17 20009344-20319026 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9" "Cell type enhanced" "Detected in many" 5 "granulocytes: 111.1;monocytes: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 35.6;SuSa: 58.4" "Low region specificity" "Detected in all" "HPA021421, HPA021430, HPA061073" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Nucleoplasm, Vesicles" "Nucleoli fibrillar center, Cytosol" "HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: " "unprognostic (1.13e-3)" "unprognostic (2.39e-1)" "unprognostic (1.98e-2)" "unprognostic (8.10e-3)" "unprognostic (8.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (9.29e-2)" "unprognostic (5.81e-2)" "unprognostic (6.23e-3)" "unprognostic (2.65e-1)" "unprognostic (3.15e-1)" "unprognostic (6.86e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" 10.7 8.3 21.3 7.2 38.0 29.9 8.1 16.0 30.8 7.0 14.9 49.9 0.7 9.5 15.4 6.1 11.4 7.3 20.0 4.1 23.1 15.4 4.3 2.0 5.6 5.7 35.8 21.2 17.0 8.3 3.0 6.8 4.8 29.3 7.3 15.5 3.0 5.9 4.9 4.3 4.8 11.4 11.5 28.2 17.3 9.8 25.8 41.5 0.2 6.7 1.4 6.0 7.0 4.2 2.9 14.7 18.9 9.4 8.5 3.4 3.0 14.2 14.8 8.0 2.6 6.1 3.1 17.4 5.8 4.8 5.8 7.2 24.2 12.7 0.8 18.9 5.0 8.7 10.6 6.1 13.8 2.9 4.3 6.5 5.8 16.2 2.6 2.2 0.6 3.4 3.3 14.0 8.2 9.3 35.6 0.0 2.4 0.7 7.2 4.5 12.1 0.1 3.2 6.4 6.3 3.6 3.5 16.2 8.2 14.3 7.1 2.6 2.7 30.4 14.6 6.4 58.4 12.9 3.8 0.4 0.7 8.9 0.8 15.7 2.8 3.5 1.1 8.6 4.9 3.3 18.9 9.4 17.8 3.1 5.3 2.9 2.4 1.9 3.4 14.7 2.9 1.8 2.4 8.1 8.5 4.6 4.4 0.9 3.0 21.3 38.0 16.0 30.8 23.1 15.4 35.8 21.2 29.3 41.5 20.8 14.3 3.2 11.9 4.8 5.9 6.1 7.6 12.0 6.8 17.4 64.8 3.9 8.3 26.9 75.7 5.2 32.8 23.3 31.4 10.8 9.5 14.6 111.1 0.2 18.6 0.0 7.5 3.1 9.7 40.7 4.6 14.0 20.3 103.6 44.0 19.3 54.5 28.3 42.1 2.4 32.8 58.2 31.9 72.4 64.5 2.3 1.8 10.2 18.6 22.1 SPG11 "FLJ21439, KIAA1840" ENSG00000104133 "SPG11, spatacsin vesicle trafficking associated" Q96JI7 15 44562696-44663678 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040412, HPA040947" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA040412: AB_10795418, HPA040947: AB_10796232" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.98e-3)" "unprognostic (1.99e-1)" "unprognostic (9.31e-2)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (2.26e-3)" "unprognostic (2.58e-2)" "unprognostic (9.19e-2)" "prognostic favorable (6.28e-5)" "unprognostic (8.73e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.06e-2)" 23.8 24.6 16.6 26.4 22.2 25.8 23.4 21.2 21.2 20.8 26.0 31.7 25.8 17.9 18.6 28.1 22.9 19.0 20.2 19.3 16.1 15.2 22.0 25.1 22.6 26.9 26.3 15.6 20.5 25.5 33.4 25.9 15.7 22.1 22.3 21.6 18.7 22.7 26.6 19.0 31.8 26.2 21.5 22.1 39.2 22.8 22.1 23.1 35.8 30.9 12.6 26.0 23.0 19.4 12.8 7.1 13.6 13.0 6.7 8.3 3.8 8.0 5.5 14.1 13.7 22.0 21.7 10.1 8.5 10.9 8.3 10.7 6.6 7.9 5.9 10.6 11.3 14.4 18.5 9.7 13.0 8.2 17.8 5.9 13.6 13.0 10.0 15.5 13.6 12.6 16.5 14.9 6.8 19.7 13.1 11.7 10.5 17.3 15.4 11.7 7.0 6.0 12.5 7.4 24.9 7.5 8.0 11.8 6.5 17.7 21.1 9.2 10.8 9.3 14.8 7.9 12.1 14.1 18.6 12.8 11.1 5.5 13.7 10.2 15.3 13.5 11.9 11.4 18.0 11.3 6.0 8.8 12.3 7.8 10.2 8.3 10.9 6.5 5.8 6.9 12.8 5.4 6.4 13.6 6.7 13.0 7.1 6.6 3.8 16.6 22.2 21.2 21.2 16.1 15.2 26.3 15.6 22.1 23.1 41.7 17.4 28.3 13.4 8.2 22.1 15.9 17.8 44.2 29.6 26.2 45.2 13.6 5.0 16.4 24.2 10.8 26.7 0.0 14.7 8.5 12.9 17.8 26.5 19.5 17.6 15.9 19.3 23.9 45.3 24.1 16.4 30.5 13.5 84.8 28.1 15.6 16.1 17.3 13.1 14.6 21.7 6.5 8.9 40.8 24.7 9.7 7.8 23.0 25.1 17.9 SPG21 "ACP33, BM-019, GL010, MAST" ENSG00000090487 "SPG21, maspardin" Q9NZD8 15 64963021-64990310 "Disease related genes, Predicted intracellular proteins" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 47.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040407, HPA040436" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA040407: AB_2676965, HPA040436: AB_10796454" "unprognostic (7.47e-2)" "unprognostic (2.94e-2)" "unprognostic (5.81e-2)" "unprognostic (2.98e-1)" "unprognostic (1.64e-1)" "unprognostic (5.40e-3)" "unprognostic (7.25e-2)" "unprognostic (1.43e-1)" "unprognostic (4.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.24e-3)" "unprognostic (1.15e-1)" "unprognostic (3.96e-1)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.57e-1)" "unprognostic (3.19e-1)" 34.2 34.0 22.4 27.6 24.3 28.2 48.6 12.6 23.7 31.1 28.7 25.1 38.7 23.8 31.6 73.3 29.4 34.9 30.6 25.3 23.4 22.9 39.2 66.3 33.3 40.4 25.7 17.8 35.6 25.3 26.3 28.4 48.2 18.8 30.0 28.3 33.7 31.9 47.0 35.4 28.9 37.8 30.4 29.3 31.7 31.1 26.8 19.3 33.5 50.1 28.9 26.1 31.4 24.7 9.4 20.4 47.7 35.8 3.9 5.5 11.5 22.3 33.4 16.9 31.9 43.7 43.3 21.1 14.0 47.7 27.9 32.6 14.9 34.8 25.7 21.9 32.7 41.4 29.9 48.3 32.8 26.6 10.5 15.5 22.2 22.6 26.9 55.4 21.0 19.8 29.4 37.6 22.1 41.9 27.3 33.3 29.7 18.4 21.0 34.0 31.8 19.2 18.4 18.6 50.3 17.5 20.1 18.1 45.0 28.6 27.1 20.7 18.5 16.5 35.2 31.7 34.9 24.0 35.8 16.2 23.7 24.7 33.7 20.9 15.0 25.5 15.1 30.7 55.8 19.9 2.1 35.8 3.8 4.0 21.3 3.7 9.4 3.8 4.1 20.4 8.1 5.5 3.1 47.7 3.9 17.2 6.6 4.3 11.5 22.4 24.3 12.6 23.7 23.4 22.9 25.7 17.8 18.8 19.3 8.9 45.9 54.6 61.1 66.5 14.3 25.4 58.6 33.5 26.1 68.0 35.3 166.4 116.0 80.1 5.4 60.2 47.1 0.0 64.4 77.8 71.7 84.8 27.7 107.5 144.0 19.1 62.2 36.8 139.1 8.1 80.3 130.4 75.9 24.4 57.1 18.1 59.2 108.9 84.5 153.7 17.7 38.8 55.6 36.9 53.7 72.4 156.0 43.6 65.2 80.2 SPHK1 SPHK ENSG00000176170 "Sphingosine kinase 1" Q9NYA1 17 76376584-76387860 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 89.4;monocytes: 99.2;Muller glia cells: 144.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 34.4;hTEC/SVTERT24-B: 30.0;TIME: 30.0;U-138 MG: 30.2;U-251 MG: 38.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 5 "olfactory region: 11.7" "HPA022829, HPA028761" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA022829: AB_1857438, HPA028761: AB_10600814" "unprognostic (1.04e-1)" "unprognostic (6.30e-2)" "unprognostic (1.09e-2)" "unprognostic (8.66e-2)" "unprognostic (2.25e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (9.32e-3)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (8.99e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.14e-6)" "unprognostic (1.39e-1)" "unprognostic (4.82e-2)" "unprognostic (8.29e-2)" "unprognostic (1.10e-3)" 9.3 2.2 4.7 10.5 3.5 15.0 20.4 0.4 3.2 5.5 5.0 4.0 0.4 1.9 6.3 8.3 13.8 5.3 12.7 10.5 5.3 2.1 4.1 2.4 12.9 10.1 4.4 1.5 5.5 15.1 3.1 2.7 7.4 4.7 4.3 1.1 11.0 11.5 1.7 6.8 8.7 6.3 5.2 4.0 2.7 3.8 3.7 6.3 3.0 9.4 16.2 12.1 5.6 7.0 0.2 8.0 2.4 3.4 0.1 1.4 1.3 9.8 1.0 4.3 0.2 2.2 2.0 4.4 22.8 15.1 19.2 11.6 5.3 1.0 0.4 2.1 16.8 8.2 2.1 3.2 29.2 4.7 0.4 1.7 0.1 7.3 34.4 4.8 0.3 0.8 3.9 0.6 30.0 11.8 8.2 18.5 1.0 4.6 0.0 3.7 12.6 0.9 0.1 0.2 2.2 8.3 0.6 1.1 0.7 1.0 0.1 0.5 1.0 2.3 0.2 19.7 2.7 0.8 1.4 30.0 30.2 5.8 23.1 38.5 0.4 0.1 0.4 22.9 1.7 4.5 2.4 3.4 0.0 1.4 1.7 0.4 0.0 0.2 0.4 1.0 0.2 0.0 0.3 0.4 0.1 0.3 8.0 0.0 1.3 4.7 3.5 0.4 3.2 5.3 2.1 4.4 1.5 4.7 6.3 0.0 0.0 0.5 42.7 11.2 1.3 3.9 33.1 0.0 3.4 1.8 0.0 0.6 0.0 89.4 0.2 35.0 0.7 0.0 10.7 14.8 17.3 28.4 6.9 0.0 31.0 31.8 0.0 4.3 5.7 0.9 3.4 17.1 11.8 99.2 1.1 144.5 62.5 0.3 18.7 1.1 1.8 0.0 39.2 0.0 7.7 9.4 1.1 5.7 0.2 22.4 SPIN4 "FLJ44984, TDRD28" ENSG00000186767 "Spindlin family member 4" Q56A73 X 63347228-63351344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 27.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA044559 Uncertain Approved Nucleoli,Cytosol NA Yes Cytosol Nucleoli "HPA044559: AB_10794171" "unprognostic (9.66e-2)" "unprognostic (2.00e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (3.12e-1)" "unprognostic (3.22e-4)" "unprognostic (3.30e-3)" "unprognostic (9.44e-3)" "unprognostic (8.62e-2)" "unprognostic (3.65e-3)" "unprognostic (9.39e-2)" "prognostic unfavorable (3.56e-6)" "unprognostic (1.74e-2)" "unprognostic (2.15e-1)" "unprognostic (2.57e-1)" "unprognostic (8.09e-2)" 3.9 3.2 4.2 5.1 4.4 13.8 13.7 2.3 5.4 5.1 5.9 6.7 2.0 3.5 6.7 4.7 16.8 3.9 3.5 3.2 4.7 6.1 3.3 2.4 16.8 7.6 4.5 2.3 6.6 4.2 4.8 4.7 12.3 5.2 7.2 6.9 4.8 27.4 2.9 1.2 3.5 4.9 5.8 5.2 5.9 3.9 3.4 3.5 11.2 5.6 6.4 11.8 4.3 8.2 1.2 1.4 3.7 2.1 6.0 1.5 0.8 16.0 4.1 9.6 7.8 2.1 3.0 6.9 8.0 3.4 4.7 5.7 2.7 16.0 0.0 3.5 3.7 5.4 5.4 12.3 5.8 8.6 6.9 3.9 20.6 5.5 2.5 0.9 17.8 16.1 1.4 2.0 7.8 4.2 2.3 5.1 3.6 6.2 20.1 10.7 5.4 5.9 9.6 9.9 2.6 6.0 8.3 20.7 4.4 3.4 4.3 0.0 5.3 14.4 4.2 1.5 20.8 9.1 8.5 2.2 9.5 10.7 15.7 5.0 4.4 5.1 10.6 5.0 14.7 5.6 1.7 1.8 3.7 1.5 2.1 0.7 1.2 0.8 0.9 1.4 1.1 0.5 1.0 0.0 6.0 1.7 0.0 0.5 0.8 4.2 4.4 2.3 5.4 4.7 6.1 4.5 2.3 5.2 3.5 0.0 1.3 0.5 1.3 3.0 5.2 1.2 0.0 4.0 2.3 3.5 2.0 5.5 1.7 0.6 0.0 2.7 1.7 0.0 1.2 5.8 3.1 2.6 9.2 0.8 2.2 1.6 6.4 8.6 1.3 0.0 2.8 1.7 5.0 0.0 7.2 1.2 1.3 7.0 3.2 1.0 2.4 0.0 1.6 0.0 0.2 5.5 2.7 3.2 6.0 4.7 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 121.0" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 913.5;Syncytiotrophoblasts: 1399.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 52.1;HaCaT: 59.5;hTCEpi: 42.4;RT4: 48.2;SK-BR-3: 89.3;T-47d: 42.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 3400000 "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: AB_2732463" "prognostic unfavorable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.2 0.5 0.9 11.6 1.2 0.0 12.6 2.9 0.8 12.9 64.4 1.2 38.6 31.9 3.6 25.5 71.1 6.4 30.7 0.8 0.8 0.7 27.9 1.5 18.5 3.7 0.9 0.6 3.4 25.0 28.8 9.7 85.5 1.3 17.5 17.9 3.2 50.8 24.0 0.6 39.1 121.0 2.3 1.0 3.1 17.6 1.9 0.7 4.8 15.4 26.9 44.3 12.8 21.5 5.1 19.0 15.3 10.9 3.6 1.8 3.8 19.0 0.1 0.0 0.1 0.0 0.0 52.1 0.3 0.4 0.6 0.3 30.4 32.0 0.0 22.8 0.0 0.5 59.5 4.9 28.6 0.4 0.1 1.6 0.8 0.5 1.6 0.3 3.3 15.1 0.0 42.4 0.6 2.7 0.5 2.3 1.9 0.4 0.1 0.0 14.8 0.1 2.5 5.9 32.2 2.8 1.9 0.0 3.7 28.8 48.2 12.8 0.6 1.4 89.3 2.3 9.6 42.7 2.5 0.0 0.0 0.3 0.1 0.0 0.1 3.6 0.1 0.1 2.5 0.1 0.0 10.9 7.9 0.3 9.3 0.5 5.1 1.8 0.8 19.0 3.9 0.7 0.2 15.3 3.6 9.6 2.3 0.2 3.8 0.9 1.2 2.9 0.8 0.8 0.7 0.9 0.6 1.3 0.7 53.6 17.1 2.7 86.0 67.5 0.0 0.4 109.5 4.0 18.2 127.4 0.0 913.5 21.6 354.0 0.5 0.7 428.8 0.0 224.2 67.1 7.5 132.0 10.3 0.4 125.6 0.0 141.5 0.0 13.6 0.8 3.4 17.8 13.5 101.8 147.7 0.0 241.9 199.9 0.0 40.0 0.1 0.0 5.2 0.6 5.2 76.9 1399.8 2.2 145.0 168.6 SPINT2 "HAI-2, Kop" ENSG00000167642 "Serine peptidase inhibitor, Kunitz type 2" O43291 19 38244035-38292614 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 1193.1;Syncytiotrophoblasts: 1181.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 77.2;CAPAN-2: 114.0;OE19: 138.0;RPTEC TERT1: 85.0;SK-BR-3: 74.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011101, CAB018969" Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" No NA "Plasma membrane, Intermediate filaments, Cytosol" "CAB018969: , HPA011101: AB_1079039" "unprognostic (5.13e-2)" "unprognostic (1.06e-3)" "unprognostic (1.40e-1)" "unprognostic (6.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.03e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.04e-1)" "prognostic favorable (3.41e-4)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (2.68e-2)" 1.5 7.2 11.9 15.1 14.0 10.7 29.2 14.3 20.8 24.0 46.3 4.7 63.2 38.3 7.1 44.9 60.6 30.4 51.8 3.3 10.4 22.9 47.5 2.8 25.6 10.3 9.3 14.6 15.3 78.7 30.2 82.7 77.3 11.0 29.6 40.3 15.3 143.1 61.6 0.7 41.7 82.3 13.1 5.6 9.4 34.1 87.0 2.8 15.0 95.6 32.0 37.5 27.1 25.0 23.1 73.9 70.7 17.9 2.6 13.2 17.6 77.2 56.1 0.2 0.3 0.0 0.0 36.8 1.5 0.1 0.1 0.2 39.7 114.0 0.6 6.2 0.4 0.1 25.6 4.0 55.0 0.1 0.7 4.6 14.5 1.4 0.0 0.0 0.1 0.0 0.0 63.5 0.0 26.9 6.8 0.1 13.4 0.3 0.0 0.1 59.9 2.2 0.2 5.6 138.0 15.8 7.9 0.0 34.7 85.0 65.9 21.2 0.3 23.0 74.8 0.2 23.2 33.4 9.6 0.0 0.1 0.4 0.3 0.3 5.3 6.7 4.3 0.1 1.0 0.1 57.2 17.9 70.7 0.5 12.5 1.1 20.0 6.5 3.2 41.7 23.1 13.2 11.9 7.8 2.6 8.4 73.9 2.5 17.6 11.9 14.0 14.3 20.8 10.4 22.9 9.3 14.6 11.0 2.8 342.4 185.3 64.0 449.2 334.9 13.5 2.4 313.4 305.1 279.8 530.4 5.9 1193.1 86.2 726.2 49.0 27.7 770.2 23.3 582.2 418.7 47.4 567.4 114.2 0.9 201.0 3.2 346.3 19.6 47.0 43.3 17.5 123.0 84.4 555.5 581.5 122.0 696.1 614.1 15.9 155.0 17.0 51.8 17.6 285.2 308.8 374.4 1181.8 32.3 502.6 795.6 SPIRE1 "KIAA1135, spir-1" ENSG00000134278 "Spire type actin nucleation factor 1" Q08AE8 18 12446512-12658134 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 147.7;Late spermatids: 226.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 41.1;U-2197: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040737, HPA040942" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040737: AB_10960987, HPA040942: AB_10960492" "unprognostic (3.39e-1)" "unprognostic (4.77e-2)" "unprognostic (9.18e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (2.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.60e-1)" "unprognostic (9.49e-2)" "unprognostic (1.04e-1)" "unprognostic (1.46e-2)" "unprognostic (4.60e-1)" "unprognostic (3.66e-3)" "prognostic unfavorable (7.92e-4)" "unprognostic (1.41e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-1)" 8.4 20.2 20.6 4.7 16.2 1.7 10.6 20.5 35.3 10.8 6.5 15.0 3.4 2.5 9.2 7.0 8.8 5.6 8.6 22.0 21.6 14.8 12.7 5.5 12.2 3.3 21.3 20.5 9.8 8.5 15.7 8.2 7.5 17.3 10.1 4.3 9.4 10.0 9.9 17.5 7.7 3.5 9.9 17.7 5.3 5.5 34.8 17.5 0.4 15.0 3.6 4.9 8.8 10.7 1.0 1.0 0.0 1.1 0.9 0.6 0.2 7.5 3.3 7.4 8.2 8.3 7.4 0.4 8.2 8.5 8.1 7.8 0.3 1.7 3.6 9.4 10.6 13.6 1.7 9.9 7.3 10.3 5.3 4.9 2.2 7.0 4.3 17.1 1.5 5.7 5.1 14.0 14.0 41.1 9.4 10.8 1.2 5.6 0.1 12.0 10.1 0.4 2.0 3.1 2.7 8.3 0.0 9.1 7.5 9.8 10.3 10.9 4.4 8.9 7.4 18.6 3.4 2.3 4.7 13.2 13.5 4.0 31.5 9.7 2.7 0.3 0.2 10.8 1.0 3.6 0.0 1.1 0.0 0.4 0.8 0.2 0.0 0.2 0.6 1.0 1.0 0.0 0.4 0.0 0.9 1.1 0.0 0.0 0.2 20.6 16.2 20.5 24.3 21.6 14.8 21.3 20.5 17.3 17.5 23.8 39.2 0.0 8.2 3.3 52.8 25.0 7.6 6.7 15.9 12.2 7.9 0.1 18.3 7.4 147.7 7.1 0.0 0.0 4.2 0.7 7.4 18.7 15.1 5.0 11.5 25.4 2.9 6.7 12.7 226.2 5.5 6.0 16.9 2.8 1.0 14.3 8.9 0.0 10.3 1.1 11.8 19.4 9.5 10.5 19.2 1.9 0.5 1.3 0.0 8.9 SPNS1 "HSpin1, LAT, nrs, PP2030, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" NA NA Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 23.4 23.9 14.5 22.0 15.9 38.3 24.2 21.0 22.8 18.2 22.1 24.1 20.1 26.9 25.1 21.3 20.9 17.1 26.8 16.1 14.9 12.1 24.1 28.3 33.4 22.6 15.4 17.0 18.3 20.8 29.5 17.2 40.7 15.4 20.1 12.6 19.8 20.8 22.8 21.3 30.9 22.3 26.3 14.5 27.3 20.7 22.3 17.2 31.0 22.0 24.5 17.2 21.2 19.5 3.1 15.6 7.2 23.5 4.2 7.9 10.1 10.3 24.5 9.3 21.6 17.9 9.9 26.5 11.6 12.0 19.4 17.4 22.3 24.9 6.6 28.6 10.4 16.1 22.0 15.0 12.8 7.0 7.6 25.5 9.6 23.9 27.7 30.4 10.6 20.7 16.5 17.2 20.9 8.9 11.4 17.8 12.4 21.5 12.0 9.7 27.7 11.6 30.4 21.9 8.4 16.2 14.7 11.2 29.6 10.5 10.1 16.7 21.6 8.2 24.7 18.0 8.1 24.6 12.9 15.0 15.8 12.0 22.0 8.9 18.2 14.3 6.2 20.2 16.3 12.7 6.4 18.2 7.2 6.0 23.5 5.0 3.1 6.0 7.9 15.6 2.8 6.2 4.1 3.3 4.2 15.7 6.5 6.8 10.1 14.5 15.9 21.0 22.8 14.9 12.1 15.4 17.0 15.4 17.2 6.0 7.4 9.0 18.6 18.9 27.1 0.4 10.2 12.0 3.4 19.2 27.5 55.8 11.6 51.1 1.5 21.6 16.8 0.0 39.5 59.8 27.5 13.4 20.9 12.1 87.9 25.4 11.7 19.6 37.6 1.9 21.0 27.5 32.1 26.2 18.9 29.6 34.8 14.0 15.6 13.5 33.9 6.5 15.3 17.2 28.3 19.8 73.0 22.5 23.8 17.0 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.9;urinary bladder: 13.7" "Cell type enhanced" "Detected in some" 19 "Ductal cells: 9.9;Hofbauer cells: 13.9;Pancreatic endocrine cells: 18.9;Urothelial cells: 44.4" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "pons and medulla: 8.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.9;hTEC/SVTERT24-B: 19.7;RT4: 33.2;TIME: 17.3;U-87 MG: 32.7" "Low region specificity" "Detected in some" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008" "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.05e-5)" 28.9 0.5 1.8 5.1 1.6 0.3 1.6 0.4 3.9 2.0 0.7 1.5 0.1 1.6 2.4 2.8 0.3 2.1 1.6 0.4 1.2 1.6 0.5 0.2 12.9 0.9 2.6 0.3 1.8 0.1 0.1 1.6 3.5 8.2 1.8 0.9 1.8 0.1 0.3 0.4 0.1 0.9 2.4 3.1 1.9 1.1 11.9 0.6 0.1 0.4 0.8 0.2 13.7 2.1 0.0 0.0 1.9 0.1 0.0 0.0 7.3 10.7 0.3 0.0 0.0 0.2 1.5 0.5 14.1 18.9 13.7 9.2 0.2 0.6 0.1 1.9 15.9 5.6 1.4 0.0 0.2 4.3 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.2 6.9 0.2 19.7 0.6 11.1 9.3 0.7 0.2 0.2 8.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.4 0.0 0.0 33.2 0.0 0.0 0.3 0.0 0.9 0.4 8.2 0.0 17.3 14.5 1.4 9.3 5.3 0.0 0.1 0.0 32.7 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 1.8 1.6 0.4 0.6 1.2 1.6 2.6 0.3 8.2 0.6 0.0 5.9 0.0 4.0 0.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 9.9 0.2 0.1 0.0 0.0 8.9 0.5 0.4 1.7 1.1 0.0 13.9 0.0 1.7 0.6 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.0 1.4 0.0 4.3 0.0 0.2 0.0 0.0 44.4 SPR SDR38C1 ENSG00000116096 "Sepiapterin reductase" P35270 2 72887360-72892158 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 61.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9" "Group enriched" "Detected in many" 13 "dendritic cells: 9.9;monocytes: 9.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039505 Uncertain Supported Nucleoplasm,Cytosol NA NA 52000 "Nucleoplasm, Cytosol" "HPA039505: AB_10795466" "unprognostic (4.09e-1)" "unprognostic (1.22e-1)" "unprognostic (7.72e-3)" "unprognostic (1.97e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-2)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (7.50e-3)" "unprognostic (2.87e-1)" "unprognostic (1.43e-3)" "unprognostic (1.95e-1)" 13.3 22.6 6.3 6.1 8.2 0.0 36.2 2.0 6.4 6.0 17.1 3.1 8.9 11.4 5.7 19.1 13.4 13.2 11.4 16.1 6.4 6.0 20.3 43.5 7.2 5.3 7.9 5.0 8.7 61.7 16.7 5.5 3.9 7.9 17.3 16.2 4.5 20.9 8.8 16.0 3.3 15.1 9.5 4.9 4.7 15.4 4.9 7.2 1.0 31.7 6.2 3.6 9.5 41.4 0.0 9.9 0.7 9.3 0.0 0.4 2.5 13.5 38.0 0.2 5.9 15.6 5.7 9.5 6.4 9.3 4.8 4.5 24.2 14.1 9.9 7.7 7.5 24.1 12.9 17.0 10.2 4.0 2.8 13.2 14.9 9.4 24.8 5.8 2.3 4.1 5.0 11.4 5.2 5.9 9.8 12.5 7.4 15.3 2.0 6.2 28.5 0.9 8.8 3.2 40.2 36.4 0.0 24.7 5.8 25.2 21.2 2.4 4.4 11.7 26.5 8.7 5.2 11.9 2.8 15.3 5.2 12.8 9.1 11.2 2.2 4.8 0.6 7.5 5.0 9.1 0.0 9.3 0.7 0.4 2.6 0.4 0.0 0.2 0.1 9.9 0.0 0.2 0.4 0.0 0.0 1.0 0.9 0.0 2.5 6.3 8.2 2.0 6.4 6.4 6.0 7.9 5.0 7.9 7.2 11.9 5.3 1.9 19.7 7.4 0.6 40.5 40.8 6.7 7.9 40.1 0.0 14.2 18.3 46.9 0.2 17.6 68.6 0.0 71.1 9.3 12.5 27.5 4.6 52.9 35.3 1.6 10.9 11.6 4.7 0.9 8.6 9.4 13.5 34.3 31.7 8.6 48.5 51.8 5.3 75.1 0.5 6.5 12.5 0.3 6.6 5.6 3.7 1.7 50.4 13.2 SPRED2 "FLJ21897, FLJ31917, Spred-2" ENSG00000198369 "Sprouty related EVH1 domain containing 2" Q7Z698 2 65310851-65432637 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 3.2;plasmacytoid DC: 7.7" "Group enriched" "Detected in many" 4 "dendritic cells: 7.7;NK-cells: 3.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038256, HPA064394" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038256: , HPA064394: AB_2732712" "unprognostic (1.49e-1)" "unprognostic (5.95e-3)" "unprognostic (3.46e-2)" "unprognostic (4.40e-3)" "unprognostic (8.94e-2)" "unprognostic (1.63e-1)" "unprognostic (2.90e-2)" "unprognostic (9.94e-2)" "unprognostic (9.07e-2)" "unprognostic (4.25e-1)" "unprognostic (5.05e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (7.21e-3)" "unprognostic (5.43e-2)" 25.1 13.5 21.0 19.3 17.8 6.7 26.2 26.2 28.9 16.9 18.9 9.0 5.8 17.2 20.1 12.3 12.8 13.8 18.3 17.5 19.0 14.3 16.1 28.1 22.0 14.8 15.3 19.0 18.3 20.6 29.5 15.1 18.1 20.5 15.1 18.7 15.1 17.9 13.6 9.6 13.6 20.7 13.7 16.5 11.0 22.6 8.1 12.9 40.3 22.1 10.4 17.1 21.2 30.5 0.1 7.7 1.2 1.2 3.2 1.2 1.5 27.0 14.3 15.6 15.9 20.4 20.4 11.3 8.1 12.0 5.2 7.2 18.8 7.7 20.9 4.3 10.0 15.1 9.1 8.9 18.2 10.7 23.9 6.5 4.3 3.8 20.3 10.3 13.3 8.9 16.3 10.8 18.7 17.9 11.4 3.3 11.7 18.6 8.2 8.4 18.3 10.3 12.4 7.8 21.1 16.8 8.2 14.1 10.8 16.3 22.9 6.7 23.8 8.5 7.3 21.7 10.1 6.9 11.3 5.1 13.3 17.9 11.8 12.9 16.2 6.5 34.1 21.6 12.8 25.6 0.0 0.4 0.0 1.2 1.2 0.1 0.0 0.2 1.0 0.8 0.1 0.2 0.3 1.2 3.2 0.6 7.7 0.0 1.5 21.0 17.8 26.2 26.7 19.0 14.3 15.3 19.0 20.5 12.9 17.9 16.5 2.2 27.6 35.4 14.1 6.5 17.8 6.7 4.5 8.7 5.9 10.2 11.6 10.1 1.3 9.8 16.0 0.0 7.4 7.2 13.1 21.2 1.1 12.7 5.9 23.8 10.9 15.4 6.5 2.5 15.8 7.8 18.6 44.1 19.7 8.9 9.7 15.8 11.7 5.7 10.7 25.8 15.4 2.8 9.8 14.6 2.5 0.7 10.1 22.0 SPRED3 ENSG00000188766 "Sprouty related EVH1 domain containing 3" Q2MJR0 19 38388421-38399587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.7" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 7.3;Intestinal endocrine cells: 10.4" "Cancer enhanced" "Detected in many" "glioma: 3.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.3;TIME: 14.7;U-87 MG: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071521 Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA071521: " "unprognostic (1.09e-1)" "unprognostic (1.88e-3)" "unprognostic (8.71e-3)" "unprognostic (3.35e-3)" "unprognostic (3.70e-2)" "unprognostic (2.00e-3)" "unprognostic (2.09e-3)" "unprognostic (7.77e-3)" "unprognostic (1.49e-1)" "unprognostic (9.22e-3)" "unprognostic (1.69e-2)" "unprognostic (3.09e-2)" "unprognostic (1.40e-11)" "unprognostic (6.21e-4)" "unprognostic (3.67e-1)" "unprognostic (1.04e-3)" "unprognostic (8.45e-3)" 2.0 1.2 4.3 2.7 10.1 0.9 1.2 2.8 10.7 0.9 0.6 1.7 0.0 4.7 1.2 1.2 0.9 0.7 2.0 1.1 5.0 4.7 1.2 0.4 0.9 0.5 2.8 4.6 0.5 2.9 4.5 5.8 0.8 4.7 1.2 0.8 0.9 0.8 1.1 0.9 2.3 3.7 2.3 1.7 0.5 1.3 1.7 0.9 0.0 1.8 0.0 0.6 0.9 0.8 0.8 0.7 2.2 0.6 0.9 0.5 0.3 0.2 1.1 3.8 3.1 0.6 1.8 2.1 7.5 5.0 2.5 2.3 0.4 0.8 0.2 2.7 2.5 2.0 0.1 0.6 0.9 2.3 0.7 1.4 0.0 0.2 0.4 1.3 2.0 0.1 1.3 0.9 5.9 1.7 12.3 7.8 0.6 0.6 1.4 7.6 0.4 0.0 0.1 1.7 0.5 3.8 0.9 1.3 0.1 5.4 0.6 0.2 2.9 0.1 0.2 0.3 1.7 0.6 0.1 14.7 2.8 8.6 2.3 4.1 0.6 0.2 0.5 9.4 0.3 4.7 1.6 0.6 0.4 0.4 0.2 0.3 0.3 0.5 0.3 0.1 0.8 0.4 0.3 2.2 0.9 0.5 0.7 0.2 0.3 4.3 10.1 2.8 9.8 5.0 4.7 2.8 4.6 4.7 0.9 0.0 0.0 0.0 1.1 0.0 7.3 1.0 0.0 0.0 0.0 1.8 2.0 0.4 0.0 0.8 0.3 0.1 0.7 0.0 0.5 0.2 0.0 1.1 0.0 0.0 0.1 1.6 10.4 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 2.5 2.2 0.0 0.0 0.0 0.2 0.0 1.0 0.9 0.6 0.1 0.7 0.0 0.6 0.6 SPRR4 ENSG00000184148 "Small proline rich protein 4" Q96PI1 1 152970666-152972574 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 51.9;tongue: 18.9" "Group enriched" "Detected in some" 27 "Early spermatids: 9.1;Late spermatids: 36.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 3.6;hTCEpi: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055963 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA055963: AB_2682988" "unprognostic (4.40e-2)" "unprognostic (7.38e-3)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" 0.1 0.0 0.1 0.7 0.1 0.0 4.9 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.4 0.1 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 51.9 0.1 0.1 0.1 0.1 0.0 2.9 0.1 1.8 0.1 18.9 0.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SPRY1 hSPRY1 ENSG00000164056 "Sprouty RTK signaling antagonist 1" O43609 4 123396795-123403760 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.1" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 160.4;Leydig cells: 414.8;Muller glia cells: 173.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 29.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 30.2;AN3-CA: 61.1;ASC diff: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013538, HPA051369, HPA070554" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.06e-1)" "unprognostic (7.15e-2)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (9.43e-2)" "unprognostic (6.99e-2)" "unprognostic (4.32e-1)" "unprognostic (4.06e-1)" "unprognostic (3.11e-2)" "unprognostic (8.77e-3)" "unprognostic (1.21e-3)" "unprognostic (4.48e-2)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" 139.1 12.6 3.3 14.7 4.3 5.8 69.0 4.9 3.5 28.5 24.8 1.9 18.0 4.5 18.6 28.0 38.1 19.1 27.1 34.1 2.6 1.7 10.2 6.4 23.1 9.1 3.3 2.8 32.2 9.8 17.0 9.5 15.6 2.9 25.0 8.8 11.8 14.6 16.5 48.1 25.5 8.1 20.7 2.8 7.1 11.6 28.4 1.5 13.0 29.6 16.3 8.6 60.8 39.9 29.9 0.7 2.8 0.1 6.1 15.5 0.9 1.9 0.5 30.2 61.1 24.8 16.9 2.0 0.1 1.5 0.1 0.6 1.8 3.2 0.0 13.6 0.9 0.1 0.3 0.8 1.4 0.2 0.0 3.1 0.6 0.0 9.4 7.0 4.2 0.0 6.8 0.8 0.2 0.6 3.3 2.5 0.7 0.5 0.5 1.4 0.2 4.9 10.5 7.2 6.9 10.0 2.1 3.2 0.0 4.1 4.4 4.6 3.9 0.0 6.1 5.8 3.3 0.6 0.0 6.2 0.4 0.0 0.1 0.9 0.3 0.0 0.0 0.4 0.8 1.0 0.0 0.1 2.8 0.5 0.0 15.5 9.6 1.8 4.2 0.0 29.9 2.7 2.9 0.1 6.1 0.0 0.7 0.0 0.9 3.3 4.3 4.9 3.5 2.6 1.7 3.3 2.8 2.9 1.5 26.8 27.0 15.2 13.8 44.1 75.2 10.9 35.7 13.4 27.3 26.2 31.4 10.0 68.0 3.5 1.7 160.4 6.3 0.0 9.4 1.5 42.7 12.9 9.2 4.4 8.2 6.4 25.4 120.9 11.6 4.0 414.8 9.7 43.9 1.0 13.1 173.3 8.4 3.5 54.5 12.6 80.4 148.8 86.8 1.9 1.5 37.9 2.6 25.5 14.1 12.5 SPRY3 HSPRY3 ENSG00000168939 "Sprouty RTK signaling antagonist 3" O43610 X 155767812-155782459 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 3.5;Cone photoreceptor cells: 3.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 8.6;EFO-21: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013505 Uncertain Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB013505: " "unprognostic (3.70e-2)" "unprognostic (4.39e-1)" "unprognostic (5.24e-2)" "unprognostic (3.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.20e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "unprognostic (3.68e-3)" "unprognostic (1.52e-4)" "unprognostic (1.21e-2)" "unprognostic (9.60e-2)" "unprognostic (5.26e-2)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (5.44e-2)" "unprognostic (3.49e-2)" 1.6 2.1 1.3 0.4 1.8 2.8 1.2 7.5 1.5 1.3 0.8 1.2 1.5 5.8 0.8 1.1 0.8 0.9 1.3 1.5 0.9 0.7 0.9 0.3 1.1 2.8 0.4 1.3 1.1 1.9 0.9 1.4 1.1 1.2 1.2 0.4 1.1 1.2 1.2 1.4 0.7 0.1 1.0 0.5 0.8 0.7 0.0 0.5 0.4 0.5 0.2 0.2 0.0 0.5 0.2 2.4 8.6 1.7 0.8 0.0 2.0 1.3 0.6 1.0 0.2 1.4 0.0 4.2 1.1 1.6 0.3 0.9 0.6 0.6 0.2 0.4 1.0 2.2 0.1 0.7 0.4 0.4 2.1 1.1 0.8 0.5 0.8 1.3 0.5 0.1 0.6 1.6 0.3 0.2 0.3 0.8 0.2 0.0 0.5 0.2 2.1 0.9 0.8 0.6 0.6 1.0 0.0 0.5 1.2 0.5 0.6 2.2 0.6 0.9 0.3 0.6 0.7 0.1 1.9 2.1 1.0 1.2 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.5 0.8 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.9 1.1 0.0 0.6 0.1 0.4 0.1 0.0 0.8 0.3 0.0 0.0 1.3 0.6 0.0 0.9 0.1 1.7 0.0 1.0 0.8 0.5 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.1 SPRY4 ENSG00000187678 "Sprouty RTK signaling antagonist 4" Q9C004 5 142310427-142326455 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 47.2;Ito cells: 48.5;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 36.0;WM-115: 50.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008086, HPA055471, HPA072661" Enhanced Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "CAB008086: AB_2195454, HPA055471: AB_2682825, HPA072661: AB_2732207" "unprognostic (9.54e-3)" "prognostic unfavorable (7.12e-4)" "unprognostic (2.18e-1)" "unprognostic (1.16e-1)" "unprognostic (8.70e-2)" "unprognostic (3.23e-2)" "unprognostic (3.98e-3)" "unprognostic (1.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.48e-1)" "unprognostic (9.89e-2)" "prognostic unfavorable (2.20e-4)" "unprognostic (6.29e-3)" "unprognostic (3.63e-2)" "unprognostic (4.59e-2)" "unprognostic (8.21e-2)" 27.3 20.8 9.0 6.8 9.0 0.7 32.9 6.2 8.3 7.1 8.0 4.9 3.6 8.7 8.3 6.2 4.9 6.5 11.3 17.1 7.4 8.0 12.5 11.5 24.3 3.7 6.5 7.6 5.7 7.4 10.6 28.7 21.8 8.5 13.0 7.5 10.7 4.6 7.3 10.6 3.6 11.7 8.8 6.7 10.7 7.8 2.4 3.9 0.2 17.8 4.0 2.4 12.7 29.1 0.0 0.9 0.0 0.0 0.2 0.1 0.0 1.1 1.9 17.5 36.0 10.5 7.5 4.8 13.1 4.5 2.1 2.3 1.9 1.8 0.0 9.7 3.2 2.3 0.9 0.0 3.7 2.5 0.0 0.0 0.0 0.0 7.7 3.5 0.0 0.0 6.2 0.0 5.7 3.2 3.3 2.0 0.0 4.4 0.0 7.6 1.5 0.0 4.7 8.1 5.8 12.5 0.4 2.5 0.4 6.2 11.3 0.2 5.5 0.2 1.7 14.9 5.2 0.1 0.7 2.9 4.6 0.1 0.9 11.7 0.0 0.6 0.0 7.2 0.0 50.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 9.0 9.0 6.2 8.3 7.4 8.0 6.5 7.6 8.5 3.9 6.0 47.2 0.0 4.2 1.4 5.9 2.8 0.0 0.0 1.2 3.5 0.0 0.9 0.0 1.8 0.7 15.4 5.6 0.0 0.3 1.7 7.2 2.5 3.5 1.7 0.2 0.0 13.3 48.5 3.7 1.3 0.3 0.9 6.8 0.0 6.5 2.2 3.1 3.4 0.4 0.8 0.3 19.4 10.3 0.0 0.1 0.3 2.9 0.5 5.2 1.4 SPRYD3 FLJ14800 ENSG00000167778 "SPRY domain containing 3" Q8NCJ5 12 53064316-53079420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039426, HPA039685" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Vesicles, Plasma membrane, Actin filaments" "HPA039426: AB_10673358, HPA039685: AB_2676623" "unprognostic (7.73e-3)" "unprognostic (6.55e-2)" "unprognostic (1.37e-2)" "unprognostic (5.05e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (1.27e-3)" "unprognostic (2.58e-1)" "unprognostic (1.83e-2)" "unprognostic (1.43e-2)" "unprognostic (2.64e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.78e-15)" "unprognostic (9.82e-2)" "unprognostic (5.27e-2)" "unprognostic (7.44e-3)" "unprognostic (1.41e-1)" 16.8 15.7 30.4 10.1 51.9 3.3 11.6 27.1 59.3 15.3 11.4 14.9 10.6 10.8 14.1 21.7 15.9 26.8 11.7 23.1 28.3 27.0 11.3 8.0 13.1 8.8 21.5 34.9 26.4 20.4 26.5 20.3 8.0 34.2 18.3 10.0 15.6 23.3 25.1 7.4 13.0 9.8 18.3 14.0 9.8 13.4 4.9 12.2 3.7 20.2 6.6 11.4 12.4 11.4 9.4 9.4 26.7 18.4 9.7 21.0 15.6 12.5 19.6 2.5 5.2 20.9 10.4 3.3 19.4 10.0 7.3 4.7 3.2 10.6 8.1 16.1 23.6 8.9 11.7 3.4 14.7 4.8 8.8 5.2 5.2 11.9 7.3 15.7 9.7 9.2 9.4 23.2 10.4 16.1 14.5 15.0 4.3 4.4 20.6 12.7 27.2 6.9 5.0 1.4 10.2 13.8 3.1 4.3 16.7 9.2 10.1 4.4 4.2 16.6 15.4 7.8 1.4 14.4 7.6 20.8 8.3 8.5 18.8 13.1 11.6 10.3 2.4 24.5 8.6 10.1 15.5 9.8 26.7 21.0 17.5 20.1 9.4 14.5 16.9 9.4 7.5 12.5 14.6 15.5 9.7 18.4 4.5 8.0 15.6 30.4 51.9 27.1 59.3 28.3 27.0 21.5 34.9 34.2 12.2 3.0 8.5 12.3 16.4 5.0 40.6 16.7 22.9 21.4 9.1 17.4 7.9 5.4 10.0 26.1 0.2 16.6 10.3 0.0 31.6 11.7 12.3 17.1 9.3 8.1 10.7 41.3 11.1 15.4 10.0 1.1 15.0 8.1 10.1 16.2 11.7 29.5 23.5 8.2 31.1 12.6 20.2 19.4 23.4 3.0 4.5 8.3 3.5 10.2 7.3 13.7 SPTB ENSG00000070182 "Spectrin beta, erythrocytic" P11277 14 64746283-64879907 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.2;brain: 25.2;skeletal muscle: 67.6" "Cell type enhanced" "Detected in some" 22 "Erythroid cells: 46.7;Horizontal cells: 15.9" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "basal ganglia: 11.6;cerebellum: 25.2;cerebral cortex: 10.4;pons and medulla: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 23.5;K-562: 28.1;U-937: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003394, HPA003398, CAB015169, CAB016232" Enhanced Approved Cytosol NA NA 43000000 Cytosol "CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074" "unprognostic (2.69e-1)" "unprognostic (4.72e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-3)" "unprognostic (1.71e-1)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.30e-3)" "unprognostic (2.66e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-3)" "unprognostic (2.11e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-2)" "unprognostic (2.97e-1)" "unprognostic (3.44e-2)" "unprognostic (2.18e-2)" 1.9 1.6 3.2 0.7 11.6 32.2 0.7 25.2 10.4 0.8 0.7 0.8 0.3 0.6 0.7 5.2 1.8 0.8 0.8 14.7 3.1 3.2 1.2 0.6 0.9 0.6 2.8 3.5 0.7 2.2 6.5 4.7 4.7 16.4 1.5 0.7 1.1 1.9 1.3 67.6 0.7 0.7 1.0 1.7 1.1 0.7 1.0 1.4 0.0 0.7 17.4 0.6 0.8 0.5 0.0 0.6 0.9 0.0 0.0 0.2 1.5 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 1.4 3.9 0.1 0.0 0.2 2.3 23.5 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.9 28.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 1.3 0.0 0.0 0.1 0.0 0.1 3.8 1.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 4.3 0.0 0.4 0.9 4.4 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 1.5 3.2 11.6 25.2 10.4 3.1 3.2 2.8 3.5 16.4 1.4 0.0 0.0 0.0 0.4 0.7 8.1 5.5 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 46.7 0.2 0.2 0.3 0.5 2.3 0.0 0.2 15.9 2.9 0.0 0.0 0.0 0.3 0.2 1.7 0.0 0.0 6.5 0.4 0.0 1.1 0.0 1.9 6.5 3.8 0.1 0.2 0.4 0.1 0.0 0.0 0.5 SQLE ENSG00000104549 "Squalene epoxidase" Q14534 8 124998497-125022283 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018038, HPA020762" Enhanced Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA018038: AB_2669753, HPA020762: AB_2670512" "unprognostic (1.37e-2)" "unprognostic (6.26e-3)" "unprognostic (5.12e-2)" "unprognostic (9.51e-3)" "unprognostic (4.63e-1)" "prognostic unfavorable (7.42e-4)" "unprognostic (4.76e-3)" "prognostic unfavorable (4.67e-4)" "unprognostic (3.45e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (7.51e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (9.71e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-3)" "unprognostic (7.74e-3)" 4.6 15.7 11.1 9.9 13.9 10.4 12.1 8.9 19.9 15.1 11.5 28.8 4.4 15.8 8.9 5.1 40.3 10.0 6.3 4.2 15.4 14.5 7.8 38.1 16.0 8.6 10.8 9.7 17.5 6.3 16.5 9.5 24.7 28.5 13.8 10.1 9.3 10.4 4.7 1.3 23.8 8.7 6.6 36.0 5.6 11.5 29.3 18.7 9.8 5.7 24.2 15.0 5.3 21.6 15.1 12.4 1.2 9.7 9.5 9.0 6.1 25.8 10.0 60.2 17.3 18.7 31.8 6.1 6.8 21.0 9.3 17.1 13.6 37.9 17.8 9.9 8.4 37.4 19.8 25.1 37.7 10.8 14.7 53.0 50.9 6.8 34.7 27.6 5.9 15.0 21.7 40.4 27.7 22.9 6.0 10.1 12.6 29.0 34.7 7.5 42.7 20.6 7.5 24.9 17.8 6.9 9.1 11.0 24.3 65.6 29.8 18.8 9.5 14.0 45.0 14.0 20.2 12.0 15.6 9.9 3.8 13.6 4.5 6.0 6.3 12.8 24.4 6.4 18.2 6.6 1.2 5.1 0.5 9.0 8.5 4.4 13.6 5.4 8.3 12.4 15.1 7.5 7.8 0.1 9.5 9.7 8.8 5.6 6.1 11.1 13.9 8.9 16.4 15.4 14.5 10.8 9.7 28.5 18.7 56.6 84.1 38.7 41.4 20.4 26.3 6.1 28.1 108.4 52.4 50.6 47.1 81.6 6.6 50.5 18.8 11.2 44.6 46.7 73.0 111.6 54.5 79.8 41.4 15.7 48.5 139.8 30.4 12.3 13.0 9.6 22.2 16.0 20.3 154.1 29.4 23.5 64.9 21.0 10.3 2.9 47.5 25.8 29.0 131.6 152.1 77.9 181.6 17.5 20.4 100.4 SQSTM1 "A170, OSIL, p60, p62, p62B, PDB3" ENSG00000161011 "Sequestosome 1" Q13501 5 179806398-179838078 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Autophagy, Differentiation, Immunity" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 1710.2;Urothelial cells: 1685.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 195.8;HHSteC: 135.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004587, HPA064165, HPA068843" Supported Enhanced Vesicles,Cytosol No No "Vesicles, Cytosol" "CAB004587: AB_628279, HPA064165: AB_2685203, HPA068843: AB_2732120" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (3.19e-1)" "unprognostic (9.45e-2)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.31e-5)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (5.65e-2)" "unprognostic (1.66e-1)" "unprognostic (1.70e-1)" "unprognostic (9.52e-2)" "unprognostic (3.21e-1)" "unprognostic (8.68e-3)" "unprognostic (4.41e-2)" "unprognostic (2.01e-1)" 47.8 74.5 12.4 21.6 16.0 19.5 60.4 26.2 23.4 25.2 31.7 20.9 39.8 22.9 29.4 27.7 30.8 23.1 45.2 51.9 13.9 12.8 38.6 88.3 33.3 33.4 23.2 16.3 32.3 51.8 22.7 33.6 72.7 15.6 36.2 15.2 28.9 39.0 36.2 102.8 15.3 22.0 36.3 15.5 25.6 40.0 18.9 17.9 18.8 60.4 45.3 17.5 47.9 64.0 27.8 34.2 100.4 58.3 28.2 38.7 52.4 13.8 79.6 3.8 11.4 56.4 38.9 57.2 20.4 60.8 16.1 20.7 15.6 57.5 2.2 56.6 31.2 107.5 17.3 7.5 17.2 7.6 195.8 11.7 6.6 28.9 24.3 135.0 6.7 36.2 32.6 21.8 30.2 46.8 44.7 16.5 1.9 6.9 46.8 34.5 10.9 2.5 6.5 9.4 41.1 24.8 5.2 8.4 21.8 23.9 61.0 8.4 7.3 30.1 29.4 72.6 8.2 14.7 11.5 36.8 28.3 12.6 26.8 26.1 70.0 73.3 7.3 64.6 11.4 31.4 90.0 58.3 59.9 32.7 39.6 38.7 27.8 28.9 29.2 34.2 27.1 24.0 24.0 100.4 28.2 36.6 14.8 38.7 52.4 12.4 16.0 26.2 23.4 13.9 12.8 23.2 16.3 15.6 17.9 172.7 223.0 86.1 1144.6 264.2 81.2 33.3 252.3 143.2 124.0 115.1 51.1 248.2 198.9 724.5 23.1 185.5 409.6 23.3 582.3 108.5 234.9 1101.4 374.4 241.5 260.7 85.8 326.4 132.0 116.5 47.7 301.2 245.4 219.4 921.6 190.4 130.1 730.8 241.9 243.6 251.6 67.2 161.7 335.8 31.2 49.4 226.5 1710.2 157.6 126.4 1685.2 SRA1 "SRA, STRAA1" ENSG00000213523 "Steroid receptor RNA activator 1" Q9HD15 5 140537340-140558252 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Receptor, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 26.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044598, HPA050153" Approved Supported Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA044598: AB_2679013, HPA050153: AB_2681033" "unprognostic (1.51e-1)" "unprognostic (1.04e-2)" "unprognostic (8.69e-2)" "prognostic favorable (8.01e-6)" "unprognostic (9.32e-2)" "unprognostic (2.56e-1)" "unprognostic (2.90e-1)" "unprognostic (2.43e-1)" "unprognostic (9.38e-2)" "unprognostic (7.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.61e-1)" "unprognostic (5.34e-2)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-1)" 4.8 9.9 2.5 4.8 3.0 5.6 2.7 13.3 3.5 2.5 3.3 3.1 3.0 4.1 2.5 2.6 3.5 4.3 2.7 3.0 3.5 14.4 4.4 3.5 2.2 4.9 2.7 4.5 7.7 3.7 3.7 3.0 5.5 4.4 4.4 3.9 3.4 3.4 2.1 5.7 4.6 6.8 4.1 3.1 2.3 2.3 9.0 15.6 26.9 16.4 7.5 11.3 14.2 6.2 15.0 8.0 8.3 3.9 5.3 11.2 10.7 6.1 7.0 7.4 27.4 3.9 5.3 7.9 4.1 3.7 4.2 1.4 7.9 2.8 8.2 9.3 4.7 16.3 10.4 8.3 8.4 6.4 10.2 4.1 3.7 1.9 6.2 3.2 9.2 4.7 8.2 4.6 19.1 6.8 13.2 2.4 3.4 12.1 7.6 6.8 5.1 3.6 7.5 5.7 6.6 6.2 5.7 7.2 2.9 7.0 9.6 5.0 6.7 3.5 5.7 8.6 10.3 6.8 5.6 8.2 11.0 4.3 8.1 16.4 12.0 7.0 14.3 6.5 9.0 6.8 6.7 15.6 7.4 5.6 6.4 26.9 7.5 13.3 9.3 11.3 14.2 6.0 53.3 35.8 43.2 46.5 23.0 70.0 68.8 34.8 30.7 31.4 7.9 84.2 96.2 79.1 75.5 39.4 72.4 0.0 128.7 102.6 52.4 64.7 66.9 57.8 81.7 14.3 36.9 43.6 67.7 108.8 23.3 67.0 64.1 111.0 51.7 47.0 131.8 77.2 28.0 111.7 19.5 25.8 48.6 45.0 29.2 40.1 149.7 55.1 40.7 117.5 SRBD1 FLJ10379 ENSG00000068784 "S1 RNA binding domain 1" Q8N5C6 2 45388680-45612165 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030567, HPA030568" Approved Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA030567: AB_10611244, HPA030568: AB_10601856" "unprognostic (1.16e-2)" "unprognostic (1.27e-1)" "unprognostic (4.97e-3)" "unprognostic (2.46e-1)" "unprognostic (8.20e-3)" "unprognostic (4.14e-1)" "unprognostic (8.69e-3)" "unprognostic (9.74e-2)" "unprognostic (7.11e-2)" "unprognostic (9.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.76e-1)" "unprognostic (3.42e-3)" "unprognostic (3.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (2.29e-1)" 11.7 9.8 5.5 12.2 7.5 6.8 10.9 6.3 6.8 13.8 10.4 6.3 15.7 6.7 19.3 14.9 8.0 8.6 7.4 9.4 5.5 5.8 11.6 13.2 8.7 11.0 6.4 4.7 11.2 14.9 25.1 20.9 11.5 8.7 12.7 9.9 8.4 16.6 14.5 9.5 8.4 10.7 8.3 7.3 13.9 9.9 12.2 8.0 16.5 12.5 6.1 11.3 9.7 9.4 6.1 7.0 14.3 13.0 9.2 7.7 4.9 13.7 7.1 14.7 9.8 5.4 12.0 11.6 10.6 9.3 10.2 9.4 5.9 5.9 11.9 7.9 7.5 7.6 6.5 14.4 13.4 18.9 16.2 8.0 15.8 5.7 12.7 6.4 13.1 9.3 7.2 5.6 12.0 14.1 4.5 12.2 4.4 11.2 9.0 15.0 12.4 17.5 10.0 16.7 8.9 7.8 12.1 21.1 10.8 11.6 9.0 12.9 10.5 9.3 10.1 10.3 8.0 6.2 4.8 11.3 14.3 11.4 6.8 9.1 9.6 3.5 7.2 8.0 13.0 10.2 3.4 7.2 14.3 6.6 7.9 5.8 6.1 4.9 7.7 7.0 5.3 6.9 6.2 2.6 9.2 13.0 6.7 5.0 4.9 5.5 7.5 6.3 6.8 5.5 5.8 6.4 4.7 8.7 8.0 17.9 4.8 7.3 3.2 3.2 7.6 8.5 12.7 9.4 13.6 3.5 3.9 7.0 8.3 6.5 2.8 8.7 5.4 0.0 8.0 5.9 6.6 2.8 8.1 11.0 8.7 12.7 6.9 6.7 9.9 1.5 6.9 9.2 6.8 10.0 8.2 14.7 4.6 6.8 6.0 8.5 13.5 12.9 3.4 24.1 26.4 3.3 4.7 9.6 4.7 1.3 SRC "ASV, c-src, SRC1" ENSG00000197122 "SRC proto-oncogene, non-receptor tyrosine kinase" P12931 20 37344685-37406050 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell adhesion, Cell cycle, Host-virus interaction, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 5.3;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 6 "dendritic cells: 3.0;monocytes: 5.3" "Cell line enhanced" "Detected in many" "A549: 35.9;HBEC3-KT: 33.4;RT4: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004023, HPA030875" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" NA NA 20000000 "Plasma membrane, Cell Junctions" "Nucleoplasm, Cytosol" "CAB004023: AB_2106059, HPA030875: AB_2673640" "unprognostic (5.58e-2)" "unprognostic (9.83e-2)" "unprognostic (3.56e-1)" "unprognostic (4.54e-3)" "unprognostic (1.52e-1)" "unprognostic (1.54e-2)" "prognostic unfavorable (4.90e-5)" "unprognostic (3.89e-2)" "unprognostic (7.04e-2)" "unprognostic (8.13e-2)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.63e-4)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.33e-2)" "unprognostic (4.72e-2)" "unprognostic (3.65e-2)" "prognostic favorable (5.22e-5)" 6.9 17.5 12.8 11.1 12.0 5.4 9.9 6.4 16.0 16.0 16.4 3.5 15.1 29.5 20.3 9.7 16.2 14.2 42.1 5.8 11.3 6.6 13.4 2.9 10.4 7.0 3.3 9.9 15.8 19.1 6.6 11.3 6.3 5.1 19.9 13.1 13.1 7.5 22.5 3.4 7.7 28.1 27.2 3.6 12.2 29.8 27.3 4.8 4.0 6.6 10.5 10.4 26.4 20.0 0.3 3.0 0.1 5.3 0.6 0.1 1.6 7.7 35.9 8.3 7.4 3.1 5.0 17.2 7.2 6.2 8.8 5.6 13.5 7.0 0.2 4.5 13.0 10.0 14.2 4.9 33.4 3.4 0.0 4.5 2.0 1.3 20.9 7.5 0.1 3.1 5.3 11.4 5.7 7.7 9.8 8.0 4.6 0.2 0.0 1.4 5.3 1.9 0.2 3.9 21.5 32.6 8.4 2.2 0.2 3.7 34.4 7.7 27.9 8.1 11.4 8.9 6.6 10.2 2.8 11.6 10.5 7.1 3.8 6.4 0.1 0.2 0.1 7.4 0.0 7.8 0.0 2.6 0.0 0.0 5.3 0.0 0.3 0.0 0.1 1.1 0.3 0.0 0.0 0.1 0.6 4.4 3.0 0.1 1.6 12.8 12.0 6.4 16.0 11.3 6.6 3.3 9.9 5.1 4.8 3.0 1.7 4.4 10.8 7.2 5.4 1.6 15.3 1.4 0.0 12.2 2.0 1.6 1.7 9.7 1.3 1.4 30.0 0.0 16.2 7.0 8.2 11.2 0.0 0.9 5.8 3.2 16.1 1.3 6.9 1.5 10.0 12.1 1.7 7.2 25.9 4.1 29.0 18.1 16.3 9.5 4.7 12.9 6.4 0.2 0.7 8.0 1.9 0.0 14.9 27.7 SRD5A3 "FLJ13352, SRD5A2L, SRD5A2L1" ENSG00000128039 "Steroid 5 alpha-reductase 3" Q9H8P0 4 55346109-55373096 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Cataract, Congenital disorder of glycosylation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 92.9;Extravillous trophoblasts: 88.2;Pancreatic endocrine cells: 133.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 42.6" "Low region specificity" "Detected in all" HPA027006 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027006: AB_1857469" "unprognostic (1.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-2)" "prognostic favorable (9.39e-4)" "unprognostic (1.50e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (9.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-2)" "unprognostic (3.29e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.85e-10)" "unprognostic (4.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-2)" "unprognostic (9.52e-2)" 13.8 12.2 11.5 5.9 13.4 6.6 17.8 7.3 18.3 22.9 11.3 20.3 3.5 6.9 13.8 9.6 24.4 5.9 22.6 10.5 13.2 10.7 12.3 15.0 12.4 10.1 15.5 12.0 3.5 26.8 14.0 7.0 8.8 13.6 8.9 10.9 6.8 16.3 6.6 5.8 15.6 8.3 6.2 22.1 6.9 13.8 4.0 15.3 10.0 7.6 9.9 12.1 12.1 12.1 5.9 28.4 10.3 25.2 3.6 9.2 10.3 4.8 3.2 5.8 5.5 19.5 12.5 2.9 5.3 6.2 2.2 3.6 3.2 10.1 11.5 6.0 8.3 6.2 3.8 4.1 4.9 2.8 3.3 7.3 6.3 3.6 8.6 5.2 11.6 3.5 11.4 9.1 3.8 3.5 4.8 9.0 21.5 10.7 25.8 12.6 6.3 17.0 5.1 7.3 27.6 4.3 5.5 1.8 6.5 7.4 5.2 9.0 5.0 5.6 42.6 3.8 6.0 5.2 10.2 4.4 14.2 2.6 1.0 4.0 13.8 7.6 4.2 18.0 16.0 13.8 10.3 16.5 4.9 7.9 25.1 9.2 5.9 6.0 7.4 14.1 5.2 5.3 7.1 0.8 3.6 25.2 28.4 5.8 10.3 11.5 13.4 7.3 18.3 13.2 10.7 15.5 12.0 13.6 15.3 8.9 15.7 3.0 9.5 12.0 4.6 4.6 45.9 12.0 12.5 5.2 3.9 22.7 3.3 67.0 2.0 14.3 8.4 0.0 92.9 88.2 17.0 22.1 13.9 17.1 62.0 9.5 11.5 17.8 20.9 0.0 1.7 27.9 23.6 24.4 19.3 18.6 133.4 5.8 5.3 12.2 3.8 12.9 9.5 2.1 18.8 26.0 6.3 4.9 20.9 49.7 SREBF1 "bHLHd1, SREBP-1c, SREBP1, SREBP1a" ENSG00000072310 "Sterol regulatory element binding transcription factor 1" P36956 17 17810399-17837002 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Group enriched" "Detected in many" 4 "granulocytes: 4.7;T-cells: 2.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 50.5;SK-BR-3: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005406, HPA043343, HPA043878" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710" "unprognostic (9.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-2)" "prognostic favorable (2.66e-4)" "unprognostic (4.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (3.14e-2)" "unprognostic (9.02e-3)" "prognostic favorable (9.05e-4)" "unprognostic (3.12e-1)" "unprognostic (9.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (7.65e-2)" "unprognostic (2.36e-3)" 34.0 78.2 16.4 9.3 17.9 14.8 15.5 5.8 22.3 15.7 13.8 31.9 30.4 28.9 8.6 23.4 20.5 15.7 17.6 10.2 13.5 10.3 9.0 49.9 11.9 14.4 20.3 16.7 20.5 7.7 9.6 12.5 16.0 11.8 18.0 6.4 15.1 72.7 33.0 16.8 14.5 27.4 7.1 13.1 7.3 13.6 16.8 16.2 15.2 9.5 13.6 13.8 11.9 15.0 0.6 0.4 4.7 0.8 0.4 2.2 0.5 14.0 33.0 4.1 25.4 8.4 15.4 7.1 5.2 16.5 4.5 11.0 6.7 27.3 8.8 4.9 4.1 4.2 40.0 4.7 13.8 1.1 5.4 2.0 4.8 27.4 7.0 10.5 0.6 9.2 12.0 5.9 6.3 3.9 3.5 5.1 20.1 9.3 31.6 1.0 34.5 11.6 8.1 5.5 10.8 6.6 8.3 3.0 50.5 3.6 7.3 4.9 20.2 6.1 49.0 14.5 3.0 16.6 9.3 5.8 2.4 12.2 5.8 3.2 9.3 0.8 4.0 14.2 6.9 12.6 0.0 0.8 0.4 1.8 0.5 0.4 0.6 0.8 0.3 0.4 0.4 1.6 2.2 4.7 0.4 0.6 0.3 0.2 0.5 16.4 17.9 5.8 22.3 13.5 10.3 20.3 16.7 11.8 16.2 6.0 17.5 8.2 12.6 8.2 22.4 7.3 17.8 5.3 11.4 19.2 27.5 4.6 1.7 13.5 1.8 8.9 29.9 0.0 20.4 13.9 14.1 19.0 14.9 58.7 10.6 55.6 28.7 12.9 10.4 3.0 27.6 8.3 8.5 13.6 18.3 29.8 13.8 13.5 10.3 5.4 29.3 12.9 10.4 11.3 5.8 15.9 16.6 7.5 21.1 21.3 SRGAP1 "ARHGAP13, KIAA1304" ENSG00000196935 "SLIT-ROBO Rho GTPase activating protein 1" Q7Z6B7 12 63844293-64162221 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 153.7;Muller glia cells: 159.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.4;hTERT-HME1: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052416, HPA078079" Uncertain Approved Cytosol NA NA Cytosol "HPA052416: AB_2681824, HPA078079: " "unprognostic (3.05e-3)" "unprognostic (2.28e-1)" "unprognostic (1.58e-2)" "unprognostic (2.22e-3)" "unprognostic (2.24e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.45e-3)" "unprognostic (1.43e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (3.54e-3)" "unprognostic (8.56e-2)" "unprognostic (1.41e-3)" "unprognostic (8.16e-2)" "unprognostic (2.08e-1)" "unprognostic (8.31e-2)" "unprognostic (1.56e-2)" 11.4 5.4 6.6 6.2 9.6 1.2 8.2 6.6 7.7 7.4 6.1 7.1 2.0 3.2 6.2 4.7 7.0 5.3 5.8 4.2 8.6 3.8 5.5 2.5 11.2 2.2 7.0 3.1 7.5 11.3 17.7 6.1 4.2 10.4 3.8 5.9 4.1 13.4 2.4 3.4 3.1 3.9 5.5 12.1 4.9 4.2 9.4 10.9 0.0 9.4 0.3 2.3 5.2 8.9 1.2 0.8 2.9 1.4 1.2 0.8 0.2 3.0 6.4 10.4 1.0 8.0 14.1 2.2 9.5 8.5 3.5 3.1 3.3 2.5 0.0 3.9 17.4 8.8 1.9 0.9 5.4 3.6 2.4 1.0 0.1 4.5 3.4 9.9 0.0 0.1 13.0 5.2 9.9 27.9 4.9 3.2 0.2 0.0 0.1 4.6 1.8 0.0 0.1 0.8 1.6 3.7 0.0 1.9 0.0 4.4 1.6 1.7 3.1 3.7 3.9 2.6 1.7 1.1 0.1 6.7 7.3 1.3 7.7 4.3 0.1 0.0 0.0 6.2 0.7 2.9 2.1 0.9 0.5 0.6 1.4 0.7 0.7 0.7 0.4 0.4 1.2 0.8 0.8 2.9 1.2 0.8 0.8 0.4 0.2 6.6 9.6 6.6 7.7 8.6 3.8 7.0 3.1 10.4 10.9 0.0 3.5 5.9 33.4 6.9 7.1 4.8 40.8 25.4 10.3 8.7 5.9 23.0 10.0 28.5 153.7 14.7 22.3 0.0 22.6 7.9 18.5 30.6 1.1 0.9 10.4 3.2 16.0 25.2 30.1 41.5 20.4 18.1 16.9 41.5 25.0 159.6 29.4 37.4 14.9 10.2 5.0 0.0 17.0 4.7 16.6 3.3 6.1 3.2 20.1 44.2 SRGAP2 "ARHGAP34, FNBP2, KIAA0456, SRGAP2A" ENSG00000266028 "SLIT-ROBO Rho GTPase activating protein 2" O75044 1 206203345-206464443 "Disease related genes, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.1" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 53.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA028191, HPA028196, HPA078079" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: " "unprognostic (2.57e-2)" "unprognostic (5.92e-2)" "unprognostic (2.40e-3)" "unprognostic (1.67e-2)" "unprognostic (5.20e-2)" "unprognostic (4.22e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (1.98e-1)" "unprognostic (2.02e-1)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (4.61e-7)" "unprognostic (2.70e-2)" "unprognostic (5.02e-2)" "unprognostic (1.45e-1)" "unprognostic (4.18e-3)" 3.5 2.4 2.2 3.3 0.7 4.3 1.3 0.0 0.0 1.4 2.0 1.2 1.7 1.5 0.5 0.7 0.5 2.4 1.9 3.1 0.5 7.4 3.4 0.1 0.1 0.0 0.9 0.0 8.5 0.0 2.3 4.2 0.6 1.0 0.0 1.8 1.1 4.8 12.7 14.1 9.9 1.4 3.0 2.2 19.1 12.9 43.9 11.1 20.9 18.9 17.2 16.6 12.4 14.5 15.9 8.8 14.7 7.5 9.6 18.3 19.4 15.6 13.0 10.9 14.6 9.3 10.6 15.4 23.1 13.2 8.7 10.6 17.3 17.1 9.5 18.6 13.0 15.8 25.1 9.8 12.6 24.4 9.2 13.3 8.4 9.4 14.1 3.4 14.9 19.1 18.0 17.7 6.2 3.5 14.6 6.7 14.1 10.6 20.6 17.2 13.1 18.9 24.9 14.3 17.3 17.5 15.2 16.2 14.5 7.1 17.2 14.8 34.7 0.6 9.3 0.5 2.6 9.4 1.0 2.2 2.1 2.6 6.3 4.8 0.8 1.8 14.1 1.4 9.9 12.7 3.0 2.2 8.9 15.5 13.7 5.2 21.2 41.0 3.3 12.7 4.0 7.9 10.4 3.9 2.9 0.0 5.7 53.8 24.8 0.3 0.0 1.8 17.0 12.3 3.6 8.1 1.5 15.6 1.6 1.2 35.6 37.7 28.5 7.2 27.3 15.1 17.2 1.5 8.2 3.3 0.2 2.5 0.5 5.3 0.0 11.5 7.9 9.4 31.9 3.5 7.5 1.2 4.9 SRGAP2B SRGAP2P2 ENSG00000196369 "SLIT-ROBO Rho GTPase activating protein 2B" P0DMP2 1 144887265-145095528 "Predicted intracellular proteins" Neurogenesis "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 9.6" "Cell type enhanced" "Detected in many" 7 "Ito cells: 54.6;Kupffer cells: 49.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA078079 Approved Cytosol NA NA Cytosol "HPA078079: " "unprognostic (1.13e-2)" "unprognostic (2.76e-1)" "unprognostic (1.48e-3)" "unprognostic (3.52e-3)" "unprognostic (1.66e-2)" "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (4.60e-2)" "unprognostic (3.13e-1)" "unprognostic (2.89e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (2.16e-5)" "unprognostic (3.12e-1)" "unprognostic (5.43e-1)" "unprognostic (8.54e-2)" "unprognostic (2.38e-1)" 2.5 3.4 1.5 1.6 0.6 2.7 1.3 0.0 0.0 1.4 0.6 1.2 1.7 1.2 0.6 2.2 0.5 2.4 0.9 2.7 0.3 4.4 3.3 0.4 0.0 0.0 0.8 1.9 6.6 0.0 1.8 3.7 0.0 0.2 0.5 0.3 1.2 1.4 4.6 5.0 9.6 0.5 1.6 1.1 6.8 14.7 32.0 6.6 15.4 13.4 10.1 7.6 6.7 6.5 7.5 4.4 12.6 3.4 10.2 4.5 11.6 11.9 8.2 4.4 8.0 3.2 8.3 5.0 10.7 6.2 10.8 4.4 6.6 9.5 6.7 16.0 14.2 9.8 13.0 3.0 2.7 12.2 3.5 7.6 1.9 5.2 5.9 3.4 5.4 5.2 6.9 5.9 5.6 3.0 4.0 5.1 10.1 3.6 16.8 8.3 7.6 11.3 23.5 14.0 14.5 12.4 8.8 5.1 6.3 2.1 5.1 6.0 19.9 1.4 5.1 0.7 0.9 6.9 0.7 1.2 1.4 1.6 3.5 1.4 1.0 1.1 5.0 0.5 9.6 4.6 1.4 1.1 23.8 7.7 8.3 3.5 0.0 11.9 3.2 0.0 14.7 4.5 8.7 2.0 4.7 0.0 5.8 1.0 24.3 0.3 23.3 2.6 14.4 12.3 3.6 1.1 4.7 10.9 0.0 2.4 54.6 49.1 1.7 14.1 15.9 0.0 23.4 0.8 6.3 4.3 0.0 9.2 0.8 2.4 6.5 9.4 2.6 6.4 0.0 2.4 10.1 1.2 3.5 SRGAP2C SRGAP2P1 ENSG00000171943 "SLIT-ROBO Rho GTPase activating protein 2C" P0DJJ0 1 121184810-121392822 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 16.5" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 50.6;Erythroid cells: 70.0;Ito cells: 64.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 39.8" HPA078079 Approved Cytosol NA NA Cytosol "HPA078079: " "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (7.65e-3)" "unprognostic (1.48e-6)" "unprognostic (2.40e-2)" "unprognostic (1.11e-1)" "unprognostic (7.18e-4)" "unprognostic (6.10e-2)" "unprognostic (7.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (2.89e-1)" "unprognostic (3.71e-7)" "unprognostic (4.90e-2)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" "unprognostic (7.66e-2)" 4.7 4.5 3.5 2.8 4.4 4.2 2.7 7.8 6.0 3.5 2.0 8.5 3.3 1.0 3.5 1.2 5.4 3.2 3.0 2.9 3.3 4.6 2.9 5.5 2.5 6.3 4.0 4.8 1.1 16.5 4.6 6.5 6.2 2.1 1.7 2.1 1.3 3.2 1.3 10.9 1.7 3.9 6.4 7.0 1.8 1.3 4.7 4.5 2.0 1.9 2.2 3.1 2.7 1.7 4.2 5.2 7.7 1.0 2.3 1.4 5.2 6.9 15.3 3.4 11.9 10.4 8.5 6.0 4.8 5.1 6.7 0.1 5.4 3.3 5.4 8.2 3.7 2.9 5.4 4.4 6.8 4.4 5.5 4.8 12.0 5.3 6.8 3.2 5.7 7.7 4.4 6.5 8.4 5.8 12.1 2.1 4.4 6.3 3.7 3.1 2.0 4.1 4.8 1.7 3.3 3.0 18.0 3.0 4.8 3.1 2.9 1.9 10.4 3.7 18.7 8.3 4.7 9.5 10.7 9.7 9.6 14.4 8.8 3.7 2.6 2.0 8.4 6.6 39.8 0.5 5.9 1.0 1.9 4.6 1.3 1.7 2.3 2.1 4.2 1.7 1.1 1.6 5.2 1.0 7.7 3.8 2.0 1.4 50.6 11.5 9.3 6.2 0.0 12.1 4.9 5.1 16.0 9.1 10.4 2.0 4.6 1.7 9.3 0.4 29.2 0.4 70.0 4.4 18.8 12.7 4.2 5.8 7.2 16.5 0.0 2.4 64.4 41.9 0.9 18.1 16.7 0.0 27.9 2.6 8.4 5.4 0.6 24.1 0.7 4.5 32.3 12.4 4.7 6.8 0.0 2.1 13.4 1.4 3.8 SRGAP3 "ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP" ENSG00000196220 "SLIT-ROBO Rho GTPase activating protein 3" O43295 3 8980591-9363053 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.9" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 228.5;Cone photoreceptor cells: 257.2;Horizontal cells: 216.1;Muller glia cells: 117.0;Rod photoreceptor cells: 104.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.7;HBEC3-KT: 8.4;hTCEpi: 8.3;RT4: 11.2;T-47d: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036959, HPA044074, HPA078079" Enhanced Approved Cytosol NA NA Cytosol "HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: " "unprognostic (3.63e-3)" "unprognostic (1.12e-3)" "unprognostic (7.61e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.70e-2)" "unprognostic (5.58e-2)" "unprognostic (1.18e-3)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "unprognostic (2.75e-2)" "unprognostic (6.39e-3)" 1.8 6.1 10.6 1.7 20.4 1.2 3.2 32.4 34.9 9.7 2.1 10.5 0.0 1.9 4.4 3.4 2.6 18.5 2.3 2.7 10.0 11.2 4.9 1.4 2.2 2.3 7.5 9.8 7.2 2.4 2.7 5.7 1.9 15.5 4.7 2.5 4.8 5.7 3.2 2.5 4.0 1.7 2.0 6.1 1.7 2.9 4.4 4.8 0.4 3.3 0.6 2.1 6.7 1.4 0.0 1.9 1.9 0.4 1.0 1.3 0.1 0.5 0.5 9.7 0.4 0.7 1.3 1.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.5 0.0 0.2 4.9 0.2 8.4 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 5.2 0.8 8.3 0.7 0.8 0.3 0.0 2.2 0.0 0.0 0.0 0.1 0.2 2.1 0.9 1.7 0.7 1.1 0.0 0.0 4.2 11.2 1.1 1.3 0.2 3.0 0.1 2.5 10.8 0.0 0.0 0.0 0.4 0.1 0.1 2.9 0.1 0.0 0.8 1.7 0.3 1.2 0.4 1.9 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.2 0.0 0.0 1.0 0.1 0.5 1.3 0.1 10.6 20.4 32.4 34.9 10.0 11.2 7.5 9.8 15.5 4.8 3.0 6.4 0.0 23.8 3.7 228.5 8.1 0.0 52.2 27.3 73.3 257.2 1.8 5.0 1.8 18.5 1.8 0.4 0.0 0.4 0.7 4.0 9.9 1.1 1.6 10.6 216.1 2.9 0.6 9.9 15.3 2.3 3.8 1.7 1.0 3.7 117.0 0.5 0.0 1.1 1.0 104.8 0.0 1.4 5.4 4.9 5.1 1.1 2.9 2.2 27.1 SRI ENSG00000075142 Sorcin P30626 7 88205118-88226993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 140.7" "Cell type enhanced" "Detected in all" 7 "Enterocytes: 1052.9;Paneth cells: 1613.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019004, HPA073666" Enhanced Supported Nucleoplasm,Cytosol No No 1400000 "Nucleoplasm, Cytosol" "HPA019004: AB_2670006, HPA073666: AB_2686623" "unprognostic (1.86e-2)" "unprognostic (2.31e-3)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-3)" "unprognostic (1.24e-3)" "prognostic favorable (3.08e-4)" "unprognostic (9.87e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.36e-1)" "unprognostic (2.10e-2)" "unprognostic (1.29e-2)" "unprognostic (9.87e-2)" "unprognostic (8.44e-2)" "unprognostic (3.14e-3)" 20.6 22.0 47.7 24.6 53.5 18.7 22.4 18.9 43.6 24.1 140.7 32.5 7.0 45.3 18.1 33.1 15.6 39.4 14.2 19.4 35.9 40.2 21.7 14.6 21.9 16.6 45.0 44.8 23.3 18.4 12.1 18.3 21.2 36.9 19.5 115.0 11.1 17.7 18.4 8.7 11.1 62.8 25.2 41.9 14.6 16.2 10.0 28.0 9.2 19.7 9.4 19.4 27.0 18.7 29.7 34.5 95.4 42.1 36.3 36.4 32.7 34.4 13.2 35.8 36.8 58.0 49.0 18.0 20.7 33.5 23.4 27.8 12.3 78.2 38.3 21.9 31.4 57.4 34.9 44.9 46.8 30.6 30.8 20.2 19.8 36.4 0.0 35.1 26.4 21.3 50.1 42.9 24.7 36.0 42.0 70.0 24.5 17.5 33.2 32.0 21.7 38.5 18.2 31.4 48.9 26.7 16.0 50.7 21.2 43.5 34.5 25.9 30.7 63.1 36.3 28.8 35.7 17.1 11.8 43.7 43.9 36.8 40.2 36.8 31.1 14.4 41.0 43.1 25.3 74.2 86.5 26.1 95.4 31.0 36.5 36.4 29.7 34.5 35.2 34.5 24.9 25.8 29.8 16.3 36.3 42.1 27.5 34.7 32.7 47.7 53.5 18.9 43.6 35.9 40.2 45.0 44.8 36.9 28.0 80.4 103.8 93.1 338.4 84.4 36.4 95.1 30.6 495.2 193.3 148.3 11.8 123.5 374.7 201.2 45.8 112.5 1052.9 210.2 371.4 826.3 181.0 282.1 132.7 33.9 132.6 44.5 90.6 92.1 77.3 23.0 159.3 104.1 99.5 215.6 393.6 112.7 336.5 1613.2 133.0 124.1 19.7 109.9 144.4 65.6 106.7 94.6 165.0 117.6 448.6 382.7 SRM "SPS1, SRML1" ENSG00000116649 "Spermidine synthase" P19623 1 11054584-11060024 "Enzymes, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 107.4" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 175.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015746 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA015746: AB_1857472" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (2.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (2.25e-5)" "unprognostic (2.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-2)" "unprognostic (3.01e-1)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.80e-8)" "unprognostic (1.74e-2)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (2.98e-2)" 26.7 17.7 20.3 29.0 35.4 15.2 16.9 10.2 30.8 14.3 13.3 14.0 11.5 10.8 18.8 9.8 17.7 15.8 14.2 24.9 19.6 16.9 13.9 45.3 14.0 31.0 15.3 15.0 22.8 107.4 8.0 14.5 14.8 15.6 13.1 11.7 15.0 36.0 17.6 43.6 18.2 9.8 22.9 11.7 21.1 14.5 14.4 14.1 17.9 11.9 21.2 20.8 20.2 19.8 10.7 10.2 0.3 6.0 5.0 10.3 2.0 24.9 36.4 12.1 40.4 24.2 26.2 19.0 38.8 19.9 55.5 29.8 44.8 15.1 48.3 22.9 33.6 17.4 19.6 38.6 31.2 18.5 23.7 58.4 30.4 40.3 50.4 35.6 51.0 27.9 26.2 22.6 53.7 47.2 13.0 23.4 31.6 49.4 40.9 27.0 54.8 43.5 44.5 26.4 23.0 70.5 32.7 12.5 78.8 19.7 9.9 23.3 22.3 20.1 43.3 30.3 9.8 15.1 25.9 19.4 36.3 28.6 62.8 43.5 33.0 33.3 72.3 25.2 68.6 41.7 0.0 5.4 0.3 7.0 6.0 10.3 10.7 7.1 9.1 6.4 9.3 8.4 9.7 0.2 5.0 3.1 10.2 7.5 2.0 20.3 35.4 10.2 30.8 19.6 16.9 15.3 15.0 15.6 14.1 0.0 2.9 57.4 63.7 84.3 27.7 26.4 30.6 2.7 1.2 27.9 19.6 62.5 64.6 20.3 3.4 46.6 5.1 23.3 36.6 175.3 66.1 60.8 27.5 47.6 85.0 28.6 26.4 35.6 21.8 10.5 66.4 35.3 64.1 8.2 27.0 28.1 26.0 7.0 49.8 69.0 12.3 0.0 49.9 12.8 74.2 98.9 30.1 23.5 26.6 92.1 SRMS "C20orf148, dJ697K14.1, PTK70, SRM" ENSG00000125508 "Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites" Q9H3Y6 20 63540810-63547504 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 10.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Lineage enriched" "Detected in single" 8 "B-cells: 1.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.5;MCF7: 4.7;OE19: 7.0;RT4: 9.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB044668, CAB044669, HPA073987" Uncertain Approved "Intermediate filaments,Actin filaments,Cytosol" No NA "Intermediate filaments" "Actin filaments, Cytosol" "CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650" "unprognostic (2.26e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.62e-1)" "unprognostic (5.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.28e-1)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (7.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.73e-3)" "unprognostic (2.58e-3)" "unprognostic (4.75e-2)" "unprognostic (4.97e-2)" "unprognostic (2.54e-3)" 0.3 0.0 0.3 0.5 0.3 0.0 1.1 1.1 0.3 0.3 1.8 0.3 0.3 0.4 0.3 10.2 0.4 0.0 0.3 0.3 0.3 0.0 0.9 0.3 0.3 0.3 0.3 0.3 0.3 2.7 0.0 0.3 0.3 0.3 2.2 0.0 0.3 2.5 0.3 0.3 1.7 0.8 0.3 0.3 2.5 4.2 0.9 0.3 0.3 0.3 0.3 0.8 1.5 0.3 1.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 5.5 0.2 2.2 0.0 0.0 2.5 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.2 0.0 7.0 0.8 0.0 0.2 0.0 0.0 9.7 0.8 0.9 0.3 2.0 0.4 0.0 2.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 1.1 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRP54 ENSG00000100883 "Signal recognition particle 54" P61011 14 34981957-35029567 "Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrolase, Ribonucleoprotein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 276.0;Late spermatids: 646.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048977, HPA062044" Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA048977: AB_2680583, HPA062044: AB_2684668" "unprognostic (1.22e-3)" "unprognostic (6.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.72e-2)" "unprognostic (3.88e-1)" "unprognostic (2.67e-3)" "unprognostic (2.06e-3)" "unprognostic (6.44e-2)" "unprognostic (2.53e-1)" "unprognostic (1.88e-2)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.50e-3)" 18.4 27.5 18.6 21.3 21.0 13.6 22.5 18.2 26.0 24.6 19.2 23.2 31.2 19.3 24.1 25.5 22.6 18.0 17.1 21.8 18.7 22.5 34.4 67.8 19.4 24.0 23.7 17.1 21.1 43.2 30.1 47.1 26.4 29.4 23.2 21.7 19.2 48.1 31.2 28.4 19.6 24.4 20.0 22.3 23.5 22.3 30.8 19.4 32.3 23.6 22.5 27.9 23.9 17.6 20.5 23.4 26.3 30.1 29.5 33.4 19.7 20.7 22.5 21.6 20.2 22.3 23.0 25.9 29.8 27.1 30.8 39.5 27.0 23.3 30.3 30.4 28.4 28.5 21.9 29.5 23.4 44.8 30.1 14.8 24.5 21.4 63.3 34.6 26.2 24.8 19.2 23.1 22.7 40.4 24.0 31.0 24.4 21.7 33.2 32.0 34.5 27.9 14.7 16.5 34.4 21.8 22.3 26.4 24.2 36.7 31.8 20.5 22.0 21.4 27.7 27.1 27.5 36.8 18.2 23.5 18.8 20.2 22.3 20.5 28.8 38.6 37.9 13.4 16.9 22.4 15.9 19.8 26.3 23.6 24.0 29.3 20.5 23.6 26.0 23.4 18.6 22.3 21.7 19.3 29.5 30.1 16.0 33.4 19.7 18.6 21.0 18.2 26.0 18.7 22.5 23.7 17.1 29.4 19.4 11.9 36.4 40.4 46.3 35.5 36.9 37.2 33.1 69.6 51.2 38.4 55.0 59.6 54.7 58.2 276.0 33.1 35.1 0.0 69.6 58.9 47.2 64.3 46.2 104.3 43.9 25.4 43.1 39.9 42.5 646.5 35.6 43.2 27.0 55.1 39.6 44.1 49.6 29.4 35.3 59.6 42.9 25.8 33.7 79.0 57.0 44.0 78.6 47.1 27.0 51.8 SRP68 ENSG00000167881 "Signal recognition particle 68" Q9UHB9 17 76038775-76072653 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023303, HPA055617" Approved Supported Cytosol NA NA Cytosol "HPA023303: AB_1857477, HPA055617: AB_2682863" "unprognostic (1.25e-1)" "unprognostic (8.97e-2)" "unprognostic (3.47e-2)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.18e-4)" "prognostic unfavorable (4.28e-5)" "unprognostic (3.31e-2)" "unprognostic (8.31e-2)" "unprognostic (1.62e-2)" "unprognostic (1.11e-1)" "unprognostic (4.10e-2)" "unprognostic (4.42e-2)" "unprognostic (8.73e-2)" "unprognostic (4.75e-2)" "prognostic favorable (2.65e-4)" "unprognostic (4.02e-3)" 23.2 23.8 39.8 20.3 41.1 17.5 22.9 35.4 44.1 25.4 28.1 16.6 26.3 18.4 25.7 34.4 37.6 26.0 16.4 25.5 32.4 24.9 24.9 28.9 21.8 22.1 23.8 32.2 32.3 43.1 33.4 29.1 32.0 34.5 24.4 25.0 16.6 27.6 25.8 71.7 35.4 19.7 30.8 30.3 22.6 25.2 18.4 32.4 20.6 32.0 20.4 34.5 25.6 27.3 17.5 20.4 20.2 16.4 26.3 24.5 10.5 38.5 34.1 21.1 22.0 30.1 24.3 38.2 28.2 20.7 33.8 26.5 28.7 21.5 30.5 14.5 28.6 28.7 26.2 39.7 29.9 50.5 12.7 44.1 28.3 27.6 42.2 35.6 33.3 22.1 21.4 33.5 29.6 26.0 25.4 39.2 19.3 40.4 28.8 28.3 23.6 32.1 20.7 19.5 38.4 36.1 27.2 56.5 31.2 28.2 34.0 26.0 25.5 25.8 41.9 31.0 37.0 37.3 30.4 25.0 36.9 28.2 17.0 37.5 28.5 12.9 34.4 26.7 24.8 27.4 3.7 16.4 20.2 15.2 15.0 16.5 17.5 21.5 23.3 20.4 14.6 24.5 18.2 2.6 26.3 14.8 15.8 18.8 10.5 39.8 41.1 35.4 44.1 32.4 24.9 23.8 32.2 34.5 32.4 26.8 19.3 22.9 42.7 27.8 22.2 22.7 17.8 24.1 18.2 12.2 35.3 74.5 31.5 33.0 12.5 26.3 16.9 70.0 35.9 53.4 23.6 31.9 16.2 20.2 33.1 35.0 13.8 18.4 16.2 13.7 22.5 16.9 23.6 38.7 16.9 28.4 35.1 14.0 26.5 20.3 21.5 0.0 28.8 30.5 24.8 27.7 135.7 22.4 20.8 41.4 SRPK1 SFRSK1 ENSG00000096063 "SRSF protein kinase 1" Q96SB4 6 35832966-35921342 "Enzymes, Predicted intracellular proteins" "Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 311.7;Late spermatids: 401.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016431, HPA056486" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA016431: AB_1857478, HPA056486: AB_2683148" "unprognostic (4.65e-3)" "unprognostic (6.82e-3)" "unprognostic (2.54e-3)" "unprognostic (1.01e-3)" "unprognostic (7.74e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (7.90e-6)" "unprognostic (1.23e-2)" "unprognostic (2.54e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (6.53e-5)" "unprognostic (7.28e-2)" "unprognostic (2.21e-3)" "unprognostic (9.24e-2)" "unprognostic (4.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.55e-3)" 13.5 7.1 8.1 15.4 11.7 32.1 11.7 22.5 17.8 12.8 23.8 7.8 10.8 20.3 15.2 7.9 24.9 8.9 10.8 8.7 8.9 7.8 17.8 18.9 14.9 14.6 8.0 8.3 9.5 26.0 11.7 17.7 27.9 9.6 10.5 28.7 12.4 17.6 9.4 19.9 26.2 25.7 11.3 7.9 19.0 13.9 32.7 7.6 21.0 8.5 17.0 19.8 15.2 15.7 4.3 2.8 24.6 3.4 5.0 6.7 2.9 29.9 11.4 16.8 25.0 9.4 12.3 21.2 18.4 17.8 17.2 18.3 32.0 10.1 40.0 15.6 11.3 20.0 15.4 32.8 21.9 31.0 27.3 23.6 21.0 13.4 27.7 8.3 31.1 10.4 7.9 12.0 19.8 26.0 13.7 21.6 22.9 44.5 17.0 14.4 10.6 32.0 24.2 13.7 18.3 12.5 22.5 20.1 24.7 17.3 50.4 35.8 13.1 18.9 18.0 12.7 17.8 10.1 20.7 15.6 16.2 12.7 11.0 23.1 10.0 22.1 37.6 6.4 36.1 14.4 24.5 2.1 13.7 4.3 2.5 6.1 4.3 5.7 5.7 2.8 3.3 4.8 5.2 24.6 5.0 3.4 1.6 6.7 2.9 8.1 11.7 22.5 17.8 8.9 7.8 8.0 8.3 9.6 7.6 8.9 26.3 24.4 65.1 37.5 33.6 21.8 12.7 32.1 38.7 21.0 35.3 43.2 24.9 50.7 311.7 24.1 38.6 23.3 58.8 43.3 21.3 68.6 7.0 40.0 19.1 9.5 44.4 11.1 17.1 401.7 20.4 16.9 15.1 36.1 44.8 13.4 78.7 42.1 23.3 44.4 84.4 6.5 23.1 154.9 90.6 36.5 33.2 34.8 87.4 132.9 SRPK2 SFRSK2 ENSG00000135250 "SRSF protein kinase 2" P78362 7 105110704-105399308 "Enzymes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 69.3" "Group enriched" "Detected in many" 6 "Early spermatids: 1076.1;Late spermatids: 1865.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 58.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 58.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015522, HPA020876" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015522: AB_1857479, HPA020876: AB_1857480" "unprognostic (9.75e-2)" "unprognostic (1.68e-2)" "unprognostic (1.12e-1)" "unprognostic (4.64e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (5.14e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" "unprognostic (2.31e-1)" "unprognostic (5.38e-2)" "unprognostic (7.95e-2)" "unprognostic (4.72e-2)" "unprognostic (2.87e-2)" "unprognostic (3.44e-1)" 9.9 12.1 24.8 10.1 27.6 7.1 13.3 28.4 47.1 12.7 9.4 21.0 7.8 8.2 13.2 11.9 11.9 10.9 11.6 10.4 26.4 28.6 10.3 10.1 9.2 11.5 27.2 30.2 13.0 10.5 11.9 15.3 12.0 27.3 14.0 10.9 7.9 10.1 11.1 7.9 16.9 8.2 13.3 23.1 12.0 11.3 69.3 32.3 22.1 11.3 4.7 14.0 13.6 9.7 12.2 7.3 58.2 8.1 10.0 11.9 6.0 13.3 8.9 14.2 28.1 15.2 17.2 7.9 13.1 15.3 13.1 15.3 6.9 11.4 8.5 16.7 16.9 14.7 8.0 14.3 13.8 16.8 14.7 12.7 12.0 8.4 6.0 17.6 11.4 18.0 11.9 25.7 11.1 20.9 12.7 22.5 20.3 11.8 34.8 14.5 25.2 42.2 8.7 11.7 7.6 9.7 13.7 15.6 18.4 18.9 20.7 20.8 14.4 14.8 22.3 13.8 19.6 8.3 8.0 14.7 24.2 17.6 23.0 12.2 38.2 37.6 20.9 9.5 11.8 18.0 11.2 8.1 26.0 11.9 5.5 7.1 12.2 9.0 8.9 7.3 11.6 8.5 9.7 58.2 10.0 6.2 6.4 10.1 6.0 24.8 27.6 28.4 38.7 26.4 28.6 27.2 30.2 27.3 32.3 26.8 28.5 33.3 51.2 189.1 70.3 20.1 33.1 48.2 27.3 22.7 47.1 40.1 23.2 44.1 1076.1 52.5 12.9 0.0 40.5 30.6 44.1 65.7 40.4 25.1 41.0 117.6 27.6 43.0 45.7 1865.0 71.1 31.8 55.6 40.5 32.1 65.3 32.7 21.0 90.2 21.7 65.2 45.3 45.3 237.2 50.3 90.3 53.9 56.8 23.6 46.7 SRRD "HC/HCC, SRR1L" ENSG00000100104 "SRR1 domain containing" Q9UH36 22 26483877-26494658 "Predicted intracellular proteins" "Biological rhythms, Heme biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA002945 Uncertain Approved Cytosol NA NA Cytosol "HPA002945: AB_1079265" "unprognostic (3.25e-1)" "unprognostic (3.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.47e-1)" "unprognostic (1.33e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (9.00e-2)" "unprognostic (8.51e-3)" "unprognostic (2.49e-2)" "unprognostic (4.50e-3)" "unprognostic (3.93e-2)" "unprognostic (2.63e-1)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (1.76e-3)" "unprognostic (2.96e-1)" 8.7 7.2 12.5 7.1 14.3 9.6 11.3 20.0 17.2 10.6 10.9 10.4 10.5 6.6 12.7 11.5 9.9 10.3 6.9 16.2 10.5 10.1 11.5 15.7 9.5 11.4 10.5 11.8 13.3 14.9 11.8 10.6 9.4 9.4 12.7 9.6 9.6 13.1 13.7 30.0 10.8 7.8 12.5 9.6 9.7 9.0 13.8 7.5 10.4 18.8 11.4 12.4 10.0 9.1 3.2 1.6 1.4 1.4 2.6 3.8 1.0 7.4 4.5 7.7 7.9 8.0 4.8 4.4 5.3 7.4 10.7 9.9 4.4 3.3 16.5 3.7 6.9 5.4 6.8 11.9 11.0 10.5 8.5 11.8 7.3 3.8 7.0 5.7 16.0 5.7 4.6 9.7 7.6 12.0 7.1 9.2 9.9 11.9 10.5 7.0 6.4 7.1 5.0 4.7 8.2 5.7 16.3 9.6 11.9 7.0 5.4 8.2 5.6 6.1 5.5 13.6 6.7 6.6 6.3 7.1 8.3 27.7 4.7 9.2 6.9 5.6 13.9 5.7 6.6 10.8 0.6 1.4 0.8 2.3 1.4 3.4 3.2 2.8 3.3 1.6 2.4 3.8 3.8 1.4 2.6 1.2 1.2 0.7 1.0 12.5 14.3 20.0 17.2 10.5 10.1 10.5 11.8 9.4 7.5 0.0 5.4 8.2 13.0 26.4 12.7 2.4 15.3 1.4 4.5 1.8 2.0 12.1 8.3 23.7 17.5 7.9 2.9 0.0 42.8 18.5 7.5 9.4 11.5 12.7 12.1 12.7 4.6 9.8 2.4 35.9 6.6 7.3 8.5 5.4 4.3 7.1 37.1 0.0 8.5 15.5 7.8 6.5 6.6 14.4 11.0 27.9 14.0 6.7 5.6 14.8 SRSF2 "PR264, SC-35, SC35, SFRS2, SFRS2A" ENSG00000161547 "Serine and arginine rich splicing factor 2" Q01130 17 76734115-76737374 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049905 Supported Approved Nucleoplasm,Cytosol NA NA 140000 Nucleoplasm Cytosol "HPA049905: AB_2680945" "unprognostic (2.50e-1)" "unprognostic (2.16e-3)" "unprognostic (2.73e-3)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.75e-2)" "unprognostic (4.19e-2)" "prognostic unfavorable (3.53e-8)" "unprognostic (1.19e-1)" "unprognostic (7.79e-3)" "unprognostic (7.03e-3)" "unprognostic (1.92e-1)" "unprognostic (1.07e-3)" "prognostic unfavorable (1.05e-7)" "unprognostic (3.85e-2)" "unprognostic (8.05e-2)" "unprognostic (1.95e-1)" "prognostic favorable (9.87e-4)" 35.4 40.2 20.6 56.6 30.3 73.1 35.3 33.3 36.2 42.1 37.7 34.0 19.5 41.8 37.0 33.6 51.1 35.1 34.8 32.4 19.9 22.6 36.9 66.7 37.3 64.3 21.6 24.0 47.1 34.2 29.1 33.8 51.2 29.5 31.3 36.5 35.5 35.6 40.5 44.9 41.1 46.6 25.5 23.9 52.5 35.6 29.2 18.9 105.3 41.1 41.3 64.5 30.6 35.7 11.1 30.2 4.2 23.5 15.6 12.7 12.2 48.2 38.9 46.2 32.2 11.3 9.6 48.0 31.2 23.1 36.2 33.6 40.8 33.8 74.4 22.8 29.3 26.1 43.7 45.8 36.0 36.5 31.1 79.8 55.8 37.7 47.4 12.9 61.6 33.4 10.6 8.2 30.0 8.7 14.7 28.2 33.3 56.7 32.9 28.3 38.6 67.6 67.3 54.1 28.1 55.5 68.5 49.7 54.9 24.2 34.8 39.4 56.3 35.6 30.6 16.8 25.4 37.5 45.0 29.5 33.5 43.1 22.2 50.4 43.3 32.5 86.0 30.1 49.0 27.6 1.0 17.5 4.2 12.3 23.5 12.6 11.1 8.5 12.7 30.2 9.8 9.8 9.0 2.1 15.6 14.7 22.4 10.6 12.2 20.6 30.3 33.3 36.2 19.9 22.6 21.6 24.0 29.5 18.9 110.2 104.2 263.7 359.4 409.3 143.7 75.1 117.2 84.3 119.4 83.7 86.4 268.2 132.6 175.8 190.8 186.2 246.5 140.2 136.4 478.7 232.5 241.3 217.7 110.3 220.7 93.8 255.6 111.1 135.5 118.5 147.3 197.1 268.2 218.2 170.4 153.0 146.8 241.8 119.9 87.2 188.9 116.4 279.5 292.6 343.6 387.6 264.3 196.1 264.9 438.8 SRSF5 "HRS, SFRS5, SRP40" ENSG00000100650 "Serine and arginine rich splicing factor 5" Q13243 14 69726900-69772005 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043484, HPA056523" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA043484: AB_10797143, HPA056523: AB_2683164" "unprognostic (2.08e-3)" "prognostic favorable (7.91e-4)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.30e-3)" "unprognostic (1.07e-3)" "unprognostic (2.37e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" 66.6 60.1 67.1 60.9 74.4 131.5 70.3 111.7 88.8 54.3 63.3 67.8 77.1 42.6 71.3 74.6 66.3 79.3 50.1 48.5 66.2 43.0 40.5 60.8 69.4 63.3 86.4 62.1 76.6 41.0 56.4 124.8 59.2 74.0 59.0 54.7 69.2 68.5 75.6 76.0 78.1 74.1 59.7 68.6 66.5 62.0 35.3 75.6 47.8 70.8 52.3 69.1 69.6 55.8 41.2 37.4 60.8 45.1 30.8 38.2 24.4 70.0 20.5 50.2 22.6 31.0 26.9 27.9 33.8 36.4 27.6 29.3 25.7 45.0 72.6 17.9 45.8 28.4 33.5 38.0 48.3 32.6 62.0 20.9 54.7 54.9 28.1 36.1 51.0 41.5 55.7 30.8 31.8 34.1 41.5 38.2 63.2 38.0 43.3 17.1 56.9 58.6 34.6 29.4 55.3 18.9 50.3 23.9 27.9 35.1 86.3 26.2 37.4 57.3 34.8 43.6 31.4 37.9 43.0 47.2 16.2 43.4 17.6 31.6 42.1 27.5 117.5 38.1 43.5 22.2 39.0 24.1 37.2 37.3 43.4 38.2 41.2 33.2 33.4 26.2 40.6 33.2 31.5 60.8 30.8 45.1 37.4 27.4 24.4 67.1 74.4 111.7 88.8 66.2 43.0 86.4 62.1 74.0 75.6 235.2 245.0 272.6 618.6 122.6 370.2 163.3 193.6 401.5 253.6 174.5 225.8 335.9 271.9 173.3 146.9 251.5 417.9 163.5 148.9 193.0 195.8 288.7 459.5 204.3 193.9 357.6 290.6 219.1 193.0 84.2 319.9 251.8 126.5 254.3 249.3 292.6 182.8 399.8 251.0 172.0 307.5 271.7 240.9 175.1 136.3 127.2 626.6 371.3 207.8 495.2 SRSF8 "SFRS2B, SRP46" ENSG00000263465 "Serine and arginine rich splicing factor 8" Q9BRL6 11 95067197-95071224 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049905 Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049905: AB_2680945" "unprognostic (2.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.23e-2)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.68e-1)" "unprognostic (2.62e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-1)" "unprognostic (3.00e-1)" "unprognostic (1.55e-2)" "unprognostic (1.05e-1)" "prognostic favorable (9.99e-7)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (5.39e-2)" "unprognostic (2.75e-3)" 5.5 6.4 6.1 4.9 9.6 5.3 9.6 6.0 14.3 8.7 6.9 8.0 9.2 7.1 8.0 8.0 6.8 7.4 6.8 6.4 6.5 9.5 6.8 6.1 8.7 6.1 9.5 10.7 10.4 9.7 8.2 6.5 7.2 9.4 7.5 10.1 11.4 8.6 5.4 6.6 7.8 7.1 4.8 9.0 7.1 3.0 5.0 3.7 11.6 5.3 6.5 6.1 5.5 7.9 3.8 7.0 2.0 5.6 12.4 3.7 4.4 4.7 11.8 0.0 15.8 10.0 13.3 6.7 7.5 3.2 3.4 11.0 14.7 23.8 20.0 10.2 5.8 9.8 9.9 14.7 3.7 14.4 10.7 20.2 5.5 9.8 11.6 20.1 11.0 12.9 15.7 3.4 15.9 9.4 9.9 11.1 15.1 13.3 6.2 6.1 10.4 18.1 6.2 11.8 13.1 13.1 3.6 19.0 12.5 15.0 15.0 15.4 8.3 14.9 9.7 7.8 5.9 11.2 9.1 6.2 8.3 8.3 6.8 7.1 10.9 12.8 3.2 13.6 13.5 7.0 2.0 0.6 5.7 1.1 8.2 7.9 9.6 8.2 3.8 6.9 12.4 9.5 0.6 5.6 1.0 3.5 9.9 3.7 41.7 24.8 82.8 42.9 0.0 45.6 20.1 61.1 17.4 21.6 31.4 31.4 33.1 127.6 32.0 1.3 32.2 43.1 23.3 40.0 43.0 21.6 37.7 10.3 52.9 23.7 17.5 54.6 35.6 22.7 4.2 38.0 25.1 0.0 34.3 75.6 40.4 26.3 42.1 57.3 77.7 48.0 32.3 29.9 3.7 5.9 0.0 42.8 65.1 58.5 30.7 SS18 "SSXT, SYT" ENSG00000141380 "SS18, nBAF chromatin remodeling complex subunit" Q15532 18 26016253-26091217 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055741, HPA059539" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055741: AB_2682901, HPA059539: AB_2684055" "unprognostic (2.03e-2)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (1.95e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "unprognostic (4.59e-2)" "unprognostic (1.53e-2)" "unprognostic (1.63e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (2.47e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (1.40e-2)" "unprognostic (1.30e-1)" 26.1 40.5 18.7 30.4 26.4 15.5 26.6 17.6 20.2 24.8 21.4 31.8 32.1 14.0 31.7 32.7 29.8 27.2 23.4 22.4 21.6 16.1 30.0 30.9 21.9 25.8 32.6 16.3 39.4 20.6 39.4 41.8 43.2 25.3 28.6 18.7 26.1 26.0 33.5 10.3 31.3 22.6 31.0 23.7 24.7 22.5 28.3 32.6 27.8 35.6 24.7 35.2 25.5 25.9 15.9 13.1 19.9 17.1 20.7 17.6 13.1 19.2 14.0 34.4 16.8 27.4 24.8 17.4 23.7 21.6 21.0 20.1 9.2 16.0 33.7 19.0 27.7 19.0 25.3 18.6 23.0 26.0 21.5 8.9 16.7 20.5 14.8 21.7 25.5 25.9 31.8 27.2 26.3 28.9 21.0 15.7 9.8 12.2 17.3 28.9 19.4 10.4 14.8 6.5 18.1 13.5 12.1 26.7 16.2 22.2 22.8 14.7 22.2 36.2 16.8 10.2 25.8 17.1 15.1 18.0 44.2 8.8 10.2 23.2 31.3 20.8 24.3 20.7 17.8 23.4 19.9 11.7 16.5 15.1 17.1 17.6 15.9 14.6 15.7 13.1 13.0 15.5 17.4 5.6 20.7 16.7 7.4 15.7 13.1 18.7 26.4 17.6 20.2 21.6 16.1 32.6 16.3 25.3 32.6 26.8 21.3 28.3 27.1 7.9 28.5 14.1 17.8 36.1 23.9 22.7 15.7 57.3 18.3 26.4 40.7 25.3 17.2 0.0 22.5 41.2 19.5 22.9 36.8 30.1 23.9 82.6 23.7 24.5 20.0 31.2 30.8 17.1 5.0 12.6 21.1 51.6 26.7 14.0 38.5 23.8 29.7 38.8 27.1 23.4 19.0 11.5 71.2 25.4 14.5 21.7 SS18L1 "CREST, KIAA0693" ENSG00000184402 "SS18L1, nBAF chromatin remodeling complex subunit" O75177 20 62143795-62182484 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011827, HPA059046" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB011827: AB_778216, HPA059046: AB_2683888" "unprognostic (4.12e-2)" "unprognostic (5.82e-2)" "unprognostic (1.54e-1)" "unprognostic (3.03e-2)" "unprognostic (6.57e-2)" "prognostic favorable (8.00e-5)" "unprognostic (1.39e-1)" "prognostic favorable (3.74e-4)" "unprognostic (1.01e-1)" "unprognostic (1.87e-1)" "unprognostic (2.47e-3)" "unprognostic (6.43e-2)" "unprognostic (2.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (9.94e-3)" 6.6 8.9 11.9 7.7 12.7 7.7 8.6 35.9 15.8 7.0 7.0 9.9 12.2 9.5 9.7 10.9 9.3 6.9 7.2 6.4 11.5 10.9 11.5 33.3 8.2 7.4 11.2 14.5 10.0 10.4 8.4 10.7 8.8 13.1 8.7 7.8 7.4 8.6 11.8 19.2 23.7 9.0 7.7 9.9 9.2 8.8 10.7 10.9 6.0 8.3 6.7 7.1 6.8 8.6 3.6 1.3 2.5 2.7 1.6 2.8 0.5 6.5 7.8 10.9 9.9 4.9 5.7 7.9 6.2 2.4 10.4 5.2 26.8 6.1 4.0 8.3 3.5 5.4 17.0 6.7 5.9 9.5 2.7 4.4 17.8 16.4 13.8 3.6 6.5 15.9 3.4 13.0 5.3 4.4 6.1 4.7 6.9 11.9 7.7 5.8 7.8 9.8 10.1 4.4 6.6 9.0 10.9 14.1 4.5 7.8 8.3 20.7 11.5 11.1 13.6 9.3 7.2 12.7 10.4 5.5 19.9 12.0 7.3 8.6 8.6 7.7 3.6 9.9 6.4 6.5 0.3 1.6 0.6 1.7 1.1 1.1 0.7 0.9 1.4 1.3 3.6 2.8 0.9 2.5 1.6 2.7 0.8 0.8 0.5 11.9 12.7 35.9 15.8 11.5 10.9 11.2 14.5 13.1 10.9 8.9 6.5 6.0 4.4 14.5 14.4 7.7 2.5 4.0 11.4 7.0 21.6 4.5 3.3 4.1 8.6 7.4 6.8 0.0 2.3 2.7 10.4 7.3 1.1 33.3 4.2 14.3 13.7 8.0 11.9 16.0 6.9 7.4 11.8 3.6 6.6 4.9 6.3 7.0 3.2 7.3 17.7 6.5 8.9 3.9 10.6 15.3 6.4 5.0 5.3 4.7 SSC5D "FLJ35258, S5D-SRCRB" ENSG00000179954 "Scavenger receptor cysteine rich family member with 5 domains" A1L4H1 19 55488404-55519098 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 16.7;Peritubular cells: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 18.9;BJ: 17.8;fHDF/TERT166: 18.0;hTERT-RPE1: 17.6;U-87 MG: 19.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA042008, HPA053316" Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" Yes NA 44000000 "Nucleoplasm, Cytosol" "HPA042008: AB_10804124, HPA053316: " "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.28e-2)" "unprognostic (4.55e-2)" "unprognostic (6.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.34e-3)" "unprognostic (1.40e-1)" "unprognostic (6.20e-3)" "prognostic unfavorable (4.26e-8)" "unprognostic (7.73e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-2)" "unprognostic (2.21e-3)" 10.7 2.1 3.3 4.9 1.8 0.1 8.1 3.5 1.9 33.0 18.4 1.6 6.3 2.1 33.1 15.2 9.8 11.0 30.9 10.6 1.4 0.6 2.5 1.8 5.8 1.2 1.2 1.6 17.0 1.8 0.3 13.4 2.5 3.0 6.8 3.2 4.7 1.9 15.7 4.7 3.8 5.8 23.8 3.2 7.3 6.9 5.7 1.4 0.5 2.4 4.2 1.6 19.3 10.9 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.3 0.0 2.2 18.9 0.0 17.8 4.0 2.5 3.0 0.2 0.0 0.7 0.2 18.0 0.8 0.0 0.0 0.0 1.3 0.0 0.1 3.1 0.8 0.0 3.7 0.1 5.6 8.9 0.0 3.3 0.0 17.6 0.0 0.4 0.1 0.2 0.3 0.0 0.0 0.4 0.6 0.0 0.1 0.4 0.9 0.1 2.0 0.0 1.9 0.2 0.2 0.0 0.3 0.3 0.2 0.7 7.2 0.8 1.0 0.7 2.8 0.2 0.0 0.1 19.3 0.2 3.9 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 1.8 3.5 1.9 1.4 0.6 1.2 1.6 3.0 1.4 3.0 1.1 0.0 0.2 1.6 5.4 1.8 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.1 0.4 1.5 1.6 0.0 0.0 0.1 6.0 0.3 0.0 0.0 1.2 3.2 0.0 3.7 0.0 0.4 16.7 1.1 1.7 1.0 0.6 3.2 0.1 0.0 14.9 0.0 1.9 0.0 5.7 0.7 1.1 1.6 0.0 0.0 1.7 0.1 SSFA2 "CS-1, KIAA1927, KRAP, SPAG13" ENSG00000138434 "Sperm specific antigen 2" P28290 2 181891833-181930738 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 85.5" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 167.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034665, HPA039989" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034665: AB_2674271, HPA039989: AB_2676788" "unprognostic (1.68e-1)" "unprognostic (3.27e-2)" "unprognostic (2.17e-2)" "unprognostic (4.70e-2)" "unprognostic (8.77e-2)" "unprognostic (8.87e-2)" "unprognostic (2.13e-1)" "unprognostic (4.74e-2)" "unprognostic (5.63e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.95e-2)" "prognostic favorable (2.91e-5)" "unprognostic (3.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (5.79e-5)" 14.2 10.1 23.3 11.8 27.0 16.1 21.6 25.8 22.5 17.7 24.4 26.2 9.4 17.5 13.0 8.9 12.0 10.7 18.7 13.6 23.7 19.1 22.8 36.0 23.0 11.2 31.3 17.7 7.2 85.5 10.5 10.2 40.9 24.8 18.1 24.1 22.3 29.2 10.0 16.6 50.6 19.5 14.2 27.8 14.7 26.0 16.7 23.8 9.3 19.6 12.2 7.9 14.3 23.5 1.2 3.8 8.1 6.4 1.0 1.4 1.8 16.4 8.2 24.0 4.0 21.0 17.4 6.8 29.2 28.4 10.3 13.7 8.5 19.1 0.4 9.5 20.5 12.7 14.3 5.8 14.0 19.9 7.5 6.6 16.6 35.3 6.8 15.5 8.5 15.6 10.3 20.7 17.7 24.1 24.4 53.7 8.0 7.4 9.2 28.6 8.3 7.5 11.9 1.6 15.3 19.4 5.6 9.7 5.7 29.0 5.0 4.2 3.7 17.1 6.1 26.1 9.5 4.4 18.6 21.3 24.4 11.8 8.7 15.1 6.3 2.7 6.6 11.4 5.1 18.2 8.1 3.9 5.7 1.4 3.9 0.9 0.6 1.0 0.9 3.8 1.2 1.3 1.1 6.6 1.0 6.4 3.1 0.6 1.8 23.3 27.0 25.8 22.5 23.7 19.1 31.3 17.7 24.8 23.8 134.0 40.6 11.2 36.2 97.1 18.5 23.0 35.7 33.5 35.2 31.4 35.3 19.9 14.9 15.8 9.0 52.6 132.6 0.0 62.2 21.0 25.9 46.7 22.0 89.3 18.4 25.4 105.7 36.8 47.5 13.4 17.5 29.8 55.6 15.4 57.0 17.2 54.1 41.9 16.3 36.3 33.6 38.8 24.5 22.3 25.4 167.2 27.9 12.9 39.3 84.6 SSH1 KIAA1298 ENSG00000084112 "Slingshot protein phosphatase 1" Q8WYL5 12 108778192-108857590 "Enzymes, Predicted intracellular proteins" "Actin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019845 Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA019845: AB_1857497" "unprognostic (1.18e-3)" "unprognostic (3.00e-1)" "unprognostic (2.49e-1)" "unprognostic (2.70e-2)" "unprognostic (9.40e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.80e-5)" "unprognostic (3.28e-2)" "unprognostic (3.69e-2)" "unprognostic (1.72e-3)" "unprognostic (7.12e-2)" "unprognostic (3.42e-1)" "unprognostic (1.71e-2)" "unprognostic (1.41e-1)" "unprognostic (8.66e-2)" "unprognostic (9.55e-2)" "unprognostic (6.22e-2)" 7.3 7.8 8.5 7.4 8.1 10.6 9.3 20.3 8.8 7.4 8.5 6.8 13.1 4.4 9.8 7.9 7.6 8.2 8.3 10.1 8.0 6.9 5.8 7.4 10.1 8.7 7.7 5.2 7.9 8.0 9.7 6.8 7.8 8.4 6.5 6.5 15.0 5.9 8.0 21.4 7.1 6.5 10.4 8.1 8.6 7.1 5.2 6.6 2.0 7.0 7.9 6.6 10.0 13.3 1.8 2.0 5.7 4.0 2.1 2.9 1.2 5.1 6.8 4.5 3.5 8.5 7.3 4.0 6.6 14.2 6.1 5.4 3.4 2.5 2.4 4.7 15.5 10.4 5.1 2.7 11.2 5.0 5.0 2.6 5.7 3.1 2.1 4.6 2.9 15.2 10.0 3.8 5.5 12.3 15.1 5.6 3.0 1.3 2.0 15.9 2.9 3.3 4.2 3.1 2.0 5.5 2.4 5.3 3.2 2.4 9.2 3.3 4.5 5.8 1.6 12.8 6.5 2.1 2.6 4.4 10.9 4.7 6.5 3.8 3.9 3.5 3.0 5.7 2.4 34.4 4.2 2.4 4.8 2.9 4.0 2.7 1.6 1.5 2.5 1.6 1.8 1.4 1.6 5.7 2.1 3.2 2.0 1.7 1.2 8.5 8.1 20.3 8.8 8.0 6.9 7.7 5.2 8.4 6.6 8.9 17.3 4.7 15.4 8.4 10.6 21.2 12.7 8.1 14.8 14.0 15.7 4.7 5.0 7.7 1.6 37.5 3.5 0.0 7.0 3.7 10.3 7.2 19.7 13.4 11.2 11.1 5.2 25.8 24.7 2.6 6.1 17.8 11.8 43.3 6.6 8.8 10.1 0.0 12.0 4.9 20.7 6.5 17.6 1.1 6.6 7.9 1.9 15.4 5.7 12.2 SSH3 "FLJ10928, FLJ20515" ENSG00000172830 "Slingshot protein phosphatase 3" Q8TE77 11 67303448-67312607 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.8;eosinophil: 10.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.8" "Cell line enhanced" "Detected in many" "HaCaT: 23.8;RT4: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA019949, HPA019957" Approved Approved "Nuclear speckles,Plasma membrane,Actin filaments,Cytosol" NA NA "Nuclear speckles, Cytosol" "Plasma membrane, Actin filaments" "HPA019949: AB_1857498, HPA019957: AB_1857499" "unprognostic (4.38e-2)" "unprognostic (1.37e-1)" "unprognostic (3.50e-3)" "unprognostic (3.73e-2)" "unprognostic (2.61e-3)" "unprognostic (9.30e-2)" "unprognostic (2.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (2.89e-4)" "unprognostic (1.50e-1)" "unprognostic (2.06e-2)" "unprognostic (1.47e-1)" "unprognostic (3.20e-1)" "unprognostic (4.94e-3)" "unprognostic (6.78e-3)" 8.6 5.5 5.6 6.8 9.7 8.1 13.5 17.8 9.4 14.6 15.9 15.4 19.5 12.4 10.1 10.6 27.0 15.2 20.5 7.7 6.0 6.1 10.3 7.5 9.0 3.5 13.6 5.4 17.1 12.0 11.3 7.4 20.0 8.5 19.8 9.2 11.9 19.1 30.5 5.2 18.2 13.6 13.1 9.3 6.9 13.9 4.2 9.7 0.8 12.8 14.0 13.2 33.3 18.6 0.3 1.6 10.8 2.3 1.5 2.2 1.0 6.2 6.7 0.1 0.2 4.8 4.9 7.4 4.1 5.4 2.1 2.0 7.3 16.5 0.3 12.6 3.7 4.5 23.8 2.2 17.2 1.2 1.3 2.5 1.6 10.9 2.9 3.3 0.3 6.1 4.3 15.9 3.1 3.3 5.0 2.4 0.1 0.0 0.6 2.5 21.0 0.2 3.0 1.5 17.0 5.4 7.7 0.2 1.1 7.0 36.0 1.4 2.2 9.5 14.1 4.4 2.6 19.8 5.2 3.9 1.7 3.7 4.8 1.1 0.7 0.3 0.2 4.9 2.7 1.6 10.8 1.4 10.5 2.2 2.3 1.7 0.3 2.1 1.8 1.6 0.2 0.8 0.9 4.5 1.5 1.1 1.1 1.8 1.0 5.6 9.7 17.8 9.4 6.0 6.1 13.6 5.4 8.5 9.7 3.0 5.4 0.0 20.7 6.3 1.1 3.4 15.3 8.1 10.3 15.7 0.0 12.6 3.3 16.4 0.0 3.9 17.2 0.0 19.0 20.2 6.2 13.1 3.5 4.3 6.8 1.6 3.5 4.3 8.6 0.0 12.0 2.9 8.5 12.6 14.7 4.6 16.4 17.5 11.3 6.3 0.4 0.0 8.3 0.3 0.0 9.2 13.2 4.3 18.5 22.9 SSRP1 FACT80 ENSG00000149136 "Structure specific recognition protein 1" Q08945 11 57325985-57335877 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002697 Approved Approved Nucleoplasm,Cytosol NA NA 8300 Cytosol Nucleoplasm "HPA002697: AB_1857509" "unprognostic (1.67e-1)" "unprognostic (3.21e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-1)" "unprognostic (2.84e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (4.03e-7)" "unprognostic (3.22e-2)" "unprognostic (1.96e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.06e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (5.92e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" 25.3 23.2 23.5 37.7 25.1 32.0 38.4 28.5 27.6 27.2 30.5 19.4 28.8 23.0 34.9 28.2 34.6 34.4 33.1 28.4 22.7 20.3 22.6 27.8 26.5 33.7 21.6 20.7 41.8 39.3 39.7 31.2 34.8 22.0 26.6 33.0 17.2 32.8 27.5 47.7 32.9 26.2 28.9 17.1 28.3 29.3 28.3 25.2 44.0 45.9 37.0 42.5 28.7 51.7 10.2 10.3 4.5 5.2 6.9 12.0 4.7 57.5 55.7 52.8 38.6 16.7 18.6 25.9 31.7 30.7 55.5 39.8 38.2 43.1 70.0 33.9 27.8 35.3 44.6 83.7 49.4 70.1 48.8 47.0 44.7 41.0 41.0 26.3 74.0 33.6 18.7 30.2 57.0 79.4 25.8 36.2 54.2 60.7 35.5 37.7 39.0 74.9 65.5 69.4 30.7 34.3 63.3 89.3 68.0 25.9 41.6 55.3 46.9 44.9 38.6 46.8 28.3 46.8 29.2 27.2 37.9 50.1 51.0 54.2 41.4 41.0 72.4 32.1 41.8 49.9 0.8 4.3 4.5 9.4 5.2 9.1 8.7 8.1 10.2 6.1 10.2 8.9 12.0 1.2 6.9 5.0 10.3 9.6 4.7 23.5 25.1 28.5 27.6 22.7 20.3 21.6 20.7 22.0 25.2 71.5 73.4 41.0 69.0 66.5 23.9 23.5 33.1 148.5 102.4 27.9 23.6 89.5 11.6 62.9 64.9 43.6 26.8 0.0 86.1 90.2 43.5 42.4 38.3 31.8 50.8 23.8 27.6 32.5 32.2 93.2 39.4 40.0 27.0 44.1 40.8 23.8 58.2 35.1 41.8 20.2 16.4 19.4 46.2 55.9 93.5 66.7 56.5 36.3 68.4 62.2 SSSCA1 p27 ENSG00000173465 "Sjogren syndrome/scleroderma autoantigen 1" O60232 11 65570430-65573942 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039789, HPA064670" Uncertain Approved Cytosol NA NA Cytosol "HPA039789: AB_2676680, HPA064670: AB_2732718" "unprognostic (9.32e-2)" "unprognostic (3.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.04e-2)" "unprognostic (1.08e-1)" "unprognostic (3.35e-3)" "unprognostic (3.03e-2)" "unprognostic (2.65e-1)" "unprognostic (4.92e-2)" "unprognostic (1.36e-2)" "unprognostic (1.20e-1)" "unprognostic (3.11e-1)" "unprognostic (5.75e-2)" "unprognostic (2.23e-1)" "unprognostic (1.95e-1)" "unprognostic (5.86e-2)" "unprognostic (9.34e-2)" 17.6 21.6 20.0 24.6 23.3 34.0 17.9 19.9 39.1 16.6 22.2 15.2 14.6 18.7 23.1 15.4 23.2 19.9 20.9 28.4 19.5 13.8 20.5 40.4 18.1 24.2 15.1 21.7 22.9 50.3 15.7 15.7 21.4 18.7 20.1 7.6 16.8 36.6 20.8 70.5 19.5 17.0 16.9 10.6 20.9 18.7 44.1 12.0 27.6 17.7 25.0 19.6 21.6 16.6 39.6 35.7 10.6 26.9 32.8 29.3 21.2 26.3 20.9 12.6 22.7 7.3 6.3 21.3 18.2 10.5 17.1 12.0 20.6 26.6 25.6 32.8 9.0 12.4 22.1 8.9 20.0 5.2 17.8 15.4 22.2 19.4 15.6 11.6 27.0 18.1 10.5 13.2 12.8 12.1 12.6 13.6 23.8 24.9 31.6 9.0 38.0 31.2 23.7 21.3 9.2 39.6 24.8 9.5 45.8 9.8 13.4 25.3 26.5 11.0 27.3 26.6 5.1 36.8 13.5 15.3 30.1 17.6 35.8 22.7 23.6 31.4 21.6 24.3 18.8 27.5 5.7 26.9 10.6 24.6 21.9 25.9 39.6 25.5 25.0 21.6 33.9 29.3 26.1 8.5 32.8 14.2 35.7 27.1 21.2 20.0 23.3 19.9 39.1 19.5 13.8 15.1 21.7 18.7 12.0 14.9 21.5 51.3 60.8 35.6 8.8 40.3 38.2 40.2 17.0 33.2 2.0 73.2 77.9 84.2 103.1 33.5 42.4 23.3 129.2 67.2 44.0 42.9 54.4 53.9 51.7 20.6 48.1 26.4 27.0 57.4 32.5 27.7 50.6 76.7 29.8 21.7 84.0 31.6 24.8 101.2 13.2 12.9 39.9 77.2 51.3 35.1 66.8 38.8 29.9 66.5 SSTR2 ENSG00000180616 "Somatostatin receptor 2" P30874 17 73165012-73176633 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 49.1;Intestinal endocrine cells: 34.5;Sertoli cells: 32.3;Smooth muscle cells: 97.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 17.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007264 Uncertain Supported Cytosol NA NA Cytosol "HPA007264: AB_1080053" "unprognostic (2.13e-3)" "unprognostic (2.61e-3)" "unprognostic (7.43e-2)" "unprognostic (9.37e-3)" "unprognostic (6.25e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-3)" "unprognostic (7.46e-2)" "unprognostic (2.96e-1)" "unprognostic (6.55e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.04e-7)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (3.71e-3)" "unprognostic (2.95e-2)" 4.5 7.4 6.1 2.3 15.8 2.5 4.2 23.1 26.6 1.4 2.2 0.5 0.6 3.3 1.9 4.1 1.5 2.3 1.8 2.2 9.3 5.3 13.6 3.3 1.4 2.7 2.6 13.1 1.5 2.0 1.4 5.7 1.0 4.9 2.8 2.7 1.1 1.8 3.6 1.7 1.9 2.5 2.2 3.3 8.3 7.2 1.4 1.9 0.3 2.3 0.0 2.9 2.0 1.9 1.4 1.0 4.7 0.9 0.9 1.0 0.3 0.3 0.5 0.6 1.2 0.2 0.2 0.7 0.2 0.3 0.5 0.5 0.5 0.5 0.7 0.3 0.1 1.4 0.5 0.1 0.1 0.2 0.6 1.0 0.6 1.1 0.5 0.1 0.4 2.3 0.2 0.1 0.2 0.1 0.3 0.0 0.7 0.7 1.2 0.2 0.6 0.4 1.3 1.6 0.2 0.6 0.7 0.9 0.4 0.4 0.6 17.2 1.5 0.3 0.3 0.2 1.0 2.2 0.3 0.3 0.4 2.2 0.6 0.3 0.8 0.4 1.6 0.3 1.8 0.4 3.8 0.9 1.2 1.0 0.7 0.8 0.8 0.8 0.8 0.3 1.4 0.8 0.9 4.7 0.9 0.8 1.0 0.5 0.3 6.1 15.8 23.1 22.1 9.3 5.3 2.6 13.1 4.9 1.9 6.0 2.4 0.0 3.0 1.0 49.1 2.6 0.0 1.4 2.3 1.8 3.9 0.4 0.0 0.0 7.0 4.0 0.0 0.0 0.0 0.3 2.2 3.0 2.3 0.8 1.1 6.4 34.5 3.7 1.0 3.0 0.9 2.6 5.0 1.8 7.2 1.7 0.6 0.0 0.7 17.4 3.9 32.3 97.1 0.7 1.9 1.0 0.8 1.5 0.4 3.1 SSU72 HSPC182 ENSG00000160075 "SSU72 homolog, RNA polymerase II CTD phosphatase" Q9NP77 1 1541673-1574869 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 520.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069290, HPA070604" Supported Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA069290: AB_2686108, HPA070604: AB_2686285" "unprognostic (3.33e-2)" "unprognostic (2.79e-2)" "unprognostic (6.37e-2)" "unprognostic (2.27e-2)" "unprognostic (2.41e-1)" "unprognostic (9.84e-2)" "unprognostic (2.40e-3)" "unprognostic (2.43e-2)" "unprognostic (3.23e-1)" "unprognostic (3.23e-1)" "unprognostic (6.75e-2)" "unprognostic (1.36e-1)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "unprognostic (8.51e-2)" "unprognostic (3.77e-1)" "unprognostic (1.06e-1)" 44.1 32.5 48.0 33.6 51.5 29.3 73.9 42.3 51.5 37.2 40.1 25.4 39.3 41.3 32.6 51.8 45.7 46.2 35.3 44.4 40.7 42.5 38.0 50.9 37.5 49.0 39.4 39.0 38.0 61.8 33.9 39.9 35.8 36.9 33.9 35.9 34.1 54.2 35.8 107.1 36.9 40.8 35.4 35.0 41.7 38.5 28.0 28.4 37.0 50.9 45.3 36.3 30.8 42.2 35.5 30.1 62.0 28.8 20.7 46.5 28.1 41.4 26.6 19.2 29.6 33.1 32.0 19.7 36.1 28.2 31.5 32.9 24.9 48.2 42.2 19.8 28.4 30.8 32.4 31.0 29.7 30.8 35.1 36.6 26.5 23.3 39.3 37.5 33.5 23.2 28.5 25.1 33.7 32.2 26.5 29.4 25.7 45.8 32.7 24.9 36.9 38.3 53.8 33.6 40.9 40.4 30.5 31.0 59.0 34.5 12.8 35.6 24.4 24.4 62.7 106.5 34.0 32.7 29.2 22.4 30.4 19.3 34.2 30.9 39.9 47.9 52.7 31.8 53.4 14.7 37.1 28.3 53.6 25.9 28.8 31.9 35.5 34.4 30.7 30.1 33.1 42.2 34.1 62.0 20.7 25.4 19.0 46.5 28.1 48.0 51.5 42.3 51.5 40.7 42.5 39.4 39.0 36.9 28.4 26.8 71.4 136.9 121.9 165.4 98.0 80.5 117.2 36.1 37.5 96.0 19.6 178.0 247.1 62.6 202.0 95.1 177.2 0.0 92.6 189.0 93.0 151.4 60.0 123.8 125.1 106.5 136.4 90.9 152.3 520.2 97.0 118.3 158.6 91.0 137.9 96.8 78.9 168.6 80.6 258.7 57.5 58.2 97.3 81.2 147.4 192.6 205.2 116.7 134.0 129.8 ST13 "FAM10A1, HIP, HSPABP1, P48, SNC6" ENSG00000100380 "ST13, Hsp70 interacting protein" P50502 22 40824535-40857022 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043233, HPA046412, HPA047114, HPA047116" Enhanced Enhanced Cytosol NA NA Cytosol "HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.69e-2)" "unprognostic (7.15e-2)" "unprognostic (2.68e-2)" "prognostic unfavorable (5.23e-4)" "unprognostic (2.73e-3)" "unprognostic (1.74e-2)" "unprognostic (3.63e-1)" "unprognostic (2.50e-1)" "unprognostic (1.00e-1)" "unprognostic (9.54e-2)" "prognostic favorable (3.10e-4)" "unprognostic (8.41e-2)" "unprognostic (3.93e-2)" "unprognostic (3.04e-1)" "unprognostic (8.40e-2)" 43.0 46.0 36.8 26.2 32.0 20.9 39.9 32.2 35.3 45.0 36.4 41.3 33.0 23.9 57.1 37.9 32.9 46.5 32.7 44.0 33.8 33.6 63.2 72.0 23.7 25.0 40.8 28.8 141.6 31.8 38.6 38.1 35.9 36.6 45.1 27.6 30.4 34.8 37.8 75.3 28.3 25.9 42.4 52.0 25.6 31.9 29.3 40.5 38.7 50.3 38.5 30.2 49.4 76.7 41.3 29.4 23.3 36.6 28.2 62.1 39.0 45.8 37.0 56.0 48.8 52.1 80.9 51.0 43.5 55.7 54.0 47.3 66.5 27.5 66.2 37.7 43.5 49.0 33.6 73.6 42.6 64.3 42.2 47.0 47.5 74.3 75.3 47.5 68.6 38.5 71.9 45.2 48.7 33.1 68.2 55.6 41.5 56.7 29.0 51.5 34.4 60.1 32.7 31.8 55.9 24.5 69.4 47.8 52.1 54.8 69.6 18.6 18.9 50.3 40.5 62.2 67.4 39.2 43.4 41.8 45.2 44.1 37.9 35.2 33.5 65.9 62.1 61.9 32.2 43.5 23.3 21.4 22.5 24.9 29.3 37.8 41.3 39.1 29.6 29.4 36.6 62.1 46.7 7.4 28.2 36.6 20.7 32.7 39.0 36.8 32.0 32.2 33.8 33.8 33.6 40.8 28.8 36.6 40.5 131.0 179.9 243.5 322.7 276.8 89.2 128.6 326.1 322.5 245.7 162.3 15.7 330.2 477.5 243.9 414.3 227.7 216.0 163.5 179.4 326.2 254.0 270.9 201.1 499.1 287.6 36.5 251.4 181.1 216.6 710.5 472.6 248.9 200.8 355.3 224.0 239.1 201.5 178.5 388.6 803.1 51.8 219.9 251.3 314.7 140.1 239.9 418.9 181.1 280.9 275.1 ST7 "ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7" ENSG00000004866 "Suppression of tumorigenicity 7" Q9NRC1 7 116953238-117230103 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 107.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038325, HPA038326" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA038325: AB_10671740, HPA038326: AB_10672644" "unprognostic (3.40e-2)" "unprognostic (1.04e-1)" "unprognostic (1.33e-1)" "unprognostic (4.70e-2)" "unprognostic (1.09e-1)" "unprognostic (8.18e-2)" "unprognostic (3.32e-2)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (4.45e-3)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "prognostic favorable (3.39e-5)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (8.41e-2)" "unprognostic (3.40e-2)" 11.1 20.0 12.9 5.0 18.0 12.0 12.3 63.0 25.7 16.7 10.7 9.2 21.6 9.8 12.3 31.2 8.5 15.8 10.0 19.8 10.9 12.3 23.1 31.5 20.0 5.4 11.1 18.7 15.9 30.8 17.6 30.1 21.8 14.9 11.7 10.1 11.0 24.9 19.3 10.1 9.7 9.7 11.3 8.1 9.1 13.5 15.9 8.2 2.9 23.8 7.6 7.0 10.0 9.8 2.6 6.2 1.6 3.3 7.6 10.6 3.2 13.1 7.6 12.4 10.8 14.4 9.9 5.7 10.4 13.2 10.7 16.0 10.2 15.6 3.4 11.4 9.1 16.3 10.8 10.6 11.1 14.6 4.6 15.3 10.3 12.7 9.0 10.0 11.6 17.7 7.6 11.3 13.9 9.7 10.5 11.2 2.3 15.2 24.8 10.1 7.6 0.1 8.9 12.0 17.0 9.1 2.9 8.4 14.5 11.5 7.0 18.6 15.2 11.8 52.1 13.8 10.0 4.5 9.6 8.5 12.6 5.0 13.6 10.2 15.7 11.9 13.0 10.2 10.4 12.6 1.6 3.3 0.4 8.3 1.2 5.9 2.6 5.1 7.3 6.2 0.9 3.5 3.6 0.1 7.6 1.2 6.2 10.6 3.2 12.9 18.0 63.0 25.7 10.9 12.3 11.1 18.7 14.9 8.2 20.8 30.2 7.2 7.2 6.6 10.2 10.1 12.7 4.0 12.5 5.2 0.0 17.1 5.0 5.8 107.8 6.7 2.6 0.0 11.6 18.9 8.8 8.0 18.5 22.6 7.9 3.2 3.5 6.2 13.0 35.2 10.3 5.8 6.8 9.0 5.9 11.8 8.4 3.4 5.6 14.6 0.6 0.0 6.1 14.0 5.6 4.8 17.7 3.1 3.9 7.8 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393828-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.7;heart muscle: 10.0" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 4.5;Muller glia cells: 2.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "pons and medulla: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 22.2;LHCN-M2: 6.5;RH-30: 10.1;RPMI-8226: 7.3;SH-SY5Y: 4.3;WM-115: 6.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.3 1.1 1.3 0.2 2.2 0.1 1.2 1.5 3.7 2.6 0.3 0.0 0.0 0.1 1.3 2.5 0.4 0.1 0.7 10.0 3.0 3.6 0.3 0.1 0.1 0.2 2.2 1.4 0.1 0.1 0.1 0.9 0.1 17.7 0.3 0.2 1.0 0.8 0.5 2.1 0.1 0.4 0.2 0.2 0.1 0.2 0.8 0.1 2.5 0.2 1.5 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.0 3.5 0.0 0.0 0.0 10.1 7.3 0.0 0.0 0.5 4.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.7 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.2 1.5 2.6 3.0 3.6 2.2 1.4 17.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 90.8" "Cell type enriched" "Detected in many" 5 "Ito cells: 1114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 68 "classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8" "Group enriched" "Detected in many" 69 "dendritic cells: 2.8;monocytes: 10.8" "Group enriched" "Detected in some" 47 "HUVEC TERT2: 33.9;NB-4: 46.8;TIME: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 60000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 39.5 37.6 8.0 26.7 12.8 6.5 41.3 3.2 6.8 13.1 23.4 6.9 4.2 16.1 13.6 26.4 9.7 15.5 16.8 19.7 5.4 4.2 19.2 35.8 21.7 80.7 9.1 2.7 9.9 7.1 4.9 11.9 32.1 10.2 13.5 18.0 23.7 10.4 9.7 8.0 5.1 18.7 18.3 7.2 90.8 11.6 9.7 8.7 2.6 11.9 11.4 11.1 15.9 15.4 0.0 2.8 0.0 10.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 33.9 0.0 0.1 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 8.0 12.8 3.2 6.8 5.4 4.2 9.1 2.7 10.2 8.7 0.0 6.7 12.3 0.5 5.4 1.0 2.0 12.7 0.0 0.0 3.5 0.0 1.3 0.0 0.0 0.4 14.5 0.0 46.7 0.0 1.5 3.8 0.0 17.4 8.3 103.3 0.0 1.2 1114.7 238.9 1.9 4.0 46.3 11.8 0.0 0.0 0.5 0.0 0.0 19.1 0.3 0.0 19.4 1.5 0.7 1.1 4.3 1.8 4.3 0.0 0.2 STAB2 "DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2" ENSG00000136011 "Stabilin 2" Q8WWQ8 12 103587273-103766727 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 71.3" "Cell type enriched" "Detected in some" 10 "Ito cells: 196.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 16.1;HaCaT: 4.4;RH-30: 2.5" "Not detected" "Not detected" "HPA026871, HPA072699" Enhanced Supported Cytosol NA NA 210000 Cytosol "HPA026871: AB_1857536, HPA072699: " "unprognostic (5.66e-3)" "unprognostic (7.51e-2)" "unprognostic (3.31e-1)" "unprognostic (3.84e-2)" "unprognostic (8.47e-2)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (5.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.05e-1)" "unprognostic (9.72e-4)" "unprognostic (1.37e-2)" "unprognostic (5.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.06e-1)" 0.6 0.2 0.1 0.5 0.1 0.4 0.5 0.1 0.1 0.7 1.4 0.1 0.1 0.1 1.1 1.1 2.5 0.9 0.6 0.4 0.1 0.1 0.1 11.7 0.5 19.9 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.2 0.5 0.2 0.1 2.1 0.3 0.1 0.2 0.3 0.2 0.1 71.3 0.3 1.5 0.1 0.2 0.7 0.5 0.4 0.3 0.4 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.8 0.2 0.0 0.0 16.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 4.4 0.0 0.0 0.0 0.0 1.1 0.4 0.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 0.5 0.1 2.5 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.1 0.9 0.3 0.1 0.6 0.8 0.4 0.0 1.1 0.2 0.2 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.1 0.0 0.0 196.4 19.9 9.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 STAC2 24b2 ENSG00000141750 "SH3 and cysteine rich domain 2" Q6ZMT1 17 39210536-39225872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 94.0;seminal vesicle: 101.5" "Cell type enriched" "Detected in many" 11 "Muller glia cells: 446.6" "Group enriched" "Detected in many" 7 "breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.3;HeLa: 25.8;hTEC/SVTERT24-B: 3.8;U-87 MG: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076925 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA076925: " "unprognostic (1.70e-3)" "unprognostic (1.05e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (4.05e-5)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.42e-1)" "unprognostic (8.66e-2)" "unprognostic (2.94e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.12e-2)" "unprognostic (5.16e-2)" "unprognostic (2.35e-3)" "unprognostic (2.05e-2)" "unprognostic (1.94e-1)" "unprognostic (3.54e-2)" "unprognostic (3.17e-1)" 2.4 0.9 4.2 1.0 7.4 0.7 29.7 9.5 21.9 4.0 0.9 0.0 94.0 0.9 2.5 13.9 0.8 1.4 0.8 1.0 6.8 3.2 4.8 0.7 0.9 0.8 3.5 6.6 1.2 1.1 0.7 0.5 1.0 13.1 1.8 0.9 8.2 7.8 101.5 0.8 20.1 0.8 1.7 1.4 0.8 0.8 0.9 0.2 0.0 0.7 0.0 0.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 8.3 0.0 3.3 0.0 0.0 0.0 0.4 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.2 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 7.4 9.5 21.7 6.8 3.2 3.5 6.6 13.1 0.2 3.0 8.0 0.0 1.2 0.3 4.8 2.9 0.0 2.7 4.5 3.5 9.8 0.1 5.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.0 2.6 0.0 40.5 0.0 0.0 446.6 0.0 0.0 0.0 0.0 11.1 0.0 3.4 0.2 0.9 1.5 0.2 0.0 0.0 0.1 STAC3 MGC2793 ENSG00000185482 "SH3 and cysteine rich domain 3" Q96MF2 12 57243453-57251193 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "skeletal muscle: 222.7;tongue: 107.8" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 36.5;Kupffer cells: 32.7;Macrophages: 17.2;monocytes: 16.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "intermediate monocyte: 8.0" "Group enriched" "Detected in many" 6 "dendritic cells: 4.9;monocytes: 8.0" "Cell line enriched" "Detected in some" 23 "RH-30: 230.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA039285, HPA039527" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039285: AB_2676427, HPA039527: AB_10673424" "unprognostic (6.16e-2)" "prognostic favorable (2.01e-4)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (5.25e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (9.12e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (7.11e-6)" "unprognostic (4.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.09e-1)" "unprognostic (1.14e-3)" 3.7 0.2 0.1 0.6 0.1 1.6 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 10.3 3.2 0.2 0.1 0.1 0.1 0.1 0.2 0.4 0.6 0.7 0.2 0.0 0.1 0.1 0.4 0.2 0.2 0.0 2.3 0.2 0.1 5.4 0.0 222.7 0.2 0.3 0.1 0.3 1.1 0.1 1.2 0.0 0.1 1.2 107.8 3.8 0.1 0.1 1.1 4.9 0.5 8.0 0.0 0.3 1.8 0.0 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 2.7 0.0 0.0 0.0 1.6 9.8 1.0 0.1 0.0 0.0 0.1 0.0 0.6 0.2 0.2 0.7 0.5 0.1 3.5 0.0 0.0 0.1 1.2 230.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.9 0.1 3.2 0.0 0.0 6.1 0.5 0.0 8.0 0.1 1.1 0.0 0.3 4.9 0.5 0.0 0.1 0.3 0.0 4.0 1.4 0.3 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.1 0.5 0.4 1.3 6.4 0.2 2.5 1.4 0.0 0.0 2.0 0.9 0.0 0.8 9.3 0.0 1.1 0.0 0.9 0.5 0.9 0.6 5.7 0.6 36.5 1.6 2.4 2.5 32.7 7.6 1.1 17.2 0.0 16.2 1.1 2.2 1.0 0.0 0.7 0.5 1.9 0.0 0.3 2.4 1.1 0.3 1.1 1.3 1.1 0.3 STAM2 Hbp ENSG00000115145 "Signal transducing adaptor molecule 2" O75886 2 152116801-152175992 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 107.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035528, HPA035529" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA035528: AB_10601606, HPA035529: AB_10672868" "unprognostic (1.53e-1)" "unprognostic (1.79e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (5.16e-2)" "unprognostic (2.76e-2)" "unprognostic (3.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-1)" "unprognostic (7.92e-2)" "unprognostic (1.11e-2)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" 17.8 19.1 17.2 12.4 19.9 4.9 21.3 16.1 19.5 19.6 16.7 17.6 17.2 15.1 18.5 16.0 17.8 21.6 15.6 16.1 15.3 15.4 24.6 17.8 17.6 13.0 19.9 14.4 20.6 20.5 23.1 34.0 16.7 20.4 22.1 18.4 14.5 19.5 19.3 14.3 17.6 19.6 19.8 20.0 14.0 18.8 24.3 21.2 16.0 23.8 13.2 14.7 19.5 16.6 2.3 3.3 14.0 6.5 2.5 2.2 1.7 5.4 5.3 5.0 6.0 13.1 15.7 5.3 11.4 13.2 7.4 9.5 5.2 5.2 7.2 9.2 16.2 6.5 5.6 5.5 10.5 12.0 8.8 4.4 5.1 3.7 7.9 15.0 7.5 10.1 11.9 10.2 13.8 18.7 10.8 7.9 4.9 3.3 5.1 15.1 5.4 4.0 5.9 3.1 4.1 7.7 3.2 6.1 3.9 11.6 9.5 2.6 4.1 6.3 5.7 9.4 5.8 7.6 7.0 10.4 16.6 5.3 13.0 6.9 4.3 4.3 4.6 12.5 6.1 9.0 14.0 3.5 4.4 1.9 4.7 1.8 1.7 2.0 2.0 2.7 2.3 1.7 2.1 8.8 2.5 6.5 3.3 2.2 1.7 17.2 19.9 16.1 19.5 15.3 15.4 19.9 14.4 20.4 21.2 23.8 24.4 5.2 9.3 12.2 10.1 27.1 7.6 68.3 35.2 15.7 15.7 6.6 19.9 12.8 107.8 9.8 14.8 0.0 12.2 11.8 13.1 14.9 25.5 13.5 14.5 1.6 7.9 20.3 24.5 38.6 14.7 14.8 13.5 17.2 16.2 13.6 17.2 17.3 14.5 11.4 12.0 25.8 11.3 26.5 19.2 11.5 16.9 6.9 11.9 13.1 STAMBP AMSH ENSG00000124356 "STAM binding protein" O95630 2 73828916-73873659 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "LHCN-M2: 162.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035800, HPA035801" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 11000 Nucleoplasm "Plasma membrane, Cytosol" "HPA035800: AB_10670591, HPA035801: AB_2732470" "unprognostic (1.86e-2)" "unprognostic (1.14e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (4.70e-5)" "unprognostic (6.13e-2)" "unprognostic (2.08e-3)" "unprognostic (3.73e-2)" "unprognostic (1.71e-1)" "unprognostic (6.58e-2)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (1.01e-1)" "unprognostic (2.29e-1)" "unprognostic (7.72e-2)" "unprognostic (2.63e-1)" "unprognostic (1.43e-1)" "unprognostic (2.89e-1)" 12.9 12.8 22.1 13.9 23.0 10.5 17.8 20.1 21.8 18.1 18.4 35.0 13.6 17.8 23.1 15.4 22.7 16.5 14.7 19.0 23.3 21.2 19.6 16.9 13.4 15.3 33.0 14.3 16.3 15.1 20.9 17.8 20.6 26.3 20.2 20.7 14.6 18.3 15.7 30.1 14.4 25.2 19.0 54.7 13.8 15.6 13.3 22.3 18.4 20.1 15.9 19.0 16.8 16.4 17.6 16.9 27.8 17.8 16.7 20.7 12.3 5.4 6.3 5.0 4.6 4.7 5.7 5.8 3.3 4.6 6.2 6.0 10.5 5.2 4.6 5.3 2.8 8.3 4.3 5.3 11.8 7.1 8.0 6.0 6.1 4.4 8.2 6.5 5.0 7.4 4.5 8.5 7.3 10.6 7.9 3.6 6.3 6.6 7.0 162.7 6.6 7.7 4.5 8.0 7.8 3.4 5.4 13.2 6.5 6.6 6.2 9.2 6.8 4.1 5.0 7.1 5.6 4.7 3.0 3.1 5.6 6.7 3.3 5.9 6.6 6.4 3.5 6.9 5.4 6.5 22.6 16.2 27.8 14.4 17.8 15.4 17.6 16.7 14.0 16.9 16.2 17.5 13.2 24.1 16.7 15.7 16.4 20.7 12.3 22.1 23.0 20.1 21.2 23.3 21.2 33.0 14.3 26.3 22.3 17.9 15.3 14.1 25.1 14.4 19.9 35.5 35.7 25.4 27.3 24.4 11.8 35.2 41.4 32.4 59.2 21.7 40.9 46.7 31.9 28.3 22.6 34.8 51.9 34.7 29.0 25.4 9.9 20.3 24.7 104.7 30.2 29.2 6.8 36.9 31.9 21.5 36.9 38.6 32.5 47.1 19.2 38.8 20.6 32.3 49.5 18.9 37.2 19.5 31.2 23.0 STARD10 "CGI-52, NY-CO-28, PCTP2, SDCCAG28" ENSG00000214530 "StAR related lipid transfer domain containing 10" Q9Y365 11 72754729-72794168 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 130.6" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 585.1;Late spermatids: 1716.5;Mucus-secreting cells: 590.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 75.1;OE19: 160.9;SK-BR-3: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026661 Uncertain Supported Cytosol NA NA Cytosol "HPA026661: AB_1857538" "prognostic favorable (6.92e-4)" "unprognostic (2.07e-1)" "unprognostic (8.03e-2)" "unprognostic (1.74e-3)" "unprognostic (3.71e-2)" "unprognostic (1.37e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "unprognostic (4.16e-1)" "unprognostic (4.69e-2)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (4.24e-3)" "unprognostic (8.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.12e-2)" "unprognostic (1.04e-1)" 4.5 34.0 11.3 6.8 16.0 2.0 16.0 17.6 15.9 18.6 42.8 5.5 16.6 11.5 6.5 26.2 10.9 6.2 28.7 15.5 10.3 6.8 11.1 130.6 10.0 3.1 10.6 5.4 8.2 47.3 16.4 9.5 22.6 10.1 17.6 46.0 9.1 21.7 12.1 15.0 12.7 15.0 6.7 4.4 4.6 47.4 40.0 14.8 3.3 21.3 12.0 9.3 7.8 10.2 2.9 2.0 15.8 1.8 5.6 1.3 0.6 6.1 1.9 0.9 3.6 1.2 1.2 12.4 0.6 3.2 2.2 2.2 25.9 4.5 0.5 2.1 2.3 5.3 3.9 2.9 5.8 2.5 3.4 1.1 0.7 1.3 26.4 4.5 0.1 1.1 0.8 16.1 2.4 3.4 6.0 2.2 1.2 1.4 2.7 0.4 75.1 0.5 1.3 0.4 160.9 2.5 0.5 1.6 0.4 2.9 7.5 1.6 1.2 1.0 53.7 7.6 4.3 29.6 0.7 1.6 2.2 1.4 0.7 1.2 2.7 2.2 0.9 0.5 0.7 0.7 7.9 1.8 11.4 1.2 0.9 1.0 2.9 1.1 1.3 0.8 2.3 1.1 1.3 15.8 5.6 0.4 2.0 1.2 0.6 11.3 16.0 17.6 15.9 10.3 6.8 10.6 5.4 10.1 14.8 32.8 67.8 18.8 64.0 27.9 9.3 39.6 239.5 24.1 33.0 52.4 21.6 163.2 104.5 65.2 406.8 12.9 92.8 0.0 83.1 75.5 15.7 146.3 25.3 585.1 23.0 31.8 290.1 26.4 19.3 1716.5 24.2 11.8 15.1 1.0 590.8 39.3 80.3 364.7 23.7 47.4 15.5 6.5 15.6 61.3 15.6 48.1 294.5 10.7 374.8 96.0 STARD5 MGC10327 ENSG00000172345 "StAR related lipid transfer domain containing 5" Q9NSY2 15 81309053-81324183 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.6" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 22.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 20.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 7.8;RPMI-8226: 7.8;U-266/70: 9.5;U-937: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040662 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA040662: AB_10959593" "unprognostic (5.35e-4)" "unprognostic (1.55e-1)" "unprognostic (2.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (2.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.08e-2)" "unprognostic (8.08e-2)" "unprognostic (6.81e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (4.84e-3)" "unprognostic (7.55e-3)" 2.8 1.0 1.2 8.6 1.5 5.9 2.7 20.8 3.4 14.3 7.7 1.5 6.6 3.5 7.3 22.3 9.2 4.3 4.4 1.9 1.0 1.1 1.4 59.6 4.3 11.1 1.1 1.0 3.2 1.1 0.6 1.0 9.3 1.2 6.1 5.9 1.5 3.2 6.6 0.9 12.4 7.7 3.6 1.9 10.8 3.3 4.4 1.4 1.7 2.5 10.6 9.8 6.1 7.9 2.1 4.8 6.9 4.6 4.8 7.6 5.6 0.4 0.1 0.1 1.2 3.0 3.1 0.2 0.4 0.4 1.0 1.6 0.1 0.1 6.2 0.0 1.8 0.3 5.2 1.5 1.2 0.8 0.1 0.5 2.3 0.3 0.5 0.6 3.5 7.8 2.5 2.6 0.4 0.8 2.0 0.1 2.5 0.7 1.7 0.7 0.2 0.6 5.0 0.4 0.3 0.0 0.1 0.9 7.8 0.4 1.8 0.4 0.1 0.2 0.7 0.7 0.5 0.8 0.8 0.2 1.7 0.9 1.7 0.1 9.5 1.9 2.4 1.2 8.8 0.5 6.9 3.0 4.2 5.8 4.6 5.0 2.1 5.4 6.1 4.8 1.6 7.6 7.5 2.4 4.8 4.0 2.5 6.3 5.6 1.2 1.5 20.8 3.4 1.0 1.1 1.1 1.0 1.2 1.4 0.0 0.6 6.7 12.4 11.7 1.8 0.2 0.0 4.0 2.3 0.0 5.9 2.0 3.3 1.2 11.0 1.0 19.1 0.0 1.2 3.1 7.5 2.2 10.3 22.1 4.8 1.6 10.9 3.7 5.3 0.5 4.6 6.1 1.7 0.0 18.1 1.7 1.6 11.4 9.2 0.5 0.7 0.0 2.1 0.5 0.4 14.3 4.1 4.5 14.0 6.8 STAT1 "ISGF-3, STAT91" ENSG00000115415 "Signal transducer and activator of transcription 1" P42224 2 190964358-191020960 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 90.5;BJ hTERT+ SV40 Large T+ RasG12V: 101.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000931, HPA000982, CAB004049" Approved Enhanced Nucleoplasm,Cytosol NA NA 22000 "Nucleoplasm, Cytosol" "CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099" "unprognostic (6.90e-2)" "unprognostic (6.47e-2)" "unprognostic (4.27e-2)" "unprognostic (2.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.91e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-2)" "unprognostic (1.35e-1)" "prognostic favorable (1.75e-4)" "prognostic unfavorable (4.23e-4)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.22e-5)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (3.35e-3)" "unprognostic (3.93e-2)" 27.9 27.2 17.4 47.8 17.8 19.5 20.4 15.0 21.7 21.0 19.8 14.9 17.5 22.7 17.1 27.4 23.3 14.5 29.0 25.5 15.6 22.2 34.9 35.7 29.4 57.9 16.9 18.8 24.3 18.7 20.0 24.0 24.3 23.6 23.6 20.3 17.9 47.5 18.0 20.1 17.4 24.6 24.8 21.8 49.0 24.2 13.5 10.4 58.7 36.2 18.5 30.2 29.3 16.5 10.8 16.2 55.0 47.1 22.7 54.1 44.6 8.9 9.6 4.5 7.5 19.9 26.9 14.6 13.7 41.9 90.5 101.9 15.2 10.4 3.7 8.7 29.3 30.1 7.6 5.1 10.9 18.0 30.7 4.2 16.6 7.6 8.9 13.8 8.5 10.4 17.8 7.0 16.7 5.9 9.9 10.8 6.5 9.0 22.0 16.6 7.3 6.4 10.8 6.3 5.8 15.8 5.4 12.4 4.5 11.9 11.2 6.3 6.1 16.1 6.2 41.9 6.7 6.4 10.6 9.5 18.0 10.6 15.5 8.8 37.4 54.8 3.5 13.7 7.3 8.3 13.0 36.9 27.0 14.7 47.1 19.9 10.8 35.1 21.0 16.2 8.6 35.8 26.0 55.0 22.7 27.6 7.4 54.1 44.6 17.4 17.8 15.0 21.7 15.6 22.2 16.9 18.8 23.6 10.4 68.5 26.4 26.1 13.6 19.7 12.8 39.2 48.4 49.5 50.0 50.6 23.6 11.6 6.6 40.3 8.8 23.9 22.2 0.0 32.6 47.9 29.1 25.0 50.7 45.1 91.4 3.2 20.2 25.8 63.7 2.6 20.1 70.4 16.9 25.2 23.9 14.3 30.0 22.8 28.0 36.2 16.5 38.8 21.7 18.5 24.5 27.4 7.0 25.4 27.4 24.1 STAT2 STAT113 ENSG00000170581 "Signal transducer and activator of transcription 2" P52630 12 56341597-56360155 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003858, HPA018888" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB003858: AB_562227, HPA018888: AB_1857550" "unprognostic (3.03e-1)" "unprognostic (8.59e-2)" "unprognostic (6.92e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "unprognostic (7.27e-2)" "unprognostic (1.93e-1)" "unprognostic (2.60e-1)" "unprognostic (4.12e-3)" "unprognostic (1.56e-1)" "unprognostic (7.45e-3)" "prognostic unfavorable (4.78e-13)" "unprognostic (1.88e-1)" "unprognostic (5.56e-2)" "unprognostic (2.77e-1)" "unprognostic (1.46e-3)" 30.8 14.7 10.4 24.2 20.8 11.9 18.4 21.3 18.6 21.4 13.8 39.8 12.2 15.1 24.0 12.6 13.9 16.7 23.0 11.6 10.9 9.2 12.8 25.7 22.1 19.9 27.3 13.3 22.9 13.1 18.3 28.0 18.7 29.1 15.8 15.1 24.5 18.7 12.4 10.6 15.2 17.3 22.9 29.2 29.4 13.9 7.0 22.1 19.9 20.3 7.6 23.1 24.2 16.7 6.6 8.5 8.2 16.9 3.5 6.8 8.1 4.7 2.5 5.9 4.7 30.5 21.1 9.6 8.5 30.4 33.9 33.6 3.5 6.3 6.2 7.9 13.8 8.5 6.5 6.9 5.0 6.7 5.2 2.1 9.4 4.7 3.5 20.9 2.1 9.1 31.4 4.5 7.7 7.7 28.7 7.9 5.6 5.1 17.3 10.9 2.8 3.2 2.6 1.8 4.4 3.3 3.0 7.0 4.9 6.9 6.9 1.7 3.5 12.2 6.7 12.7 8.3 6.3 5.3 5.2 11.8 4.2 4.0 1.5 13.8 10.0 3.2 10.9 2.7 4.0 8.2 11.2 7.6 5.8 16.9 5.8 3.7 5.7 5.9 8.5 6.6 4.4 3.7 5.7 3.5 12.6 7.6 6.8 8.1 10.4 20.8 21.3 18.6 10.9 9.2 27.3 13.3 29.1 22.1 11.9 48.6 22.1 6.7 12.7 16.2 10.1 22.9 18.7 28.4 17.4 19.6 9.4 1.7 10.6 10.6 22.4 17.5 0.0 9.4 22.2 18.4 10.4 9.3 62.1 24.2 3.2 14.9 25.8 41.9 23.3 18.1 29.9 30.4 10.8 13.8 10.3 11.6 17.5 16.3 7.8 19.8 25.8 14.6 2.3 4.4 12.7 9.3 14.0 11.0 10.1 STAT3 APRF ENSG00000168610 "Signal transducer and activator of transcription 3" P40763 17 42313324-42388568 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Diabetes mellitus, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001671, CAB003859, HPA058603, CAB068241, CAB068242" Supported Supported Nucleoplasm,Cytosol NA NA 220000 "Nucleoplasm, Cytosol" "CAB003859: AB_347629, CAB068241: AB_2665663, CAB068242: AB_2665662, HPA001671: AB_1080102, HPA058603: AB_2683772" "unprognostic (1.83e-2)" "unprognostic (2.42e-1)" "unprognostic (9.23e-3)" "unprognostic (2.91e-1)" "unprognostic (5.59e-3)" "unprognostic (1.78e-2)" "unprognostic (8.26e-2)" "unprognostic (1.51e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-1)" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (6.47e-3)" "unprognostic (7.75e-3)" "unprognostic (2.21e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" 44.6 30.7 23.2 34.4 27.5 35.3 49.3 15.7 23.5 25.1 31.5 18.4 21.7 20.5 33.2 27.4 36.4 32.7 34.0 82.9 20.1 14.7 34.5 90.0 45.7 45.5 26.0 11.1 40.6 32.1 18.6 27.9 24.6 27.6 28.9 21.8 24.3 29.3 22.9 53.4 28.4 28.6 49.7 25.1 41.4 29.4 15.4 25.7 16.8 38.0 31.2 28.8 40.4 53.1 10.8 13.7 69.7 20.2 13.9 21.7 26.7 17.0 32.3 14.3 14.1 30.5 29.2 10.4 20.0 25.4 17.3 16.9 8.5 16.5 5.3 19.8 19.8 26.2 26.0 12.9 20.4 14.2 43.9 8.9 36.9 19.6 17.4 22.6 9.0 24.1 45.5 20.1 13.8 20.0 18.2 23.5 9.8 22.6 17.0 11.4 12.0 33.3 9.0 8.3 17.4 0.0 7.4 38.2 7.8 27.4 22.1 13.1 8.5 23.0 54.6 8.2 17.9 28.7 13.5 19.7 26.9 13.7 15.9 16.3 26.2 20.4 4.5 16.6 9.5 11.9 26.2 19.4 24.9 21.7 20.2 17.3 10.8 16.0 16.8 13.7 10.4 16.6 15.8 69.7 13.9 18.7 7.5 12.0 26.7 23.2 27.5 15.7 23.5 20.1 14.7 26.0 11.1 27.6 25.7 86.4 150.9 56.2 91.3 115.1 87.1 46.2 43.3 85.6 108.1 127.4 265.1 21.1 14.9 68.7 27.3 107.9 156.0 0.0 83.8 34.3 140.9 148.0 138.6 102.5 60.4 23.8 119.1 104.3 64.9 11.1 66.4 84.8 69.2 88.4 68.1 108.0 75.8 94.7 57.3 38.3 352.3 64.7 221.4 32.2 15.1 139.9 26.1 86.3 72.7 78.8 STAT5A "MGF, STAT5" ENSG00000126561 "Signal transducer and activator of transcription 5A" P42229 17 42287547-42311943 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Lactation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 43.3;Peritubular cells: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 25.8;HEL: 39.1;HMC-1: 22.8;K-562: 65.1;MOLT-4: 47.2;NB-4: 18.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB003860, HPA027873, HPA042128, HPA049883, HPA051156" Approved Enhanced Nucleoplasm,Cytosol NA NA 140000 "Nucleoplasm, Cytosol" "CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366" "prognostic favorable (5.87e-4)" "unprognostic (3.09e-3)" "unprognostic (2.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.43e-1)" "unprognostic (3.41e-3)" "unprognostic (2.15e-1)" "unprognostic (6.22e-2)" "unprognostic (3.33e-1)" "unprognostic (6.82e-3)" "unprognostic (2.76e-1)" "unprognostic (2.11e-1)" "unprognostic (3.85e-2)" "unprognostic (5.74e-2)" "unprognostic (1.90e-2)" "unprognostic (1.98e-1)" "unprognostic (5.49e-3)" 44.0 21.5 3.6 16.5 8.1 30.0 24.1 3.4 4.0 12.6 12.8 6.3 10.5 5.1 11.0 11.4 11.6 9.6 15.3 9.8 3.9 4.7 8.9 5.5 12.8 26.7 9.1 3.2 15.6 8.3 1.9 7.0 11.3 6.1 13.9 5.8 11.9 11.9 11.7 18.3 9.7 11.6 13.6 7.4 17.3 7.9 8.5 6.1 21.9 8.6 9.1 17.0 19.9 20.2 7.2 15.0 15.2 18.5 14.3 16.2 8.8 1.1 1.3 0.1 0.0 9.3 4.5 0.0 0.5 2.0 1.0 0.6 0.1 1.0 0.0 2.4 2.1 0.0 0.0 0.2 0.0 0.3 25.8 0.0 39.1 2.9 0.3 3.8 3.3 22.8 10.4 0.7 0.4 0.5 0.0 3.1 0.9 65.1 0.0 0.5 0.1 47.2 18.6 0.3 0.6 0.0 1.1 0.3 3.3 0.3 0.7 0.1 0.0 2.3 1.2 4.3 0.3 0.7 4.2 1.7 2.4 0.6 1.1 0.0 0.0 0.0 0.0 0.2 6.4 0.6 6.8 11.8 5.9 9.1 15.1 12.8 7.2 15.8 13.2 15.0 6.7 16.2 13.0 15.2 14.3 18.5 5.7 11.2 8.8 3.6 8.1 3.4 4.0 3.9 4.7 9.1 3.2 6.1 6.1 0.0 11.7 17.9 3.4 6.5 1.5 20.2 5.1 5.3 2.3 5.2 0.0 1.2 5.0 4.9 0.3 21.8 3.8 0.0 11.8 2.1 15.5 6.7 22.0 2.6 19.4 0.0 0.0 5.5 19.7 2.1 30.2 22.7 8.5 43.3 4.2 5.1 8.2 7.0 38.5 8.4 0.3 6.5 18.7 0.0 0.7 6.8 1.1 19.1 6.2 4.1 STAT5B ENSG00000173757 "Signal transducer and activator of transcription 5B" P51692 17 42199168-42276707 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 85.5;Late spermatids: 113.5;Peritubular cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004298, CAB005418, HPA042128, HPA049883, HPA051156" Approved Approved Cytosol NA NA 170000 Cytosol "CAB004298: AB_2197067, CAB005418: AB_632445, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366" "unprognostic (1.49e-1)" "unprognostic (3.60e-2)" "unprognostic (4.06e-2)" "prognostic favorable (9.37e-4)" "unprognostic (2.68e-1)" "unprognostic (4.29e-1)" "unprognostic (2.23e-1)" "unprognostic (1.03e-1)" "unprognostic (3.06e-2)" "unprognostic (7.98e-2)" "prognostic favorable (1.63e-4)" "unprognostic (1.36e-1)" "prognostic favorable (2.39e-5)" "unprognostic (9.19e-2)" "unprognostic (2.95e-1)" "unprognostic (1.54e-1)" "unprognostic (2.13e-1)" 25.7 24.0 13.5 19.5 16.3 21.8 26.2 32.1 15.9 21.6 21.0 13.7 16.3 8.6 31.9 12.0 11.6 24.5 18.1 12.8 11.9 20.1 12.4 13.5 15.8 24.6 16.0 13.9 34.4 12.1 12.0 22.6 55.4 17.2 20.8 10.3 16.4 12.9 21.7 38.3 12.2 14.8 33.1 10.6 22.1 14.4 13.2 15.7 21.7 15.4 9.6 19.8 21.5 33.1 2.5 2.4 18.8 2.8 3.5 8.3 3.8 5.3 8.4 12.5 3.3 15.6 7.9 6.0 5.5 9.8 7.9 6.9 3.6 4.5 17.4 8.3 6.3 15.7 6.9 7.4 4.8 6.3 43.9 8.6 17.0 15.8 5.6 8.6 7.5 27.5 9.7 7.4 5.9 7.6 6.8 12.5 11.8 30.6 3.8 3.2 5.2 35.1 19.7 3.1 12.4 0.0 15.1 7.8 6.0 5.0 8.6 9.2 5.4 10.1 12.9 7.7 2.9 9.1 8.8 9.5 11.1 3.9 5.7 7.6 7.5 3.4 8.7 4.4 7.9 5.7 8.8 2.8 4.6 5.9 2.5 6.4 2.5 8.3 6.7 2.4 2.5 5.9 5.0 18.8 3.5 2.8 1.8 6.9 3.8 13.5 16.3 32.1 15.9 11.9 20.1 16.0 13.9 17.2 15.7 6.0 17.9 3.7 4.7 7.9 18.0 17.3 10.2 5.3 9.1 3.5 19.6 5.9 5.0 7.2 85.5 23.3 6.2 23.3 10.1 5.7 10.8 8.0 15.1 10.2 8.1 9.5 9.8 16.0 14.2 113.5 43.7 11.1 10.1 10.0 7.2 8.4 10.7 7.8 70.0 8.1 13.8 38.8 22.8 4.2 4.1 8.5 10.6 24.5 7.5 5.4 STAT6 "D12S1644, IL-4-STAT" ENSG00000166888 "Signal transducer and activator of transcription 6" P42226 12 57095408-57132139 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001861 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA001861: AB_1080106" "unprognostic (3.43e-3)" "unprognostic (1.87e-1)" "unprognostic (1.37e-1)" "prognostic favorable (1.69e-4)" "unprognostic (4.14e-2)" "unprognostic (2.51e-1)" "unprognostic (2.22e-1)" "unprognostic (6.70e-2)" "unprognostic (1.88e-2)" "unprognostic (3.65e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.55e-1)" "prognostic favorable (7.76e-4)" "prognostic favorable (1.14e-4)" 33.6 34.9 10.4 35.9 12.8 12.8 27.9 4.6 11.6 37.8 47.3 6.2 28.4 23.9 44.5 26.6 40.8 31.8 33.8 20.9 10.2 3.9 35.0 31.0 34.9 25.2 13.3 12.0 41.9 21.2 18.1 9.2 22.0 9.8 42.3 26.2 23.3 30.1 26.5 11.4 39.1 59.4 43.8 12.2 48.4 32.1 13.3 7.9 29.3 31.1 24.4 42.8 43.1 34.0 6.2 9.6 27.6 13.0 4.7 5.9 14.0 16.7 16.7 4.1 6.8 40.8 39.7 11.9 13.3 29.4 14.9 10.9 7.5 22.8 40.2 20.9 29.6 0.1 23.4 5.1 25.9 11.0 18.0 1.9 9.2 17.8 9.4 24.4 10.7 30.4 55.3 21.5 18.0 16.0 39.3 26.2 13.2 6.5 5.7 19.1 5.7 11.7 12.0 6.3 20.9 3.4 13.6 0.3 13.7 25.7 28.0 0.1 0.4 12.5 10.4 12.6 5.9 15.5 24.6 21.7 0.3 8.7 15.5 0.2 0.1 0.4 10.0 13.4 10.4 17.9 9.8 12.5 6.8 5.9 13.0 5.2 6.2 4.8 4.8 9.6 6.2 4.7 4.3 27.6 4.7 11.0 4.6 4.9 14.0 10.4 12.8 4.6 11.6 10.2 3.9 13.3 12.0 9.8 7.9 44.7 57.5 34.4 35.4 26.6 1.0 12.0 22.9 45.5 46.6 47.1 0.0 1.6 13.3 32.2 6.4 29.9 63.9 0.0 31.0 8.4 26.5 42.7 55.6 33.4 31.9 0.0 31.8 38.6 76.0 8.6 55.0 54.0 20.3 52.3 38.2 3.3 38.1 49.1 47.7 21.9 1.0 25.8 27.8 0.9 1.1 28.7 5.3 29.9 37.3 48.9 STAU1 "PPP1R150, STAU" ENSG00000124214 "Staufen double-stranded RNA binding protein 1" O95793 20 49113339-49188367 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020839, HPA049892, HPA072004" Approved Enhanced Cytosol NA NA Cytosol "CAB020839: , HPA049892: AB_2680938, HPA072004: " "unprognostic (7.73e-2)" "unprognostic (1.38e-1)" "unprognostic (1.97e-1)" "unprognostic (1.01e-2)" "unprognostic (7.97e-2)" "unprognostic (9.56e-2)" "unprognostic (3.70e-3)" "unprognostic (1.24e-1)" "unprognostic (2.58e-1)" "unprognostic (1.84e-1)" "unprognostic (9.17e-3)" "prognostic unfavorable (4.41e-4)" "unprognostic (1.42e-2)" "unprognostic (2.73e-1)" "unprognostic (8.08e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-2)" 30.8 34.2 33.3 32.6 30.8 34.9 59.4 28.7 38.3 28.7 35.7 31.4 24.3 34.3 34.1 25.2 31.1 43.2 31.2 37.4 30.0 27.1 55.7 77.1 30.9 26.9 33.9 28.8 31.2 44.4 58.1 20.9 31.1 39.7 30.9 30.7 26.0 31.3 31.5 51.0 30.1 38.8 34.8 45.4 25.3 33.1 28.6 28.8 39.1 48.6 20.6 28.6 45.6 36.7 14.0 13.1 29.9 15.0 11.1 17.4 9.9 26.3 20.2 22.1 9.7 22.4 27.9 24.5 20.1 24.2 60.3 27.4 68.8 29.2 18.0 34.8 25.1 28.9 29.1 29.4 35.9 50.8 7.0 16.9 14.8 15.7 54.7 19.0 11.9 14.6 22.3 31.0 24.4 28.8 24.8 29.5 13.7 25.7 11.3 22.7 16.8 20.8 19.9 18.0 25.6 28.3 16.1 29.0 17.4 24.7 23.3 25.6 22.8 50.0 48.2 29.1 23.4 30.7 17.2 26.8 36.5 31.7 22.5 23.8 10.2 11.8 20.6 26.7 12.9 21.0 19.6 15.0 14.6 14.9 12.5 16.7 14.0 16.0 15.8 13.1 13.0 14.8 13.9 29.9 11.1 14.5 12.5 17.4 9.9 33.3 30.8 28.7 38.3 30.0 27.1 33.9 28.8 39.7 28.8 83.4 74.3 59.5 85.0 99.9 31.2 58.2 71.4 119.1 60.3 73.3 13.7 88.9 79.6 112.4 15.6 81.5 80.0 23.3 102.6 32.3 76.6 153.5 46.2 138.4 56.5 41.3 72.9 65.7 53.9 17.1 60.7 63.2 47.2 82.0 66.4 57.6 115.7 64.2 65.7 143.6 25.4 58.2 69.3 110.2 58.0 104.6 162.6 48.0 59.0 164.2 STAU2 39K2 ENSG00000040341 "Staufen double-stranded RNA binding protein 2" Q9NUL3 8 73420369-73747708 "Predicted intracellular proteins" Transport RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 56.6" "Low region specificity" "Detected in all" "HPA019155, CAB020836" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020836: , HPA019155: AB_1857565" "unprognostic (5.75e-2)" "unprognostic (3.39e-1)" "unprognostic (2.31e-3)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (6.27e-2)" "unprognostic (1.07e-2)" "unprognostic (1.18e-1)" "unprognostic (6.36e-2)" "unprognostic (4.01e-2)" "unprognostic (3.31e-2)" "unprognostic (1.89e-1)" "unprognostic (3.62e-3)" "unprognostic (9.94e-2)" "unprognostic (2.98e-1)" "unprognostic (6.44e-3)" "unprognostic (4.25e-2)" 17.8 15.0 25.5 10.3 24.4 14.0 11.7 27.2 46.1 10.8 12.1 13.2 8.4 9.3 11.9 12.8 22.6 11.0 15.7 42.7 24.3 23.0 18.9 15.9 11.4 11.0 27.9 15.4 12.2 10.2 17.8 19.9 11.1 27.3 13.9 12.0 10.0 13.0 14.0 60.3 9.5 15.4 14.9 18.1 13.3 10.1 10.3 16.3 18.6 14.7 21.3 13.4 14.8 10.4 11.9 15.9 26.1 13.3 27.6 19.2 7.9 12.6 15.0 24.0 13.1 14.0 10.3 7.4 11.6 10.6 10.5 14.0 5.9 13.7 20.1 11.9 9.0 9.0 10.3 16.3 10.9 15.6 20.5 8.2 27.3 8.0 9.6 7.5 10.3 9.9 7.1 8.5 8.9 5.9 21.0 20.5 18.6 18.3 9.5 14.1 8.6 56.6 8.2 12.1 20.4 10.0 16.3 11.4 17.5 22.5 14.0 9.2 15.3 6.1 16.9 10.3 18.5 19.4 12.3 15.9 10.6 18.0 10.2 8.5 14.9 14.2 19.2 11.6 15.7 8.2 13.9 11.7 26.1 19.2 11.4 14.6 10.1 13.1 16.4 11.6 11.9 11.7 15.1 19.8 27.6 13.3 15.9 15.9 7.9 25.5 24.4 27.2 46.1 24.3 23.0 27.9 15.4 27.3 16.3 8.9 23.6 31.8 12.5 9.4 26.5 66.9 22.9 33.5 42.1 19.2 39.3 14.9 36.5 17.3 17.3 23.3 25.3 0.0 18.9 8.4 12.4 10.7 19.7 47.1 13.9 27.0 28.7 39.3 27.2 26.1 8.3 16.9 15.1 12.6 16.6 21.2 15.1 16.7 8.9 28.7 21.2 0.0 12.2 8.6 10.4 16.8 10.2 22.3 12.8 15.8 STEAP3 "dudlin-2, STMP3, TSAP6" ENSG00000115107 "STEAP3 metalloreductase" Q658P3 2 119223831-119265652 "Disease related genes, Predicted membrane proteins" "Apoptosis, Cell cycle, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 82.3;parathyroid gland: 47.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 30.8;Exocrine glandular cells: 31.3;Hepatocytes: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.1;U-87 MG: 46.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050510 Approved Approved Nucleoli,Cytosol NA NA 28000 Cytosol Nucleoli "HPA050510: AB_2681151" "unprognostic (6.51e-2)" "unprognostic (6.48e-2)" "unprognostic (4.89e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-3)" "unprognostic (9.07e-2)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (9.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.08e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.82e-1)" "unprognostic (4.45e-1)" "unprognostic (9.37e-2)" "unprognostic (6.82e-2)" 8.1 2.8 2.5 1.2 4.2 5.1 9.2 3.0 2.2 6.4 6.1 3.0 3.7 7.9 1.3 3.1 5.1 4.0 2.8 6.6 2.9 1.4 3.4 82.3 3.9 4.9 3.9 0.4 5.2 9.0 47.4 5.1 4.3 6.1 4.8 2.4 2.1 12.6 9.1 10.9 3.0 9.8 0.9 6.4 1.0 6.7 1.5 3.2 0.2 3.3 6.9 4.0 4.2 3.7 0.8 7.0 0.7 4.3 2.1 0.2 1.5 6.4 7.7 0.0 2.6 3.8 36.1 6.8 2.0 2.2 4.1 3.7 5.8 8.8 0.0 15.6 11.6 29.3 10.9 3.4 6.8 4.6 0.0 11.0 12.5 7.0 11.5 9.5 3.1 2.4 21.4 12.0 24.2 8.7 28.1 3.5 0.0 6.1 1.3 11.5 6.1 0.0 1.8 10.6 9.9 16.1 0.0 4.5 5.5 5.0 16.3 13.0 2.4 5.7 19.8 1.5 1.6 3.9 4.1 15.0 25.5 14.9 5.4 11.1 0.0 0.0 0.0 46.7 7.9 5.2 0.0 4.0 0.7 0.2 4.3 0.0 0.8 0.0 0.0 7.0 0.2 0.0 0.0 0.1 2.1 0.6 0.3 0.0 1.5 2.5 4.2 3.0 2.2 2.9 1.4 3.9 0.4 6.1 3.2 0.0 6.4 0.5 6.8 1.8 0.1 5.5 5.1 30.8 10.3 0.0 0.0 25.8 0.0 7.9 0.2 2.9 10.9 0.0 31.3 3.0 4.3 4.8 3.5 86.3 11.1 0.0 1.7 0.6 3.8 0.0 1.7 6.4 0.0 0.0 4.6 0.0 17.9 7.8 7.1 0.5 0.0 6.5 2.1 0.2 0.0 1.3 19.8 0.0 9.1 8.1 STIL "MCPH7, SIL" ENSG00000123473 "STIL, centriolar assembly protein" Q15468 1 47250139-47314147 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 36.0;testis: 23.8" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 18.6;Spermatogonia: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA046543 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA046543: AB_2679692" "unprognostic (2.07e-1)" "unprognostic (6.29e-2)" "unprognostic (5.54e-3)" "unprognostic (2.67e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-2)" "unprognostic (2.90e-5)" "unprognostic (7.35e-3)" "unprognostic (4.04e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.81e-2)" "unprognostic (3.36e-14)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" 1.2 1.4 1.3 10.8 2.4 11.0 2.9 1.4 2.2 1.2 4.1 0.9 2.5 3.6 1.5 2.2 5.8 0.9 1.7 2.0 1.4 1.2 1.5 1.6 1.7 5.0 1.3 1.5 1.2 1.5 0.9 0.9 5.5 1.1 1.7 6.4 0.8 3.6 0.5 0.8 4.2 4.0 1.3 1.2 3.4 2.2 23.8 1.0 36.0 1.1 3.5 7.1 1.3 2.1 1.9 1.6 5.4 0.7 3.3 1.2 0.5 16.9 9.1 13.1 11.7 0.9 2.3 8.4 15.0 7.2 16.8 17.7 9.8 8.4 20.0 7.1 7.5 17.3 11.3 15.3 7.9 18.1 14.9 6.9 22.5 11.3 8.6 0.5 18.2 11.5 0.8 1.3 14.4 9.4 2.1 11.1 15.3 15.9 19.1 12.6 7.7 17.6 5.7 15.9 9.4 7.5 11.5 21.4 9.6 4.7 10.2 11.7 7.0 16.1 11.9 7.8 16.3 7.7 10.4 6.5 15.9 16.1 11.4 20.3 6.3 13.1 19.7 7.4 13.9 14.7 4.3 0.7 1.1 1.1 0.4 0.5 1.7 1.2 1.0 0.5 1.9 0.8 0.8 5.4 3.3 0.3 1.6 1.1 0.5 1.3 2.4 1.4 2.2 1.4 1.2 1.3 1.5 1.1 1.0 3.0 0.3 2.2 0.5 0.8 1.2 0.5 0.0 6.7 2.3 0.0 3.9 1.2 0.0 1.2 0.7 0.9 1.8 0.0 0.4 3.8 0.8 1.2 2.3 0.5 2.3 0.0 1.7 1.8 1.9 1.3 0.3 1.2 0.0 4.6 4.3 0.8 1.8 1.5 0.7 0.3 0.7 0.0 0.0 18.6 17.8 2.0 0.7 0.8 3.4 1.4 STIMATE "MGC52022, TMEM110" ENSG00000213533 "STIM activating enhancer" Q86TL2 3 52836219-52897596 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 17.4;Collecting duct cells: 7.0;Hofbauer cells: 8.1;Proximal tubular cells: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA051855 Uncertain Approved Cytosol NA NA Cytosol "HPA051855: AB_2681639" "unprognostic (1.45e-1)" "unprognostic (7.93e-3)" "unprognostic (2.19e-1)" "unprognostic (2.49e-2)" "unprognostic (2.29e-3)" "unprognostic (3.87e-2)" "unprognostic (9.31e-2)" "unprognostic (7.55e-4)" "unprognostic (3.34e-1)" "unprognostic (6.55e-2)" "unprognostic (3.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.33e-2)" "unprognostic (1.00e-1)" "unprognostic (1.76e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" 12.0 13.0 8.9 12.0 13.9 26.4 12.8 11.6 16.1 12.5 10.7 17.8 8.8 7.8 14.4 7.9 9.2 17.7 9.6 8.3 9.5 6.7 9.9 34.7 15.2 18.1 9.9 8.1 12.2 19.2 7.7 8.9 7.8 13.0 10.2 6.7 13.0 12.8 11.5 17.9 10.5 10.1 16.5 10.2 14.9 11.2 8.4 9.5 18.0 11.8 6.8 13.2 12.5 12.5 1.7 4.0 1.7 5.8 0.7 4.6 1.4 6.8 6.0 9.2 15.9 20.9 13.3 18.5 10.1 11.3 13.7 12.6 7.3 7.2 6.7 2.0 11.5 13.1 6.5 10.8 9.8 9.6 14.9 8.3 10.9 7.6 11.4 14.0 16.4 8.4 10.5 13.6 15.3 6.9 8.6 11.1 10.9 3.8 6.7 11.4 5.6 8.9 9.2 8.3 5.6 12.3 4.9 7.1 4.5 6.4 8.9 2.0 6.8 10.2 7.0 9.5 5.4 5.9 14.3 11.2 10.9 6.4 14.3 12.0 13.1 8.4 6.3 9.5 16.5 8.3 0.0 3.3 1.7 2.2 5.8 1.8 1.7 3.5 2.4 4.0 1.5 1.9 1.4 0.3 0.7 5.5 2.3 4.6 1.4 8.9 13.9 11.6 16.1 9.5 6.7 9.9 8.1 13.0 9.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 17.4 1.2 7.0 0.0 1.5 1.7 2.1 0.0 0.0 0.0 0.0 2.5 5.3 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 2.7 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 STIP1 "HOP, STI1" ENSG00000168439 "Stress induced phosphoprotein 1" P31948 11 64185272-64204543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 168.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017448, HPA039291, HPA044062" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3700000 "Nucleoplasm, Plasma membrane" Cytosol "CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795" "unprognostic (2.49e-3)" "unprognostic (6.04e-2)" "unprognostic (1.57e-1)" "unprognostic (4.65e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.23e-4)" "prognostic unfavorable (6.18e-8)" "unprognostic (2.16e-3)" "unprognostic (4.56e-2)" "unprognostic (1.12e-2)" "unprognostic (3.56e-2)" "unprognostic (3.04e-3)" "unprognostic (1.70e-1)" "unprognostic (6.72e-2)" "unprognostic (8.23e-2)" "unprognostic (7.16e-2)" "unprognostic (2.99e-2)" 27.3 49.7 32.2 32.0 40.5 25.8 41.5 45.3 41.9 28.3 25.5 29.2 20.6 19.2 30.1 25.2 31.5 36.2 21.6 34.4 32.2 42.8 24.7 27.8 25.4 31.9 47.7 22.5 34.1 24.1 39.1 38.3 37.0 40.7 30.1 28.5 20.3 22.6 29.5 51.9 27.6 20.7 33.2 39.7 26.5 24.4 56.4 49.0 29.8 46.1 23.4 41.2 26.0 168.2 32.2 26.8 20.9 39.6 39.5 35.9 39.5 49.3 77.1 48.7 40.5 27.1 18.1 43.8 44.9 24.2 65.2 38.0 56.4 42.4 59.1 52.9 35.5 77.2 52.5 122.1 44.9 71.8 46.4 49.8 83.2 51.8 51.9 23.6 43.9 52.6 18.4 28.3 54.0 40.7 26.6 45.9 44.1 82.2 34.0 37.4 72.3 66.0 59.9 58.6 47.6 65.2 65.0 46.4 59.8 45.5 43.8 39.7 35.3 51.2 54.2 41.7 53.4 57.6 30.4 41.1 41.5 51.3 54.1 60.4 31.0 66.9 62.4 53.7 44.2 59.6 19.0 25.3 20.9 35.9 36.2 35.7 32.2 27.2 32.0 26.8 26.0 30.5 33.8 7.7 39.5 39.6 22.2 24.0 39.5 32.2 40.5 45.3 41.9 32.2 42.8 47.7 22.5 40.7 49.0 41.7 29.9 44.0 125.4 71.4 35.5 38.9 30.6 104.4 56.9 19.2 39.3 105.5 41.4 70.8 21.1 33.5 27.4 23.3 47.8 125.3 57.5 60.1 78.4 24.1 80.9 60.4 64.5 15.4 15.0 52.9 25.3 54.0 59.1 71.3 20.5 32.1 57.8 21.6 37.4 29.8 29.8 25.8 88.2 82.3 133.5 63.0 176.4 42.1 24.4 89.5 STK11 "LKB1, PJS" ENSG00000118046 "Serine/threonine kinase 11" Q15831 19 1177558-1228435 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 124.0;Late spermatids: 234.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016231, HPA017254, CAB022105, HPA067481" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: AB_2685847" "unprognostic (8.60e-2)" "unprognostic (1.68e-1)" "unprognostic (5.00e-2)" "prognostic favorable (3.69e-5)" "unprognostic (2.04e-2)" "prognostic favorable (1.96e-4)" "unprognostic (9.11e-3)" "unprognostic (3.19e-1)" "unprognostic (9.08e-2)" "unprognostic (1.26e-1)" "unprognostic (1.95e-3)" "unprognostic (7.70e-3)" "unprognostic (3.54e-2)" "unprognostic (3.16e-2)" "unprognostic (1.60e-1)" "unprognostic (3.31e-1)" "unprognostic (3.12e-3)" 13.4 13.7 13.5 11.8 12.4 19.3 16.7 17.8 16.0 12.2 16.1 8.3 19.8 18.1 10.8 8.7 15.1 10.0 11.8 15.3 12.6 9.8 10.7 22.1 9.4 12.5 9.7 10.4 11.0 16.8 10.7 11.6 12.2 9.9 12.2 5.3 11.9 16.0 12.2 49.2 16.8 18.0 7.7 7.6 16.9 15.5 59.8 7.5 11.8 12.4 14.5 19.0 11.4 9.8 2.7 1.9 11.7 6.3 1.9 1.8 0.5 21.2 10.3 7.8 14.8 7.4 6.7 16.5 10.4 10.9 9.8 10.4 8.4 14.9 13.9 11.5 10.8 4.4 13.8 7.7 16.0 3.0 26.0 18.8 14.2 0.6 10.5 16.0 14.3 23.9 12.2 11.7 7.5 11.2 8.9 9.8 11.1 26.6 19.2 5.5 15.9 13.7 14.5 15.0 7.3 12.7 21.8 8.4 15.6 8.8 15.6 18.1 13.1 0.0 7.7 11.2 4.7 12.1 23.5 13.2 10.1 11.5 19.8 16.5 37.8 15.9 10.4 10.1 19.1 10.4 2.0 4.2 4.5 0.6 6.0 0.4 2.7 1.0 1.8 1.9 1.0 1.0 0.9 11.7 1.9 6.3 1.0 0.7 0.5 13.5 12.4 17.8 16.0 12.6 9.8 9.7 10.4 9.9 7.5 6.0 13.6 11.1 6.4 14.8 23.6 11.8 17.8 2.7 6.8 22.7 17.7 6.7 6.6 8.1 124.0 14.7 29.5 0.0 11.9 4.5 10.4 14.2 2.3 25.2 12.9 17.5 14.5 16.0 22.2 234.7 22.7 10.4 15.1 17.2 29.2 19.3 13.0 25.9 19.4 8.6 19.8 12.9 20.8 49.9 19.4 13.6 7.3 8.6 33.0 10.9 STK16 "MPSK, PKL12" ENSG00000115661 "Serine/threonine kinase 16" O75716 2 219245455-219250337 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029450 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA029450: AB_10603118" "unprognostic (1.99e-1)" "unprognostic (2.08e-1)" "unprognostic (5.84e-2)" "prognostic favorable (6.09e-4)" "unprognostic (6.21e-2)" "unprognostic (5.55e-2)" "unprognostic (4.98e-3)" "unprognostic (4.25e-1)" "unprognostic (1.48e-1)" "unprognostic (4.22e-2)" "unprognostic (1.73e-2)" "unprognostic (3.17e-1)" "unprognostic (4.39e-3)" "unprognostic (1.76e-1)" "unprognostic (2.00e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" 10.2 19.0 15.7 12.8 20.3 13.3 14.6 8.8 21.0 11.5 16.2 15.2 20.5 17.2 11.4 22.1 16.0 18.3 15.5 13.0 14.5 11.9 19.5 30.1 11.4 24.6 14.2 13.2 13.2 24.5 16.5 15.1 14.0 13.3 14.3 13.7 12.8 19.0 16.3 9.9 12.2 14.2 11.5 12.3 15.9 16.8 18.9 12.7 27.2 19.8 12.8 17.0 12.9 10.3 7.9 7.8 5.8 7.6 14.5 11.2 9.7 7.4 9.8 8.6 7.3 21.5 21.0 9.9 9.6 13.3 8.2 8.2 11.4 16.6 4.3 13.5 16.0 13.1 7.7 10.0 16.0 4.4 10.5 11.5 9.7 8.9 9.8 19.5 9.2 11.4 22.4 25.7 11.3 29.9 16.2 9.9 10.1 12.1 11.8 14.0 13.7 10.0 20.1 8.0 13.5 6.0 9.5 9.7 12.6 17.1 8.6 6.9 8.8 3.4 13.7 19.7 6.5 14.3 19.5 7.6 11.2 7.9 9.1 9.2 14.6 6.2 10.3 12.4 9.8 9.8 2.0 7.6 5.8 6.0 4.2 6.8 7.8 7.5 11.2 7.8 7.9 7.8 10.0 5.2 14.5 3.6 6.7 8.4 9.7 15.7 20.3 8.8 21.0 14.5 11.9 14.2 13.2 13.3 12.7 6.0 6.4 22.9 15.0 8.8 7.4 7.8 28.1 5.3 5.7 7.0 15.7 20.2 58.0 33.5 69.7 11.7 27.6 0.0 51.6 21.3 17.4 15.1 8.1 39.4 25.1 12.7 24.8 11.6 19.1 56.4 14.1 15.7 20.3 43.3 36.3 18.3 30.3 42.9 12.7 72.1 18.4 0.0 12.2 38.1 6.9 9.8 10.8 30.5 35.9 14.0 STK17B DRAK2 ENSG00000081320 "Serine/threonine kinase 17b" O94768 2 196133566-196176503 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2" "Cell type enhanced" "Detected in many" 5 "B-cells: 158.6;granulocytes: 189.5;Kupffer cells: 142.8;Macrophages: 145.8;T-cells: 178.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.3;HMC-1: 36.8;Karpas-707: 34.1;U-698: 39.5" "Region enriched" "Detected in many" 6 "cerebellum: 71.1" "Low region specificity" "Detected in all" HPA034858 Enhanced Uncertain "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA034858: AB_10670981" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (3.68e-2)" "unprognostic (3.61e-2)" "unprognostic (3.63e-2)" "unprognostic (7.43e-3)" "unprognostic (1.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.14e-1)" "unprognostic (9.90e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.72e-8)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.64e-2)" "unprognostic (5.80e-2)" 21.0 4.1 3.2 42.8 3.8 103.4 10.1 3.2 3.3 8.2 18.8 1.1 3.8 8.5 3.4 3.9 8.9 6.3 8.6 5.7 3.3 2.2 7.2 2.9 26.2 53.7 2.3 1.8 3.1 5.0 0.7 3.8 6.5 1.7 6.8 5.7 3.5 16.7 6.1 3.4 10.9 31.8 5.3 2.7 59.3 6.0 4.6 1.4 72.2 7.5 7.0 56.2 11.3 6.0 16.9 13.6 62.0 27.0 10.3 28.4 19.0 3.2 2.2 3.4 1.2 15.0 5.7 3.8 7.7 11.6 8.5 8.9 6.8 1.1 36.3 7.1 4.4 2.2 2.2 1.4 3.3 10.4 6.4 3.8 3.4 2.9 0.6 4.5 13.7 36.8 7.2 3.3 10.5 5.5 12.1 3.5 8.6 2.6 34.1 21.1 1.7 17.8 31.0 1.9 5.9 5.2 2.9 20.7 11.0 5.0 7.6 1.3 1.3 1.9 1.9 1.6 5.5 1.3 7.2 4.2 8.3 4.1 5.9 4.3 14.0 22.6 39.5 6.2 4.7 3.6 35.9 19.7 40.2 12.0 20.7 15.3 13.3 21.5 14.5 13.6 16.9 28.4 23.1 62.0 10.3 27.0 9.7 18.5 19.0 3.2 3.8 3.2 3.3 3.3 2.2 2.3 1.8 1.7 1.4 83.4 80.3 158.6 22.9 53.1 0.3 2.2 10.2 34.8 52.4 10.4 0.0 5.9 3.3 5.2 4.6 11.6 59.1 46.7 2.5 20.9 21.2 28.7 189.5 2.4 23.5 0.0 2.9 7.4 142.8 2.0 5.2 145.8 55.6 40.5 11.0 0.9 7.9 38.6 4.2 1.4 0.2 6.5 20.5 28.6 24.9 55.5 4.2 178.5 10.5 39.9 STK24 "MST-3, MST3, MST3B, STE20, STK3" ENSG00000102572 "Serine/threonine kinase 24" Q9Y6E0 13 98445185-98577940 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026435, HPA026502" Enhanced Supported Nucleoli,Cytosol No No 2800000 "Nucleoli, Cytosol" "HPA026435: AB_1854151, HPA026502: AB_1854152" "unprognostic (3.49e-2)" "unprognostic (2.39e-2)" "unprognostic (1.78e-1)" "unprognostic (3.44e-2)" "unprognostic (2.86e-1)" "unprognostic (3.25e-2)" "unprognostic (9.67e-3)" "prognostic unfavorable (6.23e-6)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.81e-4)" "unprognostic (9.62e-2)" "prognostic favorable (6.91e-5)" "unprognostic (3.10e-2)" "unprognostic (4.49e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-2)" 28.6 14.2 15.0 29.7 16.9 19.1 34.8 12.2 21.0 36.3 37.4 12.1 23.0 31.9 24.6 26.5 68.4 20.4 41.3 30.0 14.7 12.8 30.5 14.2 23.9 31.2 10.6 10.1 20.0 20.6 12.4 13.9 38.4 14.7 28.3 28.8 36.8 30.8 21.6 18.8 60.6 67.9 34.8 9.2 31.7 30.2 22.1 7.6 38.2 28.2 41.6 48.5 39.2 45.4 8.1 11.2 11.4 13.4 1.5 13.7 6.7 36.0 11.3 20.0 18.5 30.8 18.5 28.5 16.9 23.8 23.7 23.2 33.0 49.1 25.7 8.6 21.1 14.9 32.7 18.5 37.3 22.7 64.1 9.5 27.5 14.4 18.9 43.6 27.6 19.5 11.9 59.6 18.6 54.9 25.1 20.4 20.3 9.9 17.8 15.5 15.7 20.6 11.4 17.9 49.1 8.5 26.1 12.3 13.9 22.9 32.6 11.7 16.8 10.7 17.3 22.8 31.9 20.8 26.9 27.4 15.1 11.0 12.3 19.4 17.4 9.1 9.6 23.5 16.7 24.8 5.8 13.4 6.1 6.1 10.6 7.2 6.6 11.4 8.7 11.2 8.1 7.8 6.1 11.4 1.5 12.7 7.5 13.7 6.7 15.0 16.9 12.2 21.0 14.7 12.8 10.6 10.1 14.7 7.6 11.9 24.3 29.0 62.3 63.0 20.3 2.8 68.8 34.8 44.3 64.6 53.0 35.6 21.6 29.9 2.5 26.3 110.9 0.0 47.8 36.3 36.7 53.4 18.4 22.9 24.7 9.5 40.9 27.0 68.7 3.4 24.7 40.1 54.0 16.2 70.9 22.1 67.8 59.4 28.7 31.9 11.4 38.8 29.0 1.8 3.6 71.8 16.7 21.8 51.8 117.9 STK26 "MASK, MST4" ENSG00000134602 "Serine/threonine kinase 26" Q9P289 X 132023265-132075943 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 44.8;Syncytiotrophoblasts: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 41.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059921 Approved Uncertain "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" Yes No Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA059921: AB_2684163" "unprognostic (6.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-3)" "unprognostic (4.42e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (1.42e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (4.76e-2)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" 5.4 1.4 1.1 13.5 5.1 25.9 3.3 3.8 1.1 18.0 6.4 0.3 34.8 3.7 42.3 29.6 11.7 6.0 5.2 1.9 1.2 2.3 3.5 3.2 6.7 12.8 1.2 0.3 4.7 4.0 10.2 5.8 50.7 1.2 11.5 4.8 2.2 6.3 22.4 1.2 5.1 6.1 19.1 1.5 8.5 4.7 5.2 0.8 44.7 2.3 6.8 10.2 18.0 6.6 8.4 6.2 26.4 11.6 22.0 13.3 10.2 9.1 3.2 0.4 0.0 1.5 1.4 21.0 0.3 1.1 0.1 0.1 8.4 8.3 12.5 5.7 2.0 6.5 10.4 23.4 14.7 0.0 10.8 19.1 18.0 7.9 7.9 1.4 37.6 1.5 2.0 8.8 0.0 9.9 4.4 4.1 17.2 8.0 11.8 3.5 8.1 38.7 35.0 18.8 6.2 1.2 28.0 11.6 16.1 9.5 14.8 7.8 8.6 5.5 5.0 0.2 17.0 6.4 9.9 0.1 3.8 4.0 11.4 13.5 9.1 14.2 13.9 3.4 41.0 1.9 26.4 5.1 16.6 13.3 6.7 13.0 8.4 9.1 11.3 6.2 7.3 11.8 12.2 10.0 22.0 11.6 2.3 4.0 10.2 1.1 5.1 3.8 1.1 1.2 2.3 1.2 0.3 1.2 0.8 20.8 14.1 8.6 27.8 0.0 0.0 1.1 5.1 12.0 14.8 10.4 0.0 44.8 3.3 4.4 0.4 0.4 0.9 0.0 6.3 28.5 4.9 17.5 10.5 3.0 10.7 0.0 1.2 0.6 10.1 0.0 3.1 7.2 0.0 9.0 6.4 0.0 8.6 3.5 2.1 1.2 0.0 6.5 2.9 1.1 2.3 0.0 49.4 17.5 6.3 15.3 STK32B "HSA250839, STK32, STKG6, YANK2" ENSG00000152953 "Serine/threonine kinase 32B" Q9NY57 4 5051442-5500998 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.6;lymphoid tissue: 33.6" "Cell type enhanced" "Detected in some" 25 "Distal tubular cells: 14.9;Early spermatids: 83.1;Late spermatids: 31.4;Proximal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive B-cell: 1.3;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.3;dendritic cells: 3.5" "Cell line enhanced" "Detected in some" "GAMG: 11.9;HUVEC TERT2: 11.7;REH: 10.3;U-2197: 18.7;WM-115: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015820 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA015820: AB_1858913" "unprognostic (4.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.08e-2)" "unprognostic (1.35e-1)" "unprognostic (8.12e-3)" "unprognostic (9.96e-2)" "unprognostic (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.63e-8)" "unprognostic (8.10e-3)" "unprognostic (5.04e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-3)" 5.2 0.8 6.0 2.1 4.8 2.3 7.3 1.0 5.8 6.0 2.1 5.2 1.6 1.2 5.7 1.6 2.3 2.5 4.7 0.9 4.5 7.6 23.6 0.5 1.3 2.8 5.3 2.2 1.2 4.9 0.8 0.8 5.1 4.2 2.3 2.2 3.0 2.9 1.9 2.1 3.6 1.6 7.0 3.9 0.6 9.5 7.1 2.9 33.6 2.8 2.1 1.9 4.2 6.1 1.3 3.5 0.0 0.5 0.0 0.0 0.0 0.0 5.8 0.3 0.0 0.2 0.4 0.0 4.0 0.5 2.7 0.1 0.0 0.0 0.0 0.9 8.2 11.9 0.0 0.6 0.0 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.1 11.7 0.6 0.0 0.0 1.4 0.0 0.0 0.8 1.7 0.0 0.0 10.3 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 3.5 0.3 0.0 0.0 3.0 0.0 1.2 18.7 0.0 0.4 0.0 0.0 0.0 0.0 47.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.0 4.8 1.0 5.8 4.5 7.6 5.3 2.2 4.2 2.9 0.0 0.6 0.0 0.1 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.8 83.1 1.6 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.4 1.4 0.9 5.0 0.0 0.0 0.0 0.3 0.0 1.1 13.3 0.0 0.0 0.3 0.9 3.0 0.9 0.0 0.0 0.0 0.0 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 245.0;Late spermatids: 113.1;Rod photoreceptor cells: 83.4;Spermatocytes: 126.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 7.1;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 5 "B-cells: 7.1" "Cell line enhanced" "Detected in many" "Daudi: 14.0;hTERT-RPE1: 14.2;Karpas-707: 13.1;SCLC-21H: 14.7;U-251 MG: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: AB_2683257" "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favorable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 0.9 6.1 4.7 1.6 7.5 1.1 0.6 6.1 4.4 5.4 5.3 6.8 7.7 2.6 9.6 15.3 2.3 30.7 4.5 11.4 6.6 6.1 7.7 0.4 5.3 2.3 4.9 2.7 10.3 4.6 20.4 29.9 0.3 17.7 5.3 1.3 14.8 1.6 8.9 2.6 0.3 2.5 7.0 6.7 1.2 4.4 34.4 4.6 4.5 14.6 1.5 1.8 3.7 1.4 7.1 0.7 0.0 0.0 0.2 1.4 0.3 0.0 2.0 9.7 0.0 0.0 0.0 0.0 1.7 1.9 4.2 3.9 1.1 0.0 14.0 7.3 0.3 5.5 0.0 4.3 1.3 3.7 0.0 11.9 0.0 2.6 3.3 1.6 7.8 0.0 0.4 0.0 0.1 0.0 14.2 0.3 6.9 0.0 13.1 0.1 0.0 0.2 0.0 6.9 0.0 0.0 5.2 1.3 8.8 3.8 0.0 14.7 3.9 0.0 0.0 0.1 2.7 0.0 0.8 0.0 0.0 6.6 0.1 14.8 3.1 12.4 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.1 0.0 1.4 0.0 4.4 0.0 1.1 0.0 0.2 0.0 0.7 0.2 0.3 4.7 7.5 6.1 4.4 6.6 6.1 4.9 2.7 17.7 4.6 17.9 12.6 5.4 1.1 0.0 19.2 34.4 10.2 245.0 47.8 19.2 66.8 0.1 3.3 7.5 72.9 1.3 0.0 0.0 4.4 2.7 0.3 0.2 1.1 0.0 0.2 1.6 8.7 0.0 0.0 113.1 4.0 0.4 0.0 0.0 1.3 30.6 4.5 0.0 15.9 11.9 83.4 0.0 0.2 126.9 25.1 0.0 0.0 0.0 2.9 0.0 STK36 "FU, KIAA1278" ENSG00000163482 "Serine/threonine kinase 36" Q9NRP7 2 218672026-218702716 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 20.1;Cone photoreceptor cells: 35.3;Spermatocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027409, HPA027453, HPA030058" Approved Supported Cytosol NA NA Cytosol "HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225" "unprognostic (8.11e-2)" "unprognostic (3.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (5.20e-4)" "unprognostic (1.55e-1)" "unprognostic (5.83e-3)" "unprognostic (9.04e-2)" "unprognostic (1.38e-2)" "unprognostic (1.13e-2)" "unprognostic (3.52e-3)" "unprognostic (1.46e-1)" "unprognostic (2.60e-2)" "unprognostic (1.77e-1)" "unprognostic (1.99e-3)" 4.8 10.0 7.5 4.7 11.4 2.0 6.4 7.9 11.1 9.1 7.4 7.0 11.9 4.1 14.4 13.3 5.0 13.9 9.8 3.3 6.3 3.5 10.1 4.4 6.9 3.9 2.3 6.6 13.6 9.7 12.3 23.2 3.9 7.6 9.5 6.3 9.3 7.3 8.3 3.3 4.6 5.8 7.8 5.5 4.9 7.9 63.2 4.2 3.5 11.4 3.7 5.0 9.3 7.1 1.8 1.6 3.2 1.9 2.2 1.6 1.7 2.5 5.8 12.8 10.9 14.0 10.9 7.9 7.0 5.6 8.9 8.4 7.6 4.2 3.4 9.8 7.3 6.0 5.2 8.8 7.3 7.9 1.4 7.3 3.3 17.6 10.5 6.8 4.6 5.6 11.7 5.5 8.7 6.2 23.8 6.7 4.5 7.6 4.3 7.4 5.9 2.7 5.8 7.7 3.2 3.7 5.1 5.5 3.4 10.9 12.9 10.4 8.9 5.4 8.9 3.6 13.9 9.0 3.8 6.3 12.4 4.6 4.7 4.7 5.5 4.2 1.8 7.7 2.2 5.1 0.0 1.9 3.2 1.5 1.2 0.9 1.8 1.1 1.3 1.6 0.6 1.1 1.6 0.2 2.2 1.4 1.3 1.0 1.7 7.5 11.4 7.9 11.1 6.3 3.5 2.3 6.6 7.6 4.2 8.9 4.6 1.7 1.0 1.0 7.7 2.8 5.1 20.1 1.2 3.5 35.3 1.4 0.0 2.9 11.3 2.1 2.0 0.0 2.2 1.3 1.8 1.3 1.1 4.9 2.3 1.6 2.4 4.3 2.8 4.1 5.5 1.2 0.0 1.0 4.4 5.6 1.9 3.7 4.6 3.3 9.8 6.5 2.1 26.8 8.2 0.9 0.7 1.5 3.8 0.4 STK38 NDR ENSG00000112079 "Serine/threonine kinase 38" Q15208 6 36493892-36547470 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004673, HPA038623, HPA051324" Uncertain Approved Cytosol NA NA Cytosol "CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442" "unprognostic (3.58e-3)" "unprognostic (1.80e-2)" "unprognostic (3.07e-2)" "unprognostic (6.76e-3)" "unprognostic (8.25e-2)" "unprognostic (1.47e-2)" "unprognostic (2.88e-3)" "unprognostic (2.08e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (3.78e-2)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (1.98e-2)" "unprognostic (3.80e-1)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (3.13e-3)" 19.1 8.4 12.4 39.8 10.0 19.4 32.8 18.8 12.7 16.0 26.3 7.8 14.9 17.0 18.8 16.4 28.1 14.6 18.3 15.3 12.1 7.0 15.0 17.3 21.7 45.9 11.9 6.4 12.3 9.5 7.8 11.0 15.4 9.0 17.0 27.1 11.3 24.8 18.7 14.9 21.8 29.1 28.1 13.1 25.1 16.4 24.4 11.0 34.3 10.6 13.4 28.5 22.4 19.8 10.6 13.1 33.2 30.5 25.8 27.6 22.4 17.8 13.2 14.0 15.1 28.3 21.6 12.2 20.0 16.2 20.8 21.0 10.1 12.3 24.1 15.5 29.7 17.3 19.2 11.6 8.3 24.6 9.8 9.9 17.2 17.2 9.1 14.0 6.5 9.5 14.2 21.9 16.1 10.4 24.0 13.0 12.3 14.0 14.1 29.6 10.7 10.5 17.0 5.8 21.3 11.8 40.8 17.0 6.4 19.7 22.5 16.4 7.8 24.3 11.2 14.0 16.4 12.0 17.2 12.5 16.9 15.0 13.5 12.9 11.8 21.0 17.0 3.8 25.4 16.3 33.2 19.8 15.0 27.6 22.6 21.5 10.6 22.9 24.1 13.1 8.1 20.5 22.3 27.1 25.8 30.5 6.6 21.4 22.4 12.4 10.0 18.8 12.7 12.1 7.0 11.9 6.4 9.0 11.0 17.9 16.5 10.8 8.5 11.9 2.5 15.1 22.9 37.5 50.0 7.0 0.0 11.8 1.7 16.1 5.8 12.4 32.4 0.0 11.2 15.4 19.9 11.5 12.7 13.6 11.7 4.8 13.8 11.1 28.5 4.1 25.0 31.7 16.9 9.0 22.9 6.1 19.6 25.9 28.3 13.6 8.5 12.9 13.7 23.6 9.6 18.4 12.8 23.6 22.1 22.5 STK38L "KIAA0965, NDR2" ENSG00000211455 "Serine/threonine kinase 38 like" Q9Y2H1 12 27243968-27325959 "Enzymes, Predicted intracellular proteins" "Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 19.3;granulocytes: 32.2;monocytes: 13.0" "Cell line enhanced" "Detected in all" "HDLM-2: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038623, HPA051324" Approved Approved Cytosol NA NA Cytosol "HPA038623: AB_10967059, HPA051324: AB_2681442" "unprognostic (2.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.94e-2)" "unprognostic (2.43e-2)" "unprognostic (2.02e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-2)" "unprognostic (4.68e-2)" "unprognostic (5.56e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (5.82e-4)" "unprognostic (1.16e-1)" "unprognostic (3.41e-2)" "unprognostic (1.09e-1)" "unprognostic (1.95e-1)" "unprognostic (5.05e-2)" "unprognostic (1.05e-2)" 21.2 8.4 11.0 14.6 10.9 10.9 27.2 9.6 14.6 13.0 26.3 5.7 9.7 8.4 23.9 18.2 16.8 14.8 18.2 30.2 10.9 7.8 8.9 8.5 10.8 7.8 11.1 11.8 9.6 8.9 30.2 15.2 10.6 11.9 15.3 15.0 6.8 14.0 10.9 9.1 10.8 14.6 52.3 17.0 7.6 15.6 7.5 10.1 10.0 8.8 10.5 9.8 21.9 22.7 4.5 19.3 32.2 13.0 4.0 4.0 5.3 4.2 5.8 15.1 6.7 6.9 4.7 11.2 2.7 4.0 1.7 2.5 7.3 3.2 9.9 6.5 2.4 5.2 7.9 6.8 4.7 2.7 57.8 5.6 6.1 7.0 3.6 5.8 15.0 7.1 5.7 4.9 6.4 8.2 11.2 13.9 12.8 7.4 7.8 3.5 3.0 9.8 16.3 17.9 11.2 8.8 3.7 17.6 7.6 2.5 8.1 2.4 8.1 12.2 7.5 4.7 15.4 3.7 5.1 5.4 6.0 5.3 8.6 7.4 2.8 2.8 10.4 3.0 7.0 2.4 6.0 13.0 22.9 4.0 11.1 2.8 4.5 3.1 3.9 19.3 3.4 3.8 3.1 32.2 4.0 8.1 8.2 4.0 5.3 11.0 10.9 9.6 14.6 10.9 7.8 11.1 11.8 11.9 10.1 17.9 14.4 9.8 27.4 31.5 11.3 44.5 10.2 9.4 20.5 8.7 2.0 10.0 8.3 41.2 13.6 21.5 19.7 0.0 35.8 7.9 16.0 21.3 16.3 13.0 27.6 9.5 18.5 18.4 33.1 2.3 6.1 48.1 20.3 45.1 27.7 7.5 51.1 31.7 11.3 10.5 6.4 19.4 50.7 6.5 12.1 28.0 23.2 12.5 20.5 39.1 STK39 "DCHT, SPAK" ENSG00000198648 "Serine/threonine kinase 39" Q9UEW8 2 167954020-168248141 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 35.5" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 65.7;Urothelial cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046022, HPA061803, HPA062802" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870" "prognostic favorable (3.96e-4)" "unprognostic (2.97e-2)" "unprognostic (4.40e-2)" "unprognostic (4.22e-2)" "unprognostic (4.36e-1)" "unprognostic (6.14e-2)" "prognostic unfavorable (5.67e-5)" "unprognostic (3.04e-2)" "unprognostic (8.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.20e-2)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (9.45e-2)" "unprognostic (8.61e-3)" "unprognostic (1.14e-1)" "unprognostic (6.20e-3)" 6.2 2.1 8.4 4.6 11.0 1.3 3.5 9.3 14.1 4.3 9.1 8.3 1.7 10.5 2.3 4.7 14.1 1.9 5.9 7.6 9.8 7.4 2.9 0.8 2.4 7.3 12.3 9.7 3.2 9.9 5.0 8.2 1.2 14.2 9.9 11.7 7.1 22.8 3.8 2.2 3.4 6.1 4.3 19.0 2.5 11.2 35.5 5.5 7.2 2.2 1.8 8.0 5.6 5.3 0.7 1.0 0.0 0.7 1.9 3.4 0.5 6.7 4.1 15.5 4.9 9.5 14.1 1.5 17.0 12.5 11.4 10.6 0.0 22.0 18.7 4.7 11.0 9.9 17.7 9.9 12.4 14.3 5.9 6.1 7.7 4.5 13.8 17.8 10.4 0.8 9.7 17.7 13.5 14.1 13.8 7.7 14.7 0.1 0.0 23.9 3.9 18.1 3.7 10.7 14.0 8.6 25.8 6.1 1.5 8.6 16.8 22.9 9.7 5.9 0.9 6.9 7.7 3.1 7.6 7.3 13.8 4.3 9.7 11.1 0.0 0.0 15.0 10.5 9.3 9.3 0.0 0.7 0.0 2.5 0.4 1.3 0.7 1.9 3.4 1.0 0.7 0.4 2.0 0.0 1.9 0.3 0.3 3.3 0.5 8.4 11.0 9.3 14.1 9.8 7.4 12.3 9.7 14.2 5.5 3.0 12.3 0.8 21.2 3.4 13.8 25.8 22.9 6.7 7.9 5.2 15.7 0.1 18.3 9.7 21.3 3.5 23.2 0.0 19.9 0.0 7.3 65.7 0.0 0.0 3.5 19.1 21.9 3.1 5.1 13.5 9.5 5.2 16.9 1.0 13.9 26.9 26.4 17.3 10.6 3.8 25.3 6.5 7.2 19.9 7.7 3.9 0.2 15.2 20.4 55.5 STK4 "KRS2, MST1, YSK3" ENSG00000101109 "Serine/threonine kinase 4" Q13043 20 44966474-45079959 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "monocytes: 469.7;T-cells: 231.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004038, HPA015270" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB004038: AB_2144632, HPA015270: AB_1854150" "unprognostic (2.77e-1)" "unprognostic (1.10e-1)" "unprognostic (8.83e-2)" "unprognostic (8.49e-3)" "unprognostic (2.95e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.96e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.28e-1)" "unprognostic (5.70e-2)" "unprognostic (3.96e-1)" "unprognostic (1.18e-2)" 9.5 8.8 10.4 24.5 11.5 39.5 8.1 7.5 13.4 7.8 8.6 10.3 5.4 8.1 9.3 6.5 8.9 7.3 9.4 6.1 9.3 8.8 6.3 7.4 18.8 30.6 10.5 9.1 8.3 6.4 5.9 9.3 8.2 7.7 7.5 10.6 7.4 9.3 8.7 4.2 11.4 16.1 8.2 12.0 29.1 9.6 7.4 9.6 32.3 8.0 4.9 36.6 11.5 8.7 10.8 6.9 40.6 13.3 10.3 14.5 7.9 11.8 8.0 10.3 7.3 6.3 7.9 7.1 10.5 16.0 17.7 16.1 22.7 6.5 28.9 9.1 7.4 14.9 12.6 10.8 14.0 22.8 12.9 5.7 21.1 11.7 16.0 11.1 27.1 30.0 6.4 11.6 16.6 18.2 8.9 6.5 19.6 9.7 16.7 8.9 9.3 20.2 18.3 6.2 7.7 5.5 13.1 11.3 13.4 6.5 8.1 4.9 6.0 15.5 9.0 11.8 8.2 8.2 17.1 8.3 13.4 13.0 15.4 12.0 21.8 17.1 32.3 13.1 13.0 9.8 24.4 7.6 20.5 14.5 7.7 14.4 10.3 13.8 13.3 6.9 10.8 14.3 11.9 40.6 10.3 13.3 3.9 13.3 7.9 10.4 11.5 7.5 13.4 9.3 8.8 10.5 9.1 7.7 9.6 14.9 24.0 181.6 40.4 49.5 24.2 7.0 15.3 16.0 18.2 40.1 49.1 20.3 8.3 14.1 4.8 32.3 20.5 0.0 15.3 21.4 24.3 25.1 129.5 19.1 53.0 41.3 24.6 22.7 103.3 3.6 21.0 108.8 126.5 469.7 17.4 20.3 16.0 25.9 15.9 10.9 64.0 12.9 30.2 36.4 43.8 46.3 16.2 231.2 17.4 36.3 STK40 "MGC4796, SgK495" ENSG00000196182 "Serine/threonine kinase 40" Q8N2I9 1 36339624-36385896 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 181.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.2" "Group enriched" "Detected in all" 5 "granulocytes: 19.2;monocytes: 8.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008026 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA008026: AB_1857603" "unprognostic (3.32e-1)" "unprognostic (3.00e-1)" "unprognostic (6.47e-2)" "unprognostic (4.55e-1)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (2.69e-3)" "unprognostic (6.09e-2)" "unprognostic (2.09e-1)" "unprognostic (5.96e-2)" "prognostic favorable (5.59e-4)" "unprognostic (1.19e-1)" "unprognostic (2.75e-2)" "unprognostic (7.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" 22.9 7.2 9.8 15.3 9.4 9.2 26.5 8.9 11.1 10.2 19.1 7.4 16.7 9.4 11.8 12.2 22.3 11.3 18.2 25.6 10.0 7.1 14.3 23.5 16.6 15.4 13.1 7.4 22.2 34.4 9.2 14.7 19.2 12.1 15.7 9.1 9.0 25.1 17.7 53.9 17.2 10.8 26.0 10.3 17.2 17.0 32.0 8.9 9.2 14.6 20.7 16.6 19.5 26.6 2.4 2.7 19.2 8.5 1.6 2.9 2.4 7.1 3.1 15.7 16.3 11.1 6.5 8.8 7.2 9.8 8.8 9.5 17.2 10.3 30.2 5.9 6.7 9.3 7.2 14.3 3.1 6.5 13.1 11.2 19.7 2.9 21.9 11.1 11.5 26.3 5.8 11.9 6.7 3.5 4.7 5.5 23.4 24.2 11.0 5.4 11.2 11.9 15.2 10.1 12.9 4.3 13.7 10.7 20.0 5.5 8.0 19.3 9.8 5.5 8.7 24.1 10.4 5.9 13.6 9.1 5.5 11.6 16.2 15.9 11.5 6.4 25.5 28.9 10.1 18.1 1.0 3.0 4.9 2.6 6.7 2.9 2.3 1.7 1.7 2.7 2.4 1.0 1.5 19.2 1.6 8.5 2.6 1.0 2.4 9.8 9.4 8.9 11.1 10.0 7.1 13.1 7.4 12.1 8.9 11.9 18.3 19.8 48.5 54.5 12.0 21.1 2.5 6.7 7.9 10.4 3.9 4.7 14.9 14.5 92.4 11.0 27.7 0.0 27.1 8.3 15.3 55.1 12.7 19.5 21.4 9.5 22.4 12.9 20.3 181.6 21.3 21.3 28.7 14.4 12.9 4.5 23.4 14.4 31.5 10.5 9.5 25.8 30.9 12.6 8.7 65.9 47.8 14.6 10.8 43.7 STMN1 "C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN" ENSG00000117632 "Stathmin 1" P16949 1 25884181-25906991 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 143.4;lymphoid tissue: 117.1" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 782.4;Late spermatids: 1640.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 79.3" "Group enriched" "Detected in all" 5 "dendritic cells: 79.3;T-cells: 26.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010107, HPA068438" Enhanced Approved Cytosol NA NA 210000 Cytosol "CAB010107: AB_628297, HPA068438: " "unprognostic (6.30e-2)" "unprognostic (2.40e-3)" "unprognostic (5.31e-2)" "unprognostic (7.94e-2)" "unprognostic (1.89e-1)" "unprognostic (5.02e-2)" "prognostic unfavorable (9.90e-7)" "unprognostic (9.45e-2)" "unprognostic (1.39e-2)" "unprognostic (1.61e-2)" "unprognostic (1.78e-1)" "unprognostic (3.33e-3)" "unprognostic (1.02e-2)" "unprognostic (1.68e-1)" "unprognostic (4.46e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-2)" 7.3 13.2 91.7 17.5 47.4 40.7 10.9 54.1 124.8 6.2 16.7 47.0 2.5 12.7 24.7 7.8 13.0 7.3 9.4 9.5 67.9 88.4 13.2 6.4 11.0 42.8 86.5 58.0 33.6 3.5 4.6 12.1 21.7 43.4 5.2 20.7 7.7 5.3 6.3 3.8 9.5 15.9 18.8 143.4 10.9 9.7 58.2 27.1 117.1 6.1 7.2 43.1 13.0 8.1 8.6 79.3 4.0 1.5 10.1 26.2 9.3 68.4 15.4 153.8 61.4 9.2 8.9 15.6 53.4 42.4 76.4 73.9 10.6 70.4 84.3 30.0 38.9 29.9 20.9 42.6 30.9 114.9 25.5 21.1 52.2 27.3 36.8 3.7 65.7 37.4 5.4 4.5 30.8 35.1 28.6 57.4 109.3 70.5 84.1 98.9 17.8 216.1 96.6 94.3 41.6 20.7 127.9 119.9 50.0 36.9 6.1 104.3 90.5 48.5 24.3 42.6 51.3 34.9 83.8 27.6 51.3 60.9 44.4 44.5 49.6 78.7 104.6 25.3 128.5 55.2 2.0 0.7 4.0 10.4 1.5 6.3 6.4 9.3 13.1 4.2 8.6 15.3 13.7 0.3 10.1 0.7 79.3 26.2 9.3 91.7 47.4 54.1 124.8 67.9 88.4 86.5 58.0 43.4 27.1 38.7 43.0 57.6 148.3 179.2 299.1 70.0 30.6 60.2 76.2 165.7 60.9 218.8 192.3 136.4 782.4 74.2 13.5 140.2 17.6 493.5 139.8 37.1 251.1 7.8 436.3 184.3 240.7 76.1 70.3 1640.5 41.4 141.8 254.8 48.7 70.1 201.0 61.7 45.6 44.2 144.1 147.2 38.8 101.9 532.9 205.4 79.0 109.0 151.0 130.1 26.3 STMN3 SCLIP ENSG00000197457 "Stathmin 3" Q9NZ72 20 63639705-63657682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 90.9" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 100.2;Horizontal cells: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 3.3;MAIT T-cell: 3.5;memory CD4 T-cell: 6.8;memory CD8 T-cell: 5.8;naive CD4 T-cell: 8.3;naive CD8 T-cell: 6.8" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Cell line enhanced" "Detected in many" "AN3-CA: 32.3;MOLT-4: 34.9;REH: 35.9;SCLC-21H: 50.4;SH-SY5Y: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012947 Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA012947: AB_1857606" "unprognostic (7.59e-2)" "unprognostic (4.36e-1)" "unprognostic (5.28e-2)" "unprognostic (2.33e-1)" "unprognostic (3.60e-2)" "unprognostic (6.30e-2)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.65e-3)" "unprognostic (7.52e-2)" "unprognostic (2.52e-3)" "unprognostic (2.73e-2)" "unprognostic (9.87e-2)" "unprognostic (4.08e-2)" "unprognostic (9.08e-3)" 9.0 21.0 53.5 13.1 52.7 6.9 7.7 48.8 90.9 10.9 5.3 6.7 1.2 4.2 10.9 4.2 5.9 10.3 7.6 5.0 48.9 47.7 4.6 1.6 6.2 15.2 34.2 63.6 19.8 7.6 6.2 18.6 7.0 45.8 8.2 4.2 6.2 7.5 9.5 3.3 11.6 6.5 10.1 29.5 20.3 6.5 4.1 12.3 11.0 20.9 1.9 8.4 6.6 3.5 1.0 1.3 1.2 0.1 0.0 8.3 2.5 2.5 2.9 19.3 32.3 0.5 1.9 1.3 3.0 0.1 9.4 4.4 18.5 3.5 0.1 9.5 1.1 0.5 17.5 13.4 0.3 2.9 1.2 3.6 1.2 4.0 6.8 2.6 0.9 11.0 4.0 0.1 3.0 0.7 0.4 0.3 8.8 24.2 0.5 2.4 2.9 34.9 4.4 19.8 0.6 21.1 35.9 3.1 14.4 15.8 0.5 50.4 38.4 1.4 0.8 3.6 1.6 0.5 6.5 0.5 0.2 5.4 0.2 0.6 1.2 2.5 0.8 0.5 3.6 12.5 1.0 0.1 1.2 3.3 0.1 3.5 0.3 6.8 5.8 0.1 1.0 8.3 6.8 0.2 0.0 0.1 1.3 1.1 2.5 53.5 52.7 48.8 74.0 48.9 47.7 34.2 63.6 45.8 12.3 6.0 4.5 3.7 5.3 7.2 100.2 2.0 2.5 0.0 3.4 3.5 49.1 9.6 11.6 3.7 9.8 6.7 0.2 0.0 2.1 2.5 15.9 4.6 4.6 0.0 1.9 103.3 35.7 4.9 0.6 12.6 27.9 2.2 6.8 0.0 0.5 25.6 2.3 0.0 33.6 3.9 31.2 12.9 22.6 2.3 5.2 3.8 7.3 18.1 0.6 2.0 STOM "BND7, EPB7, EPB72" ENSG00000148175 Stomatin P27105 9 121338988-121370304 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 373.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 105.9;HHSteC: 57.5;hTCEpi: 86.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010961, HPA011419" Approved Enhanced "Vesicles,Plasma membrane,Cytosol" NA NA 140000000 "Plasma membrane" "Vesicles, Cytosol" "HPA010961: AB_1080111, HPA011419: AB_1080109" "unprognostic (1.11e-1)" "unprognostic (2.15e-2)" "unprognostic (5.27e-2)" "unprognostic (7.93e-2)" "unprognostic (5.68e-3)" "unprognostic (1.65e-2)" "unprognostic (9.20e-3)" "unprognostic (7.86e-2)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (3.32e-1)" "unprognostic (1.26e-1)" "unprognostic (5.23e-2)" "unprognostic (9.15e-3)" "unprognostic (2.27e-2)" "unprognostic (7.82e-2)" "unprognostic (2.99e-2)" 96.0 27.5 29.3 29.7 41.6 89.2 78.6 15.0 19.4 28.7 46.4 23.2 14.6 14.4 35.7 26.7 34.9 28.2 45.2 46.4 27.2 18.5 35.4 114.4 66.0 40.2 24.2 15.1 31.5 11.8 21.0 11.3 77.0 28.1 36.8 16.7 27.7 23.0 28.3 50.6 25.4 25.0 50.4 37.8 48.3 34.5 17.4 23.3 4.4 29.6 25.1 16.1 56.6 51.8 1.4 8.6 5.2 13.2 33.2 43.4 25.8 1.5 9.8 0.8 4.5 105.9 30.4 0.0 26.3 26.2 7.4 11.7 1.3 1.9 12.0 6.5 32.8 4.4 2.6 5.5 24.4 13.2 7.3 2.3 27.9 21.7 3.8 57.5 10.3 5.9 50.4 86.5 11.6 15.4 2.1 26.5 3.7 6.0 16.1 16.1 7.9 0.3 7.9 12.0 0.6 3.1 1.4 0.0 26.1 5.8 0.3 1.0 0.1 22.0 19.5 11.3 8.2 6.7 8.5 33.6 17.2 5.4 17.1 2.4 6.8 7.5 0.7 6.6 10.4 9.2 3.4 8.5 0.9 43.4 13.2 42.8 1.4 22.0 38.9 8.6 1.1 4.1 22.0 5.2 33.2 9.0 1.5 2.0 25.8 29.3 41.6 15.0 19.4 27.2 18.5 24.2 15.1 28.1 23.3 148.9 81.9 21.1 213.5 93.8 3.6 29.1 119.8 124.5 113.7 33.2 5.9 85.6 3.3 48.0 2.7 299.7 8.4 373.8 19.1 46.5 164.1 41.4 34.7 315.8 77.6 3.2 0.0 270.1 169.6 5.7 61.5 72.7 84.4 33.3 0.2 8.0 31.1 14.4 96.9 74.2 4.6 135.8 215.9 21.4 6.8 104.1 144.5 93.2 0.1 170.5 STOML1 "FLJ36370, hUNC-24, SLP-1, STORP" ENSG00000067221 "Stomatin like 1" Q9UBI4 15 73978923-73994622 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042353 Approved Approved Cytosol NA NA Cytosol "HPA042353: AB_10797387" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (7.76e-2)" "unprognostic (4.54e-3)" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.78e-1)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.30e-3)" "unprognostic (2.26e-3)" "unprognostic (2.14e-1)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.67e-2)" 11.1 10.2 19.2 6.2 18.8 4.2 8.1 7.8 35.3 7.7 6.9 8.3 3.1 5.9 4.6 6.0 7.0 6.2 9.1 14.4 19.0 18.0 4.5 6.1 6.9 8.7 13.4 14.3 9.0 9.9 6.8 8.5 7.9 10.2 7.0 3.7 4.0 7.7 9.7 13.2 7.3 6.5 7.7 12.3 6.3 7.9 6.7 5.9 6.2 10.4 3.6 5.6 6.2 4.4 6.1 11.0 2.2 15.5 6.8 9.4 5.3 3.6 7.0 4.2 5.8 8.6 5.5 3.6 12.0 4.7 6.5 5.5 2.0 20.6 3.7 19.0 9.7 4.9 12.4 4.0 8.4 2.0 12.4 4.4 3.8 5.9 2.3 8.5 2.5 3.1 9.7 6.6 10.3 9.8 5.4 6.1 8.6 9.2 7.2 9.4 5.6 4.7 1.8 2.0 5.7 5.6 2.8 4.3 5.6 13.9 4.1 8.1 5.2 5.4 7.2 7.6 2.8 6.0 2.8 9.3 15.1 4.9 17.2 16.0 7.3 3.5 1.9 13.9 7.8 7.6 0.7 4.0 2.2 5.3 7.0 4.4 4.3 4.4 7.0 6.2 6.1 8.9 9.4 2.0 6.8 15.5 11.0 7.4 5.3 19.2 18.8 7.8 35.3 19.0 18.0 13.4 14.3 10.2 5.9 0.0 2.6 9.5 3.4 2.9 12.3 9.3 2.5 1.4 4.5 7.0 5.9 11.2 1.7 20.5 0.6 7.1 8.0 0.0 16.7 8.1 11.2 5.0 4.6 3.9 9.0 15.9 9.8 4.9 1.8 1.8 8.3 2.3 3.3 2.8 5.7 12.2 17.8 3.6 11.0 5.3 13.7 6.5 5.8 21.9 4.1 1.8 4.7 2.9 5.0 2.0 STOML2 "HSPC108, SLP-2" ENSG00000165283 "Stomatin like 2" Q9UJZ1 9 35099776-35103195 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015944, HPA062016" Supported Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 98000 "Plasma membrane, Cytosol" "CAB015944: , HPA062016: AB_2684659" "unprognostic (2.49e-1)" "unprognostic (2.69e-1)" "unprognostic (1.20e-2)" "unprognostic (9.43e-2)" "unprognostic (1.29e-1)" "unprognostic (6.13e-2)" "prognostic unfavorable (4.77e-4)" "unprognostic (5.14e-2)" "unprognostic (4.25e-2)" "unprognostic (1.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.00e-5)" "unprognostic (2.74e-2)" "unprognostic (5.26e-1)" "unprognostic (2.67e-1)" "unprognostic (5.47e-2)" 23.2 38.6 20.5 24.8 20.7 26.9 25.3 20.9 30.3 22.1 30.8 19.9 17.4 26.6 26.6 25.5 32.9 28.2 35.4 49.6 18.6 19.1 38.6 67.1 17.1 31.7 18.8 18.8 30.9 48.3 20.4 17.4 28.5 20.7 25.6 33.6 25.0 32.1 25.5 59.2 26.3 39.0 26.7 13.8 23.1 28.7 23.2 14.3 32.4 34.8 46.3 33.8 24.8 21.1 34.7 44.4 20.5 27.1 33.8 40.3 37.7 47.0 54.7 29.4 43.8 21.6 26.0 31.5 23.3 34.4 66.6 48.7 61.6 22.2 39.9 16.5 29.8 47.7 20.2 44.8 52.4 44.6 34.0 41.0 24.4 46.4 58.2 63.3 46.1 28.0 32.9 40.9 54.0 64.9 21.0 43.4 40.7 39.6 24.5 32.5 38.1 41.0 81.8 46.0 35.3 34.6 35.9 24.8 42.6 36.0 28.4 27.3 33.2 13.1 35.5 30.1 21.9 24.6 29.8 23.4 22.8 32.2 18.8 41.1 17.2 29.4 37.6 30.3 29.3 30.5 20.5 27.1 14.8 25.5 23.1 30.0 34.7 28.8 28.7 35.8 30.2 27.8 25.3 4.7 33.8 16.6 44.4 40.3 37.7 20.5 20.7 20.9 30.3 18.6 19.1 18.8 18.8 20.7 14.3 38.7 30.7 67.8 97.0 85.6 32.1 74.2 99.3 64.3 54.6 47.1 7.9 204.6 212.2 112.4 62.9 62.9 121.7 46.7 133.0 205.2 74.7 89.1 82.0 100.2 114.0 17.5 94.8 54.6 32.3 17.5 69.6 50.8 94.5 110.0 124.3 59.7 118.2 126.3 65.4 214.3 28.6 51.8 82.4 68.9 106.7 100.1 139.1 53.3 180.1 119.6 STON2 "STN2, STNB2" ENSG00000140022 "Stonin 2" Q8WXE9 14 81260656-81436465 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 23.2;Proximal tubular cells: 20.1;Urothelial cells: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;intermediate monocyte: 3.6" "Lineage enriched" "Detected in single" 4 "monocytes: 3.6" "Cell line enhanced" "Detected in many" "HEL: 43.7;HMC-1: 24.8;Karpas-707: 22.5;RT4: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003086 Enhanced Approved Nucleoli,Cytosol NA NA 9800 "Nucleoli, Cytosol" "HPA003086: AB_2302748" "unprognostic (5.28e-2)" "unprognostic (9.83e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.50e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (3.30e-1)" "unprognostic (9.88e-2)" "unprognostic (9.19e-2)" "unprognostic (5.82e-3)" "unprognostic (1.37e-1)" "unprognostic (6.15e-2)" "unprognostic (1.44e-1)" 6.1 1.2 26.8 1.5 23.5 5.6 11.5 2.0 22.4 4.3 5.3 18.1 1.6 4.7 1.8 6.7 11.3 13.6 7.1 4.0 26.1 11.6 17.5 3.7 5.0 1.3 10.3 11.5 3.7 1.3 0.6 7.9 4.3 9.6 2.6 6.1 7.9 4.6 3.8 9.5 9.2 4.9 2.2 4.5 18.7 6.8 4.0 15.9 0.3 13.1 4.9 3.4 6.8 6.6 0.0 0.5 0.8 3.6 0.0 0.1 3.2 1.8 1.3 4.8 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 4.3 1.5 0.0 2.2 0.0 1.3 12.0 6.7 15.1 0.0 0.2 2.3 43.7 8.0 1.6 0.0 0.0 24.8 0.6 13.3 0.0 4.6 0.0 0.0 2.5 16.0 22.5 0.4 2.7 2.1 0.0 4.8 4.3 1.1 0.0 7.1 1.4 3.2 18.1 11.8 0.7 5.3 0.2 0.0 4.0 0.6 0.1 0.2 0.9 3.7 4.0 1.0 2.6 4.6 0.0 3.3 0.1 1.1 0.0 2.4 0.0 0.1 3.6 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 3.2 26.8 23.5 2.0 17.5 26.1 11.6 10.3 11.5 9.6 15.9 3.0 0.3 0.0 9.7 12.0 0.4 1.2 2.5 2.7 1.2 17.4 11.8 0.8 6.6 0.6 0.2 2.2 4.1 0.0 0.4 0.3 5.3 4.6 0.0 0.8 2.6 3.2 0.0 4.9 10.2 1.1 9.5 2.5 1.7 0.0 2.5 23.2 2.1 1.5 8.1 20.1 6.7 0.0 1.2 0.9 6.6 7.8 12.9 0.5 3.3 26.4 STOX1 "C10orf24, FLJ25162" ENSG00000165730 "Storkhead box 1" Q6ZVD7 10 68827541-68895432 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;fallopian tube: 19.1" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;T-cells: 3.0" "Cell line enhanced" "Detected in many" "AN3-CA: 10.9;HAP1: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037844, HPA037845" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Intracellular and membrane" No NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA037844: AB_2675700, HPA037845: AB_10671369" "prognostic favorable (3.37e-5)" "unprognostic (5.53e-3)" "unprognostic (6.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.63e-3)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "prognostic favorable (2.08e-4)" "unprognostic (1.52e-1)" "unprognostic (2.45e-3)" "unprognostic (5.33e-3)" "unprognostic (5.29e-2)" "unprognostic (3.87e-2)" "unprognostic (8.77e-2)" "unprognostic (3.06e-2)" "unprognostic (2.33e-1)" "unprognostic (3.46e-2)" 8.7 6.4 17.8 1.7 13.4 0.6 4.8 1.8 13.4 2.0 2.6 6.8 1.3 2.0 2.8 11.9 2.5 19.1 1.7 0.9 16.1 9.3 4.5 0.9 2.2 1.8 11.5 10.2 1.9 1.6 6.1 8.8 1.5 5.6 2.3 2.8 5.0 2.6 2.1 1.9 1.4 2.8 2.5 2.4 0.9 2.2 3.8 7.3 3.3 8.7 0.0 1.7 1.6 0.9 0.7 3.5 0.0 0.0 0.2 3.0 0.2 2.2 2.4 5.4 10.9 2.3 0.0 3.2 0.2 0.1 1.6 1.7 2.3 3.3 2.1 3.1 0.0 4.2 0.6 10.1 0.0 0.8 2.5 4.2 0.2 0.5 3.1 0.3 2.7 3.9 0.2 0.2 0.3 0.0 0.3 0.1 5.6 0.5 0.3 0.2 2.2 4.6 3.4 1.8 0.5 1.5 3.4 0.1 0.0 3.2 5.8 1.7 5.0 3.9 1.0 0.7 3.6 2.4 2.2 0.0 0.0 0.3 0.0 1.5 1.0 1.9 2.2 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.4 0.8 0.6 0.0 0.7 3.0 1.4 0.0 0.2 0.0 3.5 0.3 0.2 17.8 13.4 1.8 12.5 16.1 9.3 11.5 10.2 5.6 7.3 0.0 0.3 0.5 3.2 1.3 0.9 0.3 0.0 48.2 9.1 1.8 0.0 1.1 3.3 0.0 0.2 0.1 0.4 0.0 0.3 0.2 0.6 1.8 2.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 1.6 1.5 0.2 0.0 0.0 1.2 0.3 6.5 5.7 1.6 11.1 0.4 1.0 0.0 5.6 1.7 STOX2 DKFZp762K222 ENSG00000173320 "Storkhead box 2" Q9P2F5 4 183797692-184023526 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 30.6;Horizontal cells: 31.8;Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.6;HeLa: 9.9;NTERA-2: 14.7;SH-SY5Y: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049776, HPA065002" Uncertain Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA049776: AB_2680875, HPA065002: " "unprognostic (9.79e-3)" "unprognostic (3.46e-1)" "unprognostic (2.10e-1)" "unprognostic (6.57e-3)" "unprognostic (3.33e-1)" "unprognostic (6.41e-2)" "unprognostic (4.57e-4)" "unprognostic (8.97e-3)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-3)" "unprognostic (2.49e-1)" 3.0 2.8 12.0 1.2 12.6 8.4 3.1 20.3 17.5 3.9 2.1 18.2 1.6 1.6 3.2 5.9 8.2 4.7 4.5 4.9 9.6 8.3 3.4 4.0 3.5 1.1 16.2 18.0 5.8 10.6 12.0 8.1 2.4 11.8 4.1 1.7 2.5 11.0 4.2 3.2 6.2 1.8 3.2 9.2 6.2 3.7 1.6 16.4 0.8 9.6 0.8 1.9 4.3 3.4 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.7 3.7 11.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 1.5 0.0 2.3 0.0 2.4 0.2 6.4 1.0 0.0 0.0 5.1 0.0 9.9 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.0 1.5 0.0 0.5 0.0 0.1 14.7 0.0 0.5 0.1 4.3 0.0 2.8 3.5 6.0 14.0 2.7 0.0 0.0 4.4 0.2 0.3 0.0 0.0 2.5 0.0 0.1 0.1 3.2 1.8 0.6 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 12.0 12.6 20.3 16.6 9.6 8.3 16.2 18.0 11.8 16.4 11.9 16.6 0.0 5.8 3.8 30.6 19.3 5.1 20.1 12.5 7.0 0.0 2.3 3.3 3.9 0.8 18.3 0.0 0.0 2.7 1.7 1.5 4.2 0.0 4.9 0.9 31.8 1.7 22.1 2.6 2.2 0.6 0.2 1.7 0.0 0.0 15.1 2.4 0.0 4.2 1.9 3.4 0.0 1.0 0.5 2.4 2.9 0.6 0.0 0.0 2.6 STPG4 "C2orf61, FLJ40172" ENSG00000239605 "Sperm-tail PG-rich repeat containing 4" Q8N801 2 47045538-47155378 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6;RT4: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA047366, HPA052691" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047366: , HPA052691: AB_2681918" "unprognostic (6.74e-3)" "unprognostic (5.81e-4)" "unprognostic (3.43e-2)" "unprognostic (1.23e-3)" "unprognostic (1.72e-1)" "unprognostic (1.55e-3)" "unprognostic (4.36e-2)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (2.78e-2)" "unprognostic (2.36e-3)" "unprognostic (6.23e-2)" "unprognostic (3.64e-6)" "unprognostic (5.14e-2)" "unprognostic (6.00e-2)" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 29.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.5 2.0 0.6 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.6 0.1 0.0 0.3 0.4 0.1 0.2 0.8 0.5 0.5 0.4 0.4 0.5 0.0 0.2 0.0 0.7 0.5 0.5 0.6 0.0 0.1 0.0 0.0 0.6 0.0 1.1 1.0 0.1 0.8 0.3 0.2 0.1 6.6 0.9 0.1 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.1 0.4 1.8 0.4 0.1 0.0 0.4 0.1 0.3 0.0 0.2 0.6 0.3 0.9 0.1 0.2 0.8 0.2 0.0 0.0 0.6 0.2 0.0 0.1 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.0 0.1 1.5 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STRADA "LYK5, NY-BR-96, Stlk, STRAD" ENSG00000266173 "STE20-related kinase adaptor alpha" Q7RTN6 17 63682336-63741986 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "monocytes: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031637 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA031637: AB_10601718" "unprognostic (1.59e-1)" "unprognostic (2.19e-1)" "unprognostic (5.59e-3)" "unprognostic (5.52e-2)" "unprognostic (8.91e-2)" "unprognostic (7.56e-5)" "unprognostic (6.79e-4)" "unprognostic (3.68e-2)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "prognostic favorable (5.34e-5)" "unprognostic (7.29e-2)" "prognostic unfavorable (6.08e-7)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "prognostic favorable (6.43e-4)" 13.3 17.7 19.4 14.6 23.7 17.5 13.0 25.0 28.4 15.2 13.2 27.1 8.7 9.5 16.1 20.6 14.3 20.9 14.5 15.1 18.9 20.2 14.7 13.0 13.9 19.6 20.9 21.7 18.5 12.5 21.9 17.5 14.4 26.0 13.8 13.1 22.2 12.6 16.7 10.3 20.1 12.0 19.1 19.4 20.7 12.6 55.4 21.4 16.2 13.3 8.9 21.3 12.9 12.8 11.2 16.2 18.6 10.0 15.6 11.7 7.5 7.2 21.7 18.9 19.0 18.6 13.9 7.4 13.8 12.7 19.9 17.8 5.7 8.4 11.0 8.6 11.7 9.9 6.0 12.5 13.3 19.8 12.2 12.1 21.8 15.2 13.4 13.2 20.6 15.7 14.5 11.5 22.6 13.1 13.3 22.0 17.3 13.9 11.8 18.8 13.4 24.2 14.1 9.4 6.2 12.4 15.8 30.1 13.5 17.8 14.3 20.7 23.2 9.4 15.5 15.1 20.4 11.4 15.0 17.6 19.0 13.5 15.3 11.4 11.8 12.6 13.9 14.2 12.5 14.9 18.6 9.5 8.6 10.5 7.1 9.7 11.2 9.7 11.7 16.2 9.0 9.6 8.5 11.4 15.6 10.0 13.7 7.2 7.5 19.4 23.7 25.0 28.4 18.9 20.2 20.9 21.7 26.0 21.4 8.9 8.2 2.2 0.1 0.0 1.5 0.5 0.0 2.7 4.5 8.7 0.0 1.5 0.0 6.0 1.1 0.6 1.6 0.0 2.5 0.7 0.7 0.3 2.3 0.0 1.3 1.6 0.0 0.6 0.3 1.6 0.6 4.6 0.0 29.7 1.6 1.0 3.9 2.5 1.4 0.6 3.7 0.0 1.4 2.7 0.5 0.4 2.1 1.0 1.9 0.1 STRADB "ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK" ENSG00000082146 "STE20-related kinase adaptor beta" Q9C0K7 2 201387858-201480846 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Erythroid cells: 186.9;Proximal tubular cells: 173.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026549, HPA028520" Approved Uncertain Aggresome,Cytosol NA NA Cytosol Aggresome "HPA026549: AB_1844779, HPA028520: AB_10604100" "unprognostic (6.34e-2)" "unprognostic (2.48e-1)" "unprognostic (2.63e-1)" "unprognostic (3.56e-3)" "unprognostic (4.04e-2)" "unprognostic (7.64e-2)" "unprognostic (1.35e-1)" "unprognostic (1.58e-1)" "unprognostic (2.63e-3)" "unprognostic (2.65e-2)" "unprognostic (6.21e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.08e-1)" "unprognostic (7.83e-2)" "prognostic favorable (4.45e-4)" "unprognostic (4.93e-2)" 13.8 28.6 13.8 7.9 11.7 32.7 9.2 8.8 13.5 6.4 13.7 16.9 4.9 18.8 10.3 9.5 8.9 5.7 7.9 15.2 15.3 11.5 35.2 50.5 7.2 10.1 15.8 11.0 7.8 9.1 3.9 14.1 11.6 12.7 7.1 15.9 10.1 7.1 7.7 48.3 4.4 21.3 7.4 21.0 7.3 4.7 7.8 9.4 8.3 9.7 7.8 7.7 6.2 6.2 24.1 10.4 9.7 8.6 16.3 10.4 9.6 3.9 6.8 11.9 15.2 19.4 24.6 8.4 8.0 14.0 11.2 17.0 9.0 3.8 0.0 5.3 12.7 13.8 4.0 11.5 7.6 20.3 4.6 9.4 4.8 3.2 19.9 14.7 5.6 5.4 20.8 6.9 14.3 12.8 20.9 8.4 9.2 10.2 1.7 60.3 2.1 5.1 9.8 16.0 3.7 7.0 7.0 4.6 2.9 9.5 3.2 2.0 9.8 5.5 4.2 23.6 22.7 2.2 10.8 8.1 6.9 5.3 8.7 6.1 6.7 11.8 1.8 11.6 2.5 6.4 3.4 8.0 9.7 6.0 8.6 5.4 16.7 8.0 8.6 10.4 24.1 10.4 10.3 1.6 16.3 7.5 4.6 9.5 9.6 13.8 11.7 8.8 13.5 15.3 11.5 15.8 11.0 12.7 9.4 8.9 3.4 20.8 6.4 1.9 10.4 29.0 15.3 5.3 3.4 14.0 78.5 41.3 33.2 9.4 3.0 4.9 62.6 186.9 13.6 22.9 10.8 10.0 5.7 77.9 16.8 11.1 16.3 3.1 17.8 5.8 10.0 8.3 15.1 17.2 23.2 13.5 11.0 26.2 3.5 173.8 17.1 6.5 4.1 27.0 44.7 1.3 23.3 9.6 22.7 7.7 STRAP "MAWD, pt-wd, UNRIP" ENSG00000023734 "Serine/threonine kinase receptor associated protein" Q9Y3F4 12 15882391-15903478 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027320, HPA055557, HPA073876" Approved Enhanced Cytosol NA NA 290000 Cytosol "HPA027320: AB_1857614, HPA055557: AB_2682849, HPA073876: AB_2686639" "unprognostic (4.64e-3)" "unprognostic (2.25e-2)" "unprognostic (9.88e-2)" "unprognostic (1.42e-2)" "unprognostic (2.88e-1)" "unprognostic (4.05e-3)" "prognostic unfavorable (6.83e-6)" "unprognostic (1.69e-2)" "unprognostic (3.71e-1)" "unprognostic (2.15e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-1)" "unprognostic (3.60e-3)" "unprognostic (5.93e-2)" "unprognostic (2.54e-1)" "prognostic unfavorable (9.07e-4)" "prognostic unfavorable (5.10e-4)" 36.7 39.8 43.5 28.1 43.2 24.1 46.4 38.1 55.3 30.5 29.4 19.3 29.2 24.7 31.8 29.1 33.7 24.7 25.8 54.0 55.7 44.9 46.4 42.9 27.7 30.4 35.8 48.3 25.5 38.7 40.4 36.7 34.4 47.1 27.8 29.5 20.5 26.0 32.2 109.2 25.3 23.6 37.4 51.5 20.7 28.9 32.9 27.5 27.9 42.6 36.6 29.4 28.6 29.8 36.9 44.6 30.8 41.8 29.2 43.4 38.5 32.4 38.2 36.5 31.1 32.4 32.4 48.8 39.0 27.2 35.2 32.9 54.7 28.7 36.2 19.4 39.6 34.4 23.6 43.6 42.8 52.0 48.3 35.4 36.6 30.4 23.9 53.2 42.4 17.8 31.2 36.5 38.8 43.7 38.9 40.9 23.8 28.0 11.1 45.7 22.6 35.2 20.3 129.0 20.9 25.1 27.2 50.3 20.8 40.7 33.5 23.6 40.1 31.4 21.7 42.5 76.0 40.6 22.8 34.2 26.4 31.3 27.9 47.8 12.7 17.2 59.4 32.4 23.6 33.2 26.8 36.7 30.8 34.6 41.8 38.9 36.9 36.0 33.3 44.6 30.8 35.4 37.3 17.0 29.2 35.9 27.4 43.4 38.5 43.5 43.2 38.1 55.3 55.7 44.9 35.8 48.3 47.1 27.5 35.7 36.8 74.9 140.3 216.3 84.6 96.8 40.8 44.2 42.1 62.8 33.4 132.9 233.8 149.7 27.7 77.1 37.6 46.7 119.4 167.9 122.0 110.6 46.1 73.0 98.2 57.2 101.9 64.4 87.9 61.5 64.7 73.5 121.4 105.6 50.2 130.3 114.5 67.4 95.8 178.6 74.9 77.6 196.1 150.4 65.6 199.2 246.8 82.2 78.1 179.1 STRIP1 "FAM40A, FAR11A, FLJ14743, KIAA1761" ENSG00000143093 "Striatin interacting protein 1" Q5VSL9 1 110031577-110074641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060302, HPA060498" Approved Supported Cytosol NA NA Cytosol "HPA060302: AB_2684247, HPA060498: AB_2684293" "unprognostic (2.75e-2)" "unprognostic (3.91e-1)" "unprognostic (2.81e-2)" "unprognostic (1.63e-1)" "unprognostic (5.09e-1)" "unprognostic (2.90e-2)" "unprognostic (1.01e-2)" "unprognostic (9.08e-2)" "unprognostic (2.83e-1)" "unprognostic (6.29e-2)" "unprognostic (1.41e-3)" "unprognostic (2.86e-1)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (1.82e-1)" "unprognostic (6.23e-2)" "unprognostic (2.23e-2)" 14.7 15.8 25.6 11.8 20.2 21.7 14.1 30.3 30.7 16.6 14.6 19.7 10.1 14.0 21.0 17.8 15.6 17.7 13.0 13.5 22.3 19.0 12.3 10.0 13.7 15.1 17.7 18.1 24.7 15.7 24.8 16.7 21.2 24.5 13.5 15.0 15.3 14.6 16.2 13.6 18.0 19.8 20.1 11.1 23.8 13.8 21.9 16.4 18.6 14.5 10.9 17.3 16.2 15.2 13.0 13.5 15.9 15.7 17.3 18.4 13.1 12.3 8.2 22.5 15.2 19.7 13.0 16.3 19.4 17.1 20.4 17.8 8.6 7.2 10.1 10.7 17.2 13.0 11.8 11.9 13.8 14.4 21.4 14.4 16.8 14.6 11.1 10.9 15.1 16.8 13.9 16.6 17.2 19.0 15.1 16.2 14.0 14.9 13.0 19.6 14.6 17.3 16.0 18.1 9.3 11.2 16.9 28.9 8.9 14.2 18.2 29.1 16.7 16.6 21.2 12.5 13.6 10.5 13.8 16.6 15.4 14.8 17.8 12.9 13.3 7.3 10.3 17.6 16.4 22.2 12.2 11.5 15.9 17.7 12.7 15.5 12.8 15.1 18.4 13.5 13.0 17.5 15.5 10.7 17.3 15.7 6.2 13.3 13.1 25.6 20.2 30.3 30.7 22.3 19.0 17.7 18.1 24.5 16.4 3.0 8.5 13.7 9.0 12.2 12.0 6.5 2.5 0.0 6.8 8.7 17.7 13.0 1.7 8.7 38.2 9.8 13.6 0.0 6.2 8.4 10.0 8.6 6.9 8.3 11.3 6.4 14.5 16.0 10.8 33.5 9.2 9.3 3.3 14.4 11.2 5.8 9.5 9.5 9.6 3.1 19.6 6.5 13.3 9.5 9.2 11.2 21.6 13.8 9.8 14.2 STRIP2 "FAM40B, FAR11B, KIAA1170" ENSG00000128578 "Striatin interacting protein 2" Q9ULQ0 7 129434433-129488399 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.6;retina: 55.6;skeletal muscle: 27.4" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 37.1;Muller glia cells: 70.1;Spermatocytes: 32.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 36.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "LHCN-M2: 20.8;U-2197: 23.7;U-87 MG: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019657 Approved Approved Cytosol NA NA Cytosol "HPA019657: AB_1848399" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "unprognostic (2.11e-1)" "unprognostic (2.41e-1)" "unprognostic (4.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.80e-3)" "prognostic unfavorable (6.78e-4)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (8.99e-2)" "unprognostic (1.95e-1)" "unprognostic (2.87e-6)" "prognostic favorable (5.41e-4)" "unprognostic (4.06e-2)" "unprognostic (5.34e-2)" "unprognostic (7.50e-2)" 0.7 2.4 1.9 2.0 36.6 3.7 0.8 7.0 10.0 0.4 0.8 3.0 0.0 0.8 0.8 1.6 1.1 0.4 1.2 10.3 1.5 2.1 5.6 0.6 1.0 2.7 2.2 2.9 0.7 1.3 0.4 4.7 1.3 7.6 1.6 1.4 55.6 1.7 0.5 27.4 1.5 1.0 0.8 1.2 1.5 1.0 13.5 9.4 0.2 0.8 2.1 2.1 0.9 0.3 0.6 0.7 2.5 0.6 0.4 0.9 0.4 7.7 3.4 3.1 4.9 1.2 1.1 13.6 3.2 4.1 5.4 5.3 1.8 4.4 3.3 0.4 1.3 17.7 8.8 3.3 2.9 8.3 19.0 2.8 2.5 5.6 1.9 0.8 1.6 13.3 1.3 1.0 9.2 5.8 9.0 9.3 3.0 10.8 2.1 20.8 0.4 4.1 4.0 3.0 1.7 7.0 2.7 5.8 0.7 2.0 2.9 0.7 0.7 7.4 0.6 1.6 2.5 0.9 3.9 3.3 3.1 3.1 23.7 9.2 1.9 1.2 3.9 21.1 4.1 4.4 2.5 0.6 0.6 0.9 0.4 0.3 0.3 0.6 0.3 0.2 0.6 0.5 0.4 2.0 0.4 0.5 0.7 0.9 0.4 1.9 36.6 7.0 4.8 1.5 2.1 2.2 2.9 7.6 9.4 3.0 0.6 0.0 0.2 0.2 11.0 37.1 0.0 1.4 0.0 0.0 2.0 0.4 0.0 0.8 4.7 0.5 0.0 0.0 3.3 3.4 1.0 0.1 7.0 0.0 0.7 1.6 0.0 0.6 0.0 7.9 0.6 1.3 1.7 13.6 0.0 70.1 3.8 0.0 0.7 9.6 3.5 0.0 0.5 32.7 9.6 0.1 0.2 0.0 0.4 0.6 STRN "PPP2R6A, STRN1" ENSG00000115808 Striatin O43815 2 36843640-36966472 "Cancer-related genes, Predicted intracellular proteins" Calmodulin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017286 Approved Approved Nucleoplasm,Cytosol No No 11000 Cytosol Nucleoplasm "HPA017286: AB_1857618" "unprognostic (1.65e-1)" "unprognostic (1.65e-1)" "unprognostic (3.57e-3)" "unprognostic (2.23e-2)" "unprognostic (3.25e-1)" "unprognostic (1.53e-1)" "unprognostic (1.63e-3)" "unprognostic (7.37e-2)" "unprognostic (1.25e-1)" "unprognostic (2.42e-1)" "unprognostic (1.77e-3)" "unprognostic (1.33e-1)" "prognostic favorable (2.27e-4)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (2.11e-1)" "unprognostic (3.43e-2)" 11.8 8.1 11.4 11.0 22.1 17.4 13.3 16.4 14.2 11.2 14.0 10.9 8.9 10.1 8.6 7.1 25.9 6.8 8.4 25.7 16.2 10.2 11.6 10.2 10.3 9.6 16.9 9.4 9.9 7.1 11.3 6.3 12.6 10.5 8.1 13.7 5.6 16.2 6.9 16.0 16.1 13.2 11.1 34.3 10.9 11.4 9.8 14.8 18.6 8.1 15.5 16.7 11.3 14.4 1.5 0.8 3.7 1.5 0.5 2.1 0.4 23.3 11.8 15.8 6.6 8.7 12.2 15.8 9.5 8.9 9.2 8.5 12.0 7.6 15.5 7.6 11.9 13.2 11.1 13.3 10.4 11.4 17.5 10.2 25.1 10.4 6.2 8.3 15.0 14.1 7.3 9.1 14.7 11.6 6.8 11.7 6.2 18.7 12.3 11.3 6.7 14.9 6.6 12.6 9.5 6.0 9.7 25.0 6.7 7.6 19.3 2.9 9.6 14.1 10.9 8.9 9.2 7.8 5.8 15.5 16.5 16.7 10.2 12.4 12.5 18.8 13.7 8.4 15.1 11.4 3.4 0.8 1.4 2.1 1.5 0.7 1.5 1.5 1.3 0.4 0.9 0.8 0.9 3.7 0.5 1.4 0.8 0.3 0.4 11.4 22.1 16.4 13.0 16.2 10.2 16.9 9.4 10.5 14.8 8.9 7.7 5.2 9.0 18.3 11.7 51.7 10.2 1.4 17.0 22.7 19.6 6.9 8.3 8.8 1.7 17.5 17.3 0.0 7.2 7.9 7.9 14.5 4.7 7.3 7.6 17.5 10.9 15.4 22.2 0.9 8.9 11.0 8.5 10.8 16.4 9.3 12.8 10.5 11.7 7.7 15.4 0.0 10.3 10.3 18.1 29.1 13.6 10.2 13.8 29.3 STRN3 "PPP2R6B, S/G2NA, SG2NA" ENSG00000196792 "Striatin 3" Q13033 14 30893799-31026401 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003392, HPA004636, CAB069925" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA 15000 Cytosol "Nucleoplasm, Actin filaments" "CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940" "unprognostic (4.08e-1)" "unprognostic (8.66e-2)" "unprognostic (8.08e-2)" "unprognostic (4.22e-2)" "unprognostic (3.06e-2)" "unprognostic (7.74e-3)" "unprognostic (3.37e-2)" "unprognostic (2.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.53e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "prognostic favorable (9.66e-4)" "unprognostic (8.74e-2)" "unprognostic (7.85e-2)" "unprognostic (4.83e-2)" "unprognostic (1.01e-2)" 18.5 14.3 15.9 12.1 16.2 10.9 13.5 23.4 17.7 15.8 17.4 11.5 16.5 8.8 14.7 14.8 16.5 10.8 14.0 21.5 14.4 12.1 15.2 22.7 11.6 7.2 12.9 10.1 12.6 13.1 18.0 20.2 14.1 13.9 16.2 14.0 11.4 12.6 17.2 52.0 12.6 11.3 22.0 11.8 11.9 12.9 22.4 14.6 9.3 14.9 13.5 9.7 25.1 20.5 7.0 10.5 8.5 7.9 7.4 10.0 2.4 18.0 15.5 17.4 12.4 14.9 11.2 14.4 17.2 12.7 14.4 14.6 20.7 12.2 10.5 12.6 12.5 7.3 9.9 19.3 11.0 21.4 9.1 6.5 10.4 10.6 40.0 16.1 8.9 11.6 11.9 11.5 11.5 14.1 12.9 11.5 9.8 12.5 10.0 13.9 12.3 11.5 8.6 8.5 12.9 14.5 8.5 20.4 2.8 21.6 25.9 10.9 9.0 19.1 14.0 9.3 17.5 16.0 7.6 13.9 14.2 12.7 8.9 6.8 9.5 10.8 10.3 7.0 6.5 11.3 6.3 7.1 8.3 6.8 7.9 8.9 7.0 8.5 7.7 5.8 6.9 8.6 10.0 8.5 7.4 6.2 10.5 6.4 2.4 15.9 16.2 23.4 17.7 14.4 12.1 12.9 10.1 13.9 14.6 20.8 21.9 13.7 39.9 87.1 24.8 45.2 22.9 24.1 22.7 29.6 25.5 19.0 10.0 31.6 16.6 27.5 18.7 0.0 23.0 16.4 24.9 45.1 8.1 36.5 11.3 35.0 30.7 33.7 22.1 10.5 24.7 21.2 42.2 16.2 16.6 25.1 30.6 14.2 26.2 21.4 28.8 25.8 45.3 61.6 46.8 84.3 27.8 16.0 14.0 41.0 STRN4 "PPP2R6C, ZIN" ENSG00000090372 "Striatin 4" Q9NRL3 19 46719507-46746994 "Predicted intracellular proteins, Predicted membrane proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043051, HPA043527, HPA056706" Supported Approved Cytosol NA NA 34000 Cytosol "HPA043051: AB_2678290, HPA043527: AB_10959664, HPA056706: AB_2683214" "unprognostic (3.57e-2)" "unprognostic (7.96e-2)" "unprognostic (2.13e-2)" "unprognostic (7.39e-2)" "unprognostic (1.81e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (6.06e-8)" "unprognostic (8.31e-3)" "unprognostic (5.34e-2)" "prognostic unfavorable (2.98e-4)" "unprognostic (1.56e-1)" "unprognostic (9.41e-3)" "unprognostic (4.86e-3)" "unprognostic (6.74e-2)" "unprognostic (4.06e-2)" "unprognostic (6.04e-2)" "unprognostic (1.84e-1)" 21.8 13.7 22.6 17.8 26.6 27.0 18.7 10.5 34.9 15.3 18.0 17.9 17.8 19.0 19.9 12.6 23.8 16.9 17.0 20.7 23.1 13.4 15.8 11.4 17.4 16.2 15.1 21.4 16.9 26.6 12.7 12.3 22.2 11.8 17.3 11.3 15.7 25.2 18.4 16.6 22.0 20.6 18.5 12.8 22.9 20.2 48.8 15.7 15.0 14.6 11.6 15.5 18.4 16.6 3.1 3.3 10.1 9.8 1.5 1.2 5.7 21.3 28.6 25.0 18.5 7.1 8.0 17.6 18.6 10.0 19.3 16.9 21.2 19.1 10.7 11.2 15.2 15.8 15.2 11.8 18.0 7.7 15.4 24.2 23.6 18.8 18.1 23.1 19.1 25.8 12.9 18.1 12.4 17.1 9.8 17.1 12.6 20.5 14.1 8.0 14.5 21.2 50.0 18.9 22.5 13.5 19.5 15.2 8.3 12.9 38.7 31.0 33.2 26.1 24.4 12.2 11.3 18.3 21.5 23.1 14.5 21.8 9.9 27.3 17.9 25.4 15.9 12.6 12.0 30.0 3.1 6.5 2.9 1.2 9.8 0.3 1.7 1.0 0.8 3.3 3.1 0.5 1.1 10.1 1.5 6.0 3.0 0.3 5.7 22.6 26.6 10.5 34.9 23.1 13.4 15.1 21.4 11.8 15.7 3.0 6.9 3.7 8.9 15.2 12.4 9.0 15.3 2.7 5.7 7.0 11.8 12.5 1.7 11.2 8.2 15.1 19.2 0.0 13.2 14.8 11.9 13.2 0.0 11.1 12.7 28.6 16.8 25.2 20.8 16.9 16.4 11.9 10.1 5.4 20.9 7.5 14.7 14.4 18.7 5.9 7.2 6.5 14.1 19.7 37.7 15.2 16.7 6.9 15.7 13.9 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3A, catalytic subunit of the oligosaccharyltransferase complex" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 202.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favorable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 20.6 20.5 8.3 13.1 11.7 8.3 16.9 10.7 13.9 27.8 19.3 17.7 39.6 12.0 30.5 41.4 19.6 20.8 15.1 19.5 8.3 9.1 26.2 67.1 18.7 14.9 9.3 7.7 30.1 59.0 202.3 27.5 35.9 11.6 22.2 17.4 20.8 50.7 41.4 9.5 12.9 19.8 17.1 12.3 21.8 17.7 17.1 6.7 19.2 38.6 13.6 20.8 19.5 18.0 15.0 53.2 27.0 15.5 17.2 27.5 13.4 21.0 19.2 24.5 33.6 46.2 35.8 26.3 38.5 46.0 31.3 39.2 58.2 56.9 27.4 46.7 56.6 44.4 38.9 33.9 33.7 41.7 21.3 18.0 64.5 13.2 40.2 51.1 38.6 30.3 27.6 24.5 43.4 84.8 36.9 34.9 12.3 27.1 41.1 39.5 15.5 15.5 12.3 15.7 42.1 20.9 18.4 20.9 41.2 34.2 32.7 15.2 13.2 27.2 44.5 13.7 30.0 52.2 27.8 31.2 45.2 16.3 19.0 30.2 12.9 15.1 21.1 17.4 39.1 35.8 27.0 15.5 11.6 19.7 14.8 27.5 15.0 19.1 18.2 21.6 11.6 13.8 16.0 5.4 17.2 13.0 53.2 14.1 13.4 8.3 11.7 10.7 13.9 8.3 9.1 9.3 7.7 11.6 6.7 26.8 23.5 18.2 11.3 14.3 10.2 18.6 12.7 14.7 14.8 15.7 19.6 40.7 1.7 26.7 7.6 11.9 13.5 23.3 23.5 56.2 25.7 16.7 16.2 32.7 27.0 1.6 15.0 33.2 22.3 2.6 19.8 13.2 23.6 8.2 32.3 15.2 29.5 14.0 17.7 11.9 13.8 19.4 10.3 29.9 10.9 12.9 38.1 13.3 22.9 12.9 STUB1 "CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1" ENSG00000103266 "STIP1 homology and U-box containing protein 1" Q9UNE7 16 680224-682870 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037202, CAB037209, HPA041222, HPA043531" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533" "unprognostic (5.70e-2)" "unprognostic (2.53e-1)" "unprognostic (1.90e-1)" "unprognostic (3.89e-1)" "unprognostic (9.00e-2)" "unprognostic (3.06e-1)" "unprognostic (4.09e-3)" "unprognostic (2.21e-1)" "unprognostic (2.23e-1)" "unprognostic (8.31e-2)" "unprognostic (5.78e-2)" "unprognostic (6.77e-2)" "prognostic favorable (6.49e-9)" "unprognostic (9.67e-2)" "unprognostic (3.57e-1)" "unprognostic (1.55e-1)" "unprognostic (1.30e-1)" 29.4 43.7 52.2 20.1 43.2 19.3 40.5 39.1 53.3 25.1 24.8 18.1 27.6 24.1 19.7 34.9 35.2 31.1 25.5 45.2 43.2 38.6 24.0 25.9 23.6 28.1 42.0 42.5 29.4 43.4 39.8 27.2 12.1 35.0 23.4 17.7 18.6 37.7 29.7 92.5 33.7 20.9 24.5 34.5 19.7 22.8 13.8 25.4 13.1 29.1 30.2 19.4 22.3 35.9 18.0 21.0 19.4 14.5 10.3 16.9 6.9 18.0 24.5 16.6 28.0 37.9 34.7 9.5 24.6 29.0 29.3 26.1 30.4 23.1 18.3 17.5 41.3 18.9 15.4 20.4 37.1 12.2 20.1 67.6 11.4 35.3 25.4 54.6 19.1 22.7 41.3 39.8 34.3 21.7 23.1 29.6 17.9 18.3 30.6 45.3 71.5 20.7 18.8 18.5 29.0 26.8 32.1 10.9 45.0 39.1 18.0 28.9 23.5 19.8 43.5 30.9 11.0 27.7 36.7 23.4 26.9 23.6 22.2 29.6 30.3 31.3 29.5 21.2 17.3 30.3 11.9 14.5 19.4 16.9 11.9 15.4 18.0 14.6 14.7 11.7 17.3 13.6 12.9 14.0 10.3 12.4 21.0 12.2 6.9 52.2 43.2 39.1 53.3 43.2 38.6 42.0 42.5 35.0 25.4 35.7 24.7 77.5 88.5 102.0 92.7 1.1 101.9 28.1 22.7 123.9 49.1 67.7 242.1 127.5 6.6 66.9 130.5 23.3 147.7 75.3 72.2 130.8 20.7 112.4 99.1 79.4 72.9 61.4 56.4 11.8 100.9 74.8 111.3 200.2 92.2 123.1 150.1 93.1 105.4 269.6 58.7 71.1 101.9 23.5 69.3 105.3 84.2 61.0 87.3 99.9 STUM "C1orf95, DKFZp761P211" ENSG00000203685 "Stum, mechanosensory transduction mediator homolog" Q69YW2 1 226548800-226609214 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 25.6" "Group enriched" "Detected in many" 5 "amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4" "Low region specificity" "Detected in many" HPA074381 Approved Cytosol NA NA Cytosol "HPA074381: AB_2732253" "unprognostic (3.23e-3)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" "unprognostic (2.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.41e-3)" "unprognostic (3.07e-1)" "unprognostic (5.15e-2)" "unprognostic (7.62e-2)" "unprognostic (3.28e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.14e-2)" "unprognostic (9.04e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-3)" 2.8 2.2 30.4 2.1 16.2 0.6 3.5 2.4 32.2 3.7 8.1 6.3 0.0 2.8 3.7 3.0 8.9 3.1 1.6 2.5 21.8 7.0 5.8 0.7 1.2 0.9 6.8 15.9 2.7 1.0 1.9 4.2 1.2 18.2 6.2 3.7 1.4 2.0 2.4 5.0 3.7 3.5 8.7 3.0 1.8 1.8 2.0 7.4 0.0 0.8 0.4 1.0 5.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 4.2 0.3 25.6 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.3 0.2 0.0 3.9 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 16.2 2.4 30.0 21.8 7.0 6.8 15.9 18.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 STX17 FLJ20651 ENSG00000136874 "Syntaxin 17" P56962 9 99906633-99970341 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001204 Approved Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA001204: AB_1080118" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (6.71e-2)" "unprognostic (1.88e-1)" "unprognostic (2.36e-1)" "unprognostic (1.70e-2)" "unprognostic (9.75e-2)" "unprognostic (1.62e-1)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.62e-5)" "unprognostic (9.48e-2)" "unprognostic (4.32e-2)" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" 15.1 15.8 13.5 16.4 16.3 13.6 16.1 10.8 17.8 19.4 18.5 14.2 29.3 13.4 21.7 25.2 19.9 12.0 14.9 14.5 13.8 13.2 14.3 26.0 13.2 11.9 15.4 14.2 18.2 17.8 25.5 37.1 17.6 14.1 18.2 14.6 16.3 20.6 28.7 28.5 20.6 18.9 20.4 19.1 13.3 15.0 12.0 10.4 17.0 21.8 18.3 15.9 18.8 17.8 7.4 4.9 15.5 8.1 14.3 10.4 4.5 10.7 9.8 10.0 12.0 11.4 11.6 19.9 8.2 12.2 9.3 8.0 12.2 14.4 21.0 8.2 8.7 15.0 12.3 8.3 11.5 7.5 18.3 6.8 13.5 12.9 7.4 13.3 19.8 4.9 11.4 13.4 10.0 15.2 9.8 10.8 18.2 18.7 11.7 7.0 13.1 11.8 5.4 8.8 14.0 7.9 10.1 17.7 9.6 12.3 12.5 5.8 10.3 16.6 12.7 8.1 6.7 12.6 5.5 8.5 6.2 8.8 10.0 6.6 16.6 20.2 4.2 8.7 8.3 6.7 15.5 4.2 7.3 7.4 4.5 10.3 7.4 9.1 8.2 4.9 5.9 10.4 9.8 4.3 14.3 8.1 3.1 4.9 4.5 13.5 16.3 10.8 17.8 13.8 13.2 15.4 14.2 14.1 10.4 14.9 21.7 14.5 18.1 9.4 14.0 16.9 10.2 24.1 22.7 22.7 19.6 20.4 24.9 15.8 40.4 13.7 9.7 0.0 17.1 15.8 11.1 23.3 25.4 23.1 9.2 9.5 24.2 20.9 8.3 24.8 23.9 15.1 8.5 27.1 15.7 20.3 14.1 15.9 17.0 15.7 12.9 38.8 13.9 25.9 16.6 10.7 22.9 16.6 13.1 12.9 STX19 MGC21382 ENSG00000178750 "Syntaxin 19" Q8N4C7 3 94014369-94028610 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.9" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 24.1;Enterocytes: 18.8;Mucus-secreting cells: 26.4;Paneth cells: 34.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.5" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.6;HaCaT: 2.2;hTCEpi: 7.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA030604 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA030604: AB_10601268" "unprognostic (7.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-1)" "unprognostic (5.17e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (9.04e-2)" "unprognostic (1.29e-2)" "unprognostic (4.32e-2)" "unprognostic (7.00e-3)" "unprognostic (1.19e-2)" "unprognostic (1.96e-1)" "unprognostic (2.12e-1)" "unprognostic (4.87e-3)" 0.4 0.2 0.3 7.0 0.4 0.0 4.0 1.8 3.5 3.9 11.7 0.1 1.5 5.7 0.5 13.6 12.8 0.8 2.3 0.3 0.5 0.3 1.0 0.4 7.1 0.1 0.3 0.7 0.5 7.7 7.1 0.5 0.7 0.1 4.3 10.6 0.1 9.8 3.2 0.2 6.9 20.9 0.1 0.4 1.0 6.0 0.4 0.1 0.4 0.4 5.0 1.5 0.7 4.1 1.2 0.0 0.0 0.3 0.0 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 10.6 0.1 0.1 0.0 0.2 2.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.1 7.3 0.0 0.8 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.5 0.1 0.1 0.5 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.4 0.0 1.2 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.3 0.5 1.2 0.7 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.4 1.8 3.5 0.5 0.3 0.3 0.7 0.1 0.1 14.9 12.8 0.0 2.2 1.4 3.5 0.0 0.0 24.1 7.9 0.0 11.8 0.1 1.7 3.2 1.1 0.0 18.8 0.0 7.3 0.0 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.4 6.7 34.8 0.7 0.0 16.1 0.0 0.3 0.2 0.0 1.6 0.2 0.0 13.9 1.0 STX8 CARB ENSG00000170310 "Syntaxin 8" Q9UNK0 17 9250471-9576591 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 209.0;Late spermatids: 802.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001540 Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nuclear bodies, Cytosol" "HPA001540: AB_1080168" "unprognostic (8.68e-2)" "unprognostic (2.29e-2)" "unprognostic (2.53e-1)" "unprognostic (4.14e-3)" "unprognostic (3.36e-1)" "unprognostic (1.58e-2)" "unprognostic (6.91e-2)" "unprognostic (1.19e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (1.86e-3)" "unprognostic (2.54e-1)" "unprognostic (1.45e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-1)" "unprognostic (1.77e-2)" "unprognostic (1.51e-1)" 28.6 24.7 26.0 16.5 25.9 23.7 28.1 20.2 33.6 28.3 28.9 23.7 21.9 15.8 36.9 42.5 26.3 19.9 18.1 28.4 20.8 21.1 29.6 29.9 18.7 19.4 23.9 22.4 24.4 30.0 14.9 21.0 20.0 29.0 24.5 23.7 25.8 40.6 26.0 38.4 20.9 20.3 28.4 25.3 19.7 23.2 43.9 20.2 30.0 29.2 17.8 21.4 23.3 23.0 35.4 45.2 48.5 46.2 49.0 59.3 55.7 11.3 19.6 22.5 9.7 27.7 32.2 7.9 16.9 18.0 15.3 19.2 6.8 8.9 13.5 12.9 28.4 17.7 14.9 11.4 23.8 23.3 23.0 16.6 8.4 4.9 14.5 36.9 6.7 18.1 29.2 35.4 15.3 22.9 25.6 19.0 16.4 3.8 6.9 16.7 6.1 13.4 11.6 5.0 14.3 11.0 21.3 16.5 8.4 21.3 10.3 2.0 11.6 9.5 6.0 15.6 27.4 6.7 8.9 23.9 14.9 9.1 8.0 18.3 6.6 6.3 5.8 21.7 14.8 13.8 31.7 46.2 48.5 42.2 38.4 38.4 35.4 45.6 46.5 45.2 32.2 29.2 34.3 14.0 49.0 39.2 38.0 59.3 55.7 26.0 25.9 20.2 33.6 20.8 21.1 23.9 22.4 29.0 20.2 29.8 24.8 41.2 46.2 40.6 15.0 52.6 30.6 28.1 40.9 27.9 11.8 46.4 87.9 54.7 209.0 35.0 37.7 0.0 72.3 39.0 48.3 29.4 53.1 35.8 75.3 6.4 24.0 27.6 43.7 802.8 42.8 53.2 74.2 64.1 37.8 35.2 58.4 54.7 44.6 77.9 19.1 12.9 64.9 40.7 21.3 39.0 36.3 58.6 30.7 36.5 STXBP1 "hUNC18, MUNC18-1, rbSec1, UNC18" ENSG00000136854 "Syntaxin binding protein 1" P61764 9 127579370-127696027 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 127.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 111.5;Cone photoreceptor cells: 147.3;Horizontal cells: 79.4;Rod photoreceptor cells: 147.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.4" "Lineage enriched" "Detected in single" 7 "T-cells: 3.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008209, HPA023483, CAB034434" Enhanced Approved Nucleoplasm,Cytosol NA NA 6400 "Nucleoplasm, Cytosol" "CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625" "unprognostic (2.32e-2)" "unprognostic (7.33e-2)" "unprognostic (3.85e-2)" "prognostic unfavorable (4.78e-4)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.47e-4)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.87e-2)" "unprognostic (2.31e-1)" "unprognostic (3.08e-3)" "prognostic favorable (9.81e-4)" "unprognostic (1.30e-2)" "unprognostic (1.67e-1)" "unprognostic (2.68e-2)" "unprognostic (5.51e-2)" "unprognostic (7.66e-2)" "unprognostic (3.36e-3)" 14.1 16.0 32.4 4.7 42.2 1.5 5.1 86.8 127.4 8.1 4.6 6.5 1.9 3.7 13.2 4.7 6.3 17.9 6.7 12.7 35.0 31.5 7.1 2.7 16.8 3.7 24.6 55.5 14.3 13.2 8.1 22.3 7.9 61.9 6.5 5.3 12.6 8.1 6.6 5.0 5.6 4.6 11.7 13.3 5.9 5.2 5.4 5.3 0.0 10.7 0.9 4.3 5.7 7.6 0.0 0.5 0.0 0.4 0.0 3.4 0.6 4.1 8.6 8.3 9.3 18.8 16.2 7.5 14.5 7.4 8.7 7.7 0.4 4.9 4.0 8.1 9.4 24.3 1.5 7.2 8.9 10.7 9.3 4.9 5.5 23.4 1.5 9.5 0.5 4.8 12.2 5.0 22.8 11.1 14.0 10.3 13.9 5.5 6.3 14.6 7.6 3.9 1.7 7.1 6.7 11.9 2.3 3.9 9.8 7.2 0.2 47.7 23.2 24.4 12.1 41.2 7.7 1.8 1.7 15.4 9.9 5.0 19.5 5.4 13.6 22.3 5.5 19.5 5.9 9.1 0.0 0.4 0.0 0.8 0.1 0.3 0.0 2.2 3.4 0.5 0.0 1.4 1.7 0.0 0.0 0.1 0.3 0.3 0.6 32.4 42.2 86.8 87.7 35.0 31.5 24.6 55.5 61.9 5.3 23.8 57.7 0.8 7.5 10.3 111.5 13.2 0.0 17.4 12.5 3.5 147.3 2.1 6.6 12.0 1.6 21.6 0.0 0.0 7.4 4.6 12.7 9.7 4.7 0.4 3.7 79.4 43.8 20.9 2.7 1.5 19.0 3.2 10.1 1.0 8.8 24.1 5.7 0.0 41.8 8.6 147.7 12.9 12.3 17.7 6.8 6.6 20.5 0.9 0.6 5.5 STXBP2 "Hunc18b, UNC18B" ENSG00000076944 "Syntaxin binding protein 2" Q15833 19 7636881-7647873 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.5;lymphoid tissue: 101.5" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 332.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 25.5;classical monocyte: 58.1;eosinophil: 35.5;intermediate monocyte: 73.1;myeloid DC: 30.2;neutrophil: 45.6;non-classical monocyte: 101.5" "Group enriched" "Detected in all" 6 "dendritic cells: 30.2;granulocytes: 45.6;monocytes: 101.5" "Cell line enhanced" "Detected in many" "HMC-1: 56.3;U-937: 49.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015564, HPA063868" Approved Enhanced Cytosol No No 53000000 Cytosol "HPA015564: AB_1857626, HPA063868: AB_2685136" "unprognostic (1.20e-2)" "unprognostic (6.17e-3)" "unprognostic (2.85e-2)" "prognostic favorable (2.29e-4)" "unprognostic (2.54e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (4.65e-4)" "unprognostic (4.22e-3)" "unprognostic (2.35e-1)" "unprognostic (6.25e-2)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "unprognostic (1.51e-1)" "unprognostic (4.62e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.68e-4)" "prognostic favorable (5.13e-6)" 7.2 7.9 5.5 17.9 9.9 49.5 9.9 2.0 5.8 6.5 17.7 5.4 15.9 19.0 3.0 10.4 23.4 9.6 14.3 18.4 5.2 2.0 20.2 19.0 46.4 61.5 12.2 1.3 4.6 28.0 10.9 9.8 24.9 5.8 16.4 10.5 8.7 24.6 9.7 1.5 15.3 32.0 3.7 16.9 101.5 20.6 22.5 8.0 73.4 19.5 5.4 17.8 11.4 18.0 6.7 30.2 45.6 101.5 9.0 9.9 31.9 24.5 8.7 0.2 0.1 0.0 0.2 17.3 3.1 0.3 0.6 1.7 20.5 15.6 6.5 12.7 2.5 11.4 16.9 0.9 15.0 0.6 27.0 10.5 28.0 10.4 12.1 15.0 18.0 56.3 1.0 15.4 3.0 8.7 0.0 13.2 16.8 17.4 22.3 0.0 15.5 8.8 42.0 6.5 16.0 15.4 9.1 0.0 24.9 12.5 28.5 2.6 0.1 7.6 11.3 0.5 8.5 14.0 46.7 13.8 0.1 5.1 0.3 0.1 24.9 12.3 8.4 0.2 49.4 0.6 25.5 58.1 35.5 9.6 73.1 7.7 6.3 7.3 8.6 30.2 6.7 5.2 6.2 45.6 9.0 101.5 11.5 9.9 31.9 5.5 9.9 2.0 5.8 5.2 2.0 12.2 1.3 5.8 8.0 0.0 7.7 46.2 41.5 20.9 3.5 0.7 40.8 5.3 3.4 33.2 2.0 85.8 28.2 91.9 74.2 5.9 162.4 23.3 104.4 107.0 3.1 43.4 72.5 17.3 155.4 0.0 57.4 21.5 332.1 169.0 1.7 76.6 13.5 138.9 84.0 0.8 109.9 133.3 1.8 54.9 3.9 6.5 1.4 29.3 18.1 18.6 127.9 56.4 58.5 59.5 STXBP3 UNC-18C ENSG00000116266 "Syntaxin binding protein 3" O00186 1 108746674-108809526 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027225 Approved Approved Nucleoplasm,Cytosol NA NA 160000 Nucleoplasm Cytosol "HPA027225: AB_1857627" "unprognostic (3.14e-3)" "unprognostic (4.33e-2)" "unprognostic (7.18e-3)" "unprognostic (4.88e-2)" "unprognostic (6.54e-2)" "unprognostic (9.78e-3)" "unprognostic (2.00e-3)" "unprognostic (1.94e-1)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "unprognostic (6.56e-2)" "unprognostic (8.21e-2)" "unprognostic (1.25e-2)" "unprognostic (1.65e-1)" "unprognostic (8.08e-2)" "unprognostic (1.08e-1)" "unprognostic (4.55e-2)" 18.3 18.4 29.8 18.7 42.1 15.2 20.9 21.9 27.1 19.4 20.5 26.3 15.6 18.7 20.3 19.9 18.8 16.0 20.8 14.3 30.4 22.1 30.2 17.8 16.8 18.2 48.0 28.0 16.2 20.5 31.9 18.0 20.3 31.4 18.1 21.9 9.8 17.5 21.3 15.4 19.7 23.8 18.4 56.6 19.8 18.0 11.3 42.5 20.0 27.8 14.6 17.8 20.2 18.3 5.9 8.3 26.2 11.6 8.7 10.2 5.9 22.3 8.9 15.3 8.0 18.7 18.1 21.6 20.8 19.3 14.1 14.4 8.2 9.0 19.9 14.2 16.8 12.8 13.5 10.3 12.3 19.8 22.1 14.3 16.4 12.1 10.6 14.8 25.5 28.2 14.0 17.4 15.7 17.3 17.4 17.3 12.8 12.1 19.6 19.4 15.2 16.1 20.6 16.3 14.8 14.1 13.5 22.3 10.9 22.8 18.7 9.2 8.5 25.5 24.7 30.2 14.6 9.9 24.3 19.4 18.4 10.8 25.5 17.8 13.2 11.4 16.5 33.1 19.7 27.9 26.2 8.8 20.8 7.8 10.6 9.9 5.9 9.2 7.8 8.3 5.4 7.9 7.5 24.3 8.7 11.6 3.9 10.2 5.9 29.8 42.1 21.9 27.1 30.4 22.1 48.0 28.0 31.4 42.5 11.9 25.1 16.6 33.8 39.0 22.8 30.7 25.5 28.1 34.2 19.2 19.6 36.5 38.1 31.9 4.1 26.9 28.6 0.0 24.1 27.4 24.9 28.7 68.1 15.3 28.0 25.4 20.2 14.7 42.9 2.5 31.1 37.2 37.1 42.3 29.5 38.2 25.3 23.0 29.7 42.3 18.4 19.4 27.8 20.9 24.3 35.3 79.9 26.1 24.1 35.8 STXBP4 "MGC50337, Synip" ENSG00000166263 "Syntaxin binding protein 4" Q6ZWJ1 17 54968727-55173632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 36.3" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 39.3;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007760, HPA022138, HPA022888, HPA024227" Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane" Cytosol "CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630" "unprognostic (5.89e-2)" "unprognostic (2.50e-2)" "unprognostic (1.30e-3)" "unprognostic (9.27e-2)" "unprognostic (1.03e-3)" "unprognostic (1.48e-1)" "unprognostic (5.00e-5)" "unprognostic (4.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.28e-2)" "unprognostic (3.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (1.31e-1)" "unprognostic (1.44e-1)" 7.7 6.4 5.5 4.3 6.0 3.4 5.2 10.6 4.7 9.9 6.4 4.2 7.5 6.3 12.0 7.2 5.1 7.3 6.6 5.9 6.7 4.7 14.5 3.8 8.0 3.2 4.2 4.5 9.9 5.4 19.3 36.3 4.7 6.8 9.5 4.6 7.6 4.5 9.4 4.0 3.7 5.1 13.2 8.6 5.0 5.5 5.6 5.1 7.2 7.9 2.7 3.5 9.6 8.2 3.2 2.9 4.0 1.2 5.1 2.9 0.7 5.5 8.3 7.7 6.8 6.5 6.4 3.1 4.3 4.2 5.7 5.6 4.9 3.0 3.8 9.3 4.3 5.0 3.3 9.8 4.3 10.5 5.7 5.6 4.9 5.7 10.0 2.7 3.1 1.5 7.3 1.3 8.1 2.0 2.6 5.6 3.3 7.9 3.0 6.7 2.5 10.2 2.0 5.5 4.7 6.0 4.3 8.9 2.3 10.0 3.4 7.4 5.6 6.7 1.1 3.6 4.3 9.7 2.1 4.3 8.0 6.3 4.9 4.5 2.7 2.5 6.5 5.2 4.1 4.7 4.0 1.1 0.1 2.6 0.8 2.9 2.1 2.3 1.7 1.4 3.2 2.1 2.7 0.3 5.1 1.2 2.9 2.1 0.7 5.5 6.0 10.6 4.7 6.7 4.7 4.2 4.5 6.8 5.1 0.0 7.8 0.8 2.2 0.8 5.5 8.1 5.1 22.7 6.8 8.7 39.3 1.3 8.3 5.7 5.2 2.1 2.6 0.0 2.3 1.7 2.8 2.6 7.0 4.0 1.9 7.9 5.8 6.2 2.5 4.6 16.4 2.6 6.8 1.8 1.6 6.6 3.3 2.3 11.0 6.3 19.0 32.3 3.9 8.6 5.8 2.6 0.2 2.9 3.0 1.0 STXBP5 "LLGL3, tomosyn" ENSG00000164506 "Syntaxin binding protein 5" Q5T5C0 6 147204425-147390476 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 82.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 11.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "HEL: 56.6;HMC-1: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039991, HPA049727, CAB079016" Enhanced Supported Enhanced Cytosol NA NA 11000 Cytosol "CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863" "prognostic unfavorable (4.48e-4)" "unprognostic (4.60e-3)" "unprognostic (2.28e-3)" "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (1.52e-1)" "unprognostic (9.56e-4)" "unprognostic (6.01e-2)" "unprognostic (3.60e-1)" "unprognostic (2.74e-2)" "unprognostic (1.70e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (2.74e-7)" "unprognostic (8.01e-2)" "unprognostic (1.74e-1)" "unprognostic (2.55e-1)" "unprognostic (1.35e-3)" 4.4 9.1 4.3 6.6 5.9 14.0 9.0 7.8 9.0 6.7 17.6 2.0 22.1 3.9 4.6 6.5 10.2 3.8 9.2 3.5 3.6 4.3 2.0 2.4 3.8 3.5 3.3 4.7 3.0 10.9 82.7 15.5 3.1 4.3 5.7 7.8 6.5 5.7 21.0 7.0 10.9 35.1 5.3 2.7 4.7 4.0 9.6 2.3 2.2 4.2 5.6 4.6 5.3 9.1 0.9 0.5 11.2 0.6 0.5 1.7 0.3 2.8 2.5 1.3 4.6 6.7 14.1 1.5 6.7 10.0 5.0 5.6 2.1 1.9 2.1 1.5 13.3 8.6 3.5 3.9 5.9 6.1 4.5 3.0 56.6 7.5 2.4 7.7 19.3 61.9 10.2 4.2 10.0 20.4 11.9 6.4 3.3 15.2 2.6 9.8 4.2 3.0 5.0 1.1 2.4 5.9 0.4 7.1 0.8 2.7 5.0 2.9 2.1 5.2 3.7 2.3 2.5 1.1 7.6 7.3 7.2 2.6 3.5 6.1 2.2 0.0 2.5 3.9 7.1 5.1 4.7 0.3 11.2 1.2 0.5 1.3 0.5 0.7 1.4 0.5 0.9 1.2 1.7 4.0 0.5 0.6 0.4 0.3 0.3 4.3 5.9 7.8 9.0 3.6 4.3 3.3 4.7 4.3 2.3 14.9 9.1 1.5 2.0 3.2 28.1 12.9 7.6 1.4 9.1 15.7 29.5 4.0 0.0 4.4 26.8 7.9 17.0 0.0 11.2 3.2 4.5 10.0 41.7 3.4 4.0 31.8 39.6 8.6 7.8 34.7 7.2 4.1 10.1 2.8 28.2 5.0 9.8 24.6 6.7 1.4 25.2 12.9 3.4 12.3 10.7 5.8 3.2 4.9 17.4 3.0 SUCLG1 ENSG00000163541 "Succinate-CoA ligase alpha subunit" P53597 2 84423523-84460045 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 125.6" "Cell type enhanced" "Detected in all" 10 "Distal tubular cells: 792.5;Proximal tubular cells: 1327.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036683, HPA036684" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Intracellular and membrane" NA NA 330000 Mitochondria "Plasma membrane, Cytosol" "HPA036683: AB_10671708, HPA036684: AB_2675248" "unprognostic (6.84e-3)" "unprognostic (7.16e-3)" "unprognostic (2.58e-3)" "prognostic unfavorable (5.23e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (3.63e-2)" "unprognostic (3.49e-2)" "unprognostic (1.02e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.21e-8)" "unprognostic (4.94e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" 26.1 23.3 18.0 15.0 18.9 10.6 23.8 18.9 19.5 14.1 50.1 17.7 23.2 53.9 13.9 19.6 25.0 13.5 14.0 57.7 17.4 17.3 125.6 44.1 12.8 13.3 19.2 17.0 12.7 33.9 36.2 16.3 13.8 17.3 17.1 39.4 16.9 39.3 24.9 57.6 15.6 71.6 26.5 17.1 12.1 21.9 13.3 16.0 16.9 28.8 42.8 15.2 24.3 16.3 26.6 43.5 31.6 40.3 35.2 39.1 46.8 20.8 23.0 18.2 22.1 34.2 23.1 31.5 23.8 20.4 30.7 22.5 52.6 17.3 28.8 16.5 28.5 24.7 30.5 37.4 28.1 36.5 27.7 34.0 25.0 19.8 29.9 29.0 25.4 20.4 27.4 23.0 25.9 35.3 18.8 27.3 23.6 25.3 23.7 27.9 31.9 36.0 23.2 9.5 78.5 41.2 22.9 42.2 31.5 41.2 25.4 22.1 12.3 19.0 39.5 37.9 17.8 24.1 20.0 22.1 24.1 23.4 29.5 29.2 20.8 29.5 24.8 28.2 35.3 21.2 31.6 34.4 28.7 31.4 40.3 34.6 26.6 29.2 35.1 43.5 20.2 32.4 34.2 18.5 35.2 40.0 23.7 39.1 46.8 18.0 18.9 18.9 19.5 17.4 17.3 19.2 17.0 17.3 16.0 59.6 67.8 89.4 89.8 31.5 32.1 379.6 132.5 91.0 108.1 134.3 21.6 202.1 792.5 102.4 24.5 56.3 282.3 23.3 99.5 100.2 83.9 68.7 90.0 177.6 116.1 42.9 102.0 59.5 64.6 28.6 50.6 82.9 113.1 78.5 140.8 56.0 65.8 217.5 69.6 1327.5 31.0 51.8 72.6 79.7 46.4 36.1 157.6 70.5 304.8 88.9 SUCO "C1orf9, CH1, OPT, SLP1" ENSG00000094975 "SUN domain containing ossification factor" Q9UBS9 1 172532349-172611833 "Predicted membrane proteins" Osteogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047251 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA 14000 "Nucleoli fibrillar center, Cytosol" "HPA047251: AB_2679999" "unprognostic (1.28e-2)" "unprognostic (6.38e-3)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (4.57e-2)" "unprognostic (1.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.20e-2)" "unprognostic (7.05e-2)" 8.8 9.2 8.0 6.2 9.8 43.4 9.0 7.9 8.4 8.9 7.6 6.5 48.6 6.1 8.1 39.5 8.3 9.9 7.3 8.0 7.6 8.3 11.2 8.0 6.4 5.5 7.5 5.1 13.4 24.7 16.9 24.7 18.2 8.7 9.0 5.9 9.4 13.0 52.5 2.8 8.7 22.9 6.1 8.8 7.1 8.0 14.3 8.0 11.1 11.0 6.0 7.1 10.7 9.1 9.5 7.7 11.3 6.7 10.4 8.9 4.6 13.9 6.3 18.3 16.3 9.4 9.1 20.7 17.0 10.0 10.8 13.3 11.2 15.0 7.0 10.3 9.7 11.1 22.1 7.8 6.7 18.7 4.0 5.6 5.5 3.9 6.8 11.0 8.7 7.9 8.1 6.8 13.3 11.0 33.7 9.3 8.1 3.5 10.0 16.2 3.3 5.8 6.0 16.6 16.1 14.7 5.9 10.6 4.5 16.8 19.6 9.9 12.7 7.8 13.6 14.9 32.9 13.4 9.6 12.2 9.8 10.4 9.4 17.3 15.2 12.2 12.7 9.5 4.6 15.4 9.4 6.6 11.3 8.6 6.0 8.3 8.3 7.8 7.2 5.4 9.5 8.7 8.9 6.1 10.4 6.7 7.7 5.6 4.6 8.0 9.8 7.9 8.4 7.6 8.3 7.5 5.1 8.7 8.0 44.7 22.8 15.2 31.2 23.4 41.5 21.5 7.6 32.1 46.6 26.2 47.1 30.1 3.3 13.2 28.0 22.2 15.8 23.3 27.4 21.5 20.9 37.1 12.8 13.9 11.7 44.5 25.3 11.6 10.8 39.6 42.3 14.1 25.3 16.2 24.1 65.0 22.9 7.0 26.5 11.8 49.4 25.8 15.3 44.7 24.5 23.6 41.3 20.3 9.9 30.9 SUDS3 "FLJ00052, SAP45, SDS3" ENSG00000111707 "SDS3 homolog, SIN3A corepressor complex component" Q9H7L9 12 118376380-118418031 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 220.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040402, HPA041972" Approved Supported "Nuclear bodies,Cytosol" "Intracellular and membrane" NA NA "Nuclear bodies, Cytosol" "HPA040402: , HPA041972: AB_2677776" "unprognostic (1.49e-1)" "unprognostic (4.08e-3)" "unprognostic (1.09e-1)" "unprognostic (6.60e-2)" "unprognostic (7.39e-2)" "unprognostic (1.45e-1)" "unprognostic (3.05e-3)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.70e-1)" "unprognostic (8.71e-2)" "unprognostic (3.03e-1)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" "unprognostic (3.65e-1)" "unprognostic (1.02e-1)" "unprognostic (2.37e-1)" 12.4 15.6 20.6 10.2 19.1 13.3 17.6 13.3 22.0 17.1 17.2 10.7 10.5 12.9 20.4 15.6 24.7 17.3 12.1 12.9 15.8 11.0 15.3 12.7 13.9 12.2 8.9 18.7 18.6 34.2 22.9 12.2 15.1 14.5 15.7 17.3 13.1 20.4 15.6 15.1 18.7 14.6 20.9 13.4 12.1 14.7 21.6 13.2 13.6 20.5 8.3 17.3 19.9 18.2 9.7 7.7 14.4 4.9 4.6 7.9 4.1 16.2 12.3 16.9 16.8 9.5 12.5 18.2 12.7 13.2 15.0 11.9 13.4 10.5 22.1 13.6 12.2 9.3 19.5 20.1 13.5 17.7 19.4 11.9 15.3 10.0 12.0 10.9 16.9 11.9 8.6 14.4 7.4 13.2 19.5 12.6 21.0 16.7 8.0 13.6 11.1 19.9 22.2 17.5 21.6 9.7 18.1 15.2 15.6 13.7 23.9 13.3 13.1 18.0 10.7 11.0 22.2 35.0 13.9 10.5 10.2 9.7 11.3 8.6 15.2 16.9 16.3 11.3 10.8 12.2 2.0 4.9 6.2 5.9 3.1 7.3 9.7 6.4 6.8 5.2 9.3 7.9 5.3 14.4 4.6 3.0 7.7 5.9 4.1 20.6 19.1 13.3 22.0 15.8 11.0 8.9 18.7 14.5 13.2 26.8 15.7 32.6 40.5 57.6 74.0 31.3 50.9 37.5 22.7 45.4 72.6 28.6 68.0 34.8 220.0 22.8 49.2 0.0 16.8 44.9 31.5 49.6 8.1 26.6 21.7 101.7 35.8 22.1 15.5 29.3 35.6 19.3 27.0 31.5 46.6 34.0 25.3 40.2 38.5 31.4 57.3 25.8 36.0 48.6 59.6 68.8 41.1 20.1 51.7 53.3 SUGT1 SGT1 ENSG00000165416 "SGT1 homolog, MIS12 kinetochore complex assembly cochaperone" Q9Y2Z0 13 52652709-52700909 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015942, HPA043949" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB015942: , HPA043949: AB_2678745" "unprognostic (3.66e-2)" "unprognostic (3.98e-2)" "unprognostic (3.57e-1)" "unprognostic (1.22e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (8.69e-4)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (3.76e-1)" "unprognostic (1.96e-3)" "unprognostic (9.51e-2)" "unprognostic (1.12e-1)" "unprognostic (6.83e-2)" "unprognostic (2.82e-3)" "unprognostic (9.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.56e-1)" 22.7 29.9 40.0 23.1 44.8 26.2 27.9 39.7 42.7 17.9 24.0 23.0 14.9 25.8 19.4 20.6 27.1 19.2 18.9 33.8 34.0 28.8 30.8 34.3 19.8 23.5 35.9 28.9 20.8 28.6 14.0 39.8 24.4 36.0 18.1 26.5 14.2 22.5 16.8 26.1 23.1 24.8 21.4 31.1 21.3 23.1 31.2 43.5 15.2 21.6 19.5 27.4 21.8 48.3 17.5 23.4 29.0 19.1 17.5 25.3 13.6 14.4 15.8 23.4 17.7 23.2 19.0 22.5 31.8 21.1 19.9 16.0 34.4 36.4 31.8 9.0 19.7 29.0 25.0 28.9 18.3 29.4 26.2 12.0 29.5 20.7 26.0 16.9 22.9 22.2 13.2 16.7 20.6 15.7 25.7 33.4 20.5 27.5 10.5 30.4 10.2 21.3 42.1 27.4 57.1 15.2 24.5 13.6 13.7 34.6 16.3 7.8 9.9 16.4 13.5 14.9 28.0 13.9 21.9 23.9 16.7 19.5 19.1 27.1 8.3 11.7 28.3 10.0 18.4 24.0 29.0 16.8 26.8 14.9 19.1 14.6 17.5 19.4 20.0 18.6 16.3 14.9 16.5 2.3 17.5 18.2 23.4 25.3 13.6 40.0 44.8 39.7 42.7 34.0 28.8 35.9 28.9 36.0 43.5 35.7 29.0 35.8 53.8 35.3 49.1 109.5 25.5 52.2 44.3 48.8 23.6 57.7 66.3 74.9 142.6 65.3 46.8 70.0 78.0 119.0 50.9 41.8 35.8 37.6 84.7 47.7 32.7 35.6 39.5 64.1 54.4 48.2 45.5 144.3 43.5 84.8 75.8 48.9 56.3 76.3 51.1 25.8 66.5 100.6 92.8 37.8 62.2 49.8 45.0 44.3 SULT1C4 "SULT1C, SULT1C2" ENSG00000198075 "Sulfotransferase family 1C member 4" O75897 2 108377911-108388057 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Cholangiocytes: 22.9;Collecting duct cells: 8.7;Muller glia cells: 12.4" "Group enriched" "Detected in many" 6 "glioma: 7.1;renal cancer: 20.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 6.4;HUVEC TERT2: 6.8;SH-SY5Y: 29.5;SuSa: 8.2" "Low region specificity" "Detected in all" HPA034530 Approved Cytosol NA NA Cytosol "HPA034530: AB_10670170" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-1)" "unprognostic (2.89e-1)" "unprognostic (5.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.35e-2)" "unprognostic (5.77e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-3)" "prognostic favorable (9.99e-7)" "unprognostic (1.79e-2)" "unprognostic (2.96e-2)" "unprognostic (1.85e-2)" "unprognostic (1.38e-1)" 5.2 2.2 9.5 1.1 14.5 0.7 4.5 7.8 16.3 20.6 3.2 13.0 1.8 1.6 9.9 5.4 2.5 8.4 24.8 9.5 9.2 11.4 15.8 3.2 13.9 1.7 12.7 6.8 25.0 3.1 1.0 6.8 11.3 13.6 6.1 2.2 10.6 1.7 7.7 2.7 0.9 3.1 5.1 8.3 1.4 2.2 2.3 10.0 1.1 4.4 1.1 1.4 4.0 5.6 0.3 0.3 1.4 0.2 0.7 0.4 0.2 0.0 0.1 6.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.2 0.1 0.1 0.2 0.3 0.2 0.0 0.3 0.2 0.4 1.4 0.7 0.1 0.3 0.1 0.2 9.5 14.5 7.8 7.1 9.2 11.4 12.7 6.8 13.6 10.0 0.0 0.3 0.0 0.2 0.2 1.5 0.6 22.9 0.0 0.0 8.7 0.0 0.2 0.0 0.3 4.9 5.9 0.0 0.0 0.2 0.1 1.6 0.6 0.0 0.0 0.7 1.6 0.0 4.3 0.6 0.4 1.4 0.4 0.0 0.0 0.0 12.4 0.1 0.0 4.2 2.7 0.7 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.1 SULT1E1 "EST, STE" ENSG00000109193 "Sulfotransferase family 1E member 1" P49888 4 69841212-69860152 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.8;liver: 26.2;vagina: 15.8" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 47.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 8 "pons and medulla: 3.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 16 "HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4" "HPA028213, HPA028728, CAB047344" Enhanced Uncertain "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894" "unprognostic (5.60e-2)" "prognostic favorable (4.06e-4)" "unprognostic (2.48e-1)" "unprognostic (1.07e-3)" "unprognostic (2.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (3.22e-3)" "unprognostic (8.62e-2)" "unprognostic (6.48e-5)" "unprognostic (2.48e-1)" "unprognostic (4.11e-2)" "unprognostic (5.55e-2)" 0.1 9.8 0.1 0.1 0.3 0.1 1.1 0.1 0.4 13.1 8.9 0.5 0.1 19.8 0.4 3.7 0.4 0.1 1.2 0.1 0.1 0.0 1.5 26.2 2.0 0.1 0.3 0.3 0.2 0.1 0.0 0.4 0.1 3.3 1.0 0.1 0.3 4.7 0.3 0.1 10.9 37.8 0.5 0.3 0.1 1.3 0.4 0.1 0.6 0.2 0.1 1.0 0.4 15.8 0.6 0.2 1.7 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 38.0 0.0 0.0 17.2 14.3 0.0 0.4 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.6 0.2 0.1 1.7 0.3 0.3 0.2 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.3 0.3 3.3 0.1 0.0 0.0 0.0 1.0 10.5 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.2 0.1 0.0 0.0 47.0 0.2 0.0 0.0 1.8 1.0 0.0 0.3 0.0 1.7 0.0 0.2 0.0 0.5 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 1.3 0.0 0.0 0.1 SULT2A1 "DHEA-ST, STD" ENSG00000105398 "Sulfotransferase family 2A member 1" Q06520 19 47870466-47886397 "Enzymes, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 211.7" "Cell type enriched" "Detected in some" 24 "Hepatocytes: 1127.7" "Cancer enriched" "Detected in some" 52 "liver cancer: 244.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 5.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 34 "Hep G2: 26.6;RT4: 18.1" "Low region specificity" "Detected in all" "CAB018755, HPA041487, HPA063633" Enhanced Supported Cytosol NA NA 210000 Cytosol "CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066" "unprognostic (2.14e-1)" "unprognostic (6.79e-3)" "unprognostic (6.82e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-2)" 0.1 46.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 11.4 1.1 1.1 8.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 211.7 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.6 0.0 0.1 0.1 3.9 0.1 0.0 42.7 0.1 0.1 0.1 2.8 0.7 0.1 0.1 0.2 0.1 0.1 0.6 0.2 1.3 1.0 5.3 0.8 2.3 1.3 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 26.6 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.2 0.0 18.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 5.3 0.8 0.7 0.9 0.4 0.6 0.7 1.0 0.6 0.3 1.3 1.3 1.0 3.1 2.3 0.4 1.0 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 7.0 0.5 0.1 0.6 0.6 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.7 0.0 0.0 0.1 0.3 0.0 1127.7 0.0 0.0 0.0 38.6 31.7 0.0 2.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.3 SUPT6H "KIAA0162, SPT6H" ENSG00000109111 "SPT6 homolog, histone chaperone" Q7KZ85 17 28662091-28702684 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012416, HPA036382" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB012416: , HPA036382: AB_2675094" "unprognostic (8.18e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (1.02e-1)" "unprognostic (2.18e-2)" "unprognostic (9.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "prognostic favorable (4.36e-5)" "unprognostic (4.75e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.06e-2)" 27.6 30.0 30.0 24.1 32.8 56.3 25.6 31.9 35.7 28.0 30.1 28.5 23.2 19.9 38.6 28.4 24.4 24.1 25.0 23.8 25.7 22.0 24.1 32.6 26.3 26.0 25.7 32.8 33.1 28.8 40.7 34.5 31.9 24.3 26.9 21.8 33.2 28.2 29.2 50.1 38.6 28.7 40.0 29.8 33.1 28.5 23.4 29.0 27.2 27.6 18.4 29.4 30.7 27.1 5.7 8.2 14.4 6.1 5.4 5.6 3.4 18.0 37.8 19.0 21.7 23.2 15.6 14.7 24.8 26.6 29.3 26.3 35.1 8.1 19.2 13.0 24.8 22.6 21.6 27.8 18.0 30.5 35.7 24.7 26.8 30.6 21.7 19.4 28.1 30.0 21.4 10.9 31.1 20.8 19.4 19.2 18.9 26.3 22.8 20.8 21.5 27.7 12.0 14.7 15.9 12.3 14.2 35.0 15.6 14.5 35.8 14.5 19.2 29.1 46.0 15.7 27.3 28.2 20.0 30.2 23.2 19.2 22.0 31.6 29.0 22.2 28.2 26.2 12.7 19.1 14.4 5.9 5.4 5.2 3.9 5.5 5.6 4.3 5.6 4.8 5.7 4.4 3.8 9.0 5.4 6.1 8.2 3.8 3.4 30.0 32.8 31.9 35.7 25.7 22.0 25.7 32.8 24.3 29.0 35.7 51.4 21.7 18.1 19.9 27.9 43.2 22.9 33.5 36.4 19.2 53.0 21.0 5.0 19.2 3.9 24.0 22.2 23.3 18.3 17.3 18.8 16.3 47.6 30.2 20.6 28.6 29.7 19.0 21.5 14.4 23.9 20.4 8.5 27.9 19.2 20.5 25.9 16.7 25.1 9.4 40.8 32.3 22.2 18.4 16.2 21.2 41.6 20.8 17.7 21.8 SV2A "KIAA0736, SV2" ENSG00000159164 "Synaptic vesicle glycoprotein 2A" Q7L0J3 1 149903318-149917882 "FDA approved drug targets, Predicted membrane proteins" "Neurotransmitter transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3;parathyroid gland: 34.0" "Group enriched" "Detected in many" 6 "Bipolar cells: 95.8;Horizontal cells: 90.6;Muller glia cells: 25.1" "Cancer enriched" "Detected in many" 6 "glioma: 27.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002226, HPA007863" Enhanced Approved Cytosol NA NA Cytosol "CAB002226: AB_564144, HPA007863: AB_1080135" "unprognostic (8.05e-3)" "unprognostic (3.86e-3)" "unprognostic (2.24e-1)" "unprognostic (5.39e-2)" "unprognostic (2.66e-1)" "unprognostic (2.02e-1)" "unprognostic (6.24e-2)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (2.06e-1)" "unprognostic (9.00e-3)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.44e-2)" "unprognostic (9.86e-2)" "unprognostic (1.95e-2)" "unprognostic (4.81e-3)" 2.0 7.3 20.4 2.8 24.7 4.5 1.5 36.8 75.3 3.2 2.3 4.8 0.9 1.9 5.6 18.0 2.0 3.2 3.2 1.5 22.3 30.5 1.7 1.2 1.8 2.3 21.6 25.1 2.6 1.9 34.0 7.2 1.9 32.9 3.1 2.2 3.1 1.7 3.7 1.1 1.5 2.2 6.6 16.8 2.0 2.0 1.6 6.0 0.3 4.0 0.0 2.0 2.5 1.2 1.2 0.8 2.1 0.7 1.7 2.5 0.6 0.1 0.0 10.3 0.0 1.0 3.0 1.1 4.3 15.2 13.0 18.8 0.3 0.4 0.1 3.9 6.5 13.7 0.2 0.1 0.9 11.2 0.0 2.4 13.5 0.7 0.7 9.9 0.1 0.2 6.8 0.1 20.7 1.5 14.5 1.1 12.4 0.1 14.1 8.5 0.1 13.0 0.6 26.1 0.0 0.0 4.5 6.5 0.2 0.1 0.3 21.6 17.4 0.0 0.1 9.9 10.3 0.1 8.2 0.0 12.1 12.2 0.5 15.8 0.1 0.1 0.0 21.2 0.1 4.8 1.5 0.7 0.4 1.8 0.3 1.9 0.7 1.9 1.1 0.2 1.2 1.0 2.2 2.1 1.7 0.3 0.8 2.5 0.6 20.4 24.7 36.8 40.0 22.3 30.5 21.6 25.1 32.9 6.0 0.0 1.4 0.0 2.0 0.1 95.8 0.6 0.0 1.4 0.0 0.0 3.9 0.3 0.0 0.0 0.3 1.4 0.0 0.0 0.3 0.7 1.5 1.0 0.0 0.0 0.2 90.6 4.1 5.5 0.0 0.0 0.0 0.3 0.0 0.0 0.2 25.1 0.2 0.0 5.3 0.0 11.4 0.0 4.1 1.2 0.8 0.4 0.3 2.5 0.3 0.6 SVBP "CCDC23, MGC45441" ENSG00000177868 "Small vasohibin binding protein" Q8N300 1 42807052-42817252 "Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 164.4;Spermatogonia: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008507 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Secreted to blood" Yes No "Nucleoplasm, Nuclear bodies, Cytosol" "HPA008507: AB_2072066" "prognostic favorable (6.33e-4)" "unprognostic (2.68e-2)" "unprognostic (2.91e-1)" "unprognostic (4.60e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.15e-2)" "unprognostic (3.35e-3)" "unprognostic (1.59e-2)" "unprognostic (6.73e-3)" "unprognostic (2.16e-1)" "unprognostic (5.37e-3)" "unprognostic (1.17e-3)" "unprognostic (7.07e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" 20.1 14.1 25.6 11.1 18.9 32.3 20.1 24.0 20.4 16.2 15.7 17.6 10.4 9.7 20.5 23.9 13.0 20.1 15.5 19.6 21.8 19.7 16.0 15.9 13.8 17.8 23.5 22.3 34.4 9.1 10.7 20.0 23.5 20.4 16.8 14.5 13.6 11.6 14.5 21.1 10.1 11.8 17.1 26.9 14.3 11.5 38.2 18.7 29.2 15.5 16.1 19.4 16.2 15.1 24.5 16.0 30.2 16.8 14.3 44.8 9.7 10.2 4.9 32.3 11.6 13.1 20.9 15.7 8.8 7.3 12.0 12.4 9.0 8.2 11.1 9.7 11.8 9.4 7.1 5.7 9.4 16.2 19.7 9.8 22.3 4.9 17.9 10.6 16.7 14.6 13.1 15.1 6.7 6.9 13.0 12.1 22.4 17.3 6.0 15.3 4.8 16.7 20.0 17.7 9.8 6.0 12.2 24.6 7.8 12.7 11.2 19.3 17.3 10.5 6.1 12.6 35.9 4.8 47.3 9.2 10.6 12.0 8.5 14.2 5.8 7.1 8.0 6.8 11.4 10.0 20.8 16.6 30.2 11.4 15.9 10.3 22.1 20.4 14.0 16.0 24.5 19.2 16.4 29.3 14.3 16.8 13.4 44.8 9.7 25.6 18.9 24.0 20.4 21.8 19.7 23.5 22.3 20.4 18.7 8.9 4.6 32.1 27.2 0.0 5.5 0.0 28.1 13.4 17.0 19.2 2.0 47.5 46.4 41.3 113.1 20.3 12.5 93.5 21.4 53.4 17.5 19.3 10.5 31.8 64.1 6.4 17.5 31.3 40.5 49.2 39.7 28.7 0.0 64.1 23.7 13.2 34.6 28.5 50.5 34.8 13.5 58.2 0.0 164.4 149.9 0.0 51.5 20.0 30.2 25.4 SVIL ENSG00000197321 Supervillin O95425 10 29457338-29736781 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 235.1;tongue: 93.5" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 411.9;Peritubular cells: 245.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 15.2" "Group enriched" "Detected in many" 6 "granulocytes: 15.2;monocytes: 4.2" "Cell line enhanced" "Detected in many" "HaCaT: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010878, HPA020095, HPA020138" Approved Supported "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.06e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-3)" "unprognostic (2.26e-2)" "unprognostic (4.12e-1)" "unprognostic (1.49e-1)" "unprognostic (4.28e-1)" "unprognostic (3.42e-3)" "unprognostic (1.55e-1)" "unprognostic (9.20e-2)" "unprognostic (2.38e-3)" "unprognostic (7.11e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (5.70e-5)" 11.9 2.1 0.7 10.5 1.1 3.7 4.5 0.6 0.9 18.7 42.3 0.6 10.7 1.7 34.3 13.3 18.2 8.9 15.5 25.5 0.5 0.6 2.8 2.0 3.8 2.3 0.8 0.7 13.9 2.4 5.1 4.1 2.9 1.7 12.6 5.3 10.0 10.6 15.3 235.1 4.7 9.1 36.4 1.3 1.5 14.2 5.5 0.5 4.6 6.9 93.5 11.6 28.6 9.9 0.1 0.7 15.2 4.2 1.2 1.7 0.6 17.4 7.5 3.4 1.2 10.0 26.8 5.6 2.8 6.8 1.1 1.1 8.9 17.3 0.0 12.4 1.1 10.9 40.4 1.9 6.6 1.1 0.2 3.7 0.0 9.6 5.7 6.0 1.5 0.3 24.6 6.5 12.5 4.5 22.5 20.0 2.5 0.0 0.1 1.7 5.4 1.4 0.8 1.7 7.8 2.7 3.2 10.2 0.1 11.9 5.8 4.2 3.4 2.5 0.3 8.9 11.7 3.1 1.9 12.9 5.7 5.9 28.3 8.4 0.1 0.0 0.0 22.2 3.4 19.7 2.9 1.1 5.2 1.2 1.9 1.5 0.0 1.1 0.6 0.7 0.1 1.7 1.1 15.2 1.2 4.2 0.2 0.1 0.6 0.7 1.1 0.6 0.9 0.5 0.6 0.8 0.7 1.7 0.5 44.7 29.1 9.7 91.1 62.4 7.4 411.9 15.3 60.2 75.1 36.6 23.6 24.9 6.6 80.7 2.3 48.5 22.2 0.0 36.6 17.5 59.3 70.6 9.3 10.2 8.5 4.8 23.0 21.5 9.7 2.7 101.5 25.2 27.0 1.8 26.4 30.4 47.2 34.5 245.1 9.7 16.1 45.3 155.7 6.3 7.7 52.4 20.7 4.4 38.0 78.2 SWI5 "bA395P17.9, C9orf119, SAE3" ENSG00000175854 "SWI5 homologous recombination repair protein" Q1ZZU3 9 128275379-128288990 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 892.4;Late spermatids: 836.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA052032 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA052032: AB_2681702" "unprognostic (1.27e-2)" "unprognostic (1.74e-2)" "unprognostic (3.56e-3)" "unprognostic (3.21e-2)" "unprognostic (1.42e-3)" "unprognostic (3.28e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (2.11e-1)" "unprognostic (1.19e-1)" "unprognostic (1.81e-1)" "unprognostic (4.58e-3)" "unprognostic (1.15e-1)" "prognostic favorable (9.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (7.38e-2)" 10.2 11.7 14.7 11.8 15.9 6.0 17.9 18.0 13.2 18.2 9.0 12.3 48.0 9.9 13.0 44.8 13.5 20.4 12.7 14.8 12.5 13.2 14.2 18.0 12.5 8.7 16.7 11.0 19.6 13.2 26.5 23.8 10.7 13.6 14.6 8.1 14.1 15.2 50.7 14.1 10.3 9.5 12.8 13.7 7.7 9.2 57.1 16.2 8.9 27.8 12.5 10.5 12.4 17.1 12.6 14.2 28.1 9.6 13.4 15.3 10.0 9.5 17.1 10.2 11.8 27.6 25.3 11.5 16.9 22.5 22.0 14.9 21.9 11.3 9.1 22.6 27.5 13.6 16.1 16.2 22.5 15.0 13.7 12.1 6.9 32.8 17.1 35.6 4.4 6.5 21.2 10.8 36.6 19.8 19.5 21.0 33.6 16.3 14.8 22.4 39.0 9.6 6.4 6.9 22.2 35.7 9.0 14.0 14.5 14.7 5.0 11.7 6.5 21.0 13.5 20.0 11.8 22.4 4.8 13.0 16.0 13.3 30.9 14.2 15.7 23.5 12.1 21.8 6.9 17.2 28.1 9.6 16.4 10.2 5.7 12.0 12.6 10.1 10.2 9.8 12.5 12.2 15.3 6.4 13.4 5.6 14.2 10.0 10.0 14.7 15.9 18.0 13.2 12.5 13.2 16.7 11.0 13.6 16.2 6.0 19.5 14.5 34.6 21.8 13.1 30.0 30.6 14.7 18.2 34.9 11.8 55.7 56.3 21.8 892.4 21.5 27.0 0.0 33.5 35.4 41.0 29.6 9.2 68.6 29.0 1.6 24.5 27.6 19.7 836.9 40.0 17.2 35.4 27.1 23.4 24.7 25.7 20.1 29.7 53.2 17.7 32.3 26.4 56.3 38.7 19.2 97.8 18.3 20.5 27.5 SWSAP1 "C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1" ENSG00000173928 "SWIM-type zinc finger 7 associated protein 1" Q6NVH7 19 11374685-11376951 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052712 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA052712: AB_2681925" "unprognostic (6.45e-2)" "unprognostic (3.99e-2)" "unprognostic (1.48e-1)" "unprognostic (2.75e-1)" "unprognostic (1.92e-1)" "unprognostic (1.79e-2)" "unprognostic (5.03e-1)" "unprognostic (1.34e-2)" "unprognostic (4.65e-2)" "unprognostic (8.62e-3)" "unprognostic (1.40e-3)" "unprognostic (2.53e-1)" "unprognostic (1.34e-2)" "prognostic favorable (4.07e-4)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (4.18e-3)" 2.9 7.8 1.9 3.6 2.7 5.8 8.3 5.0 2.5 5.3 4.3 2.7 5.9 4.5 4.8 6.0 6.2 5.4 3.9 3.8 2.1 2.0 6.9 12.8 5.8 6.1 2.8 1.8 6.0 10.2 2.9 5.3 11.9 3.5 4.7 3.2 4.5 6.8 5.1 10.7 5.4 5.1 2.0 2.5 10.5 5.0 15.3 2.7 12.2 7.6 4.8 7.8 5.0 3.4 10.6 11.9 13.5 16.4 8.8 9.6 5.9 4.8 3.9 2.6 2.0 2.7 2.2 3.7 1.3 1.4 2.8 2.6 4.3 3.9 9.1 6.2 1.2 2.1 3.7 2.2 5.0 0.3 3.1 5.3 4.6 2.4 5.8 2.1 7.4 8.1 3.6 4.6 1.6 1.4 2.1 3.4 4.4 5.0 4.7 1.5 9.9 4.1 9.1 6.0 3.8 5.8 3.4 1.2 9.5 5.2 3.4 5.0 4.0 2.0 6.1 3.5 1.6 8.0 7.9 3.4 2.9 1.9 3.5 2.6 6.4 8.0 6.0 1.5 7.9 2.0 2.0 16.4 4.0 7.1 14.6 6.8 10.6 7.4 7.5 11.9 10.2 9.6 8.0 13.5 8.8 13.5 8.3 6.7 5.9 1.9 2.7 5.0 2.5 2.1 2.0 2.8 1.8 3.5 2.7 3.0 1.3 12.6 8.4 2.4 7.1 2.8 2.5 5.3 1.2 15.7 7.9 15.4 34.9 5.9 7.7 5.0 8.4 0.0 9.3 9.5 3.7 5.2 1.1 11.3 10.5 9.5 2.4 4.9 7.1 1.3 10.9 7.6 6.8 6.4 12.0 12.1 5.1 11.5 7.4 13.4 11.0 6.5 4.9 10.3 11.9 2.8 26.5 6.2 7.4 4.7 SWT1 "C1orf26, FLJ20121, HsSwt1" ENSG00000116668 "SWT1, RNA endoribonuclease homolog" Q5T5J6 1 185157080-185291765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.1" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 99.9;Late spermatids: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024214, HPA027334" Enhanced Approved Cytosol NA NA Cytosol "HPA024214: AB_1845642, HPA027334: AB_1845643" "unprognostic (2.67e-3)" "unprognostic (1.32e-1)" "unprognostic (3.65e-1)" "unprognostic (4.26e-2)" "unprognostic (3.17e-3)" "unprognostic (8.41e-3)" "unprognostic (5.71e-3)" "unprognostic (9.26e-3)" "unprognostic (7.37e-2)" "unprognostic (2.68e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.97e-1)" "unprognostic (4.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.35e-2)" 5.0 4.8 4.1 3.4 6.0 8.7 8.4 6.5 5.9 5.0 5.8 5.7 7.1 5.6 6.6 5.4 3.8 4.1 4.5 4.4 4.2 4.7 5.7 4.7 5.4 7.6 5.2 4.6 7.7 12.4 5.8 9.9 18.1 6.8 5.7 4.1 3.2 6.7 7.9 5.0 3.9 5.4 4.0 9.1 4.8 6.1 39.1 6.5 7.6 6.1 3.2 3.6 5.2 9.1 4.5 1.5 12.0 4.8 1.0 7.2 1.5 1.9 1.7 4.7 2.6 7.9 6.1 4.0 1.9 3.3 2.4 3.8 1.4 1.6 1.9 3.9 1.5 2.5 1.6 2.8 2.6 3.1 5.1 1.9 2.0 1.2 1.8 3.9 0.6 1.7 4.4 2.7 2.7 2.4 4.2 5.9 3.9 4.3 9.6 2.5 0.6 2.2 1.8 5.1 5.1 1.0 1.7 4.2 4.6 2.3 1.1 1.0 7.4 1.6 2.4 6.7 11.6 2.8 1.3 2.8 3.2 2.1 3.1 1.2 17.5 13.3 0.7 3.6 1.2 1.2 12.0 2.5 3.4 2.0 2.2 3.7 3.1 4.0 3.0 1.5 4.5 3.9 2.9 7.2 1.0 4.8 1.4 7.2 1.5 4.1 6.0 6.5 5.9 4.2 4.7 5.2 4.6 6.8 6.5 3.0 0.6 2.2 1.7 0.9 3.9 7.0 2.5 1.4 4.5 5.2 3.9 2.8 0.0 2.2 99.9 3.4 3.5 0.0 2.3 5.4 4.1 2.4 2.3 3.2 3.0 7.9 0.0 8.6 5.7 37.0 4.4 2.8 1.7 3.6 2.9 2.4 1.6 8.6 5.3 5.0 4.4 0.0 1.9 22.7 11.5 0.5 5.6 2.1 2.4 1.6 SYAP1 "FLJ14495, PRO3113" ENSG00000169895 "Synapse associated protein 1" Q96A49 X 16719632-16765336 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000175, HPA000882, HPA048047" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240" "unprognostic (4.66e-2)" "unprognostic (2.99e-2)" "unprognostic (1.25e-2)" "unprognostic (5.44e-2)" "unprognostic (1.89e-1)" "unprognostic (1.52e-2)" "unprognostic (9.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.82e-1)" "unprognostic (1.62e-2)" "unprognostic (1.95e-1)" "unprognostic (3.95e-3)" "unprognostic (1.14e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-3)" 17.6 31.3 13.1 12.9 12.3 26.2 16.5 10.2 14.0 17.1 23.8 12.2 16.1 20.6 17.0 13.7 18.5 14.4 20.7 25.7 13.5 13.7 28.7 51.4 17.6 11.4 15.8 11.0 19.9 14.3 22.8 15.9 18.9 18.4 16.2 16.1 10.7 15.9 21.3 22.5 12.6 33.0 12.3 17.3 13.7 16.9 10.1 11.2 15.3 16.2 13.3 15.1 17.9 13.5 12.6 11.1 17.8 15.0 13.8 15.2 9.1 15.9 13.5 9.8 18.3 13.3 15.2 4.5 12.8 9.2 10.7 10.7 12.6 13.3 12.5 18.8 12.5 21.9 9.6 11.9 16.7 14.4 8.1 23.8 5.0 14.6 12.0 9.5 8.5 7.8 10.3 7.9 18.5 15.8 12.5 14.7 3.9 10.7 7.1 14.4 18.8 4.5 9.2 11.4 8.9 14.9 5.0 12.4 12.6 15.9 10.6 10.0 12.3 23.8 17.0 12.6 13.3 22.6 7.7 11.6 13.8 7.3 28.0 10.3 7.7 6.6 14.6 13.6 4.3 11.2 9.2 10.5 12.7 15.2 11.3 12.3 12.6 13.0 13.9 11.1 10.8 13.1 13.6 17.8 13.8 15.0 9.2 14.4 9.1 13.1 12.3 10.2 14.0 13.5 13.7 15.8 11.0 18.4 11.2 59.6 59.3 59.9 76.6 56.9 18.5 68.5 81.5 190.1 93.3 75.0 21.6 57.3 94.5 102.2 188.0 47.2 124.9 23.3 115.1 64.1 49.1 85.9 200.3 200.6 44.7 22.3 101.7 67.5 63.9 250.6 39.1 90.0 64.1 53.3 93.6 45.0 138.4 150.8 51.2 108.8 19.3 58.2 83.4 13.3 21.5 45.9 125.9 62.3 95.4 91.2 SYCE1 "bA108K14.6, C10orf94, CT76" ENSG00000171772 "Synaptonemal complex central element protein 1" Q8N0S2 10 133553901-133569835 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 75.4" "Group enriched" "Detected in some" 5 "Early spermatids: 103.1;Late spermatids: 85.3;Spermatocytes: 250.9;Spermatogonia: 112.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "K-562: 17.4;U-2 OS: 16.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040208 Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA040208: AB_10796450" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-2)" "unprognostic (1.61e-1)" "unprognostic (3.20e-1)" "unprognostic (5.75e-1)" "unprognostic (5.38e-2)" "unprognostic (3.36e-1)" "unprognostic (2.22e-2)" "unprognostic (7.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" 1.8 1.8 4.9 0.7 5.4 0.3 1.3 8.1 8.2 0.4 0.7 0.9 0.0 0.4 0.8 0.5 0.6 1.4 1.6 0.7 4.0 3.3 0.9 3.9 0.5 1.1 1.5 6.7 1.1 1.5 0.2 0.3 8.6 3.5 1.8 0.6 0.2 0.4 0.6 0.9 0.3 0.5 0.7 1.7 0.8 0.5 75.4 0.0 0.1 1.4 0.1 0.7 0.4 0.0 1.3 2.0 0.3 2.6 0.2 3.2 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.4 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.1 16.1 0.2 0.3 0.2 0.3 0.4 0.0 0.1 0.0 0.0 1.7 0.3 3.2 1.8 3.0 0.9 2.4 0.8 1.2 1.3 1.4 2.7 0.0 0.2 2.6 2.0 2.2 1.8 4.9 5.4 8.1 8.2 4.0 3.3 1.5 6.7 3.5 0.0 0.0 1.0 0.0 1.5 0.9 1.8 0.2 2.5 2.7 2.3 0.0 0.0 0.3 0.0 0.0 103.1 0.1 0.0 0.0 0.9 0.1 0.8 0.4 0.0 5.1 0.6 9.5 0.0 0.0 0.0 85.3 4.9 0.6 0.0 0.0 0.0 0.3 0.7 0.0 3.5 0.3 1.6 25.8 0.4 250.9 112.4 0.9 0.2 0.0 0.0 0.3 SYCP1 "CT8, HOM-TES-14, SCP1" ENSG00000198765 "Synaptonemal complex protein 1" Q15431 1 114854803-114995370 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 30.6" "Cell type enriched" "Detected in some" 14 "Spermatocytes: 1077.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 93 "THP-1: 19.5" "Region enriched" "Detected in single" 51 "cerebellum: 16.5" "Not detected" "Not detected" HPA021083 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA021083: AB_1857685" "unprognostic (2.91e-1)" "unprognostic (6.89e-3)" "unprognostic (4.87e-1)" "unprognostic (8.74e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 1077.5 21.3 0.0 0.0 0.0 0.0 0.0 SYCP2 SCP2 ENSG00000196074 "Synaptonemal complex protein 2" Q9BX26 20 59863563-59933655 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 11.1;testis: 41.7" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 330.2" "Group enriched" "Detected in many" 6 "breast cancer: 6.7;cervical cancer: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 19.1;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062401, HPA065613" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA062401: AB_2684752, HPA065613: AB_2685519" "unprognostic (8.10e-3)" "unprognostic (8.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.19e-3)" "unprognostic (2.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.11e-2)" "unprognostic (1.44e-1)" "unprognostic (3.74e-1)" "unprognostic (7.02e-3)" "unprognostic (4.84e-3)" "unprognostic (8.48e-2)" "unprognostic (2.46e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" 2.2 0.5 1.3 0.9 2.3 1.4 11.1 2.5 5.7 1.3 1.2 1.0 0.8 1.1 1.1 0.9 0.8 0.8 2.0 2.1 1.2 1.2 3.3 0.8 1.6 3.1 1.8 2.7 0.4 4.9 1.3 3.0 2.9 3.9 2.9 0.8 0.6 3.0 0.7 0.8 2.0 1.7 0.6 1.6 2.3 4.5 41.7 0.8 3.0 1.9 0.2 1.5 1.3 1.0 0.9 0.1 2.6 0.3 0.0 2.7 0.5 0.1 0.5 0.1 0.5 0.2 0.3 0.6 1.6 0.4 0.7 0.1 10.2 1.0 0.0 1.6 0.7 0.3 0.2 0.2 0.0 0.4 3.2 0.2 0.1 2.0 0.1 0.0 0.1 7.6 0.1 0.1 0.1 0.0 0.4 0.0 19.1 0.1 0.0 0.3 4.9 21.1 1.1 0.2 0.6 0.1 0.0 0.0 0.1 0.9 2.4 0.1 1.8 37.2 5.4 1.1 0.7 33.6 1.9 0.2 0.0 1.1 4.5 0.0 0.0 0.0 0.0 0.0 0.7 2.1 2.5 0.3 2.3 2.6 0.0 2.7 0.7 1.5 1.7 0.1 0.9 0.9 1.5 2.6 0.0 0.1 0.1 1.0 0.5 1.3 2.3 2.5 5.7 1.2 1.2 1.8 2.7 3.9 0.8 0.0 0.6 0.5 1.0 0.9 1.3 3.6 2.5 14.7 10.3 1.8 2.0 0.5 1.7 0.6 36.7 2.3 0.0 0.0 3.1 0.2 1.2 2.0 2.3 0.0 0.5 0.0 0.0 3.1 0.6 13.5 4.4 1.1 5.0 0.0 0.0 2.2 1.6 0.2 1.8 2.6 1.0 51.8 1.9 330.2 31.3 0.0 0.3 1.3 0.2 1.1 SYDE1 "7h3, FLJ13511, SYD1" ENSG00000105137 "Synapse defective Rho GTPase homolog 1" Q6ZW31 19 15107403-15114988 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.0" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 126.4;Sertoli cells: 84.1;Syncytiotrophoblasts: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013328 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA013328: AB_1848705" "unprognostic (9.99e-2)" "unprognostic (3.73e-2)" "unprognostic (8.17e-3)" "unprognostic (1.65e-2)" "unprognostic (6.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-2)" "unprognostic (2.46e-2)" "unprognostic (2.96e-1)" "unprognostic (5.01e-3)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (5.63e-7)" "unprognostic (1.82e-2)" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.27e-4)" 15.6 7.7 3.5 5.9 4.3 0.1 19.9 2.0 3.5 19.5 13.9 4.4 3.8 4.3 18.6 6.8 10.7 12.2 10.5 9.3 4.0 1.8 9.6 3.3 9.4 4.9 3.1 2.4 17.9 4.6 2.3 3.8 60.0 5.0 11.8 2.9 22.0 3.3 13.6 5.9 4.4 5.7 14.2 2.5 7.6 7.9 7.4 4.3 0.9 8.2 5.8 2.8 12.9 12.8 0.2 0.3 0.0 0.0 0.0 0.5 0.0 4.1 6.4 3.5 9.0 7.9 7.3 2.7 17.5 12.9 17.2 14.7 1.4 2.5 0.0 11.6 17.6 5.9 2.6 2.7 3.1 9.7 0.1 3.0 0.6 11.9 2.8 15.0 0.0 0.0 12.7 2.3 10.3 4.7 10.5 3.1 0.0 0.0 0.0 12.8 2.0 0.0 0.0 5.7 0.1 6.6 0.0 8.6 0.0 4.2 0.5 0.1 6.9 9.8 6.0 11.7 3.5 0.7 0.4 6.6 41.5 12.6 19.0 18.8 0.0 0.1 0.0 11.2 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 2.0 3.5 4.0 1.8 3.1 2.4 5.0 4.3 3.0 1.4 0.5 0.6 2.2 0.3 3.9 2.5 0.0 1.2 1.8 0.0 4.9 0.0 3.9 8.8 12.6 0.0 0.0 0.3 126.4 14.7 0.5 0.0 0.0 3.0 1.6 0.0 19.0 1.3 12.0 27.3 0.8 13.5 0.0 0.0 13.2 1.5 0.0 39.6 5.5 0.4 84.1 29.9 1.2 0.5 2.3 112.5 0.0 0.0 0.1 SYK ENSG00000165025 "Spleen associated tyrosine kinase" P43405 9 90801787-90898549 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.5" "Cell type enhanced" "Detected in many" 6 "B-cells: 53.8;Hofbauer cells: 63.0;Kupffer cells: 79.3;Macrophages: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 39.4;HEL: 22.7;HL-60: 31.3;HMC-1: 20.9;REH: 26.2;THP-1: 24.1;U-698: 18.6;U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001384, CAB007773" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" No NA 1000000 "Plasma membrane, Cytosol" Vesicles "CAB007773: AB_562232, HPA001384: AB_1080144" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.69e-2)" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (6.41e-2)" "unprognostic (1.78e-2)" "unprognostic (7.20e-2)" "unprognostic (9.93e-2)" "unprognostic (2.55e-3)" "unprognostic (8.77e-2)" "unprognostic (5.36e-3)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 7.2 3.3 6.0 38.1 9.6 18.2 6.7 1.1 4.5 3.7 10.3 6.7 1.5 12.3 2.3 6.7 16.2 6.9 6.6 5.5 7.2 3.2 8.6 2.5 13.7 36.4 9.1 2.5 2.1 8.9 25.9 3.1 5.0 6.1 4.1 8.3 2.8 8.9 1.8 1.4 8.3 22.2 3.5 11.3 38.5 7.4 5.5 7.9 30.5 18.1 7.8 32.2 8.6 7.5 23.1 24.9 32.8 21.4 8.7 0.1 10.2 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 39.4 1.1 0.0 1.3 6.1 0.8 3.2 0.0 0.0 5.4 22.7 0.0 0.0 0.0 31.3 20.9 0.0 4.5 0.0 0.4 0.0 0.0 4.9 0.6 3.2 0.0 4.8 0.0 13.7 0.2 14.8 0.0 26.2 0.0 10.8 0.8 5.9 2.1 1.8 0.0 2.8 0.0 0.1 2.5 24.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.6 0.0 22.1 0.0 1.4 21.4 23.3 0.1 19.0 0.1 23.1 0.0 0.0 24.9 17.5 0.0 0.0 32.8 8.7 16.4 18.5 0.0 10.2 6.0 9.6 1.1 4.5 7.2 3.2 9.1 2.5 6.1 7.9 11.9 22.7 53.8 3.7 3.1 0.9 1.6 12.7 12.0 17.0 14.0 0.0 1.2 13.3 12.6 5.5 1.1 18.4 0.0 10.9 1.3 1.1 1.8 40.6 0.9 63.0 0.0 9.9 4.9 79.3 4.7 0.6 66.0 11.8 24.4 23.8 0.0 15.3 28.1 0.0 0.3 0.1 6.5 1.0 0.7 0.7 5.0 1.1 5.3 24.7 6.5 SYMPK "SPK, SYM" ENSG00000125755 Symplekin Q92797 19 45815410-45863290 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 114.2;Late spermatids: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041756, HPA042449" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA041756: AB_10963544, HPA042449: AB_2678003" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (2.59e-1)" "unprognostic (1.59e-2)" "unprognostic (3.11e-2)" "unprognostic (2.33e-3)" "unprognostic (9.93e-2)" "unprognostic (9.78e-2)" "unprognostic (1.23e-1)" "unprognostic (9.16e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-1)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (2.58e-1)" "unprognostic (6.38e-2)" 14.7 15.9 15.3 23.7 24.2 20.7 15.2 25.1 32.2 17.1 18.2 25.3 20.3 18.6 22.6 18.9 17.4 19.3 17.6 14.6 17.3 18.0 15.0 21.6 15.6 27.2 19.3 16.8 21.6 16.3 20.5 24.0 34.8 19.9 17.4 12.2 16.1 21.5 17.5 33.4 21.1 18.0 13.9 18.7 23.0 19.4 38.0 22.0 28.5 20.5 11.6 23.4 16.8 16.7 7.9 9.2 6.5 7.1 4.2 5.2 2.7 19.5 34.6 14.2 10.7 13.9 17.8 23.9 15.6 11.0 16.0 18.3 15.3 18.0 34.5 10.7 17.6 9.1 16.1 19.0 17.0 14.4 26.7 21.3 19.9 23.7 16.1 16.0 21.8 23.4 12.9 10.4 17.2 19.6 11.0 16.5 18.3 26.2 22.6 13.9 18.3 20.2 23.1 12.1 17.1 8.0 21.7 16.5 21.4 11.4 35.4 16.2 20.5 19.1 12.5 12.6 14.9 17.1 30.2 18.2 13.3 21.3 10.2 22.7 29.9 56.5 28.0 15.2 14.7 21.8 2.1 5.1 2.2 3.4 3.8 3.2 4.7 3.0 5.2 4.2 7.9 2.6 2.4 6.5 4.2 7.1 9.2 2.3 2.7 15.3 24.2 25.1 32.2 17.3 18.0 19.3 16.8 19.9 22.0 0.0 7.7 30.4 14.0 18.5 20.9 5.9 22.9 5.3 5.7 24.4 33.4 28.3 46.4 19.9 114.2 15.7 30.0 0.0 14.8 27.8 19.9 17.1 12.7 31.6 15.8 20.6 34.9 31.3 25.6 108.4 17.8 20.1 13.5 41.5 31.6 9.8 17.3 23.0 19.8 10.3 28.0 19.4 14.2 22.9 39.6 18.6 47.9 13.8 27.0 18.6 SYNCRIP "dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1" ENSG00000135316 "Synaptotagmin binding cytoplasmic RNA interacting protein" O60506 6 85607785-85643792 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010895, HPA041275, HPA069241" Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA 77000 Nucleoplasm "Vesicles, Cytosol" "CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: " "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-2)" "unprognostic (6.22e-2)" "prognostic unfavorable (6.28e-5)" "unprognostic (6.84e-2)" "unprognostic (6.48e-2)" "prognostic favorable (5.59e-4)" "unprognostic (1.58e-2)" "unprognostic (1.43e-1)" "unprognostic (4.86e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "unprognostic (4.11e-1)" 29.1 28.3 27.9 31.3 36.2 30.4 28.4 35.6 37.9 32.9 29.4 19.2 31.8 20.4 32.7 18.9 48.8 24.5 21.9 31.3 29.3 19.0 25.2 31.3 25.7 35.0 31.9 23.1 26.2 34.9 37.5 27.9 31.3 28.2 23.1 29.6 17.3 31.4 32.8 41.4 27.2 23.7 53.5 28.1 24.7 25.4 19.8 30.1 38.1 42.0 29.8 41.7 31.2 39.4 13.2 20.9 4.6 20.0 18.1 18.6 12.6 32.2 24.2 40.4 23.5 26.6 31.7 25.6 47.9 39.5 43.5 43.2 39.6 21.3 76.3 34.9 46.1 34.6 31.3 59.1 47.5 76.3 26.2 27.1 68.0 29.2 27.2 22.5 83.0 29.3 25.9 27.4 49.7 51.2 23.5 45.8 22.9 68.1 36.0 50.2 35.5 38.8 35.4 38.7 31.2 25.8 58.3 64.6 32.4 35.6 51.8 38.1 30.9 33.3 28.2 19.6 25.2 24.4 51.7 42.0 29.5 24.1 30.9 57.2 22.5 44.4 50.3 27.0 50.2 41.0 1.0 13.0 4.6 17.7 18.6 18.6 13.2 16.8 15.9 20.9 11.9 15.3 16.6 1.6 18.1 20.0 15.5 16.7 12.6 27.9 36.2 35.6 37.9 29.3 19.0 31.9 23.1 28.2 30.1 107.2 97.5 44.7 111.8 131.7 43.4 77.5 48.4 87.0 134.2 43.6 15.7 88.7 46.4 116.0 77.9 92.0 42.3 0.0 85.9 107.5 80.8 88.9 59.0 74.1 86.4 58.8 54.4 52.8 60.2 17.6 68.1 69.2 50.6 61.3 65.0 37.9 106.5 45.6 60.5 62.1 40.3 19.4 102.9 77.7 58.0 123.8 98.7 52.5 77.4 123.7 SYNGR1 ENSG00000100321 "Synaptogyrin 1" O43759 22 39349925-39385588 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.9" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 133.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 21.0;monocytes: 18.9;T-cells: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029673, CAB034277" Enhanced Supported Cytosol NA NA Cytosol "CAB034277: AB_2255766, HPA029673: AB_10670430" "unprognostic (2.68e-3)" "unprognostic (1.84e-3)" "unprognostic (5.90e-2)" "unprognostic (8.51e-2)" "unprognostic (3.74e-1)" "unprognostic (5.98e-3)" "unprognostic (7.39e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.16e-1)" "prognostic favorable (4.98e-7)" "unprognostic (1.32e-3)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" "unprognostic (1.04e-1)" 4.4 11.4 19.4 2.7 31.4 39.9 8.0 66.9 62.0 15.6 6.3 8.5 1.0 3.3 9.2 6.5 17.3 9.8 6.1 21.6 31.6 22.3 5.5 2.0 3.3 3.8 17.4 35.1 38.8 14.5 10.3 4.1 3.7 23.5 10.9 2.6 19.5 23.5 10.4 13.4 26.2 3.0 7.2 7.0 4.1 4.8 7.2 5.4 0.7 4.6 4.6 5.2 7.8 9.0 2.4 21.0 0.8 18.9 2.6 15.2 7.8 2.6 4.8 8.7 15.7 0.8 2.3 3.8 11.6 20.5 14.8 13.7 1.0 0.3 0.1 2.7 3.0 1.7 3.7 5.9 0.2 4.5 0.0 18.4 0.2 0.3 0.5 2.5 0.7 5.4 3.4 0.9 4.0 0.0 10.5 0.7 3.4 5.2 0.3 2.3 6.1 2.3 2.1 1.8 2.3 9.3 6.8 0.0 0.7 0.4 7.4 13.8 2.9 3.0 12.6 12.0 3.8 18.6 13.6 0.2 0.0 10.2 0.1 0.0 3.2 0.1 7.3 0.4 14.8 15.8 0.2 18.9 0.3 15.2 5.5 0.9 2.4 0.6 4.4 21.0 2.2 0.7 8.2 0.8 2.6 0.2 15.3 0.1 7.8 19.4 31.4 66.9 62.0 31.6 22.3 17.4 35.1 23.5 5.4 8.9 1.4 11.2 51.4 27.0 109.4 55.7 68.8 1.4 11.4 62.8 25.5 19.6 13.3 38.6 27.1 6.7 0.0 46.7 10.4 12.0 41.0 29.2 2.3 5.0 13.5 44.5 0.0 13.5 15.0 64.1 123.4 10.0 133.3 1.0 0.0 35.9 25.8 0.0 112.1 9.8 36.1 19.4 28.1 74.9 12.1 32.6 11.0 22.3 0.2 63.3 SYNJ1 "INPP5G, PARK20" ENSG00000159082 "Synaptojanin 1" O43426 21 32628759-32728048 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, RNA-binding" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011916 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA011916: AB_1857692" "unprognostic (6.84e-2)" "unprognostic (8.64e-2)" "unprognostic (5.76e-2)" "unprognostic (6.44e-2)" "unprognostic (1.27e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.45e-1)" "unprognostic (3.73e-3)" "unprognostic (1.63e-1)" "unprognostic (6.22e-3)" "unprognostic (1.84e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-1)" "unprognostic (6.36e-2)" "unprognostic (5.97e-2)" "unprognostic (1.79e-1)" "unprognostic (2.92e-1)" 5.5 6.8 13.6 5.0 25.9 20.6 4.2 19.5 39.0 4.8 4.8 6.5 0.8 3.9 4.6 5.3 3.9 4.0 5.2 5.2 18.3 18.2 7.4 5.5 6.5 5.7 16.6 18.4 4.6 4.5 10.6 10.9 9.3 33.5 3.6 5.5 7.0 3.8 4.0 4.4 5.0 4.6 5.0 7.3 6.0 4.2 9.0 5.7 3.2 6.8 1.5 4.8 4.7 3.3 0.4 3.1 11.5 6.0 0.5 3.0 1.1 5.6 2.8 5.2 5.7 9.1 7.3 10.6 11.7 6.7 7.2 6.0 6.4 2.6 2.1 3.9 7.0 9.6 5.3 9.3 6.8 8.6 6.7 8.9 14.1 9.2 3.5 4.9 5.8 12.5 4.1 5.1 12.4 6.3 5.9 11.2 7.5 10.5 12.1 9.2 5.7 5.4 4.8 3.7 6.2 6.5 5.9 11.3 7.4 7.6 4.1 5.9 4.6 14.4 9.2 5.6 7.4 7.9 7.5 12.3 11.1 5.5 8.9 6.4 6.3 7.3 4.4 8.4 11.0 8.8 3.7 3.4 7.9 1.6 6.0 2.7 0.2 2.4 2.6 3.1 0.4 2.9 2.8 11.5 0.5 5.3 1.6 3.0 1.1 13.6 25.9 19.5 28.7 18.3 18.2 16.6 18.4 33.5 5.7 6.0 4.8 2.9 2.0 4.2 21.5 7.3 5.1 4.0 2.3 1.8 43.2 13.3 5.0 1.6 14.8 7.9 4.9 0.0 1.2 7.9 3.7 2.2 3.5 3.6 8.6 9.5 2.9 8.6 19.0 8.6 2.6 7.5 1.7 1.0 2.7 19.5 2.1 3.5 4.2 5.0 40.7 6.5 3.4 16.4 10.9 2.9 31.8 6.9 4.0 4.1 SYNJ2 INPP5H ENSG00000078269 "Synaptojanin 2" O15056 6 157981887-158099176 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 62.0" "Cell type enhanced" "Detected in many" 8 "Pancreatic endocrine cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 46.3;TIME: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031575 Approved Approved Microtubules,Cytosol NA NA Microtubules Cytosol "HPA031575: AB_10604101" "prognostic unfavorable (2.63e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.48e-2)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.06e-2)" "unprognostic (2.91e-1)" "unprognostic (7.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.02e-6)" "unprognostic (1.66e-2)" "unprognostic (3.75e-2)" "unprognostic (1.75e-1)" "unprognostic (9.45e-2)" 2.8 3.9 12.2 4.9 25.1 15.3 6.7 3.0 18.7 3.9 8.7 50.5 3.7 5.8 5.2 9.4 6.0 4.6 8.0 8.5 17.8 10.9 3.2 4.0 2.8 4.4 46.8 8.8 2.9 6.6 1.1 2.9 2.6 33.0 5.3 8.9 1.4 13.5 5.1 4.3 3.1 5.6 6.6 62.0 3.3 7.0 6.5 24.4 3.0 4.4 1.4 5.3 5.9 3.0 3.2 1.1 9.3 1.3 2.4 3.8 0.8 5.4 19.2 1.6 2.5 1.2 4.0 8.5 10.1 20.5 12.1 14.3 9.8 4.6 0.1 6.9 19.4 46.3 5.2 3.4 6.3 14.1 7.6 3.2 10.6 10.0 10.3 2.3 3.7 11.6 2.0 3.4 18.4 4.3 16.4 21.0 5.6 8.1 2.4 5.5 2.5 4.6 4.1 1.8 17.1 10.7 2.0 6.6 4.9 4.0 6.3 12.2 0.7 7.8 4.9 1.9 6.3 3.8 2.3 37.1 9.2 9.4 21.2 12.2 1.0 2.6 0.2 17.2 5.9 6.3 4.5 1.3 1.1 1.9 0.6 3.8 1.9 2.6 1.7 1.1 3.2 2.2 1.7 9.3 2.4 0.8 1.1 2.1 0.8 12.2 25.1 3.0 18.7 17.8 10.9 46.8 8.8 33.0 24.4 3.0 3.5 2.7 16.6 19.3 0.0 10.4 10.2 10.7 6.8 17.4 0.0 5.3 3.3 36.4 22.7 10.5 15.3 0.0 30.7 4.2 14.6 30.3 4.7 4.5 1.9 0.0 16.7 7.4 3.4 37.2 1.1 4.6 10.1 10.8 14.5 1.5 88.4 3.5 6.0 1.4 0.4 0.0 6.6 0.7 1.1 15.1 13.3 5.3 14.5 32.4 SYNPO KIAA1029 ENSG00000171992 Synaptopodin Q8N3V7 5 150601080-150659220 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 2.9;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 27 "B-cells: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 26.4;EFO-21: 21.8;HUVEC TERT2: 21.3;TIME: 51.7;U-87 MG: 45.9" "Group enriched" "Detected in many" 6 "amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1" "Low region specificity" "Detected in all" "CAB033265, HPA034631, CAB037325, HPA071347" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179" "unprognostic (2.09e-2)" "unprognostic (7.72e-3)" "unprognostic (3.95e-2)" "unprognostic (2.78e-3)" "unprognostic (3.07e-2)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.53e-6)" "unprognostic (1.23e-1)" "unprognostic (5.72e-2)" "unprognostic (2.21e-2)" "unprognostic (6.35e-2)" 17.3 14.6 17.7 4.4 18.9 0.6 5.7 1.4 24.9 4.3 5.5 2.4 0.8 6.6 5.1 4.8 6.7 4.4 6.8 66.1 16.6 4.0 15.8 7.8 11.7 2.4 4.5 5.6 23.3 6.8 2.5 2.8 63.4 3.7 7.6 4.1 16.4 2.6 6.7 222.7 1.8 7.6 8.2 4.8 14.5 4.7 17.4 3.9 0.5 4.0 5.7 2.6 6.2 17.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 7.0 0.0 0.1 1.0 0.9 26.4 4.0 5.5 1.4 1.1 6.2 2.8 0.0 21.8 5.7 8.7 2.6 0.0 3.9 0.5 0.0 0.0 0.0 10.6 1.3 6.0 0.0 0.2 1.1 6.3 1.5 1.1 8.2 21.3 0.0 0.0 0.0 1.3 0.4 0.0 0.2 0.8 2.6 3.4 0.1 0.2 0.0 1.0 0.5 2.5 11.7 5.8 6.4 0.2 9.7 0.4 1.9 51.7 5.2 16.3 0.1 1.0 0.2 0.0 0.3 45.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.7 18.9 1.4 24.9 16.6 4.0 4.5 5.6 3.7 3.9 32.8 13.5 0.9 2.8 4.0 1.3 219.1 35.7 5.3 14.8 7.0 2.0 9.9 0.0 44.4 1.6 40.9 50.6 0.0 30.5 5.8 12.3 1.6 0.0 38.0 1.9 0.0 13.3 42.4 6.7 1.9 2.6 1.1 5.0 41.5 9.9 6.1 29.3 25.9 26.2 3.3 0.6 45.3 32.0 0.7 0.4 1.9 21.6 1.3 9.1 3.0 SYNPO2L FLJ12921 ENSG00000166317 "Synaptopodin 2 like" Q9H987 10 73644881-73663803 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3" "Cell type enriched" "Detected in some" 220 "Cardiomyocytes: 650.0" "Group enriched" "Detected in some" 6 "breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 7.7;HSkMC: 6.2;RH-30: 5.9;SK-BR-3: 6.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA055192, HPA057142" Enhanced Supported "Nuclear speckles,Cell Junctions,Cytosol" NA NA "Nuclear speckles" "Cell Junctions, Cytosol" "HPA055192: AB_2682732, HPA057142: AB_2683348" "unprognostic (2.75e-1)" "unprognostic (1.58e-1)" "unprognostic (1.20e-3)" "unprognostic (3.65e-3)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (4.54e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-2)" "unprognostic (4.50e-2)" "unprognostic (2.32e-1)" "unprognostic (7.44e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-1)" 3.8 0.1 0.0 0.0 0.1 0.1 1.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 3.2 3.3 0.0 0.0 69.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.8 0.0 0.0 1.6 0.0 72.8 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.3 29.3 3.4 0.0 0.3 0.7 1.0 3.0 0.7 0.7 0.7 0.1 0.5 0.1 0.8 0.3 0.1 0.0 1.1 0.9 1.2 0.2 0.0 7.7 0.7 0.4 0.5 0.9 0.1 0.1 0.1 0.0 0.4 0.2 0.2 0.3 0.6 0.4 0.6 0.2 0.3 6.2 0.1 1.2 0.1 0.3 0.0 0.5 0.3 0.3 0.3 0.3 0.2 1.9 0.2 0.0 0.7 0.2 5.9 0.3 0.0 0.6 0.3 0.4 0.1 6.3 0.1 0.3 0.4 0.7 0.0 0.6 1.0 0.2 0.3 1.0 0.3 0.3 0.2 0.6 0.0 2.9 0.7 0.7 0.7 0.4 0.3 0.5 0.3 0.3 0.2 0.7 0.4 0.4 3.0 0.7 0.4 1.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 1.4 1.3 1.4 650.0 0.0 1.4 1.2 0.0 2.0 0.1 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.1 0.9 0.7 1.1 0.2 0.2 0.0 0.0 0.0 0.3 1.0 0.9 0.8 1.7 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.3 0.0 0.5 0.7 0.6 0.4 0.0 0.7 0.0 0.9 SYNRG "AP1GBP1, MGC104959, SYNG" ENSG00000275066 "Synergin gamma" Q9UMZ2 17 37514797-37609496 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023554, HPA023555" Approved Approved Cytosol NA NA Cytosol "HPA023554: AB_1844892, HPA023555: AB_2058337" "unprognostic (1.22e-1)" "unprognostic (1.24e-1)" "unprognostic (9.25e-2)" "unprognostic (1.11e-1)" "unprognostic (4.99e-2)" "unprognostic (3.44e-2)" "unprognostic (3.71e-2)" "unprognostic (1.90e-1)" "unprognostic (1.40e-1)" "unprognostic (1.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.21e-2)" "unprognostic (4.68e-3)" "unprognostic (8.76e-2)" "unprognostic (2.56e-1)" "unprognostic (2.91e-2)" "prognostic favorable (3.96e-4)" 6.3 5.9 5.4 10.3 9.4 4.8 5.2 9.4 8.6 5.5 6.0 10.4 4.3 5.4 7.4 8.7 5.4 5.0 5.8 6.2 4.8 7.0 5.6 5.7 14.2 6.9 6.3 5.8 6.4 9.6 14.5 5.9 10.8 5.8 6.8 6.2 6.2 6.2 7.3 4.6 5.7 4.8 8.5 10.4 7.5 10.9 8.2 22.7 7.0 3.8 14.2 6.5 4.0 10.4 11.4 8.0 3.4 13.8 13.8 3.2 5.2 8.4 11.4 7.3 7.1 7.8 5.5 7.8 7.9 8.9 10.7 7.5 8.5 9.4 7.4 7.1 8.8 5.2 9.9 4.3 12.5 8.7 7.0 5.1 5.3 4.4 9.2 8.2 11.8 9.1 8.9 10.8 5.6 7.6 12.7 16.7 11.0 8.5 9.4 3.9 18.8 5.0 4.7 4.8 3.5 11.8 9.6 6.2 7.4 9.2 9.7 8.2 7.7 2.4 6.1 14.1 7.0 6.3 11.3 6.2 7.9 5.2 7.1 9.9 12.3 17.2 7.7 4.5 6.3 8.0 3.4 7.2 10.4 2.6 13.8 8.9 9.1 10.5 2.9 10.4 9.4 9.2 7.0 13.8 2.5 11.4 9.2 3.2 50.6 34.2 39.9 14.5 7.6 45.9 24.3 25.5 22.7 25.0 31.4 51.1 13.7 14.9 20.9 33.0 26.1 19.7 0.0 18.8 9.3 12.5 15.8 24.4 19.2 18.3 35.0 40.9 22.1 30.1 39.2 21.0 25.7 15.1 22.6 21.5 37.1 20.1 22.9 22.6 21.6 52.7 12.9 14.4 56.2 22.3 8.2 22.2 76.7 16.5 19.3 SYPL2 Mg29 ENSG00000143028 "Synaptophysin like 2" Q5VXT5 1 109466628-109482137 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 102.5;tongue: 25.6" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 8.5;Collecting duct cells: 3.5;Hepatocytes: 4.5;Late spermatids: 8.5;Proximal tubular cells: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 20.2;ASC TERT1: 8.5;BJ: 8.6;BJ hTERT+: 27.3;fHDF/TERT166: 14.1;HAP1: 7.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA076657 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA076657: " "unprognostic (1.82e-2)" "unprognostic (1.81e-1)" "unprognostic (2.90e-4)" "unprognostic (6.63e-2)" "unprognostic (1.35e-1)" "unprognostic (9.36e-3)" "unprognostic (2.84e-2)" "unprognostic (2.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "prognostic favorable (3.05e-4)" "unprognostic (2.54e-3)" "unprognostic (3.40e-1)" "unprognostic (9.46e-3)" "unprognostic (6.39e-4)" 0.9 3.9 0.8 0.3 0.7 0.1 1.4 0.5 1.2 1.6 1.9 0.3 0.8 0.3 2.5 4.3 1.6 0.4 1.1 7.4 0.8 0.2 6.0 4.7 0.6 0.3 0.3 0.0 1.1 3.2 3.7 0.4 1.2 0.8 1.2 0.5 1.7 1.6 2.2 102.5 0.2 0.6 3.5 0.1 0.4 1.1 6.0 0.2 0.0 5.1 25.6 1.2 2.5 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 20.2 8.5 0.0 8.6 27.3 2.7 1.0 0.0 0.0 0.0 0.0 14.1 0.3 0.0 7.3 0.0 0.5 0.0 3.1 0.0 0.2 0.1 0.4 0.0 0.7 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.9 2.1 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.5 1.2 0.8 0.2 0.3 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 1.5 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 4.9 0.0 0.0 2.3 0.4 1.5 0.0 0.1 0.0 0.0 0.0 SYT16 "CHR14SYT, Strep14, SYT14L, yt14r" ENSG00000139973 "Synaptotagmin 16" Q17RD7 14 61811974-62112550 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.8;testis: 6.8" "Group enriched" "Detected in some" 5 "Early spermatids: 26.4;Late spermatids: 10.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.6;hTERT-HME1: 4.3;PC-3: 5.5;RPTEC TERT1: 6.5;RT4: 17.1;U-2 OS: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004199, HPA076871" Enhanced Approved Cytosol NA NA Cytosol "HPA004199: AB_1080156, HPA076871: AB_2732324" "unprognostic (2.55e-2)" "unprognostic (1.43e-2)" "unprognostic (4.12e-1)" "unprognostic (8.88e-4)" "unprognostic (1.41e-1)" "unprognostic (9.08e-2)" "unprognostic (9.57e-2)" "unprognostic (9.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (3.41e-2)" "unprognostic (1.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.53e-3)" "unprognostic (2.15e-1)" 0.4 1.3 7.2 0.4 17.2 0.6 0.6 0.7 20.8 0.4 0.4 0.4 0.0 0.4 1.0 2.1 0.4 0.7 0.5 0.5 3.3 3.4 0.7 0.4 0.5 0.5 1.6 12.3 0.4 4.0 0.4 1.9 1.1 1.8 4.6 0.4 0.0 0.4 0.6 0.4 0.5 0.5 0.4 0.9 0.5 2.6 6.8 0.7 0.0 0.5 0.0 0.4 0.9 0.6 0.2 0.1 0.6 0.1 0.1 0.2 0.0 10.6 0.2 0.3 0.0 0.0 0.0 0.1 0.7 1.0 1.0 0.6 0.0 0.0 0.1 0.2 0.0 0.6 0.6 0.0 1.0 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 5.5 0.0 0.0 0.0 6.5 17.1 0.3 3.0 0.5 0.7 0.0 1.1 0.0 0.0 0.0 2.9 6.9 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.6 0.1 0.1 0.1 0.0 0.0 7.2 17.2 0.7 18.9 3.3 3.4 1.6 12.3 1.8 0.7 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 3.5 2.0 0.3 0.0 0.1 26.4 0.0 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 2.1 0.0 0.1 0.0 0.0 0.1 SYT17 ENSG00000103528 "Synaptotagmin 17" Q9BSW7 16 19167971-19268334 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 21.0;Distal tubular cells: 23.2;Intestinal endocrine cells: 20.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 4.1;memory B-cell: 5.1;naive B-cell: 14.7;non-classical monocyte: 13.4" "Group enriched" "Detected in many" 8 "B-cells: 14.7;monocytes: 13.4" "Cell line enhanced" "Detected in many" "BEWO: 10.4;CAPAN-2: 20.2;Daudi: 8.9;MCF7: 15.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042059 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042059: AB_2677827" "unprognostic (3.43e-1)" "unprognostic (2.75e-1)" "unprognostic (2.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.74e-1)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (2.43e-1)" "unprognostic (6.76e-2)" "unprognostic (1.97e-1)" "unprognostic (3.15e-1)" "unprognostic (6.59e-2)" "unprognostic (3.00e-3)" "unprognostic (4.53e-2)" "unprognostic (3.38e-1)" "unprognostic (7.32e-2)" "unprognostic (4.95e-3)" 3.8 5.2 16.5 1.4 9.2 0.4 4.7 1.0 25.2 3.5 2.4 6.1 1.2 4.3 1.2 3.1 4.0 2.5 1.3 1.3 15.5 16.5 3.8 12.1 7.8 3.2 13.9 10.2 0.8 2.5 21.3 13.4 3.9 7.5 9.7 3.0 7.6 1.5 3.8 0.4 9.9 2.1 1.0 5.5 1.4 4.3 0.6 7.4 0.0 7.1 0.8 4.7 4.2 3.8 14.7 1.6 0.4 13.4 0.0 0.0 0.6 0.0 7.4 0.1 0.0 0.2 0.5 10.4 0.0 0.0 0.1 0.0 0.3 20.2 8.9 2.5 0.0 2.8 3.6 0.5 0.3 0.0 0.0 1.5 0.0 7.4 0.1 0.0 0.0 0.0 0.7 1.8 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.9 5.8 4.1 0.0 0.8 0.7 2.5 4.4 1.6 0.9 2.9 8.0 0.4 5.1 7.9 1.9 0.0 0.0 5.3 0.1 0.0 1.5 0.0 8.2 0.0 0.0 0.0 0.4 0.5 0.0 0.0 4.1 0.0 5.1 0.0 0.0 1.6 14.7 0.0 0.0 0.1 0.0 13.4 0.2 0.0 0.6 16.5 9.2 1.0 22.9 15.5 16.5 13.9 10.2 7.5 7.4 6.0 9.4 2.7 10.1 3.4 0.6 1.4 0.0 5.3 3.4 21.0 0.0 4.2 23.2 3.4 0.1 1.6 1.3 0.0 0.6 11.3 2.4 8.2 0.0 12.4 4.0 1.6 20.7 3.1 1.9 0.0 1.4 2.0 11.8 9.0 9.1 13.2 2.7 7.0 0.7 0.0 0.3 0.0 0.7 0.5 1.7 8.4 3.3 0.0 3.1 6.3 SYTL5 ENSG00000147041 "Synaptotagmin like 5" Q8TDW5 X 38006582-38128819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.0" "Cell type enhanced" "Detected in some" 11 "Club cells: 5.7;Mucus-secreting cells: 10.5;Syncytiotrophoblasts: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 19 "monocytes: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;MCF7: 5.2;OE19: 7.5;SK-MEL-30: 13.4;SuSa: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026074 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA026074: AB_1857697" "unprognostic (3.60e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (6.68e-2)" "unprognostic (3.09e-3)" "unprognostic (3.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.10e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (5.21e-2)" "unprognostic (1.51e-1)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" 0.5 6.0 10.5 3.4 11.0 0.0 2.9 0.5 2.5 7.0 7.3 0.5 0.5 2.3 2.6 1.0 12.2 0.2 2.9 0.9 9.2 8.9 1.0 6.1 2.4 0.5 2.4 0.5 0.5 6.4 0.0 1.1 17.0 0.5 2.0 3.5 1.5 7.1 1.7 0.5 0.0 14.3 3.9 1.3 0.8 13.8 0.7 0.5 0.7 0.9 1.2 5.9 1.3 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.6 1.3 0.0 0.0 0.5 2.1 0.6 0.0 0.0 0.0 0.0 0.6 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.7 0.1 0.0 0.1 0.1 0.2 5.2 0.0 0.0 2.3 7.5 0.0 0.0 1.9 0.0 0.0 0.4 2.9 0.0 0.3 1.1 13.4 19.0 0.0 0.0 0.0 0.1 4.5 0.0 3.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.5 11.0 0.5 2.5 9.2 8.9 2.4 0.5 0.5 0.5 0.0 1.3 0.0 0.2 0.0 0.0 0.3 0.0 1.4 5.7 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.1 0.0 0.8 3.1 0.1 0.9 0.0 0.9 0.2 0.0 2.9 0.6 0.0 0.0 0.6 0.0 0.0 0.0 10.5 0.0 3.5 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.6 0.6 SZRD1 "C1orf144, DKFZp566C0424" ENSG00000055070 "SUZ RNA binding domain containing 1" Q7Z422 1 16352575-16398145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024221 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA024221: AB_10603450" "unprognostic (3.52e-2)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "unprognostic (1.53e-1)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (5.98e-6)" "unprognostic (2.53e-1)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "unprognostic (7.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" "unprognostic (7.60e-2)" 34.9 30.7 23.1 25.0 26.3 37.5 33.1 17.1 20.6 30.7 29.0 20.8 15.4 23.0 38.5 23.2 33.7 26.5 30.5 37.0 23.5 14.3 39.8 41.4 26.2 27.2 27.4 11.8 36.3 25.1 32.2 16.8 46.4 22.4 24.8 20.9 27.9 20.8 23.7 55.2 24.9 39.3 31.3 20.9 40.6 27.1 18.3 25.0 32.1 35.0 27.6 33.6 34.3 35.1 30.4 19.2 34.3 36.7 20.0 25.5 29.6 37.4 28.8 39.9 27.6 34.1 39.4 13.2 38.4 50.0 45.7 35.6 28.8 33.4 32.9 43.1 51.2 25.1 20.7 35.7 42.3 33.9 56.6 30.9 37.7 31.0 22.6 30.8 36.6 37.2 39.7 35.5 49.8 33.4 32.3 39.5 28.6 33.8 31.0 41.7 36.4 35.7 28.0 27.8 27.8 33.0 36.7 42.1 38.7 31.0 17.6 31.7 33.0 33.7 21.8 48.6 17.2 22.5 24.2 44.0 31.2 36.5 48.6 38.1 17.2 18.9 39.6 34.8 50.1 41.2 15.0 24.3 34.3 24.5 33.2 24.2 28.3 21.2 22.8 19.2 30.4 19.6 21.1 27.1 20.0 36.7 14.9 25.5 29.6 23.1 26.3 17.1 20.6 23.5 14.3 27.4 11.8 22.4 25.0 17.9 24.2 44.6 45.3 40.5 19.7 39.9 48.4 8.1 12.5 38.4 2.0 50.0 59.7 57.9 17.5 35.9 61.6 23.3 46.5 67.2 40.6 49.4 36.8 45.6 64.1 41.3 45.9 29.4 42.2 39.0 33.4 33.2 42.2 108.2 41.3 23.4 53.3 42.1 33.6 40.9 17.7 38.8 49.1 20.2 19.8 51.1 70.3 40.6 41.6 56.6 TAB1 MAP3K7IP1 ENSG00000100324 "TGF-beta activated kinase 1 (MAP3K7) binding protein 1" Q15750 22 39399741-39437060 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032328, HPA039988, HPA057104" Approved Enhanced "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB032328: AB_2281637, HPA039988: AB_2676787, HPA057104: AB_2683338" "unprognostic (1.76e-1)" "unprognostic (1.79e-2)" "unprognostic (7.88e-2)" "unprognostic (6.73e-3)" "unprognostic (9.23e-3)" "unprognostic (4.30e-2)" "unprognostic (6.44e-2)" "unprognostic (1.79e-2)" "unprognostic (4.93e-2)" "unprognostic (7.05e-2)" "unprognostic (1.63e-1)" "unprognostic (7.35e-2)" "unprognostic (7.80e-3)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" 12.2 14.9 18.3 13.6 20.8 13.6 12.5 24.7 28.1 16.9 16.2 32.0 10.9 16.9 18.8 10.7 13.6 17.9 19.2 18.9 17.9 15.7 12.4 14.8 13.7 15.8 22.7 18.8 26.7 19.5 16.3 12.5 13.8 15.9 16.9 9.1 19.6 21.6 19.1 27.8 17.3 15.7 14.3 17.2 17.2 14.4 11.9 20.6 13.0 13.3 10.9 13.0 16.8 14.3 5.9 8.2 6.1 8.7 5.2 7.6 6.3 12.0 12.5 12.7 14.5 13.5 11.5 11.3 10.1 12.6 15.5 14.7 11.5 8.7 18.2 8.0 9.8 8.6 14.7 12.9 14.8 6.2 14.1 20.6 8.0 15.3 11.3 11.8 15.0 15.4 11.5 13.2 11.7 12.8 11.8 11.3 11.1 14.5 12.5 7.7 7.8 11.5 12.5 8.9 19.0 12.8 20.8 18.2 18.1 11.9 12.9 11.3 8.4 14.3 17.8 12.5 8.3 14.5 16.5 9.6 10.8 17.3 8.3 8.2 19.8 12.7 13.2 12.8 10.6 10.5 1.4 8.7 6.1 7.6 7.2 6.2 5.9 4.6 6.1 8.2 5.9 7.5 6.7 1.3 5.2 6.7 3.8 4.6 6.3 18.3 20.8 24.7 28.1 17.9 15.7 22.7 18.8 15.9 20.6 3.0 4.1 4.9 2.8 1.8 52.3 6.5 5.1 2.7 3.4 3.5 17.7 10.3 0.0 5.2 1.3 4.5 4.2 0.0 3.4 7.1 4.7 2.4 4.7 4.2 6.1 27.0 10.9 3.1 5.6 2.4 7.2 3.9 5.0 8.2 4.5 11.8 4.8 4.3 8.5 4.2 18.2 6.5 4.7 7.1 8.9 2.9 4.7 8.2 5.6 1.3 TAB3 MAP3K7IP3 ENSG00000157625 "TGF-beta activated kinase 1 and MAP3K7 binding protein 3" Q8N5C8 X 30827442-30975084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034980, HPA034981" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA034980: AB_10602708, HPA034981: AB_2674394" "unprognostic (4.39e-1)" "unprognostic (2.22e-1)" "unprognostic (3.04e-2)" "unprognostic (1.73e-1)" "unprognostic (6.35e-2)" "unprognostic (2.95e-3)" "unprognostic (1.49e-2)" "unprognostic (1.73e-2)" "unprognostic (3.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.51e-1)" "prognostic favorable (8.45e-4)" "unprognostic (5.91e-2)" "unprognostic (1.25e-1)" "unprognostic (9.12e-2)" "unprognostic (2.75e-1)" 6.1 8.0 5.9 6.6 6.9 10.1 6.5 9.1 9.2 7.6 6.5 4.2 17.9 5.2 40.3 7.4 13.2 9.2 10.6 6.9 6.1 5.3 16.9 23.3 8.0 8.1 6.7 6.6 11.3 17.3 25.0 9.4 39.3 9.1 12.9 6.7 9.3 11.5 15.0 8.8 8.1 7.4 9.6 5.2 7.1 8.4 26.7 3.6 8.3 7.7 14.5 15.6 6.6 7.9 1.0 0.6 0.8 1.1 3.9 1.0 0.4 23.2 5.6 5.8 5.9 4.5 6.9 6.1 7.2 9.1 4.9 5.5 6.3 20.0 10.5 4.4 8.3 9.4 12.1 8.9 18.4 7.1 18.1 8.5 9.8 6.6 15.4 3.9 10.3 7.7 4.9 11.1 8.3 21.4 8.5 8.0 8.1 11.2 8.6 6.3 11.2 8.2 5.2 6.9 4.2 9.5 5.3 10.2 7.8 8.2 6.8 4.8 6.9 8.1 12.3 15.6 11.3 10.5 4.1 7.7 5.4 8.0 27.1 6.6 11.3 8.6 10.4 8.5 4.9 7.6 0.2 0.5 0.8 0.7 1.1 0.9 0.8 1.0 0.4 0.6 1.0 1.0 1.0 0.8 3.9 0.8 0.3 0.6 0.4 5.9 6.9 9.1 9.2 6.1 5.3 6.7 6.6 9.1 3.6 11.9 10.4 5.4 6.5 8.0 6.5 10.6 17.8 16.0 7.9 10.4 11.8 12.7 3.3 8.3 0.8 7.7 7.4 23.3 5.9 4.2 5.1 13.1 13.9 24.2 6.8 11.1 6.9 8.6 13.8 0.9 10.0 10.2 5.0 7.2 12.3 6.0 7.7 8.7 15.2 10.2 19.1 0.0 3.1 3.7 1.7 8.8 18.8 6.9 9.3 9.9 TACC1 ENSG00000147526 "Transforming acidic coiled-coil containing protein 1" O75410 8 38728186-38853028 "Predicted intracellular proteins" "Cell cycle, Cell division" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017041, HPA024702, HPA056841" Approved Approved Cytosol NA NA Cytosol "CAB017041: , HPA024702: AB_1857723, HPA056841: " "unprognostic (1.83e-2)" "unprognostic (3.07e-1)" "unprognostic (2.18e-1)" "unprognostic (8.31e-2)" "unprognostic (6.55e-2)" "unprognostic (5.30e-2)" "unprognostic (1.79e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-1)" "unprognostic (7.85e-2)" "unprognostic (1.63e-1)" "unprognostic (5.94e-2)" "prognostic favorable (1.06e-5)" "unprognostic (1.03e-3)" "unprognostic (2.84e-2)" "unprognostic (2.15e-2)" "unprognostic (1.18e-1)" 55.9 12.8 15.0 15.3 16.7 23.3 39.4 8.2 20.4 32.1 31.9 16.8 25.7 8.3 44.9 16.1 28.7 29.9 18.9 19.9 14.6 12.4 21.3 9.1 26.6 15.0 17.5 13.1 19.5 17.4 13.6 8.1 28.8 15.2 22.8 18.0 23.9 11.8 32.0 20.5 10.4 17.5 36.6 17.4 28.0 20.2 14.2 16.5 8.1 18.5 15.5 13.3 40.0 39.6 1.6 21.2 19.0 8.0 2.3 4.1 3.1 10.7 20.8 15.3 4.7 16.5 11.5 9.9 14.0 18.3 13.5 13.8 9.6 1.7 11.0 8.6 13.8 11.7 10.3 9.1 6.3 28.1 7.8 3.4 42.9 6.4 6.2 19.4 8.5 19.9 20.9 5.9 21.8 7.0 14.1 48.3 13.4 4.4 27.8 40.6 8.0 20.1 4.9 2.1 17.7 9.8 4.5 34.4 1.9 4.5 10.6 1.0 1.2 11.4 11.8 9.5 9.5 5.4 6.6 38.6 16.4 9.9 20.9 11.3 14.5 9.4 9.9 14.9 9.9 19.8 6.4 6.9 9.0 3.8 6.2 4.1 1.3 2.6 3.1 4.5 1.6 2.2 2.4 19.0 2.3 8.0 21.2 2.0 3.1 15.0 16.7 8.2 20.4 14.6 12.4 17.5 13.1 15.2 16.5 202.5 130.7 53.4 44.9 31.3 23.8 42.5 170.7 8.1 51.2 43.6 58.9 51.0 101.2 129.7 3.5 172.1 11.9 0.0 51.9 48.9 114.7 69.5 111.1 31.0 67.2 103.3 36.2 302.0 73.2 7.9 155.9 86.0 38.8 73.1 117.5 67.6 55.5 35.1 193.7 20.3 43.1 187.5 177.2 39.4 58.6 16.6 78.6 66.3 52.4 32.8 TACC2 AZU-1 ENSG00000138162 "Transforming acidic coiled-coil containing protein 2" O95359 10 121989174-122254545 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 109.4" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 186.1;Syncytiotrophoblasts: 191.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 36.6" "Low region specificity" "Detected in all" "HPA031020, HPA031021, HPA061394" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 110000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500" "unprognostic (3.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.75e-2)" "unprognostic (7.07e-2)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (9.15e-2)" "unprognostic (8.43e-3)" "unprognostic (1.14e-1)" "unprognostic (3.51e-1)" "unprognostic (2.13e-1)" "unprognostic (1.83e-2)" "prognostic favorable (2.50e-10)" "unprognostic (7.02e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" 8.2 5.8 9.6 2.4 11.7 0.6 7.8 17.7 16.6 6.9 17.2 2.6 4.0 6.3 8.4 4.3 13.4 9.6 7.7 43.3 8.0 4.8 19.3 3.8 54.1 0.8 3.1 9.0 4.7 6.3 11.9 41.0 45.4 6.8 12.0 8.6 4.8 18.5 6.0 109.4 28.9 8.2 8.9 3.2 1.3 10.2 2.2 3.9 0.1 19.6 4.4 2.5 15.1 8.8 0.1 0.1 0.3 0.0 0.1 0.2 0.0 7.2 22.8 11.2 6.4 3.2 3.2 13.6 3.2 8.6 4.4 3.1 9.3 12.0 0.0 2.9 5.0 5.1 24.3 3.5 8.6 4.6 1.2 1.8 0.0 2.8 17.7 4.9 0.0 0.1 1.4 36.6 2.4 15.6 3.6 9.2 0.0 1.8 0.2 4.3 9.5 0.0 4.0 6.6 11.2 10.4 0.1 6.4 3.4 12.0 11.1 7.5 6.1 5.2 21.8 11.6 3.4 4.3 0.1 8.5 2.0 1.5 4.9 5.9 1.0 4.5 0.1 3.7 0.0 5.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 9.6 11.7 17.7 16.6 8.0 4.8 3.1 9.0 6.8 3.9 77.4 80.3 0.8 44.9 29.9 18.8 186.1 7.6 88.3 50.0 34.9 0.0 36.8 1.7 7.5 1.6 14.3 44.5 0.0 12.6 2.8 12.8 69.9 6.9 14.5 5.4 41.3 28.8 7.4 0.0 2.1 6.4 3.5 6.8 0.0 35.8 1.1 14.9 38.5 7.1 9.8 2.5 12.9 35.4 0.5 4.3 47.2 191.1 2.5 36.7 77.4 TACC3 ERIC1 ENSG00000013810 "Transforming acidic coiled-coil containing protein 3" Q9Y6A5 4 1721490-1745176 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 43.8;Late spermatids: 49.1;Spermatocytes: 69.6;Spermatogonia: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 54.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005781, HPA006050, CAB010111, HPA022039" Enhanced Enhanced "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" Yes Yes "Mitotic spindle, Centriolar satellite, Cytosol" Vesicles "CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725" "unprognostic (2.95e-1)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (4.35e-2)" "unprognostic (6.58e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.10e-3)" "unprognostic (4.61e-2)" "unprognostic (9.12e-2)" "unprognostic (2.91e-2)" "unprognostic (2.26e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.66e-2)" "unprognostic (2.09e-1)" "unprognostic (4.44e-3)" "unprognostic (9.75e-2)" 3.8 2.7 1.1 39.1 1.1 26.0 3.4 2.1 1.4 1.9 4.4 1.1 0.8 4.5 1.8 2.7 8.8 1.6 3.5 2.0 1.4 1.3 2.5 2.4 4.3 20.1 1.3 0.7 1.6 1.0 0.5 1.8 5.7 1.1 1.6 4.9 1.6 3.0 1.2 2.0 2.6 7.7 2.5 1.8 15.6 3.4 58.1 0.9 64.3 1.6 7.3 27.9 3.2 3.0 4.0 10.4 54.8 19.9 3.8 17.9 16.1 25.4 21.2 32.5 18.6 1.7 3.6 18.3 28.9 15.5 33.2 22.0 23.5 30.8 32.5 12.3 15.7 38.6 17.2 34.3 21.0 33.8 14.3 18.6 27.5 17.6 21.6 1.6 37.2 23.4 1.5 1.4 20.9 12.1 7.3 25.2 26.8 24.8 25.7 31.4 20.8 49.0 53.3 35.1 21.8 27.9 34.8 23.0 13.0 18.8 38.6 25.3 15.9 17.4 11.0 8.1 25.5 21.6 21.6 14.7 19.4 23.2 17.5 43.5 18.0 23.9 52.1 11.2 36.0 27.4 24.7 19.9 17.9 5.5 9.0 6.0 4.0 12.3 7.6 10.4 3.8 17.9 9.8 54.8 3.8 5.5 3.1 17.5 16.1 1.1 1.1 2.1 1.4 1.4 1.3 1.3 0.7 1.1 0.9 0.0 7.9 16.0 0.5 1.9 1.0 2.2 0.0 0.0 4.5 8.7 7.9 3.3 0.0 2.1 43.8 2.5 2.0 23.3 0.6 16.5 2.6 1.0 4.7 4.3 35.7 4.8 1.2 4.9 20.5 49.1 2.6 21.9 0.0 12.6 3.1 1.4 1.9 3.5 2.5 1.8 3.2 6.5 1.0 69.6 47.8 1.3 3.3 15.3 5.7 1.3 TADA1 "ADA1, hADA1, HFI1, STAF42, TADA1L" ENSG00000152382 "Transcriptional adaptor 1" Q96BN2 1 166856510-166876327 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028651 Approved Supported "Nucleoplasm,Focal adhesion sites,Cytosol" No No Nucleoplasm "Focal adhesion sites, Cytosol" "HPA028651: AB_10602476" "unprognostic (9.53e-3)" "unprognostic (2.31e-1)" "unprognostic (1.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (7.09e-2)" "unprognostic (5.99e-3)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.98e-2)" "unprognostic (3.64e-2)" "unprognostic (2.73e-2)" "unprognostic (6.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-2)" 6.5 10.6 13.8 7.1 18.5 17.8 10.2 18.2 20.0 11.3 9.1 17.0 3.4 8.3 10.5 8.6 10.1 9.8 6.6 9.2 13.2 14.6 12.9 28.9 6.7 10.1 11.1 14.3 12.7 7.5 11.3 13.7 12.5 15.0 9.2 10.2 13.4 8.7 8.4 10.7 8.5 9.0 8.5 10.8 7.3 8.0 12.0 10.3 16.7 11.5 7.1 10.9 8.6 7.8 13.4 13.0 8.1 8.2 16.2 19.5 15.1 8.2 7.9 14.9 8.8 4.5 5.8 8.9 4.3 5.3 7.3 6.3 7.2 6.7 15.7 8.5 5.1 5.9 6.3 12.0 7.7 5.9 9.9 11.5 5.2 6.8 11.8 6.7 14.6 9.6 4.4 8.9 4.3 11.0 5.2 5.9 11.9 18.5 9.6 5.6 5.7 18.0 11.6 22.7 13.3 8.9 15.2 6.6 19.9 9.7 11.1 9.6 16.8 7.8 10.1 9.1 14.3 13.8 15.4 4.4 6.0 6.9 6.5 9.1 13.6 18.5 29.4 4.1 6.7 5.6 1.8 8.1 8.1 14.0 8.2 15.5 13.1 15.2 15.8 13.0 13.4 19.5 15.3 1.3 16.2 6.2 8.5 14.3 15.1 13.8 18.5 18.2 20.0 13.2 14.6 11.1 14.3 15.0 10.3 8.9 2.4 2.9 4.3 5.5 7.4 9.4 0.0 4.0 4.5 3.5 7.9 5.3 5.0 3.2 3.4 3.7 3.8 0.0 3.5 6.3 4.0 4.4 4.7 17.1 3.7 1.6 6.9 3.7 5.1 1.3 4.0 2.5 1.7 5.4 5.3 6.6 3.0 0.0 2.8 5.0 5.7 0.0 3.8 4.7 12.9 4.4 6.1 5.3 5.1 3.2 TAF6 "MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85" ENSG00000106290 "TATA-box binding protein associated factor 6" P49848 7 100107070-100119841 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006566 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006566: AB_1080194" "unprognostic (5.60e-2)" "unprognostic (3.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (6.06e-5)" "unprognostic (2.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.29e-1)" "unprognostic (3.70e-3)" "unprognostic (1.68e-1)" "unprognostic (4.55e-2)" "unprognostic (1.95e-1)" "unprognostic (3.38e-1)" "unprognostic (4.78e-1)" "unprognostic (1.37e-1)" 14.1 19.8 21.5 15.4 23.6 13.9 12.0 23.5 35.8 19.4 17.5 12.7 12.6 12.1 24.1 17.6 16.8 23.6 16.8 17.2 20.5 16.3 16.1 10.2 12.9 14.3 13.1 15.9 26.2 16.6 22.6 21.7 19.5 19.3 15.8 13.7 15.6 17.9 23.3 23.1 17.9 13.2 23.7 13.1 14.6 14.0 27.3 14.7 21.7 21.3 11.5 17.0 19.6 14.9 15.3 14.3 13.2 25.7 14.0 18.7 13.1 17.1 32.2 20.9 34.2 27.5 14.6 29.3 18.9 21.2 24.4 22.6 23.9 21.0 15.7 21.6 28.9 41.9 14.6 28.6 22.5 26.3 25.6 18.6 15.1 31.3 15.8 27.4 14.6 14.3 14.9 14.1 35.7 39.5 19.7 19.7 27.9 26.1 29.1 22.0 61.0 31.0 23.7 30.8 15.5 26.0 22.9 25.7 23.3 17.4 14.0 19.0 27.6 23.9 37.1 15.8 31.5 13.5 14.5 19.5 37.0 38.1 47.8 24.4 18.0 31.1 26.4 25.1 20.5 31.8 12.7 11.0 13.2 15.6 11.4 18.7 10.2 15.0 15.7 14.3 15.3 15.3 14.3 6.4 14.0 25.7 8.5 13.9 13.1 21.5 23.6 23.5 35.8 20.5 16.3 13.1 15.9 19.3 14.7 8.9 10.2 11.1 17.3 10.1 12.5 0.9 15.3 16.0 6.8 24.4 0.0 61.4 14.9 20.7 21.7 10.8 11.9 0.0 14.6 30.0 16.7 12.7 0.0 6.4 18.1 12.7 15.0 10.4 7.8 34.8 20.1 9.7 11.8 24.4 11.8 16.7 14.1 14.2 29.4 17.8 11.6 25.8 18.9 24.5 61.1 10.3 28.8 17.5 14.3 12.2 TAF7L "CT40, TAF2Q" ENSG00000102387 "TATA-box binding protein associated factor 7 like" Q5H9L4 X 101268253-101293057 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 36.1" "Group enriched" "Detected in some" 6 "Early spermatids: 20.1;Late spermatids: 11.5;Spermatocytes: 29.8;Spermatogonia: 20.2" "Cancer enhanced" "Detected in some" "cervical cancer: 2.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 17 "SiHa: 36.0" "Low region specificity" "Detected in all" "HPA001879, HPA072008" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001879: AB_1857751, HPA072008: " "unprognostic (1.70e-2)" "prognostic favorable (8.71e-4)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (2.52e-2)" "unprognostic (4.97e-3)" "unprognostic (3.87e-3)" "unprognostic (1.72e-1)" "unprognostic (4.67e-3)" "unprognostic (2.16e-1)" "unprognostic (3.29e-1)" "unprognostic (1.36e-1)" "unprognostic (3.49e-3)" "unprognostic (6.76e-2)" "unprognostic (2.88e-1)" "unprognostic (5.97e-2)" "unprognostic (1.12e-2)" 0.1 0.0 1.4 0.1 1.7 0.2 0.1 0.1 0.6 1.6 0.5 0.2 0.1 0.0 0.7 3.5 0.1 0.0 0.1 0.1 0.8 0.2 0.3 0.5 0.1 0.1 0.1 0.8 0.1 0.1 2.5 0.2 0.4 0.3 1.8 0.0 0.4 0.1 1.8 0.1 0.6 0.3 0.1 0.4 0.1 0.1 36.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.1 0.1 1.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.7 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.6 0.0 0.1 0.2 0.1 1.7 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 36.0 0.2 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 1.7 0.1 0.6 0.8 0.2 0.1 0.8 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 20.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 2.4 0.1 0.0 0.0 0.6 0.0 11.5 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.2 29.8 20.2 0.1 1.4 0.0 0.0 0.0 TAGAP "ARHGAP47, FLJ32631, IDDM21" ENSG00000164691 "T cell activation RhoGTPase activating protein" Q8N103 6 159034468-159045152 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.9;bone marrow: 55.6;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 13 "B-cells: 68.1;Macrophages: 53.7;T-cells: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.4;HMC-1: 21.0;Karpas-707: 21.9;U-266/84: 9.8;U-698: 20.2;U-937: 16.1" "Low region specificity" "Detected in all" "HPA031000, HPA039982" Uncertain Approved Cytosol NA NA Cytosol "HPA031000: AB_10610560, HPA039982: " "unprognostic (9.86e-3)" "unprognostic (7.55e-2)" "unprognostic (2.41e-2)" "unprognostic (1.56e-2)" "unprognostic (6.36e-2)" "unprognostic (3.10e-3)" "unprognostic (1.04e-1)" "unprognostic (5.25e-2)" "unprognostic (3.35e-3)" "unprognostic (8.39e-2)" "unprognostic (6.19e-2)" "unprognostic (2.41e-1)" "unprognostic (1.49e-1)" "unprognostic (7.25e-2)" "unprognostic (1.15e-1)" "unprognostic (5.24e-2)" "unprognostic (7.39e-2)" 4.4 2.3 1.5 16.9 2.1 55.6 2.5 0.9 2.0 1.9 2.5 7.9 1.3 1.7 9.7 1.8 2.7 2.1 4.1 2.0 1.9 3.7 2.2 2.4 8.4 32.7 5.0 1.1 1.9 1.0 0.4 1.4 2.8 3.9 1.9 3.6 3.2 3.2 1.8 0.8 1.4 11.8 12.2 9.2 22.1 2.7 1.7 3.0 32.6 2.2 4.0 32.1 6.8 1.9 14.9 7.8 47.9 7.7 12.0 22.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.2 0.0 0.0 0.0 7.4 21.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 21.9 0.0 0.0 1.9 3.9 5.9 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.0 3.4 0.1 0.0 0.0 0.0 0.0 2.4 9.8 20.2 0.0 16.1 0.0 38.7 7.7 23.6 16.4 5.5 18.5 13.9 22.0 19.0 7.8 14.9 17.4 12.1 47.9 12.0 7.0 2.6 15.5 14.4 1.5 2.1 0.9 2.0 1.9 3.7 5.0 1.1 3.9 3.0 3.0 10.0 68.1 0.2 2.5 0.1 0.4 0.0 1.4 1.2 0.0 0.0 0.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.4 3.7 0.4 18.5 0.8 23.7 0.0 0.0 1.8 19.5 0.9 1.1 53.7 27.0 0.0 0.0 0.3 0.0 0.0 21.2 0.2 0.1 0.0 0.3 0.0 0.1 2.4 0.7 89.6 0.0 0.3 TAGLN "DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10" ENSG00000149591 Transgelin Q01995 11 117199321-117204782 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Peritubular cells: 2168.1;Sertoli cells: 2819.8;Smooth muscle cells: 4737.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "intermediate monocyte: 19.0;non-classical monocyte: 26.6" "Lineage enriched" "Detected in many" 10 "monocytes: 26.6" "Cell line enhanced" "Detected in many" "BJ: 136.7;BJ hTERT+ SV40 Large T+: 130.0;CACO-2: 122.7;EFO-21: 163.1;fHDF/TERT166: 139.3;hTERT-RPE1: 106.3;LHCN-M2: 96.2;U-138 MG: 126.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 176.0" "CAB001447, HPA019467" Enhanced Approved Microtubules,Mitochondria,Cytosol No No 8000000 "Microtubules, Mitochondria" Cytosol "CAB001447: AB_564012, HPA019467: AB_1857245" "unprognostic (1.36e-2)" "unprognostic (1.06e-1)" "unprognostic (3.57e-3)" "unprognostic (1.91e-1)" "unprognostic (6.58e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-2)" "unprognostic (7.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (4.43e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.12e-7)" "unprognostic (9.58e-3)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" "unprognostic (2.52e-3)" 73.3 22.6 2.3 67.6 5.9 0.2 60.8 2.1 7.7 278.3 328.7 6.1 156.2 22.3 399.7 156.8 337.9 133.3 227.5 48.7 3.1 3.0 49.5 12.9 44.1 38.6 7.1 11.8 159.2 9.3 1.5 8.0 36.2 14.9 237.5 51.6 39.1 24.1 347.5 36.6 17.9 81.0 481.9 9.1 26.0 114.7 65.1 2.1 1.1 47.3 30.0 11.2 473.0 78.1 2.6 1.4 0.8 26.6 0.0 0.3 0.9 1.2 0.3 21.4 0.5 10.0 9.0 18.0 136.7 59.3 130.0 48.7 122.7 1.9 0.2 163.1 139.3 0.1 3.2 0.3 1.1 37.0 0.4 0.2 0.3 4.6 8.3 55.9 0.1 0.3 23.7 4.6 19.0 2.4 106.3 0.2 0.2 0.2 0.4 96.2 0.2 0.1 1.0 6.5 1.1 0.1 0.1 1.6 0.6 0.2 1.7 0.1 0.5 2.1 0.7 0.1 53.6 0.6 0.3 14.6 126.7 21.3 0.9 5.8 0.6 0.4 1.0 0.7 0.4 0.3 0.8 1.1 0.0 0.1 19.0 0.2 1.6 0.0 0.0 1.4 2.6 0.1 0.0 0.1 0.0 26.6 0.7 0.3 0.9 2.3 5.9 2.1 7.7 3.1 3.0 7.1 11.8 14.9 2.1 35.7 6.7 4.5 353.2 56.7 9.9 1.2 5.1 13.4 5.7 38.4 17.7 30.6 0.0 230.9 2.4 73.9 6.2 0.0 68.1 27.0 232.5 54.7 1.1 9.3 37.9 1.6 2.9 944.1 20.6 8.9 44.8 43.3 91.1 9.0 9.0 3.3 40.6 3.5 2168.1 1.3 10.5 2819.8 4737.3 6.1 4.4 53.2 26.9 10.0 2.6 40.6 TAGLN2 "HA1756, KIAA0120" ENSG00000158710 "Transgelin 2" P37802 1 159918107-159925732 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 2167.7;monocytes: 1311.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001925 Approved Approved "Actin filaments,Cytosol" "Intracellular and membrane" NA NA 540000000 Cytosol "Actin filaments" "HPA001925: AB_1857756" "prognostic unfavorable (2.06e-5)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (8.06e-2)" "prognostic unfavorable (7.07e-5)" "unprognostic (4.61e-2)" "unprognostic (1.50e-1)" "unprognostic (3.21e-1)" "unprognostic (3.56e-3)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.92e-10)" "unprognostic (1.81e-1)" "unprognostic (9.22e-2)" "unprognostic (3.95e-2)" "unprognostic (2.50e-2)" 80.6 26.4 19.7 57.5 25.6 47.9 62.8 7.9 18.3 49.1 45.9 16.6 54.5 43.3 39.2 49.4 96.3 36.3 63.6 57.3 15.9 18.5 68.0 178.2 107.7 65.0 24.3 9.8 45.7 51.2 8.8 18.1 122.2 24.8 43.8 43.0 24.7 67.2 62.9 35.3 62.6 74.6 36.2 20.0 95.8 96.8 46.4 20.2 60.5 37.7 150.7 76.5 57.2 62.0 53.0 114.4 220.7 42.4 44.0 41.7 106.7 110.3 59.7 1.8 0.7 21.3 53.1 68.9 62.2 71.5 135.4 65.9 61.9 86.7 68.6 53.0 73.9 38.0 86.7 30.5 77.5 83.6 78.2 24.7 91.4 57.9 3.6 25.2 64.2 102.9 52.7 60.2 79.7 41.3 90.7 81.5 18.3 39.1 48.3 46.1 42.0 29.0 40.5 51.5 69.2 101.9 0.2 31.8 102.5 28.1 43.3 28.6 27.1 73.0 119.5 32.1 100.7 63.0 63.3 93.5 81.1 94.3 73.5 167.4 19.4 8.6 40.2 104.9 41.2 49.8 66.9 42.4 177.0 34.7 25.2 30.6 53.0 38.6 33.4 68.5 39.7 20.4 22.4 220.7 44.0 18.9 114.4 41.7 106.7 19.7 25.6 7.9 18.3 15.9 18.5 24.3 9.8 24.8 20.2 166.7 130.7 257.0 252.6 487.7 6.1 8.0 109.5 111.1 142.1 174.5 17.7 477.1 63.0 1095.0 40.8 397.3 292.6 0.0 1053.3 2167.7 440.6 225.0 408.8 47.4 432.7 3.2 305.0 192.1 247.2 61.8 109.9 313.3 317.2 1311.1 280.8 63.0 865.9 140.6 60.1 122.4 18.8 181.1 346.3 4.8 17.6 500.5 192.7 223.4 182.9 345.3 TAL2 bHLHa19 ENSG00000186051 "TAL bHLH transcription factor 2" Q16559 9 105662457-105663112 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 8.8;kidney: 4.6;skeletal muscle: 17.3" "Cell type enhanced" "Detected in some" 16 "Cone photoreceptor cells: 3.9;Distal tubular cells: 6.6;Intestinal endocrine cells: 3.4;Muller glia cells: 1.8" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Group enriched" "Detected in some" 21 "memory B-cell: 8.8;naive B-cell: 7.9;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 18 "B-cells: 8.8;dendritic cells: 2.2" "Cell line enhanced" "Detected in some" "CACO-2: 3.4;HAP1: 4.9;K-562: 12.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA030886 Uncertain Approved Cytosol NA NA Cytosol "HPA030886: AB_10601596" "unprognostic (3.89e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "unprognostic (5.54e-2)" "unprognostic (2.24e-1)" "unprognostic (9.06e-2)" "unprognostic (4.98e-2)" "unprognostic (1.03e-1)" "unprognostic (2.70e-3)" "unprognostic (2.63e-1)" "unprognostic (7.00e-4)" "unprognostic (2.84e-2)" "prognostic favorable (2.69e-4)" "unprognostic (2.70e-2)" "unprognostic (1.24e-1)" "unprognostic (1.29e-1)" "unprognostic (7.39e-2)" 0.1 0.3 0.5 0.1 0.7 0.0 0.0 0.3 0.6 0.2 0.0 0.0 0.2 0.9 0.1 0.2 0.0 0.3 0.4 0.5 4.6 0.3 0.0 0.2 0.7 0.3 0.1 0.0 0.8 0.1 0.1 0.1 0.0 0.2 17.3 0.1 0.1 0.0 0.8 0.3 0.0 0.6 0.1 0.4 0.1 0.0 8.8 2.2 0.0 0.0 0.3 0.0 0.1 0.0 0.7 2.5 0.7 0.3 0.0 0.3 0.1 0.3 0.1 0.4 3.4 0.2 0.1 0.3 0.0 0.7 0.1 4.9 0.0 0.2 0.6 0.5 1.1 0.0 0.0 0.2 0.6 1.9 0.3 0.6 0.1 0.2 0.2 0.0 0.8 12.9 0.3 0.4 0.3 0.8 0.7 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 2.9 1.2 0.2 0.3 0.2 0.1 0.2 2.1 0.5 0.3 0.8 0.7 1.1 1.0 2.0 0.1 0.2 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.9 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.4 1.1 0.9 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 TALDO1 ENSG00000177156 "Transaldolase 1" P37837 11 747329-765024 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pentose shunt" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.6" "Cell type enhanced" "Detected in all" 6 "monocytes: 1009.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 148.6;neutrophil: 204.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048089 Approved Nucleoplasm,Cytosol NA NA 39000000 Nucleoplasm Cytosol "HPA048089: AB_2680260" "unprognostic (5.29e-2)" "unprognostic (1.78e-2)" "unprognostic (3.47e-1)" "unprognostic (9.65e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.78e-2)" "unprognostic (4.27e-2)" "unprognostic (1.74e-1)" "unprognostic (7.97e-3)" "unprognostic (2.94e-1)" "unprognostic (1.59e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (2.37e-1)" "unprognostic (1.16e-3)" 39.0 24.2 26.6 34.8 31.3 117.4 44.2 20.6 38.3 27.7 28.5 51.2 18.8 34.2 20.4 20.7 90.0 23.2 33.2 37.5 29.2 23.6 45.8 48.4 37.9 60.0 46.5 26.6 23.4 31.9 14.6 15.8 34.3 30.7 28.3 23.7 15.5 38.3 19.5 31.2 38.4 29.4 40.4 47.5 45.6 35.8 14.8 33.0 34.1 42.2 82.4 43.1 51.4 37.5 8.5 36.1 204.6 60.8 5.9 10.4 45.3 42.2 53.5 15.5 29.3 32.1 18.7 45.7 32.1 41.4 31.8 26.3 22.7 92.2 23.6 43.7 42.1 24.6 45.7 24.5 34.7 16.6 30.8 49.7 40.8 20.7 79.4 34.3 65.2 60.9 15.3 28.0 21.4 17.4 23.0 43.7 29.8 52.9 39.5 29.5 40.4 37.9 77.3 24.3 62.0 43.4 31.6 18.2 84.5 57.8 24.6 38.3 13.4 30.0 62.0 31.1 14.4 29.4 49.6 58.0 14.6 13.7 11.5 30.1 16.7 16.2 28.0 32.4 57.0 58.9 64.7 60.8 148.6 5.6 23.2 6.1 8.5 7.5 6.8 36.1 6.8 6.1 5.7 204.6 5.9 23.2 14.8 10.4 45.3 26.6 31.3 20.6 38.3 29.2 23.6 46.5 26.6 30.7 33.0 131.0 100.4 88.6 136.2 65.4 45.6 40.9 122.3 141.8 86.4 143.1 13.7 355.3 212.2 199.7 61.7 74.4 141.1 280.4 236.4 383.3 78.6 213.8 155.0 128.2 368.8 47.7 97.4 79.8 301.9 17.2 109.0 235.0 133.3 1009.1 137.9 126.1 238.1 181.4 97.9 218.5 43.3 71.1 73.5 122.7 154.7 72.6 440.3 79.1 199.9 251.7 TAMM41 "C3orf31, DKFZp434E0519, MGC16471" ENSG00000144559 "TAM41 mitochondrial translocator assembly and maintenance homolog" Q96BW9 3 11790442-11846919 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036834, HPA044861" Uncertain Approved Cytosol NA NA Cytosol "HPA036834: AB_10672270, HPA044861: AB_2679116" "unprognostic (2.40e-2)" "unprognostic (4.41e-2)" "prognostic favorable (1.23e-4)" "unprognostic (4.45e-2)" "unprognostic (1.44e-2)" "unprognostic (5.60e-2)" "unprognostic (2.03e-5)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.33e-3)" "unprognostic (3.78e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-1)" "unprognostic (7.34e-2)" "unprognostic (3.59e-3)" 13.9 12.9 21.8 15.9 27.5 9.1 15.7 25.6 19.8 12.5 12.2 14.2 12.5 11.5 17.7 23.7 15.2 12.4 10.0 13.8 13.9 11.5 12.4 12.0 18.7 25.0 11.3 15.3 21.7 12.9 12.5 15.4 9.9 11.4 10.7 12.0 11.2 11.7 14.2 15.2 17.3 10.4 15.0 13.7 12.3 10.1 14.1 14.8 12.7 10.8 8.4 17.4 13.8 13.8 8.7 8.9 7.7 7.1 7.1 11.3 5.0 4.2 7.9 9.7 6.7 10.5 13.3 17.9 6.5 4.7 10.0 10.0 9.5 7.0 16.2 9.6 6.8 4.4 5.2 16.2 9.8 13.0 6.0 15.3 9.6 7.6 11.0 12.3 17.6 5.1 7.6 14.6 9.4 10.6 6.6 15.4 12.9 14.1 5.0 12.8 12.2 9.9 13.2 7.7 6.6 16.9 9.9 5.5 14.2 15.3 10.4 4.5 3.9 5.7 7.4 10.8 11.4 9.6 8.0 4.0 5.2 6.0 15.6 9.2 3.9 9.5 8.3 6.3 15.0 4.8 2.2 5.3 7.7 7.2 3.6 9.2 8.7 11.3 7.0 8.9 8.0 10.4 10.6 0.2 7.1 7.1 6.6 8.7 5.0 21.8 27.5 25.6 19.8 13.9 11.5 11.3 15.3 11.4 14.8 6.0 6.5 7.3 7.8 3.8 10.6 8.1 0.0 10.7 5.7 3.5 11.8 10.3 8.3 9.7 1.6 5.8 2.8 0.0 8.0 9.1 4.6 5.4 2.3 5.7 8.1 9.5 2.9 4.9 6.5 1.1 7.2 7.2 3.3 4.6 7.3 10.8 6.6 3.5 6.0 7.9 14.0 0.0 6.2 8.4 11.9 3.6 5.8 9.5 7.6 4.6 TANC2 "DKFZP564D166, FLJ10215, FLJ11824, KIAA1148, KIAA1636, rols, ROLSA" ENSG00000170921 "Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2" Q9HCD6 17 63009556-63427699 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 31.6" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 43.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023274 Uncertain Approved Cytosol NA NA Cytosol "HPA023274: AB_2199727" "unprognostic (8.37e-2)" "unprognostic (4.15e-2)" "unprognostic (2.21e-2)" "unprognostic (1.57e-4)" "unprognostic (1.51e-1)" "unprognostic (4.09e-2)" "unprognostic (9.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.09e-2)" "unprognostic (5.52e-2)" "unprognostic (2.62e-1)" "unprognostic (2.69e-1)" "unprognostic (2.02e-2)" "unprognostic (5.15e-2)" "unprognostic (1.47e-1)" "unprognostic (1.57e-1)" "unprognostic (2.01e-1)" 3.4 3.9 4.4 3.1 8.5 6.2 2.7 2.1 19.5 4.5 1.5 2.8 1.5 1.0 2.7 7.0 3.4 2.5 3.1 2.0 5.2 5.4 3.1 1.5 7.9 1.5 5.2 3.5 3.0 2.3 31.6 5.1 2.8 2.7 2.6 1.1 1.9 3.5 3.4 1.5 4.8 2.0 4.1 7.5 2.7 1.8 10.9 3.4 4.6 2.1 4.4 1.9 6.4 2.9 0.8 1.6 1.1 0.1 2.9 2.2 0.1 12.2 11.6 7.2 1.2 3.7 8.9 13.9 7.8 7.8 7.8 9.7 0.6 3.6 0.0 2.4 13.4 9.9 1.7 11.6 23.1 17.7 4.7 5.3 18.0 17.1 0.6 3.2 4.8 0.0 13.6 13.5 9.1 26.3 8.6 2.4 4.7 2.2 0.0 11.1 9.4 3.1 0.8 0.8 2.2 7.6 2.5 14.4 0.9 6.9 17.0 12.2 13.4 4.4 8.3 3.4 13.1 3.8 1.3 12.5 19.1 10.0 1.2 9.6 0.0 0.0 0.0 7.0 1.3 6.8 0.0 0.1 0.0 2.2 0.1 1.7 0.1 1.2 1.7 0.1 0.8 0.5 1.1 1.1 2.9 0.0 1.6 0.0 0.1 4.4 8.5 2.1 19.5 5.2 5.4 5.2 3.5 2.7 3.4 14.9 41.2 2.0 9.1 22.2 43.0 3.6 10.2 4.0 13.6 26.2 15.7 6.7 1.7 8.8 14.2 9.5 0.5 0.0 12.1 32.1 4.6 8.9 0.0 0.8 7.2 7.9 4.1 16.0 7.8 8.0 5.2 16.1 10.1 13.6 3.9 3.7 20.4 2.9 3.2 1.4 6.8 19.4 4.1 18.0 14.6 13.9 13.7 7.5 1.5 9.6 TANGO6 "FLJ12688, KIAA1746, TMCO7" ENSG00000103047 "Transport and golgi organization 6 homolog" Q9C0B7 16 68843604-69085180 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 111.9;Late spermatids: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041312 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA041312: AB_10796342" "unprognostic (8.55e-2)" "unprognostic (6.64e-2)" "unprognostic (4.66e-2)" "unprognostic (1.94e-2)" "unprognostic (3.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.50e-1)" "unprognostic (1.86e-1)" "unprognostic (2.22e-1)" "unprognostic (9.82e-3)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.20e-4)" "unprognostic (1.55e-2)" "unprognostic (1.73e-1)" "unprognostic (1.45e-3)" "unprognostic (6.02e-2)" 12.5 7.7 8.0 9.6 13.1 7.0 10.7 10.9 15.0 10.2 8.2 14.7 7.2 6.0 12.8 5.6 8.5 8.3 8.0 7.8 7.3 7.7 13.1 27.6 8.4 10.8 9.8 10.6 10.0 11.2 21.6 13.2 7.9 9.3 9.7 7.1 12.1 7.7 10.3 18.5 9.2 7.0 11.1 9.4 9.7 9.1 9.3 12.1 14.5 7.9 5.8 12.6 12.8 12.7 4.0 6.6 2.6 9.0 2.5 6.5 3.8 5.7 11.9 4.0 8.5 6.7 7.6 2.9 7.9 6.6 9.8 8.0 7.7 4.8 13.2 4.4 11.1 5.2 4.8 9.0 10.6 12.3 3.1 5.4 2.4 4.8 7.0 5.5 6.5 6.1 5.7 5.8 13.9 12.7 4.1 9.4 6.3 8.6 2.2 9.2 5.8 6.7 5.2 8.5 5.7 6.4 7.2 5.8 14.6 7.3 3.3 4.1 4.7 19.4 1.1 5.2 5.0 3.8 7.3 5.4 9.3 3.4 9.4 5.6 4.1 3.5 9.0 5.8 2.5 6.1 0.0 4.8 2.6 4.9 9.0 5.2 4.0 4.9 5.0 6.6 3.7 3.1 5.0 0.3 2.5 7.9 1.7 6.5 3.8 8.0 13.1 10.9 15.0 7.3 7.7 9.8 10.6 9.3 12.1 0.0 3.4 6.9 8.2 4.6 8.1 2.8 5.1 0.0 2.3 7.0 9.8 4.5 0.0 1.7 111.9 3.8 1.1 0.0 2.9 2.2 2.7 1.7 1.1 11.6 4.2 4.8 0.0 3.7 7.0 36.7 5.2 4.1 5.0 0.0 1.6 2.9 2.3 2.9 3.2 4.8 8.2 0.0 3.1 3.2 4.4 2.6 2.1 5.7 1.9 7.7 TANK "I-TRAF, TRAF2" ENSG00000136560 "TRAF family member associated NFKB activator" Q92844 2 161136908-161236221 "Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 219.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010345, HPA037675, HPA037676" Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601" "unprognostic (1.14e-2)" "unprognostic (9.68e-2)" "unprognostic (1.53e-1)" "unprognostic (5.27e-2)" "unprognostic (3.98e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.71e-1)" "unprognostic (2.98e-2)" "unprognostic (4.16e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (2.78e-6)" "unprognostic (2.13e-2)" "unprognostic (2.00e-1)" "unprognostic (5.69e-3)" "unprognostic (2.30e-2)" 35.9 23.6 17.2 32.0 21.1 43.0 34.2 17.7 16.8 19.6 22.3 11.7 18.0 15.8 20.6 21.8 23.2 20.9 25.1 18.4 16.2 17.2 22.7 37.2 35.4 28.8 20.1 12.7 19.7 15.4 17.0 33.3 41.7 18.2 26.0 21.5 15.7 21.9 15.5 49.5 21.4 22.6 32.2 21.3 42.1 18.2 13.5 19.1 29.2 29.0 25.1 29.0 37.3 38.6 22.4 20.7 54.0 27.9 13.3 28.1 14.7 12.1 7.7 10.2 11.6 29.9 39.5 14.7 17.4 27.5 12.7 19.3 9.5 15.9 17.3 12.7 20.7 8.7 8.7 6.3 13.6 19.3 39.9 6.6 9.3 7.5 24.2 24.4 15.4 10.4 31.6 21.9 19.3 15.1 22.4 32.6 9.9 9.3 22.7 24.4 9.2 9.2 15.5 5.9 13.0 7.0 5.4 15.1 11.2 28.8 19.8 8.7 10.2 11.3 13.4 18.8 15.1 5.6 18.9 34.3 16.1 9.8 8.1 10.4 15.4 14.2 26.2 21.3 12.2 12.2 28.1 21.6 26.4 12.1 25.1 18.5 22.1 19.5 17.5 20.7 22.4 12.9 13.2 54.0 13.3 27.9 12.1 28.1 14.7 17.2 21.1 17.7 16.8 16.2 17.2 20.1 12.7 18.2 19.1 53.6 61.0 77.0 96.8 53.1 31.6 23.2 20.4 58.9 56.9 43.6 11.8 35.7 51.4 53.0 11.7 37.9 37.3 23.3 35.6 75.1 64.1 65.4 57.8 52.3 41.5 20.6 45.5 25.8 73.5 7.0 48.9 97.6 69.2 219.2 26.2 31.1 45.1 43.2 24.8 37.4 33.3 25.8 47.6 43.1 31.7 53.2 112.8 82.3 27.5 129.1 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973641-29992261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 27.8 24.1 26.2 15.1 26.7 12.3 17.7 29.2 30.6 13.5 13.6 21.5 11.8 18.5 16.8 13.0 12.4 14.1 15.1 17.6 25.0 18.2 13.9 10.4 23.0 14.4 22.1 22.7 15.8 16.3 26.2 18.7 22.5 20.7 13.6 9.6 15.0 17.1 15.9 22.8 20.0 19.3 14.8 14.9 26.3 16.0 21.2 20.2 14.0 15.9 9.8 11.5 12.8 18.0 2.6 3.3 4.8 2.8 2.0 3.2 2.0 11.2 21.5 11.8 18.6 13.9 9.3 18.1 20.7 11.1 14.0 13.1 17.2 15.1 12.2 17.6 14.9 9.4 17.6 10.7 10.4 7.6 18.9 22.7 13.1 21.7 17.2 10.1 12.9 25.3 10.9 9.1 14.9 6.0 9.8 23.4 11.7 11.8 12.4 13.3 20.8 15.0 18.3 11.4 8.4 14.5 27.7 17.1 11.3 8.8 10.6 13.9 11.2 11.8 15.8 6.2 7.9 19.8 14.6 32.6 24.2 11.2 17.1 11.9 18.1 11.6 11.5 14.8 14.8 17.6 1.3 2.8 1.5 2.9 2.7 3.1 2.0 2.9 2.6 1.8 2.6 1.6 1.4 4.8 2.0 1.4 3.3 3.2 2.0 26.2 26.7 29.2 30.6 25.0 18.2 22.1 22.7 20.7 20.2 8.9 11.5 2.2 4.2 9.5 13.3 8.1 5.1 4.0 7.9 8.7 37.3 6.7 1.7 7.6 3.1 27.6 23.3 0.0 10.2 4.8 9.3 5.8 3.5 9.7 8.4 9.5 12.6 44.2 12.4 2.1 11.5 5.5 6.8 4.6 14.9 8.7 12.7 14.2 12.0 6.4 19.2 6.5 7.6 21.1 17.2 8.4 10.1 9.2 13.3 5.7 TARS ENSG00000113407 "Threonyl-tRNA synthetase" P26639 5 33440696-33469539 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037425 Approved Approved "Actin filaments,Cytosol" NA NA 170000 Cytosol "Actin filaments" "HPA037425: AB_10672279" "prognostic unfavorable (6.14e-5)" "unprognostic (5.13e-2)" "unprognostic (9.04e-2)" "prognostic unfavorable (5.17e-4)" "unprognostic (9.10e-2)" "unprognostic (1.07e-3)" "prognostic unfavorable (9.88e-7)" "unprognostic (1.43e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-3)" "unprognostic (5.97e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (1.37e-1)" "unprognostic (5.15e-2)" "unprognostic (1.18e-1)" "unprognostic (7.25e-2)" 17.4 25.6 10.2 16.0 13.1 19.2 17.7 14.4 17.2 12.7 22.1 12.3 18.7 11.6 18.3 19.7 31.0 12.2 11.9 19.1 10.3 10.9 19.2 57.0 17.2 12.7 17.5 7.8 21.3 27.6 21.3 27.0 18.5 16.8 13.9 24.7 10.8 42.1 15.8 25.1 11.7 21.7 21.2 19.5 18.3 21.2 9.6 15.4 17.6 22.8 27.3 21.2 21.8 21.9 13.1 16.0 14.2 12.6 24.0 15.0 9.7 29.7 24.9 20.9 29.5 13.8 26.2 30.4 33.5 28.4 25.3 28.7 30.4 18.6 11.8 12.2 27.6 41.7 21.3 44.5 33.1 52.3 17.5 16.2 17.2 64.0 17.3 43.0 27.6 18.4 25.0 53.2 34.9 45.2 15.8 27.1 29.6 33.7 31.9 32.4 16.5 21.5 9.5 22.2 27.1 18.5 18.3 37.1 17.4 28.8 23.8 12.3 13.9 31.0 22.7 22.1 19.3 11.9 24.7 14.3 19.9 29.7 15.7 23.5 18.8 37.0 18.5 22.2 36.4 21.6 14.2 11.6 10.5 15.0 12.6 14.1 13.1 12.7 15.0 16.0 11.5 11.6 14.7 1.5 24.0 10.1 8.8 12.1 9.7 10.2 13.1 14.4 17.2 10.3 10.9 17.5 7.8 16.8 15.4 23.8 23.7 38.9 37.6 25.4 23.3 57.6 35.7 26.8 39.8 17.4 17.7 32.0 41.4 75.9 12.6 24.1 36.2 93.5 83.0 34.9 31.7 29.7 61.2 66.0 28.4 42.9 39.5 25.8 26.4 6.0 17.8 26.3 10.1 83.8 30.4 67.9 95.7 33.7 22.6 30.4 36.0 12.9 31.5 24.1 22.1 17.2 43.6 22.4 28.9 37.7 TARS2 "FLJ12528, TARSL1" ENSG00000143374 "Threonyl-tRNA synthetase 2, mitochondrial" Q9BW92 1 150487364-150507609 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028626 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028626: AB_10601719" "unprognostic (2.48e-1)" "unprognostic (7.75e-2)" "unprognostic (6.68e-2)" "unprognostic (3.75e-3)" "unprognostic (2.03e-1)" "unprognostic (1.62e-1)" "unprognostic (4.93e-2)" "unprognostic (2.14e-1)" "unprognostic (9.35e-2)" "unprognostic (4.26e-2)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (9.23e-2)" "unprognostic (9.29e-3)" "unprognostic (4.19e-2)" "unprognostic (1.14e-2)" "unprognostic (5.55e-2)" 10.7 21.1 16.5 10.5 17.8 9.2 11.3 17.5 21.4 10.2 10.9 14.8 12.9 9.4 10.5 14.7 15.7 13.0 11.8 20.9 18.1 12.3 15.6 26.8 9.1 14.0 15.0 19.7 13.3 11.5 20.4 12.2 9.4 16.5 9.8 12.5 13.3 11.3 10.9 36.0 13.3 10.5 10.9 13.8 15.1 12.4 10.7 16.6 10.6 12.3 12.2 15.7 12.5 10.8 21.5 17.4 20.4 18.6 21.5 20.9 12.2 17.2 14.4 9.7 14.7 11.0 10.1 18.5 8.4 9.2 16.7 16.8 11.7 16.1 25.0 18.6 6.3 11.5 18.0 23.6 19.5 12.8 15.0 20.5 11.8 13.7 11.8 10.9 16.3 18.1 8.9 16.4 12.6 17.2 10.9 10.7 14.0 20.5 17.6 11.6 20.8 13.7 13.3 12.0 23.9 21.5 14.2 12.4 30.9 11.3 8.1 13.8 16.2 12.7 28.2 19.8 14.4 22.7 25.5 6.3 9.7 10.4 8.0 14.1 17.0 20.0 18.8 14.5 19.0 9.4 15.1 11.0 20.4 15.7 18.3 15.6 21.5 15.4 15.5 17.4 18.6 15.1 15.8 1.7 21.5 18.6 11.7 20.9 12.2 16.5 17.8 17.5 21.4 18.1 12.3 15.0 19.7 16.5 16.6 3.0 13.8 7.2 4.6 3.0 15.8 19.0 12.7 10.7 12.5 7.0 19.6 21.6 10.0 9.9 0.9 6.3 6.6 0.0 8.6 11.4 6.0 3.8 21.9 15.3 11.8 14.3 4.1 7.4 6.5 2.1 7.8 8.0 3.3 16.2 8.9 8.4 9.9 0.0 6.7 6.3 15.4 6.5 7.2 15.4 11.1 3.4 11.8 7.0 10.8 4.1 TARSL2 FLJ25005 ENSG00000185418 "Threonyl-tRNA synthetase like 2" A2RTX5 15 101653598-101724604 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.7" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 9.7;NK-cells: 9.0;T-cells: 6.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066697 Enhanced Approved Cytosol NA NA Cytosol "HPA066697: AB_2685705" "unprognostic (9.33e-3)" "unprognostic (2.13e-2)" "unprognostic (1.88e-1)" "unprognostic (2.54e-1)" "unprognostic (8.44e-2)" "unprognostic (1.92e-1)" "unprognostic (8.45e-2)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (7.77e-2)" "unprognostic (2.26e-3)" "unprognostic (9.76e-3)" "unprognostic (4.00e-2)" "unprognostic (2.23e-1)" "unprognostic (7.52e-2)" "unprognostic (6.48e-3)" "unprognostic (2.79e-2)" 7.4 6.9 15.1 6.4 20.2 4.8 7.5 15.8 16.2 7.2 7.1 20.2 5.5 6.2 6.5 6.0 6.3 6.5 5.9 21.0 16.9 13.8 8.3 5.9 6.2 6.5 20.0 11.2 11.0 9.8 12.9 10.5 3.7 15.7 9.2 6.2 4.0 7.1 9.7 47.7 4.9 6.5 6.9 19.9 6.2 8.5 5.4 18.9 3.9 9.6 8.0 7.1 7.0 7.8 9.7 2.0 1.6 1.7 9.0 6.1 1.0 2.1 4.0 6.9 3.7 7.4 5.8 3.5 7.4 4.9 5.8 3.6 5.9 1.9 2.8 2.9 8.9 4.7 6.3 12.1 4.3 5.4 3.2 19.5 6.9 2.6 4.6 3.4 3.1 1.4 4.1 4.0 2.7 3.4 6.9 4.1 6.1 6.7 6.1 5.7 3.5 1.7 6.1 8.4 10.6 2.8 3.5 10.5 7.2 4.8 2.1 11.0 6.8 10.0 3.9 4.0 13.3 2.5 6.3 5.5 2.8 6.6 5.6 2.4 8.5 9.5 3.5 7.3 5.6 5.1 0.9 1.1 1.6 3.4 1.7 3.4 4.8 6.1 5.2 0.8 9.7 5.9 3.2 0.3 9.0 0.7 2.0 1.0 1.0 15.1 20.2 15.8 16.2 16.9 13.8 20.0 11.2 15.7 18.9 0.0 5.6 26.9 18.3 16.1 51.2 37.0 5.1 12.0 11.4 5.2 41.2 2.7 16.6 7.6 13.2 12.5 18.0 0.0 10.8 4.0 18.6 13.9 24.3 14.7 4.6 30.2 23.6 8.0 8.9 5.7 21.9 8.6 10.1 9.0 13.5 34.6 17.6 9.3 17.7 17.7 78.2 19.4 16.7 27.4 21.3 10.3 3.5 31.7 12.6 7.1 TAX1BP1 "CALCOCO3, TXBP151" ENSG00000106052 "Tax1 binding protein 1" Q86VP1 7 27739331-27844564 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024432 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA024432: AB_1857783" "unprognostic (1.38e-2)" "unprognostic (5.52e-2)" "unprognostic (3.55e-2)" "unprognostic (2.71e-2)" "unprognostic (2.55e-1)" "unprognostic (9.83e-3)" "unprognostic (1.81e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.69e-1)" "prognostic favorable (2.80e-6)" "unprognostic (1.76e-1)" "unprognostic (4.76e-2)" "unprognostic (1.21e-1)" "unprognostic (3.03e-1)" 28.5 63.0 31.1 19.5 49.8 34.9 30.7 33.5 48.4 33.8 33.4 16.1 26.7 23.7 27.4 35.5 46.6 30.7 28.2 47.4 30.8 31.9 51.0 35.3 28.7 23.0 41.0 34.8 32.0 29.7 46.3 69.4 65.8 54.1 36.4 31.1 18.7 32.3 32.6 50.3 23.5 41.0 48.8 41.7 34.5 30.3 30.3 35.2 34.2 44.5 27.0 24.6 51.3 29.0 21.1 17.5 59.7 31.3 17.3 33.0 22.5 39.8 22.1 22.6 21.4 35.9 26.2 15.4 29.8 36.7 22.4 28.1 17.9 32.5 8.5 28.2 43.5 38.7 28.4 21.2 19.5 35.1 15.9 11.0 23.0 23.7 35.5 34.0 33.5 27.4 22.1 40.6 26.0 29.9 27.0 24.1 14.8 25.5 26.2 45.2 14.7 14.7 33.1 25.5 52.3 20.8 12.3 24.3 17.4 31.7 45.2 15.0 24.5 41.8 54.7 62.2 45.5 25.5 50.6 25.9 21.2 33.2 26.3 19.6 48.2 33.4 15.9 24.8 63.7 48.4 37.4 24.2 59.7 21.8 29.3 26.3 21.1 25.9 25.3 17.5 17.9 24.0 24.0 48.9 17.3 31.3 16.2 33.0 22.5 31.1 49.8 33.5 48.4 30.8 31.9 41.0 34.8 54.1 35.2 199.5 169.7 106.1 180.8 162.8 267.0 498.7 129.9 654.5 232.0 122.1 90.3 129.6 349.8 187.1 99.7 143.3 138.9 70.0 229.8 91.8 123.1 243.4 143.4 96.2 109.6 151.0 134.4 76.7 127.2 72.2 108.1 171.8 108.0 226.4 131.6 177.5 242.3 125.6 139.7 231.8 140.4 103.5 117.9 217.7 133.4 167.7 519.6 133.7 103.0 398.4 TBC1D15 "DKFZp761D0223, FLJ12085" ENSG00000121749 "TBC1 domain family member 15" Q8TC07 12 71839707-71927248 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013388, HPA015592" Supported Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA013388: AB_2199233, HPA015592: AB_1857789" "unprognostic (3.87e-2)" "prognostic favorable (7.06e-4)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (4.63e-2)" "unprognostic (6.13e-3)" "unprognostic (2.96e-2)" "unprognostic (3.10e-1)" "unprognostic (2.61e-1)" "unprognostic (1.02e-2)" "unprognostic (4.07e-2)" "unprognostic (2.18e-1)" "prognostic favorable (5.34e-4)" "unprognostic (5.73e-2)" "unprognostic (4.34e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" 37.4 27.4 20.2 14.3 22.5 35.2 26.4 19.6 23.7 21.8 20.2 17.0 19.8 15.1 22.9 15.4 20.2 15.1 20.4 15.4 16.9 16.4 22.3 32.9 24.5 19.0 28.9 18.7 22.7 26.3 19.1 38.0 25.4 23.8 18.0 14.8 12.0 20.6 14.4 44.0 19.2 20.8 19.5 26.3 21.4 17.8 19.4 27.5 22.2 25.9 14.5 18.6 27.5 16.3 5.9 6.3 13.9 8.8 7.2 13.5 6.7 13.9 13.9 11.7 12.0 23.5 23.5 17.8 15.1 34.2 18.8 23.8 9.8 11.8 17.7 10.1 13.8 14.4 8.8 14.4 10.5 20.6 15.6 12.2 16.8 13.4 9.9 19.8 21.4 12.3 22.8 13.3 14.4 27.3 26.8 15.6 16.5 16.2 9.9 16.0 10.3 14.2 13.3 24.3 13.4 12.0 11.3 13.4 19.7 14.1 13.5 12.9 11.1 19.9 17.6 16.8 17.5 18.0 15.6 15.7 16.2 7.3 18.4 8.9 25.6 23.5 22.7 9.7 14.1 14.6 2.0 6.8 8.6 8.1 7.0 9.3 5.7 10.1 7.9 6.3 5.9 12.9 11.1 13.9 7.2 8.8 3.8 13.5 6.7 20.2 22.5 19.6 23.7 16.9 16.4 28.9 18.7 23.8 27.5 44.7 61.3 35.0 26.8 52.1 32.3 22.6 17.8 62.9 40.9 17.4 9.8 16.5 11.6 22.6 88.2 47.2 16.6 0.0 22.2 13.1 33.3 37.8 31.4 33.4 20.8 49.3 13.2 81.0 48.0 11.5 32.2 32.3 30.4 19.8 19.1 26.9 22.6 11.5 30.8 28.6 24.5 19.4 30.7 44.0 22.1 59.8 32.0 28.8 14.5 29.8 TBC1D2 "Armus, PARIS1, TBC1D2A" ENSG00000095383 "TBC1 domain family member 2" Q9BYX2 9 98198999-98255721 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Hofbauer cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 18.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 27.5;HaCaT: 36.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030871, HPA076521" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "HPA030871: AB_10670046, HPA076521: " "unprognostic (2.32e-2)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (9.21e-3)" "unprognostic (6.40e-3)" "unprognostic (2.30e-1)" "unprognostic (6.07e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.30e-2)" "unprognostic (4.30e-1)" 13.1 4.1 6.6 7.0 15.6 14.5 7.6 7.7 7.6 7.8 12.0 17.8 6.0 15.5 4.4 4.3 25.3 4.4 5.3 2.2 9.5 7.4 4.6 12.6 27.4 4.5 15.2 5.3 4.3 3.0 4.5 3.1 11.9 9.0 8.1 5.9 6.2 10.1 8.8 3.3 18.8 15.2 5.7 14.3 6.7 5.1 3.1 12.2 4.7 7.1 14.7 16.8 14.7 11.6 0.9 7.0 8.1 18.4 0.7 3.9 6.4 27.5 4.0 0.2 0.9 3.1 6.1 9.1 12.2 6.8 8.9 7.4 2.6 12.1 0.4 9.3 7.1 1.9 36.4 0.2 13.6 3.1 0.9 0.5 0.2 14.1 2.0 14.6 0.6 1.1 8.4 22.5 8.9 22.3 15.8 3.1 0.7 0.8 0.3 7.0 3.5 0.1 1.6 0.6 2.7 2.3 0.4 1.8 0.0 13.6 17.2 0.3 0.5 4.1 9.1 1.2 0.6 3.0 0.9 19.0 10.9 3.3 1.8 4.9 0.6 0.5 0.2 11.1 1.0 1.2 1.1 18.4 5.5 1.9 10.8 1.3 0.9 2.8 1.6 7.0 0.6 1.2 1.4 8.1 0.7 8.0 0.9 3.9 6.4 6.6 15.6 7.7 7.6 9.5 7.4 15.2 5.3 9.0 12.2 53.6 12.2 1.9 11.4 7.3 2.4 0.6 7.6 5.3 20.5 3.5 0.0 18.5 3.3 3.7 1.5 3.1 15.0 0.0 2.8 9.4 2.1 3.8 0.0 4.7 31.3 1.6 7.5 0.6 19.8 1.0 1.7 9.3 3.3 3.6 11.1 2.9 8.7 7.0 0.7 2.5 2.2 0.0 2.0 1.6 2.8 9.5 14.5 1.9 4.2 11.1 TBC1D22B "C6orf197, dJ744I24.2, FLJ20337" ENSG00000065491 "TBC1 domain family member 22B" Q9NU19 6 37257772-37332970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027908, HPA027909, HPA027910" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203" "unprognostic (9.83e-2)" "unprognostic (5.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (8.15e-5)" "unprognostic (2.70e-1)" "unprognostic (1.45e-1)" "unprognostic (2.29e-2)" "unprognostic (1.44e-1)" "unprognostic (9.48e-2)" "unprognostic (6.06e-3)" "unprognostic (3.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.53e-3)" "unprognostic (9.87e-2)" "unprognostic (2.71e-1)" "unprognostic (3.19e-1)" "unprognostic (9.73e-2)" 11.5 17.9 9.6 11.0 12.1 26.0 12.8 15.2 17.1 9.7 13.1 11.2 14.3 13.1 13.9 13.0 19.8 14.1 16.8 11.2 10.5 10.5 13.3 8.7 11.7 9.0 8.9 9.9 15.0 20.9 16.8 11.8 13.3 13.1 12.3 13.3 12.2 21.6 11.8 32.7 20.7 16.1 11.5 8.3 11.1 10.6 19.9 8.2 20.7 13.0 10.5 14.4 10.4 13.3 4.6 7.7 8.0 6.6 5.7 6.2 4.6 7.0 3.0 5.6 6.1 5.2 5.2 8.0 4.0 8.3 7.5 9.2 6.8 4.7 6.6 4.2 5.0 10.1 4.9 7.0 6.3 8.4 10.7 5.7 10.5 5.0 9.2 7.5 5.9 9.0 4.4 9.3 7.3 8.7 7.1 10.4 11.2 11.9 1.7 5.3 6.4 8.7 4.5 7.2 8.1 2.8 5.8 5.1 5.2 7.6 5.2 7.3 4.7 4.3 6.3 7.7 7.8 4.5 10.7 10.1 4.5 7.0 3.0 5.2 6.3 6.5 43.8 3.1 9.0 7.0 2.4 5.0 8.0 4.8 6.6 5.6 3.6 5.3 4.6 7.7 4.6 6.2 5.0 2.2 5.7 2.9 2.2 3.6 4.6 9.6 12.1 15.2 17.1 10.5 10.5 8.9 9.9 13.1 8.2 3.0 6.4 2.7 7.2 7.2 5.1 3.5 2.5 12.0 9.1 1.8 3.9 5.5 3.3 10.8 4.4 4.9 11.1 23.3 13.4 7.1 4.1 7.9 5.7 3.6 4.9 0.0 1.7 4.3 4.3 2.9 2.8 4.3 1.7 7.2 5.1 3.8 13.3 5.8 1.1 7.7 4.6 0.0 2.5 5.5 5.1 13.9 5.6 4.9 4.7 10.1 TBC1D2B KIAA1055 ENSG00000167202 "TBC1 domain family member 2B" Q9UPU7 15 77984036-78077724 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041833, HPA048174, HPA052663" Approved Enhanced Cytosol NA NA Cytosol "HPA041833: AB_2732494, HPA048174: AB_2680297, HPA052663: AB_2681906" "unprognostic (3.13e-1)" "unprognostic (2.16e-1)" "unprognostic (8.25e-2)" "unprognostic (1.28e-2)" "unprognostic (3.94e-2)" "unprognostic (1.43e-1)" "unprognostic (5.07e-3)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (8.22e-3)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.23e-3)" "unprognostic (6.68e-2)" "unprognostic (3.07e-2)" "unprognostic (3.37e-1)" "unprognostic (3.19e-2)" 26.0 14.1 9.3 12.0 10.0 11.9 21.4 8.4 8.4 22.8 16.7 8.4 7.3 7.6 20.2 13.0 9.3 18.2 20.0 7.8 7.7 4.3 8.2 18.3 22.7 12.5 8.3 5.6 31.2 16.6 17.7 7.1 28.9 7.2 13.6 10.8 20.7 8.6 14.0 5.0 10.5 14.3 15.5 9.7 19.9 12.6 11.0 7.3 20.4 10.4 5.8 14.4 17.1 18.4 0.4 3.2 3.7 2.1 3.8 4.2 1.3 5.0 4.0 4.9 4.6 34.4 27.5 8.5 11.7 17.7 11.0 12.2 5.1 2.1 7.8 4.7 9.8 6.1 7.4 10.6 12.9 8.4 14.8 8.2 5.0 3.9 3.4 16.3 12.6 7.6 26.7 9.0 7.3 4.9 16.4 12.4 10.2 2.5 5.4 14.2 5.5 4.6 8.2 3.8 3.9 3.9 7.1 22.4 1.7 5.7 19.4 2.6 7.1 10.9 7.4 13.8 4.7 2.4 13.2 15.2 12.1 8.0 3.8 6.1 9.3 9.7 4.2 4.1 17.0 6.3 0.0 2.1 0.9 3.9 1.8 2.2 0.2 2.6 4.2 1.4 0.4 1.9 1.5 3.7 3.8 0.5 3.2 1.5 1.3 9.3 10.0 8.4 8.4 7.7 4.3 8.3 5.6 7.2 7.3 3.0 12.9 9.7 8.0 8.2 9.7 2.4 12.7 2.7 3.4 5.2 5.9 15.3 0.0 6.9 7.4 12.0 10.6 0.0 8.4 6.3 13.9 8.1 9.2 62.2 16.0 14.3 7.0 28.3 28.3 6.1 39.4 18.9 13.5 12.6 17.8 7.2 11.5 10.5 39.6 2.7 10.0 25.8 8.9 5.0 7.2 8.7 23.8 19.5 15.6 7.6 TBC1D30 KIAA0984 ENSG00000111490 "TBC1 domain family member 30" Q9Y2I9 12 64781193-64881032 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.8" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Group enriched" "Detected in many" 17 "granulocytes: 2.4;monocytes: 1.1;T-cells: 1.3" "Cell line enhanced" "Detected in many" "MCF7: 23.0;OE19: 15.2;RPMI-8226: 13.6;RT4: 17.6;SCLC-21H: 16.5;SK-BR-3: 17.0;T-47d: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039772, HPA040043" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA039772: AB_10795409, HPA040043: AB_10795411" "unprognostic (1.85e-1)" "unprognostic (6.95e-2)" "unprognostic (2.66e-1)" "prognostic favorable (3.61e-5)" "unprognostic (9.35e-2)" "unprognostic (2.09e-1)" "unprognostic (2.65e-5)" "prognostic favorable (5.08e-4)" "unprognostic (1.75e-3)" "unprognostic (2.16e-2)" "unprognostic (2.44e-1)" "unprognostic (9.72e-2)" "unprognostic (7.32e-2)" "unprognostic (7.62e-3)" "unprognostic (8.72e-2)" "unprognostic (2.67e-3)" "unprognostic (7.80e-3)" 1.8 1.6 4.7 2.3 11.4 0.5 5.3 13.4 15.8 7.6 3.3 1.5 12.4 5.0 3.1 2.5 1.2 2.1 4.8 1.1 7.1 5.5 3.9 1.7 3.9 0.9 4.7 7.0 1.5 19.8 8.9 6.5 1.4 16.5 3.7 3.5 2.0 14.4 11.6 0.9 1.3 3.5 2.4 3.0 2.5 6.9 3.2 2.8 0.0 3.3 0.2 0.7 4.9 1.9 0.0 0.0 2.4 1.1 0.0 1.3 0.3 6.9 1.4 0.4 0.4 0.0 0.5 0.6 0.0 0.0 0.0 0.1 6.5 2.2 0.3 1.1 0.0 0.3 0.1 6.8 0.1 0.0 0.0 6.7 0.3 1.2 0.3 0.1 2.3 1.4 0.4 0.0 0.0 0.2 0.6 5.6 1.0 0.0 2.4 0.2 23.0 0.0 0.4 0.9 15.2 6.8 0.1 0.1 13.6 0.8 17.6 16.5 1.3 1.4 17.0 0.2 0.7 12.4 1.1 5.3 0.0 1.0 0.5 3.4 0.0 0.0 0.2 0.1 0.7 0.3 0.0 1.1 0.0 0.4 1.1 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 2.4 0.0 0.7 0.0 0.0 0.3 4.7 11.4 13.4 15.8 7.1 5.5 4.7 7.0 16.5 2.8 0.0 4.6 0.5 2.1 0.8 9.4 0.4 5.1 2.7 5.7 3.5 7.9 0.4 8.3 3.1 13.6 4.2 2.6 0.0 4.3 0.3 0.5 7.1 9.2 0.0 1.5 0.0 0.0 2.5 2.5 1.0 0.3 2.8 5.0 1.0 6.3 2.5 3.6 3.5 0.0 1.7 0.5 0.0 0.3 3.3 1.5 1.3 0.1 0.9 3.3 8.4 TBC1D4 "AS160, DKFZp779C0666, KIAA0603" ENSG00000136111 "TBC1 domain family member 4" O60343 13 75284665-75482114 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "GTPase activation" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 17.4" "Group enriched" "Detected in many" 5 "dendritic cells: 7.2;T-cells: 17.4" "Cell line enhanced" "Detected in many" "CACO-2: 36.9;HUVEC TERT2: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040145, HPA059885" Approved Supported Cytosol NA NA Cytosol "HPA040145: AB_2676860, HPA059885: AB_2684152" "unprognostic (5.44e-3)" "unprognostic (5.23e-1)" "unprognostic (9.85e-2)" "unprognostic (1.39e-1)" "unprognostic (2.78e-2)" "unprognostic (9.54e-3)" "unprognostic (1.25e-2)" "unprognostic (8.87e-2)" "unprognostic (2.87e-1)" "unprognostic (5.02e-2)" "unprognostic (7.53e-2)" "unprognostic (2.64e-1)" "prognostic favorable (1.07e-11)" "unprognostic (6.40e-2)" "unprognostic (3.16e-1)" "unprognostic (8.88e-2)" "unprognostic (3.45e-1)" 12.0 43.9 6.7 6.7 7.0 1.2 17.5 9.3 10.7 6.9 5.7 4.6 4.2 1.9 5.4 10.1 6.1 5.9 8.5 25.5 8.0 4.1 15.6 5.3 8.5 14.9 5.4 7.0 22.5 8.5 9.5 4.2 9.5 11.1 7.4 4.9 2.0 20.8 2.4 40.1 10.8 6.3 4.7 4.8 9.6 6.1 3.3 4.4 1.1 17.7 17.3 14.8 4.7 8.7 0.5 7.2 2.6 0.3 0.3 17.4 1.8 5.5 6.5 4.1 0.2 9.7 10.5 5.3 4.8 2.5 3.9 4.3 36.9 6.8 1.1 1.1 6.8 1.9 5.2 10.4 4.8 4.1 18.3 10.5 18.0 8.8 11.1 2.4 8.5 0.2 11.4 8.9 4.3 10.2 6.8 27.3 20.3 5.0 0.6 4.4 2.6 12.4 1.5 5.8 10.7 3.9 11.2 3.9 6.5 3.8 4.0 7.6 2.3 2.1 6.5 3.5 2.2 2.2 0.2 11.4 4.4 5.5 2.3 5.6 0.3 0.0 0.1 7.9 8.0 6.5 2.6 0.3 0.0 0.5 0.1 0.0 0.5 8.6 1.8 0.4 0.4 8.0 3.7 0.3 0.3 0.1 7.2 17.4 1.8 6.7 7.0 9.3 10.7 8.0 4.1 5.4 7.0 11.1 4.4 6.0 26.1 0.5 7.9 32.2 0.0 70.6 12.7 4.0 9.1 14.0 0.0 9.3 13.3 9.7 13.3 32.1 3.5 0.0 6.5 8.5 8.2 13.9 4.7 16.4 21.4 1.6 20.2 33.7 17.4 3.6 3.4 8.8 20.3 47.7 10.6 0.3 5.3 0.0 6.7 7.4 0.6 6.5 12.3 0.9 6.1 38.6 4.1 13.1 16.2 8.1 TBC1D8B "FLJ20298, GRAMD8B, RP11-321G1.1" ENSG00000133138 "TBC1 domain family member 8B" Q0IIM8 X 106802680-106876145 "Predicted intracellular proteins" "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 11 "Alveolar cells type 1: 214.4;Alveolar cells type 2: 173.1;Ciliated cells: 192.7;Club cells: 159.3;granulocytes: 104.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023883, HPA027527" Enhanced Approved Cytosol NA NA Cytosol "HPA023883: AB_1857794, HPA027527: AB_2199395" "unprognostic (6.69e-2)" "unprognostic (1.06e-1)" "unprognostic (8.19e-2)" "unprognostic (4.69e-3)" "unprognostic (8.15e-2)" "unprognostic (6.97e-2)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (2.75e-1)" "unprognostic (4.89e-2)" "unprognostic (3.32e-2)" "unprognostic (4.77e-2)" "unprognostic (1.62e-1)" "unprognostic (9.97e-2)" "unprognostic (5.16e-2)" 3.8 24.5 4.6 3.5 7.9 3.3 3.9 1.2 7.9 6.0 6.6 2.6 21.5 6.0 5.1 10.4 3.7 4.4 9.6 4.7 4.2 2.5 12.4 14.5 4.1 2.0 6.8 3.3 7.2 10.7 10.0 28.6 4.5 9.0 6.1 5.6 2.2 10.1 16.8 1.8 2.9 13.3 4.1 4.7 2.7 8.5 7.6 7.6 0.5 7.9 3.1 1.8 4.9 4.8 4.7 2.8 5.2 2.2 1.5 2.0 0.4 10.0 3.2 1.5 4.9 15.8 22.4 5.7 11.3 11.7 2.0 6.1 5.4 8.9 3.6 9.3 11.3 8.3 5.2 4.1 5.6 5.1 1.9 4.5 4.8 4.0 5.2 4.1 1.4 2.0 9.8 4.6 4.2 2.0 12.2 5.5 3.0 1.6 6.2 7.0 5.1 3.2 1.9 6.9 14.7 5.1 1.6 2.8 1.5 5.6 7.4 2.5 2.1 8.9 6.9 4.0 7.1 7.9 1.7 6.9 7.4 8.3 9.7 4.1 5.7 6.1 1.1 14.3 1.1 9.2 3.7 2.2 1.1 2.0 1.2 1.6 2.2 1.7 1.5 0.7 4.7 1.4 1.7 5.2 1.5 1.1 2.8 0.7 0.4 4.6 7.9 1.2 7.9 4.2 2.5 6.8 3.3 9.0 7.6 214.4 173.1 1.5 5.8 2.2 3.4 2.2 5.1 192.7 159.3 7.0 3.9 2.4 6.6 7.5 0.8 6.0 8.4 0.0 8.3 2.5 7.6 12.9 104.6 13.9 1.4 0.0 4.6 2.5 2.7 0.4 8.3 1.9 3.3 1.0 15.4 1.5 6.2 10.5 8.1 9.7 3.4 0.0 4.1 1.4 1.7 1.3 2.2 0.0 8.4 7.2 TBC1D9 "GRAMD9, KIAA0882, MDR1" ENSG00000109436 "TBC1 domain family member 9" Q6ZT07 4 140620765-140756120 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 52.4" "Cancer enriched" "Detected in all" 7 "breast cancer: 85.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.0" "Group enriched" "Detected in many" 38 "B-cells: 9.0;dendritic cells: 4.6;monocytes: 2.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000262, HPA006503" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA000262: AB_2665956, HPA006503: AB_2667604" "unprognostic (1.41e-1)" "unprognostic (1.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.49e-2)" "unprognostic (3.00e-1)" "unprognostic (1.22e-2)" "unprognostic (9.17e-2)" "unprognostic (2.11e-3)" "unprognostic (2.64e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-3)" "unprognostic (6.77e-2)" "prognostic favorable (1.61e-6)" "unprognostic (2.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.16e-2)" 15.9 6.2 8.1 9.2 10.0 1.0 33.6 37.6 13.7 9.2 6.7 3.8 32.1 5.2 5.5 6.4 5.9 6.7 9.4 5.7 7.5 13.9 10.7 8.0 10.4 9.6 9.6 8.2 10.9 6.0 9.9 5.7 13.1 11.0 9.8 4.3 10.6 7.3 27.4 1.7 2.8 9.9 5.0 5.3 20.4 10.0 2.9 3.8 1.6 4.3 3.0 12.2 11.1 8.9 9.0 4.6 0.1 2.4 0.1 0.0 0.9 0.4 6.4 6.0 5.1 14.6 13.8 12.2 8.1 8.8 5.9 7.6 1.3 5.6 0.0 5.2 10.6 7.4 1.2 7.4 5.8 5.6 0.0 4.1 3.6 4.6 5.5 5.3 0.5 0.5 11.3 9.7 5.1 20.6 17.3 16.4 2.0 0.0 0.0 5.5 6.3 0.8 0.0 0.9 6.7 5.6 3.9 9.8 9.3 6.8 11.8 8.8 6.2 8.5 15.0 5.5 10.6 3.5 0.2 25.4 15.7 4.7 10.2 7.0 0.0 0.0 0.0 9.5 0.7 8.5 0.0 2.4 0.0 0.0 1.9 0.0 9.0 0.0 0.0 4.0 4.0 0.0 0.0 0.1 0.1 0.7 4.6 0.0 0.9 8.1 10.0 37.6 13.7 7.5 13.9 9.6 8.2 11.0 3.8 50.6 9.4 15.7 8.9 4.0 33.1 6.5 17.8 5.3 6.8 52.4 3.9 10.8 6.6 13.3 0.4 24.1 4.1 0.0 15.0 3.9 11.5 19.8 0.0 14.5 15.9 9.5 7.5 17.8 30.7 0.0 12.0 30.7 8.5 25.2 4.5 40.9 13.2 5.9 25.1 3.8 7.0 0.0 9.5 0.7 1.5 3.3 36.2 0.5 1.7 8.4 TBCB "CG22, CKAP1, CKAPI" ENSG00000105254 "Tubulin folding cofactor B" Q99426 19 36114289-36125947 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041428, HPA041722" Approved Supported Cytosol NA NA 340000 Cytosol "HPA041428: AB_10794517, HPA041722: AB_10804007" "unprognostic (3.88e-3)" "unprognostic (3.05e-1)" "unprognostic (8.52e-2)" "unprognostic (1.38e-2)" "unprognostic (7.94e-2)" "unprognostic (1.25e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.15e-2)" "unprognostic (5.19e-2)" "unprognostic (1.32e-1)" "prognostic favorable (3.11e-4)" "unprognostic (4.54e-2)" "unprognostic (6.34e-3)" "unprognostic (9.20e-2)" "unprognostic (6.11e-2)" "unprognostic (5.39e-2)" "unprognostic (1.02e-1)" 23.0 30.2 59.1 26.0 48.8 23.2 20.0 30.9 67.6 22.1 22.3 64.3 14.3 16.8 20.7 20.9 18.0 27.7 14.9 29.2 55.8 56.7 21.0 14.1 19.9 20.7 63.5 43.8 33.9 11.2 15.1 23.1 19.0 49.7 20.0 17.4 14.7 12.2 22.7 34.5 12.8 17.6 29.8 85.5 21.0 16.3 24.1 44.4 15.0 12.2 13.7 23.9 16.2 15.0 64.6 73.4 79.4 101.2 59.7 96.3 80.6 32.4 95.7 37.0 24.8 26.3 27.9 13.0 25.3 19.5 44.1 30.7 42.0 17.6 24.0 47.6 41.8 34.7 15.5 30.8 27.0 26.6 56.0 29.8 21.4 26.7 64.0 28.6 25.0 48.2 26.3 20.4 35.3 24.8 31.2 25.5 40.4 9.3 40.8 39.1 49.1 38.4 27.8 22.2 39.6 31.4 35.7 19.1 23.1 41.2 31.6 37.2 38.5 22.8 32.5 28.9 32.5 17.1 33.6 28.0 45.7 47.9 26.9 52.1 18.5 47.1 28.2 40.0 24.3 24.2 66.4 65.0 79.4 78.8 85.2 53.0 64.6 73.6 69.1 70.9 54.8 44.0 55.2 27.6 59.7 101.2 73.4 96.3 80.6 59.1 48.8 30.9 61.4 55.8 56.7 63.5 43.8 49.7 44.4 56.6 30.1 79.2 71.3 59.4 55.0 42.3 66.2 91.0 51.2 130.9 11.8 122.5 152.5 129.6 118.3 85.4 49.9 46.7 98.1 167.7 130.9 58.0 83.0 30.6 140.7 68.3 103.0 70.6 73.2 193.4 83.4 107.5 123.2 354.3 52.1 89.1 105.9 92.1 95.1 144.2 59.8 64.7 127.8 113.8 172.0 59.1 69.1 96.9 55.1 70.7 TBCC CFC ENSG00000124659 "Tubulin folding cofactor C" Q15814 6 42744481-42746096 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035073, HPA035074" Approved Supported Cytosol NA NA Cytosol "HPA035073: AB_10602897, HPA035074: AB_2674448" "unprognostic (7.16e-2)" "unprognostic (9.88e-2)" "unprognostic (2.17e-1)" "unprognostic (4.23e-2)" "unprognostic (8.20e-2)" "unprognostic (6.79e-2)" "unprognostic (5.80e-3)" "unprognostic (1.41e-2)" "unprognostic (2.47e-1)" "unprognostic (3.96e-3)" "unprognostic (1.84e-2)" "unprognostic (1.92e-1)" "unprognostic (2.22e-1)" "unprognostic (2.28e-1)" "unprognostic (1.29e-1)" "unprognostic (6.31e-2)" "unprognostic (3.76e-3)" 5.8 6.1 8.6 9.4 8.0 19.0 6.2 10.9 15.7 7.6 7.6 7.9 6.9 7.4 8.7 7.1 6.4 8.5 8.5 8.0 6.6 7.1 7.0 5.6 5.9 14.1 7.7 8.4 8.0 7.8 3.0 7.3 7.2 10.9 6.9 5.0 6.0 7.4 6.8 13.5 8.7 7.9 5.5 6.6 8.5 7.4 8.4 6.6 9.4 7.8 4.1 10.0 7.7 6.6 31.6 46.3 54.8 30.2 52.1 48.8 49.5 15.4 5.1 7.9 14.7 11.5 7.7 10.4 10.7 12.1 11.9 13.0 7.9 6.1 14.0 8.6 10.3 9.9 13.6 10.6 10.6 6.7 7.6 11.6 7.3 7.6 13.3 13.1 7.9 12.0 12.6 13.0 9.2 7.6 10.7 9.3 7.9 16.7 12.8 10.6 19.0 6.5 15.3 7.4 42.3 14.1 6.6 9.5 9.1 11.3 8.5 30.5 13.2 6.9 12.0 18.3 7.6 13.2 27.1 10.0 11.4 10.2 9.2 14.6 17.0 19.1 23.6 5.6 10.9 10.9 37.6 30.2 54.8 37.2 25.3 37.7 31.6 39.4 40.3 27.3 30.7 46.1 42.6 53.4 52.1 22.6 46.3 48.8 49.5 8.6 8.0 10.9 15.7 6.6 7.1 7.7 8.4 10.9 6.6 3.0 29.5 40.3 21.8 22.2 53.4 5.9 25.5 9.4 4.5 10.4 39.3 18.0 28.2 33.2 18.6 16.2 21.8 0.0 27.2 20.1 17.5 13.9 30.1 8.3 16.4 17.5 43.4 19.6 10.0 7.0 16.4 15.1 27.0 33.3 15.6 48.9 25.4 25.9 19.4 19.2 46.6 19.4 22.1 30.9 24.0 21.8 17.6 63.3 16.6 22.1 TBCEL "LRRC35, MGC10233" ENSG00000154114 "Tubulin folding cofactor E like" Q5QJ74 11 121024072-121090775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038593, HPA038594" Approved Uncertain Cytosol NA NA Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" "unprognostic (9.06e-3)" "unprognostic (3.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.29e-1)" "unprognostic (5.80e-2)" "unprognostic (3.13e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.27e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.07e-3)" "unprognostic (1.86e-1)" "unprognostic (1.66e-2)" "unprognostic (1.02e-1)" 12.4 10.8 9.2 8.3 11.9 6.6 12.2 12.5 13.8 10.8 11.4 15.6 25.8 7.3 18.4 18.3 8.1 11.5 10.8 12.8 9.6 9.1 11.7 19.6 13.7 9.1 12.5 11.1 15.3 10.8 30.8 22.8 14.3 15.8 12.8 8.3 13.2 12.9 17.7 11.0 7.6 9.6 13.1 11.8 14.1 10.2 26.1 12.3 9.5 14.6 6.1 9.6 10.5 10.2 1.1 2.1 0.8 1.4 2.8 2.2 1.0 4.4 4.3 7.4 6.4 13.6 12.9 5.7 8.6 10.6 6.6 9.7 4.4 7.2 5.6 13.3 10.6 6.5 1.2 8.1 2.8 8.9 6.6 6.0 9.6 3.3 4.4 16.9 6.8 6.7 14.1 9.7 6.4 7.0 6.8 10.8 3.2 2.8 10.8 9.2 3.2 2.7 5.6 4.3 0.2 4.2 2.4 10.9 2.5 8.9 2.8 3.9 9.2 8.4 8.9 5.7 6.9 8.5 5.8 14.0 14.7 3.3 5.9 4.7 4.2 3.0 2.9 2.1 0.0 5.5 0.0 1.1 0.5 1.5 1.4 2.1 0.5 2.1 2.1 1.3 1.1 2.2 1.4 0.8 2.8 1.0 2.1 1.0 1.0 9.2 11.9 12.5 13.8 9.6 9.1 12.5 11.1 15.8 12.3 6.0 7.0 4.5 1.7 2.6 8.5 7.0 7.6 6.7 1.2 7.0 13.7 1.3 1.7 3.7 7.6 4.9 2.0 46.7 2.1 1.5 4.2 2.6 1.1 17.9 2.7 7.9 3.5 12.3 6.3 4.2 8.6 2.4 10.1 14.4 2.5 6.0 3.3 0.0 9.2 3.6 8.5 0.0 4.7 12.7 5.5 1.5 1.1 4.4 2.2 1.0 TBL2 "DKFZP43N024, WBSCR13, WS-betaTRP" ENSG00000106638 "Transducin beta like 2" Q9Y4P3 7 73568932-73578791 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.5" "Group enriched" "Detected in many" 7 "Early spermatids: 291.7;Late spermatids: 375.4;Spermatocytes: 284.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007477, HPA051533" Supported Cytosol "Secreted in male reproductive system" NA NA Cytosol "HPA007477: AB_1080214, HPA051533: AB_2681523" "unprognostic (9.04e-2)" "unprognostic (6.61e-3)" "unprognostic (4.24e-2)" "unprognostic (1.10e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.24e-3)" "unprognostic (7.50e-2)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (1.74e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" 8.9 12.1 3.7 5.4 3.3 1.8 5.9 2.7 5.3 8.7 6.6 3.4 11.6 6.1 6.5 10.9 7.3 5.5 6.3 5.4 2.5 2.5 6.1 14.2 6.5 4.7 3.5 2.1 10.7 27.0 8.5 7.0 13.0 3.4 6.5 6.9 5.1 16.3 8.0 4.9 6.9 6.3 5.4 3.0 5.4 8.2 70.5 3.7 6.2 11.8 4.2 5.2 8.5 6.2 4.2 14.4 13.2 11.4 8.3 6.7 7.6 12.2 14.0 4.8 7.1 13.2 12.8 6.0 14.7 11.0 5.6 10.1 21.4 13.2 10.0 3.3 12.9 11.9 9.4 10.2 5.9 11.1 3.9 6.9 3.6 7.4 14.0 19.0 7.3 13.3 7.9 10.2 17.1 13.7 10.9 6.4 1.9 14.7 7.9 8.5 11.9 7.1 7.2 5.0 15.0 11.5 4.6 8.7 22.1 7.2 8.6 5.1 8.2 14.6 40.0 9.2 6.6 10.5 5.6 10.8 10.6 5.2 9.8 14.8 15.9 9.9 11.3 13.6 9.0 12.3 13.2 11.4 5.2 6.6 7.9 6.5 3.4 5.6 6.0 14.4 4.2 6.7 4.2 1.0 8.3 7.0 10.8 6.5 7.6 3.7 3.3 2.7 5.3 2.5 2.5 3.5 2.1 3.4 3.7 23.8 9.4 12.3 11.1 4.0 10.0 4.5 12.7 6.7 7.9 5.2 7.9 39.4 1.7 21.8 291.7 9.8 10.9 0.0 26.3 45.4 11.5 14.0 13.9 15.3 26.0 3.2 9.1 12.9 7.5 375.4 21.9 7.9 6.8 23.4 15.7 7.8 21.3 14.4 25.1 5.0 12.9 6.5 8.0 284.6 22.2 3.1 36.3 3.3 14.3 7.5 TBX2 ENSG00000121068 "T-box 2" Q13207 17 61399896-61409466 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 76.5;Collecting duct cells: 90.7;Muller glia cells: 126.1;Sertoli cells: 168.1;Smooth muscle cells: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 48.6;MCF7: 28.5;SH-SY5Y: 22.7;SK-MEL-30: 15.5;WM-115: 16.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008586, CAB013636" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013636: , HPA008586: AB_1080222" "unprognostic (6.18e-2)" "unprognostic (8.51e-2)" "unprognostic (4.50e-1)" "unprognostic (2.09e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (3.27e-1)" "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (9.29e-2)" "unprognostic (2.10e-2)" "unprognostic (2.10e-1)" "unprognostic (2.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.45e-1)" "unprognostic (6.34e-3)" 11.5 3.4 2.0 2.9 3.1 0.4 9.9 1.3 2.3 14.8 4.4 1.9 30.4 4.9 12.2 37.0 5.9 11.3 16.8 6.8 1.8 1.8 28.9 4.6 35.7 1.3 3.6 1.5 8.3 1.8 1.8 3.7 30.4 3.6 15.1 2.2 33.7 2.2 38.1 5.8 2.9 5.5 16.4 1.7 8.8 8.1 9.6 1.5 0.0 8.6 5.0 1.8 19.5 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 48.6 1.6 1.7 5.9 7.5 7.9 0.4 0.1 1.3 0.1 0.0 0.6 1.2 0.9 0.0 0.9 0.0 0.1 0.0 2.9 0.8 0.0 2.3 5.4 0.1 0.7 3.1 0.1 8.9 0.5 0.1 0.0 0.0 0.1 0.0 0.5 28.5 0.0 0.1 0.0 0.0 3.4 0.0 1.9 0.2 0.0 11.5 0.1 22.7 0.0 0.0 15.5 0.1 0.6 0.9 0.0 1.1 0.0 2.8 1.7 0.0 0.1 0.0 6.7 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.1 1.3 2.3 1.8 1.8 3.6 1.5 3.6 1.5 0.0 1.1 0.0 0.2 0.6 76.5 6.7 0.0 0.0 0.0 90.7 21.6 0.3 1.7 0.0 0.7 4.2 0.0 0.0 0.0 0.2 3.7 0.6 0.0 0.0 0.8 1.6 0.0 14.1 1.8 0.0 36.5 1.7 1.7 0.0 0.0 126.1 0.0 0.0 44.6 23.8 11.5 168.1 66.5 0.4 0.6 0.3 0.2 0.0 0.0 0.1 TBX3 "TBX3-ISO, UMS, XHL" ENSG00000135111 "T-box 3" O15119 12 114670254-114684164 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 117.7" "Cell type enriched" "Detected in many" 6 "Syncytiotrophoblasts: 513.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 34.0;BJ hTERT+: 32.4;RT4: 42.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA005799, HPA075876" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005799: AB_1857817, HPA075876: " "unprognostic (3.27e-1)" "unprognostic (2.64e-1)" "unprognostic (2.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.40e-2)" "unprognostic (5.97e-3)" "unprognostic (1.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.35e-1)" "unprognostic (3.06e-1)" "unprognostic (3.64e-3)" "unprognostic (1.09e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "prognostic favorable (3.28e-4)" 4.3 60.5 0.9 3.3 1.9 0.0 19.9 0.7 2.3 18.2 12.2 1.7 69.6 14.2 13.1 18.7 1.9 7.5 5.0 6.2 1.2 1.5 4.1 15.1 12.6 0.8 1.2 0.5 15.6 1.1 0.3 5.3 67.8 1.6 32.3 1.5 2.6 7.3 117.7 4.2 4.8 19.4 9.7 1.4 2.6 2.2 3.5 1.2 0.5 36.3 7.3 3.5 24.6 25.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 6.0 0.0 0.0 9.0 12.4 13.5 34.0 32.4 13.2 13.1 5.3 1.4 0.0 0.5 5.9 0.8 1.5 2.8 1.2 16.3 0.0 4.1 0.0 1.5 15.5 2.9 0.0 0.0 5.5 0.8 4.4 9.1 0.0 0.1 0.0 1.2 0.0 1.1 0.5 0.0 0.1 0.0 17.2 1.8 0.0 0.0 0.8 0.0 42.4 2.2 6.6 4.8 2.2 1.1 15.8 1.7 0.0 0.0 4.0 2.6 2.3 11.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.7 2.3 1.2 1.5 1.2 0.5 1.6 1.2 0.0 3.4 0.9 88.0 8.8 6.3 9.8 0.0 0.0 0.0 33.2 3.9 39.8 0.0 0.4 1.3 26.5 25.4 0.0 0.0 5.9 9.5 74.0 0.0 31.0 5.4 1.6 4.7 0.6 1.6 1.8 4.9 0.8 3.3 0.0 13.8 1.5 0.5 23.0 5.6 0.0 2.0 38.8 34.1 0.1 4.7 8.5 513.4 0.7 4.5 62.6 TCEAL2 "my048, MY0876G05, WEX1" ENSG00000184905 "Transcription elongation factor A like 2" Q9H3H9 X 102125688-102127711 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.0;ovary: 46.5" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 143.3;Distal tubular cells: 59.7;Horizontal cells: 92.2;Muller glia cells: 150.4" "Cancer enhanced" "Detected in many" "glioma: 22.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.1" "Group enriched" "Detected in some" 4 "HAP1: 7.4;SCLC-21H: 8.1;U-2 OS: 14.6" HPA076317 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA076317: AB_2686794" "unprognostic (2.34e-3)" "unprognostic (1.35e-2)" "unprognostic (7.59e-3)" "unprognostic (3.84e-3)" "unprognostic (2.07e-1)" "unprognostic (4.57e-2)" "unprognostic (4.27e-2)" "unprognostic (2.80e-2)" "unprognostic (3.47e-1)" "unprognostic (3.26e-1)" "unprognostic (7.07e-3)" "unprognostic (1.43e-1)" "unprognostic (1.56e-2)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.04e-1)" "unprognostic (4.11e-3)" 2.4 19.6 34.1 2.6 44.6 1.1 2.4 40.9 84.0 5.8 7.0 8.5 1.8 3.1 19.5 8.6 5.3 7.3 6.4 5.1 30.0 37.9 8.2 1.3 4.4 1.6 25.4 26.5 46.5 3.7 2.8 38.3 1.1 30.1 19.4 3.8 6.6 16.4 21.6 1.2 1.7 3.2 14.0 16.1 2.9 4.2 19.7 9.6 0.0 25.6 0.0 2.1 4.3 2.6 0.1 0.1 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 1.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 14.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.8 0.1 1.7 0.0 0.1 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.1 0.4 34.1 44.6 40.9 41.8 30.0 37.9 25.4 26.5 30.1 9.6 6.0 12.3 0.0 55.7 1.6 143.3 4.6 0.0 0.0 22.7 29.6 5.9 0.0 59.7 0.1 2.9 8.7 0.0 0.0 0.3 0.1 5.3 42.5 2.3 0.0 0.0 92.2 0.0 3.7 0.0 7.5 6.1 1.0 6.8 1.0 0.0 150.4 1.6 0.0 5.3 0.5 40.9 6.5 17.0 1.7 1.1 1.1 0.0 0.0 0.0 6.3 TCEAL9 "DKFZp313K1940, WBP5, WEX6" ENSG00000185222 "Transcription elongation factor A like 9" Q9UHQ7 X 103356489-103358462 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 939.8;Distal tubular cells: 305.1;Extravillous trophoblasts: 389.4;Syncytiotrophoblasts: 652.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 18.6" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011790 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA011790: AB_2214932" "unprognostic (1.26e-1)" "unprognostic (9.24e-2)" "unprognostic (3.35e-2)" "unprognostic (1.67e-3)" "unprognostic (5.52e-2)" "unprognostic (1.00e-3)" "unprognostic (1.31e-3)" "unprognostic (5.85e-2)" "unprognostic (7.64e-2)" "unprognostic (7.50e-3)" "unprognostic (1.59e-2)" "unprognostic (4.32e-2)" "unprognostic (1.10e-3)" "unprognostic (4.33e-3)" "unprognostic (1.26e-1)" "unprognostic (3.28e-2)" "unprognostic (2.58e-2)" 28.2 61.0 17.9 14.7 20.9 3.7 42.1 20.7 24.0 30.8 20.6 10.9 35.0 7.6 32.3 59.6 21.4 20.1 25.6 29.4 19.5 20.5 38.8 12.6 25.9 9.5 23.7 15.0 93.4 15.7 19.6 54.5 67.1 40.3 27.6 17.7 15.2 15.7 45.4 7.8 12.1 11.7 30.2 44.1 26.4 23.1 27.5 23.6 5.4 58.6 18.5 7.6 35.5 75.7 1.8 18.6 0.9 1.3 1.1 3.5 1.3 17.8 8.8 28.0 14.3 60.7 59.2 21.0 37.7 50.5 26.8 43.9 17.0 19.1 0.0 56.0 30.8 49.5 10.8 4.8 24.0 36.1 0.0 10.4 18.3 21.6 10.9 41.8 0.0 0.0 40.5 23.4 35.7 35.8 46.9 44.4 7.8 16.2 1.3 63.4 0.0 8.9 0.1 17.4 0.0 17.0 0.0 55.9 0.0 32.3 33.3 12.7 15.3 23.7 0.7 24.6 31.5 3.8 1.0 36.1 23.9 10.4 71.9 10.4 0.0 1.0 0.1 58.1 0.0 19.0 0.9 1.3 0.0 0.2 0.7 0.0 1.8 1.5 0.5 1.0 1.0 3.5 2.9 0.0 1.1 0.1 18.6 0.9 1.3 17.9 20.9 20.7 24.0 19.5 20.5 23.7 15.0 40.3 23.6 160.8 68.5 0.0 0.0 0.0 0.0 0.0 0.0 18.7 86.4 221.6 0.0 939.8 305.1 198.1 0.0 0.0 0.0 0.0 124.7 389.4 0.0 0.0 10.5 0.0 127.3 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 6.4 0.0 0.0 126.5 0.0 0.0 165.0 0.0 0.0 0.0 0.0 0.0 0.0 652.4 0.0 0.0 0.0 TCERG1L FLJ38950 ENSG00000176769 "Transcription elongation regulator 1 like" Q5VWI1 10 131092391-131311721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.7;thyroid gland: 24.1" "Cell type enriched" "Detected in some" 10 "Horizontal cells: 96.9" "Cancer enriched" "Detected in some" 14 "thyroid cancer: 20.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.4;NTERA-2: 1.4;RPMI-8226: 2.2;SuSa: 4.3;U-2 OS: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030816 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030816: AB_10601721" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "unprognostic (8.99e-2)" "unprognostic (1.45e-2)" "unprognostic (3.03e-1)" "unprognostic (6.69e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-1)" "unprognostic (9.71e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.08e-5)" "unprognostic (1.28e-1)" "unprognostic (2.83e-1)" "unprognostic (2.96e-2)" "unprognostic (2.03e-1)" 0.4 1.9 2.7 0.4 4.1 0.4 0.6 3.0 9.7 0.5 0.4 0.0 0.0 0.4 0.6 1.1 0.6 0.4 0.4 0.4 3.8 3.5 0.4 0.4 0.5 0.4 0.9 3.9 5.5 0.8 0.4 4.8 0.4 1.5 1.4 0.4 3.8 0.3 1.3 0.3 1.2 0.4 0.4 2.2 0.6 0.5 1.8 0.0 0.6 24.1 0.0 0.6 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 4.1 3.0 9.7 3.8 3.5 0.9 3.9 1.5 0.0 0.0 0.0 0.0 0.1 0.6 4.5 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.6 0.0 0.0 0.0 96.9 0.0 0.0 0.0 0.0 4.4 0.0 10.1 0.0 0.0 0.8 0.1 0.0 4.2 0.0 3.6 0.0 0.0 0.1 4.7 0.5 0.1 0.0 0.0 0.0 TCF4 "bHLHb19, E2-2, ITF2, SEF2-1B" ENSG00000196628 "Transcription factor 4" P15884 18 55222331-55664787 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Disease mutation, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 85.8" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 425.9;Muller glia cells: 397.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "memory B-cell: 29.7;naive B-cell: 22.0;plasmacytoid DC: 85.8" "Group enriched" "Detected in many" 36 "B-cells: 29.7;dendritic cells: 85.8" "Cell line enhanced" "Detected in many" "HDLM-2: 42.4;SH-SY5Y: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020722, HPA025958" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB020722: , HPA025958: AB_1857849" "unprognostic (2.11e-1)" "unprognostic (9.10e-2)" "unprognostic (8.69e-2)" "unprognostic (7.89e-3)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (3.03e-2)" "unprognostic (8.64e-2)" "unprognostic (1.79e-2)" "unprognostic (3.29e-2)" "unprognostic (2.77e-1)" "unprognostic (8.44e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (1.99e-3)" "unprognostic (2.68e-2)" "unprognostic (2.76e-3)" "prognostic unfavorable (9.95e-4)" 34.6 16.0 20.3 14.4 17.0 10.7 23.5 48.7 32.4 35.4 13.5 14.9 12.0 6.6 27.4 9.6 12.5 16.9 20.4 19.9 23.5 11.9 6.0 6.2 21.9 16.8 16.7 20.3 31.8 7.2 16.2 15.7 32.8 16.1 9.5 10.1 9.2 9.4 13.2 12.1 12.2 10.7 28.4 15.0 14.6 7.4 17.0 17.5 6.4 16.4 12.7 17.0 18.3 14.5 29.7 85.8 0.3 1.2 1.5 0.1 1.7 0.0 1.1 12.0 3.6 2.8 5.0 0.0 6.0 13.4 4.3 5.7 7.4 1.1 9.2 0.0 13.3 0.9 1.5 5.5 5.3 3.0 42.4 4.1 3.6 0.0 0.0 1.3 1.6 0.9 6.5 1.7 6.0 0.2 2.9 15.6 0.5 5.9 6.9 3.7 0.0 2.2 0.0 3.5 0.0 0.7 13.5 5.0 20.5 0.0 0.2 4.2 53.7 0.0 0.5 0.0 3.8 0.5 0.4 15.7 16.3 5.7 0.6 4.7 5.2 9.7 8.2 3.6 1.6 4.7 0.1 1.1 0.1 0.1 1.2 0.1 29.7 0.0 0.0 3.3 22.0 0.0 0.0 0.3 1.5 1.1 85.8 0.1 1.7 20.3 17.0 48.7 26.9 23.5 11.9 16.7 20.3 16.1 17.5 6.0 19.1 128.9 31.3 103.9 238.0 27.8 2.5 30.8 38.7 21.0 78.5 1.9 0.0 1.2 78.3 425.9 0.0 0.0 6.2 1.2 151.6 15.4 12.8 4.4 33.4 23.8 5.2 251.0 98.7 90.2 190.1 63.0 60.8 33.3 0.0 397.9 3.2 0.0 171.1 1.7 54.4 232.8 142.8 6.7 4.4 73.8 2.2 1.9 0.0 10.9 TCF7L1 TCF3 ENSG00000152284 "Transcription factor 7 like 1" Q9HCS4 2 85133410-85310388 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 37.8;Ito cells: 37.4;Leydig cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.2;NTERA-2: 42.5;RH-30: 19.3;T-47d: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071298 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA071298: AB_2686383" "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (3.64e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.05e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (6.16e-5)" "unprognostic (1.79e-2)" "unprognostic (3.59e-3)" "unprognostic (2.73e-1)" "unprognostic (5.17e-3)" "unprognostic (1.69e-1)" "prognostic unfavorable (2.06e-4)" "prognostic unfavorable (2.72e-4)" "unprognostic (1.70e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (5.38e-4)" 21.0 3.9 3.3 6.5 6.4 4.2 28.7 5.1 5.3 28.2 14.7 7.5 14.5 4.1 21.2 11.8 13.8 10.4 9.1 11.6 6.0 3.0 9.3 7.6 11.1 5.5 4.5 3.8 20.3 3.2 11.6 5.7 4.8 6.3 14.0 4.3 16.8 8.8 19.6 13.4 8.3 6.9 17.8 5.9 7.9 6.8 7.3 5.5 2.2 18.6 8.7 6.1 18.0 20.4 3.7 2.0 8.4 1.2 1.8 2.2 0.4 0.9 0.7 14.5 11.0 5.5 1.1 8.8 1.0 3.6 2.5 2.3 2.1 0.9 0.4 1.7 2.3 2.8 2.3 11.0 18.2 1.7 0.8 1.8 0.3 0.8 0.9 0.5 0.8 2.2 0.9 3.4 0.2 0.6 1.2 4.8 0.7 0.3 0.8 2.9 0.6 0.0 0.8 42.5 0.5 0.4 0.3 19.3 0.2 1.2 1.6 0.5 4.5 1.7 7.4 0.5 11.7 18.9 0.3 5.2 2.8 4.2 0.2 1.3 0.5 0.2 0.3 0.1 0.5 2.2 8.4 1.2 2.2 1.2 1.0 1.5 2.1 1.4 1.6 0.4 3.7 1.7 2.2 3.4 1.8 1.0 2.0 1.1 0.4 3.3 6.4 5.1 4.0 6.0 3.0 4.5 3.8 6.3 5.5 6.0 37.8 0.0 11.9 5.4 0.0 6.2 5.1 9.4 11.4 15.7 0.0 5.3 0.0 3.0 22.5 21.0 0.7 0.0 5.0 4.0 12.1 7.6 4.7 5.9 1.5 0.0 0.0 37.4 6.6 3.6 60.4 2.8 3.3 1.8 1.7 5.2 1.3 0.0 26.9 1.4 0.2 6.5 18.1 1.9 10.9 3.0 1.1 0.5 1.2 2.2 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950250-113167678 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 184.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 12.1;non-classical monocyte: 33.1" "Lineage enriched" "Detected in many" 13 "monocytes: 33.1" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in many" 8 "midbrain: 84.5;thalamus: 98.3" "Group enriched" "Detected in all" 5 "midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 27.4 10.3 8.7 18.7 10.0 7.3 46.4 5.4 10.3 27.4 34.2 15.4 28.1 21.0 26.6 14.9 12.6 18.2 15.3 13.5 8.1 17.9 10.2 22.9 26.9 13.9 8.5 9.0 25.6 13.9 16.5 17.9 24.0 10.2 14.4 23.7 13.9 14.9 52.8 13.7 17.6 40.4 18.0 13.9 27.3 24.0 10.6 10.1 6.6 14.3 9.3 7.0 21.5 16.3 0.0 1.7 2.5 33.1 0.0 0.6 1.1 7.1 18.6 20.4 19.7 10.7 7.1 24.4 5.1 9.9 3.5 4.3 12.3 21.6 0.0 5.7 9.5 4.8 5.1 6.9 8.8 4.5 0.8 6.4 5.0 12.4 11.3 11.4 1.9 1.8 12.6 3.2 5.5 9.4 15.1 5.9 4.2 5.2 0.3 4.1 13.9 3.2 1.2 14.6 8.0 10.7 9.0 15.0 3.2 7.7 9.9 0.4 6.3 7.7 7.6 8.1 16.5 4.9 1.1 13.7 3.3 9.6 8.5 10.4 1.3 0.1 0.1 3.3 4.2 7.4 0.1 1.8 0.1 0.6 12.1 0.4 0.0 0.1 0.5 1.7 0.0 0.1 0.3 2.5 0.0 33.1 0.0 0.0 1.1 8.7 10.0 5.4 10.3 8.1 17.9 8.5 9.0 10.2 10.1 20.8 21.6 4.7 23.8 37.8 2.4 10.6 35.7 20.1 34.2 38.4 5.9 36.9 10.0 28.5 5.5 37.0 121.0 0.0 38.6 184.2 40.4 33.1 0.0 57.7 15.1 4.8 19.0 55.3 68.7 2.7 54.7 21.0 30.4 1.0 68.2 36.6 41.7 91.2 45.6 13.4 5.7 90.5 44.3 3.0 23.4 34.8 23.8 4.3 42.7 42.0 TCHP "MGC10854, TpMs" ENSG00000139437 "Trichoplein keratin filament binding" Q9BT92 12 109900264-109983841 "Predicted intracellular proteins" "Apoptosis, Cilium biogenesis/degradation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038638, HPA061543" Supported Supported "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA038638: AB_10670785, HPA061543: AB_2684556" "unprognostic (2.21e-1)" "unprognostic (1.51e-2)" "unprognostic (2.58e-1)" "unprognostic (1.04e-1)" "unprognostic (2.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.42e-2)" "unprognostic (7.94e-2)" "unprognostic (1.59e-2)" "unprognostic (9.75e-2)" "unprognostic (1.15e-3)" "unprognostic (4.63e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.52e-4)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" 8.6 10.4 16.0 11.3 29.3 8.3 9.3 22.9 25.0 10.2 11.2 19.0 7.5 9.9 13.0 10.9 18.3 8.7 8.3 10.3 15.9 11.0 8.5 7.0 10.0 14.5 23.8 13.9 11.3 12.7 12.1 12.1 10.4 18.6 10.7 9.6 11.0 13.4 11.6 10.8 36.1 10.2 15.0 15.9 15.0 10.2 12.5 24.2 10.9 12.0 7.7 15.1 11.4 15.4 3.2 3.3 4.5 5.2 9.2 7.4 4.4 16.2 14.6 7.9 9.4 7.0 7.6 10.6 15.5 8.2 13.6 7.6 9.1 5.7 22.9 4.5 9.0 7.4 13.7 8.6 9.7 12.3 12.2 8.4 16.6 9.0 8.9 8.5 22.4 12.7 6.2 12.0 14.2 10.8 8.6 12.1 14.5 17.8 4.6 11.2 11.2 20.4 22.8 9.5 4.0 14.8 18.8 15.5 19.3 6.1 14.7 11.7 12.4 11.3 12.2 10.9 5.9 11.0 16.3 13.3 13.9 9.7 8.9 19.7 13.4 16.9 16.4 14.8 18.6 14.5 0.0 4.2 3.4 6.2 2.7 4.3 3.2 5.4 7.4 3.3 2.3 5.4 4.2 4.5 9.2 5.2 2.4 7.2 4.4 16.0 29.3 22.9 25.0 15.9 11.0 23.8 13.9 18.6 24.2 17.9 18.4 6.7 7.8 8.8 25.8 12.2 15.3 36.1 11.4 7.0 17.7 9.1 8.3 17.1 25.7 12.1 10.7 23.3 13.3 7.9 7.2 6.6 12.7 6.6 10.1 23.8 14.3 6.2 12.9 33.9 10.3 9.7 6.8 12.6 9.2 14.6 13.8 10.5 26.2 4.3 23.5 12.9 10.0 18.4 34.3 21.7 5.8 14.9 9.8 34.8 TCIM "C8orf4, hTC-1, TC-1, TC1" ENSG00000176907 "Transcriptional and immune response regulator" Q9NR00 8 40153455-40155308 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Alveolar cells type 2: 796.6;Collecting duct cells: 190.1;Distal tubular cells: 164.2;Ductal cells: 262.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 14.6;AF22: 41.5;BJ: 15.6;BJ hTERT+: 40.9;EFO-21: 27.2;HeLa: 26.1;RPTEC TERT1: 20.7;SuSa: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027188 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027188: AB_10601150" "unprognostic (8.88e-2)" "unprognostic (2.76e-2)" "unprognostic (7.89e-3)" "unprognostic (7.95e-2)" "unprognostic (7.33e-3)" "unprognostic (1.87e-3)" "unprognostic (2.11e-1)" "unprognostic (2.32e-1)" "unprognostic (2.93e-2)" "unprognostic (8.15e-2)" "unprognostic (6.23e-2)" "unprognostic (8.19e-2)" "unprognostic (2.54e-2)" "unprognostic (5.32e-3)" "unprognostic (1.39e-1)" "unprognostic (9.13e-3)" "unprognostic (4.48e-2)" 23.5 5.9 1.8 23.2 4.5 0.0 16.0 0.6 5.9 32.1 24.1 1.0 15.6 6.0 14.3 20.3 22.2 4.3 22.1 38.3 2.0 1.7 44.5 54.7 96.5 5.0 2.7 4.3 11.9 24.4 28.9 6.2 50.2 2.3 29.6 15.2 7.9 89.9 16.3 20.2 4.0 21.2 72.4 4.3 26.7 10.7 4.9 1.4 1.3 15.8 14.4 4.8 35.8 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 41.5 0.0 0.0 0.0 0.1 15.6 40.9 0.0 0.2 0.2 0.0 0.0 27.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 26.1 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 1.4 0.0 16.3 0.0 0.0 13.1 0.0 0.4 0.1 0.2 0.3 0.4 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 4.5 0.6 5.9 2.0 1.7 2.7 4.3 2.3 1.4 92.3 796.6 0.0 0.0 0.0 0.0 0.0 0.0 16.0 142.1 190.1 0.0 1.4 164.2 262.6 0.0 0.0 0.0 0.0 95.4 11.4 0.0 0.0 24.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 8.2 0.0 0.0 112.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TCL1A TCL1 ENSG00000100721 "T cell leukemia/lymphoma 1A" P56279 14 95709967-95714196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "blood: 179.4;lymphoid tissue: 63.7" "Group enriched" "Detected in some" 5 "B-cells: 166.3;Spermatogonia: 48.5" "Cancer enriched" "Detected in many" 18 "testis cancer: 64.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 381 "memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8" "Group enriched" "Detected in many" 487 "B-cells: 179.4;dendritic cells: 79.8" "Group enriched" "Detected in some" 157 "Daudi: 71.1;REH: 92.4;U-698: 94.4" "Not detected" "Not detected" "CAB004045, HPA016604" Enhanced Enhanced "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB004045: AB_2179419, HPA016604: AB_1857859" "unprognostic (1.27e-3)" "unprognostic (3.12e-4)" "unprognostic (2.61e-4)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (4.75e-4)" "unprognostic (7.70e-2)" "unprognostic (9.67e-3)" "unprognostic (1.03e-1)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-2)" "unprognostic (2.64e-2)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (4.55e-1)" 0.4 0.2 0.2 53.4 0.2 4.8 0.3 0.2 0.2 0.2 0.9 0.0 0.2 0.0 0.3 0.0 0.8 0.3 0.6 0.3 0.2 0.2 1.1 0.4 3.2 63.7 0.2 0.0 0.3 0.2 0.0 0.2 0.6 0.0 0.4 0.2 0.1 2.9 0.0 0.2 0.2 10.4 0.1 0.2 33.5 0.5 5.3 0.0 4.7 0.8 1.2 53.6 3.6 0.3 179.4 79.8 0.2 0.1 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.5 94.4 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 45.6 0.0 0.0 0.1 179.4 0.1 0.0 0.2 0.0 0.1 79.8 0.0 6.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 2.2 166.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 20.6 48.5 0.0 0.0 0.0 0.0 0.0 TCL1B TML1 ENSG00000213231 "T cell leukemia/lymphoma 1B" O95988 14 95686417-95692643 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.0;lymphoid tissue: 5.4;placenta: 12.7;testis: 7.3" "Cell type enriched" "Detected in some" 13 "Syncytiotrophoblasts: 60.8" "Cancer enriched" "Detected in single" 72 "testis cancer: 8.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "naive B-cell: 13.0;plasmacytoid DC: 5.9" "Group enriched" "Detected in many" 23 "B-cells: 13.0;dendritic cells: 5.9" "Cell line enriched" "Detected in some" 7 "U-698: 104.8" "Not detected" "Not detected" HPA053163 Uncertain Approved Cytosol NA NA Cytosol "HPA053163: AB_2682064" "unprognostic (1.55e-1)" 0.1 0.2 0.1 0.9 0.1 2.5 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 1.4 0.4 0.1 0.0 0.1 0.1 0.1 1.1 0.1 0.1 5.3 0.1 0.0 0.2 0.1 0.0 0.1 12.7 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.1 1.8 0.1 7.3 0.0 0.0 0.1 0.0 5.4 0.1 0.1 13.0 5.9 0.3 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 104.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.3 0.4 0.0 5.9 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.7 0.0 60.8 0.0 0.0 0.0 TCN2 "D22S676, D22S750, TC2" ENSG00000185339 "Transcobalamin 2" P20062 22 30606838-30627278 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 73.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 104.9;Ito cells: 111.1;Kupffer cells: 140.0;Proximal tubular cells: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 19.2;intermediate monocyte: 29.0;non-classical monocyte: 9.8" "Lineage enriched" "Detected in many" 8 "monocytes: 29.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 35.3;HUVEC TERT2: 41.4;Karpas-707: 53.8;RPTEC TERT1: 20.9;TIME: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000837 Approved Cytosol "Secreted to blood" NA NA 13000000 Cytosol "HPA000837: AB_1080235" "unprognostic (6.43e-2)" "prognostic favorable (3.47e-4)" "unprognostic (1.53e-3)" "unprognostic (3.17e-1)" "unprognostic (1.49e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.64e-4)" "unprognostic (1.52e-2)" "unprognostic (2.90e-1)" "unprognostic (1.07e-1)" "unprognostic (4.03e-2)" "unprognostic (1.59e-1)" "unprognostic (6.95e-3)" "unprognostic (4.94e-3)" "unprognostic (2.09e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" 39.8 15.2 6.5 7.2 8.1 2.2 30.0 3.4 10.9 13.1 14.8 9.2 9.6 10.9 15.0 23.9 7.0 11.2 31.7 15.8 6.6 7.3 73.2 8.7 21.7 43.3 8.6 8.5 7.8 6.3 5.7 7.9 8.7 10.7 9.6 13.5 13.5 6.8 23.0 5.4 4.5 30.4 17.6 9.0 24.8 8.4 9.7 5.1 1.9 12.8 4.8 4.6 11.6 10.9 0.0 3.4 0.6 29.0 0.0 0.3 6.5 0.0 2.6 12.1 0.0 7.2 35.3 0.4 0.8 8.8 2.2 3.7 1.2 6.1 0.1 13.4 1.7 0.2 0.4 1.0 0.6 0.7 0.0 0.6 0.0 0.3 0.5 17.3 0.1 9.9 5.8 0.7 1.7 1.5 2.5 41.4 0.0 0.2 53.8 3.6 0.0 0.0 0.9 4.7 3.3 0.3 1.3 1.7 18.1 20.9 0.3 4.2 0.5 0.0 0.1 3.5 0.8 0.1 0.5 24.2 7.8 1.0 0.9 0.3 1.4 0.3 0.0 2.7 0.4 0.1 0.0 19.2 0.0 0.0 29.0 0.3 0.0 0.3 0.2 3.4 0.0 0.1 0.2 0.6 0.0 9.8 0.6 0.1 6.5 6.5 8.1 3.4 10.9 6.6 7.3 8.6 8.5 10.7 5.1 3.0 3.8 6.0 0.8 4.6 7.3 5.0 35.7 2.7 4.5 12.2 19.6 0.4 6.6 5.9 0.8 59.1 104.9 0.0 5.2 0.7 11.2 2.0 4.6 5.0 40.3 1.6 6.4 111.1 140.0 1.0 9.8 32.3 21.9 7.2 23.3 6.0 5.6 49.1 9.2 115.0 28.1 12.9 4.7 0.7 7.8 4.5 0.3 2.1 10.0 2.4 TCP11L1 FLJ11336 ENSG00000176148 "T-complex 11 like 1" Q9NUJ3 11 33039417-33105943 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005769 Approved Approved Cytosol NA Yes Cytosol "HPA005769: AB_2202398" "unprognostic (5.22e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (3.73e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "unprognostic (6.99e-2)" "unprognostic (9.10e-2)" "unprognostic (1.42e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (9.50e-3)" 12.0 10.1 13.0 10.2 19.2 12.8 14.1 15.0 25.3 10.4 15.1 14.7 9.3 11.7 11.1 6.9 9.8 8.2 15.5 10.6 13.9 14.9 11.6 8.1 9.4 8.8 16.8 16.1 11.1 12.6 9.9 12.5 13.3 21.2 10.3 14.4 7.4 8.7 14.4 6.6 10.4 22.9 16.8 16.2 9.8 10.0 10.3 11.1 8.1 7.4 5.0 10.7 10.6 10.9 2.6 11.1 13.1 6.1 4.5 5.7 3.1 6.8 12.5 6.3 6.0 11.0 12.4 4.3 10.0 8.4 7.7 10.4 6.4 3.3 6.9 2.8 19.2 11.5 11.0 8.4 7.7 10.9 8.9 6.7 4.5 13.8 4.6 7.2 4.3 6.4 10.0 9.7 7.9 15.1 8.8 7.5 10.1 2.9 8.4 19.2 9.9 4.6 1.8 4.7 5.1 4.6 5.4 13.1 1.2 7.0 2.6 5.2 10.7 25.2 16.4 4.6 8.5 4.0 1.9 11.4 13.6 19.8 15.2 10.4 10.5 10.3 8.0 9.8 2.3 10.6 13.1 6.1 8.3 3.6 3.7 3.5 2.2 2.0 4.0 5.9 2.6 2.0 2.6 3.6 4.5 0.9 11.1 5.7 3.1 13.0 19.2 15.0 22.9 13.9 14.9 16.8 16.1 21.2 11.1 8.9 0.6 3.0 8.6 2.1 7.2 2.8 5.1 0.0 1.2 0.0 3.9 2.7 1.7 3.6 8.4 3.5 4.2 0.0 3.5 17.4 3.2 3.9 4.6 1.3 5.8 7.9 1.7 4.9 5.3 4.5 1.7 3.7 0.0 31.5 1.0 1.5 5.1 1.5 2.5 4.4 4.9 0.0 7.3 7.6 5.5 2.3 3.9 5.0 1.2 3.3 TCTA ENSG00000145022 "T cell leukemia translocation altered" P57738 3 49412206-49416475 "Disease related genes, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007342 Approved Approved Cytosol NA NA Cytosol "HPA007342: AB_2202399" "unprognostic (5.58e-2)" "unprognostic (4.33e-2)" "unprognostic (6.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.17e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "prognostic favorable (6.76e-4)" "unprognostic (3.74e-1)" "unprognostic (3.38e-3)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favorable (5.00e-15)" "unprognostic (1.68e-1)" "unprognostic (1.96e-1)" "unprognostic (3.43e-1)" "unprognostic (6.41e-3)" 15.4 29.3 21.8 9.2 21.9 7.9 16.3 12.5 26.1 18.3 16.9 23.1 19.5 14.0 13.6 46.9 12.8 20.1 19.3 13.1 20.6 20.8 35.6 27.2 17.2 14.3 23.2 18.5 19.4 18.5 17.9 28.4 19.1 22.2 25.2 21.8 23.3 16.0 20.0 10.5 7.8 19.4 16.5 25.6 15.1 16.3 9.3 12.8 12.6 34.1 10.2 11.4 13.0 8.9 9.5 10.1 14.6 28.0 13.4 13.0 13.4 5.9 7.3 4.8 7.1 21.2 9.3 6.3 12.3 9.2 12.6 10.6 4.3 6.5 7.1 9.1 29.1 14.5 6.9 9.3 12.4 10.3 10.6 6.4 11.8 9.6 5.5 12.8 5.1 15.6 20.0 13.0 13.9 11.2 12.1 12.9 5.7 4.3 16.3 30.6 5.5 6.1 4.5 3.9 11.3 17.1 3.7 5.2 16.7 21.5 7.9 12.8 4.2 14.7 16.3 13.4 10.1 13.9 4.8 11.7 9.5 5.9 19.6 4.6 9.0 11.8 4.8 22.3 9.0 13.0 12.7 11.5 14.6 13.0 21.9 7.6 8.0 8.4 10.0 6.6 9.5 10.4 11.0 13.2 13.4 28.0 10.1 10.7 13.4 21.8 21.9 12.5 26.1 20.6 20.8 23.2 18.5 22.2 12.8 23.8 17.0 11.9 9.0 2.4 10.1 11.0 25.5 29.4 12.5 26.2 11.8 21.6 39.7 13.5 5.9 10.8 32.5 0.0 10.0 10.1 10.8 18.7 5.7 27.2 21.4 9.5 16.8 12.3 20.2 11.1 14.4 13.1 13.5 16.2 16.3 20.7 12.8 21.0 15.2 42.1 10.7 6.5 15.1 7.2 6.1 4.0 16.7 20.1 15.1 7.0 TCTEX1D2 MGC33212 ENSG00000213123 "Tctex1 domain containing 2" Q8WW35 3 196291219-196318299 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 37.4" "Group enriched" "Detected in many" 4 "Ciliated cells: 301.2;Distal tubular cells: 102.8;Early spermatids: 174.6;Spermatocytes: 192.1;Spermatogonia: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 16.6;dendritic cells: 10.9;T-cells: 18.3" "Cell line enhanced" "Detected in many" "T-47d: 38.9" HPA049555 Approved Cytosol NA NA Cytosol "HPA049555: AB_2680816" "unprognostic (1.16e-1)" "prognostic favorable (7.83e-4)" "unprognostic (5.34e-2)" "unprognostic (1.59e-2)" "unprognostic (1.47e-1)" "unprognostic (5.63e-2)" "unprognostic (2.65e-2)" "unprognostic (4.61e-1)" "unprognostic (9.98e-3)" "unprognostic (3.99e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (6.23e-4)" "unprognostic (3.73e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" 4.3 7.4 20.5 5.1 21.6 5.3 7.0 15.0 18.3 5.2 5.3 7.0 7.2 4.7 8.4 10.4 10.7 37.4 6.3 6.3 15.4 18.6 11.8 2.3 9.1 9.1 12.1 15.8 8.7 6.6 6.8 18.8 4.1 10.6 6.4 4.9 6.8 7.6 6.2 3.1 9.2 3.0 5.3 8.7 4.1 5.2 24.2 8.1 6.8 11.2 5.1 6.5 4.9 5.9 16.6 10.9 1.4 2.3 2.9 18.3 5.6 13.6 10.2 15.7 10.2 4.1 8.1 2.2 5.6 3.2 6.0 6.7 3.5 16.7 8.8 10.3 4.0 2.3 14.4 6.4 5.1 5.6 7.7 5.7 3.4 10.1 1.4 4.5 2.2 0.3 4.0 13.5 4.9 6.2 10.9 3.5 17.2 4.9 4.4 11.5 33.5 11.5 11.3 11.1 12.7 19.4 14.5 3.1 3.6 12.8 5.6 19.8 16.7 12.7 6.4 11.2 6.5 38.9 6.5 7.9 5.8 2.5 2.3 6.5 7.5 14.3 18.9 17.4 4.3 9.9 0.0 2.3 1.2 9.2 0.8 5.6 16.6 11.6 7.3 6.0 9.5 7.4 7.3 1.4 2.9 0.6 10.9 18.3 5.6 20.5 21.6 15.0 18.3 15.4 18.6 12.1 15.8 10.6 8.1 8.9 6.9 10.0 18.9 14.7 17.4 5.0 30.6 301.2 39.8 34.9 9.8 24.1 102.8 23.6 174.6 10.5 4.0 0.0 9.4 7.0 11.6 10.3 8.1 3.4 13.5 28.6 24.6 14.7 3.2 30.9 16.1 6.3 18.6 19.8 9.5 29.8 9.2 3.5 29.4 35.2 18.4 12.9 7.3 192.1 110.5 15.9 5.1 11.5 11.9 14.4 TDGF1 "CR, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582463 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7" "Cell type enriched" "Detected in some" 18 "Distal tubular cells: 102.8" "Group enriched" "Detected in many" 9 "colorectal cancer: 6.4;testis cancer: 27.1" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 9.5;NTERA-2: 43.2;SuSa: 27.0" "Group enriched" "Detected in many" 5 "cerebellum: 12.5;pons and medulla: 9.1" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" NA NA Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.6 3.9 0.6 0.6 0.8 0.0 0.6 0.6 0.6 0.6 2.1 0.6 0.6 0.2 0.7 1.3 0.6 0.0 0.6 0.6 1.0 0.6 9.9 0.8 0.6 0.6 0.9 0.6 9.7 0.6 0.0 0.6 0.6 0.6 0.6 4.3 1.1 0.6 0.6 1.0 0.0 0.6 0.8 1.0 16.7 2.4 0.6 0.6 5.2 2.1 0.6 0.6 0.6 0.6 1.0 0.7 3.7 0.6 1.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 9.5 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 43.2 1.7 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.6 0.5 0.5 0.3 0.3 0.6 0.4 0.3 0.1 1.0 0.6 0.4 3.7 1.5 0.4 0.7 0.2 0.1 0.6 0.8 0.6 0.6 1.0 0.6 0.9 0.6 0.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 5.2 0.0 0.0 102.8 0.1 4.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 2.4 0.0 0.0 0.7 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 TDO2 "TDO, TPH2" ENSG00000151790 "Tryptophan 2,3-dioxygenase" P48775 4 155854738-155920406 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "liver: 187.9" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 1048.1" "Cancer enriched" "Detected in many" 18 "liver cancer: 35.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.6;HDLM-2: 16.7;U-87 MG: 9.8" "Group enriched" "Detected in some" 9 "cerebellum: 7.0;hippocampal formation: 5.9" "Not detected" "Not detected" HPA039611 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039611: " "unprognostic (1.10e-1)" "unprognostic (3.00e-3)" "unprognostic (3.84e-2)" "unprognostic (1.95e-1)" "unprognostic (7.06e-2)" "unprognostic (3.50e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (4.68e-8)" "unprognostic (7.99e-2)" "unprognostic (9.29e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-2)" 0.2 0.5 0.2 2.5 0.5 0.0 0.1 0.1 2.0 0.1 0.2 0.0 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 1.5 0.2 0.2 187.9 0.8 2.9 0.2 0.7 0.1 0.1 0.0 5.8 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 1.1 0.4 0.2 1.5 0.3 0.1 0.0 0.0 0.1 0.0 0.4 1.2 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.2 0.0 0.1 0.0 0.0 16.7 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.9 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 1.3 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.1 0.4 0.4 0.0 2.7 0.0 0.0 9.8 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 2.0 1.5 0.2 0.2 0.7 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.4 132.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 23.3 0.0 0.0 0.1 0.3 0.0 1048.1 0.9 0.0 0.0 25.2 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.8 0.2 0.2 0.0 0.2 0.0 0.0 0.0 TDRD3 FLJ21007 ENSG00000083544 "Tudor domain containing 3" Q9H7E2 13 60396457-60573878 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "granulocytes: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034925, HPA067153" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB034925: AB_2240523, HPA067153: AB_2732759" "unprognostic (8.52e-2)" "unprognostic (3.19e-1)" "unprognostic (2.23e-1)" "prognostic favorable (2.77e-4)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (7.37e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (6.18e-3)" "unprognostic (9.62e-2)" "unprognostic (9.95e-2)" "unprognostic (3.68e-2)" "unprognostic (4.40e-2)" "unprognostic (1.27e-3)" 13.7 12.0 13.0 10.3 14.7 6.9 16.9 13.8 14.2 16.7 17.2 11.7 14.2 12.9 15.2 14.2 16.5 14.4 12.7 16.7 12.9 10.6 16.2 13.5 16.9 11.3 13.5 14.8 20.6 21.3 15.3 15.4 12.4 17.7 15.5 15.5 11.1 12.5 14.8 42.4 15.2 16.7 19.0 16.8 12.9 14.8 15.9 15.0 18.7 16.9 18.6 12.1 19.0 15.4 3.8 7.2 2.3 3.5 3.0 6.9 2.1 4.4 4.9 10.9 25.4 4.4 9.5 6.5 5.1 5.8 6.0 3.9 3.2 7.4 10.9 2.1 7.5 5.1 6.3 8.9 7.5 6.5 8.2 6.8 20.3 9.4 6.2 8.5 14.2 10.6 6.4 10.7 3.5 10.6 12.5 8.1 9.0 4.5 6.7 6.5 4.8 12.7 7.4 8.3 16.1 3.8 6.8 5.3 7.2 8.2 5.9 9.7 11.6 7.4 9.0 18.5 7.8 4.6 6.2 6.8 3.8 3.9 4.3 5.6 13.3 11.5 9.4 3.6 7.4 11.7 0.5 2.3 2.3 5.5 3.5 3.8 3.8 6.2 6.2 3.3 2.7 5.2 6.4 0.1 3.0 2.5 7.2 6.9 2.1 13.0 14.7 13.8 14.2 12.9 10.6 13.5 14.8 17.7 15.0 20.8 28.8 13.4 9.0 7.0 29.0 40.4 5.1 33.5 25.0 10.4 51.1 7.3 18.3 11.5 16.8 12.8 9.3 0.0 15.4 8.8 8.3 6.1 143.8 7.2 6.3 19.1 16.7 8.0 9.4 17.0 17.5 11.6 18.6 8.2 13.8 13.4 9.6 15.3 17.3 9.9 28.8 6.5 7.5 33.9 15.5 5.8 5.6 13.8 13.8 6.3 TDRKH TDRD2 ENSG00000182134 "Tudor and KH domain containing" Q9Y2W6 1 151770107-151791416 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 46.5" "Cell type enhanced" "Detected in many" 10 "Late spermatids: 48.0;Spermatocytes: 46.8;Spermatogonia: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016419, HPA019625" Approved Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA016419: AB_1857870, HPA019625: AB_1857871" "unprognostic (2.27e-3)" "unprognostic (2.89e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (2.63e-1)" "unprognostic (2.91e-1)" "unprognostic (2.06e-1)" "unprognostic (3.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.63e-2)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-3)" "unprognostic (1.14e-1)" 2.7 3.5 8.8 4.2 10.9 1.6 4.6 18.0 9.9 2.6 3.3 6.3 7.5 2.5 2.0 6.2 2.1 2.4 2.3 3.6 8.8 8.9 3.1 3.7 4.4 5.4 8.1 7.8 1.4 3.5 46.5 5.5 3.7 15.9 6.2 4.3 2.9 6.4 6.7 4.5 2.5 2.5 3.1 7.6 5.9 3.1 19.3 4.9 8.0 7.3 1.0 5.2 3.7 2.0 3.8 5.3 5.3 7.0 7.3 13.1 4.2 6.3 5.5 4.9 11.4 0.3 0.5 4.8 1.1 0.6 3.4 2.3 3.6 9.2 7.4 10.1 0.4 8.1 3.9 7.2 7.5 5.3 19.2 5.1 7.4 1.6 2.5 2.2 1.4 1.2 0.6 3.0 7.3 3.1 1.0 3.6 14.7 5.7 6.7 1.0 17.2 11.7 2.2 3.8 9.5 9.6 1.4 3.1 15.4 6.0 3.1 7.2 11.8 7.9 6.4 7.4 9.4 13.9 5.6 1.4 1.6 2.9 5.0 6.1 13.8 16.9 8.3 7.4 6.0 2.2 5.3 0.9 1.9 8.8 4.3 13.1 3.8 8.2 8.8 2.0 3.6 6.0 7.5 0.7 7.3 7.0 5.3 9.4 4.2 8.8 10.9 18.0 9.9 8.8 8.9 8.1 7.8 15.9 4.9 3.0 8.8 0.9 1.9 0.2 3.4 2.6 0.0 1.4 2.3 7.0 3.9 2.2 1.7 2.5 17.5 1.0 0.1 0.0 2.2 2.5 0.4 1.7 4.6 0.6 4.4 6.4 0.0 1.3 1.3 48.0 0.3 1.3 1.7 3.6 0.9 1.5 1.8 0.0 2.1 1.3 3.0 12.9 1.2 46.8 21.1 0.1 2.1 1.3 1.0 0.9 TDRP "C8orf42, INM01, TDRP1, TDRP2" ENSG00000180190 "Testis development related protein" Q86YL5 8 489792-545781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 41.9" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 125.8;Syncytiotrophoblasts: 227.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 28.9;HBEC3-KT: 13.9;hTERT-RPE1: 12.3;SuSa: 14.8" "Low region specificity" "Detected in all" HPA008462 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA008462: AB_1845777" "unprognostic (1.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.51e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (4.13e-2)" "unprognostic (1.08e-1)" "prognostic favorable (9.37e-4)" "unprognostic (1.74e-1)" "unprognostic (3.43e-2)" "unprognostic (5.46e-4)" "unprognostic (2.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.50e-1)" 5.7 9.0 7.7 6.1 13.1 0.5 11.0 10.4 9.2 8.5 4.9 3.6 8.4 2.3 9.4 9.8 5.7 12.9 9.9 3.7 7.4 10.3 14.3 9.4 9.6 3.9 6.3 3.6 13.0 13.7 15.2 11.1 41.9 8.4 12.5 2.8 17.7 6.2 12.3 2.3 3.3 2.8 5.0 4.6 2.6 3.6 8.1 3.2 3.0 22.7 3.2 6.3 9.9 12.8 0.4 0.0 0.0 0.1 0.0 0.2 1.1 4.8 4.9 8.6 0.0 0.0 0.0 28.9 2.8 1.7 2.7 2.4 0.0 0.0 0.0 1.2 0.9 2.7 1.0 0.0 13.9 3.4 0.0 0.4 0.0 0.0 7.2 3.3 0.0 2.1 3.4 11.1 0.0 5.2 12.3 0.4 0.0 0.6 0.0 2.9 0.0 0.0 0.0 10.2 0.0 1.0 0.0 0.0 0.0 9.0 7.3 2.6 4.1 0.0 8.7 2.1 14.8 2.9 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 7.7 13.1 10.4 7.5 7.4 10.3 6.3 3.6 8.4 3.2 20.8 9.6 0.9 22.5 20.8 15.6 4.1 10.2 32.1 14.8 17.4 2.0 125.8 36.5 9.2 51.1 18.0 0.0 0.0 4.2 49.4 8.3 25.0 0.0 17.5 11.0 9.5 7.5 7.4 3.8 11.1 6.6 1.9 8.5 0.0 1.5 8.3 4.4 0.0 6.0 15.4 11.0 19.4 16.0 21.2 5.9 6.0 227.6 0.0 0.0 9.2 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Exocrine glandular cells: 11.1;Extravillous trophoblasts: 21.4;Hofbauer cells: 12.7;monocytes: 20.8;Pancreatic endocrine cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: AB_2676320, HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 5.1 2.0 10.5 8.5 13.6 10.8 5.2 5.1 10.3 3.3 7.6 10.7 2.0 9.4 5.5 5.0 5.2 4.0 5.5 3.4 10.3 7.4 2.9 4.0 6.2 8.8 7.9 4.6 2.7 6.4 2.5 4.5 7.9 7.1 3.7 3.2 3.9 5.8 4.6 3.9 10.1 8.3 2.1 7.4 5.9 10.6 9.1 9.5 16.0 5.1 7.1 11.8 6.1 3.5 0.8 5.7 1.4 2.2 0.1 3.7 0.7 7.9 18.5 4.4 6.6 0.4 0.7 12.0 6.4 2.5 7.7 7.4 6.6 15.1 12.1 13.4 1.0 3.0 21.3 1.5 6.8 1.5 14.3 7.6 3.2 10.2 6.5 0.3 6.1 8.9 0.1 2.3 5.2 1.6 1.0 3.0 11.3 5.0 15.2 1.2 30.8 12.7 13.9 5.7 6.8 19.6 10.4 6.8 8.4 2.1 6.8 12.6 7.4 6.6 7.8 4.6 1.0 12.4 6.1 3.8 5.4 9.2 16.4 10.5 8.9 3.7 7.3 6.9 7.0 8.7 0.0 1.2 1.4 1.5 2.2 1.0 0.3 2.2 3.7 1.7 0.8 1.4 0.4 0.4 0.1 2.0 5.7 1.6 0.7 10.5 13.6 5.1 10.3 10.3 7.4 7.9 4.6 7.1 9.5 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.2 1.8 0.0 3.9 3.3 8.1 0.0 0.0 0.0 0.0 11.1 21.4 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 20.8 0.0 0.0 10.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 TELO2 "hCLK2, KIAA0683, TEL2" ENSG00000100726 "Telomere maintenance 2" Q9Y4R8 16 1493344-1510457 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041348, HPA041473" Approved Supported "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA041348: AB_10794514, HPA041473: AB_10795593" "unprognostic (1.27e-1)" "unprognostic (2.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.91e-1)" "unprognostic (3.08e-2)" "unprognostic (2.94e-2)" "unprognostic (5.99e-3)" "unprognostic (1.47e-3)" "unprognostic (2.21e-1)" "unprognostic (6.75e-2)" "unprognostic (3.15e-3)" 13.8 11.7 9.2 14.2 9.0 19.3 14.3 21.9 14.9 11.1 11.3 15.7 11.4 17.3 11.7 14.8 12.9 11.8 13.4 9.6 9.9 9.1 9.6 11.1 8.8 14.4 10.2 15.9 12.1 18.5 8.6 10.3 12.1 10.9 12.3 3.6 11.1 18.6 11.0 18.9 23.5 16.2 10.4 8.3 20.7 14.0 9.0 10.4 17.3 10.6 11.2 14.8 10.6 10.5 8.3 8.2 3.2 11.4 3.8 5.1 5.0 8.1 12.3 3.8 7.3 1.5 1.6 14.9 13.1 2.5 6.3 4.6 15.7 7.9 12.1 11.4 2.0 3.1 8.7 2.7 4.9 1.2 7.0 23.8 6.9 14.2 9.0 2.5 8.7 10.5 3.1 1.9 5.9 1.2 2.1 3.7 10.6 17.8 4.4 2.5 27.7 10.3 23.5 12.3 2.9 10.3 30.8 5.4 12.3 2.3 7.8 16.1 9.0 11.3 10.7 4.1 1.5 10.0 10.6 5.9 13.8 9.6 13.3 10.8 8.0 5.1 22.1 4.3 12.4 11.5 0.0 6.8 3.2 5.1 8.6 5.1 5.4 3.6 4.3 8.2 8.3 4.2 3.2 0.5 3.8 11.4 5.0 3.3 5.0 9.2 9.0 21.9 14.9 9.9 9.1 10.2 15.9 10.9 10.4 0.0 2.4 15.2 7.8 6.2 12.1 1.3 10.2 0.0 2.3 8.7 11.8 20.6 5.0 7.2 0.8 5.9 10.2 23.3 6.1 15.9 10.4 5.5 2.3 10.5 16.7 17.5 2.4 9.8 12.1 1.6 6.9 4.2 8.5 13.6 12.8 17.5 6.3 5.8 13.8 5.7 19.6 12.9 9.2 9.3 7.4 5.6 18.4 10.0 18.9 3.4 TERT "EST2, hEST2, TCS1, TP2, TRT" ENSG00000164362 "Telomerase reverse transcriptase" O14746 5 1253147-1295069 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase" "Cancer-related genes, Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 1.2;Spermatogonia: 1.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 62.6;fHDF/TERT166: 59.4;HBEC3-KT: 120.8;hTEC/SVTERT24-B: 76.3;LHCN-M2: 34.4;TIME: 98.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA054641, HPA065897" Supported Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA054641: AB_2682554, HPA065897: AB_2685576" "unprognostic (1.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.24e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-3)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "unprognostic (6.91e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (9.16e-4)" "unprognostic (8.84e-11)" "unprognostic (1.92e-1)" "unprognostic (2.15e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 7.1 0.9 3.4 0.0 0.0 0.2 0.1 1.1 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 1.0 0.4 5.0 0.0 12.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 31.3 62.6 0.5 0.0 23.8 4.3 8.0 0.1 0.1 0.7 0.0 59.4 0.0 0.0 0.2 120.8 5.1 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.3 0.0 3.1 76.3 0.8 0.1 0.2 0.5 0.6 0.1 34.4 0.0 0.2 1.7 0.4 0.0 0.2 0.9 0.0 0.8 3.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 98.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 0.0 TES "DKFZP586B2022, TESS-2, TESTIN" ENSG00000135269 "Testin LIM domain protein" Q9UGI8 7 116210493-116258783 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 226.3;Early spermatids: 327.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 51.4;hTCEpi: 58.1;SK-BR-3: 58.3" "Low region specificity" "Detected in single" "HPA015269, HPA018123" Approved Supported "Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" "Plasma membrane, Cell Junctions" "HPA015269: AB_1857899, HPA018123: AB_1857900" "unprognostic (9.81e-2)" "unprognostic (5.53e-3)" "unprognostic (4.79e-2)" "unprognostic (1.31e-1)" "unprognostic (4.01e-1)" "unprognostic (6.08e-3)" "unprognostic (1.84e-3)" "unprognostic (4.81e-3)" "unprognostic (8.81e-3)" "unprognostic (6.19e-3)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.60e-2)" "prognostic favorable (8.71e-5)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (2.36e-2)" "unprognostic (3.86e-1)" 12.1 2.9 1.2 36.4 1.5 8.6 22.1 0.8 1.2 42.4 53.1 1.5 43.9 9.3 47.6 21.2 22.6 19.5 15.3 7.9 1.6 1.4 14.3 4.6 16.8 20.3 1.9 0.7 17.1 12.3 3.1 4.2 21.2 3.3 26.1 16.8 5.0 19.0 50.9 5.2 9.1 27.4 84.5 3.0 19.1 25.2 18.4 0.7 17.1 26.3 11.2 18.4 71.6 33.9 26.8 21.9 56.8 39.6 49.0 40.5 34.7 24.4 5.2 5.9 0.0 2.6 6.7 13.8 12.8 6.2 2.4 2.3 12.9 27.3 0.0 51.4 8.9 0.3 25.2 3.1 18.8 5.9 12.1 10.1 2.4 12.1 6.3 15.7 11.1 0.0 14.9 58.1 8.3 21.1 16.6 6.7 0.0 2.5 8.6 0.6 5.0 0.0 0.1 3.9 28.4 14.9 0.0 0.0 9.6 24.2 9.4 2.7 25.5 18.7 58.3 14.1 17.9 0.0 4.5 11.3 0.1 0.3 18.9 0.1 20.5 9.9 0.2 1.6 5.7 19.4 56.8 20.2 53.4 40.5 32.6 39.0 26.8 31.0 36.6 21.9 23.8 31.0 35.0 10.5 49.0 39.6 5.4 31.5 34.7 1.2 1.5 0.8 1.2 1.6 1.4 1.9 0.7 3.3 0.7 226.3 36.4 52.3 147.2 177.9 2.3 14.5 38.2 84.3 97.8 34.9 11.8 16.7 18.3 104.8 327.4 24.0 101.5 0.0 97.9 69.1 27.0 83.0 17.4 9.9 14.9 1.6 48.4 15.4 52.9 82.2 1.7 62.3 27.0 36.1 57.8 23.0 142.2 58.6 0.4 10.3 12.6 6.5 20.6 18.2 9.7 107.3 24.4 57.4 44.4 125.3 TESC "CHP3, FLJ20607, TSC" ENSG00000088992 Tescalcin Q96BS2 12 117038923-117099479 "Predicted intracellular proteins" "Differentiation, Protein transport, Transport" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.8;salivary gland: 92.6" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 186.0;Exocrine glandular cells: 427.3;Late spermatids: 257.6;Pancreatic endocrine cells: 170.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 55.8" "Lineage enriched" "Detected in all" 5 "monocytes: 55.8" "Cell line enhanced" "Detected in many" "HMC-1: 64.5;NB-4: 103.8;OE19: 43.8;U-937: 34.5" "Low region specificity" "Detected in all" HPA053200 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053200: AB_2682079" "unprognostic (4.53e-3)" "unprognostic (5.98e-2)" "unprognostic (6.50e-2)" "unprognostic (2.23e-3)" "unprognostic (6.31e-2)" "unprognostic (2.05e-3)" "unprognostic (4.98e-3)" "unprognostic (3.35e-1)" "unprognostic (4.35e-1)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.69e-2)" "unprognostic (8.65e-2)" "unprognostic (2.57e-1)" "unprognostic (1.56e-2)" "unprognostic (5.67e-3)" 1.8 8.4 5.0 2.4 12.1 25.5 2.3 1.2 6.8 1.8 1.2 1.8 19.4 1.8 1.3 32.9 1.3 1.3 45.8 13.2 6.2 2.2 4.6 1.9 2.9 1.8 2.4 3.3 1.5 40.5 0.7 4.0 2.5 2.2 2.5 0.7 0.3 92.6 24.4 1.3 1.8 1.7 1.4 1.6 2.7 34.4 5.0 2.2 1.2 2.1 1.2 2.5 6.5 2.3 1.9 8.5 11.3 55.8 2.5 2.3 3.9 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 2.3 0.7 0.0 0.0 0.1 1.2 0.0 0.0 6.3 4.1 17.7 1.4 12.1 0.0 7.5 64.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 8.4 0.1 0.0 0.3 14.6 103.8 1.4 43.8 0.0 0.0 0.0 8.3 9.0 2.3 2.7 0.9 0.0 0.0 0.5 0.1 0.0 8.1 0.0 0.0 0.2 0.0 0.0 2.7 6.1 0.0 0.0 34.5 0.0 0.0 11.9 11.3 1.8 14.9 0.1 1.3 0.6 2.3 8.5 1.9 0.0 1.0 3.0 2.5 55.8 0.6 0.7 3.9 5.0 12.1 1.2 6.8 6.2 2.2 2.4 3.3 2.2 2.2 0.0 0.0 14.1 0.2 2.4 0.6 39.2 186.0 0.0 1.2 12.2 0.0 0.4 63.0 131.7 86.8 9.5 0.0 116.8 427.3 0.6 1.2 3.9 71.4 0.2 36.5 0.0 1.7 1.8 23.5 257.6 2.8 6.3 69.2 10.0 0.1 0.0 170.4 0.0 3.2 2.8 1.4 142.3 48.4 44.5 16.4 1.8 1.0 33.7 0.2 0.7 TESMIN "CXCDC2, MTL5" ENSG00000132749 "Testis expressed metallothionein like protein" Q9Y4I5 11 68707440-68751564 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 81.0" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 5.0;Ductal cells: 5.8;Exocrine glandular cells: 3.4;Extravillous trophoblasts: 3.7;Pancreatic endocrine cells: 5.1;Proximal tubular cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 10.7;T-47d: 21.2" "Not detected" "Not detected" HPA018539 Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA018539: " "unprognostic (1.99e-1)" "unprognostic (3.97e-3)" "unprognostic (1.34e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (3.22e-2)" "unprognostic (6.71e-2)" "unprognostic (1.76e-2)" "unprognostic (6.99e-3)" "unprognostic (2.54e-1)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (8.47e-2)" "unprognostic (5.27e-2)" "unprognostic (6.39e-2)" "unprognostic (2.99e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-1)" 0.3 0.5 0.3 1.6 1.4 4.8 3.3 0.1 0.6 0.6 1.9 0.0 3.8 1.0 0.5 1.2 1.3 1.3 1.0 0.4 0.2 0.9 3.2 0.3 0.4 0.9 0.6 0.4 0.8 2.6 2.6 1.9 0.4 1.8 1.7 2.2 0.6 2.5 5.2 0.1 0.5 1.2 0.3 0.7 1.2 0.6 81.0 0.1 5.5 1.5 0.9 2.0 0.5 0.7 0.4 0.1 2.8 1.1 0.0 1.1 0.4 6.2 2.7 1.2 0.0 0.0 0.0 3.2 1.4 0.7 2.0 0.9 0.8 6.3 2.5 1.4 0.2 0.0 3.0 0.9 1.2 1.6 2.6 2.2 1.8 0.9 0.0 0.0 1.3 10.7 0.0 3.4 0.1 2.0 2.7 0.6 3.0 3.8 4.8 0.3 4.1 0.7 3.6 6.5 2.9 2.8 1.6 0.3 0.7 2.3 0.1 4.0 4.3 0.0 1.3 0.0 3.5 21.2 8.7 2.3 0.2 0.4 0.1 0.1 1.9 1.7 2.4 0.1 3.7 1.7 0.0 1.0 1.0 0.3 0.4 0.6 0.0 1.1 0.2 0.1 0.4 0.4 0.3 2.8 0.0 1.1 0.1 0.8 0.4 0.3 1.4 0.1 0.6 0.2 0.9 0.6 0.4 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.7 5.0 5.8 0.0 0.0 0.0 0.0 3.4 3.7 0.0 0.0 2.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.1 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 TET3 "hCG_40738, MGC22014" ENSG00000187605 "Tet methylcytosine dioxygenase 3" O43151 2 73986404-74108176 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 44.0;Suprabasal keratinocytes: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050845 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA050845: AB_2681256" "unprognostic (1.07e-2)" "unprognostic (1.21e-2)" "unprognostic (3.08e-1)" "unprognostic (1.12e-2)" "unprognostic (4.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (9.83e-2)" "unprognostic (7.74e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.05e-1)" "unprognostic (5.30e-1)" "unprognostic (1.55e-2)" "unprognostic (1.10e-1)" 2.9 2.3 7.2 6.1 10.8 20.9 3.9 26.0 17.1 3.2 5.1 20.6 0.5 6.7 2.9 1.9 10.2 3.0 3.3 1.6 7.1 3.3 2.6 5.1 5.6 4.3 12.0 9.5 2.9 3.6 3.5 4.2 5.7 12.4 3.6 5.5 5.9 5.9 1.8 1.8 18.9 7.2 2.7 5.3 5.5 5.3 2.1 11.7 0.6 3.4 1.7 5.1 4.0 5.0 1.1 1.4 2.5 2.2 0.4 0.9 0.9 6.2 5.5 10.5 6.4 0.9 1.0 19.4 1.3 1.7 2.5 2.0 11.8 5.8 10.5 2.6 1.7 1.1 6.7 9.3 3.7 2.6 4.5 3.7 13.4 4.6 4.0 3.9 14.0 8.3 1.5 9.8 3.1 7.3 3.1 3.8 7.4 9.1 3.5 1.4 10.3 6.9 9.2 5.9 5.4 1.9 10.5 6.6 3.6 2.8 11.7 13.2 11.3 2.8 7.5 3.6 4.4 4.8 11.4 4.8 2.7 11.4 1.3 4.7 3.1 1.3 9.1 1.8 9.8 3.5 0.5 2.0 1.0 0.4 2.2 0.9 1.1 0.5 0.5 1.4 0.9 0.7 0.6 2.5 0.4 0.7 1.4 0.0 0.9 7.2 10.8 26.0 17.1 7.1 3.3 12.0 9.5 12.4 11.7 6.0 7.0 0.0 3.0 44.0 14.5 2.8 5.1 10.7 9.1 1.8 19.6 5.5 0.0 3.0 2.9 5.6 9.5 23.3 3.8 27.5 6.6 4.8 2.3 4.4 8.9 9.5 5.8 3.7 27.8 0.6 0.6 13.8 10.1 9.0 8.4 1.5 5.1 10.5 2.8 1.2 5.8 0.0 5.3 0.5 3.1 59.6 2.1 4.3 6.4 4.8 TEX14 CT113 ENSG00000121101 "Testis expressed 14, intercellular bridge forming factor" Q8IWB6 17 58556678-58692055 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 52.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 13.5;Spermatocytes: 29.0;Spermatogonia: 15.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 9.1;Karpas-707: 11.9;MCF7: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030620, HPA077020" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA030620: AB_10601598, HPA077020: AB_2732327" "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-1)" "unprognostic (9.49e-2)" "unprognostic (2.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (6.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.61e-3)" "unprognostic (2.67e-2)" "unprognostic (8.10e-2)" "unprognostic (1.76e-9)" "unprognostic (1.77e-1)" "unprognostic (2.54e-1)" "unprognostic (5.00e-3)" "unprognostic (5.88e-2)" 0.1 0.1 0.2 0.1 0.3 1.5 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.5 0.2 0.0 52.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.1 0.0 0.2 2.6 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.2 0.0 0.2 0.0 0.4 0.0 0.2 9.1 1.4 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.5 0.1 11.9 0.0 4.8 0.4 0.1 0.6 0.1 0.1 0.5 0.4 1.8 0.0 0.1 1.4 0.2 0.0 0.1 0.6 0.4 0.4 0.1 0.0 0.1 0.3 0.0 0.0 2.1 0.5 1.1 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.8 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.1 0.4 0.1 0.0 0.0 0.0 1.2 0.8 0.4 1.4 5.1 0.0 2.3 1.8 0.0 0.9 0.0 0.0 13.5 0.2 0.0 0.0 0.0 0.7 0.6 0.6 1.1 0.4 3.1 0.0 0.0 1.8 1.2 3.6 0.3 2.4 3.3 0.0 0.0 0.5 0.1 0.0 0.4 0.0 1.1 0.0 0.9 29.0 15.8 0.1 0.9 0.0 0.0 0.3 TEX15 CT42 ENSG00000133863 "Testis expressed 15, meiosis and synapsis associated" Q9BXT5 8 30831544-30913003 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3" "Group enriched" "Detected in some" 4 "Early spermatids: 73.5;Late spermatids: 38.7;Spermatogonia: 62.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 8.9;HEL: 20.1;K-562: 5.6;NTERA-2: 3.8;OE19: 4.1;SCLC-21H: 4.3" "Not detected" "Not detected" HPA036800 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036800: AB_10671714" "unprognostic (3.10e-1)" "unprognostic (2.56e-1)" "unprognostic (3.30e-4)" "unprognostic (3.54e-1)" "unprognostic (2.45e-2)" "unprognostic (2.15e-3)" "unprognostic (2.80e-3)" "unprognostic (4.52e-2)" "unprognostic (5.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-5)" "unprognostic (8.88e-3)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (4.92e-1)" 0.1 0.1 0.7 0.2 5.4 0.1 0.1 0.1 1.1 1.2 0.1 0.0 0.0 0.1 10.0 0.6 0.2 0.1 0.8 0.1 1.7 0.5 0.1 0.1 0.1 0.1 0.3 0.3 0.4 0.1 0.1 6.9 0.1 0.9 0.1 0.1 0.3 0.1 0.5 0.1 0.1 0.2 8.5 0.4 0.4 0.9 21.3 1.4 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.0 0.0 8.9 1.1 0.0 1.2 3.2 20.1 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.6 0.0 0.0 0.1 0.1 0.1 3.8 4.1 0.3 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 3.7 0.3 0.2 1.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.4 0.1 1.1 1.7 0.5 0.3 0.3 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 38.7 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 4.2 0.0 0.0 12.9 0.0 14.2 62.1 0.0 0.1 0.0 0.0 0.0 TEX261 "MGC32043, TEG-261" ENSG00000144043 "Testis expressed 261" Q6UWH6 2 70985938-70994945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA016631 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016631: AB_2240434" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (4.23e-4)" "unprognostic (5.52e-3)" "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.70e-3)" "unprognostic (3.36e-1)" "unprognostic (5.59e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.99e-1)" 22.9 27.1 14.5 11.1 15.4 9.3 22.2 13.4 21.4 19.9 15.9 21.6 20.9 13.8 17.3 27.2 17.3 20.9 21.2 21.6 14.4 12.0 25.1 36.9 19.8 16.1 17.0 10.9 23.7 50.8 36.1 20.1 19.3 15.0 18.9 18.9 28.7 22.3 21.0 33.5 12.9 23.6 19.6 17.4 16.0 18.4 23.8 15.3 15.5 31.7 14.3 16.3 14.9 13.9 3.8 4.4 12.0 5.3 3.4 6.7 2.8 20.0 19.0 13.3 16.9 40.7 20.8 15.1 23.2 22.2 27.1 17.1 22.2 16.7 16.4 8.8 40.7 25.6 15.2 25.3 27.7 39.5 12.3 21.1 19.6 9.8 23.5 24.0 22.8 16.5 18.7 18.5 26.0 17.8 14.9 27.5 17.1 24.3 10.9 31.6 15.7 19.6 12.6 8.8 32.6 22.4 14.0 41.2 14.1 19.7 17.6 21.9 11.5 24.1 24.1 15.1 9.4 15.6 13.5 22.0 33.4 28.9 17.7 30.8 8.5 7.5 19.5 29.1 30.1 27.9 12.0 5.3 10.0 5.1 5.3 4.3 2.6 5.4 6.7 4.0 3.8 6.2 4.9 4.0 3.4 5.2 4.4 4.3 2.8 14.5 15.4 13.4 21.4 14.4 12.0 17.0 10.9 15.0 15.3 3.0 17.1 18.2 9.4 7.3 13.4 19.8 17.8 1.4 7.9 22.7 35.3 14.3 6.6 21.9 12.0 14.6 19.3 0.0 20.5 14.3 14.1 13.7 2.3 30.4 17.3 7.9 8.1 18.4 15.1 21.6 14.7 8.4 18.6 9.0 17.0 20.6 18.7 13.6 17.3 14.1 68.9 0.0 16.0 46.6 10.9 6.6 15.0 9.2 16.5 7.1 TEX264 "FLJ13935, ZSIG11" ENSG00000164081 "Testis expressed 264" Q9Y6I9 3 51662693-51704323 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 310.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005002, HPA017739" Enhanced Approved Nucleoli,Cytosol "Secreted - unknown location" NA NA "Nucleoli, Cytosol" "CAB005002: AB_425976, HPA017739: AB_1857910" "unprognostic (2.80e-3)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (2.79e-3)" "unprognostic (8.11e-2)" "unprognostic (8.26e-3)" "unprognostic (2.05e-1)" "unprognostic (3.06e-3)" "unprognostic (2.30e-1)" "unprognostic (5.19e-2)" "prognostic favorable (5.67e-4)" "unprognostic (1.83e-1)" "prognostic favorable (7.95e-9)" "unprognostic (4.99e-2)" "unprognostic (3.65e-1)" "unprognostic (3.17e-1)" "unprognostic (4.67e-2)" 15.7 34.6 15.1 15.3 18.7 9.0 20.0 8.6 22.8 17.5 21.3 15.0 36.0 18.7 20.1 25.5 17.7 21.9 24.8 19.0 14.6 15.6 35.9 30.7 17.0 22.6 15.7 17.9 15.8 29.0 29.9 12.3 24.5 12.2 20.3 16.7 22.6 43.6 44.3 16.3 29.5 20.8 16.6 15.8 18.6 19.0 90.8 11.5 16.6 33.9 18.5 15.9 16.7 16.3 33.1 34.5 24.7 36.7 22.8 50.7 41.1 11.8 21.8 3.9 20.1 40.7 19.8 8.0 10.2 24.2 17.0 17.2 11.6 28.2 17.1 7.5 14.6 28.8 11.6 11.0 20.6 8.3 13.7 17.6 16.3 13.6 15.4 36.3 10.2 18.3 26.1 32.9 19.2 19.7 15.5 12.4 13.0 8.5 29.9 17.5 13.7 16.3 23.8 4.3 19.6 24.5 7.9 5.2 32.2 26.8 16.5 5.6 9.2 12.5 34.5 15.7 5.6 16.8 21.7 9.1 17.2 7.2 18.0 13.5 20.9 22.5 8.4 21.0 21.6 17.1 24.7 36.7 21.7 41.9 36.7 41.9 32.2 43.5 39.7 34.5 33.1 36.5 37.0 7.7 22.8 34.7 30.5 50.7 41.1 15.1 18.7 8.6 22.8 14.6 15.6 15.7 17.9 12.2 11.5 32.8 15.0 27.5 46.0 30.9 30.1 22.8 53.5 25.4 28.4 94.2 55.0 125.5 53.0 63.6 30.2 49.7 69.9 0.0 67.2 73.8 45.6 36.2 16.1 51.7 92.2 39.7 31.6 28.3 36.7 48.4 47.2 49.0 62.4 55.9 51.0 59.8 56.9 65.4 46.0 101.0 46.9 25.8 20.0 310.0 58.8 30.9 63.8 52.4 81.7 32.5 TEX37 "C2orf51, FLJ25369, TSC21" ENSG00000172073 "Testis expressed 37" Q96LM6 2 88524651-88529584 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 221 "testis: 54.4" "Group enriched" "Detected in some" 176 "Early spermatids: 799.5;Late spermatids: 2063.1" "Cancer enriched" "Detected in single" 17 "testis cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "BEWO: 34.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043987, HPA070239" Enhanced Supported Cytosol NA NA Cytosol "HPA043987: AB_10961125, HPA070239: " "unprognostic (1.08e-3)" "unprognostic (2.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 34.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 799.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2063.1 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 6.5 0.0 7.7 8.1 0.0 0.2 0.0 0.0 0.0 TEX9 ENSG00000151575 "Testis expressed 9" Q8N6V9 15 56244009-56445997 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 49.7" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 165.9;Early spermatids: 67.3;Spermatocytes: 52.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 4.1;memory B-cell: 14.4;naive B-cell: 6.8" "Group enriched" "Detected in many" 11 "B-cells: 14.4;granulocytes: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039415 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039415: AB_10672775" "unprognostic (3.27e-1)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (4.71e-3)" "unprognostic (2.34e-1)" "unprognostic (5.13e-2)" "unprognostic (1.54e-2)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "unprognostic (8.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" 1.7 5.4 5.3 9.0 14.8 2.0 7.6 4.0 2.3 7.0 4.6 7.8 6.0 8.5 5.7 11.6 7.3 21.6 6.2 1.6 6.1 7.5 11.9 1.2 5.8 4.1 4.0 3.2 7.5 4.1 13.5 49.7 1.0 25.2 5.4 3.5 9.2 9.0 4.5 0.9 4.1 9.6 2.3 4.9 5.5 9.0 19.3 4.0 2.0 14.8 2.0 8.2 2.7 2.2 14.4 0.3 4.1 0.6 0.4 0.8 0.8 5.8 5.3 11.7 10.4 2.9 8.5 1.5 1.3 4.9 3.7 4.4 1.4 5.2 11.7 5.6 0.9 6.4 5.2 5.0 5.5 4.3 1.4 6.1 6.7 5.4 3.8 0.9 3.0 1.3 4.6 10.2 4.1 3.1 5.3 0.1 8.4 3.8 1.3 1.9 3.3 4.8 2.6 5.6 9.7 2.3 1.9 5.5 4.2 12.3 3.3 18.7 7.5 6.5 4.0 4.0 9.0 11.1 3.4 0.6 15.7 4.8 5.0 4.7 1.6 11.8 8.9 6.2 1.3 3.0 4.1 0.1 0.1 0.3 0.6 0.1 14.4 0.4 0.3 0.2 6.8 0.2 0.8 0.3 0.4 0.3 0.3 0.5 0.8 5.3 14.8 4.0 2.3 6.1 7.5 4.0 3.2 25.2 4.0 6.0 6.9 13.7 6.8 3.8 5.1 0.4 2.5 165.9 35.2 10.4 11.8 1.4 18.3 11.8 67.3 2.6 2.6 0.0 6.1 0.4 2.3 2.9 1.1 0.0 1.1 1.6 7.5 1.8 0.0 28.6 4.4 1.1 3.3 1.8 2.5 4.8 3.9 4.3 3.5 15.3 35.9 0.0 3.1 52.4 32.6 1.9 0.2 0.0 3.0 5.2 TFCP2 "CP2, LBP-1C, LSF, TFCP2C" ENSG00000135457 "Transcription factor CP2" Q12800 12 51093663-51173134 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070247 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA070247: AB_2686239" "unprognostic (6.27e-2)" "unprognostic (6.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (4.68e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (9.69e-2)" "unprognostic (4.91e-3)" "unprognostic (1.01e-1)" "unprognostic (3.20e-1)" "unprognostic (5.58e-2)" "unprognostic (5.31e-2)" 17.4 16.7 21.1 29.3 21.6 9.6 17.7 22.7 21.6 20.2 19.0 20.5 20.8 15.7 19.3 18.9 16.7 21.1 20.7 17.7 20.0 18.7 17.2 12.5 14.1 20.4 19.4 24.9 20.8 14.6 29.2 23.2 22.4 15.4 20.3 21.7 16.4 17.8 19.0 26.6 15.4 15.9 23.8 21.3 18.4 16.1 11.2 18.6 32.1 17.9 12.9 25.9 19.0 18.1 4.5 8.2 9.1 9.4 9.4 6.1 5.0 7.5 13.0 19.5 17.5 11.2 14.1 28.6 14.7 8.0 12.9 7.7 24.8 16.3 0.7 12.9 12.8 10.3 14.5 24.9 15.8 12.9 16.2 14.4 22.9 12.5 10.3 9.4 25.9 22.2 9.6 14.3 13.3 21.2 15.3 12.0 7.5 23.1 0.0 13.6 0.0 23.3 17.2 28.2 17.8 23.6 18.0 10.8 0.1 16.8 18.2 18.6 16.2 18.2 14.9 11.9 19.0 5.6 21.6 12.1 11.9 12.9 12.3 12.7 14.1 23.8 0.0 11.3 16.1 8.5 9.1 9.2 9.0 3.9 7.7 6.1 4.5 4.1 4.2 8.2 3.4 4.9 4.0 3.5 9.4 9.4 3.5 5.4 5.0 21.1 21.6 22.7 19.4 20.0 18.7 19.4 24.9 15.4 18.6 8.9 16.0 9.8 6.7 6.0 19.0 21.8 7.6 2.7 5.7 12.2 19.6 10.4 5.0 8.7 0.4 9.2 9.2 0.0 6.7 8.9 8.4 9.3 10.4 8.9 11.7 9.5 10.4 9.8 24.1 0.4 11.2 12.1 10.1 16.2 11.9 8.7 9.6 8.6 10.3 7.2 25.6 0.0 7.5 6.1 11.1 4.5 14.0 8.7 14.0 5.4 TFDP1 "DILC, Dp-1, DP1, DRTF1" ENSG00000198176 "Transcription factor Dp-1" Q14186 13 113584721-113641470 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 20.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB033605, HPA044754, HPA068909" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033605: AB_783105, HPA044754: AB_2679074, HPA068909: AB_2686056" "unprognostic (4.28e-2)" "unprognostic (9.50e-3)" "unprognostic (1.77e-2)" "unprognostic (1.09e-1)" "unprognostic (7.01e-2)" "unprognostic (2.10e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (5.50e-3)" "unprognostic (1.68e-2)" "unprognostic (3.96e-1)" "unprognostic (2.04e-2)" "unprognostic (2.43e-2)" "prognostic favorable (7.57e-4)" "prognostic favorable (6.17e-4)" "unprognostic (2.30e-1)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" 16.0 13.3 20.1 28.0 21.1 71.6 16.4 24.4 22.4 19.3 19.6 16.3 28.6 16.0 16.8 20.5 36.2 18.0 27.0 26.3 19.0 16.8 17.9 20.9 16.5 32.5 18.0 12.7 14.4 26.7 9.9 16.3 21.8 15.2 16.0 23.0 20.2 18.9 24.2 26.9 22.3 21.3 18.4 23.5 25.6 16.4 37.5 10.3 38.8 21.7 32.7 34.4 18.5 20.8 3.6 4.7 20.4 4.0 1.6 5.4 2.0 62.0 15.3 19.8 16.8 26.9 24.0 22.5 35.0 31.8 45.5 42.1 31.8 29.2 57.9 11.7 33.5 24.9 29.9 34.3 31.1 44.7 39.4 39.9 33.6 25.0 19.9 16.9 84.3 29.7 19.8 28.0 28.8 16.8 16.3 30.5 21.7 27.6 15.6 40.4 21.3 37.0 32.8 18.2 59.1 19.7 25.3 17.6 33.1 17.3 23.8 51.2 15.1 15.7 43.2 10.5 15.0 29.7 68.0 21.2 14.8 23.6 31.3 38.5 13.3 16.3 59.7 33.0 52.3 25.0 20.4 2.3 3.6 2.6 3.0 2.9 3.6 3.5 3.1 4.7 2.6 5.4 2.7 3.1 1.6 4.0 2.4 4.2 2.0 20.1 21.1 24.4 22.4 19.0 16.8 18.0 12.7 15.2 10.3 8.9 18.6 29.0 26.5 53.0 10.1 22.2 20.4 17.4 14.8 27.9 13.7 64.5 68.0 8.5 3.4 21.1 23.1 93.5 10.3 105.6 35.0 28.2 20.7 49.1 42.0 6.4 38.6 31.3 34.8 7.9 26.4 29.8 33.7 6.4 30.0 8.6 15.2 21.0 26.5 46.4 19.9 6.5 21.2 62.4 52.9 52.4 55.7 23.5 39.7 26.8 TFE3 "bHLHe33, TFEA" ENSG00000068323 "Transcription factor binding to IGHM enhancer 3" P19532 X 49028726-49043486 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023881 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023881: AB_1857931" "unprognostic (2.68e-2)" "unprognostic (2.89e-3)" "unprognostic (2.40e-2)" "unprognostic (5.36e-2)" "unprognostic (2.71e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (6.03e-5)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (4.32e-2)" "unprognostic (5.41e-2)" "unprognostic (1.16e-1)" "prognostic unfavorable (2.19e-8)" "unprognostic (1.93e-1)" "unprognostic (8.77e-2)" "unprognostic (4.19e-2)" "unprognostic (6.25e-1)" 31.3 20.9 12.6 18.2 14.4 22.6 53.1 16.5 18.1 22.6 17.7 16.6 30.0 9.9 22.8 21.9 20.5 18.8 16.4 15.1 11.3 11.8 21.6 14.1 22.8 10.3 13.2 9.4 24.4 15.9 16.5 16.3 22.0 15.9 21.2 10.4 15.7 12.6 30.6 13.6 14.1 13.5 21.2 14.8 23.0 14.7 10.4 15.2 4.2 21.7 10.8 10.5 28.6 20.5 1.2 1.9 10.5 4.4 0.4 1.4 1.6 11.8 15.3 5.1 14.7 16.6 15.1 5.1 15.7 18.2 16.0 13.7 9.3 9.5 4.5 6.7 23.0 17.7 9.8 9.6 14.1 13.0 9.8 5.2 4.1 11.3 8.7 22.4 4.3 10.2 13.0 9.1 26.3 18.8 14.9 7.7 3.1 7.9 19.6 13.6 7.0 2.8 4.0 13.9 3.5 13.8 4.3 8.8 10.1 10.2 5.5 4.9 4.8 16.7 7.2 5.5 18.0 10.2 3.9 16.2 17.6 18.8 17.5 8.6 12.1 11.3 3.7 21.0 5.3 12.0 0.0 3.5 1.6 0.5 4.3 0.9 0.6 0.9 0.5 1.9 1.2 0.6 0.4 10.5 0.4 4.4 0.4 1.4 1.6 12.6 14.4 16.5 14.9 11.3 11.8 13.2 9.4 15.9 15.2 14.9 9.1 5.2 18.6 17.5 6.5 6.2 17.8 4.0 11.4 19.2 3.9 13.6 8.3 16.6 0.6 14.6 11.8 0.0 13.7 7.4 16.4 16.4 5.7 13.9 19.2 17.5 12.0 9.8 23.8 1.3 25.3 13.0 8.5 10.0 8.5 9.6 17.6 14.0 23.0 8.6 5.3 12.9 13.3 2.6 0.9 19.3 31.0 8.6 6.5 15.8 TFG "FLJ36137, SPG57, TF6" ENSG00000114354 "TRK-fused gene" Q92734 3 100709331-100748966 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019473, HPA052206" Approved Supported Vesicles,Cytosol No No Vesicles Cytosol "HPA019473: AB_1857936, HPA052206: AB_2681760" "unprognostic (1.14e-1)" "unprognostic (3.58e-2)" "unprognostic (1.46e-1)" "unprognostic (2.94e-2)" "unprognostic (1.46e-1)" "unprognostic (4.14e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (3.31e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (4.58e-3)" "unprognostic (3.72e-2)" "unprognostic (2.82e-1)" "unprognostic (8.55e-2)" "unprognostic (3.33e-1)" "unprognostic (8.45e-2)" 36.4 40.3 27.2 21.9 33.8 29.7 31.0 28.1 40.5 31.2 34.7 33.3 44.2 52.5 31.2 45.8 46.7 29.0 40.8 46.2 28.1 30.7 44.6 68.6 29.9 25.4 28.2 21.5 33.5 49.2 52.3 45.1 63.3 33.7 27.5 40.7 31.9 39.6 45.8 38.6 31.0 67.1 37.5 31.7 28.3 28.9 33.5 23.0 27.6 43.6 42.9 41.2 29.5 30.1 25.8 27.8 43.2 28.4 27.7 26.8 21.8 48.7 26.6 33.1 21.0 41.8 47.4 40.9 35.3 47.5 46.2 55.1 33.5 24.4 6.5 26.0 43.8 35.8 36.6 35.6 40.3 55.0 30.0 20.9 24.5 20.5 31.1 46.8 18.1 14.7 38.8 54.4 27.6 48.8 42.9 40.8 11.5 17.6 18.1 47.6 34.1 15.9 14.3 31.5 45.4 40.0 14.0 19.4 21.2 56.0 32.9 26.2 24.0 23.2 30.2 41.1 28.7 35.6 24.6 27.3 27.9 33.8 12.8 25.5 15.5 15.6 23.4 44.6 19.8 32.7 43.2 28.3 27.0 21.8 28.4 26.4 25.8 22.6 24.4 27.8 22.9 21.6 21.6 18.7 27.7 26.4 19.4 26.8 21.8 27.2 33.8 28.1 40.5 28.1 30.7 28.2 21.5 33.7 23.0 56.6 28.8 33.5 90.7 121.3 43.5 83.1 53.5 36.1 40.9 34.9 23.6 186.8 116.0 161.1 64.7 63.1 162.1 23.3 94.6 171.9 101.9 94.0 76.1 59.6 75.5 54.0 50.5 51.0 25.1 36.9 65.6 40.7 60.8 142.5 99.4 86.6 108.9 83.4 69.6 72.7 59.0 38.8 84.4 49.9 48.5 104.0 237.9 28.8 82.9 98.7 TFIP11 "DKFZP434B194, Spp382, TIP39" ENSG00000100109 "Tuftelin interacting protein 11" Q9UBB9 22 26491225-26512505 "Plasma proteins, Predicted intracellular proteins" "Biomineralization, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027085 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027085: AB_1857964" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (4.87e-2)" "unprognostic (9.14e-2)" "unprognostic (3.24e-2)" "unprognostic (3.86e-2)" "unprognostic (6.28e-2)" "unprognostic (2.63e-1)" "unprognostic (1.76e-1)" "unprognostic (3.01e-1)" "unprognostic (4.38e-2)" "unprognostic (2.34e-1)" "unprognostic (2.96e-3)" "unprognostic (1.46e-2)" "unprognostic (9.24e-2)" "unprognostic (1.18e-1)" "unprognostic (2.62e-1)" 11.8 13.5 12.7 12.7 13.8 43.9 10.9 13.8 15.4 9.4 9.5 13.1 8.9 9.9 11.8 8.9 14.5 10.7 10.3 11.8 13.2 9.6 12.3 24.7 11.0 17.7 15.5 12.0 10.3 16.3 11.1 12.0 11.5 12.2 10.5 9.8 11.9 10.9 8.7 34.2 16.3 12.7 10.2 10.6 17.8 11.1 40.6 12.3 23.8 15.4 11.0 19.0 11.1 11.5 23.8 15.5 35.4 23.8 19.6 25.5 17.8 11.1 13.2 11.4 12.9 18.3 11.1 11.5 13.7 17.5 21.5 20.4 9.9 8.1 21.8 8.6 17.0 14.2 16.6 16.3 13.2 15.9 15.9 15.5 13.4 8.5 10.1 16.8 31.0 17.2 14.2 18.0 20.4 16.1 11.6 16.4 11.3 18.0 20.8 14.3 13.7 14.1 17.0 11.0 16.3 11.0 21.4 17.6 19.3 12.4 11.3 8.7 12.5 16.4 11.8 16.1 11.8 9.6 14.7 16.1 18.2 29.7 11.4 12.6 15.4 19.6 43.1 14.4 12.5 13.5 35.4 16.9 28.6 23.8 18.2 22.1 22.9 21.1 22.2 15.5 23.8 20.2 18.4 26.8 19.6 23.8 9.7 25.5 17.8 12.7 13.8 13.8 15.4 13.2 9.6 15.5 12.0 12.2 12.3 8.9 8.9 8.2 9.4 14.9 8.0 2.8 15.3 9.4 10.3 12.2 7.9 14.9 11.6 12.8 41.4 9.5 11.9 0.0 17.8 11.7 7.3 6.8 8.1 9.7 11.7 14.3 15.5 11.1 5.6 5.4 10.3 7.4 6.8 10.0 9.6 7.3 21.6 7.6 9.2 8.0 6.4 0.0 5.9 15.6 21.3 14.6 16.2 11.7 7.1 10.0 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574051-94596257 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 11.1 12.2 7.9 11.4 11.8 5.8 13.4 8.0 7.8 11.9 9.0 9.0 13.4 11.1 13.7 13.2 10.3 10.5 8.7 7.7 7.0 7.0 11.8 31.9 7.8 12.5 11.8 6.8 13.9 14.1 6.2 24.3 10.8 10.1 10.5 10.6 15.4 12.5 12.7 7.6 7.9 11.1 10.3 12.6 11.9 9.8 7.2 12.6 27.1 15.8 8.9 12.5 10.9 9.2 9.9 8.0 10.5 7.0 10.4 17.4 6.7 7.4 3.1 5.2 4.7 7.7 6.2 6.5 6.8 6.5 6.4 6.2 8.5 7.3 11.4 6.9 4.7 4.2 4.7 9.2 5.3 6.6 9.0 3.6 9.2 3.6 7.9 9.8 31.4 6.3 7.2 4.2 3.6 10.3 5.1 5.9 8.4 9.0 4.0 5.8 4.5 8.6 16.2 6.9 12.0 4.0 7.3 5.3 6.7 8.1 3.3 7.4 4.1 5.1 10.8 19.0 9.1 4.8 17.1 5.5 2.6 6.8 3.9 5.6 9.1 4.9 42.1 7.0 11.7 7.0 10.5 5.3 9.6 9.6 6.2 14.5 9.9 11.3 10.5 8.0 7.3 17.4 12.4 1.5 10.4 7.0 7.1 12.5 6.7 7.9 11.8 8.0 7.8 7.0 7.0 11.8 6.8 10.1 12.6 11.9 5.0 15.6 9.5 2.2 4.5 4.7 0.0 10.7 10.3 7.0 2.0 12.9 8.3 9.8 1.1 6.3 5.5 0.0 8.0 15.4 12.0 9.9 10.5 19.8 10.0 1.6 5.2 9.2 7.6 0.4 13.3 9.6 8.5 12.6 8.1 6.3 8.2 7.0 7.8 13.3 4.0 25.8 6.4 12.0 10.4 3.1 8.7 8.7 8.0 8.7 TGFB1 "CED, DPD1, TGFB, TGFbeta" ENSG00000105329 "Transforming growth factor beta 1" P01137 19 41301587-41353911 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Mitogen" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 377.2;Hofbauer cells: 124.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000361, HPA073356" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 1290000 38000000 "Golgi apparatus" Cytosol "CAB000361: AB_2201910, HPA073356: " "unprognostic (1.49e-2)" "unprognostic (5.43e-3)" "unprognostic (3.29e-2)" "unprognostic (4.90e-2)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (8.51e-3)" "unprognostic (5.63e-3)" "unprognostic (2.47e-2)" "unprognostic (5.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (1.19e-8)" "unprognostic (1.65e-3)" "unprognostic (2.79e-2)" "unprognostic (6.39e-2)" "unprognostic (4.86e-3)" 24.3 14.4 7.7 29.8 11.9 53.1 19.0 2.2 8.2 27.8 15.3 14.3 11.5 11.4 24.1 12.8 24.5 13.0 15.6 17.6 8.8 6.5 19.2 10.4 32.4 33.3 12.0 4.1 15.3 8.2 6.9 9.7 54.7 11.7 17.2 5.8 10.3 10.9 15.9 8.7 14.0 17.6 14.6 12.8 55.8 12.8 9.5 12.3 30.6 10.3 9.1 30.6 28.7 24.6 0.7 1.4 7.5 2.2 0.5 1.7 1.3 14.5 22.9 1.2 0.2 10.6 9.4 2.9 21.1 19.0 6.8 4.6 9.7 9.1 14.4 22.8 28.6 6.7 7.9 4.2 13.5 2.4 19.2 4.5 48.6 5.5 12.3 13.8 13.4 33.2 12.2 4.3 13.2 8.4 33.9 34.2 6.0 26.0 36.4 6.3 10.7 11.4 19.5 2.5 2.9 13.7 12.3 3.2 21.7 12.1 6.3 0.2 1.6 5.8 0.3 4.1 7.4 0.5 12.0 43.2 26.8 20.9 5.6 23.0 20.1 7.8 9.5 26.2 26.8 4.7 1.5 1.9 7.5 1.7 2.2 1.3 0.4 0.9 0.9 1.4 0.7 0.7 0.9 4.7 0.5 2.0 1.4 0.5 1.3 7.7 11.9 2.2 7.6 8.8 6.5 12.0 4.1 11.7 12.3 0.0 0.0 38.4 25.0 39.4 0.1 1.6 5.1 2.7 0.0 15.7 0.0 2.6 0.0 11.9 0.4 42.2 0.0 0.0 14.4 377.2 50.3 9.8 66.6 2.1 124.5 0.0 0.0 65.1 113.9 1.1 11.2 100.1 21.9 10.8 0.3 0.3 34.0 11.6 17.0 7.9 0.5 38.8 45.3 1.7 7.8 16.6 46.6 119.6 0.1 27.1 TGFB1I1 "ARA55, Hic-5, TSC-5" ENSG00000140682 "Transforming growth factor beta 1 induced transcript 1" O43294 16 31471585-31477960 "Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Leydig cells: 85.4;Peritubular cells: 168.3;Sertoli cells: 219.9;Smooth muscle cells: 134.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 8.8" "Group enriched" "Detected in many" 4 "granulocytes: 8.8;T-cells: 2.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" CAB020844 Enhanced Supported "Focal adhesion sites,Cytosol" NA NA 13000000 "Focal adhesion sites" Cytosol "CAB020844: " "unprognostic (5.80e-2)" "unprognostic (3.09e-2)" "unprognostic (5.34e-2)" "unprognostic (1.18e-1)" "unprognostic (6.64e-2)" "unprognostic (9.52e-2)" "unprognostic (1.89e-1)" "unprognostic (4.95e-2)" "unprognostic (4.19e-2)" "unprognostic (1.71e-2)" "unprognostic (1.38e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.06e-8)" "unprognostic (1.06e-2)" "unprognostic (6.57e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (7.73e-5)" 16.8 4.1 1.0 14.4 1.4 0.3 18.5 1.2 1.6 42.9 51.1 1.8 22.1 5.8 80.7 22.7 34.1 28.9 36.2 11.8 0.9 0.7 8.6 2.8 11.2 10.6 1.1 1.3 40.3 2.2 5.1 1.8 11.5 2.3 37.7 10.4 11.1 7.1 34.7 5.7 5.9 12.8 71.9 1.8 11.5 19.6 10.9 0.9 0.7 5.8 7.8 3.6 69.9 23.5 1.3 0.5 8.8 0.0 0.0 2.5 2.3 4.2 5.3 8.7 0.0 8.6 15.8 0.1 22.8 21.4 14.3 9.7 2.2 1.4 0.0 21.5 19.5 9.6 6.3 1.8 4.2 18.8 0.0 0.0 5.0 9.8 1.1 22.0 0.0 6.5 10.2 6.2 8.9 5.3 33.8 9.4 0.0 0.5 0.0 17.4 0.0 0.0 0.5 0.4 0.4 5.4 0.0 10.4 0.0 4.0 2.1 0.0 6.2 8.8 0.0 4.4 7.4 0.0 0.5 25.4 25.8 6.3 7.1 9.9 0.0 0.0 0.0 11.4 0.2 15.8 8.8 0.0 0.1 0.3 0.0 0.5 1.3 1.4 0.2 0.1 0.5 0.2 1.0 0.2 0.0 0.0 0.5 2.5 2.3 1.0 1.4 1.2 1.6 0.9 0.7 1.1 1.3 2.3 0.9 6.0 3.7 0.0 18.4 11.2 0.4 8.1 2.5 0.0 2.3 7.0 0.0 1.2 6.6 27.3 0.9 35.1 1.6 0.0 20.6 1.5 58.4 4.7 5.8 0.0 11.3 0.0 0.0 30.7 0.8 2.1 85.4 3.2 38.8 7.2 4.2 7.1 19.0 0.0 168.3 12.6 1.3 219.9 134.8 1.1 2.7 9.8 1.5 0.5 5.3 4.4 TGFBR3 "betaglycan, BGCAN" ENSG00000069702 "Transforming growth factor beta receptor 3" Q03167 1 91680343-91906335 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 105.0;Ito cells: 311.2;Leydig cells: 135.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 22 "NK-cells: 9.0;T-cells: 21.3" "Cell line enhanced" "Detected in many" "ASC diff: 67.2;ASC TERT1: 32.8;U-2197: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008257, CAB018971" Supported Approved Cytosol "Secreted to blood" NA NA 29000000 Cytosol "CAB018971: , HPA008257: AB_1080258" "unprognostic (7.57e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.36e-4)" "unprognostic (9.39e-3)" "prognostic favorable (4.84e-4)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (1.79e-1)" "unprognostic (9.32e-2)" "unprognostic (1.07e-1)" "prognostic favorable (4.99e-4)" "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.08e-2)" 40.1 15.9 3.2 6.8 3.1 1.6 63.5 1.8 4.4 30.1 15.2 3.5 30.0 3.4 17.6 21.0 22.2 17.6 23.3 16.3 3.9 1.9 12.5 11.9 18.4 18.1 2.6 2.0 62.4 8.9 4.4 4.4 25.1 4.5 21.7 5.6 8.8 14.7 46.5 19.2 13.4 9.8 34.4 4.1 27.1 11.1 14.0 3.0 1.1 7.5 6.5 3.1 39.2 42.1 0.0 0.6 0.6 0.6 9.0 21.3 3.9 2.7 2.7 4.1 0.7 67.2 32.8 13.0 2.0 10.2 2.4 2.9 1.2 0.4 0.0 0.5 3.7 1.9 0.4 1.0 0.3 1.8 9.5 2.2 0.0 3.4 11.3 1.4 0.1 0.0 7.9 1.3 5.2 1.2 0.3 1.2 0.0 6.5 0.2 0.7 0.0 0.0 0.0 1.7 1.2 0.9 0.1 1.4 0.5 0.9 16.4 0.1 0.0 1.0 0.0 5.7 1.7 0.3 1.0 3.6 4.0 1.0 22.8 0.4 10.1 0.9 0.0 0.8 0.5 0.5 0.6 0.0 0.0 21.3 0.1 11.6 0.0 5.4 11.4 0.0 0.0 1.7 8.0 0.3 9.0 0.6 0.6 2.4 3.9 3.2 3.1 1.8 4.4 3.9 1.9 2.6 2.0 4.5 3.0 8.9 11.9 3.0 10.4 33.4 0.2 17.3 28.1 6.7 6.8 29.6 2.0 23.5 3.3 1.7 48.3 64.2 0.7 23.3 4.2 9.3 105.0 7.3 2.3 17.8 9.7 0.0 23.1 311.2 19.6 18.5 135.4 3.8 33.7 0.0 0.5 2.2 3.5 0.0 70.0 15.9 0.2 12.9 35.4 0.7 1.7 29.7 48.5 30.5 2.3 5.4 TGM2 TGC ENSG00000198959 "Transglutaminase 2" P21980 20 38127387-38166578 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 187.6;placenta: 212.7" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4" "Group enriched" "Detected in many" 23 "B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5" "Group enriched" "Detected in many" 4 "CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002598, HPA021019, HPA029518" Enhanced Approved "Plasma membrane,Cytosol" Yes No 1700000 Cytosol "Plasma membrane" "CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133" "unprognostic (7.80e-2)" "unprognostic (1.51e-1)" "unprognostic (5.22e-2)" "unprognostic (1.40e-2)" "unprognostic (1.56e-2)" "unprognostic (5.61e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-3)" "unprognostic (3.29e-2)" "unprognostic (9.78e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (6.99e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.60e-2)" "unprognostic (1.93e-2)" "unprognostic (6.70e-2)" "unprognostic (6.40e-2)" 33.3 9.5 6.0 18.3 8.1 1.0 7.7 4.3 7.5 94.3 12.6 4.0 4.7 8.4 54.6 21.7 15.8 58.7 62.8 77.1 7.5 3.4 25.3 187.6 61.2 16.4 6.9 3.0 18.7 5.0 5.2 25.6 212.7 8.5 33.6 6.3 57.4 1.9 17.1 19.3 0.7 12.8 43.9 5.7 20.4 13.6 7.4 6.4 0.8 17.0 3.4 3.1 38.2 21.6 1.9 2.4 0.0 2.5 0.0 0.0 0.2 6.3 4.7 0.0 0.1 4.9 0.5 2.4 9.6 4.6 0.0 0.1 7.8 155.5 0.0 52.3 0.1 11.1 0.1 0.0 22.5 0.3 0.0 0.0 1.0 0.2 3.4 20.3 0.0 0.0 0.5 0.0 4.1 0.0 102.6 70.7 0.0 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.9 0.0 0.0 0.1 22.6 0.0 0.8 3.3 0.2 0.0 92.1 0.1 5.9 0.7 4.5 0.0 0.0 0.0 6.3 0.0 1.8 0.0 0.2 0.0 0.0 2.5 0.0 1.9 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 8.1 4.3 7.5 7.5 3.4 6.9 3.0 8.5 6.4 8.9 28.9 15.2 9.8 0.5 0.0 156.9 48.4 16.0 27.3 14.0 2.0 276.1 3.3 184.1 2.3 166.8 4.2 93.5 124.7 21.8 45.8 45.4 2.3 137.1 49.2 0.0 0.0 326.6 22.9 3.5 1.1 11.4 0.0 10.8 0.0 0.4 240.4 0.0 5.6 19.0 0.5 0.0 65.7 0.5 4.9 0.0 312.9 1.3 0.4 12.3 TGS1 "NCOA6IP, PIMT" ENSG00000137574 "Trimethylguanosine synthase 1" Q96RS0 8 55773142-55825448 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025024, HPA029824" Supported Supported Cytosol NA NA Cytosol "HPA025024: AB_1854330, HPA029824: AB_2673212" "unprognostic (4.13e-2)" "unprognostic (7.46e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.47e-1)" "unprognostic (3.70e-2)" "unprognostic (1.60e-2)" "unprognostic (4.94e-2)" "unprognostic (9.32e-2)" "unprognostic (3.15e-2)" "unprognostic (3.58e-1)" "unprognostic (2.22e-2)" "unprognostic (8.62e-2)" "unprognostic (7.23e-2)" "unprognostic (3.42e-1)" "unprognostic (2.85e-2)" 12.1 10.0 7.2 18.2 9.1 13.3 12.6 18.1 10.2 11.6 14.1 7.2 18.2 7.6 14.3 16.0 13.5 14.1 9.4 8.5 8.8 6.7 12.6 8.8 10.7 18.8 5.3 6.9 14.8 9.6 12.3 13.8 10.2 7.4 11.9 10.1 7.1 11.6 20.0 19.6 14.1 16.8 11.5 6.3 17.7 10.5 10.8 8.0 29.7 11.6 13.2 18.3 14.5 14.5 10.4 10.1 10.0 7.6 6.3 13.1 4.8 9.3 7.0 8.4 9.3 7.3 7.3 8.7 8.8 9.0 9.4 9.6 6.5 9.1 21.1 6.1 5.8 7.1 9.0 17.6 11.2 11.9 11.7 6.7 22.6 7.8 3.6 10.4 12.6 7.8 7.2 7.6 9.0 18.4 4.3 7.2 12.4 18.4 8.3 7.6 7.1 28.3 8.2 30.5 13.9 2.8 20.2 6.0 6.7 8.6 9.4 8.5 11.7 11.2 6.8 10.0 9.4 9.3 7.7 7.0 6.9 8.8 8.2 7.9 7.3 4.8 26.7 6.8 9.9 8.8 10.0 5.5 8.8 11.6 6.3 13.1 9.8 11.6 11.2 5.5 10.4 11.9 12.4 6.3 6.3 7.6 10.1 9.2 4.8 7.2 9.1 18.1 10.2 8.8 6.7 5.3 6.9 7.4 8.0 44.7 29.1 31.2 30.3 32.7 29.5 10.9 17.8 33.5 53.4 48.8 21.6 24.4 3.3 15.9 2.8 25.1 8.9 23.3 21.8 24.3 18.5 18.5 48.5 13.4 17.7 20.6 10.3 20.9 16.7 3.1 27.3 18.6 6.8 17.2 20.3 28.3 19.2 10.5 21.5 14.2 27.6 25.8 18.1 52.9 61.5 22.8 18.8 30.5 18.9 23.8 TH DYT5b ENSG00000180176 "Tyrosine hydroxylase" P07101 11 2163929-2171877 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Catecholamine biosynthesis, Neurotransmitter biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "adrenal gland: 83.5;brain: 41.4" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 1.8;Extravillous trophoblasts: 7.9;Leydig cells: 3.1;Syncytiotrophoblasts: 1.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 4.0" "Group enriched" "Detected in many" 6 "hypothalamus: 15.5;midbrain: 41.4;pons and medulla: 41.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "PC-3: 35.9;SK-BR-3: 12.8" "Region enhanced" "Detected in many" "olfactory region: 220.1" "Region enriched" "Detected in many" 19 "midbrain: 692.0" "CAB002522, HPA013768, HPA014010, HPA061003, CAB072340" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374" "unprognostic (1.31e-1)" "unprognostic (1.30e-1)" "unprognostic (9.08e-2)" "unprognostic (1.75e-4)" "unprognostic (8.82e-3)" "unprognostic (5.88e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-3)" "unprognostic (3.83e-2)" "unprognostic (4.39e-4)" "unprognostic (4.97e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (1.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-2)" "unprognostic (2.18e-2)" 1.3 83.5 0.0 0.3 5.4 0.2 0.2 0.0 0.7 1.8 0.2 6.2 0.0 0.2 0.3 0.3 0.2 0.3 0.4 0.2 0.3 15.5 0.2 0.2 0.2 0.2 41.4 0.0 0.3 0.3 0.2 0.2 0.9 41.2 0.6 0.2 0.3 0.2 2.0 0.2 0.5 0.4 0.2 0.0 0.3 0.2 0.3 1.5 0.0 0.2 0.0 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 35.9 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.7 0.3 15.5 41.4 0.0 41.2 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.1 THADA "ARMC13, FLJ21877, GITA, KIAA1767" ENSG00000115970 "THADA, armadillo repeat containing" Q6YHU6 2 43230836-43596046 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035191, HPA035192" Uncertain Approved Cytosol NA NA Cytosol "HPA035191: AB_10670290, HPA035192: AB_2674512" "unprognostic (1.20e-1)" "unprognostic (2.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (4.26e-1)" "prognostic unfavorable (6.48e-4)" "unprognostic (8.27e-2)" "unprognostic (9.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.12e-1)" "unprognostic (3.43e-2)" "unprognostic (5.25e-2)" "unprognostic (2.14e-1)" 15.7 12.5 8.6 14.2 11.9 12.0 15.8 8.8 10.6 15.0 10.6 13.8 20.2 6.6 25.3 16.8 12.8 15.8 9.7 11.8 7.5 7.1 12.6 18.5 13.5 20.0 10.9 6.1 15.8 17.1 27.2 29.9 9.6 10.9 16.4 10.1 12.7 17.7 12.6 12.7 16.2 11.7 12.4 11.4 17.2 11.1 12.3 10.0 23.1 17.9 12.3 23.3 12.6 19.4 4.9 5.2 14.7 4.7 6.5 5.4 2.6 13.1 15.8 7.2 0.2 19.5 16.9 10.4 8.8 7.3 8.4 7.2 9.2 7.9 12.1 15.2 10.5 11.4 12.3 11.1 15.1 14.5 10.0 11.0 8.6 6.3 12.2 6.8 13.3 7.0 11.0 13.8 17.6 23.1 8.8 11.3 4.5 15.3 6.5 10.1 16.5 13.1 14.9 14.4 19.0 9.0 6.1 13.0 9.1 13.2 11.8 9.5 14.8 8.4 8.2 7.9 8.7 8.4 7.0 9.6 13.9 10.2 10.5 15.9 16.5 10.2 13.7 11.2 13.3 11.1 14.7 3.3 1.4 4.5 4.7 4.8 4.8 5.0 5.4 5.2 4.9 4.7 5.3 2.6 6.5 3.4 4.1 5.3 2.6 8.6 11.9 8.8 10.6 7.5 7.1 10.9 6.1 10.9 10.0 17.9 11.8 7.9 15.9 7.6 11.6 7.5 17.8 18.7 14.8 14.0 15.7 6.6 1.7 7.8 16.4 7.1 3.3 0.0 8.4 4.7 8.7 10.7 5.8 14.0 8.8 3.2 7.0 11.6 5.7 7.4 9.2 8.6 3.3 5.4 4.5 6.7 5.9 6.2 8.1 5.4 24.9 0.0 7.5 20.2 12.8 3.9 4.0 7.5 5.6 6.9 THAP10 ENSG00000129028 "THAP domain containing 10" Q9P2Z0 15 70881342-70892785 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 17.0;Collecting duct cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 6 "monocytes: 7.3" "Cell line enhanced" "Detected in many" "U-2197: 27.6" "HPA041416, HPA073220" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA041416: AB_10795592, HPA073220: " "unprognostic (1.00e-1)" "unprognostic (3.51e-1)" "unprognostic (5.42e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-1)" "unprognostic (6.15e-2)" "unprognostic (6.25e-2)" "unprognostic (2.16e-2)" "unprognostic (2.99e-2)" "unprognostic (6.47e-2)" "unprognostic (1.55e-3)" "unprognostic (3.71e-2)" "prognostic favorable (3.05e-5)" "unprognostic (1.25e-2)" "unprognostic (2.12e-2)" "unprognostic (7.46e-2)" "unprognostic (9.44e-3)" 3.3 4.6 7.5 2.5 10.9 0.3 3.9 13.4 16.0 4.8 4.1 9.9 0.8 4.3 4.2 4.0 3.9 6.3 3.0 9.4 7.8 10.3 5.8 3.7 3.6 1.8 9.5 6.5 7.8 3.7 8.7 4.6 3.6 11.7 5.7 3.8 7.0 3.7 6.5 3.8 2.4 2.4 4.1 11.6 1.8 5.1 6.2 7.6 0.2 7.0 1.8 1.6 5.5 3.8 0.6 1.1 0.0 7.3 0.8 0.4 0.2 4.7 8.2 5.3 6.8 2.7 3.2 0.1 9.2 4.0 7.9 9.4 1.2 6.5 0.0 5.8 2.4 9.9 7.3 11.2 2.1 7.0 0.0 5.8 1.7 4.7 0.5 1.4 0.4 3.5 1.1 3.5 4.4 4.2 5.6 3.8 0.0 0.5 0.0 5.2 3.6 0.0 1.6 7.8 3.5 3.2 0.0 6.7 0.2 3.1 3.9 5.7 6.1 6.3 2.7 3.9 5.5 3.2 3.8 3.0 5.6 3.8 27.6 6.4 2.3 2.7 0.0 3.3 0.6 7.8 0.0 0.6 0.0 0.1 0.9 0.1 0.6 0.4 0.0 1.1 0.3 0.0 0.3 0.0 0.8 7.3 0.0 0.3 0.2 7.5 10.9 13.4 16.0 7.8 10.3 9.5 6.5 11.7 7.6 0.0 0.3 0.0 3.6 1.5 17.0 5.5 0.0 4.0 1.2 10.4 0.0 0.1 8.3 2.5 6.1 2.2 0.8 0.0 1.0 0.2 2.2 1.8 0.0 1.0 1.2 1.6 2.9 0.6 0.3 4.7 2.3 0.9 0.0 0.0 1.3 4.7 0.7 2.9 4.6 4.8 4.1 0.0 2.0 9.9 1.9 1.3 0.1 0.0 2.9 3.7 THAP11 "CTG-B43a, CTG-B45d, HRIHFB2206" ENSG00000168286 "THAP domain containing 11" Q96EK4 16 67842082-67844195 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041434, HPA042189, HPA072537" Supported Supported Nucleoplasm,Cytosol NA No Nucleoplasm Cytosol "HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: " "unprognostic (1.43e-1)" "unprognostic (2.51e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-3)" "unprognostic (1.93e-3)" "unprognostic (1.40e-2)" "unprognostic (1.56e-3)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (1.66e-1)" "unprognostic (9.51e-2)" "unprognostic (2.97e-1)" "unprognostic (2.11e-1)" "unprognostic (2.10e-2)" "unprognostic (4.59e-2)" "unprognostic (5.87e-2)" 15.2 12.1 13.4 13.5 14.5 8.5 31.4 15.0 17.2 23.8 19.1 16.7 13.0 12.0 19.9 13.3 18.9 18.0 16.7 29.5 12.4 12.4 13.9 13.5 14.9 22.2 11.8 9.7 22.6 23.1 17.2 13.3 14.2 12.7 20.4 11.0 17.2 14.8 20.6 40.7 17.7 16.0 19.8 10.4 21.0 15.8 11.8 9.8 30.2 29.0 17.3 18.0 21.7 27.1 10.3 8.7 8.5 10.8 11.5 19.9 10.6 12.5 16.4 11.5 10.8 16.1 11.0 12.1 6.5 11.2 15.6 13.5 21.0 9.8 27.5 13.4 6.5 9.4 14.8 20.1 11.9 8.9 10.2 23.0 10.9 9.5 25.5 14.7 13.9 12.5 10.1 11.8 10.7 9.4 11.4 11.4 19.0 15.7 6.4 9.4 19.6 15.0 25.0 23.1 15.0 14.4 29.7 13.7 24.7 7.8 8.2 16.1 18.2 18.8 6.8 13.5 8.6 16.7 14.3 9.1 10.0 12.2 9.0 7.9 25.8 25.6 27.1 7.7 15.4 10.7 3.5 8.4 8.5 16.8 10.8 13.4 8.9 15.4 15.4 8.7 10.3 19.9 15.8 2.5 11.5 9.7 7.0 18.4 10.6 13.4 14.5 15.0 17.2 12.4 12.4 11.8 9.7 12.7 9.8 20.8 12.5 18.4 21.0 26.0 25.3 13.7 10.2 5.3 4.5 10.4 3.9 17.7 44.7 7.4 0.8 21.5 10.9 0.0 8.1 20.8 20.6 18.6 7.0 10.9 19.5 7.9 12.7 17.2 15.0 1.7 21.9 13.4 10.1 15.4 14.6 27.8 6.0 0.0 29.4 16.5 13.5 19.4 23.6 17.9 25.4 34.3 11.3 30.5 16.0 14.7 THBD CD141 ENSG00000178726 Thrombomodulin P07204 20 23045633-23049741 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation, Hemolytic uremic syndrome, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Endothelial cells: 100.4;Leydig cells: 121.1;Peritubular cells: 243.6;Suprabasal keratinocytes: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 17.7;monocytes: 6.2" "Cell line enhanced" "Detected in many" "ASC diff: 12.8;CAPAN-2: 19.9;EFO-21: 17.3;HaCaT: 16.7;hTCEpi: 22.0;hTERT-RPE1: 11.9;OE19: 14.8;THP-1: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002425, HPA002982" Supported Approved Nucleoplasm,Cytosol NA NA 5550000 690000 "Nucleoplasm, Cytosol" "CAB002425: AB_563497, HPA002982: AB_1078444" "unprognostic (1.96e-1)" "unprognostic (2.93e-3)" "unprognostic (8.70e-2)" "unprognostic (3.00e-2)" "unprognostic (3.07e-2)" "unprognostic (1.88e-1)" "unprognostic (7.81e-3)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.33e-2)" "unprognostic (2.23e-2)" "unprognostic (7.35e-3)" "unprognostic (3.01e-2)" "unprognostic (7.58e-3)" "unprognostic (9.71e-2)" 27.0 6.3 1.4 10.5 6.7 6.9 11.8 1.2 2.7 13.2 14.4 1.4 4.3 2.9 9.7 11.5 21.7 15.8 18.2 24.3 5.0 1.5 7.0 10.0 61.9 26.8 2.5 0.1 10.2 7.2 10.0 10.9 16.4 6.2 6.1 3.3 8.8 6.0 4.2 55.5 32.4 14.1 8.5 7.7 44.4 14.4 15.8 2.4 2.1 18.3 32.2 10.4 14.2 10.4 0.0 7.8 17.7 6.2 1.5 0.0 1.1 5.6 5.0 0.1 0.0 12.8 0.7 0.1 0.1 0.0 0.0 0.0 0.0 19.9 0.0 17.3 1.7 0.8 16.7 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 2.4 0.0 0.1 0.5 22.0 0.3 1.4 11.9 5.6 0.0 2.1 0.0 0.5 0.4 0.0 2.0 0.0 14.8 0.8 0.0 0.0 2.4 0.1 8.1 0.3 0.0 4.7 0.6 8.6 1.6 0.0 12.3 10.9 0.0 0.3 1.6 0.0 0.0 0.0 0.0 1.0 2.9 0.4 0.0 2.8 0.0 0.0 6.2 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 17.7 1.5 5.8 7.8 0.0 1.1 1.4 6.7 1.2 2.7 5.0 1.5 2.5 0.1 6.2 2.4 20.8 30.8 2.2 6.9 30.5 0.0 9.0 0.0 2.7 18.2 0.0 0.0 2.5 0.0 1.4 0.7 100.4 0.0 0.0 0.2 35.7 22.8 3.0 7.0 0.8 14.1 0.0 0.0 52.2 38.0 4.5 121.1 62.8 15.1 1.0 0.0 0.0 5.3 0.0 243.6 0.2 0.0 6.5 63.8 0.2 0.9 86.2 35.5 0.0 0.0 32.5 THBS2 TSP2 ENSG00000186340 "Thrombospondin 2" P35442 6 169215780-169254044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 84.6;urinary bladder: 67.4" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 77.0;Fibroblasts: 41.1;Ito cells: 25.2;Melanocytes: 54.0;Smooth muscle cells: 28.6;Suprabasal keratinocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 83.6;ASC TERT1: 57.4;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HHSteC: 23.4;HSkMC: 31.0;hTEC/SVTERT24-B: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017716, HPA044304" Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 22000000 "Plasma membrane" "Nuclear speckles, Cytosol" "CAB017716: , HPA044304: AB_2678891" "unprognostic (2.85e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (8.90e-2)" "unprognostic (3.64e-2)" "unprognostic (8.73e-2)" "unprognostic (2.93e-1)" "unprognostic (5.10e-3)" "unprognostic (1.39e-1)" "unprognostic (4.71e-2)" "unprognostic (4.00e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (3.77e-6)" "unprognostic (2.19e-3)" "unprognostic (4.38e-2)" "unprognostic (4.16e-2)" "unprognostic (2.48e-3)" 43.5 4.0 4.3 10.1 7.8 0.4 84.6 1.1 9.0 24.3 17.0 6.3 3.3 1.9 26.1 16.1 9.8 14.8 43.0 21.9 5.5 3.6 4.6 5.9 8.4 3.8 8.1 1.4 26.2 5.9 1.5 4.4 2.0 14.8 10.5 3.4 0.7 3.9 2.8 14.6 22.7 3.8 22.0 16.0 2.8 2.6 12.5 5.2 0.0 13.2 10.6 4.8 67.4 29.4 0.4 0.7 0.2 0.8 0.1 0.3 0.0 0.0 0.0 0.6 0.3 83.6 57.4 0.0 15.9 21.9 22.1 27.8 0.1 0.0 0.0 0.0 19.0 0.1 0.0 0.7 0.8 12.6 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 31.0 0.0 29.8 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 3.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 10.1 0.1 22.5 1.9 0.0 0.3 0.0 6.2 0.1 0.5 0.0 0.8 0.2 0.2 0.5 0.0 0.4 0.1 0.0 0.2 0.3 0.1 0.3 0.0 0.1 0.5 0.7 0.2 0.0 4.3 7.8 1.1 3.1 5.5 3.6 8.1 1.4 14.8 5.2 6.0 0.0 0.0 1.2 77.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 41.1 1.1 0.0 0.0 0.2 0.0 0.0 25.2 0.0 0.0 7.5 0.9 54.0 0.0 0.0 0.3 0.8 0.0 15.2 0.3 0.3 0.0 28.6 0.0 0.0 36.9 0.1 0.0 0.0 0.7 THEM6 "C8orf55, DSCD75" ENSG00000130193 "Thioesterase superfamily member 6" Q8WUY1 8 142727203-142736927 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 28.9;RT4: 40.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023255 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" NA NA "Nuclear speckles, Cytosol" "HPA023255: AB_1845782" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (9.10e-2)" "unprognostic (5.33e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-2)" "unprognostic (1.74e-2)" "unprognostic (6.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.44e-1)" "unprognostic (4.91e-2)" "unprognostic (6.76e-2)" "prognostic favorable (6.66e-7)" "unprognostic (7.02e-3)" "unprognostic (3.55e-2)" "unprognostic (2.39e-2)" "prognostic favorable (4.49e-4)" 11.9 13.9 9.4 5.6 13.4 6.0 21.6 9.0 20.7 10.8 11.8 12.8 16.6 14.4 5.6 7.1 14.9 12.5 15.0 12.6 10.7 11.5 16.7 35.2 11.0 7.4 8.8 11.7 4.5 30.7 13.4 10.0 10.7 11.6 9.8 6.7 10.0 18.5 15.3 11.3 11.7 14.3 4.8 9.3 8.7 15.1 3.0 7.5 10.3 14.4 15.6 10.6 19.7 7.9 6.5 3.8 4.5 7.4 8.4 14.6 7.5 9.9 8.3 1.2 8.7 4.1 1.4 6.1 5.1 4.3 7.9 5.5 5.0 15.0 4.2 11.8 1.9 2.9 23.2 3.7 11.1 1.3 3.4 10.2 3.2 4.7 10.1 4.5 1.8 3.4 2.0 4.0 1.5 2.2 1.6 6.7 6.0 1.5 2.1 1.3 28.9 7.5 0.4 2.0 18.7 27.1 8.8 0.9 9.6 9.4 40.7 19.6 7.7 7.9 23.7 6.5 1.2 11.6 1.5 3.8 3.4 2.5 9.8 0.9 1.4 1.9 1.8 3.5 9.1 4.2 4.5 4.0 2.0 9.7 7.4 14.6 4.6 10.3 12.5 3.8 6.5 12.5 11.5 0.5 8.4 7.1 2.9 9.1 7.5 9.4 13.4 9.0 20.7 10.7 11.5 8.8 11.7 11.6 7.5 8.9 4.3 2.7 7.4 3.2 9.8 5.3 12.7 0.0 3.4 17.4 5.9 12.1 5.0 10.2 1.7 8.1 19.3 0.0 10.2 9.4 4.1 8.0 0.0 18.1 10.2 15.9 30.6 11.6 1.2 12.4 2.6 2.6 5.0 1.8 12.9 14.6 8.4 3.5 3.9 12.3 11.5 0.0 4.2 2.3 7.2 6.8 2.9 8.5 20.4 21.1 THEMIS "bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA" ENSG00000172673 "Thymocyte selection associated" Q8N1K5 6 127708072-127918631 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 109.6" "Cell type enriched" "Detected in some" 6 "T-cells: 40.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 7.1" "Group enriched" "Detected in many" 23 "gdT-cell: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2" "Lineage enriched" "Detected in single" 88 "T-cells: 25.2" "Group enriched" "Detected in some" 4 "HDLM-2: 16.8;JURKAT: 28.7;MOLT-4: 26.2;RPMI-8226: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031422, HPA031425" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA031422: AB_2673874, HPA031425: AB_10670129" "unprognostic (1.47e-4)" "unprognostic (2.50e-3)" "unprognostic (1.31e-2)" "unprognostic (1.41e-4)" "unprognostic (1.41e-1)" "unprognostic (5.20e-3)" "unprognostic (7.48e-3)" "unprognostic (9.01e-3)" "unprognostic (1.47e-1)" "unprognostic (7.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (2.65e-4)" "unprognostic (2.04e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-2)" "unprognostic (1.60e-2)" 1.4 0.6 1.9 9.6 0.8 2.4 0.8 0.2 7.1 1.0 2.8 0.1 0.5 2.2 0.9 0.9 1.2 0.8 2.4 0.5 1.8 0.6 0.9 0.9 3.6 13.2 1.1 0.1 0.9 0.6 0.0 0.4 0.2 0.5 0.9 1.3 0.8 5.2 0.9 0.3 0.5 5.0 0.8 1.5 5.8 2.0 0.4 0.4 109.6 1.3 1.6 10.4 2.3 1.2 0.0 0.0 0.2 0.0 0.0 25.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.3 0.0 14.5 0.0 14.5 20.5 0.0 0.0 13.1 25.2 0.2 0.0 0.0 0.0 0.7 7.4 1.9 0.8 0.2 7.1 1.8 0.6 1.1 0.1 0.5 0.4 0.0 4.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.1 0.0 0.0 1.8 0.3 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 40.2 0.0 0.1 THNSL1 "FLJ22002, TSH1" ENSG00000185875 "Threonine synthase like 1" Q8IYQ7 10 25016658-25026664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.0" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037585 Uncertain Approved "Nuclear bodies,Mitochondria,Cytosol" NA NA "Nuclear bodies, Cytosol" Mitochondria "HPA037585: AB_10696940" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (4.31e-2)" "unprognostic (5.26e-2)" "unprognostic (6.11e-2)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (9.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.52e-1)" "unprognostic (1.71e-3)" "unprognostic (2.08e-1)" "unprognostic (3.21e-2)" "unprognostic (9.84e-3)" "unprognostic (3.06e-2)" 2.2 8.0 8.6 2.4 10.1 0.8 4.7 4.6 10.4 5.5 3.5 5.4 3.6 3.3 4.7 6.5 2.6 7.2 2.7 4.6 8.9 6.6 12.3 26.0 2.1 5.5 9.5 5.5 9.6 8.7 7.9 13.0 2.3 8.5 3.8 4.0 2.8 4.4 3.7 5.2 2.9 3.0 3.0 9.1 3.2 3.5 7.0 7.7 5.1 10.5 2.1 3.3 2.9 3.9 5.2 3.8 0.6 0.7 11.5 10.4 3.3 5.3 6.2 3.9 7.8 4.0 5.0 1.0 2.6 1.0 2.9 1.9 4.0 6.8 24.8 8.4 1.2 3.2 3.0 5.6 4.9 3.0 3.4 3.1 9.1 1.7 2.6 4.5 0.0 1.5 3.1 9.1 2.1 4.5 5.1 2.0 10.3 7.7 2.9 6.2 8.3 4.9 1.7 7.2 9.4 3.0 2.6 1.0 10.6 8.3 1.2 6.5 3.7 5.2 4.7 9.3 2.2 4.7 0.5 1.9 3.5 3.1 4.6 2.4 2.2 2.8 0.0 5.8 5.0 2.7 0.1 0.4 0.0 3.0 0.5 5.4 5.2 4.4 4.0 2.2 4.0 10.4 6.8 0.6 11.5 0.7 3.8 2.0 3.3 8.6 10.1 4.6 10.4 8.9 6.6 9.5 5.5 8.5 7.7 3.0 2.7 2.0 2.6 0.6 4.1 6.3 2.5 9.4 6.8 3.5 0.0 5.2 13.3 2.8 20.6 1.6 1.4 0.0 1.1 3.3 2.1 1.2 0.0 6.8 1.8 3.2 1.2 1.8 1.6 4.1 2.0 1.0 0.0 1.8 1.1 6.3 1.6 0.0 1.4 8.9 4.7 0.0 1.0 6.4 13.2 0.9 0.8 0.9 3.5 0.9 THOC7 "FLJ23445, fSAP24, NIF3L1BP1" ENSG00000163634 "THO complex 7" Q6I9Y2 3 63833870-63863903 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 147.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044143 Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA044143: AB_10794892" "unprognostic (4.33e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-2)" "unprognostic (1.30e-1)" "unprognostic (2.26e-2)" "unprognostic (2.86e-1)" "unprognostic (1.20e-3)" "unprognostic (3.53e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-2)" "unprognostic (2.86e-2)" "unprognostic (9.90e-2)" "unprognostic (3.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.18e-2)" "unprognostic (4.25e-2)" "unprognostic (2.31e-1)" 24.3 28.5 41.1 19.7 34.7 29.0 33.3 20.6 37.6 24.6 29.6 14.8 24.1 27.7 22.2 24.6 43.6 18.7 27.2 36.1 38.5 28.3 30.5 32.5 17.2 25.9 33.9 35.2 21.1 35.6 18.0 23.8 42.0 33.7 24.6 30.4 14.8 30.4 22.8 52.9 27.0 34.9 31.1 27.2 20.4 21.5 24.6 15.5 34.4 21.3 43.0 27.6 28.4 22.8 25.4 31.4 32.2 24.8 27.6 32.1 17.7 19.8 12.2 14.1 3.4 18.9 25.8 13.4 17.6 18.3 20.6 20.8 14.6 22.0 23.8 7.5 22.6 20.6 11.7 15.7 27.6 28.9 24.3 11.5 21.3 16.0 16.9 19.8 29.6 10.5 18.6 23.3 17.7 31.4 20.3 22.6 16.0 16.2 23.2 25.0 147.5 25.9 26.9 17.8 43.0 9.8 18.9 13.3 32.4 35.7 19.1 7.0 16.3 15.2 21.4 23.8 14.4 13.7 41.2 16.2 15.0 16.1 18.6 31.0 15.2 22.3 28.9 18.7 38.0 19.6 32.2 21.9 17.1 22.2 24.8 30.7 25.4 27.6 30.0 31.4 17.4 23.8 24.8 13.1 27.6 20.7 28.9 32.1 17.7 41.1 34.7 20.6 37.6 38.5 28.3 33.9 35.2 33.7 15.5 83.4 45.5 85.5 64.3 54.7 49.8 132.7 66.2 89.7 81.9 80.3 17.7 145.0 175.8 128.4 54.2 60.1 73.9 93.5 108.7 140.5 54.4 56.4 52.1 76.8 98.6 46.1 53.0 41.1 67.5 71.0 82.3 73.9 64.1 181.3 101.8 52.7 119.8 91.2 67.1 197.6 51.9 51.8 72.2 202.6 43.2 62.6 178.5 55.5 119.9 83.0 THOP1 ENSG00000172009 "Thimet oligopeptidase 1" P52888 19 2785460-2815807 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 167.6;Paneth cells: 149.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025497, HPA035262" Uncertain Supported Cytosol NA NA 1400000 Cytosol "CAB025497: , HPA035262: AB_2674541" "unprognostic (1.52e-2)" "unprognostic (1.73e-3)" "unprognostic (7.94e-2)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (2.16e-2)" "unprognostic (9.35e-2)" "unprognostic (1.19e-1)" "unprognostic (4.05e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-3)" "unprognostic (3.00e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.90e-4)" "unprognostic (1.27e-1)" "unprognostic (2.64e-1)" "unprognostic (5.37e-2)" 8.2 9.4 19.1 12.3 19.8 18.4 6.2 21.7 26.1 5.2 11.8 14.1 5.8 24.6 7.5 8.4 11.0 8.4 6.7 11.6 18.5 15.4 7.1 30.4 6.2 11.9 14.1 15.2 11.1 7.8 7.0 12.7 22.3 13.1 18.1 8.2 11.9 13.7 6.8 29.1 11.9 20.0 7.1 10.7 9.8 7.8 27.3 10.9 17.0 7.5 11.5 11.3 5.8 6.8 7.5 9.8 8.0 7.5 3.9 9.5 3.2 29.4 21.9 8.6 18.3 4.4 4.3 30.5 18.4 6.8 18.3 14.8 25.7 9.4 26.6 9.0 7.1 12.8 24.0 12.7 15.1 7.7 0.1 26.6 9.4 24.1 30.4 4.7 18.1 14.7 4.8 5.4 15.2 6.8 5.2 10.4 18.0 21.8 13.0 7.7 22.8 20.1 34.0 25.2 8.8 30.2 16.7 11.4 25.1 7.6 17.1 23.3 18.5 16.1 14.5 8.9 4.6 14.0 17.6 11.7 14.1 12.1 30.0 31.1 22.8 19.1 17.9 15.7 30.4 16.7 8.0 3.5 1.6 5.5 3.9 4.5 5.6 4.0 7.4 4.9 7.5 5.1 4.3 1.7 3.9 7.5 9.8 9.5 3.2 19.1 19.8 21.7 26.1 18.5 15.4 14.1 15.2 13.1 10.9 3.0 11.7 12.3 8.7 6.1 20.3 7.3 10.2 5.3 7.9 10.4 33.4 20.9 8.3 17.0 11.4 5.7 167.6 0.0 12.9 46.8 8.4 12.6 5.7 79.1 19.9 6.4 39.2 6.2 9.5 18.4 10.6 7.0 3.3 11.8 46.9 12.9 15.9 149.7 5.6 9.1 29.7 12.9 9.2 47.9 19.4 5.1 28.3 6.5 38.5 6.4 THRA "AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3" ENSG00000126351 "Thyroid hormone receptor, alpha" P10827 17 40058290-40093867 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009654, CAB023349" Approved Supported Cytosol NA NA Cytosol "CAB023349: AB_619577, HPA009654: AB_1854603" "unprognostic (2.75e-2)" "unprognostic (2.20e-1)" "unprognostic (6.64e-2)" "unprognostic (4.22e-2)" "unprognostic (8.78e-2)" "unprognostic (1.64e-1)" "unprognostic (3.41e-3)" "prognostic favorable (1.84e-4)" "unprognostic (1.47e-1)" "unprognostic (5.47e-2)" "unprognostic (7.85e-2)" "unprognostic (2.65e-2)" "prognostic favorable (6.05e-8)" "unprognostic (3.05e-1)" "unprognostic (1.35e-1)" "unprognostic (4.21e-1)" "unprognostic (1.88e-3)" 17.1 20.7 58.6 5.7 90.7 9.9 12.9 37.4 73.1 19.8 12.6 24.1 8.2 15.1 19.3 11.5 9.7 29.3 12.7 30.1 43.8 38.1 12.1 2.7 11.6 4.5 34.3 45.5 46.5 12.3 13.0 10.7 8.5 29.6 12.4 9.6 10.4 13.7 18.8 38.5 10.0 16.7 17.4 29.4 6.1 11.9 7.8 43.6 1.8 12.5 7.9 3.3 10.0 18.6 1.0 1.5 3.7 0.7 5.1 4.7 1.4 2.1 17.3 5.4 13.5 37.3 13.7 2.0 8.9 10.7 9.2 8.7 14.3 12.6 2.5 14.8 17.2 4.1 5.2 10.5 5.4 5.0 1.0 10.0 4.7 20.6 6.1 12.6 7.5 5.2 21.7 4.5 8.6 3.4 21.6 12.4 7.7 9.4 2.4 7.6 3.2 10.1 12.5 4.9 11.2 5.4 14.4 10.7 12.4 3.1 1.5 9.2 8.4 6.8 10.9 15.4 8.6 12.8 8.9 8.5 9.2 9.2 8.3 2.6 5.6 3.9 1.5 5.7 8.7 4.9 0.3 0.6 3.7 4.7 0.3 2.0 0.6 1.9 2.8 0.8 1.0 3.4 4.1 2.5 5.1 0.7 1.5 2.2 1.4 58.6 90.7 37.4 41.8 43.8 38.1 34.3 45.5 29.6 43.6 17.9 5.3 2.2 23.4 9.4 70.7 41.6 45.9 6.7 2.3 31.4 19.6 0.7 43.1 9.9 0.6 15.7 41.1 0.0 13.1 1.1 21.6 16.7 13.9 11.5 10.8 58.8 24.1 24.5 7.8 0.8 47.8 4.6 18.6 0.0 17.6 75.1 6.8 17.5 46.7 18.8 20.2 19.4 34.9 0.0 14.9 9.2 0.2 12.5 29.5 9.5 THSD1 TMTSP ENSG00000136114 "Thrombospondin type 1 domain containing 1" Q9NS62 13 52377167-52406494 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 26.3;Ito cells: 12.9;Spermatocytes: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 12.3;HBEC3-KT: 12.3;hTCEpi: 12.3;hTERT-HME1: 12.6;HUVEC TERT2: 25.6;LHCN-M2: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012611, CAB020796" Uncertain Supported Cytosol "Intracellular and membrane" No No 810000 Cytosol "CAB020796: , HPA012611: AB_1857990" "unprognostic (1.21e-1)" "unprognostic (7.54e-3)" "unprognostic (3.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.31e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.87e-2)" "unprognostic (3.35e-1)" "unprognostic (6.10e-3)" "unprognostic (1.55e-1)" "unprognostic (3.05e-3)" "unprognostic (8.44e-2)" "unprognostic (1.31e-1)" "unprognostic (3.35e-2)" "unprognostic (4.90e-2)" 9.7 1.8 8.3 1.8 7.2 0.4 11.1 2.9 6.4 7.6 2.6 1.9 3.6 1.2 6.8 4.9 4.4 5.7 4.9 9.0 8.1 2.2 2.0 2.1 19.8 4.7 2.2 4.6 2.3 1.2 2.5 3.4 16.8 2.1 8.5 2.3 5.5 3.9 3.2 9.7 6.0 2.3 7.4 2.2 6.6 1.9 2.7 1.1 0.7 5.2 5.2 2.5 5.9 4.5 0.3 0.0 0.0 0.0 0.4 0.7 0.0 0.5 2.4 0.2 2.2 2.0 6.7 0.5 5.2 2.6 2.0 3.3 0.0 0.3 0.2 0.6 12.3 2.0 2.7 0.0 12.3 3.2 5.7 1.8 0.3 0.0 0.0 1.2 1.2 0.3 2.6 12.3 9.9 12.6 1.1 25.6 0.7 0.0 0.1 11.7 0.0 0.4 0.2 0.1 0.1 0.5 0.3 2.7 0.0 2.8 0.1 0.0 0.4 0.1 0.0 0.4 0.1 0.2 0.2 5.9 0.6 1.1 0.0 3.8 0.4 0.0 0.0 1.1 0.4 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.5 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.3 7.2 2.9 6.4 8.1 2.2 2.2 4.6 2.1 1.1 0.0 1.4 1.4 0.9 1.3 0.8 2.7 0.0 0.0 1.2 1.8 2.0 4.2 3.3 0.2 0.8 26.3 0.0 0.0 0.6 1.5 2.7 1.3 0.0 1.6 2.4 0.0 0.0 12.9 2.6 0.0 3.1 0.7 5.0 0.0 0.2 1.2 0.2 0.0 3.5 0.8 2.8 6.5 1.9 19.1 9.1 1.4 2.9 1.9 0.4 0.3 THSD7B KIAA1679 ENSG00000144229 "Thrombospondin type 1 domain containing 7B" Q9C0I4 2 136765545-137677717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;epididymis: 11.6;retina: 14.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 23.6;Horizontal cells: 85.8;Rod photoreceptor cells: 31.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Daudi: 10.3;SCLC-21H: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051416, HPA056745" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051416: AB_2681477, HPA056745: AB_2683224" "unprognostic (4.65e-3)" "unprognostic (2.25e-1)" "unprognostic (8.98e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (6.50e-2)" "unprognostic (7.80e-3)" "unprognostic (2.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.20e-1)" "unprognostic (6.56e-2)" "unprognostic (4.47e-6)" "unprognostic (2.42e-3)" "unprognostic (1.89e-1)" "unprognostic (4.31e-2)" "unprognostic (4.30e-2)" 4.7 0.3 1.7 0.3 1.6 0.1 2.6 0.7 3.2 0.9 0.5 1.1 0.8 0.3 0.9 11.6 1.6 2.8 0.8 1.4 1.8 3.3 2.7 0.6 0.5 0.2 1.8 1.5 0.4 0.3 1.3 3.0 0.7 24.2 2.1 0.3 14.9 1.2 0.7 0.3 0.2 1.5 2.2 3.2 0.2 0.3 1.1 0.3 0.1 2.1 0.0 0.3 0.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.3 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 0.7 3.2 1.8 3.3 1.8 1.5 24.2 0.3 0.0 0.0 0.0 0.4 0.1 1.2 0.6 0.0 0.0 0.0 0.0 23.6 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 85.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 31.7 6.5 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.1 THUMPD1 "FLJ20274, Tan1" ENSG00000066654 "THUMP domain containing 1" Q9NXG2 16 20702816-20742084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027851 Approved Approved Cytosol NA NA Cytosol "HPA027851: AB_10670036" "unprognostic (1.67e-1)" "unprognostic (1.62e-1)" "prognostic favorable (2.99e-4)" "unprognostic (1.48e-1)" "unprognostic (3.69e-1)" "unprognostic (2.50e-1)" "unprognostic (4.17e-2)" "unprognostic (4.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.73e-2)" "unprognostic (6.88e-2)" "unprognostic (2.45e-1)" "prognostic favorable (8.52e-8)" "unprognostic (1.98e-1)" "unprognostic (5.95e-2)" "unprognostic (1.09e-1)" "unprognostic (1.25e-2)" 22.0 20.1 17.5 17.6 24.2 17.8 36.7 23.6 24.7 27.2 23.6 12.4 25.9 12.8 29.1 27.2 16.7 23.3 17.7 16.5 17.6 15.8 22.8 16.6 16.0 18.3 14.2 20.7 29.2 21.9 37.1 27.6 20.3 19.2 33.1 19.2 12.9 18.5 28.7 17.3 16.6 19.7 31.9 13.3 18.6 27.0 15.9 17.2 27.6 23.3 15.0 19.9 25.5 22.0 10.0 5.9 17.8 7.3 13.4 19.6 8.5 9.9 10.9 19.1 10.9 16.2 14.1 11.5 10.0 9.9 9.2 9.0 8.4 10.5 24.7 19.0 11.1 8.5 9.3 12.1 13.1 14.3 14.1 7.2 22.8 9.8 18.3 10.6 36.1 45.7 11.9 17.4 10.0 11.5 10.8 10.5 11.0 43.7 19.0 10.2 11.1 16.9 13.1 16.1 8.6 6.6 23.2 18.3 19.1 10.2 8.6 14.9 10.2 8.4 14.6 9.5 11.8 10.5 11.9 10.7 13.6 7.8 9.0 9.5 20.1 18.6 18.4 10.4 10.0 10.8 7.1 6.0 17.8 15.4 7.0 18.8 10.0 14.7 14.4 5.9 9.5 19.6 16.8 2.8 13.4 7.3 5.0 11.3 8.5 17.5 24.2 23.6 24.7 17.6 15.8 14.2 20.7 19.2 17.2 38.7 40.3 41.6 30.4 42.9 33.8 26.9 45.9 44.2 45.5 29.6 19.6 50.2 33.2 24.4 3.6 42.8 25.2 23.3 29.7 30.3 36.0 37.9 68.3 39.9 26.5 33.4 35.1 35.0 34.5 4.5 38.0 26.5 32.1 32.5 36.4 47.9 21.7 24.6 63.6 39.6 36.3 45.3 41.9 45.3 67.7 48.4 61.1 52.5 39.6 29.8 THUMPD3 DKFZP434F091 ENSG00000134077 "THUMP domain containing 3" Q9BV44 3 9362842-9386791 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 224.3;Spermatocytes: 126.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036170, HPA036171" Approved Enhanced Nucleoli,Cytosol No No Cytosol Nucleoli "HPA036170: AB_10671836, HPA036171: AB_2674985" "unprognostic (2.13e-2)" "unprognostic (8.30e-2)" "unprognostic (1.74e-3)" "unprognostic (4.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.25e-7)" "unprognostic (6.54e-2)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "prognostic favorable (1.03e-4)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (4.05e-2)" "unprognostic (1.59e-2)" 17.4 17.2 13.3 12.9 14.8 22.2 14.2 13.4 19.6 15.2 14.4 13.8 12.5 12.8 14.0 15.8 16.5 12.3 10.9 19.3 12.3 13.9 20.7 23.9 11.1 13.5 18.3 11.0 14.3 14.8 22.2 27.8 14.4 23.2 15.9 15.1 14.0 16.1 14.9 29.4 13.4 14.9 12.3 15.8 14.5 12.5 42.8 14.8 22.3 18.2 17.5 13.2 16.2 11.7 13.9 15.4 12.5 19.3 11.7 22.3 10.1 12.8 17.5 12.2 6.4 16.1 15.6 49.2 15.7 12.9 16.0 12.2 13.1 13.6 13.2 12.3 14.2 25.6 8.5 22.3 16.0 16.3 14.7 13.0 16.5 17.7 11.4 15.8 21.0 12.0 12.5 18.2 18.9 19.7 13.0 10.5 21.5 25.9 19.2 21.1 18.2 24.8 9.0 23.5 14.4 17.0 15.8 21.0 18.8 10.5 19.5 5.1 16.5 13.0 9.4 13.9 13.2 15.1 13.6 7.4 15.4 13.3 18.5 17.2 24.6 57.2 42.5 18.7 19.7 22.0 10.6 13.2 12.5 16.2 17.4 21.1 12.3 14.1 16.8 15.0 13.9 22.3 16.8 2.7 11.7 19.3 15.4 13.2 10.1 13.3 14.8 13.4 19.6 12.3 13.9 18.3 11.0 23.2 14.8 23.8 17.9 6.7 21.7 9.5 20.8 43.1 20.4 16.0 29.6 21.0 15.7 29.0 44.7 33.1 224.3 13.1 8.7 0.0 25.5 25.1 18.7 25.5 26.7 23.1 24.1 36.5 2.9 11.6 15.1 105.0 19.0 17.7 11.8 17.2 15.2 28.6 27.1 3.5 24.4 25.2 34.6 6.5 13.4 126.9 51.4 11.3 23.0 15.2 18.8 18.0 THYN1 THY28 ENSG00000151500 "Thymocyte nuclear protein 1" Q9P016 11 134248279-134253370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038732, HPA038733" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA038732: AB_10697397, HPA038733: AB_2676183" "unprognostic (5.91e-2)" "unprognostic (6.22e-3)" "unprognostic (4.54e-2)" "unprognostic (3.48e-3)" "unprognostic (2.32e-2)" "unprognostic (8.99e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.01e-5)" "unprognostic (3.32e-2)" "unprognostic (1.99e-2)" "unprognostic (1.02e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" "unprognostic (1.71e-1)" "unprognostic (6.92e-2)" "unprognostic (1.66e-2)" "unprognostic (2.61e-2)" 20.1 22.4 36.7 13.3 39.3 21.4 26.1 29.6 43.6 22.8 22.7 16.0 20.8 16.8 22.8 45.2 16.0 27.9 17.3 27.8 30.2 30.4 22.4 31.6 15.8 20.4 24.9 38.1 37.6 15.6 13.6 25.2 12.3 24.5 29.7 26.0 17.5 14.3 32.7 14.3 15.5 16.7 24.5 23.2 17.7 18.7 24.3 23.1 35.0 29.9 15.6 23.9 22.6 15.7 27.8 30.6 74.0 24.4 29.7 50.7 34.4 7.9 4.8 18.1 14.4 17.6 20.1 10.7 6.9 15.2 16.2 15.3 26.9 19.6 14.9 23.2 9.5 17.4 12.4 27.3 20.9 15.9 15.2 7.7 41.4 6.9 24.2 25.2 32.8 13.7 15.2 11.2 19.2 12.7 21.2 25.4 51.0 19.0 7.2 14.5 4.4 38.1 60.5 21.0 31.8 18.1 18.1 13.4 12.6 22.2 14.0 17.3 14.0 14.2 3.5 8.1 13.8 20.2 16.7 13.4 7.0 10.8 6.3 10.4 8.1 8.4 31.6 10.4 42.9 8.0 37.6 21.7 74.0 36.0 24.4 43.1 27.8 38.3 36.2 23.1 21.8 44.3 50.7 11.3 29.7 22.5 30.6 44.7 34.4 36.7 39.3 29.6 43.6 30.2 30.4 24.9 38.1 24.5 23.1 29.8 30.3 34.7 31.3 21.2 28.4 47.5 45.9 57.6 36.4 34.9 13.7 48.6 72.9 41.7 18.7 37.2 24.6 0.0 48.8 45.0 39.0 15.9 39.3 41.5 45.5 27.0 55.3 25.2 23.0 14.4 46.6 30.2 38.8 40.5 38.5 42.7 42.8 31.6 45.6 69.9 17.8 45.3 31.6 74.4 76.8 18.1 11.6 37.3 53.4 22.6 TIA1 ENSG00000116001 "TIA1 cytotoxic granule associated RNA binding protein" P31483 2 70209444-70248660 "Disease related genes, Predicted intracellular proteins" Apoptosis RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056961 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056961: AB_2683289" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "unprognostic (3.68e-2)" "unprognostic (1.07e-1)" "unprognostic (7.64e-3)" "unprognostic (2.51e-3)" "unprognostic (3.37e-3)" "prognostic favorable (6.79e-5)" "unprognostic (5.09e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "prognostic unfavorable (8.05e-7)" "unprognostic (4.00e-1)" "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "prognostic favorable (1.02e-5)" 15.6 20.4 15.9 29.3 20.5 14.8 28.2 36.3 22.0 30.2 23.6 25.3 24.6 20.6 42.1 43.5 15.9 28.4 21.6 16.0 17.2 14.7 20.7 18.0 19.1 26.4 21.9 16.5 46.9 24.3 26.0 48.7 21.2 19.0 26.2 24.1 27.1 27.8 24.2 13.2 23.4 25.9 24.9 21.0 30.8 20.8 13.4 25.2 65.3 29.3 15.1 21.2 23.1 23.5 9.7 11.6 12.4 7.9 10.9 9.8 5.6 7.2 8.1 42.4 23.7 12.0 20.5 20.5 12.9 9.2 12.6 12.6 10.8 11.3 16.5 11.2 9.7 7.3 11.9 20.5 7.0 17.9 15.3 9.0 16.9 14.0 25.8 9.7 16.9 9.6 15.2 10.5 7.2 8.0 30.0 23.2 13.3 13.1 15.1 17.6 6.2 31.2 26.9 34.5 10.4 9.7 38.3 23.1 16.8 19.3 14.3 25.8 22.1 15.4 18.2 12.4 22.9 10.9 12.6 18.9 15.5 16.3 7.2 12.7 12.6 12.6 30.4 9.1 21.6 20.6 12.4 7.9 10.8 8.3 6.5 7.8 9.7 8.0 8.2 11.6 8.0 7.3 7.9 3.0 10.9 3.8 6.0 9.8 5.6 15.9 20.5 36.3 22.0 17.2 14.7 21.9 16.5 19.0 25.2 77.4 52.4 36.5 27.5 22.6 49.4 26.2 30.6 77.6 72.8 19.2 45.2 26.3 0.0 23.1 17.7 28.7 20.4 0.0 23.5 27.5 28.6 28.9 53.2 25.6 18.8 33.4 50.5 36.8 32.1 7.1 33.4 26.5 15.1 32.5 33.0 38.0 25.1 27.9 33.6 9.1 53.0 25.8 26.9 28.1 16.2 21.0 20.7 39.8 28.1 23.8 TIAM1 ENSG00000156299 "T cell lymphoma invasion and metastasis 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 110.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 8 "cerebellum: 110.1" "Group enriched" "Detected in many" 5 "classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 574.6" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 3.3 11.4 13.4 5.3 12.4 2.1 4.4 110.1 15.1 10.1 2.2 9.7 0.5 1.5 7.9 3.0 18.9 9.4 4.0 2.1 11.6 7.0 1.7 3.7 4.1 8.8 6.2 7.9 1.5 1.9 0.3 4.2 4.4 8.9 3.7 2.8 7.0 2.2 3.1 0.7 20.4 1.7 10.0 6.4 4.2 2.1 5.9 7.1 6.2 1.3 5.3 9.3 8.1 5.0 0.1 5.9 0.6 12.4 6.9 16.8 3.6 1.5 0.5 12.1 0.7 0.2 2.8 19.4 0.0 0.0 1.5 0.5 0.1 2.2 4.1 0.8 0.3 2.2 2.8 1.4 2.4 2.4 0.3 6.7 18.7 0.3 0.1 0.3 0.0 16.4 1.2 0.8 8.2 3.3 1.4 0.0 6.2 0.0 6.1 6.1 7.9 2.8 0.1 3.9 2.9 5.2 3.7 3.8 0.0 1.8 19.4 18.3 4.5 0.8 6.3 0.7 4.4 2.6 0.0 0.1 1.7 7.1 0.0 0.8 6.9 5.1 3.7 4.0 1.4 13.4 0.6 10.7 0.0 0.3 9.6 2.1 0.1 8.3 1.6 5.9 0.0 10.9 0.6 0.6 6.9 12.4 0.3 16.8 3.6 13.4 12.4 110.1 14.4 11.6 7.0 6.2 7.9 8.9 7.1 3.0 2.9 0.8 40.5 74.4 1.2 1.1 2.5 0.0 18.2 0.0 2.0 7.6 0.0 1.5 10.0 15.8 0.0 0.0 0.6 25.1 7.6 16.1 23.1 3.6 8.2 69.9 5.2 50.3 22.7 9.0 31.9 28.4 10.1 18.0 0.3 39.3 1.1 10.7 54.8 0.0 4.4 6.5 2.1 1.4 6.1 125.3 8.9 6.9 0.9 72.7 TIAM2 STEF ENSG00000146426 "T cell lymphoma invasion and metastasis 2" Q8IVF5 6 154832697-155257723 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 76.6;Early spermatids: 131.1;Late spermatids: 220.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.3" "Group enriched" "Detected in many" 4 "B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3" "Cell line enhanced" "Detected in many" "AF22: 35.1;HDLM-2: 15.0;RH-30: 22.9" "Group enriched" "Detected in many" 5 "amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6" "Low region specificity" "Detected in all" "HPA011134, HPA013903" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA011134: AB_1858005, HPA013903: AB_1858004" "unprognostic (9.14e-2)" "unprognostic (5.79e-2)" "unprognostic (1.44e-1)" "unprognostic (6.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (4.36e-2)" "unprognostic (1.89e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.38e-3)" "unprognostic (1.82e-1)" "unprognostic (8.13e-2)" "unprognostic (6.04e-2)" "unprognostic (1.05e-1)" 0.6 2.1 5.3 1.7 9.4 0.7 1.5 7.9 21.1 1.5 11.6 0.7 0.1 11.0 1.2 0.8 1.0 1.2 4.0 3.5 4.7 2.0 0.7 0.7 0.9 2.0 1.7 9.5 0.9 1.8 0.2 1.8 0.8 0.6 3.0 1.1 1.3 2.4 3.6 3.0 1.0 27.4 1.4 0.9 1.2 4.0 15.6 1.9 0.0 7.8 0.0 2.5 2.3 1.2 3.3 0.9 8.3 11.3 0.8 1.8 0.4 4.3 0.8 35.1 4.1 1.5 4.3 0.4 1.8 1.1 1.7 2.9 0.5 2.6 1.0 1.9 3.2 0.6 0.7 1.2 0.0 1.2 15.0 1.9 0.3 0.6 2.0 0.9 0.3 1.1 2.9 0.1 0.6 0.1 1.6 2.4 0.5 0.5 0.1 3.9 0.4 0.4 0.9 2.5 0.2 1.0 4.5 22.9 0.4 0.1 0.2 0.9 8.0 0.1 0.4 0.2 6.9 0.3 0.5 0.8 0.3 8.9 0.3 0.9 0.2 1.7 0.2 0.1 0.5 2.2 0.4 0.2 3.1 0.2 3.2 0.3 3.3 0.5 0.3 0.9 1.0 0.6 0.4 8.3 0.8 11.3 0.3 1.8 0.4 5.3 9.4 7.9 21.1 4.7 2.0 1.7 9.5 0.6 1.9 3.0 1.6 8.1 16.3 2.7 13.8 7.3 7.6 2.7 1.2 1.8 76.6 1.2 0.0 4.7 131.1 3.0 2.9 0.0 2.7 2.1 4.7 7.7 19.6 0.9 1.7 22.3 0.0 7.4 2.1 220.7 9.2 4.7 11.8 14.4 4.2 6.9 4.2 2.0 7.4 0.7 25.2 0.0 3.8 5.2 5.5 2.3 0.3 4.8 2.6 7.4 TIFA "MGC20791, T2BP, T6BP, TIFAA" ENSG00000145365 "TRAF interacting protein with forkhead associated domain" Q96CG3 4 112274542-112285903 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 46.1;U-266/70: 28.9;U-698: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045889 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoplasm, Nucleoli" Cytosol "HPA045889: AB_10963785" "unprognostic (2.41e-2)" "unprognostic (2.47e-2)" "unprognostic (4.13e-2)" "unprognostic (3.23e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-3)" "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (2.14e-2)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (6.44e-3)" "unprognostic (1.52e-1)" "unprognostic (2.56e-1)" "unprognostic (2.99e-1)" "unprognostic (8.49e-3)" 5.7 6.4 3.3 16.7 3.8 19.2 7.4 6.1 4.5 7.0 3.9 2.0 8.4 3.4 3.6 2.3 14.3 4.0 4.2 7.9 4.7 2.1 4.1 14.6 6.7 22.9 5.4 1.6 9.2 32.2 4.1 3.3 7.4 3.9 6.6 3.7 5.4 21.3 4.5 4.0 9.0 8.7 4.7 4.0 20.3 7.1 3.0 4.8 12.5 14.8 7.8 23.2 7.2 7.3 23.2 7.0 11.3 3.8 9.1 17.7 6.1 7.0 1.8 2.6 4.4 3.2 2.6 5.3 5.6 10.6 3.6 6.1 0.9 6.3 21.5 4.6 2.2 5.3 2.1 3.6 4.3 7.5 17.4 2.1 2.1 4.3 2.0 2.2 6.7 2.9 3.5 2.4 3.8 4.2 6.1 5.6 6.0 2.1 46.1 4.7 3.5 11.8 3.7 0.5 4.3 2.3 20.6 6.7 14.3 7.9 4.8 6.1 6.3 4.5 9.5 2.2 1.2 4.0 9.7 4.2 5.7 6.7 4.7 4.4 28.9 26.5 39.8 5.3 4.5 4.1 2.9 3.8 2.0 6.3 2.7 10.3 21.2 11.7 11.0 7.0 23.2 5.4 6.6 11.3 9.1 3.2 6.5 17.7 6.1 3.3 3.8 6.1 4.5 4.7 2.1 5.4 1.6 3.9 4.8 17.9 20.6 34.4 9.9 18.9 1.0 14.1 10.2 6.7 11.4 12.2 0.0 42.8 16.6 12.7 0.0 14.5 5.8 0.0 21.2 17.8 22.6 27.2 3.5 8.5 16.0 0.0 8.6 4.9 10.7 0.0 8.3 11.2 32.1 6.4 7.0 11.3 12.9 3.6 10.3 6.3 0.6 6.5 13.4 0.9 3.0 22.7 66.4 27.3 6.5 10.7 TIGAR C12orf5 ENSG00000078237 "TP53 induced glycolysis regulatory phosphatase" Q9NQ88 12 4307763-4354593 "Enzymes, Predicted intracellular proteins" "Apoptosis, Autophagy" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 53.0;monocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 36.9;SuSa: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034010, HPA040354, HPA044111" Approved Supported Cytosol NA NA Cytosol "CAB034010: AB_1128227, HPA040354: AB_2676935, HPA044111: AB_2678814" "unprognostic (1.76e-1)" "unprognostic (6.33e-2)" "unprognostic (4.08e-1)" "unprognostic (2.60e-1)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (5.41e-2)" "unprognostic (2.11e-1)" "unprognostic (9.37e-2)" "unprognostic (1.85e-1)" "unprognostic (5.21e-2)" "unprognostic (2.03e-2)" "unprognostic (2.02e-3)" "unprognostic (2.44e-1)" "unprognostic (3.31e-1)" "unprognostic (1.05e-1)" 14.3 14.3 8.3 12.3 10.8 10.5 7.1 3.7 17.8 6.3 10.4 10.1 6.4 6.7 7.5 7.3 10.3 5.7 8.5 9.8 9.5 7.9 7.7 11.0 10.4 12.3 13.5 7.9 6.0 5.2 9.0 14.4 14.6 12.2 7.5 13.5 8.4 8.2 9.5 13.6 6.2 8.7 12.5 12.3 14.9 8.5 8.4 8.3 8.9 6.0 6.6 12.6 13.9 8.9 3.7 14.0 4.7 15.5 3.2 5.7 3.6 5.3 8.6 7.0 8.1 6.6 6.4 36.9 9.3 7.9 7.1 9.7 10.4 5.5 6.0 1.3 6.4 7.6 6.8 7.4 15.9 8.9 7.7 5.4 0.1 5.7 8.5 14.0 3.3 1.2 11.6 19.2 8.3 15.0 4.4 14.4 4.4 0.6 4.5 14.3 7.9 2.9 1.7 15.0 6.3 2.6 4.2 11.4 2.2 6.9 10.9 0.2 4.2 8.8 4.4 11.5 36.2 1.4 2.9 12.4 9.6 12.4 7.5 5.2 3.8 3.8 10.3 6.7 2.3 7.6 0.5 8.2 0.7 3.6 14.4 3.4 3.7 2.8 3.9 14.0 2.9 1.9 3.2 4.7 3.2 15.5 5.5 5.7 3.6 8.3 10.8 3.7 17.8 9.5 7.9 13.5 7.9 12.2 8.3 0.0 1.7 11.5 7.6 0.0 3.3 9.7 2.5 0.0 0.0 5.2 17.7 23.6 13.3 13.4 23.6 8.7 1.6 0.0 12.0 23.6 8.6 7.1 0.0 5.1 53.0 1.6 7.0 5.5 19.7 22.4 3.4 12.3 0.0 43.3 1.8 11.0 13.1 3.5 4.2 7.3 3.1 6.5 6.6 17.0 23.4 0.0 28.7 4.4 2.0 10.8 TIGD4 ENSG00000169989 "Tigger transposable element derived 4" Q8IY51 4 152769354-152779764 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.1;testis: 11.8" "Group enriched" "Detected in some" 4 "Early spermatids: 76.3;Rod photoreceptor cells: 29.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 4.6;U-266/70: 6.8;U-266/84: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035649, HPA073768" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035649: AB_10670956, HPA073768: " "unprognostic (1.71e-1)" "unprognostic (5.97e-2)" "unprognostic (4.01e-2)" "unprognostic (1.23e-4)" "unprognostic (6.19e-3)" "unprognostic (1.82e-2)" "unprognostic (1.61e-5)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (3.89e-3)" "unprognostic (1.16e-2)" "unprognostic (3.36e-2)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-2)" "unprognostic (4.47e-2)" 0.7 1.0 2.2 0.7 8.6 0.2 2.1 3.5 3.6 2.5 0.8 2.1 3.9 1.1 2.0 4.2 0.6 5.5 0.8 1.0 4.8 2.1 2.0 0.6 3.5 0.5 1.6 3.2 1.7 0.9 5.4 14.1 0.5 5.8 1.3 0.9 5.4 2.0 1.1 1.2 1.3 0.8 0.9 2.7 0.8 1.0 11.8 1.3 0.3 2.1 0.6 0.5 1.0 0.8 0.4 0.0 1.6 1.1 2.1 1.3 0.0 0.6 0.5 3.0 1.2 0.2 0.4 0.3 0.1 0.7 0.3 0.6 0.6 1.3 1.0 0.1 0.1 1.4 0.5 1.1 0.5 0.5 1.0 0.2 1.5 0.7 0.3 0.2 0.6 0.3 0.1 0.5 0.5 0.3 0.6 0.1 2.2 0.4 4.6 0.3 0.3 2.9 0.4 1.4 0.4 0.4 0.5 0.6 0.0 2.0 0.1 1.4 1.6 0.2 0.3 2.9 1.4 0.7 0.2 0.0 0.4 0.6 0.5 0.6 6.8 13.2 0.6 1.0 1.6 2.2 0.0 0.3 0.8 0.0 1.1 0.2 0.0 0.3 1.3 0.0 0.4 0.1 0.4 1.6 2.1 0.2 0.0 0.0 0.0 2.2 8.6 3.5 3.6 4.8 2.1 1.6 3.2 5.8 1.3 0.0 1.0 0.0 0.4 0.0 6.7 0.0 0.0 12.0 0.0 1.8 11.8 0.1 0.0 0.5 76.3 0.1 0.0 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.5 1.6 1.2 0.0 0.0 8.5 0.3 0.0 0.0 0.0 0.1 12.1 0.4 0.0 0.4 1.5 29.0 0.0 0.0 5.1 1.7 0.0 0.2 0.0 0.4 0.3 TIGD7 Sancho ENSG00000140993 "Tigger transposable element derived 7" Q6NT04 16 3298832-3305729 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041357, HPA041474" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041357: AB_10794992, HPA041474: AB_10795696" "unprognostic (7.69e-2)" "unprognostic (3.04e-4)" "unprognostic (6.56e-3)" "unprognostic (1.18e-3)" "unprognostic (1.79e-1)" "unprognostic (4.04e-2)" "unprognostic (6.50e-3)" "unprognostic (2.44e-1)" "unprognostic (2.78e-2)" "unprognostic (9.81e-2)" "unprognostic (8.56e-3)" "unprognostic (2.09e-1)" "unprognostic (2.25e-2)" "unprognostic (8.87e-2)" "unprognostic (4.04e-1)" "unprognostic (5.90e-3)" "unprognostic (3.12e-2)" 3.7 5.6 7.7 8.2 7.6 1.3 11.7 8.6 6.8 8.5 5.9 5.3 5.8 3.1 9.3 8.2 5.2 8.8 4.7 7.7 7.1 8.3 6.8 3.9 4.6 4.8 7.1 3.7 17.4 4.4 16.9 17.6 5.3 7.5 8.4 3.6 3.8 4.1 8.9 5.5 3.5 4.0 6.9 6.7 6.5 3.7 12.5 7.3 8.5 11.0 2.8 5.0 11.0 6.1 4.9 1.1 6.3 2.8 3.8 5.7 1.5 0.9 2.1 5.5 3.0 2.9 4.2 4.5 2.9 1.8 4.5 4.2 0.3 1.7 2.0 4.7 2.1 3.3 0.5 2.0 0.8 5.7 0.2 2.8 5.8 1.7 0.1 3.3 1.0 7.7 4.4 1.5 4.2 1.3 4.7 3.4 1.5 2.8 3.7 3.8 1.2 1.9 8.8 6.3 0.5 5.0 10.3 1.3 8.4 2.4 0.5 7.6 2.8 6.8 0.9 2.5 5.0 3.2 3.3 1.1 2.7 6.5 2.8 1.6 7.7 7.8 6.4 1.6 3.4 3.0 1.0 1.4 6.3 3.3 1.0 5.7 1.6 2.8 4.8 1.0 4.9 5.5 3.6 3.5 3.8 2.8 1.1 2.9 1.5 7.7 7.6 8.6 6.8 7.1 8.3 7.1 3.7 7.5 7.3 8.9 5.0 0.5 3.2 0.7 7.4 8.4 5.1 2.7 5.7 0.0 3.9 1.2 3.3 2.3 2.6 1.7 0.5 0.0 1.2 0.9 0.9 2.7 1.1 0.5 0.8 4.8 1.2 0.6 1.6 1.6 2.6 1.1 5.0 0.0 0.8 3.2 0.8 0.0 4.2 0.8 1.8 6.5 1.7 10.5 10.4 0.5 1.1 2.6 0.4 1.4 TIPRL "dJ69E11.3, MGC3794, TIP41, TIPRL1" ENSG00000143155 "TOR signaling pathway regulator" O75663 1 168178933-168202114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027995, HPA054282" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA027995: AB_10602900, HPA054282: AB_2682435" "unprognostic (3.18e-2)" "unprognostic (1.05e-1)" "unprognostic (5.05e-2)" "unprognostic (3.17e-1)" "unprognostic (3.80e-1)" "unprognostic (2.35e-3)" "prognostic unfavorable (1.60e-4)" "unprognostic (5.82e-2)" "unprognostic (3.32e-2)" "unprognostic (1.12e-2)" "unprognostic (4.30e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.45e-8)" "unprognostic (3.23e-1)" "unprognostic (1.57e-1)" "unprognostic (5.55e-2)" "unprognostic (8.61e-2)" 19.6 22.3 17.0 18.6 29.6 29.7 21.4 18.4 29.1 19.4 21.9 11.2 12.9 18.9 25.9 17.7 28.5 17.5 17.1 23.1 17.4 20.5 22.9 38.3 16.2 20.2 18.0 19.3 21.6 22.2 23.8 31.9 19.8 23.1 19.9 22.7 11.4 17.9 18.6 32.0 16.2 23.2 23.5 16.0 19.0 16.1 22.8 12.4 35.2 17.8 21.1 21.2 23.3 18.5 17.7 21.5 36.2 21.4 19.3 23.9 17.7 26.2 11.5 18.1 16.4 14.8 21.5 10.8 19.7 20.8 21.6 19.4 17.8 19.6 18.4 27.2 18.8 16.1 31.8 13.4 19.1 20.9 17.7 13.7 17.8 11.9 8.5 26.0 35.4 24.7 17.3 24.7 18.8 25.2 14.4 22.7 29.4 25.6 26.2 18.6 9.1 31.6 18.4 14.5 36.8 20.6 15.5 18.5 25.2 19.4 13.0 11.7 26.2 15.2 21.6 38.6 21.5 23.6 36.5 20.6 18.3 21.0 17.1 26.5 28.7 29.7 41.1 11.9 23.5 20.9 36.2 18.7 24.2 16.2 21.4 16.2 17.7 19.0 17.2 21.5 17.7 17.1 16.9 24.2 19.3 21.4 16.1 23.9 17.7 17.0 29.6 18.4 29.1 17.4 20.5 18.0 19.3 23.1 12.4 23.8 14.8 32.8 35.9 42.7 25.6 43.2 22.9 29.4 23.9 21.0 15.7 37.2 24.9 58.5 31.5 34.6 29.9 0.0 77.6 52.7 32.1 27.7 39.3 31.6 57.2 49.3 23.1 33.7 19.7 8.9 34.8 40.9 28.7 62.3 33.7 41.8 57.8 20.1 35.7 54.3 18.4 25.8 36.3 133.2 39.6 36.5 24.3 35.2 36.5 31.3 TIRAP "Mal, wyatt" ENSG00000150455 "TIR domain containing adaptor protein" P58753 11 126283065-126298845 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054431 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA054431: AB_2682486" "unprognostic (9.30e-3)" "unprognostic (7.39e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.24e-4)" "unprognostic (2.73e-2)" "unprognostic (5.77e-2)" "unprognostic (1.27e-1)" "unprognostic (6.89e-2)" "unprognostic (2.40e-1)" "unprognostic (2.28e-1)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (3.34e-3)" "unprognostic (4.29e-3)" "unprognostic (3.62e-2)" "unprognostic (3.47e-1)" "unprognostic (2.57e-1)" 8.8 10.4 5.2 11.9 5.4 3.9 16.8 7.2 8.0 11.9 18.9 4.6 13.2 11.6 11.1 11.1 9.7 8.7 14.2 11.6 4.4 6.5 9.2 14.8 16.8 17.6 6.5 5.8 13.4 18.7 14.0 8.8 9.2 5.1 11.1 8.9 10.5 15.3 21.1 10.5 8.4 17.3 13.6 4.7 13.4 8.7 3.5 2.4 3.3 8.0 6.4 9.8 11.8 7.3 6.5 8.7 8.8 10.5 4.4 8.3 6.2 1.9 6.2 3.3 5.6 5.7 8.0 4.0 5.1 8.3 3.6 3.4 9.7 7.4 5.0 8.8 5.2 6.3 5.6 3.5 3.9 1.4 13.2 3.3 13.5 3.5 6.2 4.6 8.2 7.3 6.0 5.5 6.7 4.7 4.3 5.9 4.1 3.6 11.6 4.1 3.5 0.2 1.3 1.5 13.9 5.7 1.7 0.9 4.7 2.8 6.9 4.1 5.3 6.0 6.0 4.2 4.6 16.4 4.3 5.8 2.0 1.9 4.1 3.8 3.2 4.6 3.7 3.1 6.6 6.2 7.7 10.5 4.9 7.7 8.7 7.4 4.3 6.1 8.3 8.7 6.5 5.0 4.9 8.8 4.4 5.7 5.9 6.1 6.2 5.2 5.4 7.2 8.0 4.4 6.5 6.5 5.8 5.1 2.4 6.0 1.6 1.3 1.4 0.3 3.0 0.8 0.0 1.4 3.4 3.5 0.0 2.8 0.0 2.5 0.0 1.5 4.2 0.0 3.5 4.1 1.6 1.9 1.1 4.9 4.4 3.2 1.2 2.5 4.0 0.0 4.4 2.7 1.7 0.0 2.6 2.4 3.0 4.2 4.2 1.7 2.3 0.0 1.2 0.1 0.6 0.1 2.2 1.9 2.4 1.3 TKFC "DAK, DKFZP586B1621, NET45" ENSG00000149476 "Triokinase and FMN cyclase" Q3LXA3 11 61333210-61353295 "Enzymes, Predicted intracellular proteins" "Kinase, Lyase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 90.2;liver: 42.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 92.7;Proximal tubular cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 40.5;RPMI-8226: 42.7;T-47d: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039486, HPA048186" Enhanced Approved Nucleoplasm,Cytosol NA NA 4800000 Cytosol Nucleoplasm "HPA039486: AB_10795402, HPA048186: AB_2680305" "unprognostic (4.00e-1)" "unprognostic (3.13e-1)" "unprognostic (7.42e-2)" "prognostic favorable (1.32e-5)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (3.02e-2)" "unprognostic (2.81e-3)" "unprognostic (1.49e-1)" "unprognostic (2.47e-1)" "unprognostic (1.51e-1)" "unprognostic (2.15e-1)" "prognostic favorable (8.38e-5)" "unprognostic (2.07e-2)" "unprognostic (8.96e-2)" "unprognostic (3.30e-1)" "unprognostic (4.02e-1)" 3.1 34.7 3.6 6.1 5.3 5.3 4.6 3.7 7.3 3.4 43.4 7.6 8.0 69.5 4.6 7.8 6.2 5.9 8.8 2.8 3.1 2.6 17.4 42.8 3.5 5.2 3.3 5.3 4.5 9.8 3.0 5.5 3.9 4.4 5.0 2.3 7.3 7.2 7.1 4.6 6.1 90.2 2.6 3.1 5.4 5.7 17.1 3.4 5.5 6.4 6.3 6.7 5.4 3.9 9.7 18.4 5.4 11.4 5.3 10.9 7.8 6.1 15.6 2.7 9.5 3.4 3.7 7.7 3.6 3.9 3.4 2.2 7.1 14.8 7.6 12.6 2.6 3.5 8.6 5.1 6.7 1.1 13.1 6.8 4.7 8.2 40.5 5.9 3.9 7.9 5.9 4.6 3.2 11.2 2.9 3.3 5.3 8.2 14.8 2.4 27.9 3.5 3.6 7.5 5.8 10.7 6.2 4.3 42.7 5.4 10.9 10.6 9.5 6.6 11.6 6.0 1.9 42.8 2.8 4.0 6.7 7.0 5.3 2.1 27.4 22.6 6.9 6.9 3.7 6.1 2.3 11.4 5.4 6.7 6.8 8.6 9.7 7.8 6.5 18.4 9.7 5.6 5.9 0.9 5.3 5.3 9.0 10.9 7.8 3.6 5.3 3.7 7.3 3.1 2.6 3.3 5.3 4.4 3.4 0.0 12.6 6.7 10.8 0.0 12.9 3.4 12.7 20.1 12.5 14.0 13.7 25.7 24.9 15.5 7.9 4.5 5.4 0.0 12.8 4.4 3.0 11.6 7.0 92.7 14.9 7.9 12.9 6.2 18.3 9.3 14.1 5.9 0.0 27.9 13.9 8.7 12.3 18.1 21.2 63.4 16.0 6.5 2.4 39.2 14.5 0.0 12.7 5.7 18.4 10.6 TKTL1 "TKR, TKT2" ENSG00000007350 "Transketolase like 1" P51854 X 154295671-154330350 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 50 "blood: 28.6;testis: 103.6" "Cell type enriched" "Detected in some" 14 "Spermatogonia: 515.6" "Cancer enriched" "Detected in many" 8 "testis cancer: 44.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "eosinophil: 28.6;gdT-cell: 12.0" "Group enriched" "Detected in many" 6 "granulocytes: 28.6;T-cells: 12.0" "Cell line enriched" "Detected in single" 157 "THP-1: 102.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000505, HPA029155, CAB032191" Enhanced Enhanced Cytosol NA NA Cytosol "CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (1.98e-1)" "unprognostic (5.80e-3)" "unprognostic (2.43e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "unprognostic (2.10e-2)" "unprognostic (1.61e-1)" "unprognostic (1.98e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.34e-2)" "unprognostic (3.90e-2)" "unprognostic (5.04e-2)" "unprognostic (2.38e-1)" 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.6 0.1 3.3 12.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 102.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.8 0.0 28.6 12.0 0.1 1.8 0.0 1.4 1.1 0.0 0.0 3.1 2.7 0.4 3.3 0.1 0.1 1.5 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 23.8 0.0 0.0 0.0 16.9 3.7 1.3 0.0 0.0 0.0 5.3 0.0 0.0 1.8 0.0 1.1 25.8 1.4 35.6 515.6 0.1 0.0 0.5 0.0 0.0 TLDC1 KIAA1609 ENSG00000140950 "TBC/LysM-associated domain containing 1" Q6P9B6 16 84476421-84554033 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041020 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041020: AB_10794184" "unprognostic (8.35e-3)" "unprognostic (4.27e-2)" "unprognostic (1.48e-1)" "unprognostic (5.45e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-3)" "unprognostic (5.97e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (3.94e-1)" "unprognostic (2.85e-2)" "prognostic unfavorable (7.05e-5)" "unprognostic (2.92e-2)" "unprognostic (6.78e-3)" "unprognostic (9.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-2)" 5.5 4.9 7.6 7.1 10.7 1.8 7.3 8.1 11.5 8.1 7.1 6.3 5.2 6.0 14.0 8.8 24.4 6.9 6.5 4.7 6.3 4.5 7.6 5.1 6.4 6.1 5.0 9.4 8.7 5.2 11.3 4.4 15.8 10.7 7.8 7.8 12.9 7.7 6.1 4.5 11.0 9.3 10.7 4.0 5.4 6.8 8.1 3.4 8.3 7.6 6.5 10.0 10.4 12.1 3.3 2.7 13.6 3.5 3.1 8.7 2.6 14.7 10.4 9.1 4.9 4.2 7.4 4.3 10.9 9.8 11.3 3.3 5.9 17.9 2.0 5.9 21.0 8.3 16.5 2.5 29.3 14.9 1.1 2.2 1.6 5.1 5.1 5.2 1.2 5.1 5.1 12.7 10.5 13.9 9.2 4.7 5.9 2.7 2.5 7.6 3.5 1.1 1.2 2.8 7.7 3.6 4.5 2.3 0.7 10.0 8.3 3.0 2.1 9.9 7.1 4.9 10.0 10.2 2.0 11.5 7.9 3.6 4.2 4.5 2.0 3.5 5.4 4.7 0.6 2.7 13.6 3.1 4.4 3.8 2.7 3.7 3.3 6.8 5.5 2.7 2.7 7.6 4.7 3.1 3.1 3.5 0.8 8.7 2.6 7.6 10.7 8.1 11.5 6.3 4.5 5.0 9.4 10.7 3.4 3.0 4.5 2.7 8.9 2.1 14.1 3.3 5.1 8.1 6.8 12.2 115.8 28.9 5.0 15.5 1.4 5.8 13.6 0.0 7.5 8.8 5.1 7.2 4.7 1.5 7.3 4.8 2.9 5.5 4.8 1.2 7.5 2.7 3.3 10.8 4.5 8.1 14.4 7.0 5.3 6.1 65.7 0.0 5.1 4.6 3.9 3.0 39.4 3.2 4.8 20.0 TLN1 "ILWEQ, TLN" ENSG00000137076 "Talin 1" Q9Y490 9 35696948-35732395 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002006, HPA004748" Supported Supported "Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol" NA NA 3600000000 "Focal adhesion sites, Cytosol" "Plasma membrane, Centriolar satellite" "CAB002006: , HPA004748: AB_1857760" "unprognostic (9.71e-2)" "unprognostic (2.02e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (1.96e-1)" "unprognostic (5.55e-2)" "unprognostic (2.52e-1)" "unprognostic (3.18e-2)" "unprognostic (5.07e-2)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "prognostic favorable (7.21e-4)" "unprognostic (1.36e-1)" "unprognostic (2.71e-2)" "unprognostic (7.83e-2)" "unprognostic (8.83e-3)" 47.4 23.7 10.9 29.3 16.6 25.1 38.1 9.6 11.8 34.7 64.0 18.8 22.8 13.0 57.4 20.6 41.2 38.3 48.4 30.3 11.1 7.1 30.5 36.1 33.0 26.0 17.9 7.3 39.0 12.8 19.6 14.6 30.4 14.4 39.5 15.5 22.8 14.9 43.6 24.5 16.5 27.6 87.0 12.4 54.1 38.2 17.3 14.1 33.4 20.7 12.5 20.7 72.5 49.6 3.3 6.8 12.7 9.2 4.8 7.1 7.1 11.4 19.2 11.9 16.3 40.9 31.1 13.6 32.0 35.1 31.1 28.2 15.8 5.1 13.9 10.6 59.0 19.7 6.2 13.9 19.9 22.8 31.3 9.0 31.6 24.9 14.0 25.4 19.1 52.8 37.6 9.5 45.7 21.7 42.9 47.6 12.1 10.8 14.3 41.0 5.0 12.8 5.0 9.7 5.2 14.8 17.3 6.9 8.1 15.5 9.2 2.7 11.3 15.6 8.7 10.2 11.3 7.4 13.2 57.3 49.6 19.3 15.1 25.7 5.0 4.9 9.7 38.4 10.3 44.7 6.7 7.0 8.4 7.1 7.8 5.9 3.3 4.2 5.4 5.3 3.2 2.0 4.2 12.7 4.8 9.2 6.8 2.8 7.1 10.9 16.6 9.6 11.8 11.1 7.1 17.9 7.3 14.4 14.1 101.3 67.1 67.7 36.3 35.6 10.9 115.6 40.8 50.9 78.5 50.6 9.8 34.4 19.9 88.6 37.6 106.8 42.8 46.7 54.0 72.5 71.0 43.2 194.8 46.5 103.3 14.3 32.7 76.1 163.8 17.2 92.0 155.9 21.9 147.9 23.2 33.9 81.9 24.6 120.9 45.4 17.3 200.5 199.7 26.8 25.9 23.2 49.2 86.7 23.2 31.2 TLN2 "ILWEQ, KIAA0320" ENSG00000171914 "Talin 2" Q9Y4G6 15 62390526-62844631 "Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 36.9" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 46.1;Rod photoreceptor cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 29.8;hTERT-HME1: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017194, HPA051828, HPA054787" Enhanced Supported "Focal adhesion sites,Cytosol" NA NA 81000000 "Focal adhesion sites, Cytosol" "CAB017194: , HPA051828: AB_2732570, HPA054787: AB_2732587" "prognostic favorable (6.53e-4)" "unprognostic (2.61e-1)" "unprognostic (9.47e-2)" "unprognostic (8.95e-2)" "unprognostic (3.74e-1)" "unprognostic (1.43e-1)" "unprognostic (8.24e-2)" "unprognostic (9.94e-2)" "unprognostic (1.68e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (1.91e-1)" "prognostic favorable (1.81e-6)" "prognostic favorable (7.74e-4)" "unprognostic (1.34e-1)" "unprognostic (5.79e-2)" "unprognostic (2.30e-1)" 12.5 3.1 7.0 12.1 7.0 2.3 5.3 5.4 18.9 5.6 24.3 4.0 1.7 3.3 6.5 4.2 3.4 3.2 6.3 8.5 6.8 6.0 36.9 1.8 1.9 1.3 6.2 4.2 7.0 3.3 2.3 3.0 2.4 4.5 3.1 5.4 5.5 5.4 1.6 16.9 1.6 16.6 6.9 9.6 0.8 4.1 3.5 1.3 0.9 29.0 4.5 1.3 4.3 7.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.8 2.7 3.9 4.6 29.8 2.8 4.4 6.6 5.2 6.1 6.0 7.2 0.9 2.2 3.0 11.4 10.1 1.1 5.0 1.0 5.3 7.1 0.5 0.2 10.8 4.7 1.0 0.7 0.2 5.2 2.7 8.1 24.2 3.5 0.2 2.8 0.2 0.1 10.1 3.5 0.3 0.3 6.9 12.4 2.0 2.7 9.9 2.7 3.2 5.5 0.9 4.5 5.0 0.5 1.7 8.8 1.4 1.7 1.9 11.0 15.0 17.7 16.8 0.1 0.4 1.4 5.0 1.6 13.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 7.0 7.0 5.4 12.9 6.8 6.0 6.2 4.2 4.5 1.3 0.0 2.7 1.3 1.5 2.2 11.7 35.9 2.5 0.0 1.2 26.2 35.3 1.0 10.0 3.4 3.4 4.9 16.5 0.0 3.3 22.8 11.6 1.5 0.0 10.6 4.5 46.1 2.4 4.3 5.6 4.0 10.9 5.1 0.0 1.0 16.7 10.1 2.9 17.3 14.9 25.8 47.3 0.0 7.6 2.6 19.4 1.4 1.1 0.0 27.9 1.4 TLR10 CD290 ENSG00000174123 "Toll like receptor 10" Q9BXR5 4 38772239-38782990 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6" "Cell type enriched" "Detected in some" 18 "B-cells: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory B-cell: 23.5;naive B-cell: 14.9" "Lineage enriched" "Detected in many" 6 "B-cells: 23.5" "Group enriched" "Detected in some" 55 "Daudi: 38.2;REH: 12.8;U-698: 13.7" "Low region specificity" "Detected in all" HPA066755 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA066755: " "unprognostic (5.41e-5)" "unprognostic (2.41e-4)" "unprognostic (1.91e-3)" "unprognostic (8.22e-4)" "unprognostic (6.48e-2)" "unprognostic (9.98e-4)" "unprognostic (9.31e-2)" "unprognostic (8.76e-3)" "unprognostic (4.08e-3)" "unprognostic (7.26e-2)" "unprognostic (8.76e-2)" "unprognostic (6.90e-2)" "unprognostic (2.98e-3)" "unprognostic (3.90e-1)" "unprognostic (1.81e-2)" "unprognostic (3.14e-3)" "unprognostic (1.88e-2)" 0.8 0.5 4.2 24.5 9.4 0.9 0.6 0.6 3.5 0.6 1.0 2.5 0.0 0.9 0.5 0.3 1.7 0.9 1.0 0.5 3.2 1.8 0.8 0.7 1.2 27.0 5.5 0.5 0.5 0.6 0.1 0.7 0.2 4.8 0.8 1.4 0.0 2.6 0.3 0.5 0.5 11.2 0.3 11.3 24.4 1.8 0.4 7.4 2.7 0.9 0.0 31.6 3.2 0.6 23.5 4.0 0.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.1 0.2 0.4 0.0 1.5 0.0 23.5 0.0 0.0 3.6 14.9 0.0 0.0 0.7 0.0 1.8 4.0 0.0 0.9 4.2 9.4 0.6 3.5 3.2 1.8 5.5 0.5 4.8 7.4 0.0 1.4 39.2 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.7 0.0 1.2 0.6 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 TLR5 "FLJ10052, MGC126430, MGC126431, SLEB1, TIL3" ENSG00000187554 "Toll like receptor 5" O60602 1 223109406-223143282 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 17.8;Collecting duct cells: 21.0;Kupffer cells: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 17.0;intermediate monocyte: 15.7;myeloid DC: 12.8;neutrophil: 13.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 10 "dendritic cells: 12.8;granulocytes: 13.4;monocytes: 17.0" "Cell line enhanced" "Detected in some" "A-431: 4.4;HaCaT: 6.7;OE19: 3.9;SK-BR-3: 4.3;T-47d: 4.8" "Low region specificity" "Detected in many" CAB009013 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB009013: AB_2240732" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-2)" "unprognostic (3.81e-2)" "unprognostic (3.09e-2)" "unprognostic (6.83e-2)" "unprognostic (1.49e-2)" "unprognostic (2.71e-1)" "unprognostic (4.23e-3)" "unprognostic (1.46e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.06e-3)" "unprognostic (5.60e-2)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" 3.8 2.4 5.3 4.8 7.3 0.4 9.7 0.8 5.3 7.1 2.7 3.4 1.7 1.7 2.4 6.2 9.0 5.6 4.8 5.8 5.0 2.6 4.6 2.2 6.5 12.5 7.0 0.8 22.5 5.3 6.6 6.3 3.5 6.8 6.2 2.3 3.2 12.6 2.9 1.4 3.7 2.3 3.7 12.8 6.7 4.5 2.3 8.1 1.2 4.3 3.5 5.7 5.9 7.8 0.1 12.8 13.4 17.0 0.2 1.4 5.7 4.4 0.4 0.7 0.4 0.3 0.0 0.6 0.2 0.0 0.1 0.1 0.0 1.3 0.0 0.9 0.4 0.1 6.7 0.1 0.5 0.4 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.1 1.9 0.5 0.2 1.7 0.9 0.0 0.0 0.6 1.0 0.3 2.5 3.9 0.0 0.1 0.0 0.2 2.1 0.8 1.8 0.4 1.3 4.3 0.1 1.0 4.8 0.0 0.0 0.1 0.1 0.0 1.2 0.2 0.0 0.2 0.0 0.7 0.5 0.0 17.0 0.2 0.1 15.7 0.2 0.1 0.9 0.2 12.8 0.0 1.4 0.4 13.4 0.2 6.3 0.2 0.6 5.7 5.3 7.3 0.8 5.3 5.0 2.6 7.0 0.8 6.8 8.1 3.0 10.5 0.0 5.9 0.5 0.0 1.7 17.8 8.1 15.9 21.0 2.0 1.2 3.3 3.0 3.3 1.0 0.0 0.0 3.4 0.3 5.0 3.3 2.3 0.6 15.6 0.0 1.2 0.6 23.7 4.0 8.6 11.1 3.3 0.0 0.3 1.1 2.0 0.0 8.1 0.0 0.1 0.0 1.4 4.3 4.5 1.4 0.7 0.0 1.2 6.5 TM2D3 "BLP2, FLJ22604" ENSG00000184277 "TM2 domain containing 3" Q9BRN9 15 101621444-101652391 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054064 Uncertain Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA054064: AB_2682366" "unprognostic (1.41e-1)" "unprognostic (8.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.55e-3)" "unprognostic (1.15e-1)" "unprognostic (8.37e-2)" "unprognostic (2.29e-1)" "unprognostic (8.62e-2)" "unprognostic (2.51e-2)" "unprognostic (5.40e-2)" "unprognostic (4.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (2.92e-2)" "unprognostic (2.63e-1)" "unprognostic (3.78e-2)" "unprognostic (2.78e-2)" 17.8 25.1 32.8 14.1 33.1 15.4 26.0 30.7 46.7 24.9 16.9 21.3 15.3 15.2 26.3 29.1 15.3 22.5 18.7 28.3 35.3 49.8 20.6 32.8 17.5 23.0 28.2 35.8 37.6 28.2 23.5 25.7 19.6 26.8 21.5 15.6 19.1 20.9 24.0 22.6 16.8 15.0 20.7 22.7 17.0 15.8 20.6 19.1 16.0 29.1 14.2 19.2 19.2 16.1 21.4 14.3 38.4 20.2 24.1 24.1 18.0 8.5 21.3 11.4 20.6 32.9 24.5 14.0 11.3 18.8 13.5 15.1 11.4 24.4 14.0 15.7 15.4 22.7 20.2 17.7 14.6 10.7 13.3 39.0 20.9 18.5 19.3 21.7 16.2 25.0 20.3 29.6 8.1 16.9 18.9 18.5 18.2 17.1 21.2 21.2 17.3 11.8 17.2 17.6 38.9 7.2 14.5 14.5 21.7 27.2 22.6 15.4 14.1 15.6 16.6 22.5 20.5 15.7 21.5 14.7 14.3 14.7 9.5 12.4 20.1 29.7 15.1 12.1 20.4 11.7 14.8 20.2 38.4 21.7 19.9 24.1 15.5 17.9 16.5 14.3 21.4 23.9 22.1 34.4 24.1 15.0 12.1 18.0 18.0 32.8 33.1 30.7 46.7 35.3 49.8 28.2 35.8 26.8 19.1 23.8 33.2 37.0 49.5 58.8 44.9 33.5 22.9 16.0 28.4 40.1 31.4 64.8 16.6 54.9 5.7 52.5 22.0 0.0 37.4 54.4 51.9 46.9 24.3 51.6 29.9 65.2 25.9 53.4 45.9 8.8 68.1 37.2 25.3 39.7 23.1 57.0 28.6 23.2 59.1 32.7 43.7 71.1 42.7 85.4 85.7 48.4 76.1 47.2 25.4 34.6 TM4SF18 L6D ENSG00000163762 "Transmembrane 4 L six family member 18" Q96CE8 3 149318498-149334414 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Endothelial cells: 155.8;Ito cells: 174.3" "Cancer enhanced" "Detected in all" "renal cancer: 17.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 29.6;EFO-21: 62.5;GAMG: 12.4;HUVEC TERT2: 20.7;NTERA-2: 14.9" "Low region specificity" "Detected in all" "HPA053639, HPA069378" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA053639: , HPA069378: AB_2686133" "unprognostic (2.25e-1)" "unprognostic (3.68e-1)" "unprognostic (4.76e-2)" "unprognostic (1.08e-1)" "unprognostic (9.11e-3)" "unprognostic (1.05e-2)" "prognostic favorable (8.63e-4)" "unprognostic (2.84e-1)" "unprognostic (6.13e-3)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (1.75e-1)" "unprognostic (5.71e-2)" "unprognostic (3.56e-3)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.97e-1)" 17.9 4.8 7.1 4.0 8.8 0.1 14.4 3.7 7.3 7.9 3.5 1.7 4.7 3.1 7.6 7.2 5.4 5.6 9.0 10.8 8.4 6.2 26.6 9.7 7.4 8.0 9.3 1.5 5.4 8.0 4.2 7.4 14.1 12.3 9.1 2.9 11.9 3.5 5.6 9.3 2.7 3.9 12.3 7.4 34.6 3.5 2.6 8.2 0.6 12.0 5.7 4.0 6.0 5.8 0.9 0.6 1.2 0.4 2.8 0.5 0.0 0.0 29.6 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 62.5 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.9 20.7 0.0 0.0 0.0 1.9 0.2 0.0 0.0 14.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 2.6 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.7 1.2 0.4 0.4 0.3 0.2 0.1 0.5 0.4 0.2 0.0 0.9 0.4 0.5 0.5 2.8 0.3 0.6 0.1 0.0 7.1 8.8 3.7 7.3 8.4 6.2 9.3 1.5 12.3 8.2 0.0 4.1 2.2 0.0 2.9 0.1 1.1 7.6 1.4 0.0 1.8 0.0 0.0 8.3 21.2 0.3 155.8 0.0 0.0 0.2 0.0 0.9 1.0 1.1 0.6 0.1 0.0 0.0 174.3 13.0 1.0 2.0 0.2 1.7 1.0 0.0 0.6 1.2 0.0 6.3 25.4 0.0 0.0 2.1 0.0 0.2 2.5 0.0 1.3 0.0 0.4 TM4SF4 il-TMP ENSG00000169903 "Transmembrane 4 L six family member 4" P48230 3 149473974-149503281 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 196.0;intestine: 126.4;liver: 81.8" "Cell type enriched" "Detected in many" 5 "Cholangiocytes: 2236.9" "Group enriched" "Detected in many" 10 "liver cancer: 249.4;pancreatic cancer: 130.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Lineage enriched" "Detected in single" 13 "monocytes: 1.3" "Group enriched" "Detected in some" 6 "A549: 15.4;OE19: 14.2;RPTEC TERT1: 24.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046430 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046430: AB_2679662" "unprognostic (1.91e-2)" "unprognostic (1.71e-1)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.83e-1)" "unprognostic (4.66e-2)" "unprognostic (1.91e-2)" "unprognostic (4.97e-1)" 0.3 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 68.2 0.0 0.0 70.3 0.2 0.1 0.3 0.3 196.0 0.2 0.2 0.2 0.4 81.8 0.3 0.0 0.2 0.0 0.2 24.2 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.2 126.4 0.0 0.2 0.3 2.3 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.3 0.2 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.6 0.1 14.2 0.0 0.0 0.3 0.9 24.0 0.0 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 0.0 3.4 2236.9 0.0 1.2 0.0 0.0 0.0 0.0 20.8 0.8 0.0 2.6 23.3 1.7 0.1 0.0 0.0 0.0 475.7 0.1 0.0 2.9 8.0 11.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 7.6 0.0 0.0 2.1 0.0 0.0 1.1 3.6 0.1 0.0 0.1 0.0 0.1 0.1 TM7SF3 ENSG00000064115 "Transmembrane 7 superfamily member 3" Q9NS93 12 26973195-27014434 "Predicted intracellular proteins, Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 123.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057640 Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA057640: " "unprognostic (4.24e-1)" "unprognostic (1.90e-2)" "unprognostic (1.04e-3)" "unprognostic (8.80e-2)" "unprognostic (5.82e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-2)" "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.01e-2)" "unprognostic (1.16e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" 12.0 27.6 12.1 8.1 17.4 18.5 15.9 7.9 18.9 12.4 17.2 18.1 13.1 10.7 10.9 16.6 27.8 12.7 16.4 10.6 11.7 11.6 69.8 39.9 15.9 15.0 13.0 11.6 12.1 52.6 15.4 33.2 11.0 10.7 14.5 19.7 20.5 21.9 14.2 5.8 15.4 12.8 13.2 13.9 12.0 14.9 11.0 10.6 31.2 14.1 12.3 17.1 15.3 16.5 10.5 10.6 16.0 6.9 11.8 11.4 3.9 8.4 20.1 12.0 14.5 18.3 12.1 63.1 10.5 17.0 8.6 14.9 11.1 36.2 11.4 13.5 9.8 7.8 9.3 12.5 70.9 12.0 11.1 7.4 17.0 25.3 21.0 12.1 61.3 12.0 7.4 60.5 18.5 16.7 26.3 22.7 30.9 7.3 7.8 13.0 17.3 29.9 35.7 24.4 32.7 12.0 28.0 18.9 20.1 15.0 38.7 2.0 10.7 12.9 6.9 18.4 59.2 19.1 13.0 8.5 7.6 12.4 20.7 12.9 4.7 12.1 21.3 14.6 20.9 11.4 8.6 6.9 16.0 6.0 6.9 5.7 7.3 7.6 7.8 10.2 10.5 10.9 7.2 7.8 11.8 3.5 10.6 11.4 3.9 12.1 17.4 7.9 18.9 11.7 11.6 13.0 11.6 10.7 10.6 11.9 22.2 20.8 43.3 25.5 44.9 8.6 94.3 5.3 25.0 40.1 41.2 35.0 14.9 48.9 75.7 18.9 16.7 23.3 35.2 13.0 17.5 22.1 13.9 37.8 34.8 22.3 12.7 15.4 19.7 123.7 14.4 20.3 62.4 21.6 21.2 29.6 27.4 31.6 21.5 79.2 34.9 6.5 12.8 6.2 26.2 24.3 13.6 20.3 29.9 34.1 TMC3 ENSG00000188869 "Transmembrane channel like 3" Q7Z5M5 15 81331217-81374213 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "parathyroid gland: 66.9" "Cell type enhanced" "Detected in single" 24 "Distal tubular cells: 1.7" "Cancer enhanced" "Detected in single" "breast cancer: 0.5" "Region enhanced" "Detected in some" "pons and medulla: 1.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040265, HPA040510" Enhanced Supported Cytosol NA NA Cytosol "HPA040265: AB_10795379, HPA040510: AB_10796123" "unprognostic (1.17e-2)" "unprognostic (3.43e-1)" "unprognostic (3.14e-1)" "unprognostic (8.33e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (4.85e-3)" "unprognostic (2.20e-2)" "unprognostic (3.12e-2)" "unprognostic (1.77e-1)" "unprognostic (6.20e-5)" "unprognostic (2.32e-1)" "unprognostic (1.97e-7)" "unprognostic (1.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.26e-1)" "unprognostic (5.96e-2)" 0.0 0.1 0.0 1.7 0.0 0.3 0.2 0.4 1.4 1.5 1.5 0.0 0.0 0.2 0.8 4.6 0.7 0.8 0.2 0.2 0.0 0.1 0.1 1.3 0.0 0.1 0.0 0.0 0.2 0.2 66.9 1.5 0.7 1.6 1.0 0.1 0.4 0.2 2.9 0.0 0.2 0.5 1.7 1.9 0.1 0.8 3.0 0.0 0.0 1.5 0.0 0.0 1.3 3.6 1.6 0.7 0.2 0.2 0.2 1.8 0.7 0.9 1.0 0.5 2.7 0.4 0.2 1.9 0.8 0.3 0.2 0.3 0.7 1.9 2.3 0.1 0.0 2.4 0.7 0.3 0.2 0.1 1.7 1.4 1.9 1.1 0.9 0.3 1.5 1.1 0.5 0.1 0.4 0.3 1.2 0.0 2.8 0.6 2.8 0.2 0.8 1.0 1.4 1.5 0.8 0.9 0.7 1.0 4.3 0.2 0.6 1.1 2.0 0.9 1.0 2.0 0.6 2.3 1.1 0.4 1.5 1.8 1.3 0.5 4.6 1.8 1.4 1.1 2.5 0.9 0.1 0.0 0.2 0.7 0.1 0.6 1.2 0.8 0.4 0.1 1.6 1.8 1.3 0.2 0.2 0.2 0.7 0.9 0.7 0.0 0.0 0.4 1.4 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 TMCO3 "C13orf11, FLJ20623" ENSG00000150403 "Transmembrane and coiled-coil domains 3" Q6UWJ1 13 113490995-113554590 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 17.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039561, HPA048126" Uncertain Approved Cytosol NA NA Cytosol "HPA039561: AB_2676573, HPA048126: AB_2680276" "unprognostic (7.89e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (6.78e-2)" "unprognostic (7.88e-2)" "unprognostic (2.89e-1)" "unprognostic (6.01e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (2.93e-2)" "unprognostic (9.44e-2)" "unprognostic (3.08e-3)" "unprognostic (2.76e-2)" "unprognostic (8.47e-3)" "unprognostic (3.70e-3)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (6.27e-3)" "prognostic unfavorable (4.10e-4)" 16.1 20.5 15.1 11.1 14.2 40.3 14.5 38.7 14.6 21.3 15.7 18.6 16.7 13.0 23.1 15.5 13.1 17.2 23.2 17.0 14.4 13.0 18.0 15.5 13.8 9.4 17.4 9.6 16.9 46.1 18.6 18.6 23.2 21.2 16.1 14.1 17.1 25.8 14.5 10.2 7.7 17.6 18.9 20.7 14.8 27.8 11.0 11.3 7.2 7.5 13.4 11.3 13.2 23.9 2.6 5.0 17.4 8.5 4.1 1.8 2.0 27.1 9.2 13.4 9.2 27.7 41.0 7.3 29.8 28.5 13.1 13.3 10.1 12.1 6.5 7.6 32.6 17.9 11.0 7.0 10.8 20.5 13.3 7.2 5.8 14.9 10.0 26.1 9.5 12.3 33.2 25.6 9.8 20.4 34.1 21.4 4.2 8.3 9.3 22.9 4.9 4.9 5.7 6.7 13.0 14.6 6.3 8.2 4.6 21.9 3.7 11.8 9.8 9.2 20.4 9.5 19.9 12.0 18.1 33.3 14.9 15.9 10.8 12.5 11.5 6.5 4.2 49.2 5.0 7.1 2.4 6.9 6.8 1.1 4.4 1.4 2.6 1.4 1.8 5.0 1.4 1.5 1.5 17.4 4.1 8.5 1.1 1.2 2.0 15.1 14.2 38.7 14.6 14.4 13.0 17.4 9.6 21.2 11.3 11.9 13.7 13.7 30.6 8.8 15.6 16.5 25.5 33.5 21.6 24.4 13.7 17.6 5.0 37.3 11.6 32.2 18.2 0.0 32.8 48.1 26.7 79.7 26.5 8.9 17.4 20.6 32.8 31.9 30.8 28.3 33.9 20.1 16.9 30.7 58.9 26.1 43.8 28.3 44.9 12.8 17.6 6.5 32.0 17.7 13.2 6.1 10.9 12.7 15.2 27.6 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397792 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.6" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 96.2;Early spermatids: 57.1;Late spermatids: 29.1;Rod photoreceptor cells: 56.3" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 11.8;LHCN-M2: 6.6;SCLC-21H: 10.3;SH-SY5Y: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: AB_2684993" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 2.2 15.1 12.7 2.2 13.8 0.7 2.4 15.6 21.7 3.2 1.8 7.5 0.2 1.1 3.7 1.3 12.7 2.4 1.6 8.4 10.0 8.1 1.0 0.6 12.1 2.5 5.3 13.7 0.8 1.0 6.1 2.8 9.1 4.9 4.0 2.2 16.1 1.8 3.2 25.6 2.2 2.0 10.4 4.4 2.0 2.2 16.8 4.3 0.0 4.1 1.5 3.3 12.0 1.3 0.8 0.4 1.0 0.4 0.6 0.8 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.8 4.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.6 0.3 0.0 0.1 1.8 0.0 0.0 0.0 2.3 0.0 0.5 0.0 10.3 45.3 0.0 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.3 0.9 0.0 1.7 1.0 0.3 0.2 0.5 0.3 0.3 0.3 0.2 0.5 0.0 0.8 0.3 0.4 0.9 0.6 0.4 0.4 0.8 0.6 12.7 13.8 15.6 21.7 10.0 8.1 5.3 13.7 4.9 4.3 3.0 2.9 0.0 0.5 2.2 11.4 1.2 0.0 0.0 9.1 0.0 96.2 1.8 0.0 0.0 57.1 1.4 0.0 0.0 0.3 7.2 1.1 0.2 1.1 0.0 0.2 1.6 0.0 0.0 0.0 29.1 0.9 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.7 0.0 56.3 0.0 1.4 19.1 8.0 1.4 0.9 0.0 0.0 0.3 TMEM109 MGC5508 ENSG00000110108 "Transmembrane protein 109" Q9BVC6 11 60913874-60923443 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011785 Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA011785: AB_1858075" "unprognostic (5.23e-2)" "unprognostic (9.02e-2)" "unprognostic (2.46e-2)" "unprognostic (2.69e-2)" "unprognostic (1.23e-1)" "unprognostic (2.40e-2)" "unprognostic (5.29e-3)" "unprognostic (2.95e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.52e-1)" "unprognostic (3.63e-2)" "unprognostic (1.83e-1)" "unprognostic (2.82e-1)" "unprognostic (1.51e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (2.68e-4)" 40.2 21.2 7.7 22.4 11.5 10.4 45.4 13.4 17.4 39.7 28.8 17.0 17.7 12.0 43.1 25.9 38.0 30.0 32.0 32.7 9.9 8.3 27.0 31.7 30.0 26.0 16.5 9.5 42.6 28.5 23.2 18.9 36.2 12.4 38.5 11.8 44.1 43.4 27.5 41.9 28.4 19.2 38.0 10.5 28.8 25.1 16.6 12.1 21.5 36.9 35.2 33.0 35.6 44.7 25.5 83.1 9.5 13.7 19.9 36.2 21.9 24.5 21.7 14.0 23.3 35.5 16.4 11.7 23.1 20.8 24.5 21.3 19.3 26.1 28.3 43.0 25.5 14.7 32.2 14.5 9.9 14.9 22.0 19.3 20.0 10.2 4.2 10.5 40.5 17.9 11.1 12.6 19.0 9.5 8.7 29.6 22.9 10.3 74.5 17.4 44.5 29.8 17.4 24.0 12.5 22.2 29.7 27.3 40.6 12.0 12.6 5.7 10.1 18.3 44.4 21.9 9.8 24.9 7.4 30.3 31.6 15.2 39.8 20.9 25.6 18.8 15.2 28.1 17.5 36.5 6.2 13.7 9.5 35.8 12.1 36.2 22.3 20.8 30.3 40.8 25.5 19.0 24.3 1.5 19.9 8.8 83.1 15.5 21.9 7.7 11.5 13.4 17.4 9.9 8.3 16.5 9.5 12.4 12.1 65.5 21.0 47.9 39.3 45.1 12.5 30.7 20.4 22.7 22.7 24.4 0.0 104.3 21.6 63.3 20.4 85.0 6.5 0.0 69.7 95.5 55.6 29.5 49.7 16.6 62.1 28.6 6.9 50.3 19.6 7.5 82.8 53.7 49.0 53.3 10.1 27.1 44.7 19.5 91.6 13.3 33.9 38.8 64.8 6.0 6.8 44.3 44.5 56.6 16.5 34.5 TMEM110-MUSTN1 ENSG00000248592 "TMEM110-MUSTN1 readthrough" 3 52833121-52897562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.0" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 2: 1.4;Cholangiocytes: 2.5;Club cells: 1.2;Exocrine glandular cells: 1.6;Ito cells: 1.3;Kupffer cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.3;Karpas-707: 9.1" HPA051855 Uncertain Approved Cytosol NA NA Cytosol "HPA051855: AB_2681639" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (5.95e-2)" "unprognostic (7.28e-2)" "unprognostic (5.35e-2)" "unprognostic (3.11e-4)" "unprognostic (4.73e-2)" "unprognostic (2.66e-2)" "unprognostic (1.59e-2)" "unprognostic (2.51e-2)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.01e-6)" "unprognostic (5.49e-2)" "unprognostic (7.31e-2)" "unprognostic (4.55e-2)" "unprognostic (5.09e-5)" 13.3 6.7 3.8 5.4 7.6 5.2 5.8 5.2 9.6 4.9 5.5 8.6 3.7 4.1 8.6 3.4 6.4 4.2 3.8 5.8 4.1 3.7 8.0 23.6 5.0 8.6 6.6 3.4 5.2 9.2 2.0 3.8 3.9 6.0 4.1 2.6 6.0 5.5 3.1 58.0 4.2 7.9 7.8 4.8 5.7 5.0 3.9 4.1 8.6 4.4 2.7 6.1 5.8 5.7 0.9 1.6 1.6 1.7 0.0 2.3 0.4 1.5 0.8 1.6 6.2 0.5 0.0 0.0 3.2 1.0 0.2 0.4 0.0 1.0 1.1 0.5 0.0 2.2 1.4 1.6 1.6 0.0 8.3 3.3 2.1 0.0 0.0 0.2 1.4 3.2 0.0 0.6 0.6 1.3 0.0 0.3 4.2 0.9 9.1 0.1 1.0 1.9 1.1 1.1 0.6 4.2 0.3 0.0 2.0 0.3 0.0 0.6 0.4 0.8 0.9 1.9 0.4 0.7 3.1 0.9 1.1 2.9 1.2 1.8 4.2 3.8 1.2 1.4 4.0 1.7 0.0 0.2 1.6 0.4 1.7 2.3 0.9 0.7 0.9 0.8 0.3 0.0 0.0 0.4 0.0 0.0 1.6 0.6 0.4 3.8 7.6 5.2 7.6 4.1 3.7 6.6 3.4 6.0 4.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 1.2 0.0 0.0 0.3 0.0 1.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 TMEM120B ENSG00000188735 "Transmembrane protein 120B" A0PK00 12 121712752-121783001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 23.1;cerebellum: 35.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014066 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA014066: AB_1845296" "unprognostic (8.80e-3)" "unprognostic (3.31e-2)" "unprognostic (1.95e-2)" "unprognostic (1.40e-2)" "unprognostic (3.10e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.66e-5)" "unprognostic (3.62e-1)" "unprognostic (3.29e-1)" "unprognostic (5.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.25e-1)" "unprognostic (5.86e-2)" "unprognostic (8.02e-3)" "unprognostic (2.31e-1)" "unprognostic (2.13e-3)" "unprognostic (4.72e-2)" 7.9 7.0 5.6 4.7 23.1 9.3 5.6 35.6 6.9 11.1 4.4 3.3 8.6 4.2 10.0 5.4 2.8 12.2 4.5 3.9 5.9 3.8 4.5 4.7 5.3 4.0 4.5 4.3 5.0 14.3 5.9 11.6 2.4 6.0 5.2 3.1 5.5 14.9 6.2 17.2 5.7 3.8 8.0 2.9 4.3 4.9 3.4 5.8 1.9 10.6 4.0 3.8 3.6 7.1 4.1 4.0 3.6 1.6 2.4 3.4 1.3 4.8 16.6 3.9 11.4 4.9 6.5 8.0 6.4 7.4 6.2 5.0 10.5 5.6 5.2 4.0 6.5 6.1 8.3 9.1 7.7 3.3 3.1 8.4 7.2 5.2 6.5 6.7 5.1 5.7 6.0 6.9 7.0 5.1 11.0 3.8 11.6 6.4 3.8 3.7 7.8 8.4 7.0 7.0 3.3 10.3 10.0 16.1 6.9 3.2 5.3 15.0 10.7 6.3 5.0 5.6 7.5 11.3 4.1 5.3 8.3 9.4 5.3 5.6 8.9 3.1 3.8 10.6 6.6 8.3 3.1 1.4 1.7 3.4 1.6 2.8 2.9 3.3 2.7 1.6 4.1 2.4 2.8 3.6 2.4 1.5 4.0 2.8 1.3 5.6 23.1 35.6 6.9 5.9 3.8 4.5 4.3 6.0 5.8 23.8 12.6 12.3 4.4 5.8 35.4 6.1 12.7 4.0 7.9 10.4 21.6 5.6 6.6 7.6 14.5 4.9 21.9 0.0 10.8 5.8 6.5 5.4 4.6 2.9 5.1 12.7 6.3 1.8 4.0 26.1 6.1 8.5 1.7 36.9 3.0 2.5 19.5 4.5 6.0 4.9 21.7 6.5 7.1 6.2 4.9 6.0 9.5 28.8 3.6 3.9 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526603-105530202 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 9.5;Muller glia cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1" "Cell line enhanced" "Detected in some" "EFO-21: 9.5;MCF7: 8.9;PC-3: 11.7;REH: 7.5;SCLC-21H: 6.1;WM-115: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol NA NA Cytosol "HPA049857: AB_2680917" "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.90e-2)" 3.2 2.6 7.2 2.5 8.8 1.5 1.7 3.3 12.6 2.5 1.6 7.9 1.9 1.5 3.0 2.9 1.6 3.1 1.3 2.3 7.4 6.0 2.5 3.0 1.9 2.5 5.0 3.9 2.7 2.9 2.5 3.5 1.6 3.0 3.8 0.8 2.7 2.8 2.7 1.1 2.1 1.9 1.6 4.3 7.1 3.4 1.6 1.6 0.0 2.9 0.4 1.0 1.1 4.7 4.7 0.5 0.0 0.0 1.8 3.1 0.6 0.0 4.5 0.4 4.1 0.0 0.2 0.8 2.8 0.6 0.5 0.0 0.0 1.5 1.3 9.5 0.0 0.8 0.4 0.4 0.1 0.0 0.6 2.2 0.1 0.4 1.5 0.7 0.0 1.6 0.3 0.0 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.2 8.9 0.2 0.0 1.4 0.1 11.7 7.5 0.0 0.1 0.1 0.0 6.1 2.3 0.5 0.0 2.2 0.1 2.7 0.3 1.6 1.3 2.4 0.2 0.5 0.7 0.0 0.0 0.1 0.5 6.2 0.0 0.0 0.0 1.8 0.0 2.6 4.7 3.1 1.6 0.5 1.7 1.9 1.2 0.0 1.8 0.0 0.0 0.2 0.6 7.2 8.8 3.3 8.2 7.4 6.0 5.0 3.9 3.0 1.6 0.0 0.3 0.5 2.4 4.0 4.3 1.2 0.0 1.4 1.2 5.2 0.0 0.2 0.0 1.0 1.3 7.1 0.0 0.0 0.2 1.2 3.8 1.7 0.0 1.7 0.3 9.5 0.0 7.4 0.3 1.5 4.0 0.0 6.8 0.0 0.0 17.0 0.0 0.0 6.0 0.0 1.1 0.0 1.7 0.5 3.1 2.3 0.2 0.0 0.0 0.6 TMEM123 "KCT3, PORIMIN" ENSG00000152558 "Transmembrane protein 123" Q8N131 11 102396332-102470384 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 142.0" "Low region specificity" "Detected in all" "CAB026001, HPA062862" Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "CAB026001: , HPA062862: AB_2732691" "unprognostic (2.64e-1)" "unprognostic (8.39e-2)" "unprognostic (4.18e-3)" "unprognostic (1.40e-1)" "unprognostic (7.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.08e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.67e-1)" "unprognostic (1.38e-2)" "unprognostic (8.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-2)" "unprognostic (3.65e-2)" 21.3 23.1 18.8 30.1 23.3 39.8 38.6 7.4 18.8 35.2 38.2 19.1 15.1 12.4 65.3 20.8 31.9 21.6 20.8 36.8 20.7 14.0 27.0 95.4 39.5 55.5 22.6 13.7 27.8 24.7 14.5 8.5 23.9 21.1 34.9 19.9 13.9 53.3 22.2 13.2 29.7 17.6 29.7 22.4 39.9 23.7 22.9 24.6 71.9 66.0 20.1 27.1 43.7 39.8 23.3 30.3 48.3 29.2 52.4 55.5 51.3 29.2 26.2 27.2 25.2 34.8 28.5 18.5 22.8 49.4 46.7 52.0 33.2 142.0 49.3 58.8 52.8 33.5 31.8 29.5 37.6 51.7 29.7 10.8 25.7 10.3 49.4 30.7 54.4 19.2 31.8 42.9 33.3 50.0 65.2 52.2 26.6 17.2 0.1 38.5 9.4 47.2 17.1 16.2 48.6 24.1 29.0 75.1 47.3 44.4 29.0 12.9 15.2 27.7 37.9 15.0 30.5 23.4 21.3 61.1 31.4 35.2 27.2 17.1 19.1 10.6 50.1 9.1 60.7 20.7 30.1 26.8 48.3 26.3 29.2 40.0 16.7 41.3 31.8 30.3 23.3 55.5 46.9 17.6 52.4 24.2 8.1 42.9 51.3 18.8 23.3 7.4 18.8 20.7 14.0 22.6 13.7 21.1 24.6 116.1 70.4 106.9 216.5 142.4 0.7 46.0 145.2 156.6 139.9 155.3 0.0 39.5 68.0 142.3 41.1 161.1 25.3 46.7 102.9 31.6 66.8 247.8 57.7 245.2 98.2 1.6 86.9 279.3 203.3 16.8 87.2 149.4 153.5 211.0 157.1 3.3 143.2 24.6 87.7 40.5 1.0 64.7 91.8 25.6 58.6 154.8 25.4 130.8 142.2 235.1 TMEM125 MGC17299 ENSG00000179178 "Transmembrane protein 125" Q96AQ2 1 43269994-43274002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 73.6;salivary gland: 47.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 113.2;Alveolar cells type 2: 120.0;Enterocytes: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 13.4;BEWO: 11.5;CACO-2: 10.5;CAPAN-2: 25.1;OE19: 16.0;SK-BR-3: 21.6;T-47d: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015796 Approved Midbody,Cytosol NA NA "Midbody, Cytosol" "HPA015796: AB_1858081" "unprognostic (2.53e-3)" "unprognostic (8.70e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-1)" "unprognostic (3.14e-2)" "unprognostic (8.50e-2)" "unprognostic (8.37e-3)" "prognostic favorable (5.11e-5)" "unprognostic (3.39e-1)" "unprognostic (1.11e-1)" "unprognostic (7.76e-2)" "unprognostic (1.26e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-1)" "unprognostic (5.16e-2)" 0.8 0.0 5.3 4.6 7.1 0.0 4.9 0.9 5.0 7.4 14.4 1.0 20.7 15.1 1.8 12.5 3.3 6.6 18.9 1.0 8.9 4.3 9.4 1.4 42.5 0.8 10.7 0.8 2.0 73.6 9.6 15.7 5.6 1.1 8.8 9.1 1.5 47.8 19.0 0.8 3.7 29.4 0.8 21.1 0.8 11.6 1.2 0.8 1.1 33.6 3.8 5.0 1.4 3.5 0.0 0.8 0.0 0.0 1.8 0.9 0.2 13.4 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 10.5 25.1 0.0 0.6 0.0 0.0 6.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.5 16.0 0.0 0.0 0.0 0.3 0.2 4.3 6.5 0.0 0.0 21.6 0.0 2.0 17.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.9 0.2 0.0 1.8 0.0 0.8 0.0 0.2 5.3 7.1 0.9 1.9 8.9 4.3 10.7 0.8 1.1 0.8 113.2 120.0 0.5 1.7 0.0 0.0 0.4 43.3 29.4 47.8 15.7 0.0 26.1 14.9 32.4 3.1 0.0 84.2 0.0 34.1 1.2 0.2 16.8 1.1 0.0 2.0 0.0 20.8 0.0 0.0 6.0 0.3 0.8 0.0 1.0 59.6 1.7 27.0 37.4 1.1 23.1 0.0 0.0 0.2 1.0 0.2 0.4 6.1 0.0 32.2 5.4 TMEM126A "DKFZp586C1924, OPA7" ENSG00000171202 "Transmembrane protein 126A" Q9H061 11 85647967-85656547 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046648 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA046648: AB_2679737" "unprognostic (3.79e-2)" "unprognostic (4.75e-3)" "unprognostic (2.08e-3)" "unprognostic (1.08e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (8.60e-5)" "unprognostic (8.25e-2)" "unprognostic (6.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.02e-2)" "unprognostic (6.93e-2)" "unprognostic (1.25e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (6.94e-2)" "unprognostic (2.17e-1)" 18.3 17.4 24.9 15.9 23.3 23.7 20.0 13.2 30.0 13.9 16.2 9.5 15.6 19.8 13.2 20.6 17.2 12.5 16.0 44.4 20.9 20.7 22.0 28.5 12.6 15.0 21.8 22.9 13.7 27.7 13.1 19.9 14.1 19.9 14.0 18.3 8.9 25.2 15.7 49.5 12.2 15.1 16.5 18.0 14.1 19.1 21.4 18.8 10.5 16.5 36.4 15.6 14.0 18.7 14.5 19.1 6.3 15.3 8.4 16.5 11.1 14.7 18.6 16.7 11.5 22.5 22.7 13.6 17.6 19.2 26.4 26.1 22.9 23.8 8.5 21.0 21.1 10.1 16.2 17.2 18.6 24.5 21.6 9.6 23.3 22.1 24.9 28.3 29.4 19.7 19.6 22.9 23.3 25.0 14.2 24.1 23.2 16.4 14.0 29.3 19.6 15.9 37.5 17.1 56.2 21.2 16.3 16.8 27.5 18.5 19.5 12.0 12.2 15.9 25.1 14.6 16.2 31.2 20.2 14.2 25.7 18.3 48.0 20.1 9.4 16.5 22.3 13.5 21.2 30.4 2.9 13.4 6.3 12.5 15.3 16.5 14.5 16.4 14.6 19.1 13.2 15.6 15.4 1.2 8.4 13.1 14.4 14.1 11.1 24.9 23.3 13.2 30.0 20.9 20.7 21.8 22.9 19.9 18.8 26.8 18.7 34.9 49.1 28.2 13.7 101.5 20.4 36.1 39.8 36.6 5.9 57.3 124.3 42.5 119.6 29.2 27.0 0.0 80.4 63.4 39.0 59.0 36.9 66.1 83.8 7.9 20.8 21.5 49.7 48.6 27.3 53.8 32.1 67.7 42.7 22.6 54.2 31.6 25.1 79.5 15.1 19.4 51.4 99.1 51.5 36.8 44.3 39.2 55.6 50.7 TMEM132C "DKFZp761O2018, PPP1R152" ENSG00000181234 "Transmembrane protein 132C" Q8N3T6 12 128267403-128707915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 14.3;Cone photoreceptor cells: 5.9;Leydig cells: 8.3;Peritubular cells: 14.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.6;testis cancer: 4.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "gdT-cell: 5.4" "Lineage enriched" "Detected in single" 55 "T-cells: 5.4" "Group enriched" "Detected in some" 6 "AF22: 6.1;ASC diff: 8.7;Daudi: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015633, HPA015984" Approved Centrosome,Cytosol NA NA 110000000 "Centrosome, Cytosol" "HPA015633: AB_1858089, HPA015984: AB_1858088" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (7.34e-2)" "unprognostic (8.60e-2)" "unprognostic (2.37e-1)" "unprognostic (1.99e-3)" "unprognostic (5.48e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.85e-2)" "unprognostic (6.29e-2)" "unprognostic (7.97e-3)" "unprognostic (2.54e-1)" "unprognostic (5.71e-2)" "unprognostic (6.33e-3)" 37.5 4.2 9.6 1.1 7.0 0.8 23.3 5.0 6.6 22.0 2.5 4.2 8.9 1.2 5.9 5.7 4.7 13.4 5.1 3.5 5.0 3.8 1.3 0.8 1.6 2.0 4.9 3.1 7.9 4.1 0.9 0.6 5.1 4.6 3.7 1.3 5.3 2.9 9.1 1.9 2.2 1.4 2.1 3.9 1.1 1.5 2.1 5.4 0.0 1.1 0.9 1.3 3.8 10.5 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 6.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.6 7.0 5.0 6.6 5.0 3.8 4.9 3.1 4.6 5.4 0.0 0.0 0.0 0.0 0.3 14.3 0.7 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 0.0 1.7 0.0 0.0 0.4 0.1 0.0 14.2 0.0 2.1 0.0 1.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;kidney: 8.8" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 9.0" "Group enriched" "Detected in some" 8 "glioma: 7.6;renal cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.6" "Group enriched" "Detected in many" 20 "NK-cells: 1.4;T-cells: 2.6" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 140000 "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: AB_2686286" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.4 0.5 4.9 0.4 4.1 0.2 0.3 17.3 8.7 1.2 0.4 1.7 0.3 4.9 0.6 0.5 0.4 0.4 0.8 0.5 2.9 5.1 8.8 1.3 0.4 0.7 4.5 2.8 0.5 0.2 0.3 0.0 0.9 5.3 0.4 0.5 0.0 0.8 0.8 0.3 0.8 2.8 0.6 20.0 0.7 0.6 2.4 2.2 0.0 0.4 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.0 1.4 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 3.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.4 0.5 0.0 0.0 2.6 1.8 0.0 1.4 0.0 0.0 0.0 0.4 4.9 4.1 17.3 6.9 2.9 5.1 4.5 2.8 5.3 2.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.4 0.7 1.3 0.0 0.0 0.0 0.0 0.0 TMEM134 FLJ21749 ENSG00000172663 "Transmembrane protein 134" Q9H6X4 11 67461710-67469272 "Predicted membrane proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043744 Approved Supported Cytosol NA NA Cytosol "HPA043744: AB_10794773" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (4.67e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (7.22e-2)" "unprognostic (3.85e-1)" "unprognostic (1.39e-2)" "unprognostic (4.30e-2)" "unprognostic (3.48e-1)" "unprognostic (1.75e-1)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-2)" "unprognostic (4.43e-3)" 7.1 15.3 11.2 11.9 14.9 4.8 7.8 6.5 12.7 10.1 11.2 13.4 16.1 8.8 7.2 16.4 30.2 10.3 14.1 22.7 9.7 7.9 13.1 23.7 8.1 10.9 12.9 7.9 6.9 42.1 6.9 4.7 10.7 10.1 15.6 5.1 7.1 16.9 14.0 46.2 31.8 10.2 6.9 12.5 12.3 14.0 12.0 9.7 11.1 8.3 20.7 21.6 10.4 13.2 51.9 23.9 25.9 44.5 22.7 32.2 19.2 7.1 2.7 3.9 8.4 2.6 4.5 4.3 1.5 2.8 1.8 0.7 3.4 8.5 6.8 16.6 3.6 5.6 6.0 1.7 6.3 1.1 6.5 2.9 1.3 2.4 3.5 4.1 1.3 2.0 4.5 8.2 1.4 4.7 7.7 1.8 4.7 1.7 4.0 3.8 17.0 7.6 4.9 6.6 11.9 9.7 3.7 2.3 22.1 6.7 7.3 3.7 8.1 5.4 8.5 15.6 2.8 20.7 1.3 3.4 6.4 5.6 7.5 1.9 16.9 10.6 4.5 9.5 1.7 5.0 12.5 15.4 25.9 20.9 34.7 22.9 51.9 25.0 23.3 18.2 50.3 25.5 23.9 7.2 22.7 44.5 23.9 32.2 19.2 11.2 14.9 6.5 12.7 9.7 7.9 12.9 7.9 10.1 9.7 14.9 37.4 63.8 71.1 79.9 27.8 45.6 53.5 53.5 48.9 64.6 9.8 58.8 112.7 81.8 42.3 30.4 71.9 0.0 110.6 111.2 35.7 133.5 22.0 66.8 75.8 11.1 68.5 22.1 35.0 27.2 19.2 50.4 104.6 75.7 89.3 29.2 138.9 72.4 23.3 134.2 27.4 6.5 42.2 95.3 76.8 157.5 60.9 50.7 73.6 137.5 TMEM136 MGC17839 ENSG00000181264 "Transmembrane protein 136" Q6ZRR5 11 120325129-120333682 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 51.1;Rod photoreceptor cells: 91.0;Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 5.7" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074432 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA074432: AB_2686689" "unprognostic (1.02e-1)" "unprognostic (6.56e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.65e-2)" "unprognostic (3.31e-2)" "unprognostic (6.81e-3)" "unprognostic (1.22e-1)" "unprognostic (1.39e-2)" "unprognostic (2.58e-1)" "unprognostic (2.86e-3)" "unprognostic (2.39e-1)" "unprognostic (2.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (7.28e-2)" 4.4 18.9 9.1 2.7 13.8 1.0 5.7 5.8 15.1 4.6 2.9 13.8 3.2 2.1 7.6 14.0 2.6 7.4 5.6 19.1 8.2 5.7 4.8 1.9 4.9 4.0 13.0 7.7 9.0 9.7 9.4 7.9 10.4 12.0 8.4 2.3 9.0 2.4 5.9 1.8 2.0 3.1 6.9 13.7 4.2 2.8 5.4 8.8 0.0 7.8 0.7 2.9 3.2 4.1 0.0 5.7 0.0 0.0 0.0 0.9 0.0 1.6 4.3 8.2 7.8 8.2 12.9 2.1 3.6 8.9 5.8 9.5 2.2 7.3 0.0 11.3 2.3 12.0 1.2 7.2 2.7 6.5 0.0 4.5 5.4 3.9 3.8 9.2 0.0 0.0 11.1 2.0 8.2 12.7 13.1 6.7 6.7 1.4 10.8 7.8 2.0 0.0 0.0 3.5 0.4 2.7 4.1 3.3 0.5 7.7 1.6 5.3 5.1 5.1 0.6 1.0 9.6 6.8 0.2 4.8 6.4 6.6 1.4 2.1 0.1 0.0 0.0 1.9 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.9 0.0 9.1 13.8 5.8 11.5 8.2 5.7 13.0 7.7 12.0 8.8 8.9 5.1 0.0 16.7 3.3 12.1 21.0 7.6 6.7 9.1 22.7 51.1 9.2 5.0 19.5 1.5 6.3 0.5 0.0 11.4 3.2 11.6 28.9 0.0 0.5 1.1 12.7 18.8 4.9 0.6 1.5 3.1 1.0 5.0 23.4 1.6 17.1 17.9 0.0 2.1 3.7 91.0 45.3 14.6 6.9 6.5 3.1 7.9 0.0 0.7 10.7 TMEM151A "MGC33486, TMEM151" ENSG00000179292 "Transmembrane protein 151A" Q8N4L1 11 66291870-66296664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 48.5" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 8.1;Cholangiocytes: 5.1;Horizontal cells: 14.3;Intestinal endocrine cells: 7.5" "Cancer enhanced" "Detected in some" "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041035 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041035: AB_10794404" "unprognostic (1.20e-1)" "unprognostic (8.24e-3)" "unprognostic (4.80e-2)" "unprognostic (1.75e-2)" "unprognostic (3.44e-1)" "unprognostic (7.60e-2)" "unprognostic (9.48e-3)" "unprognostic (8.57e-2)" "unprognostic (8.73e-4)" "unprognostic (2.41e-3)" "unprognostic (2.02e-2)" "unprognostic (6.11e-3)" "unprognostic (1.69e-3)" "unprognostic (2.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.38e-2)" "unprognostic (2.67e-2)" 1.4 3.8 12.4 1.5 16.8 1.4 1.4 5.9 48.5 1.4 1.5 41.8 0.0 1.5 1.4 1.4 1.4 1.4 2.8 1.6 22.7 14.3 1.4 1.4 1.4 1.4 21.2 13.1 1.5 2.4 1.8 3.3 1.4 22.2 1.4 1.4 1.0 1.5 1.4 1.4 1.4 1.5 1.4 43.2 1.4 3.9 1.6 13.6 0.0 1.4 0.0 1.4 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 1.3 0.0 3.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 18.4 4.2 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.4 16.8 5.9 31.1 22.7 14.3 21.2 13.1 22.2 13.6 0.0 0.0 0.0 0.1 0.0 8.1 0.6 5.1 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 14.3 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TMEM161A "FLJ20422, FLJ39645" ENSG00000064545 "Transmembrane protein 161A" Q9NX61 19 19119169-19138513 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043365 Approved Approved Cytosol NA NA Cytosol "HPA043365: AB_10796793" "unprognostic (4.31e-2)" "unprognostic (9.13e-2)" "unprognostic (2.34e-2)" "unprognostic (7.42e-3)" "unprognostic (6.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-2)" "unprognostic (3.51e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (9.42e-2)" "unprognostic (2.46e-1)" "unprognostic (9.15e-2)" "prognostic favorable (2.99e-4)" "unprognostic (4.18e-1)" "unprognostic (2.79e-1)" "unprognostic (4.89e-3)" 10.4 18.3 10.6 9.2 13.5 8.1 10.3 12.8 11.7 12.2 10.5 9.8 15.8 10.0 17.2 8.6 11.7 12.4 15.5 12.7 8.6 6.9 12.7 21.1 9.1 12.1 13.4 8.4 14.2 18.6 17.3 6.6 6.4 9.9 12.8 5.3 12.7 17.1 13.6 34.5 13.5 9.1 9.9 7.8 8.8 10.6 5.3 11.6 15.0 20.8 13.8 9.1 10.8 12.6 6.8 23.5 1.5 7.2 6.7 13.5 5.4 16.1 11.3 6.4 13.8 13.9 9.3 10.2 6.8 8.4 8.5 11.2 9.5 20.2 14.1 33.6 5.1 5.8 13.1 10.3 15.8 5.6 6.4 37.5 5.4 6.2 12.8 18.5 7.1 9.0 14.5 13.3 8.4 12.5 8.1 9.4 17.2 18.0 17.1 5.9 19.5 10.3 15.0 6.1 18.7 18.6 16.5 5.4 28.0 6.5 6.6 8.7 8.8 10.3 13.1 8.3 4.7 10.5 12.7 5.5 7.9 3.9 17.7 12.7 15.9 9.9 8.4 8.7 14.7 11.4 1.5 7.2 1.4 10.0 6.3 8.8 5.7 9.1 8.1 10.1 6.8 10.8 9.1 0.8 6.7 6.3 23.5 13.5 5.4 10.6 13.5 12.8 11.7 8.6 6.9 13.4 8.4 9.9 11.6 6.0 16.5 7.3 11.6 5.5 15.3 6.9 25.5 6.7 7.9 10.4 9.8 16.1 6.6 17.7 0.7 9.4 6.3 0.0 11.1 12.3 9.1 11.9 16.1 20.4 14.0 15.9 5.2 9.8 9.1 0.5 10.9 6.7 11.8 5.4 8.4 18.1 11.0 3.5 16.6 25.9 13.1 12.9 13.3 7.9 9.8 7.5 10.3 10.0 16.6 6.7 TMEM168 "DKFZp564C012, FLJ13576" ENSG00000146802 "Transmembrane protein 168" Q9H0V1 7 112762382-112790592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020389, HPA077143" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA020389: AB_1858101, HPA077143: " "unprognostic (1.54e-1)" "unprognostic (2.23e-1)" "unprognostic (2.55e-1)" "unprognostic (4.92e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-2)" "unprognostic (2.30e-3)" "prognostic favorable (4.07e-6)" "unprognostic (1.60e-3)" "unprognostic (8.73e-2)" "unprognostic (3.07e-3)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.47e-1)" "unprognostic (1.84e-1)" "unprognostic (4.89e-3)" "unprognostic (3.30e-2)" 14.4 14.9 9.0 11.4 14.6 5.6 15.4 6.9 15.7 15.7 21.2 17.9 17.6 13.2 17.4 18.3 19.1 15.0 12.1 18.9 11.8 8.2 18.8 11.8 13.5 21.3 12.6 7.8 17.5 9.9 28.2 12.7 26.3 15.5 16.6 24.3 18.4 19.6 14.5 11.0 25.5 18.4 19.7 15.7 16.4 14.3 13.9 12.4 17.8 17.5 12.6 17.4 14.7 16.9 15.4 17.9 16.5 16.9 13.7 22.4 10.0 9.2 7.9 7.4 6.7 12.8 26.2 10.5 10.4 9.8 3.9 3.4 10.0 9.9 9.9 7.0 10.2 8.9 10.1 7.5 9.0 10.2 15.5 7.7 8.4 9.8 5.7 8.6 9.5 11.0 12.7 23.5 4.5 6.7 3.7 11.4 8.0 11.5 9.1 14.1 14.9 8.2 6.0 6.0 9.8 6.1 5.5 3.7 14.4 9.8 17.8 5.6 11.0 13.6 18.6 7.9 9.5 10.4 8.5 16.2 18.9 9.6 8.7 13.3 15.6 13.2 11.2 12.2 8.4 23.7 16.5 16.9 12.5 14.2 13.7 16.9 12.4 15.3 13.8 17.9 15.4 22.4 15.5 9.4 13.7 13.5 12.2 13.7 10.0 9.0 14.6 6.9 15.7 11.8 8.2 12.6 7.8 15.5 12.4 11.9 18.2 6.4 16.7 27.6 30.5 13.7 10.2 2.7 22.7 31.4 25.5 25.1 0.0 5.4 1.5 13.4 13.1 0.0 7.8 7.0 13.4 17.7 11.5 11.1 7.7 15.9 19.8 18.4 8.9 1.5 17.0 9.4 23.6 1.8 33.2 19.0 4.6 7.0 13.8 7.1 28.6 6.5 8.5 16.2 12.1 22.7 11.9 11.4 26.4 11.9 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 14.3;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.4;LHCN-M2: 6.9;RPTEC TERT1: 12.5;SCLC-21H: 10.7;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 1.7 2.9 5.9 2.5 6.2 1.3 0.9 9.7 16.8 2.1 1.3 3.9 1.6 1.9 1.1 1.9 0.9 2.9 2.5 1.1 5.5 6.3 4.9 4.2 2.1 2.4 5.5 4.8 1.1 1.0 0.8 2.4 0.7 9.1 1.4 1.2 4.9 0.9 1.1 1.5 1.6 1.7 1.2 6.6 2.6 1.0 1.3 2.5 0.7 6.7 0.0 2.0 1.1 0.7 3.0 0.2 4.3 5.7 0.7 6.3 1.3 0.1 0.4 8.4 0.2 1.0 0.1 0.0 0.3 0.2 0.2 0.8 0.4 2.5 0.1 6.3 0.4 0.5 0.2 1.1 0.0 0.2 1.2 0.4 2.7 0.1 1.5 1.8 0.2 0.6 0.6 0.6 0.6 0.8 2.0 0.0 0.9 0.0 0.4 6.9 0.7 0.2 0.3 4.4 0.0 0.1 1.5 2.5 0.2 12.5 0.0 10.7 15.4 0.3 0.2 6.1 4.2 0.4 1.1 0.1 0.2 0.5 0.2 0.4 1.9 2.0 0.4 1.9 0.2 1.6 1.3 1.8 0.3 2.3 1.5 1.7 2.4 4.0 2.7 0.0 3.0 4.2 1.9 4.3 0.7 5.7 0.2 6.3 1.3 5.9 6.2 9.7 11.5 5.5 6.3 5.5 4.8 9.1 2.5 0.0 0.0 0.5 0.0 0.0 14.3 0.6 5.1 0.0 0.0 5.2 21.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 4.7 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.4 2.4 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 TMEM173 "ERIS, FLJ38577, MITA, MPYS, NET23, STING" ENSG00000184584 "Transmembrane protein 173" Q86WV6 5 139475534-139482935 "Disease related genes, Predicted membrane proteins" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 25.3;EFO-21: 38.2;HDLM-2: 81.1;Karpas-707: 25.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038116, HPA038534" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA038116: AB_2675841, HPA038534: AB_2676067" "unprognostic (1.45e-1)" "unprognostic (4.10e-3)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (2.70e-2)" "unprognostic (1.71e-2)" "unprognostic (7.66e-2)" "unprognostic (2.77e-2)" "unprognostic (6.30e-2)" "unprognostic (1.01e-1)" "unprognostic (5.69e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.59e-8)" "unprognostic (9.18e-3)" "unprognostic (4.14e-2)" "unprognostic (4.45e-2)" "unprognostic (1.34e-1)" 22.9 6.5 6.3 17.4 6.7 18.1 15.9 1.2 4.5 22.5 9.4 6.0 13.3 6.4 16.7 18.1 16.0 24.4 13.5 26.3 3.8 3.1 12.5 8.1 32.0 41.3 7.9 2.3 30.7 3.9 1.9 8.1 13.9 6.8 20.3 8.8 14.7 16.6 14.6 10.3 9.6 10.9 16.2 7.1 35.8 8.0 11.1 6.3 15.8 13.0 16.5 29.7 17.7 17.9 0.3 26.9 5.8 29.1 39.8 28.9 26.1 1.2 0.5 0.0 0.0 1.3 4.1 0.1 6.6 25.3 3.2 10.5 0.0 9.1 0.0 38.2 19.7 0.7 4.8 0.1 9.7 1.2 81.1 0.9 5.5 2.5 0.3 2.2 1.6 0.1 5.8 0.4 2.2 2.6 4.4 11.3 0.6 1.7 25.4 11.8 0.0 0.8 8.5 0.0 0.2 1.9 0.3 2.4 7.5 2.9 2.5 2.5 0.0 2.2 2.4 6.3 0.2 0.3 22.0 8.2 0.9 0.4 2.5 1.9 0.0 7.7 0.0 0.1 23.7 2.9 5.8 29.1 0.0 28.8 19.4 14.2 0.3 28.2 23.2 26.9 0.2 19.4 17.5 2.4 39.8 7.8 9.2 28.9 26.1 6.3 6.7 1.2 4.5 3.8 3.1 7.9 2.3 6.8 6.3 41.7 56.7 6.7 69.0 27.4 0.1 22.6 2.5 152.6 59.1 7.0 0.0 0.7 0.0 26.9 1.0 87.0 0.5 0.0 14.2 0.7 35.0 14.4 48.7 0.0 55.0 0.0 8.1 57.7 62.8 0.4 47.8 46.4 33.7 45.9 13.3 0.0 50.6 5.8 34.3 0.0 0.3 45.3 78.8 0.0 0.3 14.6 1.5 66.0 28.2 26.1 TMEM184B "C22orf5, DKFZP586A1024, FM08, HS5O6A" ENSG00000198792 "Transmembrane protein 184B" Q9Y519 22 38219291-38273034 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 60.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024076 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "HPA024076: AB_1858106" "unprognostic (1.52e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-1)" "unprognostic (8.96e-2)" "unprognostic (3.82e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.94e-6)" "unprognostic (1.14e-2)" "unprognostic (5.18e-2)" "unprognostic (4.52e-2)" "unprognostic (9.20e-2)" "unprognostic (1.77e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.96e-1)" 21.8 16.5 23.9 14.7 24.1 6.0 27.5 26.4 40.0 22.4 14.4 31.2 12.2 18.5 12.1 9.5 11.0 14.2 16.1 17.8 25.8 21.5 13.0 7.4 20.5 8.6 26.1 22.2 10.8 18.0 27.3 21.9 41.2 23.8 12.3 12.5 20.1 16.8 17.3 19.0 10.9 16.5 15.7 41.2 14.1 19.3 5.8 20.9 3.9 16.7 10.6 9.2 20.0 15.4 1.6 7.3 12.4 3.1 6.2 5.8 2.6 17.3 15.2 9.0 7.1 17.9 14.4 20.8 18.8 26.8 15.5 13.8 11.1 8.1 3.3 14.8 28.0 14.0 21.6 8.1 18.5 10.5 11.8 14.5 6.6 11.1 9.2 18.9 5.1 9.2 12.0 16.5 18.2 20.4 16.0 19.3 5.1 4.1 11.7 13.4 9.9 3.2 4.3 7.3 13.0 14.0 5.6 8.1 3.3 11.5 19.3 19.5 3.4 14.1 20.7 10.0 10.9 11.4 3.8 28.4 15.8 16.2 13.8 11.4 24.3 60.1 2.7 22.9 3.8 13.5 12.4 3.1 4.6 5.8 2.4 5.3 1.6 3.3 4.3 4.7 1.2 2.3 2.7 11.2 6.2 1.6 7.3 1.0 2.6 23.9 24.1 26.4 35.4 25.8 21.5 26.1 22.2 23.8 20.9 6.0 15.0 1.5 15.0 11.0 17.0 14.6 10.2 4.0 9.1 14.0 2.0 27.6 3.3 15.0 4.9 26.7 7.5 0.0 19.1 38.8 21.0 27.4 2.3 3.4 13.3 14.3 24.9 16.0 7.5 1.7 10.9 10.2 13.5 16.2 16.0 40.7 22.7 7.0 12.7 4.2 8.1 19.4 23.4 2.3 6.6 8.4 65.6 10.1 9.4 30.1 TMEM187 "CXorf12, DXS9878E, ITBA1" ENSG00000177854 "Transmembrane protein 187" Q14656 X 153972327-153983195 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA038134 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA038134: AB_10669517" "unprognostic (1.51e-1)" "unprognostic (4.35e-2)" "unprognostic (1.41e-1)" "unprognostic (1.28e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (8.94e-2)" "unprognostic (2.41e-1)" "unprognostic (3.09e-1)" "unprognostic (4.22e-2)" "unprognostic (5.33e-2)" "unprognostic (7.41e-2)" "prognostic favorable (9.14e-8)" "unprognostic (6.73e-2)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (7.04e-2)" 8.8 13.0 9.2 6.8 10.2 3.4 10.5 13.2 9.0 7.6 9.0 10.5 13.9 6.8 8.8 9.3 9.5 12.0 6.8 8.1 9.6 6.0 7.6 10.2 7.7 10.2 10.4 9.0 10.9 24.4 7.5 13.0 7.3 11.0 10.3 4.5 6.7 14.1 10.1 8.5 10.7 10.9 6.8 8.0 10.0 8.0 5.9 8.7 8.4 10.8 2.9 9.9 7.9 7.4 13.4 19.6 17.8 9.8 10.1 22.5 10.9 8.4 9.7 2.1 7.7 8.4 7.5 1.2 3.5 1.7 1.0 3.4 1.9 14.6 1.3 20.0 2.8 5.3 7.7 2.9 5.1 0.8 10.9 4.0 2.3 5.1 3.1 7.1 1.1 2.6 8.4 7.7 3.0 4.3 4.8 2.6 5.1 2.1 11.0 4.4 9.1 4.5 1.5 1.6 9.5 10.7 4.2 1.2 14.1 5.3 2.7 2.9 2.8 5.1 4.3 3.6 2.1 8.1 2.8 4.8 1.7 1.8 7.0 1.9 7.8 5.2 1.7 5.2 5.1 0.9 17.8 9.8 11.9 14.7 7.3 14.7 9.7 18.1 15.9 7.4 13.4 22.5 13.9 9.5 10.1 6.9 19.6 17.6 10.9 9.2 10.2 13.2 9.0 9.6 6.0 10.4 9.0 11.0 8.7 0.0 4.6 4.1 5.2 2.5 3.5 3.6 17.8 2.7 1.2 7.0 5.9 11.8 1.7 9.2 0.3 3.8 6.5 23.3 7.7 9.1 9.6 5.3 3.5 13.5 10.8 1.6 2.4 4.9 6.0 0.0 13.6 4.8 10.1 9.0 6.7 12.4 8.0 3.5 13.4 6.8 4.3 6.5 5.5 0.2 8.8 4.1 8.2 5.1 7.6 3.3 TMEM214 FLJ20254 ENSG00000119777 "Transmembrane protein 214" Q6NUQ4 2 27032910-27041695 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034551 Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Endoplasmic reticulum, Golgi apparatus, Cytosol" "HPA034551: AB_10602481" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (3.10e-1)" "unprognostic (4.12e-3)" "unprognostic (1.90e-2)" "unprognostic (2.42e-2)" "prognostic unfavorable (4.96e-4)" "unprognostic (1.96e-1)" "unprognostic (3.70e-1)" "unprognostic (2.40e-1)" "unprognostic (1.96e-1)" "unprognostic (2.74e-2)" "prognostic unfavorable (2.39e-10)" "unprognostic (1.54e-2)" "unprognostic (1.97e-2)" "unprognostic (2.04e-1)" "unprognostic (2.92e-2)" 21.8 20.8 9.9 16.3 13.2 9.4 21.0 10.4 13.6 23.2 19.8 11.6 34.5 13.7 23.0 33.4 15.8 18.2 22.6 22.3 8.7 9.7 22.1 47.5 18.9 10.5 10.8 9.4 24.0 57.7 29.1 31.8 30.8 12.7 19.1 20.4 16.9 56.0 36.8 16.9 18.0 20.2 21.7 8.5 19.4 19.4 13.5 11.7 11.4 23.3 10.8 21.1 22.5 16.9 4.1 7.6 8.7 5.7 8.7 8.1 3.1 24.6 16.4 9.9 21.1 32.5 33.5 21.7 32.5 44.1 23.8 26.9 15.7 20.6 11.4 16.5 47.6 18.8 17.7 12.0 23.0 19.3 10.8 13.7 14.9 13.0 32.3 41.0 13.6 25.4 29.0 16.4 20.6 35.4 18.2 25.6 7.5 13.5 23.3 26.6 17.6 6.9 10.1 7.1 33.2 13.3 9.3 18.4 27.2 17.9 17.3 8.6 10.1 15.1 25.9 11.7 10.2 14.2 8.2 22.0 17.3 16.9 17.5 18.1 31.4 21.2 17.8 22.4 17.0 24.0 8.7 5.1 3.9 6.3 5.7 8.1 4.1 4.9 4.4 4.3 3.8 2.4 3.6 0.9 8.7 3.2 7.6 3.6 3.1 9.9 13.2 10.4 13.6 8.7 9.7 10.8 9.4 12.7 11.7 3.0 16.1 5.2 8.2 6.8 9.2 5.9 28.1 12.0 13.6 14.0 9.8 37.7 1.7 21.0 4.9 15.5 25.3 46.7 30.1 52.9 20.9 18.0 13.9 27.6 24.1 6.4 17.1 32.5 18.0 6.8 30.2 11.5 5.0 12.6 24.8 7.0 20.2 17.0 19.1 9.0 8.4 25.8 12.3 13.9 10.7 8.2 60.0 12.1 21.0 8.9 TMEM217 "C6orf128, dJ355M6.2" ENSG00000172738 "Transmembrane protein 217" Q8N7C4 6 37212180-37258155 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 20.1" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 13.1;Exocrine glandular cells: 13.9;Pancreatic endocrine cells: 14.4;Spermatocytes: 19.2;Urothelial cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HEL: 4.8;hTEC/SVTERT24-B: 3.4;HUVEC TERT2: 5.0;TIME: 13.1" "Not detected" "Not detected" "HPA045432, HPA071187" Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA045432: AB_2732519, HPA071187: AB_2732174" "unprognostic (7.78e-2)" "unprognostic (5.49e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-1)" "unprognostic (6.77e-3)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" "unprognostic (4.23e-4)" "unprognostic (8.22e-2)" "unprognostic (2.18e-1)" "unprognostic (5.62e-2)" "unprognostic (7.26e-2)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (1.59e-1)" 0.3 2.7 0.4 0.4 1.4 1.3 0.3 0.4 1.1 0.3 0.3 1.6 0.0 0.4 0.2 1.1 1.4 0.4 0.7 0.4 0.3 0.4 0.9 0.5 0.5 0.1 0.9 1.0 1.1 3.1 0.6 2.3 0.2 1.0 0.4 0.3 1.1 1.5 0.1 1.0 0.5 0.4 0.5 1.6 0.2 0.2 20.1 0.9 0.0 0.5 0.0 0.3 0.4 0.3 0.1 0.4 0.2 0.0 0.0 0.6 0.1 0.1 0.0 0.3 0.0 0.2 1.3 0.0 0.4 2.8 1.0 3.7 0.7 0.5 0.1 0.2 0.0 1.5 0.5 0.3 0.3 1.1 0.1 0.2 4.8 0.0 0.1 0.3 0.0 2.8 0.5 0.7 3.4 0.2 1.2 5.0 0.4 1.3 0.0 0.5 0.0 0.1 0.4 0.2 0.0 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.5 0.0 0.2 0.6 0.0 0.1 13.1 0.2 0.1 0.0 0.2 0.1 0.2 0.5 0.0 1.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.1 0.4 1.4 0.4 1.1 0.3 0.4 0.9 1.0 1.0 0.9 0.0 1.1 0.0 8.5 2.3 0.4 0.2 0.0 2.7 2.3 1.8 0.0 0.7 3.3 13.1 12.1 2.1 1.2 0.0 13.9 0.4 2.4 6.4 5.7 0.0 0.8 3.2 1.7 0.0 0.0 11.8 0.6 1.4 1.7 0.0 0.2 6.0 14.4 0.0 0.0 1.0 0.5 0.0 0.8 19.2 0.8 2.6 0.9 0.0 0.4 14.2 TMEM218 ENSG00000150433 "Transmembrane protein 218" A2RU14 11 125096545-125111763 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038489 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038489: AB_10672748" "unprognostic (3.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.60e-2)" "unprognostic (2.41e-3)" "unprognostic (8.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.63e-2)" "unprognostic (7.09e-3)" "unprognostic (2.18e-1)" "unprognostic (6.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.95e-2)" "prognostic favorable (5.50e-4)" "unprognostic (6.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.72e-2)" 24.2 19.0 14.0 13.2 15.7 7.0 13.5 11.9 12.4 14.7 12.3 16.8 12.3 12.5 17.5 16.3 12.8 20.8 16.5 10.4 14.1 9.3 13.1 13.6 11.9 13.7 13.6 10.0 17.8 19.7 12.8 17.4 8.8 10.5 17.4 9.4 18.0 15.0 11.1 9.7 8.8 12.4 14.7 11.7 17.5 13.3 7.8 11.3 10.0 13.0 12.0 12.4 14.2 13.6 18.0 28.7 18.5 25.2 19.1 14.0 15.4 7.6 15.1 9.6 11.6 8.9 12.4 5.8 7.7 5.9 6.0 7.8 1.5 22.8 9.7 19.4 4.7 9.2 9.0 6.0 7.3 8.0 13.5 8.6 21.7 4.1 6.1 8.8 6.8 8.1 9.7 9.8 10.6 12.7 9.7 8.7 12.1 8.7 12.4 10.3 3.9 1.7 14.3 7.8 21.1 14.4 10.0 11.6 7.4 5.3 7.7 8.3 12.5 10.5 4.2 5.4 5.9 20.0 9.8 11.1 7.3 6.7 8.6 8.3 7.2 6.0 8.0 5.9 14.2 12.9 18.5 25.2 10.1 14.0 18.8 12.2 18.0 13.3 13.2 28.7 13.7 11.5 13.5 9.6 19.1 17.4 24.9 11.7 15.4 14.0 15.7 11.9 12.4 14.1 9.3 13.6 10.0 10.5 11.3 17.9 12.0 16.9 15.8 10.8 6.9 7.7 10.2 20.1 6.8 14.0 0.0 24.0 23.2 17.4 1.1 15.8 5.2 0.0 14.1 15.6 17.7 11.9 3.5 13.9 37.3 22.3 10.4 17.2 20.5 1.1 9.5 19.0 16.9 21.6 10.0 21.8 12.4 0.0 15.6 16.2 12.2 25.8 16.5 14.6 10.2 12.4 8.1 13.6 13.3 15.2 TMEM222 "C1orf160, DKFZP564D0478" ENSG00000186501 "Transmembrane protein 222" Q9H0R3 1 27322145-27336400 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016579, HPA059374" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA016579: AB_2669392, HPA059374: AB_2683995" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-3)" "unprognostic (1.52e-1)" "unprognostic (1.33e-1)" "unprognostic (4.11e-2)" "unprognostic (1.16e-1)" "unprognostic (2.51e-2)" "unprognostic (1.96e-2)" "unprognostic (2.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.29e-3)" "unprognostic (5.28e-2)" "unprognostic (1.56e-1)" "unprognostic (3.83e-2)" "unprognostic (7.80e-2)" 18.4 22.0 28.0 12.0 31.4 19.5 17.8 23.2 45.4 18.1 17.1 32.1 13.2 14.4 16.5 25.0 22.8 29.8 21.3 27.5 28.9 30.8 20.6 35.0 18.8 15.0 26.0 20.8 22.3 24.6 19.9 22.4 20.0 26.7 22.9 14.3 26.4 21.7 25.2 19.9 15.6 21.3 18.6 21.5 15.2 16.7 20.7 16.4 19.4 24.0 14.9 19.1 17.8 13.3 22.8 19.9 36.5 21.0 19.2 23.2 15.7 12.2 14.9 12.5 20.5 19.6 14.2 10.1 19.0 21.9 26.0 22.2 6.1 25.8 7.8 14.9 20.2 12.1 17.0 13.7 18.5 10.9 10.3 26.3 13.0 12.4 14.0 29.1 12.9 13.0 24.8 10.5 24.9 14.2 12.0 17.3 15.6 9.8 18.1 16.2 10.9 18.5 13.6 23.5 12.7 18.7 15.4 8.7 15.7 25.2 7.2 27.0 23.8 14.7 20.8 18.3 4.7 20.5 20.9 15.8 15.4 13.0 24.7 17.9 19.5 17.3 8.1 23.3 25.1 22.1 19.3 13.7 17.0 22.3 20.3 17.0 22.8 20.7 17.0 12.0 18.9 20.9 21.4 36.5 19.2 21.0 19.9 23.2 15.7 28.0 31.4 23.2 45.4 28.9 30.8 26.0 20.8 26.7 16.4 8.9 15.7 15.7 11.9 10.4 39.6 7.7 10.2 5.3 5.7 12.2 13.7 26.0 33.2 33.2 19.8 15.4 22.2 23.3 35.0 28.5 23.5 15.6 16.2 11.3 24.4 41.3 28.7 9.2 9.1 60.6 18.7 11.4 25.3 29.7 17.4 52.7 36.4 17.5 18.7 17.0 17.1 12.9 14.6 18.9 17.7 11.8 25.7 22.3 19.1 10.1 TMEM245 "C9orf5, CG-2" ENSG00000106771 "Transmembrane protein 245" Q9H330 9 109015152-109119945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023892 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023892: AB_1845828" "unprognostic (1.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (9.58e-2)" "unprognostic (1.63e-1)" "unprognostic (6.43e-2)" "unprognostic (1.66e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.46e-9)" "unprognostic (6.11e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-1)" "unprognostic (2.24e-2)" 16.5 35.5 14.4 7.2 18.1 4.0 24.2 15.7 20.6 14.0 19.2 14.7 22.0 7.7 18.4 17.3 14.6 18.7 15.3 25.2 12.6 14.9 29.0 16.2 20.5 12.3 14.5 14.8 29.0 20.3 43.2 14.9 17.5 13.7 16.4 10.7 22.1 14.5 22.3 29.8 9.2 16.8 23.1 13.6 10.4 17.2 12.2 14.3 12.3 52.1 8.9 7.5 20.8 11.2 3.5 3.5 6.3 3.3 5.4 9.0 2.7 13.7 18.4 13.6 4.6 32.0 18.4 30.0 19.9 15.4 21.5 17.0 24.6 27.7 12.5 20.4 15.1 20.9 21.8 17.2 12.8 25.5 16.1 7.4 15.4 15.4 14.5 14.0 11.7 12.2 19.6 13.1 20.9 19.4 23.2 17.9 13.8 10.3 13.8 24.4 9.1 15.5 5.4 15.1 18.6 16.6 8.9 27.0 7.7 22.9 13.5 7.5 7.4 13.1 13.2 13.1 21.1 17.5 6.6 19.6 16.8 12.6 15.6 22.6 9.2 23.8 4.0 23.3 6.3 24.3 6.3 2.6 2.2 4.0 1.8 4.9 2.7 6.8 5.6 2.5 3.5 9.0 6.2 1.0 5.4 3.3 3.5 6.5 2.7 14.4 18.1 15.7 20.6 12.6 14.9 14.5 14.8 13.7 14.3 107.2 79.6 16.9 16.5 22.3 43.1 117.8 63.7 32.1 31.8 82.0 100.1 40.7 3.3 19.7 5.9 48.2 31.1 93.5 27.0 14.5 19.9 23.7 30.1 82.0 15.7 60.4 30.0 48.5 21.0 5.4 38.0 15.7 21.9 10.0 34.9 49.9 24.5 34.3 48.1 28.4 30.3 45.3 36.0 28.7 40.4 24.8 12.6 17.3 34.3 19.9 TMEM258 C11orf10 ENSG00000134825 "Transmembrane protein 258" P61165 11 61768501-61792802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044602 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA044602: AB_10961423" "unprognostic (6.35e-2)" "unprognostic (1.70e-1)" "unprognostic (7.49e-2)" "unprognostic (4.99e-3)" "unprognostic (9.95e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.24e-1)" "unprognostic (8.48e-2)" "prognostic favorable (4.37e-4)" "unprognostic (1.34e-3)" "unprognostic (7.39e-2)" "unprognostic (4.75e-3)" "unprognostic (2.59e-2)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.58e-1)" 15.3 23.1 18.9 16.5 22.5 23.9 31.0 16.2 25.2 28.2 21.6 19.7 34.6 17.7 21.2 81.8 18.1 26.7 22.4 36.6 19.5 15.8 19.0 32.0 33.2 35.9 24.7 19.0 32.2 117.2 6.8 29.1 19.8 18.8 20.0 24.5 13.3 54.0 31.0 22.2 14.0 16.1 18.4 20.1 19.7 21.2 19.9 19.4 17.3 25.3 24.8 22.9 15.7 19.1 53.3 107.7 87.4 51.7 31.0 51.4 50.2 24.4 42.4 36.9 29.3 57.5 56.0 20.5 19.7 32.3 19.5 22.7 36.5 44.2 17.4 37.4 46.2 38.2 26.5 32.0 37.8 25.8 25.5 28.5 14.6 46.5 56.1 54.3 30.5 17.0 47.4 58.3 24.1 63.6 49.7 36.0 39.7 36.0 66.9 31.7 81.3 21.4 53.3 45.9 57.0 29.1 24.0 24.8 111.2 40.5 40.2 29.1 30.6 17.6 37.5 34.6 35.1 41.6 61.1 17.8 22.4 20.2 28.7 14.0 43.6 34.3 28.7 31.6 18.7 23.2 87.4 51.7 59.1 40.6 43.7 49.7 53.3 48.3 45.1 42.6 42.3 41.6 41.1 39.8 31.0 42.2 107.7 51.4 50.2 18.9 22.5 16.2 25.2 19.5 15.8 24.7 19.0 18.8 19.4 95.3 210.6 191.2 192.8 203.3 34.4 466.4 425.4 301.2 234.3 301.8 17.7 370.2 250.4 433.9 186.9 238.5 290.8 23.3 568.5 499.5 345.7 260.4 219.6 452.5 405.4 35.0 298.8 324.7 368.7 111.6 310.7 338.3 539.9 431.0 448.2 326.7 464.8 390.9 201.5 405.8 52.5 168.1 247.3 313.1 426.1 243.9 424.8 226.6 405.7 222.4 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 61.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favorable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 7.8 7.4 7.3 11.0 10.6 3.8 9.1 13.3 9.9 61.0 8.8 13.7 11.6 8.1 11.8 12.1 6.7 11.4 10.3 6.0 8.9 8.6 10.7 8.7 8.4 8.8 10.8 7.5 14.8 13.6 12.4 17.2 8.7 9.7 8.7 9.1 8.7 7.4 13.0 5.2 8.6 10.7 8.9 12.2 9.2 8.4 10.1 8.3 17.6 12.6 4.6 8.8 10.1 9.7 2.0 4.6 2.9 2.8 6.3 3.5 2.0 7.4 5.2 4.0 8.6 14.4 11.9 7.9 7.9 8.8 5.2 6.3 2.4 5.5 6.0 7.8 5.9 5.9 8.6 9.3 5.8 8.3 7.5 4.7 3.9 2.4 3.3 10.1 5.4 9.4 14.5 10.4 2.9 10.1 9.6 6.8 4.7 4.8 6.5 6.8 4.9 2.8 2.0 3.7 12.2 8.3 4.0 6.4 2.0 8.8 11.0 8.5 4.2 8.9 6.5 5.2 7.9 8.2 8.4 9.5 10.6 4.1 7.9 3.9 3.9 3.1 3.5 6.7 4.0 5.2 0.0 2.8 2.9 3.5 1.9 2.4 1.8 2.4 1.8 2.2 2.0 3.2 2.3 1.4 6.3 1.7 4.6 2.9 2.0 7.3 10.6 13.3 9.9 8.9 8.6 10.8 7.5 9.7 8.3 17.9 12.1 4.2 7.4 4.7 14.2 2.9 0.0 17.4 5.7 21.0 3.9 7.9 1.7 6.8 69.7 4.7 6.3 0.0 3.3 6.5 6.7 8.2 11.5 7.5 5.5 6.4 17.2 8.6 13.9 25.8 14.1 7.8 1.7 5.4 10.8 5.6 5.0 7.0 10.3 3.7 17.1 0.0 4.2 7.9 8.5 4.8 9.3 5.7 10.8 6.8 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059837-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 50.7" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 9.8;Cytotrophoblasts: 12.8;Late spermatids: 11.1;Rod photoreceptor cells: 7.6;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enriched" "Detected in many" 12 "cerebellum: 50.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;HEK 293: 3.6;NTERA-2: 3.7;U-937: 3.3" "Region enriched" "Detected in all" 6 "cerebellum: 65.8" "Region enriched" "Detected in all" 6 "cerebellum: 66.4" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: AB_2732552" "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.1 1.9 1.1 0.2 1.9 0.2 0.4 50.7 4.2 0.2 0.2 0.6 0.0 0.3 0.2 0.1 0.3 0.3 0.1 0.1 0.9 1.3 0.9 0.1 1.1 0.3 0.7 0.3 0.1 2.4 0.2 5.1 2.4 1.9 0.4 0.2 1.1 0.2 0.1 10.6 1.5 0.1 0.1 0.4 0.6 0.3 1.4 0.0 0.0 0.2 0.7 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.9 0.1 0.8 0.8 0.0 2.0 3.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 50.7 4.2 0.9 1.3 0.7 0.3 1.9 0.0 0.0 0.0 0.0 0.9 0.0 2.6 0.0 0.0 2.7 0.0 1.8 9.8 12.8 1.7 0.0 5.9 0.0 0.0 0.0 0.2 1.7 0.7 0.8 0.0 0.0 4.2 1.6 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.5 7.6 6.5 0.0 0.5 2.1 0.0 4.9 0.0 0.0 0.4 TMEM268 "C9orf91, DKFZp547P234, FLJ38045" ENSG00000157693 "Transmembrane protein 268" Q5VZI3 9 114611206-114646422 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 9.3;Ciliated cells: 8.1;Hofbauer cells: 7.8;monocytes: 33.3;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017199 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA017199: AB_1845845" "unprognostic (8.57e-2)" "unprognostic (3.37e-1)" "unprognostic (8.33e-2)" "prognostic favorable (3.61e-4)" "unprognostic (2.09e-1)" "unprognostic (7.16e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.26e-2)" "unprognostic (2.22e-3)" "unprognostic (1.44e-1)" "unprognostic (6.67e-2)" "unprognostic (6.10e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 9.1 9.0 9.6 8.5 15.8 3.8 9.7 4.4 31.0 7.3 6.6 5.1 3.4 4.3 7.7 7.6 4.8 5.7 4.8 3.7 12.5 9.1 3.8 6.3 6.6 10.6 8.5 15.3 10.2 5.6 15.1 4.6 5.9 8.7 15.9 6.8 11.1 8.9 9.1 5.0 4.3 6.4 8.8 7.7 15.5 7.5 4.8 5.0 10.3 7.9 2.0 11.4 7.8 5.4 4.3 8.4 2.3 2.5 1.5 1.9 0.9 2.6 4.6 2.2 4.7 6.3 4.6 1.7 2.6 4.5 3.6 3.6 3.5 1.0 11.6 2.2 2.9 10.2 4.5 4.3 2.1 3.0 5.9 2.9 3.6 3.4 2.1 10.8 7.5 1.8 4.1 3.8 4.9 5.2 4.5 2.3 14.9 7.1 30.3 2.5 7.8 8.7 2.2 5.7 3.3 4.6 9.9 2.5 9.8 2.0 2.1 7.5 4.8 8.5 11.2 22.9 1.4 14.9 7.0 1.3 3.5 4.1 1.4 4.6 16.8 15.7 12.5 1.9 6.4 6.4 0.5 2.5 0.5 1.3 2.1 0.5 2.3 1.3 0.7 1.4 4.3 1.9 1.5 2.3 1.5 1.8 8.4 0.2 0.9 9.6 15.8 4.4 31.0 12.5 9.1 8.5 15.3 8.7 5.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 8.1 2.3 0.0 0.0 3.8 0.0 1.5 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 33.3 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 TMEM35A "FLJ14084, TMEM35" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078720-101096364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;seminal vesicle: 46.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.5;HUVEC TERT2: 32.3;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported Supported "Vesicles,Focal adhesion sites,Cytosol" NA NA Vesicles "Focal adhesion sites, Cytosol" "HPA048583: AB_2680451" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.6 6.7 12.8 1.7 28.2 0.7 1.3 21.2 28.6 3.3 17.3 2.5 6.8 3.5 7.4 3.9 10.4 4.3 3.6 1.1 14.4 33.8 1.1 0.7 2.6 0.8 12.2 10.0 7.7 0.9 6.1 1.5 0.8 30.0 20.5 9.1 2.9 1.0 46.4 1.3 0.9 4.1 11.8 3.9 1.3 3.4 1.8 2.3 0.0 1.3 0.0 0.9 13.3 2.7 0.2 0.0 0.2 0.1 0.6 0.8 0.4 0.0 0.0 3.4 0.0 2.5 6.5 0.0 0.6 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 2.2 0.0 1.1 0.0 4.7 32.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 8.3 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.4 0.2 0.6 0.1 0.0 0.8 0.4 12.8 28.2 21.2 28.6 14.4 33.8 12.2 10.0 30.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM37 "PR, PR1" ENSG00000171227 "Transmembrane protein 37" Q8WXS4 2 119429901-119438520 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 110.5;kidney: 82.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 276.4;Hepatocytes: 166.8;Muller glia cells: 140.1;Proximal tubular cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;naive CD4 T-cell: 3.3" "Group enriched" "Detected in many" 31 "monocytes: 2.8;T-cells: 3.3" "Group enriched" "Detected in some" 5 "EFO-21: 13.4;Hep G2: 35.1;RPTEC TERT1: 29.4" "Low region specificity" "Detected in many" HPA053794 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA053794: AB_2682265" "unprognostic (2.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.01e-1)" "unprognostic (4.59e-3)" "unprognostic (2.56e-1)" "unprognostic (9.60e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.36e-1)" "unprognostic (2.83e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-2)" "unprognostic (2.99e-1)" "unprognostic (2.61e-2)" 18.5 5.2 0.6 5.9 1.0 0.0 10.0 0.5 1.2 6.7 60.3 1.8 3.8 16.2 3.1 3.8 2.8 1.4 18.5 5.7 1.0 0.4 82.5 40.8 9.5 8.7 0.9 0.7 5.9 5.8 20.1 0.7 13.4 1.3 4.5 5.6 6.3 2.8 6.5 1.6 4.4 110.5 1.9 1.4 11.5 6.6 6.4 0.7 1.2 21.0 1.6 2.2 3.4 2.4 0.0 0.0 0.0 2.8 0.0 3.3 0.6 0.0 3.5 0.3 0.1 2.2 0.2 0.5 0.1 0.0 0.0 0.0 5.4 3.1 0.0 13.4 1.6 0.3 0.8 1.4 0.0 0.0 0.0 1.4 0.4 2.0 35.1 3.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 2.8 0.0 0.1 5.3 0.0 0.3 0.0 0.3 2.6 0.0 0.1 0.0 0.0 4.6 29.4 2.3 0.4 0.2 0.1 1.4 0.0 2.6 0.6 0.8 1.8 0.0 5.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.6 1.0 0.5 1.2 1.0 0.4 0.9 0.7 1.3 0.7 23.8 8.1 15.4 0.2 1.8 2.6 1.2 86.6 1.4 3.4 17.4 0.0 40.2 43.1 18.4 0.1 2.9 276.4 0.0 47.2 3.4 14.1 0.1 1.1 166.8 54.9 6.4 8.7 82.3 51.8 0.9 46.1 4.3 1.7 1.0 14.5 140.1 16.0 45.6 3.5 167.4 17.7 0.0 1.9 0.0 1.0 2.5 87.1 1.8 12.4 1.6 TMEM40 FLJ11036 ENSG00000088726 "Transmembrane protein 40" Q8WWA1 3 12733525-12769457 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5" "Cell type enhanced" "Detected in many" 24 "Cytotrophoblasts: 120.6;Suprabasal keratinocytes: 176.4;Syncytiotrophoblasts: 549.0;Urothelial cells: 120.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 13.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 4.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 73.7;hTCEpi: 16.6;hTERT-HME1: 21.0;RT4: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044165, HPA073122" Enhanced Approved Cytosol NA NA 7000000 Cytosol "HPA044165: AB_10961279, HPA073122: " "unprognostic (2.51e-3)" "unprognostic (1.96e-2)" "unprognostic (2.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.27e-1)" "unprognostic (1.92e-1)" "unprognostic (5.15e-4)" "unprognostic (5.96e-2)" "unprognostic (3.15e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-3)" "unprognostic (2.47e-1)" "unprognostic (1.20e-3)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (1.46e-2)" "unprognostic (6.77e-2)" 0.0 0.0 0.0 0.0 0.2 1.4 1.8 0.0 0.0 11.7 0.0 0.0 0.4 0.0 0.9 0.6 62.9 1.6 0.1 1.6 0.0 0.0 0.3 0.0 1.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 53.6 0.1 2.3 0.0 0.0 6.6 1.4 0.4 24.0 0.0 0.7 0.0 1.1 0.0 0.4 0.0 0.4 0.0 40.5 41.8 10.6 18.6 0.0 0.5 4.5 0.6 0.0 0.3 21.1 7.4 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.3 0.3 0.4 0.2 1.1 0.0 0.0 0.0 0.2 2.1 0.0 73.7 1.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 16.6 0.0 21.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.4 10.3 0.0 0.0 0.0 9.2 0.0 1.4 0.8 0.2 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.6 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.5 0.0 0.0 0.5 0.0 21.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 71.9 57.1 0.0 3.3 0.0 22.7 6.8 1.8 0.0 120.6 0.0 0.5 0.6 0.4 0.0 0.0 0.0 12.6 4.3 9.6 0.0 0.6 9.6 0.0 0.0 0.0 0.3 1.6 0.3 0.2 10.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.3 0.2 1.9 176.4 549.0 0.0 0.0 120.1 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.4" "Cell type enhanced" "Detected in many" 4 "monocytes: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: AB_2683905, HPA059790: AB_2684125" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 8.1 23.9 7.8 4.8 10.2 9.3 10.1 4.9 11.5 10.6 26.8 11.7 6.3 24.5 9.1 11.1 20.6 9.0 8.6 8.3 7.5 8.4 15.8 26.1 11.3 9.0 8.1 5.4 14.2 10.7 6.7 5.7 9.0 8.6 10.1 8.6 11.9 11.2 9.4 8.3 16.6 54.4 8.0 8.7 12.4 8.7 11.2 7.4 11.3 9.0 18.1 16.7 8.8 12.5 12.8 16.4 7.8 8.4 8.5 16.7 6.5 20.9 7.6 5.1 6.2 8.1 8.7 15.0 8.1 7.1 10.2 7.5 19.8 8.3 6.5 15.5 7.5 14.5 14.6 14.0 8.6 10.4 10.9 12.9 11.3 4.6 19.9 9.0 12.1 6.4 8.1 12.9 9.2 10.6 6.5 7.8 8.3 20.0 16.3 6.5 8.1 7.4 7.0 8.4 16.6 12.1 7.5 7.8 11.9 8.8 15.4 5.1 6.6 7.0 18.0 12.3 7.6 21.5 9.5 5.6 6.1 7.6 12.6 16.8 24.0 36.6 13.1 9.3 7.3 7.3 7.8 6.3 5.1 13.2 6.6 16.7 12.8 13.6 14.3 7.0 12.4 15.0 16.1 2.4 8.5 8.4 16.4 11.1 6.5 7.8 10.2 4.9 11.5 7.5 8.4 8.1 5.4 8.6 7.4 8.9 26.2 17.6 29.0 47.2 17.7 11.3 22.9 4.0 14.8 19.2 17.7 23.4 6.6 28.6 0.4 17.9 38.7 0.0 48.5 20.2 16.7 43.7 8.1 34.2 16.5 15.9 17.9 14.1 11.1 1.8 13.3 14.3 8.5 100.0 26.4 14.6 45.8 15.9 12.7 22.4 29.5 19.4 17.2 23.7 14.2 74.0 38.4 15.2 30.8 81.8 TMEM44 DKFZp686O18124 ENSG00000145014 "Transmembrane protein 44" Q2T9K0 3 194587673-194633689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ito cells: 50.3;Mucus-secreting cells: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 3.2;NK-cell: 11.5" "Group enriched" "Detected in many" 9 "granulocytes: 3.2;NK-cells: 11.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043718 Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA043718: AB_10794662" "unprognostic (8.94e-2)" "unprognostic (1.01e-1)" "unprognostic (8.31e-3)" "unprognostic (4.53e-2)" "unprognostic (2.78e-3)" "unprognostic (9.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (6.55e-13)" "unprognostic (1.23e-2)" "unprognostic (3.36e-1)" "unprognostic (1.65e-3)" "unprognostic (5.66e-2)" 13.2 2.8 4.8 6.2 11.8 10.6 21.2 1.9 7.3 6.6 11.8 2.4 9.2 4.6 6.8 22.9 5.1 4.9 7.9 5.9 6.1 6.3 5.6 3.6 15.1 6.3 5.2 7.8 5.1 3.3 1.3 2.3 12.0 6.7 4.8 11.9 3.3 7.0 5.8 6.7 3.4 6.0 5.6 3.7 9.0 6.7 4.1 3.3 4.1 5.3 5.5 3.7 5.0 6.7 0.3 0.6 3.2 0.4 11.5 0.8 0.0 6.3 5.1 7.8 8.3 2.9 9.8 6.9 4.9 9.2 4.1 6.5 2.8 12.6 1.1 23.3 5.7 11.8 7.4 2.6 3.7 2.7 10.4 3.7 7.1 5.3 2.1 5.3 2.2 11.3 6.3 4.1 9.2 4.1 19.4 16.6 7.0 2.0 0.3 13.2 5.9 3.3 5.6 4.1 6.2 8.4 6.3 4.9 0.2 4.2 3.6 2.2 4.7 3.5 1.1 7.2 3.4 5.3 4.7 19.6 12.3 4.6 3.8 6.3 0.9 0.7 2.2 18.4 8.6 6.1 3.2 0.3 0.3 0.5 0.2 0.1 0.2 0.2 0.8 0.0 0.3 0.1 0.3 0.8 11.5 0.4 0.6 0.0 0.0 4.8 11.8 1.9 7.3 6.1 6.3 5.2 7.8 6.7 3.3 0.0 2.9 3.7 3.0 0.5 0.8 1.1 0.0 2.7 3.4 5.2 2.0 6.6 0.0 5.1 0.6 15.2 13.4 0.0 4.3 2.8 4.8 5.1 17.3 0.8 3.0 0.0 5.8 50.3 2.2 0.0 2.8 0.8 1.7 0.0 20.6 0.6 9.6 17.5 1.8 0.1 0.3 6.5 1.2 0.5 5.9 0.5 7.3 1.5 16.2 5.1 TMEM50A SMP1 ENSG00000183726 "Transmembrane protein 50A" O95807 1 25337917-25362361 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065192 Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA065192: AB_2685429" "unprognostic (2.41e-2)" "unprognostic (2.74e-1)" "unprognostic (5.17e-3)" "prognostic favorable (8.64e-5)" "unprognostic (1.45e-1)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.34e-4)" "unprognostic (7.39e-2)" "unprognostic (7.92e-3)" "unprognostic (2.53e-1)" "unprognostic (1.02e-2)" "unprognostic (2.44e-2)" "unprognostic (2.39e-3)" "unprognostic (6.66e-2)" "unprognostic (2.91e-1)" "unprognostic (3.91e-3)" "unprognostic (3.44e-2)" 36.2 45.6 29.2 23.2 39.1 19.4 43.4 30.5 29.4 29.7 32.7 21.5 25.6 26.5 29.4 31.5 36.7 23.5 30.9 32.6 30.9 23.6 39.1 31.8 34.2 36.3 29.3 18.5 22.6 29.7 21.7 13.6 40.4 19.9 32.8 38.6 19.1 56.5 33.0 21.5 25.7 39.6 27.8 38.1 39.4 26.5 17.5 20.4 32.7 39.2 29.6 28.1 37.1 31.0 13.0 14.0 56.5 26.8 19.2 25.0 23.1 8.5 9.8 16.5 8.5 31.0 27.9 5.8 17.4 27.9 33.1 37.1 7.9 21.5 9.9 9.8 61.9 12.4 12.5 12.9 14.2 36.2 26.1 18.5 21.2 10.8 12.0 22.9 16.1 17.2 30.4 20.9 24.5 14.2 15.7 23.8 11.2 14.1 15.6 31.2 6.0 10.5 19.7 19.3 14.1 8.1 9.3 18.1 17.5 33.3 6.3 13.8 8.8 18.0 12.7 13.9 15.6 6.5 10.6 35.2 18.5 7.7 30.2 7.2 10.9 11.8 9.1 24.1 24.2 10.2 56.5 19.1 26.3 24.0 23.0 25.0 13.0 21.1 24.4 14.0 10.1 15.5 21.1 39.7 19.2 26.8 13.0 23.4 23.1 29.2 39.1 30.5 29.4 30.9 23.6 29.3 18.5 19.9 20.4 134.0 76.3 88.7 152.8 225.1 40.2 88.4 119.8 104.4 70.5 160.5 25.5 94.3 43.1 257.7 13.8 175.4 107.8 46.7 188.7 283.9 172.6 238.9 122.5 56.8 203.7 23.8 79.6 140.6 162.8 8.4 140.7 195.1 189.0 268.7 149.5 99.5 250.4 140.3 93.0 82.3 29.5 207.0 211.1 93.4 46.0 277.7 151.8 110.7 95.4 208.9 TMEM51 "C1orf72, FLJ10199" ENSG00000171729 "Transmembrane protein 51" Q9NW97 1 15152532-15220480 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Urothelial cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "classical monocyte: 1.8;intermediate monocyte: 2.3;myeloid DC: 1.7;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 23 "dendritic cells: 1.7;monocytes: 2.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014547, HPA019441" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA014547: AB_1858121, HPA019441: AB_2670142" "unprognostic (1.21e-1)" "unprognostic (1.84e-1)" "unprognostic (8.74e-2)" "unprognostic (1.89e-2)" "unprognostic (3.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.47e-2)" "unprognostic (7.81e-3)" "unprognostic (7.84e-2)" "unprognostic (1.39e-1)" "unprognostic (3.00e-2)" "unprognostic (8.91e-2)" "prognostic favorable (8.16e-8)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (5.58e-2)" "unprognostic (1.67e-3)" 4.6 14.1 4.7 7.7 4.4 0.4 7.0 14.2 5.1 9.7 22.4 4.5 14.3 15.9 5.3 7.6 12.0 7.2 25.3 3.7 5.0 2.2 23.5 3.9 10.4 7.4 4.1 3.4 15.4 36.7 14.5 5.2 7.5 4.2 12.3 7.8 16.1 7.5 15.5 1.2 5.3 22.9 8.9 5.7 7.1 18.9 3.4 3.9 2.0 3.8 12.3 8.4 18.5 22.2 0.0 1.7 0.0 2.8 0.0 0.0 0.3 19.1 10.3 5.9 1.4 1.0 2.2 0.0 2.2 9.3 6.8 9.3 13.5 21.6 0.0 7.3 1.4 9.8 18.6 2.0 7.2 3.9 0.0 5.1 0.4 0.5 13.3 8.6 0.0 18.8 0.7 6.4 8.9 9.8 4.4 6.3 0.8 2.9 0.0 3.5 6.6 0.0 0.0 1.0 15.3 3.9 2.7 3.7 3.3 17.3 19.9 0.9 17.5 1.8 7.6 18.4 3.7 1.0 2.0 4.4 7.1 6.3 3.1 6.9 0.2 0.3 0.0 7.0 0.3 8.3 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 4.7 4.4 14.2 5.1 5.0 2.2 4.1 3.4 4.2 3.9 0.0 1.6 2.7 51.9 16.3 0.0 1.8 20.4 6.7 4.5 47.1 0.0 4.2 5.0 64.9 0.4 8.7 12.9 0.0 64.3 0.7 5.6 48.2 0.0 0.4 43.7 0.0 18.4 8.6 24.2 0.0 2.6 18.8 13.5 19.8 16.3 0.0 65.3 25.9 13.1 11.8 0.0 32.3 39.4 0.5 1.9 18.4 1.1 0.0 13.2 98.9 TMEM74 "FLJ30668, NET36" ENSG00000164841 "Transmembrane protein 74" Q96NL1 8 108606850-108787615 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cone photoreceptor cells: 5.9;Rod photoreceptor cells: 7.9;Spermatogonia: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory B-cell: 1.4" "Lineage enriched" "Detected in single" 14 "B-cells: 1.4" "Cell line enhanced" "Detected in some" "HEK 293: 5.2;NTERA-2: 6.5;SCLC-21H: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015672, HPA076461" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA015672: AB_1858132, HPA076461: " "unprognostic (8.99e-2)" "unprognostic (1.18e-1)" "unprognostic (4.25e-2)" "unprognostic (6.33e-2)" "unprognostic (2.05e-1)" "unprognostic (4.18e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-2)" "unprognostic (2.01e-2)" "unprognostic (3.97e-2)" "unprognostic (3.75e-4)" "unprognostic (8.77e-2)" "unprognostic (6.36e-2)" "unprognostic (5.95e-2)" "unprognostic (1.46e-3)" 1.3 1.4 4.8 1.1 4.2 0.4 0.9 13.1 12.0 0.7 2.7 10.4 0.0 0.9 0.7 0.7 2.9 1.0 0.9 7.5 5.9 2.8 0.7 2.2 0.8 0.8 3.2 6.1 0.9 2.7 0.4 1.1 0.5 9.3 1.0 1.3 1.0 0.9 1.1 5.5 2.0 1.4 2.9 14.1 0.6 0.9 2.7 6.8 0.7 0.8 0.8 0.9 0.9 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.1 0.0 0.1 3.0 0.7 0.0 0.4 5.2 1.9 0.8 0.3 0.1 0.5 0.7 0.0 0.0 0.1 0.1 0.1 0.5 3.6 0.0 0.2 0.0 0.0 0.2 0.0 6.5 0.0 3.7 0.0 3.7 0.0 0.0 0.0 14.2 0.1 0.0 0.5 0.0 1.6 0.2 0.2 0.0 1.7 3.0 0.0 0.3 0.6 0.1 0.0 2.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 4.2 13.1 7.3 5.9 2.8 3.2 6.1 9.3 6.8 0.0 0.0 0.0 0.6 0.8 2.7 0.6 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.7 0.5 0.2 0.0 0.2 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 7.9 0.0 0.7 0.2 5.1 0.5 0.1 0.0 0.0 0.0 TMEM82 ENSG00000162460 "Transmembrane protein 82" A0PJX8 1 15742422-15747982 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 35.6;liver: 30.1" "Group enriched" "Detected in some" 9 "Enterocytes: 86.8;Hepatocytes: 38.2;Paneth cells: 57.5;Proximal tubular cells: 47.1" "Cancer enhanced" "Detected in some" "liver cancer: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "CACO-2: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060282 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060282: AB_2684241" "unprognostic (2.46e-2)" "unprognostic (7.96e-2)" "unprognostic (4.88e-2)" "unprognostic (1.40e-2)" "unprognostic (6.45e-2)" "unprognostic (6.90e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.80e-7)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (4.75e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 7.5 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.1 6.6 0.0 0.0 0.0 86.8 0.0 0.2 1.9 0.0 0.0 0.0 38.2 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.5 57.5 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 6.3 0.0 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.7;brain: 11.4" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 3.5;Distal tubular cells: 1.7;Spermatogonia: 3.1" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in single" 17 "T-cells: 6.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;EFO-21: 3.8;JURKAT: 15.0;SH-SY5Y: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038298 Uncertain Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 1.2 11.7 6.7 0.7 2.9 0.0 0.5 2.7 7.0 0.8 0.9 2.3 0.4 0.6 0.8 1.2 2.2 1.0 0.4 1.0 5.9 11.4 1.4 0.9 1.8 1.2 5.8 4.8 2.8 0.4 0.0 8.1 0.7 3.8 0.9 0.6 1.1 0.8 1.8 5.8 1.3 0.6 0.7 5.2 1.2 0.3 1.6 1.0 0.4 0.8 1.7 1.3 0.8 0.4 0.0 0.3 0.0 0.1 0.0 6.1 1.2 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.3 0.0 3.8 0.0 0.7 0.2 0.2 0.3 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 2.6 0.0 1.7 0.0 0.7 15.0 0.0 0.4 0.0 0.2 0.1 0.0 0.3 1.0 0.2 1.6 0.0 0.3 0.1 0.1 0.4 3.3 0.4 0.5 0.0 0.2 0.1 0.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.8 1.0 0.3 0.0 6.1 0.9 0.0 0.0 0.0 0.0 1.0 1.2 6.7 2.9 2.7 7.0 5.9 11.4 5.8 4.8 3.8 1.0 0.0 0.0 0.0 0.1 0.7 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.2 0.2 0.0 0.0 0.4 0.1 0.5 0.2 0.0 0.0 0.5 0.0 0.0 0.6 0.0 1.0 0.6 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.4 0.0 0.4 0.0 1.4 1.4 3.1 0.6 0.1 0.0 0.0 0.1 TMOD3 UTMOD ENSG00000138594 "Tropomodulin 3" Q9NYL9 15 51829628-51947295 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Alveolar cells type 1: 369.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001849 Approved Approved "Actin filaments,Cytosol" NA NA 21000000 Cytosol "Actin filaments" "HPA001849: AB_1080313" "unprognostic (6.31e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.39e-1)" "unprognostic (7.31e-3)" "unprognostic (1.29e-1)" "unprognostic (1.71e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (3.19e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (3.38e-5)" "unprognostic (7.06e-2)" "unprognostic (7.97e-2)" "unprognostic (1.18e-1)" "unprognostic (2.15e-1)" "unprognostic (1.97e-1)" "unprognostic (5.58e-3)" 23.0 9.6 7.3 14.2 9.7 7.7 14.1 7.5 7.7 16.4 16.0 4.6 32.4 13.3 13.4 11.8 53.1 12.0 12.0 10.5 7.7 6.3 16.6 14.6 25.4 10.3 8.1 4.2 12.7 9.3 8.0 9.2 20.2 8.5 11.0 13.9 6.9 20.8 21.4 5.9 15.4 21.7 11.1 8.7 20.5 14.4 6.6 8.0 19.6 11.4 21.9 22.7 16.5 27.2 14.4 17.6 28.3 21.9 10.7 15.1 9.4 23.6 23.7 9.6 2.5 9.5 16.0 10.9 11.0 15.1 11.5 10.4 9.1 18.0 5.8 9.0 11.7 8.2 34.8 8.8 24.8 14.8 9.6 3.9 8.5 26.2 7.4 10.7 10.9 9.4 10.7 24.2 9.3 28.9 14.3 20.3 8.4 9.0 8.8 13.9 17.5 7.2 7.3 5.3 15.1 3.9 8.7 11.4 14.9 18.8 16.3 2.3 6.3 18.4 12.4 6.6 13.5 8.4 8.8 22.1 14.8 9.8 11.9 12.7 5.3 15.5 6.4 9.5 20.0 8.7 22.7 17.7 24.0 14.8 20.9 13.1 12.0 12.8 12.9 12.4 14.4 11.1 10.3 28.3 10.7 21.9 17.6 15.1 9.4 7.3 9.7 7.5 7.7 7.7 6.3 8.1 4.2 8.5 8.0 369.2 56.9 24.7 56.4 94.9 9.3 43.7 30.6 88.3 134.2 40.1 13.7 46.5 34.9 68.2 29.3 115.0 73.8 23.3 62.5 56.4 63.7 135.6 137.6 46.1 47.0 14.3 17.9 73.1 47.6 83.9 41.7 68.9 30.4 56.9 46.7 16.4 111.6 56.1 41.8 38.7 12.9 12.9 48.2 11.7 11.4 115.6 42.9 50.7 44.2 216.2 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9" "Cell type enhanced" "Detected in many" 18 "Enterocytes: 108.9;Paneth cells: 61.7;Undifferentiated cells: 54.6;Urothelial cells: 226.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 4.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.9;HaCaT: 16.2;OE19: 64.5;RPTEC TERT1: 26.6;RT4: 33.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.3 0.3 0.2 14.2 0.3 0.0 0.3 0.3 0.2 11.4 23.5 0.1 0.0 16.1 3.1 2.8 60.9 0.6 45.4 0.3 0.3 0.3 17.7 0.3 3.2 0.0 0.2 0.0 0.3 0.4 0.0 0.3 0.8 0.1 9.9 26.2 0.2 4.0 0.0 0.3 2.4 27.4 4.2 0.2 0.3 13.7 0.7 0.0 0.6 0.3 13.7 41.0 43.9 22.3 0.5 0.1 4.5 0.7 0.2 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 37.9 0.0 1.4 0.0 0.0 16.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 64.5 0.0 0.0 0.0 0.0 26.6 33.2 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.1 0.9 0.2 0.7 0.1 0.1 0.0 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.0 1.7 0.0 21.5 1.0 0.0 0.6 0.0 17.4 36.4 10.4 0.0 0.1 0.0 0.1 2.6 0.0 108.9 0.0 6.6 1.6 0.2 6.8 5.7 0.0 0.2 0.0 4.1 0.0 0.0 1.3 0.0 1.0 0.0 0.0 49.1 0.0 30.7 61.7 0.0 1.4 0.0 0.0 0.7 0.0 0.1 5.5 0.2 0.0 54.6 226.3 TMSB4X "TB4X, TMSB4" ENSG00000205542 "Thymosin beta 4, X-linked" P62328 X 12975108-12977227 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 1074.5" "Cell type enhanced" "Detected in all" 9 "Hofbauer cells: 27421.6;monocytes: 60748.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" CAB033806 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 400000000 "Nucleoplasm, Vesicles, Cytosol" "CAB033806: AB_2256019" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.72e-2)" "unprognostic (3.27e-2)" "unprognostic (7.98e-3)" "unprognostic (1.71e-2)" "unprognostic (2.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.20e-4)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" 122.3 97.5 79.8 105.4 76.4 169.0 87.1 33.2 74.8 92.3 93.3 62.0 59.7 38.5 83.7 67.2 62.7 53.0 92.5 54.9 90.8 67.8 69.6 50.8 134.4 205.2 111.4 84.0 61.9 51.0 4.4 23.4 53.4 74.3 46.6 86.6 31.2 42.3 100.4 28.9 39.6 71.5 75.1 195.6 205.7 98.9 26.4 63.8 96.8 34.4 48.6 154.5 112.2 62.1 296.5 495.3 775.0 554.0 272.7 521.9 1074.5 144.7 121.2 238.2 375.3 292.0 320.2 0.5 76.7 200.8 59.6 102.7 24.9 121.8 34.7 74.2 232.8 107.2 63.8 35.2 51.4 80.2 202.6 2.0 43.2 71.9 0.3 68.1 168.5 358.6 149.0 73.7 70.5 61.7 146.2 358.0 92.6 5.4 0.5 210.8 51.5 200.3 365.8 85.6 69.8 83.6 154.4 84.3 141.5 354.7 42.4 25.3 10.8 111.2 5.2 14.1 184.0 139.7 171.2 287.9 87.0 43.2 493.2 76.2 113.1 82.0 67.2 133.1 69.9 62.7 544.9 512.5 775.0 364.8 524.7 309.6 296.5 407.3 391.0 495.3 275.6 345.8 349.0 576.0 272.7 554.0 204.1 521.9 1074.5 79.8 76.4 33.2 74.8 90.8 67.8 111.4 84.0 74.3 63.8 4880.5 5161.6 6027.5 2141.8 7849.2 355.4 69.7 3189.8 1104.2 2643.4 6528.7 21.6 260.6 1848.6 14106.6 104.1 8207.2 4374.5 256.9 19960.8 448.9 5187.8 2457.6 4102.8 814.3 27421.6 58.8 1698.6 5862.6 15729.2 176.0 3640.8 24463.6 6022.8 60748.0 4889.5 45.5 20394.3 5909.2 5673.8 362.6 82.8 5639.7 7491.8 44.2 114.3 8329.0 380.3 13550.6 2818.5 7177.4 TMTC1 "ARG99, FLJ31400, FLJ41625, OLF" ENSG00000133687 "Transmembrane and tetratricopeptide repeat containing 1" Q8IUR5 12 29500840-29784759 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 23.2;Endothelial cells: 46.9;Ito cells: 33.2;Sertoli cells: 45.3;Smooth muscle cells: 28.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 2.3" "Lineage enriched" "Detected in single" 5 "monocytes: 2.3" "Cell line enhanced" "Detected in many" "HHSteC: 29.2;HSkMC: 19.9;hTERT-HME1: 35.8;LHCN-M2: 19.9;RH-30: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016720 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016720: AB_1858155" "unprognostic (1.67e-1)" "unprognostic (6.35e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.63e-3)" "unprognostic (4.53e-2)" "unprognostic (3.88e-2)" "unprognostic (8.36e-2)" "unprognostic (1.77e-1)" "unprognostic (8.90e-3)" "unprognostic (3.08e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (5.49e-4)" "unprognostic (5.89e-3)" "unprognostic (6.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.51e-3)" 29.3 12.8 12.9 4.6 30.8 0.5 25.8 2.2 9.0 11.4 8.4 2.9 4.3 3.0 7.4 2.9 6.1 12.6 6.2 15.7 15.2 8.1 13.1 2.4 6.7 2.4 5.4 7.8 8.7 2.9 10.0 18.7 2.7 9.1 6.4 5.4 7.1 3.7 8.3 13.7 2.9 4.6 12.7 4.9 34.1 7.4 2.8 6.2 0.8 3.7 4.4 2.0 8.9 10.5 0.1 0.1 0.4 2.3 0.1 0.1 0.3 0.0 0.0 5.2 0.0 16.6 11.2 0.0 5.4 11.1 1.4 1.2 0.0 0.0 0.0 2.7 3.4 6.1 0.0 0.1 0.1 0.0 0.1 1.6 0.0 15.7 0.2 29.2 0.7 0.0 19.9 1.9 13.8 35.8 4.2 0.8 0.0 0.0 0.7 19.9 0.0 0.0 0.0 4.0 0.0 7.2 0.0 41.8 0.7 0.0 0.1 0.4 0.4 0.6 0.0 1.3 2.0 0.0 0.2 2.2 1.3 0.8 0.7 4.3 7.3 0.0 0.0 9.5 0.0 0.1 0.2 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 2.3 0.1 0.0 0.3 12.9 30.8 2.2 7.6 15.2 8.1 5.4 7.8 9.1 6.2 3.0 1.1 0.0 1.0 3.0 7.1 23.2 0.0 1.4 0.0 3.5 0.0 0.0 0.0 0.0 6.5 46.9 0.0 0.0 0.0 0.0 7.5 2.4 0.0 4.9 0.5 0.0 0.0 33.2 14.6 4.8 7.5 2.4 10.1 0.0 0.0 0.4 0.0 0.0 17.3 0.6 1.2 45.3 28.9 0.5 0.4 1.8 1.6 0.0 0.0 0.1 TMUB1 "C7orf21, SB144" ENSG00000164897 "Transmembrane and ubiquitin like domain containing 1" Q9BVT8 7 151081080-151083546 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029429 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029429: AB_10601825" "unprognostic (8.14e-2)" "unprognostic (2.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-3)" "unprognostic (7.73e-2)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (1.74e-2)" "unprognostic (2.24e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-3)" "unprognostic (2.74e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" 10.6 15.2 10.3 16.1 11.0 13.7 17.8 9.1 16.0 9.7 27.5 9.0 17.0 31.8 10.4 15.4 21.6 9.6 18.0 17.3 10.6 9.6 25.5 35.5 12.9 15.6 10.2 10.0 13.1 51.5 9.5 21.1 18.9 8.3 16.1 6.0 12.7 29.6 12.9 33.8 15.1 39.2 12.8 8.7 16.1 24.0 11.5 8.5 23.9 23.6 12.9 19.1 18.7 11.8 8.0 4.2 18.2 3.6 3.1 9.5 1.8 24.4 22.1 5.2 26.8 3.4 4.2 19.5 10.0 8.5 9.0 10.0 19.0 29.9 16.4 21.6 4.9 11.6 16.7 5.8 8.9 2.0 30.0 20.5 7.0 20.5 28.8 8.8 8.6 24.8 6.5 7.4 7.5 2.0 6.8 6.6 17.0 43.7 22.4 4.0 39.5 28.7 37.2 22.3 14.4 13.4 18.0 6.6 30.3 9.3 19.0 19.1 21.3 8.1 12.5 13.1 3.2 9.8 12.0 8.0 11.4 8.4 14.3 16.5 35.3 19.4 11.2 26.4 16.2 14.4 3.5 2.7 18.2 5.4 3.6 4.7 4.4 8.0 5.8 2.8 8.0 7.8 4.5 4.7 3.1 2.2 4.2 9.5 1.8 10.3 11.0 9.1 16.0 10.6 9.6 10.2 10.0 8.3 8.5 6.0 5.6 49.1 25.7 23.5 14.7 8.1 22.9 0.0 0.0 21.0 13.7 83.6 29.9 61.9 8.5 23.9 135.7 0.0 95.6 50.7 20.3 31.1 16.1 44.1 39.1 19.1 39.6 21.5 20.8 2.5 11.5 25.8 30.4 58.7 75.9 22.0 80.5 108.7 15.6 34.6 14.8 38.8 29.9 25.1 10.6 32.2 79.1 52.4 64.5 33.0 TMUB2 MGC3123 ENSG00000168591 "Transmembrane and ubiquitin like domain containing 2" Q71RG4 17 44186970-44191731 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043137 Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043137: AB_10794388" "unprognostic (4.57e-2)" "unprognostic (1.58e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-2)" "unprognostic (6.37e-2)" "unprognostic (1.85e-2)" "unprognostic (6.43e-3)" "unprognostic (1.07e-1)" "unprognostic (2.05e-1)" "unprognostic (3.35e-2)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "unprognostic (2.12e-1)" "unprognostic (9.75e-3)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.78e-3)" 22.5 27.0 21.2 22.6 26.7 39.9 37.6 32.4 39.0 27.3 24.0 25.9 30.5 25.2 27.4 26.4 31.0 24.2 26.6 21.2 21.2 20.4 28.9 29.4 22.9 24.7 19.9 23.1 27.9 33.5 30.7 25.2 38.9 21.0 30.3 23.6 23.3 30.7 34.1 22.9 29.0 29.6 23.4 18.8 40.0 25.8 46.0 19.6 21.1 34.6 20.9 23.1 26.0 25.0 10.0 10.2 29.9 13.3 5.5 8.1 8.2 11.4 22.6 14.4 13.4 22.8 18.1 11.3 15.2 16.5 28.4 29.0 11.7 21.5 8.0 16.5 18.8 21.6 21.9 10.1 14.4 17.9 19.5 21.0 8.3 20.5 17.8 23.6 9.3 18.7 21.9 21.1 19.3 12.1 24.1 19.8 13.4 9.5 23.9 18.5 8.1 12.9 12.5 4.8 9.8 19.1 11.7 17.5 12.8 17.9 13.0 11.6 11.8 7.9 7.5 15.0 15.6 22.0 12.0 16.3 23.7 14.6 16.6 13.5 17.6 12.8 7.7 18.2 7.9 15.9 29.9 13.3 24.1 8.1 11.7 6.8 7.7 6.7 7.7 8.5 10.0 6.5 7.3 29.3 5.5 11.7 10.2 7.6 8.2 21.2 26.7 32.4 39.0 21.2 20.4 19.9 23.1 21.0 19.6 32.8 32.9 37.3 18.6 11.6 29.4 15.3 20.4 16.0 23.9 21.0 29.5 39.5 3.3 17.1 42.2 20.1 33.5 0.0 16.3 24.5 18.8 21.2 20.9 10.4 35.9 20.6 32.1 20.3 30.1 22.0 20.1 27.2 13.5 27.1 22.9 27.2 20.1 34.5 22.6 6.8 25.9 25.8 17.9 60.2 26.6 13.0 80.9 25.4 23.4 20.9 TMX2 "PDIA12, TXNDC14" ENSG00000213593 "Thioredoxin related transmembrane protein 2" Q9Y320 11 57712600-57740973 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Lissencephaly, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040282, HPA063763" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA040282: AB_10697715, HPA063763: AB_2685116" "unprognostic (3.66e-3)" "unprognostic (6.96e-2)" "unprognostic (6.69e-3)" "unprognostic (2.73e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (4.11e-4)" "unprognostic (4.48e-2)" "unprognostic (2.98e-1)" "unprognostic (7.26e-3)" "unprognostic (1.90e-2)" "unprognostic (2.22e-1)" "prognostic favorable (1.55e-5)" "unprognostic (5.88e-3)" "unprognostic (4.19e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (3.37e-4)" 29.5 40.5 33.6 21.0 39.0 13.7 30.8 26.5 60.5 28.0 40.6 50.7 29.0 33.3 22.5 36.7 32.7 25.5 20.0 33.0 32.6 32.1 47.4 71.7 24.4 22.1 40.4 30.4 25.9 40.6 49.8 25.8 26.2 45.3 31.1 49.3 38.4 27.9 34.4 21.9 21.9 34.0 26.1 42.3 25.4 29.9 19.1 31.3 24.0 34.4 25.8 27.0 22.2 22.6 17.7 23.1 17.9 37.5 16.5 21.8 18.8 28.5 33.5 19.3 34.7 36.0 19.3 21.1 34.5 26.8 34.0 28.9 31.8 49.2 26.8 38.6 27.7 50.6 52.8 48.8 27.6 36.1 19.2 21.2 25.9 27.1 31.8 29.7 36.1 35.7 23.6 40.4 37.6 60.0 18.7 19.3 22.6 44.4 31.7 37.9 14.6 21.3 41.2 37.3 53.3 46.0 29.0 24.2 56.7 42.3 32.3 22.1 31.6 26.6 61.9 38.3 19.6 55.3 23.9 16.1 32.1 21.0 42.7 35.6 31.2 60.8 27.1 36.1 25.7 47.5 15.9 19.6 17.9 17.1 33.1 21.6 17.7 17.3 20.0 19.0 15.3 21.8 21.8 5.2 16.5 37.5 23.1 14.3 18.8 33.6 39.0 26.5 60.5 32.6 32.1 40.4 30.4 45.3 31.3 35.7 30.6 38.1 36.3 28.5 43.9 38.7 40.8 34.8 34.2 47.1 29.5 94.9 36.5 67.4 1.6 34.9 38.2 0.0 37.5 68.8 35.4 39.2 42.7 45.2 57.0 28.6 27.6 33.7 27.3 1.9 45.1 35.0 45.5 31.5 45.0 90.9 45.2 35.1 41.1 38.0 52.4 38.8 26.2 56.1 68.8 28.5 83.3 22.4 61.2 41.0 TNFAIP2 "B94, EXOC3L3" ENSG00000185215 "TNF alpha induced protein 2" Q03169 14 103123442-103137439 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "monocytes: 414.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 25.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "RT4: 128.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004598, HPA030624" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nuclear membrane" "CAB004598: AB_628370, HPA030624: AB_2673552" "unprognostic (5.01e-3)" "unprognostic (4.93e-2)" "unprognostic (1.56e-3)" "unprognostic (8.02e-3)" "unprognostic (3.39e-2)" "unprognostic (2.98e-2)" "unprognostic (5.52e-3)" "unprognostic (5.97e-2)" "unprognostic (1.94e-1)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.10e-4)" "prognostic favorable (2.79e-5)" "unprognostic (1.75e-2)" "unprognostic (3.83e-2)" "prognostic favorable (7.17e-5)" 27.3 17.0 3.8 58.2 5.7 20.1 19.3 2.5 3.6 23.5 12.9 2.8 4.7 8.1 16.7 18.7 35.5 14.3 30.9 12.7 2.9 3.6 18.8 13.6 32.0 17.9 4.6 3.0 9.7 9.0 17.4 3.5 33.0 6.1 21.7 6.1 16.3 25.1 7.1 12.5 13.2 11.3 28.0 3.8 35.9 8.3 13.0 2.9 11.0 8.5 31.4 48.6 39.8 16.3 0.1 5.0 25.9 9.8 0.1 0.1 1.9 5.5 27.4 0.2 0.1 1.8 7.9 9.2 1.6 7.0 4.4 1.5 0.3 24.9 0.0 20.5 8.0 23.4 17.7 1.9 0.0 2.1 0.9 0.1 2.5 19.1 0.1 3.4 1.2 3.4 3.0 0.2 1.4 0.0 1.7 2.3 1.3 2.5 6.0 0.6 0.5 0.0 1.9 1.6 3.2 2.2 1.1 3.1 4.0 14.0 128.9 0.2 0.3 25.2 8.8 0.3 1.0 14.2 8.1 4.7 0.9 2.4 5.1 5.0 5.4 0.4 0.1 6.7 5.6 2.6 2.5 8.8 4.6 0.0 9.8 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.1 25.9 0.1 6.9 0.2 0.0 1.9 3.8 5.7 2.5 3.6 2.9 3.6 4.6 3.0 6.1 2.9 0.0 33.8 0.5 27.9 25.1 0.6 12.5 40.8 25.4 30.7 26.2 0.0 0.8 0.0 129.0 29.4 40.9 0.4 0.0 39.8 58.7 62.7 91.7 33.4 6.4 46.3 0.0 16.6 22.1 116.0 36.8 7.8 125.1 28.7 414.8 0.0 8.0 86.0 6.5 2.1 5.5 0.4 19.4 41.0 1.1 2.8 29.2 4.0 2.5 0.2 83.4 TNFAIP3 "A20, OTUD7C" ENSG00000118503 "TNF alpha induced protein 3" P21580 6 137867188-137883312 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Inflammatory response, Ubl conjugation pathway" "DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 112.4" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 688.4;Suprabasal keratinocytes: 651.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 31.8;Karpas-707: 48.1;REH: 41.8;U-266/84: 35.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002116 Approved Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA002116: AB_1858162" "unprognostic (5.50e-3)" "unprognostic (9.98e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-2)" "unprognostic (4.01e-2)" "unprognostic (9.47e-2)" "unprognostic (5.01e-3)" "unprognostic (4.40e-2)" "unprognostic (2.92e-2)" "unprognostic (2.58e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (6.06e-2)" "unprognostic (3.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" 27.4 6.0 1.5 58.6 1.8 112.4 17.2 0.4 1.5 7.7 15.7 3.2 2.6 5.1 9.7 7.3 12.7 12.1 17.0 11.7 2.1 1.3 6.8 8.1 45.1 38.8 2.1 2.6 37.5 7.2 2.1 3.7 14.5 4.6 13.8 6.3 7.2 8.2 3.5 10.7 20.5 17.2 8.2 3.8 25.9 8.0 9.3 2.1 38.6 5.7 9.2 31.4 23.3 9.5 7.1 18.6 10.0 9.7 7.5 20.5 9.0 8.9 1.4 0.5 0.8 3.0 5.1 2.1 5.1 19.9 1.4 1.8 9.9 2.9 2.0 13.1 5.8 31.8 6.8 0.3 14.7 2.6 14.5 0.5 2.0 5.1 5.8 3.3 2.7 3.6 4.6 2.1 16.8 16.0 1.7 0.8 5.3 4.0 48.1 2.4 0.5 14.7 11.5 0.3 0.6 0.4 41.8 10.4 1.4 4.3 4.3 0.2 0.0 1.0 1.5 4.3 2.1 1.0 3.3 4.0 14.4 1.7 12.9 2.9 15.5 35.9 4.1 5.2 3.4 1.7 5.6 9.7 5.5 14.8 7.1 20.5 6.2 15.1 13.3 10.3 7.1 10.0 7.4 10.0 7.5 3.7 18.6 14.7 9.0 1.5 1.8 0.4 1.5 2.1 1.3 2.1 2.6 4.6 2.1 35.7 83.1 25.1 141.6 688.4 1.0 4.2 30.6 41.5 26.1 0.0 27.5 5.5 1.7 50.3 2.3 27.0 39.0 0.0 23.4 88.6 55.5 117.9 248.4 10.2 45.4 0.0 11.3 45.4 74.2 2.4 6.4 241.1 123.2 82.0 12.5 1.7 27.9 8.2 5.6 2.2 13.3 6.5 87.3 0.9 2.3 651.8 19.3 101.2 8.5 60.3 TNFAIP8L3 FLJ41287 ENSG00000183578 "TNF alpha induced protein 8 like 3" Q5GJ75 15 51056598-51105276 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.0;smooth muscle: 47.0" "Cell type enhanced" "Detected in many" 9 "Intestinal endocrine cells: 9.9;Leydig cells: 8.3;Smooth muscle cells: 9.2;Spermatocytes: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 12.9;ASC TERT1: 32.9;HSkMC: 12.1;HUVEC TERT2: 28.1;LHCN-M2: 26.4;TIME: 37.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077484 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA077484: AB_2732347" "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.12e-3)" "unprognostic (6.63e-2)" "unprognostic (2.54e-1)" "unprognostic (1.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-2)" "unprognostic (4.21e-2)" "unprognostic (4.70e-3)" "unprognostic (6.54e-2)" "unprognostic (9.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.37e-3)" "prognostic unfavorable (3.51e-4)" 4.6 2.4 11.8 4.1 3.8 0.8 10.5 0.6 5.8 9.8 4.1 1.8 2.8 1.2 47.0 9.9 11.5 20.9 3.7 5.5 11.4 3.1 1.9 1.5 6.6 5.4 1.9 5.6 17.5 1.6 0.6 1.8 1.4 3.3 6.6 5.0 0.6 1.9 3.5 2.1 10.7 3.2 47.0 1.5 14.7 2.9 3.4 1.1 0.0 2.5 4.7 2.4 12.3 18.8 1.4 1.0 3.7 1.5 1.7 0.8 0.3 0.0 0.1 0.0 0.0 12.9 32.9 0.1 0.1 0.0 0.3 0.5 0.0 0.3 0.0 0.6 1.8 4.1 0.0 0.4 0.3 0.1 0.0 0.3 0.0 0.9 2.1 3.4 0.1 0.7 12.1 2.6 2.4 9.5 2.2 28.1 0.0 0.0 0.0 26.4 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.2 37.7 2.9 0.2 9.7 0.7 0.1 0.0 0.0 6.1 0.0 0.0 2.8 1.5 0.7 0.5 0.7 0.6 0.8 0.6 0.5 0.3 1.4 0.6 0.8 3.7 1.7 1.0 1.0 0.4 0.3 11.8 3.8 0.6 5.8 11.4 3.1 1.9 5.6 3.3 1.1 0.0 0.3 0.0 0.6 3.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.3 0.0 3.7 0.4 0.0 0.0 2.7 0.0 9.9 2.5 2.5 0.4 8.3 2.8 1.7 1.0 2.8 0.0 0.1 1.1 4.9 0.0 0.2 6.5 9.2 16.8 0.4 7.3 0.0 0.0 2.6 0.4 TNFRSF11A "CD265, FEO, LOH18CR1, PDB2, RANK" ENSG00000141655 "TNF receptor superfamily member 11a" Q9Y6Q6 18 62325287-62391292 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 21.1;monocytes: 34.3;Mucus-secreting cells: 23.6;Paneth cells: 28.1;Undifferentiated cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "NK-cell: 8.9" "Lineage enriched" "Detected in many" 8 "NK-cells: 8.9" "Cell line enriched" "Detected in some" 6 "HDLM-2: 52.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010391, HPA047976" Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" Cytosol "CAB010391: AB_2205352, HPA047976: AB_2680227" "unprognostic (4.08e-1)" "unprognostic (2.71e-1)" "unprognostic (3.23e-3)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "unprognostic (1.35e-1)" "unprognostic (9.96e-4)" "unprognostic (4.24e-3)" "unprognostic (7.79e-4)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (2.88e-1)" "unprognostic (4.69e-5)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (4.02e-2)" "unprognostic (7.07e-2)" 6.5 1.7 1.7 4.8 1.2 0.2 4.3 0.4 2.3 1.5 18.4 0.8 7.6 23.1 0.9 1.9 3.8 1.3 28.7 1.1 1.3 0.7 0.9 0.8 2.3 7.4 1.0 1.0 0.7 2.9 0.1 10.1 2.8 0.7 2.1 13.9 1.3 34.3 12.9 0.6 3.3 23.9 1.3 2.9 1.2 4.3 1.2 0.8 0.7 2.0 1.8 2.3 2.3 2.3 0.0 0.6 0.2 0.0 8.9 1.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.0 1.5 0.1 0.6 0.9 3.5 0.3 0.1 52.5 2.3 0.0 0.5 0.7 0.0 0.2 0.5 0.1 0.1 0.3 1.3 1.8 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.5 2.9 8.3 0.1 0.0 0.2 0.6 0.6 8.9 0.3 0.2 1.3 0.0 0.3 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 8.9 0.0 0.6 1.0 0.0 1.7 1.2 0.4 2.3 1.3 0.7 1.0 1.0 0.7 0.8 0.0 2.1 0.0 2.9 1.1 0.4 1.1 10.2 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.2 2.2 21.1 0.0 6.5 0.6 0.3 2.6 0.0 0.0 12.8 3.2 10.4 3.7 15.0 0.0 0.6 2.5 1.7 34.3 23.6 0.0 9.6 28.1 0.0 0.0 0.0 0.0 0.3 0.7 1.4 1.9 0.1 0.0 33.6 3.8 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 1094.9;Ductal cells: 954.3;Exocrine glandular cells: 607.7;Pancreatic endocrine cells: 874.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 25.0" "Group enriched" "Detected in many" 8 "eosinophil: 38.1;neutrophil: 29.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 38.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA007853 Approved Approved "Plasma membrane,Cytosol" NA Yes 170000 "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 10.8 14.2 2.4 11.3 5.1 2.7 21.2 0.9 3.0 8.0 18.9 3.2 4.1 14.5 11.6 10.2 10.7 6.4 28.1 27.0 5.0 2.6 50.4 36.2 23.0 2.6 4.8 0.5 6.4 47.0 51.1 20.0 81.3 25.0 11.1 1.9 2.8 17.3 6.9 23.3 5.0 31.0 16.8 4.3 3.9 13.2 5.3 3.3 1.2 11.5 11.5 4.7 14.8 5.2 0.0 4.1 38.1 3.5 2.0 2.4 1.1 24.5 19.9 2.2 4.1 4.1 9.3 13.2 51.8 37.5 44.4 28.6 8.6 43.9 0.1 68.6 34.4 51.6 27.2 0.5 37.9 17.0 0.9 1.3 0.1 6.7 7.2 28.0 0.4 1.8 8.6 26.3 46.6 55.9 38.3 12.8 0.0 2.7 0.3 46.7 46.5 0.0 3.3 10.7 11.0 43.8 0.2 24.9 1.0 44.9 4.9 2.5 0.9 36.9 17.2 30.5 7.7 9.0 0.7 22.5 80.0 36.9 52.9 84.9 0.8 0.3 0.3 25.0 2.3 62.8 3.5 3.5 38.1 1.8 2.0 2.4 0.0 0.8 1.5 4.1 0.0 0.4 0.8 29.9 2.0 1.3 0.1 1.0 1.1 2.4 5.1 0.9 3.0 5.0 2.6 4.8 0.5 25.0 3.3 95.3 43.1 5.0 1094.9 544.0 0.9 57.7 163.1 50.9 130.8 172.7 2.0 112.5 54.7 954.3 0.6 22.7 41.3 0.0 607.7 131.7 179.4 600.3 58.8 15.3 38.1 0.0 26.1 28.8 4.6 0.4 5.8 29.4 106.3 16.2 4.6 20.6 874.5 25.8 6.3 93.5 5.1 6.5 212.1 7.7 4.1 314.4 158.1 8.6 12.4 560.0 TNFRSF21 "CD358, DR6" ENSG00000146072 "TNF receptor superfamily member 21" O75509 6 47231532-47309905 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.4" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 142.4;Glandular cells: 135.6;Syncytiotrophoblasts: 149.4;Urothelial cells: 360.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 35 "plasmacytoid DC: 31.6" "Lineage enriched" "Detected in single" 309 "dendritic cells: 31.6" "Cell line enhanced" "Detected in many" "OE19: 39.2;RT4: 99.8;SuSa: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006746, CAB009805" Approved Supported "Plasma membrane,Cytosol" NA NA 1300000 "Plasma membrane, Cytosol" "CAB009805: AB_2206956, HPA006746: AB_1078701" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (3.26e-1)" "unprognostic (7.85e-2)" "unprognostic (1.44e-1)" "unprognostic (3.41e-2)" "unprognostic (9.80e-3)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (7.53e-2)" "unprognostic (1.38e-3)" "unprognostic (1.74e-1)" "prognostic favorable (7.23e-6)" "unprognostic (1.48e-1)" "unprognostic (1.34e-1)" "unprognostic (9.78e-2)" "unprognostic (1.45e-2)" 25.9 3.7 9.7 8.7 13.6 5.9 7.8 7.4 20.8 9.6 19.3 26.9 1.0 6.4 9.1 3.0 21.8 9.9 18.7 4.1 13.8 16.0 26.2 4.6 9.5 11.5 26.8 7.9 5.0 17.9 35.6 4.4 17.0 29.5 10.2 18.5 3.0 15.2 2.4 3.5 2.7 10.2 8.2 63.4 11.6 30.4 5.8 10.1 11.5 2.9 19.2 16.5 41.2 11.6 0.0 31.6 0.1 0.0 0.0 0.0 0.2 29.2 9.5 9.3 2.9 25.5 7.5 10.5 3.4 6.7 1.0 0.4 16.4 20.7 2.1 13.8 2.4 20.0 17.7 1.3 12.6 0.6 0.0 2.9 0.0 1.2 16.5 14.9 0.4 0.1 13.4 15.1 0.6 11.5 0.8 4.9 1.9 0.7 0.0 0.3 5.7 2.5 0.2 7.3 39.2 9.8 5.4 2.8 3.1 17.7 99.8 6.7 1.4 2.9 2.8 2.4 43.8 2.1 2.0 1.0 2.8 2.5 0.1 3.1 0.0 0.0 3.0 4.5 2.1 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.2 9.7 13.6 7.4 20.8 13.8 16.0 26.8 7.9 29.5 10.1 0.0 12.7 0.0 142.4 21.1 0.6 7.6 35.7 10.7 25.0 1.8 0.0 24.6 13.3 69.3 45.6 5.6 30.3 0.0 25.8 16.8 14.1 135.6 19.6 0.0 20.6 0.0 11.5 1.8 36.8 29.9 2.6 5.8 11.8 0.0 40.2 4.4 63.5 46.7 1.1 48.5 1.3 77.6 16.2 0.6 1.4 8.7 149.4 1.3 14.0 360.8 TNFSF15 "MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A" ENSG00000181634 "TNF superfamily member 15" O95150 9 114784635-114806126 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;kidney: 16.2;salivary gland: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.9;monocytes: 9.0;Proximal tubular cells: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 2.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8" "Cell line enhanced" "Detected in some" "HaCaT: 11.1;hTEC/SVTERT24-B: 7.3;HUVEC TERT2: 14.0;OE19: 13.1;RT4: 13.7;TIME: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012948, HPA046522" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted to blood" NA NA 1110000 "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA012948: AB_1858024, HPA046522: AB_2679683" "unprognostic (3.41e-1)" "unprognostic (2.06e-2)" "unprognostic (3.76e-1)" "unprognostic (1.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.67e-2)" "unprognostic (1.64e-1)" "unprognostic (2.29e-2)" "unprognostic (5.40e-2)" "unprognostic (1.38e-1)" "unprognostic (7.78e-2)" "unprognostic (2.09e-1)" "unprognostic (8.64e-5)" "unprognostic (1.97e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-3)" "unprognostic (4.46e-3)" 1.2 1.3 0.3 3.1 0.5 0.0 0.7 0.2 0.9 1.9 7.3 0.1 1.3 10.8 0.9 1.3 2.8 0.8 2.0 0.3 1.7 0.3 16.2 0.5 5.2 0.5 0.4 0.1 0.7 1.4 0.2 0.5 6.0 0.7 9.8 2.2 0.6 28.7 4.4 0.3 0.6 15.0 2.0 0.4 1.5 3.0 0.6 0.1 0.9 1.3 1.8 2.4 6.4 1.6 0.3 2.8 1.2 1.8 0.3 0.1 0.4 0.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.2 2.5 1.3 0.0 0.0 0.4 11.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.0 0.0 14.0 0.0 0.0 0.8 0.4 0.5 0.0 0.0 0.2 13.1 0.0 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.0 0.6 0.0 5.0 1.0 0.0 6.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.1 0.1 1.8 0.0 0.3 0.1 0.0 2.8 0.3 0.1 0.1 1.2 0.3 0.2 1.5 0.0 0.4 0.3 0.5 0.2 0.9 1.7 0.3 0.4 0.1 0.7 0.1 11.9 8.9 0.0 4.4 0.5 0.1 0.5 0.0 0.0 1.2 7.0 0.0 0.5 0.0 4.0 0.2 0.0 6.9 0.0 1.8 0.1 0.8 4.6 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 9.0 1.8 0.2 1.1 0.0 0.4 9.6 0.1 0.0 1.0 0.0 0.0 0.5 0.2 0.0 3.9 5.1 TNIK KIAA0551 ENSG00000154310 "TRAF2 and NCK interacting kinase" Q9UKE5 3 171061339-171460408 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9" "Cell type enhanced" "Detected in many" 7 "granulocytes: 79.9;Muller glia cells: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 23 "basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3" "Group enriched" "Detected in many" 29 "granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7" "Cell line enhanced" "Detected in many" "AF22: 19.9;HEL: 27.0;HMC-1: 30.8;WM-115: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012128, HPA012297" Approved Supported Nucleoplasm,Cytosol NA NA 9100 Nucleoplasm Cytosol "HPA012128: AB_1858226, HPA012297: AB_1858225" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (1.32e-1)" "unprognostic (5.90e-2)" "unprognostic (5.25e-2)" "unprognostic (9.23e-2)" "unprognostic (4.91e-2)" "unprognostic (2.41e-3)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (5.91e-2)" "unprognostic (1.96e-2)" "unprognostic (3.34e-3)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.13e-2)" "unprognostic (3.97e-2)" 2.2 5.4 29.0 7.4 30.9 4.9 3.6 21.1 26.1 1.9 10.9 12.2 4.1 25.8 4.3 2.1 5.6 4.3 7.1 11.2 30.9 14.8 5.6 4.6 11.3 7.9 11.4 18.3 2.6 5.2 0.7 9.0 3.1 13.6 5.6 9.5 3.5 2.9 7.3 23.2 1.6 25.6 6.0 14.5 5.8 9.2 10.7 21.1 3.7 7.1 2.2 6.9 6.4 2.6 0.2 0.0 10.5 0.1 2.7 6.7 1.1 0.3 0.5 19.9 2.1 0.3 0.0 4.7 4.1 1.2 3.3 2.2 17.8 7.4 0.0 1.5 3.8 3.0 6.1 2.8 1.1 3.6 0.1 4.4 27.0 1.5 0.0 9.5 5.3 30.8 2.9 3.0 1.9 0.4 7.7 19.8 4.5 9.7 0.0 0.5 0.4 1.7 6.8 8.2 14.2 7.7 0.0 5.1 7.1 6.4 0.0 0.9 1.0 2.5 0.2 4.4 2.2 9.0 1.3 0.2 0.0 3.5 9.0 3.0 0.0 0.0 0.0 0.9 6.0 23.0 4.4 0.1 10.5 4.2 0.0 5.2 0.0 5.0 3.7 0.0 0.2 6.7 3.8 0.1 2.7 0.1 0.0 5.3 1.1 29.0 30.9 21.1 22.2 30.9 14.8 11.4 18.3 13.6 21.1 6.0 37.9 0.5 1.4 2.3 9.3 25.7 25.5 2.7 12.5 8.7 13.7 4.7 5.0 9.2 29.5 1.6 26.2 0.0 6.8 1.8 4.4 0.6 79.9 6.8 2.5 0.0 12.7 1.3 5.6 33.0 2.3 3.3 1.7 0.0 9.4 79.4 4.8 16.5 6.0 14.9 27.7 0.0 7.6 2.8 1.0 1.4 2.1 31.2 15.3 2.4 TNIP1 "ABIN-1, KIAA0113, NAF1, VAN" ENSG00000145901 "TNFAIP3 interacting protein 1" Q15025 5 151029945-151093577 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "monocytes: 370.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 82.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037893, HPA037894, HPA071950" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037893: AB_10672468, HPA037894: AB_2675723, HPA071950: AB_2686476" "prognostic favorable (5.69e-4)" "unprognostic (1.08e-1)" "unprognostic (1.10e-1)" "prognostic favorable (6.86e-5)" "unprognostic (7.45e-3)" "unprognostic (2.94e-1)" "unprognostic (5.35e-3)" "unprognostic (1.45e-2)" "unprognostic (2.82e-1)" "unprognostic (3.42e-1)" "unprognostic (2.25e-2)" "unprognostic (1.96e-1)" "unprognostic (7.68e-3)" "unprognostic (1.47e-1)" "unprognostic (4.69e-2)" "unprognostic (2.29e-1)" "unprognostic (9.84e-2)" 49.8 16.8 8.9 32.2 10.7 35.8 68.8 10.1 11.4 16.5 38.8 10.2 22.9 23.8 13.6 21.2 28.9 11.2 33.2 30.1 8.9 8.7 27.8 34.3 29.0 35.1 11.2 7.2 14.6 42.2 16.4 9.5 15.7 10.6 18.5 17.4 13.9 18.2 27.6 61.7 19.5 37.2 21.0 10.7 39.5 20.6 9.9 10.9 21.0 19.6 27.7 41.9 20.6 35.0 10.9 7.7 26.0 7.4 7.0 12.5 5.3 23.2 16.6 3.1 11.4 12.4 12.6 8.4 11.3 36.1 10.1 19.1 15.8 31.8 19.5 38.2 15.1 59.6 14.1 5.1 82.9 12.4 33.3 7.2 7.8 9.3 10.2 23.8 8.7 35.5 18.0 15.4 16.8 34.9 28.1 14.4 7.8 4.8 19.4 25.1 8.7 9.4 12.0 2.9 8.2 9.2 7.8 24.5 25.9 31.6 17.1 4.5 10.5 8.7 27.3 11.5 9.0 14.0 11.0 22.1 34.4 11.3 5.9 16.0 39.0 20.1 8.7 37.2 12.9 8.2 9.7 7.4 20.4 7.8 6.8 9.1 8.4 9.0 7.7 5.6 10.9 4.7 5.1 26.0 7.0 6.1 7.7 12.5 5.3 8.9 10.7 10.1 11.4 8.9 8.7 11.2 7.2 10.6 10.9 53.6 47.9 57.0 38.7 26.4 14.5 44.5 43.3 34.8 43.3 26.2 3.9 15.1 61.3 215.3 2.7 46.5 218.6 23.3 121.4 25.8 41.8 84.1 47.3 52.9 35.3 17.5 35.8 41.7 42.7 5.6 25.0 50.8 25.3 370.7 58.2 18.6 194.1 86.5 22.3 40.4 14.0 32.3 51.5 2.3 13.4 25.0 40.3 63.3 62.8 120.2 TNIP2 "ABIN-2, FLIP1, KLIP, MGC4289" ENSG00000168884 "TNFAIP3 interacting protein 2" Q8NFZ5 4 2741648-2756376 "Predicted intracellular proteins" "Apoptosis, Inflammatory response, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020818, HPA049886, HPA063197" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960" "unprognostic (1.22e-1)" "unprognostic (2.09e-1)" "unprognostic (2.44e-1)" "prognostic favorable (1.13e-4)" "unprognostic (3.64e-1)" "unprognostic (9.87e-2)" "unprognostic (4.36e-2)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.77e-1)" "unprognostic (2.47e-2)" "unprognostic (8.34e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.94e-5)" "unprognostic (3.00e-1)" "unprognostic (7.23e-2)" "unprognostic (1.97e-3)" "unprognostic (4.02e-3)" 16.7 10.3 7.8 14.5 14.0 18.9 32.5 3.4 12.4 9.8 26.4 7.3 7.1 16.4 11.9 10.1 14.5 9.6 13.7 26.6 7.4 6.5 23.4 16.6 16.0 17.9 11.2 4.7 12.3 24.2 3.5 11.4 15.3 12.4 13.6 10.1 9.7 10.7 13.5 21.9 10.5 37.2 23.9 12.2 17.8 15.3 11.7 11.1 8.1 14.2 12.3 18.2 15.1 33.7 9.8 7.3 20.9 11.8 4.4 11.2 4.7 12.2 16.7 5.3 8.0 17.0 11.7 23.0 13.4 12.0 12.5 12.2 19.1 19.9 11.2 15.2 14.6 28.1 8.1 9.5 15.4 7.4 8.7 11.9 13.4 9.9 21.1 21.2 10.9 17.0 15.1 14.0 13.8 12.5 9.7 17.8 10.3 13.6 15.9 8.6 25.4 14.3 27.0 13.9 18.3 28.6 9.5 8.1 5.8 13.4 13.8 8.0 9.0 10.4 10.9 14.7 9.6 12.0 16.1 20.6 9.7 10.7 15.1 20.5 16.5 11.2 8.1 17.7 19.8 10.4 6.4 7.2 20.9 6.7 11.2 7.2 7.8 10.2 11.2 7.3 9.8 8.4 7.0 7.1 4.4 11.8 3.4 10.2 4.7 7.8 14.0 3.4 12.4 7.4 6.5 11.2 4.7 12.4 11.1 6.0 9.8 20.6 45.8 54.5 2.1 12.0 5.1 6.7 11.4 14.0 2.0 44.9 11.6 51.5 2.1 31.7 65.3 0.0 52.5 89.5 32.8 52.4 12.7 14.9 31.4 0.0 18.4 28.8 18.9 5.4 19.8 35.5 25.3 104.6 33.4 10.0 53.3 52.6 16.6 33.2 6.5 19.4 37.0 15.8 60.0 69.1 80.0 34.8 32.9 71.1 TNK2 "ACK, ACK1, p21cdc42Hs" ENSG00000061938 "Tyrosine kinase non receptor 2" Q07912 3 195863364-195911945 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 47.1;Horizontal cells: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041954 Approved Approved Cytosol NA NA Cytosol "HPA041954: AB_10794164" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-3)" "prognostic unfavorable (8.96e-4)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (8.89e-3)" "unprognostic (1.13e-1)" "unprognostic (8.92e-3)" "unprognostic (4.49e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (6.82e-2)" "unprognostic (9.76e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.00e-4)" 9.2 7.6 36.3 16.2 27.6 38.9 8.5 20.7 43.7 6.0 6.3 17.6 3.8 6.6 8.0 6.6 13.0 10.7 6.5 10.6 28.4 21.8 4.1 7.2 9.3 18.1 21.6 31.8 8.6 7.8 5.1 19.3 8.4 20.0 10.8 3.9 5.3 16.8 8.2 30.5 37.1 6.9 7.6 10.3 17.0 12.1 7.7 21.8 3.4 4.6 9.8 12.8 7.7 12.3 6.1 3.1 6.3 3.2 0.9 1.9 1.2 31.9 3.1 5.2 5.5 7.2 4.6 31.1 6.2 5.9 3.7 3.4 4.9 24.7 9.3 21.6 8.4 6.3 11.4 4.5 7.6 1.1 21.9 5.7 8.4 10.4 3.5 3.2 4.3 4.2 3.4 12.2 5.1 6.1 10.6 4.7 3.5 3.4 12.9 3.4 23.5 1.8 15.7 4.9 8.5 11.5 5.4 6.2 9.4 3.3 15.5 6.3 6.4 4.0 16.2 7.9 5.2 26.5 5.4 7.6 8.6 5.0 4.4 17.1 28.2 3.0 5.8 7.7 14.0 6.3 2.0 2.4 0.9 1.9 3.2 1.1 2.7 1.8 1.0 1.1 6.1 1.4 1.3 6.3 0.9 2.8 3.1 0.2 1.2 36.3 27.6 20.7 33.3 28.4 21.8 21.6 31.8 20.0 21.8 6.0 4.8 11.8 6.8 6.2 26.5 12.8 5.1 5.3 11.4 0.0 47.1 10.6 1.7 3.5 0.8 7.5 6.9 0.0 4.5 2.6 5.3 7.2 1.1 13.5 7.2 93.8 5.8 9.8 20.5 0.8 6.1 11.4 5.0 9.0 1.4 6.6 19.1 3.5 6.0 1.4 20.9 0.0 5.5 3.9 10.0 9.3 3.5 8.9 3.3 16.3 TNNI3 "CMD2A, CMH7, TNNC1" ENSG00000129991 "Troponin I3, cardiac type" P19429 19 55151767-55157773 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 367 "heart muscle: 419.3" "Cell type enriched" "Detected in many" 56 "Cardiomyocytes: 9185.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 7.1;HMC-1: 11.9;K-562: 21.6;OE19: 30.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB009349, HPA046428" Enhanced Approved Vesicles,Cytosol NA NA 1700000 Cytosol Vesicles "CAB009349: AB_793465, HPA046428: AB_2679661" "unprognostic (2.12e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.37e-3)" "unprognostic (2.13e-1)" "unprognostic (9.62e-3)" "unprognostic (9.40e-2)" "unprognostic (3.34e-2)" "unprognostic (2.17e-3)" "unprognostic (4.02e-3)" "unprognostic (8.89e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (9.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 1.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 419.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.7 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.9 3.7 0.0 0.6 0.5 0.7 0.1 0.0 0.0 7.1 1.7 0.0 1.0 0.3 0.0 11.9 0.0 0.3 0.0 0.1 0.0 0.0 0.4 21.6 0.4 0.0 0.3 0.1 0.0 0.4 30.9 0.2 0.9 0.2 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.6 5.4 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 6.2 0.0 9185.5 10.2 6.7 2.3 5.2 0.0 0.9 0.0 0.6 46.9 0.1 0.0 0.0 0.2 0.4 3.1 0.0 0.0 0.0 1.9 1.6 1.7 0.0 0.0 164.8 0.3 0.2 1.7 0.0 0.2 1.8 1.1 0.0 1.8 0.0 0.2 0.0 0.0 4.2 10.3 2.5 2.1 0.0 0.4 0.0 TNNT1 "ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS" ENSG00000105048 "Troponin T1, slow skeletal type" P13805 19 55132794-55149354 "Disease related genes, Predicted intracellular proteins" "Muscle protein" "Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 1047.7" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 54.4;Cardiomyocytes: 49.6;Spermatogonia: 26.7;Suprabasal keratinocytes: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "eosinophil: 53.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 53.3" "Cell line enhanced" "Detected in many" "HMC-1: 121.8;RH-30: 91.7" "Region enriched" "Detected in many" 5 "thalamus: 136.6" "Low region specificity" "Detected in some" "CAB015168, HPA058448" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "CAB015168: AB_2206426, HPA058448: AB_2683720" "unprognostic (1.88e-1)" "unprognostic (7.23e-2)" "prognostic unfavorable (4.66e-4)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.47e-3)" "unprognostic (3.92e-3)" "unprognostic (1.35e-3)" "unprognostic (1.03e-3)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.23e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.91e-2)" "unprognostic (4.01e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-2)" 3.2 0.0 1.6 0.0 1.0 0.1 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.1 0.0 24.4 22.3 0.4 0.1 6.1 0.9 0.4 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 7.2 0.0 0.0 11.5 0.0 1047.7 1.8 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 9.2 124.4 17.8 0.3 0.1 0.1 9.9 53.3 11.6 0.1 0.1 2.6 24.8 14.6 0.1 3.2 0.0 0.2 4.8 1.1 4.3 1.6 4.8 5.3 16.6 0.3 9.7 0.4 13.0 12.7 3.4 10.8 1.3 1.6 27.6 4.7 1.5 0.9 0.5 0.3 121.8 5.4 17.6 0.5 18.7 18.5 0.0 5.0 23.6 23.1 1.5 23.7 0.4 0.0 3.1 6.3 29.0 15.9 91.7 2.9 3.8 0.8 0.9 7.2 1.5 0.2 8.0 1.3 15.1 14.5 0.5 24.1 35.9 0.9 1.8 0.1 0.9 1.2 25.4 3.7 7.3 0.5 11.6 53.3 0.0 5.9 0.1 0.0 0.1 0.0 9.9 0.1 0.1 0.1 0.5 0.1 2.6 0.2 0.0 2.6 1.6 1.0 0.1 1.0 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 1.5 49.6 0.0 6.7 0.0 0.0 0.0 1.3 0.0 1.8 1.3 0.0 0.0 0.0 0.0 14.0 8.0 0.0 0.0 0.0 13.2 0.0 2.4 1.8 12.0 6.0 0.3 4.2 3.3 0.0 0.2 0.8 0.4 0.0 0.0 0.0 0.6 0.0 0.9 2.8 26.7 26.6 3.0 0.0 0.3 0.1 TNPO1 "IPO2, KPNB2, MIP, MIP1, TRN" ENSG00000083312 "Transportin 1" Q92973 5 72816312-72916733 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016325 Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA 47000 Nucleoplasm "Cytosol, Cytoplasmic bodies" "CAB016325: AB_675691" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-3)" "unprognostic (1.43e-1)" "unprognostic (3.15e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (6.55e-5)" "unprognostic (8.93e-3)" "unprognostic (9.03e-2)" "unprognostic (3.40e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "unprognostic (1.27e-2)" "unprognostic (2.49e-2)" 23.9 29.3 20.1 26.2 24.5 20.7 52.3 18.5 21.9 18.5 21.6 15.7 32.3 16.4 25.4 25.4 26.5 17.9 22.8 21.9 22.5 16.5 26.2 20.8 24.2 22.4 22.9 16.4 22.5 28.9 54.1 36.5 34.9 27.0 21.2 24.4 19.4 26.1 35.3 38.0 15.9 19.9 32.0 31.2 21.7 25.3 30.9 20.8 25.2 32.6 18.0 23.6 27.5 30.8 11.1 10.7 8.9 13.3 14.1 18.3 10.6 21.8 28.8 42.0 25.1 31.3 38.9 24.8 25.9 35.4 25.9 26.6 24.5 18.8 25.6 17.8 40.7 30.9 16.0 28.6 23.1 37.4 14.8 15.8 15.8 38.3 12.4 21.2 17.4 11.6 28.1 16.7 34.6 49.2 18.7 62.7 10.8 23.5 13.7 73.4 10.4 15.8 6.6 22.6 8.1 22.1 19.2 37.8 16.0 15.9 29.3 21.8 22.5 41.7 13.4 30.6 24.1 16.5 14.3 59.4 22.0 25.8 33.1 29.0 12.6 19.5 34.2 17.4 17.8 40.2 7.3 8.3 6.9 13.4 11.5 18.3 11.1 12.2 10.0 10.7 11.0 13.4 13.4 8.9 14.1 13.3 5.0 8.1 10.6 20.1 24.5 18.5 21.9 22.5 16.5 22.9 16.4 27.0 20.8 11.9 20.6 52.7 32.3 52.5 99.6 47.6 35.7 16.0 21.6 26.2 92.3 65.2 14.9 34.0 73.5 57.3 27.7 23.3 35.6 40.7 52.1 43.3 20.9 35.0 37.7 84.2 51.1 55.3 37.6 46.9 43.1 33.6 23.6 44.1 45.5 134.9 48.6 21.0 56.6 30.6 174.6 25.8 39.2 47.7 78.6 46.5 109.8 24.9 30.8 51.9 TNRC18 "CAGL79, KIAA1856, TNRC18A" ENSG00000182095 "Trinucleotide repeat containing 18" O15417 7 5306790-5425414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020730, HPA024251" Uncertain Supported "Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" Cytosol "HPA020730: AB_2670506, HPA024251: AB_2671498" "unprognostic (1.66e-1)" "unprognostic (3.17e-3)" "unprognostic (2.67e-3)" "unprognostic (4.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (2.11e-2)" "unprognostic (6.08e-2)" "unprognostic (1.36e-1)" "unprognostic (9.29e-3)" "unprognostic (2.14e-1)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (4.34e-2)" 17.9 11.8 18.1 17.9 17.2 29.4 20.6 35.1 23.6 35.0 29.9 16.7 17.9 16.4 36.0 19.5 19.6 27.5 29.2 13.6 14.2 9.6 15.6 11.8 19.2 12.9 15.5 16.7 30.3 18.4 36.9 14.7 19.7 13.2 25.4 15.1 25.2 17.0 24.4 13.6 18.9 16.9 40.1 12.6 15.3 21.4 14.0 16.6 7.2 20.6 12.8 9.4 27.0 21.4 2.0 4.3 17.6 3.2 2.6 1.5 0.1 21.7 19.4 16.2 13.6 13.7 16.3 41.9 15.5 14.6 8.6 9.2 8.0 19.2 14.9 15.3 22.7 19.2 24.4 9.3 18.5 7.3 6.5 5.9 9.4 16.6 12.9 11.9 31.0 34.9 16.4 21.9 17.1 19.9 12.5 9.6 13.5 13.4 8.4 10.9 36.1 7.3 38.0 1.4 14.3 14.9 8.1 8.0 11.0 7.0 27.8 7.1 16.9 12.0 31.9 11.5 7.6 33.3 32.2 24.0 24.9 35.1 14.8 11.1 12.1 12.5 14.1 14.0 22.1 29.0 9.4 3.2 2.7 1.4 1.2 1.0 1.6 1.0 0.8 1.1 2.0 0.7 1.5 17.6 2.6 1.5 4.3 1.4 0.1 18.1 17.2 35.1 23.6 14.2 9.6 15.5 16.7 13.2 16.6 8.9 31.9 1.4 3.1 8.2 56.8 6.2 15.3 6.7 11.4 14.0 2.0 12.8 1.7 4.5 12.0 10.7 16.9 0.0 5.5 3.6 11.3 4.6 13.9 22.9 9.5 47.7 30.1 29.4 40.0 12.0 17.0 11.9 5.0 3.6 27.0 23.8 8.0 5.8 18.7 4.2 3.7 19.4 11.9 0.5 2.0 7.8 8.4 6.4 21.8 2.6 TOB2 "APRO5, bK223H9, TOB4, TOBL, TROB2" ENSG00000183864 "Transducer of ERBB2, 2" Q14106 22 41433492-41447023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016603, HPA054112" Approved Approved Cytosol NA NA Cytosol "HPA016603: AB_2669400, HPA054112: AB_2682385" "unprognostic (1.21e-3)" "unprognostic (3.10e-2)" "unprognostic (3.41e-1)" "prognostic favorable (3.08e-5)" "unprognostic (3.89e-2)" "unprognostic (1.38e-1)" "unprognostic (1.36e-1)" "unprognostic (5.36e-2)" "unprognostic (4.94e-2)" "unprognostic (5.74e-2)" "unprognostic (3.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.18e-6)" "unprognostic (1.50e-2)" "unprognostic (7.14e-2)" "unprognostic (1.85e-1)" "unprognostic (7.13e-2)" 27.3 20.7 25.4 12.5 27.6 5.4 14.1 53.5 22.0 18.0 16.1 23.2 12.2 14.0 14.5 9.8 17.1 25.2 24.4 16.4 25.5 9.9 16.0 13.4 13.5 10.6 35.8 13.6 21.8 18.1 26.2 13.2 13.8 23.1 17.6 10.1 17.6 9.6 15.1 47.3 13.9 16.1 13.3 18.3 12.2 17.7 9.1 36.5 13.6 23.2 17.0 12.1 12.8 21.1 13.4 10.3 4.9 10.0 4.6 9.9 5.7 16.9 7.8 13.7 9.3 32.3 22.7 13.4 11.3 17.5 14.4 12.8 10.2 8.1 10.4 11.5 16.3 5.6 14.9 12.7 6.3 13.2 10.7 16.4 5.7 10.9 15.4 22.2 15.3 7.7 20.8 10.9 17.2 7.5 14.6 14.4 3.6 8.6 11.7 11.7 18.9 6.3 8.9 11.7 22.4 8.5 13.9 9.2 8.9 10.2 11.9 6.4 4.2 28.5 15.4 20.7 8.9 8.5 7.7 17.9 14.3 13.4 11.1 10.5 11.2 4.8 5.7 8.7 6.6 9.4 4.2 6.9 4.8 9.9 10.0 9.2 13.4 8.2 8.1 6.5 10.3 4.3 6.1 4.9 4.6 9.3 10.3 6.9 5.7 25.4 27.6 53.5 22.0 25.5 9.9 35.8 13.6 23.1 36.5 44.7 45.7 18.2 58.0 112.6 49.6 49.5 50.9 56.2 36.4 45.4 60.9 28.9 19.9 26.5 38.6 35.9 84.5 0.0 16.8 27.5 49.4 69.7 32.4 25.5 17.2 23.8 52.1 48.5 21.1 45.5 61.9 25.5 50.6 35.1 55.4 65.6 27.4 54.1 77.1 26.1 95.8 51.8 63.1 24.2 25.7 119.6 53.0 27.3 50.5 89.9 TOLLIP IL-1RAcPIP ENSG00000078902 "Toll interacting protein" Q9H0E2 11 1274371-1309654 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 368.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038621, HPA038622" Enhanced Approved "Plasma membrane,Cytosol" NA NA 34000 "Plasma membrane, Cytosol" "HPA038621: AB_10673177, HPA038622: AB_10675946" "unprognostic (8.39e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (8.89e-2)" "unprognostic (2.51e-1)" "unprognostic (8.53e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.11e-16)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-2)" 15.3 16.7 31.2 8.8 32.5 9.0 11.9 28.3 63.0 10.7 12.7 12.9 8.6 18.6 8.3 10.3 29.4 10.7 13.7 15.8 28.0 20.3 20.9 37.1 12.3 9.6 18.1 32.1 12.8 41.8 13.7 18.7 9.9 17.4 15.6 6.6 12.9 15.9 16.8 23.4 24.0 15.7 9.0 13.5 13.2 15.1 24.5 11.8 5.9 12.6 11.8 10.9 14.6 14.8 13.9 26.9 49.0 34.8 11.1 12.6 18.3 15.5 16.5 8.4 9.5 18.0 11.3 7.3 13.8 12.6 16.3 14.5 17.8 9.9 7.3 13.4 12.7 24.9 14.1 7.5 16.9 4.4 14.9 15.3 5.9 3.5 26.7 25.7 11.2 15.1 17.0 19.9 9.6 9.3 8.9 10.1 11.1 9.7 19.8 13.3 13.0 14.2 13.8 10.2 16.9 21.9 10.8 8.6 7.2 10.7 20.8 22.6 13.3 12.4 15.1 15.2 4.5 11.9 12.8 18.4 17.7 7.6 7.4 7.9 20.2 17.9 8.9 27.8 7.4 13.8 9.5 34.8 35.9 9.6 30.0 8.0 10.9 10.3 8.9 26.9 13.9 8.1 7.6 49.0 11.1 27.5 14.1 12.6 18.3 31.2 32.5 28.3 63.0 28.0 20.3 18.1 32.1 17.4 11.8 8.9 20.0 26.9 36.3 59.4 38.5 20.3 48.4 8.1 11.4 22.7 7.9 44.1 59.7 60.5 147.2 26.6 50.7 0.0 59.7 34.1 29.7 40.2 38.0 95.4 77.7 69.9 49.7 36.8 41.9 368.3 20.1 32.1 67.4 51.3 30.4 38.6 64.1 38.6 29.0 95.9 16.9 6.5 26.9 57.0 27.2 86.4 87.3 22.3 24.9 55.4 TOM1 ENSG00000100284 "Target of myb1 membrane trafficking protein" O60784 22 35299275-35347994 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.8" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000818, HPA001749" Approved Approved "Plasma membrane,Centriolar satellite,Cytosol" NA NA 14000 Cytosol "Plasma membrane, Centriolar satellite" "HPA000818: AB_2666101, HPA001749: AB_1080323" "unprognostic (3.75e-1)" "unprognostic (8.07e-2)" "unprognostic (5.18e-2)" "prognostic favorable (2.20e-5)" "unprognostic (1.11e-2)" "unprognostic (7.55e-2)" "unprognostic (4.07e-3)" "unprognostic (2.24e-1)" "unprognostic (9.92e-2)" "unprognostic (2.32e-1)" "unprognostic (3.71e-1)" "unprognostic (8.16e-2)" "prognostic favorable (3.72e-5)" "unprognostic (1.22e-1)" "unprognostic (1.30e-1)" "unprognostic (7.54e-3)" "unprognostic (3.31e-2)" 17.0 21.2 9.5 10.2 13.8 31.1 13.7 10.2 24.6 16.0 14.6 12.0 7.5 17.4 14.1 15.5 31.6 11.7 15.4 19.1 8.8 15.2 16.1 27.4 17.5 8.2 11.6 11.3 12.1 11.8 21.8 16.8 39.0 23.2 10.2 6.4 17.5 37.0 10.1 83.8 29.1 18.6 7.1 8.4 10.6 8.4 13.6 8.7 10.0 14.8 25.9 19.9 12.1 17.6 4.6 15.2 40.9 31.2 4.6 14.7 17.0 6.7 6.8 3.9 6.4 28.4 16.9 18.8 6.7 20.1 12.9 14.5 9.4 6.3 2.7 12.4 20.7 8.4 3.1 4.1 7.0 4.6 7.6 9.3 2.2 7.7 19.7 26.8 4.3 10.2 22.8 8.7 18.2 6.3 8.8 9.0 5.1 4.4 6.7 6.3 6.5 3.4 10.1 3.0 8.4 4.0 6.3 5.7 5.7 5.1 5.1 6.8 5.2 15.1 15.6 14.8 3.5 8.0 7.1 9.3 15.4 13.3 11.7 3.2 7.8 4.9 7.0 20.6 4.5 5.0 5.9 31.2 13.1 6.4 18.9 5.3 4.6 9.8 6.1 15.2 4.0 7.9 5.3 40.9 4.6 19.4 8.1 14.7 17.0 9.5 13.8 10.2 24.6 8.8 15.2 11.6 11.3 23.2 8.7 20.8 37.5 13.7 9.2 11.3 9.7 19.8 10.2 14.7 20.5 12.2 11.8 57.0 23.2 33.4 21.6 14.1 43.9 0.0 34.2 48.4 23.6 12.1 22.0 27.7 54.8 11.1 15.5 14.7 31.9 17.5 10.6 37.8 18.6 22.6 16.2 19.9 27.7 15.3 12.0 28.5 8.1 6.5 16.7 9.9 5.3 19.2 142.3 10.9 12.7 9.1 TOMM34 "HTOM34P, TOM34" ENSG00000025772 "Translocase of outer mitochondrial membrane 34" Q15785 20 44942130-44960486 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.2;testis: 53.2" "Cell type enhanced" "Detected in many" 12 "monocytes: 303.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018845, HPA056875" Enhanced Supported Vesicles,Mitochondria,Cytosol NA NA Cytosol "Vesicles, Mitochondria" "HPA018845: AB_1858184, HPA056875: AB_2683264" "unprognostic (4.96e-2)" "unprognostic (6.88e-2)" "unprognostic (5.05e-2)" "unprognostic (1.36e-3)" "unprognostic (4.91e-2)" "prognostic unfavorable (4.47e-5)" "prognostic unfavorable (8.71e-6)" "unprognostic (2.55e-1)" "unprognostic (5.04e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.11e-2)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (1.02e-1)" "prognostic favorable (5.45e-4)" "unprognostic (5.79e-3)" 4.4 17.9 14.9 6.4 56.2 8.7 7.3 4.2 18.1 7.2 7.1 5.3 5.6 5.8 7.1 25.6 7.2 24.9 6.8 6.3 35.3 11.0 11.9 7.9 5.9 8.8 8.6 14.4 13.9 8.2 11.2 10.5 15.1 13.9 7.6 9.3 8.0 6.3 9.0 6.3 5.5 5.6 7.7 5.7 5.8 7.0 53.2 5.6 7.0 8.3 7.2 10.4 8.8 6.3 18.8 26.1 9.5 11.5 8.7 12.3 10.7 33.1 11.7 10.4 22.1 9.6 9.5 23.5 19.3 28.2 24.2 17.7 47.2 12.5 22.8 16.7 15.1 24.7 21.0 25.4 41.8 28.3 4.0 11.8 17.9 15.5 33.2 12.3 11.7 11.1 10.3 11.7 33.8 60.8 21.3 24.6 9.4 20.3 9.4 22.9 21.9 12.3 16.2 12.2 17.7 44.5 10.7 11.0 24.6 19.7 18.7 17.9 10.6 26.4 18.4 22.8 8.4 13.8 10.2 14.5 32.0 21.1 15.3 28.8 8.2 9.6 18.9 29.2 14.0 12.4 8.3 11.1 9.5 10.4 11.5 11.0 17.3 10.9 11.0 26.1 18.8 12.3 9.7 3.1 8.7 11.2 13.7 12.3 10.7 14.9 56.2 4.2 18.1 35.3 11.0 8.6 14.4 13.9 5.6 6.0 8.6 13.0 69.8 12.2 3.6 9.0 7.6 64.3 18.2 12.2 3.9 98.4 26.6 29.7 14.0 10.8 6.7 0.0 26.6 29.1 11.6 59.4 9.2 9.6 19.7 3.2 11.5 5.5 3.9 24.2 6.4 10.5 6.8 303.0 8.2 13.2 32.2 9.3 6.0 16.5 4.1 0.0 12.2 45.4 36.6 9.7 47.3 6.9 12.8 47.8 TOMM40 "C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40" ENSG00000130204 "Translocase of outer mitochondrial membrane 40" O96008 19 44890569-44903689 "Predicted intracellular proteins, Transporters" "Ion transport, Protein transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036231, HPA036232" Supported Enhanced Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA036231: AB_2675010, HPA036232: AB_2675011" "unprognostic (2.14e-1)" "unprognostic (9.58e-3)" "unprognostic (1.66e-1)" "unprognostic (6.75e-3)" "unprognostic (2.37e-1)" "unprognostic (2.17e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-2)" "unprognostic (7.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (5.86e-3)" "unprognostic (5.30e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-1)" 16.0 25.3 13.6 16.9 15.6 19.7 20.6 17.7 27.0 10.2 20.5 10.9 10.1 20.0 11.8 10.5 22.9 13.5 11.4 21.5 15.3 14.9 16.5 36.9 15.1 22.3 15.6 13.3 18.2 19.2 16.2 11.9 15.3 20.2 11.2 16.7 11.5 11.5 13.5 32.3 14.7 15.1 11.6 11.9 12.7 12.6 12.3 8.8 14.2 11.6 18.6 15.6 10.9 12.5 7.3 7.0 5.1 6.8 4.7 8.7 2.0 30.8 52.3 19.1 26.3 7.1 6.4 24.3 22.2 12.3 42.1 30.2 56.8 21.4 45.6 23.9 14.6 23.9 33.4 49.5 31.9 19.2 17.6 44.9 30.6 20.5 44.7 15.2 39.0 27.5 10.1 18.1 32.6 20.7 7.9 14.5 22.0 48.2 15.9 16.4 38.5 42.3 28.7 33.4 44.1 32.6 43.3 21.7 26.5 19.3 42.9 29.8 19.1 23.6 49.8 15.8 11.1 16.7 39.6 11.9 29.2 29.6 20.3 57.8 17.2 35.6 44.7 21.6 41.5 30.7 0.7 5.5 5.1 4.7 6.8 5.2 7.3 4.5 6.5 7.0 4.2 7.9 8.7 1.1 4.7 5.9 6.9 4.8 2.0 13.6 15.6 17.7 27.0 15.3 14.9 15.6 13.3 20.2 8.8 14.9 5.3 28.9 52.0 77.6 63.2 14.2 30.6 0.0 10.3 29.6 27.5 84.7 33.2 54.9 9.5 29.3 31.6 23.3 33.2 145.9 33.4 37.4 19.5 20.8 91.8 66.7 28.2 11.1 20.4 5.6 24.7 36.1 37.1 39.7 43.5 43.9 41.3 28.8 23.0 28.3 55.9 19.4 40.6 53.5 60.1 78.2 61.0 26.6 93.2 64.9 TOR1B "DQ1, MGC4386" ENSG00000136816 "Torsin family 1 member B" O14657 9 129803153-129811281 "Predicted intracellular proteins" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013403, HPA013697, CAB022709" Approved Uncertain "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA "Nuclear speckles" Cytosol "CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196" "unprognostic (2.91e-3)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-2)" "unprognostic (1.75e-1)" "unprognostic (5.73e-3)" "unprognostic (1.95e-1)" "unprognostic (7.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.13e-2)" "unprognostic (2.07e-3)" "unprognostic (4.09e-2)" "unprognostic (1.23e-1)" "unprognostic (5.40e-3)" "unprognostic (1.69e-3)" 14.2 14.4 9.7 13.8 12.2 14.0 18.4 23.6 11.9 11.3 22.5 10.5 11.6 12.3 14.0 8.2 13.5 10.5 15.0 13.3 11.7 11.5 11.8 35.3 13.0 10.8 9.4 9.0 10.8 21.1 13.3 13.6 20.0 10.6 12.9 25.8 10.8 12.8 13.7 13.5 13.0 18.1 14.2 8.9 12.4 14.9 19.5 8.3 16.8 16.4 10.0 11.9 14.9 18.0 4.6 6.2 17.2 14.6 7.3 12.3 8.4 5.3 12.3 5.1 13.7 25.9 19.4 12.0 19.2 12.5 13.2 13.1 10.1 12.2 3.8 12.2 18.8 20.6 21.8 5.6 7.9 13.6 13.9 5.9 3.3 10.4 7.1 11.1 6.3 14.9 11.0 13.9 18.8 9.3 9.8 11.7 10.1 11.5 8.9 12.3 14.9 8.6 9.9 10.8 25.1 9.7 3.5 9.0 11.5 10.1 5.6 7.1 8.3 12.4 14.3 7.6 9.7 20.6 6.2 10.7 25.0 11.9 29.7 16.4 6.5 24.2 3.2 13.7 8.2 16.9 6.3 11.5 17.2 12.2 14.6 12.3 3.9 9.5 10.5 6.2 4.6 7.1 7.1 14.2 7.3 8.5 3.8 9.1 8.4 9.7 12.2 23.6 11.9 11.7 11.5 9.4 9.0 10.6 8.3 8.9 3.7 4.5 5.2 5.8 2.5 5.1 5.1 5.3 1.2 5.2 3.9 9.7 0.0 8.8 9.2 6.7 8.0 0.0 12.2 15.2 8.5 9.2 4.6 13.5 10.8 6.4 18.4 11.6 4.3 10.9 4.0 7.6 3.3 12.6 15.5 4.8 10.0 3.5 5.3 3.0 2.5 19.4 9.5 10.3 7.0 4.6 12.7 10.0 10.7 10.1 TOX3 "CAGF9, TNRC9" ENSG00000103460 "TOX high mobility group box family member 3" O15405 16 52438005-52547802 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 18.7" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 40.8;Intestinal endocrine cells: 59.2;Muller glia cells: 158.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 20.0;HAP1: 9.8;Hep G2: 8.7;OE19: 10.4;RT4: 38.0;SCLC-21H: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040240, HPA040376" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040240: , HPA040376: AB_10795522" "unprognostic (1.14e-2)" "unprognostic (9.75e-3)" "unprognostic (9.08e-3)" "unprognostic (3.32e-2)" "unprognostic (3.50e-1)" "unprognostic (2.31e-1)" "unprognostic (4.74e-3)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.94e-2)" "unprognostic (2.59e-1)" "unprognostic (4.60e-3)" "prognostic favorable (3.08e-12)" "unprognostic (1.19e-1)" "unprognostic (1.31e-1)" "prognostic favorable (3.95e-4)" 0.7 3.1 7.1 5.0 4.7 0.0 3.9 0.6 6.0 7.0 13.5 6.0 0.2 9.4 1.3 9.2 0.9 3.0 14.8 0.2 3.2 5.3 9.5 5.8 2.7 0.1 5.4 3.6 1.0 7.8 0.0 5.8 0.3 5.1 1.8 15.1 2.7 11.0 0.7 0.3 1.1 13.5 0.9 7.0 0.2 18.7 0.7 4.7 0.0 0.2 0.3 2.1 7.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 1.7 0.0 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 10.4 0.0 0.0 3.4 0.1 4.7 38.0 13.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 4.7 0.6 4.3 3.2 5.3 5.4 3.6 5.1 4.7 6.0 5.1 0.0 0.2 0.9 2.6 0.6 40.8 17.4 6.8 33.2 0.0 0.0 3.3 1.4 2.5 0.0 22.3 0.0 4.4 0.0 0.3 13.0 0.0 4.9 0.1 38.1 59.2 1.3 0.0 0.8 0.6 0.1 0.0 0.0 31.7 158.0 9.8 8.6 0.0 8.6 1.5 0.0 0.3 0.0 0.7 0.3 0.0 0.0 28.7 1.1 TP53BP2 "53BP2, ASPP2, PPP1R13A" ENSG00000143514 "Tumor protein p53 binding protein 2" Q13625 1 223779899-223845972 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021603, HPA050429" Supported Enhanced "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA021603: AB_1844384, HPA050429: AB_2681124" "unprognostic (1.29e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-1)" "unprognostic (1.38e-3)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (7.37e-2)" "unprognostic (2.67e-1)" "unprognostic (7.99e-2)" "unprognostic (5.08e-2)" "unprognostic (1.24e-1)" "unprognostic (2.81e-2)" "unprognostic (1.83e-1)" 10.0 8.3 26.5 17.2 28.7 38.8 20.8 9.3 17.9 10.9 12.0 12.6 8.1 7.9 11.9 9.8 15.9 9.4 17.4 10.9 17.3 14.7 10.1 13.9 21.4 18.6 18.7 8.6 15.5 13.0 16.4 8.3 8.2 12.9 9.6 9.5 17.7 10.2 8.1 12.0 9.9 9.5 12.2 13.0 10.6 9.7 10.2 14.9 17.3 22.1 7.4 11.7 11.8 14.8 2.2 2.9 6.7 2.7 7.2 4.0 2.0 15.6 7.9 21.4 13.5 7.6 7.5 13.7 10.1 14.4 14.8 12.7 16.3 9.5 0.0 8.9 8.4 10.7 10.7 16.7 6.0 19.9 30.2 16.4 20.8 7.6 5.5 15.5 17.1 14.6 8.9 6.7 13.6 14.0 11.1 8.7 11.6 26.3 15.8 12.2 4.5 12.9 10.6 18.5 9.5 7.7 17.2 22.3 1.7 13.3 9.9 18.6 24.0 11.1 13.9 14.6 14.7 7.8 23.5 10.1 15.2 10.8 16.3 18.9 7.8 8.1 13.0 9.2 11.5 17.3 6.7 2.7 1.6 2.3 2.6 2.8 2.2 2.6 4.0 2.9 1.9 2.7 1.9 3.2 7.2 2.0 1.7 1.6 2.0 26.5 28.7 9.3 17.9 17.3 14.7 18.7 8.6 12.9 14.9 44.7 24.3 6.5 41.6 15.2 4.4 15.4 12.7 17.4 42.1 7.0 49.1 9.1 1.7 18.3 0.9 10.9 9.1 23.3 9.3 5.0 17.9 31.4 47.4 9.7 8.6 0.0 14.3 10.4 14.8 1.4 9.8 15.0 8.5 6.4 7.9 6.9 17.8 5.8 8.1 4.4 45.8 0.0 20.8 11.4 22.2 10.2 4.0 10.9 9.8 38.8 TP53INP1 "DKFZp434M1317, FLJ22139, P53DINP1, SIP, Teap, TP53INP1A, TP53INP1B" ENSG00000164938 "Tumor protein p53 inducible nuclear protein 1" Q96A56 8 94925972-94949411 "Predicted intracellular proteins" "Apoptosis, Autophagy, Transcription, Transcription regulation" "Activator, Antioxidant" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 81.5;Hepatocytes: 143.1;Intestinal endocrine cells: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 25.7" "Group enriched" "Detected in many" 5 "B-cells: 6.8;granulocytes: 25.7" "Cell line enhanced" "Detected in many" "Karpas-707: 32.7;U-266/70: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005856 Uncertain Supported Cytosol NA NA Cytosol "HPA005856: AB_10600832" "unprognostic (1.39e-2)" "unprognostic (4.47e-3)" "unprognostic (7.17e-2)" "unprognostic (2.70e-1)" "unprognostic (5.31e-2)" "prognostic favorable (1.11e-4)" "unprognostic (5.72e-2)" "unprognostic (1.16e-3)" "unprognostic (1.28e-1)" "unprognostic (7.54e-2)" "unprognostic (5.00e-3)" "unprognostic (1.23e-2)" "unprognostic (1.87e-2)" "unprognostic (9.83e-2)" "unprognostic (3.13e-1)" "unprognostic (1.18e-2)" "prognostic favorable (5.45e-5)" 8.2 8.3 5.1 21.0 7.6 17.9 14.3 5.9 5.9 8.3 11.1 7.4 11.5 8.4 10.2 11.6 10.6 8.4 11.2 8.6 5.5 3.1 7.8 50.0 21.0 51.9 6.9 3.5 7.4 42.7 6.7 6.9 12.4 5.7 14.9 10.4 8.4 13.3 15.3 17.9 9.1 24.8 9.9 5.3 28.9 12.3 22.3 7.4 39.8 7.9 4.6 31.4 15.5 6.6 6.8 0.8 25.7 2.1 2.9 3.6 1.3 0.2 1.0 9.9 3.8 12.4 11.7 10.2 2.3 5.5 1.0 2.6 0.8 0.2 2.1 5.1 4.4 0.9 1.7 0.0 3.8 2.4 0.1 1.2 1.3 2.0 5.8 8.3 0.0 6.9 19.1 9.2 2.8 1.1 9.3 16.2 1.0 0.7 32.7 5.0 0.6 1.5 0.6 0.9 0.0 0.2 1.3 0.7 11.3 2.6 10.6 1.4 8.0 1.4 0.8 2.0 16.6 4.8 1.3 11.1 2.0 2.4 0.0 0.3 35.3 7.3 0.9 3.5 0.0 0.0 25.7 2.1 6.1 0.8 2.0 0.8 6.8 2.4 1.6 0.7 5.9 0.5 0.4 9.6 2.9 1.2 0.8 3.6 1.3 5.1 7.6 5.9 5.9 5.5 3.1 6.9 3.5 5.7 7.4 32.8 33.1 25.7 2.9 4.0 4.8 10.5 81.5 42.8 18.2 10.4 25.5 5.4 3.3 8.3 14.0 9.8 16.6 0.0 18.1 1.2 6.6 23.2 4.6 143.1 10.2 1.6 80.3 35.6 43.5 30.1 6.6 7.9 15.1 4.6 15.5 4.8 19.9 24.6 9.6 8.6 21.0 6.5 9.0 23.2 2.5 5.6 4.8 7.9 5.1 4.8 TPD52 "D52, hD52, N8L" ENSG00000076554 "Tumor protein D52" P55327 8 80034745-80231232 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 24.3" "Group enriched" "Detected in many" 6 "B-cells: 24.3;NK-cells: 6.8;T-cells: 11.1" "Cell line enhanced" "Detected in many" "Karpas-707: 47.0;SK-BR-3: 106.8" "HPA028427, HPA062167" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 42000 Cytosol "Golgi apparatus" "HPA028427: AB_10610561, HPA062167: AB_2684704" "prognostic unfavorable (1.11e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-2)" "unprognostic (3.77e-3)" "unprognostic (8.24e-2)" "unprognostic (3.75e-1)" "unprognostic (7.99e-3)" "unprognostic (6.47e-2)" "unprognostic (2.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (4.77e-6)" "unprognostic (2.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (1.70e-2)" 3.2 3.9 33.9 20.2 23.2 3.2 30.9 37.5 43.3 8.3 45.2 19.7 7.3 38.1 4.1 23.2 18.1 6.3 13.2 4.5 35.4 26.9 18.4 15.1 7.8 15.8 27.4 24.0 1.5 26.0 19.1 19.1 13.6 20.3 42.5 51.3 17.4 33.5 8.0 3.1 18.2 40.3 4.4 31.4 9.8 32.7 2.1 19.8 3.5 25.8 7.3 22.2 9.5 10.0 24.3 2.4 2.5 0.0 6.8 11.1 4.1 23.5 6.3 0.3 4.2 0.0 0.0 9.7 1.5 2.3 6.5 3.2 3.2 6.9 34.3 8.5 0.1 4.8 9.7 9.7 6.6 4.6 4.2 8.2 4.8 9.0 5.2 0.0 1.5 0.1 0.0 4.7 0.0 2.3 4.1 0.3 23.7 0.0 47.0 0.0 7.8 7.5 7.0 2.1 26.9 15.9 0.0 0.1 21.7 11.3 5.7 12.2 8.3 7.3 106.8 19.7 10.0 10.4 6.1 0.4 0.0 6.7 0.1 5.5 17.7 15.3 28.1 4.2 0.0 0.4 0.2 0.0 2.5 6.4 0.0 11.1 24.3 6.4 5.5 1.1 22.4 4.2 4.8 0.2 6.8 0.0 2.4 4.1 4.1 33.9 23.2 37.5 43.3 35.4 26.9 27.4 24.0 20.3 19.8 41.7 50.8 108.7 73.1 71.7 178.1 18.6 71.4 9.4 42.1 62.8 111.9 80.5 144.2 102.2 14.7 19.9 163.1 23.3 69.8 107.3 5.1 215.6 1.1 34.2 11.9 30.2 163.1 7.4 9.7 11.2 1.1 9.6 99.5 155.1 243.8 34.7 73.4 282.9 1.4 102.9 204.5 0.0 9.1 1.6 17.7 108.9 193.4 42.4 174.5 107.5 TPD52L1 "D53, hD53" ENSG00000111907 "Tumor protein D52 like 1" Q16890 6 125119049-125264407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 95.2;salivary gland: 104.6" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 118.7;Distal tubular cells: 149.2;Exocrine glandular cells: 97.5;Extravillous trophoblasts: 106.8;Melanocytes: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 52.5;hTCEpi: 46.2;MCF7: 68.6;RPTEC TERT1: 53.2;SK-BR-3: 37.1;T-47d: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027915, HPA027916" Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "HPA027915: AB_10602074, HPA027916: AB_10601860" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (2.76e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (2.87e-2)" "unprognostic (1.38e-2)" "unprognostic (2.14e-1)" "unprognostic (7.85e-2)" "unprognostic (7.80e-2)" "unprognostic (9.42e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.06e-1)" "unprognostic (6.83e-2)" "prognostic favorable (3.97e-4)" "prognostic unfavorable (5.34e-4)" 10.3 95.2 31.5 4.3 47.5 1.0 25.7 2.6 32.9 10.5 8.5 9.2 31.0 4.3 6.2 27.6 43.3 13.9 10.8 26.0 21.4 9.5 11.7 22.0 4.7 2.9 15.4 12.8 9.0 18.0 10.3 8.7 4.0 16.1 16.6 5.8 13.0 104.6 32.7 34.4 11.8 4.6 27.1 5.5 1.4 10.3 2.6 18.2 0.0 23.5 20.1 11.0 18.1 14.6 1.1 0.9 5.9 1.2 5.3 1.7 1.0 7.0 8.0 0.0 52.5 0.4 0.1 12.5 1.2 1.1 0.0 0.1 12.8 9.0 0.0 27.0 5.9 1.7 16.2 1.6 11.2 0.0 0.1 11.2 0.1 11.3 0.1 1.1 0.0 0.0 1.4 46.2 0.0 6.1 16.4 0.0 0.0 5.6 0.1 0.9 68.6 0.0 0.1 0.8 6.9 4.4 0.0 0.0 0.0 53.2 1.8 1.7 0.0 13.5 37.1 0.8 2.0 31.6 0.1 0.0 0.3 1.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 2.7 1.2 0.8 0.8 0.6 0.8 0.8 1.3 0.6 0.5 1.1 1.7 1.2 5.9 5.3 0.3 0.9 0.4 1.0 31.5 47.5 2.6 32.9 21.4 9.5 15.4 12.8 16.1 18.2 0.0 21.2 0.5 40.2 17.4 1.7 40.6 17.8 13.4 13.6 118.7 3.9 27.1 149.2 28.9 5.4 30.1 4.6 0.0 97.5 106.8 3.1 35.2 2.3 56.3 9.5 0.0 15.5 4.3 1.9 3.4 16.1 4.1 124.9 1.0 9.1 3.2 37.3 0.0 34.3 26.2 1.3 0.0 15.6 2.8 5.3 32.5 12.0 2.9 9.7 17.9 TPD52L2 "D54, hD54" ENSG00000101150 "Tumor protein D52 like 2" O43399 20 63865228-63891545 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 153.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047489 Approved Approved Vesicles,Cytosol NA NA 1500000 Vesicles Cytosol "HPA047489: AB_2680067" "unprognostic (1.17e-2)" "unprognostic (2.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (3.63e-3)" "unprognostic (9.95e-2)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (5.69e-2)" "prognostic unfavorable (1.74e-8)" "unprognostic (2.79e-1)" "unprognostic (7.07e-2)" "unprognostic (3.33e-2)" "unprognostic (3.15e-3)" 48.6 40.9 28.1 33.5 33.6 55.4 43.3 33.4 40.2 40.1 35.8 35.0 34.6 25.3 38.4 29.7 52.2 33.9 32.2 45.3 27.6 30.0 31.0 24.7 30.3 38.3 26.6 34.1 33.4 30.1 20.5 30.6 42.9 33.8 33.8 24.2 29.0 27.4 43.7 32.3 33.9 25.0 48.0 27.4 36.5 28.1 35.0 24.7 19.4 40.9 32.8 31.8 40.9 55.6 13.0 17.6 50.5 25.4 16.7 14.4 23.1 33.2 17.3 10.7 13.1 24.9 39.7 16.1 38.5 34.0 68.6 29.2 63.7 38.2 13.5 42.6 38.7 40.9 32.9 21.8 52.3 40.0 7.5 9.2 12.8 22.7 38.4 26.5 16.3 13.3 28.5 59.0 27.5 44.5 24.3 31.4 14.4 26.6 19.9 26.9 18.5 15.6 20.7 15.5 33.0 61.2 21.7 11.9 21.6 27.0 14.9 16.5 18.5 45.4 35.1 31.2 16.7 23.9 33.0 33.1 55.2 15.9 32.0 28.0 12.8 20.1 16.3 51.7 15.2 17.0 18.8 25.4 16.7 11.6 19.9 14.4 13.0 12.7 13.1 17.6 11.9 13.0 11.7 50.5 16.7 16.5 8.8 13.8 23.1 28.1 33.6 33.4 40.2 27.6 30.0 26.6 34.1 33.8 24.7 14.9 22.6 28.2 24.7 39.2 18.0 36.1 12.7 13.4 13.6 21.0 5.9 67.3 33.2 47.5 6.1 36.0 31.5 0.0 28.0 87.4 44.4 36.3 38.1 12.1 153.9 7.9 17.9 20.3 47.0 9.5 38.9 46.7 27.0 53.3 22.5 31.7 55.9 19.8 61.2 27.2 17.3 45.3 60.4 11.6 22.0 36.9 91.0 26.1 25.2 37.4 TPH1 "TPH, TPRH" ENSG00000129167 "Tryptophan hydroxylase 1" P17752 11 18017564-18042426 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3" "Cell type enriched" "Detected in many" 164 "Intestinal endocrine cells: 1412.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "cerebral cortex: 4.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 4.5" "Low region specificity" "Detected in some" "CAB010767, HPA022483" Approved Uncertain Cytosol NA NA Cytosol "CAB010767: AB_261587, HPA022483: AB_1858378" "unprognostic (2.14e-4)" "unprognostic (9.97e-2)" "unprognostic (6.92e-2)" "unprognostic (6.78e-2)" "unprognostic (1.55e-1)" "unprognostic (6.26e-5)" "unprognostic (1.73e-1)" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-2)" "unprognostic (1.19e-4)" "unprognostic (6.72e-2)" "unprognostic (5.40e-8)" "unprognostic (3.76e-2)" "unprognostic (7.42e-2)" "unprognostic (3.10e-1)" "unprognostic (2.46e-5)" 0.7 0.0 0.7 0.7 0.7 0.6 0.9 0.7 4.2 0.7 7.1 0.7 0.7 8.2 0.7 0.7 0.7 1.5 0.7 0.7 0.7 0.3 0.7 0.7 0.7 0.7 0.7 0.7 1.0 0.7 0.0 5.4 0.7 0.7 1.3 16.2 0.7 0.7 0.7 0.7 1.0 9.1 0.7 0.7 1.0 13.3 0.9 0.7 0.7 0.7 0.7 0.7 0.7 0.7 1.4 0.8 1.5 0.5 0.9 1.6 0.2 0.4 0.1 1.7 1.5 0.1 0.0 0.6 0.6 0.5 0.2 1.1 1.8 0.3 1.4 0.3 0.0 0.1 0.6 0.4 1.5 0.7 1.3 3.1 2.2 0.8 3.5 0.0 4.5 1.2 0.0 1.8 0.2 0.6 0.3 0.7 2.7 0.9 0.8 0.1 0.5 1.0 0.7 0.5 0.1 0.3 1.7 0.3 0.0 0.0 1.0 1.3 0.9 0.2 0.4 0.9 0.2 0.3 2.9 0.2 0.4 1.3 0.5 1.7 0.2 0.3 1.1 0.2 1.0 1.4 1.5 0.4 0.4 1.6 0.2 0.8 0.5 0.5 0.4 0.1 1.4 0.6 0.6 1.5 0.9 0.5 0.8 0.6 0.2 0.7 0.7 0.7 4.2 0.7 0.3 0.7 0.7 0.7 0.7 0.0 0.0 0.0 0.4 0.3 4.7 0.4 0.0 1.4 0.0 5.2 2.0 0.2 0.0 0.2 0.7 0.3 1.0 0.0 0.5 0.0 0.7 2.0 0.0 0.0 0.2 1.6 1412.4 0.0 0.0 0.4 0.9 0.9 0.0 0.0 2.8 1.5 0.4 8.6 1.1 0.2 6.0 6.5 1.0 2.7 3.4 1.3 0.0 0.5 1.7 0.0 TPM1 "C15orf13, CMH3" ENSG00000140416 "Tropomyosin 1" P09493 15 63042632-63071915 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 544.2;skeletal muscle: 589.5" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 12627.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 23.8" "Group enriched" "Detected in all" 4 "dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 206.7;SuSa: 259.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, CAB017698, HPA047089, HPA053624" Supported Approved "Actin filaments,Cytosol" NA NA 280000000 "Actin filaments" Cytosol "CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.00e-2)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.20e-1)" "unprognostic (1.66e-3)" "unprognostic (3.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.53e-2)" "prognostic unfavorable (7.30e-4)" 17.9 5.7 5.5 32.4 5.2 1.2 15.2 5.6 5.1 48.1 119.7 2.4 84.2 14.6 72.4 38.3 121.6 36.2 75.3 544.2 4.1 2.6 14.5 4.4 10.5 3.3 3.3 7.0 27.0 29.3 1.9 3.2 17.7 4.1 72.5 28.0 19.1 12.9 81.3 589.5 6.5 39.5 245.2 2.7 6.5 51.7 9.6 2.3 0.4 7.7 121.7 5.9 193.8 38.7 2.7 8.4 23.8 11.6 1.2 3.4 9.9 33.8 22.3 27.0 1.3 9.4 5.9 88.9 95.4 35.1 58.7 43.6 15.7 6.7 0.1 43.8 95.3 39.4 18.8 22.9 15.3 39.1 0.8 3.2 5.0 24.1 7.6 26.5 0.2 1.1 8.3 8.8 48.2 12.8 206.7 15.3 0.8 0.5 1.2 44.8 17.5 1.5 0.4 32.1 8.0 3.8 0.5 9.5 0.9 83.8 18.7 6.4 4.4 11.4 18.1 4.0 259.0 13.2 0.9 70.7 77.6 38.1 11.5 67.6 0.3 0.2 0.4 21.9 1.3 53.7 23.8 6.1 2.9 2.5 11.6 2.0 2.7 2.4 2.7 8.4 2.6 2.6 2.3 6.7 1.2 7.9 1.7 3.4 9.9 5.5 5.2 5.6 5.1 4.1 2.6 3.3 7.0 4.1 2.3 53.6 87.9 11.7 166.6 63.8 52.3 12627.3 392.4 116.4 116.0 301.8 361.3 128.4 159.2 2265.1 4.5 128.8 537.1 0.0 1464.0 2646.2 335.9 214.6 50.8 122.9 165.5 49.3 257.1 251.7 29.3 13.2 189.8 54.2 77.6 57.7 811.2 43.7 1740.7 585.7 1062.5 207.5 461.5 1021.9 1520.7 21.6 75.4 44.2 86.2 21.9 280.4 186.5 TPM3 "NEM1, TRK" ENSG00000143549 "Tropomyosin 3" P06753 1 154155304-154194648 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Disease mutation, Nemaline myopathy, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 738.4;tongue: 203.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, HPA047089, HPA053624" Approved Approved "Actin filaments,Cytosol" NA NA 410000000 "Actin filaments" Cytosol "HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.64e-1)" "unprognostic (2.11e-2)" "unprognostic (3.01e-3)" "unprognostic (1.07e-1)" "unprognostic (2.39e-1)" "unprognostic (2.69e-3)" "prognostic unfavorable (6.73e-6)" "prognostic unfavorable (4.01e-4)" "unprognostic (2.80e-1)" "prognostic favorable (2.39e-5)" "prognostic unfavorable (3.65e-4)" "unprognostic (3.31e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.52e-2)" "unprognostic (1.67e-1)" "unprognostic (1.98e-2)" "unprognostic (1.00e-2)" 10.1 7.3 10.8 10.8 10.5 26.5 6.2 6.4 11.2 4.6 9.6 3.9 3.2 7.9 4.1 27.9 18.3 4.4 6.7 29.7 7.7 8.1 7.2 6.8 9.6 12.9 8.9 5.8 4.8 23.2 3.6 3.2 6.7 5.0 5.7 10.7 4.4 20.5 2.5 738.4 5.9 8.2 5.2 7.7 11.7 6.9 5.4 4.4 6.7 9.3 203.6 28.6 6.8 4.9 38.9 72.6 154.8 95.9 35.4 54.4 146.1 66.5 33.2 42.5 27.9 36.0 47.1 42.9 57.2 52.9 75.9 57.3 61.8 62.4 50.1 46.6 64.5 30.5 61.7 42.1 60.2 81.0 34.7 22.9 61.7 32.4 41.6 28.6 90.2 82.0 35.5 33.0 66.9 51.5 34.2 116.7 36.9 46.3 53.9 93.7 39.9 70.2 93.1 95.7 113.6 72.2 60.2 29.5 71.0 54.8 50.8 29.9 56.1 43.5 57.9 56.7 59.2 80.8 107.9 87.2 66.5 48.1 63.7 89.6 45.9 75.4 67.0 60.1 68.0 105.0 70.8 64.7 154.8 54.4 87.8 48.6 38.9 48.5 51.1 72.6 30.1 36.6 47.3 74.9 35.4 95.9 36.0 52.1 146.1 10.8 10.5 6.4 11.2 7.7 8.1 8.9 5.8 5.0 4.4 577.7 334.3 245.8 179.3 132.8 84.5 62.7 104.4 335.9 395.8 92.5 29.5 101.3 89.5 278.9 51.0 357.1 327.9 0.0 302.5 278.2 125.9 137.0 499.8 99.0 485.9 287.6 135.3 175.6 320.5 131.0 43.1 444.6 145.1 764.7 164.6 45.8 384.6 230.6 28.0 130.8 59.1 19.4 73.4 34.9 54.6 125.3 85.2 233.3 208.9 254.0 TPM4 ENSG00000167460 "Tropomyosin 4" P67936 19 16067021-16103005 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 230.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004685, HPA047089, HPA053624" Approved Approved "Actin filaments,Cytosol" NA NA 950000000 "Actin filaments" Cytosol "CAB004685: AB_425723, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.27e-1)" "unprognostic (1.53e-2)" "unprognostic (3.62e-3)" "unprognostic (7.38e-3)" "unprognostic (3.80e-1)" "unprognostic (2.40e-2)" "unprognostic (3.11e-2)" "unprognostic (2.75e-3)" "unprognostic (1.38e-2)" "unprognostic (3.61e-1)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.26e-10)" "unprognostic (3.85e-2)" "unprognostic (2.25e-1)" "unprognostic (1.48e-1)" "unprognostic (1.78e-1)" 66.2 17.9 13.3 60.0 13.7 10.8 47.4 46.2 11.5 90.2 40.5 14.6 56.4 17.4 87.1 63.3 149.3 49.4 108.4 39.2 14.5 12.4 32.4 12.2 69.7 27.1 16.0 10.5 102.4 15.4 8.4 16.2 65.0 19.7 84.1 31.8 18.6 47.6 64.6 29.9 39.0 25.2 127.2 22.5 99.7 37.5 30.6 11.7 11.5 20.0 92.2 60.1 177.3 70.5 22.2 35.0 40.7 32.7 24.7 52.5 48.6 59.8 23.7 46.0 28.0 106.9 159.3 57.6 83.9 101.8 71.1 73.4 24.6 62.6 2.7 65.6 104.6 52.4 32.3 19.2 48.1 93.0 39.4 11.0 30.2 34.1 19.7 58.8 5.4 72.2 98.6 15.6 58.1 66.8 82.3 81.3 14.1 3.4 38.0 98.1 20.3 16.2 19.0 24.0 54.9 28.9 22.2 39.5 13.0 16.4 51.3 8.3 26.3 56.4 25.3 29.7 46.3 0.5 8.3 95.2 123.9 15.7 230.2 77.5 6.6 15.6 13.3 85.9 15.9 41.9 40.7 30.1 2.2 34.8 32.7 26.3 22.2 26.9 31.2 35.0 18.8 7.8 18.3 35.2 24.7 16.2 27.4 52.5 48.6 13.3 13.7 46.2 11.5 14.5 12.4 16.0 10.5 19.7 11.7 372.2 149.0 112.7 891.9 382.9 46.3 46.3 96.8 158.0 326.4 230.3 9.8 212.0 11.6 660.1 53.8 384.6 203.3 0.0 501.5 677.9 318.1 567.0 235.4 1.9 313.9 4.8 90.0 275.0 103.4 37.2 160.2 324.4 135.0 331.0 106.2 5.7 698.7 90.9 514.4 15.6 10.7 329.8 423.9 12.0 11.3 300.5 475.8 117.4 88.9 901.5 TPP2 TPPII ENSG00000134900 "Tripeptidyl peptidase 2" P29144 13 102597003-102679958 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 9 "Early spermatids: 628.9;Late spermatids: 647.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021069, HPA049630" Approved Supported "Nuclear bodies,Cytosol" NA NA 410000 "Nuclear bodies, Cytosol" "HPA021069: AB_1858344, HPA049630: AB_2680836" "unprognostic (4.75e-2)" "unprognostic (4.78e-2)" "unprognostic (9.97e-2)" "unprognostic (1.08e-1)" "unprognostic (2.01e-2)" "unprognostic (4.43e-2)" "unprognostic (2.45e-2)" "unprognostic (8.33e-3)" "unprognostic (5.02e-2)" "unprognostic (1.51e-1)" "unprognostic (3.12e-1)" "unprognostic (2.75e-3)" "unprognostic (6.26e-2)" "unprognostic (3.12e-1)" "unprognostic (7.53e-2)" "unprognostic (3.95e-2)" "unprognostic (3.43e-3)" 19.9 12.4 10.8 21.4 14.5 24.7 18.1 23.1 18.4 16.8 14.7 12.2 50.3 13.1 20.0 21.8 14.4 16.7 13.5 17.0 11.7 9.7 12.9 22.8 18.4 32.8 11.7 13.8 21.6 16.3 15.7 15.7 19.2 15.3 13.9 21.0 12.9 15.6 34.5 35.7 14.1 17.4 19.2 13.4 20.7 15.4 34.5 14.0 23.8 21.9 16.0 19.7 17.0 16.0 6.0 5.8 9.2 6.9 10.9 12.1 4.7 16.2 6.5 18.9 16.1 12.8 17.7 13.5 16.6 12.2 10.7 13.4 13.8 21.9 17.9 5.7 13.4 12.1 16.0 14.6 11.7 19.4 12.4 13.0 34.0 17.1 11.0 10.8 38.4 20.7 13.7 5.3 12.0 16.1 11.5 15.3 17.5 20.2 20.0 15.1 5.1 17.6 28.8 15.3 21.0 9.1 19.6 14.3 16.1 13.9 13.4 17.6 14.4 10.4 17.4 7.4 15.4 10.0 43.1 12.2 10.2 7.4 6.5 13.8 19.7 23.8 15.6 17.0 27.7 13.1 9.2 6.0 4.0 9.1 6.9 10.7 6.0 10.3 10.1 5.8 5.5 12.1 11.5 1.3 10.9 5.7 4.6 10.9 4.7 10.8 14.5 23.1 18.4 11.7 9.7 11.7 13.8 15.3 14.0 35.7 35.3 24.4 13.2 13.7 25.9 36.2 7.6 50.9 23.9 14.0 68.7 24.1 8.3 16.1 628.9 16.1 9.5 23.3 7.5 23.0 16.0 13.4 37.0 19.2 27.1 7.9 19.0 25.2 21.0 647.3 29.7 22.2 16.9 16.2 16.9 12.9 12.1 15.3 17.7 11.2 44.7 25.8 17.5 51.0 29.6 11.7 27.7 27.7 18.3 16.5 TPPP "p25, p25alpha, TPPP/p25, TPPP1" ENSG00000171368 "Tubulin polymerization promoting protein" O94811 5 659862-693395 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 77.5" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 35.7;Bipolar cells: 18.7;Horizontal cells: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.5;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 8.6;AN3-CA: 6.4;SCLC-21H: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036575, HPA036576" Enhanced Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA036575: AB_10673501, HPA036576: AB_2675200" "unprognostic (3.66e-2)" "unprognostic (3.70e-3)" "unprognostic (9.98e-3)" "unprognostic (7.82e-2)" "unprognostic (2.05e-2)" "unprognostic (3.20e-2)" "unprognostic (2.12e-1)" "unprognostic (3.80e-3)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-3)" "unprognostic (5.48e-2)" "prognostic favorable (5.40e-6)" "unprognostic (4.03e-2)" "unprognostic (2.30e-1)" "unprognostic (2.03e-2)" "unprognostic (3.31e-2)" 3.5 5.8 27.0 1.3 29.6 1.0 2.7 17.0 77.5 2.1 3.2 69.0 0.1 4.6 2.3 1.3 9.0 8.6 2.1 6.0 33.9 23.9 3.2 2.3 8.3 1.0 25.8 25.0 1.8 5.2 2.4 4.4 2.4 30.1 2.4 2.2 0.2 4.8 3.7 6.2 5.6 7.5 3.5 24.7 2.7 3.8 1.6 4.3 0.0 6.0 1.9 1.8 3.4 0.6 0.0 0.2 1.5 0.0 1.0 0.5 0.1 0.3 8.6 0.4 6.4 0.9 0.0 1.2 0.2 0.0 0.0 0.0 0.3 1.0 0.2 0.6 0.0 2.2 3.4 3.4 0.0 0.0 1.7 2.9 0.2 3.6 0.2 1.0 0.3 0.4 0.0 0.8 0.0 0.2 0.2 0.1 0.2 0.1 3.2 0.0 0.3 0.2 0.5 0.2 0.9 0.9 0.3 0.1 1.2 0.3 1.2 15.8 1.9 0.9 0.4 4.2 0.4 0.8 0.2 0.1 0.2 3.4 0.1 0.2 1.2 0.3 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.2 0.1 0.1 27.0 29.6 17.0 40.8 33.9 23.9 25.8 25.0 30.1 4.3 35.7 7.7 0.0 1.0 3.7 18.7 16.1 5.1 16.0 9.1 1.8 0.0 0.0 1.7 1.7 6.9 0.0 8.5 0.0 0.6 0.1 0.7 0.6 4.6 2.0 2.5 39.7 9.8 1.3 0.0 3.6 0.3 0.0 1.7 0.0 5.7 0.8 1.0 5.8 0.4 1.1 2.1 0.0 1.9 1.4 0.2 2.8 0.0 0.0 4.1 2.4 TPRG1L "FAM79A, FLJ21811, RP11-46F15.3" ENSG00000158109 "Tumor protein p63 regulated 1 like" Q5T0D9 1 3625002-3630127 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063163, CAB079051" Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB079051: , HPA063163: AB_2684953" "unprognostic (1.92e-1)" "unprognostic (3.26e-3)" "unprognostic (4.46e-2)" "unprognostic (7.99e-2)" "unprognostic (4.50e-2)" "unprognostic (3.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (5.37e-2)" "unprognostic (1.50e-1)" "unprognostic (7.83e-3)" "prognostic favorable (1.76e-9)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" 18.3 19.1 34.3 9.7 46.6 14.5 17.4 23.1 57.7 19.3 24.0 12.9 17.2 24.5 16.5 21.2 28.7 24.8 19.3 25.0 32.9 32.8 32.1 34.9 16.8 14.6 25.7 41.7 25.9 17.4 11.7 20.5 12.7 41.4 17.1 23.4 19.1 18.7 25.0 29.5 25.4 28.3 18.1 13.2 13.4 17.4 8.7 13.6 8.0 21.9 17.3 18.2 17.1 16.3 5.1 7.9 17.0 3.2 2.6 7.1 3.2 11.3 8.2 5.0 9.0 38.3 26.7 4.7 17.0 23.5 15.8 10.5 15.3 10.5 4.2 15.2 23.1 8.5 18.0 6.0 15.7 13.4 13.3 9.7 5.9 9.5 17.7 23.3 8.5 7.0 20.1 23.2 13.0 13.4 19.3 22.2 7.4 4.2 15.1 22.0 5.2 6.1 8.8 6.8 26.3 19.2 5.1 7.5 10.0 16.3 12.0 14.2 14.0 9.1 18.9 18.0 12.1 11.8 7.4 25.2 13.3 3.9 30.1 4.8 13.7 17.7 4.7 7.8 18.8 1.7 12.8 3.2 4.9 5.6 2.6 7.1 4.2 6.4 5.5 2.8 5.1 5.9 6.8 17.0 2.6 2.5 7.9 3.4 3.2 34.3 46.6 23.1 57.7 32.9 32.8 25.7 41.7 41.4 13.6 14.9 16.2 8.0 8.5 10.6 44.4 33.5 20.4 17.4 5.7 10.4 7.9 8.9 10.0 15.8 2.4 13.0 47.9 0.0 30.6 10.6 9.7 9.0 8.1 49.9 13.0 119.2 18.5 27.0 14.8 3.1 17.3 9.7 6.8 13.6 29.1 57.4 26.8 23.0 20.1 31.6 27.8 6.5 13.8 4.7 13.2 16.6 7.7 10.0 24.1 7.2 TPRKB "CGI-121, CGI121" ENSG00000144034 "TP53RK binding protein" Q9Y3C4 2 73729104-73737400 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035712 Approved Supported Cytosol NA NA Cytosol "HPA035712: AB_10669674" "unprognostic (1.11e-1)" "unprognostic (2.41e-2)" "unprognostic (6.59e-2)" "unprognostic (2.31e-2)" "unprognostic (2.74e-1)" "unprognostic (2.67e-2)" "unprognostic (1.21e-3)" "unprognostic (4.96e-2)" "unprognostic (3.16e-3)" "unprognostic (3.01e-3)" "unprognostic (5.10e-3)" "unprognostic (6.06e-2)" "unprognostic (2.68e-3)" "unprognostic (5.66e-2)" "unprognostic (8.45e-3)" "unprognostic (1.82e-1)" "unprognostic (5.03e-2)" 15.5 13.9 13.5 9.9 16.2 30.2 23.3 24.1 17.0 18.0 16.7 11.1 21.1 19.9 16.5 19.9 22.4 29.3 10.7 24.5 15.6 12.0 24.3 23.6 14.4 17.5 17.6 12.6 22.2 19.2 8.4 21.3 14.8 18.2 16.6 18.0 8.7 20.3 13.0 36.8 13.3 24.1 20.6 16.6 15.5 15.9 25.1 15.9 21.9 14.7 30.6 16.6 14.3 17.5 20.6 22.0 24.3 21.9 19.4 22.3 14.6 23.7 18.9 18.6 20.7 6.9 9.8 14.6 14.6 9.3 18.7 13.7 28.8 15.5 15.3 12.1 8.0 34.7 15.3 14.4 17.8 29.6 9.8 20.6 31.1 12.1 21.9 6.9 37.8 17.9 6.9 11.7 18.3 20.1 9.5 19.4 27.4 28.5 24.1 19.1 15.1 33.0 32.9 24.4 34.7 25.1 19.8 51.2 22.7 17.4 22.5 16.2 20.4 12.4 20.3 26.5 17.1 14.3 20.0 8.9 14.8 24.1 29.0 43.0 17.0 22.6 40.4 14.4 29.8 17.9 14.3 17.1 24.3 14.9 21.9 19.8 20.6 20.1 18.0 19.4 17.6 22.3 21.2 13.8 19.4 17.1 22.0 18.6 14.6 13.5 16.2 24.1 17.0 15.6 12.0 17.6 12.6 18.2 15.9 29.8 38.6 44.7 60.3 47.3 13.9 56.1 40.8 53.5 47.8 21.0 3.9 65.0 74.6 70.6 93.1 68.4 61.1 70.0 161.5 88.2 43.6 39.5 46.3 40.5 77.1 7.9 32.3 90.9 47.3 15.6 54.7 59.9 32.1 54.1 64.9 20.6 92.6 71.9 49.1 126.5 18.6 51.8 35.4 189.6 92.5 46.3 38.1 41.5 73.4 42.6 TPT1 "fortilin, TCTP" ENSG00000133112 "Tumor protein, translationally-controlled 1" P13693 13 45333471-45341370 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008364, HPA039437" Approved Supported Cytosol NA NA 3000000 Cytosol "CAB008364: AB_591904, HPA039437: AB_2676508" "prognostic favorable (5.90e-5)" "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "prognostic favorable (2.35e-4)" "unprognostic (3.25e-1)" "unprognostic (3.57e-2)" "unprognostic (8.71e-3)" "unprognostic (2.04e-1)" "unprognostic (1.08e-1)" "unprognostic (1.29e-3)" "unprognostic (4.56e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (2.54e-5)" "unprognostic (1.47e-1)" "unprognostic (8.48e-2)" "prognostic favorable (4.31e-5)" "unprognostic (6.51e-2)" 197.3 108.4 81.7 126.7 74.3 156.7 185.4 35.2 41.3 173.3 229.7 66.5 131.7 101.9 197.9 162.6 234.4 97.1 168.2 292.9 74.4 58.0 141.0 317.4 179.5 286.0 85.1 27.1 273.2 671.6 32.3 97.4 188.3 46.3 203.4 91.6 77.5 460.5 124.6 772.2 98.5 178.1 169.1 101.1 180.2 107.7 95.9 52.1 211.5 306.1 322.2 178.4 211.5 356.3 106.0 111.8 76.0 91.7 110.6 165.2 205.6 58.7 53.3 90.3 58.9 266.7 372.0 107.3 125.2 195.2 80.0 84.0 119.6 153.0 125.3 105.7 129.9 53.0 102.5 72.8 183.7 110.9 57.8 63.7 100.4 48.5 132.8 269.4 136.5 157.3 304.9 374.1 50.9 308.1 260.2 165.1 107.0 74.3 34.6 163.0 107.3 165.2 326.2 102.9 198.3 56.8 104.3 85.6 93.6 205.0 123.5 38.5 103.1 41.5 133.1 191.0 96.2 76.3 398.1 107.5 36.9 52.6 59.9 76.8 85.5 86.4 118.5 98.5 109.2 28.6 76.0 91.7 44.6 82.3 71.6 149.6 106.0 154.6 111.3 87.2 84.4 165.2 133.5 42.2 110.6 65.9 111.8 134.7 205.6 81.7 74.3 35.2 41.3 74.4 58.0 85.1 27.1 46.3 52.1 1479.9 2965.6 3028.0 5179.8 3104.5 333.9 2317.0 2366.8 1212.6 2306.7 724.0 151.2 3924.7 2664.3 2026.9 855.5 2800.2 4687.9 934.5 4449.5 5200.5 3170.6 5725.2 1748.2 3780.3 3821.0 201.8 1990.0 4043.9 4707.2 1251.1 6296.7 3543.0 1682.0 2041.5 6067.3 780.7 4698.0 5432.3 3638.3 7341.6 481.8 2490.0 1772.7 484.4 364.3 3041.2 4808.3 3056.2 6095.0 6368.7 TPTE "CT44, PTEN2" ENSG00000274391 "Transmembrane phosphatase with tensin homology" P56180 21 10521553-10606140 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 69 "testis: 78.6" "Group enriched" "Detected in some" 14 "Spermatocytes: 282.4;Spermatogonia: 73.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.4;K-562: 8.6;Karpas-707: 7.0;MCF7: 5.1;PC-3: 5.2;RPMI-8226: 9.5;SuSa: 8.9;U-2 OS: 4.6;U-266/70: 8.5" "HPA049690, HPA068342" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA049690: AB_2680850, HPA068342: AB_2685976" "unprognostic (3.63e-2)" 0.1 0.0 0.0 0.7 0.2 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.8 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.4 0.0 0.9 0.0 78.6 0.0 0.4 0.1 0.4 0.8 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 7.0 0.0 5.1 0.0 0.0 1.2 0.0 5.2 0.0 0.0 9.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 8.9 0.0 0.0 0.0 2.0 4.6 2.4 0.0 8.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.6 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 12.9 0.0 282.4 73.0 0.0 0.9 0.0 0.0 0.0 TPTE2 TPIP ENSG00000132958 "Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2" Q6XPS3 13 19422877-19536762 "Enzymes, Plasma proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 12.3" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 1.8;Early spermatids: 3.5;Spermatocytes: 9.3;Spermatogonia: 2.5" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 10.1;Karpas-707: 2.9" HPA068342 Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA068342: AB_2685976" "unprognostic (2.50e-1)" "unprognostic (2.10e-1)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (5.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (5.40e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-1)" "unprognostic (1.05e-12)" "unprognostic (1.04e-1)" "unprognostic (1.47e-1)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" 0.0 0.1 0.4 0.2 1.0 0.0 0.1 0.7 0.8 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.2 12.3 0.0 0.6 0.0 0.0 0.5 0.4 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 10.1 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 2.9 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 9.3 2.5 0.1 0.1 0.0 0.0 0.0 TRA2B "Htra2-beta, PPP1R156, SFRS10" ENSG00000136527 "Transformer 2 beta homolog" P62995 3 185915906-185938136 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011692, HPA063597, HPA064972" Supported Enhanced Nucleoplasm,Cytosol NA NA 40000 Nucleoplasm Cytosol "CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396" "unprognostic (9.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.22e-2)" "unprognostic (7.58e-3)" "unprognostic (1.48e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.92e-1)" "unprognostic (2.65e-3)" "prognostic favorable (2.15e-4)" "unprognostic (1.07e-1)" "unprognostic (3.22e-3)" "unprognostic (1.71e-3)" "unprognostic (1.28e-2)" "unprognostic (2.64e-1)" "unprognostic (4.38e-1)" "unprognostic (4.36e-2)" 36.2 38.0 34.9 52.5 32.4 34.5 34.1 29.8 29.1 30.5 39.5 20.3 31.7 22.4 37.8 32.3 36.5 27.1 31.0 26.4 29.9 30.1 33.0 37.1 27.1 36.9 29.8 21.9 28.9 31.0 28.6 31.3 38.0 20.9 31.6 27.5 26.1 26.6 32.3 50.8 22.7 24.9 35.7 27.1 31.9 28.7 38.4 25.1 57.2 29.6 47.3 42.8 34.0 50.3 34.5 37.0 30.7 21.0 20.6 25.0 10.7 31.8 13.1 33.0 16.8 9.6 7.6 18.2 25.8 16.7 28.5 22.6 21.1 16.8 30.8 31.1 13.2 19.7 20.8 36.1 25.1 33.6 25.9 22.9 28.8 11.9 28.0 12.8 30.5 23.3 7.3 12.5 16.8 16.3 9.2 21.8 15.4 27.5 19.7 21.8 16.7 75.5 44.3 49.2 31.1 20.5 45.9 26.6 35.9 27.7 13.9 24.5 24.4 17.0 24.0 30.4 17.7 24.2 33.9 12.4 19.3 25.3 16.1 38.8 36.3 88.4 57.5 19.9 35.5 30.4 30.7 21.0 16.1 20.2 17.1 18.1 31.7 19.8 18.7 18.3 34.5 25.0 22.7 22.1 20.6 18.6 37.0 18.5 10.7 34.9 32.4 29.8 29.1 29.9 30.1 29.8 21.9 20.9 25.1 59.6 114.4 168.3 155.0 229.4 101.5 57.6 104.4 62.9 102.4 66.3 184.6 157.7 61.3 105.4 125.7 154.8 106.8 233.6 94.8 196.4 163.4 151.8 191.8 78.1 151.9 68.3 218.4 179.9 244.9 31.1 118.2 213.7 128.2 216.4 142.0 89.2 85.0 121.0 110.3 42.8 196.4 103.5 173.1 132.6 147.0 227.8 179.8 202.0 165.8 133.4 TRADD Hs.89862 ENSG00000102871 "TNFRSF1A associated via death domain" Q15628 16 67154180-67160298 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "monocytes: 256.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004602, HPA071341" Enhanced Approved Cytosol NA NA Cytosol "CAB004602: AB_2209061, HPA071341: AB_2732178" "unprognostic (2.66e-1)" "unprognostic (3.11e-1)" "unprognostic (2.23e-2)" "prognostic favorable (1.40e-4)" "unprognostic (1.50e-2)" "unprognostic (1.21e-1)" "unprognostic (5.68e-2)" "unprognostic (4.96e-2)" "unprognostic (4.15e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (8.27e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (1.83e-1)" 12.2 13.3 8.7 15.9 10.5 5.6 10.1 2.1 6.9 11.9 12.3 10.8 13.0 10.2 10.4 11.1 17.4 11.6 14.5 7.3 6.5 3.1 15.0 11.8 11.6 14.4 10.5 4.4 12.8 17.9 9.7 8.4 14.9 9.5 13.7 7.4 9.0 15.4 10.5 6.6 14.8 12.1 8.7 7.2 20.3 21.8 4.4 9.8 9.7 19.5 11.0 22.4 11.7 12.0 20.8 21.4 25.6 20.0 10.5 50.5 14.3 8.8 7.5 0.1 2.9 7.0 5.9 9.7 7.0 5.1 3.3 5.2 4.7 7.2 4.7 12.0 6.0 7.0 16.2 1.2 6.1 2.7 13.5 7.0 3.1 3.4 4.6 8.6 3.9 8.0 6.1 8.9 4.5 1.7 8.7 6.3 5.0 4.5 7.5 4.9 8.1 4.6 7.8 0.1 8.6 22.7 9.2 3.7 18.5 5.6 5.8 1.5 4.5 15.4 3.5 4.4 2.9 6.1 5.5 7.2 4.5 4.8 7.3 4.9 15.0 4.8 5.6 10.9 3.5 5.2 12.0 12.3 25.6 16.7 15.3 25.1 20.8 50.5 28.9 15.2 18.5 14.8 11.9 21.6 10.5 20.0 21.4 22.2 14.3 8.7 10.5 2.1 6.9 6.5 3.1 10.5 4.4 9.5 9.8 3.0 7.5 39.0 21.6 15.3 1.0 3.3 22.9 6.7 4.5 5.2 0.0 29.2 26.6 55.2 1.2 18.8 23.1 0.0 33.5 37.2 28.6 34.8 9.2 18.7 41.8 0.0 18.5 12.3 34.6 1.5 27.9 29.1 54.0 256.1 25.5 4.7 54.2 28.3 28.7 65.5 2.1 25.8 22.1 1.8 7.9 22.5 25.5 30.6 21.7 32.5 TRAF2 "RNF117, TRAP3" ENSG00000127191 "TNF receptor associated factor 2" Q12933 9 136881912-136926607 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004603, HPA009972, HPA010634" Uncertain Enhanced Cytosol NA NA Cytosol "CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347" "unprognostic (7.77e-2)" "unprognostic (4.54e-3)" "prognostic unfavorable (9.32e-4)" "unprognostic (1.15e-1)" "unprognostic (1.11e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (4.91e-2)" "unprognostic (7.23e-2)" "unprognostic (4.28e-2)" "unprognostic (7.39e-2)" "unprognostic (2.82e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.80e-3)" "unprognostic (5.52e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-2)" 7.3 6.6 8.7 20.3 10.4 15.9 8.6 16.0 10.0 7.3 8.7 7.4 7.3 11.1 12.3 6.9 12.3 9.0 8.3 8.3 7.5 6.5 8.5 12.3 11.5 19.7 11.2 8.3 6.8 13.9 5.9 8.8 12.1 8.1 10.2 6.2 7.5 13.0 10.1 6.4 13.0 10.4 10.6 8.2 13.8 10.7 13.7 6.4 16.4 14.7 5.2 15.9 8.4 37.5 12.6 11.5 6.7 8.3 10.1 17.4 6.2 10.6 32.9 8.9 7.9 2.5 4.0 17.5 8.8 4.9 12.9 8.8 20.3 19.4 13.3 11.5 5.5 17.5 28.2 12.2 14.4 5.3 20.2 9.9 10.0 29.8 12.6 3.7 9.9 10.4 3.0 4.4 10.5 6.0 4.9 6.1 12.4 16.9 15.2 5.7 15.5 15.9 14.2 14.5 24.5 14.8 15.1 13.7 18.1 7.9 8.4 14.6 6.8 11.0 25.9 10.0 10.4 18.6 11.6 6.8 16.9 10.9 11.0 14.8 6.4 10.3 13.3 6.0 8.1 12.4 1.3 3.7 6.7 10.4 4.2 14.6 12.6 11.1 13.0 4.9 10.0 9.1 10.9 3.3 10.1 8.3 11.5 17.4 6.2 8.7 10.4 16.0 10.0 7.5 6.5 11.2 8.3 8.1 6.4 0.0 8.3 13.4 12.1 10.5 6.8 6.3 12.7 0.0 3.4 5.2 0.0 16.7 3.3 18.9 2.5 8.2 15.4 0.0 11.0 25.5 7.4 11.2 10.3 4.0 11.7 17.5 10.9 4.3 2.4 2.7 3.1 7.3 13.5 55.1 9.2 4.2 16.3 5.8 7.4 5.0 10.0 19.4 12.7 9.2 22.0 11.2 14.9 13.8 12.4 9.1 TRAF4 "CART1, MLN62, RNF83" ENSG00000076604 "TNF receptor associated factor 4" Q9BUZ4 17 28743984-28750958 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Urothelial cells: 265.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 27.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 27.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009055, HPA021904, HPA052377" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB009055: AB_2209701, HPA021904: , HPA052377: AB_2681804" "unprognostic (1.77e-1)" "unprognostic (9.05e-2)" "unprognostic (1.31e-2)" "unprognostic (2.51e-3)" "unprognostic (1.76e-1)" "unprognostic (7.38e-3)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.09e-2)" "unprognostic (2.33e-1)" "unprognostic (7.13e-2)" "unprognostic (7.55e-2)" "unprognostic (1.74e-3)" "unprognostic (6.98e-2)" "unprognostic (9.26e-2)" "unprognostic (2.77e-2)" "unprognostic (5.58e-3)" 5.0 8.1 13.8 13.1 14.5 19.9 15.9 6.3 12.4 7.9 22.2 24.7 14.0 32.8 6.8 5.7 15.4 9.5 17.1 2.8 12.7 7.6 20.7 30.1 13.5 12.5 17.9 7.7 7.2 33.8 3.1 8.1 11.8 12.4 16.7 16.0 6.0 32.2 10.4 0.9 7.5 31.4 5.1 10.9 10.2 21.7 7.4 16.4 5.9 16.4 7.1 16.5 15.9 6.0 5.3 27.7 2.7 0.6 0.8 1.4 0.9 11.4 18.4 25.3 12.4 3.6 4.3 39.5 7.8 6.7 8.5 11.3 14.6 14.8 18.0 11.6 8.7 5.7 17.5 11.6 17.9 3.5 5.6 16.2 6.4 30.4 16.6 14.1 3.1 7.2 8.1 17.7 10.0 12.0 7.7 6.5 8.6 16.7 1.6 7.7 19.3 9.7 6.4 19.7 23.1 4.2 14.4 11.6 8.8 24.1 33.8 16.0 18.5 12.3 54.3 23.5 22.9 20.6 4.9 4.4 5.3 11.3 6.1 10.9 2.4 5.8 22.4 4.2 5.1 24.2 2.7 0.2 0.9 0.6 0.6 1.4 5.3 1.0 1.0 1.5 5.3 0.7 0.7 0.1 0.8 0.4 27.7 0.5 0.9 13.8 14.5 6.3 12.4 12.7 7.6 17.9 7.7 12.4 16.4 20.8 24.1 21.9 160.2 122.2 2.8 0.4 38.2 29.4 23.9 19.2 5.9 92.4 36.5 78.4 44.7 11.2 113.0 0.0 94.8 110.0 25.1 171.6 6.9 35.6 12.1 7.9 80.7 9.2 1.2 8.6 3.4 4.6 37.1 10.8 58.2 18.9 100.9 95.4 1.4 24.8 1.7 0.0 33.0 5.7 20.4 68.6 104.0 6.4 64.4 265.8 TRAF5 RNF84 ENSG00000082512 "TNF receptor associated factor 5" O00463 1 211326615-211374946 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 48.9;Early spermatids: 42.9;Late spermatids: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 22.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008052, CAB010277" Enhanced Supported Centrosome,Cytosol NA NA Cytosol Centrosome "CAB010277: AB_2287961, HPA008052: AB_1858230" "unprognostic (6.44e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (1.55e-2)" "unprognostic (1.04e-1)" "unprognostic (3.39e-2)" "unprognostic (6.44e-3)" "unprognostic (7.94e-3)" "unprognostic (1.39e-1)" "unprognostic (1.75e-1)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.94e-10)" "unprognostic (3.72e-1)" "unprognostic (1.34e-1)" "unprognostic (1.71e-2)" "prognostic favorable (7.29e-5)" 7.5 3.1 3.9 33.6 6.5 3.1 6.1 1.2 4.6 11.1 11.6 3.3 9.9 4.2 24.3 17.4 6.1 17.1 10.4 4.5 3.4 2.3 5.3 1.9 5.4 22.7 1.9 3.1 8.6 19.4 1.7 3.1 4.4 5.3 8.7 8.1 9.6 13.3 17.8 1.6 2.9 15.5 21.4 1.9 16.5 8.6 5.6 1.7 15.9 3.1 4.1 27.4 12.0 6.5 14.7 0.9 5.3 0.3 13.1 11.9 4.8 3.8 2.9 5.2 4.6 4.6 3.3 1.8 5.5 6.6 8.0 7.2 1.4 7.7 11.8 3.2 8.7 4.1 0.7 9.7 0.9 4.0 22.7 3.5 0.6 4.2 0.0 6.6 1.8 8.7 3.9 1.7 4.3 1.3 12.1 5.6 10.4 4.7 5.6 2.2 3.0 5.1 2.1 6.2 6.1 2.4 7.8 7.2 10.9 6.1 2.7 9.2 9.6 4.1 0.2 11.8 20.0 2.9 0.2 3.4 5.2 4.1 1.7 6.1 1.6 2.3 12.6 1.4 0.0 1.9 5.3 0.2 0.3 6.3 0.2 11.9 14.7 7.9 8.4 0.9 13.0 7.2 7.0 0.4 13.1 0.3 0.7 10.8 4.8 3.9 6.5 1.2 4.6 3.4 2.3 1.9 3.1 5.3 1.7 11.9 11.1 48.9 3.5 3.3 1.0 2.0 0.0 13.4 10.3 10.4 0.0 7.1 0.0 0.7 42.9 7.4 1.6 0.0 8.4 1.7 8.6 2.6 14.0 0.0 8.4 0.0 14.3 6.2 3.7 38.6 13.3 7.5 8.5 23.4 10.9 0.8 7.3 8.6 25.8 0.5 0.4 12.9 10.3 3.0 1.1 3.4 1.1 26.3 10.2 1.6 TRAFD1 FLN29 ENSG00000135148 "TRAF-type zinc finger domain containing 1" O14545 12 112125501-112153609 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "monocytes: 186.7;Spermatocytes: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039254, HPA039266" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039254: AB_10805358, HPA039266: AB_10795142" "unprognostic (7.80e-2)" "prognostic favorable (5.73e-4)" "unprognostic (6.12e-2)" "unprognostic (1.44e-1)" "unprognostic (9.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (1.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (9.26e-6)" "unprognostic (1.07e-1)" "unprognostic (6.15e-2)" "unprognostic (3.33e-3)" "prognostic favorable (3.92e-5)" 15.1 13.1 11.0 21.9 19.2 20.5 16.6 11.9 19.8 15.6 31.6 42.1 15.2 12.7 15.1 12.8 26.0 12.8 14.0 16.9 12.2 10.8 12.7 12.5 21.2 25.5 26.2 10.7 15.3 10.2 15.3 14.9 15.5 22.2 18.5 16.8 22.7 16.4 16.7 10.3 28.1 16.0 20.5 25.0 25.0 15.2 30.9 23.4 28.2 13.0 13.0 29.7 25.6 17.4 13.2 11.4 59.1 21.4 14.8 13.8 19.3 10.7 12.2 19.8 18.4 13.5 12.9 10.2 12.3 17.9 17.5 13.9 13.1 9.8 12.2 10.6 13.0 7.5 21.9 19.2 12.1 11.8 21.3 18.3 19.9 17.3 7.1 23.5 12.3 31.0 16.6 20.5 12.4 17.0 17.5 15.2 7.7 22.2 7.6 11.0 18.1 13.5 16.9 16.2 13.1 14.4 19.2 12.1 20.6 11.3 40.6 16.8 13.0 25.6 25.3 6.8 15.5 16.4 17.1 9.7 8.0 5.7 7.8 6.5 18.5 16.3 13.1 8.5 9.7 8.6 59.1 21.4 48.3 10.7 19.4 7.3 13.2 10.5 9.6 11.4 12.2 9.7 8.9 42.8 14.8 20.0 7.5 13.8 19.3 11.0 19.2 11.9 19.8 12.2 10.8 26.2 10.7 22.2 23.4 17.9 9.6 8.8 6.8 10.9 7.0 8.9 7.6 4.0 13.6 12.2 23.6 17.2 5.0 18.4 1.0 9.5 9.3 0.0 18.2 12.6 12.4 16.5 11.5 4.0 13.2 14.3 15.0 8.6 12.5 1.7 10.9 14.1 6.8 186.7 9.2 8.8 21.6 14.0 12.0 4.2 10.9 0.0 6.4 51.7 15.3 13.2 22.1 9.6 9.7 9.0 TRAIP "RNF206, TRIP" ENSG00000183763 "TRAF interacting protein" Q9BWF2 3 49828599-49856574 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.0" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 11.8;Spermatogonia: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036261, HPA036262" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA036261: AB_10673348, HPA036262: AB_2675029" "unprognostic (5.30e-3)" "unprognostic (9.41e-2)" "unprognostic (1.48e-1)" "unprognostic (6.50e-3)" "unprognostic (1.88e-1)" "unprognostic (7.68e-3)" "prognostic unfavorable (8.77e-5)" "unprognostic (4.61e-2)" "unprognostic (1.52e-2)" "unprognostic (8.61e-2)" "unprognostic (1.24e-2)" "unprognostic (7.97e-2)" "unprognostic (9.01e-5)" "unprognostic (5.84e-2)" "unprognostic (4.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" 4.8 1.6 3.4 6.0 10.7 9.5 3.0 7.4 3.0 3.5 3.7 2.0 3.2 2.3 3.8 2.4 4.5 3.0 2.9 1.5 2.7 2.7 1.6 1.2 1.3 8.1 2.0 2.8 3.4 1.6 1.6 2.0 2.5 3.0 2.9 4.8 2.7 3.1 1.7 2.8 6.7 3.4 3.4 5.1 3.7 1.9 25.0 3.4 11.5 2.2 3.1 6.8 1.9 3.0 5.1 1.6 0.6 3.0 2.7 4.9 1.6 6.4 7.9 11.3 11.4 1.0 1.6 9.4 7.8 3.8 16.6 15.9 9.6 7.5 16.0 5.6 4.5 11.6 8.6 11.9 9.0 12.4 9.2 7.9 12.0 9.6 8.5 0.4 9.8 10.1 1.1 1.3 13.3 7.1 2.0 4.3 14.3 8.6 11.6 7.3 9.4 16.2 12.5 9.1 7.7 13.1 9.0 7.7 9.3 3.0 9.1 5.5 9.4 8.7 7.3 5.5 8.5 6.6 13.9 3.3 10.6 12.7 14.6 15.3 8.5 20.3 17.1 5.3 13.3 9.5 0.0 1.5 0.6 2.3 0.8 2.0 5.1 1.3 4.9 1.3 3.8 1.7 2.6 0.3 2.7 3.0 1.6 0.8 1.6 3.4 10.7 7.4 3.0 2.7 2.7 2.0 2.8 3.0 3.4 3.0 1.1 2.2 0.6 1.0 3.1 2.0 0.0 0.0 0.0 3.5 0.0 2.1 0.0 1.3 3.3 0.7 0.5 0.0 0.8 6.7 1.4 0.5 0.0 0.8 3.0 0.0 0.0 0.6 0.3 4.0 2.3 0.5 1.7 2.8 1.3 1.9 0.9 0.0 1.1 0.3 3.6 0.0 1.0 11.8 9.5 0.3 0.8 2.9 2.3 0.1 TRAM2 KIAA0057 ENSG00000065308 "Translocation associated membrane protein 2" Q15035 6 52497402-52576915 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 84.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 54.4;ASC TERT1: 58.3;fHDF/TERT166: 52.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA035092, HPA057925" Approved Approved Cytosol NA NA Cytosol "HPA035092: AB_10610562, HPA057925: AB_2683557" "unprognostic (2.32e-2)" "unprognostic (2.19e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (1.12e-1)" "unprognostic (4.07e-2)" "unprognostic (8.90e-3)" "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.03e-1)" "unprognostic (3.01e-1)" "unprognostic (5.05e-1)" "prognostic unfavorable (1.41e-9)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "unprognostic (6.64e-2)" "unprognostic (1.19e-2)" 17.3 4.9 2.0 11.8 3.7 2.7 29.4 2.0 3.3 13.3 12.5 4.3 4.4 9.2 12.7 9.0 8.3 11.5 11.8 10.5 3.3 2.2 7.7 23.7 12.6 13.1 4.0 2.2 15.6 6.8 1.9 4.0 46.7 6.0 9.9 10.2 12.0 6.2 4.0 6.3 7.6 15.9 17.6 5.3 20.0 8.4 11.6 2.7 4.9 11.7 6.0 12.1 14.0 19.6 3.6 3.1 2.8 5.4 2.0 2.8 1.8 9.1 4.1 4.8 4.7 54.4 58.3 8.4 27.0 27.4 22.7 21.1 8.8 1.9 2.2 4.5 52.3 16.2 2.0 3.1 16.9 28.7 5.0 1.6 4.9 4.1 11.1 15.5 1.2 2.7 21.1 1.7 19.8 8.8 33.2 26.0 1.9 3.0 16.5 32.4 3.3 1.7 3.6 2.2 3.6 1.8 2.2 12.6 18.5 5.4 1.5 1.1 1.8 6.2 2.8 6.5 10.6 4.3 2.6 41.1 38.2 8.3 13.7 14.7 11.3 19.2 6.4 13.9 3.3 23.2 0.2 2.8 2.8 2.8 3.4 1.5 3.6 2.2 1.7 3.1 2.0 1.2 2.0 0.8 2.0 5.4 1.5 0.8 1.8 2.0 3.7 2.0 3.3 3.3 2.2 4.0 2.2 6.0 2.7 6.0 2.7 11.5 2.5 7.2 3.0 7.1 5.1 5.3 4.5 7.0 23.6 31.3 3.3 3.4 31.2 13.7 4.1 23.3 2.7 25.0 27.7 2.3 2.3 25.6 13.0 4.8 8.6 23.4 12.1 84.2 19.2 4.2 25.3 0.0 15.0 1.7 5.6 0.0 21.9 2.9 13.7 12.9 12.0 22.4 4.9 3.6 17.3 6.4 4.7 1.4 TRAPPC11 "C4orf41, FLJ12716, foigr, gry" ENSG00000168538 "Trafficking protein particle complex 11" Q7Z392 4 183659267-183713594 "Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038173 Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA038173: " "unprognostic (2.24e-1)" "unprognostic (6.03e-2)" "unprognostic (9.92e-3)" "unprognostic (1.31e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "unprognostic (9.14e-2)" "unprognostic (6.24e-2)" "unprognostic (2.63e-1)" "unprognostic (6.50e-2)" "unprognostic (5.78e-2)" "unprognostic (2.17e-1)" "prognostic favorable (2.66e-5)" "unprognostic (6.59e-2)" "unprognostic (1.59e-1)" "unprognostic (2.25e-2)" "unprognostic (3.92e-2)" 18.3 28.1 14.0 14.2 24.5 11.5 17.8 21.8 24.7 17.0 16.1 19.3 10.9 12.2 19.8 16.1 18.3 17.4 12.9 15.6 15.5 12.6 17.5 18.9 15.2 16.7 14.4 15.1 24.9 16.7 27.9 31.3 21.2 17.1 16.9 17.5 17.0 19.7 14.8 26.0 18.0 16.5 18.2 12.8 15.2 17.4 17.3 14.8 26.2 17.2 10.7 19.3 22.1 16.8 4.2 10.5 6.4 18.8 8.0 6.6 5.7 9.3 9.1 15.0 14.8 18.9 20.9 11.4 13.7 13.9 11.6 10.7 5.6 12.1 12.9 3.9 13.8 9.0 6.8 13.6 13.0 13.4 14.2 5.9 16.2 7.8 7.9 17.4 17.4 16.1 16.0 14.0 11.5 13.5 15.2 16.9 15.2 12.9 27.0 14.4 6.7 20.8 8.4 5.6 6.4 6.8 14.5 8.9 9.7 14.8 9.6 10.2 13.5 13.4 13.9 13.4 14.0 10.7 19.3 16.9 6.6 7.8 6.3 7.7 14.1 7.6 7.8 13.5 11.7 11.5 3.1 10.3 6.4 5.0 12.2 6.6 4.2 5.4 5.2 10.5 3.1 5.1 5.2 2.9 8.0 18.8 2.7 4.3 5.7 14.0 24.5 21.8 24.7 15.5 12.6 14.4 15.1 17.1 14.8 3.0 12.6 5.2 2.5 3.9 10.7 12.6 10.2 14.7 10.3 7.0 7.9 6.4 3.3 6.8 38.8 6.7 8.4 0.0 8.0 7.3 5.8 5.3 7.0 7.8 10.3 7.9 12.6 10.4 14.6 2.0 12.4 10.0 3.3 10.0 7.9 8.0 7.6 5.8 10.6 4.3 12.5 0.0 4.8 6.0 14.7 5.4 5.8 7.9 8.5 4.8 TRAPPC2L HSPC176 ENSG00000167515 "Trafficking protein particle complex 2 like" Q9UL33 16 88856220-88862686 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041714 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA041714: AB_10793930" "unprognostic (1.27e-2)" "unprognostic (2.32e-3)" "unprognostic (1.46e-1)" "prognostic favorable (3.75e-4)" "unprognostic (2.77e-1)" "unprognostic (2.69e-1)" "unprognostic (5.24e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-1)" "unprognostic (6.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.81e-1)" "unprognostic (1.02e-2)" "unprognostic (1.18e-1)" "unprognostic (1.00e-1)" "unprognostic (5.81e-2)" "unprognostic (1.94e-2)" 22.7 46.1 29.5 18.6 29.2 19.8 22.4 15.9 37.4 18.5 21.8 25.5 16.0 16.2 15.8 40.4 17.4 19.0 25.0 26.0 22.9 24.4 20.2 21.9 13.9 24.3 24.9 22.5 21.5 25.6 8.7 16.0 13.7 22.1 15.8 15.7 20.0 17.3 17.3 53.8 19.0 14.7 14.1 27.3 18.3 21.5 33.9 18.1 11.5 19.2 25.1 16.6 16.1 16.4 41.2 45.6 10.8 39.0 24.6 47.7 40.9 16.1 11.3 19.2 14.5 14.4 18.4 19.8 14.6 16.6 22.5 8.6 31.4 21.3 12.4 25.8 18.5 23.7 17.3 26.1 20.9 16.4 10.8 15.6 8.2 11.3 39.6 21.4 23.2 6.6 17.8 13.2 30.3 15.4 12.8 18.0 28.2 24.6 9.9 15.4 50.3 31.0 72.0 19.3 31.0 21.1 29.8 16.0 12.8 17.2 18.7 20.8 10.2 49.3 15.2 13.3 11.1 39.0 24.8 14.2 15.0 16.4 19.6 16.5 14.0 23.7 57.5 17.9 34.8 17.8 10.0 39.0 10.8 34.0 31.2 34.2 41.2 39.2 36.6 37.7 35.2 36.9 31.4 6.8 24.6 29.7 45.6 47.7 40.9 29.5 29.2 15.9 37.4 22.9 24.4 24.9 22.5 22.1 18.1 53.6 71.3 55.9 50.7 46.0 33.8 99.4 96.8 84.3 56.9 50.6 9.8 81.9 203.9 107.9 165.4 58.3 90.1 23.3 135.1 126.2 77.9 44.2 34.7 115.6 192.6 14.3 59.6 60.8 93.2 316.5 68.4 63.6 77.6 140.7 65.3 52.4 118.4 69.1 54.8 205.0 32.3 58.2 87.6 150.3 142.7 56.8 64.8 59.5 70.9 46.7 TRAPPC3 BET3 ENSG00000054116 "Trafficking protein particle complex 3" O43617 1 36136570-36156053 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028408 Approved Approved "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA028408: AB_10601826" "unprognostic (3.54e-3)" "unprognostic (1.17e-1)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (2.88e-1)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.70e-6)" "unprognostic (7.39e-3)" "unprognostic (1.15e-1)" "unprognostic (7.12e-3)" "unprognostic (7.38e-2)" "unprognostic (2.94e-1)" "unprognostic (9.25e-3)" "unprognostic (2.61e-2)" "unprognostic (9.47e-2)" "unprognostic (2.10e-3)" "unprognostic (6.53e-2)" 28.7 53.5 31.9 29.4 31.9 17.8 41.0 27.3 33.6 28.4 33.6 21.9 33.6 24.3 28.9 46.3 39.7 27.8 33.4 39.4 26.3 29.4 39.7 36.6 26.0 24.4 28.7 26.1 19.9 37.0 29.0 32.4 42.8 30.2 29.9 31.7 28.8 30.8 35.6 34.2 32.4 27.2 36.6 26.8 28.3 31.1 33.7 23.3 28.0 48.4 35.6 37.4 32.4 38.6 37.6 52.6 56.9 55.4 35.9 51.6 55.6 32.7 23.8 16.1 24.9 42.0 33.9 31.6 30.2 38.7 36.2 35.2 19.6 31.7 14.0 28.7 33.1 28.7 24.4 24.6 40.4 41.3 27.3 37.8 26.1 27.7 28.4 49.2 27.3 27.8 28.9 35.5 33.7 33.2 37.6 45.1 36.9 31.5 23.7 43.4 25.3 32.1 25.6 21.4 27.5 35.2 22.6 22.8 31.3 45.7 27.1 24.5 17.9 24.6 27.8 47.8 43.4 17.9 20.6 33.5 21.3 24.2 41.5 40.0 29.0 29.2 22.9 36.5 30.9 21.4 54.0 53.1 56.9 36.3 55.4 37.5 37.6 43.2 38.1 52.6 33.9 41.9 37.8 53.9 35.9 43.6 43.3 51.6 55.6 31.9 31.9 27.3 33.6 26.3 29.4 28.7 26.1 30.2 23.3 23.8 28.8 54.4 94.1 89.8 39.6 51.3 50.9 22.7 23.9 36.6 15.7 128.6 144.2 122.4 210.9 67.3 56.3 23.3 162.6 126.4 66.1 106.5 45.0 39.5 127.5 50.9 46.3 27.6 50.2 99.5 39.7 66.2 91.1 134.3 44.1 49.9 150.1 66.2 48.8 80.1 23.0 32.3 57.1 95.6 83.7 108.0 160.1 47.9 48.6 103.8 TRAPPC4 "PTD009, SBDN, TRS23" ENSG00000196655 "Trafficking protein particle complex 4" Q9Y296 11 119018432-119025454 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039752, HPA041371" Approved Approved Cytosol NA NA Cytosol "HPA039752: AB_2676664, HPA041371: AB_2677439" "unprognostic (5.26e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (1.18e-2)" "unprognostic (9.42e-2)" "unprognostic (7.12e-3)" "prognostic unfavorable (2.03e-5)" "unprognostic (1.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.36e-2)" "unprognostic (4.34e-2)" "unprognostic (2.01e-2)" "unprognostic (7.49e-3)" "unprognostic (3.64e-1)" "unprognostic (1.17e-1)" "unprognostic (6.28e-2)" "unprognostic (1.32e-1)" 20.4 26.8 17.1 11.8 21.2 16.3 14.8 15.6 20.1 16.1 20.4 16.1 33.7 20.4 13.6 20.4 16.3 14.3 19.4 15.4 16.1 20.1 30.1 20.3 16.3 15.3 17.5 16.2 16.4 19.4 11.9 21.1 16.2 16.5 20.2 13.8 16.2 14.4 24.8 26.4 12.7 23.8 14.5 17.1 15.5 18.1 19.6 12.1 16.4 18.2 10.0 18.1 18.1 10.6 29.9 28.6 39.7 28.0 26.3 47.2 29.4 7.8 8.1 9.2 9.5 11.3 7.9 4.3 31.5 17.3 19.3 15.5 18.7 3.2 9.1 22.3 11.7 14.2 7.4 14.1 11.5 14.8 16.4 8.5 15.3 7.8 20.5 16.3 12.2 7.7 11.4 10.4 18.5 14.0 13.0 16.7 10.9 17.0 3.6 11.1 17.9 13.9 11.7 7.3 16.2 22.2 12.6 7.2 10.9 13.4 10.3 3.5 8.6 6.1 6.9 7.6 11.5 28.3 11.0 12.3 5.3 10.3 6.6 10.2 5.0 9.5 22.7 5.9 9.8 8.7 29.8 20.8 39.7 28.9 22.9 29.3 29.9 33.7 32.9 20.0 26.7 31.4 34.0 17.9 26.3 28.0 28.6 47.2 29.4 17.1 21.2 15.6 20.1 16.1 20.1 17.5 16.2 16.5 12.1 35.7 33.8 45.4 44.7 45.6 57.7 26.6 40.8 57.6 26.1 68.0 13.7 80.8 119.3 82.0 34.8 45.8 33.3 23.3 66.2 46.8 39.3 43.2 60.1 17.8 69.7 36.5 64.9 38.6 20.9 10.4 41.1 30.8 28.7 109.2 29.3 83.4 80.0 31.7 57.3 132.7 51.2 45.3 43.2 88.9 76.0 51.6 73.0 53.2 32.6 39.9 TRAPPC8 "GSG1, HsT2706, KIAA1012, TRS85" ENSG00000153339 "Trafficking protein particle complex 8" Q9Y2L5 18 31829173-31953136 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041107 Approved Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA041107: AB_10793869" "unprognostic (4.04e-1)" "unprognostic (4.35e-2)" "unprognostic (2.62e-3)" "unprognostic (9.80e-2)" "unprognostic (8.18e-2)" "unprognostic (4.06e-2)" "unprognostic (9.68e-2)" "unprognostic (1.37e-1)" "unprognostic (7.67e-3)" "unprognostic (4.42e-2)" "unprognostic (3.00e-1)" "unprognostic (6.35e-3)" "prognostic favorable (1.85e-9)" "unprognostic (3.55e-2)" "unprognostic (7.03e-2)" "unprognostic (4.26e-1)" "unprognostic (2.92e-1)" 16.2 17.0 12.9 18.1 16.5 13.6 15.4 20.8 19.5 16.0 18.1 16.3 15.3 15.0 16.9 13.0 18.8 14.8 13.8 15.5 12.9 12.1 20.1 26.4 14.1 17.5 15.6 12.7 14.5 15.7 24.1 19.8 19.3 19.2 14.8 16.6 17.5 17.0 17.5 25.0 20.5 25.5 15.1 14.6 19.8 15.7 40.7 13.6 28.2 18.7 13.3 19.0 16.1 18.7 2.7 2.8 9.9 2.8 3.0 4.3 1.1 8.2 7.1 8.2 6.3 12.5 12.0 9.1 11.0 11.8 10.4 10.3 4.8 6.3 11.7 8.9 10.7 9.4 12.8 11.9 6.2 14.5 13.3 5.6 9.7 7.1 6.0 9.6 28.2 11.5 10.6 8.7 9.6 14.0 11.6 11.8 9.9 14.1 10.9 10.4 5.7 12.0 9.8 8.3 24.3 6.1 12.8 9.8 12.4 10.4 13.1 6.4 7.5 14.1 8.5 9.9 13.8 9.4 12.5 14.2 11.1 5.5 4.0 6.7 13.9 15.4 17.6 10.7 12.4 11.3 9.9 2.7 2.8 2.0 2.8 4.3 2.5 2.7 2.4 2.8 2.7 2.4 2.6 4.5 3.0 2.7 2.1 2.9 1.1 12.9 16.5 20.8 19.5 12.9 12.1 15.6 12.7 19.2 13.6 26.8 10.8 12.4 8.3 16.0 12.7 18.9 30.6 18.7 15.9 10.4 27.5 8.9 1.7 9.0 30.5 11.3 20.6 0.0 8.1 8.4 11.0 13.5 3.5 30.6 14.4 11.1 12.1 20.9 24.8 32.3 14.4 11.3 10.1 10.8 13.2 11.0 12.1 8.6 8.9 12.1 22.8 12.9 7.5 81.7 43.9 23.7 17.2 11.7 11.0 12.8 TRDN ENSG00000186439 Triadin Q13061 6 123216339-123637093 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 855.7;Muller glia cells: 805.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "basophil: 2.9" "Lineage enriched" "Detected in single" 30 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "HAP1: 1.6;K-562: 1.8;MCF7: 6.1;SCLC-21H: 1.2;SK-BR-3: 2.0" "Region enriched" "Detected in single" 10 "olfactory region: 13.6" "HPA038226, HPA058226" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038226: AB_10795574, HPA058226: AB_2683643" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.20e-2)" "unprognostic (3.06e-3)" "unprognostic (2.40e-1)" "unprognostic (2.38e-1)" "unprognostic (2.42e-1)" "unprognostic (8.42e-2)" "unprognostic (8.71e-2)" "unprognostic (9.93e-3)" "unprognostic (2.12e-1)" "unprognostic (2.55e-2)" "unprognostic (3.97e-2)" 3.8 0.4 0.4 0.0 0.5 0.0 0.3 0.2 0.2 0.3 0.1 0.0 0.7 0.1 0.3 9.2 3.0 1.9 0.1 52.8 1.6 1.3 0.1 0.1 0.1 0.1 1.6 0.1 1.5 0.1 0.0 3.2 0.1 1.3 1.9 0.1 1.3 2.0 0.2 215.5 0.1 0.1 0.2 3.4 0.1 0.1 0.7 0.5 0.0 1.2 80.1 1.6 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 6.1 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 1.6 1.3 1.6 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 5.8 855.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 40.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.9 12.0 0.0 1.7 0.0 0.0 805.6 0.0 0.0 10.6 0.0 13.4 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 TREML1 "dJ238O23.3, TLT1" ENSG00000161911 "Triggering receptor expressed on myeloid cells like 1" Q86YW5 6 41149342-41154337 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7" "Cell type enriched" "Detected in some" 11 "monocytes: 44.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 19.2" "Lineage enriched" "Detected in single" 31 "granulocytes: 19.2" "Cell line enriched" "Detected in single" 167 "HEL: 38.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016700, HPA017860" Enhanced Approved "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" NA NA 94000000 "Nuclear speckles, Cytosol" "Golgi apparatus, Plasma membrane" "HPA016700: AB_1858262, HPA017860: AB_1858261" "unprognostic (6.70e-2)" "unprognostic (3.50e-3)" "unprognostic (1.15e-3)" "unprognostic (1.62e-1)" "unprognostic (3.48e-2)" "unprognostic (4.53e-5)" "unprognostic (1.10e-2)" "unprognostic (2.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.12e-3)" "unprognostic (2.34e-2)" "unprognostic (7.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.36e-1)" "unprognostic (8.38e-2)" "unprognostic (7.51e-2)" "unprognostic (3.41e-2)" 1.2 1.2 2.1 3.7 1.2 10.5 0.6 0.5 1.3 0.4 0.3 0.3 0.3 0.0 0.3 0.6 0.3 0.6 1.3 10.0 2.1 1.6 0.3 0.3 2.9 7.7 3.3 0.3 1.9 0.5 0.2 0.6 1.7 1.2 0.3 1.3 0.6 1.3 0.3 0.8 0.3 0.4 0.3 4.3 26.7 0.2 0.8 0.3 1.4 0.6 0.3 7.1 1.1 0.3 0.1 0.3 19.2 0.6 0.0 0.2 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 38.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.6 0.8 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 3.9 0.0 0.1 0.3 0.0 37.9 2.1 1.2 0.5 0.7 2.1 1.6 3.3 0.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRERF1 "BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132" ENSG00000124496 "Transcriptional regulating factor 1" Q96PN7 6 42224931-42452051 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 20.8;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 55.1" "Low region specificity" "Detected in all" "HPA027771, HPA051273, HPA059943" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173" "unprognostic (5.85e-3)" "unprognostic (4.38e-2)" "unprognostic (2.39e-1)" "unprognostic (3.28e-3)" "unprognostic (6.64e-2)" "unprognostic (3.92e-3)" "unprognostic (1.19e-1)" "unprognostic (1.58e-2)" "unprognostic (2.05e-4)" "unprognostic (2.67e-1)" "unprognostic (1.16e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (3.67e-5)" "unprognostic (8.60e-2)" "unprognostic (5.39e-2)" "unprognostic (6.05e-2)" "unprognostic (2.78e-2)" 4.9 8.7 9.3 7.7 8.7 16.7 4.0 18.1 10.8 12.0 5.1 2.9 9.7 4.2 10.0 4.0 12.6 7.2 6.9 2.8 4.5 3.9 5.2 1.4 4.0 9.2 2.5 4.7 10.2 2.5 7.5 9.3 3.4 3.5 8.8 4.7 7.3 3.7 5.2 1.3 8.4 6.6 8.6 4.9 9.0 5.6 11.2 4.8 23.4 3.3 3.6 12.7 13.3 11.0 0.4 1.4 8.1 1.1 2.7 3.0 1.1 5.2 3.6 4.1 5.2 1.9 4.3 5.8 4.0 6.4 4.6 3.8 0.0 2.8 4.9 0.8 6.0 6.3 6.3 5.2 4.9 3.7 55.1 0.4 5.2 3.0 0.0 1.3 9.6 16.9 1.7 6.9 4.1 1.6 4.1 0.0 3.3 0.0 1.6 2.0 1.1 2.4 16.4 4.5 3.8 3.8 4.5 0.3 1.8 2.7 6.5 3.3 1.7 2.4 0.0 0.4 2.3 2.3 13.1 1.7 2.6 3.0 4.2 1.1 0.6 3.5 5.3 1.7 8.8 0.0 2.1 1.1 8.1 3.0 0.4 2.9 0.4 2.2 2.7 1.4 0.0 1.9 2.0 3.8 2.7 0.2 1.2 2.1 1.1 9.3 8.7 18.1 10.8 4.5 3.9 2.5 4.7 3.5 4.8 3.0 2.2 0.8 2.6 7.3 10.8 1.6 2.5 4.0 5.7 5.2 0.0 2.7 0.0 1.3 2.3 3.8 2.3 0.0 0.9 0.7 7.0 1.7 11.5 0.0 2.7 7.9 2.9 8.0 4.4 2.0 13.0 5.8 3.3 1.8 1.9 4.9 0.9 2.9 20.8 0.2 0.5 25.8 4.4 2.4 6.1 6.5 1.0 7.0 2.8 3.4 TREX1 "AGS1, DRN3" ENSG00000213689 "Three prime repair exonuclease 1" Q9NSU2 3 48465811-48467645 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Exonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease mutation, Neurodegeneration, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 8.0;Cardiomyocytes: 5.0;Melanocytes: 23.6;Smooth muscle cells: 7.6;Suprabasal keratinocytes: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 30.9" "Low region specificity" "Detected in all" "HPA035437, HPA046721" Supported Supported Cytosol NA NA Cytosol "HPA035437: AB_10672092, HPA046721: AB_2732531" 14.2 14.3 16.7 14.6 10.6 20.7 17.2 13.0 16.9 13.4 11.0 12.8 17.5 10.3 8.1 14.9 16.6 14.5 12.3 9.8 14.4 14.2 11.6 12.7 12.5 26.2 14.6 17.4 7.3 13.0 6.8 31.2 11.6 11.2 15.4 9.3 10.8 32.2 19.3 10.8 22.9 10.9 8.2 12.6 25.5 12.4 4.6 10.1 18.5 7.4 18.3 21.7 13.3 10.6 24.9 35.5 23.3 41.8 8.6 13.1 20.1 8.0 7.4 6.2 4.4 7.7 7.9 0.0 2.6 13.1 22.0 30.9 0.1 9.6 9.5 5.4 11.1 20.8 9.4 0.4 11.8 3.1 8.0 0.7 5.5 26.5 0.4 9.7 5.0 3.9 6.9 1.1 11.1 4.4 4.5 9.3 6.6 0.0 14.6 9.3 0.1 7.0 3.6 0.0 4.7 4.6 5.8 1.6 18.5 5.8 1.6 0.0 3.7 9.6 13.0 6.3 0.4 0.4 8.4 9.8 4.1 3.9 8.7 6.1 11.8 6.8 4.0 9.1 10.7 3.3 2.1 41.8 3.0 9.8 32.5 5.6 24.6 13.1 9.4 35.5 24.9 12.4 10.3 23.3 8.6 24.3 28.0 11.6 20.1 16.7 10.6 13.0 16.9 14.4 14.2 14.6 17.4 11.2 10.1 0.0 0.3 0.0 0.0 8.0 0.0 5.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 12.2 0.0 0.0 0.0 0.0 TRIB1 "C8FW, GIG2, TRB1" ENSG00000173334 "Tribbles pseudokinase 1" Q96RU8 8 125430321-125438405 "Enzymes, Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 84.2;thyroid gland: 90.7" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 192.3;Basal glandular cells: 267.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1" "Group enriched" "Detected in many" 11 "granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1" "Cell line enhanced" "Detected in many" "HEL: 55.1;U-266/70: 33.8;U-266/84: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063982 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA063982: AB_2685165" "unprognostic (1.90e-3)" "unprognostic (1.45e-1)" "unprognostic (8.80e-3)" "unprognostic (1.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.57e-2)" "unprognostic (4.12e-2)" "unprognostic (1.62e-2)" "unprognostic (6.81e-3)" "unprognostic (9.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.94e-1)" "unprognostic (1.04e-2)" "unprognostic (5.55e-2)" "unprognostic (2.08e-2)" 26.7 6.5 5.9 17.6 6.5 84.2 13.3 4.3 6.1 10.4 12.4 4.4 6.6 4.9 6.2 6.7 10.9 10.9 21.0 11.1 4.3 4.0 16.6 63.5 28.9 14.6 4.2 3.9 6.4 23.6 20.9 7.2 15.5 4.5 12.1 13.3 15.0 14.5 9.1 22.3 10.4 16.9 11.3 3.1 15.9 18.5 5.6 3.1 9.2 90.7 17.6 12.1 12.4 9.0 0.2 0.5 10.8 3.7 0.0 3.1 0.1 4.1 4.7 0.6 1.3 1.3 2.7 7.5 2.7 3.8 2.0 0.6 6.3 5.5 7.5 2.5 1.9 12.1 3.1 2.0 2.6 1.7 3.3 9.9 55.1 2.1 12.3 3.5 27.5 5.0 2.6 4.0 8.2 18.8 9.8 5.8 0.1 4.8 24.0 0.2 4.4 2.5 4.3 4.6 9.9 9.2 5.2 0.9 8.2 16.2 15.8 4.0 1.5 6.6 7.2 26.2 4.3 1.9 1.3 3.0 2.2 2.8 2.1 3.3 33.8 33.7 10.5 3.9 0.2 5.1 0.0 0.9 10.8 0.0 1.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 5.8 0.0 3.7 0.3 3.1 0.1 5.9 6.5 4.3 6.1 4.3 4.0 4.2 3.9 4.5 3.1 125.0 192.3 11.2 267.7 89.0 20.4 14.4 17.8 33.5 64.8 15.7 0.0 9.2 10.0 31.3 0.4 32.9 172.0 0.0 21.2 17.2 32.4 153.9 29.9 128.8 29.9 20.6 107.4 8.6 53.9 1.4 0.3 47.3 54.0 40.5 87.2 21.4 42.4 51.5 0.4 21.6 3.4 0.0 14.4 0.0 1.3 56.1 25.6 4.5 56.6 79.9 TRIB2 "GS3955, TRB2" ENSG00000071575 "Tribbles pseudokinase 2" Q92519 2 12716889-12742734 "Enzymes, Predicted membrane proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 89.7;Muller glia cells: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 24.8" "Group enriched" "Detected in many" 9 "B-cells: 7.1;NK-cells: 9.5;T-cells: 24.8" "Cell line enhanced" "Detected in many" "AN3-CA: 41.0;HEL: 40.3;K-562: 54.8;SK-MEL-30: 40.0;WM-115: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001305 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001305: AB_1080371" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (4.31e-3)" "unprognostic (1.86e-3)" "unprognostic (6.68e-3)" "unprognostic (3.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.80e-2)" "unprognostic (3.32e-2)" "unprognostic (2.52e-3)" "unprognostic (1.67e-2)" "unprognostic (1.08e-3)" "unprognostic (1.30e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-2)" "unprognostic (2.13e-2)" 19.6 30.9 13.2 17.7 13.3 7.0 23.2 23.2 23.0 10.8 12.3 10.5 6.7 8.7 23.0 22.6 8.1 11.6 14.5 18.2 15.0 10.8 24.8 10.6 18.9 33.0 13.4 16.2 52.3 14.4 6.6 11.3 23.0 15.5 16.3 6.9 35.7 9.9 13.6 6.9 8.2 11.9 17.6 10.4 38.9 19.5 13.9 10.1 37.3 12.1 6.2 33.4 21.9 23.2 7.1 0.6 1.5 0.1 9.5 24.8 4.5 0.0 0.0 31.3 41.0 11.3 10.4 0.0 1.7 1.6 1.1 1.8 0.2 3.4 3.5 1.2 3.7 0.2 0.5 2.3 3.5 0.9 3.9 6.4 40.3 0.1 0.6 14.0 2.2 15.4 9.6 3.6 4.5 1.2 11.1 4.9 5.3 54.8 0.0 1.7 0.3 5.1 9.6 14.8 1.5 4.0 0.0 10.4 1.4 7.1 5.1 26.9 12.8 0.2 1.6 40.0 9.8 0.0 0.2 3.0 14.9 7.5 0.1 3.8 0.0 0.0 5.0 8.0 7.9 54.9 0.8 0.1 1.5 7.3 0.0 8.8 5.3 14.4 7.7 0.6 7.1 8.5 5.2 0.3 9.5 0.1 0.0 24.8 4.5 13.2 13.3 23.2 23.0 15.0 10.8 13.4 16.2 15.5 10.1 3.0 8.8 8.0 10.2 5.5 46.7 13.3 20.4 6.7 11.4 15.7 29.5 1.9 6.6 13.3 3.9 36.4 0.0 0.0 89.7 0.1 7.1 10.3 33.5 5.4 4.4 19.1 0.0 63.3 5.3 10.7 71.7 2.5 28.7 1.8 0.0 115.1 49.1 0.0 70.0 0.7 66.1 51.8 22.5 0.9 2.7 4.6 0.7 20.8 0.0 11.1 TRIM11 "BIA1, RNF92" ENSG00000154370 "Tripartite motif containing 11" Q96F44 1 228393673-228406840 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 105.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028541, HPA043879" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028541: AB_10600833, HPA043879: AB_2678711" "unprognostic (1.73e-1)" "unprognostic (9.73e-3)" "unprognostic (5.48e-3)" "unprognostic (7.73e-2)" "unprognostic (3.27e-1)" "unprognostic (2.33e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.08e-1)" "unprognostic (9.74e-2)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (3.15e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.40e-2)" "unprognostic (4.89e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-2)" 8.8 9.2 8.9 13.8 16.5 33.2 23.8 45.2 11.5 8.7 11.2 6.4 15.1 10.1 8.7 10.6 13.3 9.4 13.9 6.9 9.2 8.5 7.7 7.1 27.5 18.6 9.0 8.0 9.0 11.9 8.5 7.2 9.4 7.1 10.5 9.7 6.0 14.4 18.2 5.0 12.5 11.8 8.6 6.0 16.5 12.6 9.5 7.8 20.0 9.0 9.7 13.1 9.5 24.3 6.4 6.9 10.0 11.4 9.4 11.8 5.4 13.9 13.2 7.1 9.7 5.4 4.4 33.6 9.1 6.1 10.6 8.5 16.1 12.2 10.5 10.2 6.1 7.0 22.7 8.6 8.8 4.5 11.6 20.6 8.7 12.2 8.6 14.6 10.9 13.2 6.0 14.0 11.0 5.5 5.4 5.2 17.2 19.7 13.5 5.4 9.0 13.2 17.2 18.1 11.8 11.7 13.0 6.4 12.6 6.9 17.1 11.9 21.8 7.6 21.6 12.0 3.0 15.3 18.3 5.8 6.8 9.5 15.7 18.8 13.9 9.2 9.2 8.4 8.8 10.6 6.1 6.9 8.3 9.6 8.2 10.2 5.8 10.7 11.8 6.9 6.4 6.3 8.4 10.0 9.4 11.4 5.5 9.8 5.4 8.9 16.5 45.2 11.5 9.2 8.5 9.0 8.0 7.1 7.8 3.0 7.2 3.9 12.3 14.1 12.6 2.8 7.6 4.0 7.9 1.8 2.0 13.8 14.9 13.0 105.9 8.3 22.7 0.0 9.7 12.0 7.0 15.1 5.7 4.9 10.0 4.8 13.8 6.7 10.0 12.4 8.9 9.7 5.0 25.2 16.1 8.1 14.3 17.3 7.1 6.3 1.7 6.5 9.7 5.5 11.8 16.9 47.9 24.9 13.4 22.9 TRIM15 "RNF93, ZNF178, ZNFB7" ENSG00000204610 "Tripartite motif containing 15" Q9C019 6 30163206-30172696 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "gallbladder: 12.1;intestine: 29.3;liver: 14.1" "Cell type enhanced" "Detected in some" 18 "Enterocytes: 70.3;Mucus-secreting cells: 18.4;Paneth cells: 56.1;Proximal tubular cells: 18.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "HEL: 19.5" "Low region specificity" "Detected in all" HPA047527 Uncertain Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA047527: " "unprognostic (2.61e-1)" "unprognostic (1.54e-1)" "unprognostic (1.85e-1)" "unprognostic (1.71e-1)" "unprognostic (5.36e-2)" "unprognostic (1.92e-2)" "unprognostic (7.57e-4)" "unprognostic (5.27e-2)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (3.83e-1)" "unprognostic (1.63e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 8.6 0.0 0.2 0.2 0.0 12.1 0.0 0.0 0.0 4.3 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 29.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 70.3 0.0 1.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 5.7 56.1 0.0 18.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 10.6 0.0 TRIM16 EBBP ENSG00000221926 "Tripartite motif containing 16" O95361 17 15627960-15684311 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 52.9" "Cell type enhanced" "Detected in many" 8 "Pancreatic endocrine cells: 96.1;Suprabasal keratinocytes: 67.9;Urothelial cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "T-reg: 25.1" "Lineage enriched" "Detected in many" 11 "T-cells: 25.1" "Cell line enhanced" "Detected in many" "A549: 58.6;HaCaT: 47.3;HeLa: 42.7;OE19: 74.3" "HPA023623, HPA066431" Uncertain Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (9.61e-2)" "unprognostic (1.31e-2)" "unprognostic (6.19e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.94e-3)" "unprognostic (3.75e-2)" "unprognostic (4.65e-1)" "unprognostic (3.31e-3)" "unprognostic (1.70e-1)" "unprognostic (2.16e-3)" "unprognostic (2.08e-1)" "unprognostic (8.48e-2)" "unprognostic (9.21e-3)" "prognostic unfavorable (6.71e-4)" 6.1 13.5 7.4 4.8 12.8 7.0 6.7 7.4 11.7 16.0 5.0 7.8 6.6 10.2 7.0 2.8 52.9 4.0 7.5 6.5 8.0 4.4 5.7 2.2 6.2 10.9 11.3 5.6 3.7 6.2 1.9 5.7 15.8 9.8 4.1 5.2 5.0 14.7 5.7 11.4 15.6 5.5 5.4 5.9 4.6 14.4 5.5 7.8 4.7 7.4 5.3 16.3 11.7 23.3 0.4 1.5 0.6 2.3 0.5 25.1 1.3 18.3 58.6 1.8 4.0 8.7 10.0 2.0 3.0 10.8 3.8 5.3 3.5 24.0 2.0 11.6 13.3 22.7 47.3 5.3 13.6 2.5 24.3 3.4 0.9 42.7 1.9 14.5 1.0 2.0 5.5 8.6 8.3 4.8 10.6 8.1 2.3 1.1 9.6 10.2 6.5 4.0 2.3 2.7 74.3 3.5 1.7 15.1 1.4 19.4 23.9 1.3 3.8 13.4 15.2 4.5 11.1 2.3 2.5 12.5 4.8 5.7 2.3 10.4 2.3 2.5 0.1 7.4 2.5 12.1 0.1 2.3 0.6 0.8 0.6 0.5 0.3 3.0 0.9 1.5 0.4 0.8 1.6 0.5 0.5 0.3 0.3 25.1 1.3 7.4 12.8 7.4 11.7 8.0 4.4 11.3 5.6 9.8 7.8 35.7 1.6 3.7 46.8 27.4 6.4 8.8 10.2 5.3 12.5 10.4 17.7 12.0 0.0 46.8 0.8 16.1 4.3 0.0 15.3 6.7 10.5 16.4 4.6 2.4 3.5 3.2 4.1 3.7 2.6 2.0 6.6 4.4 6.8 18.0 16.5 6.7 96.1 24.6 4.2 3.7 8.7 6.5 8.3 7.6 11.5 67.9 3.9 5.7 13.3 116.8 TRIM16L TRIM70 ENSG00000108448 "Tripartite motif containing 16 like" Q309B1 17 18697998-18736118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 22.5" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 44.3;HaCaT: 22.6;HeLa: 35.4;OE19: 51.5" HPA066431 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA066431: AB_2685668" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (2.00e-1)" "unprognostic (7.89e-3)" "unprognostic (5.66e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.08e-2)" "unprognostic (5.79e-2)" "unprognostic (6.28e-2)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" 2.8 4.4 2.0 1.0 3.1 0.5 7.1 1.0 3.0 2.2 3.6 1.3 1.0 2.0 1.4 3.2 10.5 3.3 8.1 16.8 2.0 2.5 3.5 2.8 2.4 1.0 4.7 1.0 1.3 1.3 0.1 1.0 1.8 3.1 3.6 1.0 2.1 2.6 3.7 22.5 0.8 1.1 6.5 4.7 1.0 3.0 2.9 1.4 1.0 4.5 12.7 3.4 6.7 11.8 1.5 0.8 0.4 1.4 2.7 2.1 1.8 4.7 44.3 0.2 1.9 5.4 2.2 3.5 0.4 3.7 1.6 3.3 0.8 19.1 0.5 3.5 12.7 8.8 22.6 0.5 1.0 0.8 0.1 0.6 0.3 35.4 0.4 13.3 0.0 0.4 2.3 1.3 2.4 0.9 7.0 0.5 0.4 0.0 0.0 4.3 4.7 0.1 0.5 0.4 51.5 0.9 0.5 2.3 0.0 3.2 2.8 0.1 1.0 5.0 1.0 2.7 0.3 2.3 0.3 9.9 1.1 5.7 1.8 6.3 0.5 0.5 0.0 3.7 0.4 8.4 0.1 0.7 0.4 0.7 1.4 1.0 1.5 1.0 0.6 0.8 1.1 1.6 1.5 0.3 2.7 0.5 0.2 2.1 1.8 2.0 3.1 1.0 1.9 2.0 2.5 4.7 1.0 3.1 1.4 6.0 3.2 0.8 8.5 3.4 2.7 5.5 10.2 8.1 1.2 1.8 7.9 2.0 3.3 9.0 0.5 2.6 0.9 0.0 5.3 3.7 2.5 3.8 3.5 2.5 1.4 3.2 2.4 2.5 3.4 0.7 3.4 2.1 0.0 15.4 3.2 3.5 21.6 0.0 1.8 6.8 2.4 0.0 2.8 3.2 5.6 5.6 0.9 1.3 3.4 6.3 TRIM25 "EFP, RNF147, ZNF147" ENSG00000121060 "Tripartite motif containing 25" Q14258 17 56887909-56914038 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Ligase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 20.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 20.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005909 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 35000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA005909: AB_1078722" "unprognostic (8.73e-3)" "unprognostic (1.57e-2)" "unprognostic (2.06e-2)" "unprognostic (6.06e-2)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (1.53e-1)" "unprognostic (4.23e-1)" "unprognostic (1.15e-1)" "prognostic favorable (3.36e-4)" "unprognostic (3.23e-1)" "unprognostic (3.11e-2)" "prognostic favorable (9.35e-4)" "unprognostic (5.21e-2)" "unprognostic (5.13e-2)" "unprognostic (7.39e-2)" 20.0 19.7 7.5 23.6 8.9 32.6 19.3 11.6 7.8 15.3 22.5 5.0 8.0 15.3 13.4 12.6 17.7 15.3 18.4 8.3 5.8 6.3 10.1 27.0 20.8 15.9 6.7 5.5 13.3 15.3 13.6 11.5 55.0 7.4 12.2 14.3 12.5 14.5 11.5 11.7 23.1 20.7 10.1 5.2 35.8 14.1 12.8 6.5 26.2 11.8 15.1 18.5 10.6 35.9 1.7 2.4 20.0 2.3 0.8 1.5 0.7 28.5 14.2 3.5 11.8 26.5 22.4 0.0 11.3 22.9 27.1 23.3 13.8 15.7 27.9 23.5 10.8 29.6 17.0 17.0 15.2 15.2 23.8 13.5 18.0 11.0 15.3 22.7 21.5 13.0 10.0 25.6 14.1 30.0 12.9 17.9 19.2 4.4 17.1 13.7 19.1 24.0 15.5 2.2 23.7 27.6 17.2 11.7 17.6 15.8 22.6 6.8 6.4 8.9 14.3 26.2 2.3 19.4 17.5 11.9 12.7 9.1 19.5 11.7 9.7 18.5 4.6 12.3 14.8 4.9 3.0 2.3 0.9 0.9 1.9 1.1 1.7 0.8 0.8 2.4 1.4 0.6 0.8 20.0 0.8 1.4 1.7 1.5 0.7 7.5 8.9 11.6 7.8 5.8 6.3 6.7 5.5 7.4 6.5 32.8 17.5 11.5 7.3 16.5 8.7 7.0 12.7 20.1 20.5 8.7 27.5 4.1 0.0 16.7 2.1 22.4 32.6 0.0 18.7 8.3 7.8 14.6 3.5 28.7 12.5 3.2 17.9 28.3 31.6 1.2 8.9 23.3 13.5 5.4 26.1 5.2 26.1 26.4 8.9 6.3 19.2 6.5 6.4 0.3 0.0 26.7 13.3 8.6 21.8 16.6 TRIM26 "RNF95, ZNF173" ENSG00000234127 "Tripartite motif containing 26" Q12899 6 30184455-30213427 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044975, HPA050456" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044975: AB_2679162, HPA050456: AB_2681133" "unprognostic (1.93e-1)" "unprognostic (5.41e-2)" "unprognostic (8.53e-2)" "unprognostic (1.96e-3)" "unprognostic (1.52e-1)" "unprognostic (5.50e-2)" "unprognostic (2.02e-1)" "unprognostic (1.40e-2)" "unprognostic (2.85e-1)" "unprognostic (3.08e-2)" "unprognostic (1.97e-1)" "unprognostic (7.00e-3)" "unprognostic (1.37e-2)" "unprognostic (1.63e-3)" "unprognostic (5.21e-2)" "unprognostic (8.82e-2)" "prognostic favorable (3.25e-5)" 11.9 12.6 10.6 20.0 12.2 13.8 13.2 17.6 14.9 10.7 16.1 15.9 14.5 18.5 12.9 18.4 21.5 21.1 18.6 8.4 10.8 11.3 19.5 19.2 12.2 21.3 13.1 8.1 10.9 15.3 16.3 11.5 10.8 12.3 13.4 9.8 17.7 18.4 20.6 9.9 21.5 21.9 14.2 13.1 17.6 15.2 10.9 14.0 13.7 15.8 10.7 21.7 14.7 24.6 3.6 3.8 1.7 4.2 2.1 4.1 3.6 10.2 2.2 0.0 14.5 4.8 2.9 4.8 2.8 3.3 7.3 7.2 0.0 0.4 23.0 8.3 7.1 10.1 11.7 0.0 10.0 2.3 0.0 6.7 3.6 1.6 8.3 4.5 4.5 2.9 3.0 3.5 7.3 4.6 0.0 4.5 11.0 1.6 0.0 0.0 0.0 7.5 11.1 0.0 0.0 3.9 9.9 6.9 3.4 6.0 9.6 0.4 6.2 10.6 4.6 2.9 2.5 3.6 1.5 7.6 5.6 3.9 0.0 0.1 9.2 16.4 12.1 0.0 13.0 9.0 1.7 3.1 0.5 3.9 4.2 3.2 3.2 2.9 3.8 3.8 3.6 1.8 2.7 1.7 2.1 2.6 1.9 4.1 3.6 10.6 12.2 17.6 14.9 10.8 11.3 13.1 8.1 12.3 14.0 26.8 17.1 17.1 21.1 26.8 20.4 11.8 22.9 28.1 13.6 12.2 15.7 16.4 10.0 13.3 0.3 16.1 16.5 0.0 13.7 10.8 12.8 21.2 4.7 45.0 12.2 12.7 21.5 8.6 13.2 1.3 6.9 20.9 16.9 17.2 13.7 11.2 10.2 14.2 11.3 13.0 18.9 6.5 12.5 2.4 12.6 29.6 14.8 22.4 13.3 19.5 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111275-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 97.6;Basal keratinocytes: 241.7;Suprabasal keratinocytes: 402.6;Urothelial cells: 144.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Region enriched" "Detected in single" 8 "pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 54.2;hTCEpi: 72.1;RT4: 28.5;SiHa: 40.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020053, HPA074841" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA020053: AB_1858280, HPA074841: " "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favorable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 0.3 0.2 0.1 0.0 0.1 0.1 7.3 0.0 0.1 30.4 0.6 0.2 1.6 0.3 3.1 2.9 176.3 3.7 0.8 0.1 0.1 0.1 0.5 0.4 1.4 0.0 0.0 0.0 0.4 0.2 0.0 2.2 24.4 1.1 11.1 0.5 0.0 25.5 4.8 0.9 90.1 0.2 1.6 0.3 0.0 0.2 0.7 0.0 7.5 0.1 113.6 93.6 9.6 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.4 0.0 0.8 0.0 0.1 54.2 0.0 12.4 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 72.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.5 0.2 0.9 40.5 5.7 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.0 97.6 241.7 0.0 1.1 2.5 33.5 13.6 0.0 0.0 37.9 0.0 1.3 21.4 0.4 2.1 0.0 3.9 5.0 5.4 34.5 1.1 0.0 4.4 0.0 2.4 0.0 0.0 78.0 0.6 1.7 21.9 0.0 2.3 0.0 33.2 0.8 0.0 0.2 0.0 0.0 7.2 0.6 1.4 402.6 20.7 0.0 1.4 144.0 TRIM36 "HAPRIN, RBCC728, RNF98" ENSG00000152503 "Tripartite motif containing 36" Q9NQ86 5 115124762-115180546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 88.8" "Group enriched" "Detected in many" 39 "Early spermatids: 1875.0;Late spermatids: 3810.8" "Cancer enhanced" "Detected in many" "prostate cancer: 9.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 7.5;non-classical monocyte: 7.7" "Group enriched" "Detected in many" 43 "dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7" "Cell line enhanced" "Detected in many" "RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061321 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA061321: AB_2684479" "unprognostic (6.36e-2)" "unprognostic (2.99e-1)" "unprognostic (4.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.31e-2)" "unprognostic (5.33e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (1.84e-1)" "unprognostic (1.90e-1)" "unprognostic (2.82e-13)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-1)" "unprognostic (6.80e-3)" 1.0 1.4 6.8 1.4 7.6 0.8 3.2 0.6 11.7 1.4 4.8 7.7 0.0 8.2 1.1 1.0 0.8 1.9 1.0 0.7 10.1 7.2 0.9 0.9 1.6 0.8 7.1 8.6 3.5 1.5 0.7 8.2 1.3 18.3 5.7 4.8 5.1 1.0 1.0 0.7 1.0 7.9 1.1 8.7 0.9 2.0 88.8 4.7 0.0 0.8 0.0 0.9 0.8 1.0 0.1 7.5 4.2 7.7 0.0 0.0 0.8 2.4 0.7 1.2 6.2 0.1 0.1 1.5 0.5 2.1 1.1 1.3 0.9 1.2 0.0 1.0 0.1 8.8 0.6 5.8 1.1 0.8 0.4 1.9 4.3 2.5 1.2 0.2 4.2 3.6 0.1 1.1 0.5 1.5 1.4 0.0 8.2 0.1 5.9 1.7 3.3 1.1 3.8 4.9 0.4 2.8 0.9 17.8 1.4 0.6 0.0 19.9 14.5 3.8 0.4 2.3 0.6 4.3 5.4 0.5 1.7 1.3 1.3 1.9 0.9 0.5 0.0 1.9 2.4 0.8 0.0 1.7 4.2 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.3 0.0 7.7 1.6 0.0 0.8 6.8 7.6 0.6 11.7 10.1 7.2 7.1 8.6 18.3 4.7 0.0 4.3 0.0 0.8 2.1 4.8 2.0 0.0 6.7 0.0 1.8 53.0 0.0 0.0 0.4 1875.0 0.7 21.6 0.0 1.6 0.4 0.6 8.8 1.1 0.0 2.5 4.8 3.4 0.6 1.6 3810.8 13.8 6.3 8.5 5.4 11.8 5.7 1.4 9.1 12.0 0.0 73.6 6.5 2.8 33.1 23.0 1.1 0.2 0.0 7.0 0.1 TRIM39 RNF23 ENSG00000204599 "Tripartite motif containing 39" Q9HCM9 6 30326479-30343729 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA051120, HPA059496" Uncertain Supported Cytosol NA NA Cytosol "HPA051120: AB_2681348, HPA059496: AB_2684040" "unprognostic (2.90e-1)" "unprognostic (1.61e-2)" "unprognostic (2.79e-2)" "unprognostic (2.86e-2)" "unprognostic (6.38e-2)" "unprognostic (4.55e-2)" "unprognostic (1.46e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-1)" "unprognostic (9.44e-2)" "prognostic favorable (2.50e-4)" "unprognostic (1.30e-2)" "unprognostic (4.69e-2)" "unprognostic (6.35e-3)" "unprognostic (1.46e-1)" "unprognostic (1.06e-1)" "unprognostic (2.39e-3)" 8.6 7.6 5.2 14.3 6.4 11.8 7.4 8.6 7.6 10.2 11.2 7.3 9.7 7.1 10.0 15.2 11.9 8.5 13.6 6.1 5.4 5.5 7.6 9.6 11.1 6.7 7.7 6.3 10.3 9.1 8.9 11.4 11.6 7.1 7.9 7.1 11.4 8.2 15.5 9.9 6.5 10.9 8.8 6.0 13.1 8.0 14.1 7.2 7.8 8.9 8.3 10.1 9.1 12.3 3.4 1.6 8.4 2.5 4.4 5.2 2.1 4.4 0.2 3.9 6.9 1.8 1.8 4.0 2.1 2.5 3.1 2.8 5.3 0.6 5.7 4.1 3.9 1.9 1.5 4.4 3.1 3.2 4.4 4.9 4.5 0.7 1.9 4.0 6.7 5.1 2.1 2.6 3.9 4.3 4.7 1.9 4.9 6.7 4.6 4.0 4.0 1.4 1.4 5.2 1.9 3.3 3.1 0.8 4.3 3.3 4.3 8.4 4.1 1.6 3.3 4.0 3.9 4.5 1.8 1.7 3.4 2.7 4.1 6.9 8.4 10.1 5.9 2.0 2.4 5.2 1.4 1.7 6.8 5.2 2.5 4.6 3.4 3.7 3.8 1.6 3.3 4.4 4.1 8.4 4.4 2.4 1.2 2.9 2.1 5.2 6.4 8.6 7.6 5.4 5.5 7.7 6.3 7.1 7.2 3.0 7.4 11.5 5.5 3.3 4.9 5.2 2.5 5.3 3.4 1.8 5.9 4.0 6.6 4.2 2.7 3.6 5.8 0.0 5.3 4.8 4.4 3.2 5.7 3.9 2.9 3.2 5.2 6.7 7.2 6.6 2.6 4.4 3.3 3.6 4.4 6.5 5.1 8.6 4.2 3.3 7.7 0.0 5.0 20.2 8.1 3.6 8.4 13.8 3.7 4.7 TRIM39-RPP21 ENSG00000248167 "TRIM39-RPP21 readthrough" 6 30328907-30346854 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 1.8;testis: 1.2" "Group enriched" "Detected in some" 10 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.3;Club cells: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.4;LHCN-M2: 2.2;MCF7: 1.8" HPA051120 Uncertain Approved Cytosol NA NA Cytosol "HPA051120: AB_2681348" "unprognostic (1.20e-1)" "unprognostic (7.35e-2)" "unprognostic (2.56e-1)" "unprognostic (1.60e-1)" "unprognostic (4.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.56e-1)" "unprognostic (5.84e-4)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (6.89e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TRIM4 RNF87 ENSG00000146833 "Tripartite motif containing 4" Q9C037 7 99876958-99919600 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019356, HPA029461" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA019356: AB_1856376, HPA029461: AB_10600834" "unprognostic (1.88e-1)" "unprognostic (2.97e-2)" "unprognostic (3.37e-1)" "unprognostic (3.46e-2)" "unprognostic (1.80e-2)" "unprognostic (7.06e-2)" "unprognostic (1.22e-1)" "unprognostic (5.42e-2)" "unprognostic (3.85e-2)" "unprognostic (2.67e-3)" "unprognostic (2.48e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.36e-6)" "unprognostic (1.00e-1)" "unprognostic (2.38e-1)" "unprognostic (7.46e-2)" "unprognostic (5.65e-2)" 19.1 22.6 13.5 22.1 15.9 6.7 22.1 20.1 15.5 19.5 17.3 12.4 22.5 13.9 21.9 18.8 16.4 19.0 19.8 11.1 13.3 9.3 16.6 17.9 21.1 22.4 15.3 8.8 35.0 23.2 18.9 27.4 16.1 12.2 21.9 15.7 18.4 19.4 33.8 9.4 20.7 18.3 18.1 11.9 18.2 17.4 16.2 14.5 18.4 20.5 11.9 18.8 20.0 28.9 18.6 17.0 20.0 19.2 13.9 30.3 17.4 9.7 11.7 7.0 5.8 18.4 17.3 3.1 16.4 20.0 13.7 16.0 6.2 9.6 14.2 0.1 13.9 12.1 11.6 9.2 10.1 14.0 14.4 0.7 11.6 6.2 9.7 26.0 16.7 16.6 18.4 21.5 10.6 27.0 18.7 11.9 7.2 16.9 22.0 11.4 12.1 12.3 15.0 5.3 14.7 10.1 7.0 10.0 16.2 15.2 12.6 8.2 5.8 12.5 19.2 19.5 10.7 8.8 9.6 14.5 15.2 13.6 29.1 15.7 18.5 20.2 11.5 10.0 18.8 20.1 20.0 19.2 15.3 20.6 19.2 23.8 18.6 21.6 23.5 17.0 18.6 30.3 22.2 8.2 13.9 16.6 12.7 21.5 17.4 13.5 15.9 20.1 15.5 13.3 9.3 15.3 8.8 12.2 14.5 23.8 15.3 18.2 24.1 22.2 20.2 4.8 12.7 16.0 10.3 21.0 17.7 13.3 8.3 12.8 5.2 16.1 9.7 23.3 11.3 5.9 15.1 19.8 27.6 17.5 12.8 6.4 8.6 17.8 20.0 8.4 28.7 15.4 21.9 18.0 10.3 34.3 12.7 11.8 25.8 13.4 20.0 0.0 23.1 19.3 8.2 20.1 13.6 18.7 12.1 22.0 TRIM40 RNF35 ENSG00000204614 "Tripartite motif containing 40" Q6P9F5 6 30136108-30148735 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 13.5;placenta: 39.4" "Group enriched" "Detected in some" 7 "Enterocytes: 3.6;Intestinal endocrine cells: 1.7;Paneth cells: 3.5;Spermatocytes: 1.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.7;stomach cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 52 "HEL: 5.1" "Region enriched" "Detected in single" 19 "thalamus: 3.4" "Low region specificity" "Detected in all" HPA043818 Uncertain Approved Cytosol NA NA Cytosol "HPA043818: AB_10963090" "unprognostic (2.88e-1)" "unprognostic (5.20e-2)" "unprognostic (4.11e-1)" "unprognostic (1.13e-1)" "unprognostic (1.77e-1)" "unprognostic (4.84e-2)" 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 4.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.1 0.3 2.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.2 0.0 TRIM45 "FLJ13181, RNF99" ENSG00000134253 "Tripartite motif containing 45" Q9H8W5 1 117111060-117122587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 8.9;Cardiomyocytes: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030266, HPA054308" Uncertain Supported "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA030266: AB_10795476, HPA054308: AB_2682445" "prognostic favorable (1.58e-4)" "unprognostic (2.68e-2)" "unprognostic (1.12e-2)" "unprognostic (3.49e-1)" "unprognostic (5.70e-2)" "unprognostic (9.66e-2)" "unprognostic (2.19e-3)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" "unprognostic (1.43e-2)" "unprognostic (3.05e-1)" "unprognostic (5.45e-2)" "unprognostic (7.09e-2)" "unprognostic (3.90e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.27e-2)" 2.3 5.4 6.3 1.4 3.6 1.9 4.9 2.4 7.2 3.4 4.5 5.8 8.0 3.8 9.0 8.0 3.3 9.4 9.3 12.4 3.9 2.6 3.8 1.1 2.6 0.9 2.6 7.5 8.5 8.9 7.3 8.8 9.4 4.5 8.3 2.3 6.0 3.4 7.4 26.6 5.9 3.1 13.3 3.4 2.4 6.1 5.4 4.1 0.7 9.9 9.0 2.1 6.3 4.5 0.4 0.7 0.6 0.4 2.8 2.2 0.0 3.2 2.9 12.1 5.7 1.0 2.8 9.2 3.6 1.5 2.5 2.5 1.3 2.9 0.1 2.7 1.7 2.7 2.9 2.8 2.9 3.4 1.8 2.9 1.9 8.9 1.5 1.8 1.7 2.8 3.6 2.9 4.2 3.0 4.7 3.1 3.5 2.3 2.4 2.3 14.0 1.0 2.1 6.6 1.8 2.6 4.6 24.0 0.7 3.4 2.9 9.2 2.4 2.9 2.7 2.2 12.0 4.7 2.3 1.0 3.5 5.1 2.1 3.1 6.8 2.5 0.2 4.6 1.6 9.0 0.6 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.1 0.7 0.4 0.2 0.2 0.5 2.8 0.1 0.3 2.2 0.0 6.3 3.6 2.4 7.2 3.9 2.6 2.6 7.5 4.5 4.1 8.9 2.4 0.0 1.8 1.0 1.7 11.2 2.5 1.4 2.3 1.8 3.9 2.2 1.7 1.5 4.1 1.4 0.1 0.0 2.8 1.2 1.5 0.4 0.0 0.0 0.7 1.6 1.7 2.5 0.8 1.9 1.7 0.0 0.0 0.0 0.9 1.7 2.1 0.0 1.8 0.2 1.3 0.0 1.7 6.3 4.3 1.4 0.9 0.0 0.9 0.7 TRIM47 "GOA, RNF100" ENSG00000132481 "Tripartite motif containing 47" Q96LD4 17 75874161-75878575 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 23.7;RPTEC TERT1: 18.0;U-266/70: 20.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014933 Uncertain Supported Cytosol NA NA Cytosol "HPA014933: AB_10603219" "prognostic favorable (6.54e-4)" "unprognostic (8.42e-2)" "unprognostic (1.42e-1)" "unprognostic (2.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (5.59e-5)" "unprognostic (2.08e-2)" "unprognostic (9.18e-3)" "unprognostic (2.74e-1)" "unprognostic (1.18e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.69e-5)" "unprognostic (3.94e-2)" "unprognostic (1.44e-2)" "unprognostic (3.01e-2)" "unprognostic (9.98e-2)" 18.8 5.2 11.2 11.6 14.3 1.3 51.5 5.9 26.9 12.5 14.9 10.4 2.6 16.0 16.1 9.5 15.3 9.0 15.9 11.3 11.3 8.5 17.6 8.8 11.2 15.4 14.9 9.4 11.6 18.4 14.5 4.6 5.3 12.4 11.0 9.0 6.2 13.4 9.8 9.3 16.3 9.4 19.9 11.3 15.6 19.7 7.5 13.2 2.6 6.5 13.3 8.1 20.7 13.5 3.5 1.7 1.8 0.0 2.9 7.2 0.7 10.2 7.7 0.0 0.0 1.7 1.8 0.2 0.4 0.8 0.6 0.5 1.4 5.3 0.0 6.8 0.3 5.3 11.8 1.9 2.8 0.0 6.6 4.8 0.0 5.2 14.0 2.8 0.0 0.0 1.5 0.8 1.2 1.0 0.5 5.3 0.8 1.0 15.8 0.3 1.7 1.0 0.1 0.8 4.0 15.0 0.7 0.9 23.7 18.0 0.3 3.0 0.2 3.1 15.1 4.0 0.4 1.8 0.3 7.9 9.5 5.9 0.9 3.6 20.5 5.8 1.1 4.1 0.0 0.8 0.0 0.0 1.8 2.6 0.0 6.8 3.5 6.0 3.3 0.2 2.0 4.0 2.5 0.0 2.9 0.0 1.7 7.2 0.7 11.2 14.3 5.9 12.8 11.3 8.5 14.9 9.4 12.4 13.2 14.9 4.8 3.2 36.4 16.0 5.7 4.4 28.1 8.1 10.3 15.7 0.0 0.3 16.6 54.8 0.4 25.1 22.2 0.0 66.8 1.1 13.6 34.6 21.9 8.3 52.4 0.0 8.1 43.6 4.5 0.4 31.7 8.0 40.5 4.6 12.3 10.9 77.6 2.9 18.0 50.6 0.8 32.3 26.4 0.3 2.7 13.9 0.7 3.9 10.0 15.6 TRIM49D1 "TRIM49D, TRIM49D1P, TRIM49DP" ENSG00000223417 "Tripartite motif containing 49D1" C9J1S8 11 89911111-89921767 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "blood: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 199 "basophil: 19.8" "Lineage enriched" "Detected in single" 199 "granulocytes: 19.8" "Cell line enhanced" "Detected in single" "U-2 OS: 2.1" HPA072153 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D2 "TRIM49D2P, TRIM49L, TRIM49L1" ENSG00000233802 "Tripartite motif containing 49D2" C9J1S8 11 89924064-89933063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "blood: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 160 "basophil: 15.9" "Lineage enriched" "Detected in single" 160 "granulocytes: 15.9" "Cell line enriched" "Detected in single" 6 "U-2 OS: 3.5" HPA072153 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM5 "RNF88, TRIM5alpha" ENSG00000132256 "Tripartite motif containing 5" Q9C035 11 5663557-5938619 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB013497, HPA023420, HPA023422" Approved Supported Cytosol NA NA Cytosol "CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379" "unprognostic (2.60e-1)" "unprognostic (9.62e-2)" "unprognostic (2.04e-2)" "unprognostic (1.41e-2)" "unprognostic (6.88e-2)" "unprognostic (4.74e-3)" "unprognostic (5.48e-3)" "unprognostic (5.82e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (8.54e-3)" "unprognostic (1.64e-1)" "unprognostic (2.20e-2)" "unprognostic (1.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (6.12e-2)" 12.5 15.0 3.7 11.6 6.7 3.0 10.7 2.4 5.1 14.2 8.5 4.8 20.1 8.4 16.1 19.9 12.0 11.9 9.9 7.8 5.6 2.9 15.1 16.2 15.2 9.2 6.5 2.9 15.3 24.8 6.1 9.2 12.2 8.8 11.8 8.3 11.8 22.0 12.4 3.0 6.5 13.2 12.0 9.0 19.8 9.5 7.7 6.5 24.9 20.5 7.9 13.3 14.8 12.3 3.9 11.7 13.8 9.8 5.9 5.4 4.6 4.7 7.3 12.5 8.7 13.9 12.8 3.7 10.1 18.8 20.6 27.9 7.4 9.4 3.0 7.9 9.9 16.6 7.8 10.1 14.7 9.3 6.5 2.8 9.1 5.0 5.9 12.3 6.7 9.8 9.7 13.2 6.8 18.1 12.8 31.7 6.6 9.5 6.2 17.3 2.2 5.5 3.1 5.7 7.0 5.1 8.6 2.7 0.8 14.3 9.0 0.3 0.7 7.1 10.3 4.4 12.7 5.3 3.9 23.9 9.7 12.9 1.8 2.4 5.5 3.9 1.2 9.0 4.5 10.0 10.2 9.8 12.9 5.4 9.8 5.3 3.9 4.1 4.3 11.7 3.9 3.4 4.9 13.8 5.9 9.2 9.7 3.3 4.6 3.7 6.7 2.4 5.1 5.6 2.9 6.5 2.9 8.8 6.5 6.0 9.4 12.9 8.1 4.6 0.1 4.8 2.5 2.7 13.6 10.4 0.0 6.5 5.0 10.5 3.2 11.6 5.9 0.0 7.7 8.4 8.9 11.0 0.0 11.1 5.7 0.0 1.2 13.5 11.5 2.3 7.2 7.7 3.3 1.8 8.6 5.7 9.0 3.5 7.1 5.7 0.0 19.4 6.8 5.8 3.6 4.6 6.5 5.7 5.6 8.2 TRIM50 "FLJ32804, TRIM50A" ENSG00000146755 "Tripartite motif containing 50" Q86XT4 7 73312539-73328082 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "pancreas: 17.2;stomach 1: 22.8" "Cell type enhanced" "Detected in some" 14 "Distal tubular cells: 1.7;Early spermatids: 1.9;Spermatocytes: 4.4;Spermatogonia: 4.5" "Group enriched" "Detected in some" 8 "liver cancer: 2.9;renal cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 33 "Hep G2: 12.3" "HPA019862, HPA047843" Uncertain Approved Cytosol NA NA Cytosol "HPA019862: AB_1858305, HPA047843: AB_2680176" "unprognostic (1.93e-1)" "unprognostic (3.93e-1)" "unprognostic (1.07e-2)" "unprognostic (5.96e-2)" "unprognostic (3.87e-1)" "unprognostic (2.66e-2)" "unprognostic (1.49e-1)" "unprognostic (3.04e-3)" "unprognostic (2.63e-2)" "unprognostic (2.00e-1)" "unprognostic (2.13e-1)" "unprognostic (1.33e-1)" "prognostic favorable (9.36e-7)" "unprognostic (3.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.20e-1)" "unprognostic (2.25e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 17.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 1.0 0.0 0.0 0.1 22.8 4.4 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 12.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 1.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 4.4 4.5 0.0 0.1 0.0 0.0 0.0 TRIM54 "MURF, MURF-3, RNF30" ENSG00000138100 "Tripartite motif containing 54" Q9BYV2 2 27282392-27307439 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 187.1" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 75.1;Exocrine glandular cells: 36.7;Pancreatic endocrine cells: 31.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Cell type enriched" "Detected in single" 16 "NK-cell: 7.0" "Lineage enriched" "Detected in single" 16 "NK-cells: 7.0" "Group enriched" "Detected in some" 9 "HAP1: 8.4;NTERA-2: 18.0" "Region enhanced" "Detected in some" "amygdala: 3.2" "Not detected" "Not detected" HPA019690 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019690: AB_1858306" "unprognostic (6.98e-3)" "unprognostic (4.56e-3)" "unprognostic (3.22e-2)" "unprognostic (2.24e-2)" "unprognostic (1.58e-3)" "unprognostic (7.49e-2)" "unprognostic (1.25e-7)" "unprognostic (3.88e-3)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.41e-2)" "unprognostic (3.19e-1)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" 2.1 1.8 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.9 0.1 6.3 1.6 0.0 0.0 35.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 187.1 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.3 40.3 2.2 0.1 0.0 0.3 0.0 0.0 0.0 7.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 8.4 0.0 0.0 0.0 0.3 0.0 1.5 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 18.0 0.0 0.0 0.6 0.7 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.1 12.7 0.0 0.0 3.5 0.0 0.0 0.0 3.6 1.0 0.0 2.0 0.0 36.7 0.0 0.0 0.2 4.6 0.0 0.1 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.0 31.1 1.9 0.7 2.1 0.0 0.0 0.2 3.7 1.9 0.0 0.0 0.0 2.9 0.3 TRIM55 "MURF-2, RNF29" ENSG00000147573 "Tripartite motif containing 55" Q9BYV6 8 66126896-66175487 "Predicted intracellular proteins, Predicted membrane proteins" "Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 96.0;Ciliated cells: 17.4;Hepatocytes: 28.0" "Group enriched" "Detected in some" 10 "liver cancer: 12.3;renal cancer: 5.8" "Region enriched" "Detected in single" 4 "cerebellum: 3.3" "Cell type enhanced" "Detected in single" "T-reg: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "LHCN-M2: 97.8" "Region enriched" "Detected in single" 8 "olfactory region: 0.5" "Not detected" "Not detected" "HPA038793, HPA053691" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA038793: AB_10673289, HPA053691: AB_2682231" "unprognostic (5.44e-3)" "unprognostic (1.25e-2)" "unprognostic (5.93e-3)" "unprognostic (4.07e-2)" "unprognostic (6.83e-3)" "unprognostic (3.77e-3)" "unprognostic (8.31e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.50e-1)" "unprognostic (5.18e-2)" "unprognostic (2.10e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-2)" "unprognostic (1.77e-3)" 2.1 0.0 0.3 0.2 0.2 0.0 0.1 3.3 0.1 0.4 0.1 0.1 0.3 0.0 0.0 6.6 0.8 3.0 0.1 34.3 0.4 0.1 2.7 22.0 0.1 0.4 0.1 0.1 0.5 0.1 0.0 2.0 1.4 0.8 0.3 0.0 0.1 1.0 0.0 37.0 0.3 0.1 0.0 0.1 0.1 0.1 3.8 0.0 0.0 0.9 24.4 1.2 0.1 0.0 0.6 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 14.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 97.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 6.4 0.0 0.5 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.2 3.3 0.1 0.4 0.1 0.1 0.1 0.8 0.0 0.0 1.3 0.0 0.1 0.0 0.0 96.0 0.0 17.4 2.3 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.1 0.0 0.0 1.3 1.3 3.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.9 0.0 6.5 0.0 9.3 1.0 0.0 3.2 0.0 0.0 0.1 TRIM56 RNF109 ENSG00000169871 "Tripartite motif containing 56" Q9BRZ2 7 101085439-101097967 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024358 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA024358: AB_1858308" "unprognostic (6.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.99e-2)" "unprognostic (1.62e-1)" "unprognostic (9.44e-3)" "unprognostic (8.30e-2)" "prognostic unfavorable (3.87e-4)" "unprognostic (2.63e-1)" "unprognostic (4.11e-1)" "unprognostic (3.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.47e-3)" "unprognostic (8.13e-2)" "unprognostic (1.49e-1)" "prognostic favorable (2.13e-4)" 14.3 12.0 6.2 15.7 9.3 4.7 24.5 3.2 11.1 14.9 15.0 6.8 22.3 9.7 14.3 13.1 12.9 12.8 13.7 8.7 7.5 5.2 10.8 10.4 23.7 11.7 15.8 5.2 17.3 10.8 10.7 15.2 14.0 8.8 12.5 8.3 7.5 12.2 22.1 8.7 13.2 12.8 15.2 8.5 17.2 10.3 5.6 12.0 9.7 14.0 9.1 12.0 13.6 22.0 3.3 2.1 7.4 2.4 7.7 3.6 1.0 9.9 12.5 5.4 6.9 12.5 13.0 6.5 8.3 7.4 13.5 12.6 5.9 14.5 11.8 9.0 6.9 18.8 11.5 2.2 7.6 9.1 11.8 3.5 7.4 15.7 4.4 11.2 13.1 16.9 8.2 11.1 8.8 14.4 13.2 7.1 7.6 12.9 15.0 9.3 13.6 11.0 14.6 5.4 5.3 10.4 10.2 8.8 7.7 7.1 10.4 0.3 0.2 9.2 25.8 7.0 7.2 5.9 8.6 13.4 19.0 16.9 14.2 8.9 7.4 7.4 9.3 9.4 10.7 14.8 2.5 2.4 2.1 3.6 1.5 2.6 2.0 2.7 2.3 0.8 3.3 2.6 3.4 7.4 7.7 2.1 2.1 1.1 1.0 6.2 9.3 3.2 11.1 7.5 5.2 15.8 5.2 8.8 12.0 68.5 72.4 41.5 67.9 4.6 3.2 19.1 89.2 77.6 52.4 48.8 2.0 33.7 3.3 51.6 1.8 75.8 45.5 23.3 41.2 22.2 26.5 58.9 14.0 41.9 17.0 9.5 28.1 86.5 38.1 0.8 122.6 36.3 1.7 21.6 43.9 23.6 46.8 49.1 88.8 6.7 2.8 64.7 27.4 4.7 6.6 2.9 24.9 62.3 41.9 50.8 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165031953-165041744 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 5.0;testis: 6.6" "Cell type enhanced" "Detected in some" 11 "Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "BEWO: 18.0" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 1.1 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.1 0.2 1.1 0.2 0.3 0.0 0.5 0.3 0.2 1.1 0.1 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.0 1.4 0.0 0.0 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 8.2 0.2 0.2 0.0 0.8 0.4 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.8 6.4 0.3 4.7 0.5 0.0 0.0 TRIM65 ENSG00000141569 "Tripartite motif containing 65" Q6PJ69 17 75880335-75897003 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021575, HPA021578, HPA064820" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359" "unprognostic (1.82e-1)" "unprognostic (1.47e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-1)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (4.74e-6)" "unprognostic (5.36e-2)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-2)" "unprognostic (6.00e-3)" "prognostic unfavorable (1.82e-5)" "unprognostic (2.86e-3)" "unprognostic (7.18e-2)" "unprognostic (4.24e-3)" "unprognostic (7.50e-3)" 15.5 8.2 12.8 12.1 20.0 10.8 13.6 26.7 16.6 15.7 12.7 17.6 11.9 13.9 15.7 9.3 14.0 14.4 12.9 11.0 16.5 12.3 11.3 8.2 13.3 14.6 22.4 8.1 17.7 15.7 14.9 12.7 8.1 16.1 12.4 12.0 15.8 14.7 15.2 16.5 21.6 12.8 13.0 11.4 17.2 12.7 5.4 21.3 11.7 13.1 11.0 14.8 12.7 15.4 5.3 3.4 4.4 3.0 5.2 5.9 1.6 13.6 14.8 5.3 14.9 9.8 13.6 2.6 5.5 7.3 9.3 6.9 5.3 11.7 14.7 4.0 5.8 10.5 9.5 11.1 12.3 4.0 6.6 19.8 11.9 13.5 7.9 10.4 12.5 12.7 9.8 9.8 6.2 10.0 6.6 20.5 18.5 18.2 14.8 5.6 14.7 22.6 20.1 12.2 13.3 12.3 21.1 7.1 23.2 6.8 5.1 11.9 11.4 8.7 13.3 14.6 6.8 15.8 15.1 11.0 19.5 9.0 8.7 10.2 12.5 4.6 3.8 12.4 20.2 8.3 2.8 3.0 4.4 5.2 2.7 5.9 4.1 3.9 5.3 2.7 5.3 4.3 4.2 3.1 5.2 1.5 3.4 3.5 1.6 12.8 20.0 26.7 16.6 16.5 12.3 22.4 8.1 16.1 21.3 6.0 4.5 7.6 5.3 2.6 15.0 3.4 5.1 1.4 3.4 8.7 11.8 0.7 1.7 3.3 0.3 5.2 2.3 23.3 3.0 3.0 4.1 4.2 6.9 3.2 8.0 4.8 0.0 6.2 5.6 0.0 12.7 7.9 8.5 1.0 6.9 7.1 4.7 2.9 8.9 4.0 12.2 0.0 3.8 0.5 2.5 3.1 0.5 5.0 4.8 2.5 TRIM68 "FLJ10369, RNF137, SS-56" ENSG00000167333 "Tripartite motif containing 68" Q6AZZ1 11 4598672-4608259 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023455 Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023455: AB_1858319" "unprognostic (4.77e-2)" "unprognostic (5.15e-2)" "unprognostic (1.18e-1)" "unprognostic (4.10e-2)" "unprognostic (4.13e-2)" "unprognostic (8.63e-2)" "unprognostic (2.01e-2)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "unprognostic (7.78e-2)" "prognostic favorable (4.14e-6)" "unprognostic (4.23e-2)" "unprognostic (2.98e-1)" "unprognostic (1.61e-1)" "unprognostic (1.37e-1)" 7.7 11.3 11.1 8.0 11.1 3.1 10.6 15.2 12.8 16.3 10.9 12.6 18.2 10.3 10.6 12.2 8.0 12.6 10.3 9.4 9.6 7.9 14.9 12.7 11.7 7.6 13.1 10.5 17.3 9.9 12.6 10.5 9.8 10.0 16.8 10.1 9.9 12.0 17.5 8.7 7.6 9.8 9.8 11.9 10.7 12.4 13.2 9.5 10.0 17.8 6.7 8.9 11.7 8.4 9.1 5.9 8.9 5.2 5.5 12.8 7.6 8.4 9.5 3.9 6.4 6.4 10.5 0.0 9.3 6.9 8.5 7.8 1.2 8.8 5.8 5.7 4.7 8.1 10.0 3.9 6.5 7.3 14.4 7.6 7.1 2.4 0.0 7.4 11.3 10.0 8.1 9.6 5.0 7.6 8.9 10.7 5.4 6.5 3.0 7.6 2.0 9.3 3.1 4.6 5.9 7.9 7.5 5.6 0.2 5.5 3.8 2.1 3.8 0.0 9.5 5.9 8.1 4.1 5.7 8.6 11.4 7.9 11.5 4.1 11.9 12.9 8.4 7.9 5.0 10.7 6.4 2.7 8.9 9.0 5.1 10.1 9.1 9.9 10.0 5.9 7.9 12.8 10.1 0.3 5.5 5.2 4.0 8.7 7.6 11.1 11.1 15.2 12.8 9.6 7.9 13.1 10.5 10.0 9.5 0.0 2.2 0.9 1.1 0.7 3.7 4.3 0.0 0.0 6.8 5.2 2.0 4.9 5.0 2.5 0.4 2.2 2.3 0.0 2.9 2.1 1.6 1.8 3.5 4.5 2.0 0.0 6.4 3.1 2.2 0.0 1.7 1.5 0.0 2.8 5.9 3.7 2.4 0.0 1.8 1.7 2.7 6.5 2.1 2.6 4.3 0.9 3.7 1.3 4.3 0.5 TRIM7 "GNIP, RNF90" ENSG00000146054 "Tripartite motif containing 7" Q9C029 5 181193924-181205293 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 81.8;tongue: 34.0" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 15.9;Cardiomyocytes: 22.9;Sertoli cells: 12.9;Suprabasal keratinocytes: 24.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 16 "cerebellum: 21.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 4.9;T-cells: 2.2" "Cell line enhanced" "Detected in many" "HaCaT: 11.4;HDLM-2: 24.1;PC-3: 13.3;TIME: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039213 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA039213: AB_10795173" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (5.20e-2)" "unprognostic (1.10e-2)" "unprognostic (6.85e-2)" "unprognostic (1.80e-2)" "unprognostic (3.89e-4)" "unprognostic (3.45e-2)" "unprognostic (3.72e-1)" "unprognostic (1.64e-1)" "unprognostic (3.48e-2)" "unprognostic (1.97e-1)" "unprognostic (7.16e-3)" "unprognostic (1.26e-1)" "unprognostic (3.90e-2)" "unprognostic (6.17e-2)" "unprognostic (1.15e-2)" 1.3 0.9 0.1 0.9 0.5 0.5 3.4 21.7 1.3 2.5 0.8 0.3 1.1 0.5 1.0 6.4 13.0 0.6 1.7 2.2 0.1 0.8 2.2 0.5 0.9 0.6 0.2 0.2 0.6 4.2 1.6 1.9 0.5 0.5 2.0 0.6 0.6 5.9 1.1 81.8 9.5 0.6 0.9 0.3 0.8 1.4 0.9 0.2 0.1 3.3 34.0 13.5 1.6 2.9 0.7 0.8 0.1 4.9 0.5 2.2 1.1 6.1 3.0 0.0 0.3 0.5 0.5 0.2 1.4 0.0 0.5 1.2 0.3 8.1 0.4 4.3 1.7 2.6 11.4 3.3 9.3 0.1 24.1 1.3 0.5 7.9 0.1 1.6 0.0 1.4 0.1 7.2 0.2 4.6 1.8 2.6 1.1 0.3 1.3 0.2 0.8 0.3 0.2 0.0 9.7 13.3 0.3 4.2 0.9 3.3 0.0 0.3 0.7 2.9 0.2 4.1 0.1 0.7 0.2 11.0 0.1 2.4 0.4 4.3 1.9 0.2 0.7 0.3 0.4 1.0 0.0 4.9 0.1 1.4 1.9 2.2 0.4 1.2 1.4 0.8 0.7 2.2 1.8 0.1 0.5 1.4 0.6 2.2 1.1 0.1 0.5 21.7 1.3 0.1 0.8 0.2 0.2 0.5 0.2 0.0 1.4 0.0 3.9 15.9 5.7 22.9 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.4 0.6 1.4 2.4 0.0 2.0 0.4 0.8 1.8 0.0 0.2 1.1 0.0 0.0 1.8 9.4 0.0 0.9 1.6 1.7 0.0 3.1 0.5 3.2 8.5 1.4 1.1 2.7 12.9 9.0 0.9 0.4 24.8 0.0 0.0 2.2 2.4 TRIM73 TRIM50B ENSG00000178809 "Tripartite motif containing 73" Q86UV7 7 75395063-75410996 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "stomach 1: 11.5" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 20.3;Cone photoreceptor cells: 17.7;Horizontal cells: 30.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.9;Hep G2: 13.3" "HPA047843, HPA051845" Uncertain Uncertain Cytosol NA NA Cytosol "HPA047843: AB_2680176, HPA051845: AB_2681635" "unprognostic (1.01e-2)" "unprognostic (9.85e-5)" "unprognostic (4.72e-3)" "unprognostic (9.44e-3)" "unprognostic (2.49e-1)" "unprognostic (1.48e-2)" "unprognostic (1.25e-3)" "unprognostic (9.17e-3)" "unprognostic (1.41e-1)" "unprognostic (2.80e-1)" "unprognostic (5.46e-3)" "unprognostic (6.79e-2)" "unprognostic (4.18e-2)" "unprognostic (9.67e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-3)" 1.9 1.6 0.3 1.2 0.9 2.4 1.6 4.0 0.6 2.4 0.6 4.2 1.7 0.3 0.3 3.8 1.0 0.9 0.4 0.5 1.7 2.3 1.1 2.3 0.2 2.3 7.2 1.3 1.7 0.1 2.1 0.0 1.9 1.9 2.6 2.4 2.2 0.0 0.5 1.8 11.5 5.4 2.4 0.2 0.7 1.3 1.3 1.4 2.0 0.8 1.7 2.2 1.3 1.3 4.1 1.7 2.5 0.0 0.9 0.6 0.5 0.1 0.1 1.0 0.0 2.0 2.3 0.4 0.2 0.3 1.4 0.3 0.0 0.2 5.1 7.9 1.5 3.1 13.3 0.9 0.8 5.6 2.3 0.0 0.3 0.4 1.2 0.1 3.3 0.7 6.5 0.0 0.9 2.1 2.7 0.2 0.3 1.4 3.6 0.2 1.2 0.4 0.0 2.1 1.6 2.6 0.9 2.1 0.7 0.6 2.4 1.6 1.1 1.9 1.7 1.1 3.1 1.8 2.4 1.7 3.3 1.5 1.1 0.8 0.7 2.2 0.6 1.2 1.1 1.3 0.4 0.4 1.3 2.1 1.6 2.0 1.7 0.2 1.4 2.0 1.3 0.0 0.3 1.9 2.2 0.8 20.3 2.0 2.5 5.3 3.4 5.2 17.7 1.9 5.0 1.6 5.0 2.2 2.0 0.0 4.0 0.6 1.3 2.7 0.0 1.8 2.5 30.2 4.7 3.1 1.0 8.5 6.1 1.7 1.7 1.0 4.0 9.5 3.1 4.0 3.5 2.9 12.6 0.0 1.1 9.4 2.7 1.8 0.9 4.5 3.3 2.4 TRIM74 "MGC45440, TRIM50C" ENSG00000155428 "Tripartite motif containing 74" Q86UV6 7 72959485-72969466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 10.9" "Cell type enhanced" "Detected in single" 22 "Ciliated cells: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.7;Hep G2: 5.4" HPA047843 Approved Cytosol NA NA Cytosol "HPA047843: AB_2680176" "unprognostic (8.78e-3)" "unprognostic (3.78e-4)" "unprognostic (5.84e-3)" "unprognostic (1.95e-2)" "unprognostic (1.03e-1)" "unprognostic (8.26e-2)" "unprognostic (3.58e-2)" "unprognostic (1.26e-3)" "unprognostic (1.65e-2)" "unprognostic (3.68e-1)" "unprognostic (8.13e-3)" "unprognostic (1.98e-2)" "unprognostic (7.78e-2)" "unprognostic (7.05e-2)" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (1.12e-3)" 1.1 1.6 0.6 1.0 1.4 1.7 1.0 4.8 0.7 1.1 0.5 2.4 1.3 2.5 0.4 2.3 0.8 0.5 0.6 0.8 1.3 2.3 0.6 1.9 0.4 1.7 5.0 0.2 1.6 0.1 1.6 0.5 1.2 1.0 0.8 1.5 1.2 0.8 0.7 1.6 10.9 6.0 1.5 0.5 0.4 1.0 2.2 0.2 0.7 0.1 0.0 1.1 0.0 0.0 0.3 1.4 1.5 0.5 0.0 0.0 0.8 0.0 0.2 0.5 2.0 1.5 1.0 0.2 0.0 0.5 0.7 0.1 0.1 0.1 0.8 7.7 1.2 0.0 5.4 0.2 2.4 3.3 0.8 0.3 0.0 0.4 1.1 0.0 1.9 1.0 4.6 0.1 2.2 0.9 3.8 0.1 0.0 1.7 1.7 0.6 0.8 2.2 0.8 0.6 0.7 0.8 0.0 1.7 0.2 0.1 1.1 2.7 0.3 1.0 0.5 0.0 3.5 2.7 0.6 1.2 1.4 0.7 0.7 0.0 0.7 1.0 0.0 1.1 2.2 0.7 0.2 0.0 0.1 0.8 0.2 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 TRIM8 "GERP, RNF27" ENSG00000171206 "Tripartite motif containing 8" Q9BZR9 10 102642310-102660680 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023560, HPA023561" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA023560: AB_10600414, HPA023561: AB_10601861" "unprognostic (4.32e-2)" "unprognostic (6.90e-2)" "unprognostic (3.02e-3)" "unprognostic (1.45e-1)" "unprognostic (1.78e-1)" "unprognostic (5.03e-1)" "unprognostic (3.82e-2)" "unprognostic (1.03e-1)" "unprognostic (2.15e-3)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (1.52e-1)" "unprognostic (9.55e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (8.34e-2)" "unprognostic (1.36e-2)" 31.7 18.4 26.1 23.9 25.2 17.0 18.0 26.1 31.6 31.8 19.5 22.9 15.4 15.8 18.0 14.3 17.8 21.6 19.8 25.0 23.2 18.0 27.2 21.9 23.0 25.4 20.1 20.0 19.3 35.9 24.7 14.7 17.5 16.3 17.4 8.1 19.4 28.5 18.5 34.8 14.6 23.7 13.6 15.7 22.5 21.2 11.7 21.9 48.3 26.6 14.5 30.3 21.4 15.9 9.0 11.9 17.8 5.3 5.5 7.2 3.9 26.9 6.3 6.3 10.2 6.9 14.1 5.8 9.7 19.7 10.5 8.5 11.4 32.6 8.7 26.0 21.5 4.6 9.9 4.2 13.0 8.7 8.8 8.2 21.9 5.3 26.0 17.6 4.9 8.8 16.1 7.2 23.1 13.7 35.0 14.0 4.5 4.1 13.1 8.2 17.5 9.3 16.4 3.4 9.8 12.9 4.6 14.1 4.3 12.5 19.0 3.8 7.4 5.3 6.6 12.8 7.4 18.8 9.8 25.9 14.2 6.3 7.9 21.7 11.9 7.8 5.0 21.6 12.3 3.6 10.7 4.8 2.6 6.8 4.4 6.7 9.0 7.2 5.3 4.1 7.0 6.4 5.5 17.8 5.5 5.3 11.9 6.9 3.9 26.1 25.2 26.1 31.6 23.2 18.0 20.1 20.0 16.3 21.9 53.6 64.6 14.3 12.5 27.9 37.2 34.1 33.1 37.5 36.4 83.7 7.9 10.3 34.9 50.3 0.9 21.5 18.8 0.0 39.1 2.9 23.8 18.6 8.1 24.1 21.7 27.0 20.7 26.4 31.7 0.4 28.7 27.1 16.9 46.9 30.1 22.7 48.9 17.5 32.2 40.0 14.3 12.9 24.3 2.3 5.3 19.9 9.2 17.5 20.4 18.7 TRIML2 "FLJ25801, SPRYD6" ENSG00000179046 "Tripartite motif family like 2" Q8N7C3 4 188091273-188109603 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 9.8;testis: 6.2" "Cell type enhanced" "Detected in some" 17 "Cytotrophoblasts: 13.9;Early spermatids: 18.8;Extravillous trophoblasts: 5.5;Syncytiotrophoblasts: 7.4" "Cancer enriched" "Detected in some" 33 "testis cancer: 24.4" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 58.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043838 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043838: AB_10963835" "unprognostic (3.32e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (9.82e-2)" "unprognostic (1.21e-5)" "unprognostic (3.06e-2)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (1.20e-1)" "unprognostic (1.28e-3)" 0.1 0.1 0.2 0.1 1.4 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 9.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 6.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 12.6 0.0 0.0 0.0 0.0 7.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.9 0.3 2.4 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 58.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 5.5 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.5 0.0 7.4 0.0 0.0 0.3 TRIO ARHGEF23 ENSG00000038382 "Trio Rho guanine nucleotide exchange factor" O75962 5 14143702-14532128 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 63.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008157, HPA064664" Supported Approved Vesicles,Cytosol No No Cytosol Vesicles "HPA008157: AB_1858327, HPA064664: AB_2685315" "unprognostic (6.65e-2)" "unprognostic (4.21e-3)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.39e-2)" "unprognostic (4.13e-1)" "unprognostic (2.18e-3)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (2.02e-1)" "unprognostic (1.82e-1)" "prognostic unfavorable (3.11e-5)" "unprognostic (1.78e-2)" "unprognostic (1.96e-1)" "unprognostic (4.58e-3)" "unprognostic (2.23e-1)" 29.7 13.7 27.6 15.8 18.9 5.8 30.3 32.6 29.7 13.7 18.5 11.3 9.2 8.3 23.1 19.3 10.4 12.2 25.2 15.1 18.9 15.0 11.7 12.6 15.8 10.9 11.0 17.7 28.9 11.5 17.2 19.6 13.7 12.3 16.3 16.5 23.3 10.5 14.0 19.8 16.0 15.6 22.7 11.6 24.2 13.7 11.3 11.5 7.4 10.0 11.9 12.3 15.6 16.9 3.8 2.7 0.3 1.9 4.3 0.6 0.4 12.3 4.4 10.7 5.1 23.0 30.2 12.3 11.5 13.7 9.2 10.6 2.8 4.9 2.8 8.6 15.5 22.5 3.8 1.8 5.4 19.1 7.9 2.5 1.5 12.0 3.5 11.9 3.8 4.3 14.1 5.7 32.5 10.4 8.7 8.1 1.9 0.3 1.9 22.3 2.3 0.0 2.6 2.7 1.3 4.0 2.8 6.5 9.5 9.0 5.6 4.9 19.7 9.7 2.5 5.1 14.1 1.5 0.6 18.8 17.8 11.3 12.9 13.5 0.0 0.6 3.6 63.2 2.5 4.2 0.3 1.5 0.0 0.1 1.9 0.3 2.0 0.0 0.0 1.4 3.8 0.0 0.0 0.0 4.3 1.4 2.7 0.6 0.4 27.6 18.9 32.6 29.7 18.9 15.0 11.0 17.7 12.3 11.5 17.9 23.4 9.0 13.2 14.5 29.9 15.7 10.2 16.0 22.7 10.4 13.7 7.6 0.0 18.3 1.9 24.8 13.6 0.0 12.1 17.8 12.4 32.5 17.3 15.3 13.2 27.0 17.3 11.1 12.3 2.4 72.8 16.8 5.0 6.4 21.7 7.1 29.1 16.1 40.3 2.9 3.0 6.5 11.5 2.8 6.4 12.0 6.9 4.6 17.1 20.1 TRIP6 "MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1" ENSG00000087077 "Thyroid hormone receptor interactor 6" Q15654 7 100867138-100873454 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046454, CAB046460, HPA052813" Approved Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 12000 "Plasma membrane, Focal adhesion sites, Cytosol" "CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: AB_2681961" "unprognostic (7.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.22e-3)" "unprognostic (2.84e-3)" "unprognostic (3.52e-2)" "unprognostic (2.92e-2)" "unprognostic (3.18e-2)" "unprognostic (4.61e-3)" "unprognostic (8.48e-2)" "unprognostic (4.18e-2)" "unprognostic (5.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.25e-2)" "unprognostic (5.07e-2)" "unprognostic (9.71e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" 15.5 14.7 10.9 16.2 11.2 6.0 18.1 4.2 7.3 36.7 14.6 9.4 22.5 4.4 28.2 30.8 27.2 18.5 43.5 14.5 8.7 7.7 21.6 24.1 18.4 5.8 11.7 9.4 22.0 19.2 28.0 6.5 13.6 9.7 22.1 3.9 22.7 23.0 38.2 8.3 23.9 6.5 25.5 9.7 7.9 9.9 17.5 7.8 7.3 26.6 30.6 12.6 25.0 23.6 3.1 7.7 0.2 4.7 0.0 1.7 0.5 27.0 11.2 5.8 27.7 8.8 10.2 29.1 16.9 18.1 23.2 21.8 10.5 31.2 1.1 17.8 19.0 28.9 20.2 8.5 32.5 5.9 3.9 11.5 0.1 18.6 0.1 23.2 13.0 1.6 18.5 21.4 15.4 24.2 13.7 11.9 4.1 17.0 0.2 20.0 47.5 0.2 20.5 20.0 11.1 10.0 10.2 5.8 2.7 14.3 6.7 2.1 0.3 14.1 42.7 16.8 9.0 4.5 16.6 18.2 34.1 32.1 36.9 39.4 0.2 0.4 0.1 21.2 1.6 51.3 0.0 1.9 0.2 0.2 3.0 0.6 3.1 1.5 1.3 3.1 2.5 1.7 0.7 0.2 0.0 4.7 7.7 1.3 0.5 10.9 11.2 4.2 7.3 8.7 7.7 11.7 9.4 9.7 7.8 44.7 35.0 7.5 130.2 117.2 0.0 14.4 38.2 10.7 37.5 57.6 0.0 99.2 68.0 79.4 0.8 30.6 3.6 0.0 73.3 72.2 63.2 50.1 8.1 26.8 40.2 1.6 4.7 19.6 7.0 2.2 60.9 26.5 35.4 31.5 10.3 87.6 78.1 10.5 68.2 104.6 3.3 71.1 72.2 0.9 2.5 85.9 111.1 6.1 17.5 140.8 TRMT1 "FLJ20244, TRM1" ENSG00000104907 "TRNA methyltransferase 1" Q9NXH9 19 13104902-13117567 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041130, HPA041380" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041130: AB_10803995, HPA041380: AB_10793873" "unprognostic (2.10e-2)" "unprognostic (2.40e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (5.54e-2)" "unprognostic (1.08e-3)" "unprognostic (2.19e-2)" "unprognostic (1.59e-1)" "unprognostic (7.62e-2)" "unprognostic (1.91e-2)" "unprognostic (8.74e-3)" "prognostic unfavorable (9.87e-7)" "unprognostic (1.19e-3)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-2)" 15.5 15.0 19.1 19.8 23.5 23.1 16.6 19.5 22.6 15.0 16.3 17.3 15.5 14.9 19.2 19.0 17.6 19.6 19.4 13.2 15.7 13.4 14.4 17.3 13.5 26.8 22.1 14.7 29.1 23.8 16.3 14.4 14.4 21.9 18.1 14.5 10.9 14.9 15.6 21.4 22.1 16.1 16.5 12.4 25.0 16.3 16.8 20.1 12.2 15.6 12.1 19.6 17.3 18.8 11.2 14.9 3.1 15.7 4.3 10.2 8.5 15.4 10.4 11.3 19.2 11.5 14.8 16.2 17.4 8.7 19.2 16.7 11.1 12.7 19.4 22.8 9.3 10.0 14.3 18.9 15.3 8.9 12.6 26.4 15.4 26.8 18.7 20.9 30.8 18.2 20.9 20.6 19.9 18.8 12.3 14.1 14.5 33.3 6.2 11.9 17.1 12.5 33.3 26.8 9.8 24.5 21.1 14.6 26.7 11.9 15.7 26.9 12.2 10.8 22.6 18.1 8.6 8.8 17.3 15.6 27.7 10.8 16.7 30.4 10.8 20.8 17.9 12.9 32.7 14.4 1.2 15.7 0.5 8.1 11.9 7.7 10.4 8.6 7.7 14.9 11.2 10.2 7.7 3.1 4.3 7.5 8.8 5.6 8.5 19.1 23.5 19.5 22.6 15.7 13.4 22.1 14.7 21.9 20.1 11.9 16.2 35.0 22.3 21.3 8.0 6.4 12.7 10.7 4.5 12.2 2.0 19.4 5.0 14.1 16.4 17.5 6.3 0.0 12.8 18.8 13.9 10.4 28.9 8.6 41.5 7.9 6.9 7.4 88.1 36.5 13.0 39.6 16.9 23.4 9.6 5.8 12.2 5.8 12.0 11.2 11.1 12.9 16.5 21.7 18.3 18.1 12.9 18.7 17.4 18.4 TRMT10A "MGC27034, RG9MTD2, TRM10" ENSG00000145331 "TRNA methyltransferase 10A" Q8TBZ6 4 99546709-99564032 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 76.6;Spermatogonia: 51.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047601, HPA058241" Uncertain Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA "Nucleoplasm, Nucleoli, Actin filaments" Cytosol "HPA047601: AB_2680099, HPA058241: AB_2683651" "unprognostic (5.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.96e-3)" "unprognostic (2.10e-1)" "unprognostic (5.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.59e-2)" "unprognostic (3.65e-2)" "unprognostic (1.57e-1)" "unprognostic (3.51e-1)" "unprognostic (7.49e-3)" "unprognostic (3.32e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.68e-2)" 7.0 8.9 6.5 7.5 8.9 3.3 13.1 6.1 8.7 4.6 6.0 9.3 7.5 7.3 5.5 7.2 9.2 10.1 6.1 5.0 7.9 6.7 9.1 16.8 4.9 7.4 9.2 6.1 6.6 12.4 6.7 12.2 10.0 9.7 7.4 6.9 2.5 7.3 4.7 9.3 6.5 10.4 5.1 10.5 7.0 7.6 16.7 10.1 10.7 10.8 5.1 8.0 7.2 10.8 8.8 10.0 9.2 7.6 5.8 7.1 4.0 6.7 4.8 9.3 4.8 5.5 7.8 6.7 8.2 3.2 5.8 4.3 3.9 8.4 9.3 3.2 4.8 5.2 3.9 10.8 5.2 8.9 11.8 4.8 6.4 4.1 6.4 5.3 16.2 6.9 4.9 13.4 5.8 12.7 3.4 5.8 8.5 14.7 8.4 4.9 7.8 13.6 3.3 5.5 12.1 4.6 7.9 8.9 5.9 7.8 5.5 5.8 5.1 4.5 24.9 8.2 8.1 8.1 7.0 4.2 5.9 6.1 4.8 9.3 5.8 9.8 8.5 4.5 9.5 4.1 4.0 7.6 3.7 3.8 7.1 3.1 6.3 6.5 6.4 10.0 8.8 6.7 6.2 9.2 5.8 6.2 5.6 7.1 4.0 6.5 8.9 6.1 8.7 7.9 6.7 9.2 6.1 9.7 10.1 3.0 9.3 6.0 5.1 7.2 4.6 5.9 12.7 20.1 4.5 10.4 3.9 14.6 36.5 11.9 34.0 6.7 10.7 0.0 16.6 14.7 5.4 5.0 8.1 24.2 7.1 4.8 6.9 9.2 7.9 11.7 6.1 4.7 5.0 5.4 9.8 7.8 14.8 11.0 7.1 17.0 5.9 12.9 7.1 76.6 51.2 8.3 14.6 4.8 9.6 5.9 TRMT13 "CCDC76, FLJ10287, FLJ11219" ENSG00000122435 "TRNA methyltransferase 13 homolog" Q9NUP7 1 100133150-100150497 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028494 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Nuclear bodies, Cytosol" "HPA028494: AB_10601254" "unprognostic (1.12e-1)" "unprognostic (3.33e-1)" "unprognostic (5.76e-2)" "unprognostic (2.37e-1)" "unprognostic (9.17e-3)" "unprognostic (4.97e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.16e-3)" "unprognostic (3.28e-2)" "unprognostic (8.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" "prognostic unfavorable (6.89e-6)" "unprognostic (3.12e-2)" "unprognostic (7.71e-2)" "unprognostic (1.99e-2)" "unprognostic (1.70e-3)" 13.0 12.2 13.9 21.7 24.1 5.9 18.3 26.5 22.5 17.4 13.1 18.2 24.2 13.6 17.4 15.4 13.7 13.9 9.6 12.0 14.4 9.0 12.1 13.0 9.6 20.9 23.1 12.8 21.4 18.1 23.8 26.8 13.2 15.6 14.9 14.4 10.8 14.3 17.4 16.9 17.9 14.2 14.3 19.4 16.5 12.6 11.1 25.8 17.8 16.5 12.0 17.6 13.9 15.8 15.1 9.6 2.2 4.5 5.4 13.6 3.9 10.7 6.3 10.6 7.4 5.7 11.3 11.7 11.4 4.5 8.7 7.3 7.5 4.5 17.8 14.2 9.0 5.8 9.8 19.5 8.8 15.1 17.9 15.5 10.6 13.9 7.2 10.4 18.3 10.0 7.8 10.1 16.4 21.7 5.5 7.9 13.3 22.2 11.5 8.7 4.1 14.9 9.7 14.8 10.4 12.7 16.0 16.1 9.7 7.1 8.6 6.9 11.6 10.5 10.1 13.4 10.9 5.9 16.3 8.2 11.6 7.8 9.7 15.1 14.8 11.9 21.1 13.1 14.7 4.4 0.1 4.5 2.2 8.5 4.4 10.4 14.8 9.0 8.3 5.2 15.1 13.6 11.1 1.9 5.4 3.5 9.6 6.2 3.9 13.9 24.1 26.5 22.5 14.4 9.0 23.1 12.8 15.6 25.8 23.8 13.4 31.3 12.1 8.7 36.7 10.0 17.8 25.4 28.4 14.0 27.5 11.7 11.6 9.2 7.7 11.7 9.1 0.0 5.2 8.8 10.8 10.7 20.8 9.9 6.7 27.0 19.5 17.2 6.1 4.3 23.0 9.9 10.1 8.2 8.1 19.7 7.8 12.5 17.3 8.4 45.1 19.4 12.2 36.3 22.8 10.5 6.1 19.7 13.2 8.4 TRMT2A HTF9C ENSG00000099899 "TRNA methyltransferase 2 homolog A" Q8IZ69 22 20111866-20117392 "Plasma proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 119.6;Late spermatids: 166.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001077 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001077: AB_1079092" "unprognostic (5.01e-2)" "unprognostic (2.45e-2)" "unprognostic (1.17e-2)" "unprognostic (9.70e-2)" "unprognostic (1.17e-1)" "unprognostic (8.05e-3)" "unprognostic (2.19e-3)" "unprognostic (5.93e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.99e-8)" "unprognostic (4.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.80e-1)" "unprognostic (1.14e-3)" 14.3 22.5 12.6 18.8 13.6 14.3 13.4 16.3 19.7 13.9 16.6 17.4 15.4 18.2 13.1 15.6 16.1 15.3 17.1 12.8 13.1 11.4 13.2 22.8 11.1 22.8 12.4 14.4 15.2 23.6 10.8 18.5 15.8 11.2 16.8 6.1 14.2 36.5 16.1 14.8 18.4 16.2 12.4 12.7 23.2 16.7 16.9 13.4 26.8 15.6 12.7 18.3 13.1 11.0 9.7 14.0 7.0 14.9 9.5 15.2 11.5 6.4 7.5 2.9 4.7 2.9 2.2 10.0 5.8 3.0 4.6 4.1 8.9 5.6 8.9 5.0 2.7 3.6 10.1 2.1 3.3 0.6 9.2 24.4 10.3 10.0 8.0 8.0 16.1 10.3 3.9 4.3 4.9 1.8 3.2 4.8 7.7 38.5 6.2 3.2 10.2 9.1 10.2 5.5 7.3 9.5 10.5 5.0 3.7 2.6 7.3 7.7 5.9 3.6 9.3 9.3 1.3 6.4 13.7 4.5 5.7 7.6 4.4 5.0 22.2 9.9 6.8 7.6 6.9 5.7 6.6 11.5 7.0 10.5 14.9 15.2 9.7 10.9 12.1 14.0 6.8 12.2 11.5 1.5 9.5 12.0 12.4 8.5 11.5 12.6 13.6 16.3 19.7 13.1 11.4 12.4 14.4 11.2 13.4 11.9 17.3 11.5 8.8 8.8 13.6 5.2 12.7 6.7 10.3 10.4 7.9 21.8 11.6 9.3 119.6 8.7 12.3 0.0 11.3 15.3 11.3 9.1 25.3 15.5 22.1 14.3 17.9 7.4 20.8 166.9 16.4 12.7 6.8 14.4 10.6 21.7 11.7 10.1 13.4 8.4 12.4 6.5 8.8 17.3 12.1 9.8 23.8 17.8 15.1 8.5 TRMT61B FLJ20628 ENSG00000171103 "TRNA methyltransferase 61B" Q9BVS5 2 28849821-28870301 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026747, HPA026751" Enhanced Uncertain Cytosol NA NA Cytosol "HPA026747: AB_1848782, HPA026751: AB_1848784" "unprognostic (1.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.63e-3)" "unprognostic (2.05e-2)" "unprognostic (3.32e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.36e-2)" "unprognostic (2.55e-2)" "unprognostic (2.77e-1)" "unprognostic (2.52e-2)" "unprognostic (2.52e-2)" "prognostic favorable (9.61e-5)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (5.38e-2)" "unprognostic (2.34e-1)" 11.6 19.5 20.4 12.8 22.5 10.9 18.5 33.7 21.0 13.8 11.7 17.4 10.9 19.2 15.6 20.4 12.6 11.8 10.1 16.3 17.2 18.4 19.8 16.9 9.0 13.8 17.0 15.6 13.7 10.0 21.1 25.4 12.2 17.8 15.2 13.2 14.2 12.6 11.8 17.9 11.9 18.6 14.4 14.7 13.2 12.4 14.6 18.7 12.6 12.8 10.4 14.5 14.8 10.8 11.9 6.8 2.7 7.0 13.9 12.4 6.3 17.9 10.8 11.0 19.4 15.0 12.9 13.3 10.7 13.3 13.7 12.8 12.3 9.7 19.0 9.9 9.3 16.4 14.1 15.3 13.0 14.2 14.2 10.3 5.8 8.9 16.1 17.1 12.2 6.6 13.1 14.5 10.8 14.8 10.1 13.0 12.5 11.7 7.3 11.2 7.1 10.8 18.6 20.3 21.4 17.4 8.1 17.7 16.4 11.9 11.7 18.6 19.8 11.5 18.2 17.5 9.6 9.3 4.3 10.2 9.2 15.4 9.0 13.4 9.1 14.9 29.5 12.1 18.4 12.2 0.0 6.6 2.7 9.8 7.0 12.1 11.9 11.1 10.5 6.4 11.6 12.4 8.9 0.9 13.9 5.7 6.8 11.6 6.3 20.4 22.5 33.7 21.0 17.2 18.4 17.0 15.6 17.8 18.7 14.9 5.4 12.0 9.6 16.1 9.9 2.0 10.2 12.0 9.1 8.7 5.9 17.9 13.3 12.4 6.3 6.8 7.1 0.0 8.9 13.0 9.9 6.1 9.2 8.3 8.0 6.4 4.6 1.3 6.9 2.7 8.1 7.1 6.8 10.0 9.5 9.1 9.0 9.9 9.9 23.8 20.7 6.5 9.5 21.8 9.6 13.8 7.3 7.9 13.3 6.5 TRMT9B "C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L" ENSG00000250305 "TRNA methyltransferase 9B (putative)" Q9P272 8 12945642-13031503 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 64.7;thyroid gland: 26.5" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 26.8;Club cells: 18.2;Collecting duct cells: 14.0;Distal tubular cells: 10.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Group enriched" "Detected in all" 7 "cerebellum: 64.7;pons and medulla: 31.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.1;BJ: 10.2;fHDF/TERT166: 13.7;RPTEC TERT1: 4.8;SCLC-21H: 5.2;U-266/84: 4.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 77.4" HPA024673 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024673: AB_1845788" "unprognostic (9.85e-3)" "unprognostic (1.20e-1)" "unprognostic (5.54e-4)" "unprognostic (1.06e-2)" "unprognostic (4.08e-2)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.88e-1)" "prognostic favorable (2.77e-7)" "unprognostic (2.22e-1)" "unprognostic (4.63e-2)" "unprognostic (4.27e-3)" "unprognostic (3.34e-2)" 2.1 0.9 2.0 1.1 4.1 1.2 3.5 64.7 6.0 2.0 1.8 6.6 0.8 1.4 1.9 2.5 1.3 2.4 2.7 6.0 6.7 2.9 2.7 1.7 1.7 1.0 2.0 2.8 0.6 1.7 2.3 1.2 7.1 31.5 1.2 2.1 5.8 2.3 1.9 4.4 5.1 1.5 0.9 1.9 1.6 1.5 1.8 1.0 0.0 26.5 1.3 0.7 1.3 0.9 1.0 0.6 2.8 0.6 1.9 0.6 0.0 0.1 0.2 7.1 0.0 0.0 0.0 1.7 10.2 2.3 1.4 0.7 0.1 0.3 0.2 0.5 13.7 1.3 0.3 0.1 0.3 1.5 0.1 0.4 0.4 0.4 0.1 0.0 0.2 0.7 0.2 3.6 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.3 0.1 0.2 0.8 0.1 0.0 1.1 0.1 0.1 4.8 0.2 5.2 0.1 0.1 0.1 0.2 2.4 0.2 0.0 0.0 0.2 0.9 1.0 0.2 0.4 4.9 0.1 0.1 0.2 1.8 2.6 0.6 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.2 1.0 0.5 0.6 2.8 1.9 0.3 0.6 0.2 0.0 2.0 4.1 64.7 5.0 6.7 2.9 2.0 2.8 31.5 1.0 6.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 26.8 18.2 14.0 0.0 0.9 10.0 0.9 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRNAU1AP "FLJ20503, SECP43, TRSPAP1" ENSG00000180098 "TRNA selenocysteine 1 associated protein 1" Q9NX07 1 28553085-28578545 "Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032068, HPA032069" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA032068: AB_2674135, HPA032069: AB_10603998" "unprognostic (4.06e-2)" "unprognostic (1.62e-2)" "unprognostic (3.28e-2)" "prognostic favorable (2.22e-4)" "unprognostic (4.93e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (8.64e-5)" "unprognostic (5.79e-3)" "unprognostic (9.48e-3)" "unprognostic (2.24e-2)" "unprognostic (1.37e-1)" "unprognostic (2.28e-3)" "prognostic unfavorable (1.16e-5)" "unprognostic (1.84e-1)" "unprognostic (2.72e-1)" "prognostic favorable (9.45e-4)" "unprognostic (2.76e-1)" 11.4 10.5 12.6 11.3 14.7 9.3 13.4 19.6 14.1 12.4 10.9 15.4 12.0 7.0 11.7 14.8 10.8 13.2 8.7 12.3 11.7 12.1 11.4 8.7 13.2 15.7 19.3 13.3 12.8 11.6 14.0 9.2 10.8 13.6 10.3 11.6 10.7 10.5 14.0 7.9 17.3 9.4 14.0 12.8 11.1 10.2 7.2 17.1 15.4 8.4 9.0 16.9 12.9 9.5 4.8 4.3 9.1 5.9 12.9 7.5 2.7 4.5 2.7 8.0 5.4 7.4 14.1 3.8 6.2 12.5 11.5 10.3 4.2 7.2 7.0 2.4 6.8 5.4 3.5 8.7 9.8 11.5 6.1 9.9 5.2 9.6 2.8 6.8 4.0 4.5 15.1 8.5 8.9 7.0 8.1 16.2 7.2 6.1 5.7 11.1 3.1 6.8 4.7 5.7 4.9 6.0 4.9 5.6 4.9 12.4 4.6 4.7 6.2 7.3 6.5 6.7 9.0 7.1 4.9 4.6 3.0 2.9 4.6 5.5 7.5 9.4 4.3 7.2 8.8 8.4 6.9 3.5 9.1 5.7 5.9 6.0 4.8 6.2 7.2 4.3 4.7 7.5 4.8 2.2 12.9 3.5 2.8 4.0 2.7 12.6 14.7 19.6 14.1 11.7 12.1 19.3 13.3 13.6 17.1 32.8 33.0 23.2 18.6 15.7 33.7 18.5 22.9 54.9 35.2 17.4 33.4 27.7 14.9 32.7 9.3 19.6 14.6 23.3 28.3 39.5 19.7 18.5 33.6 7.8 29.5 22.3 9.9 25.2 25.4 3.2 26.7 27.0 13.5 36.1 13.0 23.6 32.8 13.6 21.2 15.0 33.0 32.3 25.7 15.4 24.9 17.9 57.2 30.0 15.1 26.0 TRO "KIAA1114, MAGE-D3, MAGED3" ENSG00000067445 Trophinin Q12816 X 54920462-54931431 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.1" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 4.0;Fibroblasts: 4.4;Horizontal cells: 7.9;Leydig cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 5.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 17.9;SH-SY5Y: 16.1;SuSa: 37.2" "Low region specificity" "Detected in all" HPA071449 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA071449: " "unprognostic (6.18e-2)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (9.09e-3)" "unprognostic (2.72e-1)" "unprognostic (5.66e-2)" "unprognostic (1.46e-1)" "unprognostic (4.67e-2)" "unprognostic (3.18e-1)" "prognostic favorable (1.93e-4)" "unprognostic (1.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.67e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (6.86e-2)" 4.5 4.2 21.7 2.1 15.5 1.6 3.7 11.3 23.8 8.0 2.5 7.9 1.4 1.7 16.3 8.6 2.4 7.1 5.6 2.9 17.9 15.6 5.3 13.2 2.5 2.3 10.5 13.2 21.7 5.7 7.6 20.2 5.5 22.3 7.4 3.2 5.0 1.5 6.9 32.1 1.5 1.8 10.9 8.9 1.4 2.0 3.6 14.2 4.2 9.2 0.1 2.4 3.6 5.0 0.7 2.6 0.0 0.2 5.2 1.2 0.4 0.0 0.1 17.9 0.0 3.5 4.8 0.0 0.9 6.1 0.9 0.3 0.0 0.0 0.0 2.5 6.4 1.4 0.1 0.1 0.3 0.5 0.0 11.0 8.2 0.0 0.6 1.3 0.0 0.0 11.2 0.0 5.7 0.0 5.7 0.4 4.3 0.0 0.1 6.6 0.0 0.1 0.0 9.1 0.0 0.0 5.2 7.8 0.0 1.7 0.1 12.0 16.1 0.0 0.2 1.5 37.2 0.0 1.0 0.0 7.5 7.8 0.1 1.0 2.8 0.4 0.0 1.1 0.0 6.5 0.0 0.0 0.0 1.2 0.0 0.7 0.7 0.1 0.4 0.0 0.5 0.3 0.7 0.0 5.2 0.2 2.6 0.0 0.4 21.7 15.5 11.3 23.8 17.9 15.6 10.5 13.2 22.3 14.2 0.0 0.0 0.0 1.1 0.3 4.0 1.6 0.0 0.0 3.4 3.5 0.0 0.6 0.0 1.4 0.3 0.7 0.0 0.0 0.2 0.5 4.4 0.4 1.1 0.0 0.4 7.9 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 2.9 0.3 0.0 3.5 0.3 1.0 0.0 0.4 1.0 1.0 0.1 0.6 0.5 0.0 0.3 TROVE2 "Ro60, SSA2" ENSG00000116747 "TROVE domain family member 2" P10155 1 193059422-193091777 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 316.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002835, HPA005142" Uncertain Approved Nucleoplasm,Cytosol NA NA 28000 Cytosol Nucleoplasm "HPA002835: AB_1857490, HPA005142: AB_2667307" "unprognostic (1.91e-2)" "unprognostic (5.11e-2)" "unprognostic (3.94e-3)" "unprognostic (7.34e-2)" "unprognostic (2.34e-2)" "unprognostic (1.41e-1)" "unprognostic (3.62e-2)" "unprognostic (1.17e-1)" "unprognostic (3.77e-2)" "unprognostic (1.16e-2)" "unprognostic (8.45e-3)" "unprognostic (1.52e-1)" "unprognostic (1.05e-3)" "unprognostic (6.32e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (3.31e-4)" "unprognostic (5.62e-2)" 21.2 13.7 13.3 11.4 16.2 29.7 18.5 13.7 16.5 16.9 12.3 13.2 11.7 8.4 15.3 10.9 16.8 11.3 10.9 18.0 13.9 7.7 14.3 13.6 15.0 13.0 19.6 11.8 19.8 12.1 16.8 13.0 13.6 15.1 17.3 9.4 11.4 14.8 14.7 23.4 16.5 11.6 22.7 20.4 14.7 10.9 24.3 17.0 15.1 14.9 8.7 12.9 19.9 19.8 19.1 13.9 38.3 14.6 19.6 24.3 14.5 8.8 15.8 18.3 17.1 15.9 14.7 11.1 13.5 12.6 9.4 12.7 8.1 12.1 18.3 12.5 15.1 8.9 13.6 14.4 10.2 16.6 22.6 11.0 22.1 15.1 10.8 14.6 25.7 16.2 13.7 12.2 17.2 19.2 9.5 15.2 8.0 24.0 24.6 16.1 14.4 15.4 6.8 13.8 7.5 5.2 12.8 15.8 20.8 9.1 18.4 6.5 12.9 16.5 20.2 17.3 13.2 16.6 8.8 20.4 18.0 6.6 16.9 17.2 14.4 14.7 17.4 9.6 12.9 27.6 38.3 13.9 17.4 24.3 13.1 23.4 19.1 17.9 20.3 13.9 17.2 19.0 21.2 22.7 19.6 14.6 12.2 17.9 14.5 13.3 16.2 13.7 16.0 13.9 7.7 19.6 11.8 15.1 17.0 71.5 25.9 47.7 45.1 63.0 52.6 45.3 35.7 34.8 28.4 45.4 117.8 40.8 34.9 43.8 316.3 70.0 20.6 46.7 33.6 38.5 64.8 51.1 57.8 29.4 29.3 44.5 32.6 40.5 33.7 126.5 78.9 44.3 45.5 49.5 21.2 163.1 32.0 20.1 97.9 43.8 149.2 129.4 76.9 43.9 41.4 67.5 40.2 59.1 19.9 30.7 TRPC4AP "C20orf188, dJ756N5.2, DKFZp586C1223, DKFZP727M231, PPP1R158, TRRP4AP" ENSG00000100991 "Transient receptor potential cation channel subfamily C member 4 associated protein" Q8TEL6 20 35002404-35092871 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051197, HPA065061" Uncertain Approved Cytosol NA NA Cytosol "HPA051197: AB_2681384, HPA065061: AB_2685416" "unprognostic (3.00e-1)" "unprognostic (1.61e-1)" "unprognostic (4.06e-2)" "unprognostic (2.08e-2)" "unprognostic (2.40e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.25e-8)" "unprognostic (1.33e-1)" "unprognostic (5.56e-2)" "unprognostic (2.58e-1)" "unprognostic (1.95e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (3.38e-1)" "unprognostic (3.19e-2)" "unprognostic (5.14e-3)" "unprognostic (1.10e-1)" 36.5 43.3 26.3 30.1 38.2 51.4 35.1 36.7 48.3 27.7 31.9 64.0 36.9 30.7 33.9 31.8 31.5 28.4 30.1 30.1 29.0 31.0 30.4 41.9 38.7 32.3 43.5 34.0 30.4 45.3 41.3 47.9 48.1 43.6 32.9 31.6 29.2 39.9 33.1 50.5 35.0 31.8 32.5 31.9 43.7 37.3 24.5 38.8 46.9 34.8 23.0 34.9 29.0 28.5 10.9 23.2 28.6 20.9 14.2 15.9 13.3 16.3 20.0 17.9 18.4 27.8 26.8 27.5 26.6 31.3 30.6 35.3 43.7 24.5 15.3 25.5 30.7 31.3 21.9 16.2 37.9 23.7 8.1 12.6 39.1 17.2 39.9 27.7 22.6 26.8 29.7 24.0 22.9 19.7 32.2 33.8 31.9 18.3 18.5 24.3 12.3 27.3 25.6 14.1 15.1 27.4 17.2 25.8 15.6 26.3 21.4 15.9 16.0 28.6 48.7 18.6 22.3 17.6 18.5 33.1 38.2 17.3 20.5 15.8 17.0 9.1 12.8 41.2 11.3 19.4 16.4 16.7 28.1 14.8 18.3 15.8 10.9 12.4 15.9 23.2 10.1 11.0 11.5 28.6 14.2 20.9 10.1 14.0 13.3 26.3 38.2 36.7 48.3 29.0 31.0 43.5 34.0 43.6 38.8 17.9 13.1 18.6 13.7 13.5 24.8 11.2 10.2 9.4 11.4 19.2 74.6 43.4 3.3 26.2 11.1 23.8 26.9 0.0 24.0 36.5 21.0 20.5 19.6 18.1 32.7 63.5 19.7 17.2 20.0 5.5 23.6 23.9 11.8 25.2 22.2 25.3 31.2 21.0 21.5 8.7 28.4 38.8 17.9 22.6 25.3 13.8 57.2 20.3 20.9 18.7 TRPM7 "CHAK1, LTRPC7, TRP-PLIK" ENSG00000092439 "Transient receptor potential cation channel subfamily M member 7" Q96QT4 15 50552473-50686815 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Necrosis, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 91.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035522, HPA052173" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA035522: , HPA052173: AB_2681749" "unprognostic (3.14e-2)" "unprognostic (1.86e-1)" "unprognostic (1.58e-1)" "unprognostic (1.42e-2)" "unprognostic (1.89e-1)" "unprognostic (1.60e-2)" "unprognostic (1.85e-2)" "unprognostic (2.59e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (2.91e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-2)" "unprognostic (2.08e-1)" "unprognostic (7.59e-2)" "unprognostic (9.45e-2)" "unprognostic (1.97e-1)" 13.3 10.8 6.6 14.7 9.0 12.8 12.1 19.5 9.3 11.8 11.7 8.1 9.7 9.9 16.5 10.7 9.4 11.0 8.2 19.1 5.5 4.9 16.0 20.0 10.8 10.6 12.4 5.2 16.6 11.6 91.8 14.6 14.3 10.2 9.7 10.3 28.6 11.5 13.5 10.8 11.7 12.8 12.8 9.8 11.1 10.3 6.9 10.0 14.5 12.6 6.9 12.6 12.9 12.3 7.0 4.7 4.4 3.4 5.7 7.6 2.0 8.5 8.5 7.1 7.9 20.6 15.5 8.7 10.8 15.0 6.9 9.1 11.7 4.7 18.6 5.3 12.4 17.8 14.4 9.5 7.9 9.9 10.3 5.7 14.8 13.1 6.1 18.8 15.3 11.5 14.4 9.4 7.8 14.7 10.1 5.5 11.8 16.7 14.3 12.5 13.4 9.8 7.5 5.4 11.8 5.3 10.8 9.9 9.1 9.6 20.2 5.9 7.5 7.4 11.9 14.5 13.1 7.4 16.7 8.4 11.0 5.2 50.9 12.4 9.7 21.5 17.9 11.9 31.3 10.2 3.8 3.4 3.9 6.6 3.2 7.6 5.6 4.8 4.4 3.7 7.0 4.4 5.2 4.4 5.7 3.2 4.7 4.8 2.0 6.6 9.0 19.5 9.3 5.5 4.9 12.4 5.2 10.2 10.0 17.9 25.3 18.2 14.9 28.0 22.9 21.4 28.1 24.1 7.9 12.2 11.8 18.5 3.3 9.7 25.2 18.5 16.9 23.3 11.1 8.0 17.0 21.2 16.3 35.0 12.7 20.6 17.7 15.4 18.6 17.9 24.5 17.0 18.6 14.4 17.3 9.1 12.8 12.9 19.1 9.6 21.5 12.9 13.7 13.6 19.4 21.1 13.6 17.5 16.3 9.0 TRPV3 VRL3 ENSG00000167723 "Transient receptor potential cation channel subfamily V member 3" Q8NET8 17 3510502-3557995 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, FDA approved drug targets, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.4;skeletal muscle: 29.1" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 16.7;Enterocytes: 10.8;Suprabasal keratinocytes: 21.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 2.4" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 3.6;BEWO: 5.4;CACO-2: 4.3;RH-30: 13.3;T-47d: 5.6;U-266/70: 3.5" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 6 "cerebellum: 14.0" HPA069550 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane" "Centrosome, Cytosol" "HPA069550: AB_2686149" "unprognostic (1.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.22e-2)" "unprognostic (3.92e-4)" "unprognostic (4.87e-3)" "unprognostic (2.96e-2)" "unprognostic (6.66e-2)" "unprognostic (4.88e-2)" "unprognostic (7.02e-2)" "unprognostic (2.68e-1)" "unprognostic (4.88e-2)" "unprognostic (3.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (8.64e-2)" "unprognostic (2.93e-2)" 0.4 0.2 0.4 3.2 2.4 0.9 4.1 0.3 1.2 0.6 10.6 0.1 0.3 3.2 0.2 0.2 2.3 0.3 0.8 0.3 0.4 0.3 0.2 1.1 0.3 0.5 0.4 0.2 0.3 0.9 0.0 0.7 0.4 0.0 0.2 2.9 0.3 0.5 0.4 29.1 8.4 15.4 0.5 0.5 0.4 1.6 0.8 0.0 0.0 0.2 9.7 3.0 0.7 2.1 0.7 0.6 2.9 0.6 0.6 0.7 0.1 3.6 0.0 0.5 0.1 0.3 0.6 5.4 0.2 0.0 0.0 0.0 4.3 1.0 0.2 1.1 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.6 0.1 0.2 0.8 0.3 0.0 0.7 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.3 0.5 0.1 13.3 0.2 0.0 0.2 0.1 0.0 0.2 0.6 0.0 0.0 5.6 0.2 0.1 0.1 0.2 0.1 0.1 3.5 2.8 0.0 0.1 0.1 0.0 2.9 0.4 0.4 0.7 0.2 0.5 0.7 0.4 0.7 0.1 0.5 0.4 0.6 1.0 0.6 0.6 0.6 0.2 0.1 0.4 2.4 0.3 1.2 0.4 0.3 0.4 0.2 0.0 0.0 0.0 4.5 1.4 4.0 16.7 0.8 2.4 2.5 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.2 1.6 10.8 0.0 0.0 0.7 4.3 2.9 0.0 0.4 0.2 4.8 0.0 0.0 0.0 0.0 2.8 2.2 6.8 0.0 0.7 2.0 0.8 0.8 3.2 0.8 0.9 0.0 0.9 0.0 1.1 21.5 0.5 2.1 0.6 2.2 TSC1 "hamartin, KIAA0243, LAM, TSC" ENSG00000165699 "TSC complex subunit 1" Q92574 9 132891348-132946874 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 99.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011568, CAB012481, HPA074132" Supported Enhanced Cytosol NA NA Cytosol "CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666" "unprognostic (1.88e-1)" "unprognostic (1.51e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-1)" "unprognostic (6.67e-2)" "unprognostic (4.23e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (1.96e-2)" "unprognostic (3.48e-2)" "unprognostic (1.24e-1)" "prognostic favorable (8.01e-4)" "unprognostic (1.84e-2)" "prognostic favorable (7.91e-4)" "unprognostic (9.49e-2)" "unprognostic (1.46e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 10.4 13.6 15.8 8.8 26.8 13.6 11.4 32.1 28.3 12.7 10.8 22.6 7.9 9.1 14.6 12.3 10.9 12.4 9.7 17.6 13.0 12.1 13.1 9.4 11.6 10.2 12.5 15.1 21.2 12.1 15.9 19.5 15.8 21.1 11.8 12.6 13.1 11.6 10.4 20.0 13.8 11.2 14.2 12.4 13.7 10.6 36.2 14.9 10.5 16.2 8.6 14.2 10.9 11.1 2.8 3.1 4.8 7.0 4.9 7.1 2.6 6.2 7.4 10.1 8.3 10.4 9.9 19.0 8.4 13.6 8.8 8.7 12.5 7.3 14.6 3.7 16.0 13.4 16.2 11.9 8.5 9.0 7.0 6.3 4.6 14.7 10.2 12.4 6.8 6.3 10.7 6.4 11.2 13.8 8.8 10.1 13.0 8.1 8.0 10.0 11.5 6.1 5.8 13.9 9.2 6.2 7.4 19.1 8.2 3.9 8.2 5.1 7.8 9.8 6.1 4.8 12.5 11.1 4.0 10.4 14.4 8.7 8.6 5.7 4.5 10.0 14.2 8.2 4.0 6.4 4.1 4.4 4.8 6.5 7.0 7.1 1.9 3.6 5.7 3.1 2.8 5.9 5.3 1.7 4.9 3.2 1.8 5.7 2.6 15.8 26.8 32.1 28.3 13.0 12.1 12.5 15.1 21.1 14.9 20.8 25.6 10.8 4.8 6.6 26.0 26.6 7.6 21.4 12.5 10.4 35.3 12.8 11.6 9.5 39.6 8.7 6.3 0.0 6.2 19.5 9.1 6.5 8.1 5.0 7.8 23.8 16.1 12.3 8.7 99.6 14.4 7.4 11.8 8.2 7.9 10.4 10.9 8.4 10.6 7.5 25.2 19.4 8.0 18.9 17.8 7.5 17.6 7.1 9.9 6.5 TSC2 "LAM, PPP1R160, TSC4, tuberin" ENSG00000103197 "TSC complex subunit 2" P49815 16 2047465-2089487 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "GTPase activation" "Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002225, HPA030409, HPA049679" Approved Enhanced Cytosol NA NA Cytosol "CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848" "unprognostic (2.80e-1)" "unprognostic (1.01e-1)" "unprognostic (1.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-3)" "unprognostic (2.04e-2)" "unprognostic (6.05e-3)" "unprognostic (3.43e-1)" "unprognostic (8.94e-2)" "prognostic favorable (5.06e-4)" "unprognostic (4.32e-2)" "unprognostic (3.91e-2)" "unprognostic (2.14e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-2)" "unprognostic (8.96e-2)" 13.9 11.9 16.9 12.4 20.0 10.9 13.2 35.1 26.9 20.5 17.0 19.4 17.9 14.0 20.1 12.2 13.0 18.6 15.0 14.0 13.3 8.8 11.8 9.8 12.7 10.1 13.8 14.7 21.1 16.1 20.0 18.1 10.6 14.6 13.8 10.8 16.7 22.9 19.6 31.7 14.5 13.2 13.5 11.4 12.9 16.6 21.4 12.9 14.1 20.1 11.3 10.9 18.0 14.0 4.7 5.6 7.7 4.9 3.6 7.0 3.7 7.2 11.6 16.1 18.2 19.2 16.2 13.6 17.4 11.9 13.1 11.2 13.9 13.8 10.9 15.5 14.3 6.1 12.0 9.6 12.6 9.8 8.3 15.8 10.3 22.5 5.7 13.2 12.8 12.5 19.1 8.0 10.6 7.9 15.8 12.3 7.9 10.0 9.8 11.6 14.4 15.2 3.7 16.7 5.4 11.4 24.2 17.6 13.9 5.3 6.5 12.2 23.1 24.8 16.4 8.8 16.7 15.0 9.5 19.4 13.8 9.4 12.3 8.8 21.9 21.8 21.8 5.7 5.2 16.3 6.2 4.9 5.4 7.0 4.7 6.7 4.4 4.4 4.1 5.6 4.7 3.1 4.8 7.7 3.6 3.7 1.5 3.2 3.7 16.9 20.0 35.1 26.9 13.3 8.8 13.8 14.7 14.6 12.9 23.8 17.6 14.9 7.2 8.1 44.2 38.9 20.4 9.4 10.3 19.2 88.4 10.1 3.3 12.8 11.0 19.5 25.8 0.0 12.2 6.5 14.6 9.4 8.1 29.2 9.8 42.9 31.2 34.4 10.5 22.4 26.2 16.6 8.5 7.2 23.8 24.1 15.9 17.5 24.4 6.7 69.1 12.9 11.8 19.4 39.6 8.5 7.8 20.0 24.7 9.2 TSC22D2 "KIAA0669, TILZ4a, TILZ4b, TILZ4c" ENSG00000196428 "TSC22 domain family member 2" O75157 3 150408335-150466431 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 132.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004926 Approved Approved Cytosol NA NA Cytosol "HPA004926: AB_1080401" "unprognostic (4.65e-2)" "unprognostic (1.54e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.74e-4)" "unprognostic (2.49e-1)" "unprognostic (2.65e-2)" "unprognostic (1.89e-1)" "unprognostic (1.09e-2)" "unprognostic (7.63e-2)" "unprognostic (2.59e-1)" "unprognostic (2.28e-3)" "unprognostic (8.32e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (1.10e-2)" "unprognostic (4.86e-1)" "unprognostic (1.10e-2)" "unprognostic (3.49e-1)" 22.4 13.5 15.3 18.6 15.2 33.3 13.7 20.5 28.2 15.5 14.3 12.3 10.0 6.7 25.3 16.5 23.0 13.4 25.0 23.7 14.2 13.2 17.3 31.7 15.5 10.6 15.9 14.6 16.4 12.2 11.7 12.8 17.8 14.5 14.0 13.9 12.6 11.3 18.5 17.3 10.9 13.8 28.2 13.7 14.0 15.7 23.9 15.7 19.4 15.3 11.6 10.9 16.7 23.8 4.1 2.9 5.6 6.9 5.0 4.8 2.7 20.4 2.8 9.1 8.7 12.0 5.9 26.4 20.4 7.8 15.1 18.7 11.3 10.3 6.7 11.8 15.3 31.0 8.7 9.1 7.5 30.2 5.3 5.1 7.1 5.2 5.7 13.7 4.3 5.0 10.8 5.8 9.8 14.8 9.1 9.4 3.3 12.2 11.1 10.4 7.2 4.6 5.4 11.7 6.1 5.7 4.9 16.7 7.9 9.6 12.1 5.3 4.7 9.4 5.0 19.9 11.5 4.8 5.8 15.0 10.0 10.4 11.8 18.8 15.0 2.9 9.3 6.8 13.3 5.8 1.2 3.5 4.4 3.0 4.2 4.8 3.0 3.8 3.2 2.8 4.1 2.9 2.9 5.6 5.0 6.9 2.9 1.5 2.7 15.3 15.2 20.5 28.2 14.2 13.2 15.9 14.6 14.5 15.7 59.6 31.5 11.2 64.3 132.2 16.9 39.2 20.4 6.7 18.2 12.2 27.5 21.8 14.9 13.1 15.0 26.3 47.3 0.0 12.1 24.7 49.4 47.1 65.6 35.1 16.5 15.9 30.3 25.8 19.9 21.3 17.3 22.5 40.5 19.8 28.2 31.8 19.0 38.6 14.2 8.1 19.8 12.9 46.4 36.3 24.4 94.6 45.9 15.2 23.5 72.6 TSC22D3 "DIP, DSIPI, GILZ, hDIP, TSC-22R" ENSG00000157514 "TSC22 domain family member 3" Q99576 X 107713221-107777342 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "T-cells: 554.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 59.0;ASC TERT1: 40.6;HHSteC: 97.8;HSkMC: 37.0;hTCEpi: 87.0;Karpas-707: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001916, CAB034364" Approved Approved "Nuclear speckles,Golgi apparatus,Cytosol" NA NA Cytosol "Nuclear speckles, Golgi apparatus" "CAB034364: AB_2272198, HPA001916: AB_2666504" "unprognostic (3.67e-2)" "unprognostic (3.90e-3)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.43e-4)" "unprognostic (3.49e-2)" "unprognostic (3.21e-2)" "unprognostic (3.73e-3)" "unprognostic (4.40e-2)" "unprognostic (9.42e-2)" "unprognostic (5.32e-2)" "unprognostic (3.25e-1)" "unprognostic (7.47e-2)" "unprognostic (6.38e-2)" "unprognostic (1.37e-3)" "unprognostic (6.41e-2)" "unprognostic (4.14e-1)" "unprognostic (9.64e-2)" 69.1 48.4 18.2 72.7 21.0 72.4 142.4 31.8 32.7 53.3 49.0 10.6 36.7 16.7 37.2 26.6 58.7 45.4 47.8 42.6 18.8 12.2 33.8 20.9 83.3 98.8 22.0 16.2 54.6 20.0 7.1 18.8 31.3 20.8 51.8 37.2 39.8 172.4 40.7 163.5 65.2 54.6 45.4 22.9 55.7 49.3 20.3 19.2 29.7 59.8 36.1 62.7 75.3 89.6 47.9 31.7 191.5 62.4 69.0 82.4 105.1 1.5 2.7 1.4 3.8 59.0 40.6 0.5 2.5 2.1 1.1 1.3 0.0 5.3 3.4 6.1 2.0 0.8 7.9 2.8 8.0 0.5 1.0 1.3 1.6 11.2 0.1 97.8 0.3 5.7 37.0 87.0 0.9 24.3 12.0 4.4 0.3 0.5 54.9 10.0 5.4 0.1 5.8 2.4 1.6 1.7 0.1 3.5 7.2 3.9 1.0 0.3 3.1 2.4 13.4 18.4 2.7 2.5 7.7 6.5 3.6 1.1 0.7 0.5 12.1 5.2 1.6 1.8 6.8 1.0 42.7 34.0 126.9 55.2 40.4 40.6 47.9 63.4 53.6 31.7 45.5 59.6 55.4 191.5 69.0 62.4 6.4 82.4 105.1 18.2 21.0 31.8 32.7 18.8 12.2 22.0 16.2 20.8 19.2 59.6 147.5 391.8 38.4 97.7 53.4 30.5 48.4 41.5 87.6 45.4 0.0 2.0 197.3 24.0 16.1 115.1 41.9 210.2 19.9 91.5 234.0 81.2 340.0 64.2 107.3 58.8 61.5 157.1 231.9 22.5 213.4 235.9 415.0 13.6 19.2 6.1 17.0 17.3 300.5 23.9 16.4 426.9 193.6 5.2 6.7 69.3 8.2 554.2 28.4 23.7 TSC22D4 "THG-1, TILZ2" ENSG00000166925 "TSC22 domain family member 4" Q9Y3Q8 7 100463359-100479279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 97.2" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 493.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006757 Uncertain Approved Cytosol NA NA Cytosol "HPA006757: AB_1080403" "unprognostic (2.34e-2)" "unprognostic (3.06e-2)" "prognostic unfavorable (2.66e-4)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (9.45e-4)" "unprognostic (9.96e-2)" "unprognostic (1.27e-1)" "unprognostic (1.62e-2)" "unprognostic (2.31e-2)" "unprognostic (3.36e-1)" "unprognostic (1.09e-1)" "unprognostic (1.54e-2)" "unprognostic (3.84e-2)" "unprognostic (7.36e-2)" "unprognostic (3.81e-3)" 11.2 11.9 77.8 16.4 83.5 32.4 7.7 17.8 92.4 9.7 9.9 96.1 3.4 12.4 9.1 6.2 10.3 9.9 8.0 10.2 69.5 53.8 8.9 5.1 10.2 18.7 97.2 40.6 11.7 9.7 8.8 7.1 12.2 60.5 11.5 6.2 11.8 49.2 13.0 7.8 17.2 12.5 8.0 89.8 24.0 11.7 8.0 62.3 6.7 5.8 1.7 12.2 8.6 5.7 6.9 7.5 32.2 11.4 10.2 13.8 8.8 12.3 9.3 3.2 10.6 11.3 13.5 6.0 9.4 15.9 9.1 8.4 4.9 7.6 11.2 11.2 7.6 20.8 9.6 3.8 8.5 3.2 19.2 7.7 10.0 9.8 4.2 18.1 13.2 26.8 15.2 7.7 10.5 10.5 10.8 18.7 9.0 22.1 20.7 7.3 22.5 16.5 60.8 4.3 10.9 13.3 27.3 2.5 15.5 7.5 6.8 2.7 7.5 13.0 25.0 19.6 5.5 7.0 19.6 15.5 12.4 12.6 30.2 6.9 13.0 12.3 7.9 11.4 20.4 14.9 5.0 10.9 15.6 11.7 11.4 9.1 6.9 10.0 10.8 7.2 6.6 9.6 10.0 32.2 10.2 10.8 7.5 13.8 8.8 77.8 83.5 17.8 65.4 69.5 53.8 97.2 40.6 60.5 62.3 11.9 6.2 54.1 32.3 29.1 13.9 11.6 45.9 4.0 4.5 38.4 5.9 27.8 116.0 50.9 1.4 25.1 57.3 0.0 29.7 30.6 33.2 48.6 16.1 9.5 68.0 17.5 32.2 43.6 53.1 3.1 42.3 43.7 52.3 86.6 28.4 493.0 47.4 43.5 37.4 15.9 11.6 45.3 36.0 0.9 3.6 29.5 66.1 90.8 30.2 50.5 TSEN2 "MGC2776, SEN2, SEN2L" ENSG00000154743 "TRNA splicing endonuclease subunit 2" Q8NCE0 3 12484432-12539623 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027120, HPA027125, HPA027268" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347" "unprognostic (5.58e-2)" "unprognostic (4.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.71e-2)" "unprognostic (9.59e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.42e-1)" "unprognostic (5.66e-2)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "unprognostic (6.15e-2)" "unprognostic (1.41e-2)" "unprognostic (6.99e-2)" "unprognostic (4.90e-2)" "unprognostic (6.06e-2)" "prognostic favorable (3.49e-4)" 8.8 10.6 9.7 8.8 19.1 6.7 10.9 16.5 14.0 10.4 9.8 12.7 8.4 5.8 14.0 9.9 7.9 12.8 10.3 14.3 10.5 12.3 9.8 7.3 7.3 10.9 11.5 7.6 18.0 11.9 14.3 15.3 4.9 10.2 10.5 10.9 13.5 7.2 13.1 16.7 15.3 6.1 12.3 12.3 6.1 8.5 11.3 9.1 9.9 12.5 9.6 8.1 8.6 8.3 8.5 7.1 2.6 4.2 5.0 13.7 5.6 7.8 13.7 7.4 9.6 12.5 13.3 17.0 7.4 6.6 8.0 5.8 7.7 8.4 9.4 5.2 6.0 9.5 7.3 12.3 12.7 9.1 7.4 15.2 10.3 18.3 7.9 9.6 16.2 4.0 11.5 14.8 14.5 17.8 5.9 6.4 13.8 15.3 5.2 9.2 14.8 12.4 7.4 10.4 22.2 16.5 9.4 5.1 18.9 11.9 8.1 4.8 8.4 6.9 6.2 5.8 5.3 11.2 11.3 5.7 5.1 5.0 6.9 11.5 4.9 12.5 11.8 6.8 16.4 6.3 2.4 4.2 0.3 6.4 4.2 10.9 8.5 9.8 7.4 5.9 8.3 13.7 11.7 2.6 5.0 3.6 7.1 3.5 5.6 9.7 19.1 16.5 14.0 10.5 12.3 11.5 7.6 10.2 9.1 3.0 3.5 10.9 9.7 2.6 27.2 6.2 15.3 9.4 2.3 10.4 41.2 7.4 1.7 4.9 1.3 5.6 2.6 0.0 3.7 3.2 3.8 5.0 4.7 5.5 4.1 9.5 4.1 3.1 4.0 2.1 8.3 3.2 3.3 1.0 4.7 8.7 3.5 3.5 9.6 5.0 33.9 6.5 5.1 10.3 19.3 4.3 1.6 5.7 8.2 8.0 TSG101 "TSG10, VPS23" ENSG00000074319 "Tumor susceptibility 101" Q99816 11 18468336-18527232 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004283, HPA006161" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 14000 Cytosol "Nucleoli, Plasma membrane" "CAB004283: AB_671392, HPA006161: AB_1080408" "unprognostic (1.42e-1)" "unprognostic (7.91e-2)" "unprognostic (2.11e-1)" "unprognostic (6.77e-2)" "unprognostic (1.82e-1)" "unprognostic (2.72e-3)" "prognostic unfavorable (3.74e-6)" "unprognostic (5.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-2)" "unprognostic (4.15e-3)" "unprognostic (4.27e-2)" "prognostic favorable (5.52e-6)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" 24.7 30.5 18.4 14.2 25.5 23.5 27.6 22.7 25.9 22.5 23.1 23.7 21.6 20.5 25.8 27.7 34.3 23.9 18.4 31.8 17.7 20.6 33.4 29.0 20.1 23.4 21.6 21.4 23.2 39.5 33.2 23.5 38.5 24.6 21.9 28.4 19.4 25.4 22.4 44.5 27.3 25.7 23.1 21.7 20.5 23.0 33.7 20.2 27.5 32.3 37.1 25.5 24.2 25.5 20.5 18.2 42.3 29.2 14.3 22.0 22.2 14.4 23.8 21.1 14.6 25.0 26.2 19.7 22.4 30.3 27.5 27.2 16.3 7.6 19.5 13.8 25.0 29.6 22.2 21.0 20.3 30.5 27.4 25.7 12.1 12.6 24.0 32.2 18.1 20.9 22.6 41.4 14.3 39.0 29.0 22.5 18.9 19.6 16.6 33.2 26.0 11.4 19.7 13.0 31.3 24.2 10.3 21.4 16.2 18.4 20.6 15.1 27.0 21.5 18.1 28.6 22.1 18.0 18.2 12.1 18.5 11.3 38.4 16.6 10.7 20.5 15.5 19.0 10.1 23.5 42.3 19.5 40.7 14.9 21.7 15.0 20.5 14.4 15.9 18.2 18.0 15.4 16.4 34.5 14.3 29.2 15.4 22.0 22.2 18.4 25.5 22.7 25.9 17.7 20.6 21.6 21.4 24.6 20.2 59.6 51.0 42.1 71.0 37.8 39.6 60.3 56.0 107.1 37.5 41.8 23.6 165.8 106.1 92.2 31.6 49.6 64.6 46.7 89.0 89.6 50.5 62.3 42.8 34.8 70.2 35.0 59.1 46.6 42.2 12.6 52.0 49.4 54.0 107.4 58.3 78.3 101.0 58.3 40.7 95.2 33.9 45.3 45.3 142.6 153.8 42.3 247.6 44.5 43.7 75.7 TSGA10 "CEP4L, CT79" ENSG00000135951 "Testis specific 10" Q9BZW7 2 98997261-99154964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 55.7" "Group enriched" "Detected in many" 6 "Ciliated cells: 127.2;Early spermatids: 359.6;Late spermatids: 192.4;Spermatocytes: 112.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036879 Approved Cytosol NA NA Cytosol "HPA036879: AB_10671715" "unprognostic (1.71e-3)" "unprognostic (6.68e-2)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (4.95e-2)" "unprognostic (3.69e-2)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.15e-5)" "unprognostic (2.32e-1)" "unprognostic (2.82e-6)" "unprognostic (1.06e-2)" "unprognostic (9.91e-3)" "unprognostic (9.79e-2)" "unprognostic (8.37e-4)" 2.2 2.2 4.9 1.7 7.1 1.7 2.6 9.5 6.4 2.5 2.0 6.1 2.7 2.1 2.3 3.6 1.7 15.1 2.2 1.3 4.7 3.4 3.3 1.6 2.9 2.1 5.9 4.5 1.7 3.2 2.9 12.2 1.5 4.7 2.2 2.5 1.0 2.3 1.8 1.1 3.1 1.7 1.3 4.2 1.9 2.5 55.7 6.6 1.8 4.5 0.7 1.9 2.3 2.3 2.5 1.2 0.6 0.7 2.3 3.5 0.9 1.4 0.5 2.5 0.9 1.5 1.5 1.9 0.0 0.1 0.4 0.5 0.3 1.8 1.4 0.6 0.0 1.0 0.4 0.5 0.2 0.7 1.7 1.5 0.1 0.0 0.5 0.2 1.0 3.6 1.8 2.1 0.2 0.3 1.5 0.0 1.6 0.0 0.1 1.6 0.3 0.5 0.5 0.4 0.6 0.4 0.6 0.3 0.4 9.0 1.4 3.5 0.4 1.7 1.5 0.2 3.0 0.4 0.5 0.8 0.4 0.9 0.1 0.3 1.2 0.3 0.3 0.8 2.2 0.9 0.3 0.7 0.6 1.9 0.1 2.1 2.1 2.2 2.6 0.1 2.5 3.5 2.1 0.0 2.3 0.0 1.2 2.2 0.9 4.9 7.1 9.5 6.4 4.7 3.4 5.9 4.5 4.7 6.6 3.0 8.6 9.1 8.8 3.2 17.9 6.2 15.3 127.2 18.2 22.7 27.5 5.7 21.6 6.4 359.6 3.4 5.1 0.0 9.3 3.7 3.6 8.1 4.7 6.6 3.9 19.1 14.9 2.5 2.4 192.4 10.3 2.9 1.7 4.6 7.3 15.4 5.1 11.4 9.2 11.0 34.3 6.5 2.7 112.7 30.1 3.9 7.8 5.9 8.3 8.4 TSGA13 ENSG00000213265 "Testis specific 13" Q96PP4 7 130668648-130687432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 16.5" "Group enriched" "Detected in some" 9 "Early spermatids: 62.7;Late spermatids: 126.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.0;THP-1: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA022968 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA022968: AB_2671013" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.2 0.6 0.8 0.5 0.3 0.1 0.5 0.0 0.0 0.9 0.7 0.2 0.4 0.0 0.2 1.0 0.0 0.6 0.2 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.4 0.9 0.1 0.3 0.4 0.1 0.2 1.1 0.6 0.2 0.5 0.2 0.3 0.2 0.2 0.1 0.2 0.6 0.5 0.4 1.2 0.8 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 4.6 0.5 0.1 1.4 1.4 0.0 0.0 10.7 3.4 0.0 7.9 0.1 0.0 0.0 62.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 126.7 0.6 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 1.1 0.0 0.1 1.2 0.6 0.4 0.6 0.0 0.0 0.0 TSNARE1 FLJ31164 ENSG00000171045 "T-SNARE domain containing 1" Q96NA8 8 142212080-142403240 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 18.8" HPA074249 Approved Approved Cytosol NA NA Cytosol "HPA074249: " "unprognostic (2.92e-2)" "unprognostic (1.44e-1)" "unprognostic (3.94e-3)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (1.09e-2)" "unprognostic (1.48e-2)" "unprognostic (3.72e-3)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.87e-3)" "unprognostic (1.66e-1)" "unprognostic (6.26e-2)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "prognostic favorable (7.33e-4)" 9.0 8.4 14.3 10.1 14.3 5.3 9.0 14.4 18.4 11.2 8.9 15.6 7.4 15.2 12.6 10.5 7.4 13.2 8.2 7.2 8.6 8.0 8.6 6.6 9.2 8.2 12.7 12.9 17.9 24.3 9.0 9.8 4.8 11.6 10.5 4.3 10.5 17.1 11.5 11.7 31.9 16.5 7.4 8.4 13.2 11.3 8.9 14.3 6.3 12.3 6.5 9.7 9.3 8.8 1.2 1.5 3.9 5.0 1.2 2.3 1.4 5.0 5.0 3.3 4.1 2.6 2.4 10.4 1.5 2.4 1.5 1.6 1.5 5.5 2.7 8.2 1.2 2.6 4.5 1.5 5.2 0.6 3.0 4.7 2.9 1.2 5.4 6.9 7.1 7.4 4.6 4.9 0.0 3.5 3.1 1.6 14.2 6.0 0.3 1.0 6.6 5.9 6.4 3.3 5.0 11.9 0.0 1.7 4.5 2.9 6.2 13.7 8.3 6.7 5.6 9.9 1.7 3.7 6.4 4.1 2.4 6.6 4.5 3.1 0.4 2.0 4.2 4.5 18.8 2.5 3.9 1.3 0.3 2.3 5.0 1.6 0.8 1.3 0.6 1.5 1.2 0.5 0.9 0.1 1.2 3.5 0.0 1.5 1.4 14.3 14.3 14.4 18.4 8.6 8.0 12.7 12.9 11.6 14.3 0.0 1.4 0.0 1.9 3.9 2.0 3.1 2.5 2.7 0.0 1.8 2.0 0.2 3.3 1.4 1.8 1.4 1.3 0.0 1.6 1.5 0.6 1.2 0.0 1.1 1.7 0.0 1.7 1.3 3.0 3.9 0.9 1.2 3.3 1.8 0.7 2.9 1.4 0.0 1.4 1.4 0.7 0.0 1.3 3.9 3.2 6.6 0.2 2.2 0.8 0.9 TSNAX TRAX ENSG00000116918 "Translin associated factor X" Q99598 1 231528653-231566524 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024613, HPA031054, HPA031055, CAB034263" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 100000 Nucleoplasm "Golgi apparatus, Cytosol" "CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314" "unprognostic (6.28e-3)" "unprognostic (5.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.12e-1)" "unprognostic (5.55e-2)" "unprognostic (2.27e-1)" "unprognostic (2.96e-2)" "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-3)" "unprognostic (4.51e-2)" "unprognostic (1.91e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-2)" "unprognostic (6.52e-3)" "unprognostic (2.70e-2)" 27.4 29.9 23.9 17.1 26.7 12.0 23.4 28.0 33.1 19.7 16.2 21.9 17.2 15.8 20.0 24.6 18.0 16.4 16.7 22.7 25.1 23.9 29.1 23.0 18.4 22.6 22.1 22.1 18.6 14.6 32.3 36.0 18.3 28.5 21.3 18.0 19.6 17.5 19.9 52.5 20.6 14.8 18.9 28.2 24.0 15.5 17.5 24.4 24.5 26.7 25.4 22.0 19.1 17.3 10.0 11.7 54.6 17.5 18.7 13.5 11.0 11.0 9.1 13.9 11.4 10.3 12.7 15.8 12.6 19.1 16.2 14.0 7.8 15.6 15.6 21.3 13.7 6.0 12.1 11.0 11.4 21.1 13.9 19.2 15.0 9.4 10.3 14.2 24.7 31.9 15.5 12.6 15.6 12.1 10.2 11.7 11.4 24.2 11.1 21.9 4.5 15.9 12.1 20.5 9.3 11.1 15.8 15.3 21.1 18.1 12.8 13.3 25.6 13.1 16.7 42.4 5.9 24.3 42.0 10.9 11.2 10.2 22.4 22.6 18.9 24.9 17.4 18.3 19.6 30.6 54.6 11.2 29.2 11.4 13.5 10.8 10.0 12.3 11.2 11.7 9.9 13.2 12.7 11.4 18.7 17.5 6.8 13.5 11.0 23.9 26.7 28.0 33.1 25.1 23.9 22.1 22.1 28.5 24.4 26.8 32.9 25.4 17.9 38.9 58.2 20.9 38.2 26.8 17.0 40.1 27.5 39.1 46.4 25.0 7.5 33.3 20.5 46.7 27.1 39.0 28.8 14.4 75.1 26.0 42.6 62.0 27.7 27.6 51.1 7.5 31.1 45.0 25.3 37.9 29.8 64.5 23.0 23.4 33.9 36.6 45.9 38.8 35.6 28.1 70.9 44.9 30.3 35.8 22.4 12.2 TSNAXIP1 TXI1 ENSG00000102904 "Translin associated factor X interacting protein 1" Q2TAA8 16 67806765-67832148 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.2;testis: 40.6" "Group enriched" "Detected in many" 7 "Ciliated cells: 46.8;Early spermatids: 85.4;Late spermatids: 137.1;Spermatocytes: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 7.1;SiHa: 4.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA053516 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053516: AB_2682175" "unprognostic (9.78e-3)" "unprognostic (2.05e-1)" "unprognostic (4.65e-2)" "prognostic favorable (2.22e-4)" "unprognostic (1.92e-1)" "unprognostic (2.82e-3)" "unprognostic (2.73e-1)" "unprognostic (7.09e-2)" "unprognostic (2.93e-1)" "unprognostic (6.66e-2)" "unprognostic (1.81e-3)" "unprognostic (1.94e-1)" "unprognostic (4.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (9.49e-3)" "unprognostic (1.59e-3)" 0.9 1.9 4.8 1.1 9.2 0.6 0.9 2.0 3.9 1.3 0.9 3.3 1.9 0.5 1.8 3.6 0.7 14.2 1.2 0.7 3.8 3.3 1.6 0.8 2.1 0.7 1.2 3.7 2.5 2.2 2.9 6.9 0.7 6.3 1.0 0.7 1.0 1.0 2.0 0.5 0.8 0.6 1.2 0.9 0.8 1.2 40.6 2.5 0.0 1.1 0.0 0.7 0.9 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.4 1.1 0.4 2.5 7.1 3.5 0.9 0.9 0.0 1.6 0.5 2.4 0.7 0.8 1.1 1.1 0.2 0.8 1.4 1.0 1.1 1.5 0.4 0.9 0.0 0.8 0.1 1.1 1.7 0.2 0.9 0.9 3.6 0.5 0.5 0.0 1.4 0.5 0.3 0.0 0.0 0.3 0.6 0.7 0.2 0.4 1.7 0.7 0.1 3.6 0.7 2.0 2.1 4.5 0.1 0.4 0.9 1.8 0.1 0.9 0.4 0.1 0.3 0.2 1.3 2.1 0.2 0.3 0.2 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.8 9.2 2.0 3.9 3.8 3.3 1.2 3.7 6.3 2.5 0.0 2.4 0.0 0.4 0.1 3.1 8.1 0.0 46.8 5.7 5.2 3.9 0.4 0.0 0.6 85.4 0.6 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.8 0.2 3.2 0.0 0.6 0.0 137.1 2.6 0.5 0.0 0.0 0.0 3.5 0.1 0.0 1.8 2.1 10.0 6.5 0.3 56.4 11.2 0.3 0.5 0.0 0.0 0.1 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451473-69507669 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 106.8;Exocrine glandular cells: 167.5;Mucus-secreting cells: 103.1;Pancreatic endocrine cells: 141.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 17.4" "Lineage enriched" "Detected in many" 6 "T-cells: 17.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.9;EFO-21: 48.7;MCF7: 36.8;OE19: 33.8;PC-3: 60.5;SK-BR-3: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044657, HPA071160" Approved Approved "Nuclear bodies,Vesicles,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane" "Vesicles, Cytosol" "HPA044657: AB_10967927, HPA071160: " "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavorable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 34.2 3.1 11.5 9.7 22.7 0.9 24.9 40.4 17.0 8.9 30.4 49.2 12.5 24.0 15.1 8.4 7.1 16.2 17.1 8.3 18.0 9.2 10.2 3.0 20.4 4.9 33.1 11.2 3.0 10.8 1.4 3.3 17.7 16.8 17.6 24.9 5.4 16.8 17.0 9.9 4.6 21.5 23.0 43.0 13.5 46.4 4.0 28.3 0.8 6.7 2.7 4.8 22.6 6.8 0.0 2.7 0.0 0.0 0.1 17.4 0.5 11.1 23.2 0.4 0.0 0.5 0.0 2.7 0.0 0.4 0.6 1.5 10.0 34.9 0.0 48.7 0.5 2.1 22.8 1.6 2.5 0.7 9.2 4.6 0.6 0.7 2.2 0.2 0.0 0.4 0.5 0.7 0.3 0.3 1.7 8.9 4.6 0.2 0.0 0.2 36.8 0.1 0.2 0.6 33.8 60.5 0.8 0.4 0.4 6.8 20.7 7.9 3.0 0.1 30.7 3.8 4.1 13.4 0.5 7.7 0.0 0.1 0.0 3.8 0.2 1.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 17.4 0.0 2.7 2.5 2.7 0.0 0.9 0.2 0.0 0.1 0.0 0.2 0.9 0.5 11.5 22.7 40.4 17.0 18.0 9.2 33.1 11.2 16.8 28.3 29.8 5.8 2.7 9.7 3.2 3.0 0.8 25.5 14.7 6.8 27.9 5.9 1.5 3.3 106.8 26.3 18.7 73.5 0.0 167.5 9.1 4.7 50.7 1.1 0.0 20.5 1.6 38.6 11.1 5.6 4.9 0.6 10.5 27.0 27.1 103.1 36.7 141.3 88.3 0.0 1.3 1.4 12.9 7.6 0.9 17.7 2.8 2.5 2.5 61.6 27.1 TSPAN31 SAS ENSG00000135452 "Tetraspanin 31" Q12999 12 57738013-57750211 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 54.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030758, HPA057489" Approved Approved "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA030758: , HPA057489: AB_2683447" "unprognostic (2.66e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (4.31e-3)" "unprognostic (1.19e-1)" "unprognostic (6.51e-3)" "unprognostic (5.31e-2)" "unprognostic (2.68e-1)" "unprognostic (2.79e-1)" "prognostic favorable (9.91e-5)" "unprognostic (1.68e-1)" "unprognostic (1.59e-1)" "unprognostic (6.32e-2)" "unprognostic (1.58e-1)" 27.0 26.4 19.4 18.2 22.5 5.4 21.8 14.3 20.5 21.9 20.1 30.5 23.0 16.3 23.1 37.6 21.3 27.7 23.3 23.3 19.1 17.8 32.1 29.2 20.7 14.5 20.3 16.0 32.0 32.1 31.4 22.7 31.5 19.4 23.3 19.0 32.1 24.6 22.0 19.8 15.2 24.0 17.5 24.3 23.1 18.2 11.4 17.1 14.6 42.4 16.5 20.7 20.2 16.8 17.6 35.4 18.6 24.8 23.7 22.0 18.8 3.6 8.8 9.1 2.3 21.0 13.9 5.9 5.8 7.6 3.1 3.1 6.1 19.6 3.3 12.8 13.2 3.8 7.6 2.4 12.2 4.4 8.7 6.5 4.4 7.3 2.5 20.8 4.4 7.8 12.3 14.5 6.0 12.7 9.4 8.1 1.7 3.2 9.6 9.9 7.3 3.4 2.6 1.9 6.6 2.8 4.2 60.0 8.5 12.7 7.4 3.1 7.8 6.2 9.1 4.5 2.2 17.1 6.9 11.1 5.0 4.1 2.7 3.0 11.9 2.6 1.6 13.5 3.0 7.6 18.6 15.7 11.1 22.0 15.7 21.3 17.6 17.8 18.9 15.6 16.8 17.8 16.7 5.3 23.7 24.8 35.4 12.1 18.8 19.4 22.5 14.3 18.5 19.1 17.8 20.3 16.0 19.4 17.1 44.7 25.9 22.0 37.5 10.0 39.9 4.2 22.9 25.4 21.6 29.6 39.3 16.4 8.3 31.1 0.9 23.2 21.6 0.0 34.1 12.3 23.7 26.6 43.9 17.4 19.7 20.6 25.4 20.3 15.6 2.1 23.9 24.1 30.4 24.4 20.3 54.9 31.7 21.0 16.3 15.9 55.1 19.4 23.6 8.7 4.8 11.0 20.5 14.9 21.2 28.5 TSPAN6 "T245, TM4SF6, TSPAN-6" ENSG00000000003 "Tetraspanin 6" O43657 X 100627109-100639991 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 88.4" "Group enriched" "Detected in many" 6 "Early spermatids: 313.3;Late spermatids: 1149.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "pons and medulla: 34.2" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.6" "Lineage enriched" "Detected in single" 8 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "NTERA-2: 43.2;RT4: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004109 Approved Approved "Nucleoli fibrillar center,Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "Nucleoli fibrillar center" "HPA004109: AB_1080301" "unprognostic (7.71e-2)" "unprognostic (8.97e-2)" "unprognostic (3.56e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-3)" "unprognostic (5.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-3)" "unprognostic (2.04e-3)" "unprognostic (8.76e-2)" "unprognostic (3.83e-3)" "unprognostic (4.28e-2)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (9.54e-3)" 27.0 9.8 7.0 4.4 6.6 0.1 33.0 2.9 4.9 15.9 17.8 12.6 6.4 9.7 11.1 10.4 27.1 24.2 10.0 5.7 7.4 7.3 26.7 68.2 8.3 3.6 6.9 4.1 27.6 25.1 19.6 17.7 23.6 34.2 15.5 20.3 16.7 88.4 6.7 3.5 4.7 11.6 4.7 10.4 8.6 8.0 17.5 6.6 2.9 24.6 11.0 19.8 17.2 11.5 0.3 0.2 0.8 0.2 0.3 6.6 1.4 7.9 10.6 28.7 14.5 12.6 6.8 11.6 4.5 7.1 9.0 21.1 23.8 13.9 0.0 19.1 4.6 6.2 6.5 0.1 8.6 10.6 0.0 15.4 1.4 6.9 26.5 7.0 0.0 1.1 13.3 4.2 7.9 3.1 13.1 19.1 0.0 0.0 0.0 9.2 8.2 0.0 0.1 43.2 12.0 8.0 0.0 13.6 0.0 14.1 65.2 1.8 7.8 4.5 3.9 6.0 24.1 5.7 1.0 5.3 5.6 8.6 9.2 2.9 0.0 0.0 0.0 5.0 0.0 4.0 0.5 0.1 0.2 1.0 0.1 3.5 0.3 2.4 0.8 0.0 0.2 6.6 3.8 0.8 0.3 0.2 0.2 0.1 1.4 7.0 6.6 2.9 4.9 7.4 7.3 6.9 4.1 34.2 6.6 3.0 8.5 7.8 36.0 6.4 0.7 7.3 61.1 115.1 21.6 89.0 0.0 26.5 19.9 64.9 313.3 22.2 51.9 0.0 11.1 33.5 17.7 46.5 0.0 94.2 3.8 0.0 32.3 58.9 11.8 1149.4 30.5 2.9 10.1 1.8 42.7 38.6 20.9 46.0 33.6 37.7 1.5 19.4 7.5 19.0 32.2 4.6 11.3 3.5 78.3 78.2 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;heart muscle: 58.5" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 66.4;Extravillous trophoblasts: 79.2;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.2" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RH-30: 63.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 125.3" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 1900000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 12.7 5.3 2.6 4.0 5.9 0.3 16.2 58.2 11.5 17.6 6.6 3.0 16.1 3.6 20.9 11.2 6.8 8.8 13.8 58.5 2.9 2.7 21.3 25.3 13.6 3.9 2.8 3.3 15.3 6.5 17.4 3.8 27.7 4.5 10.7 2.7 21.8 8.4 17.7 7.1 13.3 5.4 9.5 2.6 8.4 5.6 5.7 2.3 6.0 9.4 9.4 4.3 8.1 13.6 0.0 0.0 0.6 0.1 0.0 1.1 3.6 0.4 3.5 6.0 5.1 4.9 4.7 14.1 6.8 20.6 4.4 5.8 8.2 3.2 0.2 6.8 3.9 4.2 0.9 2.4 2.5 2.6 1.1 2.7 9.3 2.7 5.8 13.5 0.0 0.7 6.0 2.2 9.1 4.2 14.8 15.0 0.3 0.2 0.2 3.8 5.3 0.0 0.2 8.4 2.1 1.9 2.7 63.6 0.8 18.4 1.6 10.7 7.2 4.5 11.5 4.4 12.9 4.0 0.0 8.8 2.4 7.3 3.9 6.4 0.0 0.0 0.0 6.1 0.1 2.6 0.0 0.1 0.0 1.1 0.1 0.3 0.0 0.2 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 3.6 2.6 5.9 58.2 11.5 2.9 2.7 2.8 3.3 4.5 2.3 0.0 2.6 0.9 10.8 17.1 66.4 45.8 10.2 1.4 3.4 12.2 2.0 49.9 5.0 16.1 1.4 32.2 2.4 0.0 7.8 79.2 21.2 16.1 0.0 33.3 5.4 31.8 5.8 38.1 3.3 2.4 16.1 0.9 11.8 1.0 2.6 3.3 9.1 0.0 16.3 18.2 4.2 19.4 19.5 1.4 3.4 10.5 67.5 0.0 1.9 9.7 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151514-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 139.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011232, HPA046260, HPA072304" Uncertain Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB011232: , HPA046260: , HPA072304: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 33.9 21.2 9.8 17.8 11.0 117.3 48.7 2.7 8.1 24.9 23.9 12.3 10.3 20.5 12.3 13.6 83.2 14.3 36.8 32.1 8.0 5.4 18.0 22.0 39.8 40.0 15.4 5.2 13.3 13.2 4.0 6.7 15.5 9.7 23.1 9.7 16.4 34.6 9.2 13.2 46.6 23.0 12.7 11.4 27.2 39.0 10.5 10.0 9.4 17.9 44.3 50.0 19.1 41.3 22.9 99.9 91.4 139.5 28.5 43.8 104.8 47.6 23.6 1.6 22.4 9.0 29.9 1.8 35.6 17.4 17.9 19.1 4.6 36.5 0.0 24.7 27.6 8.8 39.5 4.5 27.6 2.3 7.9 18.6 4.8 25.9 1.6 32.7 10.8 24.4 23.2 45.5 10.6 9.5 21.1 42.4 0.0 3.9 9.0 18.3 39.9 0.1 30.2 1.9 24.6 59.0 10.7 0.0 81.4 22.9 28.8 2.3 11.0 16.9 33.8 41.5 0.0 12.7 42.0 43.7 22.3 16.7 22.7 14.9 3.6 0.6 0.4 28.9 35.1 28.5 43.8 139.5 75.3 28.4 86.3 22.2 16.3 39.5 27.8 99.9 22.9 30.4 24.5 91.4 28.5 57.1 17.7 43.8 104.8 9.8 11.0 2.7 8.1 8.0 5.4 15.4 5.2 9.7 10.0 148.9 135.1 105.0 344.2 325.8 2.2 79.7 336.3 127.2 167.2 195.4 2.0 9.0 313.4 570.0 2.1 215.5 499.4 46.7 512.5 126.3 307.4 297.1 261.1 99.0 745.0 3.2 187.3 163.2 688.0 6.1 76.5 573.3 686.7 477.9 485.1 116.9 963.2 644.9 148.2 97.5 17.1 103.5 217.3 1.1 4.9 468.6 16.7 155.6 529.3 666.0 TSPY1 "CT78, TSPY" ENSG00000258992 "Testis specific protein, Y-linked 1" Q01534 Y 9466955-9469748 "Disease related genes, Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 105 "testis: 10.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 361 "U-266/70: 64.9;U-266/84: 60.7" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (2.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.9 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 TSPY10 ENSG00000236424 "Testis specific protein, Y-linked 10" Y 9527880-9530682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 6.3" "Cell type enriched" "Detected in single" 14 "Spermatogonia: 8.6" "Cancer enriched" "Detected in single" 13 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-266/84: 36.6" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (5.36e-1)" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.6 0.0 0.0 0.0 0.0 0.0 TSPY2 TSPYQ1 ENSG00000168757 "Testis specific protein, Y-linked 2" A6NKD2 Y 6246223-6249019 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 104 "testis: 13.5" "Cell type enriched" "Detected in some" 8 "Spermatogonia: 26.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 426 "U-266/70: 41.9;U-266/84: 43.2" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (3.69e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.9 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 26.0 0.0 0.0 0.0 0.0 0.0 TSPY3 CT78 ENSG00000228927 "Testis specific protein, Y-linked 3" P0CV98 Y 9398421-9401223 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "testis: 7.6" "Cell type enriched" "Detected in single" 25 "Spermatogonia: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 75 "U-266/70: 50.9;U-266/84: 46.1" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (4.19e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 50.9 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.0 0.0 TSPY4 ENSG00000233803 "Testis specific protein, Y-linked 4" "P0CV99, P0CW01" Y 9337464-9340284 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 222 "testis: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 604 "U-266/70: 178.3;U-266/84: 187.8" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 178.3 187.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 TSPY8 ENSG00000229549 "Testis specific protein, Y-linked 8" P0CW00 Y 9357797-9360599 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 4.1" "Cell type enriched" "Detected in single" 12 "Spermatogonia: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 230 "U-266/84: 77.1" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 77.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.9 0.0 0.0 0.0 0.0 0.0 TSPYL5 KIAA1750 ENSG00000180543 "TSPY like 5" Q86VY4 8 97273474-97277964 "Predicted intracellular proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Group enriched" "Detected in many" 8 "Early spermatids: 165.5;Late spermatids: 304.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 16.4;K-562: 13.7;SCLC-21H: 29.2;SH-SY5Y: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031347 Enhanced Approved "Golgi apparatus,Cytosol" No No Cytosol "Golgi apparatus" "HPA031347: AB_10601454" "prognostic favorable (1.21e-4)" "unprognostic (5.13e-2)" "unprognostic (4.90e-2)" "unprognostic (1.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.06e-1)" "unprognostic (1.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "unprognostic (3.46e-2)" "unprognostic (1.25e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.40e-5)" "unprognostic (3.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.31e-2)" "unprognostic (3.13e-1)" 5.5 8.3 9.0 4.0 19.7 1.3 11.3 8.4 24.0 11.5 8.0 9.3 20.1 1.9 14.2 14.9 4.5 11.9 6.3 11.1 9.1 15.0 8.5 1.9 6.6 5.5 8.6 9.1 23.9 8.0 5.5 12.8 4.1 17.4 14.6 3.4 7.1 8.7 17.7 10.5 3.8 3.7 13.3 7.1 6.4 7.4 46.4 5.2 6.3 7.9 4.4 6.6 9.8 4.6 1.5 2.3 0.7 0.5 1.0 1.3 0.4 0.0 7.4 0.0 0.0 0.2 0.2 0.0 5.8 0.0 5.8 3.8 0.0 0.2 0.0 8.1 6.9 0.0 2.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 9.4 0.0 8.2 0.0 0.0 0.0 16.4 13.7 0.0 0.2 10.7 0.0 0.0 0.0 0.0 0.1 10.6 0.0 0.0 4.9 0.0 29.2 22.6 0.0 1.9 0.0 4.1 0.0 0.9 0.0 0.0 12.8 0.0 0.0 6.9 10.3 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.5 0.0 0.7 0.5 0.1 2.3 1.5 1.3 0.5 0.0 1.0 0.2 2.2 1.1 0.4 9.0 19.7 8.4 24.0 9.1 15.0 8.6 9.1 17.4 5.2 6.0 2.6 0.0 4.2 2.1 10.9 10.6 2.5 5.3 3.4 8.7 19.6 0.1 5.0 5.6 165.5 9.0 0.0 0.0 2.9 0.1 7.3 6.3 0.0 0.8 5.1 7.9 2.4 4.9 3.9 304.7 22.7 2.6 6.8 2.8 0.0 11.4 4.2 0.0 19.8 0.9 11.5 6.5 5.6 28.1 26.0 1.4 0.1 0.0 0.2 3.1 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253184-54256272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 41.1" "Group enriched" "Detected in some" 9 "Spermatocytes: 27.4;Spermatogonia: 22.4" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 66 "K-562: 13.4" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034699: AB_2674288, HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 27.4 22.4 0.0 0.0 0.0 0.0 0.0 TSR2 "DT1P1A10, RP1-112K5.2, WGG1" ENSG00000158526 "TSR2, ribosome maturation factor" Q969E8 X 54440401-54445487 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030514 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Cytosol" "HPA030514: AB_10603457" "unprognostic (1.05e-1)" "unprognostic (1.80e-2)" "unprognostic (1.77e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-2)" "unprognostic (5.91e-2)" "unprognostic (7.15e-3)" "unprognostic (8.29e-2)" "unprognostic (4.39e-1)" "unprognostic (1.31e-1)" "unprognostic (2.94e-2)" "unprognostic (6.19e-2)" "prognostic favorable (1.21e-6)" "unprognostic (2.27e-1)" "unprognostic (1.13e-1)" "unprognostic (7.93e-3)" "unprognostic (1.80e-3)" 20.8 25.0 52.9 13.8 53.1 15.3 19.2 27.6 44.3 18.2 17.2 30.8 16.9 13.9 18.4 33.9 16.2 21.1 14.8 22.2 45.3 46.2 26.5 23.7 17.5 14.9 53.8 34.4 22.9 17.2 30.7 19.0 19.8 31.0 20.8 20.6 19.0 16.6 25.4 35.5 17.2 14.7 19.7 54.3 18.1 16.5 8.4 27.5 10.2 23.9 10.8 22.0 17.7 16.8 39.6 15.4 28.7 21.2 24.7 41.4 21.1 20.3 26.1 19.1 17.4 17.3 12.5 17.1 20.2 16.5 18.9 16.2 24.6 22.3 22.3 14.0 17.7 33.7 21.1 46.7 28.0 25.2 29.0 23.1 18.2 19.5 19.2 10.7 31.4 19.0 11.6 15.4 26.3 27.2 14.9 13.1 18.8 18.5 16.7 19.2 37.4 23.9 24.8 30.4 18.4 29.7 21.5 35.6 18.9 20.1 18.1 24.2 16.8 38.5 19.3 21.4 34.7 39.2 11.0 17.9 13.9 24.5 29.1 17.2 17.9 27.0 26.7 20.4 25.0 20.8 24.5 15.3 28.7 35.1 20.5 28.8 38.7 33.3 31.8 13.9 39.6 41.4 31.7 9.4 24.7 21.2 15.4 35.5 21.1 52.9 53.1 27.6 44.3 45.3 46.2 53.8 34.4 31.0 27.5 23.8 23.8 40.1 37.8 29.1 55.8 44.8 22.9 45.5 39.8 33.2 25.5 86.7 106.1 35.8 0.8 36.5 26.0 0.0 28.8 60.7 42.6 34.1 43.9 22.9 39.7 54.0 17.4 23.4 12.3 2.1 32.2 27.9 38.8 70.3 30.8 56.3 30.9 28.6 42.5 51.9 48.8 45.3 43.4 12.2 43.7 27.7 63.5 41.1 28.8 29.1 TSR3 "C16orf42, MGC24381" ENSG00000007520 "TSR3, acp transferase ribosome maturation factor" Q9UJK0 16 1349240-1351911 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040760, HPA046265" Uncertain Approved "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA040760: AB_2677122, HPA046265: AB_10963942" "unprognostic (4.04e-1)" "unprognostic (2.00e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (4.74e-2)" "unprognostic (4.44e-1)" "unprognostic (1.40e-2)" "unprognostic (1.12e-2)" "unprognostic (5.36e-2)" "unprognostic (3.81e-2)" "unprognostic (6.07e-2)" "unprognostic (8.32e-2)" "unprognostic (3.92e-2)" "unprognostic (9.72e-2)" "unprognostic (3.72e-1)" "unprognostic (2.82e-1)" "unprognostic (1.14e-1)" 25.1 17.9 23.3 16.6 23.2 13.0 26.1 14.3 28.0 13.1 19.1 18.4 19.7 21.8 14.1 18.2 19.9 15.1 15.4 25.2 21.6 16.9 17.5 19.3 15.7 28.6 22.7 14.2 15.2 39.6 13.0 12.7 13.9 16.4 16.8 8.4 14.2 35.0 18.9 64.6 16.3 17.7 19.3 18.0 17.1 21.3 12.2 13.5 14.5 15.0 20.8 17.6 15.7 17.8 8.9 5.5 11.9 4.5 2.4 7.1 1.8 21.2 23.7 9.8 13.0 11.7 14.3 16.6 19.9 8.8 14.2 13.2 26.2 21.7 13.6 26.7 13.3 15.1 22.4 8.9 16.4 4.9 26.3 40.9 6.0 19.5 20.5 21.3 12.8 11.8 15.0 23.8 12.7 12.5 11.1 15.4 22.0 19.0 11.9 11.6 38.0 18.7 21.7 16.5 12.3 28.8 33.4 12.0 36.5 12.4 8.5 15.6 20.1 15.3 19.2 24.9 8.2 18.4 16.0 16.8 23.5 25.3 20.0 24.1 25.5 17.0 17.8 11.9 15.5 15.9 11.1 4.5 11.9 5.3 3.7 6.7 7.2 6.7 4.9 3.6 8.9 7.1 6.5 11.8 2.4 3.9 5.5 4.8 1.8 23.3 23.2 14.3 28.0 21.6 16.9 22.7 14.2 16.4 13.5 17.9 18.1 34.4 33.5 25.0 24.4 8.0 35.7 12.0 13.6 24.4 11.8 42.7 87.9 33.9 3.1 25.1 36.0 0.0 40.4 42.3 32.0 47.2 8.1 46.4 42.5 17.5 23.1 26.4 29.8 3.3 25.9 26.9 45.5 31.5 31.0 35.9 32.5 28.8 30.1 95.2 24.1 6.5 33.5 14.2 41.5 36.3 24.9 26.6 29.9 35.3 TSSC4 ENSG00000184281 "Tumor suppressing subtransferable candidate 4" Q9Y5U2 11 2400488-2403878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041801, HPA058763" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041801: AB_10793934, HPA058763: AB_2683811" "unprognostic (1.98e-1)" "unprognostic (9.22e-2)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" "unprognostic (8.13e-2)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "unprognostic (1.13e-1)" "unprognostic (3.29e-2)" "unprognostic (2.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (6.50e-2)" "unprognostic (1.32e-2)" "unprognostic (7.38e-2)" 25.6 11.7 12.1 13.9 12.5 33.0 13.2 10.7 20.9 17.5 21.5 12.7 10.9 15.9 20.6 13.3 16.7 16.4 15.1 23.2 11.9 11.0 14.1 19.4 13.8 16.8 15.2 12.7 17.7 20.9 10.3 14.7 19.8 11.2 18.2 5.6 13.1 20.2 19.0 32.5 16.2 16.1 19.0 10.5 18.5 14.0 29.1 10.7 21.7 22.7 25.2 14.7 20.2 36.2 54.0 44.9 55.3 44.7 43.0 49.0 37.3 19.6 24.6 8.1 12.8 6.9 5.0 15.5 13.4 9.3 16.4 11.3 18.1 25.5 14.3 11.9 10.6 18.6 19.5 9.4 15.6 3.1 16.4 25.7 8.3 13.1 18.4 18.8 14.3 17.6 12.0 22.5 10.5 10.0 7.1 11.3 14.6 18.9 16.1 7.7 25.4 17.0 26.0 23.5 15.0 29.0 19.3 7.2 12.8 8.2 16.5 21.0 21.4 11.5 26.0 15.7 4.5 13.6 16.9 14.9 21.7 11.3 20.1 15.5 32.5 27.9 12.0 18.6 14.7 22.5 55.3 44.7 43.8 46.1 38.2 49.0 43.5 45.9 47.2 44.9 54.0 41.4 39.0 43.2 43.0 40.1 43.3 47.8 37.3 12.1 12.5 10.7 20.9 11.9 11.0 15.2 12.7 11.2 10.7 17.9 16.2 42.7 41.3 59.8 34.6 18.3 10.2 4.0 9.1 12.2 11.8 43.5 43.1 51.7 56.0 37.9 61.3 0.0 43.9 40.6 30.5 45.3 17.3 25.6 34.2 27.0 54.9 31.9 25.2 132.0 41.1 33.6 30.4 52.3 30.7 42.1 51.2 49.1 31.8 36.6 29.3 38.8 55.1 87.9 67.3 72.0 68.7 43.7 31.2 45.8 TSTA3 "FX, P35B, SDR4E1" ENSG00000104522 "Tissue specific transplantation antigen P35B" Q13630 8 143612618-143618048 "Enzymes, Predicted intracellular proteins" "Isomerase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023361 Approved Approved Nucleoplasm,Cytosol Yes No 600000 Cytosol Nucleoplasm "HPA023361: AB_1858420" "unprognostic (1.37e-2)" "unprognostic (5.35e-2)" "unprognostic (8.62e-3)" "unprognostic (3.55e-2)" "unprognostic (2.90e-1)" "unprognostic (5.82e-2)" "unprognostic (2.48e-2)" "unprognostic (1.98e-1)" "unprognostic (8.62e-2)" "prognostic favorable (2.41e-4)" "unprognostic (6.62e-3)" "unprognostic (6.89e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (4.23e-2)" "unprognostic (2.78e-2)" "unprognostic (1.87e-2)" "unprognostic (3.27e-2)" 9.4 12.0 7.0 9.5 10.1 16.3 10.2 6.1 13.8 8.6 18.7 8.4 16.6 24.8 8.4 9.9 28.0 7.7 23.7 15.7 8.1 7.8 11.7 40.0 8.9 16.5 6.8 8.1 9.7 60.1 6.4 14.2 21.9 12.2 13.9 14.9 9.5 35.4 14.2 16.8 28.4 20.2 6.9 4.7 11.3 35.5 24.6 5.6 14.7 13.0 17.8 24.8 9.8 10.4 18.7 25.6 17.7 21.0 28.1 26.9 20.5 16.4 12.0 6.0 18.0 5.1 4.9 11.2 13.6 13.4 9.7 7.3 14.6 17.5 7.2 13.4 9.6 4.0 11.8 9.1 18.5 4.4 18.6 13.2 10.6 21.2 16.9 10.4 7.1 12.2 6.1 9.6 6.5 23.3 7.9 15.7 12.9 11.8 10.5 7.3 49.8 9.2 10.8 8.2 47.2 16.4 10.6 4.6 22.1 19.6 16.5 12.4 9.7 9.3 18.4 13.7 4.5 23.4 10.4 13.1 6.4 25.6 7.6 13.1 7.9 5.6 5.3 9.9 16.3 9.6 10.5 15.9 17.7 21.0 21.0 21.2 16.1 22.7 22.6 18.0 18.7 16.9 18.7 16.3 28.1 16.3 25.6 26.9 20.5 7.0 10.1 6.1 13.8 8.1 7.8 6.8 8.1 12.2 5.6 14.9 27.3 38.0 42.2 74.1 12.6 12.5 61.1 18.7 12.5 8.7 5.9 73.8 46.4 110.8 79.5 30.8 86.0 46.7 170.3 125.9 25.3 69.4 25.3 62.7 61.4 12.7 59.5 26.4 25.1 197.6 38.0 25.2 28.7 33.3 168.9 16.3 123.1 69.1 32.2 68.8 9.3 12.9 27.2 56.2 48.1 108.3 73.3 42.9 88.1 73.3 TSTD1 KAT ENSG00000215845 "Thiosulfate sulfurtransferase like domain containing 1" Q8NFU3 1 161037631-161038990 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 37.5;OE19: 39.8;SK-BR-3: 52.8;T-47d: 51.1;U-266/70: 59.7;U-266/84: 41.9" "Region enriched" "Detected in some" 4 "olfactory region: 8.2" "Low region specificity" "Detected in many" "HPA006518, HPA006655" Approved Approved "Cytosol,Cytoplasmic bodies" NA NA "Cytosol, Cytoplasmic bodies" "HPA006518: AB_2667608, HPA006655: AB_10600919" "unprognostic (6.10e-2)" "unprognostic (4.70e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" "unprognostic (5.77e-2)" "unprognostic (1.63e-1)" "unprognostic (6.56e-2)" "unprognostic (2.51e-3)" "unprognostic (2.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "unprognostic (1.13e-1)" "unprognostic (4.64e-2)" "unprognostic (2.38e-2)" "unprognostic (2.83e-2)" "unprognostic (8.57e-3)" "unprognostic (8.88e-3)" 9.1 19.9 14.8 15.4 29.8 13.1 24.2 3.6 13.9 10.1 18.1 4.4 45.4 12.2 4.2 34.7 23.3 21.8 16.0 14.4 12.2 8.1 28.4 26.0 19.2 14.6 4.1 13.2 15.0 62.2 27.7 32.9 10.1 6.3 26.0 12.8 11.9 79.8 46.0 9.2 18.7 16.5 5.6 1.9 10.4 14.1 15.0 5.5 20.4 61.3 19.5 27.1 12.3 11.0 77.0 30.9 55.0 14.8 42.1 58.7 31.9 21.4 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 21.2 4.6 13.0 0.0 0.0 19.9 0.0 8.5 0.0 17.8 16.0 2.4 8.1 0.0 2.3 8.0 0.1 0.1 5.3 0.0 0.9 0.0 2.9 19.1 0.0 25.2 2.5 37.5 21.7 0.1 0.1 39.8 0.1 7.1 0.0 33.0 18.5 6.0 13.1 7.0 0.0 52.8 0.1 11.1 51.1 0.1 0.1 0.0 8.0 0.1 0.9 59.7 41.9 4.6 0.0 0.0 0.0 55.0 3.6 51.2 36.3 10.5 34.8 75.8 47.8 40.2 10.9 77.0 54.7 45.9 51.6 42.1 14.8 30.9 58.7 31.9 14.8 29.8 3.6 13.9 12.2 8.1 4.1 13.2 6.3 5.5 235.2 172.5 87.8 263.5 76.6 11.5 49.7 221.7 445.7 177.5 349.0 25.5 237.9 580.3 133.0 14.1 14.6 335.6 0.0 132.4 100.5 27.4 450.5 120.3 124.5 63.7 3.2 210.0 12.3 18.3 14.6 7.8 47.2 143.4 288.6 340.6 29.3 129.9 191.5 9.2 413.9 23.8 19.4 22.1 31.3 40.7 118.7 126.3 120.4 248.2 338.2 TTBK1 KIAA1855 ENSG00000146216 "Tau tubulin kinase 1" Q5TCY1 6 43243680-43288259 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 6.7;Horizontal cells: 4.8;Proximal tubular cells: 1.9" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "SCLC-21H: 21.3;SH-SY5Y: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031735, HPA031736" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA031735: AB_2674019, HPA031736: AB_10670294" "unprognostic (1.68e-1)" "unprognostic (7.88e-3)" "unprognostic (7.01e-2)" "unprognostic (1.62e-3)" "unprognostic (2.18e-1)" "unprognostic (2.24e-4)" "unprognostic (2.46e-3)" "unprognostic (3.01e-2)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.01e-2)" "unprognostic (2.12e-4)" "unprognostic (7.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.64e-3)" "unprognostic (3.04e-4)" 1.1 3.9 12.4 1.3 12.9 0.9 1.0 14.9 28.9 1.0 1.4 8.2 0.0 4.6 1.0 1.0 1.0 1.1 1.4 1.3 10.3 7.5 1.7 3.5 1.1 1.2 7.1 12.5 1.0 1.4 1.6 7.7 1.0 9.0 1.3 1.3 0.7 1.0 1.2 1.0 1.0 6.8 1.1 6.2 1.2 1.3 2.3 8.3 0.0 1.0 0.0 1.3 1.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 21.3 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 12.4 12.9 14.9 21.7 10.3 7.5 7.1 12.5 9.0 8.3 0.0 0.0 0.0 0.0 0.0 6.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 4.8 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 TTC1 TPR1 ENSG00000113312 "Tetratricopeptide repeat domain 1" Q99614 5 160009113-160065543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036557, HPA057502" Approved Enhanced Cytosol NA NA Cytosol "HPA036557: AB_10670112, HPA057502: AB_2683450" "unprognostic (4.34e-3)" "unprognostic (2.26e-2)" "unprognostic (3.05e-2)" "unprognostic (7.38e-2)" "unprognostic (6.62e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (8.29e-2)" "unprognostic (2.38e-1)" "unprognostic (5.50e-2)" "unprognostic (2.31e-1)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (2.04e-2)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (6.16e-2)" 25.3 28.0 44.4 21.0 36.0 14.3 25.4 31.4 44.9 21.7 25.2 25.4 16.8 16.9 21.3 38.4 24.8 21.0 16.6 33.9 41.7 42.9 31.3 27.7 20.5 26.9 48.9 33.9 23.7 16.0 25.7 23.9 22.0 56.7 22.0 29.4 15.9 23.7 25.1 50.5 21.6 20.6 26.7 37.4 25.2 19.7 20.3 26.6 27.4 26.8 20.0 33.5 25.9 18.0 46.0 38.4 54.2 41.3 43.2 45.3 52.8 24.6 25.8 19.4 32.3 23.0 16.6 22.0 27.8 24.7 30.6 36.4 36.2 28.9 25.4 54.4 23.7 41.7 19.6 25.6 38.0 49.4 47.0 27.2 22.7 20.5 26.0 32.6 37.6 19.1 15.5 25.3 27.0 22.6 22.6 36.6 22.7 21.6 25.4 34.7 19.3 27.2 29.6 21.9 20.2 26.5 26.4 27.1 28.0 38.6 23.3 16.0 18.0 19.2 23.0 51.2 19.0 36.4 36.6 25.7 20.4 17.6 18.1 42.7 18.3 33.3 24.7 28.2 43.0 26.4 47.0 39.1 52.4 32.4 41.3 40.4 46.0 38.4 37.6 38.4 40.6 35.6 39.4 54.2 43.2 39.0 34.1 45.3 52.8 44.4 36.0 31.4 44.9 41.7 42.9 48.9 33.9 56.7 26.6 62.5 43.2 61.0 31.3 41.8 35.3 213.0 38.2 119.1 63.7 43.6 19.6 89.8 137.6 100.6 91.3 58.7 48.5 70.0 92.5 63.6 46.1 30.3 78.8 57.2 77.4 33.4 33.9 48.5 45.7 22.8 43.4 66.2 27.0 80.2 40.1 73.1 84.8 45.2 60.1 114.2 37.9 58.2 62.8 148.9 94.5 41.4 83.5 54.3 45.5 19.2 TTC17 FLJ10890 ENSG00000052841 "Tetratricopeptide repeat domain 17" Q96AE7 11 43358932-43494933 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038508 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA038508: AB_10671744" "unprognostic (2.71e-1)" "unprognostic (4.04e-3)" "unprognostic (6.48e-2)" "unprognostic (2.64e-1)" "unprognostic (1.17e-1)" "unprognostic (5.66e-2)" "unprognostic (1.74e-1)" "unprognostic (9.03e-2)" "unprognostic (5.01e-3)" "unprognostic (2.62e-1)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (1.04e-2)" "unprognostic (4.40e-1)" "unprognostic (1.18e-1)" "unprognostic (1.54e-2)" 12.7 13.6 16.3 15.8 18.4 6.8 21.2 21.1 17.0 12.7 10.7 9.1 21.1 10.9 15.0 13.9 11.5 17.7 11.5 10.5 12.8 7.4 12.0 19.9 20.4 19.8 21.7 11.3 26.6 47.7 20.5 20.8 15.0 15.4 13.8 12.0 10.6 20.7 11.7 12.1 10.9 14.0 17.7 12.9 11.9 16.4 12.3 17.3 11.1 19.5 9.1 11.1 12.8 12.5 22.4 23.3 24.5 29.0 20.4 23.1 21.1 5.8 12.0 12.6 19.8 32.0 26.6 8.9 14.1 19.0 11.9 14.4 8.3 8.7 12.3 14.2 14.1 13.8 12.4 8.9 9.3 14.4 9.5 11.7 9.4 7.8 8.1 39.6 14.1 12.2 24.6 28.7 8.6 28.0 27.1 11.8 9.0 13.5 10.5 11.9 7.0 10.3 8.1 18.9 22.7 10.4 9.7 13.5 14.2 15.1 8.6 6.8 16.2 11.0 29.4 17.6 13.4 27.6 16.0 15.7 17.1 7.6 19.1 20.3 20.8 16.7 11.8 11.0 8.5 18.1 22.3 28.3 23.8 21.0 29.0 21.9 22.4 22.6 19.7 21.9 20.7 23.1 21.0 24.5 20.4 24.7 23.3 20.3 21.1 16.3 18.4 21.1 17.0 12.8 7.4 21.7 11.3 15.4 17.3 59.6 54.2 28.4 28.8 37.4 41.5 17.6 28.1 49.5 54.6 21.0 56.9 25.8 3.3 19.2 29.2 34.4 26.8 0.0 37.4 25.1 35.1 39.2 33.7 51.6 22.7 44.5 21.5 41.1 45.4 12.2 52.9 30.9 27.0 27.9 41.3 25.2 28.5 31.7 34.3 11.1 49.2 51.8 28.6 40.9 34.8 37.8 25.7 35.4 34.6 32.8 TTC23 "FLJ12572, HCC-8" ENSG00000103852 "Tetratricopeptide repeat domain 23" Q5W5X9 15 99136323-99251223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039806, HPA040369" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039806: AB_10793921, HPA040369: AB_10795381" "prognostic favorable (3.17e-4)" "unprognostic (5.41e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.40e-2)" "unprognostic (6.53e-2)" "unprognostic (9.25e-3)" "unprognostic (2.56e-1)" "unprognostic (6.18e-2)" "unprognostic (1.76e-3)" "unprognostic (1.88e-1)" "unprognostic (3.24e-1)" "unprognostic (3.21e-2)" "unprognostic (1.11e-2)" "unprognostic (4.31e-1)" "unprognostic (7.99e-2)" "unprognostic (1.23e-1)" 9.5 10.7 6.0 6.1 8.6 1.0 9.7 5.4 7.5 13.2 15.5 12.2 11.9 3.7 20.3 9.9 10.7 10.6 10.4 11.9 7.7 4.7 10.6 8.2 8.1 3.0 9.8 7.5 17.5 11.7 10.7 10.2 10.0 10.5 13.7 8.7 14.0 8.4 12.0 7.8 8.6 6.4 12.3 15.7 5.2 8.7 16.2 9.0 5.1 14.1 7.7 5.0 13.0 11.4 0.5 2.4 3.8 1.3 2.0 0.5 0.1 6.8 7.1 11.0 12.6 13.1 14.8 4.6 8.5 10.4 9.1 10.3 6.1 11.9 1.7 17.1 9.6 8.2 13.3 3.5 8.4 9.9 2.2 11.7 7.3 12.5 4.8 7.6 1.6 0.5 10.4 7.6 7.1 6.8 9.9 15.2 3.3 5.6 1.0 8.5 4.1 5.8 1.8 5.9 1.8 4.9 1.8 14.3 2.6 7.3 9.2 4.8 2.1 11.1 4.5 10.3 11.5 7.6 7.6 9.9 11.5 6.9 7.7 10.8 6.0 8.1 2.3 10.3 0.5 6.8 3.8 0.5 0.6 0.3 1.3 0.3 0.4 0.4 0.5 2.4 0.5 0.3 0.3 1.8 2.0 0.5 1.9 0.4 0.1 6.0 8.6 5.4 7.5 7.7 4.7 9.8 7.5 10.5 9.0 3.0 6.5 0.0 4.3 2.2 1.7 6.9 7.6 4.0 5.7 5.2 0.0 4.1 5.0 4.5 6.9 5.3 2.9 0.0 5.5 3.7 4.8 2.4 1.1 5.1 3.4 7.9 0.0 9.2 4.3 5.6 8.3 0.8 1.7 1.0 4.8 10.0 4.0 2.9 9.6 4.4 4.7 6.5 4.0 16.8 8.1 3.4 1.6 0.0 6.0 2.4 TTC26 "dyf-13, DYF13, FLJ12571, IFT56" ENSG00000105948 "Tetratricopeptide repeat domain 26" A0AVF1 7 139133744-139191986 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 89.7;Spermatocytes: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036338, HPA036339" Enhanced Approved "Nuclear speckles,Intermediate filaments,Cytosol" NA NA "Nuclear speckles, Intermediate filaments, Cytosol" "HPA036338: AB_10673351, HPA036339: AB_10673386" "unprognostic (3.40e-2)" "unprognostic (8.88e-2)" "unprognostic (5.01e-2)" "unprognostic (6.72e-2)" "unprognostic (8.34e-3)" "unprognostic (1.45e-1)" "unprognostic (2.46e-7)" "unprognostic (1.72e-1)" "unprognostic (4.96e-2)" "unprognostic (5.27e-2)" "unprognostic (7.12e-2)" "unprognostic (2.75e-1)" "unprognostic (5.18e-2)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" 3.5 6.5 6.9 2.5 8.1 3.3 5.6 6.9 8.3 6.1 3.1 4.4 7.4 1.3 6.6 7.6 3.1 20.9 4.5 3.5 5.7 5.1 8.3 1.9 5.1 2.8 2.7 4.8 8.8 3.2 13.0 20.1 3.8 8.4 5.6 2.8 5.4 3.6 5.5 2.3 3.2 2.2 4.6 2.7 2.6 3.1 17.4 3.9 3.8 7.3 2.8 3.1 3.7 3.9 3.6 2.5 5.3 1.5 1.6 2.3 0.9 11.2 8.5 7.5 8.9 9.4 10.9 3.7 5.5 5.7 9.0 9.2 5.4 8.1 2.4 9.2 4.2 14.7 5.6 8.3 6.4 13.1 7.0 7.2 3.0 6.8 4.6 4.7 8.6 2.1 6.2 5.8 13.4 6.1 5.6 6.6 5.9 6.7 1.6 7.1 10.5 14.7 10.1 7.5 3.3 7.5 5.1 8.9 4.0 7.7 3.3 11.0 7.9 13.4 5.7 7.7 2.3 6.9 4.7 4.6 8.4 7.3 7.6 10.0 3.6 4.6 1.8 14.6 4.3 9.8 1.2 0.5 1.2 2.1 0.5 1.1 3.6 1.5 1.4 1.1 2.4 2.3 1.7 5.3 1.6 1.5 2.5 1.0 0.9 6.9 8.1 6.9 8.3 5.7 5.1 2.7 4.8 8.4 3.9 0.0 2.6 2.7 1.7 1.0 6.9 1.7 7.6 89.7 19.4 5.2 11.8 1.0 0.0 4.8 15.8 2.1 0.0 0.0 2.3 2.8 3.1 1.1 5.7 1.7 1.8 0.0 1.2 4.3 0.6 12.2 3.7 2.2 3.3 2.8 0.9 4.5 1.6 2.9 4.9 4.6 16.0 0.0 2.1 40.9 5.7 1.5 0.3 1.7 0.6 0.5 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 22.9 22.1 34.0 18.7 36.5 12.0 23.4 39.2 40.0 34.9 20.6 15.9 26.7 13.0 21.6 33.3 15.3 19.5 19.0 21.5 29.1 16.5 21.4 17.0 15.4 14.3 17.7 27.5 34.5 25.8 27.4 50.4 15.2 34.7 28.9 19.9 16.1 24.5 25.4 21.6 16.1 16.8 21.6 21.7 13.6 21.3 19.5 19.9 19.7 35.4 11.1 15.1 23.3 18.9 10.6 12.8 4.8 5.7 9.1 18.6 3.8 21.7 7.8 36.3 6.8 35.0 51.1 12.6 24.0 29.9 10.8 14.7 10.2 11.0 18.8 8.4 40.2 10.1 7.2 10.9 14.8 15.3 19.9 7.8 38.0 11.6 13.4 12.8 21.2 12.3 26.4 9.1 11.0 9.8 21.8 16.0 16.7 22.8 22.1 20.3 16.8 20.6 5.5 10.3 14.5 13.2 27.6 17.4 9.9 12.6 16.9 27.7 21.1 29.8 17.1 15.4 8.7 19.4 8.3 20.9 15.5 6.2 19.0 9.0 22.2 15.9 18.8 25.6 21.2 11.7 2.9 4.4 4.8 9.1 4.8 13.6 9.5 10.6 12.3 7.9 10.6 18.6 11.3 0.7 9.1 5.7 12.8 7.2 3.8 34.0 36.5 39.2 40.0 29.1 16.5 17.7 27.5 34.7 19.9 116.1 118.5 109.7 81.2 58.5 344.6 127.3 56.0 75.0 101.2 71.5 214.0 39.6 140.9 74.9 160.4 67.6 60.1 0.0 65.5 79.7 132.8 164.9 62.4 80.5 56.3 311.4 182.6 102.5 80.0 149.3 194.5 74.4 200.8 61.3 133.8 187.6 72.0 84.2 245.4 81.7 228.9 51.8 103.8 264.1 280.4 54.8 44.1 76.7 118.3 90.4 TTC31 FLJ12788 ENSG00000115282 "Tetratricopeptide repeat domain 31" Q49AM3 2 74483073-74494886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041783 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA041783: AB_10794306" "unprognostic (2.38e-2)" "unprognostic (7.44e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (2.64e-1)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (6.56e-2)" "unprognostic (7.22e-2)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.46e-3)" "unprognostic (9.61e-2)" "unprognostic (3.24e-1)" "unprognostic (4.83e-2)" "prognostic favorable (2.49e-4)" 9.2 8.9 7.4 12.3 11.7 11.5 8.6 13.8 9.3 9.0 15.7 8.6 5.3 10.5 11.6 9.4 8.7 7.9 14.5 7.4 8.9 3.7 9.9 23.6 8.2 10.4 10.4 7.7 9.7 13.4 13.2 10.0 13.7 8.3 8.0 9.5 10.5 8.1 7.5 6.5 11.1 16.2 9.3 7.0 13.6 11.6 8.6 12.2 11.5 7.7 9.7 11.5 10.6 8.5 9.3 9.7 8.1 10.2 7.5 9.0 7.8 11.1 10.1 6.6 3.4 3.8 11.3 7.7 6.2 8.6 11.3 7.9 8.6 8.3 15.7 4.9 4.9 10.4 8.1 6.1 6.7 5.6 17.2 6.3 16.7 9.0 14.7 7.5 6.8 11.1 8.2 9.0 9.6 6.0 7.6 7.6 7.2 11.1 6.7 7.0 10.3 10.1 4.0 4.1 8.2 5.0 10.0 17.3 7.4 6.2 8.3 3.3 12.2 5.8 9.1 6.3 3.8 6.8 3.8 14.0 7.8 12.9 4.8 9.1 9.9 7.9 10.2 9.6 7.9 7.2 6.4 10.2 8.1 8.4 10.2 9.0 9.3 6.5 8.0 9.7 7.3 6.3 6.8 1.4 7.5 10.2 5.7 8.3 7.8 7.4 11.7 13.8 9.3 8.9 3.7 10.4 7.7 8.3 12.2 14.9 8.6 11.5 3.5 2.5 10.2 2.9 12.7 4.0 9.1 8.7 37.3 7.1 1.7 4.7 3.3 4.5 8.1 0.0 4.8 4.3 3.5 2.7 18.5 18.6 7.3 4.8 5.8 4.3 7.3 3.8 5.8 7.8 3.3 10.8 5.3 8.1 4.8 5.5 5.3 5.0 22.2 6.5 4.1 8.9 8.7 2.9 6.8 7.5 6.3 3.3 TTC37 "KIAA0372, THES" ENSG00000198677 "Tetratricopeptide repeat domain 37" Q6PGP7 5 95463895-95555007 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037905 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037905: AB_10673034" "unprognostic (5.99e-2)" "unprognostic (7.65e-3)" "prognostic favorable (2.62e-4)" "unprognostic (8.48e-2)" "unprognostic (9.49e-2)" "unprognostic (5.39e-2)" "unprognostic (1.40e-2)" "unprognostic (2.18e-1)" "unprognostic (6.88e-2)" "unprognostic (5.97e-2)" "unprognostic (6.81e-3)" "unprognostic (2.51e-1)" "unprognostic (3.30e-3)" "unprognostic (6.88e-3)" "unprognostic (3.91e-1)" "unprognostic (3.98e-2)" "unprognostic (7.90e-3)" 29.6 21.8 18.9 16.1 19.4 6.9 19.2 35.7 37.9 21.1 19.7 8.2 20.7 15.6 17.3 15.5 27.5 14.8 13.7 17.5 20.2 14.1 28.2 25.2 17.1 13.8 21.5 21.5 21.3 22.2 40.2 42.1 20.7 26.5 21.1 16.8 6.6 16.8 17.4 33.1 23.9 22.7 21.5 29.8 16.0 18.8 9.1 25.0 25.2 19.7 23.5 15.3 28.1 16.1 10.3 14.8 3.5 7.4 8.2 12.0 3.7 12.4 13.3 16.9 5.8 28.4 38.7 15.1 23.8 19.3 15.5 23.4 14.1 9.2 22.0 15.8 22.6 16.2 12.3 21.3 28.8 26.1 12.8 17.4 14.8 27.0 9.3 24.3 9.5 10.7 25.6 14.8 19.8 27.8 24.0 24.5 7.4 11.6 14.5 29.3 7.1 12.4 7.7 9.5 5.7 11.3 10.6 23.7 23.1 17.2 9.8 21.2 16.6 19.6 9.7 21.8 14.8 15.1 8.2 33.7 21.3 12.2 16.7 18.2 14.0 17.6 20.5 21.5 14.1 27.3 3.5 6.0 2.1 9.9 7.4 12.0 9.6 9.7 8.0 7.2 10.3 10.0 10.4 0.2 8.2 6.7 14.8 8.8 3.7 18.9 19.4 35.7 37.9 20.2 14.1 21.5 21.5 26.5 25.0 71.5 37.6 23.1 17.3 17.3 59.4 74.7 12.7 45.5 47.8 26.2 47.1 24.9 13.3 32.7 1.2 35.9 25.6 0.0 34.8 37.4 22.4 24.3 39.4 30.6 23.4 55.6 31.2 33.2 29.8 1.5 57.8 23.5 8.5 54.1 32.2 20.3 37.0 14.0 60.8 25.9 34.0 38.8 24.7 6.5 8.3 28.7 16.6 21.8 31.5 16.5 TTC38 FLJ20699 ENSG00000075234 "Tetratricopeptide repeat domain 38" Q5R3I4 22 46267961-46294008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 59.8;liver: 92.8" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 78.3;Hepatocytes: 110.0;Proximal tubular cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 36.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.1;NK-cells: 13.5;T-cells: 36.0" "Cell line enhanced" "Detected in many" "Hep G2: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029302, HPA075893" Approved Approved Cytosol NA NA 19000 Cytosol "HPA029302: AB_10601704, HPA075893: " "unprognostic (7.78e-2)" "unprognostic (5.85e-2)" "unprognostic (4.92e-3)" "prognostic favorable (3.21e-6)" "unprognostic (8.34e-2)" "unprognostic (6.38e-2)" "unprognostic (8.72e-2)" "unprognostic (3.62e-2)" "unprognostic (9.45e-2)" "unprognostic (7.22e-2)" "unprognostic (1.12e-1)" "unprognostic (5.66e-2)" "unprognostic (7.34e-3)" "unprognostic (9.02e-2)" "unprognostic (4.12e-1)" "unprognostic (4.97e-1)" "unprognostic (8.33e-2)" 10.5 8.1 3.8 8.8 5.0 16.1 14.0 3.9 4.4 5.5 31.6 5.5 6.2 31.2 6.6 5.0 6.7 5.9 15.0 10.9 3.8 3.3 47.2 92.8 5.3 5.0 6.0 2.2 10.0 19.8 3.0 5.9 3.1 5.3 8.7 12.9 7.5 10.4 6.9 8.6 3.9 59.8 5.2 3.9 8.4 9.1 2.5 5.5 1.0 8.2 4.7 4.2 5.3 5.8 0.9 4.0 10.1 4.3 13.5 36.0 13.4 5.6 6.3 8.0 16.7 7.5 6.5 8.1 8.4 5.5 9.1 7.2 10.3 4.2 0.0 5.4 8.5 3.6 5.2 8.0 6.7 3.3 12.7 18.0 7.5 14.1 35.4 10.5 4.1 29.5 11.2 3.5 4.1 4.8 6.3 7.6 0.1 5.5 9.4 5.8 5.6 0.1 13.1 6.1 10.6 6.3 0.0 3.9 3.8 6.2 6.6 1.4 11.3 11.5 7.9 6.2 3.8 12.7 8.4 8.9 6.5 7.2 5.0 5.2 7.3 4.3 0.8 4.3 6.5 6.6 10.1 4.3 8.0 36.0 4.1 3.9 0.9 3.5 16.0 4.0 0.7 1.5 15.4 2.9 13.5 3.0 1.6 1.6 13.4 3.8 5.0 3.9 4.4 3.8 3.3 6.0 2.2 5.3 5.5 0.0 6.9 6.0 4.9 3.0 2.5 8.7 30.6 4.0 3.4 8.7 5.9 8.8 19.9 8.8 0.1 7.2 78.3 0.0 8.9 7.4 5.2 8.0 17.3 110.0 11.4 4.8 20.1 8.0 11.1 0.7 6.9 8.7 5.0 16.2 36.7 9.0 10.3 45.8 13.1 122.9 4.9 6.5 5.2 1.7 4.3 7.2 5.4 35.9 47.2 4.2 TTF2 "HuF2, ZGRF6" ENSG00000116830 "Transcription termination factor 2" Q9UNY4 1 117060303-117107453 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005776, HPA070762" Approved Supported Cytosol NA Yes Cytosol "HPA005776: AB_1080416, HPA070762: AB_2686307" "unprognostic (1.82e-1)" "unprognostic (2.18e-1)" "unprognostic (3.29e-3)" "unprognostic (2.01e-3)" "unprognostic (4.90e-2)" "unprognostic (3.41e-3)" "unprognostic (5.27e-4)" "unprognostic (7.96e-2)" "unprognostic (1.92e-2)" "unprognostic (3.33e-1)" "unprognostic (4.64e-2)" "unprognostic (9.52e-3)" "unprognostic (7.34e-3)" "unprognostic (1.48e-3)" "unprognostic (7.73e-2)" "unprognostic (3.50e-1)" "unprognostic (3.65e-2)" 5.7 9.4 5.4 8.5 8.4 6.6 6.0 0.9 5.2 5.9 7.0 8.4 2.6 6.0 5.9 2.3 9.8 4.5 3.9 5.8 4.6 3.8 3.9 3.1 4.7 11.5 12.0 2.1 5.5 5.5 6.7 10.7 4.9 7.2 5.0 8.1 4.2 6.5 3.6 8.4 6.9 5.7 6.8 7.7 6.8 5.4 6.3 8.0 25.1 5.2 7.8 17.8 6.4 6.5 3.7 5.9 3.2 6.3 5.3 6.1 2.5 12.7 4.7 9.5 13.4 3.8 3.3 11.9 6.8 3.2 10.1 9.0 6.6 2.2 15.5 10.6 4.5 11.3 13.3 16.8 8.8 15.6 11.9 11.8 13.2 9.1 8.3 2.7 19.3 15.3 3.8 3.4 7.4 13.9 2.5 6.8 12.3 10.1 14.2 7.6 19.5 12.8 12.0 14.9 12.2 9.5 18.5 35.1 6.8 6.1 5.8 8.2 3.4 10.3 10.3 3.8 7.6 5.6 7.9 6.9 6.4 13.6 15.0 14.8 6.5 5.6 19.1 4.3 14.7 25.6 1.8 5.2 3.2 3.0 6.3 2.9 3.7 3.5 4.7 5.9 3.5 3.6 4.1 0.9 5.3 3.6 3.3 6.1 2.5 5.4 8.4 0.9 5.2 4.6 3.8 12.0 2.1 7.2 8.0 6.0 5.4 18.8 8.6 11.7 5.7 5.6 5.1 4.0 6.8 12.2 7.9 5.8 5.0 5.8 5.9 7.2 5.9 0.0 6.9 7.2 5.2 10.8 9.2 2.5 9.7 11.1 4.7 4.9 5.6 5.4 6.1 12.0 6.8 24.4 7.5 5.3 6.7 2.9 3.9 2.7 6.4 0.0 10.3 6.6 9.3 12.5 3.2 8.7 11.0 15.2 TTK "CT96, MPH1, MPS1, MPS1L1" ENSG00000112742 "TTK protein kinase" P33981 6 80003887-80042527 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.3;testis: 31.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010166, CAB013229" Enhanced Approved Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" "CAB010166: AB_632567, CAB013229: AB_2533230" "unprognostic (4.27e-2)" "unprognostic (8.71e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.97e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (3.84e-10)" "unprognostic (1.56e-3)" "unprognostic (7.95e-2)" "unprognostic (2.02e-3)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.54e-1)" "unprognostic (0.00e+0)" "unprognostic (3.51e-2)" "unprognostic (1.06e-1)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" 1.1 1.4 0.3 3.2 0.4 13.9 1.0 0.3 0.4 1.0 2.7 0.2 0.2 2.2 0.5 1.0 6.5 0.3 0.4 1.5 0.4 0.3 0.9 0.6 1.2 4.6 0.4 0.2 0.4 0.5 0.0 0.3 3.0 0.6 0.6 3.6 0.3 1.2 0.6 0.3 2.0 2.8 0.7 0.8 2.1 1.8 31.7 0.2 58.3 0.5 2.6 5.4 0.8 1.8 1.7 0.0 1.1 0.0 1.1 4.0 0.8 13.3 8.0 24.0 19.6 1.1 3.5 13.6 15.5 9.5 22.7 27.8 10.9 10.2 19.8 12.1 6.6 23.8 17.3 21.1 9.5 31.6 18.0 17.0 18.3 10.6 8.9 0.0 21.5 11.9 0.4 1.0 15.8 10.1 3.3 12.8 27.9 19.9 20.4 19.2 9.9 12.2 15.5 14.1 12.0 9.7 11.0 43.8 8.2 5.7 8.6 16.5 9.7 9.1 9.9 5.6 13.5 9.3 16.3 5.3 10.2 10.2 6.6 24.7 4.6 15.5 11.0 3.6 20.0 8.7 0.0 0.0 1.1 0.6 0.0 0.6 0.9 1.0 1.6 0.0 1.7 0.3 0.5 0.3 1.1 0.0 0.0 4.0 0.8 0.3 0.4 0.3 0.4 0.4 0.3 0.4 0.2 0.6 0.2 3.0 0.6 0.0 0.5 1.1 0.0 0.7 0.0 4.0 3.4 0.0 2.0 4.1 3.3 0.4 19.9 0.1 0.2 23.3 0.2 13.1 0.8 0.2 1.1 0.0 5.2 0.0 1.7 0.0 2.4 12.8 0.9 1.2 0.0 9.0 1.0 0.3 0.4 0.0 0.7 0.0 1.2 6.5 0.2 63.4 28.5 0.3 3.1 0.0 1.2 0.7 TTLL12 KIAA0153 ENSG00000100304 "Tubulin tyrosine ligase like 12" Q14166 22 43166622-43187133 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003054, CAB046029" Approved Approved "Plasma membrane,Cytosol" NA NA 2100000 Cytosol "Plasma membrane" "CAB046029: AB_11128395, HPA003054: AB_2666770" "unprognostic (2.45e-2)" "unprognostic (3.47e-2)" "unprognostic (7.37e-3)" "unprognostic (5.40e-2)" "unprognostic (2.65e-1)" "unprognostic (3.50e-1)" "prognostic unfavorable (2.84e-4)" "unprognostic (5.81e-3)" "unprognostic (2.24e-1)" "unprognostic (6.08e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.15e-1)" "unprognostic (1.17e-3)" "unprognostic (1.40e-1)" "unprognostic (6.66e-2)" "unprognostic (2.81e-2)" 7.3 13.8 7.2 14.7 8.3 14.0 11.2 13.6 12.3 10.9 21.5 5.5 8.9 15.0 7.1 8.7 46.3 9.0 36.0 6.9 7.3 7.1 8.4 19.4 5.3 9.2 6.5 5.9 16.5 29.8 4.4 7.0 6.8 7.1 9.4 12.1 7.0 13.5 7.9 5.5 16.4 13.9 5.9 4.0 9.7 20.7 18.3 5.3 10.7 7.6 23.7 23.5 8.3 15.2 3.5 3.8 1.3 4.7 4.3 5.6 3.3 31.6 13.4 5.4 13.4 8.3 5.7 17.6 10.5 3.7 10.1 5.3 21.7 18.2 30.6 12.7 8.6 4.9 22.7 22.6 19.2 2.6 3.8 35.8 7.5 21.5 18.6 13.1 33.6 7.8 9.1 23.3 12.0 12.9 5.4 10.6 15.1 46.0 7.2 4.6 29.5 23.3 18.2 19.7 22.3 13.4 23.8 18.7 44.0 8.5 10.5 16.6 6.8 22.2 32.6 11.7 2.6 12.8 15.0 10.1 6.7 9.5 12.9 14.5 12.3 15.1 22.6 7.6 17.3 9.1 0.0 4.7 0.7 5.6 2.4 5.5 3.5 5.5 4.1 3.8 2.7 5.5 3.7 1.3 4.3 3.1 3.3 3.5 3.3 7.2 8.3 13.6 12.3 7.3 7.1 6.5 5.9 7.1 5.3 6.0 7.0 9.9 8.6 10.0 8.4 3.6 20.4 2.7 3.4 7.0 3.9 5.7 5.0 13.9 0.7 3.6 35.1 23.3 7.3 14.1 4.1 13.4 0.0 30.4 8.7 0.0 8.7 9.2 13.8 1.6 8.1 5.0 10.1 4.6 29.3 3.8 18.9 54.1 15.9 7.7 4.6 0.0 7.2 2.2 12.8 15.8 3.4 3.8 33.9 13.1 TTLL5 KIAA0998 ENSG00000119685 "Tubulin tyrosine ligase like 5" Q6EMB2 14 75633625-75955078 "Disease related genes, Predicted intracellular proteins" Transcription Ligase "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.1" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 119.8;Early spermatids: 86.9;Late spermatids: 71.0;Rod photoreceptor cells: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032128 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA032128: AB_10600835" "unprognostic (7.35e-2)" "unprognostic (7.29e-2)" "unprognostic (7.73e-2)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (5.96e-2)" "unprognostic (7.21e-5)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (7.93e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-1)" "unprognostic (5.67e-3)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (8.97e-2)" "unprognostic (2.15e-2)" 5.9 6.5 7.6 5.9 11.1 10.1 7.4 12.0 10.4 8.0 6.5 18.0 6.4 4.9 11.8 7.7 8.1 11.8 6.7 6.8 7.9 7.1 6.6 4.4 6.6 5.0 10.1 6.9 8.1 5.8 13.2 9.5 7.6 13.9 7.4 7.6 8.2 7.7 7.5 5.2 7.2 4.8 8.9 15.8 4.2 6.0 51.1 10.5 10.1 8.1 5.5 7.3 7.1 7.1 3.8 5.7 12.4 3.8 3.4 5.1 2.3 14.3 10.5 9.3 9.5 7.3 11.4 8.5 8.5 10.3 10.2 13.1 6.5 13.5 4.0 4.7 8.9 7.5 13.7 7.9 14.0 19.4 4.8 4.8 7.9 11.0 7.1 6.2 5.7 7.7 8.7 7.0 12.8 14.3 11.1 21.9 11.4 4.5 6.9 10.1 20.1 9.7 7.9 6.6 11.3 10.8 6.0 13.0 5.5 9.8 14.2 12.2 7.8 17.9 13.1 4.4 7.5 18.0 6.3 24.7 13.6 12.1 12.0 7.8 5.8 8.3 9.4 13.8 6.6 9.0 12.4 3.5 2.7 4.6 3.3 4.0 3.8 4.2 4.5 5.1 3.5 5.1 4.7 3.8 3.4 3.8 5.7 3.4 2.3 7.6 11.1 12.0 10.4 7.9 7.1 10.1 6.9 13.9 10.5 3.0 8.5 2.4 5.1 4.4 8.9 7.6 20.4 34.8 13.6 10.4 119.8 6.8 3.3 6.0 86.9 9.0 6.3 0.0 4.6 11.2 7.8 7.7 11.6 5.8 5.0 0.0 7.5 24.5 7.0 71.0 11.5 6.4 5.0 9.0 6.1 8.1 4.3 9.9 11.0 1.4 81.7 12.9 4.4 28.7 15.8 5.5 5.0 6.9 6.8 4.1 TTPAL "C20orf121, dJ179M20.3" ENSG00000124120 "Alpha tocopherol transfer protein like" Q9BTX7 20 44475886-44494603 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 40.1;HSkMC: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046957, HPA066532" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA046957: AB_10959741, HPA066532: AB_2685686" "unprognostic (8.71e-2)" "unprognostic (3.05e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (3.47e-5)" "unprognostic (1.69e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (2.32e-1)" "unprognostic (5.06e-2)" "unprognostic (4.50e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (8.09e-5)" "unprognostic (2.09e-2)" "unprognostic (2.88e-1)" "unprognostic (2.24e-2)" "unprognostic (7.93e-2)" 9.5 6.2 6.3 7.2 8.3 9.1 7.6 6.5 13.1 8.2 4.6 4.8 5.1 4.3 6.3 9.2 7.0 6.9 5.3 4.2 5.8 7.9 5.7 32.0 4.0 9.7 5.9 11.5 6.6 7.6 11.1 12.8 5.0 9.8 6.4 5.0 6.4 6.2 7.3 3.8 14.7 5.3 6.6 3.6 5.7 5.5 6.4 3.0 5.8 9.3 5.5 9.2 5.9 7.9 5.9 3.1 4.2 3.5 7.9 7.6 3.4 8.6 4.5 3.5 6.2 40.1 15.6 3.5 9.4 13.2 9.2 7.9 16.7 5.3 5.4 8.1 8.7 16.8 8.6 4.4 14.8 10.0 5.6 2.0 2.5 4.7 4.8 11.1 3.8 6.1 34.6 9.7 9.0 15.2 4.3 3.1 4.6 3.2 5.7 7.3 10.0 3.7 2.4 4.2 4.7 7.6 1.1 3.8 2.9 3.6 6.3 7.8 3.7 13.1 5.7 5.8 4.5 6.3 2.4 3.1 20.5 8.2 6.1 8.1 8.5 5.7 5.9 9.9 2.7 6.0 0.7 1.6 2.6 6.7 3.2 7.1 5.9 5.7 6.7 1.7 5.8 5.1 7.6 4.2 7.9 3.5 3.1 5.7 3.4 6.3 8.3 6.5 13.1 5.8 7.9 5.9 11.5 9.8 3.0 8.9 10.7 18.4 13.5 5.7 21.7 4.4 12.7 6.7 10.3 21.0 23.6 6.0 1.7 10.0 4.1 5.6 7.8 70.0 8.2 6.9 9.4 11.5 9.2 37.6 4.3 17.5 9.1 6.7 11.0 7.9 17.3 5.3 3.3 3.6 4.9 11.2 10.0 8.6 10.6 3.8 18.9 6.5 11.3 7.7 10.7 17.6 9.2 13.8 8.0 9.5 TUBD1 "FLJ12709, TUBD" ENSG00000108423 "Tubulin delta 1" Q9UJT1 17 59859482-59892945 "FDA approved drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004609, HPA023980, HPA027090" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457" "unprognostic (1.92e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.32e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (2.86e-2)" "unprognostic (8.87e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (6.06e-4)" "unprognostic (4.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-1)" "unprognostic (8.83e-2)" 8.7 8.0 9.3 8.1 13.8 6.8 12.4 19.9 12.2 12.3 11.2 13.5 16.6 6.7 13.6 16.4 18.2 10.0 8.3 8.4 8.9 7.2 8.5 9.3 8.8 10.2 16.1 8.5 16.3 13.2 10.4 18.7 7.2 12.3 12.3 8.2 11.7 11.4 12.2 9.9 11.6 7.5 9.3 13.4 9.3 9.6 9.2 16.4 16.2 15.5 10.3 13.8 14.1 13.0 10.1 8.8 14.1 7.6 8.1 17.6 6.9 6.0 8.3 6.5 6.8 3.7 2.6 5.5 4.7 2.8 6.3 5.2 9.0 3.9 5.5 8.1 1.1 4.3 5.1 9.1 2.8 6.0 3.2 11.1 6.4 7.0 10.6 2.0 3.8 3.5 1.4 4.5 5.4 2.0 2.2 4.9 5.5 13.8 3.8 2.1 42.9 7.8 4.4 5.7 6.7 3.7 8.4 9.6 8.6 2.4 2.8 6.1 3.7 3.4 2.7 3.2 8.2 6.4 3.7 1.5 4.5 10.1 3.1 5.1 4.5 6.8 8.4 2.1 4.3 4.0 5.6 7.6 14.1 10.9 5.0 12.4 10.1 13.5 11.5 5.2 8.6 17.6 14.2 8.2 8.1 5.3 8.8 14.1 6.9 9.3 13.8 19.9 12.2 8.9 7.2 16.1 8.5 12.3 16.4 11.9 45.1 5.4 12.7 14.0 7.1 4.8 7.6 12.0 20.5 3.5 5.9 5.1 10.0 4.6 1.3 7.7 2.6 0.0 4.2 6.5 8.2 11.1 10.5 3.2 3.5 3.2 9.9 6.7 4.8 0.4 5.2 6.2 6.8 3.6 5.5 7.7 3.3 4.9 7.8 3.1 7.7 6.5 10.3 11.4 28.1 14.8 3.3 13.6 5.4 5.7 TUBGCP5 "GCP5, KIAA1899" ENSG00000275835 "Tubulin gamma complex associated protein 5" Q96RT8 15 22983192-23039673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 36.2;Spermatogonia: 33.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039366, HPA040366" Supported Supported Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA039366: AB_10673243, HPA040366: AB_2676942" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "unprognostic (1.30e-1)" "unprognostic (4.27e-3)" "unprognostic (2.94e-1)" "unprognostic (2.79e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.27e-1)" "unprognostic (1.42e-2)" "unprognostic (1.18e-2)" "unprognostic (6.40e-2)" "unprognostic (1.13e-2)" "unprognostic (9.53e-3)" 5.1 5.7 5.7 5.1 8.4 5.5 7.3 4.0 10.4 7.9 4.6 6.0 4.6 4.2 7.4 8.7 5.9 4.9 4.7 6.6 7.7 6.3 6.8 5.6 5.5 6.0 11.0 5.0 10.0 10.2 6.3 4.8 12.9 7.5 5.3 5.3 4.0 7.4 14.5 7.3 3.0 9.3 10.0 4.8 5.3 12.9 5.9 5.4 8.6 7.0 6.1 4.6 0.8 5.3 4.0 1.5 3.3 5.4 7.6 2.5 12.2 13.0 15.4 9.0 11.9 7.8 8.9 15.3 16.9 17.0 14.7 9.9 5.8 9.3 6.6 14.0 8.9 12.4 10.1 11.9 14.2 14.4 4.0 16.8 13.1 5.3 4.0 17.0 7.4 12.7 4.5 11.3 10.5 5.5 10.1 16.7 11.8 15.1 10.7 8.0 11.4 7.4 9.1 12.2 11.9 14.1 16.9 1.9 9.8 19.2 5.2 9.0 12.5 8.8 8.0 7.9 14.2 8.0 8.7 11.6 7.6 9.0 22.6 11.9 11.9 25.1 15.3 11.3 10.9 0.2 2.3 0.9 4.5 3.3 4.6 3.7 6.7 7.2 3.6 5.3 6.0 7.6 1.5 5.4 3.3 4.0 5.4 2.5 14.9 15.3 5.1 2.9 3.0 27.8 10.3 5.1 9.4 6.8 5.2 13.7 6.6 5.0 5.5 5.7 5.7 2.2 0.0 4.1 6.0 4.7 1.6 5.8 7.5 6.5 9.5 4.1 6.7 5.9 9.8 10.3 5.8 3.3 2.8 4.6 13.5 5.8 3.4 12.0 5.3 18.4 0.0 6.7 36.2 33.1 2.4 2.9 5.1 4.2 1.6 TULP2 "CT65, TUBL2" ENSG00000104804 "Tubby like protein 2" O00295 19 48880965-48898733 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.6;testis: 25.5" "Group enriched" "Detected in some" 43 "Early spermatids: 174.6;Late spermatids: 168.8" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 6.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 6.6" "Cell line enhanced" "Detected in some" "BEWO: 5.5;U-266/70: 6.4;U-266/84: 6.9" "Not detected" "Not detected" HPA075828 Approved Cytosol "Secreted in male reproductive system" NA NA Cytosol "HPA075828: " "unprognostic (9.97e-2)" "unprognostic (5.55e-3)" "unprognostic (1.15e-1)" "unprognostic (9.39e-2)" "unprognostic (1.69e-4)" "unprognostic (6.79e-4)" "unprognostic (1.07e-2)" "unprognostic (2.57e-1)" "unprognostic (5.94e-3)" "unprognostic (1.08e-2)" "unprognostic (9.82e-2)" "unprognostic (1.33e-1)" "unprognostic (4.59e-4)" "unprognostic (6.37e-2)" "unprognostic (1.63e-1)" "unprognostic (1.08e-1)" "unprognostic (1.97e-1)" 0.2 0.3 0.2 0.2 0.2 4.3 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.8 0.8 0.5 0.6 0.5 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 1.3 0.2 0.0 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.0 0.2 25.5 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 6.6 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 1.1 1.9 0.9 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.9 0.9 1.8 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.7 0.0 0.9 0.0 1.1 0.0 0.0 0.0 0.1 0.0 6.4 6.9 0.3 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 6.6 0.0 0.0 0.2 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 174.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.8 168.8 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.1 1.4 0.4 0.0 0.0 0.0 0.0 TUSC2 "C3orf11, FUS1, PAP, PDAP2" ENSG00000114383 "Tumor suppressor candidate 2" O75896 3 50320027-50328251 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 269.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030116 Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA030116: AB_10602253" "unprognostic (1.58e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-1)" "unprognostic (8.46e-2)" "unprognostic (2.73e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (2.84e-4)" "unprognostic (2.53e-3)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.47e-2)" "unprognostic (1.99e-2)" "prognostic favorable (8.70e-7)" "unprognostic (9.22e-3)" "unprognostic (1.98e-1)" "unprognostic (3.15e-1)" "unprognostic (6.34e-3)" 13.4 16.3 28.5 12.2 27.2 9.2 15.1 18.9 38.1 11.9 15.9 11.1 13.9 11.1 10.3 26.2 10.8 18.6 15.5 22.0 26.4 25.8 18.9 18.0 13.5 13.2 26.2 17.0 12.0 15.3 21.3 12.3 15.3 27.3 13.2 15.0 12.2 13.5 17.0 29.9 8.8 12.1 12.3 13.2 14.2 13.9 15.2 8.1 12.0 21.1 15.0 17.2 9.9 8.5 19.5 20.4 26.3 17.3 17.1 22.0 22.9 12.2 10.2 14.4 15.6 15.9 8.3 15.8 10.1 13.6 19.1 16.2 18.0 11.3 21.0 11.1 9.3 19.6 7.9 17.5 13.1 16.8 12.3 16.1 10.3 9.6 19.2 14.0 18.2 18.2 9.0 21.2 19.0 9.5 13.4 19.6 16.9 12.5 10.1 10.9 9.3 19.0 23.4 19.5 15.3 14.8 6.6 7.0 17.2 19.1 13.4 7.7 15.9 7.3 13.1 14.5 14.9 12.5 22.3 15.4 5.7 14.0 12.9 20.2 25.0 38.7 14.7 12.7 12.1 8.9 10.2 17.3 26.3 20.4 15.3 20.4 19.4 18.1 21.2 11.3 19.5 20.9 22.0 24.5 17.1 13.9 20.4 19.5 22.9 28.5 27.2 18.9 38.1 26.4 25.8 26.2 17.0 27.3 8.1 11.9 17.1 52.9 27.8 51.1 49.3 31.3 56.0 42.8 12.5 54.1 21.6 54.3 97.8 67.6 91.0 42.5 47.7 0.0 64.8 46.8 29.0 59.9 29.9 66.0 66.6 69.9 48.4 33.2 42.6 269.2 25.0 30.8 52.3 60.5 39.6 40.9 64.1 59.6 23.3 141.5 35.8 12.9 44.8 55.4 54.5 79.7 58.2 40.5 40.0 51.0 TUT1 "FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TUTase" ENSG00000149016 "Terminal uridylyl transferase 1, U6 snRNA-specific" Q9H6E5 11 62575045-62592177 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA069055, HPA071838" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA069055: AB_2686075, HPA071838: AB_2686456" "unprognostic (3.81e-2)" "unprognostic (3.54e-2)" "prognostic unfavorable (9.51e-4)" "unprognostic (2.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.59e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (2.71e-1)" "unprognostic (7.20e-3)" "unprognostic (1.03e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-1)" "unprognostic (3.97e-3)" 10.9 12.1 10.7 9.9 13.6 7.8 12.9 13.5 13.3 10.5 8.7 15.9 13.0 12.9 11.5 10.8 10.0 16.9 13.7 10.7 13.6 8.3 12.2 22.7 9.6 18.1 15.5 9.5 14.5 26.2 15.5 16.2 12.3 13.0 13.9 6.2 11.9 16.4 11.9 20.5 13.9 11.7 10.2 11.4 14.6 12.5 18.6 13.2 17.1 14.0 8.8 13.6 11.5 9.8 13.1 9.4 6.6 7.3 9.8 16.0 7.2 7.3 9.2 6.4 8.9 7.8 4.5 8.3 7.9 4.8 6.7 5.8 8.2 14.4 11.7 18.2 3.8 8.4 13.8 11.7 9.2 3.4 9.0 6.2 12.0 9.4 7.8 8.7 8.5 5.5 6.3 9.9 8.3 12.8 6.3 6.4 15.2 18.0 12.1 5.6 16.0 12.0 18.1 7.3 4.8 11.3 13.5 10.2 28.4 6.2 4.2 10.6 14.9 6.0 11.4 9.8 5.6 15.9 8.3 5.7 7.6 6.8 8.8 6.0 21.1 18.5 14.4 8.9 6.7 6.2 5.9 5.9 6.6 10.5 7.3 14.6 9.8 9.9 8.4 7.8 13.1 16.0 12.5 3.6 9.8 5.3 9.4 8.9 7.2 10.7 13.6 13.5 13.3 13.6 8.3 15.5 9.5 13.0 13.2 0.0 7.9 8.1 4.8 2.4 7.4 3.2 10.2 9.4 2.3 10.4 5.9 10.6 5.0 7.3 25.9 13.4 5.6 0.0 6.4 6.5 3.8 6.1 2.3 16.2 5.0 1.6 6.9 12.3 4.0 12.8 6.6 3.1 10.1 2.8 6.0 9.3 5.4 3.5 3.2 4.9 8.7 0.0 1.4 9.2 14.8 1.9 11.7 6.9 6.0 2.8 TWF1 "A6, PTK9" ENSG00000151239 "Twinfilin actin binding protein 1" Q12792 12 43793723-43806375 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018116 Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA018116: AB_1855899" "unprognostic (3.06e-1)" "unprognostic (1.95e-2)" "prognostic favorable (8.29e-4)" "unprognostic (7.39e-3)" "unprognostic (2.35e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (5.19e-2)" "unprognostic (1.13e-2)" "unprognostic (7.30e-2)" "unprognostic (3.11e-3)" "unprognostic (2.51e-1)" "unprognostic (8.48e-2)" "unprognostic (1.03e-1)" "unprognostic (2.19e-1)" "unprognostic (2.95e-1)" "unprognostic (2.62e-1)" 14.2 15.8 15.1 11.0 15.8 11.8 20.4 7.8 13.5 17.9 19.7 8.5 33.1 20.5 13.3 15.4 39.5 13.8 14.8 6.7 14.9 11.9 17.6 31.3 12.6 13.7 16.1 9.6 15.7 21.0 8.8 23.5 14.0 14.6 14.6 20.5 4.6 14.8 32.1 3.5 10.7 24.1 16.0 15.7 10.0 16.9 9.7 12.7 7.1 25.0 19.1 9.6 18.3 19.4 7.8 5.4 10.1 5.2 14.7 8.7 4.1 26.4 19.8 10.3 12.5 27.0 31.3 25.2 37.4 30.7 30.3 23.0 31.7 37.3 7.2 34.8 35.6 17.7 18.1 14.1 26.5 43.2 2.4 16.5 6.6 16.8 15.0 22.1 7.6 8.6 21.3 21.7 31.4 35.2 38.6 26.4 3.6 7.2 8.1 47.0 14.1 3.6 5.2 6.2 0.0 32.6 3.1 11.6 8.1 40.1 33.3 7.7 11.5 31.0 28.3 26.8 15.1 26.4 7.6 25.3 37.5 24.9 29.9 30.9 7.1 7.0 9.8 34.4 19.7 14.1 10.1 3.3 6.7 6.7 4.9 7.6 7.8 8.1 8.3 5.4 3.9 8.1 8.7 5.4 14.7 5.2 3.4 8.0 4.1 15.1 15.8 7.8 13.5 14.9 11.9 16.1 9.6 14.6 12.7 11.9 26.0 17.9 26.8 37.1 20.9 5.7 38.2 29.4 34.2 33.2 19.6 35.6 34.9 42.9 10.5 29.2 58.0 0.0 69.1 48.1 27.0 50.2 4.7 27.9 23.2 19.1 43.1 22.1 27.4 8.5 24.7 18.4 33.7 17.2 45.0 29.0 57.9 63.2 30.1 49.4 29.6 25.8 45.3 10.2 22.2 44.7 71.1 15.4 50.2 53.7 TWSG1 TSG ENSG00000128791 "Twisted gastrulation BMP signaling modulator 1" Q9GZX9 18 9334767-9402420 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 91.3;Peritubular cells: 89.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014898 Uncertain Supported Centrosome,Cytosol "Secreted - unknown location" No No 6600000 "Centrosome, Cytosol" "HPA014898: AB_1858467" "unprognostic (2.55e-1)" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (8.95e-3)" "unprognostic (2.92e-3)" "unprognostic (1.83e-1)" "unprognostic (8.29e-2)" "unprognostic (5.88e-2)" "unprognostic (6.33e-2)" "unprognostic (1.05e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-2)" "unprognostic (1.79e-1)" "unprognostic (1.32e-2)" 13.0 8.9 8.3 6.9 8.5 2.9 17.3 5.0 6.2 21.9 17.4 9.3 56.2 4.7 33.0 21.5 19.0 14.4 16.4 9.2 8.4 7.1 19.8 4.8 12.6 6.6 11.0 6.1 20.4 4.4 12.7 11.4 10.7 9.1 26.5 10.2 10.6 9.4 34.8 6.1 7.6 8.6 36.0 12.3 9.4 12.0 13.0 8.1 4.3 20.5 8.7 6.8 26.0 17.9 3.3 7.8 7.5 4.1 4.1 7.5 3.1 15.0 5.5 15.8 7.8 31.3 28.3 7.3 28.9 36.0 15.9 22.8 5.8 19.9 2.1 14.7 38.1 10.3 5.3 15.5 11.4 29.3 5.9 4.3 3.9 4.7 2.8 27.8 2.8 8.1 28.7 9.4 13.3 6.4 21.8 24.6 2.1 5.9 4.0 40.6 4.6 3.0 3.4 5.1 8.9 4.5 5.4 16.2 1.3 18.0 20.2 2.1 5.5 22.7 6.3 6.0 6.9 7.1 6.6 20.3 29.2 14.6 27.3 17.9 5.8 5.1 4.1 17.9 3.9 10.2 7.5 4.1 5.8 6.7 2.2 4.4 3.3 3.2 6.8 7.8 2.8 3.8 7.5 2.0 4.1 0.7 7.8 1.4 3.1 8.3 8.5 5.0 6.2 8.4 7.1 11.0 6.1 9.1 8.1 23.8 20.2 4.8 20.9 35.1 4.7 6.5 10.2 6.7 18.2 71.5 0.0 5.0 1.7 8.5 91.3 12.0 2.6 0.0 6.8 11.9 72.5 30.5 5.8 7.4 13.6 3.2 5.8 14.1 6.2 20.4 34.8 9.2 21.9 19.0 7.2 15.6 8.5 10.5 89.5 10.7 4.7 71.1 66.9 21.6 4.9 23.5 3.9 7.5 14.3 15.0 TXLNA DKFZp451J0118 ENSG00000084652 "Taxilin alpha" P40222 1 32179686-32198285 "Cancer-related genes, Predicted intracellular proteins" Exocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045383, HPA072477" Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA045383: AB_10967649, HPA072477: AB_2686525" "prognostic favorable (6.24e-4)" "unprognostic (1.19e-2)" "unprognostic (3.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.04e-2)" "prognostic favorable (5.53e-4)" "prognostic unfavorable (1.57e-6)" "unprognostic (3.67e-3)" "unprognostic (2.75e-1)" "unprognostic (5.25e-3)" "prognostic favorable (8.69e-5)" "unprognostic (5.06e-2)" "prognostic unfavorable (7.21e-7)" "unprognostic (3.94e-3)" "unprognostic (3.28e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" 22.5 29.4 20.2 19.4 27.5 14.0 17.9 23.2 26.4 20.3 23.7 17.0 23.4 16.6 30.4 24.7 24.2 25.0 24.6 16.4 18.5 13.9 20.9 44.8 19.0 19.9 25.6 13.4 26.5 23.6 31.5 35.9 19.3 21.8 24.6 18.5 20.8 23.9 23.3 16.5 31.0 18.9 28.3 19.9 23.5 21.2 38.4 22.9 17.0 22.8 18.8 26.0 19.3 23.5 8.0 14.3 8.4 12.2 14.2 13.9 9.0 19.5 16.8 17.5 19.7 22.8 30.0 14.2 28.1 22.4 27.2 26.1 18.7 21.3 22.4 11.5 27.2 8.9 22.2 23.9 18.4 24.8 25.6 18.5 35.5 24.4 24.4 24.2 25.7 28.2 30.0 24.8 28.7 13.6 20.1 21.4 27.3 14.4 23.2 22.2 10.9 18.8 16.6 25.5 14.0 15.5 22.2 26.6 19.7 18.6 25.1 18.4 18.9 29.1 18.5 29.8 22.5 17.1 15.7 22.2 28.8 24.9 37.9 35.8 34.7 26.8 20.4 29.8 35.1 26.5 8.4 9.0 4.5 13.9 9.7 11.9 7.3 9.6 10.3 6.9 8.0 8.4 9.1 1.3 14.2 12.2 14.3 7.0 9.0 20.2 27.5 23.2 26.4 18.5 13.9 25.6 13.4 21.8 22.9 20.8 21.3 7.7 9.2 7.8 13.9 7.7 10.2 28.1 19.4 14.0 37.3 8.8 1.7 15.8 11.5 15.8 11.9 0.0 14.2 12.0 17.1 10.3 12.7 28.6 15.9 25.4 25.2 16.0 12.4 13.3 22.2 11.7 5.0 20.8 15.4 13.8 18.6 2.9 19.4 11.8 24.5 12.9 21.1 21.8 24.5 10.7 5.7 10.2 12.1 6.7 TXLNG "CXorf15, FIAT, FLJ11209, LSR5, MGC126621, MGC126625, TXLNGX" ENSG00000086712 "Taxilin gamma" Q9NUQ3 X 16786427-16844519 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000297, HPA000841" Approved Approved Cytosol NA NA Cytosol "HPA000297: AB_1078590, HPA000841: AB_1078589" "unprognostic (2.48e-2)" "unprognostic (1.12e-2)" "unprognostic (1.54e-1)" "unprognostic (1.27e-3)" "unprognostic (4.78e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (6.33e-6)" "unprognostic (2.61e-2)" "unprognostic (5.27e-3)" "unprognostic (6.96e-2)" "unprognostic (3.61e-2)" "unprognostic (1.40e-2)" "unprognostic (1.58e-3)" "unprognostic (2.04e-2)" "unprognostic (2.22e-1)" "unprognostic (8.62e-2)" "unprognostic (6.00e-3)" 16.2 20.1 14.4 13.5 17.5 14.9 14.0 24.9 19.9 13.2 11.1 5.6 13.0 9.9 12.0 8.4 8.4 12.0 9.1 6.9 12.4 10.1 9.4 9.6 9.2 13.8 11.8 10.1 21.1 10.3 13.9 20.1 6.9 12.8 8.6 7.5 5.4 8.4 17.2 17.3 7.4 8.6 10.3 11.2 8.8 8.9 7.1 17.4 6.0 12.8 5.5 13.5 13.6 23.8 6.5 3.4 1.6 3.0 4.3 7.4 3.4 12.1 7.6 7.4 12.9 13.5 7.4 3.9 4.9 4.7 5.6 5.5 10.6 7.3 25.6 12.4 2.7 16.2 7.9 25.1 16.0 10.1 7.8 30.5 9.2 10.5 6.8 5.6 13.6 6.6 4.3 7.8 13.0 23.6 7.6 7.0 10.6 17.5 7.6 4.3 7.3 12.4 7.6 21.9 8.1 8.9 8.6 10.0 21.2 4.5 6.1 11.9 8.7 11.3 10.8 9.0 13.2 13.1 5.6 3.4 3.5 4.7 12.4 8.4 8.0 12.2 26.0 4.5 9.0 3.5 1.0 3.0 1.6 5.3 2.2 6.7 6.1 5.7 6.0 3.3 6.5 6.9 7.4 1.1 4.3 2.5 3.4 5.8 3.4 14.4 17.5 24.9 19.9 12.4 10.1 11.8 10.1 12.8 17.4 14.9 16.1 17.2 49.4 36.5 34.3 11.5 12.7 14.7 31.8 8.7 5.9 12.4 18.3 14.9 2.7 11.1 8.0 23.3 14.5 11.5 21.3 27.3 12.7 15.6 8.2 27.0 13.8 12.9 6.5 1.5 25.0 8.7 16.9 4.6 12.6 12.9 13.0 5.8 19.8 14.6 21.3 6.5 16.8 12.9 38.1 30.5 18.3 20.0 15.2 24.5 TXN TRX ENSG00000136810 Thioredoxin P10599 9 110243811-110256640 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transcription, Transcription regulation, Transport" Activator Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 447.3" "Cell type enriched" "Detected in all" 10 "monocytes: 27271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 127.1;granulocytes: 104.5" "Cell line enhanced" "Detected in all" "OE19: 265.0" "Low region specificity" "Detected in all" "CAB008678, HPA047478, HPA055752" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 25000000 "Nucleoplasm, Cytosol" "CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907" "unprognostic (2.12e-2)" "unprognostic (1.27e-1)" "unprognostic (9.77e-2)" "prognostic favorable (3.40e-6)" "unprognostic (1.80e-2)" "unprognostic (2.13e-2)" "unprognostic (5.52e-3)" "unprognostic (1.37e-2)" "unprognostic (1.75e-1)" "unprognostic (3.36e-2)" "unprognostic (5.93e-3)" "unprognostic (1.66e-1)" "unprognostic (4.96e-3)" "unprognostic (7.80e-2)" "unprognostic (8.55e-2)" "unprognostic (2.99e-2)" "unprognostic (8.51e-2)" 23.6 16.7 26.6 18.2 16.9 35.8 25.9 10.8 19.7 30.8 57.9 7.7 17.5 40.7 15.5 20.4 162.3 27.5 22.2 11.7 20.9 19.0 65.8 69.4 39.0 19.4 21.3 14.1 18.2 22.0 5.3 8.0 41.2 28.7 15.5 50.6 8.0 50.2 16.3 16.0 26.3 58.9 21.9 17.6 19.8 26.3 9.2 7.0 40.0 18.9 447.3 82.0 31.3 27.1 12.8 127.1 104.5 25.1 14.2 26.0 18.8 45.9 63.1 17.1 18.8 43.2 56.3 25.2 55.9 52.2 39.0 29.7 40.9 55.4 40.9 24.0 51.6 85.4 103.8 24.3 74.5 38.3 60.7 54.1 20.5 59.2 70.8 49.4 50.9 62.7 39.9 49.1 57.0 43.2 36.3 34.2 26.1 34.5 39.4 53.3 37.2 42.3 76.4 36.4 265.0 77.0 17.8 58.0 47.6 49.8 32.6 37.2 13.3 60.3 49.0 37.9 34.4 47.0 35.2 41.0 40.2 26.0 75.4 69.2 20.0 56.4 34.8 58.3 44.4 55.8 32.2 25.1 104.5 14.5 15.1 13.9 12.8 20.5 17.4 37.1 5.6 7.7 11.5 99.7 14.2 9.6 127.1 26.0 18.8 26.6 16.9 10.8 19.7 20.9 19.0 21.3 14.1 28.7 7.0 363.3 237.5 189.1 832.3 1158.8 34.8 96.1 504.4 436.3 374.2 249.5 19.6 560.0 824.0 1017.1 20.9 327.5 1162.8 233.6 1150.3 840.4 409.8 774.5 261.1 685.2 516.6 27.0 534.8 206.2 278.9 11.1 373.3 793.2 723.7 27271.2 934.3 40.9 1608.6 1292.8 268.3 2636.4 24.8 142.3 563.4 10.6 70.3 1303.3 391.5 213.2 1478.0 1356.2 TXNDC11 EFP1 ENSG00000153066 "Thioredoxin domain containing 11" Q6PKC3 16 11679080-11742878 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 48.2;U-266/70: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041174, HPA041390" Supported Supported "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA041174: AB_10794191, HPA041390: AB_10796670" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (6.82e-3)" "prognostic favorable (2.12e-5)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.68e-3)" "unprognostic (4.90e-2)" "unprognostic (2.17e-1)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (2.35e-2)" "unprognostic (9.96e-2)" "unprognostic (8.30e-2)" "unprognostic (3.23e-2)" "unprognostic (2.34e-2)" 12.5 12.5 6.1 10.9 8.1 24.1 12.3 12.8 9.9 12.7 20.8 8.3 13.2 19.2 12.9 16.0 12.6 12.7 17.5 11.4 7.3 4.4 21.2 47.2 22.4 21.3 7.4 4.4 13.9 22.9 28.6 11.4 15.0 7.1 13.2 15.4 18.6 24.1 14.3 23.2 9.9 27.4 7.8 5.0 23.6 17.6 5.6 6.7 15.9 28.6 11.6 33.2 15.0 10.2 5.7 3.6 9.6 3.3 7.8 9.2 3.5 8.8 6.2 2.9 4.0 7.9 6.6 5.1 8.9 12.2 8.1 10.5 3.0 14.2 22.5 15.0 11.1 11.1 8.0 3.6 7.4 6.7 10.0 4.7 4.7 7.1 14.9 11.6 7.0 9.7 5.0 8.5 9.1 14.4 6.3 10.2 5.1 7.2 29.0 7.1 8.1 5.4 2.7 3.8 6.4 3.2 7.0 5.9 48.2 9.3 4.8 4.1 3.9 17.3 13.5 9.4 3.4 8.3 9.7 10.5 3.8 4.4 17.7 5.0 39.6 21.6 13.6 8.0 8.9 6.3 4.9 3.3 9.6 2.7 2.5 6.6 5.7 4.9 6.0 3.6 4.9 4.8 3.1 1.0 7.8 2.8 2.8 9.2 3.5 6.1 8.1 12.8 9.9 7.3 4.4 7.4 4.4 7.1 6.7 41.7 44.0 21.5 22.2 13.1 15.1 7.6 20.4 10.7 26.1 17.4 47.1 17.5 13.3 17.8 2.3 13.1 35.1 0.0 34.6 26.3 14.1 29.3 15.0 32.5 27.0 22.3 23.5 16.0 15.1 1.1 18.7 21.9 21.9 24.4 36.5 14.5 23.5 21.0 12.4 11.8 22.2 6.5 18.1 11.2 9.5 10.3 20.9 18.7 22.7 27.1 TXNDC9 APACD ENSG00000115514 "Thioredoxin domain containing 9" O14530 2 99318982-99340702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031844, HPA031845, HPA031846" Approved Enhanced Cytosol NA NA Cytosol "HPA031844: AB_10600838, HPA031845: AB_10670968, HPA031846: AB_10669916" "unprognostic (3.63e-3)" "unprognostic (4.26e-2)" "unprognostic (7.28e-2)" "unprognostic (3.12e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (9.63e-7)" "unprognostic (2.06e-2)" "unprognostic (9.09e-2)" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.37e-1)" "unprognostic (2.32e-1)" "unprognostic (2.47e-3)" "unprognostic (2.03e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" 29.2 20.7 16.8 17.8 19.4 13.0 25.9 20.1 25.3 23.4 21.1 13.8 14.9 15.2 19.0 23.9 28.8 15.8 15.7 23.9 18.1 20.8 42.9 33.3 17.0 22.3 19.0 13.9 20.4 15.1 13.3 27.6 33.9 27.3 19.5 23.3 9.3 19.4 15.3 22.8 16.2 21.6 21.4 22.1 32.3 16.7 14.9 17.5 39.6 21.2 28.1 27.8 20.4 18.3 32.6 28.9 45.2 36.7 35.2 41.8 40.2 25.6 8.3 21.3 10.4 20.6 20.9 22.9 29.6 27.4 31.3 30.5 22.8 19.8 19.4 23.8 26.0 28.7 18.6 19.3 30.7 37.1 14.1 16.4 21.0 11.8 26.0 19.8 25.1 15.6 19.1 27.6 26.3 19.6 16.6 35.7 11.9 24.0 18.2 36.6 13.0 14.7 22.0 15.6 16.1 22.8 11.0 19.4 18.7 44.3 19.9 13.2 10.8 14.1 19.8 31.3 26.4 22.7 20.3 24.5 23.1 22.5 14.3 20.7 7.5 11.5 23.4 18.9 26.1 20.8 45.2 27.6 28.2 29.1 28.5 36.3 32.6 34.7 32.9 28.9 26.0 32.9 32.8 26.8 35.2 36.7 28.8 41.8 40.2 16.8 19.4 20.1 25.3 18.1 20.8 19.0 13.9 27.3 17.5 8.9 11.2 34.3 26.2 31.3 9.8 26.2 20.4 34.8 25.0 34.9 7.9 67.9 71.3 76.6 55.0 37.9 22.2 46.7 60.7 67.0 32.9 22.6 17.3 22.4 50.5 12.7 20.1 34.4 28.6 13.8 25.6 31.6 25.3 60.5 22.3 19.7 68.9 20.1 21.9 96.4 16.6 25.8 20.6 25.2 41.2 34.0 68.0 35.0 23.0 21.2 TXNIP "ARRDC6, EST01027, HHCPA78, THIF, VDUP1" ENSG00000265972 "Thioredoxin interacting protein" Q9H3M7 1 145992435-145996600 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Sertoli cells: 1177.1;T-cells: 976.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 109.0;HSkMC: 145.0;hTCEpi: 73.9;hTERT-RPE1: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031085, HPA053694" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA031085: AB_10601706, HPA053694: AB_2682232" "unprognostic (1.45e-1)" "unprognostic (1.57e-2)" "unprognostic (1.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.92e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (2.51e-1)" "unprognostic (9.23e-2)" "unprognostic (1.20e-1)" "unprognostic (3.65e-2)" "unprognostic (1.19e-1)" "unprognostic (8.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (8.19e-2)" "unprognostic (2.22e-3)" 127.7 10.6 4.1 17.0 4.6 10.5 73.6 2.5 6.0 45.9 49.8 16.1 25.0 6.3 39.3 22.8 41.0 20.3 20.4 55.3 4.8 34.8 11.7 52.3 82.6 6.5 4.2 34.1 25.8 9.3 20.2 19.1 8.3 47.4 16.1 18.8 18.5 19.5 97.0 15.3 27.7 34.6 9.2 39.0 13.6 23.1 6.0 29.0 85.3 16.0 41.5 52.5 32.3 64.9 35.5 134.9 58.3 65.3 90.0 132.5 5.9 0.0 1.4 0.1 33.1 109.0 3.3 7.1 14.4 6.5 8.9 3.8 8.1 1.6 42.4 1.9 1.0 1.6 1.4 13.5 17.4 7.8 0.7 4.8 2.1 3.4 1.5 19.9 10.2 145.0 73.9 13.2 23.2 87.5 2.5 6.7 19.3 13.4 3.3 8.1 3.3 19.0 4.0 12.0 5.3 3.0 11.9 51.8 16.9 13.3 6.8 11.1 30.7 8.9 24.4 3.0 3.2 28.5 6.1 18.0 1.1 33.6 11.6 18.8 17.9 1.5 4.4 9.2 9.4 94.7 53.3 123.0 90.0 58.3 83.1 58.8 76.5 79.9 35.5 64.9 76.0 80.3 134.9 65.3 49.9 16.7 70.6 132.5 211.4 256.3 523.2 152.7 62.8 5.2 378.6 219.1 167.3 228.6 258.2 27.5 4.8 381.3 68.3 6.0 390.7 127.9 140.2 46.4 5.0 157.0 217.7 358.0 65.3 218.0 6.4 157.7 332.7 859.8 16.4 606.1 469.7 102.9 128.0 291.4 3.4 148.2 357.3 420.4 90.8 3.3 1177.1 168.0 6.4 34.1 63.1 9.2 976.9 145.3 211.3 TXNL1 "TRP32, Txl, TXNL" ENSG00000091164 "Thioredoxin like 1" O43396 18 56597208-56651600 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002828, HPA002829, CAB016446" Supported Supported Enhanced Cytosol NA Yes 1500000 Cytosol "CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359" "unprognostic (2.05e-1)" "unprognostic (2.97e-1)" "unprognostic (3.38e-3)" "unprognostic (4.54e-2)" "unprognostic (2.51e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (9.62e-6)" "unprognostic (1.83e-1)" "unprognostic (1.03e-2)" "prognostic favorable (6.26e-5)" "unprognostic (1.44e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-3)" "unprognostic (1.24e-1)" "unprognostic (1.26e-1)" "unprognostic (2.62e-1)" "unprognostic (1.51e-1)" 20.5 31.9 27.9 17.8 30.0 34.0 24.4 20.6 34.5 22.5 20.1 21.5 17.3 20.1 22.1 33.8 29.6 18.0 19.8 37.2 27.7 28.5 28.0 38.5 16.4 21.7 27.7 22.8 26.1 34.3 21.5 23.3 26.8 32.1 23.1 21.6 17.6 22.4 20.9 64.4 17.6 21.1 26.5 23.4 20.4 24.0 19.3 21.1 22.3 96.0 27.7 23.3 27.7 18.9 22.2 29.9 39.0 35.3 23.4 23.0 30.9 24.8 24.6 33.3 34.3 29.0 42.5 23.7 29.7 30.6 38.4 32.6 21.8 24.6 27.1 26.5 32.3 27.8 31.0 31.5 26.9 39.8 27.6 14.4 37.1 20.6 40.8 34.0 54.0 24.2 32.2 27.9 36.1 33.2 40.6 30.8 20.8 27.1 45.5 38.8 23.9 31.2 35.3 24.1 17.3 26.5 25.5 22.5 47.0 44.8 38.9 27.7 25.3 16.9 23.7 28.1 27.7 25.9 29.0 24.4 40.4 21.3 14.0 28.9 44.2 47.3 42.3 26.3 41.4 29.5 39.0 35.3 25.3 15.9 29.6 21.7 22.2 19.7 20.8 29.9 19.3 19.4 19.6 26.5 23.4 27.9 25.5 23.0 30.9 27.9 30.0 20.6 34.5 27.7 28.5 27.7 22.8 32.1 21.1 53.6 38.7 77.2 102.3 119.4 77.4 92.0 48.4 57.6 61.4 27.9 131.6 212.5 92.9 122.4 165.3 62.6 79.4 46.7 112.7 104.6 91.2 91.6 51.9 68.4 133.8 54.0 72.8 56.4 76.0 218.7 71.9 78.2 62.4 131.7 97.3 59.0 117.2 83.1 78.8 104.9 82.7 64.7 97.8 196.1 99.4 110.2 299.9 68.2 101.2 105.2 TXNL4A "DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD" ENSG00000141759 "Thioredoxin like 4A" P83876 18 79970811-80033949 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041324 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA041324: AB_2677410" "unprognostic (7.56e-2)" "unprognostic (1.06e-3)" "unprognostic (5.94e-2)" "unprognostic (2.67e-2)" "unprognostic (6.99e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.45e-1)" "unprognostic (9.39e-2)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (4.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" 28.2 35.8 57.2 27.7 43.9 36.7 30.2 21.7 43.4 22.0 29.4 30.7 22.9 23.9 15.8 38.9 26.5 21.0 21.8 33.5 47.9 42.7 29.0 42.5 18.4 35.1 52.6 25.4 14.1 64.9 22.1 38.4 23.2 32.7 21.1 25.2 24.0 46.8 20.5 35.5 26.6 25.1 19.0 37.7 26.9 23.2 41.6 20.8 40.2 28.8 26.8 32.2 23.5 16.9 12.7 25.0 8.4 9.6 11.3 12.7 4.4 21.8 29.5 26.3 25.0 21.5 22.7 23.3 23.8 19.3 32.4 29.5 27.4 15.6 26.7 8.9 22.7 22.0 18.6 31.6 27.7 21.5 31.1 40.1 19.1 44.8 64.4 27.5 54.8 31.4 21.1 24.6 23.0 29.6 20.7 30.4 33.2 16.7 39.0 22.5 39.6 38.8 37.2 20.5 16.7 63.9 23.7 17.6 55.0 31.8 34.7 40.3 29.3 11.8 35.2 43.4 23.7 17.2 32.7 14.3 28.6 35.1 13.0 29.0 17.3 65.0 43.9 26.8 41.8 26.2 8.4 8.4 6.8 12.2 9.6 8.4 12.3 10.0 9.6 11.4 12.7 10.2 11.9 6.8 11.3 9.5 25.0 12.7 4.4 57.2 43.9 21.7 43.4 47.9 42.7 52.6 25.4 32.7 20.8 17.9 41.8 50.0 60.5 77.4 32.4 73.1 63.7 25.4 52.4 62.8 33.4 96.1 305.1 118.9 207.4 51.7 39.3 23.3 108.6 136.0 58.6 137.6 10.5 80.8 109.4 42.9 54.1 37.4 48.3 186.2 38.9 65.4 89.4 102.8 78.3 48.2 121.8 56.1 42.5 211.1 37.3 45.3 91.2 74.9 65.0 96.0 80.9 50.7 65.4 100.5 TXNL4B "Dim2, DLP, FLJ20511" ENSG00000140830 "Thioredoxin like 4B" Q9NX01 16 72044289-72094431 "Predicted intracellular proteins" "Cell cycle, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065865 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA065865: AB_2685571" "unprognostic (1.45e-1)" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (3.78e-2)" "unprognostic (8.72e-2)" "unprognostic (4.75e-2)" "unprognostic (2.65e-1)" "unprognostic (8.91e-2)" "unprognostic (4.75e-2)" "unprognostic (1.04e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.62e-1)" "unprognostic (2.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" 11.1 10.0 14.1 11.5 16.3 15.6 12.3 18.6 17.0 11.0 11.7 18.5 10.4 12.8 10.2 10.3 12.2 13.3 11.2 9.3 13.2 12.2 9.8 20.8 8.8 13.0 20.9 13.6 27.8 12.6 11.0 19.9 9.4 13.7 9.8 10.8 9.8 10.7 10.3 11.3 10.1 10.4 8.7 17.2 10.0 10.0 18.9 15.3 14.0 10.9 6.0 11.9 8.6 13.7 10.8 9.4 18.3 14.2 5.0 13.7 9.9 6.9 10.5 5.8 7.9 4.3 5.1 12.9 9.2 7.5 16.1 12.2 10.7 6.4 10.2 6.7 4.7 7.5 9.5 10.2 5.4 12.6 5.1 9.6 9.4 8.0 16.0 9.2 11.1 8.2 5.3 3.8 14.2 13.4 6.2 6.8 11.4 22.6 6.2 7.6 13.3 13.3 9.7 10.5 4.4 9.7 13.8 7.3 13.7 5.9 5.3 13.2 11.4 8.6 4.0 11.9 4.6 9.4 7.1 6.5 7.7 11.2 6.4 8.6 12.3 19.8 42.5 8.7 7.6 7.6 18.3 9.8 12.9 9.2 10.9 13.7 10.8 9.5 7.8 8.5 9.0 13.1 12.7 13.9 5.0 14.2 9.4 10.5 9.9 14.1 16.3 18.6 17.0 13.2 12.2 20.9 13.6 13.7 15.3 3.0 8.8 13.1 6.9 7.6 3.4 1.4 7.6 8.1 5.7 5.2 2.0 11.7 5.0 9.4 1.6 7.9 8.4 0.0 8.8 14.7 6.5 6.9 9.2 11.9 10.8 9.5 8.6 8.0 8.7 3.2 10.9 7.4 6.8 9.0 8.4 5.8 6.2 3.5 8.5 9.9 4.5 0.0 8.2 7.4 7.5 7.2 16.2 7.5 7.3 5.7 TXNRD2 "TR, TR3, TRXR2" ENSG00000184470 "Thioredoxin reductase 2" Q9NNW7 22 19875517-19941992 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002007, HPA003323" Supported Approved Vesicles,Mitochondria,Cytosol NA NA 410000 "Vesicles, Mitochondria, Cytosol" "CAB002007: , HPA003323: AB_1080396" "unprognostic (3.17e-2)" "unprognostic (8.72e-2)" "unprognostic (4.30e-1)" "unprognostic (9.71e-3)" "unprognostic (7.25e-2)" "unprognostic (6.35e-2)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (2.83e-1)" "unprognostic (4.94e-3)" "unprognostic (2.49e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.47e-1)" "unprognostic (5.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" 9.8 30.2 8.5 8.3 10.1 11.6 7.4 19.0 15.0 8.3 10.3 9.0 7.6 9.2 11.9 12.3 8.8 8.4 13.0 22.6 8.3 7.5 13.9 40.9 10.8 8.4 7.8 9.7 11.9 13.0 9.9 9.9 14.0 7.1 17.9 4.5 10.0 15.2 8.8 16.5 6.0 10.2 5.4 5.6 11.2 14.6 10.5 6.8 4.9 12.6 9.2 10.5 7.5 7.9 4.8 9.1 5.8 12.1 4.8 4.9 4.9 6.4 13.3 1.2 5.2 2.4 3.4 3.0 6.2 7.3 11.2 8.3 12.4 6.7 3.6 15.1 6.5 11.6 11.4 6.2 8.5 4.3 6.8 15.3 6.0 10.6 7.3 4.6 6.7 2.9 3.3 6.5 5.7 4.9 4.6 31.8 0.7 33.2 6.1 8.7 15.6 2.3 10.0 6.1 15.9 9.5 3.4 29.6 3.3 6.8 7.0 6.6 5.8 10.7 13.9 7.1 2.1 11.4 9.1 17.7 8.2 49.4 6.8 13.0 6.1 4.4 2.2 7.9 5.1 10.3 3.2 12.1 5.8 4.3 9.2 3.3 4.8 3.8 3.9 9.1 3.6 4.9 4.0 1.3 4.8 8.7 3.4 2.4 4.9 8.5 10.1 19.0 15.0 8.3 7.5 7.8 9.7 7.1 6.8 14.9 27.1 5.2 19.2 3.8 20.0 13.6 17.8 13.4 10.3 19.2 9.8 51.6 49.7 18.7 21.0 11.3 13.5 0.0 27.8 19.6 12.5 19.5 1.1 47.4 23.3 9.5 1.2 10.4 20.5 14.1 14.4 12.1 5.0 25.2 12.1 19.0 19.9 14.0 8.5 44.0 9.5 6.5 9.1 8.6 12.8 4.5 35.1 11.7 14.7 12.7 TXNRD3 "TGR, TR2, TRXR3" ENSG00000197763 "Thioredoxin reductase 3" Q86VQ6 3 126607052-126655155 "Enzymes, Predicted intracellular proteins" "Differentiation, Electron transport, Spermatogenesis, Transport" "Developmental protein, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.8" "Cell type enhanced" "Detected in many" 13 "Spermatocytes: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.0" "Lineage enriched" "Detected in single" 4 "T-cells: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020802, HPA036109" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020802: , HPA036109: AB_2674945" "unprognostic (1.41e-1)" "unprognostic (1.55e-2)" "unprognostic (3.92e-1)" "prognostic unfavorable (3.35e-4)" "unprognostic (3.90e-1)" "unprognostic (2.96e-1)" "unprognostic (3.01e-1)" "unprognostic (3.39e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (3.14e-1)" "prognostic favorable (2.72e-4)" "unprognostic (5.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" 5.4 5.9 4.9 2.4 4.7 0.9 7.2 5.5 5.7 7.3 4.2 4.6 5.5 1.6 8.3 7.1 6.4 4.7 5.2 4.9 4.0 2.9 6.7 10.0 7.0 5.2 4.6 3.5 8.8 7.1 12.3 8.5 3.3 7.0 5.2 3.6 6.4 5.7 5.1 7.3 4.8 2.6 8.1 5.1 3.3 4.9 27.8 5.8 5.0 7.4 3.6 2.1 6.6 5.3 0.3 0.7 0.5 0.9 0.9 4.0 0.3 14.0 3.6 4.6 7.2 8.5 13.0 2.3 6.2 5.6 5.1 7.2 6.4 7.9 0.0 7.9 8.5 3.1 5.6 5.7 6.4 6.5 0.0 4.2 1.6 3.3 4.9 7.4 5.7 0.5 11.9 5.6 1.7 11.8 7.0 3.7 4.6 3.4 0.0 8.2 10.1 1.2 3.1 6.5 3.8 2.7 0.4 4.0 2.3 5.4 7.0 8.0 4.9 17.8 5.2 9.0 3.7 7.2 2.2 6.1 6.3 1.5 8.5 2.9 3.7 1.6 0.0 3.4 2.0 5.3 0.0 0.9 0.5 0.5 0.8 0.1 0.0 0.2 0.6 0.7 0.3 4.0 1.3 0.0 0.9 0.2 0.0 0.0 0.3 4.9 4.7 5.5 5.7 4.0 2.9 4.6 3.5 7.0 5.8 3.0 7.4 0.0 4.8 0.9 1.9 3.6 5.1 2.7 3.4 3.5 2.0 7.5 3.3 4.3 15.1 1.5 0.0 0.0 3.4 4.6 3.7 2.1 5.7 7.3 2.6 0.0 4.1 1.3 0.3 2.9 4.4 0.3 0.0 0.0 2.3 2.3 3.9 0.0 8.1 2.8 0.5 0.0 2.7 54.7 15.3 0.5 6.1 0.0 1.5 2.5 TYK2 JTK1 ENSG00000105397 "Tyrosine kinase 2" P29597 19 10350529-10380676 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 63.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005157 Uncertain Approved Cytosol NA NA Cytosol "HPA005157: AB_1858480" "unprognostic (1.60e-2)" "unprognostic (6.12e-3)" "unprognostic (3.67e-2)" "prognostic favorable (9.62e-4)" "unprognostic (7.61e-2)" "prognostic favorable (1.05e-5)" "unprognostic (1.20e-2)" "unprognostic (6.16e-3)" "unprognostic (4.93e-2)" "unprognostic (1.90e-2)" "prognostic favorable (1.02e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.10e-3)" "unprognostic (1.78e-1)" "unprognostic (4.19e-1)" "prognostic favorable (4.16e-4)" 16.8 19.0 22.9 36.0 22.6 49.4 17.5 24.4 23.9 17.8 19.4 26.7 13.9 20.0 19.3 20.2 15.0 16.8 21.8 17.0 18.3 14.0 24.0 34.4 27.5 31.5 24.7 17.4 20.0 21.3 19.0 24.8 13.9 19.1 21.1 18.6 21.6 24.4 15.4 15.6 24.4 23.8 16.7 17.9 47.9 18.5 6.4 22.8 33.9 20.9 13.5 34.7 16.7 15.1 5.8 15.8 22.9 13.4 5.3 9.1 7.3 8.6 12.7 7.6 11.9 10.1 14.3 7.3 11.9 12.2 15.1 16.7 9.7 5.8 13.2 14.1 13.3 10.4 8.8 9.2 14.0 8.0 23.3 14.2 24.4 25.3 23.9 15.9 10.2 28.2 13.8 9.9 17.2 10.2 9.5 14.6 17.5 10.2 37.0 13.3 27.3 15.0 63.2 2.4 8.6 22.2 15.0 6.5 13.5 12.3 28.0 7.2 8.8 11.6 12.3 8.5 6.2 6.8 17.4 12.4 20.4 7.3 23.5 14.0 30.5 23.7 12.1 10.2 21.4 11.4 6.6 13.4 17.0 9.1 10.2 5.9 5.6 5.5 8.1 15.8 5.8 3.8 5.1 22.9 5.3 9.7 9.0 6.8 7.3 22.9 22.6 24.4 23.9 18.3 14.0 24.7 17.4 19.1 22.8 11.9 19.9 6.7 4.8 6.0 8.4 23.6 12.7 5.3 10.3 8.7 3.9 6.0 44.7 6.5 1.4 7.5 10.2 0.0 9.5 6.9 9.4 5.5 18.5 20.2 13.0 0.0 4.6 14.1 30.7 6.4 6.9 18.0 15.1 15.4 8.3 7.4 9.1 11.5 9.2 19.5 9.7 0.0 8.6 1.4 4.3 6.4 5.6 19.2 9.0 4.9 TYMP "ECGF1, MNGIE" ENSG00000025708 "Thymidine phosphorylase" P19971 22 50525752-50530056 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Glycosyltransferase, Growth factor, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.8" "Cell type enriched" "Detected in many" 5 "monocytes: 2738.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 23.0;eosinophil: 18.2;intermediate monocyte: 22.4;myeloid DC: 12.2;neutrophil: 6.7;non-classical monocyte: 15.9" "Group enriched" "Detected in many" 18 "dendritic cells: 12.2;granulocytes: 18.2;monocytes: 23.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.2;HHSteC: 40.2;Karpas-707: 38.8;U-266/70: 18.6" "Low region specificity" "Detected in some" "HPA000530, HPA001072, CAB002518" Enhanced Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 16000000 "Nuclear bodies, Golgi apparatus" Cytosol "CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274" "unprognostic (7.02e-3)" "unprognostic (1.00e-1)" "unprognostic (3.61e-1)" "prognostic favorable (4.34e-5)" "unprognostic (7.60e-2)" "unprognostic (1.16e-2)" "unprognostic (2.40e-1)" "unprognostic (7.17e-2)" "unprognostic (4.64e-2)" "unprognostic (1.33e-1)" "unprognostic (3.31e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (3.50e-8)" "unprognostic (1.32e-1)" "unprognostic (4.02e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" 25.2 7.9 2.8 41.6 8.4 12.1 19.0 1.5 4.4 10.7 10.7 3.8 2.3 10.4 4.4 15.7 22.0 13.7 9.6 15.0 7.0 2.6 18.6 38.1 28.8 57.8 6.5 0.4 7.5 5.8 1.7 3.9 11.5 9.1 7.9 4.9 5.4 16.5 3.8 10.0 8.8 13.9 7.3 15.2 43.9 12.4 3.0 5.0 13.3 12.5 25.5 28.8 12.4 9.4 0.9 12.2 18.2 23.0 0.8 0.9 2.6 6.7 0.8 0.0 0.1 1.0 1.3 0.6 1.2 0.1 2.4 5.4 0.0 16.2 0.5 0.8 2.7 0.8 5.9 0.2 0.3 0.0 2.8 1.4 0.3 1.1 0.4 40.2 0.1 7.7 2.5 2.4 3.2 0.0 0.1 0.0 0.0 0.2 38.8 0.2 0.1 0.0 1.0 0.0 0.9 2.1 0.2 0.0 7.8 0.0 0.0 0.0 1.4 6.2 8.5 0.6 0.0 0.7 4.9 1.5 0.0 0.6 0.1 0.2 18.6 3.8 0.4 0.2 0.1 0.2 2.5 23.0 18.2 0.3 22.4 0.2 0.8 0.3 0.2 12.2 0.9 0.2 0.1 6.7 0.8 15.9 1.1 0.9 2.6 2.8 8.4 1.5 4.4 7.0 2.6 6.5 0.4 9.1 5.0 11.9 35.6 80.8 45.0 52.0 2.9 2.0 40.8 21.4 19.4 31.4 3.9 11.5 24.9 326.6 1.8 45.0 161.9 0.0 563.3 281.5 67.3 63.5 54.1 80.8 472.8 0.0 16.1 38.1 417.7 8.6 4.6 429.6 108.0 2738.6 29.6 2.0 289.0 94.7 1.8 76.1 5.4 25.8 44.2 1.4 8.3 49.4 28.0 34.5 27.7 63.3 TYSND1 "MGC34695, NET41" ENSG00000156521 "Trypsin domain containing 1" Q2T9J0 10 70137981-70146676 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.7" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 90.7;Late spermatids: 154.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 18.0;PC-3: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030304 Approved Uncertain Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA030304: AB_10670560" "unprognostic (4.75e-3)" "unprognostic (4.30e-2)" "unprognostic (2.44e-2)" "unprognostic (7.69e-2)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.02e-2)" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-1)" "unprognostic (1.59e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-1)" "unprognostic (9.26e-3)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" 15.2 8.2 4.7 7.0 6.8 3.0 8.0 6.7 7.3 6.0 6.7 5.9 6.9 10.1 5.3 8.4 13.9 5.4 5.2 3.5 3.7 2.8 7.4 7.4 3.5 7.2 3.7 3.6 5.6 9.0 3.3 4.5 4.7 3.5 6.9 2.7 6.9 8.0 5.7 5.3 12.5 8.5 4.8 4.7 9.0 8.2 40.7 3.4 6.2 8.5 6.6 10.1 6.5 7.6 6.1 1.4 1.2 1.6 2.9 6.3 2.3 9.5 6.9 0.5 4.1 0.8 0.6 2.5 1.2 0.9 1.4 1.3 4.3 6.1 8.6 4.0 0.3 0.3 18.0 0.7 2.7 0.3 5.4 6.2 0.5 1.9 2.1 1.7 0.7 0.0 1.3 5.2 1.2 2.2 0.8 1.0 3.1 0.0 2.6 0.6 4.2 3.2 3.5 2.2 2.3 27.7 5.7 1.6 3.8 0.6 1.6 5.0 2.6 4.2 9.4 3.6 0.2 6.1 0.7 1.7 1.6 1.1 3.0 5.4 9.8 5.9 4.2 1.9 3.6 1.2 0.0 1.3 1.2 6.3 1.6 4.1 5.1 3.7 4.9 1.4 6.1 5.3 4.4 0.4 2.9 1.1 1.0 4.0 2.3 4.7 6.8 6.7 7.3 3.7 2.8 3.7 3.6 3.5 3.4 8.9 4.0 13.7 13.8 12.7 6.8 4.3 25.5 1.4 5.7 10.4 0.0 30.0 14.9 6.8 90.7 6.7 14.8 0.0 8.3 6.8 6.3 10.9 13.8 14.3 10.7 0.0 13.7 6.7 9.5 154.7 8.6 8.0 11.8 2.8 10.6 6.2 5.1 10.5 7.4 12.4 4.5 6.5 4.7 41.1 11.1 16.2 14.0 11.8 20.3 5.2 TYW3 "C1orf171, FLJ40918" ENSG00000162623 "TRNA-yW synthesizing protein 3 homolog" Q6IPR3 1 74733152-74766678 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029641 Approved Approved "Plasma membrane,Cytosol" No No Cytosol "Plasma membrane" "HPA029641: AB_2272535" "unprognostic (6.89e-3)" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (1.49e-7)" "unprognostic (3.79e-1)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-2)" "unprognostic (1.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (2.05e-1)" "unprognostic (8.90e-2)" "unprognostic (2.98e-3)" 16.5 19.7 13.7 13.5 17.7 11.9 18.3 15.0 19.9 20.4 17.7 7.5 13.7 9.5 21.0 15.2 20.6 16.4 10.0 21.1 11.1 12.9 20.4 17.0 11.3 14.3 16.2 17.2 30.0 14.4 22.2 34.3 13.5 17.0 20.7 12.3 8.6 13.8 15.7 12.3 10.5 10.9 24.7 15.6 16.0 14.8 12.3 18.1 12.3 23.5 14.3 16.9 23.5 33.3 9.7 9.0 6.0 8.0 13.6 13.9 5.2 8.6 7.3 12.6 8.9 14.3 15.7 19.1 14.9 13.7 14.3 12.6 15.4 7.4 22.7 13.7 12.8 21.0 7.1 14.4 17.2 17.9 14.1 12.4 17.8 22.3 29.8 9.4 35.6 11.6 11.9 17.4 18.2 17.6 11.5 12.7 15.8 30.8 17.5 18.3 7.3 17.3 11.9 33.5 13.0 17.0 16.4 26.3 10.2 12.2 11.3 9.8 8.3 7.1 19.4 22.9 14.3 10.6 13.1 8.2 6.3 17.3 17.1 17.8 10.1 18.3 15.9 14.2 12.9 18.2 6.0 6.0 1.6 10.3 8.0 9.9 9.7 9.1 9.3 9.0 8.8 13.2 13.9 0.5 13.6 5.9 8.7 8.4 5.2 13.7 17.7 15.0 19.9 11.1 12.9 16.2 17.2 17.0 18.1 14.9 22.9 32.0 34.6 22.8 31.3 26.5 17.8 24.1 36.4 15.7 3.9 37.5 66.3 29.4 14.9 24.8 8.0 0.0 51.1 41.5 28.2 34.8 20.7 29.2 29.0 47.7 13.3 17.8 27.2 18.5 40.3 22.8 20.3 29.7 17.0 18.0 31.2 7.0 57.7 43.8 19.9 12.9 38.0 31.8 45.3 19.8 18.7 27.7 24.9 23.3 UACA "FLJ10128, KIAA1561" ENSG00000137831 "Uveal autoantigen with coiled-coil domains and ankyrin repeats" Q9BZF9 15 70654554-70763593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.0" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 148.5;Leydig cells: 115.9;Peritubular cells: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 2.2;intermediate monocyte: 4.3;memory B-cell: 1.2;myeloid DC: 2.0;naive B-cell: 3.4;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 11 "B-cells: 3.4;dendritic cells: 2.0;monocytes: 4.3" "Cell line enhanced" "Detected in many" "BJ: 62.0;BJ hTERT+: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041412, HPA043503, HPA056006" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: " "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (7.01e-5)" "unprognostic (4.95e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (2.42e-2)" "prognostic unfavorable (1.03e-4)" 21.7 8.9 4.7 8.6 8.1 0.4 25.9 2.9 5.8 15.4 14.1 8.4 22.8 10.6 17.2 22.3 15.6 10.5 15.7 18.0 6.1 4.2 16.4 8.2 23.7 7.5 9.0 4.6 17.5 8.6 8.2 6.5 13.7 9.6 15.5 7.6 26.7 18.8 26.9 68.0 10.1 16.9 11.4 14.9 15.7 8.4 10.1 7.1 1.0 18.6 32.4 5.3 9.9 13.5 3.4 2.0 0.2 4.3 0.1 0.3 0.7 10.5 8.7 3.9 5.1 7.9 34.2 0.0 62.0 37.9 16.2 14.1 14.6 15.6 7.2 17.1 15.4 4.7 12.2 8.8 4.9 20.5 0.0 3.9 4.0 6.8 3.0 10.3 0.1 1.5 16.1 2.8 9.6 7.3 26.9 17.2 1.7 1.0 0.0 20.1 3.4 0.0 0.6 3.2 4.8 4.6 0.0 28.3 0.0 7.8 3.6 1.0 2.0 11.7 1.8 12.5 8.2 3.4 1.2 33.0 0.9 6.5 5.3 9.8 0.6 2.1 0.0 8.2 1.1 7.0 0.2 2.2 0.0 0.0 4.3 0.0 1.2 0.1 0.0 2.0 3.4 0.3 0.1 0.2 0.1 2.9 0.1 0.0 0.7 4.7 8.1 2.9 5.8 6.1 4.2 9.0 4.6 9.6 7.1 6.0 8.3 4.7 14.2 10.1 7.0 148.5 12.7 87.0 22.7 47.1 3.9 0.8 3.3 42.5 15.2 80.4 36.5 0.0 42.6 1.0 25.7 13.4 15.0 14.8 8.6 23.8 8.7 43.6 19.1 8.1 115.9 9.6 28.7 11.8 23.3 55.9 56.3 28.5 132.6 3.0 3.4 51.8 46.4 38.5 29.6 11.4 0.8 3.2 20.0 9.6 UAP1 "AgX, AGX1, SPAG2" ENSG00000117143 "UDP-N-acetylglucosamine pyrophosphorylase 1" Q16222 1 162561506-162599842 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 107.8;U-251 MG: 70.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014659 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No Yes 19000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA014659: AB_1857409" "unprognostic (2.32e-2)" "unprognostic (2.45e-1)" "unprognostic (2.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.71e-2)" "unprognostic (1.46e-2)" "unprognostic (1.37e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (4.96e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "unprognostic (3.51e-1)" "unprognostic (3.45e-2)" 38.4 18.5 7.0 17.4 9.8 17.2 24.8 9.0 13.4 16.1 26.9 5.7 45.7 17.2 10.9 19.4 23.6 15.7 18.3 22.5 7.7 7.8 11.0 67.1 16.0 7.4 6.6 8.9 20.4 31.4 5.1 16.0 21.5 9.1 13.9 26.9 7.8 43.9 62.5 19.4 12.4 33.4 28.8 7.1 8.1 23.0 37.7 3.7 5.6 12.4 13.5 15.3 24.4 16.7 8.3 5.6 8.1 1.6 6.2 16.1 4.8 30.5 2.2 6.1 4.9 29.8 23.9 4.2 44.9 16.6 34.7 28.3 5.8 14.4 1.2 10.1 34.4 12.5 5.3 6.9 13.1 57.2 4.8 10.3 5.4 7.0 11.4 14.0 9.2 3.7 11.0 6.2 38.0 107.8 15.9 21.2 9.6 30.5 12.6 46.4 5.6 5.3 5.9 4.5 31.4 10.0 4.8 11.9 14.9 5.4 3.6 6.6 6.8 19.6 12.2 10.4 7.5 6.0 10.5 36.0 17.5 16.1 44.0 70.2 21.2 7.4 10.1 10.0 4.3 11.0 1.0 1.6 8.1 13.0 1.6 16.1 8.3 7.9 13.3 3.4 6.5 7.6 9.5 1.6 6.2 0.8 5.6 3.9 4.8 7.0 9.8 9.0 13.4 7.7 7.8 6.6 8.9 9.1 3.7 6.0 30.4 17.9 120.0 119.7 10.0 26.6 17.8 53.5 38.7 15.7 7.9 22.4 61.3 24.8 36.3 23.3 84.7 0.0 56.9 52.1 141.3 91.8 33.4 88.9 14.0 6.4 52.6 21.5 7.0 11.8 46.9 15.2 81.0 27.9 124.5 14.0 55.8 69.1 38.9 20.2 12.3 19.4 160.3 182.9 121.8 71.5 81.7 20.1 59.9 111.6 UAP1L1 ENSG00000197355 "UDP-N-acetylglucosamine pyrophosphorylase 1 like 1" Q3KQV9 9 137077501-137084539 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 18.6;Horizontal cells: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044356 Approved Approved "Intermediate filaments,Cytosol" No No "Intermediate filaments" Cytosol "HPA044356: AB_10959902" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.25e-3)" "unprognostic (2.49e-2)" "unprognostic (3.80e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (3.01e-2)" "unprognostic (2.33e-1)" "unprognostic (5.65e-2)" "prognostic favorable (5.23e-4)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (1.67e-2)" "unprognostic (6.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.64e-3)" 10.5 14.7 13.6 9.8 20.6 5.0 16.3 3.4 17.5 13.0 8.8 22.1 8.6 10.0 7.3 9.7 5.9 5.8 9.4 11.3 14.7 8.1 12.5 3.1 11.6 12.2 24.9 9.3 3.9 10.5 8.5 14.7 10.9 14.2 12.8 6.7 14.1 15.2 10.9 2.5 9.0 9.4 6.6 13.5 20.3 10.8 3.5 29.1 1.4 13.3 4.9 10.3 11.4 13.9 2.1 1.8 0.6 3.7 0.3 3.0 1.2 0.4 2.8 0.0 7.5 13.0 6.1 2.2 3.8 10.1 10.8 7.6 5.4 1.2 1.7 2.3 3.9 19.7 5.8 14.1 0.9 2.2 4.6 1.2 3.7 4.2 5.2 29.0 0.0 15.3 4.4 1.0 6.1 5.1 5.1 8.4 3.5 1.1 8.6 7.2 6.2 0.3 3.7 1.2 13.2 4.0 5.9 0.1 5.2 4.3 0.5 4.5 2.8 0.9 21.2 8.6 1.9 11.4 10.2 6.6 19.6 4.2 13.6 1.8 9.5 13.5 3.6 17.0 4.0 5.5 0.4 3.7 0.1 0.8 2.0 3.0 2.1 0.4 1.3 1.8 1.0 1.0 1.3 0.6 0.3 0.0 1.1 1.7 1.2 13.6 20.6 3.4 17.5 14.7 8.1 24.9 9.3 14.2 29.1 0.0 5.9 2.9 0.5 5.5 4.8 3.5 7.6 0.0 1.2 0.0 2.0 0.3 10.0 1.3 0.1 2.1 0.2 0.0 0.8 4.6 4.4 1.9 4.6 0.2 18.6 19.1 1.7 7.4 12.7 0.0 2.3 8.1 8.5 5.4 1.7 6.5 0.9 1.9 3.5 3.1 4.7 0.0 3.4 0.5 1.5 3.9 1.1 2.6 2.3 0.1 UBA3 "hUba3, NAE2, UBE1C" ENSG00000144744 "Ubiquitin like modifier activating enzyme 3" Q8TBC4 3 69054730-69080408 "Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034873, HPA034874, HPA065335" Supported Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA 9600 "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473" "unprognostic (2.31e-1)" "unprognostic (1.75e-1)" "unprognostic (5.56e-3)" "unprognostic (9.26e-2)" "unprognostic (9.35e-3)" "unprognostic (5.53e-2)" "prognostic unfavorable (8.57e-4)" "unprognostic (1.08e-1)" "unprognostic (6.18e-2)" "unprognostic (1.60e-3)" "unprognostic (9.40e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-3)" "unprognostic (2.61e-3)" "unprognostic (9.24e-2)" "unprognostic (7.80e-3)" "unprognostic (2.52e-1)" 19.1 25.3 29.7 22.2 31.0 53.7 26.8 30.9 31.4 20.3 19.7 31.3 15.9 16.1 22.8 25.4 25.4 19.5 18.4 38.2 23.8 22.7 24.7 17.6 19.3 28.7 37.5 21.2 20.4 15.1 17.9 28.0 27.8 40.8 22.6 22.6 21.8 28.0 20.4 25.0 27.6 21.9 24.0 30.2 27.8 17.3 13.5 31.9 28.4 18.2 17.2 31.0 22.9 20.4 18.9 22.3 35.6 27.8 20.2 22.2 26.0 26.8 11.4 28.1 17.1 26.3 34.9 21.7 24.1 27.3 26.3 26.5 14.1 19.0 20.5 7.0 25.9 26.5 15.5 21.6 27.6 30.0 37.3 13.7 27.7 21.5 14.2 20.3 27.1 23.3 27.4 18.5 24.8 20.8 32.4 33.8 16.9 11.4 17.6 34.6 9.6 17.8 18.3 24.9 34.1 9.8 13.9 20.8 18.8 41.9 34.4 12.1 16.9 25.4 18.5 20.6 31.6 12.6 26.7 25.6 20.0 17.6 25.9 33.4 20.2 32.3 24.4 20.5 30.2 25.4 34.7 25.4 35.6 14.3 27.8 16.1 18.9 18.9 17.6 22.3 16.0 17.9 18.0 24.4 20.2 27.7 11.4 22.2 26.0 29.7 31.0 30.9 31.4 23.8 22.7 37.5 21.2 40.8 31.9 32.8 28.9 17.1 23.8 30.0 21.0 57.2 20.4 37.5 23.9 33.2 37.3 64.4 16.6 30.4 10.9 27.1 14.3 0.0 20.5 47.2 31.1 21.5 40.5 16.2 30.1 31.8 17.9 20.3 43.2 7.9 37.4 39.1 28.7 53.3 15.3 27.7 25.3 8.6 35.7 26.4 44.9 25.8 29.3 32.3 33.0 37.4 47.5 33.8 16.6 28.2 UBA5 "FLJ23251, UBE1DC1" ENSG00000081307 "Ubiquitin like modifier activating enzyme 5" Q9GZZ9 3 132654446-132678097 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 126.0;Late spermatids: 301.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017235 Uncertain Enhanced Vesicles,Cytosol NA NA Cytosol Vesicles "HPA017235: AB_1858507" "unprognostic (4.34e-3)" "unprognostic (6.44e-2)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.06e-1)" "unprognostic (3.28e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.84e-2)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" 14.8 30.3 17.8 12.3 19.8 13.2 17.4 17.9 26.2 14.5 15.0 10.5 27.8 16.2 13.4 24.2 15.1 13.3 12.7 21.2 15.3 16.3 22.7 29.8 13.7 14.8 16.0 25.0 15.1 41.4 29.3 32.7 18.1 21.2 18.8 16.7 11.7 37.8 33.5 32.5 15.7 17.9 14.6 13.6 18.9 18.5 15.3 12.7 17.9 23.5 17.5 17.4 15.1 12.5 11.1 14.1 5.0 6.6 18.9 15.0 7.9 27.3 10.2 18.0 14.8 12.7 14.6 18.9 23.7 24.4 14.9 17.3 18.5 10.2 21.8 17.4 17.1 9.8 16.7 17.8 18.7 22.2 20.7 7.6 26.5 16.5 20.7 12.7 32.5 15.6 12.7 11.0 14.1 21.3 13.9 16.7 11.9 16.5 32.4 16.6 24.3 17.9 12.2 16.4 23.5 9.8 15.7 15.7 41.3 13.7 21.2 17.4 15.7 13.9 14.0 20.0 17.2 16.8 16.5 14.9 15.8 15.5 7.6 12.4 30.6 20.5 40.4 18.0 11.9 14.0 4.1 5.1 5.0 9.6 5.8 11.6 11.1 10.8 15.0 11.8 6.9 12.9 12.8 1.1 18.9 6.6 14.1 10.7 7.9 17.8 19.8 17.9 26.2 15.3 16.3 16.0 25.0 21.2 12.7 32.8 23.4 11.1 16.1 15.2 19.2 32.5 15.3 17.4 19.4 7.0 13.7 52.9 58.0 21.3 126.0 17.0 14.5 0.0 39.4 38.1 22.6 19.5 23.1 20.2 20.4 20.6 20.7 15.4 6.4 301.4 15.5 11.7 16.9 27.9 20.1 24.6 21.2 15.9 25.5 29.4 19.8 32.3 25.0 27.9 14.9 16.2 83.4 17.5 15.6 14.8 UBA52 "CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40" ENSG00000221983 "Ubiquitin A-52 residue ribosomal protein fusion product 1" P62987 19 18571730-18577550 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 9484.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041344, HPA049132, HPA056624" Supported Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Plasma membrane" "HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196" "unprognostic (1.98e-2)" "unprognostic (9.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-3)" "unprognostic (9.35e-2)" "unprognostic (1.74e-3)" "unprognostic (4.00e-2)" "unprognostic (7.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.87e-1)" "unprognostic (5.61e-2)" "unprognostic (2.43e-1)" "unprognostic (2.23e-1)" 84.7 73.8 71.1 76.4 76.5 167.0 101.5 32.8 71.1 83.2 73.0 48.7 67.8 47.7 79.0 93.2 102.7 78.8 82.0 85.9 58.2 50.2 74.1 135.5 67.7 182.7 64.0 59.0 150.3 225.2 56.5 62.8 71.6 55.5 75.8 74.0 51.6 96.0 75.2 191.4 104.6 68.0 91.9 72.0 101.1 75.5 89.5 52.1 121.2 97.6 131.7 145.1 99.9 161.7 200.5 157.0 75.1 132.4 109.7 205.0 246.6 104.4 83.5 62.7 104.6 163.0 155.1 155.6 80.7 112.1 134.1 107.1 151.2 97.9 151.5 83.5 133.0 52.8 70.9 121.3 143.5 126.9 40.6 189.4 82.9 129.9 170.4 118.7 179.8 106.3 179.4 196.4 91.9 133.7 117.4 134.3 97.0 131.1 210.1 114.3 174.9 143.6 161.4 140.3 199.6 180.9 118.8 62.6 173.5 129.2 158.9 81.8 99.0 58.6 142.1 139.9 97.9 63.0 232.8 99.7 67.3 56.3 141.7 142.6 129.4 171.7 149.9 91.6 204.3 91.1 50.7 132.4 69.8 119.4 107.2 162.2 200.5 178.5 142.6 147.6 199.1 205.0 165.6 75.1 109.7 96.1 157.0 138.5 246.6 71.1 76.5 32.8 71.1 58.2 50.2 64.0 59.0 55.5 52.1 431.7 622.2 2582.1 1573.2 1686.3 110.3 294.0 1008.9 451.1 705.2 621.1 64.8 1723.9 1331.3 1227.6 2621.0 1327.6 1318.3 1448.3 1974.2 2396.3 1301.0 1468.3 776.0 1485.4 2254.1 98.5 1063.9 1146.6 2650.9 9484.0 1736.3 2494.7 1186.1 2394.1 1524.2 239.6 1703.1 1730.2 972.7 1715.5 163.6 685.6 1317.8 523.4 597.0 1957.5 1909.1 1690.5 1603.6 1847.3 UBA6 "FLJ10808, UBE1L2" ENSG00000033178 "Ubiquitin like modifier activating enzyme 6" A0AVT1 4 67612652-67701179 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037001 Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037001: AB_10672787" "unprognostic (2.52e-1)" "unprognostic (4.89e-2)" "unprognostic (3.97e-3)" "unprognostic (2.81e-1)" "unprognostic (3.67e-2)" "unprognostic (4.92e-2)" "unprognostic (3.55e-3)" "unprognostic (6.06e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-2)" "unprognostic (3.38e-2)" "unprognostic (5.30e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.05e-3)" 16.8 12.6 14.1 14.1 16.6 22.7 13.0 18.0 16.0 17.0 10.5 14.6 7.0 12.2 16.7 10.0 20.5 9.9 12.4 9.5 12.0 12.0 10.2 16.4 14.5 17.3 18.7 11.2 14.3 10.9 17.4 44.8 18.5 17.7 12.7 13.2 7.5 13.7 10.4 10.1 12.6 15.3 13.4 20.7 16.9 13.9 14.6 18.6 27.1 12.3 13.3 19.9 15.7 19.5 5.6 5.1 9.3 4.0 9.7 5.8 1.9 15.1 8.5 14.1 11.0 7.0 8.2 9.5 31.4 12.3 14.4 16.9 8.9 20.5 19.2 11.2 12.9 14.7 9.0 14.5 15.6 21.8 22.1 4.0 12.3 15.0 8.3 6.0 21.6 9.5 5.9 5.0 18.6 11.3 9.9 12.7 9.9 29.2 11.4 17.0 5.7 22.4 4.9 8.3 10.8 10.3 13.3 28.9 7.1 11.8 17.2 6.9 8.7 17.7 12.6 5.9 12.3 8.4 5.8 18.3 13.4 15.1 10.8 13.7 8.2 6.4 19.4 23.8 6.0 12.8 9.3 3.0 4.6 4.4 3.9 4.8 5.6 5.1 5.8 3.7 5.2 3.9 4.5 2.2 9.7 4.0 5.1 4.2 1.9 14.1 16.6 18.0 16.0 12.0 12.0 18.7 11.2 17.7 18.6 23.8 20.8 33.8 52.9 62.3 46.2 14.4 12.7 25.4 20.5 15.7 51.1 22.4 3.3 21.4 1.4 34.4 21.2 0.0 14.8 12.9 28.2 64.5 30.1 17.3 20.5 31.8 31.0 17.8 27.9 4.0 19.8 35.3 23.6 33.3 24.7 19.8 36.7 21.0 18.7 10.2 42.3 19.4 23.0 37.9 35.1 40.4 49.2 29.9 19.6 126.8 UBA7 "D8, UBA1B, UBE1L, UBE2" ENSG00000182179 "Ubiquitin like modifier activating enzyme 7" P41226 3 49805207-49813946 "Plasma proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 22.7;HEL: 21.2;HMC-1: 41.2;HSkMC: 19.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB015444, HPA058182" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA 1400000 "Nucleoplasm, Vesicles" Cytosol "CAB015444: AB_793598, HPA058182: AB_2683631" "prognostic favorable (1.55e-4)" "unprognostic (7.07e-3)" "unprognostic (1.59e-2)" "unprognostic (1.61e-2)" "unprognostic (3.77e-1)" "unprognostic (2.31e-2)" "unprognostic (5.08e-3)" "unprognostic (3.61e-2)" "unprognostic (6.33e-2)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (9.11e-2)" "unprognostic (3.81e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.48e-4)" 11.3 12.1 6.8 22.0 7.5 16.0 11.5 2.0 6.7 10.8 12.7 14.4 25.4 19.6 17.2 31.6 17.7 12.9 33.1 9.1 6.7 3.9 15.9 11.9 18.8 28.2 6.0 6.2 19.1 9.5 1.4 8.4 8.9 9.4 18.5 12.1 14.2 24.5 34.2 3.3 9.0 25.5 11.3 7.7 35.9 13.2 3.4 5.9 20.4 17.8 18.4 23.5 12.6 13.1 12.4 14.3 24.8 21.7 11.1 11.8 13.0 4.3 0.0 0.3 0.1 12.2 12.9 1.4 2.3 10.6 16.9 22.7 0.0 9.3 0.1 1.9 8.6 7.3 2.4 0.0 4.2 1.5 11.3 0.0 21.2 0.2 1.3 9.0 2.0 41.2 19.8 0.2 6.6 0.4 11.8 8.5 0.7 0.0 1.3 3.9 0.1 4.3 5.1 0.0 0.0 0.4 5.5 0.4 0.7 3.5 8.6 0.0 0.3 2.8 4.2 1.4 0.2 0.4 14.1 3.7 3.3 0.4 1.4 0.9 0.0 0.0 0.1 9.2 7.5 0.7 13.9 14.7 24.8 11.8 21.7 10.3 12.3 10.8 10.5 14.3 12.4 9.9 8.9 4.6 11.1 17.2 5.2 10.6 13.0 6.8 7.5 2.0 6.7 6.7 3.9 6.0 6.2 9.4 5.9 29.8 23.6 22.9 5.9 3.4 0.1 6.9 15.3 2.7 13.6 12.2 0.0 4.5 0.0 7.6 4.5 14.3 35.5 0.0 6.9 2.2 8.9 5.1 80.8 6.7 18.2 0.0 9.1 17.8 21.9 24.1 10.3 10.6 0.0 10.8 19.5 2.9 5.1 12.9 10.6 4.1 1.1 6.5 7.1 0.9 0.4 4.1 2.4 27.4 15.3 5.0 UBAC1 "GBDR1, KPC2, UBADC1" ENSG00000130560 "UBA domain containing 1" Q9BSL1 9 135932969-135961380 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 113.2" "Cell type enhanced" "Detected in all" 6 "Erythroid cells: 233.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 60.5;K-562: 76.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005651 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 54000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA005651: AB_1858489" "unprognostic (8.41e-2)" "prognostic favorable (4.34e-6)" "unprognostic (2.10e-1)" "unprognostic (9.15e-2)" "unprognostic (4.11e-1)" "unprognostic (3.85e-2)" "unprognostic (7.68e-3)" "unprognostic (2.85e-1)" "unprognostic (4.37e-2)" "unprognostic (3.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.20e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.95e-3)" "unprognostic (9.46e-2)" "unprognostic (3.16e-2)" "unprognostic (5.78e-2)" 7.6 5.7 12.4 5.8 13.4 27.1 6.2 10.9 12.7 6.1 11.0 8.0 6.8 9.9 6.2 10.3 10.0 9.4 5.1 22.2 11.0 8.6 8.8 7.6 6.4 5.8 11.6 7.4 7.8 6.7 6.9 6.6 9.3 8.7 7.4 7.8 7.7 9.2 9.2 113.2 15.7 9.6 9.3 10.1 5.7 6.1 10.9 7.8 3.9 6.1 21.9 9.0 7.6 8.3 3.2 9.7 5.1 18.8 2.2 3.6 4.0 9.1 10.7 7.6 11.0 5.8 6.7 14.3 8.0 6.9 10.0 8.1 14.8 11.7 11.1 7.8 6.6 11.9 31.3 10.6 9.3 4.5 60.5 10.0 9.2 19.2 8.3 6.0 12.0 8.8 6.3 12.2 6.3 6.2 6.7 8.3 10.5 76.7 9.0 7.9 18.9 9.7 12.3 18.0 21.6 18.2 11.1 14.3 14.6 7.1 5.9 11.8 13.0 11.6 10.5 8.1 7.1 8.9 13.0 6.7 5.7 8.6 6.8 9.9 5.3 9.8 13.2 10.5 10.9 7.7 3.4 11.3 5.1 3.1 17.2 3.3 3.2 3.6 2.1 9.7 2.0 1.9 2.2 2.5 2.2 18.8 1.0 2.7 4.0 12.4 13.4 10.9 12.7 11.0 8.6 11.6 7.4 8.7 7.8 14.9 7.7 13.7 32.8 36.1 36.5 74.9 12.7 91.0 14.8 26.2 29.5 121.1 79.6 15.6 80.0 25.3 39.3 233.6 20.0 20.6 17.0 18.9 6.9 26.7 64.5 12.7 16.1 16.0 27.7 144.8 18.1 30.0 33.7 43.3 32.5 43.1 17.5 46.5 21.2 21.9 35.3 19.4 19.8 43.5 52.7 56.7 50.6 10.1 47.7 37.6 UBAC2 "FLJ30548, PHGDHL1, RP11-178C10.1" ENSG00000134882 "UBA domain containing 2" Q8NBM4 13 99200774-99386434 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013448 Approved Approved Cytosol NA NA Cytosol "HPA013448: AB_1855301" "unprognostic (7.04e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "unprognostic (7.30e-3)" "unprognostic (2.23e-1)" "unprognostic (2.79e-3)" "unprognostic (9.48e-3)" "unprognostic (6.50e-3)" "unprognostic (1.58e-1)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (6.44e-2)" "unprognostic (6.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.16e-1)" "unprognostic (6.08e-2)" "unprognostic (3.26e-2)" 16.7 15.6 9.1 15.6 10.4 11.0 24.2 8.2 13.9 14.6 14.6 10.0 18.3 16.7 17.2 17.1 29.6 18.1 15.4 15.5 11.0 7.6 15.1 20.0 20.6 36.5 8.2 10.1 15.1 25.5 11.8 9.5 22.1 9.8 11.1 14.6 11.9 19.5 13.7 26.9 26.3 17.6 13.8 11.7 13.4 14.9 24.8 8.1 21.6 20.6 17.3 24.5 17.2 15.8 25.3 23.9 24.7 23.1 31.3 37.5 31.8 13.1 8.3 6.3 9.1 16.0 17.4 15.2 6.9 24.7 12.6 9.8 8.0 28.6 5.5 12.3 10.5 7.8 12.1 9.1 11.8 7.3 9.3 9.0 9.1 4.4 4.9 13.6 11.4 7.0 13.5 14.9 7.2 22.8 16.7 11.0 10.5 8.0 2.8 10.2 3.5 8.7 2.9 7.9 27.4 6.5 7.0 5.5 4.0 8.6 6.7 6.8 10.1 5.7 17.2 10.0 10.5 11.5 36.8 7.8 4.9 4.9 5.1 7.5 3.9 3.3 1.9 10.7 17.7 9.6 20.8 23.1 17.3 27.3 22.1 37.5 19.6 23.4 27.3 18.6 25.3 32.7 32.2 24.7 31.3 21.2 23.9 15.1 31.8 9.1 10.4 8.2 13.9 11.0 7.6 8.2 10.1 9.8 8.1 6.0 18.4 15.9 23.5 24.2 26.2 19.7 17.8 25.4 14.8 22.7 25.5 99.9 19.9 38.6 19.2 23.6 34.4 0.0 30.4 70.7 31.5 23.0 21.9 25.0 43.6 30.2 8.1 12.9 33.8 16.7 32.5 40.2 28.7 16.2 26.9 44.7 25.3 35.1 47.7 18.3 21.9 32.3 24.0 59.0 37.8 29.0 110.8 50.4 33.9 23.3 UBALD1 FAM100A ENSG00000153443 "UBA like domain containing 1" Q8TB05 16 4608883-4615027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066771 Approved Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA066771: AB_2685717" "unprognostic (7.09e-2)" "unprognostic (2.21e-2)" "unprognostic (1.55e-1)" "unprognostic (7.67e-3)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.54e-1)" "unprognostic (4.37e-3)" "unprognostic (2.63e-3)" "unprognostic (8.06e-2)" "unprognostic (1.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.99e-2)" "unprognostic (6.20e-2)" "unprognostic (1.35e-2)" 23.0 16.7 20.5 17.9 25.0 37.5 11.9 32.4 39.2 12.1 19.3 15.1 11.7 23.7 20.4 11.0 15.0 13.9 12.4 14.8 20.9 14.2 19.6 32.9 15.7 13.8 12.0 22.2 14.8 27.2 9.0 12.1 27.9 16.9 18.9 5.3 13.6 19.4 18.1 38.3 16.7 19.5 14.2 11.5 23.9 25.9 13.2 13.0 9.9 17.3 11.3 11.6 17.8 12.8 1.9 2.8 11.3 4.5 1.5 2.6 1.5 5.4 15.9 3.8 5.9 2.5 3.3 17.0 8.3 3.4 3.2 4.6 7.8 6.5 8.2 9.3 2.6 2.4 15.2 2.4 8.4 0.9 17.1 24.2 7.6 16.6 12.0 5.2 4.7 13.1 4.7 6.3 4.9 2.4 3.7 3.4 6.3 11.5 8.6 1.2 27.1 7.9 26.0 14.2 4.9 14.1 11.4 4.7 26.4 2.8 8.0 11.0 10.1 9.8 15.2 13.0 2.3 9.7 7.8 10.1 6.5 7.4 26.1 5.3 16.8 13.5 9.2 2.6 6.5 3.4 1.3 2.3 11.3 2.5 3.5 1.6 1.9 2.0 2.6 2.8 1.8 2.1 2.2 3.9 1.5 4.5 1.8 2.4 1.5 20.5 25.0 32.4 39.2 20.9 14.2 12.0 22.2 16.9 13.0 8.9 8.0 9.8 49.6 97.9 8.9 3.6 7.6 2.7 7.9 17.4 3.9 58.7 26.6 19.0 30.4 15.8 17.3 0.0 20.4 54.1 23.1 30.9 10.4 31.6 20.8 9.5 81.1 15.4 16.8 89.2 15.0 18.1 20.3 17.2 21.3 12.0 21.6 17.5 18.7 33.8 8.7 45.3 30.6 11.5 17.7 89.8 90.2 15.3 12.8 32.8 UBAP1 UBAP ENSG00000165006 "Ubiquitin associated protein 1" Q9NZ09 9 34179005-34252523 "Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019804 Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA019804: AB_1858494" "unprognostic (1.83e-1)" "unprognostic (4.30e-2)" "unprognostic (1.29e-1)" "unprognostic (1.70e-1)" "unprognostic (3.54e-1)" "unprognostic (3.29e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-1)" "unprognostic (2.01e-2)" "unprognostic (6.53e-2)" "unprognostic (1.25e-2)" "unprognostic (3.63e-1)" "prognostic favorable (7.49e-6)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (1.17e-1)" 26.4 34.6 25.7 17.5 25.0 81.9 28.6 29.1 29.5 24.2 26.0 26.5 14.5 16.6 25.3 20.0 40.5 20.4 22.9 34.4 24.0 23.6 25.6 38.6 27.7 17.3 27.0 20.0 26.8 20.7 26.7 19.2 26.8 25.5 20.4 19.0 21.5 19.4 24.3 62.3 22.6 24.6 26.4 26.3 21.4 20.9 33.5 26.0 17.2 23.6 22.1 25.4 29.2 29.5 10.5 17.8 45.9 19.6 17.4 26.5 19.2 20.9 11.8 13.6 14.8 25.3 15.7 11.5 16.8 23.7 18.9 25.8 12.8 8.8 14.7 7.6 25.1 16.1 10.8 18.9 26.5 18.3 21.1 8.5 13.1 26.5 13.3 23.1 14.5 17.5 19.4 44.0 22.4 29.5 28.8 20.9 14.5 10.0 14.7 17.6 8.8 13.4 20.4 14.8 14.5 17.7 12.1 9.7 8.5 40.5 14.0 7.8 10.9 18.7 19.5 8.6 12.7 9.5 14.5 14.8 9.7 15.0 14.5 15.6 7.3 9.1 15.5 19.5 11.8 28.5 9.0 19.6 24.1 15.4 17.1 26.5 10.5 15.5 16.1 17.8 8.8 15.1 12.3 45.9 17.4 14.5 9.9 19.1 19.2 25.7 25.0 29.1 29.5 24.0 23.6 27.0 20.0 25.5 26.0 62.5 24.2 13.9 57.1 41.7 12.9 11.4 12.7 25.4 38.7 7.0 23.6 29.1 16.6 29.7 56.8 17.9 20.6 23.3 35.1 29.2 28.2 45.4 24.4 20.8 19.3 6.4 15.4 12.9 17.1 45.7 27.0 22.9 23.6 20.8 15.4 23.6 35.8 23.0 40.0 15.8 11.4 19.4 28.6 21.7 20.6 51.6 74.9 25.4 16.8 59.0 UBAP2 "bA176F3.5, FLJ22435, KIAA1491" ENSG00000137073 "Ubiquitin associated protein 2" Q5T6F2 9 33921693-34048949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021684 Approved Approved Cytosol NA NA Cytosol "HPA021684: AB_2211887" "unprognostic (2.71e-1)" "unprognostic (1.99e-1)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "prognostic favorable (8.59e-4)" "unprognostic (1.75e-1)" "unprognostic (9.76e-3)" "prognostic favorable (1.95e-4)" "unprognostic (8.06e-2)" "unprognostic (2.39e-1)" "unprognostic (2.95e-1)" "unprognostic (8.77e-2)" 13.0 23.8 11.8 13.9 12.8 17.0 11.6 15.1 14.5 11.6 11.9 12.8 9.4 10.0 18.6 10.8 16.8 10.7 10.5 11.5 10.4 8.6 12.7 9.5 11.6 11.0 8.4 10.7 15.2 13.5 13.4 18.2 18.3 11.5 12.7 14.4 12.3 17.6 11.7 38.1 18.4 9.7 12.2 10.6 10.4 12.0 27.5 11.5 24.7 15.4 21.0 19.2 11.6 13.6 4.7 6.8 4.7 10.5 7.5 8.2 3.3 18.2 16.9 12.2 15.4 12.1 10.7 14.7 14.7 9.2 15.2 14.8 22.8 9.7 21.3 4.7 12.2 11.7 10.7 20.5 16.1 17.0 15.6 10.0 11.8 21.5 24.9 9.9 26.7 19.1 9.9 13.7 19.3 13.5 8.0 12.2 13.1 16.2 17.6 13.7 12.2 19.8 45.4 13.0 10.3 13.3 15.4 7.6 13.5 14.7 13.8 12.6 8.7 17.4 14.2 4.3 12.8 12.6 12.0 14.3 9.1 12.3 10.7 16.3 6.8 14.2 22.9 10.0 10.3 22.5 2.6 4.3 4.7 3.9 5.2 8.2 4.7 4.8 5.4 5.0 2.5 4.3 5.8 2.6 7.5 10.5 6.8 5.3 3.3 11.8 12.8 15.1 14.5 10.4 8.6 8.4 10.7 11.5 11.5 50.6 20.2 9.0 24.4 25.0 26.2 52.5 10.2 21.4 35.2 12.2 56.9 37.2 3.3 18.9 83.6 26.8 12.7 23.3 17.1 31.0 14.7 20.0 13.9 11.6 14.4 15.9 24.1 12.9 14.3 60.5 28.1 14.3 25.3 17.2 25.5 15.1 23.5 28.1 23.0 14.0 28.1 25.8 15.5 69.4 62.7 27.1 61.0 10.2 24.8 20.2 UBAP2L "KIAA0144, NICE-4" ENSG00000143569 "Ubiquitin associated protein 2 like" Q14157 1 154220179-154271510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 107.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035068 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA035068: AB_10696366" "unprognostic (3.14e-2)" "unprognostic (1.50e-1)" "unprognostic (8.82e-2)" "unprognostic (2.93e-3)" "unprognostic (3.98e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (4.65e-5)" "unprognostic (1.97e-2)" "unprognostic (5.10e-3)" "unprognostic (9.01e-2)" "unprognostic (1.67e-1)" "unprognostic (6.96e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (7.40e-3)" "unprognostic (9.14e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-1)" 33.8 33.0 39.1 34.8 47.5 32.7 32.3 34.3 46.6 31.2 31.3 32.9 25.5 20.6 40.6 30.3 36.1 34.8 28.3 36.9 38.3 25.2 26.7 23.9 35.1 34.1 26.5 39.5 42.7 25.0 42.1 40.6 43.9 30.5 29.2 25.8 31.2 31.8 32.8 53.2 36.8 25.3 36.6 30.2 30.5 27.4 37.5 30.2 34.6 33.8 26.6 38.5 37.9 32.4 18.3 24.3 17.6 26.5 24.6 20.6 18.3 42.5 41.1 40.3 31.7 28.7 32.9 34.6 49.1 35.5 44.7 31.1 44.1 33.2 53.3 51.1 41.1 21.2 37.1 52.8 36.2 39.4 46.9 45.2 57.6 42.6 36.8 27.1 60.0 34.2 31.3 15.8 40.3 25.8 28.0 35.2 20.9 52.4 25.9 35.0 46.4 46.8 22.5 75.0 31.3 39.1 33.7 31.8 47.1 27.9 49.9 41.2 49.8 56.5 53.1 21.4 46.3 53.4 41.6 56.5 27.7 29.4 34.0 46.6 56.8 61.1 72.6 29.7 33.0 41.4 8.8 19.2 13.2 17.5 25.1 19.1 15.6 16.4 15.7 24.3 18.3 19.1 20.6 17.6 24.6 26.5 11.4 14.7 18.3 39.1 47.5 34.3 46.6 38.3 25.2 26.5 39.5 30.5 30.2 23.8 33.4 27.4 15.2 16.4 18.0 33.7 10.2 26.8 37.5 17.4 7.9 42.0 14.9 26.8 78.5 19.4 11.8 0.0 23.4 31.4 24.6 14.5 24.3 17.8 30.9 14.3 22.4 28.3 22.4 107.3 19.8 23.2 18.6 20.8 19.9 17.4 24.0 11.5 21.2 11.9 20.2 12.9 20.8 25.7 41.7 17.9 65.1 14.6 19.9 18.0 UBE2A "HHR6A, RAD6A, UBC2" ENSG00000077721 "Ubiquitin conjugating enzyme E2 A" P49459 X 119574467-119591083 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Syncytiotrophoblasts: 425.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577" "unprognostic (2.27e-3)" "prognostic favorable (2.16e-4)" "unprognostic (1.12e-1)" "unprognostic (9.09e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.07e-4)" "unprognostic (1.66e-3)" "unprognostic (1.96e-2)" "unprognostic (6.54e-2)" "unprognostic (2.96e-2)" "unprognostic (3.49e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (2.20e-6)" "unprognostic (9.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.21e-1)" "unprognostic (7.92e-2)" 24.8 20.6 26.7 23.1 24.6 16.8 32.5 20.2 24.2 23.7 32.8 23.9 20.2 21.7 23.8 26.7 37.2 20.3 21.2 42.2 23.6 22.1 32.2 26.6 22.8 26.3 26.8 19.7 18.7 17.2 24.3 18.2 112.4 24.7 20.4 30.2 20.0 21.0 22.6 46.8 23.6 29.2 27.9 29.1 25.1 20.4 17.0 19.5 36.3 23.2 32.8 31.5 26.7 24.0 21.0 29.0 34.1 36.3 12.8 21.2 17.4 31.1 26.3 16.6 14.0 29.0 35.8 15.5 32.4 28.9 38.5 36.6 13.6 21.5 24.7 32.9 35.6 64.7 22.5 23.6 17.1 37.2 34.2 14.0 10.9 21.0 12.1 26.6 27.2 18.8 24.4 24.5 37.0 16.1 27.2 26.7 22.1 13.4 22.1 43.6 33.0 42.0 25.8 27.6 32.9 29.8 21.5 17.6 23.0 31.1 20.5 12.7 13.1 43.0 19.8 23.5 21.6 17.3 23.9 26.0 24.8 11.1 48.9 36.5 21.4 34.8 24.3 26.4 34.6 19.3 16.5 22.7 34.1 18.1 35.4 14.3 21.0 15.7 15.8 29.0 18.8 10.0 14.3 30.1 12.8 36.3 23.0 21.2 17.4 26.7 24.6 20.2 24.2 23.6 22.1 26.8 19.7 24.7 19.5 95.3 39.2 51.3 71.2 110.8 14.0 62.9 48.4 83.0 53.4 38.4 29.5 150.4 86.2 88.0 32.0 62.8 76.2 46.7 89.2 129.6 86.9 77.3 55.4 31.6 116.0 7.9 43.7 44.2 59.6 10.6 34.2 89.3 79.2 168.7 43.9 37.6 102.2 80.7 38.2 92.2 34.3 45.3 103.2 39.1 30.0 111.8 425.3 58.0 43.9 88.5 UBE2B "HHR6B, RAD6B, UBC2" ENSG00000119048 "Ubiquitin conjugating enzyme E2 B" P63146 5 134371179-134391992 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 83.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 83.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (7.39e-2)" "unprognostic (6.66e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-1)" "unprognostic (2.49e-1)" "unprognostic (8.39e-2)" "unprognostic (1.64e-3)" "unprognostic (6.30e-3)" "unprognostic (3.42e-2)" "unprognostic (2.04e-1)" "unprognostic (5.52e-2)" 17.7 27.7 20.4 17.0 16.6 25.9 22.8 16.2 28.3 13.8 18.0 7.9 11.6 14.4 19.4 17.0 25.6 13.6 18.3 59.2 20.3 16.4 17.8 19.8 21.8 18.7 13.8 18.7 16.7 26.4 7.8 16.2 27.8 17.6 15.4 15.1 10.2 16.1 18.5 106.5 15.9 16.2 21.6 15.1 16.6 14.1 21.7 12.7 13.2 18.2 34.0 16.3 19.2 22.8 9.6 8.8 83.3 14.1 9.6 14.6 10.5 35.5 9.3 19.6 18.6 17.1 18.5 31.6 26.7 14.1 17.2 20.5 28.3 23.9 19.4 32.3 17.0 47.0 14.2 14.8 19.7 18.8 30.7 16.0 10.6 25.9 30.3 20.0 12.6 21.9 15.9 27.0 15.6 13.2 23.2 14.7 16.2 19.5 35.3 15.5 20.7 20.0 33.4 8.4 10.6 8.9 20.2 21.6 27.0 15.4 27.5 26.5 20.6 21.0 9.9 46.4 22.2 21.3 34.8 29.1 20.0 14.0 26.9 29.2 29.5 40.3 27.4 22.6 23.9 19.9 34.7 11.5 31.2 9.4 12.5 8.6 9.6 12.0 9.5 7.9 9.6 14.6 12.3 83.3 9.6 14.1 8.8 14.1 10.5 20.4 16.6 16.2 28.3 20.3 16.4 13.8 18.7 17.6 12.7 68.5 53.6 80.6 311.1 324.0 73.3 287.9 109.5 50.9 37.5 71.5 76.6 127.7 145.9 138.0 194.0 119.9 104.0 210.2 148.2 103.0 162.4 304.2 116.3 90.1 106.8 82.6 126.4 82.3 121.3 244.2 143.5 139.6 215.9 189.4 109.5 124.2 180.7 129.8 106.4 130.7 89.5 148.8 178.2 201.6 171.6 323.2 605.1 89.5 82.7 405.3 UBE2C UBCH10 ENSG00000175063 "Ubiquitin conjugating enzyme E2 C" O00762 20 45812576-45816957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 130.8" "Group enriched" "Detected in many" 5 "Erythroid cells: 397.1;Extravillous trophoblasts: 368.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "CAB011464, HPA034569, CAB035990, HPA054975" Approved Supported "Plasma membrane,Cytosol" Yes Yes "Plasma membrane, Cytosol" "CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658" "unprognostic (1.45e-2)" "unprognostic (2.19e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.24e-6)" "unprognostic (2.27e-3)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.76e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-1)" "unprognostic (3.61e-1)" "unprognostic (4.65e-2)" "unprognostic (2.68e-1)" 3.1 2.3 0.4 24.0 0.9 25.1 4.3 0.4 0.7 3.8 9.5 0.4 0.8 7.8 2.0 2.6 25.6 0.6 3.2 2.8 0.5 0.4 2.1 2.1 4.6 15.6 0.6 0.5 1.2 1.3 0.0 0.6 12.6 0.9 1.3 11.7 0.7 3.7 0.6 1.0 8.3 10.0 3.5 1.2 11.6 7.0 15.3 0.5 130.8 0.8 17.6 26.3 2.8 7.8 1.2 0.9 2.7 0.6 2.4 10.0 4.2 39.3 28.9 52.2 25.0 1.4 3.2 30.0 31.3 15.9 51.6 37.1 94.9 45.6 41.8 30.7 14.9 64.3 38.9 0.2 33.5 52.7 17.8 27.5 12.9 22.2 24.9 0.4 18.4 32.3 1.0 3.6 34.9 34.2 7.8 25.1 26.7 0.2 35.6 42.4 64.9 30.3 5.2 31.3 44.8 69.3 32.2 47.3 0.2 17.4 13.7 30.1 25.1 49.3 36.1 19.8 27.4 36.5 27.1 9.1 46.3 40.5 31.4 60.5 11.3 0.3 46.5 28.1 13.1 43.8 0.0 0.1 0.0 0.2 0.0 0.0 1.2 1.2 2.3 0.9 0.2 0.2 0.1 2.7 2.4 0.6 0.5 10.0 4.2 0.4 0.9 0.4 0.7 0.5 0.4 0.6 0.5 0.9 0.5 0.0 5.9 29.5 3.6 15.3 0.0 0.0 2.5 0.0 7.9 0.0 0.0 15.5 0.0 0.8 5.8 0.2 5.5 397.1 0.4 368.9 5.1 2.7 5.7 3.9 75.1 0.0 1.2 22.7 19.9 5.4 0.9 9.3 0.0 1.8 12.8 0.0 1.0 6.2 0.0 0.0 0.0 0.0 1.9 6.1 18.0 10.2 26.1 10.1 15.1 8.2 UBE2D1 "E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A" ENSG00000072401 "Ubiquitin conjugating enzyme E2 D1" P51668 10 58334975-58370753 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 74.9" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 41.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (4.23e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.04e-6)" "unprognostic (9.71e-3)" "unprognostic (4.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.66e-2)" 8.2 10.6 8.1 10.0 7.9 17.1 7.5 7.7 9.0 6.3 7.3 5.5 4.8 4.7 8.5 5.5 8.2 5.5 6.4 25.6 7.6 7.2 5.5 5.4 7.0 13.7 8.1 6.7 5.9 4.8 5.3 7.4 6.8 7.4 6.5 7.9 3.5 6.4 5.0 74.9 4.6 5.8 8.8 8.4 11.0 5.6 3.2 8.4 5.5 6.0 25.1 7.1 9.5 10.0 3.7 7.2 41.0 13.7 2.8 3.5 7.1 10.7 5.8 10.9 14.0 22.4 18.1 7.1 7.1 12.1 8.1 12.0 11.8 9.3 0.0 11.2 10.6 6.0 9.8 21.1 10.3 11.5 11.1 12.4 2.8 2.1 6.7 14.7 8.5 6.9 20.9 11.6 8.5 15.8 11.0 16.2 7.5 5.5 4.5 11.0 3.4 9.1 9.5 13.4 6.5 9.2 7.7 9.9 5.9 12.2 6.3 8.3 11.1 13.9 23.5 11.3 17.5 8.6 5.7 13.1 3.1 10.9 10.6 7.8 11.6 9.0 9.5 9.9 17.7 3.5 2.8 13.7 6.2 2.4 9.5 2.8 3.3 2.9 3.0 7.2 3.7 3.0 2.3 41.0 2.8 7.9 3.0 3.5 7.1 8.1 7.9 7.7 9.0 7.6 7.2 8.1 6.7 7.4 8.4 11.9 9.1 36.6 70.2 172.6 16.8 82.7 20.4 12.0 15.9 26.2 17.7 26.7 64.6 55.7 3.4 26.3 20.4 0.0 37.1 42.2 48.3 73.3 23.0 12.3 68.9 15.9 39.9 20.3 88.9 2.2 30.8 81.6 50.6 49.5 35.6 15.8 57.2 16.4 30.4 41.3 13.7 6.5 58.7 28.6 16.0 166.2 124.6 28.7 24.7 105.6 UBE2D2 "UBC4, UbcH5B" ENSG00000131508 "Ubiquitin conjugating enzyme E2 D2" P62837 5 139526431-139628433 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.14e-1)" "unprognostic (2.75e-3)" "prognostic favorable (5.09e-5)" "prognostic favorable (5.90e-4)" "unprognostic (2.33e-1)" "unprognostic (8.19e-3)" "prognostic unfavorable (9.63e-7)" "unprognostic (7.41e-3)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (9.33e-2)" "unprognostic (1.41e-3)" "prognostic unfavorable (2.09e-5)" "unprognostic (8.00e-2)" "unprognostic (1.01e-1)" "unprognostic (4.20e-1)" "unprognostic (1.07e-1)" 35.6 25.0 41.2 31.5 39.9 44.2 35.9 31.9 49.6 43.9 50.4 35.5 31.5 22.2 35.5 52.2 44.8 47.6 27.1 34.8 39.5 40.5 37.2 39.5 34.8 55.6 40.5 36.1 35.3 41.7 23.8 35.3 33.6 35.9 30.8 46.4 30.7 30.5 37.9 80.6 33.2 37.4 39.3 41.9 41.3 29.1 68.0 29.3 71.0 34.4 31.2 64.5 42.2 36.1 34.3 39.3 40.8 23.0 22.5 41.7 19.5 34.1 22.8 40.0 27.9 27.0 34.7 25.6 36.1 33.8 42.6 49.9 58.6 32.5 48.8 47.6 37.2 52.7 21.7 39.2 60.9 57.1 31.5 22.9 27.7 25.2 33.7 52.9 27.0 24.7 27.2 31.5 42.3 63.3 36.9 45.4 32.3 24.0 41.8 39.5 34.3 41.6 38.5 22.0 12.0 24.8 31.8 41.6 35.3 44.8 40.4 36.5 24.1 31.5 40.6 57.4 89.9 25.4 24.0 29.7 32.6 18.1 27.0 44.1 30.1 48.9 68.5 23.3 44.6 25.9 14.8 20.9 40.8 22.6 18.8 24.7 34.1 32.7 31.7 23.4 34.3 41.7 35.2 34.5 22.5 23.0 39.3 40.0 19.5 41.2 39.9 31.9 49.6 39.5 40.5 40.5 36.1 35.9 29.3 29.8 71.1 173.0 150.9 152.6 68.0 80.9 79.0 36.1 43.3 64.6 76.6 160.4 182.4 173.6 500.3 117.4 113.7 70.0 156.3 191.8 125.8 164.5 136.2 71.0 157.1 89.0 118.5 93.9 121.3 409.1 96.7 157.7 145.1 191.2 112.3 128.4 182.8 103.7 88.1 147.6 99.0 116.4 156.8 337.7 125.2 178.2 208.7 191.8 148.1 221.1 UBE2D3 UbcH5C ENSG00000109332 "Ubiquitin conjugating enzyme E2 D3" P61077 4 102794383-102868896 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (7.43e-2)" "unprognostic (3.19e-1)" "unprognostic (1.27e-2)" "unprognostic (5.78e-2)" "unprognostic (6.44e-2)" "unprognostic (4.96e-2)" "unprognostic (1.17e-1)" "unprognostic (8.44e-3)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.75e-2)" "unprognostic (3.31e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.08e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (1.34e-2)" 67.2 70.6 39.1 52.7 44.6 132.7 70.4 36.9 50.9 45.5 51.8 37.5 38.4 49.3 46.3 39.1 63.2 45.7 47.5 72.5 37.3 39.5 63.0 91.9 67.5 68.1 43.4 36.9 60.6 53.4 42.8 49.1 66.5 45.2 49.6 48.5 38.4 46.7 43.3 91.1 53.2 58.9 48.4 44.4 68.2 49.5 40.0 42.2 88.8 66.3 55.4 61.4 74.6 81.4 24.7 31.2 118.0 36.2 29.7 33.2 50.9 53.5 30.7 51.2 41.3 54.7 79.0 44.0 54.5 72.7 48.7 46.0 46.0 76.5 57.4 35.7 55.3 63.2 30.7 54.6 73.2 67.1 53.2 27.5 52.2 31.6 37.5 57.4 73.4 45.0 59.9 46.4 53.7 75.3 63.0 63.1 47.3 65.6 58.7 64.8 43.2 107.7 41.8 37.1 61.3 30.7 56.8 50.3 41.4 49.1 51.2 51.8 43.6 33.5 86.1 61.5 63.1 35.7 43.4 57.9 51.0 43.6 33.3 49.5 52.0 67.0 87.8 54.3 40.9 54.7 71.1 35.9 54.6 25.1 36.1 33.2 24.7 31.8 29.6 31.2 20.1 32.6 29.7 118.0 29.7 36.2 21.5 32.6 50.9 39.1 44.6 36.9 50.9 37.3 39.5 43.4 36.9 45.2 42.2 154.9 181.2 227.9 605.7 749.7 127.0 210.7 150.3 190.1 129.7 132.6 117.8 279.1 464.2 286.3 668.3 228.0 265.9 93.5 333.2 474.9 260.0 477.5 219.4 203.4 354.6 116.0 231.0 159.0 357.1 423.2 152.5 359.3 339.1 356.1 198.5 111.8 351.4 245.4 140.0 328.0 157.1 103.5 376.3 128.5 151.0 711.0 533.9 297.5 192.3 680.6 UBE2D4 HBUCE1 ENSG00000078967 "Ubiquitin conjugating enzyme E2 D4 (putative)" Q9Y2X8 7 43926438-43956136 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 48.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 25.3" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (9.95e-3)" "unprognostic (6.76e-2)" "unprognostic (6.87e-2)" "unprognostic (8.94e-2)" "unprognostic (8.24e-2)" "unprognostic (5.24e-2)" "unprognostic (2.42e-1)" "unprognostic (3.58e-3)" "unprognostic (4.74e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.86e-4)" "prognostic favorable (5.77e-4)" "prognostic favorable (6.51e-4)" "unprognostic (1.11e-1)" "unprognostic (8.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.34e-1)" 10.1 13.1 14.7 5.0 13.3 4.5 9.1 13.8 17.4 8.8 7.6 11.4 7.9 5.3 7.5 11.2 8.0 9.0 7.2 23.8 14.2 10.0 12.7 15.3 8.4 5.3 12.1 9.4 7.9 17.4 8.7 6.9 5.9 11.9 8.7 6.2 8.1 10.6 9.1 48.6 9.4 5.3 10.3 12.8 7.3 6.5 5.1 6.1 2.7 9.6 16.1 5.7 7.7 6.5 10.7 11.8 12.9 20.5 7.7 14.0 6.7 3.8 3.2 2.0 9.1 9.4 3.8 1.5 1.9 4.7 2.4 3.2 1.7 4.6 3.7 5.3 5.0 6.8 4.4 2.5 2.1 3.7 8.3 4.2 4.0 5.0 4.4 3.5 8.7 8.2 2.9 4.4 2.7 4.2 3.5 3.0 4.6 4.4 7.8 3.3 2.5 5.1 5.0 4.4 4.7 4.2 3.2 2.8 5.8 5.1 4.7 7.4 25.3 4.0 8.1 3.0 3.8 4.0 2.6 2.6 1.6 5.1 3.4 5.5 11.2 8.4 1.8 4.8 11.4 8.9 6.3 11.7 12.9 9.3 18.4 9.5 10.3 11.6 10.5 11.8 10.7 14.0 11.5 1.1 7.7 20.5 10.2 9.4 6.7 14.7 13.3 13.8 17.4 14.2 10.0 12.1 9.4 11.9 6.1 0.0 6.2 8.8 8.1 5.6 8.3 21.8 5.1 2.7 6.8 15.7 2.0 9.7 46.4 15.9 5.0 11.9 8.4 0.0 24.7 17.3 10.8 9.8 4.6 22.2 24.7 11.1 18.0 9.2 7.3 8.0 11.2 12.9 15.1 24.4 7.1 9.1 14.6 5.8 20.5 38.0 10.4 6.5 12.0 15.1 8.3 9.8 6.4 6.9 7.9 9.3 UBE2F NCE2 ENSG00000184182 "Ubiquitin conjugating enzyme E2 F (putative)" Q969M7 2 237966827-238042782 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Extravillous trophoblasts: 231.1;monocytes: 312.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037444 Approved Approved Cytosol NA NA Cytosol "HPA037444: AB_10672491" "unprognostic (1.73e-1)" "unprognostic (1.65e-1)" "unprognostic (3.80e-2)" "unprognostic (6.92e-3)" "unprognostic (3.39e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (3.43e-3)" "unprognostic (6.64e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.59e-7)" "unprognostic (2.04e-2)" "unprognostic (6.39e-2)" "unprognostic (3.60e-2)" "unprognostic (2.51e-1)" 14.5 18.4 21.3 13.6 17.6 19.9 17.2 12.2 19.8 16.7 15.8 17.7 12.3 13.6 14.7 32.2 25.0 11.0 16.3 34.6 20.2 21.6 14.6 24.1 12.9 26.4 23.4 10.1 10.4 62.8 16.3 13.2 22.2 24.2 14.9 19.6 11.4 15.3 18.2 32.1 10.3 17.9 20.2 20.2 14.6 15.1 13.9 16.8 15.8 32.9 17.4 17.7 18.7 16.4 10.9 23.1 35.6 30.0 39.9 29.1 24.6 13.5 7.7 17.8 18.2 23.2 28.3 25.2 12.7 18.3 14.4 14.8 8.4 8.7 7.0 4.6 28.5 31.4 11.5 20.1 27.7 22.6 10.6 7.8 9.6 9.8 27.4 29.2 4.0 22.7 16.2 45.8 19.0 29.0 13.4 25.5 33.0 29.3 4.5 26.0 20.3 10.9 17.7 19.6 19.5 11.8 13.3 11.8 12.4 21.7 5.7 11.9 17.8 14.9 11.3 23.6 31.2 10.2 16.8 15.8 15.9 14.0 18.0 13.6 5.6 4.3 13.7 18.8 12.2 11.7 35.6 21.0 25.2 29.1 27.6 11.5 10.9 19.9 17.6 18.6 10.1 18.6 18.8 15.6 39.9 30.0 23.1 20.5 24.6 21.3 17.6 12.2 19.8 20.2 21.6 23.4 10.1 24.2 16.8 6.0 20.2 41.4 18.8 28.8 21.7 44.5 28.1 24.1 5.7 26.2 7.9 72.4 48.0 42.5 17.3 25.5 37.0 70.0 68.9 231.1 37.6 41.8 20.8 40.0 129.2 25.4 40.1 23.9 54.8 47.2 23.9 61.5 33.7 312.0 46.7 15.8 69.1 29.2 29.0 52.2 19.3 38.8 35.6 90.0 52.7 35.3 54.9 47.3 30.7 31.1 UBE2G1 "UBC7, UBE2G" ENSG00000132388 "Ubiquitin conjugating enzyme E2 G1" P62253 17 4269259-4366628 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 95.6" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 254.1;Suprabasal keratinocytes: 209.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045681, HPA050551" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045681: AB_2679417, HPA050551: AB_2681171" "unprognostic (1.57e-3)" "unprognostic (1.94e-1)" "unprognostic (2.34e-2)" "unprognostic (1.80e-2)" "unprognostic (5.16e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (5.13e-2)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" "unprognostic (3.97e-2)" "unprognostic (6.50e-2)" 10.8 11.1 12.6 17.8 13.5 14.3 11.2 11.6 15.3 13.0 19.4 17.8 8.9 11.9 13.3 8.5 27.4 9.2 9.7 26.9 13.5 11.2 14.6 17.7 8.9 18.7 15.2 9.7 9.1 17.1 12.0 6.0 11.4 14.5 14.0 13.3 8.8 11.9 12.0 95.6 14.1 16.6 14.6 19.4 15.0 11.9 11.8 13.6 21.3 12.5 20.7 23.3 17.7 16.5 23.7 13.1 24.4 11.5 20.5 20.6 13.1 21.2 23.1 21.6 15.8 17.7 18.7 30.8 20.8 16.7 19.8 17.5 15.9 10.9 33.4 21.8 20.4 16.2 23.1 26.8 19.3 32.0 17.5 21.8 12.5 12.3 18.1 17.4 18.1 23.7 15.9 28.9 18.8 27.4 14.0 26.5 22.5 21.8 36.2 16.3 9.5 23.0 16.6 23.8 15.8 12.0 29.9 11.4 30.5 23.1 14.0 9.3 17.4 19.6 17.1 16.1 33.3 16.7 11.9 19.8 19.9 15.2 23.3 23.2 14.1 16.5 47.2 15.3 17.0 15.3 8.1 10.3 24.4 15.4 10.8 20.6 23.7 20.1 20.1 13.1 15.5 20.2 20.5 18.6 20.5 11.5 9.6 18.3 13.1 12.6 13.5 11.6 15.3 13.5 11.2 15.2 9.7 14.5 13.6 20.8 11.8 63.6 34.1 254.1 16.5 62.6 30.6 13.4 13.6 24.4 5.9 36.7 69.6 27.6 105.5 28.7 35.4 0.0 23.2 45.9 34.4 47.3 20.7 52.9 41.3 14.3 36.9 32.5 36.1 173.0 18.1 34.1 64.1 33.3 32.7 23.0 32.9 27.5 19.8 61.3 13.9 6.5 47.9 63.9 47.7 209.5 55.8 43.3 26.8 53.3 UBE2K "HIP2, HYPG, UBC1" ENSG00000078140 "Ubiquitin conjugating enzyme E2 K" P61086 4 39698044-39782792 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028869, CAB033212, CAB033515" Supported Approved "Plasma membrane,Cytosol" NA NA 150000 Cytosol "Plasma membrane" "CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487" "unprognostic (1.14e-2)" "unprognostic (6.02e-2)" "unprognostic (2.42e-3)" "unprognostic (3.06e-1)" "unprognostic (6.81e-2)" "unprognostic (2.05e-1)" "unprognostic (5.05e-3)" "unprognostic (1.44e-2)" "unprognostic (2.71e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.60e-4)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "unprognostic (6.88e-2)" "unprognostic (1.22e-1)" "unprognostic (4.10e-3)" 27.2 21.8 27.0 21.2 27.6 17.3 21.6 38.6 40.7 17.0 33.2 11.8 14.1 29.1 19.9 18.5 29.9 14.9 18.5 28.1 27.7 26.8 26.6 44.5 17.1 17.9 24.1 26.4 16.9 15.8 18.9 26.9 29.8 25.2 19.7 24.0 13.4 18.4 17.3 31.8 22.0 24.6 18.8 19.2 16.9 29.3 16.0 15.9 21.3 23.6 19.7 18.8 22.8 20.4 17.6 23.7 20.6 19.9 10.9 14.1 8.9 24.2 24.9 13.4 12.7 8.4 7.9 22.8 33.4 7.1 9.0 9.4 37.6 25.0 30.3 29.4 9.4 22.1 10.2 25.8 14.6 14.4 20.3 18.5 39.2 25.2 32.5 10.6 42.1 22.2 7.4 16.5 12.6 13.6 9.4 11.7 13.3 39.8 10.9 9.2 23.5 29.3 23.4 17.8 14.0 19.0 17.3 40.3 11.3 12.5 33.8 27.9 12.3 25.0 9.5 14.9 15.5 12.2 14.1 32.0 14.0 29.7 16.6 30.7 15.4 45.0 33.3 7.3 27.0 16.4 13.9 16.6 20.6 13.5 14.3 12.7 17.6 14.1 12.6 16.6 12.5 10.7 12.0 13.3 10.9 19.9 23.7 13.7 8.9 27.0 27.6 38.6 37.7 27.7 26.8 24.1 26.4 25.2 15.9 53.6 50.8 35.6 49.5 109.2 60.1 57.3 45.9 71.0 67.1 47.1 27.5 74.8 56.3 76.3 97.5 58.3 92.6 70.0 77.7 144.5 61.6 76.6 33.5 101.0 71.4 98.5 57.3 61.4 71.5 150.7 60.4 73.4 54.0 103.6 63.5 70.2 109.4 73.0 53.0 81.7 38.2 38.8 67.9 71.4 46.9 120.6 123.3 48.4 65.5 98.3 UBE2L3 UBCH7 ENSG00000185651 "Ubiquitin conjugating enzyme E2 L3" P68036 22 21549447-21624034 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 110.3" "HPA045609, HPA062415" Approved Approved Nucleoplasm,Cytosol NA NA 8800000 "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (4.90e-2)" "unprognostic (3.05e-1)" "unprognostic (1.92e-2)" "unprognostic (1.07e-2)" "unprognostic (2.74e-2)" "unprognostic (9.99e-3)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.28e-2)" "unprognostic (3.65e-2)" "prognostic favorable (3.82e-6)" "unprognostic (3.53e-2)" "unprognostic (4.55e-2)" "unprognostic (3.18e-2)" "unprognostic (4.66e-2)" "unprognostic (5.09e-2)" "unprognostic (2.77e-1)" "unprognostic (3.15e-3)" 27.8 34.9 34.8 23.5 29.6 31.3 24.9 25.5 36.9 25.9 27.7 38.4 22.8 26.4 25.6 29.2 38.0 26.9 23.0 33.0 30.7 30.8 27.4 36.0 23.5 32.5 34.3 33.1 24.3 23.9 24.3 21.7 30.1 36.9 27.5 31.7 29.3 30.6 26.7 43.5 23.9 34.4 33.1 36.2 28.5 25.1 35.7 22.6 25.3 25.0 32.4 33.9 28.4 22.2 34.7 49.9 46.1 45.8 34.6 46.9 54.9 24.9 14.4 21.1 16.5 23.1 20.7 12.2 21.1 24.1 27.1 25.8 16.4 12.1 23.6 10.6 27.9 20.5 21.4 28.1 22.9 27.1 23.5 30.4 27.3 14.1 19.5 15.4 39.0 19.7 18.2 20.0 19.7 14.3 19.6 30.4 14.7 110.3 12.7 29.3 18.4 20.2 28.2 15.5 28.0 15.2 16.6 31.8 6.4 25.4 20.1 19.0 14.1 16.8 21.2 19.4 20.3 13.2 21.6 21.8 19.3 24.8 16.2 21.4 12.4 20.0 21.6 26.1 18.1 18.2 30.8 40.4 46.1 41.4 45.8 38.8 34.7 39.6 44.2 49.9 31.2 34.5 41.6 34.2 34.6 37.6 48.4 46.9 54.9 34.8 29.6 25.5 36.9 30.7 30.8 34.3 33.1 36.9 22.6 101.3 71.0 116.9 138.6 111.5 51.2 50.6 107.0 125.8 95.5 68.0 15.7 283.0 167.5 270.4 53.8 105.0 174.1 140.2 335.7 335.1 102.8 131.4 126.9 137.0 262.0 65.2 120.8 104.3 125.9 41.0 80.8 163.0 119.8 326.4 95.3 76.6 339.4 136.8 97.6 204.5 41.2 103.5 83.5 134.5 117.6 113.3 311.1 142.4 115.8 190.0 UBE2L5 UBE2L5P ENSG00000236444 "Ubiquitin conjugating enzyme E2 L5" 13 30422488-30428616 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 31.5" "Cell type enriched" "Detected in single" 4 "Ciliated cells: 1.4" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA045609, HPA062415" Approved Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (2.09e-1)" "unprognostic (1.18e-2)" "unprognostic (8.01e-3)" "unprognostic (6.41e-4)" "unprognostic (1.78e-1)" "unprognostic (7.13e-2)" "unprognostic (2.20e-1)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-3)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (3.50e-2)" "unprognostic (9.37e-2)" "unprognostic (2.60e-1)" "unprognostic (2.44e-2)" "unprognostic (8.75e-2)" 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.2 0.2 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 31.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 1.9 2.7 3.6 1.9 2.0 2.8 0.7 0.3 1.3 1.6 0.6 0.7 0.7 1.2 0.6 0.4 0.2 0.0 3.1 1.4 0.6 1.3 1.3 0.6 0.8 0.4 1.1 2.5 0.6 0.4 0.8 0.2 0.2 0.7 1.5 0.2 0.3 0.6 0.2 1.4 0.9 0.9 0.8 1.3 0.3 0.0 1.6 2.6 1.4 0.2 0.2 0.4 0.6 0.4 0.9 1.5 1.2 0.3 0.4 0.1 1.8 0.9 0.6 2.4 0.0 0.7 0.5 0.7 1.1 1.5 0.3 1.6 1.0 0.9 0.4 1.8 1.1 1.9 1.4 3.6 1.2 3.2 1.5 1.6 1.5 1.7 1.4 2.0 2.7 1.9 1.6 1.9 2.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBE2L6 UBCH8 ENSG00000156587 "Ubiquitin conjugating enzyme E2 L6" O14933 11 57551656-57568284 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hofbauer cells: 148.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003328, CAB073407" Enhanced Approved Cytosol NA NA 34000 Cytosol "CAB073407: , HPA003328: AB_1858539" "prognostic favorable (6.75e-4)" "unprognostic (2.10e-2)" "unprognostic (1.09e-2)" "unprognostic (2.93e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (1.36e-2)" "unprognostic (1.37e-3)" "prognostic unfavorable (4.88e-4)" "unprognostic (3.07e-2)" "unprognostic (1.02e-2)" "unprognostic (1.28e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" "unprognostic (6.42e-2)" 31.1 31.0 32.0 34.1 28.6 30.4 40.4 18.2 25.6 23.3 19.1 17.0 17.1 19.0 21.9 30.0 19.9 28.6 27.4 18.4 23.5 27.4 28.3 55.1 50.5 45.0 28.9 20.4 27.1 21.8 17.9 18.5 21.7 25.8 26.0 18.8 18.7 42.8 22.2 10.1 15.9 23.5 28.3 23.6 47.9 21.4 7.7 23.6 44.0 33.6 15.1 34.4 33.0 49.0 49.2 53.6 113.6 83.4 61.2 66.4 112.6 8.7 4.4 15.0 4.7 31.7 39.5 1.6 5.1 30.5 45.2 58.9 1.6 22.8 28.1 18.1 15.5 39.1 7.0 6.4 16.8 9.6 25.5 0.2 27.6 0.0 6.3 58.7 6.3 9.2 42.2 3.9 21.2 5.8 16.8 14.2 29.7 1.2 19.5 8.1 11.1 42.6 15.3 3.9 0.0 5.6 37.7 9.1 19.2 12.1 9.8 0.3 7.8 10.2 0.8 22.4 2.7 11.2 3.2 5.2 9.4 3.3 7.1 1.6 26.6 26.8 0.5 26.4 16.0 2.0 56.7 71.6 62.5 51.2 83.4 56.4 49.2 53.4 53.4 53.6 39.7 46.5 48.8 113.6 61.2 68.3 34.0 66.4 112.6 32.0 28.6 18.2 25.6 23.5 27.4 28.9 20.4 25.8 23.6 26.8 17.4 54.4 23.2 20.7 10.2 5.2 28.1 24.1 27.3 12.2 3.9 3.0 54.7 68.9 3.6 46.7 22.7 23.3 57.3 31.0 37.7 34.1 53.1 27.3 148.0 12.7 23.0 41.1 54.9 9.6 44.5 69.1 8.5 44.1 29.8 31.5 45.0 31.7 31.5 19.8 3.9 25.8 41.2 1.9 6.0 24.2 2.9 74.7 21.7 24.6 UBE2M "hUbc12, UBC12" ENSG00000130725 "Ubiquitin conjugating enzyme E2 M" P61081 19 58555712-58558960 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 134.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004993, HPA054551, HPA057800" Approved Enhanced "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.35e-2)" "unprognostic (1.77e-1)" "unprognostic (1.17e-3)" "unprognostic (3.90e-3)" "unprognostic (4.86e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-3)" "unprognostic (1.96e-1)" "unprognostic (1.81e-1)" "unprognostic (8.63e-3)" "unprognostic (1.76e-1)" "unprognostic (5.85e-2)" "unprognostic (8.42e-3)" 18.1 26.0 51.8 16.3 38.9 32.1 13.6 28.4 52.4 15.2 20.4 17.0 20.5 17.8 17.3 19.6 24.9 19.3 17.4 43.2 35.1 33.9 19.6 19.1 16.5 18.1 32.1 30.5 19.4 20.2 25.9 22.8 32.0 26.4 18.4 16.7 15.0 20.9 22.6 61.9 19.2 15.9 19.2 19.8 18.5 17.9 31.8 16.1 32.7 22.2 21.2 19.9 18.2 23.5 3.8 7.6 10.9 4.3 1.8 3.8 2.1 21.5 39.3 19.9 18.9 10.6 12.7 14.5 22.5 19.8 16.3 14.1 23.7 16.8 22.7 17.0 15.9 32.7 14.1 22.1 22.2 12.3 25.8 134.3 33.0 25.3 15.4 26.0 29.8 26.2 13.6 17.4 24.8 29.5 17.9 19.6 21.5 16.0 28.7 21.6 22.1 23.8 27.1 12.6 25.2 34.4 22.2 16.6 29.2 18.8 27.2 35.1 28.7 19.5 23.9 21.0 7.6 14.3 27.4 14.6 51.1 10.4 16.0 39.8 34.8 52.5 24.3 32.5 26.5 33.3 6.8 4.3 4.1 3.5 2.8 2.7 3.4 3.8 3.7 3.1 3.8 3.7 2.5 10.9 1.8 2.7 7.6 3.1 2.1 51.8 38.9 28.4 52.4 35.1 33.9 32.1 30.5 26.4 16.1 6.0 15.4 10.4 28.7 35.8 101.5 34.7 17.8 12.0 6.8 17.4 19.6 18.8 6.6 15.3 18.8 19.0 45.1 23.3 26.0 17.2 20.9 42.6 19.6 28.7 30.5 103.3 39.5 20.3 27.6 27.8 16.1 18.1 33.7 11.8 28.6 85.9 31.9 25.4 13.1 25.9 58.3 25.8 25.5 26.4 7.9 49.7 43.8 15.2 31.9 47.5 UBE2R2 "CDC34B, FLJ20419, MGC10481, UBC3B" ENSG00000107341 "Ubiquitin conjugating enzyme E2 R2" Q712K3 9 33817567-33920404 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 295.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061000, HPA074334" Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA061000: AB_2684408, HPA074334: " "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (7.08e-2)" "unprognostic (1.53e-1)" "unprognostic (6.55e-2)" "unprognostic (5.15e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.82e-3)" "unprognostic (4.61e-3)" "unprognostic (3.05e-3)" "unprognostic (2.22e-2)" "unprognostic (4.19e-1)" "unprognostic (2.01e-2)" "unprognostic (4.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (1.43e-1)" 26.1 19.7 29.4 19.7 26.8 13.9 39.3 23.7 32.3 25.6 24.1 27.9 16.3 28.0 26.1 18.4 25.3 22.3 21.8 29.2 25.5 20.3 22.1 34.5 23.0 27.1 30.5 23.2 29.8 44.5 15.7 13.9 24.6 21.6 21.0 21.4 19.3 18.7 20.8 56.1 28.1 25.7 28.5 24.2 21.6 20.8 34.5 29.6 36.7 19.5 22.5 25.7 35.8 30.5 3.3 4.2 21.9 11.6 5.0 2.1 2.4 16.5 18.1 35.0 15.2 19.3 31.5 10.8 14.7 20.5 17.3 17.3 14.5 12.4 14.1 6.0 20.5 12.6 7.4 18.3 16.8 19.0 23.2 9.7 12.2 20.0 18.4 27.5 14.4 13.3 26.7 25.0 14.1 26.8 27.7 29.0 17.0 11.4 15.2 17.1 9.6 27.1 38.0 19.9 14.2 15.1 25.3 10.6 7.3 18.3 12.5 16.4 19.7 17.2 15.4 11.0 23.2 13.5 17.6 21.7 16.7 15.2 11.5 13.6 9.7 9.1 19.8 15.9 8.4 35.9 12.4 7.5 4.1 2.0 7.5 1.3 3.1 1.9 1.6 4.2 3.3 1.9 1.7 21.9 5.0 11.6 2.6 2.1 2.4 29.4 26.8 23.7 32.3 25.5 20.3 30.5 23.2 21.6 29.6 20.8 30.7 29.5 39.6 93.8 61.0 106.8 56.0 22.7 25.0 21.0 13.7 52.6 13.3 43.8 295.7 77.1 60.6 23.3 59.7 65.2 54.0 68.4 12.7 72.1 68.5 57.2 69.2 77.3 105.2 195.4 62.2 81.9 33.7 49.5 57.3 87.1 69.4 38.6 71.5 49.6 30.1 58.2 41.9 90.2 66.2 105.3 69.2 30.5 49.0 79.7 UBE2Z "FLJ13855, USE1" ENSG00000159202 "Ubiquitin conjugating enzyme E2 Z" Q9H832 17 48908369-48929056 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007922 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007922: AB_1858551" "unprognostic (6.85e-2)" "unprognostic (5.72e-3)" "prognostic favorable (4.62e-4)" "unprognostic (9.11e-2)" "unprognostic (3.71e-3)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.32e-2)" "unprognostic (5.26e-2)" "unprognostic (8.66e-2)" "unprognostic (9.17e-3)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (2.63e-2)" "unprognostic (2.11e-2)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" 27.1 40.6 29.2 27.7 37.0 22.2 28.8 34.4 50.2 33.7 28.9 59.9 45.1 26.6 36.2 49.5 37.2 36.0 28.0 28.7 30.5 29.2 32.1 25.6 29.2 30.9 46.6 28.0 32.5 29.5 36.6 28.0 35.0 39.7 32.9 32.5 28.4 33.3 43.2 24.1 35.9 30.5 39.1 32.7 36.6 29.4 22.4 43.4 29.4 39.8 22.2 44.2 28.8 32.2 12.8 10.1 11.0 14.5 7.4 13.1 8.6 24.9 30.9 11.6 11.0 29.6 28.8 15.9 27.3 33.5 32.8 31.6 38.5 21.6 20.3 39.2 33.5 41.2 16.2 14.6 25.5 41.9 67.1 15.8 18.4 20.5 23.9 34.2 13.0 19.8 24.5 28.3 26.7 34.6 35.1 24.0 9.7 13.4 26.5 35.1 39.8 14.0 12.9 10.8 30.5 27.1 11.3 29.6 11.5 25.6 24.6 12.0 18.2 18.5 10.0 18.6 27.4 27.6 10.3 28.1 49.0 23.7 16.0 22.2 20.2 19.2 12.0 24.0 9.6 21.2 6.5 11.0 8.1 13.1 14.5 10.7 9.4 11.4 13.0 8.0 12.8 11.1 12.0 11.0 7.4 13.0 10.1 11.5 8.6 29.2 37.0 34.4 50.2 30.5 29.2 46.6 28.0 39.7 43.4 23.8 16.3 32.1 40.1 46.9 52.1 29.9 30.6 18.7 10.3 34.9 39.3 29.1 18.3 38.9 1.4 40.2 31.5 0.0 46.7 25.9 26.8 61.1 5.8 22.9 22.6 41.3 46.7 39.9 23.9 2.9 25.9 27.7 28.7 52.3 35.4 30.6 59.6 28.1 27.3 20.7 33.6 32.3 35.3 21.4 22.7 49.8 35.8 22.3 24.7 60.4 UBE3A "ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A" ENSG00000114062 "Ubiquitin protein ligase E3A" Q05086 15 25333728-25439056 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009723, HPA039410, HPA040380" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952" "unprognostic (7.95e-2)" "unprognostic (2.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.99e-1)" "unprognostic (1.13e-1)" "unprognostic (3.55e-2)" "unprognostic (1.44e-1)" "unprognostic (3.05e-1)" "unprognostic (5.07e-2)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (4.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-1)" "unprognostic (8.17e-2)" 19.3 19.4 20.3 23.1 25.0 17.8 20.2 30.0 25.1 21.7 19.9 14.3 19.8 14.1 21.0 22.1 19.8 18.5 17.2 24.0 22.2 20.8 20.2 24.6 19.7 23.1 19.1 19.5 23.0 17.2 26.1 24.6 20.1 20.9 20.6 17.9 13.3 19.3 21.5 70.2 18.4 18.8 21.2 19.9 18.8 16.9 26.4 16.4 36.4 25.0 26.6 19.5 19.9 26.6 15.6 11.9 11.6 14.8 21.1 16.0 5.7 19.6 11.1 28.1 16.7 16.4 19.5 13.8 30.3 19.0 21.5 19.6 25.7 9.8 35.4 23.0 22.6 21.2 18.2 35.5 21.4 26.3 18.2 11.9 29.3 18.8 15.2 24.7 35.3 21.7 23.1 20.1 20.3 26.0 22.4 16.9 31.1 29.5 25.3 33.7 10.7 29.3 10.3 18.2 21.5 16.2 30.0 42.0 15.6 19.5 31.0 28.9 21.8 24.6 26.7 34.9 19.0 21.8 20.0 21.6 37.7 31.2 18.1 22.1 28.9 34.1 47.7 21.6 19.3 19.6 8.6 8.7 11.6 13.3 7.6 15.2 12.0 14.0 15.9 11.9 15.6 16.0 14.2 2.0 21.1 14.8 11.1 10.1 5.7 20.3 25.0 30.0 25.1 22.2 20.8 19.1 19.5 20.9 16.4 89.3 73.3 52.7 60.3 63.2 78.1 154.5 43.3 71.0 67.1 36.6 53.0 43.4 16.6 42.2 101.1 45.8 39.4 0.0 43.1 41.8 44.5 85.9 62.2 52.0 41.5 76.3 65.9 47.3 56.6 43.8 52.6 44.6 50.6 37.9 48.7 54.8 47.5 42.1 60.8 44.0 56.4 77.6 54.5 143.0 88.7 79.3 61.9 44.9 47.9 87.8 UBL4A "DXS254E, GDX, GET5, MDY2, TMA24, UBL4" ENSG00000102178 "Ubiquitin like 4A" P11441 X 154483717-154486670 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003617 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003617: AB_1080450" "unprognostic (2.75e-2)" "unprognostic (3.39e-3)" "unprognostic (5.52e-2)" "unprognostic (2.88e-2)" "unprognostic (2.62e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (4.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.24e-2)" "unprognostic (8.26e-3)" "unprognostic (4.50e-1)" "unprognostic (4.41e-2)" "unprognostic (2.74e-2)" "unprognostic (6.01e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-2)" 11.5 15.3 14.1 7.3 16.0 6.6 12.4 11.9 28.2 11.7 12.2 8.7 11.0 12.2 10.2 13.8 14.0 10.9 10.5 26.5 14.1 11.0 10.6 13.7 10.9 12.1 11.2 16.9 11.2 25.4 11.3 8.3 9.4 13.6 15.4 9.0 8.0 18.8 15.7 59.2 13.3 9.3 14.8 8.6 9.8 10.9 4.3 6.1 8.2 12.2 20.6 11.7 14.9 10.4 10.1 9.9 32.9 10.0 14.3 22.9 17.9 29.1 18.4 5.5 15.0 11.7 11.6 18.5 13.0 9.4 13.5 14.4 18.2 11.6 22.5 39.3 11.8 11.4 11.3 27.4 14.3 7.5 14.7 17.4 16.1 17.6 10.7 14.4 19.0 17.4 9.1 17.1 8.9 15.6 13.5 9.6 16.6 17.7 11.2 10.9 24.1 17.1 18.9 6.4 25.8 30.7 15.4 16.5 23.7 11.4 12.6 10.6 16.0 7.2 24.0 20.8 7.1 11.1 14.4 9.6 13.7 15.6 22.0 27.0 22.7 21.9 40.0 14.4 32.9 15.8 32.9 10.0 9.6 16.5 8.5 22.9 10.1 15.4 17.3 9.9 8.3 13.3 14.9 3.4 14.3 7.1 5.8 15.0 17.9 14.1 16.0 11.9 28.2 14.1 11.0 11.2 16.9 13.6 6.1 3.0 7.9 15.9 10.0 8.5 16.9 28.1 12.7 4.0 9.1 15.7 3.9 22.4 36.5 22.3 0.2 14.8 17.7 0.0 27.8 38.0 13.6 14.1 9.2 14.7 21.3 17.5 8.2 8.0 14.0 0.8 11.5 11.1 27.0 20.8 16.2 14.5 24.7 14.1 17.7 19.5 9.8 0.0 12.3 0.0 6.3 10.7 10.9 18.4 16.6 7.2 UBL7 "BMSC-UbP, MGC14421" ENSG00000138629 "Ubiquitin like 7" Q96S82 15 74445977-74461182 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 133.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040423, HPA041897" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040423: AB_10673442, HPA041897: AB_2677732" "unprognostic (4.21e-2)" "prognostic favorable (6.37e-5)" "unprognostic (2.93e-3)" "unprognostic (5.56e-2)" "unprognostic (1.83e-1)" "unprognostic (1.60e-1)" "unprognostic (3.43e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (6.71e-2)" "unprognostic (5.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.47e-3)" "unprognostic (8.94e-3)" "unprognostic (7.05e-2)" "unprognostic (2.75e-1)" "unprognostic (3.43e-2)" 14.4 18.0 30.0 16.6 31.8 16.4 17.0 20.8 58.4 20.7 19.4 22.7 15.2 18.2 17.9 19.6 18.4 22.0 15.9 27.6 29.0 21.1 18.6 17.2 16.4 23.1 26.8 26.1 18.4 21.4 30.2 14.3 18.9 33.0 17.5 20.7 15.0 19.8 21.4 45.5 23.0 16.1 23.0 28.3 22.5 18.5 34.8 16.1 36.9 28.2 18.6 34.9 17.7 14.4 26.6 75.5 32.8 28.7 25.8 31.6 23.1 11.5 12.6 20.6 27.6 21.6 28.4 13.9 18.8 23.1 24.8 30.6 15.4 16.9 17.0 20.3 23.1 32.1 18.9 57.3 25.5 23.6 22.4 35.0 22.2 21.1 27.6 20.8 13.7 19.2 21.7 23.2 20.5 28.3 21.3 20.5 38.6 19.0 25.5 25.1 15.9 17.0 21.4 49.2 19.8 15.5 18.4 16.2 37.9 21.2 13.5 20.3 40.2 18.4 17.4 25.1 29.7 18.4 23.0 11.9 22.9 13.5 11.4 23.3 25.7 48.9 18.9 14.9 25.1 19.7 13.6 26.2 28.5 18.8 28.7 17.9 26.6 18.9 19.5 35.1 26.4 18.5 21.8 32.8 25.8 25.7 75.5 31.6 23.1 30.0 31.8 20.8 58.4 29.0 21.1 26.8 26.1 33.0 16.1 29.8 12.8 34.0 19.7 14.1 5.1 24.3 17.8 14.7 9.1 14.0 7.9 57.5 49.7 32.9 58.1 18.2 27.7 23.3 30.3 57.0 17.9 16.9 18.5 15.8 37.4 4.8 22.5 19.6 32.9 133.3 22.7 32.8 20.3 111.8 22.7 16.2 27.8 26.6 19.8 36.8 7.7 19.4 20.0 48.1 27.4 22.0 57.2 32.0 28.2 21.8 UBQLN1 "DA41, DSK2, PLIC-1, XDRP1" ENSG00000135018 "Ubiquilin 1" Q9UMX0 9 83659963-83708203 "Plasma proteins, Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037256, HPA054143" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB037256: AB_1858556, HPA054143: AB_2682398" "unprognostic (4.72e-3)" "unprognostic (9.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (2.77e-2)" "unprognostic (2.87e-2)" "unprognostic (1.55e-1)" "unprognostic (2.80e-3)" "unprognostic (2.35e-1)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.07e-5)" "unprognostic (3.11e-2)" "unprognostic (9.49e-2)" "unprognostic (1.44e-3)" "unprognostic (2.29e-2)" 26.8 33.9 27.2 26.2 38.7 41.1 38.1 35.0 42.2 24.9 24.4 21.2 27.8 21.9 29.1 22.2 30.5 21.4 21.0 34.5 28.9 32.1 31.6 40.8 23.3 25.8 30.0 27.8 21.5 28.1 36.0 29.5 30.4 37.2 26.5 23.7 15.2 23.8 28.9 79.1 27.8 27.6 26.9 33.9 28.6 23.1 22.9 23.3 59.8 25.7 16.2 34.8 24.8 27.3 16.0 19.2 23.4 25.0 24.7 18.8 14.9 43.9 40.7 29.9 23.1 24.9 26.6 49.6 41.1 36.5 43.7 33.2 16.7 31.4 43.7 26.6 34.3 41.7 50.6 41.4 29.2 45.5 23.0 19.2 26.8 31.3 25.9 33.0 32.5 29.5 22.0 36.8 36.8 51.3 27.0 32.6 21.0 28.9 31.3 35.7 26.1 45.4 18.0 39.1 41.6 37.4 33.7 33.5 22.8 28.5 19.2 27.0 30.2 38.0 38.2 29.3 30.9 19.1 23.6 32.3 28.0 26.1 46.2 41.1 43.9 62.0 21.4 41.6 24.0 33.8 23.4 17.1 17.6 16.6 25.0 16.2 16.0 14.5 15.2 19.2 15.5 14.7 16.0 18.5 24.7 23.1 8.2 18.8 14.9 27.2 38.7 35.0 38.7 28.9 32.1 30.0 27.8 37.2 23.3 32.8 35.6 44.2 53.6 91.8 58.5 67.1 20.4 26.8 45.5 21.0 19.6 52.3 16.6 46.7 25.2 35.9 44.6 0.0 46.1 65.6 43.2 59.5 49.6 65.2 47.2 71.5 49.3 27.0 44.2 14.7 22.7 44.6 40.5 33.3 38.0 27.6 56.0 40.3 26.2 29.3 30.6 38.8 45.3 69.1 46.4 80.8 137.4 30.9 34.3 72.7 UBQLN2 "Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157" ENSG00000188021 "Ubiquilin 2" Q9UHD9 X 56563639-56567868 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Autophagy "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006431, CAB013481" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 200000 Cytosol "Plasma membrane" "CAB013481: AB_2533341, HPA006431: AB_1078707" "unprognostic (1.23e-2)" "unprognostic (2.88e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-3)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (2.66e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.81e-2)" "unprognostic (1.35e-1)" "unprognostic (1.45e-1)" "unprognostic (8.88e-2)" "unprognostic (8.42e-3)" 13.4 20.8 27.0 13.9 40.7 9.4 16.2 34.9 35.3 17.3 13.6 17.8 15.0 11.1 17.0 16.7 18.1 18.2 14.5 20.8 26.2 28.6 13.9 18.9 14.0 16.4 21.2 26.6 27.0 10.6 25.5 18.3 15.6 20.8 21.1 12.5 13.3 13.7 21.5 24.6 13.5 11.6 18.7 18.8 13.9 12.9 5.4 16.7 18.0 20.9 10.9 17.7 16.4 14.1 5.5 10.9 25.0 19.4 12.1 20.4 10.9 18.6 13.9 14.0 16.3 32.2 20.6 8.8 15.1 18.0 11.4 12.6 7.8 8.8 14.3 16.6 17.8 17.8 11.0 26.6 16.9 13.8 22.1 16.0 5.8 19.2 8.2 16.9 11.3 12.8 19.1 21.4 15.3 13.4 16.5 9.9 9.3 6.7 15.8 17.9 8.7 14.5 9.9 11.6 6.0 16.6 13.0 18.1 13.5 23.0 14.6 17.3 16.2 21.8 9.7 8.8 25.6 16.2 8.4 11.1 12.1 12.4 17.4 9.1 6.0 7.4 9.9 13.6 12.0 10.2 25.0 14.1 14.1 9.9 19.3 11.1 5.1 15.1 11.5 10.9 5.5 20.4 12.2 12.4 12.1 19.4 3.9 14.1 10.9 27.0 40.7 34.9 35.3 26.2 28.6 21.2 26.6 20.8 16.7 20.8 12.1 13.7 34.3 27.7 41.9 31.1 12.7 13.4 9.1 17.4 17.7 23.0 14.9 17.9 0.0 17.1 14.4 0.0 14.5 22.2 23.5 24.0 12.7 19.2 21.1 39.7 32.8 18.4 34.3 0.4 23.0 18.9 16.9 27.9 18.1 22.1 15.8 14.0 34.3 10.9 31.2 12.9 32.5 0.3 0.2 26.6 33.4 17.5 18.8 32.1 UBR1 ENSG00000159459 "Ubiquitin protein ligase E3 component n-recognin 1" Q8IWV7 15 42942897-43106113 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038838, HPA038839" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA038838: AB_10673120, HPA038839: " "unprognostic (1.07e-2)" "unprognostic (5.02e-2)" "unprognostic (9.77e-2)" "unprognostic (1.55e-2)" "unprognostic (1.89e-2)" "unprognostic (1.29e-1)" "unprognostic (2.67e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-1)" "unprognostic (2.97e-2)" "unprognostic (1.93e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 16.7 13.2 13.7 18.3 16.7 28.4 18.8 21.8 18.1 18.2 16.2 14.8 10.5 11.3 21.0 12.9 10.8 15.9 14.2 19.7 10.0 15.4 14.4 10.6 16.6 14.9 11.8 10.5 16.3 16.4 26.3 25.6 16.2 18.9 15.3 12.9 12.5 11.8 16.8 23.6 11.0 14.4 18.2 12.1 14.7 13.8 13.7 14.7 23.2 18.8 9.7 14.3 17.3 19.7 4.6 5.0 5.5 4.2 6.2 7.2 1.8 5.0 7.3 8.4 6.9 13.4 10.4 8.0 12.4 13.6 10.9 14.1 9.3 3.9 5.9 7.3 12.6 13.7 8.8 12.2 10.8 13.0 12.1 5.9 23.3 14.7 4.5 9.3 16.4 11.2 11.2 6.1 13.4 10.9 10.7 12.3 12.0 13.3 9.0 13.5 2.8 8.8 4.9 4.8 13.4 7.6 11.7 11.6 5.1 11.0 11.9 8.6 7.6 16.2 8.6 5.7 10.2 8.3 8.6 16.8 13.5 8.3 12.0 12.5 10.6 18.0 17.1 9.2 10.4 12.1 4.4 3.0 5.2 5.7 4.2 6.5 4.1 5.9 6.9 2.9 4.6 5.9 7.2 5.5 6.2 3.4 5.0 4.1 1.8 13.7 16.7 21.8 18.1 10.0 15.4 11.8 10.5 18.9 14.7 44.7 27.8 14.6 10.3 9.4 26.8 24.5 17.8 17.4 25.0 8.7 25.5 10.4 0.0 8.8 11.6 17.9 10.8 0.0 12.5 6.2 15.0 9.4 27.7 8.5 7.3 30.2 13.8 14.7 16.2 13.2 15.0 10.5 8.5 10.0 10.0 15.6 8.9 9.1 19.4 6.7 39.2 12.9 19.1 25.3 14.9 6.4 30.9 20.8 10.0 7.4 UBR4 "KIAA0462, KIAA1307, RBAF600, ZUBR1" ENSG00000127481 "Ubiquitin protein ligase E3 component n-recognin 4" Q5T4S7 1 19074506-19210276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" "Calmodulin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 240.8;Suprabasal keratinocytes: 220.9;Urothelial cells: 215.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013394, HPA021046" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA013394: , HPA021046: AB_1858578" "unprognostic (1.37e-1)" "unprognostic (2.57e-2)" "unprognostic (2.82e-2)" "unprognostic (2.02e-1)" "unprognostic (8.78e-2)" "unprognostic (9.77e-2)" "unprognostic (1.14e-3)" "unprognostic (3.09e-1)" "unprognostic (1.96e-1)" "unprognostic (9.14e-3)" "unprognostic (7.48e-2)" "unprognostic (2.53e-1)" "unprognostic (7.68e-3)" "unprognostic (4.30e-1)" "unprognostic (1.19e-1)" "unprognostic (5.58e-2)" "unprognostic (1.52e-1)" 24.4 25.4 22.4 29.0 25.4 58.3 23.7 28.5 32.5 22.4 28.5 26.3 31.5 18.2 34.0 32.5 22.7 20.3 27.3 20.5 23.3 15.9 25.5 29.7 31.2 20.3 21.0 20.9 35.5 21.0 40.9 31.4 28.4 25.0 30.7 20.5 30.6 24.7 27.1 55.9 69.0 25.5 39.3 20.2 26.5 30.2 41.1 21.6 37.7 26.1 17.3 25.9 43.4 29.0 4.6 9.1 18.3 18.5 2.7 3.4 4.6 22.2 22.5 20.4 15.0 38.1 19.7 17.6 17.3 18.4 18.9 17.3 35.9 19.2 13.4 16.3 22.9 16.6 15.3 15.9 17.3 17.7 11.1 14.1 30.7 21.7 23.3 26.9 18.8 20.4 17.6 22.2 38.5 37.2 18.5 20.7 23.9 21.0 12.5 17.9 15.9 8.9 22.9 16.5 45.7 12.7 12.4 15.9 11.2 17.1 13.1 14.4 14.3 20.5 11.8 14.8 19.5 8.2 14.8 32.0 22.2 13.9 26.2 19.4 14.9 9.0 15.6 15.2 29.1 18.8 18.3 18.5 2.9 3.4 3.8 2.9 4.6 3.0 1.9 9.1 2.9 2.7 2.5 9.8 2.7 1.3 4.3 2.1 4.6 22.4 25.4 28.5 32.5 23.3 15.9 21.0 20.9 25.0 21.6 32.8 42.3 16.3 79.1 240.8 54.0 15.6 40.8 30.8 26.1 29.6 143.3 19.2 11.6 31.4 14.7 21.1 36.4 23.3 35.5 14.1 29.1 39.1 18.5 77.9 54.8 74.7 16.8 28.8 47.4 19.9 28.4 42.8 47.2 36.1 30.4 30.7 51.2 14.0 33.6 88.2 48.0 19.4 26.8 37.4 17.9 220.9 28.4 21.0 19.5 215.5 UBR5 "DD5, EDD, EDD1, HYD, KIAA0896" ENSG00000104517 "Ubiquitin protein ligase E3 component n-recognin 5" O95071 8 102253012-102412841 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053688 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053688: AB_2682230" "unprognostic (3.79e-3)" "unprognostic (7.44e-3)" "unprognostic (1.25e-1)" "unprognostic (2.10e-2)" "unprognostic (2.44e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (2.50e-1)" "unprognostic (1.75e-2)" "unprognostic (7.54e-3)" "unprognostic (8.29e-3)" "unprognostic (3.84e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.69e-2)" "unprognostic (2.45e-1)" 27.0 16.7 27.1 29.5 31.7 30.3 29.2 40.8 32.8 24.9 25.0 19.1 21.1 14.4 26.8 24.0 23.8 22.0 17.6 22.7 25.5 15.3 17.9 17.0 24.2 29.6 21.9 20.6 29.7 22.2 32.4 25.5 25.0 23.6 20.2 17.1 19.7 22.9 21.8 39.9 29.7 22.4 29.3 17.5 21.9 21.1 39.7 28.3 37.9 20.3 15.9 27.0 27.5 28.6 5.0 4.0 6.3 5.5 2.4 7.1 2.1 23.6 10.6 20.5 10.4 20.2 20.6 18.9 17.9 15.8 14.0 12.3 10.6 15.9 47.1 15.5 16.7 9.2 14.4 17.5 15.5 19.7 20.4 8.6 39.3 14.5 19.0 18.0 12.2 21.7 23.6 15.5 14.4 25.2 16.0 16.8 13.5 18.9 26.8 13.7 21.4 31.0 14.6 15.4 22.9 12.0 18.1 12.1 22.3 12.8 23.2 15.1 12.6 12.5 12.1 12.4 18.6 19.6 13.0 16.8 15.0 17.5 13.4 12.4 14.4 13.8 48.5 14.8 19.1 12.1 3.1 3.4 5.0 5.6 3.4 5.6 5.0 6.0 5.9 4.0 3.9 4.8 7.1 6.3 2.4 5.5 3.6 7.1 2.1 27.1 31.7 40.8 32.8 25.5 15.3 21.9 20.6 23.6 28.3 23.8 27.7 29.8 38.5 46.4 48.4 35.8 5.1 40.2 63.7 29.6 64.8 19.1 8.3 15.1 25.0 38.3 17.3 0.0 13.1 14.9 48.2 37.7 28.9 15.8 15.4 54.0 32.0 23.4 29.4 20.2 36.8 28.9 42.2 27.1 17.9 31.5 16.2 17.3 34.3 6.7 44.0 12.9 38.7 64.7 30.4 53.3 58.2 30.5 17.7 46.9 UBTD1 FLJ11807 ENSG00000165886 "Ubiquitin domain containing 1" Q9HAC8 10 97498868-97571209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.5;neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034825 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA034825: AB_10602254" "unprognostic (1.52e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.54e-4)" "unprognostic (2.43e-1)" "unprognostic (1.78e-1)" "unprognostic (3.90e-2)" "unprognostic (3.63e-3)" "unprognostic (1.43e-2)" "unprognostic (1.66e-3)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "unprognostic (4.78e-1)" "unprognostic (6.62e-3)" "unprognostic (8.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-3)" "unprognostic (3.50e-3)" 16.0 5.6 7.7 7.3 7.1 10.2 20.5 5.1 9.0 11.5 4.6 5.8 9.7 2.9 6.6 13.9 8.1 8.3 9.0 23.8 6.8 6.5 15.6 11.2 26.0 8.3 9.1 4.8 8.9 12.9 3.1 7.8 5.3 6.4 6.5 1.5 8.9 10.7 10.8 24.2 22.7 2.5 7.0 6.7 5.3 4.1 30.3 5.7 1.0 12.9 10.9 4.4 10.3 8.6 0.3 1.7 8.5 3.4 0.0 0.4 0.5 9.0 9.0 2.4 11.9 10.1 9.5 2.8 10.4 15.3 11.2 8.6 6.0 7.9 1.1 12.7 7.0 7.0 10.9 2.4 13.9 1.5 2.7 4.7 1.1 2.8 7.5 14.6 1.0 3.1 13.1 4.7 12.1 3.0 17.2 17.8 2.4 0.6 1.7 7.1 4.3 0.4 9.2 3.9 1.7 16.6 0.9 4.2 1.0 8.6 3.4 0.8 2.5 4.7 2.9 13.4 2.2 10.8 6.8 19.1 14.2 8.7 14.8 13.5 2.2 2.5 0.4 11.9 6.1 7.3 1.3 3.4 7.5 0.2 0.8 0.2 0.3 0.1 0.0 1.7 0.0 0.1 0.0 8.5 0.0 0.9 1.2 0.4 0.5 7.7 7.1 5.1 8.1 6.8 6.5 9.1 4.8 6.4 5.7 38.7 19.9 0.0 7.7 23.1 2.2 14.1 7.6 9.4 13.6 7.0 3.9 2.8 10.0 16.1 52.6 20.4 0.3 0.0 11.2 9.4 17.5 12.5 0.0 5.8 24.5 6.4 0.0 4.9 7.3 20.2 11.8 8.5 10.1 9.0 0.1 10.1 16.8 0.0 8.9 8.1 15.9 12.9 9.0 5.9 5.7 26.0 2.4 0.9 0.2 6.2 UBXN1 "2B28, LOC51035, SAKS1, UBXD10" ENSG00000162191 "UBX domain protein 1" Q04323 11 62676498-62679117 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012669, HPA076932" Approved Supported Nucleoplasm,Cytosol NA NA 12000 Cytosol Nucleoplasm "HPA012669: AB_1853149, HPA076932: " "unprognostic (1.76e-3)" "unprognostic (8.72e-3)" "unprognostic (3.67e-3)" "unprognostic (2.94e-2)" "unprognostic (9.39e-2)" "unprognostic (8.72e-2)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (3.52e-2)" "unprognostic (1.43e-1)" "unprognostic (3.34e-3)" "unprognostic (2.42e-1)" 40.4 37.8 33.1 33.8 35.1 27.6 44.1 27.7 37.8 36.0 36.6 36.3 32.3 36.1 38.0 33.7 36.7 37.8 42.3 38.2 30.8 27.2 30.4 26.1 27.3 46.9 33.7 28.5 62.3 41.7 31.4 25.0 29.3 27.2 37.6 19.5 26.6 29.5 32.1 115.3 42.8 31.2 51.5 36.6 37.9 35.0 35.8 29.0 58.9 56.6 40.9 41.2 43.5 67.2 84.1 54.9 27.8 64.2 44.6 85.4 77.8 19.6 31.7 23.8 33.2 33.2 35.7 21.8 17.3 31.9 33.1 22.6 22.6 25.4 31.4 31.9 23.0 29.2 28.1 19.0 29.5 15.4 28.1 24.4 21.9 28.2 30.4 65.1 34.5 24.3 46.1 45.9 29.1 45.0 35.5 30.7 39.7 33.7 20.2 20.6 44.0 26.0 63.7 1.2 15.2 22.0 19.7 26.0 30.6 26.6 19.9 23.7 41.1 16.5 25.3 74.9 10.7 35.3 42.8 30.2 26.9 20.3 27.3 19.5 26.0 19.7 28.1 31.1 14.8 24.4 21.0 51.1 24.4 46.3 53.1 58.9 83.4 70.6 54.2 54.9 84.1 85.4 62.3 27.8 44.6 64.2 43.7 84.9 77.8 33.1 35.1 27.7 37.8 30.8 27.2 33.7 28.5 27.2 29.0 86.4 85.3 236.7 136.4 234.5 60.3 74.7 104.4 105.7 99.0 71.5 43.2 143.5 132.6 157.2 130.0 200.5 201.1 93.5 159.6 151.0 161.2 139.3 157.2 69.5 190.4 28.6 121.1 125.2 291.0 195.1 193.3 259.6 173.7 301.2 133.8 117.2 161.2 178.9 134.7 178.9 48.1 194.1 250.4 238.0 204.7 264.7 271.5 236.6 131.7 176.3 UBXN11 "SOC, SOCI, UBXD5" ENSG00000158062 "UBX domain protein 11" Q5T124 1 26281328-26318363 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 103.4;Late spermatids: 252.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 32.4;intermediate monocyte: 28.1;myeloid DC: 16.6;non-classical monocyte: 22.5" "Group enriched" "Detected in all" 4 "dendritic cells: 16.6;monocytes: 32.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028600, HPA031357" Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028600: AB_10604001, HPA031357: AB_2673840" "unprognostic (1.78e-3)" "prognostic favorable (2.54e-5)" "unprognostic (8.18e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.53e-1)" "prognostic favorable (4.90e-4)" "prognostic unfavorable (5.90e-6)" "unprognostic (8.41e-2)" "unprognostic (2.70e-1)" "unprognostic (4.41e-2)" "unprognostic (1.79e-3)" "unprognostic (1.89e-2)" "unprognostic (5.59e-3)" "unprognostic (5.00e-2)" "unprognostic (2.20e-1)" "unprognostic (3.25e-1)" "unprognostic (1.31e-2)" 5.4 7.6 16.6 10.2 25.7 18.9 5.6 7.0 21.5 8.6 4.6 7.9 9.0 4.2 6.7 23.8 4.3 35.4 8.4 5.9 17.0 15.0 9.3 3.7 12.0 8.2 9.8 12.3 9.7 8.2 8.4 18.3 5.2 12.7 5.4 3.5 13.6 8.3 8.3 6.2 6.0 4.4 5.0 5.6 11.7 4.8 27.4 8.5 6.2 15.7 2.7 5.7 6.1 3.9 5.3 16.6 2.4 32.4 1.9 5.7 13.2 17.4 7.9 3.9 7.9 2.9 2.2 13.7 3.9 6.1 10.8 7.9 3.1 15.5 10.2 5.9 2.4 7.2 9.5 2.4 6.3 2.8 5.1 9.3 1.7 11.2 7.5 5.1 7.4 3.5 3.3 6.8 18.2 4.6 3.4 3.0 7.5 6.6 7.1 3.6 7.8 4.2 3.6 7.9 4.9 6.1 8.7 2.9 9.2 6.0 2.6 18.7 4.4 9.6 9.1 6.7 2.1 7.0 7.2 2.8 6.3 9.5 9.3 5.7 6.7 19.0 11.6 7.7 10.3 5.1 0.7 32.4 1.5 3.4 28.1 4.1 4.4 5.0 3.9 16.6 5.3 5.7 3.6 2.4 1.9 22.5 2.5 4.1 13.2 16.6 25.7 7.0 21.5 17.0 15.0 9.8 12.3 12.7 8.5 0.0 1.4 9.1 13.3 19.1 9.8 1.1 7.6 17.4 7.9 22.7 21.6 7.5 11.6 11.5 103.4 4.4 1.7 0.0 7.5 17.4 10.8 8.6 10.3 2.4 19.7 22.3 8.6 7.4 69.6 252.6 11.8 30.3 10.1 3.6 4.3 12.1 6.8 2.9 9.6 21.2 50.8 19.4 7.8 13.9 22.6 11.7 6.1 13.1 5.6 11.0 UBXN6 "UBXD1, UBXDC2" ENSG00000167671 "UBX domain protein 6" Q9BZV1 19 4444999-4457822 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 1030.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040906, HPA041313, HPA061872" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.50e-2)" "prognostic favorable (5.68e-5)" "unprognostic (1.67e-1)" "unprognostic (2.65e-3)" "unprognostic (1.83e-2)" "unprognostic (1.41e-2)" "unprognostic (1.09e-1)" "unprognostic (3.48e-1)" "prognostic favorable (6.95e-4)" "unprognostic (3.93e-2)" "prognostic favorable (2.78e-5)" "unprognostic (4.61e-2)" "unprognostic (2.67e-1)" "unprognostic (1.43e-1)" "unprognostic (1.79e-1)" 29.1 47.7 29.0 20.0 38.0 38.4 22.9 30.5 45.9 21.0 21.8 12.4 42.3 26.2 23.3 45.9 26.3 24.9 35.6 35.1 29.7 21.8 29.2 37.6 23.4 26.6 25.4 30.5 35.1 45.3 18.9 35.6 22.9 23.3 23.7 8.1 20.8 42.1 46.7 72.0 25.4 28.9 30.3 21.7 22.2 22.8 41.5 18.4 11.9 38.8 42.2 12.0 26.9 22.5 7.4 13.6 12.9 10.3 3.6 8.7 6.1 21.1 14.9 7.2 15.5 18.2 22.7 10.8 21.7 25.9 15.9 16.9 9.2 17.9 9.5 19.8 21.3 8.1 12.3 5.5 16.6 5.8 16.6 12.0 7.9 15.8 12.2 30.0 9.9 15.9 20.6 22.0 12.4 12.1 19.4 19.3 13.1 16.2 25.8 11.7 13.4 19.6 16.8 11.5 8.2 13.1 9.0 10.3 22.3 15.0 13.3 20.9 30.3 12.1 12.6 35.2 3.5 14.9 16.2 23.2 21.1 16.3 44.9 14.2 58.1 22.8 9.4 40.4 18.6 18.7 8.5 9.2 12.9 5.5 10.3 8.7 6.8 6.5 7.3 8.9 7.4 7.7 6.1 9.1 3.6 6.0 13.6 6.9 6.1 29.0 38.0 30.5 45.9 29.7 21.8 25.4 30.5 23.3 18.4 38.7 26.7 33.5 31.1 33.1 37.4 40.3 53.5 13.4 14.8 41.8 25.5 47.8 68.0 49.1 229.6 25.1 103.4 163.5 56.3 38.0 42.3 43.5 34.5 55.5 48.0 12.7 45.0 38.1 35.1 1030.1 92.6 36.5 50.6 50.5 58.2 45.3 60.0 59.6 68.6 86.4 28.5 71.1 28.3 142.6 29.6 35.9 66.6 27.7 54.3 44.3 UCHL1 "PARK5, PGP9.5, Uch-L1" ENSG00000154277 "Ubiquitin C-terminal hydrolase L1" P09936 4 41256413-41268455 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 225.8" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 109.9;Distal tubular cells: 218.8;Horizontal cells: 138.2;Spermatogonia: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 3.6" "Lineage enriched" "Detected in single" 37 "B-cells: 3.6" "Cell line enhanced" "Detected in many" "EFO-21: 99.0;SCLC-21H: 98.8;U-251 MG: 90.4;U-266/84: 87.2;U-87 MG: 96.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002580, HPA005993, CAB079024" Enhanced Supported Supported Nucleoplasm,Cytosol NA NA 440000 Cytosol Nucleoplasm "CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560" "unprognostic (1.54e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (2.34e-1)" "unprognostic (1.98e-1)" "unprognostic (6.28e-3)" "unprognostic (1.09e-2)" "unprognostic (4.31e-2)" "unprognostic (8.77e-3)" "unprognostic (3.56e-3)" "unprognostic (3.70e-2)" "unprognostic (1.82e-3)" "unprognostic (1.24e-2)" "unprognostic (7.12e-3)" "unprognostic (2.10e-2)" "prognostic unfavorable (1.93e-4)" 8.2 40.2 52.4 8.9 65.1 2.0 3.1 17.5 225.8 4.5 6.3 11.5 0.0 5.5 6.0 1.8 2.7 5.7 6.5 5.4 53.4 97.4 14.0 2.0 2.7 6.5 62.0 57.1 15.4 6.3 1.8 30.5 2.7 100.6 5.3 4.7 6.0 3.0 4.4 7.5 2.7 8.6 5.2 38.6 2.3 2.8 8.0 8.3 0.0 3.9 0.0 4.5 5.6 2.8 3.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 56.1 11.6 0.0 1.5 1.9 0.0 58.7 30.3 20.8 21.0 11.3 0.0 0.0 99.0 29.9 31.4 0.1 21.4 0.0 8.5 0.1 8.7 0.0 0.3 0.0 44.9 0.0 0.0 10.8 0.2 16.7 0.0 34.7 0.1 0.0 0.0 0.2 11.0 0.0 0.0 0.9 33.6 0.0 63.4 0.0 24.8 0.0 31.4 0.0 98.8 62.0 0.3 0.2 0.2 13.9 0.0 0.5 0.3 1.3 0.4 0.0 90.4 46.4 87.2 0.2 96.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 52.4 65.1 17.5 92.6 53.4 97.4 62.0 57.1 100.6 8.3 0.0 1.9 0.8 0.8 1.4 19.7 2.5 0.0 12.0 5.7 109.9 7.9 2.5 218.8 3.6 2.0 2.1 0.0 0.0 0.7 0.8 15.8 2.8 2.3 0.4 4.7 138.2 4.1 11.1 0.3 4.4 34.2 1.7 3.3 1.0 0.0 22.6 4.0 0.0 16.3 7.9 39.1 0.0 7.3 6.6 90.2 1.4 1.3 0.0 0.0 0.6 UCHL3 ENSG00000118939 "Ubiquitin C-terminal hydrolase L3" P15374 13 75549480-75606020 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019678, CAB037139, CAB037208" Approved Supported Nucleoplasm,Cytosol No No 490000 "Nucleoplasm, Cytosol" "CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583" "unprognostic (4.16e-1)" "unprognostic (3.84e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (5.15e-2)" "unprognostic (6.46e-3)" "prognostic unfavorable (6.41e-4)" "unprognostic (1.19e-1)" "unprognostic (5.59e-2)" "unprognostic (9.71e-2)" "unprognostic (1.24e-1)" "unprognostic (7.09e-2)" "unprognostic (4.47e-2)" "unprognostic (3.97e-1)" "unprognostic (2.76e-2)" "unprognostic (8.84e-2)" "unprognostic (3.26e-2)" 13.7 39.1 23.6 11.9 37.6 17.4 21.4 17.5 18.7 10.6 21.2 11.4 12.8 12.8 9.0 40.5 37.7 8.1 12.4 15.5 20.6 12.6 20.7 36.8 10.3 12.2 18.2 13.5 7.7 20.8 9.5 28.9 26.3 14.7 12.4 25.0 6.1 24.0 14.9 31.7 28.8 15.0 16.9 13.3 15.3 14.5 24.6 18.6 18.9 28.1 29.8 20.2 16.0 16.2 17.4 46.0 15.8 43.5 20.5 23.4 17.3 51.7 8.7 7.6 5.2 14.2 17.0 21.9 19.6 19.5 25.6 28.7 48.0 25.2 26.8 14.2 20.6 19.5 28.6 17.7 47.7 38.9 14.3 15.5 16.9 14.4 30.6 20.5 40.3 12.7 15.0 33.1 20.0 32.2 10.8 24.9 21.8 18.5 7.7 38.4 18.6 16.4 26.4 11.3 60.9 26.2 13.1 12.2 17.6 30.1 21.1 22.9 6.7 11.2 21.8 9.0 17.1 12.5 11.5 19.2 11.2 13.3 11.9 26.2 10.8 12.0 31.2 22.6 43.7 8.0 15.6 24.1 15.8 10.9 43.5 14.2 17.4 19.9 15.5 33.6 16.0 19.8 18.3 5.4 20.5 36.2 46.0 23.4 17.3 23.6 37.6 17.5 18.7 20.6 12.6 18.2 13.5 14.7 18.6 8.9 22.6 16.0 62.8 67.9 8.8 22.6 35.7 28.1 42.1 43.6 2.0 84.6 77.9 139.8 157.4 22.0 32.0 0.0 124.1 137.9 25.4 82.5 23.1 42.0 76.8 15.9 23.1 17.2 26.4 26.7 15.5 32.1 25.3 20.8 45.7 8.6 125.1 31.7 11.0 96.2 8.8 19.4 18.6 110.6 30.9 69.3 141.3 20.3 55.3 79.8 UCHL5 "CGI-70, INO80R, UCH37" ENSG00000116750 "Ubiquitin C-terminal hydrolase L5" Q9Y5K5 1 193012250-193060080 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005908, HPA006069" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA005908: AB_1858585, HPA006069: " "unprognostic (3.66e-2)" "unprognostic (3.84e-3)" "unprognostic (5.17e-2)" "unprognostic (5.98e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (7.41e-2)" "unprognostic (1.96e-2)" "unprognostic (1.04e-3)" "unprognostic (3.44e-3)" "unprognostic (6.92e-2)" "unprognostic (6.41e-3)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (4.33e-2)" 15.7 18.3 20.1 16.1 26.2 16.0 18.2 30.1 34.8 10.9 17.7 11.5 12.6 19.0 12.5 14.7 26.1 10.7 11.9 22.0 21.6 20.6 21.6 28.3 12.4 19.9 21.3 29.4 13.4 24.8 15.6 16.2 17.8 33.3 17.8 18.8 10.3 19.3 12.9 29.1 16.7 18.0 13.9 20.1 17.3 14.0 9.9 17.5 20.0 15.1 19.1 23.0 14.8 14.8 22.5 20.8 23.8 21.1 35.6 30.9 20.9 33.6 18.7 16.2 16.6 9.5 9.6 19.3 19.8 10.1 19.0 16.5 17.7 22.9 26.4 19.2 11.0 11.5 20.9 21.6 25.6 25.2 27.2 15.5 31.3 24.2 23.4 15.2 49.1 17.6 8.9 11.4 27.3 24.2 8.7 18.7 26.6 68.6 21.6 16.1 27.2 36.1 18.2 15.0 23.1 11.8 21.0 18.2 51.4 17.7 19.8 16.5 20.3 17.8 25.8 27.6 17.9 21.0 24.8 12.2 17.8 5.4 18.0 31.5 16.8 26.0 29.8 10.7 30.6 30.3 23.8 16.5 19.0 28.3 19.5 30.9 22.5 25.9 26.9 19.4 18.0 28.2 30.5 10.0 35.6 21.1 20.8 24.8 20.9 20.1 26.2 30.1 34.8 21.6 20.6 21.3 29.4 33.3 17.5 8.9 24.6 13.7 12.3 21.6 18.3 68.2 15.3 26.8 29.6 26.2 41.2 31.3 38.1 21.6 1.8 20.4 19.5 0.0 24.6 27.1 16.4 17.3 53.3 22.2 24.8 23.8 10.4 18.4 20.3 3.4 13.8 24.5 16.9 19.8 18.3 25.7 20.3 7.0 16.3 30.8 41.8 19.4 17.0 14.0 16.8 26.2 21.1 27.7 20.6 10.5 UCP3 SLC25A9 ENSG00000175564 "Uncoupling protein 3" P55916 11 74000281-74009435 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 99.6" "Group enriched" "Detected in some" 5 "Early spermatids: 14.7;Late spermatids: 10.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 4 "HDLM-2: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010771, HPA072225" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB010771: AB_261839, HPA072225: AB_2686498" "unprognostic (3.76e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-1)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-2)" "unprognostic (3.95e-3)" "unprognostic (6.61e-2)" "unprognostic (1.25e-1)" "unprognostic (8.58e-2)" "unprognostic (2.13e-4)" "unprognostic (1.61e-2)" "unprognostic (3.25e-6)" "unprognostic (2.68e-1)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.50e-4)" 0.9 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 1.0 0.2 99.6 0.3 0.2 0.2 0.2 0.5 0.1 0.6 0.2 0.2 0.6 6.4 0.8 0.2 0.2 0.8 0.1 0.7 0.3 0.2 2.1 0.4 0.2 2.1 2.1 1.8 0.8 0.4 0.4 0.5 0.5 0.5 0.3 0.5 0.4 1.1 0.3 0.4 0.3 2.2 0.8 0.4 0.8 18.3 0.7 0.4 2.4 0.2 0.6 1.2 1.7 0.5 1.4 1.3 0.1 0.4 0.7 1.0 0.5 1.4 0.7 1.2 0.8 1.6 1.0 1.6 1.4 1.6 4.3 0.6 1.1 0.6 1.2 1.3 0.5 0.9 0.7 0.4 0.2 1.1 0.4 0.3 1.4 0.7 1.3 1.6 1.7 0.8 0.3 1.1 0.7 0.0 0.3 0.7 2.1 0.1 0.9 0.0 1.5 1.8 0.0 0.8 0.6 1.2 0.1 0.2 0.0 0.1 0.4 0.4 0.2 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.5 0.1 0.1 2.2 0.5 0.0 2.7 1.2 0.0 0.0 0.3 0.0 0.3 14.7 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.6 0.8 10.7 0.0 0.0 0.0 0.0 0.6 0.7 0.3 0.0 0.7 0.0 1.6 0.0 0.1 1.2 0.7 0.3 0.2 2.2 0.6 0.0 UEVLD "Attp, UEV3" ENSG00000151116 "UEV and lactate/malate dehyrogenase domains" Q8IX04 11 18529609-18588747 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047134 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047134: AB_10960698" "unprognostic (1.05e-1)" "unprognostic (6.76e-2)" "prognostic favorable (7.07e-4)" "unprognostic (5.94e-3)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.38e-3)" "unprognostic (9.08e-3)" "unprognostic (9.81e-2)" "unprognostic (2.87e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (1.61e-3)" "unprognostic (2.65e-1)" "unprognostic (3.22e-1)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 17.3 15.0 13.3 11.6 12.9 5.5 20.8 9.7 13.3 17.1 18.2 16.4 12.9 15.1 15.0 16.3 17.8 12.6 13.0 13.2 13.1 12.1 21.8 17.2 13.3 12.3 15.6 10.9 13.8 11.8 19.1 14.2 16.2 15.5 17.9 20.0 11.4 14.8 13.9 20.4 20.2 15.9 18.3 23.0 12.5 13.4 10.0 15.0 14.3 15.2 11.8 11.5 16.5 13.5 5.2 7.1 11.1 8.5 8.7 7.6 3.8 9.2 11.1 5.3 5.1 17.2 15.4 5.1 10.0 14.1 13.3 12.9 4.6 2.6 2.8 5.6 11.8 11.6 14.3 4.7 10.3 15.3 8.3 6.3 4.1 5.2 5.1 7.7 6.3 6.2 10.6 11.0 6.5 9.3 9.5 12.4 0.2 3.1 2.8 16.9 6.9 0.2 2.1 1.4 14.2 11.5 1.0 12.2 3.5 16.0 14.6 2.2 4.7 11.0 14.1 8.8 6.8 11.2 3.8 9.3 12.3 6.5 20.4 9.8 0.6 6.3 0.6 10.6 5.0 12.5 6.9 8.3 5.0 7.6 8.5 7.1 4.5 5.5 6.1 5.5 5.2 3.6 4.7 11.1 8.7 6.6 7.1 3.8 3.8 13.3 12.9 9.7 13.3 13.1 12.1 15.6 10.9 15.5 15.0 14.9 17.1 0.8 5.1 5.6 8.9 8.5 2.5 21.4 13.6 22.7 9.8 7.4 3.3 9.2 2.3 7.1 18.7 0.0 11.4 6.2 6.9 7.6 5.8 13.0 10.8 14.3 8.7 12.9 15.3 1.4 7.5 10.4 6.8 6.4 14.4 12.3 11.0 7.0 17.3 11.4 11.0 12.9 7.5 6.5 5.9 8.2 6.4 6.9 13.0 6.5 UFC1 HSPC155 ENSG00000143222 "Ubiquitin-fold modifier conjugating enzyme 1" Q9Y3C8 1 161152776-161158856 "Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027481, HPA028722" Enhanced Approved "Nuclear speckles,Cytosol" NA NA 180000 "Nuclear speckles" Cytosol "HPA027481: AB_10599850, HPA028722: AB_10601674" "unprognostic (2.16e-1)" "unprognostic (6.17e-2)" "unprognostic (1.83e-1)" "unprognostic (8.25e-3)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-3)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (3.40e-2)" "unprognostic (5.04e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (2.62e-6)" "unprognostic (3.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.13e-1)" "unprognostic (6.22e-2)" 34.2 38.6 52.6 25.4 54.7 35.1 45.6 21.1 41.8 35.4 37.3 27.8 47.7 36.9 31.5 57.2 40.6 69.9 40.8 36.0 42.5 45.9 56.1 55.2 32.0 29.8 46.3 35.6 48.7 85.5 39.3 40.6 54.2 34.4 44.0 46.8 29.2 63.6 40.3 34.3 36.1 48.6 35.8 34.4 39.1 39.1 22.2 33.9 38.9 50.2 38.9 38.9 37.9 33.4 41.1 43.6 22.4 33.0 40.9 54.1 48.0 22.4 20.8 18.4 23.1 24.7 39.7 38.8 22.9 27.0 21.9 19.4 27.2 46.1 31.2 38.5 31.8 15.1 11.7 15.4 22.0 16.3 26.5 42.2 19.0 31.0 32.6 24.5 41.9 48.6 33.8 35.7 27.3 18.9 37.3 38.1 31.8 31.5 22.9 27.9 27.1 19.4 38.3 33.8 67.0 22.9 23.8 13.4 43.4 42.4 27.4 21.2 33.7 20.0 66.3 26.3 31.0 25.3 78.0 28.5 16.3 15.9 15.6 33.4 39.9 51.0 28.2 25.8 26.7 20.6 22.4 32.8 20.4 39.0 33.0 47.2 41.1 41.8 41.5 40.4 31.0 36.7 39.5 6.0 40.9 24.0 43.6 54.1 48.0 52.6 54.7 21.1 41.8 42.5 45.9 46.3 35.6 34.4 33.9 65.5 68.2 142.4 148.8 88.7 59.5 99.6 142.7 566.1 94.4 99.5 39.3 208.4 373.0 191.0 103.8 125.8 138.7 140.2 332.6 317.7 97.7 152.4 116.6 83.9 213.1 44.5 196.3 79.8 133.0 302.8 97.2 153.3 124.9 257.9 166.3 88.5 242.7 175.4 85.6 257.5 52.6 64.7 102.4 96.2 34.8 105.8 361.2 152.3 163.7 181.2 UFD1 UFD1L ENSG00000070010 "Ubiquitin recognition factor in ER associated degradation 1" Q92890 22 19449910-19479215 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 105.1;Ductal cells: 98.8;Exocrine glandular cells: 123.6;monocytes: 132.6;Pancreatic endocrine cells: 115.9;Syncytiotrophoblasts: 142.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030286, HPA030287" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA030286: , HPA030287: AB_10601830" "unprognostic (2.52e-1)" "unprognostic (5.41e-2)" "unprognostic (1.95e-3)" "unprognostic (7.61e-2)" "unprognostic (3.50e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-3)" "unprognostic (8.82e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.50e-8)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" 27.8 28.0 22.7 24.3 38.0 38.7 23.9 25.3 30.4 21.1 28.9 23.3 24.7 21.7 32.8 40.3 31.6 21.3 21.7 35.6 21.9 22.9 28.0 46.6 24.6 34.8 44.3 15.9 22.4 34.7 22.5 22.6 31.6 33.0 21.7 27.7 21.9 26.7 24.4 57.9 27.3 24.7 28.3 39.7 26.7 26.2 31.8 29.9 37.8 27.8 26.9 31.7 23.9 23.7 27.7 35.3 53.5 42.8 31.1 67.6 37.5 31.8 23.2 19.8 30.0 16.3 11.5 15.2 26.4 26.4 36.5 33.8 25.7 13.9 22.3 20.5 22.1 16.8 27.7 23.2 23.1 31.8 41.0 24.5 23.5 16.4 20.3 15.5 37.2 32.1 10.5 23.8 31.1 15.3 10.7 29.2 11.8 131.8 43.0 22.2 46.3 23.9 22.8 14.2 40.2 19.7 29.1 46.9 8.6 22.4 30.1 16.3 18.3 20.7 22.5 20.7 21.6 13.5 17.9 31.7 30.8 41.9 25.6 28.3 18.4 36.6 29.0 25.9 19.0 28.1 39.8 29.0 47.8 36.1 42.8 34.7 27.7 41.6 37.3 25.5 23.9 35.9 35.1 53.5 31.1 41.1 35.3 67.6 37.5 22.7 38.0 25.3 30.4 21.9 22.9 44.3 15.9 33.0 29.9 23.8 34.6 0.0 0.0 0.0 0.0 0.0 0.0 50.9 30.7 26.2 0.0 105.1 71.3 98.8 0.0 0.0 0.0 0.0 123.6 90.9 0.0 0.0 25.6 0.0 79.3 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 132.6 0.0 0.0 115.9 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 142.5 0.0 0.0 0.0 UFSP2 "C4orf20, FLJ11200" ENSG00000109775 "UFM1 specific peptidase 2" Q9NUQ7 4 185399540-185425985 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 125.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039985, HPA043298" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039985: AB_10794206, HPA043298: AB_10795037" "unprognostic (8.87e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-1)" "unprognostic (1.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (3.63e-2)" "unprognostic (3.19e-2)" "unprognostic (3.69e-1)" "unprognostic (1.50e-1)" "unprognostic (2.04e-2)" "unprognostic (2.56e-1)" "prognostic favorable (1.07e-8)" "unprognostic (1.92e-1)" "unprognostic (8.12e-2)" "unprognostic (9.36e-3)" "unprognostic (6.70e-3)" 15.8 20.3 12.5 10.3 14.9 4.1 18.7 11.3 20.3 17.3 17.4 16.3 17.0 11.0 19.4 17.4 20.1 17.3 13.5 24.2 11.4 11.7 28.1 19.2 13.2 11.6 14.6 11.3 30.5 20.1 18.3 22.8 12.3 17.0 18.4 12.6 13.7 14.4 20.3 40.8 16.6 13.6 16.9 20.2 14.2 17.3 23.7 14.6 15.8 23.5 19.2 12.2 20.8 13.3 15.6 13.0 5.5 7.9 13.9 17.9 8.2 12.2 7.5 21.1 15.2 19.1 19.8 11.7 12.7 12.9 15.2 14.4 12.5 15.7 12.3 5.9 15.3 11.4 9.7 16.4 20.6 15.8 13.2 9.5 6.5 7.3 11.3 21.1 9.9 8.1 11.6 16.1 13.3 13.7 19.6 24.3 16.0 16.5 24.9 19.6 7.4 13.2 7.4 5.4 8.9 10.8 13.0 8.3 14.8 14.6 7.1 12.6 11.8 7.9 12.9 15.4 13.1 9.9 7.0 14.1 6.3 11.2 4.4 9.8 22.7 8.7 5.9 20.5 6.2 16.1 5.5 7.9 5.4 16.3 6.8 17.1 15.6 16.5 17.6 9.8 11.0 17.8 17.9 0.4 13.9 6.6 13.0 14.0 8.2 12.5 14.9 11.3 20.3 11.4 11.7 14.6 11.3 17.0 14.6 6.0 19.2 16.7 28.0 19.6 46.6 23.8 10.2 28.1 29.6 19.2 62.8 22.2 94.5 25.2 125.0 22.7 9.1 23.3 28.8 24.6 26.8 16.4 27.8 14.9 23.8 17.5 18.6 14.1 16.7 32.5 32.8 19.1 33.7 14.4 16.8 50.3 19.5 19.3 39.6 62.7 79.4 64.7 30.1 53.7 53.4 16.6 35.0 21.5 15.3 15.4 UGGT1 "HUGT1, UGCGL1" ENSG00000136731 "UDP-glucose glycoprotein glucosyltransferase 1" Q9NYU2 2 128091200-128195677 "Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012761, HPA015127" Enhanced Uncertain Cytosol NA NA 3800000 Cytosol "HPA012761: AB_1858597, HPA015127: AB_1858596" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "unprognostic (4.63e-2)" "unprognostic (6.45e-2)" "unprognostic (7.03e-3)" "unprognostic (3.13e-2)" "unprognostic (3.02e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-3)" "unprognostic (7.05e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.86e-1)" "unprognostic (1.50e-1)" "unprognostic (2.23e-2)" "unprognostic (8.38e-3)" 13.7 14.7 7.6 16.4 10.2 23.8 11.3 10.7 10.8 12.7 15.2 10.0 21.1 11.4 12.3 26.3 13.1 10.6 11.3 13.0 7.7 7.9 13.7 33.4 13.9 14.6 11.0 5.7 10.4 44.1 13.4 11.2 22.1 9.1 11.7 13.5 9.7 15.5 20.5 19.3 11.1 17.4 8.9 9.0 16.1 13.0 9.9 9.5 24.3 13.8 6.4 15.7 11.4 11.0 6.3 7.4 8.8 6.2 4.7 5.9 2.8 16.5 5.8 11.1 23.8 14.6 11.7 16.9 19.1 8.4 6.4 5.8 12.8 12.3 23.5 7.7 14.0 5.8 12.3 8.4 8.3 13.1 14.9 4.0 20.6 7.6 39.1 14.5 27.5 13.0 8.5 6.6 12.9 11.8 12.8 14.9 9.8 13.2 12.8 13.5 11.6 11.1 15.8 19.6 11.7 6.0 9.1 10.6 10.0 11.8 12.3 5.8 8.8 13.2 18.1 11.2 11.9 7.1 19.5 20.5 17.7 12.1 10.1 13.6 13.4 18.6 10.8 15.0 15.1 16.3 7.1 6.2 5.4 5.9 6.0 5.8 4.0 4.8 5.3 4.5 6.3 4.1 5.9 8.8 4.7 5.7 7.4 3.8 2.8 7.6 10.2 10.7 10.8 7.7 7.9 11.0 5.7 9.1 9.5 32.8 24.8 6.7 4.9 7.2 20.0 14.1 17.8 6.7 25.0 3.5 21.6 9.5 1.7 12.2 7.0 11.3 19.4 0.0 16.8 15.8 10.8 11.7 10.5 33.0 14.7 19.1 21.9 19.6 23.0 1.8 13.8 15.5 13.5 12.6 20.8 9.7 18.4 10.5 12.7 8.7 18.9 6.5 11.1 8.9 8.1 9.4 9.0 13.8 17.5 9.8 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951010-36001028 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 44.0;liver: 47.7" "Group enriched" "Detected in some" 5 "Collecting duct cells: 47.1;Early spermatids: 91.4;Hepatocytes: 63.1;Proximal tubular cells: 58.6" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 42 "RH-30: 25.3" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA047697: AB_2680122, HPA056290: AB_2683088" "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 5.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 44.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.2 0.1 6.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.2 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 47.1 0.0 0.0 3.3 0.0 91.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.1 0.1 0.0 0.0 2.5 2.2 12.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 58.6 0.3 6.5 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.4 5.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.3 0.0 3.9 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 5.7 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 UHRF1BP1 "C6orf107, dJ349A12.1, FLJ20302, ICBP90" ENSG00000065060 "UHRF1 binding protein 1" Q6BDS2 6 34792015-34883138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032099, HPA032100" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA032099: AB_10696057, HPA032100: AB_10671087" "unprognostic (2.30e-2)" "unprognostic (9.52e-2)" "unprognostic (4.58e-3)" "unprognostic (1.28e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.58e-2)" "unprognostic (4.39e-3)" "unprognostic (9.82e-2)" "unprognostic (4.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (1.98e-1)" "unprognostic (1.90e-1)" "unprognostic (4.24e-2)" 7.6 9.3 7.6 7.6 8.2 18.7 6.7 18.5 10.9 4.8 5.9 7.1 4.7 5.1 5.5 4.4 6.0 5.3 4.5 13.7 6.1 5.8 6.1 10.9 8.0 6.9 5.5 6.8 6.6 13.1 15.1 9.5 8.1 7.7 6.0 6.3 6.8 8.6 5.1 22.2 4.9 5.5 6.4 7.6 6.8 7.2 22.5 5.5 8.5 9.4 3.2 6.8 5.9 10.8 1.5 1.2 1.1 4.5 1.4 1.3 0.8 8.5 6.1 5.5 17.7 2.9 2.1 9.9 5.0 3.4 4.9 7.0 12.1 2.3 12.9 5.5 5.2 8.6 6.5 19.9 2.8 6.7 6.6 6.4 11.4 5.9 10.1 11.8 10.3 7.2 4.8 8.3 3.9 8.4 4.6 6.1 11.3 19.0 5.1 2.1 8.1 7.9 6.7 2.5 6.2 4.3 4.8 8.8 7.7 6.6 7.9 6.6 6.7 12.6 6.6 16.9 5.9 12.7 13.5 3.7 2.4 9.0 3.8 5.5 7.7 11.9 8.2 1.3 14.4 6.0 0.5 1.2 1.1 1.3 1.7 1.3 1.3 1.2 1.3 1.2 1.5 0.6 1.0 0.7 1.4 4.5 0.5 0.4 0.8 7.6 8.2 18.5 10.9 6.1 5.8 5.5 6.8 7.7 5.5 14.9 4.6 1.5 2.5 0.9 9.5 14.6 5.1 4.0 10.3 0.0 19.6 5.6 1.7 5.1 8.0 4.5 3.5 0.0 5.0 3.0 3.5 8.1 1.1 5.1 12.9 4.8 9.1 17.8 11.7 11.0 5.2 8.2 0.0 10.8 3.4 5.6 7.9 2.9 2.5 3.8 11.3 12.9 3.4 13.7 11.9 2.5 4.1 2.6 3.7 5.4 UHRF1BP1L KIAA0701 ENSG00000111647 "UHRF1 binding protein 1 like" A0JNW5 12 100028455-100142848 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039671, HPA075150" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA039671: AB_10794201, HPA075150: " "unprognostic (4.80e-2)" "unprognostic (3.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (7.36e-2)" "unprognostic (8.10e-2)" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (5.43e-2)" "unprognostic (1.88e-2)" "unprognostic (2.53e-1)" "unprognostic (2.94e-3)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.28e-2)" 14.9 13.9 15.9 11.4 19.9 31.9 10.8 16.9 26.0 9.5 10.0 8.7 5.3 9.9 9.3 8.8 10.2 8.0 10.6 10.4 18.0 13.7 14.7 28.0 10.6 9.7 14.8 12.0 11.1 4.7 21.5 15.3 13.7 22.6 11.1 9.6 6.9 8.7 11.2 26.2 8.4 11.1 11.2 13.7 11.8 9.0 15.2 9.8 10.0 13.0 8.1 8.1 16.7 8.4 3.8 8.4 22.9 8.4 3.7 3.7 3.4 11.3 12.4 6.9 7.1 10.7 15.3 13.8 17.8 17.9 14.4 10.6 9.2 3.9 9.9 4.7 18.1 8.4 4.4 12.9 6.0 14.0 26.2 6.4 6.6 9.9 10.6 9.9 12.4 10.8 8.6 5.1 17.3 12.0 13.4 10.0 6.9 5.2 10.3 14.0 6.3 7.9 10.7 11.9 3.9 11.3 9.0 12.3 9.7 7.4 20.1 11.8 7.4 13.5 15.6 5.3 6.2 13.9 14.2 7.9 16.0 8.5 13.7 12.4 12.2 20.8 13.9 8.0 9.4 9.6 12.5 7.6 4.9 2.6 8.4 3.7 3.8 2.9 2.9 8.4 3.4 2.5 3.0 22.9 3.7 6.8 5.1 3.2 3.4 15.9 19.9 16.9 26.0 18.0 13.7 14.8 12.0 22.6 9.8 26.8 8.3 9.8 13.2 11.3 10.8 11.5 2.5 30.8 19.4 8.7 3.9 3.9 5.0 4.8 17.2 6.8 8.0 0.0 5.0 7.4 14.6 16.5 23.1 17.4 9.8 14.3 5.2 6.2 17.7 2.1 6.6 20.6 10.1 8.2 2.8 5.8 4.2 7.0 7.4 12.2 11.3 0.0 9.7 19.8 21.5 10.2 9.2 12.5 4.7 10.2 ULBP1 RAET1I ENSG00000111981 "UL16 binding protein 1" Q9BZM6 6 149964007-149973710 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.9;lung: 9.7;testis: 10.5" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 13.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 23.1;JURKAT: 17.8" "HPA007547, HPA071005" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007547: AB_1079430, HPA071005: AB_2686332" "unprognostic (8.94e-3)" "unprognostic (2.44e-1)" "unprognostic (2.85e-2)" "unprognostic (2.33e-2)" "unprognostic (3.28e-4)" "unprognostic (6.69e-3)" "unprognostic (5.27e-2)" "unprognostic (2.47e-2)" "unprognostic (5.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.57e-12)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 0.7 0.6 2.0 0.4 0.6 0.5 0.5 13.9 1.5 0.4 0.7 0.2 0.0 0.4 0.5 0.5 0.8 0.9 0.5 1.2 1.5 0.3 1.2 0.9 9.7 0.2 0.3 0.0 1.2 0.4 0.6 0.6 1.3 1.0 0.8 0.4 0.5 1.0 0.2 1.6 0.6 0.3 0.3 1.2 0.3 0.9 10.5 0.2 0.2 3.8 0.6 0.5 0.7 4.9 0.7 0.1 0.9 1.8 0.3 3.5 0.3 2.7 1.3 2.6 1.4 2.6 7.7 2.7 3.6 1.1 1.6 2.8 1.8 3.1 2.7 2.9 12.4 6.6 2.6 23.1 4.5 4.3 12.0 3.8 0.2 0.9 0.0 13.6 0.1 1.0 8.4 5.6 11.4 3.0 1.3 2.3 17.8 2.2 0.0 4.0 3.2 2.8 0.0 0.9 1.7 4.2 1.2 2.4 0.3 4.9 2.0 0.9 0.3 5.3 3.3 0.8 1.6 2.6 5.3 1.9 1.3 2.3 5.1 3.2 0.4 0.4 2.5 7.9 4.0 3.3 0.1 0.2 0.1 2.4 1.3 3.5 0.7 1.2 2.8 0.1 0.2 0.7 1.2 0.9 0.3 1.8 0.0 1.9 0.3 2.0 0.6 13.9 1.5 1.5 0.3 0.3 0.0 1.0 0.2 6.0 2.1 0.0 0.4 0.1 0.0 0.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.5 0.0 0.0 0.0 0.1 ULK1 "ATG1, ATG1A" ENSG00000177169 "Unc-51 like autophagy activating kinase 1" O75385 12 131894651-131923167 "Enzymes, Plasma proteins, Predicted intracellular proteins" Autophagy "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 50.9;Rod photoreceptor cells: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.9;plasmacytoid DC: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063990 Approved Cytosol NA NA Cytosol "HPA063990: AB_2685167" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (2.52e-3)" "unprognostic (2.21e-3)" "unprognostic (8.01e-3)" "unprognostic (5.48e-2)" "unprognostic (2.74e-2)" "unprognostic (5.04e-3)" "unprognostic (3.94e-3)" "unprognostic (2.03e-2)" "unprognostic (9.09e-3)" "unprognostic (8.19e-2)" "unprognostic (6.25e-2)" "unprognostic (2.38e-1)" "unprognostic (2.75e-1)" "unprognostic (1.82e-2)" "unprognostic (3.16e-1)" 10.9 18.6 14.6 9.2 49.6 33.2 8.9 24.0 24.4 14.4 11.8 6.9 13.3 11.7 16.5 10.7 9.8 10.6 16.2 17.4 11.5 8.3 9.0 15.8 9.0 8.3 7.9 12.0 18.2 59.6 13.8 23.8 17.2 11.6 13.4 4.0 13.9 18.1 13.4 33.4 24.3 11.5 10.2 5.4 16.5 11.4 11.4 11.4 13.8 10.7 9.6 6.5 12.1 10.9 0.6 6.4 6.9 1.7 0.2 0.8 0.6 5.2 16.9 7.8 9.7 3.5 2.9 10.7 8.3 6.0 3.6 2.9 3.6 5.4 1.4 8.8 5.8 7.2 5.2 1.7 3.3 1.0 5.6 10.2 3.5 13.8 4.9 6.6 2.5 7.8 5.3 9.1 3.9 1.6 9.9 4.4 10.8 4.6 4.2 2.3 11.9 15.6 14.7 8.6 2.4 16.2 11.8 2.8 6.9 2.1 6.5 19.9 11.0 8.9 9.2 4.6 8.3 13.9 17.1 8.3 8.5 5.1 14.8 3.8 18.6 6.7 1.9 14.4 4.4 9.8 0.2 1.7 2.3 0.8 0.7 0.2 0.1 0.7 0.7 0.3 0.6 0.5 0.5 6.9 0.2 0.7 6.4 0.5 0.6 14.6 49.6 24.0 24.4 11.5 8.3 7.9 12.0 11.6 11.4 14.9 16.7 11.8 5.7 12.8 23.0 18.0 17.8 4.0 11.4 7.0 37.3 4.0 1.7 8.0 0.7 12.0 5.2 0.0 10.9 2.6 9.3 12.0 3.5 23.1 4.8 50.9 18.4 6.2 11.9 1.9 11.5 5.4 5.0 3.6 15.4 12.6 18.3 7.0 14.9 2.4 87.3 12.9 10.3 3.9 5.9 16.9 14.4 8.3 8.3 6.9 ULK4 "FAM7C1, FLJ20574, REC01035" ENSG00000168038 "Unc-51 like kinase 4" Q96C45 3 41246599-41962430 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 279.5;Late spermatids: 329.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017930 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA017930: AB_1858615" "unprognostic (3.16e-2)" "unprognostic (2.98e-3)" "unprognostic (9.72e-3)" "unprognostic (3.46e-2)" "unprognostic (2.58e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.75e-3)" "unprognostic (3.43e-1)" "unprognostic (1.91e-2)" "unprognostic (5.46e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (6.12e-2)" 4.3 4.8 5.1 4.7 8.3 10.3 4.2 4.3 5.4 11.9 2.8 5.9 6.0 2.1 10.7 10.9 2.8 12.3 3.1 13.1 5.2 3.0 5.4 3.4 5.5 4.2 3.1 4.2 4.5 3.6 13.5 19.7 9.0 5.8 4.4 2.8 6.7 4.2 4.5 1.4 3.5 3.3 5.1 5.7 4.4 3.4 27.5 3.4 6.3 7.1 1.7 8.4 4.0 6.0 6.4 5.1 10.7 6.3 2.6 10.3 5.2 7.3 1.7 2.7 3.0 1.1 1.7 4.6 2.5 2.6 3.1 2.6 0.9 2.2 8.6 1.4 5.8 3.0 3.7 3.2 1.9 2.8 1.1 0.9 1.6 5.4 2.9 3.9 5.6 1.7 1.6 2.2 15.0 3.1 3.9 2.1 5.9 1.9 7.2 2.2 5.9 7.0 4.5 3.3 1.8 3.1 1.6 8.5 3.7 6.5 7.1 1.4 9.9 2.6 1.2 2.1 1.8 3.0 1.8 6.2 2.0 2.2 13.2 2.1 4.3 8.0 3.6 11.0 5.9 2.4 5.7 5.8 5.8 8.0 6.3 6.5 5.6 8.6 7.2 5.1 6.4 6.5 9.2 10.7 2.6 3.2 4.6 10.3 5.2 5.1 8.3 4.3 5.4 5.2 3.0 3.1 4.2 5.8 3.4 8.9 5.8 1.9 2.8 1.8 5.4 12.8 5.1 53.5 4.5 3.5 51.1 2.8 0.0 2.3 279.5 4.4 1.1 0.0 2.1 3.9 3.3 1.2 1.1 5.9 6.5 11.1 1.7 1.8 4.1 329.6 6.1 5.6 0.0 6.4 1.1 11.2 2.8 0.0 3.9 5.0 25.1 6.5 3.3 29.9 8.7 3.1 3.5 4.4 1.7 0.8 UMPS ENSG00000114491 "Uridine monophosphate synthetase" P11172 3 124730366-124749273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 91.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036178, HPA036179" Uncertain Approved Cytosol NA NA Cytosol "HPA036178: AB_10673002, HPA036179: AB_10673615" "unprognostic (6.41e-2)" "unprognostic (6.70e-2)" "unprognostic (1.79e-2)" "unprognostic (1.13e-3)" "unprognostic (2.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.15e-3)" "unprognostic (5.51e-2)" "unprognostic (4.85e-3)" "unprognostic (1.43e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.18e-2)" "unprognostic (1.58e-2)" "unprognostic (1.91e-1)" "unprognostic (4.61e-2)" "unprognostic (1.31e-1)" 8.4 12.2 4.9 6.8 6.8 4.8 8.0 9.3 7.6 5.9 9.1 8.5 5.2 8.4 6.8 6.7 13.2 8.2 6.6 3.6 4.0 3.9 9.6 20.7 5.2 10.1 7.3 3.6 8.9 19.0 9.5 9.3 11.6 4.7 6.4 7.1 6.4 8.9 4.0 10.9 9.5 8.5 5.5 5.9 9.8 8.3 6.8 6.2 10.6 7.4 12.0 9.3 7.8 6.4 16.6 13.1 4.6 9.8 10.2 13.0 7.9 1.4 4.4 5.0 2.1 3.0 3.5 5.3 7.5 2.3 3.2 2.7 3.8 2.0 3.8 8.3 2.9 6.6 8.4 7.1 2.5 5.0 4.4 4.1 7.8 2.8 2.6 2.6 8.2 5.9 3.9 2.3 2.0 3.9 1.9 1.4 7.7 3.5 1.8 2.3 3.4 10.0 1.6 11.1 3.9 2.8 6.6 6.0 3.2 2.5 2.5 4.0 2.6 11.3 4.0 4.2 3.8 4.0 3.0 14.4 2.5 5.0 6.9 3.0 7.5 10.2 10.5 2.8 3.4 2.5 4.5 9.0 4.6 12.5 9.8 12.1 13.7 8.9 11.3 13.1 16.6 13.0 10.4 0.6 10.2 8.0 9.7 10.3 7.9 4.9 6.8 9.3 5.7 4.0 3.9 7.3 3.6 4.7 6.2 6.0 7.8 5.2 15.9 14.1 8.0 5.7 12.7 22.7 10.3 8.7 3.9 56.7 24.9 23.5 3.1 13.4 10.4 0.0 26.6 27.5 9.3 9.3 11.5 28.8 19.3 4.8 9.2 8.0 5.4 3.9 12.7 9.6 3.3 21.6 9.4 10.1 19.5 7.0 13.1 19.5 7.7 12.9 9.9 19.7 30.7 16.7 91.3 12.8 15.8 15.5 UNC119B "MGC5139, POC7B" ENSG00000175970 "Unc-119 lipid binding chaperone B" A6NIH7 12 120710435-120723640 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077812 Enhanced Approved "Cytokinetic bridge,Mitotic spindle,Mitochondria,Cytosol" Yes No "Cytokinetic bridge, Mitotic spindle" "Mitochondria, Cytosol" "HPA077812: " "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.86e-3)" "unprognostic (6.71e-2)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.26e-4)" "unprognostic (9.35e-2)" "prognostic favorable (6.69e-10)" "unprognostic (2.52e-2)" "unprognostic (7.73e-2)" "unprognostic (2.20e-1)" "unprognostic (5.42e-2)" 12.7 33.5 18.1 9.2 18.6 9.5 16.3 17.0 17.2 16.0 12.1 15.0 18.7 8.6 20.7 15.0 11.6 42.8 14.9 13.2 18.9 19.7 27.1 14.7 14.0 9.3 14.2 16.0 33.7 17.1 40.8 25.8 13.4 20.4 18.4 12.3 14.6 14.1 23.8 6.7 13.6 11.4 17.5 15.5 13.4 14.5 21.9 15.2 16.1 38.6 7.3 13.7 12.1 16.3 2.1 2.5 2.1 5.8 2.5 4.0 1.4 11.5 11.2 23.4 20.0 23.5 17.5 19.9 14.4 16.8 16.4 7.4 13.4 4.8 11.7 5.7 16.0 7.9 12.3 24.7 16.1 17.0 9.1 12.5 5.4 8.3 8.3 15.9 14.8 8.6 13.7 16.6 12.2 18.9 26.5 18.4 17.8 13.1 1.3 13.8 10.2 13.5 12.2 28.9 13.2 13.9 16.3 15.6 6.0 19.6 24.3 14.1 17.8 34.4 6.8 11.8 17.3 26.8 10.2 11.5 15.3 10.5 6.5 9.6 9.5 8.2 7.2 18.1 7.5 16.5 0.2 1.1 1.3 3.3 0.6 2.1 1.8 3.0 3.8 1.2 2.1 4.0 3.2 2.1 2.5 5.8 2.5 2.8 1.4 18.1 18.6 17.0 17.2 18.9 19.7 14.2 16.0 20.4 15.2 3.0 6.9 2.9 6.5 2.6 8.1 3.5 5.1 18.7 5.7 17.4 9.8 9.1 13.3 6.6 11.8 6.3 3.5 0.0 6.7 4.0 6.2 10.2 2.3 5.5 2.7 7.9 13.7 8.6 3.7 2.2 12.0 1.8 5.0 0.0 6.1 11.2 6.9 5.8 15.2 11.8 9.8 12.9 5.0 11.4 14.5 2.9 4.3 9.2 8.0 6.4 UNC13D Munc13-4 ENSG00000092929 "Unc-13 homolog D" Q70J99 17 75827225-75844717 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Exocytosis "Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 70.2;granulocytes: 43.9;Hofbauer cells: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 56.1;HMC-1: 58.2;SK-BR-3: 39.8" "Region enriched" "Detected in single" 6 "cerebellum: 5.6" "Not detected" "Not detected" "HPA067117, HPA073525" Enhanced Supported Vesicles,Cytosol NA NA 14000000 Cytosol Vesicles "HPA067117: AB_2685784, HPA073525: AB_2686615" "unprognostic (6.79e-3)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.98e-2)" "unprognostic (1.42e-3)" "unprognostic (3.93e-1)" "unprognostic (1.37e-2)" "unprognostic (2.74e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.89e-1)" "prognostic unfavorable (5.28e-12)" "unprognostic (3.27e-2)" "unprognostic (5.58e-2)" "unprognostic (1.56e-1)" "unprognostic (8.59e-2)" 4.5 3.3 2.9 17.1 5.2 31.3 4.5 4.1 3.1 5.2 5.2 2.8 1.4 4.5 3.8 1.8 11.5 5.2 8.7 13.0 1.8 1.6 2.6 4.9 30.1 24.9 4.5 1.6 8.7 5.5 0.3 5.3 67.1 3.2 3.1 2.6 2.6 8.0 3.9 3.2 3.0 7.6 2.8 3.7 33.8 7.2 2.2 3.3 23.6 2.4 9.3 24.7 7.0 8.2 4.0 6.9 24.8 13.6 8.2 11.5 7.9 8.4 3.2 0.1 0.0 0.1 0.2 10.7 0.0 0.0 0.0 0.0 8.2 19.1 0.7 10.2 0.0 1.4 2.9 0.0 0.5 0.0 0.1 0.1 56.1 24.9 5.2 0.9 21.4 58.2 0.1 0.4 0.1 0.5 0.5 3.8 9.8 19.4 0.2 0.0 14.4 22.6 10.7 0.2 15.0 0.4 7.2 0.2 0.3 0.3 3.4 0.0 15.6 3.6 39.8 0.2 0.1 10.7 12.1 10.6 0.1 15.1 0.1 0.0 0.3 1.3 0.9 0.1 6.8 0.0 24.8 8.0 16.4 11.5 9.4 10.4 4.0 6.7 8.1 6.9 2.2 5.3 6.9 22.4 8.2 13.6 4.0 6.0 7.9 2.9 5.2 4.1 3.1 1.8 1.6 4.5 1.6 3.2 3.3 41.7 11.7 22.2 1.7 1.0 11.3 70.2 10.2 0.0 5.7 3.5 19.6 2.8 0.0 6.2 3.9 5.7 20.0 0.0 5.3 8.4 2.3 1.1 43.9 0.8 46.9 4.8 5.8 4.3 22.7 0.0 2.6 18.4 1.7 13.6 2.3 5.8 27.8 10.5 1.4 0.6 15.5 0.0 1.4 1.4 0.9 1.3 21.6 30.5 2.2 2.0 UNC45A "GC-UNC45, SMAP-1" ENSG00000140553 "Unc-45 myosin chaperone A" Q9H3U1 15 90930180-90954093 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039228 Approved Supported "Nuclear speckles,Cytosol" NA NA 21000000 "Nuclear speckles" Cytosol "HPA039228: AB_2676402" "unprognostic (1.46e-1)" "unprognostic (3.83e-2)" "unprognostic (4.51e-2)" "unprognostic (1.97e-1)" "unprognostic (2.68e-2)" "unprognostic (1.70e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (2.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (1.98e-1)" "unprognostic (9.85e-2)" "prognostic favorable (7.46e-7)" "unprognostic (9.30e-2)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-2)" 19.1 21.0 10.1 14.4 10.1 11.9 20.6 21.8 14.6 20.3 27.6 10.7 23.2 13.0 29.7 15.5 24.9 20.4 24.8 12.8 9.5 7.3 16.2 15.9 15.2 13.2 11.9 12.3 22.1 19.4 25.8 14.1 22.8 11.5 23.8 10.9 15.3 20.2 29.6 6.9 26.6 16.9 35.8 9.7 15.7 22.4 18.4 10.8 18.0 20.8 12.6 16.9 33.2 30.4 10.1 12.0 12.1 11.9 10.8 14.5 9.8 15.3 31.2 12.9 11.3 35.5 16.4 11.5 17.4 15.0 23.8 19.1 24.9 20.4 18.1 23.5 21.9 13.7 34.0 21.9 22.4 11.2 20.0 32.0 34.9 32.7 17.7 20.1 8.6 23.7 20.3 27.5 23.3 17.1 22.9 32.2 14.5 15.3 14.9 17.8 24.7 11.0 7.4 17.4 28.2 15.8 22.0 19.7 19.2 16.2 36.5 18.3 16.6 23.4 23.5 21.7 16.2 21.3 17.9 31.6 20.3 14.6 17.1 18.2 14.3 19.7 8.5 19.9 20.2 20.6 12.1 9.0 5.4 14.5 8.3 14.0 10.1 11.9 11.2 12.0 8.3 10.0 9.1 1.8 10.8 11.9 10.7 10.5 9.8 10.1 10.1 21.8 14.6 9.5 7.3 11.9 12.3 11.5 10.8 20.8 21.9 23.1 21.9 14.4 22.5 11.2 35.7 9.4 21.6 17.4 17.7 45.4 11.6 29.7 18.8 21.2 22.6 0.0 15.8 18.5 21.6 16.1 28.8 12.4 24.1 17.5 35.5 16.0 15.4 22.0 27.3 15.4 18.6 37.9 15.4 20.7 19.8 25.9 48.4 16.6 30.0 32.3 30.1 18.4 6.0 16.4 38.7 21.0 18.3 20.6 UNC45B "CMYA4, UNC45" ENSG00000141161 "Unc-45 myosin chaperone B" Q8IWX7 17 35147817-35189345 "Disease related genes, Predicted intracellular proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 181.6" "Group enriched" "Detected in some" 5 "head and neck cancer: 0.9;testis cancer: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5" "Lineage enriched" "Detected in single" 10 "T-cells: 3.5" "Group enriched" "Detected in some" 11 "BEWO: 4.7;HSkMC: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017861 Approved Cytosol NA NA Cytosol "HPA017861: AB_1847012" "unprognostic (7.17e-2)" "unprognostic (6.47e-3)" "unprognostic (9.36e-3)" "unprognostic (2.93e-1)" "unprognostic (1.49e-3)" "unprognostic (5.30e-2)" "unprognostic (3.07e-1)" "unprognostic (1.09e-2)" "unprognostic (5.46e-2)" "unprognostic (2.40e-2)" "unprognostic (8.46e-2)" "unprognostic (6.73e-2)" "unprognostic (1.13e-6)" "unprognostic (6.77e-2)" "unprognostic (5.05e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.9 0.0 0.3 48.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.9 0.2 62.5 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.2 23.2 1.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 3.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 7.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.5 0.2 2.9 0.0 0.7 1.8 0.0 0.0 0.4 2.0 0.2 0.3 0.3 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 181.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 42.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.0 UNC5A "KIAA1976, UNC5H1" ENSG00000113763 "Unc-5 netrin receptor A" Q6ZN44 5 176810477-176880898 "Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.9;brain: 35.3" "Cell type enhanced" "Detected in some" 24 "Horizontal cells: 4.8;Late spermatids: 1.9;Muller glia cells: 10.3;Rod photoreceptor cells: 2.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8;eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.8" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 44.3" "Group enriched" "Detected in all" 4 "amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1" "Low region specificity" "Detected in all" HPA071450 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA071450: AB_2686397" "unprognostic (5.95e-2)" "unprognostic (1.15e-1)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.23e-4)" "unprognostic (5.26e-2)" "unprognostic (2.23e-1)" "unprognostic (6.66e-3)" "unprognostic (5.06e-3)" "unprognostic (3.52e-1)" "unprognostic (1.36e-1)" "unprognostic (5.07e-1)" "unprognostic (9.95e-2)" "unprognostic (3.77e-5)" "unprognostic (6.39e-2)" "unprognostic (2.89e-1)" "unprognostic (2.27e-1)" "unprognostic (5.17e-2)" 0.9 11.9 10.5 1.1 11.1 1.2 1.4 35.3 30.9 1.1 0.7 0.4 0.0 1.3 0.8 0.9 0.7 1.5 1.0 0.7 7.6 4.6 0.7 0.7 0.9 1.7 1.6 12.6 0.9 3.2 0.6 5.1 0.6 2.1 0.8 0.7 0.3 0.9 0.7 0.6 0.7 0.9 0.8 0.8 0.6 1.2 1.3 0.5 0.0 0.8 0.0 0.7 0.9 0.2 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 1.7 0.0 0.0 0.0 1.2 5.1 0.0 44.3 1.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 10.5 11.1 35.3 22.2 7.6 4.6 1.6 12.6 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 10.3 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 UNG "DGU, HIGM4, UDG, UNG1, UNG2" ENSG00000076248 "Uracil DNA glycosylase" P13051 12 109097574-109110992 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 64.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB011605 Uncertain Approved Cytosol NA Yes Cytosol "CAB011605: AB_778737" "unprognostic (4.38e-2)" "unprognostic (3.82e-3)" "unprognostic (1.03e-2)" "unprognostic (1.33e-2)" "unprognostic (4.64e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (6.40e-4)" "unprognostic (5.68e-3)" "prognostic unfavorable (3.06e-4)" "unprognostic (4.66e-2)" "unprognostic (8.78e-3)" "unprognostic (1.91e-1)" "unprognostic (1.35e-3)" "unprognostic (2.57e-2)" "unprognostic (4.50e-1)" "unprognostic (1.40e-2)" "unprognostic (6.89e-2)" 16.3 44.1 17.0 19.4 17.0 10.0 22.8 10.5 14.4 13.5 20.3 10.2 21.4 12.6 11.8 10.8 22.5 11.8 11.0 15.4 13.5 13.1 20.4 23.3 7.1 12.1 19.6 12.2 12.3 12.7 17.3 8.9 18.6 12.0 12.9 22.1 10.7 16.6 19.7 29.1 22.5 13.5 11.0 19.7 13.2 12.3 35.6 9.8 35.1 25.1 19.8 19.0 11.5 14.4 9.8 3.9 5.8 3.0 8.7 19.5 7.9 20.1 20.7 20.0 18.1 33.3 9.6 19.1 11.9 8.2 18.9 14.5 16.4 13.9 26.5 18.0 10.7 9.9 12.8 22.0 12.4 18.4 22.4 40.9 25.9 12.0 27.7 5.0 38.4 16.0 8.6 11.4 9.0 5.0 15.1 13.6 31.9 20.9 8.9 12.7 25.2 35.3 45.4 35.5 32.9 32.0 32.6 30.1 22.6 11.8 25.5 28.5 15.8 21.5 18.5 10.4 27.2 34.5 18.0 7.0 16.4 14.7 10.8 16.5 17.3 37.2 50.3 12.5 25.9 20.0 5.8 1.5 2.7 13.4 3.0 19.5 9.8 15.9 15.5 3.9 9.2 10.3 11.5 0.0 8.7 3.0 2.8 14.0 7.9 17.0 17.0 10.5 14.4 13.5 13.1 19.6 12.2 12.0 9.8 0.0 4.5 6.7 10.0 16.0 2.6 10.6 7.6 2.7 2.3 40.1 3.9 41.8 16.6 11.9 3.2 11.6 7.3 0.0 5.5 24.6 10.3 5.9 7.0 20.3 15.7 4.8 8.1 14.7 2.9 3.4 13.0 4.5 13.5 5.4 18.2 11.8 5.9 7.0 13.8 14.6 3.0 6.5 9.0 18.6 64.3 18.2 17.0 17.8 34.2 7.6 UNK "KIAA1753, ZC3H5, ZC3HDC5" ENSG00000132478 "Unkempt family zinc finger" Q9C0B0 17 75784771-75825799 "Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 127.0;Spermatocytes: 103.3;Spermatogonia: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023636, HPA027962" Uncertain Supported "Cytosol,Cytoplasmic bodies" NA NA "Cytosol, Cytoplasmic bodies" "HPA023636: AB_10601774, HPA027962: AB_10611522" "unprognostic (7.94e-2)" "unprognostic (4.79e-2)" "unprognostic (3.37e-1)" "unprognostic (1.04e-3)" "unprognostic (9.51e-2)" "prognostic favorable (2.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.11e-1)" "unprognostic (6.73e-2)" "unprognostic (9.78e-2)" "prognostic favorable (6.58e-5)" "unprognostic (5.31e-2)" "unprognostic (1.41e-3)" "unprognostic (6.69e-2)" "unprognostic (4.04e-1)" "unprognostic (1.99e-2)" "unprognostic (1.01e-2)" 11.6 11.7 13.0 17.8 14.6 13.9 15.5 19.5 14.5 17.8 11.2 15.0 17.6 12.5 18.7 16.1 13.5 17.0 15.4 10.6 13.0 8.7 12.3 11.8 18.4 17.6 14.5 14.3 24.5 18.2 18.5 20.7 13.4 11.2 15.6 6.8 22.2 19.6 16.3 15.0 25.1 13.7 14.3 9.7 21.2 12.9 22.1 16.4 15.6 17.5 8.2 16.1 13.8 15.2 2.8 1.9 0.4 1.1 1.3 2.3 1.5 6.5 10.4 11.6 9.8 3.7 3.4 9.5 4.3 4.7 4.9 6.1 3.8 7.5 13.9 3.8 4.7 8.1 6.0 5.9 5.2 2.3 7.1 19.1 8.7 8.4 8.0 5.0 6.6 11.1 6.8 3.2 4.2 4.6 5.6 6.4 10.0 4.5 6.9 3.9 12.9 14.8 9.2 5.0 4.5 6.9 15.7 11.7 7.0 4.6 7.0 10.7 21.1 5.7 7.9 15.3 6.1 9.7 10.3 4.6 11.7 6.4 5.1 5.6 12.0 3.5 7.7 8.5 4.3 7.2 0.3 1.1 0.4 2.3 0.7 2.3 1.1 1.3 1.4 0.7 2.8 2.1 2.0 0.4 1.3 0.9 1.9 1.3 1.5 13.0 14.6 19.5 14.5 13.0 8.7 14.5 14.3 11.2 16.4 14.9 17.1 14.2 14.2 13.5 24.5 9.2 12.7 20.1 20.5 3.5 13.7 7.7 3.3 12.3 127.0 10.8 7.2 0.0 20.0 12.2 11.3 13.8 18.5 6.0 12.2 20.6 16.1 7.4 8.5 17.2 17.5 12.2 25.3 11.8 14.0 21.0 15.8 10.5 9.9 6.0 23.1 19.4 13.3 103.3 89.7 19.2 14.4 17.3 13.3 12.9 UNKL "C16orf28, FLJ23360, ZC3H5L, ZC3HDC5L" ENSG00000059145 "Unkempt family like zinc finger" Q9H9P5 16 1363205-1414751 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA055801, HPA073949" Uncertain Supported Cytosol NA NA Cytosol "HPA055801: AB_2682926, HPA073949: AB_2686647" "unprognostic (5.32e-3)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (8.88e-2)" "unprognostic (4.08e-2)" "unprognostic (1.82e-2)" "unprognostic (3.90e-3)" "unprognostic (8.07e-2)" "unprognostic (5.18e-2)" "unprognostic (8.56e-2)" "unprognostic (4.85e-3)" "unprognostic (1.13e-1)" "unprognostic (3.86e-3)" "unprognostic (1.89e-1)" "unprognostic (6.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.55e-1)" 9.6 10.0 14.0 10.4 12.9 12.1 10.1 27.9 16.3 10.5 7.3 9.3 10.2 11.0 15.2 7.9 6.0 11.0 5.0 5.7 12.2 4.5 6.3 4.8 9.1 11.7 9.2 8.3 18.9 10.1 6.5 7.2 9.0 10.1 10.5 4.4 9.3 12.3 12.7 14.4 10.5 10.6 7.2 5.6 14.3 9.9 8.4 11.7 11.0 11.7 7.0 7.6 10.8 9.3 1.9 3.2 7.6 2.1 2.4 3.7 1.3 3.4 9.1 2.0 5.2 1.8 2.0 16.3 8.7 2.6 2.5 2.0 6.7 7.4 1.3 18.5 3.0 4.2 6.3 2.7 0.8 1.7 15.9 7.8 2.3 9.4 6.0 1.2 1.3 5.6 2.5 1.2 3.8 1.6 3.0 4.4 3.8 7.2 4.8 1.1 5.3 3.8 4.2 5.8 1.5 10.3 10.3 1.9 9.4 1.5 0.7 7.0 4.2 4.4 3.2 0.6 1.8 5.1 2.2 3.8 5.4 7.8 4.5 3.6 10.3 5.7 6.1 4.4 2.9 6.0 5.7 2.1 4.5 3.7 0.7 2.1 1.5 1.5 0.9 0.7 1.9 2.8 1.4 7.6 2.4 0.7 3.2 1.6 1.3 14.0 12.9 27.9 16.3 12.2 4.5 9.2 8.3 10.1 11.7 6.0 6.9 20.6 5.4 4.8 28.5 2.0 5.1 8.1 10.3 5.2 13.7 10.0 1.7 4.7 4.6 6.8 5.5 0.0 2.6 5.5 6.2 14.2 4.7 5.8 3.6 6.4 3.5 9.8 5.3 14.1 15.3 5.8 6.8 9.0 7.4 18.0 6.4 7.8 14.5 1.4 35.2 6.5 6.4 11.7 20.4 7.2 17.2 8.7 3.8 4.3 UPF2 "DKFZP434D222, KIAA1408, RENT2, smg-3" ENSG00000151461 "UPF2, regulator of nonsense mediated mRNA decay" Q9HAU5 10 11920022-12043170 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067008 Supported "Cytosol,Cytoplasmic bodies" NA NA Cytosol "Cytoplasmic bodies" "HPA067008: AB_2685762" "unprognostic (1.99e-2)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.61e-2)" "unprognostic (2.48e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (5.48e-2)" "unprognostic (5.68e-2)" "unprognostic (9.27e-2)" "unprognostic (1.68e-2)" "unprognostic (3.01e-2)" "unprognostic (4.65e-3)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-1)" "unprognostic (8.48e-2)" 15.8 8.7 12.9 18.9 18.1 19.2 13.4 19.7 14.2 22.5 25.5 8.1 14.6 10.2 15.8 14.2 17.2 11.7 9.2 12.7 13.8 11.9 14.5 20.2 12.8 17.8 13.6 10.0 17.8 14.1 20.1 22.3 18.1 13.4 24.5 13.8 7.4 12.2 20.0 33.5 14.5 19.2 19.8 19.3 20.1 12.0 19.4 17.5 28.8 23.0 16.0 17.7 25.5 13.5 7.9 8.4 21.8 3.2 3.7 4.2 1.2 19.3 12.3 10.6 13.2 8.1 10.4 12.0 15.2 7.1 10.9 13.2 11.6 15.9 28.0 5.2 12.6 9.0 16.3 15.2 13.8 15.7 17.5 8.7 33.4 10.0 10.5 9.2 15.0 22.7 7.8 10.8 13.7 9.4 10.4 13.3 15.1 19.7 14.4 12.4 9.5 18.5 8.9 10.1 14.7 6.6 16.4 12.7 13.7 10.3 7.8 6.9 7.4 12.0 13.0 13.0 11.1 15.6 20.2 14.1 8.6 18.1 17.6 11.5 13.3 10.4 23.1 13.7 14.7 6.7 8.3 3.2 7.1 3.3 3.0 3.2 7.3 3.8 3.4 2.1 7.9 4.2 3.4 21.8 3.7 2.0 8.4 2.7 1.2 12.9 18.1 19.7 14.2 13.8 11.9 13.6 10.0 13.4 17.5 23.8 38.3 109.1 33.1 63.8 60.1 61.8 40.8 33.5 36.4 47.1 96.2 39.7 33.2 41.7 53.9 60.9 69.2 23.3 38.8 45.1 43.3 30.2 57.7 72.9 36.7 49.3 63.7 54.0 62.9 94.8 80.0 59.8 50.6 73.9 67.0 43.3 43.4 56.0 55.5 25.9 87.9 97.0 50.9 127.5 135.7 71.5 47.3 69.9 52.7 36.5 UPF3A "HUPF3A, RENT3A, UPF3" ENSG00000169062 "UPF3A, regulator of nonsense mediated mRNA decay" Q9H1J1 13 114281584-114305817 "Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 503.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018325, HPA061316" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA018325: AB_1858638, HPA061316: AB_2684477" "unprognostic (9.08e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-1)" "unprognostic (3.43e-2)" "unprognostic (2.51e-2)" "unprognostic (1.16e-2)" "unprognostic (6.48e-2)" "unprognostic (1.98e-1)" "unprognostic (9.80e-3)" "unprognostic (1.44e-1)" "prognostic favorable (7.09e-5)" "unprognostic (1.39e-3)" "unprognostic (1.52e-2)" "unprognostic (2.34e-2)" "unprognostic (9.21e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.71e-4)" 11.3 16.3 16.9 10.9 20.2 11.9 10.9 32.8 21.9 10.4 9.9 18.6 13.0 13.8 13.1 12.3 10.1 13.2 9.2 7.1 16.1 14.9 11.0 7.5 9.2 12.0 20.2 16.0 12.7 15.4 8.1 12.8 8.5 17.2 12.1 8.7 10.0 11.9 16.1 16.1 11.9 11.9 10.2 23.6 11.8 11.2 34.5 16.7 10.7 24.0 7.4 7.9 11.2 9.3 11.7 15.6 4.1 5.5 11.1 9.5 4.3 23.3 6.9 15.3 13.7 7.3 12.8 9.8 18.1 13.1 11.6 13.0 10.4 8.3 23.0 5.3 8.3 7.8 12.6 7.5 6.0 14.7 16.8 14.8 19.8 19.6 11.4 12.8 34.3 8.9 8.6 12.5 7.8 9.2 12.3 9.2 6.0 12.0 10.7 11.6 7.1 13.9 9.2 20.4 15.6 6.9 18.3 8.6 13.4 10.4 7.5 17.4 19.2 14.4 22.3 12.9 10.8 16.5 30.9 11.8 12.4 20.7 6.7 11.3 23.4 16.2 31.9 22.8 19.8 10.1 1.9 5.5 4.1 6.8 4.4 5.3 11.7 7.1 7.0 6.0 9.1 7.4 6.7 0.8 11.1 5.1 15.6 9.5 4.3 16.9 20.2 32.8 21.9 16.1 14.9 20.2 16.0 17.2 16.7 62.5 46.2 54.7 55.8 61.0 74.4 18.2 43.3 133.8 69.4 55.8 78.5 57.6 87.9 47.2 134.0 84.2 27.6 0.0 61.9 38.0 72.4 48.5 52.2 59.5 40.0 74.7 55.2 57.7 33.2 66.4 93.2 41.0 52.3 48.7 45.2 66.8 45.9 35.1 82.4 45.3 72.8 84.1 54.5 503.7 176.2 62.9 33.9 57.5 58.3 32.4 UPF3B "HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X" ENSG00000125351 "UPF3B, regulator of nonsense mediated mRNA decay" Q9BZI7 X 119805311-119852998 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001592, HPA001800, HPA001882" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No Cytosol "Nucleoplasm, Nucleoli" "HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474" "unprognostic (1.79e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.64e-3)" "unprognostic (8.58e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (6.61e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (5.74e-2)" "unprognostic (4.51e-2)" "unprognostic (8.63e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (8.67e-2)" "unprognostic (1.04e-1)" "unprognostic (2.34e-1)" "unprognostic (8.95e-2)" 9.7 10.3 19.4 11.5 21.9 14.5 10.8 34.1 24.0 10.2 13.0 9.3 12.8 14.2 14.6 13.5 13.0 8.8 8.4 7.8 16.9 17.5 10.0 12.4 9.0 17.2 16.5 21.7 14.8 8.7 14.3 26.7 10.5 17.2 12.4 13.2 9.1 9.7 14.4 14.5 18.6 11.1 14.2 21.7 12.9 9.9 15.0 21.0 9.9 12.5 11.5 18.3 12.6 12.9 17.5 10.0 7.1 5.9 7.9 8.1 2.7 11.9 7.2 15.1 12.2 6.9 4.5 9.7 11.5 6.5 9.0 8.0 13.5 8.6 21.5 9.8 4.8 12.9 11.4 19.5 6.9 11.5 12.2 14.3 19.9 24.0 7.1 7.9 21.5 9.9 3.9 5.3 15.4 18.8 8.2 8.3 12.9 19.2 18.0 7.5 14.5 15.1 27.0 29.1 15.3 19.8 14.8 17.3 15.8 7.3 6.0 20.1 13.9 23.5 9.5 17.2 16.4 5.0 12.6 7.2 9.4 7.2 15.0 24.3 9.9 11.0 29.1 7.5 31.7 10.9 7.1 5.3 6.8 7.5 5.1 5.7 13.8 7.0 5.9 3.8 17.5 7.6 8.1 5.9 7.9 5.9 10.0 7.8 2.7 19.4 21.9 34.1 24.0 16.9 17.5 16.5 21.7 17.2 21.0 29.8 25.5 28.9 28.2 33.5 47.9 17.1 15.3 42.8 47.8 24.4 53.0 33.2 5.0 27.3 107.2 24.5 27.1 0.0 22.8 39.7 29.2 18.5 57.7 19.2 25.4 27.0 26.6 20.3 15.4 17.6 28.1 32.2 23.6 49.5 21.8 39.5 18.6 31.7 30.8 12.4 94.7 12.9 36.2 32.2 32.4 33.2 53.8 34.8 32.2 21.3 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673687 "Disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 10.0 13.4 8.9 11.4 8.5 10.6 14.7 8.7 9.9 7.3 15.4 4.7 19.7 16.5 7.3 8.5 14.5 6.5 12.4 13.2 8.0 8.7 10.7 13.4 5.6 8.3 8.5 8.7 9.5 15.4 5.3 7.6 6.2 7.7 12.3 4.9 7.1 22.9 14.1 27.8 8.6 14.8 6.0 6.2 9.6 12.2 5.7 5.4 6.4 13.5 12.3 9.1 8.0 18.1 23.7 21.2 15.2 20.8 14.0 19.4 15.5 12.0 24.5 3.6 5.6 2.2 2.2 3.0 4.8 1.6 3.6 3.6 14.3 10.5 7.8 10.0 1.6 4.9 12.0 3.4 5.6 1.1 3.9 12.7 4.4 12.8 9.1 3.0 7.1 3.6 2.1 4.8 3.2 3.6 2.3 2.8 3.8 9.4 5.7 2.0 36.8 6.9 17.5 4.0 4.8 13.9 8.1 5.5 13.9 2.7 6.0 7.3 7.4 5.3 19.4 7.1 1.1 18.4 6.7 3.6 7.9 9.3 8.2 10.6 8.8 4.8 8.1 6.5 6.2 5.7 9.1 20.8 15.2 18.1 14.4 17.1 23.5 18.0 15.9 15.8 23.7 16.6 13.3 8.9 14.0 12.7 21.2 19.4 15.5 8.9 8.5 8.7 9.9 8.0 8.7 8.5 8.7 7.7 5.4 41.7 23.5 61.4 42.6 0.0 20.8 31.7 66.2 22.7 29.6 61.1 15.7 44.7 119.3 51.7 1.4 26.8 115.3 46.7 67.1 41.2 21.0 70.4 4.7 99.1 47.7 17.5 33.9 39.9 38.4 2.3 44.8 22.9 0.0 43.3 98.1 39.6 57.0 91.2 33.9 137.3 26.2 38.8 31.1 2.7 33.7 0.0 24.3 25.9 101.8 45.4 URGCP "DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4" ENSG00000106608 "Upregulator of cell proliferation" Q8TCY9 7 43875894-43926411 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019879, HPA020134, HPA029468" Approved Supported Cytosol NA NA Cytosol "HPA019879: AB_1858651, HPA020134: AB_1858652, HPA029468: AB_10601831" "unprognostic (5.66e-2)" "unprognostic (1.10e-3)" "unprognostic (1.18e-1)" "unprognostic (2.75e-1)" "unprognostic (2.21e-3)" "unprognostic (2.42e-2)" "unprognostic (3.74e-2)" "unprognostic (1.26e-1)" "unprognostic (3.79e-1)" "unprognostic (2.21e-1)" "unprognostic (3.23e-3)" "unprognostic (3.71e-1)" "prognostic favorable (1.90e-4)" "unprognostic (1.56e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (1.69e-3)" 13.7 27.1 18.5 13.4 21.4 8.6 13.4 28.3 29.5 15.8 18.2 18.6 14.8 22.2 18.3 15.1 13.8 15.6 11.6 19.3 18.3 15.9 20.4 21.3 12.1 9.5 13.8 19.5 21.6 18.4 22.5 22.1 14.4 17.9 17.7 19.6 19.8 18.4 17.1 26.8 17.4 21.0 19.1 10.9 13.8 12.8 7.0 17.2 8.3 14.6 7.9 12.5 15.0 12.3 6.1 9.8 5.8 7.5 2.6 11.9 6.1 13.7 12.8 5.1 16.6 14.1 13.1 5.0 15.2 30.2 18.5 18.9 10.7 11.3 8.2 8.6 16.3 28.2 22.2 14.6 12.2 18.3 15.4 8.4 5.5 12.7 9.2 15.0 8.6 10.7 9.9 15.1 14.6 14.2 12.1 9.2 9.6 13.9 6.4 12.4 10.5 8.9 7.3 9.8 16.5 12.2 12.5 7.1 11.3 17.7 14.0 13.6 23.0 17.2 25.7 8.0 9.1 13.0 10.3 8.5 10.5 4.6 11.6 12.6 17.6 25.6 10.2 12.2 13.6 19.8 2.6 4.5 5.8 9.0 7.3 9.9 6.1 9.6 11.9 9.8 5.6 10.6 9.3 0.5 2.6 7.5 1.5 9.6 6.1 18.5 21.4 28.3 29.5 18.3 15.9 13.8 19.5 17.9 17.2 3.0 8.6 8.3 10.9 9.8 24.6 17.1 10.2 9.4 5.7 12.2 7.9 5.1 14.9 11.7 1.1 9.0 34.1 0.0 11.4 10.5 13.0 11.7 6.9 22.7 5.5 15.9 8.1 12.3 3.3 3.1 17.0 7.0 11.8 4.6 11.9 11.1 13.4 15.0 17.7 20.9 19.9 6.5 12.5 5.4 5.5 12.9 2.9 6.9 12.2 12.7 URI1 "C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI" ENSG00000105176 "URI1, prefoldin like chaperone" O94763 19 29923644-30016608 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Protein phosphatase inhibitor, Repressor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 391.0;Late spermatids: 335.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071709 Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA071709: AB_2686434" "unprognostic (4.22e-2)" "unprognostic (2.75e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.96e-2)" "unprognostic (2.98e-1)" "unprognostic (1.40e-3)" "unprognostic (8.12e-2)" "unprognostic (1.26e-2)" "unprognostic (4.42e-3)" "unprognostic (1.57e-1)" "unprognostic (3.71e-1)" "unprognostic (1.33e-1)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" 16.4 21.2 19.7 15.9 21.5 17.8 21.0 21.7 19.8 18.4 18.0 18.9 16.6 12.9 19.7 19.4 20.5 17.7 14.2 17.5 19.2 16.5 16.6 22.9 13.0 20.7 22.7 15.4 26.3 21.8 21.8 28.8 15.0 21.1 22.6 18.8 12.7 16.7 18.5 45.0 25.3 17.7 15.7 28.3 18.7 14.0 69.2 22.8 21.0 32.1 14.5 20.3 18.6 17.2 6.6 3.1 3.8 2.5 3.7 6.2 1.4 22.7 31.0 14.6 22.6 10.4 15.2 24.6 14.9 12.6 10.9 12.6 16.3 15.1 35.5 29.6 17.3 8.7 16.2 30.8 19.1 24.9 24.6 17.6 32.2 15.4 21.0 15.0 31.0 13.8 13.3 26.2 9.5 35.8 11.8 8.1 21.2 38.2 10.0 13.7 19.5 20.2 13.1 13.6 29.7 9.5 20.0 27.1 14.3 7.2 27.1 23.5 18.5 17.0 20.7 21.8 16.2 8.6 19.6 10.5 27.0 24.0 13.1 22.5 27.6 29.7 24.0 13.3 27.4 16.2 3.8 2.4 3.2 5.7 2.5 4.8 3.5 5.1 5.8 2.0 6.6 6.2 6.1 0.3 3.7 2.3 3.1 3.8 1.4 19.7 21.5 21.7 19.8 19.2 16.5 22.7 15.4 21.1 22.8 41.7 32.1 25.5 69.0 50.6 54.2 48.9 40.8 46.8 36.4 38.4 23.6 16.4 89.5 13.7 391.0 26.4 17.0 0.0 23.9 21.7 30.1 73.3 29.0 41.9 13.6 49.3 27.7 27.6 28.0 335.1 40.6 27.0 30.4 9.0 34.9 44.1 17.2 24.6 38.9 64.7 59.6 12.9 29.4 63.7 50.0 64.4 11.0 35.4 30.6 76.8 UROD ENSG00000126088 "Uroporphyrinogen decarboxylase" P06132 1 45012147-45015575 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" "Decarboxylase, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Erythroid cells: 607.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 81.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027468, HPA028668, HPA030350" Uncertain Supported Nucleoplasm,Cytosol NA NA 5200000 "Nucleoplasm, Cytosol" "HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440" "unprognostic (5.90e-2)" "unprognostic (2.94e-2)" "unprognostic (2.49e-1)" "unprognostic (9.61e-2)" "unprognostic (7.94e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (2.48e-4)" "unprognostic (2.31e-2)" "unprognostic (4.76e-2)" "unprognostic (6.75e-2)" "unprognostic (7.72e-3)" "unprognostic (3.92e-1)" "unprognostic (1.24e-1)" "unprognostic (4.68e-2)" "unprognostic (1.41e-1)" "unprognostic (8.73e-2)" "unprognostic (8.12e-2)" 20.7 50.2 23.1 12.2 26.2 67.5 20.7 14.2 28.6 17.7 24.2 16.5 25.9 11.2 27.8 22.6 17.8 20.8 17.4 34.0 21.1 20.3 29.6 58.1 14.3 14.8 21.6 22.9 27.4 18.4 35.9 17.6 25.8 16.2 19.2 12.3 24.3 45.6 19.2 28.8 12.1 13.2 22.9 18.9 16.6 15.0 16.3 11.5 17.2 26.3 23.6 16.0 15.0 13.0 25.7 48.6 20.6 36.3 26.0 27.4 35.6 12.7 8.4 13.4 17.7 23.3 21.9 6.5 15.6 40.4 33.0 25.4 12.1 6.8 9.1 16.6 23.7 23.3 6.6 25.6 30.5 23.0 8.1 26.9 47.0 19.4 39.9 27.1 14.3 8.7 22.7 19.4 31.4 25.5 24.4 42.3 17.6 81.5 10.0 31.4 10.7 9.7 12.4 20.9 10.2 29.7 14.7 20.0 13.1 28.7 10.9 14.4 11.3 17.1 12.9 26.4 15.9 10.1 15.0 27.3 18.8 14.7 6.5 25.2 10.4 11.1 7.6 29.4 21.7 9.4 17.6 36.3 20.6 19.7 25.8 20.0 25.7 23.8 19.2 48.6 23.7 22.3 20.3 6.6 26.0 15.5 32.4 27.4 35.6 23.1 26.2 14.2 28.6 21.1 20.3 21.6 22.9 16.2 11.5 41.7 38.9 45.2 26.1 20.4 23.6 60.9 40.8 22.7 18.2 26.2 15.7 83.3 76.3 62.1 7.2 47.7 22.7 607.3 55.7 45.2 63.6 19.5 50.8 86.0 88.6 12.7 17.2 30.7 34.3 12.5 73.6 37.9 45.5 163.3 18.4 80.8 47.4 21.8 52.6 99.3 21.8 38.8 41.5 35.1 38.5 21.7 41.6 21.8 17.4 22.2 UROS ENSG00000188690 "Uroporphyrinogen III synthase" P10746 10 125784980-125823248 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 186.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044038 Approved Approved Nucleoplasm,Cytosol NA NA 15000 Nucleoplasm Cytosol "HPA044038: AB_10966692" "unprognostic (8.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.77e-1)" "unprognostic (7.19e-2)" "unprognostic (1.90e-1)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (5.82e-2)" "unprognostic (1.27e-1)" "unprognostic (4.35e-3)" "unprognostic (4.23e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.68e-1)" "unprognostic (3.93e-1)" 13.8 16.1 48.6 9.0 46.6 33.2 13.9 12.8 35.3 8.9 11.4 15.7 12.8 13.2 9.3 41.2 10.5 11.3 11.5 31.4 36.9 20.4 22.6 25.5 10.0 16.8 22.7 23.4 14.5 14.1 14.4 12.0 7.9 20.0 12.9 12.4 14.0 18.1 14.0 45.6 9.8 12.0 13.0 12.5 11.7 12.5 13.8 13.8 10.8 16.4 14.4 12.7 9.4 6.3 17.3 27.1 2.4 15.6 24.7 21.3 17.8 17.7 19.3 14.1 31.2 18.8 19.1 19.0 23.0 39.8 16.2 16.2 8.3 21.6 24.8 10.7 28.5 11.3 10.2 8.1 16.3 15.2 30.6 15.5 52.7 10.9 13.7 26.6 22.2 12.4 23.9 9.4 11.3 30.3 22.5 14.8 18.4 9.1 23.6 27.0 21.2 19.4 25.0 15.3 13.3 20.1 13.8 15.5 14.7 21.2 11.0 11.0 19.0 23.0 17.8 31.2 15.0 15.8 21.2 14.7 21.5 8.0 16.5 19.5 21.8 15.8 16.9 29.9 9.0 10.1 2.4 15.6 2.2 16.1 15.4 18.5 15.7 16.0 20.4 27.1 17.3 21.3 16.3 1.2 24.7 14.6 12.9 14.2 17.8 48.6 46.6 12.8 35.3 36.9 20.4 22.7 23.4 20.0 13.8 17.9 20.2 41.0 10.4 8.2 45.4 60.5 33.1 20.1 17.0 34.9 43.2 49.6 86.2 49.2 45.5 19.3 27.7 186.9 52.4 38.4 25.6 22.0 11.5 53.9 68.9 44.5 13.9 27.6 41.0 95.8 33.1 23.1 59.1 66.7 19.6 51.6 42.5 10.5 38.2 117.1 33.3 6.5 28.2 41.5 71.3 11.2 16.7 38.9 37.7 19.7 USH1C "AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C" ENSG00000006611 "USH1 protein network component harmonin" Q9Y6N9 11 17493895-17544416 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Hearing" "Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 26.0;intestine: 57.0;kidney: 22.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 240.3;Muller glia cells: 140.5;Paneth cells: 192.9;Proximal tubular cells: 119.4;Undifferentiated cells: 94.1" "Group enriched" "Detected in many" 7 "colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 31.4;HeLa: 11.2;OE19: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013690, HPA027398, HPA027492, HPA028033" Enhanced Enhanced Cytosol No NA Cytosol "CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782" "unprognostic (3.60e-2)" "unprognostic (6.19e-2)" "unprognostic (2.36e-1)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.22e-1)" "unprognostic (2.78e-1)" "unprognostic (1.51e-2)" "unprognostic (9.65e-2)" "prognostic favorable (9.41e-4)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (1.62e-1)" "unprognostic (2.61e-1)" 0.1 0.1 1.6 4.3 7.1 0.0 0.0 0.8 3.3 0.1 23.8 6.2 0.0 40.5 0.0 6.3 0.0 1.3 26.0 0.3 5.0 2.3 22.1 0.4 0.0 0.0 4.8 1.9 0.3 2.1 0.0 5.2 0.0 3.5 0.1 20.7 1.8 0.0 0.1 0.0 0.0 57.0 0.9 10.2 0.0 11.5 0.2 3.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 31.4 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 7.1 0.8 2.3 5.0 2.3 4.8 1.9 3.5 3.6 0.0 0.0 0.8 0.0 0.0 0.7 0.6 48.4 0.0 1.2 5.2 2.0 0.0 18.3 18.8 1.0 0.0 240.3 0.0 25.0 0.0 0.0 0.0 4.6 0.0 0.0 1.6 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.4 140.5 34.3 192.9 0.0 119.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 94.1 0.0 USP10 "KIAA0190, UBPO" ENSG00000103194 "Ubiquitin specific peptidase 10" Q14694 16 84699978-84779922 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 105.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 105.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 105.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006731, HPA006749" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA006731: AB_1080495, HPA006749: AB_1080492" "unprognostic (4.14e-2)" "unprognostic (2.28e-1)" "unprognostic (2.36e-2)" "unprognostic (4.85e-2)" "unprognostic (6.93e-2)" "unprognostic (1.77e-3)" "unprognostic (1.03e-3)" "unprognostic (2.91e-3)" "unprognostic (1.75e-1)" "unprognostic (3.84e-2)" "unprognostic (2.56e-2)" "unprognostic (1.82e-3)" "prognostic favorable (1.00e-4)" "unprognostic (5.91e-2)" "unprognostic (4.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.38e-1)" 13.9 18.8 16.0 24.2 19.0 13.4 14.4 24.4 20.4 15.9 18.1 15.6 8.4 16.1 20.2 10.4 19.7 18.2 12.0 16.4 19.3 15.1 16.4 20.7 13.7 18.8 19.7 17.4 18.5 17.1 35.8 15.0 23.5 16.2 15.0 15.6 17.9 15.3 17.8 47.0 17.0 17.5 20.2 16.3 16.0 15.0 15.5 16.2 20.4 17.6 15.7 20.9 19.7 15.8 7.2 10.4 105.5 8.6 7.7 17.3 10.0 13.9 19.3 18.8 23.3 6.9 11.8 25.4 13.8 14.6 23.4 12.9 27.2 12.2 24.2 16.0 14.4 11.7 16.0 26.1 21.9 31.2 9.8 13.7 13.9 9.1 18.0 9.2 20.6 8.4 7.4 17.0 24.4 28.3 13.9 17.9 16.2 37.9 5.3 16.2 29.2 21.3 10.0 22.6 15.6 13.1 27.8 10.3 11.5 14.7 11.4 17.6 10.4 33.0 10.7 9.3 17.2 24.7 13.2 13.1 16.3 13.0 8.2 13.1 8.9 12.3 61.4 10.5 13.3 16.6 2.5 8.6 1.6 5.7 7.0 6.8 7.2 17.3 6.3 10.4 6.7 9.9 6.0 105.5 7.7 6.3 3.5 6.1 10.0 16.0 19.0 24.4 20.4 19.3 15.1 19.7 17.4 16.2 16.2 50.6 41.3 27.5 36.9 45.7 24.1 56.0 25.5 124.5 62.6 26.2 27.5 85.2 26.6 26.4 61.2 28.2 27.5 23.3 21.5 65.0 33.0 35.8 53.5 33.4 27.3 19.1 27.7 27.0 34.9 79.4 21.9 31.0 23.6 27.9 26.5 20.1 22.1 17.5 21.2 35.6 48.5 25.8 38.2 32.5 29.0 43.3 50.9 25.4 33.2 36.5 USP11 UHX1 ENSG00000102226 "Ubiquitin specific peptidase 11" P51784 X 47232690-47248328 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 74.0" "Cell type enhanced" "Detected in all" 6 "Bipolar cells: 178.6;Horizontal cells: 131.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003103, HPA037536" Enhanced Supported Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA003103: AB_10671088, HPA037536: AB_10672904" "unprognostic (1.60e-1)" "unprognostic (2.77e-3)" "unprognostic (5.84e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.08e-2)" "unprognostic (2.02e-1)" "unprognostic (6.11e-3)" "unprognostic (9.21e-2)" "unprognostic (3.18e-2)" "unprognostic (3.52e-1)" "unprognostic (3.29e-3)" "unprognostic (3.74e-2)" "prognostic favorable (4.13e-5)" "unprognostic (3.14e-2)" "unprognostic (9.23e-2)" "unprognostic (9.51e-2)" "unprognostic (7.11e-2)" 11.5 17.3 32.9 11.5 55.0 4.9 9.4 35.7 74.0 17.5 9.1 19.9 5.8 6.0 22.6 12.7 9.7 26.6 12.8 20.6 27.0 44.0 13.6 6.7 12.5 13.8 23.1 47.4 38.2 13.8 28.4 32.3 12.6 27.8 15.7 7.6 17.9 9.3 21.3 13.7 7.8 7.3 19.1 17.0 13.5 9.1 19.2 14.6 19.0 27.2 4.3 14.3 11.0 9.8 21.0 20.6 22.8 8.7 19.8 31.7 16.4 14.4 22.8 39.3 26.7 14.9 10.0 10.9 11.1 17.5 22.1 24.7 21.7 11.9 9.6 8.8 20.0 23.6 17.3 31.8 7.8 19.7 14.8 24.1 11.2 18.1 19.2 17.3 12.6 23.4 14.3 3.3 23.3 10.0 12.4 8.8 22.5 8.3 1.3 17.2 22.0 24.3 13.4 29.2 7.9 20.3 27.4 38.5 8.0 10.8 20.0 22.3 38.1 20.3 4.1 12.0 26.2 8.6 7.2 9.2 18.6 19.7 26.2 12.6 17.8 11.2 16.7 11.6 15.7 16.6 22.8 3.5 7.4 22.6 7.4 19.9 20.1 10.2 22.1 4.6 21.0 15.4 31.7 2.2 19.8 8.7 20.6 12.7 16.4 32.9 55.0 35.7 74.0 27.0 44.0 23.1 47.4 27.8 14.6 20.8 15.3 34.1 35.1 12.0 178.6 20.7 12.7 41.5 29.6 31.4 53.0 16.9 43.1 13.8 20.4 19.6 7.8 23.3 9.0 11.2 33.9 14.4 45.0 6.6 12.0 131.9 34.0 23.4 8.8 28.3 27.3 12.9 27.0 26.2 7.9 89.6 11.0 7.0 39.6 12.5 53.1 25.8 33.0 11.7 38.3 5.6 13.6 30.6 8.0 25.7 USP13 IsoT-3 ENSG00000058056 "Ubiquitin specific peptidase 13" Q92995 3 179652755-179789401 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 34.8;skeletal muscle: 90.3" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 182.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "MAIT T-cell: 15.4" "Lineage enriched" "Detected in many" 8 "T-cells: 15.4" "Cell line enhanced" "Detected in many" "HDLM-2: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004827 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA004827: AB_1080497" "unprognostic (1.00e-2)" "unprognostic (2.09e-1)" "unprognostic (5.82e-2)" "unprognostic (7.14e-2)" "unprognostic (9.94e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (7.79e-2)" "unprognostic (1.69e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (4.93e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.06e-4)" 6.4 7.5 2.0 2.3 2.8 0.8 3.5 2.9 4.1 2.7 2.1 4.6 1.5 0.7 3.2 3.8 2.6 2.5 2.5 34.8 2.0 2.3 2.3 3.4 6.0 2.5 2.1 2.1 7.2 3.0 3.3 9.8 1.9 3.0 3.0 1.8 3.1 3.3 2.1 90.3 1.8 1.7 3.7 2.5 1.6 1.6 5.6 1.3 1.7 5.5 17.1 3.2 2.6 1.9 2.0 1.9 0.0 0.4 0.0 15.4 0.7 12.5 5.4 10.2 7.8 4.6 6.4 4.9 7.4 8.5 10.9 9.2 7.9 4.4 15.5 8.3 8.9 12.3 0.9 11.4 4.5 13.0 36.6 4.9 4.1 8.1 7.4 3.3 11.4 0.0 6.9 1.6 8.5 10.8 5.3 8.7 6.1 2.0 20.0 9.0 8.2 6.9 2.1 7.9 1.1 4.9 11.9 10.1 12.7 7.4 3.5 5.8 7.5 7.1 9.5 4.3 3.0 16.4 8.2 9.4 13.2 10.5 11.3 28.4 9.7 8.1 31.7 6.1 7.7 12.2 0.0 0.2 0.0 1.3 0.4 15.4 2.0 1.3 2.9 1.5 0.6 1.0 1.0 0.0 0.0 0.4 1.9 0.6 0.7 2.0 2.8 2.9 4.1 2.0 2.3 2.1 2.1 3.0 1.3 8.9 31.0 4.3 1.7 2.3 12.7 182.3 5.1 2.7 9.1 1.8 5.9 8.7 13.3 1.0 2.1 9.7 0.3 0.0 3.7 1.6 7.1 3.4 2.3 6.8 3.7 15.9 9.2 27.6 3.1 2.0 8.6 4.7 13.5 0.0 1.6 6.3 1.6 5.8 8.9 2.7 9.7 12.9 5.3 5.1 2.1 1.4 4.2 3.2 3.8 1.6 USP14 TGT ENSG00000101557 "Ubiquitin specific peptidase 14" P54578 18 158383-214629 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001308 Approved Supported "Plasma membrane,Cytosol" NA NA 1400000 "Plasma membrane, Cytosol" "HPA001308: AB_1080499" "unprognostic (2.21e-1)" "unprognostic (4.05e-2)" "unprognostic (1.90e-1)" "unprognostic (2.59e-3)" "unprognostic (6.04e-2)" "prognostic unfavorable (7.81e-5)" "prognostic unfavorable (4.30e-5)" "unprognostic (5.14e-2)" "unprognostic (5.00e-2)" "prognostic favorable (7.91e-4)" "unprognostic (1.64e-2)" "unprognostic (2.39e-1)" "unprognostic (1.51e-3)" "unprognostic (2.58e-1)" "unprognostic (1.55e-1)" "unprognostic (2.20e-2)" "unprognostic (3.76e-2)" 24.8 24.2 25.9 20.7 32.1 19.4 21.7 21.7 28.4 16.5 17.1 17.9 19.1 13.4 19.4 24.3 25.3 14.7 14.4 23.3 22.1 27.6 23.2 24.4 15.8 21.9 22.6 28.8 16.2 16.2 22.3 18.0 25.1 29.2 29.9 19.4 14.5 16.7 20.5 53.3 15.7 12.9 23.9 22.1 15.4 15.6 17.2 16.5 19.5 20.1 25.4 28.6 17.8 17.8 13.1 15.2 7.7 15.2 23.0 21.2 11.0 27.1 22.3 19.0 19.3 18.8 18.8 34.0 35.7 19.5 36.3 34.0 29.0 14.5 40.3 27.3 29.2 34.9 15.3 37.4 27.2 41.4 11.4 18.5 22.7 15.0 22.7 18.9 55.7 21.8 15.0 21.1 37.1 21.3 16.8 27.9 19.9 31.2 29.9 35.8 22.0 31.1 15.2 18.5 16.3 26.2 25.9 24.9 29.3 26.8 23.6 22.2 18.6 37.0 17.9 15.2 21.6 17.5 15.1 31.5 42.7 32.3 39.2 50.5 19.8 35.9 40.0 24.6 23.3 26.5 5.0 10.7 7.7 17.8 15.2 21.2 13.1 17.7 18.4 15.2 10.1 17.5 16.9 0.8 23.0 11.4 11.1 16.7 11.0 25.9 32.1 21.7 27.1 22.1 27.6 22.6 28.8 29.2 16.5 20.8 33.1 28.2 36.7 52.1 52.7 40.0 22.9 42.8 51.2 41.8 29.5 80.1 38.1 58.5 41.3 39.3 15.4 23.3 46.8 58.4 42.1 56.1 33.5 39.4 45.0 109.7 21.2 28.3 30.4 14.7 29.4 39.1 33.7 54.1 19.4 35.6 58.1 19.5 43.2 43.1 50.1 0.0 45.7 26.2 61.2 45.8 113.4 38.8 27.3 39.1 USP15 "KIAA0529, UNPH4" ENSG00000135655 "Ubiquitin specific peptidase 15" Q9Y4E8 12 62260338-62417431 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 68.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 68.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006237, HPA006428, HPA071014" Approved Supported "Plasma membrane,Cytosol" NA NA 280000 Cytosol "Plasma membrane" "HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333" "unprognostic (8.18e-2)" "unprognostic (3.22e-1)" "unprognostic (9.63e-2)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (6.59e-2)" "unprognostic (7.70e-3)" "unprognostic (2.19e-1)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.58e-5)" "unprognostic (9.28e-2)" "unprognostic (5.81e-3)" "unprognostic (1.11e-2)" "unprognostic (1.26e-1)" 23.1 16.8 11.5 22.5 11.9 88.9 17.8 21.1 15.7 14.5 14.5 5.2 11.9 11.4 12.7 12.4 16.1 14.1 11.2 15.2 9.6 6.2 13.8 20.4 23.8 26.2 11.6 9.4 22.5 15.8 18.9 22.5 31.0 14.9 12.4 13.8 7.6 16.2 10.7 28.5 23.0 19.7 16.3 16.2 35.6 14.3 20.0 11.0 33.1 14.1 15.4 18.9 18.4 17.9 5.7 6.0 68.5 14.2 3.3 12.1 4.8 9.4 8.9 8.9 7.8 14.1 16.5 16.0 15.4 13.7 13.6 12.2 8.9 9.5 10.1 8.8 13.2 5.8 10.4 11.9 13.4 16.0 11.2 7.3 13.9 7.6 6.8 13.6 22.0 33.8 12.0 14.0 16.1 14.3 12.8 16.2 10.3 45.0 19.6 12.6 10.5 13.1 11.1 13.0 8.6 13.2 8.4 9.4 16.3 12.7 10.9 11.3 5.4 17.8 11.3 8.7 9.7 15.0 13.2 19.3 10.6 10.6 16.5 9.5 9.3 10.4 11.6 12.2 17.9 12.0 27.2 14.2 13.8 3.4 7.3 3.5 5.7 4.6 3.2 4.9 4.7 5.9 3.5 68.5 3.3 5.8 6.0 12.1 4.8 11.5 11.9 21.1 15.7 9.6 6.2 11.6 9.4 14.9 11.0 35.7 31.3 91.0 32.3 52.2 54.5 62.7 17.8 42.8 59.1 22.7 104.1 25.1 10.0 31.3 139.8 44.6 32.3 93.5 36.2 36.1 49.5 31.6 85.6 42.0 41.1 39.7 40.4 22.1 108.1 130.5 57.2 94.6 50.6 36.1 22.9 24.4 41.2 45.6 27.6 19.4 146.4 38.8 56.5 62.9 41.8 67.2 55.0 65.0 23.3 54.9 USP16 Ubp-M ENSG00000156256 "Ubiquitin specific peptidase 16" Q9Y5T5 21 29024629-29054488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 399.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021140 Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021140: AB_1858668" "unprognostic (6.06e-2)" "unprognostic (3.14e-1)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (5.92e-2)" "unprognostic (5.79e-3)" "unprognostic (1.92e-1)" "unprognostic (8.99e-2)" "unprognostic (5.78e-2)" "unprognostic (7.40e-2)" "unprognostic (8.73e-2)" "unprognostic (8.65e-2)" "unprognostic (6.68e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-1)" "unprognostic (2.84e-2)" "unprognostic (1.54e-1)" 25.4 21.7 24.4 27.4 24.2 20.4 22.8 32.4 23.1 24.2 24.3 13.5 23.6 20.4 22.6 28.2 27.1 19.4 17.0 23.8 23.8 22.6 28.4 34.0 16.8 20.7 25.8 19.5 27.3 23.6 31.6 41.6 45.9 25.3 26.0 22.3 13.3 20.6 28.8 35.8 16.1 33.2 26.2 28.6 29.1 20.8 20.1 25.3 37.6 28.4 25.6 25.5 30.8 17.1 30.9 23.5 21.2 20.5 19.9 26.2 10.1 22.0 8.8 14.1 12.6 10.0 16.5 13.3 21.6 14.4 15.0 14.3 11.0 14.4 22.5 6.5 20.7 22.9 10.1 17.4 15.7 19.6 21.6 18.5 30.1 10.7 12.2 14.9 29.5 16.7 14.1 16.6 19.5 18.1 11.1 14.3 12.9 24.7 39.9 17.3 10.1 18.1 10.8 15.0 18.0 11.5 12.2 34.8 25.8 12.3 16.0 15.3 16.3 14.0 22.4 18.9 10.0 15.4 20.2 14.4 17.6 21.8 16.1 22.1 34.1 46.8 23.7 18.3 21.4 17.4 21.2 16.2 20.9 25.4 16.1 19.8 26.4 23.9 22.8 14.9 30.9 26.2 24.8 15.5 19.9 20.5 23.5 24.5 10.1 24.4 24.2 32.4 23.1 23.8 22.6 25.8 19.5 25.3 25.3 80.4 84.0 98.9 106.9 50.8 161.8 74.6 53.5 112.4 87.6 50.6 84.4 70.3 112.7 61.8 399.0 40.7 72.4 23.3 103.3 66.4 62.2 82.7 136.5 77.6 53.4 68.3 79.3 46.1 54.6 89.6 81.1 59.7 59.1 95.6 64.7 103.3 77.6 75.8 81.7 60.8 186.0 58.2 71.0 80.0 64.3 56.2 135.5 69.2 70.2 111.6 USP18 ENSG00000184979 "Ubiquitin specific peptidase 18" Q9UMW8 22 18149899-18177397 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 39.7;Extravillous trophoblasts: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 48.9;BJ hTERT+ SV40 Large T+ RasG12V: 53.2" HPA044768 Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA044768: AB_10963697" "unprognostic (2.06e-1)" "unprognostic (3.55e-2)" "unprognostic (1.57e-2)" "unprognostic (5.04e-3)" "unprognostic (1.40e-2)" "unprognostic (5.42e-2)" "unprognostic (3.29e-2)" "unprognostic (5.11e-3)" "unprognostic (1.81e-1)" "unprognostic (1.79e-3)" "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (4.29e-3)" "unprognostic (2.58e-1)" "unprognostic (2.77e-2)" "unprognostic (2.28e-2)" "unprognostic (8.38e-2)" 20.4 6.4 4.8 13.0 4.8 6.3 15.4 1.9 5.5 5.3 6.3 5.6 3.2 5.2 6.1 9.5 6.0 6.5 7.1 5.4 4.4 4.6 8.8 20.9 14.0 15.9 4.3 4.8 4.9 4.2 3.8 7.8 7.6 4.7 4.8 3.9 5.7 11.7 2.3 9.7 4.2 15.5 4.5 4.1 10.6 6.4 10.6 4.0 22.4 10.6 2.9 7.7 4.3 6.9 4.1 2.9 6.6 8.8 11.0 11.0 4.8 3.7 3.8 1.1 4.9 5.0 3.7 5.0 1.9 4.6 48.9 53.2 0.6 5.3 0.0 3.0 1.0 15.6 1.3 5.7 1.7 1.6 16.7 7.9 7.3 0.5 6.9 0.6 1.7 7.0 1.6 0.6 3.4 0.0 0.2 10.8 5.5 0.3 0.4 0.4 6.4 8.5 4.3 3.4 4.0 2.9 3.4 7.6 0.0 0.9 3.2 4.1 3.2 2.3 4.0 18.2 4.6 2.7 1.7 17.7 0.3 1.0 1.1 1.9 0.9 11.4 0.0 4.4 4.4 2.8 2.7 3.2 6.6 7.8 8.8 10.0 4.1 6.7 10.1 1.6 2.7 7.9 8.8 0.5 11.0 6.6 2.9 11.0 4.8 4.8 4.8 1.9 4.0 4.4 4.6 4.3 4.8 4.7 4.0 8.9 3.7 0.5 3.7 1.4 0.2 0.4 5.1 8.1 6.8 0.0 0.0 4.5 39.7 5.1 1.2 6.0 4.3 0.0 9.9 27.4 3.1 3.8 0.0 4.3 7.7 0.0 2.9 9.2 4.5 1.4 3.4 1.8 3.3 0.0 2.2 3.9 9.2 2.9 6.7 5.7 0.2 6.5 1.2 6.2 0.4 0.9 1.3 1.5 2.8 2.5 USP2 UBP41 ENSG00000036672 "Ubiquitin specific peptidase 2" O75604 11 119355215-119381726 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 79.9" "Group enriched" "Detected in many" 5 "Early spermatids: 399.1;Late spermatids: 802.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enriched" "Detected in many" 4 "U-266/70: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006777, HPA007222" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA006777: AB_1080507, HPA007222: AB_1080505" "unprognostic (6.83e-2)" "unprognostic (2.02e-2)" "unprognostic (5.54e-2)" "unprognostic (1.37e-2)" "unprognostic (1.25e-1)" "unprognostic (7.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.27e-2)" "unprognostic (1.24e-1)" "unprognostic (5.24e-3)" "unprognostic (8.02e-3)" "unprognostic (7.33e-2)" "prognostic favorable (3.09e-11)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (2.66e-2)" 3.1 4.8 6.9 1.4 12.2 1.5 1.6 12.6 16.1 2.5 5.9 10.0 0.0 7.9 2.6 6.4 5.9 7.0 2.2 26.8 5.7 3.1 29.7 10.6 2.2 0.7 5.7 6.2 2.9 10.1 18.4 7.6 1.3 6.7 2.3 3.9 19.1 3.2 2.4 79.9 4.6 11.7 4.2 3.8 0.8 2.7 36.1 8.8 0.0 2.2 25.2 1.0 1.9 2.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 3.5 0.3 0.5 2.0 0.1 0.1 0.8 0.4 0.2 0.0 0.4 3.6 0.5 6.1 1.1 0.6 0.9 0.6 4.8 1.8 0.1 4.2 0.6 1.7 2.6 7.5 1.7 0.0 1.7 0.6 0.3 0.4 1.2 0.8 0.3 4.6 8.4 0.5 1.0 2.4 0.0 0.4 0.9 1.2 0.8 0.0 1.3 0.9 2.8 0.2 7.4 2.2 2.1 1.6 0.4 1.1 5.4 3.7 0.0 0.0 0.9 0.5 0.6 35.2 7.7 0.1 0.0 1.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.3 0.3 6.9 12.2 12.6 16.1 5.7 3.1 5.7 6.2 6.7 8.8 3.0 2.4 0.0 4.5 2.2 73.3 74.6 5.1 42.8 9.1 5.2 90.3 0.3 96.2 2.6 399.1 2.2 31.5 0.0 1.4 0.5 4.6 1.0 0.0 19.8 13.2 9.5 0.0 1.3 1.5 802.9 6.1 1.3 0.0 0.0 1.6 37.9 1.5 10.5 6.7 24.9 128.7 19.4 18.6 19.9 14.9 3.4 1.1 1.5 2.2 2.0 USP20 KIAA1003 ENSG00000136878 "Ubiquitin specific peptidase 20" Q9Y2K6 9 129834698-129881838 "Enzymes, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 42.3;K-562: 25.9;MOLT-4: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006287, HPA007008" Uncertain Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA006287: AB_1080510, HPA007008: " "unprognostic (2.64e-2)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (2.48e-4)" "prognostic favorable (4.01e-4)" "unprognostic (4.69e-1)" "unprognostic (1.89e-2)" "unprognostic (2.25e-1)" "unprognostic (2.55e-3)" "unprognostic (1.24e-1)" "unprognostic (7.89e-2)" "prognostic favorable (1.54e-7)" "unprognostic (2.09e-1)" "prognostic favorable (5.65e-5)" "unprognostic (1.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.19e-2)" "unprognostic (1.24e-2)" 7.8 13.2 10.5 15.2 14.6 24.4 8.5 23.0 19.6 13.2 12.1 12.7 10.2 9.7 13.3 6.2 9.3 11.6 12.5 8.8 10.5 13.7 8.0 7.3 9.1 19.6 9.6 16.1 16.8 12.9 11.5 19.0 8.0 11.9 14.9 6.1 10.8 13.7 17.2 10.2 14.0 11.8 20.0 8.8 14.6 10.2 14.0 8.8 51.5 19.3 4.2 15.3 15.6 10.0 3.8 2.4 4.8 1.7 9.0 10.7 5.4 2.5 2.5 4.4 6.0 5.8 5.0 6.3 4.1 3.5 3.2 2.2 2.1 2.8 3.5 3.6 4.0 3.6 6.5 2.6 3.0 1.3 19.0 3.5 6.5 6.8 1.4 4.1 6.1 4.8 4.4 4.4 4.2 3.1 5.6 3.4 42.3 25.9 4.4 1.9 6.8 23.8 14.5 3.5 5.4 6.0 4.0 5.0 5.9 2.5 2.8 1.0 4.9 4.8 6.2 3.9 2.7 6.4 8.5 5.0 3.5 1.6 4.7 2.7 4.3 6.3 2.4 7.0 8.0 3.3 1.0 1.7 4.8 8.6 1.4 9.3 3.7 8.8 8.3 2.4 3.8 10.4 8.9 2.8 9.0 1.3 2.1 10.7 5.4 10.5 14.6 23.0 19.6 10.5 13.7 9.6 16.1 11.9 8.8 8.9 8.6 3.2 2.3 2.5 7.9 5.9 2.5 4.0 2.3 1.8 3.9 5.1 3.3 2.2 1.1 2.4 4.0 0.0 3.4 2.1 3.8 3.0 1.1 5.6 3.0 9.5 8.1 7.4 2.1 2.8 5.8 3.1 3.3 3.6 4.6 5.8 2.3 3.7 4.6 2.2 5.9 0.0 6.2 12.2 4.4 1.8 5.1 11.3 5.1 1.4 USP21 "USP16, USP23" ENSG00000143258 "Ubiquitin specific peptidase 21" Q9UK80 1 161159450-161165723 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028397 Uncertain Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028397: AB_10603227" "unprognostic (9.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.22e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (5.35e-2)" "unprognostic (6.73e-2)" "unprognostic (2.76e-2)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (9.50e-6)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (2.13e-2)" "prognostic favorable (3.35e-5)" 11.8 16.4 22.1 12.8 21.2 15.3 19.1 23.6 24.8 18.1 16.1 25.5 14.0 15.5 19.7 14.6 18.3 33.3 14.1 13.7 20.9 12.1 15.4 10.6 14.0 16.7 26.4 14.1 28.3 19.0 24.4 17.2 15.2 20.5 18.1 13.1 17.1 19.0 25.3 19.4 23.5 15.4 15.1 17.0 18.7 16.0 17.0 22.9 16.0 24.5 9.6 15.6 17.9 19.2 14.1 12.0 18.3 11.1 13.4 17.2 10.7 7.4 12.9 16.9 16.3 13.5 11.3 10.4 5.5 9.0 15.2 11.9 11.8 14.7 9.8 9.5 6.8 9.5 12.9 10.9 10.7 8.4 18.6 18.4 11.6 18.6 9.2 9.8 10.3 8.7 9.5 14.4 10.4 15.1 17.2 10.7 21.7 17.2 13.6 9.7 13.7 18.2 16.2 15.8 14.6 16.4 17.3 5.6 16.4 8.9 8.9 15.4 19.9 10.3 10.9 8.3 13.2 23.9 16.7 6.3 10.9 9.8 7.6 9.4 27.6 21.3 14.5 10.0 8.9 9.8 13.0 11.1 18.3 14.9 7.1 17.2 12.8 13.8 15.4 12.0 14.1 16.0 14.6 9.6 13.4 7.7 12.0 13.3 10.7 22.1 21.2 23.6 24.8 20.9 12.1 26.4 14.1 20.5 22.9 0.0 3.0 1.7 1.5 1.3 3.9 2.2 10.2 10.7 3.4 1.8 5.9 3.6 1.7 1.4 0.6 2.8 2.0 0.0 2.0 2.1 2.4 2.0 2.3 1.7 1.9 0.0 5.2 6.2 7.6 0.4 4.6 1.7 1.7 0.0 4.1 3.0 1.7 2.9 3.9 1.8 4.4 6.5 1.9 3.6 2.7 1.3 2.6 2.5 3.7 1.4 USP24 KIAA1057 ENSG00000162402 "Ubiquitin specific peptidase 24" Q9UPU5 1 55066359-55215113 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 46.0" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026723, HPA028428, HPA067124" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785" "unprognostic (2.28e-1)" "unprognostic (9.81e-3)" "unprognostic (4.70e-3)" "unprognostic (4.86e-3)" "unprognostic (9.31e-3)" "unprognostic (4.84e-3)" "prognostic unfavorable (1.34e-7)" "unprognostic (2.04e-1)" "unprognostic (6.93e-2)" "unprognostic (2.98e-1)" "unprognostic (5.08e-2)" "unprognostic (1.86e-1)" "unprognostic (8.12e-2)" "unprognostic (1.79e-1)" "unprognostic (6.42e-2)" "unprognostic (4.12e-2)" "unprognostic (1.64e-1)" 12.3 7.6 7.5 12.1 8.8 30.1 10.6 20.1 8.5 7.8 10.2 6.8 10.6 5.0 10.1 7.0 7.7 6.9 7.0 14.7 7.9 6.4 10.4 9.3 7.6 12.7 8.0 5.6 10.9 7.3 15.5 16.9 5.8 6.9 7.6 8.5 5.1 9.7 10.7 46.0 8.9 8.7 7.3 6.2 10.9 7.8 4.9 8.7 16.4 7.4 11.5 12.7 9.7 13.7 6.0 10.5 5.9 2.2 3.8 4.5 1.1 17.7 9.8 12.3 6.6 16.0 14.1 14.2 7.9 9.9 11.4 11.9 13.9 6.3 14.3 8.7 14.6 23.4 14.4 16.3 13.3 17.9 14.9 9.8 28.6 21.4 16.3 9.5 19.7 22.2 12.3 11.8 17.2 19.6 11.0 10.3 14.6 26.3 6.0 15.1 4.2 11.8 10.5 18.0 8.6 11.9 12.3 15.7 6.2 19.8 12.0 10.8 7.6 13.4 9.6 11.7 19.5 6.7 9.8 13.9 10.4 10.1 12.5 12.5 7.6 5.6 18.8 9.9 16.4 9.3 5.9 2.0 2.5 4.5 1.8 2.8 4.8 3.5 3.5 1.8 6.0 3.2 4.2 2.3 3.8 2.2 10.5 1.9 1.1 7.5 8.8 20.1 8.5 7.9 6.4 8.0 5.6 6.9 8.7 14.9 18.3 14.2 7.0 13.3 12.9 28.1 10.2 8.1 15.9 12.2 68.7 3.6 0.0 8.8 0.4 13.1 6.8 0.0 8.7 6.5 9.6 9.6 12.7 10.9 8.4 36.5 16.6 10.4 17.5 1.3 10.9 12.2 10.1 12.6 16.4 7.1 9.9 11.5 7.4 4.5 16.7 6.5 10.5 8.6 5.8 15.1 1.3 17.1 14.9 8.6 USP25 USP21 ENSG00000155313 "Ubiquitin specific peptidase 25" Q9UHP3 21 15730025-15880069 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 124.6;Late spermatids: 145.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018297, HPA024142" Approved Supported Cytosol NA NA Cytosol "HPA018297: AB_1858672, HPA024142: AB_1858673" "unprognostic (6.35e-2)" "unprognostic (1.50e-1)" "unprognostic (6.90e-2)" "unprognostic (6.29e-2)" "unprognostic (1.39e-1)" "unprognostic (2.88e-2)" "unprognostic (3.91e-2)" "unprognostic (1.65e-1)" "unprognostic (1.44e-2)" "unprognostic (1.38e-1)" "unprognostic (2.33e-2)" "unprognostic (1.40e-1)" "unprognostic (8.24e-3)" "unprognostic (2.34e-3)" "unprognostic (4.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.32e-2)" 14.9 8.5 11.0 14.2 15.5 12.4 28.7 11.3 11.1 17.5 11.8 6.6 17.8 6.5 20.7 14.5 12.6 10.6 10.1 17.8 9.9 5.8 12.9 10.4 22.1 14.8 7.6 7.1 14.5 8.2 8.1 8.4 17.7 7.7 12.9 8.6 7.8 11.4 13.6 56.3 8.3 12.3 19.2 7.3 11.6 9.0 26.1 7.5 16.5 10.5 14.6 9.6 13.8 18.1 3.1 2.8 5.8 2.9 2.3 7.2 1.6 13.2 10.0 9.5 1.4 17.6 26.3 11.2 9.5 9.5 7.1 9.0 8.8 7.6 14.3 14.1 15.0 10.8 7.1 7.3 12.6 9.9 14.2 8.4 11.7 10.6 6.7 29.2 15.4 5.4 17.0 15.4 11.4 33.2 18.7 24.9 13.1 15.0 27.1 12.8 5.5 17.6 2.9 11.7 5.3 8.9 13.5 8.8 10.8 19.3 3.6 2.1 5.7 13.6 11.5 8.8 12.1 6.1 9.1 23.6 11.1 7.2 11.6 5.3 7.9 4.8 11.4 7.2 6.9 8.1 0.0 2.9 3.6 4.0 2.8 4.4 3.1 3.4 7.2 2.5 2.2 3.2 4.8 5.8 2.3 2.5 2.8 4.4 1.6 11.0 15.5 11.3 11.1 9.9 5.8 7.6 7.1 7.7 7.5 53.6 22.7 11.5 16.1 15.1 5.7 52.1 10.2 25.4 31.8 21.0 3.9 27.3 5.0 7.8 124.6 19.1 12.8 0.0 11.4 6.8 16.0 19.0 5.8 17.3 11.9 4.8 9.2 17.2 23.7 145.9 17.5 18.8 15.1 6.4 11.9 4.2 10.4 7.0 12.0 12.2 6.0 19.4 15.5 9.8 5.3 16.8 27.7 17.5 10.2 20.5 USP31 KIAA1203 ENSG00000103404 "Ubiquitin specific peptidase 31" Q70CQ4 16 23061406-23149270 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 55.8;Basal keratinocytes: 59.3;Spermatogonia: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006937 Uncertain Approved Cytosol NA NA Cytosol "HPA006937: AB_1080523" "unprognostic (6.45e-2)" "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.43e-3)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.52e-1)" "unprognostic (6.15e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.41e-5)" "unprognostic (5.59e-2)" "unprognostic (3.75e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-3)" 6.3 5.3 11.2 4.0 16.6 7.1 8.7 12.7 16.5 10.9 4.9 19.7 2.6 3.7 15.3 7.7 9.3 6.5 4.1 11.0 9.0 6.3 6.2 7.7 7.3 3.6 24.6 8.1 3.7 6.3 20.6 10.4 7.4 17.4 9.6 4.9 2.8 6.0 8.5 10.9 15.9 3.4 14.2 14.8 2.8 3.5 20.7 19.3 1.7 4.2 2.4 4.9 13.4 9.5 0.5 0.8 0.6 1.3 0.1 2.1 0.2 9.5 10.1 2.9 4.0 5.3 4.2 2.7 3.3 3.0 4.3 5.2 6.4 5.8 3.2 3.6 4.2 7.0 12.6 7.2 13.1 7.1 2.3 2.9 1.3 5.8 13.4 6.7 3.3 3.6 3.5 11.3 8.0 18.5 1.6 7.6 3.2 3.9 10.0 5.8 6.5 1.6 2.8 5.8 3.2 3.1 7.9 8.2 6.4 6.4 14.3 7.8 5.1 5.2 10.3 2.9 3.4 4.1 7.4 4.5 8.8 6.5 4.4 9.0 3.3 5.4 3.4 6.3 4.5 3.5 0.1 0.7 0.6 0.8 0.3 2.1 0.1 0.7 1.5 0.8 0.5 0.8 0.8 0.1 0.1 1.3 0.2 1.3 0.2 11.2 16.6 12.7 16.5 9.0 6.3 24.6 8.1 17.4 19.3 6.0 3.0 6.1 55.8 59.3 12.6 9.2 10.2 8.1 7.9 5.2 2.0 11.1 0.0 6.1 3.6 14.6 1.4 0.0 7.2 6.2 5.4 14.2 1.1 25.0 4.2 0.0 4.6 7.4 3.1 8.9 7.2 2.9 6.8 1.0 3.5 4.8 7.6 0.0 4.2 9.1 7.4 19.4 7.1 23.8 60.3 23.2 6.3 1.3 5.2 19.5 USP32 "NY-REN-60, USP10" ENSG00000170832 "Ubiquitin specific peptidase 32" Q8NFA0 17 60179094-60422470 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.4" "Cell type enhanced" "Detected in all" 11 "Cone photoreceptor cells: 227.8;Rod photoreceptor cells: 128.6;Spermatocytes: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 28.4" "Group enriched" "Detected in many" 10 "dendritic cells: 28.4;granulocytes: 13.5" "Cell line enhanced" "Detected in all" "MCF7: 61.6" HPA044365 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA044365: AB_2678914" "unprognostic (4.10e-2)" "unprognostic (3.38e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.90e-3)" "unprognostic (2.33e-2)" "unprognostic (2.24e-1)" "unprognostic (3.93e-1)" "unprognostic (6.49e-2)" "unprognostic (2.78e-1)" "unprognostic (2.82e-1)" "unprognostic (1.97e-1)" "unprognostic (7.23e-2)" "unprognostic (8.35e-2)" "unprognostic (4.16e-2)" 9.5 13.9 17.3 10.8 19.5 20.6 10.9 14.6 20.3 8.0 8.5 18.9 7.9 7.2 8.2 5.4 13.1 7.4 9.1 11.1 14.7 12.2 15.5 19.7 12.5 8.6 18.8 14.3 7.4 8.5 17.3 11.4 9.8 19.2 8.7 8.9 11.6 8.2 9.0 23.0 12.2 7.2 9.8 16.5 12.1 8.1 58.4 18.1 7.3 15.6 7.9 8.5 8.8 8.5 1.4 28.4 13.5 2.1 0.6 1.1 0.9 11.1 12.7 6.8 10.8 17.2 16.2 6.4 9.1 13.8 12.0 15.4 6.6 7.3 6.9 7.7 16.8 19.3 5.9 11.5 12.6 21.2 5.2 5.1 13.8 10.1 7.2 17.1 10.9 12.6 15.1 9.3 16.1 14.9 12.4 13.1 8.3 13.9 5.7 14.8 61.6 11.0 7.7 7.9 10.7 6.1 5.3 17.9 4.1 12.6 8.1 4.8 7.2 7.6 2.2 11.7 12.3 9.4 15.2 11.0 18.2 19.0 11.4 8.5 5.9 11.2 6.5 9.1 8.6 11.8 4.3 2.1 7.2 1.0 1.8 0.7 1.4 0.7 0.8 4.1 1.1 0.5 1.0 13.5 0.6 2.0 28.4 1.1 0.9 17.3 19.5 14.6 20.3 14.7 12.2 18.8 14.3 19.2 18.1 6.0 13.1 7.7 11.6 23.9 16.9 7.6 5.1 6.7 13.6 5.2 227.8 4.3 3.3 9.0 69.1 8.4 6.8 23.3 6.3 5.3 10.4 9.3 11.5 10.6 16.5 12.7 7.9 9.2 33.2 25.6 12.0 27.7 5.0 14.4 4.2 10.3 8.4 9.1 5.3 3.7 128.6 25.8 9.5 100.3 9.1 19.2 4.1 12.9 4.4 7.1 USP38 "HP43.8KD, KIAA1891" ENSG00000170185 "Ubiquitin specific peptidase 38" Q8NB14 4 143184917-143223830 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036990, HPA047948" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA036990: AB_2675419, HPA047948: AB_2680220" "unprognostic (5.01e-2)" "unprognostic (2.45e-1)" "unprognostic (2.04e-3)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (2.61e-2)" "unprognostic (1.67e-1)" "unprognostic (7.49e-2)" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (8.03e-2)" "unprognostic (7.72e-3)" "prognostic favorable (1.20e-4)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" 7.7 7.8 6.6 6.6 6.5 19.1 8.3 7.4 7.8 7.9 12.1 8.6 8.8 8.8 8.3 7.1 8.6 7.1 7.6 12.5 6.6 5.3 9.3 15.2 12.7 11.1 10.3 5.1 6.3 8.8 10.0 6.2 11.4 5.9 6.6 6.6 7.1 7.2 7.0 45.3 8.9 13.2 6.5 10.8 10.6 7.4 7.5 8.2 22.6 8.6 10.2 8.4 7.8 8.8 6.3 8.1 12.5 5.7 12.3 9.9 5.0 4.8 4.5 4.0 6.9 5.3 5.3 3.0 7.7 7.5 7.2 6.1 13.1 7.2 6.0 5.5 6.5 4.6 3.8 9.5 7.7 5.9 14.6 6.1 5.5 5.4 2.8 7.3 11.1 5.5 6.4 7.1 7.3 5.9 5.1 7.1 6.9 11.9 18.9 4.7 7.7 14.5 2.1 3.6 9.8 8.9 9.5 6.0 5.7 4.6 5.6 8.2 7.4 6.0 10.5 6.7 3.1 6.4 4.2 8.4 6.6 5.4 5.7 8.0 21.1 35.7 10.9 6.7 8.5 5.5 12.5 5.4 11.7 7.5 5.7 9.6 6.3 6.6 6.5 8.1 5.7 6.7 5.7 5.4 12.3 5.7 3.5 9.9 5.0 6.6 6.5 7.4 7.7 6.6 5.3 10.3 5.1 5.9 8.2 20.8 13.7 10.5 16.5 47.6 7.5 15.1 7.6 13.4 14.8 0.0 11.8 10.9 1.7 7.5 27.8 12.0 18.4 0.0 6.6 5.8 9.7 16.1 3.5 32.7 9.2 7.9 29.4 17.8 14.5 15.4 6.4 12.2 11.8 1.8 19.9 13.6 8.5 11.5 8.9 14.2 8.2 12.9 15.1 9.5 5.1 51.7 22.3 13.4 14.5 38.1 USP4 "UNP, Unph" ENSG00000114316 "Ubiquitin specific peptidase 4" Q13107 3 49277831-49340712 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 100.2;Late spermatids: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018499 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA018499: AB_1858689" "unprognostic (2.34e-3)" "unprognostic (1.52e-1)" "unprognostic (2.22e-3)" "unprognostic (6.12e-2)" "unprognostic (3.51e-1)" "unprognostic (4.33e-2)" "unprognostic (9.42e-2)" "prognostic favorable (4.46e-5)" "unprognostic (3.54e-1)" "unprognostic (9.07e-3)" "unprognostic (2.78e-2)" "unprognostic (1.70e-3)" "prognostic favorable (4.29e-5)" "unprognostic (7.30e-2)" "unprognostic (1.00e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 22.1 18.4 21.4 22.4 29.3 41.4 23.1 30.3 32.5 20.7 20.1 26.8 16.9 16.1 23.6 20.9 23.5 19.3 17.5 22.8 22.2 18.0 20.2 18.5 25.7 25.5 20.2 17.5 23.6 17.1 23.6 19.7 22.1 24.3 20.9 21.9 23.6 19.1 21.3 25.7 27.6 19.4 25.9 20.4 30.6 17.7 25.0 19.7 36.8 21.2 14.1 42.4 22.1 22.0 17.0 24.1 59.4 27.3 21.5 18.6 22.2 6.4 7.4 10.2 13.6 19.0 20.4 6.9 17.5 15.6 22.7 20.5 7.8 16.2 12.4 7.0 25.5 13.1 8.7 13.6 24.8 21.2 19.1 4.0 27.5 14.7 8.7 27.9 14.5 15.9 20.9 10.9 24.9 20.5 16.5 26.2 14.1 9.6 19.7 21.0 10.9 17.1 24.6 8.7 8.0 12.9 7.1 6.4 10.8 17.8 13.3 8.5 11.4 12.7 9.0 6.5 10.7 6.2 23.3 23.2 15.3 8.3 19.1 10.2 15.8 7.6 18.1 13.7 23.0 17.5 18.0 27.3 30.0 16.9 22.1 18.6 17.0 17.6 16.9 24.1 14.1 17.1 15.0 59.4 21.5 24.4 9.6 18.6 22.2 21.4 29.3 30.3 32.5 22.2 18.0 20.2 17.5 24.3 19.7 38.7 21.4 18.1 15.0 16.7 16.6 15.3 15.3 33.5 25.0 19.2 19.6 18.9 18.3 14.2 100.2 17.9 11.6 0.0 11.9 12.1 12.3 13.1 32.4 12.1 21.7 11.1 10.3 16.0 38.8 90.2 14.4 25.3 15.1 30.7 11.4 12.0 14.6 5.8 18.0 10.5 21.5 12.9 14.7 18.5 13.6 16.2 20.3 24.9 11.9 11.8 USP45 MGC14793 ENSG00000123552 "Ubiquitin specific peptidase 45" Q70EL2 6 99432379-99521728 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029602, HPA029604" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029602: AB_10600418, HPA029604: AB_10602283" "unprognostic (7.81e-3)" "unprognostic (3.10e-3)" "unprognostic (1.63e-2)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.15e-2)" "unprognostic (1.01e-1)" "unprognostic (2.77e-2)" "unprognostic (8.65e-2)" "unprognostic (2.95e-3)" "unprognostic (1.10e-1)" "unprognostic (3.43e-3)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" "unprognostic (1.43e-1)" "unprognostic (6.91e-2)" 9.8 9.1 8.5 10.2 12.2 7.2 9.0 28.4 11.6 9.0 9.7 8.6 8.9 13.7 15.7 9.6 10.0 8.1 11.9 11.5 7.7 8.5 12.2 9.0 7.1 12.7 9.8 8.0 10.7 9.6 10.2 21.7 9.6 15.0 9.9 13.1 7.9 9.8 8.4 14.6 11.8 12.4 10.8 10.6 9.9 8.9 5.7 9.4 7.1 10.7 10.4 9.5 8.8 15.0 8.6 5.1 3.7 2.5 2.6 6.2 1.4 4.2 3.0 6.0 8.5 11.2 10.6 6.4 7.4 8.3 7.7 11.1 6.3 4.8 11.3 5.5 7.4 9.1 5.8 9.2 7.3 10.7 8.9 8.8 11.0 6.0 4.9 8.6 10.2 6.3 11.3 5.9 6.9 11.9 8.2 11.4 10.3 26.5 11.3 7.3 3.9 3.2 9.8 9.7 6.6 6.5 4.8 4.5 6.3 10.8 5.0 8.5 7.0 5.3 6.9 5.4 7.9 3.7 5.0 11.5 4.2 5.4 6.2 11.2 4.8 4.4 20.7 7.3 9.7 7.5 3.7 2.0 0.6 4.9 1.3 6.2 7.4 4.2 5.6 3.5 8.6 3.0 2.9 0.5 2.6 2.5 5.1 3.5 1.4 8.5 12.2 28.4 11.6 7.7 8.5 9.8 8.0 15.0 9.4 3.0 4.3 4.4 6.8 2.1 7.9 7.1 7.6 12.0 3.4 3.5 17.7 5.3 5.0 3.9 10.8 5.3 5.8 0.0 2.3 5.9 3.8 5.6 2.3 3.8 3.5 9.5 2.4 8.0 4.1 5.9 12.0 3.9 3.3 13.6 2.3 5.6 4.3 2.9 8.1 13.4 7.6 0.0 6.2 1.8 5.5 2.5 6.2 5.1 6.0 6.5 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 20.1 38.8 18.6 28.9 30.9 30.9 22.1 48.2 27.5 19.9 18.4 25.6 15.4 17.6 21.3 17.6 19.0 17.4 20.5 17.8 16.9 15.8 15.5 18.3 18.3 26.2 26.6 22.5 27.0 19.8 24.6 35.4 23.1 26.8 21.6 22.0 22.1 24.5 16.3 17.0 23.9 22.2 22.2 19.7 29.1 26.2 15.8 23.6 25.8 23.9 14.0 29.0 19.8 21.0 13.7 10.5 33.7 9.6 5.6 11.2 5.6 14.9 7.1 16.8 12.1 14.6 18.0 16.6 18.8 12.8 12.7 16.8 6.5 15.3 16.8 12.7 17.0 9.9 13.8 20.6 15.2 19.3 16.3 14.1 35.9 26.5 11.8 13.0 18.0 19.2 14.6 13.1 12.8 14.3 17.4 37.2 12.8 28.2 47.5 15.5 7.4 14.9 23.4 10.5 15.3 12.8 21.0 16.9 19.6 14.5 12.6 20.5 12.8 17.7 16.3 42.5 23.5 8.3 21.8 26.4 13.7 11.2 16.7 10.9 38.2 27.1 16.7 13.2 22.3 20.0 33.7 9.6 16.7 6.4 4.6 7.6 13.7 9.5 9.5 10.5 12.8 11.2 7.0 8.9 5.6 5.0 7.7 10.1 5.6 18.6 30.9 48.2 27.5 16.9 15.8 26.6 22.5 26.8 23.6 50.6 38.5 34.3 22.6 19.7 74.8 58.2 22.9 32.1 20.5 19.2 58.9 51.8 21.6 25.0 51.8 24.5 18.7 70.0 17.5 50.1 30.9 20.6 47.5 21.2 26.0 47.7 20.8 28.3 22.2 33.0 32.2 24.7 55.6 47.7 26.9 29.1 20.0 17.5 48.4 16.5 69.2 32.3 25.0 42.9 48.2 22.5 27.2 35.5 30.2 17.1 USP5 IsoT ENSG00000111667 "Ubiquitin specific peptidase 5" P45974 12 6852128-6866632 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006756 Uncertain Approved Nucleoplasm,Cytosol NA NA 820000 "Nucleoplasm, Cytosol" "HPA006756: AB_1080534" "unprognostic (2.19e-1)" "unprognostic (5.83e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-1)" "unprognostic (7.60e-2)" "unprognostic (2.21e-2)" "unprognostic (4.02e-2)" "unprognostic (3.93e-2)" "unprognostic (2.57e-1)" "unprognostic (4.71e-2)" "unprognostic (8.90e-3)" "unprognostic (4.69e-2)" "unprognostic (1.17e-2)" "unprognostic (2.65e-2)" "unprognostic (3.56e-1)" "unprognostic (3.23e-1)" "unprognostic (2.02e-3)" 18.6 28.7 23.1 17.8 32.6 13.6 12.9 24.6 50.9 15.9 21.5 26.8 13.8 17.6 22.3 12.8 27.7 19.1 14.7 22.4 23.9 28.6 14.9 24.8 14.4 18.6 23.6 33.2 14.4 13.2 29.7 19.6 21.7 36.8 19.5 16.1 11.6 14.1 22.7 41.2 33.5 18.1 25.3 23.6 14.1 15.9 30.9 18.7 22.8 19.2 20.4 19.9 21.3 16.0 10.8 18.6 5.3 16.6 10.8 17.1 16.6 25.6 40.1 27.0 30.5 18.4 17.0 34.5 27.9 21.4 33.4 24.4 37.9 25.5 31.0 14.7 29.0 26.5 22.7 29.6 27.7 21.4 58.2 25.1 28.4 32.3 20.6 14.3 25.6 30.0 17.1 16.1 28.9 20.0 22.4 28.5 12.5 24.4 12.5 27.5 28.1 38.5 12.8 52.6 26.2 17.0 30.3 35.2 21.5 19.1 25.0 14.9 30.1 19.0 29.0 12.1 35.1 11.6 21.1 27.6 28.3 34.3 21.5 34.7 15.0 34.6 47.3 31.5 16.4 27.5 2.3 12.3 5.3 17.1 16.6 16.1 10.8 15.2 14.4 18.6 10.0 14.6 14.8 0.9 10.8 14.7 13.6 12.9 16.6 23.1 32.6 24.6 50.9 23.9 28.6 23.6 33.2 36.8 18.7 8.9 12.5 13.0 9.5 10.3 18.1 8.1 17.8 4.0 5.7 21.0 56.9 38.0 10.0 25.9 8.7 7.9 17.7 0.0 17.8 24.3 16.4 7.4 14.9 19.7 24.7 38.1 16.0 9.2 12.1 15.5 21.3 9.6 15.1 47.7 14.7 13.8 16.9 17.8 31.8 14.7 14.5 32.3 9.7 24.5 23.8 13.6 44.2 14.1 22.7 5.6 USP51 ENSG00000247746 "Ubiquitin specific peptidase 51" Q70EK9 X 55484616-55489202 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 34.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 24.4;Ciliated cells: 17.4;Muller glia cells: 29.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.4;naive CD4 T-cell: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 10.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA001942 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA001942: AB_1080536" "unprognostic (1.19e-2)" "unprognostic (4.65e-2)" "unprognostic (3.67e-2)" "unprognostic (1.02e-3)" "unprognostic (8.08e-2)" "unprognostic (3.26e-1)" "unprognostic (3.17e-3)" "unprognostic (2.07e-3)" "unprognostic (5.69e-2)" "prognostic favorable (5.70e-4)" "unprognostic (1.01e-3)" "unprognostic (1.27e-1)" "prognostic favorable (2.63e-5)" "unprognostic (2.81e-3)" "unprognostic (5.92e-2)" "unprognostic (5.85e-2)" "unprognostic (1.63e-1)" 0.6 2.7 2.0 0.3 2.9 0.1 0.9 2.3 1.8 1.4 0.6 0.0 1.8 34.1 0.2 3.4 0.3 1.0 1.8 3.7 2.2 0.5 0.7 0.4 1.6 4.1 0.8 3.6 1.8 1.3 1.3 0.3 0.3 1.5 0.0 0.5 0.5 1.1 1.4 0.9 0.3 1.3 3.2 0.5 0.7 0.5 0.9 0.0 2.4 0.0 0.6 2.4 0.1 0.0 0.8 5.4 1.6 2.7 1.4 0.0 0.9 0.4 1.0 1.3 1.7 0.7 0.0 6.4 1.2 1.1 0.3 1.4 0.6 1.6 1.7 0.1 1.4 0.3 0.0 1.1 3.3 0.3 5.5 0.1 0.6 0.0 0.4 0.3 4.1 4.1 4.1 0.9 3.5 3.2 1.7 6.7 0.0 0.3 4.6 1.0 2.1 1.3 0.2 0.0 1.1 1.5 0.2 5.0 10.2 1.3 1.7 0.2 2.1 2.9 0.5 0.1 6.5 2.6 1.3 1.4 1.8 1.4 0.0 0.0 2.4 0.3 0.0 0.0 0.6 0.6 0.0 0.0 0.9 2.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 3.0 5.6 0.0 1.7 0.8 24.4 5.0 0.0 17.4 3.4 3.5 5.9 3.4 8.3 1.0 0.3 5.8 0.0 0.0 0.0 2.1 4.3 1.1 1.1 0.8 6.1 6.4 3.5 4.9 3.9 0.8 3.7 2.5 5.0 0.0 0.3 29.9 0.3 0.0 7.8 12.2 15.2 0.0 3.9 3.6 6.7 0.4 2.3 1.7 0.2 0.4 USP53 KIAA1350 ENSG00000145390 "Ubiquitin specific peptidase 53" Q70EK8 4 119212587-119295517 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 84.0;SK-MEL-30: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035844, HPA035845" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035844: AB_10669532, HPA035845: AB_2674817" "unprognostic (9.33e-2)" "unprognostic (1.49e-2)" "prognostic favorable (3.15e-6)" "unprognostic (4.37e-3)" "unprognostic (4.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.54e-6)" "prognostic favorable (3.58e-8)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" 26.7 11.9 4.6 11.2 7.9 0.7 20.7 10.9 6.2 16.5 15.0 2.9 27.4 4.5 11.6 16.1 17.9 24.7 8.2 18.6 6.4 5.3 20.2 6.6 26.1 8.7 8.8 4.0 11.4 19.3 6.2 33.9 10.4 13.4 10.7 13.1 17.2 17.7 25.8 33.7 11.3 11.2 9.0 15.5 14.1 13.6 10.2 4.9 4.8 10.7 15.6 8.0 20.5 27.0 1.9 0.8 3.1 0.0 2.2 5.1 0.9 2.8 1.7 0.6 0.0 16.1 16.2 3.5 18.0 84.0 1.6 2.1 1.8 2.6 11.5 0.6 5.3 3.1 1.4 1.4 1.3 4.2 1.5 1.1 0.7 1.3 0.6 12.6 0.9 0.1 5.4 3.9 5.7 8.2 3.1 7.6 0.7 1.7 0.4 2.1 0.6 0.7 1.3 1.7 1.7 0.9 0.2 2.9 2.2 4.2 1.8 0.9 0.7 1.0 7.1 26.0 3.6 1.8 0.6 8.2 0.5 1.8 6.8 1.6 0.8 1.2 1.9 8.2 0.4 2.0 3.1 0.0 0.2 1.3 0.0 1.4 1.7 2.6 2.0 0.4 1.9 5.1 2.7 0.6 2.2 0.0 0.8 2.2 0.9 4.6 7.9 10.9 6.2 6.4 5.3 8.8 4.0 13.4 4.9 32.8 45.2 11.8 55.8 55.0 22.5 82.3 28.1 24.1 35.2 113.4 27.5 41.0 38.1 22.7 3.3 36.0 117.1 0.0 53.9 14.3 44.2 81.1 67.2 21.7 7.6 23.8 33.3 24.5 17.1 2.6 17.5 32.4 13.5 78.5 63.2 26.1 75.8 58.3 10.3 14.2 29.1 6.5 33.5 14.1 3.0 36.9 41.6 17.0 43.2 107.0 USP8 "HumORF8, KIAA0055, SPG59, UBPY" ENSG00000138592 "Ubiquitin specific peptidase 8" P40818 15 50424380-50514419 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Cushing syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050215 Approved Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA050215: AB_2681054" "unprognostic (5.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "unprognostic (9.58e-2)" "unprognostic (2.35e-2)" "unprognostic (2.91e-1)" "unprognostic (1.42e-1)" "unprognostic (3.96e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.94e-1)" "unprognostic (3.99e-2)" "prognostic favorable (1.29e-5)" "unprognostic (4.89e-2)" "unprognostic (1.13e-1)" "unprognostic (3.79e-1)" "unprognostic (1.58e-1)" 19.4 21.9 21.0 20.6 20.6 21.6 18.1 27.3 21.6 21.4 23.9 13.8 19.5 20.2 22.1 17.4 22.3 17.4 15.5 17.4 19.7 18.2 28.2 26.4 17.0 25.4 21.8 15.2 21.9 16.7 42.6 43.2 29.1 29.7 16.7 18.9 10.7 19.9 17.9 24.3 17.8 32.1 19.2 29.3 30.3 17.7 27.5 26.1 28.9 24.1 12.7 20.9 22.3 18.4 16.7 10.6 38.1 15.1 9.5 11.9 6.9 11.2 16.2 9.1 16.0 16.6 18.7 12.6 16.2 19.2 15.8 18.7 10.8 7.5 11.9 12.5 18.5 17.8 21.8 12.4 12.1 18.7 10.4 8.2 21.9 15.1 11.0 17.1 14.7 14.9 14.4 14.6 13.9 23.6 14.7 15.3 8.5 12.5 14.5 14.8 23.1 9.4 5.8 10.4 12.9 7.5 8.5 16.9 17.8 15.0 26.5 11.6 10.6 17.0 25.5 21.2 20.1 14.0 18.0 17.3 16.4 9.2 50.5 21.3 11.3 23.4 13.1 13.1 29.7 15.8 38.1 13.3 22.4 11.1 12.4 10.7 16.5 11.4 11.1 10.6 16.7 11.9 10.7 22.7 9.5 15.1 9.9 8.5 6.9 21.0 20.6 27.3 21.6 19.7 18.2 21.8 15.2 29.7 26.1 89.3 104.5 61.4 35.4 25.6 51.6 61.8 48.4 147.2 88.7 45.4 64.8 49.9 21.6 44.4 53.0 44.9 70.6 23.3 44.6 38.3 35.3 38.8 83.3 45.5 40.2 31.8 51.2 53.4 59.1 12.4 49.8 49.2 38.8 52.3 54.2 53.3 45.7 54.3 58.0 40.7 75.6 45.3 42.6 86.1 47.1 36.3 88.0 47.9 55.0 52.6 UTP14A "NY-CO-16, SDCCAG16, Utp14" ENSG00000156697 "UTP14A, small subunit processome component" Q9BVJ6 X 129906121-129929761 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047217, HPA054023" Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (6.75e-2)" "unprognostic (2.20e-1)" "unprognostic (1.10e-1)" "unprognostic (7.84e-3)" "unprognostic (2.95e-1)" "prognostic unfavorable (7.67e-4)" "unprognostic (3.00e-3)" "unprognostic (8.24e-2)" "unprognostic (4.09e-3)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (6.99e-3)" "prognostic unfavorable (8.12e-8)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "unprognostic (9.99e-2)" 15.1 11.4 8.2 13.3 11.2 10.2 15.8 12.7 13.8 13.3 13.4 8.4 8.5 8.5 17.6 13.9 16.9 13.9 9.0 10.0 7.1 7.2 13.2 14.9 10.7 14.8 7.6 9.8 17.4 22.7 13.1 13.8 12.5 10.6 13.5 14.7 8.6 13.2 10.6 19.6 11.8 11.0 15.3 7.7 16.1 13.3 4.3 7.7 20.7 12.4 16.3 19.5 16.0 13.5 11.1 11.8 16.2 14.3 15.5 14.6 7.7 14.3 16.0 8.6 22.6 14.5 14.8 14.5 15.9 12.2 16.0 12.8 16.3 14.2 34.0 32.1 11.5 17.5 18.4 34.4 17.3 19.7 11.3 17.1 19.4 13.7 12.3 16.4 27.4 14.9 18.1 15.3 21.7 23.0 10.4 12.6 12.7 19.3 10.7 13.8 23.6 19.7 20.9 17.9 27.4 18.0 15.5 13.0 23.3 11.1 11.0 9.0 23.8 9.0 16.7 18.8 11.9 9.0 16.0 10.9 7.1 9.2 19.7 30.5 13.4 15.5 30.3 10.7 34.1 15.9 16.2 8.0 4.0 12.7 14.3 14.6 11.1 10.7 11.8 11.8 10.9 13.5 12.4 1.0 15.5 12.0 9.4 14.4 7.7 8.2 11.2 12.7 13.8 7.1 7.2 7.6 9.8 10.6 7.7 11.9 10.4 11.5 13.1 7.4 5.4 8.1 15.3 12.0 29.6 0.0 3.9 19.7 11.6 16.5 0.3 7.4 2.9 0.0 10.9 16.6 8.7 7.6 13.9 4.0 12.0 1.6 7.5 6.2 7.8 0.2 5.8 9.4 5.0 17.2 7.3 6.0 12.1 10.2 6.7 6.7 4.4 12.9 10.8 1.4 2.4 6.9 34.0 10.2 10.1 9.5 UTP14C "2700066J21Rik, KIAA0266" ENSG00000253797 "UTP14C, small subunit processome component" Q5TAP6 13 52024691-52033600 "Predicted intracellular proteins" "Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047217, HPA054023" Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (7.89e-2)" "unprognostic (5.98e-2)" "unprognostic (4.47e-1)" "unprognostic (1.25e-1)" "unprognostic (2.33e-3)" "unprognostic (2.51e-1)" "unprognostic (2.02e-1)" "unprognostic (3.30e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (7.35e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.46e-5)" "unprognostic (2.44e-2)" "unprognostic (3.43e-1)" "unprognostic (1.74e-1)" "unprognostic (3.04e-2)" 4.8 4.8 5.3 3.4 5.9 0.5 6.2 6.6 5.9 6.8 5.3 4.6 6.7 4.6 3.6 5.2 3.9 5.5 5.1 5.2 8.0 7.9 4.5 3.5 5.5 6.1 5.8 8.9 4.8 6.6 7.1 5.9 5.7 5.5 5.3 2.9 4.5 5.3 6.2 4.4 5.7 2.3 9.1 3.8 4.6 4.2 4.1 5.8 6.7 4.8 3.5 6.8 3.1 4.2 6.8 14.1 11.1 14.5 10.5 10.9 12.3 9.6 8.3 7.7 6.7 9.0 10.5 3.3 11.6 10.5 10.0 12.4 6.8 11.0 10.7 8.8 20.2 4.8 6.5 9.9 17.9 14.0 9.2 13.0 6.4 12.4 10.9 6.8 12.5 11.6 5.3 12.4 3.1 10.9 10.0 12.8 19.5 4.9 10.7 9.9 4.5 14.1 6.9 4.6 9.5 7.3 11.0 8.4 13.5 9.8 14.2 10.3 7.7 8.0 8.6 8.4 5.4 7.8 12.7 4.1 6.7 14.4 6.7 3.7 5.4 4.6 4.8 3.9 3.0 4.9 3.7 4.4 4.1 6.8 6.7 2.4 3.5 3.9 5.8 5.2 3.1 6.0 17.4 11.2 5.0 5.3 13.0 18.5 20.4 12.0 13.6 15.7 3.9 8.5 0.0 6.0 0.3 10.6 10.8 0.0 6.6 8.1 10.8 11.1 11.5 28.1 7.9 23.8 17.9 12.3 14.8 0.0 9.8 6.7 8.5 2.8 15.1 13.6 6.8 14.0 13.4 5.0 10.6 6.5 7.6 6.6 12.2 7.3 5.8 6.9 12.7 5.4 VAC14 "ArPIKfyve, FLJ10305, TAX1BP2" ENSG00000103043 "Vac14, PIKFYVE complex component" Q08AM6 16 70687439-70801161 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027766, HPA075382" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA027766: AB_1848651, HPA075382: " "unprognostic (9.25e-2)" "prognostic favorable (8.33e-5)" "unprognostic (2.83e-2)" "unprognostic (1.51e-1)" "unprognostic (8.94e-2)" "unprognostic (2.72e-1)" "unprognostic (2.21e-2)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (1.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.26e-1)" "prognostic favorable (1.56e-6)" "unprognostic (1.61e-1)" "unprognostic (1.10e-1)" "unprognostic (5.05e-2)" "unprognostic (1.80e-1)" 26.3 26.6 22.9 22.8 21.8 16.3 17.4 15.6 34.9 17.9 18.4 27.0 18.5 19.8 18.8 15.8 21.0 20.9 17.0 22.2 22.9 23.5 25.7 27.1 20.1 34.9 22.3 20.8 19.2 27.8 33.7 21.4 20.1 25.8 17.9 14.1 22.9 24.3 19.4 23.3 24.6 21.6 19.2 22.2 29.0 20.0 21.7 20.6 31.2 26.0 16.3 22.9 21.0 16.3 5.5 9.7 6.6 5.9 3.7 5.5 1.9 11.4 11.3 9.6 10.7 14.0 10.2 14.7 8.3 13.2 15.9 7.4 14.0 18.5 14.7 10.9 10.0 19.1 14.5 12.6 13.5 7.5 4.4 13.1 7.4 8.6 17.3 36.1 12.7 15.7 16.9 14.2 23.5 21.5 9.6 15.1 13.6 13.0 6.7 13.9 16.5 11.7 21.2 16.9 9.2 10.7 14.2 7.0 21.7 7.6 7.9 11.5 12.5 27.5 8.4 19.0 7.6 12.5 11.9 11.9 21.2 12.2 13.4 9.0 9.6 11.8 28.1 35.4 11.3 9.6 1.3 4.8 6.6 2.9 5.9 2.5 4.0 3.7 5.5 9.7 5.5 3.5 3.1 1.6 3.7 5.4 5.1 2.3 1.9 22.9 21.8 15.6 34.9 22.9 23.5 22.3 20.8 25.8 20.6 3.0 3.4 9.3 7.4 3.8 8.1 10.7 15.3 9.4 4.5 3.5 2.0 13.6 5.0 17.1 14.0 6.7 11.3 23.3 19.5 22.7 6.6 7.1 5.7 13.2 37.6 9.5 8.7 19.6 15.9 40.6 5.8 10.7 10.1 26.2 9.0 6.0 16.7 10.4 3.2 12.2 7.1 6.5 5.6 4.8 12.6 8.0 16.4 3.9 9.3 5.4 VARS VARS2 ENSG00000204394 "Valyl-tRNA synthetase" P26640 6 31777518-31795953 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 205.7;Late spermatids: 188.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.2;U-266/84: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046710 Approved Enhanced Cytosol NA NA 23000 Cytosol "HPA046710: AB_2679765" "unprognostic (1.86e-2)" "prognostic unfavorable (7.25e-4)" "unprognostic (2.19e-1)" "unprognostic (2.07e-1)" "unprognostic (2.49e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.86e-4)" "prognostic unfavorable (6.90e-4)" "unprognostic (3.20e-1)" "unprognostic (2.76e-1)" "unprognostic (4.72e-1)" "unprognostic (1.28e-1)" "unprognostic (1.09e-2)" "unprognostic (1.98e-1)" "unprognostic (1.69e-1)" "unprognostic (3.85e-2)" "unprognostic (2.59e-1)" 11.7 11.4 8.9 12.0 9.5 9.1 18.3 7.6 14.0 8.1 11.3 7.3 5.0 12.8 13.5 6.7 14.2 10.2 8.1 9.5 6.4 6.8 9.5 22.7 11.5 24.2 8.3 9.7 9.6 19.2 15.6 15.0 8.5 8.6 7.7 9.4 6.1 9.1 5.9 30.6 14.3 10.3 13.2 8.7 14.4 15.2 40.6 7.5 10.9 8.2 13.2 11.8 9.7 8.5 1.6 1.5 0.6 1.2 2.4 1.0 0.9 2.2 2.0 3.2 6.4 3.6 2.8 8.7 8.8 2.7 6.6 4.0 2.6 1.4 7.7 10.9 5.5 5.0 2.4 10.2 6.7 4.0 5.6 14.4 3.8 5.1 6.1 4.7 15.3 12.6 4.2 2.4 2.6 6.1 1.9 3.3 3.5 10.6 10.5 4.2 3.5 6.9 0.7 6.1 3.2 4.3 9.0 1.7 25.2 5.1 2.9 3.9 1.5 0.7 8.6 3.7 2.2 5.2 6.1 1.1 4.6 4.2 6.1 14.5 15.0 25.9 6.3 3.3 3.1 5.1 0.0 0.6 0.6 1.0 1.2 1.0 1.6 0.6 0.4 1.1 1.1 0.8 0.8 0.0 2.4 1.0 1.5 0.6 0.9 8.9 9.5 7.6 14.0 6.4 6.8 8.3 9.7 8.6 7.5 6.0 8.2 11.1 8.3 7.3 7.0 7.8 7.6 8.1 9.1 15.7 5.9 19.8 8.3 30.5 205.7 9.2 18.8 23.3 36.1 40.7 10.4 7.3 9.2 21.9 26.7 1.6 22.5 6.2 9.2 188.8 19.2 12.0 6.8 10.0 12.5 7.2 28.7 5.8 12.7 11.4 12.4 19.4 8.1 24.4 29.8 11.3 13.8 6.9 19.2 7.0 VASH2 FLJ12505 ENSG00000143494 "Vasohibin 2" Q86V25 1 212950520-212992037 "Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.2" "Group enriched" "Detected in some" 12 "Early spermatids: 75.2;Late spermatids: 59.3" "Cancer enhanced" "Detected in many" "testis cancer: 3.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "AF22: 9.6;AN3-CA: 11.7;NTERA-2: 18.4;RH-30: 54.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045820 Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA045820: " "unprognostic (2.22e-1)" "unprognostic (1.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.29e-2)" "unprognostic (1.28e-1)" "unprognostic (1.57e-2)" "unprognostic (1.25e-2)" "unprognostic (4.04e-2)" "unprognostic (2.59e-3)" "unprognostic (3.50e-2)" "unprognostic (2.45e-1)" "unprognostic (6.58e-2)" "unprognostic (1.84e-5)" "unprognostic (1.95e-3)" "unprognostic (2.74e-1)" "unprognostic (6.85e-2)" "unprognostic (6.81e-4)" 3.1 0.7 2.6 5.8 6.0 1.4 3.7 1.1 4.8 3.3 1.4 0.1 1.0 1.3 4.2 3.8 7.8 1.5 4.9 2.8 1.5 1.8 1.1 0.8 2.2 3.8 1.2 1.7 1.8 0.8 1.8 7.7 1.4 3.6 7.7 1.2 5.7 1.6 1.6 1.6 1.2 2.0 3.5 1.1 2.1 1.3 23.2 1.1 9.7 1.2 3.1 3.7 2.9 6.3 0.2 3.2 0.0 0.0 0.0 0.4 0.0 0.1 0.6 9.6 11.7 0.1 0.0 1.5 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.1 0.0 0.2 0.0 3.9 0.0 0.4 7.7 1.4 0.7 0.5 0.5 0.0 0.0 0.1 1.5 0.0 0.5 0.0 0.2 0.1 4.4 0.0 2.3 0.8 0.1 4.9 0.6 18.4 0.0 1.4 2.9 54.2 0.5 0.0 0.7 2.2 3.4 1.2 0.1 0.1 5.2 1.8 0.3 0.0 0.4 1.1 0.2 0.5 1.3 2.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 3.2 0.4 0.0 2.6 6.0 1.1 4.8 1.5 1.8 1.2 1.7 3.6 1.1 0.0 0.6 0.0 0.7 1.3 1.9 0.8 0.0 1.4 0.0 0.0 2.0 0.1 0.0 0.5 75.2 0.3 0.0 0.0 0.2 0.2 5.8 1.4 0.0 0.0 0.2 1.6 1.2 0.0 0.3 59.3 0.3 1.3 0.0 1.0 0.0 0.8 0.1 0.0 0.7 0.3 2.1 0.0 1.7 1.0 1.0 1.4 0.0 0.0 0.0 0.4 VAT1L KIAA1576 ENSG00000171724 "Vesicle amine transport 1 like" Q9HCJ6 16 77788530-77980107 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 57.3;brain: 47.1;retina: 32.1" "Group enriched" "Detected in some" 15 "Horizontal cells: 281.3;Muller glia cells: 83.1" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 9.4;BJ hTERT+: 27.7;fHDF/TERT166: 15.1;NTERA-2: 32.6;U-87 MG: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044061, CAB046032, HPA061138" Enhanced Approved Cytosol NA NA Cytosol "CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: " "unprognostic (1.49e-2)" "unprognostic (8.74e-3)" "unprognostic (8.80e-3)" "unprognostic (3.39e-2)" "unprognostic (3.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (8.57e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.01e-6)" "unprognostic (2.50e-2)" "unprognostic (6.53e-2)" "unprognostic (1.19e-1)" "unprognostic (5.96e-2)" 1.1 57.3 7.9 3.0 41.3 1.2 1.0 28.4 20.1 1.3 3.4 5.7 0.0 2.4 1.8 6.3 2.0 1.4 3.8 12.7 3.8 47.1 5.3 1.4 0.9 1.0 8.4 12.7 0.9 2.1 0.6 1.5 2.0 27.2 0.8 5.2 32.1 0.9 1.0 0.6 0.6 3.1 2.6 15.4 0.7 1.7 2.1 5.8 0.0 2.0 0.0 2.4 1.4 0.4 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 3.2 0.0 0.0 1.1 27.7 0.3 0.3 0.0 0.0 0.0 0.0 15.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 32.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.4 0.0 6.0 0.0 7.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 41.3 28.4 9.1 3.8 47.1 8.4 12.7 27.2 5.8 0.0 0.0 0.0 0.0 0.0 7.2 8.7 5.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 281.3 2.9 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 83.1 0.1 0.0 0.0 0.0 11.8 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 VAV1 VAV ENSG00000141968 "Vav guanine nucleotide exchange factor 1" P15498 19 6772714-6857366 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.7;bone marrow: 25.7;lymphoid tissue: 43.1" "Group enriched" "Detected in many" 5 "B-cells: 26.9;granulocytes: 34.6;Hofbauer cells: 42.9;Kupffer cells: 22.9;Macrophages: 27.7;T-cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 31.3;Karpas-707: 35.7;MOLT-4: 33.9;REH: 22.5;THP-1: 26.3;U-266/70: 21.4;U-266/84: 25.9;U-937: 28.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001864, HPA005925" Enhanced Approved Cytosol NA NA 30000 Cytosol "HPA001864: AB_1858722, HPA005925: " "unprognostic (2.93e-1)" "unprognostic (1.96e-1)" "unprognostic (1.80e-1)" "unprognostic (1.01e-1)" "unprognostic (6.82e-2)" "unprognostic (1.13e-2)" "unprognostic (5.62e-1)" "unprognostic (1.97e-1)" "unprognostic (1.30e-2)" "unprognostic (1.90e-2)" "unprognostic (3.56e-2)" "unprognostic (8.58e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (9.55e-2)" "unprognostic (1.78e-1)" "unprognostic (6.57e-2)" "unprognostic (3.28e-1)" 5.1 3.0 3.1 19.0 5.6 25.7 2.3 0.7 2.2 1.7 3.5 4.0 0.3 2.8 1.9 2.6 2.6 2.6 3.1 3.3 2.5 3.0 2.7 2.6 8.5 25.1 5.3 1.2 2.0 1.5 5.2 1.8 4.4 3.5 3.2 3.7 2.3 5.8 1.1 0.8 1.4 10.7 2.6 8.7 37.1 2.5 1.5 4.8 43.1 2.0 1.2 20.0 6.1 2.4 9.3 10.5 25.7 22.8 11.5 14.7 10.5 0.4 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.9 15.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.5 18.6 0.0 0.0 0.0 18.0 31.3 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.7 35.7 0.0 2.6 33.9 10.3 0.0 0.0 0.0 22.5 0.0 12.1 0.6 0.0 0.0 0.0 0.0 5.1 0.0 0.0 2.2 26.3 0.0 0.0 0.4 0.0 0.0 21.4 25.9 17.5 0.0 28.4 0.0 0.9 11.5 11.9 14.7 18.8 10.5 9.3 10.7 12.7 10.5 9.2 11.8 10.6 25.7 11.5 22.8 9.0 8.5 10.5 3.1 5.6 0.7 2.2 2.5 3.0 5.3 1.2 3.5 4.8 3.0 4.8 26.9 0.5 1.1 0.2 0.7 0.0 5.3 1.2 0.0 0.0 0.4 0.0 5.1 3.2 1.1 0.0 0.0 0.3 0.6 1.2 0.2 34.6 0.0 42.9 0.0 1.2 1.3 22.9 1.3 0.0 27.7 1.7 1.8 0.9 0.0 5.9 5.8 0.0 0.0 0.0 0.0 0.3 1.2 0.9 0.6 1.1 25.5 2.1 0.6 VBP1 "PFD3, PFDN3" ENSG00000155959 "VHL binding protein 1" P61758 X 155197007-155239817 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006260, HPA023230" Approved Supported Vesicles,Cytosol NA NA Cytosol Vesicles "CAB006260: AB_425740, HPA023230: AB_1858727" "unprognostic (1.55e-3)" "unprognostic (1.12e-3)" "unprognostic (3.35e-1)" "unprognostic (1.35e-2)" "unprognostic (3.78e-2)" "unprognostic (1.85e-3)" "unprognostic (5.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.44e-2)" "unprognostic (1.02e-2)" "unprognostic (9.80e-2)" "unprognostic (1.15e-1)" "unprognostic (5.76e-2)" "unprognostic (3.76e-2)" "unprognostic (4.54e-2)" "unprognostic (9.30e-2)" "unprognostic (3.80e-1)" 17.3 19.2 37.8 15.5 28.0 24.5 18.4 26.1 32.5 14.9 16.9 20.6 12.5 12.8 14.9 16.3 17.8 13.8 13.3 35.9 35.4 36.8 22.9 17.4 13.0 21.0 40.9 25.6 15.3 11.8 18.3 22.0 16.9 33.9 18.2 19.2 10.1 11.1 15.6 50.5 10.9 14.3 16.4 46.0 13.9 12.5 8.7 22.9 21.0 18.4 25.6 22.0 16.9 12.8 15.0 18.4 37.0 12.6 13.8 21.6 15.7 35.6 12.9 28.1 18.6 11.6 16.1 8.1 17.7 13.8 23.4 36.7 15.3 18.3 45.9 38.0 14.9 35.9 14.1 40.6 16.6 30.4 24.1 28.5 19.3 20.4 11.9 13.9 31.0 15.2 12.0 19.9 19.5 24.7 12.5 21.5 23.1 37.6 27.3 26.2 14.8 29.2 27.8 16.2 33.5 27.7 25.1 22.3 26.8 20.2 16.3 30.5 18.5 12.1 14.4 19.6 20.5 12.3 24.1 12.4 18.7 23.2 31.8 43.7 30.9 44.8 80.3 16.6 38.5 22.9 8.5 11.6 37.0 14.4 12.6 16.5 15.0 16.9 17.2 18.4 11.8 19.6 20.7 13.6 13.8 10.4 15.1 21.6 15.7 37.8 28.0 26.1 31.9 35.4 36.8 40.9 25.6 33.9 22.9 47.6 23.2 62.5 65.5 50.9 53.7 75.4 20.4 37.5 35.2 36.6 19.6 64.6 162.5 59.1 2.1 43.8 23.1 46.7 50.6 83.0 57.1 54.4 46.2 21.2 60.3 30.2 22.5 25.2 28.8 3.9 38.9 49.5 43.9 101.0 29.1 54.2 44.5 40.4 37.4 82.3 34.9 45.3 49.9 40.8 99.9 45.9 57.4 60.9 38.8 52.0 VCP "CDC48, IBMPFD, p97, TERA" ENSG00000165280 "Valosin containing protein" P55072 9 35056064-35073249 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 452.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005593, HPA012728, HPA012814" Supported Enhanced Nucleoplasm,Cytosol No No 110000000 "Nucleoplasm, Cytosol" "CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.15e-2)" "prognostic favorable (7.30e-4)" "unprognostic (5.78e-2)" "unprognostic (1.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.13e-2)" "unprognostic (3.82e-2)" "unprognostic (1.81e-2)" "unprognostic (2.19e-2)" "unprognostic (3.24e-1)" "prognostic favorable (9.63e-7)" "unprognostic (1.83e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-1)" "unprognostic (9.11e-2)" 33.7 43.6 19.6 30.3 21.8 30.8 31.4 19.4 31.0 32.2 25.7 22.7 32.9 22.2 30.5 34.0 40.0 24.7 33.8 69.6 20.0 23.4 30.1 63.4 27.6 42.7 23.1 21.1 25.0 34.9 44.5 29.0 46.3 26.3 33.4 26.5 21.2 30.7 34.1 80.4 29.2 26.3 29.2 23.0 37.8 28.9 25.6 18.2 43.3 32.1 42.2 35.7 31.5 26.5 25.9 29.4 43.4 30.6 23.0 32.1 34.4 36.0 41.2 28.4 15.3 34.3 24.2 21.7 33.6 38.1 50.3 37.2 27.5 14.9 28.6 29.5 41.7 44.2 17.4 42.3 40.1 43.6 30.7 24.5 19.9 39.0 37.6 26.7 22.3 26.6 27.6 27.0 43.6 19.5 21.1 54.4 13.1 20.6 20.8 40.2 25.4 21.8 53.7 37.0 18.7 39.4 19.4 22.1 17.7 39.3 25.8 15.5 19.5 20.3 23.0 10.2 36.9 18.5 15.9 44.5 20.2 26.1 17.9 29.5 10.6 22.4 24.5 33.1 16.1 25.8 43.4 24.5 31.9 24.7 27.2 23.8 25.9 23.6 24.8 29.4 21.1 17.7 18.5 28.4 23.0 30.6 18.9 32.1 34.4 19.6 21.8 19.4 31.0 20.0 23.4 23.1 21.1 26.3 18.2 74.5 72.0 80.5 100.9 68.5 80.1 178.9 43.3 71.0 68.2 52.4 111.9 240.5 63.0 177.8 24.1 121.1 90.3 23.3 162.4 147.5 81.6 98.2 61.1 102.4 116.5 69.9 80.8 122.8 57.9 36.5 77.6 66.7 72.6 234.4 63.9 87.7 195.1 56.3 81.7 89.3 82.6 135.8 82.4 127.7 117.9 79.3 452.1 76.6 57.1 105.3 VCPKMT "C14orf138, METTL21D, VCP-KMT" ENSG00000100483 "Valosin containing protein lysine methyltransferase" Q9H867 14 50108632-50116600 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001146, HPA076561" Uncertain Supported Cytosol NA NA Cytosol "HPA001146: AB_1845558, HPA076561: AB_2732312" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (5.05e-2)" "unprognostic (3.86e-1)" "unprognostic (3.54e-1)" "unprognostic (4.74e-2)" "unprognostic (9.97e-2)" "prognostic favorable (2.40e-4)" "unprognostic (8.20e-2)" "unprognostic (1.74e-1)" "unprognostic (4.90e-2)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (6.79e-4)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (6.27e-2)" 5.2 7.6 7.6 9.5 16.9 12.6 6.0 15.3 14.0 6.3 5.8 6.3 3.7 5.4 9.8 8.3 10.5 5.8 7.1 4.6 9.9 7.1 6.2 6.9 5.7 10.9 7.1 6.3 5.1 6.3 6.2 8.6 4.8 12.0 5.0 5.4 4.5 5.1 5.4 4.8 8.1 5.9 8.6 5.7 9.2 7.0 11.0 7.4 10.6 7.4 5.2 12.5 7.9 6.1 17.1 3.8 6.1 3.1 8.0 8.4 3.4 4.1 4.8 4.2 5.7 3.1 3.6 5.1 4.4 4.7 5.0 3.7 2.7 5.3 13.9 3.1 3.1 1.2 8.9 5.5 7.6 5.0 6.8 3.5 2.6 2.1 3.2 4.5 7.1 3.9 2.5 4.4 5.3 5.6 3.3 5.9 4.9 3.2 6.1 3.8 5.8 14.3 7.1 4.4 6.4 7.9 9.9 8.4 3.6 6.2 6.5 7.6 9.1 6.6 1.9 7.4 3.9 4.7 6.4 1.7 8.1 6.4 2.8 4.7 5.8 11.6 5.3 2.8 6.2 3.9 6.1 2.0 0.0 6.5 3.1 7.6 17.1 6.3 7.8 2.5 14.5 7.5 8.4 0.6 8.0 1.4 3.8 5.2 3.4 7.6 16.9 15.3 14.0 9.9 7.1 7.1 6.3 12.0 7.4 11.9 9.8 20.4 14.7 27.0 6.7 3.5 0.0 6.7 11.4 7.0 9.8 9.1 8.3 5.6 28.7 4.9 6.2 0.0 5.0 6.7 10.4 12.2 17.3 6.6 4.4 1.6 5.2 7.4 6.0 5.8 6.9 8.3 10.1 9.0 7.3 4.0 4.5 6.5 4.6 4.7 7.3 0.0 10.3 12.0 12.9 32.6 9.6 14.6 4.8 14.8 VDR "NR1I1, PPP1R163" ENSG00000111424 "Vitamin D receptor" P11473 12 47841537-47943048 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 57.1;parathyroid gland: 45.8" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 101.9;Paneth cells: 43.0;Undifferentiated cells: 54.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9" "Group enriched" "Detected in many" 8 "dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.0;HDLM-2: 32.4;U-937: 31.8" "Region enhanced" "Detected in single" "olfactory region: 2.5" "Not detected" "Not detected" "CAB004617, HPA047740, HPA072102" Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Intermediate filaments, Cytosol" "CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: " "unprognostic (1.11e-2)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (7.59e-3)" "unprognostic (3.33e-3)" "unprognostic (2.74e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (6.72e-2)" "prognostic favorable (4.89e-6)" "unprognostic (1.46e-1)" "unprognostic (8.76e-2)" "unprognostic (3.28e-1)" "unprognostic (3.82e-2)" 3.0 9.2 0.2 10.0 0.3 2.5 7.8 0.3 0.6 3.5 40.9 0.4 4.1 21.2 1.2 7.7 10.2 1.1 10.7 1.5 0.5 0.3 13.0 0.6 8.3 3.8 0.5 0.1 1.3 6.5 45.8 11.7 4.4 0.6 2.1 12.6 0.4 4.9 2.8 5.3 15.2 57.1 1.2 1.5 3.1 2.6 1.5 0.2 2.0 1.9 9.4 8.2 4.0 5.2 0.7 5.7 7.5 7.0 0.2 0.8 1.2 5.5 0.9 0.0 0.0 4.8 7.0 0.1 6.8 3.5 5.8 5.0 4.0 4.7 1.4 7.4 4.6 4.1 10.4 0.2 23.0 2.7 32.4 1.7 2.4 1.3 0.3 3.5 4.9 7.8 9.4 10.8 6.4 10.5 9.2 0.4 0.5 0.7 1.5 2.6 3.7 0.1 2.4 0.0 13.8 7.5 0.1 0.0 3.5 5.2 5.5 2.6 0.1 5.8 16.7 2.1 0.0 18.8 2.7 0.4 11.1 2.9 3.2 3.8 0.9 0.0 1.2 3.4 31.8 2.8 0.2 3.7 2.1 0.0 7.0 0.1 0.7 0.3 0.0 5.7 0.1 0.1 0.0 7.5 0.2 6.9 0.6 0.8 1.2 0.2 0.3 0.3 0.6 0.5 0.3 0.5 0.1 0.6 0.2 11.9 15.3 1.9 8.2 32.1 0.4 1.2 0.0 9.4 11.4 7.0 0.0 0.1 6.6 3.7 0.1 0.8 101.9 0.0 9.4 0.1 7.8 3.9 6.9 0.4 3.6 0.0 20.8 0.0 6.6 0.0 0.0 18.7 8.5 6.4 30.0 0.2 14.7 43.0 0.4 17.5 0.2 0.0 2.8 0.7 0.3 35.5 0.2 3.2 54.4 8.4 VENTX "HPX42B, VENTX2" ENSG00000151650 "VENT homeobox" O95231 10 133237404-133241929 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 2: 1.4;Collecting duct cells: 1.8;Kupffer cells: 6.5;Macrophages: 5.6" "Cancer enriched" "Detected in some" 15 "testis cancer: 30.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 2.4;classical monocyte: 4.6;intermediate monocyte: 5.1;myeloid DC: 3.1;neutrophil: 1.8;non-classical monocyte: 3.9" "Group enriched" "Detected in many" 5 "dendritic cells: 3.1;granulocytes: 2.4;monocytes: 5.1" "Group enriched" "Detected in some" 10 "NB-4: 18.0;NTERA-2: 10.3" HPA050955 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA050955: AB_2681288" "unprognostic (9.41e-2)" "unprognostic (8.89e-2)" "unprognostic (2.34e-1)" "unprognostic (4.26e-1)" "unprognostic (3.22e-2)" "unprognostic (2.01e-1)" "unprognostic (2.54e-1)" "unprognostic (9.62e-3)" "unprognostic (2.22e-1)" "unprognostic (3.00e-3)" "unprognostic (3.70e-4)" "unprognostic (4.22e-1)" "unprognostic (2.51e-3)" "unprognostic (3.43e-2)" "unprognostic (3.48e-1)" "unprognostic (7.54e-2)" "unprognostic (3.14e-1)" 5.6 2.4 1.2 6.6 1.2 4.4 2.0 1.2 1.2 1.7 1.7 1.2 1.2 0.4 1.7 1.2 1.2 2.0 2.5 1.2 1.2 1.5 1.9 1.2 4.4 1.2 1.2 1.2 1.7 2.1 1.0 1.5 1.2 1.2 1.2 0.4 1.2 1.5 1.2 1.2 2.0 1.2 2.1 2.2 7.3 0.9 6.3 1.2 2.9 1.2 1.2 1.2 1.5 1.2 0.5 3.1 2.4 5.1 0.6 0.3 1.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 18.0 10.3 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 2.4 4.6 0.6 0.3 5.1 0.1 0.5 0.2 0.2 3.1 0.5 0.2 0.3 1.8 0.6 3.9 0.2 0.1 1.0 1.2 1.2 1.2 1.2 1.2 1.5 1.2 1.2 1.2 1.2 0.0 1.4 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.5 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 38.1;pituitary gland: 70.3" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 2.2;pons and medulla: 5.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favorable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.5 16.0 0.3 0.2 0.3 1.1 1.4 2.2 3.5 1.9 0.4 0.7 2.0 0.2 0.4 12.1 0.2 3.4 1.1 0.4 0.8 0.5 20.7 0.6 38.1 0.1 0.7 0.1 1.1 8.6 0.7 70.3 1.6 5.5 1.2 0.3 17.7 6.9 4.9 0.2 0.7 0.2 0.1 0.3 2.3 0.6 1.7 0.2 0.1 1.1 0.5 0.6 0.5 0.8 0.0 0.0 1.5 0.7 0.0 0.0 5.1 1.8 0.2 4.3 0.0 2.5 9.4 0.0 11.0 24.5 3.3 4.8 0.3 1.7 0.0 4.3 11.8 0.5 0.0 0.1 0.2 18.3 0.0 0.0 1.8 0.2 0.0 0.8 0.0 0.0 2.7 0.1 14.0 2.8 26.3 65.1 0.0 0.6 0.0 8.9 0.2 0.0 0.0 1.7 0.5 1.6 0.0 0.3 0.0 1.6 0.9 0.1 0.0 0.3 0.5 4.3 0.0 18.9 0.0 38.7 13.1 0.4 4.5 15.1 0.0 0.0 0.0 10.5 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.1 0.3 0.3 2.2 0.4 0.8 0.5 0.7 0.1 5.5 0.2 247.1 124.4 0.0 0.2 1.5 0.0 0.3 12.7 14.7 26.1 29.6 2.0 1.6 39.7 5.5 67.1 0.0 0.0 0.0 8.7 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 63.8 1.4 0.4 27.0 1.0 0.2 0.8 2.0 2.8 0.4 24.1 0.3 0.0 0.0 0.3 0.6 0.4 0.0 0.0 0.6 0.1 VEZT DKFZP761C241 ENSG00000028203 "Vezatin, adherens junctions transmembrane protein" Q9HBM0 12 95217746-95302790 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004811, HPA017066" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004811: AB_1080563, HPA017066: AB_1858742" "unprognostic (3.91e-1)" "unprognostic (6.34e-3)" "unprognostic (3.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.28e-1)" "unprognostic (9.93e-2)" "unprognostic (4.18e-1)" "unprognostic (1.10e-3)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.93e-5)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.51e-1)" "unprognostic (4.06e-1)" "unprognostic (5.02e-2)" 12.3 21.4 15.4 14.3 17.2 5.1 14.6 28.3 27.2 12.9 14.4 9.1 19.0 9.5 17.1 15.9 15.6 11.5 12.1 14.7 11.8 9.5 12.1 10.4 13.8 9.6 11.0 14.0 13.3 12.6 15.7 20.4 19.6 11.4 15.8 10.6 10.3 10.9 13.9 42.7 16.1 11.0 16.2 12.5 7.2 10.7 7.2 12.2 13.6 29.8 14.5 10.0 15.7 12.2 5.2 4.4 1.1 3.5 2.4 5.0 1.2 10.3 9.6 13.3 7.2 10.2 7.3 5.1 7.6 9.6 6.1 9.7 3.5 4.9 13.4 5.0 6.6 3.3 5.4 9.5 6.7 11.4 9.0 5.3 5.1 2.5 3.6 5.5 10.1 3.0 9.2 11.7 5.7 16.5 14.2 12.8 6.6 3.0 5.3 5.5 2.8 8.7 4.8 6.7 3.3 9.8 7.9 6.3 4.3 17.7 7.5 9.0 7.8 7.3 11.1 3.5 12.4 13.7 1.7 10.2 5.5 2.1 2.4 4.2 5.2 7.8 11.4 2.1 3.7 2.8 0.5 3.1 1.1 3.6 3.5 4.7 5.2 5.0 2.1 4.4 3.6 2.4 2.0 0.3 2.4 0.9 1.8 3.5 1.2 15.4 17.2 28.3 18.8 11.8 9.5 11.0 14.0 11.4 12.2 65.5 43.0 27.5 49.9 69.0 66.8 41.6 33.1 29.4 47.8 31.4 80.5 32.2 8.3 45.1 8.5 39.8 29.7 0.0 39.7 17.6 29.0 46.9 28.8 32.6 18.8 58.8 36.9 40.5 28.3 8.3 30.2 23.7 35.4 20.8 26.8 23.0 54.7 29.1 31.1 18.9 146.1 6.5 34.3 27.3 17.9 63.2 92.6 20.3 20.7 66.0 VGLL3 VGL-3 ENSG00000206538 "Vestigial like family member 3" A8MV65 3 86876388-86991119 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 195.7" "Group enriched" "Detected in many" 4 "Early spermatids: 105.6;Extravillous trophoblasts: 167.0;Late spermatids: 52.5;Leydig cells: 122.6;Peritubular cells: 140.4;Syncytiotrophoblasts: 67.5" "Cancer enhanced" "Detected in many" "prostate cancer: 7.9" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "U-2197: 106.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054983 Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA054983: AB_2682663" "unprognostic (9.08e-2)" "unprognostic (4.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.54e-1)" "unprognostic (2.98e-2)" "unprognostic (1.13e-1)" "unprognostic (2.77e-2)" "unprognostic (3.86e-2)" "unprognostic (1.38e-2)" "unprognostic (4.94e-2)" "unprognostic (3.70e-2)" "unprognostic (3.44e-2)" "unprognostic (2.73e-8)" "unprognostic (3.85e-3)" "unprognostic (1.27e-1)" "unprognostic (5.42e-3)" "unprognostic (1.05e-1)" 22.5 1.0 0.5 3.4 0.5 0.2 8.6 0.2 0.3 6.3 6.2 0.4 3.3 0.6 8.2 7.8 6.1 5.2 6.8 4.3 1.0 0.7 1.8 0.6 16.1 3.6 0.6 0.3 10.6 2.7 0.7 0.4 195.7 0.8 8.0 1.6 2.8 1.9 3.1 7.5 4.0 2.1 11.9 0.8 2.4 2.9 8.0 0.3 0.1 3.4 1.9 1.0 12.2 9.2 1.1 0.6 2.3 0.5 0.8 0.7 0.1 1.5 2.6 14.2 0.0 19.0 23.8 0.2 9.8 6.9 8.4 10.5 3.0 0.6 0.0 0.0 15.3 0.9 1.3 0.9 0.9 11.6 5.5 0.0 0.7 0.9 0.0 8.7 0.1 0.0 18.1 1.5 12.3 5.5 4.5 1.2 0.0 0.0 0.0 10.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 18.9 0.1 0.0 1.6 0.0 0.0 4.2 0.1 0.0 0.5 0.0 0.0 0.5 18.7 2.7 106.2 0.3 0.0 0.0 0.0 3.4 0.0 0.7 2.3 0.5 0.7 0.4 0.3 0.4 0.5 0.5 0.3 0.2 1.1 0.6 0.7 2.0 0.8 0.4 0.6 0.5 0.1 0.5 0.5 0.2 0.3 1.0 0.7 0.6 0.3 0.8 0.3 3.0 2.1 0.0 7.4 7.1 0.0 0.7 0.0 5.3 4.5 10.4 0.0 20.7 0.0 10.3 105.6 1.5 0.0 0.0 2.1 167.0 26.2 18.3 0.0 0.0 6.7 0.0 0.0 4.3 0.0 52.5 122.6 2.4 3.3 0.0 0.0 15.8 8.4 0.0 140.4 0.0 0.3 12.9 17.8 1.4 1.0 4.5 67.5 0.0 0.0 3.7 VHL VHL1 ENSG00000134086 "Von Hippel-Lindau tumor suppressor" P40337 3 10141008-10152220 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Congenital erythrocytosis, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 54.7" "CAB005430, HPA031631, HPA031632" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB005430: AB_2241850, HPA031631: AB_2673968, HPA031632: AB_2673969" "prognostic unfavorable (9.02e-5)" "unprognostic (1.10e-1)" "unprognostic (4.46e-3)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (3.55e-1)" "unprognostic (3.03e-2)" "unprognostic (4.36e-2)" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (2.51e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.46e-1)" "unprognostic (2.92e-2)" "unprognostic (1.28e-3)" 13.8 17.4 18.1 29.2 18.4 24.3 15.4 25.8 21.4 13.3 19.8 19.3 14.5 15.9 15.1 13.6 16.4 14.3 18.9 10.5 17.1 18.5 13.7 16.3 14.6 27.9 13.5 12.3 15.2 22.5 13.8 14.6 18.8 12.8 15.1 16.6 12.5 21.8 13.7 14.8 14.0 22.3 13.4 17.0 22.6 16.2 17.9 11.2 39.2 16.9 11.5 29.3 15.4 19.1 5.4 3.9 8.0 4.1 4.4 4.3 1.7 6.8 6.6 14.6 8.9 13.6 10.5 54.7 6.1 8.7 7.8 9.2 7.8 8.6 24.3 8.3 8.2 11.0 5.9 13.5 8.5 9.6 11.6 12.2 18.9 10.8 10.7 12.9 16.6 15.2 10.6 9.7 10.3 13.0 10.4 8.9 15.3 16.8 18.5 7.6 12.4 15.8 12.2 9.8 7.4 8.5 20.1 12.9 12.2 9.5 17.8 5.5 18.3 12.8 6.8 7.3 9.2 13.4 21.1 7.7 7.7 10.4 7.2 9.5 13.2 26.9 38.8 8.6 20.0 7.0 2.6 4.1 3.3 3.8 2.5 3.6 4.1 2.9 4.3 3.9 5.4 2.5 2.7 8.0 4.4 3.2 2.4 3.1 1.7 18.1 18.4 25.8 21.4 17.1 18.5 13.5 12.3 12.8 11.2 11.9 12.2 25.5 15.5 13.1 15.6 5.0 20.4 5.3 5.7 15.7 17.7 13.9 6.6 9.9 7.6 12.1 10.5 0.0 4.5 15.8 9.5 19.0 4.7 12.3 12.9 17.5 13.8 17.2 20.2 6.1 13.0 18.5 11.8 15.4 9.3 10.4 8.5 9.3 10.6 7.3 13.9 6.5 6.2 14.4 25.6 17.9 14.4 17.5 10.7 19.5 VILL ENSG00000136059 "Villin like" O15195 3 37988059-38007188 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.3;stomach 1: 52.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 130.9;Paneth cells: 94.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 22.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.2;OE19: 40.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA035675, HPA035676" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA035675: AB_10671223, HPA035676: " "unprognostic (7.86e-3)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (1.35e-4)" "prognostic favorable (1.75e-4)" "unprognostic (1.69e-1)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.95e-2)" "unprognostic (3.66e-3)" "unprognostic (5.55e-2)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (7.43e-3)" 2.7 2.1 7.1 12.3 7.2 6.3 3.4 4.7 5.3 5.3 28.0 1.7 3.9 33.2 6.2 3.2 3.8 4.1 21.8 3.3 5.3 4.1 2.8 0.6 7.0 7.3 2.9 4.6 3.9 2.2 0.6 3.4 3.6 2.9 8.5 14.8 4.5 3.8 4.8 1.0 5.1 46.3 3.8 3.4 6.3 52.5 3.5 3.5 12.1 4.5 3.1 9.6 15.0 3.8 5.4 4.6 0.1 3.9 4.0 9.2 4.8 4.2 0.0 0.1 0.2 1.5 1.2 0.4 1.2 1.0 1.2 1.2 3.2 13.2 2.0 1.9 0.8 0.0 1.0 0.9 0.1 0.2 0.4 0.0 3.7 0.0 0.3 1.9 3.9 5.1 1.8 1.2 1.2 0.0 0.0 2.4 8.5 3.7 1.2 1.4 0.0 6.2 4.4 0.1 40.5 0.0 2.4 0.0 1.0 0.4 5.1 0.0 0.1 0.0 0.3 0.9 0.0 0.3 6.4 1.4 0.5 0.2 1.6 0.0 0.7 1.5 0.6 0.3 5.6 2.6 0.0 3.9 0.0 8.7 2.4 9.2 4.4 5.8 4.9 2.6 5.4 7.4 5.4 0.1 4.0 1.6 4.6 6.8 4.8 7.1 7.2 4.7 5.3 5.3 4.1 2.9 4.6 2.9 3.5 8.9 9.0 0.5 5.1 2.1 0.8 1.5 10.2 12.0 14.8 0.0 0.0 2.4 0.0 2.1 4.9 3.7 130.9 0.0 15.4 2.8 3.7 5.4 8.1 0.0 2.0 1.6 9.2 3.1 1.0 14.5 3.4 2.7 1.7 1.8 40.6 26.2 22.9 94.7 2.5 1.4 0.4 0.0 3.8 4.5 2.4 1.3 0.8 10.0 38.0 23.8 VPS11 "PEP5, RNF108" ENSG00000160695 "VPS11, CORVET/HOPS core subunit" Q9H270 11 119067692-119081978 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039020 Approved Approved Cytosol NA NA Cytosol "HPA039020: AB_10674847" "unprognostic (6.97e-2)" "unprognostic (3.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.15e-2)" "unprognostic (1.43e-2)" "unprognostic (1.28e-1)" "unprognostic (2.59e-3)" "unprognostic (1.11e-1)" "unprognostic (3.21e-1)" "unprognostic (9.17e-2)" "unprognostic (6.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (1.44e-4)" "unprognostic (4.07e-2)" "unprognostic (4.05e-2)" "unprognostic (2.71e-2)" "unprognostic (2.25e-1)" 6.2 7.3 5.3 5.3 10.2 10.2 6.5 5.6 16.3 6.7 4.6 11.3 4.5 4.8 6.6 6.9 5.1 8.2 5.6 5.5 4.7 6.3 3.4 6.2 7.4 5.7 7.9 8.6 6.5 12.5 8.3 8.4 9.4 6.6 5.2 8.6 5.8 7.5 5.5 7.5 4.6 7.5 3.2 6.3 4.4 5.2 5.4 9.3 8.6 3.4 6.7 6.0 0.9 9.8 17.8 15.7 15.2 12.8 14.3 12.0 5.7 5.7 6.7 4.9 13.4 12.6 6.7 7.0 9.6 9.1 9.1 9.3 10.8 7.9 10.2 13.5 14.7 9.6 8.1 9.6 7.2 8.3 5.6 17.7 7.2 9.7 17.6 10.2 11.1 13.6 10.6 13.9 7.3 12.8 11.5 9.0 12.6 12.9 10.7 14.1 7.9 9.4 2.9 9.7 10.7 9.3 9.1 5.2 8.7 11.9 4.8 8.1 8.5 11.0 7.7 6.7 17.2 8.8 10.2 8.9 3.7 3.7 5.2 6.1 5.5 7.1 6.0 12.8 7.6 15.7 15.2 12.8 13.2 11.6 14.3 9.8 11.5 12.5 17.8 9.8 10.8 13.1 3.0 12.8 14.5 7.6 12.9 12.0 6.0 10.9 8.0 4.2 2.6 11.2 5.5 5.1 6.7 13.6 8.7 11.8 8.9 8.3 6.7 6.7 9.8 7.9 0.0 8.8 5.8 6.6 2.8 15.0 4.7 14.9 4.8 9.2 11.6 14.3 1.4 15.8 10.8 6.8 10.8 10.9 9.5 6.7 7.0 14.5 9.1 14.2 12.9 8.9 8.6 6.5 4.3 11.8 9.6 7.9 3.1 VPS13D "FLJ10619, KIAA0453" ENSG00000048707 "Vacuolar protein sorting 13 homolog D" Q5THJ4 1 12230032-12512047 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 141.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027332, HPA051621" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA027332: AB_2672223, HPA051621: AB_2681555" "unprognostic (2.97e-1)" "unprognostic (8.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.75e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-3)" "unprognostic (3.33e-1)" "unprognostic (2.00e-2)" "unprognostic (1.57e-1)" "unprognostic (7.77e-2)" "prognostic favorable (7.42e-12)" "unprognostic (5.13e-1)" "unprognostic (1.72e-1)" "unprognostic (4.04e-2)" "unprognostic (8.31e-2)" 11.7 9.8 16.6 8.5 16.4 8.0 16.6 18.5 19.7 19.9 12.5 17.0 11.7 6.9 12.8 15.3 16.1 10.8 10.2 15.8 15.7 13.2 15.4 11.0 12.3 9.9 16.5 13.8 15.9 11.9 28.1 14.1 9.2 13.3 18.6 11.3 14.0 15.1 16.8 30.3 39.2 9.7 17.3 14.8 10.2 12.8 11.6 13.6 8.6 21.7 11.3 14.4 10.8 17.9 4.1 3.9 6.0 1.9 1.7 3.6 0.9 8.2 4.7 5.3 4.1 14.3 11.4 2.5 4.0 7.0 6.9 6.6 3.1 5.8 7.7 5.1 11.4 5.8 7.5 9.2 7.9 9.7 4.2 3.1 6.6 7.3 2.5 6.0 9.5 3.5 9.6 11.2 8.8 8.7 8.6 10.9 7.5 13.5 4.0 6.3 3.8 5.6 3.7 2.1 4.5 6.0 4.9 6.4 2.3 4.9 4.9 2.6 3.6 11.7 8.7 8.3 5.3 7.4 3.2 11.9 4.3 4.5 11.1 3.3 3.5 2.9 12.3 4.9 6.8 6.5 6.0 1.9 1.4 3.3 1.9 3.5 2.5 3.6 2.3 1.5 4.1 3.2 2.5 2.6 1.7 1.4 3.9 1.7 0.9 16.6 16.4 18.5 19.7 15.7 13.2 16.5 13.8 13.3 13.6 17.9 18.9 9.8 42.5 19.3 35.3 67.8 12.7 20.1 25.0 17.4 68.7 6.1 3.3 7.4 81.4 17.1 17.2 23.3 12.3 6.0 9.9 29.1 11.6 18.1 10.0 44.5 13.8 19.0 16.5 141.6 21.3 14.3 11.8 6.4 14.6 23.4 13.5 10.5 20.5 8.4 33.6 45.3 33.0 16.7 11.3 27.5 12.4 12.5 10.4 35.6 VPS29 "DC15, DC7, PEP11" ENSG00000111237 "VPS29, retromer complex component" Q9UBQ0 12 110491097-110502117 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039748 Uncertain Supported Vesicles,Cytosol NA NA 140000 "Vesicles, Cytosol" "HPA039748: AB_10674426" "unprognostic (9.46e-2)" "unprognostic (3.46e-3)" "unprognostic (2.16e-2)" "unprognostic (2.58e-1)" "unprognostic (3.08e-1)" "unprognostic (2.26e-2)" "prognostic unfavorable (2.79e-5)" "unprognostic (1.52e-1)" "unprognostic (3.37e-2)" "prognostic favorable (7.70e-4)" "unprognostic (1.64e-1)" "unprognostic (2.10e-3)" "unprognostic (2.96e-1)" "unprognostic (2.04e-2)" "unprognostic (2.11e-1)" "unprognostic (5.57e-2)" "unprognostic (4.29e-3)" 39.2 34.9 35.6 28.5 38.5 44.4 32.6 23.0 46.6 30.3 38.0 24.4 29.5 33.6 31.5 50.4 51.2 29.0 27.5 35.9 31.5 30.9 62.2 51.2 31.3 33.1 32.8 27.8 27.6 31.4 18.3 31.4 34.5 46.6 41.6 43.5 27.3 34.1 40.6 64.0 25.2 36.2 47.3 28.9 43.1 34.9 17.0 23.8 29.8 38.3 32.9 38.0 51.5 27.4 40.5 67.4 52.7 79.9 41.7 46.0 72.1 31.7 31.3 29.8 21.2 33.5 33.3 23.6 30.3 31.7 30.6 27.7 31.3 27.9 29.6 31.9 29.9 28.8 30.4 39.3 28.0 32.1 35.0 31.5 36.1 39.5 25.7 29.2 43.0 31.7 21.9 24.0 25.9 28.7 37.6 53.4 37.2 34.4 27.7 54.8 16.0 33.6 61.2 17.0 28.4 40.3 22.5 30.5 41.4 50.9 47.5 32.1 17.0 34.3 30.5 37.9 26.9 41.5 33.3 30.0 26.6 17.5 36.7 35.3 18.9 26.4 34.7 31.0 41.2 28.3 43.9 57.6 52.7 31.9 73.2 35.1 40.5 40.7 37.3 67.4 31.4 37.4 36.8 38.5 41.7 79.9 45.3 46.0 72.1 35.6 38.5 23.0 46.6 31.5 30.9 32.8 27.8 46.6 23.8 71.5 94.8 96.1 135.1 127.5 39.4 250.4 84.1 64.3 80.8 96.0 25.5 160.1 245.4 200.0 41.5 113.7 129.2 93.5 157.1 168.3 132.5 122.3 149.1 158.7 359.0 39.7 79.9 84.7 157.7 66.8 85.4 222.9 168.7 333.6 105.3 60.6 179.9 147.3 99.3 306.8 85.6 155.2 150.4 117.3 94.5 151.2 149.5 101.5 149.3 145.2 VPS37A "FLJ32642, HCRP1, PQBP2, SPG53" ENSG00000155975 "VPS37A, ESCRT-I subunit" Q8NEZ2 8 17246571-17302427 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024705, HPA024781" Supported Approved Vesicles,Centrosome,Cytosol NA NA Vesicles "Centrosome, Cytosol" "HPA024705: AB_10601776, HPA024781: AB_10602100" "unprognostic (8.28e-2)" "unprognostic (1.84e-1)" "unprognostic (9.39e-3)" "unprognostic (3.91e-1)" "unprognostic (2.10e-1)" "unprognostic (6.31e-2)" "unprognostic (5.88e-3)" "unprognostic (2.28e-2)" "unprognostic (1.43e-1)" "unprognostic (3.17e-1)" "unprognostic (1.02e-1)" "unprognostic (2.88e-1)" "unprognostic (5.06e-2)" "unprognostic (1.98e-2)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (2.18e-1)" 23.5 21.3 15.1 13.5 15.6 12.8 22.1 23.1 18.1 21.3 23.5 15.8 16.4 18.6 19.1 15.1 22.7 13.3 15.5 34.4 15.8 14.9 23.3 25.9 18.4 14.4 16.6 10.4 21.7 15.8 34.2 20.8 31.6 16.1 20.0 16.2 20.7 15.2 22.7 41.8 16.5 27.3 24.4 20.2 16.4 14.9 27.7 14.6 17.3 18.0 16.4 14.8 27.6 22.7 10.1 11.7 25.0 15.2 20.6 15.5 11.4 7.1 11.7 10.2 9.0 22.8 18.2 11.2 25.5 21.6 23.5 20.4 7.9 7.0 6.1 13.9 20.4 21.8 7.0 11.5 11.2 27.9 6.3 3.4 11.2 6.0 8.3 26.6 4.3 10.7 17.6 21.8 21.7 22.3 16.4 16.7 9.8 8.3 16.0 24.7 4.9 13.2 11.2 10.2 16.0 6.2 6.5 11.5 7.3 19.7 9.9 12.3 6.5 10.1 10.1 15.7 21.4 6.7 9.2 14.2 14.2 7.2 20.3 13.2 5.1 10.2 7.1 16.2 8.4 14.5 25.0 15.2 13.5 12.9 11.3 15.5 9.9 12.4 12.3 11.7 10.1 11.6 13.8 15.9 20.6 10.0 10.8 11.4 11.4 15.1 15.6 23.1 18.1 15.8 14.9 16.6 10.4 16.1 14.6 14.9 10.4 17.9 24.6 35.0 25.3 34.3 17.8 13.4 17.0 7.0 55.0 31.3 31.5 25.5 50.2 19.4 18.4 23.3 13.6 47.1 22.9 36.7 9.2 19.8 37.7 20.6 17.2 22.7 16.2 26.4 23.9 24.0 20.3 20.8 14.4 22.6 24.3 15.6 24.4 36.8 59.4 25.8 38.9 96.4 34.1 33.1 94.5 22.3 14.0 42.5 VPS50 "CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L" ENSG00000004766 "VPS50, EARP/GARPII complex subunit" Q96JG6 7 93232340-93361121 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026679 Approved Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA026679: AB_1846135" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-2)" "unprognostic (7.43e-2)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.37e-1)" "unprognostic (3.69e-1)" "unprognostic (5.17e-2)" "prognostic favorable (1.35e-6)" "unprognostic (2.08e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 15.9 16.3 16.4 15.3 24.2 6.9 21.6 26.1 28.3 13.0 16.0 9.9 13.3 11.5 17.7 17.5 15.7 11.9 10.4 12.6 19.8 16.0 20.0 12.1 13.2 15.3 16.4 22.2 15.4 13.5 23.9 30.8 12.8 26.7 14.3 18.5 7.5 15.0 14.2 18.7 16.8 12.8 14.8 15.9 15.5 14.1 13.8 19.2 15.8 15.8 14.0 15.3 14.2 12.9 5.5 10.4 4.2 8.1 5.2 11.2 4.3 11.1 6.7 8.7 13.4 16.2 11.6 8.7 10.5 9.0 10.9 12.0 9.4 13.0 9.9 11.9 9.1 20.1 9.6 12.9 10.0 15.2 11.5 9.0 18.4 13.0 5.9 9.9 9.4 10.1 9.8 11.6 13.2 13.3 10.7 14.1 9.7 14.5 12.8 14.5 11.1 8.8 8.4 6.0 15.2 9.5 7.0 11.5 13.4 10.2 8.9 6.3 13.4 12.2 26.8 10.8 13.7 9.2 7.1 12.7 15.9 9.4 29.0 10.7 7.0 15.5 11.9 11.7 9.3 12.6 4.2 7.0 3.4 6.2 8.1 11.2 5.5 6.9 7.6 10.4 5.5 5.5 7.4 1.7 5.2 4.8 5.1 8.1 4.3 16.4 24.2 26.1 28.3 19.8 16.0 16.4 22.2 26.7 19.2 11.9 9.9 3.4 3.8 0.0 11.8 0.0 2.5 10.7 9.1 5.2 15.7 5.9 3.3 6.3 12.3 5.3 1.1 23.3 4.7 9.2 1.9 2.7 7.0 6.4 9.4 9.5 2.4 9.8 10.4 11.0 8.3 6.4 0.0 6.4 9.9 8.5 6.3 7.0 6.7 6.9 13.7 6.5 0.0 17.2 12.5 0.0 7.9 6.9 5.9 2.0 VPS53 "FLJ10979, HCCS1" ENSG00000141252 "VPS53, GARP complex subunit" Q5VIR6 17 508668-721717 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 237.4;Late spermatids: 133.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 15.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022988, HPA024446" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" Cytosol "HPA022988: AB_1848679, HPA024446: AB_1848680" "unprognostic (8.62e-3)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.39e-2)" "unprognostic (9.08e-3)" "unprognostic (3.12e-1)" "unprognostic (9.67e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.53e-2)" "unprognostic (1.82e-2)" "unprognostic (1.89e-2)" "unprognostic (2.81e-1)" "unprognostic (4.82e-2)" "unprognostic (1.31e-1)" 10.0 9.7 15.7 9.0 19.3 13.0 8.8 34.5 21.6 10.5 11.4 11.5 11.7 8.5 10.2 9.1 16.3 10.0 9.2 9.1 13.4 14.0 10.0 8.8 11.1 8.0 11.8 17.5 10.6 8.8 14.4 13.0 10.4 15.9 10.8 12.0 9.3 9.6 11.3 13.9 19.6 9.1 10.5 10.3 9.2 13.5 13.5 11.7 12.2 14.7 6.0 12.5 8.9 9.9 2.8 2.8 15.5 7.2 1.2 2.3 0.8 9.4 13.2 5.9 6.3 9.1 7.1 3.2 10.0 5.7 9.9 8.1 7.9 3.1 6.4 5.9 9.7 6.0 9.4 8.2 8.1 10.9 6.0 9.2 5.3 9.9 5.8 5.7 4.8 6.9 6.8 5.4 8.7 6.3 6.2 8.2 6.5 4.7 6.2 7.9 4.7 6.0 1.8 4.7 3.6 5.1 8.8 2.7 3.5 6.5 10.0 4.2 6.8 11.8 4.4 5.1 5.7 4.5 2.1 13.9 6.2 4.5 9.1 6.4 3.8 2.5 3.9 9.0 3.0 4.9 15.5 2.0 2.3 2.3 3.5 1.6 1.9 1.8 1.8 1.7 2.8 1.8 1.9 2.4 1.2 7.2 2.8 1.0 0.8 15.7 19.3 34.5 21.6 13.4 14.0 11.8 17.5 15.9 11.7 11.9 23.4 12.8 12.1 22.7 47.2 15.5 15.3 18.7 27.3 38.4 66.8 8.1 1.7 14.5 237.4 14.3 19.3 0.0 15.8 6.2 12.3 15.8 23.1 14.7 18.3 60.4 23.6 16.5 18.4 133.5 17.3 19.0 10.1 18.0 21.4 20.4 20.3 14.0 21.5 7.9 53.1 6.5 13.3 29.9 19.0 33.9 7.4 24.5 16.6 14.8 VPS8 "FLJ32099, KIAA0804" ENSG00000156931 "VPS8, CORVET complex subunit" Q8N3P4 3 184812143-185052614 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036871 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA036871: AB_10672103" "unprognostic (4.36e-2)" "unprognostic (3.97e-3)" "unprognostic (1.53e-1)" "unprognostic (7.95e-2)" "unprognostic (5.11e-2)" "unprognostic (4.43e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (5.98e-3)" "unprognostic (1.98e-1)" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (3.15e-1)" "unprognostic (2.56e-1)" "unprognostic (8.10e-3)" "unprognostic (4.97e-2)" 12.6 11.1 14.9 11.1 20.9 22.6 12.0 21.6 24.8 15.5 12.5 18.2 8.0 9.1 16.4 19.0 11.5 10.1 12.5 20.3 17.1 19.3 12.5 9.2 13.8 14.8 21.5 13.6 16.7 10.1 21.8 23.6 13.3 28.4 12.8 16.7 12.1 9.5 12.0 28.4 14.2 9.9 14.5 21.9 14.9 14.1 17.8 15.9 13.2 17.5 9.0 11.5 12.5 11.6 3.9 6.0 17.7 4.9 3.9 6.4 3.1 10.2 6.3 9.6 9.6 20.0 17.9 6.4 10.1 11.2 7.4 10.4 7.9 5.4 11.1 17.8 15.8 30.6 12.2 10.3 12.4 14.4 20.0 9.2 12.1 7.8 4.7 12.4 8.2 16.3 12.7 11.9 10.5 10.7 13.7 18.7 10.4 6.2 8.0 13.5 7.3 6.5 4.9 6.3 10.6 6.0 8.1 18.4 8.6 7.4 18.0 9.8 6.4 11.8 12.5 9.2 14.9 19.8 4.3 16.4 11.5 6.5 11.6 8.9 9.9 12.0 15.2 13.1 10.3 8.9 11.7 4.9 16.2 4.0 3.7 3.8 3.5 4.3 4.0 6.0 3.9 6.4 4.3 17.7 3.9 4.6 1.7 3.5 3.1 14.9 20.9 21.6 24.8 17.1 19.3 21.5 13.6 28.4 15.9 11.9 8.6 13.7 7.9 9.3 20.3 23.2 12.7 16.0 7.9 8.7 17.7 10.2 6.6 7.7 11.6 12.0 9.3 0.0 4.0 4.9 9.5 7.7 2.3 6.7 17.6 11.1 17.3 12.3 16.2 13.6 9.8 20.2 10.1 31.5 14.3 12.1 6.3 11.9 12.0 7.0 16.6 6.5 8.1 45.6 24.9 14.1 6.4 14.4 10.7 12.9 VPS9D1 "ATP-BL, C16orf7" ENSG00000075399 "VPS9 domain containing 1" Q9Y2B5 16 89707134-89720986 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 13 "neutrophil: 16.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 16.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007847, HPA023620" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA007847: AB_1845582, HPA023620: AB_1845583" "unprognostic (7.08e-2)" "unprognostic (8.63e-2)" "unprognostic (6.26e-3)" "unprognostic (1.63e-3)" "unprognostic (5.67e-2)" "unprognostic (2.29e-3)" "unprognostic (5.03e-2)" "unprognostic (8.72e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (8.23e-3)" "unprognostic (1.37e-1)" "prognostic favorable (2.91e-5)" "unprognostic (4.06e-2)" "unprognostic (3.55e-1)" "unprognostic (2.25e-1)" "unprognostic (3.13e-3)" 8.6 15.4 16.1 19.2 17.9 14.2 5.3 22.7 30.6 6.7 7.1 13.3 8.8 16.6 7.1 7.2 17.0 7.0 9.3 11.0 17.2 16.3 11.7 15.0 8.2 10.4 12.6 24.1 6.4 12.2 16.5 17.6 6.8 17.6 7.9 4.9 10.2 15.3 8.4 12.8 12.6 13.0 6.2 9.3 15.7 10.3 13.5 10.6 1.7 9.3 7.5 7.7 8.5 7.6 0.2 0.2 16.6 0.6 0.1 0.4 0.1 4.6 6.9 7.7 8.3 7.8 7.7 6.5 8.5 8.8 7.3 3.6 6.0 10.2 4.7 5.5 9.2 4.1 10.6 0.6 4.8 2.1 4.2 11.8 3.3 6.0 7.2 6.0 1.9 8.2 8.4 4.4 8.8 2.0 11.9 5.0 4.4 8.4 2.9 4.8 20.7 3.5 7.4 2.9 3.6 8.0 8.8 6.4 2.9 5.8 7.3 6.5 6.9 10.8 4.1 8.6 2.5 18.3 8.2 7.9 9.7 12.1 7.8 5.1 13.4 4.2 4.1 14.0 5.1 8.0 1.2 0.6 0.3 0.2 0.4 0.0 0.2 0.1 0.1 0.2 0.2 0.4 0.2 16.6 0.1 0.2 0.0 0.2 0.1 16.1 17.9 22.7 30.6 17.2 16.3 12.6 24.1 17.6 10.6 6.0 6.1 4.1 1.8 1.8 12.3 7.2 2.5 1.4 5.7 8.7 9.8 2.6 6.6 4.4 10.5 2.2 9.8 0.0 6.7 1.9 4.1 1.4 4.6 9.6 4.3 7.9 10.4 8.6 9.4 16.4 5.8 6.4 3.3 1.0 4.1 6.6 4.9 3.6 5.6 4.9 11.9 0.0 4.3 8.6 4.3 3.3 2.5 3.1 6.3 1.7 VRK1 ENSG00000100749 "Vaccinia related kinase 1" Q99986 14 96797304-96931722 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.0" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 93.5;Spermatocytes: 141.1;Spermatogonia: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000660, HPA017929" Enhanced Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA000660: AB_1080579, HPA017929: AB_1858770" "unprognostic (1.03e-1)" "unprognostic (1.17e-2)" "unprognostic (1.84e-2)" "unprognostic (2.24e-3)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.20e-2)" "unprognostic (2.11e-2)" "unprognostic (5.47e-2)" "unprognostic (5.14e-2)" "unprognostic (1.60e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (4.56e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-1)" 6.0 4.4 7.1 9.8 17.1 39.0 8.7 8.6 10.2 6.1 7.8 4.4 4.1 5.2 5.9 5.7 9.4 6.9 3.3 6.0 7.4 6.5 6.2 4.3 4.5 18.3 6.9 6.1 5.9 3.7 3.8 5.1 7.1 6.7 5.3 9.1 4.1 4.8 4.1 4.3 6.4 6.9 5.4 6.1 15.7 6.7 33.3 6.9 33.0 4.9 6.1 18.4 5.9 5.7 20.8 13.5 20.1 9.5 28.5 22.3 12.5 15.8 9.1 22.7 10.1 2.7 5.0 14.1 12.0 9.3 19.2 19.2 10.9 15.8 40.4 8.1 7.1 11.8 17.6 21.2 15.7 26.5 23.0 11.3 25.1 6.0 11.1 3.0 48.4 15.8 2.7 2.8 14.5 10.6 3.9 13.3 31.0 21.4 25.6 16.5 18.1 38.4 20.8 14.5 12.1 17.5 36.0 39.7 13.7 8.8 16.4 16.0 9.1 10.6 10.8 8.1 11.9 12.4 19.2 7.1 8.8 7.8 15.1 12.0 13.4 15.8 39.1 13.7 21.2 10.4 20.1 7.6 14.5 15.1 9.3 18.4 20.3 17.6 18.5 9.9 20.8 19.1 19.3 4.5 28.5 9.5 13.5 22.3 12.5 7.1 17.1 8.6 10.2 7.4 6.5 6.9 6.1 6.7 6.9 3.0 2.9 30.5 11.8 14.9 12.3 10.6 15.3 42.8 13.6 14.0 7.9 19.7 10.0 9.8 13.3 11.3 2.4 93.5 16.8 39.6 10.4 5.3 27.7 2.4 16.3 9.5 2.9 6.2 9.7 10.8 5.2 11.5 11.8 12.6 8.0 5.2 7.6 0.0 9.2 8.4 6.6 19.4 11.3 141.1 122.1 12.2 12.6 26.7 11.2 8.4 VSIG1 MGC44287 ENSG00000101842 "V-set and immunoglobulin domain containing 1" Q86XK7 X 108044970-108079184 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 29.5;stomach 1: 66.6;testis: 87.4" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 14.1;Late spermatids: 8.0;Pancreatic endocrine cells: 19.7" "Group enriched" "Detected in many" 17 "lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.7;T-reg: 11.2" "Lineage enriched" "Detected in many" 4 "T-cells: 11.7" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.8;HUVEC TERT2: 11.9;PC-3: 4.0;TIME: 3.0" "Not detected" "Not detected" "HPA001445, HPA036310, HPA036311" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350" "unprognostic (4.33e-3)" "unprognostic (4.60e-2)" "unprognostic (3.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-1)" "unprognostic (4.80e-2)" "unprognostic (3.25e-2)" "unprognostic (9.79e-2)" "unprognostic (4.58e-1)" "unprognostic (2.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.25e-1)" "unprognostic (6.31e-7)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-3)" 0.1 0.0 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.3 0.8 0.1 0.3 0.1 0.2 0.2 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.0 1.3 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 66.6 87.4 0.1 0.1 0.1 0.1 0.4 1.5 0.1 2.6 0.1 0.6 0.1 0.2 11.7 2.5 0.2 1.0 0.0 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.5 0.0 5.8 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.3 0.4 1.0 0.1 1.9 0.1 11.9 0.1 0.1 0.3 0.0 0.4 0.4 0.3 0.4 1.1 4.0 0.4 0.0 0.0 0.7 1.1 0.2 0.1 0.2 0.2 0.6 0.0 0.1 0.0 3.0 0.3 0.9 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 1.0 0.0 3.7 2.6 7.7 3.3 0.0 1.0 11.7 5.4 0.4 0.2 0.1 0.1 11.2 2.5 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 23.8 14.1 0.0 0.6 0.6 0.8 0.4 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.0 4.9 0.3 0.0 0.0 4.1 0.0 0.2 0.6 2.3 0.0 0.1 0.0 0.0 0.0 0.0 8.0 0.6 0.2 0.0 0.0 0.0 0.1 19.7 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.5 0.0 0.1 0.5 0.0 0.9 VSIG10 ENSG00000176834 "V-set and immunoglobulin domain containing 10" Q8N0Z9 12 118063593-118136026 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 60.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 22.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062022 Enhanced Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA062022: AB_2732675" "unprognostic (1.32e-1)" "unprognostic (7.76e-2)" "unprognostic (2.05e-1)" "unprognostic (4.62e-3)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (1.75e-1)" "unprognostic (2.85e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.48e-2)" 8.1 10.2 2.6 9.8 3.1 0.4 18.0 2.9 2.6 8.2 31.6 2.7 5.2 11.7 4.5 4.5 8.9 4.0 7.6 3.6 2.4 2.2 6.2 11.9 11.6 3.8 3.2 1.4 5.9 10.9 8.9 4.0 12.2 3.4 8.4 13.9 4.0 6.3 6.4 12.9 4.6 60.9 3.8 2.5 3.3 5.5 3.9 2.5 1.7 26.3 6.1 4.9 6.1 8.6 0.7 2.4 3.5 2.0 0.4 0.6 0.4 4.9 7.3 3.1 10.5 13.1 5.9 7.9 8.5 5.5 4.2 3.5 2.1 11.8 0.7 3.4 6.3 7.9 12.1 22.0 2.2 5.0 2.4 3.3 1.1 6.9 3.2 2.6 0.6 1.8 2.7 6.4 3.2 2.0 12.3 9.2 2.4 1.4 0.1 3.9 5.2 0.0 0.7 9.7 14.5 4.6 1.8 8.6 0.0 6.2 16.1 2.7 3.4 8.3 3.5 2.2 7.0 7.7 3.3 10.7 4.9 3.1 6.0 4.3 0.1 0.1 0.0 7.1 3.5 9.7 0.6 2.0 2.3 0.4 0.6 0.6 0.0 0.4 0.2 2.4 0.7 0.4 0.6 3.5 0.4 0.2 0.7 0.6 0.4 2.6 3.1 2.9 2.2 2.4 2.2 3.2 1.4 3.4 2.5 17.9 22.9 0.8 12.2 2.2 9.7 9.2 20.4 4.0 6.8 27.9 11.8 33.6 16.6 22.4 5.1 15.5 75.3 0.0 17.6 31.6 6.0 13.2 2.3 24.2 9.5 4.8 48.5 16.5 4.3 6.5 16.7 7.2 3.3 10.8 45.7 23.2 20.5 45.6 13.8 9.9 8.0 0.0 5.6 3.9 6.5 2.8 11.7 2.9 51.9 14.0 VSIG4 Z39IG ENSG00000155659 "V-set and immunoglobulin domain containing 4" Q9Y279 X 66021738-66040125 "Plasma proteins, Predicted membrane proteins" "Complement alternate pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 31 "Hofbauer cells: 772.9;Kupffer cells: 436.3;Macrophages: 389.0" "Cancer enhanced" "Detected in all" "glioma: 88.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 26 "classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1" "Group enriched" "Detected in many" 30 "dendritic cells: 13.1;monocytes: 13.9" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.1;U-937: 2.7" "Low region specificity" "Detected in many" "HPA003903, CAB026000" Enhanced Uncertain "Nucleoli,Plasma membrane,Cytosol" NA NA 41000000 "Plasma membrane, Cytosol" Nucleoli "CAB026000: , HPA003903: AB_1858776" "unprognostic (6.87e-3)" "unprognostic (4.79e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (3.19e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (9.37e-3)" "unprognostic (1.24e-1)" "unprognostic (3.10e-1)" "unprognostic (1.37e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.95e-6)" "unprognostic (3.70e-2)" "unprognostic (5.45e-2)" "unprognostic (3.37e-2)" "unprognostic (3.47e-2)" 67.1 28.1 15.9 17.6 16.6 2.6 19.0 1.8 10.4 6.3 18.0 5.6 1.0 9.2 6.1 14.2 9.3 28.7 15.5 15.9 11.5 3.5 18.5 22.9 61.4 37.0 17.9 3.4 8.2 8.2 3.7 7.9 52.4 12.0 10.9 12.6 8.1 11.3 4.0 10.5 4.0 14.6 39.9 16.7 28.5 9.4 13.5 17.8 0.0 10.7 1.7 1.8 14.4 9.0 0.1 13.1 0.4 13.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.0 0.1 3.1 0.2 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.8 2.7 0.0 0.0 13.9 0.0 0.0 8.1 0.0 0.0 0.0 0.2 13.1 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 3.3 15.9 16.6 1.8 10.1 11.5 3.5 17.9 3.4 12.0 17.8 3.0 17.3 3.0 0.1 2.1 0.0 0.8 7.6 8.1 5.7 0.0 0.0 4.4 0.0 0.0 5.8 1.9 0.0 0.0 0.0 3.7 3.8 0.2 3.5 2.4 772.9 0.0 0.0 5.5 436.3 13.2 1.4 389.0 3.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 6.5 0.2 0.2 0.9 1.5 10.3 0.0 0.0 0.2 VSNL1 "HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1" ENSG00000163032 "Visinin like 1" P62760 2 17539126-17657018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 165.7" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 23.4;Cardiomyocytes: 27.7;Club cells: 29.6;Hepatocytes: 16.8;Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 44.2;Hep G2: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053808 Approved Cytosol NA NA Cytosol "HPA053808: AB_2682270" "unprognostic (1.04e-1)" "unprognostic (7.90e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (6.90e-4)" "unprognostic (4.90e-2)" "unprognostic (5.48e-2)" "unprognostic (2.81e-2)" "unprognostic (4.66e-2)" "unprognostic (2.99e-1)" "unprognostic (1.65e-1)" "unprognostic (2.18e-1)" "unprognostic (5.14e-4)" "unprognostic (3.26e-2)" "unprognostic (1.23e-1)" "unprognostic (6.19e-3)" "unprognostic (1.51e-2)" 1.4 13.6 36.5 1.7 48.8 1.2 3.9 91.6 165.7 1.8 3.0 3.3 0.0 1.3 1.7 1.2 18.0 1.9 1.3 17.5 34.8 27.9 2.0 10.5 2.4 1.2 19.9 66.1 2.8 1.7 1.2 0.2 3.4 64.0 3.0 3.6 0.1 3.2 1.5 1.7 5.2 1.3 1.6 7.1 1.3 1.7 1.5 1.4 0.0 1.5 3.1 4.1 2.3 3.4 0.1 0.7 0.2 0.1 0.1 0.5 0.1 0.2 0.0 0.5 8.0 0.9 1.3 0.0 0.0 0.0 0.0 0.2 0.1 4.8 0.0 0.0 0.0 0.0 44.2 0.3 1.5 0.0 0.0 0.2 0.0 0.0 44.7 0.0 0.0 0.1 0.3 2.3 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 8.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 3.6 3.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.6 0.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.2 0.1 0.1 0.7 0.0 0.1 36.5 48.8 91.6 138.6 34.8 27.9 19.9 66.1 64.0 1.4 0.0 0.3 0.0 23.4 16.3 6.9 27.7 2.5 0.0 29.6 0.0 0.0 0.3 1.7 0.0 3.9 0.7 0.0 0.0 0.2 0.1 5.8 4.9 0.0 16.8 0.5 3.2 1.2 0.0 0.3 4.7 0.6 0.0 3.3 1.0 4.0 3.2 0.3 0.0 0.0 1.4 10.5 0.0 1.4 1.8 0.6 17.7 0.3 0.7 4.1 8.8 VTA1 "C6orf55, HSPC228, My012" ENSG00000009844 "Vesicle trafficking 1" Q9NP79 6 142147162-142224689 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030968, HPA030969" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA 22000 "Nucleoplasm, Vesicles, Cytosol" "HPA030968: AB_10602585, HPA030969: AB_2673679" "prognostic unfavorable (7.02e-4)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.17e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (6.58e-6)" "unprognostic (2.83e-2)" "unprognostic (3.61e-1)" "unprognostic (5.18e-2)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (3.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.96e-1)" "unprognostic (3.24e-1)" 18.8 19.5 20.5 15.5 28.2 17.2 20.6 25.0 39.3 17.2 22.0 18.5 9.6 24.2 16.0 17.1 31.4 17.9 14.9 21.2 19.8 20.3 24.9 29.9 13.5 19.3 20.1 20.7 15.3 15.6 16.3 21.7 30.5 30.7 16.8 26.3 11.2 19.4 13.5 48.6 20.9 32.7 17.0 24.0 20.8 14.6 12.9 18.2 33.6 18.0 24.3 24.0 18.4 19.7 29.0 30.9 58.6 38.1 30.9 30.1 36.1 18.4 15.9 26.0 39.8 23.0 25.3 18.0 42.0 25.1 38.5 36.8 26.9 14.5 30.2 28.4 37.6 29.3 23.7 27.6 28.6 53.4 20.4 24.3 32.7 17.1 32.1 17.0 50.7 19.0 20.9 33.6 38.4 24.9 20.7 24.6 23.6 30.3 15.2 32.1 27.0 32.9 26.4 19.5 23.9 18.3 30.3 20.9 18.4 29.6 20.6 27.3 21.2 23.6 18.2 21.1 22.7 19.7 34.6 17.8 17.4 24.2 29.0 30.1 15.0 25.9 34.4 11.4 28.4 26.4 58.6 31.0 49.5 23.5 38.1 30.1 29.0 26.8 27.4 30.9 26.6 29.8 29.9 19.1 30.9 37.4 19.0 25.7 36.1 20.5 28.2 25.0 39.3 19.8 20.3 20.1 20.7 30.7 18.2 20.8 16.9 15.6 15.3 22.3 9.1 37.0 10.2 40.2 25.0 15.7 0.0 28.5 14.9 26.8 2.2 15.7 29.3 0.0 24.4 30.4 20.0 13.7 11.6 22.7 24.3 11.1 20.7 8.0 20.8 2.1 10.9 15.6 8.5 18.0 24.5 21.3 24.7 17.5 11.7 24.5 10.8 6.5 8.2 20.6 25.7 27.0 26.5 16.2 23.7 15.3 VWA3B "DKFZp686F2227, MGC26733" ENSG00000168658 "Von Willebrand factor A domain containing 3B" Q502W6 2 98087116-98313299 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "fallopian tube: 24.4;testis: 51.9" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 178.0;Early spermatids: 410.6;Late spermatids: 741.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Group enriched" "Detected in many" 5 "amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.0;U-138 MG: 1.7" "Low region specificity" "Detected in many" "HPA036700, HPA036701" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036700: AB_2675261, HPA036701: AB_10673505" "unprognostic (2.36e-2)" "unprognostic (4.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.01e-3)" "unprognostic (5.16e-2)" "unprognostic (3.27e-1)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (1.44e-2)" "unprognostic (4.53e-2)" "unprognostic (6.41e-2)" "unprognostic (2.63e-7)" "unprognostic (2.57e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (4.96e-2)" 0.0 0.0 1.0 0.2 1.7 0.0 0.0 0.0 0.2 1.1 0.2 2.0 0.0 0.0 0.5 4.3 0.0 24.4 0.5 0.4 1.7 1.6 0.0 0.0 4.0 0.0 0.1 0.1 2.3 0.0 0.0 1.1 0.1 3.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 51.9 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.1 1.7 1.6 0.1 0.1 3.2 0.3 0.0 0.6 0.0 1.1 0.2 0.6 0.8 0.0 178.0 19.4 1.8 29.5 0.0 0.0 0.0 410.6 0.0 0.2 0.0 0.4 0.1 0.4 0.3 0.0 0.0 0.2 0.0 1.7 1.8 0.0 741.4 4.4 0.9 0.0 1.0 1.3 0.3 0.1 1.5 5.3 0.0 0.5 0.0 0.3 16.1 5.4 0.4 0.0 0.0 0.8 0.5 VWA5B1 FLJ32784 ENSG00000158816 "Von Willebrand factor A domain containing 5B1" Q5TIE3 1 20290919-20354894 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.6;epididymis: 6.4;testis: 6.9" "Group enriched" "Detected in some" 12 "Early spermatids: 7.7;Late spermatids: 6.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 5 "pons and medulla: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027496, HPA028405, HPA064829" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Secreted in male reproductive system" NA NA Mitochondria "Plasma membrane, Cytosol" "HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363" "unprognostic (2.34e-1)" "unprognostic (2.91e-1)" "unprognostic (7.78e-2)" "unprognostic (1.16e-2)" "unprognostic (4.73e-2)" "unprognostic (1.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.86e-2)" "unprognostic (4.39e-2)" "unprognostic (1.73e-1)" "unprognostic (5.41e-4)" "unprognostic (7.43e-4)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" 0.0 1.2 0.7 0.2 3.3 0.0 0.0 0.0 0.5 0.0 0.0 6.1 0.0 0.0 0.0 6.4 0.1 0.7 0.5 0.1 2.8 3.3 2.0 0.0 0.1 0.2 0.2 0.4 0.0 0.1 2.2 5.6 0.2 17.6 0.2 0.0 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.9 0.5 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.5 2.8 3.3 0.2 0.4 17.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 VWA7 "C6orf27, G7c, NG37" ENSG00000204396 "Von Willebrand factor A domain containing 7" Q9Y334 6 31765590-31777294 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.6;pituitary gland: 20.5" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Enterocytes: 1.8;Intestinal endocrine cells: 4.1;Paneth cells: 2.3;Proximal tubular cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.2;HeLa: 3.4;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.5" "Group enriched" "Detected in some" 5 "cerebellum: 7.8;pons and medulla: 4.1" "Low region specificity" "Detected in many" "HPA046954, HPA054262" Approved Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA "Plasma membrane, Cytosol" "HPA046954: AB_2679875, HPA054262: AB_2682430" "unprognostic (9.13e-2)" "unprognostic (8.60e-4)" "unprognostic (9.99e-2)" "unprognostic (2.43e-1)" "unprognostic (2.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.38e-2)" "unprognostic (4.40e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-2)" "unprognostic (1.65e-2)" "unprognostic (9.25e-2)" "prognostic favorable (4.35e-8)" "unprognostic (3.75e-2)" "unprognostic (2.37e-1)" "unprognostic (9.48e-2)" "unprognostic (7.66e-2)" 1.1 1.6 3.1 1.4 9.5 1.1 1.2 5.6 10.5 1.1 1.9 0.0 3.9 2.6 4.6 3.0 1.1 19.6 2.0 3.9 1.6 5.5 5.6 1.5 2.5 1.2 1.7 5.4 1.4 2.5 5.1 20.5 1.0 9.7 1.3 1.7 0.8 1.7 2.0 5.3 1.7 3.3 2.3 2.3 1.3 5.8 1.3 2.3 0.0 1.8 0.6 1.3 1.3 0.8 0.2 0.0 1.2 0.0 0.0 0.4 0.0 0.5 1.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.1 2.2 0.5 0.7 0.3 0.1 0.9 0.7 0.2 0.0 0.0 0.0 0.1 3.4 0.5 0.1 0.0 0.9 0.1 0.9 0.1 0.0 0.2 0.0 0.6 0.2 3.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.3 0.0 2.1 2.2 0.0 0.3 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.8 0.0 0.1 4.5 1.3 0.1 0.0 0.6 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.0 3.1 9.5 5.6 10.5 1.6 5.5 1.7 5.4 9.7 2.3 0.0 0.6 0.0 0.5 0.1 0.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.4 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 VWCE "FLJ32009, URG11, VWC1" ENSG00000167992 "Von Willebrand factor C and EGF domains" Q96DN2 11 61258286-61295424 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 19.8;ovary: 10.7" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 27.5;Hepatocytes: 14.0;Rod photoreceptor cells: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.7;Hep G2: 19.3;HSkMC: 11.4;REH: 10.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA040401, HPA043921" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 1300000 Nucleoplasm "Vesicles, Cytosol" "HPA040401: AB_2676963, HPA043921: AB_2678731" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (1.15e-1)" "unprognostic (3.96e-3)" "unprognostic (9.27e-4)" "unprognostic (1.21e-2)" "unprognostic (4.01e-4)" "unprognostic (3.04e-2)" "unprognostic (3.42e-2)" "unprognostic (6.58e-4)" "unprognostic (7.20e-2)" "unprognostic (3.01e-1)" "unprognostic (1.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-1)" 2.9 1.1 0.9 0.6 1.3 2.3 3.1 0.7 1.3 2.8 1.0 1.4 3.4 0.5 1.4 2.9 1.5 5.7 1.4 1.0 1.3 1.2 0.6 19.8 0.8 0.3 0.4 1.1 10.7 0.1 0.5 0.5 9.1 0.3 1.8 0.6 1.3 1.7 1.0 1.9 0.9 1.1 1.2 0.2 0.9 0.3 1.8 0.5 6.5 0.8 1.0 1.0 1.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.2 1.1 0.4 0.2 1.8 0.0 0.3 5.7 0.0 0.3 0.0 0.4 0.1 0.0 2.0 0.0 0.1 0.4 0.0 0.5 0.0 19.3 1.1 0.0 0.1 11.4 0.5 0.5 0.0 0.1 1.8 2.6 0.2 0.3 0.3 0.1 4.2 0.0 1.6 0.0 0.0 10.9 0.1 0.0 0.1 0.1 0.4 0.9 0.0 0.1 0.6 2.0 0.7 0.0 0.5 0.2 0.3 0.5 0.1 0.2 0.4 0.9 0.8 0.2 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.7 1.3 1.3 1.2 0.4 1.1 0.3 0.5 3.0 1.7 0.0 1.5 1.5 3.2 0.7 0.0 5.3 2.3 0.0 27.5 0.9 0.0 0.1 0.4 2.2 0.0 0.0 0.4 2.2 1.4 0.4 3.5 14.0 1.1 0.0 1.7 3.1 4.0 0.0 6.4 2.2 1.7 1.8 0.0 3.2 0.0 0.0 1.8 0.3 17.1 0.0 0.5 0.9 3.0 1.9 3.7 0.5 0.1 0.7 VWDE FLJ14712 ENSG00000146530 "Von Willebrand factor D and EGF domains" Q8N2E2 7 12330885-12403941 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 29.5" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 1.7;Cardiomyocytes: 4.7;Ciliated cells: 1.4;Glandular cells: 2.2;Urothelial cells: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 10.8;NTERA-2: 5.4;SCLC-21H: 8.7" "Low region specificity" "Detected in many" "HPA026619, HPA036044" Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Cytosol Nucleoplasm "HPA026619: AB_2671920, HPA036044: AB_2674916" "unprognostic (6.39e-2)" "unprognostic (1.65e-3)" "unprognostic (5.36e-3)" "unprognostic (1.78e-4)" "unprognostic (1.39e-2)" "unprognostic (4.19e-3)" "unprognostic (2.38e-1)" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (6.25e-2)" "unprognostic (1.68e-1)" "unprognostic (6.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-3)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.73e-1)" 0.4 0.5 1.6 0.3 2.7 2.3 2.3 0.4 2.3 0.8 0.9 0.0 0.9 0.2 0.7 4.9 0.8 1.5 0.7 4.1 0.8 0.5 0.7 0.5 0.7 0.2 0.4 0.5 0.5 0.9 0.0 29.5 0.3 0.5 1.5 0.3 0.1 5.7 5.5 0.4 0.6 0.6 0.2 0.4 0.5 2.0 0.6 0.0 0.1 6.2 0.0 1.3 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.5 0.0 0.3 1.8 0.0 2.1 0.7 0.8 0.4 3.0 0.2 0.0 0.0 0.7 0.4 2.1 2.0 0.6 4.0 2.2 3.5 4.8 0.0 0.0 1.1 2.4 0.1 0.3 0.0 1.2 2.7 0.8 1.2 10.8 0.0 0.0 1.2 0.0 0.0 5.4 0.0 0.6 0.0 0.0 1.6 0.0 1.3 8.7 1.4 0.0 1.7 0.0 1.4 0.0 1.1 0.1 0.0 1.0 0.0 0.9 3.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.9 0.1 1.6 2.7 0.4 2.3 0.8 0.5 0.4 0.5 0.5 0.0 0.0 1.0 0.0 1.7 0.2 0.0 4.7 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.2 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.4 1.6 WAPL "FOE, KIAA0261, WAPAL" ENSG00000062650 "WAPL cohesin release factor" Q7Z5K2 10 86435256-86521815 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037874, HPA037875, HPA066141" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Mitotic spindle,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytokinetic bridge, Mitotic spindle, Centrosome, Cytosol" "HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: " "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (3.03e-2)" "unprognostic (2.91e-2)" "unprognostic (6.63e-2)" "unprognostic (3.51e-1)" "unprognostic (3.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (5.78e-2)" "unprognostic (5.56e-2)" "unprognostic (7.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (4.56e-1)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" 15.3 15.4 16.0 15.5 16.9 19.8 15.6 23.6 15.0 13.4 14.0 12.1 6.8 12.5 16.0 8.7 20.4 12.6 11.2 13.3 15.3 8.2 14.5 23.1 17.5 19.3 14.8 11.5 14.8 13.6 18.1 18.2 19.0 13.4 13.9 13.1 9.4 14.9 10.6 34.4 20.4 16.0 16.0 16.4 18.2 13.5 28.1 16.4 39.2 15.9 9.4 22.4 15.1 15.9 5.2 6.2 14.3 8.7 3.9 7.7 3.1 20.2 9.5 16.7 22.0 13.3 14.2 14.7 17.8 22.0 15.2 16.6 20.6 17.9 30.8 12.1 15.9 13.4 19.1 18.9 15.3 23.4 20.0 12.4 18.6 15.2 22.6 15.2 37.6 21.5 11.1 17.9 19.4 32.7 17.3 16.9 18.0 19.5 18.6 17.3 17.3 23.4 14.1 14.8 12.7 9.6 16.7 13.5 12.2 13.1 18.0 6.5 12.6 15.7 10.6 19.3 17.3 23.2 20.1 16.2 14.6 17.4 12.8 23.3 18.3 25.4 32.6 13.4 26.9 10.3 14.3 4.7 9.4 4.7 5.3 7.0 5.2 6.3 6.5 6.2 4.8 7.2 5.7 7.3 3.9 8.7 4.7 7.7 3.1 16.0 16.9 23.6 15.0 15.3 8.2 14.8 11.5 13.4 16.4 77.4 51.5 21.9 40.4 0.0 47.2 0.0 12.7 25.4 38.7 15.7 19.6 36.2 18.3 52.5 61.6 29.2 15.6 70.0 46.0 25.0 22.4 50.1 23.3 41.2 35.6 52.4 17.5 28.8 48.6 27.3 29.7 49.5 0.0 56.9 31.7 45.3 46.8 37.1 30.4 26.7 127.3 64.7 0.0 125.1 82.8 0.0 63.6 38.9 32.2 54.7 WARS "IFI53, IFP53" ENSG00000140105 "Tryptophanyl-tRNA synthetase" P23381 14 100333788-100376805 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 142.8;thyroid gland: 157.0" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "intermediate monocyte: 131.2;non-classical monocyte: 142.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 118.8;SK-MEL-30: 143.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005573, HPA018944" Enhanced Enhanced Cytosol No No 53000000 Cytosol "HPA005573: AB_2667366, HPA018944: AB_2669986" "unprognostic (5.36e-2)" "unprognostic (5.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.54e-1)" "unprognostic (2.30e-1)" "unprognostic (9.25e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.14e-2)" "unprognostic (4.26e-2)" "prognostic favorable (1.94e-4)" "unprognostic (4.84e-2)" "unprognostic (3.21e-1)" "unprognostic (3.53e-3)" "unprognostic (1.37e-1)" "unprognostic (9.45e-2)" "unprognostic (1.62e-1)" "unprognostic (5.92e-3)" 42.5 23.3 14.5 53.9 20.1 17.0 20.6 10.7 25.4 11.1 19.1 13.3 7.1 12.7 16.5 20.5 17.8 14.5 13.7 32.0 17.8 18.7 24.6 17.9 68.5 35.3 16.9 14.8 12.1 15.6 9.4 23.5 89.6 28.2 16.4 21.0 23.5 15.7 11.7 22.3 9.3 19.8 21.0 15.7 51.6 19.8 23.7 9.4 20.9 157.0 19.2 22.7 24.0 13.8 5.6 27.7 51.8 142.8 3.3 3.4 46.4 11.1 10.6 7.0 40.7 10.1 14.4 11.2 14.4 27.9 31.0 39.2 6.9 10.0 12.1 13.5 34.3 7.6 19.0 20.2 16.4 20.0 19.2 5.8 7.8 8.1 8.5 118.8 22.2 12.8 16.3 23.6 18.0 37.5 9.4 27.8 8.2 24.4 32.1 13.2 21.3 7.6 10.4 7.0 11.4 19.3 6.4 11.0 7.7 15.1 9.8 18.7 10.9 8.6 7.5 143.4 9.4 19.1 28.2 18.4 3.3 7.5 33.9 7.5 62.6 31.8 22.5 37.4 17.3 30.2 6.1 39.5 51.8 3.4 131.2 3.1 5.6 2.8 3.1 27.7 4.1 2.0 2.4 14.1 3.3 142.8 4.2 3.3 46.4 14.5 20.1 10.7 25.4 17.8 18.7 16.9 14.8 28.2 9.4 23.8 39.7 41.6 6.7 12.9 9.0 12.1 7.6 30.8 29.6 21.0 19.6 14.6 13.3 29.0 112.5 76.4 8.5 0.0 56.4 9.8 20.5 12.1 29.0 14.9 40.6 7.9 14.3 87.8 44.2 82.6 10.6 72.8 8.5 71.3 14.1 9.3 34.3 7.2 12.7 15.3 15.8 19.4 21.7 69.3 20.9 10.7 13.8 10.2 10.1 11.4 WAS "IMD2, THC, WASP, WASPA" ENSG00000015285 "Wiskott-Aldrich syndrome" P42768 X 48676596-48691427 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.7;lymphoid tissue: 55.9" "Cell type enhanced" "Detected in many" 8 "B-cells: 72.2;Hofbauer cells: 95.2;Kupffer cells: 94.9;Macrophages: 70.0;T-cells: 87.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 20.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 21.7;HEL: 19.1;HMC-1: 46.5;MOLT-4: 19.7;NB-4: 21.5;RPMI-8226: 26.5;THP-1: 19.5;U-266/70: 24.6;U-937: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002022, CAB004290" Enhanced Approved "Plasma membrane,Cytosol" NA NA 320000 "Plasma membrane" Cytosol "CAB004290: AB_628445, HPA002022: AB_1080581" "unprognostic (1.43e-3)" "unprognostic (2.09e-3)" "unprognostic (2.36e-2)" "prognostic favorable (4.95e-4)" "unprognostic (9.89e-2)" "prognostic favorable (3.78e-4)" "unprognostic (5.12e-3)" "unprognostic (7.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (7.40e-2)" "unprognostic (3.60e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (2.24e-1)" "unprognostic (2.37e-2)" "unprognostic (3.55e-2)" "unprognostic (1.71e-1)" 7.6 4.0 4.9 28.9 7.8 30.7 3.3 2.0 5.1 2.7 4.4 5.9 0.5 4.8 2.4 5.6 3.7 4.5 4.4 3.0 4.6 4.1 4.1 5.0 12.6 29.9 7.6 1.3 2.6 2.2 0.7 2.6 5.4 6.0 3.2 3.2 3.5 5.4 1.9 1.4 2.2 14.3 3.7 12.8 55.9 4.1 1.7 7.3 53.2 2.8 1.4 33.2 5.8 2.5 2.1 3.5 20.3 5.3 2.1 3.2 2.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 21.7 0.1 0.0 0.1 0.7 0.0 0.0 0.0 12.5 0.1 19.1 0.2 0.0 0.2 9.8 46.5 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.2 13.4 0.0 2.2 19.7 21.5 0.1 0.3 0.1 17.3 0.0 26.5 0.0 0.0 0.1 0.2 0.3 0.2 0.2 0.1 0.1 19.5 0.1 0.0 0.1 0.3 0.0 24.6 12.0 15.2 0.1 24.8 0.0 1.8 4.6 20.3 3.0 5.0 2.2 1.8 2.3 2.5 3.5 2.1 2.1 2.3 18.1 2.1 5.3 1.8 3.2 2.0 4.9 7.8 2.0 5.1 4.6 4.1 7.6 1.3 6.0 7.3 3.0 21.3 72.2 0.1 2.2 0.0 0.8 0.0 2.7 0.0 0.0 0.0 0.8 1.7 0.1 0.5 0.5 0.0 23.3 0.3 0.9 1.5 0.2 46.2 0.9 95.2 0.0 1.2 5.5 94.9 0.8 0.0 70.0 3.3 45.9 0.0 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.6 1.4 1.1 1.3 1.1 87.0 0.0 0.1 WASF2 "SCAR2, WAVE2" ENSG00000158195 "WAS protein family member 2" Q9Y6W5 1 27404226-27490158 "Predicted intracellular proteins" "Host-virus interaction" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022632, HPA045288" Enhanced Approved "Plasma membrane,Cytosol" NA NA 470000 "Plasma membrane" Cytosol "CAB022632: , HPA045288: AB_2679287" "unprognostic (9.58e-2)" "unprognostic (8.93e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (4.40e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (5.29e-8)" "unprognostic (3.94e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (7.60e-3)" "unprognostic (1.10e-1)" "unprognostic (9.15e-3)" "unprognostic (2.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.26e-2)" 36.9 23.3 22.0 23.8 30.0 30.0 28.6 13.6 24.0 31.9 28.8 33.2 13.2 15.7 36.9 16.0 55.3 28.8 22.3 20.5 22.8 13.1 20.2 11.6 29.4 31.1 32.5 12.6 38.8 24.0 21.3 14.8 29.7 23.2 26.4 23.3 22.2 25.6 26.1 11.4 35.1 26.7 42.9 31.5 34.0 26.4 20.7 32.7 32.3 21.6 22.2 35.2 39.1 30.3 18.9 21.8 36.9 38.4 8.5 12.9 16.8 24.4 11.7 27.3 24.8 19.9 26.1 15.8 20.0 18.6 22.1 19.9 10.1 26.5 17.0 19.4 31.2 15.0 19.7 21.9 32.8 26.5 23.8 13.8 37.1 20.8 11.9 26.8 29.6 21.4 23.8 35.8 24.0 45.0 24.0 27.6 19.0 29.5 8.9 29.9 8.8 22.0 13.6 21.9 12.5 18.1 46.1 33.5 17.4 15.8 13.9 13.6 15.0 34.9 15.6 26.1 17.3 13.0 18.0 36.2 18.4 19.1 38.0 15.7 18.3 24.1 22.8 21.7 36.8 20.6 14.8 23.3 18.5 12.9 29.1 10.5 14.1 10.2 8.9 14.8 18.9 10.7 8.1 36.9 8.5 38.4 21.8 10.2 16.8 22.0 30.0 13.6 24.0 22.8 13.1 32.5 12.6 23.2 32.7 62.5 51.0 92.0 173.5 131.5 24.5 30.1 86.6 64.3 69.4 85.5 13.7 174.6 53.0 89.1 42.3 188.8 120.0 46.7 88.6 107.9 114.2 242.5 56.7 41.4 133.0 19.1 104.2 120.3 180.2 47.6 152.8 97.4 72.6 162.3 79.4 56.5 119.6 91.2 171.5 37.6 19.4 135.8 119.5 121.8 114.1 170.0 120.0 87.1 89.2 299.4 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 35.7;Ciliated cells: 76.3;Club cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavorable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 24.0 21.0 15.8 31.4 19.3 24.7 27.1 22.5 18.3 19.1 21.2 16.2 12.6 19.4 22.8 15.3 15.7 15.5 14.4 42.9 17.6 13.9 26.1 12.1 20.7 20.2 15.3 15.8 22.5 14.0 21.2 27.0 17.7 22.0 16.7 23.0 13.1 17.5 16.5 15.5 19.2 21.3 16.8 14.6 27.4 16.2 9.4 14.8 27.0 21.4 9.8 20.2 18.4 27.4 6.6 9.0 11.7 13.9 9.0 12.5 8.8 11.1 5.4 9.2 10.8 37.6 21.0 7.5 13.1 27.8 19.5 20.8 12.5 16.7 9.8 8.2 19.5 18.3 12.2 13.3 11.0 19.3 9.4 9.7 7.0 10.8 12.5 26.2 11.9 12.2 21.6 13.9 21.3 13.5 20.5 14.7 8.4 11.3 9.9 23.4 7.9 6.5 19.5 7.5 7.1 25.5 10.0 13.4 5.8 13.4 12.8 3.2 9.9 12.2 11.3 17.4 14.2 14.0 8.2 21.5 10.0 8.4 28.1 10.7 10.3 20.3 8.4 21.9 21.9 4.0 1.2 10.7 11.7 12.0 13.9 12.5 6.6 10.2 11.0 9.0 6.5 10.2 7.4 5.1 9.0 8.2 5.3 10.4 8.8 15.8 19.3 22.5 18.3 17.6 13.9 15.3 15.8 22.0 14.8 35.7 22.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 42.1 14.0 0.0 6.6 0.0 14.2 0.0 0.0 0.0 0.0 13.5 5.7 0.0 0.0 14.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 10.0 0.0 0.0 12.2 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792961 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 26.2;Ciliated cells: 45.5;Collecting duct cells: 22.7;granulocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 17.2 15.8 10.0 33.6 15.7 30.1 27.2 24.9 17.1 16.7 15.8 10.7 15.9 12.2 18.3 17.0 12.3 13.2 13.6 23.2 14.2 10.2 20.6 12.8 17.3 14.8 16.0 8.4 20.2 10.1 22.7 16.5 13.4 16.2 13.4 18.5 13.0 15.3 24.0 17.1 14.8 17.0 15.8 14.0 15.5 12.5 10.1 15.3 19.4 14.9 13.2 14.6 19.3 14.8 10.7 11.4 17.2 20.3 12.2 13.4 11.6 11.2 12.2 9.9 11.3 25.9 23.0 6.0 13.3 21.9 15.7 15.2 7.4 11.1 9.3 9.1 19.6 15.0 10.3 11.1 6.1 15.9 8.7 9.2 9.6 15.2 5.7 27.5 9.6 12.0 21.7 14.8 17.0 12.8 15.5 16.2 7.9 15.3 7.4 19.3 5.9 6.4 16.7 7.2 6.8 1.9 8.1 14.6 4.8 11.7 17.8 4.8 10.9 15.4 7.8 18.6 10.6 10.5 9.7 27.2 8.2 8.8 21.7 8.9 10.5 16.2 9.3 11.6 23.2 4.3 12.5 16.9 11.0 13.0 18.2 12.5 10.7 10.8 13.4 11.4 9.6 10.8 9.7 17.2 12.2 20.3 8.4 10.1 11.6 10.0 15.7 24.9 17.1 14.2 10.2 16.0 8.4 16.2 15.3 32.8 26.2 0.0 0.0 0.0 0.0 0.0 0.0 45.5 21.6 22.7 0.0 6.2 3.3 10.9 0.0 0.0 0.0 0.0 12.1 5.4 0.0 0.0 27.9 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 18.0 0.0 0.0 10.6 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 WASL "N-WASP, NWASP, WASPB" ENSG00000106299 "Wiskott-Aldrich syndrome like" O00401 7 123681935-123749067 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 212.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 45.1;U-2197: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005399, HPA005750" Supported Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB005399: AB_2288632, HPA005750: AB_1854729" "unprognostic (1.91e-1)" "unprognostic (3.60e-2)" "unprognostic (8.19e-2)" "unprognostic (1.83e-1)" "unprognostic (3.20e-1)" "unprognostic (4.61e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.30e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.30e-5)" "unprognostic (7.32e-2)" "prognostic favorable (4.51e-8)" "unprognostic (9.49e-2)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.14e-1)" 17.9 19.3 25.6 11.6 29.5 3.8 20.7 21.0 39.3 23.7 31.2 17.0 8.9 27.4 21.0 14.6 22.5 14.8 21.7 15.4 35.2 22.5 33.3 34.5 15.3 5.5 18.8 23.0 27.8 21.9 36.7 16.9 25.4 28.6 19.9 28.8 18.0 16.9 19.5 21.6 14.4 30.2 18.2 16.6 12.1 22.0 17.3 15.0 10.0 26.7 12.0 9.7 23.7 21.1 4.6 4.5 4.9 6.2 6.2 4.3 1.5 10.9 8.1 8.9 7.6 14.1 14.6 11.6 7.6 12.8 5.6 7.3 6.6 13.9 1.1 6.1 11.5 12.1 8.3 16.5 8.4 8.8 1.9 6.6 0.9 6.7 7.1 15.3 1.4 0.9 11.7 15.8 8.3 14.3 12.8 9.7 1.1 4.8 2.1 13.4 6.6 1.8 1.9 16.7 11.7 7.4 1.1 7.2 2.4 11.9 45.1 11.0 16.2 10.5 31.6 20.5 14.5 6.1 1.4 11.0 15.2 4.3 42.8 7.4 2.4 0.8 2.4 13.1 1.2 12.1 4.9 4.1 1.8 4.3 4.1 3.6 4.6 2.8 2.6 3.5 3.2 3.6 3.8 1.8 6.2 6.2 4.5 1.4 1.5 25.6 29.5 21.0 39.3 35.2 22.5 18.8 23.0 28.6 15.0 80.4 46.6 7.8 37.8 53.7 27.6 63.7 61.1 45.5 51.2 50.6 19.6 36.7 44.7 43.5 16.7 34.6 105.1 0.0 46.9 46.1 45.8 67.4 3.5 49.7 11.1 25.4 65.3 56.4 14.8 6.2 44.5 13.4 28.7 14.4 96.1 57.1 59.0 118.1 60.8 80.1 28.9 19.4 43.2 15.5 19.8 59.7 68.0 7.5 56.6 212.0 WBP1 WBP-1 ENSG00000239779 "WW domain binding protein 1" Q96G27 2 74458329-74460891 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 21.4;monocytes: 9.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057067 Approved Approved Cytosol No No Cytosol "HPA057067: AB_2683326" "unprognostic (5.94e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (6.05e-2)" "unprognostic (2.98e-1)" "unprognostic (1.11e-1)" "unprognostic (5.80e-2)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "prognostic favorable (6.83e-4)" "unprognostic (1.17e-2)" "unprognostic (1.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favorable (6.36e-4)" 17.6 23.5 37.6 12.6 34.8 15.1 18.1 12.1 27.5 22.4 14.9 34.4 23.6 15.9 19.2 26.1 19.0 31.0 20.6 21.2 30.9 22.7 23.0 26.4 15.4 15.5 28.6 17.2 27.6 35.9 27.7 22.1 15.4 20.8 29.8 10.2 32.1 49.1 25.5 15.3 19.7 15.8 16.4 25.2 14.7 17.9 10.6 17.0 40.5 36.0 17.2 17.6 18.7 19.2 19.2 30.3 15.3 18.5 21.5 24.0 16.5 6.1 29.3 17.8 20.1 22.8 17.5 13.4 6.6 12.3 6.6 5.4 15.2 11.7 6.0 11.8 15.2 10.1 9.1 7.2 17.1 6.4 23.7 17.0 8.4 13.8 21.3 14.6 3.0 8.3 24.6 18.3 8.8 13.1 31.8 13.1 15.9 3.3 21.5 16.7 41.7 10.3 7.7 12.7 16.1 15.6 10.4 20.1 9.0 17.5 26.0 10.5 26.4 8.8 14.6 18.1 16.6 19.5 8.1 8.1 16.0 13.2 6.2 6.4 32.9 11.4 7.0 17.2 7.9 14.1 15.3 18.5 12.2 18.1 14.2 15.9 19.2 16.0 17.6 19.4 18.8 22.4 19.4 13.0 21.5 12.0 30.3 24.0 16.5 37.6 34.8 12.1 27.5 30.9 22.7 28.6 17.2 20.8 17.0 3.0 3.4 0.0 0.4 0.8 1.7 0.4 0.0 21.4 5.7 1.8 2.0 1.1 1.7 4.1 1.3 1.1 3.4 0.0 3.5 1.2 1.2 1.6 1.1 0.8 1.4 0.0 1.7 0.6 3.5 1.3 2.0 1.4 0.0 9.0 4.4 1.5 5.0 3.5 1.1 3.1 1.8 0.0 1.2 0.1 0.2 1.1 1.5 1.5 4.5 0.3 WBP2 "GRAMD6, WBP-2" ENSG00000132471 "WW domain binding protein 2" Q969T9 17 75845699-75856507 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065682, HPA068819" Approved Approved Nucleoplasm,Cytosol No No 870000 "Nucleoplasm, Cytosol" "HPA065682: AB_2685530, HPA068819: AB_2686042" "unprognostic (1.74e-1)" "unprognostic (1.71e-2)" "unprognostic (3.17e-2)" "unprognostic (2.85e-1)" "unprognostic (8.39e-2)" "unprognostic (7.12e-2)" "unprognostic (8.89e-2)" "unprognostic (3.09e-1)" "unprognostic (2.68e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-3)" "unprognostic (6.18e-2)" "unprognostic (2.21e-1)" "unprognostic (5.86e-3)" "unprognostic (1.30e-1)" "unprognostic (2.13e-2)" "unprognostic (1.76e-1)" 37.4 50.4 59.5 22.8 79.8 29.9 22.6 62.5 119.3 24.3 20.4 75.2 15.0 27.0 22.9 19.7 25.7 36.6 26.4 51.6 58.7 56.4 32.0 48.7 31.9 22.3 62.1 56.2 41.8 35.7 36.8 24.5 23.0 110.8 32.2 17.2 40.3 55.5 33.6 47.1 28.2 25.9 23.0 55.6 30.5 27.4 28.5 44.3 10.6 26.8 15.7 21.5 24.5 18.3 14.9 11.1 63.5 25.5 11.2 15.1 16.8 25.5 29.8 11.2 13.3 23.1 23.1 14.8 8.3 26.2 19.2 23.9 14.8 26.2 13.3 21.3 11.8 61.1 15.4 11.7 25.1 17.7 9.8 22.6 24.5 18.1 24.0 47.7 10.1 41.9 25.6 24.0 22.7 31.9 33.9 37.2 20.6 16.4 40.3 15.4 26.1 20.8 20.8 9.5 18.1 19.8 14.3 22.5 24.7 27.9 15.9 18.9 29.5 14.5 25.3 40.4 21.4 34.1 25.3 21.3 19.6 17.3 19.0 13.1 37.3 26.7 9.9 55.0 9.4 13.9 42.8 16.7 56.0 11.6 20.5 12.9 14.9 13.0 11.7 11.1 12.0 12.6 10.3 63.5 11.2 25.5 8.6 15.1 16.8 59.5 79.8 62.5 119.3 58.7 56.4 62.1 56.2 110.8 44.3 77.4 66.5 53.1 106.6 54.1 107.3 69.8 50.9 25.4 33.0 50.6 70.7 59.5 137.6 109.6 243.3 60.2 61.9 23.3 166.3 55.9 37.9 110.3 63.7 57.0 115.5 106.5 32.2 41.7 53.9 234.4 55.0 64.6 57.3 124.4 36.0 83.7 108.2 69.1 50.5 60.3 104.3 25.8 37.3 33.5 25.6 69.9 154.5 55.4 22.9 81.3 WBP2NL "FLJ26145, GRAMD7, MGC26816, PAWP" ENSG00000183066 "WBP2 N-terminal like" Q6ICG8 22 41998725-42058456 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 24.8" "Group enriched" "Detected in many" 16 "Early spermatids: 223.5;Late spermatids: 587.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;HDLM-2: 1.0;HHSteC: 1.1;HSkMC: 1.1;THP-1: 1.6" HPA048557 Enhanced Approved Cytosol NA NA Cytosol "HPA048557: AB_2680440" "unprognostic (1.90e-2)" "unprognostic (2.25e-4)" "unprognostic (2.77e-3)" "unprognostic (6.12e-2)" "unprognostic (6.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (9.84e-4)" "unprognostic (3.31e-2)" "unprognostic (4.19e-2)" "unprognostic (1.79e-1)" "unprognostic (2.06e-1)" "unprognostic (2.85e-3)" "unprognostic (9.36e-5)" 1.1 0.9 3.0 1.2 2.9 0.6 2.4 3.6 4.6 0.9 0.9 3.2 1.8 0.8 1.4 4.1 0.8 2.0 1.1 0.8 2.3 1.2 1.2 0.9 1.3 1.1 2.0 2.4 2.4 2.8 2.6 2.4 0.8 2.8 1.3 1.0 2.0 1.9 1.5 0.8 1.6 1.0 0.9 3.7 1.0 1.1 24.8 3.3 0.0 2.3 0.0 1.1 0.9 1.7 1.1 1.5 0.0 0.6 0.4 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 4.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.5 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 0.0 0.0 0.9 0.4 0.0 1.5 1.1 0.3 0.3 0.0 0.4 0.2 0.6 1.4 0.2 3.0 2.9 3.6 4.6 2.3 1.2 2.0 2.4 2.8 3.3 0.0 3.2 2.0 1.2 0.3 16.2 0.7 2.5 0.0 5.7 0.0 19.6 1.8 3.3 0.9 223.5 0.7 2.0 0.0 1.2 0.9 0.3 0.9 0.0 1.5 1.2 9.5 4.6 2.5 4.6 587.8 6.1 2.1 1.7 0.0 1.9 2.8 0.9 3.7 5.3 1.5 20.6 0.0 0.8 25.5 15.6 0.6 1.6 2.5 1.7 0.9 WDCP "C2orf44, FLJ21945" ENSG00000163026 "WD repeat and coiled coil containing" Q9H6R7 2 24029340-24049575 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Collecting duct cells: 8.7;Distal tubular cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041054 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041054: AB_10796566" "unprognostic (1.07e-1)" "unprognostic (3.19e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.32e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (5.14e-8)" "unprognostic (7.69e-2)" "unprognostic (9.01e-3)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (5.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (7.76e-2)" "unprognostic (3.00e-1)" 11.7 9.6 8.3 7.6 9.4 2.4 9.2 14.6 9.8 9.6 9.3 11.5 8.4 5.3 10.7 8.0 7.4 7.2 5.6 6.8 7.1 6.9 7.5 8.9 5.4 12.4 8.3 4.8 11.6 7.7 11.2 9.4 8.5 8.7 8.7 6.2 7.8 7.1 12.9 13.8 5.9 7.5 7.4 8.0 9.4 7.0 12.5 9.2 17.9 8.9 5.5 13.7 9.4 6.4 4.9 4.3 1.5 3.8 5.0 7.8 4.2 7.3 11.4 12.6 8.7 8.6 6.9 4.5 9.0 4.8 9.4 9.0 10.3 3.4 19.4 3.9 4.6 7.9 5.4 17.8 6.1 9.8 11.6 10.2 11.8 5.7 10.7 5.9 10.7 8.2 4.1 4.8 9.6 4.8 4.9 8.8 11.3 16.3 5.4 9.8 3.3 13.9 6.4 15.1 7.4 8.9 15.4 21.2 7.8 4.4 3.6 9.7 13.4 4.4 4.3 5.5 9.2 3.3 4.8 8.4 7.6 8.4 4.5 8.1 8.9 11.2 27.4 4.8 11.5 5.9 0.0 2.4 1.5 7.5 3.8 7.8 4.9 5.0 5.5 4.3 4.7 6.8 7.5 0.7 5.0 2.6 1.6 7.1 4.2 8.3 9.4 14.6 9.8 7.1 6.9 8.3 4.8 8.7 9.2 3.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 8.7 0.0 2.6 6.6 2.1 0.0 0.0 0.0 0.0 1.7 2.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 WDFY3 "ALFY, KIAA0993, ZFYVE25" ENSG00000163625 "WD repeat and FYVE domain containing 3" Q8IZQ1 4 84669610-84966391 "Disease related genes, Predicted intracellular proteins" Autophagy "Developmental protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.3" "Group enriched" "Detected in many" 23 "dendritic cells: 1.1;granulocytes: 4.3;monocytes: 1.5" "Cell line enhanced" "Detected in many" "TIME: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042734, HPA048572" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoli, Plasma membrane" "HPA042734: AB_2678135, HPA048572: AB_2680447" "unprognostic (7.14e-2)" "unprognostic (6.02e-2)" "unprognostic (7.68e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-2)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "prognostic favorable (3.64e-5)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.79e-1)" "unprognostic (4.41e-2)" "unprognostic (4.95e-2)" 10.1 15.2 17.2 7.5 18.7 13.1 9.0 17.9 18.6 9.6 8.3 17.6 4.8 3.6 11.5 6.9 9.4 9.3 9.0 7.3 17.3 6.5 21.3 5.8 7.9 2.4 22.8 9.5 14.7 9.0 24.0 14.6 11.8 17.0 9.2 5.9 8.6 9.8 8.1 13.7 10.9 5.6 8.7 14.8 7.5 7.8 8.0 21.4 0.4 12.1 3.2 2.6 14.2 6.6 0.0 1.1 4.3 1.5 0.0 0.0 0.3 6.5 4.5 8.1 4.5 14.5 11.4 5.1 6.3 6.7 6.6 6.0 5.0 5.4 0.0 6.5 10.4 7.0 3.3 8.7 6.9 8.4 4.5 2.7 4.1 4.9 3.0 5.5 3.2 7.8 8.3 6.3 8.6 8.7 8.0 20.9 3.4 4.1 20.0 12.0 4.7 3.1 0.7 4.2 6.3 2.2 4.6 6.5 0.9 11.4 8.6 9.6 4.5 7.7 8.6 4.3 8.1 4.4 8.0 31.7 8.7 8.7 4.8 7.9 0.0 0.0 0.0 5.9 2.8 9.5 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 0.3 17.2 18.7 17.9 18.6 17.3 6.5 22.8 9.5 17.0 21.4 17.9 11.7 1.5 8.3 13.1 41.7 15.5 15.3 10.7 12.5 15.7 33.4 9.5 1.7 8.5 6.7 16.9 4.6 0.0 6.2 5.5 12.3 13.0 0.0 7.6 17.1 27.0 8.7 22.1 39.6 7.7 17.0 17.4 6.8 5.4 7.0 26.8 8.9 5.8 23.0 14.9 41.9 25.8 15.6 7.4 7.8 14.1 12.1 0.5 6.6 10.0 WDFY4 "C10orf64, Em:AC060234.3, FLJ45748, KIAA1607" ENSG00000128815 "WDFY family member 4" Q6ZS81 10 48684876-48982956 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.7;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in some" 10 "B-cells: 20.5;Early spermatids: 25.8;Hofbauer cells: 11.8;Kupffer cells: 11.7;Late spermatids: 11.6;Macrophages: 21.6;monocytes: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7" "Group enriched" "Detected in many" 7 "B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2" "Cell line enhanced" "Detected in some" "Daudi: 30.0;HDLM-2: 27.5;HL-60: 10.5;THP-1: 9.3;U-698: 12.8;U-937: 12.4" "Low region specificity" "Detected in many" HPA040634 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040634: AB_10795491" "unprognostic (6.20e-2)" "unprognostic (6.60e-3)" "unprognostic (1.87e-1)" "unprognostic (3.31e-2)" "unprognostic (1.87e-1)" "unprognostic (9.38e-4)" "unprognostic (9.41e-2)" "unprognostic (3.89e-3)" "unprognostic (2.15e-2)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" "unprognostic (9.64e-2)" "unprognostic (3.21e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-2)" "unprognostic (1.97e-1)" "unprognostic (3.76e-2)" 2.7 1.5 3.6 31.2 5.4 8.6 1.5 0.9 2.7 1.2 1.6 5.2 0.0 1.1 1.2 1.5 1.5 1.5 2.6 1.4 3.1 1.9 1.7 1.2 9.4 20.8 5.3 0.6 1.1 1.1 0.2 1.1 0.8 3.7 1.2 1.5 1.2 5.7 0.4 0.9 2.0 10.2 1.3 7.3 19.1 1.6 1.5 4.4 4.1 1.6 0.9 26.6 3.0 1.2 12.5 19.7 6.2 1.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 3.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 12.4 0.0 0.0 1.7 0.0 0.0 1.6 0.0 8.9 0.0 0.1 6.7 12.5 0.0 0.0 6.2 0.0 0.8 19.7 0.0 0.6 3.6 5.4 0.9 2.7 3.1 1.9 5.3 0.6 3.7 4.4 0.0 0.6 20.5 0.0 0.3 0.0 1.1 0.0 0.0 1.2 1.8 0.0 0.1 1.7 0.0 25.8 0.3 0.0 0.0 0.0 0.1 0.9 0.0 5.7 0.0 11.8 0.0 0.0 0.0 11.7 11.6 0.3 21.6 1.7 17.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.6 0.6 0.3 0.2 0.0 0.0 0.0 WDR11 "BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15" ENSG00000120008 "WD repeat domain 11" Q9BZH6 10 120851175-120909524 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038980 Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA038980: AB_10675955" "unprognostic (8.98e-2)" "unprognostic (8.83e-3)" "unprognostic (1.27e-1)" "unprognostic (5.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.57e-3)" "unprognostic (1.45e-1)" "unprognostic (2.98e-3)" "unprognostic (2.84e-1)" "unprognostic (3.84e-1)" "unprognostic (8.31e-2)" "unprognostic (1.80e-3)" "prognostic favorable (5.04e-4)" "unprognostic (5.09e-2)" "unprognostic (1.87e-1)" "unprognostic (8.99e-2)" "unprognostic (2.38e-2)" 18.6 21.9 10.6 17.4 17.2 6.2 16.4 17.1 18.9 17.3 15.5 21.5 18.0 14.5 22.6 15.9 19.6 21.0 15.7 10.6 11.5 12.7 25.2 19.8 14.9 17.0 13.9 10.6 19.4 16.1 33.9 17.7 18.4 26.0 16.5 17.3 19.0 20.3 21.5 8.5 14.8 19.9 17.5 20.0 19.7 18.9 12.8 12.9 20.6 24.0 11.7 19.8 22.0 17.3 6.4 6.8 15.5 16.3 3.9 3.3 3.4 11.9 11.8 11.6 19.0 16.2 20.7 8.0 11.5 23.1 12.8 16.3 6.6 13.4 8.6 6.0 17.0 10.1 11.7 13.4 15.9 15.9 11.7 11.4 9.4 9.5 6.3 15.3 12.9 10.8 16.9 12.7 11.6 19.0 23.2 24.2 6.6 7.3 10.8 13.7 5.1 8.1 5.1 5.6 10.7 7.4 3.3 19.5 7.4 14.9 9.9 5.7 10.2 10.0 11.1 30.4 20.1 8.2 8.4 17.8 8.8 5.4 1.3 10.7 5.5 3.4 10.8 12.6 10.7 4.6 15.5 5.9 2.5 3.3 8.0 2.6 6.4 2.3 3.1 6.8 3.8 2.4 2.5 0.5 3.9 16.3 1.6 2.9 3.4 10.6 17.2 17.1 18.9 11.5 12.7 13.9 10.6 26.0 12.9 6.0 13.1 32.1 11.9 10.6 38.8 7.3 33.1 22.7 19.4 24.4 92.3 15.7 10.0 17.0 1.9 19.4 28.5 23.3 9.2 10.5 17.5 16.4 9.2 25.2 29.5 23.8 26.0 35.6 35.6 2.8 40.3 21.6 3.3 18.0 23.3 24.7 18.7 24.5 36.4 15.6 88.1 19.4 11.9 25.8 14.0 12.4 12.7 14.4 19.3 15.0 WDR12 "FLJ10881, YTM1" ENSG00000138442 "WD repeat domain 12" Q9GZL7 2 202874782-203014798 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036389 Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA036389: AB_10670716" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "unprognostic (8.17e-2)" "unprognostic (3.59e-3)" "unprognostic (1.24e-2)" "unprognostic (9.40e-3)" "prognostic unfavorable (2.57e-6)" "unprognostic (1.52e-1)" "unprognostic (6.14e-2)" "unprognostic (4.78e-2)" "unprognostic (4.58e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.66e-1)" "unprognostic (9.69e-3)" "unprognostic (4.48e-2)" 5.8 9.7 7.2 5.5 16.1 6.7 7.6 11.5 15.2 5.9 6.2 6.5 3.7 8.9 7.1 7.0 8.0 6.7 5.0 8.4 6.8 8.6 11.1 8.7 4.2 6.4 7.4 8.9 7.3 5.7 6.7 8.0 6.6 12.6 4.9 8.7 6.7 5.4 5.2 11.0 7.7 6.0 7.4 6.2 5.3 5.6 17.1 8.2 9.6 7.1 5.1 7.5 5.8 5.6 5.4 6.9 3.6 5.0 3.6 5.9 3.0 4.4 4.7 5.4 10.1 10.2 8.8 9.8 6.7 5.4 8.4 8.1 11.8 6.2 8.0 6.2 5.4 7.4 5.6 14.6 10.8 13.4 4.0 9.0 13.6 7.5 13.9 6.6 17.7 8.4 7.9 7.8 9.9 19.7 5.6 8.7 8.8 21.3 5.3 9.1 5.1 12.1 10.4 12.3 5.9 11.9 8.8 8.4 12.6 9.1 5.3 9.5 8.3 5.3 7.0 8.2 9.8 4.1 11.7 6.9 7.5 6.1 6.2 7.4 7.0 10.4 13.5 7.4 12.1 7.4 3.6 4.7 2.0 4.2 5.0 5.9 5.3 4.0 4.3 6.0 5.4 5.2 5.0 2.1 3.6 4.5 6.9 4.3 3.0 7.2 16.1 11.5 15.2 6.8 8.6 7.4 8.9 12.6 8.2 8.9 16.3 6.0 16.7 18.2 9.1 22.5 10.2 17.4 17.0 5.2 2.0 21.5 13.3 14.9 8.1 10.6 10.0 0.0 9.1 29.0 15.4 7.7 15.0 13.6 15.8 14.3 5.2 8.0 9.1 6.6 15.8 9.5 1.7 8.2 9.1 5.8 12.6 3.5 14.5 29.9 7.8 12.9 15.1 35.1 32.6 15.2 18.0 10.2 17.2 16.0 WDR24 "C16orf21, DKFZp434F054, JFP7" ENSG00000127580 "WD repeat domain 24" Q96S15 16 684622-690444 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039506 Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA039506: AB_10795148" "unprognostic (9.07e-2)" "unprognostic (2.67e-3)" "unprognostic (6.67e-2)" "unprognostic (1.48e-1)" "unprognostic (1.67e-1)" "unprognostic (8.15e-2)" "unprognostic (7.05e-2)" "unprognostic (4.35e-2)" "unprognostic (1.75e-1)" "unprognostic (5.09e-3)" "unprognostic (2.29e-3)" "unprognostic (2.05e-1)" "prognostic favorable (3.75e-6)" "unprognostic (5.38e-2)" "unprognostic (3.16e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" 8.8 11.6 10.9 9.8 11.3 9.3 9.2 18.9 17.6 7.6 7.8 8.2 6.5 12.1 10.2 10.2 9.4 9.3 8.5 9.9 9.5 7.8 9.0 15.7 15.3 17.7 8.7 11.1 12.8 14.5 17.0 11.9 9.2 8.8 10.3 3.6 8.8 16.2 8.8 16.9 13.5 10.2 10.0 10.6 13.3 10.5 17.6 9.5 17.9 11.8 7.9 6.5 9.2 7.8 7.1 7.7 6.5 10.3 4.3 10.7 7.1 4.4 10.3 4.8 6.6 4.6 3.3 8.4 5.6 5.0 7.0 6.1 11.2 6.6 6.9 9.8 2.5 1.9 7.0 4.6 5.5 1.5 11.6 14.6 4.7 13.8 4.3 7.3 5.7 7.4 5.8 3.7 5.0 4.2 3.7 3.8 6.8 9.2 7.8 2.6 16.3 10.0 4.2 7.3 2.3 8.1 14.9 3.9 12.7 2.3 3.1 11.9 5.4 6.4 11.0 6.2 2.3 10.0 5.8 5.6 5.2 5.4 5.6 5.4 16.9 15.3 11.3 3.3 5.7 7.1 6.5 7.5 4.0 10.7 4.5 8.7 7.1 6.9 7.8 7.7 6.4 8.2 7.7 1.8 4.3 10.3 6.2 8.9 7.1 10.9 11.3 18.9 17.6 9.5 7.8 8.7 11.1 8.8 9.5 6.0 3.8 4.5 2.2 1.0 4.5 3.3 2.5 20.1 4.5 7.0 2.0 5.6 6.6 4.4 13.1 2.2 6.7 23.3 4.7 3.7 2.0 3.3 4.6 7.8 4.4 20.6 9.7 2.5 8.1 30.6 5.2 2.9 0.0 3.6 5.3 5.6 3.7 2.8 2.8 5.4 2.1 19.4 2.3 19.5 8.5 1.4 6.2 3.2 4.1 1.6 WDR26 "FLJ21016, GID7" ENSG00000162923 "WD repeat domain 26" Q9H7D7 1 224385143-224437033 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.9" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 178.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028538, HPA028539, HPA061094" Enhanced Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427" "unprognostic (4.09e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-2)" "unprognostic (6.67e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (8.42e-2)" "unprognostic (6.32e-2)" "unprognostic (5.59e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.31e-6)" "unprognostic (8.40e-3)" "unprognostic (4.00e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" 8.2 7.2 6.7 6.7 6.7 18.5 7.2 8.2 7.3 7.8 7.0 6.7 6.7 4.0 6.8 9.3 13.0 5.9 7.0 7.5 6.7 5.0 6.7 9.3 9.0 7.2 6.7 6.7 7.0 6.9 9.2 6.7 8.7 6.7 7.0 6.7 6.7 7.2 6.7 15.2 9.9 6.7 7.1 6.7 10.2 6.3 63.9 6.7 6.7 7.0 6.7 7.4 6.7 8.3 1.5 2.1 8.3 3.9 2.7 2.7 1.3 11.9 6.2 19.3 8.9 25.8 29.4 13.9 17.6 28.8 16.1 15.2 9.8 13.6 14.2 17.7 28.3 6.2 10.9 11.3 15.1 26.5 11.1 12.9 9.8 8.1 9.2 28.1 10.2 17.2 27.3 21.9 17.0 16.1 26.7 26.8 8.7 12.9 14.7 21.1 6.6 10.5 9.9 18.6 12.4 7.2 9.7 20.2 11.2 19.6 12.1 7.0 17.9 20.0 27.1 21.5 21.1 31.1 16.8 28.1 13.8 6.3 12.9 21.1 15.7 7.5 9.7 15.7 7.3 17.0 4.1 1.9 3.3 2.7 2.4 1.5 1.5 1.9 2.1 1.8 1.4 1.4 2.1 8.3 2.7 3.9 2.1 1.6 1.3 6.7 6.7 8.2 6.7 6.7 5.0 6.7 6.7 6.7 6.7 98.3 43.8 19.4 25.3 99.0 23.8 42.4 45.9 41.5 50.0 33.2 29.5 23.4 5.0 19.2 178.7 37.6 21.6 0.0 20.3 11.8 51.5 39.3 46.2 31.0 44.5 36.5 34.0 44.2 119.9 79.7 34.2 49.8 43.9 12.6 40.3 16.9 26.6 25.9 26.5 17.0 22.9 19.4 41.9 36.4 24.6 107.0 57.1 31.6 23.8 59.3 WDR31 FLJ35921 ENSG00000148225 "WD repeat domain 31" Q8NA23 9 113313222-113340298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 54.9;Ciliated cells: 34.8;Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019340, HPA019347" Approved Approved "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA019340: AB_1858800, HPA019347: AB_2215267" "unprognostic (2.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.78e-3)" "prognostic favorable (1.85e-4)" "unprognostic (4.54e-2)" "unprognostic (1.59e-1)" "unprognostic (2.38e-2)" "unprognostic (2.88e-2)" "unprognostic (3.48e-1)" "unprognostic (2.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.64e-1)" "prognostic favorable (1.90e-9)" "unprognostic (9.11e-2)" "unprognostic (1.65e-1)" "unprognostic (7.96e-3)" "unprognostic (8.50e-2)" 2.2 6.8 4.1 1.0 8.2 1.5 4.7 1.7 5.5 3.2 2.4 4.0 8.8 1.5 4.5 3.3 2.4 6.3 2.3 8.9 3.3 4.1 5.6 3.1 2.3 0.9 3.5 2.7 3.7 3.0 16.6 11.2 1.0 4.0 3.4 2.2 5.8 10.2 7.5 1.3 2.5 1.1 2.2 3.6 0.8 2.1 7.3 1.7 3.8 7.1 1.4 0.8 3.0 2.0 1.6 0.9 4.4 1.0 2.3 1.4 0.8 5.5 4.2 1.5 3.0 5.1 5.9 1.4 1.4 2.7 1.4 1.7 0.7 3.6 2.1 1.0 2.1 4.1 3.7 1.2 2.7 2.7 3.3 0.3 1.7 2.2 0.7 5.8 0.9 0.3 3.1 3.6 5.8 5.2 4.0 1.1 3.3 4.5 1.9 1.5 3.8 2.4 1.4 0.9 5.3 5.3 2.1 1.3 2.6 3.7 1.2 3.6 2.7 6.7 1.2 3.2 1.2 8.8 0.9 0.6 2.0 2.2 5.0 1.5 4.0 3.8 0.5 3.0 1.4 1.9 4.4 1.0 1.0 0.9 0.6 0.8 0.9 1.0 0.8 0.8 1.6 1.4 1.3 3.4 2.3 0.7 0.9 0.7 0.8 4.1 8.2 1.7 5.5 3.3 4.1 3.5 2.7 4.0 1.7 6.0 8.0 0.0 4.6 4.7 4.5 54.9 5.1 34.8 12.5 1.8 27.5 0.3 5.0 1.4 23.9 1.5 0.3 0.0 0.2 0.2 1.7 3.4 4.7 2.6 0.7 6.4 0.0 0.6 1.2 21.5 1.7 2.0 0.0 0.0 1.5 7.2 1.2 0.0 1.4 4.8 40.9 0.0 2.3 22.7 8.7 3.8 0.2 0.0 2.3 2.4 WDR34 "bA216B9.3, DIC5, FAP133, MGC20486" ENSG00000119333 "WD repeat domain 34" Q96EX3 9 128633661-128656787 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 159.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 19.1;naive B-cell: 25.3" "Lineage enriched" "Detected in many" 4 "B-cells: 25.3" "Cell line enhanced" "Detected in all" "MCF7: 89.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040764, HPA041091" Approved Approved Cytosol NA Yes Cytosol "HPA040764: AB_10795625, HPA041091: AB_10796237" "unprognostic (1.45e-1)" "prognostic favorable (1.63e-4)" "unprognostic (2.55e-1)" "prognostic favorable (7.01e-5)" "unprognostic (2.27e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (8.79e-4)" "unprognostic (6.04e-2)" "unprognostic (4.39e-1)" "unprognostic (3.65e-1)" "unprognostic (8.55e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-3)" "unprognostic (2.06e-2)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 6.3 23.0 8.2 16.9 9.0 23.4 21.3 4.2 12.3 12.6 13.6 7.4 24.1 17.3 11.4 19.9 17.3 24.4 24.2 13.6 8.0 9.1 23.6 16.0 14.4 9.1 5.6 8.0 13.1 23.9 14.8 18.2 15.1 14.2 14.5 8.3 11.2 21.6 24.1 7.3 12.3 14.3 9.2 6.2 11.6 16.1 51.0 7.1 42.1 33.1 17.8 13.7 8.6 11.2 25.3 5.6 0.9 2.5 2.0 2.8 1.9 23.2 42.1 11.4 16.6 2.5 3.7 33.5 10.3 6.8 14.1 9.0 20.7 42.3 8.8 7.1 6.2 13.3 38.9 9.9 10.7 3.5 20.0 8.9 5.6 29.9 10.5 3.1 8.8 9.0 1.7 5.4 14.1 4.0 5.2 9.6 24.2 17.3 7.4 7.4 89.2 31.9 22.6 14.0 19.7 26.2 34.5 14.4 28.8 8.8 7.7 27.5 22.3 31.2 28.7 7.5 3.1 49.2 8.6 6.2 17.2 25.6 20.6 19.2 8.6 21.0 8.2 15.4 8.8 15.6 0.9 0.5 0.2 0.8 0.8 1.2 19.1 1.5 2.1 1.4 25.3 0.6 0.9 0.4 2.0 2.5 5.6 2.8 1.9 8.2 9.0 4.2 12.3 8.0 9.1 5.6 8.0 14.2 7.1 44.7 36.9 20.1 22.9 11.9 2.1 18.2 53.5 68.3 44.3 33.2 0.0 49.8 69.6 49.2 78.8 9.8 97.6 23.3 49.4 74.8 25.8 19.9 14.9 50.3 18.9 3.2 54.1 14.1 3.8 159.5 19.0 5.3 21.9 2.8 42.2 17.0 36.8 31.3 18.7 64.3 11.3 12.9 11.7 106.6 71.8 10.2 31.2 7.2 46.6 15.9 WDR4 "TRM82, TRMT82" ENSG00000160193 "WD repeat domain 4" P57081 21 42843094-42879568 "Predicted intracellular proteins" "DNA damage, tRNA processing" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017381 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017381: AB_1858807" "unprognostic (3.47e-2)" "unprognostic (2.15e-2)" "unprognostic (4.32e-2)" "unprognostic (2.13e-2)" "unprognostic (2.95e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (5.48e-7)" "unprognostic (2.85e-3)" "unprognostic (5.37e-2)" "unprognostic (2.27e-2)" "unprognostic (4.25e-1)" "unprognostic (4.78e-2)" "unprognostic (2.65e-2)" "unprognostic (1.74e-3)" "unprognostic (1.44e-1)" "unprognostic (1.74e-1)" "unprognostic (4.46e-2)" 9.1 9.3 8.4 14.2 8.4 12.1 7.5 9.3 11.1 7.6 7.2 6.7 6.5 10.7 12.5 5.1 17.4 8.2 8.1 6.1 8.3 4.9 7.3 12.2 7.8 18.2 8.9 8.4 9.7 22.0 6.9 8.4 8.9 8.5 7.0 7.0 6.8 11.8 8.4 13.1 10.2 7.5 7.4 6.6 11.7 7.3 10.9 9.6 10.1 9.3 11.3 17.0 8.5 11.1 7.5 9.1 0.2 8.8 4.4 5.5 4.4 14.6 20.6 5.5 7.8 3.3 3.6 13.4 8.5 3.1 7.2 4.7 20.6 7.6 24.5 5.0 6.0 10.5 8.1 19.1 10.8 5.1 7.8 18.2 24.6 21.5 17.3 5.9 15.1 6.1 2.0 4.7 9.8 7.2 2.6 9.4 8.8 29.6 9.1 6.3 12.2 15.5 8.6 13.8 11.0 20.2 17.1 3.3 24.2 5.4 9.0 13.1 8.4 8.9 13.3 4.2 1.9 8.7 11.7 6.9 11.2 7.4 5.1 17.0 12.5 8.7 19.8 5.4 24.1 13.1 0.0 5.4 0.2 3.5 8.8 4.7 7.5 4.7 4.3 9.1 7.2 4.8 4.9 0.0 4.4 5.0 4.4 5.5 4.4 8.4 8.4 9.3 11.1 8.3 4.9 8.9 8.4 8.5 9.6 0.0 4.5 6.0 7.4 7.6 3.4 2.0 0.0 1.4 1.2 0.0 2.0 14.1 0.0 6.4 2.9 4.9 3.3 0.0 5.7 17.8 3.8 5.6 10.3 6.4 11.5 3.2 5.2 3.7 1.8 2.5 2.6 4.8 6.8 1.8 3.6 2.4 6.8 0.0 2.8 5.7 4.0 6.5 6.2 9.7 9.1 9.5 9.6 3.8 7.0 8.8 WDR41 FLJ10904 ENSG00000164253 "WD repeat domain 41" Q9HAD4 5 77425970-77620611 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043124 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA043124: AB_10793990" "unprognostic (1.81e-1)" "unprognostic (9.42e-2)" "unprognostic (2.52e-3)" "unprognostic (9.69e-2)" "unprognostic (1.52e-1)" "unprognostic (4.56e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.28e-3)" "unprognostic (1.43e-1)" "unprognostic (1.68e-2)" "unprognostic (2.30e-3)" "unprognostic (1.49e-1)" "unprognostic (4.15e-3)" "unprognostic (6.11e-2)" "unprognostic (4.90e-1)" "unprognostic (1.85e-1)" "unprognostic (2.90e-3)" 16.2 12.8 18.8 13.1 21.7 17.3 16.2 19.5 23.3 15.1 12.6 17.7 9.4 9.4 13.3 13.3 20.6 17.5 12.2 16.9 18.8 17.5 15.8 14.8 14.0 13.9 21.4 20.0 9.4 21.3 14.4 15.8 11.4 28.9 12.0 13.8 11.5 13.7 12.0 19.7 12.8 11.2 19.2 23.3 12.5 11.5 26.6 19.8 8.1 23.1 12.9 16.6 13.5 13.6 8.9 24.8 24.0 18.1 15.8 5.7 7.3 6.8 11.8 16.6 24.2 17.3 24.8 13.0 21.8 23.6 10.3 19.2 10.7 11.5 20.8 10.1 20.6 17.8 8.9 12.4 29.8 11.1 25.0 14.2 8.3 13.8 9.2 26.5 17.5 20.7 15.7 38.4 11.7 25.5 11.4 16.5 11.8 8.2 22.7 16.8 14.7 9.2 11.3 6.1 6.9 4.7 22.2 22.7 14.6 11.3 5.8 9.7 11.9 18.6 11.7 18.1 20.8 11.7 22.0 14.4 14.0 11.4 7.6 15.9 20.7 16.8 37.2 19.2 7.9 23.3 11.4 14.0 24.0 5.7 16.3 5.5 8.9 3.4 5.1 24.8 5.4 2.3 4.2 6.8 15.8 18.1 11.1 2.6 7.3 18.8 21.7 19.5 23.3 18.8 17.5 21.4 20.0 28.9 19.8 35.7 10.5 11.5 21.9 10.6 34.7 14.7 12.7 20.1 9.1 17.4 19.6 7.4 31.5 19.8 146.0 11.7 3.5 0.0 18.1 22.6 22.6 18.9 15.1 11.1 24.0 22.3 5.8 8.0 22.7 78.8 8.9 25.0 16.9 8.2 7.6 12.9 15.9 5.8 7.8 14.0 16.3 6.5 18.7 46.9 43.9 12.4 5.3 17.3 10.3 21.6 WDR45B "WDR45L, WIPI3" ENSG00000141580 "WD repeat domain 45B" Q5MNZ6 17 82614562-82648553 "Predicted intracellular proteins" Autophagy "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 316.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017886 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA017886: AB_1858810" "unprognostic (1.91e-1)" "unprognostic (7.77e-2)" "unprognostic (5.13e-2)" "unprognostic (3.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.88e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (1.23e-1)" "unprognostic (6.38e-2)" "unprognostic (1.22e-2)" "unprognostic (4.41e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-2)" "unprognostic (9.93e-3)" "unprognostic (8.89e-2)" "unprognostic (4.27e-2)" "unprognostic (1.02e-1)" 25.4 31.0 37.1 17.2 39.0 38.7 38.9 30.3 38.1 27.4 23.5 35.3 19.9 21.8 25.6 24.9 39.9 32.7 29.5 29.4 36.6 29.2 26.6 22.9 23.5 26.6 38.2 28.5 32.8 35.6 29.9 24.2 19.6 39.2 26.6 21.2 18.8 32.6 23.8 20.9 28.4 25.0 29.3 53.3 19.3 29.5 47.7 39.1 6.8 26.5 23.3 23.5 23.3 24.8 10.0 15.6 22.1 19.3 8.9 12.6 11.9 29.2 20.1 17.0 15.5 15.7 14.6 20.2 21.9 24.7 35.9 30.8 24.0 15.6 8.4 13.7 19.5 22.9 16.3 16.3 18.6 33.1 5.3 32.4 17.1 11.5 18.6 20.7 13.5 13.1 15.8 19.6 19.1 18.0 15.5 28.9 11.3 12.7 7.9 20.0 18.8 9.6 9.2 21.7 23.5 26.8 10.5 30.7 8.6 19.4 29.3 22.1 32.6 21.6 22.2 25.6 20.8 26.4 10.3 19.7 37.3 29.3 26.2 39.0 20.4 8.7 12.4 24.3 13.6 27.3 16.5 19.3 22.1 12.3 19.2 12.6 10.0 9.7 10.4 15.6 9.9 8.7 7.9 16.2 8.9 14.8 8.0 7.6 11.9 37.1 39.0 30.3 38.1 36.6 29.2 38.2 28.5 39.2 39.1 29.8 45.5 39.3 40.6 53.1 35.0 17.3 63.7 66.9 76.2 40.1 11.8 45.7 74.6 105.9 126.0 49.0 65.0 0.0 119.7 62.3 43.4 67.1 71.6 61.8 40.3 42.9 45.5 45.4 49.5 316.4 52.9 44.0 54.0 54.1 58.5 56.9 135.0 52.0 45.3 50.9 30.8 32.3 51.5 70.5 153.1 63.2 90.4 39.5 52.5 79.5 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 21.6;fallopian tube: 20.7" "Group enriched" "Detected in some" 5 "Ciliated cells: 50.9;Club cells: 18.2" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2" "Group enriched" "Detected in many" 24 "dendritic cells: 5.2;monocytes: 5.6" "Cell line enhanced" "Detected in some" "AF22: 3.4;NTERA-2: 3.8;THP-1: 17.1;U-937: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: AB_2675007" "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.5 0.7 6.5 1.1 6.8 3.6 0.6 12.6 5.0 1.2 0.9 8.5 0.0 3.9 1.2 4.4 2.1 20.7 0.7 4.7 12.3 5.4 1.0 0.4 4.0 0.9 7.6 2.8 3.2 0.9 0.4 1.7 0.4 21.6 0.7 0.6 0.0 0.7 0.4 0.4 0.5 8.0 0.7 17.6 1.1 0.8 1.5 14.2 0.0 0.5 0.0 1.0 0.8 0.6 0.2 5.2 0.0 5.6 0.0 0.0 0.7 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 5.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 6.5 6.8 12.6 3.7 12.3 5.4 7.6 2.8 21.6 14.2 0.0 1.1 0.0 0.8 0.0 0.0 1.0 0.0 50.9 18.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 WDR53 "MGC12928, MGC64882" ENSG00000185798 "WD repeat domain 53" Q7Z5U6 3 196554177-196568674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.0" "Group enriched" "Detected in many" 6 "Early spermatids: 232.6;Late spermatids: 86.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016420 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016420: AB_1858812" "unprognostic (3.29e-2)" "unprognostic (4.24e-3)" "unprognostic (9.89e-2)" "unprognostic (2.29e-3)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.57e-1)" "unprognostic (2.10e-3)" "unprognostic (4.48e-3)" "unprognostic (8.01e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" 4.3 4.3 5.9 6.8 6.9 7.2 5.2 6.4 5.9 4.0 4.2 4.5 7.1 2.1 4.9 6.6 5.1 3.9 3.5 4.0 4.8 3.8 4.0 5.4 3.8 5.5 5.9 4.3 4.3 3.3 7.5 11.9 4.4 6.1 4.1 4.1 4.8 4.0 4.5 6.8 6.7 4.5 4.1 5.0 6.2 4.0 48.0 4.6 7.4 4.2 3.2 6.5 3.9 4.2 7.5 5.9 13.9 6.7 6.5 14.9 4.9 19.1 4.1 7.4 6.6 7.6 6.6 11.9 10.1 7.9 11.5 10.9 11.2 10.2 9.1 34.1 6.1 10.6 11.2 9.3 8.7 14.4 14.3 8.1 9.2 10.1 7.3 9.5 12.9 7.6 5.4 12.8 10.2 11.2 5.7 8.9 11.6 8.9 17.6 8.7 17.8 10.9 13.2 10.1 12.2 12.0 13.1 12.7 19.4 6.3 6.7 7.3 8.0 7.0 10.5 14.8 10.4 27.0 12.1 8.3 9.8 9.2 10.9 19.7 15.0 30.0 27.2 6.5 16.6 9.8 9.6 5.1 13.9 8.6 4.4 14.0 7.5 12.3 8.7 4.1 7.1 10.3 6.2 4.4 6.5 6.7 5.9 14.9 4.9 5.9 6.9 6.4 5.9 4.8 3.8 5.9 4.3 6.1 4.6 0.0 3.2 0.8 2.8 3.8 3.1 2.7 2.5 1.4 4.5 3.5 0.0 4.7 5.0 4.2 232.6 5.2 1.0 0.0 3.7 5.5 2.8 2.3 9.2 2.4 3.9 3.2 0.0 3.1 4.5 86.7 4.6 5.0 5.0 8.2 1.5 3.6 2.6 1.9 3.2 3.5 2.3 19.4 6.2 27.9 13.1 4.1 3.9 5.7 2.3 2.3 WDR54 FLJ12953 ENSG00000005448 "WD repeat domain 54" Q9H977 2 74421678-74425755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 56.8" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 297.1;Spermatocytes: 180.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043257, HPA053558" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043257: AB_10795981, HPA053558: AB_2682189" "unprognostic (1.12e-1)" "unprognostic (3.68e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (2.62e-1)" "unprognostic (3.06e-3)" "unprognostic (4.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (7.25e-3)" "unprognostic (3.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.85e-2)" 4.8 6.3 9.4 5.4 17.0 5.0 4.8 8.4 15.4 7.0 3.9 6.0 10.5 3.0 7.0 7.8 3.1 56.8 7.2 3.4 9.9 11.6 7.9 1.4 8.1 8.6 4.8 13.0 8.4 5.4 21.3 16.0 5.4 7.8 5.0 3.7 10.5 3.9 9.0 1.5 3.5 3.9 6.8 3.5 7.7 5.7 27.6 3.7 20.6 5.8 2.5 8.9 6.2 4.0 12.6 23.1 2.3 5.3 13.2 18.7 10.0 15.8 29.5 14.5 12.6 5.2 9.8 4.5 8.1 16.8 21.4 19.9 2.4 12.6 14.2 8.5 9.1 13.1 13.7 10.2 36.4 18.8 10.6 6.2 6.9 16.3 1.6 5.4 10.9 5.7 4.4 10.3 21.7 11.3 25.2 11.1 22.5 2.8 16.8 11.7 24.7 17.1 11.5 11.1 3.8 11.2 14.8 16.3 29.6 18.8 8.0 25.3 19.6 6.4 5.8 9.4 4.4 9.4 5.2 5.5 11.0 19.3 11.8 18.1 18.3 9.2 3.6 32.4 6.6 7.9 2.3 4.2 0.3 16.2 5.3 16.3 12.6 18.7 17.4 14.1 11.1 13.2 12.8 0.3 13.2 4.5 23.1 17.5 10.0 9.4 17.0 8.4 15.4 9.9 11.6 4.8 13.0 7.8 3.7 3.0 13.8 25.3 15.6 6.3 45.6 1.3 20.4 297.1 38.7 22.7 78.5 8.0 16.6 23.9 56.6 23.3 0.5 0.0 5.4 8.0 13.4 11.9 12.7 0.8 7.7 30.2 27.7 27.0 8.6 82.2 15.8 7.8 11.8 44.1 4.5 45.6 11.0 1.7 20.8 19.6 99.9 0.0 18.9 180.1 17.7 4.3 2.4 29.9 4.0 9.5 WDR59 FLJ12270 ENSG00000103091 "WD repeat domain 59" Q6PJI9 16 74871367-75000173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041084, HPA048218" Approved Approved Cytosol NA NA Cytosol "HPA041084: AB_10793867, HPA048218: AB_2680318" "unprognostic (3.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (4.16e-2)" "unprognostic (6.14e-2)" "unprognostic (3.99e-1)" "unprognostic (2.28e-2)" "unprognostic (8.83e-2)" "unprognostic (3.43e-1)" "unprognostic (2.37e-2)" "unprognostic (4.21e-3)" "unprognostic (3.25e-3)" "unprognostic (2.05e-2)" "unprognostic (9.08e-2)" "unprognostic (3.88e-2)" "unprognostic (1.78e-1)" "unprognostic (5.61e-2)" 10.1 16.8 24.2 13.5 27.4 14.7 15.2 29.0 27.6 14.4 13.6 23.8 17.4 13.7 19.9 23.4 15.2 14.9 13.7 16.2 22.3 17.6 17.5 31.3 11.5 12.3 24.7 19.1 23.3 15.1 30.3 28.7 17.9 22.9 15.0 15.4 13.6 15.5 14.5 22.9 21.9 15.9 16.2 19.7 15.0 14.5 14.0 30.6 17.7 22.4 7.3 16.2 13.0 15.0 3.5 1.6 1.5 1.6 2.0 7.6 1.0 8.2 12.7 14.8 14.1 11.7 10.6 12.6 5.3 9.2 11.4 13.1 17.1 14.6 11.5 5.8 9.8 10.7 13.3 11.7 12.6 16.3 6.9 12.5 14.8 8.2 27.6 7.1 10.6 18.0 12.2 10.3 13.7 13.2 14.7 11.7 28.4 21.7 5.8 5.4 24.2 16.3 19.1 11.8 18.0 5.2 16.4 6.5 9.5 12.3 7.4 9.1 10.0 15.1 8.8 6.7 16.4 13.3 9.4 10.1 7.1 11.0 8.1 4.5 11.1 15.0 25.2 12.6 7.5 7.7 1.3 1.5 1.4 2.4 0.8 7.6 3.5 4.2 3.4 0.9 2.6 2.8 3.1 1.5 2.0 1.6 1.6 1.9 1.0 24.2 27.4 29.0 27.6 22.3 17.6 24.7 19.1 22.9 30.6 14.9 13.9 15.2 16.6 19.9 38.3 14.9 25.5 20.1 15.9 21.0 58.9 29.8 8.3 11.4 31.1 10.5 13.6 0.0 8.4 15.3 12.7 14.4 12.7 21.2 9.3 19.1 21.2 18.4 13.0 58.8 12.4 11.8 8.5 15.4 11.8 13.3 10.6 14.0 11.0 16.8 51.1 19.4 8.2 15.6 15.2 21.1 39.6 10.7 14.0 21.7 WDR6 ENSG00000178252 "WD repeat domain 6" Q9NNW5 3 49007062-49015953 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042622 Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042622: AB_10966784" "unprognostic (2.41e-2)" "unprognostic (2.03e-1)" "unprognostic (2.14e-1)" "unprognostic (1.26e-2)" "unprognostic (4.80e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.97e-6)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (1.01e-3)" "unprognostic (1.94e-2)" "prognostic favorable (4.52e-5)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" 15.8 36.7 21.5 26.1 23.5 14.9 19.7 29.9 29.9 32.7 31.0 30.8 56.4 27.5 39.0 37.0 18.7 33.1 32.6 20.4 20.1 20.4 26.0 22.0 21.1 28.2 22.8 26.9 60.9 46.0 56.7 55.8 24.3 22.1 39.0 22.1 34.3 33.4 54.4 23.9 26.6 28.3 40.8 17.5 29.1 24.7 23.7 22.1 26.9 50.7 20.3 25.1 31.2 24.6 12.3 14.4 10.3 12.9 11.7 18.9 12.0 17.6 24.3 40.2 34.1 27.0 22.1 27.2 26.3 21.7 29.8 24.2 21.5 25.6 28.3 16.8 41.9 22.9 20.1 32.1 36.8 21.3 22.5 21.3 26.8 59.6 28.4 27.4 27.7 12.1 39.6 26.5 27.5 20.8 41.4 21.7 30.2 15.2 30.4 26.9 35.0 32.1 31.6 35.7 16.1 22.6 18.8 17.2 17.8 35.3 52.4 19.6 36.7 19.7 16.2 11.4 30.7 28.2 22.2 28.9 22.2 35.7 21.5 34.9 53.6 22.9 24.6 30.1 35.5 15.9 3.7 9.1 10.3 16.9 12.9 18.9 12.0 12.5 12.9 11.3 12.3 14.7 10.9 3.4 11.7 6.5 14.4 10.5 12.0 21.5 23.5 29.9 29.9 20.1 20.4 22.8 26.9 22.1 22.1 20.8 44.0 22.5 20.1 15.9 23.5 2.0 28.1 22.7 38.7 45.4 45.2 35.1 8.3 25.4 3.7 17.3 21.2 0.0 22.4 17.9 19.9 24.4 27.8 38.0 22.8 35.0 69.4 23.9 14.5 4.2 35.4 16.4 11.8 20.8 31.0 44.4 24.7 21.0 26.5 25.9 45.7 25.8 16.9 22.3 17.6 9.9 47.3 24.1 30.2 15.3 WDR61 REC14 ENSG00000140395 "WD repeat domain 61" Q9GZS3 15 78277835-78299794 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039932, HPA040065" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039932: AB_10796336, HPA040065: AB_10793926" "unprognostic (1.08e-1)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.09e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-1)" "unprognostic (1.60e-1)" "unprognostic (3.05e-1)" "unprognostic (2.74e-3)" "unprognostic (4.21e-1)" "unprognostic (5.72e-2)" "prognostic favorable (2.03e-10)" "unprognostic (1.04e-1)" "unprognostic (3.13e-1)" "unprognostic (3.18e-1)" "unprognostic (1.09e-2)" 23.8 34.3 23.5 17.2 31.2 29.6 34.5 25.2 32.1 24.3 22.0 27.6 22.7 20.3 24.2 69.4 25.9 27.4 19.6 23.1 23.7 28.2 34.2 28.2 22.4 18.7 26.8 23.1 20.7 30.7 22.4 37.7 27.7 30.8 27.4 25.7 24.9 28.1 23.1 26.3 29.9 18.5 23.6 27.8 18.6 20.9 38.5 20.9 26.9 32.5 30.1 24.6 19.1 20.3 21.9 45.2 11.1 32.4 22.7 25.2 28.7 9.4 24.0 19.0 19.5 18.8 17.3 14.3 14.4 16.2 18.3 18.1 22.9 17.2 18.1 18.0 16.4 29.2 20.1 40.2 17.4 15.2 11.7 31.5 14.6 22.2 22.1 16.4 22.5 16.4 13.3 13.4 7.1 6.1 13.0 20.6 19.0 26.7 20.4 23.9 29.5 19.7 21.9 14.0 23.7 19.3 18.3 14.4 22.1 21.3 29.3 26.5 14.4 19.7 22.2 78.5 20.1 14.2 31.1 12.4 14.4 17.0 10.3 24.8 17.6 26.4 25.7 20.9 36.6 28.6 11.1 31.6 10.5 21.5 32.4 23.2 21.9 21.6 22.3 45.2 16.9 23.0 25.2 2.6 22.7 26.3 24.2 23.5 28.7 23.5 31.2 25.2 32.1 23.7 28.2 26.8 23.1 30.8 20.9 32.8 43.1 20.1 47.2 43.6 50.0 23.2 30.6 62.9 22.7 36.6 45.2 87.6 106.1 52.5 15.9 38.7 22.6 23.3 48.6 62.8 54.1 49.6 46.2 41.4 58.3 41.3 22.4 45.4 29.1 10.0 46.3 46.3 55.6 48.7 33.3 72.9 38.7 28.1 47.7 102.6 46.0 6.5 49.5 95.0 66.6 51.3 77.2 35.9 50.2 41.4 WDR62 "C19orf14, DKFZP434J046, FLJ33298, MCPH2" ENSG00000075702 "WD repeat domain 62" O43379 19 36054881-36105106 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 25.6;testis: 88.4" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 42.0;Cone photoreceptor cells: 80.5;Late spermatids: 32.8;Rod photoreceptor cells: 46.1;Spermatocytes: 70.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 9 "monocytes: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043255, HPA043639" Enhanced Enhanced "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA043255: AB_2678393, HPA043639: AB_2678593" "unprognostic (1.77e-1)" "unprognostic (2.79e-3)" "unprognostic (3.16e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-1)" "unprognostic (4.22e-3)" "unprognostic (1.78e-4)" "unprognostic (2.00e-1)" "unprognostic (4.00e-2)" "unprognostic (5.82e-3)" "unprognostic (4.72e-2)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.73e-3)" "unprognostic (2.72e-1)" "unprognostic (1.50e-1)" "unprognostic (2.67e-1)" 0.5 0.2 0.2 3.3 0.4 4.3 0.6 0.4 0.5 0.4 0.5 0.4 0.4 0.4 0.4 0.8 1.0 0.2 0.5 5.5 0.5 0.2 0.5 0.3 0.5 1.4 0.2 0.2 0.4 0.2 0.0 0.3 0.7 0.4 0.3 0.3 0.3 0.6 0.2 25.6 1.4 0.7 0.4 0.5 1.1 0.3 88.4 0.3 10.3 0.2 1.3 3.0 0.3 0.7 0.1 0.1 0.0 3.7 0.0 0.3 0.2 10.8 21.8 8.5 7.8 0.5 0.7 4.3 9.4 4.5 13.1 11.9 11.4 4.3 14.1 6.4 4.9 5.9 3.8 7.9 3.0 7.8 8.9 5.6 9.6 12.4 7.3 0.1 10.4 14.5 0.2 0.2 9.9 4.0 1.2 3.2 11.4 12.3 19.4 6.5 13.6 18.2 6.3 4.6 8.9 4.5 15.3 7.9 5.7 1.9 5.0 9.5 4.8 7.7 8.8 1.5 4.3 6.0 7.6 2.6 13.2 12.9 9.9 15.5 9.4 11.8 16.8 5.3 10.0 14.2 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.3 0.2 0.2 0.4 0.4 0.5 0.5 0.2 0.2 0.2 0.4 0.3 0.0 8.5 2.2 1.1 1.9 1.5 42.0 0.0 0.0 1.2 0.0 80.5 0.9 1.7 0.3 29.4 0.6 0.2 23.3 0.8 1.6 1.3 0.6 0.0 0.0 1.9 3.2 0.0 1.3 1.5 32.8 1.1 1.1 1.7 1.0 1.3 2.0 0.4 0.0 0.4 0.0 46.1 6.5 1.0 70.1 17.0 3.1 0.2 0.7 1.7 0.7 WDR66 "CaM-IP4, MGC33630" ENSG00000158023 "WD repeat domain 66" Q8TBY9 12 121917862-122003927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 228.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 21.9;hTCEpi: 20.7;hTERT-HME1: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039902, HPA040005" Supported Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039902: AB_10795236, HPA040005: AB_10795160" "unprognostic (4.92e-3)" "unprognostic (9.05e-2)" "unprognostic (7.99e-3)" "prognostic favorable (3.11e-4)" "unprognostic (5.58e-3)" "unprognostic (6.89e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (2.89e-1)" "unprognostic (2.34e-1)" "unprognostic (7.72e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "unprognostic (4.29e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" 1.3 1.2 6.3 1.0 13.2 0.4 1.7 0.4 4.0 4.4 0.5 4.5 1.5 0.4 2.5 11.3 0.5 24.6 2.0 1.5 6.4 3.7 3.2 1.8 6.4 0.9 0.7 3.2 3.9 2.1 4.7 28.4 1.3 18.0 0.8 0.4 1.3 1.3 2.2 0.5 1.8 0.5 1.0 0.9 2.0 0.8 35.0 2.4 0.0 6.7 0.0 1.2 0.8 1.7 0.2 4.9 0.4 0.0 0.1 0.3 0.0 1.8 0.2 0.3 0.1 0.3 0.3 0.3 0.2 1.7 0.8 2.1 0.2 0.9 0.1 2.5 0.1 0.5 0.6 0.2 21.9 3.1 0.1 0.3 0.1 0.4 0.2 2.6 0.0 6.0 1.2 20.7 1.7 14.0 0.4 0.9 0.3 5.0 0.0 1.3 0.6 0.2 0.4 0.3 0.3 0.1 0.3 0.5 0.0 3.8 0.3 1.7 0.1 0.2 0.0 0.1 0.6 0.5 0.1 0.7 1.8 2.7 0.3 0.3 0.3 0.1 2.6 2.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.4 0.1 0.0 4.9 0.3 0.0 6.3 13.2 0.4 4.0 6.4 3.7 0.7 3.2 18.0 2.4 6.0 10.0 1.5 5.9 5.5 5.0 2.2 5.1 228.8 36.4 10.4 29.5 0.2 3.3 3.1 38.6 1.3 0.0 0.0 0.4 0.1 1.9 1.9 8.1 0.8 0.5 7.9 1.7 28.3 2.2 49.3 6.9 1.8 1.7 1.0 0.0 1.8 0.7 0.0 7.1 1.1 16.8 6.5 1.0 34.9 14.4 3.1 0.5 0.8 0.0 2.2 WDR7 "KIAA0541, TRAG" ENSG00000091157 "WD repeat domain 7" Q9Y4E6 18 56651343-57036606 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 29.5;Rod photoreceptor cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042074, HPA051057" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042074: AB_2677833, HPA051057: AB_2732563" "unprognostic (1.03e-1)" "unprognostic (1.32e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-2)" "unprognostic (3.66e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "unprognostic (7.70e-2)" "unprognostic (9.21e-2)" "unprognostic (2.00e-2)" "unprognostic (5.05e-2)" "prognostic favorable (1.13e-5)" "unprognostic (4.80e-2)" "unprognostic (4.52e-3)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" 8.0 11.3 14.2 7.9 21.2 9.1 6.8 16.7 34.0 7.5 7.7 11.9 6.1 6.0 7.1 8.1 6.6 6.4 7.7 8.8 17.3 17.9 7.9 10.4 7.2 9.5 14.4 16.4 6.6 6.2 15.6 19.0 6.9 21.1 11.1 7.4 7.9 6.1 8.8 10.5 5.7 6.1 8.3 12.5 8.3 6.9 6.2 12.1 13.2 13.1 4.0 8.2 7.4 6.3 4.5 6.3 9.2 8.7 7.4 9.0 3.2 3.9 6.6 7.6 4.2 12.0 7.0 1.9 7.8 6.7 6.5 7.7 2.6 2.5 10.9 3.1 7.0 5.5 4.2 7.6 6.1 8.1 12.6 4.6 10.3 5.4 2.4 7.2 15.4 13.1 5.9 5.1 8.6 5.8 5.4 8.0 5.2 4.9 15.1 8.0 3.8 10.6 4.6 3.2 2.0 4.4 4.8 5.8 5.3 4.9 7.1 9.9 4.9 5.6 2.7 3.6 6.7 4.2 4.4 7.0 9.3 4.7 2.8 4.2 15.2 11.3 11.9 7.6 7.8 6.2 7.2 5.0 9.2 6.6 7.6 8.2 4.4 7.5 6.7 6.3 4.5 7.9 7.2 4.6 7.4 8.7 3.0 9.0 3.2 14.2 21.2 16.7 23.7 17.3 17.9 14.4 16.4 21.1 12.1 3.0 4.5 3.7 1.4 2.6 22.0 11.0 7.6 5.3 10.3 0.0 29.5 1.6 3.3 2.6 13.5 6.7 3.6 0.0 3.1 1.0 3.0 3.7 10.4 6.2 5.2 25.4 8.1 8.6 19.1 4.3 5.2 6.4 0.0 4.6 2.7 7.4 2.7 2.9 7.8 3.1 26.3 6.5 3.8 1.9 1.5 2.0 0.6 4.3 3.5 1.4 WDR70 FLJ10233 ENSG00000082068 "WD repeat domain 70" Q9NW82 5 37379212-37753435 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043064, HPA048149" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA043064: , HPA048149: AB_2680287" "unprognostic (2.55e-2)" "unprognostic (3.39e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (4.40e-2)" "unprognostic (1.38e-2)" "unprognostic (1.20e-3)" "unprognostic (1.17e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (6.34e-2)" "unprognostic (8.36e-2)" "unprognostic (9.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (9.31e-2)" "unprognostic (1.22e-1)" "unprognostic (8.11e-2)" 17.5 13.4 15.4 21.9 22.8 16.3 17.7 30.9 21.1 15.7 16.3 12.0 16.9 10.4 19.6 13.5 15.0 15.6 10.0 13.0 15.8 8.7 11.2 11.8 13.0 18.8 16.2 13.0 18.6 13.9 12.6 14.4 14.0 17.9 13.2 14.3 7.9 15.6 14.4 36.3 17.2 13.3 16.2 18.3 14.0 13.9 12.7 16.5 13.9 13.2 8.4 15.1 17.4 15.7 12.7 15.8 12.6 17.5 11.1 10.3 7.1 9.2 6.1 12.2 15.3 12.4 12.2 16.6 11.8 11.1 13.6 11.6 10.0 9.6 15.1 7.0 11.4 10.6 8.6 10.1 10.8 15.3 14.4 12.6 11.4 18.7 7.0 9.3 19.1 10.2 11.7 8.3 10.4 14.5 10.5 11.2 11.4 14.2 6.3 8.5 6.2 12.3 9.4 8.4 7.4 10.9 14.2 30.5 15.4 6.9 11.1 10.5 9.9 39.1 8.7 8.5 9.7 11.4 12.1 12.8 12.5 12.0 12.1 9.3 8.4 12.5 17.5 8.3 17.1 10.3 6.2 14.5 12.6 8.8 17.5 9.7 11.4 10.3 9.5 15.3 12.7 10.2 9.8 3.5 11.1 15.8 15.8 9.8 7.1 15.4 22.8 30.9 21.1 15.8 8.7 16.2 13.0 17.9 16.5 29.8 26.1 27.6 11.3 8.1 35.4 17.3 12.7 30.8 12.5 8.7 35.3 21.8 16.6 16.0 16.9 15.5 15.1 0.0 18.0 22.3 13.1 6.6 19.6 20.9 16.6 23.8 13.3 18.4 24.4 5.4 27.3 19.8 11.8 21.6 20.9 20.1 14.0 17.5 21.2 10.3 56.8 12.9 11.7 31.2 27.5 6.8 18.5 20.2 23.2 8.6 WDR77 "MEP50, p44" ENSG00000116455 "WD repeat domain 77" Q9BQA1 1 111439890-111449376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 68.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026437, HPA026448, HPA027271" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004" "unprognostic (1.84e-1)" "unprognostic (7.01e-2)" "unprognostic (6.26e-3)" "unprognostic (1.19e-3)" "unprognostic (1.12e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.06e-6)" "unprognostic (5.14e-1)" "unprognostic (3.88e-3)" "prognostic favorable (7.88e-4)" "unprognostic (6.16e-2)" "unprognostic (1.72e-3)" "unprognostic (1.63e-2)" "unprognostic (8.13e-2)" "unprognostic (1.92e-1)" "unprognostic (6.17e-2)" "unprognostic (1.23e-2)" 11.2 16.5 10.0 17.3 16.2 5.9 9.7 8.5 18.1 9.8 10.9 14.3 5.7 9.5 13.9 15.7 19.0 68.6 15.7 16.6 9.9 10.8 13.6 19.2 9.9 16.8 12.1 9.6 14.6 14.0 15.1 11.7 12.1 15.8 12.6 16.6 10.3 16.4 13.4 27.2 8.9 11.1 13.0 7.9 16.5 14.5 12.9 9.3 19.3 9.9 23.2 22.7 19.1 11.0 24.9 25.7 6.2 17.7 26.7 16.1 11.9 20.7 18.2 17.4 14.3 10.5 6.1 24.2 15.7 8.4 24.1 15.9 26.7 7.8 35.4 15.4 13.3 15.6 15.1 31.4 30.1 29.2 14.0 24.6 21.1 21.3 38.4 11.8 21.6 36.1 7.5 21.6 23.6 15.2 6.4 16.0 15.8 28.1 9.4 23.2 26.2 27.7 11.3 34.2 19.5 30.5 27.7 27.4 13.5 21.4 36.8 14.4 10.5 13.8 17.4 12.5 23.3 14.0 14.9 11.6 13.4 26.9 25.9 33.3 7.8 9.8 31.8 16.9 24.3 39.1 6.2 11.6 2.9 13.9 17.7 15.5 24.9 15.1 15.5 25.7 21.6 16.1 15.0 1.7 26.7 15.5 16.1 12.5 11.9 10.0 16.2 8.5 18.1 9.9 10.8 12.1 9.6 15.8 9.3 11.9 10.7 30.3 21.0 18.4 11.9 21.5 12.7 37.5 9.1 17.4 23.6 49.7 21.6 29.8 2.7 9.8 7.4 0.0 11.8 45.7 9.9 13.5 15.1 13.4 41.0 7.9 15.1 8.0 19.6 2.7 6.9 17.8 5.0 10.8 16.5 8.4 20.0 7.0 8.5 24.4 9.2 12.9 13.1 12.3 22.6 16.2 38.1 17.5 21.3 22.3 WDR81 "CAMRQ2, FLJ33817, PPP1R166, SORF-2" ENSG00000167716 "WD repeat domain 81" Q562E7 17 1716523-1738599 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023044, HPA063703" Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Cytosol" "HPA023044: AB_1858822, HPA063703: " "unprognostic (1.00e-1)" "unprognostic (4.67e-2)" "unprognostic (6.63e-2)" "unprognostic (4.90e-3)" "unprognostic (6.10e-2)" "unprognostic (7.75e-3)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (3.06e-2)" "unprognostic (1.60e-2)" "prognostic favorable (3.30e-4)" "unprognostic (3.26e-1)" "unprognostic (8.72e-2)" "unprognostic (2.25e-1)" "unprognostic (8.43e-2)" "unprognostic (7.99e-2)" "unprognostic (3.90e-2)" 12.7 12.2 8.9 12.1 8.4 10.7 22.9 7.0 11.7 12.6 9.1 10.5 26.4 11.3 14.9 11.6 7.4 12.8 9.3 9.0 8.4 4.3 9.6 22.7 17.2 21.4 9.2 4.4 18.5 8.3 3.5 9.9 8.9 8.5 11.9 4.6 10.6 10.1 21.8 13.1 16.7 12.7 11.6 5.0 19.0 8.4 6.3 8.2 17.3 8.1 5.2 10.3 11.6 16.2 2.8 6.9 5.1 5.0 4.2 3.0 1.9 0.5 10.8 1.5 7.3 10.5 5.8 8.0 0.6 0.1 0.4 0.0 1.4 4.0 4.2 5.8 4.3 5.6 10.2 5.3 7.2 0.3 7.9 11.3 0.1 7.4 4.9 18.0 3.4 6.6 14.5 7.4 5.2 3.2 2.1 4.0 3.4 0.3 5.4 6.0 5.2 1.1 5.8 3.4 3.2 7.6 5.5 2.5 5.6 3.0 1.5 2.1 4.6 3.9 3.3 12.6 0.1 4.9 5.0 6.0 4.2 5.0 6.7 5.5 0.4 0.9 2.4 6.5 5.5 2.9 0.0 3.1 5.1 2.6 5.0 3.0 2.8 2.7 2.6 3.8 2.3 1.8 2.4 0.6 4.2 4.3 6.9 2.4 1.9 8.9 8.4 7.0 11.7 8.4 4.3 9.2 4.4 8.5 8.2 11.9 9.3 4.7 2.5 2.3 4.7 2.6 5.1 4.0 3.4 0.0 3.9 2.1 1.7 2.5 0.5 2.9 5.9 0.0 3.8 1.7 3.1 2.4 4.6 20.9 20.3 4.8 1.2 5.5 17.2 0.4 15.3 9.1 0.0 5.4 4.0 2.8 4.7 3.4 14.2 11.1 1.7 19.4 2.0 0.5 1.5 1.5 1.9 2.9 3.5 1.3 WDR89 "C14orf150, MGC9907" ENSG00000140006 "WD repeat domain 89" Q96FK6 14 63597039-63641861 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000813 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA000813: AB_1078324" "prognostic favorable (3.37e-4)" "unprognostic (6.46e-2)" "unprognostic (5.40e-2)" "unprognostic (1.00e-1)" "unprognostic (6.05e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (1.05e-1)" "unprognostic (3.08e-2)" "unprognostic (8.66e-3)" "unprognostic (3.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (3.08e-1)" "unprognostic (8.63e-2)" "unprognostic (3.29e-1)" 13.2 12.6 11.5 11.6 13.4 4.6 13.7 19.3 18.8 12.5 10.3 9.5 7.4 8.0 14.6 11.5 10.5 11.9 8.6 8.1 11.0 10.7 14.8 16.1 9.1 17.8 15.7 11.6 15.0 14.0 16.2 16.3 12.9 12.3 12.0 12.1 8.3 8.7 8.4 13.2 10.8 8.9 10.5 11.8 13.8 8.5 8.6 14.4 21.0 16.9 7.6 17.0 11.6 10.2 7.0 4.3 0.6 3.6 8.4 14.0 4.9 25.1 11.0 13.7 7.3 8.3 9.0 19.6 10.2 5.6 10.3 11.5 7.8 11.9 24.5 8.4 3.0 7.1 11.7 16.7 9.9 18.3 15.8 9.6 16.6 6.9 9.7 10.5 21.1 11.5 8.2 12.8 11.8 17.7 6.4 10.0 18.2 13.5 13.6 7.7 12.6 17.6 12.0 12.3 18.0 21.9 13.0 13.9 13.7 11.4 9.7 11.7 9.6 10.9 11.7 7.7 13.8 13.5 11.5 6.8 12.5 11.8 8.1 12.1 7.9 5.8 15.0 5.6 15.5 8.8 0.0 2.5 0.3 8.2 2.5 10.5 7.0 8.7 7.5 4.3 6.9 14.0 12.1 0.6 8.4 3.6 2.8 8.7 4.9 11.5 13.4 19.3 18.8 11.0 10.7 15.7 11.6 12.3 14.4 8.9 4.1 4.5 10.0 8.7 6.6 4.0 5.1 1.4 9.1 5.2 3.9 9.1 11.6 6.2 2.2 5.8 2.6 0.0 4.8 11.5 4.5 6.4 1.1 7.8 5.6 1.6 3.5 6.2 6.0 3.6 4.0 4.0 3.3 3.6 4.2 6.5 3.2 0.0 6.0 6.2 8.2 12.9 4.3 6.2 12.6 9.5 5.8 5.2 5.0 5.5 WDSUB1 "FLJ36175, UBOX6, WDSAM1" ENSG00000196151 "WD repeat, sterile alpha motif and U-box domain containing 1" Q8N9V3 2 159235793-159286799 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036840, HPA058172" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036840: AB_10670926, HPA058172: AB_2683628" "unprognostic (1.37e-2)" "prognostic favorable (3.35e-4)" "unprognostic (2.56e-1)" "unprognostic (7.33e-3)" "unprognostic (3.44e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.76e-3)" "unprognostic (4.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (6.75e-2)" "unprognostic (3.46e-3)" "unprognostic (8.49e-2)" "unprognostic (1.72e-1)" "unprognostic (1.00e-2)" "unprognostic (2.87e-2)" 10.3 14.2 9.7 6.6 12.7 10.9 14.8 18.9 14.0 10.3 8.5 8.9 10.6 5.8 9.8 22.1 11.1 11.8 9.9 11.5 9.7 10.6 27.7 8.2 10.7 16.1 11.5 7.0 16.4 15.5 19.4 23.8 15.7 9.2 11.3 9.2 16.0 11.8 8.7 7.7 8.2 7.7 9.9 9.5 10.5 9.0 7.7 10.2 8.5 22.2 6.1 9.2 10.0 15.0 9.8 10.3 2.8 9.3 16.2 13.0 6.2 6.1 4.6 4.2 6.6 7.6 8.8 14.2 4.8 9.5 8.8 15.5 9.9 10.0 8.2 5.1 7.2 15.1 3.7 11.7 4.4 12.4 3.2 9.7 8.4 5.3 10.0 9.3 7.1 11.7 5.1 16.4 10.8 8.9 16.9 7.2 10.9 11.1 6.2 8.3 6.3 5.1 13.2 5.7 10.4 9.9 8.0 6.2 4.4 10.1 8.9 7.8 5.1 5.0 6.5 11.2 20.4 5.0 12.6 3.0 6.3 4.6 8.8 4.6 3.2 5.3 7.6 11.1 8.9 3.9 2.7 9.3 2.8 13.0 7.0 9.8 9.8 5.2 8.1 10.3 8.9 6.3 7.4 0.6 16.2 6.3 9.7 2.6 6.2 9.7 12.7 18.9 14.0 9.7 10.6 11.5 7.0 9.2 10.2 11.9 5.0 6.7 7.4 4.7 6.4 10.7 10.2 17.4 9.1 19.2 2.0 20.1 29.9 7.2 3.0 6.6 5.1 0.0 3.1 7.7 8.8 6.6 11.5 1.7 15.4 4.8 5.2 6.2 13.9 2.1 11.8 9.5 5.0 3.6 5.5 6.0 4.7 9.0 10.6 17.4 8.9 0.0 7.1 10.5 20.2 5.5 19.2 10.1 7.0 5.1 WEE2 FLJ16107 ENSG00000214102 "WEE1 homolog 2" P0C1S8 7 141708353-141731271 "Enzymes, Predicted intracellular proteins" Meiosis "Kinase, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 21 "Distal tubular cells: 1.7;Proximal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CACO-2: 8.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA027418, HPA054280" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027418: AB_10603144, HPA054280: " "unprognostic (6.35e-2)" "unprognostic (1.47e-1)" "unprognostic (1.89e-1)" "unprognostic (3.18e-1)" "unprognostic (2.33e-1)" "unprognostic (4.00e-2)" "unprognostic (2.90e-1)" "unprognostic (1.97e-2)" "unprognostic (3.23e-2)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.76e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-2)" "unprognostic (2.66e-1)" "unprognostic (6.07e-2)" "unprognostic (2.88e-3)" 0.6 0.1 0.5 0.3 1.0 0.0 0.4 0.8 0.6 0.6 0.1 0.0 0.7 0.0 1.3 0.7 1.6 1.3 0.5 0.6 1.3 0.1 0.3 1.6 0.6 1.2 1.1 0.0 1.0 0.0 0.3 0.0 0.9 0.0 0.7 2.8 0.4 0.0 0.8 0.4 0.8 1.3 2.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.2 0.4 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.4 0.1 0.1 0.0 0.3 1.0 0.3 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.3 0.5 1.6 1.2 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.0 0.2 0.1 1.7 1.1 0.5 0.0 0.4 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.4 0.6 0.0 0.1 0.1 0.6 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WHAMM "KIAA1971, WHAMM1, WHDC1" ENSG00000156232 "WAS protein homolog associated with actin, golgi membranes and microtubules" Q8TF30 15 82809628-82836108 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 44.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039690, HPA040231" Supported Supported Cytosol NA NA Cytosol "HPA039690: AB_10795405, HPA040231: AB_10795361" "unprognostic (7.98e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (8.56e-2)" "unprognostic (6.68e-2)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.37e-2)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.31e-1)" "unprognostic (1.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (2.20e-2)" 10.6 6.6 7.9 9.8 11.7 44.5 10.1 14.0 9.5 8.7 8.8 11.2 7.7 8.8 8.5 6.7 10.2 7.3 6.6 7.4 10.1 5.3 9.5 11.4 10.7 9.6 10.7 8.0 10.9 9.3 16.7 7.9 8.9 13.9 10.1 8.2 7.6 9.3 7.5 23.3 12.0 10.6 12.0 12.3 11.9 8.3 5.5 14.3 8.3 9.6 6.6 11.0 11.1 13.1 3.2 2.4 5.0 1.6 5.8 3.2 0.9 4.1 4.2 2.6 4.0 8.6 6.0 4.5 5.8 5.8 6.4 6.4 2.8 7.6 9.0 7.2 5.3 6.1 9.2 8.1 4.7 4.2 2.9 4.6 5.1 4.8 4.0 8.8 3.7 6.1 5.9 6.4 3.0 6.3 6.5 4.5 4.3 4.6 11.9 6.3 3.1 3.0 5.3 1.1 5.1 2.6 4.5 5.7 2.5 11.0 16.8 2.6 2.1 8.9 5.9 5.9 5.7 4.0 7.9 7.1 8.5 3.0 5.7 6.5 12.9 7.2 4.4 6.0 5.1 5.3 5.0 1.6 1.3 3.2 1.1 2.9 2.6 3.1 2.4 1.0 3.2 2.9 2.9 3.6 5.8 1.1 2.4 2.4 0.9 7.9 11.7 14.0 9.5 10.1 5.3 10.7 8.0 13.9 14.3 14.9 12.9 35.0 39.1 23.6 15.2 13.6 7.6 5.3 7.9 19.2 13.7 12.0 5.0 7.7 5.5 16.4 14.8 0.0 8.9 13.6 13.1 41.0 10.4 11.5 16.5 22.3 6.4 16.5 10.2 2.4 16.1 17.9 18.6 9.0 16.6 17.7 11.0 14.1 22.3 8.6 17.7 32.3 15.6 22.8 30.6 22.0 21.3 26.3 12.3 64.2 WIPF1 "WASPIP, WIP" ENSG00000115935 "WAS/WASL interacting protein family member 1" O43516 2 174559572-174682916 "Disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 132.4;monocytes: 161.5;T-cells: 221.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 45.4;HMC-1: 37.8;Karpas-707: 65.4;U-266/70: 52.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003739, CAB009737, HPA070706" Enhanced Approved "Plasma membrane,Cytosol" No No 290000 Cytosol "Plasma membrane" "CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300" "unprognostic (4.76e-2)" "unprognostic (4.80e-2)" "unprognostic (1.49e-1)" "unprognostic (9.88e-2)" "unprognostic (1.87e-1)" "unprognostic (2.27e-3)" "unprognostic (2.05e-1)" "unprognostic (1.21e-1)" "unprognostic (7.22e-2)" "unprognostic (1.26e-1)" "unprognostic (3.25e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (3.65e-2)" "unprognostic (5.43e-2)" "unprognostic (1.58e-1)" "unprognostic (2.50e-2)" 20.6 7.3 10.5 47.0 14.4 23.2 21.6 2.1 9.2 17.1 16.5 20.2 6.6 8.7 14.3 11.4 10.3 9.8 17.2 12.0 14.6 10.5 9.0 7.8 22.6 55.7 21.1 5.6 8.7 4.7 5.7 4.2 15.6 10.9 10.6 10.7 10.5 10.5 11.7 4.0 7.3 21.3 13.8 44.2 55.5 9.9 4.5 14.9 42.9 11.4 8.9 51.7 22.8 15.3 12.3 8.2 52.7 12.9 17.8 25.0 15.3 0.1 1.4 3.5 0.0 8.8 15.7 3.6 6.5 5.6 2.6 4.1 0.4 0.3 45.4 2.0 9.8 3.3 0.1 0.5 0.0 3.4 30.7 0.8 23.9 5.9 0.0 3.4 19.9 37.8 6.6 1.1 6.1 0.5 3.4 5.7 3.9 0.6 65.4 7.7 0.0 22.0 18.3 4.0 0.0 0.2 19.0 1.4 8.5 2.4 0.1 0.5 7.3 0.0 1.8 3.9 6.8 0.0 9.7 4.4 9.0 2.5 6.4 6.2 52.2 31.9 23.7 13.5 13.6 24.7 12.1 10.8 26.2 25.0 11.9 21.0 12.3 16.8 24.5 8.2 10.3 13.8 18.1 52.7 17.8 12.9 3.6 18.7 15.3 10.5 14.4 2.1 9.2 14.6 10.5 21.1 5.6 10.9 14.9 17.9 30.3 74.6 5.1 11.1 0.9 8.9 0.0 0.0 7.9 3.5 23.6 1.3 5.0 1.8 29.6 27.4 0.0 0.0 10.1 70.1 48.8 3.9 65.8 1.3 77.2 0.0 4.7 37.4 132.4 57.3 23.3 101.7 25.3 161.5 1.0 1.2 12.1 0.0 17.0 27.9 3.3 12.9 27.7 3.9 2.0 9.7 3.4 221.6 1.9 2.7 WIPI1 "ATG18, ATG18A, FLJ10055, WIPI49" ENSG00000070540 "WD repeat domain, phosphoinositide interacting 1" Q5MNZ9 17 68420948-68457513 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 132.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 25.0;eosinophil: 53.0" "Lineage enriched" "Detected in all" 9 "granulocytes: 53.0" "Cell line enhanced" "Detected in many" "ASC diff: 52.6;ASC TERT1: 40.2;HHSteC: 50.7;HSkMC: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007493, CAB037230" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB037230: AB_1841265, HPA007493: AB_1848642" "unprognostic (2.83e-2)" "unprognostic (7.85e-2)" "unprognostic (1.05e-3)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-2)" "unprognostic (3.97e-3)" "unprognostic (1.78e-2)" "prognostic favorable (3.11e-4)" "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (3.06e-1)" "unprognostic (6.32e-3)" "unprognostic (6.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (1.89e-3)" 18.4 11.0 6.0 6.5 10.0 10.5 19.6 7.6 9.6 16.1 15.9 7.8 39.7 5.7 9.0 12.9 8.1 6.7 10.7 34.8 5.3 3.7 20.2 11.5 14.4 12.2 8.5 5.3 6.9 23.9 10.0 10.2 33.5 9.4 8.4 17.9 11.5 30.2 19.3 49.3 11.8 7.7 10.0 7.5 8.9 14.5 4.6 6.5 1.6 10.0 25.2 9.8 10.3 10.3 1.1 2.2 53.0 5.7 2.5 3.1 3.3 1.0 2.2 1.9 2.8 52.6 40.2 10.7 7.7 36.8 3.1 10.0 1.6 1.6 0.5 3.5 16.5 11.0 0.8 0.7 4.9 5.5 0.9 0.9 7.6 0.7 9.4 50.7 0.5 11.0 42.3 9.1 12.3 16.8 10.3 13.9 1.1 0.4 19.2 9.3 6.5 0.1 1.5 0.4 2.8 3.2 0.1 6.7 7.4 4.7 3.7 0.5 2.6 1.7 24.1 39.1 10.7 12.4 2.1 13.2 15.3 2.2 7.0 1.9 16.8 19.0 2.2 23.1 3.6 6.8 25.0 4.6 53.0 3.1 5.5 1.4 1.1 0.8 3.0 2.2 0.4 0.0 1.5 9.7 2.5 5.7 1.5 0.6 3.3 6.0 10.0 7.6 9.6 5.3 3.7 8.5 5.3 9.4 6.5 8.9 11.5 11.1 11.2 6.9 11.0 6.7 25.5 53.5 33.0 15.7 2.0 35.8 26.6 25.2 5.6 10.8 13.4 70.0 49.5 132.1 43.1 46.3 6.9 10.6 31.2 9.5 11.5 41.1 15.3 3.6 42.8 14.5 40.5 47.7 56.7 12.4 33.5 11.5 39.6 54.2 12.4 25.8 15.5 4.4 4.5 5.9 104.6 17.5 25.7 23.5 WIPI2 "ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984" ENSG00000157954 "WD repeat domain, phosphoinositide interacting 2" Q9Y4P8 7 5190188-5233826 "Predicted intracellular proteins" Autophagy "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019852, HPA021488" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA019852: AB_1846589, HPA021488: AB_1846591" "unprognostic (5.79e-2)" "unprognostic (1.47e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (7.69e-5)" "unprognostic (1.96e-3)" "unprognostic (9.27e-3)" "unprognostic (4.60e-3)" "unprognostic (4.96e-2)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "prognostic favorable (9.78e-4)" "unprognostic (1.20e-1)" "prognostic favorable (2.05e-6)" "unprognostic (2.61e-2)" "unprognostic (1.37e-1)" "unprognostic (7.41e-2)" "unprognostic (6.98e-2)" 24.5 23.6 33.9 17.8 34.7 32.7 21.9 30.6 47.4 20.6 21.7 27.8 17.4 20.3 24.4 23.1 25.4 25.3 20.5 30.5 27.9 27.2 23.5 27.5 21.9 22.3 26.0 31.2 25.0 30.8 28.7 23.2 27.0 26.1 25.0 17.2 25.0 34.7 25.5 28.3 31.8 18.2 22.9 25.6 22.0 23.0 49.3 26.0 26.6 24.1 15.9 23.4 22.9 20.5 6.1 6.9 13.0 6.3 2.6 9.2 2.2 27.2 17.4 17.1 29.1 26.3 27.6 26.3 24.3 28.0 26.0 27.5 16.9 25.4 19.5 18.7 30.4 32.4 20.0 17.2 19.8 20.3 10.0 26.7 13.3 17.6 18.6 26.0 20.8 14.6 29.0 23.9 29.5 16.4 26.0 36.1 26.8 37.6 17.7 23.5 28.3 15.8 36.1 35.5 14.6 25.6 26.1 24.4 32.0 17.1 13.3 21.3 32.1 17.8 30.7 21.1 29.9 18.8 39.8 28.6 16.6 35.0 27.7 18.1 31.8 29.6 22.2 27.1 24.2 24.5 0.3 4.9 13.0 5.1 6.3 3.1 5.6 6.7 9.1 4.5 6.1 8.5 5.4 9.9 2.6 4.2 6.9 9.2 2.2 33.9 34.7 30.6 47.4 27.9 27.2 26.0 31.2 26.1 26.0 35.7 26.9 47.2 36.3 48.8 67.7 25.4 25.5 21.4 17.0 17.4 58.9 79.1 61.3 36.3 146.8 28.9 32.1 46.7 36.2 84.9 33.8 70.9 31.1 55.0 59.9 44.5 37.9 47.9 51.5 127.3 39.4 39.2 42.2 65.9 47.0 87.1 45.2 38.5 52.6 60.3 50.4 51.8 32.0 181.0 130.5 62.0 126.1 42.4 42.2 42.4 WISP1 "CCN4, WISP-1, WISP1-OT1, WISP1-UT1" ENSG00000104415 "WNT1 inducible signaling pathway protein 1" O95388 8 133191039-133231690 "Cancer-related genes, Predicted secreted proteins" "Cell adhesion, Wnt signaling pathway" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 1.6;Fibroblasts: 2.1;Sertoli cells: 6.5;Smooth muscle cells: 2.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 8.1;HSkMC: 45.6;hTEC/SVTERT24-B: 26.0;U-2197: 24.9" "Region enriched" "Detected in single" 6 "olfactory region: 11.9" "Low region specificity" "Detected in single" "HPA007121, CAB012205" Uncertain Approved Cytosol "Secreted to extracellular matrix" NA NA Cytosol "CAB012205: , HPA007121: AB_1858844" "unprognostic (7.77e-2)" "unprognostic (2.05e-1)" "unprognostic (3.30e-2)" "unprognostic (3.20e-1)" "unprognostic (7.72e-2)" "unprognostic (6.63e-2)" "unprognostic (8.61e-3)" "unprognostic (3.26e-2)" "unprognostic (2.07e-3)" "unprognostic (1.41e-3)" "unprognostic (3.01e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (7.52e-3)" "unprognostic (2.55e-3)" "unprognostic (6.03e-2)" "unprognostic (5.67e-3)" 4.2 11.0 0.6 7.7 1.6 0.0 2.3 0.6 2.9 14.7 3.9 1.0 0.0 1.2 18.5 6.4 2.2 6.5 8.5 4.0 0.7 0.3 18.0 2.9 8.9 13.4 0.8 0.4 13.0 1.0 0.2 2.7 3.5 1.2 3.4 0.9 4.5 1.3 4.2 2.0 1.6 3.9 14.4 6.2 14.6 3.8 3.7 0.4 0.3 1.3 2.7 4.2 14.4 4.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 1.7 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 45.6 0.0 26.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 6.0 0.3 24.9 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 1.6 0.6 2.9 0.7 0.3 0.8 0.4 1.2 0.4 0.0 0.3 0.0 0.7 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 2.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 WLS "C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls" ENSG00000116729 "Wntless Wnt ligand secretion mediator" Q5T9L3 1 68098473-68233120 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 160.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 10.0;neutrophil: 29.1" "Group enriched" "Detected in many" 46 "granulocytes: 29.1;monocytes: 10.0" "Cell line enhanced" "Detected in many" "AF22: 70.0;ASC TERT1: 54.2;SuSa: 66.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069520 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA069520: AB_2686144" "prognostic favorable (4.03e-4)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (8.13e-3)" "unprognostic (5.93e-2)" "unprognostic (4.51e-3)" "unprognostic (5.41e-3)" "unprognostic (7.46e-3)" "unprognostic (7.70e-2)" "prognostic favorable (9.43e-4)" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "prognostic favorable (3.67e-7)" "unprognostic (4.48e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (3.51e-4)" 13.7 17.2 33.5 14.3 39.0 1.5 14.5 6.8 26.6 20.0 28.3 25.8 51.6 9.1 19.5 55.1 26.7 19.9 37.1 24.1 23.1 25.4 36.8 8.9 20.3 6.9 27.0 18.6 31.4 34.7 12.1 9.8 29.2 44.5 29.0 22.8 37.8 14.5 47.4 5.3 19.3 14.1 46.2 30.5 10.8 24.4 12.2 22.3 1.9 8.9 13.5 8.2 29.6 17.0 0.0 0.4 29.1 10.0 0.0 0.0 1.9 1.9 2.9 70.0 0.0 38.8 54.2 40.6 9.7 23.9 13.5 18.8 4.2 4.6 0.0 9.8 2.7 12.6 20.3 15.7 15.9 11.5 0.1 11.7 0.0 8.4 0.0 33.9 0.0 0.1 38.7 10.7 33.1 10.9 13.7 31.7 3.7 0.0 0.1 19.9 0.3 0.0 0.2 3.1 4.2 4.7 0.0 14.7 0.0 2.3 10.5 3.9 8.2 8.9 0.4 11.6 66.2 1.9 0.2 36.7 13.0 10.4 20.8 13.1 4.7 0.1 0.0 29.9 0.3 23.7 0.0 10.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.1 0.0 0.3 0.1 0.0 1.9 33.5 39.0 6.8 23.8 23.1 25.4 27.0 18.6 44.5 22.3 44.7 28.8 2.4 56.2 37.7 7.2 27.1 35.7 115.1 44.3 26.2 131.6 119.4 8.3 69.5 13.0 20.8 38.0 0.0 52.3 3.0 31.4 26.5 5.7 10.2 20.8 12.7 9.2 34.4 10.2 7.0 30.2 10.7 18.6 12.6 24.7 7.3 63.3 28.8 51.9 30.0 160.2 38.8 20.8 0.5 0.7 26.2 46.1 1.8 33.6 39.6 WNK1 "HSAN2, HSN2, PPP1R167, PRKWNK1" ENSG00000060237 "WNK lysine deficient protein kinase 1" Q9H4A3 12 752593-911452 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase" "Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046541, HPA059157" Enhanced Supported Cytosol NA NA Cytosol "HPA046541: AB_2679690, HPA059157: AB_2683935" "unprognostic (1.40e-1)" "unprognostic (1.54e-2)" "unprognostic (4.82e-2)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (7.68e-2)" "unprognostic (1.05e-3)" "unprognostic (1.57e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.67e-4)" "unprognostic (1.84e-1)" "unprognostic (2.49e-1)" "unprognostic (4.38e-1)" "unprognostic (1.40e-1)" "unprognostic (1.32e-1)" "unprognostic (5.17e-2)" "unprognostic (1.30e-2)" 30.0 12.4 49.3 19.1 47.5 28.9 45.4 22.5 36.7 21.2 12.6 42.6 10.6 8.5 15.9 19.4 45.5 16.9 16.5 38.5 53.7 36.4 45.6 18.0 33.0 34.3 62.3 27.1 18.5 11.3 29.1 12.7 20.3 41.4 17.1 14.3 12.0 15.4 20.3 43.4 31.3 10.3 22.3 82.8 16.9 15.7 23.8 38.8 23.9 16.7 17.4 24.5 18.9 26.5 3.7 2.6 10.9 7.1 2.1 5.2 1.9 14.1 26.8 35.4 3.3 25.6 24.6 13.5 14.1 17.0 15.3 14.3 15.0 16.1 20.0 5.0 30.2 18.6 10.7 23.9 16.3 21.6 34.5 14.3 44.5 35.6 13.0 18.8 24.0 19.4 19.0 24.8 25.3 45.4 17.0 20.7 18.8 20.3 48.2 23.1 13.0 43.2 4.0 28.9 12.0 6.4 20.6 39.3 5.3 22.0 30.6 10.3 12.1 32.9 21.4 9.5 49.5 23.5 24.7 22.8 19.0 22.0 26.6 20.7 7.4 12.2 30.2 18.1 12.7 15.4 0.9 2.7 2.6 3.8 4.0 5.2 3.0 4.3 3.6 2.6 3.7 2.3 4.1 10.9 2.1 7.1 1.7 4.9 1.9 49.3 47.5 22.5 36.7 53.7 36.4 62.3 27.1 41.4 38.8 95.3 107.5 34.5 38.1 100.2 81.8 197.8 58.6 61.6 53.4 85.5 141.4 27.8 72.9 26.9 18.6 99.1 21.1 210.2 21.1 25.9 54.1 46.4 50.8 62.5 49.6 79.4 56.4 45.4 101.9 17.5 57.2 66.8 35.4 48.7 24.6 57.2 32.3 29.8 52.3 16.5 92.4 12.9 41.9 139.7 38.1 118.8 23.8 69.2 21.9 46.1 WNK2 "KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43" ENSG00000165238 "WNK lysine deficient protein kinase 2" Q9Y3S1 9 93184916-93320572 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 151.2;Rod photoreceptor cells: 101.2" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "Daudi: 11.5;Hep G2: 18.8;SCLC-21H: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015555, HPA016519, CAB017813" Enhanced Approved Cytosol NA NA Cytosol "CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380" "unprognostic (5.02e-2)" "unprognostic (1.32e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-1)" "unprognostic (1.01e-1)" "unprognostic (2.04e-1)" "unprognostic (1.79e-3)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.31e-3)" "unprognostic (2.23e-1)" "unprognostic (4.48e-3)" "unprognostic (6.51e-2)" "unprognostic (1.44e-1)" "unprognostic (4.38e-4)" "unprognostic (1.62e-1)" 0.0 0.7 3.9 0.9 3.8 0.0 1.2 9.5 7.2 0.7 7.5 7.4 1.3 1.5 2.1 6.6 0.1 21.9 4.0 4.2 0.0 0.0 0.0 0.0 2.6 0.0 18.3 0.8 7.5 0.9 4.9 4.8 19.5 5.5 23.7 3.0 6.2 1.6 1.1 0.5 3.0 1.5 0.0 0.0 1.0 0.1 0.0 0.0 1.9 0.0 0.0 0.3 0.0 4.4 4.0 2.9 8.2 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.6 0.1 11.5 1.5 0.0 0.8 0.2 6.5 0.0 0.0 0.0 7.5 0.0 3.5 18.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.3 0.0 0.0 6.0 0.1 0.1 7.3 4.4 0.2 0.0 0.0 9.3 0.0 0.7 23.9 9.4 1.5 6.5 0.6 0.8 0.8 1.3 0.1 0.0 3.1 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 8.1 1.1 57.3 56.7 30.6 5.3 9.1 0.0 151.2 11.9 0.0 11.7 0.9 0.5 34.4 0.0 8.0 5.6 1.1 12.9 0.0 0.0 2.9 1.6 31.2 0.6 1.0 1.9 0.9 0.0 1.7 1.0 57.9 60.6 3.3 42.1 5.6 0.7 101.2 12.9 4.4 0.4 6.6 4.8 13.0 0.0 51.8 6.4 WRAP53 "FLJ10385, TCAB1, WDR79" ENSG00000141499 "WD repeat containing antisense to TP53" Q9BUR4 17 7686071-7703502 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Chaperone, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023026, HPA028130, HPA029928" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257" "unprognostic (1.45e-1)" "unprognostic (3.50e-3)" "unprognostic (6.81e-2)" "unprognostic (2.53e-3)" "unprognostic (3.86e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (4.70e-4)" "unprognostic (8.69e-2)" "unprognostic (3.29e-1)" "unprognostic (1.41e-1)" "prognostic favorable (8.26e-4)" "unprognostic (2.68e-2)" "unprognostic (5.67e-2)" "unprognostic (7.23e-2)" "unprognostic (2.47e-1)" "unprognostic (2.93e-2)" "unprognostic (4.04e-1)" 6.9 6.9 8.1 10.3 8.0 13.3 6.8 11.8 10.7 7.4 7.2 10.6 6.8 6.8 8.4 8.4 7.9 25.6 7.7 6.8 7.5 6.6 9.4 6.6 8.7 12.7 7.9 5.8 7.8 12.0 6.1 7.6 8.1 7.8 5.3 7.3 7.8 6.6 6.6 9.8 8.1 7.7 7.8 5.4 12.5 7.2 11.4 8.3 22.8 7.6 6.6 12.8 7.5 6.2 4.7 6.6 20.0 5.8 4.2 8.5 3.5 11.2 21.1 15.2 15.2 4.6 4.3 8.9 7.3 7.8 24.0 22.4 12.2 7.0 13.5 7.7 6.5 10.6 12.5 17.4 12.9 18.5 8.1 22.6 6.2 14.0 10.2 4.1 4.8 8.1 3.4 5.0 21.1 4.8 3.6 15.5 16.2 5.9 4.4 9.5 10.2 13.8 11.6 8.1 8.9 10.6 18.3 10.0 7.9 8.8 4.0 7.0 10.6 11.5 6.2 6.1 7.9 8.4 5.1 5.4 9.5 10.1 0.0 18.8 3.5 8.9 7.1 8.6 8.2 11.6 20.0 5.2 4.6 5.4 5.8 6.3 3.3 4.2 6.0 4.7 4.7 3.8 4.4 2.7 4.2 2.3 6.6 8.5 3.5 8.1 8.0 11.8 10.7 7.5 6.6 7.9 5.8 7.8 8.3 3.0 4.3 9.3 4.9 3.4 4.6 2.3 2.5 32.1 3.4 10.4 5.9 9.2 3.3 8.2 2.6 4.0 3.4 0.0 8.8 14.2 3.8 1.7 1.1 4.9 6.8 1.6 2.9 3.1 7.0 1.3 2.3 4.4 3.3 9.0 5.2 6.3 5.5 3.5 2.1 5.6 6.2 0.0 4.7 13.3 6.7 4.0 3.4 5.3 6.3 3.1 WWC3 "BM042, KIAA1280" ENSG00000047644 "WWC family member 3" Q9ULE0 X 10015562-10144478 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 56.9" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 58.6;Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 54.2" "Low region specificity" "Detected in all" HPA039814 Uncertain Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA039814: AB_10674987" "unprognostic (2.53e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (9.84e-3)" "unprognostic (1.05e-1)" "unprognostic (1.80e-1)" "unprognostic (3.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.83e-2)" "unprognostic (3.58e-2)" "unprognostic (4.91e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (9.90e-2)" "unprognostic (2.09e-1)" "unprognostic (5.03e-2)" "unprognostic (4.50e-2)" 10.2 13.2 8.9 9.8 12.6 5.3 10.3 13.7 10.1 10.0 13.1 18.2 56.9 4.5 11.6 22.0 12.4 8.9 10.8 15.4 10.0 7.2 7.2 3.9 21.0 12.5 13.1 6.4 18.7 9.4 9.9 6.7 25.7 10.6 11.3 5.6 12.6 9.0 44.4 7.6 12.3 10.8 13.2 9.4 11.8 11.2 6.9 11.8 6.2 12.2 8.1 10.2 10.2 18.1 6.6 0.7 12.3 1.0 2.7 6.9 2.1 6.8 7.7 9.4 3.1 4.0 5.6 8.9 3.8 6.8 2.3 2.6 1.0 7.1 0.7 0.0 5.1 9.2 3.6 2.2 4.0 1.9 5.0 0.7 1.5 5.1 0.7 8.6 0.0 2.4 3.6 8.5 5.8 6.2 12.6 10.9 1.3 0.1 9.2 5.6 14.0 1.6 0.4 8.8 3.6 2.7 4.9 0.4 2.9 2.3 3.5 1.0 2.7 4.7 6.1 4.1 18.3 54.2 0.5 14.6 6.9 0.1 10.1 4.2 7.5 5.1 2.5 4.2 2.5 10.1 4.1 1.0 0.2 6.9 0.8 6.0 2.4 3.4 5.1 0.5 6.6 3.2 3.8 12.3 2.7 0.8 0.7 1.6 2.1 8.9 12.6 13.7 10.1 10.0 7.2 13.1 6.4 10.6 11.8 20.8 58.6 4.2 12.1 4.9 6.3 17.9 7.6 6.7 13.6 5.2 5.9 11.9 0.0 5.6 0.6 20.4 5.1 46.7 8.2 5.3 11.6 11.0 3.5 5.5 9.2 3.2 15.4 31.3 21.9 0.4 11.8 7.4 15.1 0.0 3.0 3.2 7.9 5.8 23.3 2.1 2.1 19.4 16.5 0.7 1.1 11.4 6.6 7.9 3.3 7.6 WWOX "FOR, SDR41C1, WOX1" ENSG00000186153 "WW domain containing oxidoreductase" Q9NZC7 16 78099413-79212667 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" Oxidoreductase "Disease mutation, Epilepsy, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050992 Approved Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA050992: AB_2681299" "prognostic unfavorable (9.07e-5)" "unprognostic (1.14e-2)" "unprognostic (1.92e-1)" "unprognostic (9.27e-2)" "unprognostic (2.32e-1)" "unprognostic (1.81e-1)" "unprognostic (6.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.65e-1)" "unprognostic (3.61e-3)" "unprognostic (4.33e-2)" "unprognostic (3.50e-2)" "prognostic favorable (4.49e-5)" "unprognostic (3.75e-1)" "unprognostic (1.78e-1)" "unprognostic (2.36e-2)" "unprognostic (1.77e-1)" 13.2 7.4 19.2 10.5 17.9 5.3 11.9 21.5 14.6 8.9 5.9 20.5 14.8 8.9 12.6 17.1 11.6 13.4 10.0 6.1 17.0 17.7 19.2 17.8 7.1 6.5 19.7 12.5 9.4 10.5 22.3 11.5 7.6 16.1 10.9 5.3 11.4 10.6 15.4 4.9 9.6 7.2 11.9 20.9 5.4 7.6 15.8 17.9 10.3 29.4 4.9 8.9 8.7 8.6 8.5 13.8 5.4 8.8 7.8 12.3 5.4 5.0 4.5 5.0 3.2 5.3 2.4 5.3 0.7 1.5 1.7 1.5 3.5 4.3 9.5 3.8 0.7 2.4 4.4 2.5 0.6 1.3 5.0 12.8 3.1 0.8 7.2 4.0 7.8 1.5 2.9 1.8 1.1 1.0 0.4 2.2 13.4 4.2 1.9 1.2 40.0 13.4 10.6 4.3 3.1 2.6 14.2 1.9 9.6 2.4 1.7 8.1 5.2 3.1 5.8 1.7 5.0 5.7 5.4 0.5 1.3 4.5 1.0 2.9 0.0 8.9 19.4 5.1 4.0 2.2 5.4 8.8 1.9 10.5 7.2 12.3 8.5 8.5 9.2 6.8 6.4 8.4 8.9 0.8 7.8 5.0 13.8 12.3 5.4 19.2 17.9 21.5 14.2 17.0 17.7 19.7 12.5 16.1 17.9 6.0 5.8 8.5 14.2 8.1 6.9 6.9 17.8 24.1 17.0 14.0 3.9 21.1 28.2 10.9 34.6 9.0 5.1 0.0 9.1 10.9 9.9 12.1 12.7 16.6 7.7 4.8 9.2 8.6 5.4 34.4 13.0 6.5 5.0 2.8 4.5 36.6 4.6 5.8 16.6 15.7 11.6 6.5 8.3 14.4 12.4 5.9 14.5 6.4 6.3 11.1 WWP1 "AIP5, DKFZP434D2111" ENSG00000123124 "WW domain containing E3 ubiquitin protein ligase 1" Q9H0M0 8 86342738-86478420 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023180 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA023180: AB_10602587" "unprognostic (3.89e-1)" "unprognostic (6.63e-2)" "unprognostic (3.81e-2)" "unprognostic (7.91e-2)" "unprognostic (3.70e-1)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.24e-2)" "unprognostic (1.83e-1)" "unprognostic (9.43e-3)" "unprognostic (3.09e-3)" "unprognostic (1.48e-1)" "prognostic favorable (5.45e-5)" "unprognostic (2.35e-1)" "unprognostic (4.63e-1)" "unprognostic (3.19e-3)" "unprognostic (1.01e-1)" 15.4 9.1 9.7 15.6 14.1 5.2 20.9 8.5 9.5 11.5 16.9 7.5 21.1 8.7 11.9 19.3 11.7 7.2 22.0 40.7 8.7 8.5 16.9 37.2 10.2 15.9 10.0 7.8 10.1 11.3 40.7 7.3 15.6 12.7 17.8 11.3 8.9 11.8 9.4 58.0 13.8 13.0 18.4 9.9 19.1 11.4 10.4 9.5 11.1 11.2 18.0 12.5 14.5 12.3 3.7 2.6 6.5 2.8 2.9 10.4 2.3 22.6 10.6 7.4 5.2 9.3 9.2 6.8 8.3 8.8 6.6 7.9 7.5 14.0 9.7 5.6 14.1 9.2 19.5 10.3 13.3 11.4 12.1 8.3 11.2 9.4 17.5 6.8 4.4 5.8 8.3 16.9 7.2 13.4 10.2 29.1 11.5 5.9 11.5 11.1 11.3 10.6 3.4 4.5 31.7 12.0 7.0 8.9 8.6 14.8 17.3 2.2 5.2 8.2 41.6 8.8 16.8 12.4 4.2 33.4 9.9 11.7 10.4 4.2 13.6 8.3 10.0 12.2 0.8 7.5 6.5 2.8 4.8 7.2 2.4 6.0 3.7 8.7 7.1 1.9 3.6 10.4 6.3 1.7 2.9 2.8 2.6 8.0 2.3 9.7 14.1 8.5 9.5 8.7 8.5 10.0 7.8 12.7 9.5 23.8 19.9 7.5 24.5 31.8 24.5 71.8 45.9 10.7 17.0 27.9 55.0 21.8 36.5 16.7 18.9 25.5 14.8 0.0 32.4 2.7 17.3 35.8 3.5 77.6 43.8 38.1 22.8 64.4 64.9 9.4 30.0 17.5 28.7 10.8 25.5 21.3 37.0 14.0 34.3 38.8 48.9 6.5 13.0 10.9 14.7 34.5 19.2 20.3 18.3 32.8 WWTR1 "DKFZp586I1419, TAZ" ENSG00000018408 "WW domain containing transcription regulator 1" Q9GZV5 3 149517235-149736714 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 158.0;Endothelial cells: 172.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.6;memory CD8 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Cell line enhanced" "Detected in many" "EFO-21: 60.9;SK-MEL-30: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007415, CAB017483, CAB068248" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602" "unprognostic (1.85e-2)" "unprognostic (2.24e-2)" "unprognostic (3.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.41e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-2)" "unprognostic (2.34e-1)" "unprognostic (1.63e-2)" "unprognostic (3.32e-1)" "unprognostic (1.17e-3)" "unprognostic (2.76e-2)" "unprognostic (2.53e-1)" "unprognostic (3.98e-2)" "unprognostic (1.01e-3)" 25.1 9.9 9.3 16.0 18.6 0.2 20.4 7.7 10.5 27.2 38.5 18.4 15.0 5.6 27.2 17.6 41.2 16.4 25.8 20.6 14.7 9.0 31.0 13.1 29.8 6.2 15.2 5.6 30.9 21.7 10.4 8.5 29.0 20.7 34.6 9.1 29.4 15.8 22.4 12.1 13.4 11.7 81.5 25.8 13.8 20.8 12.0 16.4 0.7 18.2 13.2 7.1 68.4 31.0 0.2 0.1 0.6 0.1 0.1 2.8 0.4 16.8 20.0 10.6 14.2 12.7 22.7 11.2 9.8 14.4 4.4 4.7 11.2 14.3 0.0 60.9 11.0 13.6 10.0 6.9 7.1 4.4 4.7 5.3 0.0 5.2 9.3 7.2 0.0 0.0 12.0 1.8 15.4 6.8 17.0 34.5 0.0 0.0 0.0 15.3 2.2 0.0 0.0 2.4 0.0 25.3 0.0 14.3 0.1 37.8 2.5 0.0 0.1 6.5 4.6 42.0 8.3 7.8 0.3 28.0 8.7 4.2 7.0 19.1 0.2 0.1 0.2 18.7 0.0 22.2 0.4 0.1 0.1 2.6 0.0 0.0 0.0 0.3 2.8 0.0 0.2 0.1 1.3 0.6 0.1 0.0 0.1 1.9 0.4 9.3 18.6 7.7 10.5 14.7 9.0 15.2 5.6 20.7 16.4 59.6 79.0 0.0 158.0 45.9 2.0 42.0 147.7 60.2 128.5 47.1 3.9 10.5 6.6 55.4 14.8 172.1 0.7 0.0 23.5 70.1 58.9 72.2 7.0 20.3 3.7 0.0 0.0 92.7 6.4 3.6 53.5 8.0 28.7 3.6 0.0 10.4 31.6 0.0 118.8 48.8 2.0 58.2 48.4 1.7 0.7 31.0 12.4 5.3 0.0 80.1 XIAP "API3, BIRC4, hILP" ENSG00000101966 "X-linked inhibitor of apoptosis" P98170 X 123859724-123913979 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway, Wnt signaling pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB009203, HPA042428" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009203: AB_2257167, HPA042428: AB_2677993" "prognostic unfavorable (9.21e-4)" "unprognostic (8.43e-2)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.40e-1)" "unprognostic (9.41e-2)" "unprognostic (1.95e-2)" "unprognostic (8.51e-2)" "unprognostic (9.17e-2)" "unprognostic (3.90e-2)" "unprognostic (7.50e-2)" "unprognostic (4.41e-2)" "unprognostic (3.15e-3)" "unprognostic (8.21e-3)" "unprognostic (2.26e-1)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 17.4 14.4 20.0 18.1 20.2 12.0 15.9 21.3 18.9 17.2 19.4 14.5 22.9 16.1 17.4 17.0 18.9 12.6 14.7 15.7 18.9 22.1 19.8 19.4 16.5 15.5 18.8 14.6 13.9 19.7 36.6 26.1 18.2 15.9 15.6 16.8 16.9 14.6 22.9 21.5 14.2 23.4 17.0 19.0 15.8 16.2 7.0 12.3 13.9 24.3 11.4 14.0 15.4 20.5 5.7 4.3 11.1 3.9 3.3 5.5 1.9 11.7 10.0 7.9 6.8 9.4 12.1 10.3 12.8 9.5 7.0 6.0 4.5 13.8 11.0 19.0 10.9 13.3 4.4 11.7 8.0 12.9 11.4 6.4 7.4 8.4 6.8 11.9 13.4 15.4 8.3 12.5 11.6 15.0 8.1 9.6 8.3 11.7 12.7 13.5 12.2 7.5 6.5 6.5 11.7 7.9 8.0 9.2 11.6 10.5 17.1 5.4 7.9 17.5 10.1 10.3 7.3 6.2 6.6 11.9 0.4 4.8 21.0 14.2 10.7 10.7 12.2 14.4 9.6 8.8 11.1 2.6 3.5 5.0 2.3 4.7 4.6 3.8 5.5 1.4 5.7 4.4 3.0 8.2 3.3 3.9 4.3 2.5 1.9 20.0 20.2 21.3 18.9 18.9 22.1 18.8 14.6 15.9 12.3 74.5 82.4 26.9 28.9 23.7 71.7 36.7 56.0 46.8 63.7 50.6 90.3 15.7 23.2 32.6 2.2 45.7 74.1 0.0 46.9 25.4 27.8 42.3 57.9 73.4 26.6 71.5 45.5 66.3 41.2 1.5 39.4 43.8 8.5 27.9 52.4 42.8 52.8 48.9 48.4 48.2 129.5 64.7 27.8 10.4 19.9 31.0 31.8 33.1 39.8 58.3 XPNPEP1 "XPNPEP, XPNPEPL, XPNPEPL1" ENSG00000108039 "X-prolyl aminopeptidase 1" Q9NQW7 10 109864766-109923553 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025196, HPA030419, HPA030420, HPA030422" Supported Enhanced Cytosol NA NA 760000 Cytosol "CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783" "unprognostic (3.17e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.46e-1)" "unprognostic (2.01e-3)" "prognostic unfavorable (2.12e-5)" "unprognostic (8.03e-2)" "unprognostic (2.10e-2)" "unprognostic (1.88e-1)" "unprognostic (4.89e-2)" "unprognostic (7.61e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (5.18e-2)" 16.6 14.7 13.4 16.1 18.9 12.8 13.6 14.8 22.2 15.7 20.6 19.5 14.1 33.2 17.5 16.1 17.8 15.8 20.3 17.8 13.7 11.4 18.3 21.0 14.8 14.9 13.8 14.0 17.8 46.0 14.9 15.9 19.0 17.2 16.0 26.9 15.6 19.6 11.3 18.5 20.4 38.6 18.6 11.9 18.0 16.8 15.1 12.0 9.9 15.7 15.2 24.2 14.1 13.8 5.5 24.0 10.0 21.0 14.7 10.6 13.4 25.5 11.2 18.0 24.5 29.4 27.6 13.8 14.2 29.1 21.4 23.2 21.8 22.0 36.5 12.3 21.9 10.9 13.6 14.2 17.6 21.0 10.8 13.7 24.3 7.3 9.0 20.5 18.9 20.3 27.2 10.9 23.5 20.9 32.9 35.1 23.7 7.9 11.7 27.1 8.6 13.5 11.8 7.0 19.4 12.2 15.1 36.3 6.5 27.2 8.0 5.5 20.9 12.4 7.9 23.8 20.5 9.6 17.7 18.0 8.7 11.4 13.8 12.5 19.9 9.7 31.2 20.6 26.5 6.9 10.0 13.7 5.6 10.6 21.0 7.3 5.5 7.0 9.5 24.0 4.8 5.0 6.6 1.1 14.7 17.5 18.8 7.5 13.4 13.4 18.9 14.8 22.2 13.7 11.4 13.8 14.0 17.2 12.0 6.0 15.6 11.9 11.4 7.9 19.1 15.7 20.4 12.0 10.3 3.5 5.9 33.7 14.9 29.4 4.5 12.1 36.7 0.0 63.7 24.7 19.7 19.6 10.5 9.6 27.2 25.4 16.1 16.5 16.1 4.1 17.0 17.4 8.5 39.7 34.2 24.9 47.2 35.3 28.0 18.8 18.4 12.9 8.8 8.4 37.1 7.5 21.1 20.8 34.1 19.3 XPNPEP2 ENSG00000122121 "X-prolyl aminopeptidase 2" O43895 X 129738974-129769538 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "intestine: 145.6;kidney: 49.7" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 21.3;Hepatocytes: 11.6;Proximal tubular cells: 49.7" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2" "Group enriched" "Detected in many" 7 "monocytes: 4.4;T-cells: 7.3" "Cell line enhanced" "Detected in some" "ASC diff: 6.3;ASC TERT1: 33.4;HSkMC: 16.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000339, CAB025136, CAB025269, HPA064568" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 8900000 "Plasma membrane, Cytosol" "CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: " "unprognostic (7.95e-2)" "unprognostic (5.73e-2)" "unprognostic (2.56e-1)" "unprognostic (6.21e-3)" "unprognostic (3.54e-2)" "unprognostic (1.54e-1)" "unprognostic (4.04e-1)" "unprognostic (3.26e-1)" "unprognostic (3.01e-1)" "unprognostic (2.41e-2)" "unprognostic (3.07e-1)" "unprognostic (9.28e-3)" "unprognostic (2.77e-2)" "unprognostic (6.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-3)" 4.7 0.5 0.0 1.1 0.1 0.0 3.2 0.0 0.1 1.7 57.4 0.1 0.8 37.0 1.2 1.7 4.2 3.4 1.3 2.6 0.0 0.0 49.7 8.0 1.0 1.2 0.0 0.0 3.5 0.9 0.0 0.0 0.6 0.1 3.6 2.0 0.7 0.7 0.3 1.6 2.1 145.6 2.5 0.1 0.2 1.7 1.2 0.0 0.1 0.9 1.4 0.3 4.0 10.7 0.4 0.8 0.2 4.4 0.0 7.3 1.3 0.0 0.0 0.5 0.0 6.3 33.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.3 2.1 2.2 0.0 2.4 4.8 0.3 0.4 0.7 3.6 0.2 0.0 4.4 0.8 2.2 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 5.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 4.4 0.0 0.0 11.6 0.7 0.0 1.2 0.6 0.3 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 5.8 0.0 49.7 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.0 0.2 0.0 XPNPEP3 "APP3, ICP55, NPHPL1" ENSG00000196236 "X-prolyl aminopeptidase 3" Q9NQH7 22 40857077-40932815 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 196.2;Late spermatids: 233.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000527 Approved Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA000527: AB_1079266" "prognostic unfavorable (8.19e-4)" "unprognostic (6.77e-2)" "unprognostic (3.22e-3)" "unprognostic (5.03e-3)" "unprognostic (6.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (2.53e-1)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.24e-1)" 8.2 13.6 7.5 5.8 9.2 4.7 9.7 5.2 7.8 7.3 6.1 10.8 11.6 32.3 10.7 12.3 7.2 9.4 10.5 11.2 7.6 7.1 9.8 19.0 6.6 10.6 7.9 6.1 10.7 10.5 8.0 15.0 6.1 10.7 7.3 6.2 9.3 8.5 13.6 12.0 11.5 20.9 7.1 9.3 7.7 6.8 18.9 8.2 11.5 9.1 7.3 8.8 12.6 8.2 5.9 6.0 6.4 10.0 1.2 4.4 4.0 3.3 4.7 3.2 7.1 9.0 6.0 2.2 4.1 3.1 2.3 2.3 3.9 2.1 6.5 2.3 7.9 9.7 7.6 6.0 3.2 3.4 3.9 12.4 4.2 9.3 7.3 4.1 7.4 0.7 5.3 5.0 7.2 4.3 3.5 4.0 4.6 3.5 5.9 4.9 5.0 3.5 3.9 1.9 6.0 9.6 4.9 4.3 3.7 6.5 4.4 2.8 2.5 4.1 6.1 3.8 3.5 7.1 3.4 4.0 4.7 4.1 4.3 2.4 5.6 4.2 7.9 7.2 9.6 3.2 4.0 4.4 4.4 3.4 3.9 1.8 5.9 2.1 2.2 3.1 3.7 4.4 3.3 6.4 1.2 10.0 6.0 3.0 4.0 7.5 9.2 5.2 7.8 7.6 7.1 7.9 6.1 10.7 8.2 6.0 21.2 6.5 6.9 11.7 14.9 17.6 20.4 29.4 13.6 8.7 17.7 17.8 13.3 11.7 196.2 11.7 4.2 0.0 14.7 16.0 11.3 6.7 13.9 32.1 12.4 15.9 13.3 11.1 13.5 233.7 18.4 13.0 16.9 2.8 9.5 12.1 10.8 9.7 14.5 18.6 19.3 32.3 13.2 50.5 32.5 14.3 16.7 5.0 10.6 6.2 XPO1 "CRM1, emb" ENSG00000082898 "Exportin 1" O14980 2 61477849-61538626 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010184, HPA042933" Supported Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA 170000 "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "CAB010184: AB_2215817, HPA042933: AB_2678229" "unprognostic (7.34e-2)" "unprognostic (7.04e-2)" "unprognostic (6.37e-2)" "unprognostic (1.67e-2)" "unprognostic (5.61e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.84e-1)" "unprognostic (1.99e-3)" "unprognostic (4.43e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.43e-1)" "unprognostic (5.55e-2)" 20.7 27.9 36.1 28.1 39.6 21.6 35.1 41.5 36.3 28.2 23.2 19.5 26.0 16.5 35.7 35.3 26.1 36.0 20.3 20.1 33.0 19.2 19.5 22.2 22.0 34.5 42.0 19.5 45.0 34.6 33.4 27.6 30.8 33.6 25.8 24.5 18.0 20.2 29.9 34.9 29.8 25.0 28.4 32.1 24.5 21.9 32.1 39.3 51.1 28.2 16.4 35.7 26.0 57.8 6.1 5.4 12.6 5.1 6.2 5.1 2.5 39.4 35.3 47.9 35.9 21.7 29.2 35.3 43.7 28.2 46.0 39.4 46.9 29.7 57.9 30.6 29.9 46.8 33.5 73.0 30.3 67.7 35.3 26.9 57.0 36.3 29.3 15.7 57.4 39.0 16.4 22.7 36.3 39.6 34.9 37.5 29.2 65.7 33.8 42.3 20.8 47.7 25.2 55.7 47.2 27.1 42.8 54.7 35.2 20.9 30.0 38.3 20.4 42.5 35.9 21.3 50.4 29.4 28.4 25.0 43.2 49.1 35.1 42.9 27.5 45.3 84.0 26.8 49.3 38.9 12.6 5.1 5.8 5.1 5.0 4.7 4.3 3.6 4.5 3.9 6.1 4.3 3.7 12.4 6.2 3.2 5.4 3.2 2.5 36.1 39.6 41.5 36.3 33.0 19.2 42.0 19.5 33.6 39.3 38.7 36.3 31.8 27.6 46.2 69.7 57.0 43.3 46.8 28.4 29.6 90.3 46.3 11.6 24.4 3.2 40.7 19.3 70.0 22.5 42.3 40.9 34.4 40.5 48.0 49.4 68.3 43.4 42.4 46.3 8.0 31.1 53.2 35.4 49.5 31.2 34.0 26.3 17.5 29.0 20.8 102.5 19.4 43.7 64.6 88.2 49.7 25.2 42.9 37.6 38.3 XPO4 "FLJ13046, KIAA1721" ENSG00000132953 "Exportin 4" Q9C0E2 13 20777329-20903048 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.3" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053768 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA053768: AB_2682254" "unprognostic (2.24e-1)" "unprognostic (1.20e-2)" "unprognostic (3.79e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.67e-1)" "unprognostic (7.24e-3)" "unprognostic (9.50e-3)" "unprognostic (2.99e-1)" "unprognostic (1.67e-2)" "unprognostic (1.00e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-2)" "unprognostic (2.42e-1)" 8.9 6.6 4.9 6.9 9.6 10.9 7.9 13.6 11.1 7.5 6.7 11.6 7.9 5.0 11.4 5.9 7.5 7.3 4.9 12.8 6.1 5.3 6.9 6.1 7.7 8.6 8.0 5.3 9.0 7.8 8.1 12.9 6.8 10.2 7.3 7.6 10.7 7.4 7.4 47.3 8.2 7.2 8.2 8.3 8.6 6.7 7.9 8.0 14.3 8.4 6.3 12.3 7.8 7.3 3.1 2.7 3.1 6.0 3.1 4.0 1.2 6.7 5.1 8.4 8.0 4.1 7.2 8.7 7.7 5.7 9.1 7.6 10.4 8.5 14.9 4.2 7.4 6.9 11.1 19.4 10.4 17.1 10.1 5.5 23.6 6.4 6.9 6.2 20.6 7.7 7.0 6.6 9.2 17.6 5.3 11.0 8.6 11.1 4.9 8.6 5.5 9.8 9.1 9.5 14.3 4.8 11.0 13.9 6.2 6.3 8.2 9.6 6.6 6.6 9.7 7.9 8.9 5.7 11.3 9.0 6.5 5.1 7.9 10.9 3.3 4.8 12.4 3.2 13.3 9.6 3.1 2.0 2.1 3.4 2.3 4.0 3.1 2.9 2.9 2.7 2.6 3.6 3.5 0.0 3.1 6.0 2.0 2.7 1.2 4.9 9.6 13.6 11.1 6.1 5.3 8.0 5.3 10.2 8.0 11.9 15.1 10.4 7.2 7.3 14.3 19.9 10.2 2.7 0.0 8.7 60.9 6.9 0.0 4.9 8.1 7.1 3.5 0.0 3.6 6.4 7.7 6.1 15.0 9.6 9.1 9.5 1.2 13.5 7.9 6.1 16.1 8.0 11.8 6.4 6.8 6.4 4.3 3.5 7.8 3.4 21.0 32.3 9.3 10.9 17.2 9.8 10.8 11.5 8.5 8.7 XPO6 "FLJ22519, KIAA0370, RANBP20" ENSG00000169180 "Exportin 6" Q96QU8 16 28097979-28211920 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 7 "neutrophil: 56.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 56.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038246 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" No No "Nucleoplasm, Nucleoli" "Plasma membrane, Cytosol" "HPA038246: AB_10674550" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.68e-4)" "unprognostic (2.22e-1)" "unprognostic (1.41e-1)" "unprognostic (1.31e-2)" "unprognostic (4.48e-1)" "unprognostic (1.40e-1)" "unprognostic (1.01e-3)" "unprognostic (2.10e-1)" "unprognostic (5.36e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (8.80e-4)" 18.4 14.1 24.3 32.0 25.0 47.9 17.7 16.0 30.6 12.4 17.7 30.4 9.9 13.4 13.5 12.0 16.8 14.1 14.9 9.6 27.5 23.9 13.3 19.1 20.6 54.6 25.6 16.9 15.3 13.2 22.0 18.0 25.9 21.7 14.1 17.0 16.3 19.4 13.1 8.3 18.8 18.3 16.3 23.8 50.4 14.8 28.9 19.8 37.1 18.0 7.8 31.8 17.2 13.2 5.2 2.6 56.4 4.4 2.7 6.5 2.0 28.5 20.5 18.1 19.4 12.6 20.0 20.8 35.4 32.0 41.4 42.0 28.7 20.5 20.3 30.5 32.1 21.1 18.7 42.9 27.1 50.4 45.7 26.6 22.2 28.9 32.0 29.7 31.0 25.0 15.7 20.2 36.8 36.5 17.8 23.8 20.7 40.4 10.3 28.0 32.0 37.2 36.9 30.6 13.9 19.6 34.9 21.5 33.6 15.4 14.6 35.3 19.2 17.5 29.2 15.5 21.0 21.0 20.5 25.1 35.0 23.5 29.8 29.4 24.0 30.3 30.1 26.7 32.3 29.5 4.7 2.7 8.4 4.1 3.0 4.4 5.2 4.7 4.4 2.0 3.9 5.2 6.5 56.4 2.7 4.4 2.6 3.8 2.0 24.3 25.0 16.0 30.6 27.5 23.9 25.6 16.9 21.7 19.8 8.9 13.9 21.7 8.2 16.6 23.8 6.6 2.5 9.4 10.3 22.7 29.5 9.8 6.6 13.3 27.6 10.6 14.7 0.0 16.4 13.9 12.4 15.6 2.3 14.0 19.9 20.6 22.7 8.6 23.4 30.6 10.0 14.7 6.8 27.1 21.5 8.3 18.1 14.0 8.1 5.0 26.3 6.5 11.3 29.5 29.2 18.6 7.0 20.8 17.0 12.6 XPOT XPO3 ENSG00000184575 "Exportin for tRNA" O43592 12 64404350-64451127 "Predicted intracellular proteins, Transporters" Transport "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Muller glia cells: 71.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048067, HPA057602" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA048067: AB_2680246, HPA057602: AB_2683481" "unprognostic (4.53e-3)" "unprognostic (7.20e-2)" "unprognostic (1.38e-1)" "unprognostic (3.78e-3)" "unprognostic (1.01e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (1.81e-7)" "unprognostic (1.50e-2)" "unprognostic (2.22e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (2.41e-12)" "unprognostic (2.72e-1)" "unprognostic (3.68e-1)" "unprognostic (5.20e-2)" "prognostic unfavorable (5.79e-4)" 19.3 19.4 20.7 19.3 22.8 26.9 29.9 17.9 21.7 16.9 12.4 18.7 13.2 10.5 16.1 19.8 21.3 12.5 12.6 12.7 19.0 19.4 14.7 35.7 18.3 18.9 22.4 15.5 17.3 30.1 21.4 18.5 18.6 23.5 15.3 14.7 15.8 21.3 13.7 15.6 17.3 11.6 16.7 21.7 14.5 14.7 17.9 21.3 18.2 48.7 14.1 21.4 15.8 27.8 7.9 10.2 10.1 7.5 11.1 14.7 6.5 17.8 12.4 12.6 15.8 19.0 20.3 23.1 23.9 20.1 16.1 14.7 12.3 6.1 36.3 17.1 30.1 17.2 13.5 23.9 18.4 23.4 22.6 12.6 20.2 11.6 10.7 33.7 37.1 18.3 14.4 47.5 17.9 55.3 20.9 14.2 27.2 33.5 72.9 17.0 21.9 20.4 14.7 24.0 12.6 22.2 16.3 15.2 27.1 8.8 10.5 14.1 16.5 14.0 16.1 34.6 12.8 28.6 37.0 14.9 12.7 12.8 18.2 18.7 45.9 35.2 28.1 28.1 29.0 20.4 5.8 7.5 10.1 10.9 7.5 14.7 7.9 12.4 11.3 10.2 5.3 11.4 9.6 2.3 11.1 6.7 3.5 10.3 6.5 20.7 22.8 17.9 21.2 19.0 19.4 22.4 15.5 23.5 21.3 11.9 7.8 10.7 12.2 17.4 16.4 9.8 12.7 5.3 11.4 14.0 11.8 21.2 14.9 8.8 3.3 16.7 5.4 23.3 11.0 17.4 18.5 18.0 24.3 28.2 12.9 12.7 10.9 24.5 21.3 4.1 18.7 12.1 20.3 3.6 10.9 71.1 13.5 3.5 19.1 11.3 21.2 12.9 19.6 11.8 12.7 19.6 14.2 15.0 12.7 12.8 XRN1 SEP1 ENSG00000114127 "5'-3' exoribonuclease 1" Q8IZH2 3 142306607-142448062 "Predicted intracellular proteins" "DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "RH-30: 58.4" "Low region specificity" "Detected in all" "HPA035005, HPA035006" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035005: AB_10670695, HPA035006: AB_10672750" "unprognostic (3.52e-1)" "unprognostic (2.35e-2)" "unprognostic (2.49e-1)" "unprognostic (1.35e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (9.43e-4)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-2)" "unprognostic (6.32e-2)" 16.5 12.4 9.9 16.2 15.5 24.4 15.9 23.8 15.7 15.7 17.5 7.5 12.4 14.7 15.2 14.2 13.4 11.5 11.0 10.1 8.4 6.8 9.6 21.7 15.9 16.1 11.7 9.0 17.4 13.2 17.4 26.5 23.6 10.7 12.5 13.0 8.2 14.4 13.3 21.2 17.2 25.0 14.4 15.2 16.2 11.7 11.8 10.9 30.8 12.9 10.8 15.3 15.0 15.2 7.4 6.1 18.3 4.7 4.3 8.4 2.5 10.0 1.9 4.6 3.9 5.2 8.6 2.8 4.7 6.3 6.1 7.6 1.7 3.0 4.0 4.9 6.2 4.9 3.9 4.1 2.4 9.4 10.2 3.1 5.9 3.3 1.6 4.5 5.9 6.0 6.7 2.7 4.4 5.8 5.7 5.5 4.5 3.9 9.6 5.5 1.9 5.1 3.1 1.4 1.4 2.1 4.2 58.4 5.0 2.9 5.1 2.7 3.4 8.4 4.6 3.6 2.9 5.6 4.6 7.4 4.3 2.4 4.9 4.0 13.8 7.0 6.4 4.0 3.1 3.7 18.3 4.7 12.2 8.3 4.2 5.8 7.4 6.4 7.4 2.3 6.0 8.4 5.8 17.2 4.3 4.0 6.1 4.6 2.5 9.9 15.5 23.8 15.7 8.4 6.8 11.7 9.0 10.7 10.9 50.6 26.6 34.1 28.0 22.8 31.5 23.0 17.8 26.8 33.0 43.6 47.1 17.6 10.0 12.9 37.7 26.6 30.0 23.3 11.0 6.0 21.8 33.7 19.8 42.4 14.1 25.4 27.1 36.8 30.0 15.1 23.0 23.1 13.5 26.2 18.5 23.2 15.6 24.6 27.3 12.0 57.0 6.5 17.9 55.7 14.9 24.7 44.7 35.5 13.6 42.3 YAE1D1 "C7orf36, GK003" ENSG00000241127 "Yae1 domain containing 1" Q9NRH1 7 39566376-39610320 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019226, HPA031249" Uncertain Approved Cytosol NA NA Cytosol "HPA019226: AB_1845759, HPA031249: AB_2673807" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "unprognostic (8.73e-3)" "unprognostic (1.57e-1)" "unprognostic (8.75e-2)" "unprognostic (4.30e-1)" "prognostic unfavorable (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (3.04e-3)" "unprognostic (1.17e-2)" "unprognostic (1.45e-2)" "unprognostic (2.39e-2)" "unprognostic (1.67e-2)" "unprognostic (6.54e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-3)" 11.9 17.3 24.1 14.2 26.0 2.7 20.2 28.6 23.6 16.5 20.3 15.9 16.3 15.7 19.5 26.2 15.9 18.4 12.6 17.8 19.1 17.4 17.3 13.0 12.2 10.1 20.1 20.3 25.2 13.2 16.9 27.6 12.5 18.1 15.6 22.8 10.9 15.2 14.5 14.1 12.1 22.2 17.8 21.1 11.2 15.2 20.9 23.4 9.9 16.7 8.6 10.2 15.2 13.6 12.2 8.0 12.0 5.2 7.5 19.2 6.6 11.6 7.8 16.7 18.3 13.2 13.5 9.9 17.2 15.2 15.9 18.1 6.6 7.0 6.6 8.5 14.4 27.5 12.3 15.7 12.0 15.6 6.5 13.0 6.1 9.7 12.9 12.0 6.2 4.6 12.3 10.0 16.6 18.7 9.6 13.8 5.9 19.2 3.0 13.8 8.2 5.1 12.6 36.8 14.8 9.3 7.0 9.8 7.6 15.1 10.9 21.2 24.0 14.1 19.7 18.1 19.3 17.7 12.1 9.2 8.4 15.6 10.2 14.8 9.8 20.7 14.3 10.0 14.3 24.4 12.0 5.0 6.3 8.3 5.2 9.0 12.2 10.7 12.0 5.7 11.4 19.2 13.5 0.5 7.5 3.8 8.0 11.5 6.6 24.1 26.0 28.6 23.6 19.1 17.4 20.1 20.3 18.1 23.4 6.0 5.6 3.4 6.2 4.2 12.8 14.9 5.1 28.1 23.9 15.7 2.0 13.0 28.2 12.3 33.7 10.5 17.3 0.0 10.7 11.2 12.2 4.5 9.2 7.8 8.6 3.2 8.6 4.3 4.0 12.1 20.8 3.4 5.0 4.6 21.5 18.3 12.6 11.4 20.1 21.4 11.2 6.5 11.3 33.4 26.0 5.0 4.2 6.9 13.6 3.1 YARS "tyrRS, YRS, YTS" ENSG00000134684 "Tyrosyl-tRNA synthetase" P54577 1 32775237-32818153 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017936, HPA018950, HPA018954" Enhanced Enhanced Cytosol No No 230000 Cytosol "HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915" "unprognostic (4.05e-2)" "unprognostic (2.52e-1)" "unprognostic (4.21e-1)" "unprognostic (4.78e-2)" "unprognostic (9.54e-2)" "unprognostic (3.38e-3)" "prognostic unfavorable (6.97e-11)" "unprognostic (5.05e-2)" "unprognostic (6.29e-2)" "unprognostic (1.93e-1)" "unprognostic (1.81e-3)" "unprognostic (4.96e-2)" "prognostic unfavorable (1.02e-11)" "unprognostic (3.57e-3)" "unprognostic (1.02e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (6.57e-4)" 16.6 36.3 22.8 22.8 40.6 17.4 13.9 26.6 43.1 14.6 17.5 16.3 22.4 17.1 14.2 15.5 24.1 14.4 11.2 15.5 24.9 28.3 14.1 29.6 21.3 23.2 24.9 27.4 21.2 54.8 19.3 13.9 17.5 26.7 12.7 21.9 11.2 23.5 25.7 27.3 16.5 14.9 22.7 22.7 14.6 25.9 20.9 26.0 15.2 30.0 16.8 29.6 17.0 28.0 9.9 17.8 20.9 13.4 36.5 24.3 17.1 28.8 15.1 15.9 38.3 19.8 22.8 17.0 29.8 24.7 24.5 31.3 17.9 19.9 52.5 11.8 30.9 20.0 17.0 48.4 35.1 38.8 22.1 19.2 48.1 22.9 16.8 65.2 37.9 29.1 22.6 43.7 38.7 98.6 17.7 24.8 42.5 52.9 55.6 21.0 14.9 42.5 20.8 29.0 29.5 20.9 37.2 15.2 44.1 17.6 14.5 30.7 18.9 16.2 19.1 55.0 19.0 19.1 41.3 20.1 14.9 26.6 30.2 24.6 44.9 47.9 49.1 37.3 52.9 40.9 20.9 12.7 6.6 24.3 13.4 23.9 9.9 14.5 22.3 17.8 8.1 10.8 16.5 3.0 36.5 12.4 10.2 15.6 17.1 22.8 40.6 26.6 43.1 24.9 28.3 24.9 27.4 26.7 26.0 20.8 45.6 14.5 22.1 22.2 19.3 14.9 5.1 34.8 34.2 8.7 25.5 36.7 3.3 30.4 14.4 19.0 12.8 0.0 71.3 38.8 20.0 22.9 12.8 23.3 35.7 30.2 16.7 7.4 22.2 12.4 11.8 21.1 13.5 35.1 12.7 10.8 50.1 3.5 10.6 9.8 19.8 12.9 24.5 26.7 19.4 21.3 31.5 33.0 17.5 30.1 YBX1 "BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1" ENSG00000065978 "Y-box binding protein 1" P67809 1 42682427-42702349 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 128.1;testis: 426.5" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 6931.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005875, HPA040304, HPA057159" Supported Enhanced Vesicles,Cytosol "Intracellular and membrane" NA NA 870000 Cytosol Vesicles "CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355" "unprognostic (8.59e-2)" "unprognostic (5.16e-2)" "unprognostic (9.27e-3)" "unprognostic (2.68e-3)" "unprognostic (7.76e-2)" "unprognostic (8.03e-3)" "prognostic unfavorable (9.87e-10)" "unprognostic (2.80e-2)" "unprognostic (2.31e-2)" "unprognostic (2.79e-3)" "unprognostic (7.51e-2)" "unprognostic (5.52e-2)" "prognostic unfavorable (3.59e-7)" "unprognostic (3.66e-2)" "unprognostic (2.44e-1)" "unprognostic (1.94e-2)" "unprognostic (3.25e-1)" 47.5 20.6 15.6 36.4 18.4 57.6 35.2 13.7 14.4 27.9 44.5 21.2 20.1 25.6 35.1 36.4 40.0 25.6 32.5 57.8 15.2 12.3 33.1 38.1 35.3 49.8 17.6 13.2 30.2 36.7 9.4 12.2 26.1 15.5 32.0 33.1 31.1 26.6 23.0 128.1 22.5 27.1 50.0 21.0 47.9 33.2 426.5 15.9 53.2 31.4 64.1 37.2 39.4 41.0 23.5 26.9 21.8 40.5 11.6 23.0 10.6 92.5 54.6 87.4 87.6 85.2 77.1 77.9 68.3 63.6 95.0 74.6 74.7 86.5 117.5 71.7 68.6 40.6 56.0 98.4 103.6 94.4 62.7 91.3 119.8 108.4 95.9 68.7 160.8 89.8 70.9 89.3 94.8 117.4 52.1 78.5 98.4 124.6 51.2 88.4 58.3 181.7 156.6 197.1 59.5 73.8 110.0 157.1 126.9 94.0 68.5 120.9 85.2 67.0 90.7 127.6 97.4 30.2 320.5 61.2 67.5 115.2 91.4 138.9 75.1 94.1 133.7 63.9 120.6 71.6 4.3 18.1 21.8 16.3 37.8 19.9 23.5 19.5 15.8 26.9 20.1 16.8 17.2 3.3 11.6 40.5 20.9 23.0 10.6 15.6 18.4 13.7 14.4 15.2 12.3 17.6 13.2 15.5 15.9 160.8 193.6 710.2 1008.1 1241.5 227.0 1010.1 351.6 187.4 286.6 308.8 141.4 639.1 1235.1 944.3 6931.7 600.7 713.3 817.7 771.6 1697.6 856.8 736.8 377.2 465.4 1556.8 114.4 564.5 393.5 1134.6 2234.4 695.5 1494.6 858.7 964.0 841.6 220.6 737.9 799.5 757.7 816.8 432.4 459.2 1265.4 2608.0 287.2 1138.5 402.6 588.8 1140.5 1354.3 YBX3 "CSDA, CSDA1, dbpA, ZONAB" ENSG00000060138 "Y-box binding protein 3" P16989 12 10699089-10723312 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 612.6" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 961.9;Early spermatids: 1123.4;Urothelial cells: 1185.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 9.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034838 Approved Supported Cytosol NA NA 56000 Cytosol "HPA034838: AB_10670980" "unprognostic (1.93e-2)" "unprognostic (6.20e-2)" "unprognostic (3.56e-1)" "unprognostic (3.61e-2)" "unprognostic (4.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-1)" "unprognostic (2.41e-1)" "unprognostic (3.23e-3)" "unprognostic (1.20e-1)" "prognostic unfavorable (6.17e-13)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.44e-1)" 23.8 5.0 3.0 6.4 6.0 11.2 15.9 2.1 4.6 12.4 14.3 2.0 3.7 3.2 8.5 14.7 25.0 8.4 6.7 91.6 3.2 1.7 7.6 6.5 17.2 6.8 5.5 0.8 17.2 20.6 1.3 8.1 9.5 6.2 12.4 5.3 6.2 12.9 6.8 612.6 29.9 5.0 14.9 5.8 8.6 9.5 30.2 4.1 4.5 18.5 54.2 12.0 27.2 24.6 9.5 4.5 1.0 5.7 0.9 2.3 1.4 18.0 15.8 7.1 23.1 29.7 55.0 51.9 28.2 24.1 24.2 22.8 27.7 43.8 17.7 9.5 22.5 17.3 34.7 30.4 58.7 21.0 0.1 54.6 14.6 22.3 16.9 37.1 26.2 1.6 63.4 76.3 22.4 73.8 26.1 55.5 26.6 19.7 0.0 25.9 19.2 21.6 22.6 71.6 17.2 13.0 12.2 32.5 20.0 32.7 23.9 8.8 0.0 21.4 21.3 26.2 51.6 6.1 20.7 36.3 16.6 46.6 17.7 31.7 0.1 5.8 2.0 22.8 0.0 17.7 0.0 5.7 0.0 0.7 5.4 0.0 1.6 0.0 2.1 4.5 9.5 0.1 2.3 1.0 0.9 3.0 0.2 0.1 1.4 3.0 6.0 2.1 4.6 3.2 1.7 5.5 0.8 6.2 4.1 140.0 176.5 92.6 961.9 679.4 30.6 444.3 50.9 175.3 168.4 137.9 84.4 126.8 112.7 102.4 1123.4 256.4 56.1 654.1 122.3 76.8 207.6 567.0 61.2 16.3 93.4 15.9 64.9 106.2 162.4 213.4 245.1 187.6 246.3 24.4 118.1 52.5 144.1 38.6 210.4 172.9 294.1 122.9 393.5 248.3 90.5 918.2 105.2 24.0 146.4 1185.0 YES1 "c-yes, HsT441, Yes" ENSG00000176105 "YES proto-oncogene 1, Src family tyrosine kinase" P07947 18 721588-812546 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 14.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 14.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004370, HPA026480" Approved Supported "Plasma membrane,Cytosol" NA NA 4300000 "Plasma membrane, Cytosol" "CAB004370: AB_627370, HPA026480: AB_1858921" "unprognostic (3.28e-1)" "unprognostic (1.62e-2)" "unprognostic (5.87e-2)" "unprognostic (2.47e-2)" "unprognostic (6.24e-2)" "unprognostic (4.24e-2)" "unprognostic (6.01e-2)" "unprognostic (1.03e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-3)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.14e-1)" "unprognostic (8.12e-2)" "unprognostic (4.65e-2)" "unprognostic (1.81e-1)" "unprognostic (4.79e-2)" "unprognostic (4.11e-1)" 26.2 13.1 17.0 9.4 15.6 2.6 47.2 6.7 12.8 15.8 23.8 8.9 13.7 18.2 13.1 17.4 22.0 10.7 14.9 17.9 14.8 12.4 22.6 43.2 23.6 13.7 15.8 6.6 13.2 21.4 16.7 10.7 31.3 16.8 12.2 17.3 6.5 23.7 21.0 10.6 12.3 24.8 18.8 16.8 34.5 15.5 13.6 12.0 8.1 16.8 15.6 7.1 21.9 17.5 0.1 0.1 14.7 0.0 1.0 2.5 0.6 14.4 7.2 22.8 17.8 13.7 17.0 26.8 9.6 19.7 11.4 15.7 17.1 10.7 0.0 10.3 16.3 14.6 8.5 21.3 17.1 22.4 0.0 7.2 4.3 7.1 11.9 11.1 3.3 7.7 13.0 18.4 17.2 19.2 14.2 38.4 2.4 18.7 6.4 16.2 9.9 2.0 4.3 14.4 8.8 9.2 2.5 17.9 1.2 16.6 17.2 4.6 5.4 19.9 15.1 12.6 15.7 10.4 6.9 33.0 28.1 31.2 21.2 25.9 5.6 2.7 0.8 10.6 4.7 16.6 14.7 0.0 0.9 2.5 0.0 1.6 0.1 0.5 1.4 0.0 0.0 1.2 1.9 0.0 1.0 0.0 0.1 0.1 0.6 17.0 15.6 6.7 12.8 14.8 12.4 15.8 6.6 16.8 12.0 23.8 30.8 1.5 33.5 53.3 6.2 16.5 20.4 26.8 34.2 27.9 5.9 28.2 3.3 25.6 20.2 77.6 27.4 0.0 34.0 20.3 31.2 52.1 12.8 33.4 4.3 3.2 21.9 41.1 5.6 7.9 17.0 5.3 23.6 1.0 35.7 16.3 40.3 21.0 12.0 38.5 8.0 19.4 20.6 12.8 11.7 43.4 38.1 15.2 31.0 58.7 YKT6 ENSG00000106636 "YKT6 v-SNARE homolog" O15498 7 44200968-44214294 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030817, HPA030818" Approved Approved Mitochondria,Cytosol No No Cytosol Mitochondria "HPA030817: AB_10599828, HPA030818: AB_10602102" "unprognostic (1.25e-1)" "unprognostic (7.35e-3)" "unprognostic (1.30e-3)" "unprognostic (7.80e-3)" "unprognostic (7.45e-3)" "prognostic unfavorable (4.64e-4)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.14e-2)" "unprognostic (2.03e-1)" "unprognostic (8.77e-3)" "unprognostic (1.99e-1)" "unprognostic (1.17e-1)" "unprognostic (8.65e-2)" "unprognostic (1.63e-1)" "unprognostic (2.01e-2)" "unprognostic (1.34e-2)" "unprognostic (7.66e-3)" 26.5 21.9 35.1 21.4 30.6 31.1 23.1 19.0 32.2 21.8 27.6 26.5 27.9 21.1 21.0 32.6 31.1 16.0 16.8 22.3 34.9 33.5 24.4 17.3 19.6 25.7 36.1 24.0 14.3 51.2 29.7 21.6 25.7 26.8 21.3 26.7 18.3 39.1 24.6 29.1 21.8 21.7 27.1 31.4 20.5 24.9 27.3 25.1 22.2 21.0 23.4 26.3 17.5 15.5 7.7 11.1 15.7 12.8 7.2 12.4 6.3 22.6 23.9 20.1 28.1 25.3 22.2 16.6 45.7 35.1 25.6 26.0 25.1 18.8 21.6 20.6 44.8 49.3 28.0 24.6 30.2 32.7 26.0 23.5 12.6 17.7 15.7 31.7 26.7 23.1 20.7 29.6 31.2 33.4 22.7 30.8 19.9 29.2 16.0 33.9 23.4 19.9 29.7 49.2 30.4 40.0 21.9 18.2 18.6 21.1 19.1 23.6 46.4 21.7 34.7 24.7 29.8 27.3 27.6 35.2 27.5 34.1 27.2 50.2 42.7 47.1 32.1 37.4 23.7 53.8 5.9 11.2 15.7 7.8 12.8 11.0 6.9 9.2 12.4 10.3 7.7 8.8 8.6 9.5 7.2 12.1 11.1 9.4 6.3 35.1 30.6 19.0 32.2 34.9 33.5 36.1 24.0 26.8 25.1 11.9 10.3 13.7 14.7 23.1 6.4 17.3 7.6 1.4 6.8 19.2 9.8 21.7 21.6 42.1 21.1 14.0 30.8 0.0 71.4 49.0 21.6 29.1 1.1 14.3 36.6 12.7 13.3 11.1 19.6 5.9 9.2 17.2 25.3 55.1 24.1 9.8 58.9 17.5 12.7 18.2 7.7 0.0 18.4 15.6 18.8 22.6 41.2 8.5 18.3 28.6 YOD1 "DKFZp451J1719, DUBA8, OTUD2" ENSG00000180667 "YOD1 deubiquitinase" Q5VVQ6 1 207043849-207052980 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Unfolded protein response" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 44.7" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 69.8;Urothelial cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 40.3;K-562: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028400, HPA028439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 40000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA028400: AB_10599854, HPA028439: AB_10600994" "unprognostic (3.69e-2)" "unprognostic (8.72e-2)" "unprognostic (1.17e-1)" "unprognostic (2.39e-1)" "unprognostic (2.03e-2)" "unprognostic (3.28e-2)" "unprognostic (9.87e-3)" "unprognostic (9.38e-2)" "unprognostic (2.31e-3)" "unprognostic (8.96e-2)" "unprognostic (1.47e-3)" "unprognostic (1.03e-2)" "unprognostic (6.07e-2)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (1.79e-2)" "unprognostic (3.62e-1)" 4.5 4.6 4.0 4.0 5.3 44.7 6.6 4.8 7.5 6.1 3.9 7.6 2.6 4.1 4.0 3.1 24.5 3.7 3.5 5.0 4.0 2.2 4.5 5.2 9.4 4.2 7.1 4.4 3.5 3.6 2.5 5.1 6.3 5.1 3.4 4.0 3.4 9.7 3.0 6.5 14.9 4.8 2.7 8.5 5.2 8.4 5.6 6.9 14.3 5.8 10.0 8.2 5.8 12.3 0.5 1.3 3.9 1.5 1.2 1.8 0.9 5.4 2.9 4.6 2.7 1.6 2.1 9.0 3.6 2.8 2.7 2.8 5.5 5.6 2.8 1.5 2.2 1.3 6.0 0.0 4.4 3.1 2.3 4.9 40.3 11.9 2.6 1.5 5.2 14.2 1.5 3.4 2.2 8.6 3.2 2.4 5.9 28.0 0.0 2.3 0.0 4.6 2.9 4.4 2.2 6.5 2.3 0.2 2.1 2.7 6.1 2.4 5.3 5.9 6.9 7.7 4.2 2.4 3.7 1.1 2.4 6.2 1.9 4.7 4.6 0.2 4.2 2.8 0.0 1.6 3.9 1.2 2.0 1.1 1.5 1.5 0.4 1.7 0.9 1.3 0.5 1.4 1.8 2.9 1.2 1.0 0.7 0.8 0.9 4.0 5.3 4.8 7.5 4.0 2.2 7.1 4.4 5.1 6.9 38.7 9.8 0.8 21.4 28.0 7.8 5.3 5.1 13.4 5.7 1.8 3.9 2.3 1.7 3.8 28.6 3.5 9.8 46.7 9.3 2.7 5.7 29.8 8.1 5.4 2.4 11.1 8.5 3.7 8.5 69.8 1.4 6.4 13.5 1.8 3.5 4.2 15.5 4.9 2.1 5.4 16.2 6.5 3.1 8.8 4.1 35.1 1.5 7.5 5.4 62.9 YPEL5 CGI-127 ENSG00000119801 "Yippee like 5" P62699 2 30146941-30160533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 164.9" "Cell type enhanced" "Detected in all" 4 "monocytes: 480.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042809 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA042809: AB_2678179" "unprognostic (7.22e-3)" "unprognostic (6.50e-3)" "unprognostic (9.16e-2)" "unprognostic (5.47e-2)" "unprognostic (4.88e-2)" "unprognostic (1.83e-2)" "unprognostic (3.60e-2)" "unprognostic (3.39e-2)" "unprognostic (1.95e-1)" "unprognostic (5.73e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (7.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.67e-3)" 29.6 32.5 39.0 20.1 38.2 164.9 32.9 34.2 52.9 31.2 34.6 20.7 38.2 19.4 28.7 40.9 35.1 25.6 30.8 26.1 38.1 39.5 40.5 29.8 31.9 30.5 35.3 32.5 30.0 23.4 24.6 26.0 48.1 36.4 33.8 22.2 33.1 28.7 47.6 27.7 26.1 29.1 36.8 30.6 29.6 27.2 31.4 18.3 34.2 39.0 20.6 28.2 40.1 25.2 21.3 35.0 72.4 31.9 12.5 21.6 30.9 9.9 5.5 12.0 5.9 34.1 33.1 10.2 14.1 43.7 8.2 12.7 4.5 10.3 5.9 9.6 28.4 19.0 5.4 2.7 14.4 11.6 26.1 5.4 3.1 2.5 7.2 29.1 1.0 7.2 34.1 29.4 15.5 20.0 35.6 15.5 3.9 4.3 10.5 22.1 5.2 3.2 7.2 6.7 11.5 6.5 1.9 16.3 5.6 27.5 19.4 4.8 14.9 7.2 6.9 17.5 23.0 7.7 5.8 20.3 22.3 8.6 6.1 3.9 25.1 9.8 7.9 15.9 2.8 9.0 41.7 19.6 43.1 13.6 21.8 13.5 21.3 16.6 15.9 18.2 17.4 16.0 14.1 72.4 12.5 31.9 35.0 21.6 30.9 39.0 38.2 34.2 52.9 38.1 39.5 35.3 32.5 36.4 18.3 77.4 75.1 107.8 142.4 118.9 71.0 67.4 35.7 57.6 64.8 96.0 45.2 147.4 117.7 76.8 214.0 63.9 69.5 116.8 69.5 110.5 88.3 121.7 81.7 36.8 91.0 60.4 200.3 49.1 87.4 400.6 53.5 101.5 161.9 480.7 69.6 83.5 86.2 73.7 77.8 97.1 49.3 51.8 103.9 99.6 72.4 124.6 341.2 117.6 43.7 247.9 YTHDF2 "CAHL, HGRG8, NY-REN-2" ENSG00000198492 "YTH N6-methyladenosine RNA binding protein 2" Q9Y5A9 1 28736621-28769775 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Immunity, Innate immunity, Oogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030063, HPA054080, HPA059621" Approved Enhanced "Cytosol,Cytoplasmic bodies" NA NA Cytosol "Cytoplasmic bodies" "HPA030063: AB_2732453, HPA054080: AB_2682371, HPA059621: AB_2684084" "unprognostic (8.75e-2)" "unprognostic (1.90e-2)" "unprognostic (4.66e-3)" "unprognostic (1.63e-1)" "unprognostic (3.03e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (6.14e-9)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (4.18e-2)" "unprognostic (1.69e-1)" "unprognostic (4.11e-2)" "unprognostic (2.07e-1)" "unprognostic (1.21e-1)" "unprognostic (6.38e-2)" "unprognostic (9.29e-2)" "unprognostic (6.97e-3)" 31.1 33.0 18.2 27.0 19.9 42.0 52.4 21.5 28.3 23.7 23.6 20.4 31.5 22.1 26.6 35.1 36.0 26.1 21.7 23.3 18.5 19.4 26.8 35.8 30.0 42.5 18.1 21.3 25.5 37.2 29.7 18.4 32.6 20.2 21.7 26.2 22.1 34.4 31.3 39.6 36.5 24.4 25.1 15.1 29.8 24.8 28.0 17.0 44.2 26.4 30.4 31.7 24.7 31.0 36.5 42.2 33.3 39.9 39.0 40.4 41.8 21.7 15.2 33.3 32.3 26.0 20.0 38.3 21.2 26.6 26.6 27.1 13.8 25.8 37.4 21.3 27.2 16.1 20.4 38.5 34.5 31.8 23.5 28.0 31.4 20.9 25.4 30.7 33.0 24.8 26.8 35.8 28.6 41.0 23.6 32.5 22.5 31.5 18.7 29.8 17.1 34.9 26.0 53.5 19.7 19.4 30.3 24.6 30.8 37.3 31.3 28.5 30.3 22.1 34.1 57.3 29.0 22.5 31.3 22.2 18.8 19.4 17.5 30.0 22.5 14.4 42.9 21.5 26.1 29.8 33.3 32.4 32.6 28.9 39.9 40.0 36.5 33.9 36.4 42.2 25.5 36.1 34.1 11.5 39.0 38.0 25.9 40.4 41.8 18.2 19.9 21.5 28.3 18.5 19.4 18.1 21.3 20.2 17.0 47.6 50.4 61.8 85.7 135.7 43.7 41.5 81.5 32.1 59.1 41.8 29.5 127.2 56.3 89.8 9.8 76.8 37.5 0.0 60.6 91.0 73.1 49.8 71.5 91.0 67.2 55.6 72.6 69.3 64.2 12.7 65.9 55.7 35.4 71.3 55.9 65.9 70.7 38.6 70.7 74.9 41.0 90.5 54.6 103.5 109.1 141.3 217.6 64.7 53.3 104.3 YTHDF3 FLJ31657 ENSG00000185728 "YTH N6-methyladenosine RNA binding protein 3" Q7Z739 8 63168553-63212786 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048703 Approved "Nuclear membrane,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nuclear membrane, Cytosol" "HPA048703: " "unprognostic (1.06e-2)" "unprognostic (9.89e-3)" "unprognostic (6.65e-3)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (7.87e-2)" "unprognostic (9.57e-2)" "unprognostic (2.07e-1)" "unprognostic (6.14e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-1)" "unprognostic (1.35e-3)" "unprognostic (1.11e-1)" 21.7 17.5 12.2 12.8 15.2 53.2 16.0 16.7 17.3 19.4 20.2 14.3 16.8 14.2 24.3 13.6 17.7 17.6 17.6 26.9 11.9 11.4 18.8 26.8 16.8 12.4 14.2 10.6 25.1 15.6 16.6 19.3 29.0 16.8 21.2 15.6 12.9 18.1 18.8 28.0 12.7 24.7 19.4 14.4 18.1 15.9 13.3 14.2 20.1 17.2 15.9 14.1 21.0 15.9 8.2 16.9 21.2 24.9 9.7 11.0 10.1 16.3 22.2 21.3 16.0 28.6 24.6 14.7 29.8 25.0 18.9 22.5 18.8 16.4 17.3 6.5 29.0 21.4 15.6 28.1 19.8 28.1 14.0 13.3 32.2 16.8 12.7 26.0 9.1 15.9 32.5 15.3 20.2 28.4 19.4 15.9 10.8 18.8 15.9 28.4 11.3 17.5 8.5 29.7 21.5 16.4 13.3 16.3 8.5 17.8 29.0 8.8 15.6 21.1 19.1 21.6 19.1 25.6 11.6 28.6 17.6 17.1 15.7 15.9 19.1 17.2 25.9 18.0 12.9 21.2 20.6 16.6 17.4 8.9 19.4 9.8 7.4 9.0 10.5 16.9 8.2 11.0 10.5 21.2 9.7 24.9 5.1 9.4 10.1 12.2 15.2 16.7 17.3 11.9 11.4 14.2 10.6 16.8 14.2 29.8 42.7 14.7 18.8 34.5 15.4 42.4 22.9 28.1 25.0 19.2 5.9 17.0 6.6 14.3 5.1 22.5 31.0 0.0 14.3 22.2 31.9 23.9 22.0 57.7 27.0 19.1 39.1 32.5 51.9 4.7 22.2 36.1 16.9 17.2 28.6 14.5 18.6 28.1 24.8 23.7 12.7 12.9 21.7 10.8 21.7 27.5 22.1 20.0 23.5 30.7 YWHAB YWHAA ENSG00000166913 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta" P31946 20 44885676-44908532 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003759, HPA007925, HPA011212, HPA061603" Enhanced Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 210000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334, HPA061603: " "prognostic unfavorable (9.18e-4)" "unprognostic (1.48e-1)" "unprognostic (9.06e-2)" "prognostic unfavorable (5.46e-4)" "unprognostic (3.80e-1)" "prognostic unfavorable (6.14e-4)" "prognostic unfavorable (1.91e-6)" "prognostic unfavorable (6.01e-4)" "unprognostic (8.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.53e-2)" "unprognostic (2.35e-1)" "prognostic favorable (2.52e-5)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (6.60e-3)" "unprognostic (8.59e-2)" 39.3 38.6 65.5 39.4 79.2 28.6 33.0 60.1 87.9 34.0 47.5 27.7 28.7 37.9 35.2 26.4 48.1 30.2 29.6 40.3 68.7 63.4 47.3 36.5 37.4 46.8 49.8 76.2 25.8 18.9 41.1 18.4 36.7 50.1 31.4 53.4 22.9 30.7 43.2 28.3 38.4 39.3 43.3 38.4 53.7 36.7 16.8 33.6 48.2 36.1 31.8 60.2 41.2 34.9 30.9 41.9 37.3 58.4 26.8 43.5 26.6 52.4 39.8 32.1 30.7 53.4 47.3 43.5 47.8 46.6 58.9 51.7 82.8 59.4 56.0 50.1 63.1 64.1 55.9 45.2 88.8 70.5 21.4 27.6 41.7 35.0 49.1 35.4 67.5 40.4 36.9 66.5 46.1 59.6 40.4 58.9 34.5 44.9 27.1 60.4 62.0 52.7 55.6 30.3 60.2 61.9 41.4 46.5 43.5 63.1 58.7 34.3 36.6 81.0 86.6 55.7 39.1 63.0 65.0 66.8 91.6 47.0 51.6 48.6 18.1 33.0 51.4 66.9 45.2 46.5 34.8 40.1 34.4 29.7 52.2 30.2 30.9 37.7 36.3 41.9 28.6 30.8 36.6 37.3 26.8 58.4 26.5 43.5 26.6 65.5 79.2 60.1 87.9 68.7 63.4 49.8 76.2 50.1 33.6 235.2 267.7 257.8 195.0 245.8 236.2 168.2 214.0 242.2 213.9 235.5 47.1 316.7 195.6 394.2 12.6 314.4 343.6 0.0 427.4 513.3 214.8 235.2 219.7 140.9 363.9 276.5 286.2 292.8 365.8 16.1 174.9 402.5 210.9 466.1 277.5 222.2 471.9 382.0 197.7 259.3 98.3 226.4 208.3 50.5 174.0 284.4 444.3 286.3 279.8 359.2 YWHAE FLJ45465 ENSG00000108953 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon" P62258 17 1344272-1400378 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008445, CAB016200, CAB021109, CAB047350, HPA061603" Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 160000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336, HPA061603: " "unprognostic (1.29e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-2)" "prognostic favorable (6.48e-6)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (2.73e-2)" "unprognostic (4.77e-3)" "unprognostic (4.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.92e-3)" "unprognostic (8.33e-2)" "unprognostic (2.57e-1)" "unprognostic (3.24e-2)" "unprognostic (8.94e-2)" 55.2 54.3 107.5 35.3 87.1 32.7 37.3 71.5 118.4 28.4 40.2 60.9 23.8 40.2 35.9 54.1 43.1 44.2 23.4 57.7 92.3 81.9 64.5 50.9 32.8 25.4 94.1 77.9 40.2 40.2 41.0 37.9 45.1 73.7 35.0 42.5 27.9 42.4 27.7 135.9 36.8 36.2 32.2 101.1 26.2 38.5 46.0 53.6 30.9 47.5 36.5 37.2 31.6 32.1 19.2 41.5 17.2 36.2 15.0 23.3 31.5 79.3 59.3 71.9 60.4 31.8 36.8 69.1 51.3 30.3 45.8 35.6 106.0 32.6 53.9 60.4 42.5 36.3 55.2 60.9 51.9 65.1 37.2 113.5 37.6 49.5 45.3 38.0 36.0 38.6 33.3 38.3 45.9 70.4 41.5 55.1 39.3 43.1 39.0 58.9 38.6 47.6 28.7 65.9 49.5 38.5 57.9 34.0 38.2 46.6 46.0 40.1 60.8 61.8 25.3 40.2 42.5 48.1 33.3 52.1 44.5 37.9 56.2 90.6 24.5 45.2 45.2 53.4 43.1 64.3 17.2 31.8 8.6 12.4 36.2 15.6 19.2 18.7 13.9 41.5 16.1 17.0 14.3 10.8 15.0 30.9 28.8 23.3 31.5 107.5 87.1 71.5 90.2 92.3 81.9 94.1 77.9 73.7 53.6 276.9 161.5 157.1 381.2 509.9 135.0 437.9 257.4 539.4 243.4 352.4 47.1 418.8 631.6 405.9 192.2 338.4 245.3 70.0 366.4 587.8 367.2 359.0 204.6 255.7 335.2 104.9 338.5 239.4 235.4 296.2 260.1 221.5 403.2 401.2 274.5 253.1 384.5 266.5 277.2 497.3 121.5 239.3 263.7 441.4 573.9 512.8 434.5 126.4 277.6 415.5 YWHAG PPP1R170 ENSG00000170027 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma" P61981 7 76326794-76359031 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 117.8;skeletal muscle: 91.8" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 363.1;Suprabasal keratinocytes: 371.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013274, CAB018389, HPA026918, HPA061603" Approved Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 160000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: " "unprognostic (3.71e-2)" "prognostic unfavorable (4.53e-4)" "unprognostic (3.88e-2)" "unprognostic (1.25e-2)" "unprognostic (6.28e-3)" "unprognostic (2.40e-3)" "unprognostic (8.98e-3)" "prognostic unfavorable (5.34e-4)" "unprognostic (1.63e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.03e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (9.31e-2)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (1.70e-1)" 52.4 31.2 46.3 17.7 54.6 7.3 17.2 36.2 117.8 13.4 14.2 13.3 4.6 14.4 15.0 7.0 18.6 9.0 17.0 33.1 50.2 56.2 15.9 22.0 12.9 12.1 45.9 49.8 13.3 18.0 14.8 7.8 16.6 74.6 14.7 14.0 8.6 10.0 13.3 91.8 11.7 12.5 20.2 22.8 12.7 11.2 8.9 13.5 6.8 8.8 13.8 14.3 14.7 13.2 3.1 5.9 3.2 5.0 1.1 3.3 1.7 37.4 47.2 41.7 53.0 42.8 24.7 18.9 43.6 21.6 27.1 29.4 29.6 40.4 52.9 15.0 38.7 45.1 35.1 52.3 48.1 38.1 35.8 22.8 50.1 32.3 32.8 39.1 61.1 49.0 27.1 46.2 31.6 65.5 28.8 42.9 28.8 68.7 59.9 40.3 35.3 43.6 45.2 46.3 30.3 33.1 51.1 42.3 58.4 42.4 25.6 22.4 62.3 48.3 62.0 30.8 56.2 43.1 37.0 45.3 52.9 30.7 46.9 58.2 19.9 37.2 81.5 47.5 57.8 56.3 3.2 5.0 1.1 2.1 4.6 3.3 3.1 2.4 2.6 5.2 1.8 1.8 2.0 1.1 1.1 3.8 5.9 2.0 1.7 46.3 54.6 36.2 88.9 50.2 56.2 45.9 49.8 74.6 13.5 29.8 23.7 44.7 105.7 363.1 100.2 200.1 43.3 22.7 45.5 36.6 11.8 29.7 31.5 43.8 87.4 64.2 34.1 46.7 32.8 61.5 84.6 106.7 66.8 81.5 75.7 117.6 81.9 48.5 90.6 18.9 42.8 83.5 89.4 41.5 31.5 23.8 60.8 28.8 40.7 41.0 26.9 32.3 122.6 10.3 16.7 371.9 56.2 18.7 33.8 146.6 YWHAH YWHA1 ENSG00000128245 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta" Q04917 22 31944461-31957603 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 154.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025918, HPA061603" Uncertain Approved "Nucleoli rim,Cytosol" NA NA 130000000 Cytosol "Nucleoli rim" "CAB025918: , HPA061603: " "unprognostic (3.77e-1)" "unprognostic (6.13e-2)" "unprognostic (1.67e-2)" "unprognostic (1.86e-2)" "unprognostic (1.13e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (1.59e-5)" "unprognostic (8.62e-2)" "unprognostic (1.63e-1)" "unprognostic (4.51e-2)" "unprognostic (3.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.40e-1)" "unprognostic (1.59e-1)" "unprognostic (5.60e-2)" "unprognostic (7.00e-2)" "unprognostic (6.81e-2)" 21.5 18.6 87.9 20.6 47.4 16.3 19.3 41.9 154.3 13.7 24.4 10.0 4.3 17.2 13.1 14.1 14.0 16.4 18.6 15.2 78.8 59.1 11.7 11.5 25.0 13.5 35.5 101.6 10.0 16.7 5.2 10.4 22.4 49.5 12.3 20.1 6.8 9.9 15.6 13.9 9.9 17.4 25.9 19.4 12.8 26.9 3.7 9.1 6.3 10.5 5.5 15.1 18.5 10.6 8.1 16.6 14.9 14.4 17.7 12.8 9.6 68.7 27.5 30.8 17.9 18.7 17.3 19.5 66.8 33.0 38.6 44.0 29.1 23.9 40.6 16.3 61.3 19.6 33.3 36.8 36.7 36.4 35.9 32.0 23.9 21.6 26.0 18.9 77.1 26.8 15.7 19.6 32.4 23.2 24.5 31.5 14.6 33.0 29.7 29.3 27.7 23.4 35.5 36.6 29.8 30.1 33.6 42.3 21.5 24.3 29.7 66.1 21.7 38.0 26.6 23.8 41.9 15.2 19.1 50.3 38.9 38.9 28.5 42.4 16.5 25.5 50.8 28.2 31.1 34.1 7.8 14.4 14.9 5.7 11.8 8.1 8.1 7.0 8.1 16.6 7.6 2.8 3.6 8.7 17.7 12.2 4.5 12.8 9.6 87.9 47.4 41.9 126.3 78.8 59.1 35.5 101.6 49.5 9.1 47.6 23.7 81.8 190.9 296.7 53.4 42.8 104.4 28.1 20.5 120.4 21.6 126.3 197.3 124.3 2.1 136.1 126.2 116.8 139.6 127.7 124.6 221.7 40.3 62.5 235.5 50.9 72.4 94.5 125.5 9.1 56.7 261.3 285.1 89.2 93.7 65.8 158.8 99.3 76.0 76.7 58.1 155.2 217.9 21.2 37.4 297.2 29.1 84.7 98.9 163.9 YWHAQ "14-3-3, HS1" ENSG00000134308 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta" P27348 2 9583972-9631014 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007925, CAB010286, HPA061603" Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 120000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB010286: AB_2218221, HPA007925: AB_1844340, HPA061603: " "unprognostic (2.65e-2)" "unprognostic (3.99e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (1.53e-1)" "unprognostic (5.78e-3)" "prognostic unfavorable (9.83e-6)" "unprognostic (4.90e-3)" "unprognostic (2.98e-2)" "unprognostic (5.51e-2)" "unprognostic (6.18e-2)" "unprognostic (1.45e-1)" "unprognostic (2.95e-2)" "unprognostic (6.74e-2)" "unprognostic (9.75e-2)" "unprognostic (1.63e-1)" "unprognostic (4.39e-3)" 40.5 47.3 77.8 32.1 60.8 48.0 50.8 88.5 82.5 52.2 44.0 82.5 25.0 37.9 60.5 48.2 57.6 45.3 40.0 68.5 73.7 76.2 45.9 37.2 35.0 38.2 74.3 54.8 55.9 64.4 39.2 39.0 39.3 69.8 54.2 44.1 31.2 38.9 48.8 17.6 33.3 36.5 57.9 72.2 29.8 36.9 44.3 63.5 58.8 45.4 56.7 43.3 47.7 46.3 31.5 30.9 24.8 28.9 51.4 58.4 60.9 43.6 65.8 59.7 57.5 47.0 65.1 56.1 59.9 59.1 63.0 52.9 49.4 38.4 56.5 31.3 85.8 65.8 41.1 66.2 65.3 81.4 139.0 53.8 52.8 42.9 52.8 35.9 50.8 32.0 43.9 38.5 68.7 44.9 57.7 70.6 40.7 51.8 34.1 77.3 30.3 89.9 51.9 101.2 49.2 75.8 65.8 77.4 69.1 69.4 39.1 56.8 96.2 54.5 56.6 43.3 52.3 35.2 26.2 64.3 79.2 56.1 68.5 91.3 34.9 47.7 74.5 67.7 53.1 65.6 17.1 22.2 24.8 47.8 28.9 58.4 31.5 45.1 50.8 30.9 28.8 24.7 39.9 6.8 51.4 27.2 15.7 43.1 60.9 77.8 60.8 88.5 69.0 73.7 76.2 74.3 54.8 69.8 63.5 47.6 54.2 118.7 293.0 281.3 203.3 78.7 73.9 77.6 76.2 129.1 25.5 223.0 353.1 336.2 171.2 152.5 136.5 93.5 248.0 498.0 248.0 243.9 124.5 87.6 192.8 540.3 179.5 67.5 94.8 285.3 161.1 114.1 280.0 283.1 112.7 196.5 233.6 132.5 235.5 197.6 82.9 194.1 334.9 246.8 203.3 310.7 199.5 181.1 168.3 364.8 YWHAZ "14-3-3-zeta, KCIP-1, YWHAD" ENSG00000164924 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta" P63104 8 100916525-100953388 "Plasma proteins, Predicted intracellular proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 1590.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005065, HPA061603" Approved Approved "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 760000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB005065: AB_2218378, HPA061603: " "unprognostic (4.70e-3)" "unprognostic (7.38e-3)" "unprognostic (8.09e-2)" "prognostic unfavorable (3.91e-4)" "unprognostic (1.83e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (2.28e-5)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.65e-1)" "unprognostic (3.72e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.03e-6)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" 54.6 40.9 89.9 51.8 104.6 70.8 39.6 55.8 117.7 52.4 69.6 38.7 25.3 47.4 43.5 37.6 141.8 38.3 51.9 29.1 81.7 67.0 44.1 32.9 40.7 60.0 50.1 66.7 46.4 27.5 37.8 25.2 69.0 78.2 42.5 70.3 31.7 55.2 47.2 19.7 63.0 71.4 53.5 43.8 56.3 51.5 34.1 31.5 89.4 46.0 74.9 83.2 53.6 70.2 58.6 57.2 129.4 77.9 57.0 78.4 104.9 135.5 66.0 125.8 36.1 31.3 39.8 62.4 63.7 82.9 86.3 84.1 45.9 89.0 60.9 69.1 101.2 71.9 59.0 79.1 90.8 131.5 53.9 31.2 57.5 49.9 29.7 41.2 24.0 66.0 36.9 123.8 71.3 113.7 73.1 77.5 43.6 65.4 59.8 73.7 49.2 99.1 42.6 42.5 171.2 69.1 42.2 36.6 41.9 83.0 76.6 70.5 50.3 48.4 48.1 100.9 93.7 69.7 28.4 63.0 43.8 64.3 52.7 57.1 38.1 45.2 74.8 72.4 45.4 179.2 129.4 45.0 81.2 69.1 66.5 70.3 58.6 59.0 66.5 57.2 48.0 44.8 56.4 74.6 57.0 77.9 35.4 78.4 104.9 89.9 104.6 55.8 117.7 81.7 67.0 50.1 66.7 78.2 31.5 232.3 218.0 255.7 330.0 894.5 96.7 77.9 206.4 306.5 335.5 249.5 84.4 219.2 102.8 385.1 1094.8 171.9 335.2 46.7 365.6 441.5 215.1 349.2 432.9 89.1 253.4 127.1 254.5 172.5 286.2 1590.1 116.2 345.3 371.2 266.9 443.9 100.4 544.8 334.6 138.3 122.2 86.4 129.4 256.3 148.6 68.6 1035.6 342.0 343.9 282.9 758.7 Z83844.3 ENSG00000285304 22 37639693-37666932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA000757 Approved Approved Cytosol NA NA Cytosol "HPA000757: AB_1079951" 2.4 0.1 1.8 12.3 2.7 8.5 1.0 2.4 3.5 3.7 7.5 2.0 0.9 8.4 1.3 2.0 11.6 1.9 2.4 1.0 1.5 0.3 1.0 3.7 8.2 1.7 1.5 2.5 0.9 2.8 0.0 6.0 1.8 3.5 5.7 1.4 4.4 2.8 0.0 2.2 12.5 2.6 2.5 13.4 1.6 0.9 2.4 10.5 0.3 10.4 16.3 4.6 2.0 1.6 3.6 0.1 2.7 1.7 2.6 1.5 9.2 1.6 5.3 3.3 1.5 4.6 5.9 2.7 8.5 10.1 10.6 7.4 2.3 6.7 1.1 3.0 3.3 8.0 5.7 13.9 3.2 6.9 5.1 14.0 0.2 7.4 3.0 21.4 19.3 5.4 6.6 11.8 1.1 4.8 0.6 4.3 4.0 5.0 0.4 11.2 0.9 2.0 5.4 16.0 1.3 8.7 3.6 5.5 1.1 3.3 3.0 5.5 0.7 3.5 6.1 3.9 4.6 10.7 1.2 1.5 5.5 0.7 0.0 9.1 3.4 6.1 3.6 14.8 10.1 0.0 2.7 0.1 2.2 1.3 1.8 1.6 1.4 2.1 3.6 0.9 2.6 1.6 0.0 1.7 2.7 2.2 2.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBED2 MGC10796 ENSG00000177494 "Zinc finger BED-type containing 2" Q9BTP6 3 111592900-111595443 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 21.0;thyroid gland: 74.5" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 41.7" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 64.0" "Region enriched" "Detected in single" 6 "basal ganglia: 1.4" "Cell type enhanced" "Detected in many" "naive B-cell: 4.0" "Group enriched" "Detected in many" 6 "B-cells: 4.0;T-cells: 2.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0" "Not detected" "Not detected" HPA029786 Approved "Nuclear bodies,Mitochondria,Cytosol" No No "Mitochondria, Cytosol" "Nuclear bodies" "HPA029786: AB_10601028" "unprognostic (7.31e-3)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-3)" "unprognostic (3.49e-1)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (8.83e-4)" "unprognostic (2.59e-1)" "unprognostic (1.47e-6)" "unprognostic (3.81e-2)" "unprognostic (4.34e-1)" "unprognostic (4.69e-2)" "unprognostic (3.29e-2)" 0.1 0.0 0.1 0.9 1.4 0.0 0.1 0.1 0.1 3.7 0.1 0.1 0.1 0.0 0.2 0.2 8.1 11.1 0.2 0.1 0.1 0.0 0.3 0.1 5.6 3.4 0.1 0.1 1.2 0.1 0.0 0.4 4.0 0.1 0.1 0.0 0.1 1.7 0.1 0.1 1.3 0.3 0.1 0.1 0.1 0.1 0.2 0.2 21.0 74.5 7.5 7.4 0.2 6.2 4.0 0.0 0.1 0.0 0.5 2.5 0.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.1 14.0 0.0 0.0 19.4 0.0 43.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.0 3.6 0.6 0.3 0.0 4.0 1.9 2.5 0.1 0.5 0.0 0.0 1.1 0.3 0.1 1.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 41.7 1.4 0.0 0.2 3.9 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.7 0.0 0.1 ZBTB14 "ZFP161, ZNF478" ENSG00000198081 "Zinc finger and BTB domain containing 14" O43829 18 5289019-5297053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050758, HPA070819" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA050758: AB_2681226, HPA070819: AB_2686316" "unprognostic (5.28e-2)" "unprognostic (4.37e-2)" "unprognostic (4.25e-2)" "unprognostic (2.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-2)" "unprognostic (2.95e-2)" "unprognostic (8.64e-2)" "unprognostic (1.19e-3)" "unprognostic (4.72e-3)" "unprognostic (3.25e-2)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "unprognostic (2.03e-1)" "unprognostic (2.53e-1)" "unprognostic (3.73e-1)" "unprognostic (2.90e-2)" 11.2 9.1 13.1 11.6 13.4 6.8 10.8 24.3 12.8 8.7 8.7 10.7 10.8 7.2 12.5 14.9 10.8 9.3 10.3 7.1 13.1 10.2 9.8 11.3 11.0 19.5 14.5 7.6 14.2 12.1 12.8 8.7 8.5 7.3 9.8 8.7 10.3 9.8 11.1 6.9 11.8 12.7 7.5 16.4 17.4 9.8 10.8 8.2 30.8 15.9 7.0 18.1 11.2 11.8 10.1 8.6 14.3 8.2 7.5 13.4 7.6 7.1 9.5 12.5 9.2 9.4 12.4 8.3 7.1 10.6 10.1 8.9 9.1 9.4 25.1 6.3 8.6 11.6 6.7 9.1 10.7 10.2 4.9 4.9 9.9 8.7 8.3 6.6 12.4 12.0 9.9 9.1 7.0 6.6 10.9 15.6 18.2 6.3 8.3 10.2 7.8 18.6 8.3 11.0 8.9 4.9 11.1 8.0 7.2 8.5 8.8 11.1 10.9 10.9 7.2 11.5 13.0 8.6 14.3 8.7 13.1 10.9 10.1 10.6 5.3 5.3 15.5 13.8 10.7 11.5 10.9 5.7 14.3 9.9 8.2 9.9 8.3 12.7 11.4 8.6 10.1 13.4 12.7 1.3 7.5 7.3 6.5 7.9 7.6 13.1 13.4 24.3 12.8 13.1 10.2 14.5 7.6 7.3 8.2 6.0 4.1 11.1 1.3 2.2 6.5 2.8 2.5 1.4 1.2 5.2 0.0 4.0 5.0 4.2 0.8 6.3 4.0 0.0 2.9 4.9 4.5 2.5 16.1 5.7 6.2 4.8 1.2 9.2 5.9 1.7 5.5 5.2 1.7 4.6 5.1 8.2 3.2 4.2 5.3 4.0 5.8 0.0 4.1 0.7 11.7 2.6 1.8 4.4 4.4 0.6 ZBTB2 "bA351K16.2, KIAA1483, ZNF437" ENSG00000181472 "Zinc finger and BTB domain containing 2" Q8N680 6 151364117-151391548 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023136, HPA023137, HPA023458, HPA023487" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945" "unprognostic (1.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.93e-1)" "unprognostic (2.42e-2)" "unprognostic (8.36e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (6.36e-2)" "unprognostic (2.21e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (8.27e-2)" "prognostic unfavorable (9.36e-6)" "unprognostic (1.45e-1)" "unprognostic (1.05e-1)" "unprognostic (2.44e-3)" "unprognostic (7.73e-2)" 11.1 7.7 10.3 10.6 8.6 14.4 13.3 11.7 10.7 9.3 10.3 8.2 9.2 7.9 11.1 8.1 8.5 10.7 11.5 8.4 8.4 6.6 7.7 9.9 13.1 14.4 11.0 6.8 17.4 14.4 8.6 5.3 9.2 10.3 8.7 9.9 6.9 11.1 12.3 14.0 8.6 10.6 14.6 9.6 12.0 9.4 7.7 11.1 27.7 32.2 8.0 13.0 11.2 13.9 5.7 6.6 15.1 10.7 7.8 14.1 6.3 8.8 6.4 9.9 7.4 10.6 11.2 10.6 14.1 20.3 17.8 17.0 12.4 7.3 22.8 7.9 14.1 18.0 10.6 15.8 17.1 22.3 10.3 11.8 10.2 7.7 18.7 15.8 27.6 12.7 11.8 10.3 16.3 20.0 10.2 10.4 10.8 18.6 13.4 12.5 19.8 14.9 12.9 12.0 11.0 9.8 14.3 9.3 9.1 13.5 13.5 11.0 7.7 11.1 14.6 11.0 10.4 9.8 16.6 8.5 15.1 16.4 6.9 18.6 17.9 18.6 25.5 6.2 15.1 10.7 13.6 6.0 15.1 11.3 6.6 14.1 5.7 10.3 13.4 6.6 4.4 8.7 10.5 6.9 7.8 10.7 2.7 8.3 6.3 10.3 8.6 11.7 10.7 8.4 6.6 11.0 6.8 10.3 11.1 8.9 5.8 5.9 7.3 14.0 2.9 7.6 5.1 8.1 11.4 0.0 0.0 5.2 11.6 4.2 7.2 8.7 4.6 0.0 2.5 16.2 8.2 12.0 9.2 2.4 6.6 1.6 8.6 4.3 7.6 8.9 8.1 9.4 10.1 1.0 6.6 2.9 3.9 0.0 3.9 4.1 1.8 6.5 14.2 3.2 6.8 15.9 10.4 14.9 6.4 8.2 ZBTB33 "kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348" ENSG00000177485 "Zinc finger and BTB domain containing 33" Q86T24 X 120250752-120258398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000755, CAB001980, HPA005732" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166" "unprognostic (9.14e-3)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.47e-2)" "unprognostic (6.13e-2)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.51e-2)" "unprognostic (5.08e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (6.44e-2)" "unprognostic (2.59e-2)" 15.4 10.4 12.8 9.3 15.5 20.2 18.0 16.3 13.9 9.6 8.5 11.6 9.1 9.1 7.7 11.5 14.9 10.0 9.0 6.0 12.6 15.0 8.0 22.5 10.7 14.0 13.4 11.6 12.2 11.6 17.7 15.5 10.2 16.7 10.5 7.9 6.2 15.0 10.0 9.5 21.6 10.2 6.0 18.6 12.7 9.9 6.9 14.8 29.3 17.4 5.3 14.6 10.3 9.7 3.4 8.9 14.2 8.9 5.1 7.2 5.2 9.3 10.4 14.2 12.9 11.2 12.8 16.7 7.2 9.7 8.5 10.5 6.3 8.2 13.7 13.8 7.3 11.3 14.4 22.4 11.4 10.8 15.1 16.1 14.3 15.8 8.5 8.5 14.2 16.3 9.1 13.9 8.6 12.8 12.1 14.4 13.8 9.2 16.0 10.4 11.2 13.3 9.3 17.3 14.0 11.3 15.1 10.8 21.8 8.6 16.7 26.0 11.0 15.3 15.1 17.0 11.1 8.1 20.1 14.1 6.8 5.0 10.1 12.8 9.0 9.1 17.4 9.5 20.4 8.4 14.2 6.1 7.7 4.4 8.9 7.2 3.4 5.6 5.5 8.9 3.3 7.1 4.8 1.2 5.1 5.6 8.5 4.9 5.2 12.8 15.5 16.3 13.9 12.6 15.0 13.4 11.6 16.7 14.8 14.9 6.5 4.2 6.8 11.3 4.3 4.5 10.2 12.0 15.9 1.8 0.0 6.6 1.7 4.9 0.1 6.9 4.6 23.3 5.8 6.9 5.4 6.9 0.0 16.6 6.8 3.2 8.1 8.0 9.9 0.0 4.0 9.8 3.3 10.0 7.8 6.5 6.4 5.7 2.5 2.8 1.4 6.5 3.1 2.9 11.7 11.4 7.8 9.6 6.5 10.1 ZBTB37 "MGC2629, ZNF908" ENSG00000185278 "Zinc finger and BTB domain containing 37" Q5TC79 1 173868082-173903549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 49.0;Rod photoreceptor cells: 67.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023438 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA023438: AB_1858954" "unprognostic (1.18e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.46e-2)" "unprognostic (2.66e-4)" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (9.86e-2)" "unprognostic (2.41e-1)" "unprognostic (3.72e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (1.96e-2)" 6.4 4.0 6.9 6.5 9.8 11.1 5.8 6.4 7.9 5.3 4.0 11.2 3.7 4.0 9.1 5.5 3.4 4.6 4.7 5.6 7.2 3.7 5.3 4.8 6.0 7.7 9.9 5.2 7.6 4.5 6.8 9.2 4.7 7.8 5.3 3.9 10.6 4.6 4.9 4.0 7.0 5.2 6.8 9.5 7.9 5.1 18.4 8.8 7.7 6.1 2.8 6.3 4.8 5.5 1.8 2.4 6.0 1.0 2.3 2.8 0.8 2.4 3.7 5.6 2.4 3.5 2.8 6.2 2.2 1.6 4.0 2.9 4.6 3.1 6.6 4.7 3.4 2.1 3.1 4.8 2.4 3.4 3.7 3.0 9.1 3.9 2.2 2.1 5.3 5.8 2.5 1.7 6.0 4.0 2.5 2.0 4.7 8.0 4.4 4.2 1.8 3.6 1.4 5.4 1.8 0.9 2.4 5.0 2.2 2.2 6.1 4.2 5.3 3.1 4.3 4.4 6.2 6.2 5.6 3.6 5.3 5.7 2.6 3.5 8.0 5.9 10.6 3.5 3.0 3.2 0.4 1.0 3.4 2.8 1.0 1.2 0.7 1.3 2.0 0.6 1.8 0.7 1.8 6.0 2.3 1.0 2.4 1.0 0.8 6.9 9.8 6.4 7.9 7.2 3.7 9.9 5.2 7.8 8.8 6.0 4.6 11.9 3.1 2.6 26.9 8.4 12.7 9.4 2.3 10.4 31.4 6.8 6.6 2.8 40.4 5.2 3.9 0.0 3.3 3.4 4.3 4.2 2.3 4.3 4.2 17.5 3.4 13.5 15.1 49.0 8.1 7.6 10.1 2.8 3.6 11.9 2.5 3.5 12.4 4.4 67.3 6.5 6.2 17.6 13.3 5.1 7.7 12.9 3.3 2.7 ZBTB4 "KAISO-L1, KIAA1538, ZNF903" ENSG00000174282 "Zinc finger and BTB domain containing 4" Q9P1Z0 17 7459366-7484263 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008980, HPA064763" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB008980: , HPA064763: AB_2685347" "unprognostic (2.23e-1)" "unprognostic (3.95e-1)" "unprognostic (7.17e-2)" "unprognostic (2.92e-2)" "unprognostic (5.32e-2)" "unprognostic (7.62e-3)" "unprognostic (2.43e-1)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.63e-3)" "prognostic favorable (2.53e-4)" "unprognostic (1.73e-1)" "prognostic favorable (1.65e-9)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.88e-1)" "unprognostic (6.04e-3)" 20.1 23.5 20.1 10.9 22.7 4.7 20.6 27.9 38.3 26.3 21.8 19.8 13.7 9.2 22.8 22.7 16.6 22.5 15.1 22.3 19.6 18.3 15.6 6.3 21.4 10.7 21.0 19.4 35.1 16.3 70.1 15.4 14.6 25.8 22.3 9.9 26.2 19.9 30.0 21.4 14.8 11.3 22.3 20.2 18.7 14.2 10.6 14.7 8.2 23.9 9.5 12.7 23.4 24.7 1.8 1.3 1.4 4.6 2.0 3.5 1.5 6.3 8.7 2.2 4.2 23.5 12.2 4.0 8.9 12.9 8.1 8.1 2.9 3.1 0.6 7.1 16.9 5.9 10.1 2.2 12.5 5.9 10.1 3.8 3.2 7.1 2.0 6.6 0.6 7.6 8.5 13.1 7.8 10.0 19.1 7.0 2.4 1.0 2.1 8.9 4.2 2.2 1.3 0.9 2.6 4.2 4.0 3.8 0.9 9.9 5.4 1.3 3.3 3.9 2.8 4.1 4.1 5.2 1.4 9.7 9.1 3.6 8.6 7.3 3.8 2.6 0.4 9.8 2.0 4.7 1.1 0.9 1.4 3.2 1.4 3.5 1.6 2.6 2.6 0.7 1.8 3.4 3.1 0.6 2.0 4.6 1.3 1.3 1.5 20.1 22.7 27.9 38.3 19.6 18.3 21.0 19.4 25.8 14.7 47.6 49.8 8.2 16.6 27.2 75.9 76.7 22.9 17.4 19.4 19.2 64.8 8.5 3.3 13.6 34.6 26.1 5.4 0.0 12.4 1.9 17.3 18.9 12.8 7.8 11.9 69.9 16.7 22.1 26.3 41.2 48.1 17.7 16.9 5.4 10.3 24.7 16.4 7.0 65.7 8.9 38.5 32.3 30.9 5.4 4.1 20.6 4.3 20.1 7.6 11.1 ZBTB41 "DKFZp686C06120, FLJ36199, FRBZ1, ZNF924" ENSG00000177888 "Zinc finger and BTB domain containing 41" Q5SVQ8 1 197153680-197200542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034841, HPA034842" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" Nucleoplasm "HPA034841: AB_2674355, HPA034842: AB_10669995" "unprognostic (2.36e-1)" "unprognostic (5.58e-3)" "unprognostic (8.01e-3)" "unprognostic (6.07e-2)" "unprognostic (4.14e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.43e-1)" "unprognostic (1.81e-2)" "unprognostic (2.81e-1)" "unprognostic (7.51e-3)" "unprognostic (2.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.58e-1)" 2.6 3.8 4.1 1.8 4.0 0.2 5.9 10.8 5.0 4.5 2.2 2.1 3.2 3.8 2.4 2.8 3.2 2.3 4.0 4.7 4.3 3.3 2.3 2.4 4.2 5.9 2.9 5.6 3.8 2.2 3.3 2.5 2.9 2.6 3.3 2.4 1.8 2.2 4.8 3.0 3.2 2.6 6.4 2.2 3.1 2.1 1.5 1.4 1.7 0.7 1.8 2.2 0.7 7.3 4.1 5.5 4.4 8.8 13.3 4.4 4.4 7.3 4.7 4.5 2.6 6.2 2.7 6.5 10.1 2.8 6.1 3.8 3.9 7.5 2.4 2.3 2.2 5.6 2.4 7.8 4.3 2.2 5.4 10.2 4.7 8.2 9.6 3.2 3.1 5.1 3.3 12.0 3.6 3.2 2.4 2.1 5.1 1.5 2.2 7.7 4.8 5.8 4.2 7.9 7.0 8.0 14.1 8.4 4.2 10.7 3.3 5.2 9.3 5.4 7.3 5.8 3.8 1.9 2.9 4.4 1.6 12.9 1.7 0.7 0.4 1.2 0.4 2.2 1.5 1.6 1.6 1.4 1.4 2.2 2.0 0.0 1.8 0.6 0.7 1.0 0.7 17.9 6.2 7.2 4.6 6.6 13.6 12.8 7.6 10.7 10.3 15.7 2.0 3.3 1.7 6.1 2.9 5.5 3.8 0.0 4.9 3.2 6.1 8.3 1.1 8.3 3.7 23.8 12.6 8.0 7.9 2.7 14.4 4.6 11.8 6.4 6.5 30.0 6.0 0.0 11.3 9.1 8.1 6.5 6.1 6.5 4.5 8.8 2.9 4.5 7.6 5.2 ZBTB45 "FLJ14486, ZNF499" ENSG00000119574 "Zinc finger and BTB domain containing 45" Q96K62 19 58513530-58538911 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035754, HPA075485" Uncertain Approved "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA035754: AB_10603461, HPA075485: " "unprognostic (1.38e-1)" "unprognostic (7.12e-2)" "unprognostic (2.31e-1)" "unprognostic (7.34e-2)" "unprognostic (2.60e-1)" "unprognostic (4.50e-2)" "unprognostic (2.76e-3)" "unprognostic (2.19e-2)" "unprognostic (2.63e-2)" "unprognostic (3.02e-1)" "unprognostic (1.79e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.38e-4)" "unprognostic (2.08e-1)" "unprognostic (1.06e-1)" "unprognostic (5.47e-2)" "unprognostic (1.40e-1)" 15.3 11.1 11.8 12.0 13.4 11.1 10.2 15.1 24.9 15.2 10.9 13.5 11.4 14.6 14.9 8.7 11.6 12.5 10.3 10.0 12.6 10.0 9.8 7.7 11.0 10.1 10.3 8.5 16.6 13.9 9.1 8.8 10.9 11.2 14.5 4.7 13.2 21.5 11.0 21.0 17.2 14.7 11.8 7.3 13.3 14.6 7.5 9.2 15.8 15.9 9.1 14.4 13.5 10.5 7.9 8.7 13.2 11.3 7.0 9.8 5.5 10.4 15.1 4.0 6.2 4.0 3.3 4.7 5.5 2.3 1.4 1.4 2.9 7.0 16.7 8.4 3.2 4.2 6.6 2.0 4.9 0.6 10.8 27.0 8.8 7.6 3.6 2.4 5.3 5.7 3.1 3.6 2.3 2.0 2.8 2.9 17.6 7.8 0.8 2.3 7.6 8.7 5.7 5.7 5.9 13.1 6.8 2.4 10.1 3.1 10.1 12.7 8.8 4.2 11.8 3.0 2.4 18.4 3.8 5.4 6.7 2.9 2.2 5.5 19.4 13.6 8.7 7.8 2.2 4.2 9.2 6.7 13.2 8.1 10.2 9.8 6.1 5.8 7.7 7.2 7.9 7.1 5.0 5.9 7.0 11.3 8.7 5.1 5.5 11.8 13.4 15.1 24.9 12.6 10.0 10.3 8.5 11.2 9.2 8.9 0.3 5.9 3.1 1.4 4.1 2.8 0.0 2.7 1.2 12.2 0.0 8.2 5.0 9.9 0.6 4.4 3.9 0.0 7.7 6.0 3.2 3.2 0.0 5.7 5.8 6.4 9.9 9.8 4.0 0.6 5.5 2.6 6.8 14.4 4.7 2.9 7.4 0.0 9.2 3.6 2.8 12.9 2.7 3.1 3.2 2.4 4.7 4.5 5.7 1.7 ZBTB48 "HKR3, TZAP, ZNF855" ENSG00000204859 "Zinc finger and BTB domain containing 48" P10074 1 6580001-6589280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030417 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030417: AB_10603145" "unprognostic (6.66e-2)" "prognostic favorable (1.04e-4)" "unprognostic (7.15e-3)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (8.15e-3)" "unprognostic (6.43e-2)" "unprognostic (1.70e-1)" "prognostic favorable (5.19e-6)" "unprognostic (7.73e-2)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-2)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" 10.8 12.0 9.6 15.1 12.6 13.3 12.3 11.1 16.3 13.5 12.2 12.7 21.4 11.7 13.2 15.1 12.7 14.2 17.6 9.6 8.9 7.5 12.9 21.6 14.3 17.1 7.0 11.3 19.9 15.8 17.1 14.0 10.7 11.4 17.2 13.2 16.9 12.6 11.7 10.9 14.4 17.2 11.3 8.8 17.1 12.9 28.2 10.3 19.9 18.4 7.4 15.9 13.0 14.4 7.5 7.8 26.7 6.8 6.6 6.4 5.3 3.9 4.8 7.6 11.1 8.5 6.6 3.9 4.0 4.8 7.7 8.4 4.9 9.1 13.1 7.2 3.5 5.3 7.4 11.5 8.0 6.2 13.3 10.9 10.6 13.9 4.8 10.1 17.0 28.8 6.6 6.2 7.5 12.1 10.4 5.6 10.0 10.4 8.6 5.7 7.6 8.3 12.2 5.7 7.7 8.3 9.5 7.1 14.4 6.9 3.7 14.9 6.9 6.0 13.8 9.2 8.3 7.9 13.7 6.3 5.3 3.5 5.7 5.0 9.4 8.1 20.3 4.9 13.7 3.0 10.9 6.8 26.7 6.0 4.2 6.0 6.5 4.7 5.7 7.8 7.5 6.4 5.5 10.0 6.6 6.6 5.0 3.8 5.3 9.6 12.6 11.1 16.3 8.9 7.5 7.0 11.3 11.4 10.3 3.0 10.5 6.7 8.5 4.1 7.1 4.5 12.7 13.4 7.9 10.4 5.9 5.1 10.0 4.1 36.3 4.7 15.8 0.0 3.2 4.1 5.8 5.2 26.5 11.6 9.6 9.5 14.9 4.3 6.2 14.2 8.1 9.8 5.0 10.0 12.7 10.4 2.7 14.0 5.3 10.5 7.4 19.4 5.2 17.7 10.4 4.8 4.2 10.1 9.5 5.8 ZBTB49 "FLJ38559, ZNF509" ENSG00000168826 "Zinc finger and BTB domain containing 49" Q6ZSB9 4 4290251-4321786 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024450 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA024450: AB_1859311" "unprognostic (4.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.30e-1)" "unprognostic (2.49e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.56e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.11e-1)" "prognostic favorable (1.76e-4)" "unprognostic (5.54e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "prognostic favorable (2.88e-5)" 7.3 5.4 5.0 6.0 9.0 11.8 6.8 9.2 8.7 7.2 6.2 9.9 3.4 4.5 9.5 7.0 5.6 6.3 5.3 6.2 6.1 5.1 4.7 5.9 6.5 7.5 6.8 5.3 10.6 7.7 6.0 13.3 5.6 8.9 7.9 4.4 7.1 10.0 6.5 10.1 4.8 6.3 6.5 6.1 9.2 6.0 10.3 6.7 6.7 8.1 5.0 8.5 7.8 5.8 2.9 1.9 12.1 2.7 3.2 6.4 1.8 2.0 3.4 4.3 7.2 5.8 6.1 5.1 2.6 5.1 5.7 4.4 3.0 4.0 7.4 2.7 2.8 7.0 3.6 7.5 4.3 5.9 2.4 2.9 8.6 2.3 4.2 4.9 5.2 3.2 3.9 3.6 5.2 3.4 3.2 5.7 8.0 4.4 4.0 5.3 3.4 10.2 10.2 7.3 3.0 4.6 6.1 5.6 4.6 2.2 3.7 5.2 5.0 5.7 2.2 5.7 6.0 3.1 5.1 5.5 5.1 2.3 3.4 5.5 4.9 4.8 6.3 3.7 4.4 5.0 3.7 2.6 12.1 6.4 2.7 5.0 2.2 3.6 6.0 1.9 2.9 4.1 4.7 6.2 3.2 2.2 0.4 3.2 1.8 5.0 9.0 9.2 8.7 6.1 5.1 6.8 5.3 8.9 6.7 0.0 1.4 2.7 1.6 2.3 2.4 1.6 0.0 1.4 2.3 1.8 3.9 1.6 0.0 1.8 1.5 2.2 0.9 0.0 2.2 1.2 2.0 1.5 1.1 1.5 1.6 1.6 1.2 3.7 2.6 0.0 1.4 2.1 3.3 3.6 1.7 1.7 1.0 2.9 2.1 0.8 7.8 0.0 1.1 9.5 5.3 2.3 1.3 2.9 1.3 1.0 ZBTB9 "MGC23166, ZNF919" ENSG00000213588 "Zinc finger and BTB domain containing 9" Q96C00 6 33453970-33457548 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 3.9;Intestinal endocrine cells: 1.7;Melanocytes: 1.7;Suprabasal keratinocytes: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.3;GAMG: 15.7;U-698: 11.6" "Low region specificity" "Detected in all" "HPA036767, HPA058171" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA036767: AB_10696787, HPA058171: " "unprognostic (1.79e-2)" "unprognostic (1.46e-1)" "unprognostic (6.86e-2)" "unprognostic (2.89e-1)" "unprognostic (2.18e-1)" "unprognostic (9.16e-2)" "unprognostic (1.85e-4)" "unprognostic (4.20e-1)" "unprognostic (2.73e-1)" "unprognostic (2.13e-1)" "unprognostic (1.70e-2)" "unprognostic (4.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.95e-1)" 4.5 7.1 5.5 5.4 5.9 4.4 3.3 4.9 7.4 5.4 4.4 6.4 2.4 6.6 4.5 8.7 5.4 4.8 4.2 4.4 5.9 5.1 7.7 5.4 3.7 6.6 4.4 4.5 10.6 11.3 8.5 17.3 4.5 4.2 5.9 7.1 4.6 6.3 3.9 5.7 5.0 3.9 3.8 3.5 5.4 3.7 12.7 3.8 9.7 6.8 4.0 13.7 7.8 4.3 0.8 2.6 8.5 2.2 1.9 4.3 1.0 0.1 0.1 4.6 0.7 2.3 0.1 10.3 0.1 0.2 0.0 0.0 1.6 0.0 1.6 1.5 0.1 15.7 0.0 4.4 1.8 0.6 1.8 0.0 6.1 0.0 0.0 0.0 2.3 6.0 0.2 0.2 2.7 2.7 0.0 0.0 0.3 2.5 0.5 2.0 0.5 0.4 0.0 2.9 0.2 0.4 3.0 2.8 2.0 2.4 2.1 0.5 0.3 3.0 0.1 1.0 0.2 0.5 0.4 1.5 0.3 0.1 0.9 1.1 0.0 1.7 11.6 0.2 1.9 0.0 8.5 1.5 0.5 3.9 1.5 1.9 0.3 1.9 4.3 2.6 0.8 3.6 3.2 1.4 1.9 2.2 0.3 3.2 1.0 5.5 5.9 4.9 7.4 5.9 5.1 4.4 4.5 4.2 3.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 3.1 0.0 0.0 0.7 0.0 ZC2HC1A "C8orf70, CGI-62, FAM164A" ENSG00000104427 "Zinc finger C2HC-type containing 1A" Q96GY0 8 78666047-78719765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 128.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.6;T-reg: 17.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 20.9;SK-BR-3: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024726 Approved Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA024726: AB_1846597" "unprognostic (1.12e-1)" "unprognostic (3.02e-1)" "unprognostic (5.36e-3)" "unprognostic (4.00e-2)" "unprognostic (1.13e-1)" "unprognostic (7.79e-2)" "unprognostic (1.19e-7)" "unprognostic (2.96e-1)" "unprognostic (7.25e-2)" "prognostic unfavorable (9.00e-4)" "unprognostic (2.26e-1)" "unprognostic (1.63e-2)" "unprognostic (5.41e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (2.34e-1)" "unprognostic (5.40e-2)" "unprognostic (4.05e-3)" 7.6 6.2 16.1 6.1 21.2 2.0 14.3 23.6 20.0 12.7 8.0 8.4 6.7 3.3 19.7 9.1 11.5 19.5 10.0 8.1 16.5 15.7 8.3 2.9 12.6 5.1 11.9 22.6 23.6 4.9 26.1 26.1 11.4 25.8 12.8 7.8 5.0 7.5 10.9 4.2 43.1 5.8 13.1 13.8 5.9 5.8 8.6 11.0 1.5 19.8 4.2 8.4 11.0 12.1 5.1 3.3 20.6 8.1 0.6 17.7 1.5 2.4 3.0 5.7 4.6 12.2 12.9 2.5 6.8 4.6 3.4 4.4 0.8 4.4 4.1 2.9 6.9 7.3 2.0 3.4 3.8 5.1 13.6 2.2 0.5 2.8 2.4 7.3 0.7 1.4 9.2 6.5 2.8 8.4 10.5 4.7 1.4 0.7 20.9 7.2 2.4 0.8 1.2 1.4 0.2 4.9 0.0 7.3 0.9 5.1 5.3 2.2 9.0 5.3 39.2 7.4 5.5 1.0 0.1 3.8 10.8 4.5 4.9 3.3 5.2 5.3 2.7 5.1 0.0 4.1 20.6 3.9 0.1 0.1 4.1 0.0 5.1 4.0 0.2 3.3 3.3 1.2 0.4 0.1 0.6 8.1 0.2 17.7 1.5 16.1 21.2 23.6 20.0 16.5 15.7 11.9 22.6 25.8 11.0 62.5 21.3 5.6 36.7 26.0 25.1 14.5 5.1 128.5 31.8 17.4 3.9 23.8 23.2 15.7 8.0 13.3 0.0 0.0 7.3 25.2 18.0 13.1 5.8 0.8 13.6 44.5 8.6 17.2 6.9 3.0 17.8 11.2 15.1 16.2 2.9 34.9 8.1 0.0 34.6 8.7 22.2 6.5 20.6 29.8 28.8 36.9 14.5 4.4 3.0 10.6 ZC3H15 LEREPO4 ENSG00000065548 "Zinc finger CCCH-type containing 15" Q8WU90 2 186486156-186509363 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031099, HPA031100, HPA031101" Enhanced Enhanced Cytosol NA Yes Cytosol "HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669" "unprognostic (1.51e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (2.24e-1)" "unprognostic (3.11e-3)" "unprognostic (5.92e-2)" "unprognostic (8.15e-2)" "prognostic unfavorable (1.48e-7)" "unprognostic (9.08e-3)" "unprognostic (4.95e-2)" "prognostic favorable (3.98e-4)" "prognostic unfavorable (9.75e-4)" "unprognostic (5.72e-3)" "unprognostic (5.69e-2)" "unprognostic (1.87e-1)" "unprognostic (1.82e-1)" "unprognostic (8.89e-2)" "unprognostic (3.45e-2)" 25.2 31.1 35.7 25.2 40.1 67.3 38.0 32.9 52.6 24.7 24.7 10.5 30.2 29.0 25.1 30.7 28.2 19.8 22.6 25.2 60.0 35.4 32.8 40.3 20.3 29.5 32.3 33.5 24.5 32.7 26.9 35.3 29.4 51.6 24.3 28.9 10.7 25.8 26.2 58.0 27.0 29.9 27.4 43.4 28.5 23.3 23.7 21.7 28.3 30.5 19.0 30.1 30.0 38.8 32.8 31.1 28.3 39.1 32.5 36.9 22.4 27.2 18.5 22.9 29.4 26.1 26.5 34.4 30.4 20.8 28.2 25.5 53.9 22.1 37.2 27.9 21.5 36.2 19.9 42.1 37.1 40.0 33.8 32.2 53.4 28.6 59.6 35.3 54.3 32.8 21.6 41.2 30.6 43.6 24.9 30.2 23.2 51.0 29.2 29.4 24.5 34.6 38.8 43.2 36.0 46.9 27.7 31.0 34.6 35.7 33.3 27.7 20.4 19.2 26.3 43.9 36.0 18.5 39.6 25.9 31.9 27.6 19.5 36.2 25.5 42.7 53.2 28.3 38.6 27.8 28.3 27.5 26.9 27.2 34.0 33.7 32.8 33.8 34.5 31.1 24.7 31.5 33.2 16.8 32.5 39.1 27.5 36.9 22.4 35.7 40.1 32.9 52.6 60.0 35.4 32.3 33.5 51.6 21.7 68.5 78.9 141.2 127.1 188.5 73.2 87.6 66.2 78.9 102.4 109.9 56.9 114.7 217.2 91.2 123.7 87.8 121.8 46.7 90.4 141.8 94.0 129.7 109.7 114.6 109.7 54.0 97.5 65.7 86.1 224.0 72.8 100.6 60.8 118.2 99.1 80.5 96.4 97.7 82.0 189.8 120.6 32.3 103.2 184.4 186.8 182.8 148.5 83.7 117.5 153.1 ZC3H4 "C19orf7, KIAA1064" ENSG00000130749 "Zinc finger CCCH-type containing 4" Q9UPT8 19 47064187-47113752 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040934, HPA041068" Supported Enhanced Nucleoplasm,Cytosol NA NA 8500 Nucleoplasm Cytosol "HPA040934: AB_10795495, HPA041068: AB_10796567" "unprognostic (8.02e-3)" "unprognostic (3.68e-3)" "unprognostic (3.11e-2)" "unprognostic (1.91e-1)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (9.37e-2)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (2.93e-1)" "unprognostic (1.68e-2)" "unprognostic (1.53e-1)" "unprognostic (9.14e-2)" "unprognostic (3.00e-3)" "unprognostic (1.19e-1)" "unprognostic (5.90e-2)" "prognostic favorable (2.23e-4)" 12.0 8.2 8.6 14.5 16.9 8.5 18.2 25.6 13.9 8.9 9.6 14.7 9.8 11.5 12.8 6.0 11.8 10.4 6.5 8.2 9.3 7.6 9.2 10.9 19.9 14.1 16.5 5.2 14.6 12.5 10.4 45.4 15.4 13.9 9.7 7.2 10.8 11.8 10.4 14.1 13.5 11.5 8.5 26.0 16.0 11.5 14.5 12.4 17.5 10.5 9.3 11.5 10.3 24.0 5.2 6.8 6.2 3.7 5.2 5.6 1.2 8.8 13.8 8.6 12.2 4.8 3.0 8.8 7.1 4.0 6.7 4.5 9.8 9.9 18.7 5.3 4.8 4.1 15.4 3.8 10.1 4.3 11.5 6.1 13.3 8.4 7.4 4.2 12.6 14.2 5.1 2.8 6.2 4.9 3.6 5.4 11.6 12.8 7.1 4.3 15.4 14.2 21.3 12.8 6.0 4.7 22.4 7.4 8.4 5.0 14.5 10.5 14.9 10.8 9.1 5.3 4.4 9.5 10.2 9.5 9.1 8.9 5.8 9.9 9.3 7.5 16.7 7.1 10.3 12.9 4.6 2.2 3.2 5.5 3.7 5.6 5.2 4.9 5.5 2.9 5.1 4.3 4.8 6.2 5.2 3.5 6.8 3.1 1.2 8.6 16.9 25.6 13.9 9.3 7.6 16.5 5.2 13.9 12.4 3.0 13.3 13.6 5.5 19.8 24.1 11.2 25.5 12.0 12.5 19.2 13.7 5.7 8.3 9.9 11.9 13.0 15.8 23.3 10.1 5.8 13.5 7.5 11.6 11.9 10.9 15.9 18.4 17.2 27.8 5.4 15.5 14.8 6.8 13.6 20.6 17.4 10.3 16.7 9.2 7.0 23.0 6.5 10.2 13.0 9.2 19.6 7.2 14.4 14.9 6.7 ZC3H7A "FLJ20318, HSPC055, ZC3H7, ZC3HDC7" ENSG00000122299 "Zinc finger CCCH-type containing 7A" Q8IWR0 16 11750586-11797267 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040808, HPA059849" Supported Cytosol NA NA Cytosol "HPA040808: AB_10794150, HPA059849: AB_2684141" "unprognostic (2.82e-1)" "unprognostic (1.15e-1)" "unprognostic (1.45e-1)" "unprognostic (2.07e-1)" "unprognostic (5.64e-2)" "unprognostic (2.07e-2)" "unprognostic (5.75e-2)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (9.16e-2)" "unprognostic (1.44e-1)" "unprognostic (2.27e-2)" "unprognostic (7.27e-3)" "unprognostic (6.00e-2)" "unprognostic (1.05e-2)" "unprognostic (1.50e-2)" "unprognostic (3.55e-2)" 22.9 19.6 18.3 16.6 18.8 27.3 21.2 25.6 19.1 19.2 18.4 18.4 21.4 14.2 24.4 17.0 13.5 19.2 17.5 15.8 16.9 11.9 19.4 18.0 23.6 21.7 19.0 16.6 25.5 21.3 25.4 20.2 21.3 16.8 20.8 16.5 23.1 22.6 22.5 32.9 15.1 19.1 25.6 18.1 23.3 17.9 8.9 19.3 32.9 23.5 13.5 21.8 20.7 17.1 12.8 10.5 16.0 23.5 17.5 19.2 7.1 13.5 7.0 24.6 13.4 17.2 17.2 9.9 21.8 21.9 16.6 20.5 7.7 11.9 19.0 13.7 25.8 10.6 8.8 13.8 21.1 24.0 14.9 15.8 8.2 14.2 12.9 24.5 18.7 18.0 19.4 11.8 15.5 29.4 19.4 20.7 17.4 13.3 17.2 23.9 10.6 14.1 9.5 14.4 9.4 6.4 20.6 13.8 13.5 15.5 10.5 18.9 15.0 17.6 17.0 21.7 15.3 12.4 12.3 19.5 19.4 11.9 26.1 14.6 13.8 10.4 28.3 14.2 14.0 49.7 12.3 10.7 16.0 12.5 14.4 17.1 12.8 16.1 13.3 10.5 12.2 19.2 13.4 13.3 17.5 23.5 8.4 19.0 7.1 18.3 18.8 25.6 19.1 16.9 11.9 19.0 16.6 16.8 19.3 59.6 31.3 29.2 13.0 13.4 27.9 35.0 12.7 41.5 44.3 14.0 51.1 13.1 13.3 15.2 2.6 30.8 15.1 0.0 19.7 12.6 18.4 17.4 17.4 17.4 12.4 50.9 20.1 31.9 39.2 3.1 30.2 26.3 18.6 29.7 23.1 26.0 19.5 18.6 33.6 12.8 48.6 19.4 20.6 16.7 8.8 13.8 6.3 27.3 16.0 14.2 ZC3H7B "DKFZp434K0920, FLJ13787, KIAA1031, RoXaN" ENSG00000100403 "Zinc finger CCCH-type containing 7B" Q9UGR2 22 41301522-41360147 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001784, HPA076092" Uncertain Uncertain Cytosol NA NA Cytosol "HPA001784: AB_1080637, HPA076092: " "unprognostic (1.71e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-2)" "unprognostic (3.53e-2)" "unprognostic (3.35e-2)" "unprognostic (5.66e-2)" "unprognostic (3.73e-2)" "unprognostic (7.92e-2)" "unprognostic (7.12e-2)" "unprognostic (7.73e-2)" "unprognostic (1.39e-2)" "unprognostic (3.19e-1)" "prognostic favorable (5.43e-7)" "unprognostic (1.43e-2)" "unprognostic (2.92e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-1)" 21.7 31.9 31.0 14.7 24.9 10.9 13.4 30.0 45.6 17.8 13.3 24.2 13.7 18.8 19.0 11.3 15.1 21.3 14.4 17.1 30.5 20.2 21.3 29.0 18.4 14.9 24.5 27.8 34.3 23.9 41.7 21.9 14.4 29.4 18.8 10.7 20.4 32.8 22.7 17.2 15.4 19.6 16.6 21.7 19.4 16.1 9.8 28.0 13.1 37.2 9.2 11.7 14.4 11.8 1.9 1.5 0.5 0.6 1.4 1.4 0.3 22.2 12.5 16.6 10.0 15.3 13.9 19.5 25.6 27.4 21.4 16.9 13.5 9.3 12.6 31.6 35.5 12.0 15.2 14.0 24.0 11.0 28.8 23.1 11.3 15.4 17.2 20.5 21.6 9.9 17.4 13.8 18.4 22.6 18.3 23.1 10.0 22.6 7.0 18.0 22.5 16.9 11.2 11.9 16.9 9.5 26.1 10.5 14.4 18.2 16.0 10.8 8.1 23.5 14.4 12.1 12.1 9.5 14.6 46.1 21.0 22.0 6.4 15.6 12.3 6.8 12.7 17.6 10.7 18.1 0.0 0.6 0.5 1.0 0.4 1.0 1.9 1.2 1.1 0.5 1.8 1.4 0.9 0.0 1.4 0.2 1.5 0.9 0.3 31.0 24.9 30.0 45.6 30.5 20.2 24.5 27.8 29.4 28.0 11.9 20.3 13.7 10.3 6.4 20.6 8.3 22.9 12.0 18.2 21.0 17.7 7.7 6.6 13.0 0.7 16.5 13.8 0.0 11.2 7.7 10.8 15.7 8.1 35.4 10.0 39.7 32.2 20.3 10.8 2.4 30.8 7.4 11.8 16.2 13.6 7.8 16.5 5.8 27.3 16.7 22.5 19.4 12.5 1.9 5.1 5.1 5.1 8.3 16.9 13.7 ZC3HAV1 "FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2" ENSG00000105939 "Zinc finger CCCH-type containing, antiviral 1" Q7Z2W4 7 139043520-139109719 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "T-cells: 124.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047818, HPA059096" Approved Supported "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA047818: AB_10962642, HPA059096: AB_2683903" "unprognostic (1.68e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-1)" "unprognostic (1.51e-2)" "unprognostic (3.92e-1)" "unprognostic (2.61e-2)" "prognostic unfavorable (8.77e-7)" "unprognostic (5.40e-2)" "unprognostic (3.08e-1)" "unprognostic (2.55e-2)" "unprognostic (3.72e-1)" "unprognostic (5.41e-2)" "unprognostic (3.31e-3)" "prognostic favorable (6.86e-4)" "unprognostic (6.47e-2)" "unprognostic (1.99e-1)" "unprognostic (7.84e-2)" 14.3 14.8 6.8 19.8 6.6 52.6 13.8 1.6 5.6 11.2 11.5 6.7 10.8 6.9 10.0 10.9 14.2 9.5 10.4 7.0 5.4 7.2 11.2 13.1 17.2 44.4 7.5 4.0 10.6 11.0 9.8 11.4 8.5 8.6 11.2 10.2 9.3 16.9 11.5 3.8 9.5 14.8 10.8 9.0 22.6 9.6 7.8 6.9 43.9 18.2 8.8 26.1 10.8 29.0 16.3 7.0 28.8 11.9 15.6 27.9 11.8 11.4 14.2 2.0 11.8 18.8 18.1 8.6 13.0 10.0 22.8 23.5 10.2 15.0 10.1 12.3 20.8 19.7 13.1 15.9 15.5 13.0 17.9 5.9 20.1 14.4 12.6 10.8 23.3 18.7 18.4 9.9 25.9 5.8 8.5 16.9 15.3 17.0 11.4 9.7 10.9 19.2 27.2 8.0 8.8 8.7 22.8 7.1 9.8 15.6 14.5 3.7 7.5 20.1 14.2 17.3 4.8 8.3 14.6 21.3 4.9 7.1 13.3 10.7 8.7 9.1 23.8 10.9 21.8 11.5 28.8 8.2 11.9 19.4 10.6 24.6 14.3 27.9 23.5 6.4 16.3 27.3 26.4 22.1 15.6 11.9 7.0 24.2 11.8 6.8 6.6 1.6 5.6 5.4 7.2 7.5 4.0 8.6 6.9 23.8 44.5 82.7 23.7 25.4 2.1 4.4 30.6 28.1 20.5 50.6 3.9 10.5 8.3 17.4 2.2 46.7 36.0 23.3 18.3 17.5 51.6 34.7 31.2 29.9 30.5 0.0 51.0 46.1 44.1 1.2 17.3 62.3 37.1 37.9 31.3 15.0 19.2 26.4 25.1 31.0 0.7 12.9 57.9 0.7 0.7 19.4 1.9 124.6 27.3 23.0 ZC3HAV1L "C7orf39, MGC14289" ENSG00000146858 "Zinc finger CCCH-type containing, antiviral 1 like" Q96H79 7 139025706-139036029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "granulocytes: 4.6;Leydig cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "basophil: 10.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 10.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020386, HPA050741" Uncertain Enhanced Cytosol NA NA Cytosol "HPA020386: AB_2257412, HPA050741: AB_2681224" "unprognostic (1.12e-1)" "prognostic unfavorable (7.35e-4)" "unprognostic (3.07e-2)" "unprognostic (1.50e-1)" "unprognostic (6.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.62e-2)" "unprognostic (8.51e-2)" "unprognostic (3.34e-3)" "unprognostic (2.07e-1)" "unprognostic (3.44e-2)" "unprognostic (2.00e-2)" "unprognostic (1.49e-3)" "unprognostic (5.04e-2)" "unprognostic (2.88e-1)" "unprognostic (1.84e-2)" "unprognostic (3.08e-3)" 8.2 6.1 2.9 3.1 4.7 1.5 9.4 1.1 3.0 14.7 6.6 2.0 5.0 4.2 10.3 9.7 8.6 7.4 5.6 4.7 2.0 2.4 6.2 1.9 5.3 3.0 1.6 1.7 20.2 9.9 4.4 12.2 14.1 2.0 12.0 4.4 8.4 5.9 10.1 3.0 11.6 4.4 8.8 1.8 6.0 4.5 4.4 2.1 10.5 17.4 5.6 6.2 9.0 9.1 1.0 0.3 10.7 0.3 0.3 0.4 0.3 9.1 7.5 5.5 18.5 4.7 7.2 0.2 4.5 2.0 3.4 4.7 12.4 5.3 0.2 6.6 4.9 0.0 6.6 7.7 1.8 10.4 5.4 0.1 11.7 7.3 4.2 3.7 0.1 4.3 5.5 3.0 5.1 2.4 0.2 5.7 5.8 5.0 0.3 6.9 0.0 12.3 7.0 1.0 1.2 4.8 13.0 18.8 0.1 3.1 5.0 3.7 16.9 11.2 1.6 6.9 1.2 6.9 4.8 8.0 6.2 5.5 2.1 0.0 0.3 0.0 0.2 3.5 0.1 5.7 10.7 0.3 1.3 0.2 0.1 0.3 0.6 0.4 0.4 0.2 1.0 0.3 0.4 0.8 0.3 0.1 0.3 0.3 0.3 2.9 4.7 1.1 3.0 2.0 2.4 1.6 1.7 2.0 2.1 0.0 0.0 0.0 0.7 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.5 0.8 0.5 4.6 0.0 0.7 0.0 0.0 0.0 0.8 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.2 0.0 1.4 0.3 0.0 0.0 1.4 0.0 0.6 0.9 0.6 0.0 0.0 0.4 ZCCHC11 "KIAA0191, PAPD3, TUT4" ENSG00000134744 "Zinc finger CCHC-type containing 11" Q5TAX3 1 52408282-52553487 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 229.7;Horizontal cells: 198.6;Rod photoreceptor cells: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027412, HPA027973" Supported Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA027412: AB_1852281, HPA027973: AB_10603242" "unprognostic (2.74e-2)" "unprognostic (1.67e-2)" "unprognostic (1.19e-2)" "unprognostic (3.48e-2)" "unprognostic (1.36e-2)" "unprognostic (1.85e-3)" "prognostic unfavorable (9.00e-4)" "unprognostic (2.64e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-1)" "unprognostic (6.57e-3)" "unprognostic (3.11e-2)" "unprognostic (5.35e-3)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" 13.8 19.1 18.4 25.6 19.0 20.5 18.7 50.9 21.3 22.4 13.3 11.8 16.1 7.7 22.1 22.0 11.5 16.8 14.0 13.5 17.8 16.5 14.2 17.7 13.3 27.4 15.4 14.6 28.3 17.6 34.4 56.0 18.8 16.3 16.1 10.5 12.1 12.6 20.6 44.6 28.1 17.1 20.3 26.6 20.9 12.3 24.9 21.1 31.9 23.9 14.6 25.1 18.3 17.0 23.2 26.0 26.7 4.3 10.3 15.0 2.2 10.3 9.8 24.2 16.3 9.5 12.2 16.8 9.2 13.5 13.4 15.6 10.1 5.4 22.1 10.9 12.8 21.8 8.6 18.1 9.8 17.2 18.0 16.5 23.3 12.7 21.0 15.8 25.2 13.3 14.4 21.7 14.4 17.9 17.1 9.3 15.5 18.9 11.1 11.2 0.1 25.1 18.0 17.5 5.3 12.5 22.3 24.6 17.3 14.5 8.6 13.0 12.9 14.2 6.1 13.8 28.7 8.4 13.2 7.8 10.5 14.2 9.6 11.2 24.3 31.9 31.8 6.9 13.8 7.6 26.7 4.3 13.8 11.8 1.7 8.8 19.1 12.4 9.5 2.1 23.2 15.0 9.9 16.2 10.3 1.4 26.0 9.3 2.2 18.4 19.0 50.9 21.3 17.8 16.5 15.4 14.6 16.3 21.1 56.6 47.0 71.8 47.7 40.9 133.4 0.0 45.9 66.9 56.9 0.0 229.7 39.6 0.0 0.0 48.0 31.6 5.9 0.0 0.0 15.9 34.0 45.0 55.6 29.2 14.9 198.6 35.3 38.1 14.9 22.9 59.2 16.4 16.9 0.0 15.8 50.0 0.0 12.2 57.3 0.0 193.4 19.4 28.8 108.0 77.6 44.5 30.9 55.4 16.1 36.0 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523007-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 99.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 114.5;Late spermatids: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 12.6 5.0 6.8 7.0 7.5 22.8 16.0 8.0 6.8 7.5 8.5 6.0 5.3 6.8 6.9 7.1 6.5 7.4 9.0 8.5 5.3 5.7 5.8 23.0 10.1 7.6 8.1 5.7 8.8 6.3 7.8 8.5 8.2 5.5 8.1 5.8 4.5 99.1 5.9 16.8 11.3 7.5 7.6 5.6 8.9 6.5 13.4 8.9 10.8 7.8 4.3 6.4 11.0 19.3 1.6 1.0 4.9 1.6 0.6 2.0 0.4 6.0 5.2 4.5 8.9 13.8 5.9 8.6 3.4 5.2 8.3 8.3 2.8 3.7 17.0 4.6 5.7 6.8 10.2 14.5 7.6 3.4 11.7 6.8 4.4 12.1 19.0 4.7 8.5 6.5 5.8 9.9 5.2 9.8 6.0 15.5 7.7 4.7 5.7 2.7 4.9 5.5 3.6 2.9 4.4 5.2 7.4 4.8 0.1 5.7 6.1 5.7 3.5 5.8 13.1 5.1 8.5 4.6 6.8 6.6 8.1 5.6 3.2 4.9 2.2 4.3 7.3 6.1 3.6 3.0 0.0 1.0 2.4 1.7 1.6 1.2 0.5 1.1 1.5 0.3 1.6 2.0 1.3 4.9 0.6 0.3 1.0 1.2 0.4 6.8 7.5 8.0 6.8 5.3 5.7 8.1 5.7 5.5 8.9 23.8 19.7 4.2 13.1 23.7 27.6 18.8 15.3 9.4 14.8 15.7 51.1 6.3 3.3 5.4 114.5 20.9 7.7 0.0 5.3 10.1 7.6 13.8 2.3 28.0 12.5 41.3 12.1 17.8 39.8 110.8 7.5 21.1 6.8 4.6 13.2 9.2 4.8 10.5 7.4 4.3 19.1 6.5 15.3 11.5 6.6 16.2 5.7 7.5 10.3 10.5 ZCCHC6 "FLJ13409, KIAA1711, PAPD6, TUT7" ENSG00000083223 "Zinc finger CCHC-type containing 6" Q5VYS8 9 86287733-86354454 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Group enriched" "Detected in all" 5 "granulocytes: 42.1;monocytes: 15.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020615, HPA020620" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020615: AB_1858983, HPA020620: AB_1858984" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (3.66e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-2)" "unprognostic (2.49e-2)" "unprognostic (4.43e-2)" "unprognostic (6.51e-2)" "unprognostic (1.91e-2)" "unprognostic (3.07e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (1.40e-1)" 11.2 9.3 7.7 22.6 11.2 17.0 17.3 9.7 13.7 10.8 13.5 5.6 12.8 9.4 8.6 8.1 23.1 8.3 10.3 10.1 9.4 5.2 7.4 33.1 16.3 19.5 9.8 5.1 9.0 12.9 9.2 18.6 33.3 9.0 19.3 10.8 4.5 14.0 13.6 12.5 30.9 15.6 9.7 13.6 22.2 11.7 10.3 10.7 23.3 8.7 15.2 16.9 13.7 14.3 4.4 4.3 42.1 15.7 4.5 5.7 2.9 9.9 10.8 6.4 9.3 16.5 25.1 7.9 13.6 13.3 6.0 7.0 4.9 8.9 14.2 12.4 9.0 6.2 17.6 7.6 7.7 9.0 16.6 4.1 10.2 11.5 9.1 14.0 11.6 14.9 16.6 16.1 9.6 11.4 9.5 10.1 7.9 9.6 15.4 16.8 10.7 9.7 7.0 5.2 17.2 7.3 4.9 11.2 6.5 10.7 19.6 4.7 3.7 8.3 11.0 4.7 8.2 4.1 5.3 15.5 5.8 7.0 10.2 9.3 17.8 13.9 10.6 13.8 7.0 7.6 11.5 7.1 7.1 5.7 9.1 4.9 4.4 3.2 4.1 4.3 4.4 3.7 4.0 42.1 4.5 15.7 2.0 3.0 2.9 7.7 11.2 9.7 13.7 9.4 5.2 9.8 5.1 9.0 10.7 59.6 30.7 5.3 28.7 28.0 13.1 0.0 12.7 26.8 37.5 0.0 17.7 18.4 0.0 0.0 77.5 14.4 23.4 0.0 0.0 14.3 9.9 42.1 45.1 45.3 20.1 17.5 16.0 17.2 62.4 17.6 15.8 40.3 30.4 0.0 18.3 11.4 0.0 20.7 12.4 0.0 14.9 12.9 10.3 19.8 7.8 35.4 77.3 27.7 17.7 54.5 ZCCHC7 "AIR1, FLJ22611" ENSG00000147905 "Zinc finger CCHC-type containing 7" Q8N3Z6 9 37120539-37358149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020600, HPA021088, HPA029522" Uncertain Enhanced Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029" "unprognostic (1.19e-3)" "unprognostic (1.21e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (7.21e-3)" "unprognostic (2.78e-1)" "unprognostic (4.27e-3)" "unprognostic (3.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.29e-2)" "unprognostic (7.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.58e-2)" "unprognostic (8.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.04e-2)" "unprognostic (5.49e-2)" 15.2 12.7 9.9 28.4 11.3 16.2 16.8 16.5 12.1 16.1 13.4 10.2 20.0 11.3 19.2 14.9 11.5 13.1 12.4 10.2 10.1 10.3 10.0 11.1 10.9 27.5 11.8 8.4 21.9 19.8 8.6 30.7 10.2 11.2 13.5 14.2 9.8 14.3 19.2 9.9 12.7 13.9 14.0 11.8 18.4 11.8 14.3 12.4 19.9 16.1 12.3 29.3 19.2 12.9 29.7 7.5 10.9 8.5 10.1 11.4 5.2 7.4 5.0 7.0 7.5 7.3 11.4 6.5 7.3 8.5 5.7 7.8 5.0 3.6 26.4 4.0 5.7 6.7 3.1 6.7 6.9 8.2 12.1 4.7 7.5 8.2 4.3 11.4 12.9 7.5 7.8 10.8 5.9 23.3 10.9 6.5 9.8 20.6 9.2 5.1 3.5 9.9 7.2 7.4 8.1 7.5 48.0 4.7 6.7 7.1 2.9 7.9 5.7 5.2 6.3 6.7 7.2 4.5 8.4 5.8 4.2 5.3 6.0 4.4 3.1 5.8 31.5 6.8 8.4 7.7 4.7 4.4 10.9 7.8 5.0 7.7 18.1 8.9 8.8 4.0 29.7 11.4 10.4 8.8 10.1 8.5 7.5 7.4 5.2 9.9 11.3 16.5 12.1 10.1 10.3 11.8 8.4 11.2 12.4 32.8 14.4 78.3 25.6 25.1 15.3 9.3 5.1 24.1 20.5 5.2 9.8 13.5 23.2 14.0 40.8 19.1 9.7 0.0 13.7 21.8 25.2 22.7 23.1 10.6 14.4 11.1 18.3 15.4 13.0 15.6 25.0 16.4 15.1 9.0 19.9 18.5 12.5 14.4 18.4 15.4 23.6 6.5 21.7 45.1 42.1 28.5 15.6 27.7 19.5 19.2 ZDBF2 "FLJ45338, KIAA1571, Slx9" ENSG00000204186 "Zinc finger DBF-type containing 2" Q9HCK1 2 206274663-206314428 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SuSa: 13.4" "Low region specificity" "Detected in many" "HPA039121, HPA050311" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039121: AB_2676357, HPA050311: AB_2681081" "unprognostic (8.32e-2)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "unprognostic (2.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.52e-2)" "unprognostic (2.01e-1)" "unprognostic (2.98e-1)" "unprognostic (7.73e-3)" "unprognostic (7.59e-2)" "unprognostic (4.41e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (9.59e-2)" "unprognostic (3.08e-1)" "unprognostic (3.09e-1)" "unprognostic (1.40e-1)" 4.4 12.0 8.6 3.5 26.9 2.2 4.2 14.7 12.7 5.4 3.7 2.1 5.1 2.0 7.2 6.1 3.1 5.1 4.4 4.5 8.9 8.3 4.9 3.6 3.2 3.8 3.7 10.8 14.8 8.3 5.6 20.9 7.5 9.0 4.7 2.6 3.8 3.7 5.3 5.4 3.9 3.0 5.1 4.0 4.2 3.4 5.4 3.1 2.5 6.5 2.9 3.3 3.7 3.5 0.7 0.5 0.3 0.0 0.3 1.4 0.2 1.7 0.3 6.0 1.1 2.0 1.8 8.4 1.7 2.0 0.8 1.2 0.9 1.4 0.0 0.8 2.1 3.5 0.4 3.8 1.3 1.6 2.1 3.6 0.0 3.4 0.2 2.6 1.8 3.8 1.8 2.1 1.5 3.6 6.1 2.2 1.4 0.3 2.3 2.6 0.3 0.4 0.0 8.1 0.1 1.7 0.0 6.2 0.0 1.0 0.9 3.1 7.5 3.0 0.0 2.4 13.4 0.2 0.0 3.3 0.7 2.9 0.7 1.3 5.4 1.3 0.3 4.2 0.0 2.0 0.3 0.0 0.0 0.3 0.0 0.9 0.5 1.0 0.6 0.0 0.7 1.1 0.7 0.0 0.3 0.0 0.5 1.4 0.2 8.6 26.9 14.7 12.7 8.9 8.3 3.7 10.8 9.0 3.1 3.0 3.8 0.5 1.6 3.5 24.3 7.6 2.5 13.4 5.7 10.4 13.7 3.9 0.0 2.3 2.8 3.6 0.7 0.0 1.9 5.9 4.8 3.0 12.7 2.0 0.4 7.9 7.5 3.7 0.3 4.2 4.0 0.0 1.7 0.0 1.1 9.7 1.7 0.0 4.9 1.7 16.8 0.0 13.7 4.7 8.0 2.9 7.6 1.3 0.4 0.9 ZDHHC1 "C16orf1, HSU90653, ZNF377" ENSG00000159714 "Zinc finger DHHC-type containing 1" Q8WTX9 16 67394419-67416833 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 24.6;Late spermatids: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 2.6;intermediate monocyte: 3.6;myeloid DC: 2.4;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;monocytes: 3.6" "Cell line enhanced" "Detected in many" "ASC diff: 13.6;ASC TERT1: 15.1;U-138 MG: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042531, HPA048659" Uncertain Approved Cytosol NA NA Cytosol "HPA042531: AB_2678041, HPA048659: AB_2680483" "unprognostic (8.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.05e-3)" "prognostic favorable (1.25e-6)" "unprognostic (1.68e-2)" "unprognostic (9.33e-2)" "unprognostic (6.03e-2)" "unprognostic (1.82e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" "prognostic favorable (5.99e-4)" "unprognostic (2.17e-1)" "prognostic favorable (1.55e-6)" "unprognostic (2.10e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (5.63e-3)" 9.6 6.3 4.3 3.9 6.6 0.5 10.2 5.3 10.5 16.9 7.4 5.5 7.9 3.8 13.5 16.4 6.3 22.6 14.0 6.2 4.5 3.7 11.2 3.8 7.8 4.9 5.3 3.5 17.1 16.2 11.5 14.0 15.1 6.5 11.6 3.2 11.2 14.7 12.1 8.0 10.8 3.9 9.3 3.3 10.1 6.2 25.7 2.6 0.6 31.3 9.3 4.9 6.9 9.7 0.0 2.4 0.3 3.6 0.0 0.0 0.8 5.1 6.2 1.5 8.2 13.6 15.1 0.0 2.9 11.1 2.9 3.5 0.0 3.2 0.0 1.3 5.2 3.0 3.3 0.5 0.5 0.6 1.6 4.7 0.4 0.1 0.4 6.9 0.3 4.3 7.2 6.4 3.2 0.9 6.9 3.8 0.0 0.0 0.0 2.0 0.5 0.0 0.0 3.0 2.0 0.1 0.0 0.1 0.0 4.2 3.1 2.2 7.5 0.5 0.2 6.7 0.6 2.1 1.2 5.0 13.1 2.1 6.3 3.5 1.5 0.3 0.0 8.0 0.1 5.4 0.0 2.6 0.0 0.0 3.6 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.8 4.3 6.6 5.3 10.5 4.5 3.7 5.3 3.5 6.5 2.6 0.0 0.0 0.0 5.5 6.4 2.4 0.8 15.3 1.4 1.2 7.0 3.9 1.4 8.3 2.9 24.6 4.5 2.1 0.0 3.4 0.1 6.6 6.0 0.0 1.6 2.0 3.2 8.6 7.4 15.2 44.2 13.6 1.3 5.0 0.0 12.5 8.3 2.2 3.5 10.3 5.1 0.3 0.0 6.4 8.7 5.1 6.1 4.8 0.0 6.2 4.4 ZDHHC15 "DHHC15, FLJ31812, MRX91" ENSG00000102383 "Zinc finger DHHC-type containing 15" Q96MV8 X 75368427-75523502 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Cardiomyocytes: 6.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 5.7;K-562: 3.6;LHCN-M2: 4.0;MOLT-4: 4.2;NTERA-2: 3.7;RH-30: 5.8;RPTEC TERT1: 3.2;SH-SY5Y: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003618 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA003618: AB_2217686" "unprognostic (8.28e-2)" "unprognostic (1.73e-1)" "unprognostic (8.05e-2)" "unprognostic (1.62e-5)" "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (4.00e-4)" "unprognostic (1.96e-2)" "unprognostic (3.19e-1)" "unprognostic (8.70e-2)" "unprognostic (3.77e-3)" "unprognostic (1.40e-1)" "unprognostic (4.78e-13)" "unprognostic (2.60e-3)" "unprognostic (1.17e-2)" "unprognostic (1.09e-1)" "unprognostic (9.67e-4)" 3.0 5.4 4.9 1.5 6.8 1.1 5.3 6.2 9.9 5.8 3.4 3.9 2.4 1.3 6.5 3.7 3.2 4.5 3.3 5.4 5.9 8.7 5.3 1.2 4.1 1.6 4.8 5.3 8.5 4.7 5.0 8.7 0.7 7.0 4.0 2.3 5.4 12.7 6.9 1.6 2.8 1.8 5.2 6.4 2.9 2.1 2.6 3.1 2.0 6.6 2.1 1.5 2.6 3.1 0.3 0.4 0.7 0.2 0.5 1.6 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 3.6 0.1 4.0 0.0 4.2 0.1 3.7 0.0 0.0 0.0 5.8 0.0 3.2 0.0 1.6 4.8 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.5 1.0 0.0 0.7 2.9 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.1 0.3 0.6 0.0 0.0 0.2 1.6 1.1 0.7 0.5 0.1 0.4 0.0 0.3 4.9 6.8 6.2 9.6 5.9 8.7 4.8 5.3 7.0 3.1 6.0 1.9 0.0 1.4 3.5 3.7 6.9 2.5 0.0 2.3 5.2 3.9 0.0 0.0 0.7 0.0 2.1 0.0 0.0 0.6 0.0 0.9 1.0 1.1 0.0 0.1 0.0 1.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.3 0.3 0.0 3.5 1.0 2.1 6.5 1.4 0.1 0.4 3.1 0.0 0.0 0.0 0.3 ZDHHC16 APH2 ENSG00000171307 "Zinc finger DHHC-type containing 16" Q969W1 10 97446131-97457370 "Enzymes, Predicted membrane proteins" "Apoptosis, DNA damage" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039893, HPA040214" Uncertain Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039893: AB_10794757, HPA040214: AB_2676886" "unprognostic (4.44e-2)" "unprognostic (3.14e-2)" "unprognostic (3.34e-1)" "unprognostic (1.20e-2)" "unprognostic (8.75e-2)" "unprognostic (8.35e-3)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (6.34e-2)" "unprognostic (1.93e-3)" "unprognostic (1.34e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-1)" 12.0 13.7 15.9 10.8 17.3 6.4 17.9 17.6 24.6 17.1 17.9 15.6 18.1 15.1 15.5 21.2 17.6 11.5 14.4 18.1 13.2 11.0 23.3 37.4 20.8 11.1 10.9 13.0 15.1 22.5 21.8 15.4 30.7 10.5 16.0 18.9 18.1 28.5 14.1 20.7 14.0 15.7 17.6 8.5 13.2 19.4 16.4 10.8 14.7 19.6 15.4 16.1 15.1 20.0 9.3 14.2 9.4 10.4 13.0 12.0 5.8 21.7 25.5 17.0 21.0 27.3 18.7 17.8 23.9 31.9 27.6 26.5 19.8 19.5 19.2 27.6 34.9 24.2 25.6 21.4 33.8 24.7 19.0 24.8 12.2 17.9 18.8 21.9 14.4 17.9 20.9 22.4 32.3 23.3 30.0 28.3 17.8 9.7 14.6 35.0 20.7 21.8 19.8 13.9 19.8 22.2 15.0 17.3 17.6 23.4 10.1 8.3 11.8 14.6 15.1 12.9 17.7 19.9 14.2 17.3 17.4 16.2 11.2 27.9 14.0 22.6 11.8 20.1 22.5 9.1 0.3 9.8 9.4 7.0 10.4 8.0 8.2 12.0 11.1 14.2 9.3 9.9 9.8 0.5 13.0 10.4 10.9 9.4 5.8 15.9 17.3 17.6 24.6 13.2 11.0 10.9 13.0 10.5 10.8 17.9 17.2 14.5 15.7 4.6 15.1 9.7 15.3 6.7 27.3 12.2 3.9 35.3 21.6 31.3 20.3 9.2 12.9 0.0 28.4 55.1 10.0 16.3 6.9 15.8 21.8 12.7 6.9 8.0 7.3 5.7 8.1 7.5 3.3 24.4 16.7 10.4 30.7 10.5 3.5 17.8 10.6 6.5 4.9 16.1 12.7 3.8 31.7 7.5 17.9 14.1 ZDHHC21 "DHHC21, DNZ1, HSPC097" ENSG00000175893 "Zinc finger DHHC-type containing 21" Q8IVQ6 9 14611071-14693471 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065254 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA065254: AB_2685446" "unprognostic (2.95e-2)" "unprognostic (1.45e-1)" "unprognostic (2.06e-2)" "unprognostic (2.01e-1)" "unprognostic (4.19e-2)" "unprognostic (2.58e-2)" "unprognostic (2.81e-2)" "unprognostic (1.13e-2)" "unprognostic (2.18e-2)" "unprognostic (8.37e-2)" "unprognostic (9.79e-3)" "unprognostic (3.97e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (8.87e-2)" "prognostic favorable (9.28e-6)" 6.5 10.8 15.9 7.9 16.8 4.2 11.6 29.0 22.6 7.8 8.5 9.3 3.8 12.2 9.8 11.7 14.4 7.5 6.7 9.0 13.8 10.4 9.4 4.8 9.2 11.1 9.4 16.5 10.0 8.4 11.5 22.2 7.8 14.8 10.0 9.9 6.6 8.3 7.4 7.7 15.7 12.6 7.7 9.9 9.5 7.9 7.3 9.7 4.7 11.3 9.9 10.7 7.7 11.3 5.2 1.4 0.5 0.8 2.8 1.7 0.6 5.4 2.8 5.6 3.6 0.9 1.0 4.3 7.0 2.2 2.5 2.9 1.4 2.6 5.4 1.7 4.9 3.1 3.6 3.8 2.3 3.6 10.8 2.9 23.0 6.1 2.7 3.0 4.0 7.7 1.9 5.3 2.9 1.9 4.6 14.6 2.2 1.9 0.6 4.4 3.0 0.9 3.9 3.9 2.3 5.3 0.0 2.6 2.7 7.7 6.1 3.4 9.1 3.2 4.0 2.1 4.4 5.0 6.6 10.3 1.8 2.7 1.8 6.4 2.3 4.2 0.0 3.8 0.2 1.8 0.5 0.4 0.1 1.2 0.8 1.3 5.2 1.2 1.1 0.2 3.5 0.8 1.2 0.0 2.8 0.6 1.4 1.7 0.6 15.9 16.8 29.0 22.6 13.8 10.4 9.4 16.5 14.8 9.7 20.8 17.9 23.9 7.6 8.5 42.8 16.2 20.4 10.7 22.7 41.8 41.2 7.1 5.0 13.7 4.0 14.8 33.7 0.0 15.6 5.4 9.4 16.4 10.4 6.8 9.6 35.0 15.0 30.7 15.1 4.5 17.8 11.7 1.7 12.6 13.4 75.7 25.7 10.5 29.4 7.9 50.3 6.5 11.3 14.6 16.1 17.6 6.4 10.2 10.2 13.2 ZDHHC24 ENSG00000174165 "Zinc finger DHHC-type containing 24" Q6UX98 11 66520637-66546238 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016619 Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA016619: AB_2288672" "unprognostic (2.77e-1)" "unprognostic (2.51e-1)" "unprognostic (2.52e-1)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.28e-4)" "unprognostic (8.76e-2)" "unprognostic (7.74e-3)" "unprognostic (7.11e-2)" "unprognostic (6.20e-2)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (1.48e-1)" "unprognostic (8.10e-2)" "unprognostic (6.99e-3)" "unprognostic (3.10e-1)" "unprognostic (4.88e-1)" "unprognostic (1.35e-1)" 11.7 17.4 10.5 10.3 12.8 14.1 12.3 5.7 15.5 7.7 8.3 13.8 10.8 9.1 9.4 17.0 12.2 9.0 11.3 9.9 10.7 11.8 17.3 13.4 11.1 20.4 12.8 10.3 6.5 19.4 22.6 9.6 13.7 9.3 11.4 7.7 10.0 12.4 13.1 7.9 13.2 9.4 7.1 10.0 16.0 12.4 9.9 10.5 11.7 17.7 7.9 13.4 10.0 7.8 5.8 17.2 2.4 5.5 6.6 7.2 4.6 4.7 7.6 2.5 6.5 6.2 5.1 6.3 4.0 3.4 3.2 2.2 6.6 7.7 1.4 10.9 3.4 8.5 11.6 1.9 3.5 2.3 6.8 4.8 2.9 3.7 4.1 5.8 3.0 7.2 6.1 6.3 2.7 3.8 3.8 5.3 11.0 4.2 4.2 4.0 10.3 5.7 8.3 5.0 12.0 6.5 7.3 5.3 8.9 3.9 3.8 3.5 5.5 6.4 6.7 11.0 2.9 9.3 2.4 8.3 7.4 2.3 8.6 2.9 6.3 2.0 2.0 6.5 1.4 8.0 2.4 5.5 1.0 6.2 4.8 5.7 5.4 5.0 7.2 6.3 5.8 3.0 5.4 2.4 6.6 4.4 17.2 5.1 4.6 10.5 12.8 5.7 15.5 10.7 11.8 12.8 10.3 9.3 10.5 11.9 8.8 14.9 12.3 7.1 8.8 3.8 12.7 5.3 2.3 22.7 9.8 28.2 8.3 42.7 10.7 17.0 37.0 0.0 42.7 30.1 14.0 21.3 9.2 14.3 58.2 22.3 13.8 20.3 38.9 10.2 6.9 18.7 16.9 38.7 17.0 17.5 34.3 31.6 9.2 24.8 10.3 19.4 12.2 31.9 2.7 7.0 20.1 28.7 19.6 19.7 ZDHHC8 "KIAA1292, ZNF378" ENSG00000099904 "Zinc finger DHHC-type containing 8" Q9ULC8 22 20129456-20148007 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003422 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA003422: AB_1080640" "unprognostic (1.00e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (3.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.43e-3)" "unprognostic (9.34e-3)" "unprognostic (3.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (1.11e-1)" "unprognostic (1.02e-1)" "unprognostic (9.88e-2)" "unprognostic (9.57e-2)" 20.7 19.2 25.7 16.9 23.0 9.2 23.4 24.4 35.3 14.3 9.9 14.0 17.3 11.6 16.0 10.9 13.9 13.6 14.4 16.0 18.7 10.6 15.2 16.5 14.6 15.4 17.7 17.6 18.0 23.9 17.4 21.0 16.4 19.0 13.4 7.0 17.5 20.4 16.6 20.5 22.2 11.2 13.0 10.4 19.8 15.9 8.4 18.6 8.9 18.5 7.9 11.1 12.9 14.5 2.0 4.1 4.0 1.5 1.3 2.5 0.5 11.5 7.4 11.8 15.5 17.3 10.4 10.6 21.8 14.9 14.8 13.3 3.8 6.0 0.0 9.0 18.1 8.0 15.9 6.2 16.7 7.3 16.6 23.7 5.6 19.4 8.8 14.3 0.0 7.9 18.1 11.3 11.4 9.6 9.1 16.5 8.3 38.6 9.1 13.1 5.6 6.8 15.1 6.0 5.1 11.7 14.6 10.3 4.1 6.4 14.1 19.0 9.6 8.8 4.3 10.4 5.6 0.3 7.9 18.9 33.7 24.7 18.9 9.7 13.2 4.3 4.4 9.9 7.3 9.9 4.0 1.2 0.3 2.5 1.5 1.3 0.8 0.7 1.2 0.4 2.0 1.3 1.8 0.0 1.3 0.8 4.1 2.0 0.5 25.7 23.0 24.4 35.3 18.7 10.6 17.7 17.6 19.0 18.6 3.0 1.9 2.7 3.4 8.0 11.5 6.8 5.1 0.0 3.4 10.4 13.7 3.1 1.7 4.5 0.5 9.0 2.4 0.0 3.8 6.1 8.0 4.0 5.7 7.8 4.2 12.7 4.1 11.6 4.9 1.3 10.0 5.0 5.0 2.8 5.5 8.3 6.2 4.3 13.8 1.9 11.0 6.5 5.5 0.3 2.3 8.5 2.9 2.5 4.8 2.7 ZDHHC9 "CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380" ENSG00000188706 "Zinc finger DHHC-type containing 9" Q9Y397 X 129803288-129843909 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031814 Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA031814: AB_10610700" "prognostic unfavorable (9.77e-5)" "prognostic unfavorable (4.64e-5)" "unprognostic (2.83e-2)" "unprognostic (7.53e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (4.01e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-1)" "unprognostic (3.49e-2)" "unprognostic (9.70e-3)" "unprognostic (4.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-2)" "unprognostic (4.11e-2)" 18.2 7.3 16.7 6.7 24.7 3.2 14.2 7.8 33.9 14.1 14.7 78.3 5.1 21.1 8.4 8.4 9.8 7.9 10.4 7.4 24.1 15.2 25.4 27.0 15.6 3.0 24.9 13.9 8.0 17.4 19.6 7.1 11.5 28.4 13.4 17.3 3.8 13.2 8.3 7.4 19.7 22.2 10.4 32.7 2.4 12.8 2.8 25.3 1.2 9.6 5.7 4.3 10.8 9.4 4.6 7.8 2.6 6.8 3.4 7.6 3.3 15.0 7.9 11.4 23.0 39.4 31.1 9.3 14.9 17.1 7.2 9.0 12.5 19.7 0.5 25.5 15.9 18.6 10.2 12.8 15.0 10.4 0.8 8.0 3.0 8.3 16.4 15.6 2.0 5.4 33.7 24.4 11.7 17.4 12.6 13.5 5.0 3.2 6.1 11.5 13.1 2.8 3.7 6.1 33.8 13.7 2.7 7.3 8.8 10.4 8.4 9.0 7.6 4.2 22.1 6.9 14.0 9.4 3.3 10.9 7.3 2.5 17.1 12.0 5.7 4.0 1.8 13.1 8.3 3.6 0.0 3.3 2.6 4.8 2.9 6.1 4.6 5.8 4.7 3.7 2.7 7.6 4.3 0.0 3.4 6.8 7.8 2.5 3.3 16.7 24.7 7.8 33.9 24.1 15.2 24.9 13.9 28.4 25.3 20.8 28.7 3.0 9.8 16.6 9.1 3.5 28.1 5.3 17.0 43.6 2.0 5.0 3.3 16.9 1.1 10.3 26.8 0.0 17.0 17.3 20.5 23.0 2.3 41.5 4.4 1.6 17.3 6.7 2.1 1.3 11.2 4.6 10.1 0.0 24.9 1.2 26.6 10.5 7.1 24.6 2.4 0.0 13.7 6.1 6.0 16.8 8.6 2.5 25.5 13.6 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 626.1;Kupffer cells: 357.2;Macrophages: 271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.1;THP-1: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.5 0.0 26.9 13.7 0.0 9.2 9.4 10.4 10.1 0.0 0.2 1.7 0.0 10.0 2.8 0.1 3.8 0.0 13.0 9.6 2.6 39.1 1.6 0.0 6.1 6.7 31.1 11.2 0.2 12.9 6.2 8.8 7.8 0.0 10.9 1.1 12.2 0.0 0.0 20.5 3.2 0.0 0.5 11.5 15.5 0.0 0.1 0.2 0.2 5.9 1.1 0.0 24.3 7.5 0.0 46.5 12.1 12.0 0.2 23.3 2.9 12.7 0.0 1.9 17.9 20.2 32.2 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 6.0 25.8 45.8 1.2 22.0 178.1 50.1 2.5 6.7 18.2 5.2 3.9 1.3 1.7 0.6 2.0 23.8 0.0 23.3 0.7 1.6 146.0 1.5 150.5 2.1 126.8 626.1 0.0 81.0 357.2 4.0 111.7 271.2 97.8 46.9 0.0 84.2 0.2 0.0 62.6 7.3 8.6 181.1 167.0 2.3 7.0 17.1 3.9 99.2 0.0 2.0 ZER1 "C9orf60, Hzyg, ZYG, ZYG11BL" ENSG00000160445 "Zyg-11 related cell cycle regulator" Q7Z7L7 9 128729786-128772414 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048464 Approved Cytosol NA NA Cytosol "HPA048464: AB_2756306" "unprognostic (1.37e-1)" "prognostic favorable (1.18e-6)" "unprognostic (9.11e-3)" "unprognostic (2.36e-2)" "unprognostic (7.46e-2)" "unprognostic (9.35e-2)" "unprognostic (2.18e-1)" "unprognostic (4.81e-3)" "unprognostic (3.65e-1)" "unprognostic (4.90e-3)" "unprognostic (6.65e-3)" "unprognostic (1.69e-1)" "prognostic favorable (5.15e-11)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.14e-1)" 15.4 17.1 36.0 9.7 32.0 12.0 12.5 28.0 45.3 15.9 18.2 19.7 11.3 27.4 16.7 12.3 23.8 21.9 14.4 29.9 27.0 28.5 15.7 11.1 16.5 10.4 19.9 34.2 22.1 22.0 24.1 18.2 13.1 29.1 20.6 11.0 14.7 21.9 22.2 40.3 17.4 25.3 14.0 13.5 12.5 14.1 25.8 18.8 16.9 19.0 8.5 9.3 17.9 12.6 5.0 5.7 15.8 5.8 5.5 7.7 4.9 8.8 9.8 6.5 8.9 19.5 13.5 18.0 8.5 14.8 11.9 9.7 8.8 10.1 5.5 9.7 14.9 8.9 19.5 7.1 12.7 5.0 10.9 9.4 3.8 17.4 6.4 15.3 5.5 10.6 16.8 19.2 12.0 8.5 16.2 10.1 11.1 6.8 12.1 8.1 33.7 10.4 6.2 6.5 12.4 12.7 9.5 8.7 20.8 8.9 12.0 12.7 9.6 14.4 18.5 9.8 7.9 27.0 6.6 11.3 9.8 4.4 12.5 5.1 15.2 14.1 4.3 14.5 3.3 7.1 10.9 3.7 10.0 5.6 5.6 7.7 3.8 5.8 7.2 3.9 5.0 6.5 5.9 15.8 5.5 5.8 5.7 5.3 4.9 36.0 32.0 28.0 45.3 27.0 28.5 19.9 34.2 29.1 18.8 11.9 15.6 2.4 3.3 2.5 19.4 19.8 5.1 10.7 2.3 5.2 13.7 3.9 1.7 4.4 4.2 5.8 24.2 0.0 8.2 2.1 4.9 6.4 10.3 6.8 5.1 20.6 6.9 8.6 6.6 1.3 10.3 3.2 8.5 10.8 14.0 10.3 6.5 21.0 9.9 9.9 12.2 12.9 4.2 10.2 3.1 5.1 7.1 3.3 8.9 2.3 ZFAND1 FLJ14007 ENSG00000104231 "Zinc finger AN1-type containing 1" Q8TCF1 8 81701334-81732903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023383 Approved Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA023383: AB_1859008" "unprognostic (6.45e-2)" "unprognostic (1.48e-2)" "unprognostic (7.74e-2)" "unprognostic (8.90e-2)" "unprognostic (1.23e-1)" "unprognostic (8.04e-3)" "unprognostic (8.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (1.30e-2)" "unprognostic (3.77e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.35e-2)" "unprognostic (2.36e-2)" 18.9 17.7 12.5 10.8 23.2 14.8 25.8 24.3 25.9 22.8 19.4 8.6 16.0 16.1 21.6 17.9 19.9 20.8 14.4 14.8 12.7 15.8 19.6 26.6 16.2 13.8 14.8 16.2 35.8 35.1 16.0 31.1 12.6 27.4 23.7 18.7 10.3 23.3 18.1 16.9 13.5 20.2 23.7 16.5 17.5 20.3 10.3 13.2 19.0 42.6 16.1 17.0 26.7 21.3 18.5 20.0 6.4 13.9 17.2 25.1 16.8 19.2 6.1 8.6 7.5 11.8 23.8 8.6 11.5 15.5 10.1 13.2 6.8 15.2 18.9 13.6 8.7 11.3 13.0 9.9 16.5 15.3 15.9 9.9 10.8 10.4 8.0 21.7 13.2 7.2 19.4 39.8 7.0 69.1 17.5 12.6 18.1 16.3 27.1 10.5 12.6 16.3 9.6 2.5 40.4 19.4 11.2 7.3 8.4 12.7 17.8 8.8 5.7 8.3 5.3 18.9 10.3 17.5 9.8 8.0 7.5 11.0 10.7 15.9 10.8 6.6 11.6 8.9 1.2 5.7 6.4 13.9 3.9 11.3 10.2 19.4 18.5 18.5 15.0 20.0 13.4 25.1 18.7 1.4 17.2 11.8 11.6 21.1 16.8 12.5 23.2 24.3 25.9 12.7 15.8 14.8 16.2 27.4 13.2 23.8 31.8 35.2 67.7 85.2 26.9 16.8 43.3 10.7 26.1 24.4 3.9 30.8 87.9 21.1 2.7 39.1 10.5 46.7 43.0 38.4 35.5 55.7 34.6 19.1 26.1 22.3 22.5 24.5 42.4 2.3 36.8 31.1 47.2 22.6 34.4 13.7 30.0 28.1 28.0 54.2 12.7 32.3 63.4 18.2 18.1 68.5 27.3 52.2 30.5 52.1 ZFAND2B AIRAPL ENSG00000158552 "Zinc finger AN1-type containing 2B" Q8WV99 2 219195237-219209651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 133.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035159, HPA035160" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA035159: AB_2674499, HPA035160: AB_10670697" "unprognostic (3.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.77e-3)" "unprognostic (2.59e-1)" "unprognostic (2.97e-1)" "unprognostic (6.85e-3)" "unprognostic (1.40e-2)" "unprognostic (2.27e-1)" "unprognostic (7.36e-2)" "unprognostic (1.20e-1)" "prognostic favorable (9.38e-4)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-3)" "unprognostic (1.32e-1)" "unprognostic (6.21e-2)" "unprognostic (7.02e-2)" 13.4 12.9 16.4 14.6 16.9 23.8 13.5 22.3 24.6 14.8 30.0 20.2 15.9 30.5 15.3 14.2 22.2 13.1 22.2 11.6 16.2 13.3 20.0 28.5 15.2 27.3 18.8 17.9 14.1 29.1 18.6 18.0 22.2 15.6 14.7 18.5 11.3 17.3 14.2 15.9 23.4 34.7 24.5 17.5 22.6 21.8 9.5 13.9 23.0 30.0 12.9 19.3 14.7 16.6 29.1 20.5 36.6 27.8 30.7 32.5 25.4 10.6 7.3 8.3 11.7 8.9 9.4 11.6 10.8 12.7 15.6 15.5 16.3 9.1 8.6 11.5 18.4 12.7 7.4 7.7 13.7 12.5 13.3 12.0 19.8 12.0 14.1 18.2 10.5 22.9 7.7 30.2 15.3 36.6 8.8 10.4 19.1 11.5 24.6 15.2 18.4 17.3 22.1 4.3 14.8 8.4 10.8 5.0 14.8 14.7 9.0 18.2 8.2 5.2 8.8 12.0 9.8 7.5 22.3 11.0 15.7 14.8 18.1 15.3 10.2 3.3 15.5 15.4 20.8 12.2 17.7 21.7 28.6 32.1 27.8 28.0 25.4 29.3 31.3 16.4 29.1 26.7 32.5 36.6 30.7 21.9 20.5 30.2 25.4 16.4 16.9 22.3 24.6 16.2 13.3 18.8 17.9 15.6 13.9 20.8 26.3 36.4 21.1 24.2 13.5 11.1 25.5 8.1 9.1 19.2 13.7 22.5 48.0 34.1 3.4 27.0 133.2 0.0 57.4 20.0 23.7 23.5 32.3 35.5 29.9 7.9 38.6 14.7 29.1 5.5 29.7 26.7 33.7 13.6 57.3 20.9 46.6 94.7 28.0 57.5 14.9 25.8 33.0 5.7 13.0 31.6 42.9 46.7 47.7 24.8 ZFAND5 "ZA20D2, ZFAND5A, ZNF216" ENSG00000107372 "Zinc finger AN1-type containing 5" O76080 9 72351425-72365235 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 207.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 83.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018129, HPA077824" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA018129: AB_1859012, HPA077824: " "unprognostic (1.97e-1)" "unprognostic (5.79e-2)" "unprognostic (1.91e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.53e-1)" "unprognostic (2.24e-1)" "unprognostic (3.39e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.34e-1)" "unprognostic (2.47e-1)" "unprognostic (3.90e-2)" "unprognostic (6.85e-2)" "unprognostic (3.92e-2)" "unprognostic (3.86e-2)" "unprognostic (7.03e-2)" 82.5 57.6 26.9 15.5 35.2 36.6 57.1 31.7 34.3 28.6 23.1 20.3 31.4 10.8 25.7 35.5 29.0 27.4 28.7 33.0 24.3 22.6 32.6 56.5 31.6 23.6 24.3 21.1 59.3 20.9 17.0 45.4 22.4 25.1 24.0 15.1 22.4 17.2 52.7 207.5 17.6 15.8 28.4 25.9 24.1 23.2 26.7 21.7 14.6 23.1 29.5 16.5 39.2 29.3 7.0 13.6 15.4 32.1 8.6 6.8 7.8 22.2 22.8 26.9 11.9 34.8 16.6 20.3 26.3 36.7 14.2 11.1 2.8 21.0 12.4 16.0 41.2 20.1 24.9 62.0 10.3 21.3 83.9 9.6 9.8 13.1 13.9 25.7 14.0 14.6 21.7 19.1 14.8 16.6 33.1 25.1 12.0 9.4 16.4 16.6 5.9 18.3 8.0 34.7 20.9 15.9 14.3 14.0 13.1 46.2 21.6 19.7 17.6 16.6 18.3 21.5 29.2 8.1 12.3 19.1 11.8 14.6 20.8 18.0 23.7 20.6 6.5 15.9 9.6 29.2 15.1 13.6 15.4 5.2 21.6 5.7 7.0 6.8 6.6 13.6 6.2 6.3 5.6 12.2 8.6 32.1 2.9 4.8 7.8 26.9 35.2 31.7 34.3 24.3 22.6 24.3 21.1 25.1 21.7 163.8 158.6 37.3 496.3 301.3 88.2 288.5 91.7 88.3 127.4 125.6 70.7 117.4 126.0 118.6 62.4 115.1 102.1 46.7 122.4 145.8 149.1 300.6 109.4 271.5 176.8 38.1 131.1 95.2 243.2 35.2 109.6 177.8 197.4 297.6 71.5 51.7 193.5 79.3 87.7 95.7 65.3 84.1 204.0 123.7 99.9 254.7 189.3 64.8 81.2 398.4 ZFP28 "KIAA1431, mkr5" ENSG00000196867 "ZFP28 zinc finger protein" Q8NHY6 19 56538948-56556810 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028879 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028879: AB_10603841" "unprognostic (5.02e-3)" "unprognostic (3.67e-3)" "unprognostic (1.78e-1)" "unprognostic (1.90e-1)" "unprognostic (1.89e-1)" "unprognostic (4.24e-3)" "unprognostic (1.73e-1)" "unprognostic (7.00e-2)" "unprognostic (4.26e-3)" "unprognostic (3.16e-2)" "unprognostic (3.32e-4)" "unprognostic (1.15e-3)" "unprognostic (2.36e-5)" "unprognostic (6.77e-3)" "unprognostic (1.53e-1)" "unprognostic (1.07e-1)" "unprognostic (1.34e-1)" 3.1 3.6 4.9 1.4 4.1 0.4 3.7 6.1 7.0 3.4 2.5 1.1 5.6 4.2 2.3 3.1 3.2 3.6 5.4 5.7 3.1 0.1 3.5 1.6 5.0 10.1 2.5 6.1 4.0 2.9 4.3 1.6 2.3 4.0 1.9 2.7 1.2 4.4 5.5 2.8 2.1 5.1 4.0 1.8 2.8 2.5 3.1 1.5 3.9 0.5 2.4 3.7 0.9 0.0 1.7 7.9 2.4 2.7 2.6 4.1 5.1 4.9 4.1 6.8 0.0 1.1 0.0 2.6 6.1 8.0 0.2 3.8 1.7 6.3 0.0 6.6 5.2 0.2 0.0 7.6 0.2 6.0 7.1 2.2 6.2 0.1 8.2 0.8 2.8 1.0 0.1 5.3 0.0 2.6 0.9 3.6 0.0 1.7 4.0 10.2 0.0 5.5 3.3 0.0 7.2 0.0 0.3 1.2 7.5 3.0 5.2 1.9 3.8 4.2 0.4 6.2 0.1 0.2 0.4 0.1 0.1 0.4 0.0 0.5 3.9 0.5 0.3 2.6 1.9 2.6 1.8 1.1 3.1 2.1 1.6 0.5 2.4 0.4 1.5 3.7 0.9 8.9 2.2 0.0 2.2 5.0 7.8 3.9 0.0 2.7 2.3 5.2 3.9 0.8 6.6 2.4 2.4 3.7 0.2 0.0 0.7 0.6 2.4 2.3 3.5 0.4 0.7 9.5 2.4 2.5 0.0 1.4 3.7 1.3 5.0 1.8 0.3 5.6 1.0 1.5 4.6 2.3 5.4 0.0 4.1 3.8 5.3 3.3 0.6 1.0 0.9 1.3 ZFP3 "FLJ30726, ZNF752" ENSG00000180787 "ZFP3 zinc finger protein" Q96NJ6 17 5078248-5096374 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 13.4;Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 7.5;SH-SY5Y: 7.7;SiHa: 7.0" "Low region specificity" "Detected in all" "HPA053085, HPA057290" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA053085: AB_2682039, HPA057290: AB_2683400" "unprognostic (3.71e-2)" "prognostic favorable (5.68e-4)" "unprognostic (1.45e-1)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (3.05e-1)" "prognostic favorable (1.38e-4)" "unprognostic (5.42e-2)" "unprognostic (3.33e-1)" "prognostic favorable (1.07e-4)" "unprognostic (4.89e-2)" "prognostic favorable (7.69e-7)" "unprognostic (8.30e-2)" "unprognostic (1.16e-1)" "unprognostic (6.32e-2)" "unprognostic (3.29e-3)" 4.9 6.3 11.0 10.0 10.4 1.9 8.9 19.6 14.7 6.8 8.9 11.9 9.6 13.0 6.9 6.9 6.7 11.2 6.3 12.4 9.8 7.6 10.2 3.3 7.3 9.2 7.9 8.3 9.9 11.3 16.6 10.8 5.2 11.4 7.9 10.9 7.4 10.7 15.4 33.3 6.7 11.3 6.3 8.5 10.2 8.3 9.9 11.8 10.6 11.1 3.5 11.2 6.6 5.7 5.4 1.4 1.4 2.2 1.9 4.3 1.6 0.0 1.3 0.3 0.0 1.2 0.6 0.0 2.8 0.0 2.2 2.5 5.6 2.6 0.0 4.0 2.8 1.0 5.7 0.0 0.0 1.2 0.0 0.1 0.2 2.1 0.0 3.9 0.0 7.5 2.0 0.0 1.5 0.0 0.0 0.7 0.2 0.0 0.1 0.4 0.0 0.1 0.2 0.3 4.0 0.6 0.0 0.8 1.8 3.5 3.4 3.6 7.7 7.0 5.8 3.6 1.3 3.5 5.5 0.0 0.0 1.2 2.0 4.0 0.1 0.2 0.0 0.0 0.0 3.2 0.0 2.0 1.4 2.8 2.2 1.7 2.1 1.6 2.5 1.4 5.4 4.3 3.0 0.2 1.9 1.9 0.9 1.6 1.6 11.0 10.4 19.6 14.7 9.8 7.6 7.9 8.3 11.4 11.8 0.0 3.4 0.0 0.4 0.2 3.9 6.3 0.0 13.4 2.3 1.8 7.9 1.0 0.0 1.3 0.4 1.6 2.1 0.0 1.0 0.3 0.9 0.4 1.1 0.0 1.4 3.2 0.0 5.5 1.2 0.0 1.4 1.2 0.0 0.0 1.7 3.2 0.4 0.0 1.1 1.1 6.0 0.0 0.5 6.6 4.3 0.1 0.7 0.0 2.5 0.4 ZFP30 "KIAA0961, ZNF745" ENSG00000120784 "ZFP30 zinc finger protein" Q9Y2G7 19 37613749-37692337 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030606 Uncertain Approved Cytosol NA NA Cytosol "HPA030606: AB_10602684" "unprognostic (1.86e-2)" "unprognostic (3.00e-2)" "unprognostic (1.09e-3)" "unprognostic (3.64e-2)" "unprognostic (6.10e-3)" "unprognostic (1.14e-2)" "unprognostic (1.96e-2)" "unprognostic (1.75e-1)" "unprognostic (5.62e-3)" "unprognostic (7.03e-2)" "unprognostic (2.72e-2)" "unprognostic (5.96e-2)" "prognostic favorable (3.86e-4)" "unprognostic (3.01e-1)" "unprognostic (4.92e-2)" "unprognostic (1.24e-2)" "unprognostic (1.09e-3)" 5.0 6.6 10.2 5.4 15.3 1.7 8.3 20.0 12.3 6.1 5.5 6.5 5.5 3.8 8.5 6.9 6.0 7.4 4.6 5.3 8.0 7.1 6.0 4.1 5.4 6.4 11.2 9.4 9.4 6.3 9.5 10.7 7.5 9.6 8.0 5.0 5.0 5.3 8.0 5.2 9.3 4.9 11.3 10.9 6.6 5.3 16.5 10.6 6.1 10.8 1.9 6.4 5.9 9.2 4.3 2.0 4.9 1.3 5.8 4.0 2.1 6.6 5.7 9.6 13.5 5.2 5.1 2.9 6.9 6.4 5.2 5.6 4.7 1.1 0.0 7.1 6.2 4.2 2.5 9.5 3.6 5.3 10.1 3.7 6.6 7.2 3.6 3.9 0.9 5.1 3.8 5.7 4.5 6.9 4.2 3.0 4.7 5.0 0.1 6.7 3.0 7.1 3.4 2.0 0.8 4.0 2.9 12.5 0.1 3.2 11.1 10.7 11.6 8.1 3.2 2.5 3.9 4.3 1.8 5.8 7.1 24.0 3.3 6.9 3.7 3.8 4.3 0.0 0.0 5.3 4.9 1.2 2.8 2.8 1.3 3.7 1.3 3.1 2.4 0.9 4.3 3.8 4.0 0.9 5.8 0.4 2.0 2.3 2.1 10.2 15.3 20.0 12.3 8.0 7.1 11.2 9.4 9.6 10.6 6.0 2.6 2.7 1.2 0.7 10.9 6.3 2.5 2.7 3.4 3.5 3.9 2.1 1.7 2.4 43.5 2.8 0.9 0.0 2.0 1.2 3.0 1.7 9.2 0.9 2.0 7.9 4.1 3.7 1.6 11.7 6.9 1.1 0.0 1.8 4.2 5.2 1.6 0.0 6.0 2.1 8.0 6.5 3.1 5.9 3.3 0.4 0.7 3.1 1.7 0.7 ZFP69B "FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B" ENSG00000187801 "ZFP69 zinc finger protein B" Q9UJL9 1 40450102-40463718 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.8" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 2.9;Spermatogonia: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044289 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044289: AB_10962717" "unprognostic (2.01e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.73e-2)" "unprognostic (1.58e-1)" "unprognostic (1.36e-2)" "unprognostic (6.44e-9)" "unprognostic (2.05e-1)" "unprognostic (7.10e-2)" "unprognostic (1.02e-2)" "unprognostic (6.85e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-5)" "unprognostic (1.64e-1)" "unprognostic (8.05e-2)" "unprognostic (7.88e-2)" "unprognostic (1.89e-1)" 1.6 1.7 7.8 4.6 11.1 1.1 2.8 8.2 12.8 3.1 2.5 1.8 0.1 2.6 4.3 2.4 2.2 1.6 3.3 1.8 6.3 4.9 1.6 2.4 1.6 3.7 3.6 5.8 2.0 3.5 3.2 3.6 1.1 4.7 2.0 3.1 1.2 1.9 1.8 1.2 1.4 1.8 3.0 3.2 2.3 2.5 4.0 3.8 5.0 2.7 0.9 5.5 3.8 1.7 2.1 1.2 0.9 2.1 1.3 4.1 1.0 3.3 1.3 5.7 14.0 2.1 5.7 1.6 3.2 3.1 1.5 2.8 1.6 2.2 6.3 3.2 2.8 2.9 1.2 2.9 2.8 3.3 5.5 1.2 2.6 3.2 4.8 1.5 0.4 4.2 1.3 4.7 5.2 6.9 1.5 2.0 8.5 6.8 6.4 4.4 2.3 8.5 0.6 7.7 1.2 1.4 4.8 5.6 3.0 2.9 3.3 7.7 8.0 5.1 4.4 2.2 3.4 2.3 7.4 4.3 4.8 10.1 4.4 4.6 9.8 9.3 13.8 6.3 0.9 4.9 0.0 0.3 0.9 2.6 2.1 3.5 2.0 1.8 1.4 1.2 2.1 3.4 3.0 0.2 1.3 0.7 0.5 4.1 1.0 7.8 11.1 8.2 12.8 6.3 4.9 3.6 5.8 4.7 3.8 0.0 0.0 0.0 0.6 0.2 2.9 0.4 0.0 0.0 0.0 1.8 0.0 0.4 0.0 1.0 0.0 0.3 0.0 0.0 0.2 1.3 0.4 0.2 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.8 0.9 0.0 0.4 0.0 1.7 0.0 0.3 1.5 5.9 0.1 0.0 0.8 0.1 0.3 ZFP82 "KIAA1948, MGC45380, ZNF545" ENSG00000181007 "ZFP82 zinc finger protein" Q8N141 19 36383120-36418656 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 21.6;Horizontal cells: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051669, HPA060470" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA051669: AB_2732568, HPA060470: AB_2684290" "unprognostic (1.52e-1)" "unprognostic (2.38e-2)" "unprognostic (6.03e-2)" "unprognostic (4.14e-4)" "unprognostic (9.63e-2)" "unprognostic (9.17e-4)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (2.61e-3)" "unprognostic (4.91e-1)" "unprognostic (3.69e-2)" "unprognostic (6.00e-2)" "unprognostic (3.21e-2)" "unprognostic (3.81e-2)" "unprognostic (3.05e-1)" 4.3 5.0 9.8 8.8 9.3 1.5 8.7 15.0 13.9 9.9 5.2 5.3 2.4 2.4 9.1 12.4 2.7 9.0 5.4 7.3 8.5 9.7 5.5 1.8 4.9 7.8 8.3 6.3 13.8 2.7 8.0 10.1 7.0 8.3 7.4 3.3 3.6 4.1 6.8 2.1 2.2 3.6 7.8 6.8 6.3 3.1 6.4 8.7 9.3 10.8 1.6 8.6 5.8 6.9 9.6 3.1 1.1 1.1 4.7 9.2 2.9 0.0 2.6 8.4 8.8 2.9 3.7 2.8 3.4 4.3 7.0 9.0 1.6 1.2 7.4 5.8 4.1 5.8 0.2 0.0 0.9 8.8 6.9 4.2 6.6 1.9 2.1 6.7 0.0 5.8 5.7 1.3 5.0 1.5 0.0 3.2 9.2 0.0 0.0 6.8 0.0 11.4 0.0 7.8 0.0 1.5 9.6 5.7 2.2 3.4 4.2 0.1 8.7 0.0 0.5 5.4 8.4 1.6 5.1 0.4 2.5 4.4 4.4 5.7 5.0 3.4 11.3 0.0 0.0 5.4 0.0 0.9 1.1 6.0 1.1 6.0 9.6 5.9 6.8 2.7 9.0 9.2 8.1 0.1 4.7 1.1 3.1 3.6 2.9 9.8 9.3 15.0 13.9 8.5 9.7 8.3 6.3 8.3 8.7 0.0 8.3 1.9 2.5 0.9 19.2 3.5 2.5 8.1 3.4 5.2 21.6 6.8 8.3 4.5 4.8 4.2 0.0 0.0 1.2 5.4 4.5 1.7 5.8 0.5 3.7 31.8 2.9 2.5 1.9 1.3 5.5 3.5 5.0 1.0 0.3 9.4 1.4 0.0 7.1 4.5 10.4 19.4 4.2 10.8 6.3 0.5 1.1 4.9 1.0 0.9 ZFPM1 "FOG, FOG1, ZC2HC11A, ZNF89A" ENSG00000179588 "Zinc finger protein, FOG family member 1" Q8IX07 16 88453317-88537016 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 30.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 19.6;Cone photoreceptor cells: 27.5;Horizontal cells: 33.4;Muller glia cells: 36.6" "Cancer enhanced" "Detected in all" "stomach cancer: 12.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 14.5;K-562: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046603 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA046603: AB_2679718" "unprognostic (1.29e-1)" "unprognostic (2.42e-1)" "unprognostic (3.08e-2)" "unprognostic (3.32e-2)" "unprognostic (1.13e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-1)" "unprognostic (7.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (5.58e-2)" "unprognostic (3.05e-2)" "unprognostic (2.49e-4)" "unprognostic (1.99e-2)" "unprognostic (3.32e-1)" "unprognostic (4.89e-2)" "prognostic favorable (4.24e-4)" 4.3 3.7 3.7 7.9 2.9 12.0 2.2 6.8 3.3 2.9 11.2 1.6 4.7 18.5 3.8 4.5 2.8 3.7 30.4 4.7 3.9 3.0 2.7 15.2 5.4 5.5 2.7 1.9 7.3 24.5 1.5 5.6 1.8 2.1 7.0 1.7 7.7 6.9 7.3 2.2 3.8 15.4 1.5 2.1 12.7 21.5 12.7 0.8 15.7 3.8 1.4 9.4 4.8 2.2 0.3 0.6 1.5 0.3 0.6 1.3 0.3 1.1 2.9 2.2 4.5 0.4 0.1 9.3 3.1 0.4 1.0 0.3 9.2 1.1 4.5 2.4 0.4 1.1 7.2 0.1 2.5 0.2 3.4 1.9 14.5 5.7 8.0 1.7 0.8 4.9 1.0 1.7 1.1 0.4 1.1 1.0 1.2 21.5 0.3 0.8 5.5 5.1 5.2 1.5 7.0 2.5 1.5 1.0 2.1 1.0 3.6 6.0 10.1 3.8 0.2 3.0 1.2 2.4 2.4 3.6 3.9 2.5 1.7 0.6 1.1 0.7 0.4 1.1 1.7 3.7 0.0 0.1 1.5 0.9 0.2 0.2 0.1 0.4 1.3 0.2 0.3 0.3 0.5 0.9 0.6 0.3 0.6 0.1 0.3 3.7 2.9 6.8 3.3 3.9 3.0 2.7 1.9 2.1 0.8 3.0 2.1 0.5 4.4 0.8 19.6 11.8 7.6 0.0 0.0 1.8 27.5 0.3 1.7 1.2 0.5 1.9 5.1 0.0 4.3 0.1 2.1 2.3 0.0 5.9 0.8 33.4 5.8 4.9 4.8 0.7 0.9 0.9 1.7 0.0 6.7 36.6 2.9 4.5 1.4 1.1 17.4 0.0 1.9 0.3 0.4 1.3 0.2 0.0 4.1 1.8 ZFYVE16 "KIAA0305, PPP1R69" ENSG00000039319 "Zinc finger FYVE-type containing 16" Q7Z3T8 5 80408013-80479350 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 108.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.3" "Cell line enhanced" "Detected in all" "SK-MEL-30: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035935, HPA035936" Supported Enhanced Vesicles,Cytosol No No "Vesicles, Cytosol" "HPA035935: AB_10672076, HPA035936: AB_10669662" "unprognostic (1.11e-1)" "unprognostic (3.98e-2)" "unprognostic (1.78e-2)" "unprognostic (3.26e-1)" "unprognostic (7.19e-2)" "unprognostic (2.57e-2)" "unprognostic (7.25e-3)" "unprognostic (6.91e-2)" "unprognostic (4.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.15e-1)" "unprognostic (3.04e-1)" "unprognostic (4.64e-2)" "unprognostic (4.95e-2)" "unprognostic (6.91e-2)" "unprognostic (4.23e-2)" 10.7 11.9 11.0 10.1 28.9 6.1 11.6 14.9 19.2 21.2 9.0 33.2 7.7 6.7 17.0 6.6 9.6 9.7 14.6 17.6 11.7 9.5 13.1 13.3 11.6 6.8 25.7 16.8 16.8 7.1 13.4 15.0 16.5 37.3 11.5 8.4 9.0 8.6 9.3 12.7 6.4 8.7 12.8 26.9 11.2 8.4 11.7 21.2 3.8 12.6 4.6 5.8 12.8 10.8 2.5 2.3 17.3 3.9 2.4 1.5 0.3 5.8 6.8 12.2 11.7 7.3 7.7 8.1 9.0 7.8 8.1 10.9 5.0 6.7 4.0 6.5 7.4 8.4 6.1 8.7 7.3 8.9 2.5 5.7 4.3 9.3 5.7 6.2 1.2 3.2 8.3 4.1 6.7 6.5 6.4 9.2 3.8 4.2 6.2 8.7 7.3 2.8 1.2 2.9 2.9 3.2 5.9 25.3 4.2 6.9 11.4 4.6 10.6 12.9 6.1 42.4 7.8 8.6 4.0 8.1 4.9 5.6 7.5 7.4 1.9 3.5 4.0 6.4 4.0 10.8 11.5 3.7 1.8 1.5 2.3 0.8 2.5 0.7 1.3 1.4 2.5 0.6 0.7 17.3 2.4 3.9 2.3 0.8 0.3 11.0 28.9 14.9 19.2 11.7 9.5 25.7 16.8 37.3 21.2 23.8 20.3 13.7 11.1 16.3 81.4 44.9 5.1 53.5 40.9 29.6 108.0 16.6 8.3 13.3 3.9 24.3 16.0 0.0 10.8 9.1 22.0 16.9 9.3 14.3 23.4 76.3 20.7 36.2 49.4 4.5 35.1 47.5 18.6 9.0 11.1 33.5 13.2 20.1 41.8 10.3 75.1 32.3 29.5 32.6 20.5 22.2 31.2 13.8 11.2 15.7 ZFYVE27 "FLJ32919, SPG33" ENSG00000155256 "Zinc finger FYVE-type containing 27" Q5T4F4 10 97737121-97760907 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037523, HPA069876" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA037523: AB_10672351, HPA069876: AB_2686218" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.30e-2)" "unprognostic (2.48e-2)" "unprognostic (7.15e-2)" "unprognostic (2.05e-3)" "unprognostic (5.24e-2)" "unprognostic (3.38e-3)" "prognostic favorable (7.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.26e-2)" "prognostic favorable (7.80e-4)" 10.1 22.6 16.1 12.7 20.8 20.7 11.8 28.6 33.0 10.3 17.4 15.7 17.4 25.6 11.6 25.4 9.8 17.9 14.1 12.8 17.6 20.7 15.5 18.2 11.3 15.2 15.1 23.4 17.1 15.4 19.6 24.3 14.3 17.6 13.3 17.5 25.6 14.0 11.8 7.9 17.1 24.0 9.4 14.7 18.1 14.9 14.2 13.3 12.2 13.1 5.5 14.7 8.5 10.4 11.2 8.5 13.4 12.6 9.0 15.2 11.7 10.4 12.9 7.8 17.2 8.9 6.2 10.6 10.7 11.3 12.5 12.3 11.4 21.8 16.2 12.3 7.7 16.1 23.5 11.3 10.4 6.7 16.7 11.3 7.6 12.7 10.6 11.4 12.2 15.4 10.1 12.6 12.3 9.5 20.2 7.0 13.7 11.4 11.0 9.3 8.1 9.8 23.3 6.3 9.1 10.0 11.4 7.8 7.6 12.0 6.5 6.3 12.2 7.2 6.1 27.8 7.4 13.3 12.2 7.4 6.3 7.5 9.6 20.3 12.8 10.7 8.5 15.8 15.8 7.2 7.1 8.4 13.4 15.2 9.1 13.1 10.9 10.5 12.0 8.0 11.2 12.1 12.9 12.1 9.0 12.6 8.5 13.4 11.7 16.1 20.8 28.6 33.0 17.6 20.7 15.1 23.4 17.6 13.3 3.0 10.7 11.5 10.1 7.2 28.2 7.7 15.3 6.7 3.4 14.0 55.0 6.5 6.6 13.2 4.6 9.5 29.9 0.0 13.9 5.2 6.2 10.4 13.9 9.6 7.3 35.0 19.4 6.2 8.6 1.3 8.9 8.4 10.1 11.8 12.3 15.2 11.2 22.8 8.5 7.0 41.6 19.4 7.8 6.6 7.7 4.8 11.3 15.0 12.0 14.8 ZFYVE28 KIAA1643 ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418663 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 63.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 28.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 11.2;NB-4: 12.1;U-266/70: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: AB_2683477" "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favorable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 4.5 8.6 7.7 5.1 15.8 3.1 3.7 63.6 15.1 3.7 7.4 4.6 1.8 10.4 4.1 3.1 3.4 4.3 5.9 2.4 7.1 5.5 5.7 4.2 4.4 6.1 7.9 8.0 3.4 7.3 7.9 7.5 1.8 9.9 2.9 5.1 5.8 9.5 5.4 4.3 5.7 11.9 2.8 9.4 7.0 7.5 7.9 6.7 1.2 5.3 3.1 4.0 4.5 3.2 3.1 0.7 0.9 0.4 0.3 4.4 1.3 0.8 1.0 0.2 3.7 2.2 0.7 0.1 1.8 3.1 1.0 0.3 0.1 6.7 0.0 1.9 3.2 2.6 3.8 1.2 0.3 0.6 9.7 1.3 0.2 4.3 0.3 4.4 0.7 11.2 3.0 0.6 1.1 0.1 7.0 3.1 1.0 1.8 8.2 0.9 2.2 0.1 12.1 0.1 2.0 8.2 0.0 0.0 3.9 1.5 0.5 5.8 0.4 1.8 0.1 1.0 0.1 2.5 0.3 0.5 1.8 0.0 5.5 0.1 12.8 9.3 0.2 5.4 2.3 1.8 0.9 0.4 0.1 4.4 0.0 1.9 0.9 2.3 3.2 0.7 3.1 3.2 3.2 0.1 0.3 0.3 0.2 4.0 1.3 7.7 15.8 63.6 15.1 7.1 5.5 7.9 8.0 9.9 6.7 0.0 1.7 0.0 3.2 5.3 10.7 3.3 5.1 1.4 3.4 10.4 17.7 0.3 6.6 2.7 28.4 4.5 16.9 0.0 2.0 0.2 1.9 1.5 9.2 4.9 1.8 7.9 2.4 5.5 1.9 5.8 1.4 7.1 6.8 4.6 5.9 1.4 2.1 9.0 2.1 3.1 16.3 0.0 2.8 2.1 9.0 4.3 0.2 21.0 5.2 4.1 ZFYVE9 "MADHIP, PPP1R173, SARA, SMADIP" ENSG00000157077 "Zinc finger FYVE-type containing 9" O95405 1 52142094-52346686 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatogonia: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017702, HPA065852, HPA065862" Approved Enhanced Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB017702: AB_1128462, HPA065852: AB_2685568, HPA065862: AB_2685570" "unprognostic (5.05e-2)" "unprognostic (4.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "unprognostic (3.87e-1)" "unprognostic (2.87e-3)" "unprognostic (6.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (2.47e-2)" "unprognostic (5.36e-2)" "unprognostic (1.17e-3)" "unprognostic (2.14e-1)" "unprognostic (3.69e-1)" "unprognostic (1.99e-3)" "unprognostic (1.73e-2)" 10.2 10.0 13.6 3.8 18.4 1.0 13.0 28.4 27.7 15.5 8.0 9.5 10.1 6.8 14.1 9.1 10.8 12.2 8.1 10.4 13.8 15.7 15.2 10.7 11.3 4.1 13.8 15.8 19.5 16.9 32.3 14.6 7.4 18.7 13.6 9.9 9.6 9.8 13.8 25.5 12.3 7.4 13.3 11.6 4.2 8.6 14.9 8.0 1.5 19.5 8.8 4.2 10.9 13.8 0.4 0.0 0.0 0.0 0.2 2.1 0.4 9.8 4.7 6.8 8.7 16.7 15.0 11.1 8.1 11.1 9.7 11.1 5.5 0.8 0.0 5.0 11.5 13.4 3.6 12.0 13.0 14.9 0.0 8.2 2.8 5.4 6.5 11.1 2.5 1.7 10.1 14.8 8.4 19.2 12.0 14.0 6.7 4.3 1.8 12.9 2.2 3.5 1.8 8.8 2.7 8.3 3.1 11.6 0.9 5.5 22.2 5.7 5.9 9.0 7.8 10.4 14.3 3.6 3.3 12.9 9.8 3.9 7.4 4.8 2.5 1.5 1.2 6.9 3.1 3.9 0.0 0.0 0.0 0.3 0.0 2.1 0.3 1.6 0.4 0.0 0.4 1.3 0.7 0.0 0.2 0.0 0.0 0.0 0.4 13.6 18.4 28.4 27.7 13.8 15.7 13.8 15.8 18.7 8.0 8.9 5.1 0.0 9.7 4.5 19.7 10.9 5.1 2.7 14.8 1.8 3.9 3.5 6.6 5.2 12.6 7.9 5.6 0.0 6.4 4.8 5.2 6.5 1.1 6.8 0.4 22.3 16.8 3.7 1.2 10.3 14.1 0.5 6.8 0.0 8.1 12.2 4.3 8.2 15.6 8.2 14.1 12.9 5.8 27.1 53.7 6.5 2.4 2.1 5.2 5.7 ZGRF1 "C4orf21, FLJ11331" ENSG00000138658 "Zinc finger GRF-type containing 1" Q86YA3 4 112539333-112636995 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.0" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 19.0;Spermatocytes: 17.1;Spermatogonia: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA030704, HPA030706" Uncertain Approved Cytosol NA NA Cytosol "HPA030704: AB_2673577, HPA030706: AB_10601784" "unprognostic (8.48e-2)" "unprognostic (6.17e-2)" "unprognostic (9.51e-2)" "unprognostic (1.53e-1)" "unprognostic (1.10e-1)" "unprognostic (1.84e-3)" "unprognostic (5.83e-3)" "unprognostic (1.45e-1)" "unprognostic (5.89e-4)" "unprognostic (4.74e-2)" "unprognostic (4.30e-2)" "unprognostic (3.72e-3)" "unprognostic (7.60e-10)" "unprognostic (3.45e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (2.02e-4)" 2.5 1.8 3.3 4.9 4.8 13.8 2.8 13.8 6.5 2.5 2.4 0.5 0.1 2.6 2.6 1.5 3.0 2.1 1.3 1.5 3.1 1.0 1.6 1.6 2.7 5.0 2.5 3.3 3.2 2.2 0.9 4.5 3.5 3.5 2.1 3.1 1.1 2.7 2.3 2.9 3.0 3.2 2.1 4.2 3.8 2.6 7.3 4.1 17.0 2.7 2.2 5.8 2.1 2.5 2.5 2.8 1.3 2.9 1.1 1.6 0.4 3.7 2.7 9.4 6.6 0.7 1.3 3.6 6.7 2.8 6.8 6.1 5.2 5.6 9.8 2.0 2.0 2.8 3.0 9.7 3.5 7.8 5.3 2.5 6.1 4.3 1.6 0.3 13.7 4.1 0.6 0.4 8.5 2.3 0.9 2.7 10.5 8.7 11.1 4.6 6.1 18.3 5.0 4.9 3.9 3.3 10.3 14.0 3.3 1.2 3.3 4.4 7.4 3.0 4.1 1.2 7.2 1.9 4.0 3.2 8.6 8.4 4.5 5.3 4.2 7.3 13.1 3.9 4.7 4.8 0.0 0.6 1.3 1.0 2.9 0.6 1.3 0.5 0.2 0.1 2.5 1.6 1.6 0.9 1.1 0.7 2.8 1.0 0.4 3.3 4.8 13.8 6.5 3.1 1.0 2.5 3.3 3.5 4.1 0.0 2.2 6.4 1.2 0.0 9.0 2.0 0.0 1.4 6.8 1.8 7.9 1.9 0.0 0.8 2.3 0.7 0.7 0.0 0.4 2.7 1.4 1.0 2.3 0.4 1.5 4.8 1.2 0.0 1.0 1.4 0.6 2.6 0.0 0.0 1.1 2.0 0.5 0.9 2.1 0.3 19.0 0.0 0.8 17.1 11.5 0.0 0.7 2.2 1.2 0.4 ZHX1-C8orf76 ENSG00000259305 "ZHX1-C8orf76 readthrough" Q96EF9 8 123226189-123274284 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 9.5;Urothelial cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 24.3" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023708: AB_1845785" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.83e-3)" "unprognostic (1.13e-1)" "unprognostic (1.16e-1)" "unprognostic (2.49e-3)" "unprognostic (7.10e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-2)" "unprognostic (5.64e-11)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.06e-2)" 8.6 7.4 11.4 5.0 11.0 25.9 8.7 10.3 10.7 8.5 6.2 5.9 8.9 8.1 7.3 8.1 10.4 5.9 5.4 8.7 11.2 5.0 7.1 9.7 9.7 8.7 9.6 7.4 8.7 6.8 7.1 12.7 7.1 8.8 8.7 9.9 4.5 9.0 8.7 11.9 9.9 9.3 7.7 11.4 10.5 6.6 5.1 11.7 5.8 10.5 4.6 10.2 7.5 11.6 5.5 4.6 8.0 8.3 4.8 8.5 3.3 3.0 3.9 2.9 2.0 1.8 2.0 2.1 1.3 1.4 3.4 2.6 3.2 2.4 1.8 1.2 2.3 2.0 2.1 3.3 1.8 5.1 2.9 6.7 5.3 2.7 3.8 1.9 1.1 3.0 2.7 2.7 2.8 1.7 1.5 3.9 5.6 4.4 2.6 3.0 9.5 4.4 3.5 0.7 6.2 4.4 3.5 1.9 2.5 2.4 3.1 4.5 3.3 2.8 24.3 1.4 1.7 3.6 1.0 0.3 1.5 2.7 2.3 3.2 3.7 4.5 3.9 2.0 2.9 1.0 3.1 5.7 8.0 4.1 8.3 3.7 5.5 5.3 3.5 4.6 4.6 4.4 3.6 1.8 4.8 5.9 4.0 8.5 3.3 11.4 11.0 10.3 10.7 11.2 5.0 9.6 7.4 8.8 11.7 0.0 1.4 0.5 3.5 0.0 0.4 0.8 2.5 2.7 1.2 3.5 0.0 1.6 1.7 1.6 0.7 1.5 1.1 0.0 1.6 2.0 0.1 2.4 0.0 0.9 2.5 9.5 2.9 1.3 0.6 0.9 0.9 1.2 0.0 1.8 1.3 0.8 1.7 0.0 1.1 1.2 1.1 0.0 0.9 2.5 2.2 0.0 0.8 0.7 1.0 6.0 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406860 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 52.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 1.8;Early spermatids: 2.8;Late spermatids: 6.7;Muller glia cells: 4.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 18 "cerebellum: 52.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.7;ASC diff: 5.3;BEWO: 4.0;MCF7: 5.3;SH-SY5Y: 5.6;U-2197: 4.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 118.4" HPA030194 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030194: AB_2673367" "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.2 0.0 0.2 0.0 0.4 0.0 0.0 52.2 7.9 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 3.7 3.5 0.5 0.0 1.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.7 0.0 5.3 2.2 4.0 1.9 0.4 0.2 0.5 0.0 0.0 0.0 2.4 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.4 0.0 4.4 2.0 0.0 0.0 0.0 1.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 52.2 0.4 0.3 0.8 0.3 0.4 2.9 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ZIM2 ZNF656 ENSG00000269699 "Zinc finger imprinted 2" Q9NZV7 19 56774552-56840729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;ovary: 35.4" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 24.1;Horizontal cells: 9.5;Late spermatids: 24.5;Spermatogonia: 18.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.4;Hep G2: 9.8;NTERA-2: 2.8;RH-30: 2.9;U-2 OS: 2.1;U-266/84: 2.0" HPA071856 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA071856: AB_2686460" "unprognostic (9.01e-4)" "unprognostic (8.77e-2)" "unprognostic (5.09e-2)" "unprognostic (4.60e-2)" "unprognostic (2.45e-2)" "unprognostic (3.01e-1)" "unprognostic (2.33e-1)" "unprognostic (8.68e-3)" "unprognostic (4.12e-1)" "unprognostic (1.00e-1)" 1.6 13.1 8.5 1.6 44.0 1.4 2.5 8.2 19.1 2.2 1.7 4.8 0.0 1.6 3.2 1.2 1.7 2.8 1.4 2.6 8.1 6.5 2.0 1.7 1.4 1.5 3.0 13.7 35.4 1.5 1.8 21.1 18.3 18.2 2.0 1.5 0.1 3.7 2.0 1.3 1.4 1.8 2.2 3.9 1.7 1.5 11.4 6.1 0.0 2.2 0.0 2.0 1.9 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 44.0 8.2 19.1 8.1 6.5 3.0 13.7 18.2 6.1 0.0 0.0 0.0 0.0 0.1 3.8 0.8 0.0 0.0 0.0 0.0 0.0 4.6 1.7 0.0 24.1 0.0 0.0 0.0 0.0 0.9 0.4 0.1 0.0 0.0 0.5 9.5 0.0 0.0 0.0 24.5 1.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.4 0.0 2.4 0.0 0.0 7.5 18.3 0.1 8.2 0.0 0.0 0.0 ZKSCAN7 "FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39" ENSG00000196345 "Zinc finger with KRAB and SCAN domains 7" Q9P0L1 3 44555193-44594173 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 13.1;Late spermatids: 11.0;Spermatocytes: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 6.6;NTERA-2: 5.1;SH-SY5Y: 8.0;SuSa: 5.0" "Low region specificity" "Detected in all" "HPA048312, HPA049906, HPA071850" Uncertain Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458" "unprognostic (3.31e-2)" "unprognostic (4.49e-2)" "unprognostic (7.25e-2)" "unprognostic (5.78e-3)" "unprognostic (3.41e-2)" "unprognostic (1.21e-3)" "unprognostic (2.18e-1)" "unprognostic (2.31e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (4.22e-4)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-1)" "unprognostic (7.17e-3)" 3.4 6.0 5.7 6.3 3.9 1.9 5.3 9.9 6.1 6.1 3.9 6.0 6.1 2.0 6.9 9.5 2.9 6.4 5.3 4.8 5.6 3.9 4.5 4.6 5.1 5.1 4.4 3.4 13.0 6.7 6.8 18.2 3.4 4.1 6.6 3.5 7.2 3.7 5.8 4.3 2.2 3.8 7.2 3.9 4.8 3.7 18.6 4.4 12.1 6.0 1.9 4.8 5.5 5.9 3.7 2.5 2.0 1.2 2.4 3.4 1.2 0.0 0.0 4.6 6.6 1.3 0.7 0.0 2.2 1.9 2.3 2.7 0.0 0.1 0.1 0.8 1.5 0.8 0.0 0.0 1.4 2.9 0.0 0.0 0.2 1.4 1.7 4.1 0.0 0.0 3.2 1.5 1.3 0.0 0.0 0.6 0.1 0.0 0.1 3.5 0.0 0.0 0.0 5.1 0.0 0.0 0.0 2.1 0.0 1.3 0.6 3.1 8.0 0.1 0.2 0.0 5.0 0.0 3.1 0.7 1.4 0.5 1.8 0.0 0.2 0.1 0.0 0.3 0.0 1.1 2.0 1.2 1.6 3.4 0.5 1.0 1.3 2.1 2.6 1.0 3.7 1.6 3.2 1.6 2.4 1.1 2.5 2.1 1.2 5.7 3.9 9.9 6.1 5.6 3.9 4.4 3.4 4.1 4.4 0.0 0.3 0.0 0.6 0.1 5.0 3.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.6 13.1 0.6 0.0 0.0 0.4 0.0 0.9 0.3 0.0 1.0 0.9 3.2 2.9 0.0 0.0 11.0 0.9 0.2 0.0 1.0 0.0 4.1 0.9 0.0 2.5 0.6 4.0 0.0 0.3 9.4 3.4 0.4 0.1 0.7 0.4 0.1 ZKSCAN8 "LD5-1, ZNF192, ZSCAN40" ENSG00000198315 "Zinc finger with KRAB and SCAN domains 8" Q15776 6 28141910-28159472 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003483 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003483: AB_1080686" "unprognostic (2.02e-1)" "unprognostic (1.45e-1)" "unprognostic (3.94e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.75e-3)" "unprognostic (4.19e-2)" "unprognostic (2.24e-3)" "unprognostic (5.34e-2)" "unprognostic (9.80e-3)" "unprognostic (4.68e-3)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-2)" "unprognostic (4.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (6.33e-3)" 16.5 12.1 13.4 10.3 15.6 17.7 16.1 27.7 16.5 17.7 16.3 20.8 12.5 9.2 21.8 19.9 10.0 17.2 11.0 10.7 13.5 9.3 11.2 10.9 14.1 13.9 18.4 13.3 25.0 15.4 21.9 22.6 12.8 14.0 15.1 11.9 17.2 13.9 17.2 12.0 11.5 15.9 18.3 18.2 14.4 14.1 12.8 18.2 18.1 17.1 8.8 14.5 16.7 12.4 3.8 1.9 4.1 4.2 3.0 3.1 1.3 5.8 3.7 18.1 17.9 11.6 10.9 5.7 6.7 12.1 8.5 10.9 4.1 3.5 12.9 10.9 6.4 7.4 5.1 11.5 4.4 12.7 6.9 9.8 11.7 7.1 9.5 10.7 14.3 8.8 11.4 7.6 8.9 13.6 15.2 8.8 11.5 17.9 4.9 9.1 3.0 10.0 12.7 6.8 1.5 4.2 10.7 11.4 10.2 6.3 7.2 13.7 17.3 7.8 3.7 8.5 10.8 4.2 8.1 7.3 13.0 7.5 4.3 8.8 12.0 8.5 10.7 3.7 10.1 6.9 4.1 1.3 1.3 2.7 3.3 3.1 1.5 1.7 1.2 1.0 3.8 2.8 2.3 0.5 3.0 4.2 1.9 1.6 1.3 13.4 15.6 27.7 16.5 13.5 9.3 18.4 13.3 14.0 18.2 3.0 9.4 0.9 2.0 4.2 8.8 6.9 10.2 5.3 5.7 7.0 5.9 3.3 0.0 2.5 2.9 7.0 1.7 0.0 2.5 1.7 5.4 3.9 4.7 7.8 3.6 6.4 6.9 7.4 9.1 3.4 8.3 4.7 1.7 2.8 4.9 7.5 2.4 0.0 8.5 1.4 8.1 0.0 7.2 10.8 5.7 2.5 1.9 6.9 3.9 2.0 ZMIZ1 "FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10" ENSG00000108175 "Zinc finger MIZ-type containing 1" Q9ULJ6 10 79069035-79316528 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 174.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045144, HPA071156" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045144: AB_10962360, HPA071156: " "unprognostic (4.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.63e-1)" "unprognostic (5.59e-2)" "unprognostic (2.02e-1)" "unprognostic (2.86e-2)" "unprognostic (3.64e-3)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (1.16e-1)" "unprognostic (3.13e-2)" "unprognostic (7.90e-2)" "prognostic favorable (3.64e-7)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (8.22e-2)" "unprognostic (1.34e-2)" 24.7 21.1 15.9 15.8 18.9 20.0 24.1 43.7 35.7 41.5 21.3 23.8 26.0 16.5 42.4 18.0 28.1 22.2 35.5 25.1 19.0 17.1 17.4 13.9 23.5 13.7 22.2 15.7 44.3 20.2 14.6 12.7 18.7 22.1 21.9 13.0 33.3 24.6 26.9 38.0 24.5 21.2 25.6 16.4 36.2 21.4 8.4 21.5 16.0 33.3 22.4 16.5 25.6 30.1 1.0 4.6 5.7 6.1 5.4 2.3 1.8 7.1 9.0 17.1 7.3 17.8 5.1 5.9 6.9 12.4 4.9 2.8 2.6 3.3 3.7 5.6 16.1 12.8 10.1 2.8 5.1 2.6 7.9 1.5 13.1 3.4 7.7 12.6 7.2 27.7 6.7 5.7 7.0 5.0 31.1 7.8 3.1 5.0 19.6 4.1 13.6 7.2 11.3 5.0 4.1 13.7 32.2 3.2 3.6 3.6 6.0 17.9 26.1 4.5 54.9 14.2 6.4 17.5 7.0 10.9 18.6 7.5 9.3 8.7 3.6 6.3 0.0 24.4 12.9 3.5 1.8 3.7 2.7 2.3 6.1 1.6 1.0 1.6 1.2 4.6 0.4 0.6 1.2 5.7 5.4 5.1 4.5 1.6 1.8 15.9 18.9 43.7 19.1 19.0 17.1 22.2 15.7 22.1 21.5 35.7 24.2 15.7 8.0 20.3 45.8 47.8 22.9 18.7 18.2 15.7 0.0 6.1 6.6 17.8 40.8 38.3 20.5 0.0 21.1 4.7 23.1 10.7 48.6 8.6 34.9 60.4 13.3 62.0 35.9 174.4 26.2 39.9 23.6 13.6 15.9 13.3 18.0 20.1 22.3 7.3 3.4 19.4 18.9 1.7 2.3 20.7 3.0 8.5 13.6 10.7 ZMYM4 "KIAA0425, MYM, ZNF198L3, ZNF262" ENSG00000146463 "Zinc finger MYM-type containing 4" Q5VZL5 1 35268967-35422058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051301, HPA054802" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA051301: AB_2681431, HPA054802: AB_2682605" "unprognostic (8.95e-2)" "unprognostic (6.80e-2)" "unprognostic (1.51e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (9.75e-9)" "unprognostic (9.76e-2)" "unprognostic (4.35e-3)" "unprognostic (4.44e-2)" "unprognostic (6.70e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.18e-1)" "unprognostic (2.04e-1)" "unprognostic (9.18e-2)" "unprognostic (2.21e-1)" 16.6 15.9 17.9 17.3 22.1 13.6 19.7 28.1 24.7 22.0 14.8 17.1 18.3 10.2 19.8 18.2 15.0 17.9 15.7 13.1 17.6 19.0 15.8 14.4 14.1 15.0 15.8 14.6 27.0 15.7 26.1 22.6 19.6 22.2 21.0 13.6 18.2 18.0 26.8 15.9 12.9 12.5 16.6 15.2 16.0 15.4 36.3 13.6 26.7 21.6 13.0 18.8 17.2 14.7 4.2 9.8 3.5 8.2 9.6 4.4 2.5 12.8 10.4 32.1 16.2 9.4 20.4 11.8 15.3 23.1 18.7 24.4 11.2 12.9 23.9 9.4 19.1 9.1 8.3 22.2 11.3 27.0 13.5 15.4 29.2 12.2 9.5 17.0 25.0 13.2 15.4 10.1 18.1 17.2 15.6 20.7 13.3 31.8 6.6 22.6 7.7 21.1 13.9 26.7 6.7 10.0 23.7 20.6 11.6 13.4 17.0 18.5 18.0 18.4 13.5 20.9 21.1 10.9 19.0 24.9 17.4 18.1 7.6 16.4 7.2 13.4 18.4 12.6 19.1 16.6 2.4 5.0 3.5 4.3 7.1 4.4 4.2 4.2 3.8 4.8 3.7 4.1 3.9 1.0 9.6 8.2 9.8 3.1 2.5 17.9 22.1 28.1 24.7 17.6 19.0 15.8 14.6 22.2 13.6 11.9 15.0 11.0 16.2 10.2 27.2 29.5 35.7 22.7 22.7 26.2 29.5 12.4 5.0 19.4 48.6 21.1 5.3 0.0 20.5 10.2 15.8 19.3 13.9 16.1 11.2 22.3 21.5 17.2 18.4 69.6 24.5 13.7 5.0 13.6 13.8 20.1 18.6 9.0 21.5 9.1 33.8 19.4 15.5 22.9 10.4 9.9 11.8 11.7 12.2 24.5 ZMYND10 "BLU, CILD22" ENSG00000004838 "Zinc finger MYND-type containing 10" O75800 3 50341110-50346852 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "fallopian tube: 55.7;testis: 99.4" "Group enriched" "Detected in many" 10 "Ciliated cells: 293.1;Early spermatids: 194.4;Late spermatids: 324.6;Spermatocytes: 352.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 10.6;U-87 MG: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035255 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA035255: AB_10601928" "unprognostic (2.93e-3)" "unprognostic (2.98e-3)" "unprognostic (1.15e-2)" "unprognostic (3.85e-3)" "unprognostic (4.44e-1)" "unprognostic (7.78e-3)" "unprognostic (4.71e-2)" "unprognostic (6.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (6.73e-2)" "prognostic favorable (6.75e-5)" "unprognostic (8.25e-2)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" 0.1 0.1 1.9 0.2 4.8 0.3 0.6 0.3 0.8 1.6 0.1 5.5 0.2 0.2 0.9 4.6 0.2 55.7 0.3 0.1 2.6 3.1 0.5 0.2 4.7 0.2 0.2 0.3 4.2 0.2 1.4 1.6 0.1 10.2 0.1 0.1 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.5 0.2 0.1 99.4 1.2 0.1 0.8 0.1 0.1 0.1 0.0 0.4 1.1 0.8 0.7 3.8 2.5 0.5 2.7 1.0 0.4 0.8 1.0 1.6 0.8 0.4 1.8 3.0 0.9 0.2 1.4 1.0 1.1 1.7 0.3 0.6 2.4 0.1 0.3 1.1 1.1 2.5 3.6 0.1 0.1 0.7 1.2 0.1 0.3 3.8 0.2 2.7 0.2 2.2 0.6 0.6 0.5 1.4 0.5 3.4 0.0 0.4 1.1 1.1 0.1 0.8 3.7 0.1 2.9 1.2 0.3 0.8 0.2 0.1 10.6 0.9 0.0 0.8 0.8 1.8 0.2 1.4 0.6 0.3 7.4 3.4 0.2 0.3 0.4 0.3 2.5 0.4 1.0 0.1 0.2 0.4 1.1 0.4 0.1 0.5 0.8 3.8 0.7 0.4 0.1 0.5 1.9 4.8 0.3 0.8 2.6 3.1 0.2 0.3 10.2 1.2 3.0 6.1 0.0 0.3 0.5 1.2 0.8 0.0 293.1 29.6 1.8 3.9 0.1 0.0 0.7 194.4 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.0 0.5 0.5 0.0 0.0 1.3 0.0 324.6 8.3 0.2 1.7 0.0 0.4 1.0 0.1 0.0 5.3 0.7 5.7 0.0 0.4 352.7 8.5 0.4 0.1 0.7 0.2 0.1 ZMYND15 DKFZp434N127 ENSG00000141497 "Zinc finger MYND-type containing 15" Q9H091 17 4740015-4746119 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.6" "Group enriched" "Detected in many" 6 "Early spermatids: 141.0;monocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.1;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 11 "granulocytes: 1.1;monocytes: 1.5" "Cell line enhanced" "Detected in some" "A-431: 5.1;CAPAN-2: 4.8;HaCaT: 3.9;T-47d: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA023286 Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023286: AB_1859076" "unprognostic (2.30e-3)" "unprognostic (1.63e-2)" "unprognostic (1.61e-2)" "unprognostic (7.49e-3)" "unprognostic (3.62e-2)" "unprognostic (7.86e-2)" "unprognostic (4.97e-2)" "unprognostic (1.59e-2)" "unprognostic (1.33e-2)" "unprognostic (3.49e-1)" "unprognostic (6.72e-3)" "unprognostic (4.02e-1)" "unprognostic (5.47e-2)" "unprognostic (4.62e-2)" "unprognostic (9.24e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" 3.6 1.6 2.3 2.9 2.0 0.9 2.0 0.7 2.7 1.3 1.0 5.1 1.4 5.2 1.8 4.5 1.2 1.5 3.8 3.8 3.6 1.8 2.4 3.5 6.1 4.9 3.7 1.7 0.9 4.7 12.5 1.8 1.5 3.4 1.9 1.0 4.2 3.8 2.7 0.4 1.8 3.9 1.2 4.8 6.2 2.4 25.6 2.9 0.7 1.4 0.7 0.8 1.6 0.9 0.0 0.1 1.1 1.5 0.0 0.0 0.2 5.1 0.9 0.0 2.5 0.1 0.2 0.4 0.1 1.4 1.3 3.1 2.3 4.8 0.0 0.2 0.0 0.6 3.9 0.9 0.4 0.1 0.5 1.7 0.0 0.5 1.3 0.8 0.1 1.4 0.2 0.6 0.2 0.2 0.7 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.7 0.6 0.6 0.0 0.1 1.4 1.6 2.3 0.0 3.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 1.5 0.0 0.0 0.2 2.3 2.0 0.7 2.7 3.6 1.8 3.7 1.7 3.4 2.9 0.0 1.3 0.0 5.2 0.8 0.1 0.6 0.0 0.0 1.2 1.8 0.0 0.0 0.0 1.4 141.0 0.3 4.0 0.0 3.5 0.0 0.3 5.3 0.0 0.2 5.0 0.0 1.2 3.7 7.6 15.1 0.6 10.7 1.7 36.9 2.6 1.4 2.6 0.6 2.1 0.7 0.2 0.0 0.5 0.7 1.2 0.6 0.0 0.0 0.6 7.4 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491123 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.8;skeletal muscle: 111.1" "Cell type enriched" "Detected in all" 9 "Cardiomyocytes: 1626.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 48.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA054267: AB_2682431" "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 14.9 5.4 8.8 6.6 10.4 9.0 10.3 6.3 9.1 7.1 7.8 4.5 4.5 3.9 7.4 6.3 12.7 5.4 6.1 64.8 9.2 6.3 6.4 3.7 7.8 6.0 7.6 6.4 6.6 4.4 8.4 7.1 5.0 11.9 7.8 5.6 11.3 6.0 5.7 111.1 4.3 5.9 10.9 8.0 6.3 6.0 5.7 7.2 3.4 5.7 46.9 6.8 7.0 17.7 8.3 10.8 48.5 19.6 3.9 5.1 4.5 14.4 8.4 14.7 16.2 37.2 32.8 9.0 11.8 11.2 10.3 11.0 19.7 4.2 9.7 10.5 14.4 11.8 16.6 15.2 12.0 15.8 15.7 7.3 18.6 19.6 7.0 10.7 22.2 11.1 24.7 8.1 15.7 17.5 9.2 16.5 12.2 22.0 1.3 16.7 5.7 8.5 5.4 6.2 11.4 8.6 8.1 26.7 5.3 5.4 16.3 9.4 5.0 23.8 11.2 13.2 12.0 10.3 14.5 24.9 11.1 17.1 14.7 17.2 8.1 15.6 36.4 9.9 17.8 19.2 19.9 19.6 7.6 5.1 15.9 4.5 6.7 4.2 4.2 10.5 8.3 3.8 3.4 48.5 3.9 18.5 10.8 3.8 4.5 8.8 10.4 6.3 9.1 9.2 6.3 7.6 6.4 11.9 7.2 125.0 90.2 37.8 49.6 34.2 58.0 1626.8 56.0 188.7 61.4 27.9 90.3 31.5 34.9 37.0 133.3 49.8 30.9 23.3 36.8 30.7 62.9 79.6 42.8 32.7 46.8 33.4 38.7 57.1 104.1 80.0 34.8 64.4 62.4 28.9 28.5 43.3 51.2 23.0 87.0 34.8 75.4 45.3 46.4 55.4 37.4 26.1 25.6 29.4 33.7 64.4 ZNF114 MGC17986 ENSG00000178150 "Zinc finger protein 114" Q8NC26 19 48270102-48287608 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 11.5" "Cell type enhanced" "Detected in many" 12 "Club cells: 4.5;Syncytiotrophoblasts: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 17.0;Hep G2: 19.9;NTERA-2: 10.3;REH: 10.5" "HPA025019, HPA029553" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA025019: AB_1859080, HPA029553: AB_10603005" "unprognostic (1.82e-1)" "unprognostic (1.88e-1)" "unprognostic (5.41e-2)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.29e-4)" "unprognostic (2.67e-1)" "unprognostic (3.35e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-1)" "unprognostic (4.56e-3)" "unprognostic (5.21e-2)" "unprognostic (1.13e-7)" "unprognostic (9.74e-2)" "unprognostic (2.78e-1)" "unprognostic (9.15e-2)" "unprognostic (1.63e-1)" 1.5 1.0 3.7 2.2 2.7 2.1 1.2 1.2 3.3 2.3 0.6 2.1 1.0 0.9 2.4 2.4 1.3 1.9 1.5 1.7 3.7 4.6 1.6 0.5 1.4 1.9 2.6 0.8 1.2 5.3 4.2 1.6 7.5 2.1 3.1 0.4 2.5 3.7 1.3 3.7 3.7 0.7 1.4 3.5 1.6 0.7 1.6 1.7 1.0 11.5 0.5 1.1 1.3 5.7 2.6 3.5 5.4 0.7 2.0 0.6 0.4 2.7 4.3 5.2 0.5 0.3 0.0 17.0 0.5 0.0 1.6 2.1 1.5 4.3 0.1 5.0 0.3 1.9 5.6 7.1 0.3 1.8 0.1 0.4 0.6 1.3 19.9 1.6 2.7 0.5 0.3 0.5 0.8 0.1 0.5 0.3 0.7 0.7 0.4 0.3 8.1 0.2 8.4 10.3 7.4 0.9 10.5 0.0 0.3 0.2 2.3 2.1 2.4 2.8 0.0 3.0 3.3 1.1 5.0 0.7 0.8 1.8 1.5 0.5 0.4 0.1 0.1 0.2 1.5 0.8 3.3 0.7 0.9 0.5 0.6 0.3 0.9 0.6 0.4 1.7 2.6 0.5 0.4 5.4 2.0 0.7 3.5 0.2 0.4 3.7 2.7 1.2 3.3 3.7 4.6 2.6 0.8 2.1 1.7 3.0 2.6 0.0 0.8 0.3 1.2 0.4 0.0 1.4 4.5 0.0 0.0 1.9 1.7 0.1 2.1 1.1 0.0 0.0 0.5 2.1 0.8 0.7 0.0 0.4 1.4 0.0 0.0 1.8 0.8 0.0 1.1 1.1 0.0 0.0 0.0 1.3 0.4 0.0 0.7 0.0 0.6 0.0 0.8 0.5 2.7 0.1 12.8 0.0 0.0 1.0 ZNF117 "H-plk, HPF9" ENSG00000152926 "Zinc finger protein 117" Q03924 7 64971776-65006684 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 34.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 15.2;SuSa: 16.7;THP-1: 15.4" HPA031148 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA031148: AB_2673759" "unprognostic (1.04e-1)" "unprognostic (3.04e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.35e-2)" "unprognostic (1.45e-2)" "unprognostic (1.24e-1)" "unprognostic (6.13e-2)" "unprognostic (2.30e-1)" "unprognostic (3.35e-1)" "unprognostic (7.10e-2)" "prognostic unfavorable (2.17e-11)" "unprognostic (1.08e-1)" "unprognostic (9.19e-2)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" 11.1 13.2 1.3 3.4 1.5 2.1 7.1 2.1 3.7 3.1 2.1 0.5 4.2 6.5 5.2 2.8 5.6 2.7 1.1 1.3 2.3 0.9 3.9 2.6 1.0 5.0 2.1 2.4 4.0 5.3 2.8 2.2 3.6 2.4 0.6 4.2 1.6 2.8 1.3 3.4 1.8 5.3 3.4 2.6 2.5 4.5 1.0 0.7 6.2 1.9 0.9 0.6 0.2 1.2 0.1 14.5 15.2 5.5 2.5 8.2 3.1 0.7 0.8 1.5 0.6 6.2 5.3 2.6 1.6 2.4 0.9 1.7 0.4 1.8 1.6 1.4 2.4 0.4 2.9 0.5 0.0 1.5 3.2 0.6 0.6 0.6 5.9 2.4 6.3 9.8 3.6 3.6 2.7 5.4 5.5 6.1 1.7 0.2 7.2 1.0 1.0 2.0 2.3 2.3 12.4 1.5 0.6 0.7 16.7 2.7 15.4 7.2 4.4 0.5 2.6 1.9 2.5 4.5 2.8 1.6 6.9 2.7 0.4 0.6 1.0 0.6 1.9 0.6 1.0 0.4 0.4 0.7 1.0 0.4 0.4 6.2 0.9 0.5 0.7 0.5 0.2 3.0 34.7 0.0 4.9 3.0 14.3 6.1 15.3 22.7 25.0 5.2 0.0 4.1 10.0 9.4 1.7 7.0 1.7 0.0 24.3 2.3 5.0 6.1 10.4 3.0 5.5 27.0 5.1 19.0 9.8 2.5 8.1 7.0 5.0 1.8 3.6 10.0 17.7 0.0 4.9 2.1 7.4 6.5 4.1 6.5 7.9 4.1 9.3 4.9 2.8 10.4 ZNF135 "pHZ-17, ZNF61, ZNF78L1" ENSG00000176293 "Zinc finger protein 135" P52742 19 58059239-58086310 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 15.7;Distal tubular cells: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 6.7;MOLT-4: 7.0;T-47d: 8.2" "Low region specificity" "Detected in all" HPA006961 Approved Approved Cytosol NA NA Cytosol "HPA006961: AB_1080670" "unprognostic (4.87e-2)" "unprognostic (7.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.96e-1)" "unprognostic (1.01e-1)" "unprognostic (6.54e-2)" "unprognostic (1.70e-1)" "unprognostic (5.85e-2)" "unprognostic (9.18e-3)" "unprognostic (1.20e-2)" "unprognostic (1.01e-3)" "unprognostic (2.34e-1)" "prognostic favorable (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (1.93e-1)" "unprognostic (1.64e-1)" "unprognostic (1.25e-1)" 4.6 3.5 8.4 3.1 13.7 1.7 8.6 7.3 10.6 7.9 5.4 12.0 4.5 1.9 11.8 11.2 3.9 8.6 5.7 4.5 6.4 5.2 5.9 1.1 3.8 2.9 6.4 9.1 15.9 3.3 21.4 11.0 5.3 8.1 8.6 3.0 9.5 3.0 7.6 2.6 6.2 2.7 9.6 5.3 4.9 3.4 8.9 10.4 7.3 10.6 1.2 3.2 6.4 5.1 3.9 3.9 3.4 0.2 4.5 3.7 0.8 0.0 0.0 1.5 0.0 0.1 0.0 0.0 3.7 0.0 5.1 0.3 0.0 0.2 0.0 3.9 5.5 3.0 0.2 0.0 0.0 5.7 0.0 6.0 0.0 0.0 0.0 2.3 0.0 6.2 6.7 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 7.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 2.7 4.4 5.8 0.2 0.0 0.0 0.0 5.9 8.2 0.0 0.0 0.0 3.4 0.0 0.0 0.3 2.4 0.0 0.0 0.0 2.9 0.0 0.1 3.4 0.0 0.2 0.2 0.9 0.3 0.3 1.7 3.9 3.7 2.1 0.1 4.5 0.0 3.9 0.2 0.8 8.4 13.7 7.3 10.6 6.4 5.2 6.4 9.1 8.1 10.4 0.0 0.6 0.0 2.4 2.1 10.7 5.3 2.5 5.3 1.2 8.7 15.7 0.8 18.3 5.3 11.1 2.4 0.0 0.0 0.6 0.1 1.5 2.5 4.7 0.2 0.5 14.3 2.4 6.2 0.3 8.2 7.2 0.0 1.7 0.0 1.0 7.1 0.3 0.0 6.3 2.1 14.4 0.0 3.1 8.9 7.2 2.8 0.6 1.0 0.6 1.3 ZNF14 "GIOT-4, KOX6" ENSG00000105708 "Zinc finger protein 14" P17017 19 19710471-19733097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049863 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA049863: AB_2680921" "unprognostic (1.04e-1)" "unprognostic (9.86e-2)" "unprognostic (6.22e-2)" "unprognostic (1.61e-2)" "unprognostic (6.08e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favorable (7.96e-4)" "unprognostic (1.84e-3)" "unprognostic (1.04e-2)" "unprognostic (5.51e-3)" "unprognostic (1.55e-2)" "prognostic favorable (8.09e-6)" "unprognostic (1.83e-2)" "unprognostic (1.61e-1)" "unprognostic (5.17e-2)" "unprognostic (9.05e-3)" 7.4 5.3 7.9 8.7 10.5 11.9 12.8 23.3 10.3 11.3 7.0 8.1 6.6 3.9 9.4 9.6 5.7 9.3 6.0 6.6 8.1 7.6 8.4 1.7 4.9 10.5 12.2 6.0 15.7 7.5 12.7 10.7 8.8 9.4 12.3 5.1 6.5 7.1 9.9 3.4 7.2 7.2 8.9 9.0 9.4 7.0 6.2 10.7 7.1 13.8 3.1 10.9 9.8 7.7 10.3 3.0 11.4 3.6 6.5 18.4 6.3 3.5 3.6 6.1 7.9 4.1 4.5 7.3 3.7 5.1 5.5 6.0 3.4 2.8 9.5 6.2 3.9 3.1 3.6 6.3 3.7 6.9 2.3 7.3 4.5 2.7 4.5 5.0 0.1 6.9 4.5 3.9 3.8 3.3 7.3 3.4 4.7 5.2 4.5 5.4 5.9 8.0 5.1 7.9 6.7 10.4 4.2 9.9 4.6 3.9 7.2 6.1 4.4 0.1 4.3 5.8 5.4 6.0 9.2 2.1 4.8 1.3 5.6 4.8 3.6 4.2 8.4 0.3 5.0 2.8 11.4 1.8 6.1 9.6 3.1 15.1 10.3 13.1 12.0 2.6 8.2 18.4 14.5 4.1 6.5 3.6 3.0 8.4 6.3 7.9 10.5 23.3 10.3 8.1 7.6 12.2 6.0 9.4 10.7 0.0 3.0 1.5 3.8 2.2 4.5 1.9 0.0 4.0 1.2 3.5 0.0 2.6 3.3 1.3 0.5 2.3 0.3 0.0 1.2 1.5 2.8 1.8 1.1 0.0 1.5 6.4 2.9 1.3 0.6 0.5 1.7 2.4 3.3 0.0 1.6 3.5 1.0 0.9 3.5 2.2 5.6 6.5 2.1 3.2 3.0 1.3 1.8 5.3 1.5 2.0 ZNF155 pHZ-96 ENSG00000204920 "Zinc finger protein 155" Q12901 19 43967862-43998325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003220 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003220: AB_1080675" "unprognostic (2.71e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" "unprognostic (1.99e-1)" "unprognostic (7.98e-3)" "unprognostic (4.36e-2)" "unprognostic (2.98e-1)" "unprognostic (1.90e-1)" "unprognostic (3.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-2)" "unprognostic (2.58e-2)" "unprognostic (2.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (6.57e-2)" 9.9 9.7 6.1 5.2 9.4 4.2 9.4 16.0 11.1 10.1 7.6 11.7 9.6 5.4 12.8 12.0 7.0 7.7 6.2 9.7 7.2 7.5 8.9 10.6 7.4 8.0 6.8 5.4 10.6 5.7 15.8 13.0 7.1 9.4 9.9 8.0 7.7 10.0 8.1 6.2 8.8 10.8 10.1 9.4 11.5 8.3 5.2 7.4 10.1 13.3 8.5 8.9 13.1 6.4 6.2 5.1 11.8 3.5 6.4 9.3 4.9 4.5 3.8 9.7 8.8 5.4 6.2 2.8 3.7 3.5 2.7 3.8 2.5 2.3 0.0 4.8 5.8 3.7 3.5 3.2 8.0 4.4 5.0 8.0 9.5 8.1 2.7 5.5 3.0 5.6 8.8 6.4 5.4 8.0 7.8 6.1 0.2 0.1 0.1 7.1 4.0 4.3 3.5 5.9 1.9 3.4 0.0 10.3 3.4 7.1 14.8 6.5 8.7 9.2 0.5 3.6 8.8 6.2 8.4 4.5 5.9 8.7 3.8 5.4 10.8 7.7 0.0 5.0 0.7 5.4 10.3 3.4 11.8 8.5 3.5 8.4 5.3 6.1 9.3 5.1 6.2 7.4 6.8 3.0 6.4 2.7 3.0 5.2 4.9 6.1 9.4 16.0 11.1 7.2 7.5 6.8 5.4 9.4 7.4 0.0 2.2 0.0 1.1 1.3 4.2 0.4 0.0 0.0 1.2 0.0 0.0 1.5 1.7 1.5 0.3 1.7 1.6 0.0 1.3 0.4 1.5 0.9 1.1 1.3 1.5 6.4 0.0 2.5 0.3 0.5 2.6 1.1 1.7 1.0 1.3 3.8 0.9 0.0 5.3 1.8 2.8 0.0 1.9 0.9 1.0 1.1 0.9 1.8 1.3 1.0 ZNF160 "F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18" ENSG00000170949 "Zinc finger protein 160" Q9HCG1 19 53066606-53103436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 28.8" HPA023599 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023599: AB_2218442" "unprognostic (1.18e-2)" "unprognostic (4.75e-2)" "unprognostic (1.16e-2)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (8.31e-3)" "unprognostic (2.65e-5)" "unprognostic (5.20e-2)" "unprognostic (4.11e-3)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (6.03e-3)" "unprognostic (2.71e-3)" "unprognostic (2.87e-1)" "unprognostic (4.63e-1)" "unprognostic (1.71e-1)" "prognostic favorable (2.67e-5)" 17.7 28.0 15.7 18.5 19.9 8.1 17.2 26.4 20.0 16.3 15.5 21.6 14.1 9.6 22.7 17.2 11.0 15.5 16.8 13.8 14.5 8.9 19.7 13.2 17.3 12.8 22.5 15.2 25.9 12.7 20.9 18.2 16.1 18.8 15.1 13.3 9.9 14.3 19.3 10.2 13.1 12.1 17.4 19.6 31.5 13.2 15.2 22.4 19.0 29.5 7.5 12.5 18.0 15.0 9.1 4.3 10.7 5.9 17.5 11.2 5.4 5.6 5.1 7.1 10.8 11.9 8.4 12.1 6.2 8.4 5.0 8.1 4.4 3.6 6.5 5.4 5.7 6.7 4.2 6.6 6.4 10.1 4.8 8.1 10.0 3.8 2.4 6.5 0.0 6.9 10.4 6.6 5.4 7.7 12.8 5.4 7.7 5.0 0.0 9.5 3.9 8.3 6.2 6.6 1.5 8.3 5.3 7.5 5.0 7.9 28.8 6.0 7.8 0.0 5.0 0.9 23.7 5.3 5.8 10.3 14.1 5.1 4.1 4.5 3.7 15.4 9.3 2.5 2.5 6.7 9.0 3.1 10.7 7.1 4.2 10.3 8.4 7.3 9.5 4.3 9.1 11.2 8.7 6.5 17.5 5.9 4.1 7.3 5.4 15.7 19.9 26.4 20.0 14.5 8.9 22.5 15.2 18.8 22.4 20.8 29.1 11.9 8.4 3.5 21.1 18.3 17.8 10.7 14.8 8.7 27.5 7.4 5.0 5.9 25.5 16.1 8.1 0.0 5.9 6.7 7.1 9.0 17.4 4.3 5.6 44.5 8.1 36.2 10.0 8.1 10.0 9.5 1.7 2.8 6.8 12.0 6.4 7.0 13.4 4.7 17.9 12.9 10.0 7.9 7.6 3.4 8.7 20.0 5.1 9.8 ZNF169 MGC51961 ENSG00000175787 "Zinc finger protein 169" Q14929 9 94259311-94301454 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041769, HPA061185" Uncertain Approved "Nucleoplasm,Nuclear speckles,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" "Vesicles, Cytosol" "HPA041769: AB_2677662, HPA061185: " "unprognostic (1.07e-1)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (3.27e-2)" "unprognostic (9.08e-3)" "unprognostic (1.18e-3)" "unprognostic (7.33e-2)" "unprognostic (2.27e-1)" "unprognostic (7.45e-2)" "unprognostic (6.79e-2)" "unprognostic (1.69e-2)" "unprognostic (1.49e-4)" "unprognostic (6.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (2.15e-4)" 4.5 4.2 6.5 8.5 10.9 5.9 7.8 12.7 13.5 7.4 6.7 8.3 4.4 5.6 7.7 8.7 4.1 7.5 5.7 4.6 8.6 5.7 5.5 3.2 5.0 11.0 9.8 8.5 9.4 5.2 5.9 4.9 4.3 8.2 6.6 11.1 5.8 7.2 5.6 8.6 10.0 8.6 6.6 7.1 10.6 8.1 4.3 9.5 10.5 8.0 5.0 10.0 6.9 6.5 9.5 4.5 6.1 6.9 6.7 9.1 3.4 3.9 3.5 3.9 6.9 1.9 4.9 4.4 1.4 2.7 3.0 3.2 2.3 6.0 9.5 1.9 2.3 3.3 7.9 8.0 3.6 4.1 5.5 8.6 6.7 7.9 4.4 2.8 10.1 6.9 4.2 4.0 2.6 4.2 3.9 3.8 9.3 6.0 3.0 3.9 3.8 4.7 5.6 6.4 8.3 4.3 4.1 2.8 3.1 2.7 3.6 4.1 4.9 2.7 4.8 2.0 4.1 3.1 4.4 4.1 2.9 3.6 3.5 3.0 5.2 1.9 2.0 2.6 6.7 2.7 3.2 6.5 6.1 5.5 6.9 6.9 6.3 6.2 3.9 4.5 9.5 6.7 9.1 5.6 6.7 5.0 4.2 6.5 3.4 6.5 10.9 12.7 13.5 8.6 5.7 9.8 8.5 8.2 9.5 3.0 0.3 2.7 1.7 0.2 5.0 0.8 0.0 2.7 3.4 1.8 3.9 0.4 0.0 0.9 0.9 2.2 2.4 0.0 0.7 0.6 0.9 1.6 0.0 1.0 0.7 4.8 1.2 1.3 4.4 0.6 5.5 2.3 0.0 1.8 2.5 2.8 1.0 2.5 3.2 0.3 4.4 0.0 1.1 4.8 2.2 0.4 0.3 3.9 1.5 1.8 ZNF174 ZSCAN8 ENSG00000103343 "Zinc finger protein 174" Q15697 16 3401235-3409370 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009656 Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Nucleoplasm "Actin filaments, Cytosol" "HPA009656: AB_1080679" "unprognostic (4.33e-2)" "unprognostic (6.81e-3)" "unprognostic (2.08e-1)" "unprognostic (7.68e-2)" "unprognostic (1.94e-3)" "unprognostic (5.19e-2)" "unprognostic (2.03e-3)" "unprognostic (6.39e-3)" "unprognostic (2.41e-1)" "unprognostic (4.25e-3)" "unprognostic (2.06e-3)" "unprognostic (4.35e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (2.55e-1)" "unprognostic (1.83e-1)" 10.0 11.6 11.1 9.0 16.0 5.7 12.8 15.8 24.3 13.0 14.8 18.1 9.4 9.6 16.8 18.8 11.0 17.7 13.4 15.3 11.8 12.0 11.1 9.9 8.7 11.6 15.1 10.5 21.0 9.1 28.5 15.2 8.2 15.7 14.7 11.7 16.1 12.2 18.2 14.1 11.4 9.7 16.8 13.3 11.9 10.5 13.5 15.7 18.8 12.2 9.1 12.8 14.8 10.8 9.5 6.9 23.1 6.4 6.8 11.5 6.7 6.3 10.5 12.1 13.6 14.7 10.6 8.3 6.0 14.8 13.0 11.9 8.3 11.1 22.0 9.5 10.5 11.8 9.2 11.2 10.0 12.3 13.9 11.5 11.3 9.9 10.0 10.6 12.9 13.7 12.7 11.8 11.0 11.0 12.6 11.0 15.4 17.9 9.9 13.3 10.6 12.8 10.8 13.2 9.4 13.0 18.4 13.6 17.3 9.5 3.2 11.4 8.8 11.7 13.0 10.0 12.0 12.7 14.4 8.8 9.7 10.6 7.8 7.8 12.3 13.3 17.3 5.2 8.1 9.1 13.1 5.7 23.1 9.1 6.4 8.7 9.5 9.4 10.2 6.9 7.1 11.5 8.5 6.8 6.8 4.2 3.6 8.8 6.7 11.1 16.0 15.8 24.3 11.8 12.0 15.1 10.5 15.7 15.7 3.0 1.3 1.4 1.4 1.6 6.9 4.4 7.6 1.4 1.2 0.0 5.9 5.3 3.3 4.4 4.3 3.8 3.3 0.0 3.7 3.5 2.8 1.7 1.1 3.2 3.8 3.2 3.5 2.5 1.8 3.1 8.1 1.3 3.3 1.8 2.0 7.4 3.6 3.2 9.2 3.7 8.1 0.0 1.5 11.8 9.5 1.6 2.4 3.8 3.4 0.6 ZNF175 OTK18 ENSG00000105497 "Zinc finger protein 175" Q9Y473 19 51571298-51592508 "Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 25.5;RT4: 23.2;TIME: 23.4" "Low region specificity" "Detected in all" HPA002717 Uncertain Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA002717: AB_1080681" "unprognostic (9.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (9.50e-3)" "unprognostic (2.44e-1)" "unprognostic (1.84e-1)" "unprognostic (7.33e-3)" "unprognostic (9.94e-2)" "unprognostic (6.33e-3)" "unprognostic (6.20e-2)" "unprognostic (1.35e-3)" "unprognostic (1.50e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (3.50e-3)" 6.1 6.7 11.2 6.1 12.6 4.7 8.4 26.2 16.0 7.7 6.5 7.1 9.4 8.4 9.2 8.5 5.5 7.6 4.9 6.6 12.7 7.4 7.3 6.4 8.0 8.7 11.1 10.3 14.5 7.3 19.8 10.9 12.1 11.4 7.6 6.1 6.4 9.1 9.5 6.4 5.5 7.9 8.1 8.8 9.7 6.7 15.0 11.7 9.2 10.8 5.0 9.2 8.7 11.9 2.1 4.6 0.6 1.3 0.9 2.2 0.7 1.8 3.2 3.3 3.4 3.5 4.8 0.0 4.1 5.3 3.9 4.7 3.3 2.8 3.3 2.4 4.1 2.4 3.1 3.5 2.8 7.0 0.0 5.2 25.5 5.0 1.1 3.0 4.2 16.4 1.9 2.7 7.9 3.9 19.8 6.2 3.3 8.5 3.5 4.2 0.0 4.5 3.2 1.8 2.2 3.3 0.0 4.2 1.6 2.1 23.2 4.1 3.0 3.9 1.3 2.5 2.7 1.0 3.5 23.4 6.0 2.7 1.4 4.0 4.6 8.4 3.4 16.6 2.5 3.0 0.1 1.3 0.0 1.7 0.5 1.8 1.9 1.6 1.4 1.4 2.1 2.2 1.7 0.6 0.9 0.3 4.6 0.3 0.7 11.2 12.6 26.2 16.0 12.7 7.4 11.1 10.3 11.4 11.7 6.0 4.8 2.4 1.5 1.0 6.1 3.1 2.5 5.3 7.9 5.2 2.0 6.3 1.7 1.6 9.5 2.9 2.0 0.0 1.4 1.2 2.6 1.6 13.9 2.1 2.7 15.9 1.7 5.5 6.6 7.0 3.1 2.0 3.3 1.8 1.2 2.3 4.5 0.0 2.5 1.4 7.4 0.0 2.1 5.8 4.1 1.3 10.1 1.8 2.1 0.7 ZNF18 "HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38" ENSG00000154957 "Zinc finger protein 18" P17022 17 11977439-11997510 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006144 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA006144: AB_1080683" "unprognostic (2.99e-3)" "prognostic favorable (6.32e-4)" "unprognostic (2.32e-1)" "unprognostic (2.50e-2)" "unprognostic (4.91e-2)" "unprognostic (2.72e-3)" "unprognostic (2.28e-2)" "unprognostic (5.93e-3)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "prognostic favorable (5.12e-6)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (1.52e-2)" "unprognostic (9.31e-2)" "unprognostic (3.34e-2)" "unprognostic (3.53e-3)" 8.3 6.8 8.2 7.0 13.9 15.7 9.6 9.4 15.5 8.5 7.2 13.2 3.5 6.4 14.1 9.5 8.8 7.5 7.2 7.3 9.0 8.7 6.5 13.2 6.2 10.5 9.9 9.8 10.4 7.8 8.4 11.8 5.1 14.5 9.8 9.2 12.5 9.0 7.1 8.2 12.8 8.2 7.8 10.8 12.3 6.2 15.5 9.2 15.6 8.4 14.3 10.2 7.7 7.6 9.1 8.8 19.6 7.6 7.0 11.2 5.6 2.2 4.7 5.0 7.4 9.4 8.4 2.6 3.3 5.8 4.3 4.6 2.1 3.9 7.7 4.9 3.5 3.7 4.7 4.1 5.1 4.7 5.8 3.5 4.5 4.8 3.0 6.7 2.6 6.1 6.9 8.4 3.2 6.0 4.9 6.5 9.1 2.6 3.6 5.8 2.3 8.4 5.1 3.7 8.2 2.1 7.0 5.0 3.4 6.2 2.7 1.9 4.2 5.6 2.7 4.3 30.3 3.9 2.4 5.0 5.1 2.5 2.3 2.4 4.0 2.9 3.8 5.9 5.9 6.0 10.6 5.9 6.6 11.0 5.8 10.2 9.1 10.2 10.3 5.8 8.2 11.0 11.2 19.6 7.0 7.6 8.8 10.6 5.6 8.2 13.9 9.4 15.5 9.0 8.7 9.9 9.8 14.5 9.2 0.0 1.3 0.5 1.1 1.8 1.8 1.2 2.5 1.4 0.0 1.8 2.0 2.0 1.7 2.4 23.1 1.4 2.9 0.0 0.8 1.8 2.4 1.0 2.3 3.2 3.6 1.6 1.2 1.3 2.1 19.5 3.1 1.9 1.7 2.8 3.6 1.8 2.1 3.4 3.2 2.5 1.1 0.0 2.2 11.2 3.2 1.9 1.3 4.4 3.1 1.0 ZNF185 SCELL ENSG00000147394 "Zinc finger protein 185 with LIM domain" O15231 X 152914442-152973480 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 93.5;esophagus: 67.6" "Cell type enhanced" "Detected in many" 10 "Pancreatic endocrine cells: 42.4;Suprabasal keratinocytes: 18.4;Urothelial cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.6" "Group enriched" "Detected in many" 5 "granulocytes: 21.6;monocytes: 13.9" "Cell line enhanced" "Detected in many" "A-431: 31.7;EFO-21: 37.7;HBEC3-KT: 26.2;PC-3: 23.2;TIME: 61.8" "Low region specificity" "Detected in all" "HPA000400, HPA016438" Enhanced Supported "Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol" NA NA 5400 "Plasma membrane, Cytosol" "Actin filaments, Focal adhesion sites" "HPA000400: AB_1080685, HPA016438: AB_1859109" "unprognostic (1.34e-1)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (2.43e-2)" "unprognostic (9.75e-3)" "unprognostic (2.69e-1)" "unprognostic (2.49e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (7.94e-2)" "unprognostic (6.28e-2)" "prognostic unfavorable (3.30e-5)" "unprognostic (5.18e-2)" "unprognostic (8.12e-2)" "unprognostic (1.99e-1)" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" 3.9 1.7 1.8 2.0 3.2 0.8 1.8 2.7 2.0 14.3 1.8 1.4 10.7 0.0 3.8 93.5 67.6 3.1 2.0 1.9 1.7 0.8 2.0 1.1 3.3 3.1 2.1 1.1 1.2 0.9 0.1 2.3 4.0 1.7 4.2 0.3 1.3 10.1 28.1 1.5 9.9 1.2 1.4 1.2 3.7 0.8 1.9 2.0 1.2 3.9 1.4 6.6 2.1 22.8 0.4 3.8 21.6 13.9 0.2 0.6 10.2 31.7 6.7 0.6 0.4 0.8 1.1 1.5 1.5 0.1 3.9 0.5 0.2 9.6 0.4 37.7 2.3 0.4 4.5 0.9 26.2 16.3 0.3 0.6 2.0 2.7 1.0 1.9 0.1 0.1 0.8 18.8 0.4 15.4 3.9 20.2 0.4 0.1 0.3 0.1 7.5 0.1 0.1 0.5 8.1 23.2 0.1 0.1 0.2 2.0 3.0 0.2 2.2 0.0 6.0 0.9 6.5 6.2 0.7 61.8 0.2 13.7 0.8 1.1 0.3 0.2 0.2 0.4 2.3 0.4 21.6 13.9 5.7 0.5 12.9 0.3 0.4 0.4 0.6 3.8 0.3 0.6 0.3 9.5 0.2 10.2 2.5 0.5 10.2 1.8 3.2 2.7 2.0 1.7 0.8 2.1 1.1 1.7 2.0 11.9 1.6 0.5 4.9 8.1 0.5 1.0 2.5 2.7 4.5 8.7 2.0 3.2 0.0 8.6 0.2 0.5 0.0 0.0 2.6 4.3 2.8 5.1 1.1 0.0 8.6 0.0 0.0 0.6 8.8 0.0 1.1 4.6 3.3 4.6 2.1 3.0 42.4 0.0 1.1 0.9 0.0 0.0 0.5 2.3 5.3 18.4 0.6 0.0 3.3 17.6 ZNF195 ENSG00000005801 "Zinc finger protein 195" O14628 11 3339261-3379222 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA030605 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030605: AB_10602686" "unprognostic (2.30e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (5.40e-2)" "unprognostic (4.02e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (3.10e-2)" "unprognostic (1.39e-2)" "unprognostic (5.94e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (4.24e-4)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.79e-7)" 12.2 11.3 14.0 13.2 18.8 15.0 20.9 28.0 22.7 13.4 15.4 19.6 10.8 13.5 13.4 25.3 10.8 12.6 11.1 9.6 15.2 16.9 16.4 14.6 12.7 16.5 16.9 10.5 10.6 16.0 8.8 20.8 9.9 22.5 16.4 19.4 9.3 13.2 9.7 13.0 13.5 14.0 11.3 15.4 19.5 13.3 6.9 20.0 25.8 15.9 8.6 15.9 13.1 12.9 13.6 12.2 9.9 9.2 13.0 19.1 8.2 8.1 8.8 15.2 18.4 5.3 6.7 22.3 8.3 7.1 8.9 11.1 9.3 15.1 13.2 5.2 5.4 12.3 11.3 16.9 10.1 12.9 6.4 14.1 9.8 8.7 9.3 6.9 16.1 14.7 8.5 9.8 7.4 12.5 6.3 11.1 17.3 17.1 8.6 9.7 6.5 19.1 12.8 35.4 9.1 9.0 16.8 9.4 6.7 14.0 19.1 25.5 25.3 9.1 11.5 7.6 14.4 5.6 14.5 7.8 4.2 8.1 7.6 7.3 7.9 11.0 20.9 4.3 11.9 7.4 1.9 8.4 9.9 12.0 9.2 15.2 13.6 14.8 14.6 12.2 12.7 14.0 15.6 1.4 13.0 7.7 10.7 19.1 8.2 14.0 18.8 28.0 22.7 15.2 16.9 16.9 10.5 22.5 20.0 14.9 21.6 16.5 15.0 10.8 14.9 15.5 10.2 21.4 21.6 7.0 9.8 8.4 8.3 20.8 2.4 11.1 8.5 0.0 16.3 9.2 6.2 6.5 5.8 6.7 9.6 17.5 19.5 9.2 11.4 0.0 5.5 8.5 6.8 7.2 13.1 17.0 22.6 11.5 5.3 9.1 12.8 0.0 7.5 10.0 8.7 5.9 3.3 12.8 14.5 15.4 ZNF2 "A1-5, Zfp661, ZNF661" ENSG00000275111 "Zinc finger protein 2" Q9BSG1 2 95165432-95184317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041358 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041358: AB_10795539" "unprognostic (1.18e-1)" "unprognostic (6.41e-3)" "unprognostic (5.81e-2)" "unprognostic (9.29e-2)" "unprognostic (4.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.13e-3)" "prognostic favorable (4.69e-5)" "unprognostic (1.47e-2)" "unprognostic (1.78e-1)" "unprognostic (2.37e-2)" "unprognostic (2.63e-2)" "unprognostic (2.66e-3)" "unprognostic (2.57e-2)" "unprognostic (6.78e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" 5.1 4.1 5.2 3.2 6.3 0.7 4.0 6.4 6.1 5.3 2.6 6.4 2.5 3.3 5.4 5.7 3.5 4.8 2.3 4.6 5.1 4.2 2.7 3.5 4.3 5.3 5.0 6.5 2.8 6.5 7.1 3.1 5.2 4.8 2.5 4.9 3.7 5.5 4.2 4.7 2.2 4.1 6.1 4.3 3.5 4.3 5.9 4.3 5.0 4.5 5.0 4.3 4.0 7.2 5.0 15.1 6.2 4.2 8.6 4.5 5.4 5.2 6.5 10.8 9.7 7.6 4.2 6.1 8.0 8.4 11.0 5.6 3.7 3.5 4.3 5.7 5.9 4.5 6.9 4.6 8.8 7.6 5.9 8.0 4.3 7.0 7.9 4.1 5.2 6.5 6.5 7.6 11.9 9.3 7.2 6.6 5.3 2.9 8.6 4.9 5.9 5.7 2.8 4.8 7.2 5.7 11.2 4.5 4.8 3.2 5.5 7.5 5.7 8.2 6.9 5.7 5.1 6.3 5.8 10.1 5.9 8.0 5.1 5.0 4.3 4.3 6.8 5.4 7.7 5.9 4.4 15.1 8.6 6.2 6.2 7.2 7.0 7.5 5.0 6.9 8.5 8.6 3.6 4.2 4.7 4.1 7.6 4.5 0.0 1.7 0.5 0.6 0.9 2.8 2.4 2.5 4.0 2.3 1.8 0.0 1.3 5.0 1.5 1.6 1.6 0.7 0.0 1.6 1.1 1.2 0.7 1.1 1.6 2.2 1.6 0.0 1.3 3.2 0.4 2.0 1.7 0.0 0.0 0.7 3.6 0.8 0.0 2.8 2.2 2.9 6.5 1.9 4.2 6.8 1.0 1.4 2.1 1.2 0.6 ZNF213 "CR53, ZKSCAN21, ZSCAN53" ENSG00000085644 "Zinc finger protein 213" O14771 16 3129777-3142805 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 18.5;Late spermatids: 41.1;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035000, HPA056750" Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA035000: AB_10669997, HPA056750: AB_2683225" "unprognostic (1.94e-1)" "unprognostic (1.62e-2)" "unprognostic (3.25e-1)" "unprognostic (1.87e-2)" "unprognostic (1.31e-2)" "unprognostic (4.05e-3)" "prognostic unfavorable (6.74e-4)" "unprognostic (4.72e-2)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-1)" "unprognostic (4.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.57e-1)" 5.7 8.2 9.0 6.0 10.3 6.0 5.7 10.8 16.7 5.0 6.2 14.6 4.7 9.3 7.5 5.1 8.4 6.8 6.0 9.1 9.5 7.7 4.4 2.4 6.3 8.8 7.1 9.3 10.3 12.1 8.7 7.3 4.1 9.1 6.5 2.5 6.8 17.4 5.9 11.1 16.9 11.2 6.8 7.6 7.5 6.9 20.1 8.0 7.5 9.2 4.7 5.4 7.1 5.8 4.8 3.2 3.5 2.5 4.0 4.7 1.8 3.4 10.7 4.8 11.3 4.6 3.9 5.9 6.2 2.5 3.3 3.9 3.4 7.0 4.1 6.1 4.0 4.8 8.3 2.2 6.9 1.3 8.6 8.3 2.9 11.8 6.6 8.9 7.0 7.7 3.7 8.6 4.6 1.7 2.5 2.5 8.1 7.4 9.2 2.1 14.6 6.6 8.7 8.2 3.6 8.2 8.9 5.6 7.5 2.6 2.3 9.9 8.5 9.4 5.6 4.4 3.2 7.4 12.2 6.1 6.7 6.2 7.6 4.3 5.2 4.8 6.3 2.7 9.3 5.1 0.0 1.6 3.4 3.7 2.5 3.2 2.7 3.6 2.4 1.6 4.8 4.7 3.4 3.5 4.0 1.9 3.2 2.0 1.8 9.0 10.3 10.8 16.7 9.5 7.7 7.1 9.3 9.1 8.0 0.0 0.6 1.7 1.3 1.6 5.9 3.3 2.5 1.4 1.2 0.0 2.0 1.4 1.7 3.5 18.5 2.2 8.5 0.0 4.3 1.6 2.5 1.7 4.6 1.0 2.8 7.9 2.4 2.5 4.1 41.1 6.1 2.3 0.0 3.6 5.3 4.6 4.9 3.5 6.7 2.3 5.2 19.4 4.4 8.9 3.8 1.8 1.1 0.0 5.2 1.3 ZNF23 "KOX16, Zfp612, ZNF359, ZNF612" ENSG00000167377 "Zinc finger protein 23" P17027 16 71447597-71463095 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 6.0;Ciliated cells: 16.0;Club cells: 5.7;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023534 Uncertain Approved Cytosol NA NA Cytosol "HPA023534: AB_1859140" "unprognostic (8.49e-2)" "unprognostic (1.46e-2)" "unprognostic (1.89e-1)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" "unprognostic (9.89e-3)" "unprognostic (2.12e-1)" "unprognostic (8.37e-3)" "unprognostic (2.19e-2)" "unprognostic (2.62e-3)" "unprognostic (3.65e-1)" "unprognostic (6.94e-2)" "unprognostic (9.59e-2)" "unprognostic (6.04e-2)" 7.1 5.5 8.5 6.3 11.5 5.6 7.7 16.4 14.3 6.7 8.1 5.1 4.6 5.5 9.3 14.9 6.1 10.3 5.2 6.0 11.6 9.6 7.6 6.5 8.7 9.5 11.3 13.9 11.4 6.1 11.1 19.5 5.5 11.4 8.4 7.6 8.4 6.4 8.0 7.4 8.5 6.4 11.4 8.8 8.2 6.0 8.7 9.6 5.4 10.2 7.0 9.5 7.4 7.3 4.6 4.2 1.7 3.6 4.0 4.9 1.8 4.7 4.1 10.4 7.5 5.9 5.5 6.4 11.5 8.5 7.7 5.6 5.4 5.2 10.2 3.1 7.5 6.8 3.5 6.1 6.8 6.9 2.4 4.4 5.6 4.0 4.1 5.9 10.3 4.0 6.5 5.2 8.0 13.9 8.4 2.3 5.2 8.3 3.1 7.2 11.1 4.0 4.9 8.8 2.3 3.7 2.7 3.1 3.1 5.4 4.1 8.3 8.8 3.8 2.8 3.0 4.5 3.6 4.8 9.6 16.1 4.5 4.4 7.5 5.4 6.3 14.4 12.2 4.3 8.8 1.7 1.8 1.2 4.5 3.6 3.9 3.0 2.5 4.9 2.5 4.6 4.9 3.8 0.0 4.0 2.0 4.2 4.1 1.8 8.5 11.5 16.4 14.3 11.6 9.6 11.3 13.9 11.4 9.6 6.0 2.9 0.5 0.2 0.2 2.2 0.3 0.0 16.0 5.7 0.0 5.9 0.2 1.7 1.8 0.1 0.1 0.4 0.0 0.9 0.3 0.2 0.2 2.3 0.8 0.3 3.2 0.0 1.8 0.0 0.0 0.6 0.1 0.0 0.0 1.0 1.3 1.2 0.3 0.0 0.0 3.3 0.0 0.4 1.8 1.2 0.0 0.0 0.0 1.3 0.1 ZNF232 ZSCAN11 ENSG00000167840 "Zinc finger protein 232" Q9UNY5 17 5105541-5123116 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027309, HPA028611" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA027309: AB_10603464, HPA028611: AB_2672700" "unprognostic (4.20e-2)" "unprognostic (2.06e-3)" "unprognostic (3.69e-1)" "unprognostic (5.59e-3)" "unprognostic (5.21e-2)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.12e-2)" "unprognostic (5.46e-3)" "unprognostic (2.49e-2)" "prognostic favorable (6.55e-4)" "unprognostic (3.28e-2)" "unprognostic (3.49e-3)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (1.11e-1)" "unprognostic (8.61e-3)" 6.7 5.2 6.5 6.7 9.5 2.0 7.4 14.3 11.1 6.6 8.2 11.1 7.8 4.5 8.9 10.1 5.5 9.9 5.5 5.9 7.3 5.4 6.6 6.3 6.3 7.0 9.8 5.7 14.3 10.0 3.8 8.7 6.2 8.7 7.6 5.9 6.5 8.8 6.4 7.7 5.5 6.3 8.5 6.2 6.9 7.2 7.5 10.7 6.4 8.0 5.4 6.1 6.3 6.2 11.8 7.4 1.9 2.1 5.4 7.8 3.9 5.4 4.1 6.8 6.9 2.4 1.0 3.7 2.7 1.4 2.7 3.7 6.4 1.3 11.0 3.3 0.9 3.9 3.8 4.7 2.7 1.6 4.3 7.2 1.9 9.5 5.7 3.5 0.0 3.4 2.0 3.0 2.8 2.5 1.9 1.9 13.3 9.2 4.1 3.2 2.6 9.3 3.8 13.3 4.7 4.5 8.0 4.3 7.4 2.2 0.8 7.1 4.6 5.3 2.1 4.3 5.4 1.1 2.7 3.1 2.7 4.6 2.1 5.2 5.5 8.6 2.8 6.9 0.3 4.4 1.4 2.1 1.9 4.7 1.9 5.5 11.8 5.2 6.2 4.0 11.0 7.8 7.2 0.1 5.4 1.2 7.4 4.2 3.9 6.5 9.5 14.3 11.1 7.3 5.4 9.8 5.7 8.7 10.7 0.0 1.6 2.2 3.1 3.8 5.0 5.0 0.0 5.3 4.5 5.2 0.0 3.2 3.3 5.3 6.0 4.0 2.1 0.0 3.5 4.0 2.4 2.0 0.0 3.2 5.1 0.0 1.2 3.1 2.7 4.8 3.4 1.8 0.0 1.0 2.7 3.8 3.5 5.8 4.9 2.6 2.8 0.0 4.1 12.1 10.9 4.1 1.7 1.5 3.3 1.6 ZNF236 ENSG00000130856 "Zinc finger protein 236" Q9UL36 18 76822607-76970727 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008600 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA008600: AB_1080696" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (3.13e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (9.88e-3)" "unprognostic (5.51e-2)" "unprognostic (1.77e-1)" "unprognostic (2.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "unprognostic (2.95e-2)" "unprognostic (9.40e-2)" "unprognostic (1.74e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" 5.7 5.2 7.0 9.1 11.2 10.8 10.0 15.3 11.0 7.2 5.8 7.3 6.7 5.0 7.6 7.1 5.6 7.6 6.3 5.1 8.3 5.7 4.7 4.3 6.4 6.2 8.3 3.5 11.3 7.1 12.2 8.9 5.6 7.3 6.2 4.1 5.4 6.6 12.6 5.7 9.9 5.5 5.8 6.5 5.5 5.8 16.6 10.6 10.4 6.5 1.9 10.0 6.2 12.7 9.0 4.6 5.9 3.4 3.0 5.4 1.2 4.2 5.7 8.0 5.9 6.2 6.0 3.6 3.3 4.6 5.3 4.2 4.0 4.0 6.0 1.6 4.3 5.6 7.8 5.5 4.6 4.4 6.4 5.6 5.7 6.6 4.7 3.8 9.1 6.6 5.9 5.1 5.0 7.7 5.7 5.3 9.6 5.4 5.1 5.3 4.0 11.2 5.1 4.4 1.3 4.5 7.1 8.3 4.0 3.9 6.7 4.6 4.8 5.9 3.6 4.1 3.9 4.3 6.4 5.4 9.1 3.7 2.4 4.9 3.5 4.7 7.8 6.0 5.0 6.8 1.1 3.4 5.9 5.4 2.9 5.2 9.0 4.0 3.7 2.2 8.1 4.6 4.8 3.7 3.0 2.7 4.6 3.9 1.2 7.0 11.2 15.3 11.0 8.3 5.7 8.3 3.5 7.3 10.6 8.9 6.4 3.7 7.4 6.4 14.6 6.9 10.2 14.7 6.8 7.0 9.8 6.9 1.7 4.3 6.0 7.5 4.3 23.3 3.4 6.0 7.7 6.0 1.1 5.7 5.3 23.8 5.8 7.4 8.7 3.3 9.8 5.3 6.8 5.4 4.7 10.8 3.9 2.9 6.7 2.2 14.3 6.5 8.2 27.0 18.5 7.3 5.0 5.1 5.2 5.8 ZNF250 "MGC9718, ZFP647, ZNF647" ENSG00000196150 "Zinc finger protein 250" P15622 8 144876497-144902168 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020853 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA020853: AB_1859152" "unprognostic (1.16e-3)" "unprognostic (9.56e-2)" "unprognostic (2.63e-1)" "unprognostic (2.60e-3)" "unprognostic (1.03e-1)" "unprognostic (5.95e-3)" "unprognostic (3.73e-3)" "unprognostic (2.72e-2)" "unprognostic (6.27e-2)" "unprognostic (7.37e-2)" "unprognostic (4.94e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.43e-7)" "unprognostic (2.23e-1)" "unprognostic (6.79e-2)" "unprognostic (5.82e-2)" "prognostic favorable (8.26e-4)" 6.5 7.0 8.4 9.4 10.0 4.5 21.2 33.0 11.1 13.8 9.0 8.6 7.3 9.2 15.8 11.4 9.1 10.7 7.2 7.1 6.3 7.6 10.5 5.6 9.3 5.9 9.3 9.5 16.4 8.6 12.5 14.7 10.0 10.0 10.6 6.8 10.4 8.8 12.4 10.6 14.8 9.1 12.2 6.5 8.3 6.9 6.1 9.2 9.7 19.9 6.0 8.8 12.7 12.0 12.2 7.5 6.4 5.9 6.1 12.7 5.0 4.8 3.7 13.1 11.1 7.6 5.4 4.7 5.7 6.3 9.0 8.0 2.3 3.5 12.9 9.9 6.6 3.6 6.3 6.5 6.8 6.5 3.7 8.0 10.5 13.4 3.6 3.7 2.0 3.9 4.0 9.2 7.0 8.3 8.6 4.9 8.0 8.5 10.9 8.2 8.9 12.5 4.8 3.7 5.8 10.9 15.2 6.0 5.6 9.2 3.9 13.0 10.3 11.1 4.1 5.0 5.5 5.9 5.7 5.0 10.0 8.9 8.0 5.1 5.7 4.4 7.6 4.9 7.0 4.2 4.6 5.9 6.4 12.7 3.3 9.8 12.2 9.4 7.3 7.5 11.0 11.1 9.2 3.3 6.1 4.2 3.2 12.4 5.0 8.4 10.0 33.0 11.1 6.3 7.6 9.3 9.5 10.0 9.2 11.9 4.0 0.9 2.7 4.8 7.4 3.6 2.5 5.3 2.3 5.2 0.0 1.9 3.3 6.6 5.1 5.0 2.0 0.0 1.6 1.2 5.6 1.6 2.3 2.4 1.5 7.9 4.1 4.9 2.8 2.4 3.7 4.1 5.0 1.8 1.6 3.6 2.8 0.0 4.9 1.9 9.8 12.9 4.1 6.3 4.3 4.8 1.6 5.3 3.4 2.0 ZNF260 "ozrf1, Zfp260" ENSG00000254004 "Zinc finger protein 260" Q3ZCT1 19 36510695-36528660 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028806 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028806: AB_10795285" "unprognostic (1.34e-1)" "unprognostic (6.31e-2)" "unprognostic (8.35e-3)" "unprognostic (1.11e-3)" "unprognostic (3.55e-2)" "unprognostic (1.29e-3)" "unprognostic (7.83e-3)" "unprognostic (3.91e-1)" "unprognostic (1.13e-2)" "unprognostic (8.36e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-2)" "prognostic favorable (1.44e-4)" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (1.06e-1)" "unprognostic (7.89e-3)" 8.4 9.4 10.3 7.6 16.8 2.3 12.0 18.4 14.1 10.8 7.0 6.2 9.4 6.2 11.2 7.9 8.0 8.4 8.2 7.5 11.2 9.5 11.6 8.5 7.3 12.4 17.1 9.1 13.4 6.6 20.4 19.5 10.9 11.9 10.3 7.1 5.9 8.8 7.6 4.8 10.0 7.7 8.1 20.6 8.3 8.1 4.5 15.4 17.3 14.7 5.5 9.7 10.7 8.4 5.9 3.2 6.8 3.5 4.1 7.2 3.0 7.9 8.1 18.8 14.1 5.8 8.9 8.2 7.0 7.5 6.5 8.3 3.6 4.5 5.2 11.5 5.6 4.9 3.0 9.4 4.3 10.0 6.9 4.1 7.8 6.2 4.1 8.1 3.9 6.5 8.0 7.2 6.7 10.3 9.3 8.6 7.9 6.1 5.8 12.8 4.3 14.4 2.5 11.9 4.9 3.5 9.6 11.6 3.9 7.2 14.3 13.6 14.9 15.5 8.3 5.7 12.1 7.0 7.4 7.4 11.3 11.8 6.6 6.2 7.5 14.3 12.3 0.3 4.1 15.2 6.8 2.8 3.0 4.0 2.5 4.2 5.1 5.3 3.2 3.2 5.9 7.2 5.5 1.6 4.1 3.5 2.2 4.6 3.0 10.3 16.8 18.4 14.1 11.2 9.5 17.1 9.1 11.9 15.4 8.9 3.8 4.4 7.3 9.2 7.6 7.5 0.0 5.3 12.5 0.0 7.9 5.5 5.0 7.1 7.4 6.7 2.5 0.0 3.9 5.7 6.1 7.0 8.1 3.0 4.1 20.6 11.5 9.8 3.3 3.1 5.5 4.9 1.7 7.2 6.6 7.5 5.2 2.9 7.8 6.7 7.4 6.5 4.8 5.6 3.7 11.4 3.4 6.9 5.0 10.8 ZNF263 "FPM315, ZKSCAN12, ZSCAN44" ENSG00000006194 "Zinc finger protein 263" O14978 16 3263800-3301401 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035085, HPA035086" Approved Supported "Nucleoplasm,Mitotic spindle,Cytosol" Yes No Cytosol "Nucleoplasm, Mitotic spindle" "HPA035085: AB_10671099, HPA035086: AB_10603244" "unprognostic (2.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (3.33e-1)" "unprognostic (2.25e-1)" "unprognostic (6.42e-2)" "unprognostic (7.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (6.39e-2)" "unprognostic (2.30e-3)" "unprognostic (2.98e-3)" "unprognostic (5.10e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (2.66e-1)" 28.3 17.8 21.5 16.9 25.7 15.0 23.3 26.4 23.5 21.9 19.2 18.1 14.0 13.8 30.4 23.4 15.4 24.2 17.6 14.6 15.7 14.2 16.9 17.1 18.5 20.4 20.3 18.1 30.7 23.0 36.4 24.8 20.1 16.8 21.8 16.8 20.2 19.5 21.1 15.8 22.7 18.2 18.6 14.0 23.6 20.5 17.3 16.5 18.9 20.1 14.5 28.8 20.2 27.6 6.6 5.5 9.6 5.0 6.7 9.2 3.3 8.6 11.2 13.4 19.4 10.7 14.1 17.4 11.9 18.3 14.3 15.6 12.2 13.6 31.9 12.4 15.3 13.3 11.0 18.2 12.1 14.4 17.5 18.2 14.5 15.0 11.7 12.5 21.4 17.8 16.2 25.4 13.0 19.2 16.1 12.2 20.6 16.3 21.7 11.7 11.9 19.7 16.5 24.9 10.2 9.6 32.1 13.6 25.1 10.0 8.7 19.4 20.3 13.0 14.1 14.5 16.3 15.6 25.6 12.6 15.2 14.6 11.2 11.1 23.3 24.7 38.5 5.9 10.8 10.7 2.1 3.9 9.6 6.0 4.2 6.9 4.5 7.3 8.0 5.5 6.6 9.2 6.8 5.0 6.7 5.0 4.6 4.9 3.3 21.5 25.7 26.4 23.5 15.7 14.2 20.3 18.1 16.8 16.5 0.0 14.4 9.1 14.5 15.5 10.2 3.6 12.7 4.0 4.5 1.8 0.0 9.7 6.6 8.9 41.6 11.1 6.0 0.0 8.6 8.9 10.8 11.4 6.9 5.8 8.0 3.2 12.7 5.5 8.9 26.2 7.5 8.0 15.1 8.2 9.2 10.1 8.2 3.5 7.4 5.0 9.0 12.9 18.6 11.4 10.4 18.1 9.3 10.0 11.7 11.9 ZNF268 HZF3 ENSG00000090612 "Zinc finger protein 268" Q14587 12 133181409-133214831 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001794 Approved Approved "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA001794: AB_2666437" "unprognostic (7.65e-2)" "unprognostic (2.78e-1)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (1.16e-1)" "unprognostic (1.94e-1)" "unprognostic (4.91e-3)" "unprognostic (2.21e-1)" "unprognostic (7.63e-3)" "unprognostic (2.57e-2)" "unprognostic (6.59e-3)" "unprognostic (5.69e-2)" "unprognostic (2.30e-1)" "unprognostic (8.79e-2)" "unprognostic (1.53e-3)" 8.8 13.5 9.3 13.0 10.3 4.6 13.4 11.2 13.0 11.7 9.0 8.5 13.3 6.2 11.1 14.7 11.8 12.6 10.4 7.9 9.0 8.2 13.5 17.3 10.1 13.2 7.9 8.8 19.7 9.6 20.6 14.2 17.6 11.1 15.7 7.8 9.6 9.9 10.4 6.0 8.0 8.0 12.0 8.2 11.4 9.6 9.6 8.5 12.9 16.6 11.2 9.3 12.0 9.4 10.0 7.4 5.7 8.0 10.6 15.7 5.1 5.2 9.1 16.8 14.7 7.5 10.6 11.8 7.7 8.9 7.4 6.2 7.9 3.8 6.3 12.1 9.2 8.4 4.9 8.3 10.0 9.3 0.2 6.7 12.8 4.3 10.0 7.6 10.8 10.4 13.5 9.8 8.9 14.5 10.4 8.5 5.8 8.7 6.2 12.5 6.4 4.4 5.2 13.2 6.6 0.4 4.2 6.5 5.6 4.1 12.2 12.9 10.5 15.8 5.5 7.1 14.9 14.5 9.2 9.4 8.4 10.5 2.8 7.1 2.2 3.2 9.9 4.6 5.7 8.8 1.7 4.9 5.7 8.5 4.9 5.7 10.0 9.6 10.7 7.4 8.2 15.7 10.7 1.5 10.6 8.0 5.9 4.9 5.1 9.3 10.3 11.2 13.0 9.0 8.2 7.9 8.8 11.1 8.5 17.9 21.1 7.3 5.3 1.5 23.0 7.8 10.2 6.7 18.2 7.0 19.6 10.4 5.0 7.5 12.6 6.4 3.1 0.0 5.6 7.3 7.1 6.3 2.3 9.2 8.3 20.6 3.5 10.4 6.5 3.4 9.8 4.8 5.0 3.6 9.2 17.5 6.6 10.4 10.6 8.7 17.4 6.5 4.4 11.8 15.9 2.5 7.2 6.9 7.2 3.5 ZNF276 "CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477" ENSG00000158805 "Zinc finger protein 276" Q8N554 16 89720400-89740903 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021309, HPA022255" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "HPA021309: AB_1859024, HPA022255: AB_1859025" "unprognostic (1.45e-2)" "unprognostic (7.05e-2)" "unprognostic (1.17e-2)" "unprognostic (8.25e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (1.92e-1)" "unprognostic (7.85e-2)" "unprognostic (1.59e-2)" "unprognostic (1.36e-3)" "prognostic unfavorable (3.37e-4)" "unprognostic (2.65e-2)" "unprognostic (4.14e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-3)" 9.7 9.8 9.0 18.6 13.1 25.5 7.9 20.2 12.3 10.8 11.1 30.6 9.4 16.0 9.0 8.4 14.5 11.4 9.5 6.7 9.8 7.3 8.4 10.1 9.6 21.7 21.3 11.2 13.5 10.9 11.0 11.6 7.4 12.6 10.2 8.8 8.1 11.3 11.4 11.4 18.5 15.3 6.8 9.9 22.2 12.2 6.4 18.4 11.1 10.1 8.1 15.1 9.5 10.3 2.9 2.0 4.5 1.9 5.0 10.1 2.4 5.0 4.3 3.5 9.1 2.8 3.9 6.1 3.5 2.1 3.2 1.2 5.5 5.4 6.7 4.4 3.7 1.6 9.4 4.4 3.9 2.4 4.1 23.5 6.0 8.0 2.1 5.5 5.8 7.9 5.4 5.2 4.3 3.6 3.2 4.9 6.0 11.0 5.7 1.5 7.1 7.3 13.3 2.6 5.0 9.6 11.8 3.8 4.5 4.0 3.0 9.5 8.0 7.6 6.9 4.2 2.2 9.3 8.4 5.5 5.4 7.3 4.2 3.0 20.8 6.7 3.5 4.3 9.7 5.3 4.3 1.7 2.8 10.1 1.9 4.8 2.0 5.5 7.6 1.8 2.9 5.6 7.2 4.5 5.0 1.2 2.0 4.0 2.4 9.0 13.1 20.2 11.3 9.8 7.3 21.3 11.2 12.6 18.4 8.9 14.1 17.5 7.4 10.2 13.9 2.0 5.1 4.0 10.3 10.4 19.6 4.0 1.7 7.1 1.6 10.0 16.3 0.0 5.8 3.4 6.9 7.2 11.6 9.8 8.0 6.4 6.9 20.3 10.5 1.3 10.6 15.3 8.5 5.4 11.8 12.3 6.8 11.5 9.9 2.4 23.5 12.9 5.6 15.1 10.6 14.1 3.3 34.9 14.0 8.9 ZNF280D "FLJ20086, SUHW4, ZNF634" ENSG00000137871 "Zinc finger protein 280D" Q6N043 15 56630181-56734086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA030233 Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus, Centrosome" "HPA030233: AB_10602590" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.55e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-2)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.15e-2)" "unprognostic (3.63e-1)" "unprognostic (7.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (1.98e-1)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "unprognostic (7.72e-2)" 16.5 15.7 10.5 9.2 13.3 22.8 16.5 23.0 18.8 21.1 14.3 14.2 12.6 8.1 21.2 9.0 12.0 18.2 9.9 11.4 10.3 7.0 11.0 14.0 11.4 9.8 11.3 14.9 27.2 16.9 14.4 28.0 12.2 16.9 18.1 12.4 8.5 18.8 11.7 22.0 9.8 11.2 24.8 16.3 11.1 14.6 8.4 14.5 46.3 13.6 8.4 10.0 23.6 19.6 6.1 5.9 10.0 4.1 3.0 4.3 1.8 8.6 4.9 9.1 13.9 9.2 12.9 6.7 13.4 9.5 5.6 6.4 3.4 9.0 14.6 5.6 9.4 5.3 6.4 4.5 3.5 6.7 7.4 2.7 1.5 8.1 5.3 9.2 13.1 4.4 8.4 4.9 3.8 5.4 13.7 12.2 15.2 7.6 17.0 8.5 6.1 8.7 1.5 0.0 10.2 4.0 2.8 15.0 10.4 6.5 10.1 7.3 13.4 11.2 6.9 4.3 0.5 7.6 12.2 10.7 8.2 12.4 7.5 10.7 8.9 13.4 0.0 9.2 19.5 8.8 10.0 4.1 5.4 3.6 3.7 3.6 6.1 3.4 3.1 5.9 5.5 3.5 4.3 0.6 3.0 3.2 5.9 3.0 1.8 10.5 13.3 23.0 18.8 10.3 7.0 11.3 14.9 16.9 14.5 8.9 17.6 17.1 16.1 9.8 79.9 32.7 15.3 9.4 13.6 3.5 78.5 18.6 6.6 10.3 12.9 31.2 14.9 0.0 12.2 17.5 22.1 18.3 17.3 26.7 30.7 65.2 31.0 31.9 32.7 32.5 30.8 15.5 15.1 10.0 22.7 21.1 10.9 3.5 19.8 11.5 78.5 6.5 18.4 45.7 26.2 12.2 11.1 18.8 19.7 11.6 ZNF282 HUB1 ENSG00000170265 "Zinc finger protein 282" Q9UDV7 7 149195485-149226248 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024374 Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024374: AB_1851322" "unprognostic (1.79e-1)" "unprognostic (6.97e-2)" "unprognostic (1.19e-3)" "unprognostic (5.23e-3)" "unprognostic (3.11e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (2.73e-1)" "unprognostic (3.34e-2)" "unprognostic (1.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (7.88e-2)" "unprognostic (1.54e-1)" "unprognostic (2.03e-2)" 13.6 11.7 12.6 12.7 11.5 17.5 13.1 20.7 18.1 19.1 16.1 16.6 16.8 17.7 17.9 14.1 17.9 17.2 18.1 12.5 10.2 8.4 12.4 14.4 12.3 11.2 10.8 11.8 18.5 26.6 12.2 12.3 24.9 10.8 21.4 7.8 13.3 17.8 15.8 20.7 19.5 14.5 15.1 8.9 15.2 14.6 6.4 12.9 14.2 14.1 16.3 12.7 17.0 13.8 3.9 2.4 3.5 1.8 1.8 3.4 1.0 11.6 11.5 6.8 16.3 6.0 7.1 10.0 10.6 7.8 9.4 9.4 10.5 12.8 11.7 16.1 6.6 8.3 12.9 8.0 10.1 3.6 17.6 28.2 9.8 7.5 8.9 8.9 12.3 11.1 8.1 13.8 9.0 9.9 7.1 9.7 7.9 18.8 9.2 5.0 13.7 25.9 18.3 22.0 6.7 14.5 16.9 6.6 16.3 5.1 11.2 15.5 14.8 11.8 14.2 9.7 3.8 9.1 12.0 12.1 13.5 3.0 16.1 15.4 13.3 7.9 8.7 11.2 10.7 11.5 0.0 1.8 3.5 2.1 1.5 2.3 0.9 2.7 2.1 1.0 3.9 1.4 1.8 1.8 1.8 1.7 2.4 3.4 1.0 12.6 11.5 20.7 18.1 10.2 8.4 10.8 11.8 10.8 12.9 3.0 5.0 1.9 2.4 6.4 10.9 4.0 7.6 0.0 2.3 1.8 3.9 9.2 0.0 4.4 25.4 4.5 8.3 0.0 3.7 4.7 4.7 4.3 5.7 7.5 5.3 14.3 12.6 6.2 4.5 21.6 5.8 2.5 1.7 3.6 10.2 5.4 5.3 9.5 5.3 3.2 7.0 12.9 3.8 1.1 1.2 5.6 4.2 1.5 9.3 3.3 ZNF286B "ZNF286C, ZNF286L, ZNF590" ENSG00000249459 "Zinc finger protein 286B" P0CG31 17 18658429-18682262 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 5.8;Cholangiocytes: 5.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA068125 Uncertain Approved "Nuclear speckles,Cytosol" No No "Nuclear speckles" Cytosol "HPA068125: AB_2685960" "unprognostic (3.15e-1)" "unprognostic (1.23e-1)" "unprognostic (3.81e-1)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.78e-2)" "unprognostic (1.47e-3)" "unprognostic (3.20e-1)" "unprognostic (5.52e-3)" "unprognostic (1.97e-1)" "unprognostic (1.05e-4)" "unprognostic (1.50e-1)" "unprognostic (9.20e-4)" "unprognostic (1.16e-1)" "unprognostic (3.82e-1)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" 0.7 0.9 1.4 1.2 1.4 0.8 1.5 6.5 2.8 2.0 1.2 0.3 3.4 1.8 2.3 1.9 1.1 0.8 1.5 1.8 1.6 0.2 0.7 1.2 1.4 5.4 0.6 1.3 1.4 1.0 1.4 1.4 0.8 1.4 2.9 1.4 0.9 1.9 1.5 1.3 1.2 1.1 1.0 1.6 1.4 1.7 3.0 0.9 1.1 1.7 3.2 4.2 1.0 3.0 2.6 5.1 5.1 2.0 3.3 4.0 2.7 0.8 1.3 1.1 6.1 0.3 4.2 1.6 2.2 1.2 3.4 5.5 2.0 2.7 1.8 5.8 2.7 2.0 1.0 2.5 0.0 2.4 3.6 2.0 5.9 2.9 2.5 3.0 5.0 1.8 0.4 2.8 1.1 6.3 1.9 2.1 1.8 0.8 3.0 7.7 0.1 1.0 0.9 2.9 9.1 4.1 1.3 2.3 11.0 3.7 1.2 2.9 1.6 6.1 4.4 4.2 2.0 2.5 0.2 1.6 1.3 3.7 1.1 0.8 0.5 3.4 0.9 3.0 2.1 3.2 3.8 0.7 3.0 3.9 4.2 0.9 3.2 1.7 0.9 3.5 1.0 3.0 0.0 0.5 0.6 5.8 1.6 1.2 5.1 0.0 0.0 1.8 2.0 0.9 0.0 1.2 0.6 2.5 0.0 0.0 1.1 1.4 3.6 0.6 1.1 0.4 0.4 0.0 0.0 4.3 1.2 0.2 2.0 0.5 1.7 0.0 0.8 0.5 1.3 0.8 1.4 0.6 0.5 0.0 1.0 1.9 2.5 4.0 0.6 0.8 0.6 0.4 ZNF30 "DKFZp686N19164, FLJ20562, KOX28" ENSG00000168661 "Zinc finger protein 30" P17039 19 34926903-34945170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 12.7;Rod photoreceptor cells: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA030400 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030400: AB_10603245" "unprognostic (3.04e-1)" "unprognostic (9.77e-2)" "unprognostic (9.69e-2)" "unprognostic (3.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.49e-2)" "unprognostic (5.10e-3)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.16e-4)" "unprognostic (5.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-2)" 3.4 5.2 11.1 2.6 10.9 0.7 5.9 21.4 11.6 5.3 3.9 5.0 2.9 4.2 4.5 3.4 3.4 7.0 2.6 5.0 7.0 5.4 4.6 6.5 6.0 5.1 10.0 6.5 5.6 6.9 6.4 7.7 3.3 6.6 5.8 4.5 5.8 4.6 5.2 5.3 5.6 3.9 5.1 7.2 5.4 4.8 3.9 8.3 2.4 4.4 2.0 5.1 3.8 4.0 3.4 1.3 2.8 0.4 6.9 7.2 1.8 3.6 8.2 3.5 8.8 6.3 4.0 0.1 3.6 2.6 3.3 3.7 5.8 1.2 0.0 4.8 2.3 1.2 2.3 10.1 5.1 4.2 0.0 4.8 2.7 4.4 4.4 3.2 3.6 2.5 3.5 4.6 3.3 4.4 1.4 5.2 7.2 8.7 0.0 5.3 2.7 2.6 1.6 4.9 8.9 4.3 3.4 2.7 0.9 2.5 3.2 4.6 6.6 0.0 0.1 3.4 3.8 3.3 1.0 3.7 7.0 3.7 2.5 4.8 2.4 11.5 1.0 1.4 0.0 4.0 2.8 0.1 0.1 4.8 0.4 4.7 3.4 3.8 2.2 1.3 2.1 7.2 7.2 0.0 6.9 0.0 1.2 3.4 1.8 11.1 10.9 21.4 11.6 7.0 5.4 10.0 6.5 6.6 8.3 0.0 0.6 0.0 0.2 0.3 5.3 2.8 0.0 4.0 0.0 1.8 5.9 0.1 3.3 0.9 0.2 3.5 0.0 0.0 1.2 0.5 0.6 0.3 5.7 1.0 0.7 12.7 1.2 5.5 1.8 0.4 2.0 0.1 1.7 0.0 1.4 3.5 1.0 0.0 2.1 1.3 10.0 0.0 1.0 2.6 2.4 0.1 0.0 1.7 1.3 0.3 ZNF304 ENSG00000131845 "Zinc finger protein 304" Q9HCX3 19 57351307-57359898 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ito cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050531 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA050531: AB_2681160" "unprognostic (4.44e-1)" "unprognostic (1.73e-3)" "unprognostic (5.63e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (9.72e-2)" "unprognostic (2.86e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.54e-1)" "unprognostic (1.28e-3)" "unprognostic (5.97e-2)" "prognostic favorable (1.52e-7)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (4.31e-1)" "unprognostic (9.00e-3)" 8.5 11.3 8.5 7.8 13.5 6.0 10.8 20.1 12.0 7.7 8.5 7.7 7.2 4.2 9.3 12.6 8.8 8.9 7.1 10.6 7.1 7.0 7.6 5.6 8.7 11.8 8.8 11.0 11.7 5.2 16.4 9.6 9.0 8.6 9.7 5.2 7.4 8.1 10.9 8.5 9.9 7.1 8.8 6.7 11.0 6.8 6.9 8.6 11.1 11.7 9.9 11.4 9.2 6.1 5.5 3.9 5.7 5.6 5.9 6.1 3.8 5.6 2.8 6.9 8.7 5.7 5.4 4.3 5.6 8.7 6.5 14.8 0.0 2.6 4.6 3.6 6.5 3.4 2.0 3.9 7.5 9.6 1.5 18.4 7.4 7.3 3.9 4.1 4.0 4.6 6.6 10.0 6.2 8.8 6.9 4.1 10.5 2.2 0.0 6.8 1.5 8.5 2.3 4.6 0.0 8.9 5.5 11.1 5.9 4.6 12.1 5.5 5.9 5.9 4.6 4.0 6.5 5.6 5.9 4.6 9.3 5.5 2.8 6.0 7.5 6.4 6.9 5.7 0.1 4.7 5.7 2.8 2.3 3.3 2.3 6.1 5.5 5.6 4.6 3.9 4.6 4.7 4.8 0.2 5.9 5.6 2.1 4.4 3.8 8.5 13.5 20.1 12.0 7.1 7.0 8.8 11.0 8.6 8.6 0.0 0.3 2.0 0.6 5.7 6.0 4.0 7.6 6.7 5.7 0.0 0.0 1.5 1.7 1.4 0.3 3.7 0.4 0.0 0.9 0.7 1.3 1.4 0.0 2.1 1.3 3.2 0.0 9.2 1.9 0.6 1.7 1.4 3.3 0.0 1.5 1.0 0.8 0.0 2.1 1.3 2.3 0.0 2.0 1.6 4.2 4.8 0.9 2.5 0.9 1.0 ZNF318 "HRIHFB2436, ZFP318" ENSG00000171467 "Zinc finger protein 318" Q5VUA4 6 43307134-43369478 "Predicted intracellular proteins" "Meiosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 78.2;Spermatogonia: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "naive B-cell: 6.3" "Lineage enriched" "Detected in many" 4 "B-cells: 6.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027022, HPA027031" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027022: AB_1859189, HPA027031: AB_1859190" "unprognostic (1.64e-1)" "unprognostic (3.80e-1)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (1.97e-2)" "unprognostic (3.02e-2)" "unprognostic (2.53e-3)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (3.37e-2)" "unprognostic (8.24e-2)" "unprognostic (3.47e-1)" "unprognostic (4.61e-3)" "unprognostic (3.61e-1)" "unprognostic (3.00e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-2)" 8.3 7.1 14.2 15.3 13.7 9.9 12.2 24.7 17.7 12.5 8.9 10.4 9.2 7.1 12.7 11.1 7.0 9.0 7.1 7.6 12.8 6.3 7.3 8.3 9.2 23.6 15.4 9.4 13.2 8.6 14.6 8.0 7.9 11.4 10.2 8.2 7.9 7.9 8.6 8.6 11.7 10.0 9.2 9.0 14.6 6.8 39.2 16.8 10.0 13.7 4.7 23.6 9.8 10.9 6.3 0.9 0.4 0.7 0.7 1.4 0.5 15.4 3.9 11.3 18.8 10.0 9.0 5.6 6.7 8.9 8.2 7.1 4.1 2.0 24.6 3.8 8.9 9.6 7.0 12.6 5.9 10.7 6.4 6.4 6.8 5.0 6.5 5.0 12.1 5.5 5.7 6.3 6.9 6.1 6.9 6.3 7.0 9.1 12.3 8.6 5.5 3.6 7.7 5.1 26.2 3.7 4.5 11.0 3.9 4.5 3.7 10.4 6.4 5.2 4.6 5.5 9.2 5.7 16.9 6.3 11.5 5.7 7.7 6.6 7.3 5.9 17.6 3.6 9.3 6.4 0.0 0.7 0.0 1.4 0.5 0.4 1.4 1.2 0.9 0.9 6.3 0.9 1.0 0.4 0.7 0.4 0.7 1.2 0.5 14.2 13.7 24.7 17.7 12.8 6.3 15.4 9.4 11.4 16.8 8.9 12.6 7.3 4.2 8.7 15.4 7.7 12.7 6.7 7.9 8.7 7.9 4.9 3.3 4.1 21.1 4.7 5.7 0.0 4.0 3.8 6.4 3.2 5.8 16.8 5.5 23.8 5.2 14.1 10.8 12.9 5.8 6.6 3.3 4.6 4.9 10.2 4.2 9.1 9.2 3.4 12.1 25.8 3.9 78.2 41.7 4.4 1.5 5.0 8.5 1.3 ZNF322 "bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489" ENSG00000181315 "Zinc finger protein 322" Q6U7Q0 6 26634383-26659752 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043161, HPA046692" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA043161: AB_2678346, HPA046692: AB_2679755" "unprognostic (1.01e-2)" "unprognostic (2.81e-1)" "unprognostic (5.20e-2)" "unprognostic (3.39e-3)" "prognostic favorable (1.28e-4)" "unprognostic (1.21e-1)" "unprognostic (9.35e-2)" "prognostic favorable (8.57e-4)" "unprognostic (5.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.53e-1)" "unprognostic (2.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "unprognostic (3.55e-1)" "unprognostic (3.24e-2)" "unprognostic (5.71e-2)" 8.8 9.7 7.7 5.4 10.9 0.4 10.1 10.6 15.4 13.1 8.6 7.9 9.5 6.9 12.7 10.8 6.8 9.2 11.5 13.3 8.4 6.9 9.5 7.0 7.9 6.7 8.8 7.0 14.8 6.9 15.0 18.0 8.6 11.8 12.3 8.6 8.6 8.2 15.5 7.7 5.0 7.9 9.7 10.7 8.7 7.6 8.2 12.5 4.3 13.6 6.7 7.2 11.8 8.4 11.2 7.9 10.5 11.2 17.6 11.4 4.9 5.8 4.4 17.5 20.1 11.5 15.4 6.3 7.8 10.4 10.9 13.2 8.6 3.6 7.1 18.9 6.8 13.7 7.4 13.0 5.1 13.7 10.9 11.8 12.5 5.8 8.4 13.1 0.0 11.4 9.4 18.0 7.2 8.2 13.7 9.4 8.8 14.3 7.6 12.0 3.3 8.8 10.5 5.1 5.4 5.4 9.8 12.4 10.1 6.7 9.3 14.2 15.0 9.3 8.8 16.4 8.9 8.2 8.1 9.3 18.2 7.3 7.4 7.9 8.0 16.0 6.8 3.9 2.0 18.3 3.3 8.7 10.5 11.4 7.4 8.3 11.2 5.8 7.4 7.0 10.5 6.8 9.9 8.3 17.6 11.2 7.9 4.4 4.9 7.7 10.9 10.6 15.4 8.4 6.9 8.8 7.0 11.8 12.5 6.0 8.0 16.7 14.7 3.5 32.6 4.8 10.2 10.7 15.9 8.7 7.9 10.4 29.9 14.8 2.6 13.5 8.7 0.0 8.9 9.8 12.8 21.0 12.7 6.0 11.3 44.5 18.9 14.1 6.5 2.5 27.9 10.4 8.5 8.2 12.9 25.0 13.2 11.8 24.8 11.1 12.6 32.3 14.6 17.0 10.2 5.6 8.0 8.5 9.4 21.0 ZNF324 "ZF5128, ZNF324A" ENSG00000083812 "Zinc finger protein 324" O75467 19 58467045-58475436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 35.6;Horizontal cells: 31.8;Rod photoreceptor cells: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 35.6" HPA039774 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" No No "Nucleoplasm, Nuclear membrane, Cytosol" "HPA039774: AB_10673149" "unprognostic (8.60e-2)" "unprognostic (7.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.12e-3)" "unprognostic (3.69e-3)" "unprognostic (2.36e-2)" "unprognostic (5.09e-3)" "unprognostic (2.84e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.74e-5)" "unprognostic (6.39e-2)" "prognostic favorable (1.34e-7)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (3.56e-1)" 7.7 8.0 8.9 11.5 10.8 12.6 7.4 15.8 14.0 9.8 8.8 11.9 10.2 8.5 12.0 9.1 12.7 10.5 9.2 7.6 9.9 9.3 6.5 10.5 7.7 10.5 10.4 11.5 14.6 15.0 10.2 12.7 7.1 7.1 10.6 6.0 7.2 11.2 13.3 5.8 11.9 7.3 8.2 9.3 8.3 8.6 8.0 9.7 16.8 11.9 8.1 10.7 9.3 7.2 6.4 6.4 13.1 5.0 6.0 11.8 3.4 4.1 5.2 3.6 5.4 4.1 3.6 3.9 3.3 4.2 3.4 3.1 4.6 2.1 6.5 3.2 2.8 4.9 5.3 4.6 4.6 1.6 5.6 35.6 4.5 4.0 2.2 3.3 7.5 5.3 2.7 5.8 4.8 2.2 3.9 2.4 5.6 6.3 4.2 3.7 3.3 6.7 4.1 2.8 4.4 7.9 7.2 4.5 4.1 2.4 8.3 7.3 5.7 3.7 6.0 2.6 2.9 3.0 5.5 4.2 10.3 2.3 3.6 5.7 6.2 6.2 3.3 5.2 3.6 3.2 2.3 4.7 7.2 9.5 5.0 10.7 5.3 7.6 10.5 3.2 6.4 11.8 8.9 13.1 6.0 3.9 6.4 7.2 3.4 8.9 10.8 15.8 14.0 9.9 9.3 10.4 11.5 7.1 9.7 0.0 1.7 5.1 4.5 8.0 35.6 5.6 2.5 2.7 3.4 0.0 23.6 4.1 0.0 4.0 0.9 4.2 9.2 0.0 3.6 3.2 4.6 5.2 1.1 2.9 2.5 31.8 7.5 5.5 1.8 0.7 11.8 3.6 3.3 1.8 5.0 16.4 3.2 7.4 13.8 1.4 57.5 6.5 7.8 10.7 13.8 11.7 5.6 8.7 5.6 4.1 ZNF324B FLJ45850 ENSG00000249471 "Zinc finger protein 324B" Q6AW86 19 58451604-58457833 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "NK-cell: 8.3" "Lineage enriched" "Detected in many" 6 "NK-cells: 8.3" "Cell line enhanced" "Detected in many" "HEK 293: 29.4" HPA023400 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023400: AB_1859195" "unprognostic (2.75e-1)" "unprognostic (2.36e-2)" "unprognostic (2.27e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-1)" "unprognostic (5.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.47e-3)" "unprognostic (2.65e-1)" "unprognostic (3.21e-1)" "prognostic favorable (2.83e-4)" "unprognostic (5.58e-2)" "unprognostic (2.43e-1)" "unprognostic (9.50e-2)" "unprognostic (1.40e-1)" "unprognostic (1.56e-3)" "unprognostic (2.94e-2)" 7.4 6.2 6.9 8.3 12.4 5.0 9.0 11.4 12.6 8.7 5.9 7.6 9.8 5.9 8.5 5.0 8.4 9.0 6.8 4.7 6.6 5.5 6.2 6.6 7.3 6.8 9.1 7.0 10.2 10.1 8.0 8.4 4.8 8.8 7.5 6.1 8.4 8.9 8.5 8.2 11.2 6.0 7.4 5.3 10.3 8.0 11.3 9.3 9.4 8.0 6.0 6.4 9.3 6.9 1.1 0.6 1.3 1.0 8.3 1.3 0.7 4.3 7.2 4.0 6.6 2.8 2.5 2.9 3.9 2.9 3.2 2.3 2.5 1.9 5.9 2.5 2.3 3.3 3.6 5.2 3.6 2.5 6.0 29.4 5.1 5.4 1.0 2.9 8.3 7.6 2.5 3.6 3.6 3.1 2.1 2.3 5.3 7.3 3.6 3.3 2.8 6.1 2.0 2.2 5.1 4.1 5.8 5.2 3.5 2.1 8.7 9.5 5.4 3.7 6.0 0.9 2.9 2.2 2.4 2.6 7.7 2.0 4.1 6.3 7.8 7.0 4.4 3.0 3.6 2.9 0.0 1.0 0.1 1.3 0.6 0.9 0.5 0.6 0.9 0.6 1.1 1.3 0.9 1.3 8.3 0.4 0.6 0.4 0.7 6.9 12.4 11.4 12.6 6.6 5.5 9.1 7.0 8.8 9.3 0.0 0.3 0.5 0.9 0.7 3.0 0.8 0.0 2.7 3.4 1.8 21.6 0.8 0.0 2.0 0.7 0.7 1.1 0.0 1.4 0.7 1.1 0.6 0.0 1.0 0.8 4.8 0.0 1.3 1.9 1.3 2.8 0.4 0.0 1.8 0.8 1.5 1.5 0.0 2.5 0.8 5.8 6.5 1.1 3.1 1.9 0.9 0.6 1.5 1.1 0.9 ZNF334 bA179N14.1 ENSG00000198185 "Zinc finger protein 334" Q9HCZ1 20 46499630-46513559 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "NK-cell: 2.7;plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 5 "dendritic cells: 3.6;NK-cells: 2.7" "Cell line enhanced" "Detected in many" "AF22: 12.1;BEWO: 15.2;NTERA-2: 8.1;SCLC-21H: 10.1;SuSa: 18.1" "Low region specificity" "Detected in all" HPA050022 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050022: AB_2680994" "unprognostic (3.04e-2)" "unprognostic (1.28e-2)" "unprognostic (3.68e-1)" "unprognostic (2.74e-4)" "unprognostic (9.08e-2)" "unprognostic (5.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (3.62e-2)" "unprognostic (8.25e-2)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.55e-3)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" "unprognostic (1.71e-3)" 3.1 7.3 11.1 2.2 14.3 1.9 9.5 18.2 12.0 6.4 2.6 8.1 11.5 2.9 9.2 13.4 2.4 12.1 5.8 2.1 9.8 7.8 6.8 4.1 4.7 2.1 5.8 6.9 22.5 7.5 2.9 20.4 7.0 11.5 12.8 3.5 7.0 6.8 10.0 1.5 3.0 3.8 4.9 7.6 3.1 7.0 8.3 8.8 2.7 10.8 1.7 1.8 5.2 4.5 0.4 3.6 0.2 0.5 2.7 0.1 0.1 0.0 0.0 12.1 0.0 0.8 0.1 15.2 1.0 0.1 0.9 0.1 0.0 3.1 0.0 0.0 0.3 3.7 0.0 0.0 0.2 0.4 0.0 2.5 3.8 0.1 4.3 3.3 0.0 0.0 3.9 0.0 1.0 0.0 0.5 0.1 0.1 2.5 0.0 0.1 0.0 0.0 6.8 8.1 2.0 1.0 0.0 0.0 0.0 3.3 2.9 10.1 5.7 0.0 0.3 0.2 18.1 0.0 3.4 0.0 0.1 5.5 0.1 0.0 0.9 4.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.2 0.2 0.1 0.0 0.1 2.7 0.0 3.6 0.0 0.1 11.1 14.3 18.2 12.0 9.8 7.8 5.8 6.9 11.5 8.8 8.9 5.0 0.0 3.4 0.1 11.8 1.4 2.5 13.4 9.1 3.5 2.0 3.6 5.0 3.8 0.4 1.1 0.0 0.0 1.1 3.1 2.0 2.2 2.3 1.0 1.4 9.5 0.0 3.7 0.0 1.3 2.6 0.0 0.0 0.0 1.3 11.0 1.9 0.0 1.8 2.8 11.0 0.0 1.6 5.1 7.7 0.0 0.8 0.0 1.6 1.4 ZNF34 KOX32 ENSG00000196378 "Zinc finger protein 34" Q8IZ26 8 144773114-144787345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA053925, HPA060755, HPA066805" Uncertain Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA053925: AB_2682311, HPA060755: AB_2684354, HPA066805: AB_2685725" "unprognostic (2.54e-1)" "unprognostic (3.50e-1)" "unprognostic (5.01e-2)" "unprognostic (7.60e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-2)" "unprognostic (3.26e-2)" "unprognostic (3.54e-2)" "unprognostic (2.85e-2)" "unprognostic (1.40e-2)" "unprognostic (9.84e-3)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (5.80e-2)" "unprognostic (2.09e-3)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" 9.0 5.7 12.3 4.1 11.5 4.6 8.6 28.5 14.4 10.0 9.4 12.6 7.8 3.6 10.0 8.0 6.3 10.4 6.6 7.5 13.4 7.8 6.4 6.5 7.5 5.8 17.2 13.8 17.0 7.8 12.5 11.5 7.6 12.2 8.7 6.0 8.3 5.6 12.7 5.9 8.0 5.4 10.7 11.8 6.0 5.9 7.1 16.0 4.1 11.1 1.8 4.7 8.7 7.8 7.2 10.4 12.7 15.2 5.5 8.5 5.0 3.0 5.3 8.9 6.6 7.6 7.4 2.4 2.9 6.2 7.3 6.1 1.2 5.1 5.0 5.5 7.3 4.2 3.1 5.1 5.8 5.5 4.9 4.3 9.6 8.2 4.0 6.9 2.5 5.0 7.9 6.8 5.8 11.9 7.5 4.9 3.2 6.4 4.1 6.3 7.8 5.5 3.9 6.4 7.1 5.6 5.0 3.6 6.0 4.1 3.1 8.4 6.3 6.7 4.7 4.5 5.9 5.3 3.2 3.5 6.7 5.9 5.6 5.6 5.1 1.7 5.7 4.9 4.1 8.0 8.1 7.0 12.7 7.4 6.4 6.5 6.8 6.9 8.5 10.4 7.2 4.9 7.4 1.0 5.5 15.2 4.9 5.4 5.0 12.3 11.5 28.5 14.4 13.4 7.8 17.2 13.8 12.2 16.0 6.0 3.2 0.9 1.5 3.3 7.1 2.0 0.0 1.4 4.5 0.0 0.0 2.2 5.0 2.7 6.0 4.9 1.3 0.0 1.2 2.1 3.3 1.5 4.7 2.4 1.6 12.7 0.0 3.7 1.9 5.5 6.6 3.1 3.3 12.6 1.9 5.4 1.2 1.9 4.6 1.4 8.7 6.5 4.7 9.3 6.3 4.3 1.9 4.1 2.3 0.7 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178694605-178730702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA052043: AB_2681706" "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favorable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 14.0 7.0 13.0 12.1 13.6 14.2 14.2 13.3 14.4 12.6 15.0 6.7 11.4 7.1 13.7 13.3 10.4 11.7 9.8 14.5 13.2 9.3 18.0 6.2 10.8 12.7 16.7 16.1 10.9 15.0 11.7 14.1 14.0 13.4 13.3 10.0 7.1 8.8 15.1 11.9 12.3 10.6 13.6 12.9 17.1 10.4 14.0 14.4 13.1 15.1 8.6 14.2 17.0 25.1 5.7 5.3 15.0 5.8 6.0 6.4 3.6 4.3 3.4 7.1 18.8 12.4 10.1 29.4 5.0 6.7 7.0 7.5 5.0 7.3 5.8 6.6 4.5 12.9 8.6 2.6 21.3 10.8 7.7 8.1 1.7 4.2 0.6 9.4 0.0 4.9 7.9 13.7 6.1 12.5 9.0 6.6 7.9 1.4 0.0 10.1 8.7 8.7 5.8 6.2 4.0 8.8 6.5 1.2 3.6 6.5 4.4 7.8 8.5 6.3 7.2 9.7 9.8 5.9 8.5 5.1 7.9 5.2 4.5 4.2 1.9 4.0 3.6 0.2 1.3 9.9 4.4 5.8 14.5 5.1 3.8 6.4 5.7 4.6 5.7 5.3 3.6 5.3 3.8 15.0 6.0 3.9 1.9 4.1 3.6 13.0 13.6 13.3 14.4 13.2 9.3 16.7 16.1 13.4 14.4 11.9 6.1 3.2 10.0 4.4 8.9 5.5 0.0 12.0 10.3 7.0 13.7 10.6 11.6 9.8 9.2 8.0 2.1 0.0 6.6 10.6 6.1 5.3 5.8 0.8 8.0 6.4 4.6 6.2 8.2 3.2 6.4 7.8 10.1 3.6 2.2 7.4 6.7 0.0 9.9 13.5 9.7 6.5 9.2 22.3 9.8 4.8 10.2 10.9 4.3 6.9 ZNF385A "DKFZp586G1122, Hzf, ZFP385, ZNF385" ENSG00000161642 "Zinc finger protein 385A" Q96PM9 12 54369133-54391298 "Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation, Translation regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 81.6" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 219.7;Cone photoreceptor cells: 161.0;Horizontal cells: 136.7;Rod photoreceptor cells: 153.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 15.3;intermediate monocyte: 16.8;myeloid DC: 16.6;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 10 "dendritic cells: 16.6;monocytes: 16.8" "Cell line enhanced" "Detected in many" "HaCaT: 29.4;HBEC3-KT: 28.0;HEL: 35.2;hTCEpi: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039799 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039799: AB_10795117" "unprognostic (8.56e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (6.70e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-3)" "unprognostic (2.30e-2)" "unprognostic (1.21e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (9.75e-5)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (2.43e-1)" "unprognostic (6.07e-3)" 23.7 4.3 23.6 16.3 27.3 16.8 7.9 13.2 32.5 7.9 5.7 12.8 2.3 4.8 3.2 10.7 28.1 6.2 8.9 4.3 18.4 22.6 2.3 3.8 11.6 8.9 31.8 15.4 2.0 2.0 13.8 8.5 12.6 19.4 10.3 5.4 35.5 8.9 10.1 5.9 81.6 5.7 8.7 16.4 13.9 4.4 2.1 16.1 5.5 18.1 21.9 21.9 25.8 14.9 0.8 16.6 1.6 16.8 0.0 0.2 6.6 0.8 3.4 5.3 6.6 6.1 4.1 14.6 0.6 2.6 2.8 2.4 7.0 2.6 1.9 2.4 1.4 2.2 29.4 2.0 28.0 0.9 1.8 2.8 35.2 2.3 1.3 2.7 0.5 24.7 3.6 31.6 3.1 7.9 6.8 1.7 4.9 16.9 0.1 1.2 15.6 1.7 5.0 3.0 3.3 2.7 6.2 0.4 6.9 2.1 23.0 2.3 10.6 0.2 19.9 1.4 6.4 23.5 14.7 1.7 1.5 3.5 1.7 1.7 0.5 0.1 1.6 6.3 1.6 3.8 1.6 15.3 0.0 0.0 16.8 0.0 0.6 0.0 0.0 16.6 0.8 0.0 0.2 1.2 0.0 11.9 1.6 0.0 6.6 23.6 27.3 13.2 32.5 18.4 22.6 31.8 15.4 19.4 16.1 0.0 0.0 5.0 20.2 32.2 219.7 3.1 2.5 2.7 2.3 8.7 161.0 56.0 8.3 3.5 0.4 2.9 0.0 0.0 0.5 5.3 14.9 11.9 1.1 1.0 53.9 136.7 4.6 2.5 63.8 0.0 13.8 52.2 8.5 19.0 0.0 74.9 2.2 0.0 8.5 2.1 153.5 0.0 4.7 2.2 2.5 57.7 91.1 1.3 0.0 27.3 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99486519-99500324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Uncertain Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favorable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.09e-4)" 11.3 8.3 10.0 11.5 11.8 77.5 12.2 16.4 13.2 10.8 10.9 11.7 8.8 10.7 11.0 7.7 12.2 11.2 9.3 10.4 7.9 6.2 9.4 9.5 12.6 12.2 11.2 6.6 14.3 12.0 7.9 16.2 8.4 9.7 13.0 9.1 10.1 10.1 9.0 14.8 13.6 13.5 9.1 9.1 19.1 10.9 9.5 11.0 15.6 11.4 8.8 17.5 11.9 11.6 17.6 22.3 31.6 17.0 24.3 29.3 17.0 7.8 7.8 5.3 11.1 8.2 5.6 10.5 6.7 8.9 7.8 7.6 8.2 8.7 9.4 9.7 6.9 11.0 7.6 7.1 8.5 7.7 6.8 9.4 9.2 9.3 9.0 6.6 13.1 16.1 7.4 7.4 7.6 8.1 5.8 8.9 8.4 13.2 18.7 7.1 14.7 13.5 21.5 11.8 9.8 9.4 7.7 5.8 16.3 8.4 11.2 6.3 13.1 7.8 19.0 12.6 13.5 4.9 16.3 9.3 9.5 9.5 13.6 8.3 15.4 16.1 15.2 6.7 13.3 9.9 31.6 14.3 24.1 23.1 17.0 24.2 17.6 23.6 25.0 15.6 17.2 29.3 23.1 26.3 24.3 16.7 22.3 25.2 17.0 10.0 11.8 16.4 13.2 7.9 6.2 11.2 6.6 9.7 11.0 14.9 22.4 32.0 29.5 31.6 8.1 7.0 2.5 20.1 11.4 10.4 11.8 13.3 14.9 13.3 5.6 16.9 25.5 0.0 12.4 14.8 17.4 23.7 57.7 10.5 16.3 14.3 20.0 12.9 22.1 1.1 14.4 20.8 27.0 15.4 14.7 12.4 14.1 18.6 12.7 9.5 10.6 12.9 17.0 42.5 30.3 31.0 24.8 44.5 15.8 52.9 ZNF395 "DKFZp434K1210, HDBP2, PBF, PRF-1" ENSG00000186918 "Zinc finger protein 395" Q9H8N7 8 28345585-28402701 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049382, HPA076275" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049382: , HPA076275: " "unprognostic (1.28e-1)" "unprognostic (3.02e-1)" "unprognostic (1.95e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (9.35e-3)" "unprognostic (8.90e-2)" "unprognostic (2.15e-2)" "unprognostic (7.08e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (2.46e-2)" "unprognostic (7.42e-2)" 17.4 10.7 10.0 13.3 10.9 18.6 19.0 7.4 10.1 16.8 22.5 9.7 13.4 12.1 12.0 11.9 27.2 16.9 14.1 15.0 10.4 5.4 13.1 19.5 11.3 18.0 9.0 6.8 33.8 27.8 9.8 9.5 19.6 7.6 22.1 8.3 13.7 21.7 11.1 13.8 23.2 16.3 13.8 8.8 11.9 14.2 12.3 10.8 9.6 18.2 10.2 25.3 27.5 27.6 13.7 6.4 10.6 4.2 3.3 7.2 2.1 49.8 7.1 6.9 18.8 5.2 7.6 19.7 6.1 10.8 4.9 11.8 11.3 8.8 23.8 21.2 9.5 11.5 10.8 6.1 15.0 9.7 3.9 4.8 5.9 1.5 2.3 5.4 2.4 2.5 13.3 20.7 0.9 12.9 14.2 2.6 8.1 6.1 5.3 6.8 8.5 11.2 7.7 10.7 12.2 8.4 11.0 7.4 7.9 11.5 9.9 18.9 19.6 1.5 3.8 9.8 6.2 7.5 5.9 0.7 10.5 12.8 5.6 2.5 6.5 3.3 15.6 27.7 4.9 9.2 6.7 4.2 10.6 4.8 0.8 4.6 10.0 5.6 5.6 1.6 13.7 7.2 4.9 1.8 3.3 0.6 6.4 2.1 2.1 10.0 10.9 7.4 10.1 10.4 5.4 9.0 6.8 7.6 10.8 29.8 20.7 18.5 16.7 14.9 9.0 9.3 2.5 13.4 18.2 8.7 13.7 12.7 3.3 15.9 0.6 11.7 16.0 0.0 20.7 16.9 18.0 13.9 10.5 26.8 5.1 6.4 26.2 22.1 13.8 0.6 23.0 4.7 10.1 0.0 22.3 17.3 27.8 0.0 17.0 6.7 9.7 25.8 10.3 0.5 2.1 10.0 5.3 8.3 29.2 8.1 ZNF397 "MGC13250, ZNF47, ZSCAN15" ENSG00000186812 "Zinc finger protein 397" Q8NF99 18 35241030-35267133 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026087 Uncertain Approved "Nucleoli,Plasma membrane,Microtubules,Cytosol" NA NA "Nucleoli, Plasma membrane, Cytosol" Microtubules "HPA026087: AB_1859243" "unprognostic (1.97e-1)" "unprognostic (2.82e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-1)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.74e-3)" "unprognostic (1.45e-2)" "unprognostic (1.48e-2)" "unprognostic (3.28e-2)" "prognostic favorable (9.44e-4)" "unprognostic (2.46e-2)" "unprognostic (2.17e-3)" "unprognostic (3.83e-2)" "unprognostic (4.44e-2)" "unprognostic (1.06e-1)" "unprognostic (2.09e-3)" 15.1 17.7 20.3 16.8 31.1 5.7 20.6 23.9 26.4 16.2 15.0 27.9 16.7 13.3 22.7 16.5 13.4 15.2 12.9 14.6 20.2 13.8 14.9 12.7 13.6 18.8 34.8 19.3 23.6 17.1 25.3 24.8 14.7 25.6 18.4 18.0 13.8 17.5 16.3 15.0 17.2 15.9 18.9 30.5 19.0 16.7 11.9 35.1 22.0 20.2 8.3 19.2 17.3 16.8 13.3 8.1 12.4 9.4 4.8 9.4 2.2 2.9 5.8 13.8 12.5 15.3 13.0 6.6 6.1 6.1 3.0 4.0 2.1 4.2 15.1 5.5 4.8 4.2 8.1 8.9 6.6 4.3 9.5 5.5 0.6 7.6 6.1 5.1 7.2 5.5 5.8 9.0 3.6 10.6 10.9 1.9 11.7 8.8 10.6 7.8 6.4 12.1 5.6 11.9 2.3 2.3 12.8 4.0 10.7 6.3 7.9 15.0 12.9 9.9 5.3 5.9 12.6 9.2 5.4 3.0 10.2 5.7 3.4 2.7 17.2 6.4 8.8 9.0 5.1 9.6 9.4 5.1 8.4 6.6 8.0 4.8 10.3 6.3 5.3 3.6 13.3 9.4 6.5 12.4 4.8 9.4 8.1 3.2 2.2 20.3 31.1 23.9 26.4 20.2 13.8 34.8 19.3 25.6 35.1 32.8 16.0 27.0 17.0 3.7 46.9 14.4 12.7 21.4 22.7 14.0 33.4 18.5 11.6 16.1 39.6 17.9 14.2 0.0 9.5 11.4 15.4 13.7 11.5 11.3 9.2 31.8 29.7 25.2 15.6 39.9 17.3 10.9 8.5 14.4 12.0 27.7 9.7 16.5 21.2 8.6 46.3 32.3 7.2 26.0 19.1 4.0 12.2 15.2 13.4 9.7 ZNF408 FLJ12827 ENSG00000175213 "Zinc finger protein 408" Q9H9D4 11 46700818-46705912 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017892 Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA017892: AB_1859248" "unprognostic (7.54e-2)" "unprognostic (2.41e-1)" "unprognostic (3.02e-3)" "unprognostic (1.20e-1)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (6.59e-5)" "unprognostic (3.01e-2)" "unprognostic (6.89e-2)" "unprognostic (1.42e-1)" "unprognostic (7.13e-3)" "unprognostic (5.77e-2)" "unprognostic (3.38e-2)" "unprognostic (9.99e-3)" "unprognostic (9.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.09e-2)" 7.5 5.8 6.6 7.9 7.8 20.8 10.4 11.9 8.4 9.3 11.4 6.9 5.8 8.6 9.9 4.3 9.7 8.1 8.6 8.8 6.6 5.3 6.2 14.8 5.6 10.7 7.4 3.7 9.6 16.4 4.2 6.6 11.7 4.9 9.6 5.0 6.6 13.8 8.0 11.3 11.3 8.2 6.1 8.4 9.2 8.9 13.1 6.5 14.2 10.8 6.6 9.9 10.4 13.0 11.9 9.9 10.0 11.1 7.6 14.6 9.3 4.0 9.9 4.7 8.3 5.9 5.1 12.1 5.4 7.7 11.2 8.4 8.9 4.6 6.5 5.1 6.6 8.3 10.5 5.8 10.8 4.0 4.9 12.0 6.1 6.4 10.6 11.1 6.7 8.9 10.2 10.6 5.7 8.0 6.0 5.5 9.8 9.5 5.8 4.6 13.2 7.7 12.8 19.2 13.9 12.1 8.6 7.0 9.9 5.8 10.8 6.6 8.6 10.7 13.5 8.5 4.5 11.8 11.1 6.2 11.1 7.3 9.1 10.8 8.3 7.2 9.5 7.2 7.3 8.8 5.2 10.4 10.0 12.7 11.1 9.7 9.3 12.0 14.6 9.9 11.9 13.7 10.4 9.6 7.6 8.1 7.7 10.7 9.3 6.6 7.8 11.9 8.4 6.6 5.3 7.4 3.7 4.9 6.5 6.0 2.1 6.4 4.3 6.0 5.4 4.0 5.1 1.4 1.2 1.8 0.0 8.9 10.0 7.3 4.4 3.1 7.7 0.0 4.2 5.0 4.8 3.3 0.0 6.2 4.6 3.2 8.1 8.0 5.9 2.0 5.8 3.1 10.1 5.4 6.8 6.5 5.1 2.9 6.0 4.3 3.6 12.9 5.1 8.7 7.8 3.6 8.8 5.0 5.8 5.0 ZNF414 "MGC15716, Zfp414" ENSG00000133250 "Zinc finger protein 414" Q96IQ9 19 8509678-8514164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 59.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053769 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053769: AB_2682255" "unprognostic (7.74e-2)" "unprognostic (2.52e-2)" "unprognostic (6.26e-3)" "prognostic favorable (4.17e-4)" "unprognostic (1.45e-1)" "prognostic favorable (1.67e-6)" "unprognostic (1.21e-1)" "unprognostic (2.32e-1)" "unprognostic (6.42e-2)" "unprognostic (7.29e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.08e-1)" "unprognostic (2.07e-2)" "unprognostic (3.84e-1)" "unprognostic (1.94e-1)" "unprognostic (1.91e-1)" "prognostic favorable (8.71e-4)" 16.6 16.2 14.3 13.6 22.7 20.8 10.6 17.6 28.6 13.2 10.9 22.4 5.6 21.4 16.6 10.0 11.6 11.6 9.7 9.9 14.1 11.4 12.0 13.1 10.7 15.8 15.5 14.8 16.7 13.7 9.2 15.3 14.0 17.3 15.8 4.6 13.4 20.5 14.1 23.6 25.5 16.6 7.7 12.5 22.8 19.1 13.6 20.3 19.9 15.7 6.1 13.5 11.8 12.3 3.0 3.4 5.4 2.1 2.5 2.7 1.2 5.4 4.7 2.6 4.2 0.7 1.7 5.8 4.1 1.6 2.7 2.5 4.2 2.7 7.6 12.2 1.3 2.0 7.7 0.8 3.4 0.4 6.8 19.1 4.8 4.4 4.9 3.8 4.1 6.5 3.1 2.5 2.2 0.9 1.5 1.1 4.8 6.3 11.2 1.7 6.8 9.3 24.2 7.7 1.4 13.5 10.9 1.3 7.6 1.9 4.5 9.0 14.0 4.6 3.5 3.7 0.5 6.7 4.8 4.3 8.1 4.1 11.7 5.4 16.4 6.8 5.9 6.5 3.5 4.3 3.0 1.6 0.8 1.8 1.4 1.0 2.5 2.7 2.7 1.6 3.0 2.6 2.6 5.4 2.5 2.1 3.4 1.4 1.2 14.3 22.7 17.6 28.6 14.1 11.4 15.5 14.8 17.3 20.3 0.0 0.6 4.9 12.9 10.5 17.5 1.7 7.6 0.0 0.0 3.5 9.8 23.8 13.3 3.0 21.5 6.7 11.9 0.0 4.7 18.3 12.7 8.8 4.6 9.7 11.4 11.1 21.4 11.1 9.1 59.9 19.0 9.6 8.5 5.4 12.8 17.9 3.8 11.5 15.2 13.5 18.9 12.9 7.8 24.4 30.2 10.7 26.3 10.5 11.7 8.1 ZNF416 FLJ20557 ENSG00000083817 "Zinc finger protein 416" Q9BWM5 19 57571566-57578927 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 7.9;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA063318 Approved "Nuclear bodies,Cytosol" No No Cytosol "Nuclear bodies" "HPA063318: AB_2684983" "unprognostic (1.40e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.99e-2)" "unprognostic (1.14e-2)" "unprognostic (7.57e-3)" "unprognostic (3.66e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.54e-2)" "unprognostic (6.62e-3)" "unprognostic (5.37e-2)" "prognostic favorable (1.20e-5)" "unprognostic (1.31e-1)" "unprognostic (2.62e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-1)" 6.1 6.8 7.0 5.1 10.7 5.0 8.7 13.0 10.7 6.8 6.1 7.0 5.9 3.2 6.9 9.5 8.9 8.2 4.4 6.1 6.5 5.3 6.1 4.6 6.7 7.1 5.3 8.6 10.9 3.9 8.7 7.0 6.6 5.8 6.7 4.9 7.0 6.3 7.6 6.6 13.5 4.8 8.2 3.8 6.3 4.9 9.3 8.1 12.8 8.8 4.8 9.1 7.7 6.9 9.7 4.4 1.9 2.8 9.5 9.4 4.3 3.3 3.3 7.0 5.5 4.3 6.1 4.7 3.3 6.1 6.6 4.3 2.3 1.8 2.3 2.5 4.3 4.8 1.2 4.0 5.7 8.3 3.6 16.4 5.4 3.6 1.9 7.7 4.7 3.5 6.1 6.0 4.2 8.9 5.3 4.6 5.6 0.8 1.9 8.8 1.4 9.9 2.2 8.2 3.9 6.1 5.0 10.4 4.9 4.6 7.1 5.0 5.7 6.0 3.2 3.0 8.2 2.9 5.8 3.4 7.2 3.5 2.3 5.0 5.8 9.5 6.2 1.6 3.2 4.4 1.1 2.8 1.9 4.8 2.1 8.9 7.4 6.8 7.2 4.4 9.7 9.4 6.8 0.9 9.5 1.8 3.9 3.1 4.3 7.0 10.7 13.0 10.7 6.5 5.3 5.3 8.6 5.8 8.1 0.0 0.3 2.2 1.3 1.4 3.3 0.8 2.5 0.0 1.2 0.0 0.0 1.8 3.3 2.4 2.7 1.0 0.4 0.0 0.7 0.7 1.3 1.0 2.3 1.0 1.4 7.9 0.0 0.0 0.8 1.3 0.9 0.0 0.0 0.0 1.5 2.9 1.1 0.0 0.7 1.3 2.5 6.5 0.7 0.2 4.1 2.0 1.6 0.5 0.6 1.4 ZNF436 "KIAA1710, Zfp46" ENSG00000125945 "Zinc finger protein 436" Q9C0F3 1 23359448-23369442 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 15.2;HSkMC: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043817 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043817: AB_10794774" "unprognostic (1.50e-1)" "unprognostic (2.91e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.10e-2)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (1.76e-1)" "unprognostic (1.92e-1)" "unprognostic (9.51e-3)" "unprognostic (5.04e-2)" "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (7.75e-3)" 14.5 18.6 10.1 4.7 13.0 2.9 12.9 13.6 15.8 10.7 8.7 11.8 8.6 6.3 15.1 17.5 18.4 10.2 11.2 11.7 9.9 6.1 6.7 4.3 7.8 5.6 12.9 9.6 20.3 8.1 11.6 6.5 8.5 11.3 12.1 6.9 6.3 16.9 13.4 7.2 15.6 6.1 12.7 12.6 8.0 6.8 10.4 10.0 5.7 12.3 9.7 8.0 12.5 11.2 1.6 2.8 1.6 2.1 6.6 2.3 1.6 2.8 1.8 6.5 3.4 7.3 15.2 3.1 2.5 3.5 3.3 3.9 1.0 2.4 1.9 2.9 3.6 2.1 3.5 11.6 4.3 3.6 2.3 2.5 2.0 3.7 1.6 2.9 0.8 1.4 27.7 6.3 2.8 3.3 6.0 4.7 2.3 2.4 1.4 3.5 1.3 2.1 1.6 0.2 1.3 2.8 2.8 2.7 1.8 2.7 7.2 3.0 3.7 7.1 3.6 2.8 2.3 2.0 1.0 3.7 2.8 2.1 2.2 1.4 2.1 2.6 1.6 2.2 1.7 2.2 0.0 1.8 1.6 2.0 2.1 2.0 1.3 1.4 2.1 2.8 1.6 2.3 2.0 1.3 6.6 2.0 0.4 2.2 1.6 10.1 13.0 13.6 15.8 9.9 6.1 12.9 9.6 11.3 10.0 0.0 0.3 0.8 1.0 4.6 3.6 4.8 2.5 2.7 0.0 5.2 5.9 2.9 0.0 2.7 0.9 8.7 2.7 0.0 4.3 1.5 4.6 3.4 0.0 3.0 1.8 9.5 3.5 1.8 2.6 1.1 9.2 0.7 5.0 6.4 3.9 11.8 3.9 5.8 11.0 2.1 2.1 0.0 2.0 4.7 6.0 8.4 2.4 1.0 2.9 1.1 ZNF438 bA330O11.1 ENSG00000183621 "Zinc finger protein 438" Q7Z4V0 10 30820207-31031937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 14.5;HUVEC TERT2: 14.6;U-937: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039843 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039843: AB_10795159" "unprognostic (1.69e-1)" "unprognostic (9.49e-3)" "unprognostic (3.72e-2)" "unprognostic (9.21e-2)" "unprognostic (4.75e-2)" "unprognostic (1.22e-2)" "unprognostic (3.98e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-2)" "unprognostic (4.85e-2)" "unprognostic (1.08e-2)" "unprognostic (9.96e-2)" "unprognostic (1.52e-1)" "unprognostic (8.52e-3)" "unprognostic (9.50e-2)" 21.8 5.8 9.8 10.0 10.2 7.9 9.7 11.8 9.9 10.6 12.9 13.0 2.6 6.2 22.6 11.3 8.3 10.2 9.2 13.8 9.3 6.2 6.2 8.6 12.0 7.1 10.1 6.6 10.2 4.5 6.6 17.3 6.4 9.6 9.0 6.9 7.7 9.5 9.6 29.1 8.9 7.6 14.3 8.6 13.6 8.3 10.1 11.9 7.7 15.8 8.7 5.2 10.5 12.1 3.1 3.1 14.1 7.8 3.8 3.9 3.5 2.8 2.8 2.4 2.1 14.5 10.1 1.4 2.2 3.2 3.5 4.4 0.1 3.4 3.8 2.6 3.9 3.3 0.7 1.2 1.7 5.0 8.7 0.9 1.6 1.6 0.1 8.1 1.3 1.8 4.8 2.9 5.0 2.9 3.2 14.6 4.5 3.2 2.7 4.8 2.0 4.3 7.3 0.2 2.0 1.2 1.9 3.5 2.2 5.0 0.7 1.8 2.0 1.1 0.4 1.5 1.7 1.1 12.3 6.1 1.6 2.7 4.7 2.7 0.6 1.0 0.0 3.2 19.2 1.1 1.4 7.8 3.3 2.3 7.4 1.7 1.2 1.8 3.0 2.4 3.1 3.6 2.0 14.1 3.8 4.4 3.1 3.9 3.5 9.8 10.2 11.8 9.9 9.3 6.2 10.1 6.6 9.6 11.9 3.0 3.7 0.5 1.9 0.9 5.4 10.1 2.5 5.3 5.7 3.5 5.9 2.7 6.6 3.0 9.5 3.7 2.0 0.0 3.8 4.0 3.1 1.0 11.6 1.0 7.0 3.2 0.0 6.2 11.7 5.7 3.7 9.1 0.0 3.6 2.5 1.8 3.2 0.0 7.8 2.7 5.0 6.5 5.1 6.4 6.4 2.0 1.4 1.8 2.3 2.0 ZNF44 "KOX7, ZNF504, ZNF55, ZNF58" ENSG00000197857 "Zinc finger protein 44" P15621 19 12224686-12294887 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 81.2;Early spermatids: 95.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003146 Supported Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA003146: AB_1080723" "unprognostic (1.51e-1)" "unprognostic (2.47e-3)" "unprognostic (7.07e-2)" "unprognostic (4.60e-2)" "unprognostic (9.63e-2)" "prognostic favorable (8.74e-4)" "unprognostic (8.39e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.65e-3)" "unprognostic (9.17e-2)" "unprognostic (1.75e-3)" "unprognostic (3.56e-3)" "unprognostic (7.30e-3)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (5.69e-2)" "prognostic favorable (9.21e-6)" 10.5 8.4 9.6 7.3 13.1 20.2 13.6 19.3 9.8 9.8 11.6 7.9 20.8 8.2 9.6 13.2 10.3 9.5 8.1 7.0 8.5 4.6 11.7 15.2 9.6 9.6 12.2 6.9 15.9 11.1 8.7 12.1 7.0 9.4 11.1 13.0 9.1 9.2 18.1 17.3 15.4 11.1 14.1 11.6 13.9 9.6 13.8 12.8 6.5 11.3 6.5 10.5 10.7 10.8 4.7 3.1 15.1 3.0 11.5 9.5 3.5 3.6 1.0 2.8 4.9 2.8 2.8 12.0 5.2 2.3 8.3 7.4 4.9 2.0 3.6 6.5 4.9 2.4 3.8 3.5 3.6 7.2 0.0 3.3 3.4 4.8 12.9 3.8 0.0 9.3 2.9 5.7 5.1 6.6 3.4 3.2 4.4 2.2 0.7 5.2 3.7 5.2 6.0 2.7 3.6 6.2 3.6 6.2 4.4 5.0 8.6 3.1 3.7 6.6 2.6 1.6 7.8 5.5 5.8 3.7 10.0 2.7 9.7 4.5 7.7 9.7 3.5 0.2 3.1 2.9 9.8 1.6 15.1 8.0 3.0 9.4 4.7 8.6 8.6 1.4 3.2 9.5 9.2 5.3 11.5 3.0 3.1 5.7 3.5 9.6 13.1 19.3 9.8 8.5 4.6 12.2 6.9 9.4 12.8 26.8 14.5 9.3 5.4 8.0 16.5 15.1 22.9 32.1 17.0 61.1 35.3 14.0 81.2 8.3 95.8 7.1 14.2 0.0 8.0 6.3 8.0 6.5 23.1 11.1 7.2 15.9 15.0 14.1 7.9 23.8 13.0 10.8 10.1 3.6 11.5 10.6 7.3 11.5 5.6 9.1 35.3 19.4 9.8 17.6 17.9 10.2 7.2 19.2 11.8 8.6 ZNF445 "ZKSCAN15, ZNF168, ZSCAN47" ENSG00000185219 "Zinc finger protein 445" P59923 3 44431720-44477670 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 34.4;Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006678 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA006678: AB_10603329" "unprognostic (7.72e-2)" "unprognostic (2.55e-1)" "unprognostic (1.12e-2)" "unprognostic (1.42e-1)" "unprognostic (7.14e-2)" "unprognostic (1.67e-2)" "unprognostic (1.79e-2)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.62e-1)" "unprognostic (1.03e-2)" "unprognostic (4.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.76e-1)" "unprognostic (2.48e-1)" "unprognostic (4.40e-3)" "unprognostic (1.05e-1)" 6.8 6.4 8.3 6.4 10.9 4.5 7.5 16.5 10.9 8.6 7.1 11.7 8.0 5.1 13.6 7.7 5.2 8.3 6.1 6.3 7.7 7.0 6.3 7.5 6.7 6.6 11.3 10.5 13.0 7.6 16.1 13.9 7.1 7.9 8.6 6.6 9.9 8.1 8.2 11.2 8.2 5.7 12.3 6.6 7.0 7.3 6.5 8.9 14.2 6.9 4.8 8.1 6.7 8.2 1.1 1.1 4.1 2.5 1.9 1.5 0.5 2.5 2.9 9.1 7.1 5.1 5.2 4.1 3.5 2.9 5.3 5.3 4.4 2.3 4.5 2.2 3.6 3.4 2.1 6.1 2.4 6.4 4.9 2.3 8.3 5.9 4.3 3.2 10.5 7.0 3.6 3.0 5.9 3.8 4.5 3.7 6.4 6.4 3.4 4.2 1.7 10.0 7.1 6.2 1.6 2.7 4.5 5.7 2.2 2.9 5.3 4.5 5.6 5.4 2.8 1.4 7.1 5.2 4.6 4.4 7.5 6.7 4.6 4.4 2.7 2.0 3.8 2.8 5.3 4.5 2.7 1.3 2.3 1.2 0.8 1.1 0.7 0.9 0.9 0.9 1.1 1.5 1.1 4.1 1.9 2.5 1.1 0.4 0.5 8.3 10.9 16.5 10.9 7.7 7.0 11.3 10.5 7.9 8.9 11.9 16.7 7.3 4.1 3.7 34.4 7.8 2.5 12.0 10.3 10.4 35.3 3.3 1.7 4.4 1.9 6.8 2.6 0.0 7.3 1.5 6.1 5.2 10.5 8.5 4.7 27.0 6.9 10.4 14.0 1.6 8.6 7.7 0.0 1.0 6.5 13.4 4.4 3.5 9.2 2.3 30.0 12.9 6.1 5.7 6.1 2.3 1.1 5.7 6.9 3.4 ZNF449 "FLJ23614, ZSCAN19" ENSG00000173275 "Zinc finger protein 449" Q6P9G9 X 135344796-135363152 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018079 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA018079: AB_1859277" "unprognostic (5.51e-3)" "unprognostic (1.64e-1)" "unprognostic (6.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (2.20e-1)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-2)" "unprognostic (4.86e-2)" "unprognostic (2.69e-1)" "unprognostic (5.31e-2)" "unprognostic (1.34e-3)" "unprognostic (1.28e-1)" "unprognostic (2.54e-1)" "unprognostic (9.61e-2)" "unprognostic (4.22e-2)" 13.7 15.8 5.3 6.7 10.4 1.9 11.6 7.5 10.8 10.1 7.2 6.0 4.8 5.0 14.0 10.9 7.5 6.0 8.6 8.3 5.0 6.1 6.1 5.0 7.3 5.8 6.3 9.6 9.7 16.1 12.5 9.8 11.0 12.2 9.6 5.5 6.6 8.6 7.5 7.6 5.8 5.3 12.4 5.0 9.5 7.6 4.8 4.7 5.3 10.6 4.6 6.4 12.1 8.9 1.5 2.6 3.6 6.6 5.6 5.7 2.2 2.9 4.3 8.7 7.1 7.9 15.9 4.3 5.7 4.4 3.7 9.0 1.4 4.0 1.8 7.4 4.5 5.0 3.4 6.1 2.5 5.9 2.5 5.1 2.4 4.1 2.1 6.0 1.9 3.7 6.1 7.7 3.1 9.2 5.2 6.9 4.7 2.3 2.1 10.4 1.7 2.4 2.2 3.0 2.9 4.7 2.0 5.9 2.7 5.5 1.7 2.1 5.2 1.4 4.2 4.3 5.8 3.1 2.1 6.8 8.5 3.1 5.7 5.0 1.6 2.0 1.4 3.3 3.3 5.5 1.7 2.7 3.6 3.0 3.4 5.7 1.5 2.7 4.1 2.6 1.1 2.6 2.6 0.6 5.6 6.6 1.5 2.4 2.2 5.3 10.4 7.5 10.8 5.0 6.1 6.3 9.6 12.2 4.7 0.0 2.1 0.5 0.8 0.8 6.6 8.1 0.0 2.7 1.2 1.8 0.0 1.9 0.0 1.4 0.2 3.6 0.4 0.0 0.6 1.7 2.5 1.0 1.1 0.5 3.3 9.5 2.9 8.0 2.2 0.0 4.9 2.2 3.3 5.4 1.1 4.4 1.2 0.8 3.9 0.3 2.9 0.0 1.3 1.0 2.2 1.9 1.0 1.8 0.6 0.3 ZNF480 MGC32104 ENSG00000198464 "Zinc finger protein 480" Q8WV37 19 52297177-52325922 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042218 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042218: AB_10794791" "unprognostic (1.50e-2)" "unprognostic (1.43e-1)" "unprognostic (1.56e-1)" "unprognostic (1.35e-1)" "unprognostic (3.01e-2)" "unprognostic (5.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (4.22e-2)" "unprognostic (7.81e-3)" "unprognostic (4.97e-2)" "prognostic favorable (2.03e-4)" "unprognostic (3.05e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-1)" "unprognostic (1.82e-3)" 9.8 8.4 8.2 7.9 15.4 7.0 7.1 13.6 12.5 6.5 8.3 4.8 3.4 7.9 6.2 2.4 8.5 4.5 4.7 17.9 8.7 3.2 10.9 7.5 8.4 9.8 13.1 4.1 6.0 3.8 5.6 10.7 6.2 12.5 5.9 8.6 4.9 8.4 5.5 12.9 8.0 9.3 5.1 8.7 15.0 8.0 3.3 12.6 10.8 8.4 7.9 12.3 8.7 8.2 16.6 17.0 9.4 9.1 14.6 15.0 5.9 3.2 13.4 8.8 10.2 10.4 9.8 7.0 8.6 12.7 6.2 7.3 6.0 4.8 16.7 5.4 7.1 11.4 7.2 9.4 8.7 9.0 0.1 15.8 17.0 6.7 5.7 10.0 24.0 13.9 8.9 11.2 8.5 10.1 13.0 8.9 14.6 12.2 6.0 13.8 5.4 21.9 4.9 6.8 10.9 11.0 11.3 9.3 13.8 8.9 23.9 8.6 7.2 12.5 9.1 3.5 18.9 7.5 17.7 15.2 6.2 7.8 3.5 13.3 13.7 25.3 34.6 2.7 13.2 10.9 7.7 8.5 9.4 12.0 8.2 13.7 16.6 12.0 13.9 10.4 16.5 11.5 15.0 3.6 14.6 9.1 17.0 13.4 5.9 8.2 15.4 13.6 12.5 8.7 3.2 13.1 4.1 12.5 12.6 32.8 10.2 16.1 11.4 4.8 4.0 37.0 10.2 20.1 14.8 3.5 2.0 7.5 14.9 15.0 1.5 18.5 10.3 23.3 24.0 12.9 7.1 10.7 11.6 13.5 15.1 6.4 12.1 14.7 14.0 2.1 8.3 16.7 6.8 19.8 17.3 4.1 29.6 8.6 7.8 20.7 6.6 0.0 9.2 1.8 5.6 7.3 12.4 23.5 16.1 18.3 ZNF484 "BA526D8.4, FLJ33884" ENSG00000127081 "Zinc finger protein 484" Q5JVG2 9 92845031-92878038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.0" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 6.7;Club cells: 7.9;Horizontal cells: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA028973 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA028973: AB_10610703" "unprognostic (5.52e-2)" "unprognostic (3.05e-2)" "unprognostic (1.72e-1)" "unprognostic (6.05e-2)" "unprognostic (5.69e-2)" "unprognostic (3.86e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-1)" "unprognostic (6.04e-2)" "unprognostic (9.84e-2)" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (4.03e-2)" "unprognostic (3.74e-1)" "unprognostic (4.77e-1)" "unprognostic (6.49e-2)" "unprognostic (1.51e-1)" 6.5 6.6 9.9 5.4 14.6 10.1 6.5 33.0 13.9 7.7 4.8 7.8 4.7 3.7 7.0 5.3 4.2 6.2 4.7 4.9 11.7 7.0 7.3 5.2 5.8 6.6 12.5 7.1 9.1 4.5 12.1 14.0 7.9 12.6 7.0 5.2 4.6 5.0 6.3 3.7 4.2 5.0 6.2 17.1 7.7 6.0 4.8 13.5 2.8 9.0 1.9 7.9 7.3 5.8 5.6 2.5 5.3 3.5 4.5 7.4 3.0 4.1 5.1 6.7 4.3 3.5 4.3 0.0 3.4 5.5 6.1 6.7 1.6 3.2 3.6 3.0 2.7 4.3 6.8 4.9 5.1 6.5 5.8 2.1 3.1 4.1 3.3 5.4 2.5 5.6 4.8 3.9 6.7 7.1 4.5 5.3 4.0 3.3 14.6 6.5 4.2 3.7 1.2 5.6 4.7 2.5 3.1 8.2 2.6 3.2 4.8 4.7 4.2 6.0 1.7 3.4 5.3 0.4 2.0 5.7 5.5 5.3 2.8 2.4 5.5 2.7 2.1 3.6 2.1 4.3 1.4 2.5 5.3 5.3 3.5 6.5 3.7 5.4 4.4 2.2 5.6 7.4 6.7 1.4 4.5 3.1 2.5 4.4 3.0 9.9 14.6 33.0 13.9 11.7 7.0 12.5 7.1 12.6 13.5 0.0 1.0 0.0 0.5 0.1 4.2 1.7 0.0 6.7 7.9 1.8 0.0 0.9 1.7 1.1 0.5 0.9 0.8 0.0 0.4 0.9 0.7 0.4 2.3 0.2 0.7 4.8 0.0 0.0 0.8 0.0 0.6 0.2 0.0 0.0 0.9 3.1 0.7 0.9 1.4 1.3 3.5 0.0 1.0 0.5 0.8 0.1 0.6 1.3 0.5 0.5 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" B1APH4 10 43436841-43483179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 78.9;Early spermatids: 155.2;Late spermatids: 196.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Yes No "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 4.1 2.7 4.8 2.7 5.3 5.1 3.9 11.1 9.1 4.6 3.5 3.3 2.2 3.3 5.1 3.1 2.8 7.9 4.9 3.2 6.6 5.0 3.3 3.1 4.0 2.9 5.6 7.4 6.1 2.3 3.7 6.9 2.6 11.2 3.3 2.7 4.0 2.5 4.0 1.7 3.3 3.5 4.2 8.1 3.1 3.0 32.1 6.4 4.3 4.4 2.0 2.9 4.3 3.4 3.2 5.1 13.9 3.9 3.5 4.7 2.6 2.4 2.3 2.8 3.0 3.6 7.2 0.7 4.0 6.9 3.7 4.0 3.6 6.6 6.1 0.7 4.7 3.7 3.9 0.9 1.5 4.6 0.6 1.5 1.9 0.5 2.0 4.4 1.9 2.8 7.1 3.3 6.0 4.5 7.5 1.3 1.3 1.0 1.2 2.7 4.1 3.9 1.6 0.8 1.3 2.5 2.0 1.0 2.4 8.2 2.6 2.8 1.9 3.4 2.0 2.2 1.8 3.1 2.3 2.0 3.4 2.4 1.9 1.1 0.5 1.6 6.7 8.2 2.7 1.3 2.5 3.9 5.8 4.7 2.8 4.0 2.8 3.5 4.3 5.1 3.2 3.0 3.6 13.9 3.5 1.5 3.9 1.8 2.6 4.8 5.3 11.1 9.1 6.6 5.0 5.6 7.4 11.2 6.4 20.8 3.7 7.2 5.4 1.5 4.9 3.1 5.1 78.9 9.1 5.2 7.9 1.4 10.0 3.7 155.2 4.9 5.2 0.0 1.8 3.3 4.0 5.1 0.0 2.4 3.0 6.4 7.5 3.7 5.7 196.9 4.4 5.6 1.7 2.8 4.6 8.0 1.7 3.7 6.3 9.1 17.1 0.0 3.6 6.7 7.6 2.5 1.4 5.0 3.0 5.5 ZNF488 FLJ32104 ENSG00000265763 "Zinc finger protein 488" Q96MN9 10 47365496-47384273 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 29.7;intestine: 25.8" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 23.7;HDLM-2: 34.3;RT4: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035957, HPA035958" Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA035957: AB_10672234, HPA035958: AB_2674887" "unprognostic (3.29e-2)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (1.49e-4)" "unprognostic (1.16e-1)" "unprognostic (8.85e-2)" "unprognostic (1.60e-3)" "unprognostic (2.13e-2)" "unprognostic (3.11e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (4.02e-7)" "unprognostic (3.60e-1)" "unprognostic (6.62e-5)" "unprognostic (2.76e-1)" "unprognostic (4.47e-1)" "unprognostic (8.10e-2)" "unprognostic (3.18e-2)" 0.4 0.4 5.7 0.4 18.5 0.3 1.2 2.9 14.2 0.5 3.2 17.0 0.0 25.8 0.5 2.3 0.9 0.5 0.6 0.4 15.1 1.1 0.3 0.5 0.3 19.8 6.0 0.7 0.3 0.3 0.0 4.1 21.4 0.6 1.1 0.0 0.6 0.4 0.3 2.2 12.5 0.4 29.7 0.3 0.6 1.2 12.8 0.0 0.3 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 6.8 1.2 0.3 0.0 0.0 0.1 0.2 0.3 0.4 0.4 2.7 6.4 0.1 0.4 0.0 2.7 23.7 0.6 2.6 0.3 34.3 0.7 0.1 0.7 0.2 0.0 0.0 0.3 0.0 6.2 0.2 0.6 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.2 0.1 1.8 5.1 0.6 0.0 3.0 0.0 0.1 19.1 5.7 1.0 1.6 0.2 0.0 2.7 0.5 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 5.6 5.0 0.3 0.0 0.0 1.0 0.0 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.1 30.2 0.0 0.8 0.3 ZNF500 "KIAA0557, ZKSCAN18, ZSCAN50" ENSG00000103199 "Zinc finger protein 500" O60304 16 4748239-4767624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA035498, HPA057963" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035498: AB_10602356, HPA057963: AB_2683565" "unprognostic (3.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.57e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (3.61e-3)" "unprognostic (8.72e-3)" "unprognostic (7.77e-3)" "unprognostic (1.45e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (4.07e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.41e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (3.19e-2)" 8.1 6.4 10.2 9.4 7.5 5.9 8.1 13.8 11.4 10.3 8.0 11.7 11.5 8.4 12.2 10.9 6.2 8.9 10.4 6.0 6.2 5.1 6.0 5.2 7.2 12.5 6.6 9.4 13.9 8.5 9.1 8.0 6.7 6.6 9.3 5.3 10.6 11.3 14.9 7.5 8.5 7.5 7.5 5.4 11.4 7.7 7.2 8.4 9.9 9.2 7.1 8.3 9.2 8.4 5.3 6.5 3.4 2.5 3.0 4.9 2.1 2.0 8.4 2.8 7.3 3.3 3.0 12.8 6.1 6.8 7.6 5.2 3.7 4.0 4.4 5.3 3.3 2.8 4.7 5.8 3.2 5.6 3.2 8.8 3.6 10.6 5.0 4.7 2.5 4.0 3.5 7.8 3.4 6.5 7.5 4.3 5.6 5.3 7.0 3.0 4.6 5.2 4.4 3.6 1.6 3.0 9.3 6.7 8.7 2.5 2.4 10.4 6.8 5.2 7.9 2.3 2.0 5.1 4.1 4.8 7.2 5.5 8.0 2.9 6.7 4.5 3.9 2.2 2.1 4.5 2.3 2.5 3.4 3.9 2.4 3.3 4.9 2.5 3.0 1.4 5.3 4.2 4.9 2.9 3.0 1.7 6.5 3.9 2.1 10.2 7.5 13.8 11.4 6.2 5.1 6.6 9.4 6.6 8.4 11.9 2.4 8.9 2.6 2.2 16.8 4.8 2.5 5.3 2.3 7.0 23.6 4.9 1.7 3.8 6.8 4.9 4.9 0.0 2.7 3.8 3.6 4.3 6.9 4.0 2.7 17.5 8.1 9.2 3.3 1.3 10.6 3.1 1.7 9.0 4.9 12.1 2.9 0.0 10.6 2.2 20.5 0.0 4.1 12.6 8.3 1.9 3.8 5.7 5.2 1.6 ZNF503 "FLJ45745, MGC2555, Nlz2" ENSG00000165655 "Zinc finger protein 503" Q96F45 10 75397830-75401906 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Smooth muscle cells: 105.0" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.6;myeloid DC: 1.4" "Group enriched" "Detected in many" 16 "dendritic cells: 1.4;monocytes: 1.6" "Cell line enhanced" "Detected in many" "HEK 293: 39.0;PC-3: 50.6;U-87 MG: 15.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026848 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA026848: AB_10610704" "unprognostic (1.18e-1)" "unprognostic (8.56e-2)" "unprognostic (8.63e-3)" "unprognostic (7.41e-2)" "unprognostic (2.82e-1)" "unprognostic (3.57e-2)" "unprognostic (9.63e-2)" "unprognostic (7.42e-2)" "unprognostic (3.42e-2)" "unprognostic (3.22e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (3.50e-4)" "prognostic favorable (1.97e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" 9.4 23.1 2.3 6.2 7.2 2.2 14.1 0.8 4.7 47.8 10.2 3.0 20.8 9.0 28.1 15.1 27.8 14.1 15.3 5.8 3.4 3.0 22.1 5.7 16.5 2.6 4.8 1.5 38.1 19.4 4.0 3.0 4.8 7.5 21.3 2.5 18.5 6.4 50.7 2.9 3.2 6.6 10.1 8.0 7.6 9.4 7.3 2.9 0.5 7.7 8.5 3.7 14.4 25.0 0.0 1.4 0.0 1.6 0.0 0.0 0.1 1.7 1.6 0.3 2.1 3.7 2.5 0.5 1.6 0.9 0.6 0.6 2.5 6.9 0.0 4.6 1.5 0.3 3.1 0.2 1.6 0.4 0.0 39.0 0.0 4.2 8.1 2.9 2.0 4.4 6.7 1.6 1.2 0.7 5.7 0.1 0.2 0.0 0.0 0.9 0.8 0.0 6.1 0.0 1.2 50.6 0.0 1.9 0.0 0.9 1.3 1.4 1.8 2.8 0.2 8.4 0.3 0.3 1.4 1.3 5.1 5.8 10.5 4.2 0.0 0.0 0.0 15.7 9.0 4.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.3 7.2 0.8 3.6 3.4 3.0 4.8 1.5 7.5 2.9 35.7 12.3 2.2 37.9 24.2 18.3 13.2 7.6 0.0 9.1 38.4 19.6 0.5 49.7 39.4 0.0 21.8 0.8 23.3 30.0 0.4 30.7 20.3 5.8 8.9 12.0 6.4 3.5 39.9 27.3 1.1 55.3 16.3 23.6 5.4 6.1 5.6 32.4 0.0 46.3 28.3 21.2 38.8 105.0 0.2 2.4 12.2 0.2 0.0 7.2 12.7 ZNF507 KIAA1084 ENSG00000168813 "Zinc finger protein 507" Q8TCN5 19 32345594-32387667 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030964, HPA049728" Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA030964: AB_10670562, HPA049728: AB_2680864" "unprognostic (3.39e-1)" "unprognostic (3.78e-2)" "unprognostic (6.84e-2)" "unprognostic (2.61e-2)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (1.41e-3)" "unprognostic (1.20e-1)" "unprognostic (3.24e-2)" "unprognostic (4.28e-3)" "unprognostic (7.24e-2)" "unprognostic (7.44e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (1.46e-2)" 10.9 8.7 11.3 16.0 13.1 13.5 12.0 18.4 16.4 12.0 11.4 9.0 10.2 10.0 12.4 9.8 9.6 12.2 10.3 10.1 9.4 8.1 9.0 11.1 8.2 10.5 12.3 10.3 18.6 10.9 13.6 15.7 16.9 11.1 10.7 9.9 6.8 11.0 9.6 21.0 8.6 14.7 11.9 12.9 9.6 9.7 28.3 13.0 17.1 18.7 10.0 10.5 11.0 20.1 4.0 0.4 2.3 1.4 2.0 4.7 1.4 9.3 18.6 13.8 8.6 9.1 14.3 11.2 8.4 8.2 7.7 8.7 10.7 7.3 13.8 10.4 8.0 8.4 5.4 20.1 10.4 14.9 10.7 18.3 14.2 8.9 7.2 10.9 11.8 7.8 9.0 8.0 9.9 16.1 8.0 10.3 11.6 20.8 11.2 8.1 5.8 12.7 3.9 14.8 13.8 5.9 13.2 16.1 5.6 4.7 10.4 11.4 9.9 11.1 7.5 9.1 11.5 5.9 8.5 11.0 12.4 13.3 7.2 10.8 10.9 12.6 14.3 8.7 8.7 11.1 0.4 0.1 2.3 4.1 0.0 4.7 2.5 3.1 2.8 0.0 4.0 4.2 3.4 2.0 2.0 1.4 0.4 2.4 1.4 11.3 13.1 18.4 16.4 9.4 8.1 12.3 10.3 11.1 13.0 8.9 15.3 7.3 5.9 2.5 19.9 12.6 2.5 22.7 11.4 0.0 13.7 8.0 1.7 5.1 13.1 6.3 8.1 0.0 4.8 4.4 5.7 9.3 3.5 9.6 2.9 55.6 8.6 12.9 0.3 8.2 8.6 1.1 1.7 0.0 14.3 19.5 4.9 10.5 6.7 3.5 25.0 0.0 7.2 20.4 16.2 2.4 7.3 8.7 11.2 6.8 ZNF516 "HsT287, KIAA0222" ENSG00000101493 "Zinc finger protein 516" Q92618 18 76358190-76495190 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.2" "Cell line enhanced" "Detected in many" "THP-1: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015792 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA015792: AB_1859314" "prognostic favorable (7.09e-4)" "unprognostic (7.28e-2)" "unprognostic (4.51e-1)" "unprognostic (1.22e-3)" "unprognostic (3.33e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.63e-3)" "unprognostic (3.14e-1)" "unprognostic (3.29e-2)" "prognostic favorable (7.96e-4)" "unprognostic (5.87e-2)" "prognostic favorable (1.21e-4)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" 4.2 5.4 8.3 5.7 9.9 15.1 4.7 2.0 4.8 20.8 5.9 4.5 18.6 4.1 25.2 8.0 6.3 15.8 3.9 3.5 5.1 2.9 3.4 5.1 5.0 4.2 4.7 3.9 17.0 4.6 8.7 10.8 2.6 6.4 7.3 1.8 13.1 6.4 13.3 8.6 6.3 4.1 9.1 3.3 6.3 4.5 18.6 4.6 3.0 4.8 4.0 4.9 8.0 10.9 0.4 1.6 12.2 2.2 1.0 0.6 0.4 1.5 1.7 12.4 16.3 3.7 5.5 1.5 9.4 7.9 2.0 3.8 3.5 5.7 8.1 2.0 10.0 5.1 3.3 6.8 9.0 1.4 0.0 5.3 0.7 0.0 7.6 9.1 5.3 5.4 10.4 4.1 4.3 4.5 2.8 2.3 3.4 0.0 0.0 2.0 3.2 0.1 9.5 6.2 1.0 0.4 3.5 1.3 4.1 3.2 7.0 12.5 7.7 0.1 0.0 10.1 5.2 2.0 21.7 1.5 4.7 8.2 0.1 0.9 0.0 0.2 6.2 2.8 3.7 12.0 2.7 2.2 3.0 0.1 1.5 0.6 0.1 0.2 0.1 1.6 0.4 0.6 0.3 12.2 1.0 1.6 1.0 0.0 0.4 8.3 9.9 2.0 4.8 5.1 2.9 4.7 3.9 6.4 4.6 8.9 8.5 3.9 14.0 17.3 14.8 7.6 7.6 9.4 2.3 1.8 29.5 0.2 3.3 4.9 69.3 9.0 5.2 0.0 2.5 0.3 10.2 10.7 1.1 11.3 7.1 3.2 12.1 8.0 20.3 27.6 28.1 14.9 11.8 8.2 5.4 6.5 4.5 5.3 32.9 4.4 29.5 12.9 17.3 3.4 33.4 17.7 0.5 2.9 3.5 17.5 ZNF528 KIAA1827 ENSG00000167555 "Zinc finger protein 528" Q3MIS6 19 52397849-52418412 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 24.5;U-266/84: 30.9" HPA065435 Approved "Nuclear speckles,Cytosol" No No "Nuclear speckles" Cytosol "HPA065435: " "unprognostic (1.90e-2)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (3.73e-1)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "unprognostic (9.60e-2)" "unprognostic (4.81e-3)" "unprognostic (1.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.42e-2)" "unprognostic (2.98e-3)" "unprognostic (3.26e-3)" "unprognostic (2.78e-2)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" 9.8 11.7 16.6 8.9 20.2 5.8 12.2 21.1 21.4 12.4 9.1 15.7 7.9 5.5 15.3 21.7 10.0 15.6 11.4 11.4 15.3 11.2 11.1 5.2 9.3 9.3 17.5 11.4 21.3 6.4 12.7 21.0 10.9 15.3 13.4 10.0 13.3 12.8 12.1 7.6 12.6 7.5 9.8 15.6 11.8 10.0 13.8 22.0 8.2 19.9 5.1 11.5 12.6 10.8 10.5 8.4 10.6 5.0 16.5 12.7 3.4 0.1 0.0 2.9 17.7 6.9 8.5 7.5 6.6 10.9 4.0 9.0 0.2 3.3 0.1 1.6 8.1 10.3 2.0 0.0 4.3 5.2 0.0 4.9 2.7 1.0 1.6 10.1 0.1 7.4 8.6 7.6 4.4 0.0 1.2 9.6 0.1 1.7 0.3 5.8 0.1 9.9 1.4 7.7 0.1 4.7 0.1 12.0 3.1 5.0 24.5 12.3 10.2 0.0 0.5 4.1 11.1 11.8 1.5 11.0 7.0 8.1 2.7 8.9 0.3 30.9 6.0 3.5 0.1 10.9 7.1 5.0 10.6 6.7 4.7 12.7 7.3 8.1 10.0 5.0 10.5 8.0 7.1 1.4 16.5 5.0 8.4 8.9 3.4 16.6 20.2 21.1 21.4 15.3 11.2 17.5 11.4 15.3 22.0 6.0 2.7 2.7 3.5 3.3 18.7 10.9 5.1 10.7 6.8 1.8 13.7 3.5 3.3 4.1 1.1 7.5 2.6 0.0 1.7 4.0 3.0 6.9 8.1 1.0 3.1 20.6 1.2 4.9 3.2 2.9 4.6 4.7 1.7 0.0 4.9 14.1 5.0 7.0 3.9 3.1 21.5 0.0 3.9 13.0 10.4 2.8 2.6 9.6 3.4 3.8 ZNF540 DKFZp547B0714 ENSG00000171817 "Zinc finger protein 540" Q8NDQ6 19 37551406-37614097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 30.7" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 23.5;Early spermatids: 14.0;Horizontal cells: 17.5;Rod photoreceptor cells: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 6.8" HPA003444 Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA003444: AB_1080732" "unprognostic (2.51e-2)" "unprognostic (2.30e-4)" "unprognostic (4.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-4)" "unprognostic (4.24e-4)" "unprognostic (3.44e-3)" "unprognostic (8.88e-4)" "unprognostic (2.65e-1)" "unprognostic (3.17e-1)" "unprognostic (3.38e-5)" "unprognostic (1.50e-1)" "unprognostic (1.09e-6)" "unprognostic (2.74e-1)" "unprognostic (4.75e-2)" "unprognostic (8.08e-2)" "unprognostic (8.33e-5)" 2.8 9.3 8.6 3.9 29.9 1.2 6.0 23.7 16.7 5.8 4.4 5.0 5.3 3.9 6.0 9.4 3.0 4.2 3.6 9.1 8.6 12.1 6.3 2.6 5.0 6.3 9.0 9.1 13.8 3.8 13.3 30.7 2.3 11.0 7.1 3.6 9.0 6.1 8.9 2.9 6.0 4.5 3.8 7.9 6.3 4.6 11.5 9.5 2.7 14.4 3.1 6.0 3.4 4.0 3.1 0.3 1.2 0.1 3.0 7.1 1.8 0.4 0.0 2.6 2.6 6.8 4.1 0.2 0.9 0.9 1.1 2.1 0.2 0.0 1.2 0.3 2.4 0.6 1.0 1.8 0.9 0.9 3.7 2.6 0.9 1.2 0.0 1.8 1.2 2.0 1.8 2.4 0.7 0.0 0.5 0.1 5.1 0.4 0.0 1.6 0.1 1.7 0.7 0.9 0.3 0.5 1.4 1.6 0.8 0.6 0.4 2.7 3.0 1.0 0.3 0.3 1.9 1.3 0.7 0.0 1.0 3.1 1.2 0.9 3.6 2.0 2.5 0.0 0.4 0.6 0.0 0.0 1.2 3.9 0.1 3.9 2.9 4.1 4.4 0.1 3.1 6.8 7.1 0.2 3.0 0.0 0.3 4.2 1.8 8.6 29.9 23.7 16.7 8.6 12.1 9.0 9.1 11.0 9.5 3.0 1.6 0.8 1.1 1.4 23.5 8.7 0.0 0.0 2.3 1.8 5.9 0.2 6.6 0.1 14.0 0.9 0.4 0.0 0.4 0.3 0.9 0.4 3.5 0.8 0.7 17.5 0.0 2.5 0.3 4.3 2.3 0.9 3.3 0.0 0.0 5.2 0.3 0.0 5.3 2.1 19.7 6.5 3.3 4.4 2.7 1.1 0.1 3.5 0.2 0.0 ZNF541 DKFZp434I1930 ENSG00000118156 "Zinc finger protein 541" Q9H0D2 19 47520685-47555856 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 17.7" "Group enriched" "Detected in some" 8 "Early spermatids: 18.8;Late spermatids: 8.5;Proximal tubular cells: 10.3;Spermatocytes: 28.8;Spermatogonia: 9.8" "Cancer enhanced" "Detected in some" "cervical cancer: 2.7" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.3" "Lineage enriched" "Detected in single" 23 "T-cells: 2.3" "Group enriched" "Detected in some" 5 "HEL: 3.1;SiHa: 10.2;U-87 MG: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058541, HPA076453" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058541: AB_2683748, HPA076453: AB_2732310" "unprognostic (4.49e-2)" "prognostic favorable (2.94e-4)" "unprognostic (8.33e-2)" "unprognostic (3.09e-1)" "unprognostic (2.74e-1)" "unprognostic (5.92e-5)" "unprognostic (7.98e-2)" "unprognostic (5.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-2)" "unprognostic (7.52e-2)" "unprognostic (3.09e-2)" "unprognostic (5.20e-2)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (1.59e-2)" 1.2 2.6 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.9 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.5 0.0 17.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 0.0 0.5 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 1.0 0.3 0.0 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 1.5 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 18.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 8.5 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.3 0.8 0.0 0.0 28.8 9.8 0.1 0.0 0.0 0.0 0.0 ZNF546 "MGC43537, ZNF49" ENSG00000187187 "Zinc finger protein 546" Q86UE3 19 39984134-40021041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 25.9;Spermatocytes: 50.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA030838 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030838: AB_10603332" "unprognostic (4.38e-6)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-2)" "unprognostic (6.10e-2)" "unprognostic (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (1.73e-2)" "unprognostic (8.20e-3)" "unprognostic (4.99e-2)" "unprognostic (2.03e-3)" "unprognostic (2.70e-1)" "unprognostic (5.69e-3)" "unprognostic (2.23e-1)" "unprognostic (6.46e-2)" "unprognostic (2.28e-1)" "unprognostic (2.58e-5)" 4.1 5.1 5.0 3.7 7.1 2.5 4.7 7.9 6.6 4.2 3.6 7.6 7.3 2.0 6.3 3.8 2.8 5.7 2.9 4.9 4.7 3.8 4.8 5.5 3.2 3.8 7.9 4.4 7.3 3.7 6.5 8.5 3.1 6.8 4.6 2.7 5.2 2.9 6.1 5.6 3.8 3.4 5.3 8.3 5.4 3.1 20.8 7.9 6.6 6.0 2.8 4.4 3.6 3.3 2.7 2.8 2.6 2.4 2.5 4.7 1.2 0.2 4.6 2.0 2.6 4.7 3.4 0.3 1.8 2.8 2.2 3.0 0.2 0.6 2.5 2.1 1.6 1.2 0.2 1.0 0.3 3.3 2.6 3.3 3.2 3.2 1.7 2.5 3.2 2.2 2.7 2.0 1.3 3.5 2.8 2.8 4.5 4.0 6.1 2.3 0.6 1.5 0.7 0.7 0.3 0.6 1.8 1.7 1.2 1.1 0.4 1.4 1.5 1.0 0.2 1.8 2.7 0.9 1.4 1.1 0.7 1.5 0.3 1.4 4.6 4.4 0.5 1.7 1.3 1.4 1.6 1.5 2.6 3.7 2.4 2.5 2.7 2.4 2.2 2.8 2.4 4.7 4.1 1.1 2.5 1.2 0.7 3.0 1.2 5.0 7.1 7.9 6.6 4.7 3.8 7.9 4.4 6.8 7.9 0.0 5.8 1.9 0.7 0.5 8.2 5.1 2.5 5.3 1.2 3.5 11.8 1.0 1.7 1.0 25.9 2.9 0.3 0.0 0.4 0.1 1.3 0.7 0.0 2.9 1.6 1.6 0.0 5.5 2.1 4.8 4.0 1.8 0.0 0.0 0.0 5.6 0.5 0.0 3.9 3.1 9.1 0.0 1.2 50.8 2.6 0.0 0.2 1.3 0.8 0.6 ZNF548 FLJ32932 ENSG00000188785 "Zinc finger protein 548" Q8NEK5 19 57389850-57402992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 33.1" HPA066042 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA066042: AB_2685602" "prognostic favorable (7.85e-4)" "unprognostic (4.61e-2)" "unprognostic (5.53e-2)" "unprognostic (8.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.05e-3)" "unprognostic (1.61e-2)" "unprognostic (6.77e-2)" "unprognostic (3.01e-2)" "unprognostic (1.59e-2)" "unprognostic (4.66e-2)" "unprognostic (2.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-1)" "unprognostic (1.55e-1)" "unprognostic (3.86e-3)" "unprognostic (5.85e-2)" 18.6 9.2 11.0 17.0 18.1 26.8 17.5 27.5 16.3 9.7 13.1 13.2 7.4 7.5 14.3 12.7 11.0 14.3 13.4 16.0 9.2 7.0 9.6 9.5 16.1 24.0 12.9 10.7 18.6 8.1 14.5 14.0 10.6 11.5 13.1 10.3 14.1 10.5 10.1 13.5 12.8 19.6 16.1 9.1 23.6 10.6 9.8 10.4 13.5 14.6 9.8 20.4 12.2 11.5 10.2 4.9 3.4 3.3 7.3 9.7 3.8 5.6 5.1 10.1 7.1 5.3 5.8 1.9 4.5 7.0 6.9 13.2 1.1 14.4 5.6 2.9 4.5 4.5 2.3 4.1 5.2 7.6 2.8 13.3 5.9 33.1 6.5 4.2 6.5 12.0 6.7 7.3 6.7 10.4 6.6 3.5 11.6 0.3 0.0 6.0 1.5 10.2 2.2 2.7 0.2 5.7 11.7 10.9 8.0 3.9 10.1 6.0 7.2 6.2 2.6 3.2 8.8 5.9 5.6 5.4 8.1 7.6 2.7 7.3 13.9 9.2 8.4 5.7 3.4 8.1 2.2 2.4 3.4 6.8 2.6 9.7 6.6 6.3 8.4 4.9 10.2 9.1 9.5 2.1 7.3 3.3 4.1 9.3 3.8 11.0 18.1 27.5 16.3 9.2 7.0 12.9 10.7 11.5 10.4 3.0 7.0 7.2 4.9 6.0 4.6 4.5 10.2 5.3 3.4 7.0 5.9 3.6 3.3 3.6 7.4 9.0 2.1 0.0 2.1 2.3 4.4 3.1 9.2 6.4 3.6 1.6 5.8 10.4 4.1 3.4 5.2 2.8 0.0 2.8 3.4 5.7 2.5 0.0 3.9 2.4 9.1 0.0 8.1 11.6 5.7 5.0 3.7 7.5 2.1 1.7 ZNF549 FLJ34917 ENSG00000121406 "Zinc finger protein 549" Q6P9A3 19 57527325-57557542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 13.4" "Group enriched" "Detected in all" 4 "B-cells: 4.7;NK-cells: 13.4;T-cells: 5.8" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 16.5" HPA039511 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039511: AB_10671998" "unprognostic (6.27e-2)" "unprognostic (9.03e-3)" "unprognostic (2.02e-2)" "unprognostic (1.20e-2)" "unprognostic (4.28e-2)" "unprognostic (2.80e-1)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (2.14e-1)" "unprognostic (7.07e-2)" "unprognostic (4.01e-4)" "unprognostic (4.03e-3)" "unprognostic (2.51e-8)" "unprognostic (2.88e-2)" "unprognostic (9.92e-2)" "unprognostic (9.89e-3)" "unprognostic (9.11e-3)" 4.7 6.2 7.3 11.8 11.0 5.9 9.3 18.8 10.3 5.2 5.8 8.0 4.0 3.6 7.2 7.7 3.9 8.0 6.9 5.4 9.0 6.2 5.6 2.6 7.6 8.8 9.5 7.0 11.2 4.5 12.5 13.8 6.9 7.0 8.3 4.4 6.5 5.6 6.7 5.4 7.3 6.1 7.3 10.6 9.9 5.2 7.2 8.5 11.2 9.1 3.0 9.7 6.5 11.6 4.7 1.8 1.8 1.2 13.4 5.8 2.1 1.4 1.8 7.4 6.1 2.2 1.8 1.8 3.4 4.2 3.4 16.5 1.9 1.3 2.0 2.5 3.1 4.2 0.8 2.3 5.0 5.6 0.2 13.6 9.2 1.4 2.8 3.2 7.6 6.5 3.3 3.9 3.4 4.8 4.9 2.1 5.3 0.1 0.3 6.1 0.8 8.5 3.2 6.3 0.2 4.9 6.1 6.1 4.1 1.3 3.5 3.0 5.3 0.1 0.5 4.0 6.6 4.1 6.0 1.8 6.5 4.5 0.3 5.0 3.5 10.1 6.4 1.1 2.6 5.9 0.7 1.0 1.8 3.0 0.8 4.1 2.7 4.1 4.6 1.8 4.7 5.8 3.7 0.8 13.4 1.2 1.6 2.4 2.1 7.3 11.0 18.8 10.3 9.0 6.2 9.5 7.0 7.0 8.5 0.0 3.2 2.7 1.0 1.4 8.6 2.7 5.1 8.1 0.0 1.8 13.7 1.4 3.3 1.2 0.4 2.9 0.4 0.0 0.6 0.7 2.1 1.4 5.8 0.6 1.3 7.9 3.5 4.9 1.6 0.0 2.8 1.1 5.0 0.0 0.3 4.1 0.6 1.5 2.1 0.6 14.6 6.5 1.4 0.7 3.8 1.4 0.9 2.9 0.8 0.9 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069444-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" No No "Nucleoplasm, Intermediate filaments" Cytosol "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favorable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favorable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 6.8 9.2 7.2 8.1 9.4 13.1 8.5 12.4 9.9 7.0 6.5 11.1 7.2 5.1 9.5 7.7 8.7 8.5 6.0 5.5 5.9 5.6 6.9 10.3 6.8 9.7 7.6 8.1 9.8 9.0 7.0 12.9 6.7 9.2 7.5 6.4 7.2 9.2 10.5 5.3 7.2 7.6 7.6 6.7 11.7 8.0 8.4 9.8 21.7 9.0 4.0 11.3 7.0 7.1 10.7 11.1 9.3 6.7 13.7 11.5 4.0 3.6 4.4 4.1 8.4 6.3 4.7 3.4 3.9 5.0 5.1 6.9 5.1 2.5 7.1 6.9 4.8 3.6 5.0 8.0 5.1 4.8 9.1 4.9 10.2 7.9 2.7 4.5 10.3 10.9 6.2 6.0 5.6 7.6 4.5 4.7 6.6 4.2 12.8 7.5 5.3 7.9 3.1 3.9 3.9 6.2 5.6 6.1 4.2 3.2 9.5 4.8 5.9 5.8 4.3 4.4 3.9 3.5 6.3 7.0 4.4 3.3 8.6 4.1 12.2 9.3 6.8 4.9 5.5 3.5 9.3 6.7 8.6 9.5 5.5 10.6 7.6 10.3 8.6 7.2 10.7 11.5 9.6 7.4 13.7 5.2 11.1 9.3 4.0 7.2 9.4 12.4 9.9 5.9 5.6 7.6 8.1 9.2 9.8 3.0 4.1 8.8 5.9 1.3 8.3 4.5 2.5 5.3 7.9 7.0 0.0 5.2 13.3 6.0 0.8 5.3 4.5 23.3 5.4 3.8 4.0 5.1 8.1 4.0 5.3 15.9 5.2 7.4 7.3 0.0 4.0 6.4 0.0 4.6 6.6 5.2 5.0 3.7 5.3 6.7 6.4 0.0 4.8 15.9 16.4 1.1 4.8 6.4 5.1 6.4 ZNF559 MGC13105 ENSG00000188321 "Zinc finger protein 559" Q9BR84 19 9323772-9351162 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA059632, HPA065485" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA059632: AB_2684089, HPA065485: AB_2685497" "unprognostic (1.35e-3)" "unprognostic (1.98e-1)" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.64e-3)" "prognostic favorable (6.99e-4)" "unprognostic (7.28e-3)" "unprognostic (4.04e-2)" "unprognostic (8.48e-2)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-3)" 9.3 11.1 17.7 8.4 16.2 2.7 14.1 39.5 16.1 13.6 10.4 17.2 11.4 5.1 18.8 18.8 5.9 17.3 8.2 11.9 14.2 8.2 11.2 7.5 10.4 11.8 17.6 15.5 24.0 7.6 22.1 29.2 9.8 16.2 13.6 9.3 11.2 8.3 11.4 3.3 8.7 9.8 16.3 16.2 14.9 8.8 13.7 19.8 10.7 14.0 3.4 10.3 10.2 11.3 12.5 5.3 18.9 4.3 14.2 15.8 6.2 8.7 4.7 9.3 11.3 5.5 5.0 2.4 5.3 11.0 8.0 6.8 2.3 1.0 7.1 6.3 7.7 10.9 3.1 5.6 5.0 10.2 11.4 7.5 9.6 7.8 3.1 9.8 8.4 10.6 10.5 9.1 9.0 11.2 6.8 6.7 10.7 7.0 25.2 5.0 0.0 11.4 26.6 15.1 1.5 7.8 5.6 11.3 9.6 4.9 12.3 10.5 8.8 10.4 1.7 12.5 14.2 7.5 6.4 5.6 14.7 3.3 12.0 8.0 2.0 0.0 6.9 2.6 5.3 9.2 18.9 3.4 7.5 9.1 3.2 12.0 11.9 9.6 9.6 5.3 12.5 15.8 12.7 1.9 14.2 4.3 4.4 8.4 6.2 17.7 16.2 39.5 16.1 14.2 8.2 17.6 15.5 16.2 19.8 3.0 3.5 6.2 5.8 3.4 26.6 7.1 10.2 6.7 3.4 3.5 25.5 5.9 1.7 5.9 7.0 10.5 1.7 0.0 2.7 3.8 8.9 4.1 2.3 2.1 4.2 25.4 2.9 12.3 3.8 1.8 11.8 5.7 3.3 5.4 3.7 25.1 2.8 2.9 12.7 2.4 27.1 6.5 11.3 15.7 34.5 2.6 2.4 10.1 3.8 2.2 ZNF567 MGC45586 ENSG00000189042 "Zinc finger protein 567" Q8N184 19 36687612-36727701 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 64.6;Late spermatids: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023937 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023937: AB_1859351" "unprognostic (4.39e-3)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.03e-2)" "unprognostic (2.36e-2)" "unprognostic (6.57e-2)" "unprognostic (2.40e-2)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (1.54e-1)" "unprognostic (9.93e-2)" "unprognostic (1.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-1)" "unprognostic (7.24e-2)" "unprognostic (9.03e-2)" 5.9 7.0 6.3 6.7 6.9 5.0 10.2 12.2 10.2 8.0 6.3 4.7 6.6 3.8 9.2 7.5 7.8 7.0 5.5 5.3 7.7 6.0 6.0 7.7 5.8 8.6 7.1 2.3 8.4 4.9 10.4 15.8 13.0 8.0 9.3 5.0 5.1 7.3 12.1 7.4 5.6 5.5 9.7 9.1 7.2 5.5 14.2 9.6 9.0 8.3 3.3 8.2 6.6 7.5 8.8 3.9 7.0 2.3 7.9 8.2 3.0 6.8 5.3 9.8 8.7 5.7 5.6 9.4 5.0 7.8 5.7 9.3 3.0 2.4 4.3 6.1 4.5 4.3 1.8 9.0 5.2 7.9 8.4 4.7 8.1 5.9 2.9 5.2 10.2 6.3 8.7 6.3 5.4 10.6 7.5 6.6 8.8 3.2 2.3 6.8 4.2 13.2 3.9 9.4 4.6 4.3 6.5 13.5 6.1 3.7 10.5 7.4 7.9 9.3 4.7 5.0 11.6 5.9 7.0 4.1 7.6 7.7 3.8 5.6 8.8 7.3 14.3 0.0 4.1 6.6 5.7 2.3 7.0 7.7 2.0 6.3 7.3 8.2 7.1 3.9 8.8 8.2 8.2 1.3 7.9 2.0 2.7 6.6 3.0 6.3 6.9 12.2 10.2 7.7 6.0 7.1 2.3 8.0 9.6 6.0 5.8 9.4 9.2 10.4 7.7 5.3 2.5 2.7 7.9 8.7 9.8 13.1 3.3 7.5 64.6 8.9 3.2 0.0 4.4 11.7 5.8 10.4 17.3 6.6 6.3 11.1 4.1 12.3 4.7 69.6 9.2 3.8 6.8 7.2 4.8 8.1 4.2 7.0 14.2 5.6 5.7 6.5 9.2 35.8 10.4 15.4 23.0 11.8 4.1 10.3 ZNF573 FLJ30921 ENSG00000189144 "Zinc finger protein 573" Q86YE8 19 37735833-37817300 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 26.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042776 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA042776: AB_10961399" "unprognostic (3.79e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (3.72e-2)" "unprognostic (3.29e-2)" "unprognostic (8.26e-2)" "unprognostic (1.10e-1)" "unprognostic (3.62e-2)" "unprognostic (3.69e-1)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (9.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (3.11e-2)" "unprognostic (2.60e-2)" 6.2 6.4 7.3 4.2 8.6 7.2 7.6 14.1 9.5 6.3 4.6 8.6 5.2 4.3 7.5 10.8 4.8 5.0 6.8 5.3 5.8 4.1 5.3 4.2 6.0 4.1 10.0 5.7 8.4 6.8 6.7 11.7 5.7 6.2 5.5 4.9 5.9 6.4 5.6 5.3 7.8 5.3 6.9 6.8 5.3 7.5 10.0 9.5 4.5 9.8 4.0 6.2 7.4 6.2 6.3 3.3 3.3 2.6 3.6 5.7 1.0 1.0 3.7 2.8 2.4 1.4 3.4 1.2 2.3 2.8 0.9 2.2 3.6 2.8 3.5 2.3 2.1 1.1 2.2 2.8 3.9 3.5 1.8 1.9 4.1 5.5 1.8 1.4 3.3 2.7 3.1 1.4 4.9 2.1 1.9 2.8 2.1 1.8 1.7 0.7 1.4 2.7 2.0 4.6 1.1 0.4 2.8 5.7 1.2 0.2 1.6 3.8 3.7 4.7 1.6 0.4 1.8 3.5 3.1 1.0 3.2 3.4 2.8 3.9 4.2 5.4 5.7 0.8 0.4 2.7 3.2 1.0 3.3 4.2 1.2 3.4 3.4 3.5 4.5 1.9 6.3 5.7 4.4 0.4 3.6 2.6 3.3 2.0 1.0 7.3 8.6 14.1 9.5 5.8 4.1 10.0 5.7 6.2 9.5 0.0 4.6 2.7 1.9 1.5 14.0 9.6 2.5 2.7 1.2 3.5 11.8 3.0 1.7 2.0 26.5 4.5 1.0 0.0 0.6 2.7 3.3 2.1 0.0 1.5 3.2 15.9 1.2 1.8 1.0 13.1 8.1 1.7 3.3 1.0 1.4 8.1 1.1 0.0 6.0 1.9 10.6 0.0 2.8 5.2 8.2 2.3 1.4 4.3 2.4 1.1 ZNF575 FLJ32567 ENSG00000176472 "Zinc finger protein 575" Q86XF7 19 43525497-43536130 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Paneth cells: 5.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051865 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA051865: AB_2681643" "unprognostic (1.77e-3)" "unprognostic (2.73e-2)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (8.56e-2)" "unprognostic (6.53e-4)" "unprognostic (1.23e-1)" "unprognostic (2.37e-1)" "unprognostic (2.36e-2)" "unprognostic (2.21e-1)" "unprognostic (3.87e-5)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (7.83e-2)" "unprognostic (2.75e-1)" 8.8 3.9 10.5 3.8 10.0 2.5 3.2 12.3 13.5 4.9 13.8 6.8 2.9 5.6 4.7 4.0 2.4 3.6 4.6 3.6 6.6 4.2 3.9 3.2 3.6 3.9 5.4 6.2 6.3 2.3 3.0 5.2 2.0 6.7 5.5 7.1 5.1 5.0 4.1 12.9 4.8 6.4 3.4 6.0 5.8 4.7 1.9 6.5 2.4 3.3 2.3 4.2 3.5 3.7 3.0 1.9 0.8 0.9 7.0 4.4 1.3 2.9 2.6 0.6 0.8 4.0 3.4 0.2 1.9 1.3 0.7 1.0 0.6 1.1 0.6 1.3 1.4 0.3 1.6 0.1 0.3 0.3 4.2 0.5 2.2 0.9 0.5 0.9 0.9 2.7 1.9 1.2 1.0 0.2 2.1 0.6 4.2 0.9 4.1 1.2 1.9 11.7 0.3 0.2 2.1 1.4 6.4 0.0 1.5 0.7 1.7 0.6 1.0 1.5 2.0 1.9 0.5 0.5 1.1 2.0 3.7 2.5 0.8 1.4 2.2 3.2 1.8 2.3 2.7 3.9 0.1 0.9 0.6 3.0 0.5 1.2 1.5 2.8 2.9 1.3 3.0 4.4 3.2 0.8 7.0 0.3 1.9 2.3 1.3 10.5 10.0 12.3 13.5 6.6 4.2 5.4 6.2 6.7 6.5 6.0 0.6 0.0 0.5 0.1 1.1 1.5 0.0 0.0 1.2 0.0 3.9 1.0 3.3 0.4 0.0 1.0 2.6 0.0 0.6 0.7 1.9 0.4 0.0 2.0 1.4 0.0 1.2 2.5 1.0 0.0 2.3 1.7 1.7 0.0 2.0 0.3 0.1 5.3 3.2 1.9 0.0 0.0 2.4 0.1 0.9 1.5 0.2 1.0 2.3 0.3 ZNF582 FLJ30927 ENSG00000018869 "Zinc finger protein 582" Q96NG8 19 56375846-56393545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 11.6;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 24.3" "Low region specificity" "Detected in all" HPA028858 Uncertain Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA028858: AB_10603247" "unprognostic (1.19e-3)" "unprognostic (9.86e-4)" "unprognostic (3.88e-1)" "unprognostic (3.46e-2)" "unprognostic (4.08e-3)" "unprognostic (1.04e-2)" "unprognostic (2.12e-2)" "unprognostic (6.05e-2)" "unprognostic (3.10e-2)" "unprognostic (4.12e-2)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (2.02e-7)" "unprognostic (3.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.54e-2)" "unprognostic (5.00e-3)" 4.8 8.7 7.7 4.7 8.9 2.7 6.3 9.4 9.0 4.7 4.9 7.8 3.6 2.3 7.9 13.5 4.8 6.1 6.4 8.0 8.2 7.1 5.9 4.8 5.2 8.0 9.6 3.9 10.2 4.0 7.5 11.4 5.4 8.9 8.4 2.7 4.4 4.1 5.5 3.5 5.6 3.3 5.5 7.7 7.2 3.4 8.9 13.1 7.8 13.8 2.2 3.7 5.4 5.9 5.9 3.4 5.9 3.3 11.0 6.5 2.8 0.0 1.1 6.1 1.2 1.5 1.6 0.0 2.4 2.6 1.6 1.3 0.0 0.3 0.0 1.6 1.4 3.5 0.0 0.8 0.3 1.3 0.0 24.3 5.8 0.0 0.4 2.6 1.6 4.7 5.4 1.3 1.0 0.0 1.5 1.0 0.6 1.3 0.0 1.0 0.0 3.4 3.7 3.3 0.0 0.0 1.6 2.1 2.1 1.3 3.3 0.0 3.9 0.0 0.8 0.0 4.7 2.7 3.2 1.0 3.2 6.4 0.8 3.3 5.2 5.6 3.7 0.2 0.4 1.8 4.3 2.2 5.9 4.4 3.3 6.5 5.9 5.2 4.4 3.3 4.3 3.8 4.8 0.5 11.0 2.4 3.4 1.6 2.8 7.7 8.9 9.4 9.0 8.2 7.1 9.6 3.9 8.9 13.1 0.0 0.0 5.2 2.1 1.1 3.3 2.7 0.0 1.4 1.2 7.0 2.0 2.1 11.6 2.4 0.7 5.3 0.0 0.0 0.6 0.6 2.6 3.3 8.1 2.1 2.5 1.6 0.0 1.8 1.0 0.4 2.0 2.9 3.3 1.8 0.6 8.0 1.0 0.0 3.9 3.3 5.7 12.9 2.1 1.8 5.7 0.9 3.0 2.5 0.6 1.7 ZNF583 FLJ31030 ENSG00000198440 "Zinc finger protein 583" Q96ND8 19 56397966-56436035 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 53.6;Late spermatids: 29.3;Spermatocytes: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 14.0" "Low region specificity" "Detected in all" "HPA023805, HPA023957" Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023805: AB_2671318, HPA023957: AB_2671383" "unprognostic (9.89e-3)" "unprognostic (5.52e-3)" "unprognostic (8.14e-2)" "unprognostic (2.89e-2)" "unprognostic (1.15e-1)" "unprognostic (6.69e-3)" "unprognostic (1.49e-1)" "unprognostic (1.85e-1)" "unprognostic (2.31e-2)" "unprognostic (1.79e-2)" "unprognostic (8.43e-3)" "unprognostic (5.00e-2)" "unprognostic (9.54e-5)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" 7.2 5.9 7.9 3.9 9.3 2.3 4.7 11.6 12.4 5.6 4.6 5.6 3.7 3.2 6.1 5.5 3.6 5.8 5.4 5.0 7.7 7.3 6.6 5.9 6.6 4.5 7.5 6.3 11.2 5.9 7.3 8.4 4.7 8.3 6.0 3.5 3.3 2.6 4.7 4.8 2.1 3.1 6.2 7.6 5.4 3.9 15.8 7.6 5.0 7.9 2.1 4.1 4.4 5.7 6.3 3.5 9.4 4.7 9.2 7.4 2.8 0.0 2.0 4.7 0.0 3.3 2.7 0.0 5.8 5.9 2.7 2.2 0.2 0.6 4.3 2.9 5.3 5.0 0.3 1.9 1.8 2.9 2.0 10.2 5.7 0.0 1.0 3.8 4.7 5.2 3.7 2.9 3.9 1.9 4.0 2.6 4.5 2.1 1.6 8.8 0.0 5.8 1.6 1.2 0.0 1.9 2.9 8.9 3.2 2.1 4.2 2.7 4.1 0.0 0.5 1.5 2.5 2.9 6.1 1.8 14.0 3.8 2.7 11.4 6.0 11.0 6.8 0.3 1.3 4.9 9.4 2.2 4.7 4.9 3.2 7.2 6.3 4.0 4.5 2.5 5.5 7.4 4.4 1.0 9.2 4.7 3.5 4.9 2.8 7.9 9.3 11.6 12.4 7.7 7.3 7.5 6.3 8.3 7.6 3.0 1.0 3.2 3.1 1.5 16.1 4.4 0.0 1.4 0.0 1.8 5.9 1.4 8.3 5.1 53.6 5.5 0.4 0.0 2.4 0.4 5.0 2.5 10.4 1.6 3.4 9.5 0.0 6.2 4.0 29.3 6.4 3.5 3.3 1.8 1.5 10.2 2.3 1.5 12.7 4.8 14.3 6.5 5.3 25.1 12.8 1.5 0.9 8.5 1.7 1.4 ZNF598 "FLJ00086, HEL2" ENSG00000167962 "Zinc finger protein 598" 16 1997654-2009823 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041760, HPA041896" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041760: AB_10792490, HPA041896: AB_10796464" "unprognostic (9.43e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (6.76e-3)" "unprognostic (3.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.22e-2)" "unprognostic (7.07e-3)" "unprognostic (1.22e-1)" "unprognostic (4.45e-2)" "unprognostic (1.43e-1)" "unprognostic (5.06e-2)" "unprognostic (4.69e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.81e-2)" "unprognostic (7.81e-2)" 8.4 6.1 4.1 9.1 9.4 14.3 13.9 10.6 9.5 8.3 7.7 8.8 4.7 9.9 8.7 4.0 10.0 7.1 4.8 5.6 5.2 4.1 5.9 12.2 7.8 9.1 4.2 7.1 9.8 24.8 6.5 12.9 8.1 6.4 8.9 3.2 6.8 15.6 7.3 12.9 15.3 9.9 9.5 2.9 11.8 12.4 10.1 6.1 10.0 7.7 10.6 12.5 6.8 7.6 1.8 3.2 0.6 0.9 1.2 1.7 0.5 9.9 12.8 3.3 7.9 3.0 4.1 9.5 7.4 3.8 4.9 3.9 13.9 6.0 9.9 9.3 4.8 4.1 11.8 5.4 9.2 1.3 14.1 30.9 7.7 13.7 7.6 13.5 12.3 8.8 4.5 12.6 7.8 15.1 2.8 5.3 12.4 17.3 15.5 2.5 17.1 11.7 19.1 9.6 5.4 15.6 26.7 6.5 23.1 2.4 3.6 15.9 12.9 7.6 9.3 12.0 1.1 6.5 20.6 8.6 10.5 12.5 9.0 13.9 17.4 15.4 13.1 4.5 11.9 9.6 0.6 0.6 0.2 1.2 0.7 1.7 1.1 1.2 0.9 0.7 1.8 1.1 1.6 0.4 1.2 0.9 3.2 0.3 0.5 4.1 9.4 10.6 9.5 5.2 4.1 4.2 7.1 6.4 6.1 6.0 11.5 3.0 10.2 26.4 12.0 0.8 15.3 5.3 6.8 1.8 15.7 8.1 0.0 7.5 4.1 10.0 14.0 23.3 22.5 11.0 12.2 16.3 12.7 17.3 8.2 15.9 10.9 7.4 10.3 7.5 12.4 9.1 1.7 7.2 31.1 7.1 17.5 5.8 7.8 2.7 10.0 0.0 10.5 6.3 13.0 30.5 7.8 6.9 16.5 17.6 ZNF599 FLJ30663 ENSG00000153896 "Zinc finger protein 599" Q96NL3 19 34758076-34773229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 28.2;Early spermatids: 64.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014701 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA014701: AB_1859371" "unprognostic (3.52e-3)" "unprognostic (1.42e-3)" "unprognostic (1.99e-2)" "unprognostic (9.35e-3)" "unprognostic (9.20e-2)" "unprognostic (5.16e-3)" "unprognostic (3.95e-3)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (7.35e-3)" "unprognostic (1.77e-3)" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-2)" "unprognostic (8.12e-3)" 5.9 8.1 10.0 5.2 12.5 2.4 8.5 16.8 8.0 10.1 6.5 11.7 5.8 4.5 12.2 21.4 4.4 14.1 6.5 5.8 10.3 6.8 9.7 4.9 6.0 5.7 10.5 5.7 11.4 5.7 14.3 13.2 6.0 8.1 10.4 5.5 11.6 7.4 9.5 5.5 8.0 5.4 7.1 8.1 6.5 5.9 19.9 11.2 10.4 13.2 6.0 6.2 6.4 7.2 4.3 3.8 6.4 4.8 5.7 6.7 2.9 5.2 2.6 5.9 5.4 6.5 8.7 3.2 1.9 5.4 4.8 5.7 2.3 3.6 0.6 5.6 3.7 4.4 2.7 3.8 2.5 6.0 0.6 4.8 4.1 5.4 6.5 5.0 0.9 4.6 7.8 3.6 2.2 2.3 8.9 5.5 9.9 6.8 0.5 7.5 2.1 10.1 4.2 2.5 7.2 0.2 5.5 5.5 3.3 6.0 1.2 7.0 9.9 6.5 1.2 3.8 4.5 3.4 0.5 2.9 4.8 5.4 3.6 2.0 6.1 6.6 0.5 2.9 0.1 4.5 3.1 1.1 6.4 6.1 2.5 4.0 2.0 6.5 3.5 1.7 4.3 6.7 5.9 0.6 5.7 4.8 3.8 4.9 2.9 10.0 12.5 16.8 8.0 10.3 6.8 10.5 5.7 8.1 11.2 0.0 3.0 0.8 5.4 2.7 3.1 3.7 2.5 22.7 10.3 17.4 2.0 6.8 28.2 3.7 64.0 4.9 1.6 0.0 2.0 3.8 6.0 6.5 0.0 2.5 3.2 0.0 1.2 6.2 1.5 24.3 9.5 1.3 5.0 1.0 3.1 11.2 2.5 0.0 4.6 11.5 2.4 6.5 4.4 22.1 5.5 1.4 1.6 4.3 3.4 4.7 ZNF609 KIAA0295 ENSG00000180357 "Zinc finger protein 609" O15014 15 64460742-64686068 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 133.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040742, HPA040832" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040742: AB_10963581, HPA040832: AB_10960400" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (2.61e-1)" "unprognostic (3.11e-2)" "unprognostic (5.02e-2)" "unprognostic (7.21e-2)" "unprognostic (9.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" 11.1 11.2 14.5 14.5 12.6 7.3 11.4 17.1 15.1 17.9 14.2 16.2 19.1 12.1 18.7 8.4 10.2 15.7 14.0 10.9 12.3 10.4 9.1 10.2 13.9 11.3 10.9 11.0 29.9 11.6 18.1 11.6 16.3 10.9 15.2 11.4 14.6 12.6 22.8 9.2 11.9 11.2 16.1 12.7 12.9 11.4 28.9 13.6 21.4 12.4 4.5 12.1 15.6 28.4 1.2 2.8 3.2 1.7 4.0 3.0 0.5 6.1 15.6 16.9 6.4 6.5 8.3 5.8 8.1 10.8 10.2 10.3 9.6 9.8 10.6 6.8 9.5 13.9 13.2 24.7 11.1 10.7 12.3 5.3 19.4 9.0 4.7 12.0 11.1 13.0 8.4 10.2 10.6 21.0 14.8 18.8 9.1 30.4 6.9 8.3 5.6 8.6 4.7 12.8 8.3 4.4 7.9 15.4 5.5 7.4 11.1 13.7 10.5 11.0 12.6 7.5 16.9 6.2 7.8 18.7 9.5 15.2 4.9 10.0 7.7 8.7 9.6 5.9 12.2 7.7 3.2 1.7 1.9 2.3 0.7 1.6 0.7 1.3 1.6 0.6 1.2 3.0 3.0 2.1 4.0 0.8 2.8 0.8 0.5 14.5 12.6 17.1 15.1 12.3 10.4 10.9 11.0 10.9 13.6 11.9 20.1 6.1 13.9 16.0 28.1 18.3 17.8 30.8 25.0 17.4 133.5 12.7 3.3 12.3 17.2 14.4 9.9 0.0 12.8 11.9 12.1 18.2 9.3 11.6 8.7 42.9 17.9 17.8 23.1 9.6 16.7 11.6 13.5 9.0 10.8 19.5 11.6 11.5 13.1 3.1 56.5 19.4 9.2 31.7 14.0 15.2 26.1 13.3 10.5 15.6 ZNF614 FLJ21941 ENSG00000142556 "Zinc finger protein 614" Q8N883 19 52012765-52030240 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 37.9;Late spermatids: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021197 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA021197: AB_1859380" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (3.24e-2)" "unprognostic (1.30e-1)" "unprognostic (7.67e-3)" "unprognostic (2.68e-1)" "unprognostic (4.74e-3)" "unprognostic (5.07e-3)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.74e-2)" "unprognostic (1.66e-2)" "unprognostic (3.06e-2)" "unprognostic (1.57e-1)" "unprognostic (2.30e-1)" "unprognostic (7.15e-3)" 7.7 7.1 9.9 5.6 9.4 10.1 10.1 15.6 12.5 9.2 7.3 6.6 5.8 4.5 9.5 7.3 6.3 8.8 6.0 7.0 7.9 8.5 6.9 4.7 6.3 8.2 9.3 7.1 14.0 5.1 6.5 13.7 14.2 9.7 16.4 5.5 5.5 5.4 8.9 11.1 7.6 6.3 8.9 13.5 9.7 5.8 13.8 10.7 18.2 14.3 5.1 7.5 8.5 9.6 6.0 5.5 4.3 5.9 9.6 8.1 3.2 3.8 2.9 7.4 9.5 5.2 5.9 1.0 5.2 3.7 4.9 5.9 3.7 2.2 9.7 2.9 4.4 4.5 1.7 10.8 6.9 7.2 2.6 15.5 14.6 5.2 7.3 4.3 3.0 7.4 4.5 3.8 4.9 6.9 4.9 5.6 8.6 7.7 2.2 6.4 1.5 12.5 6.0 8.4 0.6 5.2 8.3 14.1 8.0 5.0 9.8 9.9 5.9 3.1 3.9 3.2 9.5 5.2 7.7 5.7 4.8 6.6 2.7 6.2 4.4 6.8 14.9 4.6 4.2 6.3 4.3 4.3 3.0 6.5 5.9 7.8 6.0 5.7 6.1 5.5 6.0 8.1 5.3 3.3 9.6 4.5 3.1 5.9 3.2 9.9 9.4 15.6 12.5 7.9 8.5 9.3 7.1 9.7 10.7 0.0 2.1 0.9 3.8 2.9 5.5 5.3 2.5 0.0 6.8 5.2 3.9 4.6 0.0 2.4 37.9 4.4 1.6 0.0 0.8 4.7 3.7 3.9 6.9 1.5 2.1 15.9 5.2 5.5 6.4 32.8 3.7 2.2 1.7 1.0 2.0 4.1 1.0 0.0 6.7 1.8 5.1 0.0 6.4 2.2 4.7 2.4 12.0 2.5 2.2 4.4 ZNF622 "MGC17552, MGC2485, ZPR9" ENSG00000173545 "Zinc finger protein 622" Q969S3 5 16451519-16465792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036514, HPA036515" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA036514: AB_2675167, HPA036515: AB_10672224" "unprognostic (6.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.00e-2)" "unprognostic (6.53e-2)" "unprognostic (8.24e-3)" "unprognostic (4.71e-3)" "unprognostic (1.06e-1)" "unprognostic (1.71e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (8.69e-2)" "unprognostic (5.93e-2)" "unprognostic (2.19e-1)" "unprognostic (7.42e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" 14.3 10.8 18.3 12.1 19.4 28.8 14.8 20.5 20.3 12.6 19.5 14.5 9.5 15.5 14.4 16.9 13.6 13.2 12.3 38.6 13.8 14.6 14.8 18.8 12.8 14.5 16.8 15.5 15.1 45.9 12.5 15.0 16.0 17.2 13.1 19.8 10.9 17.5 12.8 29.0 18.6 19.6 12.6 12.8 12.4 15.9 14.1 17.3 14.0 16.7 11.9 15.4 13.7 14.9 50.4 45.6 55.4 45.9 39.1 56.9 47.2 11.0 24.3 7.6 15.7 18.7 16.0 27.7 20.0 15.2 16.3 20.9 28.8 10.3 13.0 27.1 15.8 22.0 14.7 12.2 15.6 13.2 17.5 16.6 11.9 43.1 20.6 26.9 23.0 14.3 24.6 19.8 15.2 14.4 12.7 11.4 7.8 16.0 12.9 17.9 18.7 12.0 22.5 13.4 10.5 24.1 9.5 9.3 11.1 15.1 16.7 10.6 11.9 27.9 21.0 32.4 13.9 11.6 17.9 15.5 18.3 13.9 17.7 12.6 18.7 16.7 18.2 15.9 20.0 12.7 45.2 41.6 52.9 49.1 43.4 51.2 50.4 49.5 53.7 45.6 47.0 56.9 47.7 55.4 39.1 45.9 37.0 50.1 47.2 18.3 19.4 20.5 20.3 13.8 14.6 16.8 15.5 17.2 17.3 20.8 24.5 31.7 36.6 53.9 21.6 68.8 12.7 22.7 19.4 14.0 9.8 53.3 23.2 49.8 98.2 21.5 74.9 0.0 58.2 46.3 35.5 23.5 50.8 21.9 45.1 15.9 94.5 9.8 15.4 46.0 16.7 31.7 32.1 49.5 33.2 20.1 47.9 129.6 18.7 30.7 15.9 19.4 31.6 40.3 26.2 37.8 34.0 30.9 34.7 29.6 ZNF630 "BC037316, dJ54B20.2, FLJ20573, MGC138344" ENSG00000221994 "Zinc finger protein 630" Q2M218 X 47983356-48071658 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Intestinal endocrine cells: 4.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001053, HPA068130" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001053: AB_2666183, HPA068130: AB_2685961" "unprognostic (1.03e-1)" "unprognostic (2.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (8.09e-2)" "unprognostic (5.86e-3)" "unprognostic (5.83e-2)" "unprognostic (9.06e-3)" "unprognostic (8.68e-2)" "unprognostic (5.83e-2)" "unprognostic (2.14e-2)" "unprognostic (7.92e-2)" "unprognostic (6.07e-3)" "unprognostic (5.92e-2)" "unprognostic (1.31e-1)" "unprognostic (3.27e-1)" "unprognostic (7.51e-5)" 4.0 5.2 5.3 6.4 9.0 2.1 6.7 8.8 8.5 7.0 5.4 5.9 11.3 3.5 6.3 7.5 5.0 4.8 5.8 5.9 6.0 4.6 5.2 3.0 5.0 5.4 12.3 5.8 11.2 8.3 11.9 10.1 4.9 8.8 8.4 6.2 6.4 6.1 6.9 2.3 4.0 4.2 7.5 7.3 4.8 6.8 1.8 10.1 1.0 9.3 1.5 3.6 8.4 13.7 2.6 3.8 5.8 1.9 1.5 2.8 2.0 1.4 1.1 0.3 0.0 0.1 0.1 0.0 1.9 0.6 1.0 0.9 3.3 5.4 0.1 1.0 2.0 2.3 2.3 0.0 1.0 1.3 0.0 0.0 0.0 1.4 0.0 1.4 0.0 0.0 1.3 5.6 3.2 0.0 3.9 1.0 0.0 0.0 5.4 3.6 5.7 0.0 0.0 2.1 4.8 1.6 0.7 1.2 0.0 2.5 3.0 3.2 2.6 7.0 4.8 2.1 5.0 5.7 1.3 1.2 0.0 2.5 2.5 0.0 0.0 4.7 0.0 0.0 0.1 4.5 5.8 1.9 4.8 2.2 1.0 2.4 2.6 2.0 2.0 3.8 1.8 2.5 2.8 2.1 1.5 0.6 0.9 1.1 2.0 5.3 9.0 8.8 8.5 6.0 4.6 12.3 5.8 8.8 10.1 0.0 0.0 0.0 1.0 0.1 2.1 1.0 0.0 0.0 0.0 1.8 0.0 0.1 1.7 1.2 0.0 0.6 0.7 0.0 1.0 0.7 0.6 0.9 0.0 0.0 0.8 0.0 4.1 2.5 0.0 0.0 0.3 0.0 0.0 1.0 1.4 1.1 0.8 0.0 0.4 0.6 0.9 6.5 1.0 0.1 0.5 0.3 0.2 0.8 1.0 0.7 ZNF646 KIAA0296 ENSG00000167395 "Zinc finger protein 646" O15015 16 31074422-31084196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042364, HPA066468" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA042364: AB_10794796, HPA066468: AB_2732746" "unprognostic (1.61e-2)" "unprognostic (2.18e-1)" "unprognostic (8.08e-2)" "unprognostic (1.18e-2)" "unprognostic (4.66e-1)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.23e-2)" "unprognostic (4.21e-2)" "unprognostic (6.96e-2)" "unprognostic (1.16e-2)" "unprognostic (9.83e-2)" "unprognostic (2.07e-2)" "unprognostic (2.65e-1)" "unprognostic (1.93e-1)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" 9.8 6.4 5.9 10.4 7.6 13.4 7.3 12.2 7.8 10.2 6.8 10.4 8.2 10.6 9.8 6.8 7.5 8.6 7.6 5.9 6.8 5.5 6.9 6.1 13.5 11.3 10.6 5.6 10.3 8.2 10.1 9.4 8.0 7.2 7.9 4.9 5.8 9.8 14.2 12.4 10.6 9.6 6.5 7.4 12.9 9.1 36.1 9.2 24.7 7.7 5.2 11.5 7.8 10.8 4.0 5.2 19.8 3.7 3.4 4.3 1.5 6.1 12.9 8.5 6.6 6.1 4.8 11.2 6.8 7.2 8.2 7.6 9.4 5.9 12.0 10.9 5.7 5.4 8.3 7.0 7.4 3.2 13.8 6.6 8.9 11.4 7.8 6.3 11.4 13.9 6.1 6.8 8.8 5.0 6.4 4.9 10.3 14.1 7.1 6.2 9.8 12.6 7.8 11.4 2.8 6.7 20.4 16.6 12.1 2.6 5.9 12.3 12.4 7.8 8.3 4.1 3.9 6.9 10.0 9.8 10.4 5.9 6.9 6.3 11.9 10.9 12.2 9.4 12.4 8.1 5.9 3.7 9.4 4.3 3.3 2.2 3.3 2.0 1.7 3.5 4.0 2.2 2.5 19.8 3.4 2.1 5.2 2.0 1.5 5.9 7.6 12.2 7.8 6.8 5.5 10.6 5.6 7.2 9.2 3.0 2.2 2.4 0.9 3.0 3.0 1.2 2.5 1.4 1.2 1.8 3.9 1.5 1.7 3.8 19.8 2.9 5.2 0.0 2.9 1.7 2.1 2.2 1.1 1.5 4.1 1.6 5.8 0.6 2.4 2.7 2.6 4.4 0.0 3.6 3.7 3.7 3.6 5.8 4.2 1.9 1.0 0.0 1.1 10.4 6.7 3.4 2.1 2.2 3.5 2.0 ZNF660 FLJ36870 ENSG00000144792 "Zinc finger protein 660" Q6AZW8 3 44578223-44599694 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 23.8;Muller glia cells: 30.4;Rod photoreceptor cells: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "myeloid DC: 1.1;naive B-cell: 1.3;NK-cell: 1.6;plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "B-cells: 1.3;dendritic cells: 3.7;NK-cells: 1.6" "Cell line enhanced" "Detected in some" "AF22: 5.6;HEL: 5.5;NTERA-2: 8.6;RH-30: 5.7;SuSa: 4.9" "Low region specificity" "Detected in all" HPA029705 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA029705: AB_10602592" "unprognostic (5.43e-2)" "unprognostic (3.58e-2)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-1)" "unprognostic (3.73e-2)" "unprognostic (2.46e-2)" "unprognostic (1.36e-2)" "unprognostic (2.91e-3)" "unprognostic (8.56e-2)" "unprognostic (2.79e-3)" "unprognostic (4.87e-3)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" 3.1 3.1 3.5 3.0 5.9 3.5 3.0 10.3 7.2 7.6 3.8 3.8 4.4 1.3 7.9 5.2 2.2 5.2 3.6 2.9 4.4 3.8 2.5 1.3 2.9 4.2 5.7 6.2 11.3 2.6 6.3 11.5 3.7 6.0 5.7 2.2 5.5 2.1 4.7 2.3 2.1 2.7 5.9 6.4 3.4 2.7 4.4 4.7 1.8 4.7 0.8 3.1 4.1 4.1 1.3 3.7 0.4 0.4 1.6 0.3 0.2 0.0 0.0 5.6 1.3 0.1 0.0 0.8 0.6 1.4 0.8 0.8 0.0 0.0 0.1 1.2 0.5 0.0 0.0 1.8 0.0 1.0 0.0 0.0 5.5 0.4 0.8 1.3 0.1 0.0 2.3 0.1 2.0 0.0 0.1 1.3 0.0 0.0 0.3 2.9 0.0 0.0 3.2 8.6 0.0 0.0 0.1 5.7 0.0 0.1 0.3 1.4 3.8 0.0 0.0 0.1 4.9 0.1 2.1 0.4 1.6 1.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.2 0.1 0.1 0.2 0.2 0.3 1.1 1.3 0.2 0.2 0.2 1.6 0.0 3.7 0.0 0.2 3.5 5.9 10.3 7.2 4.4 3.8 5.7 6.2 6.0 4.7 0.0 5.9 0.0 0.8 0.1 23.8 1.9 5.1 1.4 5.7 0.0 5.9 0.0 0.0 0.9 8.0 3.6 0.0 0.0 0.5 0.0 2.4 0.6 5.8 0.0 1.6 11.1 4.1 1.8 0.6 1.3 4.6 1.1 0.0 3.6 0.1 30.4 0.8 0.0 3.2 0.1 22.7 0.0 2.5 3.9 3.1 0.0 0.0 0.8 0.2 0.3 ZNF670 MGC12466 ENSG00000277462 "Zinc finger protein 670" Q9BS34 1 247036784-247078755 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 21.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003142 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003142: AB_1859404" "unprognostic (2.11e-1)" "unprognostic (8.04e-3)" "unprognostic (2.05e-3)" "unprognostic (9.98e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-1)" "unprognostic (1.26e-2)" "unprognostic (1.50e-2)" "unprognostic (1.63e-2)" "unprognostic (3.23e-2)" "unprognostic (9.88e-2)" "unprognostic (5.21e-3)" "unprognostic (2.19e-2)" "unprognostic (1.23e-1)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "unprognostic (1.39e-2)" 3.5 2.2 3.1 2.9 5.5 0.7 6.2 12.0 6.1 4.1 2.6 3.2 0.0 2.8 5.7 3.4 1.9 3.7 3.8 2.5 4.5 3.9 3.0 4.0 3.4 1.8 1.3 5.5 2.8 3.1 1.3 1.4 4.0 3.4 3.5 2.5 1.9 3.1 1.6 2.6 2.4 4.3 2.9 3.1 3.3 4.8 2.7 5.4 3.7 3.0 4.7 4.2 1.0 6.6 4.1 1.7 2.3 2.8 6.5 2.3 3.8 2.7 7.8 9.6 2.0 3.4 18.1 4.9 3.3 5.9 5.9 3.2 4.1 6.2 8.2 3.0 3.2 3.2 8.6 3.8 11.2 4.6 1.1 5.5 1.8 4.9 1.7 6.8 3.4 1.9 4.0 3.8 7.4 0.9 3.8 4.9 7.9 2.7 5.9 1.5 8.0 3.3 14.5 8.6 4.9 8.3 9.7 5.8 3.5 8.4 9.0 8.2 6.9 2.7 3.8 4.6 2.8 14.3 2.4 3.6 4.1 2.6 5.4 5.2 9.9 12.7 1.3 4.9 4.5 0.0 2.0 1.7 4.4 2.3 2.3 6.6 4.1 4.6 4.1 5.9 6.5 4.9 0.2 2.8 1.4 2.3 3.0 2.3 3.0 1.7 0.0 8.6 21.5 4.3 0.6 7.6 6.7 4.5 5.2 0.0 2.2 5.0 4.6 5.2 4.4 0.4 0.0 2.5 6.7 2.3 3.8 0.0 2.8 2.1 6.4 0.0 4.9 1.9 1.0 1.7 1.6 6.8 2.8 2.7 2.0 2.7 1.5 1.4 2.8 1.4 0.0 4.4 1.6 3.3 9.8 0.7 0.0 1.1 3.7 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" Nucleoli "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 9.0 7.6 8.2 6.6 16.2 7.1 8.8 19.4 10.8 9.3 7.2 6.7 7.1 5.4 9.2 6.2 6.1 7.7 7.4 7.4 8.9 6.3 6.4 5.3 7.8 9.8 12.7 8.2 9.9 12.6 7.2 19.4 9.7 8.9 10.6 10.8 4.6 7.6 6.3 6.2 5.2 6.6 7.5 14.2 9.5 7.6 8.7 15.5 12.0 12.7 5.1 9.1 8.2 9.4 6.6 3.2 7.1 1.1 2.2 3.2 1.5 2.0 3.2 11.9 13.5 1.5 3.4 7.2 2.7 2.7 4.1 4.4 2.6 2.6 8.3 7.2 1.2 2.2 4.0 7.0 1.8 6.8 3.5 13.4 3.9 2.5 1.6 2.7 6.6 10.6 3.0 3.4 2.5 5.3 3.1 3.9 9.3 9.9 13.1 4.5 1.7 9.1 2.3 10.4 3.0 5.4 7.1 7.7 3.2 3.0 6.5 5.1 9.9 4.1 4.9 2.0 6.1 6.8 8.4 2.5 5.1 4.9 4.6 5.6 4.2 9.6 9.1 2.1 1.2 5.3 7.1 1.1 1.3 2.5 0.3 3.0 6.6 2.5 1.4 2.1 4.5 2.2 3.2 0.2 2.2 0.7 3.2 2.7 1.5 8.2 16.2 19.4 10.8 8.9 6.3 12.7 8.2 8.9 15.5 3.0 5.3 4.7 3.6 2.1 11.6 3.6 5.1 5.3 4.5 3.5 3.9 1.8 1.7 3.3 0.6 4.7 1.5 0.0 4.4 2.1 3.4 5.6 3.5 1.6 1.4 1.6 9.2 3.7 3.7 0.2 6.9 2.2 0.0 1.8 3.9 4.2 2.9 4.5 2.5 1.1 6.7 0.0 2.1 7.2 10.0 0.5 1.1 7.5 2.6 3.4 ZNF684 MGC27466 ENSG00000117010 "Zinc finger protein 684" Q5T5D7 1 40531561-40548169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 28.0" "Low region specificity" "Detected in all" HPA059153 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA059153: AB_2683932" "unprognostic (4.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-4)" "unprognostic (2.29e-2)" "unprognostic (2.96e-2)" "unprognostic (3.67e-4)" "unprognostic (8.49e-2)" "unprognostic (2.26e-3)" "unprognostic (2.10e-2)" "unprognostic (7.00e-2)" "unprognostic (4.14e-3)" "unprognostic (3.96e-2)" "prognostic favorable (4.89e-10)" "unprognostic (4.76e-3)" "unprognostic (7.11e-2)" "unprognostic (5.98e-2)" "unprognostic (1.52e-2)" 3.6 6.4 4.1 2.9 8.9 8.2 4.2 5.8 7.4 3.6 3.8 2.3 5.4 3.2 3.6 4.3 3.2 3.1 3.4 10.6 4.4 3.3 18.3 20.8 3.4 4.4 9.8 3.6 3.8 5.4 2.5 4.6 2.1 5.4 5.1 4.8 1.6 3.5 4.1 4.4 4.1 3.4 3.2 5.9 5.1 4.2 4.3 7.8 6.4 5.6 4.1 3.5 3.1 2.7 6.0 3.9 7.0 7.7 3.5 5.9 2.4 2.2 0.7 2.8 3.8 2.6 3.8 1.7 2.0 2.0 2.4 4.1 1.4 2.9 3.8 1.7 1.3 1.6 2.7 2.8 2.0 3.8 3.3 4.7 4.1 2.6 3.6 1.3 4.4 4.5 2.5 0.8 2.9 1.1 1.4 3.7 3.0 2.1 5.7 3.4 0.6 6.4 5.1 6.8 0.9 2.3 3.0 8.4 2.6 3.6 1.9 2.1 3.6 3.7 3.7 4.1 3.6 1.6 28.0 2.1 2.5 5.2 2.4 3.9 4.8 3.4 4.4 2.2 4.7 3.8 7.0 4.0 1.9 5.9 7.7 3.2 6.0 4.2 3.6 2.4 3.5 2.8 5.5 2.3 3.5 4.1 3.9 4.7 2.4 4.1 8.9 5.8 7.4 4.4 3.3 9.8 3.6 5.4 7.8 6.0 2.7 3.7 1.7 2.1 3.0 9.9 2.5 5.3 3.4 7.0 0.0 1.0 14.9 4.4 1.8 3.5 1.3 0.0 12.9 2.1 2.8 1.0 2.3 14.5 4.2 3.2 1.2 4.3 4.3 2.6 2.3 4.3 8.5 7.2 1.7 3.5 4.9 2.0 2.8 12.4 2.3 0.0 4.7 6.1 3.2 1.1 0.0 4.8 3.8 0.9 ZNF70 "Cos17, MGC48959" ENSG00000187792 "Zinc finger protein 70" Q9UC06 22 23738678-23751092 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018821 Uncertain Approved Cytosol NA NA Cytosol "HPA018821: AB_1859423" "unprognostic (3.17e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" "unprognostic (8.49e-3)" "unprognostic (1.08e-1)" "unprognostic (2.80e-2)" "unprognostic (6.07e-3)" "unprognostic (2.18e-3)" "unprognostic (9.93e-2)" "unprognostic (6.20e-2)" "unprognostic (1.73e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-2)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (4.36e-2)" "unprognostic (5.69e-2)" 5.5 5.0 8.4 7.6 8.5 5.5 5.5 14.3 10.3 7.5 5.5 8.2 10.7 3.4 7.8 8.7 3.6 7.4 5.9 6.3 8.6 3.8 4.1 3.0 4.7 4.9 7.1 5.7 15.3 6.5 10.1 6.2 4.5 7.1 5.9 4.8 9.0 7.2 8.4 9.1 4.3 5.1 7.0 4.9 5.2 5.1 4.7 10.9 3.9 6.7 1.1 5.6 5.8 5.4 1.5 1.6 4.2 1.0 2.0 1.2 0.4 1.9 2.5 4.8 5.0 7.1 3.5 1.6 1.8 3.6 4.1 5.9 2.4 1.4 2.7 1.2 3.8 2.7 2.2 3.3 2.4 5.3 1.8 3.1 5.2 4.5 2.2 4.3 4.7 4.5 3.4 1.6 5.5 4.6 5.4 3.2 2.1 1.9 4.0 3.1 2.7 2.7 2.4 1.2 1.8 1.1 11.4 4.6 0.6 1.5 2.6 2.7 3.4 2.7 3.5 2.1 3.6 1.7 2.2 4.3 4.6 5.8 3.0 2.0 4.1 0.7 2.6 4.0 2.2 3.9 4.2 1.0 0.9 1.0 0.8 0.6 0.8 1.0 0.6 0.5 1.5 1.1 1.2 3.2 2.0 0.8 1.6 0.4 0.4 8.4 8.5 14.3 10.3 8.6 3.8 7.1 5.7 7.1 10.9 0.0 3.2 0.0 0.8 0.3 4.0 2.3 2.5 6.7 3.4 3.5 9.8 0.4 0.0 1.1 1.1 1.0 0.3 0.0 1.0 0.5 1.8 0.6 1.1 0.5 0.7 6.4 1.2 4.3 1.2 2.1 5.8 0.4 0.0 1.0 0.3 2.8 0.4 0.0 3.9 0.6 4.5 6.5 0.8 2.1 2.1 0.0 0.2 0.5 0.6 0.7 ZNF720 ENSG00000197302 "Zinc finger protein 720" Q7Z2F6 16 31713229-31794869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA041570 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA041570: AB_10795126" "unprognostic (5.52e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" "unprognostic (2.58e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.82e-3)" "unprognostic (8.72e-2)" "unprognostic (5.94e-2)" "unprognostic (1.54e-1)" "unprognostic (8.91e-3)" "unprognostic (5.47e-3)" "unprognostic (3.70e-2)" "unprognostic (9.62e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-2)" 15.1 15.8 11.1 13.7 11.8 9.9 12.7 16.8 17.6 14.3 12.4 11.3 17.7 7.2 11.7 17.4 16.4 12.8 10.3 10.1 11.1 15.1 14.2 11.6 10.7 17.5 15.5 11.0 9.6 12.9 13.4 24.5 19.4 15.5 14.5 14.0 11.4 13.9 17.7 10.3 17.3 10.1 13.2 14.3 18.4 14.1 13.7 15.9 16.6 19.2 11.0 18.1 14.6 11.6 14.4 8.9 23.0 5.5 12.8 14.2 5.0 10.3 7.3 9.1 8.0 7.9 12.1 8.8 11.0 7.2 5.4 7.2 5.2 11.1 5.0 19.5 3.7 8.0 7.2 8.8 4.3 8.1 22.3 4.7 2.8 3.9 14.9 11.9 5.9 15.4 8.2 11.9 3.8 5.4 10.9 10.1 12.3 9.3 6.6 5.8 16.7 6.1 7.8 8.9 7.2 5.8 11.5 4.0 7.8 6.1 6.5 4.1 6.2 11.2 5.1 9.9 14.9 9.7 11.8 6.6 3.9 3.1 7.9 3.3 11.1 12.1 14.4 3.5 9.2 6.2 13.9 4.8 23.0 14.2 5.4 10.6 13.7 10.0 12.7 5.2 14.4 9.3 11.7 6.3 12.8 5.5 8.9 12.2 5.0 11.1 11.8 16.8 17.6 11.1 15.1 15.5 11.0 15.5 15.9 14.9 15.2 14.3 15.8 8.0 23.9 12.0 5.1 20.1 13.6 5.2 5.9 27.2 19.9 15.4 1.7 17.9 6.3 0.0 11.9 10.9 12.4 22.4 20.8 8.9 14.6 22.3 16.7 16.0 9.7 1.5 12.4 15.1 10.1 12.6 12.4 19.0 14.5 10.5 17.3 11.8 8.9 32.3 11.4 24.1 17.6 10.0 59.4 16.0 10.7 18.7 ZNF721 KIAA1982 ENSG00000182903 "Zinc finger protein 721" Q8TF20 4 425815-499156 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA065313 Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA065313: AB_2685464" "unprognostic (2.23e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" "unprognostic (1.57e-1)" "unprognostic (6.91e-2)" "unprognostic (7.66e-2)" "unprognostic (1.51e-2)" "unprognostic (3.26e-2)" "unprognostic (3.48e-2)" "unprognostic (1.96e-2)" "unprognostic (3.43e-2)" "unprognostic (1.25e-1)" "unprognostic (5.12e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-3)" "prognostic favorable (2.76e-4)" 16.1 15.3 20.9 17.2 24.5 20.8 24.7 42.3 25.6 17.7 13.9 15.9 15.4 13.4 17.2 19.3 15.4 20.4 13.5 12.1 19.4 15.3 16.1 16.3 16.4 26.9 24.6 22.8 21.5 19.2 21.1 39.2 13.1 20.7 16.5 16.4 13.9 16.1 15.0 14.5 23.5 16.0 17.5 22.1 18.3 16.2 17.7 23.9 20.3 22.5 12.7 27.8 19.0 16.7 15.1 9.5 11.3 7.8 11.5 20.8 6.5 8.8 5.8 11.2 13.9 8.4 11.2 7.0 8.2 7.2 9.1 8.2 8.5 9.1 15.2 8.8 7.8 13.1 5.8 11.6 10.0 12.1 5.4 13.6 26.4 6.0 5.8 8.0 11.0 1.7 10.2 8.8 10.3 14.9 14.0 8.9 21.7 15.4 11.0 12.5 8.7 18.1 18.0 17.5 5.9 12.3 14.8 16.3 8.4 9.4 12.4 16.7 10.6 10.7 6.1 9.9 9.9 11.5 11.9 11.4 8.3 2.9 6.3 14.1 12.6 11.8 36.9 6.2 3.1 7.4 7.0 7.8 11.3 12.0 7.6 11.9 15.1 13.1 11.5 7.6 15.1 20.8 16.0 11.1 11.5 6.7 9.5 14.6 6.5 20.9 24.5 42.3 25.6 19.4 15.3 24.6 22.8 20.7 23.9 23.8 26.4 17.4 22.0 18.7 36.4 13.2 30.6 26.8 25.0 17.4 29.5 14.3 13.3 11.7 26.5 26.3 9.5 0.0 13.0 8.4 12.5 22.0 25.4 16.3 9.5 22.3 12.2 31.3 19.9 8.8 18.1 17.6 11.8 8.2 15.7 27.0 11.4 8.6 11.3 10.2 32.8 19.4 10.3 34.4 27.7 20.3 14.5 39.2 15.3 26.8 ZNF746 "FLJ31413, PARIS" ENSG00000181220 "Zinc finger protein 746" Q6NUN9 7 149472696-149497817 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 3.0;neutrophil: 10.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020272 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA020272: AB_2670398" "unprognostic (2.66e-1)" "unprognostic (4.94e-2)" "unprognostic (4.27e-3)" "unprognostic (1.80e-2)" "unprognostic (2.10e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (2.32e-5)" "unprognostic (2.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.33e-1)" "prognostic favorable (4.22e-4)" "unprognostic (5.33e-2)" "prognostic unfavorable (7.47e-6)" "unprognostic (2.21e-2)" "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "unprognostic (2.06e-1)" 11.9 9.9 10.6 12.0 11.6 33.9 9.1 15.6 17.2 10.5 9.0 11.7 9.1 8.0 11.5 8.7 8.5 10.3 8.7 7.6 11.2 9.7 10.0 10.9 10.3 12.1 9.5 8.7 10.4 13.7 10.2 13.5 21.0 11.4 10.6 6.3 11.4 10.7 8.5 8.9 10.8 9.2 9.5 9.0 20.2 9.8 22.0 10.4 18.7 10.6 5.5 10.3 10.9 15.9 0.6 0.9 10.4 1.0 0.5 1.6 0.5 7.1 11.5 6.1 16.6 6.9 6.0 9.3 7.3 6.0 5.9 5.1 7.3 5.4 10.3 10.7 6.4 8.6 8.0 7.9 8.3 3.5 13.0 11.0 5.0 5.8 10.0 8.4 9.7 13.4 6.6 10.1 4.8 5.3 5.3 6.1 8.5 15.2 8.0 7.4 11.0 21.9 13.1 15.1 4.4 8.0 14.6 5.7 9.0 5.6 8.6 8.7 12.0 9.7 10.7 6.8 3.8 5.0 12.0 8.5 7.5 2.7 12.7 10.6 14.8 7.0 8.3 9.8 7.8 13.0 3.0 1.0 1.1 0.7 0.7 0.7 0.4 0.9 1.6 0.6 0.6 1.1 0.9 10.4 0.5 0.5 0.9 1.5 0.5 10.6 11.6 15.6 17.2 11.2 9.7 9.5 8.7 11.4 10.4 0.0 7.4 3.4 4.9 3.2 15.5 6.7 5.1 4.0 4.5 10.4 3.9 5.9 0.0 2.8 8.2 5.3 2.0 46.7 2.1 5.2 3.6 5.1 5.8 6.8 7.0 25.4 5.8 3.1 15.5 10.8 5.8 6.8 3.3 5.4 4.0 8.8 4.0 3.5 6.3 3.1 10.8 0.0 3.7 16.2 7.0 3.0 7.3 4.1 3.7 4.4 ZNF747 MGC2474 ENSG00000169955 "Zinc finger protein 747" Q9BV97 16 30530367-30535347 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003203, HPA069173" Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA003203: AB_1080753, HPA069173: AB_2686097" "unprognostic (3.82e-2)" "prognostic favorable (6.53e-4)" "unprognostic (3.73e-2)" "unprognostic (1.31e-2)" "unprognostic (4.01e-2)" "unprognostic (4.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.22e-3)" "unprognostic (2.45e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.46e-4)" "unprognostic (1.01e-2)" "unprognostic (2.60e-3)" "unprognostic (2.27e-1)" "unprognostic (4.66e-2)" "unprognostic (3.00e-1)" "unprognostic (1.01e-1)" 12.5 10.5 11.0 8.9 12.4 5.7 10.3 13.1 19.4 14.1 11.3 18.5 6.3 9.6 14.3 10.3 8.9 11.8 10.5 13.2 10.3 8.9 11.4 17.0 8.4 9.3 11.5 8.0 13.2 15.5 23.1 10.4 6.2 10.6 14.6 9.2 13.6 11.2 15.3 14.1 11.0 10.5 11.8 9.4 11.4 10.2 12.4 13.3 18.2 11.8 6.7 9.0 12.8 8.8 8.8 8.1 9.0 4.8 6.6 8.9 4.1 3.8 3.7 1.2 6.1 4.9 4.3 6.2 3.2 4.8 4.6 4.5 2.2 4.9 8.3 2.2 3.8 0.6 5.7 2.8 4.0 2.0 9.8 6.2 7.2 4.0 3.4 5.4 3.3 10.3 4.9 5.1 3.7 5.8 3.0 3.0 10.5 2.0 7.2 3.2 4.2 14.8 4.6 7.2 2.0 2.5 17.7 0.4 7.6 4.0 2.0 8.6 7.6 4.8 3.2 3.5 3.0 6.2 6.6 2.4 5.9 2.7 4.6 0.1 13.7 9.6 4.7 1.2 5.1 6.9 9.0 4.8 6.4 4.5 2.6 5.2 7.4 5.1 5.2 6.0 8.8 8.9 6.6 2.7 6.6 2.4 8.1 3.8 4.1 11.0 12.4 13.1 19.4 10.3 8.9 11.5 8.0 10.6 13.3 3.0 7.5 2.4 3.0 1.3 7.3 5.6 0.0 8.1 2.3 0.0 3.9 1.9 6.6 5.6 1.3 6.3 5.5 0.0 5.0 1.7 4.6 3.4 3.5 7.8 6.1 6.4 7.0 6.2 6.5 0.0 5.5 4.0 0.0 10.8 6.3 5.2 4.6 10.2 9.2 6.4 6.8 12.9 5.2 11.8 2.7 1.0 1.0 4.5 6.0 2.0 ZNF76 "D6S229E, Zfp523, ZNF523" ENSG00000065029 "Zinc finger protein 76" P36508 6 35258909-35295985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030090, HPA030091" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030090: AB_10603334, HPA030091: AB_10602593" "unprognostic (8.29e-3)" "unprognostic (3.61e-2)" "unprognostic (7.71e-2)" "unprognostic (8.70e-3)" "unprognostic (2.76e-1)" "unprognostic (6.51e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.18e-4)" "prognostic favorable (5.09e-4)" "unprognostic (3.66e-3)" "unprognostic (1.20e-3)" "unprognostic (5.31e-3)" "unprognostic (1.14e-1)" "unprognostic (3.76e-1)" "unprognostic (1.20e-3)" 9.2 20.0 16.0 14.6 18.4 8.5 11.3 27.2 17.8 11.4 11.5 18.1 14.5 11.9 12.5 18.5 10.4 13.7 12.7 20.8 14.8 9.6 14.1 13.0 10.6 15.0 15.3 12.3 19.5 13.9 19.5 31.4 19.7 16.9 15.6 10.2 21.8 16.0 16.6 45.1 10.5 13.1 10.6 13.6 18.3 12.2 19.9 16.4 12.6 24.0 10.3 14.6 12.4 11.0 10.5 7.4 5.4 9.3 9.3 16.0 8.8 6.6 6.1 13.5 14.9 5.7 8.8 9.7 5.7 9.8 9.8 7.8 4.5 9.0 14.5 8.6 8.6 9.4 3.8 11.3 8.7 5.7 21.6 17.0 13.9 9.4 7.2 11.4 7.0 8.3 10.8 5.5 11.2 10.6 6.0 8.8 14.9 10.2 15.3 8.8 14.6 11.7 8.2 6.6 5.4 5.9 11.3 7.0 13.3 8.7 9.3 21.2 7.8 7.0 9.0 17.3 4.7 13.5 22.7 6.7 6.9 6.0 4.7 8.2 15.5 10.7 13.5 6.0 11.0 18.0 3.8 6.6 5.4 16.0 8.6 12.7 10.0 11.7 11.3 7.4 10.5 12.5 13.0 2.0 9.3 9.3 3.7 9.0 8.8 16.0 18.4 27.2 17.8 14.8 9.6 15.3 12.3 16.9 16.4 14.9 8.1 9.5 6.7 5.0 27.5 18.5 7.6 6.7 7.9 8.7 47.1 20.4 18.3 10.5 17.1 10.1 10.5 0.0 13.4 11.0 8.5 5.8 12.7 7.4 9.8 28.6 11.6 6.2 7.8 12.0 10.3 5.8 5.0 6.4 12.5 10.3 7.1 9.7 5.6 10.5 30.2 19.4 8.6 20.9 10.0 5.5 19.0 8.6 9.0 5.8 ZNF764 MGC13138 ENSG00000169951 "Zinc finger protein 764" Q96H86 16 30553764-30558498 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003203 Uncertain Approved Cytosol NA NA Cytosol "HPA003203: AB_1080753" "unprognostic (9.48e-3)" "unprognostic (2.04e-2)" "unprognostic (2.47e-2)" "prognostic favorable (6.84e-4)" "unprognostic (6.62e-2)" "unprognostic (9.75e-3)" "unprognostic (8.26e-3)" "unprognostic (2.64e-3)" "unprognostic (2.00e-1)" "unprognostic (3.64e-1)" "unprognostic (1.77e-3)" "unprognostic (3.43e-2)" "unprognostic (3.55e-1)" "unprognostic (2.87e-1)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (3.05e-1)" 9.4 9.0 12.0 8.0 9.9 9.8 7.4 19.5 11.3 9.4 8.7 10.0 9.7 13.0 10.6 4.4 7.1 9.5 10.8 9.7 10.5 6.1 8.1 11.2 6.8 11.3 10.6 7.4 12.5 8.9 10.6 12.5 6.1 9.9 9.7 8.4 8.3 7.9 7.1 9.4 6.8 11.7 6.4 5.9 11.1 14.0 11.3 10.4 14.9 7.6 6.1 8.1 7.5 7.6 4.1 3.1 6.2 2.7 10.8 6.3 2.5 2.9 3.4 7.1 6.8 3.1 3.1 4.2 3.7 3.1 3.7 2.8 2.8 2.8 5.4 4.5 2.2 2.2 4.2 3.8 2.5 2.9 5.9 9.9 3.5 4.2 5.1 3.7 3.4 5.8 2.4 3.1 3.0 4.1 4.8 3.3 13.3 6.6 6.3 3.3 6.5 9.5 5.5 4.2 1.8 4.8 13.1 3.0 7.0 3.0 1.5 13.7 10.5 2.6 6.0 3.5 4.5 5.2 6.3 2.9 4.9 2.8 2.8 3.7 8.5 5.8 4.5 3.6 4.8 6.9 3.4 2.1 6.2 4.9 2.6 6.3 2.9 4.9 5.9 2.7 4.1 5.1 4.8 2.1 10.8 2.7 3.1 3.1 2.5 12.0 9.9 19.5 11.3 10.5 6.1 10.6 7.4 9.9 10.4 0.0 2.7 4.7 2.0 1.4 5.1 3.6 5.1 8.1 4.5 1.8 0.0 2.3 0.0 2.9 0.4 2.9 4.0 0.0 2.6 1.8 2.3 2.3 1.1 2.4 3.0 1.6 2.4 2.5 3.5 0.2 3.1 2.2 0.0 3.6 3.9 2.7 3.3 10.5 2.5 2.0 5.0 6.5 3.1 10.3 3.9 0.4 0.8 4.9 3.9 1.1 ZNF772 DKFZp686I1569 ENSG00000197128 "Zinc finger protein 772" Q68DY9 19 57466663-57477570 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 21.7" "Low region specificity" "Detected in all" HPA031312 Uncertain Approved Cytosol NA NA Cytosol "HPA031312: AB_10603941" "unprognostic (2.30e-2)" "unprognostic (5.96e-2)" "unprognostic (1.12e-1)" "unprognostic (1.82e-1)" "unprognostic (1.83e-1)" "unprognostic (3.73e-2)" "unprognostic (2.24e-1)" "unprognostic (2.35e-1)" "unprognostic (6.31e-3)" "unprognostic (1.27e-1)" "unprognostic (2.50e-2)" "unprognostic (5.01e-2)" "prognostic favorable (1.02e-6)" "unprognostic (7.99e-2)" "unprognostic (3.75e-1)" "unprognostic (1.43e-1)" "unprognostic (7.93e-2)" 3.4 8.3 11.0 2.5 14.5 2.2 7.9 21.2 11.8 5.4 3.9 8.1 3.9 3.0 3.9 9.5 4.8 8.8 4.2 10.3 9.3 6.9 6.9 4.1 4.8 5.0 8.9 10.2 10.6 4.6 18.9 19.2 6.9 8.0 7.6 2.6 8.6 6.2 7.1 15.7 6.8 3.7 4.0 6.4 7.6 4.0 5.8 9.6 7.4 14.9 3.0 6.3 5.2 3.6 7.6 3.3 2.2 2.4 3.4 4.4 1.9 2.2 1.7 9.1 3.8 2.5 5.3 4.1 3.9 4.8 6.3 21.7 0.5 2.4 0.2 2.9 3.3 2.8 0.2 1.9 5.1 7.7 0.0 14.0 7.1 0.8 2.3 3.3 0.8 7.6 4.4 2.2 4.2 8.8 6.0 4.6 2.9 2.1 1.4 5.7 1.6 1.0 1.8 5.6 0.5 4.3 1.9 11.6 7.1 2.9 5.5 9.6 6.0 0.1 2.1 2.9 6.5 6.2 4.5 2.2 5.9 3.9 1.3 4.0 9.1 15.6 2.6 1.3 0.2 5.7 0.3 2.4 2.2 0.8 1.8 2.9 4.3 2.2 0.9 3.3 7.6 4.4 2.3 1.2 3.4 1.7 1.6 0.6 1.9 11.0 14.5 21.2 11.8 9.3 6.9 8.9 10.2 8.0 9.6 6.0 1.6 1.3 0.3 0.6 6.8 3.9 2.5 1.4 1.2 15.7 5.9 2.0 0.0 1.5 0.0 3.3 0.7 0.0 0.3 0.8 0.4 1.2 2.3 2.4 2.1 6.4 2.4 2.5 4.1 0.9 0.6 1.7 0.0 1.0 1.9 5.0 0.8 0.0 2.1 1.7 8.0 0.0 1.0 0.5 1.1 1.0 1.5 0.0 1.8 0.8 ZNF774 MGC75360 ENSG00000196391 "Zinc finger protein 774" Q6NX45 15 90352245-90369146 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 10.9;Spermatocytes: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA030839, HPA030840" Uncertain Supported "Intermediate filaments,Cytosol" No No "Intermediate filaments" Cytosol "HPA030839: AB_2673630, HPA030840: AB_10602691" "unprognostic (1.11e-1)" "unprognostic (2.14e-1)" "unprognostic (1.38e-1)" "unprognostic (5.82e-3)" "unprognostic (3.29e-2)" "unprognostic (1.35e-1)" "unprognostic (6.89e-2)" "unprognostic (9.22e-3)" "unprognostic (7.82e-2)" "unprognostic (1.94e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (2.71e-1)" "unprognostic (5.62e-2)" "unprognostic (1.27e-1)" "unprognostic (4.48e-2)" "unprognostic (4.82e-2)" 1.5 5.1 5.8 3.6 8.6 1.6 5.7 14.0 8.7 5.0 7.5 4.1 0.0 3.9 5.5 7.3 2.8 5.3 5.1 4.2 4.8 5.4 2.6 2.9 2.1 1.2 3.9 5.9 2.3 6.5 7.1 5.7 1.3 9.4 4.3 12.4 3.0 6.8 10.3 11.9 5.3 3.5 3.3 3.1 1.3 4.6 8.2 4.7 3.8 4.9 3.1 1.7 3.9 3.5 2.0 1.9 4.2 1.1 2.7 1.3 0.4 2.3 1.1 3.1 3.4 1.3 0.7 7.1 1.5 2.4 1.8 2.3 3.7 2.8 0.9 2.8 1.7 5.3 3.5 3.0 5.0 1.8 1.7 6.0 2.4 11.3 1.7 2.3 1.4 2.0 0.7 6.1 2.7 2.6 5.2 3.1 4.8 2.7 1.2 3.0 2.3 1.9 1.3 0.9 6.2 3.6 1.8 2.6 0.7 3.7 6.3 6.9 2.9 2.8 4.4 1.2 3.6 2.9 0.4 1.6 2.1 1.9 1.7 3.0 7.4 5.0 0.6 3.3 3.9 0.9 3.6 1.1 2.2 1.0 0.5 0.7 0.9 0.8 1.3 1.9 2.0 1.0 0.9 4.2 2.7 0.6 1.2 0.5 0.4 5.8 8.6 14.0 8.6 4.8 5.4 3.9 5.9 9.4 4.7 6.0 2.7 0.5 2.5 0.7 6.3 4.5 0.0 0.0 1.2 0.0 0.0 1.4 1.7 2.0 10.9 1.1 2.3 0.0 1.8 1.1 0.4 1.2 0.0 1.0 0.7 7.9 2.4 0.0 0.0 8.2 0.3 0.0 0.0 0.0 3.3 2.3 1.4 3.5 2.1 0.8 5.3 0.0 1.2 9.0 1.1 0.3 1.1 0.0 5.1 1.4 ZNF776 FLJ38288 ENSG00000152443 "Zinc finger protein 776" Q68DI1 19 57746796-57758159 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA046653, HPA068553" Uncertain Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA046653: AB_10961126, HPA068553: AB_2686002" "unprognostic (6.73e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (3.99e-2)" "unprognostic (3.26e-1)" "unprognostic (6.35e-2)" "unprognostic (2.73e-2)" "unprognostic (1.62e-1)" "unprognostic (2.69e-2)" "unprognostic (2.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (7.45e-3)" "unprognostic (1.71e-3)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (6.41e-2)" "unprognostic (6.86e-2)" 5.8 9.8 14.0 10.8 15.9 19.4 12.2 34.9 15.2 9.4 8.6 7.9 17.3 8.4 8.2 29.9 7.8 10.3 6.9 9.8 11.0 9.5 10.7 9.5 8.6 11.0 10.7 8.9 12.4 7.1 17.0 18.8 10.2 12.8 11.9 9.3 9.6 10.8 13.4 11.4 8.6 8.7 7.3 9.6 11.6 10.0 8.7 15.0 19.3 14.5 6.0 10.7 10.7 8.0 4.2 2.5 11.1 2.4 7.5 4.3 2.1 4.7 4.0 12.7 8.4 2.1 6.5 5.4 3.7 6.6 6.6 4.3 2.4 5.1 5.3 3.4 3.4 3.5 3.1 6.6 6.5 10.6 5.0 24.1 7.2 9.4 2.7 4.8 4.0 5.8 7.5 5.5 4.4 4.8 7.1 5.1 8.7 4.8 3.8 8.5 2.1 13.0 3.8 7.4 2.1 8.3 8.4 9.6 6.0 4.8 14.9 14.5 10.5 6.9 5.8 4.1 7.2 5.9 5.7 4.5 7.1 3.8 0.6 5.6 10.7 12.0 8.8 4.2 3.8 5.8 7.9 2.4 11.1 1.8 1.7 3.9 3.5 2.8 3.4 2.2 4.2 4.3 3.2 6.2 7.5 2.1 2.5 2.3 2.1 14.0 15.9 34.9 15.2 11.0 9.5 10.7 8.9 12.8 15.0 3.0 2.6 5.2 3.6 2.4 7.8 10.9 10.2 5.3 1.2 8.7 2.0 2.8 5.0 2.5 0.4 5.5 2.9 0.0 1.2 2.0 2.5 4.5 3.5 6.6 2.9 11.1 8.1 11.1 5.6 0.2 1.1 3.7 0.0 1.8 4.1 10.0 2.2 2.6 4.6 2.2 7.1 0.0 2.2 2.7 4.3 1.5 2.4 1.0 3.3 4.3 ZNF783 DKFZp667J212 ENSG00000204946 "Zinc finger family member 783" Q6ZMS7 7 149262171-149297302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA020375 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA020375: AB_1859453" "unprognostic (3.17e-3)" "unprognostic (2.54e-1)" "unprognostic (8.40e-3)" "unprognostic (1.16e-1)" "unprognostic (6.13e-2)" "unprognostic (1.08e-3)" "unprognostic (4.28e-3)" "unprognostic (1.05e-1)" "unprognostic (4.24e-3)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "unprognostic (3.29e-2)" "prognostic unfavorable (2.24e-7)" "unprognostic (2.49e-2)" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "prognostic favorable (4.11e-4)" 10.1 8.1 11.4 14.4 14.9 6.5 15.1 14.3 15.8 11.5 9.4 15.4 9.9 10.0 13.1 11.2 8.2 13.0 11.0 7.2 11.6 7.7 8.5 4.6 8.6 16.1 13.1 18.4 17.2 11.2 9.4 10.2 7.2 12.5 13.0 9.7 12.2 9.3 13.5 11.6 12.6 12.2 20.1 15.4 17.7 9.1 9.2 12.5 2.9 11.8 6.2 15.0 9.9 16.1 3.8 2.7 0.5 4.5 1.5 3.2 1.1 3.4 3.5 5.7 4.1 3.8 7.3 5.4 2.2 1.1 5.0 2.2 5.5 6.4 11.6 5.6 3.5 1.2 2.3 4.0 4.3 2.2 3.2 3.7 7.5 7.6 1.1 8.7 4.8 9.4 7.6 8.9 4.6 5.6 3.2 3.4 4.1 6.0 6.0 4.1 7.3 7.3 7.5 12.9 7.9 4.7 1.6 0.5 10.1 5.6 5.7 4.6 9.6 8.5 4.0 5.8 3.1 4.4 9.8 5.0 4.0 1.0 2.2 4.8 9.3 5.8 0.1 5.8 1.7 8.7 0.3 1.1 0.5 3.2 2.2 2.5 2.3 2.0 2.0 1.3 3.8 2.7 2.2 0.4 1.5 4.5 2.7 1.2 1.1 11.4 14.9 14.3 15.8 11.6 7.7 13.1 18.4 12.5 12.5 3.0 2.4 7.8 2.4 2.3 14.3 1.4 7.6 4.0 1.2 0.0 9.8 2.5 3.3 2.0 3.9 2.9 2.0 0.0 2.4 1.7 4.5 3.6 0.0 5.0 3.6 6.4 3.5 6.7 8.5 3.5 8.1 2.8 5.0 2.8 5.1 3.4 2.1 0.0 5.3 0.8 8.6 12.9 3.1 14.7 5.9 2.6 0.9 4.1 4.7 2.1 ZNF785 FLJ32130 ENSG00000197162 "Zinc finger protein 785" A8K8V0 16 30573740-30585771 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004010 Approved Cytosol NA NA Cytosol "HPA004010: " "unprognostic (2.85e-2)" "unprognostic (1.29e-1)" "unprognostic (8.25e-2)" "unprognostic (2.47e-1)" "unprognostic (2.35e-1)" "unprognostic (4.15e-2)" "unprognostic (2.54e-4)" "prognostic favorable (8.99e-4)" "unprognostic (1.55e-1)" "unprognostic (2.08e-1)" "prognostic favorable (2.03e-5)" "unprognostic (3.37e-2)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (3.13e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-2)" 5.9 8.7 15.8 7.9 13.6 4.8 8.3 26.8 16.6 10.9 7.7 14.7 8.7 14.2 12.4 9.8 6.9 10.2 8.3 6.2 12.6 7.6 7.8 6.1 6.5 8.7 15.7 12.2 14.7 9.1 11.9 12.7 6.1 11.8 10.8 8.2 10.8 10.5 9.5 9.2 12.6 10.7 7.5 9.5 9.5 12.4 3.9 19.2 8.8 9.9 4.3 8.8 10.4 9.6 5.1 5.4 4.9 5.1 3.3 3.5 1.0 4.9 0.4 4.8 6.4 6.1 6.8 1.5 4.3 3.9 4.5 3.4 6.7 7.9 5.1 5.2 4.1 0.3 7.1 0.1 2.8 2.7 3.4 1.3 6.2 13.7 1.5 4.5 0.5 10.8 4.4 6.2 3.0 2.8 3.8 4.8 0.9 5.8 6.4 4.1 8.6 6.2 5.8 2.8 1.9 2.8 16.3 5.5 2.5 4.2 5.1 13.4 9.5 3.6 4.5 2.6 3.0 5.6 5.3 7.1 1.8 4.8 4.0 0.3 0.9 2.7 2.1 5.8 3.8 7.3 4.7 2.6 1.0 2.3 1.6 2.5 5.1 2.8 1.9 1.9 3.1 3.5 2.7 4.9 3.3 5.1 5.4 3.3 1.0 15.8 13.6 26.8 16.6 12.6 7.6 15.7 12.2 11.8 19.2 0.0 4.3 4.3 6.6 0.9 9.3 1.4 5.1 5.3 2.3 7.0 19.6 1.1 5.0 3.0 0.1 5.1 5.2 0.0 3.0 0.9 3.3 5.7 0.0 3.0 2.3 12.7 11.5 2.5 4.1 0.0 12.4 4.1 5.0 1.8 4.7 5.2 3.5 8.4 12.4 1.5 12.4 0.0 3.1 4.2 1.3 2.3 0.7 4.4 6.3 3.7 ZNF79 pT7 ENSG00000196152 "Zinc finger protein 79" Q15937 9 127424374-127445372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 5.1;Spermatocytes: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028977 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028977: AB_10602359" "unprognostic (4.56e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "prognostic favorable (6.83e-5)" "unprognostic (2.84e-2)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "prognostic favorable (5.96e-4)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.42e-5)" "unprognostic (4.53e-3)" "prognostic favorable (6.04e-7)" "unprognostic (6.09e-3)" "unprognostic (5.01e-1)" "unprognostic (5.23e-2)" "unprognostic (1.32e-1)" 9.9 11.0 7.6 6.7 7.8 6.7 8.1 18.3 8.5 9.2 9.6 10.3 6.9 5.6 12.9 10.4 7.0 9.4 5.6 6.8 6.8 5.3 6.8 9.5 6.8 8.3 7.5 5.2 9.1 9.5 13.2 11.8 8.1 8.4 11.2 8.2 10.7 12.2 8.3 13.2 8.7 7.7 8.3 6.1 10.2 8.8 21.1 8.6 12.8 8.5 4.8 10.5 13.3 9.9 8.5 7.5 7.4 6.0 9.4 11.8 4.9 2.3 4.6 6.2 3.6 6.9 4.1 17.2 5.7 6.9 6.8 7.9 4.9 2.1 4.9 2.3 4.2 9.1 7.1 4.6 6.9 5.4 4.9 3.0 3.4 7.4 5.4 8.1 8.0 5.4 4.1 7.8 8.4 6.9 4.4 7.1 5.7 5.7 7.4 6.4 5.0 6.2 3.0 4.9 5.7 5.9 5.2 8.5 7.0 2.9 3.3 7.0 4.7 10.8 5.6 3.2 5.5 7.4 4.6 4.9 4.4 4.0 4.3 4.4 9.9 21.2 6.3 5.6 2.5 7.2 3.3 4.9 7.4 9.3 6.0 10.6 7.4 6.4 11.8 7.0 8.5 8.4 9.1 6.5 9.4 4.0 7.5 7.9 4.9 7.6 7.8 18.3 8.5 6.8 5.3 7.5 5.2 8.4 8.6 0.0 0.3 0.0 1.0 1.3 0.8 1.6 5.1 0.0 2.3 0.0 0.0 1.8 1.7 1.7 2.1 0.7 0.6 0.0 0.5 0.6 1.1 0.5 0.0 1.0 1.7 1.6 0.0 1.3 0.6 3.7 0.6 0.9 0.0 0.0 0.6 1.3 0.4 0.0 1.8 0.7 1.4 0.0 1.2 5.1 1.3 0.9 2.2 0.8 0.9 0.7 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 29.5;Early spermatids: 32.2;Horizontal cells: 46.1;Rod photoreceptor cells: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;RT4: 9.8;U-266/70: 17.0;U-266/84: 11.3" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 3.1 7.7 12.5 4.9 11.9 2.1 6.4 22.1 14.0 6.4 4.2 12.8 4.6 3.0 9.3 6.9 5.2 6.7 4.6 6.8 10.3 8.0 6.2 1.1 3.3 5.6 8.3 10.0 14.1 4.0 15.7 18.4 4.5 11.2 7.5 6.0 8.1 3.6 5.8 3.7 10.7 3.6 6.1 10.1 5.6 5.3 12.3 9.6 2.1 11.0 3.2 4.9 4.9 5.7 4.0 2.1 7.2 1.6 4.0 2.8 1.4 0.1 0.2 4.2 11.5 0.9 0.9 0.2 3.3 0.2 0.7 0.3 0.2 1.3 2.9 5.5 1.7 1.0 0.4 0.3 2.9 0.3 0.8 4.2 0.3 0.4 0.3 2.1 0.2 2.6 3.4 2.6 0.6 0.1 0.3 0.1 0.3 0.1 0.5 0.5 3.2 0.3 0.4 6.9 0.0 0.3 0.1 0.1 0.6 2.9 9.8 3.1 6.7 0.2 0.2 0.0 8.1 6.4 0.3 0.4 0.1 1.8 0.3 3.3 17.0 11.3 0.3 0.0 0.2 0.5 7.2 1.6 1.2 1.5 0.6 2.3 2.0 2.8 2.5 1.2 4.0 1.9 2.4 4.2 4.0 0.6 2.1 2.2 1.4 12.5 11.9 22.1 14.0 10.3 8.0 8.3 10.0 11.2 9.6 3.0 7.2 0.8 3.4 3.0 28.0 7.3 12.7 6.7 5.7 12.2 29.5 4.8 3.3 3.1 32.2 6.3 1.4 0.0 1.3 3.6 3.1 2.6 2.3 0.4 0.8 46.1 8.6 6.2 0.0 7.7 4.6 2.0 0.0 1.8 3.4 16.2 1.6 0.0 9.6 1.5 33.5 0.0 5.1 5.4 6.4 2.9 1.6 4.3 3.4 1.4 ZNF800 ENSG00000048405 "Zinc finger protein 800" Q2TB10 7 127346790-127431924 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023090, HPA052194" Approved Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA023090: AB_1859457, HPA052194: AB_2681757" "unprognostic (2.93e-2)" "unprognostic (1.10e-1)" "unprognostic (2.27e-1)" "unprognostic (3.34e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-2)" "unprognostic (6.19e-2)" "unprognostic (2.45e-2)" "unprognostic (1.23e-3)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (8.99e-2)" "unprognostic (7.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.08e-1)" "unprognostic (2.53e-2)" "unprognostic (8.96e-3)" 17.5 11.2 10.8 14.4 11.7 61.7 18.7 18.6 12.7 11.9 11.9 6.3 12.8 10.3 14.6 10.4 15.4 13.5 11.6 9.5 10.2 5.9 8.9 14.4 16.5 20.7 13.5 9.2 15.2 15.3 16.2 18.6 10.8 12.6 10.5 10.5 7.1 15.1 16.1 14.9 22.7 14.8 11.5 15.7 15.2 13.1 19.1 12.8 22.4 12.7 10.9 13.8 14.4 15.5 14.2 12.0 16.9 6.8 18.9 17.2 5.9 9.1 4.8 5.7 9.8 8.2 11.0 5.4 8.9 10.5 9.2 8.9 4.4 8.8 15.6 5.5 8.4 9.9 6.7 9.2 9.5 12.7 13.7 5.4 10.0 4.9 4.1 10.3 13.7 19.3 9.3 8.8 10.1 13.7 7.7 9.7 9.7 12.4 16.1 9.9 7.0 15.2 9.9 4.7 8.5 6.4 9.5 7.9 10.3 6.7 11.6 8.1 8.5 8.8 34.9 11.3 8.1 4.1 9.4 10.4 15.5 4.9 10.2 10.4 19.4 8.5 22.6 11.5 12.5 12.8 16.9 6.8 10.1 13.3 6.3 14.0 12.0 10.0 13.5 7.0 14.2 16.4 17.2 6.0 18.9 6.6 12.0 13.8 5.9 10.8 11.7 18.6 12.7 10.2 5.9 13.5 9.2 12.6 12.8 35.7 19.7 27.4 41.3 39.8 25.9 12.6 15.3 16.0 21.6 12.2 21.6 9.7 10.0 20.7 27.0 23.3 24.9 23.3 16.7 8.6 17.5 40.1 28.8 12.9 12.9 73.1 15.5 23.4 26.2 8.6 25.0 26.7 27.0 27.9 22.6 16.6 19.9 25.9 29.7 10.5 26.1 25.8 25.8 97.4 48.6 41.9 18.4 33.8 20.0 57.6 ZNF852 ENSG00000178917 "Zinc finger protein 852" Q6ZMS4 3 44498970-44510636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 4.8;Ciliated cells: 6.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048312, HPA049885, HPA071850" Uncertain Approved Cytosol NA NA Cytosol "HPA048312: AB_2680352, HPA049885: AB_2680933, HPA071850: AB_2686458" "unprognostic (2.64e-1)" "unprognostic (2.62e-1)" "unprognostic (5.93e-3)" "unprognostic (1.73e-1)" "unprognostic (2.29e-2)" "unprognostic (1.30e-3)" "unprognostic (3.47e-2)" "unprognostic (2.55e-2)" "unprognostic (5.11e-2)" "unprognostic (1.43e-1)" "unprognostic (3.80e-2)" "unprognostic (1.03e-1)" "unprognostic (6.62e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (8.05e-2)" "unprognostic (1.11e-2)" 3.8 4.0 5.0 4.7 5.4 3.1 4.7 12.9 6.9 4.6 4.0 3.2 4.6 3.6 5.2 3.7 3.6 4.2 3.1 3.3 4.8 2.1 4.0 3.7 4.8 4.8 5.5 3.9 6.4 10.3 9.0 13.5 4.7 5.4 5.6 5.8 4.2 8.8 4.6 2.9 4.6 5.4 7.0 4.7 5.1 6.0 2.9 4.6 7.1 4.4 2.5 6.3 5.0 6.1 2.4 2.7 1.4 1.3 0.7 1.8 0.4 0.8 1.4 3.4 5.9 0.8 2.0 2.4 0.9 1.2 1.6 2.7 1.8 1.0 2.9 0.7 1.0 0.9 0.9 3.7 0.9 2.3 2.3 1.7 2.6 5.8 1.5 1.5 2.9 5.3 0.8 1.9 2.4 0.8 2.1 1.4 2.9 3.2 1.6 1.7 0.2 2.5 2.4 1.9 0.9 0.7 1.3 3.5 1.3 1.1 2.9 2.9 2.1 1.8 0.8 0.8 6.0 1.9 2.7 1.8 2.2 2.4 1.3 0.9 2.4 1.5 1.5 0.7 2.2 1.4 0.0 0.6 1.4 0.6 1.3 1.0 2.4 1.1 0.7 0.5 1.6 1.0 1.8 0.9 0.7 0.3 2.7 0.1 0.4 5.0 5.4 12.9 6.9 4.8 2.1 5.5 3.9 5.4 4.6 0.0 4.8 0.0 0.7 3.0 1.7 1.6 0.0 6.7 1.2 0.0 2.0 0.7 3.3 1.4 0.0 0.7 0.8 0.0 1.2 0.9 0.6 0.6 1.1 1.0 0.6 1.6 0.0 2.5 0.0 0.0 0.6 1.4 1.7 1.8 0.3 2.5 1.4 0.0 1.1 0.6 1.4 0.0 0.8 2.6 1.5 1.6 0.2 0.0 0.6 0.7 ZRANB1 TRABID ENSG00000019995 "Zinc finger RANBP2-type containing 1" Q9UGI0 10 124942123-124988189 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029239, HPA029240, HPA029241" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205" "unprognostic (2.06e-1)" "unprognostic (5.16e-2)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (1.40e-1)" "unprognostic (9.53e-3)" "unprognostic (4.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (4.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.76e-1)" "unprognostic (1.26e-1)" "unprognostic (1.47e-2)" 5.1 9.3 4.9 1.9 4.7 7.9 5.3 11.9 6.0 6.3 5.2 1.4 5.9 5.2 4.1 4.4 3.6 7.3 4.6 4.0 4.2 10.4 4.2 2.5 4.4 8.6 3.1 7.1 3.9 3.9 4.6 3.3 3.4 5.8 18.0 5.2 3.0 6.3 3.8 2.8 3.6 7.7 3.8 3.9 4.2 4.8 3.4 1.4 4.6 1.1 3.8 4.4 0.8 7.7 4.4 9.5 6.9 14.8 12.5 4.0 7.6 20.8 14.5 16.9 6.6 6.1 8.1 5.7 9.6 4.7 5.6 12.0 5.6 19.6 8.6 5.9 4.6 5.1 7.1 31.6 6.9 3.5 13.8 16.5 10.6 22.8 20.3 9.1 7.5 0.6 6.7 7.8 6.1 8.1 6.0 3.4 4.2 4.8 7.0 6.7 3.6 6.4 5.6 4.8 8.1 6.4 5.0 8.4 9.3 5.5 5.9 6.7 6.2 6.4 5.1 9.4 7.2 6.2 9.4 7.0 4.9 3.0 2.1 1.1 3.0 2.2 0.4 1.9 2.4 2.6 2.2 0.9 3.4 4.4 3.3 4.6 3.8 0.5 1.4 2.2 0.8 17.9 25.9 5.7 19.6 21.9 32.7 21.0 15.3 21.4 19.4 17.4 47.1 10.6 0.0 11.6 60.8 18.8 11.6 0.0 10.0 8.1 20.6 26.5 25.4 38.0 10.6 35.0 25.7 15.4 16.8 27.1 22.2 19.1 15.1 8.2 15.7 23.9 15.7 8.2 21.5 8.7 24.5 12.9 24.7 23.3 19.0 24.3 23.0 17.5 10.5 20.0 ZSCAN12 "dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96" ENSG00000158691 "Zinc finger and SCAN domain containing 12" O43309 6 28378955-28399734 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Club cells: 11.4;Early spermatids: 20.4;Spermatocytes: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006637, HPA006732" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006637: AB_1080646, HPA006732: " "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (8.35e-4)" "unprognostic (1.51e-2)" "unprognostic (9.99e-2)" "unprognostic (1.00e-3)" "unprognostic (4.73e-2)" "unprognostic (9.96e-2)" "unprognostic (1.91e-2)" "unprognostic (2.35e-1)" "unprognostic (4.44e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (8.71e-2)" 6.4 5.5 8.0 7.4 8.6 3.7 11.4 12.1 9.0 8.1 7.2 5.7 6.9 4.9 9.4 7.6 4.6 7.3 4.6 4.7 7.2 5.0 6.0 3.8 5.7 8.3 5.0 3.9 11.4 9.0 10.1 14.1 7.0 7.6 8.9 6.0 4.8 6.9 9.9 2.8 4.5 6.6 7.5 5.1 7.2 5.8 9.5 6.9 11.5 10.3 3.7 7.7 9.4 10.2 6.1 2.2 5.2 1.7 3.9 4.5 1.9 5.3 1.7 8.1 0.1 4.2 3.3 5.8 3.7 5.1 5.6 7.8 1.2 2.0 5.1 7.0 2.5 2.8 2.4 0.0 4.5 5.8 0.0 6.6 7.4 5.3 3.7 3.9 2.6 1.9 4.4 4.3 5.6 10.1 6.1 1.5 0.0 10.8 1.2 3.5 0.6 0.0 5.8 5.1 0.5 0.9 8.9 7.4 1.3 4.2 3.5 10.0 10.2 1.9 4.4 6.2 8.5 1.7 6.6 1.5 2.2 4.8 1.7 2.9 3.2 3.3 1.0 2.0 0.7 3.4 5.2 1.6 3.3 3.6 1.0 3.4 4.3 2.7 4.2 2.2 6.1 4.5 3.8 0.5 3.9 1.7 2.0 2.1 1.9 8.0 8.6 12.1 9.0 7.2 5.0 5.0 3.9 7.6 6.9 6.0 3.2 1.7 1.4 0.3 5.6 2.8 0.0 0.0 11.4 0.0 3.9 1.2 1.7 1.3 20.4 1.3 0.5 0.0 2.2 0.9 0.9 1.2 1.1 0.8 0.9 6.4 1.2 4.3 0.6 4.5 1.7 0.6 1.7 1.8 0.9 3.5 1.3 0.0 3.2 0.9 5.4 6.5 1.9 11.3 2.7 0.3 0.5 1.3 2.1 0.5 ZSCAN2 "FLJ20595, ZFP29, ZNF854" ENSG00000176371 "Zinc finger and SCAN domain containing 2" Q7Z7L9 15 84600986-84627796 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 36.9" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007296, HPA024331" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007296: , HPA024331: AB_1859497" "unprognostic (4.05e-1)" "unprognostic (2.08e-1)" "unprognostic (9.49e-2)" "unprognostic (6.76e-2)" "unprognostic (7.84e-2)" "unprognostic (2.47e-2)" "unprognostic (3.58e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.95e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.24e-1)" "prognostic favorable (7.46e-4)" "unprognostic (2.42e-2)" "unprognostic (3.53e-3)" "unprognostic (2.98e-1)" "prognostic favorable (4.16e-5)" 9.8 7.6 5.2 7.2 7.4 9.7 15.0 5.9 6.3 7.3 6.2 5.8 9.0 4.1 9.5 8.4 3.4 5.3 8.2 8.2 4.8 4.7 9.1 10.1 4.5 8.0 6.2 5.0 10.2 36.9 6.9 6.3 2.8 5.1 7.1 4.3 6.7 12.4 5.1 9.5 3.4 5.5 9.0 5.1 8.1 8.5 12.0 6.0 24.4 6.3 3.9 6.9 6.5 9.7 7.1 10.5 10.0 12.2 9.0 12.1 6.4 1.6 9.5 7.5 12.3 4.4 3.0 6.5 1.8 5.2 3.9 5.3 7.3 3.9 3.5 5.3 2.9 7.2 4.1 6.3 3.6 3.5 7.2 9.7 4.5 5.5 15.4 3.8 2.8 3.6 4.4 4.3 5.1 4.9 5.4 11.8 18.7 5.9 2.8 4.8 4.7 13.0 6.7 13.7 3.3 5.7 13.6 4.2 6.6 4.2 12.1 10.5 18.5 5.7 3.2 8.8 11.7 6.6 8.0 7.7 4.9 9.4 2.3 2.3 4.9 6.4 11.8 3.2 6.6 3.0 10.0 9.6 8.3 10.9 10.5 5.4 7.1 9.2 8.2 10.5 7.1 7.6 8.2 5.4 9.0 12.2 10.2 12.1 6.4 5.2 7.4 5.9 6.3 4.8 4.7 6.2 5.0 5.1 6.0 0.0 1.3 2.2 1.1 0.8 3.5 2.2 7.6 2.7 0.0 7.0 2.0 1.4 5.0 5.4 11.3 1.9 1.1 0.0 7.3 3.9 2.2 2.8 1.1 7.8 3.1 0.0 2.9 0.6 3.2 9.5 0.9 3.1 1.7 7.2 2.9 2.4 10.1 3.5 1.4 14.3 2.9 6.5 1.4 3.4 8.1 0.4 1.1 3.2 2.4 1.3 ZSCAN22 "HKR2, ZNF50" ENSG00000182318 "Zinc finger and SCAN domain containing 22" P10073 19 58327019-58342332 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 5.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 18.2" "Low region specificity" "Detected in all" HPA006471 Uncertain Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA006471: AB_2221026" "unprognostic (5.55e-3)" "unprognostic (2.24e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (3.82e-2)" "unprognostic (2.47e-3)" "unprognostic (1.52e-1)" "unprognostic (2.91e-1)" "unprognostic (1.15e-1)" "unprognostic (2.15e-3)" "unprognostic (5.00e-2)" "unprognostic (7.59e-2)" "unprognostic (2.59e-2)" "unprognostic (1.74e-1)" "unprognostic (5.22e-3)" "unprognostic (1.07e-1)" 4.8 5.6 4.1 8.5 6.1 3.0 10.8 9.3 6.2 6.7 4.8 4.7 9.3 5.1 5.7 4.2 6.1 4.6 3.5 4.9 4.3 4.1 4.2 7.7 4.8 4.8 9.7 3.7 7.8 7.3 9.4 9.1 5.3 6.8 5.1 4.3 2.7 7.0 9.2 6.1 8.1 5.2 5.6 3.9 5.2 5.5 5.7 6.2 8.0 6.5 4.3 6.4 4.6 5.3 3.2 3.0 2.7 2.3 3.2 5.6 2.3 2.8 5.3 2.9 4.4 3.4 2.1 3.1 2.4 1.2 1.5 1.4 2.8 2.0 2.4 1.6 2.1 1.9 2.3 4.1 2.8 1.6 3.6 18.2 4.9 4.9 2.6 2.7 3.9 5.1 2.4 2.8 3.4 3.6 2.8 2.2 2.4 4.9 4.5 2.6 2.4 1.9 1.8 2.5 3.6 5.9 2.7 4.5 3.9 1.6 3.8 4.6 3.3 3.6 5.0 2.2 2.5 2.4 2.6 2.1 8.3 2.4 2.1 4.2 4.5 6.1 1.8 3.3 2.7 2.9 0.3 2.1 2.7 5.6 1.8 3.9 2.6 3.3 4.6 3.0 3.2 2.9 2.9 0.7 3.2 2.3 1.4 2.6 2.3 4.1 6.1 9.3 6.2 4.3 4.1 9.7 3.7 6.8 6.2 0.0 5.5 0.0 0.4 1.5 0.7 0.4 2.5 1.4 2.3 1.8 0.0 0.7 1.7 0.8 0.1 0.9 0.5 0.0 0.6 0.7 0.9 0.9 0.0 0.8 0.4 1.6 0.0 0.0 0.8 0.0 2.0 1.1 1.7 1.8 0.7 0.3 1.2 0.9 0.4 0.5 0.7 0.0 0.8 2.2 1.3 3.1 0.6 1.3 0.9 0.4 ZSCAN30 "ZNF397OS, ZNF917" ENSG00000186814 "Zinc finger and SCAN domain containing 30" Q86W11 18 35251058-35290245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007289 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007289: AB_1079726" "unprognostic (6.02e-3)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (8.94e-2)" "unprognostic (3.56e-3)" "unprognostic (7.02e-3)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (3.05e-3)" "unprognostic (2.78e-3)" "unprognostic (8.27e-3)" "unprognostic (1.15e-1)" "unprognostic (8.44e-3)" "unprognostic (8.75e-2)" "unprognostic (1.36e-1)" 9.4 14.4 11.8 9.2 19.1 7.9 12.2 23.0 19.9 9.4 8.9 20.9 9.8 10.1 14.2 13.9 6.7 10.3 10.4 16.4 12.2 10.6 12.1 8.7 10.3 12.4 11.8 12.8 10.7 9.7 19.8 27.3 9.6 14.7 11.1 8.4 12.8 9.2 9.4 15.4 11.7 12.8 9.4 15.0 12.1 10.0 10.5 15.0 13.0 15.2 6.8 9.4 8.6 8.2 7.7 5.4 4.8 1.9 4.0 5.6 2.5 4.4 1.2 10.1 13.3 6.8 13.5 6.9 8.6 11.5 5.0 9.9 3.6 5.5 8.0 5.7 9.1 8.5 3.1 4.7 9.0 13.6 8.0 2.7 5.2 5.7 2.5 7.1 4.4 5.2 8.7 7.1 13.5 11.4 13.2 9.1 11.4 8.3 9.6 13.1 2.0 6.4 7.3 6.5 1.3 4.2 9.5 3.3 5.8 7.6 3.0 14.2 7.4 8.5 2.7 3.6 10.8 4.2 5.9 11.4 18.1 3.9 2.8 3.4 17.1 7.3 7.1 13.7 4.9 10.2 2.4 1.3 4.4 4.6 1.6 3.0 5.3 4.2 2.7 2.2 7.7 5.0 5.6 4.8 4.0 1.9 5.4 3.7 2.5 11.8 19.1 23.0 19.9 12.2 10.6 11.8 12.8 14.7 15.0 8.9 5.4 1.5 1.7 1.5 28.2 11.2 7.6 6.7 13.6 1.8 19.6 2.9 5.0 3.4 8.3 6.7 3.2 0.0 3.0 1.2 3.1 2.1 8.1 4.3 2.2 19.1 6.9 9.8 4.8 6.5 5.5 2.0 0.0 1.0 3.6 13.6 3.2 4.2 7.4 3.8 18.6 0.0 2.4 10.7 5.2 0.9 1.5 4.9 3.6 1.7 ZSCAN31 "ZNF310P, ZNF323" ENSG00000235109 "Zinc finger and SCAN domain containing 31" Q96LW9 6 28324693-28356271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 26.8;Early spermatids: 114.2;Late spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 13.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.7;EFO-21: 21.8;TIME: 16.3;U-2 OS: 26.6" "Low region specificity" "Detected in all" HPA007124 Approved Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA007124: AB_1080703" "unprognostic (1.11e-1)" "unprognostic (4.23e-2)" "unprognostic (3.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-3)" "unprognostic (6.90e-2)" "unprognostic (2.77e-1)" "unprognostic (1.29e-2)" "unprognostic (2.41e-2)" "unprognostic (4.96e-2)" "unprognostic (6.07e-2)" "unprognostic (5.10e-2)" "prognostic favorable (2.19e-5)" "unprognostic (8.43e-3)" "unprognostic (6.22e-2)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" 5.2 4.0 11.3 2.2 12.1 3.5 11.2 36.4 27.6 8.0 9.9 3.6 5.9 3.2 16.3 8.4 9.9 6.8 15.5 6.4 8.0 3.8 5.2 4.5 8.7 1.9 16.7 5.6 17.7 8.1 4.8 8.3 2.3 14.9 7.1 5.1 3.5 6.5 8.3 7.0 11.0 3.5 10.7 21.9 2.1 13.3 18.4 11.8 0.6 21.0 5.6 3.1 7.3 6.9 1.5 2.0 13.4 0.3 1.4 1.5 0.3 1.0 1.4 2.2 10.3 0.3 0.5 3.3 0.5 0.6 0.5 0.4 1.3 15.7 0.2 21.8 0.7 3.2 3.3 1.1 0.9 0.3 1.8 0.9 3.6 8.1 2.4 0.9 7.3 4.5 0.3 8.7 0.6 0.9 1.0 14.9 2.8 3.9 2.8 2.3 1.5 1.2 1.7 0.7 0.7 6.4 3.2 2.0 1.9 1.5 1.3 7.3 2.0 13.9 9.0 2.0 1.7 4.5 2.5 16.3 3.3 26.6 0.7 1.2 1.1 1.6 0.2 0.4 3.5 0.7 13.4 0.3 0.6 1.5 0.2 1.3 1.5 1.2 1.2 0.3 1.3 1.0 1.5 0.3 1.4 0.3 2.0 0.2 0.3 11.3 12.1 36.4 27.6 8.0 3.8 16.7 5.6 14.9 11.8 26.8 3.5 0.0 2.2 0.7 6.5 6.1 5.1 2.7 12.5 3.5 0.0 1.8 6.6 2.4 114.2 4.5 1.6 0.0 7.1 0.8 1.5 1.7 2.3 3.9 0.6 1.6 5.8 2.5 0.3 52.0 3.4 1.1 1.7 1.0 2.2 7.3 4.0 3.5 4.9 4.2 4.9 6.5 1.7 2.3 2.5 1.9 0.7 1.5 2.3 1.3 ZSCAN32 "FLJ20417, ZNF434" ENSG00000140987 "Zinc finger and SCAN domain containing 32" Q9NX65 16 3382081-3401065 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA005758 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005758: AB_1080720" "unprognostic (5.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-2)" "unprognostic (6.04e-2)" "unprognostic (2.84e-2)" "unprognostic (2.38e-3)" "unprognostic (7.72e-2)" "unprognostic (9.40e-2)" "unprognostic (2.19e-1)" "unprognostic (4.73e-2)" "unprognostic (3.20e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-3)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (1.18e-3)" "unprognostic (9.71e-2)" 7.4 10.0 12.0 11.1 19.7 4.7 9.2 12.0 11.9 9.5 9.0 12.5 5.5 11.6 10.8 7.2 7.5 10.6 9.9 8.0 11.5 10.3 9.3 8.3 9.2 11.2 19.3 7.3 12.4 9.8 14.3 13.2 8.0 14.1 9.5 9.0 8.3 7.2 11.7 5.6 8.3 12.4 9.1 14.1 10.1 8.7 11.1 16.1 13.9 10.9 5.9 13.7 8.9 7.0 8.2 5.1 6.9 12.2 16.3 10.4 6.0 4.7 7.4 10.9 12.9 8.6 8.7 7.7 6.1 10.7 8.7 8.3 3.6 6.7 15.6 6.5 8.6 4.8 4.3 8.6 8.8 9.9 9.9 6.3 13.9 6.5 5.4 11.1 9.4 10.1 8.5 14.6 8.1 14.7 9.0 8.1 17.1 13.1 5.7 11.5 5.4 12.3 6.4 11.2 8.3 4.3 13.1 11.7 13.4 7.5 5.2 8.7 6.8 11.5 7.7 5.0 6.6 8.2 11.2 10.6 6.5 6.8 5.7 7.0 10.1 11.4 19.3 2.4 7.5 10.6 4.9 4.9 6.9 10.4 4.3 8.8 8.2 7.2 6.6 4.6 7.4 9.8 8.8 6.0 16.3 12.2 5.1 9.4 6.0 12.0 19.7 12.0 11.9 11.5 10.3 19.3 7.3 14.1 16.1 17.9 4.0 4.4 1.9 2.1 4.5 0.8 7.6 1.4 9.1 1.8 7.9 3.6 10.0 4.3 1.4 2.7 2.5 0.0 5.3 2.5 2.3 3.2 4.7 3.0 2.5 7.9 0.0 2.5 3.5 0.7 4.0 2.2 1.7 5.4 3.0 4.8 4.9 2.9 4.9 4.1 4.4 0.0 1.9 7.1 13.4 2.5 2.2 7.5 2.5 1.3 ZSWIM1 "C20orf162, dJ337O18.5" ENSG00000168612 "Zinc finger SWIM-type containing 1" Q9BR11 20 45881227-45885266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041147, HPA046751" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041147: AB_2677329, HPA046751: AB_2679785" "unprognostic (6.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (1.51e-2)" "unprognostic (1.69e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.47e-4)" "unprognostic (9.06e-2)" "unprognostic (1.18e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.78e-1)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "unprognostic (4.64e-1)" "unprognostic (4.29e-2)" 11.3 13.8 7.3 7.6 11.4 10.2 7.8 17.2 15.7 7.3 8.5 10.4 5.6 8.8 10.1 7.8 9.3 9.3 10.1 9.8 7.5 7.7 12.8 11.3 6.9 9.5 6.9 8.5 12.6 14.1 10.0 11.4 12.2 6.3 10.3 7.7 14.1 10.4 8.1 27.3 12.3 10.6 9.1 8.1 12.2 8.7 9.0 9.5 16.1 11.5 9.8 13.3 9.6 7.0 5.4 4.4 6.9 3.7 1.2 5.3 1.4 6.4 8.1 6.1 7.4 11.1 6.5 6.2 4.4 5.8 10.2 9.4 18.5 7.6 7.7 13.4 6.4 10.7 15.6 9.9 12.6 7.6 2.9 5.9 10.1 10.1 12.6 6.8 8.1 10.4 9.3 10.6 8.4 8.1 7.4 7.9 6.9 8.9 6.2 5.8 19.6 9.1 6.7 3.3 7.3 9.1 7.0 8.9 5.4 6.5 9.6 8.1 5.2 15.4 22.7 5.2 5.7 13.5 6.1 6.4 11.1 7.0 5.9 6.5 6.2 4.4 7.9 8.8 6.4 5.6 3.8 2.9 6.9 1.0 3.7 0.7 5.4 3.7 1.6 1.6 5.1 5.3 4.7 3.1 1.2 3.5 4.4 3.0 1.4 7.3 11.4 17.2 15.7 7.5 7.7 6.9 8.5 6.3 9.5 3.0 2.4 0.5 1.7 1.0 2.4 4.8 0.0 0.0 1.2 0.0 0.0 2.5 3.3 1.8 0.2 1.3 2.6 0.0 3.3 2.3 1.4 1.9 3.5 1.7 1.5 6.4 2.4 2.5 1.6 0.4 3.1 1.2 0.0 1.0 2.6 1.4 2.8 3.2 1.4 1.2 3.2 0.0 1.7 0.6 1.7 1.4 1.9 1.7 2.3 1.6 ZSWIM3 "C20orf164, dJ337O18.7, PPP1R174" ENSG00000132801 "Zinc finger SWIM-type containing 3" Q96MP5 20 45857617-45879122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 4.1;Rod photoreceptor cells: 4.2;Spermatogonia: 3.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055692, HPA060508" Uncertain Approved "Nucleoli fibrillar center,Vesicles,Cytosol" NA NA Vesicles "Nucleoli fibrillar center, Cytosol" "HPA055692: AB_2682887, HPA060508: AB_2684297" "prognostic unfavorable (9.32e-5)" "unprognostic (8.53e-2)" "unprognostic (3.55e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (4.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.77e-3)" "unprognostic (4.49e-2)" "unprognostic (2.20e-1)" "unprognostic (1.36e-2)" "unprognostic (2.72e-3)" "unprognostic (9.28e-2)" "unprognostic (4.74e-2)" "unprognostic (5.55e-2)" "unprognostic (1.76e-1)" "unprognostic (4.69e-2)" "unprognostic (4.13e-2)" 5.1 9.6 8.3 5.6 8.2 2.2 5.7 15.2 9.6 6.1 6.7 6.3 5.2 7.4 6.7 8.9 5.9 6.8 5.4 6.0 7.3 7.2 5.6 7.0 5.9 9.3 6.2 7.4 9.0 5.0 6.9 9.5 5.3 6.7 6.1 7.3 9.4 5.4 5.4 3.9 6.7 7.4 5.5 6.0 10.5 5.8 9.5 6.3 13.7 5.9 2.9 11.2 6.1 4.7 4.3 3.8 3.2 8.5 3.3 6.3 2.1 2.1 1.8 5.4 3.1 6.6 4.7 3.2 3.3 4.1 6.2 6.2 7.5 3.4 6.7 11.7 2.8 3.1 3.6 7.7 3.6 4.7 4.1 3.2 6.5 3.4 4.8 8.0 3.6 8.9 4.3 4.1 4.7 3.0 6.6 5.3 5.9 5.9 3.2 4.7 10.7 5.0 7.3 2.1 4.9 7.3 5.0 5.0 4.9 1.7 1.3 7.1 3.5 5.4 6.3 4.2 4.2 3.0 9.6 5.2 6.3 2.0 2.3 2.0 7.1 3.7 4.3 5.3 4.4 2.0 2.1 2.3 3.2 3.0 3.2 6.3 4.3 3.3 4.2 3.8 3.6 3.2 4.3 1.7 3.3 8.5 2.3 4.9 2.1 8.3 8.2 15.2 9.6 7.3 7.2 6.2 7.4 6.7 6.3 3.0 1.4 0.5 0.2 0.3 4.1 0.8 0.0 0.0 0.0 1.8 0.0 1.2 0.0 1.2 0.4 0.7 1.5 0.0 1.2 0.5 1.5 0.2 0.0 0.8 0.8 0.0 2.4 0.6 0.8 0.0 0.3 0.9 0.0 0.0 1.1 2.2 0.7 0.0 1.1 1.0 4.2 0.0 1.0 2.1 3.9 0.3 0.7 2.9 1.0 0.3 ZSWIM6 KIAA1577 ENSG00000130449 "Zinc finger SWIM-type containing 6" Q9HCJ5 5 61332273-61546170 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal glandular cells: 75.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 24.1" "Low region specificity" "Detected in all" HPA035938 Uncertain Approved Cytosol NA NA Cytosol "HPA035938: AB_10672077" "unprognostic (2.22e-1)" "unprognostic (2.08e-2)" "unprognostic (1.12e-1)" "unprognostic (2.10e-1)" "unprognostic (2.70e-1)" "unprognostic (6.69e-2)" "unprognostic (2.00e-1)" "unprognostic (6.96e-3)" "unprognostic (6.16e-2)" "unprognostic (1.40e-2)" "unprognostic (2.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.68e-2)" "unprognostic (7.50e-3)" "unprognostic (1.11e-1)" "unprognostic (3.63e-1)" "unprognostic (1.99e-1)" 14.1 10.0 14.4 14.9 22.9 6.3 8.8 13.1 18.0 9.0 15.8 40.1 8.2 10.4 9.2 10.3 12.6 10.2 17.0 7.1 15.0 12.2 8.0 13.6 17.4 9.4 25.2 10.6 11.5 12.6 19.4 9.7 13.6 20.4 12.5 19.1 17.7 10.3 12.1 5.2 8.2 12.4 11.1 19.4 11.6 17.2 12.5 25.9 11.2 10.4 5.9 8.7 10.4 11.8 1.2 3.4 4.4 3.2 0.9 0.9 0.5 3.2 4.3 20.2 1.4 4.3 8.0 1.7 4.4 4.0 4.9 7.6 1.7 5.3 0.8 3.9 5.5 7.8 2.8 4.4 5.4 7.0 13.6 4.2 1.6 8.4 0.9 5.8 1.0 2.3 5.8 4.0 11.5 10.0 6.8 12.0 1.8 0.4 16.6 20.0 2.3 0.8 2.1 3.1 0.9 3.3 6.4 5.9 24.1 8.1 4.2 4.1 6.5 10.4 0.6 4.0 8.2 1.8 4.2 16.7 4.1 5.3 5.7 6.2 2.9 0.4 1.8 6.3 1.3 8.7 1.5 3.1 1.2 0.2 2.4 0.9 0.6 0.3 0.4 1.5 1.2 0.4 0.3 4.4 0.9 3.2 3.4 0.4 0.5 14.4 22.9 13.1 18.0 15.0 12.2 25.2 10.6 20.4 25.9 23.8 13.0 12.8 75.8 42.1 7.5 9.9 17.8 33.5 31.8 10.4 9.8 0.4 1.7 11.1 8.4 18.0 27.5 0.0 11.1 0.2 30.2 39.2 13.9 6.0 22.1 7.9 13.6 28.3 63.4 6.9 5.2 33.2 15.1 5.4 25.1 19.3 14.8 22.8 6.0 4.0 5.1 6.5 22.7 14.9 19.8 34.9 1.1 3.2 18.0 40.6 ZSWIM7 SWS1 ENSG00000214941 "Zinc finger SWIM-type containing 7" Q19AV6 17 15976560-15999717 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054681 Uncertain Uncertain Cytosol NA NA Cytosol "HPA054681: AB_2682572" "unprognostic (3.07e-2)" "unprognostic (5.51e-2)" "unprognostic (1.58e-1)" "prognostic favorable (3.54e-5)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (4.23e-2)" "unprognostic (1.84e-2)" "unprognostic (8.56e-2)" "unprognostic (2.45e-3)" "unprognostic (8.80e-3)" "unprognostic (1.70e-1)" 10.0 16.2 14.3 11.5 21.7 7.0 21.5 9.8 28.7 9.4 10.3 9.8 13.8 13.2 11.5 14.2 11.6 11.2 8.8 18.7 17.4 13.8 15.2 14.4 13.6 13.8 16.9 12.2 14.3 13.9 8.6 15.5 10.2 16.5 9.6 9.1 9.9 14.0 13.1 49.2 13.8 9.3 11.2 22.1 12.2 10.5 10.8 12.1 6.2 12.1 8.4 7.3 11.4 11.2 17.2 26.0 15.2 17.2 10.0 12.6 12.2 10.1 14.9 8.1 18.6 3.3 3.1 9.4 6.9 2.6 7.3 5.4 2.8 3.0 4.9 6.1 7.5 2.2 3.3 2.5 5.5 3.5 5.0 9.1 5.5 6.9 5.7 7.7 4.4 9.3 7.5 9.9 4.0 6.9 1.1 9.3 12.8 3.5 2.7 3.7 13.8 15.2 10.5 4.9 14.9 8.9 9.7 19.8 7.6 6.6 5.6 2.7 11.8 10.6 10.7 6.9 21.8 7.7 1.1 13.1 11.9 4.1 3.1 5.9 1.3 3.6 5.6 10.2 5.6 10.1 15.2 17.2 7.0 8.9 16.1 9.3 17.2 10.4 8.5 26.0 14.3 12.6 12.0 1.0 10.0 11.3 16.1 7.5 12.2 14.3 21.7 9.8 28.7 17.4 13.8 16.9 12.2 16.5 12.1 32.8 55.7 24.4 28.2 22.8 38.5 59.6 68.8 41.5 26.1 38.4 58.9 74.3 72.9 53.3 8.3 29.2 35.8 0.0 45.1 51.4 24.4 30.3 54.3 39.8 44.0 17.5 48.8 32.5 52.9 9.8 42.0 43.4 52.3 18.0 36.4 46.9 43.1 35.1 37.4 102.1 54.4 25.8 26.9 89.2 59.4 24.1 60.9 27.9 31.8 20.3 ZSWIM8 "4832404P21Rik, KIAA0913" ENSG00000214655 "Zinc finger SWIM-type containing 8" A7E2V4 10 73785582-73801797 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041244 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041244: AB_10794269" "unprognostic (8.83e-2)" "unprognostic (2.86e-1)" "unprognostic (2.89e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-2)" "prognostic favorable (5.61e-4)" "unprognostic (3.11e-1)" "unprognostic (1.64e-1)" "unprognostic (2.97e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-3)" "unprognostic (1.31e-1)" "unprognostic (1.52e-1)" "unprognostic (2.41e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-1)" "unprognostic (2.52e-1)" 22.5 30.2 27.1 17.7 27.9 35.3 20.6 29.8 32.4 21.7 27.2 38.1 29.7 25.6 25.5 43.3 33.1 19.9 24.9 19.8 25.9 20.4 28.8 43.1 22.3 20.9 34.0 24.9 26.4 23.3 39.0 50.0 28.1 28.6 29.9 17.8 29.8 30.3 28.9 19.5 48.2 34.8 27.9 20.0 36.8 21.8 29.1 37.0 22.7 30.1 15.9 22.2 21.7 24.0 3.5 6.6 9.0 4.2 1.9 5.7 1.7 5.7 9.9 12.4 20.3 29.6 14.2 7.2 7.4 20.7 10.6 12.8 8.7 4.8 3.3 5.4 12.3 10.5 9.0 4.3 8.7 5.4 5.2 9.1 4.6 10.5 11.4 22.3 3.1 18.1 23.0 15.8 13.2 15.5 29.1 12.5 7.0 6.5 6.4 12.1 8.8 4.8 9.5 3.7 4.7 31.2 5.8 5.8 1.9 15.1 12.5 3.0 13.6 6.1 18.4 10.5 11.2 12.3 6.7 12.5 12.0 7.1 5.3 7.5 16.4 8.8 2.1 13.0 4.7 6.1 4.3 4.1 3.2 5.7 2.7 3.3 3.5 2.6 2.4 3.2 2.7 1.1 3.7 9.0 1.9 4.2 6.6 3.2 1.7 27.1 27.9 29.8 32.4 25.9 20.4 34.0 24.9 28.6 37.0 3.0 8.6 4.8 6.7 11.0 29.7 1.4 25.5 6.7 4.5 19.2 64.8 10.5 1.7 10.6 3.4 15.2 26.1 0.0 12.8 7.3 12.7 15.2 0.0 26.9 15.6 33.4 19.5 38.1 23.2 2.1 20.4 12.0 15.1 15.4 15.5 20.3 15.7 17.5 22.6 10.2 47.4 12.9 10.8 32.1 14.5 12.4 24.0 10.0 9.9 12.2 ZUFSP "C6orf113, dJ412I7.3" ENSG00000153975 "Zinc finger with UFM1 specific peptidase domain" Q96AP4 6 116635618-116668794 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044426 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044426: AB_10960887" "unprognostic (2.28e-3)" "unprognostic (2.45e-3)" "unprognostic (3.91e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (3.27e-1)" "unprognostic (5.88e-2)" "unprognostic (2.83e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (1.90e-3)" "unprognostic (2.54e-2)" "unprognostic (1.48e-1)" "unprognostic (7.33e-2)" "unprognostic (7.92e-3)" 8.0 8.4 8.8 9.7 14.1 19.0 9.7 18.8 14.4 7.2 10.3 7.3 5.1 16.5 7.3 7.3 11.0 6.7 9.0 5.4 10.5 8.7 9.3 11.9 10.2 12.8 14.3 8.0 5.6 9.7 6.0 18.1 8.5 11.3 8.6 9.8 5.2 8.2 7.3 6.2 10.3 13.5 6.8 10.5 12.3 8.4 9.5 11.5 15.4 7.6 7.5 13.9 8.9 8.2 11.1 11.1 17.3 11.5 9.2 12.6 7.1 4.5 4.4 10.6 19.0 6.1 8.1 7.7 10.2 9.7 10.2 12.1 7.5 5.3 16.5 8.5 6.3 11.7 7.6 12.0 7.0 13.6 9.6 12.3 12.6 6.4 13.8 9.4 14.9 15.5 7.1 11.9 8.0 14.2 7.8 8.9 12.8 22.3 8.6 13.3 7.1 7.5 11.4 7.6 7.3 4.9 9.9 8.9 6.9 11.1 4.8 8.8 10.0 7.0 6.2 6.2 9.5 3.8 11.6 7.0 6.4 4.3 3.7 8.9 7.9 10.1 16.7 5.8 9.0 9.4 17.3 8.5 8.4 8.4 9.9 9.7 11.1 9.3 9.5 11.1 10.3 10.7 7.8 3.3 9.2 11.5 7.9 12.6 7.1 8.8 14.1 18.8 14.4 10.5 8.7 14.3 8.0 11.3 11.5 6.0 3.4 2.4 12.4 11.0 8.7 0.0 5.1 8.1 7.9 0.0 7.9 9.2 0.0 0.0 1.6 5.8 6.0 0.0 0.0 7.3 6.5 10.1 10.3 5.9 6.6 11.1 5.8 3.1 6.0 0.8 2.0 10.5 1.7 0.0 5.8 9.4 0.0 6.5 1.8 0.0 7.8 0.0 7.1 15.0 18.3 12.0 7.8 10.2 5.5 11.6 ZW10 KNTC1AP ENSG00000086827 "Zw10 kinetochore protein" O43264 11 113733187-113773811 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011565, HPA051253, HPA055410" Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809" "unprognostic (4.33e-3)" "unprognostic (6.65e-2)" "prognostic favorable (2.70e-4)" "unprognostic (3.12e-1)" "unprognostic (5.51e-2)" "unprognostic (6.52e-2)" "prognostic unfavorable (8.57e-4)" "unprognostic (7.44e-2)" "unprognostic (8.01e-3)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.57e-3)" "unprognostic (6.00e-2)" "unprognostic (8.73e-2)" "unprognostic (2.95e-1)" "unprognostic (1.17e-3)" 11.8 11.4 9.0 10.4 13.5 10.7 15.2 19.8 15.2 12.5 11.4 11.2 8.6 7.8 14.0 10.5 17.2 8.9 8.0 10.3 9.9 7.6 12.2 19.6 9.6 11.7 10.3 9.9 11.9 16.8 14.9 14.4 10.4 17.0 11.4 14.3 7.9 15.2 11.0 24.1 22.9 10.7 12.2 12.5 11.7 12.0 25.0 10.9 18.6 9.4 12.4 15.8 11.8 13.1 8.3 12.3 8.6 13.2 7.3 11.8 7.2 12.2 7.8 16.0 11.3 10.4 10.8 9.3 13.8 11.7 17.5 17.7 20.2 22.7 15.3 18.2 13.8 15.9 17.1 20.2 17.2 25.0 10.5 8.3 16.2 6.9 12.3 11.0 15.7 10.0 9.2 11.3 18.6 15.1 7.9 18.0 18.2 18.6 5.7 18.3 6.3 15.2 10.8 10.1 15.9 15.6 14.2 16.7 17.3 11.5 11.8 6.4 7.6 15.6 12.9 5.7 13.3 24.0 9.3 10.1 14.6 23.5 8.1 15.2 3.4 5.6 16.2 4.8 20.3 17.0 7.4 9.5 8.6 8.8 13.2 11.8 8.3 8.3 7.6 12.3 7.2 7.9 9.4 2.7 7.3 11.1 3.6 7.3 7.2 9.0 13.5 19.8 15.2 9.9 7.6 10.3 9.9 17.0 10.9 0.0 4.5 1.5 6.9 10.8 3.0 6.5 7.6 4.0 6.8 0.0 0.0 8.2 8.3 8.1 4.8 5.5 4.0 0.0 10.5 8.6 5.6 4.7 3.5 7.4 7.9 3.2 3.5 4.3 4.9 5.9 4.6 5.0 3.3 8.2 4.1 6.4 7.8 3.5 5.3 6.2 4.1 19.4 6.6 45.9 6.1 10.9 8.8 6.9 5.6 4.7 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357228-56361275 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.6;testis: 37.1" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 87.4;Late spermatids: 149.1;Spermatocytes: 124.1;Spermatogonia: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 15.2" "Lineage enriched" "Detected in many" 5 "T-cells: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No Yes "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavorable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 1.7 3.5 3.4 14.6 3.1 18.4 3.0 0.9 2.8 3.3 9.4 1.3 2.1 6.8 2.0 4.5 14.1 1.1 6.3 1.6 2.7 1.8 4.6 2.9 2.6 12.8 2.4 3.4 1.7 2.8 2.8 1.9 7.3 1.9 1.8 11.8 1.5 4.2 1.4 0.9 5.2 8.8 3.1 2.5 9.0 6.2 37.1 0.7 35.6 1.9 12.7 17.2 3.1 4.6 1.6 1.3 0.6 2.6 2.9 15.2 3.0 39.9 31.8 22.7 25.2 1.6 2.3 18.5 29.5 22.3 35.7 32.5 56.2 24.0 20.6 11.3 10.1 16.7 20.6 31.8 22.2 33.3 52.3 16.6 20.5 25.6 26.0 0.1 33.8 27.6 1.1 1.4 33.2 13.7 4.4 17.9 27.7 27.7 25.3 31.3 32.3 29.8 21.4 16.1 27.5 39.3 30.5 44.1 11.0 11.1 17.9 21.1 12.9 27.9 63.5 7.4 13.7 41.1 33.1 9.7 15.6 40.3 16.1 45.1 22.3 10.7 35.8 22.1 42.6 19.6 0.0 0.7 0.6 2.2 2.6 0.3 1.6 5.3 3.6 1.3 0.3 6.4 3.6 0.0 2.9 2.0 1.0 15.2 3.0 3.4 3.1 0.9 2.8 2.7 1.8 2.4 3.4 1.9 0.7 3.0 1.7 4.5 4.8 16.4 1.3 0.8 5.1 1.4 3.4 5.2 0.0 36.2 0.0 9.4 58.5 2.3 7.0 46.7 11.7 87.4 2.8 1.3 0.0 3.4 41.1 0.0 0.0 9.8 8.3 149.1 4.6 7.4 6.8 2.8 11.6 1.2 6.7 11.8 2.5 4.6 1.1 0.0 0.9 124.1 125.8 7.2 19.3 7.9 22.7 2.0